Citrus Sinensis ID: 039626

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550-------560-------570-------580-------590-------600-------610-------620-------63
Protein Sequence
MAFLSFAYVLITLFILCFSSPIHAQQPYVGLATTDCNNADTTSNSNSALGYSCNGLNKSCRAYLTFRSQPPFNTVASISTLLGSEPSLLSQINSVSLETNRLVIVPVNCSCSGQYYQSNTTYTIQNGDTYLFIANNTFQGLSTCQALEDQNGSPTNLIIGAGVTVPLRCACPTENQTDEGFPFLLSYLVAEGDTVSGISSRFGVDTGEILQANSLSGSNIFPFTTLLIPLENPPTSSQTVEPPSSTPVIPPPPPANSSSEDGSNKTWIYIVAGVLGGITLTLIFGATIFCKFFYTRKKEPDSIVVSGSFQANEKPSNKKFDEESQDFLESISGVAQSLKVYSFKELQSATDNFSFTCRIQGSVYRGKINGGFAAIKKVNGDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNASLNW
Secondary Structure (PSIPRED)
cccHHHHHHHHHHHHHHHHccccccccccccccccccccccccccccccccccccccccccEEEEEccccccccHHHHHHHHcccHHHHHHHcccccccccEEEEEEEEEcccccEEEEEEEEEcccccHHHHHHHHHcccHHHHHHHHccccccccccccEEEEEEEccccccccccccccEEEEEEccccccHHHHHHHHccccccHHccccccccccccccEEEEcccccccccccccccccccccccccccccccccccccEEEEEEEHHHHHHHHHHHHHHHHHHHHHHHHccccccccccccccccccccccccccccHHHHHHccccccccccccHHHHHHHHccccccccccccEEEEEEcccEEEEEcccHHHHHHHHHHHHccccccccEEEEEEEccEEEEEEEEcccccccccccccccccccccHHHHHHHHHHHHHHHHHHHccccccEEEccccccccccccccccccccccccccccccccccccccEEEcccccccHHHHHcccccccccEEHHHHHHHHHHccccccccccccccccHHHHHHHHHccccccccccccccccccccccHHHHHHHHHHHHHHccccccccccHHHHHHHHHHHHHccccc
Secondary Structure Prediction (SSPRO)
ccHHHHHHHHHHHHHHHHHHHHHHHHHHHccccccccccccccccccccEEEEccccccccEEEEEEEccccccHHHHHHHHccccccccccccccccccEEEEEEEEccccccEEEEcEEEEEcccccEEEEEccccccccHHHHHHHHcccccccccccccEEcEEcccccccccccEEEEEEcccccccccHHHHHHHccccHHHHHHccccccccccccccccEcccccccccccccccccccccccccccccccccccccccEEEEHHHHHHHHHHHHHHHHHHHHHHHHHccccccccccccccccccccccccccccccccccccccccccEEEEHHHHHHHHccccHHHccccEEEEEEEcccEEEEEEccHHHHHHHHHHHHHHHHccEEEEEEEEccccEEEEEEEcccccHHHHHcccccccccccHHHHHHHHHHHHHHHHHHHccccccEEEEcccHcHEEEcccccEEEccccHHHcccccccccEEEEEEEcccccccHHHHHccccccHHHHHHHHHHHHHHHcccccccccccccccHHHHHHHHHHHccccHccHHHHccccHcccccHHHHHHHHHHHHHHccccHcccccHHHHHHHHHHHHHHHccc
Coil and Loop (DISEMBL)
MAFLSFAYVLITLFILCfsspihaqqpyvglattdcnnadttsnsnsalgyscnglnkSCRAYLtfrsqppfntVASISTLlgsepsllsqinsvsletnrlvivpvncscsgqyyqsnttytiqngdtYLFIANntfqglstcqaledqngsptnliigagvtvplrcacptenqtdegfPFLLSYLVAegdtvsgissrfgvdtgEILQanslsgsnifpfttlliplenpptssqtveppsstpvipppppansssedgsnktWIYIVAGVLGGITLTLIFGATIFCKFfytrkkepdsivvsgsfqanekpsnkkfdeESQDFLESISGVAQSLKVYSFKElqsatdnfsftcriqgsvyrgkiNGGFAAIKKVNGDVSKEIALLNkinhsnliilsgvcfnegncyLVYEYAVNGTLSDWvfsnknegkyldWKQRIQIALDVATglnylhsftnpphvhkdinssnvlldsDLRAKIANFAmarpaegqegefALTRhivgtkgymapeylenglvstklDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLtkedgeeslrhfidptlqgnypLELALLVIRLIDAclkkdptdrptmYEIEHSLSNILNASLNW
Flexible Loop (DISEMBL)
MAFLSFAYVLITLFILCFSSPIHAQQPYVGLATTDCNNADTTSNSNSALGYSCNGLNKSCRAYLTFRSQPPFNTVASISTLLGSEPSLLSQINSVSLETNRLVIVPVNCSCSGQYYQSNTTYTIQNGDTYLFIANNTFQGLSTCQALEDQNGSPTNLIIGAGVTVPLRCACPTENQTDEGFPFLLSYLVAEGDTVSGISSRFGVDTGEILQANSLSGSNIFPFTTLLIPLENPPTSSQTVEPPSSTPVIPPPPPANSSSEDGSNKTWIYIVAGVLGGITLTLIFGATIFCKFFYTRKKEPDSIVVSgsfqanekpsnkKFDEESQDFLESISGVAQSLKVYSFKELQSATDNFSFTCRIQGSVYRGKINGGFAAIKKVNGDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAmarpaegqegefALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSlsnilnaslnw
Low Complexity Region (SEG)
MAFLSFAYVLITLFILCFSSPIHAQQPYVGLattdcnnadttsnsnsaLGYSCNGLNKSCRAYLTFRSQPPFNTVASISTLLGSEPSLLSQINSVSLETNRLVIVPVNCSCSGQYYQSNTTYTIQNGDTYLFIANNTFQGLSTCQALEDQNGSPTNLIIGAGVTVPLRCACPTENQTDEGFPFLLSYLVAEGDTVSGISSRFGVDTGEILQANSLSGSNIFPFTTLLIPLENPPTSSQTVEppsstpvipppppansssEDGSNKTWIYIVAGVLGGITLTLIFGATIFCKFFYTRKKEPDSIVVSGSFQANEKPSNKKFDEESQDFLESISGVAQSLKVYSFKELQSATDNFSFTCRIQGSVYRGKINGGFAAIKKVNGDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNASLNW
Disordered region (IsUnstruct)
**FLSFAYVLITLFILCFSSPIHAQQPYVGLATTDCNNAD******SALGYSCNGLNKSCRAYLTFRSQPPFNTVASISTLLGSEPSLLSQINSVSLETNRLVIVPVNCSCSGQYYQSNTTYTIQNGDTYLFIANNTFQGLSTCQALEDQNGSPTNLIIGAGVTVPLRCACPTENQTDEGFPFLLSYLVAEGDTVSGISSRFGVDTGEILQANSLSGSNIFPFTTLLIPL***********************************TWIYIVAGVLGGITLTLIFGATIFCKFFYTRK*********************************ISGVAQSLKVYSFKELQSATDNFSFTCRIQGSVYRGKINGGFAAIKKVNGDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKD*******Y****************
Disordered Region (DISOPRED)
***LSFAYVLITLFILCFSSPIHAQQPYVGLATTDC*********NSALGYSCNGLNKSCRAYLTFRSQPPFNTVASISTLLGSEPSLLSQINSVSLETNRLVIVPVNCSCSGQYYQSNTTYTIQNGDTYLFIANNTFQGLSTCQALEDQNGSPTNLIIGAGVTVPLRCACPTENQTDEGFPFLLSYLVAEGDTVSGISSRFGVDTGEILQANSLSGSNIFPFTTLLIPL****************************************VAGVLGGITLTLIFGATIFCKFFY******************************************SLKVYSFKELQSATDNFSFTCRIQGSVYRGKINGGFAAIKKVNGDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAA*****ENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNA****
Disordered Region (DISEMBL)
MAFLSFAYVLITLFILCFSSPIHAQQPYVGLATTDCNNADTTSNSNSALGYSCNGLNKSCRAYLTFRSQPPFNTVASISTLLGSEPSLLSQINSVSLETNRLVIVPVNCSCSGQYYQSNTTYTIQNGDTYLFIANNTFQGLSTCQALEDQNGSPTNLIIGAGVTVPLRCACPTENQTDEGFPFLLSYLVAEGDTVSGISSRFGVDTGEILQANSLSGSNIFPFTTLLIPLEN*****************************GSNKTWIYIVAGVLGGITLTLIFGATIFCKFFYTRKKEPDSIVVSGSF***************QDFLESISGVAQSLKVYSFKELQSATDNFSFTCRIQGSVYRGKINGGFAAIKKVNGDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNASLNW
Disordered Region (DISPRO)
*AFLSFAYVLITLFILCFSSPIHAQQPYVGLATTDCNNADTTSNSNSALGYSCNGLNKSCRAYLTFRSQPPFNTVASISTLLGSEPSLLSQINSVSLETNRLVIVPVNCSCSGQYYQSNTTYTIQNGDTYLFIANNTFQGLSTCQALEDQNGSPTNLIIGAGVTVPLRCACPTENQTDEGFPFLLSYLVAEGDTVSGISSRFGVDTGEILQANSLSGSNIFPFTTLLIPLENPP******************************KTWIYIVAGVLGGITLTLIFGATIFCKFFYTRKK*************************************QSLKVYSFKELQSATDNFSFTCRIQGSVYRGKINGGFAAIKKVNGDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNA*L**
Transmembrane Helix (TMHMM)
oooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
SSSSSSSSSSSSSSSSSiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
SSSSSSSSSSSSSSSSSSSSSSSSooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Signal Peptide (SignalP HMM Mode)
SSSSSSSSSSSSSSSSSSSSSSSSSooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MAFLSFAYVLITLFILCFSSPIHAQQPYVGLATTDCNNADTTSNSNSALGYSCNGLNKSCRAYLTFRSQPPFNTVASISTLLGSEPSLLSQINSVSLETNRLVIVPVNCSCSGQYYQSNTTYTIQNGDTYLFIANNTFQGLSTCQALEDQNGSPTNLIIGAGVTVPLRCACPTENQTDEGFPFLLSYLVAEGDTVSGISSRFGVDTGEILQANSLSGSNIFPFTTLLIPLENPPTSSQTVEPPSSTPVIPPPPPANSSSEDGSNKTWIYIVAGVLGGITLTLIFGATIFCKFFYTRKKEPDSIVVSGSFQANEKPSNKKFDEESQDFLESISGVAQSLKVYSFKELQSATDNFSFTCRIQGSVYRGKINGGFAAIKKVNGDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNASLNW
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	628	2.2.26 [Sep-21-2011]
O64825	612	LysM domain receptor-like	yes	no	0.942	0.967	0.485	1e-149
O22808	664	Protein LYK5 OS=Arabidops	no	no	0.966	0.914	0.421	1e-132
A8R7E6	617	Chitin elicitor receptor	no	no	0.785	0.799	0.320	1e-64
Q9SGI7	654	Protein LYK2 OS=Arabidops	no	no	0.839	0.805	0.297	3e-62
D7UPN3	605	Chitin elicitor receptor	no	no	0.75	0.778	0.309	8e-54
F4IB81	651	LysM domain receptor-like	no	no	0.729	0.703	0.305	2e-51
P43298	942	Probable receptor protein	no	no	0.554	0.369	0.327	1e-45
C0LGE0	1014	Probable LRR receptor-lik	no	no	0.461	0.285	0.355	2e-45
Q9M0X5	675	Cysteine-rich receptor-li	no	no	0.592	0.551	0.313	4e-44
Q9LFV3	436	Probable leucine-rich rep	no	no	0.429	0.619	0.335	1e-43

>sp|O64825|LYK4_ARATH LysM domain receptor-like kinase 4 OS=Arabidopsis thaliana GN=LYK4 PE=1 SV=1

 Score =  529 bits (1362), Expect = e-149,   Method: Compositional matrix adjust.
 Identities = 311/641 (48%), Positives = 414/641 (64%), Gaps = 49/641 (7%)

Query: 3   FLSFAYVLITLFILCFSSPIHAQQPYVGLATTDCNNADTTSNSNSALGYSCNGLNKSCRA 62
            +SF++ L+   +L  SS   AQQPYVG++TTDC+ +D   N+ S  GYSCNGLNK+C+A
Sbjct: 1   MISFSFHLLVFILLSLSSFATAQQPYVGISTTDCSVSD---NTTSVFGYSCNGLNKTCQA 57

Query: 63  YLTFRSQPPFNTVASISTLLGSEPSLLSQIN----SVSLETNRLVIVPVNCSCSGQYYQS 118
           Y+ FRS P F+TV SIS+L   +PSL+S +N    S S  + + VI+P+ CSC+G   QS
Sbjct: 58  YVIFRSTPSFSTVTSISSLFSVDPSLVSSLNDASPSTSFPSGQQVIIPLTCSCTGDDSQS 117

Query: 119 NTTYTIQNGDTYLFIANNTFQGLSTCQALEDQNG-SPTNLIIGAGVTVPLRCACPTENQT 177
           N TYTIQ  D+Y  IAN+T QGLSTCQAL  QN  S  +L  G  + VP+RCACPT  Q 
Sbjct: 118 NITYTIQPNDSYFAIANDTLQGLSTCQALAKQNNVSSQSLFPGMRIVVPIRCACPTAKQI 177

Query: 178 DE-GFPFLLSYLVAEGDTVSGISSRFGVDTGEILQANSLS--GSNIFPFTTLLIPLENPP 234
           +E G  +L+SY V   DT++ IS RFGV+T + L+AN +S   S +FPFTT+LIPL NPP
Sbjct: 178 NEDGVKYLMSYTVVFEDTIAIISDRFGVETSKTLKANEMSFENSEVFPFTTILIPLVNPP 237

Query: 235 --TSSQTVEPPSSTPVIPPPPPANSSSEDGSNKTWIYIVAGVLGGITLTLIFGATIFCKF 292
             T+S    PP   P    PPP +        KTW+Y +AGVLGG  +  + GA IFC  
Sbjct: 238 ANTNSLIPPPPPPPPQSVSPPPLSPDGRKSKKKTWVYALAGVLGGALVLSVIGAAIFC-- 295

Query: 293 FYTRKKEPDSIVVSG---SFQANEKP-SNKKFDEESQDFLESISG-VAQSLKVYSFKELQ 347
              +K +  +   +G   SF   + P S+++FD      L+ +SG V +SLKVY F ELQ
Sbjct: 296 LSKKKTKTQTQEETGNLDSFMGKKPPMSDQEFDP-----LDGLSGMVVESLKVYKFHELQ 350

Query: 348 SATDNFSFTCRIQGSVYRGKINGGFAAIKKVNGDVSKEIALLNKINHSNLIILSGVCFNE 407
           SAT +F+ +  I GS Y GKING  A IKK+ G+ S+E+ LL+K+NH N+I LSG CF+E
Sbjct: 351 SATSDFTSSSSIGGSGYIGKINGDGAMIKKIEGNASEEVNLLSKLNHLNIIRLSGFCFHE 410

Query: 408 GNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKD 467
           G+ YLVYE+A NG+LS+W+ + K+    L   Q++QIALD+ATGLNYLH+F +PP+VH+D
Sbjct: 411 GDWYLVYEHASNGSLSEWIHTTKS---LLSLTQKLQIALDIATGLNYLHNFADPPYVHRD 467

Query: 468 INSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLD 527
           +NS+NV LD + RAKI +   AR       +F LT+H+ GT+GY+APEYLE+GLVSTKLD
Sbjct: 468 LNSNNVFLDLEFRAKIGSLGSARST---TEDFVLTKHVEGTRGYLAPEYLEHGLVSTKLD 524

Query: 528 VYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPL 587
           VYAFGV++LE++TGKEA+ L  E                ++G+      I   L    P 
Sbjct: 525 VYAFGVVLLEIVTGKEASELKKE---------------IDEGKAIDEILIHGRL---LPE 566

Query: 588 ELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNASLNW 628
            L   V RL+  CLKKD  +RP+M E   SLS IL A+ NW
Sbjct: 567 GLTSFVERLVVDCLKKDHLNRPSMDENVMSLSKILAATQNW 607

Lysin motif (LysM) receptor kinase that functions as a cell surface receptor in chitin elicitor (chitooligosaccharides) signaling leading to innate immunity. Recognizes microbe-derived N-acetylglucosamine (NAG)-containing ligands. Involved in the resistance to the pathogenic fungus Alternaria brassicicola and to the bacterial pathogen the bacterial pathogen Pseudomonas syringae pv tomato DC3000, probably by sensing microbe-associated molecular pattern (MAMP) and pathogen-associated molecular patterns (PAMP). May play a role in detecting peptidoglycans (e.g. PGNs) during bacterial growth.
Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|O22808|LYK5_ARATH Protein LYK5 OS=Arabidopsis thaliana GN=LYK5 PE=1 SV=1

 Score =  472 bits (1214), Expect = e-132,   Method: Compositional matrix adjust.
 Identities = 283/671 (42%), Positives = 395/671 (58%), Gaps = 64/671 (9%)

Query: 1   MAFLSFAYVLITLFILCF--SSPIHAQQPYVGLATTDCNNADTTSNSNSALGYSCNGLNK 58
           MA  +   + +TLF+L F   SP  AQQPYV      C   +     N   G++CNG   
Sbjct: 1   MAACTLHALSVTLFLLLFFAVSPAKAQQPYVNNHQLAC---EVRVYDNITNGFTCNG-PP 56

Query: 59  SCRAYLTFRSQPPFNTVASISTLLGSEPSLLSQINSVSLETNR-----LVIVPVNCSCSG 113
           SCR+YLTF SQPP+NT  SI+ LL    + +  IN++   T R     LV++P NCSCS 
Sbjct: 57  SCRSYLTFWSQPPYNTADSIAKLLNVSAAEIQSINNLPTATTRIPTRELVVIPANCSCSS 116

Query: 114 Q---YYQSNTTYTI---QNGDTYLFIANNTFQGLSTCQALEDQNG-SPTNLIIGAGVTVP 166
               +YQ N TY +   +  +TY  +AN+T+Q LSTCQA+  QN      L  G  + VP
Sbjct: 117 SSGGFYQHNATYNLSGNRGDETYFSVANDTYQALSTCQAMMSQNRYGERQLTPGLNLLVP 176

Query: 167 LRCACPTENQTDEGFPFLLSYLVAEGDTVSGISSRFGVDTGEILQANSLSGSNIFPFTTL 226
           LRCACPT  QT  GF +LL+YLVA GD++SGI+  F   +  I + N L+  NIF FT +
Sbjct: 177 LRCACPTAKQTTAGFKYLLTYLVAMGDSISGIAEMFNSTSAAITEGNELTSDNIFFFTPV 236

Query: 227 LIPLENPPTS------SQTVEPPSSTPVIPPPPPANSSSEDGSNKTWIYIVAGVLGGITL 280
           L+PL   PT              ++ P  P  PP +SSS       WIYI  G+  G+ L
Sbjct: 237 LVPLTTEPTKIVISPSPPPPPVVATPPQTPVDPPGSSSSHK-----WIYIGIGIGAGLLL 291

Query: 281 TLIFGATIFCKFFYTRKKEPDSIVVSGSFQANEKPSNKKFDEESQDFLES---------- 330
            L   A  F K    +K  P S+             NK FD  ++  + +          
Sbjct: 292 LLSILALCFYKRRSKKKSLPSSL----------PEENKLFDSSTKQSIPTTTTTQWSIDL 341

Query: 331 --------ISGVAQSLKVYSFKELQSATDNFSFTCRIQGSVYRGKINGGFAAIKKVNGDV 382
                   +    +SL +Y F +LQSAT NFS   RI+GSVYR  ING  AA+K + GDV
Sbjct: 342 SNSSEAFGLKSAIESLTLYRFNDLQSATSNFSDENRIKGSVYRATINGDDAAVKVIKGDV 401

Query: 383 SK-EIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQR 441
           S  EI LL K+NHSN+I LSG C  EG  YLV+EY+ NG++SDW+ S+    K L WKQR
Sbjct: 402 SSSEINLLKKLNHSNIIRLSGFCIREGTSYLVFEYSENGSISDWLHSSGK--KSLTWKQR 459

Query: 442 IQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFAL 501
           ++IA DVA  L+YLH++  PPH+HK++ S+N+LLDS+ RAKIANF +AR  +  + +  L
Sbjct: 460 VEIARDVAEALDYLHNYITPPHIHKNLESTNILLDSNFRAKIANFGVARILDEGDLDLQL 519

Query: 502 TRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMH----LS 557
           TRH+ GT+GY+APEY+ENG++++KLDV+AFGV +LE+L+G+EA  +H ++        L 
Sbjct: 520 TRHVEGTQGYLAPEYVENGVITSKLDVFAFGVAVLELLSGREAVTIHKKKEGEEEVEMLC 579

Query: 558 DVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHS 617
            V+N+VL  E+  E L+ F+DP+L   YPLELA  + +L  +C+  D   RP++ ++  +
Sbjct: 580 KVINSVLGGENVREKLKEFMDPSLGNEYPLELAYTMAQLAKSCVATDLNSRPSVTQVLTT 639

Query: 618 LSNILNASLNW 628
           LS I+++S++W
Sbjct: 640 LSMIVSSSIDW 650

May recognize microbe-derived N-acetylglucosamine (NAG)-containing ligands.

Arabidopsis thaliana (taxid: 3702)

>sp|A8R7E6|CERK1_ARATH Chitin elicitor receptor kinase 1 OS=Arabidopsis thaliana GN=CERK1 PE=1 SV=1

 Score =  248 bits (633), Expect = 1e-64,   Method: Compositional matrix adjust.
 Identities = 180/561 (32%), Positives = 290/561 (51%), Gaps = 68/561 (12%)

Query: 97  LETNRLVIVPVNCSCS-GQYYQSNTTYTIQNGDTYLFIANNTFQGLSTCQALEDQNGSP- 154
           ++    V+VP  C C  G +   N +Y+++  DTY  +A + +  L+T ++L+ +N  P 
Sbjct: 79  IQMGSRVLVPFPCECQPGDFLGHNFSYSVRQEDTYERVAISNYANLTTMESLQARNPFPA 138

Query: 155 TNLIIGAGVTVPLRCACPTENQTDEGFPFLLSYLVAEGDTVSGISSRFGVDTGEILQ--- 211
           TN+ + A + V + C+C  E+ + + F   ++Y +   D++S I+   GV + +ILQ   
Sbjct: 139 TNIPLSATLNVLVNCSCGDESVSKD-FGLFVTYPLRPEDSLSSIARSSGV-SADILQRYN 196

Query: 212 --ANSLSGSNIFPFTTLLIPLENPPTSSQTVEPPSSTPVIPPPPPANSSSEDGSNKTWIY 269
              N  SG+ I     + +P  +P  +                PP  SS +DG       
Sbjct: 197 PGVNFNSGNGI-----VYVPGRDPNGAF---------------PPFKSSKQDGVGAG--- 233

Query: 270 IVAGVLGGITLTLIFGATIFCKFFYTRKKEPDSIVVSGSFQANEKPSNKKFDEESQDFLE 329
           ++AG++ G+ + L+    +F  ++  RK +      S S      P + K D  S   L+
Sbjct: 234 VIAGIVIGVIVALLL--ILFIVYYAYRKNKSKGDSFSSSI-----PLSTKADHASSTSLQ 286

Query: 330 S-----------ISGVAQSLKV-YSFKELQSATDNFSFTCRIQ----GSVYRGKINGGFA 373
           S           I+ ++    V +S +EL  ATDNF+ + +I     G+VY  ++ G  A
Sbjct: 287 SGGLGGAGVSPGIAAISVDKSVEFSLEELAKATDNFNLSFKIGQGGFGAVYYAELRGEKA 346

Query: 374 AIKKVNGDVSK----EIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSN 429
           AIKK++ + SK    E+ +L +++H NL+ L G C  EG+ +LVYEY  NG L   +  +
Sbjct: 347 AIKKMDMEASKQFLAELKVLTRVHHVNLVRLIGYCV-EGSLFLVYEYVENGNLGQHLHGS 405

Query: 430 KNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMA 489
             E   L W +R+QIALD A GL Y+H  T P +VH+DI S+N+L+D   RAK+A+F + 
Sbjct: 406 GREP--LPWTKRVQIALDSARGLEYIHEHTVPVYVHRDIKSANILIDQKFRAKVADFGLT 463

Query: 490 RPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHA 549
           +  E      + TR  +GT GYMAPE +  G VS K+DVYAFGV++ E+++ K A     
Sbjct: 464 KLTEVGG---SATRGAMGTFGYMAPETV-YGEVSAKVDVYAFGVVLYELISAKGAVVKMT 519

Query: 550 EENN--MHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTD 607
           E       L  V      + D EE+LR  IDP L  +YP +    +  L  AC +++   
Sbjct: 520 EAVGEFRGLVGVFEESFKETDKEEALRKIIDPRLGDSYPFDSVYKMAELGKACTQENAQL 579

Query: 608 RPTMYEIEHSLSNILNASLNW 628
           RP+M  I  +LS + +++ NW
Sbjct: 580 RPSMRYIVVALSTLFSSTGNW 600

Lysin motif (LysM) receptor kinase that functions as a cell surface receptor in chitin elicitor (chitooligosaccharides) signaling leading to innate immunity toward both biotic and abiotic stresses (e.g. tolerance to salinity, heavy-metal stresses, and Botrytis cinerea infection). Recognizes microbe-derived N-acetylglucosamine (NAG)-containing ligands. Involved in the resistance to pathogenic fungi Alternaria brassicicola and Erysiphe cichoracearum, probably by sensing microbe-associated molecular patterns (MAMP) and pathogen-associated molecular patterns (PAMP). Plays an essential role in detecting peptidoglycans (e.g. PGNs) and restricting bacterial growth. Target of the bacterial type III effector E3-ligase protein hopAB2/avrPtoB of Pseudomonas syringae pv. tomato DC3000 that mediates ubiquitination and subsequent proteolysis, thus blocking all defense responses by suppressing PAMP-triggered immunity (PTI).

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SGI7|LYK2_ARATH Protein LYK2 OS=Arabidopsis thaliana GN=LYK2 PE=2 SV=1

 Score =  240 bits (612), Expect = 3e-62,   Method: Compositional matrix adjust.
 Identities = 186/625 (29%), Positives = 307/625 (49%), Gaps = 98/625 (15%)

Query: 47  SALGYSCNGLNKSCRAYLTFRSQPPFNTVASISTLLGSEPSLLSQINSVSLETNRLVIVP 106
           S+ GY C+   + C  +   R++PPF +++ +S  LG +       +   +   +L+++P
Sbjct: 44  SSFGYVCHSNLQKCHTFAILRAKPPFYSLSDLSRHLGLDA------DDEYVPKGQLLLIP 97

Query: 107 VNCSCSGQYYQSNTTYTIQNGDTYLFIANNTFQGLSTCQALEDQNGSPTNLIIGAGVTVP 166
           + C C+G  Y+++       GDT+  ++  + QGL+TC ++ ++N   +   +G  + + 
Sbjct: 98  IECRCNGSIYEASLIKNCVKGDTFRSVSQ-SLQGLTTCLSIREKNPHISEDKLGDNIKLR 156

Query: 167 L--RCACPTENQTDEGFPFLLSYLVAEGDTVSGISSRFGVDTGEILQANSLSGSNIFPFT 224
           L  RC+CP E  ++  F  L++Y V   D+VS ++ RF      I+ AN+ SG  + P  
Sbjct: 157 LAIRCSCPQEGVSNASF--LVTYPVGVRDSVSSLAVRFNTTEDAIVSANNKSG--VVPLK 212

Query: 225 TLLIPLENPPTSSQTVEPPSSTPVIPPPPPANSSSEDGSNKTWIYI---VAGVLGGITLT 281
             LIPL++ P      E   S    P      S  +    K  I +   +AGV G +TL 
Sbjct: 213 PALIPLDHKP------EKQGSRKRNP------SKKKRSKMKLMIAVSSAIAGVCGLVTL- 259

Query: 282 LIFGATIFCKFF--------YTRKKEPDSIVVSGSFQANEKPSNKKFD-EESQD--FLES 330
           ++FG   + K          +   K+P++  +S S +     S+KK   E SQD   L+S
Sbjct: 260 MVFGYLHWKKETQIQTQTQKWISNKDPETRQLSLSIRTT---SDKKISFEGSQDGSILDS 316

Query: 331 ISGVAQS------LKVYSFKELQSATDNFSFTCRIQGSVYRGKINGGFAAIKKVNGDVSK 384
            + V  +      L++Y+F+EL+ AT+NFS +  I+GSVY G + G   AIK+VN D  K
Sbjct: 317 HNTVGTTTPRKPVLEIYAFEELEKATENFSSSNHIKGSVYFGSLKGKDLAIKQVNADEMK 376

Query: 385 --EIALLNKINH---SNLIILSGVCFNE--GNCYLVYEYAVNGTLSDWVFSNKNEGK--- 434
             +  LLN  +H    N+I + G CF E   + YLV+EYA NG+L DW+  NK   K   
Sbjct: 377 RFDFGLLNDQSHYYNHNVIRVLGTCFREIDQDSYLVFEYARNGSLWDWI-QNKLAIKNQF 435

Query: 435 ------YLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAM 488
                 +L WKQRI+I  DVA  L Y+H      +VH +I S N+ L+ DLR K+ NF M
Sbjct: 436 IESCYCFLAWKQRIKICHDVAIALKYMHRIN---YVHGNIKSRNIFLNEDLRGKVGNFGM 492

Query: 489 ARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGK------ 542
           ++                 T      E L    +S   D++A+G++++E+L+G+      
Sbjct: 493 SKCV---------------TNELATEENLIESSLSPASDIFAYGIIVMEVLSGQTPDMLL 537

Query: 543 -----EAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLI 597
                E  +L  +E  +     L  +L     +E LR  +D TL  +Y ++ A  +  + 
Sbjct: 538 GLQEVETTSLGTQETFVSEWSRLRRLL---GDKEKLREVMDSTLGESYSVDSAFEIASIA 594

Query: 598 DACLKKDPTDRPTMYEIEHSLSNIL 622
             C  ++   RP+  EI   +S ++
Sbjct: 595 RDCTAEEAESRPSAVEIAERVSRLV 619

May recognize microbe-derived N-acetylglucosamine (NAG)-containing ligands.

Arabidopsis thaliana (taxid: 3702)

>sp|D7UPN3|CERK1_ORYSJ Chitin elicitor receptor kinase 1 OS=Oryza sativa subsp. japonica GN=CERK1 PE=1 SV=1

 Score =  212 bits (539), Expect = 8e-54,   Method: Compositional matrix adjust.
 Identities = 171/553 (30%), Positives = 267/553 (48%), Gaps = 82/553 (14%)

Query: 99  TNRLVIVPVNCSCSGQYYQSNTTYTIQ-----------NGDTYLFIANNTFQGLSTCQAL 147
           T   V+VP  CSC G      +T+               GDTY  +A N +  L+T   L
Sbjct: 77  TGDRVLVPFPCSCLGLPAAPASTFLAGAIPYPLPLPRGGGDTYDAVAAN-YADLTTAAWL 135

Query: 148 EDQNGSPTNLIIGAG--VTVPLRCACPTENQTDEGFPFLLSYLVAEGDTVSGISSRFGVD 205
           E  N  P   I G    V V + C+C  E  +   +   L+Y + +G+T+  +++++G  
Sbjct: 136 EATNAYPPGRIPGGDGRVNVTINCSCGDERVSPR-YGLFLTYPLWDGETLESVAAQYGFS 194

Query: 206 TGEILQ--------ANSLSGSNIFPFTTLLIPLENPPTSSQTVEPPSSTPVIPPPPPANS 257
           +   ++           +SG  I     + IP+++P  S                 P  S
Sbjct: 195 SPAEMELIRRYNPGMGGVSGKGI-----VFIPVKDPNGSYH---------------PLKS 234

Query: 258 SSEDGSNKTWIYIVAGVLGGITLTLI--FGATIFCKFFYTRKKEPDSIVVSGSFQANEKP 315
                S      +  G + GI +  I  F   I+    + R ++          +A  +P
Sbjct: 235 GGMGNS------LSGGAIAGIVIACIAIFIVAIWLIIMFYRWQK--------FRKATSRP 280

Query: 316 SNKK---FDEESQDFLESISGVAQSLKVYSFKELQSATDNFSFTCRIQ----GSVYRGKI 368
           S ++    D+ SQ   E I  V +S++ +S++E+ +AT  FS   +I     GSVY  ++
Sbjct: 281 SPEETSHLDDASQ--AEGIK-VERSIE-FSYEEIFNATQGFSMEHKIGQGGFGSVYYAEL 336

Query: 369 NGGFAAIKKVNGDVSKE----IALLNKINHSNLIILSGVCFNEGNC-YLVYEYAVNGTLS 423
            G   AIKK+    ++E    + +L  ++H NL+ L G C    NC +LVYE+  NG LS
Sbjct: 337 RGEKTAIKKMGMQATQEFLAELKVLTHVHHLNLVRLIGYCVE--NCLFLVYEFIDNGNLS 394

Query: 424 DWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKI 483
             +   +     L W  R+QIALD A GL YLH    P +VH+DI S+N+LLD D RAKI
Sbjct: 395 QHL--QRTGYAPLSWATRVQIALDSARGLEYLHEHVVPVYVHRDIKSANILLDKDFRAKI 452

Query: 484 ANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKE 543
           A+F +A+  E      +L+  + GT GYM PE    G VS K+DVYAFGV++ E+L+ K+
Sbjct: 453 ADFGLAKLTEVGSMSQSLSTRVAGTFGYMPPE-ARYGEVSPKVDVYAFGVVLYELLSAKQ 511

Query: 544 A--AALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACL 601
           A   +  +   +  L  +    L+  +  E+L   IDP+LQG+YP++ AL +  L  +C 
Sbjct: 512 AIVRSSESVSESKGLVFLFEEALSAPNPTEALDELIDPSLQGDYPVDSALKIASLAKSCT 571

Query: 602 KKDPTDRPTMYEI 614
            ++P  RPTM  +
Sbjct: 572 HEEPGMRPTMRSV 584

Plays an essential role in detecting peptidoglycans (e.g. PGNs) and restricting bacterial growth. Recognizes microbe-derived N-acetylglucosamine (NAG)-containing ligands (By similarity). Lysin motif (LysM) receptor kinase required as a cell surface receptor for chitin elicitor (chitooligosaccharides) signaling leading to innate immunity in response to both biotic and abiotic stresses. Involved in the resistance to pathogenic fungi, probably by sensing microbe-associated molecular patterns (MAMP) and pathogen-associated molecular patterns (PAMP).

Oryza sativa subsp. japonica (taxid: 39947)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|F4IB81|LYK3_ARATH LysM domain receptor-like kinase 3 OS=Arabidopsis thaliana GN=LYK3 PE=2 SV=1

 Score =  204 bits (519), Expect = 2e-51,   Method: Compositional matrix adjust.
 Identities = 160/523 (30%), Positives = 256/523 (48%), Gaps = 65/523 (12%)

Query: 160 GAGVTVPLRCACPTENQTDEGFPFLLSYLVAEGDTVSGISSRFGV------DTGEILQAN 213
           GA V+V L C C +       + +L+SY+   GD+V  +SSRFGV      D   IL  +
Sbjct: 122 GAVVSVQLLCGCSSGL-----WNYLMSYVAMAGDSVQSLSSRFGVSMDRIEDVNGILNLD 176

Query: 214 SLSGSNIFPFTTLLIPLENPPTSSQTVEPPSSTPVIP------PPPPANSSSEDGSNKTW 267
           +++  ++       +P E   TS      PS  P              N +++ GS+  +
Sbjct: 177 NITAGDLLYIPLDSVPGEPYETSKINPPAPSPAPASSLANGNISDDQVNHTAKSGSHVPY 236

Query: 268 IYIVAGVLGGITLTLIFGATIFC-KFFYTRKKEPDS-------------IVVSGSFQANE 313
           I+IV G+   + L ++      C +       E D                 SG +    
Sbjct: 237 IWIVGGLGVVLALLVLCILVCICLRSSSCSSSEEDGNGHNFQILRKSGFFCGSGRYNCCR 296

Query: 314 KPSNKKFDEESQDFLESISGVAQSL----------KVYSFKELQSATDNFSFTCRI---- 359
               ++ + E+Q     +  + ++L           V++++E+++ATD FS +  +    
Sbjct: 297 SGDFRQTNGETQ-----VVAIPKALGDGMFEIEKPMVFTYEEIRAATDEFSDSNLLGHGN 351

Query: 360 QGSVYRGKINGGFAAIKKVNGDVSKEIA----LLNKINHSNLIILSGVCFNEGNCYLVYE 415
            GSVY G +     A+K++    +KE A    +L K++HSNL+ L G        ++VYE
Sbjct: 352 YGSVYFGLLREQEVAVKRMTATKTKEFAAEMKVLCKVHHSNLVELIGYAATVDELFVVYE 411

Query: 416 YAVNGTLSDWVFSNKNEGKY-LDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVL 474
           Y   G L   +   +++G   L W  R QIALD A GL Y+H  T   +VH+DI +SN+L
Sbjct: 412 YVRKGMLKSHLHDPQSKGNTPLSWIMRNQIALDAARGLEYIHEHTKTHYVHRDIKTSNIL 471

Query: 475 LDSDLRAKIANFAMARPAEGQ-EGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGV 533
           LD   RAKI++F +A+  E   EGE ++T+ +VGT GY+APEYL +GL ++K D+YAFGV
Sbjct: 472 LDEAFRAKISDFGLAKLVEKTGEGEISVTK-VVGTYGYLAPEYLSDGLATSKSDIYAFGV 530

Query: 534 LILEMLTGKEA-----AALHAEENNMHLSDVLNAVLTKEDGE---ESLRHFIDPTLQGNY 585
           ++ E+++G+EA     A          L+ ++ AVL          SL+ F+DP +   Y
Sbjct: 531 VLFEIISGREAVIRTEAIGTKNPERRPLASIMLAVLKNSPDSMNMSSLKEFVDPNMMDLY 590

Query: 586 PLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNASLNW 628
           P +    +  L   C+  DP  RP M ++  SLS IL +S+ W
Sbjct: 591 PHDCLFKIATLAKQCVDDDPILRPNMKQVVISLSQILLSSIEW 633

Putative Lysin motif (LysM) receptor kinase that may recognize microbe-derived N-acetylglucosamine (NAG)-containing ligands.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|P43298|TMK1_ARATH Probable receptor protein kinase TMK1 OS=Arabidopsis thaliana GN=TMK1 PE=2 SV=1

 Score =  185 bits (469), Expect = 1e-45,   Method: Compositional matrix adjust.
 Identities = 128/391 (32%), Positives = 198/391 (50%), Gaps = 43/391 (10%)

Query: 270 IVAGVLGGITLTLIFGATIFCKFFYTRKK---------------------EPDSIVVSGS 308
           IV  VLGG+    + G  +FC +   +K+                     E   I V+GS
Sbjct: 484 IVGSVLGGLLSIFLIGLLVFCWYKKRQKRFSGSESSNAVVVHPRHSGSDNESVKITVAGS 543

Query: 309 FQANEKPSNKKFDEESQDFLESISGVAQSLKVYSFKELQSATDNFSFTCRIQGS-----V 363
             +    S+      + +  ++I  V     + S + L+S T+NFS +  I GS     V
Sbjct: 544 SVSVGGISDTYTLPGTSEVGDNIQMVEAGNMLISIQVLRSVTNNFS-SDNILGSGGFGVV 602

Query: 364 YRGKINGGFA-AIKKVNGDV---------SKEIALLNKINHSNLIILSGVCFNEGNCYLV 413
           Y+G+++ G   A+K++   V           EIA+L K+ H +L+ L G C +     LV
Sbjct: 603 YKGELHDGTKIAVKRMENGVIAGKGFAEFKSEIAVLTKVRHRHLVTLLGYCLDGNEKLLV 662

Query: 414 YEYAVNGTLSDWVFSNKNEG-KYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSN 472
           YEY   GTLS  +F    EG K L WKQR+ +ALDVA G+ YLH   +   +H+D+  SN
Sbjct: 663 YEYMPQGTLSRHLFEWSEEGLKPLLWKQRLTLALDVARGVEYLHGLAHQSFIHRDLKPSN 722

Query: 473 VLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFG 532
           +LL  D+RAK+A+F + R A   EG+ ++   I GT GY+APEY   G V+TK+DVY+FG
Sbjct: 723 ILLGDDMRAKVADFGLVRLAP--EGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVYSFG 780

Query: 533 VLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQ-GNYPLELAL 591
           V+++E++TG+++      E ++HL      +   +  E S +  ID T+      L    
Sbjct: 781 VILMELITGRKSLDESQPEESIHLVSWFKRMYINK--EASFKKAIDTTIDLDEETLASVH 838

Query: 592 LVIRLIDACLKKDPTDRPTMYEIEHSLSNIL 622
            V  L   C  ++P  RP M    + LS+++
Sbjct: 839 TVAELAGHCCAREPYQRPDMGHAVNILSSLV 869

Probable receptor.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGE0|Y1765_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g07650 OS=Arabidopsis thaliana GN=At1g07650 PE=1 SV=1

 Score =  184 bits (467), Expect = 2e-45,   Method: Compositional matrix adjust.
 Identities = 110/309 (35%), Positives = 171/309 (55%), Gaps = 19/309 (6%)

Query: 319 KFDEESQDFLESISGVAQSLKVYSFKELQSATDNFSFTCRIQ----GSVYRGKIN-GGFA 373
           K   +  D  + + G+      ++ +++++ATDNF  T +I     GSVY+G+++ G   
Sbjct: 644 KKRRDKNDIDKELRGLDLQTGTFTLRQIKAATDNFDVTRKIGEGGFGSVYKGELSEGKLI 703

Query: 374 AIKKV-------NGDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWV 426
           A+K++       N +   EI +++ + H NL+ L G C       LVYEY  N  LS  +
Sbjct: 704 AVKQLSAKSRQGNREFVNEIGMISALQHPNLVKLYGCCVEGNQLILVYEYLENNCLSRAL 763

Query: 427 FSNKNEGKY-LDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIAN 485
           F      +  LDW  R +I L +A GL +LH  +    VH+DI +SNVLLD DL AKI++
Sbjct: 764 FGKDESSRLKLDWSTRKKIFLGIAKGLTFLHEESRIKIVHRDIKASNVLLDKDLNAKISD 823

Query: 486 FAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAA 545
           F +A+  +  +G   ++  I GT GYMAPEY   G ++ K DVY+FGV+ LE+++GK   
Sbjct: 824 FGLAKLND--DGNTHISTRIAGTIGYMAPEYAMRGYLTEKADVYSFGVVALEIVSGKSNT 881

Query: 546 ALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDP 605
                E+ ++L D   A + +E G  SL   +DPTL  +Y  E A+L++ +   C    P
Sbjct: 882 NFRPTEDFVYLLDW--AYVLQERG--SLLELVDPTLASDYSEEEAMLMLNVALMCTNASP 937

Query: 606 TDRPTMYEI 614
           T RPTM ++
Sbjct: 938 TLRPTMSQV 946

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9M0X5|CRK25_ARATH Cysteine-rich receptor-like protein kinase 25 OS=Arabidopsis thaliana GN=CRK25 PE=2 SV=1

 Score =  179 bits (455), Expect = 4e-44,   Method: Compositional matrix adjust.
 Identities = 131/418 (31%), Positives = 215/418 (51%), Gaps = 46/418 (11%)

Query: 213 NSLSGSNIFP---FTTLLIPLENPPTSSQTVEPPSSTPVIPPPPPANSSSEDGSNKTWIY 269
            S+ G  I P   F   L P  N   ++  + PP S+ V  PP   N  SE G  K    
Sbjct: 227 RSVGGRVIAPSCSFRYELYPFYNETIAAAPMAPPPSSTVTAPP--LNIPSEKGKGKNLTV 284

Query: 270 IVAGVLGGITL-TLIFGATIFCKFFYTRKKEPDSIVVSGSFQANEKPSNKKFDEESQDFL 328
           IV  +   +++  L+ GA   C     R+                   N K   E++D  
Sbjct: 285 IVTAIAVPVSVCVLLLGA--MCWLLARRR-------------------NNKLSAETEDLD 323

Query: 329 ESISGVAQSLKVYSFKELQSATDNFSFTCRIQ----GSVYRGK-INGGFAAIKKVNG--- 380
           E      ++L+ + F  +++AT+ FS + ++     G VY+G+ I G   AIK+++    
Sbjct: 324 EDGITSTETLQ-FQFSAIEAATNKFSESNKLGHGGFGEVYKGQLITGETVAIKRLSQGST 382

Query: 381 ----DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYL 436
               +   E+ ++ K+ H NL  L G C +     LVYE+  N +L  ++F N+   + L
Sbjct: 383 QGAEEFKNEVDVVAKLQHRNLAKLLGYCLDGEEKILVYEFVPNKSLDYFLFDNEKR-RVL 441

Query: 437 DWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQE 496
           DW++R +I   +A G+ YLH  +    +H+D+ +SN+LLD+D+  KI++F MAR   G +
Sbjct: 442 DWQRRYKIIEGIARGILYLHRDSRLTIIHRDLKASNILLDADMHPKISDFGMAR-IFGVD 500

Query: 497 GEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHL 556
              A T+ IVGT GYM+PEY  +G  S K DVY+FGVL+LE++TGK+ ++ + E+    L
Sbjct: 501 QTQANTKRIVGTYGYMSPEYAIHGKYSVKSDVYSFGVLVLELITGKKNSSFYEEDG---L 557

Query: 557 SDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEI 614
            D++  V  K   E S    +D  ++GN+     +  I +   C+++D ++RP+M +I
Sbjct: 558 GDLVTYVW-KLWVENSPLELVDEAMRGNFQTNEVIRCIHIALLCVQEDSSERPSMDDI 614

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9LFV3|Y5157_ARATH Probable leucine-rich repeat receptor-like serine/threonine-protein kinase At5g15730 OS=Arabidopsis thaliana GN=At5g15730 PE=2 SV=1

 Score =  178 bits (451), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 104/310 (33%), Positives = 178/310 (57%), Gaps = 40/310 (12%)

Query: 320 FDEESQDFLESISGVAQSLKVYSFKELQSATDNFSFTCRIQGS---VYRGKINGGFAAIK 376
           ++  ++D   S SG+ +    Y++K++Q AT NF+ T   QGS   VY+  +  G  A  
Sbjct: 87  WNNHTKDLTVSASGIPR----YNYKDIQKATQNFT-TVLGQGSFGPVYKAVMPNGELAAA 141

Query: 377 KVNG--------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFS 428
           KV+G        +   E++LL +++H NL+ L+G C ++ +  L+YE+  NG+L + ++ 
Sbjct: 142 KVHGSNSSQGDREFQTEVSLLGRLHHRNLVNLTGYCVDKSHRMLIYEFMSNGSLENLLYG 201

Query: 429 NKNEG-KYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFA 487
              EG + L+W++R+QIALD++ G+ YLH    PP +H+D+ S+N+LLD  +RAK+A+F 
Sbjct: 202 G--EGMQVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHSMRAKVADFG 259

Query: 488 MARPAEGQEGEFALTRH---IVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEA 544
           +++       E  L R    + GT GYM P Y+     + K D+Y+FGV+ILE++T    
Sbjct: 260 LSK-------EMVLDRMTSGLKGTHGYMDPTYISTNKYTMKSDIYSFGVIILELIT---- 308

Query: 545 AALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKD 604
            A+H ++N   L + +N      DG   +   +D  L GN  +E   L+ ++ + C+ K 
Sbjct: 309 -AIHPQQN---LMEYINLASMSPDG---IDEILDQKLVGNASIEEVRLLAKIANRCVHKT 361

Query: 605 PTDRPTMYEI 614
           P  RP++ E+
Sbjct: 362 PRKRPSIGEV 371

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	628
255585146	647	BRASSINOSTEROID INSENSITIVE 1-associated	0.990	0.961	0.639	0.0
224096894	643	predicted protein [Populus trichocarpa]	0.985	0.962	0.652	0.0
225430870	638	PREDICTED: wall-associated receptor kina	0.984	0.968	0.651	0.0
297735221	1305	unnamed protein product [Vitis vinifera]	0.945	0.455	0.636	0.0
224133922	630	predicted protein [Populus trichocarpa]	0.958	0.955	0.656	0.0
134032232	630	LysM-domain containing receptor-like kin	0.976	0.973	0.599	0.0
356540724	634	PREDICTED: probable receptor-like protei	0.974	0.965	0.573	0.0
356496806	633	PREDICTED: probable receptor-like protei	0.972	0.965	0.568	0.0
290490578	633	LysM type receptor kinase [Lotus japonic	0.961	0.954	0.563	0.0
290490598	633	LysM type receptor kinase [Lotus japonic	0.961	0.954	0.561	0.0

>gi|255585146|ref|XP_002533278.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis] gi|223526903|gb|EEF29110.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis]

 Score =  807 bits (2084), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 408/638 (63%), Positives = 497/638 (77%), Gaps = 16/638 (2%)

Query: 1   MAFLS-FAYVLITLFILCFSSPIHAQQPYVGLATTDCNNADTTSNSNSALGYSCNGLNKS 59
           M F+S F+   +++F+      IHAQQPYV  ATT+C N      ++SALGYSCNGLN S
Sbjct: 1   MGFISAFSLFFLSIFLAFCCLLIHAQQPYVAKATTNCTNT-----ADSALGYSCNGLNTS 55

Query: 60  CRAYLTFRSQPPFNTVASISTLLGSEPSLLSQINSVS----LETNRLVIVPVNCSCSGQY 115
           C+ YLTFRSQPP+  V SISTLL S+PS LS INSVS     +TN+LVIVPVNCSCSG Y
Sbjct: 56  CQTYLTFRSQPPYTNVTSISTLLNSDPSQLSAINSVSETATFDTNKLVIVPVNCSCSGDY 115

Query: 116 YQSNTTYTIQNGDTYLFIANNTFQGLSTCQALEDQNGSPT-NLIIGAGVTVPLRCACPTE 174
           YQ+NT+Y +Q  D   FIANNTFQGLSTCQA+ DQN   T ++     + +PLRCACPT+
Sbjct: 116 YQANTSYVVQAKDAPFFIANNTFQGLSTCQAINDQNRRQTVDIFPNEILHIPLRCACPTK 175

Query: 175 NQTDEGFPFLLSYLVAEGDTVSGISSRFGVDTGEILQANSLSGSN--IFPFTTLLIPLEN 232
           NQTD G  +LLSYLV  GDTVS +S +FG +TG  L+AN LS     I+PFTTLLIPLEN
Sbjct: 176 NQTDAGIKYLLSYLVTWGDTVSAVSVKFGGNTGRSLEANGLSEQTPTIYPFTTLLIPLEN 235

Query: 233 PPTSSQTVEPPSSTPVIPPPPPANSSSEDGSN-KTWIYIVAGVLGGITLTLIFGATIFCK 291
           PPTS+QT+ PP      PPPPP+  +  +GS+ K W+Y++ GVL GI  TL     IF  
Sbjct: 236 PPTSNQTISPPPPPASSPPPPPSTDTPNNGSSSKKWVYVLVGVLAGIVFTLGLVTIIFYA 295

Query: 292 FFYTRKKEPDSIVVSGSFQANEKPSNKKFDEESQDFLESISGVAQSLKVYSFKELQSATD 351
            F   K++P+ I+VS SF+A EK  NKK DEESQDFL+SIS +AQS+KVY FKEL++ATD
Sbjct: 296 LFRRSKRKPEPIIVSESFEAQEKSLNKKLDEESQDFLDSISSIAQSIKVYKFKELEAATD 355

Query: 352 NFSFTCRIQGSVYRGKINGGFAAIKKVNGDVSKEIALLNKINHSNLIILSGVCFNEGNCY 411
           NFS +C I+GSVYRG I+G +AAIKKVNGDVSKEI LLNK+NH NLI LSGVCF+ G+ Y
Sbjct: 356 NFSPSCWIKGSVYRGYISGDYAAIKKVNGDVSKEIELLNKVNHFNLIRLSGVCFSGGHWY 415

Query: 412 LVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSS 471
           LVYEYA NG LSDW++ + NEG +L W QR+QIALDVATGLNYLHSFT+PPH+HKDI SS
Sbjct: 416 LVYEYAANGALSDWIYYSNNEGNFLSWTQRVQIALDVATGLNYLHSFTSPPHIHKDIKSS 475

Query: 472 NVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAF 531
           NVL+DSD RAKIAN AMAR  EGQ+GEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAF
Sbjct: 476 NVLIDSDFRAKIANLAMARSTEGQDGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAF 535

Query: 532 GVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELAL 591
           G+L+LEM+TGKE AAL+ EE N++LSD+LN VL+KEDG++SL+ F+DP+++ N+P E++L
Sbjct: 536 GILMLEMVTGKEVAALYTEE-NLNLSDILNDVLSKEDGQQSLKQFVDPSMEENFPSEISL 594

Query: 592 -LVIRLIDACLKKDPTDRPTMYEIEHSLSNILNASLNW 628
            +++R+ID+CL K+P DRP M EI  SLS IL  SL+W
Sbjct: 595 FMMVRMIDSCLNKNPADRPAMDEISQSLSRILTDSLSW 632

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224096894|ref|XP_002310777.1| predicted protein [Populus trichocarpa] gi|222853680|gb|EEE91227.1| predicted protein [Populus trichocarpa]

 Score =  803 bits (2073), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 415/636 (65%), Positives = 493/636 (77%), Gaps = 17/636 (2%)

Query: 4   LSFAYVL--ITLFILCFSSPIHAQQPYVGLATTDCNNADTTSNSNSALGYSCNGLNKSCR 61
           +SF  V+    LFIL   S I AQQPYVG  TT C+N +     NSALGYSCNGLNKSC+
Sbjct: 1   MSFRSVVSPFALFILYCCSLIQAQQPYVGKGTTKCSNTE-----NSALGYSCNGLNKSCQ 55

Query: 62  AYLTFRSQPPFNTVASISTLLGSEPSLLSQINSVS----LETNRLVIVPVNCSCSGQYYQ 117
           AYL FRSQPP++TVASISTLLGS+PS LSQINSVS      TN+LV+VPVNCSCSG Y+Q
Sbjct: 56  AYLIFRSQPPYSTVASISTLLGSDPSQLSQINSVSETTSFPTNQLVLVPVNCSCSGDYFQ 115

Query: 118 SNTTYTIQNGDTYLFIANNTFQGLSTCQALEDQNGSPT-NLIIGAGVTVPLRCACPTENQ 176
           +N +Y +Q+G+T   IANNT+QGLSTCQA+ ++ G+ T N+  G  +TVPLRCACPT+NQ
Sbjct: 116 ANASYIVQSGNTPFLIANNTYQGLSTCQAIRNEKGTRTVNIFAGETLTVPLRCACPTKNQ 175

Query: 177 TDEGFPFLLSYLVAEGDTVSGISSRFGVDTGEILQANSLSGSN--IFPFTTLLIPLENPP 234
           +D G  +LLSYLV  GDTVS    RFG D G  L+AN +S  N  I+PFTTLLIPL+NPP
Sbjct: 176 SDLGIRYLLSYLVTWGDTVSIAGVRFGADIGRALEANEISEKNPTIYPFTTLLIPLKNPP 235

Query: 235 TSSQTVEPPSSTPVIPPPPPANSSSEDGS-NKTWIYIVAGVLGGITLTLIFGATIFCKFF 293
           TSSQTV PP       P PP+ S + D S NKTWIY+  G +GGI LTL+ G  IF   F
Sbjct: 236 TSSQTVVPPPPPASPSPSPPSPSPNSDKSANKTWIYVFVGAVGGIVLTLVIGTIIFFMLF 295

Query: 294 YTRKKEPDSIVVSGSFQANEKPSNKKFDEESQDFLESISGVAQSLKVYSFKELQSATDNF 353
              KK+P  I+VS SF+A+EKP N+K DEE QD LES+  +AQS+KVY++++L++ATDNF
Sbjct: 296 RKSKKQPGPIIVSQSFEAHEKPLNRKLDEEPQDLLESVYSIAQSIKVYNYEDLKAATDNF 355

Query: 354 SFTCRIQGSVYRGKINGGFAAIKKVNGDVSKEIALLNKINHSNLIILSGVCFNEGNCYLV 413
           S +  I+GSV+RG ING FAAIKK+NGDVSKEI LLNKINHSNLI LSGVCFN+G+ YLV
Sbjct: 356 SPSFWIKGSVFRGLINGDFAAIKKMNGDVSKEIDLLNKINHSNLIRLSGVCFNDGHWYLV 415

Query: 414 YEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNV 473
           YEYA NG LSDW++ + NEGK+L W QRIQIA DVATGLNYLHSFTN PHVHKDI SSN+
Sbjct: 416 YEYAANGPLSDWIYVSSNEGKFLKWTQRIQIATDVATGLNYLHSFTNYPHVHKDIKSSNI 475

Query: 474 LLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGV 533
           LLD DLRAKIANF++AR  +G EGEFALTRHIVGTKGYMAPEYLENG++ TKLDVYAFG+
Sbjct: 476 LLDKDLRAKIANFSLARSTDGPEGEFALTRHIVGTKGYMAPEYLENGIICTKLDVYAFGI 535

Query: 534 LILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDG-EESLRHFIDPTLQGNYPLELALL 592
           L LE++TGKE AAL+ EEN   LSDVLN VL++E G EESL   IDP++QGNYP  LA+L
Sbjct: 536 LTLEIMTGKEVAALYREENR-ELSDVLNGVLSEEGGLEESLSQLIDPSMQGNYPSGLAVL 594

Query: 593 VIRLIDACLKKDPTDRPTMYEIEHSLSNILNASLNW 628
           ++RLID+CL K+P  RP M EI  SLS IL  SL W
Sbjct: 595 MVRLIDSCLNKNPAGRPAMDEIVQSLSGILITSLAW 630

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225430870|ref|XP_002269408.1| PREDICTED: wall-associated receptor kinase-like 4-like [Vitis vinifera]

 Score =  781 bits (2016), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 414/635 (65%), Positives = 496/635 (78%), Gaps = 17/635 (2%)

Query: 1   MAFLSFAYVLITLFILCFSSPIHAQQPYVGLATTDCNNADTTSNSNSALGYSCNGLNKSC 60
           MA+LSF  V  TL ++ FSS I AQQ YVG  TTDC+N + TS     LGY+CNG+N SC
Sbjct: 1   MAWLSFISVF-TLSLISFSSSILAQQSYVGKGTTDCDNNNLTS----VLGYACNGVNASC 55

Query: 61  RAYLTFRSQPPFNTVASISTLLGSEPSLLSQINSV----SLETNRLVIVPVNCSCSGQYY 116
           +A+L FRS+PP+N V+SIS LLGS+PS L+QINSV    + ET + VIVPVNCSCSG++ 
Sbjct: 56  QAFLIFRSEPPYNDVSSISDLLGSDPSQLAQINSVDETATFETKKEVIVPVNCSCSGEFS 115

Query: 117 QSNTTYTIQNGDTYLFIANNTFQGLSTCQALEDQNGS-PTNLIIGAGVTVPLRCACPTEN 175
           Q+NT+Y +Q+GDTYL IANNTF+GLSTCQAL  Q  S  TN+  G  +TVPLRCACPT+N
Sbjct: 116 QANTSYVVQHGDTYLLIANNTFEGLSTCQALRSQRTSLTTNIYTGTKLTVPLRCACPTKN 175

Query: 176 QTDEGFPFLLSYLVAEGDTVSGISSRFGVDTGEILQANSLSGSN--IFPFTTLLIPLENP 233
           Q+D G  +L+SYLVA GD VS IS RFGVDTG  L+AN LS  N  I+PFTTLLIPL+N 
Sbjct: 176 QSDVGVKYLMSYLVASGDYVSSISVRFGVDTGMTLEANELSEQNPNIYPFTTLLIPLQNL 235

Query: 234 PTSSQTVEPPSSTPVIPPPPPANSSSEDGSNKTWIYIVAGVLGGITLTLIFGATIFCKFF 293
           P+SSQT+ PP   P  PPPP A SS      KTW+Y+V GV+ G  L L+FG+ IF KFF
Sbjct: 236 PSSSQTIVPPPPPPPSPPPPTAVSSPSKSLKKTWVYVVVGVVAGSALVLLFGSVIFFKFF 295

Query: 294 YTRKKEPDSIVVSGSFQANEKPSNKKFDEESQDFLESISGVAQSLKVYSFKELQSATDNF 353
              +K+ D I +S SF+A EKP      EE  +FLESIS +AQSLKVY F+ELQSATDNF
Sbjct: 296 RKTRKKTDPIAISESFEACEKP----LKEEQHEFLESISSIAQSLKVYKFEELQSATDNF 351

Query: 354 SFTCRIQGSVYRGKINGGFAAIKKVNGDVSKEIALLNKINHSNLIILSGVCFNEGNCYLV 413
           S  CRI+GSVYRG I G  AAIKK++G+VS EIALLNKINH N+I LSG+CFN+G+ YLV
Sbjct: 352 SPNCRIKGSVYRGTIKGDLAAIKKMDGEVSNEIALLNKINHFNVIRLSGICFNDGHWYLV 411

Query: 414 YEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNV 473
           +EYAVNG L+DW+++N ++ ++L W QRIQIALDVATGLNYLHS+T+PP+VHKDI S NV
Sbjct: 412 HEYAVNGPLTDWIYNNNDDSRFLVWMQRIQIALDVATGLNYLHSYTSPPYVHKDIKSGNV 471

Query: 474 LLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGV 533
           LLDSD RAKIANF +AR AEGQEG+FALTRHI+GT+GYMAPEYLENGLVSTKLDVYAFGV
Sbjct: 472 LLDSDFRAKIANFGLARSAEGQEGQFALTRHIIGTRGYMAPEYLENGLVSTKLDVYAFGV 531

Query: 534 LILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLV 593
           L+LEMLTGKE AAL+ E  NMHL DVL AVL + DG+E LR+FIDP+L GNYPLELA+++
Sbjct: 532 LMLEMLTGKEVAALY-EGENMHLPDVLVAVLHEGDGKEKLRNFIDPSLSGNYPLELAIVM 590

Query: 594 IRLIDACLKKDPTDRPTMYEIEHSLSNILNASLNW 628
           IRLID+CLKK P  RP M EI  +LS  L  S+ W
Sbjct: 591 IRLIDSCLKKSPASRPDMVEIVQALSRTLTTSVAW 625

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297735221|emb|CBI17583.3| unnamed protein product [Vitis vinifera]

 Score =  776 bits (2005), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 404/635 (63%), Positives = 486/635 (76%), Gaps = 41/635 (6%)

Query: 1   MAFLSFAYVLITLFILCFSSPIHAQQPYVGLATTDCNNADTTSNSNSALGYSCNGLNKSC 60
           MA+LSF  V  TL ++ FSS I AQQ YVG  TTDC+N + TS     LGY+CNG+N SC
Sbjct: 21  MAWLSFISVF-TLSLISFSSSILAQQSYVGKGTTDCDNNNLTS----VLGYACNGVNASC 75

Query: 61  RAYLTFRSQPPFNTVASISTLLGSEPSLLSQINSV----SLETNRLVIVPVNCSCSGQYY 116
           +A+L FRS+PP+N V+SIS LLGS+PS L+QINSV    + ET + VIVPVNCSCSG++ 
Sbjct: 76  QAFLIFRSEPPYNDVSSISDLLGSDPSQLAQINSVDETATFETKKEVIVPVNCSCSGEFS 135

Query: 117 QSNTTYTIQNGDTYLFIANNTFQGLSTCQALEDQNGS-PTNLIIGAGVTVPLRCACPTEN 175
           Q+NT+Y +Q+GDTYL IANNTF+GLSTCQAL  Q  S  TN+  G  +TVPLRCACPT+N
Sbjct: 136 QANTSYVVQHGDTYLLIANNTFEGLSTCQALRSQRTSLTTNIYTGTKLTVPLRCACPTKN 195

Query: 176 QTDEGFPFLLSYLVAEGDTVSGISSRFGVDTGEILQANSLSGSN--IFPFTTLLIPLENP 233
           Q+D G  +L+SYLVA GD VS IS RFGVDTG  L+AN LS  N  I+PFTTLLIPL+N 
Sbjct: 196 QSDVGVKYLMSYLVASGDYVSSISVRFGVDTGMTLEANELSEQNPNIYPFTTLLIPLQNL 255

Query: 234 PTSSQTVEPPSSTPVIPPPPPANSSSEDGSNKTWIYIVAGVLGGITLTLIFGATIFCKFF 293
           P+SSQT+                        KTW+Y+V GV+ G  L L+FG+ IF KFF
Sbjct: 256 PSSSQTI------------------------KTWVYVVVGVVAGSALVLLFGSVIFFKFF 291

Query: 294 YTRKKEPDSIVVSGSFQANEKPSNKKFDEESQDFLESISGVAQSLKVYSFKELQSATDNF 353
              +K+ D I +S SF+A EKP      EE  +FLESIS +AQSLKVY F+ELQSATDNF
Sbjct: 292 RKTRKKTDPIAISESFEACEKP----LKEEQHEFLESISSIAQSLKVYKFEELQSATDNF 347

Query: 354 SFTCRIQGSVYRGKINGGFAAIKKVNGDVSKEIALLNKINHSNLIILSGVCFNEGNCYLV 413
           S  CRI+GSVYRG I G  AAIKK++G+VS EIALLNKINH N+I LSG+CFN+G+ YLV
Sbjct: 348 SPNCRIKGSVYRGTIKGDLAAIKKMDGEVSNEIALLNKINHFNVIRLSGICFNDGHWYLV 407

Query: 414 YEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNV 473
           +EYAVNG L+DW+++N ++ ++L W QRIQIALDVATGLNYLHS+T+PP+VHKDI S NV
Sbjct: 408 HEYAVNGPLTDWIYNNNDDSRFLVWMQRIQIALDVATGLNYLHSYTSPPYVHKDIKSGNV 467

Query: 474 LLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGV 533
           LLDSD RAKIANF +AR AEGQEG+FALTRHI+GT+GYMAPEYLENGLVSTKLDVYAFGV
Sbjct: 468 LLDSDFRAKIANFGLARSAEGQEGQFALTRHIIGTRGYMAPEYLENGLVSTKLDVYAFGV 527

Query: 534 LILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLV 593
           L+LEMLTGKE AAL+ E  NMHL DVL AVL + DG+E LR+FIDP+L GNYPLELA+++
Sbjct: 528 LMLEMLTGKEVAALY-EGENMHLPDVLVAVLHEGDGKEKLRNFIDPSLSGNYPLELAIVM 586

Query: 594 IRLIDACLKKDPTDRPTMYEIEHSLSNILNASLNW 628
           IRLID+CLKK P  RP M EI  +LS  L  S+ W
Sbjct: 587 IRLIDSCLKKSPASRPDMVEIVQALSRTLTTSVAW 621

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224133922|ref|XP_002327712.1| predicted protein [Populus trichocarpa] gi|222836797|gb|EEE75190.1| predicted protein [Populus trichocarpa]

 Score =  774 bits (1998), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 405/617 (65%), Positives = 482/617 (78%), Gaps = 15/617 (2%)

Query: 20  SPIHAQQPYVGLATTDCNNADTTSNSNSALGYSCNGLNKSCRAYLTFRSQPPFNTVASIS 79
           S I AQQPYVG ATT+C+N +     NSALGYSCN LNKSC+AYL FRSQPP+NTVASIS
Sbjct: 8   SLIQAQQPYVGKATTNCSNTE-----NSALGYSCNALNKSCQAYLIFRSQPPYNTVASIS 62

Query: 80  TLLGSEPSLLSQINSVSLET----NRLVIVPVNCSCSGQYYQSNTTYTIQNGDTYLFIAN 135
           TLLGS+PS LS++NSVS  T    N+LVIVPVNCSCSG+Y Q+N +Y +Q  DT   IAN
Sbjct: 63  TLLGSDPSQLSEVNSVSETTSFPSNQLVIVPVNCSCSGEYSQANASYIVQPNDTLFLIAN 122

Query: 136 NTFQGLSTCQALEDQNGSPTNLII-GAGVTVPLRCACPTENQTDEGFPFLLSYLVAEGDT 194
           NT+QGLSTCQAL++Q  + T+ I+ G  +TVPLRCACPT+NQ+D G  +LLSYLV  GD 
Sbjct: 123 NTYQGLSTCQALQNQKTTRTDDILSGETLTVPLRCACPTKNQSDLGIRYLLSYLVTPGDD 182

Query: 195 VSGISSRFGVDTGEILQANSLSGSN--IFPFTTLLIPLENPPTSSQTVEPPSSTPVIPPP 252
           V  IS +FG  TG  L+AN L   N  IFPFTTLLIPL++ PTSSQTV  P   P    P
Sbjct: 183 VPAISEQFGAATGRTLEANGLPEQNPTIFPFTTLLIPLQSTPTSSQTV-VPPPPPASSSP 241

Query: 253 PPANSSSEDGSNKTWIYIVAGVLGGITLTLIFGATIFCKFFYTRKKEPDSIVVSGSFQAN 312
           P  + + E  S KTW+Y+V GV+GGI LT++ G  IF       KK+P  ++ S SF+A+
Sbjct: 242 PSPSPNPEKSSKKTWLYVVVGVVGGIALTIVIGTIIFFMLSRKSKKQPGPVIESQSFEAH 301

Query: 313 EKPSNKKFDEESQDFLESISGVAQSLKVYSFKELQSATDNFSFTCRIQGSVYRGKINGGF 372
           EKP NKK DEESQ+F ESIS +AQS+KVY F++L++ATDNFS +C I+GSVYRG ING F
Sbjct: 302 EKPLNKKLDEESQEFFESISAIAQSIKVYKFEDLKAATDNFSPSCWIKGSVYRGLINGDF 361

Query: 373 AAIKKVNGDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNE 432
           AAIKK+NGDVSKEI LLNKINHSNLI LSGVCFN+G+ YLVYEYA +G LSDW++   NE
Sbjct: 362 AAIKKMNGDVSKEIELLNKINHSNLIRLSGVCFNDGHWYLVYEYAASGQLSDWIYDRSNE 421

Query: 433 GKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPA 492
           GK+L+W +RIQIA DVATGLNYLHSFTN PHVHKDI SSN+LLDSDLRAKIANF++AR  
Sbjct: 422 GKFLNWTKRIQIASDVATGLNYLHSFTNYPHVHKDIKSSNILLDSDLRAKIANFSLARST 481

Query: 493 EGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEEN 552
             Q+ EF LTRHIVGTKGYMAPEYLENG+VS+KLDVYAFG+L LE++TGKE AALH+EE+
Sbjct: 482 GDQDDEFVLTRHIVGTKGYMAPEYLENGVVSSKLDVYAFGILTLEIITGKEVAALHSEES 541

Query: 553 NMHLSDVLNAVLTKEDG-EESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTM 611
             +LSDVLN  L++ DG EESL+  IDP+L  NYP  LA+LV+RLID+CL K+P DRPTM
Sbjct: 542 R-NLSDVLNGALSEVDGQEESLKQLIDPSLHENYPSGLAVLVVRLIDSCLNKNPGDRPTM 600

Query: 612 YEIEHSLSNILNASLNW 628
            EI  SLS IL  SL W
Sbjct: 601 DEIVQSLSRILTTSLAW 617

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|134032232|gb|ABN50364.2| LysM-domain containing receptor-like kinase [Sesbania rostrata]

 Score =  719 bits (1855), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 378/631 (59%), Positives = 484/631 (76%), Gaps = 18/631 (2%)

Query: 6   FAYVLITLFILCFSS--PIHAQQPYVGLATTDCNNADTTSNSNSALGYSCNGLNKSCRAY 63
           F ++ + +F L  S    I  QQPY+GLAT  C       +SNS  GY CNGLN +C+AY
Sbjct: 4   FPFITVFIFTLLISHFFVIQGQQPYIGLATVAC---PRRGDSNSIRGYICNGLNPTCQAY 60

Query: 64  LTFRSQPPFNTVASISTLLGSEPSLLSQINSVSL----ETNRLVIVPVNCSCSGQYYQSN 119
           LTFRSQP +++V +IS LLGS+PS L++INSVSL    +TN+LV+VPVNCSC+GQYYQ+N
Sbjct: 61  LTFRSQPIYSSVHTISALLGSDPSQLAEINSVSLNDTFDTNKLVLVPVNCSCAGQYYQAN 120

Query: 120 TTYTIQNGDTYLFIANNTFQGLSTCQALEDQNGSPTNLIIGAGVTVPLRCACPTENQTDE 179
           T+Y  QN DTYL IANNTF+GLSTCQAL  +N +P ++  G  + VPLRCACPT+NQT++
Sbjct: 121 TSYVFQNTDTYLLIANNTFEGLSTCQALMHENHNPGDIYPGRKLMVPLRCACPTKNQTEK 180

Query: 180 GFPFLLSYLVAEGDTVSGISSRFGVDTGEILQANSLS-GSNIFPFTTLLIPLENPPTSSQ 238
           G  +LLSYLV  GD+VS IS+RFGV T   L+AN+LS  S I+PFTTLL+PL + P+SSQ
Sbjct: 181 GIKYLLSYLVDWGDSVSFISNRFGVKTKTTLEANTLSLTSIIYPFTTLLVPLHDKPSSSQ 240

Query: 239 TVEPPSSTPVIPPPPPANSSSEDGSNKTWIYIVAGVLGGITL-TLIFGATIFCKFFYTRK 297
            V PP  +P  P    ++SS++  SNKTW+Y+V GVLGG+   TLI  A +F   +   K
Sbjct: 241 IVSPPQPSPSSP----SSSSTDQSSNKTWVYVVVGVLGGVLALTLILSAVMFFTRYNKSK 296

Query: 298 KEPDSIVVSGSFQANEKPSNKKFDEESQDFLESISGVAQSLKVYSFKELQSATDNFSFTC 357
           K+ DS++VS SF+A EKP  +  ++E++   E ISG+AQS KVY F+EL+ ATDNFS +C
Sbjct: 297 KKDDSMIVSKSFEAVEKPPPQ--EKENEKLQEIISGIAQSFKVYGFEELKLATDNFSPSC 354

Query: 358 RIQGSVYRGKINGGFAAIKKVNGDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYA 417
            I+GSV+RG ING  AAIKK  GDVSKEI +LNK+NHSN+I LSGV FN+G  YLVYEYA
Sbjct: 355 WIKGSVFRGVINGDLAAIKKTEGDVSKEIQILNKVNHSNVIRLSGVSFNQGQWYLVYEYA 414

Query: 418 VNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDS 477
            NG LSDW++ N  +GK+L W QRIQIA DVATG++YLHSFT+PPH+HKD+ +SN+LLDS
Sbjct: 415 ANGALSDWIYFNNVDGKFLSWTQRIQIAFDVATGVDYLHSFTSPPHIHKDLKNSNILLDS 474

Query: 478 DLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILE 537
           D RAK+AN ++AR  EG + +F  TRHIVGT+GYMAPEYLENGLVSTKLDVYAFGV++LE
Sbjct: 475 DFRAKVANLSLARSVEGVDDQFLATRHIVGTRGYMAPEYLENGLVSTKLDVYAFGVMMLE 534

Query: 538 MLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLI 597
           +LTGKE AA+  EEN  +L DVL+A+L ++ G++ L+ F+DP+LQGNYPLELA+ V+ +I
Sbjct: 535 ILTGKEVAAILTEENP-NLEDVLSAILGEKGGQQRLKEFMDPSLQGNYPLELAMFVVEMI 593

Query: 598 DACLKKDPTDRPTMYEIEHSLSNILNASLNW 628
           D C+KKDPT RP M+EI  SLS  LN+SL+W
Sbjct: 594 DNCIKKDPTSRPAMHEIVPSLSITLNSSLSW 624

Source: Sesbania rostrata

Species: Sesbania rostrata

Genus: Sesbania

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356540724|ref|XP_003538835.1| PREDICTED: probable receptor-like protein kinase At1g49730-like [Glycine max]

 Score =  690 bits (1781), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 363/633 (57%), Positives = 463/633 (73%), Gaps = 21/633 (3%)

Query: 6   FAYVLITLFILCFS--SPIHAQQPYVGLATTDCNNADTTSNSNSALGYSCNGLNKSCRAY 63
           F ++ I +F L     S I  QQPY+GL T  C       N NS  GY+CNG N SC++Y
Sbjct: 4   FPFIPIIIFTLLIHNFSLILGQQPYIGLGTVAC---PRRGNKNSIRGYTCNGANHSCQSY 60

Query: 64  LTFRSQPPFNTVASISTLLGSEPSLLSQINSVSL----ETNRLVIVPVNCSCSGQYYQSN 119
           LTFRSQP +N+V +ISTLLGS+PS L++INSVS+    ETN+LVIVPVNCSCSG+YYQ+N
Sbjct: 61  LTFRSQPIYNSVKTISTLLGSDPSQLAKINSVSMNDTFETNKLVIVPVNCSCSGEYYQTN 120

Query: 120 TTYTIQNGDTYLFIANNTFQGLSTCQALEDQNGSPTNLIIGAGVTVPLRCACPTENQTDE 179
           T+Y  QN +TYL IANNTF+GL+TCQALE+QN +P N+  G  + VPLRCACPT+NQT +
Sbjct: 121 TSYVFQNSETYLLIANNTFEGLTTCQALENQNHNPANIYPGRRLLVPLRCACPTKNQTKK 180

Query: 180 GFPFLLSYLVAEGDTVSGISSRFGVDTGEILQANSLSGSN--IFPFTTLLIPLENPPTSS 237
           G  +LLSYLV  GD+VS IS +FGV+    L+AN+L+ +   I+PFTT+L+PL + P+SS
Sbjct: 181 GIRYLLSYLVNWGDSVSFISEKFGVNFMSTLEANTLTLTQAMIYPFTTILVPLHDKPSSS 240

Query: 238 QTVEPPSSTPVIPPPPPANSSSEDGSNKTW-IYIVAGVLGGITLTLIFGATIFCKFFYTR 296
           QTV P           P+  SS+  SNKTW   +V  V+G I LT +  A IF K +   
Sbjct: 241 QTVSPTQRISPP----PSPPSSDHSSNKTWVYVVVGVVVGAIALTSVLCAVIFFKRYRKN 296

Query: 297 KKEPDSIV-VSGSFQANEKPSNKKFDEESQDFLESISGVAQSLKVYSFKELQSATDNFSF 355
           + + DS+V V  SF+A E+    K +E+     E+ISG+AQS KVY+F+ELQ ATDNFS 
Sbjct: 297 RNKDDSLVAVPKSFEAIEEKPQVKVNEK---LSENISGIAQSFKVYNFEELQRATDNFSP 353

Query: 356 TCRIQGSVYRGKINGGFAAIKKVNGDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYE 415
           +  I+GSVYRG ING  AAIKK+ GDVSKEI +LNKINH+N+I LSGV F+EG  YLVY 
Sbjct: 354 SSWIKGSVYRGVINGDLAAIKKIEGDVSKEIEILNKINHTNVIRLSGVSFHEGRWYLVYV 413

Query: 416 YAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLL 475
           YA NG LS+W++ N  +GK+L W QR+QIALDVATGL+YLHSFT+PPH+HKDINSSN+LL
Sbjct: 414 YATNGDLSEWIYFNNVDGKFLSWTQRMQIALDVATGLDYLHSFTSPPHIHKDINSSNILL 473

Query: 476 DSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLI 535
           D D R K+AN ++AR  EG + +F  TRHIVGT+GYMAPEYLENGLVSTKLDVYAFGVL+
Sbjct: 474 DGDFRGKVANLSLARCLEGGDDQFPTTRHIVGTRGYMAPEYLENGLVSTKLDVYAFGVLM 533

Query: 536 LEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIR 595
           LEM+TGKE AA+  E+    LS VL+ +  +  G+E L+ F+DP+L  N PLELA+ VI 
Sbjct: 534 LEMVTGKEVAAILTEDET-KLSHVLSGIPGERSGKEWLKEFVDPSLGENCPLELAMFVIE 592

Query: 596 LIDACLKKDPTDRPTMYEIEHSLSNILNASLNW 628
           +ID C+K DP  RP+++EI  SLS  +N+SL+W
Sbjct: 593 MIDDCIKTDPASRPSVHEIVQSLSRTVNSSLSW 625

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356496806|ref|XP_003517256.1| PREDICTED: probable receptor-like protein kinase At1g49730-like [Glycine max] gi|148362072|gb|ABQ59612.1| LYK4 [Glycine max]

 Score =  682 bits (1760), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 360/633 (56%), Positives = 461/633 (72%), Gaps = 22/633 (3%)

Query: 6   FAYVLITLFILCFS--SPIHAQQPYVGLATTDCNNADTTSNSNSALGYSCNGLNKSCRAY 63
           F ++ I +F L     S I  QQPY+GL T  C       N NS  GY+CNG N SC++Y
Sbjct: 4   FPFIPIIIFTLLIHNFSLILGQQPYIGLGTVAC---PRRGNKNSIRGYTCNGANHSCQSY 60

Query: 64  LTFRSQPPFNTVASISTLLGSEPSLLSQINSVSL----ETNRLVIVPVNCSCSGQYYQSN 119
           LTFRSQP +N+V +ISTLLGS+PS L++INSVS+    ETN+LVIVPVNCSC+G+YYQ+N
Sbjct: 61  LTFRSQPIYNSVKTISTLLGSDPSQLAKINSVSMNDTFETNKLVIVPVNCSCAGEYYQTN 120

Query: 120 TTYTIQNGDTYLFIANNTFQGLSTCQALEDQNGSPTNLIIGAGVTVPLRCACPTENQTDE 179
           T+Y   N +TY  IANNTF+GL+TCQALE+QN +P N+  G  + VPLRCACPT+NQT++
Sbjct: 121 TSYEFHNSETYFLIANNTFEGLTTCQALENQNHNPANIYPGRRLLVPLRCACPTKNQTEK 180

Query: 180 GFPFLLSYLVAEGDTVSGISSRFGVDTGEILQAN--SLSGSNIFPFTTLLIPLENPPTSS 237
           G  +LLSYLV  GD+VS IS +FGV+    L+AN  +L+ + I+PFTT+L+PL + P+SS
Sbjct: 181 GIRYLLSYLVNWGDSVSFISEKFGVNFMTTLEANTLTLTQATIYPFTTILVPLHDKPSSS 240

Query: 238 QTVEPPSSTPVIPPPPPANSSSEDGSNKTW-IYIVAGVLGGITLTLIFGATIFCKFFYTR 296
           QTV P   TP       +  SS+  SNKTW   +V  V+G I L  +  A IF   +   
Sbjct: 241 QTVSPTRRTPPP-----SPPSSDHSSNKTWVYVVVGVVVGAIALISVLCAVIFFTRYRKN 295

Query: 297 KKEPDSIVV-SGSFQANEKPSNKKFDEESQDFLESISGVAQSLKVYSFKELQSATDNFSF 355
           +K+ DS+VV S SF+A E+    K +E+     E ISG+AQS KVY+F+ELQ ATDNFS 
Sbjct: 296 RKKDDSVVVGSKSFEAIEEKPEVKVNEK---LSEIISGIAQSFKVYNFEELQRATDNFSP 352

Query: 356 TCRIQGSVYRGKINGGFAAIKKVNGDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYE 415
           +  I+GSVYRG ING  AAIK++ GDVSKEI +LNKINHSN+I LSGV F+EG  YLVYE
Sbjct: 353 SSWIKGSVYRGVINGDLAAIKRIEGDVSKEIEILNKINHSNVIRLSGVSFHEGGWYLVYE 412

Query: 416 YAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLL 475
           YA NG LS+W++ +   GK+L W QR+QIALDVATGL+YLHSFT+PPH+HKDINSSN+LL
Sbjct: 413 YAANGDLSEWIYFHNVNGKFLSWTQRMQIALDVATGLDYLHSFTSPPHIHKDINSSNILL 472

Query: 476 DSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLI 535
           D D R K+ N ++AR  EG + +   TRHIVGT+GYMAPEYLENGLVSTKLDVYAFGVL+
Sbjct: 473 DGDFRGKVTNLSLARCLEGGDDQLPATRHIVGTRGYMAPEYLENGLVSTKLDVYAFGVLM 532

Query: 536 LEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIR 595
           LEM+TGKE AA+  E+    LS VL+ +L +E G+E L+ F+DP+L  N PLELA+ VI 
Sbjct: 533 LEMVTGKEVAAILTEDET-KLSHVLSGILGEESGKEMLKEFVDPSLGENCPLELAMFVIE 591

Query: 596 LIDACLKKDPTDRPTMYEIEHSLSNILNASLNW 628
           +ID C+K DP  RP+++EI  S+S  L +SL+W
Sbjct: 592 MIDNCIKTDPASRPSVHEIVQSMSRTLKSSLSW 624

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|290490578|dbj|BAI79276.1| LysM type receptor kinase [Lotus japonicus]

 Score =  667 bits (1720), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 361/641 (56%), Positives = 462/641 (72%), Gaps = 37/641 (5%)

Query: 6   FAYVLI---TLFILCFSSPIH-AQQPYVGLATTDCNNADTTSNSNSALGYSCNG--LNKS 59
           F + LI   TLFI  F+ PI  AQQPY+GLAT  C       NSNS  GY+CNG   N +
Sbjct: 4   FPFTLIFLSTLFIF-FTFPITLAQQPYIGLATNAC---PRRGNSNSIRGYTCNGGSANHT 59

Query: 60  CRAYLTFRSQPPFNTVASISTLLGSEPSLLSQINSVS----LETNRLVIVPVNCSCSGQY 115
           C+AYLTFR+QP +N+V +ISTLL S+   L++  SVS     ETN+LVIVPV CSC+G+Y
Sbjct: 60  CQAYLTFRTQPIYNSVYTISTLLSSDARHLAETMSVSQNTTFETNKLVIVPVQCSCAGEY 119

Query: 116 YQSNTTYTIQNGDTYLFIANNTFQGLSTCQALEDQNGSPTNLIIGAGVTVPLRCACPTEN 175
           YQ+NT+Y  QN DT   IANNTF+GL+TCQAL  +N +P +L +G  +TVPLRCACPT+N
Sbjct: 120 YQANTSYAFQNTDTPFSIANNTFEGLTTCQALMHENHNPGHLYLGRELTVPLRCACPTKN 179

Query: 176 QTDEGFPFLLSYLVAEGDTVSGISSRFGVDTGEILQANSLS--GSNIFPFTTLLIPLENP 233
           QT++G  +LLSYLV  GD+VS IS +FGV     L+ANSLS   + I+PFTTLL+PL + 
Sbjct: 180 QTEKGIKYLLSYLVNWGDSVSVISEKFGVSCNNTLEANSLSLTKAKIYPFTTLLVPLHDK 239

Query: 234 PTSSQTVEPPSSTPVIPPPPPANSSSEDGSNKTWIYIVAGVLGGITLTLIFGATIFCKFF 293
           P++SQT+   S        PP +SS+   SNKTW+Y+   V+GG+   ++  A IFC  +
Sbjct: 240 PSNSQTI-LQSQPSSTSSSPPPSSSTHQSSNKTWLYV---VVGGVFALIVLTAVIFCIHY 295

Query: 294 YTRKKEPDS---IVVSGSFQANE-KPSNKKFDEESQDFLESISGVAQSLKVYSFKELQSA 349
           +  +K+ DS   + VS SF+  +     KK D +  +F   I G+AQS KVYSF+E+Q A
Sbjct: 296 HKGRKKDDSLSQLTVSESFENQQLGKEMKKGDGKLSEF---IHGIAQSFKVYSFEEIQRA 352

Query: 350 TDNFSFTCRIQGSVYRGKINGGFAAIKKVNGDVSKEIALLNKINHSNLIILSGVCFNEGN 409
           T+N + +  I+GSVYRG +NG   AIKK  GDVSKEI +LNK+NHSN+I LSGV FNEG 
Sbjct: 353 TNNLNSSSLIKGSVYRGVMNGDLVAIKKTEGDVSKEIQILNKVNHSNVIRLSGVSFNEGQ 412

Query: 410 CYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDIN 469
            YLVYEYA NG LS+W+F     GK+L W QRIQIALDVA GL+YLHSFT+PPH+HKD+ 
Sbjct: 413 WYLVYEYAANGPLSEWIFF----GKFLSWTQRIQIALDVAIGLDYLHSFTSPPHIHKDLK 468

Query: 470 SSNVLLDSDLRAKIANFAMARPAEG--QEGEFALTRHIVGTKGYMAPEYLENGLVSTKLD 527
           SSN+LLDSD RAKIAN ++AR  +G  ++ +F  TR+IVGT+GYMAPEYLENGLVSTKLD
Sbjct: 469 SSNILLDSDFRAKIANLSLARSVKGVDEDDQFLATRNIVGTRGYMAPEYLENGLVSTKLD 528

Query: 528 VYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPL 587
           VYAFGVL+LE+LTGKE AA+ AE+NN +LS VL+AVL    GEE L+ F+DP+LQ NYP 
Sbjct: 529 VYAFGVLMLEILTGKEVAAILAEDNNKNLSGVLSAVL----GEERLKEFMDPSLQSNYPF 584

Query: 588 ELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNASLNW 628
           ELA+ V  +I  C++KDP  RP+M EI  +LS  +N+SL+W
Sbjct: 585 ELAMFVFEIIVGCIEKDPASRPSMQEIVPTLSRTMNSSLSW 625

Source: Lotus japonicus

Species: Lotus japonicus

Genus: Lotus

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|290490598|dbj|BAI79286.1| LysM type receptor kinase [Lotus japonicus]

 Score =  666 bits (1719), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 360/641 (56%), Positives = 462/641 (72%), Gaps = 37/641 (5%)

Query: 6   FAYVLI---TLFILCFSSPIH-AQQPYVGLATTDCNNADTTSNSNSALGYSCNG--LNKS 59
           F + LI   TLFI  F+ PI  AQQPY+GLAT  C       NSNS  GY+CNG   N +
Sbjct: 4   FPFTLIFLSTLFIF-FTFPITLAQQPYIGLATNAC---PRRGNSNSIRGYTCNGGSANHT 59

Query: 60  CRAYLTFRSQPPFNTVASISTLLGSEPSLLSQINSVS----LETNRLVIVPVNCSCSGQY 115
           C+AYLTFR+QP +N+V +ISTLL S+   L++  SVS     ETN+LVIVPV CSC+G+Y
Sbjct: 60  CQAYLTFRTQPIYNSVYTISTLLSSDARHLAETMSVSQNTTFETNKLVIVPVQCSCAGEY 119

Query: 116 YQSNTTYTIQNGDTYLFIANNTFQGLSTCQALEDQNGSPTNLIIGAGVTVPLRCACPTEN 175
           YQ+NT+Y  QN DT   IANNTF+GL+TCQAL  +N +P +L +G  +TVPLRCACPT+N
Sbjct: 120 YQANTSYAFQNTDTPFSIANNTFEGLTTCQALMHENHNPGHLYLGRELTVPLRCACPTKN 179

Query: 176 QTDEGFPFLLSYLVAEGDTVSGISSRFGVDTGEILQANSLS--GSNIFPFTTLLIPLENP 233
           QT++G  +LLSYLV  GD++S IS +FGV     L+ANSLS   + I+PFTTLL+PL + 
Sbjct: 180 QTEKGIKYLLSYLVNWGDSISVISEKFGVSCNNTLEANSLSLTKAKIYPFTTLLVPLHDK 239

Query: 234 PTSSQTVEPPSSTPVIPPPPPANSSSEDGSNKTWIYIVAGVLGGITLTLIFGATIFCKFF 293
           P++SQT+   S        PP +SS+   SNKTW+Y+   V+GG+   ++  A IFC  +
Sbjct: 240 PSNSQTI-LQSQPSSTSSSPPPSSSTHQSSNKTWLYV---VVGGVFALIVLTAVIFCIHY 295

Query: 294 YTRKKEPDS---IVVSGSFQANE-KPSNKKFDEESQDFLESISGVAQSLKVYSFKELQSA 349
           +  +K+ DS   + VS SF+  +     KK D +  +F   I G+AQS KVYSF+E+Q A
Sbjct: 296 HKGRKKDDSLSQLTVSESFENQQLGKEMKKGDGKLSEF---IHGIAQSFKVYSFEEIQRA 352

Query: 350 TDNFSFTCRIQGSVYRGKINGGFAAIKKVNGDVSKEIALLNKINHSNLIILSGVCFNEGN 409
           T+N + +  I+GSVYRG +NG   AIKK  GDVSKEI +LNK+NHSN+I LSGV FNEG 
Sbjct: 353 TNNLNSSSLIKGSVYRGVMNGDLVAIKKTEGDVSKEIQILNKVNHSNVIRLSGVSFNEGQ 412

Query: 410 CYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDIN 469
            YLVYEYA NG LS+W+F     GK+L W QRIQIALDVA GL+YLHSFT+PPH+HKD+ 
Sbjct: 413 WYLVYEYAANGPLSEWIFF----GKFLSWTQRIQIALDVAIGLDYLHSFTSPPHIHKDLK 468

Query: 470 SSNVLLDSDLRAKIANFAMARPAEG--QEGEFALTRHIVGTKGYMAPEYLENGLVSTKLD 527
           SSN+LLDSD RAKIAN ++AR  +G  ++ +F  TR+IVGT+GYMAPEYLENGLVSTKLD
Sbjct: 469 SSNILLDSDFRAKIANLSLARSVKGVDEDDQFLATRNIVGTRGYMAPEYLENGLVSTKLD 528

Query: 528 VYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPL 587
           VYAFGVL+LE+LTGKE AA+ AE+NN +LS VL+AVL    GEE L+ F+DP+LQ NYP 
Sbjct: 529 VYAFGVLMLEILTGKEVAAILAEDNNKNLSGVLSAVL----GEERLKEFMDPSLQSNYPF 584

Query: 588 ELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNASLNW 628
           ELA+ V  +I  C++KDP  RP+M EI  +LS  +N+SL+W
Sbjct: 585 ELAMFVFEIIVGCIEKDPASRPSMQEIVPTLSRTMNSSLSW 625

Source: Lotus japonicus

Species: Lotus japonicus

Genus: Lotus

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	628
TAIR|locus:2049029	612	LYK4 "LysM-containing receptor	0.859	0.882	0.477	7.4e-137
TAIR|locus:2050987	664	LYK5 "LysM-containing receptor	0.842	0.796	0.440	3.5e-114
TAIR|locus:2195814	651	LYK3 "LysM-containing receptor	0.458	0.442	0.374	1.1e-62
TAIR|locus:2089860	617	CERK1 "chitin elicitor recepto	0.788	0.802	0.318	1.2e-58
TAIR|locus:2082359	654	LYK2 "LysM-containing receptor	0.847	0.813	0.295	1.2e-56
UNIPROTKB|D7UPN3	605	CERK1 "Chitin elicitor recepto	0.471	0.489	0.382	2e-55
TAIR|locus:2013825	942	TMK1 "transmembrane kinase 1"	0.460	0.306	0.363	6.9e-49
UNIPROTKB|O49974	848	KIK1 "Serine/threonine-protein	0.461	0.341	0.353	5.8e-46
TAIR|locus:2059703	943	AT2G01820 [Arabidopsis thalian	0.444	0.295	0.348	1.1e-43
TAIR|locus:2024016	886	AT1G24650 [Arabidopsis thalian	0.555	0.393	0.323	1.3e-43

TAIR|locus:2049029 LYK4 "LysM-containing receptor-like kinase 4" [Arabidopsis thaliana (taxid:3702)]

 Score = 1271 (452.5 bits), Expect = 7.4e-137, Sum P(2) = 7.4e-137
 Identities = 274/574 (47%), Positives = 372/574 (64%)

Query:     4 LSFAYVLITLFILCFSSPIHAQQPYVGLXXXXXXXXXXXXXXXXXLGYSCNGLNKSCRAY 63
             +SF++ L+   +L  SS   AQQPYVG+                  GYSCNGLNK+C+AY
Sbjct:     2 ISFSFHLLVFILLSLSSFATAQQPYVGISTTDCSVSDNTTSV---FGYSCNGLNKTCQAY 58

Query:    64 LTFRSQPPFNTVASISTLLGSEPSLLSQIN----SVSLETNRLVIVPVNCSCSGQYYQSN 119
             + FRS P F+TV SIS+L   +PSL+S +N    S S  + + VI+P+ CSC+G   QSN
Sbjct:    59 VIFRSTPSFSTVTSISSLFSVDPSLVSSLNDASPSTSFPSGQQVIIPLTCSCTGDDSQSN 118

Query:   120 TTYTIQNGDTYLFIANNTFQGLSTCQALEDQNG-SPTNLIIGAGVTVPLRCACPTENQTD 178
              TYTIQ  D+Y  IAN+T QGLSTCQAL  QN  S  +L  G  + VP+RCACPT  Q +
Sbjct:   119 ITYTIQPNDSYFAIANDTLQGLSTCQALAKQNNVSSQSLFPGMRIVVPIRCACPTAKQIN 178

Query:   179 E-GFPFLLSYLVAEGDTVSGISSRFGVDTGEILQANSLS--GSNIFPFTTLLIPLENPPT 235
             E G  +L+SY V   DT++ IS RFGV+T + L+AN +S   S +FPFTT+LIPL NPP 
Sbjct:   179 EDGVKYLMSYTVVFEDTIAIISDRFGVETSKTLKANEMSFENSEVFPFTTILIPLVNPPA 238

Query:   236 SSQTVEXXXXXXXXXXXXXXXXXXEDG---SNKTWIYIVAGVLGGITLTLIFGATIFCKF 292
             ++ ++                    DG     KTW+Y +AGVLGG  +  + GA IFC  
Sbjct:   239 NTNSL-IPPPPPPPPQSVSPPPLSPDGRKSKKKTWVYALAGVLGGALVLSVIGAAIFC-- 295

Query:   293 FYTRKKEPDSIVVSG---SFQANEKP-SNKKFDEESQDFLESISG-VAQSLKVYSFKELQ 347
                +K +  +   +G   SF   + P S+++FD      L+ +SG V +SLKVY F ELQ
Sbjct:   296 LSKKKTKTQTQEETGNLDSFMGKKPPMSDQEFDP-----LDGLSGMVVESLKVYKFHELQ 350

Query:   348 SATDNFSFTCRIQGSVYRGKINGGFAAIKKVNGDVSKEIALLNKINHSNLIILSGVCFNE 407
             SAT +F+ +  I GS Y GKING  A IKK+ G+ S+E+ LL+K+NH N+I LSG CF+E
Sbjct:   351 SATSDFTSSSSIGGSGYIGKINGDGAMIKKIEGNASEEVNLLSKLNHLNIIRLSGFCFHE 410

Query:   408 GNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKD 467
             G+ YLVYE+A NG+LS+W+ + K+    L   Q++QIALD+ATGLNYLH+F +PP+VH+D
Sbjct:   411 GDWYLVYEHASNGSLSEWIHTTKS---LLSLTQKLQIALDIATGLNYLHNFADPPYVHRD 467

Query:   468 INSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLD 527
             +NS+NV LD + RAKI +   AR       +F LT+H+ GT+GY+APEYLE+GLVSTKLD
Sbjct:   468 LNSNNVFLDLEFRAKIGSLGSARSTTE---DFVLTKHVEGTRGYLAPEYLEHGLVSTKLD 524

Query:   528 VYAFGVLILEMLTGKEAAALHAE-ENNMHLSDVL 560
             VYAFGV++LE++TGKEA+ L  E +    + ++L
Sbjct:   525 VYAFGVVLLEIVTGKEASELKKEIDEGKAIDEIL 558

GO:0009507 "chloroplast" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS

GO:0005886 "plasma membrane" evidence=IDA

GO:0008061 "chitin binding" evidence=IDA

GO:0045087 "innate immune response" evidence=IMP

GO:0071219 "cellular response to molecule of bacterial origin" evidence=IEP

GO:0071323 "cellular response to chitin" evidence=IEP

TAIR|locus:2050987 LYK5 "LysM-containing receptor-like kinase 5" [Arabidopsis thaliana (taxid:3702)]

 Score = 1126 (401.4 bits), Expect = 3.5e-114, P = 3.5e-114
 Identities = 244/554 (44%), Positives = 338/554 (61%)

Query:    97 LETNRLVIVPVNCSCS---GQYYQSNTTYTIQN--GD-TYLFIANNTFQGLSTCQALEDQ 150
             + T  LV++P NCSCS   G +YQ N TY +    GD TY  +AN+T+Q LSTCQA+  Q
Sbjct:   100 IPTRELVVIPANCSCSSSSGGFYQHNATYNLSGNRGDETYFSVANDTYQALSTCQAMMSQ 159

Query:   151 NG-SPTNLIIGAGVTVPLRCACPTENQTDEGFPFLLSYLVAEGDTVSGISSRFGVDTGEI 209
             N      L  G  + VPLRCACPT  QT  GF +LL+YLVA GD++SGI+  F   +  I
Sbjct:   160 NRYGERQLTPGLNLLVPLRCACPTAKQTTAGFKYLLTYLVAMGDSISGIAEMFNSTSAAI 219

Query:   210 LQANSLSGSNIFPFTTLLIPLENPPTSSQTVEXXXXXXXXXXXXXXXXXXEDGSNKT--W 267
              + N L+  NIF FT +L+PL   PT    +                     GS+ +  W
Sbjct:   220 TEGNELTSDNIFFFTPVLVPLTTEPTKI-VISPSPPPPPVVATPPQTPVDPPGSSSSHKW 278

Query:   268 IYIVAGVLGGITLTLIFGATIFCKFFYTRKKEPDSIVVSGS-FQANEKPS--NKKFDEES 324
             IYI  G+  G+ L L   A  F K    +K  P S+      F ++ K S       + S
Sbjct:   279 IYIGIGIGAGLLLLLSILALCFYKRRSKKKSLPSSLPEENKLFDSSTKQSIPTTTTTQWS 338

Query:   325 QDFLES-----ISGVAQSLKVYSFKELQSATDNFSFTCRIQGSVYRGKINGGFAAIKKVN 379
              D   S     +    +SL +Y F +LQSAT NFS   RI+GSVYR  ING  AA+K + 
Sbjct:   339 IDLSNSSEAFGLKSAIESLTLYRFNDLQSATSNFSDENRIKGSVYRATINGDDAAVKVIK 398

Query:   380 GDVSK-EIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDW 438
             GDVS  EI LL K+NHSN+I LSG C  EG  YLV+EY+ NG++SDW+ S+    K L W
Sbjct:   399 GDVSSSEINLLKKLNHSNIIRLSGFCIREGTSYLVFEYSENGSISDWLHSSGK--KSLTW 456

Query:   439 KQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGE 498
             KQR++IA DVA  L+YLH++  PPH+HK++ S+N+LLDS+ RAKIANF +AR  +  + +
Sbjct:   457 KQRVEIARDVAEALDYLHNYITPPHIHKNLESTNILLDSNFRAKIANFGVARILDEGDLD 516

Query:   499 FALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALH----AEENNM 554
               LTRH+ GT+GY+APEY+ENG++++KLDV+AFGV +LE+L+G+EA  +H     EE   
Sbjct:   517 LQLTRHVEGTQGYLAPEYVENGVITSKLDVFAFGVAVLELLSGREAVTIHKKKEGEEEVE 576

Query:   555 HLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEI 614
              L  V+N+VL  E+  E L+ F+DP+L   YPLELA  + +L  +C+  D   RP++ ++
Sbjct:   577 MLCKVINSVLGGENVREKLKEFMDPSLGNEYPLELAYTMAQLAKSCVATDLNSRPSVTQV 636

Query:   615 EHSLSNILNASLNW 628
               +LS I+++S++W
Sbjct:   637 LTTLSMIVSSSIDW 650

GO:0005576 "extracellular region" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS

GO:0005886 "plasma membrane" evidence=IDA

GO:0010200 "response to chitin" evidence=RCA

GO:0008061 "chitin binding" evidence=IDA

GO:0071323 "cellular response to chitin" evidence=IEP

TAIR|locus:2195814 LYK3 "LysM-containing receptor-like kinase 3" [Arabidopsis thaliana (taxid:3702)]

 Score = 502 (181.8 bits), Expect = 1.1e-62, Sum P(2) = 1.1e-62
 Identities = 115/307 (37%), Positives = 178/307 (57%)

Query:   340 VYSFKELQSATDNFSFTCRI----QGSVYRGKINGGFAAIKKVNGDVSKEIA----LLNK 391
             V++++E+++ATD FS +  +     GSVY G +     A+K++    +KE A    +L K
Sbjct:   328 VFTYEEIRAATDEFSDSNLLGHGNYGSVYFGLLREQEVAVKRMTATKTKEFAAEMKVLCK 387

Query:   392 INHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKY-LDWKQRIQIALDVAT 450
             ++HSNL+ L G        ++VYEY   G L   +   +++G   L W  R QIALD A 
Sbjct:   388 VHHSNLVELIGYAATVDELFVVYEYVRKGMLKSHLHDPQSKGNTPLSWIMRNQIALDAAR 447

Query:   451 GLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQ-EGEFALTRHIVGTK 509
             GL Y+H  T   +VH+DI +SN+LLD   RAKI++F +A+  E   EGE ++T+ +VGT 
Sbjct:   448 GLEYIHEHTKTHYVHRDIKTSNILLDEAFRAKISDFGLAKLVEKTGEGEISVTK-VVGTY 506

Query:   510 GYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAA----ALHAEENNMH-LSDVLNAVL 564
             GY+APEYL +GL ++K D+YAFGV++ E+++G+EA     A+  +      L+ ++ AVL
Sbjct:   507 GYLAPEYLSDGLATSKSDIYAFGVVLFEIISGREAVIRTEAIGTKNPERRPLASIMLAVL 566

Query:   565 TKEDGE---ESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNI 621
                       SL+ F+DP +   YP +    +  L   C+  DP  RP M ++  SLS I
Sbjct:   567 KNSPDSMNMSSLKEFVDPNMMDLYPHDCLFKIATLAKQCVDDDPILRPNMKQVVISLSQI 626

Query:   622 LNASLNW 628
             L +S+ W
Sbjct:   627 LLSSIEW 633

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0016998 "cell wall macromolecule catabolic process" evidence=IEA

GO:0007020 "microtubule nucleation" evidence=RCA

TAIR|locus:2089860 CERK1 "chitin elicitor receptor kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 602 (217.0 bits), Expect = 1.2e-58, P = 1.2e-58
 Identities = 174/547 (31%), Positives = 284/547 (51%)

Query:   103 VIVPVNCSCS-GQYYQSNTTYTIQNGDTYLFIANNTFQGLSTCQALEDQNGSP-TNLIIG 160
             V+VP  C C  G +   N +Y+++  DTY  +A + +  L+T ++L+ +N  P TN+ + 
Sbjct:    85 VLVPFPCECQPGDFLGHNFSYSVRQEDTYERVAISNYANLTTMESLQARNPFPATNIPLS 144

Query:   161 AGVTVPLRCACPTENQTDEGFPFLLSYLVAEGDTVSGISSRFGVDTGEILQANSLSGSNI 220
             A + V + C+C  E+ + + F   ++Y +   D++S I+   GV + +ILQ  +  G N 
Sbjct:   145 ATLNVLVNCSCGDESVSKD-FGLFVTYPLRPEDSLSSIARSSGV-SADILQRYN-PGVNF 201

Query:   221 FPFTTLL-IPLENPPTSSQTVEXXXXXXXXXXXXXXXXXXEDGSNKTWIYIVAGVLGGIT 279
                  ++ +P  +P  +    +                  +DG       ++AG++ G+ 
Sbjct:   202 NSGNGIVYVPGRDPNGAFPPFKSSK---------------QDGVGAG---VIAGIVIGVI 243

Query:   280 LTLIFGATIFCKFFYTRKKEPDSIVVSGSFQANEKPSNKKFDEESQDFL--ESIS-GVAQ 336
             + L+    +F  ++  RK +      S S   + K  +          L    +S G+A 
Sbjct:   244 VALLL--ILFIVYYAYRKNKSKGDSFSSSIPLSTKADHASSTSLQSGGLGGAGVSPGIA- 300

Query:   337 SLKV-----YSFKELQSATDNFSFTCRIQ----GSVYRGKINGGFAAIKKVNGDVSK--- 384
             ++ V     +S +EL  ATDNF+ + +I     G+VY  ++ G  AAIKK++ + SK   
Sbjct:   301 AISVDKSVEFSLEELAKATDNFNLSFKIGQGGFGAVYYAELRGEKAAIKKMDMEASKQFL 360

Query:   385 -EIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQ 443
              E+ +L +++H NL+ L G C  EG+ +LVYEY  NG L   +  +  E   L W +R+Q
Sbjct:   361 AELKVLTRVHHVNLVRLIGYCV-EGSLFLVYEYVENGNLGQHLHGSGREP--LPWTKRVQ 417

Query:   444 IALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTR 503
             IALD A GL Y+H  T P +VH+DI S+N+L+D   RAK+A+F + +  E   G  A TR
Sbjct:   418 IALDSARGLEYIHEHTVPVYVHRDIKSANILIDQKFRAKVADFGLTKLTE--VGGSA-TR 474

Query:   504 HIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMH--LSDVLN 561
               +GT GYMAPE +  G VS K+DVYAFGV++ E+++ K A     E       L  V  
Sbjct:   475 GAMGTFGYMAPETVY-GEVSAKVDVYAFGVVLYELISAKGAVVKMTEAVGEFRGLVGVFE 533

Query:   562 AVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNI 621
                 + D EE+LR  IDP L  +YP +    +  L  AC +++   RP+M  I  +LS +
Sbjct:   534 ESFKETDKEEALRKIIDPRLGDSYPFDSVYKMAELGKACTQENAQLRPSMRYIVVALSTL 593

Query:   622 LNASLNW 628
              +++ NW
Sbjct:   594 FSSTGNW 600

GO:0005576 "extracellular region" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS

GO:0005886 "plasma membrane" evidence=IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IDA

GO:0019199 "transmembrane receptor protein kinase activity" evidence=IMP;IDA

GO:0032491 "detection of molecule of fungal origin" evidence=IEP;IMP

GO:0035556 "intracellular signal transduction" evidence=RCA;IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0009817 "defense response to fungus, incompatible interaction" evidence=IMP

GO:0010200 "response to chitin" evidence=RCA;IMP

GO:0005515 "protein binding" evidence=IPI

GO:0002752 "cell surface pattern recognition receptor signaling pathway" evidence=IDA

GO:0042742 "defense response to bacterium" evidence=IDA

GO:0008061 "chitin binding" evidence=IDA

GO:2001080 "chitosan binding" evidence=IDA

GO:0032499 "detection of peptidoglycan" evidence=IMP

GO:0045087 "innate immune response" evidence=IMP

GO:0002679 "respiratory burst involved in defense response" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0006944 "cellular membrane fusion" evidence=RCA

GO:0009627 "systemic acquired resistance" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0030968 "endoplasmic reticulum unfolded protein response" evidence=RCA

GO:0031347 "regulation of defense response" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0042803 "protein homodimerization activity" evidence=IDA

GO:0071219 "cellular response to molecule of bacterial origin" evidence=IEP

GO:0071323 "cellular response to chitin" evidence=IEP

TAIR|locus:2082359 LYK2 "LysM-containing receptor-like kinase 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 583 (210.3 bits), Expect = 1.2e-56, P = 1.2e-56
 Identities = 182/616 (29%), Positives = 307/616 (49%)

Query:    50 GYSCNGLNKSCRAYLTFRSQPPFNTVASISTLLGSEPSLLSQINSVSLETNRLVIVPVNC 109
             GY C+   + C  +   R++PPF +++ +S  LG +       +   +   +L+++P+ C
Sbjct:    47 GYVCHSNLQKCHTFAILRAKPPFYSLSDLSRHLGLDA------DDEYVPKGQLLLIPIEC 100

Query:   110 SCSGQYYQSNTTYTIQNGDTYLFIANNTFQGLSTCQALEDQNGSPTNLIIGAGVTVPL-- 167
              C+G  Y+++       GDT+  ++ +  QGL+TC ++ ++N   +   +G  + + L  
Sbjct:   101 RCNGSIYEASLIKNCVKGDTFRSVSQS-LQGLTTCLSIREKNPHISEDKLGDNIKLRLAI 159

Query:   168 RCACPTENQTDEGFPFLLSYLVAEGDTVSGISSRFGVDTGEILQANSLSGSNIFPFTTLL 227
             RC+CP E  ++  F  L++Y V   D+VS ++ RF      I+ AN+ SG  + P    L
Sbjct:   160 RCSCPQEGVSNASF--LVTYPVGVRDSVSSLAVRFNTTEDAIVSANNKSG--VVPLKPAL 215

Query:   228 IPLENPPTSSQTVEXXXXXXXXXXXXXXXXXXEDGSNKTWIYIVAGVLGGITLTLIFGAT 287
             IPL++ P    + +                             +AGV G +TL ++FG  
Sbjct:   216 IPLDHKPEKQGSRKRNPSKKKRSKMKLMIAVSS---------AIAGVCGLVTL-MVFGYL 265

Query:   288 IFCKFFY----TRK----KEPDSIVVSGSFQANEKPSNKKFD-EESQD--FLESISGVAQ 336
              + K       T+K    K+P++  +S S +     S+KK   E SQD   L+S + V  
Sbjct:   266 HWKKETQIQTQTQKWISNKDPETRQLSLSIRTT---SDKKISFEGSQDGSILDSHNTVGT 322

Query:   337 S------LKVYSFKELQSATDNFSFTCRIQGSVYRGKINGGFAAIKKVNGDVSK--EIAL 388
             +      L++Y+F+EL+ AT+NFS +  I+GSVY G + G   AIK+VN D  K  +  L
Sbjct:   323 TTPRKPVLEIYAFEELEKATENFSSSNHIKGSVYFGSLKGKDLAIKQVNADEMKRFDFGL 382

Query:   389 LNKINH---SNLIILSGVCFNE--GNCYLVYEYAVNGTLSDWVFSN---KN---EGKY-- 435
             LN  +H    N+I + G CF E   + YLV+EYA NG+L DW+ +    KN   E  Y  
Sbjct:   383 LNDQSHYYNHNVIRVLGTCFREIDQDSYLVFEYARNGSLWDWIQNKLAIKNQFIESCYCF 442

Query:   436 LDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQ 495
             L WKQRI+I  DVA  L Y+H      +VH +I S N+ L+ DLR K+ NF M++     
Sbjct:   443 LAWKQRIKICHDVAIALKYMHRIN---YVHGNIKSRNIFLNEDLRGKVGNFGMSKCVTN- 498

Query:   496 EGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAAL----HAEE 551
               E A   +++           E+ L S   D++A+G++++E+L+G+    L      E 
Sbjct:   499 --ELATEENLI-----------ESSL-SPASDIFAYGIIVMEVLSGQTPDMLLGLQEVET 544

Query:   552 NNMHLSDVLNAV---LTKEDGE-ESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTD 607
              ++   +   +    L +  G+ E LR  +D TL  +Y ++ A  +  +   C  ++   
Sbjct:   545 TSLGTQETFVSEWSRLRRLLGDKEKLREVMDSTLGESYSVDSAFEIASIARDCTAEEAES 604

Query:   608 RPTMYEIEHSLSNILN 623
             RP+  EI   +S +++
Sbjct:   605 RPSAVEIAERVSRLVD 620

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0009507 "chloroplast" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

UNIPROTKB|D7UPN3 CERK1 "Chitin elicitor receptor kinase 1" [Oryza sativa Japonica Group (taxid:39947)]

 Score = 485 (175.8 bits), Expect = 2.0e-55, Sum P(2) = 2.0e-55
 Identities = 122/319 (38%), Positives = 182/319 (57%)

Query:   310 QANEKPSNKK---FDEESQDFLESISGVAQSLKVYSFKELQSATDNFSFTCRIQ----GS 362
             +A  +PS ++    D+ SQ   E I  V +S++ +S++E+ +AT  FS   +I     GS
Sbjct:   275 KATSRPSPEETSHLDDASQ--AEGIK-VERSIE-FSYEEIFNATQGFSMEHKIGQGGFGS 330

Query:   363 VYRGKINGGFAAIKKVNGDVSKE----IALLNKINHSNLIILSGVCFNEGNC-YLVYEYA 417
             VY  ++ G   AIKK+    ++E    + +L  ++H NL+ L G C    NC +LVYE+ 
Sbjct:   331 VYYAELRGEKTAIKKMGMQATQEFLAELKVLTHVHHLNLVRLIGYCVE--NCLFLVYEFI 388

Query:   418 VNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDS 477
              NG LS  +   +     L W  R+QIALD A GL YLH    P +VH+DI S+N+LLD 
Sbjct:   389 DNGNLSQHL--QRTGYAPLSWATRVQIALDSARGLEYLHEHVVPVYVHRDIKSANILLDK 446

Query:   478 DLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILE 537
             D RAKIA+F +A+  E      +L+  + GT GYM PE    G VS K+DVYAFGV++ E
Sbjct:   447 DFRAKIADFGLAKLTEVGSMSQSLSTRVAGTFGYMPPE-ARYGEVSPKVDVYAFGVVLYE 505

Query:   538 MLTGKEAAALHAEE--NNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIR 595
             +L+ K+A    +E    +  L  +    L+  +  E+L   IDP+LQG+YP++ AL +  
Sbjct:   506 LLSAKQAIVRSSESVSESKGLVFLFEEALSAPNPTEALDELIDPSLQGDYPVDSALKIAS 565

Query:   596 LIDACLKKDPTDRPTMYEI 614
             L  +C  ++P  RPTM  +
Sbjct:   566 LAKSCTHEEPGMRPTMRSV 584

GO:0005515 "protein binding" evidence=IPI

GO:0008061 "chitin binding" evidence=IDA

GO:0010200 "response to chitin" evidence=IDA

GO:0043621 "protein self-association" evidence=IDA

TAIR|locus:2013825 TMK1 "transmembrane kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 456 (165.6 bits), Expect = 6.9e-49, Sum P(3) = 6.9e-49
 Identities = 113/311 (36%), Positives = 174/311 (55%)

Query:   329 ESISGVAQSLKVYSFKELQSATDNFSFTCRIQGS-----VYRGKINGGFA-AIKKV-NGD 381
             ++I  V     + S + L+S T+NFS +  I GS     VY+G+++ G   A+K++ NG 
Sbjct:   564 DNIQMVEAGNMLISIQVLRSVTNNFS-SDNILGSGGFGVVYKGELHDGTKIAVKRMENGV 622

Query:   382 VS--------KEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEG 433
             ++         EIA+L K+ H +L+ L G C +     LVYEY   GTLS  +F    EG
Sbjct:   623 IAGKGFAEFKSEIAVLTKVRHRHLVTLLGYCLDGNEKLLVYEYMPQGTLSRHLFEWSEEG 682

Query:   434 -KYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPA 492
              K L WKQR+ +ALDVA G+ YLH   +   +H+D+  SN+LL  D+RAK+A+F + R A
Sbjct:   683 LKPLLWKQRLTLALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLA 742

Query:   493 EGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEEN 552
                EG+ ++   I GT GY+APEY   G V+TK+DVY+FGV+++E++TG+++      E 
Sbjct:   743 P--EGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVYSFGVILMELITGRKSLDESQPEE 800

Query:   553 NMHLSDVLNAVLTKEDGEESLRHFIDPTLQ-GNYPLELALLVIRLIDACLKKDPTDRPTM 611
             ++HL      +   +  E S +  ID T+      L     V  L   C  ++P  RP M
Sbjct:   801 SIHLVSWFKRMYINK--EASFKKAIDTTIDLDEETLASVHTVAELAGHCCAREPYQRPDM 858

Query:   612 YEIEHSLSNIL 622
                 + LS+++
Sbjct:   859 GHAVNILSSLV 869

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004675 "transmembrane receptor protein serine/threonine kinase activity" evidence=IDA

GO:0005576 "extracellular region" evidence=ISS

GO:0007165 "signal transduction" evidence=IDA

UNIPROTKB|O49974 KIK1 "Serine/threonine-protein kinase" [Zea mays (taxid:4577)]

 Score = 475 (172.3 bits), Expect = 5.8e-46, Sum P(2) = 5.8e-46
 Identities = 111/314 (35%), Positives = 177/314 (56%)

Query:   319 KFDEESQDFLESISGVAQSLKVYSFKELQSATDNFSFTCRIQ----GSVYRGKINGGF-A 373
             +FD++ +D      G +  LKVYS   +++AT NFS + ++     G VY G + GG   
Sbjct:   502 RFDDDVED------GKSHELKVYSLDRIRTATSNFSDSNKLGEGGFGPVYMGTLPGGEEV 555

Query:   374 AIKKV---NG----DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWV 426
             A+K++   +G    +   E+ L+ K+ H NL+ L G C       LVYEY  N +L  ++
Sbjct:   556 AVKRLCRNSGQGLEEFKNEVILIAKLQHRNLVRLLGCCIPREEKILVYEYMPNKSLDAFL 615

Query:   427 FSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANF 486
             F N  + + LDWK+R  I   +A GL YLH  +    VH+D+ +SN+LLD+D++ KI++F
Sbjct:   616 F-NPEKQRLLDWKKRFDIIEGIARGLLYLHRDSRLRVVHRDLKASNILLDADMKPKISDF 674

Query:   487 AMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAA 546
              MAR   G + +F  T  +VGT GYM+PEY   G+ S K DVY FGVLILE++TGK A +
Sbjct:   675 GMARMFGGDQNQFN-TNRVVGTFGYMSPEYAMEGIFSVKSDVYGFGVLILEIITGKRAVS 733

Query:   547 LHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPT 606
              H  E++++++        ++  E++    IDP ++ +  +   L  I +   C++    
Sbjct:   734 FHCHEDSLNIA----GYAWRQWNEDNAAELIDPVIRASCSVRQVLRCIHIALLCVQDHAD 789

Query:   607 DRPTMYEIEHSLSN 620
             +RP +  +   LSN
Sbjct:   790 ERPDIPTVILMLSN 803

GO:0005515 "protein binding" evidence=IPI

TAIR|locus:2059703 AT2G01820 [Arabidopsis thaliana (taxid:3702)]

 Score = 458 (166.3 bits), Expect = 1.1e-43, Sum P(2) = 1.1e-43
 Identities = 104/298 (34%), Positives = 172/298 (57%)

Query:   340 VYSFKELQSATDNFSFTCRIQ----GSVYRGKINGGFA-AIKKVNGDV---------SKE 385
             V S + L++ T+NFS    +     G+VY+G+++ G   A+K++   V           E
Sbjct:   572 VISIQVLRNVTNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMESSVVSDKGLTEFKSE 631

Query:   386 IALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEG-KYLDWKQRIQI 444
             I +L K+ H +L+ L G C +     LVYEY   GTLS  +F  K EG K LDW +R+ I
Sbjct:   632 ITVLTKMRHRHLVALLGYCLDGNERLLVYEYMPQGTLSQHLFHWKEEGRKPLDWTRRLAI 691

Query:   445 ALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRH 504
             ALDVA G+ YLH+  +   +H+D+  SN+LL  D+RAK+++F + R A   +G++++   
Sbjct:   692 ALDVARGVEYLHTLAHQSFIHRDLKPSNILLGDDMRAKVSDFGLVRLAP--DGKYSIETR 749

Query:   505 IVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVL 564
             + GT GY+APEY   G V+TK+D+++ GV+++E++TG++A      E+++HL      V 
Sbjct:   750 VAGTFGYLAPEYAVTGRVTTKVDIFSLGVILMELITGRKALDETQPEDSVHLVTWFRRVA 809

Query:   565 TKEDGEESLRHFIDPTLQGNYPLELAL-LVIRLIDACLKKDPTDRPTMYEIEHSLSNI 621
               +D E + ++ IDP +  +     ++  V  L   C  ++P  RP M  I + LS++
Sbjct:   810 ASKD-ENAFKNAIDPNISLDDDTVASIEKVWELAGHCCAREPYQRPDMAHIVNVLSSL 866

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0009505 "plant-type cell wall" evidence=IDA

GO:0009555 "pollen development" evidence=IMP

GO:0009506 "plasmodesma" evidence=IDA

GO:0009616 "virus induced gene silencing" evidence=RCA

GO:0010050 "vegetative phase change" evidence=RCA

TAIR|locus:2024016 AT1G24650 [Arabidopsis thaliana (taxid:3702)]

 Score = 455 (165.2 bits), Expect = 1.3e-43, Sum P(2) = 1.3e-43
 Identities = 123/380 (32%), Positives = 196/380 (51%)

Query:   270 IVAGVLGGITLTLIFGATIFC----KFFYTRKKEPDSIVVSGSFQANEKPSNKKFDEESQ 325
             IV  V+G +   L+ G  IF     K  Y +           +F+   +       E   
Sbjct:   461 IVGSVIGILLALLLIGVAIFFLVKKKMQYHKMHPQQQSSDQDAFKITIENLCTGVSESGF 520

Query:   326 DFLESISGVAQSLKVYSFKELQSATDNFSFTCRIQ----GSVYRGKINGGFA-AIKKVNG 380
                ++  G A ++ V S + L+ AT NF     +     G VY+G+++ G   A+K++  
Sbjct:   521 SGNDAHLGEAGNI-VISIQVLRDATYNFDEKNILGRGGFGIVYKGELHDGTKIAVKRMES 579

Query:   381 DV---------SKEIALLNKINHSNLIILSGVCFNEGN-CYLVYEYAVNGTLSDWVFSNK 430
              +           EIA+L ++ H NL++L G C  EGN   LVY+Y   GTLS  +F  K
Sbjct:   580 SIISGKGLDEFKSEIAVLTRVRHRNLVVLHGYCL-EGNERLLVYQYMPQGTLSRHIFYWK 638

Query:   431 NEG-KYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMA 489
              EG + L+W +R+ IALDVA G+ YLH+  +   +H+D+  SN+LL  D+ AK+A+F + 
Sbjct:   639 EEGLRPLEWTRRLIIALDVARGVEYLHTLAHQSFIHRDLKPSNILLGDDMHAKVADFGLV 698

Query:   490 RPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHA 549
             R A   EG  ++   I GT GY+APEY   G V+TK+DVY+FGV+++E+LTG++A  +  
Sbjct:   699 RLAP--EGTQSIETKIAGTFGYLAPEYAVTGRVTTKVDVYSFGVILMELLTGRKALDVAR 756

Query:   550 EENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYP-LELALLVIRLIDACLKKDPTDR 608
              E  +HL+     +   +    S    ID  ++ N   L    +V  L + C  ++P DR
Sbjct:   757 SEEEVHLATWFRRMFINKG---SFPKAIDEAMEVNEETLRSINIVAELANQCSSREPRDR 813

Query:   609 PTMYEIEHSLSNILNASLNW 628
             P M    H ++ +++  + W
Sbjct:   814 PDM---NHVVNVLVSLVVQW 830

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
O64825	LYK4_ARATH	2, ., 7, ., 1, 1, ., 1	0.4851	0.9426	0.9673	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

No EC number assignment, probably not an enzyme!

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: eugene3.00071024 hypothetical protein (643 aa) (Populus trichocarpa)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	628
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	1e-43
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	9e-42
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	2e-41
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	2e-41
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	3e-41
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	4e-40
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	8e-38
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	1e-34
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	1e-29
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	2e-27
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	4e-27
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	3e-25
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	2e-24
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	2e-23
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	3e-23
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	3e-23
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	3e-23
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	4e-23
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	1e-22
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	2e-22
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	2e-22
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	8e-22
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	1e-21
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	3e-21
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	3e-21
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	8e-21
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	2e-20
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	3e-20
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	5e-20
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	1e-19
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	2e-19
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	2e-19
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	2e-19
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	2e-19
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	2e-19
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	3e-19
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	4e-19
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	6e-19
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	6e-19
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	7e-19
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	8e-19
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	9e-19
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	1e-18
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	1e-18
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	2e-18
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	2e-18
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	2e-18
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	3e-18
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	4e-18
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	4e-18
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	8e-18
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	8e-18
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	1e-17
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	2e-17
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	2e-17
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	2e-17
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	2e-17
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	2e-17
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	3e-17
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	3e-17
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	3e-17
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	4e-17
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	4e-17
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	4e-17
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	7e-17
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	9e-17
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	1e-16
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	1e-16
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	1e-16
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	1e-16
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	1e-16
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	2e-16
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	2e-16
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	2e-16
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	2e-16
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	2e-16
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	3e-16
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	3e-16
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	4e-16
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	4e-16
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	5e-16
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	6e-16
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	1e-15
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	2e-15
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	2e-15
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	3e-15
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	3e-15
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	4e-15
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	4e-15
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	4e-15
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	5e-15
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	6e-15
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	8e-15
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	1e-14
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	1e-14
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	1e-14
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	2e-14
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	2e-14
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	2e-14
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	2e-14
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	2e-14
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	2e-14
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	2e-14
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	3e-14
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	4e-14
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	5e-14
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	6e-14
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	9e-14
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	1e-13
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	1e-13
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	1e-13
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	2e-13
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	2e-13
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	2e-13
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	3e-13
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	3e-13
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	3e-13
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	3e-13
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	4e-13
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	5e-13
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	7e-13
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	9e-13
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	9e-13
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	9e-13
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	1e-12
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	1e-12
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	2e-12
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	2e-12
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	2e-12
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	2e-12
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	3e-12
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	4e-12
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	5e-12
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	5e-12
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	5e-12
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	6e-12
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	8e-12
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	9e-12
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	9e-12
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	1e-11
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	1e-11
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	2e-11
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	2e-11
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	2e-11
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	2e-11
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	2e-11
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	2e-11
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	3e-11
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	3e-11
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	4e-11
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	4e-11
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	4e-11
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	5e-11
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	5e-11
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	5e-11
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	7e-11
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	7e-11
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	8e-11
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	8e-11
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	8e-11
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	9e-11
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	1e-10
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	1e-10
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	2e-10
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	2e-10
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	2e-10
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	2e-10
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	2e-10
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	3e-10
pfam01476	43	pfam01476, LysM, LysM domain	3e-10
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	3e-10
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	4e-10
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	4e-10
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	4e-10
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	5e-10
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	5e-10
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	6e-10
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	8e-10
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	8e-10
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	8e-10
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	9e-10
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	1e-09
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	1e-09
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	1e-09
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	1e-09
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	2e-09
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	2e-09
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	2e-09
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	2e-09
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	2e-09
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	4e-09
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	5e-09
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	5e-09
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	6e-09
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	6e-09
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	7e-09
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	7e-09
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	7e-09
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	7e-09
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	7e-09
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	8e-09
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	1e-08
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	1e-08
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	1e-08
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	1e-08
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	1e-08
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	1e-08
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	1e-08
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	2e-08
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	2e-08
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	2e-08
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	2e-08
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	2e-08
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	3e-08
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	4e-08
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	4e-08
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	4e-08
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	4e-08
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	4e-08
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	5e-08
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	5e-08
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	6e-08
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	6e-08
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	7e-08
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	8e-08
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	8e-08
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	9e-08
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	9e-08
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	1e-07
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	1e-07
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	1e-07
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	1e-07
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	1e-07
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	1e-07
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	1e-07
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	2e-07
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	2e-07
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	3e-07
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	3e-07
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	4e-07
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	4e-07
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	4e-07
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	5e-07
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	6e-07
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	6e-07
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	6e-07
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	7e-07
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	7e-07
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	7e-07
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	8e-07
cd00118	45	cd00118, LysM, Lysine Motif is a small domain invo	8e-07
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	8e-07
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	9e-07
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	9e-07
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	9e-07
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	1e-06
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	1e-06
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	1e-06
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	1e-06
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	1e-06
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	1e-06
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	1e-06
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	1e-06
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	2e-06
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	2e-06
smart00257	44	smart00257, LysM, Lysin motif	2e-06
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	3e-06
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	3e-06
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	3e-06
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	3e-06
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	4e-06
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	4e-06
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	6e-06
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	7e-06
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	7e-06
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	8e-06
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	9e-06
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	9e-06
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	1e-05
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	2e-05
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	2e-05
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	2e-05
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	2e-05
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	2e-05
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	2e-05
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	3e-05
PRK10783	456	PRK10783, mltD, membrane-bound lytic murein transg	5e-05
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	8e-05
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	1e-04
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	2e-04
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	2e-04
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	2e-04
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	2e-04
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	3e-04
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	5e-04
COG1388	124	COG1388, LytE, FOG: LysM repeat [Cell envelope bio	0.001

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  155 bits (393), Expect = 1e-43
 Identities = 76/266 (28%), Positives = 115/266 (43%), Gaps = 73/266 (27%)

Query: 361 GSVYRG--KINGGFAAIKKVN--------GDVSKEIALLNKINHSNLIILSGVCFNEGNC 410
           G+VY    K  G   AIK +          ++ +EI +L K+NH N++ L GV  +E + 
Sbjct: 7   GTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHL 66

Query: 411 YLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINS 470
           YLV EY   G+L D +  N+     L   + ++I L +  GL YLHS      +H+D+  
Sbjct: 67  YLVMEYCEGGSLKDLLKENE---GKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKP 120

Query: 471 SNVLLDSD-LRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLEN-GLVSTKLDV 528
            N+LLDSD  + K+A+F +++     +      + IVGT  YMAPE L   G  S K D+
Sbjct: 121 ENILLDSDNGKVKLADFGLSKLLTSDKSLL---KTIVGTPAYMAPEVLLGKGYYSEKSDI 177

Query: 529 YAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLE 588
           ++ GV++ E+                                  L+              
Sbjct: 178 WSLGVILYEL--------------------------------PELKD------------- 192

Query: 589 LALLVIRLIDACLKKDPTDRPTMYEI 614
                  LI   L+KDP  RP+  EI
Sbjct: 193 -------LIRKMLQKDPEKRPSAKEI 211

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  151 bits (384), Expect = 9e-42
 Identities = 78/276 (28%), Positives = 127/276 (46%), Gaps = 48/276 (17%)

Query: 361 GSVYRGKINGG------FAAIKKVNGDVS--------KEIALLNKINHSNLIILSGVCFN 406
           G VY+G + G         A+K +  D S        +E  ++ K++H N++ L GVC  
Sbjct: 13  GEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKLLGVCTE 72

Query: 407 EGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHK 466
           E    +V EY   G L D  +  KN  K L     +  AL +A G+ YL S      +H+
Sbjct: 73  EEPLMIVMEYMPGGDLLD--YLRKNRPKELSLSDLLSFALQIARGMEYLES---KNFIHR 127

Query: 467 DINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKG---YMAPEYLENGLVS 523
           D+ + N L+  +L  KI++F ++R  +  + +      + G K    +MAPE L+ G  +
Sbjct: 128 DLAARNCLVGENLVVKISDFGLSR--DLYDDD---YYKVKGGKLPIRWMAPESLKEGKFT 182

Query: 524 TKLDVYAFGVLILEMLT-GKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQ 582
           +K DV++FGVL+ E+ T G+E          M  ++VL  +   + G    +        
Sbjct: 183 SKSDVWSFGVLLWEIFTLGEEPYP------GMSNAEVLEYL---KKGYRLPK-------- 225

Query: 583 GNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSL 618
              P      + +L+  C  +DP DRPT  E+   L
Sbjct: 226 ---PPNCPPELYKLMLQCWAEDPEDRPTFSELVEIL 258

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  150 bits (382), Expect = 2e-41
 Identities = 82/284 (28%), Positives = 127/284 (44%), Gaps = 57/284 (20%)

Query: 361 GSVYRGKINGGFA-----AIKKVNGDVS--------KEIALLNKINHSNLIILSGVCFNE 407
           G VY+GK+ G        A+K +  D S        KE  ++ K+ H N++ L GVC  E
Sbjct: 9   GEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEE 68

Query: 408 GNCYLVYEYAVNGTLSD-----WVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPP 462
              YLV EY   G L D            E   L  K  +  A+ +A G+ YL S     
Sbjct: 69  EPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLAS---KK 125

Query: 463 HVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKG-----YMAPEYL 517
            VH+D+ + N L+  DL  KI++F ++R  +  + ++   +    T G     +MAPE L
Sbjct: 126 FVHRDLAARNCLVGEDLVVKISDFGLSR--DVYDDDYYRKK----TGGKLPIRWMAPESL 179

Query: 518 ENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEE--NNMHLSDVLNAVLTKEDGEESLRH 575
           ++G+ ++K DV++FGVL+ E+ T               +   +VL  +     G     +
Sbjct: 180 KDGIFTSKSDVWSFGVLLWEIFT-------LGATPYPGLSNEEVLEYL---RKG-----Y 224

Query: 576 FID-PTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSL 618
            +  P      P EL      L+ +C + DP DRPT  E+   L
Sbjct: 225 RLPKPE---YCPDELY----ELMLSCWQLDPEDRPTFSELVERL 261

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  150 bits (381), Expect = 2e-41
 Identities = 74/269 (27%), Positives = 107/269 (39%), Gaps = 43/269 (15%)

Query: 361 GSVYRG--KINGGFAAIKKVN--------GDVSKEIALLNKINHSNLIILSGVCFNEGNC 410
           G VY    K  G   AIK +           + +EI +L K+ H N++ L  V  +E   
Sbjct: 13  GKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYDVFEDEDKL 72

Query: 411 YLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPH--VHKDI 468
           YLV EY   G L D +     +   L   +       + + L YLHS        VH+D+
Sbjct: 73  YLVMEYCEGGDLFDLL----KKRGRLSEDEARFYLRQILSALEYLHS-----KGIVHRDL 123

Query: 469 NSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDV 528
              N+LLD D   K+A+F +AR    Q          VGT  YMAPE L        +D+
Sbjct: 124 KPENILLDEDGHVKLADFGLAR----QLDPGEKLTTFVGTPEYMAPEVLLGKGYGKAVDI 179

Query: 529 YAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLE 588
           ++ GV++ E+LTGK        ++ +    +   +   +         I P         
Sbjct: 180 WSLGVILYELLTGK---PPFPGDDQLLE--LFKKIGKPKPPFPPPEWDISPEA------- 227

Query: 589 LALLVIRLIDACLKKDPTDRPTMYEI-EH 616
                  LI   L KDP  R T  E  +H
Sbjct: 228 -----KDLIRKLLVKDPEKRLTAEEALQH 251

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  149 bits (380), Expect = 3e-41
 Identities = 75/276 (27%), Positives = 126/276 (45%), Gaps = 49/276 (17%)

Query: 361 GSVYRGKINGG------FAAIKKVNGDVS--------KEIALLNKINHSNLIILSGVCFN 406
           G VY+GK+ G         A+K +  D S        +E  ++ K++H N++ L GVC  
Sbjct: 13  GEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVKLLGVCTE 72

Query: 407 EGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHK 466
           E   Y+V EY   G L  ++   +     L     +  AL +A G+ YL S      +H+
Sbjct: 73  EEPLYIVMEYMEGGDLLSYL---RKNRPKLSLSDLLSFALQIARGMEYLES---KNFIHR 126

Query: 467 DINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKG---YMAPEYLENGLVS 523
           D+ + N L+  +L  KI++F ++R  +  + ++   R     K    +MAPE L+ G  +
Sbjct: 127 DLAARNCLVGENLVVKISDFGLSR--DLYDDDYYRKRG---GKLPIRWMAPESLKEGKFT 181

Query: 524 TKLDVYAFGVLILEMLT-GKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQ 582
           +K DV++FGVL+ E+ T G++          M   +VL  +   ++G    +        
Sbjct: 182 SKSDVWSFGVLLWEIFTLGEQPYP------GMSNEEVLEYL---KNGYRLPQ-------- 224

Query: 583 GNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSL 618
              P      +  L+  C  +DP DRPT  E+   L
Sbjct: 225 ---PPNCPPELYDLMLQCWAEDPEDRPTFSELVEIL 257

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  147 bits (372), Expect = 4e-40
 Identities = 76/274 (27%), Positives = 112/274 (40%), Gaps = 52/274 (18%)

Query: 361 GSVYRG--KINGGFAAIKKVNGDVSK---------EIALLNKINHSNLIILSGVCFNEGN 409
           G+VY+   K  G   A+K +     K         EI +L +++H N++ L     ++ +
Sbjct: 13  GTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDAFEDKDH 72

Query: 410 CYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPH--VHKD 467
            YLV EY   G L D++         L   +  +IAL +  GL YLHS     +  +H+D
Sbjct: 73  LYLVMEYCEGGDLFDYLSRGGP----LSEDEAKKIALQILRGLEYLHS-----NGIIHRD 123

Query: 468 INSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPE-YLENGLVSTKL 526
           +   N+LLD +   KIA+F +A+               VGT  YMAPE  L       K+
Sbjct: 124 LKPENILLDENGVVKIADFGLAKKLLKSSSSL---TTFVGTPWYMAPEVLLGGNGYGPKV 180

Query: 527 DVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYP 586
           DV++ GV++ E+LTGK                         +        I   L     
Sbjct: 181 DVWSLGVILYELLTGK--------------------PPFSGENILDQLQLIRRILGPPLE 220

Query: 587 LELALL------VIRLIDACLKKDPTDRPTMYEI 614
            +             LI  CL KDP+ RPT  EI
Sbjct: 221 FDEPKWSSGSEEAKDLIKKCLNKDPSKRPTAEEI 254

Length = 260

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  140 bits (356), Expect = 8e-38
 Identities = 82/280 (29%), Positives = 128/280 (45%), Gaps = 56/280 (20%)

Query: 361 GSVYRGKINGGFA------AIKKVNGDVS--------KEIALLNKINHSNLIILSGVCFN 406
           G VY+G + G         A+K +    S        +E +++ K++H N++ L GVC  
Sbjct: 13  GEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRLLGVCTQ 72

Query: 407 EGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHS--FTNPPHV 464
               Y+V EY   G L D++  +  +   L  K  +Q+AL +A G+ YL S  F     V
Sbjct: 73  GEPLYIVTEYMPGGDLLDFLRKHGEK---LTLKDLLQMALQIAKGMEYLESKNF-----V 124

Query: 465 HKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGY-----MAPEYLEN 519
           H+D+ + N L+  +L  KI++F ++R     +       +     G      MAPE L++
Sbjct: 125 HRDLAARNCLVTENLVVKISDFGLSRDIYEDD------YYRKRGGGKLPIKWMAPESLKD 178

Query: 520 GLVSTKLDVYAFGVLILEMLT-GKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFID 578
           G  ++K DV++FGVL+ E+ T G++          M   +VL  +   EDG    R    
Sbjct: 179 GKFTSKSDVWSFGVLLWEIFTLGEQPYP------GMSNEEVLELL---EDGYRLPRPE-- 227

Query: 579 PTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSL 618
                N P EL      L+  C   DP DRPT  E+   L
Sbjct: 228 -----NCPDELY----ELMLQCWAYDPEDRPTFSELVEDL 258

Length = 258

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  131 bits (333), Expect = 1e-34
 Identities = 72/272 (26%), Positives = 109/272 (40%), Gaps = 57/272 (20%)

Query: 361 GSVYRG--KINGGFAAIKKVNGD---------VSKEIALLNKINHSNLIILSGVCF-NEG 408
           GSVY    K  G   A+K V            + +EI +L+ + H N++   G     E 
Sbjct: 14  GSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEK 73

Query: 409 NCYLVY-EYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPH--VH 465
           N   ++ EY   G+LS  +   K  GK L      +    +  GL YLHS     +  VH
Sbjct: 74  NTLNIFLEYVSGGSLSSLL---KKFGK-LPEPVIRKYTRQILEGLAYLHS-----NGIVH 124

Query: 466 KDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTK 525
           +DI  +N+L+DSD   K+A+F  A+     E     T  + GT  +MAPE +        
Sbjct: 125 RDIKGANILVDSDGVVKLADFGCAKRLGDIETGEG-TGSVRGTPYWMAPEVIRGEEYGRA 183

Query: 526 LDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDG-------EESLRHFID 578
            D+++ G  ++EM TGK         N M     L  + +  +         E  + F  
Sbjct: 184 ADIWSLGCTVIEMATGK--PPWSELGNPMA---ALYKIGSSGEPPEIPEHLSEEAKDF-- 236

Query: 579 PTLQGNYPLELALLVIRLIDACLKKDPTDRPT 610
                             +  CL++DP  RPT
Sbjct: 237 ------------------LRKCLRRDPKKRPT 250

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  117 bits (296), Expect = 1e-29
 Identities = 74/272 (27%), Positives = 121/272 (44%), Gaps = 51/272 (18%)

Query: 361 GSVY--RGKINGGFAAIKKVN---------GDVSKEIALLNKINHSNLIILSGVCFNEGN 409
           G VY  R K +G    +K+++          D   E+ +L K+NH N+I      F E  
Sbjct: 14  GKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYE-SFEEKG 72

Query: 410 C-YLVYEYAVNGTLSDWVFSNKNEGKYLD----WKQRIQIALDVATGLNYLHSFTNPPHV 464
              +V EYA  G LS  +   K EGK           +Q+ L     L YLHS      +
Sbjct: 73  KLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCL----ALKYLHS----RKI 124

Query: 465 -HKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVS 523
            H+DI   N+ L S+   K+ +F +++       + A T  +VGT  Y++PE  +N   +
Sbjct: 125 LHRDIKPQNIFLTSNGLVKLGDFGISKVLS-STVDLAKT--VVGTPYYLSPELCQNKPYN 181

Query: 524 TKLDVYAFGVLILEMLTGKEAAALHA-EENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQ 582
            K D+++ G ++ E+ T K     H  E  N+   ++   +L  +           P + 
Sbjct: 182 YKSDIWSLGCVLYELCTLK-----HPFEGENLL--ELALKILKGQ---------YPP-IP 224

Query: 583 GNYPLELALLVIRLIDACLKKDPTDRPTMYEI 614
             Y  EL      L+ + L+KDP +RP++ +I
Sbjct: 225 SQYSSEL----RNLVSSLLQKDPEERPSIAQI 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  110 bits (278), Expect = 2e-27
 Identities = 64/268 (23%), Positives = 110/268 (41%), Gaps = 55/268 (20%)

Query: 361 GSVYRG--KINGGFAAIKKVN-------GDVSKEIALLNKINHSNLIILSGVCFNEGNCY 411
           G VY+   K  G   AIK +          +  EI +L K  H N++   G    +   +
Sbjct: 14  GEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELW 73

Query: 412 LVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPH-VHKDINS 470
           +V E+   G+L D +   K+  + L   Q   +  ++  GL YLHS       +H+DI +
Sbjct: 74  IVMEFCSGGSLKDLL---KSTNQTLTESQIAYVCKELLKGLEYLHSN----GIIHRDIKA 126

Query: 471 SNVLLDSDLRAKIANFAMARPAEGQEGEFALTR---HIVGTKGYMAPEYLENGLVSTKLD 527
           +N+LL SD   K+ +F ++        + + T+    +VGT  +MAPE +       K D
Sbjct: 127 ANILLTSDGEVKLIDFGLS-------AQLSDTKARNTMVGTPYWMAPEVINGKPYDYKAD 179

Query: 528 VYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAV-----LTKEDGEESLRHFIDPTLQ 582
           +++ G+  +E+  GK     ++E   M     +           E   +  + F      
Sbjct: 180 IWSLGITAIELAEGK---PPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDF------ 230

Query: 583 GNYPLELALLVIRLIDACLKKDPTDRPT 610
                         +  CL+K+P  RPT
Sbjct: 231 --------------LKKCLQKNPEKRPT 244

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  110 bits (276), Expect = 4e-27
 Identities = 75/274 (27%), Positives = 122/274 (44%), Gaps = 50/274 (18%)

Query: 361 GSVYRGKINGGFAAIKKVNGDVSK------EIALLNKINHSNLIILSGVCFNEGNCYLVY 414
           G V  G   G   A+K +  D +       E +++  + H NL+ L GV       Y+V 
Sbjct: 20  GDVMLGDYRGQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVT 79

Query: 415 EYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVL 474
           EY   G+L D++ S       +   Q++  ALDV  G+ YL        VH+D+ + NVL
Sbjct: 80  EYMAKGSLVDYLRS--RGRAVITLAQQLGFALDVCEGMEYLEE---KNFVHRDLAARNVL 134

Query: 475 LDSDLRAKIANFAMARPAE-GQE-GEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFG 532
           +  DL AK+++F +A+ A  GQ+ G+  +         + APE L     STK DV++FG
Sbjct: 135 VSEDLVAKVSDFGLAKEASQGQDSGKLPVK--------WTAPEALREKKFSTKSDVWSFG 186

Query: 533 VLILEMLT-GKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLE--- 588
           +L+ E+ + G+           + L DV+  V                  +  Y +E   
Sbjct: 187 ILLWEIYSFGR------VPYPRIPLKDVVPHV------------------EKGYRMEAPE 222

Query: 589 -LALLVIRLIDACLKKDPTDRPTMYEIEHSLSNI 621
                V +++  C + DP  RPT  ++   L+ I
Sbjct: 223 GCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  105 bits (263), Expect = 3e-25
 Identities = 75/273 (27%), Positives = 112/273 (41%), Gaps = 65/273 (23%)

Query: 361 GSVYRG--KINGGFAAIKKVN---------GDVSKEIALLNKINHSNLIILSGVCFNEGN 409
           G VY+G     G F AIK+++           + +EI LL  + H N++   G      +
Sbjct: 14  GVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDS 73

Query: 410 CYLVYEYAVNGTLSDWV--FSNKNE---GKYLDWKQRIQIALDVATGLNYLHSFTNPPHV 464
            Y++ EYA NG+L   +  F    E     Y+   Q       V  GL YLH       +
Sbjct: 74  LYIILEYAENGSLRQIIKKFGPFPESLVAVYV--YQ-------VLQGLAYLH---EQGVI 121

Query: 465 HKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVST 524
           H+DI ++N+L   D   K+A+F +A        +      +VGT  +MAPE +E    ST
Sbjct: 122 HRDIKAANILTTKDGVVKLADFGVATKLNDVSKD---DASVVGTPYWMAPEVIEMSGAST 178

Query: 525 KLDVYAFGVLILEMLTGK-------EAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFI 577
             D+++ G  ++E+LTG          AAL     + H        L +    E L+ F 
Sbjct: 179 ASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPP------LPEGISPE-LKDF- 230

Query: 578 DPTLQGNYPLELALLVIRLIDACLKKDPTDRPT 610
              L                  C +KDP  RPT
Sbjct: 231 ---LM----------------QCFQKDPNLRPT 244

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  105 bits (262), Expect = 2e-24
 Identities = 71/286 (24%), Positives = 109/286 (38%), Gaps = 40/286 (13%)

Query: 361 GSVYRGKINGGFAAIKKVNGDVSK----------EIALLNKINHSNLII-LSGVCFNEGN 409
           G VY  +      A+K +   +            EI +L  +NH   I+ L     +EG+
Sbjct: 14  GEVYLARDRK-LVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGS 72

Query: 410 CYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDIN 469
            YLV EY   G+L D           L   + + I   + + L YLHS      +H+DI 
Sbjct: 73  LYLVMEYVDGGSLEDL-LKKIGRKGPLSESEALFILAQILSALEYLHSKGI---IHRDIK 128

Query: 470 SSNVLLDSDL-RAKIANFAMARPAEGQEGEF---ALTRHIVGTKGYMAPEYLE---NGLV 522
             N+LLD D    K+ +F +A+            AL    VGT GYMAPE L        
Sbjct: 129 PENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYA 188

Query: 523 STKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQ 582
           S+  D+++ G+ + E+LTG                +            + +     P+L 
Sbjct: 189 SSSSDIWSLGITLYELLTGL------------PPFEGEKNSSATSQTLKIILELPTPSLA 236

Query: 583 GNY----PLELALLVIRLIDACLKKDPTDRPTMYE-IEHSLSNILN 623
                  P  ++     L+   L KDP +R +    + H L   L 
Sbjct: 237 SPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLK 282

Length = 384

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =   99 bits (250), Expect = 2e-23
 Identities = 70/283 (24%), Positives = 115/283 (40%), Gaps = 66/283 (23%)

Query: 360 QGSVYRG--KINGGFAAIKKVNGD--------VSKEIALLNKINHSNLIILSGVCFNEGN 409
            G VY+   K  G   A+KK++ D        + +E+  L       ++   G  + EG 
Sbjct: 14  SGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGE 73

Query: 410 CYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRI--QIALDVATGLNYLHSFTNPPHVHKD 467
             +V EY   G+L+D +       K     + +   IA  +  GL+YLH+  +   +H+D
Sbjct: 74  ISIVLEYMDGGSLADLL------KKVGKIPEPVLAYIARQILKGLDYLHTKRH--IIHRD 125

Query: 468 INSSNVLLDSDLRAKIANFAMARPAE---GQEGEFALTRHIVGTKGYMAPEYLENGLVST 524
           I  SN+L++S    KIA+F +++  E    Q   F      VGT  YM+PE ++    S 
Sbjct: 126 IKPSNLLINSKGEVKIADFGISKVLENTLDQCNTF------VGTVTYMSPERIQGESYSY 179

Query: 525 KLDVYAFGVLILEMLTGK---EAAALHAEENNMHLSDVLNAVLTKEDGE-------ESLR 574
             D+++ G+ +LE   GK                  +++ A+                 R
Sbjct: 180 AADIWSLGLTLLECALGKFPFLPP------GQPSFFELMQAICDGPPPSLPAEEFSPEFR 233

Query: 575 HFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYE-IEH 616
            F                    I ACL+KDP  RP+  E ++H
Sbjct: 234 DF--------------------ISACLQKDPKKRPSAAELLQH 256

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 99.1 bits (247), Expect = 3e-23
 Identities = 82/287 (28%), Positives = 126/287 (43%), Gaps = 56/287 (19%)

Query: 345 ELQSATDNFSFTCRIQGSVYRG--KINGGFAAIKKVN---------GDVSKEIALLNKIN 393
           E+ +     SF     G V++   K +    A+K+++          +   E  +L K++
Sbjct: 3   EILNKIGKGSF-----GVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLD 57

Query: 394 HSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLD----WKQRIQIALDVA 449
            S +I       ++G   +V EYA NG L   +      G+ L     W+  IQI L   
Sbjct: 58  SSYIIRYYESFLDKGKLNIVMEYAENGDLHKLL--KMQRGRPLPEDQVWRFFIQILL--- 112

Query: 450 TGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTK 509
            GL +LHS      +H+DI S N+ LD+    KI +  +A+        FA T  IVGT 
Sbjct: 113 -GLAHLHS---KKILHRDIKSLNLFLDAYDNVKIGDLGVAK-LLSDNTNFANT--IVGTP 165

Query: 510 GYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLN--AVLTKE 567
            Y++PE  E+   + K DV+A GV++ E  TGK            H  D  N  A++ K 
Sbjct: 166 YYLSPELCEDKPYNEKSDVWALGVVLYECCTGK------------HPFDANNQGALILK- 212

Query: 568 DGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEI 614
                +R    P +   Y  +L     +LID CL KD   RP  +++
Sbjct: 213 ----IIRGVFPP-VSQMYSQQL----AQLIDQCLTKDYRQRPDTFQL 250

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 98.9 bits (247), Expect = 3e-23
 Identities = 70/257 (27%), Positives = 118/257 (45%), Gaps = 34/257 (13%)

Query: 361 GSVYRG--KINGGFAAIKKV--NGD---VSKEIALLNKINHSNLIILSGVCFNEGNCYLV 413
           GSVY+   K  G   AIK V    D   + KEI++L + +   ++   G  F   + ++V
Sbjct: 17  GSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIV 76

Query: 414 YEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNV 473
            EY   G++SD +   K   K L  ++   I      GL YLHS      +H+DI + N+
Sbjct: 77  MEYCGAGSVSDIM---KITNKTLTEEEIAAILYQTLKGLEYLHSNKK---IHRDIKAGNI 130

Query: 474 LLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGV 533
           LL+ + +AK+A+F ++          A    ++GT  +MAPE ++    + K D+++ G+
Sbjct: 131 LLNEEGQAKLADFGVS---GQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGI 187

Query: 534 LILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLV 593
             +EM  GK   +      ++H    +  +  K            PTL    P + +   
Sbjct: 188 TAIEMAEGKPPYS------DIHPMRAIFMIPNKP----------PPTLSD--PEKWSPEF 229

Query: 594 IRLIDACLKKDPTDRPT 610
              +  CL KDP +RP+
Sbjct: 230 NDFVKKCLVKDPEERPS 246

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 99.3 bits (248), Expect = 3e-23
 Identities = 79/286 (27%), Positives = 124/286 (43%), Gaps = 54/286 (18%)

Query: 361 GSVYRGKING-------GFAAIKKVNGDVS--------KEIALLNKINHSNLIILSGVCF 405
           G VY G   G          AIK VN + S         E +++ + N  +++ L GV  
Sbjct: 20  GMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVS 79

Query: 406 NEGNCYLVYEYAVNGTLSDWVFS------NKNEGKYLDWKQRIQIALDVATGLNYLHSFT 459
                 +V E    G L  ++ S      N         ++ IQ+A ++A G+ YL +  
Sbjct: 80  TGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK 139

Query: 460 NPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKG-----YMAP 514
               VH+D+ + N ++  DL  KI +F M R     +       +  G KG     +MAP
Sbjct: 140 ---FVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETD------YYRKGGKGLLPVRWMAP 190

Query: 515 EYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLR 574
           E L++G+ +TK DV++FGV++ EM T        AE+    LS+           EE L+
Sbjct: 191 ESLKDGVFTTKSDVWSFGVVLWEMAT-------LAEQPYQGLSN-----------EEVLK 232

Query: 575 HFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSN 620
             ID     + P      ++ L+  C + +P  RPT  EI  SL +
Sbjct: 233 FVIDGGHL-DLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 98.5 bits (245), Expect = 4e-23
 Identities = 77/266 (28%), Positives = 133/266 (50%), Gaps = 40/266 (15%)

Query: 361 GSVYRGKINGGFAAIKKVNGDVS-----KEIALLNKINHSNLIILSGVCFNEGNCYLVYE 415
           G+V +G+  G   A+K +  DV+     +E A++ K++H NL+ L GV  + G  Y+V E
Sbjct: 20  GAVLQGEYTGQKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVILHNG-LYIVME 78

Query: 416 YAVNGTLSDWVFSNKNEGKYL-DWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVL 474
               G L +++   +  G+ L    Q +Q +LDVA G+ YL S      VH+D+ + N+L
Sbjct: 79  LMSKGNLVNFL---RTRGRALVSVIQLLQFSLDVAEGMEYLES---KKLVHRDLAARNIL 132

Query: 475 LDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVL 534
           +  D  AK+++F +AR      G   +    +  K + APE L++   S+K DV+++GVL
Sbjct: 133 VSEDGVAKVSDFGLARV-----GSMGVDNSKLPVK-WTAPEALKHKKFSSKSDVWSYGVL 186

Query: 535 ILEMLT-GKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLV 593
           + E+ + G+      A    M L +V   V      E+  R  ++P      P      V
Sbjct: 187 LWEVFSYGR------APYPKMSLKEVKECV------EKGYR--MEP------PEGCPADV 226

Query: 594 IRLIDACLKKDPTDRPTMYEIEHSLS 619
             L+ +C + +P  RP+ +++   L 
Sbjct: 227 YVLMTSCWETEPKKRPSFHKLREKLE 252

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 98.7 bits (246), Expect = 1e-22
 Identities = 77/275 (28%), Positives = 117/275 (42%), Gaps = 68/275 (24%)

Query: 361 GSVY--RGKINGGFAAIKKVN----------GDVSKEIALLNKINHSNLIILSGVCFNEG 408
           G+VY  R        AIKK++           D+ KE+  L ++ H N I   G    E 
Sbjct: 29  GAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREH 88

Query: 409 NCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIA---LDVATGLNYLHSFTNPPHVH 465
             +LV EY + G+ SD +  +K   K L   Q ++IA        GL YLHS      +H
Sbjct: 89  TAWLVMEYCL-GSASDILEVHK---KPL---QEVEIAAICHGALQGLAYLHSHER---IH 138

Query: 466 KDINSSNVLLDSDLRAKIANF---AMARPAEGQEGEFALTRHIVGTKGYMAPEY---LEN 519
           +DI + N+LL      K+A+F   ++  PA             VGT  +MAPE    ++ 
Sbjct: 139 RDIKAGNILLTEPGTVKLADFGSASLVSPANS----------FVGTPYWMAPEVILAMDE 188

Query: 520 GLVSTKLDVYAFGVLILEMLTGKEAAALHAEEN----NMHLSDVLNAVLTKEDGEESLRH 575
           G    K+DV++ G+  +E+          AE      NM+    L  +   +        
Sbjct: 189 GQYDGKVDVWSLGITCIEL----------AERKPPLFNMNAMSALYHIAQND-------- 230

Query: 576 FIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPT 610
              PTL  N   + +      +D+CL+K P DRP+
Sbjct: 231 --SPTLSSN---DWSDYFRNFVDSCLQKIPQDRPS 260

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 97.3 bits (243), Expect = 2e-22
 Identities = 74/268 (27%), Positives = 117/268 (43%), Gaps = 53/268 (19%)

Query: 360 QGSVYRG--KINGGFAAIKK--VNGDVSK----EIALLNKINHSNLIILSGVCFNEGNC- 410
            G VY+   +  G   AIKK  +     +    EI ++    H N++      +  G+  
Sbjct: 32  SGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYD-SYLVGDEL 90

Query: 411 YLVYEYAVNGTLSD---WVFSNKNEGKYLDWKQRIQIA---LDVATGLNYLHSFTNPPHV 464
           ++V EY   G+L+D     F   NE          QIA    +V  GL YLHS     +V
Sbjct: 91  WVVMEYMDGGSLTDIITQNFVRMNEP---------QIAYVCREVLQGLEYLHSQ----NV 137

Query: 465 -HKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRH-IVGTKGYMAPEYLENGLV 522
            H+DI S N+LL  D   K+A+F  A     Q  +    R+ +VGT  +MAPE ++    
Sbjct: 138 IHRDIKSDNILLSKDGSVKLADFGFA----AQLTKEKSKRNSVVGTPYWMAPEVIKRKDY 193

Query: 523 STKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQ 582
             K+D+++ G++ +EM  G+     +  E  +     L  + TK            P L+
Sbjct: 194 GPKVDIWSLGIMCIEMAEGEPP---YLREPPLRA---LFLITTKG----------IPPLK 237

Query: 583 GNYPLELALLVIRLIDACLKKDPTDRPT 610
              P + +      ++ CL KDP  RP+
Sbjct: 238 --NPEKWSPEFKDFLNKCLVKDPEKRPS 263

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 96.6 bits (241), Expect = 2e-22
 Identities = 83/269 (30%), Positives = 123/269 (45%), Gaps = 41/269 (15%)

Query: 361 GSVYRGKINGGF-AAIKKVN------GDVSKEIALLNKINHSNLIILSGVCFNEGNCYLV 413
           G V+ G  NG    A+K +           +E  ++ K+ H  L+ L  VC  E   Y+V
Sbjct: 20  GEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIV 79

Query: 414 YEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNV 473
            EY   G+L D  F    EGK L   Q + +A  +A G+ YL S     ++H+D+ + N+
Sbjct: 80  TEYMSKGSLLD--FLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNI 134

Query: 474 LLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTK---GYMAPEYLENGLVSTKLDVYA 530
           L+  +L  KIA+F +AR  E  E      R   G K    + APE    G  + K DV++
Sbjct: 135 LVGENLVCKIADFGLARLIEDDEYT---ARE--GAKFPIKWTAPEAANYGRFTIKSDVWS 189

Query: 531 FGVLILEMLT-GKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLEL 589
           FG+L+ E++T G+           M   +VL  V      E   R    P    N P EL
Sbjct: 190 FGILLTEIVTYGR------VPYPGMTNREVLEQV------ERGYRMPRPP----NCPEEL 233

Query: 590 ALLVIRLIDACLKKDPTDRPTMYEIEHSL 618
             L+++    C  KDP +RPT   ++  L
Sbjct: 234 YDLMLQ----CWDKDPEERPTFEYLQSFL 258

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 95.2 bits (237), Expect = 8e-22
 Identities = 79/282 (28%), Positives = 125/282 (44%), Gaps = 66/282 (23%)

Query: 361 GSVYRG--KINGGFAAIKKVNGD------------VSKEIALLNKINHSNLIILSGVCFN 406
           GSVY G    +G F A+K+V+              + +EIALL+K+ H N++   G    
Sbjct: 14  GSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTERE 73

Query: 407 EGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIAL---DVATGLNYLHSFTNPPH 463
           E N Y+  E    G+L+      K   KY  + +   I L    +  GL YLH   +   
Sbjct: 74  EDNLYIFLELVPGGSLA------KLLKKYGSFPE-PVIRLYTRQILLGLEYLH---DRNT 123

Query: 464 VHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYL-ENGLV 522
           VH+DI  +N+L+D++   K+A+F MA+    Q  EF+  +   G+  +MAPE + + G  
Sbjct: 124 VHRDIKGANILVDTNGVVKLADFGMAK----QVVEFSFAKSFKGSPYWMAPEVIAQQGGY 179

Query: 523 STKLDVYAFGVLILEMLTGK-------EAAALHAEENNMHLSDVLNAVLTKEDGEESLRH 575
               D+++ G  +LEM TGK         AA+        +          +   +  + 
Sbjct: 180 GLAADIWSLGCTVLEMATGKPPWSQLEGVAAV------FKIGRSKELPPIPDHLSDEAKD 233

Query: 576 FIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYE-IEH 616
           FI   L+                 CL++DP+ RPT  E +EH
Sbjct: 234 FI---LK-----------------CLQRDPSLRPTAAELLEH 255

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 94.9 bits (236), Expect = 1e-21
 Identities = 77/253 (30%), Positives = 115/253 (45%), Gaps = 47/253 (18%)

Query: 384 KEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKY---LDWKQ 440
           KE  L++  NH N++ L GVC      Y++ E    G L  ++   + E      L  K+
Sbjct: 48  KEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKE 107

Query: 441 RIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLL-----DSDLRAKIANFAMARPAEG- 494
            + I LDVA G  YL        +H+D+ + N L+     D+D   KI +F +AR     
Sbjct: 108 LLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKS 164

Query: 495 ----QEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT-GKEAAALHA 549
               +EGE  L         +MAPE L +G  +T+ DV++FGVL+ E+LT G++      
Sbjct: 165 DYYRKEGEGLLPVR------WMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPAL- 217

Query: 550 EENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQG--NYPLELALLVIRLIDACLKKDPTD 607
             NN    +VL  V     G           LQ   N P ++  L+      C  +DP++
Sbjct: 218 --NNQ---EVLQHV--TAGGR----------LQKPENCPDKIYQLMTN----CWAQDPSE 256

Query: 608 RPTMYEIEHSLSN 620
           RPT   I+  L N
Sbjct: 257 RPTFDRIQEILQN 269

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 93.4 bits (232), Expect = 3e-21
 Identities = 70/273 (25%), Positives = 116/273 (42%), Gaps = 40/273 (14%)

Query: 361 GSVYRG--KINGGFAAIKKVNGDVS------KEIALLNKINHSNLIILSGVCFNEGNCYL 412
           G VY G  K      A+K +  D        KE A++ +I H NL+ L GVC  E   Y+
Sbjct: 20  GEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 79

Query: 413 VYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSN 472
           + E+   G L D++     +   ++    + +A  +++ + YL        +H+D+ + N
Sbjct: 80  ITEFMTYGNLLDYLRECNRQ--EVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARN 134

Query: 473 VLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTK---GYMAPEYLENGLVSTKLDVY 529
            L+  +   K+A+F ++R   G       T H  G K    + APE L     S K DV+
Sbjct: 135 CLVGENHLVKVADFGLSRLMTGD----TYTAH-AGAKFPIKWTAPESLAYNKFSIKSDVW 189

Query: 530 AFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLEL 589
           AFGVL+ E+ T   +     +     LS V                 ++   +   P   
Sbjct: 190 AFGVLLWEIATYGMSPYPGID-----LSQVY--------------ELLEKGYRMERPEGC 230

Query: 590 ALLVIRLIDACLKKDPTDRPTMYEIEHSLSNIL 622
              V  L+ AC + +P+DRP+  EI  +   + 
Sbjct: 231 PPKVYELMRACWQWNPSDRPSFAEIHQAFETMF 263

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 93.6 bits (233), Expect = 3e-21
 Identities = 75/281 (26%), Positives = 133/281 (47%), Gaps = 51/281 (18%)

Query: 361 GSVYRG--KINGG---FAAIK--------KVNGDVSKEIALLNKINHSNLIILSGVCFNE 407
           G V RG  K+ G      AIK        K   D   E +++ + +H N+I L GV    
Sbjct: 18  GEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKS 77

Query: 408 GNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKD 467
               ++ EY  NG+L    F  +N+GK     Q + +   +A+G+ YL   +   +VH+D
Sbjct: 78  RPVMIITEYMENGSLDK--FLRENDGK-FTVGQLVGMLRGIASGMKYL---SEMNYVHRD 131

Query: 468 INSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKG------YMAPEYLENGL 521
           + + N+L++S+L  K+++F ++R  E  E  +        TKG      + APE +    
Sbjct: 132 LAARNILVNSNLVCKVSDFGLSRRLEDSEATYT-------TKGGKIPIRWTAPEAIAYRK 184

Query: 522 VSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTL 581
            ++  DV++FG+++ E+++  E         +M   DV+ AV   EDG      +  P  
Sbjct: 185 FTSASDVWSFGIVMWEVMSYGERPYW-----DMSNQDVIKAV---EDG------YRLPP- 229

Query: 582 QGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNIL 622
               P++    + +L+  C +KD  +RPT  +I  +L  ++
Sbjct: 230 ----PMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKMI 266

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 92.0 bits (229), Expect = 8e-21
 Identities = 70/257 (27%), Positives = 113/257 (43%), Gaps = 34/257 (13%)

Query: 374 AIKKVN--------GDVSKEIALLNKINHSNLIILSGVCFNEGNC-YLVYEYAVNGTLSD 424
           AIK+++         ++ KE+  +++ NH N++      F  G+  +LV  Y   G+L D
Sbjct: 30  AIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYT-SFVVGDELWLVMPYLSGGSLLD 88

Query: 425 WVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIA 484
            +  +      LD      +  +V  GL YLHS      +H+DI + N+LL  D   KIA
Sbjct: 89  -IMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIA 144

Query: 485 NFAMARPAEGQEGEFALTRH-IVGTKGYMAPEYLENGLVST-KLDVYAFGVLILEMLTGK 542
           +F ++             R   VGT  +MAPE +E       K D+++FG+  +E+ TG 
Sbjct: 145 DFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATG- 203

Query: 543 EAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIR-LIDACL 601
                 A  +      VL   L  +           P+L+     +      R +I  CL
Sbjct: 204 -----AAPYSKYPPMKVLMLTLQND----------PPSLETGADYKKYSKSFRKMISLCL 248

Query: 602 KKDPTDRPTMYE-IEHS 617
           +KDP+ RPT  E ++H 
Sbjct: 249 QKDPSKRPTAEELLKHK 265

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 91.5 bits (228), Expect = 2e-20
 Identities = 57/204 (27%), Positives = 94/204 (46%), Gaps = 39/204 (19%)

Query: 361 GSVYRG--KINGGFAAIKKVNGDVSK---------EIALLNKINHSNLIILSGVCFNE-- 407
           G VY+   K  G   A+KK+  +  K         EI LL K+ H N++ L  +  ++  
Sbjct: 13  GQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGK 72

Query: 408 GNCYLVYEYA---VNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPH- 463
           G+ Y+V+EY    + G L        +        Q       +  GL YLHS     + 
Sbjct: 73  GSIYMVFEYMDHDLTGLLD-------SPEVKFTESQIKCYMKQLLEGLQYLHS-----NG 120

Query: 464 -VHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLV 522
            +H+DI  SN+L+++D   K+A+F +ARP          T  ++ T  Y  PE L   L 
Sbjct: 121 ILHRDIKGSNILINNDGVLKLADFGLARPYTK-RNSADYTNRVI-TLWYRPPELL---LG 175

Query: 523 ST----KLDVYAFGVLILEMLTGK 542
           +T    ++D+++ G ++ E+  GK
Sbjct: 176 ATRYGPEVDMWSVGCILAELFLGK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 90.4 bits (224), Expect = 3e-20
 Identities = 76/257 (29%), Positives = 123/257 (47%), Gaps = 34/257 (13%)

Query: 361 GSVYRGKINGGF-AAIKKVN-GDVS-----KEIALLNKINHSNLIILSGVCFNEGNCYLV 413
           G V+ G  NG    A+K +  G +S     +E  ++ K+ H  L+ L  V  +E   Y+V
Sbjct: 20  GEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVV-SEEPIYIV 78

Query: 414 YEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNV 473
            EY   G+L D  F    EG+ L     + +A  VA G+ Y+       ++H+D+ S+N+
Sbjct: 79  TEYMSKGSLLD--FLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANI 133

Query: 474 LLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGV 533
           L+   L  KIA+F +AR  E  + E+   +       + APE    G  + K DV++FG+
Sbjct: 134 LVGDGLVCKIADFGLARLIE--DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGI 191

Query: 534 LILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLV 593
           L+ E++T  +    +   NN            +E  E+  R +  P  Q   P+ L  L+
Sbjct: 192 LLTELVT--KGRVPYPGMNN------------REVLEQVERGYRMPCPQDC-PISLHELM 236

Query: 594 IRLIDACLKKDPTDRPT 610
           ++    C KKDP +RPT
Sbjct: 237 LQ----CWKKDPEERPT 249

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 89.7 bits (222), Expect = 5e-20
 Identities = 76/267 (28%), Positives = 126/267 (47%), Gaps = 34/267 (12%)

Query: 361 GSVYRGKINGGF-AAIKKVN-GDVS-----KEIALLNKINHSNLIILSGVCFNEGNCYLV 413
           G V+ G  NG    AIK +  G +      +E  ++ K+ H  L+ L  V  +E   Y+V
Sbjct: 20  GEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVV-SEEPIYIV 78

Query: 414 YEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNV 473
            E+   G+L D  F  + +GKYL   Q + +A  +A G+ Y+       ++H+D+ ++N+
Sbjct: 79  TEFMGKGSLLD--FLKEGDGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANI 133

Query: 474 LLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGV 533
           L+  +L  KIA+F +AR  E  + E+   +       + APE    G  + K DV++FG+
Sbjct: 134 LVGDNLVCKIADFGLARLIE--DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGI 191

Query: 534 LILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLV 593
           L+ E++T                      ++ +E  E+  R +  P  QG  P  L    
Sbjct: 192 LLTELVTKGRVP--------------YPGMVNREVLEQVERGYRMPCPQG-CPESLH--- 233

Query: 594 IRLIDACLKKDPTDRPTMYEIEHSLSN 620
             L+  C KKDP +RPT   I+  L +
Sbjct: 234 -ELMKLCWKKDPDERPTFEYIQSFLED 259

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 88.6 bits (220), Expect = 1e-19
 Identities = 71/269 (26%), Positives = 114/269 (42%), Gaps = 35/269 (13%)

Query: 361 GSVYRGK-INGGFAAIK-------KVNGDVSKEIALLNKINHSNLIILSGVCFNEGNCYL 412
           G V+ G   N    AIK           D  KE+  L ++ H +LI L  VC      Y+
Sbjct: 20  GEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYI 79

Query: 413 VYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSN 472
           + E    G+L    F    EG+ L     I +A  VA G+ YL        +H+D+ + N
Sbjct: 80  ITELMEKGSLL--AFLRSPEGQVLPVASLIDMACQVAEGMAYLEE---QNSIHRDLAARN 134

Query: 473 VLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFG 532
           +L+  DL  K+A+F +AR    +E  +  +   +  K + APE   +G  STK DV++FG
Sbjct: 135 ILVGEDLVCKVADFGLARLI--KEDVYLSSDKKIPYK-WTAPEAASHGTFSTKSDVWSFG 191

Query: 533 VLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALL 592
           +L+ EM T              +       +   E  ++    +  P      P +    
Sbjct: 192 ILLYEMFT--------------YGQVPYPGMNNHEVYDQITAGYRMPC-----PAKCPQE 232

Query: 593 VIRLIDACLKKDPTDRPTMYEIEHSLSNI 621
           + +++  C   +P DRP+   +   L NI
Sbjct: 233 IYKIMLECWAAEPEDRPSFKALREELDNI 261

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 88.0 bits (219), Expect = 2e-19
 Identities = 75/264 (28%), Positives = 112/264 (42%), Gaps = 51/264 (19%)

Query: 361 GSVY--RGKINGGFAAIKKVNGD----------VSKEIALLNKINHSNLIILSGVCF-NE 407
           G V   R K  G   A+K +                E  +L++INH  ++ L    F  E
Sbjct: 7   GKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLH-YAFQTE 65

Query: 408 GNCYLVYEYAVNGTLSDWVFSN-KNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPH--V 464
              YLV EYA  G L    FS+   EG++ + + R   A ++   L YLHS        +
Sbjct: 66  EKLYLVLEYAPGGEL----FSHLSKEGRFSEERARFYAA-EIVLALEYLHS-----LGII 115

Query: 465 HKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVST 524
           ++D+   N+LLD+D   K+ +F +A+       E + T    GT  Y+APE L       
Sbjct: 116 YRDLKPENILLDADGHIKLTDFGLAKELSS---EGSRTNTFCGTPEYLAPEVLLGKGYGK 172

Query: 525 KLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGN 584
            +D ++ GVL+ EMLTGK     +AE+       +   +L           F+ P  +  
Sbjct: 173 AVDWWSLGVLLYEMLTGK--PPFYAEDRKE----IYEKILKD---PLRFPEFLSPEARD- 222

Query: 585 YPLELALLVIRLIDACLKKDPTDR 608
                      LI   L+KDPT R
Sbjct: 223 -----------LISGLLQKDPTKR 235

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 88.1 bits (219), Expect = 2e-19
 Identities = 67/276 (24%), Positives = 120/276 (43%), Gaps = 54/276 (19%)

Query: 361 GSVY--RGKINGGFAAIKKVNGDVSKEI--------ALLNKINHSNLIILSGVCFNEGNC 410
           G V     +  G   A+K +  ++++ I         +L+K N   ++   G  +N G+ 
Sbjct: 15  GVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDI 74

Query: 411 YLVYEYAVNGTLSDWVFSNKNEGKYLD-WKQRI------QIALDVATGLNYLHSFTNPPH 463
            +  EY   G+L           K L   + RI      +IA+ V  GL YLH       
Sbjct: 75  SICMEYMDGGSLD----------KILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKI-- 122

Query: 464 VHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEF--ALTRHIVGTKGYMAPEYLENGL 521
           +H+D+  SN+L++S  + K+ +F       G  G+   +L +  VGT  YMAPE ++   
Sbjct: 123 IHRDVKPSNILVNSRGQIKLCDF-------GVSGQLVNSLAKTFVGTSSYMAPERIQGND 175

Query: 522 VSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTL 581
            S K D+++ G+ ++E+ TG+       +  +    ++L  ++     E        P L
Sbjct: 176 YSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIF-ELLQYIVN----EPP------PRL 224

Query: 582 -QGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEH 616
             G +  +        ++ CL KDP +RP+  E+  
Sbjct: 225 PSGKFSPDF----QDFVNLCLIKDPRERPSYKELLE 256

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 88.6 bits (219), Expect = 2e-19
 Identities = 68/235 (28%), Positives = 116/235 (49%), Gaps = 33/235 (14%)

Query: 381 DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQ 440
           D+ +EI +L++ +   +    G    +   +++ EY   G+  D +     E   LD  Q
Sbjct: 48  DIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL-----EPGPLDETQ 102

Query: 441 RIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFA 500
              I  ++  GL+YLHS      +H+DI ++NVLL      K+A+F +A    GQ  +  
Sbjct: 103 IATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVA----GQLTDTQ 155

Query: 501 LTRH-IVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDV 559
           + R+  VGT  +MAPE ++     +K D+++ G+  +E+  G+     H+E   +H   V
Sbjct: 156 IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPP---HSE---LHPMKV 209

Query: 560 LNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEI 614
           L  ++ K +          PTL+GNY   L       ++ACL K+P+ RPT  E+
Sbjct: 210 L-FLIPKNN---------PPTLEGNYSKPLK----EFVEACLNKEPSFRPTAKEL 250

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 88.6 bits (220), Expect = 2e-19
 Identities = 75/257 (29%), Positives = 119/257 (46%), Gaps = 40/257 (15%)

Query: 381 DVSKEIALLNKI-NHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKY---- 435
           D+  E+ ++  I  H N+I L GVC  EG  Y+V EYA +G L D++ + +  G+Y    
Sbjct: 61  DLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPD 120

Query: 436 --------LDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFA 487
                   L  K  +  A  VA G+ +L S      +H+D+ + NVL+  D   KIA+F 
Sbjct: 121 DPRPPEETLTQKDLVSFAYQVARGMEFLAS---KKCIHRDLAARNVLVTEDHVMKIADFG 177

Query: 488 MARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT--GKEAA 545
           +AR     +     T   +  K +MAPE L + + + + DV++FGVL+ E+ T  G    
Sbjct: 178 LARDIHHIDYYRKTTNGRLPVK-WMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYP 236

Query: 546 ALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDP 605
            +  EE    L  +L     KE       + ++     N   EL  L+      C  + P
Sbjct: 237 GIPVEE----LFKLL-----KEG------YRMEKPQ--NCTQELYHLMRD----CWHEVP 275

Query: 606 TDRPTMYEIEHSLSNIL 622
           + RPT  ++   L  +L
Sbjct: 276 SQRPTFKQLVEDLDRML 292

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 88.0 bits (219), Expect = 2e-19
 Identities = 60/186 (32%), Positives = 83/186 (44%), Gaps = 28/186 (15%)

Query: 376 KKVNGDVSKEIALLNKIN-HSNLIILSGVCF-NEGNCYLVYEYAVNGTLSDWVFSNKNEG 433
           KKV   V  E  +L ++N H  +I L    F +E N Y V EYA NG L    +  K   
Sbjct: 43  KKVK-YVKIEKEVLTRLNGHPGIIKLYY-TFQDEENLYFVLEYAPNGEL--LQYIRKY-- 96

Query: 434 KYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMAR--- 490
             LD K     A ++   L YLHS      +H+D+   N+LLD D+  KI +F  A+   
Sbjct: 97  GSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLD 153

Query: 491 ---PAEGQEGEFALTRHI-----------VGTKGYMAPEYLENGLVSTKLDVYAFGVLIL 536
                E  +G+                  VGT  Y++PE L         D++A G +I 
Sbjct: 154 PNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIY 213

Query: 537 EMLTGK 542
           +MLTGK
Sbjct: 214 QMLTGK 219

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 88.1 bits (219), Expect = 3e-19
 Identities = 68/265 (25%), Positives = 117/265 (44%), Gaps = 44/265 (16%)

Query: 361 GSVYRG--KINGGFAAIKKVN--------GDVSKEIALLNKINHSNLIILSGVCFNEG-N 409
           G VY+   K      AIK ++         D+ +EI  L++     +    G  F +G  
Sbjct: 15  GEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYG-SFLKGSK 73

Query: 410 CYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDIN 469
            +++ EY   G+  D +   K     LD      I  +V  GL YLH       +H+DI 
Sbjct: 74  LWIIMEYCGGGSCLDLLKPGK-----LDETYIAFILREVLLGLEYLHE---EGKIHRDIK 125

Query: 470 SSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRH-IVGTKGYMAPEYLENGLVSTKLDV 528
           ++N+LL  +   K+A+F ++    GQ       R+  VGT  +MAPE ++      K D+
Sbjct: 126 AANILLSEEGDVKLADFGVS----GQLTSTMSKRNTFVGTPFWMAPEVIKQSGYDEKADI 181

Query: 529 YAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLE 588
           ++ G+  +E+  G+      ++   +H   VL  ++ K +          P+L+GN   +
Sbjct: 182 WSLGITAIELAKGE---PPLSD---LHPMRVL-FLIPKNN---------PPSLEGN---K 222

Query: 589 LALLVIRLIDACLKKDPTDRPTMYE 613
            +      +  CL KDP +RP+  E
Sbjct: 223 FSKPFKDFVSLCLNKDPKERPSAKE 247

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 87.9 bits (218), Expect = 4e-19
 Identities = 69/272 (25%), Positives = 129/272 (47%), Gaps = 41/272 (15%)

Query: 370 GGFAAIKKVNG-------DVSKEIALLNKINHSNLIILSGVCFNEG--NCYLVYEYAVNG 420
           G   A+KK+         D  +EI +L  + H N++   GVC++ G  N  LV EY   G
Sbjct: 33  GEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYG 92

Query: 421 TLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLR 480
           +L D++  ++     LD ++ +  A  +  G+ YL S     +VH+D+ + N+L++S+ R
Sbjct: 93  SLRDYLQKHRER---LDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENR 146

Query: 481 AKIANFAMAR--PAEGQEGEFALTRHIVGTKG-----YMAPEYLENGLVSTKLDVYAFGV 533
            KI +F + +  P   Q+ E+    + V   G     + APE L     S   DV++FGV
Sbjct: 147 VKIGDFGLTKVLP---QDKEY----YKVREPGESPIFWYAPESLTESKFSVASDVWSFGV 199

Query: 534 LILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNY----PLEL 589
           ++ E+ T       +++++    ++ +  +   + G+  + H I+  L+ N     P   
Sbjct: 200 VLYELFT-------YSDKSCSPPAEFMRMMGNDKQGQMIVYHLIE-LLKNNGRLPAPPGC 251

Query: 590 ALLVIRLIDACLKKDPTDRPTMYEIEHSLSNI 621
              +  ++  C   DP+ RP+  E+   +  I
Sbjct: 252 PAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 86.4 bits (214), Expect = 6e-19
 Identities = 73/267 (27%), Positives = 122/267 (45%), Gaps = 35/267 (13%)

Query: 361 GSVYRGKINGGF-AAIKKVNGDVS--------KEIALLNKINHSNLIILSGVCFNEGNCY 411
           G VY+G + G    A+K     +         +E  +L + +H N++ L GVC  +   Y
Sbjct: 9   GDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIY 68

Query: 412 LVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSS 471
           +V E    G+L  ++   KN    L  K+ +Q++LD A G+ YL S      +H+D+ + 
Sbjct: 69  IVMELVPGGSLLTFLRKKKNR---LTVKKLLQMSLDAAAGMEYLESKNC---IHRDLAAR 122

Query: 472 NVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAF 531
           N L+  +   KI++F M+R  EG     +     +  K + APE L  G  +++ DV+++
Sbjct: 123 NCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIK-WTAPEALNYGRYTSESDVWSY 181

Query: 532 GVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELAL 591
           G+L+ E  +       +   +N           T+E  E   R    P  Q   P E   
Sbjct: 182 GILLWETFSL--GDTPYPGMSNQQ---------TRERIESGYRM---PAPQL-CPEE--- 223

Query: 592 LVIRLIDACLKKDPTDRPTMYEIEHSL 618
            + RL+  C   DP +RP+  EI + L
Sbjct: 224 -IYRLMLQCWAYDPENRPSFSEIYNEL 249

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 86.7 bits (215), Expect = 6e-19
 Identities = 75/261 (28%), Positives = 118/261 (45%), Gaps = 41/261 (15%)

Query: 361 GSVYRGKINGGFA-AIKKVNG------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLV 413
           G V+ G  N     A+K +        D   E  ++ K+ H  LI L  VC  E   Y+V
Sbjct: 20  GEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIV 79

Query: 414 YEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNV 473
            E    G+L +++      G+ L   Q I +A  VA+G+ YL +     ++H+D+ + NV
Sbjct: 80  TELMKYGSLLEYL--QGGAGRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNV 134

Query: 474 LLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTK---GYMAPEYLENGLVSTKLDVYA 530
           L+  +   K+A+F +AR  +    E    R   G K    + APE       S K DV++
Sbjct: 135 LVGENNICKVADFGLARVIKEDIYE---ARE--GAKFPIKWTAPEAALYNRFSIKSDVWS 189

Query: 531 FGVLILEMLT-GKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLEL 589
           FG+L+ E++T G+           M  ++VL  V      ++  R    P      P EL
Sbjct: 190 FGILLTEIVTYGRMPYP------GMTNAEVLQQV------DQGYRMPCPP----GCPKEL 233

Query: 590 ALLVIRLIDACLKKDPTDRPT 610
             +++     C K+DP DRPT
Sbjct: 234 YDIMLD----CWKEDPDDRPT 250

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 86.3 bits (214), Expect = 7e-19
 Identities = 70/274 (25%), Positives = 112/274 (40%), Gaps = 57/274 (20%)

Query: 361 GSVYRGKIN--GGFAAIKKVN---------GDVSKEIALLNKINHSNLIILSGVCFNE-- 407
           GSVY+ K      F A+K+V+          D   EI +L  +NH N+I      + E  
Sbjct: 14  GSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNII-----SYKEAF 68

Query: 408 --GN-CYLVYEYAVNGTLSDWVFSNKNEGKYLD----WKQRIQIALDVATGLNYLHSFTN 460
             GN   +V EYA  G LS  +   K + K +     W+  IQ+      GL  LH    
Sbjct: 69  LDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLR----GLQALHEQKI 124

Query: 461 PPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENG 520
              +H+D+ S+N+LL ++   KI +  +++  +       + +  +GT  YMAPE  +  
Sbjct: 125 ---LHRDLKSANILLVANDLVKIGDLGISKVLKKN-----MAKTQIGTPHYMAPEVWKGR 176

Query: 521 LVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPT 580
             S K D+++ G L+ EM      A          + D+   V   +           P 
Sbjct: 177 PYSYKSDIWSLGCLLYEM------ATFAPPFEARSMQDLRYKVQRGKY----------PP 220

Query: 581 LQGNYPLELALLVIRLIDACLKKDPTDRPTMYEI 614
           +   Y  +L       I + L+  P  RP   +I
Sbjct: 221 IPPIYSQDL----QNFIRSMLQVKPKLRPNCDKI 250

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 87.0 bits (216), Expect = 8e-19
 Identities = 75/281 (26%), Positives = 123/281 (43%), Gaps = 48/281 (17%)

Query: 361 GSVY--RGKINGGFAAIKKV-----NGDVSK----EIALLNKINHSNLIILSGVCFNEGN 409
           G V   R K  G   AIKK      + DV K    E+ +L ++ H N++ L      +G 
Sbjct: 15  GVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGR 74

Query: 410 CYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPH--VHKD 467
            YLV+EY V  TL + + ++   G   D  +     L     + Y HS     H  +H+D
Sbjct: 75  LYLVFEY-VERTLLELLEASPG-GLPPDAVRSYIWQL--LQAIAYCHS-----HNIIHRD 125

Query: 468 INSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTK-- 525
           I   N+L+      K+ +F  AR    +     LT + V T+ Y APE L   +  T   
Sbjct: 126 IKPENILVSESGVLKLCDFGFARALRAR-PASPLTDY-VATRWYRAPELL---VGDTNYG 180

Query: 526 --LDVYAFGVLILEMLTGKEAAALHAEENNM-HLSDVLNAV--LTKEDGEESLRH----- 575
             +DV+A G ++ E+L G+    L   ++++  L  +   +  L     E    +     
Sbjct: 181 KPVDVWAIGCIMAELLDGE---PLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAG 237

Query: 576 --FIDP----TLQGNYPLELALLVIRLIDACLKKDPTDRPT 610
             F +P    +L+  YP +++   +  + ACL+ DP +R T
Sbjct: 238 VAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLT 278

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 86.2 bits (214), Expect = 9e-19
 Identities = 72/272 (26%), Positives = 112/272 (41%), Gaps = 45/272 (16%)

Query: 361 GSVYRGKIN---GGFAAIKKVN---GD------VSKEIALLNKINHSNLIILSGVCFNEG 408
           G VY   +N   G   A+K++     D      ++ E+ +L  + H NL+   GV  +  
Sbjct: 14  GKVYTA-VNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHRE 72

Query: 409 NCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPH--VHK 466
             Y+  EY   GTL + +      G+ LD        L +  GL YLHS     H  VH+
Sbjct: 73  KVYIFMEYCSGGTLEELL----EHGRILDEHVIRVYTLQLLEGLAYLHS-----HGIVHR 123

Query: 467 DINSSNVLLDSDLRAKIANFAMA-RPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTK 525
           DI  +N+ LD +   K+ +F  A +            + + GT  YMAPE +  G     
Sbjct: 124 DIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGH 183

Query: 526 L---DVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQ 582
               D+++ G ++LEM TGK        +N      ++  V               P + 
Sbjct: 184 GRAADIWSLGCVVLEMATGKR--PWSELDNEFQ---IMFHVGAGH----------KPPIP 228

Query: 583 GNYPLELALLVIRLIDACLKKDPTDRPTMYEI 614
               L+L+      +D CL+ DP  RPT  E+
Sbjct: 229 D--SLQLSPEGKDFLDRCLESDPKKRPTASEL 258

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 86.1 bits (214), Expect = 1e-18
 Identities = 58/239 (24%), Positives = 102/239 (42%), Gaps = 37/239 (15%)

Query: 385 EIALLNKINHSNLIILSGVCFNEGN--CYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRI 442
           E+ +L ++ H N++       +  N   Y+V EY   G L+  +   K E KY++ +   
Sbjct: 49  EVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIW 108

Query: 443 QIALDVATGLNYLHSFTNPPHV--HKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFA 500
           +I   +   L   H+ ++P +   H+D+  +N+ LD++   K+ +F +A+   G +  FA
Sbjct: 109 RILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL-GHDSSFA 167

Query: 501 LTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGK---EAAALHAEENNMHLS 557
            T   VGT  YM+PE L +     K D+++ G LI E+        A             
Sbjct: 168 KT--YVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN----------- 214

Query: 558 DVLNAVLTKE--DGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEI 614
                 L  +  +G+          +   Y  EL      +I + L  DP  RP+  E+
Sbjct: 215 ---QLQLASKIKEGKF-------RRIPYRYSSELN----EVIKSMLNVDPDKRPSTEEL 259

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 85.6 bits (212), Expect = 1e-18
 Identities = 52/196 (26%), Positives = 92/196 (46%), Gaps = 31/196 (15%)

Query: 361 GSVYRGKINGGF-AAIKKVN------GDVSKEIALLNKINHSNLIILSGVCFNEGNCYLV 413
           G V+ GK  G    AIK +        D  +E  ++ K++H NL+ L GVC  +   ++V
Sbjct: 18  GVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIV 77

Query: 414 YEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYL--HSFTNPPHVHKDINSS 471
            EY  NG L +++   K +      +  + +  DV   + YL  + F     +H+D+ + 
Sbjct: 78  TEYMANGCLLNYLRERKGKLGT---EWLLDMCSDVCEAMEYLESNGF-----IHRDLAAR 129

Query: 472 NVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKG------YMAPEYLENGLVSTK 525
           N L+  D   K+++F +AR        + L      ++G      +  PE  +    S+K
Sbjct: 130 NCLVGEDNVVKVSDFGLAR--------YVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSK 181

Query: 526 LDVYAFGVLILEMLTG 541
            DV++FGVL+ E+ + 
Sbjct: 182 SDVWSFGVLMWEVFSE 197

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 86.0 bits (214), Expect = 2e-18
 Identities = 63/214 (29%), Positives = 94/214 (43%), Gaps = 62/214 (28%)

Query: 361 GSVYRG--KINGGFAAIKKVNGDVSK---------EIALLNKINHSNLIILSGVCFNEGN 409
           G VY+   K  G   A+KK+  D  +         EI+LL ++ H N++ L  V   E  
Sbjct: 13  GVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERK 72

Query: 410 CYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQR------IQ-IALDVATGLNYLHSFTNPP 462
            YLV+EY            + +  KYLD +        I+ I   +  GL Y HS     
Sbjct: 73  LYLVFEYC-----------DMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHS----- 116

Query: 463 H--VHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEF-----ALTRHIVGTKGYMAPE 515
           H  +H+D+   N+L++ D   K+A+F +AR        F       T  +V T  Y APE
Sbjct: 117 HRILHRDLKPQNILINRDGVLKLADFGLAR-------AFGIPLRTYTHEVV-TLWYRAPE 168

Query: 516 -------YLENGLVSTKLDVYAFGVLILEMLTGK 542
                  Y      ST +D+++ G +  EM+TGK
Sbjct: 169 ILLGSKHY------STAVDIWSVGCIFAEMITGK 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 89.5 bits (222), Expect = 2e-18
 Identities = 80/287 (27%), Positives = 132/287 (45%), Gaps = 27/287 (9%)

Query: 346 LQSATDNFSFTCRIQGSVYRGK-INGGF----AAIKKVNGDVSKEIALLNKINHSNLIIL 400
           L S  +    +   +G+ Y+GK I  G       I  VN   S EIA + K+ H N++ L
Sbjct: 689 LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIADMGKLQHPNIVKL 748

Query: 401 SGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTN 460
            G+C +E   YL++EY     LS+ V  N      L W++R +IA+ +A  L +LH   +
Sbjct: 749 IGLCRSEKGAYLIHEYIEGKNLSE-VLRN------LSWERRRKIAIGIAKALRFLHCRCS 801

Query: 461 PPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENG 520
           P  V  +++   +++D      +             G          +  Y+APE  E  
Sbjct: 802 PAVVVGNLSPEKIIIDGKDEPHLR--------LSLPGLLCTDTKCFISSAYVAPETRETK 853

Query: 521 LVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPT 580
            ++ K D+Y FG++++E+LTGK  A     E  +H S V  A     D    L  +IDP+
Sbjct: 854 DITEKSDIYGFGLILIELLTGKSPADA---EFGVHGSIVEWARYCYSDCH--LDMWIDPS 908

Query: 581 LQGNYPLELALLV--IRLIDACLKKDPTDRPTMYEIEHSLSNILNAS 625
           ++G+  +    +V  + L   C   DPT RP   ++  +L +   +S
Sbjct: 909 IRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSS 955

Length = 968

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 85.2 bits (211), Expect = 2e-18
 Identities = 58/261 (22%), Positives = 112/261 (42%), Gaps = 37/261 (14%)

Query: 363 VYRGKINGGFAAIKKVN---------GDVSKEIALLNKINHSNLIILSGVCFNEGNCYLV 413
           +YR   +      K+VN          D   EI +L+ + H N+I       ++    + 
Sbjct: 18  LYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIE 77

Query: 414 YEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNV 473
            EYA  GTL D +   + +G+  + +  +     + + ++Y+H       +H+DI + N+
Sbjct: 78  MEYANGGTLYDKI--VRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGI---LHRDIKTLNI 132

Query: 474 LLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGV 533
            L      K+ +F +++       E+++   +VGT  YM+PE  +    + K D++A G 
Sbjct: 133 FLTKAGLIKLGDFGISKILGS---EYSMAETVVGTPYYMSPELCQGVKYNFKSDIWALGC 189

Query: 534 LILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLV 593
           ++ E+LT K       +  N    +++  ++                    Y  EL    
Sbjct: 190 VLYELLTLKRT----FDATN--PLNLVVKIVQGNYTPV----------VSVYSSEL---- 229

Query: 594 IRLIDACLKKDPTDRPTMYEI 614
           I L+ + L++DP  RPT  E+
Sbjct: 230 ISLVHSLLQQDPEKRPTADEV 250

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 85.4 bits (211), Expect = 3e-18
 Identities = 57/175 (32%), Positives = 93/175 (53%), Gaps = 24/175 (13%)

Query: 381 DVSKEIALLNKI-NHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNK--------- 430
           D + E+ +L K+ +H N+I L G C N G  Y+  EYA  G L D++  ++         
Sbjct: 48  DFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFA 107

Query: 431 ---NEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFA 487
                   L  +Q +Q A DVATG+ YL   +    +H+D+ + NVL+  +L +KIA+F 
Sbjct: 108 KEHGTASTLTSQQLLQFASDVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFG 164

Query: 488 MARPAEGQEGEFALTRHIVG--TKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT 540
           ++R      GE    +  +G     +MA E L   + +TK DV++FGVL+ E+++
Sbjct: 165 LSR------GEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 85.5 bits (211), Expect = 4e-18
 Identities = 73/243 (30%), Positives = 108/243 (44%), Gaps = 48/243 (19%)

Query: 381 DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQ 440
           D+ KE+  L +I H N I   G    E   +LV EY + G+ SD +  +K         Q
Sbjct: 71  DIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCL-GSASDLLEVHKKP------LQ 123

Query: 441 RIQIAL---DVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANF---AMARPAEG 494
            ++IA        GL YLHS      +H+DI + N+LL    + K+A+F   ++A PA  
Sbjct: 124 EVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASPANS 180

Query: 495 QEGEFALTRHIVGTKGYMAPEY---LENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEE 551
                      VGT  +MAPE    ++ G    K+DV++ G+  +E+   K         
Sbjct: 181 ----------FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF----- 225

Query: 552 NNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTM 611
            NM+    L  +   E           PTLQ N   E +      +D+CL+K P DRPT 
Sbjct: 226 -NMNAMSALYHIAQNE----------SPTLQSN---EWSDYFRNFVDSCLQKIPQDRPTS 271

Query: 612 YEI 614
            E+
Sbjct: 272 EEL 274

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 84.2 bits (208), Expect = 4e-18
 Identities = 60/245 (24%), Positives = 108/245 (44%), Gaps = 39/245 (15%)

Query: 381 DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQ 440
           D  +E  ++ K++H  L+ L GVC       LV+E+  +G LSD++ + + +      + 
Sbjct: 45  DFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGK---FSQET 101

Query: 441 RIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFA 500
            + + LDV  G+ YL S      +H+D+ + N L+  +   K+++F M R        F 
Sbjct: 102 LLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTR--------FV 150

Query: 501 LTRHIVGTKG------YMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNM 554
           L      + G      + +PE       S+K DV++FGVL+ E+ +  E    +   +N 
Sbjct: 151 LDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFS--EGKTPYENRSNS 208

Query: 555 HLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEI 614
            + + +NA      G    +  +               V  L+  C K+ P DRP+   +
Sbjct: 209 EVVETINA------GFRLYKPRLASQ-----------SVYELMQHCWKERPEDRPSFSLL 251

Query: 615 EHSLS 619
            H L+
Sbjct: 252 LHQLA 256

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 83.6 bits (207), Expect = 8e-18
 Identities = 51/166 (30%), Positives = 80/166 (48%), Gaps = 10/166 (6%)

Query: 381 DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKY---LD 437
           D   E  +++K NH N++ L GV F     +++ E    G L  ++  N+   +    L 
Sbjct: 55  DFLMEALIMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLT 114

Query: 438 WKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDS---DLRAKIANFAMARPAEG 494
            K  +  A DVA G  YL        +H+DI + N LL        AKIA+F MAR    
Sbjct: 115 MKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYR 171

Query: 495 QEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT 540
                   R ++  K +M PE   +G+ ++K DV++FGVL+ E+ +
Sbjct: 172 ASYYRKGGRAMLPIK-WMPPEAFLDGIFTSKTDVWSFGVLLWEIFS 216

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 83.6 bits (207), Expect = 8e-18
 Identities = 65/258 (25%), Positives = 107/258 (41%), Gaps = 49/258 (18%)

Query: 381 DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSN----------K 430
           D  +E  LL    H N++   GVC       +V+EY  +G L+ ++ S+           
Sbjct: 54  DFEREAELLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPD 113

Query: 431 NEGKYLDWKQRIQIALDVATGLNYLHS--FTNPPHVHKDINSSNVLLDSDLRAKIANFAM 488
           +    L   Q +QIA+ +A+G+ YL S  F     VH+D+ + N L+  DL  KI +F M
Sbjct: 114 SPMGELTLSQLLQIAVQIASGMVYLASQHF-----VHRDLATRNCLVGYDLVVKIGDFGM 168

Query: 489 ARPAEGQEGEFALTRHIVGTKG-----YMAPEYLENGLVSTKLDVYAFGVLILEMLT-GK 542
           +R        +    + VG        +M PE +     +T+ DV++FGV++ E+ T GK
Sbjct: 169 SRDV------YTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGK 222

Query: 543 EAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLK 602
           +     + E      +V+                I        P      V  ++  C K
Sbjct: 223 QPWYGLSNE------EVI--------------ECITQGRLLQRPRTCPSEVYDIMLGCWK 262

Query: 603 KDPTDRPTMYEIEHSLSN 620
           +DP  R  + +I   L  
Sbjct: 263 RDPQQRINIKDIHERLQK 280

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 82.7 bits (204), Expect = 1e-17
 Identities = 56/185 (30%), Positives = 93/185 (50%), Gaps = 19/185 (10%)

Query: 361 GSVYRGKINGGFAAIKKVNGDVSK-----EIALLNKINHSNLIILSGVCFNE-GNCYLVY 414
           G V  G   G   A+K +  D +      E +++ ++ HSNL+ L GV   E G  Y+V 
Sbjct: 20  GDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 79

Query: 415 EYAVNGTLSDWVFSNKNEGK-YLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNV 473
           EY   G+L D++   ++ G+  L     ++ +LDV   + YL +      VH+D+ + NV
Sbjct: 80  EYMAKGSLVDYL---RSRGRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNV 133

Query: 474 LLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGV 533
           L+  D  AK+++F + + A   +    L         + APE L     STK DV++FG+
Sbjct: 134 LVSEDNVAKVSDFGLTKEASSTQDTGKLPVK------WTAPEALREKKFSTKSDVWSFGI 187

Query: 534 LILEM 538
           L+ E+
Sbjct: 188 LLWEI 192

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 82.9 bits (205), Expect = 2e-17
 Identities = 54/209 (25%), Positives = 102/209 (48%), Gaps = 39/209 (18%)

Query: 361 GSVYRGKINGGFA-------AIK--------KVNGDVSKEIALLNKINHSNLIILSGVCF 405
           G VY+G++ G          AIK        KV  +  +E  L++ + H N++ L GVC 
Sbjct: 19  GKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCT 78

Query: 406 NEGNCYLVYEYAVNGTLSDWVFSN------------KNEGKYLDWKQRIQIALDVATGLN 453
            E    +++EY  +G L +++  N            +     LD    + IA+ +A G+ 
Sbjct: 79  KEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGME 138

Query: 454 YL--HSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEF--ALTRHIVGTK 509
           YL  H F     VH+D+ + N L+   L  KI++F ++R  +    ++    ++ ++  +
Sbjct: 139 YLSSHHF-----VHRDLAARNCLVGEGLTVKISDFGLSR--DIYSADYYRVQSKSLLPVR 191

Query: 510 GYMAPEYLENGLVSTKLDVYAFGVLILEM 538
            +M PE +  G  +T+ D+++FGV++ E+
Sbjct: 192 -WMPPEAILYGKFTTESDIWSFGVVLWEI 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 82.8 bits (204), Expect = 2e-17
 Identities = 63/235 (26%), Positives = 107/235 (45%), Gaps = 33/235 (14%)

Query: 381 DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQ 440
           D+ +EI +L++ +   +    G        +++ EY   G+  D + +        D  Q
Sbjct: 48  DIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGP-----FDEFQ 102

Query: 441 RIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFA 500
              +  ++  GL+YLHS      +H+DI ++NVLL      K+A+F +A    GQ  +  
Sbjct: 103 IATMLKEILKGLDYLHS---EKKIHRDIKAANVLLSEQGDVKLADFGVA----GQLTDTQ 155

Query: 501 LTRH-IVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDV 559
           + R+  VGT  +MAPE ++     +K D+++ G+  +E+  G+         ++MH   V
Sbjct: 156 IKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGE------PPNSDMHPMRV 209

Query: 560 LNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEI 614
           L  +               PTL G +           IDACL KDP+ RPT  E+
Sbjct: 210 LFLI----------PKNNPPTLTGEFSKPFK----EFIDACLNKDPSFRPTAKEL 250

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 82.5 bits (204), Expect = 2e-17
 Identities = 58/245 (23%), Positives = 114/245 (46%), Gaps = 28/245 (11%)

Query: 381 DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNK-----NEGKY 435
           +  +E+ +  K++H N++ L G+C      Y++ EY   G L  ++ + K      +   
Sbjct: 54  EFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPP 113

Query: 436 LDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQ 495
           L  KQ++ +   +A G+++L   +N   VH+D+ + N L+ S    K++  ++++     
Sbjct: 114 LSTKQKVALCTQIALGMDHL---SNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNS 170

Query: 496 EGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMH 555
           E  + L   ++  + ++APE ++    STK DV++FGVL+ E+ T  E        ++  
Sbjct: 171 E-YYKLRNALIPLR-WLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELP--FYGLSD-- 224

Query: 556 LSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIE 615
             +VLN +         L       +    P  L     +L+  C   +P DRP+  E+ 
Sbjct: 225 -EEVLNRL-----QAGKLEL----PVPEGCPSRLY----KLMTRCWAVNPKDRPSFSELV 270

Query: 616 HSLSN 620
            +L  
Sbjct: 271 SALGE 275

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 83.1 bits (205), Expect = 2e-17
 Identities = 72/253 (28%), Positives = 119/253 (47%), Gaps = 23/253 (9%)

Query: 374 AIKKVNGDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWV------- 426
             K    D  KEI +++++ + N+I L GVC ++    ++ EY  NG L+ ++       
Sbjct: 56  VTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIES 115

Query: 427 -FSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIAN 485
            F++ N    +     + +A+ +A+G+ YL S      VH+D+ + N L+ +    KIA+
Sbjct: 116 TFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNCLVGNHYTIKIAD 172

Query: 486 FAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAA 545
           F M+R     +      R ++  + +MA E +  G  +T  DV+AFGV + EM T     
Sbjct: 173 FGMSRNLYSGDYYRIQGRAVLPIR-WMAWESILLGKFTTASDVWAFGVTLWEMFT----- 226

Query: 546 ALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDP 605
            L  E+    LSD    V+  E+  E  R+          PL     V +L+  C  +D 
Sbjct: 227 -LCKEQPYSLLSD--EQVI--ENTGEFFRNQGRQIYLSQTPL-CPSPVFKLMMRCWSRDI 280

Query: 606 TDRPTMYEIEHSL 618
            DRPT  +I H L
Sbjct: 281 KDRPTFNKIHHFL 293

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 82.8 bits (205), Expect = 2e-17
 Identities = 46/182 (25%), Positives = 94/182 (51%), Gaps = 26/182 (14%)

Query: 374 AIKKVN--------GDVSKEIALLNKINHSNLIILSGVCFNEG--NCYLVYEYAVNGTLS 423
           A+K +N         D  +EI +L  ++H N++   GVC   G  +  L+ EY  +G+L 
Sbjct: 37  AVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLR 96

Query: 424 DWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKI 483
           D++  ++++   ++ K+ +  +  +  G++YL    +  ++H+D+ + N+L++S+   KI
Sbjct: 97  DYLQRHRDQ---INLKRLLLFSSQICKGMDYLG---SQRYIHRDLAARNILVESEDLVKI 150

Query: 484 ANFAMARPAEGQEGEFALTRHIVGTKG-----YMAPEYLENGLVSTKLDVYAFGVLILEM 538
           ++F +A+     +  +      V   G     + APE L     S+  DV++FGV + E+
Sbjct: 151 SDFGLAKVLPEDKDYY-----YVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYEL 205

Query: 539 LT 540
            T
Sbjct: 206 FT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 82.0 bits (202), Expect = 3e-17
 Identities = 65/238 (27%), Positives = 112/238 (47%), Gaps = 28/238 (11%)

Query: 384 KEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQ 443
           +E  L+  + H  L+ L  V   E   Y++ EY   G+L D  F   +EG  +   + I 
Sbjct: 50  EEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLD--FLKSDEGGKVLLPKLID 107

Query: 444 IALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTR 503
            +  +A G+ Y+       ++H+D+ ++NVL+   L  KIA+F +AR  E  + E+    
Sbjct: 108 FSAQIAEGMAYIE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIE--DNEYTARE 162

Query: 504 HIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT-GKEAAALHAEENNMHLSDVLNA 562
                  + APE +  G  + K DV++FG+L+ E++T GK           M  SDV++A
Sbjct: 163 GAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGK------IPYPGMSNSDVMSA 216

Query: 563 VLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSN 620
           +          R +  P ++ N P EL      ++  C K+   +RPT   ++  L +
Sbjct: 217 L---------QRGYRMPRME-NCPDEL----YDIMKTCWKEKAEERPTFDYLQSVLDD 260

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 81.4 bits (201), Expect = 3e-17
 Identities = 73/236 (30%), Positives = 110/236 (46%), Gaps = 38/236 (16%)

Query: 384 KEIALLNKINHSNLIILSGVCFNE-GNCYLVYEYAVNGTLSDWVFSNK----NEGKYLDW 438
           KE+A+L+ + H N I+     F E GN Y+V +Y   G L   + + +     E + LDW
Sbjct: 48  KEVAVLSNMKHPN-IVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDW 106

Query: 439 KQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGE 498
              +QI L     L ++H   +   +H+DI S N+ L  D   K+ +F +AR        
Sbjct: 107 --FVQICL----ALKHVH---DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNST--- 154

Query: 499 FALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSD 558
             L R  +GT  Y++PE  EN   + K D++A G ++ EM T K A     E  NM    
Sbjct: 155 VELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHA----FEAGNMK--- 207

Query: 559 VLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEI 614
             N VL    G         P +  +Y  +L  LV +L     K++P DRP++  I
Sbjct: 208 --NLVLKIIRGSY-------PPVSSHYSYDLRNLVSQL----FKRNPRDRPSVNSI 250

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 81.5 bits (201), Expect = 3e-17
 Identities = 69/241 (28%), Positives = 113/241 (46%), Gaps = 33/241 (13%)

Query: 385 EIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQI 444
           E   L + +HSN++ L GV        +V EY  NG L    F  K+EG+ L   Q + +
Sbjct: 56  EALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDS--FLRKHEGQ-LVAGQLMGM 112

Query: 445 ALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRH 504
              +A+G+ YL   +   +VHK + +  VL++SDL  KI+ F   R    QE +      
Sbjct: 113 LPGLASGMKYL---SEMGYVHKGLAAHKVLVNSDLVCKISGF---RR--LQEDKSEAIYT 164

Query: 505 IVGTKG---YMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLN 561
            +  K    + APE ++    S+  DV++FG+++ E+++  E         +M   DV+ 
Sbjct: 165 TMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYW-----DMSGQDVIK 219

Query: 562 AVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNI 621
           AV   EDG      F  P      P     L+ +L+  C +K+  +RP   +I   LS +
Sbjct: 220 AV---EDG------FRLPA-----PRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265

Query: 622 L 622
           +
Sbjct: 266 V 266

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 81.9 bits (202), Expect = 4e-17
 Identities = 47/162 (29%), Positives = 91/162 (56%), Gaps = 8/162 (4%)

Query: 381 DVSKEIALLNKINHSNLIILSGVCFNEGN--CYLVYEYAVNGTLSDWVFSNKNEGKYLDW 438
           D+ KEI +L  + H N++   G+C  +G     L+ E+  +G+L +++  NKN+   ++ 
Sbjct: 52  DLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNK---INL 108

Query: 439 KQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGE 498
           KQ+++ A+ +  G++YL S     +VH+D+ + NVL++S+ + KI +F + +  E  +  
Sbjct: 109 KQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEY 165

Query: 499 FALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT 540
           + +   +     + APE L         DV++FGV + E+LT
Sbjct: 166 YTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 81.3 bits (200), Expect = 4e-17
 Identities = 71/257 (27%), Positives = 120/257 (46%), Gaps = 34/257 (13%)

Query: 361 GSVYRGKINGGF-AAIKKVN-GDVS-----KEIALLNKINHSNLIILSGVCFNEGNCYLV 413
           G V+ G  NG    AIK +  G +S     +E  ++ K+ H  L+ L  V  +E   Y+V
Sbjct: 20  GEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV-SEEPIYIV 78

Query: 414 YEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNV 473
            EY   G+L D  F     GKYL   Q + +A  +A+G+ Y+       +VH+D+ ++N+
Sbjct: 79  TEYMSKGSLLD--FLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANI 133

Query: 474 LLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGV 533
           L+  +L  K+A+F +AR  E  + E+   +       + APE    G  + K DV++FG+
Sbjct: 134 LVGENLVCKVADFGLARLIE--DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGI 191

Query: 534 LILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLV 593
           L+ E+ T                      ++ +E  ++  R +  P      P E    +
Sbjct: 192 LLTELTTKGRVP--------------YPGMVNREVLDQVERGYRMPC-----PPECPESL 232

Query: 594 IRLIDACLKKDPTDRPT 610
             L+  C +K+P +RPT
Sbjct: 233 HDLMCQCWRKEPEERPT 249

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 81.4 bits (201), Expect = 4e-17
 Identities = 67/242 (27%), Positives = 110/242 (45%), Gaps = 29/242 (11%)

Query: 377 KVNGDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYL 436
           +V   + KEI L+ ++NH ++I + G    + +  L  E+   G++S  +       KY 
Sbjct: 45  EVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLL------SKYG 98

Query: 437 DWKQRIQIA--LDVATGLNYLHSFTNPPHVHKDINSSNVLLDSD-LRAKIANF-AMARPA 492
            +K+ + I     +  GL+YLH       +H+D+  +N+L+DS   R +IA+F A AR A
Sbjct: 99  AFKEAVIINYTEQLLRGLSYLH---ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLA 155

Query: 493 EGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEEN 552
               G       ++GT  +MAPE L         DV++ G +I+EM T K         N
Sbjct: 156 AKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSN 215

Query: 553 NMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMY 612
           ++ L   + +  T     E L     P L+         + +R    CL+  P DRP   
Sbjct: 216 HLALIFKIASATTAPSIPEHLS----PGLRD--------VTLR----CLELQPEDRPPSR 259

Query: 613 EI 614
           E+
Sbjct: 260 EL 261

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 80.4 bits (198), Expect = 7e-17
 Identities = 66/238 (27%), Positives = 111/238 (46%), Gaps = 32/238 (13%)

Query: 384 KEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQ 443
           +E  +L + +H N++ L GVC  +   Y+V E    G   D++   + EG  L  K+ IQ
Sbjct: 42  QEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGG---DFLTFLRTEGPRLKVKELIQ 98

Query: 444 IALDVATGLNYLHSFTNPPH-VHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALT 502
           +  + A G+ YL S     H +H+D+ + N L+      KI++F M+R  E ++G +A T
Sbjct: 99  MVENAAAGMEYLES----KHCIHRDLAARNCLVTEKNVLKISDFGMSR--EEEDGVYAST 152

Query: 503 RHI--VGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVL 560
             +  +  K + APE L  G  S++ DV++FG+L+ E  +                   L
Sbjct: 153 GGMKQIPVK-WTAPEALNYGRYSSESDVWSFGILLWEAFS-------------------L 192

Query: 561 NAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSL 618
            AV       +  R  I+  ++   P      V RL++ C + DP  RP+   +   L
Sbjct: 193 GAVPYANLSNQQTREAIEQGVRLPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQEL 250

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 80.6 bits (199), Expect = 9e-17
 Identities = 67/268 (25%), Positives = 116/268 (43%), Gaps = 44/268 (16%)

Query: 361 GSVYRGKIN--GGFAAIKKVN--------GDVSKEIALLNKINHS---NLIILSGVCFNE 407
           G+VYRGK    G   A+K +N         D+ +E+ALL+++  S   N+    G     
Sbjct: 15  GAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKG 74

Query: 408 GNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKD 467
              +++ EYA  G++   + +     KY+    R     +V   L Y+H       +H+D
Sbjct: 75  PRLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIR-----EVLVALKYIHK---VGVIHRD 126

Query: 468 INSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENG-LVSTKL 526
           I ++N+L+ +    K+ +F +A  A   +     +   VGT  +MAPE +  G    TK 
Sbjct: 127 IKAANILVTNTGNVKLCDFGVA--ALLNQNSSKRST-FVGTPYWMAPEVITEGKYYDTKA 183

Query: 527 DVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYP 586
           D+++ G+ I EM TG    +       M L                +     P L+ N  
Sbjct: 184 DIWSLGITIYEMATGNPPYSDVDAFRAMML----------------IPKSKPPRLEDN-- 225

Query: 587 LELALLVIRLIDACLKKDPTDRPTMYEI 614
              + L+   + ACL ++P +R +  E+
Sbjct: 226 -GYSKLLREFVAACLDEEPKERLSAEEL 252

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 80.5 bits (199), Expect = 1e-16
 Identities = 78/282 (27%), Positives = 124/282 (43%), Gaps = 48/282 (17%)

Query: 365 RGKINGGFAAIKK---------VNGDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYE 415
           + K  G   AIKK         V     +EI +L ++ H NL+ L  V   +   YLV+E
Sbjct: 21  KHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80

Query: 416 YAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPH--VHKDINSSNV 473
           + V+ T+ D +    N    LD  +  +    +  G+ + HS     H  +H+DI   N+
Sbjct: 81  F-VDHTVLDDLEKYPNG---LDESRVRKYLFQILRGIEFCHS-----HNIIHRDIKPENI 131

Query: 474 LLDSDLRAKIANFAMARP-AEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTK----LDV 528
           L+      K+ +F  AR  A   E     T + V T+ Y APE L   +  TK    +D+
Sbjct: 132 LVSQSGVVKLCDFGFARTLAAPGE---VYTDY-VATRWYRAPELL---VGDTKYGRAVDI 184

Query: 529 YAFGVLILEMLTGKEAAALHAEENNMH--------LSDVLNAVLTKEDGEESLRHFIDPT 580
           +A G L+ EMLTG+      ++ + ++        L      +  K      +R    P 
Sbjct: 185 WAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRL---PE 241

Query: 581 LQGNYPLE-----LALLVIRLIDACLKKDPTDRPTMYEIEHS 617
           ++   PLE     L+ LV+ L   CL+ DP DRP+  ++ H 
Sbjct: 242 VKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 79.9 bits (197), Expect = 1e-16
 Identities = 61/193 (31%), Positives = 98/193 (50%), Gaps = 22/193 (11%)

Query: 361 GSVYRGKINGGF-AAIKKVN-GDVSK-----EIALLNKINHSNLIILSGVCFNEGNCYLV 413
           G V  GK  G +  AIK +  G +S+     E  ++ K++H  L+ L GVC  +   Y+V
Sbjct: 18  GVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIV 77

Query: 414 YEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNV 473
            EY  NG L +++   +  GK     Q +++  DV  G+ YL S      +H+D+ + N 
Sbjct: 78  TEYMSNGCLLNYL---REHGKRFQPSQLLEMCKDVCEGMAYLES---KQFIHRDLAARNC 131

Query: 474 LLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTK---GYMAPEYLENGLVSTKLDVYA 530
           L+D     K+++F ++R     E   +     VG+K    +  PE L     S+K DV+A
Sbjct: 132 LVDDQGCVKVSDFGLSRYVLDDEYTSS-----VGSKFPVRWSPPEVLLYSKFSSKSDVWA 186

Query: 531 FGVLILEMLT-GK 542
           FGVL+ E+ + GK
Sbjct: 187 FGVLMWEVYSLGK 199

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 80.6 bits (199), Expect = 1e-16
 Identities = 62/280 (22%), Positives = 120/280 (42%), Gaps = 55/280 (19%)

Query: 360 QGSVYRGKINGGFAAIK---------KVNGDVS-KEIALLNKINHSNLIILSG--VCFNE 407
           Q S+Y+G  N     I+         KV  D++  EI  L +I+ +N++ + G  +   +
Sbjct: 33  QNSIYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVD 92

Query: 408 GNCY--LVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVH 465
                 L+ EY   G L + +   K+    L +K ++ +A+D   GL  L+ +TN P+ +
Sbjct: 93  DLPRLSLILEYCTRGYLREVLDKEKD----LSFKTKLDMAIDCCKGLYNLYKYTNKPYKN 148

Query: 466 KDINSSNVLLDSDLRAKIANFA----MARPAEGQEGEFALTRHIVGTKGYMAPEYLENGL 521
             + S + L+  + + KI        ++ P              V    Y + + L +  
Sbjct: 149 --LTSVSFLVTENYKLKIICHGLEKILSSPPFKN----------VNFMVYFSYKMLNDIF 196

Query: 522 --VSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDP 579
              + K D+Y+ GV++ E+ TGK          N+   ++ + ++  ++    L      
Sbjct: 197 SEYTIKDDIYSLGVVLWEIFTGK------IPFENLTTKEIYDLII-NKNNSLKL------ 243

Query: 580 TLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLS 619
                 PL+  L +  +++AC   D   RP + EI ++LS
Sbjct: 244 ------PLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLS 277

Length = 283

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 79.9 bits (197), Expect = 1e-16
 Identities = 59/193 (30%), Positives = 97/193 (50%), Gaps = 27/193 (13%)

Query: 361 GSVYRGKINGGF-AAIKKVN-GDVS-----KEIALLNKINHSNLIILSGVCFNEGNCYLV 413
           G V+ G  NG    AIK +  G +S      E  L+ ++ H  L+ L  V   E   Y++
Sbjct: 20  GEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVTQE-PIYII 78

Query: 414 YEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNV 473
            EY  NG+L D  F    EG  L   + I +A  +A G+ ++       ++H+D+ ++N+
Sbjct: 79  TEYMENGSLVD--FLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANI 133

Query: 474 LLDSDLRAKIANFAMARPAE-----GQEG-EFALTRHIVGTKGYMAPEYLENGLVSTKLD 527
           L+   L  KIA+F +AR  E      +EG +F +         + APE +  G  + K D
Sbjct: 134 LVSETLCCKIADFGLARLIEDNEYTAREGAKFPIK--------WTAPEAINYGTFTIKSD 185

Query: 528 VYAFGVLILEMLT 540
           V++FG+L+ E++T
Sbjct: 186 VWSFGILLTEIVT 198

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 80.2 bits (198), Expect = 1e-16
 Identities = 68/248 (27%), Positives = 116/248 (46%), Gaps = 41/248 (16%)

Query: 374 AIKKVNGDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEG 433
           A   V   + +E+ ++++     ++   G   NE N  +  E+   G+L D ++      
Sbjct: 42  AKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSL-DRIYK----- 95

Query: 434 KYLDWKQRI--QIALDVATGLNYLHSFTNPPH-VHKDINSSNVLLDSDLRAKIANFAMAR 490
           K       I  +IA+ V  GL YL+   N    +H+DI  SN+L++S  + K+ +F    
Sbjct: 96  KGGPIPVEILGKIAVAVVEGLTYLY---NVHRIMHRDIKPSNILVNSRGQIKLCDF---- 148

Query: 491 PAEGQEGEF--ALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGK-----E 543
              G  GE   ++    VGT  YM+PE ++ G  + K DV++ G+ I+E+  GK      
Sbjct: 149 ---GVSGELINSIADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFS 205

Query: 544 AAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTL-QGNYPLELALLVIRLIDACLK 602
                 +++ M + D+L  ++ +            P L   ++P +L   V    DACL 
Sbjct: 206 NIDDDGQDDPMGILDLLQQIVQEP----------PPRLPSSDFPEDLRDFV----DACLL 251

Query: 603 KDPTDRPT 610
           KDPT+RPT
Sbjct: 252 KDPTERPT 259

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 80.5 bits (198), Expect = 2e-16
 Identities = 67/237 (28%), Positives = 102/237 (43%), Gaps = 36/237 (15%)

Query: 381 DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQ 440
           D+ KE+  L ++ H N I   G    E   +LV EY + G+ SD +  +K   K L   +
Sbjct: 67  DIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCL-GSASDLLEVHK---KPLQEVE 122

Query: 441 RIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFA 500
              I      GL YLHS      +H+DI + N+LL    + K+A+F  A  +       +
Sbjct: 123 IAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKS-------S 172

Query: 501 LTRHIVGTKGYMAPEY---LENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLS 557
                VGT  +MAPE    ++ G    K+DV++ G+  +E+   K          NM+  
Sbjct: 173 PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF------NMNAM 226

Query: 558 DVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEI 614
             L  +   +           PTLQ N   E        +D CL+K P +RP   E+
Sbjct: 227 SALYHIAQND----------SPTLQSN---EWTDSFRGFVDYCLQKIPQERPASAEL 270

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 79.7 bits (196), Expect = 2e-16
 Identities = 51/175 (29%), Positives = 92/175 (52%), Gaps = 24/175 (13%)

Query: 381 DVSKEIALLNKI-NHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNK--------- 430
           D + E+ +L K+ +H N+I L G C + G  YL  EYA +G L D++  ++         
Sbjct: 41  DFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFA 100

Query: 431 ---NEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFA 487
              +    L  +Q +  A DVA G++YL   +    +H+D+ + N+L+  +  AKIA+F 
Sbjct: 101 IANSTASTLSSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFG 157

Query: 488 MARPAEGQEGEFALTRHIVG--TKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT 540
           ++R      G+    +  +G     +MA E L   + +T  DV+++GVL+ E+++
Sbjct: 158 LSR------GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 80.4 bits (198), Expect = 2e-16
 Identities = 76/260 (29%), Positives = 122/260 (46%), Gaps = 42/260 (16%)

Query: 381 DVSKEIALLNKIN-HSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEG------ 433
           D+  E+ L+  I  H N+I L GVC  EG  Y++ EYA  G L +++ + +  G      
Sbjct: 63  DLISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFD 122

Query: 434 ------KYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFA 487
                 + L +K  +  A  VA G+ YL S      +H+D+ + NVL+  D   KIA+F 
Sbjct: 123 ITKVPEEQLSFKDLVSCAYQVARGMEYLES---RRCIHRDLAARNVLVTEDNVMKIADFG 179

Query: 488 MARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT--GKEAA 545
           +AR     +     +   +  K +MAPE L + + + + DV++FG+L+ E+ T  G    
Sbjct: 180 LARGVHDIDYYKKTSNGRLPVK-WMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYP 238

Query: 546 ALHAEENNMHLSDVLNAVLTKEDGEESLRHFID-PTLQGNYPLELALLVIRLIDACLKKD 604
            +  EE    L  +L     +E       H +D P+   N   EL +    L+  C    
Sbjct: 239 GIPVEE----LFKLL-----REG------HRMDKPS---NCTHELYM----LMRECWHAV 276

Query: 605 PTDRPTMYEIEHSLSNILNA 624
           PT RPT  ++  +L  +L A
Sbjct: 277 PTQRPTFKQLVEALDKVLAA 296

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 79.3 bits (196), Expect = 2e-16
 Identities = 73/271 (26%), Positives = 112/271 (41%), Gaps = 55/271 (20%)

Query: 361 GSVYRGKI--NGGFAAIKKVN---GD----VSKEIALLNKINHSNLIILSGVCFNEGNCY 411
           G VY+ +    G   AIK +    GD    + +EI++L +  H N++   G        +
Sbjct: 17  GDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLW 76

Query: 412 LVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIAL---DVATGLNYLHSFTNPPHVHKDI 468
           +V EY   G+L D        G        +QIA    +   GL YLH       +H+DI
Sbjct: 77  IVMEYCGGGSLQD--IYQVTRGPL----SELQIAYVCRETLKGLAYLHETGK---IHRDI 127

Query: 469 NSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHI------VGTKGYMAPEYLE---N 519
             +N+LL  D   K+A+F ++  A+       LT  I      +GT  +MAPE       
Sbjct: 128 KGANILLTEDGDVKLADFGVS--AQ-------LTATIAKRKSFIGTPYWMAPEVAAVERK 178

Query: 520 GLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDP 579
           G    K D++A G+  +E+      A L     ++H    L  +        S  +F  P
Sbjct: 179 GGYDGKCDIWALGITAIEL------AELQPPMFDLHPMRALFLI--------SKSNFPPP 224

Query: 580 TLQGNYPLELALLVIRLIDACLKKDPTDRPT 610
            L+     + + +    I  CL KDP  RPT
Sbjct: 225 KLKD--KEKWSPVFHDFIKKCLTKDPKKRPT 253

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 79.3 bits (195), Expect = 2e-16
 Identities = 70/265 (26%), Positives = 117/265 (44%), Gaps = 43/265 (16%)

Query: 361 GSVYRGKINGG--FAAIKKVN--------GDVSKEIALLNKINHSNLIILSGVCFNEGNC 410
           G VY+G  N      AIK ++         D+ +EI +L++ +   +    G        
Sbjct: 18  GEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKL 77

Query: 411 YLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINS 470
           +++ EY   G+  D +     E  Y+       I  ++  GL+YLHS      +H+DI +
Sbjct: 78  WIIMEYLGGGSALDLLKPGPLEETYI-----ATILREILKGLDYLHS---ERKIHRDIKA 129

Query: 471 SNVLLDSDLRAKIANFAMARPAEGQEGEFALTRH-IVGTKGYMAPEYLENGLVSTKLDVY 529
           +NVLL      K+A+F +A    GQ  +  + R+  VGT  +MAPE ++      K D++
Sbjct: 130 ANVLLSEQGDVKLADFGVA----GQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKADIW 185

Query: 530 AFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLEL 589
           + G+  +E+  G+         +++H   VL  +               PTL+G Y    
Sbjct: 186 SLGITAIELAKGE------PPNSDLHPMRVLFLIPKNS----------PPTLEGQYSKPF 229

Query: 590 ALLVIRLIDACLKKDPTDRPTMYEI 614
                  ++ACL KDP  RPT  E+
Sbjct: 230 K----EFVEACLNKDPRFRPTAKEL 250

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 78.6 bits (194), Expect = 3e-16
 Identities = 74/274 (27%), Positives = 121/274 (44%), Gaps = 53/274 (19%)

Query: 362 SVYRG--KINGGFAAIKKVN----------GDVSKEIALLNKINHSNLI--ILSGVCFNE 407
            VY+    ++G   A+KKV            D  KEI LL +++H N+I  + S +  NE
Sbjct: 17  VVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNE 76

Query: 408 GNCYLVYEYAVNGTLSDWVFSNKNEGKYLD----WKQRIQIALDVATGLNYLHSFTNPPH 463
            N  +V E A  G LS  +   K + + +     WK  +Q+     + L ++HS      
Sbjct: 77  LN--IVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLC----SALEHMHSKRI--- 127

Query: 464 VHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYL-ENGLV 522
           +H+DI  +NV + +    K+ +  + R    +         +VGT  YM+PE + ENG  
Sbjct: 128 MHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA---AHSLVGTPYYMSPERIHENGY- 183

Query: 523 STKLDVYAFGVLILEMLTGKEAAALHA--EENNMHLSDVLNAVLTKEDGEESLRHFIDPT 580
           + K D+++ G L+ EM      AAL +    + M+L  +   +   E  +        P 
Sbjct: 184 NFKSDIWSLGCLLYEM------AALQSPFYGDKMNLYSLCKKI---EKCDYP------PL 228

Query: 581 LQGNYPLELALLVIRLIDACLKKDPTDRPTMYEI 614
              +Y  EL  LV R    C+  DP  RP +  +
Sbjct: 229 PADHYSEELRDLVSR----CINPDPEKRPDISYV 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 79.0 bits (195), Expect = 3e-16
 Identities = 73/276 (26%), Positives = 113/276 (40%), Gaps = 57/276 (20%)

Query: 361 GSVYRGKI--NGGFAAIKKV----NGDVSK----EIALLNKINHSNLIILSGVCFNEGNC 410
           GSV + ++   G   A+K +    N D+ K    E+ +        ++   G   +E + 
Sbjct: 15  GSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSS 74

Query: 411 --YLVYEYAVNGTLSDWVFSN-KNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKD 467
              +  EY   G+L D ++   K  G  +  K   +IA  V  GL+YLHS      +H+D
Sbjct: 75  SIGIAMEYCEGGSL-DSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHS---RKIIHRD 130

Query: 468 INSSNVLLDSDLRAKIANFAMARPAEGQEGEF--ALTRHIVGTKGYMAPEYLENGLVSTK 525
           I  SN+LL    + K+ +F       G  GE   +L     GT  YMAPE ++    S  
Sbjct: 131 IKPSNILLTRKGQVKLCDF-------GVSGELVNSLAGTFTGTSFYMAPERIQGKPYSIT 183

Query: 526 LDVYAFGVLILEMLTGK------EAAALHAEENNMHLSDVLNAVLTKEDGE-----ESLR 574
            DV++ G+ +LE+   +          L   E   ++ ++ N  L  E G      E  +
Sbjct: 184 SDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGIKWSEEFK 243

Query: 575 HFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPT 610
            F                    I  CL+KDPT RPT
Sbjct: 244 DF--------------------IKQCLEKDPTRRPT 259

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 78.9 bits (195), Expect = 4e-16
 Identities = 57/197 (28%), Positives = 93/197 (47%), Gaps = 26/197 (13%)

Query: 360 QGSVY--RGKINGGFAAIKKV------NGDVS---KEIALLNKINHSNLIILSGVCFNEG 408
            G VY  R K+ G   AIKK+       G      +EI LL ++NH N+I L  V  ++G
Sbjct: 12  YGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKG 71

Query: 409 NCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPH--VHK 466
           + YLV+E+      +D     K+  + L           +  GL + HS     H  +H+
Sbjct: 72  DLYLVFEF----MDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHS-----HGILHR 122

Query: 467 DINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLEN-GLVSTK 525
           D+   N+L++++   K+A+F +AR             H V T+ Y APE L      ST 
Sbjct: 123 DLKPENLLINTEGVLKLADFGLARSFGSP---VRPYTHYVVTRWYRAPELLLGDKGYSTP 179

Query: 526 LDVYAFGVLILEMLTGK 542
           +D+++ G +  E+L+ +
Sbjct: 180 VDIWSVGCIFAELLSRR 196

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 78.9 bits (194), Expect = 4e-16
 Identities = 63/262 (24%), Positives = 111/262 (42%), Gaps = 43/262 (16%)

Query: 381 DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWV-FSNKNEGKY---- 435
           D+  E  LL ++NH ++I L G C  +G   L+ EYA  G+L  ++  S K    Y    
Sbjct: 49  DLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSD 108

Query: 436 ---------------LDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLR 480
                          L     I  A  ++ G+ YL        VH+D+ + NVL+    +
Sbjct: 109 GNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARNVLVAEGRK 165

Query: 481 AKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT 540
            KI++F ++R    ++     ++  +  K +MA E L + + +T+ DV++FGVL+ E++T
Sbjct: 166 MKISDFGLSRDVYEEDSYVKRSKGRIPVK-WMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224

Query: 541 GKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDAC 600
                              L          E L + +    +   P   +  +  L+  C
Sbjct: 225 -------------------LGGNPYPGIAPERLFNLLKTGYRMERPENCSEEMYNLMLTC 265

Query: 601 LKKDPTDRPTMYEIEHSLSNIL 622
            K++P  RPT  +I   L  ++
Sbjct: 266 WKQEPDKRPTFADISKELEKMM 287

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 78.9 bits (194), Expect = 5e-16
 Identities = 73/266 (27%), Positives = 111/266 (41%), Gaps = 50/266 (18%)

Query: 361 GSVY--RGKINGGFAAIKKVN----------GDVSKEIALLNKINHSNLIILSGVCFNEG 408
           G+VY  R   N    AIKK++           D+ KE+  L K+ H N I   G    E 
Sbjct: 29  GAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREH 88

Query: 409 NCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDI 468
             +LV EY + G+ SD +  +K   K L   +   +      GL YLHS      +H+D+
Sbjct: 89  TAWLVMEYCL-GSASDLLEVHK---KPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDV 141

Query: 469 NSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEY---LENGLVSTK 525
            + N+LL      K+ +F       G     A     VGT  +MAPE    ++ G    K
Sbjct: 142 KAGNILLSEPGLVKLGDF-------GSASIMAPANXFVGTPYWMAPEVILAMDEGQYDGK 194

Query: 526 LDVYAFGVLILEMLTGKEAA-ALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGN 584
           +DV++ G+  +E+   K     ++A     H++   +  L      E  R+F        
Sbjct: 195 VDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNF-------- 246

Query: 585 YPLELALLVIRLIDACLKKDPTDRPT 610
                       +D+CL+K P DRPT
Sbjct: 247 ------------VDSCLQKIPQDRPT 260

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 78.5 bits (194), Expect = 6e-16
 Identities = 74/264 (28%), Positives = 119/264 (45%), Gaps = 42/264 (15%)

Query: 374 AIKKVNGDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVF------ 427
           A      D  KE+ +L++++  N+  L GVC  +    ++ EY  NG L+ ++       
Sbjct: 58  ASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAET 117

Query: 428 -SNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANF 486
                  K L +   + +A  +A+G+ YL S      VH+D+ + N L+  +   KIA+F
Sbjct: 118 SGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRNCLVGKNYTIKIADF 174

Query: 487 AMARPAEGQ-----EGEFAL-TRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT 540
            M+R          +G   L  R       +MA E +  G  +TK DV+AFGV + E+LT
Sbjct: 175 GMSRNLYSSDYYRVQGRAPLPIR-------WMAWESVLLGKFTTKSDVWAFGVTLWEILT 227

Query: 541 GKEAAALHAEENNMHLSD---VLNAV-LTKEDGEESLRHFIDPTLQGNYPLELALLVIRL 596
                 L  E+   HL+D   + NA    ++DG +   +   P    N P +    +  L
Sbjct: 228 ------LCREQPYEHLTDQQVIENAGHFFRDDGRQ--IYLPRPP---NCPKD----IYEL 272

Query: 597 IDACLKKDPTDRPTMYEIEHSLSN 620
           +  C ++D  DRPT  EI   L  
Sbjct: 273 MLECWRRDEEDRPTFREIHLFLQR 296

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 77.0 bits (190), Expect = 1e-15
 Identities = 67/242 (27%), Positives = 106/242 (43%), Gaps = 40/242 (16%)

Query: 381 DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQ 440
           D  KE A+++ ++H NLI L GV        +V E A  G+L D +   K+   +     
Sbjct: 42  DFLKEAAIMHSLDHENLIRLYGVVLTH-PLMMVTELAPLGSLLDRL--RKDALGHFLIST 98

Query: 441 RIQIALDVATGLNYLHS--FTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGE 498
               A+ +A G+ YL S  F     +H+D+ + N+LL SD + KI +F + R A  Q  +
Sbjct: 99  LCDYAVQIANGMRYLESKRF-----IHRDLAARNILLASDDKVKIGDFGLMR-ALPQNED 152

Query: 499 -FALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLS 557
            + +  H+     + APE L     S   DV+ FGV + EM T       + EE    LS
Sbjct: 153 HYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFT-------YGEEPWAGLS 205

Query: 558 DVLNAVLTKEDGEESLRHFIDPTLQ-----GNYPLELALLVIRLIDACLKKDPTDRPTMY 612
                      G + L   ID   +        P ++  ++++    C   +P DRPT  
Sbjct: 206 -----------GSQIL-KKIDKEGERLERPEACPQDIYNVMLQ----CWAHNPADRPTFA 249

Query: 613 EI 614
            +
Sbjct: 250 AL 251

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 76.8 bits (189), Expect = 2e-15
 Identities = 65/265 (24%), Positives = 107/265 (40%), Gaps = 59/265 (22%)

Query: 381 DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSN----------- 429
           D  +E AL+ + +H N++ L GVC       L++EY   G L++++              
Sbjct: 54  DFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHS 113

Query: 430 -----KNEGKYLDWKQRIQ--IALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAK 482
                K     L      Q  IA  VA G+ YL   +    VH+D+ + N L+  ++  K
Sbjct: 114 TSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVK 170

Query: 483 IANFAMARPA------EGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLIL 536
           IA+F ++R        +  E +    R       +M PE +     +T+ DV+A+GV++ 
Sbjct: 171 IADFGLSRNIYSADYYKASENDAIPIR-------WMPPESIFYNRYTTESDVWAYGVVLW 223

Query: 537 EMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQG---NYPLELALLV 593
           E+ +      +       H              EE + +  D  +     N PLEL  L+
Sbjct: 224 EIFS----YGMQPYYGMAH--------------EEVIYYVRDGNVLSCPDNCPLELYNLM 265

Query: 594 IRLIDACLKKDPTDRPTMYEIEHSL 618
                 C  K P+DRP+   I   L
Sbjct: 266 RL----CWSKLPSDRPSFASINRIL 286

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 77.0 bits (189), Expect = 2e-15
 Identities = 69/257 (26%), Positives = 117/257 (45%), Gaps = 43/257 (16%)

Query: 381 DVSKEIALLNKIN-HSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNK--------- 430
           D + E+ +L K+  H N+I L G C + G  YL  EYA +G L D++  ++         
Sbjct: 53  DFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFA 112

Query: 431 ---NEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFA 487
              +    L  +Q +  A DVA G++YL   +    +H+D+ + N+L+  +  AKIA+F 
Sbjct: 113 IANSTASTLSSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFG 169

Query: 488 MARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEM--LTGKEAA 545
           ++R   GQE     T   +  + +MA E L   + +T  DV+++GVL+ E+  L G    
Sbjct: 170 LSR---GQEVYVKKTMGRLPVR-WMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYC 225

Query: 546 ALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDP 605
            +   E                     L   +    +   PL     V  L+  C ++ P
Sbjct: 226 GMTCAE---------------------LYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKP 264

Query: 606 TDRPTMYEIEHSLSNIL 622
            +RP+  +I  SL+ +L
Sbjct: 265 YERPSFAQILVSLNRML 281

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 75.7 bits (186), Expect = 3e-15
 Identities = 70/274 (25%), Positives = 118/274 (43%), Gaps = 50/274 (18%)

Query: 361 GSVYRGKINGGF-AAIKKVN------GDVSKEIALLNKINHSNLIILSGVCFNEGNCYLV 413
           G V+ GK       AIK +N       D  +E  ++ K++H  L+ L GVC  +   Y+V
Sbjct: 18  GVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIV 77

Query: 414 YEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYL--HSFTNPPHVHKDINSS 471
            E+  NG L +  +  + +GK L     + +  DV  G+ YL  +SF     +H+D+ + 
Sbjct: 78  TEFMENGCLLN--YLRQRQGK-LSKDMLLSMCQDVCEGMEYLERNSF-----IHRDLAAR 129

Query: 472 NVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKG------YMAPEYLENGLVSTK 525
           N L+ S    K+++F M R        + L      + G      +  PE       S+K
Sbjct: 130 NCLVSSTGVVKVSDFGMTR--------YVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSK 181

Query: 526 LDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNY 585
            DV++FGVL+ E+ T  E      +++N    +V+  +     G    R    P L    
Sbjct: 182 SDVWSFGVLMWEVFT--EGKMPFEKKSNY---EVVEMI---SRGFRLYR----PKLASMT 229

Query: 586 PLELALLVIRLIDACLKKDPTDRPTMYEIEHSLS 619
             E+         +C  + P  RPT  E+  +++
Sbjct: 230 VYEVMY-------SCWHEKPEGRPTFAELLRAIT 256

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 75.5 bits (186), Expect = 3e-15
 Identities = 64/246 (26%), Positives = 107/246 (43%), Gaps = 41/246 (16%)

Query: 384 KEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKN--EGKYLDWKQR 441
           +E +++ +++H  ++ L GVC  E    LV E A  G L  ++   +        +    
Sbjct: 45  REASVMAQLDHPCIVRLIGVCKGEPLM-LVMELAPLGPLLKYLKKRREIPVSDLKEL--- 100

Query: 442 IQIALDVATGLNYLHS--FTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEF 499
              A  VA G+ YL S  F     VH+D+ + NVLL +  +AKI++F M+R        +
Sbjct: 101 ---AHQVAMGMAYLESKHF-----VHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYY 152

Query: 500 ALTRHIVG---TKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHL 556
             T    G    K Y APE +  G  S+K DV+++GV + E  +    A  + E   M  
Sbjct: 153 RATTA--GRWPLKWY-APECINYGKFSSKSDVWSYGVTLWEAFS--YGAKPYGE---MKG 204

Query: 557 SDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEH 616
           ++V+                ++   +   P E    +  ++ +C K  P DRPT  E+E 
Sbjct: 205 AEVIA--------------MLESGERLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELES 250

Query: 617 SLSNIL 622
           +     
Sbjct: 251 TFRRDP 256

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 75.8 bits (187), Expect = 4e-15
 Identities = 59/210 (28%), Positives = 96/210 (45%), Gaps = 32/210 (15%)

Query: 361 GSVYRGKI--NGGFAAIKKVNG---------DVSKEIALLNKINHSNLIILSGVCFNEGN 409
           G V++ K    G   A+KKV              +EI  L    H  ++ L  V F  G+
Sbjct: 14  GIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV-FPHGS 72

Query: 410 -CYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDI 468
              LV EY +   LS+ +   ++E + L   Q       +  G+ Y+H+      +H+D+
Sbjct: 73  GFVLVMEY-MPSDLSEVL---RDEERPLPEAQVKSYMRMLLKGVAYMHANGI---MHRDL 125

Query: 469 NSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTK--- 525
             +N+L+ +D   KIA+F +AR    +E    L  H V T+ Y APE L     + K   
Sbjct: 126 KPANLLISADGVLKIADFGLARLFSEEEPR--LYSHQVATRWYRAPELL---YGARKYDP 180

Query: 526 -LDVYAFGVLILEMLTGKEAAALHAEENNM 554
            +D++A G +  E+L G   + L   EN++
Sbjct: 181 GVDLWAVGCIFAELLNG---SPLFPGENDI 207

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 76.3 bits (188), Expect = 4e-15
 Identities = 60/210 (28%), Positives = 89/210 (42%), Gaps = 40/210 (19%)

Query: 404 CFN-EGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPP 462
           CF  +   + V EY VNG   D +F  +  G++ D  +    A ++  GL +LH      
Sbjct: 64  CFQTKDRLFFVMEY-VNG--GDLMFHIQRSGRF-DEPRARFYAAEIVLGLQFLHE----- 114

Query: 463 H--VHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENG 520
              +++D+   NVLLDS+   KIA+F M +  EG       T    GT  Y+APE L   
Sbjct: 115 RGIIYRDLKLDNVLLDSEGHIKIADFGMCK--EGI-LGGVTTSTFCGTPDYIAPEILSYQ 171

Query: 521 LVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFI--D 578
                +D +A GVL+ EML G+  +                      D E+ L   I  D
Sbjct: 172 PYGPAVDWWALGVLLYEMLAGQ--SPFEG------------------DDEDELFQSILED 211

Query: 579 PTLQGNYPLELALLVIRLIDACLKKDPTDR 608
                 YP  L+     ++ + L K+P  R
Sbjct: 212 EVR---YPRWLSKEAKSILKSFLTKNPEKR 238

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 76.2 bits (187), Expect = 4e-15
 Identities = 55/180 (30%), Positives = 91/180 (50%), Gaps = 17/180 (9%)

Query: 374 AIKKVNGDVSKEIALLNKI-NHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNE 432
           A +K   D+  E+ ++  I  H N+I L G C  +G  Y++ EYA  G L +++ + +  
Sbjct: 62  ATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPP 121

Query: 433 G------------KYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLR 480
           G            + L +K  +  A  VA G+ YL S      +H+D+ + NVL+  D  
Sbjct: 122 GMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNV 178

Query: 481 AKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT 540
            KIA+F +AR     +     T   +  K +MAPE L + + + + DV++FGVL+ E+ T
Sbjct: 179 MKIADFGLARDIHHIDYYKKTTNGRLPVK-WMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 75.0 bits (185), Expect = 5e-15
 Identities = 65/242 (26%), Positives = 98/242 (40%), Gaps = 34/242 (14%)

Query: 382 VSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQR 441
           V  E  +L ++NH  L+ L     +E N YLV +  + G L  +  S K   K+ + + +
Sbjct: 47  VLNERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLR-YHLSQK--VKFSEEQVK 103

Query: 442 IQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFAL 501
             I  ++   L YLHS      +H+DI   N+LLD      I +F +A           L
Sbjct: 104 FWIC-EIVLALEYLHSKGI---IHRDIKPDNILLDEQGHVHITDFNIATKVTPDT----L 155

Query: 502 TRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLN 561
           T    GT GYMAPE L     S  +D ++ GV   E L GK     H+            
Sbjct: 156 TTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHS------------ 203

Query: 562 AVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNI 621
              T  D   + +   D      +  E     I  I+  L++DP  R     +  +L ++
Sbjct: 204 --RTIRDQIRAKQETADVLYPATWSTEA----IDAINKLLERDPQKR-----LGDNLKDL 252

Query: 622 LN 623
            N
Sbjct: 253 KN 254

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 76.2 bits (187), Expect = 6e-15
 Identities = 53/173 (30%), Positives = 88/173 (50%), Gaps = 17/173 (9%)

Query: 381 DVSKEIALLNKI-NHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEG------ 433
           D+  E+ ++  I  H N+I L G C  +G  Y++ EYA  G L +++ + +  G      
Sbjct: 63  DLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFD 122

Query: 434 ------KYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFA 487
                 + L +K  +  A  VA G+ YL S      +H+D+ + NVL+  D   KIA+F 
Sbjct: 123 TCKLPEEQLTFKDLVSCAYQVARGMEYLAS---QKCIHRDLAARNVLVTEDNVMKIADFG 179

Query: 488 MARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT 540
           +AR     +     T   +  K +MAPE L + + + + DV++FGVL+ E+ T
Sbjct: 180 LARDVHNIDYYKKTTNGRLPVK-WMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 74.4 bits (183), Expect = 8e-15
 Identities = 59/197 (29%), Positives = 98/197 (49%), Gaps = 25/197 (12%)

Query: 361 GSVYRGKI-----NGGFAAIKKVN-----GDVS---KEIALLNKINHSNLIILSGVCF-N 406
           G VY G +          A+K +N      +V    KE  ++   +H N++ L G+C  +
Sbjct: 9   GCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPS 68

Query: 407 EGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHK 466
           EG+  +V  Y  +G L +++   ++E      K  I   L VA G+ YL S      VH+
Sbjct: 69  EGSPLVVLPYMKHGDLRNFI---RSETHNPTVKDLIGFGLQVAKGMEYLAS---KKFVHR 122

Query: 467 DINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTK---GYMAPEYLENGLVS 523
           D+ + N +LD     K+A+F +AR  +  + E+    +  G K    +MA E L+    +
Sbjct: 123 DLAARNCMLDESFTVKVADFGLAR--DIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFT 180

Query: 524 TKLDVYAFGVLILEMLT 540
           TK DV++FGVL+ E++T
Sbjct: 181 TKSDVWSFGVLLWELMT 197

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 74.4 bits (183), Expect = 1e-14
 Identities = 50/167 (29%), Positives = 84/167 (50%), Gaps = 19/167 (11%)

Query: 384 KEIALLNKINHSNLIILSGVCFNEGNCYLV-YEYAVNGTLSDWV----FSNKNEGKYLDW 438
           +E  LL  ++H N++ +  VC  +G    V Y Y   G L  ++        N  + L  
Sbjct: 57  QESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALST 116

Query: 439 KQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGE 498
           +Q + +A+ +A G++YLH       +HKDI + N ++D +L+ KI + A++R        
Sbjct: 117 QQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITDNALSRDL------ 167

Query: 499 FALTRHIVGTKGY-----MAPEYLENGLVSTKLDVYAFGVLILEMLT 540
           F +  H +G         MA E L N   S+  DV++FGVL+ E++T
Sbjct: 168 FPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMT 214

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 74.5 bits (183), Expect = 1e-14
 Identities = 59/208 (28%), Positives = 95/208 (45%), Gaps = 49/208 (23%)

Query: 361 GSVY--RGKINGGFAAIKKVNGDVS---------KEIALLNKINHSNLIILSGVCFNEGN 409
           G VY  R K+ G   A+KK+  D           +EI+LL ++NH N++ L  V   E  
Sbjct: 14  GVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENK 73

Query: 410 CYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVA--------TGLNYLHSFTNP 461
            YLV+E           F +++  K++D      I L +          GL + HS    
Sbjct: 74  LYLVFE-----------FLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHS---- 118

Query: 462 PH--VHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALT----RHIVGTKGYMAPE 515
            H  +H+D+   N+L++++   K+A+F +AR        F +      H V T  Y APE
Sbjct: 119 -HRVLHRDLKPQNLLINTEGAIKLADFGLARA-------FGVPVRTYTHEVVTLWYRAPE 170

Query: 516 -YLENGLVSTKLDVYAFGVLILEMLTGK 542
             L     ST +D+++ G +  EM+T +
Sbjct: 171 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 74.1 bits (182), Expect = 1e-14
 Identities = 55/203 (27%), Positives = 97/203 (47%), Gaps = 28/203 (13%)

Query: 361 GSVYRG--KINGGFAAIKKVNGD----------------VSKEIALLNKINHSNLIILSG 402
           GSVY G    +G   A+K+V                   +++EIALL ++ H N++   G
Sbjct: 14  GSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLG 73

Query: 403 VCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPP 462
              +  +  +  EY   G+++  +    N G + +   R      +  GLNYLH   N  
Sbjct: 74  SSLDADHLNIFLEYVPGGSVAALL---NNYGAFEETLVR-NFVRQILKGLNYLH---NRG 126

Query: 463 HVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRH---IVGTKGYMAPEYLEN 519
            +H+DI  +N+L+D+    KI++F +++  E              + G+  +MAPE ++ 
Sbjct: 127 IIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQ 186

Query: 520 GLVSTKLDVYAFGVLILEMLTGK 542
              + K D+++ G L++EMLTGK
Sbjct: 187 TSYTRKADIWSLGCLVVEMLTGK 209

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 73.5 bits (180), Expect = 2e-14
 Identities = 71/266 (26%), Positives = 112/266 (42%), Gaps = 40/266 (15%)

Query: 362 SVYRGKINGGFAAIKKVN---------GDVSKEIALLNKINHSNLIILSGVCFNE-GNCY 411
           S+ R + +G    IKK+N             +E  LL+++ H N++        E G  Y
Sbjct: 17  SLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLY 76

Query: 412 LVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHV-HKDINS 470
           +V  +   G L   +   K  GK L   Q ++  + +A  L YLH      H+ H+D+ +
Sbjct: 77  IVMGFCEGGDLYHKLKEQK--GKLLPENQVVEWFVQIAMALQYLHE----KHILHRDLKT 130

Query: 471 SNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYA 530
            NV L      K+ +  +AR  E Q     +   ++GT  YM+PE   N   + K DV+A
Sbjct: 131 QNVFLTRTNIIKVGDLGIARVLENQ---CDMASTLIGTPYYMSPELFSNKPYNYKSDVWA 187

Query: 531 FGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELA 590
            G  + EM T K   A +A++ N  +  ++   L              P +  +Y  EL 
Sbjct: 188 LGCCVYEMATLKH--AFNAKDMNSLVYRIIEGKL--------------PPMPKDYSPELG 231

Query: 591 LLVIRLIDACLKKDPTDRPTMYEIEH 616
                LI   L K P  RP++  I  
Sbjct: 232 ----ELIATMLSKRPEKRPSVKSILR 253

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 74.0 bits (182), Expect = 2e-14
 Identities = 50/197 (25%), Positives = 97/197 (49%), Gaps = 28/197 (14%)

Query: 361 GSVYRG---------KINGGFAAIK--------KVNGDVSKEIALLNKINHSNLIILSGV 403
           G+VY+G         KI     AIK        K N ++  E  ++  ++H +++ L G+
Sbjct: 21  GTVYKGVWIPEGEKVKIP---VAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGI 77

Query: 404 CFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPH 463
           C +     L+ +    G L D+V ++K+    +  +  +   + +A G++YL        
Sbjct: 78  CLSSQVQ-LITQLMPLGCLLDYVRNHKDN---IGSQYLLNWCVQIAKGMSYLE---EKRL 130

Query: 464 VHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVS 523
           VH+D+ + NVL+ +    KI +F +A+  +  E E+      V  K +MA E + + + +
Sbjct: 131 VHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIK-WMALESILHRIYT 189

Query: 524 TKLDVYAFGVLILEMLT 540
            K DV+++GV + E++T
Sbjct: 190 HKSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 73.1 bits (179), Expect = 2e-14
 Identities = 70/266 (26%), Positives = 116/266 (43%), Gaps = 40/266 (15%)

Query: 361 GSVY--RGKINGGFAAIKKVNGDV---------SKEIALLNKINHSNLIILSGVCFNEGN 409
           G +Y  + K +     IK+++             KE+ LL K+ H N++         G 
Sbjct: 14  GKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGR 73

Query: 410 CYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDIN 469
            ++V EY   G L   +  N+  G      Q +   + ++ GL ++H   +   +H+DI 
Sbjct: 74  LFIVMEYCDGGDLMKRI--NRQRGVLFSEDQILSWFVQISLGLKHIH---DRKILHRDIK 128

Query: 470 SSNVLLDSD-LRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDV 528
           S N+ L  + + AK+ +F +AR       E A T   VGT  Y++PE  +N   + K D+
Sbjct: 129 SQNIFLSKNGMVAKLGDFGIARQLN-DSMELAYT--CVGTPYYLSPEICQNRPYNNKTDI 185

Query: 529 YAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLE 588
           ++ G ++ E+ T K       E NN+H       VL    G       I P    N+  +
Sbjct: 186 WSLGCVLYELCTLKHP----FEGNNLH-----QLVLKICQGY---FAPISP----NFSRD 229

Query: 589 LALLVIRLIDACLKKDPTDRPTMYEI 614
           L  L+ +L     K  P DRP++  I
Sbjct: 230 LRSLISQL----FKVSPRDRPSITSI 251

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 73.7 bits (181), Expect = 2e-14
 Identities = 66/285 (23%), Positives = 125/285 (43%), Gaps = 47/285 (16%)

Query: 361 GSVYRGKING-----GFAAIK--KVNGDVSKEI-------ALLNKINHSNLIILSGVCFN 406
           GSV  G+++         A+K  K++     EI       A +   +H N++ L GVCF 
Sbjct: 13  GSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFE 72

Query: 407 EGNC------YLVYEYAVNGTLSDWVFSNKNEG--KYLDWKQRIQIALDVATGLNYLHSF 458
             +        ++  +  +G L  ++  ++  G  + L  +  ++  +D+A G+ YL   
Sbjct: 73  ASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYL--- 129

Query: 459 TNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTK-GYMAPEYL 517
           +N   +H+D+ + N +L  D+   +A+F +++      G++     I      ++A E L
Sbjct: 130 SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKI--YSGDYYRQGRIAKMPVKWIAIESL 187

Query: 518 ENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFI 577
            + + ++K DV+AFGV + E+ T  +      E + ++               + LRH  
Sbjct: 188 ADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIY---------------DYLRHGN 232

Query: 578 DPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNIL 622
                 +   EL  L+      C + DP DRPT  ++   L NIL
Sbjct: 233 RLKQPEDCLDELYDLMYS----CWRADPKDRPTFTKLREVLENIL 273

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 73.1 bits (179), Expect = 2e-14
 Identities = 63/268 (23%), Positives = 115/268 (42%), Gaps = 36/268 (13%)

Query: 361 GSVYRGKINGGFA-AIKKVNGDVSKEIAL--------LNKINHSNLIILSGVCFNEGNCY 411
           G V++G +      A+K    D+ +E+ +        L + +H N++ L GVC      Y
Sbjct: 9   GEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIY 68

Query: 412 LVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSS 471
           +V E    G    ++   K+E   L  KQ ++ ALD A G+ YL S      +H+D+ + 
Sbjct: 69  IVMELVPGGDFLSFLRKKKDE---LKTKQLVKFALDAAAGMAYLESKNC---IHRDLAAR 122

Query: 472 NVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAF 531
           N L+  +   KI++F M+R  +      +  + I     + APE L  G  S++ DV+++
Sbjct: 123 NCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI--PIKWTAPEALNYGRYSSESDVWSY 180

Query: 532 GVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELAL 591
           G+L+ E  +               L       +T +   E +      +     P +   
Sbjct: 181 GILLWETFS---------------LGVCPYPGMTNQQAREQVEKGYRMSCPQKCPDD--- 222

Query: 592 LVIRLIDACLKKDPTDRPTMYEIEHSLS 619
            V +++  C    P +RP   E++  L+
Sbjct: 223 -VYKVMQRCWDYKPENRPKFSELQKELA 249

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 73.2 bits (180), Expect = 2e-14
 Identities = 78/284 (27%), Positives = 123/284 (43%), Gaps = 59/284 (20%)

Query: 361 GSVYRG--------KINGGFAAIK--KVNGDVSK------EIALLNKINHSNLIILSGVC 404
           G VY+G        KI     A+K  K     S       E  ++ + +H +++ L GV 
Sbjct: 20  GDVYQGVYMSPENEKIA---VAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVI 76

Query: 405 FNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHV 464
             E   ++V E A  G L  ++  NK     LD    I  +  ++T L YL S      V
Sbjct: 77  -TENPVWIVMELAPLGELRSYLQVNKYS---LDLASLILYSYQLSTALAYLES-KR--FV 129

Query: 465 HKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKG-----YMAPEYLEN 519
           H+DI + NVL+ S    K+ +F ++R  E +        +   +KG     +MAPE +  
Sbjct: 130 HRDIAARNVLVSSPDCVKLGDFGLSRYLEDES-------YYKASKGKLPIKWMAPESINF 182

Query: 520 GLVSTKLDVYAFGVLILEMLT-GKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFID 578
              ++  DV+ FGV + E+L  G +       +NN    DV+  +   E+GE        
Sbjct: 183 RRFTSASDVWMFGVCMWEILMLGVK--PFQGVKNN----DVIGRI---ENGER------- 226

Query: 579 PTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNIL 622
             +  N P  L  L+ +    C   DP+ RP   E++  LS+IL
Sbjct: 227 LPMPPNCPPTLYSLMTK----CWAYDPSKRPRFTELKAQLSDIL 266

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 73.8 bits (181), Expect = 2e-14
 Identities = 53/181 (29%), Positives = 91/181 (50%), Gaps = 19/181 (10%)

Query: 374 AIKKVNGDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEG 433
           A K    D  KE+ +L+++   N+I L GVC +E    ++ EY  NG L+ ++ S+  + 
Sbjct: 58  ANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDD 117

Query: 434 K---------------YLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSD 478
           K                + +   + +AL +A+G+ YL S      VH+D+ + N L+  +
Sbjct: 118 KEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FVHRDLATRNCLVGEN 174

Query: 479 LRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEM 538
           L  KIA+F M+R     +      R ++  + +MA E +  G  +T  DV+AFGV + E+
Sbjct: 175 LTIKIADFGMSRNLYAGDYYRIQGRAVLPIR-WMAWECILMGKFTTASDVWAFGVTLWEI 233

Query: 539 L 539
           L
Sbjct: 234 L 234

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 73.5 bits (180), Expect = 3e-14
 Identities = 73/269 (27%), Positives = 121/269 (44%), Gaps = 40/269 (14%)

Query: 374 AIKKVNGDVSKEIALLNKI-NHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNE 432
           A +K   D+  E+ ++  I  H N+I L G C  +G  Y++ EYA  G L +++ + +  
Sbjct: 59  ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPP 118

Query: 433 G------------KYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLR 480
           G            + + +K  +     VA G+ YL S      +H+D+ + NVL+  +  
Sbjct: 119 GMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLAS---QKCIHRDLAARNVLVTENNV 175

Query: 481 AKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT 540
            KIA+F +AR     +     T   +  K +MAPE L + + + + DV++FGVL+ E+ T
Sbjct: 176 MKIADFGLARDVNNIDYYKKTTNGRLPVK-WMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234

Query: 541 --GKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLID 598
             G     +  EE    L  +L     KE       H +D     N   EL +    ++ 
Sbjct: 235 LGGSPYPGIPVEE----LFKLL-----KEG------HRMDKP--ANCTNELYM----MMR 273

Query: 599 ACLKKDPTDRPTMYEIEHSLSNILNASLN 627
            C    P+ RPT  ++   L  IL  + N
Sbjct: 274 DCWHAIPSHRPTFKQLVEDLDRILTLTTN 302

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 73.3 bits (180), Expect = 4e-14
 Identities = 59/208 (28%), Positives = 92/208 (44%), Gaps = 36/208 (17%)

Query: 404 CFN-EGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPP 462
           CF      Y V EY VNG   D ++  +  GK+ +    +  A ++A GL +LHS     
Sbjct: 69  CFQTMDRLYFVMEY-VNG--GDLMYHIQQVGKFKE-PHAVFYAAEIAIGLFFLHS---KG 121

Query: 463 HVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEF--ALTRHIVGTKGYMAPEYLENG 520
            +++D+   NV+LD++   KIA+F M +     E  F    TR   GT  Y+APE +   
Sbjct: 122 IIYRDLKLDNVMLDAEGHIKIADFGMCK-----ENIFGGKTTRTFCGTPDYIAPEIIAYQ 176

Query: 521 LVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPT 580
                +D +AFGVL+ EML G+                        ED +E  +  ++  
Sbjct: 177 PYGKSVDWWAFGVLLYEMLAGQ-------------------PPFDGEDEDELFQSIMEHN 217

Query: 581 LQGNYPLELALLVIRLIDACLKKDPTDR 608
           +  +YP  L+   + +    L K P  R
Sbjct: 218 V--SYPKSLSKEAVSICKGLLTKHPAKR 243

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 72.2 bits (177), Expect = 5e-14
 Identities = 63/248 (25%), Positives = 120/248 (48%), Gaps = 37/248 (14%)

Query: 381 DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQ 440
           D   E +++ + +H N+I L GV        +V EY  NG+L    F  K++G++    Q
Sbjct: 51  DFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLD--AFLRKHDGQF-TVIQ 107

Query: 441 RIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFA 500
            + +   +A+G+ YL       +VH+D+ + N+L++S+L  K+++F ++R  E  + E A
Sbjct: 108 LVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE-DDPEAA 163

Query: 501 LTRHIVGTKG------YMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNM 554
            T     T+G      + APE +     ++  DV+++G+++ E+++  E          M
Sbjct: 164 YT-----TRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYW-----EM 213

Query: 555 HLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEI 614
              DV+ A+      EE  R    P      P++    + +L+  C +KD  +RP   +I
Sbjct: 214 SNQDVIKAI------EEGYRL---PA-----PMDCPAALHQLMLDCWQKDRNERPKFEQI 259

Query: 615 EHSLSNIL 622
              L  ++
Sbjct: 260 VSILDKLI 267

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 72.6 bits (178), Expect = 6e-14
 Identities = 66/255 (25%), Positives = 118/255 (46%), Gaps = 28/255 (10%)

Query: 374 AIKKVNGDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEG 433
           A K    D  KEI +++++   N+I L  VC       ++ EY  NG L+ ++  ++ + 
Sbjct: 58  ANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQE 117

Query: 434 -------KYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANF 486
                    + +   I +A  +A+G+ YL S      VH+D+ + N L+  +   KIA+F
Sbjct: 118 AAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRNCLVGKNYTIKIADF 174

Query: 487 AMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAA 546
            M+R     +      R ++  + +M+ E +  G  +T  DV+AFGV + E+LT      
Sbjct: 175 GMSRNLYSGDYYRIQGRAVLPIR-WMSWESILLGKFTTASDVWAFGVTLWEILT------ 227

Query: 547 LHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELAL---LVIRLIDACLKK 603
           L  E+    LSD        E   E+   F     +  Y  + AL    + +L+ +C ++
Sbjct: 228 LCKEQPYSQLSD--------EQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRR 279

Query: 604 DPTDRPTMYEIEHSL 618
           +  +RP+  EI  +L
Sbjct: 280 NAKERPSFQEIHATL 294

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 71.9 bits (176), Expect = 9e-14
 Identities = 48/175 (27%), Positives = 86/175 (49%), Gaps = 16/175 (9%)

Query: 381 DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLD--- 437
           D  +E  LL  + H +++   GVC       +V+EY  +G L+ ++ S+  + K L    
Sbjct: 53  DFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGE 112

Query: 438 --------WKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMA 489
                     Q + IA  +A+G+ YL S      VH+D+ + N L+   L  KI +F M+
Sbjct: 113 DVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVVKIGDFGMS 169

Query: 490 RPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT-GKE 543
           R     +      R ++  + +M PE +     +T+ D+++FGV++ E+ T GK+
Sbjct: 170 RDIYSTDYYRVGGRTMLPIR-WMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQ 223

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 71.2 bits (174), Expect = 1e-13
 Identities = 62/238 (26%), Positives = 110/238 (46%), Gaps = 29/238 (12%)

Query: 384 KEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQ 443
            E  ++  + H  L+ L  V   E   Y++ E+   G+L D  F   +EG      + I 
Sbjct: 50  AEANVMKTLQHDKLVKLHAVVTKE-PIYIITEFMAKGSLLD--FLKSDEGSKQPLPKLID 106

Query: 444 IALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTR 503
            +  +A G+ ++       ++H+D+ ++N+L+ + L  KIA+F +AR  E  + E+    
Sbjct: 107 FSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIE--DNEYTARE 161

Query: 504 HIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT-GKEAAALHAEENNMHLSDVLNA 562
                  + APE +  G  + K DV++FG+L++E++T G+           M   +V+ A
Sbjct: 162 GAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYP------GMSNPEVIRA 215

Query: 563 VLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSN 620
           +   E G    R         N P EL  +++R    C K  P +RPT   I+  L +
Sbjct: 216 L---ERGYRMPR-------PENCPEELYNIMMR----CWKNRPEERPTFEYIQSVLDD 259

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 71.5 bits (176), Expect = 1e-13
 Identities = 72/289 (24%), Positives = 109/289 (37%), Gaps = 69/289 (23%)

Query: 361 GSVYRGKI--NGGFAAIK--KVNGDVSKEIAL----LNKI-NHSNLIILSGVCF------ 405
           G VY+ +    G   AIK   +  D  +EI      L K  NH N+    G         
Sbjct: 20  GKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPG 79

Query: 406 NEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHV- 464
           N+   +LV E    G+++D V   + +GK L  +    I  +   GL YLH       V 
Sbjct: 80  NDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHE----NKVI 135

Query: 465 HKDINSSNVLLDSDLRAKIANF---AMARPAEGQEGEFALTRHIVGTKGYMAPEYL---E 518
           H+DI   N+LL  +   K+ +F   A      G+   F      +GT  +MAPE +   E
Sbjct: 136 HRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTF------IGTPYWMAPEVIACDE 189

Query: 519 NGLVS--TKLDVYAFGVLILEMLTGKEAAALHAEENNMH--------LSDVLNAVLTKED 568
               S   + DV++ G+  +E+  GK          +MH          +    + + E+
Sbjct: 190 QPDASYDARSDVWSLGITAIELADGKPPLC------DMHPMRALFKIPRNPPPTLKSPEN 243

Query: 569 GEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEI-EH 616
             +    F                    I  CL K+   RP M E+ EH
Sbjct: 244 WSKKFNDF--------------------ISECLIKNYEQRPFMEELLEH 272

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 71.1 bits (174), Expect = 1e-13
 Identities = 66/277 (23%), Positives = 129/277 (46%), Gaps = 40/277 (14%)

Query: 361 GSVYRGKINGG-----FAAIKKVNG--------DVSKEIALLNKINHSNLIILSGVCFNE 407
           G V RG++        F AIK +          D   E +++ + +H N+I L GV    
Sbjct: 18  GEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKS 77

Query: 408 GNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKD 467
               ++ E+  NG L    F  +N+G++    Q + +   +A G+ YL       +VH+D
Sbjct: 78  RPVMIITEFMENGALDS--FLRQNDGQF-TVIQLVGMLRGIAAGMKYLSEMN---YVHRD 131

Query: 468 INSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKG--YMAPEYLENGLVSTK 525
           + + N+L++S+L  K+++F ++R  E    +   T  + G     + APE +     ++ 
Sbjct: 132 LAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSA 191

Query: 526 LDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNY 585
            DV+++G+++ E+++  E         +M   DV+NA+      E+  R  + P      
Sbjct: 192 SDVWSYGIVMWEVMSYGERPYW-----DMSNQDVINAI------EQDYR--LPP------ 232

Query: 586 PLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNIL 622
           P++    + +L+  C +KD   RP   +I  +L  ++
Sbjct: 233 PMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKMI 269

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 71.2 bits (174), Expect = 2e-13
 Identities = 42/158 (26%), Positives = 81/158 (51%), Gaps = 11/158 (6%)

Query: 385 EIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQI 444
           E+ ++   +H N++ +          ++V E+   G L+D V   +     ++ +Q   +
Sbjct: 69  EVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTHTR-----MNEEQIATV 123

Query: 445 ALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRH 504
            L V   L+YLH   N   +H+DI S ++LL SD R K+++F           E    + 
Sbjct: 124 CLSVLRALSYLH---NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSK---EVPKRKS 177

Query: 505 IVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGK 542
           +VGT  +MAPE +      T++D+++ G++++EM+ G+
Sbjct: 178 LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGE 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 70.9 bits (174), Expect = 2e-13
 Identities = 50/194 (25%), Positives = 91/194 (46%), Gaps = 25/194 (12%)

Query: 361 GSVY--RGKINGGFAAIKKVN----------GDVSKEIALLNKINHSNLIILSGVCFNEG 408
           G V+  R +I+  + A+K +             V  E  +L +++H  +I L     ++ 
Sbjct: 15  GRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQR 74

Query: 409 NCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDI 468
             Y++ EY   G L  ++   +N G++ +       A ++   L YLHS      V++D+
Sbjct: 75  FLYMLMEYVPGGELFSYL---RNSGRFSNSTGLF-YASEIVCALEYLHSKEI---VYRDL 127

Query: 469 NSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDV 528
              N+LLD +   K+ +F  A+    +      T  + GT  Y+APE +++   +  +D 
Sbjct: 128 KPENILLDKEGHIKLTDFGFAKKLRDR------TWTLCGTPEYLAPEVIQSKGHNKAVDW 181

Query: 529 YAFGVLILEMLTGK 542
           +A G+LI EML G 
Sbjct: 182 WALGILIYEMLVGY 195

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 70.6 bits (173), Expect = 2e-13
 Identities = 59/257 (22%), Positives = 112/257 (43%), Gaps = 54/257 (21%)

Query: 374 AIKKVNGDVSK---------EIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSD 424
           A+KK+  D+ K         E+ ++    H N++ +          ++V E+   G L+D
Sbjct: 48  AVKKM--DLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTD 105

Query: 425 WVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIA 484
            V   +     ++ +Q   + L V   L++LH+      +H+DI S ++LL SD R K++
Sbjct: 106 IVTHTR-----MNEEQIATVCLAVLKALSFLHA---QGVIHRDIKSDSILLTSDGRVKLS 157

Query: 485 NFAMARPAEGQ-EGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGK- 542
           +F        Q   E    + +VGT  +MAPE +      T++D+++ G++++EM+ G+ 
Sbjct: 158 DFGFC----AQVSKEVPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEP 213

Query: 543 ---EAAALHAEENNMHLSDVLNAVLTKEDGEESLR--HFIDPTLQGNYPLELALLVIRLI 597
                  L A +              +++    L+  H + P L+              +
Sbjct: 214 PYFNEPPLQAMKR------------IRDNLPPKLKNLHKVSPRLRS------------FL 249

Query: 598 DACLKKDPTDRPTMYEI 614
           D  L +DP  R T  E+
Sbjct: 250 DRMLVRDPAQRATAAEL 266

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 70.4 bits (172), Expect = 3e-13
 Identities = 48/177 (27%), Positives = 91/177 (51%), Gaps = 19/177 (10%)

Query: 381 DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSN----------- 429
           D  +E  LL  + H +++   GVC +     +V+EY  +G L+ ++ ++           
Sbjct: 53  DFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQ 112

Query: 430 --KNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFA 487
             + +G+ L   Q + IA  +A+G+ YL S      VH+D+ + N L+ ++L  KI +F 
Sbjct: 113 PRQAKGE-LGLSQMLHIASQIASGMVYLAS---QHFVHRDLATRNCLVGANLLVKIGDFG 168

Query: 488 MARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT-GKE 543
           M+R     +  + +  H +    +M PE +     +T+ DV++FGV++ E+ T GK+
Sbjct: 169 MSRDVYSTD-YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQ 224

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 69.6 bits (170), Expect = 3e-13
 Identities = 61/233 (26%), Positives = 99/233 (42%), Gaps = 34/233 (14%)

Query: 381 DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQ 440
           D  KE  LL K+ H N++        +G+ Y+V EY   G L   +      GK      
Sbjct: 44  DSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKI--KLQRGKLFPEDT 101

Query: 441 RIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFA 500
            +Q  + +  G+ ++H       +H+DI S N+ L  + + K+ +F  AR      G +A
Sbjct: 102 ILQWFVQMCLGVQHIH---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSAR-LLTSPGAYA 157

Query: 501 LTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVL 560
            T   VGT  Y+ PE  EN   + K D+++ G ++ E+ T K     H  + N       
Sbjct: 158 CT--YVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLK-----HPFQAN------- 203

Query: 561 NAVLTKEDGEESLRHFIDPTLQGNY---PLELALLVIRLIDACLKKDPTDRPT 610
                      S ++ I    QG+Y   P   +  +  LI    K++P  RP+
Sbjct: 204 -----------SWKNLILKVCQGSYKPLPSHYSYELRSLIKQMFKRNPRSRPS 245

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 70.0 bits (171), Expect = 3e-13
 Identities = 50/207 (24%), Positives = 99/207 (47%), Gaps = 31/207 (14%)

Query: 361 GSVYRGKI------NGGFAAIKKVN--------GDVSKEIALLNKINHSNLIILSGVCFN 406
           G +Y+G +      +    AIK +         G+  +E +L+ +++H N++ L GV   
Sbjct: 19  GKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQ 78

Query: 407 EGNCYLVYEYAVNGTLSDWVF----------SNKNEGKY---LDWKQRIQIALDVATGLN 453
           E    +++EY   G L +++           S+  +G     LD    + IA+ +A G+ 
Sbjct: 79  EQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGME 138

Query: 454 YLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMA 513
           YL S      VHKD+ + N+L+   L  KI++  ++R     +      + ++  + +M 
Sbjct: 139 YLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIR-WMP 194

Query: 514 PEYLENGLVSTKLDVYAFGVLILEMLT 540
           PE +  G  S+  D+++FGV++ E+ +
Sbjct: 195 PEAIMYGKFSSDSDIWSFGVVLWEIFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 69.9 bits (171), Expect = 3e-13
 Identities = 53/165 (32%), Positives = 83/165 (50%), Gaps = 22/165 (13%)

Query: 384 KEIALLNKINHSNLIILSGVCFNEGN--CYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQR 441
           KEI +L  + H N++   G C  +G     L+ EY   G+L D++  +K     L+  Q 
Sbjct: 55  KEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHK-----LNLAQL 109

Query: 442 IQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPA-EGQEGEFA 500
           +  A  +  G+ YLHS     ++H+D+ + NVLLD+D   KI +F +A+   EG E    
Sbjct: 110 LLFAQQICEGMAYLHS---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHE---- 162

Query: 501 LTRHIVGTKG-----YMAPEYLENGLVSTKLDVYAFGVLILEMLT 540
              + V   G     + A E L+    S   DV++FGV + E+LT
Sbjct: 163 --YYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLT 205

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 69.9 bits (172), Expect = 4e-13
 Identities = 55/163 (33%), Positives = 75/163 (46%), Gaps = 25/163 (15%)

Query: 385 EIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQI 444
           E  +L  I H  L+ L G   ++ N YLV EY   G L    FS      +L    R   
Sbjct: 51  EKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGEL----FS------HLRKSGRFPE 100

Query: 445 ------ALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGE 498
                 A  V   L YLHS      V++D+   N+LLDSD   KI +F  A+  +G+   
Sbjct: 101 PVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR--- 154

Query: 499 FALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTG 541
              T  + GT  Y+APE + +      +D +A G+LI EML G
Sbjct: 155 ---TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAG 194

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 69.2 bits (169), Expect = 5e-13
 Identities = 61/230 (26%), Positives = 104/230 (45%), Gaps = 27/230 (11%)

Query: 385 EIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQI 444
           E  LL+K++H  ++             ++ EY     L   +   K+ GK L   Q  + 
Sbjct: 52  EAQLLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEW 111

Query: 445 ALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRH 504
            + +  G++Y+H       +H+D+ + N+ L ++L  KI +F ++R   G   + A T  
Sbjct: 112 FIQLLLGVHYMHQRRI---LHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGS-CDLATT-- 164

Query: 505 IVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVL 564
             GT  YM+PE L++    +K D+++ G ++ EM         HA E    LS VL  V 
Sbjct: 165 FTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEM-----CCLAHAFEGQNFLSVVLRIV- 218

Query: 565 TKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEI 614
              +G         P+L   Y  +L  ++  +    L KDP+ RP+  EI
Sbjct: 219 ---EGPT-------PSLPETYSRQLNSIMQSM----LNKDPSLRPSAAEI 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 69.0 bits (169), Expect = 7e-13
 Identities = 69/272 (25%), Positives = 119/272 (43%), Gaps = 49/272 (18%)

Query: 361 GSVY--RGKINGGFAAIKKVN-------GDVSKEIALLNKINHSNLIILSGVCFNEGNCY 411
           G VY  + K  G FAA K +         D   EI +L++  H N++ L    F E   +
Sbjct: 19  GKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLW 78

Query: 412 LVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPH--VHKDIN 469
           ++ E+   G L   +       + L   Q   +   +   LN+LHS     H  +H+D+ 
Sbjct: 79  ILIEFCDGGALDSIMLE---LERGLTEPQIRYVCRQMLEALNFLHS-----HKVIHRDLK 130

Query: 470 SSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRH--IVGTKGYMAPEYL-----ENGLV 522
           + N+LL  D   K+A+F ++  A+ +     L +    +GT  +MAPE +     ++   
Sbjct: 131 AGNILLTLDGDVKLADFGVS--AKNKS---TLQKRDTFIGTPYWMAPEVVACETFKDNPY 185

Query: 523 STKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQ 582
             K D+++ G+ ++E+      A +    + ++   VL  +L  E           PTL 
Sbjct: 186 DYKADIWSLGITLIEL------AQMEPPHHELNPMRVLLKILKSE----------PPTLD 229

Query: 583 GNYPLELALLVIRLIDACLKKDPTDRPTMYEI 614
              P + +      + +CL KDP DRPT  E+
Sbjct: 230 Q--PSKWSSSFNDFLKSCLVKDPDDRPTAAEL 259

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 69.9 bits (171), Expect = 9e-13
 Identities = 61/227 (26%), Positives = 97/227 (42%), Gaps = 54/227 (23%)

Query: 347 QSATDNFSFTCRIQ-------GSVY--RGKINGGFAAIKKVNGD--------VSKEIALL 389
            SA  + S   R+        G+VY    +  G   A+K + G+        + +EI +L
Sbjct: 67  PSAAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEIL 126

Query: 390 NKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYL-DWKQRIQIALDV 448
             +NH N++    +  + G   ++ E+   G+L         EG ++ D +    +A  +
Sbjct: 127 RDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSL---------EGTHIADEQFLADVARQI 177

Query: 449 ATGLNYLHSFTNPPH-VHKDINSSNVLLDSDLRAKIANFAMAR-------PAEGQEGEFA 500
            +G+ YLH      H VH+DI  SN+L++S    KIA+F ++R       P         
Sbjct: 178 LSGIAYLHR----RHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSS----- 228

Query: 501 LTRHIVGTKGYMAPEYLENGLVSTKLDVYA-----FGVLILEMLTGK 542
                VGT  YM+PE +   L     D YA      GV ILE   G+
Sbjct: 229 -----VGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGR 270

Length = 353

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 68.8 bits (169), Expect = 9e-13
 Identities = 60/199 (30%), Positives = 97/199 (48%), Gaps = 33/199 (16%)

Query: 361 GSVYRGK--INGGFAAIKKV---NGD------VSKEIALLNKI---NHSNLIILSGVC-- 404
           G+VY+ +    G F A+KKV     +        +EIALL ++    H N++ L  VC  
Sbjct: 13  GTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHG 72

Query: 405 ---FNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNP 461
                E    LV+E+ V+  L+   + +K     L  +    +   +  G+++LHS    
Sbjct: 73  PRTDRELKLTLVFEH-VDQDLAT--YLSKCPKPGLPPETIKDLMRQLLRGVDFLHS---- 125

Query: 462 PH--VHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLEN 519
            H  VH+D+   N+L+ SD + KIA+F +AR       E ALT  +V T  Y APE L  
Sbjct: 126 -HRIVHRDLKPQNILVTSDGQVKIADFGLARI---YSFEMALTS-VVVTLWYRAPEVLLQ 180

Query: 520 GLVSTKLDVYAFGVLILEM 538
              +T +D+++ G +  E+
Sbjct: 181 SSYATPVDMWSVGCIFAEL 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 69.1 bits (169), Expect = 9e-13
 Identities = 41/155 (26%), Positives = 76/155 (49%), Gaps = 20/155 (12%)

Query: 393 NHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGL 452
           NH N++ L G C   G   ++ EY   G L +++   +    +L  +  +  +  VA G+
Sbjct: 97  NHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRE--SFLTLEDLLSFSYQVAKGM 154

Query: 453 NYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKG-- 510
            +L S      +H+D+ + NVLL      KI +F +AR           + ++V  KG  
Sbjct: 155 AFLASKNC---IHRDLAARNVLLTHGKIVKICDFGLARDIMND------SNYVV--KGNA 203

Query: 511 -----YMAPEYLENGLVSTKLDVYAFGVLILEMLT 540
                +MAPE + N + + + DV+++G+L+ E+ +
Sbjct: 204 RLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 238

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 69.0 bits (169), Expect = 1e-12
 Identities = 64/269 (23%), Positives = 110/269 (40%), Gaps = 70/269 (26%)

Query: 384 KEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGK----YLDWK 439
           +E+ +L++ N   ++   G  +++G   +  E+   G+L D V   K  G+     L   
Sbjct: 48  RELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVL--KKAGRIPENILG-- 102

Query: 440 QRIQIALDVATGLNYL---HSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQE 496
            +I IA  V  GL YL   H       +H+D+  SN+L++S    K+ +F       G  
Sbjct: 103 -KISIA--VLRGLTYLREKHKI-----MHRDVKPSNILVNSRGEIKLCDF-------GVS 147

Query: 497 GEF--ALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTG---------KEAA 545
           G+   ++    VGT+ YM+PE L+    + + D+++ G+ ++EM  G         KE  
Sbjct: 148 GQLIDSMANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELE 207

Query: 546 ALHAEENNMHLSDVLNAVLTKEDGEESLRHFID-------------------PTL-QGNY 585
           A+            ++    KE       H  D                   P L  G +
Sbjct: 208 AMFGRP--------VSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAF 259

Query: 586 PLELALLVIRLIDACLKKDPTDRPTMYEI 614
             E        +D CLKK+P +R  + E+
Sbjct: 260 SDE----FQDFVDKCLKKNPKERADLKEL 284

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 68.8 bits (168), Expect = 1e-12
 Identities = 52/147 (35%), Positives = 77/147 (52%), Gaps = 10/147 (6%)

Query: 409 NCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDI 468
           N + V EY +NG   D +F  ++  K+ D  +    A ++  GL +LHS      V++D+
Sbjct: 70  NLFFVMEY-LNG--GDLMFHIQSCHKF-DLPRATFYAAEIICGLQFLHS---KGIVYRDL 122

Query: 469 NSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDV 528
              N+LLD+D   KIA+F M +  E   G+ A T    GT  Y+APE L     +T +D 
Sbjct: 123 KLDNILLDTDGHIKIADFGMCK--ENMLGD-AKTCTFCGTPDYIAPEILLGQKYNTSVDW 179

Query: 529 YAFGVLILEMLTGKEAAALHAEENNMH 555
           ++FGVL+ EML G+     H EE    
Sbjct: 180 WSFGVLLYEMLIGQSPFHGHDEEELFQ 206

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 68.2 bits (166), Expect = 2e-12
 Identities = 47/173 (27%), Positives = 83/173 (47%), Gaps = 14/173 (8%)

Query: 381 DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDW---------VFSNKN 431
           D  +E  LL  + H +++   GVC       +V+EY  +G L+ +         + +  N
Sbjct: 53  DFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGN 112

Query: 432 EGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARP 491
               L   Q + IA  +A G+ YL S      VH+D+ + N L+  +L  KI +F M+R 
Sbjct: 113 RPAELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENLLVKIGDFGMSRD 169

Query: 492 AEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT-GKE 543
               +  + +  H +    +M PE +     +T+ DV++ GV++ E+ T GK+
Sbjct: 170 VYSTD-YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQ 221

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 68.3 bits (167), Expect = 2e-12
 Identities = 45/136 (33%), Positives = 73/136 (53%), Gaps = 10/136 (7%)

Query: 407 EGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHK 466
           + + + V EY +NG   D +F  ++ G++ + + R   A ++  GL +LH       +++
Sbjct: 68  KEHLFFVMEY-LNG--GDLMFHIQSSGRFDEARARF-YAAEIICGLQFLHKKGI---IYR 120

Query: 467 DINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKL 526
           D+   NVLLD D   KIA+F M +  E   GE        GT  Y+APE L+    +  +
Sbjct: 121 DLKLDNVLLDKDGHIKIADFGMCK--ENMNGE-GKASTFCGTPDYIAPEILKGQKYNESV 177

Query: 527 DVYAFGVLILEMLTGK 542
           D ++FGVL+ EML G+
Sbjct: 178 DWWSFGVLLYEMLIGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 67.3 bits (164), Expect = 2e-12
 Identities = 67/276 (24%), Positives = 132/276 (47%), Gaps = 40/276 (14%)

Query: 361 GSVYRG--KING---GFAAIK--------KVNGDVSKEIALLNKINHSNLIILSGVCFNE 407
           G V+RG  K+ G      AIK        K   D   E +++ + +H N+I L GV    
Sbjct: 19  GEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKF 78

Query: 408 GNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKD 467
               ++ EY  NG L    +   ++G++  + Q + +   +A G+ YL   ++  +VH+D
Sbjct: 79  KPAMIITEYMENGALDK--YLRDHDGEFSSY-QLVGMLRGIAAGMKYL---SDMNYVHRD 132

Query: 468 INSSNVLLDSDLRAKIANFAMARPAEGQ-EGEFALTRHIVGTKGYMAPEYLENGLVSTKL 526
           + + N+L++S+L  K+++F ++R  E   EG +  +   +  + + APE +     ++  
Sbjct: 133 LAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIR-WTAPEAIAYRKFTSAS 191

Query: 527 DVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYP 586
           DV++FG+++ E+++  E    + + +N  +   +N      DG      F  P      P
Sbjct: 192 DVWSFGIVMWEVMSFGERP--YWDMSNHEVMKAIN------DG------FRLPA-----P 232

Query: 587 LELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNIL 622
           ++    V +L+  C ++D   RP   +I + L  +L
Sbjct: 233 MDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKLL 268

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 67.6 bits (166), Expect = 2e-12
 Identities = 80/290 (27%), Positives = 117/290 (40%), Gaps = 69/290 (23%)

Query: 361 GSVYRGKI--NGGFAAIKKVNGDVS--------KEIALLNKIN-HSNLIILSGVCFNEGN 409
           GSVY  +    G   AIKK+             +E+  L K+N H N++ L  V F E +
Sbjct: 13  GSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEV-FREND 71

Query: 410 C-YLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHS---FTNPPHVH 465
             Y V+EY + G L         +GK         I   +  GL ++H    F      H
Sbjct: 72  ELYFVFEY-MEGNLYQ--LMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFF------H 122

Query: 466 KDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPE-YLENGLVST 524
           +D+   N+L+      KIA+F +AR    +      T + V T+ Y APE  L +   S+
Sbjct: 123 RDLKPENLLVSGPEVVKIADFGLAREIRSRP---PYTDY-VSTRWYRAPEILLRSTSYSS 178

Query: 525 KLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLN---AVL---TKEDGEE------- 571
            +D++A G ++ E+ T +    L    + +   D L    +VL   TK+D  E       
Sbjct: 179 PVDIWALGCIMAELYTLR---PLFPGSSEI---DQLYKICSVLGTPTKQDWPEGYKLASK 232

Query: 572 -----------SLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPT 610
                      SL   I P    N   E     I LI   L+ DP  RPT
Sbjct: 233 LGFRFPQFAPTSLHQLI-P----NASPEA----IDLIKDMLRWDPKKRPT 273

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 67.0 bits (163), Expect = 3e-12
 Identities = 71/284 (25%), Positives = 123/284 (43%), Gaps = 54/284 (19%)

Query: 361 GSVYRGKINGGF-------AAIKKVNGDVS--------KEIALLNKINHSNLIILSGVCF 405
           G VY G   G          AIK VN   S         E +++ + N  +++ L GV  
Sbjct: 20  GMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS 79

Query: 406 NEGNCYLVYEYAVNGTLSDWVFS-----NKNEGKYL-DWKQRIQIALDVATGLNYLHSFT 459
                 ++ E    G L  ++ S       N  +     K+ IQ+A ++A G+ YL++  
Sbjct: 80  QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNA-- 137

Query: 460 NPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKG-----YMAP 514
               VH+D+ + N ++  D   KI +F M R        +    +  G KG     +M+P
Sbjct: 138 -NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDI------YETDYYRKGGKGLLPVRWMSP 190

Query: 515 EYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLR 574
           E L++G+ +T  DV++FGV++ E+ T        AE+    +S+           E+ LR
Sbjct: 191 ESLKDGVFTTYSDVWSFGVVLWEIAT-------LAEQPYQGMSN-----------EQVLR 232

Query: 575 HFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSL 618
             ++  L  + P     ++  L+  C + +P  RP+  EI  S+
Sbjct: 233 FVMEGGLL-DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSI 275

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 67.5 bits (165), Expect = 4e-12
 Identities = 55/230 (23%), Positives = 102/230 (44%), Gaps = 41/230 (17%)

Query: 384 KEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTL-----SDWVFSNKNEGKYLDW 438
            E  +L ++NH  ++ L      EG  YL+ ++   G L      + +F+ ++   YL  
Sbjct: 47  MERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYL-- 104

Query: 439 KQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGE 498
                   ++A  L++LHS      +++D+   N+LLD +   K+ +F +++ +   E +
Sbjct: 105 -------AELALALDHLHSLGI---IYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK 154

Query: 499 FALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSD 558
                   GT  YMAPE +     +   D ++FGVL+ EMLTG  +     ++    ++ 
Sbjct: 155 ---AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG--SLPFQGKDRKETMTM 209

Query: 559 VLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDR 608
           +L A L        +  F+ P  Q             L+ A  K++P +R
Sbjct: 210 ILKAKL-------GMPQFLSPEAQS------------LLRALFKRNPANR 240

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 66.5 bits (163), Expect = 5e-12
 Identities = 66/272 (24%), Positives = 105/272 (38%), Gaps = 43/272 (15%)

Query: 361 GSVY--RGKINGGFAAIKKVNGDVSKEIALLNKINHSNLIIL-----SGVCF-----NEG 408
           G V+  + K  G   AIK +          ++++     I+        V        + 
Sbjct: 7   GRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKK 66

Query: 409 NCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDI 468
           N YLV EY   G L+  +   +N G   +   RI IA ++   L YLHS      +H+D+
Sbjct: 67  NLYLVMEYLPGGDLASLL---ENVGSLDEDVARIYIA-EIVLALEYLHSNG---IIHRDL 119

Query: 469 NSSNVLLDSDLRAKIANFA-----MARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVS 523
              N+L+DS+   K+ +F      + R       +    + IVGT  Y+APE +     S
Sbjct: 120 KPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHS 179

Query: 524 TKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQG 583
             +D ++ G ++ E L G      H E       ++LN  +   +  E     ID     
Sbjct: 180 KTVDWWSLGCILYEFLVG--IPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAID----- 232

Query: 584 NYPLELALLVIRLIDACLKKDPTDRPTMYEIE 615
                   L+ +L    L  DP  R     IE
Sbjct: 233 --------LISKL----LVPDPEKRLGAKSIE 252

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 66.6 bits (163), Expect = 5e-12
 Identities = 57/208 (27%), Positives = 93/208 (44%), Gaps = 49/208 (23%)

Query: 361 GSVY--RGKINGGFAAIKKVNGDVS---------KEIALLNKINHSNLIILSGVCFNEGN 409
           G VY  R K+ G   A+KK+  +           +EI+LL ++NH N++ L  V  +E  
Sbjct: 13  GVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENK 72

Query: 410 CYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVA--------TGLNYLHSFTNP 461
            YLV+E+ ++  L           KY+D      +   +          G+ Y HS    
Sbjct: 73  LYLVFEF-LDLDLK----------KYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHS---- 117

Query: 462 PH--VHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALT----RHIVGTKGYMAPE 515
            H  +H+D+   N+L+D +   K+A+F +AR        F +      H V T  Y APE
Sbjct: 118 -HRVLHRDLKPQNLLIDREGALKLADFGLARA-------FGVPVRTYTHEVVTLWYRAPE 169

Query: 516 YLENG-LVSTKLDVYAFGVLILEMLTGK 542
            L      ST +D+++ G +  EM+  +
Sbjct: 170 ILLGSRQYSTPVDIWSIGCIFAEMVNRR 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 66.2 bits (161), Expect = 5e-12
 Identities = 65/261 (24%), Positives = 111/261 (42%), Gaps = 39/261 (14%)

Query: 363 VYRGK--INGGFAAIKKVN----------GDVSKEIALLNKINHSNLIILSGVCFNEGNC 410
           VYR    ++G   A+KKV            D  KEI LL ++NH N+I        +   
Sbjct: 18  VYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNEL 77

Query: 411 YLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINS 470
            +V E A  G LS  +   K + + +  K   +  + + + L ++HS      +H+DI  
Sbjct: 78  NIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRV---MHRDIKP 134

Query: 471 SNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYA 530
           +NV + +    K+ +  + R    +         +VGT  YM+PE +     + K D+++
Sbjct: 135 ANVFITATGVVKLGDLGLGRFFSSKT---TAAHSLVGTPYYMSPERIHENGYNFKSDIWS 191

Query: 531 FGVLILEMLTGKEAAALHAE--ENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLE 588
            G L+ EM      AAL +    + M+L  +   +       E   +   P    +Y  E
Sbjct: 192 LGCLLYEM------AALQSPFYGDKMNLYSLCKKI-------EQCDY--PPLPSDHYSEE 236

Query: 589 LALLVIRLIDACLKKDPTDRP 609
           L     +L++ C+  DP  RP
Sbjct: 237 LR----QLVNMCINPDPEKRP 253

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 66.1 bits (161), Expect = 6e-12
 Identities = 72/275 (26%), Positives = 122/275 (44%), Gaps = 53/275 (19%)

Query: 374 AIKKVNGDVS--KEIALLNK------INHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDW 425
           A+K VN   S  + I  LN+          +++ L GV        +V E   +G L  +
Sbjct: 40  AVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSY 99

Query: 426 VFS-----NKNEGKYL-DWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDL 479
           + S       N G+     ++ IQ+A ++A G+ YL++      VH+D+ + N ++  D 
Sbjct: 100 LRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA---KKFVHRDLAARNCMVAHDF 156

Query: 480 RAKIANFAMARPAEGQEGEFALTRHIVGTKG-----YMAPEYLENGLVSTKLDVYAFGVL 534
             KI +F M R        +    +  G KG     +MAPE L++G+ +T  D+++FGV+
Sbjct: 157 TVKIGDFGMTRDI------YETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVV 210

Query: 535 ILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNY---PLELAL 591
           + E+ +        AE+    LS+           E+ L+  +D    G Y   P     
Sbjct: 211 LWEITS-------LAEQPYQGLSN-----------EQVLKFVMD----GGYLDQPDNCPE 248

Query: 592 LVIRLIDACLKKDPTDRPTMYEIEHSLSNILNASL 626
            V  L+  C + +P  RPT  EI + L + L+ S 
Sbjct: 249 RVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSF 283

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 66.2 bits (162), Expect = 8e-12
 Identities = 64/226 (28%), Positives = 93/226 (41%), Gaps = 46/226 (20%)

Query: 390 NKINHSNLIILSGVCFN-EGNCYLVYEYAVNGTL----SDWVFSNKNEGKYLDWKQRIQI 444
           N   H  L+ L   CF  E +   V EYA  G L       VFS      Y         
Sbjct: 57  NSERHPFLVNLFA-CFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPRAVFY--------- 106

Query: 445 ALDVATGLNYLHSFTNPPH--VHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALT 502
           A  V  GL YLH      +  V++D+   N+LLD++   KIA+F + +  EG  G    T
Sbjct: 107 AACVVLGLQYLHE-----NKIVYRDLKLDNLLLDTEGFVKIADFGLCK--EGM-GFGDRT 158

Query: 503 RHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNA 562
               GT  ++APE L     +  +D +  GVLI EML G+       EE      +V ++
Sbjct: 159 STFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEE------EVFDS 212

Query: 563 VLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDR 608
           ++  E                 YP  L+   I ++   L+++P  R
Sbjct: 213 IVNDE---------------VRYPRFLSREAISIMRRLLRRNPERR 243

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 66.6 bits (162), Expect = 9e-12
 Identities = 59/206 (28%), Positives = 94/206 (45%), Gaps = 25/206 (12%)

Query: 404 CFN-EGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPP 462
           CF      +LV EY VNG   D +F  + + K  +   R   A ++   LN+LH      
Sbjct: 64  CFQTTSRLFLVIEY-VNG--GDLMFHMQRQRKLPEEHARFYAA-EICIALNFLHE---RG 116

Query: 463 HVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLV 522
            +++D+   NVLLD+D   K+ ++ M +  EG  G    T    GT  Y+APE L     
Sbjct: 117 IIYRDLKLDNVLLDADGHIKLTDYGMCK--EGL-GPGDTTSTFCGTPNYIAPEILRGEEY 173

Query: 523 STKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQ 582
              +D +A GVL+ EM+ G+    +  +  +M+  D L  V+     E+ +R        
Sbjct: 174 GFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVIL----EKPIR-------- 221

Query: 583 GNYPLELALLVIRLIDACLKKDPTDR 608
              P  L++    ++   L KDP +R
Sbjct: 222 --IPRFLSVKASHVLKGFLNKDPKER 245

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 66.1 bits (162), Expect = 9e-12
 Identities = 59/205 (28%), Positives = 93/205 (45%), Gaps = 41/205 (20%)

Query: 361 GSVYRG--KINGGFAAIKK------------VNGDVSKEIALLNKINHSNLIILSGVCFN 406
             VY+   K  G   AIKK            +N    +EI LL ++ H N+I L  V  +
Sbjct: 14  AVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGH 73

Query: 407 EGNCYLVYEYAVNGTLSDW--VFSNKN----EGKYLDWKQRIQIALDVATGLNYLHSFTN 460
           + N  LV+E+      +D   V  +K+         D K  + + L    GL YLHS   
Sbjct: 74  KSNINLVFEFM----ETDLEKVIKDKSIVLTPA---DIKSYMLMTL---RGLEYLHS--- 120

Query: 461 PPH--VHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLE 518
             +  +H+D+  +N+L+ SD   K+A+F +AR + G      +T H V T+ Y APE L 
Sbjct: 121 --NWILHRDLKPNNLLIASDGVLKLADFGLAR-SFGSPNRK-MT-HQVVTRWYRAPELLF 175

Query: 519 NG-LVSTKLDVYAFGVLILEMLTGK 542
                   +D+++ G +  E+L   
Sbjct: 176 GARHYGVGVDMWSVGCIFAELLLRV 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 65.5 bits (160), Expect = 1e-11
 Identities = 60/205 (29%), Positives = 92/205 (44%), Gaps = 42/205 (20%)

Query: 361 GSVYRG--KINGGFAAIKKVNGDVS---------KEIALLNKINHSNLIILSGVCFNEGN 409
           G VY+G  K  G   A+KK+  +           +EI+LL ++ H N++ L  V   E  
Sbjct: 14  GVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESR 73

Query: 410 CYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPP---H--- 463
            YL++E+     LS      K   KYLD   + Q  +D     +YL+         H   
Sbjct: 74  LYLIFEF-----LS---MDLK---KYLDSLPKGQ-YMDAELVKSYLYQILQGILFCHSRR 121

Query: 464 -VHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALT----RHIVGTKGYMAPEYLE 518
            +H+D+   N+L+D+    K+A+F +AR        F +      H V T  Y APE L 
Sbjct: 122 VLHRDLKPQNLLIDNKGVIKLADFGLAR-------AFGIPVRVYTHEVVTLWYRAPEVLL 174

Query: 519 NG-LVSTKLDVYAFGVLILEMLTGK 542
                ST +D+++ G +  EM T K
Sbjct: 175 GSPRYSTPVDIWSIGTIFAEMATKK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 65.8 bits (160), Expect = 1e-11
 Identities = 60/258 (23%), Positives = 110/258 (42%), Gaps = 42/258 (16%)

Query: 367 KINGGFAAIKKVNGDVSK---------EIALLNKINHSNLIILSGVCFNEGNCYLVYEYA 417
           K +G   A+KK+  D+ K         E+ ++    H N++ +          ++V E+ 
Sbjct: 42  KSSGKLVAVKKM--DLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 99

Query: 418 VNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDS 477
             G L+D V   +     ++ +Q   + L V   L+ LH+      +H+DI S ++LL  
Sbjct: 100 EGGALTDIVTHTR-----MNEEQIAAVCLAVLKALSVLHA---QGVIHRDIKSDSILLTH 151

Query: 478 DLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILE 537
           D R K+++F           E    + +VGT  +MAPE +       ++D+++ G++++E
Sbjct: 152 DGRVKLSDFGFCAQVSK---EVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIE 208

Query: 538 MLTGKEAAALHAEENNMHL-SDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRL 596
           M+ G+           M +  D L   L          H + P+L+G             
Sbjct: 209 MVDGEPPYFNEPPLKAMKMIRDNLPPKLKN-------LHKVSPSLKG------------F 249

Query: 597 IDACLKKDPTDRPTMYEI 614
           +D  L +DP  R T  E+
Sbjct: 250 LDRLLVRDPAQRATAAEL 267

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 64.8 bits (158), Expect = 2e-11
 Identities = 70/285 (24%), Positives = 117/285 (41%), Gaps = 66/285 (23%)

Query: 361 GSVY--RGKINGG-FAAIKKVN-----------------GDVSKEIALLNK-INHSNLII 399
           G VY  R K NG    A+K++N                 GD+  E+ ++ + + H N I+
Sbjct: 14  GCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPN-IV 72

Query: 400 LSGVCFNEGN-CYLVYEYAVNGTLSDWVFSNKNEGKYLD----WKQRIQIALDVATGLNY 454
                F E +  Y+V +      L +   S K + +       W   +Q+ L     L Y
Sbjct: 73  RYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVL----ALRY 128

Query: 455 LHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAP 514
           LH       VH+D+  +N++L  D +  I +F +A+    Q+   +    +VGT  Y  P
Sbjct: 129 LHK--EKRIVHRDLTPNNIMLGEDDKVTITDFGLAK----QKQPESKLTSVVGTILYSCP 182

Query: 515 EYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAE--ENNMHLS---DVLNAVLTKEDG 569
           E ++N     K DV+AFG ++ +M        L       NM LS    ++ AV      
Sbjct: 183 EIVKNEPYGEKADVWAFGCILYQM------CTLQPPFYSTNM-LSLATKIVEAVY----- 230

Query: 570 EESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEI 614
                   +P  +G Y  ++      +I +CL  D   RP + ++
Sbjct: 231 --------EPLPEGMYSEDVTD----VITSCLTPDAEARPDIIQV 263

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 64.8 bits (158), Expect = 2e-11
 Identities = 54/203 (26%), Positives = 96/203 (47%), Gaps = 41/203 (20%)

Query: 362 SVYRG--KINGGFAAIKKVNGDVS--------KEIALLNKINHSNLIILSGVCFNEGNCY 411
           +VY+G  +  G   A+K+++ D          +EI+L+ ++ H N++ L  V   E    
Sbjct: 15  TVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLM 74

Query: 412 LVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLH------SFTNPPHV- 464
           LV+EY            +K+  KY+D    ++ ALD  T  ++ +      +F +   V 
Sbjct: 75  LVFEYM-----------DKDLKKYMD-THGVRGALDPNTVKSFTYQLLKGIAFCHENRVL 122

Query: 465 HKDINSSNVLLDSDLRAKIANFAMAR----PAEGQEGEFALTRHIVGTKGYMAPEYLENG 520
           H+D+   N+L++     K+A+F +AR    P      E       V T  Y AP+ L   
Sbjct: 123 HRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNE-------VVTLWYRAPDVLLGS 175

Query: 521 LV-STKLDVYAFGVLILEMLTGK 542
              ST +D+++ G ++ EM+TG+
Sbjct: 176 RTYSTSIDIWSVGCIMAEMITGR 198

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 65.4 bits (159), Expect = 2e-11
 Identities = 44/132 (33%), Positives = 70/132 (53%), Gaps = 10/132 (7%)

Query: 411 YLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINS 470
           Y V EY VNG   D ++  +  GK+ +  Q +  A +++ GL +LH       +++D+  
Sbjct: 77  YFVMEY-VNG--GDLMYHIQQVGKFKE-PQAVFYAAEISVGLFFLH---RRGIIYRDLKL 129

Query: 471 SNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYA 530
            NV+LDS+   KIA+F M +       +   TR   GT  Y+APE +        +D +A
Sbjct: 130 DNVMLDSEGHIKIADFGMCKE---HMVDGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWA 186

Query: 531 FGVLILEMLTGK 542
           +GVL+ EML G+
Sbjct: 187 YGVLLYEMLAGQ 198

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 65.0 bits (159), Expect = 2e-11
 Identities = 78/293 (26%), Positives = 116/293 (39%), Gaps = 56/293 (19%)

Query: 361 GSVYRG--KINGGFAAIKKVNGDVSK---------EIALLNKINHSNLIILSGVCFNE-- 407
           G VY+      G   A+KK+     K         EI +L K+ H N++ L  +      
Sbjct: 22  GEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPD 81

Query: 408 ------GNCYLVYEYAV---NGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSF 458
                 G+ Y+V  Y     +G L        N    L   Q     L +  G+NYLH  
Sbjct: 82  KSKRKRGSVYMVTPYMDHDLSGLLE-------NPSVKLTESQIKCYMLQLLEGINYLHE- 133

Query: 459 TNPPHV-HKDINSSNVLLDSDLRAKIANFAMARPAEGQ---------EGEFALTRHIVGT 508
               H+ H+DI ++N+L+D+    KIA+F +ARP +G           G    T  +V T
Sbjct: 134 ---NHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVV-T 189

Query: 509 KGYMAPEYLENGL--VSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTK 566
           + Y  PE L  G    +T +D++  G +  EM T +      ++ + +HL   L    T+
Sbjct: 190 RWYRPPELLL-GERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTPTE 248

Query: 567 ED--GEESLRHFIDPTLQGNYPLELALL-------VIRLIDACLKKDPTDRPT 610
           E   G  SL          NYP  L           + L+   L  DP  R T
Sbjct: 249 ETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLT 301

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 65.5 bits (159), Expect = 2e-11
 Identities = 61/219 (27%), Positives = 99/219 (45%), Gaps = 28/219 (12%)

Query: 393 NHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGL 452
           NH  L+ L      E   + V EY VNG   D +F  + + K  +   R   A +++  L
Sbjct: 54  NHPFLVGLHSCFQTESRLFFVIEY-VNG--GDLMFHMQRQRKLPEEHARFYSA-EISLAL 109

Query: 453 NYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEG-QEGEFALTRHIVGTKGY 511
           NYLH       +++D+   NVLLDS+   K+ ++ M +  EG + G+   T    GT  Y
Sbjct: 110 NYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGD--TTSTFCGTPNY 162

Query: 512 MAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENN--MHLSDVLNAVLTKEDG 569
           +APE L        +D +A GVL+ EM+ G+    +    +N   +  D L  V+ ++  
Sbjct: 163 IAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK-- 220

Query: 570 EESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDR 608
                       Q   P  L++    ++ + L KDP +R
Sbjct: 221 ------------QIRIPRSLSVKAASVLKSFLNKDPKER 247

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 64.1 bits (156), Expect = 2e-11
 Identities = 55/231 (23%), Positives = 104/231 (45%), Gaps = 30/231 (12%)

Query: 385 EIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQI 444
           E  +L  ++H N+I        +    +V EYA  GTL++++    N    LD    +  
Sbjct: 49  ECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNS--LLDEDTILHF 106

Query: 445 ALDVATGLNYLHSFTNPPHVHKDINSSNVLLDS-DLRAKIANFAMARPAEGQEGEFALTR 503
            + +   L+++H       +H+D+ + N+LLD   +  KI +F +++    +   +    
Sbjct: 107 FVQILLALHHVH---TKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYT--- 160

Query: 504 HIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAV 563
            +VGT  Y++PE  E    + K D++A G ++ E+ + K A     E  N      L A+
Sbjct: 161 -VVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAF----EAAN------LPAL 209

Query: 564 LTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEI 614
           + K      +     P +   Y  +L  L++ +    L  DP+ RP + +I
Sbjct: 210 VLK-----IMSGTFAP-ISDRYSPDLRQLILSM----LNLDPSKRPQLSQI 250

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 66.4 bits (162), Expect = 3e-11
 Identities = 65/236 (27%), Positives = 103/236 (43%), Gaps = 40/236 (16%)

Query: 384 KEIALLNKINHSNLIIL--SGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQR 441
           +E AL  ++ H N++ L  SG     G  + V+EY    TL + +     +G  L   + 
Sbjct: 27  RETALCARLYHPNIVALLDSGEA-PPGLLFAVFEYVPGRTLREVL---AADGA-LPAGET 81

Query: 442 IQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLD-SDLR--AKIANFAMAR--PAEGQE 496
            ++ L V   L   H   N   VH+D+   N+++  + +R  AK+ +F +    P     
Sbjct: 82  GRLMLQVLDALACAH---NQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDA 138

Query: 497 GEFALTR--HIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEA--AALHAEEN 552
               LTR   ++GT  Y APE L    V+   D+YA+G++ LE LTG+     A  AE  
Sbjct: 139 DVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQRVVQGASVAEIL 198

Query: 553 NMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDR 608
              LS V  +              + P + G +PL       +++   L KDP  R
Sbjct: 199 YQQLSPVDVS--------------LPPWIAG-HPLG------QVLRKALNKDPRQR 233

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 63.8 bits (155), Expect = 3e-11
 Identities = 72/275 (26%), Positives = 116/275 (42%), Gaps = 50/275 (18%)

Query: 361 GSVYRGKINGG-FAAIKKVNGDVS-------------KEIALLNKINHSNLIILSGVCFN 406
           G+VY G  N G   A+K+V  D S             +E+ LL  + H N++   G C +
Sbjct: 14  GTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLD 73

Query: 407 EGNCYLVYEYAVNGTLSDWV--FSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHV 464
           +    +  E+   G++S  +  F    E  +  + ++I   LD   G+ YLH   N   V
Sbjct: 74  DNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQI---LD---GVAYLH---NNCVV 124

Query: 465 HKDINSSNVLLDSDLRAKIANFAMARP-----AEGQEGEFALTRHIVGTKGYMAPEYLEN 519
           H+DI  +NV+L  +   K+ +F  AR        G       + H  GT  +MAPE +  
Sbjct: 125 HRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMH--GTPYWMAPEVINE 182

Query: 520 GLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDP 579
                K D+++ G  + EM TGK   A      +M   D L A+         +     P
Sbjct: 183 SGYGRKSDIWSIGCTVFEMATGKPPLA------SM---DRLAAMFYIGAHRGLM-----P 228

Query: 580 TLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEI 614
            L    P   +   I  + +CL +D  +RP+  ++
Sbjct: 229 RL----PDSFSAAAIDFVTSCLTRDQHERPSALQL 259

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 63.9 bits (156), Expect = 4e-11
 Identities = 71/290 (24%), Positives = 123/290 (42%), Gaps = 53/290 (18%)

Query: 361 GSVY--RGKINGGFAAIKKV----NGDVSKEIAL-----LNKINHSNLIILSGVCFNEGN 409
           G V+  R +  G   AIKK     +  V K+IAL     L ++ H NL+ L  V   +  
Sbjct: 15  GVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRK 74

Query: 410 CYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPH--VHKD 467
            +LV+EY  +  L++     KN  + +      +I       +N+ H      H  +H+D
Sbjct: 75  LHLVFEYCDHTVLNEL---EKNP-RGVPEHLIKKIIWQTLQAVNFCHK-----HNCIHRD 125

Query: 468 INSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLV-STKL 526
           +   N+L+    + K+ +F  AR   G   ++      V T+ Y APE L         +
Sbjct: 126 VKPENILITKQGQIKLCDFGFARILTGPGDDYT---DYVATRWYRAPELLVGDTQYGPPV 182

Query: 527 DVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRH----------- 575
           DV+A G +  E+LTG+      ++ + ++L       + K  G+   RH           
Sbjct: 183 DVWAIGCVFAELLTGQPLWPGKSDVDQLYL-------IRKTLGDLIPRHQQIFSTNQFFK 235

Query: 576 ---FIDPT----LQGNYPLELALLVIRLIDACLKKDPTDRPTMYEI-EHS 617
                +P     L+  +P  ++   +  +  CL+ DPT+R +  E+ EH 
Sbjct: 236 GLSIPEPETREPLESKFP-NISSPALSFLKGCLQMDPTERLSCEELLEHP 284

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 64.5 bits (158), Expect = 4e-11
 Identities = 60/178 (33%), Positives = 88/178 (49%), Gaps = 41/178 (23%)

Query: 384 KEIALLNKI-NHSNLIILSGV--CFNEGNCYLVYEY------AV--NGTLSDWVFSNKNE 432
           +EI  L ++ +H N++ L  V    N+ + YLV+EY      AV     L D        
Sbjct: 55  REIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYMETDLHAVIRANILED-------- 106

Query: 433 GKYLDWKQRIQIALDVATGLNYLHSFTNPPHV-HKDINSSNVLLDSDLRAKIANFAMAR- 490
                 K+ I   L  A  L Y+HS     +V H+D+  SN+LL+SD R K+A+F +AR 
Sbjct: 107 ----VHKRYIMYQLLKA--LKYIHS----GNVIHRDLKPSNILLNSDCRVKLADFGLARS 156

Query: 491 --PAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTK----LDVYAFGVLILEMLTGK 542
               E       LT + V T+ Y APE L   L ST+    +D+++ G ++ EML GK
Sbjct: 157 LSELEENPENPVLTDY-VATRWYRAPEIL---LGSTRYTKGVDMWSVGCILGEMLLGK 210

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 63.9 bits (156), Expect = 4e-11
 Identities = 77/293 (26%), Positives = 119/293 (40%), Gaps = 55/293 (18%)

Query: 361 GSVY--RGKINGGFAAIKKVNGDVSK---------EIALLNKINHSNLIILSGVCFNE-- 407
           G V+  R K      A+KKV  +  K         EI +L  + H N++ L  +C  +  
Sbjct: 26  GEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKAT 85

Query: 408 ------GNCYLVYE---YAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSF 458
                 G+ YLV+E   + + G LS     NKN    L   +++   L    GL Y+H  
Sbjct: 86  PYNRYKGSFYLVFEFCEHDLAGLLS-----NKNVKFTLSEIKKVMKML--LNGLYYIHR- 137

Query: 459 TNPPHVHKDINSSNVLLDSDLRAKIANFAMARP---AEGQEGEFALTRHIVGTKGYMAPE 515
            N   +H+D+ ++N+L+  D   K+A+F +AR    ++  +      R  V T  Y  PE
Sbjct: 138 -NKI-LHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNR--VVTLWYRPPE 193

Query: 516 YLEN----GLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKE--DG 569
            L      G     +D++  G ++ EM T       + E++ + L   L   +T E   G
Sbjct: 194 LLLGERDYG---PPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPG 250

Query: 570 EESLRHFIDPTL-QGNY---PLELALLV-----IRLIDACLKKDPTDRPTMYE 613
            + L  F    L QG        L   V     + LID  L  DP  R     
Sbjct: 251 VDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADT 303

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 64.2 bits (156), Expect = 5e-11
 Identities = 43/132 (32%), Positives = 73/132 (55%), Gaps = 10/132 (7%)

Query: 411 YLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINS 470
           + V E+ +NG   D +F  +++G++ D  +    A ++  GL +LHS      +++D+  
Sbjct: 72  FFVMEF-LNG--GDLMFHIQDKGRF-DLYRATFYAAEIVCGLQFLHS---KGIIYRDLKL 124

Query: 471 SNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYA 530
            NV+LD D   KIA+F M +  E   G+   +    GT  Y+APE L+    +  +D ++
Sbjct: 125 DNVMLDRDGHIKIADFGMCK--ENVFGDNRAST-FCGTPDYIAPEILQGLKYTFSVDWWS 181

Query: 531 FGVLILEMLTGK 542
           FGVL+ EML G+
Sbjct: 182 FGVLLYEMLIGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 63.9 bits (155), Expect = 5e-11
 Identities = 51/230 (22%), Positives = 101/230 (43%), Gaps = 29/230 (12%)

Query: 385 EIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQI 444
           E+ ++    H N++ +          +++ E+   G L+D V   +     L+ +Q   +
Sbjct: 68  EVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQTR-----LNEEQIATV 122

Query: 445 ALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRH 504
              V   L YLHS      +H+DI S ++LL  D R K+++F           +    + 
Sbjct: 123 CESVLQALCYLHS---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISK---DVPKRKS 176

Query: 505 IVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVL 564
           +VGT  +MAPE +      T++D+++ G++++EM+ G+            + SD      
Sbjct: 177 LVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPP----------YFSD------ 220

Query: 565 TKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEI 614
           +     + LR    P L+  + +   L     ++  L ++P +R T  E+
Sbjct: 221 SPVQAMKRLRDSPPPKLKNAHKISPVLR--DFLERMLTREPQERATAQEL 268

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 63.1 bits (153), Expect = 5e-11
 Identities = 64/240 (26%), Positives = 103/240 (42%), Gaps = 37/240 (15%)

Query: 377 KVNGDVSKEIALLNKINHSNLI--ILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGK 434
           K   D  KEI LL ++NH N+I  + S +  NE N  +V E A  G LS  +   K + +
Sbjct: 44  KARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELN--IVLELADAGDLSQMIKYFKKQKR 101

Query: 435 YLD----WKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMAR 490
            +     WK  +Q+     + + ++HS      +H+DI  +NV + +    K+ +  + R
Sbjct: 102 LIPERTVWKYFVQLC----SAVEHMHSRRV---MHRDIKPANVFITATGVVKLGDLGLGR 154

Query: 491 PAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAE 550
                  +      +VGT  YM+PE +     + K D+++ G L+ EM      AAL + 
Sbjct: 155 FFSS---KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEM------AALQSP 205

Query: 551 ENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIR-LIDACLKKDPTDRP 609
                  D +N          SL   I+       P E     +R L+  C+  DP  RP
Sbjct: 206 ----FYGDKMNLF--------SLCQKIEQCDYPPLPTEHYSEKLRELVSMCIYPDPDQRP 253

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 63.8 bits (155), Expect = 7e-11
 Identities = 58/200 (29%), Positives = 92/200 (46%), Gaps = 35/200 (17%)

Query: 411 YLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINS 470
           + V E+ VNG   D +F  +   ++ + + R   A ++ + L +LH       +++D+  
Sbjct: 72  FFVMEF-VNG--GDLMFHIQKSRRFDEARARFYAA-EITSALMFLHD---KGIIYRDLKL 124

Query: 471 SNVLLDSDLRAKIANFAMARPAEGQEGEF--ALTRHIVGTKGYMAPEYLENGLVSTKLDV 528
            NVLLD +   K+A+F M +     EG F    T    GT  Y+APE L+  L    +D 
Sbjct: 125 DNVLLDHEGHCKLADFGMCK-----EGIFNGKTTSTFCGTPDYIAPEILQEMLYGPSVDW 179

Query: 529 YAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLE 588
           +A GVL+ EML G   A   AE  +    D+  A+L  E                 YP  
Sbjct: 180 WAMGVLLYEMLCGH--APFEAENED----DLFEAILNDEV---------------VYPTW 218

Query: 589 LALLVIRLIDACLKKDPTDR 608
           L+   + ++ A + K+PT R
Sbjct: 219 LSQDAVDILKAFMTKNPTMR 238

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 62.9 bits (153), Expect = 7e-11
 Identities = 56/234 (23%), Positives = 109/234 (46%), Gaps = 29/234 (12%)

Query: 385 EIALLNKINHSNLIILSGVCFNEGNCYL--VYEYAVNGTLSDWVFSNKNEGKYLDWKQRI 442
           EI  L  ++H N++   G  F     YL    EY   G++   +   +  G++ +   R 
Sbjct: 58  EIETLKDLDHLNIVQYLG--FETTEEYLSIFLEYVPGGSIGSCL---RTYGRFEEQLVR- 111

Query: 443 QIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALT 502
                V  GL YLHS      +H+D+ + N+L+D+D   KI++F +++ ++         
Sbjct: 112 FFTEQVLEGLAYLHS---KGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQ-N 167

Query: 503 RHIVGTKGYMAPEYLENGL--VSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVL 560
             + G+  +MAPE + +     S K+D+++ G ++LEM  G+   +      +    + +
Sbjct: 168 MSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWS------DE---EAI 218

Query: 561 NAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEI 614
            A+   + G +     I P +  N    L+ + +  ++AC   +P +RPT  E+
Sbjct: 219 AAMF--KLGNKRSAPPIPPDVSMN----LSPVALDFLNACFTINPDNRPTAREL 266

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 63.5 bits (154), Expect = 8e-11
 Identities = 46/140 (32%), Positives = 73/140 (52%), Gaps = 11/140 (7%)

Query: 404 CFNEGN-CYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPP 462
           CF   +  Y V EY VNG   D ++  +  G++ +    +  A ++A GL +LHS     
Sbjct: 69  CFQTMDRLYFVMEY-VNG--GDLMYQIQQVGRFKE-PHAVFYAAEIAIGLFFLHS---KG 121

Query: 463 HVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLV 522
            +++D+   NV+LDS+   KIA+F M +       +   T+   GT  Y+APE +     
Sbjct: 122 IIYRDLKLDNVMLDSEGHIKIADFGMCKE---NMWDGVTTKTFCGTPDYIAPEIIAYQPY 178

Query: 523 STKLDVYAFGVLILEMLTGK 542
              +D +AFGVL+ EML G+
Sbjct: 179 GKSVDWWAFGVLLYEMLAGQ 198

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 63.5 bits (155), Expect = 8e-11
 Identities = 63/228 (27%), Positives = 97/228 (42%), Gaps = 64/228 (28%)

Query: 361 GSVY--RGKIN--GGFAAIKKVNGDVS----------KEIALLNKINHSNLIILSGVCFN 406
           G VY  + K    G   AIKK  GD            +EIALL ++ H N++ L  V   
Sbjct: 14  GRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLE 73

Query: 407 --EGNCYLVYEYAVNGTLSDWVFSNKNEGKYLD--------WKQRIQIALDVATGLNYLH 456
             + + YL+++YA +       F  + +   +         W    QI L+   G++YLH
Sbjct: 74  HADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLW----QI-LN---GVHYLH 125

Query: 457 SFTNPPHV-HKDINSSNVLLDSDL----RAKIANFAMAR--------PAEGQEGEFALTR 503
           S  N   V H+D+  +N+L+  +       KI +  +AR         A+          
Sbjct: 126 S--N--WVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDP------- 174

Query: 504 HIVGTKGYMAPEYLENGLVSTK-LDVYAFGVLILEMLT------GKEA 544
            +V T  Y APE L      TK +D++A G +  E+LT      G+EA
Sbjct: 175 -VVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREA 221

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 63.3 bits (154), Expect = 8e-11
 Identities = 53/164 (32%), Positives = 81/164 (49%), Gaps = 20/164 (12%)

Query: 411 YLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPH--VHKDI 468
           + V EY VNG   D +F  +   K+ + + R   A +V   L +LH      H  +++D+
Sbjct: 72  FFVMEY-VNG--GDLMFQIQRSRKFDEPRSRFYAA-EVTLALMFLHR-----HGVIYRDL 122

Query: 469 NSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDV 528
              N+LLD++   K+A+F M +  EG       T    GT  Y+APE L+       +D 
Sbjct: 123 KLDNILLDAEGHCKLADFGMCK--EGILNG-VTTTTFCGTPDYIAPEILQELEYGPSVDW 179

Query: 529 YAFGVLILEMLTGKEAAALHAE----ENNMHLSDVLNAV-LTKE 567
           +A GVL+ EM+ G+       E    E+ +H  DVL  V L+KE
Sbjct: 180 WALGVLMYEMMAGQPPFEADNEDDLFESILH-DDVLYPVWLSKE 222

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 62.9 bits (153), Expect = 9e-11
 Identities = 62/208 (29%), Positives = 95/208 (45%), Gaps = 39/208 (18%)

Query: 361 GSVY--RGKINGGFAAIKKVNGDVSKE---------IALLNKINHSNLIILSGVCFNE-- 407
           G VY  R K  G   A+KKV  D  KE         I +L ++NH N++ L  +  ++  
Sbjct: 21  GQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQD 80

Query: 408 --------GNCYLVYEYA---VNGTL-SDWVFSNKNEGKYLDWKQRIQIALDVATGLNYL 455
                   G  YLV+EY    + G L S  V  +++  K    KQ ++       GLNY 
Sbjct: 81  ALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSF-MKQLLE-------GLNYC 132

Query: 456 HSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPE 515
           H       +H+DI  SN+LL++  + K+A+F +AR    +E      + I  T  Y  PE
Sbjct: 133 H---KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVI--TLWYRPPE 187

Query: 516 -YLENGLVSTKLDVYAFGVLILEMLTGK 542
             L        +DV++ G ++ E+ T K
Sbjct: 188 LLLGEERYGPAIDVWSCGCILGELFTKK 215

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 62.1 bits (151), Expect = 1e-10
 Identities = 42/163 (25%), Positives = 73/163 (44%), Gaps = 17/163 (10%)

Query: 385 EIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWV-----FSNKNEGKYLDWK 439
           EI LL  + H  ++   G   ++    +  EY   G++ D +      +     KY   +
Sbjct: 54  EIQLLKNLQHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYT--R 111

Query: 440 QRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEF 499
           Q ++       G+ YLHS      VH+DI  +N+L DS    K+ +F  ++  +      
Sbjct: 112 QILE-------GVEYLHSNMI---VHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSG 161

Query: 500 ALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGK 542
              + + GT  +M+PE +       K DV++ G  ++EMLT K
Sbjct: 162 TGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEK 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 62.1 bits (151), Expect = 1e-10
 Identities = 30/98 (30%), Positives = 49/98 (50%), Gaps = 7/98 (7%)

Query: 445 ALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRH 504
           A  +  GL +LH       V++D+   NVLLD     +I++  +A   +G +      + 
Sbjct: 101 AAQIICGLEHLH---QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK----IKG 153

Query: 505 IVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGK 542
             GT GYMAPE L+  +    +D +A G  + EM+ G+
Sbjct: 154 RAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGR 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 62.4 bits (151), Expect = 2e-10
 Identities = 51/167 (30%), Positives = 84/167 (50%), Gaps = 14/167 (8%)

Query: 377 KVNGDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNK-NEGK- 434
           K N +   E  ++  ++H +L+ L GVC +     LV +   +G L D+V  +K N G  
Sbjct: 51  KANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQLVTQLMPHGCLLDYVHEHKDNIGSQ 109

Query: 435 -YLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAE 493
             L+W       + +A G+ YL        VH+D+ + NVL+ S    KI +F +AR  E
Sbjct: 110 LLLNW------CVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLE 160

Query: 494 GQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT 540
           G E E+      +  K +MA E +     + + DV+++GV I E++T
Sbjct: 161 GDEKEYNADGGKMPIK-WMALECIHYRKFTHQSDVWSYGVTIWELMT 206

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 61.9 bits (150), Expect = 2e-10
 Identities = 65/241 (26%), Positives = 103/241 (42%), Gaps = 37/241 (15%)

Query: 375 IKKVNGD----VSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNK 430
           +KK +G+    + KEI  L K+N   ++ L+    ++ +  LV      G L   +++  
Sbjct: 31  LKKKSGEKMALLEKEI--LEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVG 88

Query: 431 NEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMAR 490
             G  L+ ++ I  +  +  G+ +LHS      V++D+   NVLLD     ++++  +A 
Sbjct: 89  ERG--LEMERVIHYSAQITCGILHLHSMDI---VYRDMKPENVLLDDQGNCRLSDLGLA- 142

Query: 491 PAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAE 550
             E ++G+    R   GT GYMAPE L+    S  +D +A G  I EM+ G+     H E
Sbjct: 143 -VELKDGKTITQR--AGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKE 199

Query: 551 ENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDAC---LKKDPTD 607
                          K   EE  R     TL+     E         D C   L K P D
Sbjct: 200 ---------------KVAKEELKRR----TLEDEVKFEHQNFTEESKDICRLFLAKKPED 240

Query: 608 R 608
           R
Sbjct: 241 R 241

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 61.8 bits (150), Expect = 2e-10
 Identities = 62/240 (25%), Positives = 110/240 (45%), Gaps = 32/240 (13%)

Query: 384 KEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQ 443
            E+ +L+K     ++   G  F EG  Y+  EY   G+L D +++     + +      +
Sbjct: 48  MELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMDAGSL-DKLYAGGVATEGIPEDVLRR 106

Query: 444 IALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTR 503
           I   V  GL +L    N   +H+D+  +NVL++ + + K+ +F ++    G     +L +
Sbjct: 107 ITYAVVKGLKFLKEEHNI--IHRDVKPTNVLVNGNGQVKLCDFGVS----GNL-VASLAK 159

Query: 504 HIVGTKGYMAPEYL------ENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLS 557
             +G + YMAPE +      +N   + + DV++ G+ ILEM  G+     +  E   ++ 
Sbjct: 160 TNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYP---YPPETYANIF 216

Query: 558 DVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEI-EH 616
             L+A++   DG+        PTL   Y  +    V      CL K P  RPT  ++ EH
Sbjct: 217 AQLSAIV---DGDP-------PTLPSGYSDDAQDFV----AKCLNKIPNRRPTYAQLLEH 262

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 62.2 bits (152), Expect = 2e-10
 Identities = 64/201 (31%), Positives = 95/201 (47%), Gaps = 43/201 (21%)

Query: 367 KINGGFAAIKKVNGDVSK----------EIALLNKINHSNLIIL-------SGVCFNEGN 409
           K  G   AIKK++ +V            EI LL  + H N+I L       S   FN+  
Sbjct: 22  KRTGRKVAIKKIS-NVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFND-- 78

Query: 410 CYLVYEYAVNGT-LSDWVFSNKNEGKYLDWKQRIQ-IALDVATGLNYLHSFTNPPHV-HK 466
            Y+V E     T L   + S +     L     IQ     +  GL YLHS     +V H+
Sbjct: 79  VYIVTELM--ETDLHKVIKSPQP----LT-DDHIQYFLYQILRGLKYLHS----ANVIHR 127

Query: 467 DINSSNVLLDSDLRAKIANFAMARPAEGQEGEF-ALTRHIVGTKGYMAPEYLENGLVSTK 525
           D+  SN+L++S+   KI +F +AR  +  E E   LT ++V T+ Y APE L   L S++
Sbjct: 128 DLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVV-TRWYRAPELL---LSSSR 183

Query: 526 ----LDVYAFGVLILEMLTGK 542
               +D+++ G +  E+LT K
Sbjct: 184 YTKAIDIWSVGCIFAELLTRK 204

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 61.3 bits (149), Expect = 2e-10
 Identities = 49/196 (25%), Positives = 83/196 (42%), Gaps = 31/196 (15%)

Query: 361 GSVY--RGKINGGFAAIK---KVNGDVSKEIALLNKINHSNLIILSGVCF---------N 406
           GSVY  + +  G + AIK   K +     ++  + K   + ++I     +         +
Sbjct: 10  GSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNV-KAERAIMMIQGESPYVAKLYYSFQS 68

Query: 407 EGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHK 466
           +   YLV EY   G  +  +      G   DW +  Q   +V  G+  LH       +H+
Sbjct: 69  KDYLYLVMEYLNGGDCASLI--KTLGGLPEDWAK--QYIAEVVLGVEDLH---QRGIIHR 121

Query: 467 DINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKL 526
           DI   N+L+D     K+ +F ++R            +  VGT  Y+APE +  G+   K+
Sbjct: 122 DIKPENLLIDQTGHLKLTDFGLSRNGL-------ENKKFVGTPDYLAPETI-LGVGDDKM 173

Query: 527 -DVYAFGVLILEMLTG 541
            D ++ G +I E L G
Sbjct: 174 SDWWSLGCVIFEFLFG 189

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 61.1 bits (148), Expect = 3e-10
 Identities = 43/156 (27%), Positives = 81/156 (51%), Gaps = 12/156 (7%)

Query: 384 KEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQ 443
           +E  ++ ++++  ++ + G+C  E +  LV E A  G L+ ++  NK+    +  K   +
Sbjct: 45  REANVMQQLDNPYIVRMIGICEAE-SWMLVMELAELGPLNKFLQKNKH----VTEKNITE 99

Query: 444 IALDVATGLNYL--HSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFAL 501
           +   V+ G+ YL   +F     VH+D+ + NVLL +   AKI++F +++     E  +  
Sbjct: 100 LVHQVSMGMKYLEETNF-----VHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKA 154

Query: 502 TRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILE 537
             H      + APE +     S+K DV++FGVL+ E
Sbjct: 155 KTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWE 190

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|144899 pfam01476, LysM, LysM domain

 Score = 55.5 bits (135), Expect = 3e-10
 Identities = 17/43 (39%), Positives = 26/43 (60%)

Query: 187 YLVAEGDTVSGISSRFGVDTGEILQANSLSGSNIFPFTTLLIP 229
           Y V +GDT+S I+ R+G+   E+ + N LS  N++    L IP
Sbjct: 1   YTVKKGDTLSSIAKRYGITVEELAELNGLSSPNLYVGQKLKIP 43

The LysM (lysin motif) domain is about 40 residues long. It is found in a variety of enzymes involved in bacterial cell wall degradation. This domain may have a general peptidoglycan binding function. The structure of this domain is known. Length = 43

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 61.0 bits (148), Expect = 3e-10
 Identities = 49/168 (29%), Positives = 78/168 (46%), Gaps = 22/168 (13%)

Query: 384 KEIALLNKINHSNLIILSGVCFNEGNCYLVY-EYAVNGTLSD-----WVFSNKNEGKYLD 437
           +EIAL + + H N++   G   +E   + ++ E    G+LS      W     NE   + 
Sbjct: 54  EEIALHSYLKHRNIVQYLG-SDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIF 112

Query: 438 WKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDS-DLRAKIANFAMARPAEGQE 496
           + ++I        GL YLH   +   VH+DI   NVL+++     KI++F  ++   G  
Sbjct: 113 YTKQI------LEGLKYLH---DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGIN 163

Query: 497 GEFALTRHIVGTKGYMAPEYLENGL--VSTKLDVYAFGVLILEMLTGK 542
                T    GT  YMAPE ++ G        D+++ G  I+EM TGK
Sbjct: 164 ---PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGK 208

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 60.8 bits (147), Expect = 4e-10
 Identities = 56/254 (22%), Positives = 112/254 (44%), Gaps = 39/254 (15%)

Query: 381 DVSKEIALLNKINHSNLIILSGVCF----NEG--NCYLVYEYAVNGTLSDWVFSNK--NE 432
           D   E   + + +H N++ L GVC     +EG  +  ++  +  +G L  ++  ++  + 
Sbjct: 46  DFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDC 105

Query: 433 GKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPA 492
            +YL  +  ++   D+A+G+ YL S      +H+D+ + N +L+ ++   +A+F +++  
Sbjct: 106 PQYLPTQMLVKFMTDIASGMEYLSS---KSFIHRDLAARNCMLNENMNVCVADFGLSKKI 162

Query: 493 EGQEGEFALTRHIVGTK-GYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEE 551
               G++     I      ++A E L + + +TK DV++FGV + E+ T  +      E 
Sbjct: 163 --YNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVE- 219

Query: 552 NNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGN---YPLELALLVIRLIDACLKKDPTDR 608
            N  + D L                     QGN    P +    +  L+ +C   +P DR
Sbjct: 220 -NSEIYDYLR--------------------QGNRLKQPPDCLDGLYSLMSSCWLLNPKDR 258

Query: 609 PTMYEIEHSLSNIL 622
           P+   +   L   L
Sbjct: 259 PSFETLRCELEKAL 272

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 60.8 bits (147), Expect = 4e-10
 Identities = 50/170 (29%), Positives = 79/170 (46%), Gaps = 11/170 (6%)

Query: 375 IKKVNGD--VSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNE 432
           IKK  G+     E  +L K+N   ++ L+     +    LV      G L   +++  N 
Sbjct: 38  IKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNP 97

Query: 433 GKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPA 492
           G   + ++ +  A ++  GL  LH       V++D+   N+LLD     +I++  +A   
Sbjct: 98  G--FEEERALFYAAEILCGLEDLHRENT---VYRDLKPENILLDDYGHIRISDLGLA--V 150

Query: 493 EGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGK 542
           +  EGE    R  VGT GYMAPE L N   +   D +  G LI EM+ G+
Sbjct: 151 KIPEGE--SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQ 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 61.4 bits (149), Expect = 4e-10
 Identities = 60/220 (27%), Positives = 101/220 (45%), Gaps = 30/220 (13%)

Query: 393 NHSNLIILSGVCFN-EGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATG 451
           NH  L+ L   CF  E   + V E+ V+G   D +F  + + K  +   R   A +++  
Sbjct: 54  NHPFLVGLHS-CFQTESRLFFVIEF-VSG--GDLMFHMQRQRKLPEEHARFYSA-EISLA 108

Query: 452 LNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEG-QEGEFALTRHIVGTKG 510
           LN+LH       +++D+   NVLLD++   K+ ++ M +  EG + G+   T    GT  
Sbjct: 109 LNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCK--EGIRPGD--TTSTFCGTPN 161

Query: 511 YMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENN--MHLSDVLNAVLTKED 568
           Y+APE L        +D +A GVL+ EM+ G+    +    +N   +  D L  V+    
Sbjct: 162 YIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVIL--- 218

Query: 569 GEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDR 608
            E+ +R           P  L++    ++   L KDP +R
Sbjct: 219 -EKQIR----------IPRSLSVKASSVLKGFLNKDPKER 247

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 60.8 bits (147), Expect = 5e-10
 Identities = 47/173 (27%), Positives = 80/173 (46%), Gaps = 25/173 (14%)

Query: 439 KQRIQIAL-DVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEG 497
           +Q +QI   ++   L +LH       +++DI   N+LLDS+    + +F +++     E 
Sbjct: 104 EQEVQIYSGEIVLALEHLHKLGI---IYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEV 160

Query: 498 EFALTRHIVGTKGYMAPEYLENGLV--STKLDVYAFGVLILEMLTGKEAAALHAEENNMH 555
           E A +    GT  YMAP+ +  G       +D ++ GVL+ E+LTG     +  E+N+  
Sbjct: 161 ERAYS--FCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQ- 217

Query: 556 LSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDR 608
            +++   +L  E           P     YP E++ L   +I   L KDP  R
Sbjct: 218 -AEISRRILKSE-----------PP----YPQEMSALAKDIIQRLLMKDPKKR 254

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 61.3 bits (149), Expect = 5e-10
 Identities = 47/179 (26%), Positives = 81/179 (45%), Gaps = 23/179 (12%)

Query: 451 GLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKG 510
            L Y+H+       H+D+   N+L ++D + KI +F +AR A             V T+ 
Sbjct: 115 ALKYIHTANV---FHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRW 171

Query: 511 YMAPEYLEN--GLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKED 568
           Y APE   +     +  +D+++ G +  E+LTGK    L   +N +H  D++  +L    
Sbjct: 172 YRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK---PLFPGKNVVHQLDLITDLLGTPS 228

Query: 569 GE-------ESLRHFIDPTLQGNYPLELAL-------LVIRLIDACLKKDPTDRPTMYE 613
            E       E  R ++  +++   P+  +        L +RL++  L  DP DRPT  E
Sbjct: 229 PETISRVRNEKARRYLS-SMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEE 286

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 61.0 bits (148), Expect = 6e-10
 Identities = 51/163 (31%), Positives = 79/163 (48%), Gaps = 21/163 (12%)

Query: 384 KEIALLNKINHSNLIILSGVCFNE-GNCYLVYEYAVNGT-LSDWVFSNKNEGKYLDWKQR 441
           +E+ LL  + H N+I LS +  +   + Y V E  + GT L   + S   E      KQ 
Sbjct: 58  RELKLLKHLRHENIISLSDIFISPLEDIYFVTE--LLGTDLHRLLTSRPLE------KQF 109

Query: 442 IQ-IALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFA 500
           IQ     +  GL Y+HS      VH+D+  SN+L++ +   KI +F +AR  + Q   + 
Sbjct: 110 IQYFLYQILRGLKYVHS---AGVVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYV 166

Query: 501 LTRHIVGTKGYMAPE-YLENGLVSTKLDVYAFGVLILEMLTGK 542
            TR+      Y APE  L       ++D+++ G +  EML GK
Sbjct: 167 STRY------YRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 59.7 bits (144), Expect = 8e-10
 Identities = 56/201 (27%), Positives = 91/201 (45%), Gaps = 28/201 (13%)

Query: 361 GSVYRGK--INGGFAAIK--KVNGD----VSKEIALLNKINHSNLIILSGVCFNEGN--- 409
           G VY+G+    G  AAIK   V GD    + +EI +L K +H   I      F + N   
Sbjct: 20  GQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPG 79

Query: 410 ----CYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVH 465
                +LV E+   G+++D + + K      +W     I  ++  GL++LH       +H
Sbjct: 80  MDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIA--YICREILRGLSHLHQHKV---IH 134

Query: 466 KDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYL---EN--G 520
           +DI   NVLL  +   K+ +F ++   +   G        +GT  +MAPE +   EN   
Sbjct: 135 RDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGR---RNTFIGTPYWMAPEVIACDENPDA 191

Query: 521 LVSTKLDVYAFGVLILEMLTG 541
               K D+++ G+  +EM  G
Sbjct: 192 TYDFKSDLWSLGITAIEMAEG 212

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 60.1 bits (145), Expect = 8e-10
 Identities = 60/236 (25%), Positives = 104/236 (44%), Gaps = 38/236 (16%)

Query: 321 DEESQDFLESISGVAQSLKVYS-FKEL-QSATDNFSFTCRIQGSVYRGK--INGGFAAIK 376
           DEE  + L SI  V    K Y+ F+++ Q A+          G+VY       G   AI+
Sbjct: 2   DEEILEKLRSIVSVGDPKKKYTRFEKIGQGAS----------GTVYTAMDVATGQEVAIR 51

Query: 377 KVNGD-------VSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSN 429
           ++N         +  EI ++ +  + N++            ++V EY   G+L+D V   
Sbjct: 52  QMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET 111

Query: 430 KNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANF--- 486
                 +D  Q   +  +    L +LHS      +H+DI S N+LL  D   K+ +F   
Sbjct: 112 -----CMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFC 163

Query: 487 AMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGK 542
           A   P + +         +VGT  +MAPE +       K+D+++ G++ +EM+ G+
Sbjct: 164 AQITPEQSKRST------MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 60.4 bits (146), Expect = 8e-10
 Identities = 45/174 (25%), Positives = 86/174 (49%), Gaps = 20/174 (11%)

Query: 373 AAIKKVNGDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNE 432
           A   K N ++  E  ++  +++ ++  L G+C       L+ +    G L D+V  +K+ 
Sbjct: 47  ATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDN 105

Query: 433 --GKYL-DWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMA 489
              +YL +W       + +A G+NYL        VH+D+ + NVL+ +    KI +F +A
Sbjct: 106 IGSQYLLNW------CVQIAKGMNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLA 156

Query: 490 RPAEGQEGEFALTRHIVGTK---GYMAPEYLENGLVSTKLDVYAFGVLILEMLT 540
           +     E E+    H  G K    +MA E + + + + + DV+++GV + E++T
Sbjct: 157 KLLGADEKEY----HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 59.6 bits (144), Expect = 9e-10
 Identities = 54/202 (26%), Positives = 90/202 (44%), Gaps = 30/202 (14%)

Query: 361 GSVYRGK--INGGFAAIKKVN------GDVSKEIALLNKINHSNLIILSGVCF------- 405
           G VY+G+    G  AAIK ++       ++  EI +L K +H   I      F       
Sbjct: 30  GQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPG 89

Query: 406 NEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHV- 464
           ++   +LV E+   G+++D V + K      DW     I  ++  GL +LH+      V 
Sbjct: 90  HDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIA--YICREILRGLAHLHAH----KVI 143

Query: 465 HKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYL---EN-- 519
           H+DI   NVLL  +   K+ +F ++   +   G        +GT  +MAPE +   EN  
Sbjct: 144 HRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGR---RNTFIGTPYWMAPEVIACDENPD 200

Query: 520 GLVSTKLDVYAFGVLILEMLTG 541
                + D+++ G+  +EM  G
Sbjct: 201 ATYDYRSDIWSLGITAIEMAEG 222

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 60.3 bits (146), Expect = 1e-09
 Identities = 49/167 (29%), Positives = 84/167 (50%), Gaps = 25/167 (14%)

Query: 384 KEIALLNKINHSNLIIL-----SGVCFNE-GNCYLVYEYAVNGTLSDWVFSNKNEGKYLD 437
           +E+ LL  + H N+I L     S V  +E  + YLV  Y             K  G  L 
Sbjct: 63  RELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDL-------QKIMGHPLS 115

Query: 438 WKQRIQ-IALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQE 496
            + ++Q +   +  GL Y+HS      +H+D+   N+ ++ D   KI +F +AR A+ + 
Sbjct: 116 -EDKVQYLVYQMLCGLKYIHS---AGIIHRDLKPGNLAVNEDCELKILDFGLARHADAE- 170

Query: 497 GEFALTRHIVGTKGYMAPEYLENGLVSTK-LDVYAFGVLILEMLTGK 542
               +T ++V T+ Y APE + N +   + +D+++ G ++ EMLTGK
Sbjct: 171 ----MTGYVV-TRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 60.2 bits (146), Expect = 1e-09
 Identities = 54/178 (30%), Positives = 84/178 (47%), Gaps = 28/178 (15%)

Query: 451 GLNYLHSFTNPPHVHKDINSSNVLLDS-DLRAKIANFAMAR---PAEGQEGEFALTRHIV 506
           GL Y+HS  N   +H+D+  +NV +++ DL  KI +F +AR   P    +G  +     +
Sbjct: 126 GLKYIHS-ANV--LHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEG---L 179

Query: 507 GTKGYMAPEYLENGLVSTK-LDVYAFGVLILEMLTGKE--AAALHAEENNMHLSDVLNAV 563
            TK Y +P  L +    TK +D++A G +  EMLTGK   A A   E+  + L  V   V
Sbjct: 180 VTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESV--PV 237

Query: 564 LTKEDGEESLRHFIDPTLQGNY------PL-----ELALLVIRLIDACLKKDPTDRPT 610
           + +ED  E L   + P+   N       PL      +    +  ++  L  +P DR T
Sbjct: 238 VREEDRNELLN--VIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLT 293

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 60.0 bits (145), Expect = 1e-09
 Identities = 43/133 (32%), Positives = 66/133 (49%), Gaps = 11/133 (8%)

Query: 410 CYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDIN 469
           C+ V EYA  G L    F    E  + + + R   A ++ + L YLHS      V++DI 
Sbjct: 71  CF-VMEYANGGEL---FFHLSRERVFTEERARFYGA-EIVSALEYLHSRDV---VYRDIK 122

Query: 470 SSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVY 529
             N++LD D   KI +F + +  EG     A  +   GT  Y+APE LE+      +D +
Sbjct: 123 LENLMLDKDGHIKITDFGLCK--EGISDG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWW 179

Query: 530 AFGVLILEMLTGK 542
             GV++ EM+ G+
Sbjct: 180 GLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 59.4 bits (144), Expect = 1e-09
 Identities = 49/200 (24%), Positives = 90/200 (45%), Gaps = 28/200 (14%)

Query: 411 YLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINS 470
           +L+ +Y   G L   ++       + + + R+ IA ++   L++LH       +++DI  
Sbjct: 81  HLILDYVNGGELFTHLYQ---REHFTESEVRVYIA-EIVLALDHLHQLGI---IYRDIKL 133

Query: 471 SNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLV--STKLDV 528
            N+LLDS+    + +F +++    +E E A +    GT  YMAPE +  G       +D 
Sbjct: 134 ENILLDSEGHVVLTDFGLSKEFLAEEEERAYS--FCGTIEYMAPEVIRGGSGGHDKAVDW 191

Query: 529 YAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLE 588
           ++ GVL  E+LTG     +  E+N+   S++   +L  +           P     +P  
Sbjct: 192 WSLGVLTFELLTGASPFTVDGEQNSQ--SEISRRILKSK-----------PP----FPKT 234

Query: 589 LALLVIRLIDACLKKDPTDR 608
           ++      I   L+KDP  R
Sbjct: 235 MSAEARDFIQKLLEKDPKKR 254

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 59.0 bits (142), Expect = 2e-09
 Identities = 59/233 (25%), Positives = 105/233 (45%), Gaps = 32/233 (13%)

Query: 321 DEESQDFLESISGVAQSLKVYS-FKEL-QSATDNFSFTCRIQGSVYRGK--INGGFAAIK 376
           DEE  + L SI  V    K Y+ F+++ Q A+          G+VY       G   AIK
Sbjct: 1   DEEILEKLRSIVSVGDPKKKYTRFEKIGQGAS----------GTVYTAIDIATGQEVAIK 50

Query: 377 KVNGD-------VSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSN 429
           ++N         +  EI ++ +  + N++            ++V EY   G+L+D V   
Sbjct: 51  QMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET 110

Query: 430 KNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMA 489
                 +D  Q   +  +    L++LHS      +H+DI S N+LL  D   K+ +F   
Sbjct: 111 -----CMDEGQIAAVCRECLQALDFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFC 162

Query: 490 RPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGK 542
                ++ + +    +VGT  +MAPE +       K+D+++ G++ +EM+ G+
Sbjct: 163 AQITPEQSKRST---MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 58.9 bits (142), Expect = 2e-09
 Identities = 66/236 (27%), Positives = 101/236 (42%), Gaps = 28/236 (11%)

Query: 375 IKKVNGDVS--KEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNE 432
           IKK  G+     E  +L K+N   ++ L+     +    LV      G L   +++  N 
Sbjct: 38  IKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNP 97

Query: 433 GKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPA 492
           G   D ++ I  A ++  GL  L        V++D+   N+LLD     +I++  +A   
Sbjct: 98  G--FDEQRAIFYAAELCCGLEDLQ---RERIVYRDLKPENILLDDRGHIRISDLGLA--V 150

Query: 493 EGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEEN 552
           +  EGE    R  VGT GYMAPE + N   +   D +  G LI EM+ G+       E  
Sbjct: 151 QIPEGETVRGR--VGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKER- 207

Query: 553 NMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDR 608
            +   +V   V  KED EE    F           E A  + R++   L K+P +R
Sbjct: 208 -VKREEVDRRV--KEDQEEYSEKFS----------EDAKSICRML---LTKNPKER 247

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 58.9 bits (142), Expect = 2e-09
 Identities = 54/202 (26%), Positives = 92/202 (45%), Gaps = 30/202 (14%)

Query: 361 GSVYRGK--INGG-FAAIKKVNGDVS---------KEIALLNKIN---HSNLIILSGVCF 405
           G V++ +   NGG F A+K+V              +E+A+L  +    H N++ L  VC 
Sbjct: 15  GKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCT 74

Query: 406 -----NEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTN 460
                 E    LV+E+ V+  L+ ++      G  +  +    +   +  GL++LHS   
Sbjct: 75  VSRTDRETKLTLVFEH-VDQDLTTYLDKVPEPG--VPTETIKDMMFQLLRGLDFLHSHRV 131

Query: 461 PPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENG 520
              VH+D+   N+L+ S  + K+A+F +AR    Q         +V T  Y APE L   
Sbjct: 132 ---VHRDLKPQNILVTSSGQIKLADFGLARIYSFQ----MALTSVVVTLWYRAPEVLLQS 184

Query: 521 LVSTKLDVYAFGVLILEMLTGK 542
             +T +D+++ G +  EM   K
Sbjct: 185 SYATPVDLWSVGCIFAEMFRRK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 58.7 bits (142), Expect = 2e-09
 Identities = 36/98 (36%), Positives = 51/98 (52%), Gaps = 7/98 (7%)

Query: 445 ALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRH 504
           A ++  GL  LH       V++D+   N+LLD     +I++  +A   E  EGE    R 
Sbjct: 108 AAEITCGLEDLHR---ERIVYRDLKPENILLDDYGHIRISDLGLA--VEIPEGE--TIRG 160

Query: 505 IVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGK 542
            VGT GYMAPE ++N   +   D +  G LI EM+ GK
Sbjct: 161 RVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGK 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 58.9 bits (142), Expect = 2e-09
 Identities = 44/139 (31%), Positives = 69/139 (49%), Gaps = 22/139 (15%)

Query: 410 CYLVYEYAVNGTL-----SDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHV 464
           C+ V EYA  G L      + VFS      Y           ++ + L+YLHS  N   V
Sbjct: 71  CF-VMEYANGGELFFHLSRERVFSEDRARFY---------GAEIVSALDYLHSEKNV--V 118

Query: 465 HKDINSSNVLLDSDLRAKIANFAMARPAEG-QEGEFALTRHIVGTKGYMAPEYLENGLVS 523
           ++D+   N++LD D   KI +F + +  EG ++G  A  +   GT  Y+APE LE+    
Sbjct: 119 YRDLKLENLMLDKDGHIKITDFGLCK--EGIKDG--ATMKTFCGTPEYLAPEVLEDNDYG 174

Query: 524 TKLDVYAFGVLILEMLTGK 542
             +D +  GV++ EM+ G+
Sbjct: 175 RAVDWWGLGVVMYEMMCGR 193

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 57.7 bits (140), Expect = 4e-09
 Identities = 42/201 (20%), Positives = 83/201 (41%), Gaps = 30/201 (14%)

Query: 361 GSVYRGKINGGFAAIKKVNGDVS---------KEIALLNKINHSNLI-ILSGVCFNEGN- 409
             + + K      A+KK+N D           +EI    ++ H N++  ++   F   + 
Sbjct: 16  VHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVT--SFIVDSE 73

Query: 410 CYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIAL---DVATGLNYLHSFTNPPHVHK 466
            Y+V      G+  D + ++  EG        + IA    DV   L+Y+HS      +H+
Sbjct: 74  LYVVSPLMAYGSCEDLLKTHFPEGL-----PELAIAFILKDVLNALDYIHSKG---FIHR 125

Query: 467 DINSSNVLLDSDLRAKIANFAMARP--AEGQEGE--FALTRHIVGTKGYMAPEYLENGL- 521
            + +S++LL  D +  ++    +      G+         +  V    +++PE L+  L 
Sbjct: 126 SVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQ 185

Query: 522 -VSTKLDVYAFGVLILEMLTG 541
             + K D+Y+ G+   E+  G
Sbjct: 186 GYNEKSDIYSVGITACELANG 206

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 57.7 bits (139), Expect = 5e-09
 Identities = 44/183 (24%), Positives = 90/183 (49%), Gaps = 21/183 (11%)

Query: 381 DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNK---NEGKYLD 437
           +++  +  +  ++H+ ++ L G+C    +  LV + +  G+L D V  ++   +  + L+
Sbjct: 55  EITDHMLAMGSLDHAYIVRLLGICPG-ASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLN 113

Query: 438 WKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEG 497
           W       + +A G+ YL        VH+++ + N+LL SD   +IA+F +A      + 
Sbjct: 114 W------CVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDK 164

Query: 498 EFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT-GKEAAALHAEENNMHL 556
           ++  + H    K +MA E +  G  + + DV+++GV + EM++ G E  A       M  
Sbjct: 165 KYFYSEHKTPIK-WMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYA------GMRP 217

Query: 557 SDV 559
            +V
Sbjct: 218 HEV 220

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 57.9 bits (140), Expect = 5e-09
 Identities = 41/163 (25%), Positives = 81/163 (49%), Gaps = 19/163 (11%)

Query: 382 VSKEIALLNKINHSNLIILSGVC--FNEGNCYLVYEYAVNGTLSDWVFSN-KNEGKYLDW 438
           V++E ++L +++H    I++ +C   +E   Y + E+ V G L    F++ +  G++ + 
Sbjct: 65  VAQEKSILMELSHP--FIVNMMCSFQDENRVYFLLEFVVGGEL----FTHLRKAGRFPND 118

Query: 439 KQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGE 498
             +   A ++     YLHS      +++D+   N+LLD+    K+ +F  A+     +  
Sbjct: 119 VAKFYHA-ELVLAFEYLHSKDI---IYRDLKPENLLLDNKGHVKVTDFGFAKKV--PDRT 172

Query: 499 FALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTG 541
           F L     GT  Y+APE +++      +D +  GVL+ E + G
Sbjct: 173 FTL----CGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAG 211

Length = 329

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 57.4 bits (139), Expect = 6e-09
 Identities = 60/199 (30%), Positives = 90/199 (45%), Gaps = 30/199 (15%)

Query: 361 GSVYRG--KINGGFAAIKKVNGDVSK---------EIALLNKINHSNLIILSGVCFNE-- 407
           G VYR     +G   A+KKV  D  +         EI LL  + H N++ L  V   +  
Sbjct: 21  GIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHL 80

Query: 408 GNCYLVYEYAVN--GTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLH-SFTNPPHV 464
            + +LV EY      +L D + +  +E       Q   + L +  GL YLH +F     +
Sbjct: 81  DSIFLVMEYCEQDLASLLDNMPTPFSES------QVKCLMLQLLRGLQYLHENFI----I 130

Query: 465 HKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVST 524
           H+D+  SN+LL      KIA+F +AR          +T  +V T  Y APE L      T
Sbjct: 131 HRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKP--MTPKVV-TLWYRAPELLLGCTTYT 187

Query: 525 K-LDVYAFGVLILEMLTGK 542
             +D++A G ++ E+L  K
Sbjct: 188 TAIDMWAVGCILAELLAHK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 57.7 bits (139), Expect = 6e-09
 Identities = 48/160 (30%), Positives = 70/160 (43%), Gaps = 13/160 (8%)

Query: 382 VSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQR 441
           V  E  +LN INH   + L G   +E   YLV E+ + G    ++  NK     +     
Sbjct: 78  VFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYA 137

Query: 442 IQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFAL 501
            QI L       YL S      V++D+   N+LLD D   K+ +F  A+  + +      
Sbjct: 138 AQIVLI----FEYLQSLNI---VYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR------ 184

Query: 502 TRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTG 541
           T  + GT  Y+APE L N       D +  G+ I E+L G
Sbjct: 185 TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVG 224

Length = 340

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 57.2 bits (138), Expect = 7e-09
 Identities = 61/236 (25%), Positives = 104/236 (44%), Gaps = 38/236 (16%)

Query: 321 DEESQDFLESISGVAQSLKVYS-FKEL-QSATDNFSFTCRIQGSVYRG--KINGGFAAIK 376
           DEE  + L +I  V    K Y+ F+++ Q A+          G+VY       G   AIK
Sbjct: 1   DEEILEKLRTIVSVGDPKKKYTRFEKIGQGAS----------GTVYTAIDVATGQEVAIK 50

Query: 377 KVNGD-------VSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSN 429
           ++N         +  EI ++ +  H N++            ++V EY   G+L+D V   
Sbjct: 51  QMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET 110

Query: 430 KNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANF--- 486
                 +D  Q   +  +    L +LHS      +H+DI S N+LL  D   K+ +F   
Sbjct: 111 C-----MDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFC 162

Query: 487 AMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGK 542
           A   P + +         +VGT  +MAPE +       K+D+++ G++ +EM+ G+
Sbjct: 163 AQITPEQSKRST------MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 56.9 bits (138), Expect = 7e-09
 Identities = 46/159 (28%), Positives = 80/159 (50%), Gaps = 13/159 (8%)

Query: 384 KEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQ 443
           KEI  L + NH  ++ L     ++   Y++ EY + G L   +   ++ G + ++  R  
Sbjct: 44  KEI--LEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGELWTIL---RDRGLFDEYTARFY 98

Query: 444 IALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTR 503
           IA  V     YLH   N   +++D+   N+LLDS+   K+ +F  A+  +   G+   T 
Sbjct: 99  IAC-VVLAFEYLH---NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKS--GQKTWT- 151

Query: 504 HIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGK 542
              GT  Y+APE + N      +D ++ G+L+ E+LTG+
Sbjct: 152 -FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGR 189

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 57.4 bits (138), Expect = 7e-09
 Identities = 40/165 (24%), Positives = 86/165 (52%), Gaps = 11/165 (6%)

Query: 378 VNGDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLD 437
           +   + +E+ +L++ N   ++   G  +++G   +  E+   G+L D V     E K + 
Sbjct: 46  IRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVL---KEAKRIP 101

Query: 438 WKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEG 497
            +   ++++ V  GL YL        +H+D+  SN+L++S    K+ +F ++    GQ  
Sbjct: 102 EEILGKVSIAVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLI 155

Query: 498 EFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGK 542
           + ++    VGT+ YM+PE L+    S + D+++ G+ ++E+  G+
Sbjct: 156 D-SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGR 199

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 57.0 bits (137), Expect = 7e-09
 Identities = 54/230 (23%), Positives = 102/230 (44%), Gaps = 26/230 (11%)

Query: 321 DEESQDFLESISGVAQSLKVYS-FKELQSATDNFSFTCRIQGSVYRGKINGGFAAIKKVN 379
           DEE  + L +I  +    K Y+ ++++        FT      V  G+      AIK++N
Sbjct: 1   DEEIMEKLRTIVSIGDPKKKYTRYEKIGQGASGTVFTAI---DVATGQE----VAIKQIN 53

Query: 380 GD-------VSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNE 432
                    +  EI ++ ++ + N++            ++V EY   G+L+D V      
Sbjct: 54  LQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTET--- 110

Query: 433 GKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPA 492
              +D  Q   +  +    L +LH+      +H+DI S NVLL  D   K+ +F      
Sbjct: 111 --CMDEAQIAAVCRECLQALEFLHA---NQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQI 165

Query: 493 EGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGK 542
             ++ + +    +VGT  +MAPE +       K+D+++ G++ +EM+ G+
Sbjct: 166 TPEQSKRST---MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 57.0 bits (137), Expect = 7e-09
 Identities = 50/190 (26%), Positives = 85/190 (44%), Gaps = 22/190 (11%)

Query: 361 GSVYRGK--INGGFAAIKKVN---GD----VSKEIALLNKINHSNLIILSGVCFNEGNCY 411
           G VY+ +    G  AA+K +    GD    + +EI ++ +  H N++   G   +    +
Sbjct: 23  GDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLW 82

Query: 412 LVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSS 471
           +  EY   G+L D           L   Q   +  +   GL YLHS      +H+DI  +
Sbjct: 83  ICMEYCGGGSLQDIYHVTGP----LSELQIAYVCRETLQGLAYLHS---KGKMHRDIKGA 135

Query: 472 NVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYL---ENGLVSTKLDV 528
           N+LL  +   K+A+F +A          A  +  +GT  +MAPE     +NG  +   D+
Sbjct: 136 NILLTDNGDVKLADFGVAAKITAT---IAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDI 192

Query: 529 YAFGVLILEM 538
           +A G+  +E+
Sbjct: 193 WAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 56.6 bits (136), Expect = 8e-09
 Identities = 44/160 (27%), Positives = 72/160 (45%), Gaps = 9/160 (5%)

Query: 385 EIALLNKINHSNLIILSGVCFNEGNCYLV--YEYAVNGTLSDWVFSNKNEGKYLDWKQRI 442
           EI LL  + H  ++   G   +     L    EY   G++ D +   K  G   +   R 
Sbjct: 54  EIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQL---KAYGALTESVTR- 109

Query: 443 QIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALT 502
           +    +  G++YLHS      VH+DI  +N+L DS    K+ +F  ++  +         
Sbjct: 110 KYTRQILEGMSYLHSNMI---VHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGI 166

Query: 503 RHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGK 542
           R + GT  +M+PE +       K DV++ G  ++EMLT K
Sbjct: 167 RSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEK 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 57.0 bits (138), Expect = 1e-08
 Identities = 52/186 (27%), Positives = 88/186 (47%), Gaps = 30/186 (16%)

Query: 451 GLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMAR---PAEGQEGEFALTRHIVG 507
           GL Y+HS      +H+D+   N+L+++D   KI +F +AR      G+   F +T + V 
Sbjct: 117 GLKYIHSANV---LHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGF-MTEY-VA 171

Query: 508 TKGYMAPE-YLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMH-LSDVLNAVLT 565
           T+ Y APE  L     +  +DV++ G ++ E+L  K    +   ++ +  L+ +L  + T
Sbjct: 172 TRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK---PVFKGKDYVDQLNQILQVLGT 228

Query: 566 KEDGEESLRHFIDPTLQ------GNYP---LELAL-----LVIRLIDACLKKDPTDRPTM 611
            +  EE+L     P  Q       N P    E        L + L++  L  DPT R ++
Sbjct: 229 PD--EETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISV 286

Query: 612 YE-IEH 616
            E +EH
Sbjct: 287 EEALEH 292

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 56.9 bits (138), Expect = 1e-08
 Identities = 46/171 (26%), Positives = 80/171 (46%), Gaps = 32/171 (18%)

Query: 384 KEIALLNKINHSNLIILSGVCFNEG-------NCYLVYEYA---VNGTLSDWVFSNKNEG 433
           +E+ LL  ++H N+I L  V F          + YLV       +N  +     S+    
Sbjct: 63  RELRLLKHMDHENVIGLLDV-FTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSD---- 117

Query: 434 KYLDWKQRIQ-IALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPA 492
                   IQ +   +  GL Y+HS      +H+D+  SN+ ++ D   KI +F +AR  
Sbjct: 118 ------DHIQFLVYQILRGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLARHT 168

Query: 493 EGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKL-DVYAFGVLILEMLTGK 542
           + +     +T + V T+ Y APE + N +   +  D+++ G ++ E+LTGK
Sbjct: 169 DDE-----MTGY-VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 56.6 bits (136), Expect = 1e-08
 Identities = 71/273 (26%), Positives = 115/273 (42%), Gaps = 46/273 (16%)

Query: 361 GSVYRG--KINGGFAAIKKVNG-------DVSKEIALLNKINHSNLIILSGVCFNEGNCY 411
           G VY+   K  G  AA K +         D   EI +L   NH  ++ L G  + +G  +
Sbjct: 26  GKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLW 85

Query: 412 LVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSS 471
           ++ E+   G + D +    + G  L   Q   I   +   L YLHS      +H+D+ + 
Sbjct: 86  IMIEFCPGGAV-DAIMLELDRG--LTEPQIQVICRQMLEALQYLHSMKI---IHRDLKAG 139

Query: 472 NVLLDSDLRAKIANFAMARPAEGQEGEFALTRH--IVGTKGYMAPEY-----LENGLVST 524
           NVLL  D   K+A+F ++      +    L R    +GT  +MAPE      +++     
Sbjct: 140 NVLLTLDGDIKLADFGVS-----AKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDY 194

Query: 525 KLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGN 584
           K D+++ G+ ++EM    +    H E N M        VL K    E       PTL  +
Sbjct: 195 KADIWSLGITLIEM---AQIEPPHHELNPMR-------VLLKIAKSEP------PTL--S 236

Query: 585 YPLELALLVIRLIDACLKKDPTDRPTMYE-IEH 616
            P + ++     +   L K P  RP+  + +EH
Sbjct: 237 QPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH 269

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 56.8 bits (137), Expect = 1e-08
 Identities = 58/198 (29%), Positives = 93/198 (46%), Gaps = 28/198 (14%)

Query: 361 GSVYRG--KINGGFAAIKK---------VNGDVSKEIALLNKINHSNLIILSGVCFNEGN 409
           G VY+   ++     A+KK         V     +EI+LL ++ H N++ L  V  +E  
Sbjct: 16  GVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKR 75

Query: 410 CYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIAL-DVATGLNYLHSFTNPPH--VHK 466
            YLV+EY ++  L   + S+ +  K     + I+  L  +  G+ Y HS     H  +H+
Sbjct: 76  LYLVFEY-LDLDLKKHMDSSPDFAKNP---RLIKTYLYQILRGIAYCHS-----HRVLHR 126

Query: 467 DINSSNVLLDSDLRA-KIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGL-VST 524
           D+   N+L+D    A K+A+F +AR        F    H V T  Y APE L      ST
Sbjct: 127 DLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFT---HEVVTLWYRAPEILLGSRHYST 183

Query: 525 KLDVYAFGVLILEMLTGK 542
            +D+++ G +  EM+  K
Sbjct: 184 PVDIWSVGCIFAEMVNQK 201

Length = 294

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 57.0 bits (138), Expect = 1e-08
 Identities = 48/189 (25%), Positives = 88/189 (46%), Gaps = 36/189 (19%)

Query: 451 GLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPA--EGQEGEFALTRHIVGT 508
           GL Y+HS      +H+D+  SN+L++ D   +I +F MAR       E ++ +T + V T
Sbjct: 119 GLKYIHSANV---IHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEY-VAT 174

Query: 509 KGYMAPEYLENGLV----STKLDVYAFGVLILEMLTGKEAAALHAEENNMHL-------- 556
           + Y APE L   L     +T +D+++ G +  EML  ++        + + L        
Sbjct: 175 RWYRAPELL---LSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSP 231

Query: 557 -SDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLV-------IRLIDACLKKDPTDR 608
             +VLN +     G + +R +I   L    P+  + +        + L+   L+ DP +R
Sbjct: 232 SEEVLNRI-----GSDRVRKYIQ-NLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEER 285

Query: 609 PTMYE-IEH 616
            T+ + ++H
Sbjct: 286 ITVEQALQH 294

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 56.0 bits (135), Expect = 1e-08
 Identities = 51/230 (22%), Positives = 102/230 (44%), Gaps = 33/230 (14%)

Query: 361 GSVYRGKINGGFAA----IKKVNGDVS--------KEIALLNKINHSNLIILSGVCFNEG 408
           G V  G+ + G +     +K++    +        +E+    ++NH N++   G C    
Sbjct: 9   GKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESI 68

Query: 409 NCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQ--IALDVATGLNYLHSFTNPPHVHK 466
              LV E+   G L +++ SN+        ++ +   +A +VA+GL +LH       +H 
Sbjct: 69  PYLLVLEFCPLGDLKNYLRSNR-GMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHS 124

Query: 467 DINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLE----NGLV 522
           D+   N  L +DL  KI ++ +A     ++       H V  + ++APE +E    + L 
Sbjct: 125 DLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLR-WLAPELVEIRGQDLLP 183

Query: 523 ---STKLDVYAFGVLILEMLT-GKEAAALHAEENNMHLSDVLNAVLTKED 568
              + K ++++ GV + E+ T   +     ++E       VL  V+ ++D
Sbjct: 184 KDQTKKSNIWSLGVTMWELFTAADQPYPDLSDE------QVLKQVVREQD 227

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 55.8 bits (134), Expect = 1e-08
 Identities = 48/190 (25%), Positives = 84/190 (44%), Gaps = 22/190 (11%)

Query: 361 GSVYRGK-INGG-FAAIKKVNGD-------VSKEIALLNKINHSNLIILSGVCFNEGNCY 411
           G VY+ + +N G  AAIK +  +       V +EI ++    HSN++   G        +
Sbjct: 23  GDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLW 82

Query: 412 LVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSS 471
           +  E+   G+L D           L   Q   ++ +   GL YLH   +   +H+DI  +
Sbjct: 83  ICMEFCGGGSLQDIYHVTGP----LSESQIAYVSRETLQGLYYLH---SKGKMHRDIKGA 135

Query: 472 NVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYL---ENGLVSTKLDV 528
           N+LL  +   K+A+F ++          A  +  +GT  +MAPE       G  +   D+
Sbjct: 136 NILLTDNGHVKLADFGVSAQITAT---IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDI 192

Query: 529 YAFGVLILEM 538
           +A G+  +E+
Sbjct: 193 WAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 56.2 bits (135), Expect = 2e-08
 Identities = 39/165 (23%), Positives = 86/165 (52%), Gaps = 11/165 (6%)

Query: 378 VNGDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLD 437
           +   + +E+ +L++ N   ++   G  +++G   +  E+   G+L   +   K  G+  +
Sbjct: 46  IRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPE 102

Query: 438 WKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEG 497
            +   ++++ V  GL YL        +H+D+  SN+L++S    K+ +F ++    GQ  
Sbjct: 103 -QILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLI 155

Query: 498 EFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGK 542
           + ++    VGT+ YM+PE L+    S + D+++ G+ ++EM  G+
Sbjct: 156 D-SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGR 199

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 55.8 bits (134), Expect = 2e-08
 Identities = 47/171 (27%), Positives = 77/171 (45%), Gaps = 13/171 (7%)

Query: 375 IKKVNGDVS--KEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNE 432
           IKK  G+     E  +L K+N   ++ L+     +    LV      G L   ++     
Sbjct: 38  IKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEA 97

Query: 433 GKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMA-RP 491
           G   +  + +  A ++  GL  LH       V++D+   N+LLD     +I++  +A   
Sbjct: 98  G--FEEGRAVFYAAEICCGLEDLH---QERIVYRDLKPENILLDDHGHIRISDLGLAVHV 152

Query: 492 AEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGK 542
            EGQ       +  VGT GYMAPE ++N   +   D +A G L+ EM+ G+
Sbjct: 153 PEGQT-----IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQ 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 55.8 bits (135), Expect = 2e-08
 Identities = 58/218 (26%), Positives = 90/218 (41%), Gaps = 38/218 (17%)

Query: 402 GVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRI------QIALDVATGLNYL 455
           G  F EG+C++  E      L D       +  Y   K  I      +IA+     LNYL
Sbjct: 70  GALFREGDCWICME------LMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYL 123

Query: 456 HSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQ-EGEFALTRHIVGTKGYMAP 514
                   +H+D+  SN+LLD +   K+ +F ++    GQ     A TR   G + YMAP
Sbjct: 124 K--EELKIIHRDVKPSNILLDRNGNIKLCDFGIS----GQLVDSIAKTRD-AGCRPYMAP 176

Query: 515 EYLENGLVS---TKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEE 571
           E ++         + DV++ G+ + E+ TGK             + D L  V+    G+ 
Sbjct: 177 ERIDPSARDGYDVRSDVWSLGITLYEVATGK-----FPYPKWNSVFDQLTQVV---KGDP 228

Query: 572 SLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRP 609
                  P L  +   E +   +  I+ CL KD + RP
Sbjct: 229 -------PILSNSEEREFSPSFVNFINLCLIKDESKRP 259

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 55.6 bits (134), Expect = 2e-08
 Identities = 43/162 (26%), Positives = 71/162 (43%), Gaps = 25/162 (15%)

Query: 448 VATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMA-RPAEGQEGEFALTRHIV 506
           + +GL +LH       +++D+   NVLLD+D   +I++  +A    +GQ      T+   
Sbjct: 106 IISGLEHLHQRRI---IYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK----TKGYA 158

Query: 507 GTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTK 566
           GT G+MAPE L+       +D +A GV + EM+  +       E+       V N  L +
Sbjct: 159 GTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEK-------VENKELKQ 211

Query: 567 EDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDR 608
               +S+           YP + +       +A L KDP  R
Sbjct: 212 RILNDSV----------TYPDKFSPASKSFCEALLAKDPEKR 243

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 55.7 bits (134), Expect = 2e-08
 Identities = 49/166 (29%), Positives = 78/166 (46%), Gaps = 10/166 (6%)

Query: 376 KKVNGDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKY 435
           K+ N  +++   LL  + H  L+ L          Y V +Y VNG   +  F  + E  +
Sbjct: 37  KEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDY-VNG--GELFFHLQRERCF 93

Query: 436 LDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQ 495
           L+ + R   A +VA+ + YLHS      +++D+   N+LLDS     + +F + +  EG 
Sbjct: 94  LEPRARFYAA-EVASAIGYLHSLNI---IYRDLKPENILLDSQGHVVLTDFGLCK--EGV 147

Query: 496 EGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTG 541
           E E   T    GT  Y+APE L        +D +  G ++ EML G
Sbjct: 148 EPE-ETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 55.0 bits (132), Expect = 3e-08
 Identities = 59/201 (29%), Positives = 95/201 (47%), Gaps = 29/201 (14%)

Query: 361 GSVY--RGKINGGFAAIKKV------NG---DVSKEIALLNKI---NHSNLIILSGVCFN 406
           G+VY  R   +G F A+K V      +G      +E+ALL ++   +H N++ L  VC  
Sbjct: 14  GTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCAT 73

Query: 407 -----EGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNP 461
                E    LV+E+ V+  L  ++      G   +  + +        GL++LH   N 
Sbjct: 74  SRTDRETKVTLVFEH-VDQDLRTYLDKVPPPGLPAETIKDLMRQF--LRGLDFLH--ANC 128

Query: 462 PHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGL 521
             VH+D+   N+L+ S  + K+A+F +AR    Q    ALT  +V T  Y APE L    
Sbjct: 129 I-VHRDLKPENILVTSGGQVKLADFGLARIYSCQ---MALTPVVV-TLWYRAPEVLLQST 183

Query: 522 VSTKLDVYAFGVLILEMLTGK 542
            +T +D+++ G +  EM   K
Sbjct: 184 YATPVDMWSVGCIFAEMFRRK 204

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 55.5 bits (134), Expect = 4e-08
 Identities = 31/94 (32%), Positives = 53/94 (56%), Gaps = 8/94 (8%)

Query: 451 GLNYLHSFTNPPHV-HKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTK 509
           GL YLHS      + H+DI   N+L++S+   KI +F +AR  E  E +  +T+ +V T+
Sbjct: 115 GLKYLHS----AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKH-MTQEVV-TQ 168

Query: 510 GYMAPEYLENGL-VSTKLDVYAFGVLILEMLTGK 542
            Y APE L      ++ +D+++ G +  E+L  +
Sbjct: 169 YYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRR 202

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 54.6 bits (131), Expect = 4e-08
 Identities = 61/253 (24%), Positives = 108/253 (42%), Gaps = 43/253 (16%)

Query: 377 KVNGDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNE---G 433
           K N ++  E  ++  +    +  L G+C       LV +    G L D+V  NK+     
Sbjct: 51  KANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQLVTQLMPYGCLLDYVRENKDRIGSQ 109

Query: 434 KYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAE 493
             L+W       + +A G++YL        VH+D+ + NVL+ S    KI +F +AR  +
Sbjct: 110 DLLNW------CVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLLD 160

Query: 494 GQEGEFALTRHIVGTK---GYMAPEYLENGLVSTKLDVYAFGVLILEMLT--GKEAAALH 548
             E E+    H  G K    +MA E + +   + + DV+++GV + E++T   K    + 
Sbjct: 161 IDETEY----HADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIP 216

Query: 549 AEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDR 608
           A E    + D+L      E GE        P       +++ +++++    C   D   R
Sbjct: 217 ARE----IPDLL------EKGER----LPQPP---ICTIDVYMIMVK----CWMIDSECR 255

Query: 609 PTMYEIEHSLSNI 621
           P   E+    S +
Sbjct: 256 PRFRELVDEFSRM 268

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 55.4 bits (133), Expect = 4e-08
 Identities = 44/164 (26%), Positives = 80/164 (48%), Gaps = 20/164 (12%)

Query: 384 KEIALLNKINHSNLIILSGVCFNEG------NCYLVYEYAVNGTLSDWVFSNKNEGKYLD 437
           +E+ LL  +NH N+I L  V   +       + YLV E  ++  L   +         LD
Sbjct: 69  RELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMEL-MDANLCQVIHME------LD 121

Query: 438 WKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEG 497
            ++   +   +  G+ +LHS      +H+D+  SN+++ SD   KI +F +AR A     
Sbjct: 122 HERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTN-- 176

Query: 498 EFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTG 541
            F +T ++V T+ Y APE +        +D+++ G ++ E++ G
Sbjct: 177 -FMMTPYVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGELVKG 218

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 54.7 bits (132), Expect = 4e-08
 Identities = 43/184 (23%), Positives = 75/184 (40%), Gaps = 36/184 (19%)

Query: 443 QIALDVATGLNYL---HSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMA-RPAEGQEGE 498
           ++ + +   L+YL   H       +H+D+  SN+LLD+    K+ +F ++ R  + +   
Sbjct: 118 KMTVAIVKALHYLKEKHGV-----IHRDVKPSNILLDASGNVKLCDFGISGRLVDSK--- 169

Query: 499 FALTRHIVGTKGYMAPEYLE----NGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNM 554
            A TR   G   YMAPE ++    N     + DV++ G+ ++E+ TG+        E  +
Sbjct: 170 -AKTRS-AGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEV 227

Query: 555 HLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEI 614
            L+ +L          E                         +D CL KD   RP   E+
Sbjct: 228 -LTKILQEEPPSLPPNEGFSP----------------DFCSFVDLCLTKDHRKRPKYREL 270

Query: 615 -EHS 617
            +H 
Sbjct: 271 LQHP 274

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 54.4 bits (131), Expect = 4e-08
 Identities = 58/239 (24%), Positives = 98/239 (41%), Gaps = 46/239 (19%)

Query: 386 IALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIA 445
            +L+++++H +L+ L GVC  + N  +V EY   G L  ++   KN    L WK  + +A
Sbjct: 52  ASLMSQLSHKHLVKLYGVCVRDEN-IMVEEYVKFGPLDVFLHREKN-NVSLHWK--LDVA 107

Query: 446 LDVATGLNYLHSFTNPPHVHKDINSSNVLLDSD-------LRAKIANFAMARPAEGQEGE 498
             +A+ L+YL        VH ++   N+L+             K+++  +          
Sbjct: 108 KQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPIT------- 157

Query: 499 FALTRHI-VGTKGYMAPEYLENGLVSTKL--DVYAFGVLILEMLTGKEAAALHAEENNMH 555
             L+R   V    ++APE + NG  S  +  D ++FG  +LE+ +  E            
Sbjct: 158 -VLSREERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEP---------- 206

Query: 556 LSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEI 614
               L+ + + E           P        ELA     LI+ C   DPT RP+   I
Sbjct: 207 ----LSTLSSSEKERFYQDQHRLPMPDCA---ELA----NLINQCWTYDPTKRPSFRAI 254

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 54.8 bits (132), Expect = 5e-08
 Identities = 56/191 (29%), Positives = 88/191 (46%), Gaps = 26/191 (13%)

Query: 365 RGKINGGFAAIKKVNGDV---SKEIA-------LLNKINHSNLIILSGVCFNEGN--CYL 412
           R K  G + A+K +  +V     E+A       +L    H  L  L    F   +  C+ 
Sbjct: 15  REKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALK-YSFQTHDRLCF- 72

Query: 413 VYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSN 472
           V EYA  G L    F    E  + + + R   A ++ + L YLHS      V++D+   N
Sbjct: 73  VMEYANGGEL---FFHLSRERVFSEDRARFYGA-EIVSALGYLHSCDV---VYRDLKLEN 125

Query: 473 VLLDSDLRAKIANFAMARPAEG-QEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAF 531
           ++LD D   KI +F + +  EG  +G  A  +   GT  Y+APE LE+      +D +  
Sbjct: 126 LMLDKDGHIKITDFGLCK--EGISDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGL 181

Query: 532 GVLILEMLTGK 542
           GV++ EM+ G+
Sbjct: 182 GVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 55.0 bits (132), Expect = 5e-08
 Identities = 47/171 (27%), Positives = 84/171 (49%), Gaps = 32/171 (18%)

Query: 384 KEIALLNKINHSNLIILSGVCFNEGNC------YLVYEYAVNGTLSDWVFSNKNEGKYLD 437
           +E+ LL  + H N+I L  V   + +       YLV             F   + GK + 
Sbjct: 63  RELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMP-----------FMGTDLGKLMK 111

Query: 438 WKQ----RIQ-IALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPA 492
            ++    RIQ +   +  GL Y+H+      +H+D+   N+ ++ D   KI +F +AR  
Sbjct: 112 HEKLSEDRIQFLVYQMLKGLKYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQT 168

Query: 493 EGQEGEFALTRHIVGTKGYMAPEYLENGLVSTK-LDVYAFGVLILEMLTGK 542
           + +     +T ++V T+ Y APE + N +  T+ +D+++ G ++ EMLTGK
Sbjct: 169 DSE-----MTGYVV-TRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 54.7 bits (132), Expect = 6e-08
 Identities = 57/195 (29%), Positives = 94/195 (48%), Gaps = 48/195 (24%)

Query: 374 AIKKVNGDVS---------KEIALLNKINHSNLIILSGVC-------FNEGNCYLVYEYA 417
           AIKK+              +EI LL  ++H N+I +  +        FN+   Y+VYE  
Sbjct: 34  AIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND--VYIVYELM 91

Query: 418 ---------VNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDI 468
                     + TLSD      +  +Y  ++        +  GL Y+HS  N   +H+D+
Sbjct: 92  DTDLHQIIRSSQTLSD------DHCQYFLYQ--------LLRGLKYIHS-ANV--LHRDL 134

Query: 469 NSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLEN-GLVSTKLD 527
             SN+LL+++   KI +F +AR    + G+F +T ++V T+ Y APE L N    +T +D
Sbjct: 135 KPSNLLLNANCDLKICDFGLARTTSEK-GDF-MTEYVV-TRWYRAPELLLNCSEYTTAID 191

Query: 528 VYAFGVLILEMLTGK 542
           V++ G +  E+L  K
Sbjct: 192 VWSVGCIFAELLGRK 206

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 54.7 bits (131), Expect = 6e-08
 Identities = 52/188 (27%), Positives = 85/188 (45%), Gaps = 20/188 (10%)

Query: 365 RGKINGGFAAIKKVNGDV---SKEIA-------LLNKINHSNLIILSGVCFNEGNCYLVY 414
           R K +G + A+K +  +V     E+A       +L    H  L  L      +     V 
Sbjct: 15  REKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVM 74

Query: 415 EYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVL 474
           EY   G L    F    E  + + + R   A ++ + L+YLHS      V++D+   N++
Sbjct: 75  EYVNGGEL---FFHLSRERVFSEDRTRFYGA-EIVSALDYLHS---GKIVYRDLKLENLM 127

Query: 475 LDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVL 534
           LD D   KI +F + +  EG   + A  +   GT  Y+APE LE+      +D +  GV+
Sbjct: 128 LDKDGHIKITDFGLCK--EGIT-DAATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVV 184

Query: 535 ILEMLTGK 542
           + EM+ G+
Sbjct: 185 MYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 54.2 bits (131), Expect = 7e-08
 Identities = 54/196 (27%), Positives = 89/196 (45%), Gaps = 35/196 (17%)

Query: 367 KINGGFAAIKKVNG--------DVSKEIALLNKINHSNLI-ILSGVC------FNEGNCY 411
           K  G   AIKK++            +EI +L +  H N+I IL  +       FN+   Y
Sbjct: 27  KPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND--VY 84

Query: 412 LVYEYA---VNGTLSDWVFSNKNEGKYLDWKQRIQIAL-DVATGLNYLHSFTNPPHVHKD 467
           +V E     +   +     SN            IQ  L  +  GL Y+HS  N   +H+D
Sbjct: 85  IVQELMETDLYKLIKTQHLSN----------DHIQYFLYQILRGLKYIHS-ANV--LHRD 131

Query: 468 INSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPE-YLENGLVSTKL 526
           +  SN+LL+++   KI +F +AR A+ +          V T+ Y APE  L +   +  +
Sbjct: 132 LKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAI 191

Query: 527 DVYAFGVLILEMLTGK 542
           D+++ G ++ EML+ +
Sbjct: 192 DIWSVGCILAEMLSNR 207

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 53.7 bits (130), Expect = 8e-08
 Identities = 42/151 (27%), Positives = 64/151 (42%), Gaps = 15/151 (9%)

Query: 393 NHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGL 452
           ++ N I L           L+ +Y  +G L D +   K EGK L   +  +I   +   L
Sbjct: 67  DNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLL---KKEGK-LSEAEVKKIIRQLVEAL 122

Query: 453 NYLHSFTNPPHVHKDINSSNVLLD-SDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGY 511
           N LH       +H DI   NVL D +  R  + ++ + +   G    +       GT  Y
Sbjct: 123 NDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLCKI-IGTPSCYD------GTLDY 172

Query: 512 MAPEYLENGLVSTKLDVYAFGVLILEMLTGK 542
            +PE ++        D +A GVL  E+LTGK
Sbjct: 173 FSPEKIKGHNYDVSFDWWAVGVLTYELLTGK 203

Length = 267

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 54.2 bits (130), Expect = 8e-08
 Identities = 53/202 (26%), Positives = 86/202 (42%), Gaps = 13/202 (6%)

Query: 382 VSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQR 441
           +S+   LL  + H  L+ L          Y V +Y   G L    +  + E  +L+ + R
Sbjct: 43  MSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGEL---FYHLQRERCFLEPRAR 99

Query: 442 IQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFAL 501
              A ++A+ L YLHS      V++D+   N+LLDS     + +F + +      G    
Sbjct: 100 FYAA-EIASALGYLHSLNI---VYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGT--- 152

Query: 502 TRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLN 561
           T    GT  Y+APE L        +D +  G ++ EML G      ++        ++LN
Sbjct: 153 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYG--LPPFYSRNTAEMYDNILN 210

Query: 562 AVLT-KEDGEESLRHFIDPTLQ 582
             L  K +   S RH ++  LQ
Sbjct: 211 KPLQLKPNITNSARHLLEGLLQ 232

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 53.9 bits (129), Expect = 9e-08
 Identities = 56/222 (25%), Positives = 99/222 (44%), Gaps = 33/222 (14%)

Query: 361 GSVYRGKINGGFA----AIKKVNG-----DVSKEIALLNKINHSNLIILSGVCFNEGN-- 409
           G VY+ K   G      A+K++ G        +EIALL ++ H N+I L  V  +  +  
Sbjct: 15  GHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHADRK 74

Query: 410 CYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIA--------LDVATGLNYLHSFTNP 461
            +L+++YA +       F   ++      K+ +Q+           +  G++YLH+    
Sbjct: 75  VWLLFDYAEHDLWHIIKFHRASKAN----KKPVQLPRGMVKSLLYQILDGIHYLHANWV- 129

Query: 462 PHVHKDINSSNVLLDSD----LRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYL 517
             +H+D+  +N+L+  +     R KIA+   AR         A    +V T  Y APE L
Sbjct: 130 --LHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELL 187

Query: 518 ENGLVSTK-LDVYAFGVLILEMLTGKEAAALHAEENNMHLSD 558
                 TK +D++A G +  E+LT +     H  + ++  S+
Sbjct: 188 LGARHYTKAIDIWAIGCIFAELLTSE--PIFHCRQEDIKTSN 227

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 54.2 bits (130), Expect = 9e-08
 Identities = 46/163 (28%), Positives = 70/163 (42%), Gaps = 23/163 (14%)

Query: 447 DVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIV 506
           ++   L +LH       V++DI   N+LLDS+    + +F +++    +E E   T    
Sbjct: 113 EIILALEHLHKLGI---VYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKE--RTYSFC 167

Query: 507 GTKGYMAPEYLENGLVSTK-LDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLT 565
           GT  YMAPE +       K +D ++ G+LI E+LTG     L  E N    S+V   +L 
Sbjct: 168 GTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQ--SEVSRRILK 225

Query: 566 KEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDR 608
                       DP      P  +      L+   L+KDP  R
Sbjct: 226 -----------CDPPF----PSFIGPEAQDLLHKLLRKDPKKR 253

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 53.9 bits (129), Expect = 1e-07
 Identities = 65/256 (25%), Positives = 116/256 (45%), Gaps = 36/256 (14%)

Query: 361 GSVYRGKINGGFA----AIKKVNG-----DVSKEIALLNKINHSNLIILSGVCFNEGN-- 409
           G VY+ K   G      A+K++ G        +EIALL ++ H N+I L  V  +  +  
Sbjct: 15  GHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFLSHSDRK 74

Query: 410 CYLVYEYAVNGTLSDWVF--SNKNEGKYLDWKQRIQIAL--DVATGLNYLHSFTNPPHVH 465
            +L+++YA +       F  ++K   K +   + +  +L   +  G++YLH+      +H
Sbjct: 75  VWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWV---LH 131

Query: 466 KDINSSNVLLDSD----LRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGL 521
           +D+  +N+L+  +     R KIA+   AR         A    +V T  Y APE L    
Sbjct: 132 RDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGAR 191

Query: 522 VSTK-LDVYAFGVLILEMLTGKEAAALHAEENNMHLS-----DVLNAVLT------KEDG 569
             TK +D++A G +  E+LT +     H  + ++  S     D L+ + +       +D 
Sbjct: 192 HYTKAIDIWAIGCIFAELLTSE--PIFHCRQEDIKTSNPFHHDQLDRIFSVMGFPADKDW 249

Query: 570 EESLRHFIDPTLQGNY 585
           E+  +    PTLQ ++
Sbjct: 250 EDIRKMPEYPTLQKDF 265

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 53.4 bits (128), Expect = 1e-07
 Identities = 42/170 (24%), Positives = 87/170 (51%), Gaps = 17/170 (10%)

Query: 376 KKVNGDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKY 435
           K V  ++ +E  +++++++  ++ + GVC  E    LV E A  G L+ ++   K+E   
Sbjct: 36  KSVRDEMMREAEIMHQLDNPYIVRMIGVCEAE-ALMLVMEMASGGPLNKFLSGKKDE--- 91

Query: 436 LDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQ 495
           +     +++   V+ G+ YL        VH+D+ + NVLL +   AKI++F +++ A G 
Sbjct: 92  ITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSK-ALGA 147

Query: 496 EGEFALTRHIVGTKG-----YMAPEYLENGLVSTKLDVYAFGVLILEMLT 540
           +  +   R    + G     + APE +     S++ DV+++G+ + E  +
Sbjct: 148 DDSYYKAR----SAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFS 193

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 53.2 bits (128), Expect = 1e-07
 Identities = 47/183 (25%), Positives = 79/183 (43%), Gaps = 40/183 (21%)

Query: 443 QIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALT 502
           +IA+ +   L YLHS  +   +H+D+  SNVL++ + + K+ +F ++    G      L 
Sbjct: 107 KIAVSIVKALEYLHSKLSV--IHRDVKPSNVLINRNGQVKLCDFGIS----GY-----LV 155

Query: 503 RHIV-----GTKGYMAPEYLENGL----VSTKLDVYAFGVLILEMLTGKEAAALHAEENN 553
             +      G K YMAPE +   L       K DV++ G+ ++E+ TG+        ++ 
Sbjct: 156 DSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGR-----FPYDSW 210

Query: 554 MHLSDVLNAVLTKEDGEESLRHFIDPTL-QGNYPLELALLVIRLIDACLKKDPTDRPTMY 612
                 L  V+     EE       P L    +  E    V +    CLKK+  +RP   
Sbjct: 211 KTPFQQLKQVV-----EEP-----SPQLPAEKFSPEFQDFVNK----CLKKNYKERPNYP 256

Query: 613 EIE 615
           E+ 
Sbjct: 257 ELL 259

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 53.5 bits (128), Expect = 1e-07
 Identities = 53/218 (24%), Positives = 95/218 (43%), Gaps = 43/218 (19%)

Query: 361 GSVYRG--KINGGFAAIKKVNGD--------VSKEIALLNKINHSNLIILSGVCFNEGNC 410
            +VY+G  K+     A+K++  +          +E++LL  + H+N++ L  +   E + 
Sbjct: 20  ATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSL 79

Query: 411 YLVYEYAVNGTLSDWVFSNKNEGKYLD------WKQRIQIAL-DVATGLNYLHSFTNPPH 463
            LV+EY            +K+  +YLD          +++ L  +  GLNY H       
Sbjct: 80  TLVFEYL-----------DKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCH---RRKV 125

Query: 464 VHKDINSSNVLLDSDLRAKIANFAMAR----PAEGQEGEFALTRHIVGTKGYMAPEYLEN 519
           +H+D+   N+L++     K+A+F +AR    P +    E       V T  Y  P+ L  
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNE-------VVTLWYRPPDILLG 178

Query: 520 GL-VSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHL 556
               ST++D++  G +  EM TG+        E  +H 
Sbjct: 179 STDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHF 216

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 53.5 bits (128), Expect = 1e-07
 Identities = 68/277 (24%), Positives = 115/277 (41%), Gaps = 46/277 (16%)

Query: 361 GSVYR--GKINGGFAAIKKVN--GDVSKEIALLNKI-----NHSNLIILSGVCFNEGNC- 410
           G VY+   K +G  AA+K ++   DV +EI     I     NH N++   G+ +      
Sbjct: 36  GKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLV 95

Query: 411 ----YLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHK 466
               +LV E    G++++ V      G+ LD      I      GL +LH   N   +H+
Sbjct: 96  GGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLH---NNRIIHR 152

Query: 467 DINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHI-VGTKGYMAPEYLE-----NG 520
           D+  +N+LL ++   K+ +F ++     Q     L R+  VGT  +MAPE +      + 
Sbjct: 153 DVKGNNILLTTEGGVKLVDFGVS----AQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDY 208

Query: 521 LVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPT 580
               + DV++ G+  +E+  G           +MH    L  +    +   +L H     
Sbjct: 209 SYDARCDVWSLGITAIELGDGDPPLF------DMHPVKTLFKI--PRNPPPTLLH----- 255

Query: 581 LQGNYPLELALLVIRLIDACLKKDPTDRPTM-YEIEH 616
                P +        I  CL KD   RP++ + +EH
Sbjct: 256 -----PEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 53.4 bits (128), Expect = 1e-07
 Identities = 38/132 (28%), Positives = 65/132 (49%), Gaps = 11/132 (8%)

Query: 411 YLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINS 470
           YLV +Y   G L  W    + EG++ + + +  IA ++   L +LH +     V++D+  
Sbjct: 72  YLVTDYMSGGELF-WHL--QKEGRFSEDRAKFYIA-ELVLALEHLHKYDI---VYRDLKP 124

Query: 471 SNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTK-LDVY 529
            N+LLD+     + +F +++           T    GT  Y+APE L +    TK +D +
Sbjct: 125 ENILLDATGHIALCDFGLSKANLTDN---KTTNTFCGTTEYLAPEVLLDEKGYTKHVDFW 181

Query: 530 AFGVLILEMLTG 541
           + GVL+ EM  G
Sbjct: 182 SLGVLVFEMCCG 193

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 53.3 bits (128), Expect = 1e-07
 Identities = 54/194 (27%), Positives = 83/194 (42%), Gaps = 23/194 (11%)

Query: 361 GSVY--RGKINGGFAAIKKVNGDV------SKEI-----ALLNKINHSNLIILSGVCFNE 407
           G V   + K +G F A+K +           K I      LL  + H  L+ L       
Sbjct: 9   GKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTA 68

Query: 408 GNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKD 467
              Y V +Y VNG   +  F  + E  + + + R   A ++A+ L YLHS      +++D
Sbjct: 69  DKLYFVLDY-VNG--GELFFHLQRERSFPEPRARFYAA-EIASALGYLHSLNI---IYRD 121

Query: 468 INSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLD 527
           +   N+LLDS     + +F + +  EG E     T    GT  Y+APE L        +D
Sbjct: 122 LKPENILLDSQGHVVLTDFGLCK--EGIEHS-KTTSTFCGTPEYLAPEVLRKQPYDRTVD 178

Query: 528 VYAFGVLILEMLTG 541
            +  G ++ EML G
Sbjct: 179 WWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 52.7 bits (126), Expect = 2e-07
 Identities = 57/212 (26%), Positives = 96/212 (45%), Gaps = 34/212 (16%)

Query: 361 GSVYR--GKINGGFAAIKKVN--GDVSKEIALLNKI-----NHSNLIILSGVCF-----N 406
           G V++   K NG  AA+K ++   D+ +EI     I     +H N++   G+ +     N
Sbjct: 32  GKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKN 91

Query: 407 EGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHK 466
               +LV E    G+++D V      G+ ++      I  +   GL +LH       +H+
Sbjct: 92  GDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLH---VNKTIHR 148

Query: 467 DINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRH----IVGTKGYMAPEYL--ENG 520
           D+  +N+LL ++   K+ +F       G   +   TR      VGT  +MAPE +  E  
Sbjct: 149 DVKGNNILLTTEGGVKLVDF-------GVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQ 201

Query: 521 LVST---KLDVYAFGVLILEMLTGKEA-AALH 548
           L ST   + DV++ G+  +E+  G    A LH
Sbjct: 202 LDSTYDARCDVWSLGITAIELGDGDPPLADLH 233

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 53.1 bits (127), Expect = 2e-07
 Identities = 41/165 (24%), Positives = 79/165 (47%), Gaps = 20/165 (12%)

Query: 384 KEIALLNKINHSNLIILSGV-----CFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDW 438
           +E+ LL  + H N+I L  V        E N   +  + +   L++ V   K    ++ +
Sbjct: 65  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 124

Query: 439 KQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGE 498
                +   +  GL Y+HS      +H+D+  SN+ ++ D   KI +F +AR  + +   
Sbjct: 125 -----LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG 176

Query: 499 FALTRHIVGTKGYMAPEYLENGL-VSTKLDVYAFGVLILEMLTGK 542
           +      V T+ Y APE + N +  +  +D+++ G ++ E+LTG+
Sbjct: 177 Y------VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 52.6 bits (126), Expect = 3e-07
 Identities = 37/157 (23%), Positives = 68/157 (43%), Gaps = 15/157 (9%)

Query: 385 EIALLNKINHSNLIILSGVCFNEG-NCYLVYEYAVNGTLSD-WVFSNKNEGKYLDWKQRI 442
           E  LL  +NH ++I +     +    C ++  Y+     SD + +  K     L   Q +
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYS-----SDLYTYLTKRSRP-LPIDQAL 160

Query: 443 QIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALT 502
            I   +  GL YLH+      +H+D+ + N+ ++   +  I +   A+          L 
Sbjct: 161 IIEKQILEGLRYLHAQRI---IHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLA 217

Query: 503 RHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEML 539
               GT    APE L     ++K D+++ G+++ EML
Sbjct: 218 ----GTVETNAPEVLARDKYNSKADIWSAGIVLFEML 250

Length = 357

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 52.1 bits (125), Expect = 3e-07
 Identities = 55/203 (27%), Positives = 87/203 (42%), Gaps = 31/203 (15%)

Query: 361 GSVY--RGKINGGFAAIKK---------VNGDVSKEIALLNKINHSNLII----LSGVCF 405
           G VY  R K  G   A+KK         +     +EI+LL  ++ S  I+    +  V  
Sbjct: 15  GKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEE 74

Query: 406 NEG--NCYLVYEYAVNGTLSDWVFSN-KNEGKYLDWKQRIQIALDVATGLNYLHSFTNPP 462
             G  + YLV+EY ++  L  ++ SN +  G+ L  K        +  G+ + H      
Sbjct: 75  KNGKPSLYLVFEY-LDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHK----- 128

Query: 463 H--VHKDINSSNVLLDSDL-RAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLEN 519
           H  +H+D+   N+L+D      KIA+  + R        +  T  IV T  Y APE L  
Sbjct: 129 HGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSY--THEIV-TLWYRAPEVLLG 185

Query: 520 GL-VSTKLDVYAFGVLILEMLTG 541
               ST +D+++ G +  EM   
Sbjct: 186 STHYSTPVDIWSVGCIFAEMSRK 208

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 52.0 bits (124), Expect = 4e-07
 Identities = 46/168 (27%), Positives = 82/168 (48%), Gaps = 26/168 (15%)

Query: 384 KEIALLNKINHSNLIIL--------SGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKY 435
           +E+ LL  + H N+I L        S   FNE   YLV    +   L++ V   K   ++
Sbjct: 63  RELRLLKHMKHENVIGLLDVFTPATSIENFNE--VYLVTNL-MGADLNNIVKCQKLSDEH 119

Query: 436 LDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQ 495
           + +     +   +  GL Y+HS      +H+D+  SNV ++ D   +I +F +AR A+ +
Sbjct: 120 VQF-----LIYQLLRGLKYIHS---AGIIHRDLKPSNVAVNEDCELRILDFGLARQADDE 171

Query: 496 EGEFALTRHIVGTKGYMAPEYLENGL-VSTKLDVYAFGVLILEMLTGK 542
              +      V T+ Y APE + N +  +  +D+++ G ++ E+L GK
Sbjct: 172 MTGY------VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 52.2 bits (125), Expect = 4e-07
 Identities = 45/191 (23%), Positives = 81/191 (42%), Gaps = 36/191 (18%)

Query: 442 IQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMAR-----PAEGQE 496
           I  +  VA G+ +L S      +H+D+ + N+LL  +   KI +F +AR     P   ++
Sbjct: 176 ISYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRK 232

Query: 497 GEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT--GKEAAALHAEENNM 554
           G+  L         +MAPE + + + +T+ DV++FGVL+ E+ +        +  +    
Sbjct: 233 GDARLPLK------WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQID---- 282

Query: 555 HLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEI 614
                          EE  R   + T     P      +  ++  C   +P DRPT  E+
Sbjct: 283 ---------------EEFCRRLKEGTRMRA-PEYATPEIYSIMLDCWHNNPEDRPTFSEL 326

Query: 615 EHSLSNILNAS 625
              L ++L  +
Sbjct: 327 VEILGDLLQEN 337

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 52.1 bits (125), Expect = 4e-07
 Identities = 57/220 (25%), Positives = 92/220 (41%), Gaps = 49/220 (22%)

Query: 361 GSVYRG--KINGGFAAIKKV-----NGDVSK----------------EIALLNKINHSNL 397
           G V +    + G   AIKKV     + DV+K                E+ ++N+I H N+
Sbjct: 23  GKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENI 82

Query: 398 IILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHS 457
           + L  V        LV +  +   L   V   K     L   Q   I L +  GLN LH 
Sbjct: 83  MGLVDVYVEGDFINLVMDI-MASDLKK-VVDRK---IRLTESQVKCILLQILNGLNVLHK 137

Query: 458 FTNPPHVHKDINSSNVLLDSDLRAKIANFAMAR--------PAEGQEGEFALTRHI---V 506
           +     +H+D++ +N+ ++S    KIA+F +AR            ++        +   V
Sbjct: 138 WY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKV 194

Query: 507 GTKGYMAPEYLENGLVSTK----LDVYAFGVLILEMLTGK 542
            T  Y APE L   + + K    +D+++ G +  E+LTGK
Sbjct: 195 VTLWYRAPELL---MGAEKYHFAVDMWSVGCIFAELLTGK 231

Length = 335

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 52.2 bits (125), Expect = 5e-07
 Identities = 54/209 (25%), Positives = 89/209 (42%), Gaps = 44/209 (21%)

Query: 412 LVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPH-VHKDINS 470
           LV +YA  G L   + S     +     +   + + V   ++++HS     H +H+DI S
Sbjct: 116 LVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHS----KHMIHRDIKS 171

Query: 471 SNVLLDSDLRAKIANFAMARPAEGQEGEFALT------RHIVGTKGYMAPEYLENGLVST 524
           +N+LL S+   K+ +F  ++        +A T      R   GT  Y+APE       S 
Sbjct: 172 ANILLCSNGLVKLGDFGFSK-------MYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSK 224

Query: 525 KLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGN 584
           K D+++ GVL+ E+LT K                         DG E++   +  TL G 
Sbjct: 225 KADMFSLGVLLYELLTLKRPF----------------------DG-ENMEEVMHKTLAGR 261

Query: 585 Y---PLELALLVIRLIDACLKKDPTDRPT 610
           Y   P  ++  +  ++ A L  DP  RP+
Sbjct: 262 YDPLPPSISPEMQEIVTALLSSDPKRRPS 290

Length = 496

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 51.5 bits (123), Expect = 6e-07
 Identities = 47/186 (25%), Positives = 77/186 (41%), Gaps = 21/186 (11%)

Query: 367 KINGGFAAIKKVNGDV------SKEI-----ALLNKINHSNLIILSGVCFNEGNCYLVYE 415
           K++G   A+K +   +       K I      LL  + H  L+ L          Y V +
Sbjct: 17  KLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLD 76

Query: 416 YAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLL 475
           +   G L    F  + E  + + + R   A ++A+ L YLHS      V++D+   N+LL
Sbjct: 77  FVNGGEL---FFHLQRERSFPEPRARFYAA-EIASALGYLHSINI---VYRDLKPENILL 129

Query: 476 DSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLI 535
           DS     + +F + +    Q      T    GT  Y+APE +        +D +  G ++
Sbjct: 130 DSQGHVVLTDFGLCKEGIAQSDT---TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVL 186

Query: 536 LEMLTG 541
            EML G
Sbjct: 187 YEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 52.5 bits (126), Expect = 6e-07
 Identities = 49/208 (23%), Positives = 81/208 (38%), Gaps = 47/208 (22%)

Query: 442 IQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFA- 500
           + I   +   + Y+HS      +H+D+   N+LL       I ++  A   + +E +   
Sbjct: 116 LSIFHKICATIEYVHS---KGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLD 172

Query: 501 ------------LTR--HIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAA 546
                       +T    IVGT  YMAPE L     S   D+YA GV++ +MLT      
Sbjct: 173 IDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT------ 226

Query: 547 LHAEENNMHLSDVLNAVLTKEDGEE-SLRHFI-DPTLQGNY---PLELALLVIRLIDACL 601
                        L+    ++ G + S R  I  P     Y   P  L+ + ++ +    
Sbjct: 227 -------------LSFPYRRKKGRKISYRDVILSPIEVAPYREIPPFLSQIAMKALAV-- 271

Query: 602 KKDPTDR-PTMYEIEHSLSNILNASLNW 628
             DP +R  ++ E++  L   L  S  W
Sbjct: 272 --DPAERYSSVQELKQDLEPHLQGSPEW 297

Length = 932

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 51.0 bits (122), Expect = 6e-07
 Identities = 42/187 (22%), Positives = 82/187 (43%), Gaps = 30/187 (16%)

Query: 432 EGKYLDWKQRI------QIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIAN 485
           +G  LD  ++I      +IA+ V  GL YL S      +H+D+  SN+L+++  + K+ +
Sbjct: 82  DGGSLDVYRKIPEHVLGRIAVAVVKGLTYLWSLKI---LHRDVKPSNMLVNTRGQVKLCD 138

Query: 486 FAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAA 545
           F ++          ++ +  VGT  YMAPE +         DV++ G+  +E+  G+   
Sbjct: 139 FGVSTQLVN-----SIAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGR-FP 192

Query: 546 ALHAEENNMHLS--DVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKK 603
               ++N   L    +L  ++ ++     +  F +               +  I  C++K
Sbjct: 193 YPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEK-------------FVHFITQCMRK 239

Query: 604 DPTDRPT 610
            P +RP 
Sbjct: 240 QPKERPA 246

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 52.0 bits (124), Expect = 7e-07
 Identities = 45/175 (25%), Positives = 82/175 (46%), Gaps = 16/175 (9%)

Query: 369 NGGFAAIKKVNGDVSKEIALLNKINHSNLIILSGVCFNEGNCYLV---YEYAVNGTLSDW 425
            G  AAI+  N     EI  L ++NH N++ +  +  +E N Y++   Y++ +   + D 
Sbjct: 202 AGSRAAIQLEN-----EILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDE 256

Query: 426 VFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIAN 485
            F  K+  + L  + R  I   +   + Y+H       +H+DI   N+ L+ D +  + +
Sbjct: 257 AFDWKD--RPLLKQTR-AIMKQLLCAVEYIHD---KKLIHRDIKLENIFLNCDGKIVLGD 310

Query: 486 FAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT 540
           F  A P E +   F      VGT    +PE L         D+++ G+++L+ML+
Sbjct: 311 FGTAMPFEKEREAFDYG--WVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363

Length = 501

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 50.6 bits (121), Expect = 7e-07
 Identities = 55/232 (23%), Positives = 104/232 (44%), Gaps = 33/232 (14%)

Query: 387 ALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIAL 446
           +++++++H +L++  GVC       +V EY   G+L  ++  NKN      WK  +++A 
Sbjct: 51  SMMSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINIS-WK--LEVAK 107

Query: 447 DVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIV 506
            +A  L++L         H ++ + NVLL  +   K  N    + ++       L + I+
Sbjct: 108 QLAWALHFLEDKGLT---HGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEIL 164

Query: 507 GTK-GYMAPEYLENGL-VSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVL 564
             +  ++ PE +EN   +S   D ++FG  + E+ +G           +  LS +     
Sbjct: 165 LERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSG----------GDKPLSAL----- 209

Query: 565 TKEDGEESLRHFIDPTLQGNYP--LELALLVIRLIDACLKKDPTDRPTMYEI 614
              D ++ L+ F +   Q   P   ELA     LI+ C+  +P  RP+   I
Sbjct: 210 ---DSQKKLQ-FYEDRHQLPAPKWTELAN----LINQCMDYEPDFRPSFRAI 253

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 51.2 bits (122), Expect = 7e-07
 Identities = 44/165 (26%), Positives = 80/165 (48%), Gaps = 20/165 (12%)

Query: 384 KEIALLNKINHSNLIILSGVCFNEG------NCYLVYEYAVNGTLSDWVFSNKNEGKYLD 437
           +E+ L+  +NH N+I L  V   +       + YLV E  ++  L   +         LD
Sbjct: 65  RELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMEL-MDANLCQVIQME------LD 117

Query: 438 WKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEG 497
            ++   +   +  G+ +LHS      +H+D+  SN+++ SD   KI +F +AR A     
Sbjct: 118 HERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS-- 172

Query: 498 EFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGK 542
            F +T ++V T+ Y APE +        +D+++ G ++ EM+  K
Sbjct: 173 -FMMTPYVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 51.1 bits (122), Expect = 8e-07
 Identities = 45/185 (24%), Positives = 84/185 (45%), Gaps = 33/185 (17%)

Query: 384 KEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLD------ 437
           +E++LL  + H+N++ L  +   + +  LV+EY            +K+  +Y+D      
Sbjct: 53  REVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYL-----------DKDLKQYMDDCGNIM 101

Query: 438 WKQRIQIAL-DVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMAR----PA 492
               ++I L  +  GL Y H       +H+D+   N+L++     K+A+F +AR    P 
Sbjct: 102 SMHNVKIFLYQILRGLAYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPT 158

Query: 493 EGQEGEFALTRHIVGTKGYMAPE-YLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEE 551
           +    E       V T  Y  P+  L +   ST++D++  G +  EM +G+        E
Sbjct: 159 KTYSNE-------VVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVE 211

Query: 552 NNMHL 556
           + +HL
Sbjct: 212 DELHL 216

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|212030 cd00118, LysM, Lysine Motif is a small domain involved in binding peptidoglycan

 Score = 45.6 bits (109), Expect = 8e-07
 Identities = 16/44 (36%), Positives = 24/44 (54%), Gaps = 1/44 (2%)

Query: 186 SYLVAEGDTVSGISSRFGVDTGEILQANSLSGSN-IFPFTTLLI 228
           +Y V  GDT+  I+ ++GV   E+  AN L   + I+P   L I
Sbjct: 2   TYTVKPGDTLWSIAKKYGVTVEELAAANPLINPDCIYPGQKLKI 45

LysM, a small globular domain with approximately 40 amino acids, is a widespread protein module involved in binding peptidoglycan in bacteria and chitin in eukaryotes. The domain was originally identified in enzymes that degrade bacterial cell walls, but proteins involved in many other biological functions also contain this domain. It has been reported that the LysM domain functions as a signal for specific plant-bacteria recognition in bacterial pathogenesis. Many of these enzymes are modular and are composed of catalytic units linked to one or several repeats of LysM domains. LysM domains are found in bacteria and eukaryotes. Length = 45

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 50.8 bits (121), Expect = 8e-07
 Identities = 46/170 (27%), Positives = 77/170 (45%), Gaps = 12/170 (7%)

Query: 376 KKVNGDVSKEIALLNKINHSNLIILSGVCF---NEGNCYLVYEYAVNGTLSDWVFSNKNE 432
           K+VN  +  EI LL  + H  ++   G C     E    +  EY   G++ D +   K  
Sbjct: 46  KEVNA-LECEIQLLKNLRHDRIVQYYG-CLRDPEEKKLSIFVEYMPGGSIKDQL---KAY 100

Query: 433 GKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPA 492
           G   +   R +    +  G++YLHS      VH+DI  +N+L DS    K+ +F  ++  
Sbjct: 101 GALTENVTR-RYTRQILQGVSYLHSNMI---VHRDIKGANILRDSAGNVKLGDFGASKRI 156

Query: 493 EGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGK 542
           +         + + GT  +M+PE +       K DV++    ++EMLT K
Sbjct: 157 QTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEK 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 50.8 bits (121), Expect = 9e-07
 Identities = 46/191 (24%), Positives = 84/191 (43%), Gaps = 27/191 (14%)

Query: 365 RGKINGGFAAIKKVNGD--------VSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEY 416
           R K+     A+K++  +          +E++LL  + H+N++ L  +   E    LV+EY
Sbjct: 25  RSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84

Query: 417 AVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLD 476
            ++  L  ++    N G  +           +  GL+Y H       +H+D+   N+L++
Sbjct: 85  -LDSDLKQYL---DNCGNLMSMHNVKIFMFQLLRGLSYCH---KRKILHRDLKPQNLLIN 137

Query: 477 SDLRAKIANFAMAR----PAEGQEGEFALTRHIVGTKGYMAPEYLENGL-VSTKLDVYAF 531
                K+A+F +AR    P +    E       V T  Y  P+ L      ST +D++  
Sbjct: 138 EKGELKLADFGLARAKSVPTKTYSNE-------VVTLWYRPPDVLLGSTEYSTPIDMWGV 190

Query: 532 GVLILEMLTGK 542
           G ++ EM TG+
Sbjct: 191 GCILYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 50.4 bits (120), Expect = 9e-07
 Identities = 44/169 (26%), Positives = 79/169 (46%), Gaps = 10/169 (5%)

Query: 376 KKVNGDVSKEIALLNKINHSNLIILSGVCFN--EGNCYLVYEYAVNGTLSDWVFSNKNEG 433
           K+VN  +  EI LL  + H  ++   G   +  E    +  E+   G++ D +   K+ G
Sbjct: 46  KEVNA-LECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQL---KSYG 101

Query: 434 KYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAE 493
              +   R +    +  G++YLHS      VH+DI  +N+L DS    K+ +F  ++  +
Sbjct: 102 ALTENVTR-KYTRQILEGVSYLHSNMI---VHRDIKGANILRDSVGNVKLGDFGASKRLQ 157

Query: 494 GQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGK 542
                    + + GT  +M+PE +       K D+++ G  ++EMLT K
Sbjct: 158 TICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEK 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 50.4 bits (120), Expect = 9e-07
 Identities = 47/208 (22%), Positives = 92/208 (44%), Gaps = 33/208 (15%)

Query: 361 GSVYRGKINGGF-------AAIK----KVNGDVSKEI----ALLNKINHSNLIILSGVCF 405
           G VY+G + G          AIK    K  G + +E      + +++ H N++ L GV  
Sbjct: 19  GKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVT 78

Query: 406 NEGNCYLVYEYAVNGTLSDWVF------------SNKNEGKYLDWKQRIQIALDVATGLN 453
            E    +++ Y  +  L +++              +K     L+    + I   +A G+ 
Sbjct: 79  KEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGME 138

Query: 454 YLHSFTNPPHV-HKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYM 512
           +L S     HV HKD+ + NVL+   L  KI++  + R     +    +   ++  + +M
Sbjct: 139 FLSSH----HVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIR-WM 193

Query: 513 APEYLENGLVSTKLDVYAFGVLILEMLT 540
           +PE +  G  S   D++++GV++ E+ +
Sbjct: 194 SPEAIMYGKFSIDSDIWSYGVVLWEVFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 51.2 bits (122), Expect = 1e-06
 Identities = 38/157 (24%), Positives = 65/157 (41%), Gaps = 27/157 (17%)

Query: 464 VHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVS 523
           +H+D+ S+N+ L      K+ +F  ++          +     GT  Y+APE  E    S
Sbjct: 191 MHRDLKSANIFLMPTGIIKLGDFGFSKQYS-DSVSLDVASSFCGTPYYLAPELWERKRYS 249

Query: 524 TKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQG 583
            K D+++ GV++ E+LT                       L +     S R  +   L G
Sbjct: 250 KKADMWSLGVILYELLT-----------------------LHRPFKGPSQREIMQQVLYG 286

Query: 584 NY---PLELALLVIRLIDACLKKDPTDRPTMYEIEHS 617
            Y   P  ++  +  L+D  L K+P  RPT  ++ H+
Sbjct: 287 KYDPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHT 323

Length = 478

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 50.8 bits (121), Expect = 1e-06
 Identities = 43/165 (26%), Positives = 80/165 (48%), Gaps = 20/165 (12%)

Query: 384 KEIALLNKINHSNLIILSGVCFNEG------NCYLVYEYAVNGTLSDWVFSNKNEGKYLD 437
           +E+ L+  +NH N+I L  V   +       + Y+V E  ++  L   +         LD
Sbjct: 72  RELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMEL-MDANLCQVIQME------LD 124

Query: 438 WKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEG 497
            ++   +   +  G+ +LHS      +H+D+  SN+++ SD   KI +F +AR A     
Sbjct: 125 HERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS-- 179

Query: 498 EFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGK 542
            F +T ++V T+ Y APE +        +D+++ G ++ EM+ G 
Sbjct: 180 -FMMTPYVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 50.4 bits (120), Expect = 1e-06
 Identities = 50/199 (25%), Positives = 94/199 (47%), Gaps = 31/199 (15%)

Query: 362 SVYRG--KINGGFAAIKKVNGDVS--------KEIALLNKINHSNLIILSGVCFNEGNCY 411
           +VY+G  +ING   A+K ++            +E +LL  + H+N+++L  +   +    
Sbjct: 20  TVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLT 79

Query: 412 LVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHV-HKDINS 470
            V+EY ++  L+ ++   ++ G    +  R+     +  GL Y+H      H+ H+D+  
Sbjct: 80  FVFEY-MHTDLAQYM--IQHPGGLHPYNVRL-FMFQLLRGLAYIHG----QHILHRDLKP 131

Query: 471 SNVLLDSDLRAKIANFAMAR----PAEGQEGEFALTRHIVGTKGYMAPEYLENGL-VSTK 525
            N+L+      K+A+F +AR    P++    E       V T  Y  P+ L      S+ 
Sbjct: 132 QNLLISYLGELKLADFGLARAKSIPSQTYSSE-------VVTLWYRPPDVLLGATDYSSA 184

Query: 526 LDVYAFGVLILEMLTGKEA 544
           LD++  G + +EML G+ A
Sbjct: 185 LDIWGAGCIFIEMLQGQPA 203

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 50.5 bits (120), Expect = 1e-06
 Identities = 49/195 (25%), Positives = 91/195 (46%), Gaps = 21/195 (10%)

Query: 361 GSVYRGK--INGGFAAIKKVNGD--------VSKEIALLNKINHSNLIILSGVCFNEGNC 410
            +VY+GK  +NG   A+K +             +E +LL  + H+N+++L  +   +   
Sbjct: 19  ATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETL 78

Query: 411 YLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINS 470
            LV+EY V+  L  ++  +K+ G       ++     +  GL+Y+H       +H+D+  
Sbjct: 79  TLVFEY-VHTDLCQYM--DKHPGGLHPENVKL-FLFQLLRGLSYIHQRYI---LHRDLKP 131

Query: 471 SNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGL-VSTKLDVY 529
            N+L+      K+A+F +AR        ++   + V T  Y  P+ L      ST LD++
Sbjct: 132 QNLLISDTGELKLADFGLARAKSVPSHTYS---NEVVTLWYRPPDVLLGSTEYSTCLDMW 188

Query: 530 AFGVLILEMLTGKEA 544
             G + +EM+ G  A
Sbjct: 189 GVGCIFVEMIQGVAA 203

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 50.3 bits (121), Expect = 1e-06
 Identities = 54/206 (26%), Positives = 90/206 (43%), Gaps = 44/206 (21%)

Query: 361 GSVYRGKIN--GGFAAIKKVNGDVSK---------EIALLNKINHSNLIILSGVCFNEG- 408
           G VYR +    G   A+KK+  +  K         EI +L K+ H N++ +  V      
Sbjct: 19  GVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNL 78

Query: 409 -NCYLVYEYAVNGTLSDWVFSNKNEGKYL--DWKQRIQIA------LDVATGLNYLHSFT 459
              Y+V EY             +++ K L    KQ    +      L + +G+ +LH   
Sbjct: 79  DKIYMVMEYV------------EHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHD-- 124

Query: 460 NPPH--VHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPE-Y 516
              +  +H+D+ +SN+LL++    KI +F +AR        +     +V T  Y APE  
Sbjct: 125 ---NWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYT---QLVVTLWYRAPELL 178

Query: 517 LENGLVSTKLDVYAFGVLILEMLTGK 542
           L     ST +D+++ G +  E+LT K
Sbjct: 179 LGAKEYSTAIDMWSVGCIFAELLTKK 204

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 49.9 bits (119), Expect = 1e-06
 Identities = 42/185 (22%), Positives = 86/185 (46%), Gaps = 31/185 (16%)

Query: 442 IQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFAL 501
           ++  +D+A+G+ YL   ++   +H+D+ + N +L+ ++   +A+F +++      G++  
Sbjct: 116 VRFMIDIASGMEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKI--YSGDY-- 168

Query: 502 TRHIVGTK---GYMAPEYLENGLVSTKLDVYAFGVLILEMLT-GKEAAALHAEENNMHLS 557
            R    +K    ++A E L + + +T  DV+AFGV + E++T G+   A    EN    S
Sbjct: 169 YRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYA--GVEN----S 222

Query: 558 DVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHS 617
           ++ N ++        L+           P +    V  L+  C   +P  RP+   +   
Sbjct: 223 EIYNYLI----KGNRLKQ----------PPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQ 268

Query: 618 LSNIL 622
           L  I 
Sbjct: 269 LELIW 273

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 50.5 bits (121), Expect = 1e-06
 Identities = 52/183 (28%), Positives = 82/183 (44%), Gaps = 56/183 (30%)

Query: 384 KEIALLNKINHSNLIILSGVC--------FNEGNCYLVYEYAVNGTLSDWVFSNKNEGKY 435
           +E+ L+  +NH N+I L  V         F +   YLV E      L D           
Sbjct: 64  RELVLMKLVNHKNIIGLLNVFTPQKSLEEFQD--VYLVME------LMD----------- 104

Query: 436 LDWKQRIQIALD----------VATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIAN 485
            +  Q IQ+ LD          +  G+ +LHS      +H+D+  SN+++ SD   KI +
Sbjct: 105 ANLCQVIQMDLDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILD 161

Query: 486 FAMARPAEGQEGEFALTRHIVGTKGYMAPE------YLENGLVSTKLDVYAFGVLILEML 539
           F +AR A      F +T ++V T+ Y APE      Y EN      +D+++ G ++ EM+
Sbjct: 162 FGLARTA---GTSFMMTPYVV-TRYYRAPEVILGMGYKEN------VDIWSVGCIMGEMI 211

Query: 540 TGK 542
            G 
Sbjct: 212 RGT 214

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 50.4 bits (120), Expect = 1e-06
 Identities = 48/199 (24%), Positives = 84/199 (42%), Gaps = 36/199 (18%)

Query: 434 KYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMAR--- 490
           K L  +  I  +  VA G+ +L S      +H+D+ + N+LL  +   KI +F +AR   
Sbjct: 174 KVLTLEDLICYSFQVAKGMEFLASRKC---IHRDLAARNILLSENNVVKICDFGLARDIY 230

Query: 491 --PAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEM--LTGKEAAA 546
             P   ++G+  L         +MAPE + + + + + DV++FGVL+ E+  L       
Sbjct: 231 KDPDYVRKGDARLPLK------WMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 284

Query: 547 LHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPT 606
           +  +                   EE  R   + T           +   ++D C   +P+
Sbjct: 285 VKID-------------------EEFCRRLKEGTRMRAPDYTTPEMYQTMLD-CWHGEPS 324

Query: 607 DRPTMYEIEHSLSNILNAS 625
            RPT  E+   L N+L A+
Sbjct: 325 QRPTFSELVEHLGNLLQAN 343

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 50.0 bits (120), Expect = 2e-06
 Identities = 40/162 (24%), Positives = 63/162 (38%), Gaps = 35/162 (21%)

Query: 407 EGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQ-RIQIALDVATGLNYLHSFTNPPHVH 465
           E + YLV EY   G L + +   K+       +  R  IA ++   L+ +H       +H
Sbjct: 73  EEHLYLVMEYMPGGDLMNLL-IRKDV---FPEETARFYIA-ELVLALDSVHKLG---FIH 124

Query: 466 KDINSSNVLLDSDLRAKIANF--AMARPAEGQEGEFALTRH------------------- 504
           +DI   N+L+D+D   K+A+F              +    H                   
Sbjct: 125 RDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRR 184

Query: 505 -----IVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTG 541
                 VGT  Y+APE L       + D ++ GV++ EML G
Sbjct: 185 VRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYG 226

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 49.2 bits (117), Expect = 2e-06
 Identities = 34/128 (26%), Positives = 60/128 (46%), Gaps = 18/128 (14%)

Query: 426 VFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIAN 485
           VFS K    Y         A ++  GL ++H   N   V++D+  +N+LLD     +I++
Sbjct: 93  VFSEKEMRFY---------ATEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISD 140

Query: 486 FAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLV-STKLDVYAFGVLILEMLTGKEA 544
             +A     ++   +     VGT GYMAPE L+ G    +  D ++ G ++ ++L G   
Sbjct: 141 LGLACDFSKKKPHAS-----VGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSP 195

Query: 545 AALHAEEN 552
              H  ++
Sbjct: 196 FRQHKTKD 203

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|197609 smart00257, LysM, Lysin motif

 Score = 44.4 bits (106), Expect = 2e-06
 Identities = 13/43 (30%), Positives = 25/43 (58%), Gaps = 1/43 (2%)

Query: 187 YLVAEGDTVSGISSRFGVDTGEILQANSLSGSN-IFPFTTLLI 228
           Y V +GDT+S I+ R+G+   ++L+ N++   + +     L I
Sbjct: 2   YTVKKGDTLSSIARRYGISVSDLLELNNILDPDNLQVGQKLKI 44

Length = 44

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 49.2 bits (117), Expect = 3e-06
 Identities = 46/183 (25%), Positives = 82/183 (44%), Gaps = 32/183 (17%)

Query: 445 ALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMAR-----PAEGQEGEF 499
           +  VA G+ +L S      +H+D+ + N+LL  +   KI +F +AR     P   ++G  
Sbjct: 180 SFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSA 236

Query: 500 ALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDV 559
            L         +MAPE + + + +T+ DV++FGVL+ E+ +   +     + N       
Sbjct: 237 RLPLK------WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIN------- 283

Query: 560 LNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLS 619
                     EE  +   D T +   P      + R++ AC + DP +RPT   +   L 
Sbjct: 284 ----------EEFCQRLKDGT-RMRAPENATPEIYRIMLACWQGDPKERPTFSALVEILG 332

Query: 620 NIL 622
           ++L
Sbjct: 333 DLL 335

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 50.1 bits (119), Expect = 3e-06
 Identities = 46/180 (25%), Positives = 82/180 (45%), Gaps = 23/180 (12%)

Query: 385 EIALLNKINHSNLIILSGVCFNEGN--CYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRI 442
           E+ ++ ++ H N++       N+ N   Y++ E+   G LS  +         ++    +
Sbjct: 62  EVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIV 121

Query: 443 QIALDVATGLNYLHSFTNPPH----VHKDINSSNVLLDSDLR--AKI---ANFAMARPAE 493
            I   +   L Y H+  + P+    +H+D+   N+ L + +R   KI   AN    RP  
Sbjct: 122 DITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPI- 180

Query: 494 GQEGEFALTRHI---------VGTKGYMAPEYL--ENGLVSTKLDVYAFGVLILEMLTGK 542
            + G+F L+++I         VGT  Y +PE L  E      K D++A G +I E+ +GK
Sbjct: 181 AKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGK 240

Length = 1021

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 49.6 bits (118), Expect = 3e-06
 Identities = 34/110 (30%), Positives = 55/110 (50%), Gaps = 4/110 (3%)

Query: 431 NEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMAR 490
           NE   L +   +  +  VA G+ +L S      VH+D+ + NVL+      KI +F +AR
Sbjct: 231 NESPALSYMDLVGFSYQVANGMEFLASKNC---VHRDLAARNVLICEGKLVKICDFGLAR 287

Query: 491 PAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT 540
                    +     +  K +MAPE + N L +T  DV++FG+L+ E+ T
Sbjct: 288 DIMRDSNYISKGSTFLPLK-WMAPESIFNNLYTTLSDVWSFGILLWEIFT 336

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 48.8 bits (116), Expect = 3e-06
 Identities = 28/98 (28%), Positives = 53/98 (54%), Gaps = 9/98 (9%)

Query: 445 ALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRH 504
           A ++  GL ++H   N   V++D+  +N+LLD     +I++  +A     ++   +    
Sbjct: 103 AAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---- 155

Query: 505 IVGTKGYMAPEYLENGLV-STKLDVYAFGVLILEMLTG 541
            VGT GYMAPE L+ G+   +  D ++ G ++ ++L G
Sbjct: 156 -VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 192

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 49.0 bits (117), Expect = 4e-06
 Identities = 43/141 (30%), Positives = 67/141 (47%), Gaps = 16/141 (11%)

Query: 409 NCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIA-LDVATGLNYLHSFTNPPHVHKD 467
           N YLV EY   G L   +  N+ E ++ +   +  +A L +A     +HS     +VH+D
Sbjct: 75  NLYLVMEYQPGGDLLSLL--NRYEDQFDEDMAQFYLAELVLA-----IHSVHQMGYVHRD 127

Query: 468 INSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLE------NGL 521
           I   NVL+D     K+A+F  A  A     +   ++  VGT  Y+APE L        G 
Sbjct: 128 IKPENVLIDRTGHIKLADFGSA--ARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGT 185

Query: 522 VSTKLDVYAFGVLILEMLTGK 542
              + D ++ GV+  EM+ G+
Sbjct: 186 YGVECDWWSLGVIAYEMIYGR 206

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 48.5 bits (115), Expect = 4e-06
 Identities = 61/251 (24%), Positives = 105/251 (41%), Gaps = 29/251 (11%)

Query: 384 KEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQ 443
           +E+ +L  +   N++ L       G  YLV+EY     L   +      G   + K R  
Sbjct: 49  RELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEKNMLE--LLEEMPNGVPPE-KVRSY 105

Query: 444 IALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTR 503
           I   +   +++ H       VH+DI   N+L+  +   K+ +F  AR     EG  A   
Sbjct: 106 I-YQLIKAIHWCH---KNDIVHRDIKPENLLISHNDVLKLCDFGFARNL--SEGSNANYT 159

Query: 504 HIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAV 563
             V T+ Y +PE L        +D+++ G ++ E+  G+    L   E+ +     +  V
Sbjct: 160 EYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQ---PLFPGESEIDQLFTIQKV 216

Query: 564 LTKEDGEESLRHFIDPTLQG------NYP--LE------LALLVIRLIDACLKKDPTDRP 609
           L     E+    + +P   G      N+P  LE      L+ +++ L+   LK +PTDR 
Sbjct: 217 LGPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDR- 275

Query: 610 TMYEIEHSLSN 620
             Y  E  L++
Sbjct: 276 --YLTEQCLNH 284

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 48.1 bits (114), Expect = 6e-06
 Identities = 51/212 (24%), Positives = 91/212 (42%), Gaps = 30/212 (14%)

Query: 361 GSVYRG--KINGGFAAIKKVNG-------DVSKEIALLNKINHSNLIILSGVCFNEGNCY 411
           G VY+   K  G  AA K ++        D   EI +L   +H N++ L    + E N +
Sbjct: 19  GKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLW 78

Query: 412 LVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSS 471
           ++ E+   G +   +   +   + L   Q   +       LNYLH       +H+D+ + 
Sbjct: 79  ILIEFCAGGAVDAVMLELE---RPLTEPQIRVVCKQTLEALNYLH---ENKIIHRDLKAG 132

Query: 472 NVLLDSDLRAKIANFAMARPAEGQEGEFALTRH--IVGTKGYMAPEYL-----ENGLVST 524
           N+L   D   K+A+F ++      +    + R    +GT  +MAPE +     ++     
Sbjct: 133 NILFTLDGDIKLADFGVS-----AKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDY 187

Query: 525 KLDVYAFGVLILEMLTGKEAAALHAEENNMHL 556
           K DV++ G+ ++EM    +    H E N M +
Sbjct: 188 KADVWSLGITLIEM---AQIEPPHHELNPMRV 216

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 48.2 bits (115), Expect = 7e-06
 Identities = 42/137 (30%), Positives = 64/137 (46%), Gaps = 18/137 (13%)

Query: 411 YLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINS 470
           Y+V EY   G L + + SN +  +   W  R   A +V   L+ +HS      +H+D+  
Sbjct: 119 YMVMEYMPGGDLVN-LMSNYDIPE--KWA-RFYTA-EVVLALDAIHSMG---FIHRDVKP 170

Query: 471 SNVLLDSDLRAKIANFA--MARPAEGQEGEFALTRHIVGTKGYMAPEYLEN----GLVST 524
            N+LLD     K+A+F   M   A G           VGT  Y++PE L++    G    
Sbjct: 171 DNMLLDKSGHLKLADFGTCMKMDANGM----VRCDTAVGTPDYISPEVLKSQGGDGYYGR 226

Query: 525 KLDVYAFGVLILEMLTG 541
           + D ++ GV + EML G
Sbjct: 227 ECDWWSVGVFLYEMLVG 243

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 47.8 bits (114), Expect = 7e-06
 Identities = 48/201 (23%), Positives = 85/201 (42%), Gaps = 44/201 (21%)

Query: 361 GSVYRGK--INGGFAAIKKVNGD---------VSKEIALLNKINHSNLIILSGVCFNEGN 409
           G+V++ K        A+K+V  D           +EI LL ++ H N++ L  V  ++  
Sbjct: 14  GTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKK 73

Query: 410 CYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVAT----------GLNYLHSFT 459
             LV+EY            +++  KY D        +D             GL + HS  
Sbjct: 74  LTLVFEYC-----------DQDLKKYFD---SCNGDIDPEIVKSFMFQLLKGLAFCHSH- 118

Query: 460 NPPHV-HKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLE 518
              +V H+D+   N+L++ +   K+A+F +AR        ++     V T  Y  P+ L 
Sbjct: 119 ---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYS---AEVVTLWYRPPDVLF 172

Query: 519 NG-LVSTKLDVYAFGVLILEM 538
              L ST +D+++ G +  E+
Sbjct: 173 GAKLYSTSIDMWSAGCIFAEL 193

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 48.0 bits (114), Expect = 8e-06
 Identities = 43/158 (27%), Positives = 71/158 (44%), Gaps = 12/158 (7%)

Query: 385 EIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQI 444
           E  +L ++N   ++ L     +    YLV  +   G L       + EG++   + R   
Sbjct: 43  ERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL---FHHLQREGRFDLSRARFYT 99

Query: 445 ALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRH 504
           A ++   L  LH F     +++D+   N+LLD      + +F + +     + +   T  
Sbjct: 100 A-ELLCALENLHKFNV---IYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDK---TNT 152

Query: 505 IVGTKGYMAPEYLENGLVSTK-LDVYAFGVLILEMLTG 541
             GT  Y+APE L  G   TK +D +  GVL+ EMLTG
Sbjct: 153 FCGTPEYLAPELL-LGHGYTKAVDWWTLGVLLYEMLTG 189

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 47.9 bits (114), Expect = 9e-06
 Identities = 45/196 (22%), Positives = 87/196 (44%), Gaps = 38/196 (19%)

Query: 436 LDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQ 495
           LD    ++ +  VA G+++L S      +H+D+ + NVLL     AKI +F +AR     
Sbjct: 209 LDLDDLLRFSSQVAQGMDFLASKNC---IHRDVAARNVLLTDGRVAKICDFGLARDIMND 265

Query: 496 EGEFALTRHIVGTKG-------YMAPEYLENGLVSTKLDVYAFGVLILEMLT-GKEAAAL 547
                 + ++V  KG       +MAPE + + + + + DV+++G+L+ E+ + GK     
Sbjct: 266 ------SNYVV--KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGK----- 312

Query: 548 HAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTD 607
                + +   ++N+   K          +    Q + P      +  ++  C   +PT+
Sbjct: 313 -----SPYPGILVNSKFYK---------MVKRGYQMSRPDFAPPEIYSIMKMCWNLEPTE 358

Query: 608 RPTMYEIEHSLSNILN 623
           RPT  +I   +   L 
Sbjct: 359 RPTFSQISQLIQRQLG 374

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 47.9 bits (114), Expect = 9e-06
 Identities = 38/135 (28%), Positives = 66/135 (48%), Gaps = 12/135 (8%)

Query: 408 GNCYLVYEYAVNGTLSDWVFSN-KNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHK 466
           G  YL+ EY   G L    F + + EG +++      ++ +++  L +LH       +++
Sbjct: 73  GKLYLILEYLSGGEL----FMHLEREGIFMEDTACFYLS-EISLALEHLHQQGI---IYR 124

Query: 467 DINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKL 526
           D+   N+LLD+    K+ +F + +     EG   +T    GT  YMAPE L        +
Sbjct: 125 DLKPENILLDAQGHVKLTDFGLCK-ESIHEGT--VTHTFCGTIEYMAPEILMRSGHGKAV 181

Query: 527 DVYAFGVLILEMLTG 541
           D ++ G L+ +MLTG
Sbjct: 182 DWWSLGALMYDMLTG 196

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 47.7 bits (113), Expect = 1e-05
 Identities = 45/142 (31%), Positives = 68/142 (47%), Gaps = 13/142 (9%)

Query: 406 NEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVH 465
           +E   YLV +Y V G L      +K E +  +   R  IA  V      +HS     +VH
Sbjct: 72  DENYLYLVMDYYVGGDL--LTLLSKFEDRLPEDMARFYIAEMVLA----IHSIHQLHYVH 125

Query: 466 KDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYL---ENGL- 521
           +DI   NVLLD +   ++A+F        Q+G    +   VGT  Y++PE L   E+G+ 
Sbjct: 126 RDIKPDNVLLDMNGHIRLADFGSCLKMN-QDGTVQ-SSVAVGTPDYISPEILQAMEDGMG 183

Query: 522 -VSTKLDVYAFGVLILEMLTGK 542
               + D ++ GV + EML G+
Sbjct: 184 KYGPECDWWSLGVCMYEMLYGE 205

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 46.5 bits (110), Expect = 2e-05
 Identities = 70/279 (25%), Positives = 121/279 (43%), Gaps = 39/279 (13%)

Query: 361 GSVYRGKINGGFAAIK------KVNGDVSKEIALLNK------INHSNLIILSGVCFNEG 408
           G V  G++N G+   +      +V+  V +++  L +      + HSNL+   G C    
Sbjct: 9   GKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVT 68

Query: 409 NCYLVYEYAVNGTLSDWVFS-NKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKD 467
              LV E+   G L  ++ S  K E    D     ++A ++A GL +LH       +H D
Sbjct: 69  PYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSD 125

Query: 468 INSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLE----NGLV- 522
           +   N LL +DL  KI ++ ++   + +E  +     +     ++APE ++    N LV 
Sbjct: 126 LALRNCLLTADLTVKIGDYGLSH-NKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVV 184

Query: 523 --STKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPT 580
             + + +V++ GV I E+            +   HLSD    VLT    E+ L+    P 
Sbjct: 185 DQTKESNVWSLGVTIWELFE-------LGSQPYRHLSD--EQVLTYTVREQQLK-LPKPR 234

Query: 581 LQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLS 619
           L+    L L+     ++  C  + P  RP+  E+   LS
Sbjct: 235 LK----LPLSDRWYEVMQFCWLQ-PEQRPSAEEVHLLLS 268

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 46.8 bits (111), Expect = 2e-05
 Identities = 60/240 (25%), Positives = 101/240 (42%), Gaps = 40/240 (16%)

Query: 387 ALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIAL 446
           +L+++++H +L  + GVC       +V E+  +G L   +   K     + WK  I +A 
Sbjct: 68  SLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVP-VAWK--ITVAQ 124

Query: 447 DVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIAN-----FAMARPAEGQEGEFAL 501
            +A+ L+YL    +   VH ++ + N+LL    R  +A        ++ P        AL
Sbjct: 125 QLASALSYLE---DKNLVHGNVCAKNILL---ARLGLAEGTSPFIKLSDPGVSFT---AL 175

Query: 502 TR-HIVGTKGYMAPEYLENGL-VSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDV 559
           +R   V    ++APE +  G  +ST  D ++FG  +LE+    E        +       
Sbjct: 176 SREERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE------ 229

Query: 560 LNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLS 619
                 KE   E      +P+ +     ELA     LI  CL  +PT RP+   I   L+
Sbjct: 230 ------KERFYEKKHRLPEPSCK-----ELA----TLISQCLTYEPTQRPSFRTILRDLT 274

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 46.9 bits (111), Expect = 2e-05
 Identities = 40/137 (29%), Positives = 62/137 (45%), Gaps = 18/137 (13%)

Query: 411 YLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINS 470
           Y+V EY   G L + + +     K+     R   A +V   L+ +HS      +H+D+  
Sbjct: 119 YMVMEYMPGGDLVNLMSNYDVPEKW----ARFYTA-EVVLALDAIHSMG---FIHRDVKP 170

Query: 471 SNVLLDSDLRAKIANFA--MARPAEGQEGEFALTRHIVGTKGYMAPEYLE----NGLVST 524
            N+LLD     K+A+F   M    EG           VGT  Y++PE L+    +G    
Sbjct: 171 DNMLLDKSGHLKLADFGTCMKMNKEG----MVRCDTAVGTPDYISPEVLKSQGGDGYYGR 226

Query: 525 KLDVYAFGVLILEMLTG 541
           + D ++ GV + EML G
Sbjct: 227 ECDWWSVGVFLYEMLVG 243

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 46.6 bits (110), Expect = 2e-05
 Identities = 39/142 (27%), Positives = 68/142 (47%), Gaps = 13/142 (9%)

Query: 406 NEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVH 465
           +E N YLV +Y V G L      +K E +  +   R  +A ++   ++ +H      +VH
Sbjct: 72  DENNLYLVMDYYVGGDL--LTLLSKFEDRLPEDMARFYLA-EMVIAIDSVHQLH---YVH 125

Query: 466 KDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLE-----NG 520
           +DI   N+L+D +   ++A+F      +  E     +   VGT  Y++PE L+      G
Sbjct: 126 RDIKPDNILMDMNGHIRLADFGSC--LKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKG 183

Query: 521 LVSTKLDVYAFGVLILEMLTGK 542
               + D ++ GV + EML G+
Sbjct: 184 KYGPECDWWSLGVCMYEMLYGE 205

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 46.2 bits (110), Expect = 2e-05
 Identities = 51/203 (25%), Positives = 85/203 (41%), Gaps = 45/203 (22%)

Query: 362 SVYRG--KINGGFAAIKKVNGDVS--------KEIALLNKINHSNLIILSGVCFNEGNCY 411
           +VY+G  K+ G   A+K++  +          +E +LL  + H+N++ L  +   +    
Sbjct: 20  TVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLT 79

Query: 412 LVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVAT-------GLNYLHSFTNPPHV 464
           LV+EY ++  L           +Y+D         +V         GL Y H       V
Sbjct: 80  LVFEY-LDTDLK----------QYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQ----RRV 124

Query: 465 -HKDINSSNVLLDSDLRAKIANFAMAR----PAEGQEGEFALTRHIVGTKGYMAPEYLEN 519
            H+D+   N+L+      K+A+F +AR    P++    E       V T  Y  P+ L  
Sbjct: 125 LHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNE-------VVTLWYRPPDVLLG 177

Query: 520 GL-VSTKLDVYAFGVLILEMLTG 541
               ST LD++  G +  EM TG
Sbjct: 178 STEYSTSLDMWGVGCIFYEMATG 200

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 46.2 bits (110), Expect = 2e-05
 Identities = 21/79 (26%), Positives = 39/79 (49%), Gaps = 6/79 (7%)

Query: 463 HVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLV 522
           ++H+D+   N L+D+    K+ +F +++      G       +VG+  YMAPE L     
Sbjct: 122 YIHRDLKPENFLIDASGHIKLTDFGLSK------GIVTYANSVVGSPDYMAPEVLRGKGY 175

Query: 523 STKLDVYAFGVLILEMLTG 541
              +D ++ G ++ E L G
Sbjct: 176 DFTVDYWSLGCMLYEFLCG 194

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 46.2 bits (109), Expect = 3e-05
 Identities = 36/140 (25%), Positives = 62/140 (44%), Gaps = 14/140 (10%)

Query: 406 NEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVH 465
           ++   Y+V EY   G L + + +     K+  +        +V   L+ +HS      +H
Sbjct: 114 DDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKF-----YTAEVVLALDAIHSMG---LIH 165

Query: 466 KDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLE----NGL 521
           +D+   N+LLD     K+A+F      +  E         VGT  Y++PE L+    +G 
Sbjct: 166 RDVKPDNMLLDKHGHLKLADFGTCMKMD--ETGMVRCDTAVGTPDYISPEVLKSQGGDGY 223

Query: 522 VSTKLDVYAFGVLILEMLTG 541
              + D ++ GV + EML G
Sbjct: 224 YGRECDWWSVGVFLFEMLVG 243

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|182727 PRK10783, mltD, membrane-bound lytic murein transglycosylase D; Provisional

 Score = 45.9 bits (109), Expect = 5e-05
 Identities = 21/43 (48%), Positives = 27/43 (62%)

Query: 186 SYLVAEGDTVSGISSRFGVDTGEILQANSLSGSNIFPFTTLLI 228
           SY V  GDT+SGI+SR  V T ++ Q N+L GS +    TL I
Sbjct: 345 SYKVRSGDTLSGIASRLNVSTKDLQQWNNLRGSKLKVGQTLTI 387

Length = 456

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 44.5 bits (105), Expect = 8e-05
 Identities = 45/186 (24%), Positives = 80/186 (43%), Gaps = 20/186 (10%)

Query: 392 INHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATG 451
           + H N++   G C       LV+EY   G L  ++   +   +        ++A ++A G
Sbjct: 52  LQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAG 111

Query: 452 LNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGY 511
           + ++H       +H D+   N  L SDL  K+ ++ +  P+  +E              +
Sbjct: 112 VTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIG-PSRYKEDYIETEDDKCVPLRW 167

Query: 512 MAPEY---LENGLVS---TKL-DVYAFGVLILEMLTGKEAAALHAEENNMHLSD--VLNA 562
           +APE       GL++   TK  +V+A GV + E+         +A +   HLSD  VLN 
Sbjct: 168 LAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFE-------NAAQPYSHLSDREVLNH 220

Query: 563 VLTKED 568
           V+  + 
Sbjct: 221 VIKDQQ 226

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 44.6 bits (105), Expect = 1e-04
 Identities = 29/93 (31%), Positives = 49/93 (52%), Gaps = 4/93 (4%)

Query: 448 VATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVG 507
           VA G+ +L S      VH+D+ + NVLL      KI +F +AR         +     + 
Sbjct: 246 VARGMEFLASKNC---VHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLP 302

Query: 508 TKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT 540
            K +MAPE + + L +T  DV+++G+L+ E+ +
Sbjct: 303 VK-WMAPESIFDNLYTTLSDVWSYGILLWEIFS 334

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 43.6 bits (103), Expect = 2e-04
 Identities = 48/185 (25%), Positives = 80/185 (43%), Gaps = 25/185 (13%)

Query: 406 NEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVH 465
           +E N YLV +Y V G L      +K E +  +   R  +A ++   ++ +H      +VH
Sbjct: 72  DENNLYLVMDYYVGGDL--LTLLSKFEDRLPEDMARFYLA-EMVLAIDSVHQLG---YVH 125

Query: 466 KDINSSNVLLDSDLRAKIANFA--MARPAEGQEGEFALTRHIVGTKGYMAPEYLE----- 518
           +DI   NVLLD +   ++A+F   +   A+G       +   VGT  Y++PE L+     
Sbjct: 126 RDIKPDNVLLDKNGHIRLADFGSCLRLLADGT----VQSNVAVGTPDYISPEILQAMEDG 181

Query: 519 NGLVSTKLDVYAFGVLILEMLTGKEAAALHAEE------NNMHLSDVLNAVLTKEDGEES 572
            G    + D ++ GV + EML G+     +AE         M+  +         D  E 
Sbjct: 182 KGRYGPECDWWSLGVCMYEMLYGE--TPFYAESLVETYGKIMNHKEHFQFPPDVTDVSEE 239

Query: 573 LRHFI 577
            +  I
Sbjct: 240 AKDLI 244

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 43.4 bits (103), Expect = 2e-04
 Identities = 46/190 (24%), Positives = 69/190 (36%), Gaps = 39/190 (20%)

Query: 382 VSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQR 441
           V  E  +L  ++H  L  L      E    LV +Y   G L  +    +  GK L     
Sbjct: 48  VLTEQEILATLDHPFLPTLYASFQTETYLCLVMDYCPGGEL--FRLLQRQPGKCL----S 101

Query: 442 IQI----ALDVATGLNYLHSFTNPPHVHKDINSSNVLL---------DSDL--------- 479
            ++    A +V   L YLH       V++D+   N+LL         D DL         
Sbjct: 102 EEVARFYAAEVLLALEYLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPP 158

Query: 480 -RAKIANFAMARP-AEGQEGEFAL------TRHIVGTKGYMAPEYLENGLVSTKLDVYAF 531
             +K       R        E         +   VGT+ Y+APE +      + +D +  
Sbjct: 159 PVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTL 218

Query: 532 GVLILEMLTG 541
           G+L+ EML G
Sbjct: 219 GILLYEMLYG 228

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 43.2 bits (102), Expect = 2e-04
 Identities = 65/277 (23%), Positives = 108/277 (38%), Gaps = 63/277 (22%)

Query: 369 NGGFAAIKKVNGDVSKEIALLNKINHSNLI----------------------ILSGVCFN 406
           NG + A+  V    +++   + KIN  NLI                      ++S  C  
Sbjct: 11  NGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSF 70

Query: 407 EGNCYL--VYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHV 464
           E   +L  V EY   G  +  +   KN G       R+  A  V   L YLH++     V
Sbjct: 71  ETKRHLCMVMEYVEGGDCATLL---KNIGALPVDMARMYFAETV-LALEYLHNYGI---V 123

Query: 465 HKDINSSNVLLDSDLRAKIANFA------MARPAEGQEG-------EFALTRHIVGTKGY 511
           H+D+   N+L+ S    K+ +F       M+      EG       EF L + + GT  Y
Sbjct: 124 HRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREF-LDKQVCGTPEY 182

Query: 512 MAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEE 571
           +APE +        +D +A G+++ E L G        +        V++  +   +G+E
Sbjct: 183 IAPEVILRQGYGKPVDWWAMGIILYEFLVG--CVPFFGDTPEELFGQVISDDIEWPEGDE 240

Query: 572 SLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDR 608
           +L            P +   L+ RL    L+++P +R
Sbjct: 241 AL------------PADAQDLISRL----LRQNPLER 261

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 42.9 bits (101), Expect = 2e-04
 Identities = 48/195 (24%), Positives = 78/195 (40%), Gaps = 23/195 (11%)

Query: 396 NLIILSGVCFNEGNCYLVYEYAVNGTLSDWV--FSNKNEGKYLDWKQRIQIALDVATGLN 453
           N++ L     +E + +LV ++A  G L   +  F N  E     W   + +ALD      
Sbjct: 46  NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDA----- 100

Query: 454 YLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMA 513
            LH       V +D+N +N+LLD     ++  F+     E      A+         Y A
Sbjct: 101 -LH---REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM------YCA 150

Query: 514 PEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESL 573
           PE       +   D ++ G ++ E+LTGK     H    N H +  +   +++E      
Sbjct: 151 PEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGINTHTTLNIPEWVSEE-----A 205

Query: 574 RHFIDPTLQGNYPLE 588
           R  +   LQ N P E
Sbjct: 206 RSLLQQLLQFN-PTE 219

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 43.0 bits (102), Expect = 3e-04
 Identities = 48/187 (25%), Positives = 84/187 (44%), Gaps = 30/187 (16%)

Query: 369 NGGFAAIKKVNGDVS--------KEIALLNKIN-HSNLIILSGVCFNE--GNCYLVYEYA 417
            G + AIK +             +EI  L +++ H N++ L  V F+   G   LV+E  
Sbjct: 23  TGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFEL- 81

Query: 418 VNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHS---FTNPPHVHKDINSSNVL 474
           ++  L + +   K   + L  K+       +   L+++H    F      H+DI   N+L
Sbjct: 82  MDMNLYELI---KGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIF------HRDIKPENIL 132

Query: 475 LDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPE-YLENGLVSTKLDVYAFGV 533
           +  D+  K+A+F   R    +      T +I  T+ Y APE  L +G    K+D++A G 
Sbjct: 133 IKDDI-LKLADFGSCRGIYSKP---PYTEYI-STRWYRAPECLLTDGYYGPKMDIWAVGC 187

Query: 534 LILEMLT 540
           +  E+L+
Sbjct: 188 VFFEILS 194

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 42.6 bits (100), Expect = 5e-04
 Identities = 30/112 (26%), Positives = 58/112 (51%), Gaps = 18/112 (16%)

Query: 436 LDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQ 495
           LD +  +  +  VA G+++L S      +H+D+ + N+LL      KI +F +AR     
Sbjct: 211 LDTEDLLSFSYQVAKGMSFLASKNC---IHRDLAARNILLTHGRITKICDFGLARDIRND 267

Query: 496 EGEFALTRHIVGTKG-------YMAPEYLENGLVSTKLDVYAFGVLILEMLT 540
                 + ++V  KG       +MAPE + N + + + DV+++G+L+ E+ +
Sbjct: 268 ------SNYVV--KGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 311

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|224306 COG1388, LytE, FOG: LysM repeat [Cell envelope biogenesis, outer membrane]

 Score = 39.1 bits (91), Expect = 0.001
 Identities = 19/53 (35%), Positives = 31/53 (58%)

Query: 187 YLVAEGDTVSGISSRFGVDTGEILQANSLSGSNIFPFTTLLIPLENPPTSSQT 239
           Y V +GDT+S I+ ++GV   E+ Q N+LS   I     L +P+ +  T+ +T
Sbjct: 69  YTVKKGDTLSKIARKYGVTVAELKQLNNLSSDKIKVGQKLKLPVSSSATNVKT 121

Length = 124

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	628
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	99.98
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	99.98
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	99.98
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	99.98
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	99.98
KOG0610	459	consensus Putative serine/threonine protein kinase	99.98
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	99.98
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	99.98
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	99.98
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	99.98
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	99.98
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	99.98
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	99.98
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	99.98
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	99.98
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	99.98
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	99.98
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	99.98
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	99.98
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	99.98
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	99.98
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	99.98
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	99.98
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.98
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	99.98
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	99.98
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	99.98
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	99.98
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	99.97
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	99.97
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	99.97
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	99.97
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	99.97
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	99.97
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	99.97
KOG0596	677	consensus Dual specificity; serine/threonine and t	99.97
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	99.97
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	99.97
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	99.97
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	99.97
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	99.97
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	99.97
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	99.97
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	99.97
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	99.97
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	99.97
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	99.97
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	99.97
PLN00009	294	cyclin-dependent kinase A; Provisional	99.97
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	99.97
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	99.97
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	99.97
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	99.97
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	99.97
KOG4717	864	consensus Serine/threonine protein kinase [Signal	99.97
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	99.97
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	99.97
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	99.97
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	99.97
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	99.97
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	99.97
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	99.97
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	99.97
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.97
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	99.97
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	99.97
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	99.97
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	99.97
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	99.97
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	99.97
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	99.97
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	99.97
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	99.97
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	99.97
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	99.97
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	99.97
PHA03210	501	serine/threonine kinase US3; Provisional	99.97
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	99.97
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	99.97
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	99.97
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	99.97
KOG0586	596	consensus Serine/threonine protein kinase [General	99.97
PTZ00024	335	cyclin-dependent protein kinase; Provisional	99.97
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	99.97
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	99.97
PHA02882	294	putative serine/threonine kinase; Provisional	99.97
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	99.97
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	99.97
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.96
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	99.96
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	99.96
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	99.96
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	99.96
KOG0690	516	consensus Serine/threonine protein kinase [Signal	99.96
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.96
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.96
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	99.96
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.96
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.96
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.95
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	99.95
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	99.95
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.95
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	99.95
KOG0607	463	consensus MAP kinase-interacting kinase and relate	99.95
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.95
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.95
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.95
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.94
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.94
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	99.94
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.94
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.93
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.93
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.93
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.93
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.93
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.92
PLN00181	793	protein SPA1-RELATED; Provisional	99.92
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.92
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.91
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.91
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.9
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.9
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.89
KOG1152	772	consensus Signal transduction serine/threonine kin	99.89
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.88
PRK06347	592	autolysin; Reviewed	99.88
PRK06347	592	autolysin; Reviewed	99.87
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.86
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.84
PRK09188	365	serine/threonine protein kinase; Provisional	99.81
PRK10783	456	mltD membrane-bound lytic murein transglycosylase	99.8
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.79
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.79
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.79
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.76
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.74
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.73
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.68
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.67
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.66
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.66
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.66
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.66
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.65
PRK12274	218	serine/threonine protein kinase; Provisional	99.63
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.58
PRK14879	211	serine/threonine protein kinase; Provisional	99.58
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.55
PRK10345	210	hypothetical protein; Provisional	99.54
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.54
smart00090	237	RIO RIO-like kinase.	99.51
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.5
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.46
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.45
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.43
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.43
PRK10783	456	mltD membrane-bound lytic murein transglycosylase	99.39
PRK13914	481	invasion associated secreted endopeptidase; Provis	99.38
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.31
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.26
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.25
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.14
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.07
PF01476	44	LysM: LysM domain; InterPro: IPR018392 This domain	99.02
PRK13914	481	invasion associated secreted endopeptidase; Provis	98.98
KOG1243	690	consensus Protein kinase [General function predict	98.96
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	98.94
COG1388	124	LytE FOG: LysM repeat [Cell envelope biogenesis, o	98.91
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	98.86
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	98.8
KOG3087	229	consensus Serine/threonine protein kinase [General	98.8
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	98.78
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	98.78
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.77
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.76
PF01476	44	LysM: LysM domain; InterPro: IPR018392 This domain	98.75
KOG0606	1205	consensus Microtubule-associated serine/threonine	98.69
PRK14125	103	cell division suppressor protein YneA; Provisional	98.69
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.63
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.61
TIGR02899	44	spore_safA spore coat assembly protein SafA. in wh	98.55
COG4248	637	Uncharacterized protein with protein kinase and he	98.48
cd00118	46	LysM Lysin domain, found in a variety of enzymes i	98.42
PRK14125	103	cell division suppressor protein YneA; Provisional	98.4
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.38
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.33
TIGR02907	338	spore_VI_D stage VI sporulation protein D. SpoVID,	98.32
PRK10871	319	nlpD lipoprotein NlpD; Provisional	98.26
COG3858	423	Predicted glycosyl hydrolase [General function pre	98.2
PRK09902	216	hypothetical protein; Provisional	98.14
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.08
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.05
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.03
smart00257	44	LysM Lysin motif.	98.03
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	97.94
cd00118	46	LysM Lysin domain, found in a variety of enzymes i	97.93
TIGR02899	44	spore_safA spore coat assembly protein SafA. in wh	97.93
PRK11198	147	LysM domain/BON superfamily protein; Provisional	97.86
PRK10871	319	nlpD lipoprotein NlpD; Provisional	97.84
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	97.78
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	97.78
COG3858	423	Predicted glycosyl hydrolase [General function pre	97.77
PRK11198	147	LysM domain/BON superfamily protein; Provisional	97.74
TIGR02907	338	spore_VI_D stage VI sporulation protein D. SpoVID,	97.74
KOG0576	829	consensus Mitogen-activated protein kinase kinase	97.46
PF01636	239	APH: Phosphotransferase enzyme family This family	97.42
smart00257	44	LysM Lysin motif.	97.41
COG1388	124	LytE FOG: LysM repeat [Cell envelope biogenesis, o	97.33
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	97.21
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.18
PRK10593	297	hypothetical protein; Provisional	97.14
PLN02876	822	acyl-CoA dehydrogenase	97.12
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	97.1
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	96.99
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	96.99
PF04225	85	OapA: Opacity-associated protein A LysM-like domai	96.94
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	96.8
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	96.65
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	96.58
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	96.41

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.9e-55  Score=457.46  Aligned_cols=278  Identities=39%  Similarity=0.718  Sum_probs=241.5

Q ss_pred             cceeecHHHHHHHhcCCCcCCccc----eEEEEEEECC-ceEEEEEecc-------chHHHHHHHhhcCCCceeeeeeee
Q 039626          337 SLKVYSFKELQSATDNFSFTCRIQ----GSVYRGKING-GFAAIKKVNG-------DVSKEIALLNKINHSNLIILSGVC  404 (628)
Q Consensus       337 ~~~~~~~~el~~at~~f~~~~~i~----G~Vy~g~~~g-~~vavK~~~~-------~~~~E~~~l~~l~H~nIv~l~g~~  404 (628)
                      ..+.|+++||..||++|+..+.+|    |.||+|.+.+ ..||||++..       +|.+|+.+|.+++|+|+|+|+|||
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC  140 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC  140 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence            578999999999999999988886    8999999955 8999998743       588999999999999999999999


Q ss_pred             ecCC-eEEEEEEecCCCChHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEE
Q 039626          405 FNEG-NCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKI  483 (628)
Q Consensus       405 ~~~~-~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl  483 (628)
                      .+++ +.+||||||++|+|.++|+.....  .|+|.+|++||.++|+||+|||+...++||||||||+|||||+++++||
T Consensus       141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKl  218 (361)
T KOG1187|consen  141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKL  218 (361)
T ss_pred             ecCCceEEEEEEccCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEc
Confidence            9998 599999999999999999874433  7999999999999999999999998889999999999999999999999


Q ss_pred             ccccccccCCCCCCcceeeecc-cCCccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHH
Q 039626          484 ANFAMARPAEGQEGEFALTRHI-VGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNA  562 (628)
Q Consensus       484 ~Dfgla~~~~~~~~~~~~~~~~-~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~  562 (628)
                      +|||+|+..... ...  .... .||.+|+||||...+..++|+|||||||||+||++|+++.+.........+.+|...
T Consensus       219 sDFGLa~~~~~~-~~~--~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~  295 (361)
T KOG1187|consen  219 SDFGLAKLGPEG-DTS--VSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKP  295 (361)
T ss_pred             cCccCcccCCcc-ccc--eeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHH
Confidence            999999765431 111  1112 899999999999999999999999999999999999998876543444457777766


Q ss_pred             HhccccchhhhccccCCcCC-CCCCH-HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHh
Q 039626          563 VLTKEDGEESLRHFIDPTLQ-GNYPL-ELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILN  623 (628)
Q Consensus       563 ~~~~~~~~~~l~~~~d~~l~-~~~~~-~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~~  623 (628)
                      .+...    .+.+++|+.+. +.++. +....+..++.+|++.+|.+||+|.||++.|+.+..
T Consensus       296 ~~~~~----~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~  354 (361)
T KOG1187|consen  296 LLEEG----KLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILS  354 (361)
T ss_pred             HHHCc----chhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhcc
Confidence            55533    78899999987 77775 678889999999999999999999999999977653

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-45  Score=382.66  Aligned_cols=239  Identities=33%  Similarity=0.547  Sum_probs=201.0

Q ss_pred             ceEEEEEEECCce-EEEEEecc---------chHHHHHHHhhcCCCceeeeeeeeecCC-eEEEEEEecCCCChHHHhhh
Q 039626          360 QGSVYRGKINGGF-AAIKKVNG---------DVSKEIALLNKINHSNLIILSGVCFNEG-NCYLVYEYAVNGTLSDWVFS  428 (628)
Q Consensus       360 ~G~Vy~g~~~g~~-vavK~~~~---------~~~~E~~~l~~l~H~nIv~l~g~~~~~~-~~~lV~E~~~~gsL~~~l~~  428 (628)
                      .|+||+|.|.|.. ||||++..         +|.+|+.+|.+++|||||+++|+|.+.. .+++|||||++|+|.++|+.
T Consensus        54 ~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~GsL~~~l~~  133 (362)
T KOG0192|consen   54 FGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGGSLSVLLHK  133 (362)
T ss_pred             ceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCCcHHHHHhh
Confidence            3999999999998 99999975         6889999999999999999999999887 79999999999999999976


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCC-cEEEccccccccCCCCCCcceeeecccC
Q 039626          429 NKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDL-RAKIANFAMARPAEGQEGEFALTRHIVG  507 (628)
Q Consensus       429 ~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~-~~kl~Dfgla~~~~~~~~~~~~~~~~~g  507 (628)
                      .  ....++|..+++|+.|||+||+|||+.. + ||||||||+|||++.++ ++||+|||+++......   .......|
T Consensus       134 ~--~~~~l~~~~~l~~aldiArGm~YLH~~~-~-iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~---~~~~~~~G  206 (362)
T KOG0192|consen  134 K--RKRKLPLKVRLRIALDIARGMEYLHSEG-P-IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK---TSMTSVAG  206 (362)
T ss_pred             c--ccCCCCHHHHHHHHHHHHHHHHHHhcCC-C-eeecccChhhEEEcCCCCEEEECCCccceeecccc---ccccCCCC
Confidence            4  4567999999999999999999999954 3 99999999999999998 99999999998765321   12233689


Q ss_pred             CccccCccccc--cCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCC
Q 039626          508 TKGYMAPEYLE--NGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNY  585 (628)
Q Consensus       508 t~~Y~APE~l~--~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~  585 (628)
                      |+.|||||.+.  ...++.|+||||||++||||+||+.||.....      ......+..             ...+...
T Consensus       207 T~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~------~~~~~~v~~-------------~~~Rp~~  267 (362)
T KOG0192|consen  207 TYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP------VQVASAVVV-------------GGLRPPI  267 (362)
T ss_pred             CccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH------HHHHHHHHh-------------cCCCCCC
Confidence            99999999999  56999999999999999999999999874322      122222211             1122233


Q ss_pred             CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhh
Q 039626          586 PLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNA  624 (628)
Q Consensus       586 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~~~  624 (628)
                      |..+...+..++.+||+.||.+||++.|++..|+.+...
T Consensus       268 p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~  306 (362)
T KOG0192|consen  268 PKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSH  306 (362)
T ss_pred             CccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHh
Confidence            444667788999999999999999999999999988763

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=9.4e-44  Score=353.90  Aligned_cols=248  Identities=25%  Similarity=0.420  Sum_probs=201.7

Q ss_pred             ecHHHHHHHhcCCCcCCccceEEEEEEE--CCceEEEEEecc--------chHHHHHHHhhcCCCceeeeeeeeecCC-e
Q 039626          341 YSFKELQSATDNFSFTCRIQGSVYRGKI--NGGFAAIKKVNG--------DVSKEIALLNKINHSNLIILSGVCFNEG-N  409 (628)
Q Consensus       341 ~~~~el~~at~~f~~~~~i~G~Vy~g~~--~g~~vavK~~~~--------~~~~E~~~l~~l~H~nIv~l~g~~~~~~-~  409 (628)
                      .+..||+...   ..+.+-+|.|||+..  .+..+|+|.+..        ++.+|++++++.+||+||.++|.|++++ .
T Consensus        76 i~~~dle~~~---~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~  152 (364)
T KOG0581|consen   76 ISLSDLERLG---VLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEE  152 (364)
T ss_pred             cCHHHhhhhh---hcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCce
Confidence            4455555432   123444699999998  588999999832        4678999999999999999999999998 5


Q ss_pred             EEEEEEecCCCChHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEcccccc
Q 039626          410 CYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMA  489 (628)
Q Consensus       410 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla  489 (628)
                      ..++||||.+|||++++..    .+.+++...-+|+.+|++||.|||+.  .+||||||||+|||++..|++||+|||.+
T Consensus       153 isI~mEYMDgGSLd~~~k~----~g~i~E~~L~~ia~~VL~GL~YLh~~--~~IIHRDIKPsNlLvNskGeVKicDFGVS  226 (364)
T KOG0581|consen  153 ISICMEYMDGGSLDDILKR----VGRIPEPVLGKIARAVLRGLSYLHEE--RKIIHRDIKPSNLLVNSKGEVKICDFGVS  226 (364)
T ss_pred             EEeehhhcCCCCHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhhc--cCeeeccCCHHHeeeccCCCEEecccccc
Confidence            9999999999999999843    25599999999999999999999962  56999999999999999999999999999


Q ss_pred             ccCCCCCCcceeeecccCCccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccc
Q 039626          490 RPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDG  569 (628)
Q Consensus       490 ~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~  569 (628)
                      +...+.     .....+||..|||||.+.+..|+.++||||||++++|+..|+.|+.... .......+.+..+...+  
T Consensus       227 ~~lvnS-----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~-~~~~~~~~Ll~~Iv~~p--  298 (364)
T KOG0581|consen  227 GILVNS-----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPN-PPYLDIFELLCAIVDEP--  298 (364)
T ss_pred             HHhhhh-----hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcC-CCCCCHHHHHHHHhcCC--
Confidence            877543     3456789999999999999999999999999999999999999987552 12233344444433321  


Q ss_pred             hhhhccccCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          570 EESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       570 ~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                              .|.++..   ..+.++.+|+..||++||.+||+++|+++
T Consensus       299 --------pP~lP~~---~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~  334 (364)
T KOG0581|consen  299 --------PPRLPEG---EFSPEFRSFVSCCLRKDPSERPSAKQLLQ  334 (364)
T ss_pred             --------CCCCCcc---cCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence                    1223222   36677899999999999999999999875

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-43  Score=369.17  Aligned_cols=238  Identities=32%  Similarity=0.549  Sum_probs=203.0

Q ss_pred             eEEEEEEECCc-eEEEEEecc------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhcCCCC
Q 039626          361 GSVYRGKINGG-FAAIKKVNG------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEG  433 (628)
Q Consensus       361 G~Vy~g~~~g~-~vavK~~~~------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~  433 (628)
                      |.||.|.|++. .||+|.++.      +|.+|+++|++|+|+|||+++|+|..++.++||||||++|+|.+||..  ..+
T Consensus       220 G~V~~g~~~~~~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsLl~yLr~--~~~  297 (468)
T KOG0197|consen  220 GEVWLGKWNGSTKVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSLLDYLRT--REG  297 (468)
T ss_pred             ceEEEEEEcCCCcccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCcHHHHhhh--cCC
Confidence            99999999887 899998864      588999999999999999999999998899999999999999999965  356


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCCccccC
Q 039626          434 KYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMA  513 (628)
Q Consensus       434 ~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~Y~A  513 (628)
                      ..+...+.+.++.|||+||+||++.   ++|||||.++|||++++..+||+||||||...+..  +.......-...|.|
T Consensus       298 ~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~--Y~~~~~~kfPIkWtA  372 (468)
T KOG0197|consen  298 GLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLIGDDE--YTASEGGKFPIKWTA  372 (468)
T ss_pred             CccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccccccCCCc--eeecCCCCCCceecC
Confidence            6799999999999999999999994   59999999999999999999999999999554432  223333455678999


Q ss_pred             ccccccCCCCcccccHHHHHHHHHHHh-CCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCHHHHHH
Q 039626          514 PEYLENGLVSTKLDVYAFGVLILEMLT-GKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALL  592 (628)
Q Consensus       514 PE~l~~~~~s~k~DV~SfGvvl~ELlt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~  592 (628)
                      ||.+..+.++.|+|||||||+||||+| |+.|+.      .+...+.+..+              +...+-..|..++..
T Consensus       373 PEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~------~msn~ev~~~l--------------e~GyRlp~P~~CP~~  432 (468)
T KOG0197|consen  373 PEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYP------GMSNEEVLELL--------------ERGYRLPRPEGCPDE  432 (468)
T ss_pred             HHHHhhCCcccccceeehhhhHHHHhccCCCCCC------CCCHHHHHHHH--------------hccCcCCCCCCCCHH
Confidence            999999999999999999999999999 666654      23344444433              223344567778888


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhc
Q 039626          593 VIRLIDACLKKDPTDRPTMYEIEHSLSNILNAS  625 (628)
Q Consensus       593 l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~~~~  625 (628)
                      +.++|..||+.+|++|||++.+...|+.+...+
T Consensus       433 vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~~  465 (468)
T KOG0197|consen  433 VYELMKSCWHEDPEDRPTFETLREVLEDFFTST  465 (468)
T ss_pred             HHHHHHHHhhCCcccCCCHHHHHHHHHHhhhcc
Confidence            999999999999999999999999999988755

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=2.5e-42  Score=375.35  Aligned_cols=241  Identities=28%  Similarity=0.488  Sum_probs=200.7

Q ss_pred             eEEEEEEECC-------ceEEEEEecc--------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHH
Q 039626          361 GSVYRGKING-------GFAAIKKVNG--------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDW  425 (628)
Q Consensus       361 G~Vy~g~~~g-------~~vavK~~~~--------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~  425 (628)
                      |+||+|...|       ..||||.+++        ||++|+++|..++|+|||+|+|+|.+++.+++|+|||..|||.++
T Consensus       500 GkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~MvFEYm~~GDL~eF  579 (774)
T KOG1026|consen  500 GKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCMVFEYMDHGDLHEF  579 (774)
T ss_pred             hhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEEEEEecccccHHHH
Confidence            9999998732       4789999875        699999999999999999999999999999999999999999999


Q ss_pred             hhhcCC------CCC----CCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCC
Q 039626          426 VFSNKN------EGK----YLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQ  495 (628)
Q Consensus       426 l~~~~~------~~~----~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~  495 (628)
                      |.....      .+.    +|+..+.+.||.|||.||+||-++.   +|||||..+|+|+.++..+||+||||+|.+...
T Consensus       580 Lra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l~VKIsDfGLsRdiYss  656 (774)
T KOG1026|consen  580 LRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENLVVKISDFGLSRDIYSS  656 (774)
T ss_pred             HHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccceEEEecccccchhhhhh
Confidence            965432      222    3899999999999999999999854   999999999999999999999999999987654


Q ss_pred             CCcceeeecccCCccccCccccccCCCCcccccHHHHHHHHHHHh-CCCccccccccccccHHHHHHHHhccccchhhhc
Q 039626          496 EGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT-GKEAAALHAEENNMHLSDVLNAVLTKEDGEESLR  574 (628)
Q Consensus       496 ~~~~~~~~~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELlt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  574 (628)
                      +.. ....+-.-..+|||||.+..+++|+++|||||||||||+++ |+-|+.....+      +++.-+           
T Consensus       657 DYY-k~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~------EVIe~i-----------  718 (774)
T KOG1026|consen  657 DYY-KVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQ------EVIECI-----------  718 (774)
T ss_pred             hhh-cccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchH------HHHHHH-----------
Confidence            422 11223455679999999999999999999999999999998 77777643322      222221           


Q ss_pred             cccCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhc
Q 039626          575 HFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNAS  625 (628)
Q Consensus       575 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~~~~  625 (628)
                        -+..+ -..|+.++.++++||..||+.+|++||+++||-..|+...+++
T Consensus       719 --~~g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s  766 (774)
T KOG1026|consen  719 --RAGQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQAS  766 (774)
T ss_pred             --HcCCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcC
Confidence              11222 3567788899999999999999999999999999999887654

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-41  Score=361.74  Aligned_cols=261  Identities=24%  Similarity=0.425  Sum_probs=212.9

Q ss_pred             eeecHHHHHHHhcCCCcC---------Cccc----eEEEEEEE--CC---ceEEEEEecc--------chHHHHHHHhhc
Q 039626          339 KVYSFKELQSATDNFSFT---------CRIQ----GSVYRGKI--NG---GFAAIKKVNG--------DVSKEIALLNKI  392 (628)
Q Consensus       339 ~~~~~~el~~at~~f~~~---------~~i~----G~Vy~g~~--~g---~~vavK~~~~--------~~~~E~~~l~~l  392 (628)
                      ..++||+--.|..+|..+         ..||    |.||+|.+  .|   ..||||.+|.        +|..|..||.++
T Consensus       608 DP~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQF  687 (996)
T KOG0196|consen  608 DPHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQF  687 (996)
T ss_pred             CCccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccC
Confidence            345666666666555422         2222    89999998  33   4899999874        789999999999


Q ss_pred             CCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCC
Q 039626          393 NHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSN  472 (628)
Q Consensus       393 ~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~N  472 (628)
                      .||||++|.|+........+|.|||+||+|+.+|..+.   ..++|.+...+.++||.||.||.+.+   +|||||..+|
T Consensus       688 dHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~D---GqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARN  761 (996)
T KOG0196|consen  688 DHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQND---GQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARN  761 (996)
T ss_pred             CCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcC---CceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhh
Confidence            99999999999999999999999999999999996533   34899999999999999999999865   9999999999


Q ss_pred             EEeCCCCcEEEccccccccCCCCCCcceeeecccCCccccCccccccCCCCcccccHHHHHHHHHHHh-CCCcccccccc
Q 039626          473 VLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT-GKEAAALHAEE  551 (628)
Q Consensus       473 ILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELlt-G~~p~~~~~~~  551 (628)
                      ||++.|..+|++||||+|..+++......+..-.-..+|.|||.+...++|..+||||||+||||.++ |.+|+-     
T Consensus       762 ILVNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYW-----  836 (996)
T KOG0196|consen  762 ILVNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYW-----  836 (996)
T ss_pred             eeeccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCccc-----
Confidence            99999999999999999988665433222222233468999999999999999999999999999987 777764     


Q ss_pred             ccccHHHHHHHHhccccchhhhccccCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhc
Q 039626          552 NNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNAS  625 (628)
Q Consensus       552 ~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~~~~  625 (628)
                       ++...+++..+              +...+..-|.+++..|.+||..||++|-.+||.+.+|+..|.+++..+
T Consensus       837 -dmSNQdVIkaI--------------e~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP  895 (996)
T KOG0196|consen  837 -DMSNQDVIKAI--------------EQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNP  895 (996)
T ss_pred             -ccchHHHHHHH--------------HhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCc
Confidence             23334444333              223344557788999999999999999999999999999999998654

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-40  Score=330.76  Aligned_cols=178  Identities=29%  Similarity=0.476  Sum_probs=160.1

Q ss_pred             eEEEEEEE--CCceEEEEEeccc---------hHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhc
Q 039626          361 GSVYRGKI--NGGFAAIKKVNGD---------VSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSN  429 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~~---------~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~  429 (628)
                      |.||+|+.  ++..||||.+...         +.+|+.+|++++|+|||+|++++..++..|||||||.||+|.+||+..
T Consensus        24 avVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVMEyC~gGDLs~yi~~~  103 (429)
T KOG0595|consen   24 AVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVMEYCNGGDLSDYIRRR  103 (429)
T ss_pred             EEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEEeCCCCCHHHHHHHc
Confidence            89999998  6789999988542         467999999999999999999999999999999999999999999653


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCC------CcEEEccccccccCCCCCCcceeee
Q 039626          430 KNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSD------LRAKIANFAMARPAEGQEGEFALTR  503 (628)
Q Consensus       430 ~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~------~~~kl~Dfgla~~~~~~~~~~~~~~  503 (628)
                          +.+++.....+..|+|.||++||+   ++||||||||.||||+..      -.+||+|||+||......    ...
T Consensus       104 ----~~l~e~t~r~Fm~QLA~alq~L~~---~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~~~----~a~  172 (429)
T KOG0595|consen  104 ----GRLPEATARHFMQQLASALQFLHE---NNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQPGS----MAE  172 (429)
T ss_pred             ----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCCchh----HHH
Confidence                359999999999999999999999   559999999999999875      468999999999886433    345


Q ss_pred             cccCCccccCccccccCCCCcccccHHHHHHHHHHHhCCCcccccc
Q 039626          504 HIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHA  549 (628)
Q Consensus       504 ~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~  549 (628)
                      ...|++.|||||++..++|+.|+|+||.|+++||+++|+.||....
T Consensus       173 tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t  218 (429)
T KOG0595|consen  173 TLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAET  218 (429)
T ss_pred             HhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccC
Confidence            6789999999999999999999999999999999999999997433

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7.1e-40  Score=328.06  Aligned_cols=229  Identities=28%  Similarity=0.401  Sum_probs=185.2

Q ss_pred             eEEEEEEE--CCceEEEEEecc--------------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHH
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG--------------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSD  424 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~--------------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~  424 (628)
                      |.|-+|..  +|+.||||.+++              ++.+|+++|++|+|||||++.+++...+..|+|||||+||+|.+
T Consensus       186 g~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~YmVlE~v~GGeLfd  265 (475)
T KOG0615|consen  186 GLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSSYMVLEYVEGGELFD  265 (475)
T ss_pred             eEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCceEEEEEEecCccHHH
Confidence            78888876  789999998864              24689999999999999999999999999999999999999999


Q ss_pred             HhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCC---CcEEEccccccccCCCCCCccee
Q 039626          425 WVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSD---LRAKIANFAMARPAEGQEGEFAL  501 (628)
Q Consensus       425 ~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~---~~~kl~Dfgla~~~~~~~~~~~~  501 (628)
                      .+-.    ++.+.+..-..++.|++.|+.|||+.+   |+||||||+|||+..+   ..+||+|||+|+..+..    ..
T Consensus       266 ~vv~----nk~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDFGlAK~~g~~----sf  334 (475)
T KOG0615|consen  266 KVVA----NKYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDFGLAKVSGEG----SF  334 (475)
T ss_pred             HHHh----ccccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEecccchhhccccc----ee
Confidence            9954    445777777889999999999999955   9999999999999766   78999999999987632    35


Q ss_pred             eecccCCccccCccccccCC---CCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccC
Q 039626          502 TRHIVGTKGYMAPEYLENGL---VSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFID  578 (628)
Q Consensus       502 ~~~~~gt~~Y~APE~l~~~~---~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d  578 (628)
                      ++...||+.|.|||++.+..   +..|.|+||+|||||-+++|.+||......  ..+.+.+.   ....          
T Consensus       335 m~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~--~sl~eQI~---~G~y----------  399 (475)
T KOG0615|consen  335 MKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTD--PSLKEQIL---KGRY----------  399 (475)
T ss_pred             hhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCC--ccHHHHHh---cCcc----------
Confidence            67789999999999997653   334889999999999999999999743322  22222221   1100          


Q ss_pred             CcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          579 PTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       579 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                       ........+..++..+|+.+||..||++|||++|+++
T Consensus       400 -~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~  436 (475)
T KOG0615|consen  400 -AFGPLQWDRISEEALDLINWMLVVDPENRPSADEALN  436 (475)
T ss_pred             -cccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence             0011223456778899999999999999999999875

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.4e-40  Score=317.75  Aligned_cols=234  Identities=25%  Similarity=0.386  Sum_probs=192.4

Q ss_pred             ceEEEEEEE--CCceEEEEEecc---------chHHHHHHHhhcCCCceeeeeee-eecCCe-EEEEEEecCCCChHHHh
Q 039626          360 QGSVYRGKI--NGGFAAIKKVNG---------DVSKEIALLNKINHSNLIILSGV-CFNEGN-CYLVYEYAVNGTLSDWV  426 (628)
Q Consensus       360 ~G~Vy~g~~--~g~~vavK~~~~---------~~~~E~~~l~~l~H~nIv~l~g~-~~~~~~-~~lV~E~~~~gsL~~~l  426 (628)
                      .|+|||+..  +|..+|.|+++-         +..+|+.+|++|+|||||+++++ +.++.+ ++|||||+.+|+|...+
T Consensus        32 Fg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivmE~c~~GDLsqmI  111 (375)
T KOG0591|consen   32 FGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVMELCDAGDLSQMI  111 (375)
T ss_pred             chheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHHHhhcccCHHHHH
Confidence            399999976  899999999863         45689999999999999999994 444445 89999999999999999


Q ss_pred             hhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--eEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeec
Q 039626          427 FSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPP--HVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRH  504 (628)
Q Consensus       427 ~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~--iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~  504 (628)
                      ...+..++.++++.+++++.|++.||.++|+.. ++  ++||||||.||+|+.+|.+||+||||++......   .....
T Consensus       112 k~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~-~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~s~~---tfA~S  187 (375)
T KOG0591|consen  112 KHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKI-PRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLSSKT---TFAHS  187 (375)
T ss_pred             HHHHhccccCchHHHHHHHHHHHHHHHHHhccc-cccceeeccCcchheEEcCCCceeeccchhHhHhcchh---HHHHh
Confidence            888888899999999999999999999999954 44  9999999999999999999999999999886432   33556


Q ss_pred             ccCCccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCC
Q 039626          505 IVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGN  584 (628)
Q Consensus       505 ~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~  584 (628)
                      .+|||.||+||.+.+..|+.|+||||+||+++||+.-+.||...      .+...-..+-.          .--|    .
T Consensus       188 ~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~------n~~~L~~KI~q----------gd~~----~  247 (375)
T KOG0591|consen  188 LVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD------NLLSLCKKIEQ----------GDYP----P  247 (375)
T ss_pred             hcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc------cHHHHHHHHHc----------CCCC----C
Confidence            79999999999999999999999999999999999999999743      12222211111          1001    1


Q ss_pred             CC-HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 039626          585 YP-LELALLVIRLIDACLKKDPTDRPTMYEIEHS  617 (628)
Q Consensus       585 ~~-~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~  617 (628)
                      .| .-.+..+..++..|+..||+.||+.-.+++.
T Consensus       248 ~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~d  281 (375)
T KOG0591|consen  248 LPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQD  281 (375)
T ss_pred             CcHHHhhhHHHHHHHHHccCCcccCCCcchHHHH
Confidence            23 4567778999999999999999995444433

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=8.4e-39  Score=335.75  Aligned_cols=225  Identities=25%  Similarity=0.445  Sum_probs=192.2

Q ss_pred             eEEEEEEE--CCceEEEEEecc----------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhh
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG----------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFS  428 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  428 (628)
                      ..+|+++.  .|+.+|+|.+.+          .+.+|+++.++|+|||||+++++|++.++.|||.|++.+|+|..++. 
T Consensus        32 A~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivLELC~~~sL~el~K-  110 (592)
T KOG0575|consen   32 ARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVLELCHRGSLMELLK-  110 (592)
T ss_pred             eEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEEEecCCccHHHHHH-
Confidence            68999998  799999998854          36689999999999999999999999999999999999999999884 


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCC
Q 039626          429 NKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGT  508 (628)
Q Consensus       429 ~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt  508 (628)
                         ..+.+++.....+..||+.||.|||+.+   |+|||||..|+||+++.++||+|||||..+.....   ......||
T Consensus       111 ---rrk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~E---rk~TlCGT  181 (592)
T KOG0575|consen  111 ---RRKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGE---RKKTLCGT  181 (592)
T ss_pred             ---hcCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecCccc---ccceecCC
Confidence               3567999999999999999999999954   99999999999999999999999999998864422   24567999


Q ss_pred             ccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCHH
Q 039626          509 KGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLE  588 (628)
Q Consensus       509 ~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~  588 (628)
                      |.|.|||++.....+..+||||+|||||-|+.|++||+...      +.+....+...+               -..|..
T Consensus       182 PNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~------vkety~~Ik~~~---------------Y~~P~~  240 (592)
T KOG0575|consen  182 PNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKT------VKETYNKIKLNE---------------YSMPSH  240 (592)
T ss_pred             CcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccch------HHHHHHHHHhcC---------------cccccc
Confidence            99999999999999999999999999999999999997432      222222221111               123445


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          589 LALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       589 ~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      .+....+|+.++|+.||.+|||+++|+.
T Consensus       241 ls~~A~dLI~~lL~~~P~~Rpsl~~vL~  268 (592)
T KOG0575|consen  241 LSAEAKDLIRKLLRPNPSERPSLDEVLD  268 (592)
T ss_pred             cCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            6677889999999999999999999974

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=9.4e-40  Score=336.73  Aligned_cols=232  Identities=28%  Similarity=0.466  Sum_probs=195.9

Q ss_pred             ccceEEEEEEECCceEEEEEeccchHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhcCCCCCCCC
Q 039626          358 RIQGSVYRGKINGGFAAIKKVNGDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLD  437 (628)
Q Consensus       358 ~i~G~Vy~g~~~g~~vavK~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~  437 (628)
                      +.+|.||+|++.++.|||||++.--..+++-|++|+|+||+.+.|+|....-+|+||||+..|-|...|.    .++.++
T Consensus       135 GaQGAVF~Grl~netVAVKKV~elkETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~VLk----a~~~it  210 (904)
T KOG4721|consen  135 GAQGAVFLGRLHNETVAVKKVRELKETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYEVLK----AGRPIT  210 (904)
T ss_pred             CcccceeeeeccCceehhHHHhhhhhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHHHHHh----ccCccC
Confidence            3459999999999999999999888889999999999999999999999999999999999999999994    455688


Q ss_pred             HHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCCccccCcccc
Q 039626          438 WKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYL  517 (628)
Q Consensus       438 ~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~Y~APE~l  517 (628)
                      .....+|..+||.||+|||.+.   |||||||+-||||..+-.+||+|||.++...+..    ......||..|||||++
T Consensus       211 p~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~S----TkMSFaGTVaWMAPEvI  283 (904)
T KOG4721|consen  211 PSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSDKS----TKMSFAGTVAWMAPEVI  283 (904)
T ss_pred             HHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhhhh----hhhhhhhhHhhhCHHHh
Confidence            8888999999999999999955   9999999999999999999999999998765431    23446899999999999


Q ss_pred             ccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCHHHHHHHHHHH
Q 039626          518 ENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLI  597 (628)
Q Consensus       518 ~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~  597 (628)
                      .+...++|.||||||||||||+||.-|+..-+.      ...++.+-     ...        |....|..++..+.-|+
T Consensus       284 rnePcsEKVDIwSfGVVLWEmLT~EiPYkdVds------sAIIwGVG-----sNs--------L~LpvPstcP~GfklL~  344 (904)
T KOG4721|consen  284 RNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDS------SAIIWGVG-----SNS--------LHLPVPSTCPDGFKLLL  344 (904)
T ss_pred             hcCCcccccceehhHHHHHHHHhcCCCccccch------heeEEecc-----CCc--------ccccCcccCchHHHHHH
Confidence            999999999999999999999999988753221      11222211     111        22233455666678899


Q ss_pred             HHhcccCCCCCCCHHHHHHHHH
Q 039626          598 DACLKKDPTDRPTMYEIEHSLS  619 (628)
Q Consensus       598 ~~Cl~~dP~~RPs~~ev~~~L~  619 (628)
                      ++||+..|..|||+++++.-|+
T Consensus       345 Kqcw~sKpRNRPSFrqil~Hld  366 (904)
T KOG4721|consen  345 KQCWNSKPRNRPSFRQILLHLD  366 (904)
T ss_pred             HHHHhcCCCCCccHHHHHHHHh
Confidence            9999999999999999998875

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=1.6e-38  Score=326.24  Aligned_cols=255  Identities=22%  Similarity=0.347  Sum_probs=198.0

Q ss_pred             cceeecHHHHHHHhcCCCcCCccceEEEEEEECCceEEEEEecc----------chHHHHHHHhhcCCCceeeeeeeeec
Q 039626          337 SLKVYSFKELQSATDNFSFTCRIQGSVYRGKINGGFAAIKKVNG----------DVSKEIALLNKINHSNLIILSGVCFN  406 (628)
Q Consensus       337 ~~~~~~~~el~~at~~f~~~~~i~G~Vy~g~~~g~~vavK~~~~----------~~~~E~~~l~~l~H~nIv~l~g~~~~  406 (628)
                      +.+.++.+++...+.. ....+-.|.||+|+++|+.||||+++.          .+.+|+++|.+++||||++++|++.+
T Consensus        11 ~~~~i~~~~i~~~~~~-~i~~g~~~~v~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~   89 (283)
T PHA02988         11 DIKCIESDDIDKYTSV-LIKENDQNSIYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIID   89 (283)
T ss_pred             cceecCHHHcCCCCCe-EEeeCCceEEEEEEECCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEe
Confidence            4456666776433211 122222389999999999999998853          24589999999999999999999976


Q ss_pred             ----CCeEEEEEEecCCCChHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEE
Q 039626          407 ----EGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAK  482 (628)
Q Consensus       407 ----~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~k  482 (628)
                          ....++||||+++|+|.+++..    .+.++|..+++++.+++.||.|||+.  .+++||||||+|||+++++.+|
T Consensus        90 ~~~~~~~~~lv~Ey~~~g~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lH~~--~~~~Hrdlkp~nill~~~~~~k  163 (283)
T PHA02988         90 IVDDLPRLSLILEYCTRGYLREVLDK----EKDLSFKTKLDMAIDCCKGLYNLYKY--TNKPYKNLTSVSFLVTENYKLK  163 (283)
T ss_pred             cccCCCceEEEEEeCCCCcHHHHHhh----CCCCChhHHHHHHHHHHHHHHHHHhc--CCCCCCcCChhhEEECCCCcEE
Confidence                3468999999999999999953    34589999999999999999999973  2478999999999999999999


Q ss_pred             EccccccccCCCCCCcceeeecccCCccccCcccccc--CCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHH
Q 039626          483 IANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLEN--GLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVL  560 (628)
Q Consensus       483 l~Dfgla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~--~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~  560 (628)
                      |+|||+++......      ....|+..|+|||.+.+  ..++.++|||||||++|||++|+.||.....      .+..
T Consensus       164 l~dfg~~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~------~~~~  231 (283)
T PHA02988        164 IICHGLEKILSSPP------FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTT------KEIY  231 (283)
T ss_pred             EcccchHhhhcccc------ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCH------HHHH
Confidence            99999998654321      12468899999999976  6899999999999999999999999863221      1222


Q ss_pred             HHHhccccchhhhccccCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHh
Q 039626          561 NAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILN  623 (628)
Q Consensus       561 ~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~~  623 (628)
                      ..+....         ..+    ..+...+..+.+++.+||+.||++|||++|+++.|+.+.+
T Consensus       232 ~~i~~~~---------~~~----~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~  281 (283)
T PHA02988        232 DLIINKN---------NSL----KLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF  281 (283)
T ss_pred             HHHHhcC---------CCC----CCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence            2211111         011    1222345568899999999999999999999999998754

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-38  Score=323.26  Aligned_cols=257  Identities=26%  Similarity=0.418  Sum_probs=191.3

Q ss_pred             eEEEEEEECCceEEEEEecc----chHHHHHHHh--hcCCCceeeeeeeeecCC----eEEEEEEecCCCChHHHhhhcC
Q 039626          361 GSVYRGKINGGFAAIKKVNG----DVSKEIALLN--KINHSNLIILSGVCFNEG----NCYLVYEYAVNGTLSDWVFSNK  430 (628)
Q Consensus       361 G~Vy~g~~~g~~vavK~~~~----~~~~E~~~l~--~l~H~nIv~l~g~~~~~~----~~~lV~E~~~~gsL~~~l~~~~  430 (628)
                      |.||||.++++.||||++..    .+.+|-+|.+  .++|+||+++++.-....    +++||+||.++|+|.+||.   
T Consensus       224 g~V~KaqL~~~~VAVKifp~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh~kGsL~dyL~---  300 (534)
T KOG3653|consen  224 GCVWKAQLDNRLVAVKIFPEQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEFHPKGSLCDYLK---  300 (534)
T ss_pred             ceeehhhccCceeEEEecCHHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeeeccCCcHHHHHH---
Confidence            99999999999999999964    4666766655  568999999999987554    7999999999999999994   


Q ss_pred             CCCCCCCHHHHHHHHHHHHHHHHHHhcC------CCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeec
Q 039626          431 NEGKYLDWKQRIQIALDVATGLNYLHSF------TNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRH  504 (628)
Q Consensus       431 ~~~~~l~~~~~~~i~~~ia~gL~yLH~~------~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~  504 (628)
                        ...++|....+|+..+++||+|||+.      .+++|+|||||++|||+.+|+.+.|+|||||..+....... .+-.
T Consensus       301 --~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~~p~~~~~-d~~~  377 (534)
T KOG3653|consen  301 --ANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRLEPGKPQG-DTHG  377 (534)
T ss_pred             --hccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEecCCCCCc-chhh
Confidence              34699999999999999999999973      35789999999999999999999999999999886443222 2233


Q ss_pred             ccCCccccCccccccCCCC------cccccHHHHHHHHHHHhCCCcccc-ccccccccHHHHHHHHhccccch-hhhccc
Q 039626          505 IVGTKGYMAPEYLENGLVS------TKLDVYAFGVLILEMLTGKEAAAL-HAEENNMHLSDVLNAVLTKEDGE-ESLRHF  576 (628)
Q Consensus       505 ~~gt~~Y~APE~l~~~~~s------~k~DV~SfGvvl~ELltG~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~-~~l~~~  576 (628)
                      .+||.+|||||++.+...-      .+.||||+|.||||+++.....+. ...+..+.+...+..-...++.. -.+++-
T Consensus       378 qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~e~mq~~VV~kK  457 (534)
T KOG3653|consen  378 QVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTLEEMQELVVRKK  457 (534)
T ss_pred             hhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCCHHHHHHHHHhhc
Confidence            7999999999999875322      368999999999999998765532 11111222221111110000000 111222


Q ss_pred             cCCcCCCCCC-HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHh
Q 039626          577 IDPTLQGNYP-LELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILN  623 (628)
Q Consensus       577 ~d~~l~~~~~-~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~~  623 (628)
                      ..|.++..+- ......+.+.+..||+.||+.|.|+.=|.+.+.++..
T Consensus       458 ~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~  505 (534)
T KOG3653|consen  458 QRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMM  505 (534)
T ss_pred             cCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhc
Confidence            2333332221 1345568899999999999999999999999888764

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.8e-39  Score=359.29  Aligned_cols=243  Identities=33%  Similarity=0.516  Sum_probs=198.0

Q ss_pred             ceEEEEEEE---CCc----eEEEEEecc--------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHH
Q 039626          360 QGSVYRGKI---NGG----FAAIKKVNG--------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSD  424 (628)
Q Consensus       360 ~G~Vy~g~~---~g~----~vavK~~~~--------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~  424 (628)
                      .|.||+|.+   +|.    .||||++++        +|.+|..+|++++|||||+++|+|.+.+..++++|||++|+|..
T Consensus       705 FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i~leyM~gGDL~s  784 (1025)
T KOG1095|consen  705 FGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLILLEYMEGGDLLS  784 (1025)
T ss_pred             ccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEEEehhcccCcHHH
Confidence            399999998   343    489999875        58899999999999999999999999999999999999999999


Q ss_pred             HhhhcCC---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCccee
Q 039626          425 WVFSNKN---EGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFAL  501 (628)
Q Consensus       425 ~l~~~~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~  501 (628)
                      +|...+.   ....|+....+.++.|||+|++||++   .++|||||..+|+||++...+||+|||+||.+.+.+.. ..
T Consensus       785 flr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~---~~fvHRDLAaRNCLL~~~r~VKIaDFGlArDiy~~~yy-r~  860 (1025)
T KOG1095|consen  785 FLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLES---KHFVHRDLAARNCLLDERRVVKIADFGLARDIYDKDYY-RK  860 (1025)
T ss_pred             HHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHh---CCCcCcchhhhheeecccCcEEEcccchhHhhhhchhe-ec
Confidence            9976432   24569999999999999999999999   55999999999999999999999999999966543321 11


Q ss_pred             eecccCCccccCccccccCCCCcccccHHHHHHHHHHHh-CCCccccccccccccHHHHHHHHhccccchhhhccccCCc
Q 039626          502 TRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT-GKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPT  580 (628)
Q Consensus       502 ~~~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELlt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~  580 (628)
                      ...-.-...|||||++..+.++.|+|||||||+|||++| |..|+....      ..++...+....             
T Consensus       861 ~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~------n~~v~~~~~~gg-------------  921 (1025)
T KOG1095|consen  861 HGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRS------NFEVLLDVLEGG-------------  921 (1025)
T ss_pred             cCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcc------hHHHHHHHHhCC-------------
Confidence            111234468999999999999999999999999999999 666665322      222222222211             


Q ss_pred             CCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhcc
Q 039626          581 LQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNASL  626 (628)
Q Consensus       581 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~~~~~  626 (628)
                       +-..|..++..+.++|..||+.+|++||++..+++.+..+.+..+
T Consensus       922 -RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~  966 (1025)
T KOG1095|consen  922 -RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAAL  966 (1025)
T ss_pred             -ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhc
Confidence             224466677889999999999999999999999999999987653

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=2.5e-37  Score=369.25  Aligned_cols=262  Identities=27%  Similarity=0.460  Sum_probs=206.6

Q ss_pred             ecHHHHHHHhcCCCcCCccc----eEEEEEEE--CCceEEEEEecc---chHHHHHHHhhcCCCceeeeeeeeecCCeEE
Q 039626          341 YSFKELQSATDNFSFTCRIQ----GSVYRGKI--NGGFAAIKKVNG---DVSKEIALLNKINHSNLIILSGVCFNEGNCY  411 (628)
Q Consensus       341 ~~~~el~~at~~f~~~~~i~----G~Vy~g~~--~g~~vavK~~~~---~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~  411 (628)
                      ++++++...   +.....+|    |.||+|+.  ++..||+|+++.   ...+|++.+++++|||||+++|+|.+++..+
T Consensus       683 ~~~~~~~~~---~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~  759 (968)
T PLN00113        683 ITINDILSS---LKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIADMGKLQHPNIVKLIGLCRSEKGAY  759 (968)
T ss_pred             hhHHHHHhh---CCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccccHHHHHHHhhCCCCCcceEEEEEEcCCCCE
Confidence            455555443   33333343    89999997  688999998864   2356899999999999999999999999999


Q ss_pred             EEEEecCCCChHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEcccccccc
Q 039626          412 LVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARP  491 (628)
Q Consensus       412 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~  491 (628)
                      +||||+++|+|.++++       .++|..+.+|+.|+++||+|||+.+.++++||||||+||+++.++..++. ||....
T Consensus       760 lv~Ey~~~g~L~~~l~-------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~  831 (968)
T PLN00113        760 LIHEYIEGKNLSEVLR-------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGL  831 (968)
T ss_pred             EEEeCCCCCcHHHHHh-------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccc
Confidence            9999999999999994       28999999999999999999997766889999999999999999988876 665543


Q ss_pred             CCCCCCcceeeecccCCccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchh
Q 039626          492 AEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEE  571 (628)
Q Consensus       492 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  571 (628)
                      ...       .....+|+.|+|||++.+..++.|+|||||||++|||++|+.|+...... .....++.......    .
T Consensus       832 ~~~-------~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~----~  899 (968)
T PLN00113        832 LCT-------DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGV-HGSIVEWARYCYSD----C  899 (968)
T ss_pred             ccc-------CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCC-CCcHHHHHHHhcCc----c
Confidence            321       11236889999999999999999999999999999999999998532221 22344444333221    2


Q ss_pred             hhccccCCcCCCC--CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhc
Q 039626          572 SLRHFIDPTLQGN--YPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNAS  625 (628)
Q Consensus       572 ~l~~~~d~~l~~~--~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~~~~  625 (628)
                      ....++|+.+...  .+.+....+.+++.+||+.||++||+|+||++.|+++...+
T Consensus       900 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~  955 (968)
T PLN00113        900 HLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSS  955 (968)
T ss_pred             chhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhccc
Confidence            2445566666433  34566677889999999999999999999999999997754

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3e-38  Score=319.94  Aligned_cols=235  Identities=31%  Similarity=0.466  Sum_probs=187.9

Q ss_pred             ceEEEEEEE--CCceEEEEEeccc-------hHHHHHHHhhcCCCceeeeeeeeecCC--eEEEEEEecCCCChHHHhhh
Q 039626          360 QGSVYRGKI--NGGFAAIKKVNGD-------VSKEIALLNKINHSNLIILSGVCFNEG--NCYLVYEYAVNGTLSDWVFS  428 (628)
Q Consensus       360 ~G~Vy~g~~--~g~~vavK~~~~~-------~~~E~~~l~~l~H~nIv~l~g~~~~~~--~~~lV~E~~~~gsL~~~l~~  428 (628)
                      .|+||.+..  +|+..|||.+...       +.+|+.+|.+++|||||+++|......  .+++.|||+++|+|.+++.+
T Consensus        30 ~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~~~GsL~~~~~~  109 (313)
T KOG0198|consen   30 FGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEYAPGGSLSDLIKR  109 (313)
T ss_pred             ceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeeccCCCcHHHHHHH
Confidence            499999998  4799999998764       689999999999999999999865544  69999999999999999965


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCC-CCcEEEccccccccCCCCCCcceeeecccC
Q 039626          429 NKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDS-DLRAKIANFAMARPAEGQEGEFALTRHIVG  507 (628)
Q Consensus       429 ~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~-~~~~kl~Dfgla~~~~~~~~~~~~~~~~~g  507 (628)
                      ..  + .|++..+..++.||++||.|||+.   +|+||||||+|||++. ++.+||+|||+++................|
T Consensus       110 ~g--~-~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~~~~~~~~~G  183 (313)
T KOG0198|consen  110 YG--G-KLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTKSDSELSVQG  183 (313)
T ss_pred             cC--C-CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCccccccccccccccccccccC
Confidence            32  2 599999999999999999999984   5999999999999999 799999999999877531111222345789


Q ss_pred             CccccCccccccC-CCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCC
Q 039626          508 TKGYMAPEYLENG-LVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYP  586 (628)
Q Consensus       508 t~~Y~APE~l~~~-~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~  586 (628)
                      |+.|||||++.++ ....++|||||||+++||+||+.||....     .....+....            ..... ..+|
T Consensus       184 tp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~-----~~~~~~~~ig------------~~~~~-P~ip  245 (313)
T KOG0198|consen  184 TPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFF-----EEAEALLLIG------------REDSL-PEIP  245 (313)
T ss_pred             CccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhc-----chHHHHHHHh------------ccCCC-CCCC
Confidence            9999999999964 34469999999999999999999987430     0111111111            11111 1455


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 039626          587 LELALLVIRLIDACLKKDPTDRPTMYEIEHSL  618 (628)
Q Consensus       587 ~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L  618 (628)
                      ...+....+++.+|+..||++|||+.++++--
T Consensus       246 ~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hp  277 (313)
T KOG0198|consen  246 DSLSDEAKDFLRKCFKRDPEKRPTAEELLEHP  277 (313)
T ss_pred             cccCHHHHHHHHHHhhcCcccCcCHHHHhhCh
Confidence            56777789999999999999999999998643

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-39  Score=327.74  Aligned_cols=241  Identities=27%  Similarity=0.395  Sum_probs=194.3

Q ss_pred             eEEEEEEE--CCceEEEEEeccch--------HHHHHHHhhcC-CCceeeeeeeeecCC-eEEEEEEecCCCChHHHhhh
Q 039626          361 GSVYRGKI--NGGFAAIKKVNGDV--------SKEIALLNKIN-HSNLIILSGVCFNEG-NCYLVYEYAVNGTLSDWVFS  428 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~~~--------~~E~~~l~~l~-H~nIv~l~g~~~~~~-~~~lV~E~~~~gsL~~~l~~  428 (628)
                      |+||+|+-  .|+.||||++++.|        .+|++-|++|+ |||||++..++.+.+ .+++||||| ..+|++.+..
T Consensus        24 GsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fVfE~M-d~NLYqLmK~  102 (538)
T KOG0661|consen   24 GSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVFEFM-DCNLYQLMKD  102 (538)
T ss_pred             eeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeeeHHhh-hhhHHHHHhh
Confidence            99999987  78999999998754        37999999999 999999999999887 899999999 5699999854


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCC
Q 039626          429 NKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGT  508 (628)
Q Consensus       429 ~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt  508 (628)
                         +++.+++..+..|+.||+.||+|+|.++   +.|||+||+|||+..+..+||+|||+||.+.....    -+..+.|
T Consensus       103 ---R~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev~SkpP----YTeYVST  172 (538)
T KOG0661|consen  103 ---RNRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREVRSKPP----YTEYVST  172 (538)
T ss_pred             ---cCCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEecccccccccccCCC----cchhhhc
Confidence               3678999999999999999999999955   99999999999999999999999999998875442    2457899


Q ss_pred             ccccCcccc-ccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccch-----hhhccccCCcCC
Q 039626          509 KGYMAPEYL-ENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGE-----ESLRHFIDPTLQ  582 (628)
Q Consensus       509 ~~Y~APE~l-~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~l~~~~d~~l~  582 (628)
                      .+|+|||++ +.+.|+.+.|+||+||+++|+.+-++.|.+..+-+   ..-.+..++......     ..+...+.-.++
T Consensus       173 RWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~D---qi~KIc~VLGtP~~~~~~eg~~La~~mnf~~P  249 (538)
T KOG0661|consen  173 RWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEID---QIYKICEVLGTPDKDSWPEGYNLASAMNFRFP  249 (538)
T ss_pred             ccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHH---HHHHHHHHhCCCccccchhHHHHHHHhccCCC
Confidence            999999976 56789999999999999999999998887554322   222333444333211     222222322222


Q ss_pred             CC--------CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          583 GN--------YPLELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       583 ~~--------~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      ..        .+ ..+.+..+++.+|+.+||++||++.|.++
T Consensus       250 ~~~~~~l~~L~p-~~s~~~~~li~~ll~WDP~kRpTA~~al~  290 (538)
T KOG0661|consen  250 QVKPSPLKDLLP-NASSEAASLIERLLAWDPDKRPTASQALQ  290 (538)
T ss_pred             cCCCCChHHhCc-ccCHHHHHHHHHHhcCCCccCccHHHHhc
Confidence            11        12 25667889999999999999999999875

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.7e-37  Score=318.23  Aligned_cols=259  Identities=27%  Similarity=0.360  Sum_probs=196.6

Q ss_pred             eecHHHHHHHhcCCCcCCccceEEEEEEE--CCceEEEEEeccc---------hHHHHHHHhhcCCCceeeeeeeeecC-
Q 039626          340 VYSFKELQSATDNFSFTCRIQGSVYRGKI--NGGFAAIKKVNGD---------VSKEIALLNKINHSNLIILSGVCFNE-  407 (628)
Q Consensus       340 ~~~~~el~~at~~f~~~~~i~G~Vy~g~~--~g~~vavK~~~~~---------~~~E~~~l~~l~H~nIv~l~g~~~~~-  407 (628)
                      .-.|+.|+...++      -.|.|||++.  +|+.||+||+.-+         ..+||.||++|+||||++|.+...+. 
T Consensus       116 ~~~feki~kIGeG------Tyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~  189 (560)
T KOG0600|consen  116 ADSFEKIEKIGEG------TYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKL  189 (560)
T ss_pred             hHHHHHHHHhcCc------chhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecC
Confidence            3456666654322      2389999998  7899999999643         45899999999999999999999877 


Q ss_pred             -CeEEEEEEecCCCChHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccc
Q 039626          408 -GNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANF  486 (628)
Q Consensus       408 -~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Df  486 (628)
                       +.+|||+|||++ +|..++..   .+-.++..++..+..|++.||+|+|+   .+|+|||||.+|||||.+|.+||+||
T Consensus       190 ~~siYlVFeYMdh-DL~GLl~~---p~vkft~~qIKc~mkQLl~Gl~~cH~---~gvlHRDIK~SNiLidn~G~LKiaDF  262 (560)
T KOG0600|consen  190 SGSIYLVFEYMDH-DLSGLLSS---PGVKFTEPQIKCYMKQLLEGLEYCHS---RGVLHRDIKGSNILIDNNGVLKIADF  262 (560)
T ss_pred             CceEEEEEecccc-hhhhhhcC---CCcccChHHHHHHHHHHHHHHHHHhh---cCeeeccccccceEEcCCCCEEeccc
Confidence             689999999976 88888843   34569999999999999999999999   55999999999999999999999999


Q ss_pred             cccccCCCCCCcceeeecccCCccccCccccccC-CCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhc
Q 039626          487 AMARPAEGQEGEFALTRHIVGTKGYMAPEYLENG-LVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLT  565 (628)
Q Consensus       487 gla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~-~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~  565 (628)
                      |||+.+......  ..+..+-|.+|+|||.+.+. .|+...|+||.||+|.||+.|++.+....+-+   ..+.+..+..
T Consensus       263 GLAr~y~~~~~~--~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEve---Ql~kIfklcG  337 (560)
T KOG0600|consen  263 GLARFYTPSGSA--PYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVE---QLHKIFKLCG  337 (560)
T ss_pred             cceeeccCCCCc--ccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHH---HHHHHHHHhC
Confidence            999987654432  23456789999999998874 79999999999999999999999888655433   2333333332


Q ss_pred             ccc-c-hh--hhccccCCcCCCCCC-------HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          566 KED-G-EE--SLRHFIDPTLQGNYP-------LELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       566 ~~~-~-~~--~l~~~~d~~l~~~~~-------~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      ... . ..  .+..+.-......|.       ...+....+|+..+|..||.+|.|+.++++
T Consensus       338 SP~e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~  399 (560)
T KOG0600|consen  338 SPTEDYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ  399 (560)
T ss_pred             CCChhccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence            211 0 11  111100001111111       123445778999999999999999998875

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=1.6e-37  Score=327.21  Aligned_cols=241  Identities=24%  Similarity=0.415  Sum_probs=187.3

Q ss_pred             eEEEEEEE-------CCceEEEEEecc--------chHHHHHHHhhc-CCCceeeeeeeeecC-CeEEEEEEecCCCChH
Q 039626          361 GSVYRGKI-------NGGFAAIKKVNG--------DVSKEIALLNKI-NHSNLIILSGVCFNE-GNCYLVYEYAVNGTLS  423 (628)
Q Consensus       361 G~Vy~g~~-------~g~~vavK~~~~--------~~~~E~~~l~~l-~H~nIv~l~g~~~~~-~~~~lV~E~~~~gsL~  423 (628)
                      |.||+|..       .+..||+|+++.        .+.+|+.++.++ +|+||++++|+|... +..++||||+++|+|.
T Consensus        21 g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv~ey~~~g~L~  100 (338)
T cd05102          21 GKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNGPLMVIVEFCKYGNLS  100 (338)
T ss_pred             ceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCCceEEEEecCCCCcHH
Confidence            89999974       235799998853        366899999999 899999999998765 4589999999999999


Q ss_pred             HHhhhcCCC----------------------------------------------------------CCCCCHHHHHHHH
Q 039626          424 DWVFSNKNE----------------------------------------------------------GKYLDWKQRIQIA  445 (628)
Q Consensus       424 ~~l~~~~~~----------------------------------------------------------~~~l~~~~~~~i~  445 (628)
                      +++......                                                          ...+++..++.++
T Consensus       101 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  180 (338)
T cd05102         101 NFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYS  180 (338)
T ss_pred             HHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccccccCCCCHHHHHHHH
Confidence            999643210                                                          2358889999999


Q ss_pred             HHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCCccccCccccccCCCCcc
Q 039626          446 LDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTK  525 (628)
Q Consensus       446 ~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~k  525 (628)
                      .|++.||+|||+   .+|+||||||+|||+++++.+||+|||+++....... ........++..|+|||++.+..++.+
T Consensus       181 ~qi~~aL~~LH~---~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~  256 (338)
T cd05102         181 FQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPD-YVRKGSARLPLKWMAPESIFDKVYTTQ  256 (338)
T ss_pred             HHHHHHHHHHHH---CCEECCCCccceEEEcCCCcEEEeecccccccccCcc-hhcccCCCCCccccCcHHhhcCCCCcc
Confidence            999999999998   4599999999999999999999999999986543211 111223456788999999999999999


Q ss_pred             cccHHHHHHHHHHHh-CCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCHHHHHHHHHHHHHhcccC
Q 039626          526 LDVYAFGVLILEMLT-GKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKD  604 (628)
Q Consensus       526 ~DV~SfGvvl~ELlt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~d  604 (628)
                      +||||||+++|||++ |+.|+.......     ...... ...         ....    .+...+..+.+++.+||+.|
T Consensus       257 sDiwslG~il~el~~~g~~pf~~~~~~~-----~~~~~~-~~~---------~~~~----~~~~~~~~l~~li~~cl~~d  317 (338)
T cd05102         257 SDVWSFGVLLWEIFSLGASPYPGVQINE-----EFCQRL-KDG---------TRMR----APENATPEIYRIMLACWQGD  317 (338)
T ss_pred             cCHHHHHHHHHHHHhCCCCCCCCCCccH-----HHHHHH-hcC---------CCCC----CCCCCCHHHHHHHHHHccCC
Confidence            999999999999997 888876422111     111111 100         0011    12233456889999999999


Q ss_pred             CCCCCCHHHHHHHHHHhHhh
Q 039626          605 PTDRPTMYEIEHSLSNILNA  624 (628)
Q Consensus       605 P~~RPs~~ev~~~L~~l~~~  624 (628)
                      |++||++.|+++.|++++..
T Consensus       318 p~~RPs~~el~~~l~~~~~~  337 (338)
T cd05102         318 PKERPTFSALVEILGDLLQE  337 (338)
T ss_pred             hhhCcCHHHHHHHHHHHHhc
Confidence            99999999999999998864

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-37  Score=325.13  Aligned_cols=227  Identities=26%  Similarity=0.410  Sum_probs=190.9

Q ss_pred             eEEEEEEE--CCceEEEEEecc-------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhcCC
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG-------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKN  431 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~-------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~  431 (628)
                      |.||.++-  .++.||||++..       -+.+|+.+|+..+|+|||+++..+..++++|.|||||++|+|.|.+     
T Consensus       287 G~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ggsLTDvV-----  361 (550)
T KOG0578|consen  287 GGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEGGSLTDVV-----  361 (550)
T ss_pred             cceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecCCCchhhhh-----
Confidence            89999987  788999999853       2568999999999999999999999999999999999999999988     


Q ss_pred             CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCCccc
Q 039626          432 EGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGY  511 (628)
Q Consensus       432 ~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~Y  511 (628)
                      ....+++.++..|+.+++.||+|||..   +|+|||||++|||++.+|.+||+|||++..+....   ......+||+.|
T Consensus       362 t~~~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~---~KR~TmVGTPYW  435 (550)
T KOG0578|consen  362 TKTRMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQ---SKRSTMVGTPYW  435 (550)
T ss_pred             hcccccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeecccccc---CccccccCCCCc
Confidence            344599999999999999999999994   59999999999999999999999999998775432   245567999999


Q ss_pred             cCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCHHHHH
Q 039626          512 MAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELAL  591 (628)
Q Consensus       512 ~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~  591 (628)
                      ||||++....|.+|.||||||++++||+.|.+||-...     .+. .++.+...+            ...-..+...+.
T Consensus       436 MAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~-----Plr-AlyLIa~ng------------~P~lk~~~klS~  497 (550)
T KOG0578|consen  436 MAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNEN-----PLR-ALYLIATNG------------TPKLKNPEKLSP  497 (550)
T ss_pred             cchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCC-----hHH-HHHHHhhcC------------CCCcCCccccCH
Confidence            99999999999999999999999999999999986311     111 111111111            112233556777


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          592 LVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       592 ~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      .+.+|+.+||+.|+++|++++|+++
T Consensus       498 ~~kdFL~~cL~~dv~~RasA~eLL~  522 (550)
T KOG0578|consen  498 ELKDFLDRCLVVDVEQRASAKELLE  522 (550)
T ss_pred             HHHHHHHHHhhcchhcCCCHHHHhc
Confidence            8999999999999999999999985

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=9.2e-38  Score=301.31  Aligned_cols=242  Identities=24%  Similarity=0.377  Sum_probs=185.1

Q ss_pred             eEEEEEEE--CCceEEEEEecc---------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhc
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG---------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSN  429 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~---------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~  429 (628)
                      |.|||.+.  .|+.||||++.+         -..+|+++|++++|+|+|.|+.+|.....++|||||++.--|.+.- . 
T Consensus        16 GvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~~dhTvL~eLe-~-   93 (396)
T KOG0593|consen   16 GVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEYCDHTVLHELE-R-   93 (396)
T ss_pred             eEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeeecchHHHHHHH-h-
Confidence            99999988  789999999864         1468999999999999999999999999999999999775554432 2 


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCCc
Q 039626          430 KNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTK  509 (628)
Q Consensus       430 ~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~  509 (628)
                        ....++.....+++.|++.|+.|+|++.   +|||||||+|||++.++.+||||||+||.......   .-+..+.|.
T Consensus        94 --~p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd---~YTDYVATR  165 (396)
T KOG0593|consen   94 --YPNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSAPGD---NYTDYVATR  165 (396)
T ss_pred             --ccCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcCCcc---hhhhhhhhh
Confidence              2334888899999999999999999954   99999999999999999999999999998763221   234578999


Q ss_pred             cccCcccccc-CCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccch--------hhhcccc--C
Q 039626          510 GYMAPEYLEN-GLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGE--------ESLRHFI--D  578 (628)
Q Consensus       510 ~Y~APE~l~~-~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~l~~~~--d  578 (628)
                      +|+|||.+.+ ..|.+..||||+||++.||++|.+.|....+-+.   .-.+...+..--++        ..+..+.  +
T Consensus       166 WYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQ---Ly~I~ktLG~L~prhq~iF~~N~~F~Gv~lP~  242 (396)
T KOG0593|consen  166 WYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQ---LYLIRKTLGNLIPRHQSIFSSNPFFHGVRLPE  242 (396)
T ss_pred             hccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHH---HHHHHHHHcccCHHHHHHhccCCceeeeecCC
Confidence            9999999887 6899999999999999999999988875544321   11122111111000        0011111  1


Q ss_pred             Cc----CCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          579 PT----LQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       579 ~~----l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      +.    +...+| .....+.++++.||+.||.+|++-+|++.
T Consensus       243 ~~~~epLe~k~p-~~s~~~ld~~k~cL~~dP~~R~sc~qll~  283 (396)
T KOG0593|consen  243 PEHPEPLERKYP-KISNVLLDLLKKCLKMDPDDRLSCEQLLH  283 (396)
T ss_pred             CCCccchhhhcc-cchHHHHHHHHHHhcCCccccccHHHHhc
Confidence            11    112222 23446889999999999999999998864

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-36  Score=307.48  Aligned_cols=240  Identities=25%  Similarity=0.382  Sum_probs=188.0

Q ss_pred             eEEEEEEE--CCceEEEEEecc--------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhcC
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG--------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNK  430 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~--------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~  430 (628)
                      ++||+|..  .++.||||++.-        .+.+|+..|+.++||||+++...|..+..+|+||.||.+||+.+.++..-
T Consensus        40 a~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpfMa~GS~ldIik~~~  119 (516)
T KOG0582|consen   40 AVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPFMAGGSLLDIIKTYY  119 (516)
T ss_pred             eEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehhhcCCcHHHHHHHHc
Confidence            78999987  789999999863        36789999999999999999999999999999999999999999997643


Q ss_pred             CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceee-ecccCCc
Q 039626          431 NEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALT-RHIVGTK  509 (628)
Q Consensus       431 ~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~-~~~~gt~  509 (628)
                      ..  .+++..+.-|.+++++||.|||..   +.||||||+.||||+.+|.+||+|||.+-.+.......... ...+||+
T Consensus       120 ~~--Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R~~~rf~tfvgtp  194 (516)
T KOG0582|consen  120 PD--GLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDRQVTRFNTFVGTP  194 (516)
T ss_pred             cc--cccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeeecccCceeeEeeccccCcc
Confidence            33  389999999999999999999994   59999999999999999999999999877664433222222 5679999


Q ss_pred             cccCcccccc--CCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCH
Q 039626          510 GYMAPEYLEN--GLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPL  587 (628)
Q Consensus       510 ~Y~APE~l~~--~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~  587 (628)
                      .|||||++..  ..|+-|+||||||+...||.+|..||......      +.+-.-+......- .-    ..+..+...
T Consensus       195 ~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPm------kvLl~tLqn~pp~~-~t----~~~~~d~~k  263 (516)
T KOG0582|consen  195 CWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPM------KVLLLTLQNDPPTL-LT----SGLDKDEDK  263 (516)
T ss_pred             cccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChH------HHHHHHhcCCCCCc-cc----ccCChHHhh
Confidence            9999999643  46899999999999999999999998743221      11111111110000 00    011111122


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          588 ELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       588 ~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      .....+..++..||++||.+|||+.++++
T Consensus       264 ~~~ksf~e~i~~CL~kDP~kRptAskLlk  292 (516)
T KOG0582|consen  264 KFSKSFREMIALCLVKDPSKRPTASKLLK  292 (516)
T ss_pred             hhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence            34457889999999999999999999875

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-37  Score=323.81  Aligned_cols=238  Identities=28%  Similarity=0.438  Sum_probs=198.3

Q ss_pred             eEEEEEEEC--CceEEEEEecc------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhcCCC
Q 039626          361 GSVYRGKIN--GGFAAIKKVNG------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNE  432 (628)
Q Consensus       361 G~Vy~g~~~--g~~vavK~~~~------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~  432 (628)
                      |.||.|.|.  .-.||||.++.      +|.+|..+|+.++|||+|+|+|+|..+..+|+|.|||.+|+|.+||..-  .
T Consensus       281 GeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~yGNLLdYLRec--n  358 (1157)
T KOG4278|consen  281 GEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMCYGNLLDYLREC--N  358 (1157)
T ss_pred             cceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecccCccHHHHHHHh--c
Confidence            899999994  56899999986      4788999999999999999999999999999999999999999999643  2


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCCcccc
Q 039626          433 GKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYM  512 (628)
Q Consensus       433 ~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~Y~  512 (628)
                      ...++-...+.+|.||+.||+||..   +.+|||||..+|+|+.++..+|++||||+|.+..+...  ......-...|.
T Consensus       359 r~ev~avvLlyMAtQIsSaMeYLEk---knFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYT--AHAGAKFPIKWT  433 (1157)
T KOG4278|consen  359 RSEVPAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYT--AHAGAKFPIKWT  433 (1157)
T ss_pred             hhhcchhHHHHHHHHHHHHHHHHHH---hhhhhhhhhhhhccccccceEEeeccchhhhhcCCcee--cccCccCccccc
Confidence            3446777788999999999999998   55999999999999999999999999999998755422  112223456899


Q ss_pred             CccccccCCCCcccccHHHHHHHHHHHh-CCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCHHHHH
Q 039626          513 APEYLENGLVSTKLDVYAFGVLILEMLT-GKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELAL  591 (628)
Q Consensus       513 APE~l~~~~~s~k~DV~SfGvvl~ELlt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~  591 (628)
                      |||.+-...++.|+|||+|||+|||+.| |..|+...+      +.+ +..+++             ...+-+.|..++.
T Consensus       434 APEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGid------lSq-VY~LLE-------------kgyRM~~PeGCPp  493 (1157)
T KOG4278|consen  434 APESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGID------LSQ-VYGLLE-------------KGYRMDGPEGCPP  493 (1157)
T ss_pred             CcccccccccccchhhHHHHHHHHHHHhcCCCCCCCcc------HHH-HHHHHh-------------ccccccCCCCCCH
Confidence            9999999999999999999999999988 666665322      222 222222             2233445677888


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhc
Q 039626          592 LVIRLIDACLKKDPTDRPTMYEIEHSLSNILNAS  625 (628)
Q Consensus       592 ~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~~~~  625 (628)
                      .+++||++||+++|.+||++.|+-+.++.|++++
T Consensus       494 kVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~s  527 (1157)
T KOG4278|consen  494 KVYELMRACWNWSPSDRPSFAEIHQAFETMFSSS  527 (1157)
T ss_pred             HHHHHHHHHhcCCcccCccHHHHHHHHHHHhccc
Confidence            8999999999999999999999999999998754

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.4e-37  Score=308.25  Aligned_cols=254  Identities=25%  Similarity=0.436  Sum_probs=188.8

Q ss_pred             eEEEEEEECCceEEEEEecc----chHHHHHHHhh--cCCCceeeeeeeeecCC----eEEEEEEecCCCChHHHhhhcC
Q 039626          361 GSVYRGKINGGFAAIKKVNG----DVSKEIALLNK--INHSNLIILSGVCFNEG----NCYLVYEYAVNGTLSDWVFSNK  430 (628)
Q Consensus       361 G~Vy~g~~~g~~vavK~~~~----~~~~E~~~l~~--l~H~nIv~l~g~~~~~~----~~~lV~E~~~~gsL~~~l~~~~  430 (628)
                      |.||+|.|.|+.||||.+..    .+.+|.++.+.  |+|+||+.+++.-..+.    +++||.+|.++|||.|||..  
T Consensus       225 GEVwrG~wrGe~VAVKiF~srdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r--  302 (513)
T KOG2052|consen  225 GEVWRGRWRGEDVAVKIFSSRDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTDYHEHGSLYDYLNR--  302 (513)
T ss_pred             cceeeccccCCceEEEEecccchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeeecccCCcHHHHHhh--
Confidence            99999999999999999864    35567666665  59999999999876443    58999999999999999943  


Q ss_pred             CCCCCCCHHHHHHHHHHHHHHHHHHhc-----CCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcc-eeeec
Q 039626          431 NEGKYLDWKQRIQIALDVATGLNYLHS-----FTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEF-ALTRH  504 (628)
Q Consensus       431 ~~~~~l~~~~~~~i~~~ia~gL~yLH~-----~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~-~~~~~  504 (628)
                         ..++-...++++..+|.||+|||-     .++|.|.|||||+.|||+..++.+.|+|+|||.......... .....
T Consensus       303 ---~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~  379 (513)
T KOG2052|consen  303 ---NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNP  379 (513)
T ss_pred             ---ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEEecccCCcccCCCCC
Confidence               468889999999999999999995     467899999999999999999999999999998765443322 23355


Q ss_pred             ccCCccccCccccccCCC------CcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhcc---
Q 039626          505 IVGTKGYMAPEYLENGLV------STKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRH---  575 (628)
Q Consensus       505 ~~gt~~Y~APE~l~~~~~------s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~---  575 (628)
                      .+||.+|||||++.....      -..+||||||.|+||+.....--. ..++....+.+++..-.    ..+.+++   
T Consensus       380 rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~gg-i~eey~~Pyyd~Vp~DP----s~eeMrkVVC  454 (513)
T KOG2052|consen  380 RVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGG-IVEEYQLPYYDVVPSDP----SFEEMRKVVC  454 (513)
T ss_pred             ccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCC-EehhhcCCcccCCCCCC----CHHHHhccee
Confidence            799999999999975422      236899999999999876332100 00111111111111100    1111111   


Q ss_pred             --ccCCcCCCCC-CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhh
Q 039626          576 --FIDPTLQGNY-PLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNA  624 (628)
Q Consensus       576 --~~d~~l~~~~-~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~~~  624 (628)
                        -+.|..+..+ ..+....+.++|+.||..+|..|-|+-.+.+.|.++.++
T Consensus       455 v~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~~  506 (513)
T KOG2052|consen  455 VQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSNS  506 (513)
T ss_pred             ecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhcC
Confidence              1223333222 346677899999999999999999999999999999854

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=6.5e-37  Score=319.90  Aligned_cols=255  Identities=28%  Similarity=0.506  Sum_probs=195.9

Q ss_pred             HHHHHHhcCCCcCCccc----eEEEEEEECCceEEEEEecc---------chHHHHHHHhhcCCCceeeeeeeeecCCeE
Q 039626          344 KELQSATDNFSFTCRIQ----GSVYRGKINGGFAAIKKVNG---------DVSKEIALLNKINHSNLIILSGVCFNEGNC  410 (628)
Q Consensus       344 ~el~~at~~f~~~~~i~----G~Vy~g~~~g~~vavK~~~~---------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~  410 (628)
                      ++...-.+++....+||    |+||||+|.|+ ||||.++.         .|++|+..+++-+|.||+-++|+|.+.+. 
T Consensus       385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whGd-VAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-  462 (678)
T KOG0193|consen  385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWHGD-VAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-  462 (678)
T ss_pred             cccccCHHHhhccceeccccccceeecccccc-eEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-
Confidence            33333334444445554    99999999764 89999864         48899999999999999999999998877 


Q ss_pred             EEEEEecCCCChHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccc
Q 039626          411 YLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMAR  490 (628)
Q Consensus       411 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~  490 (628)
                      .+|.-|++|-+|+.+||-.+   ..+...+.++||.|||.||.|||.   ++|||||||+.||+|.+++.+||+||||+.
T Consensus       463 AIiTqwCeGsSLY~hlHv~e---tkfdm~~~idIAqQiaqGM~YLHA---K~IIHrDLKSnNIFl~~~~kVkIgDFGLat  536 (678)
T KOG0193|consen  463 AIITQWCEGSSLYTHLHVQE---TKFDMNTTIDIAQQIAQGMDYLHA---KNIIHRDLKSNNIFLHEDLKVKIGDFGLAT  536 (678)
T ss_pred             eeeehhccCchhhhhccchh---hhhhHHHHHHHHHHHHHhhhhhhh---hhhhhhhccccceEEccCCcEEEeccccee
Confidence            99999999999999997543   458889999999999999999999   559999999999999999999999999986


Q ss_pred             cCCCCCCcceeeecccCCccccCcccccc---CCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccc
Q 039626          491 PAEGQEGEFALTRHIVGTKGYMAPEYLEN---GLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKE  567 (628)
Q Consensus       491 ~~~~~~~~~~~~~~~~gt~~Y~APE~l~~---~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~  567 (628)
                      .-..-.... -.....|...|||||+++.   ..|+..+||||||+|+|||++|..|+.....+.       +..+...+
T Consensus       537 vk~~w~g~~-q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dq-------IifmVGrG  608 (678)
T KOG0193|consen  537 VKTRWSGEQ-QLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQ-------IIFMVGRG  608 (678)
T ss_pred             eeeeecccc-ccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhh-------eEEEeccc
Confidence            543221111 1122357788999999874   368999999999999999999999987322211       11111101


Q ss_pred             cchhhhccccCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHh
Q 039626          568 DGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILN  623 (628)
Q Consensus       568 ~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~~  623 (628)
                              ...+.+- ....++..+|.+|+..||..++++||.+.+|+..|+.++-
T Consensus       609 --------~l~pd~s-~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~  655 (678)
T KOG0193|consen  609 --------YLMPDLS-KIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP  655 (678)
T ss_pred             --------ccCccch-hhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence                    0111110 1122456678999999999999999999999999988875

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-37  Score=325.20  Aligned_cols=236  Identities=31%  Similarity=0.518  Sum_probs=191.1

Q ss_pred             ceEEEEEEE--C-C--ce-EEEEEecc----------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChH
Q 039626          360 QGSVYRGKI--N-G--GF-AAIKKVNG----------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLS  423 (628)
Q Consensus       360 ~G~Vy~g~~--~-g--~~-vavK~~~~----------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~  423 (628)
                      .|.||+|++  . +  .. ||||..+.          ++.+|.++|++++|+|||+++|++..+..+++|||++.||+|.
T Consensus       170 FGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ivmEl~~gGsL~  249 (474)
T KOG0194|consen  170 FGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLVMELCNGGSLD  249 (474)
T ss_pred             ccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEEEEecCCCcHH
Confidence            399999998  2 2  23 89998874          4678999999999999999999999999999999999999999


Q ss_pred             HHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeee
Q 039626          424 DWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTR  503 (628)
Q Consensus       424 ~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~  503 (628)
                      ++|...   ...++..+++.++.+.|.||+|||+   .++|||||.++|+|++.++.+||+|||+++....    +....
T Consensus       250 ~~L~k~---~~~v~~~ek~~~~~~AA~Gl~YLh~---k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~----~~~~~  319 (474)
T KOG0194|consen  250 DYLKKN---KKSLPTLEKLRFCYDAARGLEYLHS---KNCIHRDIAARNCLYSKKGVVKISDFGLSRAGSQ----YVMKK  319 (474)
T ss_pred             HHHHhC---CCCCCHHHHHHHHHHHHhHHHHHHH---CCCcchhHhHHHheecCCCeEEeCccccccCCcc----eeecc
Confidence            999543   3369999999999999999999999   4599999999999999999999999999886531    11111


Q ss_pred             -cccCCccccCccccccCCCCcccccHHHHHHHHHHHh-CCCccccccccccccHHHHHHHHhccccchhhhccccCCcC
Q 039626          504 -HIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT-GKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTL  581 (628)
Q Consensus       504 -~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELlt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l  581 (628)
                       ...-...|+|||.+..+.++.++|||||||++||+++ |..|+....      ..+....+...             ..
T Consensus       320 ~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~------~~~v~~kI~~~-------------~~  380 (474)
T KOG0194|consen  320 FLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMK------NYEVKAKIVKN-------------GY  380 (474)
T ss_pred             ccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCC------HHHHHHHHHhc-------------Cc
Confidence             2245678999999999999999999999999999998 777765322      22222222111             11


Q ss_pred             CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhh
Q 039626          582 QGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNA  624 (628)
Q Consensus       582 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~~~  624 (628)
                      +...+...+..+..++.+||..||++||+|.++.+.|+.+...
T Consensus       381 r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~  423 (474)
T KOG0194|consen  381 RMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKK  423 (474)
T ss_pred             cCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhc
Confidence            1222334556678899999999999999999999999988754

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-37  Score=306.97  Aligned_cols=219  Identities=26%  Similarity=0.364  Sum_probs=181.2

Q ss_pred             eEEEEEEE--CCceEEEEEecc----------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhh
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG----------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFS  428 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  428 (628)
                      |.||..+-  .++.+|+|.+++          ....|..+|.+++||.||++.-.|.+.+++|||+||+.||.|..+|.+
T Consensus        39 GkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVld~~~GGeLf~hL~~  118 (357)
T KOG0598|consen   39 GKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVLDYLNGGELFYHLQR  118 (357)
T ss_pred             ceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEEeccCCccHHHHHHh
Confidence            89998876  678999998865          245799999999999999999999999999999999999999999943


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCC
Q 039626          429 NKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGT  508 (628)
Q Consensus       429 ~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt  508 (628)
                          .+.+++....-++.+|+.||.|||+.+   ||||||||+|||||++|.++|+||||++..-...   ..+...+||
T Consensus       119 ----eg~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~---~~t~tfcGT  188 (357)
T KOG0598|consen  119 ----EGRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDG---DATRTFCGT  188 (357)
T ss_pred             ----cCCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhcccCC---CccccccCC
Confidence                345888888889999999999999954   9999999999999999999999999999653322   134557999


Q ss_pred             ccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCHH
Q 039626          509 KGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLE  588 (628)
Q Consensus       509 ~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~  588 (628)
                      +.|||||++....++..+|.||+|+++|||++|.+||.....      .++...+....              ....|.-
T Consensus       189 ~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~------~~~~~~I~~~k--------------~~~~p~~  248 (357)
T KOG0598|consen  189 PEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDV------KKMYDKILKGK--------------LPLPPGY  248 (357)
T ss_pred             ccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccH------HHHHHHHhcCc--------------CCCCCcc
Confidence            999999999999999999999999999999999999974332      22333332211              0112222


Q ss_pred             HHHHHHHHHHHhcccCCCCCC
Q 039626          589 LALLVIRLIDACLKKDPTDRP  609 (628)
Q Consensus       589 ~~~~l~~l~~~Cl~~dP~~RP  609 (628)
                      .+....+++++.|.+||++|.
T Consensus       249 ls~~ardll~~LL~rdp~~RL  269 (357)
T KOG0598|consen  249 LSEEARDLLKKLLKRDPRQRL  269 (357)
T ss_pred             CCHHHHHHHHHHhccCHHHhc
Confidence            455678999999999999996

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=4.4e-36  Score=285.26  Aligned_cols=243  Identities=27%  Similarity=0.333  Sum_probs=191.6

Q ss_pred             eEEEEEEE--CCceEEEEEecc---------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhc
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG---------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSN  429 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~---------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~  429 (628)
                      |.||+|+.  .|+.|||||++-         ...+|++.|+.++|+||+.++++|-+.+...||+|||+. +|+..+.  
T Consensus        16 gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEfm~t-dLe~vIk--   92 (318)
T KOG0659|consen   16 GVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEFMPT-DLEVVIK--   92 (318)
T ss_pred             EEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEeccc-cHHHHhc--
Confidence            89999998  799999999863         356899999999999999999999999999999999954 8999884  


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCCc
Q 039626          430 KNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTK  509 (628)
Q Consensus       430 ~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~  509 (628)
                       .....++-.++..++.++++||+|||+..   |+||||||.|+|++++|.+||+|||+|+.+......   ..+.+-|.
T Consensus        93 -d~~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~---~~~~V~TR  165 (318)
T KOG0659|consen   93 -DKNIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRI---QTHQVVTR  165 (318)
T ss_pred             -ccccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCCcc---cccceeee
Confidence             45667999999999999999999999965   999999999999999999999999999998754432   23348899


Q ss_pred             cccCcccccc-CCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccc--h---------hhhcccc
Q 039626          510 GYMAPEYLEN-GLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDG--E---------ESLRHFI  577 (628)
Q Consensus       510 ~Y~APE~l~~-~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~---------~~l~~~~  577 (628)
                      +|+|||.+.+ ..|+...|+||.||++.||+-|.+-+.+..+-   .....+.+.+.....  .         ..++.+-
T Consensus       166 WYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDi---dQL~~If~~LGTP~~~~WP~~~~lpdY~~~~~~P  242 (318)
T KOG0659|consen  166 WYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDI---DQLSKIFRALGTPTPDQWPEMTSLPDYVKIQQFP  242 (318)
T ss_pred             eccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchH---HHHHHHHHHcCCCCcccCccccccccHHHHhcCC
Confidence            9999998876 57999999999999999999998766644332   222333333322211  1         1122122


Q ss_pred             CCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 039626          578 DPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHS  617 (628)
Q Consensus       578 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~  617 (628)
                      .+.+..-++ .....+.+|+..++..||.+|.++.|+++.
T Consensus       243 ~~~~~~lf~-aas~d~ldLl~~m~~ynP~~Rita~qaL~~  281 (318)
T KOG0659|consen  243 KPPLNNLFP-AASSDALDLLSKMLTYNPKKRITASQALKH  281 (318)
T ss_pred             CCccccccc-cccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence            222222222 344556899999999999999999998764

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=2e-36  Score=313.48  Aligned_cols=242  Identities=24%  Similarity=0.414  Sum_probs=191.9

Q ss_pred             eEEEEEEECC-ceEEEEEecc--------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhcCC
Q 039626          361 GSVYRGKING-GFAAIKKVNG--------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKN  431 (628)
Q Consensus       361 G~Vy~g~~~g-~~vavK~~~~--------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~  431 (628)
                      |.|.....++ ..||||+++.        +|.+|+++|.+++|||||+|+|+|..++.+++|+|||++|+|.++|..+..
T Consensus       552 GEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYmEnGDLnqFl~ahea  631 (807)
T KOG1094|consen  552 GEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYMENGDLNQFLSAHEL  631 (807)
T ss_pred             ceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHHhcCcHHHHHHhccC
Confidence            8899998876 8999999975        588999999999999999999999999999999999999999999976533


Q ss_pred             CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCCccc
Q 039626          432 EGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGY  511 (628)
Q Consensus       432 ~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~Y  511 (628)
                      ..  +.-..-.+|+.||+.||+||.+..   ++||||.++|+|+|.++++||+|||++|.....+. +....+.+-..+|
T Consensus       632 pt--~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~y-y~vqgr~vlpiRw  705 (807)
T KOG1094|consen  632 PT--AETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDY-YRVQGRAVLPIRW  705 (807)
T ss_pred             cc--cccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccccCCc-eeeecceeeeeee
Confidence            22  444566779999999999999965   99999999999999999999999999997654432 2334456777899


Q ss_pred             cCccccccCCCCcccccHHHHHHHHHHHh--CCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCHHH
Q 039626          512 MAPEYLENGLVSTKLDVYAFGVLILEMLT--GKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLEL  589 (628)
Q Consensus       512 ~APE~l~~~~~s~k~DV~SfGvvl~ELlt--G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~  589 (628)
                      ||+|.+..+++++++|||+||+.+||+++  ...|+....++   ...+....++....          +..-...|.-+
T Consensus       706 mawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e---~vven~~~~~~~~~----------~~~~l~~P~~c  772 (807)
T KOG1094|consen  706 MAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDE---QVVENAGEFFRDQG----------RQVVLSRPPAC  772 (807)
T ss_pred             hhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHH---HHHHhhhhhcCCCC----------cceeccCCCcC
Confidence            99999999999999999999999999865  44565422211   11112222221111          00111234556


Q ss_pred             HHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 039626          590 ALLVIRLIDACLKKDPTDRPTMYEIEHSLSNI  621 (628)
Q Consensus       590 ~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l  621 (628)
                      +..+.+++.+||..|.++||+++++...|...
T Consensus       773 p~~lyelml~Cw~~es~~RPsFe~lh~~lq~~  804 (807)
T KOG1094|consen  773 PQGLYELMLRCWRRESEQRPSFEQLHLFLQED  804 (807)
T ss_pred             cHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence            67788999999999999999999999888764

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=4e-36  Score=320.74  Aligned_cols=239  Identities=23%  Similarity=0.424  Sum_probs=186.9

Q ss_pred             eEEEEEEE-------CCceEEEEEecc--------chHHHHHHHhhc-CCCceeeeeeeeecCCeEEEEEEecCCCChHH
Q 039626          361 GSVYRGKI-------NGGFAAIKKVNG--------DVSKEIALLNKI-NHSNLIILSGVCFNEGNCYLVYEYAVNGTLSD  424 (628)
Q Consensus       361 G~Vy~g~~-------~g~~vavK~~~~--------~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~  424 (628)
                      |.||++..       ++..||+|+++.        .+.+|+++++++ +|+||++++++|...+..++||||+++|+|.+
T Consensus        52 g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~~lv~ey~~~g~L~~  131 (374)
T cd05106          52 GKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLN  131 (374)
T ss_pred             ccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCeEEeHhhccCCcHHH
Confidence            89999875       224799999864        356799999999 89999999999999999999999999999999


Q ss_pred             HhhhcCC------------------------------------------------------------------CCCCCCH
Q 039626          425 WVFSNKN------------------------------------------------------------------EGKYLDW  438 (628)
Q Consensus       425 ~l~~~~~------------------------------------------------------------------~~~~l~~  438 (628)
                      ++.....                                                                  ....++|
T Consensus       132 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  211 (374)
T cd05106         132 FLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSKDEEDTEDSWPLDL  211 (374)
T ss_pred             HHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccccchhccCCCCCcCH
Confidence            9854211                                                                  1234789


Q ss_pred             HHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCCccccCccccc
Q 039626          439 KQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLE  518 (628)
Q Consensus       439 ~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~  518 (628)
                      .++++++.|++.||+|||+   .+++||||||+|||+++++.+||+|||+++....... ........++..|+|||++.
T Consensus       212 ~~~~~i~~qi~~aL~yLH~---~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~-~~~~~~~~~~~~y~aPE~~~  287 (374)
T cd05106         212 DDLLRFSSQVAQGMDFLAS---KNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSN-YVVKGNARLPVKWMAPESIF  287 (374)
T ss_pred             HHHHHHHHHHHHHHHHHHH---CCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcc-eeeccCCCCccceeCHHHhc
Confidence            9999999999999999998   4599999999999999999999999999986543221 11222334567899999999


Q ss_pred             cCCCCcccccHHHHHHHHHHHh-CCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCHHHHHHHHHHH
Q 039626          519 NGLVSTKLDVYAFGVLILEMLT-GKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLI  597 (628)
Q Consensus       519 ~~~~s~k~DV~SfGvvl~ELlt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~  597 (628)
                      +..++.++||||||+++|||++ |+.|+.......      .........         ..+    ..+...+..+.+++
T Consensus       288 ~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~------~~~~~~~~~---------~~~----~~~~~~~~~l~~li  348 (374)
T cd05106         288 DCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS------KFYKMVKRG---------YQM----SRPDFAPPEIYSIM  348 (374)
T ss_pred             CCCCCccccHHHHHHHHHHHHhCCCCCCccccccH------HHHHHHHcc---------cCc----cCCCCCCHHHHHHH
Confidence            9999999999999999999997 998876432111      111111100         011    11112235678999


Q ss_pred             HHhcccCCCCCCCHHHHHHHHHHhH
Q 039626          598 DACLKKDPTDRPTMYEIEHSLSNIL  622 (628)
Q Consensus       598 ~~Cl~~dP~~RPs~~ev~~~L~~l~  622 (628)
                      .+||+.||++||++.+|++.|++++
T Consensus       349 ~~cl~~dp~~RPs~~~l~~~l~~~~  373 (374)
T cd05106         349 KMCWNLEPTERPTFSQISQLIQRQL  373 (374)
T ss_pred             HHHcCCChhhCcCHHHHHHHHHHHh
Confidence            9999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=1e-35  Score=308.49  Aligned_cols=242  Identities=26%  Similarity=0.413  Sum_probs=183.3

Q ss_pred             eEEEEEEEC------------------CceEEEEEecc--------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEE
Q 039626          361 GSVYRGKIN------------------GGFAAIKKVNG--------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVY  414 (628)
Q Consensus       361 G~Vy~g~~~------------------g~~vavK~~~~--------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~  414 (628)
                      |.||++.++                  +..+|+|.+..        ++.+|+++|.+++|+||+++++++.+.+..++||
T Consensus        19 g~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~   98 (304)
T cd05096          19 GEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMIT   98 (304)
T ss_pred             eEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEecCCceEEEE
Confidence            899999752                  23689998754        4678999999999999999999999999999999


Q ss_pred             EecCCCChHHHhhhcCC---------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCC
Q 039626          415 EYAVNGTLSDWVFSNKN---------------EGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDL  479 (628)
Q Consensus       415 E~~~~gsL~~~l~~~~~---------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~  479 (628)
                      ||+++|+|.+++.....               ....++|..+++++.|++.||.|||+.   +++||||||+|||+++++
T Consensus        99 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~ivH~dlkp~Nill~~~~  175 (304)
T cd05096          99 EYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFVHRDLATRNCLVGENL  175 (304)
T ss_pred             ecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---CccccCcchhheEEcCCc
Confidence            99999999999854321               123578999999999999999999985   499999999999999999


Q ss_pred             cEEEccccccccCCCCCCcceeeecccCCccccCccccccCCCCcccccHHHHHHHHHHHhCC--CccccccccccccHH
Q 039626          480 RAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGK--EAAALHAEENNMHLS  557 (628)
Q Consensus       480 ~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~--~p~~~~~~~~~~~~~  557 (628)
                      .+||+|||+++....... ........++..|+|||++.++.++.++||||||++++||+++.  .|+......   ...
T Consensus       176 ~~kl~DfG~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~---~~~  251 (304)
T cd05096         176 TIKIADFGMSRNLYAGDY-YRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGELTDE---QVI  251 (304)
T ss_pred             cEEECCCccceecccCce-eEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCCCCcCCHH---HHH
Confidence            999999999986643321 12233445688999999999889999999999999999999754  444322111   111


Q ss_pred             HHHHHHhccccchhhhccccCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 039626          558 DVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLS  619 (628)
Q Consensus       558 ~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~  619 (628)
                      ...........     .. ..    ...+..++..+.+++.+||+.||++|||+.||.+.|+
T Consensus       252 ~~~~~~~~~~~-----~~-~~----~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~  303 (304)
T cd05096         252 ENAGEFFRDQG-----RQ-VY----LFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT  303 (304)
T ss_pred             HHHHHHhhhcc-----cc-cc----ccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence            11111111000     00 00    0111233456889999999999999999999998876

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=5e-36  Score=320.14  Aligned_cols=238  Identities=22%  Similarity=0.404  Sum_probs=184.9

Q ss_pred             eEEEEEEE-------CCceEEEEEecc--------chHHHHHHHhhc-CCCceeeeeeeeecCCeEEEEEEecCCCChHH
Q 039626          361 GSVYRGKI-------NGGFAAIKKVNG--------DVSKEIALLNKI-NHSNLIILSGVCFNEGNCYLVYEYAVNGTLSD  424 (628)
Q Consensus       361 G~Vy~g~~-------~g~~vavK~~~~--------~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~  424 (628)
                      |.||++++       .+..||+|+++.        .+.+|+++|..+ +||||++++|+|.+++..++||||+++|+|.+
T Consensus        49 G~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~~g~L~~  128 (375)
T cd05104          49 GKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPTLVITEYCCYGDLLN  128 (375)
T ss_pred             ceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcceeeehhccCCcHHH
Confidence            89999974       245799998863        356799999999 89999999999999999999999999999999


Q ss_pred             HhhhcCC-----------------------------------------------------------------------CC
Q 039626          425 WVFSNKN-----------------------------------------------------------------------EG  433 (628)
Q Consensus       425 ~l~~~~~-----------------------------------------------------------------------~~  433 (628)
                      ++.....                                                                       ..
T Consensus       129 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  208 (375)
T cd05104         129 FLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYIDQDVTSEILEEDE  208 (375)
T ss_pred             HHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccceecccccHHHHHhccC
Confidence            9964321                                                                       12


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCCccccC
Q 039626          434 KYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMA  513 (628)
Q Consensus       434 ~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~Y~A  513 (628)
                      ..++|..+++++.||+.||+|||+   .+++||||||+|||+++++.+||+|||+++....... ........++..|+|
T Consensus       209 ~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~-~~~~~~~~~~~~y~a  284 (375)
T cd05104         209 LALDTEDLLSFSYQVAKGMSFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSN-YVVKGNARLPVKWMA  284 (375)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCchhhEEEECCCcEEEecCccceeccCccc-ccccCCCCCCcceeC
Confidence            258899999999999999999998   4599999999999999999999999999986643221 111222345678999


Q ss_pred             ccccccCCCCcccccHHHHHHHHHHHh-CCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCHHHHHH
Q 039626          514 PEYLENGLVSTKLDVYAFGVLILEMLT-GKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALL  592 (628)
Q Consensus       514 PE~l~~~~~s~k~DV~SfGvvl~ELlt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~  592 (628)
                      ||.+.+..++.++||||||+++|||++ |..|+......      ......+...             .....+...+..
T Consensus       285 PE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~------~~~~~~~~~~-------------~~~~~~~~~~~~  345 (375)
T cd05104         285 PESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD------SKFYKMIKEG-------------YRMLSPECAPSE  345 (375)
T ss_pred             hhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCch------HHHHHHHHhC-------------ccCCCCCCCCHH
Confidence            999999999999999999999999998 77776532111      1111111110             000111122346


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 039626          593 VIRLIDACLKKDPTDRPTMYEIEHSLSNI  621 (628)
Q Consensus       593 l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l  621 (628)
                      +.+++.+||+.||++||++.||++.|++.
T Consensus       346 l~~li~~cl~~dP~~RPs~~eil~~l~~~  374 (375)
T cd05104         346 MYDIMKSCWDADPLKRPTFKQIVQLIEQQ  374 (375)
T ss_pred             HHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence            88999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-36  Score=310.99  Aligned_cols=246  Identities=27%  Similarity=0.413  Sum_probs=195.3

Q ss_pred             CCCcCCccc----eEEEEEEE--CCceEEEEEeccc----------hHHHHHHHhhc-CCCceeeeeeeeecCCeEEEEE
Q 039626          352 NFSFTCRIQ----GSVYRGKI--NGGFAAIKKVNGD----------VSKEIALLNKI-NHSNLIILSGVCFNEGNCYLVY  414 (628)
Q Consensus       352 ~f~~~~~i~----G~Vy~g~~--~g~~vavK~~~~~----------~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV~  414 (628)
                      +|.++..+|    .+|++++.  .+..+|||++.++          +..|-+.|.+| +||.|++|+-.|.++..+|+|+
T Consensus        74 DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFvL  153 (604)
T KOG0592|consen   74 DFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFVL  153 (604)
T ss_pred             hcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEEE
Confidence            344444443    68999987  6889999988653          45688899999 8999999999999999999999


Q ss_pred             EecCCCChHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCC
Q 039626          415 EYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEG  494 (628)
Q Consensus       415 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~  494 (628)
                      ||++||+|.++|...    +.+++.-...++.+|+.||+|||+.+   ||||||||+|||||+|+++||+|||.|+.+..
T Consensus       154 e~A~nGdll~~i~K~----Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK~l~~  226 (604)
T KOG0592|consen  154 EYAPNGDLLDLIKKY----GSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAKILSP  226 (604)
T ss_pred             EecCCCcHHHHHHHh----CcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeeccccccCCh
Confidence            999999999999643    45888888899999999999999954   99999999999999999999999999998754


Q ss_pred             CCCc--------ceee--ecccCCccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHh
Q 039626          495 QEGE--------FALT--RHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVL  564 (628)
Q Consensus       495 ~~~~--------~~~~--~~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~  564 (628)
                      ....        ....  ...+||..|.+||.+.....++.+|+|+|||+||.|+.|++||....+      ...+++++
T Consensus       227 ~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ne------yliFqkI~  300 (604)
T KOG0592|consen  227 SQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANE------YLIFQKIQ  300 (604)
T ss_pred             hhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccH------HHHHHHHH
Confidence            3211        0111  347999999999999999999999999999999999999999874322      12223322


Q ss_pred             ccccchhhhccccCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhccCC
Q 039626          565 TKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNASLNW  628 (628)
Q Consensus       565 ~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~~~~~~w  628 (628)
                      .               +.-.+|...++.+.+|+++.|..||.+|++..+|.+   .-.-..+||
T Consensus       301 ~---------------l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~---HpFF~~Vdw  346 (604)
T KOG0592|consen  301 A---------------LDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKA---HPFFEGVDW  346 (604)
T ss_pred             H---------------hcccCCCCCCHHHHHHHHHHHccCccccccHHHHhh---CcccccCCh
Confidence            2               111334444566789999999999999999977754   233444444

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=7.6e-36  Score=303.44  Aligned_cols=234  Identities=26%  Similarity=0.374  Sum_probs=185.6

Q ss_pred             eEEEEEEE-----CCceEEEEEecc--------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhh
Q 039626          361 GSVYRGKI-----NGGFAAIKKVNG--------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVF  427 (628)
Q Consensus       361 G~Vy~g~~-----~g~~vavK~~~~--------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~  427 (628)
                      |.||+|++     .+..+|+|..+.        .+.+|+..+.+++|+||++++|++..++..++||||+++|+|.+++.
T Consensus        19 g~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~   98 (266)
T cd05064          19 GELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLR   98 (266)
T ss_pred             CeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEEEEeCCCCcHHHHHH
Confidence            89999986     245889998764        35679999999999999999999999999999999999999999995


Q ss_pred             hcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccC
Q 039626          428 SNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVG  507 (628)
Q Consensus       428 ~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~g  507 (628)
                      ..   ...++|.+++.++.|++.||+|||+.   +++||||||+|||++.++.+|++|||.+.......  ........+
T Consensus        99 ~~---~~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~  170 (266)
T cd05064          99 KH---EGQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEA--IYTTMSGKS  170 (266)
T ss_pred             hC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCcccccccccc--hhcccCCCC
Confidence            42   24689999999999999999999984   59999999999999999999999999876542211  111122345


Q ss_pred             CccccCccccccCCCCcccccHHHHHHHHHHHh-CCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCC
Q 039626          508 TKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT-GKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYP  586 (628)
Q Consensus       508 t~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELlt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~  586 (628)
                      +..|+|||.+.+..++.++||||||+++||+++ |+.|+.....      .+....+..          ...    ...+
T Consensus       171 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~------~~~~~~~~~----------~~~----~~~~  230 (266)
T cd05064         171 PVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSG------QDVIKAVED----------GFR----LPAP  230 (266)
T ss_pred             ceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCH------HHHHHHHHC----------CCC----CCCC
Confidence            678999999999999999999999999999875 9888753221      111111110          000    1112


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhH
Q 039626          587 LELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNIL  622 (628)
Q Consensus       587 ~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~  622 (628)
                      ...+..+.+++.+||+.+|.+||++++|.+.|++++
T Consensus       231 ~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~~  266 (266)
T cd05064         231 RNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKMV  266 (266)
T ss_pred             CCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhhC
Confidence            334556889999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=3e-36  Score=305.33  Aligned_cols=232  Identities=32%  Similarity=0.545  Sum_probs=179.6

Q ss_pred             eEEEEEEEC------CceEEEEEecc--------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHh
Q 039626          361 GSVYRGKIN------GGFAAIKKVNG--------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWV  426 (628)
Q Consensus       361 G~Vy~g~~~------g~~vavK~~~~--------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l  426 (628)
                      |.||+|.+.      +..|+||.++.        ++.+|++.+++++|+||++++|+|...+..++|+||+++|+|.++|
T Consensus        13 g~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~~~g~L~~~L   92 (259)
T PF07714_consen   13 GKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYCPGGSLDDYL   92 (259)
T ss_dssp             EEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--TTEBHHHHH
T ss_pred             cEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccccccccccccc
Confidence            899999997      67899999953        4678999999999999999999999888899999999999999999


Q ss_pred             hhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeeccc
Q 039626          427 FSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIV  506 (628)
Q Consensus       427 ~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~  506 (628)
                      ...  ....+++.++..|+.|+++||.|||+.   +++|+||+++||++++++.+||+|||+++....... ........
T Consensus        93 ~~~--~~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~-~~~~~~~~  166 (259)
T PF07714_consen   93 KSK--NKEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK-YKNDSSQQ  166 (259)
T ss_dssp             HHT--CTTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS-EEESTTSE
T ss_pred             ccc--ccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccc-cccccccc
Confidence            764  345699999999999999999999994   499999999999999999999999999987632221 12223345


Q ss_pred             CCccccCccccccCCCCcccccHHHHHHHHHHHh-CCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCC
Q 039626          507 GTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT-GKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNY  585 (628)
Q Consensus       507 gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELlt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~  585 (628)
                      +...|+|||.+....++.++||||||+++||+++ |+.|+...      ...+....+....              +...
T Consensus       167 ~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~------~~~~~~~~~~~~~--------------~~~~  226 (259)
T PF07714_consen  167 LPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDY------DNEEIIEKLKQGQ--------------RLPI  226 (259)
T ss_dssp             SGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTS------CHHHHHHHHHTTE--------------ETTS
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccc------ccccccccccccc--------------ccee
Confidence            7788999999999999999999999999999999 66665422      1222222221110              0111


Q ss_pred             CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 039626          586 PLELALLVIRLIDACLKKDPTDRPTMYEIEHSL  618 (628)
Q Consensus       586 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L  618 (628)
                      +...+..+.+++.+||+.||++||++.++++.|
T Consensus       227 ~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  227 PDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             BTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             ccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence            223345678999999999999999999999886

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=1.7e-35  Score=300.09  Aligned_cols=235  Identities=27%  Similarity=0.424  Sum_probs=188.4

Q ss_pred             eEEEEEEE--CCceEEEEEecc------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhcCCC
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNE  432 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~  432 (628)
                      |.||+|.+  .++.+|+|..+.      ++.+|++++++++|+||+++++++..++..+++|||+++++|.+++...  .
T Consensus        20 ~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~   97 (263)
T cd05052          20 GEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLREC--N   97 (263)
T ss_pred             ceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCCCCcHHHHHHhC--C
Confidence            89999998  578899998864      3667999999999999999999999999999999999999999998542  2


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCCcccc
Q 039626          433 GKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYM  512 (628)
Q Consensus       433 ~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~Y~  512 (628)
                      ...++|..++.++.|++.||+|||+   .+++||||||+||++++++.+||+|||+++.......  .......++..|+
T Consensus        98 ~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~--~~~~~~~~~~~y~  172 (263)
T cd05052          98 RQEVNAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY--TAHAGAKFPIKWT  172 (263)
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCcEEeCCCcccccccccee--eccCCCCCccccC
Confidence            3458999999999999999999998   4599999999999999999999999999987643221  1111223466899


Q ss_pred             CccccccCCCCcccccHHHHHHHHHHHh-CCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCHHHHH
Q 039626          513 APEYLENGLVSTKLDVYAFGVLILEMLT-GKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELAL  591 (628)
Q Consensus       513 APE~l~~~~~s~k~DV~SfGvvl~ELlt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~  591 (628)
                      |||++.+..++.++||||||++++||++ |..|+.....      .+.......          .    .....+...+.
T Consensus       173 aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~------~~~~~~~~~----------~----~~~~~~~~~~~  232 (263)
T cd05052         173 APESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL------SQVYELLEK----------G----YRMERPEGCPP  232 (263)
T ss_pred             CHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH------HHHHHHHHC----------C----CCCCCCCCCCH
Confidence            9999999999999999999999999998 8887753221      111111110          0    11122233446


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHHHHHHhH
Q 039626          592 LVIRLIDACLKKDPTDRPTMYEIEHSLSNIL  622 (628)
Q Consensus       592 ~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~  622 (628)
                      .+.+++.+||+.||++||++.++++.|+.+.
T Consensus       233 ~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~  263 (263)
T cd05052         233 KVYELMRACWQWNPSDRPSFAEIHQAFETMF  263 (263)
T ss_pred             HHHHHHHHHccCCcccCCCHHHHHHHHHhhC
Confidence            6889999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=1.5e-35  Score=303.59  Aligned_cols=237  Identities=26%  Similarity=0.506  Sum_probs=188.9

Q ss_pred             eEEEEEEECC-------ceEEEEEecc--------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHH
Q 039626          361 GSVYRGKING-------GFAAIKKVNG--------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDW  425 (628)
Q Consensus       361 G~Vy~g~~~g-------~~vavK~~~~--------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~  425 (628)
                      |.||+|...+       ..+|+|.++.        ++.+|++++.+++|+||+++++++...+..+++|||+++|+|.++
T Consensus        19 g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~L~~~   98 (283)
T cd05048          19 GKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEF   98 (283)
T ss_pred             CcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEEEEecCCCCcHHHH
Confidence            8999998732       4689998863        367899999999999999999999998999999999999999999


Q ss_pred             hhhcCC------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCC
Q 039626          426 VFSNKN------------EGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAE  493 (628)
Q Consensus       426 l~~~~~------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~  493 (628)
                      +.....            ....+++..++.++.|++.||+|||+.   +++|+||||+||++++++.+||+|||+++...
T Consensus        99 l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~~~~~~L~dfg~~~~~~  175 (283)
T cd05048          99 LVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGLTVKISDFGLSRDIY  175 (283)
T ss_pred             HHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcCCCcEEECCCcceeecc
Confidence            965321            114588999999999999999999984   59999999999999999999999999998654


Q ss_pred             CCCCcceeeecccCCccccCccccccCCCCcccccHHHHHHHHHHHh-CCCccccccccccccHHHHHHHHhccccchhh
Q 039626          494 GQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT-GKEAAALHAEENNMHLSDVLNAVLTKEDGEES  572 (628)
Q Consensus       494 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELlt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  572 (628)
                      .... ........+++.|+|||++.+..++.++|||||||+++||++ |+.|+.....      .+....+..       
T Consensus       176 ~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~------~~~~~~i~~-------  241 (283)
T cd05048         176 SADY-YRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSN------QEVIEMIRS-------  241 (283)
T ss_pred             cccc-ccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCH------HHHHHHHHc-------
Confidence            3221 112233457889999999998899999999999999999998 9888764322      111111111       


Q ss_pred             hccccCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 039626          573 LRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNI  621 (628)
Q Consensus       573 l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l  621 (628)
                             ......+...+..+.+|+.+||+.||++||++.||++.|+.+
T Consensus       242 -------~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~  283 (283)
T cd05048         242 -------RQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW  283 (283)
T ss_pred             -------CCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence                   011122334557789999999999999999999999999753

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=1.9e-35  Score=303.77  Aligned_cols=230  Identities=24%  Similarity=0.322  Sum_probs=183.9

Q ss_pred             eEEEEEEE--CCceEEEEEecc----------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhh
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG----------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFS  428 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  428 (628)
                      |.||++..  +|+.+|+|++..          .+.+|++++.+++|+||+++.+++.+++..++||||+++|+|.+++..
T Consensus        14 g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~   93 (285)
T cd05631          14 GEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYN   93 (285)
T ss_pred             EEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEecCCCcHHHHHHh
Confidence            89999987  688999998753          245799999999999999999999999999999999999999988854


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCC
Q 039626          429 NKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGT  508 (628)
Q Consensus       429 ~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt  508 (628)
                      .  ....+++..+..++.|++.||+|||+   .+++||||||+|||+++++.+||+|||++.......    ......||
T Consensus        94 ~--~~~~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~----~~~~~~g~  164 (285)
T cd05631          94 M--GNPGFDEQRAIFYAAELCCGLEDLQR---ERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE----TVRGRVGT  164 (285)
T ss_pred             h--CCCCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC----eecCCCCC
Confidence            2  23458999999999999999999998   459999999999999999999999999998654221    12345799


Q ss_pred             ccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCHH
Q 039626          509 KGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLE  588 (628)
Q Consensus       509 ~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~  588 (628)
                      ..|+|||++.+..++.++|||||||++|||++|+.||.......   ..+.+.....            .  ....++..
T Consensus       165 ~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~---~~~~~~~~~~------------~--~~~~~~~~  227 (285)
T cd05631         165 VGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERV---KREEVDRRVK------------E--DQEEYSEK  227 (285)
T ss_pred             CCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcch---hHHHHHHHhh------------c--ccccCCcc
Confidence            99999999999999999999999999999999999987433211   1111111100            0  01122333


Q ss_pred             HHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 039626          589 LALLVIRLIDACLKKDPTDRPT-----MYEIEH  616 (628)
Q Consensus       589 ~~~~l~~l~~~Cl~~dP~~RPs-----~~ev~~  616 (628)
                      .+..+.+|+.+||+.||.+||+     ++++++
T Consensus       228 ~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~  260 (285)
T cd05631         228 FSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ  260 (285)
T ss_pred             CCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence            4556789999999999999997     666664

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=8.6e-35  Score=308.31  Aligned_cols=226  Identities=25%  Similarity=0.420  Sum_probs=176.7

Q ss_pred             eEEEEEEE--CCceEEEEEecc--------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhcC
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG--------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNK  430 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~--------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~  430 (628)
                      |.||+++.  +++.||||.+..        .+.+|++++++++|+||+++++++.+++..++||||+++|+|.+..    
T Consensus        88 g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~----  163 (353)
T PLN00034         88 GTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTH----  163 (353)
T ss_pred             eEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCCCCcccccc----
Confidence            89999998  588999998843        3678999999999999999999999999999999999999986532    


Q ss_pred             CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCCcc
Q 039626          431 NEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKG  510 (628)
Q Consensus       431 ~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~  510 (628)
                          ...+..+..++.||+.||+|||+.   +++||||||+|||+++++.+||+|||+++.......   ......||..
T Consensus       164 ----~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~---~~~~~~gt~~  233 (353)
T PLN00034        164 ----IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD---PCNSSVGTIA  233 (353)
T ss_pred             ----cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceecccccc---cccccccCcc
Confidence                256777889999999999999985   499999999999999999999999999987643211   1234579999


Q ss_pred             ccCcccccc-----CCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCC
Q 039626          511 YMAPEYLEN-----GLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNY  585 (628)
Q Consensus       511 Y~APE~l~~-----~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~  585 (628)
                      |+|||++..     ...+.++|||||||++|||++|+.||......   ............              .....
T Consensus       234 y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~---~~~~~~~~~~~~--------------~~~~~  296 (353)
T PLN00034        234 YMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQG---DWASLMCAICMS--------------QPPEA  296 (353)
T ss_pred             ccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc---cHHHHHHHHhcc--------------CCCCC
Confidence            999998743     23456899999999999999999998732211   111111111000              00111


Q ss_pred             CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 039626          586 PLELALLVIRLIDACLKKDPTDRPTMYEIEHS  617 (628)
Q Consensus       586 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~  617 (628)
                      +......+.+++.+||+.||++||++.|+++.
T Consensus       297 ~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h  328 (353)
T PLN00034        297 PATASREFRHFISCCLQREPAKRWSAMQLLQH  328 (353)
T ss_pred             CCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            22344568899999999999999999999863

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=4.4e-36  Score=310.05  Aligned_cols=225  Identities=25%  Similarity=0.417  Sum_probs=192.0

Q ss_pred             ceEEEEEEE--CCceEEEEEecc---------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhh
Q 039626          360 QGSVYRGKI--NGGFAAIKKVNG---------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFS  428 (628)
Q Consensus       360 ~G~Vy~g~~--~g~~vavK~~~~---------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  428 (628)
                      .|.||||+-  +.+.||+|.+.+         .+.+|++++++++|||||.++++|+...++++|.||+.| +|..+|..
T Consensus        15 fg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~a~g-~L~~il~~   93 (808)
T KOG0597|consen   15 FGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEYAVG-DLFTILEQ   93 (808)
T ss_pred             cceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehhhhh-hHHHHHHh
Confidence            399999987  678999998753         267899999999999999999999999999999999976 99999954


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCC
Q 039626          429 NKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGT  508 (628)
Q Consensus       429 ~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt  508 (628)
                          .+.+++.+...|+.|++.||.|||+   .+|+|||+||.|||++.++.+|++|||+||.+....   ...+.+.||
T Consensus        94 ----d~~lpEe~v~~~a~~LVsaL~yLhs---~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t---~vltsikGt  163 (808)
T KOG0597|consen   94 ----DGKLPEEQVRAIAYDLVSALYYLHS---NRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT---SVLTSIKGT  163 (808)
T ss_pred             ----ccCCCHHHHHHHHHHHHHHHHHHHh---cCcccccCCcceeeecCCCceeechhhhhhhcccCc---eeeeeccCc
Confidence                3459999999999999999999999   459999999999999999999999999999876432   355678999


Q ss_pred             ccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCHH
Q 039626          509 KGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLE  588 (628)
Q Consensus       509 ~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~  588 (628)
                      |.|||||.+.++.++..+|.||+||++||+++|++||...      .+.+.+..+...+               -.+|..
T Consensus       164 PlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~------si~~Lv~~I~~d~---------------v~~p~~  222 (808)
T KOG0597|consen  164 PLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR------SITQLVKSILKDP---------------VKPPST  222 (808)
T ss_pred             ccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH------HHHHHHHHHhcCC---------------CCCccc
Confidence            9999999999999999999999999999999999998732      2333333333211               134557


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          589 LALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       589 ~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      ....+..++...|.+||.+|.+..+++.
T Consensus       223 ~S~~f~nfl~gLL~kdP~~RltW~~Ll~  250 (808)
T KOG0597|consen  223 ASSSFVNFLQGLLIKDPAQRLTWTDLLG  250 (808)
T ss_pred             ccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence            7778899999999999999999888763

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-35  Score=308.12  Aligned_cols=228  Identities=21%  Similarity=0.300  Sum_probs=182.8

Q ss_pred             ceEEEEEEE--CCceEEEEEecc----------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhh
Q 039626          360 QGSVYRGKI--NGGFAAIKKVNG----------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVF  427 (628)
Q Consensus       360 ~G~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~  427 (628)
                      .|.||+++.  +++.+|+|+++.          .+.+|+.++.+++|+||+++++++.+++..++||||+++|+|.+++.
T Consensus         6 ~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~   85 (312)
T cd05585           6 FGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGELFHHLQ   85 (312)
T ss_pred             CeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcHHHHHH
Confidence            389999998  577899998853          24569999999999999999999999999999999999999999995


Q ss_pred             hcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccC
Q 039626          428 SNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVG  507 (628)
Q Consensus       428 ~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~g  507 (628)
                      .    ...+++..+..++.|++.||+|||+.   +++||||||+|||++.++.+||+|||+++.......   ......|
T Consensus        86 ~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~g  155 (312)
T cd05585          86 R----EGRFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD---KTNTFCG  155 (312)
T ss_pred             h----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccCCC---ccccccC
Confidence            4    33589999999999999999999984   599999999999999999999999999885432211   2234579


Q ss_pred             CccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCH
Q 039626          508 TKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPL  587 (628)
Q Consensus       508 t~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~  587 (628)
                      |+.|+|||.+.+..++.++|||||||+++||++|+.||....      ..+........               ...++.
T Consensus       156 t~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~------~~~~~~~~~~~---------------~~~~~~  214 (312)
T cd05585         156 TPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDEN------VNEMYRKILQE---------------PLRFPD  214 (312)
T ss_pred             CcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCC------HHHHHHHHHcC---------------CCCCCC
Confidence            999999999999999999999999999999999999986322      11222222111               011223


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 039626          588 ELALLVIRLIDACLKKDPTDRPTMYEIEHSL  618 (628)
Q Consensus       588 ~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L  618 (628)
                      .....+.+++.+||+.||.+||++..+.+.|
T Consensus       215 ~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l  245 (312)
T cd05585         215 GFDRDAKDLLIGLLSRDPTRRLGYNGAQEIK  245 (312)
T ss_pred             cCCHHHHHHHHHHcCCCHHHcCCCCCHHHHH
Confidence            3445678999999999999998755444443

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=4.7e-35  Score=297.21  Aligned_cols=238  Identities=23%  Similarity=0.324  Sum_probs=191.4

Q ss_pred             eEEEEEEE--CCceEEEEEecc----------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhh
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG----------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFS  428 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  428 (628)
                      |.||+|+.  +++.+|||+++.          ++.+|++++++++|+||+++++++...+..++|+||+++|+|.+++..
T Consensus        16 ~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~   95 (267)
T cd08228          16 SEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKY   95 (267)
T ss_pred             eeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEEecCCCcHHHHHHH
Confidence            89999987  788999997642          356799999999999999999999999999999999999999999865


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCC
Q 039626          429 NKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGT  508 (628)
Q Consensus       429 ~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt  508 (628)
                      .......+++..+..++.+++.||.|||+.   +++|+||||+||+++.++.++|+|||++........   ......++
T Consensus        96 ~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~---~~~~~~~~  169 (267)
T cd08228          96 FKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT---AAHSLVGT  169 (267)
T ss_pred             hhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceeccchhH---HHhcCCCC
Confidence            444455689999999999999999999984   599999999999999999999999999886643221   12234688


Q ss_pred             ccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCHH
Q 039626          509 KGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLE  588 (628)
Q Consensus       509 ~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~  588 (628)
                      ..|+|||.+.+..++.++|+||||+++|||++|+.|+.....    ...+....+..          ...+   ...+..
T Consensus       170 ~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~----~~~~~~~~~~~----------~~~~---~~~~~~  232 (267)
T cd08228         170 PYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLFSLCQKIEQ----------CDYP---PLPTEH  232 (267)
T ss_pred             ccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccc----cHHHHHHHHhc----------CCCC---CCChhh
Confidence            899999999988899999999999999999999998753221    11122211111          0011   111224


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 039626          589 LALLVIRLIDACLKKDPTDRPTMYEIEHSLSNI  621 (628)
Q Consensus       589 ~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l  621 (628)
                      ....+.+++.+||+.+|.+||++.||++.|+.+
T Consensus       233 ~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~  265 (267)
T cd08228         233 YSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM  265 (267)
T ss_pred             cCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence            456688999999999999999999999999876

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=3.1e-35  Score=308.89  Aligned_cols=243  Identities=20%  Similarity=0.335  Sum_probs=185.0

Q ss_pred             eEEEEEEE--CCceEEEEEecc--------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhcC
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG--------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNK  430 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~--------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~  430 (628)
                      |.||++..  .|..+|+|.+..        .+.+|+++|++++|+||+++++++..++..++||||+++|+|.+++..  
T Consensus        19 g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--   96 (331)
T cd06649          19 GVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKE--   96 (331)
T ss_pred             EEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeecCCCCcHHHHHHH--
Confidence            89999998  577889998753        367899999999999999999999999999999999999999999954  


Q ss_pred             CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCCcc
Q 039626          431 NEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKG  510 (628)
Q Consensus       431 ~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~  510 (628)
                        ...+++..+..++.+++.||.|||+.  .+++||||||+|||++.++.+||+|||+++......     .....|+..
T Consensus        97 --~~~~~~~~~~~~~~~i~~~l~~lH~~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-----~~~~~g~~~  167 (331)
T cd06649          97 --AKRIPEEILGKVSIAVLRGLAYLREK--HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-----ANSFVGTRS  167 (331)
T ss_pred             --cCCCCHHHHHHHHHHHHHHHHHHhhc--CCEEcCCCChhhEEEcCCCcEEEccCcccccccccc-----cccCCCCcC
Confidence              23589999999999999999999973  359999999999999999999999999987653221     233578999


Q ss_pred             ccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccch--------------------
Q 039626          511 YMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGE--------------------  570 (628)
Q Consensus       511 Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--------------------  570 (628)
                      |+|||++.+..++.++|||||||++|||++|+.|+......+   +...+..........                    
T Consensus       168 y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (331)
T cd06649         168 YMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKE---LEAIFGRPVVDGEEGEPHSISPRPRPPGRPVSGHG  244 (331)
T ss_pred             cCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHhcccccccccCCccccCcccccccccccccc
Confidence            999999999999999999999999999999999986432211   111111000000000                    


Q ss_pred             ----------hhhccccCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 039626          571 ----------ESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHS  617 (628)
Q Consensus       571 ----------~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~  617 (628)
                                +....+................+.+|+.+||+.||++||+++|+++.
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h  301 (331)
T cd06649         245 MDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH  301 (331)
T ss_pred             cccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence                      00000000000000011234568899999999999999999999864

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.1e-35  Score=296.90  Aligned_cols=234  Identities=29%  Similarity=0.439  Sum_probs=186.5

Q ss_pred             eEEEEEEE-CCceEEEEEecc------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhcCCCC
Q 039626          361 GSVYRGKI-NGGFAAIKKVNG------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEG  433 (628)
Q Consensus       361 G~Vy~g~~-~g~~vavK~~~~------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~  433 (628)
                      |.||+|.+ +++.+|+|.++.      ++.+|++++++++|+||+++++++...+..++||||+++++|.+++...  .+
T Consensus        20 ~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~   97 (261)
T cd05068          20 GEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGG--AG   97 (261)
T ss_pred             ccEEEEEecCCeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecccCCcHHHHHhcc--CC
Confidence            79999998 556899998864      4778999999999999999999999999999999999999999998542  24


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCCccccC
Q 039626          434 KYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMA  513 (628)
Q Consensus       434 ~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~Y~A  513 (628)
                      ..++|..+..++.+++.||.|||+   .+++|+||||+||++++++.+||+|||+++........  .......+..|+|
T Consensus        98 ~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~~y~a  172 (261)
T cd05068          98 RALKLPQLIDMAAQVASGMAYLEA---QNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE--AREGAKFPIKWTA  172 (261)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCCcceEEEcCCCCEEECCcceEEEccCCccc--ccCCCcCceeccC
Confidence            568999999999999999999998   45999999999999999999999999999876522111  1111223457999


Q ss_pred             ccccccCCCCcccccHHHHHHHHHHHh-CCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCHHHHHH
Q 039626          514 PEYLENGLVSTKLDVYAFGVLILEMLT-GKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALL  592 (628)
Q Consensus       514 PE~l~~~~~s~k~DV~SfGvvl~ELlt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~  592 (628)
                      ||++.+..++.++||||||++++||++ |+.|+.....      ......+..              ......+...+..
T Consensus       173 PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~------~~~~~~~~~--------------~~~~~~~~~~~~~  232 (261)
T cd05068         173 PEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTN------AEVLQQVDQ--------------GYRMPCPPGCPKE  232 (261)
T ss_pred             ccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCH------HHHHHHHHc--------------CCCCCCCCcCCHH
Confidence            999999999999999999999999999 8877753221      111111111              0001112234466


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 039626          593 VIRLIDACLKKDPTDRPTMYEIEHSLSNI  621 (628)
Q Consensus       593 l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l  621 (628)
                      +.+++.+|++.+|.+||+++++.+.|+.+
T Consensus       233 ~~~li~~~l~~~P~~Rp~~~~l~~~l~~~  261 (261)
T cd05068         233 LYDIMLDCWKEDPDDRPTFETLQWKLEDF  261 (261)
T ss_pred             HHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence            88999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=2.9e-35  Score=307.00  Aligned_cols=237  Identities=23%  Similarity=0.401  Sum_probs=185.3

Q ss_pred             eEEEEEEE--CCc----eEEEEEecc--------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHh
Q 039626          361 GSVYRGKI--NGG----FAAIKKVNG--------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWV  426 (628)
Q Consensus       361 G~Vy~g~~--~g~----~vavK~~~~--------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l  426 (628)
                      |.||+|++  +++    .+|+|.++.        ++.+|+.+++.++|+||++++|+|..+ ..++++||+++|+|.+++
T Consensus        21 g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~v~e~~~~g~l~~~l   99 (316)
T cd05108          21 GTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYV   99 (316)
T ss_pred             ceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-CceeeeecCCCCCHHHHH
Confidence            89999987  344    389998753        366799999999999999999999864 568999999999999999


Q ss_pred             hhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeeccc
Q 039626          427 FSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIV  506 (628)
Q Consensus       427 ~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~  506 (628)
                      ...   ...+++..++.++.||+.||+|||+.   +++||||||+|||+++++.+||+|||+++......... ......
T Consensus       100 ~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~-~~~~~~  172 (316)
T cd05108         100 REH---KDNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEY-HAEGGK  172 (316)
T ss_pred             Hhc---cccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEccccccccccCCCcce-eccCCc
Confidence            642   34589999999999999999999984   59999999999999999999999999998765332211 112223


Q ss_pred             CCccccCccccccCCCCcccccHHHHHHHHHHHh-CCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCC
Q 039626          507 GTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT-GKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNY  585 (628)
Q Consensus       507 gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELlt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~  585 (628)
                      ++..|+|||++.+..++.++||||||+++|||++ |+.|+.....      .+. ........             ....
T Consensus       173 ~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~------~~~-~~~~~~~~-------------~~~~  232 (316)
T cd05108         173 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA------SEI-SSILEKGE-------------RLPQ  232 (316)
T ss_pred             cceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH------HHH-HHHHhCCC-------------CCCC
Confidence            4678999999999999999999999999999998 8888753211      111 11111100             0001


Q ss_pred             CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhc
Q 039626          586 PLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNAS  625 (628)
Q Consensus       586 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~~~~  625 (628)
                      +..+...+.+++.+||..||.+||++.+++..|.++....
T Consensus       233 ~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~  272 (316)
T cd05108         233 PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP  272 (316)
T ss_pred             CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence            1122345789999999999999999999999999888654

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=5.5e-35  Score=296.76  Aligned_cols=239  Identities=24%  Similarity=0.354  Sum_probs=192.3

Q ss_pred             eEEEEEEE--CCceEEEEEecc----------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhh
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG----------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFS  428 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  428 (628)
                      |.||++..  +++.+|||++..          ++.+|+++++.++|+||+++++++..++..+++|||+++++|.+++..
T Consensus        16 g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~   95 (267)
T cd08229          16 SEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKH   95 (267)
T ss_pred             eEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEEecCCCCHHHHHHH
Confidence            89999996  788999997642          466799999999999999999999999999999999999999999865


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCC
Q 039626          429 NKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGT  508 (628)
Q Consensus       429 ~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt  508 (628)
                      .......++|.++..++.+++.||.|||+.   +++|+||||+||+++.++.++|+|||++........   ......++
T Consensus        96 ~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~  169 (267)
T cd08229          96 FKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT---AAHSLVGT  169 (267)
T ss_pred             hhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhccccCCc---ccccccCC
Confidence            444456789999999999999999999984   599999999999999999999999999876643221   12234688


Q ss_pred             ccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCHH
Q 039626          509 KGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLE  588 (628)
Q Consensus       509 ~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~  588 (628)
                      ..|+|||++.+..++.++|+||||+++|||++|..|+......    ........          .....+..   .+..
T Consensus       170 ~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~----------~~~~~~~~---~~~~  232 (267)
T cd08229         170 PYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYSLCKKI----------EQCDYPPL---PSDH  232 (267)
T ss_pred             cCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch----HHHHhhhh----------hcCCCCCC---Cccc
Confidence            9999999999888999999999999999999999987532211    11111111          11111111   1123


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhH
Q 039626          589 LALLVIRLIDACLKKDPTDRPTMYEIEHSLSNIL  622 (628)
Q Consensus       589 ~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~  622 (628)
                      ....+.+++.+||+.||.+||||.+|++.++++.
T Consensus       233 ~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~  266 (267)
T cd08229         233 YSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH  266 (267)
T ss_pred             ccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence            4557889999999999999999999999998874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.5e-35  Score=312.14  Aligned_cols=224  Identities=29%  Similarity=0.411  Sum_probs=189.7

Q ss_pred             eEEEEEEE--CCceEEEEEeccc----------hHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhh
Q 039626          361 GSVYRGKI--NGGFAAIKKVNGD----------VSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFS  428 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~~----------~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  428 (628)
                      |.|-.|+.  .|+.+|||.+.+.          +.+|+-+|+-++|||++++++++++..++|||.||+++|.|.++|..
T Consensus        26 g~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEyv~gGELFdylv~  105 (786)
T KOG0588|consen   26 GCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEYVPGGELFDYLVR  105 (786)
T ss_pred             ceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEecCCchhHHHHHh
Confidence            78888887  8999999988653          67899999999999999999999999999999999999999999953


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCC
Q 039626          429 NKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGT  508 (628)
Q Consensus       429 ~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt  508 (628)
                          .+.+++....+++.||+.|+.|+|.++   |+|||+||+|+|||.++++||+|||+|.....+.    ....-+|+
T Consensus       106 ----kG~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gk----lLeTSCGS  174 (786)
T KOG0588|consen  106 ----KGPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEVPGK----LLETSCGS  174 (786)
T ss_pred             ----hCCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecccCCc----cccccCCC
Confidence                456899999999999999999999965   9999999999999999999999999998654322    34556899


Q ss_pred             ccccCccccccCCC-CcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCH
Q 039626          509 KGYMAPEYLENGLV-STKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPL  587 (628)
Q Consensus       509 ~~Y~APE~l~~~~~-s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~  587 (628)
                      +.|.+||++.+..| ..++||||.||+|+.|++|+.||+.      ..+...+..+-.+.               -+.|.
T Consensus       175 PHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdD------dNir~LLlKV~~G~---------------f~MPs  233 (786)
T KOG0588|consen  175 PHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDD------DNIRVLLLKVQRGV---------------FEMPS  233 (786)
T ss_pred             cccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCC------ccHHHHHHHHHcCc---------------ccCCC
Confidence            99999999999877 5689999999999999999999971      22333333332211               12344


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          588 ELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       588 ~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      ..+.++.+|+.+|+..||++|.|++||++
T Consensus       234 ~Is~eaQdLLr~ml~VDp~~RiT~~eI~k  262 (786)
T KOG0588|consen  234 NISSEAQDLLRRMLDVDPSTRITTEEILK  262 (786)
T ss_pred             cCCHHHHHHHHHHhccCccccccHHHHhh
Confidence            55667889999999999999999999986

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=3.7e-35  Score=297.11  Aligned_cols=234  Identities=27%  Similarity=0.432  Sum_probs=186.7

Q ss_pred             eEEEEEEE-CCceEEEEEecc------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhcCCCC
Q 039626          361 GSVYRGKI-NGGFAAIKKVNG------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEG  433 (628)
Q Consensus       361 G~Vy~g~~-~g~~vavK~~~~------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~  433 (628)
                      |.||+|.. ++..+|+|+...      .+.+|+.++++++|+||+++++++.+++..+++|||+++|+|.+++...  ..
T Consensus        20 g~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~   97 (261)
T cd05072          20 GEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSD--EG   97 (261)
T ss_pred             ceEEEEEecCCceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCCCCcHHHHHHHh--cC
Confidence            89999988 566799998763      4667999999999999999999999999999999999999999999653  34


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCCccccC
Q 039626          434 KYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMA  513 (628)
Q Consensus       434 ~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~Y~A  513 (628)
                      ..+++..++.++.+++.||+|||+   .+++||||||+||++++++.+||+|||+++.......  .......++..|+|
T Consensus        98 ~~~~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~y~a  172 (261)
T cd05072          98 GKVLLPKLIDFSAQIAEGMAYIER---KNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY--TAREGAKFPIKWTA  172 (261)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEecCCCcEEECCCccceecCCCce--eccCCCccceecCC
Confidence            468999999999999999999998   4599999999999999999999999999987643221  11222346678999


Q ss_pred             ccccccCCCCcccccHHHHHHHHHHHh-CCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCHHHHHH
Q 039626          514 PEYLENGLVSTKLDVYAFGVLILEMLT-GKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALL  592 (628)
Q Consensus       514 PE~l~~~~~s~k~DV~SfGvvl~ELlt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~  592 (628)
                      ||++....++.++||||||+++|||++ |+.|+......      +....+..          ........    ..+..
T Consensus       173 PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~------~~~~~~~~----------~~~~~~~~----~~~~~  232 (261)
T cd05072         173 PEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS------DVMSALQR----------GYRMPRME----NCPDE  232 (261)
T ss_pred             HHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH------HHHHHHHc----------CCCCCCCC----CCCHH
Confidence            999998899999999999999999998 88887532211      11111110          00011111    23345


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 039626          593 VIRLIDACLKKDPTDRPTMYEIEHSLSNI  621 (628)
Q Consensus       593 l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l  621 (628)
                      +.+++.+||+.+|++||+++++.+.|+++
T Consensus       233 ~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  261 (261)
T cd05072         233 LYDIMKTCWKEKAEERPTFDYLQSVLDDF  261 (261)
T ss_pred             HHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence            78999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=5e-35  Score=297.35  Aligned_cols=236  Identities=25%  Similarity=0.438  Sum_probs=186.5

Q ss_pred             eEEEEEEE--CCc---eEEEEEecc--------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhh
Q 039626          361 GSVYRGKI--NGG---FAAIKKVNG--------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVF  427 (628)
Q Consensus       361 G~Vy~g~~--~g~---~vavK~~~~--------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~  427 (628)
                      |.||+|+.  +++   .+|+|+.+.        ++..|++++++++|+||+++.+++...+..++||||+++++|.+++.
T Consensus        19 g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~   98 (268)
T cd05063          19 GEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLR   98 (268)
T ss_pred             ccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEEEEcCCCCCHHHHHH
Confidence            89999987  333   689998753        35679999999999999999999999999999999999999999985


Q ss_pred             hcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccC
Q 039626          428 SNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVG  507 (628)
Q Consensus       428 ~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~g  507 (628)
                      ..   ...++|.++..++.+++.||+|||+.   +++|+||||+||++++++.+||+|||++..................
T Consensus        99 ~~---~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~  172 (268)
T cd05063          99 DH---DGEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKI  172 (268)
T ss_pred             hc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCccceecccccccceeccCCCc
Confidence            42   34589999999999999999999984   5999999999999999999999999998866433222111122234


Q ss_pred             CccccCccccccCCCCcccccHHHHHHHHHHHh-CCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCC
Q 039626          508 TKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT-GKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYP  586 (628)
Q Consensus       508 t~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELlt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~  586 (628)
                      +..|+|||++.+..++.++||||||+++|||++ |+.|+.....      .+....+.. .             .....+
T Consensus       173 ~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~------~~~~~~i~~-~-------------~~~~~~  232 (268)
T cd05063         173 PIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN------HEVMKAIND-G-------------FRLPAP  232 (268)
T ss_pred             CceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH------HHHHHHHhc-C-------------CCCCCC
Confidence            567999999998899999999999999999997 9988753221      111111110 0             011112


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhH
Q 039626          587 LELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNIL  622 (628)
Q Consensus       587 ~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~  622 (628)
                      .+.+..+.+++.+||+.+|++||++.+|++.|.+++
T Consensus       233 ~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~~  268 (268)
T cd05063         233 MDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKLL  268 (268)
T ss_pred             CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence            234456789999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=3e-35  Score=307.92  Aligned_cols=226  Identities=25%  Similarity=0.361  Sum_probs=183.0

Q ss_pred             ceEEEEEEE--CCceEEEEEecc----------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhh
Q 039626          360 QGSVYRGKI--NGGFAAIKKVNG----------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVF  427 (628)
Q Consensus       360 ~G~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~  427 (628)
                      .|.||+++.  +|+.+|+|.++.          .+.+|++++++++|+||+++.+++..++..++||||+++|+|.+++.
T Consensus         8 ~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~   87 (323)
T cd05571           8 FGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLS   87 (323)
T ss_pred             CeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCCcHHHHHH
Confidence            389999987  678999998864          24568999999999999999999999999999999999999999985


Q ss_pred             hcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccC
Q 039626          428 SNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVG  507 (628)
Q Consensus       428 ~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~g  507 (628)
                      .    ...+++.+...++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++.......   ......|
T Consensus        88 ~----~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~---~~~~~~g  157 (323)
T cd05571          88 R----ERVFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGA---TMKTFCG  157 (323)
T ss_pred             H----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCC---cccceec
Confidence            3    34689999999999999999999985   499999999999999999999999999875422111   1234579


Q ss_pred             CccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCH
Q 039626          508 TKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPL  587 (628)
Q Consensus       508 t~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~  587 (628)
                      |+.|+|||.+.+..++.++|||||||+++||++|+.||.....      ......+...           +.    .++.
T Consensus       158 t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~------~~~~~~~~~~-----------~~----~~p~  216 (323)
T cd05571         158 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH------EKLFELILME-----------EI----RFPR  216 (323)
T ss_pred             CccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCH------HHHHHHHHcC-----------CC----CCCC
Confidence            9999999999999999999999999999999999999863221      1111111110           01    1223


Q ss_pred             HHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 039626          588 ELALLVIRLIDACLKKDPTDRP-----TMYEIEH  616 (628)
Q Consensus       588 ~~~~~l~~l~~~Cl~~dP~~RP-----s~~ev~~  616 (628)
                      .....+.+++.+||+.||++||     ++.++++
T Consensus       217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  250 (323)
T cd05571         217 TLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME  250 (323)
T ss_pred             CCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence            3455678999999999999999     7887764

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=6.6e-35  Score=296.26  Aligned_cols=235  Identities=26%  Similarity=0.461  Sum_probs=187.0

Q ss_pred             eEEEEEEEC-----CceEEEEEecc--------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhh
Q 039626          361 GSVYRGKIN-----GGFAAIKKVNG--------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVF  427 (628)
Q Consensus       361 G~Vy~g~~~-----g~~vavK~~~~--------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~  427 (628)
                      |.||+|++.     ...+|+|..+.        ++.+|+.++++++|+||+++++++.+++..++||||+++|+|.+++.
T Consensus        18 g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~   97 (266)
T cd05033          18 GEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLR   97 (266)
T ss_pred             ceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEEEEcCCCCCHHHHHH
Confidence            899999983     24789998753        35679999999999999999999999999999999999999999995


Q ss_pred             hcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccC
Q 039626          428 SNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVG  507 (628)
Q Consensus       428 ~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~g  507 (628)
                      ..   ...++|..+.+++.+++.||+|||+   .+++|+||||+||++++++.+||+|||+++........ .......+
T Consensus        98 ~~---~~~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~  170 (266)
T cd05033          98 EN---DGKFTVGQLVGMLRGIASGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEAT-YTTKGGKI  170 (266)
T ss_pred             hc---cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCCEEECccchhhcccccccc-eeccCCCC
Confidence            42   2368999999999999999999998   45999999999999999999999999999877522221 12223345


Q ss_pred             CccccCccccccCCCCcccccHHHHHHHHHHHh-CCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCC
Q 039626          508 TKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT-GKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYP  586 (628)
Q Consensus       508 t~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELlt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~  586 (628)
                      +..|+|||.+.+..++.++||||||++++||++ |..|+.....      .+....... .        .     ....+
T Consensus       171 ~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~------~~~~~~~~~-~--------~-----~~~~~  230 (266)
T cd05033         171 PIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSN------QDVIKAVED-G--------Y-----RLPPP  230 (266)
T ss_pred             CccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCH------HHHHHHHHc-C--------C-----CCCCC
Confidence            678999999999999999999999999999998 8887742211      111111110 0        0     00112


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhH
Q 039626          587 LELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNIL  622 (628)
Q Consensus       587 ~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~  622 (628)
                      .+.+..+.+++.+||+.+|++||++.||++.|++++
T Consensus       231 ~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~~  266 (266)
T cd05033         231 MDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKMI  266 (266)
T ss_pred             CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence            233456789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=6.9e-35  Score=300.19  Aligned_cols=241  Identities=27%  Similarity=0.442  Sum_probs=188.2

Q ss_pred             eEEEEEEECC-------ceEEEEEecc--------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHH
Q 039626          361 GSVYRGKING-------GFAAIKKVNG--------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDW  425 (628)
Q Consensus       361 G~Vy~g~~~g-------~~vavK~~~~--------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~  425 (628)
                      |.||+|+...       ..+++|....        ++.+|+.++++++|+||+++++.|..++..++++||+.+|+|.++
T Consensus        14 g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~   93 (290)
T cd05045          14 GKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSF   93 (290)
T ss_pred             cceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEEEEecCCCCHHHH
Confidence            8999998632       4688887653        366799999999999999999999999999999999999999999


Q ss_pred             hhhcCC--------------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEcc
Q 039626          426 VFSNKN--------------------EGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIAN  485 (628)
Q Consensus       426 l~~~~~--------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~D  485 (628)
                      +.....                    ....++|..++.++.|++.||+|||+.   +++||||||+|||+++++.+||+|
T Consensus        94 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp~nill~~~~~~kl~d  170 (290)
T cd05045          94 LRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAARNVLVAEGRKMKISD  170 (290)
T ss_pred             HHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---CeehhhhhhheEEEcCCCcEEecc
Confidence            854221                    123588999999999999999999984   599999999999999999999999


Q ss_pred             ccccccCCCCCCcceeeecccCCccccCccccccCCCCcccccHHHHHHHHHHHh-CCCccccccccccccHHHHHHHHh
Q 039626          486 FAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT-GKEAAALHAEENNMHLSDVLNAVL  564 (628)
Q Consensus       486 fgla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELlt-G~~p~~~~~~~~~~~~~~~~~~~~  564 (628)
                      ||+++........ .......++..|+|||++.+..++.++||||||++++||++ |+.|+......   .+.+.    .
T Consensus       171 fg~~~~~~~~~~~-~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~~~----~  242 (290)
T cd05045         171 FGLSRDVYEEDSY-VKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE---RLFNL----L  242 (290)
T ss_pred             ccccccccCccch-hcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHH---HHHHH----H
Confidence            9999865332211 11122345678999999988899999999999999999998 88887532211   11111    1


Q ss_pred             ccccchhhhccccCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhc
Q 039626          565 TKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNAS  625 (628)
Q Consensus       565 ~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~~~~  625 (628)
                      ..         ..    ....+...+..+.+++.+||+.+|++||+++|+++.|++++..+
T Consensus       243 ~~---------~~----~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~~~  290 (290)
T cd05045         243 KT---------GY----RMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMVKS  290 (290)
T ss_pred             hC---------CC----CCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHhcC
Confidence            10         00    11112233456889999999999999999999999999998653

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=7.1e-35  Score=299.85  Aligned_cols=244  Identities=26%  Similarity=0.438  Sum_probs=191.9

Q ss_pred             eEEEEEEE-------CCceEEEEEecc-------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHh
Q 039626          361 GSVYRGKI-------NGGFAAIKKVNG-------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWV  426 (628)
Q Consensus       361 G~Vy~g~~-------~g~~vavK~~~~-------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l  426 (628)
                      |.||++..       ++..+|+|.+..       ++.+|++++++++|+||+++++++...+..++||||+++++|.+++
T Consensus        19 ~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i   98 (288)
T cd05093          19 GKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFL   98 (288)
T ss_pred             eeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEcCCCCCHHHHH
Confidence            89999975       234688998753       4678999999999999999999999999999999999999999999


Q ss_pred             hhcC---------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCC
Q 039626          427 FSNK---------NEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEG  497 (628)
Q Consensus       427 ~~~~---------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~  497 (628)
                      ....         .....++|.+++.++.|++.||+|||+.   +++||||||+||++++++.+||+|||+++.......
T Consensus        99 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~  175 (288)
T cd05093          99 RAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDY  175 (288)
T ss_pred             HHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcEEeccCCccccccCCce
Confidence            6432         1223589999999999999999999984   599999999999999999999999999986643221


Q ss_pred             cceeeecccCCccccCccccccCCCCcccccHHHHHHHHHHHh-CCCccccccccccccHHHHHHHHhccccchhhhccc
Q 039626          498 EFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT-GKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHF  576 (628)
Q Consensus       498 ~~~~~~~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELlt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  576 (628)
                       ........++..|+|||++.+..++.++||||||++++||++ |+.|+.....      .+....+....         
T Consensus       176 -~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~------~~~~~~i~~~~---------  239 (288)
T cd05093         176 -YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN------NEVIECITQGR---------  239 (288)
T ss_pred             -eecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH------HHHHHHHHcCC---------
Confidence             111223446778999999999999999999999999999998 8877653221      11222211110         


Q ss_pred             cCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhccCC
Q 039626          577 IDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNASLNW  628 (628)
Q Consensus       577 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~~~~~~w  628 (628)
                       ......    ..+..+.+++.+||+.||.+||++.|+.+.|+++...+..|
T Consensus       240 -~~~~~~----~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~~~~~  286 (288)
T cd05093         240 -VLQRPR----TCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKASPVY  286 (288)
T ss_pred             -cCCCCC----CCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHhcccc
Confidence             001111    22345889999999999999999999999999999876543

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=6.1e-35  Score=299.21  Aligned_cols=234  Identities=23%  Similarity=0.336  Sum_probs=185.9

Q ss_pred             ceEEEEEEE--CCceEEEEEecc----------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhh
Q 039626          360 QGSVYRGKI--NGGFAAIKKVNG----------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVF  427 (628)
Q Consensus       360 ~G~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~  427 (628)
                      .|.||++..  +++.+|+|++..          .+..|++++++++|+||+++.+++..+...++||||+++|+|.+++.
T Consensus         6 ~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~~~   85 (280)
T cd05608           6 FGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDLRYHIY   85 (280)
T ss_pred             ceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCHHHHHH
Confidence            389999987  678999999853          23569999999999999999999999999999999999999999886


Q ss_pred             hcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccC
Q 039626          428 SNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVG  507 (628)
Q Consensus       428 ~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~g  507 (628)
                      ........+++..+..++.|++.||+|||+.   +++||||||+||++++++.+||+|||++........   ......|
T Consensus        86 ~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~---~~~~~~g  159 (280)
T cd05608          86 NVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS---KTKGYAG  159 (280)
T ss_pred             hccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc---cccccCC
Confidence            5444456799999999999999999999984   599999999999999999999999999976543221   1233578


Q ss_pred             CccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCH
Q 039626          508 TKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPL  587 (628)
Q Consensus       508 t~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~  587 (628)
                      |+.|+|||.+.+..++.++||||||+++|||++|+.|+........  .........             ..  ...++.
T Consensus       160 ~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~--~~~~~~~~~-------------~~--~~~~~~  222 (280)
T cd05608         160 TPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE--NKELKQRIL-------------ND--SVTYPD  222 (280)
T ss_pred             CcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchh--HHHHHHhhc-------------cc--CCCCcc
Confidence            9999999999999999999999999999999999999864322110  111111111             00  012233


Q ss_pred             HHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 039626          588 ELALLVIRLIDACLKKDPTDRP-----TMYEIEH  616 (628)
Q Consensus       588 ~~~~~l~~l~~~Cl~~dP~~RP-----s~~ev~~  616 (628)
                      ..+..+.+++.+||+.||++||     +++++++
T Consensus       223 ~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~  256 (280)
T cd05608         223 KFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT  256 (280)
T ss_pred             cCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence            4456688999999999999999     5566654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=4.8e-35  Score=314.15  Aligned_cols=240  Identities=23%  Similarity=0.408  Sum_probs=187.6

Q ss_pred             eEEEEEEEC-------CceEEEEEecc--------chHHHHHHHhhcC-CCceeeeeeeeecCCeEEEEEEecCCCChHH
Q 039626          361 GSVYRGKIN-------GGFAAIKKVNG--------DVSKEIALLNKIN-HSNLIILSGVCFNEGNCYLVYEYAVNGTLSD  424 (628)
Q Consensus       361 G~Vy~g~~~-------g~~vavK~~~~--------~~~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~  424 (628)
                      |.||+|+..       +..||||+++.        .+.+|+++|++++ ||||++++|+|.+.+..+|||||+++|+|.+
T Consensus        51 G~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~  130 (400)
T cd05105          51 GKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPIYIITEYCFYGDLVN  130 (400)
T ss_pred             ceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCceEEEEEecCCCcHHH
Confidence            899999862       23699998863        3667999999996 9999999999999999999999999999999


Q ss_pred             HhhhcCC-------------------------------------------------------------------------
Q 039626          425 WVFSNKN-------------------------------------------------------------------------  431 (628)
Q Consensus       425 ~l~~~~~-------------------------------------------------------------------------  431 (628)
                      +|+....                                                                         
T Consensus       131 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  210 (400)
T cd05105         131 YLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKEASKYSDIQRSNYDR  210 (400)
T ss_pred             HHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhhhhhhhhhcccCcccc
Confidence            9865321                                                                         


Q ss_pred             -------------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccC
Q 039626          432 -------------------EGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPA  492 (628)
Q Consensus       432 -------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~  492 (628)
                                         ....++|..+++++.|++.||+|||+   .+++||||||+|||+++++.+||+|||+++..
T Consensus       211 ~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dikp~Nill~~~~~~kL~DfGla~~~  287 (400)
T cd05105         211 PASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLAS---KNCVHRDLAARNVLLAQGKIVKICDFGLARDI  287 (400)
T ss_pred             cccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHhEEEeCCCEEEEEeCCcceec
Confidence                               11348899999999999999999998   45999999999999999999999999999865


Q ss_pred             CCCCCcceeeecccCCccccCccccccCCCCcccccHHHHHHHHHHHh-CCCccccccccccccHHHHHHHHhccccchh
Q 039626          493 EGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT-GKEAAALHAEENNMHLSDVLNAVLTKEDGEE  571 (628)
Q Consensus       493 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELlt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  571 (628)
                      ..... ........++..|+|||.+.+..++.++||||||+++|||++ |+.|+......      +.+......     
T Consensus       288 ~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~------~~~~~~~~~-----  355 (400)
T cd05105         288 MHDSN-YVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVD------STFYNKIKS-----  355 (400)
T ss_pred             ccccc-ccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchh------HHHHHHHhc-----
Confidence            43221 111223456788999999999899999999999999999997 88877532111      111111110     


Q ss_pred             hhccccCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHh
Q 039626          572 SLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILN  623 (628)
Q Consensus       572 ~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~~  623 (628)
                          ...+    ..+...+..+.+++.+||+.||++||++.+|.+.|++++.
T Consensus       356 ----~~~~----~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~  399 (400)
T cd05105         356 ----GYRM----AKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP  399 (400)
T ss_pred             ----CCCC----CCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence                0001    1122344568899999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=1e-34  Score=293.62  Aligned_cols=236  Identities=21%  Similarity=0.361  Sum_probs=183.9

Q ss_pred             ceEEEEEEEC----CceEEEEEecc--------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhh
Q 039626          360 QGSVYRGKIN----GGFAAIKKVNG--------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVF  427 (628)
Q Consensus       360 ~G~Vy~g~~~----g~~vavK~~~~--------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~  427 (628)
                      .|.||+|.+.    +..+|+|....        ++.+|+.++++++|+||+++++++. ....++||||+++|+|.+++.
T Consensus         8 ~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~L~~~l~   86 (257)
T cd05115           8 FGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGPLNKFLS   86 (257)
T ss_pred             cccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCCHHHHHH
Confidence            3899999872    34689998753        3668999999999999999999986 456899999999999999985


Q ss_pred             hcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccC
Q 039626          428 SNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVG  507 (628)
Q Consensus       428 ~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~g  507 (628)
                      .   ....+++..+++++.|++.||+|||+.   +++||||||+||+++.++.+||+|||+++................+
T Consensus        87 ~---~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~  160 (257)
T cd05115          87 G---KKDEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKW  160 (257)
T ss_pred             h---CCCCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCCCC
Confidence            3   234689999999999999999999984   5999999999999999999999999999865433221111122234


Q ss_pred             CccccCccccccCCCCcccccHHHHHHHHHHHh-CCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCC
Q 039626          508 TKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT-GKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYP  586 (628)
Q Consensus       508 t~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELlt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~  586 (628)
                      +..|+|||.+.+..++.++||||||+++||+++ |+.|+.....      .+....+...              .....+
T Consensus       161 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~------~~~~~~~~~~--------------~~~~~~  220 (257)
T cd05115         161 PLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKG------PEVMSFIEQG--------------KRLDCP  220 (257)
T ss_pred             CcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCH------HHHHHHHHCC--------------CCCCCC
Confidence            578999999998889999999999999999996 8888753221      1111111110              011122


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhH
Q 039626          587 LELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNIL  622 (628)
Q Consensus       587 ~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~  622 (628)
                      ......+.+++.+||..||++||++.+|.+.|+.+.
T Consensus       221 ~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~~  256 (257)
T cd05115         221 AECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTYY  256 (257)
T ss_pred             CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhhc
Confidence            234566889999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=9.4e-35  Score=297.62  Aligned_cols=240  Identities=24%  Similarity=0.388  Sum_probs=185.6

Q ss_pred             eEEEEEEE--CCc----eEEEEEecc--------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHh
Q 039626          361 GSVYRGKI--NGG----FAAIKKVNG--------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWV  426 (628)
Q Consensus       361 G~Vy~g~~--~g~----~vavK~~~~--------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l  426 (628)
                      |.||+|++  +++    .+++|+...        ++..|+..+++++|+||++++|++.. ...++++||+++|+|.+++
T Consensus        21 ~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~i~e~~~~gsL~~~l   99 (279)
T cd05111          21 GTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQLVTQLSPLGSLLDHV   99 (279)
T ss_pred             cceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEEEEEeCCCCcHHHHH
Confidence            89999998  454    467787742        34567778899999999999999864 4578999999999999999


Q ss_pred             hhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeeccc
Q 039626          427 FSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIV  506 (628)
Q Consensus       427 ~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~  506 (628)
                      ...   ...++|..+..++.|++.||+|||+   .+++||||||+|||+++++.+||+|||+++........ .......
T Consensus       100 ~~~---~~~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~  172 (279)
T cd05111         100 RQH---RDSLDPQRLLNWCVQIAKGMYYLEE---HRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKK-YFYSEHK  172 (279)
T ss_pred             Hhc---ccCCCHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEEcCCccceeccCCCcc-cccCCCC
Confidence            642   3458999999999999999999998   45999999999999999999999999999865432211 1123345


Q ss_pred             CCccccCccccccCCCCcccccHHHHHHHHHHHh-CCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCC
Q 039626          507 GTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT-GKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNY  585 (628)
Q Consensus       507 gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELlt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~  585 (628)
                      ++..|+|||++.++.++.++||||||+++||+++ |+.|+......       ..........      ....       
T Consensus       173 ~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~-------~~~~~~~~~~------~~~~-------  232 (279)
T cd05111         173 TPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH-------EVPDLLEKGE------RLAQ-------  232 (279)
T ss_pred             CcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHH-------HHHHHHHCCC------cCCC-------
Confidence            7788999999998899999999999999999998 88887532211       1111111110      0001       


Q ss_pred             CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhccCC
Q 039626          586 PLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNASLNW  628 (628)
Q Consensus       586 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~~~~~~w  628 (628)
                      +......+.+++.+||..||++||++.|+++.|..+.+.+-.|
T Consensus       233 ~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~~~~~  275 (279)
T cd05111         233 PQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARDPPRY  275 (279)
T ss_pred             CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhCCcce
Confidence            1112345678999999999999999999999999988776544

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=5.3e-35  Score=298.89  Aligned_cols=246  Identities=25%  Similarity=0.409  Sum_probs=188.1

Q ss_pred             hcCCCcCCccc----eEEEEEEEC-------CceEEEEEecc--------chHHHHHHHhhcCCCceeeeeeeeecCCeE
Q 039626          350 TDNFSFTCRIQ----GSVYRGKIN-------GGFAAIKKVNG--------DVSKEIALLNKINHSNLIILSGVCFNEGNC  410 (628)
Q Consensus       350 t~~f~~~~~i~----G~Vy~g~~~-------g~~vavK~~~~--------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~  410 (628)
                      +++|.....+|    |.||+|.+.       +..+|+|+...        ++.+|+.++++++|+||+++++++..+...
T Consensus         5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~   84 (277)
T cd05062           5 REKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT   84 (277)
T ss_pred             HHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCe
Confidence            34455444443    899998763       35799998753        356799999999999999999999999999


Q ss_pred             EEEEEecCCCChHHHhhhcCCC------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEc
Q 039626          411 YLVYEYAVNGTLSDWVFSNKNE------GKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIA  484 (628)
Q Consensus       411 ~lV~E~~~~gsL~~~l~~~~~~------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~  484 (628)
                      ++||||+++|+|.+++......      ...++|..++.++.|++.||+|||+   .+++|+||||+||++++++.+||+
T Consensus        85 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~~vH~dlkp~Nil~~~~~~~~l~  161 (277)
T cd05062          85 LVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIG  161 (277)
T ss_pred             EEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCcchheEEEcCCCCEEEC
Confidence            9999999999999999653221      2347899999999999999999998   459999999999999999999999


Q ss_pred             cccccccCCCCCCcceeeecccCCccccCccccccCCCCcccccHHHHHHHHHHHh-CCCccccccccccccHHHHHHHH
Q 039626          485 NFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT-GKEAAALHAEENNMHLSDVLNAV  563 (628)
Q Consensus       485 Dfgla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELlt-G~~p~~~~~~~~~~~~~~~~~~~  563 (628)
                      |||+++........ .......++..|+|||++.+..++.++||||||++++||++ |..|+.....      .+.....
T Consensus       162 dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~------~~~~~~~  234 (277)
T cd05062         162 DFGMTRDIYETDYY-RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN------EQVLRFV  234 (277)
T ss_pred             CCCCccccCCccee-ecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH------HHHHHHH
Confidence            99998865432211 11122345788999999999899999999999999999999 6767643211      1111111


Q ss_pred             hccccchhhhccccCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 039626          564 LTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLS  619 (628)
Q Consensus       564 ~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~  619 (628)
                      ....        .      ...+...+..+.+++.+||+.||++||++.|+++.|+
T Consensus       235 ~~~~--------~------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~  276 (277)
T cd05062         235 MEGG--------L------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK  276 (277)
T ss_pred             HcCC--------c------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence            1100        0      0112223456889999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=9e-35  Score=293.83  Aligned_cols=233  Identities=24%  Similarity=0.387  Sum_probs=183.9

Q ss_pred             eEEEEEEE----CCceEEEEEecc---------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhh
Q 039626          361 GSVYRGKI----NGGFAAIKKVNG---------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVF  427 (628)
Q Consensus       361 G~Vy~g~~----~g~~vavK~~~~---------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~  427 (628)
                      |.||+|.+    ++..+|+|+++.         ++.+|+.++++++|+||++++|++. ++..++||||+++|+|.+++.
T Consensus         9 g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~   87 (257)
T cd05116           9 GTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELGPLNKFLQ   87 (257)
T ss_pred             cceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCCcHHHHHH
Confidence            89999976    467899998753         3667999999999999999999986 456799999999999999984


Q ss_pred             hcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccC
Q 039626          428 SNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVG  507 (628)
Q Consensus       428 ~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~g  507 (628)
                      .    ...+++..+..++.|++.||+|||+.   +++||||||+||++++++.+||+|||+++................+
T Consensus        88 ~----~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~  160 (257)
T cd05116          88 K----NKHVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKW  160 (257)
T ss_pred             h----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCCCC
Confidence            3    23589999999999999999999984   5999999999999999999999999999876543322111222344


Q ss_pred             CccccCccccccCCCCcccccHHHHHHHHHHHh-CCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCC
Q 039626          508 TKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT-GKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYP  586 (628)
Q Consensus       508 t~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELlt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~  586 (628)
                      +..|+|||.+....++.++|+||||++++||++ |+.|+.....      .+....+ ...             .....+
T Consensus       161 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~------~~~~~~i-~~~-------------~~~~~~  220 (257)
T cd05116         161 PVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG------NEVTQMI-ESG-------------ERMECP  220 (257)
T ss_pred             CccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH------HHHHHHH-HCC-------------CCCCCC
Confidence            678999999988889999999999999999998 8888763221      1111111 110             011122


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 039626          587 LELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNI  621 (628)
Q Consensus       587 ~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l  621 (628)
                      ...+..+.+++.+||+.||++||++.+|.+.|++.
T Consensus       221 ~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~  255 (257)
T cd05116         221 QRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY  255 (257)
T ss_pred             CCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence            23445678999999999999999999999999763

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=8.9e-35  Score=299.59  Aligned_cols=241  Identities=25%  Similarity=0.438  Sum_probs=190.4

Q ss_pred             eEEEEEEEC-------CceEEEEEecc-------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHh
Q 039626          361 GSVYRGKIN-------GGFAAIKKVNG-------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWV  426 (628)
Q Consensus       361 G~Vy~g~~~-------g~~vavK~~~~-------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l  426 (628)
                      |.||+++..       +..+++|+.+.       .+.+|++++++++|+||+++++++..++..++||||+++++|.+++
T Consensus        19 g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i   98 (291)
T cd05094          19 GKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFL   98 (291)
T ss_pred             CeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEEEEecCCCCcHHHHH
Confidence            899999852       34688898763       4678999999999999999999999999999999999999999999


Q ss_pred             hhcCC------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCC
Q 039626          427 FSNKN------------EGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEG  494 (628)
Q Consensus       427 ~~~~~------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~  494 (628)
                      .....            ....++|..++.++.+++.||+|||+.   +++||||||+||+++.++.+||+|||+++....
T Consensus        99 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~dfg~a~~~~~  175 (291)
T cd05094          99 RAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYS  175 (291)
T ss_pred             HhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcEEECCCCcccccCC
Confidence            65321            123589999999999999999999984   599999999999999999999999999976543


Q ss_pred             CCCcceeeecccCCccccCccccccCCCCcccccHHHHHHHHHHHh-CCCccccccccccccHHHHHHHHhccccchhhh
Q 039626          495 QEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT-GKEAAALHAEENNMHLSDVLNAVLTKEDGEESL  573 (628)
Q Consensus       495 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELlt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  573 (628)
                      ... ........++..|+|||++.+..++.++||||||++++||++ |+.|+.....      .+....... ..     
T Consensus       176 ~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~------~~~~~~~~~-~~-----  242 (291)
T cd05094         176 TDY-YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSN------TEVIECITQ-GR-----  242 (291)
T ss_pred             Cce-eecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH------HHHHHHHhC-CC-----
Confidence            221 112233456788999999999999999999999999999999 8888753221      111111111 00     


Q ss_pred             ccccCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhc
Q 039626          574 RHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNAS  625 (628)
Q Consensus       574 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~~~~  625 (628)
                              ....+...+..+.+++.+||+.||++||++++|++.|+++....
T Consensus       243 --------~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~~  286 (291)
T cd05094         243 --------VLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKAT  286 (291)
T ss_pred             --------CCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhhc
Confidence                    00111123456789999999999999999999999999997654

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=6.7e-35  Score=294.46  Aligned_cols=231  Identities=27%  Similarity=0.420  Sum_probs=183.5

Q ss_pred             eEEEEEEE-CCceEEEEEecc------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhcCCCC
Q 039626          361 GSVYRGKI-NGGFAAIKKVNG------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEG  433 (628)
Q Consensus       361 G~Vy~g~~-~g~~vavK~~~~------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~  433 (628)
                      |.||++.+ ++..+|+|..+.      ++.+|++++++++|+||+++++++.+++..++||||+++|+|.+++...   .
T Consensus        18 ~~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~---~   94 (256)
T cd05114          18 GVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQR---Q   94 (256)
T ss_pred             ceEEEEEeccCceEEEEecccCCccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCCCcHHHHHHhC---c
Confidence            89999998 455889998653      5678999999999999999999999999999999999999999998542   2


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCCccccC
Q 039626          434 KYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMA  513 (628)
Q Consensus       434 ~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~Y~A  513 (628)
                      ..++|..+..++.+++.||+|||+   .+++|+||||+||++++++.+||+|||+++.......  .......++..|+|
T Consensus        95 ~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~--~~~~~~~~~~~y~a  169 (256)
T cd05114          95 GKLSKDMLLSMCQDVCEGMEYLER---NSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY--TSSSGAKFPVKWSP  169 (256)
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcceEEEcCCCeEEECCCCCccccCCCce--eccCCCCCchhhCC
Confidence            358999999999999999999998   4599999999999999999999999999886533221  11122245668999


Q ss_pred             ccccccCCCCcccccHHHHHHHHHHHh-CCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCHHHHHH
Q 039626          514 PEYLENGLVSTKLDVYAFGVLILEMLT-GKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALL  592 (628)
Q Consensus       514 PE~l~~~~~s~k~DV~SfGvvl~ELlt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~  592 (628)
                      ||.+.+..++.++||||||++++||++ |+.|+.....      .+.+..+....       ...       .+...+..
T Consensus       170 PE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~------~~~~~~i~~~~-------~~~-------~~~~~~~~  229 (256)
T cd05114         170 PEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN------YEVVEMISRGF-------RLY-------RPKLASMT  229 (256)
T ss_pred             hhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH------HHHHHHHHCCC-------CCC-------CCCCCCHH
Confidence            999998889999999999999999999 8888753221      12222221110       000       11122356


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHHHHHH
Q 039626          593 VIRLIDACLKKDPTDRPTMYEIEHSLS  619 (628)
Q Consensus       593 l~~l~~~Cl~~dP~~RPs~~ev~~~L~  619 (628)
                      +.+++.+||+.+|.+||+++|+++.|.
T Consensus       230 ~~~li~~c~~~~p~~Rps~~~l~~~l~  256 (256)
T cd05114         230 VYEVMYSCWHEKPEGRPTFAELLRAIT  256 (256)
T ss_pred             HHHHHHHHccCCcccCcCHHHHHHhhC
Confidence            789999999999999999999998873

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.5e-35  Score=305.83  Aligned_cols=224  Identities=27%  Similarity=0.422  Sum_probs=184.6

Q ss_pred             eEEEEEEE--CCceEEEEEeccc------------hHHHHHHHhhcC-CCceeeeeeeeecCCeEEEEEEecCCCChHHH
Q 039626          361 GSVYRGKI--NGGFAAIKKVNGD------------VSKEIALLNKIN-HSNLIILSGVCFNEGNCYLVYEYAVNGTLSDW  425 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~~------------~~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~  425 (628)
                      |.|+.|..  .|+.||+|.+.++            +.+|+.++++++ ||||++++.++......++||||+.+|+|.++
T Consensus        31 gkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~~ivmEy~~gGdL~~~  110 (370)
T KOG0583|consen   31 GKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKIYIVMEYCSGGDLFDY  110 (370)
T ss_pred             eeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeEEEEEEecCCccHHHH
Confidence            89999987  7899999965442            336999999999 99999999999999999999999999999999


Q ss_pred             hhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCC-CcEEEccccccccCCCCCCcceeeec
Q 039626          426 VFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSD-LRAKIANFAMARPAEGQEGEFALTRH  504 (628)
Q Consensus       426 l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~-~~~kl~Dfgla~~~~~~~~~~~~~~~  504 (628)
                      +..    ...+.+.....++.|++.|++|+|+.   +|+||||||+|||+|.+ +++||+|||++......   ......
T Consensus       111 i~~----~g~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~~~---~~~l~t  180 (370)
T KOG0583|consen  111 IVN----KGRLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDFGLSAISPGE---DGLLKT  180 (370)
T ss_pred             HHH----cCCCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEeccccccccCCC---CCcccC
Confidence            954    44588899999999999999999995   49999999999999999 99999999999977411   123456


Q ss_pred             ccCCccccCccccccCC-CC-cccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCC
Q 039626          505 IVGTKGYMAPEYLENGL-VS-TKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQ  582 (628)
Q Consensus       505 ~~gt~~Y~APE~l~~~~-~s-~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~  582 (628)
                      ..||+.|+|||++.+.. |+ .++||||+||+||-|++|+.||....      .......+...               .
T Consensus       181 ~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~------~~~l~~ki~~~---------------~  239 (370)
T KOG0583|consen  181 FCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSN------VPNLYRKIRKG---------------E  239 (370)
T ss_pred             CCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCcc------HHHHHHHHhcC---------------C
Confidence            78999999999999876 75 78999999999999999999997411      11222221111               0


Q ss_pred             CCCCHHH-HHHHHHHHHHhcccCCCCCCCHHHHH
Q 039626          583 GNYPLEL-ALLVIRLIDACLKKDPTDRPTMYEIE  615 (628)
Q Consensus       583 ~~~~~~~-~~~l~~l~~~Cl~~dP~~RPs~~ev~  615 (628)
                      -.+|... +.++.+++.+|+..||.+|+++.||+
T Consensus       240 ~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~  273 (370)
T KOG0583|consen  240 FKIPSYLLSPEARSLIEKMLVPDPSTRITLLEIL  273 (370)
T ss_pred             ccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence            1223333 66788999999999999999999998

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.3e-35  Score=302.10  Aligned_cols=222  Identities=25%  Similarity=0.365  Sum_probs=181.5

Q ss_pred             eEEEEEEE--CCceEEEEEecc----------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhh
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG----------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFS  428 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  428 (628)
                      |.||++..  +|+.+|+|++..          .+.+|++++++++||||+++++++.+++..++||||+++|+|.+++..
T Consensus        15 g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~   94 (291)
T cd05612          15 GRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRN   94 (291)
T ss_pred             eEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEeCCCCCCHHHHHHH
Confidence            89999998  588999998752          256799999999999999999999999999999999999999999854


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCC
Q 039626          429 NKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGT  508 (628)
Q Consensus       429 ~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt  508 (628)
                          ...+++.....++.|++.||+|||+.   +++||||||+|||+++++.+||+|||+++.....      .....||
T Consensus        95 ----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~------~~~~~gt  161 (291)
T cd05612          95 ----SGRFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR------TWTLCGT  161 (291)
T ss_pred             ----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhccCC------cccccCC
Confidence                34589999999999999999999984   5999999999999999999999999999866432      1234689


Q ss_pred             ccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCHH
Q 039626          509 KGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLE  588 (628)
Q Consensus       509 ~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~  588 (628)
                      +.|+|||.+.+..++.++|||||||+++||++|+.|+.....      ......+....               ..++..
T Consensus       162 ~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~------~~~~~~i~~~~---------------~~~~~~  220 (291)
T cd05612         162 PEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNP------FGIYEKILAGK---------------LEFPRH  220 (291)
T ss_pred             hhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHhCC---------------cCCCcc
Confidence            999999999998899999999999999999999999864321      11111211110               012222


Q ss_pred             HHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 039626          589 LALLVIRLIDACLKKDPTDRPT-----MYEIEH  616 (628)
Q Consensus       589 ~~~~l~~l~~~Cl~~dP~~RPs-----~~ev~~  616 (628)
                      ....+.+++++||+.||.+||+     ++|+++
T Consensus       221 ~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~  253 (291)
T cd05612         221 LDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKN  253 (291)
T ss_pred             CCHHHHHHHHHHcCCCHHHccCCccCCHHHHhc
Confidence            3456789999999999999995     666653

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.7e-35  Score=308.57  Aligned_cols=231  Identities=20%  Similarity=0.316  Sum_probs=184.4

Q ss_pred             eEEEEEEE--CCceEEEEEecc----------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhh
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG----------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFS  428 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  428 (628)
                      |.||+++.  .++.||+|+++.          .+.+|++++.+++|+||+++++++.+++..++||||+++|+|.+++..
T Consensus        15 g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~   94 (333)
T cd05600          15 GQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNN   94 (333)
T ss_pred             eEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEeCCCCCCHHHHHHH
Confidence            89999998  578999999864          245799999999999999999999999999999999999999999953


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCC
Q 039626          429 NKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGT  508 (628)
Q Consensus       429 ~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt  508 (628)
                          ...+++.....++.|++.||.|||+.   +++||||||+|||++.++.+||+|||+++....      ......||
T Consensus        95 ----~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~------~~~~~~gt  161 (333)
T cd05600          95 ----LGVLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT------YANSVVGS  161 (333)
T ss_pred             ----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCccccc------ccCCcccC
Confidence                34588999999999999999999985   499999999999999999999999999986543      12345799


Q ss_pred             ccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCHH
Q 039626          509 KGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLE  588 (628)
Q Consensus       509 ~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~  588 (628)
                      +.|+|||++.+..++.++|||||||++|||++|+.|+......      +....+....   ..+.   .+.. ......
T Consensus       162 ~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~------~~~~~i~~~~---~~~~---~~~~-~~~~~~  228 (333)
T cd05600         162 PDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPN------ETWENLKYWK---ETLQ---RPVY-DDPRFN  228 (333)
T ss_pred             ccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHH------HHHHHHHhcc---cccc---CCCC-Cccccc
Confidence            9999999999999999999999999999999999998643221      1111111100   0000   0000 000013


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 039626          589 LALLVIRLIDACLKKDPTDRPTMYEIEHS  617 (628)
Q Consensus       589 ~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~  617 (628)
                      .+..+.+++.+||..+|.+||+++|+++.
T Consensus       229 ~s~~~~~li~~~l~~~~~rr~s~~~ll~h  257 (333)
T cd05600         229 LSDEAWDLITKLINDPSRRFGSLEDIKNH  257 (333)
T ss_pred             cCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence            35567899999999999999999998853

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=7.3e-35  Score=306.73  Aligned_cols=241  Identities=25%  Similarity=0.400  Sum_probs=187.2

Q ss_pred             eEEEEEEEC-------CceEEEEEecc--------chHHHHHHHhhc-CCCceeeeeeeeecC-CeEEEEEEecCCCChH
Q 039626          361 GSVYRGKIN-------GGFAAIKKVNG--------DVSKEIALLNKI-NHSNLIILSGVCFNE-GNCYLVYEYAVNGTLS  423 (628)
Q Consensus       361 G~Vy~g~~~-------g~~vavK~~~~--------~~~~E~~~l~~l-~H~nIv~l~g~~~~~-~~~~lV~E~~~~gsL~  423 (628)
                      |.||+|...       ++.||+|+++.        .+.+|++++.++ +|+||++++++|... ...++++||+++|+|.
T Consensus        21 g~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~~~~v~ey~~~~~L~  100 (337)
T cd05054          21 GKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEYCKFGNLS  100 (337)
T ss_pred             ceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCCEEEEEecCCCCCHH
Confidence            899999752       36799998753        245799999999 899999999998754 5688999999999999


Q ss_pred             HHhhhcCCC---------------------------------------------------------CCCCCHHHHHHHHH
Q 039626          424 DWVFSNKNE---------------------------------------------------------GKYLDWKQRIQIAL  446 (628)
Q Consensus       424 ~~l~~~~~~---------------------------------------------------------~~~l~~~~~~~i~~  446 (628)
                      +++......                                                         ...++|..+.+++.
T Consensus       101 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~  180 (337)
T cd05054         101 NYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSF  180 (337)
T ss_pred             HHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHhhcCCCHHHHHHHHH
Confidence            998543210                                                         13689999999999


Q ss_pred             HHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCCccccCccccccCCCCccc
Q 039626          447 DVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKL  526 (628)
Q Consensus       447 ~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~k~  526 (628)
                      ||+.||+|||+   .+|+||||||+|||+++++.+||+|||+++.+...... .......++..|+|||++.+..++.++
T Consensus       181 qi~~aL~~lH~---~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~  256 (337)
T cd05054         181 QVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY-VRKGDARLPLKWMAPESIFDKVYTTQS  256 (337)
T ss_pred             HHHHHHHHHHh---CCeecCCCCcceEEEeCCCcEEEeccccchhcccCcch-hhccCCCCCccccCcHHhcCCCCCccc
Confidence            99999999998   45999999999999999999999999999876432211 112234567789999999999999999


Q ss_pred             ccHHHHHHHHHHHh-CCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCHHHHHHHHHHHHHhcccCC
Q 039626          527 DVYAFGVLILEMLT-GKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDP  605 (628)
Q Consensus       527 DV~SfGvvl~ELlt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP  605 (628)
                      |||||||+++||++ |+.|+......      +.....+...         .    ....+......+.+++.+||+.+|
T Consensus       257 Di~SlGv~l~el~t~g~~p~~~~~~~------~~~~~~~~~~---------~----~~~~~~~~~~~~~~l~~~cl~~~p  317 (337)
T cd05054         257 DVWSFGVLLWEIFSLGASPYPGVQID------EEFCRRLKEG---------T----RMRAPEYATPEIYSIMLDCWHNNP  317 (337)
T ss_pred             cHHHHHHHHHHHHHcCCCCCCCCCcc------HHHHHHHhcc---------C----CCCCCccCCHHHHHHHHHHccCCh
Confidence            99999999999998 88887532211      1111111110         0    001122334568899999999999


Q ss_pred             CCCCCHHHHHHHHHHhHhh
Q 039626          606 TDRPTMYEIEHSLSNILNA  624 (628)
Q Consensus       606 ~~RPs~~ev~~~L~~l~~~  624 (628)
                      ++||++.|+++.|+++++.
T Consensus       318 ~~RPs~~ell~~l~~~~~~  336 (337)
T cd05054         318 EDRPTFSELVEILGDLLQE  336 (337)
T ss_pred             hhCcCHHHHHHHHHHHHhc
Confidence            9999999999999999875

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=3.4e-35  Score=287.14  Aligned_cols=243  Identities=26%  Similarity=0.296  Sum_probs=187.9

Q ss_pred             eEEEEEEE--CCceEEEEEeccc---------hHHHHHHHhhcCCCceeeeeeeeecC--CeEEEEEEecCCCChHHHhh
Q 039626          361 GSVYRGKI--NGGFAAIKKVNGD---------VSKEIALLNKINHSNLIILSGVCFNE--GNCYLVYEYAVNGTLSDWVF  427 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~~---------~~~E~~~l~~l~H~nIv~l~g~~~~~--~~~~lV~E~~~~gsL~~~l~  427 (628)
                      |.||+|+.  +++.||+|+++.+         ..+|+.+|.+++|||||.+-.+....  +..|+||||++. +|...+.
T Consensus        90 GiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe~~Eh-DLksl~d  168 (419)
T KOG0663|consen   90 GVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVMEYVEH-DLKSLME  168 (419)
T ss_pred             eeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHHHHHh-hHHHHHH
Confidence            99999998  7889999999863         35899999999999999998887743  579999999976 8988885


Q ss_pred             hcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccC
Q 039626          428 SNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVG  507 (628)
Q Consensus       428 ~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~g  507 (628)
                      .-   .+.+...+..-+..|+++|++|||...   |+|||||++|+|++..|.+||+|||+||.++....   ..+..+-
T Consensus       169 ~m---~q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~k---~~T~lVV  239 (419)
T KOG0663|consen  169 TM---KQPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYGSPLK---PYTPLVV  239 (419)
T ss_pred             hc---cCCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhcCCcc---cCcceEE
Confidence            42   356888899999999999999999966   99999999999999999999999999998875422   2455788


Q ss_pred             CccccCcccccc-CCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhcccc----chhhhcccc-----
Q 039626          508 TKGYMAPEYLEN-GLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKED----GEESLRHFI-----  577 (628)
Q Consensus       508 t~~Y~APE~l~~-~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~----~~~~l~~~~-----  577 (628)
                      |.+|+|||.+.+ ..|++..|+||+||++.||+++++.+....+   ....+.+...+....    +.-......     
T Consensus       240 TLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE---~dQl~~If~llGtPte~iwpg~~~lp~~k~~~f  316 (419)
T KOG0663|consen  240 TLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSE---IDQLDKIFKLLGTPSEAIWPGYSELPAVKKMTF  316 (419)
T ss_pred             EeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCch---HHHHHHHHHHhCCCccccCCCccccchhhcccc
Confidence            999999999887 4799999999999999999999988775443   223333333332211    000000000     


Q ss_pred             ----CCcCCCCCCHH-HHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          578 ----DPTLQGNYPLE-LALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       578 ----d~~l~~~~~~~-~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                          -..++..++.. ....-++|+...|..||++|.|+.|.++
T Consensus       317 ~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~  360 (419)
T KOG0663|consen  317 SEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK  360 (419)
T ss_pred             CCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence                01112222222 4566789999999999999999998764

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.8e-34  Score=295.92  Aligned_cols=249  Identities=24%  Similarity=0.367  Sum_probs=187.4

Q ss_pred             eEEEEEEE------CCceEEEEEecc--------chHHHHHHHhhcCCCceeeeeeeeecC--CeEEEEEEecCCCChHH
Q 039626          361 GSVYRGKI------NGGFAAIKKVNG--------DVSKEIALLNKINHSNLIILSGVCFNE--GNCYLVYEYAVNGTLSD  424 (628)
Q Consensus       361 G~Vy~g~~------~g~~vavK~~~~--------~~~~E~~~l~~l~H~nIv~l~g~~~~~--~~~~lV~E~~~~gsL~~  424 (628)
                      |.||.+..      ++..+|+|..+.        .+.+|++++++++|+||+++++++...  ...++||||+++|+|.+
T Consensus        18 g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~   97 (283)
T cd05080          18 GKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRD   97 (283)
T ss_pred             cEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEEecCCCCCCHHH
Confidence            88987653      467899998863        256799999999999999999998754  35799999999999999


Q ss_pred             HhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeec
Q 039626          425 WVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRH  504 (628)
Q Consensus       425 ~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~  504 (628)
                      ++..     ..++|.++..++.+++.||+|||+.   +++||||||+||++++++.+||+|||+++..............
T Consensus        98 ~~~~-----~~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~  169 (283)
T cd05080          98 YLPK-----HKLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVRED  169 (283)
T ss_pred             HHHH-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeecccccccCCcchhhccCCC
Confidence            9843     2489999999999999999999984   5999999999999999999999999999876543221111222


Q ss_pred             ccCCccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCC
Q 039626          505 IVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGN  584 (628)
Q Consensus       505 ~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~  584 (628)
                      ..++..|+|||.+.+..++.++||||||++++||++|+.|+.......    .+...... .......+...++......
T Consensus       170 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~----~~~~~~~~-~~~~~~~~~~~~~~~~~~~  244 (283)
T cd05080         170 GDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKF----EEMIGPKQ-GQMTVVRLIELLERGMRLP  244 (283)
T ss_pred             CCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchh----hhhhcccc-cccchhhhhhhhhcCCCCC
Confidence            345677999999998899999999999999999999998875332110    01110000 0000111111122222222


Q ss_pred             CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhH
Q 039626          585 YPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNIL  622 (628)
Q Consensus       585 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~  622 (628)
                      .+...+..+.+++.+||+.||++||+++++++.|+++.
T Consensus       245 ~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~  282 (283)
T cd05080         245 CPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH  282 (283)
T ss_pred             CCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence            33344567899999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=4.9e-35  Score=300.62  Aligned_cols=243  Identities=22%  Similarity=0.302  Sum_probs=182.4

Q ss_pred             eEEEEEEE--CCceEEEEEecc---------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhc
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG---------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSN  429 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~---------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~  429 (628)
                      |.||+++.  +++.+|+|+++.         .+.+|++++++++|+||+++++++..++..++||||++++.|..+..  
T Consensus        15 ~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~--   92 (287)
T cd07848          15 GVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEKNMLELLEE--   92 (287)
T ss_pred             EEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEecCCCCHHHHHHh--
Confidence            89999998  577899998753         35689999999999999999999999999999999999887765442  


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCCc
Q 039626          430 KNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTK  509 (628)
Q Consensus       430 ~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~  509 (628)
                        ....+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||+++........  ......|++
T Consensus        93 --~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~~~~  165 (287)
T cd07848          93 --MPNGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNA--NYTEYVATR  165 (287)
T ss_pred             --cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCcccccccccc--ccccccccc
Confidence              234589999999999999999999984   5999999999999999999999999999876432211  122356899


Q ss_pred             cccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhh---------ccccCCc
Q 039626          510 GYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESL---------RHFIDPT  580 (628)
Q Consensus       510 ~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l---------~~~~d~~  580 (628)
                      .|+|||++.+..++.++|||||||+++||++|+.|+........  +. .+....... ..+.+         .....+.
T Consensus       166 ~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~--~~-~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~  241 (287)
T cd07848         166 WYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQ--LF-TIQKVLGPL-PAEQMKLFYSNPRFHGLRFPA  241 (287)
T ss_pred             ccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHH--HH-HHHHhhCCC-CHHHHHhhhccchhcccccCc
Confidence            99999999988899999999999999999999998864322111  00 011111000 00000         0000011


Q ss_pred             CCC------CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          581 LQG------NYPLELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       581 l~~------~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      ...      .+....+..+.+++++||+.||++|||++|+++
T Consensus       242 ~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~  283 (287)
T cd07848         242 VNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN  283 (287)
T ss_pred             ccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            100      111124456899999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=5.6e-35  Score=306.65  Aligned_cols=221  Identities=22%  Similarity=0.358  Sum_probs=180.1

Q ss_pred             eEEEEEEE--CCceEEEEEecc----------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhh
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG----------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFS  428 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  428 (628)
                      |.||+++.  +++.+|+|.++.          .+.+|+.++++++|+||+++++++.+++..++||||+++|+|.+++..
T Consensus        32 g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~  111 (329)
T PTZ00263         32 GRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRK  111 (329)
T ss_pred             eEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEEcCCCCChHHHHHHH
Confidence            89999998  578999998853          256799999999999999999999999999999999999999999954


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCC
Q 039626          429 NKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGT  508 (628)
Q Consensus       429 ~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt  508 (628)
                          ...+++.....++.|++.||+|||+.   +|+||||||+|||+++++.+||+|||+++......      ....||
T Consensus       112 ----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~------~~~~gt  178 (329)
T PTZ00263        112 ----AGRFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT------FTLCGT  178 (329)
T ss_pred             ----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEcCCCc------ceecCC
Confidence                34578889999999999999999994   49999999999999999999999999998664321      234689


Q ss_pred             ccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCHH
Q 039626          509 KGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLE  588 (628)
Q Consensus       509 ~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~  588 (628)
                      +.|+|||.+.+..++.++|||||||++|||++|+.||.....      .+....+....             +  .++..
T Consensus       179 ~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~------~~~~~~i~~~~-------------~--~~p~~  237 (329)
T PTZ00263        179 PEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP------FRIYEKILAGR-------------L--KFPNW  237 (329)
T ss_pred             hhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCH------HHHHHHHhcCC-------------c--CCCCC
Confidence            999999999999999999999999999999999999863221      11111111110             0  11122


Q ss_pred             HHHHHHHHHHHhcccCCCCCCC-----HHHHH
Q 039626          589 LALLVIRLIDACLKKDPTDRPT-----MYEIE  615 (628)
Q Consensus       589 ~~~~l~~l~~~Cl~~dP~~RPs-----~~ev~  615 (628)
                      ....+.+++.+||+.||.+||+     +++++
T Consensus       238 ~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll  269 (329)
T PTZ00263        238 FDGRARDLVKGLLQTDHTKRLGTLKGGVADVK  269 (329)
T ss_pred             CCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHh
Confidence            3345789999999999999997     56655

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=1.4e-34  Score=291.40  Aligned_cols=232  Identities=27%  Similarity=0.448  Sum_probs=183.0

Q ss_pred             eEEEEEEE--CCceEEEEEecc--------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhcC
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG--------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNK  430 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~--------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~  430 (628)
                      |.||+|..  +++.+|+|....        .+.+|++++++++|+||++++++|...+..++||||+++++|.+++..  
T Consensus         9 g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--   86 (252)
T cd05084           9 GEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRT--   86 (252)
T ss_pred             ccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcHHHHHHh--
Confidence            89999988  688899997653        367899999999999999999999999999999999999999999853  


Q ss_pred             CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCCcc
Q 039626          431 NEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKG  510 (628)
Q Consensus       431 ~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~  510 (628)
                       ....++|..++.++.|++.||+|||+.   +++||||||+||+++.++.+||+|||+++........ ........+..
T Consensus        87 -~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~  161 (252)
T cd05084          87 -EGPRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYA-STGGMKQIPVK  161 (252)
T ss_pred             -CCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCccccccccc-ccCCCCCCcee
Confidence             234589999999999999999999984   5999999999999999999999999998765422110 00111223457


Q ss_pred             ccCccccccCCCCcccccHHHHHHHHHHHh-CCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCHHH
Q 039626          511 YMAPEYLENGLVSTKLDVYAFGVLILEMLT-GKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLEL  589 (628)
Q Consensus       511 Y~APE~l~~~~~s~k~DV~SfGvvl~ELlt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~  589 (628)
                      |+|||.+.++.++.++||||||++++||++ |..|+......      +. .....         .    ......+...
T Consensus       162 y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~------~~-~~~~~---------~----~~~~~~~~~~  221 (252)
T cd05084         162 WTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ------QT-REAIE---------Q----GVRLPCPELC  221 (252)
T ss_pred             ecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHH------HH-HHHHH---------c----CCCCCCcccC
Confidence            999999999999999999999999999998 77776432111      00 01100         0    0111222334


Q ss_pred             HHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 039626          590 ALLVIRLIDACLKKDPTDRPTMYEIEHSLS  619 (628)
Q Consensus       590 ~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~  619 (628)
                      +..+.+++.+||+.||++||++.|+.+.|+
T Consensus       222 ~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         222 PDAVYRLMERCWEYDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence            556889999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=3.5e-34  Score=290.55  Aligned_cols=238  Identities=23%  Similarity=0.349  Sum_probs=192.1

Q ss_pred             eEEEEEEE--CCceEEEEEecc----------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhh
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG----------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFS  428 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  428 (628)
                      |.||+|..  +|+.+|+|.++.          .+.+|++++++++|+|++++++++..++..++||||+++|+|.+++..
T Consensus        16 ~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   95 (267)
T cd08224          16 SVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKH   95 (267)
T ss_pred             eEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEecCCCCCHHHHHHH
Confidence            89999998  588999997742          356899999999999999999999999999999999999999999865


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCC
Q 039626          429 NKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGT  508 (628)
Q Consensus       429 ~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt  508 (628)
                      .......+++.++..++.+++.||.|||+.   +++|+||+|+||+++.++.++|+|||+++........   .....++
T Consensus        96 ~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~---~~~~~~~  169 (267)
T cd08224          96 FKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA---AHSLVGT  169 (267)
T ss_pred             hcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeeccCCCcc---cceecCC
Confidence            444456689999999999999999999984   5999999999999999999999999998765432211   2234688


Q ss_pred             ccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCH-
Q 039626          509 KGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPL-  587 (628)
Q Consensus       509 ~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~-  587 (628)
                      ..|+|||++.+..++.++||||||+++|||++|+.|+....    ....+........          .    ....+. 
T Consensus       170 ~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~----~~~~~~~~~~~~~----------~----~~~~~~~  231 (267)
T cd08224         170 PYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK----MNLYSLCKKIEKC----------D----YPPLPAD  231 (267)
T ss_pred             ccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCC----ccHHHHHhhhhcC----------C----CCCCChh
Confidence            89999999998889999999999999999999999875322    1122222111110          0    011111 


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhH
Q 039626          588 ELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNIL  622 (628)
Q Consensus       588 ~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~  622 (628)
                      .....+.+++.+||+.+|.+||++.+|++.|+.+.
T Consensus       232 ~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~  266 (267)
T cd08224         232 HYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH  266 (267)
T ss_pred             hcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence            34456889999999999999999999999998874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=8.7e-35  Score=299.68  Aligned_cols=239  Identities=28%  Similarity=0.466  Sum_probs=188.2

Q ss_pred             eEEEEEEEC-------CceEEEEEecc--------chHHHHHHHhhc-CCCceeeeeeeeecCCeEEEEEEecCCCChHH
Q 039626          361 GSVYRGKIN-------GGFAAIKKVNG--------DVSKEIALLNKI-NHSNLIILSGVCFNEGNCYLVYEYAVNGTLSD  424 (628)
Q Consensus       361 G~Vy~g~~~-------g~~vavK~~~~--------~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~  424 (628)
                      |.||++...       ...+|+|....        ++.+|++++.++ +|+||+++++++..++..+++|||+++|+|.+
T Consensus        26 g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~li~e~~~~~~L~~  105 (293)
T cd05053          26 GQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRD  105 (293)
T ss_pred             ccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCeEEEEEeCCCCcHHH
Confidence            899999873       25789998764        256799999999 89999999999999999999999999999999


Q ss_pred             HhhhcC------------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccC
Q 039626          425 WVFSNK------------NEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPA  492 (628)
Q Consensus       425 ~l~~~~------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~  492 (628)
                      ++....            .....++|..+++++.|++.||+|||+   .+++||||||+||++++++.+||+|||+++..
T Consensus       106 ~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivH~dlkp~Nil~~~~~~~kL~Dfg~~~~~  182 (293)
T cd05053         106 FLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLAS---KKCIHRDLAARNVLVTEDHVMKIADFGLARDI  182 (293)
T ss_pred             HHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCccccccceeeEEEcCCCeEEeCcccccccc
Confidence            996432            234568999999999999999999998   45999999999999999999999999999876


Q ss_pred             CCCCCcceeeecccCCccccCccccccCCCCcccccHHHHHHHHHHHh-CCCccccccccccccHHHHHHHHhccccchh
Q 039626          493 EGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT-GKEAAALHAEENNMHLSDVLNAVLTKEDGEE  571 (628)
Q Consensus       493 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELlt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  571 (628)
                      ...... .......++..|+|||.+.+..++.++|||||||++|||++ |..|+....      ..+.......      
T Consensus       183 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~------~~~~~~~~~~------  249 (293)
T cd05053         183 HHIDYY-RKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP------VEELFKLLKE------  249 (293)
T ss_pred             ccccce-eccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCC------HHHHHHHHHc------
Confidence            432211 11122345678999999999999999999999999999998 877765221      1111111111      


Q ss_pred             hhccccCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHh
Q 039626          572 SLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILN  623 (628)
Q Consensus       572 ~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~~  623 (628)
                              ......+......+.+++.+||+.||++|||+.|+++.|+++++
T Consensus       250 --------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~~  293 (293)
T cd05053         250 --------GYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRMLT  293 (293)
T ss_pred             --------CCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhhC
Confidence                    00111222344568899999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=6.1e-35  Score=305.57  Aligned_cols=226  Identities=25%  Similarity=0.369  Sum_probs=182.2

Q ss_pred             ceEEEEEEE--CCceEEEEEeccc----------hHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhh
Q 039626          360 QGSVYRGKI--NGGFAAIKKVNGD----------VSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVF  427 (628)
Q Consensus       360 ~G~Vy~g~~--~g~~vavK~~~~~----------~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~  427 (628)
                      .|.||++..  +|..+|+|+++.+          +.+|++++++++||||+++++++..++..++||||+++|+|.+++.
T Consensus         8 ~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~   87 (323)
T cd05595           8 FGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLS   87 (323)
T ss_pred             CEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCCcHHHHHH
Confidence            389999987  6889999998642          3469999999999999999999999999999999999999999884


Q ss_pred             hcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccC
Q 039626          428 SNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVG  507 (628)
Q Consensus       428 ~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~g  507 (628)
                      .    ...+++..+..++.|++.||+|||+.   +++||||||+|||+++++.+||+|||+++.......   ......|
T Consensus        88 ~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~---~~~~~~g  157 (323)
T cd05595          88 R----ERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA---TMKTFCG  157 (323)
T ss_pred             H----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCCCC---ccccccC
Confidence            3    34589999999999999999999984   599999999999999999999999999875422211   1233579


Q ss_pred             CccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCH
Q 039626          508 TKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPL  587 (628)
Q Consensus       508 t~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~  587 (628)
                      |+.|+|||++.+..++.++|||||||++|||++|+.|+......      .........           +.    ..+.
T Consensus       158 t~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~------~~~~~~~~~-----------~~----~~p~  216 (323)
T cd05595         158 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE------RLFELILME-----------EI----RFPR  216 (323)
T ss_pred             CcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHH------HHHHHHhcC-----------CC----CCCC
Confidence            99999999999999999999999999999999999998633211      111111110           00    1222


Q ss_pred             HHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 039626          588 ELALLVIRLIDACLKKDPTDRP-----TMYEIEH  616 (628)
Q Consensus       588 ~~~~~l~~l~~~Cl~~dP~~RP-----s~~ev~~  616 (628)
                      ..+..+.+++.+||+.||++||     ++.++++
T Consensus       217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~  250 (323)
T cd05595         217 TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  250 (323)
T ss_pred             CCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence            3445678999999999999998     7777764

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=1.1e-34  Score=311.22  Aligned_cols=239  Identities=25%  Similarity=0.432  Sum_probs=187.8

Q ss_pred             eEEEEEEECC-------ceEEEEEecc--------chHHHHHHHhhcC-CCceeeeeeeeecCCeEEEEEEecCCCChHH
Q 039626          361 GSVYRGKING-------GFAAIKKVNG--------DVSKEIALLNKIN-HSNLIILSGVCFNEGNCYLVYEYAVNGTLSD  424 (628)
Q Consensus       361 G~Vy~g~~~g-------~~vavK~~~~--------~~~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~  424 (628)
                      |.||+|++.+       ..||+|+++.        .+.+|+++|.++. |+||++++|+|..++..++|+||+++|+|.+
T Consensus        51 G~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~~iv~E~~~~g~L~~  130 (401)
T cd05107          51 GRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPIYIITEYCRYGDLVD  130 (401)
T ss_pred             eeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCcEEEEeccCCCcHHH
Confidence            8999998743       5799999864        3567999999997 9999999999999999999999999999999


Q ss_pred             HhhhcCC-------------------------------------------------------------------------
Q 039626          425 WVFSNKN-------------------------------------------------------------------------  431 (628)
Q Consensus       425 ~l~~~~~-------------------------------------------------------------------------  431 (628)
                      +++....                                                                         
T Consensus       131 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  210 (401)
T cd05107         131 YLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMKGTVKYADIESSNYE  210 (401)
T ss_pred             HHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcchhhhhhhhhhccCcC
Confidence            9975321                                                                         


Q ss_pred             ---------------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccc
Q 039626          432 ---------------------EGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMAR  490 (628)
Q Consensus       432 ---------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~  490 (628)
                                           ....++|...+.++.|++.||+|||+   ++++||||||+|||+++++.+||+|||+++
T Consensus       211 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrdlkp~NiLl~~~~~~kL~DfGla~  287 (401)
T cd05107         211 SPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLAS---KNCVHRDLAARNVLICEGKLVKICDFGLAR  287 (401)
T ss_pred             CchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhc---CCcCcccCCcceEEEeCCCEEEEEecCcce
Confidence                                 11347888999999999999999998   559999999999999999999999999998


Q ss_pred             cCCCCCCcceeeecccCCccccCccccccCCCCcccccHHHHHHHHHHHh-CCCccccccccccccHHHHHHHHhccccc
Q 039626          491 PAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT-GKEAAALHAEENNMHLSDVLNAVLTKEDG  569 (628)
Q Consensus       491 ~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELlt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~  569 (628)
                      ........ .......++..|+|||.+.+..++.++||||||++++||++ |+.|+.....      .+.........  
T Consensus       288 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~------~~~~~~~~~~~--  358 (401)
T cd05107         288 DIMRDSNY-ISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPM------NEQFYNAIKRG--  358 (401)
T ss_pred             eccccccc-ccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCc------hHHHHHHHHcC--
Confidence            65322111 11122356788999999998889999999999999999998 7877653211      11111111110  


Q ss_pred             hhhhccccCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhH
Q 039626          570 EESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNIL  622 (628)
Q Consensus       570 ~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~  622 (628)
                                 .+...+...+..+.+++.+||+.+|.+||+++||++.|++++
T Consensus       359 -----------~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~  400 (401)
T cd05107         359 -----------YRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL  400 (401)
T ss_pred             -----------CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence                       011122233466889999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.6e-34  Score=296.32  Aligned_cols=248  Identities=25%  Similarity=0.439  Sum_probs=184.3

Q ss_pred             eEEEEEEE------CCceEEEEEecc-------chHHHHHHHhhcCCCceeeeeeeeecC--CeEEEEEEecCCCChHHH
Q 039626          361 GSVYRGKI------NGGFAAIKKVNG-------DVSKEIALLNKINHSNLIILSGVCFNE--GNCYLVYEYAVNGTLSDW  425 (628)
Q Consensus       361 G~Vy~g~~------~g~~vavK~~~~-------~~~~E~~~l~~l~H~nIv~l~g~~~~~--~~~~lV~E~~~~gsL~~~  425 (628)
                      |.||++..      ++..+|+|++..       .+.+|++++++++|+||+++.+++...  ...++|+||+++|+|.++
T Consensus        18 g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~   97 (284)
T cd05081          18 GSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDY   97 (284)
T ss_pred             ceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEEEEEecCCCCHHHH
Confidence            89999875      467899999853       467899999999999999999987643  468999999999999999


Q ss_pred             hhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecc
Q 039626          426 VFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHI  505 (628)
Q Consensus       426 l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~  505 (628)
                      +...   ...++|..+..++.|++.||+|||+.   +++||||||+||++++++.+||+|||+++...............
T Consensus        98 l~~~---~~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~  171 (284)
T cd05081          98 LQKH---RERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPG  171 (284)
T ss_pred             HHhc---CcCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCcccccccCCCcceeecCCC
Confidence            9542   23589999999999999999999984   59999999999999999999999999998764332211111222


Q ss_pred             cCCccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhcccc---chhhhccccCCcCC
Q 039626          506 VGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKED---GEESLRHFIDPTLQ  582 (628)
Q Consensus       506 ~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~l~~~~d~~l~  582 (628)
                      .++..|+|||++.+..++.++||||||++++||++|..+.......       +...+.....   ....+.+.+.....
T Consensus       172 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (284)
T cd05081         172 ESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAE-------FMRMMGNDKQGQMIVYHLIELLKNNGR  244 (284)
T ss_pred             CCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchh-------hhhhcccccccccchHHHHHHHhcCCc
Confidence            3445699999999889999999999999999999987654321110       0000000000   00001111111111


Q ss_pred             CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 039626          583 GNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNI  621 (628)
Q Consensus       583 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l  621 (628)
                      ...+...+..+.+++.+||..+|++|||++||++.|+.+
T Consensus       245 ~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~  283 (284)
T cd05081         245 LPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI  283 (284)
T ss_pred             CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence            112223445688999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=8.9e-35  Score=319.98  Aligned_cols=232  Identities=21%  Similarity=0.300  Sum_probs=186.5

Q ss_pred             eEEEEEEE--C-CceEEEEEecc-------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhcC
Q 039626          361 GSVYRGKI--N-GGFAAIKKVNG-------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNK  430 (628)
Q Consensus       361 G~Vy~g~~--~-g~~vavK~~~~-------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~  430 (628)
                      |.||++..  + ++.+|+|+...       .+.+|+.+|++++|||||++++++..++..+|||||+++|+|.++|....
T Consensus        81 g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~  160 (478)
T PTZ00267         81 TAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRL  160 (478)
T ss_pred             cEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCCCCCHHHHHHHHH
Confidence            89999976  3 56788887642       35679999999999999999999999999999999999999999986544


Q ss_pred             CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCCcc
Q 039626          431 NEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKG  510 (628)
Q Consensus       431 ~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~  510 (628)
                      .....+++.....++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++....... ........||++
T Consensus       161 ~~~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~-~~~~~~~~gt~~  236 (478)
T PTZ00267        161 KEHLPFQEYEVGLLFYQIVLALDEVHS---RKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS-LDVASSFCGTPY  236 (478)
T ss_pred             hccCCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCcCHHhEEECCCCcEEEEeCcCceecCCccc-cccccccCCCcc
Confidence            445568999999999999999999998   4599999999999999999999999999987643221 112334579999


Q ss_pred             ccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCHHHH
Q 039626          511 YMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELA  590 (628)
Q Consensus       511 Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~  590 (628)
                      |+|||++.+..++.++|||||||+++||++|+.|+.....      .+.........         .+     ..+...+
T Consensus       237 y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~------~~~~~~~~~~~---------~~-----~~~~~~s  296 (478)
T PTZ00267        237 YLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ------REIMQQVLYGK---------YD-----PFPCPVS  296 (478)
T ss_pred             ccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHhCC---------CC-----CCCccCC
Confidence            9999999999999999999999999999999999863221      12222221110         00     1122334


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          591 LLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       591 ~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      ..+.+++.+||+.||++||++.+++.
T Consensus       297 ~~~~~li~~~L~~dP~~Rps~~~~l~  322 (478)
T PTZ00267        297 SGMKALLDPLLSKNPALRPTTQQLLH  322 (478)
T ss_pred             HHHHHHHHHHhccChhhCcCHHHHHh
Confidence            56889999999999999999999864

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=1.2e-34  Score=304.68  Aligned_cols=177  Identities=23%  Similarity=0.391  Sum_probs=154.8

Q ss_pred             eEEEEEEE--CCceEEEEEecc--------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhcC
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG--------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNK  430 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~--------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~  430 (628)
                      |.||++..  .+..+|+|.++.        ++.+|++++++++|+||++++++|.+++..++||||+++|+|.+++..  
T Consensus        19 g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--   96 (333)
T cd06650          19 GVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK--   96 (333)
T ss_pred             EEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEecCCCCcHHHHHHH--
Confidence            89999998  577888887653        367899999999999999999999999999999999999999999953  


Q ss_pred             CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCCcc
Q 039626          431 NEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKG  510 (628)
Q Consensus       431 ~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~  510 (628)
                        ...+++.....++.+++.||.|||+.  .+++|+||||+|||+++++.+||+|||++.......     .....|+..
T Consensus        97 --~~~~~~~~~~~~~~~l~~~l~~lH~~--~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~-----~~~~~~~~~  167 (333)
T cd06650          97 --AGRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-----ANSFVGTRS  167 (333)
T ss_pred             --cCCCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhc-----cccCCCCcc
Confidence              23588999999999999999999972  359999999999999999999999999987653221     223468999


Q ss_pred             ccCccccccCCCCcccccHHHHHHHHHHHhCCCccccc
Q 039626          511 YMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALH  548 (628)
Q Consensus       511 Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~  548 (628)
                      |+|||.+.+..++.++|||||||++|||++|+.|+...
T Consensus       168 y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~  205 (333)
T cd06650         168 YMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP  205 (333)
T ss_pred             ccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence            99999999989999999999999999999999998643

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=1.4e-34  Score=303.43  Aligned_cols=225  Identities=25%  Similarity=0.359  Sum_probs=182.4

Q ss_pred             eEEEEEEE--CCceEEEEEecc----------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhh
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG----------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFS  428 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  428 (628)
                      |.||++..  +|..+|+|.++.          .+.+|++++++++|+||+++.+++..++..++||||+++|+|.+++..
T Consensus         9 g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~   88 (328)
T cd05593           9 GKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGELFFHLSR   88 (328)
T ss_pred             EEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCCCHHHHHHh
Confidence            89999987  678999998864          245689999999999999999999999999999999999999998853


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCC
Q 039626          429 NKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGT  508 (628)
Q Consensus       429 ~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt  508 (628)
                          ...+++.++..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++......   .......||
T Consensus        89 ----~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~---~~~~~~~gt  158 (328)
T cd05593          89 ----ERVFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA---ATMKTFCGT  158 (328)
T ss_pred             ----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCcc---cccccccCC
Confidence                34589999999999999999999984   59999999999999999999999999987543221   112345799


Q ss_pred             ccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCHH
Q 039626          509 KGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLE  588 (628)
Q Consensus       509 ~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~  588 (628)
                      +.|+|||.+.+..++.++|||||||++|||++|+.||.....      .+........           +.    .++..
T Consensus       159 ~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~------~~~~~~~~~~-----------~~----~~p~~  217 (328)
T cd05593         159 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH------EKLFELILME-----------DI----KFPRT  217 (328)
T ss_pred             cCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCH------HHHHHHhccC-----------Cc----cCCCC
Confidence            999999999999999999999999999999999999863221      1111111110           01    12223


Q ss_pred             HHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 039626          589 LALLVIRLIDACLKKDPTDRP-----TMYEIEH  616 (628)
Q Consensus       589 ~~~~l~~l~~~Cl~~dP~~RP-----s~~ev~~  616 (628)
                      .+..+.+++.+||+.||++||     ++.|+++
T Consensus       218 ~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~  250 (328)
T cd05593         218 LSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMR  250 (328)
T ss_pred             CCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhc
Confidence            445678999999999999997     7888764

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=1.9e-34  Score=295.80  Aligned_cols=236  Identities=24%  Similarity=0.477  Sum_probs=185.5

Q ss_pred             eEEEEEEE------CCceEEEEEecc--------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHh
Q 039626          361 GSVYRGKI------NGGFAAIKKVNG--------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWV  426 (628)
Q Consensus       361 G~Vy~g~~------~g~~vavK~~~~--------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l  426 (628)
                      |.||+|.+      .+..+++|.++.        ++.+|++++++++|+||+++++++..+...++||||+++|+|.+++
T Consensus        19 g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l   98 (283)
T cd05090          19 GKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFL   98 (283)
T ss_pred             cceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEEEEEcCCCCcHHHHH
Confidence            89999985      346889999863        4678999999999999999999999999999999999999999998


Q ss_pred             hhcCC-------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCC
Q 039626          427 FSNKN-------------EGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAE  493 (628)
Q Consensus       427 ~~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~  493 (628)
                      .....             ....+++.+.+.++.+++.||.|||+.   +++||||||+|||+++++.+||+|||+++...
T Consensus        99 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~  175 (283)
T cd05090          99 IMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQLHVKISDLGLSREIY  175 (283)
T ss_pred             HhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcCCCcEEecccccccccc
Confidence            54321             123588999999999999999999984   59999999999999999999999999998764


Q ss_pred             CCCCcceeeecccCCccccCccccccCCCCcccccHHHHHHHHHHHh-CCCccccccccccccHHHHHHHHhccccchhh
Q 039626          494 GQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT-GKEAAALHAEENNMHLSDVLNAVLTKEDGEES  572 (628)
Q Consensus       494 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELlt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  572 (628)
                      ..... .......++..|+|||++.+..++.++||||||++++||++ |..|+.....      .+....+....     
T Consensus       176 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~------~~~~~~~~~~~-----  243 (283)
T cd05090         176 SADYY-RVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN------QEVIEMVRKRQ-----  243 (283)
T ss_pred             CCcce-ecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH------HHHHHHHHcCC-----
Confidence            32211 12233446778999999998889999999999999999998 8877653221      11111111100     


Q ss_pred             hccccCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 039626          573 LRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSN  620 (628)
Q Consensus       573 l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~  620 (628)
                               ....+...+..+.+++.+||+.||++||++.+|.+.|.+
T Consensus       244 ---------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         244 ---------LLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             ---------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence                     001122334567899999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=9.5e-35  Score=293.96  Aligned_cols=233  Identities=30%  Similarity=0.488  Sum_probs=188.0

Q ss_pred             eEEEEEEE-CCceEEEEEecc-------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhcCCC
Q 039626          361 GSVYRGKI-NGGFAAIKKVNG-------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNE  432 (628)
Q Consensus       361 G~Vy~g~~-~g~~vavK~~~~-------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~  432 (628)
                      |.||+|.. ++..+++|.+..       ++.+|++++++++|+||+++++++.+.+..++||||+++|+|.+++...  .
T Consensus        20 ~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~   97 (261)
T cd05148          20 GEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSP--E   97 (261)
T ss_pred             ccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeecccCCHHHHHhcC--C
Confidence            89999998 567889998753       4667999999999999999999999999999999999999999999643  3


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCCcccc
Q 039626          433 GKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYM  512 (628)
Q Consensus       433 ~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~Y~  512 (628)
                      +..+++.++..++.+++.||+|||+   .+++|+||||+||++++++.+||+|||++........   ......++..|+
T Consensus        98 ~~~~~~~~~~~~~~~i~~al~~lH~---~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~---~~~~~~~~~~~~  171 (261)
T cd05148          98 GQVLPVASLIDMACQVAEGMAYLEE---QNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY---LSSDKKIPYKWT  171 (261)
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccCcceEEEcCCceEEEccccchhhcCCccc---cccCCCCceEec
Confidence            4568999999999999999999998   4599999999999999999999999999986643221   122334677899


Q ss_pred             CccccccCCCCcccccHHHHHHHHHHHh-CCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCHHHHH
Q 039626          513 APEYLENGLVSTKLDVYAFGVLILEMLT-GKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELAL  591 (628)
Q Consensus       513 APE~l~~~~~s~k~DV~SfGvvl~ELlt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~  591 (628)
                      |||.+.+..++.++||||||++++||++ |+.|+.....      .+.......              ..+...+...+.
T Consensus       172 ~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~------~~~~~~~~~--------------~~~~~~~~~~~~  231 (261)
T cd05148         172 APEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNN------HEVYDQITA--------------GYRMPCPAKCPQ  231 (261)
T ss_pred             CHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCH------HHHHHHHHh--------------CCcCCCCCCCCH
Confidence            9999998899999999999999999998 7887753221      111111111              011112234445


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 039626          592 LVIRLIDACLKKDPTDRPTMYEIEHSLSNI  621 (628)
Q Consensus       592 ~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l  621 (628)
                      .+.+++.+||+.||.+|||++++.+.|+.+
T Consensus       232 ~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~  261 (261)
T cd05148         232 EIYKIMLECWAAEPEDRPSFKALREELDNI  261 (261)
T ss_pred             HHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence            688999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.5e-34  Score=304.08  Aligned_cols=244  Identities=24%  Similarity=0.372  Sum_probs=179.5

Q ss_pred             eEEEEEEE--CCceEEEEEecc---------chHHHHHHHhhcCCCceeeeeeeeecC-----CeEEEEEEecCCCChHH
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG---------DVSKEIALLNKINHSNLIILSGVCFNE-----GNCYLVYEYAVNGTLSD  424 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~---------~~~~E~~~l~~l~H~nIv~l~g~~~~~-----~~~~lV~E~~~~gsL~~  424 (628)
                      |.||+|+.  +|..||||+++.         .+.+|++++++++|+||+++++++...     ...++||||+ +++|.+
T Consensus        14 g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~   92 (338)
T cd07859          14 GVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELM-ESDLHQ   92 (338)
T ss_pred             eEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEEEEecC-CCCHHH
Confidence            89999987  678999998763         256799999999999999999998643     2479999999 478999


Q ss_pred             HhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeec
Q 039626          425 WVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRH  504 (628)
Q Consensus       425 ~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~  504 (628)
                      ++..    ...+++..+..++.|++.||.|||+.   +++||||||+|||++.++.+||+|||+++..............
T Consensus        93 ~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~  165 (338)
T cd07859          93 VIKA----NDDLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD  165 (338)
T ss_pred             HHHh----cccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCccccccccccCccccccC
Confidence            8843    34589999999999999999999995   4999999999999999999999999999865432222122234


Q ss_pred             ccCCccccCcccccc--CCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhcccc-----------chh
Q 039626          505 IVGTKGYMAPEYLEN--GLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKED-----------GEE  571 (628)
Q Consensus       505 ~~gt~~Y~APE~l~~--~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~  571 (628)
                      ..||+.|+|||++.+  ..++.++|||||||+++||++|+.||.......   ..+.+........           ..+
T Consensus       166 ~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~---~~~~~~~~~~~~~~~~~~~i~~~~~~~  242 (338)
T cd07859         166 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVH---QLDLITDLLGTPSPETISRVRNEKARR  242 (338)
T ss_pred             CCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHH---HHHHHHHHhCCCCHHHHHHhhhhhHHH
Confidence            579999999999875  678999999999999999999999886432111   1111111111000           000


Q ss_pred             hhccccCCcCCCCCC---HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          572 SLRHFIDPTLQGNYP---LELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       572 ~l~~~~d~~l~~~~~---~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      .+.. +.........   ......+.+++.+||+.||++||+++|+++
T Consensus       243 ~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~  289 (338)
T cd07859         243 YLSS-MRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA  289 (338)
T ss_pred             HHHh-hcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhc
Confidence            0000 0000000000   012345789999999999999999999985

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.8e-34  Score=288.80  Aligned_cols=230  Identities=30%  Similarity=0.485  Sum_probs=187.0

Q ss_pred             eEEEEEEECCceEEEEEeccc------hHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhcCCCCC
Q 039626          361 GSVYRGKINGGFAAIKKVNGD------VSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGK  434 (628)
Q Consensus       361 G~Vy~g~~~g~~vavK~~~~~------~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~  434 (628)
                      |.||++...|+.+|+|+.+.+      +.+|+.++++++|+||+++++++.++...++||||+++++|.+++...  ...
T Consensus        20 g~v~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~--~~~   97 (256)
T cd05039          20 GDVMLGDYRGQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSR--GRA   97 (256)
T ss_pred             ceEEEEEecCcEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCCCcHHHHHHhc--CCC
Confidence            899999999999999998753      557999999999999999999999988999999999999999998542  223


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCCccccCc
Q 039626          435 YLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAP  514 (628)
Q Consensus       435 ~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~Y~AP  514 (628)
                      .++|..+..++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||+++......      .....+..|+||
T Consensus        98 ~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~------~~~~~~~~~~ap  168 (256)
T cd05039          98 VITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ------DSGKLPVKWTAP  168 (256)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEccccccccccccc------ccCCCcccccCc
Confidence            689999999999999999999984   59999999999999999999999999998663221      122345679999


Q ss_pred             cccccCCCCcccccHHHHHHHHHHHh-CCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCHHHHHHH
Q 039626          515 EYLENGLVSTKLDVYAFGVLILEMLT-GKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLV  593 (628)
Q Consensus       515 E~l~~~~~s~k~DV~SfGvvl~ELlt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l  593 (628)
                      |++..+.++.++||||||++++|+++ |+.|+.....      .+........              .....+...+..+
T Consensus       169 e~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~------~~~~~~~~~~--------------~~~~~~~~~~~~~  228 (256)
T cd05039         169 EALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL------KDVVPHVEKG--------------YRMEAPEGCPPEV  228 (256)
T ss_pred             hhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCH------HHHHHHHhcC--------------CCCCCccCCCHHH
Confidence            99998899999999999999999997 8887753221      1111111100              0111122334567


Q ss_pred             HHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 039626          594 IRLIDACLKKDPTDRPTMYEIEHSLSNI  621 (628)
Q Consensus       594 ~~l~~~Cl~~dP~~RPs~~ev~~~L~~l  621 (628)
                      .+++.+||..+|.+||+++|++++|+.+
T Consensus       229 ~~li~~~l~~~p~~Rp~~~~l~~~l~~~  256 (256)
T cd05039         229 YKVMKDCWELDPAKRPTFKQLREQLALI  256 (256)
T ss_pred             HHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence            8999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=2e-34  Score=294.73  Aligned_cols=235  Identities=29%  Similarity=0.469  Sum_probs=186.4

Q ss_pred             eEEEEEEEC-------CceEEEEEecc--------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHH
Q 039626          361 GSVYRGKIN-------GGFAAIKKVNG--------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDW  425 (628)
Q Consensus       361 G~Vy~g~~~-------g~~vavK~~~~--------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~  425 (628)
                      |.||+|...       +..+|+|..+.        ++.+|+++|++++|+||+++++++..+...++||||+++|+|.++
T Consensus        19 ~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~   98 (280)
T cd05049          19 GKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKF   98 (280)
T ss_pred             ceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeEEEEecCCCCCHHHH
Confidence            899999862       36799998753        467899999999999999999999999999999999999999999


Q ss_pred             hhhcC----------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCC
Q 039626          426 VFSNK----------NEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQ  495 (628)
Q Consensus       426 l~~~~----------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~  495 (628)
                      +....          .....+++.++..++.+++.||+|||+.   +++||||||+||+++.++.+||+|||+++.....
T Consensus        99 i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~kl~d~g~~~~~~~~  175 (280)
T cd05049          99 LRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTT  175 (280)
T ss_pred             HHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCCCeEEECCcccceecccC
Confidence            96542          1234589999999999999999999984   5999999999999999999999999999765322


Q ss_pred             CCcceeeecccCCccccCccccccCCCCcccccHHHHHHHHHHHh-CCCccccccccccccHHHHHHHHhccccchhhhc
Q 039626          496 EGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT-GKEAAALHAEENNMHLSDVLNAVLTKEDGEESLR  574 (628)
Q Consensus       496 ~~~~~~~~~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELlt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  574 (628)
                      .. ........++..|+|||++.+..+++++||||||++++||++ |+.|+......      +........        
T Consensus       176 ~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~------~~~~~~~~~--------  240 (280)
T cd05049         176 DY-YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE------EVIECITQG--------  240 (280)
T ss_pred             cc-eecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHH------HHHHHHHcC--------
Confidence            11 111223356788999999999999999999999999999998 99887532221      111111100        


Q ss_pred             cccCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 039626          575 HFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLS  619 (628)
Q Consensus       575 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~  619 (628)
                            .....+...+..+.+++.+||+.||++||++.||++.|+
T Consensus       241 ------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~  279 (280)
T cd05049         241 ------RLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ  279 (280)
T ss_pred             ------CcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence                  000112234456889999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.5e-35  Score=294.75  Aligned_cols=245  Identities=24%  Similarity=0.322  Sum_probs=186.4

Q ss_pred             ceEEEEEEE--CCceEEEEEeccc---hHHHHHHHhhcCCCceeeeeeeeecCC-----eEEEEEEecCCCChHHHhhhc
Q 039626          360 QGSVYRGKI--NGGFAAIKKVNGD---VSKEIALLNKINHSNLIILSGVCFNEG-----NCYLVYEYAVNGTLSDWVFSN  429 (628)
Q Consensus       360 ~G~Vy~g~~--~g~~vavK~~~~~---~~~E~~~l~~l~H~nIv~l~g~~~~~~-----~~~lV~E~~~~gsL~~~l~~~  429 (628)
                      .|.||+|+.  +++.|||||+..+   -.+|+++|+++.|||||+|+-++....     ...||||||+. +|.+.+...
T Consensus        37 Fg~Vyq~~~~e~~~~vAIKKv~~d~r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleymP~-tL~~~~r~~  115 (364)
T KOG0658|consen   37 FGVVYQAKLRETEEEVAIKKVLQDKRYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYMPE-TLYRVIRHY  115 (364)
T ss_pred             cceEEEEEEcCCCceeEEEEecCCCCcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhchH-HHHHHHHHH
Confidence            399999999  6789999999654   357999999999999999999987432     24689999965 899998654


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCC-CcEEEccccccccCCCCCCcceeeecccCC
Q 039626          430 KNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSD-LRAKIANFAMARPAEGQEGEFALTRHIVGT  508 (628)
Q Consensus       430 ~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~-~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt  508 (628)
                      ...+..++...+.-+..|+++||.|||+.+   |+||||||.|+|+|.+ |.+||+|||.|+.....+..    .....|
T Consensus       116 ~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~epn----iSYicS  188 (364)
T KOG0658|consen  116 TRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGEPN----ISYICS  188 (364)
T ss_pred             hhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCcceeeccCCCc----eeEEEe
Confidence            444556777777789999999999999954   9999999999999987 99999999999988655432    234578


Q ss_pred             ccccCcccccc-CCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhc-------cccCCc
Q 039626          509 KGYMAPEYLEN-GLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLR-------HFIDPT  580 (628)
Q Consensus       509 ~~Y~APE~l~~-~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~-------~~~d~~  580 (628)
                      ..|+|||.+.+ ..|+.+.||||.|||+.||+-|++.|.+.+..   .....+..++..... +.+.       ++..|.
T Consensus       189 RyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~---dQL~eIik~lG~Pt~-e~I~~mn~~y~~~~~p~  264 (364)
T KOG0658|consen  189 RYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSV---DQLVEIIKVLGTPTR-EDIKSMNPNYTEFKFPQ  264 (364)
T ss_pred             ccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHH---HHHHHHHHHhCCCCH-HHHhhcCcccccccCcc
Confidence            89999998876 47999999999999999999999888764332   222333333332211 1111       111111


Q ss_pred             CC-----CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          581 LQ-----GNYPLELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       581 l~-----~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      +.     .-+......+..+|+.++++.+|.+|.++.|++.
T Consensus       265 ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~  305 (364)
T KOG0658|consen  265 IKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA  305 (364)
T ss_pred             cccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence            11     1123345567889999999999999999988864

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-34  Score=295.10  Aligned_cols=242  Identities=30%  Similarity=0.391  Sum_probs=186.0

Q ss_pred             hcCCCcCCccc----eEEEEEEE--CCceEEEEEecc---------------------chHHHHHHHhhcCCCceeeeee
Q 039626          350 TDNFSFTCRIQ----GSVYRGKI--NGGFAAIKKVNG---------------------DVSKEIALLNKINHSNLIILSG  402 (628)
Q Consensus       350 t~~f~~~~~i~----G~Vy~g~~--~g~~vavK~~~~---------------------~~~~E~~~l~~l~H~nIv~l~g  402 (628)
                      .+.|.....+|    |.|-++..  +++.+|||.+.+                     .+.+|+.+|++++|+|||+|+.
T Consensus        96 lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiE  175 (576)
T KOG0585|consen   96 LNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIE  175 (576)
T ss_pred             hhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEE
Confidence            34444444443    88888877  789999998753                     3567999999999999999999


Q ss_pred             eeecC--CeEEEEEEecCCCChHHHhhhcCCCCCC-CCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCC
Q 039626          403 VCFNE--GNCYLVYEYAVNGTLSDWVFSNKNEGKY-LDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDL  479 (628)
Q Consensus       403 ~~~~~--~~~~lV~E~~~~gsL~~~l~~~~~~~~~-l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~  479 (628)
                      +..+.  +..|||+||+..|.+.. .    ...+. |+..+..+++.++..||+|||.++   ||||||||+|+||+++|
T Consensus       176 vLDDP~s~~~YlVley~s~G~v~w-~----p~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~g  247 (576)
T KOG0585|consen  176 VLDDPESDKLYLVLEYCSKGEVKW-C----PPDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSDG  247 (576)
T ss_pred             eecCcccCceEEEEEeccCCcccc-C----CCCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCCC
Confidence            98754  57999999999998753 2    23334 999999999999999999999965   99999999999999999


Q ss_pred             cEEEccccccccCCCCC--CcceeeecccCCccccCccccccCC----CCcccccHHHHHHHHHHHhCCCcccccccccc
Q 039626          480 RAKIANFAMARPAEGQE--GEFALTRHIVGTKGYMAPEYLENGL----VSTKLDVYAFGVLILEMLTGKEAAALHAEENN  553 (628)
Q Consensus       480 ~~kl~Dfgla~~~~~~~--~~~~~~~~~~gt~~Y~APE~l~~~~----~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~  553 (628)
                      ++||+|||.+.......  +........+|||.|+|||.+.++.    .+.+.||||+||+||-|+.|+.||.....   
T Consensus       248 ~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~---  324 (576)
T KOG0585|consen  248 TVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFE---  324 (576)
T ss_pred             cEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchH---
Confidence            99999999988652221  1111223468999999999987633    46789999999999999999999863221   


Q ss_pred             ccHHHHHHHHhccccchhhhccccCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 039626          554 MHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSL  618 (628)
Q Consensus       554 ~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L  618 (628)
                         .+             ..++++...+.-....++.+.+.+|++++|++||++|.+..+|..-.
T Consensus       325 ---~~-------------l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hp  373 (576)
T KOG0585|consen  325 ---LE-------------LFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHP  373 (576)
T ss_pred             ---HH-------------HHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecc
Confidence               11             22233333332222235677889999999999999999999886543

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=3.3e-34  Score=297.24  Aligned_cols=242  Identities=26%  Similarity=0.442  Sum_probs=189.7

Q ss_pred             eEEEEEEE---------CCceEEEEEecc--------chHHHHHHHhhc-CCCceeeeeeeeecCCeEEEEEEecCCCCh
Q 039626          361 GSVYRGKI---------NGGFAAIKKVNG--------DVSKEIALLNKI-NHSNLIILSGVCFNEGNCYLVYEYAVNGTL  422 (628)
Q Consensus       361 G~Vy~g~~---------~g~~vavK~~~~--------~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL  422 (628)
                      |.||+++.         ++..+|+|..+.        ++.+|+.+++.+ +|+||+++++++......++||||+++|+|
T Consensus        29 g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L  108 (304)
T cd05101          29 GQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL  108 (304)
T ss_pred             ceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecCCceEEEEecCCCCcH
Confidence            89999974         234689998754        356799999999 899999999999999999999999999999


Q ss_pred             HHHhhhcCC------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccc
Q 039626          423 SDWVFSNKN------------EGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMAR  490 (628)
Q Consensus       423 ~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~  490 (628)
                      .+++.....            ....++|.+++.++.|++.||+|||+.   +++||||||+||++++++.+||+|||+++
T Consensus       109 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nili~~~~~~kl~D~g~~~  185 (304)
T cd05101         109 REYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLAR  185 (304)
T ss_pred             HHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---CeeecccccceEEEcCCCcEEECCCccce
Confidence            999965432            123588999999999999999999984   59999999999999999999999999998


Q ss_pred             cCCCCCCcceeeecccCCccccCccccccCCCCcccccHHHHHHHHHHHh-CCCccccccccccccHHHHHHHHhccccc
Q 039626          491 PAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT-GKEAAALHAEENNMHLSDVLNAVLTKEDG  569 (628)
Q Consensus       491 ~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELlt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~  569 (628)
                      ........ .......++..|+|||.+.+..++.++||||||+++|||++ |..|+....      ..+.........  
T Consensus       186 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~------~~~~~~~~~~~~--  256 (304)
T cd05101         186 DVNNIDYY-KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP------VEELFKLLKEGH--  256 (304)
T ss_pred             eccccccc-ccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC------HHHHHHHHHcCC--
Confidence            76432211 11222346678999999998889999999999999999998 666654221      122222211100  


Q ss_pred             hhhhccccCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhcc
Q 039626          570 EESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNASL  626 (628)
Q Consensus       570 ~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~~~~~  626 (628)
                                  ....+...+..+.+++.+||+.+|.+||++.|+++.|++++..+.
T Consensus       257 ------------~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~~  301 (304)
T cd05101         257 ------------RMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLTT  301 (304)
T ss_pred             ------------cCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhhh
Confidence                        001122344568899999999999999999999999999987643

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=3.7e-34  Score=294.62  Aligned_cols=243  Identities=21%  Similarity=0.349  Sum_probs=181.5

Q ss_pred             eEEEEEEE--CCceEEEEEecc--------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhcC
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG--------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNK  430 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~--------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~  430 (628)
                      |.||+|..  ++..||+|+++.        .+.+|++++++++|+||+++++++..++..++||||++ |+|.+++..  
T Consensus        19 g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~--   95 (288)
T cd07871          19 ATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLD-SDLKQYLDN--   95 (288)
T ss_pred             EEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCCC-cCHHHHHHh--
Confidence            89999987  678999998752        35689999999999999999999999899999999996 599998853  


Q ss_pred             CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCCcc
Q 039626          431 NEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKG  510 (628)
Q Consensus       431 ~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~  510 (628)
                       .+..+++..+..++.|++.||+|||+.   +|+||||||+|||+++++.+||+|||+++.......   ......+++.
T Consensus        96 -~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~---~~~~~~~~~~  168 (288)
T cd07871          96 -CGNLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK---TYSNEVVTLW  168 (288)
T ss_pred             -cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc---cccCceeccc
Confidence             234578999999999999999999984   599999999999999999999999999976532221   1233468999


Q ss_pred             ccCcccccc-CCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhcccc--------chhhhccccCCcC
Q 039626          511 YMAPEYLEN-GLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKED--------GEESLRHFIDPTL  581 (628)
Q Consensus       511 Y~APE~l~~-~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~l~~~~d~~l  581 (628)
                      |+|||.+.+ ..++.++||||+||+++||++|+.|+......+.   ...+........        ..+.+.....+..
T Consensus       169 y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (288)
T cd07871         169 YRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEE---LHLIFRLLGTPTEETWPGITSNEEFRSYLFPQY  245 (288)
T ss_pred             ccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHhCCCChHHhhccccchhhhccccCcc
Confidence            999998865 5689999999999999999999999864332211   111111111100        0011111111111


Q ss_pred             CCCC----CHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          582 QGNY----PLELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       582 ~~~~----~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      ....    .......+.+++.+||+.||.+|||++|+++
T Consensus       246 ~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~  284 (288)
T cd07871         246 RAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR  284 (288)
T ss_pred             CCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence            1000    0122345789999999999999999999874

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=4.3e-34  Score=290.99  Aligned_cols=238  Identities=23%  Similarity=0.424  Sum_probs=182.5

Q ss_pred             eEEEEEEEC--Cc--eEEEEEecc---------chHHHHHHHhhcCCCceeeeeeeeecC------CeEEEEEEecCCCC
Q 039626          361 GSVYRGKIN--GG--FAAIKKVNG---------DVSKEIALLNKINHSNLIILSGVCFNE------GNCYLVYEYAVNGT  421 (628)
Q Consensus       361 G~Vy~g~~~--g~--~vavK~~~~---------~~~~E~~~l~~l~H~nIv~l~g~~~~~------~~~~lV~E~~~~gs  421 (628)
                      |.||+|.+.  +.  .+|+|..+.         ++.+|++++++++|+||++++++|...      ...++++||+++|+
T Consensus        13 g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~   92 (272)
T cd05075          13 GSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGD   92 (272)
T ss_pred             ceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcEEEEEeCCCCc
Confidence            899999983  22  589997642         356799999999999999999988532      24689999999999


Q ss_pred             hHHHhhhcC--CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcc
Q 039626          422 LSDWVFSNK--NEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEF  499 (628)
Q Consensus       422 L~~~l~~~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~  499 (628)
                      |.+++...+  .....++|.....++.|++.||+|||+   .+++||||||+|||+++++.+||+|||+++........ 
T Consensus        93 l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-  168 (272)
T cd05075          93 LHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSS---KSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYY-  168 (272)
T ss_pred             HHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhheEEcCCCCEEECCCCcccccCcccce-
Confidence            999985432  223458999999999999999999998   45999999999999999999999999999876432211 


Q ss_pred             eeeecccCCccccCccccccCCCCcccccHHHHHHHHHHHh-CCCccccccccccccHHHHHHHHhccccchhhhccccC
Q 039626          500 ALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT-GKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFID  578 (628)
Q Consensus       500 ~~~~~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELlt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d  578 (628)
                      .......+++.|++||++.+..++.++||||||+++|||++ |+.|+.....      .+....... ..   .      
T Consensus       169 ~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~------~~~~~~~~~-~~---~------  232 (272)
T cd05075         169 RQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN------SEIYDYLRQ-GN---R------  232 (272)
T ss_pred             ecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH------HHHHHHHHc-CC---C------
Confidence            11122346678999999999999999999999999999999 7777753211      111111111 00   0      


Q ss_pred             CcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhH
Q 039626          579 PTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNIL  622 (628)
Q Consensus       579 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~  622 (628)
                      .    ..+......+.+++.+||+.||++|||+.|+++.|++++
T Consensus       233 ~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~~  272 (272)
T cd05075         233 L----KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKAL  272 (272)
T ss_pred             C----CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence            0    011223455789999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=2.9e-34  Score=293.56  Aligned_cols=235  Identities=29%  Similarity=0.427  Sum_probs=182.5

Q ss_pred             eEEEEEEECC-------ceEEEEEecc--------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHH
Q 039626          361 GSVYRGKING-------GFAAIKKVNG--------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDW  425 (628)
Q Consensus       361 G~Vy~g~~~g-------~~vavK~~~~--------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~  425 (628)
                      |.||+|.+.+       ..+|+|....        ++.+|+.++++++|+||+++++++.+.+..++||||+++|+|.++
T Consensus        20 g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~   99 (277)
T cd05036          20 GEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSF   99 (277)
T ss_pred             CcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcEEEEecCCCCCHHHH
Confidence            8999999843       5788887652        367799999999999999999999988899999999999999999


Q ss_pred             hhhcCC---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCC---cEEEccccccccCCCCCCcc
Q 039626          426 VFSNKN---EGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDL---RAKIANFAMARPAEGQEGEF  499 (628)
Q Consensus       426 l~~~~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~---~~kl~Dfgla~~~~~~~~~~  499 (628)
                      +...+.   ....++|..+++++.||+.||+|||+.   +++||||||+||+++.++   .+||+|||+++........ 
T Consensus       100 i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~-  175 (277)
T cd05036         100 LRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYY-  175 (277)
T ss_pred             HHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcceEeccCccccccCCccce-
Confidence            965432   123589999999999999999999984   599999999999998764   5999999999876322111 


Q ss_pred             eeeecccCCccccCccccccCCCCcccccHHHHHHHHHHHh-CCCccccccccccccHHHHHHHHhccccchhhhccccC
Q 039626          500 ALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT-GKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFID  578 (628)
Q Consensus       500 ~~~~~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELlt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d  578 (628)
                      ........+..|+|||++.+..++.++|||||||+++||++ |+.|+......      +....+...            
T Consensus       176 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~------~~~~~~~~~------------  237 (277)
T cd05036         176 RKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ------EVMEFVTGG------------  237 (277)
T ss_pred             ecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH------HHHHHHHcC------------
Confidence            11112234568999999999999999999999999999997 88887532211      111111110            


Q ss_pred             CcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 039626          579 PTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLS  619 (628)
Q Consensus       579 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~  619 (628)
                        .....+...+..+.+++.+||+.+|++||++.+|++.|.
T Consensus       238 --~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~  276 (277)
T cd05036         238 --GRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ  276 (277)
T ss_pred             --CcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence              011122233456889999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4e-34  Score=289.57  Aligned_cols=240  Identities=23%  Similarity=0.294  Sum_probs=186.7

Q ss_pred             CCCcCCccc----eEEEEEEE--CCceEEEEEecc------------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEE
Q 039626          352 NFSFTCRIQ----GSVYRGKI--NGGFAAIKKVNG------------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLV  413 (628)
Q Consensus       352 ~f~~~~~i~----G~Vy~g~~--~g~~vavK~~~~------------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV  413 (628)
                      +|.....+|    |.||++..  ++..+|+|.+..            .+.+|++++++++|+||+++++++.+++..++|
T Consensus         3 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v   82 (263)
T cd06625           3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIF   82 (263)
T ss_pred             cccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEE
Confidence            344444443    89999987  678999998642            356799999999999999999999999999999


Q ss_pred             EEecCCCChHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCC
Q 039626          414 YEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAE  493 (628)
Q Consensus       414 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~  493 (628)
                      +||+++++|.+++..    ...+++..+..++.+++.||.|||+.   +++|+||+|+||++++++.+||+|||+++...
T Consensus        83 ~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~  155 (263)
T cd06625          83 MEYMPGGSVKDQLKA----YGALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQ  155 (263)
T ss_pred             EEECCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence            999999999999854    23588899999999999999999984   59999999999999999999999999987654


Q ss_pred             CCCCcceeeecccCCccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhh
Q 039626          494 GQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESL  573 (628)
Q Consensus       494 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  573 (628)
                      .............++..|+|||.+.+..++.++||||||+++|||++|+.|+.....      ..........       
T Consensus       156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~------~~~~~~~~~~-------  222 (263)
T cd06625         156 TICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEA------MAAIFKIATQ-------  222 (263)
T ss_pred             ccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccch------HHHHHHHhcc-------
Confidence            321111111234578899999999998899999999999999999999998753211      1111111110       


Q ss_pred             ccccCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 039626          574 RHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHS  617 (628)
Q Consensus       574 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~  617 (628)
                            ......+......+.+++.+||..+|.+||++.|+++.
T Consensus       223 ------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  260 (263)
T cd06625         223 ------PTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH  260 (263)
T ss_pred             ------CCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence                  01112233344567899999999999999999999763

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=3.1e-34  Score=291.56  Aligned_cols=236  Identities=25%  Similarity=0.435  Sum_probs=185.7

Q ss_pred             eEEEEEEE--CC---ceEEEEEecc--------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhh
Q 039626          361 GSVYRGKI--NG---GFAAIKKVNG--------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVF  427 (628)
Q Consensus       361 G~Vy~g~~--~g---~~vavK~~~~--------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~  427 (628)
                      |.||+|..  ++   ..+|+|.++.        .+.+|+.++.+++||||+++.+++.+++..++||||+++|+|.+++.
T Consensus        18 g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~   97 (267)
T cd05066          18 GEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLR   97 (267)
T ss_pred             CceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEcCCCCCHHHHHH
Confidence            89999987  22   3689998753        36779999999999999999999999999999999999999999995


Q ss_pred             hcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccC
Q 039626          428 SNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVG  507 (628)
Q Consensus       428 ~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~g  507 (628)
                      ..   ...+++.+++.++.|++.||+|||+.   +++||||||+|||++.++.+|++|||+++................+
T Consensus        98 ~~---~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~  171 (267)
T cd05066          98 KH---DGQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI  171 (267)
T ss_pred             hc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCcccccccccceeeecCCCcc
Confidence            42   24589999999999999999999984   5999999999999999999999999999876543221111122234


Q ss_pred             CccccCccccccCCCCcccccHHHHHHHHHHHh-CCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCC
Q 039626          508 TKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT-GKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYP  586 (628)
Q Consensus       508 t~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELlt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~  586 (628)
                      +..|+|||++.+..++.++|+||||++++|+++ |+.|+.....      .+....+...          ...    ..+
T Consensus       172 ~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~------~~~~~~~~~~----------~~~----~~~  231 (267)
T cd05066         172 PIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSN------QDVIKAIEEG----------YRL----PAP  231 (267)
T ss_pred             ceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCH------HHHHHHHhCC----------CcC----CCC
Confidence            568999999998899999999999999999887 9988753221      1111111110          000    111


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhH
Q 039626          587 LELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNIL  622 (628)
Q Consensus       587 ~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~  622 (628)
                      ...+..+.+++.+||+.+|.+||+|.++++.|.+++
T Consensus       232 ~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~  267 (267)
T cd05066         232 MDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKLI  267 (267)
T ss_pred             CCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhhC
Confidence            233456789999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.4e-33  Score=306.65  Aligned_cols=257  Identities=21%  Similarity=0.274  Sum_probs=186.4

Q ss_pred             CCCcCCccc----eEEEEEEE--CCceEEEEEec-cchHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHH
Q 039626          352 NFSFTCRIQ----GSVYRGKI--NGGFAAIKKVN-GDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSD  424 (628)
Q Consensus       352 ~f~~~~~i~----G~Vy~g~~--~g~~vavK~~~-~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~  424 (628)
                      +|.....+|    |.||++..  .+..||||... ..+.+|+++|++++|+|||++++++..++..++|||++ .++|.+
T Consensus       170 gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~-~~~L~~  248 (461)
T PHA03211        170 GFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWYASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKY-RSDLYT  248 (461)
T ss_pred             CeEEEEEEccCCCeEEEEEEECCCCCEEEEecccccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEcc-CCCHHH
Confidence            455444443    89999998  46789999754 35778999999999999999999999999999999999 578998


Q ss_pred             HhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeec
Q 039626          425 WVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRH  504 (628)
Q Consensus       425 ~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~  504 (628)
                      ++...   ...++|.+++.|+.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++........ .....
T Consensus       249 ~l~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~-~~~~~  321 (461)
T PHA03211        249 YLGAR---LRPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWST-PFHYG  321 (461)
T ss_pred             HHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceeccccccc-ccccc
Confidence            88532   34699999999999999999999984   5999999999999999999999999999866432211 11224


Q ss_pred             ccCCccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccc-ccccc----HHHHHHHHhcc--ccc-------h
Q 039626          505 IVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAE-ENNMH----LSDVLNAVLTK--EDG-------E  570 (628)
Q Consensus       505 ~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~-~~~~~----~~~~~~~~~~~--~~~-------~  570 (628)
                      ..||..|+|||++.+..++.++|||||||++|||++|..++..... .....    +.+.+......  +..       .
T Consensus       322 ~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l~  401 (461)
T PHA03211        322 IAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRLV  401 (461)
T ss_pred             cCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchHHH
Confidence            5799999999999999999999999999999999998865432211 11111    12222111100  000       0


Q ss_pred             hhhcc----ccCCcC-CCCCC--HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          571 ESLRH----FIDPTL-QGNYP--LELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       571 ~~l~~----~~d~~l-~~~~~--~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      ..+..    ...+.. ...+.  ......+.+|+.+||+.||.+|||+.|+++
T Consensus       402 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~  454 (461)
T PHA03211        402 SQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLR  454 (461)
T ss_pred             HHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhh
Confidence            00000    000000 00000  012335789999999999999999999986

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.2e-34  Score=289.62  Aligned_cols=230  Identities=27%  Similarity=0.405  Sum_probs=182.6

Q ss_pred             eEEEEEEE-CCceEEEEEecc------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhcCCCC
Q 039626          361 GSVYRGKI-NGGFAAIKKVNG------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEG  433 (628)
Q Consensus       361 G~Vy~g~~-~g~~vavK~~~~------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~  433 (628)
                      |.||++.+ .+..+|+|....      ++.+|++++++++|+||+++++++...+..++||||+++++|.+++...   .
T Consensus        18 ~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~   94 (256)
T cd05059          18 GVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRER---K   94 (256)
T ss_pred             ceEEEeEecCCccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCCCCHHHHHHhc---c
Confidence            89999988 455789998754      4678999999999999999999999999999999999999999999642   2


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCCccccC
Q 039626          434 KYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMA  513 (628)
Q Consensus       434 ~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~Y~A  513 (628)
                      ..++|..++.++.|++.||+|||+.   +++||||||+||++++++.+||+|||+++.......  .......++..|+|
T Consensus        95 ~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~~y~~  169 (256)
T cd05059          95 GKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY--TSSQGTKFPVKWAP  169 (256)
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceecccccc--cccCCCCCCccccC
Confidence            3689999999999999999999984   499999999999999999999999999986543211  11111234457999


Q ss_pred             ccccccCCCCcccccHHHHHHHHHHHh-CCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCHHHHHH
Q 039626          514 PEYLENGLVSTKLDVYAFGVLILEMLT-GKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALL  592 (628)
Q Consensus       514 PE~l~~~~~s~k~DV~SfGvvl~ELlt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~  592 (628)
                      ||.+.+..++.++||||||+++|||++ |+.|+......      +......          .....    ..+...+..
T Consensus       170 Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~------~~~~~~~----------~~~~~----~~~~~~~~~  229 (256)
T cd05059         170 PEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS------EVVESVS----------AGYRL----YRPKLAPTE  229 (256)
T ss_pred             HHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHH------HHHHHHH----------cCCcC----CCCCCCCHH
Confidence            999999999999999999999999999 78777532211      1111111          01111    112224556


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHHHHH
Q 039626          593 VIRLIDACLKKDPTDRPTMYEIEHSL  618 (628)
Q Consensus       593 l~~l~~~Cl~~dP~~RPs~~ev~~~L  618 (628)
                      +.+++.+||..+|++||++.|+++.|
T Consensus       230 ~~~li~~cl~~~p~~Rpt~~~~l~~l  255 (256)
T cd05059         230 VYTIMYSCWHEKPEDRPAFKKLLSQL  255 (256)
T ss_pred             HHHHHHHHhcCChhhCcCHHHHHHHh
Confidence            88999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=3.7e-34  Score=296.80  Aligned_cols=237  Identities=22%  Similarity=0.414  Sum_probs=186.0

Q ss_pred             eEEEEEEE-------CCceEEEEEecc--------chHHHHHHHhhc-CCCceeeeeeeeecCCeEEEEEEecCCCChHH
Q 039626          361 GSVYRGKI-------NGGFAAIKKVNG--------DVSKEIALLNKI-NHSNLIILSGVCFNEGNCYLVYEYAVNGTLSD  424 (628)
Q Consensus       361 G~Vy~g~~-------~g~~vavK~~~~--------~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~  424 (628)
                      |.||+++.       .+..+|+|+.+.        .+.+|+++++++ +|+||+++++++...+..++||||+++|+|.+
T Consensus        49 g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~  128 (302)
T cd05055          49 GKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLN  128 (302)
T ss_pred             eeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCceEEEEEcCCCCcHHH
Confidence            89999975       234789998753        366799999999 89999999999999999999999999999999


Q ss_pred             HhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeec
Q 039626          425 WVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRH  504 (628)
Q Consensus       425 ~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~  504 (628)
                      ++...  ....+++.++..++.+++.||+|||+.   +++|+||||+|||++.++.+|++|||+++....... ......
T Consensus       129 ~i~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~  202 (302)
T cd05055         129 FLRRK--RESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSN-YVVKGN  202 (302)
T ss_pred             HHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCCcccccccCCCc-eeecCC
Confidence            99642  233489999999999999999999984   599999999999999999999999999986643221 112223


Q ss_pred             ccCCccccCccccccCCCCcccccHHHHHHHHHHHh-CCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCC
Q 039626          505 IVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT-GKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQG  583 (628)
Q Consensus       505 ~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELlt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~  583 (628)
                      ..++..|+|||.+.+..++.++||||||++++||++ |+.|+......      +.........             ...
T Consensus       203 ~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~------~~~~~~~~~~-------------~~~  263 (302)
T cd05055         203 ARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVD------SKFYKLIKEG-------------YRM  263 (302)
T ss_pred             CCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCch------HHHHHHHHcC-------------CcC
Confidence            356788999999999999999999999999999998 88886532211      1111111100             000


Q ss_pred             CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhH
Q 039626          584 NYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNIL  622 (628)
Q Consensus       584 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~  622 (628)
                      ..+...+..+.+++.+||+.+|++||++.|+++.|++++
T Consensus       264 ~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~~  302 (302)
T cd05055         264 AQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQL  302 (302)
T ss_pred             CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhhC
Confidence            111223456889999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=2.9e-34  Score=297.70  Aligned_cols=239  Identities=30%  Similarity=0.467  Sum_probs=186.1

Q ss_pred             eEEEEEEE--CCc--eEEEEEecc--------chHHHHHHHhhc-CCCceeeeeeeeecCCeEEEEEEecCCCChHHHhh
Q 039626          361 GSVYRGKI--NGG--FAAIKKVNG--------DVSKEIALLNKI-NHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVF  427 (628)
Q Consensus       361 G~Vy~g~~--~g~--~vavK~~~~--------~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~  427 (628)
                      |.||+|.+  ++.  .+++|+.+.        ++.+|++++.++ +|+||+++++++..++..++|+||+++|+|.+++.
T Consensus        21 g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~  100 (303)
T cd05088          21 GQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLR  100 (303)
T ss_pred             ceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEEEEeCCCCcHHHHHH
Confidence            89999987  343  457887653        356799999999 89999999999999999999999999999999996


Q ss_pred             hcCC------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCC
Q 039626          428 SNKN------------EGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQ  495 (628)
Q Consensus       428 ~~~~------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~  495 (628)
                      ....            ....+++.+++.++.|++.||+|||+   .+++||||||+|||+++++.+||+|||+++.....
T Consensus       101 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~  177 (303)
T cd05088         101 KSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVY  177 (303)
T ss_pred             hcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHh---CCccccccchheEEecCCCcEEeCccccCcccchh
Confidence            5421            12358999999999999999999998   45999999999999999999999999998643211


Q ss_pred             CCcceeeecccCCccccCccccccCCCCcccccHHHHHHHHHHHh-CCCccccccccccccHHHHHHHHhccccchhhhc
Q 039626          496 EGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT-GKEAAALHAEENNMHLSDVLNAVLTKEDGEESLR  574 (628)
Q Consensus       496 ~~~~~~~~~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELlt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  574 (628)
                      .    ......++..|+|||++.+..++.++||||||++++||++ |..|+.....      .+.......         
T Consensus       178 ~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~------~~~~~~~~~---------  238 (303)
T cd05088         178 V----KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC------AELYEKLPQ---------  238 (303)
T ss_pred             h----hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCCh------HHHHHHHhc---------
Confidence            1    1111234667999999988889999999999999999998 8888753221      111111110         


Q ss_pred             cccCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhcc
Q 039626          575 HFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNASL  626 (628)
Q Consensus       575 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~~~~~  626 (628)
                       .    .....+...+..+.+++.+||+.+|++||+++++++.|++++....
T Consensus       239 -~----~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~  285 (303)
T cd05088         239 -G----YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK  285 (303)
T ss_pred             -C----CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhh
Confidence             0    0011122234467899999999999999999999999999886543

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=1e-34  Score=302.46  Aligned_cols=236  Identities=27%  Similarity=0.415  Sum_probs=196.5

Q ss_pred             eEEEEEEEC----Cc--eEEEEEecc--------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHh
Q 039626          361 GSVYRGKIN----GG--FAAIKKVNG--------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWV  426 (628)
Q Consensus       361 G~Vy~g~~~----g~--~vavK~~~~--------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l  426 (628)
                      |.||+|.+.    |+  .||||..+.        .|..|..+|++++|||||+|+|+|.+ ...++|||.++-|.|..||
T Consensus       403 GdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~WivmEL~~~GELr~yL  481 (974)
T KOG4257|consen  403 GDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWIVMELAPLGELREYL  481 (974)
T ss_pred             cceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeEEEecccchhHHHHH
Confidence            999999982    33  678998875        37889999999999999999999974 5689999999999999999


Q ss_pred             hhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeeccc
Q 039626          427 FSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIV  506 (628)
Q Consensus       427 ~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~  506 (628)
                      ..+   ...|+......++.||+.||.|||+   .+++||||..+|||+...--+||+|||++|.+.+....  ......
T Consensus       482 q~n---k~sL~l~tL~ly~~Qi~talaYLeS---krfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~yY--kaS~~k  553 (974)
T KOG4257|consen  482 QQN---KDSLPLRTLTLYCYQICTALAYLES---KRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAYY--KASRGK  553 (974)
T ss_pred             Hhc---cccchHHHHHHHHHHHHHHHHHHHh---hchhhhhhhhhheeecCcceeeecccchhhhccccchh--hccccc
Confidence            653   3458889999999999999999999   55999999999999999999999999999998765432  233445


Q ss_pred             CCccccCccccccCCCCcccccHHHHHHHHHHHh-CCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCC
Q 039626          507 GTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT-GKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNY  585 (628)
Q Consensus       507 gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELlt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~  585 (628)
                      -...|||||.+...+++.++|||-|||++||+++ |..||..-...+.                -..    +...-+...
T Consensus       554 LPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDV----------------I~~----iEnGeRlP~  613 (974)
T KOG4257|consen  554 LPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDV----------------IGH----IENGERLPC  613 (974)
T ss_pred             cceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccce----------------EEE----ecCCCCCCC
Confidence            6778999999999999999999999999999876 8888875433211                011    111223345


Q ss_pred             CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhc
Q 039626          586 PLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNAS  625 (628)
Q Consensus       586 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~~~~  625 (628)
                      |..++..+..++.+||..||.+||.+.|+...|+.+++.+
T Consensus       614 P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~qee  653 (974)
T KOG4257|consen  614 PPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQEE  653 (974)
T ss_pred             CCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHHHh
Confidence            6677788999999999999999999999999999998743

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=5.2e-34  Score=287.40  Aligned_cols=229  Identities=27%  Similarity=0.414  Sum_probs=186.3

Q ss_pred             eEEEEEEE--CCceEEEEEecc---------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhc
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG---------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSN  429 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~---------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~  429 (628)
                      |.||+++.  +++.+++|.+..         ++.+|++++++++|+||+++++++.+++..++||||+++++|.+++...
T Consensus        14 ~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~   93 (256)
T cd08529          14 GVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQ   93 (256)
T ss_pred             eEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeCCCCcHHHHHHHh
Confidence            89999988  678999998742         3567999999999999999999999999999999999999999999653


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCCc
Q 039626          430 KNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTK  509 (628)
Q Consensus       430 ~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~  509 (628)
                        ....+++..+..++.+++.||.|||+   .+++|+||||+||++++++.+||+|||+++.......   ......|+.
T Consensus        94 --~~~~~~~~~~~~i~~~l~~al~~lH~---~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~  165 (256)
T cd08529          94 --RGRPLPEDQVWRFFIQILLGLAHLHS---KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN---FANTIVGTP  165 (256)
T ss_pred             --cCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEEeCCCCEEEcccccceeccCccc---hhhccccCc
Confidence              24568999999999999999999998   4599999999999999999999999999887643321   123346889


Q ss_pred             cccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCHHH
Q 039626          510 GYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLEL  589 (628)
Q Consensus       510 ~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~  589 (628)
                      .|+|||++.+..++.++|+||||++++||++|+.|+.....      ..........         .     ....+...
T Consensus       166 ~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~---------~-----~~~~~~~~  225 (256)
T cd08529         166 YYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ------GALILKIIRG---------V-----FPPVSQMY  225 (256)
T ss_pred             cccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHcC---------C-----CCCCcccc
Confidence            99999999999999999999999999999999999864321      1111111110         0     01122234


Q ss_pred             HHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 039626          590 ALLVIRLIDACLKKDPTDRPTMYEIEHS  617 (628)
Q Consensus       590 ~~~l~~l~~~Cl~~dP~~RPs~~ev~~~  617 (628)
                      ...+.+++.+||+.+|++||++.++++.
T Consensus       226 ~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  253 (256)
T cd08529         226 SQQLAQLIDQCLTKDYRQRPDTFQLLRN  253 (256)
T ss_pred             CHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence            4568899999999999999999999763

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=4.4e-34  Score=288.50  Aligned_cols=230  Identities=29%  Similarity=0.475  Sum_probs=184.9

Q ss_pred             eEEEEEEECCceEEEEEecc-----chHHHHHHHhhcCCCceeeeeeeee-cCCeEEEEEEecCCCChHHHhhhcCCCCC
Q 039626          361 GSVYRGKINGGFAAIKKVNG-----DVSKEIALLNKINHSNLIILSGVCF-NEGNCYLVYEYAVNGTLSDWVFSNKNEGK  434 (628)
Q Consensus       361 G~Vy~g~~~g~~vavK~~~~-----~~~~E~~~l~~l~H~nIv~l~g~~~-~~~~~~lV~E~~~~gsL~~~l~~~~~~~~  434 (628)
                      |.||++...|..+|+|..+.     .+.+|+.++++++|+|++++++++. .++..++|+||+++|+|.+++...  ...
T Consensus        20 ~~v~~~~~~~~~~~~k~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~   97 (256)
T cd05082          20 GDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR--GRS   97 (256)
T ss_pred             CeEEEEEEcCCcEEEEEeCCCchHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCCCCcHHHHHHhc--CCC
Confidence            89999999999999998865     3668999999999999999999865 446789999999999999998642  234


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCCccccCc
Q 039626          435 YLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAP  514 (628)
Q Consensus       435 ~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~Y~AP  514 (628)
                      .++|..++.++.+++.||+|||+.   +++||||||+||++++++.+||+|||+++......      ....++..|+||
T Consensus        98 ~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~------~~~~~~~~y~aP  168 (256)
T cd05082          98 VLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ------DTGKLPVKWTAP  168 (256)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceeccccC------CCCccceeecCH
Confidence            589999999999999999999984   59999999999999999999999999987553221      122345689999


Q ss_pred             cccccCCCCcccccHHHHHHHHHHHh-CCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCHHHHHHH
Q 039626          515 EYLENGLVSTKLDVYAFGVLILEMLT-GKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLV  593 (628)
Q Consensus       515 E~l~~~~~s~k~DV~SfGvvl~ELlt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l  593 (628)
                      |++.+..++.++||||||++++||++ |+.|+....      ..+....+.. .             .....+...+..+
T Consensus       169 E~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~------~~~~~~~~~~-~-------------~~~~~~~~~~~~~  228 (256)
T cd05082         169 EALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP------LKDVVPRVEK-G-------------YKMDAPDGCPPVV  228 (256)
T ss_pred             HHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCC------HHHHHHHHhc-C-------------CCCCCCCCCCHHH
Confidence            99999899999999999999999998 887765221      2222222111 0             0111122334568


Q ss_pred             HHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 039626          594 IRLIDACLKKDPTDRPTMYEIEHSLSNI  621 (628)
Q Consensus       594 ~~l~~~Cl~~dP~~RPs~~ev~~~L~~l  621 (628)
                      .+++.+||+.+|++||++.++++.|+.+
T Consensus       229 ~~li~~~l~~~p~~Rpt~~~l~~~l~~~  256 (256)
T cd05082         229 YDVMKQCWHLDAATRPSFLQLREQLEHI  256 (256)
T ss_pred             HHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence            8999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.5e-34  Score=287.98  Aligned_cols=234  Identities=27%  Similarity=0.408  Sum_probs=183.8

Q ss_pred             eEEEEEEE--CC---ceEEEEEecc--------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhh
Q 039626          361 GSVYRGKI--NG---GFAAIKKVNG--------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVF  427 (628)
Q Consensus       361 G~Vy~g~~--~g---~~vavK~~~~--------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~  427 (628)
                      |.||+|++  .+   ..+|+|....        ++.+|++++++++|+||+++++++. ....++||||+++|+|.+++.
T Consensus         9 g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~~~L~~~l~   87 (257)
T cd05060           9 GSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPLGPLLKYLK   87 (257)
T ss_pred             eeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCCCcHHHHHH
Confidence            89999987  22   5789998763        3567999999999999999999876 456799999999999999995


Q ss_pred             hcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccC
Q 039626          428 SNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVG  507 (628)
Q Consensus       428 ~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~g  507 (628)
                      ..    ..++|..+..++.|++.||+|||+.   +++|+||||+|||++.++.+||+|||+++................+
T Consensus        88 ~~----~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~  160 (257)
T cd05060          88 KR----REIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRW  160 (257)
T ss_pred             hC----CCCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCcccccccCccc
Confidence            42    2689999999999999999999984   4999999999999999999999999999876443322111122234


Q ss_pred             CccccCccccccCCCCcccccHHHHHHHHHHHh-CCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCC
Q 039626          508 TKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT-GKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYP  586 (628)
Q Consensus       508 t~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELlt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~  586 (628)
                      +..|+|||.+.+..++.++||||||+++||+++ |+.|+.....      .+....+....              ....+
T Consensus       161 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~------~~~~~~~~~~~--------------~~~~~  220 (257)
T cd05060         161 PLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG------AEVIAMLESGE--------------RLPRP  220 (257)
T ss_pred             cccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH------HHHHHHHHcCC--------------cCCCC
Confidence            567999999999999999999999999999998 8888753221      11111111100              00112


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhH
Q 039626          587 LELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNIL  622 (628)
Q Consensus       587 ~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~  622 (628)
                      ...+..+.+++.+||..+|++||++.++++.|+++.
T Consensus       221 ~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~  256 (257)
T cd05060         221 EECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP  256 (257)
T ss_pred             CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence            233456889999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=3.4e-34  Score=294.15  Aligned_cols=242  Identities=24%  Similarity=0.449  Sum_probs=186.5

Q ss_pred             eEEEEEEE------CCceEEEEEecc--------chHHHHHHHhhcCCCceeeeeeeeecC--CeEEEEEEecCCCChHH
Q 039626          361 GSVYRGKI------NGGFAAIKKVNG--------DVSKEIALLNKINHSNLIILSGVCFNE--GNCYLVYEYAVNGTLSD  424 (628)
Q Consensus       361 G~Vy~g~~------~g~~vavK~~~~--------~~~~E~~~l~~l~H~nIv~l~g~~~~~--~~~~lV~E~~~~gsL~~  424 (628)
                      |.||.+++      .+..+|+|.++.        .+.+|++++++++|+||+++.+++...  ...++||||+++++|.+
T Consensus        18 g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~g~~L~~   97 (284)
T cd05079          18 GKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKE   97 (284)
T ss_pred             eeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceEEEEEccCCCCHHH
Confidence            89999874      467899998863        467899999999999999999999875  56899999999999999


Q ss_pred             HhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeec
Q 039626          425 WVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRH  504 (628)
Q Consensus       425 ~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~  504 (628)
                      ++...   ...++|..+..++.+++.||+|||+   .+++||||||+||+++.++.+||+|||+++..............
T Consensus        98 ~l~~~---~~~~~~~~~~~i~~~i~~aL~~lH~---~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~  171 (284)
T cd05079          98 YLPRN---KNKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDD  171 (284)
T ss_pred             HHHhc---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccchheEEEcCCCCEEECCCccccccccCccceeecCC
Confidence            98532   2358999999999999999999998   45999999999999999999999999999876543322222234


Q ss_pred             ccCCccccCccccccCCCCcccccHHHHHHHHHHHhCCCcccccccc---------ccccHHHHHHHHhccccchhhhcc
Q 039626          505 IVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEE---------NNMHLSDVLNAVLTKEDGEESLRH  575 (628)
Q Consensus       505 ~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~l~~  575 (628)
                      ..++..|+|||++.+..++.++||||||++++||++++.+.......         ............            
T Consensus       172 ~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------  239 (284)
T cd05079         172 LDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVL------------  239 (284)
T ss_pred             CCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHH------------
Confidence            56777899999999889999999999999999999987654321100         000011111000            


Q ss_pred             ccCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhH
Q 039626          576 FIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNIL  622 (628)
Q Consensus       576 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~  622 (628)
                        ........+...+..+.+++.+||+.||++||+++++++.|++++
T Consensus       240 --~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~~  284 (284)
T cd05079         240 --EEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAIL  284 (284)
T ss_pred             --HcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhhC
Confidence              000011112234567889999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=2e-34  Score=303.58  Aligned_cols=222  Identities=26%  Similarity=0.318  Sum_probs=179.7

Q ss_pred             eEEEEEEEC---CceEEEEEecc----------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhh
Q 039626          361 GSVYRGKIN---GGFAAIKKVNG----------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVF  427 (628)
Q Consensus       361 G~Vy~g~~~---g~~vavK~~~~----------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~  427 (628)
                      |.||+|++.   +..+|+|++..          .+.+|+.+++.++||||+++++++.+++..++||||+++|+|.+++.
T Consensus        44 g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~i~  123 (340)
T PTZ00426         44 GRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLR  123 (340)
T ss_pred             eEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEEEeCCCCCcHHHHHH
Confidence            899999862   25799998753          24579999999999999999999999999999999999999999995


Q ss_pred             hcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccC
Q 039626          428 SNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVG  507 (628)
Q Consensus       428 ~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~g  507 (628)
                      .    ...+++..+..++.|++.||.|||+.   +++||||||+|||++.++.+||+|||+++.....      .....|
T Consensus       124 ~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~------~~~~~g  190 (340)
T PTZ00426        124 R----NKRFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR------TYTLCG  190 (340)
T ss_pred             H----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCeecCCC------cceecC
Confidence            4    34589999999999999999999984   5999999999999999999999999999865422      123579


Q ss_pred             CccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCH
Q 039626          508 TKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPL  587 (628)
Q Consensus       508 t~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~  587 (628)
                      |+.|+|||++.+..++.++|||||||++|||++|+.|+.....      ......+....               ..+|.
T Consensus       191 t~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~------~~~~~~i~~~~---------------~~~p~  249 (340)
T PTZ00426        191 TPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEP------LLIYQKILEGI---------------IYFPK  249 (340)
T ss_pred             ChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCH------HHHHHHHhcCC---------------CCCCC
Confidence            9999999999998899999999999999999999999864321      11111111110               01122


Q ss_pred             HHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 039626          588 ELALLVIRLIDACLKKDPTDRP-----TMYEIEH  616 (628)
Q Consensus       588 ~~~~~l~~l~~~Cl~~dP~~RP-----s~~ev~~  616 (628)
                      .....+.+++++|++.||.+|+     +++|+++
T Consensus       250 ~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~  283 (340)
T PTZ00426        250 FLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKE  283 (340)
T ss_pred             CCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHc
Confidence            2334578999999999999995     7777654

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=6.6e-34  Score=289.77  Aligned_cols=236  Identities=30%  Similarity=0.482  Sum_probs=183.7

Q ss_pred             eEEEEEEEC--Cc--eEEEEEecc--------chHHHHHHHhhc-CCCceeeeeeeeecCCeEEEEEEecCCCChHHHhh
Q 039626          361 GSVYRGKIN--GG--FAAIKKVNG--------DVSKEIALLNKI-NHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVF  427 (628)
Q Consensus       361 G~Vy~g~~~--g~--~vavK~~~~--------~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~  427 (628)
                      |.||+|.+.  +.  .+++|..+.        ++.+|++++.++ +|+||+++++++...+..++||||+++|+|.+++.
T Consensus         9 g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~   88 (270)
T cd05047           9 GQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLR   88 (270)
T ss_pred             ceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCCCcHHHHHH
Confidence            899999983  33  468887763        356799999999 89999999999999999999999999999999996


Q ss_pred             hcCC------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCC
Q 039626          428 SNKN------------EGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQ  495 (628)
Q Consensus       428 ~~~~------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~  495 (628)
                      ....            ....+++.++..++.|++.||+|||+   .+++||||||+||++++++.+||+|||+++.....
T Consensus        89 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nili~~~~~~kl~dfgl~~~~~~~  165 (270)
T cd05047          89 KSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVY  165 (270)
T ss_pred             hccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccccceEEEcCCCeEEECCCCCccccchh
Confidence            5321            12358899999999999999999998   45999999999999999999999999998633211


Q ss_pred             CCcceeeecccCCccccCccccccCCCCcccccHHHHHHHHHHHh-CCCccccccccccccHHHHHHHHhccccchhhhc
Q 039626          496 EGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT-GKEAAALHAEENNMHLSDVLNAVLTKEDGEESLR  574 (628)
Q Consensus       496 ~~~~~~~~~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELlt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  574 (628)
                      .    .......+..|+|||++....++.++||||||++++||++ |+.|+....      ..+........        
T Consensus       166 ~----~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~------~~~~~~~~~~~--------  227 (270)
T cd05047         166 V----KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT------CAELYEKLPQG--------  227 (270)
T ss_pred             h----hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccC------HHHHHHHHhCC--------
Confidence            1    0111234567999999998899999999999999999997 888875321      11112111110        


Q ss_pred             cccCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHh
Q 039626          575 HFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILN  623 (628)
Q Consensus       575 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~~  623 (628)
                            .....+......+.+++.+||+.||.+|||+.|++..|.++++
T Consensus       228 ------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~~  270 (270)
T cd05047         228 ------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE  270 (270)
T ss_pred             ------CCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhhC
Confidence                  0001112233467899999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=5.4e-34  Score=294.69  Aligned_cols=237  Identities=32%  Similarity=0.471  Sum_probs=184.8

Q ss_pred             eEEEEEEEC--Cc--eEEEEEecc--------chHHHHHHHhhc-CCCceeeeeeeeecCCeEEEEEEecCCCChHHHhh
Q 039626          361 GSVYRGKIN--GG--FAAIKKVNG--------DVSKEIALLNKI-NHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVF  427 (628)
Q Consensus       361 G~Vy~g~~~--g~--~vavK~~~~--------~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~  427 (628)
                      |.||+|...  +.  .+++|.++.        ++.+|++++.++ +||||+++++++...+..++|+||+++|+|.+++.
T Consensus        16 g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~   95 (297)
T cd05089          16 GQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLR   95 (297)
T ss_pred             ceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEEEecCCCcHHHHHH
Confidence            899999873  32  468887763        467799999999 79999999999999999999999999999999996


Q ss_pred             hcCC------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCC
Q 039626          428 SNKN------------EGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQ  495 (628)
Q Consensus       428 ~~~~------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~  495 (628)
                      ....            ....+++..+..++.|++.||+|||+   .+++||||||+|||+++++.+||+|||++......
T Consensus        96 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~  172 (297)
T cd05089          96 KSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSE---KQFIHRDLAARNVLVGENLASKIADFGLSRGEEVY  172 (297)
T ss_pred             hccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCcCCcceEEECCCCeEEECCcCCCccccce
Confidence            5321            12358999999999999999999998   45999999999999999999999999998643211


Q ss_pred             CCcceeeecccCCccccCccccccCCCCcccccHHHHHHHHHHHh-CCCccccccccccccHHHHHHHHhccccchhhhc
Q 039626          496 EGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT-GKEAAALHAEENNMHLSDVLNAVLTKEDGEESLR  574 (628)
Q Consensus       496 ~~~~~~~~~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELlt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  574 (628)
                      .    .......+..|+|||++....++.++|||||||+++||++ |+.|+.....      .+.......         
T Consensus       173 ~----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~------~~~~~~~~~---------  233 (297)
T cd05089         173 V----KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTC------AELYEKLPQ---------  233 (297)
T ss_pred             e----ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH------HHHHHHHhc---------
Confidence            0    1111223557999999998889999999999999999997 8888753221      111111111         


Q ss_pred             cccCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhh
Q 039626          575 HFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNA  624 (628)
Q Consensus       575 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~~~  624 (628)
                       ...+    ..+...+..+.+++.+||+.+|.+||++.++++.|+++.+.
T Consensus       234 -~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~  278 (297)
T cd05089         234 -GYRM----EKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEA  278 (297)
T ss_pred             -CCCC----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence             0011    11223345678999999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.5e-34  Score=308.29  Aligned_cols=255  Identities=19%  Similarity=0.242  Sum_probs=187.3

Q ss_pred             CCCcCCccc----eEEEEEEE--CCceEEEEEecc-chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHH
Q 039626          352 NFSFTCRIQ----GSVYRGKI--NGGFAAIKKVNG-DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSD  424 (628)
Q Consensus       352 ~f~~~~~i~----G~Vy~g~~--~g~~vavK~~~~-~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~  424 (628)
                      +|.....+|    |.||++..  .++.||+|+... .+.+|+++|++++||||+++++++..+...++|+|++ +++|.+
T Consensus        93 ~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~-~~~L~~  171 (391)
T PHA03212         93 GFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQRGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRY-KTDLYC  171 (391)
T ss_pred             CcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhhhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecC-CCCHHH
Confidence            455444443    89999988  678999998764 5788999999999999999999999999999999999 578988


Q ss_pred             HhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeec
Q 039626          425 WVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRH  504 (628)
Q Consensus       425 ~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~  504 (628)
                      ++..    ...+++..++.++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++.......  .....
T Consensus       172 ~l~~----~~~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~--~~~~~  242 (391)
T PHA03212        172 YLAA----KRNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA--NKYYG  242 (391)
T ss_pred             HHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCcccccccccc--ccccc
Confidence            8843    34589999999999999999999985   599999999999999999999999999975432211  11233


Q ss_pred             ccCCccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccc-----cccHHHHHHHHhccc-----cchhhhc
Q 039626          505 IVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEEN-----NMHLSDVLNAVLTKE-----DGEESLR  574 (628)
Q Consensus       505 ~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~-----~~~~~~~~~~~~~~~-----~~~~~l~  574 (628)
                      ..||+.|+|||++.+..++.++|||||||++|||++|+.|+.......     ...+...+.......     .....+.
T Consensus       243 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~  322 (391)
T PHA03212        243 WAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLD  322 (391)
T ss_pred             ccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHHH
Confidence            579999999999999899999999999999999999998765322111     011111111110000     0000000


Q ss_pred             cc---------cCCcCCCCC--CHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          575 HF---------IDPTLQGNY--PLELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       575 ~~---------~d~~l~~~~--~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      ..         ..+..+..+  ..+.+..+.+++.+||+.||++|||++|+++
T Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~  375 (391)
T PHA03212        323 EIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD  375 (391)
T ss_pred             HHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence            00         001001000  0134557889999999999999999999985

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=4.5e-34  Score=296.71  Aligned_cols=241  Identities=27%  Similarity=0.441  Sum_probs=188.4

Q ss_pred             eEEEEEEEC---------CceEEEEEecc--------chHHHHHHHhhc-CCCceeeeeeeeecCCeEEEEEEecCCCCh
Q 039626          361 GSVYRGKIN---------GGFAAIKKVNG--------DVSKEIALLNKI-NHSNLIILSGVCFNEGNCYLVYEYAVNGTL  422 (628)
Q Consensus       361 G~Vy~g~~~---------g~~vavK~~~~--------~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL  422 (628)
                      |.||+++..         +..+|+|.++.        ++.+|++++.++ +|+||++++++|..++..++||||+++|+|
T Consensus        32 g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L  111 (307)
T cd05098          32 GQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL  111 (307)
T ss_pred             eeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEecCCCCcH
Confidence            899999762         24689998864        255699999999 799999999999999999999999999999


Q ss_pred             HHHhhhcCC------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccc
Q 039626          423 SDWVFSNKN------------EGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMAR  490 (628)
Q Consensus       423 ~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~  490 (628)
                      .+++.....            ....++|.++++++.|++.||+|||+.   +++||||||+||++++++.+||+|||+++
T Consensus       112 ~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill~~~~~~kL~dfg~a~  188 (307)
T cd05098         112 REYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLAR  188 (307)
T ss_pred             HHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHheEEcCCCcEEECCCcccc
Confidence            999965432            123589999999999999999999984   59999999999999999999999999987


Q ss_pred             cCCCCCCcceeeecccCCccccCccccccCCCCcccccHHHHHHHHHHHh-CCCccccccccccccHHHHHHHHhccccc
Q 039626          491 PAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT-GKEAAALHAEENNMHLSDVLNAVLTKEDG  569 (628)
Q Consensus       491 ~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELlt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~  569 (628)
                      ........ .......++..|+|||.+.+..++.++||||||+++|||++ |+.|+....      ..+..... ...  
T Consensus       189 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~------~~~~~~~~-~~~--  258 (307)
T cd05098         189 DIHHIDYY-KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP------VEELFKLL-KEG--  258 (307)
T ss_pred             cccccchh-hccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCC------HHHHHHHH-HcC--
Confidence            65432111 11112234568999999999899999999999999999998 777764321      11111111 100  


Q ss_pred             hhhhccccCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhc
Q 039626          570 EESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNAS  625 (628)
Q Consensus       570 ~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~~~~  625 (628)
                                 .....+......+.+++.+||+.+|.+||++.||++.|++++...
T Consensus       259 -----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~  303 (307)
T cd05098         259 -----------HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALT  303 (307)
T ss_pred             -----------CCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHh
Confidence                       011122334457889999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-34  Score=277.20  Aligned_cols=214  Identities=27%  Similarity=0.415  Sum_probs=182.1

Q ss_pred             eEEEEEEE--CCceEEEEEeccc----------hHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhh
Q 039626          361 GSVYRGKI--NGGFAAIKKVNGD----------VSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFS  428 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~~----------~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  428 (628)
                      |.|...+.  +|..+|+|.++.+          ..+|..+|+.+.||.++++.+.|.+.+..+|||||.+||.|..+|++
T Consensus        58 GrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvmeyv~GGElFS~Lrk  137 (355)
T KOG0616|consen   58 GRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVMEYVPGGELFSYLRK  137 (355)
T ss_pred             ceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEEeccCCccHHHHHHh
Confidence            89998877  7889999998752          45799999999999999999999999999999999999999999953


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCC
Q 039626          429 NKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGT  508 (628)
Q Consensus       429 ~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt  508 (628)
                          .+.++.+...-+|.+|+.||+|||+.   .|++||+||+|||||.+|.+||+|||+|+.+..      .+...+||
T Consensus       138 ----~~rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~------rT~TlCGT  204 (355)
T KOG0616|consen  138 ----SGRFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFAKRVSG------RTWTLCGT  204 (355)
T ss_pred             ----cCCCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccceEEecC------cEEEecCC
Confidence                34588999999999999999999995   499999999999999999999999999997753      25668999


Q ss_pred             ccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCHH
Q 039626          509 KGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLE  588 (628)
Q Consensus       509 ~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~  588 (628)
                      |.|+|||.++...+...+|.|||||++|||+.|.+||.....      ......++..             .  -.+|.-
T Consensus       205 PeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~------~~iY~KI~~~-------------~--v~fP~~  263 (355)
T KOG0616|consen  205 PEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP------IQIYEKILEG-------------K--VKFPSY  263 (355)
T ss_pred             ccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh------HHHHHHHHhC-------------c--ccCCcc
Confidence            999999999999999999999999999999999999975433      1222222221             1  134555


Q ss_pred             HHHHHHHHHHHhcccCCCCC
Q 039626          589 LALLVIRLIDACLKKDPTDR  608 (628)
Q Consensus       589 ~~~~l~~l~~~Cl~~dP~~R  608 (628)
                      ....+.+|++..++.|-.+|
T Consensus       264 fs~~~kdLl~~LL~vD~t~R  283 (355)
T KOG0616|consen  264 FSSDAKDLLKKLLQVDLTKR  283 (355)
T ss_pred             cCHHHHHHHHHHHhhhhHhh
Confidence            56678899999999998888

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=3.8e-34  Score=289.23  Aligned_cols=231  Identities=28%  Similarity=0.432  Sum_probs=182.9

Q ss_pred             eEEEEEEECC-ceEEEEEecc------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhcCCCC
Q 039626          361 GSVYRGKING-GFAAIKKVNG------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEG  433 (628)
Q Consensus       361 G~Vy~g~~~g-~~vavK~~~~------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~  433 (628)
                      |.||+|.+.+ ..+|+|.++.      ++.+|+.++.+++||||+++++++.+....++||||+++|+|.+++...   .
T Consensus        18 ~~vy~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~i~~~---~   94 (256)
T cd05113          18 GVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREH---G   94 (256)
T ss_pred             ceEEEEEecCCCcEEEEEcCCCcccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCCCcHHHHHHhc---C
Confidence            8999999854 4699998764      3678999999999999999999999888899999999999999998542   2


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCCccccC
Q 039626          434 KYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMA  513 (628)
Q Consensus       434 ~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~Y~A  513 (628)
                      ..++|.+++.++.+++.||+|||+.   +++|+||||+||++++++.+||+|||.++......  ........++..|+|
T Consensus        95 ~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~--~~~~~~~~~~~~y~~  169 (256)
T cd05113          95 KRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE--YTSSVGSKFPVRWSP  169 (256)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCCc--eeecCCCccChhhCC
Confidence            3589999999999999999999984   59999999999999999999999999988654322  111112345678999


Q ss_pred             ccccccCCCCcccccHHHHHHHHHHHh-CCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCHHHHHH
Q 039626          514 PEYLENGLVSTKLDVYAFGVLILEMLT-GKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALL  592 (628)
Q Consensus       514 PE~l~~~~~s~k~DV~SfGvvl~ELlt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~  592 (628)
                      ||.+.+..++.++||||||+++|||++ |+.|+.....      .+.........          .+    ..+......
T Consensus       170 pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~------~~~~~~~~~~~----------~~----~~~~~~~~~  229 (256)
T cd05113         170 PEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNN------SETVEKVSQGL----------RL----YRPHLASEK  229 (256)
T ss_pred             HHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCH------HHHHHHHhcCC----------CC----CCCCCCCHH
Confidence            999998889999999999999999998 8888753221      11111111110          00    111122456


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHHHHHH
Q 039626          593 VIRLIDACLKKDPTDRPTMYEIEHSLS  619 (628)
Q Consensus       593 l~~l~~~Cl~~dP~~RPs~~ev~~~L~  619 (628)
                      +.+++.+||+.||.+||++.++++.|+
T Consensus       230 ~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         230 VYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             HHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence            789999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=5.7e-34  Score=287.60  Aligned_cols=234  Identities=29%  Similarity=0.439  Sum_probs=186.3

Q ss_pred             eEEEEEEEC---Cc--eEEEEEecc--------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhh
Q 039626          361 GSVYRGKIN---GG--FAAIKKVNG--------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVF  427 (628)
Q Consensus       361 G~Vy~g~~~---g~--~vavK~~~~--------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~  427 (628)
                      |.||+|.+.   +.  .+|+|....        ++.+|++++++++|+||+++++++.. ...++|+||+++|+|.+++.
T Consensus         9 ~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~~~L~~~l~   87 (257)
T cd05040           9 GVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPLGSLLDRLR   87 (257)
T ss_pred             ccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCCCcHHHHHH
Confidence            899999872   22  589998764        35579999999999999999999988 88999999999999999996


Q ss_pred             hcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccC
Q 039626          428 SNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVG  507 (628)
Q Consensus       428 ~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~g  507 (628)
                      ....  ..++|.....++.|++.||+|||+   .+++|+||||+||+++.++.+||+|||+++................+
T Consensus        88 ~~~~--~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~  162 (257)
T cd05040          88 KDAL--GHFLISTLCDYAVQIANGMRYLES---KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV  162 (257)
T ss_pred             hccc--ccCcHHHHHHHHHHHHHHHHHHHh---CCccccccCcccEEEecCCEEEeccccccccccccccceecccCCCC
Confidence            5322  568999999999999999999998   45999999999999999999999999999877543322222334567


Q ss_pred             CccccCccccccCCCCcccccHHHHHHHHHHHh-CCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCC
Q 039626          508 TKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT-GKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYP  586 (628)
Q Consensus       508 t~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELlt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~  586 (628)
                      +..|+|||++.+..++.++||||||++++||++ |+.|+.....      .+.........             .....+
T Consensus       163 ~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~------~~~~~~~~~~~-------------~~~~~~  223 (257)
T cd05040         163 PFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSG------SQILKKIDKEG-------------ERLERP  223 (257)
T ss_pred             CceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCH------HHHHHHHHhcC-------------CcCCCC
Confidence            889999999999999999999999999999999 9988753211      11111111100             000112


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 039626          587 LELALLVIRLIDACLKKDPTDRPTMYEIEHSLS  619 (628)
Q Consensus       587 ~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~  619 (628)
                      ...+..+.+++.+||+.+|++||++.|+++.|.
T Consensus       224 ~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         224 EACPQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             ccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence            233456889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=6.1e-34  Score=291.38  Aligned_cols=238  Identities=24%  Similarity=0.372  Sum_probs=185.1

Q ss_pred             eEEEEEEE--CCc----eEEEEEecc--------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHh
Q 039626          361 GSVYRGKI--NGG----FAAIKKVNG--------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWV  426 (628)
Q Consensus       361 G~Vy~g~~--~g~----~vavK~~~~--------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l  426 (628)
                      |.||+|++  +|+    .||+|..+.        ++.+|+.++..++|+||+++++++... ..++++||+++|+|.+++
T Consensus        21 g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~l~~~~~~~g~l~~~l   99 (279)
T cd05109          21 GTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQLVTQLMPYGCLLDYV   99 (279)
T ss_pred             ceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcEEEEEcCCCCCHHHHH
Confidence            89999987  444    479998753        356799999999999999999999754 568999999999999998


Q ss_pred             hhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeeccc
Q 039626          427 FSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIV  506 (628)
Q Consensus       427 ~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~  506 (628)
                      +..   ...+++..++.++.|++.||+|||+   .+++||||||+|||+++++.+||+|||+++......... ......
T Consensus       100 ~~~---~~~~~~~~~~~~~~qi~~~L~~lH~---~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~~~~-~~~~~~  172 (279)
T cd05109         100 REN---KDRIGSQDLLNWCVQIAKGMSYLEE---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEY-HADGGK  172 (279)
T ss_pred             hhc---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccceEEEcCCCcEEECCCCceeeccccccee-ecCCCc
Confidence            542   3458999999999999999999998   459999999999999999999999999998764322111 112234


Q ss_pred             CCccccCccccccCCCCcccccHHHHHHHHHHHh-CCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCC
Q 039626          507 GTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT-GKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNY  585 (628)
Q Consensus       507 gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELlt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~  585 (628)
                      ++..|+|||.+.+..++.++||||||+++|||++ |..|+......   .+...    +...         ..+    ..
T Consensus       173 ~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~~~----~~~~---------~~~----~~  232 (279)
T cd05109         173 VPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAR---EIPDL----LEKG---------ERL----PQ  232 (279)
T ss_pred             cchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHH----HHCC---------CcC----CC
Confidence            5678999999999999999999999999999998 88877532211   11111    1110         000    11


Q ss_pred             CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhcc
Q 039626          586 PLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNASL  626 (628)
Q Consensus       586 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~~~~~  626 (628)
                      +...+..+.+++.+||+.||++||++.|+++.|+.+...+-
T Consensus       233 ~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~~  273 (279)
T cd05109         233 PPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDPS  273 (279)
T ss_pred             CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCCc
Confidence            12234567899999999999999999999999998876553

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=4.8e-34  Score=293.70  Aligned_cols=241  Identities=26%  Similarity=0.395  Sum_probs=186.2

Q ss_pred             eEEEEEEEC-------CceEEEEEecc--------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHH
Q 039626          361 GSVYRGKIN-------GGFAAIKKVNG--------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDW  425 (628)
Q Consensus       361 G~Vy~g~~~-------g~~vavK~~~~--------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~  425 (628)
                      |.||+|...       +..+|+|.++.        ++.+|+.++++++|+||+++++++.+.+..++||||+++|+|.++
T Consensus        20 g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~   99 (288)
T cd05061          20 GMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSY   99 (288)
T ss_pred             cEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEeCCCCCCHHHH
Confidence            899999752       34789998753        356799999999999999999999988899999999999999999


Q ss_pred             hhhcCC------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcc
Q 039626          426 VFSNKN------EGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEF  499 (628)
Q Consensus       426 l~~~~~------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~  499 (628)
                      +.....      ....+++..+.+++.|++.||.|||+   ++++||||||+||++++++.+||+|||+++........ 
T Consensus       100 l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dikp~nili~~~~~~~L~Dfg~~~~~~~~~~~-  175 (288)
T cd05061         100 LRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYY-  175 (288)
T ss_pred             HHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCCcCCCCChheEEEcCCCcEEECcCCccccccccccc-
Confidence            964321      12346788899999999999999998   45999999999999999999999999999865432211 


Q ss_pred             eeeecccCCccccCccccccCCCCcccccHHHHHHHHHHHh-CCCccccccccccccHHHHHHHHhccccchhhhccccC
Q 039626          500 ALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT-GKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFID  578 (628)
Q Consensus       500 ~~~~~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELlt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d  578 (628)
                      .......++..|+|||.+.++.++.++||||||++++||++ |+.|+.....      .+..........          
T Consensus       176 ~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~------~~~~~~~~~~~~----------  239 (288)
T cd05061         176 RKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN------EQVLKFVMDGGY----------  239 (288)
T ss_pred             cccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCH------HHHHHHHHcCCC----------
Confidence            11112245678999999999899999999999999999998 6666643211      111111111100          


Q ss_pred             CcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhc
Q 039626          579 PTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNAS  625 (628)
Q Consensus       579 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~~~~  625 (628)
                      +    ..+...+..+.+++.+||+.||++||++.++++.|++.+..+
T Consensus       240 ~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~  282 (288)
T cd05061         240 L----DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPS  282 (288)
T ss_pred             C----CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCC
Confidence            0    112233457899999999999999999999999999877655

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=8.9e-34  Score=288.53  Aligned_cols=238  Identities=24%  Similarity=0.419  Sum_probs=185.6

Q ss_pred             eEEEEEEEC-----CceEEEEEecc---------chHHHHHHHhhcCCCceeeeeeeeecCCe------EEEEEEecCCC
Q 039626          361 GSVYRGKIN-----GGFAAIKKVNG---------DVSKEIALLNKINHSNLIILSGVCFNEGN------CYLVYEYAVNG  420 (628)
Q Consensus       361 G~Vy~g~~~-----g~~vavK~~~~---------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~------~~lV~E~~~~g  420 (628)
                      |.||+|+..     +..+|+|+++.         .+.+|++++++++|+||+++++++.....      .++++||+++|
T Consensus        13 g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~   92 (273)
T cd05035          13 GSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHG   92 (273)
T ss_pred             ceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCcccEEEEeccCCC
Confidence            899999873     25799998763         35679999999999999999999876554      79999999999


Q ss_pred             ChHHHhhhcCC--CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCc
Q 039626          421 TLSDWVFSNKN--EGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGE  498 (628)
Q Consensus       421 sL~~~l~~~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~  498 (628)
                      +|.+++.....  ....+++.....++.|++.||.|||+.   +++||||||+||++++++.+||+|||+++........
T Consensus        93 ~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~  169 (273)
T cd05035          93 DLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYY  169 (273)
T ss_pred             CHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECCccceeeccccccc
Confidence            99999865432  234689999999999999999999984   5999999999999999999999999999876433211


Q ss_pred             ceeeecccCCccccCccccccCCCCcccccHHHHHHHHHHHh-CCCccccccccccccHHHHHHHHhccccchhhhcccc
Q 039626          499 FALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT-GKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFI  577 (628)
Q Consensus       499 ~~~~~~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELlt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  577 (628)
                       .......++..|+|||++.+..++.++||||||++++||++ |..|+.....      .+.........          
T Consensus       170 -~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~------~~~~~~~~~~~----------  232 (273)
T cd05035         170 -RQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN------HEIYDYLRHGN----------  232 (273)
T ss_pred             -cccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH------HHHHHHHHcCC----------
Confidence             11112235678999999998899999999999999999999 7777653221      11221111110          


Q ss_pred             CCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhH
Q 039626          578 DPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNIL  622 (628)
Q Consensus       578 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~  622 (628)
                      .+    ..+......+.+++.+||+.||.+||++.|+++.|++++
T Consensus       233 ~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~~  273 (273)
T cd05035         233 RL----KQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENIL  273 (273)
T ss_pred             CC----CCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhhC
Confidence            01    112234456889999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=2.2e-34  Score=317.34  Aligned_cols=242  Identities=23%  Similarity=0.332  Sum_probs=190.0

Q ss_pred             cCCCcCCccc----eEEEEEEE--CCceEEEEEecc---------chHHHHHHHhhcCCCceeeeeeeeecCC-------
Q 039626          351 DNFSFTCRIQ----GSVYRGKI--NGGFAAIKKVNG---------DVSKEIALLNKINHSNLIILSGVCFNEG-------  408 (628)
Q Consensus       351 ~~f~~~~~i~----G~Vy~g~~--~g~~vavK~~~~---------~~~~E~~~l~~l~H~nIv~l~g~~~~~~-------  408 (628)
                      ++|.....+|    |.||+++.  +|+.+|||++..         .+.+|+.++..++|+||+++...+...+       
T Consensus        32 ~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~  111 (496)
T PTZ00283         32 KKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENV  111 (496)
T ss_pred             CCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccc
Confidence            3444444443    89999987  788999998753         3567999999999999999988775332       


Q ss_pred             -eEEEEEEecCCCChHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEcccc
Q 039626          409 -NCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFA  487 (628)
Q Consensus       409 -~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfg  487 (628)
                       ..++||||+++|+|.+++.........+++.....++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||
T Consensus       112 ~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~---~~IiHrDLKP~NILl~~~~~vkL~DFG  188 (496)
T PTZ00283        112 LMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHS---KHMIHRDIKSANILLCSNGLVKLGDFG  188 (496)
T ss_pred             eEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEeCCCCEEEEecc
Confidence             3689999999999999997655555679999999999999999999998   459999999999999999999999999


Q ss_pred             ccccCCCCCCcceeeecccCCccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccc
Q 039626          488 MARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKE  567 (628)
Q Consensus       488 la~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~  567 (628)
                      +++........ .......||+.|+|||++.+..++.++|||||||++|||++|+.||....      ..+.+.......
T Consensus       189 ls~~~~~~~~~-~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~------~~~~~~~~~~~~  261 (496)
T PTZ00283        189 FSKMYAATVSD-DVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN------MEEVMHKTLAGR  261 (496)
T ss_pred             cCeeccccccc-cccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC------HHHHHHHHhcCC
Confidence            99866432211 12334579999999999999999999999999999999999999986322      122222222110


Q ss_pred             cchhhhccccCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          568 DGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       568 ~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                               .+     ..+...+..+.+++.+||+.||.+||++.+++.
T Consensus       262 ---------~~-----~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~  296 (496)
T PTZ00283        262 ---------YD-----PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLN  296 (496)
T ss_pred             ---------CC-----CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHh
Confidence                     11     112234456889999999999999999999875

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=9.6e-35  Score=303.39  Aligned_cols=222  Identities=24%  Similarity=0.365  Sum_probs=180.2

Q ss_pred             eEEEEEEE-----CCceEEEEEecc---------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHh
Q 039626          361 GSVYRGKI-----NGGFAAIKKVNG---------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWV  426 (628)
Q Consensus       361 G~Vy~g~~-----~g~~vavK~~~~---------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l  426 (628)
                      |.||+++.     .|+.+|+|.++.         .+..|+++|++++|+||+++++++.+++..++||||+++|+|.+++
T Consensus        10 g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l   89 (318)
T cd05582          10 GKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRL   89 (318)
T ss_pred             EEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCCCCcHHHHH
Confidence            89998864     578999998864         2456999999999999999999999999999999999999999998


Q ss_pred             hhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeeccc
Q 039626          427 FSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIV  506 (628)
Q Consensus       427 ~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~  506 (628)
                      ..    ...+++..+..++.|++.||+|||+.   +++||||||+|||+++++.+||+|||+++.......   ......
T Consensus        90 ~~----~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~---~~~~~~  159 (318)
T cd05582          90 SK----EVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK---KAYSFC  159 (318)
T ss_pred             HH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC---ceeccc
Confidence            43    34589999999999999999999985   499999999999999999999999999886543211   223457


Q ss_pred             CCccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCC
Q 039626          507 GTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYP  586 (628)
Q Consensus       507 gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~  586 (628)
                      ||+.|+|||.+.+..++.++||||||+++|||++|+.|+.....      .+....+....               ...+
T Consensus       160 g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~------~~~~~~i~~~~---------------~~~p  218 (318)
T cd05582         160 GTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDR------KETMTMILKAK---------------LGMP  218 (318)
T ss_pred             CChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCH------HHHHHHHHcCC---------------CCCC
Confidence            99999999999988899999999999999999999999864321      11111111110               0122


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCCHHH
Q 039626          587 LELALLVIRLIDACLKKDPTDRPTMYE  613 (628)
Q Consensus       587 ~~~~~~l~~l~~~Cl~~dP~~RPs~~e  613 (628)
                      ...+..+.+++.+||+.||++||++.+
T Consensus       219 ~~~~~~~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         219 QFLSPEAQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             CCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence            233456789999999999999999766

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=8.1e-34  Score=290.41  Aligned_cols=233  Identities=24%  Similarity=0.310  Sum_probs=183.3

Q ss_pred             eEEEEEEE--CCceEEEEEecc----------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhh
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG----------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFS  428 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  428 (628)
                      |.||++..  .|+.+|+|++..          .+..|++++++++|+||+++.+++.++...++||||+++|+|.+++..
T Consensus         7 g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~~~~   86 (277)
T cd05607           7 GEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYN   86 (277)
T ss_pred             eEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCHHHHHHh
Confidence            89999987  588999998853          134599999999999999999999999999999999999999998854


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCC
Q 039626          429 NKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGT  508 (628)
Q Consensus       429 ~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt  508 (628)
                      .  ....+++..+..++.|++.||+|||+   .+++||||||+||++++++.+||+|||++.......    ......|+
T Consensus        87 ~--~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~----~~~~~~~~  157 (277)
T cd05607          87 V--GERGLEMERVIHYSAQITCGILHLHS---MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK----TITQRAGT  157 (277)
T ss_pred             c--cccCCCHHHHHHHHHHHHHHHHHHHH---CCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc----eeeccCCC
Confidence            3  23458999999999999999999998   459999999999999999999999999988664321    12334689


Q ss_pred             ccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCHH
Q 039626          509 KGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLE  588 (628)
Q Consensus       509 ~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~  588 (628)
                      ..|+|||++.+..++.++|||||||++|||++|+.|+.......  ...+........         .+..  .   ...
T Consensus       158 ~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~--~~~~~~~~~~~~---------~~~~--~---~~~  221 (277)
T cd05607         158 NGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKV--AKEELKRRTLED---------EVKF--E---HQN  221 (277)
T ss_pred             CCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchh--hHHHHHHHhhcc---------cccc--c---ccc
Confidence            99999999998889999999999999999999999986432211  111111111110         0000  0   012


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 039626          589 LALLVIRLIDACLKKDPTDRPTMYEIEHSL  618 (628)
Q Consensus       589 ~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L  618 (628)
                      .+..+.+++.+||+.||++||+++|+++.+
T Consensus       222 ~~~~~~~li~~~L~~~P~~R~~~~~~~~~~  251 (277)
T cd05607         222 FTEESKDICRLFLAKKPEDRLGSREKNDDP  251 (277)
T ss_pred             CCHHHHHHHHHHhccCHhhCCCCccchhhh
Confidence            344578999999999999999998776433

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.7e-34  Score=292.27  Aligned_cols=235  Identities=29%  Similarity=0.446  Sum_probs=185.6

Q ss_pred             eEEEEEEECC-------ceEEEEEecc--------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHH
Q 039626          361 GSVYRGKING-------GFAAIKKVNG--------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDW  425 (628)
Q Consensus       361 G~Vy~g~~~g-------~~vavK~~~~--------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~  425 (628)
                      |.||+|...+       ..+|+|....        .+.+|+.+++.++|+||+++++++......++||||+++|+|.++
T Consensus        20 g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~   99 (277)
T cd05032          20 GMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSY   99 (277)
T ss_pred             ceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcEEEEecCCCCCHHHH
Confidence            8999998742       5799999753        356799999999999999999999999999999999999999999


Q ss_pred             hhhcCCC------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcc
Q 039626          426 VFSNKNE------GKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEF  499 (628)
Q Consensus       426 l~~~~~~------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~  499 (628)
                      +......      ...++|..++.++.|++.||.|||+   .+++||||||+||++++++.+||+|||+++........ 
T Consensus       100 l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~di~p~nill~~~~~~kl~dfg~~~~~~~~~~~-  175 (277)
T cd05032         100 LRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYY-  175 (277)
T ss_pred             HHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccChheEEEcCCCCEEECCcccchhhccCccc-
Confidence            9654321      2348899999999999999999998   45999999999999999999999999999866433211 


Q ss_pred             eeeecccCCccccCccccccCCCCcccccHHHHHHHHHHHh-CCCccccccccccccHHHHHHHHhccccchhhhccccC
Q 039626          500 ALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT-GKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFID  578 (628)
Q Consensus       500 ~~~~~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELlt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d  578 (628)
                      .......++..|+|||.+.+..++.++||||||++++|+++ |+.|+.....      .+....... ..         .
T Consensus       176 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~------~~~~~~~~~-~~---------~  239 (277)
T cd05032         176 RKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN------EEVLKFVID-GG---------H  239 (277)
T ss_pred             ccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCH------HHHHHHHhc-CC---------C
Confidence            11223356789999999998889999999999999999998 8877653221      111111110 00         0


Q ss_pred             CcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 039626          579 PTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLS  619 (628)
Q Consensus       579 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~  619 (628)
                      +    ..+...+..+.+++.+||+.+|++|||+.|+++.|+
T Consensus       240 ~----~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~  276 (277)
T cd05032         240 L----DLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK  276 (277)
T ss_pred             C----CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence            1    112223566889999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=8.5e-34  Score=290.34  Aligned_cols=239  Identities=24%  Similarity=0.388  Sum_probs=187.5

Q ss_pred             eEEEEEEEC------CceEEEEEecc--------chHHHHHHHhhcCCCceeeeeeeeec-CCeEEEEEEecCCCChHHH
Q 039626          361 GSVYRGKIN------GGFAAIKKVNG--------DVSKEIALLNKINHSNLIILSGVCFN-EGNCYLVYEYAVNGTLSDW  425 (628)
Q Consensus       361 G~Vy~g~~~------g~~vavK~~~~--------~~~~E~~~l~~l~H~nIv~l~g~~~~-~~~~~lV~E~~~~gsL~~~  425 (628)
                      |.||+|...      +..+++|+++.        .+.+|+.++++++|+||+++++++.. +...++++||+++|+|.++
T Consensus        20 g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~~~~~~~L~~~   99 (280)
T cd05043          20 GRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLF   99 (280)
T ss_pred             ceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCCEEEEEcCCCCcHHHH
Confidence            899999983      47889998764        25679999999999999999999876 4678999999999999999


Q ss_pred             hhhcCCC----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCccee
Q 039626          426 VFSNKNE----GKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFAL  501 (628)
Q Consensus       426 l~~~~~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~  501 (628)
                      +......    +..+++.++..++.+++.||+|||+   .+++|+||||+||++++++.+||+|||+++.+...... ..
T Consensus       100 l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kl~d~g~~~~~~~~~~~-~~  175 (280)
T cd05043         100 LQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK---RGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYH-CL  175 (280)
T ss_pred             HHhccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccCHhhEEEcCCCcEEECCCCCcccccCCceE-Ee
Confidence            8654322    2569999999999999999999998   45999999999999999999999999999866433211 11


Q ss_pred             eecccCCccccCccccccCCCCcccccHHHHHHHHHHHh-CCCccccccccccccHHHHHHHHhccccchhhhccccCCc
Q 039626          502 TRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT-GKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPT  580 (628)
Q Consensus       502 ~~~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELlt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~  580 (628)
                      .....++..|+|||++.+..++.++||||||+++||+++ |+.|+.....      .+....... .         ....
T Consensus       176 ~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~------~~~~~~~~~-~---------~~~~  239 (280)
T cd05043         176 GDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP------FEMAAYLKD-G---------YRLA  239 (280)
T ss_pred             CCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH------HHHHHHHHc-C---------CCCC
Confidence            122346778999999998889999999999999999999 8888753211      111111111 0         0001


Q ss_pred             CCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHh
Q 039626          581 LQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILN  623 (628)
Q Consensus       581 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~~  623 (628)
                          .+...+..+.+++.+||..||++||++.|+++.|+.+..
T Consensus       240 ----~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~  278 (280)
T cd05043         240 ----QPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA  278 (280)
T ss_pred             ----CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence                111234567899999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=6e-34  Score=291.93  Aligned_cols=236  Identities=23%  Similarity=0.427  Sum_probs=186.1

Q ss_pred             eEEEEEEEC-------CceEEEEEecc--------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHH
Q 039626          361 GSVYRGKIN-------GGFAAIKKVNG--------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDW  425 (628)
Q Consensus       361 G~Vy~g~~~-------g~~vavK~~~~--------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~  425 (628)
                      |.||+|...       +..+|+|+++.        .+.+|+.++.+++|+||+++++++...+..++++||+++++|.++
T Consensus        19 g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~~e~~~~~~l~~~   98 (283)
T cd05091          19 GKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEF   98 (283)
T ss_pred             CeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEEEEEcCCCCcHHHH
Confidence            899999873       36799999863        356799999999999999999999999999999999999999999


Q ss_pred             hhhcC------------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCC
Q 039626          426 VFSNK------------NEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAE  493 (628)
Q Consensus       426 l~~~~------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~  493 (628)
                      +....            .....+++..+.+++.|++.||+|||+.   +++||||||+||++++++.+||+|||+++...
T Consensus        99 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  175 (283)
T cd05091          99 LVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKISDLGLFREVY  175 (283)
T ss_pred             HHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecCCCceEecccccccccc
Confidence            85321            1123588999999999999999999984   59999999999999999999999999988664


Q ss_pred             CCCCcceeeecccCCccccCccccccCCCCcccccHHHHHHHHHHHh-CCCccccccccccccHHHHHHHHhccccchhh
Q 039626          494 GQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT-GKEAAALHAEENNMHLSDVLNAVLTKEDGEES  572 (628)
Q Consensus       494 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELlt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  572 (628)
                      .... ........+++.|+|||.+.++.++.++||||||++++||++ |..|+.....      .+....+....     
T Consensus       176 ~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~------~~~~~~i~~~~-----  243 (283)
T cd05091         176 AADY-YKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN------QDVIEMIRNRQ-----  243 (283)
T ss_pred             cchh-eeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH------HHHHHHHHcCC-----
Confidence            3221 112233456789999999998889999999999999999998 7767653211      12222221111     


Q ss_pred             hccccCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 039626          573 LRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSN  620 (628)
Q Consensus       573 l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~  620 (628)
                               ....+.+.+..+.+++.+||+.+|.+||++++|+..|+.
T Consensus       244 ---------~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         244 ---------VLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             ---------cCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence                     011233445668899999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=9.5e-34  Score=287.34  Aligned_cols=234  Identities=29%  Similarity=0.457  Sum_probs=184.6

Q ss_pred             eEEEEEEE-CCceEEEEEecc------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhcCCCC
Q 039626          361 GSVYRGKI-NGGFAAIKKVNG------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEG  433 (628)
Q Consensus       361 G~Vy~g~~-~g~~vavK~~~~------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~  433 (628)
                      |.||+|++ ++..+|+|+.+.      ++.+|++++++++|+||+++++++. +...++||||+++|+|.+++...  .+
T Consensus        20 ~~v~~~~~~~~~~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~--~~   96 (262)
T cd05071          20 GEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKGE--MG   96 (262)
T ss_pred             CcEEEEEecCCceEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcCCCCcHHHHHhhc--cc
Confidence            89999988 445799998864      3678999999999999999999875 45679999999999999999642  23


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCCccccC
Q 039626          434 KYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMA  513 (628)
Q Consensus       434 ~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~Y~A  513 (628)
                      ..++|..+..++.+++.||+|||+   .+++|+||||+||++++++.+||+|||.++........  ......++..|+|
T Consensus        97 ~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~--~~~~~~~~~~y~~  171 (262)
T cd05071          97 KYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT--ARQGAKFPIKWTA  171 (262)
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcccEEEcCCCcEEeccCCceeeccccccc--cccCCcccceecC
Confidence            468999999999999999999998   45999999999999999999999999999866433211  1123346678999


Q ss_pred             ccccccCCCCcccccHHHHHHHHHHHh-CCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCHHHHHH
Q 039626          514 PEYLENGLVSTKLDVYAFGVLILEMLT-GKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALL  592 (628)
Q Consensus       514 PE~l~~~~~s~k~DV~SfGvvl~ELlt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~  592 (628)
                      ||++.+..++.++||||||++++||++ |+.|+.....      .+........              .....+.+.+..
T Consensus       172 PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~------~~~~~~~~~~--------------~~~~~~~~~~~~  231 (262)
T cd05071         172 PEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN------REVLDQVERG--------------YRMPCPPECPES  231 (262)
T ss_pred             HhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCh------HHHHHHHhcC--------------CCCCCccccCHH
Confidence            999998899999999999999999999 7767643211      1111111100              001112344566


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHHHHHHHhH
Q 039626          593 VIRLIDACLKKDPTDRPTMYEIEHSLSNIL  622 (628)
Q Consensus       593 l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~  622 (628)
                      +.+++.+|++.||++||+++++.+.|+..+
T Consensus       232 l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~  261 (262)
T cd05071         232 LHDLMCQCWRKEPEERPTFEYLQAFLEDYF  261 (262)
T ss_pred             HHHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence            889999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=5.5e-34  Score=299.16  Aligned_cols=227  Identities=23%  Similarity=0.365  Sum_probs=178.9

Q ss_pred             eEEEEEEE--CCceEEEEEeccc----------hHHHHHHHhhc-CCCceeeeeeeeecCCeEEEEEEecCCCChHHHhh
Q 039626          361 GSVYRGKI--NGGFAAIKKVNGD----------VSKEIALLNKI-NHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVF  427 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~~----------~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~  427 (628)
                      |.||+++.  ++..+|+|.++.+          +..|..++.++ +||||+++++++.+++..++||||+++|+|.+++.
T Consensus         9 g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~   88 (329)
T cd05588           9 AKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQ   88 (329)
T ss_pred             eEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCCCCHHHHHH
Confidence            89999988  5789999988642          45688888888 79999999999999999999999999999999884


Q ss_pred             hcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccC
Q 039626          428 SNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVG  507 (628)
Q Consensus       428 ~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~g  507 (628)
                      .    .+.+++..+..++.|++.||+|||+.   +++||||||+|||++.++.+||+|||+++.......   ......|
T Consensus        89 ~----~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~---~~~~~~g  158 (329)
T cd05588          89 R----QRKLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD---TTSTFCG  158 (329)
T ss_pred             H----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccccccCCC---ccccccC
Confidence            3    34599999999999999999999984   599999999999999999999999999875321111   1234579


Q ss_pred             CccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccc--cccHHHHHHHHhccccchhhhccccCCcCCCCC
Q 039626          508 TKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEEN--NMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNY  585 (628)
Q Consensus       508 t~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~  585 (628)
                      |+.|+|||++.+..++.++|+|||||++|||++|+.|+.......  .....+.........          ..    ..
T Consensus       159 t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~----------~~----~~  224 (329)
T cd05588         159 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEK----------QI----RI  224 (329)
T ss_pred             CccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcC----------CC----CC
Confidence            999999999999999999999999999999999999986422211  111112221111110          00    12


Q ss_pred             CHHHHHHHHHHHHHhcccCCCCCCCH
Q 039626          586 PLELALLVIRLIDACLKKDPTDRPTM  611 (628)
Q Consensus       586 ~~~~~~~l~~l~~~Cl~~dP~~RPs~  611 (628)
                      |...+..+.+++.+||+.||.+||++
T Consensus       225 p~~~~~~~~~li~~~L~~dP~~R~~~  250 (329)
T cd05588         225 PRSLSVKASSVLKGFLNKDPKERLGC  250 (329)
T ss_pred             CCCCCHHHHHHHHHHhccCHHHcCCC
Confidence            22334567899999999999999983

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=9.9e-34  Score=286.61  Aligned_cols=232  Identities=29%  Similarity=0.474  Sum_probs=183.8

Q ss_pred             eEEEEEEE-CCceEEEEEecc------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhcCCCC
Q 039626          361 GSVYRGKI-NGGFAAIKKVNG------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEG  433 (628)
Q Consensus       361 G~Vy~g~~-~g~~vavK~~~~------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~  433 (628)
                      |.||++.. .+..+|+|+++.      ++.+|+.++++++|+|++++++++. +...+++|||+++++|.+++...  ..
T Consensus        20 ~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~--~~   96 (260)
T cd05070          20 GEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKDG--EG   96 (260)
T ss_pred             ceEEEEEecCCceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecCCCcHHHHHHhc--CC
Confidence            89999987 556899998864      4678999999999999999999885 45689999999999999998642  23


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCCccccC
Q 039626          434 KYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMA  513 (628)
Q Consensus       434 ~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~Y~A  513 (628)
                      ..+++.++..++.+++.||+|||+.   +++||||||+||++++++.+||+|||++.........  ......++..|+|
T Consensus        97 ~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~~y~a  171 (260)
T cd05070          97 RALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT--ARQGAKFPIKWTA  171 (260)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccCcccc--cccCCCCCccccC
Confidence            4589999999999999999999984   5999999999999999999999999999865432211  1112245668999


Q ss_pred             ccccccCCCCcccccHHHHHHHHHHHh-CCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCHHHHHH
Q 039626          514 PEYLENGLVSTKLDVYAFGVLILEMLT-GKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALL  592 (628)
Q Consensus       514 PE~l~~~~~s~k~DV~SfGvvl~ELlt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~  592 (628)
                      ||++.+..++.++||||||++++||++ |+.|+.....      .+.......              ......+.+.+..
T Consensus       172 PE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~------~~~~~~~~~--------------~~~~~~~~~~~~~  231 (260)
T cd05070         172 PEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN------REVLEQVER--------------GYRMPCPQDCPIS  231 (260)
T ss_pred             hHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCH------HHHHHHHHc--------------CCCCCCCCcCCHH
Confidence            999988899999999999999999999 7777753211      111111111              0111223344567


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 039626          593 VIRLIDACLKKDPTDRPTMYEIEHSLSN  620 (628)
Q Consensus       593 l~~l~~~Cl~~dP~~RPs~~ev~~~L~~  620 (628)
                      +.+++.+||+.+|.+|||++++.+.|+.
T Consensus       232 ~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         232 LHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             HHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            8999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=3.5e-34  Score=299.87  Aligned_cols=225  Identities=23%  Similarity=0.356  Sum_probs=180.5

Q ss_pred             eEEEEEEE-----CCceEEEEEecc-----------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHH
Q 039626          361 GSVYRGKI-----NGGFAAIKKVNG-----------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSD  424 (628)
Q Consensus       361 G~Vy~g~~-----~g~~vavK~~~~-----------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~  424 (628)
                      |.||+++.     .++.+|+|.++.           .+.+|+++|++++||||+++++++..++..++||||+++|+|.+
T Consensus        10 g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~   89 (323)
T cd05584          10 GKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFM   89 (323)
T ss_pred             eEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeCCCCchHHH
Confidence            89999875     467899998763           23569999999999999999999999999999999999999999


Q ss_pred             HhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeec
Q 039626          425 WVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRH  504 (628)
Q Consensus       425 ~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~  504 (628)
                      ++..    ...+.+.....++.|++.||+|||+.   +++||||||+|||++.++.+||+|||+++......   .....
T Consensus        90 ~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~---~~~~~  159 (323)
T cd05584          90 HLER----EGIFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG---TVTHT  159 (323)
T ss_pred             HHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC---Ccccc
Confidence            9853    34578888899999999999999984   59999999999999999999999999987543221   11233


Q ss_pred             ccCCccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCC
Q 039626          505 IVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGN  584 (628)
Q Consensus       505 ~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~  584 (628)
                      ..||+.|+|||++.+..++.++||||||+++|||++|+.||.....      ......+....               ..
T Consensus       160 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~------~~~~~~~~~~~---------------~~  218 (323)
T cd05584         160 FCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENR------KKTIDKILKGK---------------LN  218 (323)
T ss_pred             cCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCH------HHHHHHHHcCC---------------CC
Confidence            5799999999999988899999999999999999999999864221      11222221110               01


Q ss_pred             CCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 039626          585 YPLELALLVIRLIDACLKKDPTDRP-----TMYEIEH  616 (628)
Q Consensus       585 ~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~ev~~  616 (628)
                      .+......+.+++.+||+.||++||     ++.++++
T Consensus       219 ~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~  255 (323)
T cd05584         219 LPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS  255 (323)
T ss_pred             CCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence            1223345678999999999999999     7777654

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=1.1e-33  Score=294.97  Aligned_cols=240  Identities=29%  Similarity=0.473  Sum_probs=186.7

Q ss_pred             eEEEEEEE---------CCceEEEEEecc--------chHHHHHHHhhc-CCCceeeeeeeeecCCeEEEEEEecCCCCh
Q 039626          361 GSVYRGKI---------NGGFAAIKKVNG--------DVSKEIALLNKI-NHSNLIILSGVCFNEGNCYLVYEYAVNGTL  422 (628)
Q Consensus       361 G~Vy~g~~---------~g~~vavK~~~~--------~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL  422 (628)
                      |.||+++.         ....+|+|.++.        ++.+|+++++++ +|+||++++++|..++..+++|||+++|+|
T Consensus        26 g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L  105 (314)
T cd05099          26 GQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNL  105 (314)
T ss_pred             ccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCCceEEEEecCCCCcH
Confidence            89999975         234689998763        356799999999 699999999999998999999999999999


Q ss_pred             HHHhhhcCC------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccc
Q 039626          423 SDWVFSNKN------------EGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMAR  490 (628)
Q Consensus       423 ~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~  490 (628)
                      .+++.....            ....++|.++++++.|++.||.|||+   .+++||||||+|||+++++.+||+|||+++
T Consensus       106 ~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~dlkp~Nill~~~~~~kL~Dfg~~~  182 (314)
T cd05099         106 REFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLES---RRCIHRDLAARNVLVTEDNVMKIADFGLAR  182 (314)
T ss_pred             HHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHH---CCeeeccccceeEEEcCCCcEEEccccccc
Confidence            999965321            12458999999999999999999998   459999999999999999999999999998


Q ss_pred             cCCCCCCcceeeecccCCccccCccccccCCCCcccccHHHHHHHHHHHh-CCCccccccccccccHHHHHHHHhccccc
Q 039626          491 PAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT-GKEAAALHAEENNMHLSDVLNAVLTKEDG  569 (628)
Q Consensus       491 ~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELlt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~  569 (628)
                      ........ .......++..|+|||.+.+..++.++||||||+++|||++ |+.|+....      ..+....... .  
T Consensus       183 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~------~~~~~~~~~~-~--  252 (314)
T cd05099         183 GVHDIDYY-KKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIP------VEELFKLLRE-G--  252 (314)
T ss_pred             cccccccc-cccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCC------HHHHHHHHHc-C--
Confidence            76432211 11112234567999999999899999999999999999999 777764321      1111111111 0  


Q ss_pred             hhhhccccCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhh
Q 039626          570 EESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNA  624 (628)
Q Consensus       570 ~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~~~  624 (628)
                                 .....+...+..+.+++.+||+.||++||++.|+++.|+++...
T Consensus       253 -----------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~  296 (314)
T cd05099         253 -----------HRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAA  296 (314)
T ss_pred             -----------CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHH
Confidence                       00111223345678999999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=6.5e-34  Score=322.76  Aligned_cols=247  Identities=23%  Similarity=0.319  Sum_probs=191.8

Q ss_pred             eEEEEEEE--CCceEEEEEecc----------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhh
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG----------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFS  428 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  428 (628)
                      |.||+|..  .|+.||+|++..          ++.+|++++++++||||+++++++.+++..++||||+++|+|.+++..
T Consensus        16 G~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVMEY~eGGSL~~lL~s   95 (932)
T PRK13184         16 GEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKS   95 (932)
T ss_pred             EEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEEcCCCCCHHHHHHH
Confidence            89999988  578999998853          366799999999999999999999999999999999999999999864


Q ss_pred             cCC-------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCc---
Q 039626          429 NKN-------EGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGE---  498 (628)
Q Consensus       429 ~~~-------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~---  498 (628)
                      ...       ....+++..+++++.|+++||+|||+.   +|+||||||+|||++.++.+||+|||+++........   
T Consensus        96 ~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFGLAk~i~~~~~~~~~  172 (932)
T PRK13184         96 VWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLD  172 (932)
T ss_pred             hhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEecCcceecccccccccc
Confidence            211       123467888999999999999999984   5999999999999999999999999999866211100   


Q ss_pred             ------------ceeeecccCCccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhcc
Q 039626          499 ------------FALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTK  566 (628)
Q Consensus       499 ------------~~~~~~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~  566 (628)
                                  ........||+.|+|||++.+..++.++|||||||+++||++|+.|+.........     ....   
T Consensus       173 l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki~-----~~~~---  244 (932)
T PRK13184        173 IDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKIS-----YRDV---  244 (932)
T ss_pred             cccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhhh-----hhhh---
Confidence                        01112347999999999999999999999999999999999999998642211100     0000   


Q ss_pred             ccchhhhccccCCcCCCCCCHHHHHHHHHHHHHhcccCCCCC-CCHHHHHHHHHHhHhhccCC
Q 039626          567 EDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDR-PTMYEIEHSLSNILNASLNW  628 (628)
Q Consensus       567 ~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~R-Ps~~ev~~~L~~l~~~~~~w  628 (628)
                               ..++.... ...+.+..+.+++.+|++.||++| ++++++.+.|+..++..-+|
T Consensus       245 ---------i~~P~~~~-p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~~p~w  297 (932)
T PRK13184        245 ---------ILSPIEVA-PYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQGSPEW  297 (932)
T ss_pred             ---------ccChhhcc-ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhcCccc
Confidence                     00000000 011334567899999999999999 57888999999988765554

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=9.7e-34  Score=284.70  Aligned_cols=231  Identities=25%  Similarity=0.418  Sum_probs=183.5

Q ss_pred             eEEEEEEE-CCceEEEEEecc--------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhcCC
Q 039626          361 GSVYRGKI-NGGFAAIKKVNG--------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKN  431 (628)
Q Consensus       361 G~Vy~g~~-~g~~vavK~~~~--------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~  431 (628)
                      |.||+|.. ++..+|+|..+.        .+.+|++++++++|+||+++++++...+..++||||+++|+|.+++...  
T Consensus         9 g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--   86 (250)
T cd05085           9 GEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKK--   86 (250)
T ss_pred             ceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHHHHHHhc--
Confidence            89999987 567899998754        3567999999999999999999999999999999999999999998532  


Q ss_pred             CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCCccc
Q 039626          432 EGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGY  511 (628)
Q Consensus       432 ~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~Y  511 (628)
                       ...++|..++.++.+++.||.|||+   .+++|+||||+||++++++.+||+|||+++.......  .......++..|
T Consensus        87 -~~~~~~~~~~~~~~~i~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~~y  160 (250)
T cd05085          87 -KDELKTKQLVKFALDAAAGMAYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIY--SSSGLKQIPIKW  160 (250)
T ss_pred             -CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccChheEEEcCCCeEEECCCccceecccccc--ccCCCCCCcccc
Confidence             2358999999999999999999998   4599999999999999999999999999875432211  111222446789


Q ss_pred             cCccccccCCCCcccccHHHHHHHHHHHh-CCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCHHHH
Q 039626          512 MAPEYLENGLVSTKLDVYAFGVLILEMLT-GKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELA  590 (628)
Q Consensus       512 ~APE~l~~~~~s~k~DV~SfGvvl~ELlt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~  590 (628)
                      +|||++....++.++||||||++++|+++ |..|+.....      .........          ..    +...+...+
T Consensus       161 ~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~------~~~~~~~~~----------~~----~~~~~~~~~  220 (250)
T cd05085         161 TAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTN------QQAREQVEK----------GY----RMSCPQKCP  220 (250)
T ss_pred             cCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCH------HHHHHHHHc----------CC----CCCCCCCCC
Confidence            99999999999999999999999999998 8888753211      111111110          00    111122344


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 039626          591 LLVIRLIDACLKKDPTDRPTMYEIEHSLS  619 (628)
Q Consensus       591 ~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~  619 (628)
                      ..+.+++.+||..+|++||++.|+++.|.
T Consensus       221 ~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         221 DDVYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             HHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence            56889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=1.1e-33  Score=286.27  Aligned_cols=237  Identities=28%  Similarity=0.408  Sum_probs=181.3

Q ss_pred             eEEEEEEEC-----CceEEEEEecc--------chHHHHHHHhhcCCCceeeeeeeeec-CCeEEEEEEecCCCChHHHh
Q 039626          361 GSVYRGKIN-----GGFAAIKKVNG--------DVSKEIALLNKINHSNLIILSGVCFN-EGNCYLVYEYAVNGTLSDWV  426 (628)
Q Consensus       361 G~Vy~g~~~-----g~~vavK~~~~--------~~~~E~~~l~~l~H~nIv~l~g~~~~-~~~~~lV~E~~~~gsL~~~l  426 (628)
                      |.||+|++.     +..+|+|+...        .+.+|+.+++.++|+||+++++++.. ++..++|+||+.+|+|.+++
T Consensus         9 g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~~   88 (262)
T cd05058           9 GCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFI   88 (262)
T ss_pred             ceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCCCCCHHHHH
Confidence            899999862     24689998743        35579999999999999999998764 55689999999999999999


Q ss_pred             hhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCc-ceeeecc
Q 039626          427 FSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGE-FALTRHI  505 (628)
Q Consensus       427 ~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~~  505 (628)
                      ...   ...+.+..++.++.+++.||+|||+   .+++||||||+|||+++++.+||+|||+++........ .......
T Consensus        89 ~~~---~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~  162 (262)
T cd05058          89 RSE---THNPTVKDLIGFGLQVAKGMEYLAS---KKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGA  162 (262)
T ss_pred             Hhc---CCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCccccccccCCcceeecccccC
Confidence            542   2346888889999999999999998   45999999999999999999999999999865432111 1111233


Q ss_pred             cCCccccCccccccCCCCcccccHHHHHHHHHHHhCCCc-cccccccccccHHHHHHHHhccccchhhhccccCCcCCCC
Q 039626          506 VGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEA-AALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGN  584 (628)
Q Consensus       506 ~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~  584 (628)
                      .++..|+|||++.+..++.++||||||++++||++|+.| +....      ..+....+...          ..+..   
T Consensus       163 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~------~~~~~~~~~~~----------~~~~~---  223 (262)
T cd05058         163 KLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVD------SFDITVYLLQG----------RRLLQ---  223 (262)
T ss_pred             cCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCC------HHHHHHHHhcC----------CCCCC---
Confidence            567789999999988999999999999999999996544 33211      11111111110          00111   


Q ss_pred             CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHh
Q 039626          585 YPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILN  623 (628)
Q Consensus       585 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~~  623 (628)
                       +...+..+.+++.+||+.+|++||++.|+++.|++++.
T Consensus       224 -~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~  261 (262)
T cd05058         224 -PEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS  261 (262)
T ss_pred             -CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence             11223467899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=4.8e-34  Score=299.30  Aligned_cols=228  Identities=25%  Similarity=0.380  Sum_probs=180.7

Q ss_pred             eEEEEEEE--CCceEEEEEeccc----------hHHHHHHHhhc-CCCceeeeeeeeecCCeEEEEEEecCCCChHHHhh
Q 039626          361 GSVYRGKI--NGGFAAIKKVNGD----------VSKEIALLNKI-NHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVF  427 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~~----------~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~  427 (628)
                      |.||+++.  ++..+|+|.++.+          +.+|+.++.++ +|+||+++++++...+..++||||+++|+|.+++.
T Consensus         9 g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~   88 (327)
T cd05617           9 AKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQ   88 (327)
T ss_pred             eEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCCCcHHHHHH
Confidence            89999988  5678999998742          45788888888 69999999999999999999999999999998884


Q ss_pred             hcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccC
Q 039626          428 SNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVG  507 (628)
Q Consensus       428 ~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~g  507 (628)
                      .    .+.+++..+..++.|++.||+|||+.   +++||||||+|||++.++.+||+|||+++.......   ......|
T Consensus        89 ~----~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~g  158 (327)
T cd05617          89 R----QRKLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD---TTSTFCG  158 (327)
T ss_pred             H----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCCCC---ceecccC
Confidence            3    24599999999999999999999994   599999999999999999999999999875322111   1234579


Q ss_pred             CccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCH
Q 039626          508 TKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPL  587 (628)
Q Consensus       508 t~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~  587 (628)
                      |+.|+|||++.+..++.++|||||||+++||++|+.||............+.........              ....|.
T Consensus       159 t~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~--------------~~~~p~  224 (327)
T cd05617         159 TPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEK--------------PIRIPR  224 (327)
T ss_pred             CcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhC--------------CCCCCC
Confidence            999999999999999999999999999999999999996533322222222222221110              011222


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCCHH
Q 039626          588 ELALLVIRLIDACLKKDPTDRPTMY  612 (628)
Q Consensus       588 ~~~~~l~~l~~~Cl~~dP~~RPs~~  612 (628)
                      ..+..+.+++.+||+.||++|+++.
T Consensus       225 ~~~~~~~~li~~~L~~dP~~R~~~~  249 (327)
T cd05617         225 FLSVKASHVLKGFLNKDPKERLGCQ  249 (327)
T ss_pred             CCCHHHHHHHHHHhccCHHHcCCCC
Confidence            3345578999999999999999854

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-34  Score=305.56  Aligned_cols=231  Identities=25%  Similarity=0.349  Sum_probs=183.8

Q ss_pred             eEEEEEEE--CCceEEEEEecc----------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhh
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG----------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFS  428 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  428 (628)
                      |.||++..  +|+.+|+|+++.          .+.+|++++..++|+||+++++++.+++..++||||+++|+|.+++..
T Consensus        15 g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   94 (350)
T cd05573          15 GEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIR   94 (350)
T ss_pred             EEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEcCCCCCCHHHHHHH
Confidence            89999998  488999999863          256799999999999999999999999999999999999999999954


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCC-----------
Q 039626          429 NKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEG-----------  497 (628)
Q Consensus       429 ~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~-----------  497 (628)
                      .    ..+++..+..++.|++.||+|||+   .+++||||||+|||++.++.+||+|||+++.......           
T Consensus        95 ~----~~l~~~~~~~i~~qi~~aL~~LH~---~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~  167 (350)
T cd05573          95 K----DVFPEETARFYIAELVLALDSVHK---LGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNL  167 (350)
T ss_pred             c----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCcccccccccccc
Confidence            3    458999999999999999999999   4599999999999999999999999999986643220           


Q ss_pred             ---------------cceeeecccCCccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHH
Q 039626          498 ---------------EFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNA  562 (628)
Q Consensus       498 ---------------~~~~~~~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~  562 (628)
                                     .........||+.|+|||.+.+..++.++|||||||+++||++|+.|+.....      ......
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~------~~~~~~  241 (350)
T cd05573         168 LFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTL------QETYNK  241 (350)
T ss_pred             cccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCH------HHHHHH
Confidence                           00112335799999999999999999999999999999999999999864331      111111


Q ss_pred             HhccccchhhhccccCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCC-HHHHHH
Q 039626          563 VLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPT-MYEIEH  616 (628)
Q Consensus       563 ~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-~~ev~~  616 (628)
                      +....   ..   ..-+.     ....+..+.+++.+|+. ||.+||+ ++|+++
T Consensus       242 i~~~~---~~---~~~p~-----~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~  284 (350)
T cd05573         242 IINWK---ES---LRFPP-----DPPVSPEAIDLICRLLC-DPEDRLGSFEEIKS  284 (350)
T ss_pred             HhccC---Cc---ccCCC-----CCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhc
Confidence            11100   00   00000     01134567899999997 9999999 999876

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=3.3e-34  Score=300.28  Aligned_cols=226  Identities=26%  Similarity=0.368  Sum_probs=181.4

Q ss_pred             eEEEEEEE--CCceEEEEEeccc----------hHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhh
Q 039626          361 GSVYRGKI--NGGFAAIKKVNGD----------VSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFS  428 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~~----------~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  428 (628)
                      |.||++..  +|..+|+|.++.+          +.+|++++.+++|+||+++.+++..++..++||||+++|+|.+++..
T Consensus         9 g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~   88 (325)
T cd05594           9 GKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSR   88 (325)
T ss_pred             EEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCCcHHHHHHh
Confidence            89999987  6889999988642          35688999999999999999999999999999999999999998843


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCC
Q 039626          429 NKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGT  508 (628)
Q Consensus       429 ~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt  508 (628)
                          ...+++..+..++.|++.||+|||+.  .+++||||||+|||+++++.+||+|||+++.......   ......||
T Consensus        89 ----~~~l~~~~~~~~~~qi~~aL~~lH~~--~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~---~~~~~~gt  159 (325)
T cd05594          89 ----ERVFSEDRARFYGAEIVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA---TMKTFCGT  159 (325)
T ss_pred             ----cCCCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc---ccccccCC
Confidence                34589999999999999999999972  3599999999999999999999999999875432211   12335699


Q ss_pred             ccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCHH
Q 039626          509 KGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLE  588 (628)
Q Consensus       509 ~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~  588 (628)
                      +.|+|||.+.+..++.++|||||||++|||++|+.|+......      .........           ..    .++..
T Consensus       160 ~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~------~~~~~i~~~-----------~~----~~p~~  218 (325)
T cd05594         160 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE------KLFELILME-----------EI----RFPRT  218 (325)
T ss_pred             cccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHH------HHHHHHhcC-----------CC----CCCCC
Confidence            9999999999999999999999999999999999998632211      111111110           00    11223


Q ss_pred             HHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 039626          589 LALLVIRLIDACLKKDPTDRP-----TMYEIEH  616 (628)
Q Consensus       589 ~~~~l~~l~~~Cl~~dP~~RP-----s~~ev~~  616 (628)
                      ....+.+++.+||+.||++|+     ++.++++
T Consensus       219 ~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~  251 (325)
T cd05594         219 LSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQ  251 (325)
T ss_pred             CCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhc
Confidence            345678999999999999996     8888764

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=1.4e-33  Score=292.43  Aligned_cols=244  Identities=24%  Similarity=0.324  Sum_probs=179.0

Q ss_pred             eEEEEEEE--CCceEEEEEecc--------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhcC
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG--------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNK  430 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~--------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~  430 (628)
                      |.||+|+.  +++.+|+|+++.        .+.+|+.++++++|+||+++++++.++...++||||+. ++|.+++... 
T Consensus        19 g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~-   96 (303)
T cd07869          19 ATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYVH-TDLCQYMDKH-   96 (303)
T ss_pred             EEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEECCC-cCHHHHHHhC-
Confidence            89999998  678999998753        35689999999999999999999999999999999995 6888887532 


Q ss_pred             CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCCcc
Q 039626          431 NEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKG  510 (628)
Q Consensus       431 ~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~  510 (628)
                        ...+++..+..++.|++.||+|||+.   +|+||||||+|||+++++.+||+|||+++.......   ......+|+.
T Consensus        97 --~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~~  168 (303)
T cd07869          97 --PGGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSVPSH---TYSNEVVTLW  168 (303)
T ss_pred             --CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceeccCCCc---cCCCCcccCC
Confidence              34588899999999999999999985   499999999999999999999999999875432211   1223468899


Q ss_pred             ccCcccccc-CCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccch-----hhhccccCCcCCCC
Q 039626          511 YMAPEYLEN-GLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGE-----ESLRHFIDPTLQGN  584 (628)
Q Consensus       511 Y~APE~l~~-~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~l~~~~d~~l~~~  584 (628)
                      |+|||.+.+ ..++.++|||||||+++||++|+.||.......  ...+.+..........     .....+........
T Consensus       169 y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (303)
T cd07869         169 YRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQ--DQLERIFLVLGTPNEDTWPGVHSLPHFKPERFTLY  246 (303)
T ss_pred             CCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHH--HHHHHHHHHhCCCChhhccchhhcccccccccccc
Confidence            999998865 458899999999999999999999987432110  0111111111110000     00000000000000


Q ss_pred             CCH---------HHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          585 YPL---------ELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       585 ~~~---------~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      .+.         .....+.+++.+||+.||++|||+.|+++
T Consensus       247 ~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~  287 (303)
T cd07869         247 SPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS  287 (303)
T ss_pred             CCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence            000         11245679999999999999999999875

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-35  Score=297.82  Aligned_cols=227  Identities=27%  Similarity=0.435  Sum_probs=188.0

Q ss_pred             ceEEEEEEE--CCceEEEEEecc--------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhc
Q 039626          360 QGSVYRGKI--NGGFAAIKKVNG--------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSN  429 (628)
Q Consensus       360 ~G~Vy~g~~--~g~~vavK~~~~--------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~  429 (628)
                      +|.||||..  .++.||+|.+.-        +..+|+.+|.+++++||.+++|.+..+..++++|||+.+|++.+.|.  
T Consensus        26 fG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~gGsv~~lL~--  103 (467)
T KOG0201|consen   26 FGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCGGGSVLDLLK--  103 (467)
T ss_pred             cceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhcCcchhhhhc--
Confidence            399999998  688999999863        46789999999999999999999999999999999999999999983  


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCCc
Q 039626          430 KNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTK  509 (628)
Q Consensus       430 ~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~  509 (628)
                        .+..+.+....-|.+++..||.|||+.+   .+|||||+.|||+..+|.+|++|||.+-.......   .....+||+
T Consensus       104 --~~~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~---rr~tfvGTP  175 (467)
T KOG0201|consen  104 --SGNILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK---RRKTFVGTP  175 (467)
T ss_pred             --cCCCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechhh---ccccccccc
Confidence              3444577777778999999999999955   99999999999999999999999999987654321   235579999


Q ss_pred             cccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCHHH
Q 039626          510 GYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLEL  589 (628)
Q Consensus       510 ~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~  589 (628)
                      .|||||++.+..|+.|+||||||++.+||.+|.+|+........                --.+.+-..|.+.+    ..
T Consensus       176 fwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrv----------------lflIpk~~PP~L~~----~~  235 (467)
T KOG0201|consen  176 FWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRV----------------LFLIPKSAPPRLDG----DF  235 (467)
T ss_pred             cccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceE----------------EEeccCCCCCcccc----cc
Confidence            99999999998999999999999999999999998763222110                01112222344443    44


Q ss_pred             HHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          590 ALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       590 ~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      ...+.+|+..||++||+.||++.++++
T Consensus       236 S~~~kEFV~~CL~k~P~~RpsA~~LLK  262 (467)
T KOG0201|consen  236 SPPFKEFVEACLDKNPEFRPSAKELLK  262 (467)
T ss_pred             CHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence            566889999999999999999999986

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.4e-34  Score=291.97  Aligned_cols=230  Identities=25%  Similarity=0.318  Sum_probs=183.9

Q ss_pred             eEEEEEEE--CCceEEEEEecc----------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhh
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG----------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFS  428 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  428 (628)
                      |.||++..  +++.+|+|++..          .+.+|++++++++|+||+++++++..++..++||||+++|+|.+++..
T Consensus        14 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~   93 (285)
T cd05605          14 GEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYN   93 (285)
T ss_pred             eEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEeccCCCcHHHHHHh
Confidence            89999987  578999998853          245699999999999999999999999999999999999999998854


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCC
Q 039626          429 NKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGT  508 (628)
Q Consensus       429 ~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt  508 (628)
                      .  ....+++..+..++.|++.||+|||+.   +++||||||+||++++++.++|+|||+++......    ......|+
T Consensus        94 ~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~----~~~~~~~~  164 (285)
T cd05605          94 M--GNPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE----TIRGRVGT  164 (285)
T ss_pred             c--CcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC----ccccccCC
Confidence            2  234589999999999999999999984   59999999999999999999999999988654322    11234689


Q ss_pred             ccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCHH
Q 039626          509 KGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLE  588 (628)
Q Consensus       509 ~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~  588 (628)
                      ..|+|||.+.+..++.++||||||+++|||++|+.||.......   ..+.+.....         .     ....++..
T Consensus       165 ~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~---~~~~~~~~~~---------~-----~~~~~~~~  227 (285)
T cd05605         165 VGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKV---KREEVERRVK---------E-----DQEEYSEK  227 (285)
T ss_pred             CCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhh---HHHHHHHHhh---------h-----cccccCcc
Confidence            99999999998899999999999999999999999986432211   1111111110         0     01122334


Q ss_pred             HHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 039626          589 LALLVIRLIDACLKKDPTDRP-----TMYEIEH  616 (628)
Q Consensus       589 ~~~~l~~l~~~Cl~~dP~~RP-----s~~ev~~  616 (628)
                      .+..+.+++.+||+.||++||     +++++++
T Consensus       228 ~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05605         228 FSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA  260 (285)
T ss_pred             cCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence            556688999999999999999     7777754

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=1.5e-33  Score=285.33  Aligned_cols=232  Identities=30%  Similarity=0.480  Sum_probs=183.2

Q ss_pred             eEEEEEEEC-CceEEEEEecc------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhcCCCC
Q 039626          361 GSVYRGKIN-GGFAAIKKVNG------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEG  433 (628)
Q Consensus       361 G~Vy~g~~~-g~~vavK~~~~------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~  433 (628)
                      |.||++.+. +..+|+|+...      .+.+|++++++++|+|++++++++. ++..++||||+++|+|.+++...  ..
T Consensus        20 ~~v~~~~~~~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~~~~~~~--~~   96 (260)
T cd05069          20 GEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMGKGSLLDFLKEG--DG   96 (260)
T ss_pred             CeEEEEEEcCCceEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCCCCCHHHHHhhC--CC
Confidence            899999984 45789998764      3678999999999999999999875 45678999999999999999642  33


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCCccccC
Q 039626          434 KYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMA  513 (628)
Q Consensus       434 ~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~Y~A  513 (628)
                      ..++|..+..++.+++.||+|||+.   +++|+||||+||++++++.+||+|||+++........  ......++..|+|
T Consensus        97 ~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~~y~~  171 (260)
T cd05069          97 KYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT--ARQGAKFPIKWTA  171 (260)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccCCccc--ccCCCccchhhCC
Confidence            4589999999999999999999984   5999999999999999999999999999866432211  1122346678999


Q ss_pred             ccccccCCCCcccccHHHHHHHHHHHh-CCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCHHHHHH
Q 039626          514 PEYLENGLVSTKLDVYAFGVLILEMLT-GKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALL  592 (628)
Q Consensus       514 PE~l~~~~~s~k~DV~SfGvvl~ELlt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~  592 (628)
                      ||++.+...+.++||||||++++||++ |+.|+......      +........              .....+.+.+..
T Consensus       172 Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~------~~~~~~~~~--------------~~~~~~~~~~~~  231 (260)
T cd05069         172 PEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNR------EVLEQVERG--------------YRMPCPQGCPES  231 (260)
T ss_pred             HHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH------HHHHHHHcC--------------CCCCCCcccCHH
Confidence            999998899999999999999999999 88777532211      111111100              001122344567


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 039626          593 VIRLIDACLKKDPTDRPTMYEIEHSLSN  620 (628)
Q Consensus       593 l~~l~~~Cl~~dP~~RPs~~ev~~~L~~  620 (628)
                      +.+++.+||+.||++||++++|++.|++
T Consensus       232 ~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         232 LHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             HHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence            8899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=5.5e-34  Score=298.47  Aligned_cols=219  Identities=28%  Similarity=0.415  Sum_probs=173.9

Q ss_pred             eEEEEEEE--CCceEEEEEeccc----------hHHHHHH---HhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHH
Q 039626          361 GSVYRGKI--NGGFAAIKKVNGD----------VSKEIAL---LNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDW  425 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~~----------~~~E~~~---l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~  425 (628)
                      |.||++..  +|+.+|||.++..          +..|+++   +++++|+||+++++++..++..++||||+++|+|..+
T Consensus        13 g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~   92 (324)
T cd05589          13 GKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMH   92 (324)
T ss_pred             EEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEEEcCCCCCcHHHH
Confidence            89999988  5789999998642          3345444   4567899999999999999999999999999999988


Q ss_pred             hhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecc
Q 039626          426 VFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHI  505 (628)
Q Consensus       426 l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~  505 (628)
                      +..     ..+++..+..++.|++.||+|||+.   +++||||||+||++++++.+||+|||+++.......   .....
T Consensus        93 ~~~-----~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~---~~~~~  161 (324)
T cd05589          93 IHT-----DVFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGD---RTSTF  161 (324)
T ss_pred             hhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccCCCCCC---ccccc
Confidence            732     3589999999999999999999984   599999999999999999999999999875432211   12345


Q ss_pred             cCCccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCC
Q 039626          506 VGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNY  585 (628)
Q Consensus       506 ~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~  585 (628)
                      .|++.|+|||.+.+..++.++|||||||++|||++|+.|+.....      .+....+....           +    .+
T Consensus       162 ~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~------~~~~~~i~~~~-----------~----~~  220 (324)
T cd05589         162 CGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDE------EEVFDSIVNDE-----------V----RY  220 (324)
T ss_pred             ccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCH------HHHHHHHHhCC-----------C----CC
Confidence            799999999999999999999999999999999999999864322      11111111100           1    12


Q ss_pred             CHHHHHHHHHHHHHhcccCCCCCCCH
Q 039626          586 PLELALLVIRLIDACLKKDPTDRPTM  611 (628)
Q Consensus       586 ~~~~~~~l~~l~~~Cl~~dP~~RPs~  611 (628)
                      +...+..+.+++.+||+.||.+||++
T Consensus       221 p~~~~~~~~~li~~~L~~dP~~R~~~  246 (324)
T cd05589         221 PRFLSREAISIMRRLLRRNPERRLGS  246 (324)
T ss_pred             CCCCCHHHHHHHHHHhhcCHhHcCCC
Confidence            22334567899999999999999954

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=2.4e-34  Score=306.61  Aligned_cols=241  Identities=22%  Similarity=0.298  Sum_probs=185.7

Q ss_pred             HhcCCCcCCccc----eEEEEEEE--CCceEEEEEecc----------chHHHHHHHhhcCCCceeeeeeeeecCCeEEE
Q 039626          349 ATDNFSFTCRIQ----GSVYRGKI--NGGFAAIKKVNG----------DVSKEIALLNKINHSNLIILSGVCFNEGNCYL  412 (628)
Q Consensus       349 at~~f~~~~~i~----G~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l  412 (628)
                      ..++|.....+|    |.||+++.  +++.+|+|.+..          .+.+|+.+++.++|+||+++++++.++...++
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l  120 (370)
T cd05596          41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM  120 (370)
T ss_pred             CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence            344565555554    89999988  578999998853          24579999999999999999999999999999


Q ss_pred             EEEecCCCChHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccC
Q 039626          413 VYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPA  492 (628)
Q Consensus       413 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~  492 (628)
                      ||||+++|+|.+++..     ..++......++.|++.||+|||+.   +|+||||||+|||+++++.+||+|||+++..
T Consensus       121 v~Ey~~gg~L~~~l~~-----~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~  192 (370)
T cd05596         121 VMEYMPGGDLVNLMSN-----YDIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKM  192 (370)
T ss_pred             EEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccceeec
Confidence            9999999999998843     2477888889999999999999984   5999999999999999999999999999865


Q ss_pred             CCCCCcceeeecccCCccccCccccccC----CCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhcccc
Q 039626          493 EGQEGEFALTRHIVGTKGYMAPEYLENG----LVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKED  568 (628)
Q Consensus       493 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~----~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  568 (628)
                      .....  .......||+.|+|||.+.+.    .++.++|||||||++|||++|+.||.....      ......+.....
T Consensus       193 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~------~~~~~~i~~~~~  264 (370)
T cd05596         193 DANGM--VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL------VGTYSKIMDHKN  264 (370)
T ss_pred             cCCCc--ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCH------HHHHHHHHcCCC
Confidence            43211  112335799999999998653    478999999999999999999999864321      111122211100


Q ss_pred             chhhhccccCCcCCCCCCHHHHHHHHHHHHHhcccCCCC--CCCHHHHHH
Q 039626          569 GEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTD--RPTMYEIEH  616 (628)
Q Consensus       569 ~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPs~~ev~~  616 (628)
                         .      .....  ....+..+.+++.+||+.+|.+  |++++|++.
T Consensus       265 ---~------~~~~~--~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~  303 (370)
T cd05596         265 ---S------LTFPD--DIEISKQAKDLICAFLTDREVRLGRNGVDEIKS  303 (370)
T ss_pred             ---c------CCCCC--cCCCCHHHHHHHHHHccChhhccCCCCHHHHhc
Confidence               0      00000  1123456789999999999987  999999864

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-34  Score=272.68  Aligned_cols=243  Identities=25%  Similarity=0.336  Sum_probs=191.2

Q ss_pred             eEEEEEEE--CCceEEEEEecc-------chHHHHHHHhhcCCCceeeeeeeeecCC-----eEEEEEEecCCCChHHHh
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG-------DVSKEIALLNKINHSNLIILSGVCFNEG-----NCYLVYEYAVNGTLSDWV  426 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~-------~~~~E~~~l~~l~H~nIv~l~g~~~~~~-----~~~lV~E~~~~gsL~~~l  426 (628)
                      ..||.++.  +++.+|+||+.-       ...+|++..++++|||++++++++..+.     +.||+++|...|+|.+.+
T Consensus        35 sfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yll~Pyy~~Gsl~d~i  114 (302)
T KOG2345|consen   35 SFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYLLLPYYKRGSLLDEI  114 (302)
T ss_pred             eeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEEEeehhccccHHHHH
Confidence            35777775  788999999852       3578999999999999999999987543     489999999999999999


Q ss_pred             hhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCC----ccee-
Q 039626          427 FSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEG----EFAL-  501 (628)
Q Consensus       427 ~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~----~~~~-  501 (628)
                      .....++..+++.+.++|+.++++||++||+.. +++.||||||.|||+.+.+.+++.|||.+....-.-.    .... 
T Consensus       115 ~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~~~a~i~i~~~~~a~~lQ  193 (302)
T KOG2345|consen  115 ERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSATQAPIQIEGSRQALRLQ  193 (302)
T ss_pred             HHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCccccceEeechHHHHHHH
Confidence            887777889999999999999999999999976 7899999999999999999999999999876532110    0000 


Q ss_pred             -eecccCCccccCccccc---cCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhc-cc
Q 039626          502 -TRHIVGTKGYMAPEYLE---NGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLR-HF  576 (628)
Q Consensus       502 -~~~~~gt~~Y~APE~l~---~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~-~~  576 (628)
                       -.....|..|+|||.+.   +...++++|||||||+||+|+.|..||+...+.+                  .++. ..
T Consensus       194 e~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~G------------------gSlaLAv  255 (302)
T KOG2345|consen  194 EWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQG------------------GSLALAV  255 (302)
T ss_pred             HHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcC------------------CeEEEee
Confidence             11236889999999885   5578999999999999999999999987432211                  0110 01


Q ss_pred             cCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhH
Q 039626          577 IDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNIL  622 (628)
Q Consensus       577 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~  622 (628)
                      ..+.+.-......++.+.+++++|++.||.+||++.+++..+.++.
T Consensus       256 ~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li  301 (302)
T KOG2345|consen  256 QNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI  301 (302)
T ss_pred             eccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence            1111110111125567899999999999999999999999998775

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=8.4e-34  Score=297.71  Aligned_cols=227  Identities=26%  Similarity=0.383  Sum_probs=178.1

Q ss_pred             eEEEEEEE--CCceEEEEEeccc----------hHHHHHHHhhc-CCCceeeeeeeeecCCeEEEEEEecCCCChHHHhh
Q 039626          361 GSVYRGKI--NGGFAAIKKVNGD----------VSKEIALLNKI-NHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVF  427 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~~----------~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~  427 (628)
                      |.||++..  +++.+|+|.++.+          +..|+.++.++ +|+||+++++++..++..++||||+++|+|.+++.
T Consensus         9 g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~~~L~~~~~   88 (329)
T cd05618           9 AKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQ   88 (329)
T ss_pred             eEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCCCCHHHHHH
Confidence            89999988  5778999988642          44688888776 89999999999999999999999999999998884


Q ss_pred             hcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccC
Q 039626          428 SNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVG  507 (628)
Q Consensus       428 ~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~g  507 (628)
                      .    ...+++..+..++.|++.||+|||+.   +++||||||+|||++.++.+||+|||+++.......   ......|
T Consensus        89 ~----~~~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~---~~~~~~g  158 (329)
T cd05618          89 R----QRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD---TTSTFCG  158 (329)
T ss_pred             H----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC---ccccccC
Confidence            3    34589999999999999999999985   599999999999999999999999999875422111   1234579


Q ss_pred             CccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccc--cccHHHHHHHHhccccchhhhccccCCcCCCCC
Q 039626          508 TKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEEN--NMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNY  585 (628)
Q Consensus       508 t~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~  585 (628)
                      |+.|+|||++.+..++.++||||||++++||++|+.|+.......  .....+.+.......              ....
T Consensus       159 t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~--------------~~~~  224 (329)
T cd05618         159 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK--------------QIRI  224 (329)
T ss_pred             CccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcC--------------CCCC
Confidence            999999999999999999999999999999999999986322111  111111111111110              0112


Q ss_pred             CHHHHHHHHHHHHHhcccCCCCCCCH
Q 039626          586 PLELALLVIRLIDACLKKDPTDRPTM  611 (628)
Q Consensus       586 ~~~~~~~l~~l~~~Cl~~dP~~RPs~  611 (628)
                      |......+.+++.+||+.||++||+.
T Consensus       225 p~~~~~~~~~ll~~~L~~dP~~R~~~  250 (329)
T cd05618         225 PRSLSVKAASVLKSFLNKDPKERLGC  250 (329)
T ss_pred             CCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence            33344567899999999999999984

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=8.7e-34  Score=296.60  Aligned_cols=225  Identities=26%  Similarity=0.380  Sum_probs=179.4

Q ss_pred             ceEEEEEEE--CCceEEEEEeccc----------hHHHHHHHhhc-CCCceeeeeeeeecCCeEEEEEEecCCCChHHHh
Q 039626          360 QGSVYRGKI--NGGFAAIKKVNGD----------VSKEIALLNKI-NHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWV  426 (628)
Q Consensus       360 ~G~Vy~g~~--~g~~vavK~~~~~----------~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l  426 (628)
                      .|.||+|+.  .++.+|+|.++.+          +..|.+++..+ +|+||+++++++.+++..++||||+++|+|.+++
T Consensus         8 ~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l   87 (321)
T cd05591           8 FGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNGGDLMFQI   87 (321)
T ss_pred             CeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCCCcHHHHH
Confidence            389999988  4678999988642          34688888866 7999999999999999999999999999999988


Q ss_pred             hhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeeccc
Q 039626          427 FSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIV  506 (628)
Q Consensus       427 ~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~  506 (628)
                      ..    ...+++..+..++.|++.||.|||+.   +++||||||+|||++.++.+||+|||+++.......   ......
T Consensus        88 ~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~---~~~~~~  157 (321)
T cd05591          88 QR----SRKFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV---TTTTFC  157 (321)
T ss_pred             HH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccCCc---cccccc
Confidence            53    34589999999999999999999995   499999999999999999999999999875432211   123456


Q ss_pred             CCccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCC
Q 039626          507 GTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYP  586 (628)
Q Consensus       507 gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~  586 (628)
                      ||+.|+|||++.+..++.++||||||+++|||++|+.|+.....      .+....+....           .    ..+
T Consensus       158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~------~~~~~~i~~~~-----------~----~~p  216 (321)
T cd05591         158 GTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNE------DDLFESILHDD-----------V----LYP  216 (321)
T ss_pred             cCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCH------HHHHHHHHcCC-----------C----CCC
Confidence            89999999999999999999999999999999999999864322      11222221110           0    112


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCC-------CHHHHH
Q 039626          587 LELALLVIRLIDACLKKDPTDRP-------TMYEIE  615 (628)
Q Consensus       587 ~~~~~~l~~l~~~Cl~~dP~~RP-------s~~ev~  615 (628)
                      ......+.+++.+||+.||++||       ++.+++
T Consensus       217 ~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~  252 (321)
T cd05591         217 VWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIK  252 (321)
T ss_pred             CCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHh
Confidence            22345678999999999999999       666655

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=1e-33  Score=287.93  Aligned_cols=235  Identities=26%  Similarity=0.470  Sum_probs=184.3

Q ss_pred             eEEEEEEEC--C---ceEEEEEecc--------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhh
Q 039626          361 GSVYRGKIN--G---GFAAIKKVNG--------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVF  427 (628)
Q Consensus       361 G~Vy~g~~~--g---~~vavK~~~~--------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~  427 (628)
                      |.||+|.+.  +   ..+|+|..+.        ++..|+.++++++|+||+++.+++.+++..++||||+++|+|.+++.
T Consensus        18 g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~   97 (269)
T cd05065          18 GEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLR   97 (269)
T ss_pred             CeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEEecCCCCcHHHHHh
Confidence            899999872  3   2589998763        46679999999999999999999999999999999999999999985


Q ss_pred             hcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeeccc-
Q 039626          428 SNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIV-  506 (628)
Q Consensus       428 ~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~-  506 (628)
                      ..   ...+++.+++.++.|++.||+|||+.   +++|+||||+||+++.++.+||+|||+++................ 
T Consensus        98 ~~---~~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~  171 (269)
T cd05065          98 QN---DGQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGG  171 (269)
T ss_pred             hC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCccccccccCccccccccccCC
Confidence            42   34589999999999999999999984   599999999999999999999999999886643322111111112 


Q ss_pred             -CCccccCccccccCCCCcccccHHHHHHHHHHHh-CCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCC
Q 039626          507 -GTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT-GKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGN  584 (628)
Q Consensus       507 -gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELlt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~  584 (628)
                       .+..|+|||++.+..++.++||||||++++|+++ |+.|+.....      .+....+.. .         .    ...
T Consensus       172 ~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~------~~~~~~i~~-~---------~----~~~  231 (269)
T cd05065         172 KIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN------QDVINAIEQ-D---------Y----RLP  231 (269)
T ss_pred             CcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCH------HHHHHHHHc-C---------C----cCC
Confidence             2457999999999999999999999999999886 8888753221      111111110 0         0    001


Q ss_pred             CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 039626          585 YPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNI  621 (628)
Q Consensus       585 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l  621 (628)
                      .+.+.+..+.+++.+||+.+|.+||++++|+..|+++
T Consensus       232 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  268 (269)
T cd05065         232 PPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM  268 (269)
T ss_pred             CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            1223345678999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=9.5e-34  Score=299.08  Aligned_cols=242  Identities=25%  Similarity=0.410  Sum_probs=185.0

Q ss_pred             eEEEEEEE-------CCceEEEEEecc--------chHHHHHHHhhc-CCCceeeeeeeeecC-CeEEEEEEecCCCChH
Q 039626          361 GSVYRGKI-------NGGFAAIKKVNG--------DVSKEIALLNKI-NHSNLIILSGVCFNE-GNCYLVYEYAVNGTLS  423 (628)
Q Consensus       361 G~Vy~g~~-------~g~~vavK~~~~--------~~~~E~~~l~~l-~H~nIv~l~g~~~~~-~~~~lV~E~~~~gsL~  423 (628)
                      |.||+|..       .++.+|||+++.        .+.+|+.+|.++ +|+||++++++|... ...++||||+++|+|.
T Consensus        21 g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv~ey~~~g~L~  100 (343)
T cd05103          21 GQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLS  100 (343)
T ss_pred             ceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCceEEEEeccCCCcHH
Confidence            89999974       457899998864        256799999999 789999999988754 4679999999999999


Q ss_pred             HHhhhcCCC---------------------------------------------------------------CCCCCHHH
Q 039626          424 DWVFSNKNE---------------------------------------------------------------GKYLDWKQ  440 (628)
Q Consensus       424 ~~l~~~~~~---------------------------------------------------------------~~~l~~~~  440 (628)
                      +++......                                                               ...++|.+
T Consensus       101 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  180 (343)
T cd05103         101 NYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQEDLYKKVLTLED  180 (343)
T ss_pred             HHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhhhhhhhhhccCCHHH
Confidence            998643210                                                               12478899


Q ss_pred             HHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCCccccCccccccC
Q 039626          441 RIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENG  520 (628)
Q Consensus       441 ~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~  520 (628)
                      +..++.|+++||+|||+.   +++||||||+|||+++++.+||+|||+++....... ........++..|+|||.+.+.
T Consensus       181 ~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~  256 (343)
T cd05103         181 LICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPD-YVRKGDARLPLKWMAPETIFDR  256 (343)
T ss_pred             HHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcc-hhhcCCCCCCcceECcHHhcCC
Confidence            999999999999999984   599999999999999999999999999986532211 1112223456789999999988


Q ss_pred             CCCcccccHHHHHHHHHHHh-CCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCHHHHHHHHHHHHH
Q 039626          521 LVSTKLDVYAFGVLILEMLT-GKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDA  599 (628)
Q Consensus       521 ~~s~k~DV~SfGvvl~ELlt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~  599 (628)
                      .++.++||||||++++||++ |..|+......      ...........         ....    +......+.+++.+
T Consensus       257 ~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~------~~~~~~~~~~~---------~~~~----~~~~~~~~~~~~~~  317 (343)
T cd05103         257 VYTIQSDVWSFGVLLWEIFSLGASPYPGVKID------EEFCRRLKEGT---------RMRA----PDYTTPEMYQTMLD  317 (343)
T ss_pred             CCCchhhHHHHHHHHHHHHHCCCCCCCCcccc------HHHHHHHhccC---------CCCC----CCCCCHHHHHHHHH
Confidence            99999999999999999997 88776532111      01111111000         0001    11123457899999


Q ss_pred             hcccCCCCCCCHHHHHHHHHHhHhhc
Q 039626          600 CLKKDPTDRPTMYEIEHSLSNILNAS  625 (628)
Q Consensus       600 Cl~~dP~~RPs~~ev~~~L~~l~~~~  625 (628)
                      ||+.||++||++.||++.|+.+++.+
T Consensus       318 cl~~~p~~Rps~~eil~~l~~~~~~~  343 (343)
T cd05103         318 CWHGEPSQRPTFSELVEHLGNLLQAN  343 (343)
T ss_pred             HccCChhhCcCHHHHHHHHHHHHhcC
Confidence            99999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=1.7e-33  Score=286.46  Aligned_cols=239  Identities=24%  Similarity=0.363  Sum_probs=179.8

Q ss_pred             eEEEEEEEC----CceEEEEEecc--------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhh
Q 039626          361 GSVYRGKIN----GGFAAIKKVNG--------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFS  428 (628)
Q Consensus       361 G~Vy~g~~~----g~~vavK~~~~--------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  428 (628)
                      |.||+|++.    +..+|+|+++.        ++.+|+.++++++|+||+++++++.+....++||||+++|+|.+++..
T Consensus         9 g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~   88 (269)
T cd05087           9 GKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRS   88 (269)
T ss_pred             ceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCcHHHHHHH
Confidence            899999873    34689998753        356799999999999999999999988899999999999999999965


Q ss_pred             cCC-CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccC
Q 039626          429 NKN-EGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVG  507 (628)
Q Consensus       429 ~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~g  507 (628)
                      ... ....+++..+..++.|++.||+|||+   .+++|+||||+||+++.++.+||+|||+++....... ........+
T Consensus        89 ~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~-~~~~~~~~~  164 (269)
T cd05087          89 CRKAELMTPDPTTLQRMACEIALGLLHLHK---NNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDY-YVTPDQLWV  164 (269)
T ss_pred             hhhcccccccHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEECCccccccccCcce-eecCCCcCC
Confidence            432 22356788888999999999999998   4599999999999999999999999999875432211 111123457


Q ss_pred             CccccCccccccC-------CCCcccccHHHHHHHHHHHh-CCCccccccccccccHHHHHHHHhccccchhhhccccCC
Q 039626          508 TKGYMAPEYLENG-------LVSTKLDVYAFGVLILEMLT-GKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDP  579 (628)
Q Consensus       508 t~~Y~APE~l~~~-------~~s~k~DV~SfGvvl~ELlt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~  579 (628)
                      +..|+|||++.+.       .++.++|+||||+++|||++ |+.|+.......      .......     +......++
T Consensus       165 ~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~------~~~~~~~-----~~~~~~~~~  233 (269)
T cd05087         165 PLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQ------VLTYTVR-----EQQLKLPKP  233 (269)
T ss_pred             cccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHH------HHHHHhh-----cccCCCCCC
Confidence            7889999988642       35889999999999999996 998886432211      1111000     111112222


Q ss_pred             cCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 039626          580 TLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLS  619 (628)
Q Consensus       580 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~  619 (628)
                      .+...    ....+.+++.+|| .+|++|||++||+..|+
T Consensus       234 ~~~~~----~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         234 RLKLP----LSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             ccCCC----CChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            22222    2334678999999 68999999999998875

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=9.6e-34  Score=296.12  Aligned_cols=223  Identities=28%  Similarity=0.401  Sum_probs=178.3

Q ss_pred             ceEEEEEEE--CCceEEEEEeccc----------hHHHHHHHhhc-CCCceeeeeeeeecCCeEEEEEEecCCCChHHHh
Q 039626          360 QGSVYRGKI--NGGFAAIKKVNGD----------VSKEIALLNKI-NHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWV  426 (628)
Q Consensus       360 ~G~Vy~g~~--~g~~vavK~~~~~----------~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l  426 (628)
                      .|.||+++.  +++.+|+|.++.+          +..|..++..+ +|+||+++++++...+..++||||+++|+|.+++
T Consensus         8 ~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~g~L~~~i   87 (320)
T cd05590           8 FGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNGGDLMFHI   87 (320)
T ss_pred             CeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCCchHHHHH
Confidence            389999998  5789999988642          34577888776 6999999999999999999999999999999988


Q ss_pred             hhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeeccc
Q 039626          427 FSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIV  506 (628)
Q Consensus       427 ~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~  506 (628)
                      ..    ...+++..+..++.|++.||+|||+.   +++||||||+|||++.++.+||+|||+++......   .......
T Consensus        88 ~~----~~~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~---~~~~~~~  157 (320)
T cd05590          88 QK----SRRFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG---KTTSTFC  157 (320)
T ss_pred             HH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC---Ccccccc
Confidence            53    34589999999999999999999984   59999999999999999999999999987542211   1123457


Q ss_pred             CCccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCC
Q 039626          507 GTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYP  586 (628)
Q Consensus       507 gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~  586 (628)
                      ||+.|+|||.+.+..++.++|||||||++|||++|+.||.....      .+....+....               ...+
T Consensus       158 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~------~~~~~~i~~~~---------------~~~~  216 (320)
T cd05590         158 GTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENE------DDLFEAILNDE---------------VVYP  216 (320)
T ss_pred             cCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH------HHHHHHHhcCC---------------CCCC
Confidence            99999999999999999999999999999999999999864322      11222221110               0112


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCCHHH
Q 039626          587 LELALLVIRLIDACLKKDPTDRPTMYE  613 (628)
Q Consensus       587 ~~~~~~l~~l~~~Cl~~dP~~RPs~~e  613 (628)
                      ......+.+++.+||+.||++||++.+
T Consensus       217 ~~~~~~~~~li~~~L~~dP~~R~~~~~  243 (320)
T cd05590         217 TWLSQDAVDILKAFMTKNPTMRLGSLT  243 (320)
T ss_pred             CCCCHHHHHHHHHHcccCHHHCCCCCC
Confidence            223456789999999999999999833

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=7.4e-34  Score=292.32  Aligned_cols=243  Identities=26%  Similarity=0.393  Sum_probs=177.6

Q ss_pred             eEEEEEEE---CCceEEEEEecc---------chHHHHHHHhhc---CCCceeeeeeeeec-----CCeEEEEEEecCCC
Q 039626          361 GSVYRGKI---NGGFAAIKKVNG---------DVSKEIALLNKI---NHSNLIILSGVCFN-----EGNCYLVYEYAVNG  420 (628)
Q Consensus       361 G~Vy~g~~---~g~~vavK~~~~---------~~~~E~~~l~~l---~H~nIv~l~g~~~~-----~~~~~lV~E~~~~g  420 (628)
                      |.||+++.   .+..+|+|+++.         .+.+|+.+++++   +||||++++++|..     ....++||||+. +
T Consensus        15 g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~-~   93 (290)
T cd07862          15 GKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-Q   93 (290)
T ss_pred             eEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCCCcEEEEEccCC-C
Confidence            89999987   356799998753         245677777665   69999999999862     356899999995 6


Q ss_pred             ChHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcce
Q 039626          421 TLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFA  500 (628)
Q Consensus       421 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~  500 (628)
                      +|.+++...  ....+++..+..++.|++.||.|||+.   +++||||||+|||++.++.+||+|||+++......    
T Consensus        94 ~l~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~----  164 (290)
T cd07862          94 DLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM----  164 (290)
T ss_pred             CHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEccccceEeccCCc----
Confidence            999998542  234589999999999999999999984   59999999999999999999999999998654321    


Q ss_pred             eeecccCCccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchh---h--h-c
Q 039626          501 LTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEE---S--L-R  574 (628)
Q Consensus       501 ~~~~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~---~--l-~  574 (628)
                      ......||+.|+|||.+.+..++.++|||||||++|||++|+.|+......+  .+...+... ......+   .  + .
T Consensus       165 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~--~~~~i~~~~-~~~~~~~~~~~~~~~~  241 (290)
T cd07862         165 ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD--QLGKILDVI-GLPGEEDWPRDVALPR  241 (290)
T ss_pred             ccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHH--HHHHHHHHh-CCCChhhchhhhcccc
Confidence            2234568999999999998899999999999999999999999887533211  111111111 1000000   0  0 0


Q ss_pred             cccCCcCCC---CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          575 HFIDPTLQG---NYPLELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       575 ~~~d~~l~~---~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      ....+....   ....+....+.+++.+||+.||++|||+.|+++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  286 (290)
T cd07862         242 QAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  286 (290)
T ss_pred             hhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence            000000000   001123456789999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=4e-34  Score=296.12  Aligned_cols=254  Identities=22%  Similarity=0.330  Sum_probs=190.7

Q ss_pred             hcCCCcCCccc----eEEEEEEE--CCceEEEEEecc----------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEE
Q 039626          350 TDNFSFTCRIQ----GSVYRGKI--NGGFAAIKKVNG----------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLV  413 (628)
Q Consensus       350 t~~f~~~~~i~----G~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV  413 (628)
                      .++|..-..||    |+||.++-  .|+.+|+|++++          .+..|-++|....+++||+|+..|.+.+.+|||
T Consensus       140 ~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLi  219 (550)
T KOG0605|consen  140 LDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLI  219 (550)
T ss_pred             cccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEE
Confidence            34454433443    99999976  789999999976          245688999999999999999999999999999


Q ss_pred             EEecCCCChHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCC
Q 039626          414 YEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAE  493 (628)
Q Consensus       414 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~  493 (628)
                      |||++||++..+|.    ....|++.....++.+++-|++-||.++   +|||||||+|+|||..|++||+||||+....
T Consensus       220 MEylPGGD~mTLL~----~~~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~  292 (550)
T KOG0605|consen  220 MEYLPGGDMMTLLM----RKDTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTGLD  292 (550)
T ss_pred             EEecCCccHHHHHH----hcCcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccchhh
Confidence            99999999999994    3456999999999999999999999965   9999999999999999999999999985432


Q ss_pred             CC--------------------CCcce------------------------eeecccCCccccCccccccCCCCcccccH
Q 039626          494 GQ--------------------EGEFA------------------------LTRHIVGTKGYMAPEYLENGLVSTKLDVY  529 (628)
Q Consensus       494 ~~--------------------~~~~~------------------------~~~~~~gt~~Y~APE~l~~~~~s~k~DV~  529 (628)
                      ..                    .....                        .....+|||.|||||++.+..++..+|.|
T Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwW  372 (550)
T KOG0605|consen  293 KKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWW  372 (550)
T ss_pred             hhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHH
Confidence            10                    00000                        01124799999999999999999999999


Q ss_pred             HHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCC
Q 039626          530 AFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRP  609 (628)
Q Consensus       530 SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP  609 (628)
                      |+||++|||+.|-+||......+.  ....+.+.       ..+.        ..-....+.+..+||.+|+. ||++|-
T Consensus       373 SLG~ImyEmLvGyPPF~s~tp~~T--~rkI~nwr-------~~l~--------fP~~~~~s~eA~DLI~rll~-d~~~RL  434 (550)
T KOG0605|consen  373 SLGCIMYEMLVGYPPFCSETPQET--YRKIVNWR-------ETLK--------FPEEVDLSDEAKDLITRLLC-DPENRL  434 (550)
T ss_pred             HHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHh-------hhcc--------CCCcCcccHHHHHHHHHHhc-CHHHhc
Confidence            999999999999999985443221  11111111       1111        11111233667899999999 999997


Q ss_pred             CHHHHHHHHHHhHhhccCC
Q 039626          610 TMYEIEHSLSNILNASLNW  628 (628)
Q Consensus       610 s~~ev~~~L~~l~~~~~~w  628 (628)
                      -..-+.++-..-.-..+||
T Consensus       435 G~~G~~EIK~HPfF~~v~W  453 (550)
T KOG0605|consen  435 GSKGAEEIKKHPFFKGVDW  453 (550)
T ss_pred             CcccHHHHhcCCccccCCc
Confidence            6444443333333344444

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=1.1e-33  Score=287.65  Aligned_cols=235  Identities=29%  Similarity=0.458  Sum_probs=184.3

Q ss_pred             eEEEEEEECC--------ceEEEEEecc--------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHH
Q 039626          361 GSVYRGKING--------GFAAIKKVNG--------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSD  424 (628)
Q Consensus       361 G~Vy~g~~~g--------~~vavK~~~~--------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~  424 (628)
                      |.||+|+..+        ..+|+|.+..        ++.+|++++++++|+||+++++++...+..++||||+++|+|.+
T Consensus         9 g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~   88 (269)
T cd05044           9 GEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLS   88 (269)
T ss_pred             eeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEeccCCCcHHH
Confidence            8999998732        4688887643        35689999999999999999999999899999999999999999


Q ss_pred             HhhhcCC---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCC-----cEEEccccccccCCCCC
Q 039626          425 WVFSNKN---EGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDL-----RAKIANFAMARPAEGQE  496 (628)
Q Consensus       425 ~l~~~~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~-----~~kl~Dfgla~~~~~~~  496 (628)
                      ++.....   ....++|.+++.++.+++.||+|||+   .+++|+||||+||+++.++     .+|++|||+++......
T Consensus        89 ~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~~~~~~  165 (269)
T cd05044          89 YLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSD  165 (269)
T ss_pred             HHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHh---CCcccCCCChheEEEecCCCCCCcceEECCccccccccccc
Confidence            9965322   22458999999999999999999998   4599999999999999887     89999999998654322


Q ss_pred             CcceeeecccCCccccCccccccCCCCcccccHHHHHHHHHHHh-CCCccccccccccccHHHHHHHHhccccchhhhcc
Q 039626          497 GEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT-GKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRH  575 (628)
Q Consensus       497 ~~~~~~~~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELlt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  575 (628)
                      .. .......++..|+|||++.++.++.++||||||++++||++ |+.|+.....      .+....+..          
T Consensus       166 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~------~~~~~~~~~----------  228 (269)
T cd05044         166 YY-RKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN------QEVLQHVTA----------  228 (269)
T ss_pred             cc-ccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCH------HHHHHHHhc----------
Confidence            11 11122345788999999999999999999999999999998 8888753221      111111100          


Q ss_pred             ccCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 039626          576 FIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLS  619 (628)
Q Consensus       576 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~  619 (628)
                          ......+...+..+.+++.+||..+|.+||+++++.+.|+
T Consensus       229 ----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~  268 (269)
T cd05044         229 ----GGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ  268 (269)
T ss_pred             ----CCccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence                0011122334567889999999999999999999999886

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.8e-34  Score=305.34  Aligned_cols=231  Identities=19%  Similarity=0.280  Sum_probs=177.1

Q ss_pred             eEEEEEEE--CCceEEEEEecc----------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhh
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG----------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFS  428 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  428 (628)
                      |.||++..  +++.+|||++..          .+.+|++++++++|+||+++++++.+++..|+||||+++|+|.+++..
T Consensus        15 g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~   94 (377)
T cd05629          15 GEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIK   94 (377)
T ss_pred             EEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEeCCCCCcHHHHHHh
Confidence            89999987  788999998753          245799999999999999999999999999999999999999999853


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCc----------
Q 039626          429 NKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGE----------  498 (628)
Q Consensus       429 ~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~----------  498 (628)
                          ...+++.....++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++........          
T Consensus        95 ----~~~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~  167 (377)
T cd05629          95 ----YDTFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGK  167 (377)
T ss_pred             ----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeeccccccccccccccccccccccc
Confidence                34588899999999999999999985   4999999999999999999999999998643211000          


Q ss_pred             --c--------------------------------eeeecccCCccccCccccccCCCCcccccHHHHHHHHHHHhCCCc
Q 039626          499 --F--------------------------------ALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEA  544 (628)
Q Consensus       499 --~--------------------------------~~~~~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p  544 (628)
                        .                                .......||+.|+|||++.+..++.++|||||||+++||++|+.|
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~P  247 (377)
T cd05629         168 SNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFECLIGWPP  247 (377)
T ss_pred             ccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchhhhhhhcCCCC
Confidence              0                                000124699999999999999999999999999999999999999


Q ss_pred             cccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCHHHHHHHHHHHHHhcccCCCCC---CCHHHHHH
Q 039626          545 AALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDR---PTMYEIEH  616 (628)
Q Consensus       545 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~R---Ps~~ev~~  616 (628)
                      |......      +....+....   ..+      .+..  .......+.+++.+|+. +|.+|   +++.|++.
T Consensus       248 f~~~~~~------~~~~~i~~~~---~~~------~~p~--~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~  304 (377)
T cd05629         248 FCSENSH------ETYRKIINWR---ETL------YFPD--DIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKS  304 (377)
T ss_pred             CCCCCHH------HHHHHHHccC---Ccc------CCCC--CCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhc
Confidence            8643221      1111111100   000      0000  01233457889999997 66665   58888765

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3e-34  Score=269.11  Aligned_cols=225  Identities=25%  Similarity=0.381  Sum_probs=187.8

Q ss_pred             eEEEEEEE--CCceEEEEEecc----------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhh
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG----------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFS  428 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  428 (628)
                      |.||.|+.  ++..||+|.+.+          ++.+|+++-+.|+||||++++|++.++...||++||..+|+|...|..
T Consensus        36 G~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLilEya~~gel~k~L~~  115 (281)
T KOG0580|consen   36 GNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLILEYAPRGELYKDLQE  115 (281)
T ss_pred             ccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEEEecCCchHHHHHHh
Confidence            89999998  567899998854          567899999999999999999999999999999999999999999964


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCC
Q 039626          429 NKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGT  508 (628)
Q Consensus       429 ~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt  508 (628)
                      .  ....++......+..|+|.||.|+|.   +++|||||||+|+|++.++..|++|||-+......     ......||
T Consensus       116 ~--~~~~f~e~~~a~Yi~q~A~Al~y~h~---k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~~-----kR~tlcgt  185 (281)
T KOG0580|consen  116 G--RMKRFDEQRAATYIKQLANALLYCHL---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSN-----KRKTLCGT  185 (281)
T ss_pred             c--ccccccccchhHHHHHHHHHHHHhcc---CCcccCCCCHHHhccCCCCCeeccCCCceeecCCC-----Cceeeecc
Confidence            3  34457777888899999999999998   66999999999999999999999999998755321     24457899


Q ss_pred             ccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCHH
Q 039626          509 KGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLE  588 (628)
Q Consensus       509 ~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~  588 (628)
                      ..|++||...+...+.+.|+|++|++.+|++.|.+||......      +...++..               ..-.+|..
T Consensus       186 ~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~------etYkrI~k---------------~~~~~p~~  244 (281)
T KOG0580|consen  186 LDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHS------ETYKRIRK---------------VDLKFPST  244 (281)
T ss_pred             cccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhH------HHHHHHHH---------------ccccCCcc
Confidence            9999999999999999999999999999999999999744321      11111111               11123344


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          589 LALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       589 ~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      .+..+.+++.+|+..+|.+|.+..|+++
T Consensus       245 is~~a~dlI~~ll~~~p~~r~~l~~v~~  272 (281)
T KOG0580|consen  245 ISGGAADLISRLLVKNPIERLALTEVMD  272 (281)
T ss_pred             cChhHHHHHHHHhccCccccccHHHHhh
Confidence            5566789999999999999999998875

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=1.8e-33  Score=284.75  Aligned_cols=232  Identities=27%  Similarity=0.430  Sum_probs=184.8

Q ss_pred             eEEEEEEE-CCceEEEEEecc------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhcCCCC
Q 039626          361 GSVYRGKI-NGGFAAIKKVNG------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEG  433 (628)
Q Consensus       361 G~Vy~g~~-~g~~vavK~~~~------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~  433 (628)
                      |.||++.. +++.+|+|.+..      ++.+|+.++++++|+||+++++++. ++..+++|||+++|+|.+++...  .+
T Consensus        20 g~v~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~~~~~~~--~~   96 (260)
T cd05067          20 GEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTP--EG   96 (260)
T ss_pred             ceEEeeecCCCceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcCCCCCHHHHHHhc--CC
Confidence            89999998 678899998864      4678999999999999999999874 55689999999999999998543  34


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCCccccC
Q 039626          434 KYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMA  513 (628)
Q Consensus       434 ~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~Y~A  513 (628)
                      ..+++.++..++.+++.||+|||+.   +++|+||||+||++++++.++|+|||++........  .......++..|+|
T Consensus        97 ~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~y~~  171 (260)
T cd05067          97 IKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIEDNEY--TAREGAKFPIKWTA  171 (260)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecCCCCc--ccccCCcccccccC
Confidence            5689999999999999999999984   499999999999999999999999999976642221  11122346678999


Q ss_pred             ccccccCCCCcccccHHHHHHHHHHHh-CCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCHHHHHH
Q 039626          514 PEYLENGLVSTKLDVYAFGVLILEMLT-GKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALL  592 (628)
Q Consensus       514 PE~l~~~~~s~k~DV~SfGvvl~ELlt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~  592 (628)
                      ||++....++.++||||||++++|+++ |+.|+.....      .+....+..          ....    ..+...+..
T Consensus       172 pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~------~~~~~~~~~----------~~~~----~~~~~~~~~  231 (260)
T cd05067         172 PEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTN------PEVIQNLER----------GYRM----PRPDNCPEE  231 (260)
T ss_pred             HHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCCh------HHHHHHHHc----------CCCC----CCCCCCCHH
Confidence            999998889999999999999999999 8888753221      111111110          0001    112223456


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 039626          593 VIRLIDACLKKDPTDRPTMYEIEHSLSN  620 (628)
Q Consensus       593 l~~l~~~Cl~~dP~~RPs~~ev~~~L~~  620 (628)
                      +.+++.+||+.+|++||+++++...|+.
T Consensus       232 ~~~li~~~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         232 LYELMRLCWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             HHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence            8899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=6.7e-34  Score=297.71  Aligned_cols=221  Identities=25%  Similarity=0.380  Sum_probs=176.0

Q ss_pred             eEEEEEEE--CCceEEEEEeccc----------hHHHH-HHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhh
Q 039626          361 GSVYRGKI--NGGFAAIKKVNGD----------VSKEI-ALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVF  427 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~~----------~~~E~-~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~  427 (628)
                      |.||+++.  +|+.+|+|++...          +..|. .+++.++|+||+++++++.+++..++||||+++|+|.+++.
T Consensus         9 g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~   88 (323)
T cd05575           9 GKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNGGELFFHLQ   88 (323)
T ss_pred             eEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCCCCHHHHHH
Confidence            89999998  6889999998642          22333 35678999999999999999999999999999999999985


Q ss_pred             hcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccC
Q 039626          428 SNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVG  507 (628)
Q Consensus       428 ~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~g  507 (628)
                      .    ...+++.....++.||+.||+|||+.   +|+||||||+|||+++++.+||+|||+++.......   ......|
T Consensus        89 ~----~~~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~g  158 (323)
T cd05575          89 R----ERSFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK---TTSTFCG  158 (323)
T ss_pred             h----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCC---ccccccC
Confidence            3    34588999999999999999999984   599999999999999999999999999875422211   1234579


Q ss_pred             CccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCH
Q 039626          508 TKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPL  587 (628)
Q Consensus       508 t~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~  587 (628)
                      |+.|+|||++.+..++.++|||||||+++||++|+.|+.....      .+....+....           ..+..    
T Consensus       159 t~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~------~~~~~~i~~~~-----------~~~~~----  217 (323)
T cd05575         159 TPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDT------AEMYDNILNKP-----------LRLKP----  217 (323)
T ss_pred             ChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCH------HHHHHHHHcCC-----------CCCCC----
Confidence            9999999999999999999999999999999999999864221      12222221110           01111    


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCCHH
Q 039626          588 ELALLVIRLIDACLKKDPTDRPTMY  612 (628)
Q Consensus       588 ~~~~~l~~l~~~Cl~~dP~~RPs~~  612 (628)
                      ..+..+.+++.+||+.||.+||+++
T Consensus       218 ~~~~~~~~li~~~l~~~p~~R~~~~  242 (323)
T cd05575         218 NISVSARHLLEGLLQKDRTKRLGAK  242 (323)
T ss_pred             CCCHHHHHHHHHHhhcCHHhCCCCC
Confidence            2245678999999999999999986

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=9.4e-34  Score=303.47  Aligned_cols=232  Identities=20%  Similarity=0.302  Sum_probs=177.5

Q ss_pred             eEEEEEEE--CCceEEEEEecc----------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhh
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG----------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFS  428 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  428 (628)
                      |.||+++.  ++..+|+|++..          .+.+|++++.+++|+||+++++++.+++..++||||+++|+|.+++..
T Consensus        15 g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~   94 (381)
T cd05626          15 GEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIR   94 (381)
T ss_pred             EEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEecCCCCcHHHHHHh
Confidence            89999988  678999999853          246799999999999999999999999999999999999999999854


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCc----------
Q 039626          429 NKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGE----------  498 (628)
Q Consensus       429 ~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~----------  498 (628)
                          ...+++.....++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++........          
T Consensus        95 ----~~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~~~~~~~~  167 (381)
T cd05626          95 ----MEVFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIR  167 (381)
T ss_pred             ----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCccccccccccccccccccc
Confidence                33588899999999999999999984   5999999999999999999999999997643110000          


Q ss_pred             ----------------------------------ceeeecccCCccccCccccccCCCCcccccHHHHHHHHHHHhCCCc
Q 039626          499 ----------------------------------FALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEA  544 (628)
Q Consensus       499 ----------------------------------~~~~~~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p  544 (628)
                                                        ........||+.|+|||.+.+..++.++|||||||+++||++|+.|
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~P  247 (381)
T cd05626         168 QDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQPP  247 (381)
T ss_pred             ccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHHHHHHhCCCC
Confidence                                              0011234799999999999988899999999999999999999999


Q ss_pred             cccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCHHHHHHHHHHHHH--hcccCCCCCCCHHHHHH
Q 039626          545 AALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDA--CLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       545 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~--Cl~~dP~~RPs~~ev~~  616 (628)
                      |.......      ....+....   ..      ....  ........+.+++.+  |+..+|..||+++|++.
T Consensus       248 f~~~~~~~------~~~~i~~~~---~~------~~~~--~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~  304 (381)
T cd05626         248 FLAPTPTE------TQLKVINWE---NT------LHIP--PQVKLSPEAVDLITKLCCSAEERLGRNGADDIKA  304 (381)
T ss_pred             CcCCCHHH------HHHHHHccc---cc------cCCC--CCCCCCHHHHHHHHHHccCcccccCCCCHHHHhc
Confidence            86432211      111111000   00      0000  011223456677777  55667777999999875

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=1.7e-33  Score=286.14  Aligned_cols=244  Identities=26%  Similarity=0.360  Sum_probs=186.5

Q ss_pred             HHHHhcCCCcCCccc----eEEEEEEE--CCceEEEEEecc-------chHHHHHHHhhcCCCceeeeeeeeecCCeEEE
Q 039626          346 LQSATDNFSFTCRIQ----GSVYRGKI--NGGFAAIKKVNG-------DVSKEIALLNKINHSNLIILSGVCFNEGNCYL  412 (628)
Q Consensus       346 l~~at~~f~~~~~i~----G~Vy~g~~--~g~~vavK~~~~-------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l  412 (628)
                      ++.+++++.....++    |.||+|..  ++..+++|....       .+.+|+.++++++|+||+++++++..++..++
T Consensus         3 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   82 (268)
T cd06624           3 YEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKI   82 (268)
T ss_pred             cccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEE
Confidence            445566665555553    89999987  466899998753       36689999999999999999999999999999


Q ss_pred             EEEecCCCChHHHhhhcCCCCCCC--CHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCC-CCcEEEcccccc
Q 039626          413 VYEYAVNGTLSDWVFSNKNEGKYL--DWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDS-DLRAKIANFAMA  489 (628)
Q Consensus       413 V~E~~~~gsL~~~l~~~~~~~~~l--~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~-~~~~kl~Dfgla  489 (628)
                      |+||+++++|.+++....   ..+  ++..+..++.|++.||+|||+   .+++||||||+||+++. ++.+||+|||++
T Consensus        83 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~h~dl~p~nil~~~~~~~~~l~dfg~~  156 (268)
T cd06624          83 FMEQVPGGSLSALLRSKW---GPLKDNEQTIIFYTKQILEGLKYLHD---NQIVHRDIKGDNVLVNTYSGVVKISDFGTS  156 (268)
T ss_pred             EEecCCCCCHHHHHHHhc---ccCCCcHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCeEEEecchhh
Confidence            999999999999996431   234  788899999999999999998   45999999999999986 679999999998


Q ss_pred             ccCCCCCCcceeeecccCCccccCccccccC--CCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccc
Q 039626          490 RPAEGQEGEFALTRHIVGTKGYMAPEYLENG--LVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKE  567 (628)
Q Consensus       490 ~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~--~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~  567 (628)
                      ........   ......++..|+|||++...  .++.++||||||+++|||++|+.|+........     ......   
T Consensus       157 ~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~-----~~~~~~---  225 (268)
T cd06624         157 KRLAGINP---CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA-----AMFKVG---  225 (268)
T ss_pred             eecccCCC---ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhh-----hHhhhh---
Confidence            76543221   12234588999999998654  378999999999999999999998753221100     000000   


Q ss_pred             cchhhhccccCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          568 DGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       568 ~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                           .     .......+......+.+++.+||+.+|.+||++.|+++
T Consensus       226 -----~-----~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  264 (268)
T cd06624         226 -----M-----FKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ  264 (268)
T ss_pred             -----h-----hccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence                 0     00011223344566889999999999999999999875

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=1.4e-33  Score=293.17  Aligned_cols=242  Identities=21%  Similarity=0.377  Sum_probs=183.4

Q ss_pred             eEEEEEEE--CCceEEEEEecc--------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhcC
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG--------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNK  430 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~--------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~  430 (628)
                      |.||++..  ++..+|+|..+.        ++.+|++++.+++|+||+++++++..++..++||||+++++|.+++... 
T Consensus        15 g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~~~~L~~~l~~~-   93 (308)
T cd06615          15 GVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA-   93 (308)
T ss_pred             eEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeeccCCCcHHHHHHhc-
Confidence            89999988  577888888753        3668999999999999999999999999999999999999999999542 


Q ss_pred             CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCCcc
Q 039626          431 NEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKG  510 (628)
Q Consensus       431 ~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~  510 (628)
                         ..+++..+..++.|++.||.|||+.  .+++|+||||+|||+++++.+||+|||++.......     .....++..
T Consensus        94 ---~~~~~~~~~~~~~~i~~~l~~lH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-----~~~~~~~~~  163 (308)
T cd06615          94 ---GRIPENILGKISIAVLRGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-----ANSFVGTRS  163 (308)
T ss_pred             ---CCCCHHHHHHHHHHHHHHHHHHHhh--CCEEECCCChHHEEEecCCcEEEccCCCcccccccc-----cccCCCCcC
Confidence               4588999999999999999999972  359999999999999999999999999987653221     233568899


Q ss_pred             ccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccch--------------------
Q 039626          511 YMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGE--------------------  570 (628)
Q Consensus       511 Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--------------------  570 (628)
                      |+|||.+.+..++.++|+||||++++||++|+.|+.......   ...............                    
T Consensus       164 ~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (308)
T cd06615         164 YMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKE---LEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIF  240 (308)
T ss_pred             ccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhh---HHHhhcCccccccccCCcccccCCCCCccchhhHH
Confidence            999999988889999999999999999999999875332111   111110000000000                    


Q ss_pred             hhhccccCCcCCCCCC-HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 039626          571 ESLRHFIDPTLQGNYP-LELALLVIRLIDACLKKDPTDRPTMYEIEHS  617 (628)
Q Consensus       571 ~~l~~~~d~~l~~~~~-~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~  617 (628)
                      +..+...... ....+ ......+.+++.+||..||++||+++|+++.
T Consensus       241 ~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  287 (308)
T cd06615         241 ELLDYIVNEP-PPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH  287 (308)
T ss_pred             HHHHHHhcCC-CccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            0000000000 00011 1234568899999999999999999999876

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.9e-34  Score=303.77  Aligned_cols=231  Identities=22%  Similarity=0.315  Sum_probs=179.6

Q ss_pred             eEEEEEEE--CCceEEEEEecc----------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhh
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG----------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFS  428 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  428 (628)
                      |.||+++.  +|+.+|||+++.          .+.+|+++|..++|+||+++++++.+++..++||||+++|+|.+++..
T Consensus        15 g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~   94 (364)
T cd05599          15 GEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMK   94 (364)
T ss_pred             EEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEECCCCCcHHHHHHHH
Confidence            89999998  678999999864          245799999999999999999999999999999999999999999854


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcc---------
Q 039626          429 NKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEF---------  499 (628)
Q Consensus       429 ~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~---------  499 (628)
                          ...+++..+..++.|++.||+|||+.   +++||||||+|||++.++.+||+|||+++.........         
T Consensus        95 ----~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~  167 (364)
T cd05599          95 ----KDTFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHAL  167 (364)
T ss_pred             ----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceeccccccccccccccccc
Confidence                23589999999999999999999985   49999999999999999999999999987543211000         


Q ss_pred             --------------------------eeeecccCCccccCccccccCCCCcccccHHHHHHHHHHHhCCCcccccccccc
Q 039626          500 --------------------------ALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENN  553 (628)
Q Consensus       500 --------------------------~~~~~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~  553 (628)
                                                .......||+.|+|||++....++.++|||||||+++||++|+.||.....   
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~Pf~~~~~---  244 (364)
T cd05599         168 PSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFCSDNP---  244 (364)
T ss_pred             cccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCCCCCCCH---
Confidence                                      001124699999999999999999999999999999999999999864321   


Q ss_pred             ccHHHHHHHHhccccchhhhccccCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCC---HHHHHH
Q 039626          554 MHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPT---MYEIEH  616 (628)
Q Consensus       554 ~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs---~~ev~~  616 (628)
                         .+....+....   ..+      ....  ....+..+.+++.+|+. +|.+|++   ++|+++
T Consensus       245 ---~~~~~~i~~~~---~~~------~~~~--~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~  295 (364)
T cd05599         245 ---QETYRKIINWK---ETL------QFPD--EVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS  295 (364)
T ss_pred             ---HHHHHHHHcCC---Ccc------CCCC--CCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence               11111211100   000      0000  11223456789999996 9999998   777754

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=1.4e-33  Score=290.54  Aligned_cols=253  Identities=25%  Similarity=0.381  Sum_probs=194.6

Q ss_pred             eecHHHHHHHhcCCCcCCccc----eEEEEEEE--CCceEEEEEecc------chHHHHHHHhhc-CCCceeeeeeeeec
Q 039626          340 VYSFKELQSATDNFSFTCRIQ----GSVYRGKI--NGGFAAIKKVNG------DVSKEIALLNKI-NHSNLIILSGVCFN  406 (628)
Q Consensus       340 ~~~~~el~~at~~f~~~~~i~----G~Vy~g~~--~g~~vavK~~~~------~~~~E~~~l~~l-~H~nIv~l~g~~~~  406 (628)
                      .+..+++..++++|.....++    |.||++..  +++.+|+|....      ++.+|+.++.++ +|+|++++++++..
T Consensus        11 ~~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~   90 (291)
T cd06639          11 MLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYK   90 (291)
T ss_pred             hhhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence            355566777788888766665    89999988  578899998753      356799999999 89999999999875


Q ss_pred             C-----CeEEEEEEecCCCChHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcE
Q 039626          407 E-----GNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRA  481 (628)
Q Consensus       407 ~-----~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~  481 (628)
                      .     +..++|+||+++|+|.+++......+..++|..+..++.|++.||+|||+.   +++|+||||+||++++++.+
T Consensus        91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~~~  167 (291)
T cd06639          91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGV  167 (291)
T ss_pred             ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCE
Confidence            3     358999999999999999865444456789999999999999999999984   59999999999999999999


Q ss_pred             EEccccccccCCCCCCcceeeecccCCccccCccccccC-----CCCcccccHHHHHHHHHHHhCCCccccccccccccH
Q 039626          482 KIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENG-----LVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHL  556 (628)
Q Consensus       482 kl~Dfgla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~-----~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~  556 (628)
                      ||+|||+++.......   ......|+..|+|||.+...     .++.++|||||||+++||++|+.|+......     
T Consensus       168 kl~dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~-----  239 (291)
T cd06639         168 KLVDFGVSAQLTSTRL---RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV-----  239 (291)
T ss_pred             EEeecccchhcccccc---cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHH-----
Confidence            9999999886543221   12234688999999988643     3689999999999999999999887532211     


Q ss_pred             HHHHHHHhccccchhhhccccCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          557 SDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       557 ~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                       ..+.......          .+.+  ..+.+....+.+++.+||+.+|++||++.|+++
T Consensus       240 -~~~~~~~~~~----------~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~  286 (291)
T cd06639         240 -KTLFKIPRNP----------PPTL--LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLE  286 (291)
T ss_pred             -HHHHHHhcCC----------CCCC--CcccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence             1111111100          0001  112233456889999999999999999999875

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=1.5e-33  Score=289.31  Aligned_cols=253  Identities=24%  Similarity=0.374  Sum_probs=192.2

Q ss_pred             ecHHHHHHHhcCCCcCCccc----eEEEEEEE--CCceEEEEEecc------chHHHHHHHhhc-CCCceeeeeeeee--
Q 039626          341 YSFKELQSATDNFSFTCRIQ----GSVYRGKI--NGGFAAIKKVNG------DVSKEIALLNKI-NHSNLIILSGVCF--  405 (628)
Q Consensus       341 ~~~~el~~at~~f~~~~~i~----G~Vy~g~~--~g~~vavK~~~~------~~~~E~~~l~~l-~H~nIv~l~g~~~--  405 (628)
                      +.++.+..++++|.....++    |.||+++.  .++.+|+|..+.      ++.+|+.++.++ +|+||+++++++.  
T Consensus         8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   87 (286)
T cd06638           8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKK   87 (286)
T ss_pred             EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeec
Confidence            44556666777777666664    89999988  678899998753      466799999999 6999999999985  


Q ss_pred             ---cCCeEEEEEEecCCCChHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEE
Q 039626          406 ---NEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAK  482 (628)
Q Consensus       406 ---~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~k  482 (628)
                         .++..++||||+++|+|.+++.........+++..+..++.+++.||.|||+.   +++||||||+||++++++.+|
T Consensus        88 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~k  164 (286)
T cd06638          88 DVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVK  164 (286)
T ss_pred             ccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCCCEE
Confidence               34568999999999999999865444455689999999999999999999984   599999999999999999999


Q ss_pred             EccccccccCCCCCCcceeeecccCCccccCcccccc-----CCCCcccccHHHHHHHHHHHhCCCccccccccccccHH
Q 039626          483 IANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLEN-----GLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLS  557 (628)
Q Consensus       483 l~Dfgla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~-----~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~  557 (628)
                      |+|||+++.......   ......|+..|+|||++..     ..++.++|||||||++|||++|+.|+......      
T Consensus       165 l~dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~------  235 (286)
T cd06638         165 LVDFGVSAQLTSTRL---RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPM------  235 (286)
T ss_pred             EccCCceeecccCCC---ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchh------
Confidence            999999886543211   1223468999999998853     45789999999999999999999987532110      


Q ss_pred             HHHHHHhccccchhhhccccCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 039626          558 DVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHS  617 (628)
Q Consensus       558 ~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~  617 (628)
                      ........          ...+.+  ..+......+.+++.+||+.||++||+++|+++.
T Consensus       236 ~~~~~~~~----------~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~  283 (286)
T cd06638         236 RALFKIPR----------NPPPTL--HQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH  283 (286)
T ss_pred             HHHhhccc----------cCCCcc--cCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence            11100000          000000  0111123457899999999999999999999864

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=2.6e-33  Score=279.23  Aligned_cols=247  Identities=26%  Similarity=0.338  Sum_probs=187.8

Q ss_pred             eEEEEEEE--CCceEEEEEeccc---------hHHHHHHHhhcCCCc-eeeeeeeeecCC------eEEEEEEecCCCCh
Q 039626          361 GSVYRGKI--NGGFAAIKKVNGD---------VSKEIALLNKINHSN-LIILSGVCFNEG------NCYLVYEYAVNGTL  422 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~~---------~~~E~~~l~~l~H~n-Iv~l~g~~~~~~------~~~lV~E~~~~gsL  422 (628)
                      |.||+|+.  +|+.||+|+++-+         ..+|+.+|++++|+| ||+|.+++....      .++|||||+ .-+|
T Consensus        25 g~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l~lvfe~~-d~DL  103 (323)
T KOG0594|consen   25 GVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKLYLVFEFL-DRDL  103 (323)
T ss_pred             eEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceEEEEEEee-cccH
Confidence            99999988  7899999998642         368999999999999 999999999877      789999999 5699


Q ss_pred             HHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceee
Q 039626          423 SDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALT  502 (628)
Q Consensus       423 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~  502 (628)
                      .+++.........++-..+..+..|+++||+|||+++   |+||||||.|||++++|.+||+|||+|+...-...   ..
T Consensus       104 ~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFGlAra~~ip~~---~y  177 (323)
T KOG0594|consen  104 KKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFGLARAFSIPMR---TY  177 (323)
T ss_pred             HHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccchHHHhcCCcc---cc
Confidence            9999654432245677889999999999999999955   99999999999999999999999999997653221   13


Q ss_pred             ecccCCccccCccccccC-CCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhcccc--chhhhccccCC
Q 039626          503 RHIVGTKGYMAPEYLENG-LVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKED--GEESLRHFIDP  579 (628)
Q Consensus       503 ~~~~gt~~Y~APE~l~~~-~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~l~~~~d~  579 (628)
                      .+.++|.+|.|||++.+. .|++..||||+||++.||++++..|....+.   .....+.+.+....  ....+..+.+-
T Consensus       178 t~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~---~ql~~If~~lGtP~e~~Wp~v~~~~~~  254 (323)
T KOG0594|consen  178 TPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEI---DQLFRIFRLLGTPNEKDWPGVSSLPDY  254 (323)
T ss_pred             cccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHH---HHHHHHHHHcCCCCccCCCCccccccc
Confidence            456899999999999886 7999999999999999999999887755441   12222333332221  11111111111


Q ss_pred             c--CCCCC-CHHHH-------HHHHHHHHHhcccCCCCCCCHHHHHHH
Q 039626          580 T--LQGNY-PLELA-------LLVIRLIDACLKKDPTDRPTMYEIEHS  617 (628)
Q Consensus       580 ~--l~~~~-~~~~~-------~~l~~l~~~Cl~~dP~~RPs~~ev~~~  617 (628)
                      .  .+... +....       ....+++.+|++.+|.+|.|++.++..
T Consensus       255 k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h  302 (323)
T KOG0594|consen  255 KAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH  302 (323)
T ss_pred             cccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence            1  11000 11111       367899999999999999999998864

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=1.1e-33  Score=297.11  Aligned_cols=230  Identities=26%  Similarity=0.392  Sum_probs=179.8

Q ss_pred             eEEEEEEE-----CCceEEEEEecc-----------chHHHHHHHhhc-CCCceeeeeeeeecCCeEEEEEEecCCCChH
Q 039626          361 GSVYRGKI-----NGGFAAIKKVNG-----------DVSKEIALLNKI-NHSNLIILSGVCFNEGNCYLVYEYAVNGTLS  423 (628)
Q Consensus       361 G~Vy~g~~-----~g~~vavK~~~~-----------~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~  423 (628)
                      |.||+++.     .+..+|+|.++.           .+.+|++++.++ +|+||+++++++..++..++||||+++|+|.
T Consensus        14 g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~   93 (332)
T cd05614          14 GKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMF   93 (332)
T ss_pred             EEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEEEEEeCCCCCcHH
Confidence            89999875     467899998853           245699999999 5899999999999999999999999999999


Q ss_pred             HHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeee
Q 039626          424 DWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTR  503 (628)
Q Consensus       424 ~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~  503 (628)
                      +++..    ...+++.....++.|++.||+|||+.   +++||||||+|||++.++.+||+|||+++........  ...
T Consensus        94 ~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~~~--~~~  164 (332)
T cd05614          94 THLYQ----RDNFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKE--RTY  164 (332)
T ss_pred             HHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCCccccccCCC--ccc
Confidence            99854    34589999999999999999999985   4999999999999999999999999999865332211  223


Q ss_pred             cccCCccccCccccccC-CCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCC
Q 039626          504 HIVGTKGYMAPEYLENG-LVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQ  582 (628)
Q Consensus       504 ~~~gt~~Y~APE~l~~~-~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~  582 (628)
                      ...||+.|+|||.+.+. .++.++|||||||+++||++|+.|+.......  ........+..           .++.. 
T Consensus       165 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~--~~~~~~~~~~~-----------~~~~~-  230 (332)
T cd05614         165 SFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERN--TQSEVSRRILK-----------CDPPF-  230 (332)
T ss_pred             cccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCC--CHHHHHHHHhc-----------CCCCC-
Confidence            45799999999999865 47899999999999999999999986432211  11111111111           11112 


Q ss_pred             CCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 039626          583 GNYPLELALLVIRLIDACLKKDPTDRP-----TMYEIEH  616 (628)
Q Consensus       583 ~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~ev~~  616 (628)
                         +......+.+++.+||+.||++||     +++++++
T Consensus       231 ---~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~  266 (332)
T cd05614         231 ---PSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE  266 (332)
T ss_pred             ---CCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence               223345678999999999999999     5666653

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=1.1e-33  Score=288.00  Aligned_cols=229  Identities=26%  Similarity=0.464  Sum_probs=178.0

Q ss_pred             eEEEEEEE--CCceEEEEEecc------chHHHHHHHhhc-CCCceeeeeeeeecC------CeEEEEEEecCCCChHHH
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG------DVSKEIALLNKI-NHSNLIILSGVCFNE------GNCYLVYEYAVNGTLSDW  425 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~------~~~~E~~~l~~l-~H~nIv~l~g~~~~~------~~~~lV~E~~~~gsL~~~  425 (628)
                      |.||+|..  .++.+|+|....      ++..|+.++.++ +|+||+++++++...      ...++||||+++|+|.++
T Consensus        20 g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~   99 (272)
T cd06637          20 GQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDL   99 (272)
T ss_pred             eEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEEEEEEcCCCCcHHHH
Confidence            89999988  577899998753      467899999998 799999999998753      458999999999999999


Q ss_pred             hhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecc
Q 039626          426 VFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHI  505 (628)
Q Consensus       426 l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~  505 (628)
                      +...  ....++|..+..++.|++.||+|||+.   +++|+||||+||++++++.+||+|||+++.......   .....
T Consensus       100 l~~~--~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~~~~~---~~~~~  171 (272)
T cd06637         100 IKNT--KGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVG---RRNTF  171 (272)
T ss_pred             HHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccCCCceecccccc---cCCcc
Confidence            8542  234689999999999999999999984   599999999999999999999999999886543211   12335


Q ss_pred             cCCccccCccccc-----cCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCc
Q 039626          506 VGTKGYMAPEYLE-----NGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPT  580 (628)
Q Consensus       506 ~gt~~Y~APE~l~-----~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~  580 (628)
                      .|+..|+|||++.     +..++.++|||||||++|||++|+.|+......     .... ....     ..     .+.
T Consensus       172 ~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~-----~~~~-~~~~-----~~-----~~~  235 (272)
T cd06637         172 IGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM-----RALF-LIPR-----NP-----APR  235 (272)
T ss_pred             cccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHH-----HHHH-HHhc-----CC-----CCC
Confidence            6899999999986     346788999999999999999999987532111     1110 0000     00     000


Q ss_pred             CCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          581 LQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       581 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      .   .+...+..+.+++.+||..||.+||+++|+++
T Consensus       236 ~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  268 (272)
T cd06637         236 L---KSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK  268 (272)
T ss_pred             C---CCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence            0   11123345789999999999999999999875

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-33  Score=309.29  Aligned_cols=239  Identities=21%  Similarity=0.340  Sum_probs=189.1

Q ss_pred             eEEEEEEE-CC-ceEEEEEecc-------chHHHHHHHhhcC-CCceeeeeee-eecC------CeEEEEEEecCCCChH
Q 039626          361 GSVYRGKI-NG-GFAAIKKVNG-------DVSKEIALLNKIN-HSNLIILSGV-CFNE------GNCYLVYEYAVNGTLS  423 (628)
Q Consensus       361 G~Vy~g~~-~g-~~vavK~~~~-------~~~~E~~~l~~l~-H~nIv~l~g~-~~~~------~~~~lV~E~~~~gsL~  423 (628)
                      +.||.+.. .+ ..+|+|++..       .+.+|+++|++|+ |+|||.+++. ....      -+.+|.||||.||+|-
T Consensus        51 a~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~EvllLmEyC~gg~Lv  130 (738)
T KOG1989|consen   51 AQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEVLLLMEYCKGGSLV  130 (738)
T ss_pred             EEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEEEeehhhccCCcHH
Confidence            78999999 34 7999999853       3678999999997 9999999993 3221      2679999999999999


Q ss_pred             HHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCC-Cc--ce
Q 039626          424 DWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQE-GE--FA  500 (628)
Q Consensus       424 ~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~-~~--~~  500 (628)
                      |++..+...  .|++.++++|+.|+++|+.+||... ++|||||||-+||||+.++..||||||.+...-... ..  ..
T Consensus       131 d~mn~Rlq~--~lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLCDFGSatt~~~~~~~~~e~~  207 (738)
T KOG1989|consen  131 DFMNTRLQT--RLTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLCDFGSATTKILSPTSAQEVN  207 (738)
T ss_pred             HHHHHHHhc--cCChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeCcccccccccCCCccHHHHH
Confidence            999654333  3999999999999999999999986 999999999999999999999999999987542221 10  00


Q ss_pred             -eee--cccCCccccCcccc---ccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhc
Q 039626          501 -LTR--HIVGTKGYMAPEYL---ENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLR  574 (628)
Q Consensus       501 -~~~--~~~gt~~Y~APE~l---~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  574 (628)
                       ...  ...-|+-|+|||.+   .+..+++|+|||||||+||-|+-...||+....                       .
T Consensus       208 ~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~-----------------------l  264 (738)
T KOG1989|consen  208 YVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK-----------------------L  264 (738)
T ss_pred             HHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc-----------------------e
Confidence             001  12468899999977   467899999999999999999999999873211                       1


Q ss_pred             cccCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhc
Q 039626          575 HFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNAS  625 (628)
Q Consensus       575 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~~~~  625 (628)
                      .+++....-.-.......+.+||+.||+.||.+||++-+|+..+.+|.+..
T Consensus       265 aIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~  315 (738)
T KOG1989|consen  265 AILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKP  315 (738)
T ss_pred             eEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCC
Confidence            112222211112367788999999999999999999999999999988654

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-34  Score=287.00  Aligned_cols=243  Identities=29%  Similarity=0.403  Sum_probs=187.1

Q ss_pred             ceEEEEEEE--CCceEEEEEeccc---------hHHHHHHHhhcCCCceeeeeeeeec-----CCeEEEEEEecCCCChH
Q 039626          360 QGSVYRGKI--NGGFAAIKKVNGD---------VSKEIALLNKINHSNLIILSGVCFN-----EGNCYLVYEYAVNGTLS  423 (628)
Q Consensus       360 ~G~Vy~g~~--~g~~vavK~~~~~---------~~~E~~~l~~l~H~nIv~l~g~~~~-----~~~~~lV~E~~~~gsL~  423 (628)
                      .|.|+.++.  +|+.|||||+.+-         ..+|+++|+.++|+||+.+++.+.-     -...|+|+|+| .-+|.
T Consensus        35 yGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~elM-etDL~  113 (359)
T KOG0660|consen   35 YGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFELM-ETDLH  113 (359)
T ss_pred             eeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEehhHH-hhHHH
Confidence            389999988  7899999999753         3479999999999999999999875     24689999999 66999


Q ss_pred             HHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeee
Q 039626          424 DWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTR  503 (628)
Q Consensus       424 ~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~  503 (628)
                      +.++    .+..|+.....-+..|+++||.|+|+.+   ++|||+||+|+|++.+...||+|||+||..... ......+
T Consensus       114 ~iik----~~~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~-~~~~~mT  185 (359)
T KOG0660|consen  114 QIIK----SQQDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGLARYLDKF-FEDGFMT  185 (359)
T ss_pred             HHHH----cCccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEeccccceeecccc-Ccccchh
Confidence            9884    3445888999999999999999999965   999999999999999999999999999988543 2222345


Q ss_pred             cccCCccccCccccc-cCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhcccc-----
Q 039626          504 HIVGTKGYMAPEYLE-NGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFI-----  577 (628)
Q Consensus       504 ~~~gt~~Y~APE~l~-~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~-----  577 (628)
                      ..+.|.+|.|||.+. ...|+...||||.||++.||++|++.|.+.+.-   .....+..++.... .+.+..+-     
T Consensus       186 eYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v---~Ql~lI~~~lGtP~-~e~l~~i~s~~ar  261 (359)
T KOG0660|consen  186 EYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYV---HQLQLILELLGTPS-EEDLQKIRSEKAR  261 (359)
T ss_pred             cceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchH---HHHHHHHHhcCCCC-HHHHHHhccHHHH
Confidence            678999999999875 468999999999999999999999888754432   22223333332221 11111111     


Q ss_pred             ---C--CcC-C----CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          578 ---D--PTL-Q----GNYPLELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       578 ---d--~~l-~----~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                         .  |.. +    .-+| .......+|+.+||..||.+|+|++|+++
T Consensus       262 ~yi~slp~~p~~~f~~~fp-~a~p~AidLlekmL~fdP~kRita~eAL~  309 (359)
T KOG0660|consen  262 PYIKSLPQIPKQPFSSIFP-NANPLAIDLLEKMLVFDPKKRITAEEALA  309 (359)
T ss_pred             HHHHhCCCCCCCCHHHHcC-CCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence               1  000 0    0112 23446789999999999999999999875

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.1e-34  Score=302.99  Aligned_cols=229  Identities=26%  Similarity=0.419  Sum_probs=188.7

Q ss_pred             cCCCcCCccc----eEEEEEEE--CCceEEEEEeccc----------hHHHHHHHhhc-CCCceeeeeeeeecCCeEEEE
Q 039626          351 DNFSFTCRIQ----GSVYRGKI--NGGFAAIKKVNGD----------VSKEIALLNKI-NHSNLIILSGVCFNEGNCYLV  413 (628)
Q Consensus       351 ~~f~~~~~i~----G~Vy~g~~--~g~~vavK~~~~~----------~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV  413 (628)
                      ++|.....+|    |+|+.+.+  +++.+|||.++++          .+.|.+++.-. +||.+++++.++...++.|+|
T Consensus       368 ~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fv  447 (694)
T KOG0694|consen  368 DDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFV  447 (694)
T ss_pred             cceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEE
Confidence            3454433343    99999998  6789999999863          34577777776 599999999999999999999


Q ss_pred             EEecCCCChHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCC
Q 039626          414 YEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAE  493 (628)
Q Consensus       414 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~  493 (628)
                      |||+.||++..+.+     ...+++....-++..|+.||+|||+.   +|||||||.+|||||.+|.+||+|||+++..-
T Consensus       448 mey~~Ggdm~~~~~-----~~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m  519 (694)
T KOG0694|consen  448 MEYVAGGDLMHHIH-----TDVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGLCKEGM  519 (694)
T ss_pred             EEecCCCcEEEEEe-----cccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEecccccccccC
Confidence            99999999665552     34589999999999999999999994   59999999999999999999999999998653


Q ss_pred             CCCCcceeeecccCCccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhh
Q 039626          494 GQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESL  573 (628)
Q Consensus       494 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  573 (628)
                      ...   ..+....||+.|||||++.+..|+...|.|||||+||||+.|..||...++++      ++..++.        
T Consensus       520 ~~g---~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee------~FdsI~~--------  582 (694)
T KOG0694|consen  520 GQG---DRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEE------VFDSIVN--------  582 (694)
T ss_pred             CCC---CccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHH------HHHHHhc--------
Confidence            222   24677899999999999999999999999999999999999999998655432      1222211        


Q ss_pred             ccccCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCH
Q 039626          574 RHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTM  611 (628)
Q Consensus       574 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~  611 (628)
                           .  ...||..++.+..++++++|.++|++|.-+
T Consensus       583 -----d--~~~yP~~ls~ea~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  583 -----D--EVRYPRFLSKEAIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             -----C--CCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence                 1  124677788889999999999999999877

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=2.2e-33  Score=290.14  Aligned_cols=228  Identities=24%  Similarity=0.389  Sum_probs=183.5

Q ss_pred             eEEEEEEE--CCceEEEEEecc-------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhcCC
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG-------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKN  431 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~-------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~  431 (628)
                      |.||+|..  +++.+|+|.+..       .+.+|+.++++++|+||+++++.+..+...++||||+++++|.+++..   
T Consensus        34 ~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~---  110 (296)
T cd06654          34 GTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE---  110 (296)
T ss_pred             eEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecccCCCCHHHHHHh---
Confidence            89999987  678999998853       356799999999999999999999999999999999999999999842   


Q ss_pred             CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCCccc
Q 039626          432 EGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGY  511 (628)
Q Consensus       432 ~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~Y  511 (628)
                        ..+++.++..++.|++.||+|||+.   +++|+||||+||+++.++.+||+|||++........   ......+++.|
T Consensus       111 --~~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~~y  182 (296)
T cd06654         111 --TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS---KRSTMVGTPYW  182 (296)
T ss_pred             --cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhcccccc---ccCcccCCccc
Confidence              3478999999999999999999984   499999999999999999999999999886543221   12234688999


Q ss_pred             cCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCHHHHH
Q 039626          512 MAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELAL  591 (628)
Q Consensus       512 ~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~  591 (628)
                      +|||.+.+..++.++|||||||+++||++|+.||......     ..... ....            .......+.....
T Consensus       183 ~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~-----~~~~~-~~~~------------~~~~~~~~~~~~~  244 (296)
T cd06654         183 MAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL-----RALYL-IATN------------GTPELQNPEKLSA  244 (296)
T ss_pred             cCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHH-----HhHHH-HhcC------------CCCCCCCccccCH
Confidence            9999999888999999999999999999999998633211     11110 1000            0000112234455


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHHH
Q 039626          592 LVIRLIDACLKKDPTDRPTMYEIEHS  617 (628)
Q Consensus       592 ~l~~l~~~Cl~~dP~~RPs~~ev~~~  617 (628)
                      .+.+++.+||..||++||++.|+++.
T Consensus       245 ~l~~li~~~l~~~p~~Rpt~~eil~~  270 (296)
T cd06654         245 IFRDFLNRCLDMDVEKRGSAKELLQH  270 (296)
T ss_pred             HHHHHHHHHCcCCcccCcCHHHHhhC
Confidence            68899999999999999999999873

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=8.5e-34  Score=296.64  Aligned_cols=221  Identities=25%  Similarity=0.351  Sum_probs=175.2

Q ss_pred             eEEEEEEE--CCceEEEEEeccc----------hHHHH-HHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhh
Q 039626          361 GSVYRGKI--NGGFAAIKKVNGD----------VSKEI-ALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVF  427 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~~----------~~~E~-~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~  427 (628)
                      |.||+++.  +++.+|+|.+...          +..|. .+++.++|+||+++++++.+.+..++||||+++|+|.+++.
T Consensus         9 g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~   88 (321)
T cd05603           9 GKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQ   88 (321)
T ss_pred             EEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCCCCHHHHHH
Confidence            89999998  6789999988531          23343 46788999999999999999999999999999999998884


Q ss_pred             hcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccC
Q 039626          428 SNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVG  507 (628)
Q Consensus       428 ~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~g  507 (628)
                      .    ...+++.....++.||+.||+|||+.   +++||||||+||+++.++.+||+|||+++.......   ......|
T Consensus        89 ~----~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~g  158 (321)
T cd05603          89 R----ERCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE---TTSTFCG  158 (321)
T ss_pred             H----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCC---ccccccC
Confidence            3    34578888899999999999999984   599999999999999999999999999875422211   2234578


Q ss_pred             CccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCH
Q 039626          508 TKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPL  587 (628)
Q Consensus       508 t~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~  587 (628)
                      |+.|+|||.+.+..++.++|||||||++|||++|+.|+.....      ......+....               ...+.
T Consensus       159 t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~~~~~~i~~~~---------------~~~~~  217 (321)
T cd05603         159 TPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDV------SQMYDNILHKP---------------LQLPG  217 (321)
T ss_pred             CcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCH------HHHHHHHhcCC---------------CCCCC
Confidence            9999999999998999999999999999999999999864321      11222211110               01122


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCCHH
Q 039626          588 ELALLVIRLIDACLKKDPTDRPTMY  612 (628)
Q Consensus       588 ~~~~~l~~l~~~Cl~~dP~~RPs~~  612 (628)
                      .....+.+++.+||+.||.+||+..
T Consensus       218 ~~~~~~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         218 GKTVAACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             CCCHHHHHHHHHHccCCHhhcCCCC
Confidence            3345678999999999999999864

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=1.6e-33  Score=289.55  Aligned_cols=236  Identities=26%  Similarity=0.434  Sum_probs=183.8

Q ss_pred             eEEEEEEE-------CCceEEEEEecc--------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHH
Q 039626          361 GSVYRGKI-------NGGFAAIKKVNG--------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDW  425 (628)
Q Consensus       361 G~Vy~g~~-------~g~~vavK~~~~--------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~  425 (628)
                      |.||+++.       .+..+|+|.+..        ++.+|+.++++++|+||+++++++.++...++||||+++|+|.++
T Consensus        19 g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~   98 (288)
T cd05050          19 GRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEF   98 (288)
T ss_pred             ccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccEEEEecCCCCCHHHH
Confidence            89999986       356889998753        366799999999999999999999999999999999999999999


Q ss_pred             hhhcCC------------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEcccc
Q 039626          426 VFSNKN------------------EGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFA  487 (628)
Q Consensus       426 l~~~~~------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfg  487 (628)
                      +.....                  ....+++..++.++.+++.||+|||+   .+++||||||+||++++++.+||+|||
T Consensus        99 l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg  175 (288)
T cd05050          99 LRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFG  175 (288)
T ss_pred             HHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---CCeecccccHhheEecCCCceEECccc
Confidence            964321                  12347899999999999999999998   459999999999999999999999999


Q ss_pred             ccccCCCCCCcceeeecccCCccccCccccccCCCCcccccHHHHHHHHHHHh-CCCccccccccccccHHHHHHHHhcc
Q 039626          488 MARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT-GKEAAALHAEENNMHLSDVLNAVLTK  566 (628)
Q Consensus       488 la~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELlt-G~~p~~~~~~~~~~~~~~~~~~~~~~  566 (628)
                      +++........ ........+..|+|||.+.+..++.++|||||||++|||++ |..|+.....      .+........
T Consensus       176 ~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~------~~~~~~~~~~  248 (288)
T cd05050         176 LSRNIYSADYY-KASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAH------EEVIYYVRDG  248 (288)
T ss_pred             cceecccCccc-cccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH------HHHHHHHhcC
Confidence            98765322111 11122345667999999998999999999999999999998 7767642211      1222111110


Q ss_pred             ccchhhhccccCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 039626          567 EDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSN  620 (628)
Q Consensus       567 ~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~  620 (628)
                      .             . ...+...+..+.+++.+||+.||.+||++.|+++.|++
T Consensus       249 ~-------------~-~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~  288 (288)
T cd05050         249 N-------------V-LSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR  288 (288)
T ss_pred             C-------------C-CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence            0             0 01122334568899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=2e-33  Score=287.85  Aligned_cols=236  Identities=24%  Similarity=0.446  Sum_probs=184.2

Q ss_pred             eEEEEEEE-------CCceEEEEEecc-------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHh
Q 039626          361 GSVYRGKI-------NGGFAAIKKVNG-------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWV  426 (628)
Q Consensus       361 G~Vy~g~~-------~g~~vavK~~~~-------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l  426 (628)
                      |.||++..       ++..+|+|..+.       ++.+|++++++++|+||+++++++.+.+..+++|||+++|+|.+++
T Consensus        19 g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i   98 (280)
T cd05092          19 GKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFL   98 (280)
T ss_pred             CeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEEEEecCCCCCHHHHH
Confidence            89999964       345788988763       5778999999999999999999999999999999999999999999


Q ss_pred             hhcCC-----------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCC
Q 039626          427 FSNKN-----------EGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQ  495 (628)
Q Consensus       427 ~~~~~-----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~  495 (628)
                      .....           ....++|..++.++.|++.||+|||+.   +++||||||+|||+++++.+||+|||+++.....
T Consensus        99 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~  175 (280)
T cd05092          99 RSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYST  175 (280)
T ss_pred             HhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcCCCCEEECCCCceeEcCCC
Confidence            65321           113589999999999999999999984   5999999999999999999999999998765432


Q ss_pred             CCcceeeecccCCccccCccccccCCCCcccccHHHHHHHHHHHh-CCCccccccccccccHHHHHHHHhccccchhhhc
Q 039626          496 EGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT-GKEAAALHAEENNMHLSDVLNAVLTKEDGEESLR  574 (628)
Q Consensus       496 ~~~~~~~~~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELlt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  574 (628)
                      .. ........+++.|+|||++.+..++.++||||||++++||++ |+.|+.....      .+........        
T Consensus       176 ~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~------~~~~~~~~~~--------  240 (280)
T cd05092         176 DY-YRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSN------TEAIECITQG--------  240 (280)
T ss_pred             ce-eecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCH------HHHHHHHHcC--------
Confidence            21 111222345678999999999999999999999999999998 8887653211      1111111110        


Q ss_pred             cccCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 039626          575 HFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSN  620 (628)
Q Consensus       575 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~  620 (628)
                        ...    ..+...+..+.+++.+||+.||.+||+++||.+.|++
T Consensus       241 --~~~----~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~  280 (280)
T cd05092         241 --REL----ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA  280 (280)
T ss_pred             --ccC----CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence              000    1112234557899999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=1.3e-33  Score=300.33  Aligned_cols=180  Identities=22%  Similarity=0.313  Sum_probs=155.8

Q ss_pred             eEEEEEEE--CCceEEEEEecc----------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhh
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG----------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFS  428 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  428 (628)
                      |.||++..  +++.+|+|.++.          .+.+|+.++.+++|+||+++++.+.++...++||||+++|+|.+++..
T Consensus        15 g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~   94 (363)
T cd05628          15 GEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMK   94 (363)
T ss_pred             EEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEcCCCCCcHHHHHHh
Confidence            89999987  578999999864          255799999999999999999999999999999999999999999954


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCc----------
Q 039626          429 NKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGE----------  498 (628)
Q Consensus       429 ~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~----------  498 (628)
                          ...+++.....++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++........          
T Consensus        95 ----~~~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~  167 (363)
T cd05628          95 ----KDTLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSL  167 (363)
T ss_pred             ----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCcccccccccccccccccccc
Confidence                34589999999999999999999984   5999999999999999999999999998765321100          


Q ss_pred             ----------------------ceeeecccCCccccCccccccCCCCcccccHHHHHHHHHHHhCCCcccc
Q 039626          499 ----------------------FALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAAL  547 (628)
Q Consensus       499 ----------------------~~~~~~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~  547 (628)
                                            ........||+.|+|||.+.+..++.++|||||||++|||++|+.||..
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~  238 (363)
T cd05628         168 PSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCS  238 (363)
T ss_pred             cccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCC
Confidence                                  0001234799999999999999999999999999999999999999864

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=1.3e-33  Score=307.25  Aligned_cols=254  Identities=23%  Similarity=0.352  Sum_probs=184.2

Q ss_pred             cCCCcCCccc----eEEEEEEE--CCceEEEEEeccc---hHHHHHHHhhcCCCceeeeeeeeecC--------CeEEEE
Q 039626          351 DNFSFTCRIQ----GSVYRGKI--NGGFAAIKKVNGD---VSKEIALLNKINHSNLIILSGVCFNE--------GNCYLV  413 (628)
Q Consensus       351 ~~f~~~~~i~----G~Vy~g~~--~g~~vavK~~~~~---~~~E~~~l~~l~H~nIv~l~g~~~~~--------~~~~lV  413 (628)
                      .+|.....+|    |.||+|..  .++.||||++..+   ..+|+.+|++++|+||+++.+++...        ...++|
T Consensus        66 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~lv  145 (440)
T PTZ00036         66 KSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVV  145 (440)
T ss_pred             CeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCcchHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEEEE
Confidence            3455444443    89999988  6789999988643   45799999999999999999887532        246799


Q ss_pred             EEecCCCChHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCC-cEEEccccccccC
Q 039626          414 YEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDL-RAKIANFAMARPA  492 (628)
Q Consensus       414 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~-~~kl~Dfgla~~~  492 (628)
                      |||++ ++|.+++.........+++.....++.|++.||+|||+.   +|+||||||+|||++.++ .+||+|||+++..
T Consensus       146 mE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~DFGla~~~  221 (440)
T PTZ00036        146 MEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCDFGSAKNL  221 (440)
T ss_pred             EecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeeccccchhc
Confidence            99996 578887755444556799999999999999999999985   499999999999999665 7999999999866


Q ss_pred             CCCCCcceeeecccCCccccCcccccc-CCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchh
Q 039626          493 EGQEGEFALTRHIVGTKGYMAPEYLEN-GLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEE  571 (628)
Q Consensus       493 ~~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  571 (628)
                      .....    .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||.......  .+...+ ..+.... .+
T Consensus       222 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~--~~~~i~-~~~~~p~-~~  293 (440)
T PTZ00036        222 LAGQR----SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVD--QLVRII-QVLGTPT-ED  293 (440)
T ss_pred             cCCCC----cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHH-HHhCCCC-HH
Confidence            43221    223468999999998865 468999999999999999999999986432211  111111 1111110 01


Q ss_pred             hhcc----ccC--------CcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          572 SLRH----FID--------PTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       572 ~l~~----~~d--------~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      .+..    +.+        ..+...+|...+..+.+|+.+||+.||.+|||+.|+++
T Consensus       294 ~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~  350 (440)
T PTZ00036        294 QLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA  350 (440)
T ss_pred             HHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence            0000    000        01111122233456889999999999999999999873

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=7.2e-34  Score=302.81  Aligned_cols=245  Identities=22%  Similarity=0.280  Sum_probs=185.7

Q ss_pred             HHHHhcCCCcCCccc----eEEEEEEE--CCceEEEEEecc----------chHHHHHHHhhcCCCceeeeeeeeecCCe
Q 039626          346 LQSATDNFSFTCRIQ----GSVYRGKI--NGGFAAIKKVNG----------DVSKEIALLNKINHSNLIILSGVCFNEGN  409 (628)
Q Consensus       346 l~~at~~f~~~~~i~----G~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~  409 (628)
                      +....++|.....+|    |.||+++.  +++.+|+|.+..          .+.+|+.+++.++||||+++++++.+++.
T Consensus        38 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~  117 (370)
T cd05621          38 LQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKY  117 (370)
T ss_pred             cCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCE
Confidence            333445666555554    89999998  577899998753          25579999999999999999999999999


Q ss_pred             EEEEEEecCCCChHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEcccccc
Q 039626          410 CYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMA  489 (628)
Q Consensus       410 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla  489 (628)
                      .++||||+++|+|.+++..     ..+++.....++.|++.||+|||+.   +|+||||||+|||+++++.+||+|||++
T Consensus       118 ~~lv~Ey~~gg~L~~~l~~-----~~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~a  189 (370)
T cd05621         118 LYMVMEYMPGGDLVNLMSN-----YDVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTC  189 (370)
T ss_pred             EEEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEecccc
Confidence            9999999999999999843     2478889999999999999999984   5999999999999999999999999999


Q ss_pred             ccCCCCCCcceeeecccCCccccCccccccC----CCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhc
Q 039626          490 RPAEGQEGEFALTRHIVGTKGYMAPEYLENG----LVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLT  565 (628)
Q Consensus       490 ~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~----~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~  565 (628)
                      +.......  .......||+.|+|||.+.+.    .++.++|||||||++|||++|+.||.....      ......+..
T Consensus       190 ~~~~~~~~--~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~------~~~~~~i~~  261 (370)
T cd05621         190 MKMDETGM--VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSL------VGTYSKIMD  261 (370)
T ss_pred             eecccCCc--eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCH------HHHHHHHHh
Confidence            87643211  112345799999999998753    378999999999999999999999864321      111112111


Q ss_pred             cccchhhhccccCCcCCCCCCHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 039626          566 KEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTD--RPTMYEIEHS  617 (628)
Q Consensus       566 ~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPs~~ev~~~  617 (628)
                      ...           .+........+..+.+++.+|+..++.+  |+++.|+++.
T Consensus       262 ~~~-----------~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h  304 (370)
T cd05621         262 HKN-----------SLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH  304 (370)
T ss_pred             CCc-----------ccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence            100           0000011123456778999999855543  8899888763

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=2.4e-33  Score=292.55  Aligned_cols=223  Identities=27%  Similarity=0.403  Sum_probs=176.5

Q ss_pred             ceEEEEEEE--CCceEEEEEeccc----------hHHHHHHHhh-cCCCceeeeeeeeecCCeEEEEEEecCCCChHHHh
Q 039626          360 QGSVYRGKI--NGGFAAIKKVNGD----------VSKEIALLNK-INHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWV  426 (628)
Q Consensus       360 ~G~Vy~g~~--~g~~vavK~~~~~----------~~~E~~~l~~-l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l  426 (628)
                      .|.||+++.  +++.||+|.++.+          ...|..++.. .+|+||+++++++..++..++||||+++|+|.+++
T Consensus         8 ~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~gg~L~~~~   87 (316)
T cd05592           8 FGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHI   87 (316)
T ss_pred             CeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCCcHHHHH
Confidence            389999998  5678999988642          2345566654 48999999999999999999999999999999988


Q ss_pred             hhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeeccc
Q 039626          427 FSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIV  506 (628)
Q Consensus       427 ~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~  506 (628)
                      ..    ...+++.....++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++......   .......
T Consensus        88 ~~----~~~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~---~~~~~~~  157 (316)
T cd05592          88 QS----SGRFDEARARFYAAEIICGLQFLHK---KGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE---GKASTFC  157 (316)
T ss_pred             HH----cCCCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC---Ccccccc
Confidence            53    2358899999999999999999999   459999999999999999999999999997643222   1223457


Q ss_pred             CCccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCC
Q 039626          507 GTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYP  586 (628)
Q Consensus       507 gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~  586 (628)
                      ||+.|+|||.+.+..++.++|||||||+++||++|+.|+.....      .+....+...           .+    .++
T Consensus       158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~------~~~~~~i~~~-----------~~----~~~  216 (316)
T cd05592         158 GTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDE------DELFDSILND-----------RP----HFP  216 (316)
T ss_pred             CCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCH------HHHHHHHHcC-----------CC----CCC
Confidence            99999999999998999999999999999999999999864321      1111111110           01    122


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCCHHH
Q 039626          587 LELALLVIRLIDACLKKDPTDRPTMYE  613 (628)
Q Consensus       587 ~~~~~~l~~l~~~Cl~~dP~~RPs~~e  613 (628)
                      ......+.+++.+||+.||.+||++.+
T Consensus       217 ~~~~~~~~~ll~~~l~~~P~~R~~~~~  243 (316)
T cd05592         217 RWISKEAKDCLSKLFERDPTKRLGVDG  243 (316)
T ss_pred             CCCCHHHHHHHHHHccCCHHHcCCChH
Confidence            233455789999999999999999753

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=2.1e-33  Score=293.37  Aligned_cols=225  Identities=27%  Similarity=0.381  Sum_probs=180.2

Q ss_pred             eEEEEEEE--CCceEEEEEeccc----------hHHHHHHHhhc-CCCceeeeeeeeecCCeEEEEEEecCCCChHHHhh
Q 039626          361 GSVYRGKI--NGGFAAIKKVNGD----------VSKEIALLNKI-NHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVF  427 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~~----------~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~  427 (628)
                      |.||+++.  +++.+|+|.++.+          +..|..++..+ +|+||+++++++.+.+..++||||+++|+|.+++.
T Consensus         9 g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~   88 (318)
T cd05570           9 GKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQ   88 (318)
T ss_pred             eEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCCCHHHHHH
Confidence            89999998  5678999988642          34678888877 79999999999999999999999999999999885


Q ss_pred             hcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccC
Q 039626          428 SNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVG  507 (628)
Q Consensus       428 ~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~g  507 (628)
                      .    ...+++..+..++.|++.||.|||+.   +++||||||+|||+++++.+||+|||+++.......   ......|
T Consensus        89 ~----~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~g  158 (318)
T cd05570          89 R----SGRFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV---TTSTFCG  158 (318)
T ss_pred             H----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC---cccceec
Confidence            3    23589999999999999999999984   599999999999999999999999999875322111   1233468


Q ss_pred             CccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCH
Q 039626          508 TKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPL  587 (628)
Q Consensus       508 t~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~  587 (628)
                      ++.|+|||.+.+..++.++|||||||+++||++|+.||.....      ..........           ..    .++.
T Consensus       159 ~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~------~~~~~~i~~~-----------~~----~~~~  217 (318)
T cd05570         159 TPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDE------DELFQSILED-----------EV----RYPR  217 (318)
T ss_pred             CccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCH------HHHHHHHHcC-----------CC----CCCC
Confidence            9999999999999999999999999999999999999864321      1111111110           00    1222


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCCH-----HHHHH
Q 039626          588 ELALLVIRLIDACLKKDPTDRPTM-----YEIEH  616 (628)
Q Consensus       588 ~~~~~l~~l~~~Cl~~dP~~RPs~-----~ev~~  616 (628)
                      ..+..+.+++.+||+.||.+||++     .++++
T Consensus       218 ~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~  251 (318)
T cd05570         218 WLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG  251 (318)
T ss_pred             cCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence            334567899999999999999999     66653

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.6e-33  Score=288.30  Aligned_cols=250  Identities=23%  Similarity=0.382  Sum_probs=188.2

Q ss_pred             eEEEEEEEC------CceEEEEEecc--------chHHHHHHHhhcCCCceeeeeeeeec--CCeEEEEEEecCCCChHH
Q 039626          361 GSVYRGKIN------GGFAAIKKVNG--------DVSKEIALLNKINHSNLIILSGVCFN--EGNCYLVYEYAVNGTLSD  424 (628)
Q Consensus       361 G~Vy~g~~~------g~~vavK~~~~--------~~~~E~~~l~~l~H~nIv~l~g~~~~--~~~~~lV~E~~~~gsL~~  424 (628)
                      |.||+++++      +..+|+|.++.        ++.+|++++++++|+||+++++++..  +...++||||+++++|.+
T Consensus        18 ~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~   97 (284)
T cd05038          18 GKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRD   97 (284)
T ss_pred             eeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceEEEEecCCCCCHHH
Confidence            899999873      56899998853        36789999999999999999999987  557899999999999999


Q ss_pred             HhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeec
Q 039626          425 WVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRH  504 (628)
Q Consensus       425 ~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~  504 (628)
                      ++...   ...++|..+..++.+++.||+|||+.   +++|+||||+||+++.++.+||+|||++...............
T Consensus        98 ~l~~~---~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~  171 (284)
T cd05038          98 YLQRH---RDQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEP  171 (284)
T ss_pred             HHHhC---ccccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccccccccccCCcceeccCC
Confidence            99543   23599999999999999999999984   5999999999999999999999999999877533222222222


Q ss_pred             ccCCccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCC
Q 039626          505 IVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGN  584 (628)
Q Consensus       505 ~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~  584 (628)
                      ..++..|++||.+.+..++.++||||||++++||++|+.|+............    . .........+...+.......
T Consensus       172 ~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~----~-~~~~~~~~~~~~~~~~~~~~~  246 (284)
T cd05038         172 GESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIG----I-AQGQMIVTRLLELLKEGERLP  246 (284)
T ss_pred             CCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccc----c-ccccccHHHHHHHHHcCCcCC
Confidence            34566799999999889999999999999999999999886532211100000    0 000000011111111111111


Q ss_pred             CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 039626          585 YPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNI  621 (628)
Q Consensus       585 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l  621 (628)
                      .+...+..+.+++.+||+.+|.+||++.||++.|+++
T Consensus       247 ~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i  283 (284)
T cd05038         247 RPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL  283 (284)
T ss_pred             CCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence            2223446688999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=3.9e-34  Score=300.34  Aligned_cols=230  Identities=23%  Similarity=0.299  Sum_probs=181.4

Q ss_pred             eEEEEEEE--CCceEEEEEecc----------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhh
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG----------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFS  428 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  428 (628)
                      |.||+++.  +|+.+|+|+++.          .+.+|+.+++.++|+||+++++++.+++..++||||+++|+|.+++..
T Consensus        15 g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   94 (330)
T cd05601          15 GEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNR   94 (330)
T ss_pred             EEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEECCCCCCCHHHHHHH
Confidence            89999987  688999999864          255789999999999999999999999999999999999999999954


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCC
Q 039626          429 NKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGT  508 (628)
Q Consensus       429 ~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt  508 (628)
                      .   ...+++.....++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++.......  .......||
T Consensus        95 ~---~~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~--~~~~~~~gt  166 (330)
T cd05601          95 Y---EDQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM--VNSKLPVGT  166 (330)
T ss_pred             h---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeECCCCCc--eeeecccCC
Confidence            3   24589999999999999999999984   599999999999999999999999999987643221  122335799


Q ss_pred             ccccCccccc------cCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCC
Q 039626          509 KGYMAPEYLE------NGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQ  582 (628)
Q Consensus       509 ~~Y~APE~l~------~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~  582 (628)
                      +.|+|||++.      ...++.++|||||||++|||++|+.||.....      ......+....       ....  ..
T Consensus       167 ~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~------~~~~~~i~~~~-------~~~~--~~  231 (330)
T cd05601         167 PDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTS------AKTYNNIMNFQ-------RFLK--FP  231 (330)
T ss_pred             ccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCH------HHHHHHHHcCC-------CccC--CC
Confidence            9999999986      45678999999999999999999999863221      11122221110       0000  00


Q ss_pred             CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          583 GNYPLELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       583 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                        .....+..+.+++.+|+. +|.+||++.+++.
T Consensus       232 --~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~  262 (330)
T cd05601         232 --EDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC  262 (330)
T ss_pred             --CCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence              011234557889999998 9999999998864

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=2.8e-33  Score=292.13  Aligned_cols=225  Identities=29%  Similarity=0.414  Sum_probs=178.4

Q ss_pred             ceEEEEEEE--CCceEEEEEeccc----------hHHHHHHHhh-cCCCceeeeeeeeecCCeEEEEEEecCCCChHHHh
Q 039626          360 QGSVYRGKI--NGGFAAIKKVNGD----------VSKEIALLNK-INHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWV  426 (628)
Q Consensus       360 ~G~Vy~g~~--~g~~vavK~~~~~----------~~~E~~~l~~-l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l  426 (628)
                      .|.||+|..  .++.+|+|.++.+          ...|..++.. ++||||+++++++.+++..++||||+++|+|.+++
T Consensus         8 ~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~g~L~~~l   87 (316)
T cd05619           8 FGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNGGDLMFHI   87 (316)
T ss_pred             CEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCCCcHHHHH
Confidence            389999998  5678999988643          3347777776 49999999999999999999999999999999998


Q ss_pred             hhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeeccc
Q 039626          427 FSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIV  506 (628)
Q Consensus       427 ~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~  506 (628)
                      ..    ...+++.+...++.|++.||+|||+.   +++||||||+|||++.++.+||+|||+++.......   ......
T Consensus        88 ~~----~~~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~  157 (316)
T cd05619          88 QS----CHKFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA---KTCTFC  157 (316)
T ss_pred             HH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC---ceeeec
Confidence            43    34589999999999999999999984   599999999999999999999999999875322111   123457


Q ss_pred             CCccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCC
Q 039626          507 GTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYP  586 (628)
Q Consensus       507 gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~  586 (628)
                      ||+.|+|||.+.+..++.++|||||||++|||++|+.|+.....      .+....+...           .+.    ++
T Consensus       158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~------~~~~~~i~~~-----------~~~----~~  216 (316)
T cd05619         158 GTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDE------EELFQSIRMD-----------NPC----YP  216 (316)
T ss_pred             CCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCH------HHHHHHHHhC-----------CCC----CC
Confidence            99999999999998999999999999999999999999864321      1111111100           011    12


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCCHH-HHH
Q 039626          587 LELALLVIRLIDACLKKDPTDRPTMY-EIE  615 (628)
Q Consensus       587 ~~~~~~l~~l~~~Cl~~dP~~RPs~~-ev~  615 (628)
                      ......+.+++.+||+.||.+||++. ++.
T Consensus       217 ~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  246 (316)
T cd05619         217 RWLTREAKDILVKLFVREPERRLGVKGDIR  246 (316)
T ss_pred             ccCCHHHHHHHHHHhccCHhhcCCChHHHH
Confidence            22344578999999999999999997 553

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.8e-33  Score=283.22  Aligned_cols=233  Identities=30%  Similarity=0.487  Sum_probs=185.8

Q ss_pred             eEEEEEEE-CCceEEEEEecc------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhcCCCC
Q 039626          361 GSVYRGKI-NGGFAAIKKVNG------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEG  433 (628)
Q Consensus       361 G~Vy~g~~-~g~~vavK~~~~------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~  433 (628)
                      |.||++.. ++..+|+|.+..      ++.+|+.++++++|+||+++++++..+...++||||+++++|.+++...  .+
T Consensus        20 ~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~i~~~--~~   97 (261)
T cd05034          20 GEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSG--EG   97 (261)
T ss_pred             eEEEEEEEcCCceEEEEEecCCccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEeccCCCCHHHHHhcc--cc
Confidence            89999988 456789998864      4778999999999999999999999888999999999999999999542  33


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCCccccC
Q 039626          434 KYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMA  513 (628)
Q Consensus       434 ~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~Y~A  513 (628)
                      ..+++..+..++.+++.||+|||+.   +++|+||||+||++++++.+||+|||+++......  ........++..|+|
T Consensus        98 ~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~--~~~~~~~~~~~~y~~  172 (261)
T cd05034          98 KKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIEDDE--YTAREGAKFPIKWTA  172 (261)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceeccchh--hhhhhccCCCccccC
Confidence            4689999999999999999999984   59999999999999999999999999988664321  111112234568999


Q ss_pred             ccccccCCCCcccccHHHHHHHHHHHh-CCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCHHHHHH
Q 039626          514 PEYLENGLVSTKLDVYAFGVLILEMLT-GKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALL  592 (628)
Q Consensus       514 PE~l~~~~~s~k~DV~SfGvvl~ELlt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~  592 (628)
                      ||.+.+..++.++|+||||++++||++ |+.|+.....      ..........          .    ....+.+.+..
T Consensus       173 PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~------~~~~~~~~~~----------~----~~~~~~~~~~~  232 (261)
T cd05034         173 PEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTN------REVLEQVERG----------Y----RMPRPPNCPEE  232 (261)
T ss_pred             HHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH------HHHHHHHHcC----------C----CCCCCCCCCHH
Confidence            999998889999999999999999998 8888753221      1111111110          0    00111223456


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 039626          593 VIRLIDACLKKDPTDRPTMYEIEHSLSN  620 (628)
Q Consensus       593 l~~l~~~Cl~~dP~~RPs~~ev~~~L~~  620 (628)
                      +.+++.+||..+|.+||+++++.+.|+.
T Consensus       233 ~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         233 LYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             HHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence            8899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=3.8e-33  Score=281.33  Aligned_cols=235  Identities=31%  Similarity=0.515  Sum_probs=189.5

Q ss_pred             eEEEEEEEC-----CceEEEEEecc--------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhh
Q 039626          361 GSVYRGKIN-----GGFAAIKKVNG--------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVF  427 (628)
Q Consensus       361 G~Vy~g~~~-----g~~vavK~~~~--------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~  427 (628)
                      |.||++...     +..+++|..+.        ++.+|++++.+++|+||+++++++..+...++||||+++++|.+++.
T Consensus         9 g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~   88 (262)
T cd00192           9 GEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLR   88 (262)
T ss_pred             eEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccCCcHHHHHh
Confidence            899999984     77899998864        34579999999999999999999999999999999999999999996


Q ss_pred             hcCCC-----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceee
Q 039626          428 SNKNE-----GKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALT  502 (628)
Q Consensus       428 ~~~~~-----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~  502 (628)
                      .....     ...+++..+.+++.+++.||+|||+   .+++|+||||+||++++++.+||+|||.++....... ....
T Consensus        89 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~-~~~~  164 (262)
T cd00192          89 KSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDY-YRKK  164 (262)
T ss_pred             hccccccccccccCCHHHHHHHHHHHHHHHHHHHc---CCcccCccCcceEEECCCCcEEEcccccccccccccc-cccc
Confidence            53221     3679999999999999999999998   4599999999999999999999999999987754321 1223


Q ss_pred             ecccCCccccCccccccCCCCcccccHHHHHHHHHHHh-CCCccccccccccccHHHHHHHHhccccchhhhccccCCcC
Q 039626          503 RHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT-GKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTL  581 (628)
Q Consensus       503 ~~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELlt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l  581 (628)
                      ....++..|+|||.+....++.++||||||++++||++ |+.|+.....      .+........              .
T Consensus       165 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~------~~~~~~~~~~--------------~  224 (262)
T cd00192         165 TGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN------EEVLEYLRKG--------------Y  224 (262)
T ss_pred             cCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH------HHHHHHHHcC--------------C
Confidence            34567889999999988899999999999999999999 5887764321      1111111110              0


Q ss_pred             CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 039626          582 QGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLS  619 (628)
Q Consensus       582 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~  619 (628)
                      ....+...+..+.+++.+||+.||.+|||+.|+++.|+
T Consensus       225 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         225 RLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             CCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence            11223334567889999999999999999999998873

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=9.4e-34  Score=296.59  Aligned_cols=220  Identities=26%  Similarity=0.360  Sum_probs=175.9

Q ss_pred             eEEEEEEE--CCceEEEEEeccc----------hHHHHHHHhhc-CCCceeeeeeeeecCCeEEEEEEecCCCChHHHhh
Q 039626          361 GSVYRGKI--NGGFAAIKKVNGD----------VSKEIALLNKI-NHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVF  427 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~~----------~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~  427 (628)
                      |.||++..  ++..+|+|.++.+          ...|..++..+ +|++|+++.+++.+.+..++||||+++|+|.+++.
T Consensus        14 g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~~~   93 (323)
T cd05616          14 GKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQ   93 (323)
T ss_pred             eEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEcCCCCCCHHHHHH
Confidence            89999988  5678999988642          34467777776 58899999999999999999999999999999885


Q ss_pred             hcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccC
Q 039626          428 SNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVG  507 (628)
Q Consensus       428 ~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~g  507 (628)
                      .    ...+++..+..++.|++.||+|||+.   +++||||||+|||+++++.+||+|||+++.......   ......|
T Consensus        94 ~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~---~~~~~~g  163 (323)
T cd05616          94 Q----VGRFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGV---TTKTFCG  163 (323)
T ss_pred             H----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecCCCCC---ccccCCC
Confidence            3    23589999999999999999999984   599999999999999999999999999875432111   1234579


Q ss_pred             CccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCH
Q 039626          508 TKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPL  587 (628)
Q Consensus       508 t~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~  587 (628)
                      |+.|+|||++.+..++.++|||||||++|||++|+.|+.....      .+....+...               ...++.
T Consensus       164 t~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~------~~~~~~i~~~---------------~~~~p~  222 (323)
T cd05616         164 TPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE------DELFQSIMEH---------------NVAYPK  222 (323)
T ss_pred             ChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCH------HHHHHHHHhC---------------CCCCCC
Confidence            9999999999999999999999999999999999999864321      1112121111               011233


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCCH
Q 039626          588 ELALLVIRLIDACLKKDPTDRPTM  611 (628)
Q Consensus       588 ~~~~~l~~l~~~Cl~~dP~~RPs~  611 (628)
                      .....+.+++.+|++.||.+|++.
T Consensus       223 ~~s~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05616         223 SMSKEAVAICKGLMTKHPGKRLGC  246 (323)
T ss_pred             cCCHHHHHHHHHHcccCHHhcCCC
Confidence            345567899999999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=4.3e-33  Score=280.72  Aligned_cols=229  Identities=28%  Similarity=0.438  Sum_probs=184.8

Q ss_pred             eEEEEEEE--CCceEEEEEecc-----chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhcCCCC
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG-----DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEG  433 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~-----~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~  433 (628)
                      |.||+|+.  ++..+++|.+..     ++.+|++++++++|+||+++++++.++...++++||+++++|.+++..   ..
T Consensus        17 ~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~~---~~   93 (256)
T cd06612          17 GSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKI---TN   93 (256)
T ss_pred             eEEEEEEEcCCCcEEEEEEeecHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCCCCcHHHHHHh---Cc
Confidence            89999998  368899998864     477899999999999999999999999999999999999999999853   23


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCCccccC
Q 039626          434 KYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMA  513 (628)
Q Consensus       434 ~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~Y~A  513 (628)
                      ..++|..+..++.+++.||.|||+.   +++|+||+|+||++++++.+||+|||++........   ......++..|+|
T Consensus        94 ~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~y~~  167 (256)
T cd06612          94 KTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA---KRNTVIGTPFWMA  167 (256)
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhcccCcc---ccccccCCccccC
Confidence            5689999999999999999999984   499999999999999999999999999887643321   1223457889999


Q ss_pred             ccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCHHHHHHH
Q 039626          514 PEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLV  593 (628)
Q Consensus       514 PE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l  593 (628)
                      ||++.+..++.++||||||++++||++|+.|+.......     . .....          ....+.  ...+......+
T Consensus       168 PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~-----~-~~~~~----------~~~~~~--~~~~~~~~~~~  229 (256)
T cd06612         168 PEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMR-----A-IFMIP----------NKPPPT--LSDPEKWSPEF  229 (256)
T ss_pred             HHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhh-----h-hhhhc----------cCCCCC--CCchhhcCHHH
Confidence            999999899999999999999999999999876322111     0 00000          000000  11122344568


Q ss_pred             HHHHHHhcccCCCCCCCHHHHHH
Q 039626          594 IRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       594 ~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      .+++.+||+.||++||++.|+++
T Consensus       230 ~~~i~~~l~~~P~~Rps~~~il~  252 (256)
T cd06612         230 NDFVKKCLVKDPEERPSAIQLLQ  252 (256)
T ss_pred             HHHHHHHHhcChhhCcCHHHHhc
Confidence            89999999999999999999875

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=1.3e-33  Score=295.77  Aligned_cols=224  Identities=25%  Similarity=0.354  Sum_probs=176.1

Q ss_pred             eEEEEEEE--CCceEEEEEeccc----------hHHH-HHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhh
Q 039626          361 GSVYRGKI--NGGFAAIKKVNGD----------VSKE-IALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVF  427 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~~----------~~~E-~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~  427 (628)
                      |.||+++.  +++.+|+|.+...          +..| ..+++.++|+||+++++++..++..++||||+++|+|.+++.
T Consensus         9 g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~   88 (325)
T cd05602           9 GKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQ   88 (325)
T ss_pred             eEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCCCcHHHHHH
Confidence            89999988  5678999988531          2223 335678899999999999999999999999999999999985


Q ss_pred             hcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccC
Q 039626          428 SNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVG  507 (628)
Q Consensus       428 ~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~g  507 (628)
                      .    ...+.+.....++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++.......   ......|
T Consensus        89 ~----~~~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~---~~~~~~g  158 (325)
T cd05602          89 R----ERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG---TTSTFCG  158 (325)
T ss_pred             h----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC---CcccccC
Confidence            3    23477888888999999999999985   499999999999999999999999999875432211   1234579


Q ss_pred             CccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCH
Q 039626          508 TKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPL  587 (628)
Q Consensus       508 t~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~  587 (628)
                      |+.|+|||++.+..++.++|||||||++|||++|+.|+.....      .+....+....             .  ..+.
T Consensus       159 t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~~~~~~i~~~~-------------~--~~~~  217 (325)
T cd05602         159 TPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT------AEMYDNILNKP-------------L--QLKP  217 (325)
T ss_pred             CccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCH------HHHHHHHHhCC-------------c--CCCC
Confidence            9999999999999999999999999999999999999863221      11111211110             0  1111


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 039626          588 ELALLVIRLIDACLKKDPTDRPTMYEIE  615 (628)
Q Consensus       588 ~~~~~l~~l~~~Cl~~dP~~RPs~~ev~  615 (628)
                      ..+..+.+++.+||+.||.+||++.+.+
T Consensus       218 ~~~~~~~~li~~~l~~~p~~R~~~~~~~  245 (325)
T cd05602         218 NITNSARHLLEGLLQKDRTKRLGAKDDF  245 (325)
T ss_pred             CCCHHHHHHHHHHcccCHHHCCCCCCCH
Confidence            2345678999999999999999987544

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=3.5e-33  Score=288.00  Aligned_cols=242  Identities=26%  Similarity=0.421  Sum_probs=183.5

Q ss_pred             eEEEEEEECC------------------ceEEEEEecc--------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEE
Q 039626          361 GSVYRGKING------------------GFAAIKKVNG--------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVY  414 (628)
Q Consensus       361 G~Vy~g~~~g------------------~~vavK~~~~--------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~  414 (628)
                      |.||+++..+                  ..+|+|++..        ++.+|++++++++|+||+++++++..++..++++
T Consensus        19 g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   98 (296)
T cd05051          19 GEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIM   98 (296)
T ss_pred             ccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEEEEEEecCCCcEEEE
Confidence            8899987632                  4579998764        3567999999999999999999999999999999


Q ss_pred             EecCCCChHHHhhhcCC-------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEcccc
Q 039626          415 EYAVNGTLSDWVFSNKN-------EGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFA  487 (628)
Q Consensus       415 E~~~~gsL~~~l~~~~~-------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfg  487 (628)
                      ||+++++|.+++.....       ....+++..++.++.|++.||+|||+.   +++|+||||+||++++++.++|+|||
T Consensus        99 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp~Nili~~~~~~~l~dfg  175 (296)
T cd05051          99 EYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRNCLVGKNYTIKIADFG  175 (296)
T ss_pred             ecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---CccccccchhceeecCCCceEEcccc
Confidence            99999999999965431       123689999999999999999999984   49999999999999999999999999


Q ss_pred             ccccCCCCCCcceeeecccCCccccCccccccCCCCcccccHHHHHHHHHHHh--CCCccccccccccccHHHHHHHHhc
Q 039626          488 MARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT--GKEAAALHAEENNMHLSDVLNAVLT  565 (628)
Q Consensus       488 la~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELlt--G~~p~~~~~~~~~~~~~~~~~~~~~  565 (628)
                      +++...... .........++..|+|||++.+..++.++||||||+++|||++  |..|+.....   ....+.......
T Consensus       176 ~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~---~~~~~~~~~~~~  251 (296)
T cd05051         176 MSRNLYSSD-YYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD---QQVIENAGHFFR  251 (296)
T ss_pred             ceeecccCc-ceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcCh---HHHHHHHHhccc
Confidence            988654322 1122334467789999999998889999999999999999998  4555532111   111111111100


Q ss_pred             cccchhhhccccCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 039626          566 KEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLS  619 (628)
Q Consensus       566 ~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~  619 (628)
                      ...          .......+...+..+.+++.+||+.||.+||++.||++.|+
T Consensus       252 ~~~----------~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~  295 (296)
T cd05051         252 DDG----------RQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ  295 (296)
T ss_pred             ccc----------ccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence            000          00001112223456899999999999999999999998885

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-34  Score=309.38  Aligned_cols=246  Identities=24%  Similarity=0.363  Sum_probs=198.9

Q ss_pred             CCCcCCccceEEEEEEE--CCc----eEEEEEecc--------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEec
Q 039626          352 NFSFTCRIQGSVYRGKI--NGG----FAAIKKVNG--------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYA  417 (628)
Q Consensus       352 ~f~~~~~i~G~Vy~g~~--~g~----~vavK~~~~--------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~  417 (628)
                      .+..+.+..|+||||.|  +|+    +||||.+..        ++.+|+..|.+++|+|+++|+|+|.... ..||.+||
T Consensus       701 ~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~m  779 (1177)
T KOG1025|consen  701 DKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQLM  779 (1177)
T ss_pred             hceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHhc
Confidence            34444555699999999  554    678888753        5788999999999999999999998665 78999999


Q ss_pred             CCCChHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCC
Q 039626          418 VNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEG  497 (628)
Q Consensus       418 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~  497 (628)
                      +.|+|.||++.++   ..+.-+..+.|..|||+||.|||+   .+++||||..+|||+.+-..+||.|||+++.......
T Consensus       780 P~G~LlDyvr~hr---~~igsq~lLnw~~QIAkgM~YLe~---qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~  853 (1177)
T KOG1025|consen  780 PLGCLLDYVREHR---DNIGSQDLLNWCYQIAKGMKYLEE---QRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEK  853 (1177)
T ss_pred             ccchHHHHHHHhh---ccccHHHHHHHHHHHHHHHHHHHh---cchhhhhhhhhheeecCCCeEEEEecchhhccCcccc
Confidence            9999999997644   347788899999999999999998   4599999999999999999999999999998765543


Q ss_pred             cceeeecccCCccccCccccccCCCCcccccHHHHHHHHHHHh-CCCccccccccccccHHHHHHHHhccccchhhhccc
Q 039626          498 EFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT-GKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHF  576 (628)
Q Consensus       498 ~~~~~~~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELlt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  576 (628)
                      ++. .....-.+.|||-|.+....++.++|||||||.+||++| |..|++....       +.+..             +
T Consensus       854 ey~-~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~-------~eI~d-------------l  912 (1177)
T KOG1025|consen  854 EYS-APGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPA-------EEIPD-------------L  912 (1177)
T ss_pred             ccc-ccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCH-------HHhhH-------------H
Confidence            322 233345578999999999999999999999999999998 7777653221       12222             2


Q ss_pred             cCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhc
Q 039626          577 IDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNAS  625 (628)
Q Consensus       577 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~~~~  625 (628)
                      +....+-..|.-+...+..++.+||..|++.||.++++..++.++...+
T Consensus       913 le~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ardp  961 (1177)
T KOG1025|consen  913 LEKGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARDP  961 (1177)
T ss_pred             HhccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcCc
Confidence            2222234456667778899999999999999999999999999887543

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=5.3e-33  Score=282.36  Aligned_cols=229  Identities=24%  Similarity=0.319  Sum_probs=177.2

Q ss_pred             eEEEEEEE--CCceEEEEEecc------------chHHHHHHHhhcCCCceeeeeeeeec--CCeEEEEEEecCCCChHH
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG------------DVSKEIALLNKINHSNLIILSGVCFN--EGNCYLVYEYAVNGTLSD  424 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~------------~~~~E~~~l~~l~H~nIv~l~g~~~~--~~~~~lV~E~~~~gsL~~  424 (628)
                      |.||++..  .+..+++|++..            .+.+|++++++++|+||+++++++.+  +...++++||+++++|.+
T Consensus        16 g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l~~e~~~~~~L~~   95 (266)
T cd06651          16 GRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKD   95 (266)
T ss_pred             EEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEEEEeCCCCCcHHH
Confidence            89999987  578999998742            25679999999999999999999875  356889999999999999


Q ss_pred             HhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeec
Q 039626          425 WVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRH  504 (628)
Q Consensus       425 ~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~  504 (628)
                      ++..    ...+++..++.++.|++.||+|||+.   +++|+||||+||+++.++.+||+|||+++..............
T Consensus        96 ~l~~----~~~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~  168 (266)
T cd06651          96 QLKA----YGALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRS  168 (266)
T ss_pred             HHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCccccccccccCCcccc
Confidence            9953    23488999999999999999999984   5999999999999999999999999998765322111111223


Q ss_pred             ccCCccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCC
Q 039626          505 IVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGN  584 (628)
Q Consensus       505 ~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~  584 (628)
                      ..++..|+|||++.+..++.++||||||++++||++|+.|+.....      ...+.....         ....    ..
T Consensus       169 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~------~~~~~~~~~---------~~~~----~~  229 (266)
T cd06651         169 VTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEA------MAAIFKIAT---------QPTN----PQ  229 (266)
T ss_pred             CCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccch------HHHHHHHhc---------CCCC----CC
Confidence            4688999999999998899999999999999999999998863211      111111110         0011    12


Q ss_pred             CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          585 YPLELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       585 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      .+......+.+++ +||..+|++||+++||++
T Consensus       230 ~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~  260 (266)
T cd06651         230 LPSHISEHARDFL-GCIFVEARHRPSAEELLR  260 (266)
T ss_pred             CchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence            2333344566676 688899999999999974

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=3.1e-33  Score=292.85  Aligned_cols=220  Identities=27%  Similarity=0.369  Sum_probs=175.7

Q ss_pred             eEEEEEEE--CCceEEEEEeccc----------hHHHHHHHhhcCCC-ceeeeeeeeecCCeEEEEEEecCCCChHHHhh
Q 039626          361 GSVYRGKI--NGGFAAIKKVNGD----------VSKEIALLNKINHS-NLIILSGVCFNEGNCYLVYEYAVNGTLSDWVF  427 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~~----------~~~E~~~l~~l~H~-nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~  427 (628)
                      |.||+|+.  .++.+|+|.++.+          +..|.+++..++|+ +|+++.+++.+.+..++||||+++|+|.+++.
T Consensus        14 g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~~~   93 (324)
T cd05587          14 GKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQ   93 (324)
T ss_pred             eEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEcCCCCCcHHHHHH
Confidence            89999988  4678999988642          44688889988765 58889999998999999999999999999985


Q ss_pred             hcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccC
Q 039626          428 SNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVG  507 (628)
Q Consensus       428 ~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~g  507 (628)
                      .    ...+++..+..++.|++.||+|||+.   +|+||||||+|||+++++.+||+|||+++.......   ......|
T Consensus        94 ~----~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~---~~~~~~g  163 (324)
T cd05587          94 Q----VGKFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK---TTRTFCG  163 (324)
T ss_pred             H----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCC---ceeeecC
Confidence            3    23588999999999999999999984   599999999999999999999999999875322111   1234579


Q ss_pred             CccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCH
Q 039626          508 TKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPL  587 (628)
Q Consensus       508 t~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~  587 (628)
                      |+.|+|||++.+..++.++|||||||++|||++|+.|+.....      .+....+...               ...++.
T Consensus       164 t~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~------~~~~~~i~~~---------------~~~~~~  222 (324)
T cd05587         164 TPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE------DELFQSIMEH---------------NVSYPK  222 (324)
T ss_pred             CccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH------HHHHHHHHcC---------------CCCCCC
Confidence            9999999999999999999999999999999999999864321      1112221110               011222


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCCH
Q 039626          588 ELALLVIRLIDACLKKDPTDRPTM  611 (628)
Q Consensus       588 ~~~~~l~~l~~~Cl~~dP~~RPs~  611 (628)
                      .....+.+++.+||+.||.+|++.
T Consensus       223 ~~~~~~~~li~~~l~~~P~~R~~~  246 (324)
T cd05587         223 SLSKEAVSICKGLLTKHPAKRLGC  246 (324)
T ss_pred             CCCHHHHHHHHHHhhcCHHHcCCC
Confidence            344567899999999999999986

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=3.3e-33  Score=284.22  Aligned_cols=240  Identities=23%  Similarity=0.364  Sum_probs=177.3

Q ss_pred             ceEEEEEEE-C---CceEEEEEecc--------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhh
Q 039626          360 QGSVYRGKI-N---GGFAAIKKVNG--------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVF  427 (628)
Q Consensus       360 ~G~Vy~g~~-~---g~~vavK~~~~--------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~  427 (628)
                      .|.||+|.. +   ...+++|....        .+.+|+.+++.++|+||+++++.+......++||||+++|+|.+++.
T Consensus         8 fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~L~~~l~   87 (269)
T cd05042           8 FGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLR   87 (269)
T ss_pred             CceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCcHHHHHH
Confidence            389999976 2   34678887642        35679999999999999999999999999999999999999999996


Q ss_pred             hcCCC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeeccc
Q 039626          428 SNKNE-GKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIV  506 (628)
Q Consensus       428 ~~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~  506 (628)
                      ..... ....++...+.++.|++.||+|||+.   +++||||||+|||+++++.+||+|||+++....... ........
T Consensus        88 ~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~  163 (269)
T cd05042          88 SNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDY-YITKDCHA  163 (269)
T ss_pred             hccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccchh-eeccCCCC
Confidence            54322 23457888899999999999999984   599999999999999999999999999875432211 11112234


Q ss_pred             CCccccCcccccc-------CCCCcccccHHHHHHHHHHHh-CCCccccccccccccHHHHHHHHhccccchhhhccccC
Q 039626          507 GTKGYMAPEYLEN-------GLVSTKLDVYAFGVLILEMLT-GKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFID  578 (628)
Q Consensus       507 gt~~Y~APE~l~~-------~~~s~k~DV~SfGvvl~ELlt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d  578 (628)
                      ++..|+|||++..       ..++.++||||||+++|||++ |+.|+......      +.........     ...+.+
T Consensus       164 ~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~------~~~~~~~~~~-----~~~~~~  232 (269)
T cd05042         164 VPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDE------QVLKQVVREQ-----DIKLPK  232 (269)
T ss_pred             CcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHH------HHHHHHhhcc-----CccCCC
Confidence            6678999998743       456889999999999999999 66666532211      1111111111     011222


Q ss_pred             CcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 039626          579 PTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLS  619 (628)
Q Consensus       579 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~  619 (628)
                      +....    .....+.+++..|| .||++||+++||++.|.
T Consensus       233 ~~~~~----~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~  268 (269)
T cd05042         233 PQLDL----KYSDRWYEVMQFCW-LDPETRPTAEEVHELLT  268 (269)
T ss_pred             Ccccc----cCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence            22222    23345667888898 59999999999998874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=3.2e-33  Score=281.98  Aligned_cols=230  Identities=27%  Similarity=0.451  Sum_probs=183.2

Q ss_pred             eEEEEEEE-CCceEEEEEecc------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhcCCCC
Q 039626          361 GSVYRGKI-NGGFAAIKKVNG------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEG  433 (628)
Q Consensus       361 G~Vy~g~~-~g~~vavK~~~~------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~  433 (628)
                      |.||++.+ ++..+|+|.+..      ++.+|++++++++|+|++++++++......++|+||+++++|.+++...   .
T Consensus        18 g~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~---~   94 (256)
T cd05112          18 GLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQ---R   94 (256)
T ss_pred             ceEEEEEEeCCCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCCCcHHHHHHhC---c
Confidence            89999988 478899998764      4778999999999999999999999999999999999999999998542   2


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCCccccC
Q 039626          434 KYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMA  513 (628)
Q Consensus       434 ~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~Y~A  513 (628)
                      ..++|..+..++.+++.||+|||+.   +++|+||||+||+++.++.+||+|||+++.......  .......++.+|+|
T Consensus        95 ~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~~~~a  169 (256)
T cd05112          95 GKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY--TSSTGTKFPVKWSS  169 (256)
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccCcc--cccCCCccchhhcC
Confidence            3588999999999999999999985   499999999999999999999999999876533211  11122345678999


Q ss_pred             ccccccCCCCcccccHHHHHHHHHHHh-CCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCHHHHHH
Q 039626          514 PEYLENGLVSTKLDVYAFGVLILEMLT-GKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALL  592 (628)
Q Consensus       514 PE~l~~~~~s~k~DV~SfGvvl~ELlt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~  592 (628)
                      ||++.+..++.++||||||+++|||++ |+.|+.....      .+....... .      .....+       ...+..
T Consensus       170 Pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~------~~~~~~~~~-~------~~~~~~-------~~~~~~  229 (256)
T cd05112         170 PEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSN------SEVVETINA-G------FRLYKP-------RLASQS  229 (256)
T ss_pred             HhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCH------HHHHHHHhC-C------CCCCCC-------CCCCHH
Confidence            999998899999999999999999998 8887753221      111111110 0      000111       112356


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHHHHH
Q 039626          593 VIRLIDACLKKDPTDRPTMYEIEHSL  618 (628)
Q Consensus       593 l~~l~~~Cl~~dP~~RPs~~ev~~~L  618 (628)
                      +.+++.+||+.+|++||+++|+++.|
T Consensus       230 ~~~l~~~~l~~~p~~Rp~~~~~l~~l  255 (256)
T cd05112         230 VYELMQHCWKERPEDRPSFSLLLHQL  255 (256)
T ss_pred             HHHHHHHHcccChhhCCCHHHHHHhh
Confidence            88999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=4.5e-33  Score=281.91  Aligned_cols=233  Identities=24%  Similarity=0.428  Sum_probs=184.2

Q ss_pred             eEEEEEEE-CCceEEEEEecc------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhcCCCC
Q 039626          361 GSVYRGKI-NGGFAAIKKVNG------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEG  433 (628)
Q Consensus       361 G~Vy~g~~-~g~~vavK~~~~------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~  433 (628)
                      |.||++.+ .+..+|+|....      ++.+|++++++++|+||+++.+++.+ ...+++|||+++|+|.+++...  .+
T Consensus        20 ~~vy~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~~~~~--~~   96 (260)
T cd05073          20 GEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSD--EG   96 (260)
T ss_pred             eEEEEEEecCCccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeCCCCcHHHHHHhC--Cc
Confidence            89999987 556789998754      46689999999999999999999887 7789999999999999999543  34


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCCccccC
Q 039626          434 KYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMA  513 (628)
Q Consensus       434 ~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~Y~A  513 (628)
                      ..++|..+..++.+++.||+|||+   .+++|+||||+||+++.++.+||+|||++........  .......++..|+|
T Consensus        97 ~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~y~~  171 (260)
T cd05073          97 SKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY--TAREGAKFPIKWTA  171 (260)
T ss_pred             cccCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCCcceeeccCCCc--ccccCCcccccccC
Confidence            568999999999999999999998   4599999999999999999999999999976543221  11222345678999


Q ss_pred             ccccccCCCCcccccHHHHHHHHHHHh-CCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCHHHHHH
Q 039626          514 PEYLENGLVSTKLDVYAFGVLILEMLT-GKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALL  592 (628)
Q Consensus       514 PE~l~~~~~s~k~DV~SfGvvl~ELlt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~  592 (628)
                      ||++....++.++|+||||++++|+++ |+.|+.....      .+....... .         .    ....+...+..
T Consensus       172 PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~------~~~~~~~~~-~---------~----~~~~~~~~~~~  231 (260)
T cd05073         172 PEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN------PEVIRALER-G---------Y----RMPRPENCPEE  231 (260)
T ss_pred             HhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCH------HHHHHHHhC-C---------C----CCCCcccCCHH
Confidence            999998889999999999999999999 8887753221      111111110 0         0    00111233456


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 039626          593 VIRLIDACLKKDPTDRPTMYEIEHSLSNI  621 (628)
Q Consensus       593 l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l  621 (628)
                      +.+++.+||+.+|++||+++++.+.|+.+
T Consensus       232 ~~~~i~~~l~~~p~~Rp~~~~l~~~L~~~  260 (260)
T cd05073         232 LYNIMMRCWKNRPEERPTFEYIQSVLDDF  260 (260)
T ss_pred             HHHHHHHHcccCcccCcCHHHHHHHHhcC
Confidence            88999999999999999999999999753

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=3.4e-33  Score=283.67  Aligned_cols=231  Identities=25%  Similarity=0.386  Sum_probs=180.4

Q ss_pred             eEEEEEEE--CCceEEEEEecc-------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhcCC
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG-------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKN  431 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~-------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~  431 (628)
                      |.||+|+.  +++.+|+|+...       .+.+|+.++++++|+||+++++++..++..++|+||+++++|.+++..   
T Consensus        23 g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~---   99 (267)
T cd06646          23 GDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHV---   99 (267)
T ss_pred             eEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCCCCCcHHHHHHh---
Confidence            89999997  678899998753       256799999999999999999999999999999999999999999853   


Q ss_pred             CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCCccc
Q 039626          432 EGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGY  511 (628)
Q Consensus       432 ~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~Y  511 (628)
                       ...+++..+..++.|++.||+|||+.   +++||||||+||++++++.+||+|||+++.......   ......|+..|
T Consensus       100 -~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~y  172 (267)
T cd06646         100 -TGPLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA---KRKSFIGTPYW  172 (267)
T ss_pred             -cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeeccccc---ccCccccCccc
Confidence             23589999999999999999999984   599999999999999999999999999986542211   12234688899


Q ss_pred             cCccccc---cCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCHH
Q 039626          512 MAPEYLE---NGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLE  588 (628)
Q Consensus       512 ~APE~l~---~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~  588 (628)
                      +|||.+.   ...++.++||||||++++||++|+.|+........      .... .    .   ..+..+....  ...
T Consensus       173 ~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~------~~~~-~----~---~~~~~~~~~~--~~~  236 (267)
T cd06646         173 MAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA------LFLM-S----K---SNFQPPKLKD--KTK  236 (267)
T ss_pred             cCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhh------heee-e----c---CCCCCCCCcc--ccc
Confidence            9999884   44578899999999999999999988752211100      0000 0    0   0011111111  112


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 039626          589 LALLVIRLIDACLKKDPTDRPTMYEIEHS  617 (628)
Q Consensus       589 ~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~  617 (628)
                      .+..+.+++.+||..||++||+++++++.
T Consensus       237 ~~~~~~~li~~~l~~~P~~Rp~~~~il~~  265 (267)
T cd06646         237 WSSTFHNFVKISLTKNPKKRPTAERLLTH  265 (267)
T ss_pred             cCHHHHHHHHHHhhCChhhCcCHHHHhcC
Confidence            34568899999999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=4e-33  Score=283.52  Aligned_cols=234  Identities=23%  Similarity=0.395  Sum_probs=184.7

Q ss_pred             eEEEEEEEC---CceEEEEEecc-----------------chHHHHHHHhh-cCCCceeeeeeeeecCCeEEEEEEecCC
Q 039626          361 GSVYRGKIN---GGFAAIKKVNG-----------------DVSKEIALLNK-INHSNLIILSGVCFNEGNCYLVYEYAVN  419 (628)
Q Consensus       361 G~Vy~g~~~---g~~vavK~~~~-----------------~~~~E~~~l~~-l~H~nIv~l~g~~~~~~~~~lV~E~~~~  419 (628)
                      |.||+|...   ++.+|+|.+..                 ++..|+.++.+ ++|+||+++++++.+++..+++|||+++
T Consensus        14 ~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   93 (269)
T cd08528          14 GCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEG   93 (269)
T ss_pred             ceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccCCeEEEEEecCCC
Confidence            899999983   47889997641                 24568887765 7999999999999999999999999999


Q ss_pred             CChHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcc
Q 039626          420 GTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEF  499 (628)
Q Consensus       420 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~  499 (628)
                      ++|.+++.........+++..+++++.|++.||.|||+.  .+++|+||+|+||+++.++.+||+|||++.......   
T Consensus        94 ~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~--~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~---  168 (269)
T cd08528          94 APLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPES---  168 (269)
T ss_pred             CcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccC--CceeecCCCHHHEEECCCCcEEEecccceeeccccc---
Confidence            999999855434455699999999999999999999962  459999999999999999999999999998654322   


Q ss_pred             eeeecccCCccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCC
Q 039626          500 ALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDP  579 (628)
Q Consensus       500 ~~~~~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~  579 (628)
                       ......|+..|+|||.+.+..++.++||||||+++|||++|+.|+.....      ..........         ...+
T Consensus       169 -~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~------~~~~~~~~~~---------~~~~  232 (269)
T cd08528         169 -KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNM------LSLATKIVEA---------VYEP  232 (269)
T ss_pred             -ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCH------HHHHHHHhhc---------cCCc
Confidence             22345688999999999998899999999999999999999988753211      1111111110         0001


Q ss_pred             cCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 039626          580 TLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLS  619 (628)
Q Consensus       580 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~  619 (628)
                      ...    ......+.+++.+||+.||++||++.|+..+|+
T Consensus       233 ~~~----~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~  268 (269)
T cd08528         233 LPE----GMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS  268 (269)
T ss_pred             CCc----ccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence            111    122356789999999999999999999998875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=2.6e-33  Score=282.46  Aligned_cols=228  Identities=28%  Similarity=0.465  Sum_probs=182.4

Q ss_pred             eEEEEEEECCceEEEEEecc-----chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhcCCCCCC
Q 039626          361 GSVYRGKINGGFAAIKKVNG-----DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKY  435 (628)
Q Consensus       361 G~Vy~g~~~g~~vavK~~~~-----~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~  435 (628)
                      |.||+|+..++.+|+|+.+.     .+.+|+.++++++|+|++++++++..+ ..++||||+++|+|.+++...  ....
T Consensus        20 g~v~~~~~~~~~~~iK~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~~~~L~~~l~~~--~~~~   96 (254)
T cd05083          20 GAVLQGEYTGQKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMSKGNLVNFLRTR--GRAL   96 (254)
T ss_pred             CceEecccCCCceEEEeecCcchHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCCCCCHHHHHHhc--CcCC
Confidence            89999999999999999864     367899999999999999999998755 479999999999999999643  2345


Q ss_pred             CCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCCccccCcc
Q 039626          436 LDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPE  515 (628)
Q Consensus       436 l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~Y~APE  515 (628)
                      +++..++.++.|++.||.|||+   .+++||||||+||+++.++.+||+|||+++......      .....+..|+|||
T Consensus        97 ~~~~~~~~~~~qi~~al~~lH~---~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~------~~~~~~~~y~~pe  167 (254)
T cd05083          97 VSVIQLLQFSLDVAEGMEYLES---KKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV------DNSKLPVKWTAPE  167 (254)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCcEEECCCccceeccccC------CCCCCCceecCHH
Confidence            8999999999999999999998   459999999999999999999999999987543211      1123456799999


Q ss_pred             ccccCCCCcccccHHHHHHHHHHHh-CCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCHHHHHHHH
Q 039626          516 YLENGLVSTKLDVYAFGVLILEMLT-GKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVI  594 (628)
Q Consensus       516 ~l~~~~~s~k~DV~SfGvvl~ELlt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~  594 (628)
                      ++.+..++.++|+||||++++||++ |+.|+.....      .+....... .             .....+...+..+.
T Consensus       168 ~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~------~~~~~~~~~-~-------------~~~~~~~~~~~~~~  227 (254)
T cd05083         168 ALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSL------KEVKECVEK-G-------------YRMEPPEGCPADVY  227 (254)
T ss_pred             HhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCH------HHHHHHHhC-C-------------CCCCCCCcCCHHHH
Confidence            9998899999999999999999998 8887753221      111111100 0             00111223345678


Q ss_pred             HHHHHhcccCCCCCCCHHHHHHHHHH
Q 039626          595 RLIDACLKKDPTDRPTMYEIEHSLSN  620 (628)
Q Consensus       595 ~l~~~Cl~~dP~~RPs~~ev~~~L~~  620 (628)
                      +++.+||+.+|++||+++++++.|++
T Consensus       228 ~li~~~l~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         228 VLMTSCWETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             HHHHHHcCCChhhCcCHHHHHHHHcc
Confidence            99999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.4e-33  Score=287.52  Aligned_cols=242  Identities=27%  Similarity=0.415  Sum_probs=180.9

Q ss_pred             eEEEEEEECC----------------ceEEEEEecc--------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEe
Q 039626          361 GSVYRGKING----------------GFAAIKKVNG--------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEY  416 (628)
Q Consensus       361 G~Vy~g~~~g----------------~~vavK~~~~--------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~  416 (628)
                      |.||++...+                ..+|+|+.+.        ++.+|++++++++|+|++++++++..++..++||||
T Consensus        19 g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   98 (295)
T cd05097          19 GEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEY   98 (295)
T ss_pred             ceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEcCCCccEEEEec
Confidence            8899886522                2589998764        366799999999999999999999999999999999


Q ss_pred             cCCCChHHHhhhcCC--------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccc
Q 039626          417 AVNGTLSDWVFSNKN--------EGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAM  488 (628)
Q Consensus       417 ~~~gsL~~~l~~~~~--------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgl  488 (628)
                      +++++|.+++.....        ....++|..++.++.+++.||+|||+.   +++|+||||+||++++++.+||+|||+
T Consensus        99 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nill~~~~~~kl~dfg~  175 (295)
T cd05097          99 MENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRNCLVGNHYTIKIADFGM  175 (295)
T ss_pred             CCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChhhEEEcCCCcEEeccccc
Confidence            999999999854321        112478999999999999999999984   499999999999999999999999999


Q ss_pred             cccCCCCCCcceeeecccCCccccCccccccCCCCcccccHHHHHHHHHHHhC--CCccccccccccccHHHHHHHHhcc
Q 039626          489 ARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTG--KEAAALHAEENNMHLSDVLNAVLTK  566 (628)
Q Consensus       489 a~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG--~~p~~~~~~~~~~~~~~~~~~~~~~  566 (628)
                      ++....... ........++..|+|||++.++.++.++||||||++++||+++  ..|+.....      .+.+......
T Consensus       176 ~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~------~~~~~~~~~~  248 (295)
T cd05097         176 SRNLYSGDY-YRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSD------EQVIENTGEF  248 (295)
T ss_pred             ccccccCcc-eeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccCh------HHHHHHHHHh
Confidence            986543221 1122233557789999999988999999999999999999984  444432211      1111111000


Q ss_pred             ccchhhhccccCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 039626          567 EDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLS  619 (628)
Q Consensus       567 ~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~  619 (628)
                      .  ......     .....+...+..+.+++.+||+.||++||++++|++.|+
T Consensus       249 ~--~~~~~~-----~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~  294 (295)
T cd05097         249 F--RNQGRQ-----IYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR  294 (295)
T ss_pred             h--hhcccc-----ccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence            0  000000     000011123456899999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=3.3e-33  Score=291.58  Aligned_cols=224  Identities=25%  Similarity=0.378  Sum_probs=177.7

Q ss_pred             eEEEEEEE--CCceEEEEEeccc----------hHHHHHHHhhc-CCCceeeeeeeeecCCeEEEEEEecCCCChHHHhh
Q 039626          361 GSVYRGKI--NGGFAAIKKVNGD----------VSKEIALLNKI-NHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVF  427 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~~----------~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~  427 (628)
                      |.||+++.  +|+.+|+|.++.+          ...|..++... +|+||+++++++.+++..++||||+++|+|.+++.
T Consensus         9 g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~i~   88 (316)
T cd05620           9 GKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQ   88 (316)
T ss_pred             eEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCCCcHHHHHH
Confidence            89999998  6789999998642          33467777654 89999999999999999999999999999999885


Q ss_pred             hcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccC
Q 039626          428 SNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVG  507 (628)
Q Consensus       428 ~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~g  507 (628)
                      .    ...+++.+...++.|++.||+|||+.   +++||||||+|||++.++.+||+|||+++......   .......|
T Consensus        89 ~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~g  158 (316)
T cd05620          89 D----KGRFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD---NRASTFCG  158 (316)
T ss_pred             H----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecccCC---CceeccCC
Confidence            3    34588999999999999999999984   59999999999999999999999999987532211   12334579


Q ss_pred             CccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCH
Q 039626          508 TKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPL  587 (628)
Q Consensus       508 t~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~  587 (628)
                      |+.|+|||.+.+..++.++|||||||+++||++|+.|+......      +....+..           ..+..    +.
T Consensus       159 t~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~------~~~~~~~~-----------~~~~~----~~  217 (316)
T cd05620         159 TPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED------ELFESIRV-----------DTPHY----PR  217 (316)
T ss_pred             CcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH------HHHHHHHh-----------CCCCC----CC
Confidence            99999999999999999999999999999999999998643221      11111110           01111    22


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCCHH-HHH
Q 039626          588 ELALLVIRLIDACLKKDPTDRPTMY-EIE  615 (628)
Q Consensus       588 ~~~~~l~~l~~~Cl~~dP~~RPs~~-ev~  615 (628)
                      .....+.+++.+||+.||.+||++. ++.
T Consensus       218 ~~~~~~~~li~~~l~~dP~~R~~~~~~~~  246 (316)
T cd05620         218 WITKESKDILEKLFERDPTRRLGVVGNIR  246 (316)
T ss_pred             CCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence            2345578999999999999999985 443

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=3.3e-33  Score=293.87  Aligned_cols=241  Identities=27%  Similarity=0.446  Sum_probs=187.8

Q ss_pred             eEEEEEEEC---------CceEEEEEecc--------chHHHHHHHhhc-CCCceeeeeeeeecCCeEEEEEEecCCCCh
Q 039626          361 GSVYRGKIN---------GGFAAIKKVNG--------DVSKEIALLNKI-NHSNLIILSGVCFNEGNCYLVYEYAVNGTL  422 (628)
Q Consensus       361 G~Vy~g~~~---------g~~vavK~~~~--------~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL  422 (628)
                      |.||++...         +..+|+|..+.        ++.+|++++.++ +|+||++++++|..++..++++||+++|+|
T Consensus        26 g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L  105 (334)
T cd05100          26 GQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNL  105 (334)
T ss_pred             CcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCCceEEEEecCCCCcH
Confidence            899999751         23689998763        366799999999 899999999999999999999999999999


Q ss_pred             HHHhhhcCC------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccc
Q 039626          423 SDWVFSNKN------------EGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMAR  490 (628)
Q Consensus       423 ~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~  490 (628)
                      .+++.....            ....++|.+++.++.|++.||+|||+   .+++||||||+|||+++++.+||+|||+++
T Consensus       106 ~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~givH~dlkp~Nill~~~~~~kL~Dfg~~~  182 (334)
T cd05100         106 REYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLAS---QKCIHRDLAARNVLVTEDNVMKIADFGLAR  182 (334)
T ss_pred             HHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccceEEEcCCCcEEECCcccce
Confidence            999965321            23458999999999999999999998   459999999999999999999999999998


Q ss_pred             cCCCCCCcceeeecccCCccccCccccccCCCCcccccHHHHHHHHHHHh-CCCccccccccccccHHHHHHHHhccccc
Q 039626          491 PAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT-GKEAAALHAEENNMHLSDVLNAVLTKEDG  569 (628)
Q Consensus       491 ~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELlt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~  569 (628)
                      ........ .......++..|+|||.+.+..++.++||||||+++|||++ |+.|+....      ..+....+...   
T Consensus       183 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~------~~~~~~~~~~~---  252 (334)
T cd05100         183 DVHNIDYY-KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP------VEELFKLLKEG---  252 (334)
T ss_pred             eccccccc-ccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCC------HHHHHHHHHcC---
Confidence            66432211 11122344567999999999999999999999999999998 777764321      11222111110   


Q ss_pred             hhhhccccCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhc
Q 039626          570 EESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNAS  625 (628)
Q Consensus       570 ~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~~~~  625 (628)
                                 .....+...+..+.+++.+||+.+|++||++.|+++.|+++...+
T Consensus       253 -----------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~  297 (334)
T cd05100         253 -----------HRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVT  297 (334)
T ss_pred             -----------CCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhc
Confidence                       001112233456889999999999999999999999999998543

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=7.1e-33  Score=288.96  Aligned_cols=184  Identities=27%  Similarity=0.413  Sum_probs=150.5

Q ss_pred             eEEEEEEE----CCceEEEEEecc-----chHHHHHHHhhcCCCceeeeeeeeec--CCeEEEEEEecCCCChHHHhhhc
Q 039626          361 GSVYRGKI----NGGFAAIKKVNG-----DVSKEIALLNKINHSNLIILSGVCFN--EGNCYLVYEYAVNGTLSDWVFSN  429 (628)
Q Consensus       361 G~Vy~g~~----~g~~vavK~~~~-----~~~~E~~~l~~l~H~nIv~l~g~~~~--~~~~~lV~E~~~~gsL~~~l~~~  429 (628)
                      |.||+|+.    .+..+|+|++..     .+.+|+++|++++|+||+++++++..  +...+++|||+. ++|.+++...
T Consensus        15 g~Vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~   93 (317)
T cd07868          15 GHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE-HDLWHIIKFH   93 (317)
T ss_pred             eEEEEEEEccCCCCceEEEEEECCCCCcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC-CCHHHHHHhc
Confidence            89999986    346899998864     46789999999999999999999864  456899999984 5888887532


Q ss_pred             CC-----CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEe----CCCCcEEEccccccccCCCCCCcce
Q 039626          430 KN-----EGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLL----DSDLRAKIANFAMARPAEGQEGEFA  500 (628)
Q Consensus       430 ~~-----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl----~~~~~~kl~Dfgla~~~~~~~~~~~  500 (628)
                      ..     ....+++..+..++.|++.||+|||+.   +|+||||||+|||+    +.++.+||+|||+++..........
T Consensus        94 ~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~  170 (317)
T cd07868          94 RASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLA  170 (317)
T ss_pred             ccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeecCceeccCCCCcccc
Confidence            21     123588999999999999999999985   49999999999999    4668999999999987643322222


Q ss_pred             eeecccCCccccCcccccc-CCCCcccccHHHHHHHHHHHhCCCccccc
Q 039626          501 LTRHIVGTKGYMAPEYLEN-GLVSTKLDVYAFGVLILEMLTGKEAAALH  548 (628)
Q Consensus       501 ~~~~~~gt~~Y~APE~l~~-~~~s~k~DV~SfGvvl~ELltG~~p~~~~  548 (628)
                      ......||+.|+|||++.+ ..++.++||||+||+++||++|+.|+...
T Consensus       171 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~  219 (317)
T cd07868         171 DLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             ccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence            2334578999999999876 45899999999999999999999998643

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=5.6e-33  Score=294.79  Aligned_cols=184  Identities=20%  Similarity=0.288  Sum_probs=156.0

Q ss_pred             cCCCcCCccc----eEEEEEEE--CCceEEEEEecc-chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChH
Q 039626          351 DNFSFTCRIQ----GSVYRGKI--NGGFAAIKKVNG-DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLS  423 (628)
Q Consensus       351 ~~f~~~~~i~----G~Vy~g~~--~g~~vavK~~~~-~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~  423 (628)
                      .+|.....+|    |.||+|+.  .++.||+|.... ....|+.++++++|+||+++++++..++..++|+||+ .|+|.
T Consensus        66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~-~~~l~  144 (357)
T PHA03209         66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGTTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY-SSDLY  144 (357)
T ss_pred             cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCccccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEcc-CCcHH
Confidence            4566555554    89999998  456899997654 4678999999999999999999999999999999999 57899


Q ss_pred             HHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeee
Q 039626          424 DWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTR  503 (628)
Q Consensus       424 ~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~  503 (628)
                      +++..   ....++|..+..|+.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++......    ...
T Consensus       145 ~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~----~~~  214 (357)
T PHA03209        145 TYLTK---RSRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP----AFL  214 (357)
T ss_pred             HHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCccccccccCc----ccc
Confidence            88854   345689999999999999999999985   59999999999999999999999999997543221    122


Q ss_pred             cccCCccccCccccccCCCCcccccHHHHHHHHHHHhCCCcc
Q 039626          504 HIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAA  545 (628)
Q Consensus       504 ~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~  545 (628)
                      ...||..|+|||++.+..++.++|||||||++|||+++..++
T Consensus       215 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~  256 (357)
T PHA03209        215 GLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI  256 (357)
T ss_pred             cccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence            356899999999999999999999999999999999876554

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=8.3e-33  Score=283.12  Aligned_cols=228  Identities=23%  Similarity=0.400  Sum_probs=179.8

Q ss_pred             eEEEEEEE--CCceEEEEEecc--------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhcC
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG--------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNK  430 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~--------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~  430 (628)
                      |.||+|..  +++.+|+|....        ++.+|++++++++|+||+++++++..++..++||||+++|+|..+.    
T Consensus        15 ~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~----   90 (279)
T cd06619          15 GTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDGGSLDVYR----   90 (279)
T ss_pred             eEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCCCCChHHhh----
Confidence            89999987  678899998753        3567999999999999999999999999999999999999997543    


Q ss_pred             CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCCcc
Q 039626          431 NEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKG  510 (628)
Q Consensus       431 ~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~  510 (628)
                          .+++.....++.|++.||+|||+.   +++|+||||+|||++.++.+||+|||++.......     .....|+..
T Consensus        91 ----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~-----~~~~~~~~~  158 (279)
T cd06619          91 ----KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI-----AKTYVGTNA  158 (279)
T ss_pred             ----cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc-----ccCCCCChh
Confidence                367888999999999999999984   59999999999999999999999999997654321     223578999


Q ss_pred             ccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccc-cHHHHHHHHhccccchhhhccccCCcCCCCCCHHH
Q 039626          511 YMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNM-HLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLEL  589 (628)
Q Consensus       511 Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~  589 (628)
                      |+|||++.+..++.++||||||+++|||++|+.|+......... ............          ..+.+.   ....
T Consensus       159 y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~---~~~~  225 (279)
T cd06619         159 YMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDE----------DPPVLP---VGQF  225 (279)
T ss_pred             hcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhcc----------CCCCCC---CCcC
Confidence            99999999989999999999999999999999998643221111 111111111100          011111   1123


Q ss_pred             HHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 039626          590 ALLVIRLIDACLKKDPTDRPTMYEIEHS  617 (628)
Q Consensus       590 ~~~l~~l~~~Cl~~dP~~RPs~~ev~~~  617 (628)
                      ...+.+++.+||+.||++||+++|+++.
T Consensus       226 ~~~~~~li~~~l~~~P~~Rp~~~eil~~  253 (279)
T cd06619         226 SEKFVHFITQCMRKQPKERPAPENLMDH  253 (279)
T ss_pred             CHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence            3457899999999999999999998764

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-33  Score=298.13  Aligned_cols=233  Identities=28%  Similarity=0.403  Sum_probs=196.5

Q ss_pred             eEEEEEEE---CCc--eEEEEEecc--------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhh
Q 039626          361 GSVYRGKI---NGG--FAAIKKVNG--------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVF  427 (628)
Q Consensus       361 G~Vy~g~~---~g~--~vavK~~~~--------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~  427 (628)
                      |.|++|.|   .|+  .||||.++.        +|.+|+.+|.+|+|+|+++|+|+..+ ....+|+|.++.|||.+.|+
T Consensus       124 gvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELaplGSLldrLr  202 (1039)
T KOG0199|consen  124 GVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELAPLGSLLDRLR  202 (1039)
T ss_pred             eeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhcccchHHHHHh
Confidence            99999999   344  569998864        68999999999999999999999987 67889999999999999997


Q ss_pred             hcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccC
Q 039626          428 SNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVG  507 (628)
Q Consensus       428 ~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~g  507 (628)
                      .  .....|-......++.|||.||.||.+   .++|||||..+|+||-..-.+||+||||.|.++..+..+.+..+..-
T Consensus       203 k--a~~~~llv~~Lcdya~QiA~aM~YLes---krlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Yvm~p~rkv  277 (1039)
T KOG0199|consen  203 K--AKKAILLVSRLCDYAMQIAKAMQYLES---KRLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMYVMAPQRKV  277 (1039)
T ss_pred             h--ccccceeHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhhhheecccceeeeecccceeccCCCCcceEecCCCcC
Confidence            6  234457778888999999999999998   55999999999999999999999999999999877777766677777


Q ss_pred             CccccCccccccCCCCcccccHHHHHHHHHHHh-CCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCC
Q 039626          508 TKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT-GKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYP  586 (628)
Q Consensus       508 t~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELlt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~  586 (628)
                      .+.|.|||.+....++.++|||+|||.+|||+| |.+||..-..      ..              +.+.+|..-+...|
T Consensus       278 PfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g------~q--------------IL~~iD~~erLpRP  337 (1039)
T KOG0199|consen  278 PFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRG------IQ--------------ILKNIDAGERLPRP  337 (1039)
T ss_pred             cccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCH------HH--------------HHHhccccccCCCC
Confidence            889999999999999999999999999999999 5566653221      11              12223333344557


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 039626          587 LELALLVIRLIDACLKKDPTDRPTMYEIEHSLS  619 (628)
Q Consensus       587 ~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~  619 (628)
                      ..+++.++++++.||..+|++||++..|.+.+-
T Consensus       338 k~csedIY~imk~cWah~paDRptFsair~~~~  370 (1039)
T KOG0199|consen  338 KYCSEDIYQIMKNCWAHNPADRPTFSAIREDLV  370 (1039)
T ss_pred             CCChHHHHHHHHHhccCCccccccHHHHHHhHH
Confidence            788899999999999999999999999985543

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=4.6e-33  Score=288.68  Aligned_cols=237  Identities=27%  Similarity=0.416  Sum_probs=183.7

Q ss_pred             eEEEEEEE--CCc----eEEEEEecc--------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHh
Q 039626          361 GSVYRGKI--NGG----FAAIKKVNG--------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWV  426 (628)
Q Consensus       361 G~Vy~g~~--~g~----~vavK~~~~--------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l  426 (628)
                      |.||+|.+  +|+    .+|+|....        ++.+|+.++++++|+||++++|+|... ..++++||+++|+|.+++
T Consensus        21 g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~v~e~~~~g~l~~~~   99 (303)
T cd05110          21 GTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQLVTQLMPHGCLLDYV   99 (303)
T ss_pred             ccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-CceeeehhcCCCCHHHHH
Confidence            89999987  444    468887753        356799999999999999999999754 467999999999999998


Q ss_pred             hhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeeccc
Q 039626          427 FSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIV  506 (628)
Q Consensus       427 ~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~  506 (628)
                      ...   ...+++..++.++.|++.||+|||+   .+++|+||||+||++++++.+||+|||+++........ .......
T Consensus       100 ~~~---~~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~-~~~~~~~  172 (303)
T cd05110         100 HEH---KDNIGSQLLLNWCVQIAKGMMYLEE---RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKE-YNADGGK  172 (303)
T ss_pred             Hhc---ccCCCHHHHHHHHHHHHHHHHHHhh---cCeeccccccceeeecCCCceEEccccccccccCcccc-cccCCCc
Confidence            542   3358999999999999999999998   45999999999999999999999999999876432211 1122234


Q ss_pred             CCccccCccccccCCCCcccccHHHHHHHHHHHh-CCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCC
Q 039626          507 GTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT-GKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNY  585 (628)
Q Consensus       507 gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELlt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~  585 (628)
                      ++..|+|||++.+..++.++||||||+++|||++ |+.|+.....      .+ .........   .      ...    
T Consensus       173 ~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~------~~-~~~~~~~~~---~------~~~----  232 (303)
T cd05110         173 MPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT------RE-IPDLLEKGE---R------LPQ----  232 (303)
T ss_pred             cccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCH------HH-HHHHHHCCC---C------CCC----
Confidence            5778999999999999999999999999999997 8888753211      11 111111100   0      000    


Q ss_pred             CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhc
Q 039626          586 PLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNAS  625 (628)
Q Consensus       586 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~~~~  625 (628)
                      +......+.+++.+||..+|++||+++++++.|+++...+
T Consensus       233 ~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~  272 (303)
T cd05110         233 PPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDP  272 (303)
T ss_pred             CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhch
Confidence            1112345789999999999999999999999999987543

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=8.5e-33  Score=282.89  Aligned_cols=237  Identities=23%  Similarity=0.396  Sum_probs=186.1

Q ss_pred             eEEEEEEE--CCc----eEEEEEecc--------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHh
Q 039626          361 GSVYRGKI--NGG----FAAIKKVNG--------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWV  426 (628)
Q Consensus       361 G~Vy~g~~--~g~----~vavK~~~~--------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l  426 (628)
                      |.||+|.+  +|+    .+|+|..+.        ++.+|+.++++++|+||++++++|.. ...++|+||+++|+|.+++
T Consensus        21 g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~g~L~~~l   99 (279)
T cd05057          21 GTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQLITQLMPLGCLLDYV   99 (279)
T ss_pred             ccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEEEEecCCCCcHHHHH
Confidence            89999987  333    588988753        35679999999999999999999987 7889999999999999999


Q ss_pred             hhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeeccc
Q 039626          427 FSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIV  506 (628)
Q Consensus       427 ~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~  506 (628)
                      ...   ...+++..++.++.|++.||+|||+   .+++|+||||+||++++++.+||+|||+++......... ......
T Consensus       100 ~~~---~~~~~~~~~~~~~~qi~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~~~~~-~~~~~~  172 (279)
T cd05057         100 RNH---KDNIGSQYLLNWCVQIAKGMSYLEE---KRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEY-HAEGGK  172 (279)
T ss_pred             Hhc---cCCCCHHHHHHHHHHHHHHHHHHHh---CCEEecccCcceEEEcCCCeEEECCCcccccccCcccce-ecCCCc
Confidence            542   3348999999999999999999998   459999999999999999999999999998765332211 111223


Q ss_pred             CCccccCccccccCCCCcccccHHHHHHHHHHHh-CCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCC
Q 039626          507 GTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT-GKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNY  585 (628)
Q Consensus       507 gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELlt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~  585 (628)
                      ++..|+|||.+....++.++|+||||++++|+++ |+.|+.....      .+....+....              ....
T Consensus       173 ~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~------~~~~~~~~~~~--------------~~~~  232 (279)
T cd05057         173 VPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA------VEIPDLLEKGE--------------RLPQ  232 (279)
T ss_pred             ccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCH------HHHHHHHhCCC--------------CCCC
Confidence            4568999999988899999999999999999998 9988763221      11111111100              0011


Q ss_pred             CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhc
Q 039626          586 PLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNAS  625 (628)
Q Consensus       586 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~~~~  625 (628)
                      +......+.+++.+||..||.+||++.++++.|+.+...+
T Consensus       233 ~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~~  272 (279)
T cd05057         233 PPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARDP  272 (279)
T ss_pred             CCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhCC
Confidence            1123345789999999999999999999999999987654

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=6.4e-33  Score=298.06  Aligned_cols=247  Identities=21%  Similarity=0.281  Sum_probs=183.9

Q ss_pred             eEEEEEEEC----CceEEEEEecc--chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhcCCCCC
Q 039626          361 GSVYRGKIN----GGFAAIKKVNG--DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGK  434 (628)
Q Consensus       361 G~Vy~g~~~----g~~vavK~~~~--~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~  434 (628)
                      |.||++...    +..+|+|.+..  ...+|+++|++++|+||+++++++..+...++|||++. ++|.+++.    ...
T Consensus       106 g~Vy~~~~~~~~~~~~v~vK~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~----~~~  180 (392)
T PHA03207        106 GEVFVCTKHGDEQRKKVIVKAVTGGKTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYK-CDLFTYVD----RSG  180 (392)
T ss_pred             eEEEEEEEcCCccceeEEEEeccccccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEehhcC-CCHHHHHH----hcC
Confidence            899998763    45789998864  46789999999999999999999999999999999994 78988883    234


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCCccccCc
Q 039626          435 YLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAP  514 (628)
Q Consensus       435 ~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~Y~AP  514 (628)
                      .++|..++.++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++........ .......||+.|+||
T Consensus       181 ~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~-~~~~~~~gt~~y~aP  256 (392)
T PHA03207        181 PLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDT-PQCYGWSGTLETNSP  256 (392)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCccccccCccccc-ccccccccccCccCH
Confidence            699999999999999999999985   5999999999999999999999999999866433211 122345799999999


Q ss_pred             cccccCCCCcccccHHHHHHHHHHHhCCCcccccccccc-ccHHHHHHHHhcccc-----ch----hhhccccCCcCCCC
Q 039626          515 EYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENN-MHLSDVLNAVLTKED-----GE----ESLRHFIDPTLQGN  584 (628)
Q Consensus       515 E~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~-~~~~~~~~~~~~~~~-----~~----~~l~~~~d~~l~~~  584 (628)
                      |++.+..++.++|||||||++|||++|+.|+........ ..+...+...-....     ..    ..+..+ ....+..
T Consensus       257 E~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~  335 (392)
T PHA03207        257 ELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCKHFKQY-AIVLRPP  335 (392)
T ss_pred             hHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhHHHHHHhh-cccccCC
Confidence            999999999999999999999999999999865332221 111111111100000     00    000000 0001111


Q ss_pred             CC-------HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 039626          585 YP-------LELALLVIRLIDACLKKDPTDRPTMYEIEHS  617 (628)
Q Consensus       585 ~~-------~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~  617 (628)
                      +.       ......+.+++++||..||++||++.|++..
T Consensus       336 ~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~  375 (392)
T PHA03207        336 YTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL  375 (392)
T ss_pred             ccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence            10       1123457789999999999999999998753

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=5.9e-33  Score=279.99  Aligned_cols=229  Identities=24%  Similarity=0.362  Sum_probs=184.0

Q ss_pred             eEEEEEEE--CCceEEEEEecc--------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhcC
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG--------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNK  430 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~--------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~  430 (628)
                      |.||++..  ++..+|+|.++.        ++.+|+.++++++|+||+++.+.+.+++..++||||+++|+|.+++... 
T Consensus        14 g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-   92 (255)
T cd08219          14 GRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQ-   92 (255)
T ss_pred             eEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCCCCcHHHHHHhc-
Confidence            88999987  678999998742        3567999999999999999999999999999999999999999988542 


Q ss_pred             CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCCcc
Q 039626          431 NEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKG  510 (628)
Q Consensus       431 ~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~  510 (628)
                       .+..+++...+.++.+++.||.|||+.   +++|+||||+||++++++.++++|||+++.......   ......|+..
T Consensus        93 -~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~  165 (255)
T cd08219          93 -RGKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA---YACTYVGTPY  165 (255)
T ss_pred             -cCCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeeccccc---ccccccCCcc
Confidence             334588999999999999999999984   599999999999999999999999999876643211   1233568899


Q ss_pred             ccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCHHHH
Q 039626          511 YMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELA  590 (628)
Q Consensus       511 Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~  590 (628)
                      |+|||.+.+..++.++|+||||++++||++|+.|+.....      ...........         .     ...+...+
T Consensus       166 ~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~------~~~~~~~~~~~---------~-----~~~~~~~~  225 (255)
T cd08219         166 YVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSW------KNLILKVCQGS---------Y-----KPLPSHYS  225 (255)
T ss_pred             ccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCH------HHHHHHHhcCC---------C-----CCCCcccC
Confidence            9999999998999999999999999999999999863221      11111111100         0     01122334


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHHH
Q 039626          591 LLVIRLIDACLKKDPTDRPTMYEIEHS  617 (628)
Q Consensus       591 ~~l~~l~~~Cl~~dP~~RPs~~ev~~~  617 (628)
                      ..+.+++.+||+.||++||++.|++..
T Consensus       226 ~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         226 YELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             HHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence            567899999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=1e-32  Score=277.42  Aligned_cols=232  Identities=27%  Similarity=0.449  Sum_probs=183.8

Q ss_pred             eEEEEEEEC-CceEEEEEecc--------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhcCC
Q 039626          361 GSVYRGKIN-GGFAAIKKVNG--------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKN  431 (628)
Q Consensus       361 G~Vy~g~~~-g~~vavK~~~~--------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~  431 (628)
                      |.||++... ++.+|+|+...        .+.+|++++++++|+||+++++++.+....++||||+++++|.+++...  
T Consensus         9 g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~--   86 (251)
T cd05041           9 GDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKK--   86 (251)
T ss_pred             ceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHHHHHHhc--
Confidence            899999984 88999998753        3667999999999999999999999999999999999999999998542  


Q ss_pred             CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCCccc
Q 039626          432 EGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGY  511 (628)
Q Consensus       432 ~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~Y  511 (628)
                       ...+++..++.++.+++.||+|||+.   +++||||||+||+++.++.+||+|||+++........ .......++..|
T Consensus        87 -~~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~-~~~~~~~~~~~y  161 (251)
T cd05041          87 -KNRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYT-VSDGLKQIPIKW  161 (251)
T ss_pred             -CCCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcce-eccccCcceecc
Confidence             33588999999999999999999984   5999999999999999999999999999865422111 011122345679


Q ss_pred             cCccccccCCCCcccccHHHHHHHHHHHh-CCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCHHHH
Q 039626          512 MAPEYLENGLVSTKLDVYAFGVLILEMLT-GKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELA  590 (628)
Q Consensus       512 ~APE~l~~~~~s~k~DV~SfGvvl~ELlt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~  590 (628)
                      +|||.+.++.++.++|+||||++++||++ |..|+......      ...... .             .......+...+
T Consensus       162 ~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~------~~~~~~-~-------------~~~~~~~~~~~~  221 (251)
T cd05041         162 TAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQ------QTRERI-E-------------SGYRMPAPQLCP  221 (251)
T ss_pred             CChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHH------HHHHHH-h-------------cCCCCCCCccCC
Confidence            99999998899999999999999999999 77666432211      111111 0             000111233445


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 039626          591 LLVIRLIDACLKKDPTDRPTMYEIEHSLS  619 (628)
Q Consensus       591 ~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~  619 (628)
                      ..+.+++.+||+.+|.+||++.|+++.|.
T Consensus       222 ~~~~~li~~~l~~~p~~Rp~~~ell~~l~  250 (251)
T cd05041         222 EEIYRLMLQCWAYDPENRPSFSEIYNELQ  250 (251)
T ss_pred             HHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence            67899999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=6.7e-33  Score=282.12  Aligned_cols=236  Identities=27%  Similarity=0.384  Sum_probs=185.0

Q ss_pred             eEEEEEEECC-----ceEEEEEecc--------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhh
Q 039626          361 GSVYRGKING-----GFAAIKKVNG--------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVF  427 (628)
Q Consensus       361 G~Vy~g~~~g-----~~vavK~~~~--------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~  427 (628)
                      |.||+|.+.+     ..+++|....        .+.+|+.++++++|+||+++++++.+ +..++||||+++|+|.+++.
T Consensus        20 g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~   98 (270)
T cd05056          20 GDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIVMELAPLGELRSYLQ   98 (270)
T ss_pred             eeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEEEEcCCCCcHHHHHH
Confidence            8999998732     3688998753        36679999999999999999999875 45789999999999999995


Q ss_pred             hcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccC
Q 039626          428 SNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVG  507 (628)
Q Consensus       428 ~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~g  507 (628)
                      ..   ...++|..++.++.+++.||+|||+.   +++|+||||+||+++.++.+||+|||+++.......  .......+
T Consensus        99 ~~---~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~  170 (270)
T cd05056          99 VN---KYSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESY--YKASKGKL  170 (270)
T ss_pred             hC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceeeecccccc--eecCCCCc
Confidence            42   33589999999999999999999984   599999999999999999999999999986643311  11122234


Q ss_pred             CccccCccccccCCCCcccccHHHHHHHHHHHh-CCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCC
Q 039626          508 TKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT-GKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYP  586 (628)
Q Consensus       508 t~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELlt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~  586 (628)
                      +..|+|||.+....++.++||||||++++|+++ |+.||......      +........          ...    ..+
T Consensus       171 ~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~------~~~~~~~~~----------~~~----~~~  230 (270)
T cd05056         171 PIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNN------DVIGRIENG----------ERL----PMP  230 (270)
T ss_pred             cccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHH------HHHHHHHcC----------CcC----CCC
Confidence            568999999988889999999999999999986 99887633221      111111100          000    112


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhc
Q 039626          587 LELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNAS  625 (628)
Q Consensus       587 ~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~~~~  625 (628)
                      ...+..+.+++.+|+..+|.+||++.++++.|+++.+.+
T Consensus       231 ~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~~  269 (270)
T cd05056         231 PNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQEE  269 (270)
T ss_pred             CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence            233456889999999999999999999999999988754

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=3.7e-33  Score=292.11  Aligned_cols=221  Identities=26%  Similarity=0.367  Sum_probs=176.4

Q ss_pred             eEEEEEEE--CCceEEEEEeccc----------hHHHHHHHhhcC-CCceeeeeeeeecCCeEEEEEEecCCCChHHHhh
Q 039626          361 GSVYRGKI--NGGFAAIKKVNGD----------VSKEIALLNKIN-HSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVF  427 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~~----------~~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~  427 (628)
                      |.||++..  +|+.+|+|.++.+          +..|..++..+. |++|+++.+++.+++..++||||+++|+|.+++.
T Consensus        14 g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~Ey~~~g~L~~~i~   93 (323)
T cd05615          14 GKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQ   93 (323)
T ss_pred             eEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEcCCCCCcHHHHHH
Confidence            89999987  6789999988642          345788888885 5678889999998899999999999999999984


Q ss_pred             hcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccC
Q 039626          428 SNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVG  507 (628)
Q Consensus       428 ~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~g  507 (628)
                      .    ...+++.++..++.|++.||+|||+.   +++||||||+|||+++++.+||+|||+++......   .......|
T Consensus        94 ~----~~~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~---~~~~~~~g  163 (323)
T cd05615          94 Q----VGKFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG---VTTRTFCG  163 (323)
T ss_pred             H----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccCCCC---ccccCccC
Confidence            3    24589999999999999999999984   59999999999999999999999999987543221   11234569


Q ss_pred             CccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCH
Q 039626          508 TKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPL  587 (628)
Q Consensus       508 t~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~  587 (628)
                      |+.|+|||++.+..++.++|||||||++|||++|+.|+.....      ......+....               ..++.
T Consensus       164 t~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~------~~~~~~i~~~~---------------~~~p~  222 (323)
T cd05615         164 TPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE------DELFQSIMEHN---------------VSYPK  222 (323)
T ss_pred             CccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCH------HHHHHHHHhCC---------------CCCCc
Confidence            9999999999998999999999999999999999999864321      11222221110               11223


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCCHH
Q 039626          588 ELALLVIRLIDACLKKDPTDRPTMY  612 (628)
Q Consensus       588 ~~~~~l~~l~~~Cl~~dP~~RPs~~  612 (628)
                      ..+..+.+++.+||+.||.+|++..
T Consensus       223 ~~~~~~~~li~~~l~~~p~~R~~~~  247 (323)
T cd05615         223 SLSKEAVSICKGLMTKHPSKRLGCG  247 (323)
T ss_pred             cCCHHHHHHHHHHcccCHhhCCCCC
Confidence            3445678999999999999999853

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=5.7e-33  Score=287.01  Aligned_cols=227  Identities=25%  Similarity=0.414  Sum_probs=182.6

Q ss_pred             eEEEEEEE--CCceEEEEEecc-------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhcCC
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG-------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKN  431 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~-------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~  431 (628)
                      |.||+|..  +++.+++|.+..       .+.+|+.++++++|+||+++++++..++..++|+||+++++|.+++..   
T Consensus        33 g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~---  109 (296)
T cd06655          33 GTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTE---  109 (296)
T ss_pred             eEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecCCCcHHHHHHh---
Confidence            89999986  788999998753       356799999999999999999999999999999999999999998842   


Q ss_pred             CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCCccc
Q 039626          432 EGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGY  511 (628)
Q Consensus       432 ~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~Y  511 (628)
                        ..++|.++..++.+++.||+|||+.   +++|+||||+||+++.++.+||+|||++........   ......++..|
T Consensus       110 --~~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~~y  181 (296)
T cd06655         110 --TCMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS---KRSTMVGTPYW  181 (296)
T ss_pred             --cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhcccccc---cCCCcCCCccc
Confidence              3489999999999999999999985   599999999999999999999999999876543221   12234688999


Q ss_pred             cCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCHHHHH
Q 039626          512 MAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELAL  591 (628)
Q Consensus       512 ~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~  591 (628)
                      +|||.+.+..++.++|||||||++|||++|+.|+.......     . ........          .+.  ...+.....
T Consensus       182 ~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~-----~-~~~~~~~~----------~~~--~~~~~~~~~  243 (296)
T cd06655         182 MAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR-----A-LYLIATNG----------TPE--LQNPEKLSP  243 (296)
T ss_pred             cCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-----H-HHHHHhcC----------Ccc--cCCcccCCH
Confidence            99999999889999999999999999999999886432211     1 11111000          000  011223445


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          592 LVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       592 ~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      .+.+++.+||..||.+||++.++++
T Consensus       244 ~~~~li~~~l~~dp~~Rpt~~~il~  268 (296)
T cd06655         244 IFRDFLNRCLEMDVEKRGSAKELLQ  268 (296)
T ss_pred             HHHHHHHHHhhcChhhCCCHHHHhh
Confidence            6789999999999999999999875

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=9.5e-33  Score=279.14  Aligned_cols=233  Identities=22%  Similarity=0.370  Sum_probs=186.5

Q ss_pred             eEEEEEEE--CCceEEEEEecc---------chHHHHHHHhhcCCCceeeeeeeeec--CCeEEEEEEecCCCChHHHhh
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG---------DVSKEIALLNKINHSNLIILSGVCFN--EGNCYLVYEYAVNGTLSDWVF  427 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~---------~~~~E~~~l~~l~H~nIv~l~g~~~~--~~~~~lV~E~~~~gsL~~~l~  427 (628)
                      |.||++..  ++..+|+|.+..         .+.+|++++++++|+||+++++++..  +...+++|||+++++|.+++.
T Consensus        14 ~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~   93 (265)
T cd08217          14 GTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQ   93 (265)
T ss_pred             eEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEehhccCCCHHHHHH
Confidence            89999987  678899998752         35579999999999999999998864  356799999999999999997


Q ss_pred             hcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC--CCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecc
Q 039626          428 SNKNEGKYLDWKQRIQIALDVATGLNYLHSFT--NPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHI  505 (628)
Q Consensus       428 ~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~  505 (628)
                      ........+++..++.++.+++.||.|||..+  ..+++|+||||+||++++++.+||+|||++........   .....
T Consensus        94 ~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~---~~~~~  170 (265)
T cd08217          94 KCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSS---FAKTY  170 (265)
T ss_pred             HHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccccCCcc---ccccc
Confidence            65445567999999999999999999999432  36699999999999999999999999999987654321   12334


Q ss_pred             cCCccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCC
Q 039626          506 VGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNY  585 (628)
Q Consensus       506 ~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~  585 (628)
                      .++..|+|||.+.+..++.++|+||||++++||++|+.|+.....      .........          ...    ...
T Consensus       171 ~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~----------~~~----~~~  230 (265)
T cd08217         171 VGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ------LQLASKIKE----------GKF----RRI  230 (265)
T ss_pred             ccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH------HHHHHHHhc----------CCC----CCC
Confidence            689999999999988899999999999999999999998864321      111111110          001    122


Q ss_pred             CHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          586 PLELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       586 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      +...+..+.+++.+||+.+|++||++++|++
T Consensus       231 ~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~  261 (265)
T cd08217         231 PYRYSSELNEVIKSMLNVDPDKRPSTEELLQ  261 (265)
T ss_pred             ccccCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence            3344566889999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=7.6e-33  Score=285.93  Aligned_cols=232  Identities=25%  Similarity=0.440  Sum_probs=174.9

Q ss_pred             ceEEEEEecc--------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhcCCC-------CCC
Q 039626          371 GFAAIKKVNG--------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNE-------GKY  435 (628)
Q Consensus       371 ~~vavK~~~~--------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~-------~~~  435 (628)
                      ..+|+|..+.        ++.+|++++++++|+||+++++++..++..++||||+++|+|.+++......       ...
T Consensus        47 ~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~  126 (296)
T cd05095          47 VLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVT  126 (296)
T ss_pred             eEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccc
Confidence            3689998863        3668999999999999999999999999999999999999999999654221       235


Q ss_pred             CCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCCccccCcc
Q 039626          436 LDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPE  515 (628)
Q Consensus       436 l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~Y~APE  515 (628)
                      +++.+...++.|++.||+|||+.   +++|+||||+|||+++++.+||+|||+++....... ........++..|++||
T Consensus       127 ~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~~~~~pe  202 (296)
T cd05095         127 ISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDY-YRIQGRAVLPIRWMSWE  202 (296)
T ss_pred             cCHHHHHHHHHHHHHHHHHHHHC---CeecccCChheEEEcCCCCEEeccCcccccccCCcc-eeccCcCcCccccCCHH
Confidence            88999999999999999999985   499999999999999999999999999986543221 11122234567899999


Q ss_pred             ccccCCCCcccccHHHHHHHHHHHh--CCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCHHHHHHH
Q 039626          516 YLENGLVSTKLDVYAFGVLILEMLT--GKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLV  593 (628)
Q Consensus       516 ~l~~~~~s~k~DV~SfGvvl~ELlt--G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l  593 (628)
                      ...++.++.++||||||+++|||++  |..|+.......   .............     .....+     .+..++..+
T Consensus       203 ~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~---~~~~~~~~~~~~~-----~~~~~~-----~~~~~~~~~  269 (296)
T cd05095         203 SILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ---VIENTGEFFRDQG-----RQVYLP-----KPALCPDSL  269 (296)
T ss_pred             HHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHH---HHHHHHHHHhhcc-----ccccCC-----CCCCCCHHH
Confidence            9888889999999999999999998  555654221111   1111111110000     000000     111233568


Q ss_pred             HHHHHHhcccCCCCCCCHHHHHHHHH
Q 039626          594 IRLIDACLKKDPTDRPTMYEIEHSLS  619 (628)
Q Consensus       594 ~~l~~~Cl~~dP~~RPs~~ev~~~L~  619 (628)
                      .+++.+||+.||.+||++.||.+.|+
T Consensus       270 ~~li~~cl~~~p~~Rp~~~~i~~~l~  295 (296)
T cd05095         270 YKLMLSCWRRNAKERPSFQEIHATLL  295 (296)
T ss_pred             HHHHHHHcCCCcccCCCHHHHHHHHh
Confidence            89999999999999999999999886

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=1.6e-33  Score=300.77  Aligned_cols=243  Identities=24%  Similarity=0.321  Sum_probs=180.4

Q ss_pred             eEEEEEEE--CCceEEEEEecc---------chHHHHHHHhhcCCCceeeeeeeeecCC-----eEEEEEEecCCCChHH
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG---------DVSKEIALLNKINHSNLIILSGVCFNEG-----NCYLVYEYAVNGTLSD  424 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~---------~~~~E~~~l~~l~H~nIv~l~g~~~~~~-----~~~lV~E~~~~gsL~~  424 (628)
                      |.||++..  +|+.+|+|++..         ++.+|+++++.++|+||+++++++...+     ..++|+||+. ++|.+
T Consensus        14 g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~   92 (372)
T cd07853          14 GVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVTELMQ-SDLHK   92 (372)
T ss_pred             EEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEEeeccc-cCHHH
Confidence            89999986  688999998853         3567999999999999999999998766     7899999995 68888


Q ss_pred             HhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeec
Q 039626          425 WVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRH  504 (628)
Q Consensus       425 ~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~  504 (628)
                      ++..    ...+++..+..++.|++.||+|||+.   +++||||||+|||+++++.+||+|||+++........  ....
T Consensus        93 ~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~~--~~~~  163 (372)
T cd07853          93 IIVS----PQPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESK--HMTQ  163 (372)
T ss_pred             HHhc----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccceeecccCccc--cCCC
Confidence            7742    34689999999999999999999985   4999999999999999999999999999865432211  1223


Q ss_pred             ccCCccccCccccccC-CCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchh------hhcccc
Q 039626          505 IVGTKGYMAPEYLENG-LVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEE------SLRHFI  577 (628)
Q Consensus       505 ~~gt~~Y~APE~l~~~-~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~------~l~~~~  577 (628)
                      ..+++.|+|||.+.+. .++.++|||||||+++||++|+.||.......   ..+.+...........      .....+
T Consensus       164 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~~i~~~~g~~~~~~~~~~~~~~~~~~  240 (372)
T cd07853         164 EVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQ---QLDLITDLLGTPSLEAMRSACEGARAHI  240 (372)
T ss_pred             CCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHH---HHHHHHHHcCCCCHHHHHHhhHHHHHHH
Confidence            4688999999998774 57999999999999999999999986433211   1111111111110000      000000


Q ss_pred             -----CCc-CC--CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          578 -----DPT-LQ--GNYPLELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       578 -----d~~-l~--~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                           .+. ..  .....+....+.+++.+||+.||++|||+.|+++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  287 (372)
T cd07853         241 LRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALA  287 (372)
T ss_pred             HhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhc
Confidence                 000 00  0011122456789999999999999999999875

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.3e-32  Score=279.24  Aligned_cols=223  Identities=19%  Similarity=0.326  Sum_probs=172.9

Q ss_pred             eEEEEEEECC--------------ceEEEEEecc-------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCC
Q 039626          361 GSVYRGKING--------------GFAAIKKVNG-------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVN  419 (628)
Q Consensus       361 G~Vy~g~~~g--------------~~vavK~~~~-------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~  419 (628)
                      |.||+|++..              ..+++|.+..       .+.+|+.++.+++||||+++++++..+...++||||+++
T Consensus         9 ~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   88 (262)
T cd05077           9 TQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEF   88 (262)
T ss_pred             ceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCEEEEecccC
Confidence            8999998632              2478887653       356788999999999999999999998899999999999


Q ss_pred             CChHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCc-------EEEccccccccC
Q 039626          420 GTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLR-------AKIANFAMARPA  492 (628)
Q Consensus       420 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~-------~kl~Dfgla~~~  492 (628)
                      |+|..++..   ....+++..+++++.|++.||+|||+   .+++||||||+|||++.++.       +|++|||++...
T Consensus        89 ~~l~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~~~~  162 (262)
T cd05077          89 GPLDLFMHR---KSDVLTTPWKFKVAKQLASALSYLED---KDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITV  162 (262)
T ss_pred             CCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHhhh---CCeECCCCCcccEEEecCCccCCCCceeEeCCCCCCccc
Confidence            999988853   23458999999999999999999998   45999999999999987664       899999998755


Q ss_pred             CCCCCcceeeecccCCccccCccccc-cCCCCcccccHHHHHHHHHHH-hCCCccccccccccccHHHHHHHHhccccch
Q 039626          493 EGQEGEFALTRHIVGTKGYMAPEYLE-NGLVSTKLDVYAFGVLILEML-TGKEAAALHAEENNMHLSDVLNAVLTKEDGE  570 (628)
Q Consensus       493 ~~~~~~~~~~~~~~gt~~Y~APE~l~-~~~~s~k~DV~SfGvvl~ELl-tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  570 (628)
                      ...       ....++..|+|||.+. +..++.++||||||+++|||+ .|+.|+.....      .+.. .....    
T Consensus       163 ~~~-------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~------~~~~-~~~~~----  224 (262)
T cd05077         163 LSR-------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTL------AEKE-RFYEG----  224 (262)
T ss_pred             cCc-------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcch------hHHH-HHHhc----
Confidence            321       2245788999999887 467899999999999999998 57766542211      1100 00000    


Q ss_pred             hhhccccCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 039626          571 ESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSL  618 (628)
Q Consensus       571 ~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L  618 (628)
                               ....  .......+.+++.+||+.||.+||++.+|++.|
T Consensus       225 ---------~~~~--~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~  261 (262)
T cd05077         225 ---------QCML--VTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI  261 (262)
T ss_pred             ---------CccC--CCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence                     0000  011234578999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=6.9e-33  Score=283.23  Aligned_cols=225  Identities=28%  Similarity=0.423  Sum_probs=182.1

Q ss_pred             eEEEEEEE--CCceEEEEEecc--------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhcC
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG--------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNK  430 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~--------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~  430 (628)
                      |.||+|..  .+..+|+|..+.        .+.+|++++++++|+||+++++++..+...++|+||+++++|.+++..  
T Consensus        18 ~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--   95 (277)
T cd06642          18 GEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLKP--   95 (277)
T ss_pred             eeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccCCCcHHHHhhc--
Confidence            89999987  577899998752        367899999999999999999999999999999999999999998832  


Q ss_pred             CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCCcc
Q 039626          431 NEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKG  510 (628)
Q Consensus       431 ~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~  510 (628)
                         ..+++..+..++.+++.||.|||+   .+++|+||+|+||++++++.+|++|||++........   ......++..
T Consensus        96 ---~~~~~~~~~~~~~~i~~~l~~lH~---~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~  166 (277)
T cd06642          96 ---GPLEETYIATILREILKGLDYLHS---ERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI---KRNTFVGTPF  166 (277)
T ss_pred             ---CCCCHHHHHHHHHHHHHHHHHHhc---CCeeccCCChheEEEeCCCCEEEccccccccccCcch---hhhcccCccc
Confidence               358999999999999999999998   4599999999999999999999999999876543221   1122467889


Q ss_pred             ccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCHHHH
Q 039626          511 YMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELA  590 (628)
Q Consensus       511 Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~  590 (628)
                      |+|||++.+..++.++||||||++++||++|+.|+......      ......          .....+.+    +...+
T Consensus       167 y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~------~~~~~~----------~~~~~~~~----~~~~~  226 (277)
T cd06642         167 WMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPM------RVLFLI----------PKNSPPTL----EGQYS  226 (277)
T ss_pred             ccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchh------hHHhhh----------hcCCCCCC----CcccC
Confidence            99999999989999999999999999999999887532111      011100          00011111    22344


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          591 LLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       591 ~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      ..+.+++.+||+.+|++||++.|+++
T Consensus       227 ~~~~~li~~~l~~~p~~Rp~~~~il~  252 (277)
T cd06642         227 KPFKEFVEACLNKDPRFRPTAKELLK  252 (277)
T ss_pred             HHHHHHHHHHccCCcccCcCHHHHHH
Confidence            56789999999999999999999997

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=2.7e-33  Score=293.40  Aligned_cols=224  Identities=24%  Similarity=0.340  Sum_probs=177.0

Q ss_pred             eEEEEEEE--CCceEEEEEeccc----------hHHHHH-HHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhh
Q 039626          361 GSVYRGKI--NGGFAAIKKVNGD----------VSKEIA-LLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVF  427 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~~----------~~~E~~-~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~  427 (628)
                      |.||+++.  +|+.+|+|.+...          +..|.. +++.++|+||+++++++..++..++||||+++|+|.+++.
T Consensus         9 g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~   88 (325)
T cd05604           9 GKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQ   88 (325)
T ss_pred             eEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCCCCHHHHHH
Confidence            89999987  6889999988542          233433 5678999999999999999999999999999999998884


Q ss_pred             hcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccC
Q 039626          428 SNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVG  507 (628)
Q Consensus       428 ~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~g  507 (628)
                      .    ...+++.....++.||+.||+|||+.   +++||||||+|||+++++.+||+|||+++.......   ......|
T Consensus        89 ~----~~~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~---~~~~~~g  158 (325)
T cd05604          89 R----ERSFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD---TTTTFCG  158 (325)
T ss_pred             H----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC---CcccccC
Confidence            3    34589999999999999999999984   599999999999999999999999999875422111   1234579


Q ss_pred             CccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCH
Q 039626          508 TKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPL  587 (628)
Q Consensus       508 t~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~  587 (628)
                      |+.|+|||.+.+..++.++|||||||+++||++|+.|+.....      .+.........           ..+..    
T Consensus       159 t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~------~~~~~~~~~~~-----------~~~~~----  217 (325)
T cd05604         159 TPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDV------AEMYDNILHKP-----------LVLRP----  217 (325)
T ss_pred             ChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCH------HHHHHHHHcCC-----------ccCCC----
Confidence            9999999999999999999999999999999999999864321      12222222110           00111    


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 039626          588 ELALLVIRLIDACLKKDPTDRPTMYEIE  615 (628)
Q Consensus       588 ~~~~~l~~l~~~Cl~~dP~~RPs~~ev~  615 (628)
                      .....+.+++.+|++.||.+||++++.+
T Consensus       218 ~~~~~~~~ll~~ll~~~p~~R~~~~~~~  245 (325)
T cd05604         218 GASLTAWSILEELLEKDRQRRLGAKEDF  245 (325)
T ss_pred             CCCHHHHHHHHHHhccCHHhcCCCCCCH
Confidence            2334577899999999999999986443

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=6.1e-33  Score=283.52  Aligned_cols=213  Identities=23%  Similarity=0.362  Sum_probs=166.0

Q ss_pred             eEEEEEecc-------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhcCCCCCCCCHHHHHHH
Q 039626          372 FAAIKKVNG-------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQI  444 (628)
Q Consensus       372 ~vavK~~~~-------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i  444 (628)
                      .|++|.+..       .+.+|+.++++++|+||++++|+|.++...++||||+++|+|.+++..   ....+++..++.+
T Consensus        46 ~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~---~~~~~~~~~~~~i  122 (274)
T cd05076          46 RVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRK---EKGRVPVAWKITV  122 (274)
T ss_pred             eEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCceEEEEecCCCCcHHHHHHh---cCCCCCHHHHHHH
Confidence            578888753       356789999999999999999999999999999999999999999853   2345899999999


Q ss_pred             HHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCC-------cEEEccccccccCCCCCCcceeeecccCCccccCcccc
Q 039626          445 ALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDL-------RAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYL  517 (628)
Q Consensus       445 ~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~-------~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~Y~APE~l  517 (628)
                      +.|++.||+|||+   .+++||||||+|||+++++       .+|++|||++......       ....++..|+|||.+
T Consensus       123 ~~qi~~~l~~lH~---~~iiH~dlkp~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~-------~~~~~~~~~~aPe~~  192 (274)
T cd05076         123 AQQLASALSYLED---KNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSR-------EERVERIPWIAPECV  192 (274)
T ss_pred             HHHHHHHHHHHHc---CCccCCCCCcccEEEeccCcccCccceeeecCCccccccccc-------cccccCCcccCchhh
Confidence            9999999999998   4599999999999997654       3799999988654321       123577889999988


Q ss_pred             cc-CCCCcccccHHHHHHHHHHH-hCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCHHHHHHHHH
Q 039626          518 EN-GLVSTKLDVYAFGVLILEML-TGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIR  595 (628)
Q Consensus       518 ~~-~~~s~k~DV~SfGvvl~ELl-tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~  595 (628)
                      .+ ..++.++||||||+++||++ +|+.|+.......   .....    ...           ...    +......+.+
T Consensus       193 ~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~---~~~~~----~~~-----------~~~----~~~~~~~~~~  250 (274)
T cd05076         193 PGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE---KERFY----EKK-----------HRL----PEPSCKELAT  250 (274)
T ss_pred             cCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH---HHHHH----Hhc-----------cCC----CCCCChHHHH
Confidence            75 56899999999999999995 6887775322111   01111    000           001    1112235789


Q ss_pred             HHHHhcccCCCCCCCHHHHHHHHH
Q 039626          596 LIDACLKKDPTDRPTMYEIEHSLS  619 (628)
Q Consensus       596 l~~~Cl~~dP~~RPs~~ev~~~L~  619 (628)
                      ++.+||+.+|++||++++|++.|+
T Consensus       251 li~~cl~~~p~~Rps~~~il~~L~  274 (274)
T cd05076         251 LISQCLTYEPTQRPSFRTILRDLT  274 (274)
T ss_pred             HHHHHcccChhhCcCHHHHHHhhC
Confidence            999999999999999999998873

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=8.1e-33  Score=286.00  Aligned_cols=227  Identities=24%  Similarity=0.391  Sum_probs=182.9

Q ss_pred             eEEEEEEE--CCceEEEEEecc-------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhcCC
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG-------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKN  431 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~-------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~  431 (628)
                      |.||++..  +++.+|+|.+..       .+.+|+.+++.++|+||+++++++..++..++||||+++++|.+++..   
T Consensus        33 g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~---  109 (297)
T cd06656          33 GTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE---  109 (297)
T ss_pred             eEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecccCCCCHHHHHHh---
Confidence            89999986  688999998853       356799999999999999999999999999999999999999999842   


Q ss_pred             CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCCccc
Q 039626          432 EGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGY  511 (628)
Q Consensus       432 ~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~Y  511 (628)
                        ..+++.++..++.+++.||.|||+.   +++||||||+||+++.++.+||+|||++........   ......+++.|
T Consensus       110 --~~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~---~~~~~~~~~~y  181 (297)
T cd06656         110 --TCMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS---KRSTMVGTPYW  181 (297)
T ss_pred             --CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEccCCcc---CcCcccCCccc
Confidence              3488999999999999999999984   599999999999999999999999999876543221   12234688899


Q ss_pred             cCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCHHHHH
Q 039626          512 MAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELAL  591 (628)
Q Consensus       512 ~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~  591 (628)
                      +|||.+.+..++.++|+||||++++|+++|+.|+.........     . ...            .........+.....
T Consensus       182 ~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~-----~-~~~------------~~~~~~~~~~~~~~~  243 (297)
T cd06656         182 MAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL-----Y-LIA------------TNGTPELQNPERLSA  243 (297)
T ss_pred             cCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhe-----e-eec------------cCCCCCCCCccccCH
Confidence            9999999988999999999999999999999988532211100     0 000            000001112233455


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          592 LVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       592 ~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      .+.+++.+||+.||++||+++++++
T Consensus       244 ~~~~li~~~l~~~p~~Rps~~~il~  268 (297)
T cd06656         244 VFRDFLNRCLEMDVDRRGSAKELLQ  268 (297)
T ss_pred             HHHHHHHHHccCChhhCcCHHHHhc
Confidence            6789999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1e-32  Score=280.09  Aligned_cols=229  Identities=26%  Similarity=0.448  Sum_probs=182.6

Q ss_pred             eEEEEEEE--CCceEEEEEecc----------------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCCh
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG----------------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTL  422 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~----------------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL  422 (628)
                      |.||+|..  +++.+|+|.+..                .+.+|++++++++|+||+++++++.+.+..++|+||+++++|
T Consensus        14 ~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   93 (267)
T cd06628          14 GSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHLNIFLEYVPGGSV   93 (267)
T ss_pred             eEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCccEEEEEecCCCCH
Confidence            89999987  578899997742                356799999999999999999999999999999999999999


Q ss_pred             HHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcce--
Q 039626          423 SDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFA--  500 (628)
Q Consensus       423 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~--  500 (628)
                      .+++..    ...+++..+..++.+++.||+|||+.   +++||||+|+||++++++.+||+|||+++..........  
T Consensus        94 ~~~l~~----~~~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~  166 (267)
T cd06628          94 AALLNN----YGAFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTN  166 (267)
T ss_pred             HHHHHh----ccCccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCCCcccccccccCCcc
Confidence            999943    24588999999999999999999984   599999999999999999999999999987653211100  


Q ss_pred             -eeecccCCccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCC
Q 039626          501 -LTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDP  579 (628)
Q Consensus       501 -~~~~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~  579 (628)
                       ......|+..|+|||.+.+..++.++|+||||++++||++|+.|+.....     . ..+...          .....+
T Consensus       167 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~-~~~~~~----------~~~~~~  230 (267)
T cd06628         167 GARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQ-----L-QAIFKI----------GENASP  230 (267)
T ss_pred             ccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccH-----H-HHHHHH----------hccCCC
Confidence             11224588899999999988899999999999999999999999863211     0 111111          011112


Q ss_pred             cCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          580 TLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       580 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      ..    +...+..+.+++.+||+.||.+||++.|+++
T Consensus       231 ~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  263 (267)
T cd06628         231 EI----PSNISSEAIDFLEKTFEIDHNKRPTAAELLK  263 (267)
T ss_pred             cC----CcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence            22    2234456789999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=1.9e-32  Score=280.06  Aligned_cols=226  Identities=27%  Similarity=0.417  Sum_probs=184.2

Q ss_pred             eEEEEEEE--CCceEEEEEecc--------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhcC
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG--------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNK  430 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~--------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~  430 (628)
                      |.||+|..  .+..+|+|.++.        ++.+|++++++++|+||+++++++.++...++||||+++|+|.+++..  
T Consensus        18 ~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~--   95 (277)
T cd06640          18 GEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRA--   95 (277)
T ss_pred             eEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecCCCCcHHHHHhc--
Confidence            89999987  578899998753        366799999999999999999999999999999999999999999842  


Q ss_pred             CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCCcc
Q 039626          431 NEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKG  510 (628)
Q Consensus       431 ~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~  510 (628)
                         ..+++.+...++.+++.||+|||+   .+++|+||+|+||+++.++.++|+|||++........   ......++..
T Consensus        96 ---~~l~~~~~~~~~~~l~~~l~~lh~---~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~  166 (277)
T cd06640          96 ---GPFDEFQIATMLKEILKGLDYLHS---EKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI---KRNTFVGTPF  166 (277)
T ss_pred             ---CCCCHHHHHHHHHHHHHHHHHHHh---CCccCcCCChhhEEEcCCCCEEEcccccceeccCCcc---ccccccCccc
Confidence               348889999999999999999998   4599999999999999999999999999976643221   1223468889


Q ss_pred             ccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCHHHH
Q 039626          511 YMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELA  590 (628)
Q Consensus       511 Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~  590 (628)
                      |+|||++.+..++.++|+||||++++||++|+.|+......      ......              ........+...+
T Consensus       167 y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~------~~~~~~--------------~~~~~~~~~~~~~  226 (277)
T cd06640         167 WMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPM------RVLFLI--------------PKNNPPTLTGEFS  226 (277)
T ss_pred             ccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChH------hHhhhh--------------hcCCCCCCchhhh
Confidence            99999999888999999999999999999999887532211      000000              0011122334566


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHHH
Q 039626          591 LLVIRLIDACLKKDPTDRPTMYEIEHS  617 (628)
Q Consensus       591 ~~l~~l~~~Cl~~dP~~RPs~~ev~~~  617 (628)
                      ..+.+++.+||+.+|++||+++++++.
T Consensus       227 ~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06640         227 KPFKEFIDACLNKDPSFRPTAKELLKH  253 (277)
T ss_pred             HHHHHHHHHHcccCcccCcCHHHHHhC
Confidence            778899999999999999999999765

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=1.5e-32  Score=286.38  Aligned_cols=184  Identities=27%  Similarity=0.416  Sum_probs=150.1

Q ss_pred             eEEEEEEEC----CceEEEEEecc-----chHHHHHHHhhcCCCceeeeeeeeec--CCeEEEEEEecCCCChHHHhhhc
Q 039626          361 GSVYRGKIN----GGFAAIKKVNG-----DVSKEIALLNKINHSNLIILSGVCFN--EGNCYLVYEYAVNGTLSDWVFSN  429 (628)
Q Consensus       361 G~Vy~g~~~----g~~vavK~~~~-----~~~~E~~~l~~l~H~nIv~l~g~~~~--~~~~~lV~E~~~~gsL~~~l~~~  429 (628)
                      |.||+++..    +..+|+|++..     .+.+|++++++++|+||+++++++..  +...++|+||++ ++|.+++...
T Consensus        15 g~Vy~~~~~~~~~~~~~a~k~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~   93 (317)
T cd07867          15 GHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE-HDLWHIIKFH   93 (317)
T ss_pred             eeEEEEEecCCCccceEEEEEecCCCCcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC-CcHHHHHHhh
Confidence            899999872    36799998864     46789999999999999999999864  457899999985 5788877432


Q ss_pred             C-----CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEe----CCCCcEEEccccccccCCCCCCcce
Q 039626          430 K-----NEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLL----DSDLRAKIANFAMARPAEGQEGEFA  500 (628)
Q Consensus       430 ~-----~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl----~~~~~~kl~Dfgla~~~~~~~~~~~  500 (628)
                      .     .....+++..+..++.|++.||.|||+.   +++||||||+|||+    ++++.+||+|||+++..........
T Consensus        94 ~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~  170 (317)
T cd07867          94 RASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLA  170 (317)
T ss_pred             hccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeeccceeccCCCccccc
Confidence            1     1223588999999999999999999984   49999999999999    5678999999999987654322222


Q ss_pred             eeecccCCccccCcccccc-CCCCcccccHHHHHHHHHHHhCCCccccc
Q 039626          501 LTRHIVGTKGYMAPEYLEN-GLVSTKLDVYAFGVLILEMLTGKEAAALH  548 (628)
Q Consensus       501 ~~~~~~gt~~Y~APE~l~~-~~~s~k~DV~SfGvvl~ELltG~~p~~~~  548 (628)
                      ......||+.|+|||.+.+ ..++.++|||||||+++||++|+.|+...
T Consensus       171 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~  219 (317)
T cd07867         171 DLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             ccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence            2234578999999999876 45899999999999999999999998643

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=7.4e-33  Score=284.55  Aligned_cols=230  Identities=23%  Similarity=0.334  Sum_probs=182.5

Q ss_pred             eEEEEEEE--CCceEEEEEecc----------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhh
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG----------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFS  428 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  428 (628)
                      |.||++..  .++.+|+|++..          .+.+|+.++++++|+|++++.+.+.+++..++||||+++|+|.+++..
T Consensus        14 g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~   93 (285)
T cd05630          14 GEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYH   93 (285)
T ss_pred             eEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEecCCCcHHHHHHH
Confidence            89999988  578999998753          245699999999999999999999999999999999999999999854


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCC
Q 039626          429 NKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGT  508 (628)
Q Consensus       429 ~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt  508 (628)
                      .  ....+++..+..++.|++.||.|||+   .+++||||||+||++++++.++|+|||++........    .....|+
T Consensus        94 ~--~~~~l~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~----~~~~~g~  164 (285)
T cd05630          94 M--GEAGFEEGRAVFYAAEICCGLEDLHQ---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT----IKGRVGT  164 (285)
T ss_pred             h--cccCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc----ccCCCCC
Confidence            2  23458999999999999999999998   4599999999999999999999999999876532211    1234689


Q ss_pred             ccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCHH
Q 039626          509 KGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLE  588 (628)
Q Consensus       509 ~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~  588 (628)
                      ..|+|||.+.+..++.++||||||++++||++|+.||.......   ..+........      .        ...++..
T Consensus       165 ~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~---~~~~~~~~~~~------~--------~~~~~~~  227 (285)
T cd05630         165 VGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI---KREEVERLVKE------V--------QEEYSEK  227 (285)
T ss_pred             ccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccc---hHHHHHhhhhh------h--------hhhcCcc
Confidence            99999999999999999999999999999999999986432211   01111111100      0        0011222


Q ss_pred             HHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 039626          589 LALLVIRLIDACLKKDPTDRPT-----MYEIEH  616 (628)
Q Consensus       589 ~~~~l~~l~~~Cl~~dP~~RPs-----~~ev~~  616 (628)
                      ....+.+++.+||+.||++|||     ++|+++
T Consensus       228 ~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~  260 (285)
T cd05630         228 FSPDARSLCKMLLCKDPKERLGCQGGGAREVKE  260 (285)
T ss_pred             CCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence            3455789999999999999999     777765

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=3.6e-33  Score=299.12  Aligned_cols=180  Identities=22%  Similarity=0.342  Sum_probs=154.0

Q ss_pred             eEEEEEEE--CCceEEEEEecc----------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhh
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG----------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFS  428 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  428 (628)
                      |.||+++.  +++.+|+|++..          .+.+|++++++++|+||+++++.+.+++..++||||+++|+|.+++..
T Consensus        15 g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~   94 (382)
T cd05625          15 GEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIR   94 (382)
T ss_pred             EEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeCCCCCcHHHHHHh
Confidence            89999988  678899999864          356799999999999999999999999999999999999999999854


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCC-----------
Q 039626          429 NKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEG-----------  497 (628)
Q Consensus       429 ~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~-----------  497 (628)
                          ...+++.....++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++.......           
T Consensus        95 ----~~~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~~~~~~~~  167 (382)
T cd05625          95 ----MGIFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVR  167 (382)
T ss_pred             ----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCccccccccccccccccccc
Confidence                23578888899999999999999985   499999999999999999999999999754311000           


Q ss_pred             ---------------------------------cceeeecccCCccccCccccccCCCCcccccHHHHHHHHHHHhCCCc
Q 039626          498 ---------------------------------EFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEA  544 (628)
Q Consensus       498 ---------------------------------~~~~~~~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p  544 (628)
                                                       .........||+.|+|||++.+..++.++|||||||++|||++|+.|
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~P  247 (382)
T cd05625         168 QDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPP  247 (382)
T ss_pred             cccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHHHHHHhCCCC
Confidence                                             00011234699999999999999999999999999999999999999


Q ss_pred             ccc
Q 039626          545 AAL  547 (628)
Q Consensus       545 ~~~  547 (628)
                      |..
T Consensus       248 f~~  250 (382)
T cd05625         248 FLA  250 (382)
T ss_pred             CCC
Confidence            864

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=5.2e-33  Score=285.28  Aligned_cols=234  Identities=27%  Similarity=0.418  Sum_probs=185.2

Q ss_pred             eEEEEEEE--CCceEEEEEecc--------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhcC
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG--------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNK  430 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~--------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~  430 (628)
                      |.||++..  +|..+|+|....        ++.+|+++++.++|+||+++++++...+..++||||+++|+|.+++..  
T Consensus        19 g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--   96 (284)
T cd06620          19 GSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKK--   96 (284)
T ss_pred             eEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEecCCCCCHHHHHHh--
Confidence            89999998  478899997642        366899999999999999999999999999999999999999998843  


Q ss_pred             CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCCcc
Q 039626          431 NEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKG  510 (628)
Q Consensus       431 ~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~  510 (628)
                        ...+++.....++.+++.||.|||+.  .+++|+||||+||++++++.++|+|||++.......     .....|+..
T Consensus        97 --~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~-----~~~~~~~~~  167 (284)
T cd06620          97 --GGPIPVEILGKIAVAVVEGLTYLYNV--HRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI-----ADTFVGTST  167 (284)
T ss_pred             --ccCCCHHHHHHHHHHHHHHHHHHHHh--cCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc-----cCccccCcc
Confidence              34589999999999999999999972  359999999999999999999999999987543211     223578999


Q ss_pred             ccCccccccCCCCcccccHHHHHHHHHHHhCCCcccccccccc-----ccHHHHHHHHhccccchhhhccccCCcCCCCC
Q 039626          511 YMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENN-----MHLSDVLNAVLTKEDGEESLRHFIDPTLQGNY  585 (628)
Q Consensus       511 Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~  585 (628)
                      |+|||++.+..++.++|+|||||+++||++|+.|+........     ....+......             ........
T Consensus       168 ~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~  234 (284)
T cd06620         168 YMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIV-------------QEPPPRLP  234 (284)
T ss_pred             cCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHh-------------hccCCCCC
Confidence            9999999888999999999999999999999999875332210     11111111111             11111011


Q ss_pred             CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 039626          586 PLELALLVIRLIDACLKKDPTDRPTMYEIEHSL  618 (628)
Q Consensus       586 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L  618 (628)
                      ..+.+..+.+++.+||+.||.+||+++|+++..
T Consensus       235 ~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~  267 (284)
T cd06620         235 SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP  267 (284)
T ss_pred             chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence            112445688999999999999999999999753

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=6.6e-33  Score=284.24  Aligned_cols=245  Identities=27%  Similarity=0.387  Sum_probs=180.9

Q ss_pred             eEEEEEEE--CCceEEEEEecc---------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhc
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG---------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSN  429 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~---------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~  429 (628)
                      |.||+|+.  ++..+|+|+++.         .+.+|+.++++++|+||+++++++.+++..++||||++ ++|.+++...
T Consensus        14 ~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~~~~~   92 (285)
T cd07861          14 GVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFLS-MDLKKYLDSL   92 (285)
T ss_pred             eEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecCC-CCHHHHHhcC
Confidence            89999988  578999998752         36789999999999999999999999999999999996 6899888543


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCCc
Q 039626          430 KNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTK  509 (628)
Q Consensus       430 ~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~  509 (628)
                      . .+..+++..+..++.|++.||+|||+.   +++|+||||+||++++++.+||+|||++........   ......+++
T Consensus        93 ~-~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~  165 (285)
T cd07861          93 P-KGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR---VYTHEVVTL  165 (285)
T ss_pred             C-CCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecCCCcc---cccCCcccc
Confidence            2 235689999999999999999999984   599999999999999999999999999876532211   122346788


Q ss_pred             cccCccccccC-CCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccc-----------cchhhhcccc
Q 039626          510 GYMAPEYLENG-LVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKE-----------DGEESLRHFI  577 (628)
Q Consensus       510 ~Y~APE~l~~~-~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~l~~~~  577 (628)
                      .|+|||.+.+. .++.++||||||++++||++|+.|+.......  .............           ........+.
T Consensus       166 ~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (285)
T cd07861         166 WYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEID--QLFRIFRILGTPTEDVWPGVTSLPDYKNTFPKWK  243 (285)
T ss_pred             cccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH--HHHHHHHHhCCCChhhhhcchhhHHHHhhccccC
Confidence            99999988654 57899999999999999999998886432211  0111111100000           0000000000


Q ss_pred             CCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          578 DPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       578 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      ..... ......+.++.+++.+||+.||.+|||+++|+.
T Consensus       244 ~~~~~-~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~  281 (285)
T cd07861         244 KGSLR-SAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN  281 (285)
T ss_pred             cchhH-HhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence            00000 001123456789999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=1e-32  Score=279.88  Aligned_cols=231  Identities=25%  Similarity=0.417  Sum_probs=182.2

Q ss_pred             eEEEEEEE-CCceEEEEEecc-------------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHh
Q 039626          361 GSVYRGKI-NGGFAAIKKVNG-------------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWV  426 (628)
Q Consensus       361 G~Vy~g~~-~g~~vavK~~~~-------------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l  426 (628)
                      |.||+|.. +|+.+|+|.++.             .+.+|++++++++|+||+++++++.+.+..++|+||+++++|.+++
T Consensus        14 ~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l   93 (265)
T cd06631          14 GTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSIL   93 (265)
T ss_pred             eEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEEecCCCCcHHHHH
Confidence            89999987 678899998752             3567999999999999999999999999999999999999999999


Q ss_pred             hhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCC---cceeee
Q 039626          427 FSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEG---EFALTR  503 (628)
Q Consensus       427 ~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~---~~~~~~  503 (628)
                      ...    ..+++..+..++.|++.||+|||+.   +++|+||+|+||++++++.+||+|||++........   ......
T Consensus        94 ~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~  166 (265)
T cd06631          94 NRF----GPLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLK  166 (265)
T ss_pred             Hhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHhhhhcccccccccccc
Confidence            532    3478999999999999999999984   499999999999999999999999999876532111   011123


Q ss_pred             cccCCccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCC
Q 039626          504 HIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQG  583 (628)
Q Consensus       504 ~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~  583 (628)
                      ...++..|+|||++.+..++.++||||||++++||++|+.|+......     .... ......        ...+.+  
T Consensus       167 ~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~-----~~~~-~~~~~~--------~~~~~~--  230 (265)
T cd06631         167 SMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRL-----AAMF-YIGAHR--------GLMPRL--  230 (265)
T ss_pred             ccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChH-----HHHH-Hhhhcc--------CCCCCC--
Confidence            356899999999999988999999999999999999999998632211     1110 100000        011112  


Q ss_pred             CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          584 NYPLELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       584 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                        +......+.+++.+||+.+|.+||++.|+++
T Consensus       231 --~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~  261 (265)
T cd06631         231 --PDSFSAAAIDFVTSCLTRDQHERPSALQLLR  261 (265)
T ss_pred             --CCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence              2233456789999999999999999999874

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=2.3e-33  Score=299.95  Aligned_cols=231  Identities=22%  Similarity=0.286  Sum_probs=176.5

Q ss_pred             eEEEEEEE--CCceEEEEEecc----------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhh
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG----------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFS  428 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  428 (628)
                      |.||+++.  .++.+|+|.+..          .+.+|+++|.+++|+||+++++.+.+++..++||||+++|+|.+++..
T Consensus        15 g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~i~~   94 (376)
T cd05598          15 GEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIR   94 (376)
T ss_pred             eEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEeCCCCCcHHHHHHh
Confidence            89999987  578999998853          256799999999999999999999999999999999999999999953


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCC-----------
Q 039626          429 NKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEG-----------  497 (628)
Q Consensus       429 ~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~-----------  497 (628)
                          ...+++.....++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||++........           
T Consensus        95 ----~~~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~~~~~~~~  167 (376)
T cd05598          95 ----LGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHR  167 (376)
T ss_pred             ----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCccccccccccccccccccc
Confidence                34588888899999999999999984   599999999999999999999999999753310000           


Q ss_pred             -----------------------------cceeeecccCCccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccc
Q 039626          498 -----------------------------EFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALH  548 (628)
Q Consensus       498 -----------------------------~~~~~~~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~  548 (628)
                                                   .........||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~  247 (376)
T cd05598         168 QDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLAD  247 (376)
T ss_pred             cccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeehhhCCCCCCCC
Confidence                                         000112347999999999999999999999999999999999999998643


Q ss_pred             cccccccHHHHHHHHhccccchhhhccccCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCC---CHHHHHH
Q 039626          549 AEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRP---TMYEIEH  616 (628)
Q Consensus       549 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP---s~~ev~~  616 (628)
                      ...      +....+....   .        .+........+..+.+++.+|+ .+|.+|+   ++.|+++
T Consensus       248 ~~~------~~~~~i~~~~---~--------~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~  300 (376)
T cd05598         248 TPA------ETQLKVINWE---T--------TLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKA  300 (376)
T ss_pred             CHH------HHHHHHhccC---c--------cccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhC
Confidence            321      1111111000   0        0000011123345667777766 5999999   7777764

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=3.1e-33  Score=298.15  Aligned_cols=249  Identities=21%  Similarity=0.269  Sum_probs=188.4

Q ss_pred             cHHHHHHHhcCCCcCCccc----eEEEEEEE--CCceEEEEEecc----------chHHHHHHHhhcCCCceeeeeeeee
Q 039626          342 SFKELQSATDNFSFTCRIQ----GSVYRGKI--NGGFAAIKKVNG----------DVSKEIALLNKINHSNLIILSGVCF  405 (628)
Q Consensus       342 ~~~el~~at~~f~~~~~i~----G~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~nIv~l~g~~~  405 (628)
                      .+.++....++|.....+|    |.||++..  .++.+|+|.+..          .+.+|+.+++.++||||+++++++.
T Consensus        34 ~~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~  113 (371)
T cd05622          34 KIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQ  113 (371)
T ss_pred             HHhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence            3445555667777666665    89999988  577899998753          2457999999999999999999999


Q ss_pred             cCCeEEEEEEecCCCChHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEcc
Q 039626          406 NEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIAN  485 (628)
Q Consensus       406 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~D  485 (628)
                      +++..++||||+++|+|.+++..     ..++...+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|
T Consensus       114 ~~~~~~lv~Ey~~gg~L~~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~D  185 (371)
T cd05622         114 DDRYLYMVMEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLAD  185 (371)
T ss_pred             cCCEEEEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEe
Confidence            99999999999999999999843     2378888899999999999999984   599999999999999999999999


Q ss_pred             ccccccCCCCCCcceeeecccCCccccCccccccC----CCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHH
Q 039626          486 FAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENG----LVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLN  561 (628)
Q Consensus       486 fgla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~----~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~  561 (628)
                      ||+++.......  .......||+.|+|||.+.+.    .++.++|||||||++|||++|+.||.....      .....
T Consensus       186 fG~a~~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~------~~~~~  257 (371)
T cd05622         186 FGTCMKMNKEGM--VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL------VGTYS  257 (371)
T ss_pred             CCceeEcCcCCc--ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCH------HHHHH
Confidence            999987643211  112345799999999998753    378999999999999999999999864321      11122


Q ss_pred             HHhccccchhhhccccCCcCCCCCCHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 039626          562 AVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTD--RPTMYEIEHS  617 (628)
Q Consensus       562 ~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPs~~ev~~~  617 (628)
                      .+.....   .        +........+..+.+++.+|+..++.+  |+++.|+++.
T Consensus       258 ~i~~~~~---~--------~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h  304 (371)
T cd05622         258 KIMNHKN---S--------LTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH  304 (371)
T ss_pred             HHHcCCC---c--------ccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence            2211110   0        000011134456788999999844433  6788877753

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=1.5e-33  Score=299.50  Aligned_cols=180  Identities=21%  Similarity=0.322  Sum_probs=155.0

Q ss_pred             eEEEEEEE--CCceEEEEEecc----------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhh
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG----------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFS  428 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  428 (628)
                      |.||++..  .++.+|+|.++.          .+..|+.++.+++|+||+++++.+.+++..++||||+++|+|.+++..
T Consensus        15 g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~   94 (360)
T cd05627          15 GEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMK   94 (360)
T ss_pred             EEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCCccHHHHHHh
Confidence            89999988  578999998853          245699999999999999999999999999999999999999999853


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCc----------
Q 039626          429 NKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGE----------  498 (628)
Q Consensus       429 ~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~----------  498 (628)
                          ...+++.....++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++........          
T Consensus        95 ----~~~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~~~~~~~~  167 (360)
T cd05627          95 ----KDTLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNP  167 (360)
T ss_pred             ----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCcccccccccccccccccCC
Confidence                34589999999999999999999984   5999999999999999999999999998754321100          


Q ss_pred             ----------------------ceeeecccCCccccCccccccCCCCcccccHHHHHHHHHHHhCCCcccc
Q 039626          499 ----------------------FALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAAL  547 (628)
Q Consensus       499 ----------------------~~~~~~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~  547 (628)
                                            ........||+.|+|||++.+..++.++|||||||+++||++|+.||..
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~  238 (360)
T cd05627         168 PSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCS  238 (360)
T ss_pred             cccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCC
Confidence                                  0011234799999999999999999999999999999999999999864

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=6.6e-33  Score=288.26  Aligned_cols=242  Identities=22%  Similarity=0.358  Sum_probs=180.6

Q ss_pred             eEEEEEEE--CCceEEEEEecc--------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhcC
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG--------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNK  430 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~--------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~  430 (628)
                      |.||+|+.  .++.+|+|+++.        .+.+|++++++++|+||+++++++..++..++||||++ ++|.+++..  
T Consensus        20 g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~--   96 (309)
T cd07872          20 ATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLD-KDLKQYMDD--   96 (309)
T ss_pred             EEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeCCC-CCHHHHHHh--
Confidence            89999987  577899998763        35689999999999999999999999999999999996 488888753  


Q ss_pred             CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCCcc
Q 039626          431 NEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKG  510 (628)
Q Consensus       431 ~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~  510 (628)
                       .+..+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||+++.......   ......++..
T Consensus        97 -~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~~  169 (309)
T cd07872          97 -CGNIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK---TYSNEVVTLW  169 (309)
T ss_pred             -cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCCCcc---cccccccccc
Confidence             234588999999999999999999984   599999999999999999999999999876532221   1223467899


Q ss_pred             ccCcccccc-CCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhc------cccC---Cc
Q 039626          511 YMAPEYLEN-GLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLR------HFID---PT  580 (628)
Q Consensus       511 Y~APE~l~~-~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~------~~~d---~~  580 (628)
                      |+|||.+.+ ..++.++||||||++++||++|+.||......+   ....+......... +...      .+.+   +.
T Consensus       170 y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~---~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~  245 (309)
T cd07872         170 YRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVED---ELHLIFRLLGTPTE-ETWPGISSNDEFKNYNFPK  245 (309)
T ss_pred             ccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHHhCCCCH-HHHhhhcchhhhhhhhcCc
Confidence            999998865 568999999999999999999999986433221   11111111111100 0000      0000   00


Q ss_pred             CCC----CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          581 LQG----NYPLELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       581 l~~----~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      ...    .........+.+++.+||+.||.+|||+.|+++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~  285 (309)
T cd07872         246 YKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK  285 (309)
T ss_pred             cCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence            000    001123456789999999999999999999876

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.3e-33  Score=293.00  Aligned_cols=229  Identities=26%  Similarity=0.439  Sum_probs=192.5

Q ss_pred             eEEE--EEEECCceEEEEEecc---------chHHHHHHHhhcCCCceeeeeeeeecCCe-EEEEEEecCCCChHHHhhh
Q 039626          361 GSVY--RGKINGGFAAIKKVNG---------DVSKEIALLNKINHSNLIILSGVCFNEGN-CYLVYEYAVNGTLSDWVFS  428 (628)
Q Consensus       361 G~Vy--~g~~~g~~vavK~~~~---------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~-~~lV~E~~~~gsL~~~l~~  428 (628)
                      |+++  +++.++..+++|++.-         ...+|+.++++++|||||.+.+.+.+++. .++||+|++||+|.+.+..
T Consensus        18 G~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~Y~eGg~l~~~i~~   97 (426)
T KOG0589|consen   18 GSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVMEYCEGGDLAQLIKE   97 (426)
T ss_pred             chhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEEeecCCCCHHHHHHH
Confidence            5554  5555888999998853         35789999999999999999999999888 9999999999999999976


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCC
Q 039626          429 NKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGT  508 (628)
Q Consensus       429 ~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt  508 (628)
                      .+  +..+++.++..++.|++.|++|||+   ..|+|||||+.||+++.+..+||+|||+|+......   ......+||
T Consensus        98 ~k--~~~f~E~~i~~~~~Q~~~av~ylH~---~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~---~~a~tvvGT  169 (426)
T KOG0589|consen   98 QK--GVLFPEERILKWFVQILLAVNYLHE---NRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED---SLASTVVGT  169 (426)
T ss_pred             Hh--hccccHHHHHHHHHHHHHHHHHHHh---hhhhcccchhhhhhccccCceeecchhhhhhcCCch---hhhheecCC
Confidence            43  5678999999999999999999997   559999999999999999999999999999886543   235567999


Q ss_pred             ccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCHH
Q 039626          509 KGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLE  588 (628)
Q Consensus       509 ~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~  588 (628)
                      +.||.||.+.+..|..|+|||||||+++||++-+++|...+      +...+..+...         .     ....|..
T Consensus       170 p~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~------m~~Li~ki~~~---------~-----~~Plp~~  229 (426)
T KOG0589|consen  170 PYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASN------MSELILKINRG---------L-----YSPLPSM  229 (426)
T ss_pred             CcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccc------hHHHHHHHhhc---------c-----CCCCCcc
Confidence            99999999999999999999999999999999999887432      22233222211         1     1233556


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 039626          589 LALLVIRLIDACLKKDPTDRPTMYEIEHS  617 (628)
Q Consensus       589 ~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~  617 (628)
                      .+.++..+++.|+..+|..||++.+++..
T Consensus       230 ys~el~~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  230 YSSELRSLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             ccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence            67778999999999999999999999876

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=2.4e-32  Score=286.43  Aligned_cols=249  Identities=17%  Similarity=0.309  Sum_probs=180.2

Q ss_pred             eEEEEEEE--CCceEEEEEeccc---------hHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhc
Q 039626          361 GSVYRGKI--NGGFAAIKKVNGD---------VSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSN  429 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~~---------~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~  429 (628)
                      |.||++..  +|+.||+|+++.+         +.+|+++++.++||||+++++++..++..++|+||+++|+|.+++...
T Consensus        14 ~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~   93 (327)
T cd08227          14 MTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTH   93 (327)
T ss_pred             EEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccCCCcHHHHHHhh
Confidence            68999987  6889999998642         456999999999999999999999999999999999999999998543


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcc----eeeecc
Q 039626          430 KNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEF----ALTRHI  505 (628)
Q Consensus       430 ~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~----~~~~~~  505 (628)
                      .  ...+++..+..++.|++.||+|||+.   +++||||||+|||++.++.++++||+............    ......
T Consensus        94 ~--~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  168 (327)
T cd08227          94 F--MDGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYS  168 (327)
T ss_pred             c--cCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhccccccccccccccccccc
Confidence            2  23489999999999999999999984   49999999999999999999999998655432111100    011223


Q ss_pred             cCCccccCcccccc--CCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccc-c----chhhh-----
Q 039626          506 VGTKGYMAPEYLEN--GLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKE-D----GEESL-----  573 (628)
Q Consensus       506 ~gt~~Y~APE~l~~--~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~-~----~~~~l-----  573 (628)
                      .++..|+|||++.+  ..++.++|||||||+++||++|+.|+.......  ............. +    ..+.+     
T Consensus       169 ~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (327)
T cd08227         169 VKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQ--MLLEKLNGTVPCLLDTTTIPAEELTMKPS  246 (327)
T ss_pred             cceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhH--HHHHHhcCCccccccccchhhhhcccCCc
Confidence            56778999999976  468999999999999999999999986322110  0000000000000 0    00000     


Q ss_pred             ccccCC-----------------cCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          574 RHFIDP-----------------TLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       574 ~~~~d~-----------------~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      ....+.                 .............+.+++.+||+.||++|||++|+++
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~  306 (327)
T cd08227         247 RSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN  306 (327)
T ss_pred             ccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence            000000                 0001112234557889999999999999999999975

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=1.8e-32  Score=278.15  Aligned_cols=229  Identities=23%  Similarity=0.276  Sum_probs=178.3

Q ss_pred             eEEEEEEE--CCceEEEEEecc------------chHHHHHHHhhcCCCceeeeeeeeecC--CeEEEEEEecCCCChHH
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG------------DVSKEIALLNKINHSNLIILSGVCFNE--GNCYLVYEYAVNGTLSD  424 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~------------~~~~E~~~l~~l~H~nIv~l~g~~~~~--~~~~lV~E~~~~gsL~~  424 (628)
                      |.||+|..  ++..+|+|++..            .+.+|++++++++|+||+++++++.+.  ...+++|||+++++|.+
T Consensus        16 g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~   95 (265)
T cd06652          16 GRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKD   95 (265)
T ss_pred             eEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEEEEEecCCCcHHH
Confidence            89999987  578999998741            245699999999999999999998764  46789999999999999


Q ss_pred             HhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeec
Q 039626          425 WVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRH  504 (628)
Q Consensus       425 ~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~  504 (628)
                      ++...    ..+++...++++.+++.||+|||+.   +++|+||||+||+++.++.+||+|||+++..............
T Consensus        96 ~l~~~----~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~  168 (265)
T cd06652          96 QLKSY----GALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKS  168 (265)
T ss_pred             HHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCcccccccccccccccccc
Confidence            98532    3478889999999999999999984   4999999999999999999999999998865422111111223


Q ss_pred             ccCCccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCC
Q 039626          505 IVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGN  584 (628)
Q Consensus       505 ~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~  584 (628)
                      ..++..|+|||.+.+..++.++||||||+++|||++|+.|+.....     ... +.....             ......
T Consensus       169 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~-----~~~-~~~~~~-------------~~~~~~  229 (265)
T cd06652         169 VTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEA-----MAA-IFKIAT-------------QPTNPV  229 (265)
T ss_pred             CCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccch-----HHH-HHHHhc-------------CCCCCC
Confidence            4688999999999988899999999999999999999998753211     111 111110             001122


Q ss_pred             CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          585 YPLELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       585 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      .+......+.+++.+|+. +|++||+++|+++
T Consensus       230 ~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~  260 (265)
T cd06652         230 LPPHVSDHCRDFLKRIFV-EAKLRPSADELLR  260 (265)
T ss_pred             CchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence            344555667889999995 9999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-32  Score=280.48  Aligned_cols=226  Identities=26%  Similarity=0.425  Sum_probs=183.0

Q ss_pred             eEEEEEEE--CCceEEEEEecc--------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhcC
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG--------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNK  430 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~--------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~  430 (628)
                      |.||+|+.  +++.+|+|.+..        .+.+|++++++++|+||+++.+++.++...++|+||+++++|.+++..  
T Consensus        15 ~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~--   92 (274)
T cd06609          15 GEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKP--   92 (274)
T ss_pred             eEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEeeCCCcHHHHHhh--
Confidence            89999998  678999998753        356799999999999999999999999999999999999999999843  


Q ss_pred             CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCCcc
Q 039626          431 NEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKG  510 (628)
Q Consensus       431 ~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~  510 (628)
                         ..+++..+..++.|++.||.|||+.   +++|+||+|+||++++++.++|+|||+++.......   ......++..
T Consensus        93 ---~~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~---~~~~~~~~~~  163 (274)
T cd06609          93 ---GKLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS---KRNTFVGTPF  163 (274)
T ss_pred             ---cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeeccccc---ccccccCCcc
Confidence               2689999999999999999999984   599999999999999999999999999987653321   1233468889


Q ss_pred             ccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCHHHH
Q 039626          511 YMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELA  590 (628)
Q Consensus       511 Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~  590 (628)
                      |+|||++.+..++.++||||||+++|||++|+.|+......      .......          ....+.+...   ..+
T Consensus       164 y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~------~~~~~~~----------~~~~~~~~~~---~~~  224 (274)
T cd06609         164 WMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPM------RVLFLIP----------KNNPPSLEGN---KFS  224 (274)
T ss_pred             ccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchH------HHHHHhh----------hcCCCCCccc---ccC
Confidence            99999999988999999999999999999999998632211      1111111          0011111111   134


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          591 LLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       591 ~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      ..+.+++.+||..||++||+++++++
T Consensus       225 ~~~~~~l~~~l~~~p~~Rpt~~~il~  250 (274)
T cd06609         225 KPFKDFVSLCLNKDPKERPSAKELLK  250 (274)
T ss_pred             HHHHHHHHHHhhCChhhCcCHHHHhh
Confidence            45789999999999999999999975

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=2.5e-32  Score=279.87  Aligned_cols=229  Identities=25%  Similarity=0.380  Sum_probs=179.9

Q ss_pred             eEEEEEEE--CCceEEEEEecc-------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhcCC
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG-------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKN  431 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~-------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~  431 (628)
                      |.||+|..  .+..+++|....       .+.+|+++++.++|+||+++++++..++..++|+||+++|+|..++..   
T Consensus        19 g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~---   95 (282)
T cd06643          19 GKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLE---   95 (282)
T ss_pred             eEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCCCcHHHHHHh---
Confidence            89999998  466788888753       356799999999999999999999999999999999999999998753   


Q ss_pred             CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCCccc
Q 039626          432 EGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGY  511 (628)
Q Consensus       432 ~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~Y  511 (628)
                      ....++|..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++.......   .......++..|
T Consensus        96 ~~~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~~y  169 (282)
T cd06643          96 LERPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI---QRRDSFIGTPYW  169 (282)
T ss_pred             cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEccccccccccccc---cccccccccccc
Confidence            234689999999999999999999984   59999999999999999999999999987653221   112334689999


Q ss_pred             cCccccc-----cCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCC
Q 039626          512 MAPEYLE-----NGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYP  586 (628)
Q Consensus       512 ~APE~l~-----~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~  586 (628)
                      +|||++.     +..++.++|||||||++|||++|+.|+.....      .+.........          .+..  ..+
T Consensus       170 ~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~------~~~~~~~~~~~----------~~~~--~~~  231 (282)
T cd06643         170 MAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNP------MRVLLKIAKSE----------PPTL--AQP  231 (282)
T ss_pred             cCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCH------HHHHHHHhhcC----------CCCC--CCc
Confidence            9999984     45678899999999999999999988753221      11111111100          0000  112


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          587 LELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       587 ~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      ...+..+.+++.+||+.||.+||++.++++
T Consensus       232 ~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  261 (282)
T cd06643         232 SRWSSEFKDFLKKCLEKNVDARWTTTQLLQ  261 (282)
T ss_pred             cccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            233456789999999999999999998874

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=1.3e-32  Score=282.79  Aligned_cols=230  Identities=25%  Similarity=0.331  Sum_probs=181.7

Q ss_pred             eEEEEEEE--CCceEEEEEecc----------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhh
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG----------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFS  428 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  428 (628)
                      |.||++..  +++.+|+|.+..          .+.+|+++|++++|+||+++.+++..++..++||||+++|+|.+++..
T Consensus        14 g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~   93 (285)
T cd05632          14 GEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYN   93 (285)
T ss_pred             eEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEeccCccHHHHHHH
Confidence            89999998  578999998753          245799999999999999999999999999999999999999998864


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCC
Q 039626          429 NKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGT  508 (628)
Q Consensus       429 ~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt  508 (628)
                      .  ....+++..+..++.|++.||.|||+.   +|+||||||+||++++++.+||+|||++.......    ......|+
T Consensus        94 ~--~~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~----~~~~~~g~  164 (285)
T cd05632          94 M--GNPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE----SIRGRVGT  164 (285)
T ss_pred             h--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecCCCC----cccCCCCC
Confidence            2  234599999999999999999999984   59999999999999999999999999987653221    11234789


Q ss_pred             ccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCHH
Q 039626          509 KGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLE  588 (628)
Q Consensus       509 ~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~  588 (628)
                      ..|+|||++.+..++.++|+||||++++||++|+.|+........  .......+...               ...++..
T Consensus       165 ~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~--~~~~~~~~~~~---------------~~~~~~~  227 (285)
T cd05632         165 VGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVK--REEVDRRVLET---------------EEVYSAK  227 (285)
T ss_pred             cCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHhhhcc---------------ccccCcc
Confidence            999999999988999999999999999999999999864321110  01111111000               0112223


Q ss_pred             HHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 039626          589 LALLVIRLIDACLKKDPTDRPT-----MYEIEH  616 (628)
Q Consensus       589 ~~~~l~~l~~~Cl~~dP~~RPs-----~~ev~~  616 (628)
                      ....+.+|+.+||+.||++||+     +++++.
T Consensus       228 ~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05632         228 FSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR  260 (285)
T ss_pred             CCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence            3456789999999999999999     555554

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=2.1e-32  Score=278.43  Aligned_cols=239  Identities=20%  Similarity=0.348  Sum_probs=176.7

Q ss_pred             eEEEEEEE-CCc---eEEEEEecc--------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhh
Q 039626          361 GSVYRGKI-NGG---FAAIKKVNG--------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFS  428 (628)
Q Consensus       361 G~Vy~g~~-~g~---~vavK~~~~--------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  428 (628)
                      |.||+|.. ++.   .+++|..+.        .+.+|+.+++.++|+||+++++.|.+....++||||+++|+|.+++..
T Consensus         9 g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   88 (268)
T cd05086           9 GKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQ   88 (268)
T ss_pred             ceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCcHHHHHHh
Confidence            89999976 332   456676542        467789999999999999999999999999999999999999999976


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCC
Q 039626          429 NKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGT  508 (628)
Q Consensus       429 ~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt  508 (628)
                      .......+++.....++.|++.||+|||+.   +++||||||+|||++.++.+||+|||++....... .........++
T Consensus        89 ~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~~~~~  164 (268)
T cd05086          89 EQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKED-YIETEDDKCVP  164 (268)
T ss_pred             hhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcch-hhhcccCCcCc
Confidence            433344577788889999999999999984   59999999999999999999999999986432211 11112234678


Q ss_pred             ccccCcccccc-------CCCCcccccHHHHHHHHHHHhC-CCccccccccccccHHHHHHHHhccccchhhhccccCCc
Q 039626          509 KGYMAPEYLEN-------GLVSTKLDVYAFGVLILEMLTG-KEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPT  580 (628)
Q Consensus       509 ~~Y~APE~l~~-------~~~s~k~DV~SfGvvl~ELltG-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~  580 (628)
                      ..|+|||++..       ..++.++||||||+++|||+++ ..|+.....      .+........     ......++.
T Consensus       165 ~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~------~~~~~~~~~~-----~~~~~~~~~  233 (268)
T cd05086         165 LRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD------REVLNHVIKD-----QQVKLFKPQ  233 (268)
T ss_pred             ccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH------HHHHHHHHhh-----cccccCCCc
Confidence            89999998753       2457899999999999999975 555542211      1222222111     111223333


Q ss_pred             CCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 039626          581 LQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLS  619 (628)
Q Consensus       581 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~  619 (628)
                      +...+    ...+.+++..|| .+|++||+++||++.|.
T Consensus       234 ~~~~~----~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         234 LELPY----SERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             cCCCC----cHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence            33333    345677899999 67999999999998874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.1e-33  Score=269.06  Aligned_cols=227  Identities=29%  Similarity=0.423  Sum_probs=180.8

Q ss_pred             EEEEEEE--CCceEEEEEecc---------------chHHHHHHHhhc-CCCceeeeeeeeecCCeEEEEEEecCCCChH
Q 039626          362 SVYRGKI--NGGFAAIKKVNG---------------DVSKEIALLNKI-NHSNLIILSGVCFNEGNCYLVYEYAVNGTLS  423 (628)
Q Consensus       362 ~Vy~g~~--~g~~vavK~~~~---------------~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~  423 (628)
                      .|-+...  .|+..|+|++..               .-.+|+.+|+++ -||+|+.+.+++..+...++|+|.|+.|.|.
T Consensus        32 ~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~FlVFdl~prGELF  111 (411)
T KOG0599|consen   32 VVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAFVFLVFDLMPRGELF  111 (411)
T ss_pred             hhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcchhhhhhhhcccchHH
Confidence            3444433  577888887742               234699999999 5999999999999999999999999999999


Q ss_pred             HHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeee
Q 039626          424 DWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTR  503 (628)
Q Consensus       424 ~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~  503 (628)
                      |+|    ...-.++++...+|..++.+|++|||.   ..|+||||||+|||+|+|.++||+|||++..++.+.    ..+
T Consensus       112 DyL----ts~VtlSEK~tR~iMrqlfegVeylHa---~~IVHRDLKpENILlddn~~i~isDFGFa~~l~~Ge----kLr  180 (411)
T KOG0599|consen  112 DYL----TSKVTLSEKETRRIMRQLFEGVEYLHA---RNIVHRDLKPENILLDDNMNIKISDFGFACQLEPGE----KLR  180 (411)
T ss_pred             HHh----hhheeecHHHHHHHHHHHHHHHHHHHH---hhhhhcccChhheeeccccceEEeccceeeccCCch----hHH
Confidence            999    345569999999999999999999998   459999999999999999999999999999886554    356


Q ss_pred             cccCCccccCccccc------cCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhcccc
Q 039626          504 HIVGTKGYMAPEYLE------NGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFI  577 (628)
Q Consensus       504 ~~~gt~~Y~APE~l~------~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  577 (628)
                      ...|||+|+|||.+.      ...|+...|.||.||+++-|+.|.+||.....   +.   .++.++. +.-     ++ 
T Consensus       181 elCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQ---ml---MLR~Ime-Gky-----qF-  247 (411)
T KOG0599|consen  181 ELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQ---ML---MLRMIME-GKY-----QF-  247 (411)
T ss_pred             HhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHH---HH---HHHHHHh-ccc-----cc-
Confidence            689999999999885      34688999999999999999999999753221   11   1111111 110     01 


Q ss_pred             CCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          578 DPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       578 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                          +.....+.+..+.+|+.+||+.||.+|.|.+|++.
T Consensus       248 ----~speWadis~~~KdLIsrlLqVdp~~Ritake~La  282 (411)
T KOG0599|consen  248 ----RSPEWADISATVKDLISRLLQVDPTKRITAKEALA  282 (411)
T ss_pred             ----CCcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence                11122356677899999999999999999999875

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=1.1e-32  Score=282.52  Aligned_cols=244  Identities=22%  Similarity=0.279  Sum_probs=180.1

Q ss_pred             eEEEEEEE--CCceEEEEEecc---------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhc
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG---------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSN  429 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~---------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~  429 (628)
                      |.||+++.  +|+.+|+|+++.         .+.+|++++++++|+||+++++++.+....++|+||++ ++|.+++...
T Consensus        14 ~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~   92 (284)
T cd07839          14 GTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYCD-QDLKKYFDSC   92 (284)
T ss_pred             eEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecCC-CCHHHHHHhc
Confidence            89999998  688999998752         35679999999999999999999999999999999996 5888887532


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCCc
Q 039626          430 KNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTK  509 (628)
Q Consensus       430 ~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~  509 (628)
                         ...+++.....++.||++||.|||+.   +++||||||+||+++.++.+||+|||+++.......   ......++.
T Consensus        93 ---~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~  163 (284)
T cd07839          93 ---NGDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR---CYSAEVVTL  163 (284)
T ss_pred             ---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC---CcCCCcccc
Confidence               34589999999999999999999984   599999999999999999999999999986543221   122346788


Q ss_pred             cccCccccccC-CCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccc--hhhhccccCCc----CC
Q 039626          510 GYMAPEYLENG-LVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDG--EESLRHFIDPT----LQ  582 (628)
Q Consensus       510 ~Y~APE~l~~~-~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~l~~~~d~~----l~  582 (628)
                      .|+|||.+.+. .++.++||||||++++||++|+.|+....... . ..+.+.........  ...+....+..    ..
T Consensus       164 ~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~-~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (284)
T cd07839         164 WYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD-D-QLKRIFRLLGTPTEESWPGVSKLPDYKPYPMYP  241 (284)
T ss_pred             CCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHH-H-HHHHHHHHhCCCChHHhHHhhhcccccccCCCC
Confidence            99999998764 47999999999999999999998864322111 1 11111111111000  00001111100    00


Q ss_pred             C-----CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          583 G-----NYPLELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       583 ~-----~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      .     .........+.+++.+||+.||.+|||++|+++
T Consensus       242 ~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~  280 (284)
T cd07839         242 ATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ  280 (284)
T ss_pred             CcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence            0     011123456789999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=2.7e-32  Score=275.22  Aligned_cols=228  Identities=28%  Similarity=0.424  Sum_probs=182.0

Q ss_pred             eEEEEEEE--CCceEEEEEecc---------chHHHHHHHhhcCCCceeeeeeeeec-CCeEEEEEEecCCCChHHHhhh
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG---------DVSKEIALLNKINHSNLIILSGVCFN-EGNCYLVYEYAVNGTLSDWVFS  428 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~---------~~~~E~~~l~~l~H~nIv~l~g~~~~-~~~~~lV~E~~~~gsL~~~l~~  428 (628)
                      |.||+++.  +++.+|+|++..         .+.+|++++++++|+|++++.+.+.. +...+++|||+++++|.+++..
T Consensus        14 ~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~   93 (257)
T cd08223          14 GEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKE   93 (257)
T ss_pred             eEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecccCCCcHHHHHHH
Confidence            89999987  577899998753         25679999999999999999998764 4467999999999999999964


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCC
Q 039626          429 NKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGT  508 (628)
Q Consensus       429 ~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt  508 (628)
                      .  ....+++.++..++.+++.||+|||+.   +++|+||||+||+++.++.++|+|||++........   ......++
T Consensus        94 ~--~~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~  165 (257)
T cd08223          94 Q--KGKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD---MASTLIGT  165 (257)
T ss_pred             h--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEecccCC---ccccccCC
Confidence            2  234689999999999999999999984   599999999999999999999999999886643221   22335688


Q ss_pred             ccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCHH
Q 039626          509 KGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLE  588 (628)
Q Consensus       509 ~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~  588 (628)
                      +.|+|||.+.+..++.++||||||++++||++|+.|+....      ............         + +    ..+..
T Consensus       166 ~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~------~~~~~~~~~~~~---------~-~----~~~~~  225 (257)
T cd08223         166 PYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKD------MNSLVYRIIEGK---------L-P----PMPKD  225 (257)
T ss_pred             cCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC------HHHHHHHHHhcC---------C-C----CCccc
Confidence            99999999999999999999999999999999998875322      111111111100         0 1    12233


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          589 LALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       589 ~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      ....+.+++.+||+.||++||++.++++
T Consensus       226 ~~~~~~~li~~~l~~~p~~Rp~~~~~l~  253 (257)
T cd08223         226 YSPELGELIATMLSKRPEKRPSVKSILR  253 (257)
T ss_pred             cCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            4456889999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=3.1e-32  Score=274.72  Aligned_cols=229  Identities=23%  Similarity=0.377  Sum_probs=183.6

Q ss_pred             eEEEEEEE--CCceEEEEEecc---------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhc
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG---------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSN  429 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~---------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~  429 (628)
                      |.||.++.  +++.+++|++..         ++.+|++++++++|+||+++++++.+.+..+++|||+++|+|.+++...
T Consensus        14 g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~~~~~L~~~~~~~   93 (256)
T cd08221          14 GEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQ   93 (256)
T ss_pred             ceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEecCCCcHHHHHHhc
Confidence            66666665  788999997642         3678999999999999999999999999999999999999999999643


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCCc
Q 039626          430 KNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTK  509 (628)
Q Consensus       430 ~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~  509 (628)
                      .  ...+++.++..++.+++.||.|||+.   +++|+||+|+||++++++.+||+|||+++.......   ......+++
T Consensus        94 ~--~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~---~~~~~~~~~  165 (256)
T cd08221          94 K--GQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS---MAETVVGTP  165 (256)
T ss_pred             c--ccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEcccccc---cccccCCCc
Confidence            2  34689999999999999999999985   499999999999999999999999999986643321   123456899


Q ss_pred             cccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCHHH
Q 039626          510 GYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLEL  589 (628)
Q Consensus       510 ~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~  589 (628)
                      .|+|||.+.+..++.++||||||++++||++|+.|+.....      .+.........         ..     ..+...
T Consensus       166 ~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~------~~~~~~~~~~~---------~~-----~~~~~~  225 (256)
T cd08221         166 YYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNP------LNLVVKIVQGN---------YT-----PVVSVY  225 (256)
T ss_pred             cccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCH------HHHHHHHHcCC---------CC-----CCcccc
Confidence            99999999988899999999999999999999988753221      12222221110         00     111233


Q ss_pred             HHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 039626          590 ALLVIRLIDACLKKDPTDRPTMYEIEHS  617 (628)
Q Consensus       590 ~~~l~~l~~~Cl~~dP~~RPs~~ev~~~  617 (628)
                      ...+.+++.+||+.+|.+||+++|+++.
T Consensus       226 ~~~~~~~i~~~l~~~p~~R~s~~~ll~~  253 (256)
T cd08221         226 SSELISLVHSLLQQDPEKRPTADEVLDQ  253 (256)
T ss_pred             CHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence            4567899999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=2.5e-32  Score=279.92  Aligned_cols=243  Identities=24%  Similarity=0.359  Sum_probs=181.3

Q ss_pred             eEEEEEEE--CCceEEEEEecc---------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhc
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG---------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSN  429 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~---------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~  429 (628)
                      |.||+++.  +|+.+|+|+...         .+.+|++++++++|+|++++++++..+...++||||++++.|..++.. 
T Consensus        15 ~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~-   93 (286)
T cd07847          15 GVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKN-   93 (286)
T ss_pred             eEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEeccCccHHHHHHhC-
Confidence            89999998  578999997642         256799999999999999999999999999999999999988877632 


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCCc
Q 039626          430 KNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTK  509 (628)
Q Consensus       430 ~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~  509 (628)
                         ...++|..+..++.|++.||+|||+   .+++|+||||+||+++.++.+||+|||++........   ......++.
T Consensus        94 ---~~~~~~~~~~~~~~ql~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~  164 (286)
T cd07847          94 ---PRGVPEHLIKKIIWQTLQAVNFCHK---HNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD---DYTDYVATR  164 (286)
T ss_pred             ---CCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCChhhEEEcCCCcEEECccccceecCCCcc---cccCccccc
Confidence               3358999999999999999999999   4599999999999999999999999999987643321   122345788


Q ss_pred             cccCcccccc-CCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccc-cc-------hhhhccccCCc
Q 039626          510 GYMAPEYLEN-GLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKE-DG-------EESLRHFIDPT  580 (628)
Q Consensus       510 ~Y~APE~l~~-~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~-~~-------~~~l~~~~d~~  580 (628)
                      .|+|||++.+ ..++.++||||||++++||++|+.|+......+.  +.... ...... ..       .........+.
T Consensus       165 ~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~--~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (286)
T cd07847         165 WYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQ--LYLIR-KTLGDLIPRHQQIFSTNQFFKGLSIPE  241 (286)
T ss_pred             ccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHH--HHHHH-HHhCCCChHHhhhcccccccccccCCC
Confidence            9999999876 5678999999999999999999998864332111  11111 100000 00       00000011111


Q ss_pred             CCCCCC-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          581 LQGNYP-----LELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       581 l~~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      .....+     ......+.+++.+||+.||++||++.|++.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  282 (286)
T cd07847         242 PETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE  282 (286)
T ss_pred             cccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence            111111     123456889999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-32  Score=279.18  Aligned_cols=244  Identities=27%  Similarity=0.417  Sum_probs=186.4

Q ss_pred             HhcCCCcCCccc----eEEEEEEE--CCceEEEEEecc------chHHHHHHHhhc-CCCceeeeeeeeecCC------e
Q 039626          349 ATDNFSFTCRIQ----GSVYRGKI--NGGFAAIKKVNG------DVSKEIALLNKI-NHSNLIILSGVCFNEG------N  409 (628)
Q Consensus       349 at~~f~~~~~i~----G~Vy~g~~--~g~~vavK~~~~------~~~~E~~~l~~l-~H~nIv~l~g~~~~~~------~  409 (628)
                      ++++|.....++    |.||+|..  +++.+++|....      ++.+|+.+++++ +|+||+++++++....      .
T Consensus         4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~   83 (275)
T cd06608           4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQ   83 (275)
T ss_pred             chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceE
Confidence            344555444443    89999998  567899998753      467899999999 7999999999997644      4


Q ss_pred             EEEEEEecCCCChHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEcccccc
Q 039626          410 CYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMA  489 (628)
Q Consensus       410 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla  489 (628)
                      .++||||+++++|.+++.........+++..+..++.|++.||.|||+.   +++|+||+|+||++++++.+||+|||++
T Consensus        84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d~~~~  160 (275)
T cd06608          84 LWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVS  160 (275)
T ss_pred             EEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECCCccc
Confidence            8999999999999999865443456789999999999999999999985   4999999999999999999999999998


Q ss_pred             ccCCCCCCcceeeecccCCccccCcccccc-----CCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHh
Q 039626          490 RPAEGQEGEFALTRHIVGTKGYMAPEYLEN-----GLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVL  564 (628)
Q Consensus       490 ~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~-----~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~  564 (628)
                      ........   ......|+..|+|||.+..     ..++.++||||||++++||++|+.|+......      .......
T Consensus       161 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~~~~  231 (275)
T cd06608         161 AQLDSTLG---RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM------RALFKIP  231 (275)
T ss_pred             eecccchh---hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH------HHHHHhh
Confidence            76543221   1223468899999998753     35788999999999999999999998532110      1111111


Q ss_pred             ccccchhhhccccCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          565 TKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       565 ~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      ..          ..+.  ...+......+.+++.+||..||++|||+.|+++
T Consensus       232 ~~----------~~~~--~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~  271 (275)
T cd06608         232 RN----------PPPT--LKSPENWSKKFNDFISECLIKNYEQRPFMEELLE  271 (275)
T ss_pred             cc----------CCCC--CCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence            10          0011  1112234567889999999999999999999975

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=2.1e-32  Score=280.35  Aligned_cols=247  Identities=25%  Similarity=0.436  Sum_probs=184.5

Q ss_pred             HHHHHHHhcCCCcCCccc----eEEEEEEE--CCceEEEEEecc------chHHHHHHHhhc-CCCceeeeeeeeec---
Q 039626          343 FKELQSATDNFSFTCRIQ----GSVYRGKI--NGGFAAIKKVNG------DVSKEIALLNKI-NHSNLIILSGVCFN---  406 (628)
Q Consensus       343 ~~el~~at~~f~~~~~i~----G~Vy~g~~--~g~~vavK~~~~------~~~~E~~~l~~l-~H~nIv~l~g~~~~---  406 (628)
                      +.++....+.|.....++    |.||+|..  .++.+|+|....      ++..|+.++.++ +|+||+++++++..   
T Consensus         8 ~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~   87 (282)
T cd06636           8 LSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSP   87 (282)
T ss_pred             hhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccc
Confidence            334444445555444443    89999998  678899998743      356788999998 79999999999863   


Q ss_pred             ---CCeEEEEEEecCCCChHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEE
Q 039626          407 ---EGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKI  483 (628)
Q Consensus       407 ---~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl  483 (628)
                         ....+++|||+++|+|.+++....  ...+++..+..++.|++.||.|||+.   +++|+||||+||++++++.++|
T Consensus        88 ~~~~~~~~iv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~~~~l  162 (282)
T cd06636          88 PGHDDQLWLVMEFCGAGSVTDLVKNTK--GNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKL  162 (282)
T ss_pred             cCCCCEEEEEEEeCCCCcHHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEE
Confidence               457899999999999999985432  34588889999999999999999984   4999999999999999999999


Q ss_pred             ccccccccCCCCCCcceeeecccCCccccCccccc-----cCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHH
Q 039626          484 ANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLE-----NGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSD  558 (628)
Q Consensus       484 ~Dfgla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~-----~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~  558 (628)
                      +|||+++.......   ......|+..|+|||.+.     ...++.++||||||+++|||++|+.|+......     ..
T Consensus       163 ~dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~-----~~  234 (282)
T cd06636         163 VDFGVSAQLDRTVG---RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPM-----RA  234 (282)
T ss_pred             eeCcchhhhhcccc---CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHH-----hh
Confidence            99999876532211   122346889999999876     346788999999999999999999988532211     00


Q ss_pred             HHHHHhccccchhhhccccCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          559 VLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       559 ~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      .. ...          ....+..   .....+..+.+++.+||+.||.+||++.|+++
T Consensus       235 ~~-~~~----------~~~~~~~---~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~  278 (282)
T cd06636         235 LF-LIP----------RNPPPKL---KSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK  278 (282)
T ss_pred             hh-hHh----------hCCCCCC---cccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence            00 000          0000111   11123456889999999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.2e-32  Score=313.63  Aligned_cols=232  Identities=21%  Similarity=0.335  Sum_probs=180.1

Q ss_pred             eEEEEEEE--CCceEEEEEecc---------chHHHHHHHhhcCCCceeeeeeeeecC--CeEEEEEEecCCCChHHHhh
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG---------DVSKEIALLNKINHSNLIILSGVCFNE--GNCYLVYEYAVNGTLSDWVF  427 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~---------~~~~E~~~l~~l~H~nIv~l~g~~~~~--~~~~lV~E~~~~gsL~~~l~  427 (628)
                      |.||+++.  .+..+|+|.+..         .+..|+.+|.+|+|||||++++++.+.  ..+||||||+++|+|.++|.
T Consensus        27 GtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyIVMEY~~gGSL~~lL~  106 (1021)
T PTZ00266         27 GEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQ  106 (1021)
T ss_pred             eEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEEEEeCCCCCcHHHHHH
Confidence            89999998  567889998752         366799999999999999999988643  56899999999999999996


Q ss_pred             hcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCC----CCeEecCCCCCCEEeCC-----------------CCcEEEccc
Q 039626          428 SNKNEGKYLDWKQRIQIALDVATGLNYLHSFTN----PPHVHKDINSSNVLLDS-----------------DLRAKIANF  486 (628)
Q Consensus       428 ~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~----~~iiH~dik~~NILl~~-----------------~~~~kl~Df  486 (628)
                      ........+++..++.|+.||+.||.|||+.+.    .+|+||||||+||||+.                 ...+||+||
T Consensus       107 k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~n~ng~~iVKLsDF  186 (1021)
T PTZ00266        107 KCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDF  186 (1021)
T ss_pred             HHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccccccccCCCCceEEccC
Confidence            544444569999999999999999999998542    45999999999999964                 345899999


Q ss_pred             cccccCCCCCCcceeeecccCCccccCcccccc--CCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHh
Q 039626          487 AMARPAEGQEGEFALTRHIVGTKGYMAPEYLEN--GLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVL  564 (628)
Q Consensus       487 gla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~--~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~  564 (628)
                      |+++......    ......||+.|+|||.+.+  ..++.++|||||||+||||++|+.||.....     ....+..+.
T Consensus       187 GlAr~l~~~s----~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~-----~~qli~~lk  257 (1021)
T PTZ00266        187 GLSKNIGIES----MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANN-----FSQLISELK  257 (1021)
T ss_pred             Cccccccccc----cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCc-----HHHHHHHHh
Confidence            9998664321    1234579999999999854  4589999999999999999999999863221     112221111


Q ss_pred             ccccchhhhccccCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          565 TKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       565 ~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      ..            +.+.   ....+..+.+|+..||+.+|.+||++.|++.
T Consensus       258 ~~------------p~lp---i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~  294 (1021)
T PTZ00266        258 RG------------PDLP---IKGKSKELNILIKNLLNLSAKERPSALQCLG  294 (1021)
T ss_pred             cC------------CCCC---cCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence            10            0110   0112356789999999999999999999984

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=1.8e-32  Score=284.43  Aligned_cols=236  Identities=20%  Similarity=0.249  Sum_probs=182.7

Q ss_pred             eEEEEEEE--CCceEEEEEecc----------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhh
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG----------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFS  428 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  428 (628)
                      |.||++..  .++.+++|.+..          .+.+|+++++.++|+||+++++.+..++..++||||+++++|.+++..
T Consensus        15 ~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~   94 (305)
T cd05609          15 GAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKN   94 (305)
T ss_pred             eeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEecCCCCcHHHHHHH
Confidence            89999988  567899998753          245799999999999999999999999999999999999999999943


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCC-----------
Q 039626          429 NKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEG-----------  497 (628)
Q Consensus       429 ~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~-----------  497 (628)
                          ...+++..+..++.+++.||+|||+.   +++||||||+||+++.++.+||+|||+++.......           
T Consensus        95 ----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~  167 (305)
T cd05609          95 ----IGALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKD  167 (305)
T ss_pred             ----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccccCcCccccccccccccc
Confidence                24589999999999999999999984   599999999999999999999999999874211100           


Q ss_pred             -cceeeecccCCccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccc
Q 039626          498 -EFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHF  576 (628)
Q Consensus       498 -~~~~~~~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  576 (628)
                       .........++..|+|||++.+..++.++|+||||+++|||++|+.|+.....      .+........        ..
T Consensus       168 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~------~~~~~~~~~~--------~~  233 (305)
T cd05609         168 TREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP------EELFGQVISD--------DI  233 (305)
T ss_pred             hhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHhc--------cc
Confidence             00011124578899999999988899999999999999999999998753221      1111111110        00


Q ss_pred             cCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 039626          577 IDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNI  621 (628)
Q Consensus       577 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l  621 (628)
                      ..+....    ..+..+.+++.+||+.||++||++.++.+.|+.-
T Consensus       234 ~~~~~~~----~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~  274 (305)
T cd05609         234 EWPEGDE----ALPADAQDLISRLLRQNPLERLGTGGAFEVKQHR  274 (305)
T ss_pred             CCCCccc----cCCHHHHHHHHHHhccChhhccCccCHHHHHhCc
Confidence            1111111    2344578999999999999999987777766653

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=4.5e-32  Score=279.50  Aligned_cols=229  Identities=26%  Similarity=0.417  Sum_probs=179.3

Q ss_pred             eEEEEEEE--CCceEEEEEecc-------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhcCC
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG-------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKN  431 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~-------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~  431 (628)
                      |.||+|+.  .+..+++|....       ++.+|+.++++++|+||+++++++..++..++||||+++++|..++...  
T Consensus        26 g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~--  103 (292)
T cd06644          26 GKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLEL--  103 (292)
T ss_pred             eEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecCCCCcHHHHHHhh--
Confidence            89999998  578899998753       3567999999999999999999999999999999999999998887432  


Q ss_pred             CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCCccc
Q 039626          432 EGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGY  511 (628)
Q Consensus       432 ~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~Y  511 (628)
                       ...+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||++........   ......++..|
T Consensus       104 -~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~~y  176 (292)
T cd06644         104 -DRGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQ---RRDSFIGTPYW  176 (292)
T ss_pred             -cCCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceecccccc---ccceecCCccc
Confidence             34589999999999999999999984   599999999999999999999999999875432211   12234688899


Q ss_pred             cCccccc-----cCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCC
Q 039626          512 MAPEYLE-----NGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYP  586 (628)
Q Consensus       512 ~APE~l~-----~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~  586 (628)
                      +|||++.     ...++.++|||||||++|||++|+.|+.....      ...........          .+..  ..+
T Consensus       177 ~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~------~~~~~~~~~~~----------~~~~--~~~  238 (292)
T cd06644         177 MAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP------MRVLLKIAKSE----------PPTL--SQP  238 (292)
T ss_pred             cCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccH------HHHHHHHhcCC----------CccC--CCC
Confidence            9999985     34568899999999999999999988753221      11111111100          0100  112


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          587 LELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       587 ~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      ......+.+++.+||+.||++||+++|+++
T Consensus       239 ~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  268 (292)
T cd06644         239 SKWSMEFRDFLKTALDKHPETRPSAAQLLE  268 (292)
T ss_pred             cccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            233456789999999999999999999875

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=3.7e-32  Score=279.48  Aligned_cols=237  Identities=26%  Similarity=0.407  Sum_probs=184.4

Q ss_pred             eEEEEEEE--CCceEEEEEecc--------chHHHHHHHhhcCCCceeeeeeeeecC--CeEEEEEEecCCCChHHHhhh
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG--------DVSKEIALLNKINHSNLIILSGVCFNE--GNCYLVYEYAVNGTLSDWVFS  428 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~--------~~~~E~~~l~~l~H~nIv~l~g~~~~~--~~~~lV~E~~~~gsL~~~l~~  428 (628)
                      |.||++..  +++.+|+|....        ++.+|++++++++|+||+++++++.+.  +..++||||+++++|.+++..
T Consensus        15 ~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   94 (287)
T cd06621          15 GSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKK   94 (287)
T ss_pred             eEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEecCCCCHHHHHHH
Confidence            89999998  578899998753        367899999999999999999998653  468999999999999998865


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCC
Q 039626          429 NKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGT  508 (628)
Q Consensus       429 ~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt  508 (628)
                      .......+++.....++.+++.||.|||+.   +++|+||+|+||++++++.++|+|||++.......     .....++
T Consensus        95 ~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~-----~~~~~~~  166 (287)
T cd06621          95 VKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL-----AGTFTGT  166 (287)
T ss_pred             HHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeeccccccccccc-----cccccCC
Confidence            444456689999999999999999999984   49999999999999999999999999987553221     1234578


Q ss_pred             ccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCC--
Q 039626          509 KGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYP--  586 (628)
Q Consensus       509 ~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~--  586 (628)
                      ..|+|||.+.+..++.++||||||+++|||++|+.|+....... ....+.........          .+.+.....  
T Consensus       167 ~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~----------~~~~~~~~~~~  235 (287)
T cd06621         167 SFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPP-LGPIELLSYIVNMP----------NPELKDEPGNG  235 (287)
T ss_pred             ccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCC-CChHHHHHHHhcCC----------chhhccCCCCC
Confidence            89999999999999999999999999999999999987442211 11112221111100          001110100  


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          587 LELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       587 ~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      ......+.+++.+||+.+|.+|||+.|+++
T Consensus       236 ~~~~~~~~~li~~~l~~~p~~Rpt~~eil~  265 (287)
T cd06621         236 IKWSEEFKDFIKQCLEKDPTRRPTPWDMLE  265 (287)
T ss_pred             CchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence            123456889999999999999999999987

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=2.5e-32  Score=279.71  Aligned_cols=231  Identities=23%  Similarity=0.389  Sum_probs=177.3

Q ss_pred             eEEEEEEE--CCceEEEEEeccc--------hHHHHHH-HhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhc
Q 039626          361 GSVYRGKI--NGGFAAIKKVNGD--------VSKEIAL-LNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSN  429 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~~--------~~~E~~~-l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~  429 (628)
                      |.||++..  +|+.||+|+++..        +..|+.+ ++.++|+||+++++++..++..+++|||++ |+|.+++...
T Consensus        15 g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~   93 (283)
T cd06617          15 GVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVMD-TSLDKFYKKV   93 (283)
T ss_pred             eEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhhc-ccHHHHHHHh
Confidence            89999998  5889999988642        3345554 566789999999999999999999999995 7898888654


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCCc
Q 039626          430 KNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTK  509 (628)
Q Consensus       430 ~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~  509 (628)
                      ......+++..+..++.|++.||+|||+.  .+++||||||+||+++.++.+||+|||+++......    ......++.
T Consensus        94 ~~~~~~~~~~~~~~~~~qi~~~l~~lH~~--~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~  167 (283)
T cd06617          94 YDKGLTIPEDILGKIAVSIVKALEYLHSK--LSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSV----AKTIDAGCK  167 (283)
T ss_pred             ccCCCCCCHHHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHEEECCCCCEEEeeccccccccccc----ccccccCCc
Confidence            44456799999999999999999999983  259999999999999999999999999988653221    112346888


Q ss_pred             cccCcccccc----CCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCC
Q 039626          510 GYMAPEYLEN----GLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNY  585 (628)
Q Consensus       510 ~Y~APE~l~~----~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~  585 (628)
                      .|+|||.+.+    ..++.++|+||||++++||++|+.|+......    . +........          ..+...   
T Consensus       168 ~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~----~-~~~~~~~~~----------~~~~~~---  229 (283)
T cd06617         168 PYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP----F-QQLKQVVEE----------PSPQLP---  229 (283)
T ss_pred             cccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC----H-HHHHHHHhc----------CCCCCC---
Confidence            9999998865    45688999999999999999999987532110    1 111111110          011111   


Q ss_pred             CHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          586 PLELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       586 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      ....+..+.+++.+||..+|.+||+++++++
T Consensus       230 ~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~  260 (283)
T cd06617         230 AEKFSPEFQDFVNKCLKKNYKERPNYPELLQ  260 (283)
T ss_pred             ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            1123456789999999999999999999986

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=1.2e-32  Score=302.84  Aligned_cols=258  Identities=22%  Similarity=0.324  Sum_probs=185.3

Q ss_pred             HHHHHHHhcCCCcCCccc----eEEEEEEE--CCceEEEEEecc------chHHHHHHHhhcCCC------ceeeeeeee
Q 039626          343 FKELQSATDNFSFTCRIQ----GSVYRGKI--NGGFAAIKKVNG------DVSKEIALLNKINHS------NLIILSGVC  404 (628)
Q Consensus       343 ~~el~~at~~f~~~~~i~----G~Vy~g~~--~g~~vavK~~~~------~~~~E~~~l~~l~H~------nIv~l~g~~  404 (628)
                      .+++...+++|.....+|    |.||++..  .++.||||+++.      +...|++++++++|.      +++++++++
T Consensus       121 ~~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~  200 (467)
T PTZ00284        121 GEDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYF  200 (467)
T ss_pred             CCccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEE
Confidence            344555667777666665    89999987  578899999853      345688888887654      588999988


Q ss_pred             ecC-CeEEEEEEecCCCChHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCC----
Q 039626          405 FNE-GNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDL----  479 (628)
Q Consensus       405 ~~~-~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~----  479 (628)
                      ..+ ++.++|||++ +++|.+++..    ...+++..+..|+.||+.||+|||+.  .+|+||||||+|||++.++    
T Consensus       201 ~~~~~~~~iv~~~~-g~~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~yLH~~--~gIiHrDlKP~NILl~~~~~~~~  273 (467)
T PTZ00284        201 QNETGHMCIVMPKY-GPCLLDWIMK----HGPFSHRHLAQIIFQTGVALDYFHTE--LHLMHTDLKPENILMETSDTVVD  273 (467)
T ss_pred             EcCCceEEEEEecc-CCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhc--CCeecCCCCHHHEEEecCCcccc
Confidence            754 5789999988 7899998854    24589999999999999999999972  3599999999999998765    


Q ss_pred             ------------cEEEccccccccCCCCCCcceeeecccCCccccCccccccCCCCcccccHHHHHHHHHHHhCCCcccc
Q 039626          480 ------------RAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAAL  547 (628)
Q Consensus       480 ------------~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~  547 (628)
                                  .+||+|||++......      .....||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       274 ~~~~~~~~~~~~~vkl~DfG~~~~~~~~------~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~  347 (467)
T PTZ00284        274 PVTNRALPPDPCRVRICDLGGCCDERHS------RTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDT  347 (467)
T ss_pred             cccccccCCCCceEEECCCCccccCccc------cccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence                        4999999987643221      2345799999999999999999999999999999999999999875


Q ss_pred             ccccccccHHHHHHHHhcccc-------chhhhccc----------cCCcC-----CCC--CCHHHHHHHHHHHHHhccc
Q 039626          548 HAEENNMHLSDVLNAVLTKED-------GEESLRHF----------IDPTL-----QGN--YPLELALLVIRLIDACLKK  603 (628)
Q Consensus       548 ~~~~~~~~~~~~~~~~~~~~~-------~~~~l~~~----------~d~~l-----~~~--~~~~~~~~l~~l~~~Cl~~  603 (628)
                      ....+   ....+...+....       .....+.+          .++..     ...  ........+.+|+.+||+.
T Consensus       348 ~~~~~---~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~  424 (467)
T PTZ00284        348 HDNLE---HLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHY  424 (467)
T ss_pred             CChHH---HHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCc
Confidence            43221   1111111110000       00000000          00000     000  0001134577999999999


Q ss_pred             CCCCCCCHHHHHH
Q 039626          604 DPTDRPTMYEIEH  616 (628)
Q Consensus       604 dP~~RPs~~ev~~  616 (628)
                      ||++|||++|+++
T Consensus       425 dP~~R~ta~e~L~  437 (467)
T PTZ00284        425 DRQKRLNARQMTT  437 (467)
T ss_pred             ChhhCCCHHHHhc
Confidence            9999999999985

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=2e-32  Score=281.28  Aligned_cols=242  Identities=25%  Similarity=0.362  Sum_probs=177.6

Q ss_pred             eEEEEEEE--CCceEEEEEecc---------chHHHHHHHhhc---CCCceeeeeeeeecC-----CeEEEEEEecCCCC
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG---------DVSKEIALLNKI---NHSNLIILSGVCFNE-----GNCYLVYEYAVNGT  421 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~---------~~~~E~~~l~~l---~H~nIv~l~g~~~~~-----~~~~lV~E~~~~gs  421 (628)
                      |.||++..  +++.+|+|.++.         .+.+|+++++++   +|+||+++++++...     ...++||||++ ++
T Consensus        14 g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~-~~   92 (288)
T cd07863          14 GTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVD-QD   92 (288)
T ss_pred             eEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCceEEEEEcccc-cC
Confidence            89999988  678899998753         245687777766   799999999998642     45799999996 58


Q ss_pred             hHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCccee
Q 039626          422 LSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFAL  501 (628)
Q Consensus       422 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~  501 (628)
                      |.+++...  ....+++..+..++.|++.||+|||+.   +++||||||+|||+++++.+||+|||+++......    .
T Consensus        93 l~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~~~~----~  163 (288)
T cd07863          93 LRTYLDKV--PPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGLARIYSCQM----A  163 (288)
T ss_pred             HHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccCccccccCcc----c
Confidence            99888542  234589999999999999999999995   49999999999999999999999999998664321    1


Q ss_pred             eecccCCccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhc-------
Q 039626          502 TRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLR-------  574 (628)
Q Consensus       502 ~~~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~-------  574 (628)
                      .....||..|+|||.+.+..++.++|||||||+++||++|++|+.......  .+.+... ...... .....       
T Consensus       164 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~--~~~~~~~-~~~~~~-~~~~~~~~~~~~  239 (288)
T cd07863         164 LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD--QLGKIFD-LIGLPP-EDDWPRDVTLPR  239 (288)
T ss_pred             CCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHH--HHHHHHH-HhCCCC-hhhCcccccccc
Confidence            223468999999999998899999999999999999999998875432211  1111111 111000 00000       


Q ss_pred             cccCCcCC---CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          575 HFIDPTLQ---GNYPLELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       575 ~~~d~~l~---~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      ....+...   .....+....+.+++.+||+.||++|||+.|++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~  284 (288)
T cd07863         240 GAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ  284 (288)
T ss_pred             cccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            00000000   0011123456789999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.9e-32  Score=276.45  Aligned_cols=224  Identities=22%  Similarity=0.402  Sum_probs=174.6

Q ss_pred             ceEEEEEEECCc------------eEEEEEecc------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCC
Q 039626          360 QGSVYRGKINGG------------FAAIKKVNG------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGT  421 (628)
Q Consensus       360 ~G~Vy~g~~~g~------------~vavK~~~~------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gs  421 (628)
                      .|.||+|.+.+.            .+++|....      .+.+|+.++++++|+||+++++++.. ...++||||+++|+
T Consensus         8 ~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~~   86 (259)
T cd05037           8 FTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVEEYVKFGP   86 (259)
T ss_pred             cceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEEEcCCCCc
Confidence            389999998432            377776543      46689999999999999999999988 77899999999999


Q ss_pred             hHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCC-------cEEEccccccccCCC
Q 039626          422 LSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDL-------RAKIANFAMARPAEG  494 (628)
Q Consensus       422 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~-------~~kl~Dfgla~~~~~  494 (628)
                      |.+++....   ..+++..++.++.|++.||+|||+   .+++||||||+|||++.++       .+||+|||+++....
T Consensus        87 L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~~~~  160 (259)
T cd05037          87 LDVFLHREK---NNVSLHWKLDVAKQLASALHYLED---KKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLS  160 (259)
T ss_pred             HHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhh---CCeecccCccceEEEecCccccCCceeEEeCCCCccccccc
Confidence            999996432   268999999999999999999998   4599999999999999888       799999999986543


Q ss_pred             CCCcceeeecccCCccccCccccccC--CCCcccccHHHHHHHHHHHhC-CCccccccccccccHHHHHHHHhccccchh
Q 039626          495 QEGEFALTRHIVGTKGYMAPEYLENG--LVSTKLDVYAFGVLILEMLTG-KEAAALHAEENNMHLSDVLNAVLTKEDGEE  571 (628)
Q Consensus       495 ~~~~~~~~~~~~gt~~Y~APE~l~~~--~~s~k~DV~SfGvvl~ELltG-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  571 (628)
                             .....++..|+|||++.+.  .++.++||||||+++|||++| ..|+.......   ......          
T Consensus       161 -------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~---~~~~~~----------  220 (259)
T cd05037         161 -------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSE---KERFYQ----------  220 (259)
T ss_pred             -------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchh---HHHHHh----------
Confidence                   1223567789999999876  789999999999999999995 55554321110   000000          


Q ss_pred             hhccccCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 039626          572 SLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLS  619 (628)
Q Consensus       572 ~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~  619 (628)
                            ...   ..+......+.+++.+||..+|.+||++.|+++.|+
T Consensus       221 ------~~~---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  259 (259)
T cd05037         221 ------DQH---RLPMPDCAELANLINQCWTYDPTKRPSFRAILRDLN  259 (259)
T ss_pred             ------cCC---CCCCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence                  000   001111156789999999999999999999998773

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=6.1e-33  Score=280.68  Aligned_cols=224  Identities=19%  Similarity=0.366  Sum_probs=174.1

Q ss_pred             eEEEEEEEC---------CceEEEEEecc-------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHH
Q 039626          361 GSVYRGKIN---------GGFAAIKKVNG-------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSD  424 (628)
Q Consensus       361 G~Vy~g~~~---------g~~vavK~~~~-------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~  424 (628)
                      |.||+|...         ...+++|....       .+.+|+.++++++|+||+++++++..+...++||||+++|+|.+
T Consensus         9 ~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~   88 (258)
T cd05078           9 TKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDT   88 (258)
T ss_pred             hhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEecCCCCcHHH
Confidence            899999762         22477887653       35679999999999999999999999889999999999999999


Q ss_pred             HhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCc--------EEEccccccccCCCCC
Q 039626          425 WVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLR--------AKIANFAMARPAEGQE  496 (628)
Q Consensus       425 ~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~--------~kl~Dfgla~~~~~~~  496 (628)
                      ++...   +..++|..+++++.|++.||+|||+   .+++||||||+||+++.++.        +|++|||++...... 
T Consensus        89 ~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~~~-  161 (258)
T cd05078          89 YLKKN---KNLINISWKLEVAKQLAWALHFLED---KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPK-  161 (258)
T ss_pred             HHhcC---CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCccceEEEecccccccCCCceEEecccccccccCCc-
Confidence            99542   2358999999999999999999998   45999999999999987765        599999988755321 


Q ss_pred             CcceeeecccCCccccCcccccc-CCCCcccccHHHHHHHHHHHhCCC-ccccccccccccHHHHHHHHhccccchhhhc
Q 039626          497 GEFALTRHIVGTKGYMAPEYLEN-GLVSTKLDVYAFGVLILEMLTGKE-AAALHAEENNMHLSDVLNAVLTKEDGEESLR  574 (628)
Q Consensus       497 ~~~~~~~~~~gt~~Y~APE~l~~-~~~s~k~DV~SfGvvl~ELltG~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  574 (628)
                            ....++..|+|||++.+ ..++.++||||||+++|||++|.. |+......      ... .....        
T Consensus       162 ------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~------~~~-~~~~~--------  220 (258)
T cd05078         162 ------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQ------KKL-QFYED--------  220 (258)
T ss_pred             ------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHH------HHH-HHHHc--------
Confidence                  22457889999999986 457999999999999999999964 33321110      000 00000        


Q ss_pred             cccCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 039626          575 HFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLS  619 (628)
Q Consensus       575 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~  619 (628)
                             ....+......+.+++.+||+.||++|||++++++.|+
T Consensus       221 -------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~  258 (258)
T cd05078         221 -------RHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN  258 (258)
T ss_pred             -------cccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence                   00112222346789999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-32  Score=279.65  Aligned_cols=230  Identities=28%  Similarity=0.444  Sum_probs=181.1

Q ss_pred             eEEEEEEE--CCceEEEEEecc-------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhcCC
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG-------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKN  431 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~-------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~  431 (628)
                      |.||++..  ++..+|+|....       ++..|++++++++|+||+++++++..+...++||||+++++|.+++...  
T Consensus        19 ~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--   96 (280)
T cd06611          19 GKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLEL--   96 (280)
T ss_pred             ceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeeccCCCcHHHHHHHh--
Confidence            89999998  578899998753       3667999999999999999999999999999999999999999998542  


Q ss_pred             CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCCccc
Q 039626          432 EGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGY  511 (628)
Q Consensus       432 ~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~Y  511 (628)
                       ...+++.....++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||++........   ......++..|
T Consensus        97 -~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~---~~~~~~~~~~y  169 (280)
T cd06611          97 -ERGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ---KRDTFIGTPYW  169 (280)
T ss_pred             -cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhccccc---ccceeecchhh
Confidence             34589999999999999999999985   499999999999999999999999999876532211   12234688999


Q ss_pred             cCccccc-----cCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCC
Q 039626          512 MAPEYLE-----NGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYP  586 (628)
Q Consensus       512 ~APE~l~-----~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~  586 (628)
                      +|||.+.     ...++.++|+||||+++|||++|+.|+.....      ...........          .+.+  ..+
T Consensus       170 ~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~~----------~~~~--~~~  231 (280)
T cd06611         170 MAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNP------MRVLLKILKSE----------PPTL--DQP  231 (280)
T ss_pred             cCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCH------HHHHHHHhcCC----------CCCc--CCc
Confidence            9999875     34578899999999999999999998753221      11111111100          0111  112


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 039626          587 LELALLVIRLIDACLKKDPTDRPTMYEIEHS  617 (628)
Q Consensus       587 ~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~  617 (628)
                      ......+.+++.+||+.+|.+||++.++++.
T Consensus       232 ~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  262 (280)
T cd06611         232 SKWSSSFNDFLKSCLVKDPDDRPTAAELLKH  262 (280)
T ss_pred             ccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence            2334567899999999999999999999763

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=2.9e-32  Score=278.07  Aligned_cols=235  Identities=26%  Similarity=0.463  Sum_probs=182.7

Q ss_pred             eEEEEEEEC-------CceEEEEEecc--------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHH
Q 039626          361 GSVYRGKIN-------GGFAAIKKVNG--------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDW  425 (628)
Q Consensus       361 G~Vy~g~~~-------g~~vavK~~~~--------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~  425 (628)
                      |.||+++..       ...+++|....        ++.+|++++++++|+||+++++++.+.+..++||||+++|+|.++
T Consensus        19 g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~   98 (275)
T cd05046          19 GEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQF   98 (275)
T ss_pred             eEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcceEEEEecCCCcHHHH
Confidence            899999862       35788987742        367899999999999999999999988899999999999999999


Q ss_pred             hhhcCCCC-----CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcce
Q 039626          426 VFSNKNEG-----KYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFA  500 (628)
Q Consensus       426 l~~~~~~~-----~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~  500 (628)
                      +.......     ..++|..+..++.|++.||+|||+.   +++||||||+||+++.++.++++|||+++......  ..
T Consensus        99 i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~~~~~~~~~~~~~--~~  173 (275)
T cd05046          99 LRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSE--YY  173 (275)
T ss_pred             HHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEEcccccccccCccc--cc
Confidence            96543221     2589999999999999999999984   49999999999999999999999999987543221  11


Q ss_pred             eeecccCCccccCccccccCCCCcccccHHHHHHHHHHHh-CCCccccccccccccHHHHHHHHhccccchhhhccccCC
Q 039626          501 LTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT-GKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDP  579 (628)
Q Consensus       501 ~~~~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELlt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~  579 (628)
                      ......++..|+|||.+.+...+.++||||||++++||++ |..|+.....      ...........            
T Consensus       174 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~------~~~~~~~~~~~------------  235 (275)
T cd05046         174 KLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD------EEVLNRLQAGK------------  235 (275)
T ss_pred             ccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccch------HHHHHHHHcCC------------
Confidence            1223356778999999988889999999999999999999 6666642111      11111111100            


Q ss_pred             cCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 039626          580 TLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLS  619 (628)
Q Consensus       580 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~  619 (628)
                       .....+...+..+.+++.+||+.||.+||++.|++..|+
T Consensus       236 -~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~  274 (275)
T cd05046         236 -LELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG  274 (275)
T ss_pred             -cCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence             000111223456889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=1.5e-32  Score=284.48  Aligned_cols=242  Identities=23%  Similarity=0.341  Sum_probs=180.8

Q ss_pred             eEEEEEEE--CCceEEEEEecc--------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhcC
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG--------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNK  430 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~--------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~  430 (628)
                      |.||+|+.  .++.||+|.++.        .+.+|+.++++++|+||+++++++..++..++||||++ ++|.+++... 
T Consensus        20 g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~-   97 (301)
T cd07873          20 ATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD-KDLKQYLDDC-   97 (301)
T ss_pred             EEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEeccc-cCHHHHHHhc-
Confidence            89999987  578899998752        35679999999999999999999999999999999996 6899888542 


Q ss_pred             CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCCcc
Q 039626          431 NEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKG  510 (628)
Q Consensus       431 ~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~  510 (628)
                        ...+++.....++.|++.||+|||+   .+++|+||||+||++++++.+||+|||++........   ......+++.
T Consensus        98 --~~~~~~~~~~~~~~qi~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~~  169 (301)
T cd07873          98 --GNSINMHNVKLFLFQLLRGLNYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK---TYSNEVVTLW  169 (301)
T ss_pred             --CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC---cccccceeec
Confidence              3458899999999999999999998   4599999999999999999999999999876532221   1223457889


Q ss_pred             ccCcccccc-CCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccc---------cCCc
Q 039626          511 YMAPEYLEN-GLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHF---------IDPT  580 (628)
Q Consensus       511 Y~APE~l~~-~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~---------~d~~  580 (628)
                      |+|||.+.+ ..++.++||||||++++||++|+.|+......+   ....+........ ......+         -.+.
T Consensus       170 y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~---~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~  245 (301)
T cd07873         170 YRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEE---QLHFIFRILGTPT-EETWPGILSNEEFKSYNYPK  245 (301)
T ss_pred             ccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHcCCCC-hhhchhhhccccccccccCc
Confidence            999998865 457889999999999999999999886433211   1111111111100 0000000         0011


Q ss_pred             CCCC----CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          581 LQGN----YPLELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       581 l~~~----~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      ....    ........+.+++.+||+.||.+|||++|+++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~  285 (301)
T cd07873         246 YRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK  285 (301)
T ss_pred             cccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            1110    01123446789999999999999999999875

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=2.1e-32  Score=277.36  Aligned_cols=231  Identities=25%  Similarity=0.445  Sum_probs=184.3

Q ss_pred             eEEEEEEE--CCceEEEEEecc--------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhcC
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG--------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNK  430 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~--------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~  430 (628)
                      |.||++..  +++.+|+|++..        ++.+|++++++++|+||+++++++..++..++++||+++++|.+++....
T Consensus        15 ~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~   94 (265)
T cd06605          15 GVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQ   94 (265)
T ss_pred             eEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEecCCCcHHHHHHHcc
Confidence            89999998  478999998753        35679999999999999999999999999999999999999999985432


Q ss_pred             CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCCcc
Q 039626          431 NEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKG  510 (628)
Q Consensus       431 ~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~  510 (628)
                         ..+++....+++.+++.||+|||+  ..+++|+||||+||++++++.+||+|||.+.......     .....++..
T Consensus        95 ---~~~~~~~~~~~~~~l~~~l~~lH~--~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~-----~~~~~~~~~  164 (265)
T cd06605          95 ---GRIPERILGKIAVAVLKGLTYLHE--KHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL-----AKTFVGTSS  164 (265)
T ss_pred             ---CCCCHHHHHHHHHHHHHHHHHHcC--CCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHH-----hhcccCChh
Confidence               568899999999999999999998  1349999999999999999999999999987653221     111568889


Q ss_pred             ccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCHH-H
Q 039626          511 YMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLE-L  589 (628)
Q Consensus       511 Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~-~  589 (628)
                      |+|||++.+..++.++||||||++++||++|+.|+....... ....+.........          .+.    .+.. .
T Consensus       165 y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~----------~~~----~~~~~~  229 (265)
T cd06605         165 YMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPP-DGIFELLQYIVNEP----------PPR----LPSGKF  229 (265)
T ss_pred             ccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccc-ccHHHHHHHHhcCC----------CCC----CChhhc
Confidence            999999999999999999999999999999999886432211 11122222221110          011    1111 4


Q ss_pred             HHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          590 ALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       590 ~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      ...+.+++.+||..||++||++.+++.
T Consensus       230 ~~~~~~li~~~l~~~p~~Rpt~~~ll~  256 (265)
T cd06605         230 SPDFQDFVNLCLIKDPRERPSYKELLE  256 (265)
T ss_pred             CHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence            556889999999999999999999874

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=3.9e-32  Score=276.72  Aligned_cols=233  Identities=24%  Similarity=0.419  Sum_probs=181.1

Q ss_pred             eEEEEEEE--CCceEEEEEecc-----------------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCC
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG-----------------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGT  421 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~-----------------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gs  421 (628)
                      |.||+|..  +|+.+|+|+++.                 .+.+|+.++++++|+|++++++++...+..++||||+++|+
T Consensus        15 ~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~   94 (272)
T cd06629          15 GRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGS   94 (272)
T ss_pred             eEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCceEEEEecCCCCc
Confidence            89999986  688999997642                 24579999999999999999999999999999999999999


Q ss_pred             hHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCccee
Q 039626          422 LSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFAL  501 (628)
Q Consensus       422 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~  501 (628)
                      |.+++...    ..+++..+..++.+++.||.|||+.   +++|+||+|+||++++++.+|++|||+++........ ..
T Consensus        95 L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-~~  166 (272)
T cd06629          95 IGSCLRTY----GRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGISKKSDDIYDN-DQ  166 (272)
T ss_pred             HHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeeccccccccccccc-cc
Confidence            99998542    4589999999999999999999984   5999999999999999999999999998765432111 11


Q ss_pred             eecccCCccccCccccccCC--CCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCC
Q 039626          502 TRHIVGTKGYMAPEYLENGL--VSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDP  579 (628)
Q Consensus       502 ~~~~~gt~~Y~APE~l~~~~--~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~  579 (628)
                      .....++..|+|||.+....  ++.++|+||||++++|+++|+.|+.....     . ........     ....    +
T Consensus       167 ~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~-----~-~~~~~~~~-----~~~~----~  231 (272)
T cd06629         167 NMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEA-----I-AAMFKLGN-----KRSA----P  231 (272)
T ss_pred             cccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcch-----H-HHHHHhhc-----cccC----C
Confidence            23346889999999987654  89999999999999999999998752111     1 11111100     0000    1


Q ss_pred             cCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          580 TLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       580 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      ........+.+..+.+++.+||+.||.+||++++|++
T Consensus       232 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (272)
T cd06629         232 PIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQ  268 (272)
T ss_pred             cCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence            1111111233567889999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=2.1e-32  Score=287.57  Aligned_cols=233  Identities=21%  Similarity=0.290  Sum_probs=177.8

Q ss_pred             eEEEEEEE--CCceEEEEEecc----------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhh
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG----------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFS  428 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  428 (628)
                      |.||+++.  .++.+|+|.+.+          .+.+|+.++..++|+||+++.+++.+++..++||||+++|+|.+++..
T Consensus        15 g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~   94 (332)
T cd05623          15 GEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSK   94 (332)
T ss_pred             eEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEeccCCCcHHHHHHH
Confidence            89999998  467899998853          256789999999999999999999999999999999999999999954


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCC
Q 039626          429 NKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGT  508 (628)
Q Consensus       429 ~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt  508 (628)
                      .   ...+++..+..++.|++.||+|||+.   +++||||||+|||++.++.+||+|||+++.......  .......||
T Consensus        95 ~---~~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~--~~~~~~~gt  166 (332)
T cd05623          95 F---EDRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT--VQSSVAVGT  166 (332)
T ss_pred             h---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheecccCCc--ceecccccC
Confidence            2   33589999999999999999999984   499999999999999999999999999876532211  122335799


Q ss_pred             ccccCccccc-----cCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCC
Q 039626          509 KGYMAPEYLE-----NGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQG  583 (628)
Q Consensus       509 ~~Y~APE~l~-----~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~  583 (628)
                      +.|+|||++.     ...++.++|||||||++|||++|+.||....      ..+....+.....   .   +   ... 
T Consensus       167 ~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~------~~~~~~~i~~~~~---~---~---~~p-  230 (332)
T cd05623         167 PDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAES------LVETYGKIMNHKE---R---F---QFP-  230 (332)
T ss_pred             ccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCC------HHHHHHHHhCCCc---c---c---cCC-
Confidence            9999999986     3468899999999999999999999986322      1222222221110   0   0   000 


Q ss_pred             CCCHHHHHHHHHHHHHhcccCCC--CCCCHHHHHHH
Q 039626          584 NYPLELALLVIRLIDACLKKDPT--DRPTMYEIEHS  617 (628)
Q Consensus       584 ~~~~~~~~~l~~l~~~Cl~~dP~--~RPs~~ev~~~  617 (628)
                      .........+.+++.+|+..++.  .|++++|+++.
T Consensus       231 ~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h  266 (332)
T cd05623         231 AQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH  266 (332)
T ss_pred             CccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence            01122345677888998865444  46888888654

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=3.9e-32  Score=274.00  Aligned_cols=228  Identities=26%  Similarity=0.419  Sum_probs=184.3

Q ss_pred             eEEEEEEE--CCceEEEEEecc---------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhc
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG---------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSN  429 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~---------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~  429 (628)
                      |.+|++..  +|+.+|+|++..         ++.+|++++++++|+||+++.+++.+.+..++|+||+++++|.+++...
T Consensus        14 g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~   93 (256)
T cd08218          14 GKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQ   93 (256)
T ss_pred             eEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecCCCCcHHHHHHhc
Confidence            78999887  678999998752         4667999999999999999999999999999999999999999988542


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCCc
Q 039626          430 KNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTK  509 (628)
Q Consensus       430 ~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~  509 (628)
                        ....+++.++++++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++........   ......|+.
T Consensus        94 --~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~  165 (256)
T cd08218          94 --RGVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE---LARTCIGTP  165 (256)
T ss_pred             --cCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh---hhhhccCCc
Confidence              233578999999999999999999984   599999999999999999999999999986643221   122346888


Q ss_pred             cccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCHHH
Q 039626          510 GYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLEL  589 (628)
Q Consensus       510 ~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~  589 (628)
                      .|+|||++.+...+.++|+||||++++||++|+.|+....      ..+.........          .+    ..+...
T Consensus       166 ~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~------~~~~~~~~~~~~----------~~----~~~~~~  225 (256)
T cd08218         166 YYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGN------MKNLVLKIIRGS----------YP----PVSSHY  225 (256)
T ss_pred             cccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCC------HHHHHHHHhcCC----------CC----CCcccC
Confidence            9999999999999999999999999999999998875321      112222211110          00    112334


Q ss_pred             HHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          590 ALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       590 ~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      ...+.+++.+||+.+|.+||+++||++
T Consensus       226 ~~~~~~li~~~l~~~p~~Rp~~~~vl~  252 (256)
T cd08218         226 SYDLRNLVSQLFKRNPRDRPSVNSILE  252 (256)
T ss_pred             CHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence            556889999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.2e-33  Score=278.42  Aligned_cols=224  Identities=24%  Similarity=0.400  Sum_probs=185.6

Q ss_pred             eEEEEEEE--CCceEEEEEeccc----------hHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhh
Q 039626          361 GSVYRGKI--NGGFAAIKKVNGD----------VSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFS  428 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~~----------~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  428 (628)
                      |.|-++..  .|+.||||.++++          +++|++||+.|+||||+.++.+|++.+...|||||..+|.|+||+..
T Consensus        67 GKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivMEYaS~GeLYDYiSe  146 (668)
T KOG0611|consen   67 GKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVMEYASGGELYDYISE  146 (668)
T ss_pred             cceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEEEecCCccHHHHHHH
Confidence            78888765  7899999977652          56899999999999999999999999999999999999999999953


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCC
Q 039626          429 NKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGT  508 (628)
Q Consensus       429 ~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt  508 (628)
                          .+.|++....+++.||..|+.|+|.   ++++|||||.+|||||.|+++||+||||+..+.+..    ......|+
T Consensus       147 ----r~~LsErEaRhfFRQIvSAVhYCHk---nrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~k----fLqTFCGS  215 (668)
T KOG0611|consen  147 ----RGSLSEREARHFFRQIVSAVHYCHK---NRVVHRDLKLENILLDQNNNIKIADFGLSNLYADKK----FLQTFCGS  215 (668)
T ss_pred             ----hccccHHHHHHHHHHHHHHHHHHhh---ccceecccchhheeecCCCCeeeeccchhhhhcccc----HHHHhcCC
Confidence                4569999999999999999999998   559999999999999999999999999998776443    34557899


Q ss_pred             ccccCccccccCCC-CcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCH
Q 039626          509 KGYMAPEYLENGLV-STKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPL  587 (628)
Q Consensus       509 ~~Y~APE~l~~~~~-s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~  587 (628)
                      +.|.+||.+.+..| .+..|-||+||+||-|+.|.-||+..+.      ...+.++-...        +..|..    | 
T Consensus       216 PLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dh------k~lvrQIs~Ga--------YrEP~~----P-  276 (668)
T KOG0611|consen  216 PLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDH------KRLVRQISRGA--------YREPET----P-  276 (668)
T ss_pred             cccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchH------HHHHHHhhccc--------ccCCCC----C-
Confidence            99999999998766 5789999999999999999999985432      23333332211        111211    2 


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 039626          588 ELALLVIRLIDACLKKDPTDRPTMYEIEHS  617 (628)
Q Consensus       588 ~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~  617 (628)
                         ....-|++|||..+|++|.|+.+|..-
T Consensus       277 ---SdA~gLIRwmLmVNP~RRATieDiAsH  303 (668)
T KOG0611|consen  277 ---SDASGLIRWMLMVNPERRATIEDIASH  303 (668)
T ss_pred             ---chHHHHHHHHHhcCcccchhHHHHhhh
Confidence               234578999999999999999998653

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=2e-32  Score=276.41  Aligned_cols=232  Identities=30%  Similarity=0.481  Sum_probs=182.8

Q ss_pred             eEEEEEEE--CCceEEEEEeccc---------hHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhc
Q 039626          361 GSVYRGKI--NGGFAAIKKVNGD---------VSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSN  429 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~~---------~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~  429 (628)
                      |.||+++.  +++.+|+|.....         ..+|+.++++++|+||+++++++.++...++||||+++++|.+++.  
T Consensus        13 g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~~~~~L~~~l~--   90 (260)
T PF00069_consen   13 GTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYCPGGSLQDYLQ--   90 (260)
T ss_dssp             EEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEETTEBHHHHHH--
T ss_pred             EEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccccccccccccc--
Confidence            89999999  4568999998652         2348999999999999999999999999999999999999999996  


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCCc
Q 039626          430 KNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTK  509 (628)
Q Consensus       430 ~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~  509 (628)
                        ....+++..+..++.|+++||.|||+.   +++|+||||+||++++++.++|+|||.+......   ........++.
T Consensus        91 --~~~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~---~~~~~~~~~~~  162 (260)
T PF00069_consen   91 --KNKPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKLSEN---NENFNPFVGTP  162 (260)
T ss_dssp             --HHSSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEESTST---TSEBSSSSSSG
T ss_pred             --ccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccc---ccccccccccc
Confidence              234589999999999999999999995   5999999999999999999999999998764211   12334567899


Q ss_pred             cccCccccc-cCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCHH
Q 039626          510 GYMAPEYLE-NGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLE  588 (628)
Q Consensus       510 ~Y~APE~l~-~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~  588 (628)
                      .|+|||.+. +...+.++||||+|++++||++|+.|+.......   ............. .....          ....
T Consensus       163 ~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~---~~~~~~~~~~~~~-~~~~~----------~~~~  228 (260)
T PF00069_consen  163 EYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDD---QLEIIEKILKRPL-PSSSQ----------QSRE  228 (260)
T ss_dssp             GGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHH---HHHHHHHHHHTHH-HHHTT----------SHTT
T ss_pred             cccccccccccccccccccccccccccccccccccccccccchh---hhhhhhhcccccc-ccccc----------ccch
Confidence            999999998 8899999999999999999999998887441111   1111111111000 00000          0001


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          589 LALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       589 ~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      ....+.+++.+||+.||++||++.++++
T Consensus       229 ~~~~l~~li~~~l~~~p~~R~~~~~l~~  256 (260)
T PF00069_consen  229 KSEELRDLIKKMLSKDPEQRPSAEELLK  256 (260)
T ss_dssp             SHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred             hHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            1267899999999999999999999875

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=2.3e-32  Score=290.32  Aligned_cols=239  Identities=24%  Similarity=0.278  Sum_probs=176.3

Q ss_pred             eEEEEEEE--CCceEEEEEecc---------chHHHHHHHhhcCCCceeeeeeeeecCC------eEEEEEEecCCCChH
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG---------DVSKEIALLNKINHSNLIILSGVCFNEG------NCYLVYEYAVNGTLS  423 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~---------~~~~E~~~l~~l~H~nIv~l~g~~~~~~------~~~lV~E~~~~gsL~  423 (628)
                      |.||++..  .|..+|+|++..         .+.+|+.+++.++|+||+++++++...+      ..++||||+++ +|.
T Consensus        35 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~  113 (359)
T cd07876          35 GIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDA-NLC  113 (359)
T ss_pred             EEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccceeEEEEeCCCc-CHH
Confidence            89999987  678999999853         3557999999999999999999986443      47999999964 676


Q ss_pred             HHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeee
Q 039626          424 DWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTR  503 (628)
Q Consensus       424 ~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~  503 (628)
                      +.+..      .+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++......    ...
T Consensus       114 ~~~~~------~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~----~~~  180 (359)
T cd07876         114 QVIHM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNF----MMT  180 (359)
T ss_pred             HHHhc------cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecCCCccccccCc----cCC
Confidence            66632      378888999999999999999995   59999999999999999999999999997643221    123


Q ss_pred             cccCCccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhcccc---------------
Q 039626          504 HIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKED---------------  568 (628)
Q Consensus       504 ~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~---------------  568 (628)
                      ...||+.|+|||.+.+..++.++||||||+++|||++|+.||.......   ....+........               
T Consensus       181 ~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (359)
T cd07876         181 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHID---QWNKVIEQLGTPSAEFMNRLQPTVRNYV  257 (359)
T ss_pred             CCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHhcCCCcHHHHHHHHHHHHHHH
Confidence            3578999999999999999999999999999999999999987432211   0000000000000               


Q ss_pred             ------chhhh----ccccCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 039626          569 ------GEESL----RHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHS  617 (628)
Q Consensus       569 ------~~~~l----~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~  617 (628)
                            ....+    ..+..+.. ..........+.+++.+||+.||++|||++|+++.
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  315 (359)
T cd07876         258 ENRPQYPGISFEELFPDWIFPSE-SERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH  315 (359)
T ss_pred             hhCCCCCCcchhhhccccccccc-cccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence                  00000    00000000 00111223567899999999999999999999863

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=2.6e-32  Score=277.18  Aligned_cols=230  Identities=24%  Similarity=0.399  Sum_probs=179.3

Q ss_pred             eEEEEEEE--CCceEEEEEecc-------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhcCC
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG-------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKN  431 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~-------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~  431 (628)
                      |.||++..  ++..+|+|.++.       .+.+|+.+++.++|+||+++++.+..++..++|+||+++++|.+++..   
T Consensus        23 ~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~---   99 (267)
T cd06645          23 GDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHV---   99 (267)
T ss_pred             eEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccCCCcHHHHHHh---
Confidence            89999987  678899998753       256799999999999999999999999999999999999999998843   


Q ss_pred             CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCCccc
Q 039626          432 EGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGY  511 (628)
Q Consensus       432 ~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~Y  511 (628)
                       ...+++.+...++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||++........   ......|+..|
T Consensus       100 -~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~y  172 (267)
T cd06645         100 -TGPLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITATIA---KRKSFIGTPYW  172 (267)
T ss_pred             -cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccCccc---ccccccCcccc
Confidence             33589999999999999999999985   499999999999999999999999999876542211   12334789999


Q ss_pred             cCccccc---cCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCHH
Q 039626          512 MAPEYLE---NGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLE  588 (628)
Q Consensus       512 ~APE~l~---~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~  588 (628)
                      +|||++.   ...++.++|+|||||+++||++|+.|+.......     ... .....        ....+....  ...
T Consensus       173 ~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~-----~~~-~~~~~--------~~~~~~~~~--~~~  236 (267)
T cd06645         173 MAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMR-----ALF-LMTKS--------NFQPPKLKD--KMK  236 (267)
T ss_pred             cChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchh-----hHH-hhhcc--------CCCCCcccc--cCC
Confidence            9999874   4568899999999999999999998875322111     000 00000        000011110  011


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          589 LALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       589 ~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      .+..+.+++.+||+.||++||+++++++
T Consensus       237 ~~~~~~~li~~~l~~~P~~R~~~~~ll~  264 (267)
T cd06645         237 WSNSFHHFVKMALTKNPKKRPTAEKLLQ  264 (267)
T ss_pred             CCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence            2345789999999999999999999874

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=4.2e-32  Score=275.58  Aligned_cols=233  Identities=26%  Similarity=0.404  Sum_probs=184.1

Q ss_pred             eEEEEEEE--CCceEEEEEecc-------------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHH
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG-------------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDW  425 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~-------------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~  425 (628)
                      |.||++..  +++.+|+|.+..             ++.+|++++++++|+||+++++++.+.+..++|+||+++++|.++
T Consensus        14 ~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~   93 (268)
T cd06630          14 SSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHL   93 (268)
T ss_pred             eEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEEEeccCCCcHHHH
Confidence            89999987  788999998752             356799999999999999999999999999999999999999999


Q ss_pred             hhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCC-cEEEccccccccCCCCCCc-ceeee
Q 039626          426 VFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDL-RAKIANFAMARPAEGQEGE-FALTR  503 (628)
Q Consensus       426 l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~-~~kl~Dfgla~~~~~~~~~-~~~~~  503 (628)
                      +..    ...+++..+..++.|++.||+|||+.   +++|+||+|+||+++.++ .+||+|||++......... .....
T Consensus        94 l~~----~~~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~  166 (268)
T cd06630          94 LSK----YGAFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQG  166 (268)
T ss_pred             HHH----hCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEcccccccccccccccCCcccc
Confidence            853    23588999999999999999999984   599999999999998776 5999999998776432111 11122


Q ss_pred             cccCCccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCC
Q 039626          504 HIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQG  583 (628)
Q Consensus       504 ~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~  583 (628)
                      ...++..|+|||.+.+..++.++||||+|++++||++|+.|+.......   ..........             .....
T Consensus       167 ~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~---~~~~~~~~~~-------------~~~~~  230 (268)
T cd06630         167 QLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSN---HLALIFKIAS-------------ATTAP  230 (268)
T ss_pred             ccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcc---hHHHHHHHhc-------------cCCCC
Confidence            3468899999999988889999999999999999999998875322111   1111111100             00112


Q ss_pred             CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          584 NYPLELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       584 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      ..+......+.+++.+||+.+|.+||++.|+++
T Consensus       231 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~  263 (268)
T cd06630         231 SIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK  263 (268)
T ss_pred             CCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence            334455667889999999999999999999874

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.1e-32  Score=273.83  Aligned_cols=231  Identities=26%  Similarity=0.402  Sum_probs=182.9

Q ss_pred             eEEEEEEE--CCceEEEEEecc-------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhcCC
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG-------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKN  431 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~-------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~  431 (628)
                      |.||++..  +++.+++|....       .+.+|++++++++|+||+++++++.+++..+++|||+++++|.+++...  
T Consensus        17 ~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~~~~l~~~~~~~--   94 (262)
T cd06613          17 GDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVT--   94 (262)
T ss_pred             eEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCCCCCcHHHHHHhh--
Confidence            89999987  567899998753       3678999999999999999999999999999999999999999988542  


Q ss_pred             CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCCccc
Q 039626          432 EGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGY  511 (628)
Q Consensus       432 ~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~Y  511 (628)
                       ...+++.++..++.|++.||.|||+.   +++|+||+|+||++++++.+||+|||++........   ......++..|
T Consensus        95 -~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~---~~~~~~~~~~y  167 (262)
T cd06613          95 -RGPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA---KRKSFIGTPYW  167 (262)
T ss_pred             -ccCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhhhhhh---ccccccCCccc
Confidence             24589999999999999999999985   499999999999999999999999999876543211   12234688899


Q ss_pred             cCccccccC---CCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCHH
Q 039626          512 MAPEYLENG---LVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLE  588 (628)
Q Consensus       512 ~APE~l~~~---~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~  588 (628)
                      +|||.+.+.   .++.++||||||++++||++|+.|+......      +.......        ..+..+.+  ..+..
T Consensus       168 ~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~------~~~~~~~~--------~~~~~~~~--~~~~~  231 (262)
T cd06613         168 MAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPM------RALFLISK--------SNFPPPKL--KDKEK  231 (262)
T ss_pred             cCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHh--------ccCCCccc--cchhh
Confidence            999999776   8899999999999999999999987632211      11111100        00001111  11234


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          589 LALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       589 ~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      .+..+.+++.+||..+|.+||++.+|+.
T Consensus       232 ~~~~~~~li~~~l~~~p~~Rpt~~~il~  259 (262)
T cd06613         232 WSPVFHDFIKKCLTKDPKKRPTATKLLQ  259 (262)
T ss_pred             hhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            4567899999999999999999999874

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=5.6e-32  Score=275.55  Aligned_cols=237  Identities=23%  Similarity=0.381  Sum_probs=182.0

Q ss_pred             eEEEEEEE-----CCceEEEEEecc---------chHHHHHHHhhcCCCceeeeeeeeecCC------eEEEEEEecCCC
Q 039626          361 GSVYRGKI-----NGGFAAIKKVNG---------DVSKEIALLNKINHSNLIILSGVCFNEG------NCYLVYEYAVNG  420 (628)
Q Consensus       361 G~Vy~g~~-----~g~~vavK~~~~---------~~~~E~~~l~~l~H~nIv~l~g~~~~~~------~~~lV~E~~~~g  420 (628)
                      |.||+|.+     .+..+|+|.++.         ++.+|++++++++|+||+++++++....      ..++++||+++|
T Consensus        13 g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   92 (273)
T cd05074          13 GSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHG   92 (273)
T ss_pred             CCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccceEEEEecCCCC
Confidence            89999986     257899998764         3567999999999999999999987532      247899999999


Q ss_pred             ChHHHhhhcCC--CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCc
Q 039626          421 TLSDWVFSNKN--EGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGE  498 (628)
Q Consensus       421 sL~~~l~~~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~  498 (628)
                      +|.+++.....  ....+++...++++.|++.||+|||+.   +++||||||+||++++++.+||+|||+++........
T Consensus        93 ~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg~~~~~~~~~~~  169 (273)
T cd05074          93 DLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYY  169 (273)
T ss_pred             cHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECcccccccccCCcce
Confidence            99998854322  223589999999999999999999984   5999999999999999999999999999866432211


Q ss_pred             ceeeecccCCccccCccccccCCCCcccccHHHHHHHHHHHh-CCCccccccccccccHHHHHHHHhccccchhhhcccc
Q 039626          499 FALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT-GKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFI  577 (628)
Q Consensus       499 ~~~~~~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELlt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  577 (628)
                       .......++..|++||.+.+..++.++||||||+++|||++ |+.|+.....      .+.........          
T Consensus       170 -~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~------~~~~~~~~~~~----------  232 (273)
T cd05074         170 -RQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN------SEIYNYLIKGN----------  232 (273)
T ss_pred             -ecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH------HHHHHHHHcCC----------
Confidence             11122345678999999999899999999999999999999 7777653211      11111111110          


Q ss_pred             CCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 039626          578 DPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNI  621 (628)
Q Consensus       578 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l  621 (628)
                      ..    ..+......+.+++.+||+.+|++|||+.|+++.|+++
T Consensus       233 ~~----~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         233 RL----KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             cC----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            00    01122345688999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=4.1e-32  Score=278.72  Aligned_cols=232  Identities=24%  Similarity=0.380  Sum_probs=182.6

Q ss_pred             eEEEEEEE--CCceEEEEEecc--------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhcC
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG--------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNK  430 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~--------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~  430 (628)
                      |.||++..  .|..+|+|.++.        ++.+|++++++++|+||+++++.+..++..++||||+++++|..++....
T Consensus        15 g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~   94 (286)
T cd06622          15 GSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGV   94 (286)
T ss_pred             eEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeecCCCCHHHHHHhcc
Confidence            89999998  588999998753        35679999999999999999999999999999999999999999885421


Q ss_pred             CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCCcc
Q 039626          431 NEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKG  510 (628)
Q Consensus       431 ~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~  510 (628)
                       ....+++..+..++.+++.||.|||+.  .+++|+||||+||+++.++.+||+|||++.......     .....++..
T Consensus        95 -~~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-----~~~~~~~~~  166 (286)
T cd06622          95 -ATEGIPEDVLRRITYAVVKGLKFLKEE--HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL-----AKTNIGCQS  166 (286)
T ss_pred             -ccCCCCHHHHHHHHHHHHHHHHHHHhc--CCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc-----cccCCCccC
Confidence             234689999999999999999999962  359999999999999999999999999987653221     223468889


Q ss_pred             ccCccccccCC------CCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCC
Q 039626          511 YMAPEYLENGL------VSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGN  584 (628)
Q Consensus       511 Y~APE~l~~~~------~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~  584 (628)
                      |+|||.+.+..      ++.++|+|||||+++||++|+.|+......   .....+.....          ..    ...
T Consensus       167 y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~---~~~~~~~~~~~----------~~----~~~  229 (286)
T cd06622         167 YMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYA---NIFAQLSAIVD----------GD----PPT  229 (286)
T ss_pred             ccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchh---hHHHHHHHHhh----------cC----CCC
Confidence            99999986543      488999999999999999999998532211   11111111110          00    112


Q ss_pred             CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 039626          585 YPLELALLVIRLIDACLKKDPTDRPTMYEIEHS  617 (628)
Q Consensus       585 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~  617 (628)
                      .+.+....+.+++.+||+.+|.+||++++++..
T Consensus       230 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~  262 (286)
T cd06622         230 LPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH  262 (286)
T ss_pred             CCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence            233455668899999999999999999999863

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=8.3e-32  Score=272.95  Aligned_cols=236  Identities=29%  Similarity=0.424  Sum_probs=185.2

Q ss_pred             eEEEEEEE--CCceEEEEEecc--------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhcC
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG--------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNK  430 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~--------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~  430 (628)
                      |.||+|..  ++..+++|+...        ++.+|+++++.++|+||+++++.+..++..++|+||+++++|.+++....
T Consensus        15 ~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~l~~~~~~~~   94 (267)
T cd06610          15 AVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSY   94 (267)
T ss_pred             eEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEeccCCCcHHHHHHHhc
Confidence            89999987  677899998753        46789999999999999999999999999999999999999999996432


Q ss_pred             CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcc-eeeecccCCc
Q 039626          431 NEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEF-ALTRHIVGTK  509 (628)
Q Consensus       431 ~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~-~~~~~~~gt~  509 (628)
                      . ...+++.....++.|++.||.|||+.   +++|+||+|+||++++++.+||+|||++.......... .......|+.
T Consensus        95 ~-~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~  170 (267)
T cd06610          95 P-RGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTP  170 (267)
T ss_pred             c-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccccccccccccCCh
Confidence            2 24589999999999999999999984   59999999999999999999999999987765432211 1223346889


Q ss_pred             cccCccccccC-CCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCC-CH
Q 039626          510 GYMAPEYLENG-LVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNY-PL  587 (628)
Q Consensus       510 ~Y~APE~l~~~-~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~-~~  587 (628)
                      .|+|||++... ..+.++|+||||++++||++|+.|+......      ..........          .+.+.... ..
T Consensus       171 ~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~------~~~~~~~~~~----------~~~~~~~~~~~  234 (267)
T cd06610         171 CWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPM------KVLMLTLQND----------PPSLETGADYK  234 (267)
T ss_pred             hhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChh------hhHHHHhcCC----------CCCcCCccccc
Confidence            99999998877 7899999999999999999999998632211      1111111110          01111100 12


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          588 ELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       588 ~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      ..+..+.+++.+||+.||++||++.++++
T Consensus       235 ~~~~~~~~li~~~l~~~p~~Rp~~~~ll~  263 (267)
T cd06610         235 KYSKSFRKMISLCLQKDPSKRPTAEELLK  263 (267)
T ss_pred             cccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence            34466789999999999999999999875

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.2e-32  Score=282.29  Aligned_cols=232  Identities=24%  Similarity=0.348  Sum_probs=181.9

Q ss_pred             eEEEEEEE--CCceEEEEEecc----------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhh
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG----------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFS  428 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  428 (628)
                      |.||++..  .++.+|+|....          .+.+|++++++++|+||+++++.+.++...++||||+.+++|.+++..
T Consensus        15 g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~   94 (316)
T cd05574          15 GRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQR   94 (316)
T ss_pred             EEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEEecCCCCHHHHHHh
Confidence            89999998  478999998853          256799999999999999999999999999999999999999999853


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcc---------
Q 039626          429 NKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEF---------  499 (628)
Q Consensus       429 ~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~---------  499 (628)
                      .  .+..+++..+..++.|++.||+|||+.   +++|+||||+||+++.++.++|+|||++..........         
T Consensus        95 ~--~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~  169 (316)
T cd05574          95 Q--PGKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSR  169 (316)
T ss_pred             C--CCCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhcccccccccccccccccc
Confidence            2  345689999999999999999999984   59999999999999999999999999987653221100         


Q ss_pred             -----------------eeeecccCCccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHH
Q 039626          500 -----------------ALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNA  562 (628)
Q Consensus       500 -----------------~~~~~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~  562 (628)
                                       .......|+..|+|||++.+..++.++||||||+++|||++|+.|+......      .....
T Consensus       170 ~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~------~~~~~  243 (316)
T cd05574         170 RSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRD------ETFSN  243 (316)
T ss_pred             cccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchH------HHHHH
Confidence                             0112346889999999999888999999999999999999999998643221      11111


Q ss_pred             HhccccchhhhccccCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCC----HHHHHH
Q 039626          563 VLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPT----MYEIEH  616 (628)
Q Consensus       563 ~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs----~~ev~~  616 (628)
                      ...             ...........+..+.+++.+||+.||++||+    ++|++.
T Consensus       244 ~~~-------------~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~  288 (316)
T cd05574         244 ILK-------------KEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ  288 (316)
T ss_pred             Hhc-------------CCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence            111             00100011114567899999999999999999    555544

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=5.2e-32  Score=272.99  Aligned_cols=226  Identities=29%  Similarity=0.426  Sum_probs=181.4

Q ss_pred             eEEEEEEE--CCceEEEEEecc------------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHh
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG------------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWV  426 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~------------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l  426 (628)
                      |.||+|..  +++.+++|.+..            .+.+|++++++++|+||+++++++.++...++++||+++++|.+++
T Consensus        14 ~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~   93 (258)
T cd06632          14 GSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLELVPGGSLAKLL   93 (258)
T ss_pred             ceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEEEecCCCcHHHHH
Confidence            89999998  578999997632            3567999999999999999999999999999999999999999998


Q ss_pred             hhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeeccc
Q 039626          427 FSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIV  506 (628)
Q Consensus       427 ~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~  506 (628)
                      ..    ...+++..+..++.+++.||+|||+.   +++|+||+|+||+++.++.+||+|||++.......    ......
T Consensus        94 ~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~----~~~~~~  162 (258)
T cd06632          94 KK----YGSFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS----FAKSFK  162 (258)
T ss_pred             Hh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceeccccc----cccccC
Confidence            53    23588999999999999999999984   59999999999999999999999999987654322    123456


Q ss_pred             CCccccCccccccCC-CCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCC
Q 039626          507 GTKGYMAPEYLENGL-VSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNY  585 (628)
Q Consensus       507 gt~~Y~APE~l~~~~-~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~  585 (628)
                      ++..|++||.+.... ++.++|+||||++++||++|+.|+.....      .+.........    .         ....
T Consensus       163 ~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~------~~~~~~~~~~~----~---------~~~~  223 (258)
T cd06632         163 GSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG------VAAVFKIGRSK----E---------LPPI  223 (258)
T ss_pred             CCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcH------HHHHHHHHhcc----c---------CCCc
Confidence            889999999988766 89999999999999999999999763221      11111111000    0         0111


Q ss_pred             CHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          586 PLELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       586 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      +......+.+++.+||+.+|.+||++++++.
T Consensus       224 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  254 (258)
T cd06632         224 PDHLSDEAKDFILKCLQRDPSLRPTAAELLE  254 (258)
T ss_pred             CCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence            2233456789999999999999999999875

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=3.1e-32  Score=288.89  Aligned_cols=241  Identities=24%  Similarity=0.310  Sum_probs=177.4

Q ss_pred             eEEEEEEE--CCceEEEEEecc---------chHHHHHHHhhcCCCceeeeeeeeecC------CeEEEEEEecCCCChH
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG---------DVSKEIALLNKINHSNLIILSGVCFNE------GNCYLVYEYAVNGTLS  423 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~---------~~~~E~~~l~~l~H~nIv~l~g~~~~~------~~~~lV~E~~~~gsL~  423 (628)
                      |.||++..  .++.+|+|++..         .+.+|+.+++.++|+||+++++++...      ...++||||++ ++|.
T Consensus        31 g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~  109 (355)
T cd07874          31 GIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMD-ANLC  109 (355)
T ss_pred             EEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccceeEEEhhhhc-ccHH
Confidence            89999987  678999998863         345799999999999999999998643      35799999995 4677


Q ss_pred             HHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeee
Q 039626          424 DWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTR  503 (628)
Q Consensus       424 ~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~  503 (628)
                      +++.      ..+++..+..++.|++.||+|||+.   +++||||||+|||++.++.+||+|||+++......    ...
T Consensus       110 ~~~~------~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Dfg~~~~~~~~~----~~~  176 (355)
T cd07874         110 QVIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF----MMT  176 (355)
T ss_pred             HHHh------hcCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeCcccccCCCcc----ccC
Confidence            7763      2378899999999999999999984   59999999999999999999999999998654321    123


Q ss_pred             cccCCccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccc-c----chhhhccccC
Q 039626          504 HIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKE-D----GEESLRHFID  578 (628)
Q Consensus       504 ~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~-~----~~~~l~~~~d  578 (628)
                      ...||..|+|||.+.+..++.++|||||||+++||++|+.||.......  .....+....... .    ....+..+++
T Consensus       177 ~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (355)
T cd07874         177 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID--QWNKVIEQLGTPCPEFMKKLQPTVRNYVE  254 (355)
T ss_pred             CccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCCCHHHHHhhcHHHHHHHh
Confidence            3578999999999999999999999999999999999999986432111  0111111100000 0    0000000000


Q ss_pred             ----------Cc------C--CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 039626          579 ----------PT------L--QGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHS  617 (628)
Q Consensus       579 ----------~~------l--~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~  617 (628)
                                +.      .  ....+......+.+++.+||+.||++|||+.|+++.
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h  311 (355)
T cd07874         255 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH  311 (355)
T ss_pred             cCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence                      00      0  001112234567899999999999999999999873

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=5.6e-32  Score=287.97  Aligned_cols=239  Identities=24%  Similarity=0.283  Sum_probs=176.9

Q ss_pred             eEEEEEEE--CCceEEEEEecc---------chHHHHHHHhhcCCCceeeeeeeeecC------CeEEEEEEecCCCChH
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG---------DVSKEIALLNKINHSNLIILSGVCFNE------GNCYLVYEYAVNGTLS  423 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~---------~~~~E~~~l~~l~H~nIv~l~g~~~~~------~~~~lV~E~~~~gsL~  423 (628)
                      |.||++..  .++.+|||++..         .+.+|+.+++.++|+||+++++++...      ...++||||++ ++|.
T Consensus        38 g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~  116 (364)
T cd07875          38 GIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD-ANLC  116 (364)
T ss_pred             eEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccCeEEEEEeCCC-CCHH
Confidence            89999987  678899999863         355799999999999999999987643      35799999996 5787


Q ss_pred             HHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeee
Q 039626          424 DWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTR  503 (628)
Q Consensus       424 ~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~  503 (628)
                      +++..      .+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++......    ...
T Consensus       117 ~~~~~------~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~----~~~  183 (364)
T cd07875         117 QVIQM------ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF----MMT  183 (364)
T ss_pred             HHHHh------cCCHHHHHHHHHHHHHHHHHHhh---CCeecCCCCHHHEEECCCCcEEEEeCCCccccCCCC----ccc
Confidence            77732      37889999999999999999998   459999999999999999999999999998654321    123


Q ss_pred             cccCCccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccc--------------
Q 039626          504 HIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDG--------------  569 (628)
Q Consensus       504 ~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~--------------  569 (628)
                      ...||..|+|||++.+..++.++|||||||++|||++|+.||.......  .....+.. ......              
T Consensus       184 ~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~--~~~~~~~~-~~~~~~~~~~~~~~~~~~~~  260 (364)
T cd07875         184 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHID--QWNKVIEQ-LGTPCPEFMKKLQPTVRTYV  260 (364)
T ss_pred             CCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHh-cCCCCHHHHHhhhHHHHHHH
Confidence            3578999999999999999999999999999999999999986433211  01111110 000000              


Q ss_pred             -------hhhhccccCCcC---CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          570 -------EESLRHFIDPTL---QGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       570 -------~~~l~~~~d~~l---~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                             ............   ...........+.+++.+||+.||.+|||+.|+++
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~  317 (364)
T cd07875         261 ENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ  317 (364)
T ss_pred             hhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence                   000000000000   00111112346789999999999999999999876

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=5.6e-32  Score=273.98  Aligned_cols=228  Identities=24%  Similarity=0.362  Sum_probs=183.8

Q ss_pred             eEEEEEEEC--CceEEEEEecc----------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhh
Q 039626          361 GSVYRGKIN--GGFAAIKKVNG----------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFS  428 (628)
Q Consensus       361 G~Vy~g~~~--g~~vavK~~~~----------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  428 (628)
                      |.||+++..  ++.+|+|.+..          .+.+|++++++++|+||+++++++.++...++|+||+++++|.+++..
T Consensus         7 ~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   86 (262)
T cd05572           7 GRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGELWTILRD   86 (262)
T ss_pred             eEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcHHHHHhh
Confidence            899999995  88999998753          356799999999999999999999999999999999999999999954


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCC
Q 039626          429 NKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGT  508 (628)
Q Consensus       429 ~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt  508 (628)
                      .    ..+++..+..++.+++.||+|||+   .+++|+||+|+||+++.++.+||+|||+++......    ......++
T Consensus        87 ~----~~l~~~~~~~~~~~i~~~l~~lH~---~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~----~~~~~~~~  155 (262)
T cd05572          87 R----GLFDEYTARFYIACVVLAFEYLHN---RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ----KTWTFCGT  155 (262)
T ss_pred             c----CCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc----ccccccCC
Confidence            2    348999999999999999999998   459999999999999999999999999998765432    12234688


Q ss_pred             ccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCHH
Q 039626          509 KGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLE  588 (628)
Q Consensus       509 ~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~  588 (628)
                      ..|++||.+.+..++.++|+||||+++|||++|+.|+.....+    ..+......             +......++..
T Consensus       156 ~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~~-------------~~~~~~~~~~~  218 (262)
T cd05572         156 PEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDED----PMEIYNDIL-------------KGNGKLEFPNY  218 (262)
T ss_pred             cCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCC----HHHHHHHHh-------------ccCCCCCCCcc
Confidence            9999999998888999999999999999999999988644321    111111111             11111223333


Q ss_pred             HHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 039626          589 LALLVIRLIDACLKKDPTDRPT-----MYEIEH  616 (628)
Q Consensus       589 ~~~~l~~l~~~Cl~~dP~~RPs-----~~ev~~  616 (628)
                      ....+.+++.+||+.||++||+     ++|+++
T Consensus       219 ~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~  251 (262)
T cd05572         219 IDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK  251 (262)
T ss_pred             cCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence            3567899999999999999999     555543

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.7e-33  Score=289.79  Aligned_cols=223  Identities=19%  Similarity=0.270  Sum_probs=172.6

Q ss_pred             ceEEEEEEE--CCceEEEEEeccc----------hHHHHHHHhhc---CCCceeeeeeeeecCCeEEEEEEecCCCChHH
Q 039626          360 QGSVYRGKI--NGGFAAIKKVNGD----------VSKEIALLNKI---NHSNLIILSGVCFNEGNCYLVYEYAVNGTLSD  424 (628)
Q Consensus       360 ~G~Vy~g~~--~g~~vavK~~~~~----------~~~E~~~l~~l---~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~  424 (628)
                      .|.||+++.  .++.+|+|++...          +..|..++.+.   +|+||+++++++.++...++||||+++|+|.+
T Consensus         6 ~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~g~L~~   85 (330)
T cd05586           6 FGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSGGELFW   85 (330)
T ss_pred             ceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCCChHHH
Confidence            389999987  5889999998541          23456666655   69999999999999999999999999999999


Q ss_pred             HhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeec
Q 039626          425 WVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRH  504 (628)
Q Consensus       425 ~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~  504 (628)
                      ++..    ...+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++.......   ....
T Consensus        86 ~l~~----~~~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~---~~~~  155 (330)
T cd05586          86 HLQK----EGRFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK---TTNT  155 (330)
T ss_pred             HHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC---CccC
Confidence            8853    34589999999999999999999984   599999999999999999999999999875432211   1234


Q ss_pred             ccCCccccCccccccC-CCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCC
Q 039626          505 IVGTKGYMAPEYLENG-LVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQG  583 (628)
Q Consensus       505 ~~gt~~Y~APE~l~~~-~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~  583 (628)
                      ..||+.|+|||.+.+. .++.++|||||||++|||++|+.|+.....      .+....+....           ..+..
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~------~~~~~~i~~~~-----------~~~~~  218 (330)
T cd05586         156 FCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDT------QQMYRNIAFGK-----------VRFPK  218 (330)
T ss_pred             ccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCH------HHHHHHHHcCC-----------CCCCC
Confidence            5799999999998764 479999999999999999999999864221      11111111100           00110


Q ss_pred             CCCHHHHHHHHHHHHHhcccCCCCCCCHH
Q 039626          584 NYPLELALLVIRLIDACLKKDPTDRPTMY  612 (628)
Q Consensus       584 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~  612 (628)
                         ......+.+++.+||+.||.+||++.
T Consensus       219 ---~~~~~~~~~li~~~L~~~P~~R~~~~  244 (330)
T cd05586         219 ---NVLSDEGRQFVKGLLNRNPQHRLGAH  244 (330)
T ss_pred             ---ccCCHHHHHHHHHHcCCCHHHCCCCC
Confidence               11234567999999999999999543

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=5.1e-32  Score=277.97  Aligned_cols=244  Identities=25%  Similarity=0.395  Sum_probs=182.6

Q ss_pred             eEEEEEEE--CCceEEEEEecc---------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhc
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG---------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSN  429 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~---------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~  429 (628)
                      |.||++..  +++.+|+|+++.         .+.+|++++++++|+||+++++++..++..++||||++++.+..+..  
T Consensus        15 ~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~l~~~~~--   92 (288)
T cd07833          15 GVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVERTLLELLEA--   92 (288)
T ss_pred             eeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEecCCCCHHHHHHh--
Confidence            89999988  577899997652         46789999999999999999999999999999999999877766552  


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCCc
Q 039626          430 KNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTK  509 (628)
Q Consensus       430 ~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~  509 (628)
                        ....+++..+..++.+++.||+|||+.   +++|+||+|+||++++++.+||+|||++........  .......++.
T Consensus        93 --~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~--~~~~~~~~~~  165 (288)
T cd07833          93 --SPGGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARPA--SPLTDYVATR  165 (288)
T ss_pred             --cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc--ccccCccccc
Confidence              233489999999999999999999984   599999999999999999999999999987654322  1123356788


Q ss_pred             cccCccccccC-CCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccch--------hhhc--cccC
Q 039626          510 GYMAPEYLENG-LVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGE--------ESLR--HFID  578 (628)
Q Consensus       510 ~Y~APE~l~~~-~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~l~--~~~d  578 (628)
                      .|+|||++.+. .++.++||||||++++||++|+.|+......+  .+.. ...........        ....  +..+
T Consensus       166 ~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~--~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (288)
T cd07833         166 WYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDID--QLYL-IQKCLGPLPPSHQELFSSNPRFAGVAFPE  242 (288)
T ss_pred             CCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHH-HHHHhCCCCHHHhhhcccCccccccccCC
Confidence            99999999887 88999999999999999999998876432211  0111 11110000000        0000  0000


Q ss_pred             Cc----CCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          579 PT----LQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       579 ~~----l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      ..    ....++...+..+.+++++||..+|++||+++++++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  284 (288)
T cd07833         243 PSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ  284 (288)
T ss_pred             CCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence            00    001122234677899999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=6.9e-32  Score=271.90  Aligned_cols=231  Identities=30%  Similarity=0.506  Sum_probs=183.0

Q ss_pred             eEEEEEEECC------ceEEEEEecc--------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHh
Q 039626          361 GSVYRGKING------GFAAIKKVNG--------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWV  426 (628)
Q Consensus       361 G~Vy~g~~~g------~~vavK~~~~--------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l  426 (628)
                      |.||+++..+      ..+|+|+.+.        .+..|+.++.+++|+||+++++++.+.+..+++|||+++++|.+++
T Consensus        13 g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e~~~~~~l~~~~   92 (258)
T smart00219       13 GEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEYMEGGDLLDYL   92 (258)
T ss_pred             cceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEeccCCCCHHHHH
Confidence            8999999843      7899998864        3567999999999999999999999999999999999999999999


Q ss_pred             hhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeeccc
Q 039626          427 FSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIV  506 (628)
Q Consensus       427 ~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~  506 (628)
                      ....  ...+++.++..++.|++.||+|||+.   +++|+||||+||++++++.++|+|||+++........  ......
T Consensus        93 ~~~~--~~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~  165 (258)
T smart00219       93 RKNR--PKELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYY--KKKGGK  165 (258)
T ss_pred             Hhhh--hccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceeccccccc--ccccCC
Confidence            5422  12289999999999999999999985   5999999999999999999999999999876543211  111234


Q ss_pred             CCccccCccccccCCCCcccccHHHHHHHHHHHh-CCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCC
Q 039626          507 GTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT-GKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNY  585 (628)
Q Consensus       507 gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELlt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~  585 (628)
                      +++.|+|||.+.+..++.++||||+|++++||++ |+.|+....      ..+.........              ....
T Consensus       166 ~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~------~~~~~~~~~~~~--------------~~~~  225 (258)
T smart00219      166 LPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMS------NEEVLEYLKKGY--------------RLPK  225 (258)
T ss_pred             CcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC------HHHHHHHHhcCC--------------CCCC
Confidence            7789999999988899999999999999999998 677665321      112221111100              0011


Q ss_pred             CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 039626          586 PLELALLVIRLIDACLKKDPTDRPTMYEIEHSL  618 (628)
Q Consensus       586 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L  618 (628)
                      +...+..+.+++.+|+..||.+|||+.|+++.|
T Consensus       226 ~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      226 PENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             CCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence            122445688999999999999999999998764

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.5e-32  Score=285.68  Aligned_cols=233  Identities=22%  Similarity=0.298  Sum_probs=176.1

Q ss_pred             eEEEEEEE--CCceEEEEEecc----------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhh
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG----------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFS  428 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  428 (628)
                      |.||+++.  +++.+|+|.+..          .+.+|..++..++|+||+++++++.+++..++||||+++|+|.+++..
T Consensus        15 g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~   94 (331)
T cd05597          15 GEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSK   94 (331)
T ss_pred             eEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEecCCCCcHHHHHHH
Confidence            89999998  578999999853          256799999999999999999999999999999999999999999953


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCC
Q 039626          429 NKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGT  508 (628)
Q Consensus       429 ~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt  508 (628)
                      .   ...+++..+..++.|++.||+|||+.   +++||||||+|||++.++.+||+|||+++........  ......||
T Consensus        95 ~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~gt  166 (331)
T cd05597          95 F---EDRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTV--QSNVAVGT  166 (331)
T ss_pred             h---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCc--cccceecc
Confidence            2   34588999999999999999999984   5999999999999999999999999998765432211  12224699


Q ss_pred             ccccCcccccc-----CCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCC
Q 039626          509 KGYMAPEYLEN-----GLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQG  583 (628)
Q Consensus       509 ~~Y~APE~l~~-----~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~  583 (628)
                      +.|+|||++..     ..++.++|||||||++|||++|+.||....      ..+....+.....   .. .     +..
T Consensus       167 ~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~------~~~~~~~i~~~~~---~~-~-----~~~  231 (331)
T cd05597         167 PDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAES------LVETYGKIMNHKE---HF-Q-----FPP  231 (331)
T ss_pred             ccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCC------HHHHHHHHHcCCC---cc-c-----CCC
Confidence            99999999863     457889999999999999999999986322      1122222211110   00 0     000


Q ss_pred             CCCHHHHHHHHHHHHHhcccCC--CCCCCHHHHHHH
Q 039626          584 NYPLELALLVIRLIDACLKKDP--TDRPTMYEIEHS  617 (628)
Q Consensus       584 ~~~~~~~~~l~~l~~~Cl~~dP--~~RPs~~ev~~~  617 (628)
                      . ....+..+.+++.+|+..++  ..||+++++++.
T Consensus       232 ~-~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h  266 (331)
T cd05597         232 D-VTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH  266 (331)
T ss_pred             c-cCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence            0 01134456778888775433  347888887653

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=9.3e-32  Score=275.00  Aligned_cols=226  Identities=27%  Similarity=0.440  Sum_probs=182.2

Q ss_pred             eEEEEEEE--CCceEEEEEecc--------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhcC
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG--------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNK  430 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~--------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~  430 (628)
                      |.||+|..  ++..+|+|....        ++.+|++++.+++|+||+++++++..+...++||||+++++|.+++..  
T Consensus        18 ~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~i~~--   95 (277)
T cd06641          18 GEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP--   95 (277)
T ss_pred             eEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCCCCcHHHHHhc--
Confidence            89999987  678899998652        366799999999999999999999999999999999999999999842  


Q ss_pred             CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCCcc
Q 039626          431 NEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKG  510 (628)
Q Consensus       431 ~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~  510 (628)
                         ..+++.....++.+++.|+.|||+   .+++|+||+|+||+++.++.++|+|||++........   ......++..
T Consensus        96 ---~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~  166 (277)
T cd06641          96 ---GPLDETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI---KRNTFVGTPF  166 (277)
T ss_pred             ---CCCCHHHHHHHHHHHHHHHHHHcc---CCeecCCCCHHhEEECCCCCEEEeecccceecccchh---hhccccCCcc
Confidence               358999999999999999999998   4599999999999999999999999999876543211   1223467889


Q ss_pred             ccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCHHHH
Q 039626          511 YMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELA  590 (628)
Q Consensus       511 Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~  590 (628)
                      |+|||++.+..++.++|+||||++++||++|..|+.....      ......+...          -.+.+    +...+
T Consensus       167 y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~------~~~~~~~~~~----------~~~~~----~~~~~  226 (277)
T cd06641         167 WMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHP------MKVLFLIPKN----------NPPTL----EGNYS  226 (277)
T ss_pred             ccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccch------HHHHHHHhcC----------CCCCC----CcccC
Confidence            9999999988899999999999999999999988753211      1111111100          01111    22334


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHHH
Q 039626          591 LLVIRLIDACLKKDPTDRPTMYEIEHS  617 (628)
Q Consensus       591 ~~l~~l~~~Cl~~dP~~RPs~~ev~~~  617 (628)
                      ..+.+++.+||+.+|.+||++.++++.
T Consensus       227 ~~~~~~i~~~l~~~p~~Rp~~~~~l~~  253 (277)
T cd06641         227 KPLKEFVEACLNKEPSFRPTAKELLKH  253 (277)
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            567899999999999999999999883

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=1.3e-32  Score=282.18  Aligned_cols=243  Identities=28%  Similarity=0.384  Sum_probs=180.7

Q ss_pred             eEEEEEEE--CCceEEEEEecc---------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhc
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG---------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSN  429 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~---------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~  429 (628)
                      |.||++..  .++.+|+|+...         .+.+|++++++++|+||+++++++..++..++|+||+++++|.++... 
T Consensus        15 ~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-   93 (286)
T cd07846          15 GMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKY-   93 (286)
T ss_pred             eEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEecCCccHHHHHHhc-
Confidence            89999998  478999997642         356899999999999999999999999999999999999999887632 


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCCc
Q 039626          430 KNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTK  509 (628)
Q Consensus       430 ~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~  509 (628)
                         ...++|.+++.++.|++.||.|||+.   +++|+||+|+||++++++.+||+|||++........   ......++.
T Consensus        94 ---~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~  164 (286)
T cd07846          94 ---PNGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE---VYTDYVATR  164 (286)
T ss_pred             ---cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcc---ccCccccee
Confidence               23489999999999999999999984   599999999999999999999999999886543221   123346789


Q ss_pred             cccCcccccc-CCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccch--hh------hccccCCc
Q 039626          510 GYMAPEYLEN-GLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGE--ES------LRHFIDPT  580 (628)
Q Consensus       510 ~Y~APE~l~~-~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--~~------l~~~~d~~  580 (628)
                      .|+|||++.+ ..++.++||||||++++||++|+.|+......+   ....+..........  +.      ......+.
T Consensus       165 ~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (286)
T cd07846         165 WYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDID---QLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPE  241 (286)
T ss_pred             eccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHH---HHHHHHHHhCCCchhhHHHhccchHhhcccccc
Confidence            9999999875 457889999999999999999998875332111   111111111000000  00      00000000


Q ss_pred             CCC-----CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          581 LQG-----NYPLELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       581 l~~-----~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      ...     ......+..+.+++.+||+.+|++||++.++++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  282 (286)
T cd07846         242 VKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH  282 (286)
T ss_pred             ccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence            000     001133566889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=2.8e-32  Score=281.34  Aligned_cols=228  Identities=24%  Similarity=0.420  Sum_probs=182.6

Q ss_pred             eEEEEEEE--CCceEEEEEecc-------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhcCC
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG-------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKN  431 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~-------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~  431 (628)
                      |.||++..  ++..+|||++..       .+.+|+.++++++|+||+++++.+..++..++||||+++++|.+++..   
T Consensus        36 g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~---  112 (292)
T cd06658          36 GIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTH---  112 (292)
T ss_pred             eEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcHHHHHhc---
Confidence            89999987  678999998753       366899999999999999999999999999999999999999998832   


Q ss_pred             CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCCccc
Q 039626          432 EGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGY  511 (628)
Q Consensus       432 ~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~Y  511 (628)
                        ..+++..+..++.+++.||+|||+.   +++||||||+||++++++.+||+|||++........   ......|+..|
T Consensus       113 --~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~---~~~~~~~~~~y  184 (292)
T cd06658         113 --TRMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP---KRKSLVGTPYW  184 (292)
T ss_pred             --CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc---cCceeecCccc
Confidence              2488999999999999999999984   599999999999999999999999999876532221   12234688999


Q ss_pred             cCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCHHHHH
Q 039626          512 MAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELAL  591 (628)
Q Consensus       512 ~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~  591 (628)
                      +|||.+.+..++.++||||||++++||++|+.|+.....      ...+...          ...+.+....  ......
T Consensus       185 ~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~------~~~~~~~----------~~~~~~~~~~--~~~~~~  246 (292)
T cd06658         185 MAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPP------LQAMRRI----------RDNLPPRVKD--SHKVSS  246 (292)
T ss_pred             cCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHH----------HhcCCCcccc--ccccCH
Confidence            999999988899999999999999999999998763221      1111111          1111111111  112344


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHHH
Q 039626          592 LVIRLIDACLKKDPTDRPTMYEIEHS  617 (628)
Q Consensus       592 ~l~~l~~~Cl~~dP~~RPs~~ev~~~  617 (628)
                      .+.+++.+||..||.+||+++|+++.
T Consensus       247 ~~~~li~~~l~~~P~~Rpt~~~il~~  272 (292)
T cd06658         247 VLRGFLDLMLVREPSQRATAQELLQH  272 (292)
T ss_pred             HHHHHHHHHccCChhHCcCHHHHhhC
Confidence            67899999999999999999999864

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=5.9e-32  Score=278.27  Aligned_cols=243  Identities=23%  Similarity=0.319  Sum_probs=178.1

Q ss_pred             eEEEEEEE--CCceEEEEEecc--------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhcC
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG--------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNK  430 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~--------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~  430 (628)
                      |.||+|+.  +++.+|+|.+..        .+.+|++++++++|+||+++++++.+++..++||||++ ++|.+++... 
T Consensus        19 ~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~-   96 (291)
T cd07844          19 ATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLD-TDLKQYMDDC-   96 (291)
T ss_pred             eEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEecCC-CCHHHHHHhC-
Confidence            89999987  678999998753        24679999999999999999999999999999999997 5999988542 


Q ss_pred             CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCCcc
Q 039626          431 NEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKG  510 (628)
Q Consensus       431 ~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~  510 (628)
                        ...+++.....++.|++.||.|||+.   +++||||||+||+++.++++||+|||+++.......   ......++..
T Consensus        97 --~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~~  168 (291)
T cd07844          97 --GGGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK---TYSNEVVTLW  168 (291)
T ss_pred             --CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccCCCCc---cccccccccc
Confidence              23689999999999999999999984   599999999999999999999999999875432211   1122346889


Q ss_pred             ccCcccccc-CCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhcc--------------
Q 039626          511 YMAPEYLEN-GLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRH--------------  575 (628)
Q Consensus       511 Y~APE~l~~-~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~--------------  575 (628)
                      |+|||.+.+ ..++.++||||||+++|||++|+.|+......  ..........+.... .+....              
T Consensus       169 ~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~--~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~  245 (291)
T cd07844         169 YRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDV--EDQLHKIFRVLGTPT-EETWPGVSSNPEFKPYSFPF  245 (291)
T ss_pred             cCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccH--HHHHHHHHHhcCCCC-hhhhhhhhhccccccccccc
Confidence            999998865 45789999999999999999999888533211  001111111111100 000000              


Q ss_pred             ccCCcCCCCC-CHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          576 FIDPTLQGNY-PLELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       576 ~~d~~l~~~~-~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      .....+.... .......+.+++.+||+.||.+||++.|+++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~  287 (291)
T cd07844         246 YPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK  287 (291)
T ss_pred             cCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence            0000000000 0111256789999999999999999999874

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=3e-32  Score=286.25  Aligned_cols=232  Identities=21%  Similarity=0.272  Sum_probs=177.0

Q ss_pred             eEEEEEEE--CCceEEEEEecc----------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhh
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG----------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFS  428 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  428 (628)
                      |.||+++.  .++.+|+|.+..          .+.+|..++..++|+||+++.+++.+++..++||||+++|+|.+++..
T Consensus        15 g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~Ey~~gg~L~~~l~~   94 (331)
T cd05624          15 GEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSK   94 (331)
T ss_pred             eEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCCCcHHHHHHH
Confidence            89999988  577899998853          256789999999999999999999999999999999999999999964


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCC
Q 039626          429 NKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGT  508 (628)
Q Consensus       429 ~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt  508 (628)
                      .   ...+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++.......  .......||
T Consensus        95 ~---~~~l~~~~~~~~~~qi~~~L~~lH~---~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~--~~~~~~~gt  166 (331)
T cd05624          95 F---EDRLPEDMARFYIAEMVLAIHSIHQ---LHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT--VQSSVAVGT  166 (331)
T ss_pred             h---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCc--eeeccccCC
Confidence            2   2358899999999999999999998   4599999999999999999999999999986643221  112235699


Q ss_pred             ccccCcccccc-----CCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCC
Q 039626          509 KGYMAPEYLEN-----GLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQG  583 (628)
Q Consensus       509 ~~Y~APE~l~~-----~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~  583 (628)
                      +.|+|||++.+     +.++.++||||||+++|||++|+.|+.....      .+....+.....   ..      .+..
T Consensus       167 ~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~------~~~~~~i~~~~~---~~------~~p~  231 (331)
T cd05624         167 PDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESL------VETYGKIMNHEE---RF------QFPS  231 (331)
T ss_pred             cccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCH------HHHHHHHHcCCC---cc------cCCC
Confidence            99999999875     5678999999999999999999999863221      122222211100   00      0110


Q ss_pred             CCCHHHHHHHHHHHHHhcccCCCC--CCCHHHHHH
Q 039626          584 NYPLELALLVIRLIDACLKKDPTD--RPTMYEIEH  616 (628)
Q Consensus       584 ~~~~~~~~~l~~l~~~Cl~~dP~~--RPs~~ev~~  616 (628)
                      . ..+.+..+.+++.+|+..++.+  |++++++++
T Consensus       232 ~-~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~  265 (331)
T cd05624         232 H-ITDVSEEAKDLIQRLICSRERRLGQNGIEDFKK  265 (331)
T ss_pred             c-cccCCHHHHHHHHHHccCchhhcCCCCHHHHhc
Confidence            0 1123456788999998865543  457776653

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.4e-32  Score=289.48  Aligned_cols=226  Identities=26%  Similarity=0.423  Sum_probs=181.7

Q ss_pred             eEEEEEEEC--CceEE---EEE---ec-----cchHHHHHHHhhcCCCceeeeeeeeecCCe--EEEEEEecCCCChHHH
Q 039626          361 GSVYRGKIN--GGFAA---IKK---VN-----GDVSKEIALLNKINHSNLIILSGVCFNEGN--CYLVYEYAVNGTLSDW  425 (628)
Q Consensus       361 G~Vy~g~~~--g~~va---vK~---~~-----~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~--~~lV~E~~~~gsL~~~  425 (628)
                      -+||||...  |-.||   +|.   .+     ..|..|+.+|+.|+|+||++++.++.+..+  ..+|.|.|..|+|..|
T Consensus        54 KtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL~TSGtLr~Y  133 (632)
T KOG0584|consen   54 KTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITELFTSGTLREY  133 (632)
T ss_pred             eeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeecccCCcHHHH
Confidence            589999883  44444   221   11     247789999999999999999999987655  7899999999999999


Q ss_pred             hhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCC-CcEEEccccccccCCCCCCcceeeec
Q 039626          426 VFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSD-LRAKIANFAMARPAEGQEGEFALTRH  504 (628)
Q Consensus       426 l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~-~~~kl~Dfgla~~~~~~~~~~~~~~~  504 (628)
                      +.+.    +.++.+....|++||++||.|||++. |||||||||-+||+|+.+ |.+||+|+|||.......     ..+
T Consensus       134 ~kk~----~~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~-----aks  203 (632)
T KOG0584|consen  134 RKKH----RRVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH-----AKS  203 (632)
T ss_pred             HHHh----ccCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhhccc-----cce
Confidence            9654    44788899999999999999999986 999999999999999876 899999999999876432     345


Q ss_pred             ccCCccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCC
Q 039626          505 IVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGN  584 (628)
Q Consensus       505 ~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~  584 (628)
                      +.|||.|||||... ..|++..||||||++++||+|+..|+..     -.........+..+ .....+.+.-||     
T Consensus       204 vIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsE-----C~n~AQIYKKV~SG-iKP~sl~kV~dP-----  271 (632)
T KOG0584|consen  204 VIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSE-----CTNPAQIYKKVTSG-IKPAALSKVKDP-----  271 (632)
T ss_pred             eccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhh-----hCCHHHHHHHHHcC-CCHHHhhccCCH-----
Confidence            79999999999888 7899999999999999999999988752     12233344444432 223444444343     


Q ss_pred             CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          585 YPLELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       585 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                             ++.+||.+|+.. ..+|||+.|++.
T Consensus       272 -------evr~fIekCl~~-~~~R~sa~eLL~  295 (632)
T KOG0584|consen  272 -------EVREFIEKCLAT-KSERLSAKELLK  295 (632)
T ss_pred             -------HHHHHHHHHhcC-chhccCHHHHhh
Confidence                   467999999999 999999999875

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.1e-33  Score=287.10  Aligned_cols=224  Identities=33%  Similarity=0.477  Sum_probs=184.9

Q ss_pred             ceEEEEEEE--CCceEEEEEec----------cchHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhh
Q 039626          360 QGSVYRGKI--NGGFAAIKKVN----------GDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVF  427 (628)
Q Consensus       360 ~G~Vy~g~~--~g~~vavK~~~----------~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~  427 (628)
                      +|-||.+..  +.+.|||||+.          .|+.+|+..|.+++|||++.+-|+|..+...||||||| -||-.|.|.
T Consensus        39 FGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYC-lGSAsDlle  117 (948)
T KOG0577|consen   39 FGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYC-LGSASDLLE  117 (948)
T ss_pred             cceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHHH-hccHHHHHH
Confidence            499999987  78899999985          26889999999999999999999999999999999999 567888874


Q ss_pred             hcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccC
Q 039626          428 SNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVG  507 (628)
Q Consensus       428 ~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~g  507 (628)
                      -   -.++|.+..+..|+.+.+.||+|||+++   .||||||..||||++.|.+||+|||.|.....       ....+|
T Consensus       118 V---hkKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P-------AnsFvG  184 (948)
T KOG0577|consen  118 V---HKKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMAP-------ANSFVG  184 (948)
T ss_pred             H---HhccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcCc-------hhcccC
Confidence            3   2456899999999999999999999966   99999999999999999999999999876643       234689


Q ss_pred             CccccCccccc---cCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCC
Q 039626          508 TKGYMAPEYLE---NGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGN  584 (628)
Q Consensus       508 t~~Y~APE~l~---~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~  584 (628)
                      ||.|||||++.   .+.|+-|+||||+|++..||...++|....      ..-.-+..+...+          .|.+.  
T Consensus       185 TPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnM------NAMSALYHIAQNe----------sPtLq--  246 (948)
T KOG0577|consen  185 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM------NAMSALYHIAQNE----------SPTLQ--  246 (948)
T ss_pred             CccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCc------hHHHHHHHHHhcC----------CCCCC--
Confidence            99999999875   578999999999999999999999886521      1112222222211          23332  


Q ss_pred             CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          585 YPLELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       585 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                       ..+.+..+..|+..||++-|.+|||..+++.
T Consensus       247 -s~eWS~~F~~Fvd~CLqKipqeRptse~ll~  277 (948)
T KOG0577|consen  247 -SNEWSDYFRNFVDSCLQKIPQERPTSEELLK  277 (948)
T ss_pred             -CchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence             2355667889999999999999999998875

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=1.2e-31  Score=278.44  Aligned_cols=224  Identities=31%  Similarity=0.472  Sum_probs=177.7

Q ss_pred             eEEEEEEE--CCceEEEEEecc----------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhh
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG----------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFS  428 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  428 (628)
                      |.||+|+.  +++.+|+|++..          ++.+|++++++++|+||+++.++|.+++..++|+||++ |+|.+++..
T Consensus        29 g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-g~l~~~~~~  107 (307)
T cd06607          29 GAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCL-GSASDILEV  107 (307)
T ss_pred             eEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEHHhhC-CCHHHHHHH
Confidence            89999987  688999998752          36689999999999999999999999999999999996 678777743


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCC
Q 039626          429 NKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGT  508 (628)
Q Consensus       429 ~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt  508 (628)
                      .   ...+++..+..++.|++.||.|||+.   +++|+||+|+||++++++.+||+|||++......       ....++
T Consensus       108 ~---~~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~-------~~~~~~  174 (307)
T cd06607         108 H---KKPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA-------NSFVGT  174 (307)
T ss_pred             c---ccCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcceecCCC-------CCccCC
Confidence            2   23589999999999999999999984   5999999999999999999999999998765322       224678


Q ss_pred             ccccCccccc---cCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCC
Q 039626          509 KGYMAPEYLE---NGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNY  585 (628)
Q Consensus       509 ~~Y~APE~l~---~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~  585 (628)
                      ..|+|||.+.   ...++.++||||||+++|||++|+.|+.....      ...........          .+.+   .
T Consensus       175 ~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~------~~~~~~~~~~~----------~~~~---~  235 (307)
T cd06607         175 PYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA------MSALYHIAQND----------SPTL---S  235 (307)
T ss_pred             ccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccH------HHHHHHHhcCC----------CCCC---C
Confidence            8999999874   45688999999999999999999988753211      11111111000          0111   1


Q ss_pred             CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 039626          586 PLELALLVIRLIDACLKKDPTDRPTMYEIEHS  617 (628)
Q Consensus       586 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~  617 (628)
                      +......+.+++.+||+.||++||++.+++..
T Consensus       236 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  267 (307)
T cd06607         236 SNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH  267 (307)
T ss_pred             chhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence            22345568999999999999999999999863

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=99.98  E-value=9.6e-32  Score=270.87  Aligned_cols=227  Identities=22%  Similarity=0.357  Sum_probs=181.8

Q ss_pred             eEEEEEEE--CCceEEEEEecc---------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhc
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG---------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSN  429 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~---------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~  429 (628)
                      |.||++..  +++.+|+|++..         .+.+|++++++++|+|++++++.+..++..++||||+++++|.+++...
T Consensus        14 ~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~   93 (256)
T cd08220          14 GIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKR   93 (256)
T ss_pred             eEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecCCCCCHHHHHHHh
Confidence            89999887  678899998743         3677999999999999999999999999999999999999999999642


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCC-CcEEEccccccccCCCCCCcceeeecccCC
Q 039626          430 KNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSD-LRAKIANFAMARPAEGQEGEFALTRHIVGT  508 (628)
Q Consensus       430 ~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~-~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt  508 (628)
                        ....+++..+.+++.+++.||+|||+.   +++|+||+|+||+++++ +.+||+|||++........    .....++
T Consensus        94 --~~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~----~~~~~~~  164 (256)
T cd08220          94 --CNSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK----AYTVVGT  164 (256)
T ss_pred             --cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc----ccccccC
Confidence              234589999999999999999999984   59999999999999855 5689999999987643321    2234688


Q ss_pred             ccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCHH
Q 039626          509 KGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLE  588 (628)
Q Consensus       509 ~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~  588 (628)
                      ..|+|||.+.+...+.++||||||++++||++|+.|+.....      ...........              ....+..
T Consensus       165 ~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~------~~~~~~~~~~~--------------~~~~~~~  224 (256)
T cd08220         165 PCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANL------PALVLKIMSGT--------------FAPISDR  224 (256)
T ss_pred             CcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCch------HHHHHHHHhcC--------------CCCCCCC
Confidence            999999999988899999999999999999999988753221      11111111100              0011222


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          589 LALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       589 ~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      ....+.+++.+||+.||.+||+++|+++
T Consensus       225 ~~~~l~~li~~~l~~~p~~Rpt~~~ll~  252 (256)
T cd08220         225 YSPDLRQLILSMLNLDPSKRPQLSQIMA  252 (256)
T ss_pred             cCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence            3456789999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=99.98  E-value=7.1e-32  Score=276.57  Aligned_cols=244  Identities=25%  Similarity=0.344  Sum_probs=180.6

Q ss_pred             eEEEEEEE--CCceEEEEEecc---------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhc
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG---------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSN  429 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~---------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~  429 (628)
                      |.||+|+.  +|..+|||+++.         .+.+|++++++++|+||+++++++.+++..++||||+. ++|.+++...
T Consensus        14 ~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~~~~~   92 (284)
T cd07860          14 GVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDAS   92 (284)
T ss_pred             eEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeeccc-cCHHHHHHhC
Confidence            89999988  688999998753         36689999999999999999999999999999999995 6899988542


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCCc
Q 039626          430 KNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTK  509 (628)
Q Consensus       430 ~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~  509 (628)
                        ....+++..+..++.+++.||+|||+.   +++|+||+|+||++++++.+||+|||+++.......   ......++.
T Consensus        93 --~~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~  164 (284)
T cd07860          93 --PLSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR---TYTHEVVTL  164 (284)
T ss_pred             --CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc---ccccccccc
Confidence              335689999999999999999999984   599999999999999999999999999876543221   122335788


Q ss_pred             cccCccccccCC-CCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhcccc-----------chhhhcccc
Q 039626          510 GYMAPEYLENGL-VSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKED-----------GEESLRHFI  577 (628)
Q Consensus       510 ~Y~APE~l~~~~-~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~l~~~~  577 (628)
                      .|+|||.+.+.. ++.++||||||++++||++|+.|+.......  ...+..........           .......+.
T Consensus       165 ~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (284)
T cd07860         165 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID--QLFRIFRTLGTPDEVVWPGVTSLPDYKPSFPKWA  242 (284)
T ss_pred             cccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH--HHHHHHHHhCCCChhhhhhhhHHHHHHhhccccc
Confidence            999999887644 6889999999999999999999886432211  11111111100000           000000000


Q ss_pred             CCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          578 DPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       578 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      ..... .........+.+++.+||+.||.+||+++|+++
T Consensus       243 ~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  280 (284)
T cd07860         243 RQDFS-KVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA  280 (284)
T ss_pred             ccCHH-HHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence            00000 001123345789999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=99.98  E-value=2.1e-31  Score=277.37  Aligned_cols=251  Identities=25%  Similarity=0.339  Sum_probs=182.0

Q ss_pred             eEEEEEEE----CCceEEEEEecc----------chHHHHHHHhhcCCCceeeeeeeeecC--CeEEEEEEecCCCChHH
Q 039626          361 GSVYRGKI----NGGFAAIKKVNG----------DVSKEIALLNKINHSNLIILSGVCFNE--GNCYLVYEYAVNGTLSD  424 (628)
Q Consensus       361 G~Vy~g~~----~g~~vavK~~~~----------~~~~E~~~l~~l~H~nIv~l~g~~~~~--~~~~lV~E~~~~gsL~~  424 (628)
                      |.||+|+.    .+..+|+|.+..          .+.+|+.++++++|+||+++++++.+.  ...++||||+++ +|.+
T Consensus        14 g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l~~   92 (316)
T cd07842          14 GRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYLLFDYAEH-DLWQ   92 (316)
T ss_pred             EEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEEEEeCCCc-CHHH
Confidence            89999998    468999998865          356799999999999999999999987  789999999964 7777


Q ss_pred             HhhhcCCC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCC----CCcEEEccccccccCCCCCCcc
Q 039626          425 WVFSNKNE-GKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDS----DLRAKIANFAMARPAEGQEGEF  499 (628)
Q Consensus       425 ~l~~~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~----~~~~kl~Dfgla~~~~~~~~~~  499 (628)
                      ++...... ...+++.....++.|++.||+|||+.   +++||||||+||+++.    ++.+||+|||+++.........
T Consensus        93 ~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~  169 (316)
T cd07842          93 IIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPL  169 (316)
T ss_pred             HHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECCCccccccCCCcccc
Confidence            77543332 23689999999999999999999984   4999999999999999    9999999999998764432211


Q ss_pred             eeeecccCCccccCcccccc-CCCCcccccHHHHHHHHHHHhCCCcccccccccc-------ccHHHHHHHHhccccc--
Q 039626          500 ALTRHIVGTKGYMAPEYLEN-GLVSTKLDVYAFGVLILEMLTGKEAAALHAEENN-------MHLSDVLNAVLTKEDG--  569 (628)
Q Consensus       500 ~~~~~~~gt~~Y~APE~l~~-~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~-------~~~~~~~~~~~~~~~~--  569 (628)
                      .......++..|+|||.+.+ ..++.++||||||++++||++|+.|+........       ..+...+ ..+.....  
T Consensus       170 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~l~~~~~~~  248 (316)
T cd07842         170 ADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIF-EVLGTPTEKD  248 (316)
T ss_pred             cccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHH-HHhCCCchhH
Confidence            12233567899999998876 4579999999999999999999999875433220       0011111 11110000  


Q ss_pred             hhh------hccccCCcCCCCCC---------H--HHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          570 EES------LRHFIDPTLQGNYP---------L--ELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       570 ~~~------l~~~~d~~l~~~~~---------~--~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      ...      .....+......++         .  .....+.+++.+||+.||++|||+.|+++
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~  312 (316)
T cd07842         249 WPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE  312 (316)
T ss_pred             HHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            000      00000000000111         0  23346789999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=99.98  E-value=1.3e-31  Score=271.18  Aligned_cols=232  Identities=29%  Similarity=0.492  Sum_probs=181.9

Q ss_pred             eEEEEEEE--CCceEEEEEecc---------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhc
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG---------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSN  429 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~---------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~  429 (628)
                      |.||+|..  ++..+++|.++.         ++.+|++++++++|+||+++++++.+.+..++|+||+++++|.+++.. 
T Consensus        14 ~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-   92 (264)
T cd06626          14 GKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYCSGGTLEELLEH-   92 (264)
T ss_pred             cEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecCCCCcHHHHHhh-
Confidence            89999987  678899998753         356799999999999999999999999999999999999999999853 


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCccee-eecccCC
Q 039626          430 KNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFAL-TRHIVGT  508 (628)
Q Consensus       430 ~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~-~~~~~gt  508 (628)
                         +..+++..+..++.+++.||.|||+.   +++|+||+|+||++++++.+||+|||++............ .....++
T Consensus        93 ---~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~  166 (264)
T cd06626          93 ---GRILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGT  166 (264)
T ss_pred             ---cCCCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcccccccCCcCC
Confidence               33578999999999999999999985   4999999999999999999999999998876543221111 2235678


Q ss_pred             ccccCccccccCC---CCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCC
Q 039626          509 KGYMAPEYLENGL---VSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNY  585 (628)
Q Consensus       509 ~~Y~APE~l~~~~---~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~  585 (628)
                      ..|+|||++.+..   .+.++||||||++++|+++|+.|+.....     ...........          ..+.++.  
T Consensus       167 ~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~-----~~~~~~~~~~~----------~~~~~~~--  229 (264)
T cd06626         167 PAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDN-----EFQIMFHVGAG----------HKPPIPD--  229 (264)
T ss_pred             cCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcc-----hHHHHHHHhcC----------CCCCCCc--
Confidence            8999999998766   89999999999999999999999863221     11111111110          0111111  


Q ss_pred             CHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          586 PLELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       586 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      .......+.+++.+||+.+|.+||++.|++.
T Consensus       230 ~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~  260 (264)
T cd06626         230 SLQLSPEGKDFLDRCLESDPKKRPTASELLQ  260 (264)
T ss_pred             ccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            1122456789999999999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=99.98  E-value=5.1e-32  Score=273.81  Aligned_cols=240  Identities=25%  Similarity=0.383  Sum_probs=191.2

Q ss_pred             eEEEEEEE--CCceEEEEEecc----------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhh
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG----------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFS  428 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  428 (628)
                      |.||+++.  +|+.+++|.+..          .+.+|++++++++|+||+++++.+..+...++++||+++++|.+++..
T Consensus         7 ~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   86 (265)
T cd05579           7 GRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDLASLLEN   86 (265)
T ss_pred             eEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcHHHHHHH
Confidence            89999998  488999998753          255789999999999999999999999999999999999999999954


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCc-----ceeee
Q 039626          429 NKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGE-----FALTR  503 (628)
Q Consensus       429 ~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~-----~~~~~  503 (628)
                      .    ..+++..+..++.|++.||+|||+.   +++|+||+|+||++++++.+||+|||++.........     .....
T Consensus        87 ~----~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~  159 (265)
T cd05579          87 V----GSLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDK  159 (265)
T ss_pred             c----CCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccccccc
Confidence            2    2589999999999999999999984   5999999999999999999999999998765322110     01123


Q ss_pred             cccCCccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCC
Q 039626          504 HIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQG  583 (628)
Q Consensus       504 ~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~  583 (628)
                      ...++..|++||.+.....+.++||||||++++||++|+.|+.....      .+.........             .  
T Consensus       160 ~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~------~~~~~~~~~~~-------------~--  218 (265)
T cd05579         160 RIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETP------EEIFQNILNGK-------------I--  218 (265)
T ss_pred             CcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHhcCC-------------c--
Confidence            34678899999999888899999999999999999999998763321      11121111100             0  


Q ss_pred             CCCHH--HHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhccCC
Q 039626          584 NYPLE--LALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNASLNW  628 (628)
Q Consensus       584 ~~~~~--~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~~~~~~w  628 (628)
                      ..+..  .+..+.+++.+||+.+|.+||++.++.+.|+.-.-..++|
T Consensus       219 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~~~  265 (265)
T cd05579         219 EWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGIDW  265 (265)
T ss_pred             CCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCccccCCCC
Confidence            01111  2456789999999999999999988888887766667777

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=99.98  E-value=7e-32  Score=271.23  Aligned_cols=231  Identities=25%  Similarity=0.355  Sum_probs=185.2

Q ss_pred             eEEEEEEECC--ceEEEEEeccc----------hHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhh
Q 039626          361 GSVYRGKING--GFAAIKKVNGD----------VSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFS  428 (628)
Q Consensus       361 G~Vy~g~~~g--~~vavK~~~~~----------~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  428 (628)
                      |+||.+.+.|  ...|+|.+.++          ...|-+||+.+.||.+..|++.+..+...|||||||+||+|...++.
T Consensus        91 G~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~meyCpGGdL~~Lrqk  170 (459)
T KOG0610|consen   91 GTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVMEYCPGGDLHSLRQK  170 (459)
T ss_pred             eeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEecCCCccHHHHHhh
Confidence            9999999955  68899999763          34599999999999999999999999999999999999999988864


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCC------------
Q 039626          429 NKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQE------------  496 (628)
Q Consensus       429 ~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~------------  496 (628)
                        ..++.+++....-++.+|+-||+|||-.+   ||+|||||+||||.++|.+-|+||.|+.......            
T Consensus       171 --Qp~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt~~~s~~~~~~~  245 (459)
T KOG0610|consen  171 --QPGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPTLVKSSSPRSSG  245 (459)
T ss_pred             --CCCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCCCCCeeeccCCCCCCC
Confidence              45677999999999999999999999965   9999999999999999999999999865431100            


Q ss_pred             -------------------C-c---------------------ceeeecccCCccccCccccccCCCCcccccHHHHHHH
Q 039626          497 -------------------G-E---------------------FALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLI  535 (628)
Q Consensus       497 -------------------~-~---------------------~~~~~~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl  535 (628)
                                         . .                     .......+||-.|+|||++.+...+...|.|+|||++
T Consensus       246 ~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgsAVDWWtfGIfl  325 (459)
T KOG0610|consen  246 SQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGSAVDWWTFGIFL  325 (459)
T ss_pred             CCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCchhhHHHHHHHH
Confidence                               0 0                     0111234799999999999999999999999999999


Q ss_pred             HHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCC----H
Q 039626          536 LEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPT----M  611 (628)
Q Consensus       536 ~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs----~  611 (628)
                      |||+.|+.||.....++  .+.++                 +-..+.-......+..+.+||++.|.+||.+|..    +
T Consensus       326 YEmLyG~TPFKG~~~~~--Tl~NI-----------------v~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA  386 (459)
T KOG0610|consen  326 YEMLYGTTPFKGSNNKE--TLRNI-----------------VGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGA  386 (459)
T ss_pred             HHHHhCCCCcCCCCchh--hHHHH-----------------hcCCCcCCCCCcchhHHHHHHHHHhccChhhhhccccch
Confidence            99999999997544322  12222                 2222211111245667899999999999999987    5


Q ss_pred             HHHH
Q 039626          612 YEIE  615 (628)
Q Consensus       612 ~ev~  615 (628)
                      .||.
T Consensus       387 ~eIK  390 (459)
T KOG0610|consen  387 AEIK  390 (459)
T ss_pred             HHhh
Confidence            5553

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=99.98  E-value=8.6e-32  Score=277.22  Aligned_cols=221  Identities=30%  Similarity=0.397  Sum_probs=180.2

Q ss_pred             eEEEEEEE--CCceEEEEEecc----------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhh
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG----------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFS  428 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  428 (628)
                      |.||++..  +++.+|+|.+..          .+.+|++++++++|+||+++++++.+++..++||||+++++|.+++..
T Consensus        15 ~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~   94 (290)
T cd05580          15 GRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRK   94 (290)
T ss_pred             eEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEecCCCCCHHHHHHH
Confidence            89999998  578999998753          255799999999999999999999999999999999999999999854


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCC
Q 039626          429 NKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGT  508 (628)
Q Consensus       429 ~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt  508 (628)
                      .    ..+++..+..++.|++.||.|||+   .+++|+||+|+||++++++.+||+|||+++.....      .....++
T Consensus        95 ~----~~l~~~~~~~~~~qil~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~------~~~~~~~  161 (290)
T cd05580          95 S----GRFPEPVARFYAAQVVLALEYLHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR------TYTLCGT  161 (290)
T ss_pred             c----CCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC------CCCCCCC
Confidence            2    458999999999999999999998   45999999999999999999999999999876433      2234688


Q ss_pred             ccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCHH
Q 039626          509 KGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLE  588 (628)
Q Consensus       509 ~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~  588 (628)
                      +.|+|||.+.+...+.++||||||++++||++|+.|+.....      .+........           ..    ..+..
T Consensus       162 ~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~-----------~~----~~~~~  220 (290)
T cd05580         162 PEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNP------IQIYEKILEG-----------KV----RFPSF  220 (290)
T ss_pred             ccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHhcC-----------Cc----cCCcc
Confidence            999999999888899999999999999999999998763321      1111111110           00    11222


Q ss_pred             HHHHHHHHHHHhcccCCCCCC-----CHHHHH
Q 039626          589 LALLVIRLIDACLKKDPTDRP-----TMYEIE  615 (628)
Q Consensus       589 ~~~~l~~l~~~Cl~~dP~~RP-----s~~ev~  615 (628)
                      ....+.+++.+||..||.+|+     +++|++
T Consensus       221 ~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~  252 (290)
T cd05580         221 FSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIK  252 (290)
T ss_pred             CCHHHHHHHHHHccCCHHHccCcccCCHHHHH
Confidence            345678999999999999998     666654

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=99.98  E-value=8.2e-32  Score=271.22  Aligned_cols=228  Identities=28%  Similarity=0.385  Sum_probs=186.6

Q ss_pred             eEEEEEEE--CCceEEEEEecc---------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhc
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG---------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSN  429 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~---------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~  429 (628)
                      |.||+++.  +++.+++|++..         ++.+|++++++++|+||+++.+++.++...++|+||+++++|.+++...
T Consensus        14 ~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~   93 (256)
T cd08530          14 GSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKR   93 (256)
T ss_pred             eeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhcCCCCHHHHHHHH
Confidence            89999987  677899998753         3567999999999999999999999999999999999999999999664


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCCc
Q 039626          430 KNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTK  509 (628)
Q Consensus       430 ~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~  509 (628)
                      ......+++..+..++.+++.||+|||+.   +++|+||+|+||++++++.+||+|||+++.....     ......++.
T Consensus        94 ~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~  165 (256)
T cd08530          94 KKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKN-----MAKTQIGTP  165 (256)
T ss_pred             HhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhhccC-----CcccccCCc
Confidence            44456789999999999999999999984   4999999999999999999999999999876543     122346888


Q ss_pred             cccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCHHH
Q 039626          510 GYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLEL  589 (628)
Q Consensus       510 ~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~  589 (628)
                      .|++||++.+..++.++|+||||++++||++|+.|+......      +.......              ......+...
T Consensus       166 ~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~------~~~~~~~~--------------~~~~~~~~~~  225 (256)
T cd08530         166 HYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ------DLRYKVQR--------------GKYPPIPPIY  225 (256)
T ss_pred             cccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHhc--------------CCCCCCchhh
Confidence            999999999999999999999999999999999988643211      11111110              0011122345


Q ss_pred             HHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          590 ALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       590 ~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      ...+.+++.+|++.+|++||++.|+++
T Consensus       226 ~~~~~~li~~~l~~~p~~Rp~~~~~l~  252 (256)
T cd08530         226 SQDLQNFIRSMLQVKPKLRPNCDKILA  252 (256)
T ss_pred             CHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            566899999999999999999999875

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.98  E-value=1.2e-32  Score=289.59  Aligned_cols=229  Identities=27%  Similarity=0.408  Sum_probs=187.5

Q ss_pred             eEEEEEEEC--CceEEEEEecc-------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhcCC
Q 039626          361 GSVYRGKIN--GGFAAIKKVNG-------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKN  431 (628)
Q Consensus       361 G~Vy~g~~~--g~~vavK~~~~-------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~  431 (628)
                      |.||.|+..  ..++|||.+..       .+.+|+.+-++|+|.|||+++|.|.+++.+-+.||-++||||.+.|...  
T Consensus       589 G~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSsLLrsk--  666 (1226)
T KOG4279|consen  589 GTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSSLLRSK--  666 (1226)
T ss_pred             eEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHHHHHhc--
Confidence            999999984  44679998754       3678999999999999999999999999999999999999999999542  


Q ss_pred             CCCCC--CHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeC-CCCcEEEccccccccCCCCCCcceeeecccCC
Q 039626          432 EGKYL--DWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLD-SDLRAKIANFAMARPAEGQEGEFALTRHIVGT  508 (628)
Q Consensus       432 ~~~~l--~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~-~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt  508 (628)
                       =+++  ++.+.-.+.+||++||.|||+   ..|+|||||-.|+|++ -.|.+||+|||.++....-.   ..+...-||
T Consensus       667 -WGPlKDNEstm~fYtkQILeGLkYLHe---n~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgin---P~TETFTGT  739 (1226)
T KOG4279|consen  667 -WGPLKDNESTMNFYTKQILEGLKYLHE---NKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGIN---PCTETFTGT  739 (1226)
T ss_pred             -cCCCccchhHHHHHHHHHHHHhhhhhh---cceeeccccCCcEEEeeccceEEecccccchhhccCC---ccccccccc
Confidence             2334  677888899999999999999   5599999999999996 46899999999998765432   245667899


Q ss_pred             ccccCccccccC--CCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCC
Q 039626          509 KGYMAPEYLENG--LVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYP  586 (628)
Q Consensus       509 ~~Y~APE~l~~~--~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~  586 (628)
                      ..|||||++..+  .|...+|||||||.+.||.||++||..-....    ...++-    +         + -....+.|
T Consensus       740 LQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgspq----AAMFkV----G---------m-yKvHP~iP  801 (1226)
T KOG4279|consen  740 LQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQ----AAMFKV----G---------M-YKVHPPIP  801 (1226)
T ss_pred             hhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChh----Hhhhhh----c---------c-eecCCCCc
Confidence            999999999865  58999999999999999999999987332211    111110    0         0 01234678


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          587 LELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       587 ~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      .+.+.+...++.+|+..||.+||+++++++
T Consensus       802 eelsaeak~FilrcFepd~~~R~sA~~LL~  831 (1226)
T KOG4279|consen  802 EELSAEAKNFILRCFEPDPCDRPSAKDLLQ  831 (1226)
T ss_pred             HHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence            899999999999999999999999999875

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=99.98  E-value=7.1e-32  Score=278.98  Aligned_cols=228  Identities=22%  Similarity=0.394  Sum_probs=181.9

Q ss_pred             eEEEEEEE--CCceEEEEEecc-------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhcCC
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG-------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKN  431 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~-------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~  431 (628)
                      |.||++..  ++..+|+|.+..       .+.+|+.++..++|+||+++++++..++..++|+||+++++|.+++..   
T Consensus        35 g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~---  111 (297)
T cd06659          35 GIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ---  111 (297)
T ss_pred             eeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCHHHHHhh---
Confidence            89999987  688999998742       366799999999999999999999999999999999999999987732   


Q ss_pred             CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCCccc
Q 039626          432 EGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGY  511 (628)
Q Consensus       432 ~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~Y  511 (628)
                        ..+++..+..++.|++.||+|||+.   +++|+||||+||+++.++.+||+|||++........   ......|+..|
T Consensus       112 --~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~---~~~~~~~~~~y  183 (297)
T cd06659         112 --TRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP---KRKSLVGTPYW  183 (297)
T ss_pred             --cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhcccccc---cccceecCccc
Confidence              3589999999999999999999984   499999999999999999999999999875533211   12335689999


Q ss_pred             cCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCHHHHH
Q 039626          512 MAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELAL  591 (628)
Q Consensus       512 ~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~  591 (628)
                      +|||++.+..++.++||||||++++||++|+.|+......      +....+....          .+...  .......
T Consensus       184 ~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~------~~~~~~~~~~----------~~~~~--~~~~~~~  245 (297)
T cd06659         184 MAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPV------QAMKRLRDSP----------PPKLK--NAHKISP  245 (297)
T ss_pred             cCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHhccC----------CCCcc--ccCCCCH
Confidence            9999999888999999999999999999999988632211      1111111100          00000  0112234


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHHH
Q 039626          592 LVIRLIDACLKKDPTDRPTMYEIEHS  617 (628)
Q Consensus       592 ~l~~l~~~Cl~~dP~~RPs~~ev~~~  617 (628)
                      .+.+++.+||+.+|.+||+++|+++.
T Consensus       246 ~l~~~i~~~l~~~P~~Rps~~~ll~~  271 (297)
T cd06659         246 VLRDFLERMLTREPQERATAQELLDH  271 (297)
T ss_pred             HHHHHHHHHhcCCcccCcCHHHHhhC
Confidence            57899999999999999999999873

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=99.98  E-value=1.1e-31  Score=275.61  Aligned_cols=229  Identities=29%  Similarity=0.460  Sum_probs=183.0

Q ss_pred             eEEEEEEEC--CceEEEEEecc------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhcCCC
Q 039626          361 GSVYRGKIN--GGFAAIKKVNG------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNE  432 (628)
Q Consensus       361 G~Vy~g~~~--g~~vavK~~~~------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~  432 (628)
                      |.||+|...  +..+++|+++.      .+.+|++++++++|+|++++++++..++..++|+||+++++|.+++....  
T Consensus        33 ~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--  110 (286)
T cd06614          33 GEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNF--  110 (286)
T ss_pred             eEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccCCCcHHHHHHHhc--
Confidence            899999994  88999998863      46689999999999999999999999999999999999999999996532  


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCCcccc
Q 039626          433 GKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYM  512 (628)
Q Consensus       433 ~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~Y~  512 (628)
                       ..+++..+..++.+++.||.|||+   .+++|+||+|+||+++.++.+||+|||++........   ......++..|+
T Consensus       111 -~~l~~~~~~~i~~~i~~~L~~lH~---~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~y~  183 (286)
T cd06614         111 -VRMNEPQIAYVCREVLQGLEYLHS---QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS---KRNSVVGTPYWM  183 (286)
T ss_pred             -cCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCChhhEEEcCCCCEEECccchhhhhccchh---hhccccCCcccC
Confidence             369999999999999999999998   4599999999999999999999999999875532211   112345788999


Q ss_pred             CccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCHHHHHH
Q 039626          513 APEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALL  592 (628)
Q Consensus       513 APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~  592 (628)
                      +||.+.+..++.++|+||||++++||++|+.|+......      ..........         . +..  ..+......
T Consensus       184 ~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~------~~~~~~~~~~---------~-~~~--~~~~~~~~~  245 (286)
T cd06614         184 APEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPL------RALFLITTKG---------I-PPL--KNPEKWSPE  245 (286)
T ss_pred             CHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhcC---------C-CCC--cchhhCCHH
Confidence            999999888999999999999999999999887532211      1111110000         0 000  111123456


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHHH
Q 039626          593 VIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       593 l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      +.+++.+||+.+|.+||++.++++
T Consensus       246 l~~li~~~l~~~p~~Rpt~~~il~  269 (286)
T cd06614         246 FKDFLNKCLVKDPEKRPSAEELLQ  269 (286)
T ss_pred             HHHHHHHHhccChhhCcCHHHHhh
Confidence            889999999999999999999975

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=99.98  E-value=7.1e-32  Score=284.76  Aligned_cols=238  Identities=26%  Similarity=0.363  Sum_probs=175.0

Q ss_pred             eEEEEEEE--CCceEEEEEecc---------chHHHHHHHhhcCCCceeeeeeeeecC------CeEEEEEEecCCCChH
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG---------DVSKEIALLNKINHSNLIILSGVCFNE------GNCYLVYEYAVNGTLS  423 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~---------~~~~E~~~l~~l~H~nIv~l~g~~~~~------~~~~lV~E~~~~gsL~  423 (628)
                      |.||++..  .++.||||++..         .+.+|+++|++++|+||+++++++...      ...++++|++ +++|.
T Consensus        29 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l~  107 (343)
T cd07878          29 GSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLM-GADLN  107 (343)
T ss_pred             eEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCcEEEEeecC-CCCHH
Confidence            89999987  677899999864         245799999999999999999988643      3578999998 88998


Q ss_pred             HHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeee
Q 039626          424 DWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTR  503 (628)
Q Consensus       424 ~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~  503 (628)
                      +++.     ...+++..+..++.|++.||+|||+.   +|+||||||+|||+++++.+||+|||+++.....      ..
T Consensus       108 ~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~------~~  173 (343)
T cd07878         108 NIVK-----CQKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFGLARQADDE------MT  173 (343)
T ss_pred             HHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcCCccceecCCC------cC
Confidence            8873     23589999999999999999999985   5999999999999999999999999999865432      12


Q ss_pred             cccCCccccCcccccc-CCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccc-------hhhhcc
Q 039626          504 HIVGTKGYMAPEYLEN-GLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDG-------EESLRH  575 (628)
Q Consensus       504 ~~~gt~~Y~APE~l~~-~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~l~~  575 (628)
                      ...||+.|+|||.+.+ ..++.++|||||||+++||++|+.|+.......  .+.... ........       .+....
T Consensus       174 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~~~-~~~~~~~~~~~~~~~~~~~~~  250 (343)
T cd07878         174 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYID--QLKRIM-EVVGTPSPEVLKKISSEHARK  250 (343)
T ss_pred             CccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH--HHHHHH-HHhCCCCHHHHHhcchhhHHH
Confidence            3468999999999876 578999999999999999999999886432111  011111 00000000       000000


Q ss_pred             ccC--CcCCCC----CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          576 FID--PTLQGN----YPLELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       576 ~~d--~~l~~~----~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      .+.  +.....    ........+.+++.+||+.||.+|||+.|++.
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~  297 (343)
T cd07878         251 YIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALA  297 (343)
T ss_pred             HhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            000  000000    00012234679999999999999999999985

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.98  E-value=6.5e-32  Score=303.36  Aligned_cols=240  Identities=28%  Similarity=0.470  Sum_probs=191.2

Q ss_pred             ceEEEEEEEC---------CceEEEEEecc--------chHHHHHHHhhc-CCCceeeeeeeeecCCeEEEEEEecCCCC
Q 039626          360 QGSVYRGKIN---------GGFAAIKKVNG--------DVSKEIALLNKI-NHSNLIILSGVCFNEGNCYLVYEYAVNGT  421 (628)
Q Consensus       360 ~G~Vy~g~~~---------g~~vavK~~~~--------~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV~E~~~~gs  421 (628)
                      .|.|++|...         ...||||..+.        ++..|+++|+.+ +|+||+.++|+|..++..++|.||++.|+
T Consensus       309 fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~~~v~Ey~~~G~  388 (609)
T KOG0200|consen  309 FGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPLYVIVEYAEHGD  388 (609)
T ss_pred             ccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCceEEEEEeccCCc
Confidence            4999999862         34689999874        467899999999 69999999999999999999999999999


Q ss_pred             hHHHhhhcC---C-------CC--CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEcccccc
Q 039626          422 LSDWVFSNK---N-------EG--KYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMA  489 (628)
Q Consensus       422 L~~~l~~~~---~-------~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla  489 (628)
                      |.++|...+   .       ..  ..|+....+.++.|||.||+||++   .+++||||..+|||+.++..+||+|||++
T Consensus       389 L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~---~~~vHRDLAaRNVLi~~~~~~kIaDFGla  465 (609)
T KOG0200|consen  389 LLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLAS---VPCVHRDLAARNVLITKNKVIKIADFGLA  465 (609)
T ss_pred             HHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhh---CCccchhhhhhhEEecCCCEEEEccccce
Confidence            999997655   0       01  238999999999999999999998   55999999999999999999999999999


Q ss_pred             ccCCCCCCcceeeeccc--CCccccCccccccCCCCcccccHHHHHHHHHHHh-CCCccccccccccccHHHHHHHHhcc
Q 039626          490 RPAEGQEGEFALTRHIV--GTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT-GKEAAALHAEENNMHLSDVLNAVLTK  566 (628)
Q Consensus       490 ~~~~~~~~~~~~~~~~~--gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELlt-G~~p~~~~~~~~~~~~~~~~~~~~~~  566 (628)
                      |........  ....-.  -...|||||.+....++.|+|||||||+|||++| |..|+..-.     ...+...     
T Consensus       466 r~~~~~~~y--~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~-----~~~~l~~-----  533 (609)
T KOG0200|consen  466 RDHYNKDYY--RTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP-----PTEELLE-----  533 (609)
T ss_pred             eccCCCCce--EecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCC-----cHHHHHH-----
Confidence            976544322  111112  3456999999999999999999999999999999 555654210     0111211     


Q ss_pred             ccchhhhccccCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHh
Q 039626          567 EDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILN  623 (628)
Q Consensus       567 ~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~~  623 (628)
                               .+....+...|..+..++.++|+.||+.+|++||++.|+.+.++.++.
T Consensus       534 ---------~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~  581 (609)
T KOG0200|consen  534 ---------FLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQ  581 (609)
T ss_pred             ---------HHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHH
Confidence                     122222334455667778999999999999999999999999999754

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=99.98  E-value=2.1e-31  Score=274.34  Aligned_cols=255  Identities=22%  Similarity=0.295  Sum_probs=182.2

Q ss_pred             hcCCCcCCccc----eEEEEEEE--CCceEEEEEecc--------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEE
Q 039626          350 TDNFSFTCRIQ----GSVYRGKI--NGGFAAIKKVNG--------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYE  415 (628)
Q Consensus       350 t~~f~~~~~i~----G~Vy~g~~--~g~~vavK~~~~--------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  415 (628)
                      +++|.....+|    |.||+|..  +|+.+|+|.+..        .+.+|++++++++|+||+++.+++..++..++|+|
T Consensus         4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e   83 (291)
T cd07870           4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFE   83 (291)
T ss_pred             cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEe
Confidence            34454444443    89999987  688999998753        35679999999999999999999999999999999


Q ss_pred             ecCCCChHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCC
Q 039626          416 YAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQ  495 (628)
Q Consensus       416 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~  495 (628)
                      |+. ++|.+++...   ...+++..+..++.|++.||.|||+.   +++|+||||+||+++.++++||+|||+++.....
T Consensus        84 ~~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~  156 (291)
T cd07870          84 YMH-TDLAQYMIQH---PGGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIP  156 (291)
T ss_pred             ccc-CCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccccccCCC
Confidence            995 7887777432   23578888999999999999999985   4999999999999999999999999998764322


Q ss_pred             CCcceeeecccCCccccCccccccC-CCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhcccc--c---
Q 039626          496 EGEFALTRHIVGTKGYMAPEYLENG-LVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKED--G---  569 (628)
Q Consensus       496 ~~~~~~~~~~~gt~~Y~APE~l~~~-~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~--~---  569 (628)
                      ..   ......++..|+|||.+.+. .++.++||||||++++||++|+.|+....... ..+.+. ........  .   
T Consensus       157 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~-~~~~~~-~~~~~~~~~~~~~~  231 (291)
T cd07870         157 SQ---TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVF-EQLEKI-WTVLGVPTEDTWPG  231 (291)
T ss_pred             CC---CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHH-HHHHHH-HHHcCCCChhhhhh
Confidence            11   11233578899999998754 57889999999999999999999986432211 011111 11000000  0   


Q ss_pred             hhhhccccCCcC----CCCC-----CHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          570 EESLRHFIDPTL----QGNY-----PLELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       570 ~~~l~~~~d~~l----~~~~-----~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      ...+........    ....     .......+.+++.+|++.||.+|||++|++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~  287 (291)
T cd07870         232 VSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL  287 (291)
T ss_pred             hhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence            000000000000    0000     0012356789999999999999999999864

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=99.98  E-value=1.8e-31  Score=272.57  Aligned_cols=226  Identities=27%  Similarity=0.460  Sum_probs=180.0

Q ss_pred             eEEEEEEE--CCceEEEEEecc--------chHHHHHHHhhcC---CCceeeeeeeeecCCeEEEEEEecCCCChHHHhh
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG--------DVSKEIALLNKIN---HSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVF  427 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~--------~~~~E~~~l~~l~---H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~  427 (628)
                      |.||+|..  ++..+|+|.++.        ++.+|++++++++   |+|++++++++..+...++||||+++++|.+++.
T Consensus        15 g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e~~~~~~L~~~~~   94 (277)
T cd06917          15 GAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMK   94 (277)
T ss_pred             ceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEecCCCCcHHHHHH
Confidence            89999997  678999998743        3667999999997   9999999999999999999999999999999884


Q ss_pred             hcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccC
Q 039626          428 SNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVG  507 (628)
Q Consensus       428 ~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~g  507 (628)
                      .     ..+++...+.++.+++.||.|||+.   +++|+||+|+||++++++.++|+|||++........   ......|
T Consensus        95 ~-----~~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~  163 (277)
T cd06917          95 A-----GPIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS---KRSTFVG  163 (277)
T ss_pred             c-----cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeecCCCcc---ccccccC
Confidence            2     2589999999999999999999984   599999999999999999999999999987654321   1223468


Q ss_pred             CccccCccccccC-CCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCC
Q 039626          508 TKGYMAPEYLENG-LVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYP  586 (628)
Q Consensus       508 t~~Y~APE~l~~~-~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~  586 (628)
                      +..|+|||.+.++ .++.++|+||||+++|||++|+.|+......      .....          +.....+.+...  
T Consensus       164 ~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~------~~~~~----------~~~~~~~~~~~~--  225 (277)
T cd06917         164 TPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAF------RAMML----------IPKSKPPRLEDN--  225 (277)
T ss_pred             CcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChh------hhhhc----------cccCCCCCCCcc--
Confidence            8999999988754 4689999999999999999999998632211      11100          000011111111  


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          587 LELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       587 ~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                       .....+.+++.+||+.||++||++.|++.
T Consensus       226 -~~~~~~~~~i~~~l~~~p~~R~~~~~il~  254 (277)
T cd06917         226 -GYSKLLREFVAACLDEEPKERLSAEELLK  254 (277)
T ss_pred             -cCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence             13456789999999999999999999975

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=99.98  E-value=8.1e-32  Score=278.24  Aligned_cols=243  Identities=25%  Similarity=0.312  Sum_probs=181.3

Q ss_pred             eEEEEEEE--CCceEEEEEeccc------------hHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHh
Q 039626          361 GSVYRGKI--NGGFAAIKKVNGD------------VSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWV  426 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~~------------~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l  426 (628)
                      |.||+|..  +|+.+|+|+++..            +..|++++++++|+||+++++++.+.+..++||||+ +|+|.+++
T Consensus        14 ~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~i   92 (298)
T cd07841          14 AVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVFEFM-ETDLEKVI   92 (298)
T ss_pred             cEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEEccc-CCCHHHHH
Confidence            89999997  5789999998642            346999999999999999999999999999999999 99999999


Q ss_pred             hhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeeccc
Q 039626          427 FSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIV  506 (628)
Q Consensus       427 ~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~  506 (628)
                      ...   ...+++..+..++.|+++||.|||+.   +++|+||||+||+++.++.+||+|||+++.......   ......
T Consensus        93 ~~~---~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~---~~~~~~  163 (298)
T cd07841          93 KDK---SIVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNR---KMTHQV  163 (298)
T ss_pred             hcc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeeccCCCc---cccccc
Confidence            532   23699999999999999999999995   499999999999999999999999999987654321   122335


Q ss_pred             CCccccCcccccc-CCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccc-----hhhhccccCCc
Q 039626          507 GTKGYMAPEYLEN-GLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDG-----EESLRHFIDPT  580 (628)
Q Consensus       507 gt~~Y~APE~l~~-~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~l~~~~d~~  580 (628)
                      ++..|+|||.+.+ ..++.++||||||++++||++|..++.......  .+.... ........     ...+.......
T Consensus       164 ~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~--~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  240 (298)
T cd07841         164 VTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDID--QLGKIF-EALGTPTEENWPGVTSLPDYVEFK  240 (298)
T ss_pred             cceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHH--HHHHHH-HHcCCCchhhhhhccccccccccc
Confidence            6788999998865 467899999999999999999977665322111  111111 11110000     00011111111


Q ss_pred             CCCCC-----CHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          581 LQGNY-----PLELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       581 l~~~~-----~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      .....     .......+.+++.+||+.||++|||++|+++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~  281 (298)
T cd07841         241 PFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE  281 (298)
T ss_pred             ccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence            11111     1223567889999999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=99.98  E-value=2.5e-31  Score=268.94  Aligned_cols=230  Identities=28%  Similarity=0.461  Sum_probs=186.5

Q ss_pred             eEEEEEEE--CCceEEEEEecc--------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhcC
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG--------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNK  430 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~--------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~  430 (628)
                      |.||+++.  +++.+++|+...        ++.+|++.+.+++|+||+++++++..++..++|+||+++++|.+++... 
T Consensus        15 ~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-   93 (264)
T cd06623          15 GVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKV-   93 (264)
T ss_pred             eEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEecCCCcHHHHHHHc-
Confidence            88999988  488999998753        3668999999999999999999999999999999999999999999542 


Q ss_pred             CCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCCc
Q 039626          431 NEGKYLDWKQRIQIALDVATGLNYLHS-FTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTK  509 (628)
Q Consensus       431 ~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~  509 (628)
                         ..+++..++.++.++++||+|||+ .+   ++|+||+|+||+++.++.++|+|||++.........   .....++.
T Consensus        94 ---~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~---~~~~~~~~  164 (264)
T cd06623          94 ---GKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ---CNTFVGTV  164 (264)
T ss_pred             ---CCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCCCc---ccceeecc
Confidence               568999999999999999999998 55   999999999999999999999999998876433221   12346788


Q ss_pred             cccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCHH-
Q 039626          510 GYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLE-  588 (628)
Q Consensus       510 ~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~-  588 (628)
                      .|+|||.+.+..++.++|+||||+++|||++|+.|+......   ...+....+...          ..+    ..+.. 
T Consensus       165 ~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~---~~~~~~~~~~~~----------~~~----~~~~~~  227 (264)
T cd06623         165 TYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQP---SFFELMQAICDG----------PPP----SLPAEE  227 (264)
T ss_pred             cccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccccc---CHHHHHHHHhcC----------CCC----CCCccc
Confidence            999999999999999999999999999999999998644321   122222222110          011    11222 


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 039626          589 LALLVIRLIDACLKKDPTDRPTMYEIEHS  617 (628)
Q Consensus       589 ~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~  617 (628)
                      .+..+.+++.+||+.+|++||++.|+++.
T Consensus       228 ~~~~l~~li~~~l~~~p~~R~~~~~ll~~  256 (264)
T cd06623         228 FSPEFRDFISACLQKDPKKRPSAAELLQH  256 (264)
T ss_pred             CCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence            44678899999999999999999999863

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=99.98  E-value=6.5e-34  Score=273.75  Aligned_cols=229  Identities=29%  Similarity=0.431  Sum_probs=190.7

Q ss_pred             eEEEEEEE--CCceEEEEEecc-----chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhcCCCC
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG-----DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEG  433 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~-----~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~  433 (628)
                      |+|||+..  .|+.+|||++.-     ++.+|+.+|++.+.+++|+++|.+.....+++|||||-.|+..|.+..   .+
T Consensus        47 GSV~KAIH~EsG~v~AIK~VPV~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAGSiSDI~R~---R~  123 (502)
T KOG0574|consen   47 GSVHKAIHRESGHVLAIKKVPVDTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAGSISDIMRA---RR  123 (502)
T ss_pred             hHHHHHHHhccCcEEEEEecCccchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCCcHHHHHHH---hc
Confidence            89999976  799999999863     567899999999999999999999999999999999999999999954   45


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCCccccC
Q 039626          434 KYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMA  513 (628)
Q Consensus       434 ~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~Y~A  513 (628)
                      ++|++..+..++.+.++||+|||...   -||||||..||||+.+|.+||+|||.|-...+..   .....+.||+.|||
T Consensus       124 K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM---AKRNTVIGTPFWMA  197 (502)
T KOG0574|consen  124 KPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM---AKRNTVIGTPFWMA  197 (502)
T ss_pred             CCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhhhH---HhhCccccCccccc
Confidence            67999999999999999999999854   7999999999999999999999999997664322   23455789999999


Q ss_pred             ccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCHHHHHHH
Q 039626          514 PEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLV  593 (628)
Q Consensus       514 PE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l  593 (628)
                      ||+++.-.|..++||||+|+...||..|++|+..-....         .++.         ---.|.-.-..|+..+..+
T Consensus       198 PEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMR---------AIFM---------IPT~PPPTF~KPE~WS~~F  259 (502)
T KOG0574|consen  198 PEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMR---------AIFM---------IPTKPPPTFKKPEEWSSEF  259 (502)
T ss_pred             HHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccc---------eeEe---------ccCCCCCCCCChHhhhhHH
Confidence            999999999999999999999999999999976221100         0000         0001111223466777889


Q ss_pred             HHHHHHhcccCCCCCCCHHHHHH
Q 039626          594 IRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       594 ~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      -+++++||-++|++|-++.++++
T Consensus       260 ~DFi~~CLiK~PE~R~TA~~L~~  282 (502)
T KOG0574|consen  260 NDFIRSCLIKKPEERKTALRLCE  282 (502)
T ss_pred             HHHHHHHhcCCHHHHHHHHHHhh
Confidence            99999999999999999888765

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=99.98  E-value=1.7e-31  Score=275.49  Aligned_cols=228  Identities=25%  Similarity=0.400  Sum_probs=182.4

Q ss_pred             eEEEEEEE--CCceEEEEEecc-------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhcCC
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG-------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKN  431 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~-------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~  431 (628)
                      |.||++..  +++.+|+|.+..       .+.+|+.++++++|+||+++++++..++..++|+||+++++|.+++..   
T Consensus        33 g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~---  109 (293)
T cd06647          33 GTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE---  109 (293)
T ss_pred             eEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecCCCCcHHHHHhh---
Confidence            89999986  678899998753       356799999999999999999999999999999999999999999843   


Q ss_pred             CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCCccc
Q 039626          432 EGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGY  511 (628)
Q Consensus       432 ~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~Y  511 (628)
                        ..+++..+..++.+++.||.|||+.   +++|+||||+||+++.++.+||+|||++........   ......+++.|
T Consensus       110 --~~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~---~~~~~~~~~~y  181 (293)
T cd06647         110 --TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS---KRSTMVGTPYW  181 (293)
T ss_pred             --cCCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceeccccccc---ccccccCChhh
Confidence              3478999999999999999999984   599999999999999999999999999876543221   12234688899


Q ss_pred             cCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCHHHHH
Q 039626          512 MAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELAL  591 (628)
Q Consensus       512 ~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~  591 (628)
                      +|||.+....++.++|+||||+++||+++|+.||.........      .....            .+......+.....
T Consensus       182 ~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~------~~~~~------------~~~~~~~~~~~~~~  243 (293)
T cd06647         182 MAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL------YLIAT------------NGTPELQNPEKLSA  243 (293)
T ss_pred             cCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhe------eehhc------------CCCCCCCCccccCH
Confidence            9999998888999999999999999999999998643221100      00000            00000111223445


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHHH
Q 039626          592 LVIRLIDACLKKDPTDRPTMYEIEHS  617 (628)
Q Consensus       592 ~l~~l~~~Cl~~dP~~RPs~~ev~~~  617 (628)
                      .+.+++.+||..+|.+||++++++..
T Consensus       244 ~l~~li~~~l~~~p~~Rp~~~~il~h  269 (293)
T cd06647         244 IFRDFLNRCLEMDVEKRGSAKELLQH  269 (293)
T ss_pred             HHHHHHHHHccCChhhCcCHHHHhcC
Confidence            68899999999999999999999864

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=99.98  E-value=1.1e-31  Score=276.64  Aligned_cols=244  Identities=25%  Similarity=0.354  Sum_probs=180.4

Q ss_pred             eEEEEEEE--CCceEEEEEecc---------chHHHHHHHhhcCCCceeeeeeeeecC--CeEEEEEEecCCCChHHHhh
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG---------DVSKEIALLNKINHSNLIILSGVCFNE--GNCYLVYEYAVNGTLSDWVF  427 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~---------~~~~E~~~l~~l~H~nIv~l~g~~~~~--~~~~lV~E~~~~gsL~~~l~  427 (628)
                      |.||+|+.  ++..+|+|+++.         .+.+|++++.+++|+||+++++++..+  +..++|+||++ ++|.+++.
T Consensus        19 ~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~   97 (293)
T cd07843          19 GVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVE-HDLKSLME   97 (293)
T ss_pred             eEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEehhcC-cCHHHHHH
Confidence            89999998  477899998853         245799999999999999999999877  78999999996 59999885


Q ss_pred             hcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccC
Q 039626          428 SNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVG  507 (628)
Q Consensus       428 ~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~g  507 (628)
                      ..   ...+++..+..++.|++.||+|||+.   +++|+||||+||++++++.+||+|||+++........   .....+
T Consensus        98 ~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~---~~~~~~  168 (293)
T cd07843          98 TM---KQPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKP---YTQLVV  168 (293)
T ss_pred             hc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceeeccCCccc---cccccc
Confidence            42   23689999999999999999999984   4999999999999999999999999999876543211   123457


Q ss_pred             CccccCccccccC-CCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhcccc------------chhhhc
Q 039626          508 TKGYMAPEYLENG-LVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKED------------GEESLR  574 (628)
Q Consensus       508 t~~Y~APE~l~~~-~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~l~  574 (628)
                      +..|+|||.+.+. .++.++|+||||++++||++|+.|+.......  ..............            ......
T Consensus       169 ~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (293)
T cd07843         169 TLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEID--QLNKIFKLLGTPTEKIWPGFSELPGAKKKTFT  246 (293)
T ss_pred             cccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHHHHhCCCchHHHHHhhccchhcccccc
Confidence            8899999998764 46899999999999999999998886432211  01111110000000            000000


Q ss_pred             cccCCcCCCCCCHH-HHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          575 HFIDPTLQGNYPLE-LALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       575 ~~~d~~l~~~~~~~-~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      ......+...++.. ....+.+++.+||+.||++|||+.|++.
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~  289 (293)
T cd07843         247 KYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK  289 (293)
T ss_pred             cccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence            00111111222222 3556789999999999999999999875

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=99.98  E-value=1.4e-31  Score=275.99  Aligned_cols=247  Identities=25%  Similarity=0.323  Sum_probs=178.9

Q ss_pred             eEEEEEEE--CCceEEEEEecc---------chHHHHHHHhhcC-CCceeeeeeeeecCCe-----EEEEEEecCCCChH
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG---------DVSKEIALLNKIN-HSNLIILSGVCFNEGN-----CYLVYEYAVNGTLS  423 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~---------~~~~E~~~l~~l~-H~nIv~l~g~~~~~~~-----~~lV~E~~~~gsL~  423 (628)
                      |.||+|..  +++.+|+|+.+.         .+.+|+.++++++ |+||+++++++...+.     .++||||+++ +|.
T Consensus        15 g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~   93 (295)
T cd07837          15 GKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLK   93 (295)
T ss_pred             eEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEEEEeeccCc-CHH
Confidence            89999998  678999998753         3567999999995 6999999999987665     8999999975 899


Q ss_pred             HHhhhcCCC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCC-CCcEEEccccccccCCCCCCccee
Q 039626          424 DWVFSNKNE-GKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDS-DLRAKIANFAMARPAEGQEGEFAL  501 (628)
Q Consensus       424 ~~l~~~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~-~~~~kl~Dfgla~~~~~~~~~~~~  501 (628)
                      +++...... ...+++..+..++.||+.||+|||+.   +++||||||+||+++. ++.+||+|||+++.......   .
T Consensus        94 ~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~~~~~~~---~  167 (295)
T cd07837          94 KFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVK---S  167 (295)
T ss_pred             HHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeecccceecCCCcc---c
Confidence            988654332 45689999999999999999999984   5999999999999999 89999999999886533211   1


Q ss_pred             eecccCCccccCcccccc-CCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccc----hhhhccc
Q 039626          502 TRHIVGTKGYMAPEYLEN-GLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDG----EESLRHF  576 (628)
Q Consensus       502 ~~~~~gt~~Y~APE~l~~-~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~----~~~l~~~  576 (628)
                      .....+++.|+|||++.+ ..++.++||||||++++||++|+.|+.......  .+.+...........    ...+...
T Consensus       168 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (295)
T cd07837         168 YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQ--QLLHIFKLLGTPTEQVWPGVSKLRDW  245 (295)
T ss_pred             cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHH--HHHHHHHHhCCCChhhCcchhhccch
Confidence            123356889999998865 457999999999999999999998886432211  111111111000000    0000000


Q ss_pred             cC-CcCC----CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          577 ID-PTLQ----GNYPLELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       577 ~d-~~l~----~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      .. +...    ..........+.+++.+||+.||.+||+++|++.
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~  290 (295)
T cd07837         246 HEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT  290 (295)
T ss_pred             hhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence            00 0000    0001124556889999999999999999999874

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=99.98  E-value=5.9e-32  Score=287.38  Aligned_cols=178  Identities=24%  Similarity=0.351  Sum_probs=153.8

Q ss_pred             eEEEEEEE--CCceEEEEEeccc------hHHHHHHHhhcC-C-----CceeeeeeeeecCCeEEEEEEecCCCChHHHh
Q 039626          361 GSVYRGKI--NGGFAAIKKVNGD------VSKEIALLNKIN-H-----SNLIILSGVCFNEGNCYLVYEYAVNGTLSDWV  426 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~~------~~~E~~~l~~l~-H-----~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l  426 (628)
                      |.|-|+..  +++.||||.++++      ...|+.+|..|+ |     -|+|++++++..++++|||+|.+ .-+|.++|
T Consensus       200 GQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciVfELL-~~NLYell  278 (586)
T KOG0667|consen  200 GQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIVFELL-STNLYELL  278 (586)
T ss_pred             ceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeeeehhh-hhhHHHHH
Confidence            89999988  6899999999863      456999999997 4     48999999999999999999999 66999999


Q ss_pred             hhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCC--CcEEEccccccccCCCCCCcceeeec
Q 039626          427 FSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSD--LRAKIANFAMARPAEGQEGEFALTRH  504 (628)
Q Consensus       427 ~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~--~~~kl~Dfgla~~~~~~~~~~~~~~~  504 (628)
                      ..++  ...++......|+.||+.||.+||+.+   |||+||||+||||.+-  .++||+|||.+........      .
T Consensus       279 K~n~--f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q~vy------t  347 (586)
T KOG0667|consen  279 KNNK--FRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSSCFESQRVY------T  347 (586)
T ss_pred             HhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEecccccccCCcce------e
Confidence            7643  345899999999999999999999855   9999999999999654  4699999999987654321      4


Q ss_pred             ccCCccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccc
Q 039626          505 IVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAE  550 (628)
Q Consensus       505 ~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~  550 (628)
                      ...+..|+|||++.+..|+.+.||||||||+.||++|.+.|.+..+
T Consensus       348 YiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne  393 (586)
T KOG0667|consen  348 YIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNE  393 (586)
T ss_pred             eeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCH
Confidence            5678899999999999999999999999999999999877665433

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=99.98  E-value=1.3e-31  Score=270.05  Aligned_cols=228  Identities=25%  Similarity=0.432  Sum_probs=182.3

Q ss_pred             eEEEEEEE--CCceEEEEEecc---------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhc
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG---------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSN  429 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~---------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~  429 (628)
                      |.||+|..  +|..+|+|.+..         .+.+|++++++++|+||+++++.+..++..++|+||+++++|.+++...
T Consensus        14 ~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~   93 (257)
T cd08225          14 GKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQ   93 (257)
T ss_pred             ceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecCCCCcHHHHHHhc
Confidence            89999998  578899998742         3568999999999999999999999999999999999999999999542


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCC-cEEEccccccccCCCCCCcceeeecccCC
Q 039626          430 KNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDL-RAKIANFAMARPAEGQEGEFALTRHIVGT  508 (628)
Q Consensus       430 ~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~-~~kl~Dfgla~~~~~~~~~~~~~~~~~gt  508 (628)
                        .+..++|..+..++.+++.||.|||+.   +++|+||||+||++++++ .+||+|||.+........   ......|+
T Consensus        94 --~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~  165 (257)
T cd08225          94 --RGVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME---LAYTCVGT  165 (257)
T ss_pred             --cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhccCCcc---cccccCCC
Confidence              234589999999999999999999984   499999999999999885 569999999887643221   12334688


Q ss_pred             ccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCHH
Q 039626          509 KGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLE  588 (628)
Q Consensus       509 ~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~  588 (628)
                      +.|+|||++.+..++.++|+||||++++|+++|+.|+....      ..+.+......         ...+ .    +..
T Consensus       166 ~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~------~~~~~~~~~~~---------~~~~-~----~~~  225 (257)
T cd08225         166 PYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN------LHQLVLKICQG---------YFAP-I----SPN  225 (257)
T ss_pred             ccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc------HHHHHHHHhcc---------cCCC-C----CCC
Confidence            99999999998889999999999999999999999875322      11222211110         1111 1    112


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          589 LALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       589 ~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      ....+.+++.+||+.+|++||++.|+++
T Consensus       226 ~~~~~~~~i~~~l~~~p~~Rpt~~~ll~  253 (257)
T cd08225         226 FSRDLRSLISQLFKVSPRDRPSITSILK  253 (257)
T ss_pred             CCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence            3346789999999999999999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.98  E-value=5.4e-32  Score=269.02  Aligned_cols=238  Identities=24%  Similarity=0.363  Sum_probs=188.0

Q ss_pred             eEEEEEEEC-------CceEEEEEeccc--------hHHHHHHHhhcCCCceeeeeeeeecC-CeEEEEEEecCCCChHH
Q 039626          361 GSVYRGKIN-------GGFAAIKKVNGD--------VSKEIALLNKINHSNLIILSGVCFNE-GNCYLVYEYAVNGTLSD  424 (628)
Q Consensus       361 G~Vy~g~~~-------g~~vavK~~~~~--------~~~E~~~l~~l~H~nIv~l~g~~~~~-~~~~lV~E~~~~gsL~~  424 (628)
                      |.||+|.|.       .+.|-+|.++..        +..|--++..+.|+|+..+.|++.++ ...+.+|.++.-|+|..
T Consensus       298 Gri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~V~y~~~~~gNLK~  377 (563)
T KOG1024|consen  298 GRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATPFVLYPATGVGNLKS  377 (563)
T ss_pred             hheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcceEEEeccCcchHHH
Confidence            999999773       234566766653        45688888889999999999999866 46789999999999999


Q ss_pred             Hhhhc----CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcce
Q 039626          425 WVFSN----KNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFA  500 (628)
Q Consensus       425 ~l~~~----~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~  500 (628)
                      +|..-    ....+.++-.+...++.|++.|++|||+++   +||.||..+|++||+..++||+|-.++|..-..+.. .
T Consensus       378 FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~LqVkltDsaLSRDLFP~DYh-c  453 (563)
T KOG1024|consen  378 FLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQLQVKLTDSALSRDLFPGDYH-C  453 (563)
T ss_pred             HHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhheeEEeccchhccccCccccc-c
Confidence            99622    223456788889999999999999999965   999999999999999999999999999987544321 2


Q ss_pred             eeecccCCccccCccccccCCCCcccccHHHHHHHHHHHh-CCCccccccccccccHHHHHHHHhccccchhhhccccCC
Q 039626          501 LTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT-GKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDP  579 (628)
Q Consensus       501 ~~~~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELlt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~  579 (628)
                      ..........||+||.+.+..++..+|||||||+||||+| |+.|+..-+.                    ..+...+..
T Consensus       454 LGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDP--------------------fEm~~ylkd  513 (563)
T KOG1024|consen  454 LGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDP--------------------FEMEHYLKD  513 (563)
T ss_pred             cCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCH--------------------HHHHHHHhc
Confidence            2333455678999999999999999999999999999998 7767642221                    111222222


Q ss_pred             cCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhH
Q 039626          580 TLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNIL  622 (628)
Q Consensus       580 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~  622 (628)
                      ..+-..|..++.+++.+|..||..+|++||++.+++..|++.-
T Consensus       514 GyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~  556 (563)
T KOG1024|consen  514 GYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFH  556 (563)
T ss_pred             cceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHH
Confidence            3334456677778999999999999999999999999998753

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=99.98  E-value=1.1e-31  Score=275.96  Aligned_cols=235  Identities=23%  Similarity=0.368  Sum_probs=179.6

Q ss_pred             eEEEEEEE--CCceEEEEEecc--------chHHHHHHHhhcC-CCceeeeeeeeecCCeEEEEEEecCCCChHHHhhh-
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG--------DVSKEIALLNKIN-HSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFS-  428 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~--------~~~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~-  428 (628)
                      |.||++..  ++..+|+|++..        .+.+|+.++.++. |+||+++++++..++..+++|||+. ++|.++... 
T Consensus        18 g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~-~~l~~l~~~~   96 (288)
T cd06616          18 GTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMD-ISLDKFYKYV   96 (288)
T ss_pred             eEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEeccc-CCHHHHHHHH
Confidence            89999998  578999998753        3567999999996 9999999999999889999999985 466554321 


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCC
Q 039626          429 NKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGT  508 (628)
Q Consensus       429 ~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt  508 (628)
                      .......+++....+++.+++.||+|||+.  .+++||||||+||+++.++.+||+|||+++......    ......|+
T Consensus        97 ~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~  170 (288)
T cd06616          97 YEVLKSVIPEEILGKIAVATVKALNYLKEE--LKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSI----AKTRDAGC  170 (288)
T ss_pred             HHhhcCCCCHHHHHHHHHHHHHHHHHHhhc--CCeeccCCCHHHEEEccCCcEEEeecchhHHhccCC----ccccccCc
Confidence            112235689999999999999999999973  359999999999999999999999999987654321    11234688


Q ss_pred             ccccCccccccC---CCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCC
Q 039626          509 KGYMAPEYLENG---LVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNY  585 (628)
Q Consensus       509 ~~Y~APE~l~~~---~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~  585 (628)
                      ..|+|||.+.+.   .++.++||||||++++||++|+.|+....     ...+.+......          ..+.+....
T Consensus       171 ~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-----~~~~~~~~~~~~----------~~~~~~~~~  235 (288)
T cd06616         171 RPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN-----SVFDQLTQVVKG----------DPPILSNSE  235 (288)
T ss_pred             cCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc-----hHHHHHhhhcCC----------CCCcCCCcC
Confidence            999999998766   68999999999999999999999976322     111111111111          011222222


Q ss_pred             CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 039626          586 PLELALLVIRLIDACLKKDPTDRPTMYEIEHS  617 (628)
Q Consensus       586 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~  617 (628)
                      +...+..+.+++.+||+.||++||+++||+..
T Consensus       236 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~  267 (288)
T cd06616         236 EREFSPSFVNFINLCLIKDESKRPKYKELLEH  267 (288)
T ss_pred             CCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            22345678899999999999999999998863

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=99.98  E-value=3.1e-31  Score=279.06  Aligned_cols=227  Identities=27%  Similarity=0.375  Sum_probs=189.9

Q ss_pred             eEEEEEEE--CCceEEEEEecc----------chHHHHHHHhhcC-CCceeeeeeeeecCCeEEEEEEecCCCChHHHhh
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG----------DVSKEIALLNKIN-HSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVF  427 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~  427 (628)
                      |.||+++.  +|+.+|+|.+++          ++.+|+.+|+++. |||||.+.+.+++....++|||++.||.|.+.+.
T Consensus        49 g~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lvmEL~~GGeLfd~i~  128 (382)
T KOG0032|consen   49 GVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLVMELCEGGELFDRIV  128 (382)
T ss_pred             eEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEEEEecCCchHHHHHH
Confidence            89999988  588999998853          4678999999998 9999999999999999999999999999999996


Q ss_pred             hcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCC----CcEEEccccccccCCCCCCcceeee
Q 039626          428 SNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSD----LRAKIANFAMARPAEGQEGEFALTR  503 (628)
Q Consensus       428 ~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~----~~~kl~Dfgla~~~~~~~~~~~~~~  503 (628)
                      ..     .+++.....++.+++.+++|||+.   +++||||||+|+|+...    +.+|++|||++......    ....
T Consensus       129 ~~-----~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~~----~~~~  196 (382)
T KOG0032|consen  129 KK-----HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKPG----ERLH  196 (382)
T ss_pred             Hc-----cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEeeCCCceEccCC----ceEe
Confidence            54     289999999999999999999995   49999999999999543    57999999999987652    2355


Q ss_pred             cccCCccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCC
Q 039626          504 HIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQG  583 (628)
Q Consensus       504 ~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~  583 (628)
                      ..+||+.|+|||.+....++...||||+||++|.|++|..||........      ...+.....           ....
T Consensus       197 ~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~------~~~i~~~~~-----------~f~~  259 (382)
T KOG0032|consen  197 TIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEI------FLAILRGDF-----------DFTS  259 (382)
T ss_pred             eecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHH------HHHHHcCCC-----------CCCC
Confidence            67999999999999999999999999999999999999999875443221      112221111           1222


Q ss_pred             CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          584 NYPLELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       584 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      .+-......+.++++.|+..||.+|+++.++++
T Consensus       260 ~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~  292 (382)
T KOG0032|consen  260 EPWDDISESAKDFIRKLLEFDPRKRLTAAQALQ  292 (382)
T ss_pred             CCccccCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence            333455777899999999999999999999987

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=99.98  E-value=2e-31  Score=273.25  Aligned_cols=244  Identities=25%  Similarity=0.311  Sum_probs=182.2

Q ss_pred             eEEEEEEE--CCceEEEEEecc---------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhc
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG---------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSN  429 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~---------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~  429 (628)
                      |.||+|+.  +|..+|+|++..         ++.+|+.++++++|+||+++++++..+...++|+||+ +++|.+++...
T Consensus        14 ~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~-~~~L~~~~~~~   92 (286)
T cd07832          14 GIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM-PSDLSEVLRDE   92 (286)
T ss_pred             cEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEeccc-CCCHHHHHHhc
Confidence            89999997  678999998753         4668999999999999999999999999999999999 99999998542


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCCc
Q 039626          430 KNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTK  509 (628)
Q Consensus       430 ~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~  509 (628)
                         ...+++.++..++.|++.||+|||+.   +++|+||||+||+++.++.++|+|||++........  .......++.
T Consensus        93 ---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~  164 (286)
T cd07832          93 ---ERPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP--RLYSHQVATR  164 (286)
T ss_pred             ---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC--CccccccCcc
Confidence               25699999999999999999999985   499999999999999999999999999987643321  1122346889


Q ss_pred             cccCccccccC-CCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccc--h---hhh---ccccCCc
Q 039626          510 GYMAPEYLENG-LVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDG--E---ESL---RHFIDPT  580 (628)
Q Consensus       510 ~Y~APE~l~~~-~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~---~~l---~~~~d~~  580 (628)
                      .|+|||.+.+. .++.++||||+|++++||++|+.++......   .....+.........  .   ..+   .....+.
T Consensus       165 ~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (286)
T cd07832         165 WYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDI---EQLAIVFRTLGTPNEETWPGLTSLPDYNKITFPE  241 (286)
T ss_pred             cccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHH---HHHHHHHHHcCCCChHHHhhccCcchhhcccCCC
Confidence            99999988654 4689999999999999999997766533221   111111111110000  0   000   0000000


Q ss_pred             CC----CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          581 LQ----GNYPLELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       581 l~----~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      ..    .....+....+.+++.+||+.||++||++++++.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~  281 (286)
T cd07832         242 SKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR  281 (286)
T ss_pred             CCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence            00    0001123467899999999999999999999875

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.98  E-value=3.4e-31  Score=268.73  Aligned_cols=229  Identities=23%  Similarity=0.274  Sum_probs=179.1

Q ss_pred             eEEEEEEE--CCceEEEEEecc------------chHHHHHHHhhcCCCceeeeeeeeecC--CeEEEEEEecCCCChHH
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG------------DVSKEIALLNKINHSNLIILSGVCFNE--GNCYLVYEYAVNGTLSD  424 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~------------~~~~E~~~l~~l~H~nIv~l~g~~~~~--~~~~lV~E~~~~gsL~~  424 (628)
                      |.||+|..  ++..+|+|.+..            .+.+|++++++++|+||+++++++.+.  ...++++||+++++|.+
T Consensus        16 g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~   95 (264)
T cd06653          16 GEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKD   95 (264)
T ss_pred             eEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEEEEEeCCCCcHHH
Confidence            89999987  688999997631            356799999999999999999998754  46889999999999999


Q ss_pred             HhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeec
Q 039626          425 WVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRH  504 (628)
Q Consensus       425 ~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~  504 (628)
                      ++..    ...+++....+++.+++.||.|||+.   +++|+||||+||+++.++.++|+|||+++..............
T Consensus        96 ~~~~----~~~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~  168 (264)
T cd06653          96 QLKA----YGALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKS  168 (264)
T ss_pred             HHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECccccccccccccccCccccc
Confidence            9853    23488999999999999999999984   4999999999999999999999999999865422111111223


Q ss_pred             ccCCccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCC
Q 039626          505 IVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGN  584 (628)
Q Consensus       505 ~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~  584 (628)
                      ..++..|+|||++.+..++.++|+||||++++||++|+.|+.....     . ..+.....             ......
T Consensus       169 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~-~~~~~~~~-------------~~~~~~  229 (264)
T cd06653         169 VTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEA-----M-AAIFKIAT-------------QPTKPM  229 (264)
T ss_pred             cCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCH-----H-HHHHHHHc-------------CCCCCC
Confidence            5688999999999988899999999999999999999999753211     1 11111111             111122


Q ss_pred             CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          585 YPLELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       585 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      .+......+.+++.+||. +|.+||+..+++.
T Consensus       230 ~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~  260 (264)
T cd06653         230 LPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR  260 (264)
T ss_pred             CCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence            344555678899999999 5799999998764

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=99.97  E-value=4.7e-31  Score=274.74  Aligned_cols=249  Identities=19%  Similarity=0.287  Sum_probs=182.4

Q ss_pred             eEEEEEEECCceEEEEEecc---------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhcCC
Q 039626          361 GSVYRGKINGGFAAIKKVNG---------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKN  431 (628)
Q Consensus       361 G~Vy~g~~~g~~vavK~~~~---------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~  431 (628)
                      +.||+++.+++.+|+|+++.         .+.+|++++++++|+||+++++++.+++..+++|||+++|+|.+++.... 
T Consensus        16 v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~-   94 (314)
T cd08216          16 VHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHF-   94 (314)
T ss_pred             EEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHHHhc-
Confidence            45666666899999998753         35689999999999999999999999999999999999999999996532 


Q ss_pred             CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCc----ceeeecccC
Q 039626          432 EGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGE----FALTRHIVG  507 (628)
Q Consensus       432 ~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~----~~~~~~~~g  507 (628)
                       ...+++.....++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||.+.........    ........+
T Consensus        95 -~~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~  170 (314)
T cd08216          95 -PEGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVK  170 (314)
T ss_pred             -ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeeccccccccccccccccccc
Confidence             23588899999999999999999985   4999999999999999999999999988765322110    111233467


Q ss_pred             CccccCcccccc--CCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhcc----cc---chhhhc----
Q 039626          508 TKGYMAPEYLEN--GLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTK----ED---GEESLR----  574 (628)
Q Consensus       508 t~~Y~APE~l~~--~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~----~~---~~~~l~----  574 (628)
                      +..|+|||++..  ..++.++|+||||++++||++|+.||.......  ...+........    ..   ....+.    
T Consensus       171 ~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (314)
T cd08216         171 NLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ--MLLEKVRGTVPCLLDKSTYPLYEDSMSQSRS  248 (314)
T ss_pred             cccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHhccCccccccCchhhhcCCcCcccc
Confidence            788999999876  358899999999999999999999986422111  011111000000    00   000000    


Q ss_pred             cccCCcC----CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          575 HFIDPTL----QGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       575 ~~~d~~l----~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      ...++..    ...........+.+++.+||+.||++|||++++++
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~  294 (314)
T cd08216         249 SNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN  294 (314)
T ss_pred             cccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence            0111111    11123344567889999999999999999999986

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=99.97  E-value=4e-31  Score=275.91  Aligned_cols=226  Identities=31%  Similarity=0.449  Sum_probs=178.8

Q ss_pred             eEEEEEEE--CCceEEEEEecc----------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhh
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG----------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFS  428 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  428 (628)
                      |.||+++.  ++..+|+|++..          ++.+|++++++++|+|++++++++.++...++||||++ |+|.+++..
T Consensus        39 ~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-g~l~~~~~~  117 (317)
T cd06635          39 GAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCL-GSASDLLEV  117 (317)
T ss_pred             eEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeCCC-CCHHHHHHH
Confidence            89999987  678999998752          35679999999999999999999999999999999996 588887753


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCC
Q 039626          429 NKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGT  508 (628)
Q Consensus       429 ~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt  508 (628)
                      .   ...++|.++..++.+++.||.|||+.   +++||||+|+||+++.++.+||+|||++......       ....|+
T Consensus       118 ~---~~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~-------~~~~~~  184 (317)
T cd06635         118 H---KKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPA-------NSFVGT  184 (317)
T ss_pred             h---cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccccCCc-------ccccCC
Confidence            2   34589999999999999999999984   5999999999999999999999999998754321       224688


Q ss_pred             ccccCccccc---cCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCC
Q 039626          509 KGYMAPEYLE---NGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNY  585 (628)
Q Consensus       509 ~~Y~APE~l~---~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~  585 (628)
                      ..|+|||++.   .+.++.++||||||++++||++|+.|+.....      ...........             .....
T Consensus       185 ~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~------~~~~~~~~~~~-------------~~~~~  245 (317)
T cd06635         185 PYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA------MSALYHIAQNE-------------SPTLQ  245 (317)
T ss_pred             ccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccH------HHHHHHHHhcc-------------CCCCC
Confidence            8999999874   46789999999999999999999988753211      11111111100             00011


Q ss_pred             CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 039626          586 PLELALLVIRLIDACLKKDPTDRPTMYEIEHSLS  619 (628)
Q Consensus       586 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~  619 (628)
                      .......+.+++.+||+.+|.+||++.++++.+.
T Consensus       246 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~  279 (317)
T cd06635         246 SNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMF  279 (317)
T ss_pred             CccccHHHHHHHHHHccCCcccCcCHHHHHhChh
Confidence            1233456789999999999999999999997543

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=99.97  E-value=1.7e-31  Score=273.60  Aligned_cols=244  Identities=26%  Similarity=0.362  Sum_probs=181.2

Q ss_pred             eEEEEEEE--CCceEEEEEecc---------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhc
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG---------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSN  429 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~---------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~  429 (628)
                      |.||+|..  +|..+|+|++..         .+.+|++++++++|+|++++++++.+++..+++|||+ +++|.+++...
T Consensus        13 ~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~-~~~l~~~~~~~   91 (283)
T cd07835          13 GVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL-DLDLKKYMDSS   91 (283)
T ss_pred             eEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc-CcCHHHHHhhC
Confidence            89999987  688999998752         3667999999999999999999999999999999999 57999998543


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCCc
Q 039626          430 KNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTK  509 (628)
Q Consensus       430 ~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~  509 (628)
                      .  ...+++..++.++.|+++||+|||+   .+++|+||+|+||++++++.++|+|||+++.......   ......++.
T Consensus        92 ~--~~~~~~~~~~~~~~~i~~~L~~lH~---~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~  163 (283)
T cd07835          92 P--LTGLDPPLIKSYLYQLLQGIAYCHS---HRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR---TYTHEVVTL  163 (283)
T ss_pred             C--CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc---ccCcccccc
Confidence            2  2458999999999999999999998   4599999999999999999999999999976532211   112335688


Q ss_pred             cccCccccccC-CCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccc-----------cchhhhcccc
Q 039626          510 GYMAPEYLENG-LVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKE-----------DGEESLRHFI  577 (628)
Q Consensus       510 ~Y~APE~l~~~-~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~l~~~~  577 (628)
                      .|+|||++.+. .++.++||||||+++|||++|+.|+.......  .+.+.........           +.........
T Consensus       164 ~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (283)
T cd07835         164 WYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEID--QLFRIFRTLGTPDEDVWPGVTSLPDYKPTFPKWA  241 (283)
T ss_pred             CCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCCChHHhhhhhhchhhhhhccccc
Confidence            99999988664 57899999999999999999999886432211  1111111110000           0000011110


Q ss_pred             CCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          578 DPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       578 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      ..... .........+.+++.+||+.||.+||+++|+++
T Consensus       242 ~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~  279 (283)
T cd07835         242 RQDLS-KVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ  279 (283)
T ss_pred             ccchh-hhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence            00000 111223356789999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=99.97  E-value=2.7e-31  Score=272.19  Aligned_cols=244  Identities=23%  Similarity=0.359  Sum_probs=180.7

Q ss_pred             eEEEEEEE--CCceEEEEEecc--------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhcC
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG--------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNK  430 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~--------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~  430 (628)
                      |.||+|+.  +|..+|+|+++.        .+.+|++++++++|+||+++++++.+.+..++||||++ |+|.+++....
T Consensus        14 ~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~   92 (284)
T cd07836          14 ATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMD-KDLKKYMDTHG   92 (284)
T ss_pred             eEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCC-ccHHHHHHhcC
Confidence            89999998  588999998753        34579999999999999999999999999999999997 48998885432


Q ss_pred             CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCCcc
Q 039626          431 NEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKG  510 (628)
Q Consensus       431 ~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~  510 (628)
                       ....+++..+..++.|++.||+|||+.   +++|+||||+||++++++.+||+|||+++.......   ......++..
T Consensus        93 -~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~---~~~~~~~~~~  165 (284)
T cd07836          93 -VRGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN---TFSNEVVTLW  165 (284)
T ss_pred             -CCCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc---cccccccccc
Confidence             234689999999999999999999984   599999999999999999999999999976533211   1123457889


Q ss_pred             ccCcccccc-CCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccC-CcCCCC----
Q 039626          511 YMAPEYLEN-GLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFID-PTLQGN----  584 (628)
Q Consensus       511 Y~APE~l~~-~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d-~~l~~~----  584 (628)
                      |++||.+.+ ..++.++||||||++++||++|+.|+......+  ....... ...... ...+..+.+ +.+...    
T Consensus       166 y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~--~~~~~~~-~~~~~~-~~~~~~~~~~~~~~~~~~~~  241 (284)
T cd07836         166 YRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNED--QLLKIFR-IMGTPT-ESTWPGISQLPEYKPTFPRY  241 (284)
T ss_pred             ccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHH--HHHHHHH-HhCCCC-hhhHHHHhcCchhcccccCC
Confidence            999998865 457899999999999999999999876432211  1111111 110000 000000000 000000    


Q ss_pred             -------CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          585 -------YPLELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       585 -------~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                             .....+..+.+++.+|++.||.+||++.|+++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  280 (284)
T cd07836         242 PPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ  280 (284)
T ss_pred             ChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence                   11123456789999999999999999999874

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=99.97  E-value=3e-31  Score=271.78  Aligned_cols=227  Identities=19%  Similarity=0.322  Sum_probs=174.8

Q ss_pred             ceEEEEEEE--CCceEEEEEeccc----------hHHHHH---HHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHH
Q 039626          360 QGSVYRGKI--NGGFAAIKKVNGD----------VSKEIA---LLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSD  424 (628)
Q Consensus       360 ~G~Vy~g~~--~g~~vavK~~~~~----------~~~E~~---~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~  424 (628)
                      .|.||++..  ++..+|+|.+...          +.+|..   ++...+|+||+.+.+++..++..++||||+++|+|.+
T Consensus         7 ~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~   86 (279)
T cd05633           7 FGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHY   86 (279)
T ss_pred             CeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCCCCCHHH
Confidence            389999988  5789999977431          223433   3334479999999999999999999999999999999


Q ss_pred             HhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeec
Q 039626          425 WVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRH  504 (628)
Q Consensus       425 ~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~  504 (628)
                      ++..    ...++|.....++.|++.||+|||+.   +++||||||+|||+++++.+||+|||++.......     ...
T Consensus        87 ~i~~----~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~-----~~~  154 (279)
T cd05633          87 HLSQ----HGVFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-----PHA  154 (279)
T ss_pred             HHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceeccccC-----ccC
Confidence            8853    34599999999999999999999984   49999999999999999999999999987553221     122


Q ss_pred             ccCCccccCcccccc-CCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCC
Q 039626          505 IVGTKGYMAPEYLEN-GLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQG  583 (628)
Q Consensus       505 ~~gt~~Y~APE~l~~-~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~  583 (628)
                      ..|+..|+|||.+.. ..++.++||||||++++||++|+.||........    ..+.....          ..+.    
T Consensus       155 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~----~~~~~~~~----------~~~~----  216 (279)
T cd05633         155 SVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK----HEIDRMTL----------TVNV----  216 (279)
T ss_pred             cCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCH----HHHHHHhh----------cCCc----
Confidence            468999999998864 5689999999999999999999999864322111    11111100          0111    


Q ss_pred             CCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 039626          584 NYPLELALLVIRLIDACLKKDPTDRP-----TMYEIEH  616 (628)
Q Consensus       584 ~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~ev~~  616 (628)
                      ..+...+..+.+++.+||+.||.+||     +++|+++
T Consensus       217 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~  254 (279)
T cd05633         217 ELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKE  254 (279)
T ss_pred             CCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHh
Confidence            12333455678999999999999999     5888765

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=99.97  E-value=4.7e-31  Score=271.10  Aligned_cols=227  Identities=24%  Similarity=0.403  Sum_probs=181.5

Q ss_pred             eEEEEEEE--CCceEEEEEecc-------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhcCC
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG-------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKN  431 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~-------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~  431 (628)
                      |.||++..  ++..+++|+...       .+.+|+.++++++|+||+++++++..++..++++||+++++|.+++..   
T Consensus        33 g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~---  109 (285)
T cd06648          33 GIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTH---  109 (285)
T ss_pred             eEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCCCHHHHHHh---
Confidence            89999986  678899998742       356799999999999999999999999999999999999999999843   


Q ss_pred             CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCCccc
Q 039626          432 EGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGY  511 (628)
Q Consensus       432 ~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~Y  511 (628)
                        ..+++..+..++.+++.||+|||+.   +++||||+|+||+++.++.++|+|||++........   ......|+..|
T Consensus       110 --~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~---~~~~~~~~~~y  181 (285)
T cd06648         110 --TRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP---RRKSLVGTPYW  181 (285)
T ss_pred             --CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccCCc---ccccccCCccc
Confidence              3489999999999999999999985   499999999999999999999999998875533211   12234688999


Q ss_pred             cCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCHHHHH
Q 039626          512 MAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELAL  591 (628)
Q Consensus       512 ~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~  591 (628)
                      +|||.+.+..++.++||||||++++||++|+.|+.....      .........          ...+...  .+...+.
T Consensus       182 ~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~------~~~~~~~~~----------~~~~~~~--~~~~~~~  243 (285)
T cd06648         182 MAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP------LQAMKRIRD----------NLPPKLK--NLHKVSP  243 (285)
T ss_pred             cCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCH------HHHHHHHHh----------cCCCCCc--ccccCCH
Confidence            999999888899999999999999999999998753211      111111111          0011111  1112345


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          592 LVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       592 ~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      .+.+++.+||+.+|++||++.++++
T Consensus       244 ~l~~li~~~l~~~p~~Rpt~~~il~  268 (285)
T cd06648         244 RLRSFLDRMLVRDPAQRATAAELLN  268 (285)
T ss_pred             HHHHHHHHHcccChhhCcCHHHHcc
Confidence            6889999999999999999999885

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=3.3e-31  Score=267.97  Aligned_cols=237  Identities=25%  Similarity=0.326  Sum_probs=182.0

Q ss_pred             eEEEEEEE--CCceEEEEEeccc----------hHHHHHH-HhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhh
Q 039626          361 GSVYRGKI--NGGFAAIKKVNGD----------VSKEIAL-LNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVF  427 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~~----------~~~E~~~-l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~  427 (628)
                      |.||++..  +|+.+|+|.+...          +..|..+ ....+|+|++++++++..++..++|+||+++++|.+++.
T Consensus        10 ~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~   89 (260)
T cd05611          10 GSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIK   89 (260)
T ss_pred             eeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCCCCHHHHHH
Confidence            89999988  6789999988531          2234333 345589999999999999999999999999999999985


Q ss_pred             hcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccC
Q 039626          428 SNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVG  507 (628)
Q Consensus       428 ~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~g  507 (628)
                      .    ...+++..+..++.|++.||.|||+.   +++|+||+|+||++++++.+||+|||+++....       .....+
T Consensus        90 ~----~~~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-------~~~~~~  155 (260)
T cd05611          90 T----LGGLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-------NKKFVG  155 (260)
T ss_pred             H----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceeccc-------cccCCC
Confidence            3    23588999999999999999999984   599999999999999999999999999875432       123468


Q ss_pred             CccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCH
Q 039626          508 TKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPL  587 (628)
Q Consensus       508 t~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~  587 (628)
                      +..|+|||.+.+..++.++||||||++++||++|..|+.....      ...........         .  ........
T Consensus       156 ~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~~---------~--~~~~~~~~  218 (260)
T cd05611         156 TPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETP------DAVFDNILSRR---------I--NWPEEVKE  218 (260)
T ss_pred             CcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCH------HHHHHHHHhcc---------c--CCCCcccc
Confidence            8899999999888899999999999999999999999863221      11111111000         0  00001111


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhccCC
Q 039626          588 ELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNASLNW  628 (628)
Q Consensus       588 ~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~~~~~~w  628 (628)
                      ..+..+.+++.+||+.||++||++.++.+.|+.-.=...+|
T Consensus       219 ~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~~~~~~  259 (260)
T cd05611         219 FCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKSINW  259 (260)
T ss_pred             cCCHHHHHHHHHHccCCHHHccCCCcHHHHHcChHhhcCCC
Confidence            23456889999999999999999887777666544455555

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=1.2e-31  Score=277.43  Aligned_cols=229  Identities=26%  Similarity=0.373  Sum_probs=181.3

Q ss_pred             eEEEEEEE-CCceEEEEEecc---------chHHHHHHHhhcC-CCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhc
Q 039626          361 GSVYRGKI-NGGFAAIKKVNG---------DVSKEIALLNKIN-HSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSN  429 (628)
Q Consensus       361 G~Vy~g~~-~g~~vavK~~~~---------~~~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~  429 (628)
                      .+||++.. +.+.+|+|++..         -+.+|+.+|.+|+ |.+||+|++|-..++.+|+||||= ..+|..+|...
T Consensus       375 SkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE~G-d~DL~kiL~k~  453 (677)
T KOG0596|consen  375 SKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVMECG-DIDLNKILKKK  453 (677)
T ss_pred             ceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEeecc-cccHHHHHHhc
Confidence            58999998 456778888753         3678999999995 899999999999999999999996 66999999542


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCCc
Q 039626          430 KNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTK  509 (628)
Q Consensus       430 ~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~  509 (628)
                        ......| .+..+..||+.++.++|.++   |||.||||.|+|+- .|++||+|||+|..+..+... ......+||+
T Consensus       454 --~~~~~~~-~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~DTTs-I~kdsQvGT~  525 (677)
T KOG0596|consen  454 --KSIDPDW-FLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLV-KGRLKLIDFGIANAIQPDTTS-IVKDSQVGTV  525 (677)
T ss_pred             --cCCCchH-HHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEE-eeeEEeeeechhcccCccccc-eeeccccCcc
Confidence              2233445 67789999999999999966   99999999999985 468999999999988755432 3345579999


Q ss_pred             cccCccccccC-----------CCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccC
Q 039626          510 GYMAPEYLENG-----------LVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFID  578 (628)
Q Consensus       510 ~Y~APE~l~~~-----------~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d  578 (628)
                      .||+||.+...           ++++++||||+||+||+|+-|+.||...        ...          ..++..+.|
T Consensus       526 NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~--------~n~----------~aKl~aI~~  587 (677)
T KOG0596|consen  526 NYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQI--------INQ----------IAKLHAITD  587 (677)
T ss_pred             cccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHH--------HHH----------HHHHHhhcC
Confidence            99999988532           3678999999999999999999998621        111          234455666


Q ss_pred             CcCCCCCCHHH-HHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          579 PTLQGNYPLEL-ALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       579 ~~l~~~~~~~~-~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      |...-+||.-- ..++.++|+.||.+||++||++.|+++
T Consensus       588 P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLq  626 (677)
T KOG0596|consen  588 PNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQ  626 (677)
T ss_pred             CCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence            65543443211 122889999999999999999999975

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=99.97  E-value=8.8e-31  Score=262.23  Aligned_cols=228  Identities=28%  Similarity=0.473  Sum_probs=183.3

Q ss_pred             eEEEEEEE--CCceEEEEEecc-------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhcCC
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG-------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKN  431 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~-------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~  431 (628)
                      |.||++..  ++..+++|+...       ++.+|++++++++|+|++++++++..++..++++||+++++|.+++...  
T Consensus        14 ~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~~--   91 (253)
T cd05122          14 GEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKST--   91 (253)
T ss_pred             eEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCCCcHHHHHhhc--
Confidence            89999998  478899998754       3667999999999999999999999999999999999999999998542  


Q ss_pred             CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCCccc
Q 039626          432 EGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGY  511 (628)
Q Consensus       432 ~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~Y  511 (628)
                       ...+++..+..++.+++.||.|||+   .+++|+||+|+||++++++.++|+|||.+........    .....++..|
T Consensus        92 -~~~~~~~~~~~i~~~i~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~----~~~~~~~~~~  163 (253)
T cd05122          92 -NQTLTESQIAYVCKELLKGLEYLHS---NGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA----RNTMVGTPYW  163 (253)
T ss_pred             -CCCCCHHHHHHHHHHHHHHHHHhhc---CCEecCCCCHHHEEEccCCeEEEeecccccccccccc----ccceecCCcc
Confidence             2468999999999999999999998   4599999999999999999999999999887654321    2345688999


Q ss_pred             cCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCHHHHH
Q 039626          512 MAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELAL  591 (628)
Q Consensus       512 ~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~  591 (628)
                      +|||++.+...+.++||||||++++||++|+.|+......      ........ .    ..     +...  .+.....
T Consensus       164 ~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~-~----~~-----~~~~--~~~~~~~  225 (253)
T cd05122         164 MAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPM------KALFKIAT-N----GP-----PGLR--NPEKWSD  225 (253)
T ss_pred             cCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchH------HHHHHHHh-c----CC-----CCcC--cccccCH
Confidence            9999999888999999999999999999999887632211      11111100 0    00     0000  0111245


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          592 LVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       592 ~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      .+.+++.+||+.||.+||++.|+++
T Consensus       226 ~~~~~i~~~l~~~p~~R~t~~~~l~  250 (253)
T cd05122         226 EFKDFLKKCLQKNPEKRPTAEQLLK  250 (253)
T ss_pred             HHHHHHHHHccCChhhCCCHHHHhc
Confidence            6889999999999999999999875

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=99.97  E-value=6.1e-31  Score=264.63  Aligned_cols=230  Identities=28%  Similarity=0.454  Sum_probs=187.5

Q ss_pred             eEEEEEEEC--CceEEEEEecc---------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhc
Q 039626          361 GSVYRGKIN--GGFAAIKKVNG---------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSN  429 (628)
Q Consensus       361 G~Vy~g~~~--g~~vavK~~~~---------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~  429 (628)
                      |.||++...  +..+++|++..         ++.+|++++++++|+|++++.+.+..++..++|+||+++++|.+++...
T Consensus        14 ~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~   93 (258)
T cd08215          14 GKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQ   93 (258)
T ss_pred             eEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEecCCCcHHHHHHHh
Confidence            899999984  88999998863         2567999999999999999999999999999999999999999999765


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCCc
Q 039626          430 KNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTK  509 (628)
Q Consensus       430 ~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~  509 (628)
                      ...+..+++..+..++.+++.||.|||+.   +++|+||+|+||++++++.++|+|||++.......   .......|++
T Consensus        94 ~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~  167 (258)
T cd08215          94 KKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV---DLAKTVVGTP  167 (258)
T ss_pred             hccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeecccCc---ceecceeeee
Confidence            43456799999999999999999999985   59999999999999999999999999998764432   1233346888


Q ss_pred             cccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCHHH
Q 039626          510 GYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLEL  589 (628)
Q Consensus       510 ~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~  589 (628)
                      .|+|||.+.+..++.++|+||+|++++||++|+.|+....      ..+.........          .+    ..+...
T Consensus       168 ~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~------~~~~~~~~~~~~----------~~----~~~~~~  227 (258)
T cd08215         168 YYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN------LLELALKILKGQ----------YP----PIPSQY  227 (258)
T ss_pred             cccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCc------HHHHHHHHhcCC----------CC----CCCCCC
Confidence            9999999998889999999999999999999998875322      112221111100          01    112233


Q ss_pred             HHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          590 ALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       590 ~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      ...+.+++.+||..+|.+||++.|+++
T Consensus       228 ~~~~~~~i~~~l~~~p~~Rp~~~~ll~  254 (258)
T cd08215         228 SSELRNLVSSLLQKDPEERPSIAQILQ  254 (258)
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            456789999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=99.97  E-value=1.8e-31  Score=280.82  Aligned_cols=254  Identities=24%  Similarity=0.345  Sum_probs=182.6

Q ss_pred             cCCCcCCccc----eEEEEEEE--CCceEEEEEecc--------chHHHHHHHhhcCCCceeeeeeeeecC-----CeEE
Q 039626          351 DNFSFTCRIQ----GSVYRGKI--NGGFAAIKKVNG--------DVSKEIALLNKINHSNLIILSGVCFNE-----GNCY  411 (628)
Q Consensus       351 ~~f~~~~~i~----G~Vy~g~~--~g~~vavK~~~~--------~~~~E~~~l~~l~H~nIv~l~g~~~~~-----~~~~  411 (628)
                      ++|.....+|    |.||+|+.  +|+.||+|+++.        .+.+|+.++++++|+||+++++++...     ...+
T Consensus         5 ~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   84 (336)
T cd07849           5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVY   84 (336)
T ss_pred             cceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEE
Confidence            3444444443    89999987  688999998752        256799999999999999999987644     3579


Q ss_pred             EEEEecCCCChHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEcccccccc
Q 039626          412 LVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARP  491 (628)
Q Consensus       412 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~  491 (628)
                      +|+||+. ++|.+++.     ...+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||+++.
T Consensus        85 lv~e~~~-~~l~~~~~-----~~~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~  155 (336)
T cd07849          85 IVQELME-TDLYKLIK-----TQHLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLARI  155 (336)
T ss_pred             EEehhcc-cCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECcccceee
Confidence            9999996 58887773     23589999999999999999999994   499999999999999999999999999886


Q ss_pred             CCCCCCcceeeecccCCccccCcccccc-CCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccch
Q 039626          492 AEGQEGEFALTRHIVGTKGYMAPEYLEN-GLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGE  570 (628)
Q Consensus       492 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  570 (628)
                      ...............|+..|+|||.+.+ ..++.++||||||++++||++|+.|+......   .....+...+.... .
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~---~~~~~~~~~~~~~~-~  231 (336)
T cd07849         156 ADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYL---HQLNLILGVLGTPS-Q  231 (336)
T ss_pred             ccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHcCCCC-H
Confidence            5432221112233568999999998754 56899999999999999999999988542211   11111111111111 0


Q ss_pred             hhhccccCCcC---------CCCCC-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 039626          571 ESLRHFIDPTL---------QGNYP-----LELALLVIRLIDACLKKDPTDRPTMYEIEHS  617 (628)
Q Consensus       571 ~~l~~~~d~~l---------~~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~  617 (628)
                      +.+....+...         ....+     ......+.+++.+||+.||++||++.|+++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h  292 (336)
T cd07849         232 EDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH  292 (336)
T ss_pred             HHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            11111111000         00000     1124568899999999999999999999874

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=99.97  E-value=6.1e-31  Score=268.94  Aligned_cols=228  Identities=25%  Similarity=0.340  Sum_probs=179.6

Q ss_pred             ceEEEEEEE--CCceEEEEEecc----------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhh
Q 039626          360 QGSVYRGKI--NGGFAAIKKVNG----------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVF  427 (628)
Q Consensus       360 ~G~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~  427 (628)
                      .|.||++..  +|+.+|+|.+..          .+..|++++++++|+||+++.+++..++..++||||+++++|.+++.
T Consensus         6 ~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~   85 (277)
T cd05577           6 FGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDLKYHIY   85 (277)
T ss_pred             ceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcHHHHHH
Confidence            389999987  588999998743          24579999999999999999999999999999999999999999996


Q ss_pred             hcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccC
Q 039626          428 SNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVG  507 (628)
Q Consensus       428 ~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~g  507 (628)
                      ...  ...+++..+..++.|++.||.|||+.   +++|+||+|+||++++++.+||+|||+++......    ......+
T Consensus        86 ~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~----~~~~~~~  156 (277)
T cd05577          86 NVG--EPGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK----KIKGRAG  156 (277)
T ss_pred             HcC--cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhccCC----ccccccC
Confidence            432  24689999999999999999999984   59999999999999999999999999987654311    1223467


Q ss_pred             CccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCH
Q 039626          508 TKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPL  587 (628)
Q Consensus       508 t~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~  587 (628)
                      +..|+|||++.+..++.++||||||++++||++|+.|+........   .+.+.....              ......+.
T Consensus       157 ~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~~~~~~~~~--------------~~~~~~~~  219 (277)
T cd05577         157 TPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVE---KEELKRRTL--------------EMAVEYPD  219 (277)
T ss_pred             CCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCccccc---HHHHHhccc--------------cccccCCc
Confidence            8899999999888899999999999999999999999864332110   111110000              00112223


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCCHHH
Q 039626          588 ELALLVIRLIDACLKKDPTDRPTMYE  613 (628)
Q Consensus       588 ~~~~~l~~l~~~Cl~~dP~~RPs~~e  613 (628)
                      .....+.+++.+||+.||.+||+.+|
T Consensus       220 ~~~~~~~~li~~~l~~~p~~R~~~~~  245 (277)
T cd05577         220 KFSPEAKDLCEALLQKDPEKRLGCRG  245 (277)
T ss_pred             cCCHHHHHHHHHHccCChhHccCCCc
Confidence            34556789999999999999995444

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.97  E-value=5.4e-33  Score=311.04  Aligned_cols=230  Identities=27%  Similarity=0.396  Sum_probs=185.2

Q ss_pred             eEEEEEEE--CCceEEEEEecc---------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhc
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG---------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSN  429 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~---------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~  429 (628)
                      |.||-+..  +|+..|+|.++-         ...+|+.+|..|+|||+|+++|+-.+++..+|.||||++|+|.+.+.. 
T Consensus      1249 G~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~GsLa~ll~~- 1327 (1509)
T KOG4645|consen 1249 GKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCEGGSLASLLEH- 1327 (1509)
T ss_pred             eeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHhccCcHHHHHHh-
Confidence            89999987  788889987653         467899999999999999999999999999999999999999999843 


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCc-ceeeecccCC
Q 039626          430 KNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGE-FALTRHIVGT  508 (628)
Q Consensus       430 ~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~~~gt  508 (628)
                         ++-+++....-+..|++.|+.|||+++   ||||||||.||+|+.+|.+|++|||.|..+...... ..-..+..||
T Consensus      1328 ---gri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~el~~~~GT 1401 (1509)
T KOG4645|consen 1328 ---GRIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGELQSMMGT 1401 (1509)
T ss_pred             ---cchhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEecCchhcCCHHHHhhcCC
Confidence               334566666678899999999999966   999999999999999999999999999988654311 1122457899


Q ss_pred             ccccCccccccC---CCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCC
Q 039626          509 KGYMAPEYLENG---LVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNY  585 (628)
Q Consensus       509 ~~Y~APE~l~~~---~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~  585 (628)
                      +-|||||.+.+.   .-..+.||||+|||++||+||++||...+.     -+.....+....              ....
T Consensus      1402 ~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn-----e~aIMy~V~~gh--------------~Pq~ 1462 (1509)
T KOG4645|consen 1402 PMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN-----EWAIMYHVAAGH--------------KPQI 1462 (1509)
T ss_pred             chhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc-----hhHHHhHHhccC--------------CCCC
Confidence            999999999764   345689999999999999999999974332     122333322211              1234


Q ss_pred             CHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          586 PLELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       586 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      |...+.+-.+++.+||+.||++|-++.|+++
T Consensus      1463 P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle 1493 (1509)
T KOG4645|consen 1463 PERLSSEGRDFLEHCLEQDPKMRWTASQLLE 1493 (1509)
T ss_pred             chhhhHhHHHHHHHHHhcCchhhhHHHHHHH
Confidence            5556777789999999999999988877664

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=99.97  E-value=3.6e-31  Score=272.15  Aligned_cols=242  Identities=22%  Similarity=0.372  Sum_probs=189.4

Q ss_pred             eEEEEEEE-----CCceEEEEEecc-----------chHHHHHHHhhc-CCCceeeeeeeeecCCeEEEEEEecCCCChH
Q 039626          361 GSVYRGKI-----NGGFAAIKKVNG-----------DVSKEIALLNKI-NHSNLIILSGVCFNEGNCYLVYEYAVNGTLS  423 (628)
Q Consensus       361 G~Vy~g~~-----~g~~vavK~~~~-----------~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~  423 (628)
                      |.||+++.     ++..+|+|.++.           .+.+|++++.++ +|+||+++.+.+..+...++||||+++|+|.
T Consensus        14 ~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   93 (288)
T cd05583          14 GKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELF   93 (288)
T ss_pred             ceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEEEEEecCCCCcHH
Confidence            89999875     457899998753           245799999999 5999999999999899999999999999999


Q ss_pred             HHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeee
Q 039626          424 DWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTR  503 (628)
Q Consensus       424 ~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~  503 (628)
                      +++..    ...+++.....++.|+++||.|||+   .+++|+||||+||+++.++.++|+|||+++........  ...
T Consensus        94 ~~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~---~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~--~~~  164 (288)
T cd05583          94 THLYQ----REHFTESEVRVYIAEIVLALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEE--RAY  164 (288)
T ss_pred             HHHhh----cCCcCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEEECcccccccccccc--ccc
Confidence            99853    2458899999999999999999998   45999999999999999999999999998765432211  122


Q ss_pred             cccCCccccCccccccCC--CCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcC
Q 039626          504 HIVGTKGYMAPEYLENGL--VSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTL  581 (628)
Q Consensus       504 ~~~gt~~Y~APE~l~~~~--~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l  581 (628)
                      ...|+..|+|||.+.+..  .+.++||||||++++||++|+.|+......  ....+........           .+  
T Consensus       165 ~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~--~~~~~~~~~~~~~-----------~~--  229 (288)
T cd05583         165 SFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQ--NSQSEISRRILKS-----------KP--  229 (288)
T ss_pred             cccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCccc--chHHHHHHHHHcc-----------CC--
Confidence            346889999999987655  788999999999999999999987532211  1111111111110           01  


Q ss_pred             CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhccCC
Q 039626          582 QGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNASLNW  628 (628)
Q Consensus       582 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~~~~~~w  628 (628)
                        ..+......+.+++.+||+.||++|||++++.+.|+...-.+.+|
T Consensus       230 --~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~~  274 (288)
T cd05583         230 --PFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGIDW  274 (288)
T ss_pred             --CCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCCH
Confidence              112233456789999999999999999999999988877777766

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=99.97  E-value=1.7e-31  Score=269.81  Aligned_cols=226  Identities=29%  Similarity=0.362  Sum_probs=181.9

Q ss_pred             eEEEEEEE--CCceEEEEEecc----------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhh
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG----------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFS  428 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  428 (628)
                      |.||++..  .++.+|+|....          .+.+|++++++++||||+++++++.++...++|+||+++++|.+++..
T Consensus        14 ~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   93 (258)
T cd05578          14 GKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQ   93 (258)
T ss_pred             ceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeCCCCCCHHHHHHh
Confidence            89999998  488999998753          356799999999999999999999999999999999999999999843


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCC
Q 039626          429 NKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGT  508 (628)
Q Consensus       429 ~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt  508 (628)
                      .    ..+++.....++.++++||.|||+.   +++|+||+|+||++++++.++|+|||++.......    ......|+
T Consensus        94 ~----~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~----~~~~~~~~  162 (258)
T cd05578          94 K----VKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT----LTTSTSGT  162 (258)
T ss_pred             c----CCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccCCCc----cccccCCC
Confidence            2    4689999999999999999999984   59999999999999999999999999988664322    12234688


Q ss_pred             ccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCHH
Q 039626          509 KGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLE  588 (628)
Q Consensus       509 ~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~  588 (628)
                      ..|+|||.+.+..++.++|+||||++++||++|+.|+.......    .+........              .....+..
T Consensus       163 ~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~----~~~~~~~~~~--------------~~~~~~~~  224 (258)
T cd05578         163 PGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTI----RDQIRAKQET--------------ADVLYPAT  224 (258)
T ss_pred             hhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccH----HHHHHHHhcc--------------ccccCccc
Confidence            89999999998889999999999999999999999987433211    1111111100              01122223


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCH--HHHH
Q 039626          589 LALLVIRLIDACLKKDPTDRPTM--YEIE  615 (628)
Q Consensus       589 ~~~~l~~l~~~Cl~~dP~~RPs~--~ev~  615 (628)
                      .+..+.+++.+||+.||.+||++  +|++
T Consensus       225 ~~~~~~~~i~~~l~~~p~~R~~~~~~~l~  253 (258)
T cd05578         225 WSTEAIDAINKLLERDPQKRLGDNLKDLK  253 (258)
T ss_pred             CcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence            44678899999999999999999  5543

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=99.97  E-value=1.1e-30  Score=267.35  Aligned_cols=241  Identities=24%  Similarity=0.321  Sum_probs=177.7

Q ss_pred             eEEEEEEE--CCceEEEEEeccc--------hHHHHHHHhhcC-CCceeeeeeeeecC--CeEEEEEEecCCCChHHHhh
Q 039626          361 GSVYRGKI--NGGFAAIKKVNGD--------VSKEIALLNKIN-HSNLIILSGVCFNE--GNCYLVYEYAVNGTLSDWVF  427 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~~--------~~~E~~~l~~l~-H~nIv~l~g~~~~~--~~~~lV~E~~~~gsL~~~l~  427 (628)
                      |.||+|+.  ++..+|+|+.+..        ..+|+.++.++. |+|++++++++.++  +..++|+||++ |+|.+++.
T Consensus        13 ~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~   91 (282)
T cd07831          13 SEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFELMD-MNLYELIK   91 (282)
T ss_pred             ceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEecCC-ccHHHHHH
Confidence            89999987  6789999987642        236888899885 99999999999987  88999999996 68888875


Q ss_pred             hcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccC
Q 039626          428 SNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVG  507 (628)
Q Consensus       428 ~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~g  507 (628)
                      ..   ...++|..+..++.|++.||+|||+.   +++||||||+||+++. +.+||+|||+++.......    .....+
T Consensus        92 ~~---~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~----~~~~~~  160 (282)
T cd07831          92 GR---KRPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP----YTEYIS  160 (282)
T ss_pred             hc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEecccccccccCCC----cCCCCC
Confidence            32   24689999999999999999999984   5999999999999999 9999999999987643221    122457


Q ss_pred             CccccCccccc-cCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccch--hh-----hccccCC
Q 039626          508 TKGYMAPEYLE-NGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGE--ES-----LRHFIDP  579 (628)
Q Consensus       508 t~~Y~APE~l~-~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--~~-----l~~~~d~  579 (628)
                      +..|+|||++. +..++.++|||||||+++||++|+.|+......+   ...............  ..     ...+..+
T Consensus       161 ~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (282)
T cd07831         161 TRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELD---QIAKIHDVLGTPDAEVLKKFRKSRHMNYNFP  237 (282)
T ss_pred             CcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHH---HHHHHHHHcCCCCHHHHHhhcccccccccCc
Confidence            88999999765 4567899999999999999999999886432211   111111111110000  00     0000000


Q ss_pred             cCCC----CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          580 TLQG----NYPLELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       580 ~l~~----~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      ....    ......+..+.+++.+||+.+|++||+++++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  278 (282)
T cd07831         238 SKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR  278 (282)
T ss_pred             ccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence            0000    001134567899999999999999999999875

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=99.97  E-value=1.3e-30  Score=262.22  Aligned_cols=230  Identities=29%  Similarity=0.401  Sum_probs=186.0

Q ss_pred             eEEEEEEEC--CceEEEEEecc---------chHHHHHHHhhcCCCceeeeeeeeecC--CeEEEEEEecCCCChHHHhh
Q 039626          361 GSVYRGKIN--GGFAAIKKVNG---------DVSKEIALLNKINHSNLIILSGVCFNE--GNCYLVYEYAVNGTLSDWVF  427 (628)
Q Consensus       361 G~Vy~g~~~--g~~vavK~~~~---------~~~~E~~~l~~l~H~nIv~l~g~~~~~--~~~~lV~E~~~~gsL~~~l~  427 (628)
                      |.||+|+..  +..+++|+...         .+.+|++++++++|+||+++++.+...  ...++++||+++++|.+++.
T Consensus        14 ~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~   93 (260)
T cd06606          14 GSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLK   93 (260)
T ss_pred             eEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEEecCCCcHHHHHH
Confidence            899999984  88899998753         356799999999999999999999988  88999999999999999985


Q ss_pred             hcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccC
Q 039626          428 SNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVG  507 (628)
Q Consensus       428 ~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~g  507 (628)
                      ..    ..++|..+..++.+++.||+|||+   .+++|+||+|+||+++.++.+||+|||.+......... .......+
T Consensus        94 ~~----~~~~~~~~~~~~~~l~~~l~~lh~---~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~  165 (260)
T cd06606          94 KF----GKLPEPVIRKYTRQILEGLAYLHS---NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETG-EGTGSVRG  165 (260)
T ss_pred             Hc----CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEcccccEEeccccccc-ccccCCCC
Confidence            42    269999999999999999999999   45999999999999999999999999998876543211 01233568


Q ss_pred             CccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCH
Q 039626          508 TKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPL  587 (628)
Q Consensus       508 t~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~  587 (628)
                      +..|+|||.+.+...+.++||||||++++||++|+.|+.....     ........             .........+.
T Consensus       166 ~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~-------------~~~~~~~~~~~  227 (260)
T cd06606         166 TPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGN-----PMAALYKI-------------GSSGEPPEIPE  227 (260)
T ss_pred             CccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc-----hHHHHHhc-------------cccCCCcCCCc
Confidence            8899999999988899999999999999999999999864331     11111111             11111122333


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          588 ELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       588 ~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      .....+.+++.+|++.||.+||++.|++.
T Consensus       228 ~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~  256 (260)
T cd06606         228 HLSEEAKDFLRKCLRRDPKKRPTADELLQ  256 (260)
T ss_pred             ccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence            44567899999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=99.97  E-value=1.2e-30  Score=265.40  Aligned_cols=225  Identities=23%  Similarity=0.264  Sum_probs=175.4

Q ss_pred             eEEEEEEE--CCceEEEEEeccchH--HHHHHHhhc-CCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhcCCCCCC
Q 039626          361 GSVYRGKI--NGGFAAIKKVNGDVS--KEIALLNKI-NHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKY  435 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~~~~--~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~  435 (628)
                      |.||++..  ++..+|+|.......  .|+.....+ +|+||+++++.+..++..++||||+++|+|.+++...    ..
T Consensus        30 g~v~~~~~~~~~~~~~~k~~~~~~~~~~e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~----~~  105 (267)
T PHA03390         30 GKVSVLKHKPTQKLFVQKIIKAKNFNAIEPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKE----GK  105 (267)
T ss_pred             eEEEEEEEcCCCcEEEEEEEehhhcchhhHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEcCCCCcHHHHHHhc----CC
Confidence            89999987  677889998865322  234333323 7999999999999999999999999999999999532    36


Q ss_pred             CCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCC-cEEEccccccccCCCCCCcceeeecccCCccccCc
Q 039626          436 LDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDL-RAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAP  514 (628)
Q Consensus       436 l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~-~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~Y~AP  514 (628)
                      ++|..+..++.|+++||.|||+.   +++||||||+||+++.++ .++|+|||+++.....       ....++..|+||
T Consensus       106 l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~-------~~~~~~~~y~aP  175 (267)
T PHA03390        106 LSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP-------SCYDGTLDYFSP  175 (267)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC-------ccCCCCCcccCh
Confidence            99999999999999999999985   499999999999999998 9999999998765422       123588999999


Q ss_pred             cccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCHHHHHHHH
Q 039626          515 EYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVI  594 (628)
Q Consensus       515 E~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~  594 (628)
                      |++.+..++.++||||||++++||++|+.|+....... ....++.... .             .  ....+...+..+.
T Consensus       176 E~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~-~-------------~--~~~~~~~~~~~~~  238 (267)
T PHA03390        176 EKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE-LDLESLLKRQ-Q-------------K--KLPFIKNVSKNAN  238 (267)
T ss_pred             hhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch-hhHHHHHHhh-c-------------c--cCCcccccCHHHH
Confidence            99999899999999999999999999999987332211 1111111111 0             0  0011223455688


Q ss_pred             HHHHHhcccCCCCCCC-HHHHHH
Q 039626          595 RLIDACLKKDPTDRPT-MYEIEH  616 (628)
Q Consensus       595 ~l~~~Cl~~dP~~RPs-~~ev~~  616 (628)
                      +++.+||+.||.+||+ ++|+++
T Consensus       239 ~li~~~l~~~p~~R~~~~~~~l~  261 (267)
T PHA03390        239 DFVQSMLKYNINYRLTNYNEIIK  261 (267)
T ss_pred             HHHHHHhccChhhCCchHHHHhc
Confidence            9999999999999995 688763

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=99.97  E-value=2e-30  Score=272.01  Aligned_cols=246  Identities=17%  Similarity=0.286  Sum_probs=180.9

Q ss_pred             eEEEEEEE--CCceEEEEEecc---------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhc
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG---------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSN  429 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~---------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~  429 (628)
                      |.||+++.  .|+.||+|....         .+.+|+.+++.++|+||+++++++..++..++|+||+.+|+|.+++...
T Consensus        14 ~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~   93 (328)
T cd08226          14 TSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTY   93 (328)
T ss_pred             eeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCCCHHHHHHhh
Confidence            78999987  789999998752         2567899999999999999999999999999999999999999998653


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCc----ceeeecc
Q 039626          430 KNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGE----FALTRHI  505 (628)
Q Consensus       430 ~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~----~~~~~~~  505 (628)
                      .  ...+++..+..++.|++.||+|||+   .+++||||||+||+++.++.+|++||+.+.........    .......
T Consensus        94 ~--~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  168 (328)
T cd08226          94 F--PEGMSEALIGNILFGALRGLNYLHQ---NGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFS  168 (328)
T ss_pred             c--ccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccccccccccc
Confidence            2  2358999999999999999999998   45999999999999999999999999865433211100    0001112


Q ss_pred             cCCccccCccccccC--CCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhcccc---------------
Q 039626          506 VGTKGYMAPEYLENG--LVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKED---------------  568 (628)
Q Consensus       506 ~gt~~Y~APE~l~~~--~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~---------------  568 (628)
                      .++..|+|||++.+.  .++.++||||||++++||++|+.|+.......     ...........               
T Consensus       169 ~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (328)
T cd08226         169 TSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQ-----MLLQKLKGPPYSPLDITTFPCEESRM  243 (328)
T ss_pred             cCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHH-----HHHHHhcCCCCCCccccccchhhhhh
Confidence            356679999999763  57899999999999999999999986432110     00000000000               


Q ss_pred             -----------chhhhc-----cccCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          569 -----------GEESLR-----HFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       569 -----------~~~~l~-----~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                                 ....+.     ...+..+....+......+.+|+++||+.||++|||++|+++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~  307 (328)
T cd08226         244 KNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS  307 (328)
T ss_pred             ccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence                       000000     111112222233456678899999999999999999999974

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=99.97  E-value=8.3e-31  Score=268.53  Aligned_cols=243  Identities=26%  Similarity=0.370  Sum_probs=180.8

Q ss_pred             eEEEEEEE--CCceEEEEEeccc---------hHHHHHHHhhcCCCceeeeeeeeecC--CeEEEEEEecCCCChHHHhh
Q 039626          361 GSVYRGKI--NGGFAAIKKVNGD---------VSKEIALLNKINHSNLIILSGVCFNE--GNCYLVYEYAVNGTLSDWVF  427 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~~---------~~~E~~~l~~l~H~nIv~l~g~~~~~--~~~~lV~E~~~~gsL~~~l~  427 (628)
                      |.||+|+.  +++.+|+|++...         +.+|++++++++|+|++++++++...  +..++|+||++ ++|.+++.
T Consensus        13 ~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~   91 (287)
T cd07840          13 GQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMD-HDLTGLLD   91 (287)
T ss_pred             eEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEecccc-ccHHHHHh
Confidence            89999998  4689999998642         56799999999999999999999988  78999999997 48988884


Q ss_pred             hcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccC
Q 039626          428 SNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVG  507 (628)
Q Consensus       428 ~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~g  507 (628)
                      ..   ...+++..++.++.+++.||+|||+.   +++|+||+|+||++++++.+||+|||++.........  ......+
T Consensus        92 ~~---~~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~--~~~~~~~  163 (287)
T cd07840          92 SP---EVKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSA--DYTNRVI  163 (287)
T ss_pred             cc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccCCCcc--ccccccc
Confidence            32   24689999999999999999999985   4999999999999999999999999999876543211  1223456


Q ss_pred             CccccCcccccc-CCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccC--------
Q 039626          508 TKGYMAPEYLEN-GLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFID--------  578 (628)
Q Consensus       508 t~~Y~APE~l~~-~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d--------  578 (628)
                      +..|+|||.+.+ ..++.++||||||++++||++|+.|+.......   ....+........ ......+.+        
T Consensus       164 ~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~---~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~  239 (287)
T cd07840         164 TLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELE---QLEKIFELCGSPT-DENWPGVSKLPWFENLK  239 (287)
T ss_pred             ccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHHhCCCc-hhhccccccchhhhhcc
Confidence            888999998765 467999999999999999999999886433211   1111111111000 000000000        


Q ss_pred             ------CcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          579 ------PTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       579 ------~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                            ..+...+...++..+.+++.+||..+|.+||+++++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  283 (287)
T cd07840         240 PKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ  283 (287)
T ss_pred             ccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence                  00000011112567889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=99.97  E-value=5.2e-31  Score=271.78  Aligned_cols=243  Identities=27%  Similarity=0.357  Sum_probs=177.0

Q ss_pred             eEEEEEEE--CCceEEEEEecc---------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhc
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG---------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSN  429 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~---------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~  429 (628)
                      |.||+|+.  +|+.+|+|+...         .+.+|++++++++|+||+++++++.++...++||||++ ++|.+++...
T Consensus        16 ~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~   94 (294)
T PLN00009         16 GVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYLD-LDLKKHMDSS   94 (294)
T ss_pred             EEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEeccc-ccHHHHHHhC
Confidence            89999997  578899998742         35689999999999999999999999999999999995 5888887432


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCC-CCcEEEccccccccCCCCCCcceeeecccCC
Q 039626          430 KNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDS-DLRAKIANFAMARPAEGQEGEFALTRHIVGT  508 (628)
Q Consensus       430 ~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~-~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt  508 (628)
                        ....+++.....++.|++.||+|||+   .+++|+||+|+||++++ ++.+||+|||++........   ......++
T Consensus        95 --~~~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~  166 (294)
T PLN00009         95 --PDFAKNPRLIKTYLYQILRGIAYCHS---HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR---TFTHEVVT  166 (294)
T ss_pred             --CCCCcCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCcceEEEECCCCEEEEcccccccccCCCcc---ccccCcee
Confidence              23346788888999999999999998   45999999999999985 56799999999976543211   11234678


Q ss_pred             ccccCcccccc-CCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhh------hccccC--C
Q 039626          509 KGYMAPEYLEN-GLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEES------LRHFID--P  579 (628)
Q Consensus       509 ~~Y~APE~l~~-~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~------l~~~~d--~  579 (628)
                      +.|+|||++.+ ..++.++||||||++++||++|+.|+......+  ...+.. ....... ...      +..+..  +
T Consensus       167 ~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~--~~~~~~-~~~~~~~-~~~~~~~~~~~~~~~~~~  242 (294)
T PLN00009        167 LWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEID--ELFKIF-RILGTPN-EETWPGVTSLPDYKSAFP  242 (294)
T ss_pred             ecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHH-HHhCCCC-hhhccccccchhhhhhcc
Confidence            89999998876 457899999999999999999999886432211  111111 1100000 000      000000  0


Q ss_pred             cCCC----CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          580 TLQG----NYPLELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       580 ~l~~----~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      ....    ......+..+.+++.+|++.+|++||++.++++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~  283 (294)
T PLN00009        243 KWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE  283 (294)
T ss_pred             cCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence            0000    001123455789999999999999999999985

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=99.97  E-value=5.1e-31  Score=273.48  Aligned_cols=246  Identities=22%  Similarity=0.316  Sum_probs=176.4

Q ss_pred             eEEEEEEE--CCceEEEEEecc---------chHHHHHHHhhcCCCceeeeeeeeecCC--------eEEEEEEecCCCC
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG---------DVSKEIALLNKINHSNLIILSGVCFNEG--------NCYLVYEYAVNGT  421 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~---------~~~~E~~~l~~l~H~nIv~l~g~~~~~~--------~~~lV~E~~~~gs  421 (628)
                      |.||+++.  +++.+|+|++..         .+.+|++++++++|+||++++++|...+        ..++||||+. ++
T Consensus        26 ~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~  104 (310)
T cd07865          26 GEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCE-HD  104 (310)
T ss_pred             EEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCceEEEEEcCCC-cC
Confidence            89999998  688999998743         2357999999999999999999987653        4599999995 58


Q ss_pred             hHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcc-e
Q 039626          422 LSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEF-A  500 (628)
Q Consensus       422 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~-~  500 (628)
                      |.+++..   ....+++.....++.|++.||+|||+.   +++|+||||+||+++.++.+||+|||++.......... .
T Consensus       105 l~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  178 (310)
T cd07865         105 LAGLLSN---KNVKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPN  178 (310)
T ss_pred             HHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECcCCCcccccCCcccCCC
Confidence            8888743   233589999999999999999999985   59999999999999999999999999998664322111 1


Q ss_pred             eeecccCCccccCccccccC-CCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccc-----hhhhc
Q 039626          501 LTRHIVGTKGYMAPEYLENG-LVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDG-----EESLR  574 (628)
Q Consensus       501 ~~~~~~gt~~Y~APE~l~~~-~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~l~  574 (628)
                      ......++..|+|||.+.+. .++.++||||||++++||++|+.|+.......   ....+..+......     ...+.
T Consensus       179 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~  255 (310)
T cd07865         179 RYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQH---QLTLISQLCGSITPEVWPGVDKLE  255 (310)
T ss_pred             CccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCCChhhcccccchh
Confidence            12234678899999988664 47899999999999999999998876433211   11222221110000     00000


Q ss_pred             cccCCcCCCCC---------CHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          575 HFIDPTLQGNY---------PLELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       575 ~~~d~~l~~~~---------~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      .+-........         +......+.+++.+||..||.+||+++|+++
T Consensus       256 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~  306 (310)
T cd07865         256 LFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN  306 (310)
T ss_pred             hhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence            00000000000         0011235678999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=99.97  E-value=1.1e-30  Score=267.27  Aligned_cols=226  Identities=20%  Similarity=0.330  Sum_probs=175.2

Q ss_pred             eEEEEEEE--CCceEEEEEeccc----------hHHHH---HHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHH
Q 039626          361 GSVYRGKI--NGGFAAIKKVNGD----------VSKEI---ALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDW  425 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~~----------~~~E~---~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~  425 (628)
                      |.||++..  +++.+|+|.+...          +..|.   .+++..+|+||+++.+++.+++..++||||+++|+|.++
T Consensus         8 g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~g~~L~~~   87 (278)
T cd05606           8 GEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYH   87 (278)
T ss_pred             eEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCCCCcHHHH
Confidence            89999987  5789999987531          22333   344456899999999999999999999999999999998


Q ss_pred             hhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecc
Q 039626          426 VFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHI  505 (628)
Q Consensus       426 l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~  505 (628)
                      +..    ...++|..+..++.|++.||+|||+.   +++||||||+||++++++.+||+|||+++......     ....
T Consensus        88 l~~----~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~-----~~~~  155 (278)
T cd05606          88 LSQ----HGVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-----PHAS  155 (278)
T ss_pred             HHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCccC-----CcCc
Confidence            843    34699999999999999999999984   59999999999999999999999999987653221     1234


Q ss_pred             cCCccccCccccccC-CCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCC
Q 039626          506 VGTKGYMAPEYLENG-LVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGN  584 (628)
Q Consensus       506 ~gt~~Y~APE~l~~~-~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~  584 (628)
                      .|+..|+|||.+.++ .++.++||||||++++||++|+.|+.........   . .....          ...++.    
T Consensus       156 ~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~---~-~~~~~----------~~~~~~----  217 (278)
T cd05606         156 VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH---E-IDRMT----------LTMAVE----  217 (278)
T ss_pred             CCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchH---H-HHHHh----------hccCCC----
Confidence            689999999998754 6899999999999999999999998643221111   0 00000          001111    


Q ss_pred             CCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 039626          585 YPLELALLVIRLIDACLKKDPTDRP-----TMYEIEH  616 (628)
Q Consensus       585 ~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~ev~~  616 (628)
                      .+...+..+.+++.+|+..+|.+||     ++.++++
T Consensus       218 ~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  254 (278)
T cd05606         218 LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  254 (278)
T ss_pred             CCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence            2223345688999999999999999     8888874

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=99.97  E-value=6.6e-31  Score=269.12  Aligned_cols=243  Identities=28%  Similarity=0.384  Sum_probs=180.1

Q ss_pred             eEEEEEEE--CCceEEEEEeccc--------hHHHHHHHhhcC-CCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhc
Q 039626          361 GSVYRGKI--NGGFAAIKKVNGD--------VSKEIALLNKIN-HSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSN  429 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~~--------~~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~  429 (628)
                      |.||+|+.  +++.++||+....        ..+|+..+.+++ |+||+++++++.+++..++||||+ +|+|.+++...
T Consensus        13 g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~   91 (283)
T cd07830          13 GSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM-EGNLYQLMKDR   91 (283)
T ss_pred             eEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC-CCCHHHHHHhc
Confidence            89999998  5778999987642        245889999999 999999999999999999999999 88999988543


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCCc
Q 039626          430 KNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTK  509 (628)
Q Consensus       430 ~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~  509 (628)
                      .  +..++|.++..++.|++.+|.|||+.   +++|+||+|+||++++++.++|+|||++........    .....++.
T Consensus        92 ~--~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~----~~~~~~~~  162 (283)
T cd07830          92 K--GKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP----YTDYVSTR  162 (283)
T ss_pred             c--cccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccCCCC----cCCCCCcc
Confidence            2  34689999999999999999999984   599999999999999999999999999986643221    12346788


Q ss_pred             cccCccccc-cCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccc-----hhhhccccCCcCCC
Q 039626          510 GYMAPEYLE-NGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDG-----EESLRHFIDPTLQG  583 (628)
Q Consensus       510 ~Y~APE~l~-~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~l~~~~d~~l~~  583 (628)
                      .|+|||.+. ...++.++|+||||++++||++|+.|+........  .. .....+.....     ...+...++..+..
T Consensus       163 ~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~--~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (283)
T cd07830         163 WYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQ--LY-KICSVLGTPTKQDWPEGYKLASKLGFRFPQ  239 (283)
T ss_pred             cccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHH--HH-HHHHhcCCCChhhhhhHhhhhccccccccc
Confidence            999999875 45689999999999999999999988754322110  00 00011000000     00000001100000


Q ss_pred             -------CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          584 -------NYPLELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       584 -------~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                             .........+.+++++||+.||++||+++|++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  279 (283)
T cd07830         240 FAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ  279 (283)
T ss_pred             cccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence                   000111456889999999999999999999875

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=99.97  E-value=9.3e-31  Score=269.96  Aligned_cols=227  Identities=23%  Similarity=0.406  Sum_probs=180.6

Q ss_pred             eEEEEEEE--CCceEEEEEecc-------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhcCC
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG-------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKN  431 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~-------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~  431 (628)
                      |.||++..  +++.+|+|+...       .+.+|+.++++++|+||+++++++..++..++||||+++++|.+++..   
T Consensus        34 g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~---  110 (292)
T cd06657          34 GIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTH---  110 (292)
T ss_pred             eEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHHHHHhc---
Confidence            89999988  678999998742       366799999999999999999999999999999999999999998732   


Q ss_pred             CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCCccc
Q 039626          432 EGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGY  511 (628)
Q Consensus       432 ~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~Y  511 (628)
                        ..+++.....++.|++.||+|||+.   +++|+||+|+||++++++.++|+|||++........   ......|+..|
T Consensus       111 --~~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~y  182 (292)
T cd06657         111 --TRMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP---RRKSLVGTPYW  182 (292)
T ss_pred             --CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceecccccc---cccccccCccc
Confidence              2479999999999999999999984   599999999999999999999999999876543221   12234688999


Q ss_pred             cCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCHHHHH
Q 039626          512 MAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELAL  591 (628)
Q Consensus       512 ~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~  591 (628)
                      +|||++.+..++.++|+||||++++||++|+.|+......      +..... .         ....+.+..  ......
T Consensus       183 ~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~------~~~~~~-~---------~~~~~~~~~--~~~~~~  244 (292)
T cd06657         183 MAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL------KAMKMI-R---------DNLPPKLKN--LHKVSP  244 (292)
T ss_pred             cCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHH-H---------hhCCcccCC--cccCCH
Confidence            9999998888999999999999999999999987532211      111111 0         000111100  112234


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          592 LVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       592 ~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      .+.+++.+||+.||.+||++.++++
T Consensus       245 ~l~~li~~~l~~~P~~R~~~~~ll~  269 (292)
T cd06657         245 SLKGFLDRLLVRDPAQRATAAELLK  269 (292)
T ss_pred             HHHHHHHHHHhCCcccCcCHHHHhc
Confidence            5778999999999999999999876

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=99.97  E-value=8e-31  Score=270.83  Aligned_cols=230  Identities=21%  Similarity=0.369  Sum_probs=175.3

Q ss_pred             eEEEEEEEC--CceEEEEEecc--------chHHHHHHHhhcC-CCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhc
Q 039626          361 GSVYRGKIN--GGFAAIKKVNG--------DVSKEIALLNKIN-HSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSN  429 (628)
Q Consensus       361 G~Vy~g~~~--g~~vavK~~~~--------~~~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~  429 (628)
                      |.||++++.  ++.+|||.++.        ++..|+.++.+.+ |+||++++++|.++...++||||+. ++|.+++...
T Consensus        29 ~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~l~~~~  107 (296)
T cd06618          29 GQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELMS-TCLDKLLKRI  107 (296)
T ss_pred             eEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEeeccC-cCHHHHHHHh
Confidence            899999995  88999999863        2345676666665 9999999999999999999999984 5777776432


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCCc
Q 039626          430 KNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTK  509 (628)
Q Consensus       430 ~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~  509 (628)
                         ...+++..+..++.+++.||+|||+.  .+++||||+|+||++++++.+||+|||++........    .....++.
T Consensus       108 ---~~~l~~~~~~~i~~~i~~~l~~lH~~--~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~----~~~~~~~~  178 (296)
T cd06618         108 ---QGPIPEDILGKMTVAIVKALHYLKEK--HGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKA----KTRSAGCA  178 (296)
T ss_pred             ---cCCCCHHHHHHHHHHHHHHHHHHHhh--CCEecCCCcHHHEEEcCCCCEEECccccchhccCCCc----ccCCCCCc
Confidence               23689999999999999999999972  3599999999999999999999999999876543221    12235788


Q ss_pred             cccCccccccCC----CCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCC
Q 039626          510 GYMAPEYLENGL----VSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNY  585 (628)
Q Consensus       510 ~Y~APE~l~~~~----~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~  585 (628)
                      .|+|||.+.+..    ++.++||||||++++||++|+.|+......     .+..........          +...  .
T Consensus       179 ~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-----~~~~~~~~~~~~----------~~~~--~  241 (296)
T cd06618         179 AYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE-----FEVLTKILQEEP----------PSLP--P  241 (296)
T ss_pred             cccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH-----HHHHHHHhcCCC----------CCCC--C
Confidence            999999987553    789999999999999999999997532111     112222221110          0000  0


Q ss_pred             CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 039626          586 PLELALLVIRLIDACLKKDPTDRPTMYEIEHS  617 (628)
Q Consensus       586 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~  617 (628)
                      .......+.+++.+||+.||.+||+++++++.
T Consensus       242 ~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~  273 (296)
T cd06618         242 NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH  273 (296)
T ss_pred             CCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            11234567899999999999999999999765

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=5.4e-31  Score=269.35  Aligned_cols=219  Identities=21%  Similarity=0.369  Sum_probs=185.8

Q ss_pred             EECCceEEEEEecc---------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhcCCCCCCCC
Q 039626          367 KINGGFAAIKKVNG---------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLD  437 (628)
Q Consensus       367 ~~~g~~vavK~~~~---------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~  437 (628)
                      ++.|+.||||.+.+         .+.+|++.|+-++|||||+|+.+......+|||+|.-.+|+|.||+..+.   ..+.
T Consensus        40 VFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLELGD~GDl~DyImKHe---~Gl~  116 (864)
T KOG4717|consen   40 VFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILELGDGGDLFDYIMKHE---EGLN  116 (864)
T ss_pred             hcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEecCCchHHHHHHhhh---cccc
Confidence            45899999999864         46789999999999999999999998899999999999999999997643   3488


Q ss_pred             HHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEe-CCCCcEEEccccccccCCCCCCcceeeecccCCccccCccc
Q 039626          438 WKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLL-DSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEY  516 (628)
Q Consensus       438 ~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl-~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~Y~APE~  516 (628)
                      +....+++.||..|+.|+|...   ++||||||+|+.+ ..-|-+||.|||++..+..+.    ......|+..|-|||.
T Consensus       117 E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~----kL~TsCGSLAYSAPEI  189 (864)
T KOG4717|consen  117 EDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGK----KLTTSCGSLAYSAPEI  189 (864)
T ss_pred             HHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCCcc----hhhcccchhhccCchh
Confidence            8999999999999999999965   9999999999876 556899999999998776543    2344689999999999


Q ss_pred             cccCCCC-cccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCHHHHHHHHH
Q 039626          517 LENGLVS-TKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIR  595 (628)
Q Consensus       517 l~~~~~s-~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~  595 (628)
                      +.+..|+ +..||||+||+||-|++|+.||+...+                   .+.+-.++|...  ..|.-.+.+..+
T Consensus       190 LLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeAND-------------------SETLTmImDCKY--tvPshvS~eCrd  248 (864)
T KOG4717|consen  190 LLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEAND-------------------SETLTMIMDCKY--TVPSHVSKECRD  248 (864)
T ss_pred             hhcCccCCcchhhhHHHHHHHHHHhCCCccccccc-------------------hhhhhhhhcccc--cCchhhhHHHHH
Confidence            9988765 689999999999999999999873322                   445555666554  346677888899


Q ss_pred             HHHHhcccCCCCCCCHHHHHH
Q 039626          596 LIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       596 l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      ||..||.+||++|.+.+||+.
T Consensus       249 LI~sMLvRdPkkRAslEeI~s  269 (864)
T KOG4717|consen  249 LIQSMLVRDPKKRASLEEIVS  269 (864)
T ss_pred             HHHHHHhcCchhhccHHHHhc
Confidence            999999999999999999864

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=99.97  E-value=1.6e-31  Score=258.88  Aligned_cols=252  Identities=28%  Similarity=0.362  Sum_probs=186.5

Q ss_pred             eEEEEEEE---C---CceEEEEEeccc---------hHHHHHHHhhcCCCceeeeeeeeec-CCeEEEEEEecCCCChHH
Q 039626          361 GSVYRGKI---N---GGFAAIKKVNGD---------VSKEIALLNKINHSNLIILSGVCFN-EGNCYLVYEYAVNGTLSD  424 (628)
Q Consensus       361 G~Vy~g~~---~---g~~vavK~~~~~---------~~~E~~~l~~l~H~nIv~l~g~~~~-~~~~~lV~E~~~~gsL~~  424 (628)
                      |.||+++-   +   ...+|||+++.+         ..+|+.+++.++|+|++.|..++.+ +...+|++||++. +|..
T Consensus        38 G~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~l~fdYAEh-DL~~  116 (438)
T KOG0666|consen   38 GKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKVWLLFDYAEH-DLWH  116 (438)
T ss_pred             ceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEEEEehhhhh-hHHH
Confidence            99999965   2   236799999764         5689999999999999999999987 7889999999976 8988


Q ss_pred             HhhhcC-CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCC----CcEEEccccccccCCCCCCcc
Q 039626          425 WVFSNK-NEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSD----LRAKIANFAMARPAEGQEGEF  499 (628)
Q Consensus       425 ~l~~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~----~~~kl~Dfgla~~~~~~~~~~  499 (628)
                      .++-++ ...+.++......|..||+.|+.|||+..   ++||||||.|||+..+    |++||+|||++|.+.+.-...
T Consensus       117 II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIaDlGlaR~~~~plkpl  193 (438)
T KOG0666|consen  117 IIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIADLGLARLFNNPLKPL  193 (438)
T ss_pred             HHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEeecccHHHHhhcccccc
Confidence            886543 33467899999999999999999999966   9999999999999877    999999999999987654433


Q ss_pred             eeeecccCCccccCcccccc-CCCCcccccHHHHHHHHHHHhCCCcccccccccc---ccHHHHHH---HHhcccc--ch
Q 039626          500 ALTRHIVGTKGYMAPEYLEN-GLVSTKLDVYAFGVLILEMLTGKEAAALHAEENN---MHLSDVLN---AVLTKED--GE  570 (628)
Q Consensus       500 ~~~~~~~gt~~Y~APE~l~~-~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~---~~~~~~~~---~~~~~~~--~~  570 (628)
                      .....++-|.+|+|||.+.+ ..||+..||||.||++.||++-++.|...+....   ....+.+.   .++....  ..
T Consensus       194 ~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rIf~vLG~Pt~~~W  273 (438)
T KOG0666|consen  194 ASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRIFEVLGTPTDKDW  273 (438)
T ss_pred             ccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHHHHHHcCCCccccc
Confidence            34456788999999999887 4799999999999999999998877765433211   11222222   2222111  11


Q ss_pred             hhhccccCC---------cCCCCCCH--------HHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          571 ESLRHFIDP---------TLQGNYPL--------ELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       571 ~~l~~~~d~---------~l~~~~~~--------~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      ..+++.-+-         ....+...        .-.....+|+.++|..||.+|.|+++.++
T Consensus       274 p~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAle  336 (438)
T KOG0666|consen  274 PDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALE  336 (438)
T ss_pred             hhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhc
Confidence            111111110         00000000        01123678999999999999999988765

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=99.97  E-value=1.8e-30  Score=275.23  Aligned_cols=239  Identities=24%  Similarity=0.288  Sum_probs=177.9

Q ss_pred             eEEEEEEE--CCceEEEEEecc---------chHHHHHHHhhcCCCceeeeeeeeecC------CeEEEEEEecCCCChH
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG---------DVSKEIALLNKINHSNLIILSGVCFNE------GNCYLVYEYAVNGTLS  423 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~---------~~~~E~~~l~~l~H~nIv~l~g~~~~~------~~~~lV~E~~~~gsL~  423 (628)
                      |.||++..  +|+.+|+|++..         .+.+|+.++++++|+||+++++++...      ...++||||+. ++|.
T Consensus        30 g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~  108 (353)
T cd07850          30 GIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMD-ANLC  108 (353)
T ss_pred             EEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCcEEEEEeccC-CCHH
Confidence            89999987  688999998753         345799999999999999999998643      35799999995 5888


Q ss_pred             HHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeee
Q 039626          424 DWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTR  503 (628)
Q Consensus       424 ~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~  503 (628)
                      +++..      .+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||+++......    ...
T Consensus       109 ~~~~~------~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~----~~~  175 (353)
T cd07850         109 QVIQM------DLDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF----MMT  175 (353)
T ss_pred             HHHhh------cCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCccceeCCCCC----CCC
Confidence            88732      288899999999999999999984   59999999999999999999999999998654321    122


Q ss_pred             cccCCccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhcccc---------------
Q 039626          504 HIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKED---------------  568 (628)
Q Consensus       504 ~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~---------------  568 (628)
                      ...++..|+|||.+.+..++.++||||||++++||++|+.|+.......   ....+...+....               
T Consensus       176 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (353)
T cd07850         176 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHID---QWNKIIEQLGTPSDEFMSRLQPTVRNYV  252 (353)
T ss_pred             CCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHH---HHHHHHHhcCCCCHHHHHHhhhhhhHHh
Confidence            3467889999999999999999999999999999999999886432111   0111101000000               


Q ss_pred             ---c---hhhhccccC----CcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          569 ---G---EESLRHFID----PTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       569 ---~---~~~l~~~~d----~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                         .   ...+.+.+.    +......+...+..+.+++.+||+.||++||++.|++.
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~  310 (353)
T cd07850         253 ENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQ  310 (353)
T ss_pred             hcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhc
Confidence               0   000001111    00111112234556789999999999999999999985

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=99.97  E-value=7.6e-31  Score=276.23  Aligned_cols=245  Identities=27%  Similarity=0.374  Sum_probs=178.3

Q ss_pred             eEEEEEEE--CCceEEEEEecc---------chHHHHHHHhhc-CCCceeeeeeeeecC--CeEEEEEEecCCCChHHHh
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG---------DVSKEIALLNKI-NHSNLIILSGVCFNE--GNCYLVYEYAVNGTLSDWV  426 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~---------~~~~E~~~l~~l-~H~nIv~l~g~~~~~--~~~~lV~E~~~~gsL~~~l  426 (628)
                      |.||+|..  .|+.+|+|++..         .+.+|+.+++++ +|+||++++++|...  ...++||||++ ++|.+++
T Consensus        21 ~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~   99 (337)
T cd07852          21 GIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYME-TDLHAVI   99 (337)
T ss_pred             eeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEEEecccc-cCHHHHH
Confidence            89999988  578899998743         255799999999 999999999998643  36899999996 6999888


Q ss_pred             hhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCc--ceeeec
Q 039626          427 FSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGE--FALTRH  504 (628)
Q Consensus       427 ~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~--~~~~~~  504 (628)
                      ..     ..++|..+..++.|++.||+|||+   .+++|+||||+||++++++.+||+|||+++........  ......
T Consensus       100 ~~-----~~~~~~~~~~i~~qi~~~L~~LH~---~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~  171 (337)
T cd07852         100 RA-----NILEDVHKRYIMYQLLKALKYIHS---GNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTD  171 (337)
T ss_pred             hc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeeccchhccccccccccCcchhc
Confidence            43     268899999999999999999998   45999999999999999999999999999876433211  012234


Q ss_pred             ccCCccccCcccccc-CCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhc----------cccchhhh
Q 039626          505 IVGTKGYMAPEYLEN-GLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLT----------KEDGEESL  573 (628)
Q Consensus       505 ~~gt~~Y~APE~l~~-~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~l  573 (628)
                      ..|+..|+|||.+.+ ..++.++||||||++++||++|+.|+........  ..........          .......+
T Consensus       172 ~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (337)
T cd07852         172 YVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQ--LEKIIEVIGPPSAEDIESIKSPFAATML  249 (337)
T ss_pred             ccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHHHHhCCCCHHHHHHHHhhhHHHhh
Confidence            568999999998765 5678999999999999999999998854322110  0110000000          00000000


Q ss_pred             ccccCC---cCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 039626          574 RHFIDP---TLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHS  617 (628)
Q Consensus       574 ~~~~d~---~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~  617 (628)
                      ....+.   ......+ ..+..+.+++.+||+.||.+|||+.++++.
T Consensus       250 ~~~~~~~~~~~~~~~~-~~~~~l~~li~~~l~~~P~~Rps~~~il~~  295 (337)
T cd07852         250 DSLPSRPRKPLDELLP-KASDDALDLLKKLLVFNPNKRLTAEEALEH  295 (337)
T ss_pred             hhcccccccchhhhcc-CCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence            000000   0000011 134568899999999999999999999864

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=99.97  E-value=2.1e-30  Score=269.33  Aligned_cols=243  Identities=29%  Similarity=0.340  Sum_probs=177.9

Q ss_pred             eEEEEEEE--CCceEEEEEecc---------chHHHHHHHhhcCCCceeeeeeeeecC--CeEEEEEEecCCCChHHHhh
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG---------DVSKEIALLNKINHSNLIILSGVCFNE--GNCYLVYEYAVNGTLSDWVF  427 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~---------~~~~E~~~l~~l~H~nIv~l~g~~~~~--~~~~lV~E~~~~gsL~~~l~  427 (628)
                      |.||+|..  +|+.||+|+.+.         .+.+|+.++++++|+||+++++++.+.  +..++||||+. ++|.+++.
T Consensus        21 ~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~   99 (309)
T cd07845          21 GIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCE-QDLASLLD   99 (309)
T ss_pred             EEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEEecCC-CCHHHHHH
Confidence            89999998  588999998752         245799999999999999999998755  56899999996 58988885


Q ss_pred             hcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccC
Q 039626          428 SNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVG  507 (628)
Q Consensus       428 ~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~g  507 (628)
                      ..   ...+++.++..++.|++.||+|||+.+   ++||||||+||++++++.+||+|||+++.......   ......+
T Consensus       100 ~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~~---~~~~~~~  170 (309)
T cd07845         100 NM---PTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAK---PMTPKVV  170 (309)
T ss_pred             hc---ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecCCccC---CCCcccc
Confidence            42   256899999999999999999999954   99999999999999999999999999987653221   1122345


Q ss_pred             CccccCcccccc-CCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccc--hhhhc------cccC
Q 039626          508 TKGYMAPEYLEN-GLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDG--EESLR------HFID  578 (628)
Q Consensus       508 t~~Y~APE~l~~-~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~l~------~~~d  578 (628)
                      +..|+|||.+.+ ..++.++||||||+++|||++|+.|+.......   ....+.........  ...+.      .+.-
T Consensus       171 ~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (309)
T cd07845         171 TLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIE---QLDLIIQLLGTPNESIWPGFSDLPLVGKFTL  247 (309)
T ss_pred             cccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHhcCCCChhhchhhhcccccccccc
Confidence            788999998865 567999999999999999999998886432211   11111111110000  00000      0000


Q ss_pred             CcCCCCC----CHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          579 PTLQGNY----PLELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       579 ~~l~~~~----~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      +.-....    .......+.+++.+||+.||++||+++|++.
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~  289 (309)
T cd07845         248 PKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE  289 (309)
T ss_pred             cCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence            0000000    0012456789999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=99.97  E-value=1.4e-30  Score=269.40  Aligned_cols=242  Identities=26%  Similarity=0.371  Sum_probs=177.4

Q ss_pred             eEEEEEEE--CCceEEEEEecc---------chHHHHHHHhhcCCCceeeeeeeeecCC----------eEEEEEEecCC
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG---------DVSKEIALLNKINHSNLIILSGVCFNEG----------NCYLVYEYAVN  419 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~---------~~~~E~~~l~~l~H~nIv~l~g~~~~~~----------~~~lV~E~~~~  419 (628)
                      |.||+|..  +|+.+|+|+++.         .+.+|++++++++|+||+++++++.+..          ..++|+||+++
T Consensus        21 g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~  100 (302)
T cd07864          21 GQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDH  100 (302)
T ss_pred             EEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhccccCCcEEEEEcccCc
Confidence            89999998  578999998853         2457999999999999999999987654          78999999975


Q ss_pred             CChHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcc
Q 039626          420 GTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEF  499 (628)
Q Consensus       420 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~  499 (628)
                       +|.+.+..   ....+++..+..++.|++.||+|||+.   +++|+||||+||++++++.+||+|||++......... 
T Consensus       101 -~l~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~-  172 (302)
T cd07864         101 -DLMGLLES---GLVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESR-  172 (302)
T ss_pred             -cHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcEEeCcccccccccCCccc-
Confidence             77777643   234589999999999999999999984   5999999999999999999999999999876433211 


Q ss_pred             eeeecccCCccccCcccccc-CCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccc--
Q 039626          500 ALTRHIVGTKGYMAPEYLEN-GLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHF--  576 (628)
Q Consensus       500 ~~~~~~~gt~~Y~APE~l~~-~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~--  576 (628)
                       ......++..|+|||.+.+ ...+.++|||||||+++||++|+.|+......   .....+........ ......+  
T Consensus       173 -~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~---~~~~~~~~~~~~~~-~~~~~~~~~  247 (302)
T cd07864         173 -PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQEL---AQLELISRLCGSPC-PAVWPDVIK  247 (302)
T ss_pred             -ccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHHhCCCC-hhhcccccc
Confidence             1122346778999998865 45789999999999999999999888643211   11111212111110 0000000  


Q ss_pred             ------cCC------cCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          577 ------IDP------TLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       577 ------~d~------~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                            .++      ...... ...+..+.+++.+||+.||.+||++++++.
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  298 (302)
T cd07864         248 LPYFNTMKPKKQYRRRLREEF-SFIPTPALDLLDHMLTLDPSKRCTAEEALN  298 (302)
T ss_pred             cccccccccccccccchhhhc-CCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence                  000      000000 113456889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=99.97  E-value=2.8e-30  Score=268.40  Aligned_cols=225  Identities=30%  Similarity=0.441  Sum_probs=177.2

Q ss_pred             eEEEEEEE--CCceEEEEEecc----------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhh
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG----------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFS  428 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  428 (628)
                      |.||+|+.  +++.+|+|++..          ++.+|++++++++|+|++++.+++..+...++||||+. |+|.+++..
T Consensus        29 g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~  107 (308)
T cd06634          29 GAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEV  107 (308)
T ss_pred             EEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEccC-CCHHHHHHH
Confidence            89999998  678899998742          35679999999999999999999999999999999996 688887753


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCC
Q 039626          429 NKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGT  508 (628)
Q Consensus       429 ~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt  508 (628)
                      .   ...+++.++..++.+++.||.|||+.   +++||||+|+||+++.++.+||+|||++......       ....++
T Consensus       108 ~---~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~-------~~~~~~  174 (308)
T cd06634         108 H---KKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-------NXFVGT  174 (308)
T ss_pred             c---CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceeecCc-------ccccCC
Confidence            2   34589999999999999999999984   5999999999999999999999999998765321       234678


Q ss_pred             ccccCccccc---cCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCC
Q 039626          509 KGYMAPEYLE---NGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNY  585 (628)
Q Consensus       509 ~~Y~APE~l~---~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~  585 (628)
                      ..|+|||.+.   ...++.++||||||++++||++|+.|+......      +........          ..+..   .
T Consensus       175 ~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------~~~~~~~~~----------~~~~~---~  235 (308)
T cd06634         175 PYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------SALYHIAQN----------ESPAL---Q  235 (308)
T ss_pred             ccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHH------HHHHHHhhc----------CCCCc---C
Confidence            8999999874   456889999999999999999999887532111      111111100          00111   1


Q ss_pred             CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 039626          586 PLELALLVIRLIDACLKKDPTDRPTMYEIEHSL  618 (628)
Q Consensus       586 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L  618 (628)
                      +......+.+++.+||+.+|++||++.+++..-
T Consensus       236 ~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~  268 (308)
T cd06634         236 SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR  268 (308)
T ss_pred             cccccHHHHHHHHHHhhCCcccCCCHHHHhhCc
Confidence            123445678999999999999999999988653

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=2.5e-30  Score=259.94  Aligned_cols=226  Identities=28%  Similarity=0.465  Sum_probs=182.7

Q ss_pred             eEEEEEEE--CCceEEEEEecc---------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhc
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG---------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSN  429 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~---------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~  429 (628)
                      |.||+++.  .++.+++|....         ++.+|++++.+++|+|++++++++.+++..++++||+++++|.+++...
T Consensus        14 ~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~   93 (254)
T cd06627          14 GVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKF   93 (254)
T ss_pred             eEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecCCCCcHHHHHHhc
Confidence            89999987  567899998754         3578999999999999999999999999999999999999999998542


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCCc
Q 039626          430 KNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTK  509 (628)
Q Consensus       430 ~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~  509 (628)
                          ..+++..+..++.+++.||.|||+.   +++|+||+|+||+++.++.+||+|||++.........   .....++.
T Consensus        94 ----~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~---~~~~~~~~  163 (254)
T cd06627          94 ----GPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD---DASVVGTP  163 (254)
T ss_pred             ----cCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCCCccc---ccccccch
Confidence                4689999999999999999999984   5999999999999999999999999999876543321   22346888


Q ss_pred             cccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCHHH
Q 039626          510 GYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLEL  589 (628)
Q Consensus       510 ~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~  589 (628)
                      .|+|||.+.+...+.++|||++|++++||++|+.|+.....     ..... .....          ..+    ..+...
T Consensus       164 ~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~-----~~~~~-~~~~~----------~~~----~~~~~~  223 (254)
T cd06627         164 YWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP-----MAALF-RIVQD----------DHP----PLPEGI  223 (254)
T ss_pred             hhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccH-----HHHHH-HHhcc----------CCC----CCCCCC
Confidence            99999999888889999999999999999999988753221     11111 11000          001    112233


Q ss_pred             HHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          590 ALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       590 ~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      ...+.+++.+||..+|++||++.+++.
T Consensus       224 ~~~~~~~i~~~l~~~p~~R~~~~~~l~  250 (254)
T cd06627         224 SPELKDFLMQCFQKDPNLRPTAKQLLK  250 (254)
T ss_pred             CHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence            456789999999999999999999874

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=99.97  E-value=1.3e-30  Score=263.63  Aligned_cols=229  Identities=24%  Similarity=0.368  Sum_probs=179.1

Q ss_pred             eEEEEEEEC--CceEEEEEecc------------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHh
Q 039626          361 GSVYRGKIN--GGFAAIKKVNG------------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWV  426 (628)
Q Consensus       361 G~Vy~g~~~--g~~vavK~~~~------------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l  426 (628)
                      |.||+++..  +..+++|..+.            ++..|+.++++++||||+++++++.+....++||||+++++|.+++
T Consensus        14 g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~   93 (260)
T cd08222          14 GTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKL   93 (260)
T ss_pred             ceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEEEeCCCCCHHHHH
Confidence            899999883  33444444431            2456889999999999999999999889999999999999999998


Q ss_pred             hhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeeccc
Q 039626          427 FSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIV  506 (628)
Q Consensus       427 ~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~  506 (628)
                      ......+..+++..++.++.|++.||.|||+.   +++|+||||+||++++ +.+||+|||+++.......   ......
T Consensus        94 ~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~~---~~~~~~  166 (260)
T cd08222          94 EELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSCD---LATTFT  166 (260)
T ss_pred             HHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCceeecCCCcc---cccCCC
Confidence            75444556799999999999999999999984   5999999999999976 5699999999876643221   223346


Q ss_pred             CCccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCC
Q 039626          507 GTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYP  586 (628)
Q Consensus       507 gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~  586 (628)
                      |+..|+|||.+.+..++.++|+||||++++||++|+.|+....      ...........          ..+    ..+
T Consensus       167 ~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~------~~~~~~~~~~~----------~~~----~~~  226 (260)
T cd08222         167 GTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN------FLSVVLRIVEG----------PTP----SLP  226 (260)
T ss_pred             CCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc------HHHHHHHHHcC----------CCC----CCc
Confidence            7889999999988888999999999999999999998875221      11111111110          111    123


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          587 LELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       587 ~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      ......+.+++.+||+.||++||++.|+++
T Consensus       227 ~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  256 (260)
T cd08222         227 ETYSRQLNSIMQSMLNKDPSLRPSAAEILR  256 (260)
T ss_pred             chhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence            344567889999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.97  E-value=1.6e-30  Score=259.79  Aligned_cols=217  Identities=20%  Similarity=0.183  Sum_probs=173.8

Q ss_pred             ceEEEEEEE--CCceEEEEEecc--chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhcCCCCCC
Q 039626          360 QGSVYRGKI--NGGFAAIKKVNG--DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKY  435 (628)
Q Consensus       360 ~G~Vy~g~~--~g~~vavK~~~~--~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~  435 (628)
                      .|.||++..  +++.+|+|+++.  .+.+|...+....|+||+++++++.+.+..++||||+++|+|.+++...    ..
T Consensus         6 ~~~v~~~~~~~~~~~~~~K~i~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----~~   81 (237)
T cd05576           6 IDKVLLVMDTRTQQTFILKGLRKSSEYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKF----LN   81 (237)
T ss_pred             cceEEEEEEccCCcEEEEEeecchhhhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHHh----cC
Confidence            388999988  788999999976  3556766666778999999999999999999999999999999998542    34


Q ss_pred             CCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCCccccCcc
Q 039626          436 LDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPE  515 (628)
Q Consensus       436 l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~Y~APE  515 (628)
                      +++..+..++.|++.||+|||+   .+++||||||+||+++.++.++++|||.+.......      ....++..|+|||
T Consensus        82 l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~------~~~~~~~~y~aPE  152 (237)
T cd05576          82 IPEECVKRWAAEMVVALDALHR---EGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC------DGEAVENMYCAPE  152 (237)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCCCCEEEecccchhcccccc------ccCCcCccccCCc
Confidence            8999999999999999999998   459999999999999999999999999876554321      1234577899999


Q ss_pred             ccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCHHHHHHHHH
Q 039626          516 YLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIR  595 (628)
Q Consensus       516 ~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~  595 (628)
                      .+....++.++||||+|++++||++|+.++.......                     .....    ...+......+.+
T Consensus       153 ~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~---------------------~~~~~----~~~~~~~~~~~~~  207 (237)
T cd05576         153 VGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI---------------------NTHTT----LNIPEWVSEEARS  207 (237)
T ss_pred             ccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc---------------------ccccc----cCCcccCCHHHHH
Confidence            9988889999999999999999999997654211000                     00000    0112233456789


Q ss_pred             HHHHhcccCCCCCCCHHHH
Q 039626          596 LIDACLKKDPTDRPTMYEI  614 (628)
Q Consensus       596 l~~~Cl~~dP~~RPs~~ev  614 (628)
                      ++.+|++.||++||++.+.
T Consensus       208 li~~~l~~dp~~R~~~~~~  226 (237)
T cd05576         208 LLQQLLQFNPTERLGAGVA  226 (237)
T ss_pred             HHHHHccCCHHHhcCCCcc
Confidence            9999999999999997443

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=99.97  E-value=4.3e-30  Score=267.69  Aligned_cols=223  Identities=31%  Similarity=0.471  Sum_probs=176.1

Q ss_pred             eEEEEEEE--CCceEEEEEecc----------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhh
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG----------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFS  428 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  428 (628)
                      |.||+|+.  .++.+++|++..          ++.+|++++++++|+|++++.+++.++...++||||+. |+|.+++..
T Consensus        35 g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~  113 (313)
T cd06633          35 GAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCL-GSASDLLEV  113 (313)
T ss_pred             eEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEecCC-CCHHHHHHh
Confidence            89999987  678999998752          35679999999999999999999999999999999995 688887743


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCC
Q 039626          429 NKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGT  508 (628)
Q Consensus       429 ~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt  508 (628)
                         ....++|.++..++.|++.||.|||+.   +++|+||+|+||++++++.+||+|||++.....       .....|+
T Consensus       114 ---~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~-------~~~~~~~  180 (313)
T cd06633         114 ---HKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSP-------ANSFVGT  180 (313)
T ss_pred             ---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccCC-------CCCcccc
Confidence               234589999999999999999999984   599999999999999999999999999864321       1234688


Q ss_pred             ccccCccccc---cCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCC
Q 039626          509 KGYMAPEYLE---NGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNY  585 (628)
Q Consensus       509 ~~Y~APE~l~---~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~  585 (628)
                      ..|+|||++.   ...++.++||||||++++||++|+.|+.....      ...........          .+...   
T Consensus       181 ~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~------~~~~~~~~~~~----------~~~~~---  241 (313)
T cd06633         181 PYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA------MSALYHIAQND----------SPTLQ---  241 (313)
T ss_pred             ccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHHHhcC----------CCCCC---
Confidence            8999999984   46688999999999999999999998753221      11111111100          01111   


Q ss_pred             CHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          586 PLELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       586 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      .......+.+++.+||+.+|.+||++.+++.
T Consensus       242 ~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~  272 (313)
T cd06633         242 SNEWTDSFRGFVDYCLQKIPQERPASAELLR  272 (313)
T ss_pred             ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            1122345789999999999999999999985

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=99.97  E-value=1.9e-30  Score=273.83  Aligned_cols=247  Identities=25%  Similarity=0.361  Sum_probs=177.7

Q ss_pred             cCCCcCCccc----eEEEEEEE--CCceEEEEEecc---------chHHHHHHHhhcCCCceeeeeeeeecC------Ce
Q 039626          351 DNFSFTCRIQ----GSVYRGKI--NGGFAAIKKVNG---------DVSKEIALLNKINHSNLIILSGVCFNE------GN  409 (628)
Q Consensus       351 ~~f~~~~~i~----G~Vy~g~~--~g~~vavK~~~~---------~~~~E~~~l~~l~H~nIv~l~g~~~~~------~~  409 (628)
                      ++|.....+|    |.||+|+.  +|+.+|+|+++.         .+.+|+.++++++|+||+++++++...      .+
T Consensus        15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   94 (342)
T cd07879          15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQD   94 (342)
T ss_pred             cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCce
Confidence            4555444443    89999987  688999998853         256799999999999999999998754      35


Q ss_pred             EEEEEEecCCCChHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEcccccc
Q 039626          410 CYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMA  489 (628)
Q Consensus       410 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla  489 (628)
                      .++|+||+. .+|.+++      +..+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||++
T Consensus        95 ~~lv~e~~~-~~l~~~~------~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg~~  164 (342)
T cd07879          95 FYLVMPYMQ-TDLQKIM------GHPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGLA  164 (342)
T ss_pred             EEEEecccc-cCHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCCCC
Confidence            699999995 4777665      22488999999999999999999985   4999999999999999999999999998


Q ss_pred             ccCCCCCCcceeeecccCCccccCcccccc-CCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhcccc
Q 039626          490 RPAEGQEGEFALTRHIVGTKGYMAPEYLEN-GLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKED  568 (628)
Q Consensus       490 ~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  568 (628)
                      +......      ....++..|+|||.+.+ ..++.++||||||++++||++|+.|+.......   ....+........
T Consensus       165 ~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~---~~~~~~~~~~~~~  235 (342)
T cd07879         165 RHADAEM------TGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD---QLTQILKVTGVPG  235 (342)
T ss_pred             cCCCCCC------CCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHhcCCCC
Confidence            7653211      22457889999999876 468999999999999999999999986432111   1111111110000


Q ss_pred             c--hhh-----hccccC--CcC-CCCCC---HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          569 G--EES-----LRHFID--PTL-QGNYP---LELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       569 ~--~~~-----l~~~~d--~~l-~~~~~---~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      .  ...     ...+..  +.. +....   ......+.+++.+||+.||++||+++|++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~  296 (342)
T cd07879         236 PEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALE  296 (342)
T ss_pred             HHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            0  000     000000  000 00000   012345789999999999999999999984

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=99.97  E-value=3.2e-31  Score=252.64  Aligned_cols=229  Identities=20%  Similarity=0.371  Sum_probs=176.3

Q ss_pred             eEEEEEEE--CCceEEEEEeccc--------hHHHHHHHhhcC-CCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhc
Q 039626          361 GSVYRGKI--NGGFAAIKKVNGD--------VSKEIALLNKIN-HSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSN  429 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~~--------~~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~  429 (628)
                      |.||+.++  .|...|||.+.+.        +...++++.+-+ .|.||+.+|+|..+...++.||.| ...++..|.+ 
T Consensus       106 G~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelM-s~C~ekLlkr-  183 (391)
T KOG0983|consen  106 GQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELM-STCAEKLLKR-  183 (391)
T ss_pred             cceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHH-HHHHHHHHHH-
Confidence            99999999  5689999998752        223444444444 799999999999999999999999 4466766643 


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCCc
Q 039626          430 KNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTK  509 (628)
Q Consensus       430 ~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~  509 (628)
                        -.+++++...-++...+++||.||.+  +.+|+|||+||+|||+|+.|++|++|||++-.+-+..    ......|.+
T Consensus       184 --ik~piPE~ilGk~tva~v~AL~YLKe--KH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk----AhtrsAGC~  255 (391)
T KOG0983|consen  184 --IKGPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK----AHTRSAGCA  255 (391)
T ss_pred             --hcCCchHHhhhhhHHHHHHHHHHHHH--hcceeecccCccceEEccCCCEEeecccccceeeccc----ccccccCCc
Confidence              23458888888999999999999987  3569999999999999999999999999987664332    234457999


Q ss_pred             cccCccccc---cCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCC
Q 039626          510 GYMAPEYLE---NGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYP  586 (628)
Q Consensus       510 ~Y~APE~l~---~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~  586 (628)
                      .|||||.+.   ...|+-++||||||+.|+||.||+.|+.....+     .+.+..++..+          .|.+++.  
T Consensus       256 ~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~td-----Fe~ltkvln~e----------PP~L~~~--  318 (391)
T KOG0983|consen  256 AYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTD-----FEVLTKVLNEE----------PPLLPGH--  318 (391)
T ss_pred             cccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCcc-----HHHHHHHHhcC----------CCCCCcc--
Confidence            999999986   457889999999999999999999998753322     12222222211          1223222  


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          587 LELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       587 ~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      ...+..+.++...||.+|+.+||...++++
T Consensus       319 ~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~  348 (391)
T KOG0983|consen  319 MGFSPDFQSFVKDCLTKDHRKRPKYNKLLE  348 (391)
T ss_pred             cCcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence            125567889999999999999999999875

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=99.97  E-value=3.8e-31  Score=267.66  Aligned_cols=247  Identities=26%  Similarity=0.346  Sum_probs=195.7

Q ss_pred             eecHHHHHHHhcC-CCcCCccc----eEEEEEEE--CCceEEEEEeccc----------hHHHHHHHhhcCCCceeeeee
Q 039626          340 VYSFKELQSATDN-FSFTCRIQ----GSVYRGKI--NGGFAAIKKVNGD----------VSKEIALLNKINHSNLIILSG  402 (628)
Q Consensus       340 ~~~~~el~~at~~-f~~~~~i~----G~Vy~g~~--~g~~vavK~~~~~----------~~~E~~~l~~l~H~nIv~l~g  402 (628)
                      .+.+-|++..|.+ |+.-+.+|    |.||-...  .|+.+|.|++.+.          ..+|-.+|.+++.+.||.+--
T Consensus       173 QWK~lE~qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaY  252 (591)
T KOG0986|consen  173 QWKWLELQPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAY  252 (591)
T ss_pred             HHHHHHhhhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEee
Confidence            3455566666654 44333333    88987766  7888898877432          356999999999999999999


Q ss_pred             eeecCCeEEEEEEecCCCChHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEE
Q 039626          403 VCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAK  482 (628)
Q Consensus       403 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~k  482 (628)
                      .++..+.++||+..|.||+|.-+|+....  ..+++...+-++.+|+.||++||+..   ||+||+||+|||||++|+++
T Consensus       253 AfeTkd~LClVLtlMNGGDLkfHiyn~g~--~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvR  327 (591)
T KOG0986|consen  253 AFETKDALCLVLTLMNGGDLKFHIYNHGN--PGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVR  327 (591)
T ss_pred             eecCCCceEEEEEeecCCceeEEeeccCC--CCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeE
Confidence            99999999999999999999999976433  45899999999999999999999954   99999999999999999999


Q ss_pred             EccccccccCCCCCCcceeeecccCCccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHH
Q 039626          483 IANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNA  562 (628)
Q Consensus       483 l~Dfgla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~  562 (628)
                      |+|+|||..+....    ..+..+||.||||||++.++.|+...|.||+||++|||+.|+.||..+.+...  ..++-+.
T Consensus       328 ISDLGLAvei~~g~----~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk--~eEvdrr  401 (591)
T KOG0986|consen  328 ISDLGLAVEIPEGK----PIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVK--REEVDRR  401 (591)
T ss_pred             eeccceEEecCCCC----ccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhh--HHHHHHH
Confidence            99999999876543    23345999999999999999999999999999999999999999875443211  0011111


Q ss_pred             HhccccchhhhccccCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHH
Q 039626          563 VLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMY  612 (628)
Q Consensus       563 ~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~  612 (628)
                      +..               ...++++..+++..++.+..|++||.+|.--+
T Consensus       402 ~~~---------------~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcr  436 (591)
T KOG0986|consen  402 TLE---------------DPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCR  436 (591)
T ss_pred             Hhc---------------chhhcccccCHHHHHHHHHHHccCHHHhccCC
Confidence            111               12356677778889999999999999996543

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=99.97  E-value=3.2e-30  Score=270.44  Aligned_cols=253  Identities=25%  Similarity=0.347  Sum_probs=184.0

Q ss_pred             HHHhcCCCcCCccc----eEEEEEEE--CCceEEEEEecc---------chHHHHHHHhhcCCCceeeeeeeeec-CCeE
Q 039626          347 QSATDNFSFTCRIQ----GSVYRGKI--NGGFAAIKKVNG---------DVSKEIALLNKINHSNLIILSGVCFN-EGNC  410 (628)
Q Consensus       347 ~~at~~f~~~~~i~----G~Vy~g~~--~g~~vavK~~~~---------~~~~E~~~l~~l~H~nIv~l~g~~~~-~~~~  410 (628)
                      ...+++|.....++    |.||++..  +++.+|+|++..         .+.+|++++++++||||+++.+++.. +...
T Consensus         6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~   85 (328)
T cd07856           6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDI   85 (328)
T ss_pred             eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcE
Confidence            34566666555553    89999986  678999998642         45679999999999999999999875 4578


Q ss_pred             EEEEEecCCCChHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccc
Q 039626          411 YLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMAR  490 (628)
Q Consensus       411 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~  490 (628)
                      ++++||+ +++|.+++.     ...+++.....++.|+++||.|||+.   +++||||+|+||++++++.+||+|||+++
T Consensus        86 ~lv~e~~-~~~L~~~~~-----~~~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~~~  156 (328)
T cd07856          86 YFVTELL-GTDLHRLLT-----SRPLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLAR  156 (328)
T ss_pred             EEEeehh-ccCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCcccccc
Confidence            9999998 678988873     23478888889999999999999984   59999999999999999999999999987


Q ss_pred             cCCCCCCcceeeecccCCccccCcccccc-CCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccc--
Q 039626          491 PAEGQEGEFALTRHIVGTKGYMAPEYLEN-GLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKE--  567 (628)
Q Consensus       491 ~~~~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~--  567 (628)
                      ......      ....++..|+|||.+.+ ..++.++||||||++++||++|+.|+.......   ....+.......  
T Consensus       157 ~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~---~~~~~~~~~~~~~~  227 (328)
T cd07856         157 IQDPQM------TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVN---QFSIITDLLGTPPD  227 (328)
T ss_pred             ccCCCc------CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCCCH
Confidence            553221      22357889999998866 568999999999999999999998886433211   011111111000  


Q ss_pred             ------cchhhhccccCCcCCCCCCH-----HHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 039626          568 ------DGEESLRHFIDPTLQGNYPL-----ELALLVIRLIDACLKKDPTDRPTMYEIEHS  617 (628)
Q Consensus       568 ------~~~~~l~~~~d~~l~~~~~~-----~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~  617 (628)
                            ......+-+.+-......+.     ..+..+.+++.+||+.+|++||++.+++..
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~  288 (328)
T cd07856         228 DVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH  288 (328)
T ss_pred             HHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence                  00000000000011111111     234578899999999999999999998754

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=99.97  E-value=6.9e-30  Score=261.84  Aligned_cols=244  Identities=25%  Similarity=0.366  Sum_probs=179.5

Q ss_pred             eEEEEEEE--CCceEEEEEecc---------chHHHHHHHhhc---CCCceeeeeeeeecCCe-----EEEEEEecCCCC
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG---------DVSKEIALLNKI---NHSNLIILSGVCFNEGN-----CYLVYEYAVNGT  421 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~---------~~~~E~~~l~~l---~H~nIv~l~g~~~~~~~-----~~lV~E~~~~gs  421 (628)
                      |.||+|+.  ++..+|+|+++.         .+.+|+.++.++   +|+|++++++++...+.     .+++|||+. ++
T Consensus        13 ~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~l~~e~~~-~~   91 (287)
T cd07838          13 GTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVD-QD   91 (287)
T ss_pred             eEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCceeEEEehhcc-cC
Confidence            89999998  478999999862         245687777666   69999999999987766     899999996 58


Q ss_pred             hHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCccee
Q 039626          422 LSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFAL  501 (628)
Q Consensus       422 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~  501 (628)
                      |.+++....  ...++|..+..++.|++.||.|||+.   +++|+||+|+||++++++.+||+|||++........    
T Consensus        92 l~~~l~~~~--~~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~~~~----  162 (287)
T cd07838          92 LATYLSKCP--KPGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMA----  162 (287)
T ss_pred             HHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCcceeccCCcc----
Confidence            999885432  23589999999999999999999984   599999999999999999999999999877643221    


Q ss_pred             eecccCCccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhh-h----ccc
Q 039626          502 TRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEES-L----RHF  576 (628)
Q Consensus       502 ~~~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-l----~~~  576 (628)
                      .....++..|+|||.+.+..++.++|+||||++++||++|+.|+......  ..+.+.............. .    ...
T Consensus       163 ~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (287)
T cd07838         163 LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEA--DQLDKIFDVIGLPSEEEWPRNVSLPRSS  240 (287)
T ss_pred             cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChH--HHHHHHHHHcCCCChHhcCCCcccchhh
Confidence            12335788999999999999999999999999999999998887643221  1111121111100000000 0    000


Q ss_pred             cCCcCC---CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          577 IDPTLQ---GNYPLELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       577 ~d~~l~---~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      ......   .....+....+.+++.+||+.||.+||+++|++.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~  283 (287)
T cd07838         241 FPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ  283 (287)
T ss_pred             cccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence            000000   1111234567789999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=99.97  E-value=1.4e-30  Score=265.78  Aligned_cols=227  Identities=31%  Similarity=0.412  Sum_probs=182.7

Q ss_pred             eEEEEEEE--CCceEEEEEecc----------chHHHHHHHhhcC-CCceeeeeeeeecCCeEEEEEEecCCCChHHHhh
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG----------DVSKEIALLNKIN-HSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVF  427 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~  427 (628)
                      |.||+++.  ++..+|+|....          .+.+|.+++++++ |+||+++++++.+++..++||||+++++|.+++.
T Consensus        15 ~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~   94 (280)
T cd05581          15 STVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIR   94 (280)
T ss_pred             eEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEEcCCCCCcHHHHHH
Confidence            89999998  688999998753          3567899999998 9999999999999999999999999999999995


Q ss_pred             hcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCc---------
Q 039626          428 SNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGE---------  498 (628)
Q Consensus       428 ~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~---------  498 (628)
                      .    ...+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++++|||++.........         
T Consensus        95 ~----~~~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~  167 (280)
T cd05581          95 K----YGSLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATN  167 (280)
T ss_pred             H----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCccccccCCccccccCCCCCcc
Confidence            4    23699999999999999999999985   4999999999999999999999999998866432211         


Q ss_pred             --------ceeeecccCCccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccch
Q 039626          499 --------FALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGE  570 (628)
Q Consensus       499 --------~~~~~~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  570 (628)
                              ........++..|+|||.+....++.++|+||||++++|+++|+.|+.....      .........     
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~------~~~~~~~~~-----  236 (280)
T cd05581         168 IDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNE------YLTFQKILK-----  236 (280)
T ss_pred             ccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccH------HHHHHHHHh-----
Confidence                    0122334678899999999888899999999999999999999998864331      111111110     


Q ss_pred             hhhccccCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCH----HHHH
Q 039626          571 ESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTM----YEIE  615 (628)
Q Consensus       571 ~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~----~ev~  615 (628)
                                .....+...+..+.+++.+||+.||.+||++    ++++
T Consensus       237 ----------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll  275 (280)
T cd05581         237 ----------LEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELK  275 (280)
T ss_pred             ----------cCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHh
Confidence                      0112223335668899999999999999999    6654

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=99.97  E-value=1.8e-30  Score=265.68  Aligned_cols=242  Identities=26%  Similarity=0.374  Sum_probs=182.4

Q ss_pred             eEEEEEEE--CCceEEEEEecc---------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhc
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG---------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSN  429 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~---------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~  429 (628)
                      |.||++..  +++.+++|+++.         .+.+|++++++++|+||+++++++..+...++|+||+++ +|.+++...
T Consensus        13 ~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~-~l~~~l~~~   91 (283)
T cd05118          13 GVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMDT-DLYKLIKDR   91 (283)
T ss_pred             ceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccCC-CHHHHHHhh
Confidence            89999988  678899998753         256799999999999999999999999999999999964 888888542


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCCc
Q 039626          430 KNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTK  509 (628)
Q Consensus       430 ~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~  509 (628)
                         ...+++..+..++.+++.||.|||+.   +++|+||||+||++++++.+||+|||.+........   ......++.
T Consensus        92 ---~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~  162 (283)
T cd05118          92 ---QRGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR---PYTHYVVTR  162 (283)
T ss_pred             ---cccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcc---cccCccCcc
Confidence               24689999999999999999999984   499999999999999999999999999887654321   122346788


Q ss_pred             cccCccccccC-CCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccC------CcC-
Q 039626          510 GYMAPEYLENG-LVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFID------PTL-  581 (628)
Q Consensus       510 ~Y~APE~l~~~-~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d------~~l-  581 (628)
                      .|+|||.+.+. ..+.++|+||||++++||++|+.|+......+  ........ ..... .+....+.+      ... 
T Consensus       163 ~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~--~~~~~~~~-~~~~~-~~~~~~~~~~~~~~~~~~~  238 (283)
T cd05118         163 WYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEID--QLFKIFRT-LGTPD-PEVWPKFTSLARNYKFSFP  238 (283)
T ss_pred             cccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHH-cCCCc-hHhcccchhhhhhhhhhhc
Confidence            99999998876 78999999999999999999998875432211  11111111 10000 000011100      000 


Q ss_pred             ------CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          582 ------QGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       582 ------~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                            ...........+.+++.+||+.||.+||++.+++.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~  279 (283)
T cd05118         239 KKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA  279 (283)
T ss_pred             cccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence                  00111235667899999999999999999999875

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=99.97  E-value=5e-30  Score=263.89  Aligned_cols=230  Identities=24%  Similarity=0.378  Sum_probs=177.9

Q ss_pred             eEEEEEEE-----CCceEEEEEecc-----------chHHHHHHHhhc-CCCceeeeeeeeecCCeEEEEEEecCCCChH
Q 039626          361 GSVYRGKI-----NGGFAAIKKVNG-----------DVSKEIALLNKI-NHSNLIILSGVCFNEGNCYLVYEYAVNGTLS  423 (628)
Q Consensus       361 G~Vy~g~~-----~g~~vavK~~~~-----------~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~  423 (628)
                      |.||++..     +|..+|+|.++.           .+.+|++++.++ +|+||+++.+++..+...++|+||+++++|.
T Consensus        14 g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   93 (290)
T cd05613          14 GKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELF   93 (290)
T ss_pred             ceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEEEEEecCCCCcHH
Confidence            89999886     578899998753           245699999999 5899999999999888999999999999999


Q ss_pred             HHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeee
Q 039626          424 DWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTR  503 (628)
Q Consensus       424 ~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~  503 (628)
                      +++..    ...+++.....++.|++.||.|||+.   +++||||+|+|||+++++.+||+|||+++........  ...
T Consensus        94 ~~l~~----~~~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~--~~~  164 (290)
T cd05613          94 THLSQ----RERFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVE--RAY  164 (290)
T ss_pred             HHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCccceeccccccc--ccc
Confidence            99954    24588899999999999999999984   5999999999999999999999999999865432211  122


Q ss_pred             cccCCccccCccccccC--CCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcC
Q 039626          504 HIVGTKGYMAPEYLENG--LVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTL  581 (628)
Q Consensus       504 ~~~gt~~Y~APE~l~~~--~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l  581 (628)
                      ...|+..|+|||.+...  ..+.++||||||++++||++|+.|+......  ....+........               
T Consensus       165 ~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~--~~~~~~~~~~~~~---------------  227 (290)
T cd05613         165 SFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEK--NSQAEISRRILKS---------------  227 (290)
T ss_pred             cccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcc--ccHHHHHHHhhcc---------------
Confidence            34688999999998753  4688999999999999999999987632211  1112222111110               


Q ss_pred             CCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 039626          582 QGNYPLELALLVIRLIDACLKKDPTDRP-----TMYEIEH  616 (628)
Q Consensus       582 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~ev~~  616 (628)
                      ...++......+.+++.+||+.||++||     ++++++.
T Consensus       228 ~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~  267 (290)
T cd05613         228 EPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK  267 (290)
T ss_pred             CCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence            0112333455678999999999999997     5555543

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=99.97  E-value=2.4e-30  Score=272.16  Aligned_cols=245  Identities=24%  Similarity=0.359  Sum_probs=178.5

Q ss_pred             eEEEEEEE--CCceEEEEEecc---------chHHHHHHHhhcCCCceeeeeeeeec----CCeEEEEEEecCCCChHHH
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG---------DVSKEIALLNKINHSNLIILSGVCFN----EGNCYLVYEYAVNGTLSDW  425 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~---------~~~~E~~~l~~l~H~nIv~l~g~~~~----~~~~~lV~E~~~~gsL~~~  425 (628)
                      |.||++..  +|+.+|+|++..         .+.+|+.+|++++|+||+++.+++..    ....++|+||+. |+|.++
T Consensus        19 g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~   97 (334)
T cd07855          19 GVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMDLME-SDLHHI   97 (334)
T ss_pred             eEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEEEEEehhh-hhHHHH
Confidence            88999987  688999998754         24579999999999999999998763    346899999995 689998


Q ss_pred             hhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCc-ceeeec
Q 039626          426 VFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGE-FALTRH  504 (628)
Q Consensus       426 l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~  504 (628)
                      +..    ...+++.....++.|++.||+|||+.   +++||||||+||++++++.+||+|||+++........ ......
T Consensus        98 ~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  170 (334)
T cd07855          98 IHS----DQPLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTE  170 (334)
T ss_pred             hcc----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEecccccceeecccCcCCCccccc
Confidence            843    34489999999999999999999984   5999999999999999999999999999765432211 111233


Q ss_pred             ccCCccccCcccccc-CCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhcccc-------chhhhccc
Q 039626          505 IVGTKGYMAPEYLEN-GLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKED-------GEESLRHF  576 (628)
Q Consensus       505 ~~gt~~Y~APE~l~~-~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~l~~~  576 (628)
                      ..++..|+|||.+.+ ..++.++||||||++++||++|+.||.......   ....+........       ....+.+.
T Consensus       171 ~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~---~~~~~~~~~g~~~~~~~~~~~~~~~~~~  247 (334)
T cd07855         171 YVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVH---QLKLILSVLGSPSEEVLNRIGSDRVRKY  247 (334)
T ss_pred             ccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHH---HHHHHHHHhCCChhHhhhhhchhhHHHH
Confidence            478899999998865 468999999999999999999999986422111   1111111110000       00001111


Q ss_pred             cCC-cCCCCCC-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          577 IDP-TLQGNYP-----LELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       577 ~d~-~l~~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      .+. ......+     ...+..+.+++++||+.||.+||++.+++.
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  293 (334)
T cd07855         248 IQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ  293 (334)
T ss_pred             HhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence            000 0000111     123567899999999999999999999876

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=99.97  E-value=1.1e-30  Score=274.02  Aligned_cols=251  Identities=26%  Similarity=0.345  Sum_probs=185.2

Q ss_pred             eEEEEEEE--CCceEEEEEecc---------chHHHHHHHhhcCCCceeeeeeeeecCC-----eEEEEEEecCCCChHH
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG---------DVSKEIALLNKINHSNLIILSGVCFNEG-----NCYLVYEYAVNGTLSD  424 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~---------~~~~E~~~l~~l~H~nIv~l~g~~~~~~-----~~~lV~E~~~~gsL~~  424 (628)
                      |.||+++.  .++.+|+|++..         .+.+|+.++++++|+||+++.+++....     ..++||||++ ++|.+
T Consensus        14 ~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~   92 (330)
T cd07834          14 GVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIVTELME-TDLHK   92 (330)
T ss_pred             eEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEEEecchh-hhHHH
Confidence            89999998  478999998754         3567999999999999999999998765     7899999997 58988


Q ss_pred             HhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeec
Q 039626          425 WVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRH  504 (628)
Q Consensus       425 ~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~  504 (628)
                      ++..    ...+++..+..++.+++.||+|||+.   +++|+||||+|||++.++.++|+|||++...............
T Consensus        93 ~l~~----~~~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~~~~~~~~  165 (330)
T cd07834          93 VIKS----PQPLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTE  165 (330)
T ss_pred             HHhC----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceEeecccccccccccc
Confidence            8843    23699999999999999999999985   4999999999999999999999999999876543211111233


Q ss_pred             ccCCccccCccccccC-CCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccc-------hhhhccc
Q 039626          505 IVGTKGYMAPEYLENG-LVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDG-------EESLRHF  576 (628)
Q Consensus       505 ~~gt~~Y~APE~l~~~-~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~l~~~  576 (628)
                      ..++..|+|||.+.+. .++.++|+||||++++||++|+.|+......+   ....+.........       ......+
T Consensus       166 ~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~---~~~~i~~~~~~~~~~~~~~~~~~~~~~~  242 (330)
T cd07834         166 YVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYID---QLNLIVEVLGTPSEEDLKFITSEKARNY  242 (330)
T ss_pred             cccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHH---HHHHHHHhcCCCChhHhhhccccchhhH
Confidence            4678899999999887 89999999999999999999999886443211   11111111100000       0000000


Q ss_pred             cCC-cCCC-----CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HHHhH
Q 039626          577 IDP-TLQG-----NYPLELALLVIRLIDACLKKDPTDRPTMYEIEHS--LSNIL  622 (628)
Q Consensus       577 ~d~-~l~~-----~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~--L~~l~  622 (628)
                      +.. ....     .........+.+++.+||+.||.+||++.+++..  ++++.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~  296 (330)
T cd07834         243 LKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLH  296 (330)
T ss_pred             HhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhc
Confidence            000 0000     0011235568899999999999999999999874  44443

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=99.97  E-value=3.6e-30  Score=267.25  Aligned_cols=246  Identities=26%  Similarity=0.355  Sum_probs=175.7

Q ss_pred             eEEEEEEE--CCceEEEEEecc---------chHHHHHHHhhcCCCceeeeeeeeecCC--------eEEEEEEecCCCC
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG---------DVSKEIALLNKINHSNLIILSGVCFNEG--------NCYLVYEYAVNGT  421 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~---------~~~~E~~~l~~l~H~nIv~l~g~~~~~~--------~~~lV~E~~~~gs  421 (628)
                      |.||++..  +++.+|+|++..         .+.+|++++++++|+||+++++++....        ..++|+||+. ++
T Consensus        22 ~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~lv~~~~~-~~  100 (311)
T cd07866          22 GEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMD-HD  100 (311)
T ss_pred             EEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccccCceEEEEEecCC-cC
Confidence            89999998  578899998742         3567999999999999999999876433        4699999995 47


Q ss_pred             hHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcc--
Q 039626          422 LSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEF--  499 (628)
Q Consensus       422 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~--  499 (628)
                      |.+.+..   ....+++.++..++.|+++||+|||+.   +++|+||||+||++++++.+||+|||+++.........  
T Consensus       101 l~~~~~~---~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~  174 (311)
T cd07866         101 LSGLLEN---PSVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKG  174 (311)
T ss_pred             HHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcCccchhccCCCccccc
Confidence            7777743   234699999999999999999999985   49999999999999999999999999998654322110  


Q ss_pred             ------eeeecccCCccccCcccccc-CCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhcccc-c--
Q 039626          500 ------ALTRHIVGTKGYMAPEYLEN-GLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKED-G--  569 (628)
Q Consensus       500 ------~~~~~~~gt~~Y~APE~l~~-~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~-~--  569 (628)
                            .......+++.|+|||.+.+ ..++.++||||||++++||++|+.|+.......   ..+.+........ .  
T Consensus       175 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~---~~~~~~~~~~~~~~~~~  251 (311)
T cd07866         175 GGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDID---QLHLIFKLCGTPTEETW  251 (311)
T ss_pred             CCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCCChhhc
Confidence                  11123467888999998765 458999999999999999999998876432211   1111111111000 0  


Q ss_pred             --hhhhccccCCcCCCCCC-------HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          570 --EESLRHFIDPTLQGNYP-------LELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       570 --~~~l~~~~d~~l~~~~~-------~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                        ...+....+.......+       ......+.+++.+||+.||.+|||+.|++.
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~  307 (311)
T cd07866         252 PGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE  307 (311)
T ss_pred             hhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence              00000100000000001       112256789999999999999999998874

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>PHA03210 serine/threonine kinase US3; Provisional

Probab=99.97  E-value=2.1e-30  Score=286.50  Aligned_cols=230  Identities=22%  Similarity=0.315  Sum_probs=161.4

Q ss_pred             chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhcCCC-CCCCCHHHHHHHHHHHHHHHHHHhcCC
Q 039626          381 DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNE-GKYLDWKQRIQIALDVATGLNYLHSFT  459 (628)
Q Consensus       381 ~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~  459 (628)
                      .+.+|+++|++++|+||+++++++.+.+..++|+|++ +++|.+++...... .......+...|+.|++.||+|||+. 
T Consensus       209 ~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~-  286 (501)
T PHA03210        209 QLENEILALGRLNHENILKIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK-  286 (501)
T ss_pred             HHHHHHHHHHhCCCCCcCcEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC-
Confidence            3568999999999999999999999999999999998 56788877543211 12234566778999999999999984 


Q ss_pred             CCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCCccccCccccccCCCCcccccHHHHHHHHHHH
Q 039626          460 NPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEML  539 (628)
Q Consensus       460 ~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELl  539 (628)
                        +|+||||||+|||++.++.+||+|||+++.......  .......||..|+|||++.+..++.++|||||||++|||+
T Consensus       287 --gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell  362 (501)
T PHA03210        287 --KLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKERE--AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDML  362 (501)
T ss_pred             --CeecCCCCHHHEEECCCCCEEEEeCCCceecCcccc--cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHH
Confidence              599999999999999999999999999987643221  1223357999999999999999999999999999999999


Q ss_pred             hCCCccccccc-cccccHHHHHHHHhccc----cchhhhccccCCc-C---CCCCC-----HHHHHHHHHHHHHhcccCC
Q 039626          540 TGKEAAALHAE-ENNMHLSDVLNAVLTKE----DGEESLRHFIDPT-L---QGNYP-----LELALLVIRLIDACLKKDP  605 (628)
Q Consensus       540 tG~~p~~~~~~-~~~~~~~~~~~~~~~~~----~~~~~l~~~~d~~-l---~~~~~-----~~~~~~l~~l~~~Cl~~dP  605 (628)
                      +|+.++..... .....+.+.+..+....    +....+..+++.. .   ....+     ......+.+++.+||+.||
T Consensus       363 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP  442 (501)
T PHA03210        363 SHDFCPIGDGGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDW  442 (501)
T ss_pred             HCCCCCccCCCCCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCc
Confidence            98854332111 11111222221111000    0000111111100 0   00000     0122346778999999999


Q ss_pred             CCCCCHHHHHH
Q 039626          606 TDRPTMYEIEH  616 (628)
Q Consensus       606 ~~RPs~~ev~~  616 (628)
                      ++|||+.|++.
T Consensus       443 ~~Rpsa~elL~  453 (501)
T PHA03210        443 HLRPGAAELLA  453 (501)
T ss_pred             ccCcCHHHHhh
Confidence            99999999975

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=99.97  E-value=1.7e-30  Score=273.54  Aligned_cols=247  Identities=27%  Similarity=0.379  Sum_probs=181.2

Q ss_pred             eEEEEEEE--CCceEEEEEecc---------chHHHHHHHhhcCCCceeeeeeeeecC-----CeEEEEEEecCCCChHH
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG---------DVSKEIALLNKINHSNLIILSGVCFNE-----GNCYLVYEYAVNGTLSD  424 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~---------~~~~E~~~l~~l~H~nIv~l~g~~~~~-----~~~~lV~E~~~~gsL~~  424 (628)
                      |.||++..  ++..+|||+++.         .+.+|+.++++++|+||+++++++...     ...++|+||+. ++|.+
T Consensus        19 ~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~   97 (337)
T cd07858          19 GIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYELMD-TDLHQ   97 (337)
T ss_pred             eEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEEEEEeCCC-CCHHH
Confidence            89999987  688999998753         245699999999999999999988644     34799999995 78988


Q ss_pred             HhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeec
Q 039626          425 WVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRH  504 (628)
Q Consensus       425 ~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~  504 (628)
                      ++..    ...+++.....++.|++.||.|||+.   +++||||||+||+++.++.+||+|||+++......   .....
T Consensus        98 ~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~---~~~~~  167 (337)
T cd07858          98 IIRS----SQTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKG---DFMTE  167 (337)
T ss_pred             HHhc----CCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCccccccCCCc---ccccc
Confidence            8843    34599999999999999999999984   59999999999999999999999999998764321   11223


Q ss_pred             ccCCccccCcccccc-CCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccc-------hhhhccc
Q 039626          505 IVGTKGYMAPEYLEN-GLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDG-------EESLRHF  576 (628)
Q Consensus       505 ~~gt~~Y~APE~l~~-~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~l~~~  576 (628)
                      ..++..|+|||.+.. ..++.++||||||++++||++|+.|+.......   ....+.........       .......
T Consensus       168 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (337)
T cd07858         168 YVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVH---QLKLITELLGSPSEEDLGFIRNEKARRY  244 (337)
T ss_pred             cccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHH---HHHHHHHHhCCCChHHhhhcCchhhhHH
Confidence            467889999998865 568999999999999999999999886432111   11111111110000       0000000


Q ss_pred             c-------CCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HHHhH
Q 039626          577 I-------DPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHS--LSNIL  622 (628)
Q Consensus       577 ~-------d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~--L~~l~  622 (628)
                      +       ++.... ...+.+..+.+++.+||+.||++|||++|+++.  ++.+.
T Consensus       245 ~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~  298 (337)
T cd07858         245 IRSLPYTPRQSFAR-LFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLH  298 (337)
T ss_pred             HHhcCcccccCHHH-HcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhc
Confidence            0       000000 011345667899999999999999999999876  55443

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=99.97  E-value=2.6e-30  Score=242.87  Aligned_cols=227  Identities=24%  Similarity=0.306  Sum_probs=176.8

Q ss_pred             EEEEEEE--CCceEEEEEec---------cchHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhcC
Q 039626          362 SVYRGKI--NGGFAAIKKVN---------GDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNK  430 (628)
Q Consensus       362 ~Vy~g~~--~g~~vavK~~~---------~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~  430 (628)
                      .||+...  .|+.+|+|.++         +++.+|++|.+.|+|||||+|.....+.+..|||+|+|.|++|..=+-.  
T Consensus        26 vVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe~m~G~dl~~eIV~--  103 (355)
T KOG0033|consen   26 VVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVA--  103 (355)
T ss_pred             HHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEecccchHHHHHHHH--
Confidence            3444433  45556655442         2567899999999999999999999999999999999999999766533  


Q ss_pred             CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCC---CCcEEEccccccccCCCCCCcceeeecccC
Q 039626          431 NEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDS---DLRAKIANFAMARPAEGQEGEFALTRHIVG  507 (628)
Q Consensus       431 ~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~---~~~~kl~Dfgla~~~~~~~~~~~~~~~~~g  507 (628)
                        ....++...-....||+++|.|+|.   ++|+|||+||.|+||-.   .--+||+|||+|..+.++.    .....+|
T Consensus       104 --R~~ySEa~aSH~~rQiLeal~yCH~---n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g~----~~~G~~G  174 (355)
T KOG0033|consen  104 --REFYSEADASHCIQQILEALAYCHS---NGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDGE----AWHGFAG  174 (355)
T ss_pred             --HHHHHHHHHHHHHHHHHHHHHHHHh---cCceeccCChhheeeeeccCCCceeecccceEEEeCCcc----ccccccC
Confidence              2457788888999999999999998   55999999999999943   3458999999999876322    3445789


Q ss_pred             CccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCH
Q 039626          508 TKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPL  587 (628)
Q Consensus       508 t~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~  587 (628)
                      ||+|||||++....++..+|||+-||+|+-|+.|+.||...+      ..+...++.....           ...+.+-.
T Consensus       175 tP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~------~~rlye~I~~g~y-----------d~~~~~w~  237 (355)
T KOG0033|consen  175 TPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED------QHRLYEQIKAGAY-----------DYPSPEWD  237 (355)
T ss_pred             CCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCcc------HHHHHHHHhcccc-----------CCCCcccC
Confidence            999999999999999999999999999999999999987422      2233333332211           11122223


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          588 ELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       588 ~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      ...++..+|+++||..||.+|.|+.|.+.
T Consensus       238 ~is~~Ak~LvrrML~~dP~kRIta~EAL~  266 (355)
T KOG0033|consen  238 TVTPEAKSLIRRMLTVNPKKRITADEALK  266 (355)
T ss_pred             cCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence            44566789999999999999999998764

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=99.97  E-value=7.4e-30  Score=260.95  Aligned_cols=242  Identities=28%  Similarity=0.378  Sum_probs=181.1

Q ss_pred             eEEEEEEE--CCceEEEEEecc---------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhc
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG---------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSN  429 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~---------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~  429 (628)
                      |.||+|+.  +++.+|+|....         .+..|+.++++++|+|++++.+++.+.+..++|+||++ ++|.+++...
T Consensus        13 ~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~i~~~   91 (282)
T cd07829          13 GVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCD-MDLKKYLDKR   91 (282)
T ss_pred             ceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcC-cCHHHHHHhh
Confidence            89999998  478999998764         35679999999999999999999999999999999997 5999999643


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCCc
Q 039626          430 KNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTK  509 (628)
Q Consensus       430 ~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~  509 (628)
                      .   ..+++..+..++.+++.||+|||+.   +++|+||+|+||++++++.+||+|||+++........   .....++.
T Consensus        92 ~---~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~---~~~~~~~~  162 (282)
T cd07829          92 P---GPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRT---YTHEVVTL  162 (282)
T ss_pred             c---cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCCccc---cCccccCc
Confidence            2   4589999999999999999999995   4999999999999999999999999998876432211   12234577


Q ss_pred             cccCccccccC-CCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccc------------hhhhccc
Q 039626          510 GYMAPEYLENG-LVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDG------------EESLRHF  576 (628)
Q Consensus       510 ~Y~APE~l~~~-~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~------------~~~l~~~  576 (628)
                      .|+|||.+.+. .++.++||||||++++|+++|+.|+.......   ....+.........            ......+
T Consensus       163 ~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (282)
T cd07829         163 WYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEID---QLFKIFQILGTPTEESWPGVTKLPDYKPTFPKF  239 (282)
T ss_pred             CcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHH---HHHHHHHHhCCCcHHHHHhhccccccccccccc
Confidence            89999998766 88999999999999999999998876433211   11111111110000            0000000


Q ss_pred             cCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          577 IDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       577 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      .........+ .....+.+++++||+.||++||++.+++.
T Consensus       240 ~~~~~~~~~~-~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  278 (282)
T cd07829         240 PPKDLEKVLP-RLDPEGIDLLSKMLQYNPAKRISAKEALK  278 (282)
T ss_pred             CccchHHhcc-cccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence            0000000011 12456899999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=99.97  E-value=2.8e-30  Score=275.31  Aligned_cols=255  Identities=25%  Similarity=0.383  Sum_probs=195.0

Q ss_pred             eEEEEEEE--CCceEEEEEecc--------chHHHHHHHhhcCCCceeeeeeeeecCC------eEEEEEEecCCCChHH
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG--------DVSKEIALLNKINHSNLIILSGVCFNEG------NCYLVYEYAVNGTLSD  424 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~--------~~~~E~~~l~~l~H~nIv~l~g~~~~~~------~~~lV~E~~~~gsL~~  424 (628)
                      |.||+|+.  .|+.||||..+.        ...+|+++|++++|+|||++++.-....      ...+||||+.+|||..
T Consensus        27 g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmEyC~gGsL~~  106 (732)
T KOG4250|consen   27 GNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVMEYCSGGSLRK  106 (732)
T ss_pred             ceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEEeecCCCcHHH
Confidence            89999996  799999998865        2457999999999999999999977544      5789999999999999


Q ss_pred             HhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeC--C--CCcEEEccccccccCCCCCCcce
Q 039626          425 WVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLD--S--DLRAKIANFAMARPAEGQEGEFA  500 (628)
Q Consensus       425 ~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~--~--~~~~kl~Dfgla~~~~~~~~~~~  500 (628)
                      .|... .+...|++.+.+.+..+++.||.|||+   ++|+||||||.||++-  +  .-.-||+|||.|+...+..    
T Consensus       107 ~L~~P-EN~~GLpE~e~l~lL~d~~~al~~LrE---n~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel~d~s----  178 (732)
T KOG4250|consen  107 VLNSP-ENAYGLPESEFLDLLSDLVSALRHLRE---NGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARELDDNS----  178 (732)
T ss_pred             HhcCc-ccccCCCHHHHHHHHHHHHHHHHHHHH---cCceeccCCCCcEEEeecCCCceEEeeecccccccCCCCC----
Confidence            99653 334569999999999999999999998   4599999999999983  2  2347999999999886543    


Q ss_pred             eeecccCCccccCccccc-cCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccc--------hh
Q 039626          501 LTRHIVGTKGYMAPEYLE-NGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDG--------EE  571 (628)
Q Consensus       501 ~~~~~~gt~~Y~APE~l~-~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~--------~~  571 (628)
                      .....+||..|++||... ...++...|.|||||++||.+||..||........  ..+..+....+...        .+
T Consensus       179 ~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~--~~~~~~~~~tkkp~~v~i~~~~~e  256 (732)
T KOG4250|consen  179 LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKN--NKEIMWHIITKKPSGVAIGAQEEE  256 (732)
T ss_pred             eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccc--cchhhhhhhccCCCceeEeeeccc
Confidence            456789999999999998 58899999999999999999999999986554321  12222222221110        00


Q ss_pred             --hhccccCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCC--CHHHHHHHHHHhHhhc
Q 039626          572 --SLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRP--TMYEIEHSLSNILNAS  625 (628)
Q Consensus       572 --~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP--s~~ev~~~L~~l~~~~  625 (628)
                        .++.-..-.............+-.++..+|..+|++|-  ...+....+..|++-.
T Consensus       257 Ngpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~~~  314 (732)
T KOG4250|consen  257 NGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILNLK  314 (732)
T ss_pred             CCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHhhh
Confidence              01000000012222345556677888889999999998  8888888888887643

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.97  E-value=2e-30  Score=272.93  Aligned_cols=222  Identities=24%  Similarity=0.402  Sum_probs=182.3

Q ss_pred             eEEEEEEE--CCceEEEEEecc---------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhc
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG---------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSN  429 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~---------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~  429 (628)
                      +.|..++.  .+..||||.+.+         .+.+|+++|+.++|||||+++.+......+|+||||+.+|.+.+||..+
T Consensus        70 ~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~eya~~ge~~~yl~~~  149 (596)
T KOG0586|consen   70 AKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVMEYASGGELFDYLVKH  149 (596)
T ss_pred             EEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEEeccCchhHHHHHhc
Confidence            78888877  789999998865         2467999999999999999999999999999999999999999999654


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCCc
Q 039626          430 KNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTK  509 (628)
Q Consensus       430 ~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~  509 (628)
                      .    .+.......++.|+.+|++|||+.+   |+|||||++||||+.+.++||+|||++..+....    ......|++
T Consensus       150 g----r~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~----~lqt~cgsp  218 (596)
T KOG0586|consen  150 G----RMKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFDYGL----MLQTFCGSP  218 (596)
T ss_pred             c----cchhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeecccc----cccccCCCC
Confidence            3    2445777889999999999999955   9999999999999999999999999998875332    345678999


Q ss_pred             cccCccccccCC-CCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCC--CC
Q 039626          510 GYMAPEYLENGL-VSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGN--YP  586 (628)
Q Consensus       510 ~Y~APE~l~~~~-~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~--~~  586 (628)
                      .|.|||.+.+.. ..+++|+||+|++||-|++|..||+...-.+                       +-++.+.+.  .+
T Consensus       219 pyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~-----------------------Lr~rvl~gk~rIp  275 (596)
T KOG0586|consen  219 PYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKE-----------------------LRPRVLRGKYRIP  275 (596)
T ss_pred             CccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccccc-----------------------ccchheeeeeccc
Confidence            999999998765 4789999999999999999999987433211                       111111111  12


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          587 LELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       587 ~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      .-...+..+++++++..+|.+|++++++.+
T Consensus       276 ~~ms~dce~lLrk~lvl~Pskr~~~dqim~  305 (596)
T KOG0586|consen  276 FYMSCDCEDLLRKFLVLNPSKRGPCDQIMK  305 (596)
T ss_pred             ceeechhHHHHHHhhccCccccCCHHHhhh
Confidence            233445678999999999999999999865

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=99.97  E-value=1.2e-29  Score=266.72  Aligned_cols=243  Identities=26%  Similarity=0.282  Sum_probs=179.0

Q ss_pred             eEEEEEEE--CCceEEEEEecc---------------------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEec
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG---------------------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYA  417 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~---------------------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~  417 (628)
                      |.||++..  .++.+|+|+++.                     .+.+|++++++++|+||+++++++..++..++||||+
T Consensus        23 g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  102 (335)
T PTZ00024         23 GKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIM  102 (335)
T ss_pred             eeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecCCcEEEEEecc
Confidence            89999987  688999998753                     2567999999999999999999999999999999999


Q ss_pred             CCCChHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCC
Q 039626          418 VNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEG  497 (628)
Q Consensus       418 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~  497 (628)
                      . |+|.+++..    ...+++.....++.|++.||+|||+.   +++|+||+|+||+++.++.+||+|||+++.......
T Consensus       103 ~-~~l~~~l~~----~~~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~~kl~dfg~~~~~~~~~~  174 (335)
T PTZ00024        103 A-SDLKKVVDR----KIRLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICKIADFGLARRYGYPPY  174 (335)
T ss_pred             c-cCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCCEEECCccceeecccccc
Confidence            6 699998843    34589999999999999999999984   599999999999999999999999999876541110


Q ss_pred             -----------cceeeecccCCccccCccccccC-CCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhc
Q 039626          498 -----------EFALTRHIVGTKGYMAPEYLENG-LVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLT  565 (628)
Q Consensus       498 -----------~~~~~~~~~gt~~Y~APE~l~~~-~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~  565 (628)
                                 .........++..|+|||.+.+. .++.++||||||++++||++|+.|+......+   ....+.....
T Consensus       175 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~---~~~~i~~~~~  251 (335)
T PTZ00024        175 SDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEID---QLGRIFELLG  251 (335)
T ss_pred             cccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhC
Confidence                       00011123467889999998764 46899999999999999999999886443211   1111111111


Q ss_pred             cccchhhhcc------------ccCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          566 KEDGEESLRH------------FIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       566 ~~~~~~~l~~------------~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      ... ......            ...+.... ........+.+++.+||+.+|++||+++|++.
T Consensus       252 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  312 (335)
T PTZ00024        252 TPN-EDNWPQAKKLPLYTEFTPRKPKDLKT-IFPNASDDAIDLLQSLLKLNPLERISAKEALK  312 (335)
T ss_pred             CCc-hhhCcchhhcccccccCcCCcccHHH-hCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence            100 000000            00000000 00122456789999999999999999999985

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=99.97  E-value=6.9e-30  Score=256.40  Aligned_cols=222  Identities=29%  Similarity=0.400  Sum_probs=180.8

Q ss_pred             eEEEEEEE--CCceEEEEEecc----------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhh
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG----------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFS  428 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  428 (628)
                      |.||++..  +++.+|+|.+..          .+..|++++++++|+||+++++.+..+...++||||+++++|.+++..
T Consensus         7 ~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~   86 (250)
T cd05123           7 GKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGELFSHLSK   86 (250)
T ss_pred             eEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcHHHHHHh
Confidence            89999998  478999998753          356799999999999999999999999999999999999999999953


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCC
Q 039626          429 NKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGT  508 (628)
Q Consensus       429 ~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt  508 (628)
                      .    ..+++.....++.|++.||.|||+   .+++|+||+|+||+++.++.++|+|||++.......   .......++
T Consensus        87 ~----~~l~~~~~~~~~~qi~~~l~~lh~---~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~  156 (250)
T cd05123          87 E----GRFSEERARFYAAEIVLALEYLHS---LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG---SRTNTFCGT  156 (250)
T ss_pred             c----CCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcceEEEcCCCcEEEeecCcceecccCC---CcccCCcCC
Confidence            2    358999999999999999999998   459999999999999999999999999988764322   123345688


Q ss_pred             ccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCHH
Q 039626          509 KGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLE  588 (628)
Q Consensus       509 ~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~  588 (628)
                      ..|++||...+...+.++|+||||++++|+++|+.|+.....      .........             .  ....+..
T Consensus       157 ~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~------~~~~~~~~~-------------~--~~~~~~~  215 (250)
T cd05123         157 PEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR------KEIYEKILK-------------D--PLRFPEF  215 (250)
T ss_pred             ccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH------HHHHHHHhc-------------C--CCCCCCC
Confidence            899999999888899999999999999999999998863321      111111111             0  0112223


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCHHH
Q 039626          589 LALLVIRLIDACLKKDPTDRPTMYE  613 (628)
Q Consensus       589 ~~~~l~~l~~~Cl~~dP~~RPs~~e  613 (628)
                      .+..+.+++++||..||++||++.+
T Consensus       216 ~~~~l~~~i~~~l~~~p~~R~~~~~  240 (250)
T cd05123         216 LSPEARDLISGLLQKDPTKRLGSGG  240 (250)
T ss_pred             CCHHHHHHHHHHhcCCHhhCCCccc
Confidence            3456789999999999999999965

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=99.97  E-value=8e-30  Score=269.37  Aligned_cols=262  Identities=23%  Similarity=0.316  Sum_probs=188.3

Q ss_pred             eeecHHHHHHHhcCCCcCCccc----eEEEEEEE--CCceEEEEEecc---------chHHHHHHHhhcCCCceeeeeee
Q 039626          339 KVYSFKELQSATDNFSFTCRIQ----GSVYRGKI--NGGFAAIKKVNG---------DVSKEIALLNKINHSNLIILSGV  403 (628)
Q Consensus       339 ~~~~~~el~~at~~f~~~~~i~----G~Vy~g~~--~g~~vavK~~~~---------~~~~E~~~l~~l~H~nIv~l~g~  403 (628)
                      ++...+++...+++|.....+|    |.||++..  +++.+|+|+++.         .+.+|++++.+++|+||+++.++
T Consensus         5 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~   84 (345)
T cd07877           5 RQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV   84 (345)
T ss_pred             hhhHHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeee
Confidence            3445567777888887665554    89999986  688999998863         24569999999999999999998


Q ss_pred             eecC------CeEEEEEEecCCCChHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCC
Q 039626          404 CFNE------GNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDS  477 (628)
Q Consensus       404 ~~~~------~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~  477 (628)
                      +...      ...+++++++ +++|.+++..     ..+++..+..++.|++.||+|||+.   +++||||||+||++++
T Consensus        85 ~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~  155 (345)
T cd07877          85 FTPARSLEEFNDVYLVTHLM-GADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNE  155 (345)
T ss_pred             eeecccccccccEEEEehhc-ccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcC
Confidence            8643      3468888887 8899988732     3489999999999999999999984   4999999999999999


Q ss_pred             CCcEEEccccccccCCCCCCcceeeecccCCccccCcccccc-CCCCcccccHHHHHHHHHHHhCCCccccccccccccH
Q 039626          478 DLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLEN-GLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHL  556 (628)
Q Consensus       478 ~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~  556 (628)
                      ++.+||+|||+++.....      .....++..|+|||.+.+ ..++.++||||||++++||++|+.|+.......  .+
T Consensus       156 ~~~~kl~dfg~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~--~~  227 (345)
T cd07877         156 DCELKILDFGLARHTDDE------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID--QL  227 (345)
T ss_pred             CCCEEEeccccccccccc------ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HH
Confidence            999999999998865322      123467889999998866 568899999999999999999999875322111  11


Q ss_pred             HHHHHHHhccc---------cchhhhccccCCcCCCCC---CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 039626          557 SDVLNAVLTKE---------DGEESLRHFIDPTLQGNY---PLELALLVIRLIDACLKKDPTDRPTMYEIEHS  617 (628)
Q Consensus       557 ~~~~~~~~~~~---------~~~~~l~~~~d~~l~~~~---~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~  617 (628)
                      ...........         .........++......+   .......+.+++.+|++.||.+||++.+++..
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h  300 (345)
T cd07877         228 KLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  300 (345)
T ss_pred             HHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence            11111000000         000000000000000000   00124467899999999999999999998753

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>PHA02882 putative serine/threonine kinase; Provisional

Probab=99.97  E-value=1.3e-29  Score=261.68  Aligned_cols=234  Identities=17%  Similarity=0.165  Sum_probs=166.1

Q ss_pred             eEEEEEEECC-----ceEEEEEecc---chH---------------HHHHHHhhcCCCceeeeeeeeecCC----eEEEE
Q 039626          361 GSVYRGKING-----GFAAIKKVNG---DVS---------------KEIALLNKINHSNLIILSGVCFNEG----NCYLV  413 (628)
Q Consensus       361 G~Vy~g~~~g-----~~vavK~~~~---~~~---------------~E~~~l~~l~H~nIv~l~g~~~~~~----~~~lV  413 (628)
                      |.||+|...+     ..+|+|....   .+.               .+...+..++|+|++++++++....    ..+++
T Consensus        26 G~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~~  105 (294)
T PHA02882         26 GCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGCGSFKRCRMYYRFIL  105 (294)
T ss_pred             ceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEeeeEecCCceEEEEE
Confidence            8999999843     3556664321   111               1233455678999999999876543    34677


Q ss_pred             EEecCCCChHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCC
Q 039626          414 YEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAE  493 (628)
Q Consensus       414 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~  493 (628)
                      +|++ ..++.+.+..    ....++..+..++.|++.||+|||+.   +++||||||+|||++.++.+||+|||+++...
T Consensus       106 ~~~~-~~~~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~~~~~~~l~DFGla~~~~  177 (294)
T PHA02882        106 LEKL-VENTKEIFKR----IKCKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGNNRGYIIDYGIASHFI  177 (294)
T ss_pred             Eehh-ccCHHHHHHh----hccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCcEEEEEcCCceeec
Confidence            7876 3466666532    22357888899999999999999984   59999999999999999999999999998764


Q ss_pred             CCCCcc----eeeecccCCccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccH---HHHHHHHhcc
Q 039626          494 GQEGEF----ALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHL---SDVLNAVLTK  566 (628)
Q Consensus       494 ~~~~~~----~~~~~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~---~~~~~~~~~~  566 (628)
                      ......    .......||+.|+|||.+.+..++.++|||||||+++||++|+.||...........   .+....+.  
T Consensus       178 ~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~~~~~~~~~--  255 (294)
T PHA02882        178 IHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAKCDFIKRLH--  255 (294)
T ss_pred             cCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhHHHHHHHhh--
Confidence            221110    111234699999999999999999999999999999999999999975422211100   11111111  


Q ss_pred             ccchhhhccccCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 039626          567 EDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSL  618 (628)
Q Consensus       567 ~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L  618 (628)
                                 .....   ....+..+.+++..|++.+|++||++.++.+.|
T Consensus       256 -----------~~~~~---~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~  293 (294)
T PHA02882        256 -----------EGKIK---IKNANKFIYDFIECVTKLSYEEKPDYDALIKIF  293 (294)
T ss_pred             -----------hhhhc---cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence                       01100   112245688999999999999999999999876

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=9.3e-31  Score=272.85  Aligned_cols=230  Identities=24%  Similarity=0.399  Sum_probs=181.5

Q ss_pred             ceEEEEEEEC--CceEEEEEec-------cchHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhcC
Q 039626          360 QGSVYRGKIN--GGFAAIKKVN-------GDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNK  430 (628)
Q Consensus       360 ~G~Vy~g~~~--g~~vavK~~~-------~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~  430 (628)
                      +|.|||++..  +-..|.|.+.       .++.-|++||....||+||+|++.|+.++.++++.|||.||..+..+..  
T Consensus        45 FGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~GGAVDaimlE--  122 (1187)
T KOG0579|consen   45 FGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGGGAVDAIMLE--  122 (1187)
T ss_pred             chhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCCchHhHHHHH--
Confidence            4999999884  3344666653       2577799999999999999999999999999999999999999888743  


Q ss_pred             CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCCcc
Q 039626          431 NEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKG  510 (628)
Q Consensus       431 ~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~  510 (628)
                       -++.|+..++.-++.+++.||.|||+   ..|||||||..|||++-+|.++|+|||.+-...   ..........|||.
T Consensus       123 -L~r~LtE~QIqvvc~q~ldALn~LHs---~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~---~t~qkRDsFIGTPY  195 (1187)
T KOG0579|consen  123 -LGRVLTEDQIQVVCYQVLDALNWLHS---QNIIHRDLKAGNILLTLDGDIRLADFGVSAKNK---STRQKRDSFIGTPY  195 (1187)
T ss_pred             -hccccchHHHHHHHHHHHHHHHHHhh---cchhhhhccccceEEEecCcEeeecccccccch---hHHhhhccccCCcc
Confidence             35679999999999999999999999   459999999999999999999999999975432   12223445689999


Q ss_pred             ccCccccc-----cCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCC
Q 039626          511 YMAPEYLE-----NGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNY  585 (628)
Q Consensus       511 Y~APE~l~-----~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~  585 (628)
                      |||||++.     ...|+.++||||||+.|.||.-+.+|-..      .....++-.+...+          .|.+  -.
T Consensus       196 WMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhe------lnpMRVllKiaKSe----------PPTL--lq  257 (1187)
T KOG0579|consen  196 WMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHE------LNPMRVLLKIAKSE----------PPTL--LQ  257 (1187)
T ss_pred             cccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccc------cchHHHHHHHhhcC----------CCcc--cC
Confidence            99999874     56799999999999999999999877431      11122222222111          1111  12


Q ss_pred             CHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          586 PLELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       586 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      |......+.+++++||.+||..||++.++++
T Consensus       258 PS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~  288 (1187)
T KOG0579|consen  258 PSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK  288 (1187)
T ss_pred             cchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence            3445667889999999999999999999875

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=99.97  E-value=1.5e-29  Score=267.03  Aligned_cols=249  Identities=24%  Similarity=0.370  Sum_probs=180.2

Q ss_pred             hcCCCcCCccc----eEEEEEEE--CCceEEEEEecc---------chHHHHHHHhhcCCCceeeeeeeeecCC------
Q 039626          350 TDNFSFTCRIQ----GSVYRGKI--NGGFAAIKKVNG---------DVSKEIALLNKINHSNLIILSGVCFNEG------  408 (628)
Q Consensus       350 t~~f~~~~~i~----G~Vy~g~~--~g~~vavK~~~~---------~~~~E~~~l~~l~H~nIv~l~g~~~~~~------  408 (628)
                      .++|.....+|    |.||++..  +|..||+|+...         .+.+|++++++++|+||+++++++..+.      
T Consensus        14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   93 (343)
T cd07880          14 PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFH   93 (343)
T ss_pred             ccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccc
Confidence            44555444443    89999987  688999998753         2567999999999999999999987553      


Q ss_pred             eEEEEEEecCCCChHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccc
Q 039626          409 NCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAM  488 (628)
Q Consensus       409 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgl  488 (628)
                      ..++||||+ +++|.+++.     ...+++..+..++.|++.||+|||+.   +++||||||+||++++++.+||+|||+
T Consensus        94 ~~~lv~e~~-~~~l~~~~~-----~~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~dfg~  164 (343)
T cd07880          94 DFYLVMPFM-GTDLGKLMK-----HEKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGL  164 (343)
T ss_pred             eEEEEEecC-CCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeccc
Confidence            458999999 789988873     23589999999999999999999984   499999999999999999999999999


Q ss_pred             cccCCCCCCcceeeecccCCccccCcccccc-CCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHH------
Q 039626          489 ARPAEGQEGEFALTRHIVGTKGYMAPEYLEN-GLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLN------  561 (628)
Q Consensus       489 a~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~------  561 (628)
                      +......      .....+++.|+|||.+.+ ..++.++|+||||++++||++|+.|+.......  ...+...      
T Consensus       165 ~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~  236 (343)
T cd07880         165 ARQTDSE------MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLD--QLMEIMKVTGTPS  236 (343)
T ss_pred             ccccccC------ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHhcCCCC
Confidence            9865422      122457889999999876 468899999999999999999999886432110  0111100      


Q ss_pred             ----HHhccccchhhhc---cccCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          562 ----AVLTKEDGEESLR---HFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       562 ----~~~~~~~~~~~l~---~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                          ..+..........   ......+. .........+.+++.+|++.||.+||++.+++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~  297 (343)
T cd07880         237 KEFVQKLQSEDAKNYVKKLPRFRKKDFR-SLLPNANPLAVNVLEKMLVLDAESRITAAEALA  297 (343)
T ss_pred             HHHHHhhcchhHHHHHHhccccCcchHH-HhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence                0000000000000   00000000 001123445789999999999999999999883

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.96  E-value=1.8e-29  Score=250.81  Aligned_cols=228  Identities=32%  Similarity=0.454  Sum_probs=182.7

Q ss_pred             eEEEEEEE--CCceEEEEEec--------cchHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhcC
Q 039626          361 GSVYRGKI--NGGFAAIKKVN--------GDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNK  430 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~--------~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~  430 (628)
                      |.||+|+.  +|+.+++|+..        .++.+|++.+++++|+|++++++++..+...++++||+++++|.+++... 
T Consensus         3 g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~~-   81 (244)
T smart00220        3 GKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKKR-   81 (244)
T ss_pred             eEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHhc-
Confidence            89999999  46899999875        35678999999999999999999999999999999999999999998542 


Q ss_pred             CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCCcc
Q 039626          431 NEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKG  510 (628)
Q Consensus       431 ~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~  510 (628)
                         ..+++..+..++.+++.++.|||+.   +++|+||+|+||++++++.++++|||.+.......    ......++..
T Consensus        82 ---~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~----~~~~~~~~~~  151 (244)
T smart00220       82 ---GRLSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG----LLTTFVGTPE  151 (244)
T ss_pred             ---cCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc----ccccccCCcC
Confidence               2289999999999999999999995   59999999999999999999999999998765432    2234568889


Q ss_pred             ccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCHHHH
Q 039626          511 YMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELA  590 (628)
Q Consensus       511 Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~  590 (628)
                      |++||.+.+..++.++|||+||++++|+++|+.|+.....     ........ ....        ....   .......
T Consensus       152 ~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~-----~~~~~~~~-~~~~--------~~~~---~~~~~~~  214 (244)
T smart00220      152 YMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQ-----LLELFKKI-GKPK--------PPFP---PPEWKIS  214 (244)
T ss_pred             CCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc-----HHHHHHHH-hccC--------CCCc---cccccCC
Confidence            9999999988899999999999999999999988754211     11111111 1000        0000   0000034


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          591 LLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       591 ~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      ..+.+++.+|+..+|++||++.++++
T Consensus       215 ~~~~~~i~~~l~~~p~~Rp~~~~~~~  240 (244)
T smart00220      215 PEAKDLIRKLLVKDPEKRLTAEEALQ  240 (244)
T ss_pred             HHHHHHHHHHccCCchhccCHHHHhh
Confidence            56889999999999999999999986

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=99.96  E-value=5.8e-30  Score=270.11  Aligned_cols=245  Identities=23%  Similarity=0.313  Sum_probs=172.9

Q ss_pred             eEEEEEEE--CCceEEEEEecc-------chHHHHHHHhhcCCCceeeeeeeeecC--------------CeEEEEEEec
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG-------DVSKEIALLNKINHSNLIILSGVCFNE--------------GNCYLVYEYA  417 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~-------~~~~E~~~l~~l~H~nIv~l~g~~~~~--------------~~~~lV~E~~  417 (628)
                      |.||+|..  +|+.+|+|++..       .+.+|++++++++|+||+++++++...              ...++|+||+
T Consensus        19 g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~   98 (342)
T cd07854          19 GLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYM   98 (342)
T ss_pred             EEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccccccccceEEEEeecc
Confidence            89999988  578999998743       367899999999999999999876644              3578999999


Q ss_pred             CCCChHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeC-CCCcEEEccccccccCCCCC
Q 039626          418 VNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLD-SDLRAKIANFAMARPAEGQE  496 (628)
Q Consensus       418 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~-~~~~~kl~Dfgla~~~~~~~  496 (628)
                      + ++|.+++.     ...+++.....++.|++.||+|||+.   +++||||||+||+++ +++.+|++|||+++......
T Consensus        99 ~-~~L~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~~kl~dfg~~~~~~~~~  169 (342)
T cd07854          99 E-TDLANVLE-----QGPLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHY  169 (342)
T ss_pred             c-ccHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCceEEECCcccceecCCcc
Confidence            6 58988873     23488999999999999999999985   499999999999997 45678999999997653221


Q ss_pred             CcceeeecccCCccccCcccccc-CCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhcccc-chhh--
Q 039626          497 GEFALTRHIVGTKGYMAPEYLEN-GLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKED-GEES--  572 (628)
Q Consensus       497 ~~~~~~~~~~gt~~Y~APE~l~~-~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~--  572 (628)
                      ..........++..|+|||.+.. ..++.++|||||||+++||++|+.|+........  ............. ....  
T Consensus       170 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~  247 (342)
T cd07854         170 SHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQ--MQLILESVPVVREEDRNELL  247 (342)
T ss_pred             ccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHhcCCCChHHhhhhh
Confidence            11111123357889999997654 5688999999999999999999999864322110  0111110000000 0000  


Q ss_pred             --hccccC-CcCCCCC-----CHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          573 --LRHFID-PTLQGNY-----PLELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       573 --l~~~~d-~~l~~~~-----~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                        +...+. .......     .......+.+++.+||..||.+||++.|++.
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  299 (342)
T cd07854         248 NVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM  299 (342)
T ss_pred             hhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence              000000 0000000     1123456789999999999999999999874

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=99.96  E-value=1.2e-29  Score=267.94  Aligned_cols=238  Identities=27%  Similarity=0.395  Sum_probs=176.1

Q ss_pred             eEEEEEEE--CCceEEEEEecc---------chHHHHHHHhhcCCCceeeeeeeeecCCe------EEEEEEecCCCChH
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG---------DVSKEIALLNKINHSNLIILSGVCFNEGN------CYLVYEYAVNGTLS  423 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~---------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~------~~lV~E~~~~gsL~  423 (628)
                      |.||+|+.  ++..+|+|++..         .+.+|+.++++++|+||+++.+++..++.      .++|+||+ +++|.
T Consensus        29 g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~  107 (343)
T cd07851          29 GQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLM-GADLN  107 (343)
T ss_pred             eEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccccEEEEEecC-CCCHH
Confidence            89999998  578899998753         24569999999999999999998876554      89999998 77999


Q ss_pred             HHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeee
Q 039626          424 DWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTR  503 (628)
Q Consensus       424 ~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~  503 (628)
                      +++..     ..+++..+..++.+++.||+|||+.   +++|+||||+||++++++.+||+|||++......      ..
T Consensus       108 ~~~~~-----~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~~------~~  173 (343)
T cd07851         108 NIVKC-----QKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE------MT  173 (343)
T ss_pred             HHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEcccccccccccc------cc
Confidence            98842     3589999999999999999999984   5999999999999999999999999999865432      22


Q ss_pred             cccCCccccCcccccc-CCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhcccc-------chhhhcc
Q 039626          504 HIVGTKGYMAPEYLEN-GLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKED-------GEESLRH  575 (628)
Q Consensus       504 ~~~gt~~Y~APE~l~~-~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~l~~  575 (628)
                      ...++..|+|||.+.+ ..++.++||||||++++||++|+.|+.......  .+ ..+........       ..+....
T Consensus       174 ~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~--~~-~~i~~~~~~~~~~~~~~~~~~~~~~  250 (343)
T cd07851         174 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHID--QL-KRIMNLVGTPDEELLQKISSESARN  250 (343)
T ss_pred             CCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH--HH-HHHHHhcCCCCHHHHhhccchhHHH
Confidence            3467889999998865 467899999999999999999999886332211  01 11111110000       0000000


Q ss_pred             ccCC---cCCCCCC---HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          576 FIDP---TLQGNYP---LELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       576 ~~d~---~l~~~~~---~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      ++..   .....+.   ...+..+.+++.+||+.||.+|||+.||+.
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~  297 (343)
T cd07851         251 YIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA  297 (343)
T ss_pred             HHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence            1000   0000000   112456889999999999999999999864

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=99.96  E-value=4.4e-29  Score=262.29  Aligned_cols=243  Identities=26%  Similarity=0.353  Sum_probs=174.3

Q ss_pred             eEEEEEEEC----CceEEEEEecc---------chHHHHHHHhhc-CCCceeeeeeeeecC----CeEEEEEEecCCCCh
Q 039626          361 GSVYRGKIN----GGFAAIKKVNG---------DVSKEIALLNKI-NHSNLIILSGVCFNE----GNCYLVYEYAVNGTL  422 (628)
Q Consensus       361 G~Vy~g~~~----g~~vavK~~~~---------~~~~E~~~l~~l-~H~nIv~l~g~~~~~----~~~~lV~E~~~~gsL  422 (628)
                      |.||++...    +..+|+|++..         .+.+|+++++++ +|+||+++++++...    ...++++||+. ++|
T Consensus        14 g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~e~~~-~~L   92 (332)
T cd07857          14 GIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNELYLYEELME-ADL   92 (332)
T ss_pred             eEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcEEEEEeccc-CCH
Confidence            899999983    66899998753         356799999999 599999999986532    35788889885 689


Q ss_pred             HHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCc-cee
Q 039626          423 SDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGE-FAL  501 (628)
Q Consensus       423 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~-~~~  501 (628)
                      .+++..    ...+++..+..++.|++.||+|||+.   +++||||||+||++++++.+||+|||+++........ ...
T Consensus        93 ~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~  165 (332)
T cd07857          93 HQIIRS----GQPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGF  165 (332)
T ss_pred             HHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCCceeccccccccccc
Confidence            998843    34689999999999999999999985   4999999999999999999999999999865432211 111


Q ss_pred             eecccCCccccCcccccc-CCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccC--
Q 039626          502 TRHIVGTKGYMAPEYLEN-GLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFID--  578 (628)
Q Consensus       502 ~~~~~gt~~Y~APE~l~~-~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d--  578 (628)
                      .....|+..|+|||++.+ ..++.++|+||||++++||++|+.|+.......   ........+.... .+.+..+.+  
T Consensus       166 ~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~---~~~~~~~~~~~~~-~~~~~~~~~~~  241 (332)
T cd07857         166 MTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVD---QLNQILQVLGTPD-EETLSRIGSPK  241 (332)
T ss_pred             ccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHH---HHHHHHHHhCCCC-HHHHHhhhhhh
Confidence            223478999999998765 468999999999999999999998876432110   0110000000000 000000000  


Q ss_pred             -------------CcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          579 -------------PTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       579 -------------~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                                   ..+.... ......+.+++.+|++.||.+||+++|++.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~R~t~~~ll~  291 (332)
T cd07857         242 AQNYIRSLPNIPKKPFESIF-PNANPLALDLLEKLLAFDPTKRISVEEALE  291 (332)
T ss_pred             HHHHHHhccccCCcchHhhC-CCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence                         0000000 112456889999999999999999999864

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=99.96  E-value=8.7e-30  Score=245.78  Aligned_cols=236  Identities=20%  Similarity=0.237  Sum_probs=183.0

Q ss_pred             ccceEEEEEEE--CCceEEEEEecc--chHHHHHHHhhc-CCCceeeeeeeeecC----CeEEEEEEecCCCChHHHhhh
Q 039626          358 RIQGSVYRGKI--NGGFAAIKKVNG--DVSKEIALLNKI-NHSNLIILSGVCFNE----GNCYLVYEYAVNGTLSDWVFS  428 (628)
Q Consensus       358 ~i~G~Vy~g~~--~g~~vavK~~~~--~~~~E~~~l~~l-~H~nIv~l~g~~~~~----~~~~lV~E~~~~gsL~~~l~~  428 (628)
                      ++.|.|-....  .++.+|+|.+..  ..++|+++--.. .|+|||++++++.+.    .-+++|||.|+||.|...+..
T Consensus        73 GinGkV~~C~~k~T~ekfALKvL~Ds~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~meGGeLfsriq~  152 (400)
T KOG0604|consen   73 GINGKVVQCVHKRTQEKFALKVLLDSPKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECMEGGELFSRIQD  152 (400)
T ss_pred             ccCCceEEEEeccchhhhHHHHHhcCHHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeecccchHHHHHHHH
Confidence            34488877765  788999998865  578899876666 599999999998743    457889999999999998865


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCC---CCcEEEccccccccCCCCCCcceeeecc
Q 039626          429 NKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDS---DLRAKIANFAMARPAEGQEGEFALTRHI  505 (628)
Q Consensus       429 ~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~---~~~~kl~Dfgla~~~~~~~~~~~~~~~~  505 (628)
                      +  ....+++.+..+|..||+.|+.|||+..   |.||||||+|+|...   |-.+||+|||+|+.....    ......
T Consensus       153 ~--g~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~~----~~L~TP  223 (400)
T KOG0604|consen  153 R--GDQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQEP----GDLMTP  223 (400)
T ss_pred             c--ccccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEecccccccccCCC----ccccCC
Confidence            3  3456899999999999999999999965   999999999999964   567899999999865421    223456


Q ss_pred             cCCccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccc-cccHHHHHHHHhccccchhhhccccCCcCCCC
Q 039626          506 VGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEEN-NMHLSDVLNAVLTKEDGEESLRHFIDPTLQGN  584 (628)
Q Consensus       506 ~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~  584 (628)
                      .-|+.|.|||++...+++...|+||+||++|-|++|-+||....+.. ...+.             .+++..- -..+.+
T Consensus       224 c~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk-------------~rI~~gq-y~FP~p  289 (400)
T KOG0604|consen  224 CFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK-------------RRIRTGQ-YEFPEP  289 (400)
T ss_pred             cccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHH-------------hHhhccC-ccCCCh
Confidence            78999999999999999999999999999999999999998654321 00011             1110000 001111


Q ss_pred             CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          585 YPLELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       585 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      -....++...++++.+|..+|.+|.++.|++.
T Consensus       290 EWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~  321 (400)
T KOG0604|consen  290 EWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD  321 (400)
T ss_pred             hHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence            12356778899999999999999999998864

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=8.9e-30  Score=247.73  Aligned_cols=237  Identities=27%  Similarity=0.383  Sum_probs=191.3

Q ss_pred             eEEEEEEE--CCceEEEEEeccch----------HHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhh
Q 039626          361 GSVYRGKI--NGGFAAIKKVNGDV----------SKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFS  428 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~~~----------~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  428 (628)
                      |.|-..+-  .|+.+|+|.+++++          ..|-++|+..+||.+..|.-.+...+++|+||||+.||.|.-+|.+
T Consensus       182 GKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVMeyanGGeLf~HLsr  261 (516)
T KOG0690|consen  182 GKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVMEYANGGELFFHLSR  261 (516)
T ss_pred             ceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEEEEccCceEeeehhh
Confidence            77776665  78999999998753          2477899999999999998888899999999999999999988843


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCC
Q 039626          429 NKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGT  508 (628)
Q Consensus       429 ~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt  508 (628)
                          .+.+++....-+-..|+.||.|||+   .+|+.||+|.+|.|||.+|.+||+|||+++..-...   ..+....||
T Consensus       262 ----er~FsE~RtRFYGaEIvsAL~YLHs---~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~g---~t~kTFCGT  331 (516)
T KOG0690|consen  262 ----ERVFSEDRTRFYGAEIVSALGYLHS---RNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKYG---DTTKTFCGT  331 (516)
T ss_pred             ----hhcccchhhhhhhHHHHHHhhhhhh---CCeeeeechhhhheeccCCceEeeecccchhccccc---ceeccccCC
Confidence                4457777777789999999999999   459999999999999999999999999998542211   245668999


Q ss_pred             ccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCHH
Q 039626          509 KGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLE  588 (628)
Q Consensus       509 ~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~  588 (628)
                      |.|+|||++....|....|.|.+|||+|||++|+.||...+.+.   +-+.   ++. ++              -.+|..
T Consensus       332 PEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~k---LFeL---Il~-ed--------------~kFPr~  390 (516)
T KOG0690|consen  332 PEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEK---LFEL---ILM-ED--------------LKFPRT  390 (516)
T ss_pred             hhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhH---HHHH---HHh-hh--------------ccCCcc
Confidence            99999999999999999999999999999999999987433211   1111   111 00              134555


Q ss_pred             HHHHHHHHHHHhcccCCCCCC--CHHHHHHHHHHhHhhccCC
Q 039626          589 LALLVIRLIDACLKKDPTDRP--TMYEIEHSLSNILNASLNW  628 (628)
Q Consensus       589 ~~~~l~~l~~~Cl~~dP~~RP--s~~ev~~~L~~l~~~~~~w  628 (628)
                      +..+...|+...|.+||++|.  ..+++.+..+.-.-.++||
T Consensus       391 ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W  432 (516)
T KOG0690|consen  391 LSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDW  432 (516)
T ss_pred             CCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCCH
Confidence            566678899999999999994  4567777777777777887

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.96  E-value=7.8e-29  Score=282.47  Aligned_cols=123  Identities=26%  Similarity=0.440  Sum_probs=111.9

Q ss_pred             eEEEEEEEC--CceEEEEEecc----------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhh
Q 039626          361 GSVYRGKIN--GGFAAIKKVNG----------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFS  428 (628)
Q Consensus       361 G~Vy~g~~~--g~~vavK~~~~----------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  428 (628)
                      |.||+|...  ++.||||+++.          .+..|+.++..++|+||+++++++......++||||+++++|.+++..
T Consensus        18 g~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmEy~~g~~L~~li~~   97 (669)
T cd05610          18 GKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHI   97 (669)
T ss_pred             eEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEEeCCCCCCHHHHHHh
Confidence            899999984  88999998863          466799999999999999999999999999999999999999999953


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccc
Q 039626          429 NKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMAR  490 (628)
Q Consensus       429 ~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~  490 (628)
                          ...+++...+.|+.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++
T Consensus        98 ----~~~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          98 ----YGYFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             ----cCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence                23588899999999999999999984   59999999999999999999999999986

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.96  E-value=7.7e-30  Score=275.44  Aligned_cols=232  Identities=27%  Similarity=0.422  Sum_probs=179.9

Q ss_pred             ceEEEEEEECCceEEEEEeccc----hHHHHHHHhhc-CCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhcCCCCC
Q 039626          360 QGSVYRGKINGGFAAIKKVNGD----VSKEIALLNKI-NHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGK  434 (628)
Q Consensus       360 ~G~Vy~g~~~g~~vavK~~~~~----~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~  434 (628)
                      |+.||+|.+.|+.||||++-.+    ..+|+++|+.- +|+|||++++.-.++...|+..|.| ..+|.+++........
T Consensus       523 Gt~Vf~G~ye~R~VAVKrll~e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC-~~sL~dlie~~~~d~~  601 (903)
T KOG1027|consen  523 GTVVFRGVYEGREVAVKRLLEEFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC-ACSLQDLIESSGLDVE  601 (903)
T ss_pred             CcEEEEEeeCCceehHHHHhhHhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-hhhHHHHHhccccchh
Confidence            3689999999999999999775    35899999988 6999999999999999999999999 6799999965311111


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCC-----CCcEEEccccccccCCCCCCcceeeecccCCc
Q 039626          435 YLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDS-----DLRAKIANFAMARPAEGQEGEFALTRHIVGTK  509 (628)
Q Consensus       435 ~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~-----~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~  509 (628)
                      ...-...+.+..|+++||+|||+.+   |+||||||.||||+.     ..+++|+|||+++....+...........||-
T Consensus       602 ~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS~~r~s~~sGt~  678 (903)
T KOG1027|consen  602 MQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKSSFSRLSGGSGTS  678 (903)
T ss_pred             hcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccccccCCCcchhhcccCCCCcc
Confidence            1111334568899999999999955   999999999999976     36799999999999987666655556678999


Q ss_pred             cccCccccccCCCCcccccHHHHHHHHHHHhC-CCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCHH
Q 039626          510 GYMAPEYLENGLVSTKLDVYAFGVLILEMLTG-KEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLE  588 (628)
Q Consensus       510 ~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~  588 (628)
                      ||+|||.+....-+...||||+|||+|+.++| ..||......+.        .++...   ..+..+     . ..+ +
T Consensus       679 GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~--------NIl~~~---~~L~~L-----~-~~~-d  740 (903)
T KOG1027|consen  679 GWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQA--------NILTGN---YTLVHL-----E-PLP-D  740 (903)
T ss_pred             cccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhh--------hhhcCc---cceeee-----c-cCc-h
Confidence            99999999999889999999999999999987 677763322211        111111   111111     0 001 1


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCHHHHH
Q 039626          589 LALLVIRLIDACLKKDPTDRPTMYEIE  615 (628)
Q Consensus       589 ~~~~l~~l~~~Cl~~dP~~RPs~~ev~  615 (628)
                      +  +..+|+.+|++.||..||++.+|+
T Consensus       741 ~--eA~dLI~~ml~~dP~~RPsa~~VL  765 (903)
T KOG1027|consen  741 C--EAKDLISRMLNPDPQLRPSATDVL  765 (903)
T ss_pred             H--HHHHHHHHhcCCCcccCCCHHHHh
Confidence            1  567999999999999999999986

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=99.96  E-value=7.3e-29  Score=276.94  Aligned_cols=179  Identities=26%  Similarity=0.415  Sum_probs=127.2

Q ss_pred             EEEEEEecCCCChHHHhhhcCCCCCCC-CHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccc
Q 039626          410 CYLVYEYAVNGTLSDWVFSNKNEGKYL-DWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAM  488 (628)
Q Consensus       410 ~~lV~E~~~~gsL~~~l~~~~~~~~~l-~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgl  488 (628)
                      +|+-||||+...|.+++..+.    .. .-...++++.+|++||.|+|+.+   +|||||||.||+||++..+||+|||+
T Consensus       671 LYIQMEyCE~~ll~~iI~~N~----~~~~~d~~wrLFreIlEGLaYIH~~g---iIHRDLKP~NIFLd~~~~VKIGDFGL  743 (1351)
T KOG1035|consen  671 LYIQMEYCEKTLLRDIIRRNH----FNSQRDEAWRLFREILEGLAYIHDQG---IIHRDLKPRNIFLDSRNSVKIGDFGL  743 (1351)
T ss_pred             EEEEHhhhhhhHHHHHHHhcc----cchhhHHHHHHHHHHHHHHHHHHhCc---eeeccCCcceeEEcCCCCeeeccccc
Confidence            467788888877777664322    11 23456789999999999999955   99999999999999999999999999


Q ss_pred             cccCC----CC----------CC-cceeeecccCCccccCccccccC---CCCcccccHHHHHHHHHHHhCCCccccccc
Q 039626          489 ARPAE----GQ----------EG-EFALTRHIVGTKGYMAPEYLENG---LVSTKLDVYAFGVLILEMLTGKEAAALHAE  550 (628)
Q Consensus       489 a~~~~----~~----------~~-~~~~~~~~~gt~~Y~APE~l~~~---~~s~k~DV~SfGvvl~ELltG~~p~~~~~~  550 (628)
                      |....    ..          .+ .....+..+||..|+|||.+.+.   .|+.|+|+||+|||++||+--   |...  
T Consensus       744 At~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~yP---F~Ts--  818 (1351)
T KOG1035|consen  744 ATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEMLYP---FGTS--  818 (1351)
T ss_pred             chhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccchhhhHHHHHHHHHHhcc---CCch--
Confidence            98721    00          00 11123446899999999999765   499999999999999999863   3321  


Q ss_pred             cccccHHHHHHHHhccccchhhhccccCCcCCCC--CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          551 ENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGN--YPLELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       551 ~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~--~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                         |.....+...             .++.++..  +..+....-+++++++++.||.+|||+.|++.
T Consensus       819 ---MERa~iL~~L-------------R~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~  870 (1351)
T KOG1035|consen  819 ---MERASILTNL-------------RKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELLN  870 (1351)
T ss_pred             ---HHHHHHHHhc-------------ccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHhh
Confidence               2122222221             11222111  22233334578999999999999999999875

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.96  E-value=2.4e-28  Score=272.01  Aligned_cols=256  Identities=18%  Similarity=0.219  Sum_probs=164.2

Q ss_pred             HhcCCCcCCccc----eEEEEEEE--C----CceEEEEEeccchHHHHHHHhhcCC---Cceeeeeee------eecCCe
Q 039626          349 ATDNFSFTCRIQ----GSVYRGKI--N----GGFAAIKKVNGDVSKEIALLNKINH---SNLIILSGV------CFNEGN  409 (628)
Q Consensus       349 at~~f~~~~~i~----G~Vy~g~~--~----g~~vavK~~~~~~~~E~~~l~~l~H---~nIv~l~g~------~~~~~~  409 (628)
                      ..++|.....+|    |.||+|++  +    +..+|+|++......|..+..+++|   .+++.++..      +..+..
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e~~~~e~l~~~~~~~~~~~~~~~~~~~~~~~~~~  209 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEIWMNERVRRACPNSCADFVYGFLEPVSSKKEDE  209 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhHHHHHHHHHhhchhhHHHHHHhhhcccccccCCc
Confidence            456677666665    89999998  4    6799999987655555544444432   233322222      235567


Q ss_pred             EEEEEEecCCCChHHHhhhcCCC----------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCE
Q 039626          410 CYLVYEYAVNGTLSDWVFSNKNE----------------GKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNV  473 (628)
Q Consensus       410 ~~lV~E~~~~gsL~~~l~~~~~~----------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NI  473 (628)
                      .++||||+.+++|.+++......                .....+..+..++.|++.||+|||+.   +|+||||||+||
T Consensus       210 ~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDLKP~NI  286 (566)
T PLN03225        210 YWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDVKPQNI  286 (566)
T ss_pred             eEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcCCHHHE
Confidence            99999999999999998542110                00112334567999999999999984   599999999999


Q ss_pred             EeCC-CCcEEEccccccccCCCCCCcceeeecccCCccccCccccccC----------------------CCCcccccHH
Q 039626          474 LLDS-DLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENG----------------------LVSTKLDVYA  530 (628)
Q Consensus       474 Ll~~-~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~----------------------~~s~k~DV~S  530 (628)
                      |+++ ++.+||+|||+++.......  .......+++.|+|||.+...                      .++.++||||
T Consensus       287 Ll~~~~~~~KL~DFGlA~~l~~~~~--~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwS  364 (566)
T PLN03225        287 IFSEGSGSFKIIDLGAAADLRVGIN--YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYS  364 (566)
T ss_pred             EEeCCCCcEEEEeCCCccccccccc--cCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHH
Confidence            9986 58999999999986543221  123345789999999965322                      2345679999


Q ss_pred             HHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCC----C--CHHHHHHHHHHHHHhcccC
Q 039626          531 FGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGN----Y--PLELALLVIRLIDACLKKD  604 (628)
Q Consensus       531 fGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~----~--~~~~~~~l~~l~~~Cl~~d  604 (628)
                      |||+||||+++..+....       +......+.........+.....+....+    +  .........+|+.+||+.|
T Consensus       365 lGviL~el~~~~~~~~~~-------~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~d  437 (566)
T PLN03225        365 AGLIFLQMAFPNLRSDSN-------LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFK  437 (566)
T ss_pred             HHHHHHHHHhCcCCCchH-------HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCC
Confidence            999999999976543211       11111111111111111111111111000    0  0011223568999999999


Q ss_pred             CCCCCCHHHHHH
Q 039626          605 PTDRPTMYEIEH  616 (628)
Q Consensus       605 P~~RPs~~ev~~  616 (628)
                      |++|||++|+++
T Consensus       438 P~kR~ta~e~L~  449 (566)
T PLN03225        438 GRQRISAKAALA  449 (566)
T ss_pred             cccCCCHHHHhC
Confidence            999999999976

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.96  E-value=1.1e-28  Score=261.19  Aligned_cols=220  Identities=24%  Similarity=0.289  Sum_probs=175.8

Q ss_pred             eEEEEEEE--CCceEEEEEeccc---hHHHHHHHhhc-CCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhcCCCCC
Q 039626          361 GSVYRGKI--NGGFAAIKKVNGD---VSKEIALLNKI-NHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGK  434 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~~---~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~  434 (628)
                      +.|-++..  .+...++|.+.+.   ..+|+.++.+. +|+||+++.+.+.++.+.|+|||.+.+|-|.+.+...    +
T Consensus       336 s~~~~~~~~~t~~~~~vkii~~~~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~g~ell~ri~~~----~  411 (612)
T KOG0603|consen  336 SAVKYCESSPTDQEPAVKIISKRADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLDGGELLRRIRSK----P  411 (612)
T ss_pred             cceeeeeccccccchhheeccccccccccccchhhhhcCCCcceeecceecCCceeeeeehhccccHHHHHHHhc----c
Confidence            44445544  5677888888664   77888777766 7999999999999999999999999999888777432    2


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEe-CCCCcEEEccccccccCCCCCCcceeeecccCCccccC
Q 039626          435 YLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLL-DSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMA  513 (628)
Q Consensus       435 ~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl-~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~Y~A  513 (628)
                      ... ..+.+|+.+|+.++.|||+++   ++||||||+|||+ ++.+.++|+|||.++..+..      .....-|..|.|
T Consensus       412 ~~~-~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~------~~tp~~t~~y~A  481 (612)
T KOG0603|consen  412 EFC-SEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS------CDTPALTLQYVA  481 (612)
T ss_pred             hhH-HHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCchh------hcccchhhcccC
Confidence            223 677889999999999999955   9999999999999 58899999999999876543      223456789999


Q ss_pred             ccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCHHHHHHH
Q 039626          514 PEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLV  593 (628)
Q Consensus       514 PE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l  593 (628)
                      ||++....+++.+|+||||++||||++|+.|+..+...     .+....+                 ..+.+....+...
T Consensus       482 PEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~-----~ei~~~i-----------------~~~~~s~~vS~~A  539 (612)
T KOG0603|consen  482 PEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG-----IEIHTRI-----------------QMPKFSECVSDEA  539 (612)
T ss_pred             hhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch-----HHHHHhh-----------------cCCccccccCHHH
Confidence            99999999999999999999999999999998765443     1111111                 1122234566778


Q ss_pred             HHHHHHhcccCCCCCCCHHHHHH
Q 039626          594 IRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       594 ~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      .+|+.+||+.||.+||+|+++..
T Consensus       540 KdLl~~LL~~dP~~Rl~~~~i~~  562 (612)
T KOG0603|consen  540 KDLLQQLLQVDPALRLGADEIGA  562 (612)
T ss_pred             HHHHHHhccCChhhCcChhhhcc
Confidence            89999999999999999999865

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.95  E-value=7.4e-29  Score=247.29  Aligned_cols=241  Identities=20%  Similarity=0.263  Sum_probs=181.9

Q ss_pred             eEEEEEEE--CCceEEEEEecc------chHHHHHHHhhcCC-C-----ceeeeeeeeecCCeEEEEEEecCCCChHHHh
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG------DVSKEIALLNKINH-S-----NLIILSGVCFNEGNCYLVYEYAVNGTLSDWV  426 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~------~~~~E~~~l~~l~H-~-----nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l  426 (628)
                      |.|-....  .+..||||.++.      ...-|+++|+++++ .     -+|.+.+|+...++.|+|+|.+ |-|+.++|
T Consensus       103 GkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghiCivfell-G~S~~dFl  181 (415)
T KOG0671|consen  103 GKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHICIVFELL-GLSTFDFL  181 (415)
T ss_pred             cceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCceEEEEecc-ChhHHHHh
Confidence            77777665  467899998874      24559999999942 2     3788899999999999999998 77999999


Q ss_pred             hhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCC--------------------CCcEEEccc
Q 039626          427 FSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDS--------------------DLRAKIANF  486 (628)
Q Consensus       427 ~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~--------------------~~~~kl~Df  486 (628)
                      ..  +.-.+++..++..|+.|++++++|||+.   +++|-||||+|||+.+                    +..+||+||
T Consensus       182 k~--N~y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~~~~~k~~~~~~r~~ks~~I~vIDF  256 (415)
T KOG0671|consen  182 KE--NNYIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFKTYNPKKKVCFIRPLKSTAIKVIDF  256 (415)
T ss_pred             cc--CCccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceEEEeccCCccceeccCCCcceEEEec
Confidence            54  3445688899999999999999999994   5999999999999831                    345899999


Q ss_pred             cccccCCCCCCcceeeecccCCccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhcc
Q 039626          487 AMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTK  566 (628)
Q Consensus       487 gla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~  566 (628)
                      |.|+......      ..++.|..|.|||++.+-.++..+||||+||+|.||.+|...|+.+++.+.+.+   .+.++..
T Consensus       257 GsAtf~~e~h------s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLaM---MerIlGp  327 (415)
T KOG0671|consen  257 GSATFDHEHH------STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEHLAM---MERILGP  327 (415)
T ss_pred             CCcceeccCc------ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHHHHH---HHHhhCC
Confidence            9998764332      446789999999999999999999999999999999999999988775443222   2222211


Q ss_pred             ccc---h-h--------------------hhccccCCcCC----CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          567 EDG---E-E--------------------SLRHFIDPTLQ----GNYPLELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       567 ~~~---~-~--------------------~l~~~~d~~l~----~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      ...   . .                    .++...++..+    ......+...+++|+++||..||.+|+|++|++.
T Consensus       328 ~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~EAL~  405 (415)
T KOG0671|consen  328 IPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITLREALS  405 (415)
T ss_pred             CcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccccHHHHhc
Confidence            000   0 0                    00111111110    0123356778999999999999999999999874

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=99.95  E-value=1.2e-28  Score=252.88  Aligned_cols=226  Identities=27%  Similarity=0.413  Sum_probs=183.0

Q ss_pred             eEEEEEEE--CCceEEEEEecc---------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhc
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG---------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSN  429 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~---------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~  429 (628)
                      |.||-|+.  +|+.||||.+.+         ++++|+.||++++||.||.+-..|+..+..+.|||.+ +|+..+.+.. 
T Consensus       578 G~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl-~GDMLEMILS-  655 (888)
T KOG4236|consen  578 GTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKL-HGDMLEMILS-  655 (888)
T ss_pred             eeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhh-cchHHHHHHH-
Confidence            99999988  799999998854         4788999999999999999999999999999999999 5566665543 


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCC---CcEEEccccccccCCCCCCcceeeeccc
Q 039626          430 KNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSD---LRAKIANFAMARPAEGQEGEFALTRHIV  506 (628)
Q Consensus       430 ~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~---~~~kl~Dfgla~~~~~~~~~~~~~~~~~  506 (628)
                       .+...|++..-.-+..||+.||.|||..   +|+|+||||+||||...   -++||+|||+||.++...    ..+.++
T Consensus       656 -sEkgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks----FRrsVV  727 (888)
T KOG4236|consen  656 -SEKGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS----FRRSVV  727 (888)
T ss_pred             -hhcccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecchhh----hhhhhc
Confidence             2345688888888999999999999984   59999999999999654   469999999999987543    456789


Q ss_pred             CCccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCC
Q 039626          507 GTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYP  586 (628)
Q Consensus       507 gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~  586 (628)
                      ||+.|+|||+++...|....|+||.||++|--++|..||...+     .+.+.++..           .+|-|.   +-.
T Consensus       728 GTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdE-----dIndQIQNA-----------aFMyPp---~PW  788 (888)
T KOG4236|consen  728 GTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDE-----DINDQIQNA-----------AFMYPP---NPW  788 (888)
T ss_pred             CCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCcc-----chhHHhhcc-----------ccccCC---Cch
Confidence            9999999999999999999999999999999999999886322     233333221           122221   112


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 039626          587 LELALLVIRLIDACLKKDPTDRPTMYEIE  615 (628)
Q Consensus       587 ~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~  615 (628)
                      .+......+|+...|+..-.+|-|.+.-+
T Consensus       789 ~eis~~AidlIn~LLqVkm~kRysvdk~l  817 (888)
T KOG4236|consen  789 SEISPEAIDLINNLLQVKMRKRYSVDKSL  817 (888)
T ss_pred             hhcCHHHHHHHHHHHHHHHHHhcchHhhc
Confidence            35556678999999999999999876543

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=99.95  E-value=1.1e-29  Score=241.36  Aligned_cols=235  Identities=23%  Similarity=0.373  Sum_probs=177.9

Q ss_pred             ceEEEEEEE--CCceEEEEEecc--------chHHHHHHH-hhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhh
Q 039626          360 QGSVYRGKI--NGGFAAIKKVNG--------DVSKEIALL-NKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFS  428 (628)
Q Consensus       360 ~G~Vy~g~~--~g~~vavK~~~~--------~~~~E~~~l-~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  428 (628)
                      .|+|+|-..  .|...|||+++.        ++..|.+.. +.-+.||||+++|.+..++..|+.||.| .-||+.+...
T Consensus        77 fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELM-d~SlDklYk~  155 (361)
T KOG1006|consen   77 FGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELM-DISLDKLYKR  155 (361)
T ss_pred             chhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHH-hhhHHHHHHH
Confidence            489999877  688999999864        244455543 3447899999999999999999999999 5577655421


Q ss_pred             c-CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccC
Q 039626          429 N-KNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVG  507 (628)
Q Consensus       429 ~-~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~g  507 (628)
                      - ......+++...-+|..-.++||.||.+.  ..|||||+||+|||+|..|.+||+|||++-...+.   . ..+...|
T Consensus       156 vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~--lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~S---i-AkT~daG  229 (361)
T KOG1006|consen  156 VYSVQKSRIPENILGHITVATVDALDYLKEE--LKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDS---I-AKTVDAG  229 (361)
T ss_pred             HHHHHhccCcHhhhhheeeeehhHHHHHHHH--hhhhhccCChhheEEecCCCEeeecccchHhHHHH---H-HhhhccC
Confidence            1 12345588888888999999999999873  56999999999999999999999999998655322   1 2344579


Q ss_pred             CccccCcccccc--CCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCC-C
Q 039626          508 TKGYMAPEYLEN--GLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQG-N  584 (628)
Q Consensus       508 t~~Y~APE~l~~--~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~-~  584 (628)
                      ...|||||.+..  ..++-++||||+|+.|+|+.||+.|+.....     ..+.+..+..+..          |.+.. .
T Consensus       230 CrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s-----vfeql~~Vv~gdp----------p~l~~~~  294 (361)
T KOG1006|consen  230 CRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS-----VFEQLCQVVIGDP----------PILLFDK  294 (361)
T ss_pred             CccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH-----HHHHHHHHHcCCC----------CeecCcc
Confidence            999999999864  3589999999999999999999999874332     3344444433221          11111 1


Q ss_pred             CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          585 YPLELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       585 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      ........+.+++.-|+.+|-..||..+++.+
T Consensus       295 ~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~  326 (361)
T KOG1006|consen  295 ECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK  326 (361)
T ss_pred             cccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence            12345667899999999999999999999865

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.95  E-value=6.9e-28  Score=261.58  Aligned_cols=231  Identities=27%  Similarity=0.434  Sum_probs=185.7

Q ss_pred             ceEEEEEEE--CCceEEEEEecc------chHHHHHHHhhc-CCCceeeeeeeeec-----CCeEEEEEEecCCCChHHH
Q 039626          360 QGSVYRGKI--NGGFAAIKKVNG------DVSKEIALLNKI-NHSNLIILSGVCFN-----EGNCYLVYEYAVNGTLSDW  425 (628)
Q Consensus       360 ~G~Vy~g~~--~g~~vavK~~~~------~~~~E~~~l~~l-~H~nIv~l~g~~~~-----~~~~~lV~E~~~~gsL~~~  425 (628)
                      +|.||+++.  +|+.+|+|.+..      +...|.++|+.+ +|||++.++|++..     ++.+|||||||.+||.-|+
T Consensus        32 ygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWLVMEfC~gGSVTDL  111 (953)
T KOG0587|consen   32 YGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWLVMEFCGGGSVTDL  111 (953)
T ss_pred             ceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEEEeeccCCccHHHH
Confidence            378887766  788889888753      355677888877 69999999999973     4689999999999999999


Q ss_pred             hhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecc
Q 039626          426 VFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHI  505 (628)
Q Consensus       426 l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~  505 (628)
                      +..-.  +..+.|..+..|++.++.||.|||.   +.++|||||-.|||++.++.+|+.|||++........   .....
T Consensus       112 VKn~~--g~rl~E~~IaYI~re~lrgl~HLH~---nkviHRDikG~NiLLT~e~~VKLvDFGvSaQldsT~g---rRnT~  183 (953)
T KOG0587|consen  112 VKNTK--GNRLKEEWIAYILREILRGLAHLHN---NKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDSTVG---RRNTF  183 (953)
T ss_pred             Hhhhc--ccchhhHHHHHHHHHHHHHHHHHhh---cceeeecccCceEEEeccCcEEEeeeeeeeeeecccc---cccCc
Confidence            97654  6779999999999999999999998   5599999999999999999999999999886653321   23446


Q ss_pred             cCCccccCcccccc-----CCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCc
Q 039626          506 VGTKGYMAPEYLEN-----GLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPT  580 (628)
Q Consensus       506 ~gt~~Y~APE~l~~-----~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~  580 (628)
                      .||+.|||||++..     ..|+.++|+||+|++..||--|.+|+..      +.-.            +..+.-..+|.
T Consensus       184 iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~D------mHPm------------raLF~IpRNPP  245 (953)
T KOG0587|consen  184 IGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCD------MHPM------------RALFLIPRNPP  245 (953)
T ss_pred             CCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccC------cchh------------hhhccCCCCCC
Confidence            89999999999853     4578899999999999999999988652      1111            11112222344


Q ss_pred             CCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          581 LQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       581 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      .....|..-..++.+++..||.+|-++||++.++++
T Consensus       246 PkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~  281 (953)
T KOG0587|consen  246 PKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK  281 (953)
T ss_pred             ccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence            444456777888999999999999999999998874

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.95  E-value=1.5e-27  Score=214.42  Aligned_cols=244  Identities=25%  Similarity=0.338  Sum_probs=184.7

Q ss_pred             eEEEEEEE--CCceEEEEEecc---------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhc
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG---------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSN  429 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~---------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~  429 (628)
                      |+||||+.  .++.||+|+++-         ...+|+-+|+.++|+|||+++++...+..+-||+||+ .-+|..+... 
T Consensus        16 gtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~c-dqdlkkyfds-   93 (292)
T KOG0662|consen   16 GTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC-DQDLKKYFDS-   93 (292)
T ss_pred             eeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHh-hHHHHHHHHh-
Confidence            99999987  678999999863         3578999999999999999999999999999999999 5688888732 


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCCc
Q 039626          430 KNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTK  509 (628)
Q Consensus       430 ~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~  509 (628)
                        -+..++......+..|+.+||.|+|++.   +.|||+||.|.|++.||+.|++|||+++.++-.-.   --...+-|.
T Consensus        94 --lng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgipvr---cysaevvtl  165 (292)
T KOG0662|consen   94 --LNGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR---CYSAEVVTL  165 (292)
T ss_pred             --cCCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCceE---eeeceeeee
Confidence              3456888889999999999999999965   99999999999999999999999999998753321   123346789


Q ss_pred             cccCccccccC-CCCcccccHHHHHHHHHHHh-CCCccccccccccccHHHHHHHHhcc-ccchhhhccccCCcCCCCCC
Q 039626          510 GYMAPEYLENG-LVSTKLDVYAFGVLILEMLT-GKEAAALHAEENNMHLSDVLNAVLTK-EDGEESLRHFIDPTLQGNYP  586 (628)
Q Consensus       510 ~Y~APE~l~~~-~~s~k~DV~SfGvvl~ELlt-G~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~~~d~~l~~~~~  586 (628)
                      +|.+|.++.+. .|++..|+||-||++.|+.. |++.|...+-  ...+...++..-.. ++....+.++.|-..-.-||
T Consensus       166 wyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dv--ddqlkrif~~lg~p~ed~wps~t~lpdyk~yp~yp  243 (292)
T KOG0662|consen  166 WYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV--DDQLKRIFRLLGTPTEDQWPSMTKLPDYKPYPIYP  243 (292)
T ss_pred             eccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcH--HHHHHHHHHHhCCCccccCCccccCCCCcccCCcc
Confidence            99999998774 68999999999999999987 5544443322  12233333322221 22233444444443333332


Q ss_pred             H---------HHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          587 L---------ELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       587 ~---------~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      .         .....=.+++.+.+.-+|.+|.++++.++
T Consensus       244 attswsqivp~lns~grdllqkll~cnp~qrisaeaalq  282 (292)
T KOG0662|consen  244 ATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ  282 (292)
T ss_pred             ccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence            1         12223467888999999999999988764

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.95  E-value=6.1e-28  Score=234.70  Aligned_cols=261  Identities=21%  Similarity=0.298  Sum_probs=186.7

Q ss_pred             cHHHHHHHhcCCCcCCccceEEEEEEE--CCceEEEEEecc-------chHHHHHHHhhcC-CCceeeeeeeeecCCeEE
Q 039626          342 SFKELQSATDNFSFTCRIQGSVYRGKI--NGGFAAIKKVNG-------DVSKEIALLNKIN-HSNLIILSGVCFNEGNCY  411 (628)
Q Consensus       342 ~~~el~~at~~f~~~~~i~G~Vy~g~~--~g~~vavK~~~~-------~~~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~  411 (628)
                      +|+|+-+.|++...+ +..++|--.+.  +|..+|||.+.+       .+.+|++++.+.+ |+||++|+.+|+++..+|
T Consensus        74 ~F~d~YkLt~e~LGe-GAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FY  152 (463)
T KOG0607|consen   74 KFEDMYKLTSELLGE-GAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFY  152 (463)
T ss_pred             hHHHHHHhHHHHhcC-ccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEE
Confidence            356666666554321 11255554443  889999998865       3668999999985 999999999999999999


Q ss_pred             EEEEecCCCChHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCC---cEEEccccc
Q 039626          412 LVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDL---RAKIANFAM  488 (628)
Q Consensus       412 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~---~~kl~Dfgl  488 (628)
                      ||||.|.||+|..+++.    .+.+++....++..+|+.||.|||.   ++|.|||+||+|||-.+-.   -+||+||.|
T Consensus       153 LVfEKm~GGplLshI~~----~~~F~E~EAs~vvkdia~aLdFlH~---kgIAHRDlKPENiLC~~pn~vsPvKiCDfDL  225 (463)
T KOG0607|consen  153 LVFEKMRGGPLLSHIQK----RKHFNEREASRVVKDIASALDFLHT---KGIAHRDLKPENILCESPNKVSPVKICDFDL  225 (463)
T ss_pred             EEEecccCchHHHHHHH----hhhccHHHHHHHHHHHHHHHHHHhh---cCcccccCCccceeecCCCCcCceeeecccc
Confidence            99999999999999954    4568999999999999999999998   5599999999999975543   479999988


Q ss_pred             cccCCCCCCc-cee---eecccCCccccCccccc-----cCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHH
Q 039626          489 ARPAEGQEGE-FAL---TRHIVGTKGYMAPEYLE-----NGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDV  559 (628)
Q Consensus       489 a~~~~~~~~~-~~~---~~~~~gt~~Y~APE~l~-----~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~  559 (628)
                      ..-+.....- ...   ....+|+..|||||+..     ...|+.+.|.||+||+||-|++|..||..+.+.+-.|-.-.
T Consensus       226 gSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe  305 (463)
T KOG0607|consen  226 GSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGE  305 (463)
T ss_pred             ccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCC
Confidence            7654322111 111   12357888999999774     34689999999999999999999999998766542221000


Q ss_pred             HHHHhccccchhhhccccCCcCCCCCCH----HHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          560 LNAVLTKEDGEESLRHFIDPTLQGNYPL----ELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       560 ~~~~~~~~~~~~~l~~~~d~~l~~~~~~----~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      ..+.     ..+.+.+-+... .-++|+    ..+.+..+++...+.+|+.+|-++.+++.
T Consensus       306 ~Cr~-----CQ~~LFesIQEG-kYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln  360 (463)
T KOG0607|consen  306 VCRV-----CQNKLFESIQEG-KYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN  360 (463)
T ss_pred             ccHH-----HHHHHHHHHhcc-CCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence            0000     000110000000 011222    35566788999999999999999888764

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.95  E-value=6.5e-27  Score=254.48  Aligned_cols=254  Identities=20%  Similarity=0.199  Sum_probs=169.9

Q ss_pred             hcCCCcCCccc----eEEEEEEE------------------CCceEEEEEecc-------ch--------------HHHH
Q 039626          350 TDNFSFTCRIQ----GSVYRGKI------------------NGGFAAIKKVNG-------DV--------------SKEI  386 (628)
Q Consensus       350 t~~f~~~~~i~----G~Vy~g~~------------------~g~~vavK~~~~-------~~--------------~~E~  386 (628)
                      .++|...++||    |.||+|.+                  .+..||||+++.       +|              ..|+
T Consensus       144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~  223 (507)
T PLN03224        144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA  223 (507)
T ss_pred             ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence            56777777775    89999964                  345799999753       12              2367


Q ss_pred             HHHhhcCCCce-----eeeeeeeec--------CCeEEEEEEecCCCChHHHhhhcCC--------------------CC
Q 039626          387 ALLNKINHSNL-----IILSGVCFN--------EGNCYLVYEYAVNGTLSDWVFSNKN--------------------EG  433 (628)
Q Consensus       387 ~~l~~l~H~nI-----v~l~g~~~~--------~~~~~lV~E~~~~gsL~~~l~~~~~--------------------~~  433 (628)
                      .++.+++|.++     ++++++|..        ++..+|||||+++|+|.++++....                    ..
T Consensus       224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~  303 (507)
T PLN03224        224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ  303 (507)
T ss_pred             HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence            77888877655     678888763        3568999999999999999974321                    11


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCCccccC
Q 039626          434 KYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMA  513 (628)
Q Consensus       434 ~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~Y~A  513 (628)
                      ..++|..+..++.+++.||.|||+.   +++||||||+|||++.++.+||+|||+++.......  .......+++.|+|
T Consensus       304 ~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~--~~~~~g~~tp~Y~a  378 (507)
T PLN03224        304 DKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN--FNPLYGMLDPRYSP  378 (507)
T ss_pred             ccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCc--cCccccCCCcceeC
Confidence            2357888999999999999999984   599999999999999999999999999976533211  11112345789999


Q ss_pred             ccccccCC----------------------CCcccccHHHHHHHHHHHhCCC-ccccccccccccHHHHHHHHhccccch
Q 039626          514 PEYLENGL----------------------VSTKLDVYAFGVLILEMLTGKE-AAALHAEENNMHLSDVLNAVLTKEDGE  570 (628)
Q Consensus       514 PE~l~~~~----------------------~s~k~DV~SfGvvl~ELltG~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~  570 (628)
                      ||.+....                      ...+.||||+||+++||++|.. |+.....     ........   ....
T Consensus       379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~-----f~~~~~~~---~~~~  450 (507)
T PLN03224        379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRL-----FNTELRQY---DNDL  450 (507)
T ss_pred             hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhh-----hhhHHhhc---cchH
Confidence            99875432                      1235799999999999999874 4431100     00000000   0000


Q ss_pred             hhhccccCCcCCCCCCHHHHHHHHHHHHHhcccCC---CCCCCHHHHHH
Q 039626          571 ESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDP---TDRPTMYEIEH  616 (628)
Q Consensus       571 ~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP---~~RPs~~ev~~  616 (628)
                      ...+........-...........+++.+++..+|   .+|+|++|+++
T Consensus       451 ~~~r~~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~  499 (507)
T PLN03224        451 NRWRMYKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS  499 (507)
T ss_pred             HHHHhhcccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence            00000000000001112234567899999999866   68999999874

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.95  E-value=6.3e-29  Score=234.37  Aligned_cols=249  Identities=24%  Similarity=0.350  Sum_probs=179.5

Q ss_pred             eEEEEEEE--CCceEEEEEecc---------chHHHHHHHhhcCCCceeeeeeeeecC--------CeEEEEEEecCCCC
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG---------DVSKEIALLNKINHSNLIILSGVCFNE--------GNCYLVYEYAVNGT  421 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~---------~~~~E~~~l~~l~H~nIv~l~g~~~~~--------~~~~lV~E~~~~gs  421 (628)
                      |.||+++-  .|+.||+|++..         ...+|+++|..++|+|++.++..|...        ..+||||++++. +
T Consensus        31 geVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t~ylVf~~ceh-D  109 (376)
T KOG0669|consen   31 GEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRATFYLVFDFCEH-D  109 (376)
T ss_pred             HHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccceeeeeHHHhhh-h
Confidence            77888876  567788887632         356899999999999999999999642        358999999966 7


Q ss_pred             hHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCc-ce
Q 039626          422 LSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGE-FA  500 (628)
Q Consensus       422 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~-~~  500 (628)
                      |...|..   ....++...+.++..++..||.|+|.   ..|+|||+|+.|+||+.++.+||+|||++|.+...... ..
T Consensus       110 LaGlLsn---~~vr~sls~Ikk~Mk~Lm~GL~~iHr---~kilHRDmKaaNvLIt~dgilklADFGlar~fs~~~n~~kp  183 (376)
T KOG0669|consen  110 LAGLLSN---RKVRFSLSEIKKVMKGLMNGLYYIHR---NKILHRDMKAANVLITKDGILKLADFGLARAFSTSKNVVKP  183 (376)
T ss_pred             HHHHhcC---ccccccHHHHHHHHHHHHHHHHHHHH---hhHHhhcccHhhEEEcCCceEEeeccccccceecccccCCC
Confidence            8888843   33458889999999999999999998   55999999999999999999999999999876432211 11


Q ss_pred             eeecccCCccccCcccccc-CCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccc-----hhhhc
Q 039626          501 LTRHIVGTKGYMAPEYLEN-GLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDG-----EESLR  574 (628)
Q Consensus       501 ~~~~~~gt~~Y~APE~l~~-~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~l~  574 (628)
                      .-+..+-|.+|++||.+.+ ..++++.|||+-||++.||++|.+.+..+.+.....+...+.....++..     -+...
T Consensus       184 rytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP~~d~lpL~~  263 (376)
T KOG0669|consen  184 RYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWPNVDNLPLYQ  263 (376)
T ss_pred             CcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCCCcccchHHH
Confidence            1234567999999998876 57999999999999999999999888765544333333322222222111     00011


Q ss_pred             cccCCcCC-CCC--------CHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          575 HFIDPTLQ-GNY--------PLELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       575 ~~~d~~l~-~~~--------~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      .+--+.++ +.+        |-.-.....+|+..++..||.+|+.+++++.
T Consensus       264 sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~aln  314 (376)
T KOG0669|consen  264 SIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALN  314 (376)
T ss_pred             hccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhc
Confidence            11001011 000        0001124678999999999999999988763

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=9.6e-28  Score=241.71  Aligned_cols=235  Identities=21%  Similarity=0.348  Sum_probs=180.4

Q ss_pred             eEEEEEEE--CCceEEEEEec--c------------chHHHHHHHhhcCCCceeeeeeeee-cCCeEEEEEEecCCCChH
Q 039626          361 GSVYRGKI--NGGFAAIKKVN--G------------DVSKEIALLNKINHSNLIILSGVCF-NEGNCYLVYEYAVNGTLS  423 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~--~------------~~~~E~~~l~~l~H~nIv~l~g~~~-~~~~~~lV~E~~~~gsL~  423 (628)
                      ..|||+..  ..+.||+|.-.  +            ...+|.+|-+.|.||.||++++++. +.+.+|-|+||++|.+|+
T Consensus       477 SEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsFCTVLEYceGNDLD  556 (775)
T KOG1151|consen  477 SEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSFCTVLEYCEGNDLD  556 (775)
T ss_pred             HHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccceeeeeecCCCchh
Confidence            47999987  67788998642  1            2456999999999999999999997 456789999999999999


Q ss_pred             HHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCC---CCcEEEccccccccCCCCCCc--
Q 039626          424 DWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDS---DLRAKIANFAMARPAEGQEGE--  498 (628)
Q Consensus       424 ~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~---~~~~kl~Dfgla~~~~~~~~~--  498 (628)
                      -||.    ..+.++++....|+.||+.||.||.+.. +||||-||||.||||-+   .|.+||.||||++.+++....  
T Consensus       557 FYLK----QhklmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeIKITDFGLSKIMdddSy~~v  631 (775)
T KOG1151|consen  557 FYLK----QHKLMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEIKITDFGLSKIMDDDSYNSV  631 (775)
T ss_pred             HHHH----hhhhhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccceeEeeecchhhhccCCccCcc
Confidence            9994    4566899999999999999999999976 99999999999999954   488999999999998754322  


Q ss_pred             --ceeeecccCCccccCcccccc----CCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhh
Q 039626          499 --FALTRHIVGTKGYMAPEYLEN----GLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEES  572 (628)
Q Consensus       499 --~~~~~~~~gt~~Y~APE~l~~----~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  572 (628)
                        ..++....||.+|++||.+.-    .+++.|.||||.||++|..+-|+.||..+..     ..+.+...        .
T Consensus       632 dGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqs-----QQdILqeN--------T  698 (775)
T KOG1151|consen  632 DGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQS-----QQDILQEN--------T  698 (775)
T ss_pred             cceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchh-----HHHHHhhh--------c
Confidence              345667799999999998854    3688999999999999999999999974322     12222111        0


Q ss_pred             hccccCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 039626          573 LRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIE  615 (628)
Q Consensus       573 l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~  615 (628)
                      +-....-..  ..-.....+...++++||+..-++|....++.
T Consensus       699 IlkAtEVqF--P~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA  739 (775)
T KOG1151|consen  699 ILKATEVQF--PPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLA  739 (775)
T ss_pred             hhcceeccC--CCCCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence            000000000  00112344567899999999888888766654

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.94  E-value=1.3e-27  Score=239.05  Aligned_cols=219  Identities=28%  Similarity=0.383  Sum_probs=178.7

Q ss_pred             eEEEEEEE--CCceEEEEEeccch----------HHHHHHHhhc-CCCceeeeeeeeecCCeEEEEEEecCCCChHHHhh
Q 039626          361 GSVYRGKI--NGGFAAIKKVNGDV----------SKEIALLNKI-NHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVF  427 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~~~----------~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~  427 (628)
                      |.|..+.-  ..+.+|||.+++++          +.|-++|.-- +-|.++++..++..-+.+|+||||+.||+|..++.
T Consensus       363 GKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFVMEyvnGGDLMyhiQ  442 (683)
T KOG0696|consen  363 GKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFVMEYVNGGDLMYHIQ  442 (683)
T ss_pred             ceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeEEEEecCchhhhHHH
Confidence            88888877  45688999998753          3477777666 46788899999988899999999999999998885


Q ss_pred             hcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccC
Q 039626          428 SNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVG  507 (628)
Q Consensus       428 ~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~g  507 (628)
                      .-    ..+.++...-+|..||-||-|||+   .+||.||||..|||||.+|.+||+|||+++.--..   ...++...|
T Consensus       443 Q~----GkFKEp~AvFYAaEiaigLFFLh~---kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~---~~TTkTFCG  512 (683)
T KOG0696|consen  443 QV----GKFKEPVAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFD---GVTTKTFCG  512 (683)
T ss_pred             Hh----cccCCchhhhhhHHHHHHhhhhhc---CCeeeeeccccceEeccCCceEeeecccccccccC---CcceeeecC
Confidence            32    336677888899999999999999   45999999999999999999999999999853211   234677899


Q ss_pred             CccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCH
Q 039626          508 TKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPL  587 (628)
Q Consensus       508 t~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~  587 (628)
                      |+.|+|||.+..+.|....|.|||||+||||+.|++||+..+++      +.++.+             ++.  .-.||.
T Consensus       513 TPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~------elF~aI-------------~eh--nvsyPK  571 (683)
T KOG0696|consen  513 TPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED------ELFQAI-------------MEH--NVSYPK  571 (683)
T ss_pred             CCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHH------HHHHHH-------------HHc--cCcCcc
Confidence            99999999999999999999999999999999999999854432      222222             222  125777


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCC
Q 039626          588 ELALLVIRLIDACLKKDPTDRPT  610 (628)
Q Consensus       588 ~~~~~l~~l~~~Cl~~dP~~RPs  610 (628)
                      ..+.+..++.+..+.+.|.+|..
T Consensus       572 slSkEAv~ickg~ltK~P~kRLG  594 (683)
T KOG0696|consen  572 SLSKEAVAICKGLLTKHPGKRLG  594 (683)
T ss_pred             cccHHHHHHHHHHhhcCCccccC
Confidence            88888899999999999999953

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.94  E-value=2.5e-28  Score=249.88  Aligned_cols=238  Identities=23%  Similarity=0.300  Sum_probs=192.6

Q ss_pred             eEEEEEEECCce--EEEEEecc----------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhh
Q 039626          361 GSVYRGKINGGF--AAIKKVNG----------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFS  428 (628)
Q Consensus       361 G~Vy~g~~~g~~--vavK~~~~----------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  428 (628)
                      |.|=..+.+++.  .|+|.+++          .+..|-++|.+.+.|.||+++-.|.+....|+.||-|-||.|+..|..
T Consensus       434 GRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaClGGElWTiLrd  513 (732)
T KOG0614|consen  434 GRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEACLGGELWTILRD  513 (732)
T ss_pred             ceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHhhcCchhhhhhhh
Confidence            888888886665  67777654          255799999999999999999999999999999999999999999943


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCC
Q 039626          429 NKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGT  508 (628)
Q Consensus       429 ~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt  508 (628)
                          ...++.....-++.-+.+|++|||+.+   ||+|||||+|.+||.+|.+||.|||+|+.+....    .++...||
T Consensus       514 ----Rg~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~----KTwTFcGT  582 (732)
T KOG0614|consen  514 ----RGSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGR----KTWTFCGT  582 (732)
T ss_pred             ----cCCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhccCC----ceeeecCC
Confidence                344677777788999999999999954   9999999999999999999999999999987554    56778999


Q ss_pred             ccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCHH
Q 039626          509 KGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLE  588 (628)
Q Consensus       509 ~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~  588 (628)
                      +.|.|||.+.+...+...|.||+|++++||++|++||...+.   +.....+   +..          +|   .-.+|..
T Consensus       583 pEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dp---mktYn~I---LkG----------id---~i~~Pr~  643 (732)
T KOG0614|consen  583 PEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDP---MKTYNLI---LKG----------ID---KIEFPRR  643 (732)
T ss_pred             cccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCch---HHHHHHH---Hhh----------hh---hhhcccc
Confidence            999999999999999999999999999999999999985443   2122221   111          11   1134555


Q ss_pred             HHHHHHHHHHHhcccCCCCCCC--HHHHHHHHHHhHhhccCC
Q 039626          589 LALLVIRLIDACLKKDPTDRPT--MYEIEHSLSNILNASLNW  628 (628)
Q Consensus       589 ~~~~l~~l~~~Cl~~dP~~RPs--~~ev~~~L~~l~~~~~~w  628 (628)
                      ......+++++....+|.+|..  ...|-++=....-..+||
T Consensus       644 I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdw  685 (732)
T KOG0614|consen  644 ITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDW  685 (732)
T ss_pred             cchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCCh
Confidence            6667789999999999999976  555555555566666776

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=99.94  E-value=1.3e-27  Score=265.05  Aligned_cols=256  Identities=25%  Similarity=0.313  Sum_probs=191.7

Q ss_pred             HHHHHHhcCCCcCCccc----eEEEEEEE--CCceEEEEEecc----------chHHHHHHHhhcCCCceeeeeeeeecC
Q 039626          344 KELQSATDNFSFTCRIQ----GSVYRGKI--NGGFAAIKKVNG----------DVSKEIALLNKINHSNLIILSGVCFNE  407 (628)
Q Consensus       344 ~el~~at~~f~~~~~i~----G~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~nIv~l~g~~~~~  407 (628)
                      .+++-..++|.....||    |.|...+.  .++.+|.|++++          -|.+|-++|..-+.+-|+++.-.|.++
T Consensus        68 ~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~  147 (1317)
T KOG0612|consen   68 KELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDE  147 (1317)
T ss_pred             HHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCc
Confidence            34444445555444443    89998887  577889998865          367899999988999999999999999


Q ss_pred             CeEEEEEEecCCCChHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEcccc
Q 039626          408 GNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFA  487 (628)
Q Consensus       408 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfg  487 (628)
                      .++|+|||||+||+|-..+...    ..+++....-++..|+-||.-||+.+   +|||||||+|||||.+|++||+|||
T Consensus       148 ~~LYlVMdY~pGGDlltLlSk~----~~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFG  220 (1317)
T KOG0612|consen  148 RYLYLVMDYMPGGDLLTLLSKF----DRLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFG  220 (1317)
T ss_pred             cceEEEEecccCchHHHHHhhc----CCChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccch
Confidence            9999999999999999999542    25888888899999999999999965   9999999999999999999999999


Q ss_pred             ccccCCCCCCcceeeecccCCccccCccccc----c-CCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHH
Q 039626          488 MARPAEGQEGEFALTRHIVGTKGYMAPEYLE----N-GLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNA  562 (628)
Q Consensus       488 la~~~~~~~~~~~~~~~~~gt~~Y~APE~l~----~-~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~  562 (628)
                      .+-.+....  .......+|||.|.+||++.    + +.|.+.+|.||+||++|||+.|..||+...      +.+....
T Consensus       221 sClkm~~dG--~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYads------lveTY~K  292 (1317)
T KOG0612|consen  221 SCLKMDADG--TVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADS------LVETYGK  292 (1317)
T ss_pred             hHHhcCCCC--cEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHH------HHHHHHH
Confidence            988775332  22345569999999999985    3 678999999999999999999999987321      2222222


Q ss_pred             HhccccchhhhccccCCcCCCCCC--HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhccCC
Q 039626          563 VLTKEDGEESLRHFIDPTLQGNYP--LELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNASLNW  628 (628)
Q Consensus       563 ~~~~~~~~~~l~~~~d~~l~~~~~--~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~~~~~~w  628 (628)
                                   +++-.-.-.+|  .+.+....+||++.+ -+|..|..-..|-++-..-+-..+||
T Consensus       293 -------------Im~hk~~l~FP~~~~VSeeakdLI~~ll-~~~e~RLgrngiedik~HpFF~g~~W  346 (1317)
T KOG0612|consen  293 -------------IMNHKESLSFPDETDVSEEAKDLIEALL-CDREVRLGRNGIEDIKNHPFFEGIDW  346 (1317)
T ss_pred             -------------HhchhhhcCCCcccccCHHHHHHHHHHh-cChhhhcccccHHHHHhCccccCCCh
Confidence                         22222122233  346677788888755 46777777333333323344444555

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.94  E-value=3e-25  Score=214.80  Aligned_cols=196  Identities=37%  Similarity=0.610  Sum_probs=171.3

Q ss_pred             eEEEEEEEC--CceEEEEEeccc--------hHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhcC
Q 039626          361 GSVYRGKIN--GGFAAIKKVNGD--------VSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNK  430 (628)
Q Consensus       361 G~Vy~g~~~--g~~vavK~~~~~--------~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~  430 (628)
                      |.||++...  ++.+++|+....        +.+|++.+++++|++++++++++......++++||+++++|.+++....
T Consensus         7 ~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~   86 (215)
T cd00180           7 GTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKDLLKENE   86 (215)
T ss_pred             eEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHHHHHhcc
Confidence            899999996  889999998653        6789999999999999999999999899999999999999999985421


Q ss_pred             CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCC-CCcEEEccccccccCCCCCCcceeeecccCCc
Q 039626          431 NEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDS-DLRAKIANFAMARPAEGQEGEFALTRHIVGTK  509 (628)
Q Consensus       431 ~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~-~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~  509 (628)
                         ..+++..+..++.+++++|+|||+.   +++|+||+|.||+++. ++.++|+|||.+........   ......+..
T Consensus        87 ---~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~  157 (215)
T cd00180          87 ---GKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS---LLKTIVGTP  157 (215)
T ss_pred             ---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc---hhhcccCCC
Confidence               4589999999999999999999995   5999999999999999 89999999999886643321   123346788


Q ss_pred             cccCccccccC-CCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCHH
Q 039626          510 GYMAPEYLENG-LVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLE  588 (628)
Q Consensus       510 ~Y~APE~l~~~-~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~  588 (628)
                      .|++||.+... ..+.+.|+|++|++++|+                                                  
T Consensus       158 ~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l--------------------------------------------------  187 (215)
T cd00180         158 AYMAPEVLLGKGYYSEKSDIWSLGVILYEL--------------------------------------------------  187 (215)
T ss_pred             CccChhHhcccCCCCchhhhHHHHHHHHHH--------------------------------------------------
Confidence            99999999887 889999999999999999                                                  


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 039626          589 LALLVIRLIDACLKKDPTDRPTMYEIEHS  617 (628)
Q Consensus       589 ~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~  617 (628)
                        ..+.+++.+|++.||.+||++.++++.
T Consensus       188 --~~~~~~l~~~l~~~p~~R~~~~~l~~~  214 (215)
T cd00180         188 --PELKDLIRKMLQKDPEKRPSAKEILEH  214 (215)
T ss_pred             --HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence              236789999999999999999999864

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.93  E-value=3.5e-26  Score=210.22  Aligned_cols=181  Identities=23%  Similarity=0.349  Sum_probs=148.9

Q ss_pred             EEEEEEECCceEEEEEeccc--------hHHHHHHHhhc-CCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhcCCC
Q 039626          362 SVYRGKINGGFAAIKKVNGD--------VSKEIALLNKI-NHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNE  432 (628)
Q Consensus       362 ~Vy~g~~~g~~vavK~~~~~--------~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~  432 (628)
                      .+|+-..+|...|+|++...        ...|+++..+- ..|.+|.++|....++..++.||.| .-||+.+-..--..
T Consensus        63 ekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M-~tSldkfy~~v~~~  141 (282)
T KOG0984|consen   63 EKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELM-DTSLDKFYRKVLKK  141 (282)
T ss_pred             hheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHh-hhhHHHHHHHHHhc
Confidence            45666668999999998642        33466654443 6899999999999999999999999 56888876555566


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCCcccc
Q 039626          433 GKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYM  512 (628)
Q Consensus       433 ~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~Y~  512 (628)
                      +..+++...=+||..+..||.|||+.  -.+||||+||+|||++.+|++|++|||.+-...+.-    ..+-..|...||
T Consensus       142 g~~ipE~vlGkIa~Svv~al~~L~~k--L~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSi----Akt~daGCkpYm  215 (282)
T KOG0984|consen  142 GGTIPEDVLGKIAVSVVHALEFLHSK--LSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSI----AKTMDAGCKPYM  215 (282)
T ss_pred             CCcCchHHhhHhHHHHHHHHHHHHHH--hhhhhccCCcceEEEccCCcEEEcccccceeehhhh----HHHHhcCCCccC
Confidence            77899999999999999999999994  569999999999999999999999999987664321    112246888999


Q ss_pred             Ccccccc----CCCCcccccHHHHHHHHHHHhCCCcccccc
Q 039626          513 APEYLEN----GLVSTKLDVYAFGVLILEMLTGKEAAALHA  549 (628)
Q Consensus       513 APE~l~~----~~~s~k~DV~SfGvvl~ELltG~~p~~~~~  549 (628)
                      |||.+..    ..|+-|+||||+|+.+.||.+++.|++...
T Consensus       216 aPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~  256 (282)
T KOG0984|consen  216 APERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWG  256 (282)
T ss_pred             ChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccC
Confidence            9998853    368999999999999999999999987543

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.93  E-value=1.3e-26  Score=226.28  Aligned_cols=231  Identities=25%  Similarity=0.320  Sum_probs=172.1

Q ss_pred             CCceEEEEEeccc---------hHHHHHHHhhcCCCceeeeeeeeecC------CeEEEEEEecCCCChHHHhhhcCCCC
Q 039626          369 NGGFAAIKKVNGD---------VSKEIALLNKINHSNLIILSGVCFNE------GNCYLVYEYAVNGTLSDWVFSNKNEG  433 (628)
Q Consensus       369 ~g~~vavK~~~~~---------~~~E~~~l~~l~H~nIv~l~g~~~~~------~~~~lV~E~~~~gsL~~~l~~~~~~~  433 (628)
                      .+..||+|++...         ..+|..++..++|+||++++.++.-.      .+.|+|||+| .++|...++.     
T Consensus        40 ~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e~m-~~nl~~vi~~-----  113 (369)
T KOG0665|consen   40 LGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVMELM-DANLCQVILM-----  113 (369)
T ss_pred             ccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHHhh-hhHHHHHHHH-----
Confidence            6889999998653         45799999999999999999999733      3579999999 6789988852     


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCCccccC
Q 039626          434 KYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMA  513 (628)
Q Consensus       434 ~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~Y~A  513 (628)
                       .++-.....|..|++.|++|||+.+   |+||||||+||++..+..+||.|||+|+..+..    ...+..+.|..|.|
T Consensus       114 -elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~----~~mtpyVvtRyyra  185 (369)
T KOG0665|consen  114 -ELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD----FMMTPYVVTRYYRA  185 (369)
T ss_pred             -hcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhhcccCcc----cccCchhheeeccC
Confidence             3666788899999999999999954   999999999999999999999999999866432    24556789999999


Q ss_pred             ccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccch------------------h---h
Q 039626          514 PEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGE------------------E---S  572 (628)
Q Consensus       514 PE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~------------------~---~  572 (628)
                      ||++.+..+.+.+||||.||++.||++|+..|.+.+   ..+.+..+...+...+.+                  .   .
T Consensus       186 pevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d---~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~  262 (369)
T KOG0665|consen  186 PEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKD---HIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAIS  262 (369)
T ss_pred             chheeccCCcccchhhhhhhHHHHHhhceEEecCch---HHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccc
Confidence            999998889999999999999999999997665321   111111111111111110                  0   0


Q ss_pred             h-ccccCCcCCC--CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          573 L-RHFIDPTLQG--NYPLELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       573 l-~~~~d~~l~~--~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      . +.+-|...+.  +.+.-....+.+++.+||-.||++|.|+++++.
T Consensus       263 f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~  309 (369)
T KOG0665|consen  263 FSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALR  309 (369)
T ss_pred             hhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhc
Confidence            0 0111111110  111122345678999999999999999999874

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.93  E-value=1.3e-27  Score=227.63  Aligned_cols=245  Identities=24%  Similarity=0.331  Sum_probs=177.9

Q ss_pred             cceEEEEEEE--CCceEEEEEecc---------chHHHHHHHhhcCCCceeeeeeeeecC-----CeEEEEEEecCCCCh
Q 039626          359 IQGSVYRGKI--NGGFAAIKKVNG---------DVSKEIALLNKINHSNLIILSGVCFNE-----GNCYLVYEYAVNGTL  422 (628)
Q Consensus       359 i~G~Vy~g~~--~g~~vavK~~~~---------~~~~E~~~l~~l~H~nIv~l~g~~~~~-----~~~~lV~E~~~~gsL  422 (628)
                      ..|.||..+.  +|+.||+||+..         .+.+|+++|..++|.|++..++.-.-.     .+.|.+.|.|. .+|
T Consensus        65 AFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TELmQ-SDL  143 (449)
T KOG0664|consen   65 AFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTELMQ-SDL  143 (449)
T ss_pred             ceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHHHHH-hhh
Confidence            3499999988  789999999875         356799999999999999888776532     35788999884 478


Q ss_pred             HHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceee
Q 039626          423 SDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALT  502 (628)
Q Consensus       423 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~  502 (628)
                      .+.+    -....|+-....-+..||++||.|||+.+   |.||||||.|.|++.|...||+|||++|..+..+..  ..
T Consensus       144 HKII----VSPQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~--hM  214 (449)
T KOG0664|consen  144 HKII----VSPQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRL--NM  214 (449)
T ss_pred             hhee----ccCCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccccchhhhh--hh
Confidence            7777    34456787888889999999999999955   999999999999999999999999999987644322  23


Q ss_pred             ecccCCccccCcccccc-CCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccch-------hhhc
Q 039626          503 RHIVGTKGYMAPEYLEN-GLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGE-------ESLR  574 (628)
Q Consensus       503 ~~~~gt~~Y~APE~l~~-~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~l~  574 (628)
                      ++.+-|..|.|||.+.+ ..|+...||||.||++.||+..+-.|.....-   ...+.+...+.....+       ..-.
T Consensus       215 TqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~Pi---qQL~lItdLLGTPs~EaMr~ACEGAk~  291 (449)
T KOG0664|consen  215 THEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPI---EQLQMIIDLLGTPSQEAMKYACEGAKN  291 (449)
T ss_pred             HHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChH---HHHHHHHHHhCCCcHHHHHHHhhhhHH
Confidence            44578899999999987 47999999999999999999888766543322   2223333333222110       0001


Q ss_pred             cccC-----CcCCCCC----CHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          575 HFID-----PTLQGNY----PLELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       575 ~~~d-----~~l~~~~----~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      +++.     |.+.--|    +..-..+...+...++..||++|.+..+.+.
T Consensus       292 H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~  342 (449)
T KOG0664|consen  292 HVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQ  342 (449)
T ss_pred             HhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcc
Confidence            1111     1111111    1122234557778899999999999887764

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.93  E-value=1.4e-25  Score=219.24  Aligned_cols=225  Identities=25%  Similarity=0.394  Sum_probs=175.9

Q ss_pred             EEEEEEE--CCceEEEEEeccch----------HHHHHHHhhc-CCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhh
Q 039626          362 SVYRGKI--NGGFAAIKKVNGDV----------SKEIALLNKI-NHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFS  428 (628)
Q Consensus       362 ~Vy~g~~--~g~~vavK~~~~~~----------~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  428 (628)
                      .|-.+.+  ..+.+|+|.+++++          ..|-.+..+- +||.+|.+..++..+..+++|.||++||+|.-++.+
T Consensus       265 kvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffvieyv~ggdlmfhmqr  344 (593)
T KOG0695|consen  265 KVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQR  344 (593)
T ss_pred             hhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEEEEecCcceeeehhh
Confidence            3444444  56788999988753          3455555554 799999999999999999999999999999877743


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCC
Q 039626          429 NKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGT  508 (628)
Q Consensus       429 ~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt  508 (628)
                          .+.|++....-+...|+-||.|||+   .+||.||||..|+|+|..|.+|+.|+|+++.--...   ..+....||
T Consensus       345 ----qrklpeeharfys~ei~lal~flh~---rgiiyrdlkldnvlldaeghikltdygmcke~l~~g---d~tstfcgt  414 (593)
T KOG0695|consen  345 ----QRKLPEEHARFYSAEICLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGPG---DTTSTFCGT  414 (593)
T ss_pred             ----hhcCcHHHhhhhhHHHHHHHHHHhh---cCeeeeeccccceEEccCCceeecccchhhcCCCCC---cccccccCC
Confidence                3458888888899999999999999   459999999999999999999999999998543221   245678999


Q ss_pred             ccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccc-cccHHHHHHHHhccccchhhhccccCCcCCCCCCH
Q 039626          509 KGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEEN-NMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPL  587 (628)
Q Consensus       509 ~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~  587 (628)
                      +.|.|||.+++..|.-..|.|++||+++||+.|+.||+.-...+ ++.-.+++.+++-+.            .  -..|.
T Consensus       415 pnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilek------------q--iripr  480 (593)
T KOG0695|consen  415 PNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEK------------Q--IRIPR  480 (593)
T ss_pred             CcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhh------------c--ccccc
Confidence            99999999999999999999999999999999999998543322 223334443333211            1  12344


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCC
Q 039626          588 ELALLVIRLIDACLKKDPTDRPT  610 (628)
Q Consensus       588 ~~~~~l~~l~~~Cl~~dP~~RPs  610 (628)
                      ..+.....+++.-|.+||.+|..
T Consensus       481 slsvkas~vlkgflnkdp~erlg  503 (593)
T KOG0695|consen  481 SLSVKASHVLKGFLNKDPKERLG  503 (593)
T ss_pred             eeehhhHHHHHHhhcCCcHHhcC
Confidence            55566778899999999999853

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.93  E-value=3.1e-25  Score=232.16  Aligned_cols=204  Identities=21%  Similarity=0.330  Sum_probs=159.7

Q ss_pred             ecHHHHHHHhcCCCcCCc---c----ceEEEEEEE--CCceEEEEEecc----------chHHHHHHHhhcCCCceeeee
Q 039626          341 YSFKELQSATDNFSFTCR---I----QGSVYRGKI--NGGFAAIKKVNG----------DVSKEIALLNKINHSNLIILS  401 (628)
Q Consensus       341 ~~~~el~~at~~f~~~~~---i----~G~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~nIv~l~  401 (628)
                      -.|-.|++|...-+.--+   |    .|.|..+.-  ....+|.|.+++          .+..|-+||..-..+-||+|+
T Consensus       616 SnYiRLkRaKMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLy  695 (1034)
T KOG0608|consen  616 SNYIRLKRAKMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLY  695 (1034)
T ss_pred             hhHHHHHHhhccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEE
Confidence            345556666554332112   2    288887754  445678887754          245699999999999999999


Q ss_pred             eeeecCCeEEEEEEecCCCChHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcE
Q 039626          402 GVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRA  481 (628)
Q Consensus       402 g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~  481 (628)
                      -.|.+++.+|+||||++||++..+|.+    ...+.+....-++.++..|+++.|..+   +|||||||+|||||.+|.+
T Consensus       696 ySFQDkdnLYFVMdYIPGGDmMSLLIr----mgIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHI  768 (1034)
T KOG0608|consen  696 YSFQDKDNLYFVMDYIPGGDMMSLLIR----MGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHI  768 (1034)
T ss_pred             EEeccCCceEEEEeccCCccHHHHHHH----hccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCce
Confidence            999999999999999999999999853    344677777778889999999999955   9999999999999999999


Q ss_pred             EEccccccccCC---------CCC------------------------------CcceeeecccCCccccCccccccCCC
Q 039626          482 KIANFAMARPAE---------GQE------------------------------GEFALTRHIVGTKGYMAPEYLENGLV  522 (628)
Q Consensus       482 kl~Dfgla~~~~---------~~~------------------------------~~~~~~~~~~gt~~Y~APE~l~~~~~  522 (628)
                      ||.||||+.-+.         ..+                              .........+||+.|+|||++....+
T Consensus       769 KLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~  848 (1034)
T KOG0608|consen  769 KLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGY  848 (1034)
T ss_pred             eeeeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCc
Confidence            999999975321         000                              00001123479999999999999999


Q ss_pred             CcccccHHHHHHHHHHHhCCCcccccccc
Q 039626          523 STKLDVYAFGVLILEMLTGKEAAALHAEE  551 (628)
Q Consensus       523 s~k~DV~SfGvvl~ELltG~~p~~~~~~~  551 (628)
                      +..+|.||.||+|+||+.|+.||......
T Consensus       849 ~q~cdwws~gvil~em~~g~~pf~~~tp~  877 (1034)
T KOG0608|consen  849 TQLCDWWSVGVILYEMLVGQPPFLADTPG  877 (1034)
T ss_pred             cccchhhHhhHHHHHHhhCCCCccCCCCC
Confidence            99999999999999999999998755443

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.92  E-value=2e-24  Score=221.07  Aligned_cols=121  Identities=23%  Similarity=0.307  Sum_probs=100.2

Q ss_pred             cCCCcCCccc----eEEEEEEE--CCceEEEEEecc------chHHHHHHHhhcC-----C---Cceeeeeeeeec----
Q 039626          351 DNFSFTCRIQ----GSVYRGKI--NGGFAAIKKVNG------DVSKEIALLNKIN-----H---SNLIILSGVCFN----  406 (628)
Q Consensus       351 ~~f~~~~~i~----G~Vy~g~~--~g~~vavK~~~~------~~~~E~~~l~~l~-----H---~nIv~l~g~~~~----  406 (628)
                      +.|-...++|    .+||.+..  +.+.||+|+.+.      ....|+++|++++     |   .+||+|++.|..    
T Consensus        78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpN  157 (590)
T KOG1290|consen   78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPN  157 (590)
T ss_pred             ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCC
Confidence            3444555665    69999987  678999999986      2567999999994     3   479999999985    


Q ss_pred             CCeEEEEEEecCCCChHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeC
Q 039626          407 EGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLD  476 (628)
Q Consensus       407 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~  476 (628)
                      +.+.++|+|++ |.+|..+|...  .-+.++...+.+|+.||+.||.|||..+  +|||-||||+|||+.
T Consensus       158 G~HVCMVfEvL-GdnLLklI~~s--~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~  222 (590)
T KOG1290|consen  158 GQHVCMVFEVL-GDNLLKLIKYS--NYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLC  222 (590)
T ss_pred             CcEEEEEehhh-hhHHHHHHHHh--CCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeee
Confidence            45899999999 88999999653  3455899999999999999999999964  699999999999983

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.92  E-value=1e-25  Score=262.93  Aligned_cols=198  Identities=17%  Similarity=0.211  Sum_probs=139.2

Q ss_pred             hhcCC-Cceeeeeeee-------ecCCeEEEEEEecCCCChHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC
Q 039626          390 NKINH-SNLIILSGVC-------FNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNP  461 (628)
Q Consensus       390 ~~l~H-~nIv~l~g~~-------~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~  461 (628)
                      +.++| .||++++++|       .+.+..++++||+ +++|.+||..   ....+++.+++.++.||++||+|||+.   
T Consensus        27 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~---   99 (793)
T PLN00181         27 KSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDN---PDRSVDAFECFHVFRQIVEIVNAAHSQ---   99 (793)
T ss_pred             chhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhc---ccccccHHHHHHHHHHHHHHHHHHHhC---
Confidence            45566 6888899988       2334578889988 6699999953   234599999999999999999999984   


Q ss_pred             CeEecCCCCCCEEeCC-------------------CCcEEEccccccccCCCCCCc-------------ceeeecccCCc
Q 039626          462 PHVHKDINSSNVLLDS-------------------DLRAKIANFAMARPAEGQEGE-------------FALTRHIVGTK  509 (628)
Q Consensus       462 ~iiH~dik~~NILl~~-------------------~~~~kl~Dfgla~~~~~~~~~-------------~~~~~~~~gt~  509 (628)
                      +|+||||||+||||+.                   ++.+|++|||+++........             ........||+
T Consensus       100 gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~  179 (793)
T PLN00181        100 GIVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMS  179 (793)
T ss_pred             CeeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCc
Confidence            5999999999999954                   445666677766543210000             00011236889


Q ss_pred             cccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCHHH
Q 039626          510 GYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLEL  589 (628)
Q Consensus       510 ~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~  589 (628)
                      .|||||++.+..++.++|||||||+||||++|..|+....        .......         ...+.+...     ..
T Consensus       180 ~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~--------~~~~~~~---------~~~~~~~~~-----~~  237 (793)
T PLN00181        180 WYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS--------RTMSSLR---------HRVLPPQIL-----LN  237 (793)
T ss_pred             ceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH--------HHHHHHH---------HhhcChhhh-----hc
Confidence            9999999999999999999999999999999887643110        0110000         000111110     11


Q ss_pred             HHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          590 ALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       590 ~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      ......++.+||+.||.+||+|.|+++
T Consensus       238 ~~~~~~~~~~~L~~~P~~Rps~~eil~  264 (793)
T PLN00181        238 WPKEASFCLWLLHPEPSCRPSMSELLQ  264 (793)
T ss_pred             CHHHHHHHHHhCCCChhhCcChHHHhh
Confidence            223467889999999999999999975

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.92  E-value=1.2e-24  Score=206.85  Aligned_cols=172  Identities=20%  Similarity=0.227  Sum_probs=128.8

Q ss_pred             CChHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcc
Q 039626          420 GTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEF  499 (628)
Q Consensus       420 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~  499 (628)
                      |+|.+++..   .+..++|.+++.|+.|++.||+|||+.+         ||+|||++.++.+|+  ||+++......   
T Consensus         1 GsL~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~~---   63 (176)
T smart00750        1 VSLADILEV---RGRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPEQ---   63 (176)
T ss_pred             CcHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeecccc---
Confidence            789999954   2446999999999999999999999843         999999999999999  99988654321   


Q ss_pred             eeeecccCCccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCC
Q 039626          500 ALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDP  579 (628)
Q Consensus       500 ~~~~~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~  579 (628)
                           ..||+.|+|||++.+..++.++|||||||++|||++|+.|+...... ...+......... .          ++
T Consensus        64 -----~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~-~~~~~~~~~~~~~-~----------~~  126 (176)
T smart00750       64 -----SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEEREL-SAILEILLNGMPA-D----------DP  126 (176)
T ss_pred             -----CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchh-cHHHHHHHHHhcc-C----------Cc
Confidence                 25889999999999999999999999999999999999987532211 1111111111110 0          00


Q ss_pred             cCCCCCCHHHHH--HHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhcc
Q 039626          580 TLQGNYPLELAL--LVIRLIDACLKKDPTDRPTMYEIEHSLSNILNASL  626 (628)
Q Consensus       580 ~l~~~~~~~~~~--~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~~~~~  626 (628)
                      .. ...+.....  .+.+++.+||+.||.+||++.|+++.+..+...+.
T Consensus       127 ~~-~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~~~~  174 (176)
T smart00750      127 RD-RSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFAETL  174 (176)
T ss_pred             cc-cccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHHHHh
Confidence            00 011222222  58999999999999999999999999988776543

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.91  E-value=3.9e-25  Score=227.15  Aligned_cols=180  Identities=23%  Similarity=0.240  Sum_probs=152.3

Q ss_pred             ceEEEEEEE--CCceEEEEEeccc------hHHHHHHHhhcC------CCceeeeeeeeecCCeEEEEEEecCCCChHHH
Q 039626          360 QGSVYRGKI--NGGFAAIKKVNGD------VSKEIALLNKIN------HSNLIILSGVCFNEGNCYLVYEYAVNGTLSDW  425 (628)
Q Consensus       360 ~G~Vy~g~~--~g~~vavK~~~~~------~~~E~~~l~~l~------H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~  425 (628)
                      ++.|.+|..  .|..||||.+...      -.+|+++|++|+      .-|+++|+..|...+++|||||-+ ..+|.+.
T Consensus       445 Fs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHLClVFE~L-slNLRev  523 (752)
T KOG0670|consen  445 FSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNHLCLVFEPL-SLNLREV  523 (752)
T ss_pred             eeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcceeEEEehhh-hchHHHH
Confidence            377888877  6789999999753      347999999995      358999999999999999999988 7799999


Q ss_pred             hhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCC-CcEEEccccccccCCCCCCcceeeec
Q 039626          426 VFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSD-LRAKIANFAMARPAEGQEGEFALTRH  504 (628)
Q Consensus       426 l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~-~~~kl~Dfgla~~~~~~~~~~~~~~~  504 (628)
                      |.... ..-.|.......++.|+.-||..|...+   |+|.||||.|||+++. ..+||||||.|.......     .+.
T Consensus       524 LKKyG-~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~~ene-----itP  594 (752)
T KOG0670|consen  524 LKKYG-RNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNILKLCDFGSASFASENE-----ITP  594 (752)
T ss_pred             HHHhC-cccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcceeeeccCcccccccccc-----ccH
Confidence            97643 3445888899999999999999999865   9999999999999876 568999999998775433     223


Q ss_pred             ccCCccccCccccccCCCCcccccHHHHHHHHHHHhCCCcccccc
Q 039626          505 IVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHA  549 (628)
Q Consensus       505 ~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~  549 (628)
                      ..-+..|.|||++.+-.|+...|+||.||.||||.||+-.|.+..
T Consensus       595 YLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~T  639 (752)
T KOG0670|consen  595 YLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRT  639 (752)
T ss_pred             HHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCC
Confidence            345678999999999999999999999999999999998777544

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.91  E-value=3.7e-24  Score=199.65  Aligned_cols=236  Identities=21%  Similarity=0.320  Sum_probs=175.4

Q ss_pred             eEEEEEEE--CCceEEEEEecc----chHHHHHHHhhcC-CCceeeeeeeeecC--CeEEEEEEecCCCChHHHhhhcCC
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG----DVSKEIALLNKIN-HSNLIILSGVCFNE--GNCYLVYEYAVNGTLSDWVFSNKN  431 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~----~~~~E~~~l~~l~-H~nIv~l~g~~~~~--~~~~lV~E~~~~gsL~~~l~~~~~  431 (628)
                      ..||.|..  +++.++||.++.    .+.+|+++|..|+ |+||++|++...+.  ....||+||+.+.+.....     
T Consensus        52 SEVFeg~~~~~~eK~ViKiLKPVkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~v~n~Dfk~ly-----  126 (338)
T KOG0668|consen   52 SEVFEGINITNNEKCVIKILKPVKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFEYVNNTDFKQLY-----  126 (338)
T ss_pred             hhHhcccccCCCceEEEeeechHHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhhhhccccHHHHh-----
Confidence            57888874  788999998874    5789999999997 99999999998865  4578999999998877654     


Q ss_pred             CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCC-CcEEEccccccccCCCCCCcceeeecccCCcc
Q 039626          432 EGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSD-LRAKIANFAMARPAEGQEGEFALTRHIVGTKG  510 (628)
Q Consensus       432 ~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~-~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~  510 (628)
                        ..|+...+.....+++.||.|+|+.+   |.|||+||.|+++|.. -..+|+|+|+|.+......-    .-.+.+..
T Consensus       127 --~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~eY----nVRVASRy  197 (338)
T KOG0668|consen  127 --PTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY----NVRVASRY  197 (338)
T ss_pred             --hhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhcCCCcee----eeeeehhh
Confidence              23777788889999999999999955   9999999999999975 46899999999887544321    12356777


Q ss_pred             ccCcccccc-CCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccc--------------------
Q 039626          511 YMAPEYLEN-GLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDG--------------------  569 (628)
Q Consensus       511 Y~APE~l~~-~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~--------------------  569 (628)
                      |--||.+.. ..++...|+|||||+|.+|+..++||....+. ...+.... .++...+.                    
T Consensus       198 fKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN-~DQLVkIa-kVLGt~el~~Yl~KY~i~Ldp~~~~i~~  275 (338)
T KOG0668|consen  198 FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN-YDQLVKIA-KVLGTDELYAYLNKYQIDLDPQFEDILG  275 (338)
T ss_pred             cCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCC-HHHHHHHH-HHhChHHHHHHHHHHccCCChhHhhHhh
Confidence            899998865 57899999999999999999999998643222 12222221 11111111                    


Q ss_pred             ---hhhhccccCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          570 ---EESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       570 ---~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                         +.....++.+.-+.-    ...+..+++.+.|..|-.+|+|++|...
T Consensus       276 ~~~rk~w~~Fi~~~n~hl----~~peaiDlldklLrYDHqeRlTakEam~  321 (338)
T KOG0668|consen  276 RHSRKPWSRFINSENQHL----VSPEAIDLLDKLLRYDHQERLTAKEAMA  321 (338)
T ss_pred             ccccccHHHhCCcccccc----CChHHHHHHHHHHhhccccccchHHHhc
Confidence               111122222211111    2356789999999999999999999763

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.90  E-value=3.8e-23  Score=203.37  Aligned_cols=179  Identities=31%  Similarity=0.491  Sum_probs=153.9

Q ss_pred             eEEEEEEEC--CceEEEEEecc--------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhcC
Q 039626          361 GSVYRGKIN--GGFAAIKKVNG--------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNK  430 (628)
Q Consensus       361 G~Vy~g~~~--g~~vavK~~~~--------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~  430 (628)
                      |.||++...  ++.+++|....        .+.+|++.+.+++|+|++++++++..+...++++||+++++|.+++....
T Consensus        13 ~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~   92 (225)
T smart00221       13 GKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEGGDLFDYLRKKG   92 (225)
T ss_pred             eEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCCCCHHHHHHhcc
Confidence            899999994  68999998864        35679999999999999999999998899999999999999999985432


Q ss_pred             CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCCcc
Q 039626          431 NEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKG  510 (628)
Q Consensus       431 ~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~  510 (628)
                      .   .+++..+..++.+++.++.|||+.   +++|+||+++||+++.++.++|+|||.+.........  ......++..
T Consensus        93 ~---~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~--~~~~~~~~~~  164 (225)
T smart00221       93 G---KLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA--LLKTVKGTPF  164 (225)
T ss_pred             c---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc--cccceeccCC
Confidence            1   188999999999999999999985   5999999999999999999999999998876543210  1233467888


Q ss_pred             ccCcccc-ccCCCCcccccHHHHHHHHHHHhCCCcccc
Q 039626          511 YMAPEYL-ENGLVSTKLDVYAFGVLILEMLTGKEAAAL  547 (628)
Q Consensus       511 Y~APE~l-~~~~~s~k~DV~SfGvvl~ELltG~~p~~~  547 (628)
                      |++||.+ ....++.++|+|+||++++||++|+.||..
T Consensus       165 ~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      165 YLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             cCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            9999998 667788899999999999999999999853

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.90  E-value=1.3e-24  Score=207.14  Aligned_cols=230  Identities=24%  Similarity=0.397  Sum_probs=182.0

Q ss_pred             eEEEEEEECCceEEEEEec---------cchHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhcCC
Q 039626          361 GSVYRGKINGGFAAIKKVN---------GDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKN  431 (628)
Q Consensus       361 G~Vy~g~~~g~~vavK~~~---------~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~  431 (628)
                      |..|+|+|.|..+++|.++         ++|.+|.-.|+-+.||||+.++|.|....++.++..||+.|||+..||..  
T Consensus       204 gelwrgrwqgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gslynvlhe~--  281 (448)
T KOG0195|consen  204 GELWRGRWQGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGSLYNVLHEQ--  281 (448)
T ss_pred             cccccccccCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchHHHHHHhcC--
Confidence            9999999998888877653         47889999999999999999999999999999999999999999999763  


Q ss_pred             CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEc--cccccccCCCCCCcceeeecccCCc
Q 039626          432 EGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIA--NFAMARPAEGQEGEFALTRHIVGTK  509 (628)
Q Consensus       432 ~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~--Dfgla~~~~~~~~~~~~~~~~~gt~  509 (628)
                      .+...+-.+..+++.++|+|++|||+.. +-|.---+.+..+++|++..++|+  |--++...          ....-.+
T Consensus       282 t~vvvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmidedltarismad~kfsfqe----------~gr~y~p  350 (448)
T KOG0195|consen  282 TSVVVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDLTARISMADTKFSFQE----------VGRAYSP  350 (448)
T ss_pred             ccEEEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchhhhheecccceeeeec----------cccccCc
Confidence            4456778899999999999999999975 445555789999999999988876  32222111          1123467


Q ss_pred             cccCccccccCC---CCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCC
Q 039626          510 GYMAPEYLENGL---VSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYP  586 (628)
Q Consensus       510 ~Y~APE~l~~~~---~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~  586 (628)
                      .||+||.++...   .-..+|+|||.+++|||.|...||......+-.                   -++.-..++-..|
T Consensus       351 awmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecg-------------------mkialeglrv~ip  411 (448)
T KOG0195|consen  351 AWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECG-------------------MKIALEGLRVHIP  411 (448)
T ss_pred             ccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhh-------------------hhhhhccccccCC
Confidence            899999997643   345799999999999999999888643322110                   0111123444556


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhH
Q 039626          587 LELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNIL  622 (628)
Q Consensus       587 ~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~  622 (628)
                      ...+..+.+++.-|+..||.+||.++.|+-+|+++.
T Consensus       412 pgis~hm~klm~icmnedpgkrpkfdmivpilekm~  447 (448)
T KOG0195|consen  412 PGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI  447 (448)
T ss_pred             CCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence            677778899999999999999999999999999875

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.89  E-value=6.2e-24  Score=224.46  Aligned_cols=230  Identities=25%  Similarity=0.422  Sum_probs=180.3

Q ss_pred             eEEEEEEE--CCceEEEEEeccc-------hHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhcCC
Q 039626          361 GSVYRGKI--NGGFAAIKKVNGD-------VSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKN  431 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~~-------~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~  431 (628)
                      |.|||++.  .++..|+|.++-+       .++|+-+++..+|+|||.++|-+..+...+++|||+.+|+|.+.-+.   
T Consensus        29 gdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEycgggslQdiy~~---  105 (829)
T KOG0576|consen   29 GDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYCGGGSLQDIYHV---  105 (829)
T ss_pred             cchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEecCCCcccceeee---
Confidence            89999988  7889999988742       46799999999999999999999999999999999999999987642   


Q ss_pred             CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCCccc
Q 039626          432 EGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGY  511 (628)
Q Consensus       432 ~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~Y  511 (628)
                       ..++++.++..+++...+||+|||+.+   =+|||||-.|||+++.+.+|++|||.+-.+...   ........||+.|
T Consensus       106 -TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqitat---i~KrksfiGtpyw  178 (829)
T KOG0576|consen  106 -TGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITAT---IAKRKSFIGTPYW  178 (829)
T ss_pred             -cccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhhh---hhhhhcccCCccc
Confidence             456999999999999999999999955   799999999999999999999999998765422   2334557899999


Q ss_pred             cCcccc---ccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCHH
Q 039626          512 MAPEYL---ENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLE  588 (628)
Q Consensus       512 ~APE~l---~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~  588 (628)
                      ||||+.   +.+.+..++|||+.|+...|+-.-++|...      ....... -++.        +...+|....+ +..
T Consensus       179 mapEvaaverkggynqlcdiwa~gitAiel~eLqpplfd------lhpmr~l-~LmT--------kS~~qpp~lkD-k~k  242 (829)
T KOG0576|consen  179 MAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFD------LHPMRAL-FLMT--------KSGFQPPTLKD-KTK  242 (829)
T ss_pred             cchhHHHHHhcccccccccccccccchhhhhhcCCcccc------cchHHHH-HHhh--------ccCCCCCcccC-Ccc
Confidence            999976   457799999999999999999877765431      0000111 0111        11122221111 223


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          589 LALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       589 ~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      -...+-+|++.|+.++|++||+++.+++
T Consensus       243 ws~~fh~fvK~altknpKkRptaeklL~  270 (829)
T KOG0576|consen  243 WSEFFHNFVKGALTKNPKKRPTAEKLLQ  270 (829)
T ss_pred             chHHHHHHHHHHhcCCCccCCChhhhee
Confidence            3456789999999999999999987654

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.89  E-value=2.1e-23  Score=217.09  Aligned_cols=174  Identities=27%  Similarity=0.332  Sum_probs=148.7

Q ss_pred             eEEEEEEE--CCceEEEEEeccc---------------hHHHHHHHhhcC---CCceeeeeeeeecCCeEEEEEEecC-C
Q 039626          361 GSVYRGKI--NGGFAAIKKVNGD---------------VSKEIALLNKIN---HSNLIILSGVCFNEGNCYLVYEYAV-N  419 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~~---------------~~~E~~~l~~l~---H~nIv~l~g~~~~~~~~~lV~E~~~-~  419 (628)
                      |.|+.+..  +...|+||.+.++               +--|++||..++   |+||++++++|++++.+||++|-.. +
T Consensus       575 GkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEddd~yyl~te~hg~g  654 (772)
T KOG1152|consen  575 GKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDDDYYYLETEVHGEG  654 (772)
T ss_pred             ceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecCCeeEEEecCCCCC
Confidence            89999988  5668899987653               235999999998   9999999999999999999999864 4


Q ss_pred             CChHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcc
Q 039626          420 GTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEF  499 (628)
Q Consensus       420 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~  499 (628)
                      -+|.+++..    ...+++....-|++||+-|+++||+.+   |+|||||-+|+.+|.+|-+||+|||.+.....+.   
T Consensus       655 IDLFd~IE~----kp~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klidfgsaa~~ksgp---  724 (772)
T KOG1152|consen  655 IDLFDFIEF----KPRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLIDFGSAAYTKSGP---  724 (772)
T ss_pred             cchhhhhhc----cCccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEeeccchhhhcCCC---
Confidence            589999843    345899999999999999999999965   9999999999999999999999999987765443   


Q ss_pred             eeeecccCCccccCccccccCCC-CcccccHHHHHHHHHHHhCCCccc
Q 039626          500 ALTRHIVGTKGYMAPEYLENGLV-STKLDVYAFGVLILEMLTGKEAAA  546 (628)
Q Consensus       500 ~~~~~~~gt~~Y~APE~l~~~~~-s~k~DV~SfGvvl~ELltG~~p~~  546 (628)
                        ....+||.+|.|||++.+..| ...-|||++|++||-++-...|+.
T Consensus       725 --fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  725 --FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             --cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence              234589999999999998876 455899999999998887766654

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.88  E-value=1.4e-22  Score=205.20  Aligned_cols=255  Identities=22%  Similarity=0.348  Sum_probs=181.4

Q ss_pred             cCCCcCCccc----eEEEEEEE-----CCceEEEEEecc-----chHHHHHHHhhcC-CCceeeeeeeeecCCeEEEEEE
Q 039626          351 DNFSFTCRIQ----GSVYRGKI-----NGGFAAIKKVNG-----DVSKEIALLNKIN-HSNLIILSGVCFNEGNCYLVYE  415 (628)
Q Consensus       351 ~~f~~~~~i~----G~Vy~g~~-----~g~~vavK~~~~-----~~~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~lV~E  415 (628)
                      +.|...++||    ++||++++     .++.||+|.+..     .+..|+++|..+. +.||+++.+++..++...+|+|
T Consensus        36 ~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp  115 (418)
T KOG1167|consen   36 NAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLP  115 (418)
T ss_pred             hhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCchHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEec
Confidence            3445555554    78999987     356899999864     5789999999995 8999999999999999999999


Q ss_pred             ecCCCChHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCC-CcEEEccccccccCCC
Q 039626          416 YAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSD-LRAKIANFAMARPAEG  494 (628)
Q Consensus       416 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~-~~~kl~Dfgla~~~~~  494 (628)
                      |++.....+++..       ++...+..+...+..||.|+|.   .+||||||||+|+|.+.. ++-.|.|||+|...+.
T Consensus       116 ~~~H~~f~~l~~~-------l~~~~i~~Yl~~ll~Al~~~h~---~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~  185 (418)
T KOG1167|consen  116 YFEHDRFRDLYRS-------LSLAEIRWYLRNLLKALAHLHK---NGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDG  185 (418)
T ss_pred             ccCccCHHHHHhc-------CCHHHHHHHHHHHHHHhhhhhc---cCccccCCCccccccccccCCceEEechhHHHHHh
Confidence            9999999988832       6788889999999999999999   459999999999999765 6789999999872110


Q ss_pred             CC--------------------------------Ccc---------eeeecccCCccccCcccccc-CCCCcccccHHHH
Q 039626          495 QE--------------------------------GEF---------ALTRHIVGTKGYMAPEYLEN-GLVSTKLDVYAFG  532 (628)
Q Consensus       495 ~~--------------------------------~~~---------~~~~~~~gt~~Y~APE~l~~-~~~s~k~DV~SfG  532 (628)
                      ..                                ...         ...-...||+||.|||++.. +..++++||||-|
T Consensus       186 ~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~G  265 (418)
T KOG1167|consen  186 YQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAG  265 (418)
T ss_pred             hhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeecc
Confidence            00                                000         00112479999999998864 6779999999999


Q ss_pred             HHHHHHHhCCCccccccccccccHHHHHH--------HHhccccc------------hhhhccccCC----cCC------
Q 039626          533 VLILEMLTGKEAAALHAEENNMHLSDVLN--------AVLTKEDG------------EESLRHFIDP----TLQ------  582 (628)
Q Consensus       533 vvl~ELltG~~p~~~~~~~~~~~~~~~~~--------~~~~~~~~------------~~~l~~~~d~----~l~------  582 (628)
                      |+++-+++++.||.....+-. .+.+.+.        ......+.            .+....+...    ...      
T Consensus       266 VI~Lslls~~~PFf~a~dd~~-al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~  344 (418)
T KOG1167|consen  266 VILLSLLSRRYPFFKAKDDAD-ALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNT  344 (418)
T ss_pred             ceeehhhccccccccCccccc-hHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccce
Confidence            999999999999864333211 1111110        00000000            0000011110    000      


Q ss_pred             --CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          583 --GNYPLELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       583 --~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                        ..+.+..+..+.+++.+|++.||.+|.|++|.++
T Consensus       345 ~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALk  380 (418)
T KOG1167|consen  345 EREIGSDVFPALLLDLLDKCLELNPQKRITAEDALK  380 (418)
T ss_pred             eeccccccccHHHHHHHHHHccCChhhcccHHHHhc
Confidence              1111223446789999999999999999999875

>PRK06347 autolysin; Reviewed

Probab=99.88  E-value=3.7e-22  Score=217.84  Aligned_cols=162  Identities=19%  Similarity=0.188  Sum_probs=128.9

Q ss_pred             EeeecCCCCCCHHHHHHHhCCChHhhhhhcCcc---ccCCcEEEEcccCccCC----------------CCcccceeEEE
Q 039626           64 LTFRSQPPFNTVASISTLLGSEPSLLSQINSVS---LETNRLVIVPVNCSCSG----------------QYYQSNTTYTI  124 (628)
Q Consensus        64 ~~~~~~~~~~tl~~Ia~~~~~~~~~i~~~N~~~---~~~gq~l~vp~~c~c~~----------------~~~~~~~~y~V  124 (628)
                      ..|.++ +||||+.||+.||+++.+|+++|++.   |.+||.|.||..-.-..                ........|+|
T Consensus       406 ~~ytVk-~GDTL~sIA~kygVSv~~L~~~N~l~s~~L~~Gq~L~IP~~~~~~~~t~~~s~~~~~~k~~s~~~~~~~~YtV  484 (592)
T PRK06347        406 KVYTVV-KGDSLWRIANNNKVTIANLKSWNNLKSDFIYPGQKLKVSAGSTSNTNTSKPSTNTNTSKPSTNTNTNAKVYTV  484 (592)
T ss_pred             eeEEec-CCCCHHHHHHHhCCCHHHHHHHhCCCcceeccCcEEEEecCCcccccccccccccccccccccccccceeeee
Confidence            366664 58999999999999999999999887   99999999997421100                00111246999


Q ss_pred             ecCChHHHHHhhhcCCCccHHHHHhccCCC-CccCCCcEEEEeecCCCCCCCC-----CCCCCCeEEEEEccCCCcHHHH
Q 039626          125 QNGDTYLFIANNTFQGLSTCQALEDQNGSP-TNLIIGAGVTVPLRCACPTENQ-----TDEGFPFLLSYLVAEGDTVSGI  198 (628)
Q Consensus       125 ~~gdt~~~IA~~~~~~l~t~~~l~~~N~~~-~~l~~Gq~l~vp~~~~c~~~~~-----~~~~~~~~~~y~v~~gdtl~~i  198 (628)
                      ++|||||.||++|+.   ++++|+++|++. +.|++||+|.||....-.....     ..........|+|+.|||||+|
T Consensus       485 k~GDTL~sIAkkygV---Sv~~L~~~N~l~s~~L~~GQ~L~Ip~~~~~s~~~t~~~s~~~~~~~~~~~Y~Vk~GDTL~sI  561 (592)
T PRK06347        485 AKGDSLWRIANNNKV---TIANLKSWNNLKSDFIYPGQKLKVSAGSTTNNTNTAKPSTNKPSNSTVKTYTVKKGDSLWAI  561 (592)
T ss_pred             cCCCCHHHHHHHHCC---CHHHHHHhcCCCcccccCCcEEEEecCcccccccccCCccCCccCccceeeecCCCCcHHHH
Confidence            999999999998865   889999999988 8899999999998653211100     0011123568999999999999


Q ss_pred             HHHhCCChHHHhhhcCCCCCCccccceeecc
Q 039626          199 SSRFGVDTGEILQANSLSGSNIFPFTTLLIP  229 (628)
Q Consensus       199 a~~f~~~~~~l~~~N~~~~~~~~~~~~l~iP  229 (628)
                      |+|||+++++|++||++.++.|++||.|.|+
T Consensus       562 A~KygvSv~~L~~~N~L~~~~L~~GQ~L~I~  592 (592)
T PRK06347        562 SRQYKTTVDNIKAWNKLTSNMIHVGQKLTIK  592 (592)
T ss_pred             HHHhCCCHHHHHHhcCCCcccCCCCCEEecC
Confidence            9999999999999999987799999999875

>PRK06347 autolysin; Reviewed

Probab=99.87  E-value=2.5e-21  Score=211.29  Aligned_cols=166  Identities=19%  Similarity=0.196  Sum_probs=131.2

Q ss_pred             eEeeecCCCCCCHHHHHHHhCCChHhhhhhcCcc---ccCCcEEEEcccCccCC-----------------CCcccceeE
Q 039626           63 YLTFRSQPPFNTVASISTLLGSEPSLLSQINSVS---LETNRLVIVPVNCSCSG-----------------QYYQSNTTY  122 (628)
Q Consensus        63 ~~~~~~~~~~~tl~~Ia~~~~~~~~~i~~~N~~~---~~~gq~l~vp~~c~c~~-----------------~~~~~~~~y  122 (628)
                      ...|.++ .||||+.||++||+++++|+++|++.   |.+||.|+||..-.-..                 ........|
T Consensus       330 ~~~Y~V~-sGDTL~~IA~rygvSv~eL~~~N~l~~d~L~~Gq~L~VP~~~~~~~~~t~~~~~~~~~~~~~~~~~~~~~~y  408 (592)
T PRK06347        330 AKIYTVV-KGDSLWRIANNHKVTVANLKAWNNLKSDFIYPGQKLKVSAGSTTSDTNTSKPSTGTSTSKPSTGTSTNAKVY  408 (592)
T ss_pred             ceEEEeC-CCCCHHHHHHHhCCCHHHHHHHhCCCccccccCcEEEEeccccccccccccccccccccccccccccCceeE
Confidence            3467775 59999999999999999999999988   99999999997421100                 001123479


Q ss_pred             EEecCChHHHHHhhhcCCCccHHHHHhccCCC-CccCCCcEEEEeecCCC------CCCCC-----CCCCCCeEEEEEcc
Q 039626          123 TIQNGDTYLFIANNTFQGLSTCQALEDQNGSP-TNLIIGAGVTVPLRCAC------PTENQ-----TDEGFPFLLSYLVA  190 (628)
Q Consensus       123 ~V~~gdt~~~IA~~~~~~l~t~~~l~~~N~~~-~~l~~Gq~l~vp~~~~c------~~~~~-----~~~~~~~~~~y~v~  190 (628)
                      +|++|||++.||++|+.   ++.+|+++|++. +.|.+||.|.||..-.-      +....     .+.......+|+|+
T Consensus       409 tVk~GDTL~sIA~kygV---Sv~~L~~~N~l~s~~L~~Gq~L~IP~~~~~~~~t~~~s~~~~~~k~~s~~~~~~~~YtVk  485 (592)
T PRK06347        409 TVVKGDSLWRIANNNKV---TIANLKSWNNLKSDFIYPGQKLKVSAGSTSNTNTSKPSTNTNTSKPSTNTNTNAKVYTVA  485 (592)
T ss_pred             EecCCCCHHHHHHHhCC---CHHHHHHHhCCCcceeccCcEEEEecCCcccccccccccccccccccccccccceeeeec
Confidence            99999999999998875   788899999988 88999999999975321      10000     00111234689999


Q ss_pred             CCCcHHHHHHHhCCChHHHhhhcCCCCCCccccceeeccCCC
Q 039626          191 EGDTVSGISSRFGVDTGEILQANSLSGSNIFPFTTLLIPLEN  232 (628)
Q Consensus       191 ~gdtl~~ia~~f~~~~~~l~~~N~~~~~~~~~~~~l~iP~~~  232 (628)
                      .|||||+||++||+++++|++||++.++.|++||.|.||...
T Consensus       486 ~GDTL~sIAkkygVSv~~L~~~N~l~s~~L~~GQ~L~Ip~~~  527 (592)
T PRK06347        486 KGDSLWRIANNNKVTIANLKSWNNLKSDFIYPGQKLKVSAGS  527 (592)
T ss_pred             CCCCHHHHHHHHCCCHHHHHHhcCCCcccccCCcEEEEecCc
Confidence            999999999999999999999999987799999999999864

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.86  E-value=8.1e-22  Score=188.41  Aligned_cols=233  Identities=20%  Similarity=0.285  Sum_probs=165.1

Q ss_pred             eEEEEEEE--CCceEEEEEecc------chHHHHHHHhhc-CCCceeeeeee-eecCCeEEEEEEecCCCChHHHhhhcC
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG------DVSKEIALLNKI-NHSNLIILSGV-CFNEGNCYLVYEYAVNGTLSDWVFSNK  430 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~------~~~~E~~~l~~l-~H~nIv~l~g~-~~~~~~~~lV~E~~~~gsL~~~l~~~~  430 (628)
                      |.+-.+..  ....+++|-+..      +|.+|..---.| .|.||+.-+++ |...+.+++++||++.|+|..-+.   
T Consensus        38 gkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE~aP~gdL~snv~---  114 (378)
T KOG1345|consen   38 GKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQEFAPRGDLRSNVE---  114 (378)
T ss_pred             eeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeeccCccchhhhhcC---
Confidence            66666666  456889998876      455555432233 58999977655 445677889999999999987762   


Q ss_pred             CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEe-CC-CCcEEEccccccccCCCCCCcceeeecccCC
Q 039626          431 NEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLL-DS-DLRAKIANFAMARPAEGQEGEFALTRHIVGT  508 (628)
Q Consensus       431 ~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl-~~-~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt  508 (628)
                        ...+.+..-.+++.|+++|+.|||+   ..+||||||.+|||+ +. ..++||+|||+.+..+..      .....-+
T Consensus       115 --~~GigE~~~K~v~~ql~SAi~fMHs---knlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~t------V~~~~~~  183 (378)
T KOG1345|consen  115 --AAGIGEANTKKVFAQLLSAIEFMHS---KNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTT------VKYLEYV  183 (378)
T ss_pred             --cccccHHHHHHHHHHHHHHHHHhhc---cchhhcccccceEEEecCCccEEEeeecccccccCce------ehhhhhh
Confidence              2347778888999999999999999   459999999999998 33 348999999999876532      2223455


Q ss_pred             ccccCcccccc-----CCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCC
Q 039626          509 KGYMAPEYLEN-----GLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQG  583 (628)
Q Consensus       509 ~~Y~APE~l~~-----~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~  583 (628)
                      ..|.+||....     ....+.+|+|.||++++.+++|+.||+... ......+++..+.-.+.           +.++.
T Consensus       184 ~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~-~~d~~Y~~~~~w~~rk~-----------~~~P~  251 (378)
T KOG1345|consen  184 NNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKAS-IMDKPYWEWEQWLKRKN-----------PALPK  251 (378)
T ss_pred             cccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhh-ccCchHHHHHHHhcccC-----------ccCch
Confidence            67999997643     246788999999999999999999998322 22344566655433221           12222


Q ss_pred             CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 039626          584 NYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSN  620 (628)
Q Consensus       584 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~  620 (628)
                      .+. ...+.+.++.++-+..+|++|--..++.+....
T Consensus       252 ~F~-~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~  287 (378)
T KOG1345|consen  252 KFN-PFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKC  287 (378)
T ss_pred             hhc-ccCHHHHHHHHHhcCCcccccchhHHHHHHHHH
Confidence            111 123456788889999999999666666655443

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.84  E-value=1e-20  Score=201.26  Aligned_cols=219  Identities=26%  Similarity=0.433  Sum_probs=164.8

Q ss_pred             HhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCC
Q 039626          389 LNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDI  468 (628)
Q Consensus       389 l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~di  468 (628)
                      |+.+.|.|+.+++|.+.++...+.|.+|+..|+|.|.+..   ....++|.-...+.++++.||+|||+.  +-..|+.+
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~---~~~~~d~~F~~s~~rdi~~Gl~ylh~s--~i~~hg~l   75 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN---EDIKLDYFFILSFIRDISKGLAYLHNS--PIGYHGAL   75 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc---cccCccHHHHHHHHHHHHHHHHHHhcC--cceeeeee
Confidence            4678999999999999999999999999999999999964   345699999999999999999999983  33399999


Q ss_pred             CCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCCccccCccccccC-------CCCcccccHHHHHHHHHHHhC
Q 039626          469 NSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENG-------LVSTKLDVYAFGVLILEMLTG  541 (628)
Q Consensus       469 k~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~-------~~s~k~DV~SfGvvl~ELltG  541 (628)
                      +++|+++|..+.+|++|||+....... ..........-...|.|||.+...       ..+.+.||||||++++|+++.
T Consensus        76 ~s~nClvd~~w~lklt~~Gl~~~~~~~-~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r  154 (484)
T KOG1023|consen   76 KSSNCLVDSRWVLKLTDFGLNSLLEET-AEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFR  154 (484)
T ss_pred             ccccceeeeeEEEEechhhhccccccc-ccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhc
Confidence            999999999999999999998766421 011111112244579999998763       257889999999999999999


Q ss_pred             CCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 039626          542 KEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNI  621 (628)
Q Consensus       542 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l  621 (628)
                      +.||.........  .+.+..+..  .....++    |.+....  +....+..++..||..+|.+||++++|...++.+
T Consensus       155 ~~~~~~~~~~~~~--~eii~~~~~--~~~~~~r----P~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~  224 (484)
T KOG1023|consen  155 SGPFDLRNLVEDP--DEIILRVKK--GGSNPFR----PSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTI  224 (484)
T ss_pred             cCccccccccCCh--HHHHHHHHh--cCCCCcC----cchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhhh
Confidence            9999854333221  233333222  1111111    2211110  3333688999999999999999999999998877


Q ss_pred             Hh
Q 039626          622 LN  623 (628)
Q Consensus       622 ~~  623 (628)
                      ..
T Consensus       225 ~~  226 (484)
T KOG1023|consen  225 NK  226 (484)
T ss_pred             cc
Confidence            65

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.81  E-value=1.8e-19  Score=188.57  Aligned_cols=152  Identities=21%  Similarity=0.240  Sum_probs=114.6

Q ss_pred             cCCCcCCccc----eEEEEEEE---CCceEEEEEecc------------chHHHHHHHhhcCCCceeeeeeeeecCCeEE
Q 039626          351 DNFSFTCRIQ----GSVYRGKI---NGGFAAIKKVNG------------DVSKEIALLNKINHSNLIILSGVCFNEGNCY  411 (628)
Q Consensus       351 ~~f~~~~~i~----G~Vy~g~~---~g~~vavK~~~~------------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~  411 (628)
                      ++|.....+|    |.||+|..   ++..+|||+...            .+.+|+++|++++|+|+++.+..   .+..+
T Consensus        18 ~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~~~~   94 (365)
T PRK09188         18 ARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TGKDG   94 (365)
T ss_pred             CCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cCCcE
Confidence            4455555554    89999987   466779998531            26789999999999999853322   24579


Q ss_pred             EEEEecCCCChHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCC-CCCCEEeCCCCcEEEccccccc
Q 039626          412 LVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDI-NSSNVLLDSDLRAKIANFAMAR  490 (628)
Q Consensus       412 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~di-k~~NILl~~~~~~kl~Dfgla~  490 (628)
                      |||||++|++|.. +.   ...       ...++.++++||.|||+.   +|+|||| ||+|||++.++++||+|||+++
T Consensus        95 LVmE~~~G~~L~~-~~---~~~-------~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLiDFGlA~  160 (365)
T PRK09188         95 LVRGWTEGVPLHL-AR---PHG-------DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVIDFQLAS  160 (365)
T ss_pred             EEEEccCCCCHHH-hC---ccc-------hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEEECccce
Confidence            9999999999963 21   111       145788999999999994   5999999 9999999999999999999999


Q ss_pred             cCCCCCCccee-----eecccCCccccCcccccc
Q 039626          491 PAEGQEGEFAL-----TRHIVGTKGYMAPEYLEN  519 (628)
Q Consensus       491 ~~~~~~~~~~~-----~~~~~gt~~Y~APE~l~~  519 (628)
                      ...........     .+...+++.|+|||++..
T Consensus       161 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~  194 (365)
T PRK09188        161 VFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP  194 (365)
T ss_pred             ecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence            77543211111     135678899999999863

>PRK10783 mltD membrane-bound lytic murein transglycosylase D; Provisional

Probab=99.80  E-value=5.5e-19  Score=189.66  Aligned_cols=155  Identities=21%  Similarity=0.301  Sum_probs=123.7

Q ss_pred             CCCCHHHHHHHhCCChHhhhhhc-Ccc---cc-CC-cEEEEcccCccC-------C------------CCcccceeEEEe
Q 039626           71 PFNTVASISTLLGSEPSLLSQIN-SVS---LE-TN-RLVIVPVNCSCS-------G------------QYYQSNTTYTIQ  125 (628)
Q Consensus        71 ~~~tl~~Ia~~~~~~~~~i~~~N-~~~---~~-~g-q~l~vp~~c~c~-------~------------~~~~~~~~y~V~  125 (628)
                      .+.+|..||+++|++.++|.++| ++.   +. .| +.|+||..-.-.       +            +......+|+|+
T Consensus       270 ~~i~L~~iA~~~gvs~~eL~~LNP~~kr~~t~p~g~~~llvP~~~~~~f~~~l~~~~~~~~~p~~~~~~~~~~~~~y~Vk  349 (456)
T PRK10783        270 QQIELAQAAEMAGMSLTKLKTFNAGYKRSTTAPSGPHYIMVPKKHADQLRESLASGEIAAVQSTLVADNTPLNSRSYKVR  349 (456)
T ss_pred             CCcCHHHHHHHcCCCHHHHHHhCccccCCCcCCCCCeEEEecCchhhHHHHhhhhhhhhhcccccccccCcCCceEEEEC
Confidence            36799999999999999999999 565   33 34 778888853210       0            000123479999


Q ss_pred             cCChHHHHHhhhcCCCccHHHHHhccCCC-CccCCCcEEEEeecCCCCCCCCCCCCCCeEEEEEccCCCcHHHHHHHhCC
Q 039626          126 NGDTYLFIANNTFQGLSTCQALEDQNGSP-TNLIIGAGVTVPLRCACPTENQTDEGFPFLLSYLVAEGDTVSGISSRFGV  204 (628)
Q Consensus       126 ~gdt~~~IA~~~~~~l~t~~~l~~~N~~~-~~l~~Gq~l~vp~~~~c~~~~~~~~~~~~~~~y~v~~gdtl~~ia~~f~~  204 (628)
                      +|||++.||++|+.   +.++|.++|+.. +.|.+||+|.||..+.|..    .......++|+|+.||||++||++|||
T Consensus       350 ~GDTL~sIA~r~gv---s~~~L~~~N~l~~~~L~~Gq~L~Ip~~~~~~~----~~~~~~~~~Y~Vr~GDTL~sIA~kygV  422 (456)
T PRK10783        350 SGDTLSGIASRLNV---STKDLQQWNNLRGSKLKVGQTLTIGAGSSAQR----LANNSDSITYRVRKGDSLSSIAKRHGV  422 (456)
T ss_pred             CCCcHHHHHHHHCc---CHHHHHHHcCCCcccCCCCCEEEecCCccccc----ccccccceeEEeCCCCCHHHHHHHhCC
Confidence            99999999998864   778899999988 8899999999998766532    122234578999999999999999999


Q ss_pred             ChHHHhhhcCCCCCCccccceeeccCCC
Q 039626          205 DTGEILQANSLSGSNIFPFTTLLIPLEN  232 (628)
Q Consensus       205 ~~~~l~~~N~~~~~~~~~~~~l~iP~~~  232 (628)
                      ++++|++||++.++.|.|||+|.|++..
T Consensus       423 tv~~L~~~N~l~~~~L~pGq~L~l~v~~  450 (456)
T PRK10783        423 NIKDVMRWNSDTAKNLQPGDKLTLFVKN  450 (456)
T ss_pred             CHHHHHHhcCCCCCcCCCCCEEEEecCC
Confidence            9999999999865599999999998754

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.79  E-value=4.1e-18  Score=178.07  Aligned_cols=251  Identities=18%  Similarity=0.191  Sum_probs=182.0

Q ss_pred             CCCcCCccc----eEEEEEEECC---ceEEEEEecc-------chHHHHHHHhhcCC----Cceeeeeeee-ecCCeEEE
Q 039626          352 NFSFTCRIQ----GSVYRGKING---GFAAIKKVNG-------DVSKEIALLNKINH----SNLIILSGVC-FNEGNCYL  412 (628)
Q Consensus       352 ~f~~~~~i~----G~Vy~g~~~g---~~vavK~~~~-------~~~~E~~~l~~l~H----~nIv~l~g~~-~~~~~~~l  412 (628)
                      .|.....+|    |.||.+....   ..+|+|....       .+..|..++..+.+    .++..+++.. ..+...++
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i   98 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI   98 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence            444444443    8999999843   3678876643       36679999999973    5888888888 46778899


Q ss_pred             EEEecCCCChHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCC-----CcEEEcccc
Q 039626          413 VYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSD-----LRAKIANFA  487 (628)
Q Consensus       413 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~-----~~~kl~Dfg  487 (628)
                      ||+.+ |.+|.++.....  .+.++..+.++|+.|++.+|++||+.+   ++||||||.|+++...     ..+.|.|||
T Consensus        99 VM~l~-G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfG  172 (322)
T KOG1164|consen   99 VMSLL-GPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFG  172 (322)
T ss_pred             EEecc-CccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecC
Confidence            99988 889999774432  467899999999999999999999955   9999999999999765     468999999


Q ss_pred             ccc--cCCCCCCcc---ee--eecccCCccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHH
Q 039626          488 MAR--PAEGQEGEF---AL--TRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVL  560 (628)
Q Consensus       488 la~--~~~~~~~~~---~~--~~~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~  560 (628)
                      +++  .........   ..  .....||..|.+++.+.+...+.+.|+||++.++.|++.|..||........   ...+
T Consensus       173 lar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~---~~~~  249 (322)
T KOG1164|consen  173 LARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL---KSKF  249 (322)
T ss_pred             CCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch---HHHH
Confidence            999  332222111   10  1224599999999999999999999999999999999999988854332211   1111


Q ss_pred             HHHhccccchhhhccccCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhh
Q 039626          561 NAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNA  624 (628)
Q Consensus       561 ~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~~~  624 (628)
                      .....        ......     .....+..+.++...+-..+..++|....+...|+.+...
T Consensus       250 ~~~~~--------~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~  300 (322)
T KOG1164|consen  250 EKDPR--------KLLTDR-----FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDS  300 (322)
T ss_pred             HHHhh--------hhcccc-----ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHh
Confidence            11000        000000     1112234456666666679999999999999999888764

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.79  E-value=1.6e-17  Score=171.19  Aligned_cols=244  Identities=29%  Similarity=0.415  Sum_probs=179.9

Q ss_pred             eEEEEEEECCceEEEEEecc----------chHHHHHHHhhcCCC-ceeeeeeeeecCCeEEEEEEecCCCChHHHhhhc
Q 039626          361 GSVYRGKINGGFAAIKKVNG----------DVSKEIALLNKINHS-NLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSN  429 (628)
Q Consensus       361 G~Vy~g~~~g~~vavK~~~~----------~~~~E~~~l~~l~H~-nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~  429 (628)
                      |.||++... ..+++|.+..          .+.+|+.++.++.|+ +++++.+++......++++||+.+++|.+++...
T Consensus        14 ~~v~~~~~~-~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~   92 (384)
T COG0515          14 GEVYLARDR-KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKI   92 (384)
T ss_pred             eEEEEEEec-cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecCCCCcHHHHHHhc
Confidence            889999888 7788887753          366789999999988 7999999997777789999999999999776432


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCC-cEEEccccccccCCCCCCcc---eeeecc
Q 039626          430 KNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDL-RAKIANFAMARPAEGQEGEF---ALTRHI  505 (628)
Q Consensus       430 ~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~-~~kl~Dfgla~~~~~~~~~~---~~~~~~  505 (628)
                      ... ..+.......+..+++.++.|+|+.+   ++|||+||+||+++... .+++.|||+++.........   ......
T Consensus        93 ~~~-~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~  168 (384)
T COG0515          93 GRK-GPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTS  168 (384)
T ss_pred             ccc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcccccccccccc
Confidence            211 36888999999999999999999955   99999999999999998 79999999998654332221   123556


Q ss_pred             cCCccccCcccccc---CCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCC
Q 039626          506 VGTKGYMAPEYLEN---GLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQ  582 (628)
Q Consensus       506 ~gt~~Y~APE~l~~---~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~  582 (628)
                      .|+..|++||.+.+   ...+...|+|++|++++++++|..|+......  .........+..... .     .......
T Consensus       169 ~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~--~~~~~~~~~~~~~~~-~-----~~~~~~~  240 (384)
T COG0515         169 VGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS--SATSQTLKIILELPT-P-----SLASPLS  240 (384)
T ss_pred             ccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc--ccHHHHHHHHHhcCC-c-----ccccccC
Confidence            89999999999987   68899999999999999999999885533221  001111111111100 0     0000011


Q ss_pred             CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 039626          583 GNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHS  617 (628)
Q Consensus       583 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~  617 (628)
                      ..........+.+++..|+..+|..|.++.+....
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         241 PSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             ccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence            01012223467889999999999999998877653

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.79  E-value=5.6e-19  Score=173.56  Aligned_cols=252  Identities=17%  Similarity=0.206  Sum_probs=186.7

Q ss_pred             CCCcCCccc----eEEEEEEE--CCceEEEEEecc-----chHHHHHHHhhcC-CCceeeeeeeeecCCeEEEEEEecCC
Q 039626          352 NFSFTCRIQ----GSVYRGKI--NGGFAAIKKVNG-----DVSKEIALLNKIN-HSNLIILSGVCFNEGNCYLVYEYAVN  419 (628)
Q Consensus       352 ~f~~~~~i~----G~Vy~g~~--~g~~vavK~~~~-----~~~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~lV~E~~~~  419 (628)
                      +|..+.+||    |..+.|+.  +++.||||.-..     ++..|.+..+.|. .++|..++-|..++.+-.||+|.+ |
T Consensus        29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL-G  107 (449)
T KOG1165|consen   29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL-G  107 (449)
T ss_pred             cceeccccccCcceeeecccccccCceEEEEeccccCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh-C
Confidence            455566665    89999986  999999997643     5788999888886 478888887777777788999998 8


Q ss_pred             CChHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCC-----CCcEEEccccccccCCC
Q 039626          420 GTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDS-----DLRAKIANFAMARPAEG  494 (628)
Q Consensus       420 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~-----~~~~kl~Dfgla~~~~~  494 (628)
                      -||+|++.   -.++.++.++.+.+|.|++.-++|+|+..   +|.|||||+|+||..     ...+.++|||+|+.+.+
T Consensus       108 PSLEDLFD---~CgR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrD  181 (449)
T KOG1165|consen  108 PSLEDLFD---LCGRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRD  181 (449)
T ss_pred             cCHHHHHH---HhcCcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchhhhcC
Confidence            89999873   35667999999999999999999999954   999999999999964     34689999999998876


Q ss_pred             CCCccee----eecccCCccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccch
Q 039626          495 QEGEFAL----TRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGE  570 (628)
Q Consensus       495 ~~~~~~~----~~~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  570 (628)
                      .....+.    .....||.+||+-..+.+...+.+.|.-|+|-|+++.+.|..||..-..+...   +..+.+-+... .
T Consensus       182 p~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK---~kYeKIGe~Kr-~  257 (449)
T KOG1165|consen  182 PKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNK---EKYEKIGETKR-S  257 (449)
T ss_pred             ccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchH---HHHHHhccccc-c
Confidence            5543322    23457999999999999999999999999999999999999999865543322   11112111100 0


Q ss_pred             hhhccccCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHh
Q 039626          571 ESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILN  623 (628)
Q Consensus       571 ~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~~  623 (628)
                      -.+     ..|...+|    .++..-++-.-..+-.+-|..+-+...+..+++
T Consensus       258 T~i-----~~Lc~g~P----~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvld  301 (449)
T KOG1165|consen  258 TPI-----EVLCEGFP----EEFATYLRYVRRLDFFETPDYDYLRKLFDDVLD  301 (449)
T ss_pred             CCH-----HHHHhcCH----HHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHH
Confidence            000     11222334    344555555556677778888777766666653

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.76  E-value=2.4e-19  Score=199.50  Aligned_cols=215  Identities=21%  Similarity=0.229  Sum_probs=162.5

Q ss_pred             hHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC
Q 039626          382 VSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNP  461 (628)
Q Consensus       382 ~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~  461 (628)
                      +..|+.+-.+++|+|++..+..+.+....+-+|||+++ +|...+..    ...+.-..+..+..|+..|++|||+.+  
T Consensus       368 i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE~~~~-Dlf~~~~~----~~~~~~~e~~c~fKqL~~Gv~y~h~~G--  440 (601)
T KOG0590|consen  368 ITSEFCIGSSLSHPNIIETLDIVQEIDGILQSMEYCPY-DLFSLVMS----NGKLTPLEADCFFKQLLRGVKYLHSMG--  440 (601)
T ss_pred             hhhheeecccccCCchhhhHHHHhhcccchhhhhcccH-HHHHHHhc----ccccchhhhhHHHHHHHHHHHHHHhcC--
Confidence            34466667778999999888888877666666999999 99998843    235777888899999999999999965  


Q ss_pred             CeEecCCCCCCEEeCCCCcEEEccccccccCCCCCC-cceeeecccCCccccCccccccCCCCcc-cccHHHHHHHHHHH
Q 039626          462 PHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEG-EFALTRHIVGTKGYMAPEYLENGLVSTK-LDVYAFGVLILEML  539 (628)
Q Consensus       462 ~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~~~gt~~Y~APE~l~~~~~s~k-~DV~SfGvvl~ELl  539 (628)
                       +.|||+|++|++++.++.+||+|||.+........ .........|+..|+|||.+.+..|.+. .||||.|+++..|+
T Consensus       441 -iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~  519 (601)
T KOG0590|consen  441 -LAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMI  519 (601)
T ss_pred             -ceeccCccccEEEecCCceEEeecCcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEe
Confidence             99999999999999999999999999876643322 1234456789999999999999888775 79999999999999


Q ss_pred             hCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          540 TGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       540 tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      +|+.||.......... .    ....       ..+.-...-....-..++.....++.++|+.||.+|.++++|++
T Consensus       520 ~~~~~Wk~a~~~~~~~-~----~~~~-------~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~  584 (601)
T KOG0590|consen  520 LGRFPWKVAKKSDNSF-K----TNNY-------SDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN  584 (601)
T ss_pred             cCCCccccccccccch-h----hhcc-------ccccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence            9999987655433211 0    0000       00000000001112345666788999999999999999999976

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.74  E-value=9.8e-19  Score=194.41  Aligned_cols=230  Identities=23%  Similarity=0.335  Sum_probs=165.1

Q ss_pred             EEEEEEECCceEEEEEecc--------ch---HHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhcC
Q 039626          362 SVYRGKINGGFAAIKKVNG--------DV---SKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNK  430 (628)
Q Consensus       362 ~Vy~g~~~g~~vavK~~~~--------~~---~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~  430 (628)
                      +|.|++.+.+.|+||.+-+        .+   .+|++ ...++|||.+++.-+-..+...|||-+|.. -+|+|.|    
T Consensus        38 Kv~r~k~~eG~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRqyvk-hnLyDRl----  111 (1431)
T KOG1240|consen   38 KVARAKDREGLVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQYVK-HNLYDRL----  111 (1431)
T ss_pred             hhhhccCCCceEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHHHHh-hhhhhhh----
Confidence            5778888777799998743        23   34555 556699999999888777777889999984 4888887    


Q ss_pred             CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCC---CCcce-eeeccc
Q 039626          431 NEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQ---EGEFA-LTRHIV  506 (628)
Q Consensus       431 ~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~---~~~~~-~~~~~~  506 (628)
                      ..+..|...+..-|+.|++.||..+|..+   |+|+|||.+|||++.=+.+.|+||..-+...-.   ...+. ......
T Consensus       112 STRPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPadf~fFFDTSr  188 (1431)
T KOG1240|consen  112 STRPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPADFTFFFDTSR  188 (1431)
T ss_pred             ccchHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCCCCCcccceEEEecCC
Confidence            45566888888889999999999999955   999999999999999999999999876654211   11111 111122


Q ss_pred             CCccccCcccccc-----------CCCCcccccHHHHHHHHHHHh-CCCccccccccccccHHHHHHHHhc-cccchhhh
Q 039626          507 GTKGYMAPEYLEN-----------GLVSTKLDVYAFGVLILEMLT-GKEAAALHAEENNMHLSDVLNAVLT-KEDGEESL  573 (628)
Q Consensus       507 gt~~Y~APE~l~~-----------~~~s~k~DV~SfGvvl~ELlt-G~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l  573 (628)
                      .-..|.|||.+-.           ...+++.||||+|||+.||++ |+++|..         ...+.---. ..+.+..+
T Consensus       189 RRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L---------SQL~aYr~~~~~~~e~~L  259 (1431)
T KOG1240|consen  189 RRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL---------SQLLAYRSGNADDPEQLL  259 (1431)
T ss_pred             ceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH---------HHHHhHhccCccCHHHHH
Confidence            3346999998743           126889999999999999987 6777652         222111101 11122233


Q ss_pred             ccccCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 039626          574 RHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNI  621 (628)
Q Consensus       574 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l  621 (628)
                      +++-|+            .+..++..|+++||.+|.|+++.++.-.++
T Consensus       260 e~Ied~------------~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~  295 (1431)
T KOG1240|consen  260 EKIEDV------------SLRNLILSMIQRDPSKRLSAEDYLQKYRGL  295 (1431)
T ss_pred             HhCcCc------------cHHHHHHHHHccCchhccCHHHHHHhhhcc
Confidence            333333            356899999999999999999999875544

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.73  E-value=3.8e-17  Score=154.22  Aligned_cols=242  Identities=15%  Similarity=0.190  Sum_probs=179.5

Q ss_pred             eEEEEEEE--CCceEEEEEecc-----chHHHHHHHhhcCC-CceeeeeeeeecCCeEEEEEEecCCCChHHHhhhcCCC
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG-----DVSKEIALLNKINH-SNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNE  432 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~-----~~~~E~~~l~~l~H-~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~  432 (628)
                      |.+|.|..  +|+.||||.-..     ++.-|.++...|+| ..|..+..+..++..-.||||.+ |-||++.+.-   .
T Consensus        29 GdIy~~~~i~~ge~VAiK~Es~~a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdLL-GPsLEdLfnf---C  104 (341)
T KOG1163|consen   29 GDIYLGISITSGEEVAIKLESSKAKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDLL-GPSLEDLFNF---C  104 (341)
T ss_pred             hheeeeeeccCCceEEEEeecccCCCcchhHHHHHHHHhccCCCCchhhhhccccccceeeeecc-CccHHHHHHH---H
Confidence            88999987  899999998765     46779999999987 46666777777778889999998 8899998742   3


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCC---CcEEEccccccccCCCCCCccee----eecc
Q 039626          433 GKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSD---LRAKIANFAMARPAEGQEGEFAL----TRHI  505 (628)
Q Consensus       433 ~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~---~~~kl~Dfgla~~~~~~~~~~~~----~~~~  505 (628)
                      .+.++.++.+.++-|++.-++|+|..+   ++||||||+|+|..-+   ..+.++|||+++...+.....+.    .+..
T Consensus       105 ~R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~~HIpyre~r~l  181 (341)
T KOG1163|consen  105 SRRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTRQHIPYREDRNL  181 (341)
T ss_pred             hhhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhhccccccccCccccCCcc
Confidence            455888999999999999999999955   9999999999998543   56889999999987655433222    2446


Q ss_pred             cCCccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCC
Q 039626          506 VGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNY  585 (628)
Q Consensus       506 ~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~  585 (628)
                      .||.+|.+-..+.+...+.+.|+-|+|.||+.+-.|..||..-.......-.+.+   .++.     +.. .-..+...+
T Consensus       182 tGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI---~EkK-----~s~-~ie~LC~G~  252 (341)
T KOG1163|consen  182 TGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKI---SEKK-----MST-PIEVLCKGF  252 (341)
T ss_pred             ceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHH---HHhh-----cCC-CHHHHhCCC
Confidence            8999999999888888899999999999999999999999864433221111111   1110     000 001122233


Q ss_pred             CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhH
Q 039626          586 PLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNIL  622 (628)
Q Consensus       586 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~  622 (628)
                      |    .++.-.+.-|-..--++-|...-+.+.+.-++
T Consensus       253 P----~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLf  285 (341)
T KOG1163|consen  253 P----AEFAMYLNYCRGLGFEEKPDYMYLRQLFRILF  285 (341)
T ss_pred             c----HHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHH
Confidence            3    34556677788888888888877766655444

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.68  E-value=1.6e-16  Score=152.71  Aligned_cols=123  Identities=20%  Similarity=0.226  Sum_probs=96.4

Q ss_pred             eEEEEEEE-CCceEEEEEeccc----------------h-----------------HHHHHHHhhcCCCceeeeeeeeec
Q 039626          361 GSVYRGKI-NGGFAAIKKVNGD----------------V-----------------SKEIALLNKINHSNLIILSGVCFN  406 (628)
Q Consensus       361 G~Vy~g~~-~g~~vavK~~~~~----------------~-----------------~~E~~~l~~l~H~nIv~l~g~~~~  406 (628)
                      |.||+|.. +|+.||||+++.+                |                 ..|+++|.++.|+++.....+.. 
T Consensus        11 ~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v~~p~~~~~-   89 (190)
T cd05147          11 ANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGIPCPEPILL-   89 (190)
T ss_pred             eEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCcEEEe-
Confidence            89999998 6899999988532                1                 13899999998877644333322 


Q ss_pred             CCeEEEEEEecCCCChHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHH-hcCCCCCeEecCCCCCCEEeCCCCcEEEcc
Q 039626          407 EGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYL-HSFTNPPHVHKDINSSNVLLDSDLRAKIAN  485 (628)
Q Consensus       407 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yL-H~~~~~~iiH~dik~~NILl~~~~~~kl~D  485 (628)
                       ...+|||||+++++|...+.    ....+++....+++.|++.+|.|+ |+.   +++||||||+|||++ ++.++|+|
T Consensus        90 -~~~~iVmE~i~g~~l~~~~~----~~~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli~-~~~v~LiD  160 (190)
T cd05147          90 -KSHVLVMEFIGDDGWAAPRL----KDAPLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLYH-DGKLYIID  160 (190)
T ss_pred             -cCCEEEEEEeCCCCCcchhh----hcCCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEE-CCcEEEEE
Confidence             22389999999887765432    123588899999999999999999 564   499999999999998 47899999


Q ss_pred             ccccccCC
Q 039626          486 FAMARPAE  493 (628)
Q Consensus       486 fgla~~~~  493 (628)
                      ||++....
T Consensus       161 FG~a~~~~  168 (190)
T cd05147         161 VSQSVEHD  168 (190)
T ss_pred             ccccccCC
Confidence            99997553

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.67  E-value=3.7e-17  Score=174.11  Aligned_cols=207  Identities=23%  Similarity=0.333  Sum_probs=165.4

Q ss_pred             chHHHHHHHhhcC-CCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC
Q 039626          381 DVSKEIALLNKIN-HSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFT  459 (628)
Q Consensus       381 ~~~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~  459 (628)
                      ....|-.++..++ |+.+|++.-.+..+...+++.+|..+|+|...+.    ................++-+++++|+.+
T Consensus        42 ~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rgg~lft~l~----~~~~f~~~~~~~~~aelaLald~lh~l~  117 (612)
T KOG0603|consen   42 HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRGGDLFTRLS----KEVMFDELDVAFYLAELALALDHLHKLG  117 (612)
T ss_pred             ccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcccchhhhccc----cCCchHHHHHHHHHHHHHHHHhhcchhH
Confidence            3445788888887 9999999999999999999999999999987773    2334556666667888999999999965


Q ss_pred             CCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCCccccCccccccCCCCcccccHHHHHHHHHHH
Q 039626          460 NPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEML  539 (628)
Q Consensus       460 ~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELl  539 (628)
                         ++|||+|++||+++.+|.+|+.|||+++..-...       ...||..|||||++.  ......|-||||++++||+
T Consensus       118 ---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~-------~~cgt~eymApEI~~--gh~~a~D~ws~gvl~fell  185 (612)
T KOG0603|consen  118 ---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK-------IACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELL  185 (612)
T ss_pred             ---HHHhcccccceeecccCccccCCchhhhHhHhhh-------hcccchhhhhhHhhh--ccCCcccchhhhhhHHHHh
Confidence               9999999999999999999999999998653322       117899999999998  4578999999999999999


Q ss_pred             hCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCH--HHHHHH
Q 039626          540 TGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTM--YEIEHS  617 (628)
Q Consensus       540 tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~--~ev~~~  617 (628)
                      +|-.|+..          +....++.               .....|.+....+.+++..++.++|..|--.  +.+.+.
T Consensus       186 tg~~pf~~----------~~~~~Il~---------------~~~~~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~ei  240 (612)
T KOG0603|consen  186 TGTLPFGG----------DTMKRILK---------------AELEMPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEI  240 (612)
T ss_pred             hCCCCCch----------HHHHHHhh---------------hccCCchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHH
Confidence            99988763          12222211               1123466777788899999999999999665  677777


Q ss_pred             HHHhHhhccCC
Q 039626          618 LSNILNASLNW  628 (628)
Q Consensus       618 L~~l~~~~~~w  628 (628)
                      ++.-+-..+||
T Consensus       241 k~h~f~~~i~~  251 (612)
T KOG0603|consen  241 KQHEFFQSIDW  251 (612)
T ss_pred             hccchheeeeH
Confidence            77766666666

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.66  E-value=1.3e-16  Score=155.55  Aligned_cols=148  Identities=14%  Similarity=0.135  Sum_probs=115.1

Q ss_pred             eEEEEEEECCceEEEEEeccc----------------hHHHHHHHhhcCCCceeeeeeeeecC--------CeEEEEEEe
Q 039626          361 GSVYRGKINGGFAAIKKVNGD----------------VSKEIALLNKINHSNLIILSGVCFNE--------GNCYLVYEY  416 (628)
Q Consensus       361 G~Vy~g~~~g~~vavK~~~~~----------------~~~E~~~l~~l~H~nIv~l~g~~~~~--------~~~~lV~E~  416 (628)
                      |.||....+++.+|+|.+..+                +.+|++.+.+++|++|..+..++...        +..+|||||
T Consensus        45 ~~v~l~~~~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~~~~~~~~~~~~lvmEy  124 (232)
T PRK10359         45 TKVSLIDTDYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAERKTLRYAHTYIMLIEY  124 (232)
T ss_pred             eEEEEEecCCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecccccccccCCeEEEEEE
Confidence            899997777889999998631                46789999999999999998886533        358999999


Q ss_pred             cCCCChHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCC
Q 039626          417 AVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQE  496 (628)
Q Consensus       417 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~  496 (628)
                      ++|.+|.++..        ++.    ....+++.+|..+|+.+   ++|||+||+||+++.++ ++|+|||..+......
T Consensus       125 i~G~tL~~~~~--------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g-i~liDfg~~~~~~e~~  188 (232)
T PRK10359        125 IEGVELNDMPE--------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG-LRIIDLSGKRCTAQRK  188 (232)
T ss_pred             ECCccHHHhhh--------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC-EEEEECCCcccccchh
Confidence            99999988741        222    24569999999999854   99999999999999998 9999999887553211


Q ss_pred             CcceeeecccCCccccCccccccCCCCcccccHHHHHHHHHHH
Q 039626          497 GEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEML  539 (628)
Q Consensus       497 ~~~~~~~~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELl  539 (628)
                      ..               ..++....+..++|+|+||+.+.-+.
T Consensus       189 a~---------------d~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        189 AK---------------DRIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             hH---------------HHHHHHhHhcccccccceeEeehHHH
Confidence            00               11334445567999999999987664

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.66  E-value=6.7e-16  Score=148.71  Aligned_cols=123  Identities=18%  Similarity=0.217  Sum_probs=97.7

Q ss_pred             eEEEEEEE-CCceEEEEEeccc---------------------------------hHHHHHHHhhcCCCceeeeeeeeec
Q 039626          361 GSVYRGKI-NGGFAAIKKVNGD---------------------------------VSKEIALLNKINHSNLIILSGVCFN  406 (628)
Q Consensus       361 G~Vy~g~~-~g~~vavK~~~~~---------------------------------~~~E~~~l~~l~H~nIv~l~g~~~~  406 (628)
                      |.||+|.. +|+.||||..+..                                 +..|.+.+.+++|+++.....+...
T Consensus        11 ~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~   90 (190)
T cd05145          11 ANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGVPVPEPILLK   90 (190)
T ss_pred             cEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCCCCceEEEec
Confidence            89999998 5999999987632                                 1358899999999987544443332


Q ss_pred             CCeEEEEEEecCCCChHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCeEecCCCCCCEEeCCCCcEEEcc
Q 039626          407 EGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHS-FTNPPHVHKDINSSNVLLDSDLRAKIAN  485 (628)
Q Consensus       407 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~iiH~dik~~NILl~~~~~~kl~D  485 (628)
                        ..+|||||++++++......    ...++.....+++.+++.++.+||+ .+   ++||||||+|||++ ++.++|+|
T Consensus        91 --~~~lVmE~~~g~~~~~~~l~----~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~-~~~~~liD  160 (190)
T cd05145          91 --KNVLVMEFIGDDGSPAPRLK----DVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH-DGKPYIID  160 (190)
T ss_pred             --CCEEEEEEecCCCchhhhhh----hccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE-CCCEEEEE
Confidence              24899999988865443211    2346778889999999999999998 55   99999999999999 88999999


Q ss_pred             ccccccCC
Q 039626          486 FAMARPAE  493 (628)
Q Consensus       486 fgla~~~~  493 (628)
                      ||+++...
T Consensus       161 FG~a~~~~  168 (190)
T cd05145         161 VSQAVELD  168 (190)
T ss_pred             cccceecC
Confidence            99998664

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.66  E-value=4.7e-17  Score=170.15  Aligned_cols=175  Identities=26%  Similarity=0.451  Sum_probs=130.4

Q ss_pred             eEEEEEEecCCCChHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccc
Q 039626          409 NCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAM  488 (628)
Q Consensus       409 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgl  488 (628)
                      .+|+.|+++...+|.+||.+. ......+|...+.++.|++.|+.|      ++.+|+|+||.||++..+..+||.|||+
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr-~~~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDFgl  402 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRR-RTGEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDFGL  402 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCC-CcccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhhhh
Confidence            578999999999999999643 345568899999999999999999      3489999999999999999999999999


Q ss_pred             cccCCCCC---CcceeeecccCCccccCccccccCCCCcccccHHHHHHHHHHHhCC-CccccccccccccHHHHHHHHh
Q 039626          489 ARPAEGQE---GEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGK-EAAALHAEENNMHLSDVLNAVL  564 (628)
Q Consensus       489 a~~~~~~~---~~~~~~~~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~-~p~~~~~~~~~~~~~~~~~~~~  564 (628)
                      ........   ..........||..||+||.+.+..++.|+||||+|++|+||+.-- ..+.               ...
T Consensus       403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~e---------------r~~  467 (516)
T KOG1033|consen  403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFE---------------RIA  467 (516)
T ss_pred             eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHH---------------HHH
Confidence            87765433   1122344568999999999999999999999999999999998721 1111               000


Q ss_pred             ccccchhhhccccCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHH
Q 039626          565 TKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYE  613 (628)
Q Consensus       565 ~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~e  613 (628)
                      .   ..+.-+..++|....++|.+     ..|+.+++...|.+||++.+
T Consensus       468 t---~~d~r~g~ip~~~~~d~p~e-----~~ll~~lls~~p~~RP~~~~  508 (516)
T KOG1033|consen  468 T---LTDIRDGIIPPEFLQDYPEE-----YTLLQQLLSPSPEERPSAIE  508 (516)
T ss_pred             h---hhhhhcCCCChHHhhcCcHH-----HHHHHHhcCCCcccCchHHH
Confidence            0   00111122222333344433     47899999999999994433

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.66  E-value=6.9e-16  Score=155.13  Aligned_cols=199  Identities=21%  Similarity=0.322  Sum_probs=137.7

Q ss_pred             CCCceeeeeeeeecC---------------------------CeEEEEEEecCCCChHHHhhhcCCCCCCCCHHHHHHHH
Q 039626          393 NHSNLIILSGVCFNE---------------------------GNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIA  445 (628)
Q Consensus       393 ~H~nIv~l~g~~~~~---------------------------~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~  445 (628)
                      +|||||++.++|.+.                           ..+||||.-. ..+|..++..     +..+...+.-|+
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~-----~~~s~r~~~~~l  347 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWT-----RHRSYRTGRVIL  347 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhc-----CCCchHHHHHHH
Confidence            688888888777431                           2478999887 4589999843     235556677799


Q ss_pred             HHHHHHHHHHhcCCCCCeEecCCCCCCEEe--CCCC--cEEEccccccccCCCCCCcceee---ecccCCccccCccccc
Q 039626          446 LDVATGLNYLHSFTNPPHVHKDINSSNVLL--DSDL--RAKIANFAMARPAEGQEGEFALT---RHIVGTKGYMAPEYLE  518 (628)
Q Consensus       446 ~~ia~gL~yLH~~~~~~iiH~dik~~NILl--~~~~--~~kl~Dfgla~~~~~~~~~~~~~---~~~~gt~~Y~APE~l~  518 (628)
                      .|+++|+.|||.++   +.|||+|++|||+  |+|.  ...|+|||.+-.-+...-.....   -...|.-.-||||+..
T Consensus       348 aQlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~t  424 (598)
T KOG4158|consen  348 AQLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIAT  424 (598)
T ss_pred             HHHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhh
Confidence            99999999999966   9999999999998  4444  46899999765433211111111   2235777899999886


Q ss_pred             cC------CCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCHHHHHH
Q 039626          519 NG------LVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALL  592 (628)
Q Consensus       519 ~~------~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~  592 (628)
                      ..      ..-.|+|.|+.|-+.||+++...||....+.. .....              .++---|.+    |+.++..
T Consensus       425 a~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~-L~~r~--------------Yqe~qLPal----p~~vpp~  485 (598)
T KOG4158|consen  425 AVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEML-LDTRT--------------YQESQLPAL----PSRVPPV  485 (598)
T ss_pred             cCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchhe-echhh--------------hhhhhCCCC----cccCChH
Confidence            42      12458999999999999999999987532211 11111              111111223    3344556


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHHHHHH
Q 039626          593 VIRLIDACLKKDPTDRPTMYEIEHSLS  619 (628)
Q Consensus       593 l~~l~~~Cl~~dP~~RPs~~ev~~~L~  619 (628)
                      +.+++...|++||.+|+|.+-....|.
T Consensus       486 ~rqlV~~lL~r~pskRvsp~iAANvl~  512 (598)
T KOG4158|consen  486 ARQLVFDLLKRDPSKRVSPNIAANVLN  512 (598)
T ss_pred             HHHHHHHHhcCCccccCCccHHHhHHH
Confidence            788999999999999999877666554

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.65  E-value=2e-15  Score=151.75  Aligned_cols=213  Identities=21%  Similarity=0.259  Sum_probs=135.7

Q ss_pred             eEEEEEEE--CCceEEEEEecc----------chHHHHHHHhhcC----------CCceeeeeeeeec---------C--
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG----------DVSKEIALLNKIN----------HSNLIILSGVCFN---------E--  407 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~----------H~nIv~l~g~~~~---------~--  407 (628)
                      +.||.++.  .|+..|+|....          ++.+|.-....+.          |-.++-.++...-         .  
T Consensus        26 ~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~~~~~~~~~~~  105 (288)
T PF14531_consen   26 SIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPGKPPFFERGPG  105 (288)
T ss_dssp             EEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETTS-SEEEECET
T ss_pred             eEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcCCCcceecCCC
Confidence            78999999  579999998742          2444444443322          2222222222210         1  


Q ss_pred             -C-----eEEEEEEecCCCChHHHhh---hcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCC
Q 039626          408 -G-----NCYLVYEYAVNGTLSDWVF---SNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSD  478 (628)
Q Consensus       408 -~-----~~~lV~E~~~~gsL~~~l~---~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~  478 (628)
                       .     +.+++|+-+ -++|.+.+.   ........+....|+.+..|+++.+++||+.+   ++|+||+|+|++++.+
T Consensus       106 ~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVHgdi~~~nfll~~~  181 (288)
T PF14531_consen  106 QSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVHGDIKPENFLLDQD  181 (288)
T ss_dssp             TEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEE-TT
T ss_pred             Cccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEecccceeeEEEcCC
Confidence             1     347788887 568888753   32233344667788889999999999999965   9999999999999999


Q ss_pred             CcEEEccccccccCCCCCCcceeeecccCCccccCcccccc--------CCCCcccccHHHHHHHHHHHhCCCccccccc
Q 039626          479 LRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLEN--------GLVSTKLDVYAFGVLILEMLTGKEAAALHAE  550 (628)
Q Consensus       479 ~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~--------~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~  550 (628)
                      |.++|+||+.....+..      ......+..|.+||....        -.++.+.|.|++|+++|.|++|+.|+.....
T Consensus       182 G~v~Lg~F~~~~r~g~~------~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~~~  255 (288)
T PF14531_consen  182 GGVFLGDFSSLVRAGTR------YRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFGLSSP  255 (288)
T ss_dssp             S-EEE--GGGEEETTEE------EEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STCCCGG
T ss_pred             CCEEEcChHHHeecCce------eeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCCCCCc
Confidence            99999999887655421      111345578999997643        2578899999999999999999999886543


Q ss_pred             cccccHHHHHHHHhccccchhhhccccCCcCCCCCCHHHHHHHHHHHHHhcccCCCCC
Q 039626          551 ENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDR  608 (628)
Q Consensus       551 ~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~R  608 (628)
                      ......                        .-..+. +.++.+..|+..+|++||.+|
T Consensus       256 ~~~~~~------------------------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  256 EADPEW------------------------DFSRCR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             GSTSGG------------------------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred             cccccc------------------------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence            322110                        011334 677789999999999999988

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.63  E-value=2.1e-15  Score=144.10  Aligned_cols=169  Identities=14%  Similarity=0.068  Sum_probs=125.6

Q ss_pred             ceEEEEEEECCceEEEEEecc-----------chHHHHHHHhhcC-CCceeeeeeeeecCCeEEEEEEecCCCChHHHhh
Q 039626          360 QGSVYRGKINGGFAAIKKVNG-----------DVSKEIALLNKIN-HSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVF  427 (628)
Q Consensus       360 ~G~Vy~g~~~g~~vavK~~~~-----------~~~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~  427 (628)
                      .|+||...-.+..++.+.+..           -+.+|+++|++|+ |+++.+++++    +..+++|||++|.+|.+.+.
T Consensus        15 f~~v~~~~~~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~G~~L~~~~~   90 (218)
T PRK12274         15 FGRILLVRGGERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLAGAAMYQRPP   90 (218)
T ss_pred             cceEEEeecCCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeecCccHHhhhh
Confidence            389997777777888776653           2568999999995 5789999886    34699999999999875431


Q ss_pred             hcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCC-CCCCEEeCCCCcEEEccccccccCCCCCCcc---e---
Q 039626          428 SNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDI-NSSNVLLDSDLRAKIANFAMARPAEGQEGEF---A---  500 (628)
Q Consensus       428 ~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~di-k~~NILl~~~~~~kl~Dfgla~~~~~~~~~~---~---  500 (628)
                          .       ....+..+++.+|.++|+.+   |+|||| ||+|||++.++.++|+|||++..........   .   
T Consensus        91 ----~-------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~L~~rD  156 (218)
T PRK12274         91 ----R-------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRLLARED  156 (218)
T ss_pred             ----h-------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHHHHHHH
Confidence                1       11357789999999999955   999999 7999999999999999999998554322100   0   


Q ss_pred             ----eeecccCCccccCccccccC-CCC-cccccHHHHHHHHHHHhCCCccc
Q 039626          501 ----LTRHIVGTKGYMAPEYLENG-LVS-TKLDVYAFGVLILEMLTGKEAAA  546 (628)
Q Consensus       501 ----~~~~~~gt~~Y~APE~l~~~-~~s-~k~DV~SfGvvl~ELltG~~p~~  546 (628)
                          .......++.|+.|+...-. ..+ ...+.++-|..++.++|++.+.-
T Consensus       157 l~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~  208 (218)
T PRK12274        157 LRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHW  208 (218)
T ss_pred             HHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcc
Confidence                01122467788888754322 223 56788999999999999986643

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.58  E-value=1.2e-14  Score=165.37  Aligned_cols=230  Identities=19%  Similarity=0.250  Sum_probs=166.5

Q ss_pred             eEEEEEEE-CCceEEEEEeccchHHH----HHHHhhcC---CCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhcCCC
Q 039626          361 GSVYRGKI-NGGFAAIKKVNGDVSKE----IALLNKIN---HSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNE  432 (628)
Q Consensus       361 G~Vy~g~~-~g~~vavK~~~~~~~~E----~~~l~~l~---H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~  432 (628)
                      |+||+|+. +|+.||+|.-+..-.-|    .+++.+|+   -+.|..+...+...+..+||+||.+-|+|.+++.    .
T Consensus       712 ~~vy~a~~~~~~~~alK~e~P~~~WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~ey~~~Gtlld~~N----~  787 (974)
T KOG1166|consen  712 GSVYVATHSNGKLVALKVEKPPNPWEFYICLQVMERLKPQMLPSIMHISSAHVFQNASVLVSEYSPYGTLLDLIN----T  787 (974)
T ss_pred             eEEEEeecCCCcEEEEEeecCCCceeeeehHHHHHhhchhhhcchHHHHHHHccCCcceeeeeccccccHHHhhc----c
Confidence            89999998 78899999987633222    34555565   2344455555555677899999999999999993    5


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeC-------CCCcEEEccccccccCCCCCCcceeeecc
Q 039626          433 GKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLD-------SDLRAKIANFAMARPAEGQEGEFALTRHI  505 (628)
Q Consensus       433 ~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~-------~~~~~kl~Dfgla~~~~~~~~~~~~~~~~  505 (628)
                      .+.++|.....++.++++-+++||..+   |||+||||+|.||.       ++.-++|+|||-+..+...... ..-...
T Consensus       788 ~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm~lfp~~-~~F~~~  863 (974)
T KOG1166|consen  788 NKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDMKLFPDG-TKFKAV  863 (974)
T ss_pred             CCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEEEecccceeeeEcCCC-cEEeee
Confidence            677999999999999999999999965   99999999999994       2456899999998766432222 234456


Q ss_pred             cCCccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCC
Q 039626          506 VGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNY  585 (628)
Q Consensus       506 ~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~  585 (628)
                      .+|-++-.+|...+..++...|.|.|.-+++-|+.|+..- .                .  .+....    ++..++.-+
T Consensus       864 ~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q-~----------------~--~g~~~~----~~~~~~Ry~  920 (974)
T KOG1166|consen  864 WHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYME-V----------------K--NGSSWM----VKTNFPRYW  920 (974)
T ss_pred             eccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHH-h----------------c--CCccee----ccccchhhh
Confidence            7899999999999999999999999999999999998421 0                0  000000    001111111


Q ss_pred             CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhh
Q 039626          586 PLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNA  624 (628)
Q Consensus       586 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~~~  624 (628)
                      ..+   ..-++...+|..|-..=|...++...|+++++.
T Consensus       921 ~~~---~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~~~  956 (974)
T KOG1166|consen  921 KRD---MWNKFFDLLLNPDCDTLPNLQELRTELEEVLAE  956 (974)
T ss_pred             hHH---HHHHHHHHHhCcCcccchhHHHHHHHHHHHHHH
Confidence            111   234566667776655668888888888887754

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.58  E-value=1.2e-14  Score=142.43  Aligned_cols=119  Identities=21%  Similarity=0.317  Sum_probs=103.0

Q ss_pred             eEEEEEEECCceEEEEEecc---------------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHH
Q 039626          361 GSVYRGKINGGFAAIKKVNG---------------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDW  425 (628)
Q Consensus       361 G~Vy~g~~~g~~vavK~~~~---------------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~  425 (628)
                      |.||+|.+.|..+++|+...               .+.+|++++.+++|+++.....++......++||||++|++|.++
T Consensus        10 ~~vy~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~G~~L~~~   89 (211)
T PRK14879         10 AEIYLGDFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEYIEGEPLKDL   89 (211)
T ss_pred             EEEEEEeeCCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEEeCCcCHHHH
Confidence            89999999999999997542               245799999999999998777777777788999999999999999


Q ss_pred             hhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEcccccccc
Q 039626          426 VFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARP  491 (628)
Q Consensus       426 l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~  491 (628)
                      +...       .+ .+..++.+++.+|.+||+.   +++|+|++|.|||++ ++.++|+|||.++.
T Consensus        90 ~~~~-------~~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         90 INSN-------GM-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             HHhc-------cH-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            8431       22 7889999999999999985   499999999999999 78899999999874

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.55  E-value=2.7e-14  Score=138.55  Aligned_cols=118  Identities=20%  Similarity=0.268  Sum_probs=97.6

Q ss_pred             ceEEEEEEECCceEEEEEecc---------------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHH
Q 039626          360 QGSVYRGKINGGFAAIKKVNG---------------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSD  424 (628)
Q Consensus       360 ~G~Vy~g~~~g~~vavK~~~~---------------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~  424 (628)
                      .|.||+|.++|..+++|+...               .+.+|++++.+++|+++.....++......++||||++|++|.+
T Consensus         7 ~~~vy~~~~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~g~~l~~   86 (199)
T TIGR03724         7 EAIIYLGDFLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIEGKPLKD   86 (199)
T ss_pred             eEEEEEeecCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEECCccHHH
Confidence            389999999999999998532               23469999999998876655555566667799999999999999


Q ss_pred             HhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccC
Q 039626          425 WVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPA  492 (628)
Q Consensus       425 ~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~  492 (628)
                      ++...    ..       .++.+++.+|.+||+.   +++|+|++|.||+++ ++.+++.|||+++..
T Consensus        87 ~~~~~----~~-------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~  139 (199)
T TIGR03724        87 VIEEG----ND-------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS  139 (199)
T ss_pred             HHhhc----HH-------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence            87431    10       7899999999999984   599999999999999 889999999998753

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PRK10345 hypothetical protein; Provisional

Probab=99.54  E-value=4.4e-14  Score=137.29  Aligned_cols=119  Identities=13%  Similarity=0.176  Sum_probs=90.4

Q ss_pred             ceEEEEEEECCceEEEEEecc-------chHHHHHHHhhc-----CCCceeeeeeeeecCC---e-EEEEEEe--cCCCC
Q 039626          360 QGSVYRGKINGGFAAIKKVNG-------DVSKEIALLNKI-----NHSNLIILSGVCFNEG---N-CYLVYEY--AVNGT  421 (628)
Q Consensus       360 ~G~Vy~g~~~g~~vavK~~~~-------~~~~E~~~l~~l-----~H~nIv~l~g~~~~~~---~-~~lV~E~--~~~gs  421 (628)
                      .|.||....++. .+||+...       ++.+|+++++++     +||||++++|++.++.   . ..+|+||  +++|+
T Consensus        15 ~~~Vy~hp~~~~-k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~e~~G~~~~t   93 (210)
T PRK10345         15 HRKCYAHPEDAQ-RCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIADFDGKPSIT   93 (210)
T ss_pred             ceEEEECCCCcC-eEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEecCCCCcchh
Confidence            388996332333 47887653       477899999999     5799999999998763   3 3478999  55799


Q ss_pred             hHHHhhhcCCCCCCCCHHHHHHHHHHHHHHH-HHHhcCCCCCeEecCCCCCCEEeCC----CCcEEEcccccc
Q 039626          422 LSDWVFSNKNEGKYLDWKQRIQIALDVATGL-NYLHSFTNPPHVHKDINSSNVLLDS----DLRAKIANFAMA  489 (628)
Q Consensus       422 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL-~yLH~~~~~~iiH~dik~~NILl~~----~~~~kl~Dfgla  489 (628)
                      |.+++..    . .+++.  ..++.+++.++ +|||+.+   |+||||||+|||++.    +++++|+||+.+
T Consensus        94 L~~~l~~----~-~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~  156 (210)
T PRK10345         94 LTEFAEQ----C-RYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCDNIGE  156 (210)
T ss_pred             HHHHHHc----c-cccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence            9999943    1 24544  35677888888 9999954   999999999999974    348999995444

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.54  E-value=2.7e-14  Score=159.43  Aligned_cols=116  Identities=21%  Similarity=0.225  Sum_probs=99.0

Q ss_pred             eEEEEEEECCceEEEEEec---------------cchHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHH
Q 039626          361 GSVYRGKINGGFAAIKKVN---------------GDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDW  425 (628)
Q Consensus       361 G~Vy~g~~~g~~vavK~~~---------------~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~  425 (628)
                      |.||+|.+.+..+++|+..               ..+.+|++++.+++|++++....++......++||||+++++|.++
T Consensus       347 g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~E~~~g~~L~~~  426 (535)
T PRK09605        347 ADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIVMEYIGGKDLKDV  426 (535)
T ss_pred             EEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEEEEecCCCcHHHH
Confidence            8999999977766665431               1256799999999999999888888877788999999999999998


Q ss_pred             hhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccC
Q 039626          426 VFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPA  492 (628)
Q Consensus       426 l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~  492 (628)
                      +.            .+..++.+++.+|.|||+.   +++||||||+|||+ +++.++|+|||+++..
T Consensus       427 l~------------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDFGla~~~  477 (535)
T PRK09605        427 LE------------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDFGLGKYS  477 (535)
T ss_pred             HH------------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence            83            3567999999999999995   49999999999999 6789999999999754

>smart00090 RIO RIO-like kinase

Probab=99.51  E-value=9.2e-14  Score=138.24  Aligned_cols=121  Identities=17%  Similarity=0.172  Sum_probs=94.6

Q ss_pred             eEEEEEE--E-CCceEEEEEeccc-------------------------------hHHHHHHHhhcCCCc--eeeeeeee
Q 039626          361 GSVYRGK--I-NGGFAAIKKVNGD-------------------------------VSKEIALLNKINHSN--LIILSGVC  404 (628)
Q Consensus       361 G~Vy~g~--~-~g~~vavK~~~~~-------------------------------~~~E~~~l~~l~H~n--Iv~l~g~~  404 (628)
                      |.||+|.  . +|..||+|..+..                               +..|++++.++.+.+  +.+++++ 
T Consensus        42 g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~~~i~~p~~~~~-  120 (237)
T smart00090       42 ANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYEAGVPVPKPIAW-  120 (237)
T ss_pred             eeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCeeeEe-
Confidence            8999998  2 7899999987521                               246999999997633  3344443 


Q ss_pred             ecCCeEEEEEEecCCCChHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC-eEecCCCCCCEEeCCCCcEEE
Q 039626          405 FNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPP-HVHKDINSSNVLLDSDLRAKI  483 (628)
Q Consensus       405 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~-iiH~dik~~NILl~~~~~~kl  483 (628)
                         ...++||||+++++|..+...    ...+.......++.+++.+|++||+   .+ ++||||||+||+++ ++.++|
T Consensus       121 ---~~~~lV~E~~~g~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~LH~---~g~iiH~Dikp~NIli~-~~~i~L  189 (237)
T smart00090      121 ---RRNVLVMEFIGGDGLPAPRLK----DVEPEEEEEFELYDDILEEMRKLYK---EGELVHGDLSEYNILVH-DGKVVI  189 (237)
T ss_pred             ---cCceEEEEEecCCcccccccc----cCCcchHHHHHHHHHHHHHHHHHHh---cCCEEeCCCChhhEEEE-CCCEEE
Confidence               235899999999888765422    2235556678899999999999998   55 99999999999999 889999


Q ss_pred             ccccccccCC
Q 039626          484 ANFAMARPAE  493 (628)
Q Consensus       484 ~Dfgla~~~~  493 (628)
                      +|||.+...+
T Consensus       190 iDFg~a~~~~  199 (237)
T smart00090      190 IDVSQSVELD  199 (237)
T ss_pred             EEChhhhccC
Confidence            9999987553

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.50  E-value=1.7e-13  Score=132.97  Aligned_cols=117  Identities=17%  Similarity=0.147  Sum_probs=93.2

Q ss_pred             eEEEEEEE-CCceEEEEEecc-----------------------------chHHHHHHHhhcCCCc--eeeeeeeeecCC
Q 039626          361 GSVYRGKI-NGGFAAIKKVNG-----------------------------DVSKEIALLNKINHSN--LIILSGVCFNEG  408 (628)
Q Consensus       361 G~Vy~g~~-~g~~vavK~~~~-----------------------------~~~~E~~~l~~l~H~n--Iv~l~g~~~~~~  408 (628)
                      |.||++.. +|+.+|||+...                             ....|..++.++.|++  +...++.    .
T Consensus        29 g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~v~~~~~~----~  104 (198)
T cd05144          29 SDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFPVPKPIDW----N  104 (198)
T ss_pred             eEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCCCCceeec----C
Confidence            89999988 689999997532                             1456888999998874  4444442    3


Q ss_pred             eEEEEEEecCCCChHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccc
Q 039626          409 NCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAM  488 (628)
Q Consensus       409 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgl  488 (628)
                      ..++||||+++++|.+....          .....++.+++.++.++|+   .+++|+||||+||++++++.++|+|||+
T Consensus       105 ~~~lv~e~~~g~~L~~~~~~----------~~~~~~~~~i~~~l~~lh~---~gi~H~Dl~p~Nill~~~~~~~liDfg~  171 (198)
T cd05144         105 RHAVVMEYIDGVELYRVRVL----------EDPEEVLDEILEEIVKAYK---HGIIHGDLSEFNILVDDDEKIYIIDWPQ  171 (198)
T ss_pred             CceEEEEEeCCcchhhcccc----------ccHHHHHHHHHHHHHHHHH---CCCCcCCCCcccEEEcCCCcEEEEECCc
Confidence            45899999999999765420          2345788999999999999   4599999999999999999999999999


Q ss_pred             cccCCC
Q 039626          489 ARPAEG  494 (628)
Q Consensus       489 a~~~~~  494 (628)
                      +.....
T Consensus       172 ~~~~~~  177 (198)
T cd05144         172 MVSTDH  177 (198)
T ss_pred             cccCCC
Confidence            976543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.46  E-value=6.1e-14  Score=138.29  Aligned_cols=207  Identities=21%  Similarity=0.296  Sum_probs=145.0

Q ss_pred             HHHHhhcCCCceeeeeeeeecCC-----eEEEEEEecCCCChHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCC
Q 039626          386 IALLNKINHSNLIILSGVCFNEG-----NCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTN  460 (628)
Q Consensus       386 ~~~l~~l~H~nIv~l~g~~~~~~-----~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~  460 (628)
                      ..-|-++-|.|||++..|+.+..     +..++.|||..|+|..+|.+-+.....+......+|+-||..||.|||+.. 
T Consensus       118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~-  196 (458)
T KOG1266|consen  118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD-  196 (458)
T ss_pred             HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC-
Confidence            44566678999999999987543     468999999999999999877767777888888999999999999999975 


Q ss_pred             CCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCC-cceeeecccCCccccCccccccCCCCcccccHHHHHHHHHHH
Q 039626          461 PPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEG-EFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEML  539 (628)
Q Consensus       461 ~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELl  539 (628)
                      |+|+|+++.-+-|++..++-+|+.--.-......-.. ...-+....+-++|.+||+-..-..+..+|||+||+..+||.
T Consensus       197 PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlema  276 (458)
T KOG1266|consen  197 PPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMA  276 (458)
T ss_pred             CccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHH
Confidence            9999999999999999999998874221111000000 000112235678999999988888899999999999999998


Q ss_pred             hCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          540 TGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       540 tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      -|..-....  +.......-+..         .+...-++..            +.++.+|++-.|..||+|++++.
T Consensus       277 ilEiq~tns--eS~~~~ee~ia~---------~i~~len~lq------------r~~i~kcl~~eP~~rp~ar~llf  330 (458)
T KOG1266|consen  277 ILEIQSTNS--ESKVEVEENIAN---------VIIGLENGLQ------------RGSITKCLEGEPNGRPDARLLLF  330 (458)
T ss_pred             HheeccCCC--cceeehhhhhhh---------heeeccCccc------------cCcCcccccCCCCCCcchhhhhc
Confidence            775321110  000000000000         0111111111            24678899999999999998753

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.45  E-value=6.3e-13  Score=121.79  Aligned_cols=121  Identities=21%  Similarity=0.229  Sum_probs=105.2

Q ss_pred             eEEEEEEECCceEEEEEecc-----chHHHHHHHhhcCC--CceeeeeeeeecCCeEEEEEEecCCCChHHHhhhcCCCC
Q 039626          361 GSVYRGKINGGFAAIKKVNG-----DVSKEIALLNKINH--SNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEG  433 (628)
Q Consensus       361 G~Vy~g~~~g~~vavK~~~~-----~~~~E~~~l~~l~H--~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~  433 (628)
                      +.||++..++..+++|....     ++.+|+.++..++|  .++.+++++....+..++++||++++.+..+        
T Consensus        12 ~~v~~~~~~~~~~~iK~~~~~~~~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~~~~--------   83 (155)
T cd05120          12 NRVYLLGTKDEDYVLKINPSREKGADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETLDEV--------   83 (155)
T ss_pred             cceEEEEecCCeEEEEecCCCCchhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeecccC--------
Confidence            78999999888999998865     37889999999977  5889999988877889999999988776542        


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccC
Q 039626          434 KYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPA  492 (628)
Q Consensus       434 ~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~  492 (628)
                         ++.....++.+++++|++||.....+++|+|++|+||++++++.+++.|||.++..
T Consensus        84 ---~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~  139 (155)
T cd05120          84 ---SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG  139 (155)
T ss_pred             ---CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence               55677889999999999999865567999999999999999999999999998743

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.43  E-value=1.3e-13  Score=154.24  Aligned_cols=160  Identities=21%  Similarity=0.332  Sum_probs=111.9

Q ss_pred             HHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCC------------CcceeeecccCCccccCcc
Q 039626          448 VATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQE------------GEFALTRHIVGTKGYMAPE  515 (628)
Q Consensus       448 ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~------------~~~~~~~~~~gt~~Y~APE  515 (628)
                      ++.+++|||+.+   |+|||+||+|.+++.-|.+|+.|||+.+......            ......+.+.||+.|.|||
T Consensus       152 mvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPe  228 (1205)
T KOG0606|consen  152 MVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPE  228 (1205)
T ss_pred             hhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChh
Confidence            388999999954   9999999999999999999999999987642211            1111234568999999999


Q ss_pred             ccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCHHHHHHHHH
Q 039626          516 YLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIR  595 (628)
Q Consensus       516 ~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~  595 (628)
                      ++.-+.|..-.|.|++|++++|.+-|+.||.....++      .+..++...      -.|.+      -.+....++.+
T Consensus       229 VilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpee------lfg~visd~------i~wpE------~dea~p~Ea~d  290 (1205)
T KOG0606|consen  229 VILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE------LFGQVISDD------IEWPE------EDEALPPEAQD  290 (1205)
T ss_pred             hhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHH------HHhhhhhhh------ccccc------cCcCCCHHHHH
Confidence            9999999999999999999999999999998654432      111111110      00000      02233456788


Q ss_pred             HHHHhcccCCCCCCCHHHHHHHHHHhHhhccCC
Q 039626          596 LIDACLKKDPTDRPTMYEIEHSLSNILNASLNW  628 (628)
Q Consensus       596 l~~~Cl~~dP~~RPs~~ev~~~L~~l~~~~~~w  628 (628)
                      ++.+.|+.+|..|---...++.-..=.-..+||
T Consensus       291 li~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw  323 (1205)
T KOG0606|consen  291 LIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDW  323 (1205)
T ss_pred             HHHHHHHhChHhhcccchhhhhhhccceeeccc
Confidence            999999999999954444443333322333444

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.43  E-value=1e-12  Score=130.97  Aligned_cols=120  Identities=16%  Similarity=0.130  Sum_probs=95.7

Q ss_pred             eEEEEEEECCceEEEEEecc--------------------chHHHHHHHhhcCCCce--eeeeeeeecCC----eEEEEE
Q 039626          361 GSVYRGKINGGFAAIKKVNG--------------------DVSKEIALLNKINHSNL--IILSGVCFNEG----NCYLVY  414 (628)
Q Consensus       361 G~Vy~g~~~g~~vavK~~~~--------------------~~~~E~~~l~~l~H~nI--v~l~g~~~~~~----~~~lV~  414 (628)
                      |+||+....++.+++|+...                    .+.+|++++.+++|+++  +..+++...+.    ..++|+
T Consensus        46 gtv~~v~~~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~~~~~~~~lV~  125 (239)
T PRK01723         46 GTTWFVQTPGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRHGLFYRADILI  125 (239)
T ss_pred             ccEEEEEeCCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeecCcceeeeEEE
Confidence            89999999999999987632                    24569999999998885  67777755432    235999


Q ss_pred             EecCC-CChHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccC
Q 039626          415 EYAVN-GTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPA  492 (628)
Q Consensus       415 E~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~  492 (628)
                      ||+++ .+|.+++..     ..++..    .+.+++.+|.+||+.   +|+||||||.|||++.++.++|+|||.++..
T Consensus       126 e~l~G~~~L~~~l~~-----~~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v~LIDfg~~~~~  192 (239)
T PRK01723        126 ERIEGARDLVALLQE-----APLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKFWLIDFDRGELR  192 (239)
T ss_pred             EecCCCCCHHHHHhc-----CCCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCEEEEECCCcccC
Confidence            99997 699988742     224433    356899999999995   4999999999999999999999999988753

>PRK10783 mltD membrane-bound lytic murein transglycosylase D; Provisional

Probab=99.39  E-value=1.3e-12  Score=140.68  Aligned_cols=102  Identities=19%  Similarity=0.247  Sum_probs=87.1

Q ss_pred             EeeecCCCCCCHHHHHHHhCCChHhhhhhcCcc---ccCCcEEEEcccCccCC-CCcccceeEEEecCChHHHHHhhhcC
Q 039626           64 LTFRSQPPFNTVASISTLLGSEPSLLSQINSVS---LETNRLVIVPVNCSCSG-QYYQSNTTYTIQNGDTYLFIANNTFQ  139 (628)
Q Consensus        64 ~~~~~~~~~~tl~~Ia~~~~~~~~~i~~~N~~~---~~~gq~l~vp~~c~c~~-~~~~~~~~y~V~~gdt~~~IA~~~~~  139 (628)
                      .+|+++ +|||+++||+.||++..+|+++|++.   |.+||.|.||.+|.|.. .......+|+|++|||+|+||++|..
T Consensus       344 ~~y~Vk-~GDTL~sIA~r~gvs~~~L~~~N~l~~~~L~~Gq~L~Ip~~~~~~~~~~~~~~~~Y~Vr~GDTL~sIA~kygV  422 (456)
T PRK10783        344 RSYKVR-SGDTLSGIASRLNVSTKDLQQWNNLRGSKLKVGQTLTIGAGSSAQRLANNSDSITYRVRKGDSLSSIAKRHGV  422 (456)
T ss_pred             eEEEEC-CCCcHHHHHHHHCcCHHHHHHHcCCCcccCCCCCEEEecCCcccccccccccceeEEeCCCCCHHHHHHHhCC
Confidence            467776 48999999999999999999999876   99999999998887642 12233457999999999999998875


Q ss_pred             CCccHHHHHhccCCC-CccCCCcEEEEeecC
Q 039626          140 GLSTCQALEDQNGSP-TNLIIGAGVTVPLRC  169 (628)
Q Consensus       140 ~l~t~~~l~~~N~~~-~~l~~Gq~l~vp~~~  169 (628)
                         |+++|+++|+.. ..|.+||+|.|++.-
T Consensus       423 ---tv~~L~~~N~l~~~~L~pGq~L~l~v~~  450 (456)
T PRK10783        423 ---NIKDVMRWNSDTAKNLQPGDKLTLFVKN  450 (456)
T ss_pred             ---CHHHHHHhcCCCCCcCCCCCEEEEecCC
Confidence               889999999987 789999999998753

>PRK13914 invasion associated secreted endopeptidase; Provisional

Probab=99.38  E-value=2.8e-12  Score=135.30  Aligned_cols=110  Identities=25%  Similarity=0.315  Sum_probs=88.0

Q ss_pred             eeEEEecCChHHHHHhhhcCCCccHHHHHhccCCC-CccCCCcEEEEeecCC-----------------CCCCCC-----
Q 039626          120 TTYTIQNGDTYLFIANNTFQGLSTCQALEDQNGSP-TNLIIGAGVTVPLRCA-----------------CPTENQ-----  176 (628)
Q Consensus       120 ~~y~V~~gdt~~~IA~~~~~~l~t~~~l~~~N~~~-~~l~~Gq~l~vp~~~~-----------------c~~~~~-----  176 (628)
                      .+|+|++|||||.||++|+.   ++++|+++|++. +.|++||+|.||....                 -|..+.     
T Consensus        28 ~tytVq~GDTLw~IA~~ygv---tv~~I~~~N~l~~~~I~~Gq~L~Ip~~~~~~~~~~~Vta~~LNVRsgps~s~~IIgs  104 (481)
T PRK13914         28 STVVVEAGDTLWGIAQSKGT---TVDAIKKANNLTTDKIVPGQKLQVNEVAAAEKTEKSVSATWLNVRSGAGVDNSIITS  104 (481)
T ss_pred             ceEEECCCCCHHHHHHHHCC---CHHHHHHHhCCCcccccCCCEEEeCCCCcccccceeEecceEEEecCCCCCcceeee
Confidence            46999999999999998875   899999999988 8999999999994310                 000000     


Q ss_pred             ------------CC---------CC-------------------------------------------------------
Q 039626          177 ------------TD---------EG-------------------------------------------------------  180 (628)
Q Consensus       177 ------------~~---------~~-------------------------------------------------------  180 (628)
                                  .+         .|                                                       
T Consensus       105 l~~G~~V~Vl~~~~ngW~kI~~~~GktGwV~~~YLs~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  184 (481)
T PRK13914        105 IKGGTKVTVETTESNGWHKITYNDGKTGFVNGKYLTDKVTSTPVAPTQEVKKETTTQQAAPAAETKTEVKQTTQATTPAP  184 (481)
T ss_pred             ecCCCEEEEeecccCCeEEEEcCCCCEEEEecccccCCCccCccccchhhhhccccccccchhcccchhccCCcccCCcc
Confidence                        00         00                                                       


Q ss_pred             -----------CCeEEEEEccCCCcHHHHHHHhCCChHHHhhhcCCCCCCccccceeeccCCC
Q 039626          181 -----------FPFLLSYLVAEGDTVSGISSRFGVDTGEILQANSLSGSNIFPFTTLLIPLEN  232 (628)
Q Consensus       181 -----------~~~~~~y~v~~gdtl~~ia~~f~~~~~~l~~~N~~~~~~~~~~~~l~iP~~~  232 (628)
                                 .....+|+|++||+||.||++||+++++|.+||++.+..|++||.|.||...
T Consensus       185 ~~~~~~~~~~~~~~a~tytVq~GDTL~sIAkrYgVtv~eI~~~N~l~s~~L~pGQ~L~Ip~sa  247 (481)
T PRK13914        185 KVAETKETPVVDQNATTHAVKSGDTIWALSVKYGVSVQDIMSWNNLSSSSIYVGQKLAIKQTA  247 (481)
T ss_pred             cccccccCccccCCCeEEEECCCCCHHHHHHHHCCCHHHHHHhcCCCccccCCCCEEEecCCC
Confidence                       0123589999999999999999999999999999987789999999999764

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.31  E-value=3.4e-13  Score=150.55  Aligned_cols=209  Identities=22%  Similarity=0.320  Sum_probs=156.1

Q ss_pred             HHHHHHhhcC-CCceeeeeeeeecCCeEEEEEEecCCCChHHHh-hhcCCCCCCCCHHHHHHHHHHHHHHHHHHh-cCCC
Q 039626          384 KEIALLNKIN-HSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWV-FSNKNEGKYLDWKQRIQIALDVATGLNYLH-SFTN  460 (628)
Q Consensus       384 ~E~~~l~~l~-H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l-~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH-~~~~  460 (628)
                      .|..+-.++. |.|++++++...+.+..+++.||..+|++.+-+ +..   ....+....-.+..|+..++.|+| +   
T Consensus        69 ~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~~s~g~~~f~~i~~~~---~~~~~~~~~~~~~~ql~s~l~~~H~~---  142 (601)
T KOG0590|consen   69 TETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLSYSDGGSLFSKISHPD---STGTSSSSASRYLPQLNSGLSYLHPE---  142 (601)
T ss_pred             ccccccccccccccccccCCccCCCcccccccCcccccccccccccCC---ccCCCCcchhhhhhhhccCccccCcc---
Confidence            3555555565 999999999999999999999999999998877 321   113444556678999999999999 6   


Q ss_pred             CCeEecCCCCCCEEeCCCC-cEEEccccccccCCCCCCcceeeecccC-CccccCcccccc-CCCCcccccHHHHHHHHH
Q 039626          461 PPHVHKDINSSNVLLDSDL-RAKIANFAMARPAEGQEGEFALTRHIVG-TKGYMAPEYLEN-GLVSTKLDVYAFGVLILE  537 (628)
Q Consensus       461 ~~iiH~dik~~NILl~~~~-~~kl~Dfgla~~~~~~~~~~~~~~~~~g-t~~Y~APE~l~~-~~~s~k~DV~SfGvvl~E  537 (628)
                      .++.|+||||+|.+++..+ ..|++|||+|.......+.........| ++.|+|||...+ ....+..|+||.|+++.-
T Consensus       143 ~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~  222 (601)
T KOG0590|consen  143 NGVTHRDIKPSNSLLDESGSALKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSA  222 (601)
T ss_pred             cccccCCCCCccchhccCCCcccCCCchhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccc
Confidence            5599999999999999999 9999999999987663333344455678 999999999887 466788999999999999


Q ss_pred             HHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCC--CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 039626          538 MLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQ--GNYPLELALLVIRLIDACLKKDPTDRPTMYEIE  615 (628)
Q Consensus       538 LltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~--~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~  615 (628)
                      +++|..|+......... .                 ..+++....  ............++..+++..+|..|.+.+++.
T Consensus       223 ~~~g~~p~~~~~~~~~~-~-----------------~~~~~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~  284 (601)
T KOG0590|consen  223 MLTGELPWDFPSRKDGR-Y-----------------SSWKSNKGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELK  284 (601)
T ss_pred             cccCCCCcccccccccc-c-----------------eeecccccccccCccccCChhhhhcccccccCCchhcccccccc
Confidence            99999988765443211 0                 011111000  011112333456788889999999999988875


Q ss_pred             H
Q 039626          616 H  616 (628)
Q Consensus       616 ~  616 (628)
                      .
T Consensus       285 ~  285 (601)
T KOG0590|consen  285 L  285 (601)
T ss_pred             c
Confidence            3

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.26  E-value=2.6e-11  Score=116.27  Aligned_cols=121  Identities=18%  Similarity=0.164  Sum_probs=85.4

Q ss_pred             eEEEEEEEC-CceEEEEEeccch-------------------------------HHHHHHHhhcCCCc--eeeeeeeeec
Q 039626          361 GSVYRGKIN-GGFAAIKKVNGDV-------------------------------SKEIALLNKINHSN--LIILSGVCFN  406 (628)
Q Consensus       361 G~Vy~g~~~-g~~vavK~~~~~~-------------------------------~~E~~~l~~l~H~n--Iv~l~g~~~~  406 (628)
                      |.||++... |+.||||..+...                               ..|.+.+.++++..  +.+.+++   
T Consensus        11 g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~---   87 (187)
T cd05119          11 ADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPVPKPIDL---   87 (187)
T ss_pred             eeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCCCceEec---
Confidence            899999984 8899999875310                               23555555554432  3334433   


Q ss_pred             CCeEEEEEEecCCCChHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccc
Q 039626          407 EGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANF  486 (628)
Q Consensus       407 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Df  486 (628)
                       ...++||||++++.+.........    .. .....++.+++.++.++|..  .+++|+||||+||+++ ++.++++||
T Consensus        88 -~~~~lv~e~~~g~~~~~~~l~~~~----~~-~~~~~~~~~~~~~l~~lh~~--~~ivH~Dl~p~Nili~-~~~~~liDf  158 (187)
T cd05119          88 -NRHVLVMEFIGGDGIPAPRLKDVR----LL-EDPEELYDQILELMRKLYRE--AGLVHGDLSEYNILVD-DGKVYIIDV  158 (187)
T ss_pred             -CCCEEEEEEeCCCCccChhhhhhh----hc-ccHHHHHHHHHHHHHHHhhc--cCcCcCCCChhhEEEE-CCcEEEEEC
Confidence             245899999999654321111000    11 55678999999999999981  3499999999999999 899999999


Q ss_pred             cccccCC
Q 039626          487 AMARPAE  493 (628)
Q Consensus       487 gla~~~~  493 (628)
                      |.+....
T Consensus       159 g~a~~~~  165 (187)
T cd05119         159 PQAVEID  165 (187)
T ss_pred             ccccccc
Confidence            9997654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.25  E-value=4.1e-11  Score=129.78  Aligned_cols=124  Identities=19%  Similarity=0.237  Sum_probs=87.5

Q ss_pred             eEEEEEEE-CCceEEEEEeccc-----------------------------------------------hHHHHHHHhhc
Q 039626          361 GSVYRGKI-NGGFAAIKKVNGD-----------------------------------------------VSKEIALLNKI  392 (628)
Q Consensus       361 G~Vy~g~~-~g~~vavK~~~~~-----------------------------------------------~~~E~~~l~~l  392 (628)
                      |.||+|++ +|+.||||..+..                                               +..|.+.+.++
T Consensus       131 gQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~Ea~n~~~~  210 (437)
T TIGR01982       131 AQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRREAANASEL  210 (437)
T ss_pred             hheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHHHHHHHHHH
Confidence            89999999 7999999987542                                               22244444444


Q ss_pred             ----CCCceeeeeeeee-cCCeEEEEEEecCCCChHHHhhhcCCCCCCCCHHHHHHHHHHHHH-HHHHHhcCCCCCeEec
Q 039626          393 ----NHSNLIILSGVCF-NEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVAT-GLNYLHSFTNPPHVHK  466 (628)
Q Consensus       393 ----~H~nIv~l~g~~~-~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~-gL~yLH~~~~~~iiH~  466 (628)
                          +|.+-+.+-.++. .....+|||||++|++|.++......   ..   .+.+++..++. .+..+|..   +++|+
T Consensus       211 ~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~---~~---~~~~ia~~~~~~~l~ql~~~---g~~H~  281 (437)
T TIGR01982       211 GENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA---GL---DRKALAENLARSFLNQVLRD---GFFHA  281 (437)
T ss_pred             HHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc---CC---CHHHHHHHHHHHHHHHHHhC---CceeC
Confidence                2333333333332 23457999999999999988743211   12   24557777766 46788874   59999


Q ss_pred             CCCCCCEEeCCCCcEEEccccccccCC
Q 039626          467 DINSSNVLLDSDLRAKIANFAMARPAE  493 (628)
Q Consensus       467 dik~~NILl~~~~~~kl~Dfgla~~~~  493 (628)
                      |++|.||++++++++++.|||++....
T Consensus       282 D~hPgNilv~~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       282 DLHPGNIFVLKDGKIIALDFGIVGRLS  308 (437)
T ss_pred             CCCcccEEECCCCcEEEEeCCCeeECC
Confidence            999999999999999999999998764

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.14  E-value=2e-10  Score=108.12  Aligned_cols=116  Identities=18%  Similarity=0.120  Sum_probs=88.8

Q ss_pred             eEEEEEEECCceEEEEEecc------chHHHHHHHhhcCCCcee-eeeeeeecCCeEEEEEEecCCCChHHHhhhcCCCC
Q 039626          361 GSVYRGKINGGFAAIKKVNG------DVSKEIALLNKINHSNLI-ILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEG  433 (628)
Q Consensus       361 G~Vy~g~~~g~~vavK~~~~------~~~~E~~~l~~l~H~nIv-~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~  433 (628)
                      +.||+....++.+++|....      ++.+|+.+++.+.+.+++ +++++.  ....++||||++|.++.+.-       
T Consensus        12 ~~vy~~~~~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l~~~~-------   82 (170)
T cd05151          12 NKNYRVEVANKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSELLTED-------   82 (170)
T ss_pred             CceEEEEECCeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcccccc-------
Confidence            78999999999999998644      357899999999766655 444443  33458999999998875420       


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhcCC--CCCeEecCCCCCCEEeCCCCcEEEcccccccc
Q 039626          434 KYLDWKQRIQIALDVATGLNYLHSFT--NPPHVHKDINSSNVLLDSDLRAKIANFAMARP  491 (628)
Q Consensus       434 ~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~  491 (628)
                        .   ....+..+++++|+.||...  ...++|+|++|.||+++ ++.++++||+.+..
T Consensus        83 --~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          83 --F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             --c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence              0   11245678999999999864  23469999999999999 66899999998763

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.07  E-value=1.5e-10  Score=124.02  Aligned_cols=228  Identities=21%  Similarity=0.270  Sum_probs=162.6

Q ss_pred             ceEEEEEEE----CCceEEEEEeccch---------HHHHHHHhhc-CCCceeeeeeeeecCCeEEEEEEecCCCChHHH
Q 039626          360 QGSVYRGKI----NGGFAAIKKVNGDV---------SKEIALLNKI-NHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDW  425 (628)
Q Consensus       360 ~G~Vy~g~~----~g~~vavK~~~~~~---------~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~  425 (628)
                      .|.||++..    .+..+|+|+-+..+         .+|+.-..++ .|+|.++....+.+++..++-.|++ +.+|..+
T Consensus       129 ~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lfiqtE~~-~~sl~~~  207 (524)
T KOG0601|consen  129 KGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILFIQTELC-GESLQSY  207 (524)
T ss_pred             CceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcceeeeccc-cchhHHh
Confidence            388998876    56788999854322         3566666666 4999999888888899999999988 5788887


Q ss_pred             hhhcCCCCCCCCHHHHHHHHHHHHH----HHHHHhcCCCCCeEecCCCCCCEEeCCC-CcEEEccccccccCCCCCCc--
Q 039626          426 VFSNKNEGKYLDWKQRIQIALDVAT----GLNYLHSFTNPPHVHKDINSSNVLLDSD-LRAKIANFAMARPAEGQEGE--  498 (628)
Q Consensus       426 l~~~~~~~~~l~~~~~~~i~~~ia~----gL~yLH~~~~~~iiH~dik~~NILl~~~-~~~kl~Dfgla~~~~~~~~~--  498 (628)
                      .+.   ....++......+..+...    ||.++|+   +.++|-|+||.||++..+ ...+++|||+...+......  
T Consensus       208 ~~~---~~~~~p~~~l~~~~~~~~~~~~~al~~~hs---~~~~~~~~kp~~i~~~~~~~s~~~~df~~v~~i~~~~~~~~  281 (524)
T KOG0601|consen  208 CHT---PCNFLPDNLLWNSLRDWLSRDVTALSHLHS---NNIVHDDLKPANIFTTSDWTSCKLTDFGLVSKISDGNFSSV  281 (524)
T ss_pred             hhc---ccccCCchhhhhHHhhhhhcccccccccCC---CcccccccchhheecccccceeecCCcceeEEccCCccccc
Confidence            753   2334555666666777777    9999998   559999999999999999 88999999999888655422  


Q ss_pred             ceeeecccCCccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccC
Q 039626          499 FALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFID  578 (628)
Q Consensus       499 ~~~~~~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d  578 (628)
                      .....+..|...|++||...+ .++.+.|+|++|.+.+|...+...........                 ...++++. 
T Consensus       282 ~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~-----------------W~~~r~~~-  342 (524)
T KOG0601|consen  282 FKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGKNSS-----------------WSQLRQGY-  342 (524)
T ss_pred             eeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCCCCC-----------------cccccccc-
Confidence            222233478889999997764 57899999999999999998875433221000                 11111111 


Q ss_pred             CcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 039626          579 PTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIE  615 (628)
Q Consensus       579 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~  615 (628)
                        ++.++.......+...+..+++.+|..|++.+.+.
T Consensus       343 --ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~  377 (524)
T KOG0601|consen  343 --IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILT  377 (524)
T ss_pred             --CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHh
Confidence              11122222233455588899999999999877664

>PF01476 LysM: LysM domain; InterPro: IPR018392 This domain is about 40 residues long and is found in a variety of enzymes involved in bacterial cell wall degradation []

Probab=99.02  E-value=2.1e-10  Score=82.14  Aligned_cols=43  Identities=35%  Similarity=0.670  Sum_probs=36.5

Q ss_pred             EEccCCCcHHHHHHHhCCChHHHhhhc-CCCCCCccccceeecc
Q 039626          187 YLVAEGDTVSGISSRFGVDTGEILQAN-SLSGSNIFPFTTLLIP  229 (628)
Q Consensus       187 y~v~~gdtl~~ia~~f~~~~~~l~~~N-~~~~~~~~~~~~l~iP  229 (628)
                      |+|++|||+++||++||++.++|+++| ++..+.|.+||.|.||
T Consensus         1 y~V~~gDtl~~IA~~~~~~~~~l~~~N~~~~~~~l~~G~~l~iP   44 (44)
T PF01476_consen    1 YTVQPGDTLWSIAKRYGISVDELMELNPNIDSDNLQPGQKLCIP   44 (44)
T ss_dssp             EEE-TT--HHHHHHHTTS-HHHHHHHCCTTHGGCGGTTEEEEEC
T ss_pred             CEECcCCcHHHHHhhhhhhHhHHHHhcCCCCcccCCCCCEEEeC
Confidence            899999999999999999999999999 7766579999999998

This domain may have a general peptidoglycan binding function.; GO: 0016998 cell wall macromolecule catabolic process; PDB: 2DJP_A 3ZQD_A 1Y7M_B 4A52_A 2L9Y_A 1E0G_A.

>PRK13914 invasion associated secreted endopeptidase; Provisional

Probab=98.98  E-value=2.8e-09  Score=112.88  Aligned_cols=46  Identities=15%  Similarity=0.233  Sum_probs=41.7

Q ss_pred             eEEEecCChHHHHHhhhcCCCccHHHHHhccCCC-CccCCCcEEEEeecC
Q 039626          121 TYTIQNGDTYLFIANNTFQGLSTCQALEDQNGSP-TNLIIGAGVTVPLRC  169 (628)
Q Consensus       121 ~y~V~~gdt~~~IA~~~~~~l~t~~~l~~~N~~~-~~l~~Gq~l~vp~~~  169 (628)
                      .|+|++|||||.||++|..   ++++|+++|++. ..|++||+|.||...
T Consensus       201 tytVq~GDTL~sIAkrYgV---tv~eI~~~N~l~s~~L~pGQ~L~Ip~sa  247 (481)
T PRK13914        201 THAVKSGDTIWALSVKYGV---SVQDIMSWNNLSSSSIYVGQKLAIKQTA  247 (481)
T ss_pred             EEEECCCCCHHHHHHHHCC---CHHHHHHhcCCCccccCCCCEEEecCCC
Confidence            5999999999999998875   899999999998 889999999999653

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=98.96  E-value=1.4e-08  Score=110.20  Aligned_cols=158  Identities=18%  Similarity=0.286  Sum_probs=116.8

Q ss_pred             CCceEEEEEeccc-------hHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhcCCCCCCCCHHHH
Q 039626          369 NGGFAAIKKVNGD-------VSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQR  441 (628)
Q Consensus       369 ~g~~vavK~~~~~-------~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~  441 (628)
                      ++..|.|...+..       ..+-++-|+.+|||||++++.....++..|||+|-+  ..|..++...       .-...
T Consensus        36 ~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~l-------~~~~v  106 (690)
T KOG1243|consen   36 DGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLKEL-------GKEEV  106 (690)
T ss_pred             cCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHHHh-------HHHHH
Confidence            5667766665431       345678899999999999999999999999999987  4577777432       23334


Q ss_pred             HHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCCccccCccccccCC
Q 039626          442 IQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGL  521 (628)
Q Consensus       442 ~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~  521 (628)
                      .-.+.||+.||.|||+.  ..++|++|.-..|++++.|+-||++|-++........   .......-..|..|+.+....
T Consensus       107 ~~Gl~qIl~AL~FL~~d--~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~---~~~~~~~~~s~~~P~~~~~s~  181 (690)
T KOG1243|consen  107 CLGLFQILAALSFLNDD--CNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA---PAKSLYLIESFDDPEEIDPSE  181 (690)
T ss_pred             HHHHHHHHHHHHHHhcc--CCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc---ccccchhhhcccChhhcCccc
Confidence            44688999999999974  4599999999999999999999999988765432221   011122233466666543322


Q ss_pred             CCcccccHHHHHHHHHHHhCC
Q 039626          522 VSTKLDVYAFGVLILEMLTGK  542 (628)
Q Consensus       522 ~s~k~DV~SfGvvl~ELltG~  542 (628)
                        -..|.|-||++++|++.|.
T Consensus       182 --~s~D~~~Lg~li~el~ng~  200 (690)
T KOG1243|consen  182 --WSIDSWGLGCLIEELFNGS  200 (690)
T ss_pred             --cchhhhhHHHHHHHHhCcc
Confidence              3469999999999999993

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=98.94  E-value=3.4e-09  Score=116.37  Aligned_cols=125  Identities=17%  Similarity=0.225  Sum_probs=77.8

Q ss_pred             eEEEEEEE-C-CceEEEEEeccc-----------------------------------------------hHHHHHHHhh
Q 039626          361 GSVYRGKI-N-GGFAAIKKVNGD-----------------------------------------------VSKEIALLNK  391 (628)
Q Consensus       361 G~Vy~g~~-~-g~~vavK~~~~~-----------------------------------------------~~~E~~~l~~  391 (628)
                      |.||++++ + |+.||||..+..                                               +.+|+..+.+
T Consensus       133 aQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~~Ea~N~~~  212 (537)
T PRK04750        133 AQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDLMREAANASQ  212 (537)
T ss_pred             cEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCHHHHHHHHHH
Confidence            89999999 4 899999988632                                               1223333333


Q ss_pred             cC----CCceeeeeeeeec-CCeEEEEEEecCCCChHHHhhhcCCCCCCCCHHHHHHHHHHHHHH-HHHHhcCCCCCeEe
Q 039626          392 IN----HSNLIILSGVCFN-EGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATG-LNYLHSFTNPPHVH  465 (628)
Q Consensus       392 l~----H~nIv~l~g~~~~-~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~g-L~yLH~~~~~~iiH  465 (628)
                      ++    +.+.+.+-.++.+ ....+|||||++|+.+.++-.-. ..+  .+   +..++...+.. +..++.   .+++|
T Consensus       213 ~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~-~~g--~d---~~~la~~~v~~~~~Qif~---~GffH  283 (537)
T PRK04750        213 LRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALR-AAG--TD---MKLLAERGVEVFFTQVFR---DGFFH  283 (537)
T ss_pred             HHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHH-hcC--CC---HHHHHHHHHHHHHHHHHh---CCeee
Confidence            32    3333333333322 34568999999999998753111 111  11   11222222221 122233   44999


Q ss_pred             cCCCCCCEEeCCCC----cEEEccccccccCCC
Q 039626          466 KDINSSNVLLDSDL----RAKIANFAMARPAEG  494 (628)
Q Consensus       466 ~dik~~NILl~~~~----~~kl~Dfgla~~~~~  494 (628)
                      +|+||.||+++.++    ++++.|||+......
T Consensus       284 aDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        284 ADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             CCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence            99999999999988    999999999887643

>COG1388 LytE FOG: LysM repeat [Cell envelope biogenesis, outer membrane]

Probab=98.91  E-value=1.3e-09  Score=97.29  Aligned_cols=107  Identities=26%  Similarity=0.428  Sum_probs=88.0

Q ss_pred             HHHHhCCChHhhhhhcCcc-----ccCCcEEEEcccCccCCCCcccceeEEEecCChHHHHHhhhcCCCccHHHHHhccC
Q 039626           78 ISTLLGSEPSLLSQINSVS-----LETNRLVIVPVNCSCSGQYYQSNTTYTIQNGDTYLFIANNTFQGLSTCQALEDQNG  152 (628)
Q Consensus        78 Ia~~~~~~~~~i~~~N~~~-----~~~gq~l~vp~~c~c~~~~~~~~~~y~V~~gdt~~~IA~~~~~~l~t~~~l~~~N~  152 (628)
                      ||..|++++.+|..+|++.     +.+||.+.+|..           ..+.+..+++.+..+..+.....          
T Consensus         1 ia~~~~~~v~~l~~~n~~~~~s~~i~~gq~l~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~----------   59 (124)
T COG1388           1 IASKYGVSVKALKKANALTGKSDAIKPGQVLKIPGD-----------ISSTVNAGQTLSSLSNKVSDSSS----------   59 (124)
T ss_pred             CcccccccHHHHHHHhcccCCCCccccCceEEccCC-----------cccccccccccccccceeecccc----------
Confidence            5788999999999999544     899999999975           24778889999988875544211          


Q ss_pred             CCCccCCCcEEEEeecCCCCCCCCCCCCCCeEEEEEccCCCcHHHHHHHhCCChHHHhhhcCCCCCCccccceeeccC
Q 039626          153 SPTNLIIGAGVTVPLRCACPTENQTDEGFPFLLSYLVAEGDTVSGISSRFGVDTGEILQANSLSGSNIFPFTTLLIPL  230 (628)
Q Consensus       153 ~~~~l~~Gq~l~vp~~~~c~~~~~~~~~~~~~~~y~v~~gdtl~~ia~~f~~~~~~l~~~N~~~~~~~~~~~~l~iP~  230 (628)
                                               ........+|+|+.||+|+.||++|++++.+|+++|++.++.+++||.|.+|.
T Consensus        60 -------------------------~~~~~~~~~~~V~~gdtL~~Ia~~~~~tv~~l~~~n~l~~~~i~~gq~l~~~~  112 (124)
T COG1388          60 -------------------------ASKAPPVVTYTVKKGDTLSKIARKYGVTVAELKQLNNLSSDKIKVGQKLKLPV  112 (124)
T ss_pred             -------------------------ccccCCCceEEEecCCCHHHHHHHhCCCHHHHHHHhccCCCceecCcEEEEec
Confidence                                     01112345899999999999999999999999999999999999999999987

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=98.86  E-value=2e-08  Score=93.05  Aligned_cols=117  Identities=21%  Similarity=0.234  Sum_probs=92.3

Q ss_pred             eEEEEEEECCceEEEEEecc---------------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHH
Q 039626          361 GSVYRGKINGGFAAIKKVNG---------------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDW  425 (628)
Q Consensus       361 G~Vy~g~~~g~~vavK~~~~---------------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~  425 (628)
                      ..+|.+.+-|..+++|....               ...+|.+++.+++--.|--.+=+..+.....|+|||++|..|.+.
T Consensus        10 a~i~~~~~~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I~G~~lkd~   89 (204)
T COG3642          10 AIIYLTDFLGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYIEGELLKDA   89 (204)
T ss_pred             eeEEeeeccCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEeCChhHHHH
Confidence            56888888777777775432               234699999999766665555566677788999999999999988


Q ss_pred             hhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccC
Q 039626          426 VFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPA  492 (628)
Q Consensus       426 l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~  492 (628)
                      +...           +..++..+-.-+.-||..   +|+|+||.++||++..+. +.++||||+...
T Consensus        90 l~~~-----------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg~~s  141 (204)
T COG3642          90 LEEA-----------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLGEFS  141 (204)
T ss_pred             HHhc-----------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCccccc
Confidence            8432           356778888888999994   599999999999998765 999999998754

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=98.80  E-value=5e-08  Score=93.40  Aligned_cols=98  Identities=14%  Similarity=0.143  Sum_probs=71.6

Q ss_pred             HHHHHHhhcCCC--ceeeeeeeeecCCeEEEEEEecCCCChHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHH-hcCCC
Q 039626          384 KEIALLNKINHS--NLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYL-HSFTN  460 (628)
Q Consensus       384 ~E~~~l~~l~H~--nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yL-H~~~~  460 (628)
                      +|.+.|++++..  ++..++++    ...+|||||+.++.+..-..    ....++..+..++..+++.+|..| |..  
T Consensus        75 kE~r~L~rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~L----kd~~~~~~~~~~i~~~i~~~l~~l~H~~--  144 (197)
T cd05146          75 KEMHNLKRMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKL----KDAKLNDEEMKNAYYQVLSMMKQLYKEC--  144 (197)
T ss_pred             HHHHHHHHHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhh----hccccCHHHHHHHHHHHHHHHHHHHHhC--
Confidence            699999999643  45566654    45689999997654422111    111244455677889999999999 774  


Q ss_pred             CCeEecCCCCCCEEeCCCCcEEEccccccccCC
Q 039626          461 PPHVHKDINSSNVLLDSDLRAKIANFAMARPAE  493 (628)
Q Consensus       461 ~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~  493 (628)
                       +++|+||++.|||++ ++.+.|+|||.+....
T Consensus       145 -glVHGDLs~~NIL~~-~~~v~iIDF~qav~~~  175 (197)
T cd05146         145 -NLVHADLSEYNMLWH-DGKVWFIDVSQSVEPT  175 (197)
T ss_pred             -CeecCCCCHHHEEEE-CCcEEEEECCCceeCC
Confidence             599999999999997 4679999999887654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=98.80  E-value=4.8e-08  Score=90.08  Aligned_cols=127  Identities=21%  Similarity=0.277  Sum_probs=94.3

Q ss_pred             eEEEEEEECCceEEEEEecc---------------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCC-CChHH
Q 039626          361 GSVYRGKINGGFAAIKKVNG---------------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVN-GTLSD  424 (628)
Q Consensus       361 G~Vy~g~~~g~~vavK~~~~---------------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~-gsL~~  424 (628)
                      +.|+++.+.|+...||....               ....|+++|.+++--.|.-..-++.+...-.|+|||+++ -++.+
T Consensus        21 Arv~~~~~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME~~~g~~~vk~  100 (229)
T KOG3087|consen   21 ARVPRGSFSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYMEFIDGASTVKD  100 (229)
T ss_pred             eeEeeeccCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEEeccchhHHHH
Confidence            68999999999999986532               245699999999766665444455556666899999966 37888


Q ss_pred             HhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCC---cEEEccccccccC
Q 039626          425 WVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDL---RAKIANFAMARPA  492 (628)
Q Consensus       425 ~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~---~~kl~Dfgla~~~  492 (628)
                      ++...-..  ...-.....++..|-+.+.-||.   +.++|+||..+||+|..++   .+.++|||++...
T Consensus       101 ~i~~~~~~--~~~d~~~~~~~~~iG~~igklH~---ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~s  166 (229)
T KOG3087|consen  101 FILSTMED--ESEDEGLAELARRIGELIGKLHD---NDIIHGDLTTSNILLRSDGNQITPILIDFGLSSVS  166 (229)
T ss_pred             HHHHHccC--cccchhHHHHHHHHHHHHHHhhh---CCeecccccccceEEecCCCcCceEEEeecchhcc
Confidence            88543221  11222236788999999999998   5599999999999996554   3589999998654

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=98.78  E-value=6.9e-08  Score=94.81  Aligned_cols=126  Identities=22%  Similarity=0.298  Sum_probs=98.3

Q ss_pred             eEEEEEEECC-ceEEEEEecc--------chHHHHHHHhhcCCCc--eeeeeeeeecC---CeEEEEEEecCCCChHHHh
Q 039626          361 GSVYRGKING-GFAAIKKVNG--------DVSKEIALLNKINHSN--LIILSGVCFNE---GNCYLVYEYAVNGTLSDWV  426 (628)
Q Consensus       361 G~Vy~g~~~g-~~vavK~~~~--------~~~~E~~~l~~l~H~n--Iv~l~g~~~~~---~~~~lV~E~~~~gsL~~~l  426 (628)
                      +.||+....+ +.+++|....        ++..|.++++.+++.+  +.+++.+....   +..++||||++|+++.+.+
T Consensus        12 n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~G~~l~~~~   91 (223)
T cd05154          12 NLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVDGRVLRDRL   91 (223)
T ss_pred             ceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeCCEecCCCC
Confidence            7899998865 7899997653        4678999999997644  56777777654   3568999999999887755


Q ss_pred             hhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC-----------------------------------------------
Q 039626          427 FSNKNEGKYLDWKQRIQIALDVATGLNYLHSFT-----------------------------------------------  459 (628)
Q Consensus       427 ~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-----------------------------------------------  459 (628)
                      ..     ..++..++..++.++++.|.+||+..                                               
T Consensus        92 ~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (223)
T cd05154          92 LR-----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLLRWLEA  166 (223)
T ss_pred             CC-----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHHHHHHh
Confidence            21     34677788888899999999998631                                               


Q ss_pred             ------CCCeEecCCCCCCEEeCC--CCcEEEcccccccc
Q 039626          460 ------NPPHVHKDINSSNVLLDS--DLRAKIANFAMARP  491 (628)
Q Consensus       460 ------~~~iiH~dik~~NILl~~--~~~~kl~Dfgla~~  491 (628)
                            ...++|+|+.+.||+++.  ++.+.|+||+.+..
T Consensus       167 ~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         167 HLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             hCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                  244799999999999998  66789999988764

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=98.78  E-value=3.5e-09  Score=113.60  Aligned_cols=239  Identities=21%  Similarity=0.272  Sum_probs=161.6

Q ss_pred             HHHhcCCCcCCccc----eEEEEEEE---CCceEEEEEeccch---------HHHHHHHhhc-CCCceeeeeeeeecCCe
Q 039626          347 QSATDNFSFTCRIQ----GSVYRGKI---NGGFAAIKKVNGDV---------SKEIALLNKI-NHSNLIILSGVCFNEGN  409 (628)
Q Consensus       347 ~~at~~f~~~~~i~----G~Vy~g~~---~g~~vavK~~~~~~---------~~E~~~l~~l-~H~nIv~l~g~~~~~~~  409 (628)
                      ...+..|.....++    +.|++...   ++..+++|...+..         ..|+.+...+ .|.++++....+....+
T Consensus       261 s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~  340 (524)
T KOG0601|consen  261 SCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQ  340 (524)
T ss_pred             eeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccc
Confidence            33445555555554    45665544   45677888765521         2455555555 58888888777777777


Q ss_pred             EEEEEEecCCCChHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCC-CcEEEccccc
Q 039626          410 CYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSD-LRAKIANFAM  488 (628)
Q Consensus       410 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~-~~~kl~Dfgl  488 (628)
                      .|+--||++++++...+    .....++...++++..+++.++.++|+   +.++|+|+||+||++..+ +..++.|||.
T Consensus       341 ~~ip~e~~~~~s~~l~~----~~~~~~d~~~~~~~~~q~~~~l~~i~s---~~~~~~d~~psni~i~~~~~~~~~~~~~~  413 (524)
T KOG0601|consen  341 GYIPLEFCEGGSSSLRS----VTSQMLDEDPRLRLTAQILTALNVIHS---KLFVHLDVKPSNILISNDGFFSKLGDFGC  413 (524)
T ss_pred             ccCchhhhcCcchhhhh----HHHHhcCcchhhhhHHHHHhccccccc---hhhhcccccccceeeccchhhhhcccccc
Confidence            88999999999887665    223457778889999999999999998   669999999999999886 8889999999


Q ss_pred             cccCCCCCCcceeeecccCCccc-cCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccc
Q 039626          489 ARPAEGQEGEFALTRHIVGTKGY-MAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKE  567 (628)
Q Consensus       489 a~~~~~~~~~~~~~~~~~gt~~Y-~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~  567 (628)
                      +..+.....     .....+..| .+++......+..+.|+|+||.-+.|.+++.........                 
T Consensus       414 ~t~~~~~~~-----~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~-----------------  471 (524)
T KOG0601|consen  414 WTRLAFSSG-----VFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ-----------------  471 (524)
T ss_pred             ccccceecc-----cccccccccccchhhccccccccccccccccccccccccCcccCccccc-----------------
Confidence            864321111     111233344 366667778889999999999999999998743221100                 


Q ss_pred             cchhhhccccCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 039626          568 DGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNI  621 (628)
Q Consensus       568 ~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l  621 (628)
                        ...++.-.-+..    +... ..+..+.+.+...++..||++.++....+..
T Consensus       472 --~~~i~~~~~p~~----~~~~-~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~  518 (524)
T KOG0601|consen  472 --SLTIRSGDTPNL----PGLK-LQLQVLLKVMINPDRKRRPSAVELSLHSEFY  518 (524)
T ss_pred             --ceeeecccccCC----CchH-HhhhhhhhhhcCCccccchhhhhhcccchhh
Confidence              000111111111    1112 4566788889999999999988877655443

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.77  E-value=8.3e-08  Score=96.93  Aligned_cols=126  Identities=16%  Similarity=0.167  Sum_probs=95.9

Q ss_pred             eEEEEEEECCceEEEEEecc------------------chHHHHHHHhhcCCCce--eeeeeeeec-----CCeEEEEEE
Q 039626          361 GSVYRGKINGGFAAIKKVNG------------------DVSKEIALLNKINHSNL--IILSGVCFN-----EGNCYLVYE  415 (628)
Q Consensus       361 G~Vy~g~~~g~~vavK~~~~------------------~~~~E~~~l~~l~H~nI--v~l~g~~~~-----~~~~~lV~E  415 (628)
                      ..|++..++|+.+.||+...                  .+.+|...+.++...+|  ..++++...     ....+||+|
T Consensus        36 rrvvr~~~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte  115 (268)
T PRK15123         36 RRTLRFELAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITE  115 (268)
T ss_pred             ceEEEEEECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEe
Confidence            45778888999999996632                  25689999988854444  355666543     235789999


Q ss_pred             ecCCC-ChHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCC-------CCcEEEcccc
Q 039626          416 YAVNG-TLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDS-------DLRAKIANFA  487 (628)
Q Consensus       416 ~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~-------~~~~kl~Dfg  487 (628)
                      ++++- +|.+++....  ....+...+..++.+++..+.-||..+   ++|+|++++|||++.       +..+.++||+
T Consensus       116 ~l~~~~sL~~~~~~~~--~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~  190 (268)
T PRK15123        116 DLAPTISLEDYCADWA--TNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDLKLSVIDLH  190 (268)
T ss_pred             eCCCCccHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCceEEEEECC
Confidence            99876 8999874321  123455677789999999999999955   999999999999975       5789999999


Q ss_pred             cccc
Q 039626          488 MARP  491 (628)
Q Consensus       488 la~~  491 (628)
                      .++.
T Consensus       191 r~~~  194 (268)
T PRK15123        191 RAQI  194 (268)
T ss_pred             cccc
Confidence            8753

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.76  E-value=2.1e-07  Score=98.12  Aligned_cols=160  Identities=22%  Similarity=0.339  Sum_probs=125.4

Q ss_pred             eEEEEEEE--CCceEEEEEeccc-------hHHHHHHHhhcCCCceeeeeeeee----cCCeEEEEEEecCC-CChHHHh
Q 039626          361 GSVYRGKI--NGGFAAIKKVNGD-------VSKEIALLNKINHSNLIILSGVCF----NEGNCYLVYEYAVN-GTLSDWV  426 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~~-------~~~E~~~l~~l~H~nIv~l~g~~~----~~~~~~lV~E~~~~-gsL~~~l  426 (628)
                      -+.||+.-  +|..+++|++..+       -..-++.++++.|.|+|++..++.    .+..++|||+|.++ ++|.++-
T Consensus       290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~  369 (655)
T KOG3741|consen  290 ITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLY  369 (655)
T ss_pred             ceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHH
Confidence            57899876  8999999999432       235688999999999999998887    34568999999986 5888876


Q ss_pred             hhcCC-----------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCC
Q 039626          427 FSNKN-----------EGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQ  495 (628)
Q Consensus       427 ~~~~~-----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~  495 (628)
                      +....           .+..+++...+.++.|+..||.++|+.+   +.-+-|.+++||++.+.+++|+..|........
T Consensus       370 F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d  446 (655)
T KOG3741|consen  370 FANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQED  446 (655)
T ss_pred             ccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecCC
Confidence            54332           2234778889999999999999999965   777999999999999999999988877655432


Q ss_pred             CCcceeeecccCCccccCccccccCCCCcccccHHHHHHHHHHHhCCC
Q 039626          496 EGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKE  543 (628)
Q Consensus       496 ~~~~~~~~~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~  543 (628)
                      ..                 |-+.+   -.+-|.=.||.+++.|.+|..
T Consensus       447 ~~-----------------~~le~---~Qq~D~~~lG~ll~aLAt~~~  474 (655)
T KOG3741|consen  447 PT-----------------EPLES---QQQNDLRDLGLLLLALATGTE  474 (655)
T ss_pred             CC-----------------cchhH---HhhhhHHHHHHHHHHHhhccc
Confidence            20                 11111   346899999999999999974

>PF01476 LysM: LysM domain; InterPro: IPR018392 This domain is about 40 residues long and is found in a variety of enzymes involved in bacterial cell wall degradation []

Probab=98.75  E-value=8.3e-09  Score=73.79  Aligned_cols=42  Identities=33%  Similarity=0.397  Sum_probs=33.5

Q ss_pred             EEEecCChHHHHHhhhcCCCccHHHHHhccC-CC-CccCCCcEEEEe
Q 039626          122 YTIQNGDTYLFIANNTFQGLSTCQALEDQNG-SP-TNLIIGAGVTVP  166 (628)
Q Consensus       122 y~V~~gdt~~~IA~~~~~~l~t~~~l~~~N~-~~-~~l~~Gq~l~vp  166 (628)
                      |+||+|||+|.||++|.   +++++|+++|+ +. ..|.+||+|.||
T Consensus         1 y~V~~gDtl~~IA~~~~---~~~~~l~~~N~~~~~~~l~~G~~l~iP   44 (44)
T PF01476_consen    1 YTVQPGDTLWSIAKRYG---ISVDELMELNPNIDSDNLQPGQKLCIP   44 (44)
T ss_dssp             EEE-TT--HHHHHHHTT---S-HHHHHHHCCTTHGGCGGTTEEEEEC
T ss_pred             CEECcCCcHHHHHhhhh---hhHhHHHHhcCCCCcccCCCCCEEEeC
Confidence            89999999999998885   48999999994 44 679999999998

This domain may have a general peptidoglycan binding function.; GO: 0016998 cell wall macromolecule catabolic process; PDB: 2DJP_A 3ZQD_A 1Y7M_B 4A52_A 2L9Y_A 1E0G_A.

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=98.69  E-value=8.9e-09  Score=116.11  Aligned_cols=196  Identities=21%  Similarity=0.243  Sum_probs=133.4

Q ss_pred             cCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCC
Q 039626          392 INHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSS  471 (628)
Q Consensus       392 l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~  471 (628)
                      .+||-++...--+.-....+|+++|+.+++|...|+...    ..+..........+..+++|||..   .+.|+|++|.
T Consensus       861 p~~P~v~~~~~s~~~rsP~~L~~~~~~~~~~~Skl~~~~----~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~  933 (1205)
T KOG0606|consen  861 PRSPAVVRSFPSFPCRSPLPLVGHYLNGGDLPSKLHNSG----CLSAEPARSPILERVQSLESLHSS---LRKHRDLKPD  933 (1205)
T ss_pred             CCCCceecccCCCCCCCCcchhhHHhccCCchhhhhcCC----CcccccccchhHHHHhhhhccccc---hhhccccccc
Confidence            345656655444445677899999999999999886532    222222233455677889999984   3899999999


Q ss_pred             CEEeCCCCcEEEccccccccCCCC---------------------CCcc-------eeeecccCCccccCccccccCCCC
Q 039626          472 NVLLDSDLRAKIANFAMARPAEGQ---------------------EGEF-------ALTRHIVGTKGYMAPEYLENGLVS  523 (628)
Q Consensus       472 NILl~~~~~~kl~Dfgla~~~~~~---------------------~~~~-------~~~~~~~gt~~Y~APE~l~~~~~s  523 (628)
                      |++...++..+++|||........                     ....       .......||+.|.+||.+.+....
T Consensus       934 ~~l~~~~gh~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hg 1013 (1205)
T KOG0606|consen  934 SLLIAYDGHRPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHG 1013 (1205)
T ss_pred             chhhcccCCcccCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCC
Confidence            999999999999999843322110                     0000       012235799999999999999999


Q ss_pred             cccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCHHHHHHHHHHHHHhccc
Q 039626          524 TKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKK  603 (628)
Q Consensus       524 ~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~  603 (628)
                      ..+|.|++|++++|.++|..|+......      +.+..+...           +... ..-+.+.+..+.+++...+..
T Consensus      1014 s~ad~~~~g~~l~e~l~g~pp~na~tpq------~~f~ni~~~-----------~~~~-p~g~~~~s~~aq~~~~~ll~~ 1075 (1205)
T KOG0606|consen 1014 SAADWWSSGVCLFEVLTGIPPFNAETPQ------QIFENILNR-----------DIPW-PEGPEEGSYEAQDLINRLLTE 1075 (1205)
T ss_pred             CcchhhhhhhhhhhhhcCCCCCCCcchh------hhhhccccC-----------CCCC-CCCccccChhhhhhhhhhhcc
Confidence            9999999999999999999887633221      111111110           0000 112334455677888888999


Q ss_pred             CCCCCCCHH
Q 039626          604 DPTDRPTMY  612 (628)
Q Consensus       604 dP~~RPs~~  612 (628)
                      +|.+|-.|.
T Consensus      1076 ~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1076 EPTQRLGAK 1084 (1205)
T ss_pred             CchhccCcc
Confidence            999997765

>PRK14125 cell division suppressor protein YneA; Provisional

Probab=98.69  E-value=2.7e-08  Score=84.34  Aligned_cols=50  Identities=22%  Similarity=0.305  Sum_probs=43.5

Q ss_pred             eEEEEEccCCCcHHHHHHHhCCC--------hHHHhhhcCCCCCCccccceeeccCCC
Q 039626          183 FLLSYLVAEGDTVSGISSRFGVD--------TGEILQANSLSGSNIFPFTTLLIPLEN  232 (628)
Q Consensus       183 ~~~~y~v~~gdtl~~ia~~f~~~--------~~~l~~~N~~~~~~~~~~~~l~iP~~~  232 (628)
                      ...+|+|++|||||+||++|+.+        ++.|.+.|++.++.|+|||+|.||...
T Consensus        35 ~~~~~tV~~GDTLW~IA~~y~~~~~l~~~~~v~~I~~~N~l~~~~I~~Gq~L~IP~~~   92 (103)
T PRK14125         35 QYVEITVQEGDTLWALADQYAGKHHMAKNEFIEWVEDVNNLPSGHIKAGDKLVIPVLK   92 (103)
T ss_pred             CcEEEEECCCCCHHHHHHHhCCCcCCCHHHHHHHHHHhcCCCCCcCCCCCEEEEecCC
Confidence            34689999999999999999865        467778899988899999999999865

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.63  E-value=1.1e-08  Score=111.32  Aligned_cols=152  Identities=24%  Similarity=0.307  Sum_probs=101.9

Q ss_pred             HHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCc------ceeeecccCCccccCcccccc
Q 039626          446 LDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGE------FALTRHIVGTKGYMAPEYLEN  519 (628)
Q Consensus       446 ~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~------~~~~~~~~gt~~Y~APE~l~~  519 (628)
                      .+++.||.|+|..  ..+||++|.|++|.++.++..||+.|+.+.........      .....-..-...|.|||++.+
T Consensus       106 ~~v~dgl~flh~s--Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~  183 (700)
T KOG2137|consen  106 GNVADGLAFLHRS--AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG  183 (700)
T ss_pred             hcccchhhhhccC--cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence            3455999999984  67999999999999999999999999987655432111      011111234457999999999


Q ss_pred             CCCCcccccHHHHHHHHHHHh-CCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCHHHHHHHHHHHH
Q 039626          520 GLVSTKLDVYAFGVLILEMLT-GKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLID  598 (628)
Q Consensus       520 ~~~s~k~DV~SfGvvl~ELlt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~  598 (628)
                      ...+.++|+||+|++++-+.. |+..+........   .              ......+..-...++...+.++.+=+.
T Consensus       184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~---~--------------~~~~~~~~~~~~~~s~~~p~el~~~l~  246 (700)
T KOG2137|consen  184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLS---Y--------------SFSRNLLNAGAFGYSNNLPSELRESLK  246 (700)
T ss_pred             ccccccccceeeeeEEEEEecCCcchhhccCCcch---h--------------hhhhcccccccccccccCcHHHHHHHH
Confidence            999999999999999999984 4433332211100   0              000011111111223445556677778


Q ss_pred             HhcccCCCCCCCHHHHHH
Q 039626          599 ACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       599 ~Cl~~dP~~RPs~~ev~~  616 (628)
                      +++..++.-||++.++..
T Consensus       247 k~l~~~~~~rp~~~~l~~  264 (700)
T KOG2137|consen  247 KLLNGDSAVRPTLDLLLS  264 (700)
T ss_pred             HHhcCCcccCcchhhhhc
Confidence            889999999998777654

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.61  E-value=2.1e-07  Score=88.77  Aligned_cols=117  Identities=20%  Similarity=0.209  Sum_probs=77.7

Q ss_pred             EEEEEE-CCceEEEEEecc---------------------------------chHHHHHHHhhcCCCc--eeeeeeeeec
Q 039626          363 VYRGKI-NGGFAAIKKVNG---------------------------------DVSKEIALLNKINHSN--LIILSGVCFN  406 (628)
Q Consensus       363 Vy~g~~-~g~~vavK~~~~---------------------------------~~~~E~~~l~~l~H~n--Iv~l~g~~~~  406 (628)
                      ||.|.. +|..+|+|..+.                                 ...+|.+.|.+++..+  +.+++++.  
T Consensus         2 Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~--   79 (188)
T PF01163_consen    2 VYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN--   79 (188)
T ss_dssp             EEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE--
T ss_pred             EEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe--
Confidence            899987 788999997642                                 1246999999998764  45665442  


Q ss_pred             CCeEEEEEEecC--CCChHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHH-hcCCCCCeEecCCCCCCEEeCCCCcEEE
Q 039626          407 EGNCYLVYEYAV--NGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYL-HSFTNPPHVHKDINSSNVLLDSDLRAKI  483 (628)
Q Consensus       407 ~~~~~lV~E~~~--~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yL-H~~~~~~iiH~dik~~NILl~~~~~~kl  483 (628)
                        ...|||||++  |..+..+....      ++......++.+++..+..+ |..   +++|+|+.+.|||++++ .+.+
T Consensus        80 --~~~ivME~I~~~G~~~~~l~~~~------~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~~~i  147 (188)
T PF01163_consen   80 --RNVIVMEYIGEDGVPLPRLKDVD------LSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-KVYI  147 (188)
T ss_dssp             --TTEEEEE--EETTEEGGCHHHCG------GGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-CEEE
T ss_pred             --CCEEEEEecCCCccchhhHHhcc------ccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-eEEE
Confidence              3479999998  54554433111      11234456777888866664 664   59999999999999988 9999


Q ss_pred             ccccccccCC
Q 039626          484 ANFAMARPAE  493 (628)
Q Consensus       484 ~Dfgla~~~~  493 (628)
                      +|||.+....
T Consensus       148 IDf~qav~~~  157 (188)
T PF01163_consen  148 IDFGQAVDSS  157 (188)
T ss_dssp             --GTTEEETT
T ss_pred             EecCcceecC
Confidence            9999887654

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>TIGR02899 spore_safA spore coat assembly protein SafA

Probab=98.55  E-value=7.9e-08  Score=68.50  Aligned_cols=41  Identities=44%  Similarity=0.707  Sum_probs=37.0

Q ss_pred             ccCCCcHHHHHHHhCCChHHHhhhcC-CCCC-Cccccceeecc
Q 039626          189 VAEGDTVSGISSRFGVDTGEILQANS-LSGS-NIFPFTTLLIP  229 (628)
Q Consensus       189 v~~gdtl~~ia~~f~~~~~~l~~~N~-~~~~-~~~~~~~l~iP  229 (628)
                      |++|||||+||++||++.++|.++|+ +.+. .+++|++|.||
T Consensus         1 v~~gdtl~~IA~~~~~~~~~l~~~N~~~~~~~~~~~g~~l~ip   43 (44)
T TIGR02899         1 VQKGDTLWKIAKKYGVDFDELIQANPQLSNPNLIYPGMKIKIP   43 (44)
T ss_pred             CCCCCCHHHHHHHHCcCHHHHHHHhhcCCCCCCcCCCCEEecC
Confidence            68999999999999999999999997 4443 89999999997

in which one of which is found in most examples of endospore-forming bacteria. Lysin motifs are repeated in many proteins.

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.48  E-value=3e-06  Score=87.38  Aligned_cols=204  Identities=18%  Similarity=0.226  Sum_probs=128.9

Q ss_pred             EEEEEEecCCCC-hHHHhhhc--CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccc
Q 039626          410 CYLVYEYAVNGT-LSDWVFSN--KNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANF  486 (628)
Q Consensus       410 ~~lV~E~~~~gs-L~~~l~~~--~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Df  486 (628)
                      .-+.|..+.+.. ..+++...  +.......|.-.++.+..+|.+.+-||+++   ..-+|+.++|+|+.+++.+.|.|-
T Consensus        85 iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVds  161 (637)
T COG4248          85 IGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDS  161 (637)
T ss_pred             eEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEcc
Confidence            456666665542 22222111  122234789999999999999999999966   889999999999999999999975


Q ss_pred             cccccCCCCCCcceeeecccCCccccCccccc-----cCCCCcccccHHHHHHHHHHHhC-CCccccccccc--cccHH-
Q 039626          487 AMARPAEGQEGEFALTRHIVGTKGYMAPEYLE-----NGLVSTKLDVYAFGVLILEMLTG-KEAAALHAEEN--NMHLS-  557 (628)
Q Consensus       487 gla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~-----~~~~s~k~DV~SfGvvl~ELltG-~~p~~~~~~~~--~~~~~-  557 (628)
                      ..-....++    ......+|...|.+||.-.     +..-+...|-|.+||++++|+.| +.|+..-....  ...+. 
T Consensus       162 Dsfqi~~ng----~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~  237 (637)
T COG4248         162 DSFQINANG----TLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLET  237 (637)
T ss_pred             cceeeccCC----ceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchh
Confidence            432222111    1234468999999999654     34567889999999999999876 88876422111  11111 


Q ss_pred             HHHHHHhccccchhhhccccCCcCCCCCCHH-HHHHHHHHHHHhcccC--CCCCCCHHHHHHHHHHhHhh
Q 039626          558 DVLNAVLTKEDGEESLRHFIDPTLQGNYPLE-LALLVIRLIDACLKKD--PTDRPTMYEIEHSLSNILNA  624 (628)
Q Consensus       558 ~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~-~~~~l~~l~~~Cl~~d--P~~RPs~~ev~~~L~~l~~~  624 (628)
                      +.....+...  .. -+.-..+ .+..+|.+ +...+..+..+|+...  +.-|||.+-.+..|..+.++
T Consensus       238 ~Ia~g~f~ya--~~-~~~g~~p-~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~  303 (637)
T COG4248         238 DIAHGRFAYA--SD-QRRGLKP-PPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQ  303 (637)
T ss_pred             hhhcceeeec--hh-ccCCCCC-CCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHh
Confidence            1110000000  00 0000011 12233333 4456778888898754  56899999999988877654

>cd00118 LysM Lysin domain, found in a variety of enzymes involved in bacterial cell wall degradation

Probab=98.42  E-value=4.2e-07  Score=64.66  Aligned_cols=44  Identities=41%  Similarity=0.660  Sum_probs=40.5

Q ss_pred             EEEccCCCcHHHHHHHhCCChHHHhhhcCCCCC-Cccccceeecc
Q 039626          186 SYLVAEGDTVSGISSRFGVDTGEILQANSLSGS-NIFPFTTLLIP  229 (628)
Q Consensus       186 ~y~v~~gdtl~~ia~~f~~~~~~l~~~N~~~~~-~~~~~~~l~iP  229 (628)
                      +|+|+.|||+++||++||++..++.++|+.... .+.+|+.+.||
T Consensus         2 ~~~v~~gdt~~~ia~~~~~~~~~~~~~N~~~~~~~~~~g~~l~ip   46 (46)
T cd00118           2 TYTVKKGDTLSSIAQRYGISVEELLKLNGLSDPDNLQVGQKLKIP   46 (46)
T ss_pred             EEEECCCCCHHHHHHHHCcCHHHHHHHcCCCCccccCCCCEEecC
Confidence            699999999999999999999999999998444 89999999887

This domain may have a general peptidoglycan binding function.

>PRK14125 cell division suppressor protein YneA; Provisional

Probab=98.40  E-value=4.6e-07  Score=76.86  Aligned_cols=51  Identities=24%  Similarity=0.367  Sum_probs=41.8

Q ss_pred             eeEEEecCChHHHHHhhhcCC--Ccc---HHHHHhccCCC-CccCCCcEEEEeecCC
Q 039626          120 TTYTIQNGDTYLFIANNTFQG--LST---CQALEDQNGSP-TNLIIGAGVTVPLRCA  170 (628)
Q Consensus       120 ~~y~V~~gdt~~~IA~~~~~~--l~t---~~~l~~~N~~~-~~l~~Gq~l~vp~~~~  170 (628)
                      .+|+|++|||+|.||++|...  ++.   +++|++.|.+. +.|++||+|.||...+
T Consensus        37 ~~~tV~~GDTLW~IA~~y~~~~~l~~~~~v~~I~~~N~l~~~~I~~Gq~L~IP~~~~   93 (103)
T PRK14125         37 VEITVQEGDTLWALADQYAGKHHMAKNEFIEWVEDVNNLPSGHIKAGDKLVIPVLKS   93 (103)
T ss_pred             EEEEECCCCCHHHHHHHhCCCcCCCHHHHHHHHHHhcCCCCCcCCCCCEEEEecCCC
Confidence            469999999999999988653  222   57788889988 8899999999997644

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.38  E-value=2.6e-06  Score=93.22  Aligned_cols=162  Identities=17%  Similarity=0.213  Sum_probs=99.4

Q ss_pred             hhhhhhhcccccCcceeecHHHHHHHh------------cCCCcCCccc---eEEEEEEE-CCceEEEEEecc-------
Q 039626          324 SQDFLESISGVAQSLKVYSFKELQSAT------------DNFSFTCRIQ---GSVYRGKI-NGGFAAIKKVNG-------  380 (628)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~el~~at------------~~f~~~~~i~---G~Vy~g~~-~g~~vavK~~~~-------  380 (628)
                      ..++.+++....+....|++++.+...            .+|...-.-.   |.||+|++ +|+.||||..+.       
T Consensus        87 p~e~~~eL~~LQD~vpp~~~~~~~~iie~eLG~~iee~F~eF~~~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~  166 (517)
T COG0661          87 PPEYAEELAKLQDRVPPFPFEEAERIIEEELGRPIEELFSEFEPEPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIE  166 (517)
T ss_pred             CHHHHHHHHHhhcCCCCCCHHHHHHHHHHHhCCCHHHHHHHcCCCchhhhhHhhheeEEecCCCEEEEEecCCChHHHHH
Confidence            344455555555555566665544422            2333211111   89999999 599999998653       


Q ss_pred             ----------------------------------------chHHHHHHHhhcC-----CCceeeeeeeeecCCeEEEEEE
Q 039626          381 ----------------------------------------DVSKEIALLNKIN-----HSNLIILSGVCFNEGNCYLVYE  415 (628)
Q Consensus       381 ----------------------------------------~~~~E~~~l~~l~-----H~nIv~l~g~~~~~~~~~lV~E  415 (628)
                                                              |+.+|...+.+++     .+++.-.-=|..-.+...|+||
T Consensus       167 ~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE  246 (517)
T COG0661         167 ADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTME  246 (517)
T ss_pred             HHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEE
Confidence                                                    2234555555552     3444322222223466789999


Q ss_pred             ecCCCChHHHhhhcCCCCCCCCHHHHHHHHHHHHHHH-HHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCC
Q 039626          416 YAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGL-NYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEG  494 (628)
Q Consensus       416 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL-~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~  494 (628)
                      |++|-.+.+......   ...+   +..++..++++. ..+-.   .++.|.|..|.||+++.++++-+.|||+......
T Consensus       247 ~i~Gi~i~d~~~l~~---~g~d---~k~ia~~~~~~f~~q~~~---dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~  317 (517)
T COG0661         247 WIDGIKISDIAALKS---AGID---RKELAELLVRAFLRQLLR---DGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP  317 (517)
T ss_pred             eeCCEecccHHHHHh---cCCC---HHHHHHHHHHHHHHHHHh---cCccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence            999999988853222   1233   333444444332 22222   3499999999999999999999999999877654

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.33  E-value=4.3e-06  Score=81.49  Aligned_cols=104  Identities=23%  Similarity=0.225  Sum_probs=81.8

Q ss_pred             hHHHHHHHhhcCCCc--eeeeeeeeecCC----eEEEEEEecCCC-ChHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHH
Q 039626          382 VSKEIALLNKINHSN--LIILSGVCFNEG----NCYLVYEYAVNG-TLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNY  454 (628)
Q Consensus       382 ~~~E~~~l~~l~H~n--Iv~l~g~~~~~~----~~~lV~E~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~y  454 (628)
                      ..+|...+.++....  ..+.+++.....    ..+||+|++++- +|.+++.....    ++...+..++.+++..+.-
T Consensus        58 a~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~----~~~~~~~~ll~~l~~~i~~  133 (206)
T PF06293_consen   58 AKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ----LDPSQRRELLRALARLIAK  133 (206)
T ss_pred             HHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc----cchhhHHHHHHHHHHHHHH
Confidence            567888888885443  456677766532    458999999874 89998854211    5556778899999999999


Q ss_pred             HhcCCCCCeEecCCCCCCEEeCCCC---cEEEccccccccC
Q 039626          455 LHSFTNPPHVHKDINSSNVLLDSDL---RAKIANFAMARPA  492 (628)
Q Consensus       455 LH~~~~~~iiH~dik~~NILl~~~~---~~kl~Dfgla~~~  492 (628)
                      ||+.+   ++|+|++++|||++.+.   .+.++||+.++..
T Consensus       134 lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  134 LHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             HHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence            99955   99999999999999887   8999999987653

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>TIGR02907 spore_VI_D stage VI sporulation protein D

Probab=98.32  E-value=6.2e-07  Score=89.94  Aligned_cols=48  Identities=27%  Similarity=0.448  Sum_probs=44.2

Q ss_pred             CeEEEEEccCCCcHHHHHHHhCCChHHHhhhcCCCCCCccccceeecc
Q 039626          182 PFLLSYLVAEGDTVSGISSRFGVDTGEILQANSLSGSNIFPFTTLLIP  229 (628)
Q Consensus       182 ~~~~~y~v~~gdtl~~ia~~f~~~~~~l~~~N~~~~~~~~~~~~l~iP  229 (628)
                      ....+|+|++|||||+||+|||++++.|+++|++..+.+.+|++|+||
T Consensus       291 ~~~~~YiVq~GDTL~sIAkRYGVSV~~L~r~N~L~~~~L~~GQ~L~IP  338 (338)
T TIGR02907       291 TKLRMCIVQEGDTIETIAERYEISVSQLIRHNQLEDFEVNEGQILYIP  338 (338)
T ss_pred             cccEEEEECCCCCHHHHHHHHCcCHHHHHHHhCCCccccCCCCEEEeC
Confidence            345689999999999999999999999999999985699999999998

SpoVID, the stage VI sporulation protein D, is restricted to endospore-forming members of the bacteria, all of which are found among the Firmicutes. It is widely distributed but not quite universal in this group. Between well-conserved N-terminal and C-terminal domains is a poorly conserved, low-complexity region of variable length, rich enough in glutamic acid to cause spurious BLAST search results unless a filter is used. The seed alignment for this model was trimmed, in effect, by choosing member sequences in which these regions are relatively short. SpoVID is involved in spore coat assembly by the mother cell compartment late in the process of sporulation.

>PRK10871 nlpD lipoprotein NlpD; Provisional

Probab=98.26  E-value=1e-06  Score=89.59  Aligned_cols=47  Identities=26%  Similarity=0.264  Sum_probs=44.1

Q ss_pred             EEEccCCCcHHHHHHHhCCChHHHhhhcCCCCC-CccccceeeccCCC
Q 039626          186 SYLVAEGDTVSGISSRFGVDTGEILQANSLSGS-NIFPFTTLLIPLEN  232 (628)
Q Consensus       186 ~y~v~~gdtl~~ia~~f~~~~~~l~~~N~~~~~-~~~~~~~l~iP~~~  232 (628)
                      +|+|++|||||.||.+||++..+|.+||++.++ .|++||.|.||...
T Consensus        62 ~y~Vk~GDTL~~IA~~~g~~~~~La~~N~l~~p~~I~~GQ~L~i~~~~  109 (319)
T PRK10871         62 TYTVKKGDTLFYIAWITGNDFRDLAQRNNIQAPYSLNVGQTLQVGNAS  109 (319)
T ss_pred             ceEECCCCHHHHHHHHHCcCHHHHHHhcCCCCCccccCCCEEEeCCCC
Confidence            799999999999999999999999999999876 99999999998653

>COG3858 Predicted glycosyl hydrolase [General function prediction only]

Probab=98.20  E-value=1.3e-06  Score=90.06  Aligned_cols=94  Identities=24%  Similarity=0.220  Sum_probs=76.2

Q ss_pred             eEEEecCChHHHHHhhhcCCCccHHHHHhccCCC-CccCCCcEEEEeecCCCCCCCCCCCCCCeEEEEEccCCCcHHHHH
Q 039626          121 TYTIQNGDTYLFIANNTFQGLSTCQALEDQNGSP-TNLIIGAGVTVPLRCACPTENQTDEGFPFLLSYLVAEGDTVSGIS  199 (628)
Q Consensus       121 ~y~V~~gdt~~~IA~~~~~~l~t~~~l~~~N~~~-~~l~~Gq~l~vp~~~~c~~~~~~~~~~~~~~~y~v~~gdtl~~ia  199 (628)
                      .|.|++||+++.||+.|..   +...+...|... +.|.+||.+.||..               ...|.|++||++++||
T Consensus         3 i~~~~pg~~~~~i~~~~~~---~~~~i~~~~~~~~d~~~~~q~~~v~~~---------------~~~y~~~~~d~~~Sia   64 (423)
T COG3858           3 IHLVGPGDSRLIIAVYFPY---TNNRIVNGNDYTNDDLVDGQTFVVPPS---------------GHFYDVGPGDTLTSIA   64 (423)
T ss_pred             EEEccCCceeeeehhhccc---cccccccccccccccccCceeEEECCc---------------ceEEEecCCcchhhhh
Confidence            5889999999999965544   555565555555 67999999999952               2379999999999999


Q ss_pred             HHhCCChHHHhhhcCCCCC-CccccceeeccCCC
Q 039626          200 SRFGVDTGEILQANSLSGS-NIFPFTTLLIPLEN  232 (628)
Q Consensus       200 ~~f~~~~~~l~~~N~~~~~-~~~~~~~l~iP~~~  232 (628)
                      ++||++++++..+|..... .+.+|-.+.+|-..
T Consensus        65 ~~~~vt~~~~~~m~~~~~~~~l~~~~~l~~P~~~   98 (423)
T COG3858          65 RTVGVTQDSAAIMNFVICPGYLQYGLNLYIPSAR   98 (423)
T ss_pred             hhhcCCHHHHHhhcccccccceeeeeEEeccCCC
Confidence            9999999999999987655 77778888888654

>PRK09902 hypothetical protein; Provisional

Probab=98.14  E-value=6.3e-05  Score=72.45  Aligned_cols=124  Identities=16%  Similarity=0.198  Sum_probs=94.0

Q ss_pred             eEEEEEEECCceEEEEEecc-------------chHHHHHHHhhcCCCc--eeeeeeeee-c--C--CeEEEEEEecCC-
Q 039626          361 GSVYRGKINGGFAAIKKVNG-------------DVSKEIALLNKINHSN--LIILSGVCF-N--E--GNCYLVYEYAVN-  419 (628)
Q Consensus       361 G~Vy~g~~~g~~vavK~~~~-------------~~~~E~~~l~~l~H~n--Iv~l~g~~~-~--~--~~~~lV~E~~~~-  419 (628)
                      ..|++-.++|..+-+|+..+             .|.+|+..|.++...+  +.+++ ++. .  .  -.-+||+|-+.| 
T Consensus        32 SgV~r~~~~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LVTe~L~g~  110 (216)
T PRK09902         32 SGVQCVERNGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLVTEDMAGF  110 (216)
T ss_pred             ceEEEEEeCCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEEEEeCCCC
Confidence            57888888888899998752             3678999999996433  34444 332 1  1  236899998854 


Q ss_pred             CChHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCc--EEEccccccc
Q 039626          420 GTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLR--AKIANFAMAR  490 (628)
Q Consensus       420 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~--~kl~Dfgla~  490 (628)
                      -+|.+|+...  .-...+...+..+..+++..+.-||+.+   +.|+|+.+.||+++.++.  ++++||--++
T Consensus       111 ~~L~~~l~~~--~~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r  178 (216)
T PRK09902        111 ISIADWYAQH--AVSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSR  178 (216)
T ss_pred             ccHHHHHhcC--CcCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence            5899998432  1224577788899999999999999955   999999999999986666  8999996554

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.08  E-value=3.5e-05  Score=84.23  Aligned_cols=161  Identities=16%  Similarity=0.219  Sum_probs=94.7

Q ss_pred             hhhhhhcccccCcceeecHHHHHHHhc------------CCCcCCcc---ceEEEEEEE-CCceEEEEEecc--------
Q 039626          325 QDFLESISGVAQSLKVYSFKELQSATD------------NFSFTCRI---QGSVYRGKI-NGGFAAIKKVNG--------  380 (628)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~el~~at~------------~f~~~~~i---~G~Vy~g~~-~g~~vavK~~~~--------  380 (628)
                      .++...++...+....++++|+.+.-+            .|+.+-.-   -|.||++++ +|+.||||.-+.        
T Consensus       124 ~Eyv~~L~~LqD~~Pp~~~ee~~~i~e~ElG~~ie~if~~f~~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~  203 (538)
T KOG1235|consen  124 KEYVKTLSELQDQAPPFPWEEAFKIFEEELGAPIEDIFSEFDEEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIML  203 (538)
T ss_pred             HHHHHHHHHHhccCCCCCHHHHHHHHHHHhCCCHHHHHHhcCcchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHH
Confidence            344444444455555666666554322            23221111   289999999 788899998653        


Q ss_pred             ------------------------------------chHHHHHHHhhc----CCCc---eeeeeeeee-cCCeEEEEEEe
Q 039626          381 ------------------------------------DVSKEIALLNKI----NHSN---LIILSGVCF-NEGNCYLVYEY  416 (628)
Q Consensus       381 ------------------------------------~~~~E~~~l~~l----~H~n---Iv~l~g~~~-~~~~~~lV~E~  416 (628)
                                                          ||.+|.+-..++    +|-+   -|.+=.++. -.....|+|||
T Consensus       204 Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~  283 (538)
T KOG1235|consen  204 DLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAKNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEY  283 (538)
T ss_pred             HHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHHhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEe
Confidence                                                233454433333    4555   122222222 23467999999


Q ss_pred             cCCCChHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCC----CCcEEEccccccccC
Q 039626          417 AVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDS----DLRAKIANFAMARPA  492 (628)
Q Consensus       417 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~----~~~~kl~Dfgla~~~  492 (628)
                      |+|..+.|.-.-...   .++-.   .++..+.++.  ++..-..+++|+|-.|.||+++.    ++++.+.|||+....
T Consensus       284 ~~G~~i~Dl~~i~~~---gi~~~---~i~~~l~~~~--~~qIf~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~i  355 (538)
T KOG1235|consen  284 VDGIKINDLDAIDKR---GISPH---DILNKLVEAY--LEQIFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVI  355 (538)
T ss_pred             cCCccCCCHHHHHHc---CCCHH---HHHHHHHHHH--HHHHHhcCCccCCCCCCcEEEecCCCCCccEEEEcccccccc
Confidence            999977776432221   24433   3444443332  22211245999999999999983    678999999998766


Q ss_pred             C
Q 039626          493 E  493 (628)
Q Consensus       493 ~  493 (628)
                      .
T Consensus       356 s  356 (538)
T KOG1235|consen  356 S  356 (538)
T ss_pred             c
Confidence            4

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.05  E-value=1.6e-05  Score=76.09  Aligned_cols=105  Identities=23%  Similarity=0.214  Sum_probs=82.5

Q ss_pred             HHHHHHhhcCC-CceeeeeeeeecCCeEEEEEEecCCCChHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC
Q 039626          384 KEIALLNKINH-SNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPP  462 (628)
Q Consensus       384 ~E~~~l~~l~H-~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~  462 (628)
                      .|.-+|+.+++ +++.+++|+|-    .++|.||...+++...- ..-..-..-+|..|.+||.++++.+++|++.....
T Consensus         8 ~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~-~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~   82 (188)
T PF12260_consen    8 NEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIY-RPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF   82 (188)
T ss_pred             cHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccc-cccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence            58888999977 59999999994    36799999877664220 00011123689999999999999999999855445


Q ss_pred             eEecCCCCCCEEeCCCCcEEEccccccccCC
Q 039626          463 HVHKDINSSNVLLDSDLRAKIANFAMARPAE  493 (628)
Q Consensus       463 iiH~dik~~NILl~~~~~~kl~Dfgla~~~~  493 (628)
                      +.-+|++++|+-+++++++|+.|...+....
T Consensus        83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~~  113 (188)
T PF12260_consen   83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVED  113 (188)
T ss_pred             EEEeecchHHeEEeCCCcEEEEechhcchhH
Confidence            8889999999999999999999998776543

Proteins in this uncharacterised family are described as transmembrane proteins.

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.03  E-value=2.6e-05  Score=76.90  Aligned_cols=116  Identities=19%  Similarity=0.163  Sum_probs=82.1

Q ss_pred             eEEEEEEE-CCceEEEEEecc-----------------------------chHHHHHHHhhcCCC--ceeeeeeeeecCC
Q 039626          361 GSVYRGKI-NGGFAAIKKVNG-----------------------------DVSKEIALLNKINHS--NLIILSGVCFNEG  408 (628)
Q Consensus       361 G~Vy~g~~-~g~~vavK~~~~-----------------------------~~~~E~~~l~~l~H~--nIv~l~g~~~~~~  408 (628)
                      +.||.|.. +|..+|||.-+-                             ...+|.++|.+|.-.  .+.+.+++    +
T Consensus       105 sdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~VP~P~~~----n  180 (304)
T COG0478         105 SDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKVPKPIAW----N  180 (304)
T ss_pred             ceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCCCCcccc----c
Confidence            68999998 699999995321                             134699999999755  66666655    4


Q ss_pred             eEEEEEEecCCCChHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccc
Q 039626          409 NCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAM  488 (628)
Q Consensus       409 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgl  488 (628)
                      ...+||||++|-.|...-         ++-...-.++..|++-+.-+-.   .+++|+|+..-||+++++|.+.++||--
T Consensus       181 RHaVvMe~ieG~eL~~~r---------~~~en~~~il~~il~~~~~~~~---~GiVHGDlSefNIlV~~dg~~~vIDwPQ  248 (304)
T COG0478         181 RHAVVMEYIEGVELYRLR---------LDVENPDEILDKILEEVRKAYR---RGIVHGDLSEFNILVTEDGDIVVIDWPQ  248 (304)
T ss_pred             cceeeeehcccceeeccc---------CcccCHHHHHHHHHHHHHHHHH---cCccccCCchheEEEecCCCEEEEeCcc
Confidence            568999999887665422         1122223344444444444444   4599999999999999999999999976


Q ss_pred             cccC
Q 039626          489 ARPA  492 (628)
Q Consensus       489 a~~~  492 (628)
                      +...
T Consensus       249 ~v~~  252 (304)
T COG0478         249 AVPI  252 (304)
T ss_pred             cccC
Confidence            6544

>smart00257 LysM Lysin motif

Probab=98.03  E-value=7.5e-06  Score=57.30  Aligned_cols=43  Identities=33%  Similarity=0.580  Sum_probs=37.3

Q ss_pred             EEEccCCCcHHHHHHHhCCChHHHhhhcCCCC-CCccccceeec
Q 039626          186 SYLVAEGDTVSGISSRFGVDTGEILQANSLSG-SNIFPFTTLLI  228 (628)
Q Consensus       186 ~y~v~~gdtl~~ia~~f~~~~~~l~~~N~~~~-~~~~~~~~l~i  228 (628)
                      +|.|++||++++||++|+++..++.++|+... ..+.+|+.+.|
T Consensus         1 ~~~v~~gdt~~~ia~~~~~~~~~~~~~N~~~~~~~~~~g~~l~i   44 (44)
T smart00257        1 TYTVKKGDTLSSIARRYGISVSDLLELNNILDPDNLQVGQKLKI   44 (44)
T ss_pred             CeEeCCCCCHHHHHHHhCCCHHHHHHHcCCCCccccCCCCEEeC
Confidence            38999999999999999999999999999544 37888887753

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=97.94  E-value=9.1e-05  Score=74.12  Aligned_cols=130  Identities=12%  Similarity=0.065  Sum_probs=82.6

Q ss_pred             eEEEEEEECCceEEEEEecc----chHHHHHHHhhcC-CCceeeeeeeeecCCeEEEEEEecCCCChHHHh---------
Q 039626          361 GSVYRGKINGGFAAIKKVNG----DVSKEIALLNKIN-HSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWV---------  426 (628)
Q Consensus       361 G~Vy~g~~~g~~vavK~~~~----~~~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l---------  426 (628)
                      ..||+...+++.+.+|....    +..+|+++++.+. +--+.+++++...++..++|||+++|.+|....         
T Consensus        13 ~~v~~~~~~~~~~~vk~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~~~~~~~~~~~   92 (244)
T cd05150          13 ATVYRLDGKNPGLYLKIAPSGPTYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAALWEELEPERLV   92 (244)
T ss_pred             CeEEEEcCCCCcEEEEecCCCcccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhHhhcccCHHHHH
Confidence            67899988777888888765    4789999999884 333457788777666789999999998776442         


Q ss_pred             ----------hhcCCCCCCCC--HHHHHHHHH--------------------HHHHHHHHHhc----CCCCCeEecCCCC
Q 039626          427 ----------FSNKNEGKYLD--WKQRIQIAL--------------------DVATGLNYLHS----FTNPPHVHKDINS  470 (628)
Q Consensus       427 ----------~~~~~~~~~l~--~~~~~~i~~--------------------~ia~gL~yLH~----~~~~~iiH~dik~  470 (628)
                                |..........  +..++....                    .+...+..|-.    ...+.++|+|+.|
T Consensus        93 ~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~  172 (244)
T cd05150          93 DALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEEDLVVTHGDACL  172 (244)
T ss_pred             HHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcCceEEECCCCCC
Confidence                      11101011111  001110000                    01111222211    1235589999999


Q ss_pred             CCEEeCCCCcEEEccccccc
Q 039626          471 SNVLLDSDLRAKIANFAMAR  490 (628)
Q Consensus       471 ~NILl~~~~~~kl~Dfgla~  490 (628)
                      .|||++++....|+||+.+.
T Consensus       173 ~Nil~~~~~~~~iIDwe~a~  192 (244)
T cd05150         173 PNIIVDPGKFSGFIDLGRLG  192 (244)
T ss_pred             ccEEEeCCcEEEEEEccccc
Confidence            99999998888999998765

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>cd00118 LysM Lysin domain, found in a variety of enzymes involved in bacterial cell wall degradation

Probab=97.93  E-value=1.5e-05  Score=56.37  Aligned_cols=43  Identities=35%  Similarity=0.500  Sum_probs=38.0

Q ss_pred             eEEEecCChHHHHHhhhcCCCccHHHHHhccCCC--CccCCCcEEEEe
Q 039626          121 TYTIQNGDTYLFIANNTFQGLSTCQALEDQNGSP--TNLIIGAGVTVP  166 (628)
Q Consensus       121 ~y~V~~gdt~~~IA~~~~~~l~t~~~l~~~N~~~--~~l~~Gq~l~vp  166 (628)
                      .|+|++|||++.||.++..   +..++.+.|+..  ..+.+|+.|.||
T Consensus         2 ~~~v~~gdt~~~ia~~~~~---~~~~~~~~N~~~~~~~~~~g~~l~ip   46 (46)
T cd00118           2 TYTVKKGDTLSSIAQRYGI---SVEELLKLNGLSDPDNLQVGQKLKIP   46 (46)
T ss_pred             EEEECCCCCHHHHHHHHCc---CHHHHHHHcCCCCccccCCCCEEecC
Confidence            5999999999999988754   788899999984  789999999987

This domain may have a general peptidoglycan binding function.

>TIGR02899 spore_safA spore coat assembly protein SafA

Probab=97.93  E-value=9.5e-06  Score=57.57  Aligned_cols=40  Identities=25%  Similarity=0.305  Sum_probs=34.6

Q ss_pred             EecCChHHHHHhhhcCCCccHHHHHhccCC-C--CccCCCcEEEEe
Q 039626          124 IQNGDTYLFIANNTFQGLSTCQALEDQNGS-P--TNLIIGAGVTVP  166 (628)
Q Consensus       124 V~~gdt~~~IA~~~~~~l~t~~~l~~~N~~-~--~~l~~Gq~l~vp  166 (628)
                      |++|||+|.||++|+.   +.++|.+.|+. .  ..+.+||+|.||
T Consensus         1 v~~gdtl~~IA~~~~~---~~~~l~~~N~~~~~~~~~~~g~~l~ip   43 (44)
T TIGR02899         1 VQKGDTLWKIAKKYGV---DFDELIQANPQLSNPNLIYPGMKIKIP   43 (44)
T ss_pred             CCCCCCHHHHHHHHCc---CHHHHHHHhhcCCCCCCcCCCCEEecC
Confidence            6899999999998865   78889999974 2  579999999998

in which one of which is found in most examples of endospore-forming bacteria. Lysin motifs are repeated in many proteins.

>PRK11198 LysM domain/BON superfamily protein; Provisional

Probab=97.86  E-value=1.6e-05  Score=72.62  Aligned_cols=47  Identities=21%  Similarity=0.371  Sum_probs=41.5

Q ss_pred             eeEEEecCChHHHHHhhhcCCCccHHHHHhccC--CC--CccCCCcEEEEe
Q 039626          120 TTYTIQNGDTYLFIANNTFQGLSTCQALEDQNG--SP--TNLIIGAGVTVP  166 (628)
Q Consensus       120 ~~y~V~~gdt~~~IA~~~~~~l~t~~~l~~~N~--~~--~~l~~Gq~l~vp  166 (628)
                      ..|+|++|||+|.||.+||..-..+++|.++|+  +.  +.|++||+|.||
T Consensus        96 ~~y~Vk~GDTL~~IA~~~~g~~~~~~~I~~~N~~~l~~~~~I~pGq~L~IP  146 (147)
T PRK11198         96 QFYTVKSGDTLSAIAKKVYGNANKYNKIFEANKPMLKSPDKIYPGQVLRIP  146 (147)
T ss_pred             eEEEECCCCCHHHHHHHHcCChhhHHHHHHhhhhcCCCcCCcCcCCEEecC
Confidence            469999999999999999876667889999997  44  679999999998

>PRK10871 nlpD lipoprotein NlpD; Provisional

Probab=97.84  E-value=1.6e-05  Score=80.94  Aligned_cols=46  Identities=30%  Similarity=0.408  Sum_probs=40.8

Q ss_pred             eeEEEecCChHHHHHhhhcCCCccHHHHHhccCCC--CccCCCcEEEEeec
Q 039626          120 TTYTIQNGDTYLFIANNTFQGLSTCQALEDQNGSP--TNLIIGAGVTVPLR  168 (628)
Q Consensus       120 ~~y~V~~gdt~~~IA~~~~~~l~t~~~l~~~N~~~--~~l~~Gq~l~vp~~  168 (628)
                      .+|+||+|||||.||.++..   ++.+|.++|++.  +.|++||+|.||..
T Consensus        61 ~~y~Vk~GDTL~~IA~~~g~---~~~~La~~N~l~~p~~I~~GQ~L~i~~~  108 (319)
T PRK10871         61 STYTVKKGDTLFYIAWITGN---DFRDLAQRNNIQAPYSLNVGQTLQVGNA  108 (319)
T ss_pred             CceEECCCCHHHHHHHHHCc---CHHHHHHhcCCCCCccccCCCEEEeCCC
Confidence            46999999999999987765   899999999996  78999999999854

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=97.78  E-value=0.00032  Score=69.37  Aligned_cols=125  Identities=16%  Similarity=0.191  Sum_probs=76.1

Q ss_pred             eEEEEEEECCceEEEEEecc-----chHHHHHHHhhcCCCce--eeeeeeeecCCeEEEEEEecCCCC-hHHHh------
Q 039626          361 GSVYRGKINGGFAAIKKVNG-----DVSKEIALLNKINHSNL--IILSGVCFNEGNCYLVYEYAVNGT-LSDWV------  426 (628)
Q Consensus       361 G~Vy~g~~~g~~vavK~~~~-----~~~~E~~~l~~l~H~nI--v~l~g~~~~~~~~~lV~E~~~~gs-L~~~l------  426 (628)
                      +.||+.  .|+..++|....     +..+|.+++..+..-.+  .+.++++...+...+|||+++|.. +...+      
T Consensus        15 ~~~y~~--~~~~~VlR~~~~~~~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~~~~~~~~~~~~   92 (226)
T TIGR02172        15 GESYTH--KTGKWMLKLYNPGFDKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRSFSRIISDNPSR   92 (226)
T ss_pred             cceeEe--cCCCEEEEeCCCCCCHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccchhhhhcCCHHH
Confidence            678873  355677787654     46789999999875544  577888777777889999998863 21111      


Q ss_pred             ---------------hhcCCCCCCCCHHHHHH-HH----------HHHHH-HHHHHhcC-CCCCeEecCCCCCCEEeCCC
Q 039626          427 ---------------FSNKNEGKYLDWKQRIQ-IA----------LDVAT-GLNYLHSF-TNPPHVHKDINSSNVLLDSD  478 (628)
Q Consensus       427 ---------------~~~~~~~~~l~~~~~~~-i~----------~~ia~-gL~yLH~~-~~~~iiH~dik~~NILl~~~  478 (628)
                                     |.-....  .....+.. +.          .++.. ...+|... ..+.++|+|+.|.||+++++
T Consensus        93 ~~~l~~~la~~l~~lH~~~~~~--~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~~~Nii~~~~  170 (226)
T TIGR02172        93 LEEIAKIFAEMAKKLHSTKCDT--STFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQIGNLITSGK  170 (226)
T ss_pred             HHHHHHHHHHHHHHHhCCCCCC--CcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCCCCcEEEcCC
Confidence                           1110011  11111100 00          01111 12233221 12457899999999999988


Q ss_pred             CcEEEccccccc
Q 039626          479 LRAKIANFAMAR  490 (628)
Q Consensus       479 ~~~kl~Dfgla~  490 (628)
                      + ..+.||+.+.
T Consensus       171 ~-~~iIDwe~a~  181 (226)
T TIGR02172       171 G-TYWIDLGDFG  181 (226)
T ss_pred             C-cEEEechhcC
Confidence            8 9999998875

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=97.78  E-value=0.00022  Score=69.05  Aligned_cols=115  Identities=20%  Similarity=0.162  Sum_probs=77.5

Q ss_pred             eEEEEEEECCceEEEEEeccc----------------hHHHHHHHhhcCCC---ceeeeeeeeec-----CCeEEEEEEe
Q 039626          361 GSVYRGKINGGFAAIKKVNGD----------------VSKEIALLNKINHS---NLIILSGVCFN-----EGNCYLVYEY  416 (628)
Q Consensus       361 G~Vy~g~~~g~~vavK~~~~~----------------~~~E~~~l~~l~H~---nIv~l~g~~~~-----~~~~~lV~E~  416 (628)
                      -.|.+-..+|+..++|..+.+                ..+++..+.+++..   ..+.++.+...     ....+|+|||
T Consensus        45 ~~ValIei~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ekk~~~~~~~~~ll~EY  124 (229)
T PF06176_consen   45 NYVALIEIDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAEKKIFRYTSSYVLLMEY  124 (229)
T ss_pred             cEEEEEEECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeeeeeeccceeEEEEEEEE
Confidence            346666668899999976542                23345555555332   22333333322     2345799999


Q ss_pred             cCCCChHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEcccccccc
Q 039626          417 AVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARP  491 (628)
Q Consensus       417 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~  491 (628)
                      ++|..|.+...        ++.    .++..+..++.-||+.+   +.|+|..|+|+++++++ +++.||+..+.
T Consensus       125 IeG~~l~d~~~--------i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~~-i~iID~~~k~~  183 (229)
T PF06176_consen  125 IEGVELNDIED--------IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNNG-IRIIDTQGKRM  183 (229)
T ss_pred             ecCeecccchh--------cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECCc-EEEEECccccc
Confidence            99988876541        221    35567788899999966   99999999999998665 89999987653

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>COG3858 Predicted glycosyl hydrolase [General function prediction only]

Probab=97.77  E-value=2.5e-05  Score=80.71  Aligned_cols=90  Identities=19%  Similarity=0.128  Sum_probs=75.7

Q ss_pred             eeecCCCCCCHHHHHHHhCCChHhhhhhcCcc---ccCCcEEEEcccCccCCCCcccceeEEEecCChHHHHHhhhcCCC
Q 039626           65 TFRSQPPFNTVASISTLLGSEPSLLSQINSVS---LETNRLVIVPVNCSCSGQYYQSNTTYTIQNGDTYLFIANNTFQGL  141 (628)
Q Consensus        65 ~~~~~~~~~tl~~Ia~~~~~~~~~i~~~N~~~---~~~gq~l~vp~~c~c~~~~~~~~~~y~V~~gdt~~~IA~~~~~~l  141 (628)
                      ++-+ +||+++..|+..|+.+..+|...|.++   +.+||.+.||..-          ..|.|++|||+++||++++.  
T Consensus         3 i~~~-~pg~~~~~i~~~~~~~~~~i~~~~~~~~d~~~~~q~~~v~~~~----------~~y~~~~~d~~~Sia~~~~v--   69 (423)
T COG3858           3 IHLV-GPGDSRLIIAVYFPYTNNRIVNGNDYTNDDLVDGQTFVVPPSG----------HFYDVGPGDTLTSIARTVGV--   69 (423)
T ss_pred             EEEc-cCCceeeeehhhccccccccccccccccccccCceeEEECCcc----------eEEEecCCcchhhhhhhhcC--
Confidence            3444 469999999999999999997777666   9999999999642          46999999999999998876  


Q ss_pred             ccHHHHHhccCCC--CccCCCcEEEEeec
Q 039626          142 STCQALEDQNGSP--TNLIIGAGVTVPLR  168 (628)
Q Consensus       142 ~t~~~l~~~N~~~--~~l~~Gq~l~vp~~  168 (628)
                       |.+.+...|...  .-+.+|-.+.+|-.
T Consensus        70 -t~~~~~~m~~~~~~~~l~~~~~l~~P~~   97 (423)
T COG3858          70 -TQDSAAIMNFVICPGYLQYGLNLYIPSA   97 (423)
T ss_pred             -CHHHHHhhcccccccceeeeeEEeccCC
Confidence             778888888766  57889999999853

>PRK11198 LysM domain/BON superfamily protein; Provisional

Probab=97.74  E-value=3.5e-05  Score=70.44  Aligned_cols=45  Identities=36%  Similarity=0.521  Sum_probs=39.0

Q ss_pred             EEEEccCCCcHHHHHHHhC---CChHHHhhhcC--CCCC-Cccccceeecc
Q 039626          185 LSYLVAEGDTVSGISSRFG---VDTGEILQANS--LSGS-NIFPFTTLLIP  229 (628)
Q Consensus       185 ~~y~v~~gdtl~~ia~~f~---~~~~~l~~~N~--~~~~-~~~~~~~l~iP  229 (628)
                      .+|+|+.|||||+||++|.   .....|.++|+  +.+. .|+|||+|.||
T Consensus        96 ~~y~Vk~GDTL~~IA~~~~g~~~~~~~I~~~N~~~l~~~~~I~pGq~L~IP  146 (147)
T PRK11198         96 QFYTVKSGDTLSAIAKKVYGNANKYNKIFEANKPMLKSPDKIYPGQVLRIP  146 (147)
T ss_pred             eEEEECCCCCHHHHHHHHcCChhhHHHHHHhhhhcCCCcCCcCcCCEEecC
Confidence            4799999999999999985   34668999998  6655 89999999998

>TIGR02907 spore_VI_D stage VI sporulation protein D

Probab=97.74  E-value=3.5e-05  Score=77.59  Aligned_cols=46  Identities=22%  Similarity=0.156  Sum_probs=41.5

Q ss_pred             cceeEEEecCChHHHHHhhhcCCCccHHHHHhccCCC-CccCCCcEEEEe
Q 039626          118 SNTTYTIQNGDTYLFIANNTFQGLSTCQALEDQNGSP-TNLIIGAGVTVP  166 (628)
Q Consensus       118 ~~~~y~V~~gdt~~~IA~~~~~~l~t~~~l~~~N~~~-~~l~~Gq~l~vp  166 (628)
                      ....|+|++|||+|.||++|+.   +++.|+++|++. +.|.+||.|.||
T Consensus       292 ~~~~YiVq~GDTL~sIAkRYGV---SV~~L~r~N~L~~~~L~~GQ~L~IP  338 (338)
T TIGR02907       292 KLRMCIVQEGDTIETIAERYEI---SVSQLIRHNQLEDFEVNEGQILYIP  338 (338)
T ss_pred             ccEEEEECCCCCHHHHHHHHCc---CHHHHHHHhCCCccccCCCCEEEeC
Confidence            3457999999999999998876   899999999988 899999999998

SpoVID, the stage VI sporulation protein D, is restricted to endospore-forming members of the bacteria, all of which are found among the Firmicutes. It is widely distributed but not quite universal in this group. Between well-conserved N-terminal and C-terminal domains is a poorly conserved, low-complexity region of variable length, rich enough in glutamic acid to cause spurious BLAST search results unless a filter is used. The seed alignment for this model was trimmed, in effect, by choosing member sequences in which these regions are relatively short. SpoVID is involved in spore coat assembly by the mother cell compartment late in the process of sporulation.

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=97.46  E-value=3.8e-05  Score=83.37  Aligned_cols=170  Identities=19%  Similarity=0.170  Sum_probs=119.3

Q ss_pred             eEEEEEEECCc-eEEEEEecc--chHHHHHHHhhcCCCc-eeeeeeeeecCCeEEEEEEecCCC-ChHHHhhhcCCCCCC
Q 039626          361 GSVYRGKINGG-FAAIKKVNG--DVSKEIALLNKINHSN-LIILSGVCFNEGNCYLVYEYAVNG-TLSDWVFSNKNEGKY  435 (628)
Q Consensus       361 G~Vy~g~~~g~-~vavK~~~~--~~~~E~~~l~~l~H~n-Iv~l~g~~~~~~~~~lV~E~~~~g-sL~~~l~~~~~~~~~  435 (628)
                      +++||.+-..+ ....+.+..  ...-++++|.+++||| .++.++-+..+...++++++..+| +-..-.   ......
T Consensus       256 tknpKkRptaeklL~h~fvs~~l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~~~~~---~~se~~  332 (829)
T KOG0576|consen  256 TKNPKKRPTAEKLLQHPFVSQTLSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSSALEM---TVSEIA  332 (829)
T ss_pred             cCCCccCCChhhheeceeeccchhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCccccccC---ChhhHh
Confidence            66677665222 223454444  3455899999999999 677777777777889999999776 211110   011122


Q ss_pred             CCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCCccccCcc
Q 039626          436 LDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPE  515 (628)
Q Consensus       436 l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~Y~APE  515 (628)
                      +...+...+...-.++++|||+..   =+|+|    ||+..+ +..|..||+....+....    ..+...+++.++|||
T Consensus       333 ~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~----~~~t~~~~~~~~~pe  400 (829)
T KOG0576|consen  333 LEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQLTRTM----KPRTAIGTPEPLAPE  400 (829)
T ss_pred             hhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcccCccc----ccccCCCCCCCCCch
Confidence            344455567777889999999842   48888    777665 678999999887665432    345568999999999


Q ss_pred             ccccCCCCcccccHHHHHHHHHHHhCCCcc
Q 039626          516 YLENGLVSTKLDVYAFGVLILEMLTGKEAA  545 (628)
Q Consensus       516 ~l~~~~~s~k~DV~SfGvvl~ELltG~~p~  545 (628)
                      ......+..+.|+|+.|+--.++--|-+|-
T Consensus       401 v~~~~~~~~~p~~~~~~~~~~~~ap~~pPr  430 (829)
T KOG0576|consen  401 VIQENTIDGCPDSGSLAVSAIQMAPGLPPR  430 (829)
T ss_pred             hhcccccccCCCccCCCcchhhcCCCCCCC
Confidence            999999999999999998766766665543

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=97.42  E-value=0.0012  Score=64.84  Aligned_cols=130  Identities=22%  Similarity=0.220  Sum_probs=76.1

Q ss_pred             eEEEEEEECCceEEEEEeccc-----hHHHHHHHhhcCCCc--eeeeeeeeec---CCeEEEEEEecCCCChHH------
Q 039626          361 GSVYRGKINGGFAAIKKVNGD-----VSKEIALLNKINHSN--LIILSGVCFN---EGNCYLVYEYAVNGTLSD------  424 (628)
Q Consensus       361 G~Vy~g~~~g~~vavK~~~~~-----~~~E~~~l~~l~H~n--Iv~l~g~~~~---~~~~~lV~E~~~~gsL~~------  424 (628)
                      +.||+...+++.+++|.....     +.+|..++..+....  +.+++.++..   ....+++|+++++..+..      
T Consensus        11 n~~~~v~~~~~~~vlK~~~~~~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g~~~~~~~~~~~   90 (239)
T PF01636_consen   11 NRVYRVTTDDGRYVLKFYRPPDAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPGRPLDDELSPEQ   90 (239)
T ss_dssp             SEEEEEEETTSEEEEEEESSHHHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESSEEHHHTSTHHH
T ss_pred             eeEEEEEECCcEEEEEEeCCCCCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEeccccccccccccc
Confidence            689999998889999998653     567888988885433  4566665433   235799999999988877      


Q ss_pred             ----------Hh---hhcCCCCCCCCHHH---------HHHH------------HHHHHH-HHHHHhc----CCCCCeEe
Q 039626          425 ----------WV---FSNKNEGKYLDWKQ---------RIQI------------ALDVAT-GLNYLHS----FTNPPHVH  465 (628)
Q Consensus       425 ----------~l---~~~~~~~~~l~~~~---------~~~i------------~~~ia~-gL~yLH~----~~~~~iiH  465 (628)
                                .+   +..........+..         ....            ...+.. .++.+++    .....++|
T Consensus        91 ~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~H  170 (239)
T PF01636_consen   91 RPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEALLPKPLPPVLIH  170 (239)
T ss_dssp             HHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHCCSCEEEE-
T ss_pred             cccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhhhccCCCcEEEE
Confidence                      11   11111111111111         0000            112222 3333332    12356999


Q ss_pred             cCCCCCCEEeC-CCCcEEEccccccc
Q 039626          466 KDINSSNVLLD-SDLRAKIANFAMAR  490 (628)
Q Consensus       466 ~dik~~NILl~-~~~~~kl~Dfgla~  490 (628)
                      +|+.+.|||++ +++++.|.||+.+.
T Consensus       171 gD~~~~Nil~~~~~~~i~iID~e~a~  196 (239)
T PF01636_consen  171 GDLHPGNILVDPSDGRIGIIDFEDAG  196 (239)
T ss_dssp             SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred             eccccccceeeeccceeEEEecccce
Confidence            99999999999 66777899998764

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>smart00257 LysM Lysin motif

Probab=97.41  E-value=0.00024  Score=49.41  Aligned_cols=42  Identities=31%  Similarity=0.384  Sum_probs=35.2

Q ss_pred             eEEEecCChHHHHHhhhcCCCccHHHHHhccCCC--CccCCCcEEEE
Q 039626          121 TYTIQNGDTYLFIANNTFQGLSTCQALEDQNGSP--TNLIIGAGVTV  165 (628)
Q Consensus       121 ~y~V~~gdt~~~IA~~~~~~l~t~~~l~~~N~~~--~~l~~Gq~l~v  165 (628)
                      .|+|++|||++.||.+++.   +..++.+.|+..  ..+.+|+.|.|
T Consensus         1 ~~~v~~gdt~~~ia~~~~~---~~~~~~~~N~~~~~~~~~~g~~l~i   44 (44)
T smart00257        1 TYTVKKGDTLSSIARRYGI---SVSDLLELNNILDPDNLQVGQKLKI   44 (44)
T ss_pred             CeEeCCCCCHHHHHHHhCC---CHHHHHHHcCCCCccccCCCCEEeC
Confidence            3899999999999987765   668899999953  78999998864

>COG1388 LytE FOG: LysM repeat [Cell envelope biogenesis, outer membrane]

Probab=97.33  E-value=0.00027  Score=62.81  Aligned_cols=45  Identities=29%  Similarity=0.429  Sum_probs=41.7

Q ss_pred             eeEEEecCChHHHHHhhhcCCCccHHHHHhccCCC-CccCCCcEEEEee
Q 039626          120 TTYTIQNGDTYLFIANNTFQGLSTCQALEDQNGSP-TNLIIGAGVTVPL  167 (628)
Q Consensus       120 ~~y~V~~gdt~~~IA~~~~~~l~t~~~l~~~N~~~-~~l~~Gq~l~vp~  167 (628)
                      .+|+|++||||+.||++++.   ++.+|++.|.+. +.+++||.|.+|.
T Consensus        67 ~~~~V~~gdtL~~Ia~~~~~---tv~~l~~~n~l~~~~i~~gq~l~~~~  112 (124)
T COG1388          67 VTYTVKKGDTLSKIARKYGV---TVAELKQLNNLSSDKIKVGQKLKLPV  112 (124)
T ss_pred             ceEEEecCCCHHHHHHHhCC---CHHHHHHHhccCCCceecCcEEEEec
Confidence            46999999999999998886   888899999999 8999999999997

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=97.21  E-value=0.0058  Score=60.04  Aligned_cols=122  Identities=20%  Similarity=0.214  Sum_probs=81.4

Q ss_pred             eEEEEEEE-CCceEEEEEeccc-------------------------------hHHHHHHHhhcCC--Cceeeeeeeeec
Q 039626          361 GSVYRGKI-NGGFAAIKKVNGD-------------------------------VSKEIALLNKINH--SNLIILSGVCFN  406 (628)
Q Consensus       361 G~Vy~g~~-~g~~vavK~~~~~-------------------------------~~~E~~~l~~l~H--~nIv~l~g~~~~  406 (628)
                      ..||+|.- ++..+|+|+.+..                               ..+|..-|.++..  -.+.+.+++.  
T Consensus        62 A~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP~Pi~~~--  139 (268)
T COG1718          62 ANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVPEPIAFR--  139 (268)
T ss_pred             eEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCCCceeec--
Confidence            57999886 6889999987531                               1357888887743  3334455443  


Q ss_pred             CCeEEEEEEecCCCChHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccc
Q 039626          407 EGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANF  486 (628)
Q Consensus       407 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Df  486 (628)
                        +-.|||||+....+    -...-..-.+.......+..++++.+.-|-..  .+++|+||..-|||+. ++.+.|+||
T Consensus       140 --~nVLvMEfIg~~g~----pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~--a~LVHgDLSEyNiL~~-~~~p~iID~  210 (268)
T COG1718         140 --NNVLVMEFIGDDGL----PAPRLKDVPLELEEAEGLYEDVVEYMRRLYKE--AGLVHGDLSEYNILVH-DGEPYIIDV  210 (268)
T ss_pred             --CCeEEEEeccCCCC----CCCCcccCCcCchhHHHHHHHHHHHHHHHHHh--cCcccccchhhheEEE-CCeEEEEEC
Confidence              24799999954311    00000111122224556777788888777652  3599999999999999 889999999


Q ss_pred             cccccCC
Q 039626          487 AMARPAE  493 (628)
Q Consensus       487 gla~~~~  493 (628)
                      |-|....
T Consensus       211 ~QaV~~~  217 (268)
T COG1718         211 SQAVTID  217 (268)
T ss_pred             ccccccC
Confidence            9887664

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.18  E-value=0.0037  Score=61.99  Aligned_cols=59  Identities=15%  Similarity=0.216  Sum_probs=40.1

Q ss_pred             eEEEEEEEC---CceEEEEEecc------chHHHHHHHhhcCCCcee-eeeeeeecCCeEEEEEEecCCCChH
Q 039626          361 GSVYRGKIN---GGFAAIKKVNG------DVSKEIALLNKINHSNLI-ILSGVCFNEGNCYLVYEYAVNGTLS  423 (628)
Q Consensus       361 G~Vy~g~~~---g~~vavK~~~~------~~~~E~~~l~~l~H~nIv-~l~g~~~~~~~~~lV~E~~~~gsL~  423 (628)
                      ..+|+....   ++.+++|....      +..+|+.+++.+...+++ ++++.+. +   .++|||++|.++.
T Consensus        12 N~~~~v~~~~~~~~~~vlR~~~~~~~~~~d~~~E~~~~~~l~~~gl~P~v~~~~~-~---~~l~e~i~G~~l~   80 (235)
T cd05157          12 NKLVKVSNKEDNQDAVLVRVYGNKTELIIDRERELRIHKLLSKHGLAPKLYATFQ-N---GLIYEFIPGRTLE   80 (235)
T ss_pred             ceEEEEEcCCCCCCeEEEEEccCCccceecHHHHHHHHHHHHhCCCCCeEEEEeC-C---cEEEEeeCCCcCC
Confidence            678888775   46788886643      345799999999654444 4444332 2   3799999987653

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>PRK10593 hypothetical protein; Provisional

Probab=97.14  E-value=0.0054  Score=63.33  Aligned_cols=62  Identities=13%  Similarity=0.053  Sum_probs=46.0

Q ss_pred             eEEEEEEECCceEEEEEecc-----chHHHHHHHhhcCC---Cceeeeeeeeec---CCeEEEEEEecCCCCh
Q 039626          361 GSVYRGKINGGFAAIKKVNG-----DVSKEIALLNKINH---SNLIILSGVCFN---EGNCYLVYEYAVNGTL  422 (628)
Q Consensus       361 G~Vy~g~~~g~~vavK~~~~-----~~~~E~~~l~~l~H---~nIv~l~g~~~~---~~~~~lV~E~~~~gsL  422 (628)
                      +.||+-...++.+.+|..+.     .+..|.+.|+.+..   -.+.+++++|..   .+..+||||+++++++
T Consensus        28 ~~vy~~~~~~~~~~~k~~~~~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i~G~~~  100 (297)
T PRK10593         28 AALWALYDSQGNPMPLMARSFSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERLRGVSV  100 (297)
T ss_pred             eeEEEEEcCCCCEEEEEecccccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEeccCCEec
Confidence            67888877666666666543     46789999998853   356788888764   3668999999998765

>PLN02876 acyl-CoA dehydrogenase

Probab=97.12  E-value=0.0042  Score=73.31  Aligned_cols=132  Identities=15%  Similarity=0.278  Sum_probs=79.8

Q ss_pred             eEEEEEEECC----ceEEEEEec--------cchHHHHHHHhhcC-CCce--eeeeeeeecC---CeEEEEEEecCCCCh
Q 039626          361 GSVYRGKING----GFAAIKKVN--------GDVSKEIALLNKIN-HSNL--IILSGVCFNE---GNCYLVYEYAVNGTL  422 (628)
Q Consensus       361 G~Vy~g~~~g----~~vavK~~~--------~~~~~E~~~l~~l~-H~nI--v~l~g~~~~~---~~~~lV~E~~~~gsL  422 (628)
                      +.+|+-...+    ..+++|+..        ..+.+|.++|+.+. |.++  .+++++|.+.   +..|+||||++|..+
T Consensus        52 n~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flVME~v~G~~~  131 (822)
T PLN02876         52 NPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYIMEYLEGRIF  131 (822)
T ss_pred             CceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEEEEecCCccc
Confidence            5678776643    356777653        24678999999995 6665  6888888764   467999999987643


Q ss_pred             HH--------------------H---hhhcCCC-------CCCCCHH--HHHHH---------------HHHHHHHHHHH
Q 039626          423 SD--------------------W---VFSNKNE-------GKYLDWK--QRIQI---------------ALDVATGLNYL  455 (628)
Q Consensus       423 ~~--------------------~---l~~~~~~-------~~~l~~~--~~~~i---------------~~~ia~gL~yL  455 (628)
                      .+                    .   ||.-...       +....+.  +...+               ...+...+++|
T Consensus       132 ~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~~~~~l~~wL  211 (822)
T PLN02876        132 VDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPRNPKMLELIDWL  211 (822)
T ss_pred             CCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCCChhHHHHHHHH
Confidence            22                    1   1211000       1111111  11111               11233446677


Q ss_pred             hcCC--------CCCeEecCCCCCCEEeCC-CCc-EEEccccccccC
Q 039626          456 HSFT--------NPPHVHKDINSSNVLLDS-DLR-AKIANFAMARPA  492 (628)
Q Consensus       456 H~~~--------~~~iiH~dik~~NILl~~-~~~-~kl~Dfgla~~~  492 (628)
                      ....        .+.++|+|+++.||+++. +.+ .-|.||.++..-
T Consensus       212 ~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~G  258 (822)
T PLN02876        212 RENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLG  258 (822)
T ss_pred             HhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccC
Confidence            4422        134999999999999985 333 578999887654

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=97.10  E-value=0.0012  Score=76.78  Aligned_cols=194  Identities=19%  Similarity=0.215  Sum_probs=130.2

Q ss_pred             HHHHHHhhcCCCceeeeeeeeecCCeE----EEEEEecCCCChHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC
Q 039626          384 KEIALLNKINHSNLIILSGVCFNEGNC----YLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFT  459 (628)
Q Consensus       384 ~E~~~l~~l~H~nIv~l~g~~~~~~~~----~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~  459 (628)
                      .|+..+.++.|+|++.+++|...+...    .+..|++..-++...+.    .-..++....+.+..+..+||.|+|+..
T Consensus       231 ~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q----~v~~i~~~~~r~~~~~~~~GL~~~h~~~  306 (1351)
T KOG1035|consen  231 IELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQ----SVGSIPLETLRILHQKLLEGLAYLHSLS  306 (1351)
T ss_pred             HHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHh----hccccCHHHHHHHHHHHhhhHHHHHHhc
Confidence            477888899999999999998765332    34566777777777663    2345777888889999999999999953


Q ss_pred             CCCeEecCCCCC---CEEeCCCCcEEEc--cccccccCCCCCCcceeeecccCCccccCccccccCCCCc--ccccHHHH
Q 039626          460 NPPHVHKDINSS---NVLLDSDLRAKIA--NFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVST--KLDVYAFG  532 (628)
Q Consensus       460 ~~~iiH~dik~~---NILl~~~~~~kl~--Dfgla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~--k~DV~SfG  532 (628)
                         ..|.-+..+   +--.+..+...++  ||+..+...+....    ........+.++|.........  +.|+|.+|
T Consensus       307 ---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~----~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lg  379 (1351)
T KOG1035|consen  307 ---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS----FSDLLAEIRNADEDLKENTAKKSRLTDLWCLG  379 (1351)
T ss_pred             ---cceeEEecccccccccCccceeecchhhhcccccCCCcccc----hhhcCccccccccccccccchhhhhhHHHHHH
Confidence               455444444   4445666777777  88888766544322    1223455678888776654443  47999999


Q ss_pred             HHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHH
Q 039626          533 VLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMY  612 (628)
Q Consensus       533 vvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~  612 (628)
                      ..+..+..|..+....         ..             ...+++.    ...    ..+.+...+|+..++++|++..
T Consensus       380 ll~~~~~~~~~i~~~~---------~~-------------~~~~l~~----~~~----~~~~d~~~~~~~~~~~~Rl~~~  429 (1351)
T KOG1035|consen  380 LLLLQLSQGEDISEKS---------AV-------------PVSLLDV----LST----SELLDALPKCLDEDSEERLSAL  429 (1351)
T ss_pred             HHHhhhhhcCcccccc---------cc-------------hhhhhcc----ccc----hhhhhhhhhhcchhhhhccchh
Confidence            9999999887542210         00             0111110    111    1356778889999999999999


Q ss_pred             HHHHHH
Q 039626          613 EIEHSL  618 (628)
Q Consensus       613 ev~~~L  618 (628)
                      +++...
T Consensus       430 ~ll~~~  435 (1351)
T KOG1035|consen  430 ELLTHP  435 (1351)
T ss_pred             hhhhch
Confidence            887643

>TIGR02721 ycfN_thiK thiamine kinase

Probab=96.99  E-value=0.0094  Score=60.04  Aligned_cols=126  Identities=17%  Similarity=0.121  Sum_probs=74.9

Q ss_pred             eEEEEEEECCceEEEEEecc-------chHHHHHHHhhcCCCcee-eeeeeeecCCeEEEEEEecCCCChHHH-------
Q 039626          361 GSVYRGKINGGFAAIKKVNG-------DVSKEIALLNKINHSNLI-ILSGVCFNEGNCYLVYEYAVNGTLSDW-------  425 (628)
Q Consensus       361 G~Vy~g~~~g~~vavK~~~~-------~~~~E~~~l~~l~H~nIv-~l~g~~~~~~~~~lV~E~~~~gsL~~~-------  425 (628)
                      +.+|+...+++.+++|....       +..+|.++++.+....++ ++++.+.    -++||||++|..+...       
T Consensus        10 n~~y~~~~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~~~~~~~~~   85 (256)
T TIGR02721        10 NRSWRIEHPGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITLDQFVALDL   85 (256)
T ss_pred             CCeEEEEeCCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcccccccccCchh
Confidence            67888887888888886432       457899999999754443 4444432    3689999998765421       


Q ss_pred             ----------hhhcCCCCCCCCHHHHH-HHH---------HHHHHHHHHHhcC-----CCCCeEecCCCCCCEEeCCCCc
Q 039626          426 ----------VFSNKNEGKYLDWKQRI-QIA---------LDVATGLNYLHSF-----TNPPHVHKDINSSNVLLDSDLR  480 (628)
Q Consensus       426 ----------l~~~~~~~~~l~~~~~~-~i~---------~~ia~gL~yLH~~-----~~~~iiH~dik~~NILl~~~~~  480 (628)
                                ||........++...++ ...         ..+..-+..+-..     ....++|+|+.|.||++++++ 
T Consensus        86 ~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~Nil~~~~~-  164 (256)
T TIGR02721        86 LLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYNLVVTPQG-  164 (256)
T ss_pred             HHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCcEEEeCCC-
Confidence                      12211112222222211 111         1111112222111     123589999999999999877 


Q ss_pred             EEEcccccccc
Q 039626          481 AKIANFAMARP  491 (628)
Q Consensus       481 ~kl~Dfgla~~  491 (628)
                      +.+.||..+..
T Consensus       165 ~~lIDwE~a~~  175 (256)
T TIGR02721       165 LKLIDWEYASD  175 (256)
T ss_pred             CEEEeccccCc
Confidence            78999987753

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=96.99  E-value=0.0036  Score=62.18  Aligned_cols=31  Identities=19%  Similarity=0.370  Sum_probs=26.3

Q ss_pred             CCeEecCCCCCCEEeCCCCcEEEcccccccc
Q 039626          461 PPHVHKDINSSNVLLDSDLRAKIANFAMARP  491 (628)
Q Consensus       461 ~~iiH~dik~~NILl~~~~~~kl~Dfgla~~  491 (628)
                      +.++|+|+.+.||+++++...-|.||+.+..
T Consensus       164 ~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~  194 (235)
T cd05155         164 PVWFHGDLAPGNLLVQDGRLSAVIDFGCLGV  194 (235)
T ss_pred             ceEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence            4489999999999999876667999998753

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>PF04225 OapA: Opacity-associated protein A LysM-like domain; InterPro: IPR007340 This entry includes the Haemophilus influenzae opacity-associated protein

Probab=96.94  E-value=0.00065  Score=55.74  Aligned_cols=48  Identities=27%  Similarity=0.317  Sum_probs=33.9

Q ss_pred             eEEEecCChHHHHHhhhcCCCccHHHHHhccCCC---CccCCCcEEEEeec
Q 039626          121 TYTIQNGDTYLFIANNTFQGLSTCQALEDQNGSP---TNLIIGAGVTVPLR  168 (628)
Q Consensus       121 ~y~V~~gdt~~~IA~~~~~~l~t~~~l~~~N~~~---~~l~~Gq~l~vp~~  168 (628)
                      .|+|++||||..|=++.+.+..++.+|.+++...   ..|+|||+|.+-+.
T Consensus         4 ~~~V~~GDtLs~iF~~~gls~~dl~~v~~~~~~~k~L~~L~pGq~l~f~~d   54 (85)
T PF04225_consen    4 EYTVKSGDTLSTIFRRAGLSASDLYAVLEADGEAKPLTRLKPGQTLEFQLD   54 (85)
T ss_dssp             EEE--TT--HHHHHHHTT--HHHHHHHHHHGGGT--GGG--TT-EEEEEE-
T ss_pred             EEEECCCCcHHHHHHHcCCCHHHHHHHHhccCccchHhhCCCCCEEEEEEC
Confidence            6999999999999999999999999999988543   78999999999774

This protein is required for efficient nasopharyngeal mucosal colonization, and its expression is associated with a distinctive transparent colony phenotype. OapA is thought to be a secreted protein, and its expression exhibits high-frequency phase variation [].; PDB: 2GU1_A.

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=96.80  E-value=0.0061  Score=62.75  Aligned_cols=130  Identities=16%  Similarity=0.149  Sum_probs=79.7

Q ss_pred             eEEEEEEECCceEEEEEecc----chHHHHHHHhhcCCCc--eeeeeeee------ecCCeEEEEEEecCCCChHH----
Q 039626          361 GSVYRGKINGGFAAIKKVNG----DVSKEIALLNKINHSN--LIILSGVC------FNEGNCYLVYEYAVNGTLSD----  424 (628)
Q Consensus       361 G~Vy~g~~~g~~vavK~~~~----~~~~E~~~l~~l~H~n--Iv~l~g~~------~~~~~~~lV~E~~~~gsL~~----  424 (628)
                      ..+|+...+++.+++|....    +...|++++..+++.+  +.+++...      ..++..++|++|++|..+..    
T Consensus        28 n~~y~v~~~~~~~vLr~~~~~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~i~G~~~~~~~~~  107 (296)
T cd05153          28 NTNYFVTTDSGRYVLTLFEKVSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEFLAGEHLTRPTAA  107 (296)
T ss_pred             cceEEEEeCCCcEEEEEcCCCChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEeCCCCCCCCCCHH
Confidence            46899888778899998653    3556888888885443  34444321      22345689999999876532    


Q ss_pred             H----------hhhcCC-------CCCCCCHHHHHH----------HHHHHHHHHHHHhc----CCCCCeEecCCCCCCE
Q 039626          425 W----------VFSNKN-------EGKYLDWKQRIQ----------IALDVATGLNYLHS----FTNPPHVHKDINSSNV  473 (628)
Q Consensus       425 ~----------l~~~~~-------~~~~l~~~~~~~----------i~~~ia~gL~yLH~----~~~~~iiH~dik~~NI  473 (628)
                      .          +|....       ......|.....          ....+...+.++..    .....++|+|+.|.||
T Consensus       108 ~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Ni  187 (296)
T cd05153         108 HCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPRGVIHADLFRDNV  187 (296)
T ss_pred             HHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCCcCCccCcCcccE
Confidence            0          111100       011223433211          11223344455543    1124599999999999


Q ss_pred             EeCCCCcEEEccccccc
Q 039626          474 LLDSDLRAKIANFAMAR  490 (628)
Q Consensus       474 Ll~~~~~~kl~Dfgla~  490 (628)
                      +++++....|.||+.+.
T Consensus       188 l~~~~~~~~iIDfe~a~  204 (296)
T cd05153         188 LFDGDELSGVIDFYFAC  204 (296)
T ss_pred             EEeCCceEEEeehhhhc
Confidence            99998778999998765

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=96.65  E-value=0.012  Score=54.87  Aligned_cols=113  Identities=20%  Similarity=0.181  Sum_probs=76.6

Q ss_pred             eEEEEEEECCceEEEEEecc-----chHHHHHHHhhcCCCcee-eeeeeeecCCeEEEEEEecCCCChHHHhhhcCCCCC
Q 039626          361 GSVYRGKINGGFAAIKKVNG-----DVSKEIALLNKINHSNLI-ILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGK  434 (628)
Q Consensus       361 G~Vy~g~~~g~~vavK~~~~-----~~~~E~~~l~~l~H~nIv-~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~  434 (628)
                      |.||.|.|.|..+|+|+.+.     .+.+|.++|..++--++- +++.|..    -++.|||+.|-.|.++-..      
T Consensus        36 s~Vyl~~~~~~~~a~Kvrr~ds~r~~l~kEakiLeil~g~~~~p~vy~yg~----~~i~me~i~G~~L~~~~~~------  105 (201)
T COG2112          36 SVVYLGEWRGGEVALKVRRRDSPRRNLEKEAKILEILAGEGVTPEVYFYGE----DFIRMEYIDGRPLGKLEIG------  105 (201)
T ss_pred             cEEEEeeccCceEEEEEecCCcchhhHHHHHHHHHHhhhcCCCceEEEech----hhhhhhhhcCcchhhhhhc------
Confidence            78999999999999998875     477899999999877765 4554432    2455999988888876521      


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCC-CCCEEeCCCCcEEEcccccccc
Q 039626          435 YLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDIN-SSNVLLDSDLRAKIANFAMARP  491 (628)
Q Consensus       435 ~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik-~~NILl~~~~~~kl~Dfgla~~  491 (628)
                       .+-.+.+    .+++.---|..   .+|-|..|. |..+++-.+..+.|+||.-|+.
T Consensus       106 -~~rk~l~----~vlE~a~~LD~---~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~  155 (201)
T COG2112         106 -GDRKHLL----RVLEKAYKLDR---LGIEHGELSRPWKNVLVNDRDVYIIDFDSATF  155 (201)
T ss_pred             -ccHHHHH----HHHHHHHHHHH---hccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence             1222333    33333223333   347888776 3444444455999999998874

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=96.58  E-value=0.014  Score=60.41  Aligned_cols=126  Identities=21%  Similarity=0.220  Sum_probs=75.1

Q ss_pred             eEEEEEEEC--------CceEEEEEecc------chHHHHHHHhhcCCCcee-eeeeeeecCCeEEEEEEecCCCChHHH
Q 039626          361 GSVYRGKIN--------GGFAAIKKVNG------DVSKEIALLNKINHSNLI-ILSGVCFNEGNCYLVYEYAVNGTLSDW  425 (628)
Q Consensus       361 G~Vy~g~~~--------g~~vavK~~~~------~~~~E~~~l~~l~H~nIv-~l~g~~~~~~~~~lV~E~~~~gsL~~~  425 (628)
                      ..+|+....        ++.+++|....      +...|.+++..+...++. ++++++. +   .+|+||++|..+...
T Consensus        12 N~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~-~---~~v~e~i~G~~l~~~   87 (302)
T cd05156          12 NAVYKVSLPDEDALSDEPRKVLLRVYGQSVELLIDRERELVVFARLSERNLGPKLYGIFP-N---GRIEEFIPSRTLTTE   87 (302)
T ss_pred             ceeEEEEcCCcccccCCCCeEEEEEecCCCcceechHHHHHHHHHHHhCCCCCceEEEeC-C---CchhheeCCCcCCHh
Confidence            578887764        36788887654      356899999988654444 5555553 2   358999988776431


Q ss_pred             -----------------hhhcCCC--C-----CCCCHHHHHHH--------------------------HHHHHHHHHHH
Q 039626          426 -----------------VFSNKNE--G-----KYLDWKQRIQI--------------------------ALDVATGLNYL  455 (628)
Q Consensus       426 -----------------l~~~~~~--~-----~~l~~~~~~~i--------------------------~~~ia~gL~yL  455 (628)
                                       +|.....  .     ...-|....++                          ...+..-+.+|
T Consensus        88 ~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  167 (302)
T cd05156          88 ELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLEDEAKYLRFL  167 (302)
T ss_pred             HcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHHHHHHHHHHH
Confidence                             1211111  0     01112111111                          11222233344


Q ss_pred             hc------CCCCCeEecCCCCCCEEeCCC----CcEEEccccccc
Q 039626          456 HS------FTNPPHVHKDINSSNVLLDSD----LRAKIANFAMAR  490 (628)
Q Consensus       456 H~------~~~~~iiH~dik~~NILl~~~----~~~kl~Dfgla~  490 (628)
                      ..      .....++|+|+.+.|||++++    +.++++||..+.
T Consensus       168 ~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~  212 (302)
T cd05156         168 LESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS  212 (302)
T ss_pred             HhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence            32      123568999999999999985    889999998875

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=96.41  E-value=0.00077  Score=79.92  Aligned_cols=158  Identities=13%  Similarity=0.041  Sum_probs=112.6

Q ss_pred             HHHHHhhcCCCceeeeeeeee--cCCeEEEEEEecCCCChHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCC--
Q 039626          385 EIALLNKINHSNLIILSGVCF--NEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTN--  460 (628)
Q Consensus       385 E~~~l~~l~H~nIv~l~g~~~--~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~--  460 (628)
                      |.+.+++..|+++.....=..  +..+.+.+++|+.+|.+.+.|.....+...+...-....-.+...+..-.|+..+  
T Consensus      1279 e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg 1358 (2724)
T KOG1826|consen 1279 ERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLG 1358 (2724)
T ss_pred             hhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCC
Confidence            444555668988876554433  2345689999999999999997655554445443333333332555555554332  


Q ss_pred             CCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCCccccCccccccCCCCcccccHHHHHHHHHHHh
Q 039626          461 PPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT  540 (628)
Q Consensus       461 ~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELlt  540 (628)
                      .--+|+++|+-|.+|..+.++|++++|+.+.....   ........+++-|+.|+....-.++.|+|+|..|+-++++--
T Consensus      1359 ~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~---~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~ 1435 (2724)
T KOG1826|consen 1359 NTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPV---LSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSD 1435 (2724)
T ss_pred             ccchhhhhhhhccceecCCcccccccccccccCch---HhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhc
Confidence            33689999999999999999999999999833221   112344578889999999988899999999999999999988


Q ss_pred             CCCcc
Q 039626          541 GKEAA  545 (628)
Q Consensus       541 G~~p~  545 (628)
                      |..++
T Consensus      1436 ~n~~f 1440 (2724)
T KOG1826|consen 1436 GNAYF 1440 (2724)
T ss_pred             ccHHH
Confidence            87554

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	628
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		1e-40
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		4e-39
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		2e-28
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		2e-28
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		2e-28
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		7e-27
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		7e-26
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		1e-25
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		5e-25
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		7e-25
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		1e-19
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		2e-18
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		4e-18
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		5e-18
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		7e-18
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		9e-18
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		9e-18
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		1e-17
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		1e-17
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		1e-17
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		1e-17
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		2e-17
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		2e-17
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		2e-17
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		2e-17
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		2e-17
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		3e-17
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		3e-17
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		4e-17
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		4e-17
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		5e-17
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		8e-17
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		9e-17
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		2e-16
3a7f_A	303	Human Mst3 Kinase Length = 303		2e-16
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		3e-16
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		3e-16
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		3e-16
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		5e-16
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		6e-16
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		6e-16
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		1e-15
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		2e-15
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		2e-15
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		3e-15
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		3e-15
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		4e-15
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-15
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		5e-15
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		5e-15
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		5e-15
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		5e-15
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		5e-15
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		5e-15
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		5e-15
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		6e-15
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		6e-15
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		6e-15
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		6e-15
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		6e-15
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		6e-15
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		7e-15
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		7e-15
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		7e-15
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		8e-15
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		8e-15
2pl0_A	289	Lck Bound To Imatinib Length = 289		1e-14
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		1e-14
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		1e-14
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		1e-14
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		1e-14
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		1e-14
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-14
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		1e-14
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		1e-14
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		2e-14
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		2e-14
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		2e-14
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		2e-14
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		2e-14
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		2e-14
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		2e-14
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		2e-14
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		2e-14
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		2e-14
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		2e-14
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		2e-14
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		2e-14
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		2e-14
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		2e-14
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		2e-14
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		2e-14
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		2e-14
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		2e-14
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		2e-14
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		3e-14
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		3e-14
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		3e-14
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		3e-14
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		3e-14
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		3e-14
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		3e-14
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		3e-14
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		3e-14
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-14
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-14
1fvr_A	327	Tie2 Kinase Domain Length = 327		3e-14
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		3e-14
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		3e-14
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		4e-14
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		4e-14
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		4e-14
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		4e-14
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		4e-14
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-14
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		4e-14
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		4e-14
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		4e-14
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		4e-14
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		5e-14
3a4o_X	286	Lyn Kinase Domain Length = 286		5e-14
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		5e-14
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		5e-14
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		5e-14
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		5e-14
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		6e-14
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		6e-14
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		7e-14
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		7e-14
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		7e-14
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		7e-14
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		8e-14
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		9e-14
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		9e-14
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		9e-14
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		9e-14
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		9e-14
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		9e-14
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		1e-13
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		1e-13
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		1e-13
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		1e-13
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		1e-13
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		1e-13
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		1e-13
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		1e-13
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		1e-13
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		1e-13
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-13
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		2e-13
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		2e-13
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		2e-13
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-13
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		2e-13
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		2e-13
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-13
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-13
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		2e-13
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		2e-13
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		2e-13
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		2e-13
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		2e-13
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		2e-13
4h58_A	275	Braf In Complex With Compound 3 Length = 275		2e-13
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		3e-13
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		3e-13
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		3e-13
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		3e-13
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		3e-13
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		3e-13
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		3e-13
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		3e-13
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		3e-13
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-13
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		4e-13
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		4e-13
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		4e-13
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		4e-13
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		4e-13
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-13
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		4e-13
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		4e-13
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		4e-13
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		4e-13
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		4e-13
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		5e-13
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		5e-13
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		5e-13
3b2t_A	311	Structure Of Phosphotransferase Length = 311		5e-13
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		5e-13
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		5e-13
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		6e-13
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		6e-13
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		6e-13
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		7e-13
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-13
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		7e-13
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		8e-13
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		8e-13
1oec_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		8e-13
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		1e-12
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		1e-12
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		1e-12
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-12
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		2e-12
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-12
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-12
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		2e-12
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		2e-12
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		2e-12
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		2e-12
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		2e-12
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		2e-12
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		2e-12
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		3e-12
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		3e-12
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		3e-12
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		3e-12
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		3e-12
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		3e-12
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		3e-12
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		3e-12
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		3e-12
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		3e-12
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		3e-12
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		4e-12
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		4e-12
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		4e-12
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		4e-12
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		4e-12
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		4e-12
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		4e-12
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		4e-12
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		4e-12
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		4e-12
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		4e-12
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		4e-12
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		4e-12
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		4e-12
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		4e-12
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		4e-12
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		4e-12
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		4e-12
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		5e-12
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-12
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		5e-12
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		6e-12
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		6e-12
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		6e-12
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		7e-12
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		7e-12
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		7e-12
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		7e-12
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		7e-12
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-12
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		7e-12
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		7e-12
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		8e-12
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		8e-12
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		8e-12
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		8e-12
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		8e-12
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		8e-12
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		8e-12
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		8e-12
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		8e-12
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		8e-12
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		8e-12
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		8e-12
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		9e-12
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		9e-12
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		9e-12
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		9e-12
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		9e-12
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		9e-12
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		9e-12
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		9e-12
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		9e-12
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		9e-12
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		1e-11
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		1e-11
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		1e-11
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		1e-11
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		1e-11
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		1e-11
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		1e-11
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		1e-11
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		2e-11
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		2e-11
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		2e-11
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		2e-11
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-11
4fie_A	423	Full-Length Human Pak4 Length = 423		2e-11
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		2e-11
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		2e-11
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-11
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		3e-11
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		3e-11
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		3e-11
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		3e-11
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		3e-11
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		3e-11
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		3e-11
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		4e-11
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		4e-11
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		4e-11
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		4e-11
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		4e-11
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		4e-11
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		4e-11
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		5e-11
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		5e-11
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		5e-11
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		5e-11
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		5e-11
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		5e-11
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		6e-11
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		6e-11
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		6e-11
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		6e-11
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		6e-11
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		6e-11
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		6e-11
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		6e-11
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		7e-11
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		7e-11
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		7e-11
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		7e-11
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		7e-11
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		7e-11
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		8e-11
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		8e-11
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		8e-11
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		9e-11
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		9e-11
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		9e-11
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		9e-11
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		9e-11
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		9e-11
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		9e-11
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		9e-11
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		9e-11
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		9e-11
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		9e-11
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		9e-11
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		1e-10
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		1e-10
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		1e-10
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		1e-10
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		1e-10
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		1e-10
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		1e-10
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		1e-10
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-10
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		1e-10
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		1e-10
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		1e-10
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		1e-10
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		1e-10
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		2e-10
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		2e-10
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		2e-10
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		2e-10
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		2e-10
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		2e-10
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		2e-10
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		2e-10
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		2e-10
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		2e-10
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		2e-10
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		2e-10
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		2e-10
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		3e-10
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		3e-10
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		3e-10
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		3e-10
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		3e-10
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		3e-10
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		3e-10
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		3e-10
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		3e-10
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		3e-10
3g51_A	325	Structural Diversity Of The Active Conformation Of		3e-10
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		3e-10
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		4e-10
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		4e-10
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		4e-10
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		4e-10
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		4e-10
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		4e-10
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		5e-10
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		5e-10
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		5e-10
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		5e-10
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		5e-10
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		5e-10
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		5e-10
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		5e-10
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		5e-10
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		5e-10
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		5e-10
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		5e-10
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		6e-10
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		6e-10
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		6e-10
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		6e-10
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		6e-10
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		6e-10
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		6e-10
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		6e-10
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		7e-10
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		7e-10
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		7e-10
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		7e-10
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		8e-10
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		8e-10
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		8e-10
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		9e-10
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		9e-10
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		9e-10
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		1e-09
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		1e-09
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		1e-09
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		1e-09
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		1e-09
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		1e-09
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		1e-09
4fl3_A	635	Structural And Biophysical Characterization Of The		1e-09
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		1e-09
4fl2_A	636	Structural And Biophysical Characterization Of The		2e-09
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		2e-09
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-09
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		2e-09
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		2e-09
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		2e-09
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		2e-09
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		2e-09
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		2e-09
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		2e-09
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		2e-09
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		2e-09
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		2e-09
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-09
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-09
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		2e-09
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		2e-09
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-09
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		2e-09
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-09
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		2e-09
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-09
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		2e-09
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		2e-09
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		2e-09
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		2e-09
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		2e-09
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		2e-09
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		2e-09
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		2e-09
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-09
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		2e-09
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		2e-09
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		2e-09
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		2e-09
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		2e-09
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-09
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		2e-09
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		2e-09
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		2e-09
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		2e-09
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		2e-09
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		2e-09
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		2e-09
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-09
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		2e-09
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		2e-09
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-09
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		2e-09
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		3e-09
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		3e-09
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		3e-09
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		3e-09
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		3e-09
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		3e-09
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		3e-09
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		3e-09
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		3e-09
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		3e-09
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		3e-09
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		3e-09
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		3e-09
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		3e-09
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		3e-09
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		3e-09
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		3e-09
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		3e-09
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		3e-09
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		3e-09
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		3e-09
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		3e-09
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		3e-09
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		3e-09
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		3e-09
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		3e-09
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		3e-09
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		3e-09
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		3e-09
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		3e-09
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		3e-09
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		3e-09
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		3e-09
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		4e-09
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		4e-09
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		4e-09
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		4e-09
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		4e-09
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		4e-09
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		4e-09
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		4e-09
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		4e-09
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		4e-09
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		4e-09
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		4e-09
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		4e-09
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		5e-09
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		5e-09
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		5e-09
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		5e-09
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		5e-09
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		5e-09
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		5e-09
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		5e-09
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		5e-09
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		5e-09
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		5e-09
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		5e-09
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		5e-09
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		5e-09
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		5e-09
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		5e-09
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		6e-09
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		6e-09
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		6e-09
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		6e-09
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		6e-09
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		6e-09
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		6e-09
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		6e-09
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		6e-09
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		6e-09
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		7e-09
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		7e-09
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		7e-09
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		7e-09
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		7e-09
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		7e-09
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		7e-09
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		7e-09
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		7e-09
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		7e-09
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		7e-09
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		7e-09
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		7e-09
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		7e-09
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		7e-09
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		7e-09
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		7e-09
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		7e-09
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		8e-09
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		8e-09
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		8e-09
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		8e-09
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		8e-09
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		8e-09
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		8e-09
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		8e-09
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		8e-09
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		8e-09
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		8e-09
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		8e-09
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		8e-09
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		8e-09
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		8e-09
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		9e-09
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		9e-09
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		9e-09
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		9e-09
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		9e-09
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		9e-09
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		9e-09
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		1e-08
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		1e-08
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		1e-08
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		1e-08
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		1e-08
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		1e-08
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		1e-08
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		1e-08
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		1e-08
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		1e-08
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		1e-08
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-08
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		1e-08
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		1e-08
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		1e-08
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-08
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		1e-08
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		1e-08
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		1e-08
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		1e-08
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		1e-08
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		1e-08
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		1e-08
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		1e-08
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-08
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		1e-08
4ae9_A	343	Structure And Function Of The Human Sperm-specific		1e-08
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		1e-08
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		1e-08
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		1e-08
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		1e-08
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		1e-08
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		1e-08
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		1e-08
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		1e-08
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		1e-08
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		2e-08
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		2e-08
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		2e-08
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-08
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		2e-08
4ae6_A	343	Structure And Function Of The Human Sperm-specific		2e-08
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		2e-08
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		2e-08
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		2e-08
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		2e-08
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-08
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		2e-08
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		2e-08
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-08
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		2e-08
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		2e-08
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		2e-08
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		2e-08
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		2e-08
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		2e-08
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		3e-08
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		3e-08
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		3e-08
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		3e-08
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		3e-08
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		3e-08
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		3e-08
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-08
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		3e-08
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		3e-08
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		3e-08
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		3e-08
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		3e-08
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		3e-08
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		4e-08
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		4e-08
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		4e-08
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		4e-08
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		4e-08
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		4e-08
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		4e-08
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		4e-08
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		4e-08
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		4e-08
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		4e-08
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		4e-08
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		4e-08
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		4e-08
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		4e-08
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		4e-08
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		4e-08
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		4e-08
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		4e-08
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		4e-08
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		4e-08
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		4e-08
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		5e-08
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		5e-08
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		5e-08
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		5e-08
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		5e-08
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		5e-08
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		5e-08
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		5e-08
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		6e-08
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		6e-08
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		6e-08
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		6e-08
3soa_A	444	Full-Length Human Camkii Length = 444		7e-08
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		7e-08
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		7e-08
3kmu_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		7e-08
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		8e-08
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		8e-08
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		8e-08
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		8e-08
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		8e-08
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		9e-08
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		9e-08
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		9e-08
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		9e-08
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		9e-08
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		9e-08
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		9e-08
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		9e-08
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		9e-08
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		9e-08
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		9e-08
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		9e-08
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		9e-08
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		9e-08
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		9e-08
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		9e-08
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		9e-08
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		9e-08
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		1e-07
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		1e-07
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		1e-07
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-07
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		1e-07
3hec_A	348	P38 In Complex With Imatinib Length = 348		1e-07
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		1e-07
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-07
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		1e-07
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		1e-07
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		1e-07
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		1e-07
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		1e-07
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		1e-07
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		1e-07
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		1e-07
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		1e-07
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		1e-07
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		1e-07
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		1e-07
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		1e-07
2oza_B	366	Structure Of P38alpha Complex Length = 366		1e-07
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		1e-07
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		1e-07
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		1e-07
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		1e-07
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		1e-07
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		1e-07
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		1e-07
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		1e-07
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		1e-07
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		1e-07
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		1e-07
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		1e-07
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		1e-07
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		1e-07
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		1e-07
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		1e-07
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		1e-07
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		1e-07
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		1e-07
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		1e-07
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		1e-07
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		1e-07
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		2e-07
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		2e-07
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		2e-07
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		2e-07
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-07
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		2e-07
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		2e-07
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		2e-07
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		2e-07
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		2e-07
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		2e-07
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		2e-07
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		2e-07
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-07
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		2e-07
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		2e-07
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		2e-07
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		2e-07
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		2e-07
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		2e-07
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		2e-07
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		2e-07
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		2e-07
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		2e-07
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-07
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		2e-07
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		2e-07
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		2e-07
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		2e-07
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		2e-07
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		2e-07
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		2e-07
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		2e-07
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		2e-07
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-07
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-07
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		2e-07
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-07
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		2e-07
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		2e-07
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		2e-07
4exu_A	371	Mapk13, Inactive Form Length = 371		3e-07
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		3e-07
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		3e-07
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		3e-07
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		3e-07
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		3e-07
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		3e-07
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		3e-07
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		3e-07
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		3e-07
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		3e-07
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		3e-07
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		3e-07
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		3e-07
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		3e-07
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		4e-07
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		4e-07
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		4e-07
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		4e-07
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		4e-07
4eby_A	212	Crystal Structure Of The Ectodomain Of A Receptor L		5e-07
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		5e-07
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		5e-07
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		5e-07
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		5e-07
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		5e-07
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		5e-07
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		6e-07
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		6e-07
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		6e-07
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		6e-07
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		6e-07
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		7e-07
3kk8_A	284	Camkii Substrate Complex A Length = 284		7e-07
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		7e-07
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		7e-07
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		7e-07
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		7e-07
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		7e-07
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		7e-07
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		7e-07
3kk9_A	282	Camkii Substrate Complex B Length = 282		8e-07
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		8e-07
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		8e-07
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		8e-07
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		8e-07
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		8e-07
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		9e-07
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		1e-06
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		1e-06
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		1e-06
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		1e-06
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-06
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		1e-06
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		1e-06
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		1e-06
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		1e-06
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		1e-06
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-06
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-06
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		2e-06
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		2e-06
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		2e-06
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		2e-06
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		2e-06
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		2e-06
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		2e-06
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		2e-06
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		2e-06
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		2e-06
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		2e-06
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		2e-06
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		2e-06
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		2e-06
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		2e-06
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		2e-06
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		2e-06
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		2e-06
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		2e-06
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		2e-06
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		2e-06
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		3e-06
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		3e-06
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		3e-06
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		3e-06
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		3e-06
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		3e-06
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		3e-06
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		4e-06
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		4e-06
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		4e-06
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		4e-06
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		4e-06
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		5e-06
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		5e-06
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		5e-06
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		5e-06
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		5e-06
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		5e-06
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		6e-06
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		7e-06
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		8e-06
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		8e-06
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		9e-06
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		9e-06
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		9e-06
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		1e-05
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		1e-05
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		1e-05
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		1e-05
3gni_B	389	Structure Of Strad And Mo25 Length = 389		1e-05
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		1e-05
2wtk_B	373	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		1e-05
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		1e-05
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		2e-05
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		2e-05
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		2e-05
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		2e-05
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		2e-05
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		2e-05
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		2e-05
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		2e-05
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		2e-05
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		2e-05
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		2e-05
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		3e-05
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		3e-05
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		3e-05
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		3e-05
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		3e-05
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		3e-05
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		3e-05
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		3e-05
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		3e-05
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		3e-05
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		4e-05
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		4e-05
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		4e-05
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		4e-05
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		5e-05
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-05
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		6e-05
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		6e-05
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		6e-05
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		7e-05
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		7e-05
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		1e-04
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		1e-04
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		1e-04
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		1e-04
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		1e-04
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		1e-04
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		3e-04
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		3e-04
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		4e-04
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		5e-04
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		5e-04
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		6e-04
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		6e-04
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		7e-04
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		7e-04
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		7e-04
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		8e-04
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		8e-04
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		8e-04
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		8e-04

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  164 bits (416), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 101/318 (31%), Positives = 169/318 (53%), Gaps = 24/318 (7%)
Query: 312 NEKPSNKKFDEESQDFLESISGVAQSLKVYSFKELQSATDNFSFTCRIQ----GSVYRGK 367
            +KP +  FD  +++  E   G    LK +S +ELQ A+DNFS    +     G VY+G+
Sbjct: 2   RKKPQDHFFDVPAEEDPEVHLG---QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGR 58
Query: 368 I-NGGFAAIKKVNGDVSK--------EIALLNKINHSNLIILSGVCFNEGNCYLVYEYAV 418
           + +G   A+K++  +  +        E+ +++   H NL+ L G C       LVY Y  
Sbjct: 59  LADGTLVAVKRLKEERXQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMA 118
Query: 419 NGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSD 478
           NG+++  +         LDW +R +IAL  A GL YLH   +P  +H+D+ ++N+LLD +
Sbjct: 119 NGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEE 178
Query: 479 LRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEM 538
             A + +F +A+  + ++        + GT G++APEYL  G  S K DV+ +GV++LE+
Sbjct: 179 FEAVVGDFGLAKLMDYKDXHVXXA--VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLEL 236
Query: 539 LTGKEAAALH--AEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRL 596
           +TG+ A  L   A ++++ L D +  +L     E+ L   +D  LQGNY  E    +I++
Sbjct: 237 ITGQRAFDLARLANDDDVMLLDWVKGLLK----EKKLEALVDVDLQGNYKDEEVEQLIQV 292
Query: 597 IDACLKKDPTDRPTMYEI 614
              C +  P +RP M E+
Sbjct: 293 ALLCTQSSPMERPKMSEV 310

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  159 bits (402), Expect = 4e-39,   Method: Compositional matrix adjust.
 Identities = 93/293 (31%), Positives = 157/293 (53%), Gaps = 21/293 (7%)
Query: 337 SLKVYSFKELQSATDNFSFTCRIQ----GSVYRGKI-NGGFAAIKKVNGDVSK------- 384
            LK +S +ELQ A+DNF     +     G VY+G++ +G   A+K++  + ++       
Sbjct: 16  QLKRFSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLKEERTQGGELQFQ 75
Query: 385 -EIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQ 443
            E+ +++   H NL+ L G C       LVY Y  NG+++  +         LDW +R +
Sbjct: 76  TEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQR 135
Query: 444 IALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTR 503
           IAL  A GL YLH   +P  +H+D+ ++N+LLD +  A + +F +A+  + ++       
Sbjct: 136 IALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXA- 194
Query: 504 HIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALH--AEENNMHLSDVLN 561
            + G  G++APEYL  G  S K DV+ +GV++LE++TG+ A  L   A ++++ L D + 
Sbjct: 195 -VRGXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK 253
Query: 562 AVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEI 614
            +L     E+ L   +D  LQGNY  E    +I++   C +  P +RP M E+
Sbjct: 254 GLLK----EKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEV 302

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  124 bits (310), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 83/231 (35%), Positives = 122/231 (52%), Gaps = 27/231 (11%)
Query: 341 YSFKELQSATDNFSFTCRIQGS----------VYRGKINGGFAAIKKVNGDVS------- 383
           +SF EL++ T+NF       G           VY+G +N    A+KK+   V        
Sbjct: 9   FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELK 68
Query: 384 ----KEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWK 439
               +EI ++ K  H NL+ L G   +  +  LVY Y  NG+L D + S  +    L W 
Sbjct: 69  QQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRL-SCLDGTPPLSWH 127
Query: 440 QRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEF 499
            R +IA   A G+N+LH      H+H+DI S+N+LLD    AKI++F +AR +E +  + 
Sbjct: 128 MRCKIAQGAANGINFLHE---NHHIHRDIKSANILLDEAFTAKISDFGLARASE-KFAQX 183
Query: 500 ALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAE 550
            +   IVGT  YMAPE L  G ++ K D+Y+FGV++LE++TG  A   H E
Sbjct: 184 VMXXRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDEHRE 233

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  123 bits (309), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 83/231 (35%), Positives = 122/231 (52%), Gaps = 27/231 (11%)
Query: 341 YSFKELQSATDNFSFTCRIQGS----------VYRGKINGGFAAIKKVNGDVS------- 383
           +SF EL++ T+NF       G           VY+G +N    A+KK+   V        
Sbjct: 15  FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELK 74
Query: 384 ----KEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWK 439
               +EI ++ K  H NL+ L G   +  +  LVY Y  NG+L D + S  +    L W 
Sbjct: 75  QQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRL-SCLDGTPPLSWH 133
Query: 440 QRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEF 499
            R +IA   A G+N+LH      H+H+DI S+N+LLD    AKI++F +AR +E +  + 
Sbjct: 134 MRCKIAQGAANGINFLHE---NHHIHRDIKSANILLDEAFTAKISDFGLARASE-KFAQT 189
Query: 500 ALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAE 550
            +   IVGT  YMAPE L  G ++ K D+Y+FGV++LE++TG  A   H E
Sbjct: 190 VMXSRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDEHRE 239

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  123 bits (309), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 83/231 (35%), Positives = 122/231 (52%), Gaps = 27/231 (11%)
Query: 341 YSFKELQSATDNFSFTCRIQGS----------VYRGKINGGFAAIKKVNGDVS------- 383
           +SF EL++ T+NF       G           VY+G +N    A+KK+   V        
Sbjct: 15  FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELK 74
Query: 384 ----KEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWK 439
               +EI ++ K  H NL+ L G   +  +  LVY Y  NG+L D + S  +    L W 
Sbjct: 75  QQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRL-SCLDGTPPLSWH 133
Query: 440 QRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEF 499
            R +IA   A G+N+LH      H+H+DI S+N+LLD    AKI++F +AR +E +  + 
Sbjct: 134 MRCKIAQGAANGINFLHE---NHHIHRDIKSANILLDEAFTAKISDFGLARASE-KFAQT 189
Query: 500 ALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAE 550
            +   IVGT  YMAPE L  G ++ K D+Y+FGV++LE++TG  A   H E
Sbjct: 190 VMXXRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDEHRE 239

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  119 bits (297), Expect = 7e-27,   Method: Compositional matrix adjust.
 Identities = 83/231 (35%), Positives = 119/231 (51%), Gaps = 27/231 (11%)
Query: 341 YSFKELQSATDNFSFTCRIQGS----------VYRGKINGGFAAIKKVNGDVS------- 383
           +SF EL++ T+NF       G           VY+G +N    A+KK+   V        
Sbjct: 6   FSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELK 65
Query: 384 ----KEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWK 439
               +EI +  K  H NL+ L G   +  +  LVY Y  NG+L D + S  +    L W 
Sbjct: 66  QQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRL-SCLDGTPPLSWH 124
Query: 440 QRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEF 499
            R +IA   A G+N+LH      H+H+DI S+N+LLD    AKI++F +AR +E      
Sbjct: 125 XRCKIAQGAANGINFLHE---NHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQXV 181
Query: 500 ALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAE 550
             +R IVGT  Y APE L  G ++ K D+Y+FGV++LE++TG  A   H E
Sbjct: 182 XXSR-IVGTTAYXAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDEHRE 230

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  115 bits (288), Expect = 7e-26,   Method: Compositional matrix adjust.
 Identities = 87/291 (29%), Positives = 146/291 (50%), Gaps = 26/291 (8%)
Query: 345 ELQSATDNFSFTCRIQ----GSVYRGKI-NGGFAAIKKVNGDVSK-------EIALLNKI 392
           +L+ AT+NF     I     G VY+G + +G   A+K+   + S+       EI  L+  
Sbjct: 33  DLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFC 92
Query: 393 NHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGL 452
            H +L+ L G C       L+Y+Y  NG L   ++ +      + W+QR++I +  A GL
Sbjct: 93  RHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGL 152
Query: 453 NYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQE-GEFALTRHIVGTKGY 511
           +YLH+      +H+D+ S N+LLD +   KI +F +++  +G E G+  L   + GT GY
Sbjct: 153 HYLHTRAI---IHRDVKSINILLDENFVPKITDFGISK--KGTELGQTHLXXVVKGTLGY 207
Query: 512 MAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEE 571
           + PEY   G ++ K DVY+FGV++ E+L  + A         ++L++   AV +  +G+ 
Sbjct: 208 IDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEW--AVESHNNGQ- 264
Query: 572 SLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTM----YEIEHSL 618
            L   +DP L      E           CL     DRP+M    +++E++L
Sbjct: 265 -LEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYAL 314

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  114 bits (286), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 79/276 (28%), Positives = 137/276 (49%), Gaps = 35/276 (12%)
Query: 361 GSVYRGKINGGFAAIK----------KVNGDVSKEIALLNKINHSNLIILSGVCFNEGNC 410
           G+V+R + +G   A+K          +VN +  +E+A++ ++ H N+++  G      N 
Sbjct: 51  GTVHRAEWHGSDVAVKILMEQDFHAERVN-EFLREVAIMKRLRHPNIVLFMGAVTQPPNL 109
Query: 411 YLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINS 470
            +V EY   G+L   +       + LD ++R+ +A DVA G+NYLH+  NPP VH+D+ S
Sbjct: 110 SIVTEYLSRGSLYR-LLHKSGAREQLDERRRLSMAYDVAKGMNYLHN-RNPPIVHRDLKS 167
Query: 471 SNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYA 530
            N+L+D     K+ +F ++R    +   F  ++   GT  +MAPE L +   + K DVY+
Sbjct: 168 PNLLVDKKYTVKVCDFGLSR---LKASXFLXSKXAAGTPEWMAPEVLRDEPSNEKSDVYS 224
Query: 531 FGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELA 590
           FGV++ E+      A L     N++ + V+ AV     G +  R  I        P  L 
Sbjct: 225 FGVILWEL------ATLQQPWGNLNPAQVVAAV-----GFKCKRLEI--------PRNLN 265
Query: 591 LLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNASL 626
             V  +I+ C   +P  RP+   I   L  ++ +++
Sbjct: 266 PQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAV 301

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  112 bits (281), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 86/291 (29%), Positives = 145/291 (49%), Gaps = 26/291 (8%)
Query: 345 ELQSATDNFSFTCRIQ----GSVYRGKI-NGGFAAIKKVNGDVSK-------EIALLNKI 392
           +L+ AT+NF     I     G VY+G + +G   A+K+   + S+       EI  L+  
Sbjct: 33  DLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFC 92
Query: 393 NHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGL 452
            H +L+ L G C       L+Y+Y  NG L   ++ +      + W+QR++I +  A GL
Sbjct: 93  RHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGL 152
Query: 453 NYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQE-GEFALTRHIVGTKGY 511
           +YLH+      +H+D+ S N+LLD +   KI +F +++  +G E  +  L   + GT GY
Sbjct: 153 HYLHTRAI---IHRDVKSINILLDENFVPKITDFGISK--KGTELDQTHLXXVVKGTLGY 207
Query: 512 MAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEE 571
           + PEY   G ++ K DVY+FGV++ E+L  + A         ++L++   AV +  +G+ 
Sbjct: 208 IDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEW--AVESHNNGQ- 264
Query: 572 SLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTM----YEIEHSL 618
            L   +DP L      E           CL     DRP+M    +++E++L
Sbjct: 265 -LEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYAL 314

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  112 bits (279), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 78/276 (28%), Positives = 137/276 (49%), Gaps = 35/276 (12%)
Query: 361 GSVYRGKINGGFAAIK----------KVNGDVSKEIALLNKINHSNLIILSGVCFNEGNC 410
           G+V+R + +G   A+K          +VN +  +E+A++ ++ H N+++  G      N 
Sbjct: 51  GTVHRAEWHGSDVAVKILMEQDFHAERVN-EFLREVAIMKRLRHPNIVLFMGAVTQPPNL 109
Query: 411 YLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINS 470
            +V EY   G+L   +       + LD ++R+ +A DVA G+NYLH+  NPP VH+++ S
Sbjct: 110 SIVTEYLSRGSLYR-LLHKSGAREQLDERRRLSMAYDVAKGMNYLHN-RNPPIVHRNLKS 167
Query: 471 SNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYA 530
            N+L+D     K+ +F ++R    +   F  ++   GT  +MAPE L +   + K DVY+
Sbjct: 168 PNLLVDKKYTVKVCDFGLSR---LKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYS 224
Query: 531 FGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELA 590
           FGV++ E+      A L     N++ + V+ AV     G +  R  I        P  L 
Sbjct: 225 FGVILWEL------ATLQQPWGNLNPAQVVAAV-----GFKCKRLEI--------PRNLN 265
Query: 591 LLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNASL 626
             V  +I+ C   +P  RP+   I   L  ++ +++
Sbjct: 266 PQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAV 301

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 67/201 (33%), Positives = 95/201 (47%), Gaps = 29/201 (14%)
Query: 361 GSVYRGKINGGFAAIKKVNGD-----------VSKEIALLNKINHSNLIILSGVCFNEGN 409
           G VYR    G   A+K    D           V +E  L   + H N+I L GVC  E N
Sbjct: 21  GKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPN 80
Query: 410 CYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDIN 469
             LV E+A  G L+  V S    GK +     +  A+ +A G+NYLH     P +H+D+ 
Sbjct: 81  LCLVMEFARGGPLNR-VLS----GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLK 135
Query: 470 SSNVLL-----DSDLR---AKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGL 521
           SSN+L+     + DL     KI +F +AR     E          G   +MAPE +   +
Sbjct: 136 SSNILILQKVENGDLSNKILKITDFGLAR-----EWHRTTKMSAAGAYAWMAPEVIRASM 190
Query: 522 VSTKLDVYAFGVLILEMLTGK 542
            S   DV+++GVL+ E+LTG+
Sbjct: 191 FSKGSDVWSYGVLLWELLTGE 211

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 65/249 (26%), Positives = 119/249 (47%), Gaps = 35/249 (14%)
Query: 384 KEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQ 443
           KE+ ++  + H N++   GV + +     + EY   GTL   + S  ++     W QR+ 
Sbjct: 56  KEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQ---YPWSQRVS 112
Query: 444 IALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQ----EGEF 499
            A D+A+G+ YLHS      +H+D+NS N L+  +    +A+F +AR    +    EG  
Sbjct: 113 FAKDIASGMAYLHSMNI---IHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLR 169
Query: 500 ALTRH-------IVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEEN 552
           +L +        +VG   +MAPE +       K+DV++FG+++ E++       ++A+ +
Sbjct: 170 SLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEII-----GRVNADPD 224
Query: 553 NMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMY 612
             +L   ++  L       ++R F+D     N P     + +R    C   DP  RP+  
Sbjct: 225 --YLPRTMDFGL-------NVRGFLDRYCPPNCPPSFFPITVR----CCDLDPEKRPSFV 271
Query: 613 EIEHSLSNI 621
           ++EH L  +
Sbjct: 272 KLEHWLETL 280

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 83/275 (30%), Positives = 130/275 (47%), Gaps = 40/275 (14%)
Query: 361 GSVYRGKINGGF-AAIKKVN-GDVS-----KEIALLNKINHSNLIILSGVCFNEGNCYLV 413
           G V+ G  NG    AIK +  G +S     +E  ++ K+ H  L+ L  V  +E   Y+V
Sbjct: 23  GEVWMGTWNGNTKVAIKTLKPGTMSPESFLEEAQIMKKLKHDKLVQLYAVV-SEEPIYIV 81
Query: 414 YEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNV 473
            EY   G+L D  F    EG+ L     + +A  VA G+ Y+       ++H+D+ S+N+
Sbjct: 82  TEYMNKGSLLD--FLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANI 136
Query: 474 LLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTK---GYMAPEYLENGLVSTKLDVYA 530
           L+ + L  KIA+F +AR  E  E      R   G K    + APE    G  + K DV++
Sbjct: 137 LVGNGLICKIADFGLARLIEDNE---XTARQ--GAKFPIKWTAPEAALYGRFTIKSDVWS 191
Query: 531 FGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELA 590
           FG+L+ E++T  +    +   NN            +E  E+  R +  P  Q + P+ L 
Sbjct: 192 FGILLTELVT--KGRVPYPGMNN------------REVLEQVERGYRMPCPQ-DCPISLH 236
Query: 591 LLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNAS 625
            L+I     C KKDP +RPT   ++  L +   A+
Sbjct: 237 ELMIH----CWKKDPEERPTFEYLQSFLEDYFTAT 267

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 89.7 bits (221), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 74/272 (27%), Positives = 126/272 (46%), Gaps = 34/272 (12%)
Query: 361 GSVYRGKINGG-FAAIKKVN-GDVS-----KEIALLNKINHSNLIILSGVCFNEGNCYLV 413
           G V+ G  NG    AIK +  G +S     +E  ++ KI H  L+ L  V  +E   Y+V
Sbjct: 32  GEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKIRHEKLVQLYAVV-SEEPIYIV 90
Query: 414 YEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNV 473
            EY   G+L D  F     GKYL   Q + +A  +A+G+ Y+       +VH+D+ ++N+
Sbjct: 91  TEYMSKGSLLD--FLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANI 145
Query: 474 LLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGV 533
           L+  +L  K+A+F +AR  E  + E+   +       + APE    G  + K DV++FG+
Sbjct: 146 LVGENLVCKVADFGLARLIE--DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGI 203
Query: 534 LILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLV 593
           L+ E+ T                      ++ +E  ++  R +  P      P E    +
Sbjct: 204 LLTELTTKGRVP--------------YPGMVNREVLDQVERGYRMPC-----PPECPESL 244
Query: 594 IRLIDACLKKDPTDRPTMYEIEHSLSNILNAS 625
             L+  C +KDP +RPT   ++  L +   ++
Sbjct: 245 HDLMCQCWRKDPEERPTFEYLQAFLEDYFTST 276

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 89.0 bits (219), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 73/272 (26%), Positives = 126/272 (46%), Gaps = 34/272 (12%)
Query: 361 GSVYRGKINGG-FAAIKKVN-GDVS-----KEIALLNKINHSNLIILSGVCFNEGNCYLV 413
           G V+ G  NG    AIK +  G +S     +E  ++ K+ H  L+ L  V  +E   Y+V
Sbjct: 21  GEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV-SEEPIYIV 79
Query: 414 YEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNV 473
            EY   G+L D  F     GKYL   Q + +A  +A+G+ Y+       +VH+D+ ++N+
Sbjct: 80  TEYMSKGSLLD--FLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANI 134
Query: 474 LLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGV 533
           L+  +L  K+A+F +AR  E  + E+   +       + APE    G  + K DV++FG+
Sbjct: 135 LVGENLVCKVADFGLARLIE--DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGI 192
Query: 534 LILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLV 593
           L+ E+ T                      ++ +E  ++  R +  P      P E    +
Sbjct: 193 LLTELTTKGRVP--------------YPGMVNREVLDQVERGYRMPC-----PPECPESL 233
Query: 594 IRLIDACLKKDPTDRPTMYEIEHSLSNILNAS 625
             L+  C +KDP +RPT   ++  L +   ++
Sbjct: 234 HDLMCQCWRKDPEERPTFEYLQAFLEDYFTST 265

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 88.6 bits (218), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 73/272 (26%), Positives = 126/272 (46%), Gaps = 34/272 (12%)
Query: 361 GSVYRGKINGG-FAAIKKVN-GDVS-----KEIALLNKINHSNLIILSGVCFNEGNCYLV 413
           G V+ G  NG    AIK +  G +S     +E  ++ K+ H  L+ L  V  +E   Y+V
Sbjct: 32  GEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV-VSEEPIYIV 90
Query: 414 YEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNV 473
            EY   G+L D  F     GKYL   Q + +A  +A+G+ Y+       +VH+D+ ++N+
Sbjct: 91  CEYMSKGSLLD--FLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANI 145
Query: 474 LLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGV 533
           L+  +L  K+A+F +AR  E  + E+   +       + APE    G  + K DV++FG+
Sbjct: 146 LVGENLVCKVADFGLARLIE--DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGI 203
Query: 534 LILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLV 593
           L+ E+ T                      ++ +E  ++  R +  P      P E    +
Sbjct: 204 LLTELTTKGRVP--------------YPGMVNREVLDQVERGYRMPC-----PPECPESL 244
Query: 594 IRLIDACLKKDPTDRPTMYEIEHSLSNILNAS 625
             L+  C +KDP +RPT   ++  L +   ++
Sbjct: 245 HDLMCQCWRKDPEERPTFEYLQAFLEDYFTST 276

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 88.6 bits (218), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 73/272 (26%), Positives = 126/272 (46%), Gaps = 34/272 (12%)
Query: 361 GSVYRGKINGG-FAAIKKVN-GDVS-----KEIALLNKINHSNLIILSGVCFNEGNCYLV 413
           G V+ G  NG    AIK +  G +S     +E  ++ K+ H  L+ L  V  +E   Y+V
Sbjct: 23  GEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV-SEEPIYIV 81
Query: 414 YEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNV 473
            EY   G+L D  F     GKYL   Q + +A  +A+G+ Y+       +VH+D+ ++N+
Sbjct: 82  TEYMSKGSLLD--FLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANI 136
Query: 474 LLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGV 533
           L+  +L  K+A+F +AR  E  + E+   +       + APE    G  + K DV++FG+
Sbjct: 137 LVGENLVCKVADFGLARLIE--DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGI 194
Query: 534 LILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLV 593
           L+ E+ T                      ++ +E  ++  R +  P      P E    +
Sbjct: 195 LLTELTTKGRVP--------------YPGMVNREVLDQVERGYRMPC-----PPECPESL 235
Query: 594 IRLIDACLKKDPTDRPTMYEIEHSLSNILNAS 625
             L+  C +KDP +RPT   ++  L +   ++
Sbjct: 236 HDLMCQCWRKDPEERPTFEYLQAFLEDYFTST 267

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 73/272 (26%), Positives = 126/272 (46%), Gaps = 34/272 (12%)
Query: 361 GSVYRGKINGG-FAAIKKVN-GDVS-----KEIALLNKINHSNLIILSGVCFNEGNCYLV 413
           G V+ G  NG    AIK +  G +S     +E  ++ K+ H  L+ L  V  +E   Y+V
Sbjct: 32  GEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV-SEEPIYIV 90
Query: 414 YEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNV 473
            EY   G+L D  F     GKYL   Q + +A  +A+G+ Y+       +VH+D+ ++N+
Sbjct: 91  TEYMSKGSLLD--FLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANI 145
Query: 474 LLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGV 533
           L+  +L  K+A+F +AR  E  + E+   +       + APE    G  + K DV++FG+
Sbjct: 146 LVGENLVCKVADFGLARLIE--DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGI 203
Query: 534 LILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLV 593
           L+ E+ T                      ++ +E  ++  R +  P      P E    +
Sbjct: 204 LLTELTTKGRVP--------------YPGMVNREVLDQVERGYRMPC-----PPECPESL 244
Query: 594 IRLIDACLKKDPTDRPTMYEIEHSLSNILNAS 625
             L+  C +KDP +RPT   ++  L +   ++
Sbjct: 245 HDLMCQCWRKDPEERPTFEYLQAFLEDYFTST 276

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 73/272 (26%), Positives = 126/272 (46%), Gaps = 34/272 (12%)
Query: 361 GSVYRGKINGG-FAAIKKVN-GDVS-----KEIALLNKINHSNLIILSGVCFNEGNCYLV 413
           G V+ G  NG    AIK +  G +S     +E  ++ K+ H  L+ L  V  +E   Y+V
Sbjct: 32  GEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV-SEEPIYIV 90
Query: 414 YEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNV 473
            EY   G+L D  F     GKYL   Q + +A  +A+G+ Y+       +VH+D+ ++N+
Sbjct: 91  IEYMSKGSLLD--FLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANI 145
Query: 474 LLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGV 533
           L+  +L  K+A+F +AR  E  + E+   +       + APE    G  + K DV++FG+
Sbjct: 146 LVGENLVCKVADFGLARLIE--DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGI 203
Query: 534 LILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLV 593
           L+ E+ T                      ++ +E  ++  R +  P      P E    +
Sbjct: 204 LLTELTTKGRVP--------------YPGMVNREVLDQVERGYRMPC-----PPECPESL 244
Query: 594 IRLIDACLKKDPTDRPTMYEIEHSLSNILNAS 625
             L+  C +KDP +RPT   ++  L +   ++
Sbjct: 245 HDLMCQCWRKDPEERPTFEYLQAFLEDYFTST 276

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 73/272 (26%), Positives = 125/272 (45%), Gaps = 34/272 (12%)
Query: 361 GSVYRGKINGG-FAAIKKVN-GDVS-----KEIALLNKINHSNLIILSGVCFNEGNCYLV 413
           G V+ G  NG    AIK +  G +S     +E  ++ K+ H  L+ L  V  +E   Y+V
Sbjct: 32  GEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV-VSEEPIYIV 90
Query: 414 YEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNV 473
            EY   G L D  F     GKYL   Q + +A  +A+G+ Y+       +VH+D+ ++N+
Sbjct: 91  MEYMSKGCLLD--FLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANI 145
Query: 474 LLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGV 533
           L+  +L  K+A+F +AR  E  + E+   +       + APE    G  + K DV++FG+
Sbjct: 146 LVGENLVCKVADFGLARLIE--DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGI 203
Query: 534 LILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLV 593
           L+ E+ T                      ++ +E  ++  R +  P      P E    +
Sbjct: 204 LLTELTTKGRVP--------------YPGMVNREVLDQVERGYRMPC-----PPECPESL 244
Query: 594 IRLIDACLKKDPTDRPTMYEIEHSLSNILNAS 625
             L+  C +KDP +RPT   ++  L +   ++
Sbjct: 245 HDLMCQCWRKDPEERPTFEYLQAFLEDYFTST 276

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 73/272 (26%), Positives = 125/272 (45%), Gaps = 34/272 (12%)
Query: 361 GSVYRGKINGG-FAAIKKVN-GDVS-----KEIALLNKINHSNLIILSGVCFNEGNCYLV 413
           G V+ G  NG    AIK +  G +S     +E  ++ K+ H  L+ L  V  +E   Y+V
Sbjct: 32  GEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV-VSEEPIYIV 90
Query: 414 YEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNV 473
            EY   G L D  F     GKYL   Q + +A  +A+G+ Y+       +VH+D+ ++N+
Sbjct: 91  TEYMSKGCLLD--FLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANI 145
Query: 474 LLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGV 533
           L+  +L  K+A+F +AR  E  + E+   +       + APE    G  + K DV++FG+
Sbjct: 146 LVGENLVCKVADFGLARLIE--DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGI 203
Query: 534 LILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLV 593
           L+ E+ T                      ++ +E  ++  R +  P      P E    +
Sbjct: 204 LLTELTTKGRVP--------------YPGMVNREVLDQVERGYRMPC-----PPECPESL 244
Query: 594 IRLIDACLKKDPTDRPTMYEIEHSLSNILNAS 625
             L+  C +KDP +RPT   ++  L +   ++
Sbjct: 245 HDLMCQCWRKDPEERPTFEYLQAFLEDYFTST 276

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 73/272 (26%), Positives = 126/272 (46%), Gaps = 34/272 (12%)
Query: 361 GSVYRGKINGG-FAAIKKVN-GDVS-----KEIALLNKINHSNLIILSGVCFNEGNCYLV 413
           G V+ G  NG    AIK +  G +S     +E  ++ K+ H  L+ L  V  +E   Y+V
Sbjct: 32  GEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV-SEEPIYIV 90
Query: 414 YEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNV 473
            EY   G+L D  F     GKYL   Q + +A  +A+G+ Y+       +VH+D+ ++N+
Sbjct: 91  TEYMSKGSLLD--FLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLAAANI 145
Query: 474 LLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGV 533
           L+  +L  K+A+F +AR  E  + E+   +       + APE    G  + K DV++FG+
Sbjct: 146 LVGENLVCKVADFGLARLIE--DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGI 203
Query: 534 LILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLV 593
           L+ E+ T                      ++ +E  ++  R +  P      P E    +
Sbjct: 204 LLTELTTKGRVP--------------YPGMVNREVLDQVERGYRMPC-----PPECPESL 244
Query: 594 IRLIDACLKKDPTDRPTMYEIEHSLSNILNAS 625
             L+  C +KDP +RPT   ++  L +   ++
Sbjct: 245 HDLMCQCWRKDPEERPTFEYLQAFLEDYFTST 276

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 72/272 (26%), Positives = 126/272 (46%), Gaps = 34/272 (12%)
Query: 361 GSVYRGKINGG-FAAIKKVN-GDVS-----KEIALLNKINHSNLIILSGVCFNEGNCYLV 413
           G V+ G  NG    AIK +  G++S     +E  ++ K+ H  L+ L  V  +E   Y+V
Sbjct: 199 GEVWMGTWNGTTRVAIKTLKPGNMSPEAFLQEAQVMKKLRHEKLVQLYAVV-SEEPIYIV 257
Query: 414 YEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNV 473
            EY   G+L D  F     GKYL   Q + +A  +A+G+ Y+       +VH+D+ ++N+
Sbjct: 258 TEYMSKGSLLD--FLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANI 312
Query: 474 LLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGV 533
           L+  +L  K+A+F + R  E  + E+   +       + APE    G  + K DV++FG+
Sbjct: 313 LVGENLVCKVADFGLGRLIE--DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGI 370
Query: 534 LILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLV 593
           L+ E+ T                      ++ +E  ++  R +  P      P E    +
Sbjct: 371 LLTELTTKGRVP--------------YPGMVNREVLDQVERGYRMPC-----PPECPESL 411
Query: 594 IRLIDACLKKDPTDRPTMYEIEHSLSNILNAS 625
             L+  C +KDP +RPT   ++  L +   ++
Sbjct: 412 HDLMCQCWRKDPEERPTFEYLQAFLEDYFTST 443

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 72/272 (26%), Positives = 126/272 (46%), Gaps = 34/272 (12%)
Query: 361 GSVYRGKINGG-FAAIKKVN-GDVS-----KEIALLNKINHSNLIILSGVCFNEGNCYLV 413
           G V+ G  NG    AIK +  G +S     +E  ++ K+ H  L+ L  V  +E   Y+V
Sbjct: 198 GEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV-SEEPIYIV 256
Query: 414 YEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNV 473
            EY   G+L D  F     GKYL   Q + +A  +A+G+ Y+       +VH+D+ ++N+
Sbjct: 257 TEYMSKGSLLD--FLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANI 311
Query: 474 LLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGV 533
           L+  +L  K+A+F +AR  E  + E+   +       + APE    G  + K DV++FG+
Sbjct: 312 LVGENLVCKVADFGLARLIE--DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGI 369
Query: 534 LILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLV 593
           L+ E+ T                      ++ +E  ++  R +  P      P E    +
Sbjct: 370 LLTELTTKGRVP--------------YPGMVNREVLDQVERGYRMPC-----PPECPESL 410
Query: 594 IRLIDACLKKDPTDRPTMYEIEHSLSNILNAS 625
             L+  C +K+P +RPT   ++  L +   ++
Sbjct: 411 HDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 442

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 72/272 (26%), Positives = 126/272 (46%), Gaps = 34/272 (12%)
Query: 361 GSVYRGKINGG-FAAIKKVN-GDVS-----KEIALLNKINHSNLIILSGVCFNEGNCYLV 413
           G V+ G  NG    AIK +  G +S     +E  ++ K+ H  L+ L  V  +E   Y+V
Sbjct: 198 GEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV-SEEPIYIV 256
Query: 414 YEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNV 473
            EY   G+L D  F     GKYL   Q + +A  +A+G+ Y+       +VH+D+ ++N+
Sbjct: 257 TEYMSKGSLLD--FLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANI 311
Query: 474 LLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGV 533
           L+  +L  K+A+F +AR  E  + E+   +       + APE    G  + K DV++FG+
Sbjct: 312 LVGENLVCKVADFGLARLIE--DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGI 369
Query: 534 LILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLV 593
           L+ E+ T                      ++ +E  ++  R +  P      P E    +
Sbjct: 370 LLTELTTKGRVP--------------YPGMVNREVLDQVERGYRMPC-----PPECPESL 410
Query: 594 IRLIDACLKKDPTDRPTMYEIEHSLSNILNAS 625
             L+  C +K+P +RPT   ++  L +   ++
Sbjct: 411 HDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 442

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 72/272 (26%), Positives = 126/272 (46%), Gaps = 34/272 (12%)
Query: 361 GSVYRGKINGG-FAAIKKVN-GDVS-----KEIALLNKINHSNLIILSGVCFNEGNCYLV 413
           G V+ G  NG    AIK +  G +S     +E  ++ K+ H  L+ L  V  +E   Y+V
Sbjct: 25  GEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV-SEEPIYIV 83
Query: 414 YEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNV 473
            EY   G+L D  F     GKYL   Q + +A  +A+G+ Y+       +VH+D+ ++N+
Sbjct: 84  TEYMSKGSLLD--FLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANI 138
Query: 474 LLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGV 533
           L+  +L  K+A+F +AR  E  + E+   +       + APE    G  + K DV++FG+
Sbjct: 139 LVGENLVCKVADFGLARLIE--DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGI 196
Query: 534 LILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLV 593
           L+ E+ T                      ++ +E  ++  R +  P      P E    +
Sbjct: 197 LLTELTTKGRVP--------------YPGMVNREVLDQVERGYRMPC-----PPECPESL 237
Query: 594 IRLIDACLKKDPTDRPTMYEIEHSLSNILNAS 625
             L+  C +K+P +RPT   ++  L +   ++
Sbjct: 238 HDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 269

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 76/275 (27%), Positives = 126/275 (45%), Gaps = 40/275 (14%)
Query: 361 GSVYRGKINGG-FAAIKKVN-GDVS-----KEIALLNKINHSNLIILSGVCFNEGNCYLV 413
           G V+ G  NG    AIK +  G +S     +E  ++ K+ H  L+ L  V  +E   Y+V
Sbjct: 32  GEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV-SEEPIYIV 90
Query: 414 YEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNV 473
            EY   G+L D  F     GKYL   Q + +A  +A+G+ Y+       +VH+D+ ++N+
Sbjct: 91  IEYMSKGSLLD--FLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANI 145
Query: 474 LLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTK---GYMAPEYLENGLVSTKLDVYA 530
           L+  +L  K+A+F +AR  E  E      R   G K    + APE    G  + K DV++
Sbjct: 146 LVGENLVCKVADFGLARLIEDNE---XTARQ--GAKFPIKWTAPEAALYGRFTIKSDVWS 200
Query: 531 FGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELA 590
           FG+L+ E+ T                      ++ +E  ++  R +  P      P E  
Sbjct: 201 FGILLTELTTKGRVP--------------YPGMVNREVLDQVERGYRMPC-----PPECP 241
Query: 591 LLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNAS 625
             +  L+  C +KDP +RPT   ++  L +   ++
Sbjct: 242 ESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFTST 276

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 72/272 (26%), Positives = 126/272 (46%), Gaps = 34/272 (12%)
Query: 361 GSVYRGKINGG-FAAIKKVN-GDVS-----KEIALLNKINHSNLIILSGVCFNEGNCYLV 413
           G V+ G  NG    AIK +  G +S     +E  ++ K+ H  L+ L  V  +E   Y+V
Sbjct: 281 GEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV-SEEPIYIV 339
Query: 414 YEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNV 473
            EY   G+L D  F     GKYL   Q + +A  +A+G+ Y+       +VH+D+ ++N+
Sbjct: 340 TEYMSKGSLLD--FLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANI 394
Query: 474 LLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGV 533
           L+  +L  K+A+F +AR  E  + E+   +       + APE    G  + K DV++FG+
Sbjct: 395 LVGENLVCKVADFGLARLIE--DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGI 452
Query: 534 LILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLV 593
           L+ E+ T                      ++ +E  ++  R +  P      P E    +
Sbjct: 453 LLTELTTKGRVP--------------YPGMVNREVLDQVERGYRMPC-----PPECPESL 493
Query: 594 IRLIDACLKKDPTDRPTMYEIEHSLSNILNAS 625
             L+  C +K+P +RPT   ++  L +   ++
Sbjct: 494 HDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 525

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 86.7 bits (213), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 72/272 (26%), Positives = 126/272 (46%), Gaps = 34/272 (12%)
Query: 361 GSVYRGKINGG-FAAIKKVN-GDVS-----KEIALLNKINHSNLIILSGVCFNEGNCYLV 413
           G V+ G  NG    AIK +  G +S     +E  ++ K+ H  L+ L  V  +E   Y+V
Sbjct: 198 GEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV-SEEPIYIV 256
Query: 414 YEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNV 473
            EY   G+L D  F     GKYL   Q + +A  +A+G+ Y+       +VH+D+ ++N+
Sbjct: 257 GEYMSKGSLLD--FLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANI 311
Query: 474 LLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGV 533
           L+  +L  K+A+F +AR  E  + E+   +       + APE    G  + K DV++FG+
Sbjct: 312 LVGENLVCKVADFGLARLIE--DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGI 369
Query: 534 LILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLV 593
           L+ E+ T                      ++ +E  ++  R +  P      P E    +
Sbjct: 370 LLTELTTKGRVP--------------YPGMVNREVLDQVERGYRMPC-----PPECPESL 410
Query: 594 IRLIDACLKKDPTDRPTMYEIEHSLSNILNAS 625
             L+  C +K+P +RPT   ++  L +   ++
Sbjct: 411 HDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 442

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 72/272 (26%), Positives = 120/272 (44%), Gaps = 39/272 (14%)
Query: 361 GSVYRGKINGGFAAIKKVNGDVSK-----EIALLNKINHSNLIILSGVCFNEGNCYLVYE 415
           G V + K      AIK++  +  +     E+  L+++NH N++ L G C N     LV E
Sbjct: 23  GVVCKAKWRAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGACLNP--VCLVME 80
Query: 416 YAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLL 475
           YA  G+L + V        Y      +   L  + G+ YLHS      +H+D+   N+LL
Sbjct: 81  YAEGGSLYN-VLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLL 139
Query: 476 DSDLRA-KIANFAMARPAEGQEGEFALTRHIVGTKG---YMAPEYLENGLVSTKLDVYAF 531
            +     KI +F  A           +  H+   KG   +MAPE  E    S K DV+++
Sbjct: 140 VAGGTVLKICDFGTA---------CDIQTHMTNNKGSAAWMAPEVFEGSNYSEKCDVFSW 190
Query: 532 GVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELAL 591
           G+++ E++T ++      +E       ++ AV           +   P L  N P  +  
Sbjct: 191 GIILWEVITRRKP----FDEIGGPAFRIMWAV----------HNGTRPPLIKNLPKPIES 236
Query: 592 LVIRLIDACLKKDPTDRPTMYEIEHSLSNILN 623
           L+ R    C  KDP+ RP+M EI   +++++ 
Sbjct: 237 LMTR----CWSKDPSQRPSMEEIVKIMTHLMR 264

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 72/272 (26%), Positives = 120/272 (44%), Gaps = 39/272 (14%)
Query: 361 GSVYRGKINGGFAAIKKVNGDVSK-----EIALLNKINHSNLIILSGVCFNEGNCYLVYE 415
           G V + K      AIK++  +  +     E+  L+++NH N++ L G C N     LV E
Sbjct: 22  GVVCKAKWRAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGACLNP--VCLVME 79
Query: 416 YAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLL 475
           YA  G+L + V        Y      +   L  + G+ YLHS      +H+D+   N+LL
Sbjct: 80  YAEGGSLYN-VLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLL 138
Query: 476 DSDLRA-KIANFAMARPAEGQEGEFALTRHIVGTKG---YMAPEYLENGLVSTKLDVYAF 531
            +     KI +F  A           +  H+   KG   +MAPE  E    S K DV+++
Sbjct: 139 VAGGTVLKICDFGTA---------CDIQTHMTNNKGSAAWMAPEVFEGSNYSEKCDVFSW 189
Query: 532 GVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELAL 591
           G+++ E++T ++      +E       ++ AV           +   P L  N P  +  
Sbjct: 190 GIILWEVITRRKP----FDEIGGPAFRIMWAV----------HNGTRPPLIKNLPKPIES 235
Query: 592 LVIRLIDACLKKDPTDRPTMYEIEHSLSNILN 623
           L+ R    C  KDP+ RP+M EI   +++++ 
Sbjct: 236 LMTR----CWSKDPSQRPSMEEIVKIMTHLMR 263

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 85.5 bits (210), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 74/272 (27%), Positives = 126/272 (46%), Gaps = 34/272 (12%)
Query: 361 GSVYRGKINGG-FAAIKKVN-GDVS-----KEIALLNKINHSNLIILSGVCFNEGNCYLV 413
           G V+ G  NG    AIK +  G +S     +E  ++ K+ H  L+ L  V  +E   Y+V
Sbjct: 29  GEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV-SEEPIYIV 87
Query: 414 YEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNV 473
            EY   G+L D  F     GKYL   Q + ++  +A+G+ Y+       +VH+D+ ++N+
Sbjct: 88  TEYMNKGSLLD--FLKGETGKYLRLPQLVDMSAQIASGMAYVERMN---YVHRDLRAANI 142
Query: 474 LLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGV 533
           L+  +L  K+A+F +AR  E  + E+   +       + APE    G  + K DV++FG+
Sbjct: 143 LVGENLVCKVADFGLARLIE--DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGI 200
Query: 534 LILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLV 593
           L+ E+ T             M   +VL+ V          R +  P      P E    +
Sbjct: 201 LLTELTTKGRVPY-----PGMVNREVLDQV---------ERGYRMPC-----PPECPESL 241
Query: 594 IRLIDACLKKDPTDRPTMYEIEHSLSNILNAS 625
             L+  C +K+P +RPT   ++  L +   ++
Sbjct: 242 HDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 273

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 85.5 bits (210), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 74/272 (27%), Positives = 126/272 (46%), Gaps = 34/272 (12%)
Query: 361 GSVYRGKINGG-FAAIKKVN-GDVS-----KEIALLNKINHSNLIILSGVCFNEGNCYLV 413
           G V+ G  NG    AIK +  G +S     +E  ++ K+ H  L+ L  V  +E   Y+V
Sbjct: 29  GEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV-SEEPIYIV 87
Query: 414 YEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNV 473
            EY   G+L D  F     GKYL   Q + ++  +A+G+ Y+       +VH+D+ ++N+
Sbjct: 88  TEYMNKGSLLD--FLKGETGKYLRLPQLVDMSAQIASGMAYVERMN---YVHRDLRAANI 142
Query: 474 LLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGV 533
           L+  +L  K+A+F +AR  E  + E+   +       + APE    G  + K DV++FG+
Sbjct: 143 LVGENLVCKVADFGLARLIE--DNEWTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGI 200
Query: 534 LILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLV 593
           L+ E+ T             M   +VL+ V          R +  P      P E    +
Sbjct: 201 LLTELTTKGRVPY-----PGMVNREVLDQV---------ERGYRMPC-----PPECPESL 241
Query: 594 IRLIDACLKKDPTDRPTMYEIEHSLSNILNAS 625
             L+  C +K+P +RPT   ++  L +   ++
Sbjct: 242 HDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 273

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 66/233 (28%), Positives = 111/233 (47%), Gaps = 33/233 (14%)
Query: 383 SKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRI 442
            +EI +L++ +   +    G    +   +++ EY   G+  D +     E   LD  Q  
Sbjct: 73  QQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL-----EPGPLDETQIA 127
Query: 443 QIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALT 502
            I  ++  GL+YLHS      +H+DI ++NVLL      K+A+F +A    GQ  +  + 
Sbjct: 128 TILREILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVA----GQLTDTQIK 180
Query: 503 RH-IVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLN 561
           R+  VGT  +MAPE ++     +K D+++ G+  +E+  G+     H+E   +H   VL 
Sbjct: 181 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPP---HSE---LHPMKVLF 234
Query: 562 AVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEI 614
            +               PTL+GNY   L       ++ACL K+P+ RPT  E+
Sbjct: 235 LIPKNN----------PPTLEGNYSKPLK----EFVEACLNKEPSFRPTAKEL 273

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 66/233 (28%), Positives = 111/233 (47%), Gaps = 33/233 (14%)
Query: 383 SKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRI 442
            +EI +L++ +   +    G    +   +++ EY   G+  D +     E   LD  Q  
Sbjct: 68  QQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL-----EPGPLDETQIA 122
Query: 443 QIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALT 502
            I  ++  GL+YLHS      +H+DI ++NVLL      K+A+F +A    GQ  +  + 
Sbjct: 123 TILREILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVA----GQLTDTQIK 175
Query: 503 RH-IVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLN 561
           R+  VGT  +MAPE ++     +K D+++ G+  +E+  G+     H+E   +H   VL 
Sbjct: 176 RNXFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPP---HSE---LHPMKVLF 229
Query: 562 AVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEI 614
            +               PTL+GNY   L       ++ACL K+P+ RPT  E+
Sbjct: 230 LIPKNN----------PPTLEGNYSKPLK----EFVEACLNKEPSFRPTAKEL 268

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 66/233 (28%), Positives = 111/233 (47%), Gaps = 33/233 (14%)
Query: 383 SKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRI 442
            +EI +L++ +   +    G    +   +++ EY   G+  D +     E   LD  Q  
Sbjct: 53  QQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL-----EPGPLDETQIA 107
Query: 443 QIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALT 502
            I  ++  GL+YLHS      +H+DI ++NVLL      K+A+F +A    GQ  +  + 
Sbjct: 108 TILREILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVA----GQLTDTQIK 160
Query: 503 RH-IVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLN 561
           R+  VGT  +MAPE ++     +K D+++ G+  +E+  G+     H+E   +H   VL 
Sbjct: 161 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPP---HSE---LHPMKVLF 214
Query: 562 AVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEI 614
            +               PTL+GNY   L       ++ACL K+P+ RPT  E+
Sbjct: 215 LIPKNN----------PPTLEGNYSKPLK----EFVEACLNKEPSFRPTAKEL 253

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 66/233 (28%), Positives = 111/233 (47%), Gaps = 33/233 (14%)
Query: 383 SKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRI 442
            +EI +L++ +   +    G    +   +++ EY   G+  D +     E   LD  Q  
Sbjct: 53  QQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL-----EPGPLDETQIA 107
Query: 443 QIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALT 502
            I  ++  GL+YLHS      +H+DI ++NVLL      K+A+F +A    GQ  +  + 
Sbjct: 108 TILREILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVA----GQLTDTQIK 160
Query: 503 RH-IVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLN 561
           R+  VGT  +MAPE ++     +K D+++ G+  +E+  G+     H+E   +H   VL 
Sbjct: 161 RNXFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPP---HSE---LHPMKVLF 214
Query: 562 AVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEI 614
            +               PTL+GNY   L       ++ACL K+P+ RPT  E+
Sbjct: 215 LIPKNN----------PPTLEGNYSKPLK----EFVEACLNKEPSFRPTAKEL 253

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 74/265 (27%), Positives = 124/265 (46%), Gaps = 42/265 (15%)
Query: 361 GSVYRGKINGGF-AAIKKVN-GDVS-----KEIALLNKINHSNLIILSGVCFNEGNCYLV 413
           G V  GK  G +  A+K +  G +S     +E   + K++H  L+   GVC  E   Y+V
Sbjct: 22  GVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIV 81
Query: 414 YEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNV 473
            EY  NG L +++   ++ GK L+  Q +++  DV  G+ +L S      +H+D+ + N 
Sbjct: 82  TEYISNGCLLNYL---RSHGKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNC 135
Query: 474 LLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTK---GYMAPEYLENGLVSTKLDVYA 530
           L+D DL  K+++F M R     + ++  +   VGTK    + APE       S+K DV+A
Sbjct: 136 LVDRDLCVKVSDFGMTRYV--LDDQYVSS---VGTKFPVKWSAPEVFHYFKYSSKSDVWA 190
Query: 531 FGVLILEMLT-GKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLEL 589
           FG+L+ E+ + GK    L+              VL    G    R    P L  +     
Sbjct: 191 FGILMWEVFSLGKMPYDLYTNS---------EVVLKVSQGHRLYR----PHLASD----- 232
Query: 590 ALLVIRLIDACLKKDPTDRPTMYEI 614
              + +++ +C  + P  RPT  ++
Sbjct: 233 --TIYQIMYSCWHELPEKRPTFQQL 255

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 47/163 (28%), Positives = 89/163 (54%), Gaps = 8/163 (4%)
Query: 380 GDVSKEIALLNKINHSNLIILSGVCFNEGN--CYLVYEYAVNGTLSDWVFSNKNEGKYLD 437
            D+ KEI +L  + H N++   G+C  +G     L+ E+  +G+L +++  NKN+   ++
Sbjct: 68  ADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNK---IN 124
Query: 438 WKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEG 497
            KQ+++ A+ +  G++YL S     +VH+D+ + NVL++S+ + KI +F + +  E  + 
Sbjct: 125 LKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKE 181
Query: 498 EFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT 540
              +         + APE L         DV++FGV + E+LT
Sbjct: 182 XXTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLT 224

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 82.8 bits (203), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 47/163 (28%), Positives = 89/163 (54%), Gaps = 8/163 (4%)
Query: 380 GDVSKEIALLNKINHSNLIILSGVCFNEGN--CYLVYEYAVNGTLSDWVFSNKNEGKYLD 437
            D+ KEI +L  + H N++   G+C  +G     L+ E+  +G+L +++  NKN+   ++
Sbjct: 56  ADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNK---IN 112
Query: 438 WKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEG 497
            KQ+++ A+ +  G++YL S     +VH+D+ + NVL++S+ + KI +F + +  E  + 
Sbjct: 113 LKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKE 169
Query: 498 EFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT 540
              +         + APE L         DV++FGV + E+LT
Sbjct: 170 XXTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLT 212

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 77/275 (28%), Positives = 125/275 (45%), Gaps = 40/275 (14%)
Query: 361 GSVYRGKINGG-FAAIKKVN-GDVS-----KEIALLNKINHSNLIILSGVCFNEGNCYLV 413
           G V+ G  NG    AIK +  G +S     +E  ++ K+ H  L+ L  V  +E    +V
Sbjct: 22  GEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV-SEEPIXIV 80
Query: 414 YEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNV 473
            EY   G+L D  F     GKYL   Q + +A  +A+G+ Y+       +VH+D+ ++N+
Sbjct: 81  TEYMSKGSLLD--FLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANI 135
Query: 474 LLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTK---GYMAPEYLENGLVSTKLDVYA 530
           L+  +L  K+A+F +AR  E  E      R   G K    + APE    G  + K DV++
Sbjct: 136 LVGENLVCKVADFGLARLIEDNE---XTARQ--GAKFPIKWTAPEAALYGRFTIKSDVWS 190
Query: 531 FGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELA 590
           FG+L+ E+ T             M   +VL+ V          R +  P      P E  
Sbjct: 191 FGILLTELTTKGRVPY-----PGMVNREVLDQV---------ERGYRMPC-----PPECP 231
Query: 591 LLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNAS 625
             +  L+  C +K+P +RPT   ++  L +   ++
Sbjct: 232 ESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 266

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 61/247 (24%), Positives = 121/247 (48%), Gaps = 25/247 (10%)
Query: 377 KVNGDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYL 436
           K   D   E +++ + +H N+I L GV        ++ EY  NG+L    F  KN+G++ 
Sbjct: 51  KQRRDFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLD--AFLRKNDGRFT 108
Query: 437 DWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQE 496
              Q + +   + +G+ YL   +   +VH+D+ + N+L++S+L  K+++F M+R  E   
Sbjct: 109 V-IQLVGMLRGIGSGMKYLSDMS---YVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDP 164
Query: 497 GEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHL 556
                TR       + APE +     ++  DV+++G+++ E+++  E         +M  
Sbjct: 165 EAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYW-----DMSN 219
Query: 557 SDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEH 616
            DV+ A+      EE  R  + P      P++  + + +L+  C +K+ +DRP   +I +
Sbjct: 220 QDVIKAI------EEGYR--LPP------PMDCPIALHQLMLDCWQKERSDRPKFGQIVN 265
Query: 617 SLSNILN 623
            L  ++ 
Sbjct: 266 MLDKLIR 272

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/247 (24%), Positives = 121/247 (48%), Gaps = 25/247 (10%)
Query: 377 KVNGDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYL 436
           K   D   E +++ + +H N+I L GV        ++ EY  NG+L    F  KN+G++ 
Sbjct: 57  KQRRDFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLD--AFLRKNDGRFT 114
Query: 437 DWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQE 496
              Q + +   + +G+ YL   +   +VH+D+ + N+L++S+L  K+++F M+R  E   
Sbjct: 115 V-IQLVGMLRGIGSGMKYLSDMS---YVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDP 170
Query: 497 GEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHL 556
                TR       + APE +     ++  DV+++G+++ E+++  E         +M  
Sbjct: 171 EAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYW-----DMSN 225
Query: 557 SDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEH 616
            DV+ A+      EE  R  + P      P++  + + +L+  C +K+ +DRP   +I +
Sbjct: 226 QDVIKAI------EEGYR--LPP------PMDCPIALHQLMLDCWQKERSDRPKFGQIVN 271
Query: 617 SLSNILN 623
            L  ++ 
Sbjct: 272 MLDKLIR 278

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/247 (24%), Positives = 120/247 (48%), Gaps = 25/247 (10%)
Query: 377 KVNGDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYL 436
           K   D   E +++ + +H N+I L GV        ++ EY  NG+L    F  KN+G++ 
Sbjct: 72  KQRRDFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLD--AFLRKNDGRFT 129
Query: 437 DWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQE 496
              Q + +   + +G+ YL   +    VH+D+ + N+L++S+L  K+++F M+R  E   
Sbjct: 130 V-IQLVGMLRGIGSGMKYLSDMS---AVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDP 185
Query: 497 GEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHL 556
                TR       + APE +     ++  DV+++G+++ E+++  E         +M  
Sbjct: 186 EAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYW-----DMSN 240
Query: 557 SDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEH 616
            DV+ A+      EE  R  + P      P++  + + +L+  C +K+ +DRP   +I +
Sbjct: 241 QDVIKAI------EEGYR--LPP------PMDCPIALHQLMLDCWQKERSDRPKFGQIVN 286
Query: 617 SLSNILN 623
            L  ++ 
Sbjct: 287 MLDKLIR 293

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 107/232 (46%), Gaps = 33/232 (14%)
Query: 384 KEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQ 443
           +EI +L++ + S +    G        +++ EY   G+  D + +        D  Q   
Sbjct: 70  QEITVLSQCDSSYVTKYYGSYLKGSKLWIIMEYLGGGSALDLLRAGP-----FDEFQIAT 124
Query: 444 IALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTR 503
           +  ++  GL+YLHS      +H+DI ++NVLL      K+A+F +A    GQ  +  + R
Sbjct: 125 MLKEILKGLDYLHS---EKKIHRDIKAANVLLSEQGDVKLADFGVA----GQLTDTQIKR 177
Query: 504 H-IVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNA 562
           +  VGT  +MAPE ++     +K D+++ G+  +E+  G+         ++MH   VL  
Sbjct: 178 NTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGE------PPNSDMHPMRVLFL 231
Query: 563 VLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEI 614
           +               PTL G++           IDACL KDP+ RPT  E+
Sbjct: 232 IPKNN----------PPTLVGDFTKSFK----EFIDACLNKDPSFRPTAKEL 269

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 77/277 (27%), Positives = 119/277 (42%), Gaps = 40/277 (14%)
Query: 365 RGKINGGFAAIKK---------VNGDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYE 415
           R K  G   AIKK         V     +EI LL ++ H NL+ L  VC  +   YLV+E
Sbjct: 45  RNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFE 104
Query: 416 YAVNGTLSDW-VFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVL 474
           +  +  L D  +F N      LD++   +    +  G+ + HS      +H+DI   N+L
Sbjct: 105 FVDHTILDDLELFPNG-----LDYQVVQKYLFQIINGIGFCHSHNI---IHRDIKPENIL 156
Query: 475 LDSDLRAKIANFAMAR----PAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTK-LDVY 529
           +      K+ +F  AR    P E  + E       V T+ Y APE L   +   K +DV+
Sbjct: 157 VSQSGVVKLCDFGFARTLAAPGEVYDDE-------VATRWYRAPELLVGDVKYGKAVDVW 209
Query: 530 AFGVLILEMLTGKEAAALHAEENNM-HLSDVLNAVLTKE----DGEESLRHFIDPTLQGN 584
           A G L+ EM  G+      ++ + + H+   L  ++ +     +          P ++  
Sbjct: 210 AIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKER 269
Query: 585 YPLE-----LALLVIRLIDACLKKDPTDRPTMYEIEH 616
            PLE     L+ +VI L   CL  DP  RP   E+ H
Sbjct: 270 EPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 63/197 (31%), Positives = 102/197 (51%), Gaps = 25/197 (12%)
Query: 361 GSVYRGKI--NGG---FAAIKKVN-----GDVSK---EIALLNKINHSNLIILSGVCF-N 406
           G VY G +  N G     A+K +N     G+VS+   E  ++   +H N++ L G+C  +
Sbjct: 63  GCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS 122
Query: 407 EGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHK 466
           EG+  +V  Y  +G L +++   +NE      K  I   L VA G+ YL S      VH+
Sbjct: 123 EGSPLVVLPYMKHGDLRNFI---RNETHNPTVKDLIGFGLQVAKGMKYLAS---KKFVHR 176
Query: 467 DINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTK---GYMAPEYLENGLVS 523
           D+ + N +LD     K+A+F +AR  +  + E+    +  G K    +MA E L+    +
Sbjct: 177 DLAARNCMLDEKFTVKVADFGLAR--DMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFT 234
Query: 524 TKLDVYAFGVLILEMLT 540
           TK DV++FGVL+ E++T
Sbjct: 235 TKSDVWSFGVLLWELMT 251

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 63/197 (31%), Positives = 102/197 (51%), Gaps = 25/197 (12%)
Query: 361 GSVYRGKI--NGG---FAAIKKVN-----GDVSK---EIALLNKINHSNLIILSGVCF-N 406
           G VY G +  N G     A+K +N     G+VS+   E  ++   +H N++ L G+C  +
Sbjct: 103 GCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS 162
Query: 407 EGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHK 466
           EG+  +V  Y  +G L +++   +NE      K  I   L VA G+ +L S      VH+
Sbjct: 163 EGSPLVVLPYMKHGDLRNFI---RNETHNPTVKDLIGFGLQVAKGMKFLAS---KKFVHR 216
Query: 467 DINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTK---GYMAPEYLENGLVS 523
           D+ + N +LD     K+A+F +AR  +  + EF    +  G K    +MA E L+    +
Sbjct: 217 DLAARNCMLDEKFTVKVADFGLAR--DMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFT 274
Query: 524 TKLDVYAFGVLILEMLT 540
           TK DV++FGVL+ E++T
Sbjct: 275 TKSDVWSFGVLLWELMT 291

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 63/197 (31%), Positives = 102/197 (51%), Gaps = 25/197 (12%)
Query: 361 GSVYRGKI--NGG---FAAIKKVN-----GDVSK---EIALLNKINHSNLIILSGVCF-N 406
           G VY G +  N G     A+K +N     G+VS+   E  ++   +H N++ L G+C  +
Sbjct: 62  GCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS 121
Query: 407 EGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHK 466
           EG+  +V  Y  +G L +++   +NE      K  I   L VA G+ YL S      VH+
Sbjct: 122 EGSPLVVLPYMKHGDLRNFI---RNETHNPTVKDLIGFGLQVAKGMKYLAS---KKFVHR 175
Query: 467 DINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTK---GYMAPEYLENGLVS 523
           D+ + N +LD     K+A+F +AR  +  + E+    +  G K    +MA E L+    +
Sbjct: 176 DLAARNCMLDEKFTVKVADFGLAR--DMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFT 233
Query: 524 TKLDVYAFGVLILEMLT 540
           TK DV++FGVL+ E++T
Sbjct: 234 TKSDVWSFGVLLWELMT 250

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 63/197 (31%), Positives = 102/197 (51%), Gaps = 25/197 (12%)
Query: 361 GSVYRGKI--NGG---FAAIKKVN-----GDVSK---EIALLNKINHSNLIILSGVCF-N 406
           G VY G +  N G     A+K +N     G+VS+   E  ++   +H N++ L G+C  +
Sbjct: 44  GCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS 103
Query: 407 EGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHK 466
           EG+  +V  Y  +G L +++   +NE      K  I   L VA G+ YL S      VH+
Sbjct: 104 EGSPLVVLPYMKHGDLRNFI---RNETHNPTVKDLIGFGLQVAKGMKYLAS---KKFVHR 157
Query: 467 DINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTK---GYMAPEYLENGLVS 523
           D+ + N +LD     K+A+F +AR  +  + E+    +  G K    +MA E L+    +
Sbjct: 158 DLAARNCMLDEKFTVKVADFGLAR--DMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFT 215
Query: 524 TKLDVYAFGVLILEMLT 540
           TK DV++FGVL+ E++T
Sbjct: 216 TKSDVWSFGVLLWELMT 232

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 56/184 (30%), Positives = 89/184 (48%), Gaps = 17/184 (9%)
Query: 361 GSVYRGKINGGFAAIKKVNGDVSK-----EIALLNKINHSNLIILSGVCFNE-GNCYLVY 414
           G V  G   G   A+K +  D +      E +++ ++ HSNL+ L GV   E G  Y+V 
Sbjct: 26  GDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 85
Query: 415 EYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVL 474
           EY   G+L D++ S       L     ++ +LDV   + YL        VH+D+ + NVL
Sbjct: 86  EYMAKGSLVDYLRSRGRS--VLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVL 140
Query: 475 LDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVL 534
           +  D  AK+++F + + A   +    L         + APE L     STK DV++FG+L
Sbjct: 141 VSEDNVAKVSDFGLTKEASSTQDTGKLPVK------WTAPEALREAAFSTKSDVWSFGIL 194
Query: 535 ILEM 538
           + E+
Sbjct: 195 LWEI 198

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 63/197 (31%), Positives = 102/197 (51%), Gaps = 25/197 (12%)
Query: 361 GSVYRGKI--NGG---FAAIKKVN-----GDVSK---EIALLNKINHSNLIILSGVCF-N 406
           G VY G +  N G     A+K +N     G+VS+   E  ++   +H N++ L G+C  +
Sbjct: 36  GCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS 95
Query: 407 EGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHK 466
           EG+  +V  Y  +G L +++   +NE      K  I   L VA G+ YL S      VH+
Sbjct: 96  EGSPLVVLPYMKHGDLRNFI---RNETHNPTVKDLIGFGLQVAKGMKYLAS---KKFVHR 149
Query: 467 DINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTK---GYMAPEYLENGLVS 523
           D+ + N +LD     K+A+F +AR  +  + E+    +  G K    +MA E L+    +
Sbjct: 150 DLAARNCMLDEKFTVKVADFGLAR--DMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFT 207
Query: 524 TKLDVYAFGVLILEMLT 540
           TK DV++FGVL+ E++T
Sbjct: 208 TKSDVWSFGVLLWELMT 224

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 63/197 (31%), Positives = 102/197 (51%), Gaps = 25/197 (12%)
Query: 361 GSVYRGKI--NGG---FAAIKKVN-----GDVSK---EIALLNKINHSNLIILSGVCF-N 406
           G VY G +  N G     A+K +N     G+VS+   E  ++   +H N++ L G+C  +
Sbjct: 42  GCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS 101
Query: 407 EGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHK 466
           EG+  +V  Y  +G L +++   +NE      K  I   L VA G+ YL S      VH+
Sbjct: 102 EGSPLVVLPYMKHGDLRNFI---RNETHNPTVKDLIGFGLQVAKGMKYLAS---KKFVHR 155
Query: 467 DINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTK---GYMAPEYLENGLVS 523
           D+ + N +LD     K+A+F +AR  +  + E+    +  G K    +MA E L+    +
Sbjct: 156 DLAARNCMLDEKFTVKVADFGLAR--DMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFT 213
Query: 524 TKLDVYAFGVLILEMLT 540
           TK DV++FGVL+ E++T
Sbjct: 214 TKSDVWSFGVLLWELMT 230

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 63/197 (31%), Positives = 102/197 (51%), Gaps = 25/197 (12%)
Query: 361 GSVYRGKI--NGG---FAAIKKVN-----GDVSK---EIALLNKINHSNLIILSGVCF-N 406
           G VY G +  N G     A+K +N     G+VS+   E  ++   +H N++ L G+C  +
Sbjct: 41  GCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS 100
Query: 407 EGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHK 466
           EG+  +V  Y  +G L +++   +NE      K  I   L VA G+ YL S      VH+
Sbjct: 101 EGSPLVVLPYMKHGDLRNFI---RNETHNPTVKDLIGFGLQVAKGMKYLAS---KKFVHR 154
Query: 467 DINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTK---GYMAPEYLENGLVS 523
           D+ + N +LD     K+A+F +AR  +  + E+    +  G K    +MA E L+    +
Sbjct: 155 DLAARNCMLDEKFTVKVADFGLAR--DMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFT 212
Query: 524 TKLDVYAFGVLILEMLT 540
           TK DV++FGVL+ E++T
Sbjct: 213 TKSDVWSFGVLLWELMT 229

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 63/197 (31%), Positives = 102/197 (51%), Gaps = 25/197 (12%)
Query: 361 GSVYRGKI--NGG---FAAIKKVN-----GDVSK---EIALLNKINHSNLIILSGVCF-N 406
           G VY G +  N G     A+K +N     G+VS+   E  ++   +H N++ L G+C  +
Sbjct: 39  GCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS 98
Query: 407 EGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHK 466
           EG+  +V  Y  +G L +++   +NE      K  I   L VA G+ YL S      VH+
Sbjct: 99  EGSPLVVLPYMKHGDLRNFI---RNETHNPTVKDLIGFGLQVAKGMKYLAS---KKFVHR 152
Query: 467 DINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTK---GYMAPEYLENGLVS 523
           D+ + N +LD     K+A+F +AR  +  + E+    +  G K    +MA E L+    +
Sbjct: 153 DLAARNCMLDEKFTVKVADFGLAR--DMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFT 210
Query: 524 TKLDVYAFGVLILEMLT 540
           TK DV++FGVL+ E++T
Sbjct: 211 TKSDVWSFGVLLWELMT 227

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 63/197 (31%), Positives = 102/197 (51%), Gaps = 25/197 (12%)
Query: 361 GSVYRGKI--NGG---FAAIKKVN-----GDVSK---EIALLNKINHSNLIILSGVCF-N 406
           G VY G +  N G     A+K +N     G+VS+   E  ++   +H N++ L G+C  +
Sbjct: 44  GCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS 103
Query: 407 EGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHK 466
           EG+  +V  Y  +G L +++   +NE      K  I   L VA G+ YL S      VH+
Sbjct: 104 EGSPLVVLPYMKHGDLRNFI---RNETHNPTVKDLIGFGLQVAKGMKYLAS---KKFVHR 157
Query: 467 DINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTK---GYMAPEYLENGLVS 523
           D+ + N +LD     K+A+F +AR  +  + E+    +  G K    +MA E L+    +
Sbjct: 158 DLAARNCMLDEKFTVKVADFGLAR--DMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFT 215
Query: 524 TKLDVYAFGVLILEMLT 540
           TK DV++FGVL+ E++T
Sbjct: 216 TKSDVWSFGVLLWELMT 232

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 63/197 (31%), Positives = 102/197 (51%), Gaps = 25/197 (12%)
Query: 361 GSVYRGKI--NGG---FAAIKKVN-----GDVSK---EIALLNKINHSNLIILSGVCF-N 406
           G VY G +  N G     A+K +N     G+VS+   E  ++   +H N++ L G+C  +
Sbjct: 43  GCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS 102
Query: 407 EGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHK 466
           EG+  +V  Y  +G L +++   +NE      K  I   L VA G+ YL S      VH+
Sbjct: 103 EGSPLVVLPYMKHGDLRNFI---RNETHNPTVKDLIGFGLQVAKGMKYLAS---KKFVHR 156
Query: 467 DINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTK---GYMAPEYLENGLVS 523
           D+ + N +LD     K+A+F +AR  +  + E+    +  G K    +MA E L+    +
Sbjct: 157 DLAARNCMLDEKFTVKVADFGLAR--DMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFT 214
Query: 524 TKLDVYAFGVLILEMLT 540
           TK DV++FGVL+ E++T
Sbjct: 215 TKSDVWSFGVLLWELMT 231

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 63/197 (31%), Positives = 102/197 (51%), Gaps = 25/197 (12%)
Query: 361 GSVYRGKI--NGG---FAAIKKVN-----GDVSK---EIALLNKINHSNLIILSGVCF-N 406
           G VY G +  N G     A+K +N     G+VS+   E  ++   +H N++ L G+C  +
Sbjct: 44  GCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS 103
Query: 407 EGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHK 466
           EG+  +V  Y  +G L +++   +NE      K  I   L VA G+ +L S      VH+
Sbjct: 104 EGSPLVVLPYMKHGDLRNFI---RNETHNPTVKDLIGFGLQVAKGMKFLAS---KKFVHR 157
Query: 467 DINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTK---GYMAPEYLENGLVS 523
           D+ + N +LD     K+A+F +AR  +  + EF    +  G K    +MA E L+    +
Sbjct: 158 DLAARNCMLDEKFTVKVADFGLAR--DMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFT 215
Query: 524 TKLDVYAFGVLILEMLT 540
           TK DV++FGVL+ E++T
Sbjct: 216 TKSDVWSFGVLLWELMT 232

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 63/197 (31%), Positives = 102/197 (51%), Gaps = 25/197 (12%)
Query: 361 GSVYRGKI--NGG---FAAIKKVN-----GDVSK---EIALLNKINHSNLIILSGVCF-N 406
           G VY G +  N G     A+K +N     G+VS+   E  ++   +H N++ L G+C  +
Sbjct: 44  GCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS 103
Query: 407 EGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHK 466
           EG+  +V  Y  +G L +++   +NE      K  I   L VA G+ +L S      VH+
Sbjct: 104 EGSPLVVLPYMKHGDLRNFI---RNETHNPTVKDLIGFGLQVAKGMKFLAS---KKFVHR 157
Query: 467 DINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTK---GYMAPEYLENGLVS 523
           D+ + N +LD     K+A+F +AR  +  + EF    +  G K    +MA E L+    +
Sbjct: 158 DLAARNCMLDEKFTVKVADFGLAR--DMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFT 215
Query: 524 TKLDVYAFGVLILEMLT 540
           TK DV++FGVL+ E++T
Sbjct: 216 TKSDVWSFGVLLWELMT 232

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 63/197 (31%), Positives = 102/197 (51%), Gaps = 25/197 (12%)
Query: 361 GSVYRGKI--NGG---FAAIKKVN-----GDVSK---EIALLNKINHSNLIILSGVCF-N 406
           G VY G +  N G     A+K +N     G+VS+   E  ++   +H N++ L G+C  +
Sbjct: 49  GCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS 108
Query: 407 EGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHK 466
           EG+  +V  Y  +G L +++   +NE      K  I   L VA G+ +L S      VH+
Sbjct: 109 EGSPLVVLPYMKHGDLRNFI---RNETHNPTVKDLIGFGLQVAKGMKFLAS---KKFVHR 162
Query: 467 DINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTK---GYMAPEYLENGLVS 523
           D+ + N +LD     K+A+F +AR  +  + EF    +  G K    +MA E L+    +
Sbjct: 163 DLAARNCMLDEKFTVKVADFGLAR--DMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFT 220
Query: 524 TKLDVYAFGVLILEMLT 540
           TK DV++FGVL+ E++T
Sbjct: 221 TKSDVWSFGVLLWELMT 237

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 63/197 (31%), Positives = 102/197 (51%), Gaps = 25/197 (12%)
Query: 361 GSVYRGKI--NGG---FAAIKKVN-----GDVSK---EIALLNKINHSNLIILSGVCF-N 406
           G VY G +  N G     A+K +N     G+VS+   E  ++   +H N++ L G+C  +
Sbjct: 45  GCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS 104
Query: 407 EGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHK 466
           EG+  +V  Y  +G L +++   +NE      K  I   L VA G+ +L S      VH+
Sbjct: 105 EGSPLVVLPYMKHGDLRNFI---RNETHNPTVKDLIGFGLQVAKGMKFLAS---KKFVHR 158
Query: 467 DINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTK---GYMAPEYLENGLVS 523
           D+ + N +LD     K+A+F +AR  +  + EF    +  G K    +MA E L+    +
Sbjct: 159 DLAARNCMLDEKFTVKVADFGLAR--DMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFT 216
Query: 524 TKLDVYAFGVLILEMLT 540
           TK DV++FGVL+ E++T
Sbjct: 217 TKSDVWSFGVLLWELMT 233

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 79.3 bits (194), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 63/197 (31%), Positives = 102/197 (51%), Gaps = 25/197 (12%)
Query: 361 GSVYRGKI--NGG---FAAIKKVN-----GDVSK---EIALLNKINHSNLIILSGVCF-N 406
           G VY G +  N G     A+K +N     G+VS+   E  ++   +H N++ L G+C  +
Sbjct: 42  GCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS 101
Query: 407 EGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHK 466
           EG+  +V  Y  +G L +++   +NE      K  I   L VA G+ +L S      VH+
Sbjct: 102 EGSPLVVLPYMKHGDLRNFI---RNETHNPTVKDLIGFGLQVAKGMKFLAS---KKFVHR 155
Query: 467 DINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTK---GYMAPEYLENGLVS 523
           D+ + N +LD     K+A+F +AR  +  + EF    +  G K    +MA E L+    +
Sbjct: 156 DLAARNCMLDEKFTVKVADFGLAR--DMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFT 213
Query: 524 TKLDVYAFGVLILEMLT 540
           TK DV++FGVL+ E++T
Sbjct: 214 TKSDVWSFGVLLWELMT 230

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 63/197 (31%), Positives = 102/197 (51%), Gaps = 25/197 (12%)
Query: 361 GSVYRGKI--NGG---FAAIKKVN-----GDVSK---EIALLNKINHSNLIILSGVCF-N 406
           G VY G +  N G     A+K +N     G+VS+   E  ++   +H N++ L G+C  +
Sbjct: 45  GCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS 104
Query: 407 EGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHK 466
           EG+  +V  Y  +G L +++   +NE      K  I   L VA G+ +L S      VH+
Sbjct: 105 EGSPLVVLPYMKHGDLRNFI---RNETHNPTVKDLIGFGLQVAKGMKFLAS---KKFVHR 158
Query: 467 DINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTK---GYMAPEYLENGLVS 523
           D+ + N +LD     K+A+F +AR  +  + EF    +  G K    +MA E L+    +
Sbjct: 159 DLAARNCMLDEKFTVKVADFGLAR--DMLDKEFDSVHNKTGAKLPVKWMALESLQTQKFT 216
Query: 524 TKLDVYAFGVLILEMLT 540
           TK DV++FGVL+ E++T
Sbjct: 217 TKSDVWSFGVLLWELMT 233

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 75/299 (25%), Positives = 137/299 (45%), Gaps = 46/299 (15%)
Query: 361 GSVYRGKINGGFAAIK------KVNGDVSKEIALLNKINHSNLIILSGVCFNEGNC---- 410
           G V++ ++   F A+K      K +    +EI     + H NL+          N     
Sbjct: 29  GCVWKAQLMNDFVAVKIFPLQDKQSWQSEREIFSTPGMKHENLLQFIAAEKRGSNLEVEL 88
Query: 411 YLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFT--------NPP 462
           +L+  +   G+L+D++     +G  + W +   +A  ++ GL+YLH            P 
Sbjct: 89  WLITAFHDKGSLTDYL-----KGNIITWNELCHVAETMSRGLSYLHEDVPWCRGEGHKPS 143
Query: 463 HVHKDINSSNVLLDSDLRAKIANFAMA------RPAEGQEGEFALTRHIVGTKGYMAPEY 516
             H+D  S NVLL SDL A +A+F +A      +P     G+       VGT+ YMAPE 
Sbjct: 144 IAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQ-------VGTRRYMAPEV 196
Query: 517 LENGL-----VSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEE 571
           LE  +        ++D+YA G+++ E+++  +AA    +E  +   + +    + E+ +E
Sbjct: 197 LEGAINFQRDAFLRIDMYAMGLVLWELVSRCKAADGPVDEYMLPFEEEIGQHPSLEELQE 256
Query: 572 SLRH-FIDPTLQGNYPLE--LALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNASLN 627
            + H  + PT++ ++     LA L +  I+ C   D   R +   +E  +S ++  S+N
Sbjct: 257 VVVHKKMRPTIKDHWLKHPGLAQLCV-TIEECWDHDAEARLSAGCVEERVS-LIRRSVN 313

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 79.0 bits (193), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 56/186 (30%), Positives = 90/186 (48%), Gaps = 17/186 (9%)
Query: 361 GSVYRGKINGGFAAIKKVNGDVSK-----EIALLNKINHSNLIILSGVCFNE-GNCYLVY 414
           G V  G   G   A+K +  D +      E +++ ++ HSNL+ L GV   E G  Y+V 
Sbjct: 207 GDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 266
Query: 415 EYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVL 474
           EY   G+L D++ S       L     ++ +LDV   + YL        VH+D+ + NVL
Sbjct: 267 EYMAKGSLVDYLRSRGRS--VLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVL 321
Query: 475 LDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVL 534
           +  D  AK+++F + + A   +    L         + APE L     STK DV++FG+L
Sbjct: 322 VSEDNVAKVSDFGLTKEASSTQDTGKLPVK------WTAPEALREKKFSTKSDVWSFGIL 375
Query: 535 ILEMLT 540
           + E+ +
Sbjct: 376 LWEIYS 381

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 79.0 bits (193), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 56/194 (28%), Positives = 99/194 (51%), Gaps = 18/194 (9%)
Query: 361 GSVYRG--KINGGFAAIKKVN-----GDVSKEIALLNKINHSNLIILSGVCFNEGNCYLV 413
           GSVY+   K  G   AIK+V       ++ KEI+++ + +  +++   G  F   + ++V
Sbjct: 43  GSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIV 102
Query: 414 YEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNV 473
            EY   G++SD +   +   K L   +   I      GL YLH       +H+DI + N+
Sbjct: 103 MEYCGAGSVSDII---RLRNKTLTEDEIATILQSTLKGLEYLHFMRK---IHRDIKAGNI 156
Query: 474 LLDSDLRAKIANFAMARPAEGQEGEFALTRH-IVGTKGYMAPEYLENGLVSTKLDVYAFG 532
           LL+++  AK+A+F +A    GQ  +    R+ ++GT  +MAPE ++    +   D+++ G
Sbjct: 157 LLNTEGHAKLADFGVA----GQLTDXMAKRNXVIGTPFWMAPEVIQEIGYNCVADIWSLG 212
Query: 533 VLILEMLTGKEAAA 546
           +  +EM  GK   A
Sbjct: 213 ITAIEMAEGKPPYA 226

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 73/272 (26%), Positives = 122/272 (44%), Gaps = 34/272 (12%)
Query: 361 GSVYRGKINGGF-AAIKKVN-GDVSK-----EIALLNKINHSNLIILSGVCFNEGNCYLV 413
           G V+ G  NG    A+K +  G +S      E  L+ ++ H  L+ L  V   E   Y++
Sbjct: 37  GEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQE-PIYII 95
Query: 414 YEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNV 473
            EY  NG+L D  F     G  L   + + +A  +A G+ ++       ++H+D+ ++N+
Sbjct: 96  TEYMENGSLVD--FLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANI 150
Query: 474 LLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGV 533
           L+   L  KIA+F +AR  E  + E+           + APE +  G  + K DV++FG+
Sbjct: 151 LVSDTLSCKIADFGLARLIE--DNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGI 208
Query: 534 LILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLV 593
           L+ E++T             M   +V+  +   E G   +R         N P EL    
Sbjct: 209 LLTEIVTHGRIPY-----PGMTNPEVIQNL---ERGYRMVR-------PDNCPEEL---- 249
Query: 594 IRLIDACLKKDPTDRPTMYEIEHSLSNILNAS 625
            +L+  C K+ P DRPT   +   L +   A+
Sbjct: 250 YQLMRLCWKERPEDRPTFDYLRSVLEDFFTAT 281

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/197 (31%), Positives = 101/197 (51%), Gaps = 25/197 (12%)
Query: 361 GSVYRGKI--NGG---FAAIKKVN-----GDVSK---EIALLNKINHSNLIILSGVCF-N 406
           G VY G +  N G     A+K +N     G+VS+   E  ++   +H N++ L G+C  +
Sbjct: 43  GCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS 102
Query: 407 EGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHK 466
           EG+  +V  Y  +G L +++   +NE      K  I   L VA G+ YL S      VH+
Sbjct: 103 EGSPLVVLPYMKHGDLRNFI---RNETHNPTVKDLIGFGLQVAKGMKYLAS---KKFVHR 156
Query: 467 DINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTK---GYMAPEYLENGLVS 523
           D+ + N +LD     K+A+F +AR  +  + E     +  G K    +MA E L+    +
Sbjct: 157 DLAARNCMLDEKFTVKVADFGLAR--DMYDKEXXSVHNKTGAKLPVKWMALESLQTQKFT 214
Query: 524 TKLDVYAFGVLILEMLT 540
           TK DV++FGVL+ E++T
Sbjct: 215 TKSDVWSFGVLLWELMT 231

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 73/272 (26%), Positives = 122/272 (44%), Gaps = 34/272 (12%)
Query: 361 GSVYRGKINGGF-AAIKKVN-GDVS-----KEIALLNKINHSNLIILSGVCFNEGNCYLV 413
           G V+ G  NG    A+K +  G +S      E  L+ ++ H  L+ L  V   E   Y++
Sbjct: 33  GEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEP-IYII 91
Query: 414 YEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNV 473
            EY  NG+L D  F     G  L   + + +A  +A G+ ++       ++H+D+ ++N+
Sbjct: 92  TEYMENGSLVD--FLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANI 146
Query: 474 LLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGV 533
           L+   L  KIA+F +AR  E  + E+           + APE +  G  + K DV++FG+
Sbjct: 147 LVSDTLSCKIADFGLARLIE--DNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGI 204
Query: 534 LILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLV 593
           L+ E++T             M   +V+  +   E G   +R         N P EL    
Sbjct: 205 LLTEIVTHGRIPY-----PGMTNPEVIQNL---ERGYRMVR-------PDNCPEEL---- 245
Query: 594 IRLIDACLKKDPTDRPTMYEIEHSLSNILNAS 625
            +L+  C K+ P DRPT   +   L +   A+
Sbjct: 246 YQLMRLCWKERPEDRPTFDYLRSVLEDFFTAT 277

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 56/184 (30%), Positives = 89/184 (48%), Gaps = 17/184 (9%)
Query: 361 GSVYRGKINGGFAAIKKVNGDVSK-----EIALLNKINHSNLIILSGVCFNE-GNCYLVY 414
           G V  G   G   A+K +  D +      E +++ ++ HSNL+ L GV   E G  Y+V 
Sbjct: 35  GDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 94
Query: 415 EYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVL 474
           EY   G+L D++ S       L     ++ +LDV   + YL        VH+D+ + NVL
Sbjct: 95  EYMAKGSLVDYLRSRGRS--VLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVL 149
Query: 475 LDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVL 534
           +  D  AK+++F + + A   +    L         + APE L     STK DV++FG+L
Sbjct: 150 VSEDNVAKVSDFGLTKEASSTQDTGKLPVK------WTAPEALREKKFSTKSDVWSFGIL 203
Query: 535 ILEM 538
           + E+
Sbjct: 204 LWEI 207

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 56/184 (30%), Positives = 89/184 (48%), Gaps = 17/184 (9%)
Query: 361 GSVYRGKINGGFAAIKKVNGDVSK-----EIALLNKINHSNLIILSGVCFNE-GNCYLVY 414
           G V  G   G   A+K +  D +      E +++ ++ HSNL+ L GV   E G  Y+V 
Sbjct: 20  GDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 79
Query: 415 EYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVL 474
           EY   G+L D++ S       L     ++ +LDV   + YL        VH+D+ + NVL
Sbjct: 80  EYMAKGSLVDYLRSRGRS--VLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVL 134
Query: 475 LDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVL 534
           +  D  AK+++F + + A   +    L         + APE L     STK DV++FG+L
Sbjct: 135 VSEDNVAKVSDFGLTKEASSTQDTGKLPVK------WTAPEALREKKFSTKSDVWSFGIL 188
Query: 535 ILEM 538
           + E+
Sbjct: 189 LWEI 192

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 73/272 (26%), Positives = 122/272 (44%), Gaps = 34/272 (12%)
Query: 361 GSVYRGKINGGF-AAIKKVN-GDVS-----KEIALLNKINHSNLIILSGVCFNEGNCYLV 413
           G V+ G  NG    A+K +  G +S      E  L+ ++ H  L+ L  V   E   Y++
Sbjct: 32  GEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEP-IYII 90
Query: 414 YEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNV 473
            EY  NG+L D  F     G  L   + + +A  +A G+ ++       ++H+D+ ++N+
Sbjct: 91  TEYMENGSLVD--FLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANI 145
Query: 474 LLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGV 533
           L+   L  KIA+F +AR  E  + E+           + APE +  G  + K DV++FG+
Sbjct: 146 LVSDTLSCKIADFGLARLIE--DNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGI 203
Query: 534 LILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLV 593
           L+ E++T             M   +V+  +   E G   +R         N P EL    
Sbjct: 204 LLTEIVTHGRIPY-----PGMTNPEVIQNL---ERGYRMVR-------PDNCPEEL---- 244
Query: 594 IRLIDACLKKDPTDRPTMYEIEHSLSNILNAS 625
            +L+  C K+ P DRPT   +   L +   A+
Sbjct: 245 YQLMRLCWKERPEDRPTFDYLRSVLEDFFTAT 276

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 55/180 (30%), Positives = 90/180 (50%), Gaps = 17/180 (9%)
Query: 374 AIKKVNGDVSKEIALLNKI-NHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNE 432
           A +K   D+  E+ ++  I  H N+I L G C  +G  Y++ EYA  G L +++ + +  
Sbjct: 72  ATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPP 131
Query: 433 G------------KYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLR 480
           G            + L  K  +  A  VA G+ YL S      +H+D+ + NVL+  D  
Sbjct: 132 GLEFSFNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKC---IHRDLAARNVLVTEDNV 188
Query: 481 AKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT 540
            KIA+F +AR     +     T   +  K +MAPE L + + + + DV++FGVL+ E+ T
Sbjct: 189 MKIADFGLARDIHHIDXXKKTTNGRLPVK-WMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 76/268 (28%), Positives = 111/268 (41%), Gaps = 54/268 (20%)
Query: 361 GSVY--RGKINGGFAAIKKVN----------GDVSKEIALLNKINHSNLIILSGVCFNEG 408
           G+VY  R   N    AIKK++           D+ KE+  L K+ H N I   G    E 
Sbjct: 68  GAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREH 127
Query: 409 NCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIAL---DVATGLNYLHSFTNPPHVH 465
             +LV EY + G+ SD +  +K         Q ++IA        GL YLHS      +H
Sbjct: 128 TAWLVMEYCL-GSASDLLEVHKKP------LQEVEIAAVTHGALQGLAYLHSHNM---IH 177
Query: 466 KDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEY---LENGLV 522
           +D+ + N+LL      K+ +F       G     A     VGT  +MAPE    ++ G  
Sbjct: 178 RDVKAGNILLSEPGLVKLGDF-------GSASIMAPANXFVGTPYWMAPEVILAMDEGQY 230
Query: 523 STKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQ 582
             K+DV++ G+  +E+   K          NM+    L  +   E           P LQ
Sbjct: 231 DGKVDVWSLGITCIELAERKPPLF------NMNAMSALYHIAQNE----------SPALQ 274
Query: 583 GNYPLELALLVIRLIDACLKKDPTDRPT 610
             +  E        +D+CL+K P DRPT
Sbjct: 275 SGHWSE---YFRNFVDSCLQKIPQDRPT 299

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 73/272 (26%), Positives = 122/272 (44%), Gaps = 34/272 (12%)
Query: 361 GSVYRGKINGGF-AAIKKVN-GDVS-----KEIALLNKINHSNLIILSGVCFNEGNCYLV 413
           G V+ G  NG    A+K +  G +S      E  L+ ++ H  L+ L  V   E   Y++
Sbjct: 27  GEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEP-IYII 85
Query: 414 YEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNV 473
            EY  NG+L D  F     G  L   + + +A  +A G+ ++       ++H+D+ ++N+
Sbjct: 86  TEYMENGSLVD--FLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANI 140
Query: 474 LLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGV 533
           L+   L  KIA+F +AR  E  + E+           + APE +  G  + K DV++FG+
Sbjct: 141 LVSDTLSCKIADFGLARLIE--DNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGI 198
Query: 534 LILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLV 593
           L+ E++T             M   +V+  +   E G   +R         N P EL    
Sbjct: 199 LLTEIVTHGRIPY-----PGMTNPEVIQNL---ERGYRMVR-------PDNCPEEL---- 239
Query: 594 IRLIDACLKKDPTDRPTMYEIEHSLSNILNAS 625
            +L+  C K+ P DRPT   +   L +   A+
Sbjct: 240 YQLMRLCWKERPEDRPTFDYLRSVLEDFFTAT 271

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 76/268 (28%), Positives = 111/268 (41%), Gaps = 54/268 (20%)
Query: 361 GSVY--RGKINGGFAAIKKVN----------GDVSKEIALLNKINHSNLIILSGVCFNEG 408
           G+VY  R   N    AIKK++           D+ KE+  L K+ H N I   G    E 
Sbjct: 29  GAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREH 88
Query: 409 NCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIAL---DVATGLNYLHSFTNPPHVH 465
             +LV EY + G+ SD +  +K         Q ++IA        GL YLHS      +H
Sbjct: 89  TAWLVMEYCL-GSASDLLEVHKKP------LQEVEIAAVTHGALQGLAYLHSHNM---IH 138
Query: 466 KDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEY---LENGLV 522
           +D+ + N+LL      K+ +F       G     A     VGT  +MAPE    ++ G  
Sbjct: 139 RDVKAGNILLSEPGLVKLGDF-------GSASIMAPANXFVGTPYWMAPEVILAMDEGQY 191
Query: 523 STKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQ 582
             K+DV++ G+  +E+   K          NM+    L  +   E           P LQ
Sbjct: 192 DGKVDVWSLGITCIELAERKPPLF------NMNAMSALYHIAQNE----------SPALQ 235
Query: 583 GNYPLELALLVIRLIDACLKKDPTDRPT 610
             +  E        +D+CL+K P DRPT
Sbjct: 236 SGHWSE---YFRNFVDSCLQKIPQDRPT 260

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 76/275 (27%), Positives = 123/275 (44%), Gaps = 40/275 (14%)
Query: 361 GSVYRGKINGGF-AAIKKVN-GDVSK-----EIALLNKINHSNLIILSGVCFNEGNCYLV 413
           G V+ G  NG    A+K +  G +S      E  L+ ++ H  L+ L  V   E   Y++
Sbjct: 35  GEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQE-PIYII 93
Query: 414 YEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNV 473
            EY  NG+L D  F     G  L   + + +A  +A G+ ++       ++H+D+ ++N+
Sbjct: 94  TEYMENGSLVD--FLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANI 148
Query: 474 LLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTK---GYMAPEYLENGLVSTKLDVYA 530
           L+   L  KIA+F +AR  E  E      R   G K    + APE +  G  + K DV++
Sbjct: 149 LVSDTLSCKIADFGLARLIEDNE---XTARE--GAKFPIKWTAPEAINYGTFTIKSDVWS 203
Query: 531 FGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELA 590
           FG+L+ E++T             M   +V+  +   E G   +R         N P EL 
Sbjct: 204 FGILLTEIVTHGRIPY-----PGMTNPEVIQNL---ERGYRMVR-------PDNCPEEL- 247
Query: 591 LLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNAS 625
               +L+  C K+ P DRPT   +   L +   A+
Sbjct: 248 ---YQLMRLCWKERPEDRPTFDYLRSVLEDFFTAT 279

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/252 (25%), Positives = 113/252 (44%), Gaps = 39/252 (15%)
Query: 381 DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQ 440
           D  +E  ++ K++H  L+ L GVC  +    LV+E+  +G LSD++ + +        + 
Sbjct: 48  DFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRG---LFAAET 104
Query: 441 RIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFA 500
            + + LDV  G+ YL        +H+D+ + N L+  +   K+++F M R        F 
Sbjct: 105 LLGMCLDVCEGMAYLEEACV---IHRDLAARNCLVGENQVIKVSDFGMTR--------FV 153
Query: 501 LTRHIVGTKG------YMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNM 554
           L      + G      + +PE       S+K DV++FGVL+ E+ +  E    +   +N 
Sbjct: 154 LDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFS--EGKIPYENRSN- 210
Query: 555 HLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEI 614
             S+V+      ED     R +  P L   +       V ++++ C K+ P DRP    +
Sbjct: 211 --SEVV------EDISTGFRLY-KPRLASTH-------VYQIMNHCWKERPEDRPAFSRL 254
Query: 615 EHSLSNILNASL 626
              L+ I  + L
Sbjct: 255 LRQLAEIAESGL 266

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 76/275 (27%), Positives = 123/275 (44%), Gaps = 40/275 (14%)
Query: 361 GSVYRGKINGGF-AAIKKVN-GDVSK-----EIALLNKINHSNLIILSGVCFNEGNCYLV 413
           G V+ G  NG    A+K +  G +S      E  L+ ++ H  L+ L  V   E   Y++
Sbjct: 36  GEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQE-PIYII 94
Query: 414 YEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNV 473
            EY  NG+L D  F     G  L   + + +A  +A G+ ++       ++H+D+ ++N+
Sbjct: 95  TEYMENGSLVD--FLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANI 149
Query: 474 LLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTK---GYMAPEYLENGLVSTKLDVYA 530
           L+   L  KIA+F +AR  E  E      R   G K    + APE +  G  + K DV++
Sbjct: 150 LVSDTLSCKIADFGLARLIEDNE---XTARE--GAKFPIKWTAPEAINYGTFTIKSDVWS 204
Query: 531 FGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELA 590
           FG+L+ E++T             M   +V+  +   E G   +R         N P EL 
Sbjct: 205 FGILLTEIVTHGRIPY-----PGMTNPEVIQNL---ERGYRMVR-------PDNCPEEL- 248
Query: 591 LLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNAS 625
               +L+  C K+ P DRPT   +   L +   A+
Sbjct: 249 ---YQLMRLCWKERPEDRPTFDYLRSVLEDFFTAT 280

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 76/275 (27%), Positives = 123/275 (44%), Gaps = 40/275 (14%)
Query: 361 GSVYRGKINGGF-AAIKKVN-GDVSK-----EIALLNKINHSNLIILSGVCFNEGNCYLV 413
           G V+ G  NG    A+K +  G +S      E  L+ ++ H  L+ L  V   E   Y++
Sbjct: 33  GEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEP-IYII 91
Query: 414 YEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNV 473
            EY  NG+L D  F     G  L   + + +A  +A G+ ++       ++H+D+ ++N+
Sbjct: 92  TEYMENGSLVD--FLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANI 146
Query: 474 LLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTK---GYMAPEYLENGLVSTKLDVYA 530
           L+   L  KIA+F +AR  E  E      R   G K    + APE +  G  + K DV++
Sbjct: 147 LVSDTLSCKIADFGLARLIEDNE---XTARE--GAKFPIKWTAPEAINYGTFTIKSDVWS 201
Query: 531 FGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELA 590
           FG+L+ E++T             M   +V+  +   E G   +R         N P EL 
Sbjct: 202 FGILLTEIVTHGRIPY-----PGMTNPEVIQNL---ERGYRMVR-------PDNCPEEL- 245
Query: 591 LLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNAS 625
               +L+  C K+ P DRPT   +   L +   A+
Sbjct: 246 ---YQLMRLCWKERPEDRPTFDYLRSVLEDFFTAT 277

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/252 (25%), Positives = 113/252 (44%), Gaps = 39/252 (15%)
Query: 381 DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQ 440
           D  +E  ++ K++H  L+ L GVC  +    LV+E+  +G LSD++ + +        + 
Sbjct: 68  DFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRG---LFAAET 124
Query: 441 RIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFA 500
            + + LDV  G+ YL        +H+D+ + N L+  +   K+++F M R        F 
Sbjct: 125 LLGMCLDVCEGMAYLEEACV---IHRDLAARNCLVGENQVIKVSDFGMTR--------FV 173
Query: 501 LTRHIVGTKG------YMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNM 554
           L      + G      + +PE       S+K DV++FGVL+ E+ +  E    +   +N 
Sbjct: 174 LDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFS--EGKIPYENRSN- 230
Query: 555 HLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEI 614
             S+V+      ED     R +  P L   +       V ++++ C K+ P DRP    +
Sbjct: 231 --SEVV------EDISTGFRLY-KPRLASTH-------VYQIMNHCWKERPEDRPAFSRL 274
Query: 615 EHSLSNILNASL 626
              L+ I  + L
Sbjct: 275 LRQLAEIAESGL 286

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 73/277 (26%), Positives = 118/277 (42%), Gaps = 42/277 (15%)
Query: 361 GSVYRG--KINGGFAAIKKVNGDVS------KEIALLNKINHSNLIILSGVCFNEGNCYL 412
           G VY G  K      A+K +  D        KE A++ +I H NL+ L GVC  E   Y+
Sbjct: 32  GEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 91
Query: 413 VYEYAVNGTLSDWVFS-NKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSS 471
           + E+   G L D++   N+ E   +     + +A  +++ + YL        +H+D+ + 
Sbjct: 92  ITEFMTYGNLLDYLRECNRQEVSAV---VLLYMATQISSAMEYLEKKN---FIHRDLAAR 145
Query: 472 NVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTK---GYMAPEYLENGLVSTKLDV 528
           N L+  +   K+A+F ++R   G       T H  G K    + APE L     S K DV
Sbjct: 146 NCLVGENHLVKVADFGLSRLMTGD----TYTAH-AGAKFPIKWTAPESLAYNKFSIKSDV 200
Query: 529 YAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLE 588
           +AFGVL+ E+ T   +         + LS V                 ++   +   P  
Sbjct: 201 WAFGVLLWEIATYGMSPY-----PGIDLSQVYE--------------LLEKDYRMERPEG 241
Query: 589 LALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNAS 625
               V  L+ AC + +P+DRP+  EI  +   +   S
Sbjct: 242 CPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 278

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 76/275 (27%), Positives = 123/275 (44%), Gaps = 40/275 (14%)
Query: 361 GSVYRGKINGGF-AAIKKV-NGDVSK-----EIALLNKINHSNLIILSGVCFNEGNCYLV 413
           G V+ G  NG    A+K +  G +S      E  L+ ++ H  L+ L  V   E   Y++
Sbjct: 27  GEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQE-PIYII 85
Query: 414 YEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNV 473
            EY  NG+L D  F     G  L   + + +A  +A G+ ++       ++H+D+ ++N+
Sbjct: 86  TEYMENGSLVD--FLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANI 140
Query: 474 LLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTK---GYMAPEYLENGLVSTKLDVYA 530
           L+   L  KIA+F +AR  E  E      R   G K    + APE +  G  + K DV++
Sbjct: 141 LVSDTLSCKIADFGLARLIEDNE---XTARE--GAKFPIKWTAPEAINYGTFTIKSDVWS 195
Query: 531 FGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELA 590
           FG+L+ E++T             M   +V+  +   E G   +R         N P EL 
Sbjct: 196 FGILLTEIVTHGRIPY-----PGMTNPEVIQNL---ERGYRMVR-------PDNCPEEL- 239
Query: 591 LLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNAS 625
               +L+  C K+ P DRPT   +   L +   A+
Sbjct: 240 ---YQLMRLCWKERPEDRPTFDYLRSVLEDFFTAT 271

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 73/277 (26%), Positives = 118/277 (42%), Gaps = 42/277 (15%)
Query: 361 GSVYRG--KINGGFAAIKKVNGDVS------KEIALLNKINHSNLIILSGVCFNEGNCYL 412
           G VY G  K      A+K +  D        KE A++ +I H NL+ L GVC  E   Y+
Sbjct: 27  GEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 86
Query: 413 VYEYAVNGTLSDWVFS-NKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSS 471
           + E+   G L D++   N+ E   +     + +A  +++ + YL        +H+D+ + 
Sbjct: 87  IIEFMTYGNLLDYLRECNRQEVSAV---VLLYMATQISSAMEYLE---KKNFIHRDLAAR 140
Query: 472 NVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTK---GYMAPEYLENGLVSTKLDV 528
           N L+  +   K+A+F ++R   G       T H  G K    + APE L     S K DV
Sbjct: 141 NCLVGENHLVKVADFGLSRLMTGD----TYTAH-AGAKFPIKWTAPESLAYNKFSIKSDV 195
Query: 529 YAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLE 588
           +AFGVL+ E+ T   +         + LS V                 ++   +   P  
Sbjct: 196 WAFGVLLWEIATYGMSPY-----PGIDLSQVYE--------------LLEKDYRMERPEG 236
Query: 589 LALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNAS 625
               V  L+ AC + +P+DRP+  EI  +   +   S
Sbjct: 237 CPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 273

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 73/277 (26%), Positives = 118/277 (42%), Gaps = 42/277 (15%)
Query: 361 GSVYRG--KINGGFAAIKKVNGDVS------KEIALLNKINHSNLIILSGVCFNEGNCYL 412
           G VY G  K      A+K +  D        KE A++ +I H NL+ L GVC  E   Y+
Sbjct: 28  GEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 87
Query: 413 VYEYAVNGTLSDWVFS-NKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSS 471
           + E+   G L D++   N+ E   +     + +A  +++ + YL        +H+D+ + 
Sbjct: 88  IIEFMTYGNLLDYLRECNRQEVNAV---VLLYMATQISSAMEYLEKKN---FIHRDLAAR 141
Query: 472 NVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTK---GYMAPEYLENGLVSTKLDV 528
           N L+  +   K+A+F ++R   G       T H  G K    + APE L     S K DV
Sbjct: 142 NCLVGENHLVKVADFGLSRLMTGD----TXTAH-AGAKFPIKWTAPESLAYNKFSIKSDV 196
Query: 529 YAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLE 588
           +AFGVL+ E+ T   +         + LS V                 ++   +   P  
Sbjct: 197 WAFGVLLWEIATYGMSPY-----PGIDLSQVYE--------------LLEKDYRMERPEG 237
Query: 589 LALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNAS 625
               V  L+ AC + +P+DRP+  EI  +   +   S
Sbjct: 238 CPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 274

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 76/275 (27%), Positives = 123/275 (44%), Gaps = 40/275 (14%)
Query: 361 GSVYRGKINGGF-AAIKKVN-GDVS-----KEIALLNKINHSNLIILSGVCFNEGNCYLV 413
           G V+ G  NG    A+K +  G +S      E  L+ ++ H  L+ L  V   E   Y++
Sbjct: 27  GEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQE-PIYII 85
Query: 414 YEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNV 473
            EY  NG+L D  F     G  L   + + +A  +A G+ ++       ++H+D+ ++N+
Sbjct: 86  TEYMENGSLVD--FLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANI 140
Query: 474 LLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTK---GYMAPEYLENGLVSTKLDVYA 530
           L+   L  KIA+F +AR  E  E      R   G K    + APE +  G  + K DV++
Sbjct: 141 LVSDTLSCKIADFGLARLIEDAE---XTARE--GAKFPIKWTAPEAINYGTFTIKSDVWS 195
Query: 531 FGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELA 590
           FG+L+ E++T             M   +V+  +   E G   +R         N P EL 
Sbjct: 196 FGILLTEIVTHGRIPY-----PGMTNPEVIQNL---ERGYRMVR-------PDNCPEEL- 239
Query: 591 LLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNAS 625
               +L+  C K+ P DRPT   +   L +   A+
Sbjct: 240 ---YQLMRLCWKERPEDRPTFDYLRSVLEDFFTAT 271

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 48/180 (26%), Positives = 89/180 (49%), Gaps = 15/180 (8%)
Query: 370 GGFAAIKKVNG-------DVSKEIALLNKINHSNLIILSGVCFNEG--NCYLVYEYAVNG 420
           G   A+KK+         D  +EI +L  + H N++   GVC++ G  N  L+ EY   G
Sbjct: 39  GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG 98
Query: 421 TLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLR 480
           +L D++  +K     +D  + +Q    +  G+ YL +     ++H+D+ + N+L++++ R
Sbjct: 99  SLRDYLQKHKER---IDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENR 152
Query: 481 AKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT 540
            KI +F + +     +  F +         + APE L     S   DV++FGV++ E+ T
Sbjct: 153 VKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 73/277 (26%), Positives = 118/277 (42%), Gaps = 42/277 (15%)
Query: 361 GSVYRG--KINGGFAAIKKVNGDVS------KEIALLNKINHSNLIILSGVCFNEGNCYL 412
           G VY G  K      A+K +  D        KE A++ +I H NL+ L GVC  E   Y+
Sbjct: 31  GEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 90
Query: 413 VYEYAVNGTLSDWVFS-NKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSS 471
           + E+   G L D++   N+ E   +     + +A  +++ + YL        +H+D+ + 
Sbjct: 91  ITEFMTYGNLLDYLRECNRQEVNAV---VLLYMATQISSAMEYLEKKN---FIHRDLAAR 144
Query: 472 NVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTK---GYMAPEYLENGLVSTKLDV 528
           N L+  +   K+A+F ++R   G       T H  G K    + APE L     S K DV
Sbjct: 145 NCLVGENHLVKVADFGLSRLMTGD----TYTAH-AGAKFPIKWTAPESLAYNKFSIKSDV 199
Query: 529 YAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLE 588
           +AFGVL+ E+ T   +         + LS V                 ++   +   P  
Sbjct: 200 WAFGVLLWEIATYGMSPY-----PGIDLSQVYE--------------LLEKDYRMERPEG 240
Query: 589 LALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNAS 625
               V  L+ AC + +P+DRP+  EI  +   +   S
Sbjct: 241 CPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 277

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/252 (25%), Positives = 113/252 (44%), Gaps = 39/252 (15%)
Query: 381 DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQ 440
           D  +E  ++ K++H  L+ L GVC  +    LV+E+  +G LSD++ + +        + 
Sbjct: 46  DFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRG---LFAAET 102
Query: 441 RIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFA 500
            + + LDV  G+ YL        +H+D+ + N L+  +   K+++F M R        F 
Sbjct: 103 LLGMCLDVCEGMAYLEEACV---IHRDLAARNCLVGENQVIKVSDFGMTR--------FV 151
Query: 501 LTRHIVGTKG------YMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNM 554
           L      + G      + +PE       S+K DV++FGVL+ E+ +  E    +   +N 
Sbjct: 152 LDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFS--EGKIPYENRSN- 208
Query: 555 HLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEI 614
             S+V+      ED     R +  P L   +       V ++++ C K+ P DRP    +
Sbjct: 209 --SEVV------EDISTGFRLY-KPRLASTH-------VYQIMNHCWKERPEDRPAFSRL 252
Query: 615 EHSLSNILNASL 626
              L+ I  + L
Sbjct: 253 LRQLAEIAESGL 264

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 76/275 (27%), Positives = 123/275 (44%), Gaps = 40/275 (14%)
Query: 361 GSVYRGKINGGF-AAIKKVN-GDVS-----KEIALLNKINHSNLIILSGVCFNEGNCYLV 413
           G V+ G  NG    A+K +  G +S      E  L+ ++ H  L+ L  V   E   Y++
Sbjct: 29  GEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEP-IYII 87
Query: 414 YEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNV 473
            EY  NG+L D  F     G  L   + + +A  +A G+ ++       ++H+D+ ++N+
Sbjct: 88  TEYMENGSLVD--FLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANI 142
Query: 474 LLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTK---GYMAPEYLENGLVSTKLDVYA 530
           L+   L  KIA+F +AR  E  E      R   G K    + APE +  G  + K DV++
Sbjct: 143 LVSDTLSCKIADFGLARLIEDNE---XTARE--GAKFPIKWTAPEAINYGTFTIKSDVWS 197
Query: 531 FGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELA 590
           FG+L+ E++T             M   +V+  +   E G   +R         N P EL 
Sbjct: 198 FGILLTEIVTHGRIPY-----PGMTNPEVIQNL---ERGYRMVR-------PDNCPEEL- 241
Query: 591 LLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNAS 625
               +L+  C K+ P DRPT   +   L +   A+
Sbjct: 242 ---YQLMRLCWKERPEDRPTFDYLRSVLEDFFTAT 273

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 73/277 (26%), Positives = 118/277 (42%), Gaps = 42/277 (15%)
Query: 361 GSVYRG--KINGGFAAIKKVNGDVS------KEIALLNKINHSNLIILSGVCFNEGNCYL 412
           G VY G  K      A+K +  D        KE A++ +I H NL+ L GVC  E   Y+
Sbjct: 27  GEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 86
Query: 413 VYEYAVNGTLSDWVFS-NKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSS 471
           + E+   G L D++   N+ E   +     + +A  +++ + YL        +H+D+ + 
Sbjct: 87  ITEFMTYGNLLDYLRECNRQEVSAV---VLLYMATQISSAMEYLE---KKNFIHRDLAAR 140
Query: 472 NVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTK---GYMAPEYLENGLVSTKLDV 528
           N L+  +   K+A+F ++R   G       T H  G K    + APE L     S K DV
Sbjct: 141 NCLVGENHLVKVADFGLSRLMTGD----TYTAH-AGAKFPIKWTAPESLAYNKFSIKSDV 195
Query: 529 YAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLE 588
           +AFGVL+ E+ T   +         + LS V                 ++   +   P  
Sbjct: 196 WAFGVLLWEIATYGMSPY-----PGIDLSQVYE--------------LLEKDYRMERPEG 236
Query: 589 LALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNAS 625
               V  L+ AC + +P+DRP+  EI  +   +   S
Sbjct: 237 CPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 273

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 73/277 (26%), Positives = 119/277 (42%), Gaps = 42/277 (15%)
Query: 361 GSVYRG--KINGGFAAIKKVNGDVS------KEIALLNKINHSNLIILSGVCFNEGNCYL 412
           G VY G  K      A+K +  D        KE A++ +I H NL+ L GVC  E   Y+
Sbjct: 32  GEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 91
Query: 413 VYEYAVNGTLSDWVFS-NKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSS 471
           + E+   G L D++   N+ E   ++    + +A  +++ + YL        +H+D+ + 
Sbjct: 92  ITEFMTYGNLLDYLRECNRQE---VNAVVLLYMATQISSAMEYLEKKN---FIHRDLAAR 145
Query: 472 NVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTK---GYMAPEYLENGLVSTKLDV 528
           N L+  +   K+A+F ++R   G       T H  G K    + APE L     S K DV
Sbjct: 146 NCLVGENHLVKVADFGLSRLMTGD----TYTAH-AGAKFPIKWTAPESLAYNKFSIKSDV 200
Query: 529 YAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLE 588
           +AFGVL+ E+ T   +         + LS V                 ++   +   P  
Sbjct: 201 WAFGVLLWEIATYGMSPY-----PGIDLSQVYE--------------LLEKDYRMERPEG 241
Query: 589 LALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNAS 625
               V  L+ AC + +P+DRP+  EI  +   +   S
Sbjct: 242 CPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 278

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 73/277 (26%), Positives = 118/277 (42%), Gaps = 42/277 (15%)
Query: 361 GSVYRG--KINGGFAAIKKVNGDVS------KEIALLNKINHSNLIILSGVCFNEGNCYL 412
           G VY G  K      A+K +  D        KE A++ +I H NL+ L GVC  E   Y+
Sbjct: 27  GEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 86
Query: 413 VYEYAVNGTLSDWVFS-NKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSS 471
           + E+   G L D++   N+ E   +     + +A  +++ + YL        +H+D+ + 
Sbjct: 87  ITEFMTYGNLLDYLRECNRQEVNAV---VLLYMATQISSAMEYLEKKN---FIHRDLAAR 140
Query: 472 NVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTK---GYMAPEYLENGLVSTKLDV 528
           N L+  +   K+A+F ++R   G       T H  G K    + APE L     S K DV
Sbjct: 141 NCLVGENHLVKVADFGLSRLMTGD----TYTAH-AGAKFPIKWTAPESLAYNKFSIKSDV 195
Query: 529 YAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLE 588
           +AFGVL+ E+ T   +         + LS V                 ++   +   P  
Sbjct: 196 WAFGVLLWEIATYGMSPY-----PGIDLSQVYE--------------LLEKDYRMERPEG 236
Query: 589 LALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNAS 625
               V  L+ AC + +P+DRP+  EI  +   +   S
Sbjct: 237 CPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 273

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 73/277 (26%), Positives = 118/277 (42%), Gaps = 42/277 (15%)
Query: 361 GSVYRG--KINGGFAAIKKVNGDVS------KEIALLNKINHSNLIILSGVCFNEGNCYL 412
           G VY G  K      A+K +  D        KE A++ +I H NL+ L GVC  E   Y+
Sbjct: 27  GEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 86
Query: 413 VYEYAVNGTLSDWVFS-NKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSS 471
           + E+   G L D++   N+ E   +     + +A  +++ + YL        +H+D+ + 
Sbjct: 87  ITEFMTYGNLLDYLRECNRQEVSAV---VLLYMATQISSAMEYLE---KKNFIHRDLAAR 140
Query: 472 NVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTK---GYMAPEYLENGLVSTKLDV 528
           N L+  +   K+A+F ++R   G       T H  G K    + APE L     S K DV
Sbjct: 141 NCLVGENHLVKVADFGLSRLMTGD----TYTAH-AGAKFPIKWTAPESLAYNKFSIKSDV 195
Query: 529 YAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLE 588
           +AFGVL+ E+ T   +         + LS V                 ++   +   P  
Sbjct: 196 WAFGVLLWEIATYGMSPY-----PGIDLSQVYE--------------LLEKDYRMERPEG 236
Query: 589 LALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNAS 625
               V  L+ AC + +P+DRP+  EI  +   +   S
Sbjct: 237 CPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 273

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 73/277 (26%), Positives = 118/277 (42%), Gaps = 42/277 (15%)
Query: 361 GSVYRG--KINGGFAAIKKVNGDVS------KEIALLNKINHSNLIILSGVCFNEGNCYL 412
           G VY G  K      A+K +  D        KE A++ +I H NL+ L GVC  E   Y+
Sbjct: 32  GEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 91
Query: 413 VYEYAVNGTLSDWVFS-NKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSS 471
           + E+   G L D++   N+ E   +     + +A  +++ + YL        +H+D+ + 
Sbjct: 92  ITEFMTYGNLLDYLRECNRQEVNAV---VLLYMATQISSAMEYLEKKN---FIHRDLAAR 145
Query: 472 NVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTK---GYMAPEYLENGLVSTKLDV 528
           N L+  +   K+A+F ++R   G       T H  G K    + APE L     S K DV
Sbjct: 146 NCLVGENHLVKVADFGLSRLMTGD----TXTAH-AGAKFPIKWTAPESLAYNKFSIKSDV 200
Query: 529 YAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLE 588
           +AFGVL+ E+ T   +         + LS V                 ++   +   P  
Sbjct: 201 WAFGVLLWEIATYGMSPY-----PGIDLSQVYE--------------LLEKDYRMERPEG 241
Query: 589 LALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNAS 625
               V  L+ AC + +P+DRP+  EI  +   +   S
Sbjct: 242 CPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 278

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 108/240 (45%), Gaps = 30/240 (12%)
Query: 384 KEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQ 443
           +E  +L + +H N++ L GVC  +   Y+V E    G   D++   + EG  L  K  +Q
Sbjct: 161 QEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGG---DFLTFLRTEGARLRVKTLLQ 217
Query: 444 IALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTR 503
           +  D A G+ YL S      +H+D+ + N L+      KI++F M+R  E  +G +A + 
Sbjct: 218 MVGDAAAGMEYLESKCC---IHRDLAARNCLVTEKNVLKISDFGMSR--EEADGVYAASG 272
Query: 504 HI--VGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLN 561
            +  V  K + APE L  G  S++ DV++FG+L+ E  +                   L 
Sbjct: 273 GLRQVPVK-WTAPEALNYGRYSSESDVWSFGILLWETFS-------------------LG 312
Query: 562 AVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNI 621
           A        +  R F++   +   P      V RL++ C   +P  RP+   I   L +I
Sbjct: 313 ASPYPNLSNQQTREFVEKGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSI 372

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 76/275 (27%), Positives = 123/275 (44%), Gaps = 40/275 (14%)
Query: 361 GSVYRGKINGGF-AAIKKVN-GDVS-----KEIALLNKINHSNLIILSGVCFNEGNCYLV 413
           G V+ G  NG    A+K +  G +S      E  L+ ++ H  L+ L  V   E   Y++
Sbjct: 28  GEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEP-IYII 86
Query: 414 YEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNV 473
            EY  NG+L D  F     G  L   + + +A  +A G+ ++       ++H+D+ ++N+
Sbjct: 87  TEYMENGSLVD--FLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANI 141
Query: 474 LLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTK---GYMAPEYLENGLVSTKLDVYA 530
           L+   L  KIA+F +AR  E  E      R   G K    + APE +  G  + K DV++
Sbjct: 142 LVSDTLSCKIADFGLARLIEDNE---XTARE--GAKFPIKWTAPEAINYGTFTIKSDVWS 196
Query: 531 FGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELA 590
           FG+L+ E++T             M   +V+  +   E G   +R         N P EL 
Sbjct: 197 FGILLTEIVTHGRIPY-----PGMTNPEVIQNL---ERGYRMVR-------PDNCPEEL- 240
Query: 591 LLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNAS 625
               +L+  C K+ P DRPT   +   L +   A+
Sbjct: 241 ---YQLMRLCWKERPEDRPTFDYLRSVLEDFFTAT 272

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 76/275 (27%), Positives = 123/275 (44%), Gaps = 40/275 (14%)
Query: 361 GSVYRGKINGGF-AAIKKVN-GDVS-----KEIALLNKINHSNLIILSGVCFNEGNCYLV 413
           G V+ G  NG    A+K +  G +S      E  L+ ++ H  L+ L  V   E   Y++
Sbjct: 27  GEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEP-IYII 85
Query: 414 YEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNV 473
            EY  NG+L D  F     G  L   + + +A  +A G+ ++       ++H+D+ ++N+
Sbjct: 86  TEYMENGSLVD--FLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANI 140
Query: 474 LLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTK---GYMAPEYLENGLVSTKLDVYA 530
           L+   L  KIA+F +AR  E  E      R   G K    + APE +  G  + K DV++
Sbjct: 141 LVSDTLSCKIADFGLARLIEDNE---XTARE--GAKFPIKWTAPEAINYGTFTIKSDVWS 195
Query: 531 FGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELA 590
           FG+L+ E++T             M   +V+  +   E G   +R         N P EL 
Sbjct: 196 FGILLTEIVTHGRIPY-----PGMTNPEVIQNL---ERGYRMVR-------PDNCPEEL- 239
Query: 591 LLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNAS 625
               +L+  C K+ P DRPT   +   L +   A+
Sbjct: 240 ---YQLMRLCWKERPEDRPTFDYLRSVLEDFFTAT 271

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 73/277 (26%), Positives = 118/277 (42%), Gaps = 42/277 (15%)
Query: 361 GSVYRG--KINGGFAAIKKVNGDVS------KEIALLNKINHSNLIILSGVCFNEGNCYL 412
           G VY G  K      A+K +  D        KE A++ +I H NL+ L GVC  E   Y+
Sbjct: 27  GEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 86
Query: 413 VYEYAVNGTLSDWVFS-NKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSS 471
           + E+   G L D++   N+ E   +     + +A  +++ + YL        +H+D+ + 
Sbjct: 87  IIEFMTYGNLLDYLRECNRQEVSAV---VLLYMATQISSAMEYLE---KKNFIHRDLAAR 140
Query: 472 NVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTK---GYMAPEYLENGLVSTKLDV 528
           N L+  +   K+A+F ++R   G       T H  G K    + APE L     S K DV
Sbjct: 141 NCLVGENHLVKVADFGLSRLMTGD----TYTAH-AGAKFPIKWTAPESLAYNKFSIKSDV 195
Query: 529 YAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLE 588
           +AFGVL+ E+ T   +         + LS V                 ++   +   P  
Sbjct: 196 WAFGVLLWEIATYGMSPY-----PGIDLSQVYE--------------LLEKDYRMERPEG 236
Query: 589 LALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNAS 625
               V  L+ AC + +P+DRP+  EI  +   +   S
Sbjct: 237 CPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 273

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 73/277 (26%), Positives = 119/277 (42%), Gaps = 42/277 (15%)
Query: 361 GSVYRG--KINGGFAAIKKVNGDVS------KEIALLNKINHSNLIILSGVCFNEGNCYL 412
           G VY G  K      A+K +  D        KE A++ +I H NL+ L GVC  E   Y+
Sbjct: 40  GEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 99
Query: 413 VYEYAVNGTLSDWVFS-NKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSS 471
           + E+   G L D++   N+ E   ++    + +A  +++ + YL        +H+D+ + 
Sbjct: 100 ITEFMTYGNLLDYLRECNRQE---VNAVVLLYMATQISSAMEYLE---KKNFIHRDLAAR 153
Query: 472 NVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTK---GYMAPEYLENGLVSTKLDV 528
           N L+  +   K+A+F ++R   G       T H  G K    + APE L     S K DV
Sbjct: 154 NCLVGENHLVKVADFGLSRLMTGD----TYTAH-AGAKFPIKWTAPESLAYNKFSIKSDV 208
Query: 529 YAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLE 588
           +AFGVL+ E+ T   +         + LS V                 ++   +   P  
Sbjct: 209 WAFGVLLWEIATYGMSPY-----PGIDLSQVYE--------------LLEKDYRMERPEG 249
Query: 589 LALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNAS 625
               V  L+ AC + +P+DRP+  EI  +   +   S
Sbjct: 250 CPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 286

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 71/264 (26%), Positives = 121/264 (45%), Gaps = 43/264 (16%)
Query: 374 AIKKVNGDVSKEIALLNKI-NHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNK-- 430
           A K  + D + E+ +L K+ +H N+I L G C + G  YL  EYA +G L D++  ++  
Sbjct: 54  ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVL 113
Query: 431 ----------NEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLR 480
                     +    L  +Q +  A DVA G++YL   +    +H+D+ + N+L+  +  
Sbjct: 114 ETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYV 170
Query: 481 AKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEM-- 538
           AKIA+F ++R   GQE     T   +  + +MA E L   + +T  DV+++GVL+ E+  
Sbjct: 171 AKIADFGLSR---GQEVYVKKTMGRLPVR-WMAIESLNYSVYTTNSDVWSYGVLLWEIVS 226
Query: 539 LTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLID 598
           L G     +   E                     L   +    +   PL     V  L+ 
Sbjct: 227 LGGTPYCGMTCAE---------------------LYEKLPQGYRLEKPLNCDDEVYDLMR 265
Query: 599 ACLKKDPTDRPTMYEIEHSLSNIL 622
            C ++ P +RP+  +I  SL+ +L
Sbjct: 266 QCWREKPYERPSFAQILVSLNRML 289

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 73/271 (26%), Positives = 121/271 (44%), Gaps = 34/271 (12%)
Query: 361 GSVYRGKINGGF-AAIKKVN-GDVS-----KEIALLNKINHSNLIILSGVCFNEGNCYLV 413
           G V+ G  NG    A+K +  G +S      E  L+ ++ H  L+ L  V   E   Y++
Sbjct: 22  GEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEP-IYII 80
Query: 414 YEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNV 473
            EY  NG+L D  F     G  L   + + +A  +A G+ ++       ++H+D+ ++N+
Sbjct: 81  TEYMENGSLVD--FLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANI 135
Query: 474 LLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGV 533
           L+   L  KIA+F +AR  E  + E+           + APE +  G  + K DV++FG+
Sbjct: 136 LVSDTLSCKIADFGLARLIE--DNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGI 193
Query: 534 LILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLV 593
           L+ E++T             M   +V+  +   E G   +R         N P EL    
Sbjct: 194 LLTEIVTHGRIPY-----PGMTNPEVIQNL---ERGYRMVR-------PDNCPEEL---- 234
Query: 594 IRLIDACLKKDPTDRPTMYEIEHSLSNILNA 624
            +L+  C K+ P DRPT   +   L +   A
Sbjct: 235 YQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 265

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/262 (24%), Positives = 126/262 (48%), Gaps = 35/262 (13%)
Query: 372 FAAIK--------KVNGDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLS 423
           F AIK        K   D   E +++ + +H N+I L GV        ++ E+  NG+L 
Sbjct: 63  FVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLD 122
Query: 424 DWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKI 483
              F  +N+G++    Q + +   +A G+ YL       +VH+D+ + N+L++S+L  K+
Sbjct: 123 S--FLRQNDGQFTV-IQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKV 176
Query: 484 ANFAMARPAEGQEGEFALTRHIVGT--KGYMAPEYLENGLVSTKLDVYAFGVLILEMLTG 541
           ++F ++R  E    +   T  + G     + APE ++    ++  DV+++G+++ E+++ 
Sbjct: 177 SDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSY 236
Query: 542 KEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACL 601
            E         +M   DV+NA+      E+  R  + P      P++    + +L+  C 
Sbjct: 237 GERPYW-----DMTNQDVINAI------EQDYR--LPP------PMDCPSALHQLMLDCW 277
Query: 602 KKDPTDRPTMYEIEHSLSNILN 623
           +KD   RP   +I ++L  ++ 
Sbjct: 278 QKDRNHRPKFGQIVNTLDKMIR 299

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/252 (25%), Positives = 114/252 (45%), Gaps = 39/252 (15%)
Query: 381 DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQ 440
           D  +E  ++ K++H  L+ L GVC  +    LV+E+  +G LSD++ + +        + 
Sbjct: 48  DFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRG---LFAAET 104
Query: 441 RIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFA 500
            + + LDV  G+ YL   +    +H+D+ + N L+  +   K+++F M R        F 
Sbjct: 105 LLGMCLDVCEGMAYLEEASV---IHRDLAARNCLVGENQVIKVSDFGMTR--------FV 153
Query: 501 LTRHIVGTKG------YMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNM 554
           L      + G      + +PE       S+K DV++FGVL+ E+ +  E    +   +N 
Sbjct: 154 LDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFS--EGKIPYENRSN- 210
Query: 555 HLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEI 614
             S+V+      ED     R +  P L   +       V ++++ C K+ P DRP    +
Sbjct: 211 --SEVV------EDISTGFRLY-KPRLASTH-------VYQIMNHCWKERPEDRPAFSRL 254
Query: 615 EHSLSNILNASL 626
              L+ I  + L
Sbjct: 255 LRQLAAIAASGL 266

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 76/286 (26%), Positives = 122/286 (42%), Gaps = 60/286 (20%)
Query: 361 GSVYRG--KINGGFAAIKKVNGDVS------KEIALLNKINHSNLIILSGVCFNEGNCYL 412
           G VY G  K      A+K +  D        KE A++ +I H NL+ L GVC  E   Y+
Sbjct: 25  GEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 84
Query: 413 VYEYAVNGTLSDWVFS-NKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSS 471
           + E+   G L D++   N+ E   +     + +A  +++ + YL        +H+D+ + 
Sbjct: 85  ITEFMTYGNLLDYLRECNRQEVSAV---VLLYMATQISSAMEYLE---KKNFIHRDLAAR 138
Query: 472 NVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTK---GYMAPEYLENGLVSTKLDV 528
           N L+  +   K+A+F ++R   G       T H  G K    + APE L     S K DV
Sbjct: 139 NCLVGENHLVKVADFGLSRLMTGD----TFTAH-AGAKFPIKWTAPESLAYNKFSIKSDV 193
Query: 529 YAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPT-----LQG 583
           +AFGVL+ E+ T                       ++   G       IDP+     L+ 
Sbjct: 194 WAFGVLLWEIAT---------------------YGMSPYPG-------IDPSQVYELLEK 225
Query: 584 NYPLE----LALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNAS 625
           +Y +E        V  L+ AC + +P+DRP+  EI  +   +   S
Sbjct: 226 DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 271

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 76/286 (26%), Positives = 122/286 (42%), Gaps = 60/286 (20%)
Query: 361 GSVYRG--KINGGFAAIKKVNGDVS------KEIALLNKINHSNLIILSGVCFNEGNCYL 412
           G VY G  K      A+K +  D        KE A++ +I H NL+ L GVC  E   Y+
Sbjct: 25  GEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 84
Query: 413 VYEYAVNGTLSDWVFS-NKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSS 471
           + E+   G L D++   N+ E   +     + +A  +++ + YL        +H+D+ + 
Sbjct: 85  IIEFMTYGNLLDYLRECNRQEVSAV---VLLYMATQISSAMEYLEKKN---FIHRDLAAR 138
Query: 472 NVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTK---GYMAPEYLENGLVSTKLDV 528
           N L+  +   K+A+F ++R   G       T H  G K    + APE L     S K DV
Sbjct: 139 NCLVGENHLVKVADFGLSRLMTGD----TXTAH-AGAKFPIKWTAPESLAYNKFSIKSDV 193
Query: 529 YAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPT-----LQG 583
           +AFGVL+ E+ T                       ++   G       IDP+     L+ 
Sbjct: 194 WAFGVLLWEIATYG---------------------MSPYPG-------IDPSQVYELLEK 225
Query: 584 NYPLE----LALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNAS 625
           +Y +E        V  L+ AC + +P+DRP+  EI  +   +   S
Sbjct: 226 DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 271

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 71/264 (26%), Positives = 121/264 (45%), Gaps = 43/264 (16%)
Query: 374 AIKKVNGDVSKEIALLNKI-NHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNK-- 430
           A K  + D + E+ +L K+ +H N+I L G C + G  YL  EYA +G L D++  ++  
Sbjct: 64  ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVL 123
Query: 431 ----------NEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLR 480
                     +    L  +Q +  A DVA G++YL   +    +H+D+ + N+L+  +  
Sbjct: 124 ETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYV 180
Query: 481 AKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEM-- 538
           AKIA+F ++R   GQE     T   +  + +MA E L   + +T  DV+++GVL+ E+  
Sbjct: 181 AKIADFGLSR---GQEVYVKKTMGRLPVR-WMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236
Query: 539 LTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLID 598
           L G     +   E                     L   +    +   PL     V  L+ 
Sbjct: 237 LGGTPYCGMTCAE---------------------LYEKLPQGYRLEKPLNCDDEVYDLMR 275
Query: 599 ACLKKDPTDRPTMYEIEHSLSNIL 622
            C ++ P +RP+  +I  SL+ +L
Sbjct: 276 QCWREKPYERPSFAQILVSLNRML 299

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 55/180 (30%), Positives = 90/180 (50%), Gaps = 17/180 (9%)
Query: 374 AIKKVNGDVSKEIALLNKI-NHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNE 432
           A +K   D+  E+ ++  I  H N+I L G C  +G  Y++ EYA  G L +++ + +  
Sbjct: 113 ATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPP 172
Query: 433 G------------KYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLR 480
           G            + L  K  +  A  VA G+ YL S      +H+D+ + NVL+  D  
Sbjct: 173 GLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKC---IHRDLAARNVLVTEDNV 229
Query: 481 AKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT 540
            KIA+F +AR     +     T   +  K +MAPE L + + + + DV++FGVL+ E+ T
Sbjct: 230 MKIADFGLARDIHHIDYYKKTTNGRLPVK-WMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 69/267 (25%), Positives = 128/267 (47%), Gaps = 37/267 (13%)
Query: 362 SVYRGKINGGFAAIKKVNGDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGT 421
           S+  G   G    I+K   +  +E+ +++ +NH N++ L G+  N     +V E+   G 
Sbjct: 51  SLILGDSEGETEMIEKFQ-EFQREVFIMSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGD 107
Query: 422 LSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDS---- 477
           L   +    ++   + W  ++++ LD+A G+ Y+ +  NPP VH+D+ S N+ L S    
Sbjct: 108 LYHRLL---DKAHPIKWSVKLRLMLDIALGIEYMQN-QNPPIVHRDLRSPNIFLQSLDEN 163
Query: 478 -DLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYL--ENGLVSTKLDVYAFGVL 534
             + AK+A+F+++     Q+   +++  ++G   +MAPE +  E    + K D Y+F ++
Sbjct: 164 APVCAKVADFSLS-----QQSVHSVS-GLLGNFQWMAPETIGAEEESYTEKADTYSFAMI 217
Query: 535 ILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVI 594
           +  +LTG+       +E +      +N +      EE LR    PT+  + P  L     
Sbjct: 218 LYTILTGEGP----FDEYSYGKIKFINMIR-----EEGLR----PTIPEDCPPRLR---- 260
Query: 595 RLIDACLKKDPTDRPTMYEIEHSLSNI 621
            +I+ C   DP  RP    I   LS +
Sbjct: 261 NVIELCWSGDPKKRPHFSYIVKELSEL 287

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 73/277 (26%), Positives = 119/277 (42%), Gaps = 42/277 (15%)
Query: 361 GSVYRG--KINGGFAAIKKVNGDVS------KEIALLNKINHSNLIILSGVCFNEGNCYL 412
           G VY G  K      A+K +  D        KE A++ +I H NL+ L GVC  E   Y+
Sbjct: 29  GEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 88
Query: 413 VYEYAVNGTLSDWVFS-NKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSS 471
           + E+   G L D++   N+ E   ++    + +A  +++ + YL        +H+D+ + 
Sbjct: 89  ITEFMTYGNLLDYLRECNRQE---VNAVVLLYMATQISSAMEYLEKKN---FIHRDLAAR 142
Query: 472 NVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTK---GYMAPEYLENGLVSTKLDV 528
           N L+  +   K+A+F ++R   G       T H  G K    + APE L     S K DV
Sbjct: 143 NCLVGENHLVKVADFGLSRLMTGD----TYTAH-AGAKFPIKWTAPESLAYNKFSIKSDV 197
Query: 529 YAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLE 588
           +AFGVL+ E+ T   +         + LS V                 ++   +   P  
Sbjct: 198 WAFGVLLWEIATYGMSPY-----PGIDLSQVYE--------------LLEKDYRMERPEG 238
Query: 589 LALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNAS 625
               V  L+ AC + +P+DRP+  EI  +   +   S
Sbjct: 239 CPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 275

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 73/277 (26%), Positives = 118/277 (42%), Gaps = 42/277 (15%)
Query: 361 GSVYRG--KINGGFAAIKKVNGDVS------KEIALLNKINHSNLIILSGVCFNEGNCYL 412
           G VY G  K      A+K +  D        KE A++ +I H NL+ L GVC  E   Y+
Sbjct: 29  GEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 88
Query: 413 VYEYAVNGTLSDWVFS-NKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSS 471
           + E+   G L D++   N+ E   +     + +A  +++ + YL        +H+D+ + 
Sbjct: 89  ITEFMTYGNLLDYLRECNRQEVNAV---VLLYMATQISSAMEYLEKKN---FIHRDLAAR 142
Query: 472 NVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTK---GYMAPEYLENGLVSTKLDV 528
           N L+  +   K+A+F ++R   G       T H  G K    + APE L     S K DV
Sbjct: 143 NCLVGENHLVKVADFGLSRLMTGD----TYTAH-AGAKFPIKWTAPESLAYNKFSIKSDV 197
Query: 529 YAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLE 588
           +AFGVL+ E+ T   +         + LS V                 ++   +   P  
Sbjct: 198 WAFGVLLWEIATYGMSPY-----PGIDLSQVYE--------------LLEKDYRMERPEG 238
Query: 589 LALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNAS 625
               V  L+ AC + +P+DRP+  EI  +   +   S
Sbjct: 239 CPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 275

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 55/180 (30%), Positives = 90/180 (50%), Gaps = 17/180 (9%)
Query: 374 AIKKVNGDVSKEIALLNKI-NHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNE 432
           A +K   D+  E+ ++  I  H N+I L G C  +G  Y++ EYA  G L +++ + +  
Sbjct: 57  ATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPP 116
Query: 433 G------------KYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLR 480
           G            + L  K  +  A  VA G+ YL S      +H+D+ + NVL+  D  
Sbjct: 117 GLEYCYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKC---IHRDLAARNVLVTEDNV 173
Query: 481 AKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT 540
            KIA+F +AR     +     T   +  K +MAPE L + + + + DV++FGVL+ E+ T
Sbjct: 174 MKIADFGLARDIHHIDYYKKTTNGRLPVK-WMAPEALFDRIYTHQSDVWSFGVLLWEIFT 232

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 62/252 (24%), Positives = 113/252 (44%), Gaps = 39/252 (15%)
Query: 381 DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQ 440
           D  +E  ++ K++H  L+ L GVC  +    LV+E+  +G LSD++ + +        + 
Sbjct: 51  DFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRG---LFAAET 107
Query: 441 RIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFA 500
            + + LDV  G+ YL        +H+D+ + N L+  +   K+++F M R        F 
Sbjct: 108 LLGMCLDVCEGMAYLEEACV---IHRDLAARNCLVGENQVIKVSDFGMTR--------FV 156
Query: 501 LTRHIVGTKG------YMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNM 554
           L      + G      + +PE       S+K DV++FGVL+ E+ +  E    +   +N 
Sbjct: 157 LDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFS--EGKIPYENRSN- 213
Query: 555 HLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEI 614
             S+V+      ED     R +  P L   +       V ++++ C ++ P DRP    +
Sbjct: 214 --SEVV------EDISTGFRLY-KPRLASTH-------VYQIMNHCWRERPEDRPAFSRL 257
Query: 615 EHSLSNILNASL 626
              L+ I  + L
Sbjct: 258 LRQLAEIAESGL 269

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 63/239 (26%), Positives = 104/239 (43%), Gaps = 28/239 (11%)
Query: 384 KEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQ 443
           +E  +L + +H N++ L GVC  +   Y+V E    G   D++   + EG  L  K  +Q
Sbjct: 161 QEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGG---DFLTFLRTEGARLRVKTLLQ 217
Query: 444 IALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMAR-PAEGQEGEFALT 502
           +  D A G+ YL S      +H+D+ + N L+      KI++F M+R  A+G        
Sbjct: 218 MVGDAAAGMEYLESKCC---IHRDLAARNCLVTEKNVLKISDFGMSREEADGVXAASGGL 274
Query: 503 RHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNA 562
           R +     + APE L  G  S++ DV++FG+L+ E  +                   L A
Sbjct: 275 RQV--PVKWTAPEALNYGRYSSESDVWSFGILLWETFS-------------------LGA 313
Query: 563 VLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNI 621
                   +  R F++   +   P      V RL++ C   +P  RP+   I   L +I
Sbjct: 314 SPYPNLSNQQTREFVEKGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSI 372

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 55/180 (30%), Positives = 90/180 (50%), Gaps = 17/180 (9%)
Query: 374 AIKKVNGDVSKEIALLNKI-NHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNE 432
           A +K   D+  E+ ++  I  H N+I L G C  +G  Y++ EYA  G L +++ + +  
Sbjct: 65  ATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPP 124
Query: 433 G------------KYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLR 480
           G            + L  K  +  A  VA G+ YL S      +H+D+ + NVL+  D  
Sbjct: 125 GLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKC---IHRDLAARNVLVTEDNV 181
Query: 481 AKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT 540
            KIA+F +AR     +     T   +  K +MAPE L + + + + DV++FGVL+ E+ T
Sbjct: 182 MKIADFGLARDIHHIDYYKKTTNGRLPVK-WMAPEALFDRIYTHQSDVWSFGVLLWEIFT 240

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 55/180 (30%), Positives = 90/180 (50%), Gaps = 17/180 (9%)
Query: 374 AIKKVNGDVSKEIALLNKI-NHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNE 432
           A +K   D+  E+ ++  I  H N+I L G C  +G  Y++ EYA  G L +++ + +  
Sbjct: 61  ATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPP 120
Query: 433 G------------KYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLR 480
           G            + L  K  +  A  VA G+ YL S      +H+D+ + NVL+  D  
Sbjct: 121 GLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKC---IHRDLAARNVLVTEDNV 177
Query: 481 AKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT 540
            KIA+F +AR     +     T   +  K +MAPE L + + + + DV++FGVL+ E+ T
Sbjct: 178 MKIADFGLARDIHHIDYYKKTTNGRLPVK-WMAPEALFDRIYTHQSDVWSFGVLLWEIFT 236

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 55/180 (30%), Positives = 90/180 (50%), Gaps = 17/180 (9%)
Query: 374 AIKKVNGDVSKEIALLNKI-NHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNE 432
           A +K   D+  E+ ++  I  H N+I L G C  +G  Y++ EYA  G L +++ + +  
Sbjct: 64  ATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPP 123
Query: 433 G------------KYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLR 480
           G            + L  K  +  A  VA G+ YL S      +H+D+ + NVL+  D  
Sbjct: 124 GLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKC---IHRDLAARNVLVTEDNV 180
Query: 481 AKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT 540
            KIA+F +AR     +     T   +  K +MAPE L + + + + DV++FGVL+ E+ T
Sbjct: 181 MKIADFGLARDIHHIDYYKKTTNGRLPVK-WMAPEALFDRIYTHQSDVWSFGVLLWEIFT 239

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 55/180 (30%), Positives = 90/180 (50%), Gaps = 17/180 (9%)
Query: 374 AIKKVNGDVSKEIALLNKI-NHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNE 432
           A +K   D+  E+ ++  I  H N+I L G C  +G  Y++ EYA  G L +++ + +  
Sbjct: 72  ATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPP 131
Query: 433 G------------KYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLR 480
           G            + L  K  +  A  VA G+ YL S      +H+D+ + NVL+  D  
Sbjct: 132 GLEYCYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKC---IHRDLAARNVLVTEDNV 188
Query: 481 AKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT 540
            KIA+F +AR     +     T   +  K +MAPE L + + + + DV++FGVL+ E+ T
Sbjct: 189 MKIADFGLARDIHHIDYYKKTTNGRLPVK-WMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 55/180 (30%), Positives = 90/180 (50%), Gaps = 17/180 (9%)
Query: 374 AIKKVNGDVSKEIALLNKI-NHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNE 432
           A +K   D+  E+ ++  I  H N+I L G C  +G  Y++ EYA  G L +++ + +  
Sbjct: 72  ATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPP 131
Query: 433 G------------KYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLR 480
           G            + L  K  +  A  VA G+ YL S      +H+D+ + NVL+  D  
Sbjct: 132 GLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKC---IHRDLAARNVLVTEDNV 188
Query: 481 AKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT 540
            KIA+F +AR     +     T   +  K +MAPE L + + + + DV++FGVL+ E+ T
Sbjct: 189 MKIADFGLARDIHHIDYYKKTTNGRLPVK-WMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 69/267 (25%), Positives = 127/267 (47%), Gaps = 37/267 (13%)
Query: 362 SVYRGKINGGFAAIKKVNGDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGT 421
           S+  G   G    I+K   +  +E+ +++ +NH N++ L G+  N     +V E+   G 
Sbjct: 51  SLILGDSEGETEMIEKFQ-EFQREVFIMSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGD 107
Query: 422 LSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDS---- 477
           L   +    ++   + W  ++++ LD+A G+ Y+ +  NPP VH+D+ S N+ L S    
Sbjct: 108 LYHRLL---DKAHPIKWSVKLRLMLDIALGIEYMQN-QNPPIVHRDLRSPNIFLQSLDEN 163
Query: 478 -DLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYL--ENGLVSTKLDVYAFGVL 534
             + AK+A+F ++     Q+   +++  ++G   +MAPE +  E    + K D Y+F ++
Sbjct: 164 APVCAKVADFGLS-----QQSVHSVS-GLLGNFQWMAPETIGAEEESYTEKADTYSFAMI 217
Query: 535 ILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVI 594
           +  +LTG+       +E +      +N +      EE LR    PT+  + P  L     
Sbjct: 218 LYTILTGEGP----FDEYSYGKIKFINMIR-----EEGLR----PTIPEDCPPRLR---- 260
Query: 595 RLIDACLKKDPTDRPTMYEIEHSLSNI 621
            +I+ C   DP  RP    I   LS +
Sbjct: 261 NVIELCWSGDPKKRPHFSYIVKELSEL 287

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 46/157 (29%), Positives = 80/157 (50%), Gaps = 7/157 (4%)
Query: 384 KEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQ 443
           +E  L+  + H  L+ L  V   E   Y++ EY   G+L D  F   +EG  +   + I 
Sbjct: 57  EEANLMKTLQHDKLVRLYAVVTREEPIYIITEYMAKGSLLD--FLKSDEGGKVLLPKLID 114
Query: 444 IALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTR 503
            +  +A G+ Y+       ++H+D+ ++NVL+   L  KIA+F +AR  E  + E+    
Sbjct: 115 FSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIE--DNEYTARE 169
Query: 504 HIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT 540
                  + APE +  G  + K DV++FG+L+ E++T
Sbjct: 170 GAKFPIKWTAPEAINFGCFTIKSDVWSFGILLYEIVT 206

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 76/286 (26%), Positives = 122/286 (42%), Gaps = 60/286 (20%)
Query: 361 GSVYRG--KINGGFAAIKKVNGDVS------KEIALLNKINHSNLIILSGVCFNEGNCYL 412
           G VY G  K      A+K +  D        KE A++ +I H NL+ L GVC  E   Y+
Sbjct: 25  GEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 84
Query: 413 VYEYAVNGTLSDWVFS-NKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSS 471
           + E+   G L D++   N+ E   +     + +A  +++ + YL        +H+D+ + 
Sbjct: 85  ITEFMTYGNLLDYLRECNRQEVSAV---VLLYMATQISSAMEYLE---KKNFIHRDLAAR 138
Query: 472 NVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTK---GYMAPEYLENGLVSTKLDV 528
           N L+  +   K+A+F ++R   G       T H  G K    + APE L     S K DV
Sbjct: 139 NCLVGENHLVKVADFGLSRLMTGD----TXTAH-AGAKFPIKWTAPESLAYNKFSIKSDV 193
Query: 529 YAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPT-----LQG 583
           +AFGVL+ E+ T                       ++   G       IDP+     L+ 
Sbjct: 194 WAFGVLLWEIAT---------------------YGMSPYPG-------IDPSQVYELLEK 225
Query: 584 NYPLE----LALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNAS 625
           +Y +E        V  L+ AC + +P+DRP+  EI  +   +   S
Sbjct: 226 DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 271

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 72/275 (26%), Positives = 117/275 (42%), Gaps = 42/275 (15%)
Query: 361 GSVYRG--KINGGFAAIKKVNGDVS------KEIALLNKINHSNLIILSGVCFNEGNCYL 412
           G VY G  K      A+K +  D        KE A++ +I H NL+ L GVC  E   Y+
Sbjct: 32  GEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 91
Query: 413 VYEYAVNGTLSDWVFS-NKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSS 471
           + E+   G L D++   N+ E   +     + +A  +++ + YL        +H+D+ + 
Sbjct: 92  IIEFMTYGNLLDYLRECNRQEVNAV---VLLYMATQISSAMEYLEKKN---FIHRDLAAR 145
Query: 472 NVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTK---GYMAPEYLENGLVSTKLDV 528
           N L+  +   K+A+F ++R   G       T H  G K    + APE L     S K DV
Sbjct: 146 NCLVGENHLVKVADFGLSRLMTGD----TYTAH-AGAKFPIKWTAPESLAYNKFSIKSDV 200
Query: 529 YAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLE 588
           +AFGVL+ E+ T   +         + LS V                 ++   +   P  
Sbjct: 201 WAFGVLLWEIATYGMSPY-----PGIDLSQVYE--------------LLEKDYRMERPEG 241
Query: 589 LALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILN 623
               V  L+ AC + +P+DRP+  EI  +   +  
Sbjct: 242 CPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 276

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 72/275 (26%), Positives = 117/275 (42%), Gaps = 42/275 (15%)
Query: 361 GSVYRG--KINGGFAAIKKVNGDVS------KEIALLNKINHSNLIILSGVCFNEGNCYL 412
           G VY G  K      A+K +  D        KE A++ +I H NL+ L GVC  E   Y+
Sbjct: 32  GEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 91
Query: 413 VYEYAVNGTLSDWVFS-NKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSS 471
           + E+   G L D++   N+ E   +     + +A  +++ + YL        +H+D+ + 
Sbjct: 92  ITEFMTYGNLLDYLRECNRQEVNAV---VLLYMATQISSAMEYLEKKN---FIHRDLAAR 145
Query: 472 NVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTK---GYMAPEYLENGLVSTKLDV 528
           N L+  +   K+A+F ++R   G       T H  G K    + APE L     S K DV
Sbjct: 146 NCLVGENHLVKVADFGLSRLMTGD----TYTAH-AGAKFPIKWTAPESLAYNKFSIKSDV 200
Query: 529 YAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLE 588
           +AFGVL+ E+ T   +         + LS V                 ++   +   P  
Sbjct: 201 WAFGVLLWEIATYGMSPY-----PGIDLSQVYE--------------LLEKDYRMERPEG 241
Query: 589 LALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILN 623
               V  L+ AC + +P+DRP+  EI  +   +  
Sbjct: 242 CPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 276

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 57/194 (29%), Positives = 95/194 (48%), Gaps = 24/194 (12%)
Query: 361 GSVYRGK--INGGFAAIKKVN----------GDVSKEIALLNKINHSNLIILSGVCFNEG 408
           G V  GK  + G   A+K +N          G + +EI  L    H ++I L  V     
Sbjct: 30  GKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPS 89
Query: 409 NCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDI 468
           + ++V EY   G L D++  N      LD K+  ++   + +G++Y H       VH+D+
Sbjct: 90  DIFMVMEYVSGGELFDYICKNGR----LDEKESRRLFQQILSGVDYCHRHMV---VHRDL 142
Query: 469 NSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVS-TKLD 527
              NVLLD+ + AKIA+F ++      +GEF   R   G+  Y APE +   L +  ++D
Sbjct: 143 KPENVLLDAHMNAKIADFGLSNMM--SDGEF--LRXSCGSPNYAAPEVISGRLYAGPEVD 198
Query: 528 VYAFGVLILEMLTG 541
           +++ GV++  +L G
Sbjct: 199 IWSSGVILYALLCG 212

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 72/272 (26%), Positives = 122/272 (44%), Gaps = 34/272 (12%)
Query: 361 GSVYRGKINGGF-AAIKKVN-GDVS-----KEIALLNKINHSNLIILSGVCFNEGNCYLV 413
           G V+ G  NG    A+K +  G +S      E  L+ ++ H  L+ L  V   E   Y++
Sbjct: 23  GEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQE-PIYII 81
Query: 414 YEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNV 473
            EY  NG+L D  F     G  L   + + +A  +A G+ ++       ++H+++ ++N+
Sbjct: 82  TEYMENGSLVD--FLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRNLRAANI 136
Query: 474 LLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGV 533
           L+   L  KIA+F +AR  E  + E+           + APE +  G  + K DV++FG+
Sbjct: 137 LVSDTLSCKIADFGLARLIE--DNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGI 194
Query: 534 LILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLV 593
           L+ E++T             M   +V+  +   E G   +R         N P EL    
Sbjct: 195 LLTEIVTHGRIPY-----PGMTNPEVIQNL---ERGYRMVR-------PDNCPEEL---- 235
Query: 594 IRLIDACLKKDPTDRPTMYEIEHSLSNILNAS 625
            +L+  C K+ P DRPT   +   L +   A+
Sbjct: 236 YQLMRLCWKERPEDRPTFDYLRSVLEDFFTAT 267

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 62/245 (25%), Positives = 109/245 (44%), Gaps = 42/245 (17%)
Query: 377 KVNGDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNK----NE 432
           K   +  +E+A+L  + H N++         G+ Y+V +Y   G L   + + K     E
Sbjct: 65  KEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQE 124
Query: 433 GKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPA 492
            + LDW   +QI L     L ++H   +   +H+DI S N+ L  D   ++ +F +AR  
Sbjct: 125 DQILDW--FVQICL----ALKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVL 175
Query: 493 EGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEEN 552
                   L R  +GT  Y++PE  EN   + K D++A G ++ E+ T K     HA E 
Sbjct: 176 NST---VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLK-----HAFEA 227
Query: 553 NMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYP---LELALLVIRLIDACLKKDPTDRP 609
                              S+++ +   + G++P   L  +  +  L+    K++P DRP
Sbjct: 228 G------------------SMKNLVLKIISGSFPPVSLHYSYDLRSLVSQLFKRNPRDRP 269
Query: 610 TMYEI 614
           ++  I
Sbjct: 270 SVNSI 274

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 75.9 bits (185), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 55/180 (30%), Positives = 90/180 (50%), Gaps = 17/180 (9%)
Query: 374 AIKKVNGDVSKEIALLNKI-NHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNE 432
           A +K   D+  E+ ++  I  H N+I L G C  +G  Y++ EYA  G L +++ + +  
Sbjct: 72  ATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQAREPP 131
Query: 433 G------------KYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLR 480
           G            + L  K  +  A  VA G+ YL S      +H+D+ + NVL+  D  
Sbjct: 132 GLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKC---IHRDLAARNVLVTEDNV 188
Query: 481 AKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT 540
            KIA+F +AR     +     T   +  K +MAPE L + + + + DV++FGVL+ E+ T
Sbjct: 189 MKIADFGLARDIHHIDYYKKTTNGRLPVK-WMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 75.9 bits (185), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 47/180 (26%), Positives = 88/180 (48%), Gaps = 15/180 (8%)
Query: 370 GGFAAIKKVNG-------DVSKEIALLNKINHSNLIILSGVCFNEG--NCYLVYEYAVNG 420
           G   A+KK+         D  +EI +L  + H N++   GVC++ G  N  L+ EY   G
Sbjct: 70  GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG 129
Query: 421 TLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLR 480
           +L D++  +K     +D  + +Q    +  G+ YL +     ++H+D+ + N+L++++ R
Sbjct: 130 SLRDYLQKHKER---IDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENR 183
Query: 481 AKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT 540
            KI +F + +     +    +         + APE L     S   DV++FGV++ E+ T
Sbjct: 184 VKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 243

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 58/238 (24%), Positives = 113/238 (47%), Gaps = 24/238 (10%)
Query: 306 SGSFQANEKPSNKKFDEESQDFLESI-SGVAQSLKVYSFKELQSATDNFSFTCRIQGSVY 364
           SG+F+ +  P+  +F+E    FL+ +  G   S+++  +  LQ  T       ++Q S  
Sbjct: 1   SGAFE-DRDPT--QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST- 56
Query: 365 RGKINGGFAAIKKVNGDVSKEIALLNKINHSNLIILSGVCFNEG--NCYLVYEYAVNGTL 422
                      ++   D  +EI +L  + H N++   GVC++ G  N  L+ EY   G+L
Sbjct: 57  -----------EEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSL 105
Query: 423 SDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAK 482
            D++  +K     +D  + +Q    +  G+ YL +     ++H+D+ + N+L++++ R K
Sbjct: 106 RDYLQKHKER---IDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVK 159
Query: 483 IANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT 540
           I +F + +     +    +         + APE L     S   DV++FGV++ E+ T
Sbjct: 160 IGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 217

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 58/237 (24%), Positives = 109/237 (45%), Gaps = 21/237 (8%)
Query: 307 GSFQANEKPSNKKFDEESQDFLESI-SGVAQSLKVYSFKELQSATDNFSFTCRIQGSVYR 365
           GS  A E     +F+E    FL+ +  G   S+++  +  LQ  T       ++Q S   
Sbjct: 1   GSSGAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST-- 58
Query: 366 GKINGGFAAIKKVNGDVSKEIALLNKINHSNLIILSGVCFNEG--NCYLVYEYAVNGTLS 423
                     ++   D  +EI +L  + H N++   GVC++ G  N  L+ EY   G+L 
Sbjct: 59  ----------EEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 108
Query: 424 DWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKI 483
           D++  +K     +D  + +Q    +  G+ YL +     ++H+D+ + N+L++++ R KI
Sbjct: 109 DYLQKHKER---IDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKI 162
Query: 484 ANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT 540
            +F + +     +    +         + APE L     S   DV++FGV++ E+ T
Sbjct: 163 GDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 219

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 68/269 (25%), Positives = 127/269 (47%), Gaps = 42/269 (15%)
Query: 361 GSVYRGKINGGFAAIKKVN---------GDVSKEIALLNKINHSNLIILSGVCFNEGNCY 411
           G+VY+GK +G   A+K +N              E+ +L K  H N+++  G    +    
Sbjct: 38  GTVYKGKWHGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TKPQLA 95
Query: 412 LVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSS 471
           +V ++    +L   + +++ +    + K+ I IA   A G++YLH+ +    +H+D+ S+
Sbjct: 96  IVTQWCEGSSLYHHLHASETK---FEMKKLIDIARQTARGMDYLHAKSI---IHRDLKSN 149
Query: 472 NVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYL---ENGLVSTKLDV 528
           N+ L  D   KI +F +A       G     + + G+  +MAPE +   ++   S + DV
Sbjct: 150 NIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQ-LSGSILWMAPEVIRMQDSNPYSFQSDV 208
Query: 529 YAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTL---QGNY 585
           YAFG+++ E++TG+   +      N++  D +  ++         R  + P L   + N 
Sbjct: 209 YAFGIVLYELMTGQLPYS------NINNRDQIIEMVG--------RGSLSPDLSKVRSNC 254
Query: 586 PLELALLVIRLIDACLKKDPTDRPTMYEI 614
           P  +     RL+  CLKK   +RP+   I
Sbjct: 255 PKRMK----RLMAECLKKKRDERPSFPRI 279

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 75.5 bits (184), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 62/248 (25%), Positives = 117/248 (47%), Gaps = 25/248 (10%)
Query: 376 KKVNGDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKY 435
           +K   D   E +++ + +H N+I L GV        +V EY  NG+L    F  KN+G++
Sbjct: 64  EKQRRDFLGEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLD--TFLKKNDGQF 121
Query: 436 LDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQ 495
               Q + +   ++ G+ YL       +VH+D+ + N+L++S+L  K+++F ++R  E  
Sbjct: 122 TV-IQLVGMLRGISAGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLSRVLEDD 177
Query: 496 EGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMH 555
                 TR       + APE +     ++  DV+++G+++ E+++  E          M 
Sbjct: 178 PEAAYTTRGGKIPIRWTAPEAIAFRKFTSASDVWSYGIVMWEVVSYGERPYWE-----MT 232
Query: 556 LSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIE 615
             DV+ AV      EE  R    P+     P++    + +L+  C +K+   RP   EI 
Sbjct: 233 NQDVIKAV------EEGYRL---PS-----PMDCPAALYQLMLDCWQKERNSRPKFDEIV 278
Query: 616 HSLSNILN 623
           + L  ++ 
Sbjct: 279 NMLDKLIR 286

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 75.5 bits (184), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 47/180 (26%), Positives = 88/180 (48%), Gaps = 15/180 (8%)
Query: 370 GGFAAIKKVNG-------DVSKEIALLNKINHSNLIILSGVCFNEG--NCYLVYEYAVNG 420
           G   A+KK+         D  +EI +L  + H N++   GVC++ G  N  L+ EY   G
Sbjct: 37  GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG 96
Query: 421 TLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLR 480
           +L D++  +K     +D  + +Q    +  G+ YL +     ++H+D+ + N+L++++ R
Sbjct: 97  SLRDYLQKHKER---IDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENR 150
Query: 481 AKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT 540
            KI +F + +     +    +         + APE L     S   DV++FGV++ E+ T
Sbjct: 151 VKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 210

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 75.5 bits (184), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 47/180 (26%), Positives = 88/180 (48%), Gaps = 15/180 (8%)
Query: 370 GGFAAIKKVN-------GDVSKEIALLNKINHSNLIILSGVCFNEG--NCYLVYEYAVNG 420
           G   A+KK+         D  +EI +L  + H N++   GVC++ G  N  L+ EY   G
Sbjct: 43  GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG 102
Query: 421 TLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLR 480
           +L D++  +K     +D  + +Q    +  G+ YL +     ++H+D+ + N+L++++ R
Sbjct: 103 SLRDYLQKHKER---IDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENR 156
Query: 481 AKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT 540
            KI +F + +     +    +         + APE L     S   DV++FGV++ E+ T
Sbjct: 157 VKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 216

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 75.5 bits (184), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 72/274 (26%), Positives = 117/274 (42%), Gaps = 42/274 (15%)
Query: 361 GSVYRG--KINGGFAAIKKVNGDVS------KEIALLNKINHSNLIILSGVCFNEGNCYL 412
           G VY G  K      A+K +  D        KE A++ +I H NL+ L GVC  E   Y+
Sbjct: 27  GEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 86
Query: 413 VYEYAVNGTLSDWVFS-NKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSS 471
           + E+   G L D++   N+ E   +     + +A  +++ + YL        +H+D+ + 
Sbjct: 87  ITEFMTYGNLLDYLRECNRQEVNAV---VLLYMATQISSAMEYLEKKN---FIHRDLAAR 140
Query: 472 NVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTK---GYMAPEYLENGLVSTKLDV 528
           N L+  +   K+A+F ++R   G       T H  G K    + APE L     S K DV
Sbjct: 141 NCLVGENHLVKVADFGLSRLMTGD----TYTAH-AGAKFPIKWTAPESLAYNKFSIKSDV 195
Query: 529 YAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLE 588
           +AFGVL+ E+ T   +         + LS V                 ++   +   P  
Sbjct: 196 WAFGVLLWEIATYGMSPY-----PGIDLSQVYE--------------LLEKDYRMERPEG 236
Query: 589 LALLVIRLIDACLKKDPTDRPTMYEIEHSLSNIL 622
               V  L+ AC + +P+DRP+  EI  +   + 
Sbjct: 237 CPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 270

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 75.5 bits (184), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 47/180 (26%), Positives = 88/180 (48%), Gaps = 15/180 (8%)
Query: 370 GGFAAIKKVNG-------DVSKEIALLNKINHSNLIILSGVCFNEG--NCYLVYEYAVNG 420
           G   A+KK+         D  +EI +L  + H N++   GVC++ G  N  L+ EY   G
Sbjct: 38  GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG 97
Query: 421 TLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLR 480
           +L D++  +K     +D  + +Q    +  G+ YL +     ++H+D+ + N+L++++ R
Sbjct: 98  SLRDYLQKHKER---IDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENR 151
Query: 481 AKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT 540
            KI +F + +     +    +         + APE L     S   DV++FGV++ E+ T
Sbjct: 152 VKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 211

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 75.5 bits (184), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 47/180 (26%), Positives = 88/180 (48%), Gaps = 15/180 (8%)
Query: 370 GGFAAIKKVNG-------DVSKEIALLNKINHSNLIILSGVCFNEG--NCYLVYEYAVNG 420
           G   A+KK+         D  +EI +L  + H N++   GVC++ G  N  L+ EY   G
Sbjct: 39  GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG 98
Query: 421 TLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLR 480
           +L D++  +K     +D  + +Q    +  G+ YL +     ++H+D+ + N+L++++ R
Sbjct: 99  SLRDYLQKHKER---IDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENR 152
Query: 481 AKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT 540
            KI +F + +     +    +         + APE L     S   DV++FGV++ E+ T
Sbjct: 153 VKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 47/180 (26%), Positives = 88/180 (48%), Gaps = 15/180 (8%)
Query: 370 GGFAAIKKVNG-------DVSKEIALLNKINHSNLIILSGVCFNEG--NCYLVYEYAVNG 420
           G   A+KK+         D  +EI +L  + H N++   GVC++ G  N  L+ EY   G
Sbjct: 39  GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG 98
Query: 421 TLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLR 480
           +L D++  +K     +D  + +Q    +  G+ YL +     ++H+D+ + N+L++++ R
Sbjct: 99  SLRDYLQKHKER---IDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENR 152
Query: 481 AKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT 540
            KI +F + +     +    +         + APE L     S   DV++FGV++ E+ T
Sbjct: 153 VKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 69/267 (25%), Positives = 126/267 (47%), Gaps = 37/267 (13%)
Query: 362 SVYRGKINGGFAAIKKVNGDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGT 421
           S+  G   G    I+K   +  +E+ +++ +NH N++ L G+  N     +V E+   G 
Sbjct: 51  SLILGDSEGETEMIEKFQ-EFQREVFIMSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGD 107
Query: 422 LSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDS---- 477
           L   +    ++   + W  ++++ LD+A G+ Y+ +  NPP VH+D+ S N+ L S    
Sbjct: 108 LYHRLL---DKAHPIKWSVKLRLMLDIALGIEYMQN-QNPPIVHRDLRSPNIFLQSLDEN 163
Query: 478 -DLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYL--ENGLVSTKLDVYAFGVL 534
             + AK+A+F  +     Q+   +++  ++G   +MAPE +  E    + K D Y+F ++
Sbjct: 164 APVCAKVADFGTS-----QQSVHSVS-GLLGNFQWMAPETIGAEEESYTEKADTYSFAMI 217
Query: 535 ILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVI 594
           +  +LTG+       +E +      +N +      EE LR    PT+  + P  L     
Sbjct: 218 LYTILTGEGP----FDEYSYGKIKFINMIR-----EEGLR----PTIPEDCPPRLR---- 260
Query: 595 RLIDACLKKDPTDRPTMYEIEHSLSNI 621
            +I+ C   DP  RP    I   LS +
Sbjct: 261 NVIELCWSGDPKKRPHFSYIVKELSEL 287

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 47/180 (26%), Positives = 88/180 (48%), Gaps = 15/180 (8%)
Query: 370 GGFAAIKKVNG-------DVSKEIALLNKINHSNLIILSGVCFNEG--NCYLVYEYAVNG 420
           G   A+KK+         D  +EI +L  + H N++   GVC++ G  N  L+ EY   G
Sbjct: 45  GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG 104
Query: 421 TLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLR 480
           +L D++  +K     +D  + +Q    +  G+ YL +     ++H+D+ + N+L++++ R
Sbjct: 105 SLRDYLQKHKER---IDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENR 158
Query: 481 AKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT 540
            KI +F + +     +    +         + APE L     S   DV++FGV++ E+ T
Sbjct: 159 VKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 218

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 47/180 (26%), Positives = 88/180 (48%), Gaps = 15/180 (8%)
Query: 370 GGFAAIKKVNG-------DVSKEIALLNKINHSNLIILSGVCFNEG--NCYLVYEYAVNG 420
           G   A+KK+         D  +EI +L  + H N++   GVC++ G  N  L+ EY   G
Sbjct: 42  GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG 101
Query: 421 TLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLR 480
           +L D++  +K     +D  + +Q    +  G+ YL +     ++H+D+ + N+L++++ R
Sbjct: 102 SLRDYLQKHKER---IDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENR 155
Query: 481 AKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT 540
            KI +F + +     +    +         + APE L     S   DV++FGV++ E+ T
Sbjct: 156 VKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 69/265 (26%), Positives = 117/265 (44%), Gaps = 43/265 (16%)
Query: 361 GSVYRGKIN--GGFAAIKKVN--------GDVSKEIALLNKINHSNLIILSGVCFNEGNC 410
           G VY+G  N      AIK ++         D+ +EI +L++ +   +    G        
Sbjct: 33  GEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYFGSYLKSTKL 92
Query: 411 YLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINS 470
           +++ EY   G+  D +     E  Y+       I  ++  GL+YLHS      +H+DI +
Sbjct: 93  WIIMEYLGGGSALDLLKPGPLEETYI-----ATILREILKGLDYLHSERK---IHRDIKA 144
Query: 471 SNVLLDSDLRAKIANFAMARPAEGQEGEFALTRH-IVGTKGYMAPEYLENGLVSTKLDVY 529
           +NVLL      K+A+F +A    GQ  +  + R+  VGT  +MAPE ++      K D++
Sbjct: 145 ANVLLSEQGDVKLADFGVA----GQLTDTQIKRNXFVGTPFWMAPEVIKQSAYDFKADIW 200
Query: 530 AFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLEL 589
           + G+  +E+  G+         +++H   VL  +               PTL+G +    
Sbjct: 201 SLGITAIELAKGE------PPNSDLHPMRVLFLIPKNS----------PPTLEGQHSKPF 244
Query: 590 ALLVIRLIDACLKKDPTDRPTMYEI 614
                  ++ACL KDP  RPT  E+
Sbjct: 245 K----EFVEACLNKDPRFRPTAKEL 265

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/266 (24%), Positives = 126/266 (47%), Gaps = 36/266 (13%)
Query: 361 GSVYRGKINGGFAAIKKVN---------GDVSKEIALLNKINHSNLIILSGVCFNEGNCY 411
           G+VY+GK +G   A+K +N              E+ +L K  H N+++  G    +    
Sbjct: 26  GTVYKGKWHGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TKPQLA 83
Query: 412 LVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSS 471
           +V ++    +L   + +++ +    + K+ I IA   A G++YLH+ +    +H+D+ S+
Sbjct: 84  IVTQWCEGSSLYHHLHASETK---FEMKKLIDIARQTARGMDYLHAKSI---IHRDLKSN 137
Query: 472 NVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYL---ENGLVSTKLDV 528
           N+ L  D   KI +F +A       G     + + G+  +MAPE +   ++   S + DV
Sbjct: 138 NIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQ-LSGSILWMAPEVIRMQDSNPYSFQSDV 196
Query: 529 YAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLE 588
           YAFG+++ E++TG+   +      N++  D +  ++ +      L       ++ N P  
Sbjct: 197 YAFGIVLYELMTGQLPYS------NINNRDQIIEMVGRGSLSPDL-----SKVRSNCPKR 245
Query: 589 LALLVIRLIDACLKKDPTDRPTMYEI 614
           +     RL+  CLKK   +RP+   I
Sbjct: 246 MK----RLMAECLKKKRDERPSFPRI 267

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 72/273 (26%), Positives = 124/273 (45%), Gaps = 32/273 (11%)
Query: 361 GSVYRGKINGGFAAIK------KVNGDVSKEIALLNKINHSNLIILSGVCFN----EGNC 410
           G V++ ++   + A+K      K +     E+  L  + H N++   G        + + 
Sbjct: 38  GCVWKAQLLNEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDL 97
Query: 411 YLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFT-------NPPH 463
           +L+  +   G+LSD++ +N      + W +   IA  +A GL YLH           P  
Sbjct: 98  WLITAFHEKGSLSDFLKAN-----VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAI 152
Query: 464 VHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRH-IVGTKGYMAPEYLENGL- 521
            H+DI S NVLL ++L A IA+F +A   E   G+ A   H  VGT+ YMAPE LE  + 
Sbjct: 153 SHRDIKSKNVLLKNNLTACIADFGLALKFEA--GKSAGDTHGQVGTRRYMAPEVLEGAIN 210
Query: 522 ----VSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFI 577
                  ++D+YA G+++ E+ +   AA    +E  +   + +    + ED +E + H  
Sbjct: 211 FQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKK 270
Query: 578 D-PTLQGNYPLELAL-LVIRLIDACLKKDPTDR 608
             P L+  +     + ++   I+ C   D   R
Sbjct: 271 KRPVLRDYWQKHAGMAMLCETIEECWDHDAEAR 303

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 47/180 (26%), Positives = 88/180 (48%), Gaps = 15/180 (8%)
Query: 370 GGFAAIKKVNG-------DVSKEIALLNKINHSNLIILSGVCFNEG--NCYLVYEYAVNG 420
           G   A+KK+         D  +EI +L  + H N++   GVC++ G  N  L+ EY   G
Sbjct: 57  GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG 116
Query: 421 TLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLR 480
           +L D++  +K     +D  + +Q    +  G+ YL +     ++H+D+ + N+L++++ R
Sbjct: 117 SLRDYLQKHKER---IDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENR 170
Query: 481 AKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT 540
            KI +F + +     +    +         + APE L     S   DV++FGV++ E+ T
Sbjct: 171 VKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 47/180 (26%), Positives = 88/180 (48%), Gaps = 15/180 (8%)
Query: 370 GGFAAIKKVNG-------DVSKEIALLNKINHSNLIILSGVCFNEG--NCYLVYEYAVNG 420
           G   A+KK+         D  +EI +L  + H N++   GVC++ G  N  L+ EY   G
Sbjct: 57  GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG 116
Query: 421 TLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLR 480
           +L D++  +K     +D  + +Q    +  G+ YL +     ++H+D+ + N+L++++ R
Sbjct: 117 SLRDYLQKHKER---IDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENR 170
Query: 481 AKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT 540
            KI +F + +     +    +         + APE L     S   DV++FGV++ E+ T
Sbjct: 171 VKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 70/264 (26%), Positives = 121/264 (45%), Gaps = 43/264 (16%)
Query: 374 AIKKVNGDVSKEIALLNKI-NHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNK-- 430
           A K  + D + E+ +L K+ +H N+I L G C + G  YL  EYA +G L D++  ++  
Sbjct: 61  ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVL 120
Query: 431 ----------NEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLR 480
                     +    L  +Q +  A DVA G++YL   +    +H+++ + N+L+  +  
Sbjct: 121 ETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL---SQKQFIHRNLAARNILVGENYV 177
Query: 481 AKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEM-- 538
           AKIA+F ++R   GQE     T   +  + +MA E L   + +T  DV+++GVL+ E+  
Sbjct: 178 AKIADFGLSR---GQEVYVKKTMGRLPVR-WMAIESLNYSVYTTNSDVWSYGVLLWEIVS 233
Query: 539 LTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLID 598
           L G     +   E                     L   +    +   PL     V  L+ 
Sbjct: 234 LGGTPYCGMTCAE---------------------LYEKLPQGYRLEKPLNCDDEVYDLMR 272
Query: 599 ACLKKDPTDRPTMYEIEHSLSNIL 622
            C ++ P +RP+  +I  SL+ +L
Sbjct: 273 QCWREKPYERPSFAQILVSLNRML 296

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/248 (24%), Positives = 117/248 (47%), Gaps = 25/248 (10%)
Query: 376 KKVNGDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKY 435
           +K   D   E +++ + +H N+I L GV        +V EY  NG+L    F  K++ ++
Sbjct: 87  EKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDS--FLRKHDAQF 144
Query: 436 LDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQ 495
               Q + +   +A+G+ YL       +VH+D+ + N+L++S+L  K+++F +AR  E  
Sbjct: 145 TV-IQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLARVLEDD 200
Query: 496 EGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMH 555
                 TR       + +PE +     ++  DV+++G+++ E+++  E          M 
Sbjct: 201 PEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWE-----MS 255
Query: 556 LSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIE 615
             DV+ AV      +E  R  + P      P++    + +L+  C +KD  +RP   +I 
Sbjct: 256 NQDVIKAV------DEGYR--LPP------PMDCPAALYQLMLDCWQKDRNNRPKFEQIV 301
Query: 616 HSLSNILN 623
             L  ++ 
Sbjct: 302 SILDKLIR 309

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 67/246 (27%), Positives = 107/246 (43%), Gaps = 34/246 (13%)
Query: 384 KEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFS-NKNEGKYLDWKQRI 442
           KE A++ +I H NL+ L GVC  E   Y+V EY   G L D++   N+ E   +     +
Sbjct: 77  KEAAVMKEIKHPNLVQLLGVCTLEPPFYIVTEYMPYGNLLDYLRECNREEVTAV---VLL 133
Query: 443 QIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALT 502
            +A  +++ + YL        +H+D+ + N L+  +   K+A+F ++R   G       T
Sbjct: 134 YMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHVVKVADFGLSRLMTGD----TYT 186
Query: 503 RHIVGTK---GYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDV 559
            H  G K    + APE L     S K DV+AFGVL+ E+ T   +         + LS V
Sbjct: 187 AH-AGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPY-----PGIDLSQV 240
Query: 560 LNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLS 619
            +               ++   +   P      V  L+ AC K  P DRP+  E   +  
Sbjct: 241 YD--------------LLEKGYRMEQPEGCPPKVYELMRACWKWSPADRPSFAETHQAFE 286
Query: 620 NILNAS 625
            + + S
Sbjct: 287 TMFHDS 292

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 69/273 (25%), Positives = 128/273 (46%), Gaps = 42/273 (15%)
Query: 361 GSVYRGKINGGFAAIKKVN---------GDVSKEIALLNKINHSNLIILSGVCFNEGNCY 411
           G+VY+GK +G   A+K +N              E+ +L K  H N+++  G    +    
Sbjct: 22  GTVYKGKWHGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TKPQLA 79
Query: 412 LVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSS 471
           +V ++    +L   +   + + + +   + I IA   A G++YLH+ +    +H+D+ S+
Sbjct: 80  IVTQWCEGSSLYHHLHIIETKFEMI---KLIDIARQTAQGMDYLHAKSI---IHRDLKSN 133
Query: 472 NVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYL---ENGLVSTKLDV 528
           N+ L  DL  KI +F +A       G     + + G+  +MAPE +   +    S + DV
Sbjct: 134 NIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQ-LSGSILWMAPEVIRMQDKNPYSFQSDV 192
Query: 529 YAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTL---QGNY 585
           YAFG+++ E++TG+         +N++  D +  ++         R ++ P L   + N 
Sbjct: 193 YAFGIVLYELMTGQ------LPYSNINNRDQIIFMVG--------RGYLSPDLSKVRSNC 238
Query: 586 PLELALLVIRLIDACLKKDPTDRPTMYEIEHSL 618
           P  +     RL+  CLKK   +RP   +I  S+
Sbjct: 239 PKAMK----RLMAECLKKKRDERPLFPQILASI 267

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/252 (24%), Positives = 112/252 (44%), Gaps = 39/252 (15%)
Query: 381 DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQ 440
           D  +E  ++ K++H  L+ L GVC  +    LV E+  +G LSD++ + +        + 
Sbjct: 49  DFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRG---LFAAET 105
Query: 441 RIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFA 500
            + + LDV  G+ YL        +H+D+ + N L+  +   K+++F M R        F 
Sbjct: 106 LLGMCLDVCEGMAYLEEACV---IHRDLAARNCLVGENQVIKVSDFGMTR--------FV 154
Query: 501 LTRHIVGTKG------YMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNM 554
           L      + G      + +PE       S+K DV++FGVL+ E+ +  E    +   +N 
Sbjct: 155 LDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFS--EGKIPYENRSN- 211
Query: 555 HLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEI 614
             S+V+      ED     R +  P L   +       V ++++ C ++ P DRP    +
Sbjct: 212 --SEVV------EDISTGFRLY-KPRLASTH-------VYQIMNHCWRERPEDRPAFSRL 255
Query: 615 EHSLSNILNASL 626
              L+ I  + L
Sbjct: 256 LRQLAEIAESGL 267

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 68/266 (25%), Positives = 127/266 (47%), Gaps = 36/266 (13%)
Query: 361 GSVYRGKINGGFAAIKKVN---------GDVSKEIALLNKINHSNLIILSGVCFNEGNCY 411
           G+VY+GK +G   A+K +N              E+ +L K  H N+++  G         
Sbjct: 38  GTVYKGKWHGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLA 95
Query: 412 LVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSS 471
           +V ++    +L   + +++ +    + K+ I IA   A G++YLH+ +    +H+D+ S+
Sbjct: 96  IVTQWCEGSSLYHHLHASETK---FEMKKLIDIARQTARGMDYLHAKSI---IHRDLKSN 149
Query: 472 NVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYL---ENGLVSTKLDV 528
           N+ L  D   KI +F +A       G     + + G+  +MAPE +   ++   S + DV
Sbjct: 150 NIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQ-LSGSILWMAPEVIRMQDSNPYSFQSDV 208
Query: 529 YAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLE 588
           YAFG+++ E++TG+   +      N++  D +  ++    G  SL   +   ++ N P  
Sbjct: 209 YAFGIVLYELMTGQLPYS------NINNRDQIIEMV----GRGSLSPDLS-KVRSNCPKR 257
Query: 589 LALLVIRLIDACLKKDPTDRPTMYEI 614
           +     RL+  CLKK   +RP+   I
Sbjct: 258 MK----RLMAECLKKKRDERPSFPRI 279

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 46/180 (25%), Positives = 89/180 (49%), Gaps = 15/180 (8%)
Query: 370 GGFAAIKKVNG-------DVSKEIALLNKINHSNLIILSGVCFNEG--NCYLVYEYAVNG 420
           G   A+KK+         D  +EI +L  + H N++   GVC++ G  N  L+ EY   G
Sbjct: 40  GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG 99
Query: 421 TLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLR 480
           +L D++  +K     +D  + +Q    +  G+ YL +     ++H+++ + N+L++++ R
Sbjct: 100 SLRDYLQKHKER---IDHIKLLQYTSQICKGMEYLGT---KRYIHRNLATRNILVENENR 153
Query: 481 AKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT 540
            KI +F + +     +  + +         + APE L     S   DV++FGV++ E+ T
Sbjct: 154 VKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 213

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/241 (25%), Positives = 111/241 (46%), Gaps = 27/241 (11%)
Query: 385 EIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQI 444
           E  ++  + H  L+ L  V   E   Y++ E+   G+L D  F   +EG      + I  
Sbjct: 233 EANVMKTLQHDKLVKLHAVVTKE-PIYIITEFMAKGSLLD--FLKSDEGSKQPLPKLIDF 289
Query: 445 ALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRH 504
           +  +A G+ ++       ++H+D+ ++N+L+ + L  KIA+F +AR  E  + E+     
Sbjct: 290 SAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIE--DNEYTAREG 344
Query: 505 IVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVL 564
                 + APE +  G  + K DV++FG+L++E++T             M   +V+ A+ 
Sbjct: 345 AKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPY-----PGMSNPEVIRAL- 398
Query: 565 TKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNA 624
                    R +  P  + N P EL  +++R    C K  P +RPT   I+  L +   A
Sbjct: 399 --------ERGYRMPRPE-NCPEELYNIMMR----CWKNRPEERPTFEYIQSVLDDFYTA 445
Query: 625 S 625
           +
Sbjct: 446 T 446

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 72/277 (25%), Positives = 118/277 (42%), Gaps = 42/277 (15%)
Query: 361 GSVYRG--KINGGFAAIKKVNGDVS------KEIALLNKINHSNLIILSGVCFNEGNCYL 412
           G VY G  K      A+K +  D        KE A++ +I H NL+ L GVC  E   Y+
Sbjct: 234 GEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 293
Query: 413 VYEYAVNGTLSDWVFS-NKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSS 471
           + E+   G L D++   N+ E   +     + +A  +++ + YL        +H+++ + 
Sbjct: 294 ITEFMTYGNLLDYLRECNRQEVSAV---VLLYMATQISSAMEYLEKKN---FIHRNLAAR 347
Query: 472 NVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTK---GYMAPEYLENGLVSTKLDV 528
           N L+  +   K+A+F ++R   G       T H  G K    + APE L     S K DV
Sbjct: 348 NCLVGENHLVKVADFGLSRLMTGD----TYTAH-AGAKFPIKWTAPESLAYNKFSIKSDV 402
Query: 529 YAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLE 588
           +AFGVL+ E+ T   +         + LS V                 ++   +   P  
Sbjct: 403 WAFGVLLWEIATYGMSPY-----PGIDLSQVYE--------------LLEKDYRMERPEG 443
Query: 589 LALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNAS 625
               V  L+ AC + +P+DRP+  EI  +   +   S
Sbjct: 444 CPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 480

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 72/277 (25%), Positives = 119/277 (42%), Gaps = 42/277 (15%)
Query: 361 GSVYRG--KINGGFAAIKKVNGDVS------KEIALLNKINHSNLIILSGVCFNEGNCYL 412
           G VY G  K      A+K +  D        KE A++ +I H NL+ L GVC  E   Y+
Sbjct: 273 GEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 332
Query: 413 VYEYAVNGTLSDWVFS-NKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSS 471
           + E+   G L D++   N+ E   ++    + +A  +++ + YL        +H+++ + 
Sbjct: 333 ITEFMTYGNLLDYLRECNRQE---VNAVVLLYMATQISSAMEYLEKKN---FIHRNLAAR 386
Query: 472 NVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTK---GYMAPEYLENGLVSTKLDV 528
           N L+  +   K+A+F ++R   G       T H  G K    + APE L     S K DV
Sbjct: 387 NCLVGENHLVKVADFGLSRLMTGD----TYTAH-AGAKFPIKWTAPESLAYNKFSIKSDV 441
Query: 529 YAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLE 588
           +AFGVL+ E+ T   +         + LS V                 ++   +   P  
Sbjct: 442 WAFGVLLWEIATYGMSPY-----PGIDLSQVYE--------------LLEKDYRMERPEG 482
Query: 589 LALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNAS 625
               V  L+ AC + +P+DRP+  EI  +   +   S
Sbjct: 483 CPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 519

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 69/273 (25%), Positives = 128/273 (46%), Gaps = 42/273 (15%)
Query: 361 GSVYRGKINGGFAAIKKVN---------GDVSKEIALLNKINHSNLIILSGVCFNEGNCY 411
           G+VY+GK +G   A+K +N              E+ +L K  H N+++  G    +    
Sbjct: 27  GTVYKGKWHGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TKPQLA 84
Query: 412 LVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSS 471
           +V ++    +L   +   + + + +   + I IA   A G++YLH+ +    +H+D+ S+
Sbjct: 85  IVTQWCEGSSLYHHLHIIETKFEMI---KLIDIARQTAQGMDYLHAKSI---IHRDLKSN 138
Query: 472 NVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYL---ENGLVSTKLDV 528
           N+ L  DL  KI +F +A       G     + + G+  +MAPE +   +    S + DV
Sbjct: 139 NIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQ-LSGSILWMAPEVIRMQDKNPYSFQSDV 197
Query: 529 YAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTL---QGNY 585
           YAFG+++ E++TG+         +N++  D +  ++         R ++ P L   + N 
Sbjct: 198 YAFGIVLYELMTGQ------LPYSNINNRDQIIFMVG--------RGYLSPDLSKVRSNC 243
Query: 586 PLELALLVIRLIDACLKKDPTDRPTMYEIEHSL 618
           P  +     RL+  CLKK   +RP   +I  S+
Sbjct: 244 PKAMK----RLMAECLKKKRDERPLFPQILASI 272

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 71/277 (25%), Positives = 117/277 (42%), Gaps = 42/277 (15%)
Query: 361 GSVYRG--KINGGFAAIKKVNGDVS------KEIALLNKINHSNLIILSGVCFNEGNCYL 412
           G VY G  K      A+K +  D        KE A++ +I H NL+ L GVC  E   Y+
Sbjct: 28  GEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 87
Query: 413 VYEYAVNGTLSDWVFS-NKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSS 471
           + E+   G L D++   N+ E   ++    + +A  +++ + YL        +H+D+ + 
Sbjct: 88  ITEFMTYGNLLDYLRECNRQE---VNAVVLLYMATQISSAMEYLEKKN---FIHRDLAAR 141
Query: 472 NVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTK---GYMAPEYLENGLVSTKLDV 528
           N L+  +   K+A+F ++R   G            G K    + APE L     S K DV
Sbjct: 142 NCLVGENHLVKVADFGLSRLMTGD-----TYTAPAGAKFPIKWTAPESLAYNKFSIKSDV 196
Query: 529 YAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLE 588
           +AFGVL+ E+ T   +         + LS V                 ++   +   P  
Sbjct: 197 WAFGVLLWEIATYGMSPY-----PGIDLSQVYE--------------LLEKDYRMERPEG 237
Query: 589 LALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNAS 625
               V  L+ AC + +P+DRP+  EI  +   +   S
Sbjct: 238 CPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 274

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/258 (23%), Positives = 121/258 (46%), Gaps = 29/258 (11%)
Query: 368 INGGFAAIKKVNGDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVF 427
           +  G+   ++V  D   E  ++ + +H N+I L GV        ++ EY  NG L  ++ 
Sbjct: 81  LKAGYTEKQRV--DFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLR 138
Query: 428 SNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFA 487
               E   L   Q + +   +A G+ YL    N  +VH+D+ + N+L++S+L  K+++F 
Sbjct: 139 EKDGEFSVL---QLVGMLRGIAAGMKYL---ANMNYVHRDLAARNILVNSNLVCKVSDFG 192
Query: 488 MARPAEGQ-EGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAA 546
           ++R  E   E  +  +   +  + + APE +     ++  DV++FG+++ E++T  E   
Sbjct: 193 LSRVLEDDPEATYTTSGGKIPIR-WTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERP- 250
Query: 547 LHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPT 606
            + E +N  +   +N      DG      F  PT     P++    + +L+  C +++  
Sbjct: 251 -YWELSNHEVMKAIN------DG------FRLPT-----PMDCPSAIYQLMMQCWQQERA 292
Query: 607 DRPTMYEIEHSLSNILNA 624
            RP   +I   L  ++ A
Sbjct: 293 RRPKFADIVSILDKLIRA 310

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 68/269 (25%), Positives = 126/269 (46%), Gaps = 42/269 (15%)
Query: 361 GSVYRGKINGGFAAIKKVN---------GDVSKEIALLNKINHSNLIILSGVCFNEGNCY 411
           G+VY+GK +G   A+K +N              E+ +L K  H N+++  G    +    
Sbjct: 24  GTVYKGKWHGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TKPQLA 81
Query: 412 LVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSS 471
           +V ++    +L   +   + + + +   + I IA   A G++YLH+ +    +H+D+ S+
Sbjct: 82  IVTQWCEGSSLYHHLHIIETKFEMI---KLIDIARQTAQGMDYLHAKSI---IHRDLKSN 135
Query: 472 NVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYL---ENGLVSTKLDV 528
           N+ L  DL  KI +F +A       G     + + G+  +MAPE +   +    S + DV
Sbjct: 136 NIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQ-LSGSILWMAPEVIRMQDKNPYSFQSDV 194
Query: 529 YAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTL---QGNY 585
           YAFG+++ E++TG+         +N++  D +  ++         R ++ P L   + N 
Sbjct: 195 YAFGIVLYELMTGQ------LPYSNINNRDQIIFMVG--------RGYLSPDLSKVRSNC 240
Query: 586 PLELALLVIRLIDACLKKDPTDRPTMYEI 614
           P  +     RL+  CLKK   +RP   +I
Sbjct: 241 PKAMK----RLMAECLKKKRDERPLFPQI 265

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/248 (23%), Positives = 119/248 (47%), Gaps = 25/248 (10%)
Query: 376 KKVNGDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKY 435
           +K   D   E +++ + +H N+I L GV        +V EY  NG+L    F  K++ ++
Sbjct: 58  EKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDS--FLRKHDAQF 115
Query: 436 LDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQ 495
               Q + +   +A+G+ YL   ++  +VH+D+ + N+L++S+L  K+++F ++R  E  
Sbjct: 116 TV-IQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDD 171
Query: 496 EGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMH 555
                 TR       + +PE +     ++  DV+++G+++ E+++  E          M 
Sbjct: 172 PEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWE-----MS 226
Query: 556 LSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIE 615
             DV+ AV      +E  R  + P      P++    + +L+  C +KD  +RP   +I 
Sbjct: 227 NQDVIKAV------DEGYR--LPP------PMDCPAALYQLMLDCWQKDRNNRPKFEQIV 272
Query: 616 HSLSNILN 623
             L  ++ 
Sbjct: 273 SILDKLIR 280

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 69/273 (25%), Positives = 128/273 (46%), Gaps = 42/273 (15%)
Query: 361 GSVYRGKINGGFAAIKKVN---------GDVSKEIALLNKINHSNLIILSGVCFNEGNCY 411
           G+VY+GK +G   A+K +N              E+ +L K  H N+++  G    +    
Sbjct: 22  GTVYKGKWHGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TKPQLA 79
Query: 412 LVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSS 471
           +V ++    +L   +   + + + +   + I IA   A G++YLH+ +    +H+D+ S+
Sbjct: 80  IVTQWCEGSSLYHHLHIIETKFEMI---KLIDIARQTAQGMDYLHAKSI---IHRDLKSN 133
Query: 472 NVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYL---ENGLVSTKLDV 528
           N+ L  DL  KI +F +A       G     + + G+  +MAPE +   +    S + DV
Sbjct: 134 NIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQ-LSGSILWMAPEVIRMQDKNPYSFQSDV 192
Query: 529 YAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTL---QGNY 585
           YAFG+++ E++TG+         +N++  D +  ++         R ++ P L   + N 
Sbjct: 193 YAFGIVLYELMTGQ------LPYSNINNRDQIIFMVG--------RGYLSPDLSKVRSNC 238
Query: 586 PLELALLVIRLIDACLKKDPTDRPTMYEIEHSL 618
           P  +     RL+  CLKK   +RP   +I  S+
Sbjct: 239 PKAMK----RLMAECLKKKRDERPLFPQILASI 267

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 51/180 (28%), Positives = 90/180 (50%), Gaps = 17/180 (9%)
Query: 374 AIKKVNGDVSKEIALLNKI-NHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNE 432
           A +K   D+  E+ ++  I  H N+I L G C  +G  Y++ EYA  G L +++ + +  
Sbjct: 79  ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPP 138
Query: 433 G------------KYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLR 480
           G            + + +K  +     +A G+ YL S      +H+D+ + NVL+  +  
Sbjct: 139 GMEXSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKC---IHRDLAARNVLVTENNV 195
Query: 481 AKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT 540
            KIA+F +AR     +     T   +  K +MAPE L + + + + DV++FGVL+ E+ T
Sbjct: 196 MKIADFGLARDINNIDXXKKTTNGRLPVK-WMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 59/248 (23%), Positives = 117/248 (47%), Gaps = 25/248 (10%)
Query: 376 KKVNGDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKY 435
           +K   D   E +++ + +H N+I L GV        +V EY  NG+L    F  K++ ++
Sbjct: 75  EKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDS--FLRKHDAQF 132
Query: 436 LDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQ 495
               Q + +   +A+G+ YL       +VH+D+ + N+L++S+L  K+++F ++R  E  
Sbjct: 133 TV-IQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLSRVLEDD 188
Query: 496 EGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMH 555
                 TR       + +PE +     ++  DV+++G+++ E+++  E          M 
Sbjct: 189 PEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWE-----MS 243
Query: 556 LSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIE 615
             DV+ AV      +E  R  + P      P++    + +L+  C +KD  +RP   +I 
Sbjct: 244 NQDVIKAV------DEGYR--LPP------PMDCPAALYQLMLDCWQKDRNNRPKFEQIV 289
Query: 616 HSLSNILN 623
             L  ++ 
Sbjct: 290 SILDKLIR 297

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 71/277 (25%), Positives = 117/277 (42%), Gaps = 42/277 (15%)
Query: 361 GSVYRG--KINGGFAAIKKVNGDVS------KEIALLNKINHSNLIILSGVCFNEGNCYL 412
           G VY G  K      A+K +  D        KE A++ +I H NL+ L GVC  E   Y+
Sbjct: 29  GEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 88
Query: 413 VYEYAVNGTLSDWVFS-NKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSS 471
           + E+   G L D++   N+ E   ++    + +A  +++ + YL        +H+D+ + 
Sbjct: 89  ITEFMTYGNLLDYLRECNRQE---VNAVVLLYMATQISSAMEYLEKKN---FIHRDLAAR 142
Query: 472 NVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTK---GYMAPEYLENGLVSTKLDV 528
           N L+  +   K+A+F ++R   G            G K    + APE L     S K DV
Sbjct: 143 NCLVGENHLVKVADFGLSRLMTGD-----TYTAPAGAKFPIKWTAPESLAYNKFSIKSDV 197
Query: 529 YAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLE 588
           +AFGVL+ E+ T   +         + LS V                 ++   +   P  
Sbjct: 198 WAFGVLLWEIATYGMSPY-----PGIDLSQVYE--------------LLEKDYRMERPEG 238
Query: 589 LALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNAS 625
               V  L+ AC + +P+DRP+  EI  +   +   S
Sbjct: 239 CPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 275

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 68/269 (25%), Positives = 126/269 (46%), Gaps = 42/269 (15%)
Query: 361 GSVYRGKINGGFAAIKKVN---------GDVSKEIALLNKINHSNLIILSGVCFNEGNCY 411
           G+VY+GK +G   A+K +N              E+ +L K  H N+++  G    +    
Sbjct: 27  GTVYKGKWHGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TKPQLA 84
Query: 412 LVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSS 471
           +V ++    +L   +   + + + +   + I IA   A G++YLH+ +    +H+D+ S+
Sbjct: 85  IVTQWCEGSSLYHHLHIIETKFEMI---KLIDIARQTAQGMDYLHAKSI---IHRDLKSN 138
Query: 472 NVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYL---ENGLVSTKLDV 528
           N+ L  DL  KI +F +A       G     + + G+  +MAPE +   +    S + DV
Sbjct: 139 NIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQ-LSGSILWMAPEVIRMQDKNPYSFQSDV 197
Query: 529 YAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTL---QGNY 585
           YAFG+++ E++TG+         +N++  D +  ++         R ++ P L   + N 
Sbjct: 198 YAFGIVLYELMTGQ------LPYSNINNRDQIIFMVG--------RGYLSPDLSKVRSNC 243
Query: 586 PLELALLVIRLIDACLKKDPTDRPTMYEI 614
           P  +     RL+  CLKK   +RP   +I
Sbjct: 244 PKAMK----RLMAECLKKKRDERPLFPQI 268

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 46/180 (25%), Positives = 89/180 (49%), Gaps = 15/180 (8%)
Query: 370 GGFAAIKKVNG-------DVSKEIALLNKINHSNLIILSGVCFNEG--NCYLVYEYAVNG 420
           G   A+KK+         D  +EI +L  + H N++   GVC++ G  N  L+ EY   G
Sbjct: 42  GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG 101
Query: 421 TLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLR 480
           +L D++ ++    + +D  + +Q    +  G+ YL +     ++H+D+ + N+L++++ R
Sbjct: 102 SLRDYLQAH---AERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENR 155
Query: 481 AKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT 540
            KI +F + +     +    +         + APE L     S   DV++FGV++ E+ T
Sbjct: 156 VKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 51/180 (28%), Positives = 90/180 (50%), Gaps = 17/180 (9%)
Query: 374 AIKKVNGDVSKEIALLNKI-NHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNE 432
           A +K   D+  E+ ++  I  H N+I L G C  +G  Y++ EYA  G L +++ + +  
Sbjct: 79  ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPP 138
Query: 433 G------------KYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLR 480
           G            + + +K  +     +A G+ YL S      +H+D+ + NVL+  +  
Sbjct: 139 GMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKC---IHRDLAARNVLVTENNV 195
Query: 481 AKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT 540
            KIA+F +AR     +     T   +  K +MAPE L + + + + DV++FGVL+ E+ T
Sbjct: 196 MKIADFGLARDINNIDXXKKTTNGRLPVK-WMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 62/262 (23%), Positives = 125/262 (47%), Gaps = 35/262 (13%)
Query: 372 FAAIK--------KVNGDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLS 423
           F AIK        K   D   E +++ + +H N+I L GV        ++ E+  NG+L 
Sbjct: 37  FVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLD 96
Query: 424 DWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKI 483
              F  +N+G++    Q + +   +A G+ YL       +VH+ + + N+L++S+L  K+
Sbjct: 97  S--FLRQNDGQFTV-IQLVGMLRGIAAGMKYLADMN---YVHRALAARNILVNSNLVCKV 150
Query: 484 ANFAMARPAEGQEGEFALTRHIVGT--KGYMAPEYLENGLVSTKLDVYAFGVLILEMLTG 541
           ++F ++R  E    +   T  + G     + APE ++    ++  DV+++G+++ E+++ 
Sbjct: 151 SDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSY 210
Query: 542 KEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACL 601
            E         +M   DV+NA+      E+  R  + P      P++    + +L+  C 
Sbjct: 211 GERPYW-----DMTNQDVINAI------EQDYR--LPP------PMDCPSALHQLMLDCW 251
Query: 602 KKDPTDRPTMYEIEHSLSNILN 623
           +KD   RP   +I ++L  ++ 
Sbjct: 252 QKDRNHRPKFGQIVNTLDKMIR 273

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 68/269 (25%), Positives = 126/269 (46%), Gaps = 42/269 (15%)
Query: 361 GSVYRGKINGGFAAIKKVN---------GDVSKEIALLNKINHSNLIILSGVCFNEGNCY 411
           G+VY+GK +G   A+K +N              E+ +L K  H N+++  G    +    
Sbjct: 42  GTVYKGKWHGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TKPQLA 99
Query: 412 LVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSS 471
           +V ++    +L   +   + + + +   + I IA   A G++YLH+ +    +H+D+ S+
Sbjct: 100 IVTQWCEGSSLYHHLHIIETKFEMI---KLIDIARQTAQGMDYLHAKSI---IHRDLKSN 153
Query: 472 NVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYL---ENGLVSTKLDV 528
           N+ L  DL  KI +F +A       G     + + G+  +MAPE +   +    S + DV
Sbjct: 154 NIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQ-LSGSILWMAPEVIRMQDKNPYSFQSDV 212
Query: 529 YAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTL---QGNY 585
           YAFG+++ E++TG+   +      N++  D +  ++         R ++ P L   + N 
Sbjct: 213 YAFGIVLYELMTGQLPYS------NINNRDQIIFMVG--------RGYLSPDLSKVRSNC 258
Query: 586 PLELALLVIRLIDACLKKDPTDRPTMYEI 614
           P  +     RL+  CLKK   +RP   +I
Sbjct: 259 PKAMK----RLMAECLKKKRDERPLFPQI 283

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 62/243 (25%), Positives = 115/243 (47%), Gaps = 28/243 (11%)
Query: 384 KEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQ 443
           +E  L+  + H  L+ L  V   E   Y++ E+   G+L D  F   +EG  +   + I 
Sbjct: 56  EEANLMKTLQHDKLVRLYAVVTKEEPIYIITEFMAKGSLLD--FLKSDEGGKVLLPKLID 113
Query: 444 IALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTR 503
            +  +A G+ Y+       ++H+D+ ++NVL+   L  KIA+F +AR  E  + E+    
Sbjct: 114 FSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIE--DNEYTARE 168
Query: 504 HIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT-GKEAAALHAEENNMHLSDVLNA 562
                  + APE +  G  + K +V++FG+L+ E++T GK     +    N   +DV++A
Sbjct: 169 GAKFPIKWTAPEAINFGCFTIKSNVWSFGILLYEIVTYGK---IPYPGRTN---ADVMSA 222
Query: 563 VLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNIL 622
           +          + +  P ++ N P EL      ++  C K+   +RPT   ++  L +  
Sbjct: 223 L---------SQGYRMPRME-NCPDEL----YDIMKMCWKEKAEERPTFDYLQSVLDDFY 268
Query: 623 NAS 625
            A+
Sbjct: 269 TAT 271

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 59/248 (23%), Positives = 117/248 (47%), Gaps = 25/248 (10%)
Query: 376 KKVNGDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKY 435
           +K   D   E +++ + +H N+I L GV        +V EY  NG+L    F  K++ ++
Sbjct: 87  EKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDS--FLRKHDAQF 144
Query: 436 LDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQ 495
               Q + +   +A+G+ YL       +VH+D+ + N+L++S+L  K+++F ++R  E  
Sbjct: 145 TV-IQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLSRVLEDD 200
Query: 496 EGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMH 555
                 TR       + +PE +     ++  DV+++G+++ E+++  E          M 
Sbjct: 201 PEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWE-----MS 255
Query: 556 LSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIE 615
             DV+ AV      +E  R  + P      P++    + +L+  C +KD  +RP   +I 
Sbjct: 256 NQDVIKAV------DEGYR--LPP------PMDCPAALYQLMLDCWQKDRNNRPKFEQIV 301
Query: 616 HSLSNILN 623
             L  ++ 
Sbjct: 302 SILDKLIR 309

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 68/269 (25%), Positives = 126/269 (46%), Gaps = 42/269 (15%)
Query: 361 GSVYRGKINGGFAAIKKVN---------GDVSKEIALLNKINHSNLIILSGVCFNEGNCY 411
           G+VY+GK +G   A+K +N              E+ +L K  H N+++  G    +    
Sbjct: 50  GTVYKGKWHGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TKPQLA 107
Query: 412 LVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSS 471
           +V ++    +L   +   + + + +   + I IA   A G++YLH+ +    +H+D+ S+
Sbjct: 108 IVTQWCEGSSLYHHLHIIETKFEMI---KLIDIARQTAQGMDYLHAKSI---IHRDLKSN 161
Query: 472 NVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYL---ENGLVSTKLDV 528
           N+ L  DL  KI +F +A       G     + + G+  +MAPE +   +    S + DV
Sbjct: 162 NIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQ-LSGSILWMAPEVIRMQDKNPYSFQSDV 220
Query: 529 YAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTL---QGNY 585
           YAFG+++ E++TG+   +      N++  D +  ++         R ++ P L   + N 
Sbjct: 221 YAFGIVLYELMTGQLPYS------NINNRDQIIFMVG--------RGYLSPDLSKVRSNC 266
Query: 586 PLELALLVIRLIDACLKKDPTDRPTMYEI 614
           P  +     RL+  CLKK   +RP   +I
Sbjct: 267 PKAMK----RLMAECLKKKRDERPLFPQI 291

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 59/248 (23%), Positives = 117/248 (47%), Gaps = 25/248 (10%)
Query: 376 KKVNGDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKY 435
           +K   D   E +++ + +H N+I L GV        +V EY  NG+L    F  K++ ++
Sbjct: 87  EKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDS--FLRKHDAQF 144
Query: 436 LDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQ 495
               Q + +   +A+G+ YL       +VH+D+ + N+L++S+L  K+++F ++R  E  
Sbjct: 145 TV-IQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLSRVLEDD 200
Query: 496 EGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMH 555
                 TR       + +PE +     ++  DV+++G+++ E+++  E          M 
Sbjct: 201 PEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWE-----MS 255
Query: 556 LSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIE 615
             DV+ AV      +E  R  + P      P++    + +L+  C +KD  +RP   +I 
Sbjct: 256 NQDVIKAV------DEGYR--LPP------PMDCPAALYQLMLDCWQKDRNNRPKFEQIV 301
Query: 616 HSLSNILN 623
             L  ++ 
Sbjct: 302 SILDKLIR 309

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 59/248 (23%), Positives = 117/248 (47%), Gaps = 25/248 (10%)
Query: 376 KKVNGDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKY 435
           +K   D   E +++ + +H N+I L GV        +V EY  NG+L    F  K++ ++
Sbjct: 87  EKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDS--FLRKHDAQF 144
Query: 436 LDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQ 495
               Q + +   +A+G+ YL       +VH+D+ + N+L++S+L  K+++F ++R  E  
Sbjct: 145 TV-IQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLSRVLEDD 200
Query: 496 EGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMH 555
                 TR       + +PE +     ++  DV+++G+++ E+++  E          M 
Sbjct: 201 PEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWE-----MS 255
Query: 556 LSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIE 615
             DV+ AV      +E  R  + P      P++    + +L+  C +KD  +RP   +I 
Sbjct: 256 NQDVIKAV------DEGYR--LPP------PMDCPAALYQLMLDCWQKDRNNRPKFEQIV 301
Query: 616 HSLSNILN 623
             L  ++ 
Sbjct: 302 SILDKLIR 309

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 61/264 (23%), Positives = 115/264 (43%), Gaps = 47/264 (17%)
Query: 381 DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEG------- 433
           D+  E  +L ++NH ++I L G C  +G   L+ EYA  G+L  ++  ++  G       
Sbjct: 72  DLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSG 131
Query: 434 -------------KYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLR 480
                        + L     I  A  ++ G+ YL   +    VH+D+ + N+L+    +
Sbjct: 132 GSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMS---LVHRDLAARNILVAEGRK 188
Query: 481 AKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT 540
            KI++F ++R    ++     ++  +  K +MA E L + + +T+ DV++FGVL+ E++T
Sbjct: 189 MKISDFGLSRDVYEEDSXVKRSQGRIPVK-WMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247
Query: 541 --GKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLID 598
             G     +  E        + N + T    E               P   +  + RL+ 
Sbjct: 248 LGGNPYPGIPPER-------LFNLLKTGHRMER--------------PDNCSEEMYRLML 286
Query: 599 ACLKKDPTDRPTMYEIEHSLSNIL 622
            C K++P  RP   +I   L  ++
Sbjct: 287 QCWKQEPDKRPVFADISKDLEKMM 310

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 59/248 (23%), Positives = 117/248 (47%), Gaps = 25/248 (10%)
Query: 376 KKVNGDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKY 435
           +K   D   E +++ + +H N+I L GV        +V EY  NG+L    F  K++ ++
Sbjct: 87  EKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDS--FLRKHDAQF 144
Query: 436 LDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQ 495
               Q + +   +A+G+ YL       +VH+D+ + N+L++S+L  K+++F ++R  E  
Sbjct: 145 TV-IQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLSRVLEDD 200
Query: 496 EGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMH 555
                 TR       + +PE +     ++  DV+++G+++ E+++  E          M 
Sbjct: 201 PEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWE-----MS 255
Query: 556 LSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIE 615
             DV+ AV      +E  R  + P      P++    + +L+  C +KD  +RP   +I 
Sbjct: 256 NQDVIKAV------DEGYR--LPP------PMDCPAALYQLMLDCWQKDRNNRPKFEQIV 301
Query: 616 HSLSNILN 623
             L  ++ 
Sbjct: 302 SILDKLIR 309

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 51/180 (28%), Positives = 90/180 (50%), Gaps = 17/180 (9%)
Query: 374 AIKKVNGDVSKEIALLNKI-NHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNE 432
           A +K   D+  E+ ++  I  H N+I L G C  +G  Y++ EYA  G L +++ + +  
Sbjct: 79  ATEKDLSDLVSEMEMMKMIGKHKNIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPP 138
Query: 433 G------------KYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLR 480
           G            + + +K  +     +A G+ YL S      +H+D+ + NVL+  +  
Sbjct: 139 GMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKC---IHRDLAARNVLVTENNV 195
Query: 481 AKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT 540
            KIA+F +AR     +     T   +  K +MAPE L + + + + DV++FGVL+ E+ T
Sbjct: 196 MKIADFGLARDINNIDYYKKTTNGRLPVK-WMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 65/250 (26%), Positives = 116/250 (46%), Gaps = 27/250 (10%)
Query: 376 KKVNGDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKY 435
           ++   D   E +++ + +H N+I L GV        +V EY  NG+L    F   ++G++
Sbjct: 91  ERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLD--TFLRTHDGQF 148
Query: 436 LDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQ 495
               Q + +   V  G+ YL       +VH+D+ + NVL+DS+L  K+++F ++R  E  
Sbjct: 149 TI-MQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDD 204
Query: 496 -EGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNM 554
            +  +  T   +  + + APE +     S+  DV++FGV++ E+L   E         NM
Sbjct: 205 PDAAYTTTGGKIPIR-WTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYW-----NM 258
Query: 555 HLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEI 614
              DV+++V      EE  R    P      P+     + +L+  C  KD   RP   +I
Sbjct: 259 TNRDVISSV------EEGYRL---PA-----PMGCPHALHQLMLDCWHKDRAQRPRFSQI 304
Query: 615 EHSLSNILNA 624
              L  ++ +
Sbjct: 305 VSVLDALIRS 314

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 59/248 (23%), Positives = 116/248 (46%), Gaps = 25/248 (10%)
Query: 376 KKVNGDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKY 435
           +K   D   E +++ + +H N+I L GV        +V EY  NG+L    F  K++ ++
Sbjct: 87  EKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDS--FLRKHDAQF 144
Query: 436 LDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQ 495
               Q + +   +A+G+ YL       +VH+D+ + N+L++S+L  K+++F + R  E  
Sbjct: 145 TV-IQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLEDD 200
Query: 496 EGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMH 555
                 TR       + +PE +     ++  DV+++G+++ E+++  E          M 
Sbjct: 201 PEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWE-----MS 255
Query: 556 LSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIE 615
             DV+ AV      +E  R  + P      P++    + +L+  C +KD  +RP   +I 
Sbjct: 256 NQDVIKAV------DEGYR--LPP------PMDCPAALYQLMLDCWQKDRNNRPKFEQIV 301
Query: 616 HSLSNILN 623
             L  ++ 
Sbjct: 302 SILDKLIR 309

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 61/236 (25%), Positives = 108/236 (45%), Gaps = 27/236 (11%)
Query: 385 EIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQI 444
           E  ++  + H  L+ L  V   E   Y++ E+   G+L D  F   +EG      + I  
Sbjct: 60  EANVMKTLQHDKLVKLHAVVTKEP-IYIITEFMAKGSLLD--FLKSDEGSKQPLPKLIDF 116
Query: 445 ALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRH 504
           +  +A G+ ++       ++H+D+ ++N+L+ + L  KIA+F +AR  E  + E+     
Sbjct: 117 SAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIE--DNEYTAREG 171
Query: 505 IVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVL 564
                 + APE +  G  + K DV++FG+L++E++T             M   +V+ A+ 
Sbjct: 172 AKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPY-----PGMSNPEVIRAL- 225
Query: 565 TKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSN 620
             E G    R         N P EL  +++R    C K  P +RPT   I+  L +
Sbjct: 226 --ERGYRMPR-------PENCPEELYNIMMR----CWKNRPEERPTFEYIQSVLDD 268

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 70/279 (25%), Positives = 127/279 (45%), Gaps = 41/279 (14%)
Query: 361 GSVYRGKINGGFAA--IKKVNGDVSK------EIALLNKINHSNLIILSGVCFNEGNCYL 412
           G+VY+GK +G  A   +K V+    +      E+A+L K  H N+++  G    + N  +
Sbjct: 50  GTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGY-MTKDNLAI 108
Query: 413 VYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSN 472
           V ++    +L   +   + + +     Q I IA   A G++YLH+      +H+D+ S+N
Sbjct: 109 VTQWCEGSSLYKHLHVQETKFQMF---QLIDIARQTAQGMDYLHAKNI---IHRDMKSNN 162
Query: 473 VLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYL---ENGLVSTKLDVY 529
           + L   L  KI +F +A       G   + +   G+  +MAPE +   +N   S + DVY
Sbjct: 163 IFLHEGLTVKIGDFGLATVKSRWSGSQQVEQP-TGSVLWMAPEVIRMQDNNPFSFQSDVY 221
Query: 530 AFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLEL 589
           ++G+++ E++TG+   +        H+++    +     G      +  P L   Y    
Sbjct: 222 SYGIVLYELMTGELPYS--------HINNRDQIIFMVGRG------YASPDLSKLYK-NC 266
Query: 590 ALLVIRLIDACLKKDPTDRPTMYEI-------EHSLSNI 621
              + RL+  C+KK   +RP   +I       +HSL  I
Sbjct: 267 PKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKI 305

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 69/273 (25%), Positives = 127/273 (46%), Gaps = 42/273 (15%)
Query: 361 GSVYRGKINGGFAAIKKVN---------GDVSKEIALLNKINHSNLIILSGVCFNEGNCY 411
           G+VY+GK +G   A+K +N              E+ +L K  H N+++  G         
Sbjct: 22  GTVYKGKWHGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLA 79
Query: 412 LVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSS 471
           +V ++    +L   +   + + + +   + I IA   A G++YLH+ +    +H+D+ S+
Sbjct: 80  IVTQWCEGSSLYHHLHIIETKFEMI---KLIDIARQTAQGMDYLHAKSI---IHRDLKSN 133
Query: 472 NVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYL---ENGLVSTKLDV 528
           N+ L  DL  KI +F +A       G     + + G+  +MAPE +   +    S + DV
Sbjct: 134 NIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQ-LSGSILWMAPEVIRMQDKNPYSFQSDV 192
Query: 529 YAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTL---QGNY 585
           YAFG+++ E++TG+         +N++  D +  ++         R ++ P L   + N 
Sbjct: 193 YAFGIVLYELMTGQ------LPYSNINNRDQIIFMVG--------RGYLSPDLSKVRSNC 238
Query: 586 PLELALLVIRLIDACLKKDPTDRPTMYEIEHSL 618
           P  +     RL+  CLKK   +RP   +I  S+
Sbjct: 239 PKAMK----RLMAECLKKKRDERPLFPQILASI 267

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 68/269 (25%), Positives = 126/269 (46%), Gaps = 42/269 (15%)
Query: 361 GSVYRGKINGGFAAIKKVN---------GDVSKEIALLNKINHSNLIILSGVCFNEGNCY 411
           G+VY+GK +G   A+K +N              E+ +L K  H N+++  G    +    
Sbjct: 50  GTVYKGKWHGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TKPQLA 107
Query: 412 LVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSS 471
           +V ++    +L   +   + + + +   + I IA   A G++YLH+ +    +H+D+ S+
Sbjct: 108 IVTQWCEGSSLYHHLHIIETKFEMI---KLIDIARQTAQGMDYLHAKSI---IHRDLKSN 161
Query: 472 NVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYL---ENGLVSTKLDV 528
           N+ L  DL  KI +F +A       G     + + G+  +MAPE +   +    S + DV
Sbjct: 162 NIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQ-LSGSILWMAPEVIRMQDKNPYSFQSDV 220
Query: 529 YAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTL---QGNY 585
           YAFG+++ E++TG+   +      N++  D +  ++         R ++ P L   + N 
Sbjct: 221 YAFGIVLYELMTGQLPYS------NINNRDQIIFMVG--------RGYLSPDLSKVRSNC 266
Query: 586 PLELALLVIRLIDACLKKDPTDRPTMYEI 614
           P  +     RL+  CLKK   +RP   +I
Sbjct: 267 PKAMK----RLMAECLKKKRDERPLFPQI 291

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 68/269 (25%), Positives = 126/269 (46%), Gaps = 42/269 (15%)
Query: 361 GSVYRGKINGGFAAIKKVN---------GDVSKEIALLNKINHSNLIILSGVCFNEGNCY 411
           G+VY+GK +G   A+K +N              E+ +L K  H N+++  G    +    
Sbjct: 49  GTVYKGKWHGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TKPQLA 106
Query: 412 LVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSS 471
           +V ++    +L   +   + + + +   + I IA   A G++YLH+ +    +H+D+ S+
Sbjct: 107 IVTQWCEGSSLYHHLHIIETKFEMI---KLIDIARQTAQGMDYLHAKSI---IHRDLKSN 160
Query: 472 NVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYL---ENGLVSTKLDV 528
           N+ L  DL  KI +F +A       G     + + G+  +MAPE +   +    S + DV
Sbjct: 161 NIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQ-LSGSILWMAPEVIRMQDKNPYSFQSDV 219
Query: 529 YAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTL---QGNY 585
           YAFG+++ E++TG+   +      N++  D +  ++         R ++ P L   + N 
Sbjct: 220 YAFGIVLYELMTGQLPYS------NINNRDQIIFMVG--------RGYLSPDLSKVRSNC 265
Query: 586 PLELALLVIRLIDACLKKDPTDRPTMYEI 614
           P  +     RL+  CLKK   +RP   +I
Sbjct: 266 PKAMK----RLMAECLKKKRDERPLFPQI 290

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 59/248 (23%), Positives = 117/248 (47%), Gaps = 25/248 (10%)
Query: 376 KKVNGDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKY 435
           +K   D   E +++ + +H N+I L GV        +V EY  NG+L    F  K++ ++
Sbjct: 85  EKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDS--FLRKHDAQF 142
Query: 436 LDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQ 495
               Q + +   +A+G+ YL       +VH+D+ + N+L++S+L  K+++F ++R  E  
Sbjct: 143 TV-IQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLSRVLEDD 198
Query: 496 EGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMH 555
                 TR       + +PE +     ++  DV+++G+++ E+++  E          M 
Sbjct: 199 PEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWE-----MS 253
Query: 556 LSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIE 615
             DV+ AV      +E  R  + P      P++    + +L+  C +KD  +RP   +I 
Sbjct: 254 NQDVIKAV------DEGYR--LPP------PMDCPAALYQLMLDCWQKDRNNRPKFEQIV 299
Query: 616 HSLSNILN 623
             L  ++ 
Sbjct: 300 SILDKLIR 307

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 65/269 (24%), Positives = 115/269 (42%), Gaps = 40/269 (14%)
Query: 374 AIKKVNGDVSKEIALLNKI-NHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNE 432
           A +K   D+  E+ ++  I  H N+I L G C  +G  Y++ EYA  G L +++ + +  
Sbjct: 66  ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPP 125
Query: 433 G------------KYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLR 480
           G            + + +K  +     +A G+ YL S      +H+D+ + NVL+  +  
Sbjct: 126 GMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKC---IHRDLTARNVLVTENNV 182
Query: 481 AKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT 540
            KIA+F +AR     +     T   +  K +MAPE L + + + + DV++FGVL+ E+ T
Sbjct: 183 MKIADFGLARDINNIDYYKKTTNGRLPVK-WMAPEALFDRVYTHQSDVWSFGVLMWEIFT 241
Query: 541 --GKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLID 598
             G     +  EE                     L   +    + + P      +  ++ 
Sbjct: 242 LGGSPYPGIPVEE---------------------LFKLLKEGHRMDKPANCTNELYMMMR 280
Query: 599 ACLKKDPTDRPTMYEIEHSLSNILNASLN 627
            C    P+ RPT  ++   L  IL  + N
Sbjct: 281 DCWHAVPSQRPTFKQLVEDLDRILTLTTN 309

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 63/244 (25%), Positives = 109/244 (44%), Gaps = 43/244 (17%)
Query: 385 EIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQI 444
           E  ++  + H  L+ L  V   E   Y++ E+   G+L D  F   +EG      + I  
Sbjct: 227 EANVMKTLQHDKLVKLHAVVTKE-PIYIITEFMAKGSLLD--FLKSDEGSKQPLPKLIDF 283
Query: 445 ALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRH 504
           +  +A G+ ++       ++H+D+ ++N+L+ + L  KIA+F +AR              
Sbjct: 284 SAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLAR-------------- 326
Query: 505 IVGTK---GYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLN 561
            VG K    + APE +  G  + K DV++FG+L++E++T             M   +V+ 
Sbjct: 327 -VGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPY-----PGMSNPEVIR 380
Query: 562 AVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNI 621
           A+   E G    R         N P EL  +++R    C K  P +RPT   I+  L + 
Sbjct: 381 AL---ERGYRMPR-------PENCPEELYNIMMR----CWKNRPEERPTFEYIQSVLDDF 426
Query: 622 LNAS 625
             A+
Sbjct: 427 YTAT 430

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 51/180 (28%), Positives = 90/180 (50%), Gaps = 17/180 (9%)
Query: 374 AIKKVNGDVSKEIALLNKI-NHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNE 432
           A +K   D+  E+ ++  I  H N+I L G C  +G  Y++ EYA  G L +++ + +  
Sbjct: 125 ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPP 184
Query: 433 G------------KYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLR 480
           G            + + +K  +     +A G+ YL S      +H+D+ + NVL+  +  
Sbjct: 185 GMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKC---IHRDLAARNVLVTENNV 241
Query: 481 AKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT 540
            KIA+F +AR     +     T   +  K +MAPE L + + + + DV++FGVL+ E+ T
Sbjct: 242 MKIADFGLARDINNIDYYKKTTNGRLPVK-WMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 65/249 (26%), Positives = 112/249 (44%), Gaps = 25/249 (10%)
Query: 376 KKVNGDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKY 435
           ++   D   E +++ + +H N+I L GV        +V EY  NG+L    F   ++G++
Sbjct: 91  ERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLD--TFLRTHDGQF 148
Query: 436 LDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQ 495
               Q + +   V  G+ YL       +VH+D+ + NVL+DS+L  K+++F ++R  E  
Sbjct: 149 TI-MQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDD 204
Query: 496 EGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMH 555
                 T        + APE +     S+  DV++FGV++ E+L   E         NM 
Sbjct: 205 PDAAXTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYW-----NMT 259
Query: 556 LSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIE 615
             DV+++V      EE  R    P      P+     + +L+  C  KD   RP   +I 
Sbjct: 260 NRDVISSV------EEGYRL---PA-----PMGCPHALHQLMLDCWHKDRAQRPRFSQIV 305
Query: 616 HSLSNILNA 624
             L  ++ +
Sbjct: 306 SVLDALIRS 314

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 61/264 (23%), Positives = 114/264 (43%), Gaps = 47/264 (17%)
Query: 381 DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEG------- 433
           D+  E  +L ++NH ++I L G C  +G   L+ EYA  G+L  ++  ++  G       
Sbjct: 72  DLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSG 131
Query: 434 -------------KYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLR 480
                        + L     I  A  ++ G+ YL        VH+D+ + N+L+    +
Sbjct: 132 GSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDLAARNILVAEGRK 188
Query: 481 AKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT 540
            KI++F ++R    ++     ++  +  K +MA E L + + +T+ DV++FGVL+ E++T
Sbjct: 189 MKISDFGLSRDVYEEDSXVKRSQGRIPVK-WMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247
Query: 541 --GKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLID 598
             G     +  E        + N + T    E               P   +  + RL+ 
Sbjct: 248 LGGNPYPGIPPER-------LFNLLKTGHRMER--------------PDNCSEEMYRLML 286
Query: 599 ACLKKDPTDRPTMYEIEHSLSNIL 622
            C K++P  RP   +I   L  ++
Sbjct: 287 QCWKQEPDKRPVFADISKDLEKMM 310

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 49/185 (26%), Positives = 91/185 (49%), Gaps = 22/185 (11%)
Query: 367 KINGGFAAIKKVNGDVSK---------EIALLNKINHSNLIILSGVCFNEGNCYLVYEYA 417
           K  G   A+KK+  D+ K         E+ ++   +H N++ +          ++V E+ 
Sbjct: 67  KHTGKQVAVKKM--DLRKQQRRELLFNEVVIMRDYHHDNVVDMYSSYLVGDELWVVMEFL 124
Query: 418 VNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDS 477
             G L+D V   +     ++ +Q   + L V   L+YLH   N   +H+DI S ++LL S
Sbjct: 125 EGGALTDIVTHTR-----MNEEQIATVCLSVLRALSYLH---NQGVIHRDIKSDSILLTS 176
Query: 478 DLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILE 537
           D R K+++F           E    + +VGT  +MAPE +      T++D+++ G++++E
Sbjct: 177 DGRIKLSDFGFCAQVSK---EVPKRKXLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIE 233
Query: 538 MLTGK 542
           M+ G+
Sbjct: 234 MIDGE 238

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 65/278 (23%), Positives = 128/278 (46%), Gaps = 40/278 (14%)
Query: 361 GSVYRGKING-----GFAAIKKVNGDVSK--------EIALLNKINHSNLIILSGVCFNE 407
           G V RG++          AIK + G  ++        E +++ +  H N+I L GV  N 
Sbjct: 28  GEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRLEGVVTNS 87
Query: 408 GNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKD 467
               ++ E+  NG L    F   N+G++    Q + +   +A+G+ YL   +   +VH+D
Sbjct: 88  MPVMILTEFMENGALDS--FLRLNDGQFTV-IQLVGMLRGIASGMRYLAEMS---YVHRD 141
Query: 468 INSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGT--KGYMAPEYLENGLVSTK 525
           + + N+L++S+L  K+++F ++R  E    +   T  + G     + APE +     ++ 
Sbjct: 142 LAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTAPEAIAFRKFTSA 201
Query: 526 LDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNY 585
            D +++G+++ E+++  E         +M   DV+NA+      E+  R    P    + 
Sbjct: 202 SDAWSYGIVMWEVMSFGERPYW-----DMSNQDVINAI------EQDYRLPPPP----DC 246
Query: 586 PLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILN 623
           P  L  L++     C +KD   RP   ++  +L  ++ 
Sbjct: 247 PTSLHQLML----DCWQKDRNARPRFPQVVSALDKMIR 280

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 51/180 (28%), Positives = 90/180 (50%), Gaps = 17/180 (9%)
Query: 374 AIKKVNGDVSKEIALLNKI-NHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNE 432
           A +K   D+  E+ ++  I  H N+I L G C  +G  Y++ EYA  G L +++ + +  
Sbjct: 79  ATEKDLSDLVSEMEMMKMIGKHKNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPP 138
Query: 433 G------------KYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLR 480
           G            + + +K  +     +A G+ YL S      +H+D+ + NVL+  +  
Sbjct: 139 GMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKC---IHRDLAARNVLVTENNV 195
Query: 481 AKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT 540
            KIA+F +AR     +     T   +  K +MAPE L + + + + DV++FGVL+ E+ T
Sbjct: 196 MKIADFGLARDINNIDYYKKTTNGRLPVK-WMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 59/248 (23%), Positives = 118/248 (47%), Gaps = 25/248 (10%)
Query: 376 KKVNGDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKY 435
           +K   D   E +++ + +H N+I L GV        +V EY  NG+L    F  K++ ++
Sbjct: 87  EKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDS--FLRKHDAQF 144
Query: 436 LDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQ 495
               Q + +   +A+G+ YL   ++   VH+D+ + N+L++S+L  K+++F ++R  E  
Sbjct: 145 TV-IQLVGMLRGIASGMKYL---SDMGFVHRDLAARNILINSNLVCKVSDFGLSRVLEDD 200
Query: 496 EGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMH 555
                 TR       + +PE +     ++  DV+++G+++ E+++  E          M 
Sbjct: 201 PEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWE-----MS 255
Query: 556 LSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIE 615
             DV+ AV      +E  R  + P      P++    + +L+  C +KD  +RP   +I 
Sbjct: 256 NQDVIKAV------DEGYR--LPP------PMDCPAALYQLMLDCWQKDRNNRPKFEQIV 301
Query: 616 HSLSNILN 623
             L  ++ 
Sbjct: 302 SILDKLIR 309

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 72.4 bits (176), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 65/269 (24%), Positives = 115/269 (42%), Gaps = 40/269 (14%)
Query: 374 AIKKVNGDVSKEIALLNKI-NHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNE 432
           A +K   D+  E+ ++  I  H N+I L G C  +G  Y++ EYA  G L +++ + +  
Sbjct: 68  ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPP 127
Query: 433 G------------KYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLR 480
           G            + + +K  +     +A G+ YL S      +H+D+ + NVL+  +  
Sbjct: 128 GMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKC---IHRDLAARNVLVTENNV 184
Query: 481 AKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT 540
            KIA+F +AR     +     T   +  K +MAPE L + + + + DV++FGVL+ E+ T
Sbjct: 185 MKIADFGLARDINNIDYYKKTTNGRLPVK-WMAPEALFDRVYTHQSDVWSFGVLMWEIFT 243
Query: 541 --GKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLID 598
             G     +  EE                     L   +    + + P      +  ++ 
Sbjct: 244 LGGSPYPGIPVEE---------------------LFKLLKEGHRMDKPANCTNELYMMMR 282
Query: 599 ACLKKDPTDRPTMYEIEHSLSNILNASLN 627
            C    P+ RPT  ++   L  IL  + N
Sbjct: 283 DCWHAVPSQRPTFKQLVEDLDRILTLTTN 311

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 72.4 bits (176), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 61/264 (23%), Positives = 114/264 (43%), Gaps = 47/264 (17%)
Query: 381 DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEG------- 433
           D+  E  +L ++NH ++I L G C  +G   L+ EYA  G+L  ++  ++  G       
Sbjct: 72  DLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSG 131
Query: 434 -------------KYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLR 480
                        + L     I  A  ++ G+ YL        VH+D+ + N+L+    +
Sbjct: 132 GSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDLAARNILVAEGRK 188
Query: 481 AKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT 540
            KI++F ++R    ++     ++  +  K +MA E L + + +T+ DV++FGVL+ E++T
Sbjct: 189 MKISDFGLSRDVYEEDSYVKRSQGRIPVK-WMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247
Query: 541 --GKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLID 598
             G     +  E        + N + T    E               P   +  + RL+ 
Sbjct: 248 LGGNPYPGIPPER-------LFNLLKTGHRMER--------------PDNCSEEMYRLML 286
Query: 599 ACLKKDPTDRPTMYEIEHSLSNIL 622
            C K++P  RP   +I   L  ++
Sbjct: 287 QCWKQEPDKRPVFADISKDLEKMM 310

>pdb|1OEC|A Chain A, Fgfr2 Kinase Domain Length = 316

Iteration: 1
 Score = 72.0 bits (175), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 65/269 (24%), Positives = 115/269 (42%), Gaps = 40/269 (14%)
Query: 374 AIKKVNGDVSKEIALLNKI-NHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNE 432
           A +K   D+  E+ ++  I  H N+I L G C  +G  Y++ EYA  G L +++ + +  
Sbjct: 71  ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPP 130
Query: 433 G------------KYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLR 480
           G            + + +K  +     +A G+ YL S      +H+D+ + NVL+  +  
Sbjct: 131 GMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKC---IHRDLAARNVLVTENNV 187
Query: 481 AKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT 540
            KIA+F +AR     +     T   +  K +MAPE L + + + + DV++FGVL+ E+ T
Sbjct: 188 MKIADFGLARDINNIDYYKKTTNGRLPVK-WMAPEALFDRVYTHQSDVWSFGVLMWEIFT 246
Query: 541 --GKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLID 598
             G     +  EE                     L   +    + + P      +  ++ 
Sbjct: 247 LGGSPYPGIPVEE---------------------LFKLLKEGHRMDKPANCTNELYMMMR 285
Query: 599 ACLKKDPTDRPTMYEIEHSLSNILNASLN 627
            C    P+ RPT  ++   L  IL  + N
Sbjct: 286 DCWHAVPSQRPTFKQLVEDLDRILTLTTN 314

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/245 (25%), Positives = 105/245 (42%), Gaps = 27/245 (11%)
Query: 384 KEIALLNKINHSNLIILSGVCFN-EGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRI 442
           +E  L+  +NH N++ L G+    EG  +++  Y  +G L  ++ S +        K  I
Sbjct: 71  REGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTV---KDLI 127
Query: 443 QIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQE-GEFAL 501
              L VA G+ YL        VH+D+ + N +LD     K+A+F +AR    +E      
Sbjct: 128 SFGLQVARGMEYL---AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQ 184
Query: 502 TRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLN 561
            RH      + A E L+    +TK DV++FGVL+ E+LT       H +  +        
Sbjct: 185 HRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFD-------- 236
Query: 562 AVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNI 621
                      L HF+    +   P      + +++  C + DP  RPT   +   +  I
Sbjct: 237 -----------LTHFLAQGRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQI 285
Query: 622 LNASL 626
           ++A L
Sbjct: 286 VSALL 290

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 45/180 (25%), Positives = 88/180 (48%), Gaps = 15/180 (8%)
Query: 370 GGFAAIKKVN-------GDVSKEIALLNKINHSNLIILSGVCFNEG--NCYLVYEYAVNG 420
           G   A+KK+         D  +EI +L  + H N++   GVC++ G  N  L+ E+   G
Sbjct: 42  GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEFLPYG 101
Query: 421 TLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLR 480
           +L +++  +K     +D  + +Q    +  G+ YL +     ++H+D+ + N+L++++ R
Sbjct: 102 SLREYLQKHKER---IDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENR 155
Query: 481 AKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT 540
            KI +F + +     +    +         + APE L     S   DV++FGV++ E+ T
Sbjct: 156 VKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 48/165 (29%), Positives = 78/165 (47%), Gaps = 12/165 (7%)
Query: 378 VNGDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLD 437
           V   + +E+ + + + H N++ L G   +    YL+ EYA  GT    V+    +    D
Sbjct: 53  VEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGT----VYRELQKLSKFD 108
Query: 438 WKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEG 497
            ++      ++A  L+Y HS      +H+DI   N+LL S    KIANF  +  A     
Sbjct: 109 EQRTATYITELANALSYCHSKRV---IHRDIKPENLLLGSAGELKIANFGWSVHAPS--- 162
Query: 498 EFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGK 542
             +    + GT  Y+ PE +E  +   K+D+++ GVL  E L GK
Sbjct: 163 --SRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 205

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 65/269 (24%), Positives = 115/269 (42%), Gaps = 40/269 (14%)
Query: 374 AIKKVNGDVSKEIALLNKI-NHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNE 432
           A +K   D+  E+ ++  I  H N+I L G C  +G  Y++ EYA  G L +++ + +  
Sbjct: 79  ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPP 138
Query: 433 G------------KYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLR 480
           G            + + +K  +     +A G+ YL S      +H+D+ + NVL+  +  
Sbjct: 139 GMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKC---IHRDLAARNVLVTENNV 195
Query: 481 AKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT 540
            KIA+F +AR     +     T   +  K +MAPE L + + + + DV++FGVL+ E+ T
Sbjct: 196 MKIADFGLARDINNIDYYKNTTNGRLPVK-WMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254
Query: 541 --GKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLID 598
             G     +  EE                     L   +    + + P      +  ++ 
Sbjct: 255 LGGSPYPGIPVEE---------------------LFKLLKEGHRMDKPANCTNELYMMMR 293
Query: 599 ACLKKDPTDRPTMYEIEHSLSNILNASLN 627
            C    P+ RPT  ++   L  IL  + N
Sbjct: 294 DCWHAVPSQRPTFKQLVEDLDRILTLTTN 322

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 48/165 (29%), Positives = 78/165 (47%), Gaps = 12/165 (7%)
Query: 378 VNGDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLD 437
           V   + +E+ + + + H N++ L G   +    YL+ EYA  GT    V+    +    D
Sbjct: 54  VEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGT----VYRELQKLSKFD 109
Query: 438 WKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEG 497
            ++      ++A  L+Y HS      +H+DI   N+LL S    KIANF  +  A     
Sbjct: 110 EQRTATYITELANALSYCHSKRV---IHRDIKPENLLLGSAGELKIANFGWSVHAPS--- 163
Query: 498 EFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGK 542
             +    + GT  Y+ PE +E  +   K+D+++ GVL  E L GK
Sbjct: 164 --SRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 87/173 (50%), Gaps = 17/173 (9%)
Query: 381 DVSKEIALLNKI-NHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEG------ 433
           D+  E+ ++  I  H N+I L G C  +G  Y++ EYA  G L +++ + +  G      
Sbjct: 86  DLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYD 145
Query: 434 ------KYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFA 487
                 + + +K  +     +A G+ YL S      +H+D+ + NVL+  +   KIA+F 
Sbjct: 146 INRVPEEQMTFKDLVSCTYQLARGMEYLASQKC---IHRDLAARNVLVTENNVMKIADFG 202
Query: 488 MARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT 540
           +AR     +     T   +  K +MAPE L + + + + DV++FGVL+ E+ T
Sbjct: 203 LARDINNIDYYKKTTNGRLPVK-WMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 50/180 (27%), Positives = 90/180 (50%), Gaps = 17/180 (9%)
Query: 374 AIKKVNGDVSKEIALLNKI-NHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNE 432
           A +K   D+  E+ ++  I  H N+I L G C  +G  Y++ EYA  G L +++ + +  
Sbjct: 79  ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPP 138
Query: 433 G------------KYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLR 480
           G            + + +K  +     +A G+ YL S      +H+D+ + NVL+  +  
Sbjct: 139 GMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKC---IHRDLAARNVLVTENNV 195
Query: 481 AKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT 540
            +IA+F +AR     +     T   +  K +MAPE L + + + + DV++FGVL+ E+ T
Sbjct: 196 MRIADFGLARDINNIDYYKKTTNGRLPVK-WMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 47/165 (28%), Positives = 78/165 (47%), Gaps = 12/165 (7%)
Query: 378 VNGDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLD 437
           V   + +E+ + + + H N++ L G   +    YL+ EYA  GT    V+    +    D
Sbjct: 77  VEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGT----VYRELQKLSKFD 132
Query: 438 WKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEG 497
            ++      ++A  L+Y HS      +H+DI   N+LL S    KIA+F  +  A     
Sbjct: 133 EQRTATYITELANALSYCHSKRV---IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR 189
Query: 498 EFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGK 542
           +      + GT  Y+ PE +E  +   K+D+++ GVL  E L GK
Sbjct: 190 D-----DLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 229

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 47/165 (28%), Positives = 78/165 (47%), Gaps = 12/165 (7%)
Query: 378 VNGDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLD 437
           V   + +E+ + + + H N++ L G   +    YL+ EYA  GT    V+    +    D
Sbjct: 54  VEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGT----VYRELQKLSKFD 109
Query: 438 WKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEG 497
            ++      ++A  L+Y HS      +H+DI   N+LL S    KIA+F  +  A     
Sbjct: 110 EQRTATYITELANALSYCHSKRV---IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR 166
Query: 498 EFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGK 542
           +      + GT  Y+ PE +E  +   K+D+++ GVL  E L GK
Sbjct: 167 D-----DLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/278 (23%), Positives = 128/278 (46%), Gaps = 40/278 (14%)
Query: 361 GSVYRGKING-----GFAAIKKVNGDVSK--------EIALLNKINHSNLIILSGVCFNE 407
           G V RG++          AIK + G  ++        E +++ +  H N+I L GV  N 
Sbjct: 30  GEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRLEGVVTNS 89
Query: 408 GNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKD 467
               ++ E+  NG L    F   N+G++    Q + +   +A+G+ YL   +   +VH+D
Sbjct: 90  MPVMILTEFMENGALDS--FLRLNDGQFTV-IQLVGMLRGIASGMRYLAEMS---YVHRD 143
Query: 468 INSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGT--KGYMAPEYLENGLVSTK 525
           + + N+L++S+L  K+++F ++R  E    +   T  + G     + APE +     ++ 
Sbjct: 144 LAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAPEAIAFRKFTSA 203
Query: 526 LDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNY 585
            D +++G+++ E+++  E         +M   DV+NA+      E+  R    P    + 
Sbjct: 204 SDAWSYGIVMWEVMSFGERPYW-----DMSNQDVINAI------EQDYRLPPPP----DC 248
Query: 586 PLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILN 623
           P  L  L++     C +KD   RP   ++  +L  ++ 
Sbjct: 249 PTSLHQLML----DCWQKDRNARPRFPQVVSALDKMIR 282

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 92/199 (46%), Gaps = 20/199 (10%)
Query: 385 EIALLNKINHSNLIILSGVCFNEGNC--YLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRI 442
           E+ LL ++ H N++       +  N   Y+V EY   G L+  +     E +YLD +  +
Sbjct: 55  EVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVL 114
Query: 443 QIALDVATGLNYLHSFTNPPH--VHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFA 500
           ++   +   L   H  ++  H  +H+D+  +NV LD     K+ +F +AR     E +FA
Sbjct: 115 RVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDE-DFA 173
Query: 501 LTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEM---------LTGKEAAALHAEE 551
             +  VGT  YM+PE +     + K D+++ G L+ E+          + KE A    E 
Sbjct: 174 --KEFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREG 231
Query: 552 NNMHL----SDVLNAVLTK 566
               +    SD LN ++T+
Sbjct: 232 KFRRIPYRYSDELNEIITR 250

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 47/165 (28%), Positives = 78/165 (47%), Gaps = 12/165 (7%)
Query: 378 VNGDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLD 437
           V   + +E+ + + + H N++ L G   +    YL+ EYA  GT    V+    +    D
Sbjct: 51  VEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGT----VYRELQKLSKFD 106
Query: 438 WKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEG 497
            ++      ++A  L+Y HS      +H+DI   N+LL S    KIA+F  +  A     
Sbjct: 107 EQRTATYITELANALSYCHSKRV---IHRDIKPENLLLGSAGELKIADFGWSVHAPS--- 160
Query: 498 EFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGK 542
             +    + GT  Y+ PE +E  +   K+D+++ GVL  E L GK
Sbjct: 161 --SRRTELCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 47/165 (28%), Positives = 78/165 (47%), Gaps = 12/165 (7%)
Query: 378 VNGDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLD 437
           V   + +E+ + + + H N++ L G   +    YL+ EYA  GT    V+    +    D
Sbjct: 52  VEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGT----VYRELQKLSKFD 107
Query: 438 WKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEG 497
            ++      ++A  L+Y HS      +H+DI   N+LL S    KIA+F  +  A     
Sbjct: 108 EQRTATYITELANALSYCHSKRV---IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR 164
Query: 498 EFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGK 542
           +      + GT  Y+ PE +E  +   K+D+++ GVL  E L GK
Sbjct: 165 DT-----LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 204

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/248 (23%), Positives = 118/248 (47%), Gaps = 25/248 (10%)
Query: 376 KKVNGDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKY 435
           +K   D   E +++ + +H N+I L GV        +V E   NG+L    F  K++ ++
Sbjct: 58  EKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDS--FLRKHDAQF 115
Query: 436 LDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQ 495
               Q + +   +A+G+ YL   ++  +VH+D+ + N+L++S+L  K+++F ++R  E  
Sbjct: 116 TV-IQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDD 171
Query: 496 EGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMH 555
                 TR       + +PE +     ++  DV+++G+++ E+++  E          M 
Sbjct: 172 PEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWE-----MS 226
Query: 556 LSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIE 615
             DV+ AV      +E  R  + P      P++    + +L+  C +KD  +RP   +I 
Sbjct: 227 NQDVIKAV------DEGYR--LPP------PMDCPAALYQLMLDCWQKDRNNRPKFEQIV 272
Query: 616 HSLSNILN 623
             L  ++ 
Sbjct: 273 SILDKLIR 280

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 47/165 (28%), Positives = 78/165 (47%), Gaps = 12/165 (7%)
Query: 378 VNGDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLD 437
           V   + +E+ + + + H N++ L G   +    YL+ EYA  GT    V+    +    D
Sbjct: 53  VEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGT----VYRELQKLSKFD 108
Query: 438 WKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEG 497
            ++      ++A  L+Y HS      +H+DI   N+LL S    KIA+F  +  A     
Sbjct: 109 EQRTATYITELANALSYCHSKRV---IHRDIKPENLLLGSAGELKIADFGWSVHAPS--- 162
Query: 498 EFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGK 542
             +    + GT  Y+ PE +E  +   K+D+++ GVL  E L GK
Sbjct: 163 --SRRXXLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 205

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 47/165 (28%), Positives = 78/165 (47%), Gaps = 12/165 (7%)
Query: 378 VNGDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLD 437
           V   + +E+ + + + H N++ L G   +    YL+ EYA  GT    V+    +    D
Sbjct: 51  VEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGT----VYRELQKLSKFD 106
Query: 438 WKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEG 497
            ++      ++A  L+Y HS      +H+DI   N+LL S    KIA+F  +  A     
Sbjct: 107 EQRTATYITELANALSYCHSKRV---IHRDIKPENLLLGSAGELKIADFGWSVHAPS--- 160
Query: 498 EFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGK 542
             +    + GT  Y+ PE +E  +   K+D+++ GVL  E L GK
Sbjct: 161 --SRRXXLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 47/165 (28%), Positives = 78/165 (47%), Gaps = 12/165 (7%)
Query: 378 VNGDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLD 437
           V   + +E+ + + + H N++ L G   +    YL+ EYA  GT    V+    +    D
Sbjct: 77  VEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGT----VYRELQKLSKFD 132
Query: 438 WKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEG 497
            ++      ++A  L+Y HS      +H+DI   N+LL S    KIA+F  +  A     
Sbjct: 133 EQRTATYITELANALSYCHSKRV---IHRDIKPENLLLGSAGELKIADFGWSVHAPS--- 186
Query: 498 EFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGK 542
             +    + GT  Y+ PE +E  +   K+D+++ GVL  E L GK
Sbjct: 187 --SRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 229

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 61/271 (22%), Positives = 117/271 (43%), Gaps = 24/271 (8%)
Query: 366 GKINGGFAAIKKVNG-------DVSKEIALLNKINHSNLIILSGVCFNEG--NCYLVYEY 416
           G   G   A+K++         D  +EI +L  ++   ++   GV +  G  +  LV EY
Sbjct: 36  GDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEY 95
Query: 417 AVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLD 476
             +G L D++  ++     LD  + +  +  +  G+ YL S      VH+D+ + N+L++
Sbjct: 96  LPSGCLRDFLQRHRAR---LDASRLLLYSSQICKGMEYLGSRRC---VHRDLAARNILVE 149
Query: 477 SDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLIL 536
           S+   KIA+F +A+     +  + +         + APE L + + S + DV++FGV++ 
Sbjct: 150 SEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLY 209
Query: 537 EMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALL--VI 594
           E+ T       + +++    ++ L  +  + D     R           P   A    V 
Sbjct: 210 ELFT-------YCDKSCSPSAEFLRMMGCERDVPALCRLLELLEEGQRLPAPPACPAEVH 262
Query: 595 RLIDACLKKDPTDRPTMYEIEHSLSNILNAS 625
            L+  C    P DRP+   +   L  + + S
Sbjct: 263 ELMKLCWAPSPQDRPSFSALGPQLDMLWSGS 293

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 47/165 (28%), Positives = 78/165 (47%), Gaps = 12/165 (7%)
Query: 378 VNGDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLD 437
           V   + +E+ + + + H N++ L G   +    YL+ EYA  GT    V+    +    D
Sbjct: 51  VEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGT----VYRELQKLSKFD 106
Query: 438 WKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEG 497
            ++      ++A  L+Y HS      +H+DI   N+LL S    KIA+F  +  A     
Sbjct: 107 EQRTATYITELANALSYCHSKRV---IHRDIKPENLLLGSAGELKIADFGWSVHAPS--- 160
Query: 498 EFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGK 542
             +    + GT  Y+ PE +E  +   K+D+++ GVL  E L GK
Sbjct: 161 --SRRTXLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 46/164 (28%), Positives = 78/164 (47%), Gaps = 12/164 (7%)
Query: 378 VNGDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLD 437
           V   + +E+ + + + H N++ L G   +    YL+ EYA  GT    V+    +    D
Sbjct: 55  VEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGT----VYRELQKLSRFD 110
Query: 438 WKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEG 497
            ++      ++A  L+Y HS      +H+DI   N+LL S+   KIA+F  +  A     
Sbjct: 111 EQRTATYITELANALSYCHSKRV---IHRDIKPENLLLGSNGELKIADFGWSVHAPSSRR 167
Query: 498 EFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTG 541
           +      + GT  Y+ PE +E  +   K+D+++ GVL  E L G
Sbjct: 168 DT-----LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG 206

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 47/165 (28%), Positives = 78/165 (47%), Gaps = 12/165 (7%)
Query: 378 VNGDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLD 437
           V   + +E+ + + + H N++ L G   +    YL+ EYA  GT    V+    +    D
Sbjct: 52  VEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGT----VYRELQKLSKFD 107
Query: 438 WKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEG 497
            ++      ++A  L+Y HS      +H+DI   N+LL S    KIA+F  +  A     
Sbjct: 108 EQRTATYITELANALSYCHSKRV---IHRDIKPENLLLGSAGELKIADFGWSVHAPS--- 161
Query: 498 EFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGK 542
             +    + GT  Y+ PE +E  +   K+D+++ GVL  E L GK
Sbjct: 162 --SRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 204

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 68/257 (26%), Positives = 116/257 (45%), Gaps = 31/257 (12%)
Query: 374 AIKKVN--------GDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDW 425
           AIK++N         ++ KEI  +++ +H N++        +   +LV +    G++ D 
Sbjct: 39  AIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDI 98
Query: 426 VFSNKNEGKY----LDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRA 481
           +     +G++    LD      I  +V  GL YLH       +H+D+ + N+LL  D   
Sbjct: 99  IKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQ---IHRDVKAGNILLGEDGSV 155
Query: 482 KIANFAMAR--PAEGQEGEFALTRHIVGTKGYMAPEYLENGL-VSTKLDVYAFGVLILEM 538
           +IA+F ++      G      + +  VGT  +MAPE +E       K D+++FG+  +E+
Sbjct: 156 QIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIEL 215
Query: 539 LTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFI-DPTLQGNYPLELALLVIRLI 597
            TG  AA  H       L      +LT ++   SL   + D  +   Y         ++I
Sbjct: 216 ATG--AAPYHKYPPMKVL------MLTLQNDPPSLETGVQDKEMLKKYGKSFR----KMI 263
Query: 598 DACLKKDPTDRPTMYEI 614
             CL+KDP  RPT  E+
Sbjct: 264 SLCLQKDPEKRPTAAEL 280

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 47/165 (28%), Positives = 78/165 (47%), Gaps = 12/165 (7%)
Query: 378 VNGDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLD 437
           V   + +E+ + + + H N++ L G   +    YL+ EYA  GT    V+    +    D
Sbjct: 51  VEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGT----VYRELQKLSKFD 106
Query: 438 WKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEG 497
            ++      ++A  L+Y HS      +H+DI   N+LL S    KIA+F  +  A     
Sbjct: 107 EQRTATYITELANALSYCHSKRV---IHRDIKPENLLLGSAGELKIADFGWSVHAPS--- 160
Query: 498 EFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGK 542
             +    + GT  Y+ PE +E  +   K+D+++ GVL  E L GK
Sbjct: 161 --SRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 47/165 (28%), Positives = 78/165 (47%), Gaps = 12/165 (7%)
Query: 378 VNGDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLD 437
           V   + +E+ + + + H N++ L G   +    YL+ EYA  GT    V+    +    D
Sbjct: 51  VEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGT----VYRELQKLSKFD 106
Query: 438 WKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEG 497
            ++      ++A  L+Y HS      +H+DI   N+LL S    KIA+F  +  A     
Sbjct: 107 EQRTATYITELANALSYCHSKRV---IHRDIKPENLLLGSAGELKIADFGWSVHAPS--- 160
Query: 498 EFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGK 542
             +    + GT  Y+ PE +E  +   K+D+++ GVL  E L GK
Sbjct: 161 --SRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 47/165 (28%), Positives = 78/165 (47%), Gaps = 12/165 (7%)
Query: 378 VNGDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLD 437
           V   + +E+ + + + H N++ L G   +    YL+ EYA  GT    V+    +    D
Sbjct: 51  VEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGT----VYRELQKLSKFD 106
Query: 438 WKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEG 497
            ++      ++A  L+Y HS      +H+DI   N+LL S    KIA+F  +  A     
Sbjct: 107 EQRTATYITELANALSYCHSKRV---IHRDIKPENLLLGSAGELKIADFGWSVHAPS--- 160
Query: 498 EFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGK 542
             +    + GT  Y+ PE +E  +   K+D+++ GVL  E L GK
Sbjct: 161 --SRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 47/165 (28%), Positives = 78/165 (47%), Gaps = 12/165 (7%)
Query: 378 VNGDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLD 437
           V   + +E+ + + + H N++ L G   +    YL+ EYA  GT    V+    +    D
Sbjct: 54  VEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGT----VYRELQKLSKFD 109
Query: 438 WKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEG 497
            ++      ++A  L+Y HS      +H+DI   N+LL S    KIA+F  +  A     
Sbjct: 110 EQRTATYITELANALSYCHSKRV---IHRDIKPENLLLGSAGELKIADFGWSVHAPS--- 163
Query: 498 EFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGK 542
             +    + GT  Y+ PE +E  +   K+D+++ GVL  E L GK
Sbjct: 164 --SRRXXLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 47/165 (28%), Positives = 78/165 (47%), Gaps = 12/165 (7%)
Query: 378 VNGDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLD 437
           V   + +E+ + + + H N++ L G   +    YL+ EYA  GT    V+    +    D
Sbjct: 56  VEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGT----VYRELQKLSKFD 111
Query: 438 WKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEG 497
            ++      ++A  L+Y HS      +H+DI   N+LL S    KIA+F  +  A     
Sbjct: 112 EQRTATYITELANALSYCHSKRV---IHRDIKPENLLLGSAGELKIADFGWSVHAPS--- 165
Query: 498 EFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGK 542
             +    + GT  Y+ PE +E  +   K+D+++ GVL  E L GK
Sbjct: 166 --SRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 208

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 58/248 (23%), Positives = 116/248 (46%), Gaps = 25/248 (10%)
Query: 376 KKVNGDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKY 435
           +K   D   E +++ + +H N+I L GV        +V E   NG+L    F  K++ ++
Sbjct: 87  EKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDS--FLRKHDAQF 144
Query: 436 LDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQ 495
               Q + +   +A+G+ YL       +VH+D+ + N+L++S+L  K+++F ++R  E  
Sbjct: 145 TV-IQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLSRVLEDD 200
Query: 496 EGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMH 555
                 TR       + +PE +     ++  DV+++G+++ E+++  E          M 
Sbjct: 201 PEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWE-----MS 255
Query: 556 LSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIE 615
             DV+ AV      +E  R  + P      P++    + +L+  C +KD  +RP   +I 
Sbjct: 256 NQDVIKAV------DEGYR--LPP------PMDCPAALYQLMLDCWQKDRNNRPKFEQIV 301
Query: 616 HSLSNILN 623
             L  ++ 
Sbjct: 302 SILDKLIR 309

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 77/165 (46%), Gaps = 12/165 (7%)
Query: 378 VNGDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLD 437
           V   + +E+ + + + H N++ L G   +    YL+ EYA  G     V+    +    D
Sbjct: 56  VEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGE----VYKELQKLSKFD 111
Query: 438 WKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEG 497
            ++      ++A  L+Y HS      +H+DI   N+LL S    KIA+F  +  A     
Sbjct: 112 EQRTATYITELANALSYCHSKRV---IHRDIKPENLLLGSAGELKIADFGWSVHAPS--- 165
Query: 498 EFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGK 542
             +    + GT  Y+ PE +E  +   K+D+++ GVL  E L GK
Sbjct: 166 --SRRXXLXGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 208

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 47/165 (28%), Positives = 78/165 (47%), Gaps = 12/165 (7%)
Query: 378 VNGDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLD 437
           V   + +E+ + + + H N++ L G   +    YL+ EYA  GT    V+    +    D
Sbjct: 56  VEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGT----VYRELQKLSKFD 111
Query: 438 WKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEG 497
            ++      ++A  L+Y HS      +H+DI   N+LL S    KIA+F  +  A     
Sbjct: 112 EQRTATYITELANALSYCHSKRV---IHRDIKPENLLLGSAGELKIADFGWSVHAPS--- 165
Query: 498 EFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGK 542
             +    + GT  Y+ PE +E  +   K+D+++ GVL  E L GK
Sbjct: 166 --SRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 208

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 47/165 (28%), Positives = 78/165 (47%), Gaps = 12/165 (7%)
Query: 378 VNGDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLD 437
           V   + +E+ + + + H N++ L G   +    YL+ EYA  GT    V+    +    D
Sbjct: 54  VEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGT----VYRELQKLSKFD 109
Query: 438 WKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEG 497
            ++      ++A  L+Y HS      +H+DI   N+LL S    KIA+F  +  A     
Sbjct: 110 EQRTATYITELANALSYCHSKRV---IHRDIKPENLLLGSAGELKIADFGWSVHAPS--- 163
Query: 498 EFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGK 542
             +    + GT  Y+ PE +E  +   K+D+++ GVL  E L GK
Sbjct: 164 --SRRAALCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 61/271 (22%), Positives = 118/271 (43%), Gaps = 24/271 (8%)
Query: 366 GKINGGFAAIKKVNG-------DVSKEIALLNKINHSNLIILSGVCFNEG--NCYLVYEY 416
           G   G   A+K++         D  +EI +L  ++   ++   GV +  G  +  LV EY
Sbjct: 35  GDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEY 94
Query: 417 AVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLD 476
             +G L D++  ++     LD  + +  +  +  G+ YL S      VH+D+ + N+L++
Sbjct: 95  LPSGCLRDFLQRHRAR---LDASRLLLYSSQICKGMEYLGSRRC---VHRDLAARNILVE 148
Query: 477 SDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLIL 536
           S+   KIA+F +A+     +  + +         + APE L + + S + DV++FGV++ 
Sbjct: 149 SEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLY 208
Query: 537 EMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALL--VI 594
           E+ T       + +++    ++ L  + ++ D     R           P   A    V 
Sbjct: 209 ELFT-------YCDKSCSPSAEFLRMMGSERDVPALSRLLELLEEGQRLPAPPACPAEVH 261
Query: 595 RLIDACLKKDPTDRPTMYEIEHSLSNILNAS 625
            L+  C    P DRP+   +   L  + + S
Sbjct: 262 ELMKLCWAPSPQDRPSFSALGPQLDMLWSGS 292

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 47/165 (28%), Positives = 77/165 (46%), Gaps = 12/165 (7%)
Query: 378 VNGDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLD 437
           V   + +E+ + + + H N++ L G   +    YL+ EYA  GT    V+    +    D
Sbjct: 51  VEHQLRREVEIQSHLRHPNILRLYGYFHDSTRVYLILEYAPLGT----VYRELQKLSKFD 106
Query: 438 WKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEG 497
            ++      ++A  L+Y HS      +H+DI   N+LL S    KIA+F  +  A     
Sbjct: 107 EQRTATYITELANALSYCHSKKV---IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR 163
Query: 498 EFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGK 542
                  + GT  Y+ PE +E  +   K+D+++ GVL  E L GK
Sbjct: 164 AA-----LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 94/202 (46%), Gaps = 37/202 (18%)
Query: 361 GSVY--RGKINGGFAAIKKVNGDVS---------KEIALLNKINHSNLIILSGVCFNEGN 409
           G VY  R K+ G   A+KK+  D           +EI+LL ++NH N++ L  V   E  
Sbjct: 17  GVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENK 76
Query: 410 CYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIAL--------DVATGLNYLHSFTNP 461
            YLV+E           F +++  K++D      I L         +  GL++ HS    
Sbjct: 77  LYLVFE-----------FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLSFCHSHRV- 124
Query: 462 PHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLEN-G 520
             +H+D+   N+L++++   K+A+F +AR        +    H V T  Y APE L    
Sbjct: 125 --LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT---HEVVTLWYRAPEILLGCK 179
Query: 521 LVSTKLDVYAFGVLILEMLTGK 542
             ST +D+++ G +  EM+T +
Sbjct: 180 YYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 47/165 (28%), Positives = 78/165 (47%), Gaps = 12/165 (7%)
Query: 378 VNGDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLD 437
           V   + +E+ + + + H N++ L G   +    YL+ EYA  GT    V+    +    D
Sbjct: 50  VEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGT----VYRELQKLSKFD 105
Query: 438 WKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEG 497
            ++      ++A  L+Y HS      +H+DI   N+LL S    KIA+F  +  A     
Sbjct: 106 EQRTATYITELANALSYCHSKRV---IHRDIKPENLLLGSAGELKIADFGWSVHAPS--- 159
Query: 498 EFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGK 542
             +    + GT  Y+ PE +E  +   K+D+++ GVL  E L GK
Sbjct: 160 --SRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 202

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 47/184 (25%), Positives = 90/184 (48%), Gaps = 15/184 (8%)
Query: 366 GKINGGFAAIKKVNG-------DVSKEIALLNKINHSNLIILSGVCFNEG--NCYLVYEY 416
           G   G   A+K++         D  +EI +L  ++   ++   GV +  G  +  LV EY
Sbjct: 48  GDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEY 107
Query: 417 AVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLD 476
             +G L D++  ++     LD  + +  +  +  G+ YL S      VH+D+ + N+L++
Sbjct: 108 LPSGCLRDFLQRHRAR---LDASRLLLYSSQICKGMEYLGSRRC---VHRDLAARNILVE 161
Query: 477 SDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLIL 536
           S+   KIA+F +A+     +  + +         + APE L + + S + DV++FGV++ 
Sbjct: 162 SEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLY 221
Query: 537 EMLT 540
           E+ T
Sbjct: 222 ELFT 225

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 68/257 (26%), Positives = 116/257 (45%), Gaps = 31/257 (12%)
Query: 374 AIKKVN--------GDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDW 425
           AIK++N         ++ KEI  +++ +H N++        +   +LV +    G++ D 
Sbjct: 44  AIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDI 103
Query: 426 VFSNKNEGKY----LDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRA 481
           +     +G++    LD      I  +V  GL YLH       +H+D+ + N+LL  D   
Sbjct: 104 IKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH---KNGQIHRDVKAGNILLGEDGSV 160
Query: 482 KIANFAMAR--PAEGQEGEFALTRHIVGTKGYMAPEYLENGL-VSTKLDVYAFGVLILEM 538
           +IA+F ++      G      + +  VGT  +MAPE +E       K D+++FG+  +E+
Sbjct: 161 QIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIEL 220
Query: 539 LTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFI-DPTLQGNYPLELALLVIRLI 597
            TG  AA  H       L      +LT ++   SL   + D  +   Y         ++I
Sbjct: 221 ATG--AAPYHKYPPMKVL------MLTLQNDPPSLETGVQDKEMLKKYGKSFR----KMI 268
Query: 598 DACLKKDPTDRPTMYEI 614
             CL+KDP  RPT  E+
Sbjct: 269 SLCLQKDPEKRPTAAEL 285

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 47/165 (28%), Positives = 78/165 (47%), Gaps = 12/165 (7%)
Query: 378 VNGDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLD 437
           V   + +E+ + + + H N++ L G   +    YL+ EYA  GT    V+    +    D
Sbjct: 54  VEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGT----VYRELQKLSKFD 109
Query: 438 WKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEG 497
            ++      ++A  L+Y HS      +H+DI   N+LL S    KIA+F  +  A     
Sbjct: 110 EQRTATYITELANALSYCHSKRV---IHRDIKPENLLLGSAGELKIADFGWSVHAPS--- 163
Query: 498 EFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGK 542
             +    + GT  Y+ PE +E  +   K+D+++ GVL  E L GK
Sbjct: 164 --SRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 47/165 (28%), Positives = 77/165 (46%), Gaps = 12/165 (7%)
Query: 378 VNGDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLD 437
           V   + +E+ + + + H N++ L G   +    YL+ EYA  GT    V+    +    D
Sbjct: 51  VEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGT----VYRELQKLSKFD 106
Query: 438 WKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEG 497
            ++      ++A  L+Y HS      +H+DI   N+LL S    KIA+F  +  A     
Sbjct: 107 EQRTATYITELANALSYCHSKRV---IHRDIKPENLLLGSAGELKIADFGWSVHAPSSR- 162
Query: 498 EFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGK 542
                  + GT  Y+ PE +E  +   K+D+++ GVL  E L GK
Sbjct: 163 ----RAALCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 91/199 (45%), Gaps = 20/199 (10%)
Query: 385 EIALLNKINHSNLIILSGVCFNEGNC--YLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRI 442
           E+ LL ++ H N++       +  N   Y+V EY   G L+  +     E +YLD +  +
Sbjct: 55  EVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVL 114
Query: 443 QIALDVATGLNYLHSFTNPPH--VHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFA 500
           ++   +   L   H  ++  H  +H+D+  +NV LD     K+ +F +AR     +  FA
Sbjct: 115 RVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL-NHDTSFA 173
Query: 501 LTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEM---------LTGKEAAALHAEE 551
            T   VGT  YM+PE +     + K D+++ G L+ E+          + KE A    E 
Sbjct: 174 KT--FVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREG 231
Query: 552 NNMHL----SDVLNAVLTK 566
               +    SD LN ++T+
Sbjct: 232 KFRRIPYRYSDELNEIITR 250

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 47/165 (28%), Positives = 77/165 (46%), Gaps = 12/165 (7%)
Query: 378 VNGDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLD 437
           V   + +E+ + + + H N++ L G   +    YL+ EYA  GT    V+    +    D
Sbjct: 55  VEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGT----VYRELQKLSKFD 110
Query: 438 WKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEG 497
            ++      ++A  L+Y HS      +H+DI   N+LL S    KIA+F  +  A     
Sbjct: 111 EQRTATYITELANALSYCHSKRV---IHRDIKPENLLLGSAGELKIADFGWSVHAPSSR- 166
Query: 498 EFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGK 542
                  + GT  Y+ PE +E  +   K+D+++ GVL  E L GK
Sbjct: 167 ----RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 207

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 57/194 (29%), Positives = 95/194 (48%), Gaps = 21/194 (10%)
Query: 361 GSVY--RGKINGGFAAIKKVNGDVS---------KEIALLNKINHSNLIILSGVCFNEGN 409
           G VY  R K+ G   A+KK+  D           +EI+LL ++NH N++ L  V   E  
Sbjct: 17  GVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENK 76
Query: 410 CYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDIN 469
            YLV+E+ ++  L D++ ++   G  L   +     L    GL + HS      +H+D+ 
Sbjct: 77  LYLVFEF-LHQDLKDFMDASALTGIPLPLIKSYLFQL--LQGLAFCHSHRV---LHRDLK 130
Query: 470 SSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLEN-GLVSTKLDV 528
             N+L++++   K+A+F +AR        +    H V T  Y APE L      ST +D+
Sbjct: 131 PENLLINTEGAIKLADFGLARAFGVPVRTYX---HEVVTLWYRAPEILLGCKYYSTAVDI 187
Query: 529 YAFGVLILEMLTGK 542
           ++ G +  EM+T +
Sbjct: 188 WSLGCIFAEMVTRR 201

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 47/165 (28%), Positives = 78/165 (47%), Gaps = 12/165 (7%)
Query: 378 VNGDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLD 437
           V   + +E+ + + + H N++ L G   +    YL+ EYA  GT    V+    +    D
Sbjct: 48  VEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGT----VYRELQKLSKFD 103
Query: 438 WKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEG 497
            ++      ++A  L+Y HS      +H+DI   N+LL S    KIA+F  +  A     
Sbjct: 104 EQRTATYITELANALSYCHSKRV---IHRDIKPENLLLGSAGELKIADFGWSVHAPS--- 157
Query: 498 EFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGK 542
             +    + GT  Y+ PE +E  +   K+D+++ GVL  E L GK
Sbjct: 158 --SRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 200

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 47/165 (28%), Positives = 78/165 (47%), Gaps = 12/165 (7%)
Query: 378 VNGDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLD 437
           V   + +E+ + + + H N++ L G   +    YL+ EYA  GT    V+    +    D
Sbjct: 68  VEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGT----VYRELQKLSKFD 123
Query: 438 WKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEG 497
            ++      ++A  L+Y HS      +H+DI   N+LL S    KIA+F  +  A     
Sbjct: 124 EQRTATYITELANALSYCHSKRV---IHRDIKPENLLLGSAGELKIADFGWSVHAPS--- 177
Query: 498 EFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGK 542
             +    + GT  Y+ PE +E  +   K+D+++ GVL  E L GK
Sbjct: 178 --SRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 220

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 50/180 (27%), Positives = 89/180 (49%), Gaps = 17/180 (9%)
Query: 374 AIKKVNGDVSKEIALLNKI-NHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNE 432
           A +K   D+  E+ ++  I  H N+I L G C  +G  Y++  YA  G L +++ + +  
Sbjct: 79  ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPP 138
Query: 433 G------------KYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLR 480
           G            + + +K  +     +A G+ YL S      +H+D+ + NVL+  +  
Sbjct: 139 GMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKC---IHRDLAARNVLVTENNV 195
Query: 481 AKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT 540
            KIA+F +AR     +     T   +  K +MAPE L + + + + DV++FGVL+ E+ T
Sbjct: 196 MKIADFGLARDINNIDYYKKTTNGRLPVK-WMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 47/165 (28%), Positives = 78/165 (47%), Gaps = 12/165 (7%)
Query: 378 VNGDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLD 437
           V   + +E+ + + + H N++ L G   +    YL+ EYA  GT    V+    +    D
Sbjct: 54  VEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGT----VYRELQKLSKFD 109
Query: 438 WKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEG 497
            ++      ++A  L+Y HS      +H+DI   N+LL S    KIA+F  +  A     
Sbjct: 110 EQRTATYITELANALSYCHSKRV---IHRDIKPENLLLGSAGELKIADFGWSVHAPS--- 163
Query: 498 EFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGK 542
             +    + GT  Y+ PE +E  +   K+D+++ GVL  E L GK
Sbjct: 164 --SRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 77/165 (46%), Gaps = 12/165 (7%)
Query: 378 VNGDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLD 437
           V   + +E+ + + + H N++ L G   +    YL+ EYA  G     V+    +    D
Sbjct: 56  VEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGE----VYKELQKLSKFD 111
Query: 438 WKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEG 497
            ++      ++A  L+Y HS      +H+DI   N+LL S    KIA+F  +  A     
Sbjct: 112 EQRTATYITELANALSYCHSKRV---IHRDIKPENLLLGSAGELKIADFGWSVHAPS--- 165
Query: 498 EFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGK 542
             +    + GT  Y+ PE +E  +   K+D+++ GVL  E L GK
Sbjct: 166 --SRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 208

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 58/249 (23%), Positives = 120/249 (48%), Gaps = 27/249 (10%)
Query: 376 KKVNGDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKY 435
           +K   D   E +++ + +H N++ L GV        +V E+  NG L    F  K++G++
Sbjct: 85  EKQRRDFLCEASIMGQFDHPNVVHLEGVVTRGKPVMIVIEFMENGALD--AFLRKHDGQF 142
Query: 436 LDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQ 495
               Q + +   +A G+ YL       +VH+D+ + N+L++S+L  K+++F ++R  E  
Sbjct: 143 TV-IQLVGMLRGIAAGMRYLADMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVIEDD 198
Query: 496 -EGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNM 554
            E  +  T   +  + + APE ++    ++  DV+++G+++ E+++  E         +M
Sbjct: 199 PEAVYTTTGGKIPVR-WTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYW-----DM 252
Query: 555 HLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEI 614
              DV+ A+      EE  R    P      P++    + +L+  C +K+  +RP   +I
Sbjct: 253 SNQDVIKAI------EEGYRL---PA-----PMDCPAGLHQLMLDCWQKERAERPKFEQI 298
Query: 615 EHSLSNILN 623
              L  ++ 
Sbjct: 299 VGILDKMIR 307

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 57/194 (29%), Positives = 95/194 (48%), Gaps = 21/194 (10%)
Query: 361 GSVY--RGKINGGFAAIKKVNGDVS---------KEIALLNKINHSNLIILSGVCFNEGN 409
           G VY  R K+ G   A+KK+  D           +EI+LL ++NH N++ L  V   E  
Sbjct: 20  GVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENK 79
Query: 410 CYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDIN 469
            YLV+E+ ++  L D++ ++   G  L   +     L    GL + HS      +H+D+ 
Sbjct: 80  LYLVFEF-LSMDLKDFMDASALTGIPLPLIKSYLFQL--LQGLAFCHSHRV---LHRDLK 133
Query: 470 SSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLEN-GLVSTKLDV 528
             N+L++++   K+A+F +AR        +    H V T  Y APE L      ST +D+
Sbjct: 134 PQNLLINTEGAIKLADFGLARAFGVPVRTYX---HEVVTLWYRAPEILLGCKYYSTAVDI 190
Query: 529 YAFGVLILEMLTGK 542
           ++ G +  EM+T +
Sbjct: 191 WSLGCIFAEMVTRR 204

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 50/183 (27%), Positives = 83/183 (45%), Gaps = 13/183 (7%)
Query: 378 VNGDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLD 437
           V   + +E+ + + + H N++ L G   +    YL+ EYA  GT    V+    +    D
Sbjct: 55  VEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGT----VYRELQKLSRFD 110
Query: 438 WKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEG 497
            ++      ++A  L+Y HS      +H+DI   N+LL S+   KIA+F  +  A     
Sbjct: 111 EQRTATYITELANALSYCHSKRV---IHRDIKPENLLLGSNGELKIADFGWSVHAPSSRR 167
Query: 498 EFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHA-EENNMHL 556
                  + GT  Y+ PE +E  +   K+D+++ GVL  E L G      H  +E    +
Sbjct: 168 TT-----LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRI 222
Query: 557 SDV 559
           S V
Sbjct: 223 SRV 225

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 61/271 (22%), Positives = 115/271 (42%), Gaps = 24/271 (8%)
Query: 366 GKINGGFAAIKKVN-------GDVSKEIALLNKINHSNLIILSGVCFNEGN--CYLVYEY 416
           G   G   A+K++         D  +EI +L  ++   ++   GV +  G     LV EY
Sbjct: 32  GDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRPELRLVMEY 91
Query: 417 AVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLD 476
             +G L D++  ++     LD  + +  +  +  G+ YL S      VH+D+ + N+L++
Sbjct: 92  LPSGCLRDFLQRHRAR---LDASRLLLYSSQICKGMEYLGSRRC---VHRDLAARNILVE 145
Query: 477 SDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLIL 536
           S+   KIA+F +A+     +    +         + APE L + + S + DV++FGV++ 
Sbjct: 146 SEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLY 205
Query: 537 EMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALL--VI 594
           E+ T       + +++    ++ L  +  + D     R           P   A    V 
Sbjct: 206 ELFT-------YCDKSCSPSAEFLRMMGCERDVPALCRLLELLEEGQRLPAPPACPAEVH 258
Query: 595 RLIDACLKKDPTDRPTMYEIEHSLSNILNAS 625
            L+  C    P DRP+   +   L  + + S
Sbjct: 259 ELMKLCWAPSPQDRPSFSALGPQLDMLWSGS 289

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 93/202 (46%), Gaps = 37/202 (18%)
Query: 361 GSVY--RGKINGGFAAIKKVNGDVS---------KEIALLNKINHSNLIILSGVCFNEGN 409
           G VY  R K+ G   A+KK+  D           +EI+LL ++NH N++ L  V   E  
Sbjct: 17  GVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENK 76
Query: 410 CYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIAL--------DVATGLNYLHSFTNP 461
            YLV+E           F +++  K++D      I L         +  GL + HS    
Sbjct: 77  LYLVFE-----------FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV- 124
Query: 462 PHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLEN-G 520
             +H+D+   N+L++++   K+A+F +AR        +    H V T  Y APE L    
Sbjct: 125 --LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT---HEVVTLWYRAPEILLGCK 179
Query: 521 LVSTKLDVYAFGVLILEMLTGK 542
             ST +D+++ G +  EM+T +
Sbjct: 180 YYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 93/202 (46%), Gaps = 37/202 (18%)
Query: 361 GSVY--RGKINGGFAAIKKVNGDVS---------KEIALLNKINHSNLIILSGVCFNEGN 409
           G VY  R K+ G   A+KK+  D           +EI+LL ++NH N++ L  V   E  
Sbjct: 16  GVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENK 75
Query: 410 CYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIAL--------DVATGLNYLHSFTNP 461
            YLV+E           F +++  K++D      I L         +  GL + HS    
Sbjct: 76  LYLVFE-----------FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV- 123
Query: 462 PHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLEN-G 520
             +H+D+   N+L++++   K+A+F +AR        +    H V T  Y APE L    
Sbjct: 124 --LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT---HEVVTLWYRAPEILLGCK 178
Query: 521 LVSTKLDVYAFGVLILEMLTGK 542
             ST +D+++ G +  EM+T +
Sbjct: 179 YYSTAVDIWSLGCIFAEMVTRR 200

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 57/194 (29%), Positives = 95/194 (48%), Gaps = 21/194 (10%)
Query: 361 GSVY--RGKINGGFAAIKKVNGDVS---------KEIALLNKINHSNLIILSGVCFNEGN 409
           G VY  R K+ G   A+KK+  D           +EI+LL ++NH N++ L  V   E  
Sbjct: 19  GVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENK 78
Query: 410 CYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDIN 469
            YLV+E+ ++  L D++ ++   G  L   +     L    GL + HS      +H+D+ 
Sbjct: 79  LYLVFEF-LSMDLKDFMDASALTGIPLPLIKSYLFQL--LQGLAFCHSHRV---LHRDLK 132
Query: 470 SSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLEN-GLVSTKLDV 528
             N+L++++   K+A+F +AR        +    H V T  Y APE L      ST +D+
Sbjct: 133 PQNLLINTEGAIKLADFGLARAFGVPVRTYX---HEVVTLWYRAPEILLGCKYYSTAVDI 189
Query: 529 YAFGVLILEMLTGK 542
           ++ G +  EM+T +
Sbjct: 190 WSLGCIFAEMVTRR 203

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 64/269 (23%), Positives = 114/269 (42%), Gaps = 40/269 (14%)
Query: 374 AIKKVNGDVSKEIALLNKI-NHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNE 432
           A +K   D+  E+ ++  I  H N+I L G C  +G  Y++  YA  G L +++ + +  
Sbjct: 79  ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPP 138
Query: 433 G------------KYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLR 480
           G            + + +K  +     +A G+ YL S      +H+D+ + NVL+  +  
Sbjct: 139 GMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKC---IHRDLAARNVLVTENNV 195
Query: 481 AKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT 540
            KIA+F +AR     +     T   +  K +MAPE L + + + + DV++FGVL+ E+ T
Sbjct: 196 MKIADFGLARDINNIDYYKKTTNGRLPVK-WMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254
Query: 541 --GKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLID 598
             G     +  EE                     L   +    + + P      +  ++ 
Sbjct: 255 LGGSPYPGIPVEE---------------------LFKLLKEGHRMDKPANCTNELYMMMR 293
Query: 599 ACLKKDPTDRPTMYEIEHSLSNILNASLN 627
            C    P+ RPT  ++   L  IL  + N
Sbjct: 294 DCWHAVPSQRPTFKQLVEDLDRILTLTTN 322

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 47/165 (28%), Positives = 78/165 (47%), Gaps = 12/165 (7%)
Query: 378 VNGDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLD 437
           V   + +E+ + + + H N++ L G   +    YL+ EYA  GT    V+    +    D
Sbjct: 52  VEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGT----VYRELQKLSKFD 107
Query: 438 WKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEG 497
            ++      ++A  L+Y HS      +H+DI   N+LL S    KIA+F  +  A     
Sbjct: 108 EQRTATYITELANALSYCHSKRV---IHRDIKPENLLLGSAGELKIADFGWSCHAPS--- 161
Query: 498 EFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGK 542
             +    + GT  Y+ PE +E  +   K+D+++ GVL  E L GK
Sbjct: 162 --SRRTTLSGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 204

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 52/183 (28%), Positives = 87/183 (47%), Gaps = 20/183 (10%)
Query: 369 NGGFAAIKKVNGDV--------SKEIALLNKINHSNLIILSGVCFNEG--NCYLVYEYAV 418
            G   A+K +  D          +EI +L  + H ++I   G C + G  +  LV EY  
Sbjct: 59  TGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVP 118
Query: 419 NGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSD 478
            G+L D++  +      +   Q +  A  +  G+ YLH+     ++H+D+ + NVLLD+D
Sbjct: 119 LGSLRDYLPRHS-----IGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDND 170
Query: 479 LRAKIANFAMARPA-EGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILE 537
              KI +F +A+   EG E  + +         + APE L+        DV++FGV + E
Sbjct: 171 RLVKIGDFGLAKAVPEGHE-XYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYE 229
Query: 538 MLT 540
           +LT
Sbjct: 230 LLT 232

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 93/202 (46%), Gaps = 37/202 (18%)
Query: 361 GSVY--RGKINGGFAAIKKVNGDVS---------KEIALLNKINHSNLIILSGVCFNEGN 409
           G VY  R K+ G   A+KK+  D           +EI+LL ++NH N++ L  V   E  
Sbjct: 24  GVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENK 83
Query: 410 CYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIAL--------DVATGLNYLHSFTNP 461
            YLV+E           F +++  K++D      I L         +  GL + HS    
Sbjct: 84  LYLVFE-----------FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV- 131
Query: 462 PHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLEN-G 520
             +H+D+   N+L++++   K+A+F +AR        +    H V T  Y APE L    
Sbjct: 132 --LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT---HEVVTLWYRAPEILLGCK 186
Query: 521 LVSTKLDVYAFGVLILEMLTGK 542
             ST +D+++ G +  EM+T +
Sbjct: 187 YYSTAVDIWSLGCIFAEMVTRR 208

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 93/202 (46%), Gaps = 37/202 (18%)
Query: 361 GSVY--RGKINGGFAAIKKVNGDVS---------KEIALLNKINHSNLIILSGVCFNEGN 409
           G VY  R K+ G   A+KK+  D           +EI+LL ++NH N++ L  V   E  
Sbjct: 17  GVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENK 76
Query: 410 CYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIAL--------DVATGLNYLHSFTNP 461
            YLV+E           F +++  K++D      I L         +  GL + HS    
Sbjct: 77  LYLVFE-----------FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV- 124
Query: 462 PHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPE-YLENG 520
             +H+D+   N+L++++   K+A+F +AR        +    H V T  Y APE  L   
Sbjct: 125 --LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT---HEVVTLWYRAPEILLGXK 179
Query: 521 LVSTKLDVYAFGVLILEMLTGK 542
             ST +D+++ G +  EM+T +
Sbjct: 180 YYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 93/202 (46%), Gaps = 37/202 (18%)
Query: 361 GSVY--RGKINGGFAAIKKVNGDVS---------KEIALLNKINHSNLIILSGVCFNEGN 409
           G VY  R K+ G   A+KK+  D           +EI+LL ++NH N++ L  V   E  
Sbjct: 17  GVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENK 76
Query: 410 CYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIAL--------DVATGLNYLHSFTNP 461
            YLV+E           F +++  K++D      I L         +  GL + HS    
Sbjct: 77  LYLVFE-----------FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV- 124
Query: 462 PHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLEN-G 520
             +H+D+   N+L++++   K+A+F +AR        +    H V T  Y APE L    
Sbjct: 125 --LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYX---HEVVTLWYRAPEILLGCK 179
Query: 521 LVSTKLDVYAFGVLILEMLTGK 542
             ST +D+++ G +  EM+T +
Sbjct: 180 YYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 93/202 (46%), Gaps = 37/202 (18%)
Query: 361 GSVY--RGKINGGFAAIKKVNGDVS---------KEIALLNKINHSNLIILSGVCFNEGN 409
           G VY  R K+ G   A+KK+  D           +EI+LL ++NH N++ L  V   E  
Sbjct: 16  GVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENK 75
Query: 410 CYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIAL--------DVATGLNYLHSFTNP 461
            YLV+E           F +++  K++D      I L         +  GL + HS    
Sbjct: 76  LYLVFE-----------FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV- 123
Query: 462 PHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLEN-G 520
             +H+D+   N+L++++   K+A+F +AR        +    H V T  Y APE L    
Sbjct: 124 --LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT---HEVVTLWYRAPEILLGCK 178
Query: 521 LVSTKLDVYAFGVLILEMLTGK 542
             ST +D+++ G +  EM+T +
Sbjct: 179 YYSTAVDIWSLGCIFAEMVTRR 200

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 93/202 (46%), Gaps = 37/202 (18%)
Query: 361 GSVY--RGKINGGFAAIKKVNGDVS---------KEIALLNKINHSNLIILSGVCFNEGN 409
           G VY  R K+ G   A+KK+  D           +EI+LL ++NH N++ L  V   E  
Sbjct: 17  GVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENK 76
Query: 410 CYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIAL--------DVATGLNYLHSFTNP 461
            YLV+E           F +++  K++D      I L         +  GL + HS    
Sbjct: 77  LYLVFE-----------FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV- 124
Query: 462 PHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLEN-G 520
             +H+D+   N+L++++   K+A+F +AR        +    H V T  Y APE L    
Sbjct: 125 --LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT---HEVVTLWYRAPEILLGCK 179
Query: 521 LVSTKLDVYAFGVLILEMLTGK 542
             ST +D+++ G +  EM+T +
Sbjct: 180 YYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 93/202 (46%), Gaps = 37/202 (18%)
Query: 361 GSVY--RGKINGGFAAIKKVNGDVS---------KEIALLNKINHSNLIILSGVCFNEGN 409
           G VY  R K+ G   A+KK+  D           +EI+LL ++NH N++ L  V   E  
Sbjct: 18  GVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENK 77
Query: 410 CYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIAL--------DVATGLNYLHSFTNP 461
            YLV+E           F +++  K++D      I L         +  GL + HS    
Sbjct: 78  LYLVFE-----------FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV- 125
Query: 462 PHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLEN-G 520
             +H+D+   N+L++++   K+A+F +AR        +    H V T  Y APE L    
Sbjct: 126 --LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT---HEVVTLWYRAPEILLGCK 180
Query: 521 LVSTKLDVYAFGVLILEMLTGK 542
             ST +D+++ G +  EM+T +
Sbjct: 181 YYSTAVDIWSLGCIFAEMVTRR 202

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 93/202 (46%), Gaps = 37/202 (18%)
Query: 361 GSVY--RGKINGGFAAIKKVNGDVS---------KEIALLNKINHSNLIILSGVCFNEGN 409
           G VY  R K+ G   A+KK+  D           +EI+LL ++NH N++ L  V   E  
Sbjct: 24  GVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENK 83
Query: 410 CYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIAL--------DVATGLNYLHSFTNP 461
            YLV+E           F +++  K++D      I L         +  GL + HS    
Sbjct: 84  LYLVFE-----------FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV- 131
Query: 462 PHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPE-YLENG 520
             +H+D+   N+L++++   K+A+F +AR        +    H V T  Y APE  L   
Sbjct: 132 --LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT---HEVVTLWYRAPEILLGXK 186
Query: 521 LVSTKLDVYAFGVLILEMLTGK 542
             ST +D+++ G +  EM+T +
Sbjct: 187 YYSTAVDIWSLGCIFAEMVTRR 208

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 93/202 (46%), Gaps = 37/202 (18%)
Query: 361 GSVY--RGKINGGFAAIKKVNGDVS---------KEIALLNKINHSNLIILSGVCFNEGN 409
           G VY  R K+ G   A+KK+  D           +EI+LL ++NH N++ L  V   E  
Sbjct: 21  GVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENK 80
Query: 410 CYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIAL--------DVATGLNYLHSFTNP 461
            YLV+E           F +++  K++D      I L         +  GL + HS    
Sbjct: 81  LYLVFE-----------FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV- 128
Query: 462 PHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLEN-G 520
             +H+D+   N+L++++   K+A+F +AR        +    H V T  Y APE L    
Sbjct: 129 --LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT---HEVVTLWYRAPEILLGCK 183
Query: 521 LVSTKLDVYAFGVLILEMLTGK 542
             ST +D+++ G +  EM+T +
Sbjct: 184 YYSTAVDIWSLGCIFAEMVTRR 205

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 93/202 (46%), Gaps = 37/202 (18%)
Query: 361 GSVY--RGKINGGFAAIKKVNGDVS---------KEIALLNKINHSNLIILSGVCFNEGN 409
           G VY  R K+ G   A+KK+  D           +EI+LL ++NH N++ L  V   E  
Sbjct: 20  GVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENK 79
Query: 410 CYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIAL--------DVATGLNYLHSFTNP 461
            YLV+E           F +++  K++D      I L         +  GL + HS    
Sbjct: 80  LYLVFE-----------FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV- 127
Query: 462 PHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLEN-G 520
             +H+D+   N+L++++   K+A+F +AR        +    H V T  Y APE L    
Sbjct: 128 --LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYX---HEVVTLWYRAPEILLGCK 182
Query: 521 LVSTKLDVYAFGVLILEMLTGK 542
             ST +D+++ G +  EM+T +
Sbjct: 183 YYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 93/202 (46%), Gaps = 37/202 (18%)
Query: 361 GSVY--RGKINGGFAAIKKVNGDVS---------KEIALLNKINHSNLIILSGVCFNEGN 409
           G VY  R K+ G   A+KK+  D           +EI+LL ++NH N++ L  V   E  
Sbjct: 19  GVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENK 78
Query: 410 CYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIAL--------DVATGLNYLHSFTNP 461
            YLV+E           F +++  K++D      I L         +  GL + HS    
Sbjct: 79  LYLVFE-----------FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV- 126
Query: 462 PHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLEN-G 520
             +H+D+   N+L++++   K+A+F +AR        +    H V T  Y APE L    
Sbjct: 127 --LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYX---HEVVTLWYRAPEILLGCK 181
Query: 521 LVSTKLDVYAFGVLILEMLTGK 542
             ST +D+++ G +  EM+T +
Sbjct: 182 YYSTAVDIWSLGCIFAEMVTRR 203

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 93/202 (46%), Gaps = 37/202 (18%)
Query: 361 GSVY--RGKINGGFAAIKKVNGDVS---------KEIALLNKINHSNLIILSGVCFNEGN 409
           G VY  R K+ G   A+KK+  D           +EI+LL ++NH N++ L  V   E  
Sbjct: 19  GVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENK 78
Query: 410 CYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIAL--------DVATGLNYLHSFTNP 461
            YLV+E           F +++  K++D      I L         +  GL + HS    
Sbjct: 79  LYLVFE-----------FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV- 126
Query: 462 PHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLEN-G 520
             +H+D+   N+L++++   K+A+F +AR        +    H V T  Y APE L    
Sbjct: 127 --LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYX---HEVVTLWYRAPEILLGCK 181
Query: 521 LVSTKLDVYAFGVLILEMLTGK 542
             ST +D+++ G +  EM+T +
Sbjct: 182 YYSTAVDIWSLGCIFAEMVTRR 203

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 91/199 (45%), Gaps = 20/199 (10%)
Query: 385 EIALLNKINHSNLIILSGVCFNEGNC--YLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRI 442
           E+ LL ++ H N++       +  N   Y+V EY   G L+  +     E +YLD +  +
Sbjct: 55  EVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVL 114
Query: 443 QIALDVATGLNYLHSFTNPPH--VHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFA 500
           ++   +   L   H  ++  H  +H+D+  +NV LD     K+ +F +AR     +  FA
Sbjct: 115 RVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL-NHDTSFA 173
Query: 501 LTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEM---------LTGKEAAALHAEE 551
             +  VGT  YM+PE +     + K D+++ G L+ E+          + KE A    E 
Sbjct: 174 --KAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREG 231
Query: 552 NNMHL----SDVLNAVLTK 566
               +    SD LN ++T+
Sbjct: 232 KFRRIPYRYSDELNEIITR 250

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 68.9 bits (167), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 47/176 (26%), Positives = 88/176 (50%), Gaps = 17/176 (9%)
Query: 381 DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSN----------- 429
           D  +E  LL  + H +++   GVC +     +V+EY  +G L+ ++ ++           
Sbjct: 63  DFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQ 122
Query: 430 -KNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAM 488
            +     L   Q + IA  +A+G+ YL S      VH+D+ + N L+ ++L  KI +F M
Sbjct: 123 PRQAKGELGLSQMLHIASQIASGMVYLAS---QHFVHRDLATRNCLVGANLLVKIGDFGM 179
Query: 489 ARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT-GKE 543
           +R     +  + +  H +    +M PE +     +T+ DV++FGV++ E+ T GK+
Sbjct: 180 SRDVYSTD-YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQ 234

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 68.9 bits (167), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 93/202 (46%), Gaps = 37/202 (18%)
Query: 361 GSVY--RGKINGGFAAIKKVNGDVS---------KEIALLNKINHSNLIILSGVCFNEGN 409
           G VY  R K+ G   A+KK+  D           +EI+LL ++NH N++ L  V   E  
Sbjct: 17  GVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENK 76
Query: 410 CYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIAL--------DVATGLNYLHSFTNP 461
            YLV+E           F +++  K++D      I L         +  GL + HS    
Sbjct: 77  LYLVFE-----------FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV- 124
Query: 462 PHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLEN-G 520
             +H+D+   N+L++++   K+A+F +AR        +    H V T  Y APE L    
Sbjct: 125 --LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYX---HEVVTLWYRAPEILLGCK 179
Query: 521 LVSTKLDVYAFGVLILEMLTGK 542
             ST +D+++ G +  EM+T +
Sbjct: 180 YYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 68.9 bits (167), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 93/202 (46%), Gaps = 37/202 (18%)
Query: 361 GSVY--RGKINGGFAAIKKVNGDVS---------KEIALLNKINHSNLIILSGVCFNEGN 409
           G VY  R K+ G   A+KK+  D           +EI+LL ++NH N++ L  V   E  
Sbjct: 16  GVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENK 75
Query: 410 CYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIAL--------DVATGLNYLHSFTNP 461
            YLV+E           F +++  K++D      I L         +  GL + HS    
Sbjct: 76  LYLVFE-----------FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV- 123
Query: 462 PHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLEN-G 520
             +H+D+   N+L++++   K+A+F +AR        +    H V T  Y APE L    
Sbjct: 124 --LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYX---HEVVTLWYRAPEILLGCK 178
Query: 521 LVSTKLDVYAFGVLILEMLTGK 542
             ST +D+++ G +  EM+T +
Sbjct: 179 YYSTAVDIWSLGCIFAEMVTRR 200

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 68.9 bits (167), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 93/202 (46%), Gaps = 37/202 (18%)
Query: 361 GSVY--RGKINGGFAAIKKVNGDVS---------KEIALLNKINHSNLIILSGVCFNEGN 409
           G VY  R K+ G   A+KK+  D           +EI+LL ++NH N++ L  V   E  
Sbjct: 17  GVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENK 76
Query: 410 CYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIAL--------DVATGLNYLHSFTNP 461
            YLV+E           F +++  K++D      I L         +  GL + HS    
Sbjct: 77  LYLVFE-----------FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV- 124
Query: 462 PHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLEN-G 520
             +H+D+   N+L++++   K+A+F +AR        +    H V T  Y APE L    
Sbjct: 125 --LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYX---HEVVTLWYRAPEILLGCK 179
Query: 521 LVSTKLDVYAFGVLILEMLTGK 542
             ST +D+++ G +  EM+T +
Sbjct: 180 YYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 93/202 (46%), Gaps = 37/202 (18%)
Query: 361 GSVY--RGKINGGFAAIKKVNGDVS---------KEIALLNKINHSNLIILSGVCFNEGN 409
           G VY  R K+ G   A+KK+  D           +EI+LL ++NH N++ L  V   E  
Sbjct: 19  GVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENK 78
Query: 410 CYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIAL--------DVATGLNYLHSFTNP 461
            YLV+E           F +++  K++D      I L         +  GL + HS    
Sbjct: 79  LYLVFE-----------FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV- 126
Query: 462 PHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLEN-G 520
             +H+D+   N+L++++   K+A+F +AR        +    H V T  Y APE L    
Sbjct: 127 --LHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYX---HEVVTLWYRAPEILLGCK 181
Query: 521 LVSTKLDVYAFGVLILEMLTGK 542
             ST +D+++ G +  EM+T +
Sbjct: 182 YYSTAVDIWSLGCIFAEMVTRR 203

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 93/202 (46%), Gaps = 37/202 (18%)
Query: 361 GSVY--RGKINGGFAAIKKVNGDVS---------KEIALLNKINHSNLIILSGVCFNEGN 409
           G VY  R K+ G   A+KK+  D           +EI+LL ++NH N++ L  V   E  
Sbjct: 18  GVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENK 77
Query: 410 CYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIAL--------DVATGLNYLHSFTNP 461
            YLV+E           F +++  K++D      I L         +  GL + HS    
Sbjct: 78  LYLVFE-----------FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV- 125
Query: 462 PHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLEN-G 520
             +H+D+   N+L++++   K+A+F +AR        +    H V T  Y APE L    
Sbjct: 126 --LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYX---HEVVTLWYRAPEILLGCK 180
Query: 521 LVSTKLDVYAFGVLILEMLTGK 542
             ST +D+++ G +  EM+T +
Sbjct: 181 YYSTAVDIWSLGCIFAEMVTRR 202

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 58/248 (23%), Positives = 115/248 (46%), Gaps = 25/248 (10%)
Query: 376 KKVNGDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKY 435
           +K   D   E +++ + +H N+I L GV        +V E   NG+L    F  K++ ++
Sbjct: 87  EKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDS--FLRKHDAQF 144
Query: 436 LDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQ 495
               Q + +   +A+G+ YL        VH+D+ + N+L++S+L  K+++F ++R  E  
Sbjct: 145 TV-IQLVGMLRGIASGMKYLSDMGA---VHRDLAARNILINSNLVCKVSDFGLSRVLEDD 200
Query: 496 EGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMH 555
                 TR       + +PE +     ++  DV+++G+++ E+++  E          M 
Sbjct: 201 PEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWE-----MS 255
Query: 556 LSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIE 615
             DV+ AV      +E  R  + P      P++    + +L+  C +KD  +RP   +I 
Sbjct: 256 NQDVIKAV------DEGYR--LPP------PMDCPAALYQLMLDCWQKDRNNRPKFEQIV 301
Query: 616 HSLSNILN 623
             L  ++ 
Sbjct: 302 SILDKLIR 309

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 93/202 (46%), Gaps = 37/202 (18%)
Query: 361 GSVY--RGKINGGFAAIKKVNGDVS---------KEIALLNKINHSNLIILSGVCFNEGN 409
           G VY  R K+ G   A+KK+  D           +EI+LL ++NH N++ L  V   E  
Sbjct: 16  GVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENK 75
Query: 410 CYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIAL--------DVATGLNYLHSFTNP 461
            YLV+E           F +++  K++D      I L         +  GL + HS    
Sbjct: 76  LYLVFE-----------FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV- 123
Query: 462 PHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLEN-G 520
             +H+D+   N+L++++   K+A+F +AR        +    H V T  Y APE L    
Sbjct: 124 --LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYX---HEVVTLWYRAPEILLGCK 178
Query: 521 LVSTKLDVYAFGVLILEMLTGK 542
             ST +D+++ G +  EM+T +
Sbjct: 179 YYSTAVDIWSLGCIFAEMVTRR 200

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 93/202 (46%), Gaps = 37/202 (18%)
Query: 361 GSVY--RGKINGGFAAIKKVNGDVS---------KEIALLNKINHSNLIILSGVCFNEGN 409
           G VY  R K+ G   A+KK+  D           +EI+LL ++NH N++ L  V   E  
Sbjct: 20  GVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENK 79
Query: 410 CYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIAL--------DVATGLNYLHSFTNP 461
            YLV+E           F +++  K++D      I L         +  GL + HS    
Sbjct: 80  LYLVFE-----------FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV- 127
Query: 462 PHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLEN-G 520
             +H+D+   N+L++++   K+A+F +AR        +    H V T  Y APE L    
Sbjct: 128 --LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYX---HEVVTLWYRAPEILLGCK 182
Query: 521 LVSTKLDVYAFGVLILEMLTGK 542
             ST +D+++ G +  EM+T +
Sbjct: 183 YYSTAVDIWSLGCIFAEMVTRR 204

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 52/183 (28%), Positives = 88/183 (48%), Gaps = 20/183 (10%)
Query: 369 NGGFAAIKKVNGDV--------SKEIALLNKINHSNLIILSGVCFNEG--NCYLVYEYAV 418
            G   A+K +  D          +EI +L  + H ++I   G C ++G  +  LV EY  
Sbjct: 42  TGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVP 101
Query: 419 NGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSD 478
            G+L D++  +      +   Q +  A  +  G+ YLHS     ++H+++ + NVLLD+D
Sbjct: 102 LGSLRDYLPRHS-----IGLAQLLLFAQQICEGMAYLHSQH---YIHRNLAARNVLLDND 153
Query: 479 LRAKIANFAMARPA-EGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILE 537
              KI +F +A+   EG E  + +         + APE L+        DV++FGV + E
Sbjct: 154 RLVKIGDFGLAKAVPEGHE-YYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYE 212
Query: 538 MLT 540
           +LT
Sbjct: 213 LLT 215

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 93/202 (46%), Gaps = 37/202 (18%)
Query: 361 GSVY--RGKINGGFAAIKKVNGDVS---------KEIALLNKINHSNLIILSGVCFNEGN 409
           G VY  R K+ G   A+KK+  D           +EI+LL ++NH N++ L  V   E  
Sbjct: 21  GVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENK 80
Query: 410 CYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIAL--------DVATGLNYLHSFTNP 461
            YLV+E           F +++  K++D      I L         +  GL + HS    
Sbjct: 81  LYLVFE-----------FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV- 128
Query: 462 PHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLEN-G 520
             +H+D+   N+L++++   K+A+F +AR        +    H V T  Y APE L    
Sbjct: 129 --LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYX---HEVVTLWYRAPEILLGCK 183
Query: 521 LVSTKLDVYAFGVLILEMLTGK 542
             ST +D+++ G +  EM+T +
Sbjct: 184 YYSTAVDIWSLGCIFAEMVTRR 205

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 93/202 (46%), Gaps = 37/202 (18%)
Query: 361 GSVY--RGKINGGFAAIKKVNGDVS---------KEIALLNKINHSNLIILSGVCFNEGN 409
           G VY  R K+ G   A+KK+  D           +EI+LL ++NH N++ L  V   E  
Sbjct: 18  GVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENK 77
Query: 410 CYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIAL--------DVATGLNYLHSFTNP 461
            YLV+E           F +++  K++D      I L         +  GL + HS    
Sbjct: 78  LYLVFE-----------FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV- 125
Query: 462 PHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLEN-G 520
             +H+D+   N+L++++   K+A+F +AR        +    H V T  Y APE L    
Sbjct: 126 --LHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYX---HEVVTLWYRAPEILLGCK 180
Query: 521 LVSTKLDVYAFGVLILEMLTGK 542
             ST +D+++ G +  EM+T +
Sbjct: 181 YYSTAVDIWSLGCIFAEMVTRR 202

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 47/165 (28%), Positives = 77/165 (46%), Gaps = 12/165 (7%)
Query: 378 VNGDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLD 437
           V   + +E+ + + + H N++ L G   +    YL+ EYA  GT    V+    +    D
Sbjct: 56  VEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGT----VYRELQKLSKFD 111
Query: 438 WKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEG 497
            ++      ++A  L+Y HS      +H+DI   N+LL S    KIA+F  +  A     
Sbjct: 112 EQRTATYITELANALSYCHSKRV---IHRDIKPENLLLGSAGELKIADFGWSVHAPS--- 165
Query: 498 EFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGK 542
             +    + GT  Y+ PE +E      K+D+++ GVL  E L GK
Sbjct: 166 --SRRTTLCGTLDYLPPEXIEGRXHDEKVDLWSLGVLCYEFLVGK 208

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 93/202 (46%), Gaps = 37/202 (18%)
Query: 361 GSVY--RGKINGGFAAIKKVNGDVS---------KEIALLNKINHSNLIILSGVCFNEGN 409
           G VY  R K+ G   A+KK+  D           +EI+LL ++NH N++ L  V   E  
Sbjct: 18  GVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENK 77
Query: 410 CYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIAL--------DVATGLNYLHSFTNP 461
            YLV+E           F +++  K++D      I L         +  GL + HS    
Sbjct: 78  LYLVFE-----------FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV- 125
Query: 462 PHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLEN-G 520
             +H+D+   N+L++++   K+A+F +AR        +    H V T  Y APE L    
Sbjct: 126 --LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYX---HEVVTLWYRAPEILLGCK 180
Query: 521 LVSTKLDVYAFGVLILEMLTGK 542
             ST +D+++ G +  EM+T +
Sbjct: 181 YYSTAVDIWSLGCIFAEMVTRR 202

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 93/202 (46%), Gaps = 37/202 (18%)
Query: 361 GSVY--RGKINGGFAAIKKVNGDVS---------KEIALLNKINHSNLIILSGVCFNEGN 409
           G VY  R K+ G   A+KK+  D           +EI+LL ++NH N++ L  V   E  
Sbjct: 17  GVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENK 76
Query: 410 CYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIAL--------DVATGLNYLHSFTNP 461
            YLV+E           F +++  K++D      I L         +  GL + HS    
Sbjct: 77  LYLVFE-----------FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV- 124
Query: 462 PHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLEN-G 520
             +H+D+   N+L++++   K+A+F +AR        +    H V T  Y APE L    
Sbjct: 125 --LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYX---HEVVTLWYRAPEILLGCK 179
Query: 521 LVSTKLDVYAFGVLILEMLTGK 542
             ST +D+++ G +  EM+T +
Sbjct: 180 YYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/246 (25%), Positives = 114/246 (46%), Gaps = 36/246 (14%)
Query: 384 KEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQ 443
           +E+   ++++H N++ +  V   +   YLV EY    TLS+++ S+      L     I 
Sbjct: 60  REVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGP----LSVDTAIN 115
Query: 444 IALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTR 503
               +  G+ + H       VH+DI   N+L+DS+   KI +F +A+     E     T 
Sbjct: 116 FTNQILDGIKHAHDMRI---VHRDIKPQNILIDSNKTLKIFDFGIAKAL--SETSLTQTN 170
Query: 504 HIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGK-----EAAALHAEENNMHLSD 558
           H++GT  Y +PE  +        D+Y+ G+++ EML G+     E A   A +   H+ D
Sbjct: 171 HVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIK---HIQD 227
Query: 559 VLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDR-PTMYEIEHS 617
            +  V T               ++ + P  L+ +++R      +KD  +R  T+ E++  
Sbjct: 228 SVPNVTTD--------------VRKDIPQSLSNVILR----ATEKDKANRYKTIQEMKDD 269
Query: 618 LSNILN 623
           LS++L+
Sbjct: 270 LSSVLH 275

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 84/171 (49%), Gaps = 14/171 (8%)
Query: 374 AIKKVNGDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEG 433
           A++   G +  EIA+L+KI H N++ L  +  + G+ YL+ +    G L D +     +G
Sbjct: 55  ALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIV---EKG 111
Query: 434 KYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVL---LDSDLRAKIANFAMAR 490
            Y + +   ++   V   + YLH       VH+D+   N+L   LD D +  I++F +++
Sbjct: 112 FYTE-RDASRLIFQVLDAVKYLHDLGI---VHRDLKPENLLYYSLDEDSKIMISDFGLSK 167
Query: 491 PAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTG 541
                E   ++     GT GY+APE L     S  +D ++ GV+   +L G
Sbjct: 168 ----MEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 84/171 (49%), Gaps = 14/171 (8%)
Query: 374 AIKKVNGDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEG 433
           A++   G +  EIA+L+KI H N++ L  +  + G+ YL+ +    G L D +     +G
Sbjct: 55  ALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIV---EKG 111
Query: 434 KYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVL---LDSDLRAKIANFAMAR 490
            Y + +   ++   V   + YLH       VH+D+   N+L   LD D +  I++F +++
Sbjct: 112 FYTE-RDASRLIFQVLDAVKYLHDLGI---VHRDLKPENLLYYSLDEDSKIMISDFGLSK 167
Query: 491 PAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTG 541
                E   ++     GT GY+APE L     S  +D ++ GV+   +L G
Sbjct: 168 ----MEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 93/202 (46%), Gaps = 37/202 (18%)
Query: 361 GSVY--RGKINGGFAAIKKVNGDVS---------KEIALLNKINHSNLIILSGVCFNEGN 409
           G VY  R K+ G   A+KK+  D           +EI+LL ++NH N++ L  V   E  
Sbjct: 20  GVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENK 79
Query: 410 CYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIAL--------DVATGLNYLHSFTNP 461
            YLV+E+            +++  K++D      I L         +  GL + HS    
Sbjct: 80  LYLVFEHV-----------DQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV- 127
Query: 462 PHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLEN-G 520
             +H+D+   N+L++++   K+A+F +AR        +    H V T  Y APE L    
Sbjct: 128 --LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYX---HEVVTLWYRAPEILLGCK 182
Query: 521 LVSTKLDVYAFGVLILEMLTGK 542
             ST +D+++ G +  EM+T +
Sbjct: 183 YYSTAVDIWSLGCIFAEMVTRR 204

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/194 (29%), Positives = 94/194 (48%), Gaps = 21/194 (10%)
Query: 361 GSVY--RGKINGGFAAIKKVNGDVS---------KEIALLNKINHSNLIILSGVCFNEGN 409
           G VY  R K+ G   A+KK+  D           +EI+LL ++NH N++ L  V   E  
Sbjct: 16  GVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENK 75
Query: 410 CYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDIN 469
            YLV+E+ V+  L  ++ ++   G  L   +     L    GL + HS      +H+D+ 
Sbjct: 76  LYLVFEH-VHQDLKTFMDASALTGIPLPLIKSYLFQL--LQGLAFCHSHRV---LHRDLK 129
Query: 470 SSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLEN-GLVSTKLDV 528
             N+L++++   K+A+F +AR        +    H V T  Y APE L      ST +D+
Sbjct: 130 PQNLLINTEGAIKLADFGLARAFGVPVRTYT---HEVVTLWYRAPEILLGCKYYSTAVDI 186
Query: 529 YAFGVLILEMLTGK 542
           ++ G +  EM+T +
Sbjct: 187 WSLGCIFAEMVTRR 200

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 84/171 (49%), Gaps = 14/171 (8%)
Query: 374 AIKKVNGDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEG 433
           A++   G +  EIA+L+KI H N++ L  +  + G+ YL+ +    G L D +     +G
Sbjct: 55  ALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIV---EKG 111
Query: 434 KYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVL---LDSDLRAKIANFAMAR 490
            Y + +   ++   V   + YLH       VH+D+   N+L   LD D +  I++F +++
Sbjct: 112 FYTE-RDASRLIFQVLDAVKYLHDLGI---VHRDLKPENLLYYSLDEDSKIMISDFGLSK 167
Query: 491 PAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTG 541
                E   ++     GT GY+APE L     S  +D ++ GV+   +L G
Sbjct: 168 ----MEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 51/183 (27%), Positives = 88/183 (48%), Gaps = 20/183 (10%)
Query: 369 NGGFAAIKKVNGDV--------SKEIALLNKINHSNLIILSGVCFNEG--NCYLVYEYAV 418
            G   A+K +  D          +EI +L  + H ++I   G C ++G  +  LV EY  
Sbjct: 42  TGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVP 101
Query: 419 NGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSD 478
            G+L D++  +      +   Q +  A  +  G+ YLH+     ++H+++ + NVLLD+D
Sbjct: 102 LGSLRDYLPRHS-----IGLAQLLLFAQQICEGMAYLHAQH---YIHRNLAARNVLLDND 153
Query: 479 LRAKIANFAMARPA-EGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILE 537
              KI +F +A+   EG E  + +         + APE L+        DV++FGV + E
Sbjct: 154 RLVKIGDFGLAKAVPEGHE-YYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYE 212
Query: 538 MLT 540
           +LT
Sbjct: 213 LLT 215

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 92/202 (45%), Gaps = 37/202 (18%)
Query: 361 GSVY--RGKINGGFAAIKKVNGDVS---------KEIALLNKINHSNLIILSGVCFNEGN 409
           G VY  R K+ G   A+KK+  D           +EI+LL ++NH N++ L  V   E  
Sbjct: 20  GVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENK 79
Query: 410 CYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIAL--------DVATGLNYLHSFTNP 461
            YLV+E           F + +  K++D      I L         +  GL + HS    
Sbjct: 80  LYLVFE-----------FLSMDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV- 127
Query: 462 PHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLEN-G 520
             +H+D+   N+L++++   K+A+F +AR        +    H V T  Y APE L    
Sbjct: 128 --LHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYX---HEVVTLWYRAPEILLGCK 182
Query: 521 LVSTKLDVYAFGVLILEMLTGK 542
             ST +D+++ G +  EM+T +
Sbjct: 183 YYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/256 (23%), Positives = 109/256 (42%), Gaps = 42/256 (16%)
Query: 369 NGGFAAIKKVNGDVSK---------EIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVN 419
           +G   A+KK+  D+ K         E+ ++    H N++ +          ++V E+   
Sbjct: 175 SGKLVAVKKM--DLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG 232
Query: 420 GTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDL 479
           G L+D V   +     ++ +Q   + L V   L+ LH+      +H+DI S ++LL  D 
Sbjct: 233 GALTDIVTHTR-----MNEEQIAAVCLAVLQALSVLHAQGV---IHRDIKSDSILLTHDG 284
Query: 480 RAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEML 539
           R K+++F           E    + +VGT  +MAPE +       ++D+++ G++++EM+
Sbjct: 285 RVKLSDFGFC---AQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMV 341
Query: 540 TGKEAAALHAEENNMHL-SDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLID 598
            G+           M +  D L   L          H + P+L+G             +D
Sbjct: 342 DGEPPYFNEPPLKAMKMIRDNLPPRLKN-------LHKVSPSLKG------------FLD 382
Query: 599 ACLKKDPTDRPTMYEI 614
             L +DP  R T  E+
Sbjct: 383 RLLVRDPAQRATAAEL 398

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 84/171 (49%), Gaps = 14/171 (8%)
Query: 374 AIKKVNGDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEG 433
           A++   G +  EIA+L+KI H N++ L  +  + G+ YL+ +    G L D +     +G
Sbjct: 55  ALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIV---EKG 111
Query: 434 KYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVL---LDSDLRAKIANFAMAR 490
            Y + +   ++   V   + YLH       VH+D+   N+L   LD D +  I++F +++
Sbjct: 112 FYTE-RDASRLIFQVLDAVKYLHDLGI---VHRDLKPENLLYYSLDEDSKIMISDFGLSK 167
Query: 491 PAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTG 541
                E   ++     GT GY+APE L     S  +D ++ GV+   +L G
Sbjct: 168 ----MEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 66/285 (23%), Positives = 124/285 (43%), Gaps = 65/285 (22%)
Query: 361 GSVYRGK--INGGFAAIKKV---NGDVSKEIALLNKINHSNLIILSGVCFN--------- 406
           G V++ K  I+G    IK+V   N    +E+  L K++H N++  +G C++         
Sbjct: 25  GQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNG-CWDGFDYDPETS 83
Query: 407 -------EGNC-YLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSF 458
                  +  C ++  E+   GTL  W+   K  G+ LD    +++   +  G++Y+HS 
Sbjct: 84  SKNSSRSKTKCLFIQMEFCDKGTLEQWI--EKRRGEKLDKVLALELFEQITKGVDYIHS- 140
Query: 459 TNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLE 518
                +++D+  SN+ L    + KI +F +    +  +G+   ++   GT  YM+PE + 
Sbjct: 141 --KKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKN-DGKRXRSK---GTLRYMSPEQIS 194
Query: 519 NGLVSTKLDVYAFGVLILEML----TGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLR 574
           +     ++D+YA G+++ E+L    T  E +    +  +  +SD+        D +E   
Sbjct: 195 SQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIF-------DKKEKT- 246
Query: 575 HFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLS 619
                                L+   L K P DRP   EI  +L+
Sbjct: 247 ---------------------LLQKLLSKKPEDRPNTSEILRTLT 270

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 92/202 (45%), Gaps = 37/202 (18%)
Query: 361 GSVY--RGKINGGFAAIKKVNGDVS---------KEIALLNKINHSNLIILSGVCFNEGN 409
           G VY  R K+ G   A+KK+  D           +EI+LL ++NH N++ L  V   E  
Sbjct: 18  GVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENK 77
Query: 410 CYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIAL--------DVATGLNYLHSFTNP 461
            YLV+E           F + +  K++D      I L         +  GL + HS    
Sbjct: 78  LYLVFE-----------FLSMDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV- 125
Query: 462 PHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLEN-G 520
             +H+D+   N+L++++   K+A+F +AR        +    H V T  Y APE L    
Sbjct: 126 --LHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYX---HEVVTLWYRAPEILLGCK 180
Query: 521 LVSTKLDVYAFGVLILEMLTGK 542
             ST +D+++ G +  EM+T +
Sbjct: 181 YYSTAVDIWSLGCIFAEMVTRR 202

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/262 (22%), Positives = 111/262 (42%), Gaps = 34/262 (12%)
Query: 374 AIKKVNGDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEG 433
           A +    D  +E  LL  + H +++   GVC       +V+EY  +G L+ ++ S+  + 
Sbjct: 82  ASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDA 141
Query: 434 KY-----------LDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAK 482
           K            L   Q + +A  VA G+ YL        VH+D+ + N L+   L  K
Sbjct: 142 KLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVVK 198
Query: 483 IANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGK 542
           I +F M+R     +      R ++  + +M PE +     +T+ DV++FGV++ E+ T  
Sbjct: 199 IGDFGMSRDIYSTDYYRVGGRTMLPIR-WMPPESILYRKFTTESDVWSFGVVLWEIFT-- 255
Query: 543 EAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLK 602
                + ++    LS+   A+     G E  R           P      V  ++  C +
Sbjct: 256 -----YGKQPWYQLSNT-EAIDCITQGRELER-----------PRACPPEVYAIMRGCWQ 298
Query: 603 KDPTDRPTMYEIEHSLSNILNA 624
           ++P  R ++ ++   L  +  A
Sbjct: 299 REPQQRHSIKDVHARLQALAQA 320

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 57/257 (22%), Positives = 111/257 (43%), Gaps = 44/257 (17%)
Query: 369 NGGFAAIKKVNGDVSK---------EIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVN 419
           +G   A+KK+  D+ K         E+ ++    H N++ +          ++V E+   
Sbjct: 55  SGKLVAVKKM--DLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG 112
Query: 420 GTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDL 479
           G L+D V   +     ++ +Q   + L V   L+ LH+      +H+DI S ++LL  D 
Sbjct: 113 GALTDIVTHTR-----MNEEQIAAVCLAVLQALSVLHAQGV---IHRDIKSDSILLTHDG 164
Query: 480 RAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEML 539
           R K+++F           E    + +VGT  +MAPE +       ++D+++ G++++EM+
Sbjct: 165 RVKLSDFGFCAQVSK---EVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMV 221
Query: 540 TGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLR--HFIDPTLQGNYPLELALLVIRLI 597
            G+           M         + +++    L+  H + P+L+G             +
Sbjct: 222 DGEPPYFNEPPLKAMK--------MIRDNLPPRLKNLHKVSPSLKG------------FL 261
Query: 598 DACLKKDPTDRPTMYEI 614
           D  L +DP  R T  E+
Sbjct: 262 DRLLVRDPAQRATAAEL 278

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 57/257 (22%), Positives = 112/257 (43%), Gaps = 44/257 (17%)
Query: 369 NGGFAAIKKVNGDVSK---------EIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVN 419
           +G   A+KK+  D+ K         E+ ++    H N++ +          ++V E+   
Sbjct: 98  SGKLVAVKKM--DLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG 155
Query: 420 GTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDL 479
           G L+D V   +     ++ +Q   + L V   L+ LH+      +H+DI S ++LL  D 
Sbjct: 156 GALTDIVTHTR-----MNEEQIAAVCLAVLQALSVLHAQGV---IHRDIKSDSILLTHDG 207
Query: 480 RAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEML 539
           R K+++F           E    + +VGT  +MAPE +       ++D+++ G++++EM+
Sbjct: 208 RVKLSDFGFCAQVSK---EVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMV 264
Query: 540 TGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLR--HFIDPTLQGNYPLELALLVIRLI 597
            G        E    +   +    + +++    L+  H + P+L+G             +
Sbjct: 265 DG--------EPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKG------------FL 304
Query: 598 DACLKKDPTDRPTMYEI 614
           D  L +DP  R T  E+
Sbjct: 305 DRLLVRDPAQRATAAEL 321

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 57/257 (22%), Positives = 111/257 (43%), Gaps = 44/257 (17%)
Query: 369 NGGFAAIKKVNGDVSK---------EIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVN 419
           +G   A+KK+  D+ K         E+ ++    H N++ +          ++V E+   
Sbjct: 53  SGKLVAVKKM--DLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG 110
Query: 420 GTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDL 479
           G L+D V   +     ++ +Q   + L V   L+ LH+      +H+DI S ++LL  D 
Sbjct: 111 GALTDIVTHTR-----MNEEQIAAVCLAVLQALSVLHAQGV---IHRDIKSDSILLTHDG 162
Query: 480 RAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEML 539
           R K+++F           E    + +VGT  +MAPE +       ++D+++ G++++EM+
Sbjct: 163 RVKLSDFGFCAQVSK---EVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMV 219
Query: 540 TGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLR--HFIDPTLQGNYPLELALLVIRLI 597
            G+           M         + +++    L+  H + P+L+G             +
Sbjct: 220 DGEPPYFNEPPLKAMK--------MIRDNLPPRLKNLHKVSPSLKG------------FL 259
Query: 598 DACLKKDPTDRPTMYEI 614
           D  L +DP  R T  E+
Sbjct: 260 DRLLVRDPAQRATAAEL 276

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 47/173 (27%), Positives = 83/173 (47%), Gaps = 14/173 (8%)
Query: 381 DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDW---------VFSNKN 431
           D  +E  LL  + H +++   GVC       +V+EY  +G L+ +         + +  N
Sbjct: 61  DFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGN 120
Query: 432 EGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARP 491
               L   Q + IA  +A G+ YL S      VH+D+ + N L+  +L  KI +F M+R 
Sbjct: 121 PPTELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENLLVKIGDFGMSRD 177
Query: 492 AEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT-GKE 543
               +  + +  H +    +M PE +     +T+ DV++ GV++ E+ T GK+
Sbjct: 178 VYSTD-YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQ 229

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 49/187 (26%), Positives = 94/187 (50%), Gaps = 15/187 (8%)
Query: 361 GSVYRGKINGGF-AAIKKVN-GDVSK-----EIALLNKINHSNLIILSGVCFNEGNCYLV 413
           G V  GK  G +  AIK +  G +S+     E  ++  ++H  L+ L GVC  +   +++
Sbjct: 23  GVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFII 82
Query: 414 YEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNV 473
            EY  NG L +++   ++  +    +Q +++  DV   + YL S      +H+D+ + N 
Sbjct: 83  TEYMANGCLLNYLREMRHRFQT---QQLLEMCKDVCEAMEYLES---KQFLHRDLAARNC 136
Query: 474 LLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGV 533
           L++     K+++F ++R     + E+  +R       +  PE L     S+K D++AFGV
Sbjct: 137 LVNDQGVVKVSDFGLSRYV--LDDEYTSSRGSKFPVRWSPPEVLMYSKFSSKSDIWAFGV 194
Query: 534 LILEMLT 540
           L+ E+ +
Sbjct: 195 LMWEIYS 201

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 47/165 (28%), Positives = 85/165 (51%), Gaps = 12/165 (7%)
Query: 378 VNGDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLD 437
           V G + +EI  L    H ++I L  V     + ++V EY   G L D++  +   G+  +
Sbjct: 54  VVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKH---GRVEE 110
Query: 438 WKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEG 497
            + R ++   + + ++Y H       VH+D+   NVLLD+ + AKIA+F ++      +G
Sbjct: 111 MEAR-RLFQQILSAVDYCHRHMV---VHRDLKPENVLLDAHMNAKIADFGLSNMM--SDG 164
Query: 498 EFALTRHIVGTKGYMAPEYLENGLVS-TKLDVYAFGVLILEMLTG 541
           EF  T    G+  Y APE +   L +  ++D+++ GV++  +L G
Sbjct: 165 EFLRTS--CGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCG 207

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 92/202 (45%), Gaps = 37/202 (18%)
Query: 361 GSVY--RGKINGGFAAIKKVNGDVS---------KEIALLNKINHSNLIILSGVCFNEGN 409
           G VY  R K+ G   A+ K+  D           +EI+LL ++NH N++ L  V   E  
Sbjct: 17  GVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENK 76
Query: 410 CYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIAL--------DVATGLNYLHSFTNP 461
            YLV+E           F +++  K++D      I L         +  GL + HS    
Sbjct: 77  LYLVFE-----------FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV- 124
Query: 462 PHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLEN-G 520
             +H+D+   N+L++++   K+A+F +AR        +    H V T  Y APE L    
Sbjct: 125 --LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT---HEVVTLWYRAPEILLGCK 179
Query: 521 LVSTKLDVYAFGVLILEMLTGK 542
             ST +D+++ G +  EM+T +
Sbjct: 180 YYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 92/202 (45%), Gaps = 37/202 (18%)
Query: 361 GSVY--RGKINGGFAAIKKVNGDVS---------KEIALLNKINHSNLIILSGVCFNEGN 409
           G VY  R K+ G   A+ K+  D           +EI+LL ++NH N++ L  V   E  
Sbjct: 16  GVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENK 75
Query: 410 CYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIAL--------DVATGLNYLHSFTNP 461
            YLV+E           F +++  K++D      I L         +  GL + HS    
Sbjct: 76  LYLVFE-----------FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV- 123
Query: 462 PHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLEN-G 520
             +H+D+   N+L++++   K+A+F +AR        +    H V T  Y APE L    
Sbjct: 124 --LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT---HEVVTLWYRAPEILLGCK 178
Query: 521 LVSTKLDVYAFGVLILEMLTGK 542
             ST +D+++ G +  EM+T +
Sbjct: 179 YYSTAVDIWSLGCIFAEMVTRR 200

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 47/165 (28%), Positives = 85/165 (51%), Gaps = 12/165 (7%)
Query: 378 VNGDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLD 437
           V G + +EI  L    H ++I L  V     + ++V EY   G L D++  +   G+  +
Sbjct: 54  VVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKH---GRVEE 110
Query: 438 WKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEG 497
            + R ++   + + ++Y H       VH+D+   NVLLD+ + AKIA+F ++      +G
Sbjct: 111 MEAR-RLFQQILSAVDYCHRHMV---VHRDLKPENVLLDAHMNAKIADFGLSNMM--SDG 164
Query: 498 EFALTRHIVGTKGYMAPEYLENGLVS-TKLDVYAFGVLILEMLTG 541
           EF   R   G+  Y APE +   L +  ++D+++ GV++  +L G
Sbjct: 165 EF--LRDSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCG 207

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/194 (28%), Positives = 94/194 (48%), Gaps = 21/194 (10%)
Query: 361 GSVY--RGKINGGFAAIKKVNGDVS---------KEIALLNKINHSNLIILSGVCFNEGN 409
           G VY  R K+ G   A+KK+  D           +EI+LL ++NH N++ L  V   E  
Sbjct: 20  GVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENK 79
Query: 410 CYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDIN 469
            YLV+E+ ++  L  ++ ++   G  L   +     L    GL + HS      +H+D+ 
Sbjct: 80  LYLVFEF-LHQDLKTFMDASALTGIPLPLIKSYLFQL--LQGLAFCHSHRV---LHRDLK 133
Query: 470 SSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLEN-GLVSTKLDV 528
             N+L++++   K+A+F +AR        +    H V T  Y APE L      ST +D+
Sbjct: 134 PQNLLINTEGAIKLADFGLARAFGVPVRTYX---HEVVTLWYRAPEILLGCKYYSTAVDI 190
Query: 529 YAFGVLILEMLTGK 542
           ++ G +  EM+T +
Sbjct: 191 WSLGCIFAEMVTRR 204

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 57/257 (22%), Positives = 111/257 (43%), Gaps = 44/257 (17%)
Query: 369 NGGFAAIKKVNGDVSK---------EIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVN 419
           +G   A+KK+  D+ K         E+ ++    H N++ +          ++V E+   
Sbjct: 48  SGKLVAVKKM--DLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG 105
Query: 420 GTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDL 479
           G L+D V   +     ++ +Q   + L V   L+ LH+      +H+DI S ++LL  D 
Sbjct: 106 GALTDIVTHTR-----MNEEQIAAVCLAVLQALSVLHAQGV---IHRDIKSDSILLTHDG 157
Query: 480 RAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEML 539
           R K+++F           E    + +VGT  +MAPE +       ++D+++ G++++EM+
Sbjct: 158 RVKLSDFGFCAQVSK---EVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMV 214
Query: 540 TGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLR--HFIDPTLQGNYPLELALLVIRLI 597
            G+           M         + +++    L+  H + P+L+G             +
Sbjct: 215 DGEPPYFNEPPLKAMK--------MIRDNLPPRLKNLHKVSPSLKG------------FL 254
Query: 598 DACLKKDPTDRPTMYEI 614
           D  L +DP  R T  E+
Sbjct: 255 DRLLVRDPAQRATAAEL 271

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 57/257 (22%), Positives = 111/257 (43%), Gaps = 44/257 (17%)
Query: 369 NGGFAAIKKVNGDVSK---------EIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVN 419
           +G   A+KK+  D+ K         E+ ++    H N++ +          ++V E+   
Sbjct: 44  SGKLVAVKKM--DLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG 101
Query: 420 GTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDL 479
           G L+D V   +     ++ +Q   + L V   L+ LH+      +H+DI S ++LL  D 
Sbjct: 102 GALTDIVTHTR-----MNEEQIAAVCLAVLQALSVLHAQGV---IHRDIKSDSILLTHDG 153
Query: 480 RAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEML 539
           R K+++F           E    + +VGT  +MAPE +       ++D+++ G++++EM+
Sbjct: 154 RVKLSDFGFCAQVSK---EVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMV 210
Query: 540 TGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLR--HFIDPTLQGNYPLELALLVIRLI 597
            G+           M         + +++    L+  H + P+L+G             +
Sbjct: 211 DGEPPYFNEPPLKAMK--------MIRDNLPPRLKNLHKVSPSLKG------------FL 250
Query: 598 DACLKKDPTDRPTMYEI 614
           D  L +DP  R T  E+
Sbjct: 251 DRLLVRDPAQRATAAEL 267

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 60/262 (22%), Positives = 111/262 (42%), Gaps = 34/262 (12%)
Query: 374 AIKKVNGDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEG 433
           A +    D  +E  LL  + H +++   GVC       +V+EY  +G L+ ++ S+  + 
Sbjct: 53  ASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDA 112
Query: 434 KY-----------LDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAK 482
           K            L   Q + +A  VA G+ YL        VH+D+ + N L+   L  K
Sbjct: 113 KLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVVK 169
Query: 483 IANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGK 542
           I +F M+R     +      R ++  + +M PE +     +T+ DV++FGV++ E+ T  
Sbjct: 170 IGDFGMSRDIYSTDYYRVGGRTMLPIR-WMPPESILYRKFTTESDVWSFGVVLWEIFT-- 226
Query: 543 EAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLK 602
                + ++    LS+   A+     G E  R           P      V  ++  C +
Sbjct: 227 -----YGKQPWYQLSNT-EAIDCITQGRELER-----------PRACPPEVYAIMRGCWQ 269
Query: 603 KDPTDRPTMYEIEHSLSNILNA 624
           ++P  R ++ ++   L  +  A
Sbjct: 270 REPQQRHSIKDVHARLQALAQA 291

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 69/275 (25%), Positives = 121/275 (44%), Gaps = 53/275 (19%)
Query: 374 AIKKVNGDVS--------KEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDW 425
           A+K VN   S         E +++      +++ L GV        +V E   +G L  +
Sbjct: 51  AVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSY 110
Query: 426 VFSNKNEGKY------LDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDL 479
           + S + E +          ++ IQ+A ++A G+ YL++      VH+D+ + N ++  D 
Sbjct: 111 LRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA---KKFVHRDLAARNCMVAHDF 167
Query: 480 RAKIANFAMARPAEGQEGEFALTRHIVGTKG-----YMAPEYLENGLVSTKLDVYAFGVL 534
             KI +F M R        +    +  G KG     +MAPE L++G+ +T  D+++FGV+
Sbjct: 168 TVKIGDFGMTRDI------YETAYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVV 221
Query: 535 ILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNY---PLELAL 591
           + E+ +        AE+    LS+           E+ L+  +D    G Y   P     
Sbjct: 222 LWEITS-------LAEQPYQGLSN-----------EQVLKFVMD----GGYLDQPDNCPE 259
Query: 592 LVIRLIDACLKKDPTDRPTMYEIEHSLSNILNASL 626
            V  L+  C + +P  RPT  EI + L + L+ S 
Sbjct: 260 RVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSF 294

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 74/306 (24%), Positives = 134/306 (43%), Gaps = 48/306 (15%)
Query: 340 VYSFKELQSATDNFSFTCRI-QGS---VYRGKINGGF-------AAIKKVNGDVS----- 383
           VY   E + A +  + +  + QGS   VY G   G          AIK VN   S     
Sbjct: 8   VYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI 67
Query: 384 ---KEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKY----- 435
               E +++ + N  +++ L GV        ++ E    G L  ++ S + E +      
Sbjct: 68  EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLA 127
Query: 436 -LDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEG 494
                + IQ+A ++A G+ YL++      VH+D+ + N ++  D   KI +F M R    
Sbjct: 128 PPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIXE 184
Query: 495 QEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNM 554
            +      + ++  + +M+PE L++G+ +T  DV++FGV++ E+ T        AE+   
Sbjct: 185 TDXXRKGGKGLLPVR-WMSPESLKDGVFTTYSDVWSFGVVLWEIAT-------LAEQPYQ 236
Query: 555 HLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEI 614
            LS+           E+ LR  ++  L  + P     ++  L+  C + +P  RP+  EI
Sbjct: 237 GLSN-----------EQVLRFVMEGGLL-DKPDNCPDMLFELMRMCWQYNPKMRPSFLEI 284
Query: 615 EHSLSN 620
             S+  
Sbjct: 285 ISSIKE 290

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 77/311 (24%), Positives = 134/311 (43%), Gaps = 58/311 (18%)
Query: 340 VYSFKELQSATDNFSFTCRI-QGS---VYRGKINGGF-------AAIKKVNGDVS----- 383
           VY   E + A +  + +  + QGS   VY G   G          AIK VN   S     
Sbjct: 14  VYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI 73
Query: 384 ---KEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKY----- 435
               E +++ + N  +++ L GV        ++ E    G L  ++ S + E +      
Sbjct: 74  EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLA 133
Query: 436 -LDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEG 494
                + IQ+A ++A G+ YL++      VH+D+ + N ++  D   KI +F M R    
Sbjct: 134 PPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDI-- 188
Query: 495 QEGEFALTRHIVGTKG-----YMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHA 549
               +    +  G KG     +M+PE L++G+ +T  DV++FGV++ E+ T        A
Sbjct: 189 ----YETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT-------LA 237
Query: 550 EENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRP 609
           E+    LS+           E+ LR  ++  L  + P     ++  L+  C + +P  RP
Sbjct: 238 EQPYQGLSN-----------EQVLRFVMEGGLL-DKPDNCPDMLFELMRMCWQYNPKMRP 285
Query: 610 TMYEIEHSLSN 620
           +  EI  S+  
Sbjct: 286 SFLEIISSIKE 296

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 51/190 (26%), Positives = 95/190 (50%), Gaps = 21/190 (11%)
Query: 361 GSVYRGKINGGF-AAIKKVN-GDVSK-----EIALLNKINHSNLIILSGVCFNEGNCYLV 413
           G V  GK  G +  AIK +  G +S+     E  ++  ++H  L+ L GVC  +   +++
Sbjct: 18  GVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFII 77
Query: 414 YEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNV 473
            EY  NG L +++   ++  +    +Q +++  DV   + YL S      +H+D+ + N 
Sbjct: 78  TEYMANGCLLNYLREMRHRFQT---QQLLEMCKDVCEAMEYLES---KQFLHRDLAARNC 131
Query: 474 LLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTK---GYMAPEYLENGLVSTKLDVYA 530
           L++     K+++F ++R     E   +     VG+K    +  PE L     S+K D++A
Sbjct: 132 LVNDQGVVKVSDFGLSRYVLDDEYTSS-----VGSKFPVRWSPPEVLMYSKFSSKSDIWA 186
Query: 531 FGVLILEMLT 540
           FGVL+ E+ +
Sbjct: 187 FGVLMWEIYS 196

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 61/231 (26%), Positives = 103/231 (44%), Gaps = 27/231 (11%)
Query: 381 DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQ 440
           D  +E+  ++ ++H NLI L GV        +V E A  G+L D +   K++G +L    
Sbjct: 61  DFIREVNAMHSLDHRNLIRLYGVVLTP-PMKMVTELAPLGSLLDRL--RKHQGHFL-LGT 116
Query: 441 RIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFA 500
             + A+ VA G+ YL S      +H+D+ + N+LL +    KI +F + R     +  + 
Sbjct: 117 LSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYV 173
Query: 501 LTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT-GKEAAALHAEENNMHLSDV 559
           +  H      + APE L+    S   D + FGV + EM T G+E          ++ S +
Sbjct: 174 MQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWI------GLNGSQI 227
Query: 560 LNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPT 610
           L+ +   ++GE   R           P +    +  ++  C    P DRPT
Sbjct: 228 LHKI--DKEGERLPR-----------PEDCPQDIYNVMVQCWAHKPEDRPT 265

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 77/311 (24%), Positives = 134/311 (43%), Gaps = 58/311 (18%)
Query: 340 VYSFKELQSATDNFSFTCRI-QGS---VYRGKINGGF-------AAIKKVNGDVS----- 383
           VY   E + A +  + +  + QGS   VY G   G          AIK VN   S     
Sbjct: 8   VYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI 67
Query: 384 ---KEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKY----- 435
               E +++ + N  +++ L GV        ++ E    G L  ++ S + E +      
Sbjct: 68  EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLA 127
Query: 436 -LDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEG 494
                + IQ+A ++A G+ YL++      VH+D+ + N ++  D   KI +F M R    
Sbjct: 128 PPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDI-- 182
Query: 495 QEGEFALTRHIVGTKG-----YMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHA 549
               +    +  G KG     +M+PE L++G+ +T  DV++FGV++ E+ T        A
Sbjct: 183 ----YETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT-------LA 231
Query: 550 EENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRP 609
           E+    LS+           E+ LR  ++  L  + P     ++  L+  C + +P  RP
Sbjct: 232 EQPYQGLSN-----------EQVLRFVMEGGLL-DKPDNCPDMLFELMRMCWQYNPKMRP 279
Query: 610 TMYEIEHSLSN 620
           +  EI  S+  
Sbjct: 280 SFLEIISSIKE 290

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 61/231 (26%), Positives = 103/231 (44%), Gaps = 27/231 (11%)
Query: 381 DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQ 440
           D  +E+  ++ ++H NLI L GV        +V E A  G+L D +   K++G +L    
Sbjct: 67  DFIREVNAMHSLDHRNLIRLYGVVLTP-PMKMVTELAPLGSLLDRL--RKHQGHFL-LGT 122
Query: 441 RIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFA 500
             + A+ VA G+ YL S      +H+D+ + N+LL +    KI +F + R     +  + 
Sbjct: 123 LSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYV 179
Query: 501 LTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT-GKEAAALHAEENNMHLSDV 559
           +  H      + APE L+    S   D + FGV + EM T G+E          ++ S +
Sbjct: 180 MQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWI------GLNGSQI 233
Query: 560 LNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPT 610
           L+ +   ++GE   R           P +    +  ++  C    P DRPT
Sbjct: 234 LHKI--DKEGERLPR-----------PEDCPQDIYNVMVQCWAHKPEDRPT 271

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 51/190 (26%), Positives = 95/190 (50%), Gaps = 21/190 (11%)
Query: 361 GSVYRGKINGGF-AAIKKVN-GDVSK-----EIALLNKINHSNLIILSGVCFNEGNCYLV 413
           G V  GK  G +  AIK +  G +S+     E  ++  ++H  L+ L GVC  +   +++
Sbjct: 22  GVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFII 81
Query: 414 YEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNV 473
            EY  NG L +++   ++  +    +Q +++  DV   + YL S      +H+D+ + N 
Sbjct: 82  TEYMANGCLLNYLREMRHRFQT---QQLLEMCKDVCEAMEYLES---KQFLHRDLAARNC 135
Query: 474 LLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTK---GYMAPEYLENGLVSTKLDVYA 530
           L++     K+++F ++R     E   +     VG+K    +  PE L     S+K D++A
Sbjct: 136 LVNDQGVVKVSDFGLSRYVLDDEYTSS-----VGSKFPVRWSPPEVLMYSKFSSKSDIWA 190
Query: 531 FGVLILEMLT 540
           FGVL+ E+ +
Sbjct: 191 FGVLMWEIYS 200

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 51/190 (26%), Positives = 94/190 (49%), Gaps = 21/190 (11%)
Query: 361 GSVYRGKINGGF-AAIKKVN-GDVSK-----EIALLNKINHSNLIILSGVCFNEGNCYLV 413
           G V  GK  G +  AIK +  G +S+     E  ++  ++H  L+ L GVC  +   +++
Sbjct: 38  GVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFII 97
Query: 414 YEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNV 473
            EY  NG L +++   ++       +Q +++  DV   + YL S      +H+D+ + N 
Sbjct: 98  TEYMANGCLLNYLREMRHR---FQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNC 151
Query: 474 LLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTK---GYMAPEYLENGLVSTKLDVYA 530
           L++     K+++F ++R     E   +     VG+K    +  PE L     S+K D++A
Sbjct: 152 LVNDQGVVKVSDFGLSRYVLDDEETSS-----VGSKFPVRWSPPEVLMYSKFSSKSDIWA 206
Query: 531 FGVLILEMLT 540
           FGVL+ E+ +
Sbjct: 207 FGVLMWEIYS 216

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 69/275 (25%), Positives = 121/275 (44%), Gaps = 53/275 (19%)
Query: 374 AIKKVNGDVS--------KEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDW 425
           A+K VN   S         E +++      +++ L GV        +V E   +G L  +
Sbjct: 51  AVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSY 110
Query: 426 VFSNKNEGKY------LDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDL 479
           + S + E +          ++ IQ+A ++A G+ YL++      VH+D+ + N ++  D 
Sbjct: 111 LRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA---KKFVHRDLAARNCMVAHDF 167
Query: 480 RAKIANFAMARPAEGQEGEFALTRHIVGTKG-----YMAPEYLENGLVSTKLDVYAFGVL 534
             KI +F M R        +    +  G KG     +MAPE L++G+ +T  D+++FGV+
Sbjct: 168 TVKIGDFGMTRDI------YETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVV 221
Query: 535 ILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNY---PLELAL 591
           + E+ +        AE+    LS+           E+ L+  +D    G Y   P     
Sbjct: 222 LWEITS-------LAEQPYQGLSN-----------EQVLKFVMD----GGYLDQPDNCPE 259
Query: 592 LVIRLIDACLKKDPTDRPTMYEIEHSLSNILNASL 626
            V  L+  C + +P  RPT  EI + L + L+ S 
Sbjct: 260 RVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSF 294

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 66/270 (24%), Positives = 121/270 (44%), Gaps = 43/270 (15%)
Query: 374 AIKKVNGDVS--------KEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDW 425
           A+K VN   S         E +++      +++ L GV        +V E   +G L  +
Sbjct: 51  AVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSY 110
Query: 426 VFSNKNEGKY------LDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDL 479
           + S + E +          ++ IQ+A ++A G+ YL++      VH+D+ + N ++  D 
Sbjct: 111 LRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA---KKFVHRDLAARNCMVAHDF 167
Query: 480 RAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEML 539
             KI +F M R     +      + ++  + +MAPE L++G+ +T  D+++FGV++ E+ 
Sbjct: 168 TVKIGDFGMTRDIXETDXXRKGGKGLLPVR-WMAPESLKDGVFTTSSDMWSFGVVLWEIT 226
Query: 540 TGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNY---PLELALLVIRL 596
           +        AE+    LS+           E+ L+  +D    G Y   P      V  L
Sbjct: 227 S-------LAEQPYQGLSN-----------EQVLKFVMD----GGYLDQPDNCPERVTDL 264
Query: 597 IDACLKKDPTDRPTMYEIEHSLSNILNASL 626
           +  C + +P  RPT  EI + L + L+ S 
Sbjct: 265 MRMCWQFNPKMRPTFLEIVNLLKDDLHPSF 294

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 60/262 (22%), Positives = 111/262 (42%), Gaps = 34/262 (12%)
Query: 374 AIKKVNGDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEG 433
           A +    D  +E  LL  + H +++   GVC       +V+EY  +G L+ ++ S+  + 
Sbjct: 59  ASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDA 118
Query: 434 KY-----------LDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAK 482
           K            L   Q + +A  VA G+ YL        VH+D+ + N L+   L  K
Sbjct: 119 KLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVVK 175
Query: 483 IANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGK 542
           I +F M+R     +      R ++  + +M PE +     +T+ DV++FGV++ E+ T  
Sbjct: 176 IGDFGMSRDIYSTDYYRVGGRTMLPIR-WMPPESILYRKFTTESDVWSFGVVLWEIFT-- 232
Query: 543 EAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLK 602
                + ++    LS+   A+     G E  R           P      V  ++  C +
Sbjct: 233 -----YGKQPWYQLSNT-EAIDCITQGRELER-----------PRACPPEVYAIMRGCWQ 275
Query: 603 KDPTDRPTMYEIEHSLSNILNA 624
           ++P  R ++ ++   L  +  A
Sbjct: 276 REPQQRHSIKDVHARLQALAQA 297

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 77/311 (24%), Positives = 134/311 (43%), Gaps = 58/311 (18%)
Query: 340 VYSFKELQSATDNFSFTCRI-QGS---VYRGKINGGF-------AAIKKVNGDVS----- 383
           VY   E + A +  + +  + QGS   VY G   G          AIK VN   S     
Sbjct: 7   VYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI 66
Query: 384 ---KEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKY----- 435
               E +++ + N  +++ L GV        ++ E    G L  ++ S + E +      
Sbjct: 67  EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLA 126
Query: 436 -LDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEG 494
                + IQ+A ++A G+ YL++      VH+D+ + N ++  D   KI +F M R    
Sbjct: 127 PPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDI-- 181
Query: 495 QEGEFALTRHIVGTKG-----YMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHA 549
               +    +  G KG     +M+PE L++G+ +T  DV++FGV++ E+ T        A
Sbjct: 182 ----YETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT-------LA 230
Query: 550 EENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRP 609
           E+    LS+           E+ LR  ++  L  + P     ++  L+  C + +P  RP
Sbjct: 231 EQPYQGLSN-----------EQVLRFVMEGGLL-DKPDNCPDMLFELMRMCWQYNPKMRP 278
Query: 610 TMYEIEHSLSN 620
           +  EI  S+  
Sbjct: 279 SFLEIISSIKE 289

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 77/310 (24%), Positives = 134/310 (43%), Gaps = 58/310 (18%)
Query: 340 VYSFKELQSATDNFSFTCRI-QGS---VYRGKINGGF-------AAIKKVNGDVS----- 383
           VY   E + A +  + +  + QGS   VY G   G          AIK VN   S     
Sbjct: 7   VYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI 66
Query: 384 ---KEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKY----- 435
               E +++ + N  +++ L GV        ++ E    G L  ++ S + E +      
Sbjct: 67  EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLA 126
Query: 436 -LDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEG 494
                + IQ+A ++A G+ YL++      VH+D+ + N ++  D   KI +F M R    
Sbjct: 127 PPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDI-- 181
Query: 495 QEGEFALTRHIVGTKG-----YMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHA 549
               +    +  G KG     +M+PE L++G+ +T  DV++FGV++ E+ T        A
Sbjct: 182 ----YETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT-------LA 230
Query: 550 EENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRP 609
           E+    LS+           E+ LR  ++  L  + P     ++  L+  C + +P  RP
Sbjct: 231 EQPYQGLSN-----------EQVLRFVMEGGLL-DKPDNCPDMLFELMRMCWQYNPKMRP 278
Query: 610 TMYEIEHSLS 619
           +  EI  S+ 
Sbjct: 279 SFLEIISSIK 288

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 68/281 (24%), Positives = 124/281 (44%), Gaps = 44/281 (15%)
Query: 361 GSVYRGKINGGF-------AAIKKVNGDVS--------KEIALLNKINHSNLIILSGVCF 405
           G VY G   G          AIK VN   S         E +++ + N  +++ L GV  
Sbjct: 24  GMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS 83
Query: 406 NEGNCYLVYEYAVNGTLSDWVFSNKNEGKY------LDWKQRIQIALDVATGLNYLHSFT 459
                 ++ E    G L  ++ S + E +           + IQ+A ++A G+ YL++  
Sbjct: 84  QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANK 143
Query: 460 NPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLEN 519
               VH+D+ + N ++  D   KI +F M R     +      + ++  + +M+PE L++
Sbjct: 144 ---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVR-WMSPESLKD 199
Query: 520 GLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDP 579
           G+ +T  DV++FGV++ E+ T        AE+    LS+           E+ LR  ++ 
Sbjct: 200 GVFTTYSDVWSFGVVLWEIAT-------LAEQPYQGLSN-----------EQVLRFVMEG 241
Query: 580 TLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSN 620
            L  + P     +++ L+  C + +P  RP+  EI  S+  
Sbjct: 242 GLL-DKPDNCPDMLLELMRMCWQYNPKMRPSFLEIISSIKE 281

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 61/231 (26%), Positives = 103/231 (44%), Gaps = 27/231 (11%)
Query: 381 DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQ 440
           D  +E+  ++ ++H NLI L GV        +V E A  G+L D +   K++G +L    
Sbjct: 61  DFIREVNAMHSLDHRNLIRLYGVVLTP-PMKMVTELAPLGSLLDRL--RKHQGHFL-LGT 116
Query: 441 RIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFA 500
             + A+ VA G+ YL S      +H+D+ + N+LL +    KI +F + R     +  + 
Sbjct: 117 LSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYV 173
Query: 501 LTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT-GKEAAALHAEENNMHLSDV 559
           +  H      + APE L+    S   D + FGV + EM T G+E          ++ S +
Sbjct: 174 MQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWI------GLNGSQI 227
Query: 560 LNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPT 610
           L+ +   ++GE   R           P +    +  ++  C    P DRPT
Sbjct: 228 LHKI--DKEGERLPR-----------PEDCPQDIYNVMVQCWAHKPEDRPT 265

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 66/270 (24%), Positives = 121/270 (44%), Gaps = 43/270 (15%)
Query: 374 AIKKVNGDVS--------KEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDW 425
           A+K VN   S         E +++      +++ L GV        +V E   +G L  +
Sbjct: 51  AVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSY 110
Query: 426 VFSNKNEGKY------LDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDL 479
           + S + E +          ++ IQ+A ++A G+ YL++      VH+D+ + N ++  D 
Sbjct: 111 LRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA---KKFVHRDLAARNCMVAHDF 167
Query: 480 RAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEML 539
             KI +F M R     +      + ++  + +MAPE L++G+ +T  D+++FGV++ E+ 
Sbjct: 168 TVKIGDFGMTRDIXETDXXRKGGKGLLPVR-WMAPESLKDGVFTTSSDMWSFGVVLWEIT 226
Query: 540 TGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNY---PLELALLVIRL 596
           +        AE+    LS+           E+ L+  +D    G Y   P      V  L
Sbjct: 227 S-------LAEQPYQGLSN-----------EQVLKFVMD----GGYLDQPDNCPERVTDL 264
Query: 597 IDACLKKDPTDRPTMYEIEHSLSNILNASL 626
           +  C + +P  RPT  EI + L + L+ S 
Sbjct: 265 MRMCWQFNPNMRPTFLEIVNLLKDDLHPSF 294

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 51/190 (26%), Positives = 95/190 (50%), Gaps = 21/190 (11%)
Query: 361 GSVYRGKINGGF-AAIKKVN-GDVSK-----EIALLNKINHSNLIILSGVCFNEGNCYLV 413
           G V  GK  G +  AIK +  G +S+     E  ++  ++H  L+ L GVC  +   +++
Sbjct: 23  GVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFII 82
Query: 414 YEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNV 473
            EY  NG L +++   ++  +    +Q +++  DV   + YL S      +H+D+ + N 
Sbjct: 83  TEYMANGCLLNYLREMRHRFQT---QQLLEMCKDVCEAMEYLES---KQFLHRDLAARNC 136
Query: 474 LLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTK---GYMAPEYLENGLVSTKLDVYA 530
           L++     K+++F ++R     E   +     VG+K    +  PE L     S+K D++A
Sbjct: 137 LVNDQGVVKVSDFGLSRYVLDDEYTSS-----VGSKFPVRWSPPEVLMYSKFSSKSDIWA 191
Query: 531 FGVLILEMLT 540
           FGVL+ E+ +
Sbjct: 192 FGVLMWEIYS 201

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 61/231 (26%), Positives = 103/231 (44%), Gaps = 27/231 (11%)
Query: 381 DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQ 440
           D  +E+  ++ ++H NLI L GV        +V E A  G+L D +   K++G +L    
Sbjct: 57  DFIREVNAMHSLDHRNLIRLYGVVLTP-PMKMVTELAPLGSLLDRL--RKHQGHFL-LGT 112
Query: 441 RIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFA 500
             + A+ VA G+ YL S      +H+D+ + N+LL +    KI +F + R     +  + 
Sbjct: 113 LSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYV 169
Query: 501 LTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT-GKEAAALHAEENNMHLSDV 559
           +  H      + APE L+    S   D + FGV + EM T G+E          ++ S +
Sbjct: 170 MQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWI------GLNGSQI 223
Query: 560 LNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPT 610
           L+ +   ++GE   R           P +    +  ++  C    P DRPT
Sbjct: 224 LHKI--DKEGERLPR-----------PEDCPQDIYNVMVQCWAHKPEDRPT 261

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 69/275 (25%), Positives = 121/275 (44%), Gaps = 53/275 (19%)
Query: 374 AIKKVNGDVS--------KEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDW 425
           A+K VN   S         E +++      +++ L GV        +V E   +G L  +
Sbjct: 50  AVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSY 109
Query: 426 VFSNKNEGKY------LDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDL 479
           + S + E +          ++ IQ+A ++A G+ YL++      VH+D+ + N ++  D 
Sbjct: 110 LRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA---KKFVHRDLAARNCMVAHDF 166
Query: 480 RAKIANFAMARPAEGQEGEFALTRHIVGTKG-----YMAPEYLENGLVSTKLDVYAFGVL 534
             KI +F M R        +    +  G KG     +MAPE L++G+ +T  D+++FGV+
Sbjct: 167 TVKIGDFGMTRDI------YETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVV 220
Query: 535 ILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNY---PLELAL 591
           + E+ +        AE+    LS+           E+ L+  +D    G Y   P     
Sbjct: 221 LWEITS-------LAEQPYQGLSN-----------EQVLKFVMD----GGYLDQPDNCPE 258
Query: 592 LVIRLIDACLKKDPTDRPTMYEIEHSLSNILNASL 626
            V  L+  C + +P  RPT  EI + L + L+ S 
Sbjct: 259 RVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSF 293

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 51/190 (26%), Positives = 94/190 (49%), Gaps = 21/190 (11%)
Query: 361 GSVYRGKINGGF-AAIKKVN-GDVSK-----EIALLNKINHSNLIILSGVCFNEGNCYLV 413
           G V  GK  G +  AIK +  G +S+     E  ++  ++H  L+ L GVC  +   +++
Sbjct: 29  GVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFII 88
Query: 414 YEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNV 473
            EY  NG L +++   ++       +Q +++  DV   + YL S      +H+D+ + N 
Sbjct: 89  TEYMANGCLLNYLREMRHR---FQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNC 142
Query: 474 LLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTK---GYMAPEYLENGLVSTKLDVYA 530
           L++     K+++F ++R     E   +     VG+K    +  PE L     S+K D++A
Sbjct: 143 LVNDQGVVKVSDFGLSRYVLDDEYTSS-----VGSKFPVRWSPPEVLMYSKFSSKSDIWA 197
Query: 531 FGVLILEMLT 540
           FGVL+ E+ +
Sbjct: 198 FGVLMWEIYS 207

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 51/187 (27%), Positives = 88/187 (47%), Gaps = 15/187 (8%)
Query: 358 RIQGSVYRGKINGGFAAIKKVNGDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYA 417
           RI    Y  K+    +A  K    + +E+ LL K++H N++ L  +  +  + Y+V E  
Sbjct: 44  RITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELY 103
Query: 418 VNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDS 477
             G L D +   K   ++       +I   V +G+ Y+H       VH+D+   N+LL+S
Sbjct: 104 TGGELFDEIIKRKRFSEH----DAARIIKQVFSGITYMHKHN---IVHRDLKPENILLES 156
Query: 478 ---DLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVL 534
              D   KI +F ++   +         +  +GT  Y+APE L  G    K DV++ GV+
Sbjct: 157 KEKDCDIKIIDFGLSTCFQQN----TKMKDRIGTAYYIAPEVL-RGTYDEKCDVWSAGVI 211
Query: 535 ILEMLTG 541
           +  +L+G
Sbjct: 212 LYILLSG 218

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 66/270 (24%), Positives = 121/270 (44%), Gaps = 43/270 (15%)
Query: 374 AIKKVNGDVS--------KEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDW 425
           A+K VN   S         E +++      +++ L GV        +V E   +G L  +
Sbjct: 48  AVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSY 107
Query: 426 VFSNKNEGKY------LDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDL 479
           + S + E +          ++ IQ+A ++A G+ YL++      VH+D+ + N ++  D 
Sbjct: 108 LRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA---KKFVHRDLAARNCMVAHDF 164
Query: 480 RAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEML 539
             KI +F M R     +      + ++  + +MAPE L++G+ +T  D+++FGV++ E+ 
Sbjct: 165 TVKIGDFGMTRDIXETDXXRKGGKGLLPVR-WMAPESLKDGVFTTSSDMWSFGVVLWEIT 223
Query: 540 TGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNY---PLELALLVIRL 596
           +        AE+    LS+           E+ L+  +D    G Y   P      V  L
Sbjct: 224 S-------LAEQPYQGLSN-----------EQVLKFVMD----GGYLDQPDNCPERVTDL 261
Query: 597 IDACLKKDPTDRPTMYEIEHSLSNILNASL 626
           +  C + +P  RPT  EI + L + L+ S 
Sbjct: 262 MRMCWQFNPKMRPTFLEIVNLLKDDLHPSF 291

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 77/310 (24%), Positives = 134/310 (43%), Gaps = 58/310 (18%)
Query: 340 VYSFKELQSATDNFSFTCRI-QGS---VYRGKINGGF-------AAIKKVNGDVS----- 383
           VY   E + A +  + +  + QGS   VY G   G          AIK VN   S     
Sbjct: 36  VYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI 95
Query: 384 ---KEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKY----- 435
               E +++ + N  +++ L GV        ++ E    G L  ++ S + E +      
Sbjct: 96  EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLA 155
Query: 436 -LDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEG 494
                + IQ+A ++A G+ YL++      VH+D+ + N ++  D   KI +F M R    
Sbjct: 156 PPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDI-- 210
Query: 495 QEGEFALTRHIVGTKG-----YMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHA 549
               +    +  G KG     +M+PE L++G+ +T  DV++FGV++ E+ T        A
Sbjct: 211 ----YETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT-------LA 259
Query: 550 EENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRP 609
           E+    LS+           E+ LR  ++  L  + P     ++  L+  C + +P  RP
Sbjct: 260 EQPYQGLSN-----------EQVLRFVMEGGLL-DKPDNCPDMLFELMRMCWQYNPKMRP 307
Query: 610 TMYEIEHSLS 619
           +  EI  S+ 
Sbjct: 308 SFLEIISSIK 317

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 39/132 (29%), Positives = 66/132 (50%), Gaps = 7/132 (5%)
Query: 411 YLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINS 470
           Y+V EY    TL D V +   EG  +  K+ I++  D    LN+ H       +H+D+  
Sbjct: 92  YIVMEYVDGVTLRDIVHT---EGP-MTPKRAIEVIADACQALNFSHQNGI---IHRDVKP 144
Query: 471 SNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYA 530
           +N+L+ +    K+ +F +AR           T  ++GT  Y++PE      V  + DVY+
Sbjct: 145 ANILISATNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQYLSPEQARGDSVDARSDVYS 204
Query: 531 FGVLILEMLTGK 542
            G ++ E+LTG+
Sbjct: 205 LGCVLYEVLTGE 216

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 46/162 (28%), Positives = 79/162 (48%), Gaps = 20/162 (12%)
Query: 385 EIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTL-----SDWVFSNKNEGKYLDWK 439
           E  +L  +NH  ++ L      EG  YL+ ++   G L      + +F+ ++   YL   
Sbjct: 80  ERDILADVNHPFVVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYL--- 136
Query: 440 QRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEF 499
                  ++A GL++LHS      +++D+   N+LLD +   K+ +F +++ A   E + 
Sbjct: 137 ------AELALGLDHLHSLGI---IYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKK- 186
Query: 500 ALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTG 541
                  GT  YMAPE +     S   D +++GVL+ EMLTG
Sbjct: 187 --AYSFCGTVEYMAPEVVNRQGHSHSADWWSYGVLMFEMLTG 226

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 51/190 (26%), Positives = 94/190 (49%), Gaps = 21/190 (11%)
Query: 361 GSVYRGKINGGF-AAIKKVN-GDVSK-----EIALLNKINHSNLIILSGVCFNEGNCYLV 413
           G V  GK  G +  AIK +  G +S+     E  ++  ++H  L+ L GVC  +   +++
Sbjct: 38  GVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFII 97
Query: 414 YEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNV 473
            EY  NG L +++   ++       +Q +++  DV   + YL S      +H+D+ + N 
Sbjct: 98  TEYMANGCLLNYLREMRHR---FQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNC 151
Query: 474 LLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTK---GYMAPEYLENGLVSTKLDVYA 530
           L++     K+++F ++R     E   +     VG+K    +  PE L     S+K D++A
Sbjct: 152 LVNDQGVVKVSDFGLSRYVLDDEYTSS-----VGSKFPVRWSPPEVLMYSKFSSKSDIWA 206
Query: 531 FGVLILEMLT 540
           FGVL+ E+ +
Sbjct: 207 FGVLMWEIYS 216

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 45/163 (27%), Positives = 83/163 (50%), Gaps = 20/163 (12%)
Query: 384 KEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQ 443
           +E+ ++  +NH N++ L  V   E   YLV EYA  G + D++ ++   G+  + + R +
Sbjct: 62  REVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAH---GRMKEKEARAK 118
Query: 444 IALDVATGLNYLH-SFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALT 502
               + + + Y H  F     VH+D+ + N+LLD+D+  KIA+F       G   EF   
Sbjct: 119 FR-QIVSAVQYCHQKFI----VHRDLKAENLLLDADMNIKIADF-------GFSNEFTFG 166
Query: 503 RHI---VGTKGYMAPEYLENGLVS-TKLDVYAFGVLILEMLTG 541
             +    G+  Y APE  +       ++DV++ GV++  +++G
Sbjct: 167 NKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 77/311 (24%), Positives = 134/311 (43%), Gaps = 58/311 (18%)
Query: 340 VYSFKELQSATDNFSFTCRI-QGS---VYRGKINGGF-------AAIKKVNGDVS----- 383
           VY   E + A +  + +  + QGS   VY G   G          AIK VN   S     
Sbjct: 1   VYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI 60
Query: 384 ---KEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKY----- 435
               E +++ + N  +++ L GV        ++ E    G L  ++ S + E +      
Sbjct: 61  EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLA 120
Query: 436 -LDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEG 494
                + IQ+A ++A G+ YL++      VH+D+ + N  +  D   KI +F M R    
Sbjct: 121 PPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCXVAEDFTVKIGDFGMTRDI-- 175
Query: 495 QEGEFALTRHIVGTKG-----YMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHA 549
               +    +  G KG     +M+PE L++G+ +T  DV++FGV++ E+ T        A
Sbjct: 176 ----YETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT-------LA 224
Query: 550 EENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRP 609
           E+    LS+           E+ LR  ++  L  + P     +++ L+  C + +P  RP
Sbjct: 225 EQPYQGLSN-----------EQVLRFVMEGGLL-DKPDNCPDMLLELMRMCWQYNPKMRP 272
Query: 610 TMYEIEHSLSN 620
           +  EI  S+  
Sbjct: 273 SFLEIISSIKE 283

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 45/163 (27%), Positives = 83/163 (50%), Gaps = 20/163 (12%)
Query: 384 KEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQ 443
           +E+ ++  +NH N++ L  V   E   YLV EYA  G + D++ ++   G+  + + R +
Sbjct: 62  REVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAH---GRMKEKEARAK 118
Query: 444 IALDVATGLNYLH-SFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALT 502
               + + + Y H  F     VH+D+ + N+LLD+D+  KIA+F       G   EF   
Sbjct: 119 FR-QIVSAVQYCHQKFI----VHRDLKAENLLLDADMNIKIADF-------GFSNEFTFG 166
Query: 503 RHI---VGTKGYMAPEYLENGLVS-TKLDVYAFGVLILEMLTG 541
             +    G+  Y APE  +       ++DV++ GV++  +++G
Sbjct: 167 NKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 61/231 (26%), Positives = 103/231 (44%), Gaps = 27/231 (11%)
Query: 381 DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQ 440
           D  +E+  ++ ++H NLI L GV        +V E A  G+L D +   K++G +L    
Sbjct: 57  DFIREVNAMHSLDHRNLIRLYGVVLTP-PMKMVTELAPLGSLLDRL--RKHQGHFL-LGT 112
Query: 441 RIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFA 500
             + A+ VA G+ YL S      +H+D+ + N+LL +    KI +F + R     +  + 
Sbjct: 113 LSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYV 169
Query: 501 LTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT-GKEAAALHAEENNMHLSDV 559
           +  H      + APE L+    S   D + FGV + EM T G+E          ++ S +
Sbjct: 170 MQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWI------GLNGSQI 223
Query: 560 LNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPT 610
           L+ +   ++GE   R           P +    +  ++  C    P DRPT
Sbjct: 224 LHKI--DKEGERLPR-----------PEDCPQDIYNVMVQCWAHKPEDRPT 261

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 51/187 (27%), Positives = 88/187 (47%), Gaps = 15/187 (8%)
Query: 358 RIQGSVYRGKINGGFAAIKKVNGDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYA 417
           RI    Y  K+    +A  K    + +E+ LL K++H N++ L  +  +  + Y+V E  
Sbjct: 44  RITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELY 103
Query: 418 VNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDS 477
             G L D +   K   ++       +I   V +G+ Y+H       VH+D+   N+LL+S
Sbjct: 104 TGGELFDEIIKRKRFSEH----DAARIIKQVFSGITYMHKHNI---VHRDLKPENILLES 156
Query: 478 ---DLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVL 534
              D   KI +F ++   +         +  +GT  Y+APE L  G    K DV++ GV+
Sbjct: 157 KEKDCDIKIIDFGLSTCFQQN----TKMKDRIGTAYYIAPEVL-RGTYDEKCDVWSAGVI 211
Query: 535 ILEMLTG 541
           +  +L+G
Sbjct: 212 LYILLSG 218

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 45/163 (27%), Positives = 83/163 (50%), Gaps = 20/163 (12%)
Query: 384 KEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQ 443
           +E+ ++  +NH N++ L  V   E   YLV EYA  G + D++ ++   G+  + + R +
Sbjct: 62  REVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAH---GRMKEKEARAK 118
Query: 444 IALDVATGLNYLH-SFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALT 502
               + + + Y H  F     VH+D+ + N+LLD+D+  KIA+F       G   EF   
Sbjct: 119 FR-QIVSAVQYCHQKFI----VHRDLKAENLLLDADMNIKIADF-------GFSNEFTFG 166
Query: 503 RHI---VGTKGYMAPEYLENGLVS-TKLDVYAFGVLILEMLTG 541
             +    G+  Y APE  +       ++DV++ GV++  +++G
Sbjct: 167 NKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 51/187 (27%), Positives = 88/187 (47%), Gaps = 15/187 (8%)
Query: 358 RIQGSVYRGKINGGFAAIKKVNGDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYA 417
           RI    Y  K+    +A  K    + +E+ LL K++H N++ L  +  +  + Y+V E  
Sbjct: 44  RITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELY 103
Query: 418 VNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDS 477
             G L D +   K   ++       +I   V +G+ Y+H       VH+D+   N+LL+S
Sbjct: 104 TGGELFDEIIKRKRFSEH----DAARIIKQVFSGITYMHKHNI---VHRDLKPENILLES 156
Query: 478 ---DLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVL 534
              D   KI +F ++   +         +  +GT  Y+APE L  G    K DV++ GV+
Sbjct: 157 KEKDCDIKIIDFGLSTCFQQN----TKMKDRIGTAYYIAPEVL-RGTYDEKCDVWSAGVI 211
Query: 535 ILEMLTG 541
           +  +L+G
Sbjct: 212 LYILLSG 218

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 45/163 (27%), Positives = 83/163 (50%), Gaps = 20/163 (12%)
Query: 384 KEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQ 443
           +E+ ++  +NH N++ L  V   E   YLV EYA  G + D++ ++   G+  + + R +
Sbjct: 62  REVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAH---GRMKEKEARAK 118
Query: 444 IALDVATGLNYLH-SFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALT 502
               + + + Y H  F     VH+D+ + N+LLD+D+  KIA+F       G   EF   
Sbjct: 119 FR-QIVSAVQYCHQKFI----VHRDLKAENLLLDADMNIKIADF-------GFSNEFTFG 166
Query: 503 RHI---VGTKGYMAPEYLENGLVS-TKLDVYAFGVLILEMLTG 541
             +    G+  Y APE  +       ++DV++ GV++  +++G
Sbjct: 167 NKLDEFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 66/298 (22%), Positives = 124/298 (41%), Gaps = 78/298 (26%)
Query: 361 GSVYRGK--INGGFAAIKKV---NGDVSKEIALLNKINHSNLIILSGVCFN--------- 406
           G V++ K  I+G    I++V   N    +E+  L K++H N++  +G C++         
Sbjct: 26  GQVFKAKHRIDGKTYVIRRVKYNNEKAEREVKALAKLDHVNIVHYNG-CWDGFDYDPETS 84
Query: 407 --------------------EGNC-YLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIA 445
                               +  C ++  E+   GTL  W+   K  G+ LD    +++ 
Sbjct: 85  DDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWI--EKRRGEKLDKVLALELF 142
Query: 446 LDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHI 505
             +  G++Y+HS      +H+D+  SN+ L    + KI +F +    +  +G+   ++  
Sbjct: 143 EQITKGVDYIHS---KKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKN-DGKRTRSK-- 196
Query: 506 VGTKGYMAPEYLENGLVSTKLDVYAFGVLILEML----TGKEAAALHAEENNMHLSDVLN 561
            GT  YM+PE + +     ++D+YA G+++ E+L    T  E +    +  +  +SD+  
Sbjct: 197 -GTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIF- 254
Query: 562 AVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLS 619
                 D +E                        L+   L K P DRP   EI  +L+
Sbjct: 255 ------DKKEKT----------------------LLQKLLSKKPEDRPNTSEILRTLT 284

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 71/286 (24%), Positives = 123/286 (43%), Gaps = 54/286 (18%)
Query: 361 GSVYRGKINGGF-------AAIKKVNGDVS--------KEIALLNKINHSNLIILSGVCF 405
           G VY G   G          AIK VN   S         E +++ + N  +++ L GV  
Sbjct: 26  GMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS 85
Query: 406 NEGNCYLVYEYAVNGTLSDWVFSNKNEGKY------LDWKQRIQIALDVATGLNYLHSFT 459
                 ++ E    G L  ++ S + E +           + IQ+A ++A G+ YL++  
Sbjct: 86  QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANK 145
Query: 460 NPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKG-----YMAP 514
               VH+D+ + N ++  D   KI +F M R        +    +  G KG     +M+P
Sbjct: 146 ---FVHRDLAARNCMVAEDFTVKIGDFGMTRDI------YETDYYRKGGKGLLPVRWMSP 196
Query: 515 EYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLR 574
           E L++G+ +T  DV++FGV++ E+ T        AE+    LS+           E+ LR
Sbjct: 197 ESLKDGVFTTYSDVWSFGVVLWEIAT-------LAEQPYQGLSN-----------EQVLR 238
Query: 575 HFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSN 620
             ++  L  + P     ++  L+  C + +P  RP+  EI  S+  
Sbjct: 239 FVMEGGLL-DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 283

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 71/286 (24%), Positives = 123/286 (43%), Gaps = 54/286 (18%)
Query: 361 GSVYRGKINGGF-------AAIKKVNGDVS--------KEIALLNKINHSNLIILSGVCF 405
           G VY G   G          AIK VN   S         E +++ + N  +++ L GV  
Sbjct: 30  GMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS 89
Query: 406 NEGNCYLVYEYAVNGTLSDWVFSNKNEGKY------LDWKQRIQIALDVATGLNYLHSFT 459
                 ++ E    G L  ++ S + E +           + IQ+A ++A G+ YL++  
Sbjct: 90  QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANK 149
Query: 460 NPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKG-----YMAP 514
               VH+D+ + N ++  D   KI +F M R        +    +  G KG     +M+P
Sbjct: 150 ---FVHRDLAARNCMVAEDFTVKIGDFGMTRDI------YETDYYRKGGKGLLPVRWMSP 200
Query: 515 EYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLR 574
           E L++G+ +T  DV++FGV++ E+ T        AE+    LS+           E+ LR
Sbjct: 201 ESLKDGVFTTYSDVWSFGVVLWEIAT-------LAEQPYQGLSN-----------EQVLR 242
Query: 575 HFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSN 620
             ++  L  + P     ++  L+  C + +P  RP+  EI  S+  
Sbjct: 243 FVMEGGLL-DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 287

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 72/294 (24%), Positives = 129/294 (43%), Gaps = 48/294 (16%)
Query: 361 GSVYRGKINGGFAAIKKVNGDVSK----EIALLNKI--NHSNLI--ILSGVCFNEGNC-- 410
           G V+RG   G   A+K  +    K    E  L N +   H N++  I S +     +   
Sbjct: 51  GEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL 110
Query: 411 YLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLH-----SFTNPPHVH 465
           +L+  Y   G+L D++     +   LD    ++I L +A+GL +LH     +   P   H
Sbjct: 111 WLITHYHEMGSLYDYL-----QLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAH 165
Query: 466 KDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRH-IVGTKGYMAPEYLENGLVS- 523
           +D+ S N+L+  + +  IA+  +A        +  +  +  VGTK YMAPE L+  +   
Sbjct: 166 RDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVD 225
Query: 524 -----TKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESL----- 573
                 ++D++AFG+++ E+     +  +  E+      DV+    + ED  + +     
Sbjct: 226 CFDSYKRVDIWAFGLVLWEVARRMVSNGI-VEDYKPPFYDVVPNDPSFEDMRKVVCVDQQ 284
Query: 574 ------RHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNI 621
                 R F DPTL           + +L+  C  ++P+ R T   I+ +L+ I
Sbjct: 285 RPNIPNRWFSDPTLTS---------LAKLMKECWYQNPSARLTALRIKKTLTKI 329

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 47/140 (33%), Positives = 73/140 (52%), Gaps = 11/140 (7%)
Query: 404 CFNE-GNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPP 462
           CF      Y V EY VNG   D ++  +  GK+ +  Q +  A +++ GL +LH      
Sbjct: 88  CFQTVDRLYFVMEY-VNG--GDLMYHIQQVGKFKE-PQAVFYAAEISIGLFFLHKRGI-- 141
Query: 463 HVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLV 522
            +++D+   NV+LDS+   KIA+F M +     +G    TR   GT  Y+APE +     
Sbjct: 142 -IYRDLKLDNVMLDSEGHIKIADFGMCK-EHMMDG--VTTREFCGTPDYIAPEIIAYQPY 197
Query: 523 STKLDVYAFGVLILEMLTGK 542
              +D +A+GVL+ EML G+
Sbjct: 198 GKSVDWWAYGVLLYEMLAGQ 217

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/166 (33%), Positives = 84/166 (50%), Gaps = 16/166 (9%)
Query: 382 VSKEIALLNKINHSNLIILSGVCF--NEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWK 439
           V +EIA+L K++H N++ L  V    NE + Y+V+E    G + +         K L   
Sbjct: 83  VYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEV-----PTLKPLSED 137
Query: 440 QRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEF 499
           Q      D+  G+ YLH       +H+DI  SN+L+  D   KIA+F ++   +G +   
Sbjct: 138 QARFYFQDLIKGIEYLHYQKI---IHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSD--- 191
Query: 500 ALTRHIVGTKGYMAPEYLE--NGLVSTK-LDVYAFGVLILEMLTGK 542
           AL  + VGT  +MAPE L     + S K LDV+A GV +   + G+
Sbjct: 192 ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 96/222 (43%), Gaps = 34/222 (15%)
Query: 393 NHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGL 452
           NH  L+ L      E   + V EY VNG   D +F  + + K  +   R   A +++  L
Sbjct: 111 NHPFLVGLHSCFQTESRLFFVIEY-VNG--GDLMFHMQRQRKLPEEHARFYSA-EISLAL 166
Query: 453 NYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMA----RPAEGQEGEFALTRHIVGT 508
           NYLH       +++D+   NVLLDS+   K+ ++ M     RP +        T    GT
Sbjct: 167 NYLHERGI---IYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD-------TTSTFCGT 216
Query: 509 KGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENN--MHLSDVLNAVLTK 566
             Y+APE L        +D +A GVL+ EM+ G+    +    +N   +  D L  V+ +
Sbjct: 217 PNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE 276
Query: 567 EDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDR 608
           +              Q   P  L++    ++ + L KDP +R
Sbjct: 277 K--------------QIRIPRSLSVKAASVLKSFLNKDPKER 304

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 46/161 (28%), Positives = 81/161 (50%), Gaps = 12/161 (7%)
Query: 383 SKEIALLNKINHSNLIILSGVCFNEG--NCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQ 440
            +EI +L  + H +++   G C ++G  +  LV EY   G+L D++  +      +   Q
Sbjct: 59  QREIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRH-----CVGLAQ 113
Query: 441 RIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPA-EGQEGEF 499
            +  A  +  G+ YLH+     ++H+ + + NVLLD+D   KI +F +A+   EG E  +
Sbjct: 114 LLLFAQQICEGMAYLHA---QHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHE-YY 169
Query: 500 ALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT 540
            +         + APE L+        DV++FGV + E+LT
Sbjct: 170 RVREDGDSPVFWYAPECLKECKFYYASDVWSFGVTLYELLT 210

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 45/163 (27%), Positives = 82/163 (50%), Gaps = 20/163 (12%)
Query: 384 KEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQ 443
           +E+ ++  +NH N++ L  V   E   YLV EYA  G + D++ ++   G+  + + R +
Sbjct: 62  REVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAH---GRMKEKEARAK 118
Query: 444 IALDVATGLNYLH-SFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALT 502
               + + + Y H  F     VH+D+ + N+LLD+D+  KIA+F       G   EF   
Sbjct: 119 FR-QIVSAVQYCHQKFI----VHRDLKAENLLLDADMNIKIADF-------GFSNEFTFG 166
Query: 503 RHI---VGTKGYMAPEYLENGLVS-TKLDVYAFGVLILEMLTG 541
             +    G   Y APE  +       ++DV++ GV++  +++G
Sbjct: 167 NKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 96/222 (43%), Gaps = 34/222 (15%)
Query: 393 NHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGL 452
           NH  L+ L      E   + V EY VNG   D +F  + + K  +   R   A +++  L
Sbjct: 68  NHPFLVGLHSCFQTESRLFFVIEY-VNG--GDLMFHMQRQRKLPEEHARFYSA-EISLAL 123
Query: 453 NYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMA----RPAEGQEGEFALTRHIVGT 508
           NYLH       +++D+   NVLLDS+   K+ ++ M     RP +        T    GT
Sbjct: 124 NYLHERGI---IYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD-------TTSXFCGT 173
Query: 509 KGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENN--MHLSDVLNAVLTK 566
             Y+APE L        +D +A GVL+ EM+ G+    +    +N   +  D L  V+ +
Sbjct: 174 PNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE 233
Query: 567 EDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDR 608
           +              Q   P  L++    ++ + L KDP +R
Sbjct: 234 K--------------QIRIPRSLSVKAASVLKSFLNKDPKER 261

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 96/222 (43%), Gaps = 34/222 (15%)
Query: 393 NHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGL 452
           NH  L+ L      E   + V EY VNG   D +F  + + K  +   R   A +++  L
Sbjct: 64  NHPFLVGLHSCFQTESRLFFVIEY-VNG--GDLMFHMQRQRKLPEEHARFYSA-EISLAL 119
Query: 453 NYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMA----RPAEGQEGEFALTRHIVGT 508
           NYLH       +++D+   NVLLDS+   K+ ++ M     RP +        T    GT
Sbjct: 120 NYLHERGI---IYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD-------TTSXFCGT 169
Query: 509 KGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENN--MHLSDVLNAVLTK 566
             Y+APE L        +D +A GVL+ EM+ G+    +    +N   +  D L  V+ +
Sbjct: 170 PNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE 229
Query: 567 EDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDR 608
           +              Q   P  L++    ++ + L KDP +R
Sbjct: 230 K--------------QIRIPRSLSVKAASVLKSFLNKDPKER 257

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 72/294 (24%), Positives = 129/294 (43%), Gaps = 48/294 (16%)
Query: 361 GSVYRGKINGGFAAIKKVNGDVSK----EIALLNKI--NHSNLI--ILSGVCFNEGNC-- 410
           G V+RG   G   A+K  +    K    E  L N +   H N++  I S +     +   
Sbjct: 22  GEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL 81
Query: 411 YLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLH-----SFTNPPHVH 465
           +L+  Y   G+L D++     +   LD    ++I L +A+GL +LH     +   P   H
Sbjct: 82  WLITHYHEMGSLYDYL-----QLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAH 136
Query: 466 KDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRH-IVGTKGYMAPEYLENGLVS- 523
           +D+ S N+L+  + +  IA+  +A        +  +  +  VGTK YMAPE L+  +   
Sbjct: 137 RDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVD 196
Query: 524 -----TKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESL----- 573
                 ++D++AFG+++ E+     +  +  E+      DV+    + ED  + +     
Sbjct: 197 CFDSYKRVDIWAFGLVLWEVARRMVSNGI-VEDYKPPFYDVVPNDPSFEDMRKVVCVDQQ 255
Query: 574 ------RHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNI 621
                 R F DPTL           + +L+  C  ++P+ R T   I+ +L+ I
Sbjct: 256 RPNIPNRWFSDPTLTS---------LAKLMKECWYQNPSARLTALRIKKTLTKI 300

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 46/161 (28%), Positives = 81/161 (50%), Gaps = 12/161 (7%)
Query: 383 SKEIALLNKINHSNLIILSGVCFNEG--NCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQ 440
            +EI +L  + H +++   G C ++G  +  LV EY   G+L D++  +      +   Q
Sbjct: 58  QREIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRH-----CVGLAQ 112
Query: 441 RIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPA-EGQEGEF 499
            +  A  +  G+ YLH+     ++H+ + + NVLLD+D   KI +F +A+   EG E  +
Sbjct: 113 LLLFAQQICEGMAYLHA---QHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHE-YY 168
Query: 500 ALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT 540
            +         + APE L+        DV++FGV + E+LT
Sbjct: 169 RVREDGDSPVFWYAPECLKECKFYYASDVWSFGVTLYELLT 209

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 72/294 (24%), Positives = 129/294 (43%), Gaps = 48/294 (16%)
Query: 361 GSVYRGKINGGFAAIKKVNGDVSK----EIALLNKI--NHSNLI--ILSGVCFNEGNC-- 410
           G V+RG   G   A+K  +    K    E  L N +   H N++  I S +     +   
Sbjct: 22  GEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL 81
Query: 411 YLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLH-----SFTNPPHVH 465
           +L+  Y   G+L D++     +   LD    ++I L +A+GL +LH     +   P   H
Sbjct: 82  WLITHYHEMGSLYDYL-----QLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAH 136
Query: 466 KDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRH-IVGTKGYMAPEYLENGLVS- 523
           +D+ S N+L+  + +  IA+  +A        +  +  +  VGTK YMAPE L+  +   
Sbjct: 137 RDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVD 196
Query: 524 -----TKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESL----- 573
                 ++D++AFG+++ E+     +  +  E+      DV+    + ED  + +     
Sbjct: 197 CFDSYKRVDIWAFGLVLWEVARRMVSNGI-VEDYKPPFYDVVPNDPSFEDMRKVVCVDQQ 255
Query: 574 ------RHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNI 621
                 R F DPTL           + +L+  C  ++P+ R T   I+ +L+ I
Sbjct: 256 RPNIPNRWFSDPTLTS---------LAKLMKECWYQNPSARLTALRIKKTLTKI 300

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 82/162 (50%), Gaps = 18/162 (11%)
Query: 384 KEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQ 443
           +E+ ++  +NH N++ L  V   E   YLV EYA  G + D++ ++   G+  + + R +
Sbjct: 63  REVRIMKILNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAH---GRMKEKEARAK 119
Query: 444 IALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTR 503
               + + + Y H       VH+D+ + N+LLD D+  KIA+F  +        EF +  
Sbjct: 120 FR-QIVSAVQYCHQ---KYIVHRDLKAENLLLDGDMNIKIADFGFS-------NEFTVGN 168
Query: 504 HI---VGTKGYMAPEYLENGLVS-TKLDVYAFGVLILEMLTG 541
            +    G+  Y APE  +       ++DV++ GV++  +++G
Sbjct: 169 KLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSG 210

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/230 (22%), Positives = 107/230 (46%), Gaps = 29/230 (12%)
Query: 385 EIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQI 444
           E+ ++    H N++ +          +++ E+   G L+D V   +     L+ +Q   +
Sbjct: 92  EVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVR-----LNEEQIATV 146
Query: 445 ALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRH 504
              V   L YLH+      +H+DI S ++LL  D R K+++F           +    + 
Sbjct: 147 CEAVLQALAYLHAQGV---IHRDIKSDSILLTLDGRVKLSDFGFCAQISK---DVPKRKX 200
Query: 505 IVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVL 564
           +VGT  +MAPE +   L +T++D+++ G++++EM+ G+            + SD      
Sbjct: 201 LVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPP----------YFSD------ 244
Query: 565 TKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEI 614
           +     + LR    P L+ ++  +++ ++   ++  L +DP +R T  E+
Sbjct: 245 SPVQAMKRLRDSPPPKLKNSH--KVSPVLRDFLERMLVRDPQERATAQEL 292

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 38/132 (28%), Positives = 66/132 (50%), Gaps = 7/132 (5%)
Query: 411 YLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINS 470
           Y+V EY    TL D V +   EG  +  K+ I++  D    LN+ H       +H+D+  
Sbjct: 92  YIVMEYVDGVTLRDIVHT---EGP-MTPKRAIEVIADACQALNFSHQNGI---IHRDVKP 144
Query: 471 SNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYA 530
           +N+++ +    K+ +F +AR           T  ++GT  Y++PE      V  + DVY+
Sbjct: 145 ANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYS 204
Query: 531 FGVLILEMLTGK 542
            G ++ E+LTG+
Sbjct: 205 LGCVLYEVLTGE 216

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 38/132 (28%), Positives = 66/132 (50%), Gaps = 7/132 (5%)
Query: 411 YLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINS 470
           Y+V EY    TL D V +   EG  +  K+ I++  D    LN+ H       +H+D+  
Sbjct: 92  YIVMEYVDGVTLRDIVHT---EGP-MTPKRAIEVIADACQALNFSHQNGI---IHRDVKP 144
Query: 471 SNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYA 530
           +N+++ +    K+ +F +AR           T  ++GT  Y++PE      V  + DVY+
Sbjct: 145 ANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYS 204
Query: 531 FGVLILEMLTGK 542
            G ++ E+LTG+
Sbjct: 205 LGCVLYEVLTGE 216

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 38/132 (28%), Positives = 66/132 (50%), Gaps = 7/132 (5%)
Query: 411 YLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINS 470
           Y+V EY    TL D V +   EG  +  K+ I++  D    LN+ H       +H+D+  
Sbjct: 92  YIVMEYVDGVTLRDIVHT---EGP-MTPKRAIEVIADACQALNFSHQNGI---IHRDVKP 144
Query: 471 SNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYA 530
           +N+++ +    K+ +F +AR           T  ++GT  Y++PE      V  + DVY+
Sbjct: 145 ANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYS 204
Query: 531 FGVLILEMLTGK 542
            G ++ E+LTG+
Sbjct: 205 LGCVLYEVLTGE 216

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 38/132 (28%), Positives = 66/132 (50%), Gaps = 7/132 (5%)
Query: 411 YLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINS 470
           Y+V EY    TL D V +   EG  +  K+ I++  D    LN+ H       +H+D+  
Sbjct: 92  YIVMEYVDGVTLRDIVHT---EGP-MTPKRAIEVIADACQALNFSHQNGI---IHRDVKP 144
Query: 471 SNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYA 530
           +N+++ +    K+ +F +AR           T  ++GT  Y++PE      V  + DVY+
Sbjct: 145 ANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYS 204
Query: 531 FGVLILEMLTGK 542
            G ++ E+LTG+
Sbjct: 205 LGCVLYEVLTGE 216

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 42/162 (25%), Positives = 83/162 (51%), Gaps = 18/162 (11%)
Query: 384 KEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQ 443
           +E+ ++  +NH N++ L  V   E   YL+ EYA  G + D++ ++   G+  + + R +
Sbjct: 60  REVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAH---GRMKEKEARSK 116
Query: 444 IALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTR 503
               + + + Y H       VH+D+ + N+LLD+D+  KIA+F  +        EF +  
Sbjct: 117 FR-QIVSAVQYCH---QKRIVHRDLKAENLLLDADMNIKIADFGFS-------NEFTVGG 165
Query: 504 HI---VGTKGYMAPEYLENGLVS-TKLDVYAFGVLILEMLTG 541
            +    G+  Y APE  +       ++DV++ GV++  +++G
Sbjct: 166 KLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSG 207

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/231 (26%), Positives = 102/231 (44%), Gaps = 27/231 (11%)
Query: 381 DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQ 440
           D  +E+  ++ ++H NLI L GV        +V E A  G+L D +   K++G +L    
Sbjct: 67  DFIREVNAMHSLDHRNLIRLYGVVLTP-PMKMVTELAPLGSLLDRL--RKHQGHFL-LGT 122
Query: 441 RIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFA 500
             + A+ VA G+ YL S      +H+D+ + N+LL +    KI +F + R     +    
Sbjct: 123 LSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXV 179
Query: 501 LTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT-GKEAAALHAEENNMHLSDV 559
           +  H      + APE L+    S   D + FGV + EM T G+E          ++ S +
Sbjct: 180 MQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWI------GLNGSQI 233
Query: 560 LNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPT 610
           L+ +   ++GE   R           P +    +  ++  C    P DRPT
Sbjct: 234 LHKI--DKEGERLPR-----------PEDCPQDIYNVMVQCWAHKPEDRPT 271

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 96/222 (43%), Gaps = 34/222 (15%)
Query: 393 NHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGL 452
           NH  L+ L      E   + V EY VNG   D +F  + + K  +   R   A +++  L
Sbjct: 79  NHPFLVGLHSCFQTESRLFFVIEY-VNG--GDLMFHMQRQRKLPEEHARFYSA-EISLAL 134
Query: 453 NYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMA----RPAEGQEGEFALTRHIVGT 508
           NYLH       +++D+   NVLLDS+   K+ ++ M     RP +        T    GT
Sbjct: 135 NYLHERGI---IYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD-------TTSXFCGT 184
Query: 509 KGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENN--MHLSDVLNAVLTK 566
             Y+APE L        +D +A GVL+ EM+ G+    +    +N   +  D L  V+ +
Sbjct: 185 PNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE 244
Query: 567 EDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDR 608
           +              Q   P  +++    ++ + L KDP +R
Sbjct: 245 K--------------QIRIPRSMSVKAASVLKSFLNKDPKER 272

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 66/281 (23%), Positives = 118/281 (41%), Gaps = 42/281 (14%)
Query: 363 VYRGK--INGGFAAIKKV----------NGDVSKEIALLNKINHSNLIILSGVCFNEGNC 410
           VYR    ++G   A+KKV            D  KEI LL ++NH N+I        +   
Sbjct: 48  VYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNEL 107
Query: 411 YLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINS 470
            +V E A  G LS  +   K + + +  +   +  + + + L ++HS      +H+DI  
Sbjct: 108 NIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRV---MHRDIKP 164
Query: 471 SNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYA 530
           +NV + +    K+ +  + R    +         +VGT  YM+PE +     + K D+++
Sbjct: 165 ANVFITATGVVKLGDLGLGRFFSSKT---TAAHSLVGTPYYMSPERIHENGYNFKSDIWS 221
Query: 531 FGVLILEMLTGKEAAALHAE--ENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLE 588
            G L+ EM      AAL +    + M+L  +   +   +           P    +Y  E
Sbjct: 222 LGCLLYEM------AALQSPFYGDKMNLYSLCKKIEQCD---------YPPLPSDHYSEE 266
Query: 589 LALLVIRLIDACLKKDPTDRPT---MYEIEHSLSNILNASL 626
           L     +L++ C+  DP  RP    +Y++   +     +SL
Sbjct: 267 LR----QLVNMCINPDPEKRPDVTYVYDVAKRMHACTASSL 303

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 48/167 (28%), Positives = 83/167 (49%), Gaps = 14/167 (8%)
Query: 377 KVNGDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKN---EG 433
           K N +   E  ++  ++H +L+ L GVC +     LV +   +G L ++V  +K+     
Sbjct: 82  KANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQLVTQLMPHGCLLEYVHEHKDNIGSQ 140
Query: 434 KYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAE 493
             L+W       + +A G+ YL        VH+D+ + NVL+ S    KI +F +AR  E
Sbjct: 141 LLLNW------CVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLE 191
Query: 494 GQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT 540
           G E E+      +  K +MA E +     + + DV+++GV I E++T
Sbjct: 192 GDEKEYNADGGKMPIK-WMALECIHYRKFTHQSDVWSYGVTIWELMT 237

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 38/132 (28%), Positives = 66/132 (50%), Gaps = 7/132 (5%)
Query: 411 YLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINS 470
           Y+V EY    TL D V +   EG  +  K+ I++  D    LN+ H       +H+D+  
Sbjct: 109 YIVMEYVDGVTLRDIVHT---EGP-MTPKRAIEVIADACQALNFSHQNGI---IHRDVKP 161
Query: 471 SNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYA 530
           +N+++ +    K+ +F +AR           T  ++GT  Y++PE      V  + DVY+
Sbjct: 162 ANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYS 221
Query: 531 FGVLILEMLTGK 542
            G ++ E+LTG+
Sbjct: 222 LGCVLYEVLTGE 233

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/231 (26%), Positives = 102/231 (44%), Gaps = 27/231 (11%)
Query: 381 DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQ 440
           D  +E+  ++ ++H NLI L GV        +V E A  G+L D +   K++G +L    
Sbjct: 57  DFIREVNAMHSLDHRNLIRLYGVVLTP-PMKMVTELAPLGSLLDRL--RKHQGHFL-LGT 112
Query: 441 RIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFA 500
             + A+ VA G+ YL S      +H+D+ + N+LL +    KI +F + R     +    
Sbjct: 113 LSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXV 169
Query: 501 LTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT-GKEAAALHAEENNMHLSDV 559
           +  H      + APE L+    S   D + FGV + EM T G+E          ++ S +
Sbjct: 170 MQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWI------GLNGSQI 223
Query: 560 LNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPT 610
           L+ +   ++GE   R           P +    +  ++  C    P DRPT
Sbjct: 224 LHKI--DKEGERLPR-----------PEDCPQDIYNVMVQCWAHKPEDRPT 261

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 77/311 (24%), Positives = 132/311 (42%), Gaps = 58/311 (18%)
Query: 340 VYSFKELQSATDNFSFTCRI-QGS---VYRGKINGGF-------AAIKKVNGDVS----- 383
           VY   E + A +  + +  + QGS   VY G   G          AIK VN   S     
Sbjct: 14  VYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI 73
Query: 384 ---KEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFS------NKNEGK 434
               E +++ + N  +++ L GV        ++ E    G L  ++ S      N     
Sbjct: 74  EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLA 133
Query: 435 YLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEG 494
                + IQ+A ++A G+ YL++      VH+D+ + N ++  D   KI +F M R    
Sbjct: 134 PPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDI-- 188
Query: 495 QEGEFALTRHIVGTKG-----YMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHA 549
               +    +  G KG     +M+PE L++G+ +T  DV++FGV++ E+ T        A
Sbjct: 189 ----YETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT-------LA 237
Query: 550 EENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRP 609
           E+    LS+           E+ LR  ++  L  + P     ++  L+  C + +P  RP
Sbjct: 238 EQPYQGLSN-----------EQVLRFVMEGGLL-DKPDNCPDMLFELMRMCWQYNPKMRP 285
Query: 610 TMYEIEHSLSN 620
           +  EI  S+  
Sbjct: 286 SFLEIISSIKE 296

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 82/162 (50%), Gaps = 18/162 (11%)
Query: 384 KEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQ 443
           +E+ ++  +NH N++ L  V   E   YL+ EYA  G + D++ ++   G+  + + R +
Sbjct: 63  REVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAH---GRMKEKEARSK 119
Query: 444 IALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTR 503
               + + + Y H       VH+D+ + N+LLD+D+  KIA+F       G   EF +  
Sbjct: 120 FR-QIVSAVQYCH---QKRIVHRDLKAENLLLDADMNIKIADF-------GFSNEFTVGG 168
Query: 504 HI---VGTKGYMAPEYLENGLVS-TKLDVYAFGVLILEMLTG 541
            +    G   Y APE  +       ++DV++ GV++  +++G
Sbjct: 169 KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSG 210

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 47/161 (29%), Positives = 81/161 (50%), Gaps = 15/161 (9%)
Query: 384 KEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQ 443
           +E+ LL +++H N++ L     ++G  YLV E    G L D + S K   +        +
Sbjct: 81  REVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEV----DAAR 136
Query: 444 IALDVATGLNYLHSFTNPPHVHKDINSSNVLLDS---DLRAKIANFAMARPAEGQEGEFA 500
           I   V +G+ Y+H       VH+D+   N+LL+S   D   +I +F ++   E  +    
Sbjct: 137 IIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK--- 190
Query: 501 LTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTG 541
             +  +GT  Y+APE L +G    K DV++ GV++  +L+G
Sbjct: 191 -MKDKIGTAYYIAPEVL-HGTYDEKCDVWSTGVILYILLSG 229

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 70/257 (27%), Positives = 109/257 (42%), Gaps = 45/257 (17%)
Query: 375 IKKVNGDVSK--------EIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWV 426
           IK +N D S+        EI +L  ++H N+I +  V  +  N Y+V E    G L + +
Sbjct: 52  IKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERI 111
Query: 427 FSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPH-VHKDINSSNVLL-DSDLRA--K 482
            S +  GK L      ++   +   L Y HS     H VHKD+   N+L  D+   +  K
Sbjct: 112 VSAQARGKALSEGYVAELMKQMMNALAYFHS----QHVVHKDLKPENILFQDTSPHSPIK 167
Query: 483 IANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGK 542
           I +F +A   +  E     + +  GT  YMAPE  +   V+ K D+++ GV++  +LTG 
Sbjct: 168 IIDFGLAELFKSDEH----STNAAGTALYMAPEVFKRD-VTFKCDIWSAGVVMYFLLTGC 222
Query: 543 EAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLE---LALLVIRLIDA 599
                        L +V      KE                NY +E   L    + L+  
Sbjct: 223 LPF------TGTSLEEVQQKATYKEP---------------NYAVECRPLTPQAVDLLKQ 261
Query: 600 CLKKDPTDRPTMYEIEH 616
            L KDP  RP+  ++ H
Sbjct: 262 MLTKDPERRPSAAQVLH 278

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 48/167 (28%), Positives = 83/167 (49%), Gaps = 14/167 (8%)
Query: 377 KVNGDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKN---EG 433
           K N +   E  ++  ++H +L+ L GVC +     LV +   +G L ++V  +K+     
Sbjct: 59  KANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQLVTQLMPHGCLLEYVHEHKDNIGSQ 117
Query: 434 KYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAE 493
             L+W       + +A G+ YL        VH+D+ + NVL+ S    KI +F +AR  E
Sbjct: 118 LLLNW------CVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLE 168
Query: 494 GQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT 540
           G E E+      +  K +MA E +     + + DV+++GV I E++T
Sbjct: 169 GDEKEYNADGGKMPIK-WMALECIHYRKFTHQSDVWSYGVTIWELMT 214

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 77/311 (24%), Positives = 132/311 (42%), Gaps = 58/311 (18%)
Query: 340 VYSFKELQSATDNFSFTCRI-QGS---VYRGKINGGF-------AAIKKVNGDVS----- 383
           VY   E + A +  + +  + QGS   VY G   G          AIK VN   S     
Sbjct: 4   VYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI 63
Query: 384 ---KEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFS------NKNEGK 434
               E +++ + N  +++ L GV        ++ E    G L  ++ S      N     
Sbjct: 64  EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLA 123
Query: 435 YLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEG 494
                + IQ+A ++A G+ YL++      VH+D+ + N ++  D   KI +F M R    
Sbjct: 124 PPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDI-- 178
Query: 495 QEGEFALTRHIVGTKG-----YMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHA 549
               +    +  G KG     +M+PE L++G+ +T  DV++FGV++ E+ T        A
Sbjct: 179 ----YETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT-------LA 227
Query: 550 EENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRP 609
           E+    LS+           E+ LR  ++  L  + P     ++  L+  C + +P  RP
Sbjct: 228 EQPYQGLSN-----------EQVLRFVMEGGLL-DKPDNCPDMLFELMRMCWQYNPKMRP 275
Query: 610 TMYEIEHSLSN 620
           +  EI  S+  
Sbjct: 276 SFLEIISSIKE 286

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 68/275 (24%), Positives = 121/275 (44%), Gaps = 53/275 (19%)
Query: 374 AIKKVNGDVS--------KEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDW 425
           A+K VN   S         E +++      +++ L GV        +V E   +G L  +
Sbjct: 52  AVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSY 111
Query: 426 VFSNKNEGKY------LDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDL 479
           + S + E +          ++ IQ+A ++A G+ YL++      VH+++ + N ++  D 
Sbjct: 112 LRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA---KKFVHRNLAARNCMVAHDF 168
Query: 480 RAKIANFAMARPAEGQEGEFALTRHIVGTKG-----YMAPEYLENGLVSTKLDVYAFGVL 534
             KI +F M R        +    +  G KG     +MAPE L++G+ +T  D+++FGV+
Sbjct: 169 TVKIGDFGMTRDI------YETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVV 222
Query: 535 ILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNY---PLELAL 591
           + E+ +        AE+    LS+           E+ L+  +D    G Y   P     
Sbjct: 223 LWEITS-------LAEQPYQGLSN-----------EQVLKFVMD----GGYLDQPDNCPE 260
Query: 592 LVIRLIDACLKKDPTDRPTMYEIEHSLSNILNASL 626
            V  L+  C + +P  RPT  EI + L + L+ S 
Sbjct: 261 RVTDLMRMCWQFNPNMRPTFLEIVNLLKDDLHPSF 295

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 47/161 (29%), Positives = 81/161 (50%), Gaps = 15/161 (9%)
Query: 384 KEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQ 443
           +E+ LL +++H N++ L     ++G  YLV E    G L D + S K   +        +
Sbjct: 75  REVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEV----DAAR 130
Query: 444 IALDVATGLNYLHSFTNPPHVHKDINSSNVLLDS---DLRAKIANFAMARPAEGQEGEFA 500
           I   V +G+ Y+H       VH+D+   N+LL+S   D   +I +F ++   E  +    
Sbjct: 131 IIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK--- 184
Query: 501 LTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTG 541
             +  +GT  Y+APE L +G    K DV++ GV++  +L+G
Sbjct: 185 -MKDKIGTAYYIAPEVL-HGTYDEKCDVWSTGVILYILLSG 223

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 50/147 (34%), Positives = 75/147 (51%), Gaps = 10/147 (6%)
Query: 409 NCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDI 468
           N + V EY +NG   D ++  ++  K+ D  +    A ++  GL +LHS      V++D+
Sbjct: 93  NLFFVMEY-LNG--GDLMYHIQSCHKF-DLSRATFYAAEIILGLQFLHS---KGIVYRDL 145
Query: 469 NSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDV 528
              N+LLD D   KIA+F M +  E   G+ A T    GT  Y+APE L     +  +D 
Sbjct: 146 KLDNILLDKDGHIKIADFGMCK--ENMLGD-AKTNEFCGTPDYIAPEILLGQKYNHSVDW 202
Query: 529 YAFGVLILEMLTGKEAAALHAEENNMH 555
           ++FGVL+ EML G+       EE   H
Sbjct: 203 WSFGVLLYEMLIGQSPFHGQDEEELFH 229

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 68/275 (24%), Positives = 121/275 (44%), Gaps = 53/275 (19%)
Query: 374 AIKKVNGDVS--------KEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDW 425
           A+K VN   S         E +++      +++ L GV        +V E   +G L  +
Sbjct: 51  AVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSY 110
Query: 426 VFSNKNEGKY------LDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDL 479
           + S + E +          ++ IQ+A ++A G+ YL++      VH+++ + N ++  D 
Sbjct: 111 LRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA---KKFVHRNLAARNCMVAHDF 167
Query: 480 RAKIANFAMARPAEGQEGEFALTRHIVGTKG-----YMAPEYLENGLVSTKLDVYAFGVL 534
             KI +F M R        +    +  G KG     +MAPE L++G+ +T  D+++FGV+
Sbjct: 168 TVKIGDFGMTRDI------YETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVV 221
Query: 535 ILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNY---PLELAL 591
           + E+ +        AE+    LS+           E+ L+  +D    G Y   P     
Sbjct: 222 LWEITS-------LAEQPYQGLSN-----------EQVLKFVMD----GGYLDQPDNCPE 259
Query: 592 LVIRLIDACLKKDPTDRPTMYEIEHSLSNILNASL 626
            V  L+  C + +P  RPT  EI + L + L+ S 
Sbjct: 260 RVTDLMRMCWQFNPNMRPTFLEIVNLLKDDLHPSF 294

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/229 (23%), Positives = 100/229 (43%), Gaps = 41/229 (17%)
Query: 385 EIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTL-----SDWVFSNKNEGKYLDWK 439
           E  +L ++NH  ++ L      EG  YL+ ++   G L      + +F+ ++   YL   
Sbjct: 76  ERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYL--- 132
Query: 440 QRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEF 499
                  ++A  L++LHS      +++D+   N+LLD +   K+ +F +++ +   E + 
Sbjct: 133 ------AELALALDHLHSLGI---IYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK- 182
Query: 500 ALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDV 559
                  GT  YMAPE +     +   D ++FGVL+ EMLTG        ++    ++ +
Sbjct: 183 --AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG--TLPFQGKDRKETMTMI 238
Query: 560 LNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDR 608
           L A L        +  F+ P  Q             L+    K++P +R
Sbjct: 239 LKAKL-------GMPQFLSPEAQS------------LLRMLFKRNPANR 268

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 47/161 (29%), Positives = 81/161 (50%), Gaps = 15/161 (9%)
Query: 384 KEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQ 443
           +E+ LL +++H N++ L     ++G  YLV E    G L D + S K   +        +
Sbjct: 98  REVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEV----DAAR 153
Query: 444 IALDVATGLNYLHSFTNPPHVHKDINSSNVLLDS---DLRAKIANFAMARPAEGQEGEFA 500
           I   V +G+ Y+H       VH+D+   N+LL+S   D   +I +F ++   E  +    
Sbjct: 154 IIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK--- 207
Query: 501 LTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTG 541
             +  +GT  Y+APE L +G    K DV++ GV++  +L+G
Sbjct: 208 -MKDKIGTAYYIAPEVL-HGTYDEKCDVWSTGVILYILLSG 246

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 47/161 (29%), Positives = 81/161 (50%), Gaps = 15/161 (9%)
Query: 384 KEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQ 443
           +E+ LL +++H N++ L     ++G  YLV E    G L D + S K   +        +
Sbjct: 99  REVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEV----DAAR 154
Query: 444 IALDVATGLNYLHSFTNPPHVHKDINSSNVLLDS---DLRAKIANFAMARPAEGQEGEFA 500
           I   V +G+ Y+H       VH+D+   N+LL+S   D   +I +F ++   E  +    
Sbjct: 155 IIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK--- 208
Query: 501 LTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTG 541
             +  +GT  Y+APE L +G    K DV++ GV++  +L+G
Sbjct: 209 -MKDKIGTAYYIAPEVL-HGTYDEKCDVWSTGVILYILLSG 247

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 71/239 (29%), Positives = 106/239 (44%), Gaps = 43/239 (17%)
Query: 351 DNFSFTCRIQGSVYRGKI-------NGGFAAIKKVNGDV------------SKEIALLNK 391
           DNF F  R+ G    GK+        G   A+K +  DV             K I  L +
Sbjct: 23  DNFEFI-RVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLAR 81
Query: 392 INHSNLIILSGVCFNEGN-CYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVAT 450
            NH  L  L   CF   +  + V E+ VNG   D +F  +   ++ + + R   A ++ +
Sbjct: 82  -NHPFLTQLF-CCFQTPDRLFFVMEF-VNG--GDLMFHIQKSRRFDEARARF-YAAEIIS 135
Query: 451 GLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEG--EFALTRHIVGT 508
            L +LH   +   +++D+   NVLLD +   K+A+F M +     EG      T    GT
Sbjct: 136 ALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCK-----EGICNGVTTATFCGT 187
Query: 509 KGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKE 567
             Y+APE L+  L    +D +A GVL+ EML G   A   AE  +    D+  A+L  E
Sbjct: 188 PDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGH--APFEAENED----DLFEAILNDE 240

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 50/147 (34%), Positives = 75/147 (51%), Gaps = 10/147 (6%)
Query: 409 NCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDI 468
           N + V EY +NG   D ++  ++  K+ D  +    A ++  GL +LHS      V++D+
Sbjct: 92  NLFFVMEY-LNG--GDLMYHIQSCHKF-DLSRATFYAAEIILGLQFLHS---KGIVYRDL 144
Query: 469 NSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDV 528
              N+LLD D   KIA+F M +  E   G+ A T    GT  Y+APE L     +  +D 
Sbjct: 145 KLDNILLDKDGHIKIADFGMCK--ENMLGD-AKTNXFCGTPDYIAPEILLGQKYNHSVDW 201
Query: 529 YAFGVLILEMLTGKEAAALHAEENNMH 555
           ++FGVL+ EML G+       EE   H
Sbjct: 202 WSFGVLLYEMLIGQSPFHGQDEEELFH 228

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 70/290 (24%), Positives = 127/290 (43%), Gaps = 40/290 (13%)
Query: 361 GSVYRGKINGGFAAIKKVNGDVSK------EIALLNKINHSNLI-ILSGVCFNEG---NC 410
           G V+RGK  G   A+K  +    +      EI     + H N++  ++    + G     
Sbjct: 43  GEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL 102
Query: 411 YLVYEYAVNGTLSDWV--FSNKNEGKYLDWKQRIQIALDVATGLNYLH-----SFTNPPH 463
           +LV +Y  +G+L D++  ++   EG        I++AL  A+GL +LH     +   P  
Sbjct: 103 WLVSDYHEHGSLFDYLNRYTVTVEGM-------IKLALSTASGLAHLHMEIVGTQGKPAI 155
Query: 464 VHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALT-RHIVGTKGYMAPEYLENGL- 521
            H+D+ S N+L+  +    IA+  +A   +       +   H VGTK YMAPE L++ + 
Sbjct: 156 AHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSIN 215
Query: 522 -----VSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHF 576
                   + D+YA G++  E+        +H E+  +   D+   V +    EE  +  
Sbjct: 216 MKHFESFKRADIYAMGLVFWEIARRCSIGGIH-EDYQLPYYDL---VPSDPSVEEMRKVV 271
Query: 577 IDPTLQGNYP-----LELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNI 621
            +  L+ N P      E   ++ +++  C   +   R T   I+ +LS +
Sbjct: 272 CEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 321

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 44/163 (26%), Positives = 81/163 (49%), Gaps = 20/163 (12%)
Query: 384 KEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQ 443
           +E+ ++  +NH N++ L  V   E   YLV EYA  G + D++ ++     ++  K+   
Sbjct: 55  REVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAH----GWMKEKEARA 110
Query: 444 IALDVATGLNYLH-SFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALT 502
               + + + Y H  F     VH+D+ + N+LLD+D+  KIA+F       G   EF   
Sbjct: 111 KFRQIVSAVQYCHQKFI----VHRDLKAENLLLDADMNIKIADF-------GFSNEFTFG 159
Query: 503 RHI---VGTKGYMAPEYLENGLVS-TKLDVYAFGVLILEMLTG 541
             +    G+  Y APE  +       ++DV++ GV++  +++G
Sbjct: 160 NKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSG 202

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 70/290 (24%), Positives = 127/290 (43%), Gaps = 40/290 (13%)
Query: 361 GSVYRGKINGGFAAIKKVNGDVSK------EIALLNKINHSNLI-ILSGVCFNEG---NC 410
           G V+RGK  G   A+K  +    +      EI     + H N++  ++    + G     
Sbjct: 56  GEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL 115
Query: 411 YLVYEYAVNGTLSDWV--FSNKNEGKYLDWKQRIQIALDVATGLNYLH-----SFTNPPH 463
           +LV +Y  +G+L D++  ++   EG        I++AL  A+GL +LH     +   P  
Sbjct: 116 WLVSDYHEHGSLFDYLNRYTVTVEGM-------IKLALSTASGLAHLHMEIVGTQGKPAI 168
Query: 464 VHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALT-RHIVGTKGYMAPEYLENGL- 521
            H+D+ S N+L+  +    IA+  +A   +       +   H VGTK YMAPE L++ + 
Sbjct: 169 AHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSIN 228
Query: 522 -----VSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHF 576
                   + D+YA G++  E+        +H E+  +   D+   V +    EE  +  
Sbjct: 229 MKHFESFKRADIYAMGLVFWEIARRCSIGGIH-EDYQLPYYDL---VPSDPSVEEMRKVV 284
Query: 577 IDPTLQGNYP-----LELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNI 621
            +  L+ N P      E   ++ +++  C   +   R T   I+ +LS +
Sbjct: 285 CEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 334

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 95/200 (47%), Gaps = 35/200 (17%)
Query: 361 GSVYRGK-INGGFAAIKKVNGDVS---------KEIALLNKINHSNLIILSGVCFNEGNC 410
           G VY+ K   G   A+K++  D           +EI+LL +++H N++ L  V  +E   
Sbjct: 35  GVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCL 94
Query: 411 YLVYEYAVNGTLSDWVFSNKNEGKYLDWKQ------RIQIAL-DVATGLNYLHSFTNPPH 463
            LV+E           F  K+  K LD  +      +I+I L  +  G+ + H       
Sbjct: 95  TLVFE-----------FMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRI--- 140
Query: 464 VHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLE-NGLV 522
           +H+D+   N+L++SD   K+A+F +AR        +    H V T  Y AP+ L  +   
Sbjct: 141 LHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYT---HEVVTLWYRAPDVLMGSKKY 197
Query: 523 STKLDVYAFGVLILEMLTGK 542
           ST +D+++ G +  EM+TGK
Sbjct: 198 STSVDIWSIGCIFAEMITGK 217

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 67/245 (27%), Positives = 109/245 (44%), Gaps = 38/245 (15%)
Query: 384 KEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQ 443
           +E   + + +H +++ L GV   E   +++ E    G L  ++   K     LD    I 
Sbjct: 88  QEALTMRQFDHPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKYS---LDLASLIL 143
Query: 444 IALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTR 503
            A  ++T L YL S      VH+DI + NVL+ S+   K+ +F ++R  E        + 
Sbjct: 144 YAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED-------ST 193
Query: 504 HIVGTKG-----YMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSD 558
           +   +KG     +MAPE +     ++  DV+ FGV + E+L           +NN    D
Sbjct: 194 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILM-HGVKPFQGVKNN----D 248
Query: 559 VLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSL 618
           V+  +   E+GE   R  + P    N P  L  L+ +    C   DP+ RP   E++  L
Sbjct: 249 VIGRI---ENGE---RLPMPP----NCPPTLYSLMTK----CWAYDPSRRPRFTELKAQL 294
Query: 619 SNILN 623
           S IL 
Sbjct: 295 STILE 299

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 67/245 (27%), Positives = 109/245 (44%), Gaps = 38/245 (15%)
Query: 384 KEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQ 443
           +E   + + +H +++ L GV   E   +++ E    G L  ++   K     LD    I 
Sbjct: 65  QEALTMRQFDHPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKYS---LDLASLIL 120
Query: 444 IALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTR 503
            A  ++T L YL S      VH+DI + NVL+ S+   K+ +F ++R  E        + 
Sbjct: 121 YAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED-------ST 170
Query: 504 HIVGTKG-----YMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSD 558
           +   +KG     +MAPE +     ++  DV+ FGV + E+L           +NN    D
Sbjct: 171 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILM-HGVKPFQGVKNN----D 225
Query: 559 VLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSL 618
           V+  +   E+GE   R  + P    N P  L  L+ +    C   DP+ RP   E++  L
Sbjct: 226 VIGRI---ENGE---RLPMPP----NCPPTLYSLMTK----CWAYDPSRRPRFTELKAQL 271
Query: 619 SNILN 623
           S IL 
Sbjct: 272 STILE 276

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 63/253 (24%), Positives = 108/253 (42%), Gaps = 32/253 (12%)
Query: 363 VYRGKINGGFAAIKKVNGD-VSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGT 421
           V+ GKI      +K    + +S EI++   + H +++   G   +    ++V E     +
Sbjct: 48  VFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRS 107
Query: 422 LSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRA 481
           L +    +K      + + R  +   +  G  YLH       +H+D+   N+ L+ DL  
Sbjct: 108 LLEL---HKRRKALTEPEARYYLR-QIVLGCQYLHRNRV---IHRDLKLGNLFLNEDLEV 160
Query: 482 KIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTG 541
           KI +F +A   E  +GE   T  + GT  Y+APE L     S ++DV++ G ++  +L G
Sbjct: 161 KIGDFGLATKVE-YDGERKKT--LCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVG 217
Query: 542 KEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACL 601
           K              S +    L  +  E S+   I+P            +   LI   L
Sbjct: 218 KPP---------FETSCLKETYLRIKKNEYSIPKHINP------------VAASLIQKML 256
Query: 602 KKDPTDRPTMYEI 614
           + DPT RPT+ E+
Sbjct: 257 QTDPTARPTINEL 269

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 95/200 (47%), Gaps = 35/200 (17%)
Query: 361 GSVYRGK-INGGFAAIKKVNGDVS---------KEIALLNKINHSNLIILSGVCFNEGNC 410
           G VY+ K   G   A+K++  D           +EI+LL +++H N++ L  V  +E   
Sbjct: 35  GVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCL 94
Query: 411 YLVYEYAVNGTLSDWVFSNKNEGKYLDWKQ------RIQIAL-DVATGLNYLHSFTNPPH 463
            LV+E           F  K+  K LD  +      +I+I L  +  G+ + H       
Sbjct: 95  TLVFE-----------FMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRI--- 140
Query: 464 VHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLE-NGLV 522
           +H+D+   N+L++SD   K+A+F +AR        +    H V T  Y AP+ L  +   
Sbjct: 141 LHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYT---HEVVTLWYRAPDVLMGSKKY 197
Query: 523 STKLDVYAFGVLILEMLTGK 542
           ST +D+++ G +  EM+TGK
Sbjct: 198 STSVDIWSIGCIFAEMITGK 217

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 70/290 (24%), Positives = 127/290 (43%), Gaps = 40/290 (13%)
Query: 361 GSVYRGKINGGFAAIKKVNGDVSK------EIALLNKINHSNLI-ILSGVCFNEG---NC 410
           G V+RGK  G   A+K  +    +      EI     + H N++  ++    + G     
Sbjct: 18  GEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL 77
Query: 411 YLVYEYAVNGTLSDWV--FSNKNEGKYLDWKQRIQIALDVATGLNYLH-----SFTNPPH 463
           +LV +Y  +G+L D++  ++   EG        I++AL  A+GL +LH     +   P  
Sbjct: 78  WLVSDYHEHGSLFDYLNRYTVTVEGM-------IKLALSTASGLAHLHMEIVGTQGKPAI 130
Query: 464 VHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALT-RHIVGTKGYMAPEYLENGL- 521
            H+D+ S N+L+  +    IA+  +A   +       +   H VGTK YMAPE L++ + 
Sbjct: 131 AHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSIN 190
Query: 522 -----VSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHF 576
                   + D+YA G++  E+        +H E+  +   D+   V +    EE  +  
Sbjct: 191 MKHFESFKRADIYAMGLVFWEIARRCSIGGIH-EDYQLPYYDL---VPSDPSVEEMRKVV 246
Query: 577 IDPTLQGNYP-----LELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNI 621
            +  L+ N P      E   ++ +++  C   +   R T   I+ +LS +
Sbjct: 247 CEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 296

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 64/269 (23%), Positives = 112/269 (41%), Gaps = 45/269 (16%)
Query: 374 AIKKVNGDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNE- 432
           A   +  D  +E AL+ + ++ N++ L GVC       L++EY   G L++++ S     
Sbjct: 89  ASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHT 148
Query: 433 -------------------GKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNV 473
                                 L   +++ IA  VA G+ YL   +    VH+D+ + N 
Sbjct: 149 VCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYL---SERKFVHRDLATRNC 205
Query: 474 LLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGV 533
           L+  ++  KIA+F ++R     +   A     +  + +M PE +     +T+ DV+A+GV
Sbjct: 206 LVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIR-WMPPESIFYNRYTTESDVWAYGV 264
Query: 534 LILEMLT-GKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALL 592
           ++ E+ + G +     A E  ++     N +   E                N PLEL   
Sbjct: 265 VLWEIFSYGLQPYYGMAHEEVIYYVRDGNILACPE----------------NCPLEL--- 305
Query: 593 VIRLIDACLKKDPTDRPTMYEIEHSLSNI 621
              L+  C  K P DRP+   I   L  +
Sbjct: 306 -YNLMRLCWSKLPADRPSFCSIHRILQRM 333

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 63/254 (24%), Positives = 108/254 (42%), Gaps = 32/254 (12%)
Query: 362 SVYRGKINGGFAAIKKVNGD-VSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNG 420
            V+ GKI      +K    + +S EI++   + H +++   G   +    ++V E     
Sbjct: 43  EVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRR 102
Query: 421 TLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLR 480
           +L +    +K      + + R  +   +  G  YLH       +H+D+   N+ L+ DL 
Sbjct: 103 SLLEL---HKRRKALTEPEARYYLR-QIVLGCQYLHRNRV---IHRDLKLGNLFLNEDLE 155
Query: 481 AKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT 540
            KI +F +A   E  +GE   T  + GT  Y+APE L     S ++DV++ G ++  +L 
Sbjct: 156 VKIGDFGLATKVE-YDGERKKT--LCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLV 212
Query: 541 GKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDAC 600
           GK              S +    L  +  E S+   I+P            +   LI   
Sbjct: 213 GKPP---------FETSCLKETYLRIKKNEYSIPKHINP------------VAASLIQKM 251
Query: 601 LKKDPTDRPTMYEI 614
           L+ DPT RPT+ E+
Sbjct: 252 LQTDPTARPTINEL 265

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 41/160 (25%), Positives = 78/160 (48%), Gaps = 8/160 (5%)
Query: 382 VSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQR 441
           V++E  ++++++H   + L     ++   Y    YA NG L  ++   +  G + +   R
Sbjct: 79  VTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGCLLKYI---RKIGSFDETCTR 135
Query: 442 IQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFAL 501
              A ++ + L YLH       +H+D+   N+LL+ D+  +I +F  A+     E + A 
Sbjct: 136 FYTA-EIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAK-VLSPESKQAR 190
Query: 502 TRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTG 541
               VGT  Y++PE L     S   D++A G +I +++ G
Sbjct: 191 ANSFVGTAQYVSPELLTEKSASKSSDLWALGCIIYQLVAG 230

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 61/236 (25%), Positives = 105/236 (44%), Gaps = 38/236 (16%)
Query: 321 DEESQDFLESISGVAQSLKVYS-FKEL-QSATDNFSFTCRIQGSVYRGK--INGGFAAIK 376
           DEE  + L SI  V    K Y+ F+++ Q A+          G+VY       G   AI+
Sbjct: 2   DEEILEKLRSIVSVGDPKKKYTRFEKIGQGAS----------GTVYTAMDVATGQEVAIR 51
Query: 377 KVNGD-------VSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSN 429
           ++N         +  EI ++ +  + N++            ++V EY   G+L+D V   
Sbjct: 52  QMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET 111
Query: 430 KNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANF--- 486
                 +D  Q   +  +    L +LHS      +H+DI S N+LL  D   K+ +F   
Sbjct: 112 -----CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFC 163
Query: 487 AMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGK 542
           A   P + +  E      +VGT  +MAPE +       K+D+++ G++ +EM+ G+
Sbjct: 164 AQITPEQSKRSE------MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 63/254 (24%), Positives = 108/254 (42%), Gaps = 32/254 (12%)
Query: 362 SVYRGKINGGFAAIKKVNGD-VSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNG 420
            V+ GKI      +K    + +S EI++   + H +++   G   +    ++V E     
Sbjct: 43  EVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRR 102
Query: 421 TLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLR 480
           +L +    +K      + + R  +   +  G  YLH       +H+D+   N+ L+ DL 
Sbjct: 103 SLLEL---HKRRKALTEPEARYYLR-QIVLGCQYLHRNRV---IHRDLKLGNLFLNEDLE 155
Query: 481 AKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT 540
            KI +F +A   E  +GE   T  + GT  Y+APE L     S ++DV++ G ++  +L 
Sbjct: 156 VKIGDFGLATKVE-YDGERKKT--LCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLV 212
Query: 541 GKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDAC 600
           GK              S +    L  +  E S+   I+P            +   LI   
Sbjct: 213 GKPP---------FETSCLKETYLRIKKNEYSIPKHINP------------VAASLIQKM 251
Query: 601 LKKDPTDRPTMYEI 614
           L+ DPT RPT+ E+
Sbjct: 252 LQTDPTARPTINEL 265

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 95/212 (44%), Gaps = 42/212 (19%)
Query: 361 GSVYRGKINGGFAAIKK---------VNGDVSKEIALLNKINHSNLIILSGVCFNEGNC- 410
           G+VY+G ++    A+K          +N      + L+   N +  I+       +G   
Sbjct: 27  GAVYKGSLDERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRME 86
Query: 411 -YLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHS------FTNPPH 463
             LV EY  NG+L  ++  + +     DW    ++A  V  GL YLH+         P  
Sbjct: 87  YLLVMEYYPNGSLXKYLSLHTS-----DWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAI 141
Query: 464 VHKDINSSNVLLDSDLRAKIANFAMA---------RPAEGQEGEFALTRHIVGTKGYMAP 514
            H+D+NS NVL+ +D    I++F ++         RP  G+E   A++   VGT  YMAP
Sbjct: 142 SHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRP--GEEDNAAISE--VGTIRYMAP 197
Query: 515 EYLENGL-------VSTKLDVYAFGVLILEML 539
           E LE  +          ++D+YA G++  E+ 
Sbjct: 198 EVLEGAVNLRDXESALKQVDMYALGLIYWEIF 229

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 61/271 (22%), Positives = 118/271 (43%), Gaps = 60/271 (22%)
Query: 361 GSVYRGKINGGFAAIK---------KVNGDVSKEIALLNKINHSNLIILSGVCFNEGNCY 411
           G +++G+  G    +K         + + D ++E   L   +H N++ + G C +    +
Sbjct: 24  GELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPH 83
Query: 412 --LVYEYAVNGTLSDWVFSNKNEGK--YLDWKQRIQIALDVATGLNYLHSFTN--PPHVH 465
             L+  +   G+L    ++  +EG    +D  Q ++ ALD+A G+ +LH+     P H  
Sbjct: 84  PTLITHWMPYGSL----YNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHA- 138
Query: 466 KDINSSNVLLDSDLRAKIA----NFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGL 521
             +NS +V++D D+ A+I+     F+   P              +    ++APE L+   
Sbjct: 139 --LNSRSVMIDEDMTARISMADVKFSFQSPGR------------MYAPAWVAPEALQKKP 184
Query: 522 VST---KLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFID 578
             T     D+++F VL+ E++T             +  +D+ N  +  +   E LR  I 
Sbjct: 185 EDTNRRSADMWSFAVLLWELVT-----------REVPFADLSNMEIGMKVALEGLRPTIP 233
Query: 579 PTLQGNYPLELALLVIRLIDACLKKDPTDRP 609
           P +  +        V +L+  C+ +DP  RP
Sbjct: 234 PGISPH--------VSKLMKICMNEDPAKRP 256

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 70/290 (24%), Positives = 127/290 (43%), Gaps = 40/290 (13%)
Query: 361 GSVYRGKINGGFAAIKKVNGDVSK------EIALLNKINHSNLI-ILSGVCFNEG---NC 410
           G V+RGK  G   A+K  +    +      EI     + H N++  ++    + G     
Sbjct: 23  GEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL 82
Query: 411 YLVYEYAVNGTLSDWV--FSNKNEGKYLDWKQRIQIALDVATGLNYLH-----SFTNPPH 463
           +LV +Y  +G+L D++  ++   EG        I++AL  A+GL +LH     +   P  
Sbjct: 83  WLVSDYHEHGSLFDYLNRYTVTVEGM-------IKLALSTASGLAHLHMEIVGTQGKPAI 135
Query: 464 VHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALT-RHIVGTKGYMAPEYLENGL- 521
            H+D+ S N+L+  +    IA+  +A   +       +   H VGTK YMAPE L++ + 
Sbjct: 136 AHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSIN 195
Query: 522 -----VSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHF 576
                   + D+YA G++  E+        +H E+  +   D+   V +    EE  +  
Sbjct: 196 MKHFESFKRADIYAMGLVFWEIARRCSIGGIH-EDYQLPYYDL---VPSDPSVEEMRKVV 251
Query: 577 IDPTLQGNYP-----LELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNI 621
            +  L+ N P      E   ++ +++  C   +   R T   I+ +LS +
Sbjct: 252 CEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 301

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 67/245 (27%), Positives = 109/245 (44%), Gaps = 38/245 (15%)
Query: 384 KEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQ 443
           +E   + + +H +++ L GV   E   +++ E    G L  ++   K     LD    I 
Sbjct: 63  QEALTMRQFDHPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKYS---LDLASLIL 118
Query: 444 IALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTR 503
            A  ++T L YL S      VH+DI + NVL+ S+   K+ +F ++R  E        + 
Sbjct: 119 YAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED-------ST 168
Query: 504 HIVGTKG-----YMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSD 558
           +   +KG     +MAPE +     ++  DV+ FGV + E+L           +NN    D
Sbjct: 169 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILM-HGVKPFQGVKNN----D 223
Query: 559 VLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSL 618
           V+  +   E+GE   R  + P    N P  L  L+ +    C   DP+ RP   E++  L
Sbjct: 224 VIGRI---ENGE---RLPMPP----NCPPTLYSLMTK----CWAYDPSRRPRFTELKAQL 269
Query: 619 SNILN 623
           S IL 
Sbjct: 270 STILE 274

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 80/171 (46%), Gaps = 14/171 (8%)
Query: 374 AIKKVNGDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEG 433
           A+K     +  EIA+L KI H N++ L  +  +  + YLV +    G L D +     +G
Sbjct: 59  ALKGKESSIENEIAVLRKIKHENIVALEDIYESPNHLYLVMQLVSGGELFDRIV---EKG 115
Query: 434 KYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLL---DSDLRAKIANFAMAR 490
            Y + K    +   V   + YLH       VH+D+   N+L    D + +  I++F +++
Sbjct: 116 FYTE-KDASTLIRQVLDAVYYLHRMGI---VHRDLKPENLLYYSQDEESKIMISDFGLSK 171
Query: 491 PAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTG 541
                EG+  +     GT GY+APE L     S  +D ++ GV+   +L G
Sbjct: 172 ----MEGKGDVMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 218

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 44/162 (27%), Positives = 79/162 (48%), Gaps = 20/162 (12%)
Query: 385 EIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTL-----SDWVFSNKNEGKYLDWK 439
           E  +L ++NH  ++ L      EG  YL+ ++   G L      + +F+ ++   YL   
Sbjct: 76  ERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYL--- 132
Query: 440 QRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEF 499
                  ++A  L++LHS      +++D+   N+LLD +   K+ +F +++ +   E + 
Sbjct: 133 ------AELALALDHLHSLGI---IYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK- 182
Query: 500 ALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTG 541
                  GT  YMAPE +     +   D ++FGVL+ EMLTG
Sbjct: 183 --AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 222

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 70/290 (24%), Positives = 127/290 (43%), Gaps = 40/290 (13%)
Query: 361 GSVYRGKINGGFAAIKKVNGDVSK------EIALLNKINHSNLI-ILSGVCFNEG---NC 410
           G V+RGK  G   A+K  +    +      EI     + H N++  ++    + G     
Sbjct: 17  GEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL 76
Query: 411 YLVYEYAVNGTLSDWV--FSNKNEGKYLDWKQRIQIALDVATGLNYLH-----SFTNPPH 463
           +LV +Y  +G+L D++  ++   EG        I++AL  A+GL +LH     +   P  
Sbjct: 77  WLVSDYHEHGSLFDYLNRYTVTVEGM-------IKLALSTASGLAHLHMEIVGTQGKPAI 129
Query: 464 VHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALT-RHIVGTKGYMAPEYLENGL- 521
            H+D+ S N+L+  +    IA+  +A   +       +   H VGTK YMAPE L++ + 
Sbjct: 130 AHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSIN 189
Query: 522 -----VSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHF 576
                   + D+YA G++  E+        +H E+  +   D+   V +    EE  +  
Sbjct: 190 MKHFESFKRADIYAMGLVFWEIARRCSIGGIH-EDYQLPYYDL---VPSDPSVEEMRKVV 245
Query: 577 IDPTLQGNYP-----LELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNI 621
            +  L+ N P      E   ++ +++  C   +   R T   I+ +LS +
Sbjct: 246 CEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 295

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 44/162 (27%), Positives = 79/162 (48%), Gaps = 20/162 (12%)
Query: 385 EIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTL-----SDWVFSNKNEGKYLDWK 439
           E  +L ++NH  ++ L      EG  YL+ ++   G L      + +F+ ++   YL   
Sbjct: 77  ERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYL--- 133
Query: 440 QRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEF 499
                  ++A  L++LHS      +++D+   N+LLD +   K+ +F +++ +   E + 
Sbjct: 134 ------AELALALDHLHSLGI---IYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK- 183
Query: 500 ALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTG 541
                  GT  YMAPE +     +   D ++FGVL+ EMLTG
Sbjct: 184 --AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 223

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 67/245 (27%), Positives = 109/245 (44%), Gaps = 38/245 (15%)
Query: 384 KEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQ 443
           +E   + + +H +++ L GV   E   +++ E    G L  ++   K     LD    I 
Sbjct: 60  QEALTMRQFDHPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKYS---LDLASLIL 115
Query: 444 IALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTR 503
            A  ++T L YL S      VH+DI + NVL+ S+   K+ +F ++R  E        + 
Sbjct: 116 YAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED-------ST 165
Query: 504 HIVGTKG-----YMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSD 558
           +   +KG     +MAPE +     ++  DV+ FGV + E+L           +NN    D
Sbjct: 166 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILM-HGVKPFQGVKNN----D 220
Query: 559 VLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSL 618
           V+  +   E+GE   R  + P    N P  L  L+ +    C   DP+ RP   E++  L
Sbjct: 221 VIGRI---ENGE---RLPMPP----NCPPTLYSLMTK----CWAYDPSRRPRFTELKAQL 266
Query: 619 SNILN 623
           S IL 
Sbjct: 267 STILE 271

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 67/245 (27%), Positives = 109/245 (44%), Gaps = 38/245 (15%)
Query: 384 KEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQ 443
           +E   + + +H +++ L GV   E   +++ E    G L  ++   K     LD    I 
Sbjct: 62  QEALTMRQFDHPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKYS---LDLASLIL 117
Query: 444 IALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTR 503
            A  ++T L YL S      VH+DI + NVL+ S+   K+ +F ++R  E        + 
Sbjct: 118 YAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMED-------ST 167
Query: 504 HIVGTKG-----YMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSD 558
           +   +KG     +MAPE +     ++  DV+ FGV + E+L           +NN    D
Sbjct: 168 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHG-VKPFQGVKNN----D 222
Query: 559 VLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSL 618
           V+  +   E+GE   R  + P    N P  L  L+ +    C   DP+ RP   E++  L
Sbjct: 223 VIGRI---ENGE---RLPMPP----NCPPTLYSLMTK----CWAYDPSRRPRFTELKAQL 268
Query: 619 SNILN 623
           S IL 
Sbjct: 269 STILE 273

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 67/245 (27%), Positives = 109/245 (44%), Gaps = 38/245 (15%)
Query: 384 KEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQ 443
           +E   + + +H +++ L GV   E   +++ E    G L  ++   K     LD    I 
Sbjct: 60  QEALTMRQFDHPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKYS---LDLASLIL 115
Query: 444 IALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTR 503
            A  ++T L YL S      VH+DI + NVL+ S+   K+ +F ++R  E        + 
Sbjct: 116 YAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMED-------ST 165
Query: 504 HIVGTKG-----YMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSD 558
           +   +KG     +MAPE +     ++  DV+ FGV + E+L           +NN    D
Sbjct: 166 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHG-VKPFQGVKNN----D 220
Query: 559 VLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSL 618
           V+  +   E+GE   R  + P    N P  L  L+ +    C   DP+ RP   E++  L
Sbjct: 221 VIGRI---ENGE---RLPMPP----NCPPTLYSLMTK----CWAYDPSRRPRFTELKAQL 266
Query: 619 SNILN 623
           S IL 
Sbjct: 267 STILE 271

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 70/290 (24%), Positives = 127/290 (43%), Gaps = 40/290 (13%)
Query: 361 GSVYRGKINGGFAAIKKVNGDVSK------EIALLNKINHSNLI-ILSGVCFNEG---NC 410
           G V+RGK  G   A+K  +    +      EI     + H N++  ++    + G     
Sbjct: 20  GEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL 79
Query: 411 YLVYEYAVNGTLSDWV--FSNKNEGKYLDWKQRIQIALDVATGLNYLH-----SFTNPPH 463
           +LV +Y  +G+L D++  ++   EG        I++AL  A+GL +LH     +   P  
Sbjct: 80  WLVSDYHEHGSLFDYLNRYTVTVEGM-------IKLALSTASGLAHLHMEIVGTQGKPAI 132
Query: 464 VHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALT-RHIVGTKGYMAPEYLENGL- 521
            H+D+ S N+L+  +    IA+  +A   +       +   H VGTK YMAPE L++ + 
Sbjct: 133 AHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSIN 192
Query: 522 -----VSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHF 576
                   + D+YA G++  E+        +H E+  +   D+   V +    EE  +  
Sbjct: 193 MKHFESFKRADIYAMGLVFWEIARRCSIGGIH-EDYQLPYYDL---VPSDPSVEEMRKVV 248
Query: 577 IDPTLQGNYP-----LELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNI 621
            +  L+ N P      E   ++ +++  C   +   R T   I+ +LS +
Sbjct: 249 CEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 298

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 55/230 (23%), Positives = 105/230 (45%), Gaps = 32/230 (13%)
Query: 393 NHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFS------NKNEGKYLDWKQRIQIAL 446
            H N++ L G C + G   ++ EY   G L +++        +K +G+ L+ +  +  + 
Sbjct: 100 QHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSS 159
Query: 447 DVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIV 506
            VA G+ +L S      +H+D+ + NVLL +   AKI +F +AR               +
Sbjct: 160 QVAQGMAFLASKNC---IHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARL 216
Query: 507 GTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTK 566
             K +MAPE + + + + + DV+++G+L+ E+ +      L     N +   ++N+   K
Sbjct: 217 PVK-WMAPESIFDCVYTVQSDVWSYGILLWEIFS----LGL-----NPYPGILVNSKFYK 266
Query: 567 --EDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEI 614
             +DG +  +    P             +  ++ AC   +PT RPT  +I
Sbjct: 267 LVKDGYQMAQPAFAPK-----------NIYSIMQACWALEPTHRPTFQQI 305

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 67/245 (27%), Positives = 109/245 (44%), Gaps = 38/245 (15%)
Query: 384 KEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQ 443
           +E   + + +H +++ L GV   E   +++ E    G L  ++   K     LD    I 
Sbjct: 57  QEALTMRQFDHPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKYS---LDLASLIL 112
Query: 444 IALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTR 503
            A  ++T L YL S      VH+DI + NVL+ S+   K+ +F ++R  E        + 
Sbjct: 113 YAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMED-------ST 162
Query: 504 HIVGTKG-----YMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSD 558
           +   +KG     +MAPE +     ++  DV+ FGV + E+L           +NN    D
Sbjct: 163 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHG-VKPFQGVKNN----D 217
Query: 559 VLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSL 618
           V+  +   E+GE   R  + P    N P  L  L+ +    C   DP+ RP   E++  L
Sbjct: 218 VIGRI---ENGE---RLPMPP----NCPPTLYSLMTK----CWAYDPSRRPRFTELKAQL 263
Query: 619 SNILN 623
           S IL 
Sbjct: 264 STILE 268

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 44/163 (26%), Positives = 80/163 (49%), Gaps = 20/163 (12%)
Query: 384 KEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQ 443
           +E+ +   +NH N++ L  V   E   YLV EYA  G + D++ ++   G+  + + R +
Sbjct: 62  REVRIXKVLNHPNIVKLFEVIETEKTLYLVXEYASGGEVFDYLVAH---GRXKEKEARAK 118
Query: 444 IALDVATGLNYLH-SFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALT 502
               + + + Y H  F     VH+D+ + N+LLD+D   KIA+F  +        EF   
Sbjct: 119 FR-QIVSAVQYCHQKFI----VHRDLKAENLLLDADXNIKIADFGFS-------NEFTFG 166
Query: 503 RHI---VGTKGYMAPEYLENGLVS-TKLDVYAFGVLILEMLTG 541
             +    G   Y APE  +       ++DV++ GV++  +++G
Sbjct: 167 NKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 68/271 (25%), Positives = 119/271 (43%), Gaps = 52/271 (19%)
Query: 317 NKKFDEESQDFLESISGVAQSLKVY-SFKELQS------ATDNFSFTCRIQGSVYRGKIN 369
            K+F  ESQ  +  ++G + +   Y  F+E +         +N  F  ++ GS   GK+ 
Sbjct: 4   KKQFRYESQLQMVQVTGSSDNEYFYVDFREYEYDLKWEFPRENLEFG-KVLGSGAFGKVM 62
Query: 370 GGFA------------AIK--KVNGDVSKEIALLNKI-------NHSNLIILSGVCFNEG 408
              A            A+K  K   D S+  AL++++       +H N++ L G C   G
Sbjct: 63  NATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 122
Query: 409 NCYLVYEYAVNGTLSDWVFSNK-----NEGKY--------------LDWKQRIQIALDVA 449
             YL++EY   G L +++ S +     +E +Y              L ++  +  A  VA
Sbjct: 123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVA 182
Query: 450 TGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTK 509
            G+ +L        VH+D+ + NVL+      KI +F +AR               +  K
Sbjct: 183 KGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVK 239
Query: 510 GYMAPEYLENGLVSTKLDVYAFGVLILEMLT 540
            +MAPE L  G+ + K DV+++G+L+ E+ +
Sbjct: 240 -WMAPESLFEGIYTIKSDVWSYGILLWEIFS 269

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 55/230 (23%), Positives = 105/230 (45%), Gaps = 32/230 (13%)
Query: 393 NHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFS------NKNEGKYLDWKQRIQIAL 446
            H N++ L G C + G   ++ EY   G L +++        +K +G+ L+ +  +  + 
Sbjct: 108 QHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSS 167
Query: 447 DVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIV 506
            VA G+ +L S      +H+D+ + NVLL +   AKI +F +AR               +
Sbjct: 168 QVAQGMAFLASKNC---IHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARL 224
Query: 507 GTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTK 566
             K +MAPE + + + + + DV+++G+L+ E+ +      L     N +   ++N+   K
Sbjct: 225 PVK-WMAPESIFDCVYTVQSDVWSYGILLWEIFS----LGL-----NPYPGILVNSKFYK 274
Query: 567 --EDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEI 614
             +DG +  +    P             +  ++ AC   +PT RPT  +I
Sbjct: 275 LVKDGYQMAQPAFAPK-----------NIYSIMQACWALEPTHRPTFQQI 313

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 70/287 (24%), Positives = 128/287 (44%), Gaps = 34/287 (11%)
Query: 361 GSVYRGKINGGFAAIK------KVNGDVSKEIALLNKINHSNLI-ILSGVCFNEGNC--- 410
           G V+ GK  G   A+K      + +     EI     + H N++  ++      G+    
Sbjct: 51  GEVWMGKWRGEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQL 110
Query: 411 YLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHS--FT---NPPHVH 465
           YL+ +Y  NG+L D++ S       LD K  +++A    +GL +LH+  F+    P   H
Sbjct: 111 YLITDYHENGSLYDYLKSTT-----LDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAH 165
Query: 466 KDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFAL---TRHIVGTKGYMAPEYLENGLV 522
           +D+ S N+L+  +    IA+  +A        E  +   TR  VGTK YM PE L+  L 
Sbjct: 166 RDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTR--VGTKRYMPPEVLDESLN 223
Query: 523 STKL------DVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESL-RH 575
                     D+Y+FG+++ E+     +  +  EE  +   D++ +  + ED  E +   
Sbjct: 224 RNHFQSYIMADMYSFGLILWEVARRCVSGGI-VEEYQLPYHDLVPSDPSYEDMREIVCIK 282
Query: 576 FIDPTLQGNYPLELALLVI-RLIDACLKKDPTDRPTMYEIEHSLSNI 621
            + P+    +  +  L  + +L+  C   +P  R T   ++ +L+ +
Sbjct: 283 KLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKM 329

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 73/278 (26%), Positives = 120/278 (43%), Gaps = 49/278 (17%)
Query: 361 GSVYRG--------KINGGFAAIKKVNGDVS--------KEIALLNKINHSNLIILSGVC 404
           G VY G        KIN    A+K    D +         E  ++  ++H +++ L G+ 
Sbjct: 38  GEVYEGVYTNHKGEKIN---VAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGI- 93
Query: 405 FNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHV 464
             E   +++ E    G L  ++  NKN  K L     +  +L +   + YL S      V
Sbjct: 94  IEEEPTWIIMELYPYGELGHYLERNKNSLKVL---TLVLYSLQICKAMAYLESINC---V 147
Query: 465 HKDINSSNVLLDSDLRAKIANFAMARPAEGQE-GEFALTRHIVGTKGYMAPEYLENGLVS 523
           H+DI   N+L+ S    K+ +F ++R  E ++  + ++TR  +    +M+PE +     +
Sbjct: 148 HRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPI---KWMSPESINFRRFT 204
Query: 524 TKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQG 583
           T  DV+ F V + E+L+  +      E       DV+  VL K D          P L  
Sbjct: 205 TASDVWMFAVCMWEILSFGKQPFFWLENK-----DVI-GVLEKGD------RLPKPDLC- 251
Query: 584 NYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNI 621
             P  L  L+ R    C   DP+DRP   E+  SLS++
Sbjct: 252 --PPVLYTLMTR----CWDYDPSDRPRFTELVCSLSDV 283

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 73/278 (26%), Positives = 120/278 (43%), Gaps = 49/278 (17%)
Query: 361 GSVYRG--------KINGGFAAIKKVNGDVS--------KEIALLNKINHSNLIILSGVC 404
           G VY G        KIN    A+K    D +         E  ++  ++H +++ L G+ 
Sbjct: 26  GEVYEGVYTNHKGEKIN---VAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGI- 81
Query: 405 FNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHV 464
             E   +++ E    G L  ++  NKN  K L     +  +L +   + YL S      V
Sbjct: 82  IEEEPTWIIMELYPYGELGHYLERNKNSLKVL---TLVLYSLQICKAMAYLESINC---V 135
Query: 465 HKDINSSNVLLDSDLRAKIANFAMARPAEGQE-GEFALTRHIVGTKGYMAPEYLENGLVS 523
           H+DI   N+L+ S    K+ +F ++R  E ++  + ++TR  +    +M+PE +     +
Sbjct: 136 HRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPI---KWMSPESINFRRFT 192
Query: 524 TKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQG 583
           T  DV+ F V + E+L+  +      E       DV+  VL K D          P L  
Sbjct: 193 TASDVWMFAVCMWEILSFGKQPFFWLENK-----DVI-GVLEKGD------RLPKPDLC- 239
Query: 584 NYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNI 621
             P  L  L+ R    C   DP+DRP   E+  SLS++
Sbjct: 240 --PPVLYTLMTR----CWDYDPSDRPRFTELVCSLSDV 271

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 68/245 (27%), Positives = 108/245 (44%), Gaps = 38/245 (15%)
Query: 384 KEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQ 443
           +E   + + +H +++ L GV   E   +++ E    G L  ++   K     LD    I 
Sbjct: 60  QEALTMRQFDHPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKFS---LDLASLIL 115
Query: 444 IALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTR 503
            A  ++T L YL S      VH+DI + NVL+ S+   K+ +F ++R  E      A   
Sbjct: 116 YAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKA--- 169
Query: 504 HIVGTKG-----YMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSD 558
               +KG     +MAPE +     ++  DV+ FGV + E+L           +NN    D
Sbjct: 170 ----SKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHG-VKPFQGVKNN----D 220
Query: 559 VLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSL 618
           V+  +   E+GE   R  + P    N P  L  L+ +    C   DP+ RP   E++  L
Sbjct: 221 VIGRI---ENGE---RLPMPP----NCPPTLYSLMTK----CWAYDPSRRPRFTELKAQL 266
Query: 619 SNILN 623
           S IL 
Sbjct: 267 STILE 271

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 73/278 (26%), Positives = 120/278 (43%), Gaps = 49/278 (17%)
Query: 361 GSVYRG--------KINGGFAAIKKVNGDVS--------KEIALLNKINHSNLIILSGVC 404
           G VY G        KIN    A+K    D +         E  ++  ++H +++ L G+ 
Sbjct: 22  GEVYEGVYTNHKGEKIN---VAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGI- 77
Query: 405 FNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHV 464
             E   +++ E    G L  ++  NKN  K L     +  +L +   + YL S      V
Sbjct: 78  IEEEPTWIIMELYPYGELGHYLERNKNSLKVL---TLVLYSLQICKAMAYLESINC---V 131
Query: 465 HKDINSSNVLLDSDLRAKIANFAMARPAEGQE-GEFALTRHIVGTKGYMAPEYLENGLVS 523
           H+DI   N+L+ S    K+ +F ++R  E ++  + ++TR  +    +M+PE +     +
Sbjct: 132 HRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPI---KWMSPESINFRRFT 188
Query: 524 TKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQG 583
           T  DV+ F V + E+L+  +      E       DV+  VL K D          P L  
Sbjct: 189 TASDVWMFAVCMWEILSFGKQPFFWLENK-----DVI-GVLEKGD------RLPKPDLC- 235
Query: 584 NYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNI 621
             P  L  L+ R    C   DP+DRP   E+  SLS++
Sbjct: 236 --PPVLYTLMTR----CWDYDPSDRPRFTELVCSLSDV 267

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/235 (22%), Positives = 94/235 (40%), Gaps = 29/235 (12%)
Query: 381 DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNK---NEGKYLD 437
           D   E  +++K NH N++   GV       +++ E    G L  ++   +   ++   L 
Sbjct: 97  DFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLA 156
Query: 438 WKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLL---DSDLRAKIANFAMARPAEG 494
               + +A D+A G  YL        +H+DI + N LL        AKI +F MAR    
Sbjct: 157 MLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY- 212
Query: 495 QEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNM 554
           + G +      +    +M PE    G+ ++K D ++FGVL+ E+ +              
Sbjct: 213 RAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS-------------- 258
Query: 555 HLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRP 609
                L  +       + +  F+    + + P      V R++  C +  P DRP
Sbjct: 259 -----LGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRP 308

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/235 (22%), Positives = 94/235 (40%), Gaps = 29/235 (12%)
Query: 381 DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNK---NEGKYLD 437
           D   E  +++K NH N++   GV       +++ E    G L  ++   +   ++   L 
Sbjct: 120 DFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLA 179
Query: 438 WKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSD---LRAKIANFAMARPAEG 494
               + +A D+A G  YL        +H+DI + N LL        AKI +F MAR    
Sbjct: 180 MLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY- 235
Query: 495 QEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNM 554
           + G +      +    +M PE    G+ ++K D ++FGVL+ E+ +              
Sbjct: 236 RAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS-------------- 281
Query: 555 HLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRP 609
                L  +       + +  F+    + + P      V R++  C +  P DRP
Sbjct: 282 -----LGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRP 331

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/254 (24%), Positives = 108/254 (42%), Gaps = 32/254 (12%)
Query: 362 SVYRGKINGGFAAIKKVNGD-VSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNG 420
            V+ GKI      +K    + +S EI++   + H +++   G   +    ++V E     
Sbjct: 67  EVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRR 126
Query: 421 TLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLR 480
           +L +    +K      + + R  +   +  G  YLH       +H+D+   N+ L+ DL 
Sbjct: 127 SLLEL---HKRRKALTEPEARYYLR-QIVLGCQYLHRNRV---IHRDLKLGNLFLNEDLE 179
Query: 481 AKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT 540
            KI +F +A   E  +GE    + + GT  Y+APE L     S ++DV++ G ++  +L 
Sbjct: 180 VKIGDFGLATKVE-YDGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLV 236
Query: 541 GKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDAC 600
           GK              S +    L  +  E S+   I+P            +   LI   
Sbjct: 237 GKPP---------FETSCLKETYLRIKKNEYSIPKHINP------------VAASLIQKM 275
Query: 601 LKKDPTDRPTMYEI 614
           L+ DPT RPT+ E+
Sbjct: 276 LQTDPTARPTINEL 289

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/187 (25%), Positives = 84/187 (44%), Gaps = 23/187 (12%)
Query: 365 RGKINGGFAAIKKVNGDV----------SKEIALLNKINHSNLIILSGVCFNEGNCYLVY 414
           R + NG + A+K +  ++          + E  +L+ + H  +I + G   +    +++ 
Sbjct: 26  RSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 85
Query: 415 EYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVL 474
           +Y   G L    FS   + +          A +V   L YLHS      +++D+   N+L
Sbjct: 86  DYIEGGEL----FSLLRKSQRFPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENIL 138
Query: 475 LDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVL 534
           LD +   KI +F  A+          +T  + GT  Y+APE +     +  +D ++FG+L
Sbjct: 139 LDKNGHIKITDFGFAKYVPD------VTYXLCGTPDYIAPEVVSTKPYNKSIDWWSFGIL 192
Query: 535 ILEMLTG 541
           I EML G
Sbjct: 193 IYEMLAG 199

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 42/156 (26%), Positives = 80/156 (51%), Gaps = 8/156 (5%)
Query: 385 EIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQI 444
           E  ++ ++++  ++ + G+C  E +  LV E A  G L+ ++  N+    ++  K  I++
Sbjct: 420 EANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAELGPLNKYLQQNR----HVKDKNIIEL 474
Query: 445 ALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRH 504
              V+ G+ YL        VH+D+ + NVLL +   AKI++F +++     E  +    H
Sbjct: 475 VHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTH 531
Query: 505 IVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT 540
                 + APE +     S+K DV++FGVL+ E  +
Sbjct: 532 GKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 567

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/254 (24%), Positives = 107/254 (42%), Gaps = 32/254 (12%)
Query: 362 SVYRGKINGGFAAIKKVNGD-VSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNG 420
            V+ GKI      +K    + +S EI++   + H +++   G   +    ++V E     
Sbjct: 41  EVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRR 100
Query: 421 TLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLR 480
           +L +    +K      + + R  +   +  G  YLH       +H+D+   N+ L+ DL 
Sbjct: 101 SLLEL---HKRRKALTEPEARYYLR-QIVLGCQYLHRNRV---IHRDLKLGNLFLNEDLE 153
Query: 481 AKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT 540
            KI +F +A   E  +GE    + + GT  Y+APE L     S ++DV++ G ++  +L 
Sbjct: 154 VKIGDFGLATKVE-YDGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLV 210
Query: 541 GKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDAC 600
           GK              S +    L  +  E S+   I+P                LI   
Sbjct: 211 GKPP---------FETSCLKETYLRIKKNEYSIPKHINPVAAS------------LIQKM 249
Query: 601 LKKDPTDRPTMYEI 614
           L+ DPT RPT+ E+
Sbjct: 250 LQTDPTARPTINEL 263

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 42/156 (26%), Positives = 80/156 (51%), Gaps = 8/156 (5%)
Query: 385 EIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQI 444
           E  ++ ++++  ++ + G+C  E +  LV E A  G L+ ++  N+    ++  K  I++
Sbjct: 421 EANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAELGPLNKYLQQNR----HVKDKNIIEL 475
Query: 445 ALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRH 504
              V+ G+ YL        VH+D+ + NVLL +   AKI++F +++     E  +    H
Sbjct: 476 VHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTH 532
Query: 505 IVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT 540
                 + APE +     S+K DV++FGVL+ E  +
Sbjct: 533 GKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 568

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/260 (23%), Positives = 116/260 (44%), Gaps = 34/260 (13%)
Query: 367 KINGGFAAIKKVNGDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTL---S 423
           K N    +IK    D   E+ ++  I +   +   G+  N    Y++YEY  N ++    
Sbjct: 75  KSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFD 134
Query: 424 DWVFS-NKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAK 482
           ++ F  +KN   ++  +    I   V    +Y+H+  N    H+D+  SN+L+D + R K
Sbjct: 135 EYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNI--CHRDVKPSNILMDKNGRVK 192
Query: 483 IANFAMARPAEGQEGEFALTRHIVGTKG---YMAPEYL--ENGLVSTKLDVYAFGVLILE 537
           +++F         E E+ + + I G++G   +M PE+   E+     K+D+++ G+ +  
Sbjct: 193 LSDFG--------ESEYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYV 244
Query: 538 MLTGKEAAALHAEENNMHLSDVLNAVLTKE-DGEESLRHFIDP------TLQGNYPLELA 590
           M       +L      + L ++ N + TK  +      HF+ P      T   N+   L+
Sbjct: 245 MFYNVVPFSLK-----ISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNF---LS 296
Query: 591 LLVIRLIDACLKKDPTDRPT 610
              I  +   L+K+P +R T
Sbjct: 297 NEDIDFLKLFLRKNPAERIT 316

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 47/161 (29%), Positives = 79/161 (49%), Gaps = 15/161 (9%)
Query: 384 KEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQ 443
           +E+ LL +++H N+  L     ++G  YLV E    G L D + S K   +        +
Sbjct: 75  REVQLLKQLDHPNIXKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEV----DAAR 130
Query: 444 IALDVATGLNYLHSFTNPPHVHKDINSSNVLLDS---DLRAKIANFAMARPAEGQEGEFA 500
           I   V +G+ Y H       VH+D+   N+LL+S   D   +I +F ++   E  +    
Sbjct: 131 IIRQVLSGITYXH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK--- 184
Query: 501 LTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTG 541
             +  +GT  Y+APE L +G    K DV++ GV++  +L+G
Sbjct: 185 -XKDKIGTAYYIAPEVL-HGTYDEKCDVWSTGVILYILLSG 223

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/243 (22%), Positives = 95/243 (39%), Gaps = 45/243 (18%)
Query: 381 DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNK---NEGKYLD 437
           D   E  +++K+NH N++   GV       +++ E    G L  ++   +   ++   L 
Sbjct: 94  DFLMEALIISKLNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLA 153
Query: 438 WKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSD---LRAKIANFAMARPAEG 494
               + +A D+A G  YL        +H+DI + N LL        AKI +F MAR    
Sbjct: 154 MLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR---- 206
Query: 495 QEGEFALTRHIVGTKG--------YMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAA 546
                 + R     KG        +M PE    G+ ++K D ++FGVL+ E+ +      
Sbjct: 207 -----DIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS------ 255
Query: 547 LHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPT 606
                        L  +       + +  F+    + + P      V R++  C +  P 
Sbjct: 256 -------------LGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPE 302
Query: 607 DRP 609
           DRP
Sbjct: 303 DRP 305

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/254 (24%), Positives = 108/254 (42%), Gaps = 32/254 (12%)
Query: 362 SVYRGKINGGFAAIKKVNGD-VSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNG 420
            V+ GKI      +K    + +S EI++   + H +++   G   +    ++V E     
Sbjct: 65  EVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRR 124
Query: 421 TLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLR 480
           +L +    +K      + + R  +   +  G  YLH       +H+D+   N+ L+ DL 
Sbjct: 125 SLLEL---HKRRKALTEPEARYYLR-QIVLGCQYLHRNRV---IHRDLKLGNLFLNEDLE 177
Query: 481 AKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT 540
            KI +F +A   E  +GE    + + GT  Y+APE L     S ++DV++ G ++  +L 
Sbjct: 178 VKIGDFGLATKVE-YDGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLV 234
Query: 541 GKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDAC 600
           GK              S +    L  +  E S+   I+P            +   LI   
Sbjct: 235 GKPP---------FETSCLKETYLRIKKNEYSIPKHINP------------VAASLIQKM 273
Query: 601 LKKDPTDRPTMYEI 614
           L+ DPT RPT+ E+
Sbjct: 274 LQTDPTARPTINEL 287

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 84/166 (50%), Gaps = 17/166 (10%)
Query: 381 DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQ 440
           D+ +E+++L +I H N+I L  V  N+ +  L+ E    G L D++     E + L  ++
Sbjct: 60  DIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL----AEKESLTEEE 115
Query: 441 RIQIALDVATGLNYLHSFTNPPHVHKDINSSNV-LLDSDL---RAKIANFAMARPAE-GQ 495
             +    +  G+ YLHS       H D+   N+ LLD ++   R KI +F +A   + G 
Sbjct: 116 ATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN 172
Query: 496 EGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTG 541
           E      ++I GT  ++APE +    +  + D+++ GV+   +L+G
Sbjct: 173 E-----FKNIFGTPAFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 42/164 (25%), Positives = 74/164 (45%), Gaps = 12/164 (7%)
Query: 378 VNGDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLD 437
           V   + +EI + + + H N++ +     +    YL+ E+A  G L   +   +  G++ D
Sbjct: 58  VEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKEL---QKHGRF-D 113
Query: 438 WKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEG 497
            ++      ++A  L+Y H       +H+DI   N+L+      KIA+F  +  A     
Sbjct: 114 EQRSATFMEELADALHYCHERKV---IHRDIKPENLLMGYKGELKIADFGWSVHAPSLR- 169
Query: 498 EFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTG 541
                R + GT  Y+ PE +E      K+D++  GVL  E L G
Sbjct: 170 ----RRXMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVG 209

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/189 (29%), Positives = 84/189 (44%), Gaps = 22/189 (11%)
Query: 365 RGKINGGFAAIKKVNGDV---SKEIA-------LLNKINHSNLIILSGVCFNEGNCYLVY 414
           R K  G + A+K +  +V     E+A       +L    H  L  L            V 
Sbjct: 25  REKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84
Query: 415 EYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVL 474
           EYA  G L    F    E  + + + R   A ++ + L YLHS      V++DI   N++
Sbjct: 85  EYANGGEL---FFHLSRERVFTEERARFYGA-EIVSALEYLHSRDV---VYRDIKLENLM 137
Query: 475 LDSDLRAKIANFAMARPAEG-QEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGV 533
           LD D   KI +F + +  EG  +G  A  +   GT  Y+APE LE+      +D +  GV
Sbjct: 138 LDKDGHIKITDFGLCK--EGISDG--ATMKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGV 193
Query: 534 LILEMLTGK 542
           ++ EM+ G+
Sbjct: 194 VMYEMMCGR 202

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 42/164 (25%), Positives = 74/164 (45%), Gaps = 12/164 (7%)
Query: 378 VNGDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLD 437
           V   + +EI + + + H N++ +     +    YL+ E+A  G L   +   +  G++ D
Sbjct: 57  VEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKEL---QKHGRF-D 112
Query: 438 WKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEG 497
            ++      ++A  L+Y H       +H+DI   N+L+      KIA+F  +  A     
Sbjct: 113 EQRSATFMEELADALHYCHERKV---IHRDIKPENLLMGYKGELKIADFGWSVHAPSLR- 168
Query: 498 EFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTG 541
                R + GT  Y+ PE +E      K+D++  GVL  E L G
Sbjct: 169 ----RRXMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVG 208

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 40/160 (25%), Positives = 77/160 (48%), Gaps = 8/160 (5%)
Query: 382 VSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQR 441
           V++E  ++++++H   + L     ++   Y    YA NG L  ++   +  G + +   R
Sbjct: 57  VTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI---RKIGSFDETCTR 113
Query: 442 IQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFAL 501
              A ++ + L YLH       +H+D+   N+LL+ D+  +I +F  A+     E + A 
Sbjct: 114 FYTA-EIVSALEYLHGKGI---IHRDLKPENILLNEDMHIQITDFGTAK-VLSPESKQAR 168
Query: 502 TRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTG 541
               VGT  Y++PE L         D++A G +I +++ G
Sbjct: 169 ANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 208

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 40/160 (25%), Positives = 77/160 (48%), Gaps = 8/160 (5%)
Query: 382 VSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQR 441
           V++E  ++++++H   + L     ++   Y    YA NG L  ++   +  G + +   R
Sbjct: 80  VTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI---RKIGSFDETCTR 136
Query: 442 IQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFAL 501
              A ++ + L YLH       +H+D+   N+LL+ D+  +I +F  A+     E + A 
Sbjct: 137 FYTA-EIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAK-VLSPESKQAR 191
Query: 502 TRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTG 541
               VGT  Y++PE L         D++A G +I +++ G
Sbjct: 192 ANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 231

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 42/161 (26%), Positives = 79/161 (49%), Gaps = 10/161 (6%)
Query: 382 VSKEIALLNKINHSNLIILSGVCF-NEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQ 440
           V++E  ++++++H   + L   CF ++   Y    YA NG L  ++   +  G + +   
Sbjct: 84  VTRERDVMSRLDHPFFVKLY-FCFQDDEKLYFGLSYAKNGELLKYI---RKIGSFDETCT 139
Query: 441 RIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFA 500
           R   A ++ + L YLH       +H+D+   N+LL+ D+  +I +F  A+     E + A
Sbjct: 140 RFYTA-EIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAK-VLSPESKQA 194
Query: 501 LTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTG 541
                VGT  Y++PE L         D++A G +I +++ G
Sbjct: 195 RANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 235

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 40/160 (25%), Positives = 77/160 (48%), Gaps = 8/160 (5%)
Query: 382 VSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQR 441
           V++E  ++++++H   + L     ++   Y    YA NG L  ++   +  G + +   R
Sbjct: 77  VTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI---RKIGSFDETCTR 133
Query: 442 IQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFAL 501
              A ++ + L YLH       +H+D+   N+LL+ D+  +I +F  A+     E + A 
Sbjct: 134 FYTA-EIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAK-VLSPESKQAR 188
Query: 502 TRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTG 541
               VGT  Y++PE L         D++A G +I +++ G
Sbjct: 189 ANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 94/201 (46%), Gaps = 29/201 (14%)
Query: 361 GSVYRGK--INGGFAAIKKV---NGD------VSKEIALLNKIN---HSNLIILSGVCF- 405
           G+VY+ +   +G F A+K V   NG+        +E+ALL ++    H N++ L  VC  
Sbjct: 18  GTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT 77
Query: 406 ----NEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNP 461
                E    LV+E+ V+  L  ++  +K     L  +    +      GL++LH+    
Sbjct: 78  SRTDREIKVTLVFEH-VDQDLRTYL--DKAPPPGLPAETIKDLMRQFLRGLDFLHANCI- 133
Query: 462 PHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGL 521
             VH+D+   N+L+ S    K+A+F +AR    Q   F     +V T  Y APE L    
Sbjct: 134 --VHRDLKPENILVTSGGTVKLADFGLARIYSYQMALFP----VVVTLWYRAPEVLLQST 187
Query: 522 VSTKLDVYAFGVLILEMLTGK 542
            +T +D+++ G +  EM   K
Sbjct: 188 YATPVDMWSVGCIFAEMFRRK 208

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/189 (29%), Positives = 84/189 (44%), Gaps = 22/189 (11%)
Query: 365 RGKINGGFAAIKKVNGDV---SKEIA-------LLNKINHSNLIILSGVCFNEGNCYLVY 414
           R K  G + A+K +  +V     E+A       +L    H  L  L            V 
Sbjct: 25  REKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84
Query: 415 EYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVL 474
           EYA  G L    F    E  + + + R   A ++ + L YLHS      V++DI   N++
Sbjct: 85  EYANGGEL---FFHLSRERVFTEERARFYGA-EIVSALEYLHSRDV---VYRDIKLENLM 137
Query: 475 LDSDLRAKIANFAMARPAEG-QEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGV 533
           LD D   KI +F + +  EG  +G  A  +   GT  Y+APE LE+      +D +  GV
Sbjct: 138 LDKDGHIKITDFGLCK--EGISDG--ATMKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGV 193
Query: 534 LILEMLTGK 542
           ++ EM+ G+
Sbjct: 194 VMYEMMCGR 202

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 40/160 (25%), Positives = 77/160 (48%), Gaps = 8/160 (5%)
Query: 382 VSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQR 441
           V++E  ++++++H   + L     ++   Y    YA NG L  ++   +  G + +   R
Sbjct: 82  VTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI---RKIGSFDETCTR 138
Query: 442 IQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFAL 501
              A ++ + L YLH       +H+D+   N+LL+ D+  +I +F  A+     E + A 
Sbjct: 139 FYTA-EIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAK-VLSPESKQAR 193
Query: 502 TRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTG 541
               VGT  Y++PE L         D++A G +I +++ G
Sbjct: 194 ANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 233

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 40/160 (25%), Positives = 77/160 (48%), Gaps = 8/160 (5%)
Query: 382 VSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQR 441
           V++E  ++++++H   + L     ++   Y    YA NG L  ++   +  G + +   R
Sbjct: 77  VTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI---RKIGSFDETCTR 133
Query: 442 IQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFAL 501
              A ++ + L YLH       +H+D+   N+LL+ D+  +I +F  A+     E + A 
Sbjct: 134 FYTA-EIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAK-VLSPESKQAR 188
Query: 502 TRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTG 541
               VGT  Y++PE L         D++A G +I +++ G
Sbjct: 189 ANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/258 (24%), Positives = 110/258 (42%), Gaps = 44/258 (17%)
Query: 385 EIALLNKINHS-NLIILSGVCFNEGNCYLV-YEYAVNGTLSDWVFSNKNE---------- 432
           E+ +L  I H  N++ L G C   G   +V  E+   G LS ++ S +NE          
Sbjct: 82  ELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLY 141
Query: 433 GKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMAR-- 490
             +L  +  I  +  VA G+ +L S      +H+D+ + N+LL      KI +F +AR  
Sbjct: 142 KDFLTLEHLIXYSFQVAKGMEFLASRKX---IHRDLAARNILLSEKNVVKICDFGLARDI 198
Query: 491 ---PAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAAL 547
              P   ++G+  L         +MAPE + + + + + DV++FGVL+ E+ +   +   
Sbjct: 199 XKDPDXVRKGDARLPLK------WMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 252
Query: 548 HAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTD 607
             + +                 EE  R   + T           +   ++D C   +P+ 
Sbjct: 253 GVKID-----------------EEFCRRLKEGTRMRAPDYTTPEMYQTMLD-CWHGEPSQ 294
Query: 608 RPTMYEIEHSLSNILNAS 625
           RPT  E+   L N+L A+
Sbjct: 295 RPTFSELVEHLGNLLQAN 312

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 40/160 (25%), Positives = 77/160 (48%), Gaps = 8/160 (5%)
Query: 382 VSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQR 441
           V++E  ++++++H   + L     ++   Y    YA NG L  ++   +  G + +   R
Sbjct: 56  VTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI---RKIGSFDETCTR 112
Query: 442 IQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFAL 501
              A ++ + L YLH       +H+D+   N+LL+ D+  +I +F  A+     E + A 
Sbjct: 113 FYTA-EIVSALEYLHGKGI---IHRDLKPENILLNEDMHIQITDFGTAK-VLSPESKQAR 167
Query: 502 TRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTG 541
               VGT  Y++PE L         D++A G +I +++ G
Sbjct: 168 ANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 207

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 40/160 (25%), Positives = 77/160 (48%), Gaps = 8/160 (5%)
Query: 382 VSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQR 441
           V++E  ++++++H   + L     ++   Y    YA NG L  ++   +  G + +   R
Sbjct: 80  VTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI---RKIGSFDETCTR 136
Query: 442 IQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFAL 501
              A ++ + L YLH       +H+D+   N+LL+ D+  +I +F  A+     E + A 
Sbjct: 137 FYTA-EIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAK-VLSPESKQAR 191
Query: 502 TRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTG 541
               VGT  Y++PE L         D++A G +I +++ G
Sbjct: 192 ANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 231

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 41/165 (24%), Positives = 86/165 (52%), Gaps = 11/165 (6%)
Query: 378 VNGDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLD 437
           +   + +E+ +L++ N   ++   G  +++G   +  E+   G+L D V     E K + 
Sbjct: 57  IRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVL---KEAKRIP 112
Query: 438 WKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEG 497
            +   ++++ V  GL YL        +H+D+  SN+L++S    K+ +F ++    GQ  
Sbjct: 113 EEILGKVSIAVLRGLAYLREKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVS----GQLI 166
Query: 498 EFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGK 542
           + ++    VGT+ YMAPE L+    S + D+++ G+ ++E+  G+
Sbjct: 167 D-SMANSFVGTRSYMAPERLQGTHYSVQSDIWSMGLSLVELAVGR 210

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 40/160 (25%), Positives = 77/160 (48%), Gaps = 8/160 (5%)
Query: 382 VSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQR 441
           V++E  ++++++H   + L     ++   Y    YA NG L  ++   +  G + +   R
Sbjct: 79  VTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI---RKIGSFDETCTR 135
Query: 442 IQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFAL 501
              A ++ + L YLH       +H+D+   N+LL+ D+  +I +F  A+     E + A 
Sbjct: 136 FYTA-EIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAK-VLSPESKQAR 190
Query: 502 TRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTG 541
               VGT  Y++PE L         D++A G +I +++ G
Sbjct: 191 ANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/188 (28%), Positives = 83/188 (44%), Gaps = 20/188 (10%)
Query: 365 RGKINGGFAAIKKVNGDV---SKEIA-------LLNKINHSNLIILSGVCFNEGNCYLVY 414
           R K  G + A+K +  +V     E+A       +L    H  L  L            V 
Sbjct: 25  REKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84
Query: 415 EYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVL 474
           EYA  G L    F    E  + + + R   A ++ + L YLHS      V++DI   N++
Sbjct: 85  EYANGGEL---FFHLSRERVFTEERARFYGA-EIVSALEYLHSRDV---VYRDIKLENLM 137
Query: 475 LDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVL 534
           LD D   KI +F + +  EG   + A  +   GT  Y+APE LE+      +D +  GV+
Sbjct: 138 LDKDGHIKITDFGLCK--EGI-SDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVV 194
Query: 535 ILEMLTGK 542
           + EM+ G+
Sbjct: 195 MYEMMCGR 202

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 40/160 (25%), Positives = 77/160 (48%), Gaps = 8/160 (5%)
Query: 382 VSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQR 441
           V++E  ++++++H   + L     ++   Y    YA NG L  ++   +  G + +   R
Sbjct: 55  VTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI---RKIGSFDETCTR 111
Query: 442 IQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFAL 501
              A ++ + L YLH       +H+D+   N+LL+ D+  +I +F  A+     E + A 
Sbjct: 112 FYTA-EIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAK-VLSPESKQAR 166
Query: 502 TRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTG 541
               VGT  Y++PE L         D++A G +I +++ G
Sbjct: 167 ANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 206

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 40/160 (25%), Positives = 77/160 (48%), Gaps = 8/160 (5%)
Query: 382 VSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQR 441
           V++E  ++++++H   + L     ++   Y    YA NG L  ++   +  G + +   R
Sbjct: 54  VTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI---RKIGSFDETCTR 110
Query: 442 IQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFAL 501
              A ++ + L YLH       +H+D+   N+LL+ D+  +I +F  A+     E + A 
Sbjct: 111 FYTA-EIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAK-VLSPESKQAR 165
Query: 502 TRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTG 541
               VGT  Y++PE L         D++A G +I +++ G
Sbjct: 166 ANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 205

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/278 (22%), Positives = 107/278 (38%), Gaps = 60/278 (21%)
Query: 361 GSVYRGKINGGF-------AAIKKVNG--------DVSKEIALLNKINHSNLIILSGVCF 405
           G VY G+++G          A+K +          D   E  +++K+NH N++   GV  
Sbjct: 45  GEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVRCIGVSL 104
Query: 406 NEGNCYLVYEYAVNGTLSDWVFSNK---NEGKYLDWKQRIQIALDVATGLNYLHSFTNPP 462
                +++ E    G L  ++   +   ++   L     + +A D+A G  YL       
Sbjct: 105 QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--- 161
Query: 463 HVHKDINSSNVLLDSD---LRAKIANFAMARPAEGQEGEFALTRHIVGTKG--------Y 511
            +H+DI + N LL        AKI +F MAR          + R     KG        +
Sbjct: 162 FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR---------DIYRASYYRKGGCAMLPVKW 212
Query: 512 MAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEE 571
           M PE    G+ ++K D ++FGVL+ E+ +                   L  +       +
Sbjct: 213 MPPEAFMEGIFTSKTDTWSFGVLLWEIFS-------------------LGYMPYPSKSNQ 253
Query: 572 SLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRP 609
            +  F+    + + P      V R++  C +  P DRP
Sbjct: 254 EVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRP 291

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/276 (23%), Positives = 113/276 (40%), Gaps = 38/276 (13%)
Query: 365 RGKINGGFAAIKK---------VNGDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYE 415
           R +  G   AIKK         +     +EI +L ++ H NL+ L  V   +   +LV+E
Sbjct: 23  RNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82
Query: 416 YAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLL 475
           Y  +  L +     +   ++L       I       +N+ H       +H+D+   N+L+
Sbjct: 83  YCDHTVLHELDRYQRGVPEHL----VKSITWQTLQAVNFCHKHNC---IHRDVKPENILI 135
Query: 476 DSDLRAKIANFAMAR----PAEGQEGEFALTRHIVGTKGYMAPEYL-ENGLVSTKLDVYA 530
                 K+ +F  AR    P++  + E       V T+ Y +PE L  +      +DV+A
Sbjct: 136 TKHSVIKLCDFGFARLLTGPSDYYDDE-------VATRWYRSPELLVGDTQYGPPVDVWA 188
Query: 531 FGVLILEMLTGKEAAALHAEENNMHL-SDVLNAVLTKEDGEESLRHFID----PTLQGNY 585
            G +  E+L+G       ++ + ++L    L  ++ +     S   +      P  +   
Sbjct: 189 IGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDME 248
Query: 586 PLELALLVIR-----LIDACLKKDPTDRPTMYEIEH 616
           PLEL    I      L+  CL  DPT+R T  ++ H
Sbjct: 249 PLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH 284

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 40/160 (25%), Positives = 77/160 (48%), Gaps = 8/160 (5%)
Query: 382 VSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQR 441
           V++E  ++++++H   + L     ++   Y    YA NG L  ++   +  G + +   R
Sbjct: 79  VTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI---RKIGSFDETCTR 135
Query: 442 IQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFAL 501
              A ++ + L YLH       +H+D+   N+LL+ D+  +I +F  A+     E + A 
Sbjct: 136 FYTA-EIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAK-VLSPESKQAR 190
Query: 502 TRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTG 541
               VGT  Y++PE L         D++A G +I +++ G
Sbjct: 191 ANXFVGTAQYVSPELLTEKSAXKSSDLWALGCIIYQLVAG 230

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 40/160 (25%), Positives = 77/160 (48%), Gaps = 8/160 (5%)
Query: 382 VSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQR 441
           V++E  ++++++H   + L     ++   Y    YA NG L  ++   +  G + +   R
Sbjct: 79  VTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI---RKIGSFDETCTR 135
Query: 442 IQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFAL 501
              A ++ + L YLH       +H+D+   N+LL+ D+  +I +F  A+     E + A 
Sbjct: 136 FYTA-EIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAK-VLSPESKQAR 190
Query: 502 TRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTG 541
               VGT  Y++PE L         D++A G +I +++ G
Sbjct: 191 ANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 40/160 (25%), Positives = 77/160 (48%), Gaps = 8/160 (5%)
Query: 382 VSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQR 441
           V++E  ++++++H   + L     ++   Y    YA NG L  ++   +  G + +   R
Sbjct: 77  VTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI---RKIGSFDETCTR 133
Query: 442 IQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFAL 501
              A ++ + L YLH       +H+D+   N+LL+ D+  +I +F  A+     E + A 
Sbjct: 134 FYTA-EIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAK-VLSPESKQAR 188
Query: 502 TRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTG 541
               VGT  Y++PE L         D++A G +I +++ G
Sbjct: 189 ANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/188 (28%), Positives = 83/188 (44%), Gaps = 20/188 (10%)
Query: 365 RGKINGGFAAIKKVNGDV---SKEIA-------LLNKINHSNLIILSGVCFNEGNCYLVY 414
           R K  G + A+K +  +V     E+A       +L    H  L  L            V 
Sbjct: 30  REKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 89
Query: 415 EYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVL 474
           EYA  G L    F    E  + + + R   A ++ + L YLHS      V++DI   N++
Sbjct: 90  EYANGGEL---FFHLSRERVFTEERARFYGA-EIVSALEYLHSRDV---VYRDIKLENLM 142
Query: 475 LDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVL 534
           LD D   KI +F + +  EG   + A  +   GT  Y+APE LE+      +D +  GV+
Sbjct: 143 LDKDGHIKITDFGLCK--EGI-SDGATMKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVV 199
Query: 535 ILEMLTGK 542
           + EM+ G+
Sbjct: 200 MYEMMCGR 207

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/189 (29%), Positives = 84/189 (44%), Gaps = 22/189 (11%)
Query: 365 RGKINGGFAAIKKVNGDV---SKEIA-------LLNKINHSNLIILSGVCFNEGNCYLVY 414
           R K  G + A+K +  +V     E+A       +L    H  L  L            V 
Sbjct: 25  REKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84
Query: 415 EYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVL 474
           EYA  G L    F    E  + + + R   A ++ + L YLHS      V++DI   N++
Sbjct: 85  EYANGGEL---FFHLSRERVFTEERARFYGA-EIVSALEYLHSRDV---VYRDIKLENLM 137
Query: 475 LDSDLRAKIANFAMARPAEG-QEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGV 533
           LD D   KI +F + +  EG  +G  A  +   GT  Y+APE LE+      +D +  GV
Sbjct: 138 LDKDGHIKITDFGLCK--EGISDG--ATMKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGV 193
Query: 534 LILEMLTGK 542
           ++ EM+ G+
Sbjct: 194 VMYEMMCGR 202

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 40/160 (25%), Positives = 77/160 (48%), Gaps = 8/160 (5%)
Query: 382 VSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQR 441
           V++E  ++++++H   + L     ++   Y    YA NG L  ++   +  G + +   R
Sbjct: 79  VTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI---RKIGSFDETCTR 135
Query: 442 IQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFAL 501
              A ++ + L YLH       +H+D+   N+LL+ D+  +I +F  A+     E + A 
Sbjct: 136 FYTA-EIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAK-VLSPESKQAR 190
Query: 502 TRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTG 541
               VGT  Y++PE L         D++A G +I +++ G
Sbjct: 191 ANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/243 (22%), Positives = 94/243 (38%), Gaps = 45/243 (18%)
Query: 381 DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNK---NEGKYLD 437
           D   E  +++K NH N++   GV       +++ E    G L  ++   +   ++   L 
Sbjct: 94  DFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLA 153
Query: 438 WKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSD---LRAKIANFAMARPAEG 494
               + +A D+A G  YL        +H+DI + N LL        AKI +F MAR    
Sbjct: 154 MLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR---- 206
Query: 495 QEGEFALTRHIVGTKG--------YMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAA 546
                 + R     KG        +M PE    G+ ++K D ++FGVL+ E+ +      
Sbjct: 207 -----DIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS------ 255
Query: 547 LHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPT 606
                        L  +       + +  F+    + + P      V R++  C +  P 
Sbjct: 256 -------------LGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPE 302
Query: 607 DRP 609
           DRP
Sbjct: 303 DRP 305

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/233 (24%), Positives = 104/233 (44%), Gaps = 32/233 (13%)
Query: 321 DEESQDFLESISGVAQSLKVYS-FKEL-QSATDNFSFTCRIQGSVYRGK--INGGFAAIK 376
           DEE  + L SI  V    K Y+ F+++ Q A+          G+VY       G   AI+
Sbjct: 2   DEEILEKLRSIVSVGDPKKKYTRFEKIGQGAS----------GTVYTAMDVATGQEVAIR 51
Query: 377 KVNGD-------VSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSN 429
           ++N         +  EI ++ +  + N++            ++V EY   G+L+D V   
Sbjct: 52  QMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET 111
Query: 430 KNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMA 489
                 +D  Q   +  +    L +LHS      +H+DI S N+LL  D   K+ +F   
Sbjct: 112 -----CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFC 163
Query: 490 RPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGK 542
                ++ + +    +VGT  +MAPE +       K+D+++ G++ +EM+ G+
Sbjct: 164 AQITPEQSKRS---XMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 67/244 (27%), Positives = 109/244 (44%), Gaps = 38/244 (15%)
Query: 384 KEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQ 443
           +E   + + +H +++ L GV   E   +++ E    G L  ++   K     LD    I 
Sbjct: 440 QEALTMRQFDHPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKFS---LDLASLIL 495
Query: 444 IALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTR 503
            A  ++T L YL S      VH+DI + NVL+ S+   K+ +F ++R  E        + 
Sbjct: 496 YAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED-------ST 545
Query: 504 HIVGTKG-----YMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSD 558
           +   +KG     +MAPE +     ++  DV+ FGV + E+L           +NN    D
Sbjct: 546 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHG-VKPFQGVKNN----D 600
Query: 559 VLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSL 618
           V+  +   E+GE   R  + P    N P  L  L+ +    C   DP+ RP   E++  L
Sbjct: 601 VIGRI---ENGE---RLPMPP----NCPPTLYSLMTK----CWAYDPSRRPRFTELKAQL 646
Query: 619 SNIL 622
           S IL
Sbjct: 647 STIL 650

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 40/160 (25%), Positives = 77/160 (48%), Gaps = 8/160 (5%)
Query: 382 VSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQR 441
           V++E  ++++++H   + L     ++   Y    YA NG L  ++   +  G + +   R
Sbjct: 79  VTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI---RKIGSFDETCTR 135
Query: 442 IQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFAL 501
              A ++ + L YLH       +H+D+   N+LL+ D+  +I +F  A+     E + A 
Sbjct: 136 FYTA-EIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAK-VLSPESKQAR 190
Query: 502 TRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTG 541
               VGT  Y++PE L         D++A G +I +++ G
Sbjct: 191 ANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 76/158 (48%), Gaps = 15/158 (9%)
Query: 385 EIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSN-KNEGKYLDWKQRIQ 443
           E  +L  +N   L+ L     +  N Y+V EYA  G +    FS+ +  G++ +   R  
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEM----FSHLRRIGRFXEPHARFY 146
Query: 444 IALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTR 503
            A  V T   YLHS      +++D+   N+++D     K+ +F  A+  +G+      T 
Sbjct: 147 AAQIVLT-FEYLHSLD---LIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGR------TW 196
Query: 504 HIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTG 541
            + GT  Y+APE + +   +  +D +A GVLI EM  G
Sbjct: 197 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/240 (22%), Positives = 118/240 (49%), Gaps = 32/240 (13%)
Query: 378 VNGDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLD 437
           +   + +E+ +L++ N   ++   G  +++G   +  E+   G+L D V   K  G+   
Sbjct: 66  IRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVL--KKAGRI-- 120
Query: 438 WKQRI--QIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQ 495
             ++I  ++++ V  GL YL        +H+D+  SN+L++S    K+ +F ++    GQ
Sbjct: 121 -PEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQ 173
Query: 496 EGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMH 555
             + ++    VGT+ YM+PE L+    S + D+++ G+ ++EM  G+    + +   +M 
Sbjct: 174 LID-SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR--YPIGSGSGSMA 230
Query: 556 LSDVLNAVLTKEDGEESLRHFIDPTL-QGNYPLELALLVIRLIDACLKKDPTDRPTMYEI 614
           + ++L+ ++ +            P L  G + LE        ++ CL K+P +R  + ++
Sbjct: 231 IFELLDYIVNEP----------PPKLPSGVFSLEFQ----DFVNKCLIKNPAERADLKQL 276

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 40/160 (25%), Positives = 77/160 (48%), Gaps = 8/160 (5%)
Query: 382 VSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQR 441
           V++E  ++++++H   + L     ++   Y    YA NG L  ++   +  G + +   R
Sbjct: 61  VTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI---RKIGSFDETCTR 117
Query: 442 IQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFAL 501
              A ++ + L YLH       +H+D+   N+LL+ D+  +I +F  A+     E + A 
Sbjct: 118 FYTA-EIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAK-VLSPESKQAR 172
Query: 502 TRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTG 541
               VGT  Y++PE L         D++A G +I +++ G
Sbjct: 173 ANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 212

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 40/160 (25%), Positives = 77/160 (48%), Gaps = 8/160 (5%)
Query: 382 VSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQR 441
           V++E  ++++++H   + L     ++   Y    YA NG L  ++   +  G + +   R
Sbjct: 77  VTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI---RKIGSFDETCTR 133
Query: 442 IQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFAL 501
              A ++ + L YLH       +H+D+   N+LL+ D+  +I +F  A+     E + A 
Sbjct: 134 FYTA-EIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAK-VLSPESKQAR 188
Query: 502 TRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTG 541
               VGT  Y++PE L         D++A G +I +++ G
Sbjct: 189 ANAFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/233 (24%), Positives = 104/233 (44%), Gaps = 32/233 (13%)
Query: 321 DEESQDFLESISGVAQSLKVYS-FKEL-QSATDNFSFTCRIQGSVYRGK--INGGFAAIK 376
           DEE  + L SI  V    K Y+ F+++ Q A+          G+VY       G   AI+
Sbjct: 2   DEEILEKLRSIVSVGDPKKKYTRFEKIGQGAS----------GTVYTAMDVATGQEVAIR 51
Query: 377 KVNGD-------VSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSN 429
           ++N         +  EI ++ +  + N++            ++V EY   G+L+D V   
Sbjct: 52  QMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET 111
Query: 430 KNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMA 489
                 +D  Q   +  +    L +LHS      +H+DI S N+LL  D   K+ +F   
Sbjct: 112 -----CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFC 163
Query: 490 RPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGK 542
                ++ + +    +VGT  +MAPE +       K+D+++ G++ +EM+ G+
Sbjct: 164 AQITPEQSKRST---MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 76/158 (48%), Gaps = 15/158 (9%)
Query: 385 EIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSN-KNEGKYLDWKQRIQ 443
           E  +L  +N   L+ L     +  N Y+V EY   G +    FS+ +  G++ +   R  
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFY 146
Query: 444 IALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTR 503
            A  V T   YLHS      +++D+   N+L+D     K+A+F  A+  +G+      T 
Sbjct: 147 AAQIVLT-FEYLHSLD---LIYRDLKPENLLIDQQGYIKVADFGFAKRVKGR------TW 196
Query: 504 HIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTG 541
            + GT  Y+APE + +   +  +D +A GVLI EM  G
Sbjct: 197 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 77/158 (48%), Gaps = 15/158 (9%)
Query: 385 EIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSN-KNEGKYLDWKQRIQ 443
           E  +L  +N   L+ L     +  N Y+V EYA  G +    FS+ +  G++ +   R  
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEM----FSHLRRIGRFSEPHARFY 146
Query: 444 IALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTR 503
            A  V T   YLHS      +++D+   N+++D     K+ +F +A+  +G+      T 
Sbjct: 147 AAQIVLT-FEYLHSLD---LIYRDLKPENLMIDQQGYIKVTDFGLAKRVKGR------TW 196
Query: 504 HIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTG 541
            + GT  Y+APE + +   +  +D +A GVLI EM  G
Sbjct: 197 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/188 (28%), Positives = 83/188 (44%), Gaps = 20/188 (10%)
Query: 365 RGKINGGFAAIKKVNGDV---SKEIA-------LLNKINHSNLIILSGVCFNEGNCYLVY 414
           R K  G + A+K +  +V     E+A       +L    H  L  L            V 
Sbjct: 28  REKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 87
Query: 415 EYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVL 474
           EYA  G L    F    E  + + + R   A ++ + L YLHS      V++DI   N++
Sbjct: 88  EYANGGEL---FFHLSRERVFTEERARFYGA-EIVSALEYLHSRDV---VYRDIKLENLM 140
Query: 475 LDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVL 534
           LD D   KI +F + +  EG   + A  +   GT  Y+APE LE+      +D +  GV+
Sbjct: 141 LDKDGHIKITDFGLCK--EGI-SDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVV 197
Query: 535 ILEMLTGK 542
           + EM+ G+
Sbjct: 198 MYEMMCGR 205

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/243 (22%), Positives = 94/243 (38%), Gaps = 45/243 (18%)
Query: 381 DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNK---NEGKYLD 437
           D   E  +++K NH N++   GV       +++ E    G L  ++   +   ++   L 
Sbjct: 71  DFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLA 130
Query: 438 WKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLL---DSDLRAKIANFAMARPAEG 494
               + +A D+A G  YL        +H+DI + N LL        AKI +F MAR    
Sbjct: 131 MLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR---- 183
Query: 495 QEGEFALTRHIVGTKG--------YMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAA 546
                 + R     KG        +M PE    G+ ++K D ++FGVL+ E+ +      
Sbjct: 184 -----DIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS------ 232
Query: 547 LHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPT 606
                        L  +       + +  F+    + + P      V R++  C +  P 
Sbjct: 233 -------------LGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPE 279
Query: 607 DRP 609
           DRP
Sbjct: 280 DRP 282

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 66/245 (26%), Positives = 108/245 (44%), Gaps = 38/245 (15%)
Query: 384 KEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQ 443
           +E   + + +H +++ L GV   E   +++ E    G L  ++   K     LD    I 
Sbjct: 60  QEALTMRQFDHPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKFS---LDLASLIL 115
Query: 444 IALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTR 503
            A  ++T L YL S      VH+DI + NVL+ +    K+ +F ++R  E        + 
Sbjct: 116 YAYQLSTALAYLES---KRFVHRDIAARNVLVSATDCVKLGDFGLSRYMED-------ST 165
Query: 504 HIVGTKG-----YMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSD 558
           +   +KG     +MAPE +     ++  DV+ FGV + E+L           +NN    D
Sbjct: 166 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHG-VKPFQGVKNN----D 220
Query: 559 VLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSL 618
           V+  +   E+GE   R  + P    N P  L  L+ +    C   DP+ RP   E++  L
Sbjct: 221 VIGRI---ENGE---RLPMPP----NCPPTLYSLMTK----CWAYDPSRRPRFTELKAQL 266
Query: 619 SNILN 623
           S IL 
Sbjct: 267 STILE 271

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 40/160 (25%), Positives = 77/160 (48%), Gaps = 8/160 (5%)
Query: 382 VSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQR 441
           V++E  ++++++H   + L     ++   Y    YA NG L  ++   +  G + +   R
Sbjct: 76  VTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI---RKIGSFDETCTR 132
Query: 442 IQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFAL 501
              A ++ + L YLH       +H+D+   N+LL+ D+  +I +F  A+     E + A 
Sbjct: 133 FYTA-EIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAK-VLSPESKQAR 187
Query: 502 TRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTG 541
               VGT  Y++PE L         D++A G +I +++ G
Sbjct: 188 ANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 227

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 84/166 (50%), Gaps = 17/166 (10%)
Query: 381 DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQ 440
           D+ +E+++L +I H N+I L  V  N+ +  L+ E    G L D++     E + L  ++
Sbjct: 59  DIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL----AEKESLTEEE 114
Query: 441 RIQIALDVATGLNYLHSFTNPPHVHKDINSSNV-LLDSDL---RAKIANFAMARPAE-GQ 495
             +    +  G+ YLHS       H D+   N+ LLD ++   R KI +F +A   + G 
Sbjct: 115 ATEFLKQILNGVYYLHSLQI---AHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN 171
Query: 496 EGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTG 541
           E      ++I GT  ++APE +    +  + D+++ GV+   +L+G
Sbjct: 172 E-----FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 212

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 58/233 (24%), Positives = 104/233 (44%), Gaps = 32/233 (13%)
Query: 321 DEESQDFLESISGVAQSLKVYS-FKEL-QSATDNFSFTCRIQGSVYRGK--INGGFAAIK 376
           DEE  + L SI  V    K Y+ F+++ Q A+          G+VY       G   AI+
Sbjct: 3   DEEILEKLRSIVSVGDPKKKYTRFEKIGQGAS----------GTVYTAMDVATGQEVAIR 52
Query: 377 KVNGD-------VSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSN 429
           ++N         +  EI ++ +  + N++            ++V EY   G+L+D V   
Sbjct: 53  QMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET 112
Query: 430 KNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMA 489
                 +D  Q   +  +    L +LHS      +H+DI S N+LL  D   K+ +F   
Sbjct: 113 -----CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFC 164
Query: 490 RPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGK 542
                ++ + +    +VGT  +MAPE +       K+D+++ G++ +EM+ G+
Sbjct: 165 AQITPEQSKRS---XMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 214

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 63/256 (24%), Positives = 110/256 (42%), Gaps = 42/256 (16%)
Query: 385 EIALLNKINHS-NLIILSGVCFNEGNCYLV-YEYAVNGTLSDWVFSNKNE--------GK 434
           E+ +L  I H  N++ L G C   G   +V  E+   G LS ++ S +NE          
Sbjct: 80  ELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKD 139
Query: 435 YLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMAR---- 490
           +L  +  I  +  VA G+ +L S      +H+D+ + N+LL      KI +F +AR    
Sbjct: 140 FLTLEHLIXYSFQVAKGMEFLASRKX---IHRDLAARNILLSEKNVVKIXDFGLARDIYK 196
Query: 491 -PAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHA 549
            P   ++G+  L         +MAPE + + + + + DV++FGVL+ E+ +   +     
Sbjct: 197 DPDYVRKGDARLPLK------WMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 250
Query: 550 EENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRP 609
           + +                 EE  R   + T           +   ++D C   +P+ RP
Sbjct: 251 KID-----------------EEFXRRLKEGTRMRAPDYTTPEMYQTMLD-CWHGEPSQRP 292
Query: 610 TMYEIEHSLSNILNAS 625
           T  E+   L N+L A+
Sbjct: 293 TFSELVEHLGNLLQAN 308

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/243 (22%), Positives = 94/243 (38%), Gaps = 45/243 (18%)
Query: 381 DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNK---NEGKYLD 437
           D   E  +++K NH N++   GV       +++ E    G L  ++   +   ++   L 
Sbjct: 94  DFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLA 153
Query: 438 WKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLL---DSDLRAKIANFAMARPAEG 494
               + +A D+A G  YL        +H+DI + N LL        AKI +F MAR    
Sbjct: 154 MLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR---- 206
Query: 495 QEGEFALTRHIVGTKG--------YMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAA 546
                 + R     KG        +M PE    G+ ++K D ++FGVL+ E+ +      
Sbjct: 207 -----DIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS------ 255
Query: 547 LHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPT 606
                        L  +       + +  F+    + + P      V R++  C +  P 
Sbjct: 256 -------------LGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPE 302
Query: 607 DRP 609
           DRP
Sbjct: 303 DRP 305

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 84/166 (50%), Gaps = 17/166 (10%)
Query: 381 DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQ 440
           D+ +E+++L +I H N+I L  V  N+ +  L+ E    G L D++     E + L  ++
Sbjct: 60  DIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL----AEKESLTEEE 115
Query: 441 RIQIALDVATGLNYLHSFTNPPHVHKDINSSNV-LLDSDL---RAKIANFAMARPAE-GQ 495
             +    +  G+ YLHS       H D+   N+ LLD ++   R KI +F +A   + G 
Sbjct: 116 ATEFLKQILNGVYYLHSLQI---AHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN 172
Query: 496 EGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTG 541
           E      ++I GT  ++APE +    +  + D+++ GV+   +L+G
Sbjct: 173 E-----FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 40/160 (25%), Positives = 77/160 (48%), Gaps = 8/160 (5%)
Query: 382 VSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQR 441
           V++E  ++++++H   + L     ++   Y    YA NG L  ++   +  G + +   R
Sbjct: 76  VTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI---RKIGSFDETCTR 132
Query: 442 IQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFAL 501
              A ++ + L YLH       +H+D+   N+LL+ D+  +I +F  A+     E + A 
Sbjct: 133 FYTA-EIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAK-VLSPESKQAR 187
Query: 502 TRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTG 541
               VGT  Y++PE L         D++A G +I +++ G
Sbjct: 188 ANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 227

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 84/166 (50%), Gaps = 17/166 (10%)
Query: 381 DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQ 440
           D+ +E+++L +I H N+I L  V  N+ +  L+ E    G L D++     E + L  ++
Sbjct: 60  DIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL----AEKESLTEEE 115
Query: 441 RIQIALDVATGLNYLHSFTNPPHVHKDINSSNV-LLDSDL---RAKIANFAMARPAE-GQ 495
             +    +  G+ YLHS       H D+   N+ LLD ++   R KI +F +A   + G 
Sbjct: 116 ATEFLKQILNGVYYLHSLQI---AHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN 172
Query: 496 EGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTG 541
           E      ++I GT  ++APE +    +  + D+++ GV+   +L+G
Sbjct: 173 E-----FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 84/166 (50%), Gaps = 17/166 (10%)
Query: 381 DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQ 440
           D+ +E+++L +I H N+I L  V  N+ +  L+ E    G L D++     E + L  ++
Sbjct: 60  DIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL----AEKESLTEEE 115
Query: 441 RIQIALDVATGLNYLHSFTNPPHVHKDINSSNV-LLDSDL---RAKIANFAMARPAE-GQ 495
             +    +  G+ YLHS       H D+   N+ LLD ++   R KI +F +A   + G 
Sbjct: 116 ATEFLKQILNGVYYLHSLQI---AHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN 172
Query: 496 EGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTG 541
           E      ++I GT  ++APE +    +  + D+++ GV+   +L+G
Sbjct: 173 E-----FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 62/278 (22%), Positives = 106/278 (38%), Gaps = 60/278 (21%)
Query: 361 GSVYRGKINGGF-------AAIKKVNG--------DVSKEIALLNKINHSNLIILSGVCF 405
           G VY G+++G          A+K +          D   E  +++K NH N++   GV  
Sbjct: 61  GEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSL 120
Query: 406 NEGNCYLVYEYAVNGTLSDWVFSNK---NEGKYLDWKQRIQIALDVATGLNYLHSFTNPP 462
                +++ E    G L  ++   +   ++   L     + +A D+A G  YL       
Sbjct: 121 QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--- 177
Query: 463 HVHKDINSSNVLLDSD---LRAKIANFAMARPAEGQEGEFALTRHIVGTKG--------Y 511
            +H+DI + N LL        AKI +F MAR          + R     KG        +
Sbjct: 178 FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR---------DIYRASYYRKGGCAMLPVKW 228
Query: 512 MAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEE 571
           M PE    G+ ++K D ++FGVL+ E+ +                   L  +       +
Sbjct: 229 MPPEAFMEGIFTSKTDTWSFGVLLWEIFS-------------------LGYMPYPSKSNQ 269
Query: 572 SLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRP 609
            +  F+    + + P      V R++  C +  P DRP
Sbjct: 270 EVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRP 307

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/243 (22%), Positives = 94/243 (38%), Gaps = 45/243 (18%)
Query: 381 DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNK---NEGKYLD 437
           D   E  +++K NH N++   GV       +++ E    G L  ++   +   ++   L 
Sbjct: 79  DFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLA 138
Query: 438 WKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSD---LRAKIANFAMARPAEG 494
               + +A D+A G  YL        +H+DI + N LL        AKI +F MAR    
Sbjct: 139 MLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR---- 191
Query: 495 QEGEFALTRHIVGTKG--------YMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAA 546
                 + R     KG        +M PE    G+ ++K D ++FGVL+ E+ +      
Sbjct: 192 -----DIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS------ 240
Query: 547 LHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPT 606
                        L  +       + +  F+    + + P      V R++  C +  P 
Sbjct: 241 -------------LGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPE 287
Query: 607 DRP 609
           DRP
Sbjct: 288 DRP 290

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 84/166 (50%), Gaps = 17/166 (10%)
Query: 381 DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQ 440
           D+ +E+++L +I H N+I L  V  N+ +  L+ E    G L D++     E + L  ++
Sbjct: 59  DIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL----AEKESLTEEE 114
Query: 441 RIQIALDVATGLNYLHSFTNPPHVHKDINSSNV-LLDSDL---RAKIANFAMARPAE-GQ 495
             +    +  G+ YLHS       H D+   N+ LLD ++   R KI +F +A   + G 
Sbjct: 115 ATEFLKQILNGVYYLHSLQI---AHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN 171
Query: 496 EGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTG 541
           E      ++I GT  ++APE +    +  + D+++ GV+   +L+G
Sbjct: 172 E-----FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 212

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 48/166 (28%), Positives = 82/166 (49%), Gaps = 21/166 (12%)
Query: 382 VSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNK----NEGKYLD 437
           V +EI+ L  + H ++I L  V     +  +V EYA  G L D++   K    +EG+   
Sbjct: 56  VEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRF- 113
Query: 438 WKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEG 497
           ++Q       +   + Y H       VH+D+   N+LLD +L  KIA+F ++      +G
Sbjct: 114 FQQ-------IICAIEYCHRHKI---VHRDLKPENLLLDDNLNVKIADFGLSNIM--TDG 161
Query: 498 EFALTRHIVGTKGYMAPEYLENGLVS-TKLDVYAFGVLILEMLTGK 542
            F  T    G+  Y APE +   L +  ++DV++ G+++  ML G+
Sbjct: 162 NFLKTS--CGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGR 205

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 84/166 (50%), Gaps = 17/166 (10%)
Query: 381 DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQ 440
           D+ +E+++L +I H N+I L  V  N+ +  L+ E    G L D++     E + L  ++
Sbjct: 60  DIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL----AEKESLTEEE 115
Query: 441 RIQIALDVATGLNYLHSFTNPPHVHKDINSSNV-LLDSDL---RAKIANFAMARPAE-GQ 495
             +    +  G+ YLHS       H D+   N+ LLD ++   R KI +F +A   + G 
Sbjct: 116 ATEFLKQILNGVYYLHSLQI---AHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN 172
Query: 496 EGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTG 541
           E      ++I GT  ++APE +    +  + D+++ GV+   +L+G
Sbjct: 173 E-----FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 84/166 (50%), Gaps = 17/166 (10%)
Query: 381 DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQ 440
           D+ +E+++L +I H N+I L  V  N+ +  L+ E    G L D++     E + L  ++
Sbjct: 60  DIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL----AEKESLTEEE 115
Query: 441 RIQIALDVATGLNYLHSFTNPPHVHKDINSSNV-LLDSDL---RAKIANFAMARPAE-GQ 495
             +    +  G+ YLHS       H D+   N+ LLD ++   R KI +F +A   + G 
Sbjct: 116 ATEFLKQILNGVYYLHSLQI---AHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN 172
Query: 496 EGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTG 541
           E      ++I GT  ++APE +    +  + D+++ GV+   +L+G
Sbjct: 173 E-----FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/243 (22%), Positives = 94/243 (38%), Gaps = 45/243 (18%)
Query: 381 DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNK---NEGKYLD 437
           D   E  +++K NH N++   GV       +++ E    G L  ++   +   ++   L 
Sbjct: 79  DFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLA 138
Query: 438 WKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSD---LRAKIANFAMARPAEG 494
               + +A D+A G  YL        +H+DI + N LL        AKI +F MAR    
Sbjct: 139 MLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR---- 191
Query: 495 QEGEFALTRHIVGTKG--------YMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAA 546
                 + R     KG        +M PE    G+ ++K D ++FGVL+ E+ +      
Sbjct: 192 -----DIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS------ 240
Query: 547 LHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPT 606
                        L  +       + +  F+    + + P      V R++  C +  P 
Sbjct: 241 -------------LGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPE 287
Query: 607 DRP 609
           DRP
Sbjct: 288 DRP 290

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/188 (28%), Positives = 83/188 (44%), Gaps = 20/188 (10%)
Query: 365 RGKINGGFAAIKKVNGDV---SKEIA-------LLNKINHSNLIILSGVCFNEGNCYLVY 414
           R K  G + A+K +  +V     E+A       +L    H  L  L            V 
Sbjct: 25  REKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84
Query: 415 EYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVL 474
           EYA  G L    F    E  + + + R   A ++ + L YLHS      V++DI   N++
Sbjct: 85  EYANGGEL---FFHLSRERVFTEERARFYGA-EIVSALEYLHSRDV---VYRDIKLENLM 137
Query: 475 LDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVL 534
           LD D   KI +F + +  EG   + A  +   GT  Y+APE LE+      +D +  GV+
Sbjct: 138 LDKDGHIKITDFGLCK--EGI-SDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVV 194
Query: 535 ILEMLTGK 542
           + EM+ G+
Sbjct: 195 MYEMMCGR 202

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 42/156 (26%), Positives = 80/156 (51%), Gaps = 8/156 (5%)
Query: 385 EIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQI 444
           E  ++ ++++  ++ + G+C  E +  LV E A  G L+ ++  N+    ++  K  I++
Sbjct: 62  EANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAELGPLNKYLQQNR----HVKDKNIIEL 116
Query: 445 ALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRH 504
              V+ G+ YL        VH+D+ + NVLL +   AKI++F +++     E  +    H
Sbjct: 117 VHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTH 173
Query: 505 IVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT 540
                 + APE +     S+K DV++FGVL+ E  +
Sbjct: 174 GKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 209

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 90/202 (44%), Gaps = 34/202 (16%)
Query: 361 GSVYRG--KINGGFAAIKKVNGDVS--------KEIALLNKINHSNLIILSGVCFNEGNC 410
            +VY+G  K  G + A+K+V  D          +EI+L+ ++ H N++ L  V   E   
Sbjct: 19  ATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKL 78
Query: 411 YLVYEYAVNGT---LSDWVFSNKNEG------KYLDWKQRIQIALDVATGLNYLHSFTNP 461
            LV+E+  N     +      N   G      KY  W+        +  GL + H     
Sbjct: 79  TLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQ--------LLQGLAFCHENKI- 129
Query: 462 PHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGL 521
             +H+D+   N+L++   + K+ +F +AR        F+     V T  Y AP+ L    
Sbjct: 130 --LHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSE---VVTLWYRAPDVLMGSR 184
Query: 522 V-STKLDVYAFGVLILEMLTGK 542
             ST +D+++ G ++ EM+TGK
Sbjct: 185 TYSTSIDIWSCGCILAEMITGK 206

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 84/166 (50%), Gaps = 17/166 (10%)
Query: 381 DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQ 440
           D+ +E+++L +I H N+I L  V  N+ +  L+ E    G L D++     E + L  ++
Sbjct: 60  DIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL----AEKESLTEEE 115
Query: 441 RIQIALDVATGLNYLHSFTNPPHVHKDINSSNV-LLDSDL---RAKIANFAMARPAE-GQ 495
             +    +  G+ YLHS       H D+   N+ LLD ++   R KI +F +A   + G 
Sbjct: 116 ATEFLKQILNGVYYLHSLQI---AHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN 172
Query: 496 EGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTG 541
           E      ++I GT  ++APE +    +  + D+++ GV+   +L+G
Sbjct: 173 E-----FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 68/246 (27%), Positives = 108/246 (43%), Gaps = 31/246 (12%)
Query: 318 KKFDEESQDFLE---SISGVAQSLKVYSFKELQSATDNFSFTCRIQGSVYRGKI------ 368
           KK +EE  DF     S +  A+ ++V   K     T N     ++ G    GK+      
Sbjct: 114 KKQEEEEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEK 173
Query: 369 -NGGFAAIKKVNGDV---SKEIA-------LLNKINHSNLIILSGVCFNEGNCYLVYEYA 417
             G + A+K +  +V     E+A       +L    H  L  L            V EYA
Sbjct: 174 ATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYA 233
Query: 418 VNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDS 477
             G L    F    E  + + + R   A ++ + L+YLHS  N   V++D+   N++LD 
Sbjct: 234 NGGEL---FFHLSRERVFSEDRARFYGA-EIVSALDYLHSEKNV--VYRDLKLENLMLDK 287
Query: 478 DLRAKIANFAMARPAEG-QEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLIL 536
           D   KI +F + +  EG ++G  A  +   GT  Y+APE LE+      +D +  GV++ 
Sbjct: 288 DGHIKITDFGLCK--EGIKDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMY 343
Query: 537 EMLTGK 542
           EM+ G+
Sbjct: 344 EMMCGR 349

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 70/297 (23%), Positives = 128/297 (43%), Gaps = 48/297 (16%)
Query: 361 GSVYRGKINGGFAAIK----KVNGDVSKEIALLNKI--NHSNLIILSGVCFNEGNC---- 410
           G V+RG  +G   A+K    +      +E  + N +   H N++          N     
Sbjct: 22  GEVWRGLWHGESVAVKIFSSRDEQSWFRETEIYNTVLLRHDNILGFIASDMTSRNSSTQL 81
Query: 411 YLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLH-----SFTNPPHVH 465
           +L+  Y  +G+L D++     + + L+    +++A+  A GL +LH     +   P   H
Sbjct: 82  WLITHYHEHGSLYDFL-----QRQTLEPHLALRLAVSAACGLAHLHVEIFGTQGKPAIAH 136
Query: 466 KDINSSNVLLDSDLRAKIANFAMA-RPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVS- 523
           +D  S NVL+ S+L+  IA+  +A   ++G +         VGTK YMAPE L+  + + 
Sbjct: 137 RDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPRVGTKRYMAPEVLDEQIRTD 196
Query: 524 -----TKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESL----- 573
                   D++AFG+++ E+        +  E+      DV+    + ED ++ +     
Sbjct: 197 CFESYKWTDIWAFGLVLWEIARRTIVNGI-VEDYRPPFYDVVPNDPSFEDMKKVVCVDQQ 255
Query: 574 ------RHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNA 624
                 R   DP L G         + +++  C   +P+ R T   I+ +L  I N+
Sbjct: 256 TPTIPNRLAADPVLSG---------LAQMMRECWYPNPSARLTALRIKKTLQKISNS 303

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 84/166 (50%), Gaps = 17/166 (10%)
Query: 381 DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQ 440
           D+ +E+++L +I H N+I L  V  N+ +  L+ E    G L D++     E + L  ++
Sbjct: 60  DIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL----AEKESLTEEE 115
Query: 441 RIQIALDVATGLNYLHSFTNPPHVHKDINSSNV-LLDSDL---RAKIANFAMARPAE-GQ 495
             +    +  G+ YLHS       H D+   N+ LLD ++   R KI +F +A   + G 
Sbjct: 116 ATEFLKQILNGVYYLHSLQI---AHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN 172
Query: 496 EGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTG 541
           E      ++I GT  ++APE +    +  + D+++ GV+   +L+G
Sbjct: 173 E-----FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 76/158 (48%), Gaps = 15/158 (9%)
Query: 385 EIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSN-KNEGKYLDWKQRIQ 443
           E  +L  +N   L+ L     +  N Y+V EY   G +    FS+ +  G++ +   R  
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDM----FSHLRRIGRFSEPHARFY 146
Query: 444 IALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTR 503
            A  V T   YLHS      +++D+   N+L+D     K+A+F  A+  +G+      T 
Sbjct: 147 AAQIVLT-FEYLHSLD---LIYRDLKPENLLIDQQGYIKVADFGFAKRVKGR------TW 196
Query: 504 HIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTG 541
            + GT  Y+APE + +   +  +D +A GVLI EM  G
Sbjct: 197 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 76/158 (48%), Gaps = 15/158 (9%)
Query: 385 EIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSN-KNEGKYLDWKQRIQ 443
           E  +L  +N   L+ L     +  N Y+V EY   G +    FS+ +  G++ +   R  
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDM----FSHLRRIGRFSEPHARFY 146
Query: 444 IALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTR 503
            A  V T   YLHS      +++D+   N+L+D     K+A+F  A+  +G+      T 
Sbjct: 147 AAQIVLT-FEYLHSLD---LIYRDLKPENLLIDQQGYIKVADFGFAKRVKGR------TW 196
Query: 504 HIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTG 541
            + GT  Y+APE + +   +  +D +A GVLI EM  G
Sbjct: 197 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 77/165 (46%), Gaps = 14/165 (8%)
Query: 378 VNGDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLD 437
           V   + +EI +   ++H N++ L    ++    YL+ EYA  G L    +    +    D
Sbjct: 66  VEHQLRREIEIQAHLHHPNILRLYNYFYDRRRIYLILEYAPRGEL----YKELQKSCTFD 121
Query: 438 WKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEG 497
            ++   I  ++A  L Y H       +H+DI   N+LL      KIA+F  +  A     
Sbjct: 122 EQRTATIMEELADALMYCHGKKV---IHRDIKPENLLLGLKGELKIADFGWSVHAP---- 174
Query: 498 EFALTRH-IVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTG 541
             +L R  + GT  Y+ PE +E  + + K+D++  GVL  E+L G
Sbjct: 175 --SLRRKTMCGTLDYLPPEMIEGRMHNEKVDLWCIGVLCYELLVG 217

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 90/201 (44%), Gaps = 28/201 (13%)
Query: 361 GSVYRGK--INGGFAAIK--KVNGD----VSKEIALLNKINHSNLIILSGVCFNEGN--- 409
           G VY+G+    G  AAIK   V GD    + +EI +L K +H   I      F + N   
Sbjct: 38  GQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPG 97
Query: 410 ----CYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVH 465
                +LV E+   G+++D + + K      +W     I  ++  GL++LH       +H
Sbjct: 98  MDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWI--AYICREILRGLSHLHQHKV---IH 152
Query: 466 KDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLE-----NG 520
           +DI   NVLL  +   K+ +F ++   +   G        +GT  +MAPE +      + 
Sbjct: 153 RDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGR---RNTFIGTPYWMAPEVIACDENPDA 209
Query: 521 LVSTKLDVYAFGVLILEMLTG 541
               K D+++ G+  +EM  G
Sbjct: 210 TYDFKSDLWSLGITAIEMAEG 230

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/243 (22%), Positives = 94/243 (38%), Gaps = 45/243 (18%)
Query: 381 DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNK---NEGKYLD 437
           D   E  +++K NH N++   GV       +++ E    G L  ++   +   ++   L 
Sbjct: 80  DFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLA 139
Query: 438 WKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSD---LRAKIANFAMARPAEG 494
               + +A D+A G  YL        +H+DI + N LL        AKI +F MAR    
Sbjct: 140 MLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR---- 192
Query: 495 QEGEFALTRHIVGTKG--------YMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAA 546
                 + R     KG        +M PE    G+ ++K D ++FGVL+ E+ +      
Sbjct: 193 -----DIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS------ 241
Query: 547 LHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPT 606
                        L  +       + +  F+    + + P      V R++  C +  P 
Sbjct: 242 -------------LGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPE 288
Query: 607 DRP 609
           DRP
Sbjct: 289 DRP 291

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 84/166 (50%), Gaps = 17/166 (10%)
Query: 381 DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQ 440
           D+ +E+++L +I H N+I L  V  N+ +  L+ E    G L D++     E + L  ++
Sbjct: 60  DIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL----AEKESLTEEE 115
Query: 441 RIQIALDVATGLNYLHSFTNPPHVHKDINSSNV-LLDSDL---RAKIANFAMARPAE-GQ 495
             +    +  G+ YLHS       H D+   N+ LLD ++   R KI +F +A   + G 
Sbjct: 116 ATEFLKQILNGVYYLHSLQI---AHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN 172
Query: 496 EGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTG 541
           E      ++I GT  ++APE +    +  + D+++ GV+   +L+G
Sbjct: 173 E-----FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 84/166 (50%), Gaps = 17/166 (10%)
Query: 381 DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQ 440
           D+ +E+++L +I H N+I L  V  N+ +  L+ E    G L D++     E + L  ++
Sbjct: 60  DIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL----AEKESLTEEE 115
Query: 441 RIQIALDVATGLNYLHSFTNPPHVHKDINSSNV-LLDSDL---RAKIANFAMARPAE-GQ 495
             +    +  G+ YLHS       H D+   N+ LLD ++   R KI +F +A   + G 
Sbjct: 116 ATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN 172
Query: 496 EGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTG 541
           E      ++I GT  ++APE +    +  + D+++ GV+   +L+G
Sbjct: 173 E-----FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/243 (22%), Positives = 94/243 (38%), Gaps = 45/243 (18%)
Query: 381 DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNK---NEGKYLD 437
           D   E  +++K NH N++   GV       +++ E    G L  ++   +   ++   L 
Sbjct: 86  DFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLA 145
Query: 438 WKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSD---LRAKIANFAMARPAEG 494
               + +A D+A G  YL        +H+DI + N LL        AKI +F MAR    
Sbjct: 146 MLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR---- 198
Query: 495 QEGEFALTRHIVGTKG--------YMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAA 546
                 + R     KG        +M PE    G+ ++K D ++FGVL+ E+ +      
Sbjct: 199 -----DIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS------ 247
Query: 547 LHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPT 606
                        L  +       + +  F+    + + P      V R++  C +  P 
Sbjct: 248 -------------LGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPE 294
Query: 607 DRP 609
           DRP
Sbjct: 295 DRP 297

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/274 (22%), Positives = 108/274 (39%), Gaps = 52/274 (18%)
Query: 361 GSVYRGKINGGF-------AAIKKVNG--------DVSKEIALLNKINHSNLIILSGVCF 405
           G VY G+++G          A+K +          D   E  +++K NH N++   GV  
Sbjct: 45  GEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSL 104
Query: 406 NEGNCYLVYEYAVNGTLSDWVFSNK---NEGKYLDWKQRIQIALDVATGLNYLHSFTNPP 462
                +++ E    G L  ++   +   ++   L     + +A D+A G  YL       
Sbjct: 105 QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--- 161
Query: 463 HVHKDINSSNVLLDSD---LRAKIANFAMA----RPAEGQEGEFALTRHIVGTKGYMAPE 515
            +H+DI + N LL        AKI +F MA    R +  ++G  A+         +M PE
Sbjct: 162 FIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYRASYYRKGGCAML-----PVKWMPPE 216
Query: 516 YLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRH 575
               G+ ++K D ++FGVL+ E+ +                   L  +       + +  
Sbjct: 217 AFMEGIFTSKTDTWSFGVLLWEIFS-------------------LGYMPYPSKSNQEVLE 257
Query: 576 FIDPTLQGNYPLELALLVIRLIDACLKKDPTDRP 609
           F+    + + P      V R++  C +  P DRP
Sbjct: 258 FVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRP 291

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 63/256 (24%), Positives = 110/256 (42%), Gaps = 42/256 (16%)
Query: 385 EIALLNKINHS-NLIILSGVCFNEGNCYLV-YEYAVNGTLSDWVFSNKNE--------GK 434
           E+ +L  I H  N++ L G C   G   +V  E+   G LS ++ S +NE          
Sbjct: 80  ELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKD 139
Query: 435 YLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMAR---- 490
           +L  +  I  +  VA G+ +L S      +H+D+ + N+LL      KI +F +AR    
Sbjct: 140 FLTLEHLICYSFQVAKGMEFLASRKX---IHRDLAARNILLSEKNVVKICDFGLARDIYK 196
Query: 491 -PAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHA 549
            P   ++G+  L         +MAPE + + + + + DV++FGVL+ E+ +   +     
Sbjct: 197 DPDYVRKGDARLPLK------WMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 250
Query: 550 EENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRP 609
           + +                 EE  R   + T           +   ++D C   +P+ RP
Sbjct: 251 KID-----------------EEFCRRLKEGTRMRAPDYTTPEMYQTMLD-CWHGEPSQRP 292
Query: 610 TMYEIEHSLSNILNAS 625
           T  E+   L N+L A+
Sbjct: 293 TFSELVEHLGNLLQAN 308

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 76/158 (48%), Gaps = 15/158 (9%)
Query: 385 EIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSN-KNEGKYLDWKQRIQ 443
           E  +L  +N   L+ L     +  N Y+V EYA  G +    FS+ +  G++ +   R  
Sbjct: 92  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEM----FSHLRRIGRFSEPHARFY 147
Query: 444 IALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTR 503
            A  V T   YLHS      +++D+   N+++D     K+ +F  A+  +G+      T 
Sbjct: 148 AAQIVLT-FEYLHSLD---LIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGR------TW 197
Query: 504 HIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTG 541
            + GT  Y+APE + +   +  +D +A GVLI EM  G
Sbjct: 198 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 54/189 (28%), Positives = 87/189 (46%), Gaps = 21/189 (11%)
Query: 365 RGKINGGFAAIKKVNGDV---SKEIA-------LLNKINHSNLIILSGVCFNEGNCYLVY 414
           + K  G + A+K +  +V     E+A       +L    H  L  L            V 
Sbjct: 30  KEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVM 89
Query: 415 EYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVL 474
           EYA  G L    F    E  + + + R   A ++ + L+YLHS  N   V++D+   N++
Sbjct: 90  EYANGGEL---FFHLSRERVFSEDRARFYGA-EIVSALDYLHSEKNV--VYRDLKLENLM 143
Query: 475 LDSDLRAKIANFAMARPAEG-QEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGV 533
           LD D   KI +F + +  EG ++G  A  +   GT  Y+APE LE+      +D +  GV
Sbjct: 144 LDKDGHIKITDFGLCK--EGIKDG--ATMKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGV 199
Query: 534 LILEMLTGK 542
           ++ EM+ G+
Sbjct: 200 VMYEMMCGR 208

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 95/202 (47%), Gaps = 30/202 (14%)
Query: 361 GSVYRGK--INGG-FAAIKKVNGDVS---------KEIALLNKIN---HSNLIILSGVCF 405
           G V++ +   NGG F A+K+V              +E+A+L  +    H N++ L  VC 
Sbjct: 25  GKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCT 84
Query: 406 -----NEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTN 460
                 E    LV+E+ V+  L+ ++      G   +  + +   L    GL++LHS   
Sbjct: 85  VSRTDRETKLTLVFEH-VDQDLTTYLDKVPEPGVPTETIKDMMFQL--LRGLDFLHSHRV 141
Query: 461 PPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENG 520
              VH+D+   N+L+ S  + K+A+F +AR    Q    ALT  +V T  Y APE L   
Sbjct: 142 ---VHRDLKPQNILVTSSGQIKLADFGLARIYSFQ---MALT-SVVVTLWYRAPEVLLQS 194
Query: 521 LVSTKLDVYAFGVLILEMLTGK 542
             +T +D+++ G +  EM   K
Sbjct: 195 SYATPVDLWSVGCIFAEMFRRK 216

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 54/189 (28%), Positives = 87/189 (46%), Gaps = 21/189 (11%)
Query: 365 RGKINGGFAAIKKVNGDV---SKEIA-------LLNKINHSNLIILSGVCFNEGNCYLVY 414
           + K  G + A+K +  +V     E+A       +L    H  L  L            V 
Sbjct: 28  KEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVM 87
Query: 415 EYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVL 474
           EYA  G L    F    E  + + + R   A ++ + L+YLHS  N   V++D+   N++
Sbjct: 88  EYANGGEL---FFHLSRERVFSEDRARFYGA-EIVSALDYLHSEKNV--VYRDLKLENLM 141
Query: 475 LDSDLRAKIANFAMARPAEG-QEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGV 533
           LD D   KI +F + +  EG ++G  A  +   GT  Y+APE LE+      +D +  GV
Sbjct: 142 LDKDGHIKITDFGLCK--EGIKDG--ATMKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGV 197
Query: 534 LILEMLTGK 542
           ++ EM+ G+
Sbjct: 198 VMYEMMCGR 206

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 42/156 (26%), Positives = 79/156 (50%), Gaps = 8/156 (5%)
Query: 385 EIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQI 444
           E  ++ ++++  ++ + G+C  E +  LV E A  G L+ ++  N++       K  I++
Sbjct: 78  EANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAELGPLNKYLQQNRHVKD----KNIIEL 132
Query: 445 ALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRH 504
              V+ G+ YL        VH+D+ + NVLL +   AKI++F +++     E  +    H
Sbjct: 133 VHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTH 189
Query: 505 IVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT 540
                 + APE +     S+K DV++FGVL+ E  +
Sbjct: 190 GKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 225

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 42/156 (26%), Positives = 79/156 (50%), Gaps = 8/156 (5%)
Query: 385 EIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQI 444
           E  ++ ++++  ++ + G+C  E +  LV E A  G L+ ++  N++       K  I++
Sbjct: 78  EANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAELGPLNKYLQQNRHVKD----KNIIEL 132
Query: 445 ALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRH 504
              V+ G+ YL        VH+D+ + NVLL +   AKI++F +++     E  +    H
Sbjct: 133 VHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTH 189
Query: 505 IVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT 540
                 + APE +     S+K DV++FGVL+ E  +
Sbjct: 190 GKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 225

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 42/169 (24%), Positives = 86/169 (50%), Gaps = 19/169 (11%)
Query: 378 VNGDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLD 437
           +   + +E+ +L++ N   ++   G  +++G   +  E+   G+L D V   K  G+   
Sbjct: 109 IRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVL--KKAGRI-- 163
Query: 438 WKQRI--QIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQ 495
             ++I  ++++ V  GL YL        +H+D+  SN+L++S    K+ +F       G 
Sbjct: 164 -PEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDF-------GV 213
Query: 496 EGEF--ALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGK 542
            G+   ++    VGT+ YM+PE L+    S + D+++ G+ ++EM  G+
Sbjct: 214 SGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 262

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 76/158 (48%), Gaps = 15/158 (9%)
Query: 385 EIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSN-KNEGKYLDWKQRIQ 443
           E  +L  +N   L+ L     +  N Y+V EYA  G +    FS+ +  G++ +   R  
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEM----FSHLRRIGRFSEPHARFY 146
Query: 444 IALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTR 503
            A  V T   YLHS      +++D+   N+++D     K+ +F  A+  +G+      T 
Sbjct: 147 AAQIVLT-FEYLHSLD---LIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGR------TW 196
Query: 504 HIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTG 541
            + GT  Y+APE + +   +  +D +A GVLI EM  G
Sbjct: 197 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 76/158 (48%), Gaps = 15/158 (9%)
Query: 385 EIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSN-KNEGKYLDWKQRIQ 443
           E  +   +N   L+ L     +  N Y+V EYA  G +    FS+ +  G++ +   R  
Sbjct: 92  EKRIQQAVNFPFLVKLEFSFKDNSNLYMVLEYAPGGEM----FSHLRRIGRFSEPHARFY 147
Query: 444 IALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTR 503
            A  V T   YLHS      +++D+   N+L+D     K+A+F  A+  +G+      T 
Sbjct: 148 AAQIVLT-FEYLHSLD---LIYRDLKPENLLIDQQGYIKVADFGFAKRVKGR------TW 197
Query: 504 HIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTG 541
            + GT  Y+APE + +   +  +D +A GVLI EM  G
Sbjct: 198 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 45/150 (30%), Positives = 75/150 (50%), Gaps = 12/150 (8%)
Query: 411 YLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINS 470
           Y V EY VNG   D ++  +  G++ +    +  A ++A GL +L S      +++D+  
Sbjct: 418 YFVMEY-VNG--GDLMYHIQQVGRFKE-PHAVFYAAEIAIGLFFLQSKGI---IYRDLKL 470
Query: 471 SNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYA 530
            NV+LDS+   KIA+F M +       +   T+   GT  Y+APE +        +D +A
Sbjct: 471 DNVMLDSEGHIKIADFGMCKE---NIWDGVTTKXFCGTPDYIAPEIIAYQPYGKSVDWWA 527
Query: 531 FGVLILEMLTGKEAAALHAEENNMHLSDVL 560
           FGVL+ EML G+  A    E+ +     ++
Sbjct: 528 FGVLLYEMLAGQ--APFEGEDEDELFQSIM 555

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 62/278 (22%), Positives = 106/278 (38%), Gaps = 60/278 (21%)
Query: 361 GSVYRGKINGGF-------AAIKKVNG--------DVSKEIALLNKINHSNLIILSGVCF 405
           G VY G+++G          A+K +          D   E  +++K NH N++   GV  
Sbjct: 71  GEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSL 130
Query: 406 NEGNCYLVYEYAVNGTLSDWVFSNK---NEGKYLDWKQRIQIALDVATGLNYLHSFTNPP 462
                +++ E    G L  ++   +   ++   L     + +A D+A G  YL       
Sbjct: 131 QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--- 187
Query: 463 HVHKDINSSNVLLDSD---LRAKIANFAMARPAEGQEGEFALTRHIVGTKG--------Y 511
            +H+DI + N LL        AKI +F MAR          + R     KG        +
Sbjct: 188 FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR---------DIYRASYYRKGGCAMLPVKW 238
Query: 512 MAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEE 571
           M PE    G+ ++K D ++FGVL+ E+ +                   L  +       +
Sbjct: 239 MPPEAFMEGIFTSKTDTWSFGVLLWEIFS-------------------LGYMPYPSKSNQ 279
Query: 572 SLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRP 609
            +  F+    + + P      V R++  C +  P DRP
Sbjct: 280 EVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRP 317

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 42/156 (26%), Positives = 80/156 (51%), Gaps = 8/156 (5%)
Query: 385 EIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQI 444
           E  ++ ++++  ++ + G+C  E +  LV E A  G L+ ++  N+    ++  K  I++
Sbjct: 76  EANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAELGPLNKYLQQNR----HVKDKNIIEL 130
Query: 445 ALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRH 504
              V+ G+ YL        VH+D+ + NVLL +   AKI++F +++     E  +    H
Sbjct: 131 VHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTH 187
Query: 505 IVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT 540
                 + APE +     S+K DV++FGVL+ E  +
Sbjct: 188 GKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 223

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 47/159 (29%), Positives = 77/159 (48%), Gaps = 13/159 (8%)
Query: 404 CFNE-GNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPP 462
           CF      Y V EY VNG   D ++  +  G++ +    +  A ++A GL +L S     
Sbjct: 89  CFQTMDRLYFVMEY-VNG--GDLMYHIQQVGRFKE-PHAVFYAAEIAIGLFFLQS---KG 141
Query: 463 HVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLV 522
            +++D+   NV+LDS+   KIA+F M +       +   T+   GT  Y+APE +     
Sbjct: 142 IIYRDLKLDNVMLDSEGHIKIADFGMCKE---NIWDGVTTKXFCGTPDYIAPEIIAYQPY 198
Query: 523 STKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLN 561
              +D +AFGVL+ EML G+  A    E+ +     ++ 
Sbjct: 199 GKSVDWWAFGVLLYEMLAGQ--APFEGEDEDELFQSIME 235

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 84/166 (50%), Gaps = 17/166 (10%)
Query: 381 DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQ 440
           D+ +E+++L +I H N+I L  V  N+ +  L+ E    G L D++     E + L  ++
Sbjct: 60  DIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL----AEKESLTEEE 115
Query: 441 RIQIALDVATGLNYLHSFTNPPHVHKDINSSNV-LLDSDL---RAKIANFAMARPAE-GQ 495
             +    +  G+ YLHS       H D+   N+ LLD ++   R KI +F +A   + G 
Sbjct: 116 ATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN 172
Query: 496 EGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTG 541
           E      ++I GT  ++APE +    +  + D+++ GV+   +L+G
Sbjct: 173 E-----FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 44/170 (25%), Positives = 86/170 (50%), Gaps = 20/170 (11%)
Query: 377 KVNGDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNE--GK 434
           K N ++  E  ++  +++ ++  L G+C       L+ +    G L D+V  +K+    +
Sbjct: 63  KANKEILDEAYVMASVDNPHVCRLLGICLT-STVQLIMQLMPFGCLLDYVREHKDNIGSQ 121
Query: 435 YL-DWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAE 493
           YL +W       + +A G+NYL        VH+D+ + NVL+ +    KI +F +A+   
Sbjct: 122 YLLNW------CVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 172
Query: 494 GQEGEFALTRHIVGTK---GYMAPEYLENGLVSTKLDVYAFGVLILEMLT 540
            +E E+    H  G K    +MA E + + + + + DV+++GV + E++T
Sbjct: 173 AEEKEY----HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 218

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 95/202 (47%), Gaps = 30/202 (14%)
Query: 361 GSVYRGK--INGG-FAAIKKVNGDVS---------KEIALLNKIN---HSNLIILSGVCF 405
           G V++ +   NGG F A+K+V              +E+A+L  +    H N++ L  VC 
Sbjct: 25  GKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCT 84
Query: 406 -----NEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTN 460
                 E    LV+E+ V+  L+ ++      G   +  + +   L    GL++LHS   
Sbjct: 85  VSRTDRETKLTLVFEH-VDQDLTTYLDKVPEPGVPTETIKDMMFQL--LRGLDFLHSHRV 141
Query: 461 PPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENG 520
              VH+D+   N+L+ S  + K+A+F +AR    Q    ALT  +V T  Y APE L   
Sbjct: 142 ---VHRDLKPQNILVTSSGQIKLADFGLARIYSFQ---MALT-SVVVTLWYRAPEVLLQS 194
Query: 521 LVSTKLDVYAFGVLILEMLTGK 542
             +T +D+++ G +  EM   K
Sbjct: 195 SYATPVDLWSVGCIFAEMFRRK 216

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 54/189 (28%), Positives = 87/189 (46%), Gaps = 21/189 (11%)
Query: 365 RGKINGGFAAIKKVNGDV---SKEIA-------LLNKINHSNLIILSGVCFNEGNCYLVY 414
           + K  G + A+K +  +V     E+A       +L    H  L  L            V 
Sbjct: 29  KEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVM 88
Query: 415 EYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVL 474
           EYA  G L    F    E  + + + R   A ++ + L+YLHS  N   V++D+   N++
Sbjct: 89  EYANGGEL---FFHLSRERVFSEDRARFYGA-EIVSALDYLHSEKNV--VYRDLKLENLM 142
Query: 475 LDSDLRAKIANFAMARPAEG-QEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGV 533
           LD D   KI +F + +  EG ++G  A  +   GT  Y+APE LE+      +D +  GV
Sbjct: 143 LDKDGHIKITDFGLCK--EGIKDG--ATMKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGV 198
Query: 534 LILEMLTGK 542
           ++ EM+ G+
Sbjct: 199 VMYEMMCGR 207

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 42/156 (26%), Positives = 79/156 (50%), Gaps = 8/156 (5%)
Query: 385 EIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQI 444
           E  ++ ++++  ++ + G+C  E +  LV E A  G L+ ++  N++       K  I++
Sbjct: 62  EANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAELGPLNKYLQQNRHVKD----KNIIEL 116
Query: 445 ALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRH 504
              V+ G+ YL        VH+D+ + NVLL +   AKI++F +++     E  +    H
Sbjct: 117 VHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTH 173
Query: 505 IVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT 540
                 + APE +     S+K DV++FGVL+ E  +
Sbjct: 174 GKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 209

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 44/170 (25%), Positives = 86/170 (50%), Gaps = 20/170 (11%)
Query: 377 KVNGDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNE--GK 434
           K N ++  E  ++  +++ ++  L G+C       L+ +    G L D+V  +K+    +
Sbjct: 60  KANKEILDEAYVMASVDNPHVCRLLGICLT-STVQLIMQLMPFGXLLDYVREHKDNIGSQ 118
Query: 435 YL-DWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAE 493
           YL +W       + +A G+NYL        VH+D+ + NVL+ +    KI +F +A+   
Sbjct: 119 YLLNW------CVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 169
Query: 494 GQEGEFALTRHIVGTK---GYMAPEYLENGLVSTKLDVYAFGVLILEMLT 540
            +E E+    H  G K    +MA E + + + + + DV+++GV + E++T
Sbjct: 170 AEEKEY----HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 215

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 44/170 (25%), Positives = 86/170 (50%), Gaps = 20/170 (11%)
Query: 377 KVNGDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNE--GK 434
           K N ++  E  ++  +++ ++  L G+C       L+ +    G L D+V  +K+    +
Sbjct: 60  KANKEILDEAYVMASVDNPHVCRLLGICLT-STVQLIMQLMPFGCLLDYVREHKDNIGSQ 118
Query: 435 YL-DWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAE 493
           YL +W       + +A G+NYL        VH+D+ + NVL+ +    KI +F +A+   
Sbjct: 119 YLLNW------CVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 169
Query: 494 GQEGEFALTRHIVGTK---GYMAPEYLENGLVSTKLDVYAFGVLILEMLT 540
            +E E+    H  G K    +MA E + + + + + DV+++GV + E++T
Sbjct: 170 AEEKEY----HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 215

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 44/170 (25%), Positives = 86/170 (50%), Gaps = 20/170 (11%)
Query: 377 KVNGDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNE--GK 434
           K N ++  E  ++  +++ ++  L G+C       L+ +    G L D+V  +K+    +
Sbjct: 59  KANKEILDEAYVMASVDNPHVCRLLGICLT-STVQLIMQLMPFGCLLDYVREHKDNIGSQ 117
Query: 435 YL-DWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAE 493
           YL +W       + +A G+NYL        VH+D+ + NVL+ +    KI +F +A+   
Sbjct: 118 YLLNW------CVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168
Query: 494 GQEGEFALTRHIVGTK---GYMAPEYLENGLVSTKLDVYAFGVLILEMLT 540
            +E E+    H  G K    +MA E + + + + + DV+++GV + E++T
Sbjct: 169 AEEKEY----HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 95/202 (47%), Gaps = 30/202 (14%)
Query: 361 GSVYRGK--INGG-FAAIKKVNGDVS---------KEIALLNKIN---HSNLIILSGVCF 405
           G V++ +   NGG F A+K+V              +E+A+L  +    H N++ L  VC 
Sbjct: 25  GKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCT 84
Query: 406 -----NEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTN 460
                 E    LV+E+ V+  L+ ++      G   +  + +   L    GL++LHS   
Sbjct: 85  VSRTDRETKLTLVFEH-VDQDLTTYLDKVPEPGVPTETIKDMMFQL--LRGLDFLHSHRV 141
Query: 461 PPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENG 520
              VH+D+   N+L+ S  + K+A+F +AR    Q    ALT  +V T  Y APE L   
Sbjct: 142 ---VHRDLKPQNILVTSSGQIKLADFGLARIYSFQ---MALT-SVVVTLWYRAPEVLLQS 194
Query: 521 LVSTKLDVYAFGVLILEMLTGK 542
             +T +D+++ G +  EM   K
Sbjct: 195 SYATPVDLWSVGCIFAEMFRRK 216

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 44/170 (25%), Positives = 86/170 (50%), Gaps = 20/170 (11%)
Query: 377 KVNGDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNE--GK 434
           K N ++  E  ++  +++ ++  L G+C       L+ +    G L D+V  +K+    +
Sbjct: 93  KANKEILDEAYVMASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQ 151
Query: 435 YL-DWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAE 493
           YL +W       + +A G+NYL        VH+D+ + NVL+ +    KI +F +A+   
Sbjct: 152 YLLNW------CVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 202
Query: 494 GQEGEFALTRHIVGTK---GYMAPEYLENGLVSTKLDVYAFGVLILEMLT 540
            +E E+    H  G K    +MA E + + + + + DV+++GV + E++T
Sbjct: 203 AEEKEY----HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 248

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 44/170 (25%), Positives = 86/170 (50%), Gaps = 20/170 (11%)
Query: 377 KVNGDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNE--GK 434
           K N ++  E  ++  +++ ++  L G+C       L+ +    G L D+V  +K+    +
Sbjct: 61  KANKEILDEAYVMASVDNPHVCRLLGICLT-STVQLIMQLMPFGCLLDYVREHKDNIGSQ 119
Query: 435 YL-DWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAE 493
           YL +W       + +A G+NYL        VH+D+ + NVL+ +    KI +F +A+   
Sbjct: 120 YLLNW------CVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 170
Query: 494 GQEGEFALTRHIVGTK---GYMAPEYLENGLVSTKLDVYAFGVLILEMLT 540
            +E E+    H  G K    +MA E + + + + + DV+++GV + E++T
Sbjct: 171 AEEKEY----HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/244 (22%), Positives = 120/244 (49%), Gaps = 34/244 (13%)
Query: 378 VNGDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLD 437
           +   + +E+ +L++ N   ++   G  +++G   +  E+   G+L D V   K  G+   
Sbjct: 47  IRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVL--KKAGRI-- 101
Query: 438 WKQRI--QIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQ 495
             ++I  ++++ V  GL YL        +H+D+  SN+L++S    K+ +F ++    GQ
Sbjct: 102 -PEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVS----GQ 154
Query: 496 EGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGK-EAAALHAEENN- 553
             + ++    VGT+ YM+PE L+    S + D+++ G+ ++EM  G+       A+E++ 
Sbjct: 155 LID-SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKEDSR 213
Query: 554 --MHLSDVLNAVLTKEDGEESLRHFIDPTL-QGNYPLELALLVIRLIDACLKKDPTDRPT 610
             M + ++L+ ++ +            P L  G + LE        ++ CL K+P +R  
Sbjct: 214 PPMAIFELLDYIVNEP----------PPKLPSGVFSLEFQ----DFVNKCLIKNPAERAD 259
Query: 611 MYEI 614
           + ++
Sbjct: 260 LKQL 263

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 84/166 (50%), Gaps = 17/166 (10%)
Query: 381 DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQ 440
           D+ +E+++L +I H N+I L  V  N+ +  L+ E    G L D++     E + L  ++
Sbjct: 60  DIEREVSILKEIQHPNVITLHEVYENKTDVILIGELVAGGELFDFL----AEKESLTEEE 115
Query: 441 RIQIALDVATGLNYLHSFTNPPHVHKDINSSNV-LLDSDL---RAKIANFAMARPAE-GQ 495
             +    +  G+ YLHS       H D+   N+ LLD ++   R KI +F +A   + G 
Sbjct: 116 ATEFLKQILNGVYYLHSLQI---AHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN 172
Query: 496 EGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTG 541
           E      ++I GT  ++APE +    +  + D+++ GV+   +L+G
Sbjct: 173 E-----FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 42/156 (26%), Positives = 80/156 (51%), Gaps = 8/156 (5%)
Query: 385 EIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQI 444
           E  ++ ++++  ++ + G+C  E +  LV E A  G L+ ++  N+    ++  K  I++
Sbjct: 68  EANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAELGPLNKYLQQNR----HVKDKNIIEL 122
Query: 445 ALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRH 504
              V+ G+ YL        VH+D+ + NVLL +   AKI++F +++     E  +    H
Sbjct: 123 VHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTH 179
Query: 505 IVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT 540
                 + APE +     S+K DV++FGVL+ E  +
Sbjct: 180 GKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 215

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 42/156 (26%), Positives = 79/156 (50%), Gaps = 8/156 (5%)
Query: 385 EIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQI 444
           E  ++ ++++  ++ + G+C  E +  LV E A  G L+ ++  N++       K  I++
Sbjct: 58  EANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAELGPLNKYLQQNRHVKD----KNIIEL 112
Query: 445 ALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRH 504
              V+ G+ YL        VH+D+ + NVLL +   AKI++F +++     E  +    H
Sbjct: 113 VHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTH 169
Query: 505 IVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT 540
                 + APE +     S+K DV++FGVL+ E  +
Sbjct: 170 GKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 205

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 44/170 (25%), Positives = 86/170 (50%), Gaps = 20/170 (11%)
Query: 377 KVNGDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNE--GK 434
           K N ++  E  ++  +++ ++  L G+C       L+ +    G L D+V  +K+    +
Sbjct: 66  KANKEILDEAYVMASVDNPHVCRLLGICLT-STVQLIMQLMPFGCLLDYVREHKDNIGSQ 124
Query: 435 YL-DWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAE 493
           YL +W       + +A G+NYL        VH+D+ + NVL+ +    KI +F +A+   
Sbjct: 125 YLLNW------CVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 175
Query: 494 GQEGEFALTRHIVGTK---GYMAPEYLENGLVSTKLDVYAFGVLILEMLT 540
            +E E+    H  G K    +MA E + + + + + DV+++GV + E++T
Sbjct: 176 AEEKEY----HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 44/170 (25%), Positives = 86/170 (50%), Gaps = 20/170 (11%)
Query: 377 KVNGDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNE--GK 434
           K N ++  E  ++  +++ ++  L G+C       L+ +    G L D+V  +K+    +
Sbjct: 62  KANKEILDEAYVMASVDNPHVCRLLGICLT-STVQLIMQLMPFGCLLDYVREHKDNIGSQ 120
Query: 435 YL-DWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAE 493
           YL +W       + +A G+NYL        VH+D+ + NVL+ +    KI +F +A+   
Sbjct: 121 YLLNW------CVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 171
Query: 494 GQEGEFALTRHIVGTK---GYMAPEYLENGLVSTKLDVYAFGVLILEMLT 540
            +E E+    H  G K    +MA E + + + + + DV+++GV + E++T
Sbjct: 172 AEEKEY----HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 75/158 (47%), Gaps = 15/158 (9%)
Query: 385 EIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSN-KNEGKYLDWKQRIQ 443
           E  +L  +N   L+ L     +  N Y+V EY   G +    FS+ +  G++ +   R  
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFXEPHARFY 146
Query: 444 IALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTR 503
            A  V T   YLHS      +++D+   N+L+D     ++ +F  A+  +G+      T 
Sbjct: 147 AAQIVLT-FEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR------TW 196
Query: 504 HIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTG 541
            + GT  Y+APE + +   +  +D +A GVLI EM  G
Sbjct: 197 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 42/156 (26%), Positives = 79/156 (50%), Gaps = 8/156 (5%)
Query: 385 EIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQI 444
           E  ++ ++++  ++ + G+C  E +  LV E A  G L+ ++  N++       K  I++
Sbjct: 56  EANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAELGPLNKYLQQNRHVKD----KNIIEL 110
Query: 445 ALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRH 504
              V+ G+ YL        VH+D+ + NVLL +   AKI++F +++     E  +    H
Sbjct: 111 VHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTH 167
Query: 505 IVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT 540
                 + APE +     S+K DV++FGVL+ E  +
Sbjct: 168 GKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 203

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 64/257 (24%), Positives = 111/257 (43%), Gaps = 40/257 (15%)
Query: 363 VYRGKINGGFAAIKKVNGD-VSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGT 421
           V+ GK+      +K    + +S EIA+   +++ +++   G   ++   Y+V E     +
Sbjct: 69  VFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRS 128
Query: 422 LSDWVFSNK----NEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDS 477
           L +     K     E +Y   +Q IQ       G+ YLH   N   +H+D+   N+ L+ 
Sbjct: 129 LLELHKRRKAVTEPEARYF-MRQTIQ-------GVQYLH---NNRVIHRDLKLGNLFLND 177
Query: 478 DLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILE 537
           D+  KI +F +A   E  +GE   T  + GT  Y+APE L     S ++D+++ G ++  
Sbjct: 178 DMDVKIGDFGLATKIEF-DGERKKT--LCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYT 234
Query: 538 MLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLI 597
           +L GK              S +    +  +  E S+   I+P                LI
Sbjct: 235 LLVGKPP---------FETSCLKETYIRIKKNEYSVPRHINPVASA------------LI 273
Query: 598 DACLKKDPTDRPTMYEI 614
              L  DPT RP++ E+
Sbjct: 274 RRMLHADPTLRPSVAEL 290

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 44/170 (25%), Positives = 86/170 (50%), Gaps = 20/170 (11%)
Query: 377 KVNGDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNE--GK 434
           K N ++  E  ++  +++ ++  L G+C       L+ +    G L D+V  +K+    +
Sbjct: 69  KANKEILDEAYVMASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQ 127
Query: 435 YL-DWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAE 493
           YL +W       + +A G+NYL        VH+D+ + NVL+ +    KI +F +A+   
Sbjct: 128 YLLNW------CVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 178
Query: 494 GQEGEFALTRHIVGTK---GYMAPEYLENGLVSTKLDVYAFGVLILEMLT 540
            +E E+    H  G K    +MA E + + + + + DV+++GV + E++T
Sbjct: 179 AEEKEY----HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 224

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 44/170 (25%), Positives = 86/170 (50%), Gaps = 20/170 (11%)
Query: 377 KVNGDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNE--GK 434
           K N ++  E  ++  +++ ++  L G+C       L+ +    G L D+V  +K+    +
Sbjct: 59  KANKEILDEAYVMASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQ 117
Query: 435 YL-DWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAE 493
           YL +W       + +A G+NYL        VH+D+ + NVL+ +    KI +F +A+   
Sbjct: 118 YLLNW------CVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168
Query: 494 GQEGEFALTRHIVGTK---GYMAPEYLENGLVSTKLDVYAFGVLILEMLT 540
            +E E+    H  G K    +MA E + + + + + DV+++GV + E++T
Sbjct: 169 AEEKEY----HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 63/259 (24%), Positives = 110/259 (42%), Gaps = 45/259 (17%)
Query: 385 EIALLNKINHS-NLIILSGVCFNEGNCYLV-YEYAVNGTLSDWVFSNKNE---------- 432
           E+ +L  I H  N++ L G C   G   +V  E+   G LS ++ S +NE          
Sbjct: 81  ELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDL 140
Query: 433 -GKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMAR- 490
              +L  +  I  +  VA G+ +L S      +H+D+ + N+LL      KI +F +AR 
Sbjct: 141 YKDFLTLEHLICYSFQVAKGMEFLASRKC---IHRDLAARNILLSEKNVVKICDFGLARD 197
Query: 491 ----PAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAA 546
               P   ++G+  L         +MAPE + + + + + DV++FGVL+ E+ +   +  
Sbjct: 198 IXKDPDXVRKGDARLPLK------WMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 251
Query: 547 LHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPT 606
              + +                 EE  R   + T           +   ++D C   +P+
Sbjct: 252 PGVKID-----------------EEFCRRLKEGTRMRAPDYTTPEMYQTMLD-CWHGEPS 293
Query: 607 DRPTMYEIEHSLSNILNAS 625
            RPT  E+   L N+L A+
Sbjct: 294 QRPTFSELVEHLGNLLQAN 312

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 75/158 (47%), Gaps = 15/158 (9%)
Query: 385 EIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSN-KNEGKYLDWKQRIQ 443
           E  +L  +N   L+ L     +  N Y+V EY   G +    FS+ +  G++ +   R  
Sbjct: 112 EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFXEPHARFY 167
Query: 444 IALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTR 503
            A  V T   YLHS      +++D+   N+L+D     ++ +F  A+  +G+      T 
Sbjct: 168 AAQIVLT-FEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR------TW 217
Query: 504 HIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTG 541
            + GT  Y+APE + +   +  +D +A GVLI EM  G
Sbjct: 218 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 44/170 (25%), Positives = 86/170 (50%), Gaps = 20/170 (11%)
Query: 377 KVNGDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNE--GK 434
           K N ++  E  ++  +++ ++  L G+C       L+ +    G L D+V  +K+    +
Sbjct: 59  KANKEILDEAYVMASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQ 117
Query: 435 YL-DWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAE 493
           YL +W       + +A G+NYL        VH+D+ + NVL+ +    KI +F +A+   
Sbjct: 118 YLLNW------CVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168
Query: 494 GQEGEFALTRHIVGTK---GYMAPEYLENGLVSTKLDVYAFGVLILEMLT 540
            +E E+    H  G K    +MA E + + + + + DV+++GV + E++T
Sbjct: 169 AEEKEY----HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 77/158 (48%), Gaps = 15/158 (9%)
Query: 385 EIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSN-KNEGKYLDWKQRIQ 443
           E  +L  +N   L+ L     +  N Y+V EYA  G +    FS+ +  G++ +   R  
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEM----FSHLRRIGRFSEPHARFY 146
Query: 444 IALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTR 503
            A  V T   YLHS      +++D+   N+++D     ++ +F +A+  +G+      T 
Sbjct: 147 AAQIVLT-FEYLHSLD---LIYRDLKPENLMIDQQGYIQVTDFGLAKRVKGR------TW 196
Query: 504 HIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTG 541
            + GT  Y+APE + +   +  +D +A GVLI EM  G
Sbjct: 197 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 44/170 (25%), Positives = 86/170 (50%), Gaps = 20/170 (11%)
Query: 377 KVNGDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNE--GK 434
           K N ++  E  ++  +++ ++  L G+C       L+ +    G L D+V  +K+    +
Sbjct: 59  KANKEILDEAYVMASVDNPHVCRLLGICLT-STVQLITQLMPFGXLLDYVREHKDNIGSQ 117
Query: 435 YL-DWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAE 493
           YL +W       + +A G+NYL        VH+D+ + NVL+ +    KI +F +A+   
Sbjct: 118 YLLNW------CVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168
Query: 494 GQEGEFALTRHIVGTK---GYMAPEYLENGLVSTKLDVYAFGVLILEMLT 540
            +E E+    H  G K    +MA E + + + + + DV+++GV + E++T
Sbjct: 169 AEEKEY----HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 44/170 (25%), Positives = 86/170 (50%), Gaps = 20/170 (11%)
Query: 377 KVNGDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNE--GK 434
           K N ++  E  ++  +++ ++  L G+C       L+ +    G L D+V  +K+    +
Sbjct: 66  KANKEILDEAYVMASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQ 124
Query: 435 YL-DWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAE 493
           YL +W       + +A G+NYL        VH+D+ + NVL+ +    KI +F +A+   
Sbjct: 125 YLLNW------CVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 175
Query: 494 GQEGEFALTRHIVGTK---GYMAPEYLENGLVSTKLDVYAFGVLILEMLT 540
            +E E+    H  G K    +MA E + + + + + DV+++GV + E++T
Sbjct: 176 AEEKEY----HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 75/158 (47%), Gaps = 15/158 (9%)
Query: 385 EIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSN-KNEGKYLDWKQRIQ 443
           E  +L  +N   L  L     +  N Y+V EYA  G +    FS+ +  G++ +   R  
Sbjct: 92  EKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEM----FSHLRRIGRFXEPHARFY 147
Query: 444 IALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTR 503
            A  V T   YLHS      +++D+   N+++D     K+ +F  A+  +G+      T 
Sbjct: 148 AAQIVLT-FEYLHSLD---LIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGR------TW 197
Query: 504 HIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTG 541
            + GT  Y+APE + +   +  +D +A GVLI EM  G
Sbjct: 198 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 75/158 (47%), Gaps = 15/158 (9%)
Query: 385 EIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSN-KNEGKYLDWKQRIQ 443
           E  +L  +N   L+ L     +  N Y+V EY   G +    FS+ +  G++ +   R  
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFXEPHARFY 146
Query: 444 IALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTR 503
            A  V T   YLHS      +++D+   N+L+D     ++ +F  A+  +G+      T 
Sbjct: 147 AAQIVLT-FEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR------TW 196
Query: 504 HIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTG 541
            + GT  Y+APE + +   +  +D +A GVLI EM  G
Sbjct: 197 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 42/167 (25%), Positives = 88/167 (52%), Gaps = 15/167 (8%)
Query: 378 VNGDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLD 437
           +   + +E+ +L++ N   ++   G  +++G   +  E+   G+L D V   K  G+   
Sbjct: 47  IRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVL--KKAGRI-- 101
Query: 438 WKQRI--QIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQ 495
             ++I  ++++ V  GL YL        +H+D+  SN+L++S    K+ +F ++    GQ
Sbjct: 102 -PEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVS----GQ 154
Query: 496 EGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGK 542
             + ++    VGT+ YM+PE L+    S + D+++ G+ ++EM  G+
Sbjct: 155 LID-SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 44/170 (25%), Positives = 86/170 (50%), Gaps = 20/170 (11%)
Query: 377 KVNGDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNE--GK 434
           K N ++  E  ++  +++ ++  L G+C       L+ +    G L D+V  +K+    +
Sbjct: 61  KANKEILDEAYVMASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQ 119
Query: 435 YL-DWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAE 493
           YL +W       + +A G+NYL        VH+D+ + NVL+ +    KI +F +A+   
Sbjct: 120 YLLNW------CVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 170
Query: 494 GQEGEFALTRHIVGTK---GYMAPEYLENGLVSTKLDVYAFGVLILEMLT 540
            +E E+    H  G K    +MA E + + + + + DV+++GV + E++T
Sbjct: 171 AEEKEY----HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 75/158 (47%), Gaps = 15/158 (9%)
Query: 385 EIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSN-KNEGKYLDWKQRIQ 443
           E  +L  +N   L+ L     +  N Y+V EY   G +    FS+ +  G++ +   R  
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFXEPHARFY 146
Query: 444 IALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTR 503
            A  V T   YLHS      +++D+   N+L+D     ++ +F  A+  +G+      T 
Sbjct: 147 AAQIVLT-FEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR------TW 196
Query: 504 HIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTG 541
            + GT  Y+APE + +   +  +D +A GVLI EM  G
Sbjct: 197 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 54/189 (28%), Positives = 87/189 (46%), Gaps = 21/189 (11%)
Query: 365 RGKINGGFAAIKKVNGDV---SKEIA-------LLNKINHSNLIILSGVCFNEGNCYLVY 414
           + K  G + A+K +  +V     E+A       +L    H  L  L            V 
Sbjct: 168 KEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVM 227
Query: 415 EYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVL 474
           EYA  G L    F    E  + + + R   A ++ + L+YLHS  N   V++D+   N++
Sbjct: 228 EYANGGEL---FFHLSRERVFSEDRARFYGA-EIVSALDYLHSEKNV--VYRDLKLENLM 281
Query: 475 LDSDLRAKIANFAMARPAEG-QEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGV 533
           LD D   KI +F + +  EG ++G  A  +   GT  Y+APE LE+      +D +  GV
Sbjct: 282 LDKDGHIKITDFGLCK--EGIKDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGV 337
Query: 534 LILEMLTGK 542
           ++ EM+ G+
Sbjct: 338 VMYEMMCGR 346

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 44/170 (25%), Positives = 86/170 (50%), Gaps = 20/170 (11%)
Query: 377 KVNGDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNE--GK 434
           K N ++  E  ++  +++ ++  L G+C       L+ +    G L D+V  +K+    +
Sbjct: 66  KANKEILDEAYVMASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQ 124
Query: 435 YL-DWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAE 493
           YL +W       + +A G+NYL        VH+D+ + NVL+ +    KI +F +A+   
Sbjct: 125 YLLNW------CVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 175
Query: 494 GQEGEFALTRHIVGTK---GYMAPEYLENGLVSTKLDVYAFGVLILEMLT 540
            +E E+    H  G K    +MA E + + + + + DV+++GV + E++T
Sbjct: 176 AEEKEY----HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 42/167 (25%), Positives = 88/167 (52%), Gaps = 15/167 (8%)
Query: 378 VNGDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLD 437
           +   + +E+ +L++ N   ++   G  +++G   +  E+   G+L D V   K  G+   
Sbjct: 47  IRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVL--KKAGRI-- 101
Query: 438 WKQRI--QIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQ 495
             ++I  ++++ V  GL YL        +H+D+  SN+L++S    K+ +F ++    GQ
Sbjct: 102 -PEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVS----GQ 154
Query: 496 EGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGK 542
             + ++    VGT+ YM+PE L+    S + D+++ G+ ++EM  G+
Sbjct: 155 LID-SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 44/170 (25%), Positives = 86/170 (50%), Gaps = 20/170 (11%)
Query: 377 KVNGDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNE--GK 434
           K N ++  E  ++  +++ ++  L G+C       L+ +    G L D+V  +K+    +
Sbjct: 62  KANKEILDEAYVMASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQ 120
Query: 435 YL-DWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAE 493
           YL +W       + +A G+NYL        VH+D+ + NVL+ +    KI +F +A+   
Sbjct: 121 YLLNW------CVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 171
Query: 494 GQEGEFALTRHIVGTK---GYMAPEYLENGLVSTKLDVYAFGVLILEMLT 540
            +E E+    H  G K    +MA E + + + + + DV+++GV + E++T
Sbjct: 172 AEEKEY----HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 44/170 (25%), Positives = 86/170 (50%), Gaps = 20/170 (11%)
Query: 377 KVNGDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNE--GK 434
           K N ++  E  ++  +++ ++  L G+C       L+ +    G L D+V  +K+    +
Sbjct: 84  KANKEILDEAYVMASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQ 142
Query: 435 YL-DWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAE 493
           YL +W       + +A G+NYL        VH+D+ + NVL+ +    KI +F +A+   
Sbjct: 143 YLLNW------CVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 193
Query: 494 GQEGEFALTRHIVGTK---GYMAPEYLENGLVSTKLDVYAFGVLILEMLT 540
            +E E+    H  G K    +MA E + + + + + DV+++GV + E++T
Sbjct: 194 AEEKEY----HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 239

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 44/170 (25%), Positives = 86/170 (50%), Gaps = 20/170 (11%)
Query: 377 KVNGDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNE--GK 434
           K N ++  E  ++  +++ ++  L G+C       L+ +    G L D+V  +K+    +
Sbjct: 59  KANKEILDEAYVMASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQ 117
Query: 435 YL-DWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAE 493
           YL +W       + +A G+NYL        VH+D+ + NVL+ +    KI +F +A+   
Sbjct: 118 YLLNW------CVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168
Query: 494 GQEGEFALTRHIVGTK---GYMAPEYLENGLVSTKLDVYAFGVLILEMLT 540
            +E E+    H  G K    +MA E + + + + + DV+++GV + E++T
Sbjct: 169 AEEKEY----HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 75/158 (47%), Gaps = 15/158 (9%)
Query: 385 EIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSN-KNEGKYLDWKQRIQ 443
           E  +L  +N   L+ L     +  N Y+V EY   G +    FS+ +  G++ +   R  
Sbjct: 86  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFXEPHARFY 141
Query: 444 IALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTR 503
            A  V T   YLHS      +++D+   N+L+D     ++ +F  A+  +G+      T 
Sbjct: 142 AAQIVLT-FEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR------TW 191
Query: 504 HIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTG 541
            + GT  Y+APE + +   +  +D +A GVLI EM  G
Sbjct: 192 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 229

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 44/170 (25%), Positives = 86/170 (50%), Gaps = 20/170 (11%)
Query: 377 KVNGDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNE--GK 434
           K N ++  E  ++  +++ ++  L G+C       L+ +    G L D+V  +K+    +
Sbjct: 62  KANKEILDEAYVMASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQ 120
Query: 435 YL-DWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAE 493
           YL +W       + +A G+NYL        VH+D+ + NVL+ +    KI +F +A+   
Sbjct: 121 YLLNW------CVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 171
Query: 494 GQEGEFALTRHIVGTK---GYMAPEYLENGLVSTKLDVYAFGVLILEMLT 540
            +E E+    H  G K    +MA E + + + + + DV+++GV + E++T
Sbjct: 172 AEEKEY----HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 63/260 (24%), Positives = 110/260 (42%), Gaps = 46/260 (17%)
Query: 385 EIALLNKINHS-NLIILSGVCFNEGNCYLV-YEYAVNGTLSDWVFSNKNE---------- 432
           E+ +L  I H  N++ L G C   G   +V  E+   G LS ++ S +NE          
Sbjct: 80  ELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPED 139
Query: 433 --GKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMAR 490
               +L  +  I  +  VA G+ +L S      +H+D+ + N+LL      KI +F +AR
Sbjct: 140 LYKDFLTLEHLICYSFQVAKGMEFLASRKC---IHRDLAARNILLSEKNVVKICDFGLAR 196
Query: 491 -----PAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAA 545
                P   ++G+  L         +MAPE + + + + + DV++FGVL+ E+ +   + 
Sbjct: 197 DIYKDPDXVRKGDARLPLK------WMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250
Query: 546 ALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDP 605
               + +                 EE  R   + T           +   ++D C   +P
Sbjct: 251 YPGVKID-----------------EEFCRRLKEGTRMRAPDYTTPEMYQTMLD-CWHGEP 292
Query: 606 TDRPTMYEIEHSLSNILNAS 625
           + RPT  E+   L N+L A+
Sbjct: 293 SQRPTFSELVEHLGNLLQAN 312

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 44/170 (25%), Positives = 86/170 (50%), Gaps = 20/170 (11%)
Query: 377 KVNGDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNE--GK 434
           K N ++  E  ++  +++ ++  L G+C       L+ +    G L D+V  +K+    +
Sbjct: 62  KANKEILDEAYVMASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQ 120
Query: 435 YL-DWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAE 493
           YL +W       + +A G+NYL        VH+D+ + NVL+ +    KI +F +A+   
Sbjct: 121 YLLNW------CVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 171
Query: 494 GQEGEFALTRHIVGTK---GYMAPEYLENGLVSTKLDVYAFGVLILEMLT 540
            +E E+    H  G K    +MA E + + + + + DV+++GV + E++T
Sbjct: 172 AEEKEY----HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 44/170 (25%), Positives = 86/170 (50%), Gaps = 20/170 (11%)
Query: 377 KVNGDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNE--GK 434
           K N ++  E  ++  +++ ++  L G+C       L+ +    G L D+V  +K+    +
Sbjct: 65  KANKEILDEAYVMASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQ 123
Query: 435 YL-DWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAE 493
           YL +W       + +A G+NYL        VH+D+ + NVL+ +    KI +F +A+   
Sbjct: 124 YLLNW------CVQIAKGMNYLEDRRL---VHRDLAARNVLVKTPQHVKITDFGLAKLLG 174
Query: 494 GQEGEFALTRHIVGTK---GYMAPEYLENGLVSTKLDVYAFGVLILEMLT 540
            +E E+    H  G K    +MA E + + + + + DV+++GV + E++T
Sbjct: 175 AEEKEY----HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 220

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 75/158 (47%), Gaps = 15/158 (9%)
Query: 385 EIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSN-KNEGKYLDWKQRIQ 443
           E  +L  +N   L+ L     +  N Y+V EY   G +    FS+ +  G++ +   R  
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFAEPHARFY 146
Query: 444 IALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTR 503
            A  V T   YLHS      +++D+   N+L+D     ++ +F  A+  +G+      T 
Sbjct: 147 AAQIVLT-FEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR------TW 196
Query: 504 HIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTG 541
            + GT  Y+APE + +   +  +D +A GVLI EM  G
Sbjct: 197 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 63/260 (24%), Positives = 110/260 (42%), Gaps = 46/260 (17%)
Query: 385 EIALLNKINHS-NLIILSGVCFNEGNCYLV-YEYAVNGTLSDWVFSNKNE---------- 432
           E+ +L  I H  N++ L G C   G   +V  E+   G LS ++ S +NE          
Sbjct: 71  ELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPED 130
Query: 433 --GKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMAR 490
               +L  +  I  +  VA G+ +L S      +H+D+ + N+LL      KI +F +AR
Sbjct: 131 LYKDFLTLEHLICYSFQVAKGMEFLASRKC---IHRDLAARNILLSEKNVVKICDFGLAR 187
Query: 491 -----PAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAA 545
                P   ++G+  L         +MAPE + + + + + DV++FGVL+ E+ +   + 
Sbjct: 188 DIXKDPDXVRKGDARLPLK------WMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 241
Query: 546 ALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDP 605
               + +                 EE  R   + T           +   ++D C   +P
Sbjct: 242 YPGVKID-----------------EEFCRRLKEGTRMRAPDYTTPEMYQTMLD-CWHGEP 283
Query: 606 TDRPTMYEIEHSLSNILNAS 625
           + RPT  E+   L N+L A+
Sbjct: 284 SQRPTFSELVEHLGNLLQAN 303

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 63/260 (24%), Positives = 110/260 (42%), Gaps = 46/260 (17%)
Query: 385 EIALLNKINHS-NLIILSGVCFNEGNCYLV-YEYAVNGTLSDWVFSNKNE---------- 432
           E+ +L  I H  N++ L G C   G   +V  E+   G LS ++ S +NE          
Sbjct: 80  ELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPED 139
Query: 433 --GKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMAR 490
               +L  +  I  +  VA G+ +L S      +H+D+ + N+LL      KI +F +AR
Sbjct: 140 LYKDFLTLEHLICYSFQVAKGMEFLASRKC---IHRDLAARNILLSEKNVVKICDFGLAR 196
Query: 491 -----PAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAA 545
                P   ++G+  L         +MAPE + + + + + DV++FGVL+ E+ +   + 
Sbjct: 197 DIXKDPDXVRKGDARLPLK------WMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250
Query: 546 ALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDP 605
               + +                 EE  R   + T           +   ++D C   +P
Sbjct: 251 YPGVKID-----------------EEFCRRLKEGTRMRAPDYTTPEMYQTMLD-CWHGEP 292
Query: 606 TDRPTMYEIEHSLSNILNAS 625
           + RPT  E+   L N+L A+
Sbjct: 293 SQRPTFSELVEHLGNLLQAN 312

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 42/167 (25%), Positives = 88/167 (52%), Gaps = 15/167 (8%)
Query: 378 VNGDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLD 437
           +   + +E+ +L++ N   ++   G  +++G   +  E+   G+L D V   K  G+   
Sbjct: 74  IRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVL--KKAGRI-- 128
Query: 438 WKQRI--QIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQ 495
             ++I  ++++ V  GL YL        +H+D+  SN+L++S    K+ +F ++    GQ
Sbjct: 129 -PEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVS----GQ 181
Query: 496 EGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGK 542
             + ++    VGT+ YM+PE L+    S + D+++ G+ ++EM  G+
Sbjct: 182 LID-SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 227

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 47/187 (25%), Positives = 84/187 (44%), Gaps = 15/187 (8%)
Query: 359 IQGSVYRGKINGGFAAIKKVNGDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAV 418
           + G  Y  KI        + +  + +E  +   + H N++ L      EG+ YL+++   
Sbjct: 45  LAGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVT 104
Query: 419 NGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSD 478
            G L + + + +   +  D    IQ  L+     + +        VH+D+   N+LL S 
Sbjct: 105 GGELFEDIVAREYYSE-ADASHCIQQILEAVLHCHQMGV------VHRDLKPENLLLASK 157
Query: 479 LRA---KIANFAMARPAEG-QEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVL 534
           L+    K+A+F +A   EG Q+  F       GT GY++PE L        +D++A GV+
Sbjct: 158 LKGAAVKLADFGLAIEVEGEQQAWFGFA----GTPGYLSPEVLRKDPYGKPVDLWACGVI 213
Query: 535 ILEMLTG 541
           +  +L G
Sbjct: 214 LYILLVG 220

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 43/169 (25%), Positives = 86/169 (50%), Gaps = 18/169 (10%)
Query: 377 KVNGDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNE--GK 434
           K N ++  E  ++  +++ ++  L G+C       L+ +    G L D+V  +K+    +
Sbjct: 53  KANKEILDEAYVMASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQ 111
Query: 435 YLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEG 494
           YL     +   + +A G+NYL    +   VH+D+ + NVL+ +    KI +F +A+    
Sbjct: 112 YL-----LNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 163
Query: 495 QEGEFALTRHIVGTK---GYMAPEYLENGLVSTKLDVYAFGVLILEMLT 540
           +E E+    H  G K    +MA E + + + + + DV+++GV + E++T
Sbjct: 164 EEKEY----HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 208

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 63/260 (24%), Positives = 110/260 (42%), Gaps = 46/260 (17%)
Query: 385 EIALLNKINHS-NLIILSGVCFNEGNCYLVY-EYAVNGTLSDWVFSNKNE---------- 432
           E+ +L  I H  N++ L G C   G   +V  E+   G LS ++ S +NE          
Sbjct: 71  ELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPED 130
Query: 433 --GKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMAR 490
               +L  +  I  +  VA G+ +L S      +H+D+ + N+LL      KI +F +AR
Sbjct: 131 LYKDFLTLEHLICYSFQVAKGMEFLASRKC---IHRDLAARNILLSEKNVVKICDFGLAR 187
Query: 491 -----PAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAA 545
                P   ++G+  L         +MAPE + + + + + DV++FGVL+ E+ +   + 
Sbjct: 188 DIXKDPDXVRKGDARLPLK------WMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 241
Query: 546 ALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDP 605
               + +                 EE  R   + T           +   ++D C   +P
Sbjct: 242 YPGVKID-----------------EEFCRRLKEGTRMRAPDYTTPEMYQTMLD-CWHGEP 283
Query: 606 TDRPTMYEIEHSLSNILNAS 625
           + RPT  E+   L N+L A+
Sbjct: 284 SQRPTFSELVEHLGNLLQAN 303

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 44/170 (25%), Positives = 86/170 (50%), Gaps = 20/170 (11%)
Query: 377 KVNGDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNE--GK 434
           K N ++  E  ++  +++ ++  L G+C       L+ +    G L D+V  +K+    +
Sbjct: 56  KANKEILDEAYVMASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQ 114
Query: 435 YL-DWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAE 493
           YL +W       + +A G+NYL        VH+D+ + NVL+ +    KI +F +A+   
Sbjct: 115 YLLNW------CVQIAEGMNYLEDRRL---VHRDLAARNVLVKTPQHVKITDFGLAKLLG 165
Query: 494 GQEGEFALTRHIVGTK---GYMAPEYLENGLVSTKLDVYAFGVLILEMLT 540
            +E E+    H  G K    +MA E + + + + + DV+++GV + E++T
Sbjct: 166 AEEKEY----HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 211

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 47/176 (26%), Positives = 83/176 (47%), Gaps = 13/176 (7%)
Query: 368 INGGFAAIKKVNGDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVF 427
           IN    A   + G + +EI+ L  + H ++I L  V  ++    +V EYA N  L D++ 
Sbjct: 37  INKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYAGN-ELFDYIV 95
Query: 428 SNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFA 487
                   +  ++  +    + + + Y H       VH+D+   N+LLD  L  KIA+F 
Sbjct: 96  QRDK----MSEQEARRFFQQIISAVEYCHRHKI---VHRDLKPENLLLDEHLNVKIADFG 148
Query: 488 MARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVS-TKLDVYAFGVLILEMLTGK 542
           ++      +G F  T    G+  Y APE +   L +  ++DV++ GV++  ML  +
Sbjct: 149 LSNIM--TDGNFLKTS--CGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRR 200

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 67/242 (27%), Positives = 117/242 (48%), Gaps = 33/242 (13%)
Query: 381 DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQ 440
           ++ +E+ +L +I H N+I L  +  N+ +  L+ E    G L D++     E + L   +
Sbjct: 54  EIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFL----AEKESLTEDE 109
Query: 441 RIQIALDVATGLNYLHSFTNPPHVHKDINSSNV-LLDSDL---RAKIANFAMARPAEGQE 496
             Q    +  G++YLHS       H D+   N+ LLD ++   R K+ +F +A   E   
Sbjct: 110 ATQFLKQILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAG- 165
Query: 497 GEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHL 556
            EF   ++I GT  ++APE +    +  + D+++ GV+   +L+G  A+    E     L
Sbjct: 166 NEF---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG--ASPFLGETKQETL 220
Query: 557 SDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYE-IE 615
           +++ +AV    D E    +F + +       ELA   IR +   L KDP  R T+ + +E
Sbjct: 221 TNI-SAVNYDFDEE----YFSNTS-------ELAKDFIRRL---LVKDPKRRMTIAQSLE 265
Query: 616 HS 617
           HS
Sbjct: 266 HS 267

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 42/167 (25%), Positives = 88/167 (52%), Gaps = 15/167 (8%)
Query: 378 VNGDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLD 437
           +   + +E+ +L++ N   ++   G  +++G   +  E+   G+L D V   K  G+   
Sbjct: 47  IRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVL--KKAGRI-- 101
Query: 438 WKQRI--QIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQ 495
             ++I  ++++ V  GL YL        +H+D+  SN+L++S    K+ +F ++    GQ
Sbjct: 102 -PEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVS----GQ 154
Query: 496 EGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGK 542
             + ++    VGT+ YM+PE L+    S + D+++ G+ ++EM  G+
Sbjct: 155 LID-SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 42/167 (25%), Positives = 88/167 (52%), Gaps = 15/167 (8%)
Query: 378 VNGDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLD 437
           +   + +E+ +L++ N   ++   G  +++G   +  E+   G+L D V   K  G+   
Sbjct: 47  IRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVL--KKAGRI-- 101
Query: 438 WKQRI--QIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQ 495
             ++I  ++++ V  GL YL        +H+D+  SN+L++S    K+ +F ++    GQ
Sbjct: 102 -PEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVS----GQ 154
Query: 496 EGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGK 542
             + ++    VGT+ YM+PE L+    S + D+++ G+ ++EM  G+
Sbjct: 155 LID-SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 63/257 (24%), Positives = 111/257 (43%), Gaps = 40/257 (15%)
Query: 363 VYRGKINGGFAAIKKVNGD-VSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGT 421
           V+ GK+      +K    + +S EIA+   +++ +++   G   ++   Y+V E     +
Sbjct: 69  VFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRS 128
Query: 422 LSDWVFSNK----NEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDS 477
           L +     K     E +Y   +Q IQ       G+ YLH   N   +H+D+   N+ L+ 
Sbjct: 129 LLELHKRRKAVTEPEARYF-MRQTIQ-------GVQYLH---NNRVIHRDLKLGNLFLND 177
Query: 478 DLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILE 537
           D+  KI +F +A   E  +GE    + + GT  Y+APE L     S ++D+++ G ++  
Sbjct: 178 DMDVKIGDFGLATKIEF-DGE--RKKXLCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYT 234
Query: 538 MLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLI 597
           +L GK              S +    +  +  E S+   I+P                LI
Sbjct: 235 LLVGKPP---------FETSCLKETYIRIKKNEYSVPRHINPVASA------------LI 273
Query: 598 DACLKKDPTDRPTMYEI 614
              L  DPT RP++ E+
Sbjct: 274 RRMLHADPTLRPSVAEL 290

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 75/158 (47%), Gaps = 15/158 (9%)
Query: 385 EIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSN-KNEGKYLDWKQRIQ 443
           E  +L  +N   L+ L     +  N Y+V EY   G +    FS+ +  G++ +   R  
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFSEPHARFY 146
Query: 444 IALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTR 503
            A  V T   YLHS      +++D+   N+L+D     ++ +F  A+  +G+      T 
Sbjct: 147 AAQIVLT-FEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR------TW 196
Query: 504 HIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTG 541
            + GT  Y+APE + +   +  +D +A GVLI EM  G
Sbjct: 197 XLAGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 63/260 (24%), Positives = 110/260 (42%), Gaps = 46/260 (17%)
Query: 385 EIALLNKINHS-NLIILSGVCFNEGNCYLV-YEYAVNGTLSDWVFSNKNE---------- 432
           E+ +L  I H  N++ L G C   G   +V  E+   G LS ++ S +NE          
Sbjct: 117 ELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPED 176
Query: 433 --GKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMAR 490
               +L  +  I  +  VA G+ +L S      +H+D+ + N+LL      KI +F +AR
Sbjct: 177 LYKDFLTLEHLICYSFQVAKGMEFLASRKC---IHRDLAARNILLSEKNVVKICDFGLAR 233
Query: 491 -----PAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAA 545
                P   ++G+  L         +MAPE + + + + + DV++FGVL+ E+ +   + 
Sbjct: 234 DIYKDPDYVRKGDARLPLK------WMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 287
Query: 546 ALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDP 605
               + +                 EE  R   + T           +   ++D C   +P
Sbjct: 288 YPGVKID-----------------EEFCRRLKEGTRMRAPDYTTPEMYQTMLD-CWHGEP 329
Query: 606 TDRPTMYEIEHSLSNILNAS 625
           + RPT  E+   L N+L A+
Sbjct: 330 SQRPTFSELVEHLGNLLQAN 349

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 45/165 (27%), Positives = 83/165 (50%), Gaps = 15/165 (9%)
Query: 381 DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQ 440
           ++ +E+ +L +I H N+I L  +  N+ +  L+ E    G L D++     E + L   +
Sbjct: 61  EIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFL----AEKESLTEDE 116
Query: 441 RIQIALDVATGLNYLHSFTNPPHVHKDINSSNV-LLDSDL---RAKIANFAMARPAEGQE 496
             Q    +  G++YLHS       H D+   N+ LLD ++   R K+ +F +A   E   
Sbjct: 117 ATQFLKQILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAG- 172
Query: 497 GEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTG 541
            EF   ++I GT  ++APE +    +  + D+++ GV+   +L+G
Sbjct: 173 NEF---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 66/245 (26%), Positives = 108/245 (44%), Gaps = 38/245 (15%)
Query: 384 KEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQ 443
           +E   + + +H +++ L GV   E   +++ E    G L  ++   K     LD    I 
Sbjct: 440 QEALTMRQFDHPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKFS---LDLASLIL 495
Query: 444 IALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTR 503
            A  ++T L YL S      VH+DI + NVL+ +    K+ +F ++R  E        + 
Sbjct: 496 YAYQLSTALAYLES---KRFVHRDIAARNVLVSATDCVKLGDFGLSRYMED-------ST 545
Query: 504 HIVGTKG-----YMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSD 558
           +   +KG     +MAPE +     ++  DV+ FGV + E+L           +NN    D
Sbjct: 546 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHG-VKPFQGVKNN----D 600
Query: 559 VLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSL 618
           V+  +   E+GE   R  + P    N P  L  L+ +    C   DP+ RP   E++  L
Sbjct: 601 VIGRI---ENGE---RLPMPP----NCPPTLYSLMTK----CWAYDPSRRPRFTELKAQL 646
Query: 619 SNILN 623
           S IL 
Sbjct: 647 STILE 651

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 63/257 (24%), Positives = 111/257 (43%), Gaps = 40/257 (15%)
Query: 363 VYRGKINGGFAAIKKVNGD-VSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGT 421
           V+ GK+      +K    + +S EIA+   +++ +++   G   ++   Y+V E     +
Sbjct: 69  VFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRS 128
Query: 422 LSDWVFSNK----NEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDS 477
           L +     K     E +Y   +Q IQ       G+ YLH   N   +H+D+   N+ L+ 
Sbjct: 129 LLELHKRRKAVTEPEARYF-MRQTIQ-------GVQYLH---NNRVIHRDLKLGNLFLND 177
Query: 478 DLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILE 537
           D+  KI +F +A   E  +GE    + + GT  Y+APE L     S ++D+++ G ++  
Sbjct: 178 DMDVKIGDFGLATKIEF-DGE--RKKDLCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYT 234
Query: 538 MLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLI 597
           +L GK              S +    +  +  E S+   I+P                LI
Sbjct: 235 LLVGKPP---------FETSCLKETYIRIKKNEYSVPRHINPVASA------------LI 273
Query: 598 DACLKKDPTDRPTMYEI 614
              L  DPT RP++ E+
Sbjct: 274 RRMLHADPTLRPSVAEL 290

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 63/258 (24%), Positives = 111/258 (43%), Gaps = 40/258 (15%)
Query: 362 SVYRGKINGGFAAIKKVNGD-VSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNG 420
            V+ GK+      +K    + +S EIA+   +++ +++   G   ++   Y+V E     
Sbjct: 52  EVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRR 111
Query: 421 TLSDWVFSNK----NEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLD 476
           +L +     K     E +Y   +Q IQ       G+ YLH   N   +H+D+   N+ L+
Sbjct: 112 SLLELHKRRKAVTEPEARYF-MRQTIQ-------GVQYLH---NNRVIHRDLKLGNLFLN 160
Query: 477 SDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLIL 536
            D+  KI +F +A   E  +GE    + + GT  Y+APE L     S ++D+++ G ++ 
Sbjct: 161 DDMDVKIGDFGLATKIEF-DGE--RKKDLCGTPNYIAPEVLCKKGHSFEVDIWSLGCILY 217
Query: 537 EMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRL 596
            +L GK              S +    +  +  E S+   I+P                L
Sbjct: 218 TLLVGKPP---------FETSCLKETYIRIKKNEYSVPRHINPVASA------------L 256
Query: 597 IDACLKKDPTDRPTMYEI 614
           I   L  DPT RP++ E+
Sbjct: 257 IRRMLHADPTLRPSVAEL 274

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 63/260 (24%), Positives = 110/260 (42%), Gaps = 46/260 (17%)
Query: 385 EIALLNKINHS-NLIILSGVCFNEGNCYLVY-EYAVNGTLSDWVFSNKNE---------- 432
           E+ +L  I H  N++ L G C   G   +V  E+   G LS ++ S +NE          
Sbjct: 71  ELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPED 130
Query: 433 --GKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMAR 490
               +L  +  I  +  VA G+ +L S      +H+D+ + N+LL      KI +F +AR
Sbjct: 131 LYKDFLTLEHLICYSFQVAKGMEFLASRKC---IHRDLAARNILLSEKNVVKICDFGLAR 187
Query: 491 -----PAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAA 545
                P   ++G+  L         +MAPE + + + + + DV++FGVL+ E+ +   + 
Sbjct: 188 DIYKDPDYVRKGDARLPLK------WMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 241
Query: 546 ALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDP 605
               + +                 EE  R   + T           +   ++D C   +P
Sbjct: 242 YPGVKID-----------------EEFCRRLKEGTRMRAPDYTTPEMYQTMLD-CWHGEP 283
Query: 606 TDRPTMYEIEHSLSNILNAS 625
           + RPT  E+   L N+L A+
Sbjct: 284 SQRPTFSELVEHLGNLLQAN 303

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 49/166 (29%), Positives = 82/166 (49%), Gaps = 15/166 (9%)
Query: 379 NGDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDW 438
           N  + +E+A+L  ++H N++ L     ++ N YLV E    G L D +    +  K+ + 
Sbjct: 80  NSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEII---HRMKFNEV 136
Query: 439 KQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDS---DLRAKIANFAMARPAEGQ 495
              + I   V +G+ YLH       VH+D+   N+LL+S   D   KI +F ++   E Q
Sbjct: 137 DAAV-IIKQVLSGVTYLHKHNI---VHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ 192
Query: 496 EGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTG 541
           +      +  +GT  Y+APE L       K DV++ GV++  +L G
Sbjct: 193 KK----MKERLGTAYYIAPEVLRKK-YDEKCDVWSIGVILFILLAG 233

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 95/201 (47%), Gaps = 29/201 (14%)
Query: 361 GSVYRGK--INGGFAAIKKV---NGD------VSKEIALLNKIN---HSNLIILSGVCF- 405
           G+VY+ +   +G F A+K V   NG+        +E+ALL ++    H N++ L  VC  
Sbjct: 18  GTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT 77
Query: 406 ----NEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNP 461
                E    LV+E+ V+  L  ++  +K     L  +    +      GL++LH+    
Sbjct: 78  SRTDREIKVTLVFEH-VDQDLRTYL--DKAPPPGLPAETIKDLMRQFLRGLDFLHANCI- 133
Query: 462 PHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGL 521
             VH+D+   N+L+ S    K+A+F +AR    Q    AL   +V T  Y APE L    
Sbjct: 134 --VHRDLKPENILVTSGGTVKLADFGLARIYSYQ---MALA-PVVVTLWYRAPEVLLQST 187
Query: 522 VSTKLDVYAFGVLILEMLTGK 542
            +T +D+++ G +  EM   K
Sbjct: 188 YATPVDMWSVGCIFAEMFRRK 208

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 47/176 (26%), Positives = 83/176 (47%), Gaps = 13/176 (7%)
Query: 368 INGGFAAIKKVNGDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVF 427
           IN    A   + G + +EI+ L  + H ++I L  V  ++    +V EYA N  L D++ 
Sbjct: 41  INKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYAGN-ELFDYIV 99
Query: 428 SNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFA 487
                   +  ++  +    + + + Y H       VH+D+   N+LLD  L  KIA+F 
Sbjct: 100 QRDK----MSEQEARRFFQQIISAVEYCHRHKI---VHRDLKPENLLLDEHLNVKIADFG 152
Query: 488 MARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVS-TKLDVYAFGVLILEMLTGK 542
           ++      +G F  T    G+  Y APE +   L +  ++DV++ GV++  ML  +
Sbjct: 153 LSNIM--TDGNFLKTS--CGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRR 204

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 75/158 (47%), Gaps = 15/158 (9%)
Query: 385 EIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSN-KNEGKYLDWKQRIQ 443
           E  +L  +N   L+ L     +  N Y+V EY   G +    FS+ +  G++ +   R  
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFSEPHARFY 146
Query: 444 IALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTR 503
            A  V T   YLHS      +++D+   N+L+D     ++ +F  A+  +G+      T 
Sbjct: 147 AAQIVLT-FEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR------TW 196
Query: 504 HIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTG 541
            + GT  Y+APE + +   +  +D +A GVLI EM  G
Sbjct: 197 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 45/165 (27%), Positives = 83/165 (50%), Gaps = 15/165 (9%)
Query: 381 DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQ 440
           ++ +E+ +L +I H N+I L  +  N+ +  L+ E    G L D++     E + L   +
Sbjct: 75  EIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFL----AEKESLTEDE 130
Query: 441 RIQIALDVATGLNYLHSFTNPPHVHKDINSSNV-LLDSDL---RAKIANFAMARPAEGQE 496
             Q    +  G++YLHS       H D+   N+ LLD ++   R K+ +F +A   E   
Sbjct: 131 ATQFLKQILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAG- 186
Query: 497 GEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTG 541
            EF   ++I GT  ++APE +    +  + D+++ GV+   +L+G
Sbjct: 187 NEF---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 228

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 44/170 (25%), Positives = 85/170 (50%), Gaps = 20/170 (11%)
Query: 377 KVNGDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNE--GK 434
           K N ++  E  ++  +++ ++  L G+C       L+ +    G L D+V  +K+    +
Sbjct: 61  KANKEILDEAYVMASVDNPHVCRLLGICLT-STVQLIMQLMPFGCLLDYVREHKDNIGSQ 119
Query: 435 YL-DWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAE 493
           YL +W       + +A G+NYL        VH+D+ + NVL+ +    KI +F  A+   
Sbjct: 120 YLLNW------CVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGRAKLLG 170
Query: 494 GQEGEFALTRHIVGTK---GYMAPEYLENGLVSTKLDVYAFGVLILEMLT 540
            +E E+    H  G K    +MA E + + + + + DV+++GV + E++T
Sbjct: 171 AEEKEY----HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 44/170 (25%), Positives = 85/170 (50%), Gaps = 20/170 (11%)
Query: 377 KVNGDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNE--GK 434
           K N ++  E  ++  +++ ++  L G+C       L+ +    G L D+V  +K+    +
Sbjct: 63  KANKEILDEAYVMASVDNPHVCRLLGICLT-STVQLIMQLMPFGCLLDYVREHKDNIGSQ 121
Query: 435 YL-DWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAE 493
           YL +W       + +A G+NYL        VH+D+ + NVL+ +    KI +F  A+   
Sbjct: 122 YLLNW------CVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGRAKLLG 172
Query: 494 GQEGEFALTRHIVGTK---GYMAPEYLENGLVSTKLDVYAFGVLILEMLT 540
            +E E+    H  G K    +MA E + + + + + DV+++GV + E++T
Sbjct: 173 AEEKEY----HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 218

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 76/158 (48%), Gaps = 15/158 (9%)
Query: 385 EIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSN-KNEGKYLDWKQRIQ 443
           E  +L  +N   L+ L     +  N Y+V EYA  G +    FS+ +  G++ +   R  
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEM----FSHLRRIGRFSEPHARFY 146
Query: 444 IALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTR 503
            A  V T   YLHS      +++D+   N+++D     ++ +F  A+  +G+      T 
Sbjct: 147 AAQIVLT-FEYLHSLD---LIYRDLKPENLMIDQQGYIQVTDFGFAKRVKGR------TW 196
Query: 504 HIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTG 541
            + GT  Y+APE + +   +  +D +A GVLI EM  G
Sbjct: 197 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/176 (26%), Positives = 83/176 (47%), Gaps = 13/176 (7%)
Query: 368 INGGFAAIKKVNGDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVF 427
           IN    A   + G + +EI+ L  + H ++I L  V  ++    +V EYA N  L D++ 
Sbjct: 46  INKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYAGN-ELFDYIV 104
Query: 428 SNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFA 487
                   +  ++  +    + + + Y H       VH+D+   N+LLD  L  KIA+F 
Sbjct: 105 QRDK----MSEQEARRFFQQIISAVEYCHRHKI---VHRDLKPENLLLDEHLNVKIADFG 157
Query: 488 MARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVS-TKLDVYAFGVLILEMLTGK 542
           ++      +G F  T    G+  Y APE +   L +  ++DV++ GV++  ML  +
Sbjct: 158 LSNIM--TDGNFLKTS--CGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRR 209

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 75/158 (47%), Gaps = 15/158 (9%)
Query: 385 EIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSN-KNEGKYLDWKQRIQ 443
           E  +L  +N   L+ L     +  N Y+V EY   G +    FS+ +  G++ +   R  
Sbjct: 78  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFSEPHARFY 133
Query: 444 IALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTR 503
            A  V T   YLHS      +++D+   N+L+D     ++ +F  A+  +G+      T 
Sbjct: 134 AAQIVLT-FEYLHSLD---LIYRDLKPENLLIDEQGYIQVTDFGFAKRVKGR------TW 183
Query: 504 HIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTG 541
            + GT  Y+APE + +   +  +D +A GVLI EM  G
Sbjct: 184 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 221

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 75/158 (47%), Gaps = 15/158 (9%)
Query: 385 EIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSN-KNEGKYLDWKQRIQ 443
           E  +L  +N   L+ L     +  N Y+V EY   G +    FS+ +  G++ +   R  
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFSEPHARFY 146
Query: 444 IALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTR 503
            A  V T   YLHS      +++D+   N+L+D     ++ +F  A+  +G+      T 
Sbjct: 147 AAQIVLT-FEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR------TW 196
Query: 504 HIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTG 541
            + GT  Y+APE + +   +  +D +A GVLI EM  G
Sbjct: 197 XLXGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 75/158 (47%), Gaps = 15/158 (9%)
Query: 385 EIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSN-KNEGKYLDWKQRIQ 443
           E  +L  +N   L+ L     +  N Y+V EY   G +    FS+ +  G++ +   R  
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFSEPHARFY 146
Query: 444 IALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTR 503
            A  V T   YLHS      +++D+   N+L+D     ++ +F  A+  +G+      T 
Sbjct: 147 AAQIVLT-FEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR------TW 196
Query: 504 HIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTG 541
            + GT  Y+APE + +   +  +D +A GVLI EM  G
Sbjct: 197 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 75/158 (47%), Gaps = 15/158 (9%)
Query: 385 EIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSN-KNEGKYLDWKQRIQ 443
           E  +L  +N   L  L     +  N Y+V EYA  G +    FS+ +  G++ +   R  
Sbjct: 92  EKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEM----FSHLRRIGRFSEPHARFY 147
Query: 444 IALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTR 503
            A  V T   YLHS      +++D+   N+++D     K+ +F  A+  +G+      T 
Sbjct: 148 AAQIVLT-FEYLHSLD---LIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGR------TW 197
Query: 504 HIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTG 541
            + GT  Y+APE + +   +  +D +A GVLI EM  G
Sbjct: 198 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 42/167 (25%), Positives = 87/167 (52%), Gaps = 15/167 (8%)
Query: 378 VNGDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLD 437
           +   + +E+ +L++ N   ++   G  +++G   +  E+   G+L D V   K  G+   
Sbjct: 50  IRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVL--KKAGRI-- 104
Query: 438 WKQRI--QIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQ 495
             ++I  ++++ V  GL YL        +H+D+  SN+L++S    K+ +F ++    GQ
Sbjct: 105 -PEQILGKVSIAVIKGLTYLREKHKI--MHRDVKPSNILVNSRGEIKLCDFGVS----GQ 157
Query: 496 EGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGK 542
             +  +    VGT+ YM+PE L+    S + D+++ G+ ++EM  G+
Sbjct: 158 LID-EMANEFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 203

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/260 (24%), Positives = 110/260 (42%), Gaps = 46/260 (17%)
Query: 385 EIALLNKINHS-NLIILSGVCFNEGNCYLVY-EYAVNGTLSDWVFSNKNE---------- 432
           E+ +L  I H  N++ L G C   G   +V  E+   G LS ++ S +NE          
Sbjct: 71  ELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPED 130
Query: 433 --GKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMAR 490
               +L  +  I  +  VA G+ +L S      +H+D+ + N+LL      KI +F +AR
Sbjct: 131 LYKDFLTLEHLICYSFQVAKGMEFLASRKC---IHRDLAARNILLSEKNVVKICDFGLAR 187
Query: 491 -----PAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAA 545
                P   ++G+  L         +MAPE + + + + + DV++FGVL+ E+ +   + 
Sbjct: 188 DIYKDPDYVRKGDARLPLK------WMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 241
Query: 546 ALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDP 605
               + +                 EE  R   + T           +   ++D C   +P
Sbjct: 242 YPGVKID-----------------EEFCRRLKEGTRMRAPDYTTPEMYQTMLD-CWHGEP 283
Query: 606 TDRPTMYEIEHSLSNILNAS 625
           + RPT  E+   L N+L A+
Sbjct: 284 SQRPTFSELVEHLGNLLQAN 303

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 44/170 (25%), Positives = 85/170 (50%), Gaps = 20/170 (11%)
Query: 377 KVNGDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNE--GK 434
           K N ++  E  ++  +++ ++  L G+C       L+ +    G L D+V  +K+    +
Sbjct: 61  KANKEILDEAYVMASVDNPHVCRLLGICLT-STVQLIMQLMPFGCLLDYVREHKDNIGSQ 119
Query: 435 YL-DWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAE 493
           YL +W       + +A G+NYL        VH+D+ + NVL+ +    KI +F  A+   
Sbjct: 120 YLLNW------CVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGRAKLLG 170
Query: 494 GQEGEFALTRHIVGTK---GYMAPEYLENGLVSTKLDVYAFGVLILEMLT 540
            +E E+    H  G K    +MA E + + + + + DV+++GV + E++T
Sbjct: 171 AEEKEY----HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 75/158 (47%), Gaps = 15/158 (9%)
Query: 385 EIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSN-KNEGKYLDWKQRIQ 443
           E  +L  +N   L  L     +  N Y+V EYA  G +    FS+ +  G++ +   R  
Sbjct: 92  EKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEM----FSHLRRIGRFSEPHARFY 147
Query: 444 IALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTR 503
            A  V T   YLHS      +++D+   N+++D     K+ +F  A+  +G+      T 
Sbjct: 148 AAQIVLT-FEYLHSLD---LIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGR------TW 197
Query: 504 HIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTG 541
            + GT  Y+APE + +   +  +D +A GVLI EM  G
Sbjct: 198 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 75/158 (47%), Gaps = 15/158 (9%)
Query: 385 EIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSN-KNEGKYLDWKQRIQ 443
           E  +L  +N   L+ L     +  N Y+V EY   G +    FS+ +  G++ +   R  
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFSEPHARFY 146
Query: 444 IALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTR 503
            A  V T   YLHS      +++D+   N+L+D     ++ +F  A+  +G+      T 
Sbjct: 147 AAQIVLT-FEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR------TW 196
Query: 504 HIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTG 541
            + GT  Y+APE + +   +  +D +A GVLI EM  G
Sbjct: 197 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/260 (24%), Positives = 110/260 (42%), Gaps = 46/260 (17%)
Query: 385 EIALLNKINHS-NLIILSGVCFNEGNCYLV-YEYAVNGTLSDWVFSNKNE---------- 432
           E+ +L  I H  N++ L G C   G   +V  E+   G LS ++ S +NE          
Sbjct: 80  ELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPED 139
Query: 433 --GKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMAR 490
               +L  +  I  +  VA G+ +L S      +H+D+ + N+LL      KI +F +AR
Sbjct: 140 LYKDFLTLEHLICYSFQVAKGMEFLASRKC---IHRDLAARNILLSEKNVVKICDFGLAR 196
Query: 491 -----PAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAA 545
                P   ++G+  L         +MAPE + + + + + DV++FGVL+ E+ +   + 
Sbjct: 197 DIYKDPDYVRKGDARLPLK------WMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250
Query: 546 ALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDP 605
               + +                 EE  R   + T           +   ++D C   +P
Sbjct: 251 YPGVKID-----------------EEFCRRLKEGTRMRAPDYTTPEMYQTMLD-CWHGEP 292
Query: 606 TDRPTMYEIEHSLSNILNAS 625
           + RPT  E+   L N+L A+
Sbjct: 293 SQRPTFSELVEHLGNLLQAN 312

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 75/158 (47%), Gaps = 15/158 (9%)
Query: 385 EIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSN-KNEGKYLDWKQRIQ 443
           E  +L  +N   L+ L     +  N Y+V EY   G +    FS+ +  G++ +   R  
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFSEPHARFY 146
Query: 444 IALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTR 503
            A  V T   YLHS      +++D+   N+L+D     ++ +F  A+  +G+      T 
Sbjct: 147 AAQIVLT-FEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR------TW 196
Query: 504 HIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTG 541
            + GT  Y+APE + +   +  +D +A GVLI EM  G
Sbjct: 197 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 43/174 (24%), Positives = 86/174 (49%), Gaps = 18/174 (10%)
Query: 375 IKKVNGDVSKEIALLNKI-NHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEG 433
           +++V     +E  +L ++  H ++I L     +    +LV++    G L D++     E 
Sbjct: 139 LEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYL----TEK 194
Query: 434 KYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAE 493
             L  K+   I   +   +++LH+      VH+D+   N+LLD +++ ++++F  +   E
Sbjct: 195 VALSEKETRSIMRSLLEAVSFLHANNI---VHRDLKPENILLDDNMQIRLSDFGFSCHLE 251
Query: 494 GQEGEFALTRHIVGTKGYMAPEYLENGLVST------KLDVYAFGVLILEMLTG 541
             E      R + GT GY+APE L+  +  T      ++D++A GV++  +L G
Sbjct: 252 PGEK----LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAG 301

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 65/257 (25%), Positives = 116/257 (45%), Gaps = 33/257 (12%)
Query: 303 IVVSGSFQANEKPSNKKFDEES---------QDFLESISGVAQ-SLKVYSFKELQS-ATD 351
           +V  GS   N   + K  ++ES         +DFL+     AQ +  +  F+ +++  T 
Sbjct: 14  LVPRGSHMGNAAAAKKGSEQESVKEFLAKAKEDFLKKWESPAQNTAHLDQFERIKTLGTG 73
Query: 352 NFSFTCRIQ----GSVYRGKI--NGGFAAIKKVNGDVSKEIALLNKINHSNLIILSGVCF 405
           +F     ++    G+ Y  KI        +K++   ++ E  +L  +N   L+ L     
Sbjct: 74  SFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLN-EKRILQAVNFPFLVKLEFSFK 132
Query: 406 NEGNCYLVYEYAVNGTLSDWVFSN-KNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHV 464
           +  N Y+V EY   G +    FS+ +  G++ +   R   A  V T   YLHS      +
Sbjct: 133 DNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFYAAQIVLT-FEYLHSLD---LI 184
Query: 465 HKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVST 524
           ++D+   N+L+D     ++ +F  A+  +G+      T  + GT  Y+APE + +   + 
Sbjct: 185 YRDLKPENLLIDQQGYIQVTDFGFAKRVKGR------TWXLCGTPEYLAPEIILSKGYNK 238
Query: 525 KLDVYAFGVLILEMLTG 541
            +D +A GVLI EM  G
Sbjct: 239 AVDWWALGVLIYEMAAG 255

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/176 (26%), Positives = 83/176 (47%), Gaps = 13/176 (7%)
Query: 368 INGGFAAIKKVNGDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVF 427
           IN    A   + G + +EI+ L  + H ++I L  V  ++    +V EYA N  L D++ 
Sbjct: 47  INKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYAGN-ELFDYIV 105
Query: 428 SNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFA 487
                   +  ++  +    + + + Y H       VH+D+   N+LLD  L  KIA+F 
Sbjct: 106 QRDK----MSEQEARRFFQQIISAVEYCHRHKI---VHRDLKPENLLLDEHLNVKIADFG 158
Query: 488 MARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVS-TKLDVYAFGVLILEMLTGK 542
           ++      +G F  T    G+  Y APE +   L +  ++DV++ GV++  ML  +
Sbjct: 159 LSNIM--TDGNFLKTS--CGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRR 210

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 75/158 (47%), Gaps = 15/158 (9%)
Query: 385 EIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSN-KNEGKYLDWKQRIQ 443
           E  +L  +N   L+ L     +  N Y+V EY   G +    FS+ +  G++ +   R  
Sbjct: 92  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFSEPHARFY 147
Query: 444 IALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTR 503
            A  V T   YLHS      +++D+   N+L+D     ++ +F  A+  +G+      T 
Sbjct: 148 AAQIVLT-FEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR------TW 197
Query: 504 HIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTG 541
            + GT  Y+APE + +   +  +D +A GVLI EM  G
Sbjct: 198 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/260 (24%), Positives = 110/260 (42%), Gaps = 46/260 (17%)
Query: 385 EIALLNKINHS-NLIILSGVCFNEGNCYLV-YEYAVNGTLSDWVFSNKNE---------- 432
           E+ +L  I H  N++ L G C   G   +V  E+   G LS ++ S +NE          
Sbjct: 82  ELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPED 141
Query: 433 --GKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMAR 490
               +L  +  I  +  VA G+ +L S      +H+D+ + N+LL      KI +F +AR
Sbjct: 142 LYKDFLTLEHLICYSFQVAKGMEFLASRKC---IHRDLAARNILLSEKNVVKICDFGLAR 198
Query: 491 -----PAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAA 545
                P   ++G+  L         +MAPE + + + + + DV++FGVL+ E+ +   + 
Sbjct: 199 DIYKDPDYVRKGDARLPLK------WMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 252
Query: 546 ALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDP 605
               + +                 EE  R   + T           +   ++D C   +P
Sbjct: 253 YPGVKID-----------------EEFCRRLKEGTRMRAPDYTTPEMYQTMLD-CWHGEP 294
Query: 606 TDRPTMYEIEHSLSNILNAS 625
           + RPT  E+   L N+L A+
Sbjct: 295 SQRPTFSELVEHLGNLLQAN 314

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/180 (29%), Positives = 91/180 (50%), Gaps = 15/180 (8%)
Query: 365 RGKINGGFAAIKKVNGDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSD 424
           +G+ +     I+K + ++  EI+LL  ++H N+I L  V  ++   YLV E+   G L +
Sbjct: 76  KGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFE 135
Query: 425 WVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSD---LRA 481
            +    N  K+ D      I   + +G+ YLH       VH+DI   N+LL++    L  
Sbjct: 136 QII---NRHKF-DECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNI 188
Query: 482 KIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTG 541
           KI +F ++        ++ L R  +GT  Y+APE L+    + K DV++ GV++  +L G
Sbjct: 189 KIVDFGLSSFF---SKDYKL-RDRLGTAYYIAPEVLKKK-YNEKCDVWSCGVIMYILLCG 243

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 75/158 (47%), Gaps = 15/158 (9%)
Query: 385 EIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSN-KNEGKYLDWKQRIQ 443
           E  +L  +N   L+ L     +  N Y+V EY   G +    FS+ +  G++ +   R  
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFSEPHARFY 146
Query: 444 IALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTR 503
            A  V T   YLHS      +++D+   N+L+D     ++ +F  A+  +G+      T 
Sbjct: 147 AAQIVLT-FEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR------TW 196
Query: 504 HIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTG 541
            + GT  Y+APE + +   +  +D +A GVLI EM  G
Sbjct: 197 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 95/201 (47%), Gaps = 29/201 (14%)
Query: 361 GSVYRGK--INGGFAAIKKV---NGD------VSKEIALLNKIN---HSNLIILSGVCF- 405
           G+VY+ +   +G F A+K V   NG+        +E+ALL ++    H N++ L  VC  
Sbjct: 18  GTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT 77
Query: 406 ----NEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNP 461
                E    LV+E+ V+  L  ++  +K     L  +    +      GL++LH+    
Sbjct: 78  SRTDREIKVTLVFEH-VDQDLRTYL--DKAPPPGLPAETIKDLMRQFLRGLDFLHANCI- 133
Query: 462 PHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGL 521
             VH+D+   N+L+ S    K+A+F +AR    Q    AL   +V T  Y APE L    
Sbjct: 134 --VHRDLKPENILVTSGGTVKLADFGLARIYSYQ---MALD-PVVVTLWYRAPEVLLQST 187
Query: 522 VSTKLDVYAFGVLILEMLTGK 542
            +T +D+++ G +  EM   K
Sbjct: 188 YATPVDMWSVGCIFAEMFRRK 208

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/248 (21%), Positives = 108/248 (43%), Gaps = 32/248 (12%)
Query: 385 EIALLNKINHSNLIILSGVCFNEGN-----CYLVYEYAVNGTLSDWVFSNKNEG--KYLD 437
           E A +   +H N+I L GVC    +       ++  +   G L  ++  ++ E   K++ 
Sbjct: 86  EAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIP 145
Query: 438 WKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEG 497
            +  ++  +D+A G+ YL   +N   +H+D+ + N +L  D+   +A+F +++      G
Sbjct: 146 LQTLLKFMVDIALGMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKI--YSG 200
Query: 498 EFALTRHIVGTK-GYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHL 556
           ++     I      ++A E L + + ++K DV+AFGV + E+ T       +    N  +
Sbjct: 201 DYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIAT--RGMTPYPGVQNHEM 258
Query: 557 SDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEH 616
            D L      +  E+ L    +                 ++ +C + DP DRPT   +  
Sbjct: 259 YDYLLHGHRLKQPEDCLDELYE-----------------IMYSCWRTDPLDRPTFSVLRL 301
Query: 617 SLSNILNA 624
            L  +L +
Sbjct: 302 QLEKLLES 309

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 75/158 (47%), Gaps = 15/158 (9%)
Query: 385 EIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSN-KNEGKYLDWKQRIQ 443
           E  +L  +N   L+ L     +  N Y+V EY   G +    FS+ +  G++ +   R  
Sbjct: 84  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFXEPHARFY 139
Query: 444 IALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTR 503
            A  V T   YLHS      +++D+   N+L+D     ++ +F  A+  +G+      T 
Sbjct: 140 AAQIVLT-FEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR------TW 189
Query: 504 HIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTG 541
            + GT  Y+APE + +   +  +D +A GVLI EM  G
Sbjct: 190 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 227

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 75/158 (47%), Gaps = 15/158 (9%)
Query: 385 EIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSN-KNEGKYLDWKQRIQ 443
           E  +L  +N   L+ L     +  N Y+V EY   G +    FS+ +  G++ +   R  
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFSEPHARFY 146
Query: 444 IALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTR 503
            A  V T   YLHS      +++D+   N+L+D     ++ +F  A+  +G+      T 
Sbjct: 147 AAQIVLT-FEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR------TW 196
Query: 504 HIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTG 541
            + GT  Y+APE + +   +  +D +A GVLI EM  G
Sbjct: 197 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 44/170 (25%), Positives = 85/170 (50%), Gaps = 20/170 (11%)
Query: 377 KVNGDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNE--GK 434
           K N ++  E  ++  +++ ++  L G+C       L+ +    G L D+V  +K+    +
Sbjct: 61  KANKEILDEAYVMASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQ 119
Query: 435 YL-DWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAE 493
           YL +W       + +A G+NYL        VH+D+ + NVL+ +    KI +F  A+   
Sbjct: 120 YLLNW------CVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGRAKLLG 170
Query: 494 GQEGEFALTRHIVGTK---GYMAPEYLENGLVSTKLDVYAFGVLILEMLT 540
            +E E+    H  G K    +MA E + + + + + DV+++GV + E++T
Sbjct: 171 AEEKEY----HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/243 (22%), Positives = 105/243 (43%), Gaps = 45/243 (18%)
Query: 393 NHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFS-------------------NKNEG 433
            H N++ L G C + G   ++ EY   G L +++                     +K +G
Sbjct: 93  QHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGLDKEDG 152
Query: 434 KYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAE 493
           + L+ +  +  +  VA G+ +L S      +H+D+ + NVLL +   AKI +F +AR   
Sbjct: 153 RPLELRDLLHFSSQVAQGMAFLASKNC---IHRDVAARNVLLTNGHVAKIGDFGLARDIM 209
Query: 494 GQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENN 553
                       +  K +MAPE + + + + + DV+++G+L+ E+ +      L     N
Sbjct: 210 NDSNYIVKGNARLPVK-WMAPESIFDCVYTVQSDVWSYGILLWEIFS----LGL-----N 259
Query: 554 MHLSDVLNAVLTK--EDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTM 611
            +   ++N+   K  +DG +  +    P             +  ++ AC   +PT RPT 
Sbjct: 260 PYPGILVNSKFYKLVKDGYQMAQPAFAPK-----------NIYSIMQACWALEPTHRPTF 308
Query: 612 YEI 614
            +I
Sbjct: 309 QQI 311

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/191 (27%), Positives = 83/191 (43%), Gaps = 21/191 (10%)
Query: 363 VYRGKINGGFA--AIKKVNGDVSK-----EIALLNKINHSNLIILSGVCFNEGNCYLVYE 415
           VYR K  G     A+K +   V K     EI +L +++H N+I L  +        LV E
Sbjct: 69  VYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE 128
Query: 416 YAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLL 475
               G L D +     E  Y   +        +   + YLH       VH+D+   N+L 
Sbjct: 129 LVTGGELFDRIV----EKGYYSERDAADAVKQILEAVAYLHENGI---VHRDLKPENLLY 181
Query: 476 DS---DLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFG 532
            +   D   KIA+F +++  E Q     L + + GT GY APE L       ++D+++ G
Sbjct: 182 ATPAPDAPLKIADFGLSKIVEHQ----VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVG 237
Query: 533 VLILEMLTGKE 543
           ++   +L G E
Sbjct: 238 IITYILLCGFE 248

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 44/170 (25%), Positives = 85/170 (50%), Gaps = 20/170 (11%)
Query: 377 KVNGDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNE--GK 434
           K N ++  E  ++  +++ ++  L G+C       L+ +    G L D+V  +K+    +
Sbjct: 59  KANKEILDEAYVMASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQ 117
Query: 435 YL-DWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAE 493
           YL +W       + +A G+NYL        VH+D+ + NVL+ +    KI +F  A+   
Sbjct: 118 YLLNW------CVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGRAKLLG 168
Query: 494 GQEGEFALTRHIVGTK---GYMAPEYLENGLVSTKLDVYAFGVLILEMLT 540
            +E E+    H  G K    +MA E + + + + + DV+++GV + E++T
Sbjct: 169 AEEKEY----HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 75/158 (47%), Gaps = 15/158 (9%)
Query: 385 EIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSN-KNEGKYLDWKQRIQ 443
           E  +L  +N   L+ L     +  N Y+V EY   G +    FS+ +  G++ +   R  
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFXEPHARFY 146
Query: 444 IALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTR 503
            A  V T   YLHS      +++D+   N+L+D     ++ +F  A+  +G+      T 
Sbjct: 147 AAQIVLT-FEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR------TW 196
Query: 504 HIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTG 541
            + GT  Y+APE + +   +  +D +A GVLI EM  G
Sbjct: 197 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 62/242 (25%), Positives = 114/242 (47%), Gaps = 25/242 (10%)
Query: 310 QANEKPSNKKF-DEESQDFLESISGVAQ-SLKVYSFKELQS-ATDNFSFTCRIQ----GS 362
           + +E+ S K+F  +  +DFL+     AQ +  +  F+ +++  T +F     ++    G+
Sbjct: 9   KGSEQESVKEFLAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGN 68
Query: 363 VYRGKI--NGGFAAIKKVNGDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNG 420
            Y  KI        +K++   ++ E  +L  +N   L+ L     +  N Y+V EY   G
Sbjct: 69  HYAMKILDKQKVVKLKQIEHTLN-EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGG 127
Query: 421 TLSDWVFSN-KNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDL 479
            +    FS+ +  G++ +   R   A  V T   YLHS      +++D+   N+L+D   
Sbjct: 128 EM----FSHLRRIGRFXEPHARFYAAQIVLT-FEYLHSLD---LIYRDLKPENLLIDQQG 179
Query: 480 RAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEML 539
             ++ +F  A+  +G+      T  + GT  Y+APE + +   +  +D +A GVLI EM 
Sbjct: 180 YIQVTDFGFAKRVKGR------TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMA 233
Query: 540 TG 541
            G
Sbjct: 234 AG 235

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 75/158 (47%), Gaps = 15/158 (9%)
Query: 385 EIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSN-KNEGKYLDWKQRIQ 443
           E  +L  +N   L+ L     +  N Y+V EY   G +    FS+ +  G++ +   R  
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFXEPHARFY 146
Query: 444 IALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTR 503
            A  V T   YLHS      +++D+   N+L+D     ++ +F  A+  +G+      T 
Sbjct: 147 AAQIVLT-FEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR------TW 196
Query: 504 HIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTG 541
            + GT  Y+APE + +   +  +D +A GVLI EM  G
Sbjct: 197 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 89/204 (43%), Gaps = 13/204 (6%)
Query: 382 VSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQR 441
           +S+   LL  + H  L+ L          Y V +Y   G L    +  + E  +L+ + R
Sbjct: 86  MSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGEL---FYHLQRERCFLEPRAR 142
Query: 442 IQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFAL 501
              A ++A+ L YLHS      V++D+   N+LLDS     + +F + +  E  E   + 
Sbjct: 143 F-YAAEIASALGYLHSLNI---VYRDLKPENILLDSQGHIVLTDFGLCK--ENIEHN-ST 195
Query: 502 TRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLN 561
           T    GT  Y+APE L        +D +  G ++ EML G      ++        ++LN
Sbjct: 196 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYG--LPPFYSRNTAEMYDNILN 253
Query: 562 AVLT-KEDGEESLRHFIDPTLQGN 584
             L  K +   S RH ++  LQ +
Sbjct: 254 KPLQLKPNITNSARHLLEGLLQKD 277

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/170 (25%), Positives = 85/170 (50%), Gaps = 20/170 (11%)
Query: 377 KVNGDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNE--GK 434
           K N ++  E  ++  +++ ++  L G+C       L+ +    G L D+V  +K+    +
Sbjct: 66  KANKEILDEAYVMASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQ 124
Query: 435 YL-DWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAE 493
           YL +W       + +A G+NYL        VH+D+ + NVL+ +    KI +F  A+   
Sbjct: 125 YLLNW------CVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGRAKLLG 175
Query: 494 GQEGEFALTRHIVGTK---GYMAPEYLENGLVSTKLDVYAFGVLILEMLT 540
            +E E+    H  G K    +MA E + + + + + DV+++GV + E++T
Sbjct: 176 AEEKEY----HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/228 (25%), Positives = 101/228 (44%), Gaps = 31/228 (13%)
Query: 385 EIALLNKINHSNLIILSGVCFN-EGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQ 443
           E  +L  I  S  ++     F  E   +L+ +Y   G L    F++ ++ +    +  +Q
Sbjct: 108 ERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGEL----FTHLSQRERFT-EHEVQ 162
Query: 444 IAL-DVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALT 502
           I + ++   L +LH       +++DI   N+LLDS+    + +F +++     E E A  
Sbjct: 163 IYVGEIVLALEHLHKLGI---IYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYD 219
Query: 503 RHIVGTKGYMAPEYLENGLV--STKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVL 560
               GT  YMAP+ +  G       +D ++ GVL+ E+LTG     +  E+N+   +++ 
Sbjct: 220 --FCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ--AEIS 275
Query: 561 NAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDR 608
             +L  E           P     YP E++ L   LI   L KDP  R
Sbjct: 276 RRILKSE-----------PP----YPQEMSALAKDLIQRLLMKDPKKR 308

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/195 (24%), Positives = 89/195 (45%), Gaps = 21/195 (10%)
Query: 354 SFTCRIQGSVYRGKINGGFAAIKKVNGDVSKEIALLNKINHSNLIILSGV-----CFNEG 408
           +F  +    V   K++  F +I        +E+ LL  + H N+I L  V        E 
Sbjct: 41  AFDTKTGHRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLDVFTPARSLEEF 99
Query: 409 NCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDI 468
           N   +  + +   L++ V   K    ++ +     +   +  GL Y+HS      +H+D+
Sbjct: 100 NDVYLVTHLMGADLNNIVKCQKLTDDHVQF-----LIYQILRGLKYIHSADI---IHRDL 151
Query: 469 NSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGL-VSTKLD 527
             SN+ ++ D   KI +F +AR  + +   F      V T+ Y APE + N +  +  +D
Sbjct: 152 KPSNLAVNEDCELKILDFGLARHTDDEMAGF------VATRWYRAPEIMLNWMHYNQTVD 205
Query: 528 VYAFGVLILEMLTGK 542
           +++ G ++ E+LTG+
Sbjct: 206 IWSVGCIMAELLTGR 220

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 75/158 (47%), Gaps = 15/158 (9%)
Query: 385 EIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSN-KNEGKYLDWKQRIQ 443
           E  +L  +N   L+ L     +  N Y+V EY   G +    FS+ +  G++ +   R  
Sbjct: 92  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFY 147
Query: 444 IALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTR 503
            A  V T   YLHS      +++D+   N+L+D     ++ +F  A+  +G+      T 
Sbjct: 148 AAQIVLT-FEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR------TW 197
Query: 504 HIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTG 541
            + GT  Y+APE + +   +  +D +A GVLI EM  G
Sbjct: 198 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 42/164 (25%), Positives = 73/164 (44%), Gaps = 15/164 (9%)
Query: 382 VSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQR 441
           + +E  +   + H N++ L      EG  YLV++    G L    F +    +Y      
Sbjct: 77  LEREARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGEL----FEDIVAREYYSEADA 132
Query: 442 IQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRA---KIANFAMARPAEG-QEG 497
                 +   +N++H       VH+D+   N+LL S  +    K+A+F +A   +G Q+ 
Sbjct: 133 SHCIHQILESVNHIHQHDI---VHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQA 189
Query: 498 EFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTG 541
            F       GT GY++PE L        +D++A GV++  +L G
Sbjct: 190 WFGFA----GTPGYLSPEVLRKDPYGKPVDIWACGVILYILLVG 229

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 75/158 (47%), Gaps = 15/158 (9%)
Query: 385 EIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSN-KNEGKYLDWKQRIQ 443
           E  +L  +N   L+ L     +  N Y+V EY   G +    FS+ +  G++ +   R  
Sbjct: 84  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFY 139
Query: 444 IALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTR 503
            A  V T   YLHS      +++D+   N+L+D     ++ +F  A+  +G+      T 
Sbjct: 140 AAQIVLT-FEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR------TW 189
Query: 504 HIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTG 541
            + GT  Y+APE + +   +  +D +A GVLI EM  G
Sbjct: 190 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 227

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 62/242 (25%), Positives = 114/242 (47%), Gaps = 25/242 (10%)
Query: 310 QANEKPSNKKF-DEESQDFLESISGVAQ-SLKVYSFKELQS-ATDNFSFTCRIQ----GS 362
           + +E+ S K+F  +  +DFL+     AQ +  +  F+ +++  T +F     ++    G+
Sbjct: 9   KGSEQESVKEFLAKAKEDFLKKWESPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGN 68
Query: 363 VYRGKI--NGGFAAIKKVNGDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNG 420
            Y  KI        +K++   ++ E  +L  +N   L+ L     +  N Y+V EY   G
Sbjct: 69  HYAMKILDKQKVVKLKQIEHTLN-EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGG 127
Query: 421 TLSDWVFSN-KNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDL 479
            +    FS+ +  G++ +   R   A  V T   YLHS      +++D+   N+L+D   
Sbjct: 128 EM----FSHLRRIGRFSEPHARFYAAQIVLT-FEYLHSLD---LIYRDLKPENLLIDQQG 179
Query: 480 RAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEML 539
             ++ +F  A+  +G+      T  + GT  Y+APE + +   +  +D +A GVLI EM 
Sbjct: 180 YIQVTDFGFAKRVKGR------TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMA 233
Query: 540 TG 541
            G
Sbjct: 234 AG 235

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 75/158 (47%), Gaps = 15/158 (9%)
Query: 385 EIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSN-KNEGKYLDWKQRIQ 443
           E  +L  +N   L+ L     +  N Y+V EY   G +    FS+ +  G++ +   R  
Sbjct: 91  EKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFY 146
Query: 444 IALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTR 503
            A  V T   YLHS      +++D+   N+L+D     ++ +F  A+  +G+      T 
Sbjct: 147 AAQIVLT-FEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR------TW 196
Query: 504 HIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTG 541
            + GT  Y+APE + +   +  +D +A GVLI EM  G
Sbjct: 197 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 75/158 (47%), Gaps = 15/158 (9%)
Query: 385 EIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSN-KNEGKYLDWKQRIQ 443
           E  +L  +N   L+ L     +  N Y+V EY   G +    FS+ +  G++ +   R  
Sbjct: 91  EKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFY 146
Query: 444 IALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTR 503
            A  V T   YLHS      +++D+   N+L+D     ++ +F  A+  +G+      T 
Sbjct: 147 AAQIVLT-FEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR------TW 196
Query: 504 HIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTG 541
            + GT  Y+APE + +   +  +D +A GVLI EM  G
Sbjct: 197 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/195 (24%), Positives = 89/195 (45%), Gaps = 21/195 (10%)
Query: 354 SFTCRIQGSVYRGKINGGFAAIKKVNGDVSKEIALLNKINHSNLIILSGV-----CFNEG 408
           +F  +    V   K++  F +I        +E+ LL  + H N+I L  V        E 
Sbjct: 41  AFDTKTGHRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLDVFTPARSLEEF 99
Query: 409 NCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDI 468
           N   +  + +   L++ V   K    ++ +     +   +  GL Y+HS      +H+D+
Sbjct: 100 NDVYLVTHLMGADLNNIVKCQKLTDDHVQF-----LIYQILRGLKYIHSADI---IHRDL 151
Query: 469 NSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGL-VSTKLD 527
             SN+ ++ D   KI +F +AR  + +   F      V T+ Y APE + N +  +  +D
Sbjct: 152 KPSNLAVNEDCELKILDFGLARHTDDEMAGF------VATRWYRAPEIMLNWMHYNQTVD 205
Query: 528 VYAFGVLILEMLTGK 542
           +++ G ++ E+LTG+
Sbjct: 206 IWSVGCIMAELLTGR 220

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 75/158 (47%), Gaps = 15/158 (9%)
Query: 385 EIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSN-KNEGKYLDWKQRIQ 443
           E  +L  +N   L+ L     +  N Y+V EY   G +    FS+ +  G++ +   R  
Sbjct: 92  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFY 147
Query: 444 IALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTR 503
            A  V T   YLHS      +++D+   N+L+D     ++ +F  A+  +G+      T 
Sbjct: 148 AAQIVLT-FEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR------TW 197
Query: 504 HIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTG 541
            + GT  Y+APE + +   +  +D +A GVLI EM  G
Sbjct: 198 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 75/158 (47%), Gaps = 15/158 (9%)
Query: 385 EIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSN-KNEGKYLDWKQRIQ 443
           E  +L  +N   L+ L     +  N Y+V EY   G +    FS+ +  G++ +   R  
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFY 146
Query: 444 IALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTR 503
            A  V T   YLHS      +++D+   N+L+D     ++ +F  A+  +G+      T 
Sbjct: 147 AAQIVLT-FEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR------TW 196
Query: 504 HIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTG 541
            + GT  Y+APE + +   +  +D +A GVLI EM  G
Sbjct: 197 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 75/158 (47%), Gaps = 15/158 (9%)
Query: 385 EIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSN-KNEGKYLDWKQRIQ 443
           E  +L  +N   L+ L     +  N Y+V EY   G +    FS+ +  G++ +   R  
Sbjct: 91  EKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFY 146
Query: 444 IALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTR 503
            A  V T   YLHS      +++D+   N+L+D     ++ +F  A+  +G+      T 
Sbjct: 147 AAQIVLT-FEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR------TW 196
Query: 504 HIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTG 541
            + GT  Y+APE + +   +  +D +A GVLI EM  G
Sbjct: 197 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 62/242 (25%), Positives = 114/242 (47%), Gaps = 25/242 (10%)
Query: 310 QANEKPSNKKF-DEESQDFLESISGVAQ-SLKVYSFKELQS-ATDNFSFTCRIQ----GS 362
           + +E+ S K+F  +  +DFL+     AQ +  +  F+ +++  T +F     ++    G+
Sbjct: 9   KGSEQESVKEFLAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGN 68
Query: 363 VYRGKI--NGGFAAIKKVNGDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNG 420
            Y  KI        +K++   ++ E  +L  +N   L+ L     +  N Y+V EY   G
Sbjct: 69  HYAMKILDKQKVVKLKQIEHTLN-EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGG 127
Query: 421 TLSDWVFSN-KNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDL 479
            +    FS+ +  G++ +   R   A  V T   YLHS      +++D+   N+L+D   
Sbjct: 128 EM----FSHLRRIGRFSEPHARFYAAQIVLT-FEYLHSLD---LIYRDLKPENLLIDQQG 179
Query: 480 RAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEML 539
             ++ +F  A+  +G+      T  + GT  Y+APE + +   +  +D +A GVLI EM 
Sbjct: 180 YIQVTDFGFAKRVKGR------TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMA 233
Query: 540 TG 541
            G
Sbjct: 234 AG 235

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 75/158 (47%), Gaps = 15/158 (9%)
Query: 385 EIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSN-KNEGKYLDWKQRIQ 443
           E  +L  +N   L+ L     +  N Y+V EY   G +    FS+ +  G++ +   R  
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFY 146
Query: 444 IALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTR 503
            A  V T   YLHS      +++D+   N+L+D     ++ +F  A+  +G+      T 
Sbjct: 147 AAQIVLT-FEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR------TW 196
Query: 504 HIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTG 541
            + GT  Y+APE + +   +  +D +A GVLI EM  G
Sbjct: 197 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 93/204 (45%), Gaps = 32/204 (15%)
Query: 361 GSVYRGK--INGGFAAIKKVNG------------DVSKEIALLNKIN---HSNLIILSGV 403
           G+VY+ +   +G F A+K V                 +E+ALL ++    H N++ L  V
Sbjct: 23  GTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDV 82
Query: 404 CF-----NEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSF 458
           C       E    LV+E+ V+  L  ++  +K     L  +    +      GL++LH+ 
Sbjct: 83  CATSRTDREIKVTLVFEH-VDQDLRTYL--DKAPPPGLPAETIKDLMRQFLRGLDFLHAN 139
Query: 459 TNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLE 518
                VH+D+   N+L+ S    K+A+F +AR    Q    ALT  +V T  Y APE L 
Sbjct: 140 CI---VHRDLKPENILVTSGGTVKLADFGLARIYSYQ---MALT-PVVVTLWYRAPEVLL 192
Query: 519 NGLVSTKLDVYAFGVLILEMLTGK 542
               +T +D+++ G +  EM   K
Sbjct: 193 QSTYATPVDMWSVGCIFAEMFRRK 216

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 75/158 (47%), Gaps = 15/158 (9%)
Query: 385 EIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSN-KNEGKYLDWKQRIQ 443
           E  +L  +N   L+ L     +  N Y+V EY   G +    FS+ +  G++ +   R  
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFY 146
Query: 444 IALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTR 503
            A  V T   YLHS      +++D+   N+L+D     ++ +F  A+  +G+      T 
Sbjct: 147 AAQIVLT-FEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR------TW 196
Query: 504 HIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTG 541
            + GT  Y+APE + +   +  +D +A GVLI EM  G
Sbjct: 197 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/158 (27%), Positives = 75/158 (47%), Gaps = 15/158 (9%)
Query: 385 EIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSN-KNEGKYLDWKQRIQ 443
           E  +L  +N   L+ L     +  N Y+V EY   G +    FS+ +  G++ +   R  
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFSEPHARFY 146
Query: 444 IALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTR 503
            A  V T   YLHS      +++D+   N+++D     ++ +F  A+  +G+      T 
Sbjct: 147 AAQIVLT-FEYLHSLD---LIYRDLKPENLIIDQQGYIQVTDFGFAKRVKGR------TW 196
Query: 504 HIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTG 541
            + GT  Y+APE + +   +  +D +A GVLI EM  G
Sbjct: 197 XLCGTPEYLAPEIIISKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 63/270 (23%), Positives = 112/270 (41%), Gaps = 52/270 (19%)
Query: 367 KINGGFAAIKKVNGDVSKE-----IALLNKINHSN----LIILSGVCFNEGNCYLVYE-- 415
           K +G   A+K++   V ++     +  L+ +  S+    ++   G  F EG+C++  E  
Sbjct: 44  KPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELM 103
Query: 416 -------YAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDI 468
                  Y    ++ D V   +  GK         I L     LN+L    N   +H+DI
Sbjct: 104 STSFDKFYKYVYSVLDDVIPEEILGK---------ITLATVKALNHLKE--NLKIIHRDI 152
Query: 469 NSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGL----VST 524
             SN+LLD     K+ +F ++    GQ  +        G + YMAPE ++          
Sbjct: 153 KPSNILLDRSGNIKLCDFGIS----GQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDV 208
Query: 525 KLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGN 584
           + DV++ G+ + E+ TG+     + + N++   D L  V+  +           P L  +
Sbjct: 209 RSDVWSLGITLYELATGRFP---YPKWNSVF--DQLTQVVKGD----------PPQLSNS 253
Query: 585 YPLELALLVIRLIDACLKKDPTDRPTMYEI 614
              E +   I  ++ CL KD + RP   E+
Sbjct: 254 EEREFSPSFINFVNLCLTKDESKRPKYKEL 283

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 42/165 (25%), Positives = 79/165 (47%), Gaps = 20/165 (12%)
Query: 384 KEIALLNKINHSNLIILSGV-----CFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDW 438
           +E+ LL  + H N+I L  V        E N   +  + +   L++ V   K    ++ +
Sbjct: 66  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 125
Query: 439 KQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGE 498
                +   +  GL Y+HS      +H+D+  SN+ ++ D   KI +F +AR  + +   
Sbjct: 126 -----LIYQILRGLKYIHSADI---IHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAG 177
Query: 499 FALTRHIVGTKGYMAPEYLENGL-VSTKLDVYAFGVLILEMLTGK 542
           F      V T+ Y APE + N +  +  +D+++ G ++ E+LTG+
Sbjct: 178 F------VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 62/242 (25%), Positives = 114/242 (47%), Gaps = 25/242 (10%)
Query: 310 QANEKPSNKKF-DEESQDFLESISGVAQ-SLKVYSFKELQS-ATDNFSFTCRIQ----GS 362
           + +E+ S K+F  +  +DFL+     AQ +  +  F+ +++  T +F     ++    G+
Sbjct: 9   KGSEQESVKEFLAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGN 68
Query: 363 VYRGKI--NGGFAAIKKVNGDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNG 420
            Y  KI        +K++   ++ E  +L  +N   L+ L     +  N Y+V EY   G
Sbjct: 69  HYAMKILDKQKVVKLKQIEHTLN-EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGG 127
Query: 421 TLSDWVFSN-KNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDL 479
            +    FS+ +  G++ +   R   A  V T   YLHS      +++D+   N+L+D   
Sbjct: 128 EM----FSHLRRIGRFSEPHARFYAAQIVLT-FEYLHSLD---LIYRDLKPENLLIDQQG 179
Query: 480 RAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEML 539
             ++ +F  A+  +G+      T  + GT  Y+APE + +   +  +D +A GVLI EM 
Sbjct: 180 YIQVTDFGFAKRVKGR------TWTLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMA 233
Query: 540 TG 541
            G
Sbjct: 234 AG 235

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 45/181 (24%), Positives = 89/181 (49%), Gaps = 20/181 (11%)
Query: 370 GGFAA--IKKVNGDVSKEIALLNKIN-HSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWV 426
           G F+A  ++++     KE+ +L K++ H N+I L          +LV++    G L D++
Sbjct: 43  GSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL 102
Query: 427 FSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANF 486
            + K      + ++ ++  L+V   L+ L+       VH+D+   N+LLD D+  K+ +F
Sbjct: 103 -TEKVTLSEKETRKIMRALLEVICALHKLNI------VHRDLKPENILLDDDMNIKLTDF 155
Query: 487 AMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGL------VSTKLDVYAFGVLILEMLT 540
             +   +  E      R + GT  Y+APE +E  +         ++D+++ GV++  +L 
Sbjct: 156 GFSCQLDPGEK----LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLA 211
Query: 541 G 541
           G
Sbjct: 212 G 212

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/242 (22%), Positives = 110/242 (45%), Gaps = 29/242 (11%)
Query: 387 ALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIAL 446
           ++++K++H +L++  GVCF      LV E+   G+L  ++  NKN    L WK  +++A 
Sbjct: 64  SMMSKLSHKHLVLNYGVCFCGDENILVQEFVKFGSLDTYLKKNKNCINIL-WK--LEVAK 120
Query: 447 DVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIV 506
            +A  +++L   T    +H ++ + N+LL  +   K  N    + ++       L + I+
Sbjct: 121 QLAWAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDIL 177
Query: 507 GTK-GYMAPEYLENGL-VSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVL 564
             +  ++ PE +EN   ++   D ++FG  + E+ +G +                    L
Sbjct: 178 QERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKP------------------L 219
Query: 565 TKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNA 624
           +  D +  L+ + D   +   P   A  +  LI+ C+  +P  RP+   I   L+++   
Sbjct: 220 SALDSQRKLQFYED---RHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTP 276
Query: 625 SL 626
            L
Sbjct: 277 DL 278

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 44/158 (27%), Positives = 75/158 (47%), Gaps = 15/158 (9%)
Query: 385 EIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSN-KNEGKYLDWKQRIQ 443
           E  +L  +N   L+ L     +  N Y+V EY   G +    FS+ +  G++ +   R  
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFSEPHARFY 146
Query: 444 IALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTR 503
            A  V T   YLHS      +++D+   N+L+D     ++ +F  A+  +G+      T 
Sbjct: 147 AAQIVLT-FEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR------TW 196
Query: 504 HIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTG 541
            + GT  Y+APE + +   +  +D +A GVLI +M  G
Sbjct: 197 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYQMAAG 234

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 75/158 (47%), Gaps = 15/158 (9%)
Query: 385 EIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSN-KNEGKYLDWKQRIQ 443
           E  +L  +N   L+ L     +  N Y+V EY   G +    FS+ +  G++ +   R  
Sbjct: 77  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFY 132
Query: 444 IALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTR 503
            A  V T   YLHS      +++D+   N+L+D     ++ +F  A+  +G+      T 
Sbjct: 133 AAQIVLT-FEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR------TW 182
Query: 504 HIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTG 541
            + GT  Y+APE + +   +  +D +A GVLI EM  G
Sbjct: 183 TLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 220

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 45/181 (24%), Positives = 89/181 (49%), Gaps = 20/181 (11%)
Query: 370 GGFAA--IKKVNGDVSKEIALLNKIN-HSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWV 426
           G F+A  ++++     KE+ +L K++ H N+I L          +LV++    G L D++
Sbjct: 56  GSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL 115
Query: 427 FSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANF 486
            + K      + ++ ++  L+V   L+ L+       VH+D+   N+LLD D+  K+ +F
Sbjct: 116 -TEKVTLSEKETRKIMRALLEVICALHKLNI------VHRDLKPENILLDDDMNIKLTDF 168
Query: 487 AMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGL------VSTKLDVYAFGVLILEMLT 540
             +   +  E      R + GT  Y+APE +E  +         ++D+++ GV++  +L 
Sbjct: 169 GFSCQLDPGEK----LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLA 224
Query: 541 G 541
           G
Sbjct: 225 G 225

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 74/158 (46%), Gaps = 15/158 (9%)
Query: 385 EIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSN-KNEGKYLDWKQRIQ 443
           E  +L  +N   L+ L     +  N Y+V EY   G +    FS+ +  G++ +   R  
Sbjct: 112 EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFSEPHARFY 167
Query: 444 IALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTR 503
            A  V T   YLHS      +++D+   N+L+D     ++ +F  A+  +G       T 
Sbjct: 168 AAQIVLT-FEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGA------TW 217
Query: 504 HIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTG 541
            + GT  Y+APE + +   +  +D +A GVLI EM  G
Sbjct: 218 TLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 85/207 (41%), Gaps = 39/207 (18%)
Query: 365 RGKINGGFAAIKKVNGDVSK------EIALLNKINHSNLIILSGVCFNEGN--------- 409
           R  ++  + AIKK+     K      E+ LL  +NH  ++          N         
Sbjct: 26  RNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVK 85
Query: 410 ----CYLVYEYAVNGTLSDWVFS-NKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHV 464
                ++  EY  NGTL D + S N N+ +   W+   QI       L+Y+HS      +
Sbjct: 86  KKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQIL----EALSYIHS---QGII 138
Query: 465 HKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRH-----------IVGTKGYMA 513
           H+D+   N+ +D     KI +F +A+          L               +GT  Y+A
Sbjct: 139 HRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVA 198
Query: 514 PEYLE-NGLVSTKLDVYAFGVLILEML 539
            E L+  G  + K+D+Y+ G++  EM+
Sbjct: 199 TEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 45/164 (27%), Positives = 82/164 (50%), Gaps = 20/164 (12%)
Query: 384 KEIALLNKINHSNLIILSGVCFNEG------NCYLVYEYAVNGTLSDWVFSNKNEGKYLD 437
           +E+ L+  +NH N+I L  V   +       + Y+V E  ++  LS  +         LD
Sbjct: 72  RELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVME-LMDANLSQVIQME------LD 124
Query: 438 WKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEG 497
            ++   +   +  G+ +LHS      +H+D+  SN+++ SD   KI +F +AR A     
Sbjct: 125 HERMSYLLYQMLVGIKHLHSAGI---IHRDLKPSNIVVKSDATLKILDFGLARTAGTS-- 179
Query: 498 EFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTG 541
            F +T ++V T+ Y APE +        +D+++ GV++ EM+ G
Sbjct: 180 -FMMTPYVV-TRYYRAPEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 31/96 (32%), Positives = 52/96 (54%), Gaps = 4/96 (4%)
Query: 448 VATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVG 507
           +  GL Y+HS      +H+D+  SN+LL++    KI +F +AR A+            V 
Sbjct: 137 ILRGLKYIHSANV---LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVA 193
Query: 508 TKGYMAPEYLENGLVSTK-LDVYAFGVLILEMLTGK 542
           T+ Y APE + N    TK +D+++ G ++ EML+ +
Sbjct: 194 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 31/96 (32%), Positives = 52/96 (54%), Gaps = 4/96 (4%)
Query: 448 VATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVG 507
           +  GL Y+HS      +H+D+  SN+LL++    KI +F +AR A+            V 
Sbjct: 138 ILRGLKYIHSANV---LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVA 194
Query: 508 TKGYMAPEYLENGLVSTK-LDVYAFGVLILEMLTGK 542
           T+ Y APE + N    TK +D+++ G ++ EML+ +
Sbjct: 195 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 230

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 47/207 (22%), Positives = 87/207 (42%), Gaps = 39/207 (18%)
Query: 365 RGKINGGFAAIKKVN--------GDVSKEIALLNKINHSNLIILSGVCFNEGNC------ 410
           + K++    AIK++           V +E+  L K+ H  ++        +         
Sbjct: 25  KNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84
Query: 411 ------YLVYEYAVNGTLSDWVFSNKNEGKYLDWKQR---IQIALDVATGLNYLHSFTNP 461
                 Y+  +      L DW+    N    ++ ++R   + I L +A  + +LHS    
Sbjct: 85  SPKVYLYIQMQLCRKENLKDWM----NGRCTIEERERSVCLHIFLQIAEAVEFLHS---K 137
Query: 462 PHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEF-------ALTRHI--VGTKGYM 512
             +H+D+  SN+    D   K+ +F +    +  E E        A  RH   VGTK YM
Sbjct: 138 GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYM 197
Query: 513 APEYLENGLVSTKLDVYAFGVLILEML 539
           +PE +     S K+D+++ G+++ E+L
Sbjct: 198 SPEQIHGNSYSHKVDIFSLGLILFELL 224

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 36/118 (30%), Positives = 58/118 (49%), Gaps = 10/118 (8%)
Query: 448 VATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVG 507
           +  GL Y+HS      +H+D+  SN+LL++    KI +F +AR A+            V 
Sbjct: 137 ILRGLKYIHSANV---LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 193
Query: 508 TKGYMAPEYLENGLVSTK-LDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVL 564
           T+ Y APE + N    TK +D+++ G ++ EML+ +            H  D LN +L
Sbjct: 194 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFP------GKHYLDQLNHIL 245

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 47/185 (25%), Positives = 82/185 (44%), Gaps = 15/185 (8%)
Query: 361 GSVYRGKINGGFAAIKKVNGDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNG 420
           G  Y  KI        + +  + +E  +   + HSN++ L      EG  YLV++    G
Sbjct: 29  GHEYAAKIINTKKLSARDHQKLEREARICRLLKHSNIVRLHDSISEEGFHYLVFDLVTGG 88
Query: 421 TLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLR 480
            L + + + +   +  D    IQ  L+     + +        VH+D+   N+LL S  +
Sbjct: 89  ELFEDIVAREYYSE-ADASHCIQQILEAVLHCHQMGV------VHRDLKPENLLLASKCK 141
Query: 481 A---KIANFAMARPAEG-QEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLIL 536
               K+A+F +A   +G Q+  F       GT GY++PE L        +D++A GV++ 
Sbjct: 142 GAAVKLADFGLAIEVQGDQQAWFGFA----GTPGYLSPEVLRKEAYGKPVDIWACGVILY 197
Query: 537 EMLTG 541
            +L G
Sbjct: 198 ILLVG 202

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 45/164 (27%), Positives = 82/164 (50%), Gaps = 20/164 (12%)
Query: 384 KEIALLNKINHSNLIILSGVCFNEG------NCYLVYEYAVNGTLSDWVFSNKNEGKYLD 437
           +E+ L+  +NH N+I L  V   +       + Y+V E  ++  LS  +         LD
Sbjct: 72  RELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVME-LMDANLSQVIQME------LD 124
Query: 438 WKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEG 497
            ++   +   +  G+ +LHS      +H+D+  SN+++ SD   KI +F +AR A     
Sbjct: 125 HERMSYLLYQMLVGIKHLHSAGI---IHRDLKPSNIVVKSDATLKILDFGLARTAGTS-- 179
Query: 498 EFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTG 541
            F +T ++V T+ Y APE +        +D+++ GV++ EM+ G
Sbjct: 180 -FMMTPYVV-TRYYRAPEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 36/118 (30%), Positives = 58/118 (49%), Gaps = 10/118 (8%)
Query: 448 VATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVG 507
           +  GL Y+HS      +H+D+  SN+LL++    KI +F +AR A+            V 
Sbjct: 135 ILRGLKYIHSANV---LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 191
Query: 508 TKGYMAPEYLENGLVSTK-LDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVL 564
           T+ Y APE + N    TK +D+++ G ++ EML+ +            H  D LN +L
Sbjct: 192 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFP------GKHYLDQLNHIL 243

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 31/96 (32%), Positives = 52/96 (54%), Gaps = 4/96 (4%)
Query: 448 VATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVG 507
           +  GL Y+HS      +H+D+  SN+LL++    KI +F +AR A+            V 
Sbjct: 135 ILRGLKYIHSANV---LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 191
Query: 508 TKGYMAPEYLENGLVSTK-LDVYAFGVLILEMLTGK 542
           T+ Y APE + N    TK +D+++ G ++ EML+ +
Sbjct: 192 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 36/118 (30%), Positives = 58/118 (49%), Gaps = 10/118 (8%)
Query: 448 VATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVG 507
           +  GL Y+HS      +H+D+  SN+LL++    KI +F +AR A+            V 
Sbjct: 137 ILRGLKYIHSANV---LHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVA 193
Query: 508 TKGYMAPEYLENGLVSTK-LDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVL 564
           T+ Y APE + N    TK +D+++ G ++ EML+ +            H  D LN +L
Sbjct: 194 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFP------GKHYLDQLNHIL 245

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 36/118 (30%), Positives = 58/118 (49%), Gaps = 10/118 (8%)
Query: 448 VATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVG 507
           +  GL Y+HS      +H+D+  SN+LL++    KI +F +AR A+            V 
Sbjct: 131 ILRGLKYIHSANV---LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 187
Query: 508 TKGYMAPEYLENGLVSTK-LDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVL 564
           T+ Y APE + N    TK +D+++ G ++ EML+ +            H  D LN +L
Sbjct: 188 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFP------GKHYLDQLNHIL 239

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 47/170 (27%), Positives = 81/170 (47%), Gaps = 18/170 (10%)
Query: 377 KVNGDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYL 436
           K   +V  EI+++N+++H+NLI L     ++ +  LV EY   G L D +         L
Sbjct: 128 KDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTEL 187
Query: 437 DWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVL-LDSDLRA-KIANFAMAR---P 491
           D    I     +  G+ ++H       +H D+   N+L ++ D +  KI +F +AR   P
Sbjct: 188 D---TILFMKQICEGIRHMHQMYI---LHLDLKPENILCVNRDAKQIKIIDFGLARRYKP 241
Query: 492 AEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTG 541
            E  +  F       GT  ++APE +    VS   D+++ GV+   +L+G
Sbjct: 242 REKLKVNF-------GTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSG 284

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 31/96 (32%), Positives = 52/96 (54%), Gaps = 4/96 (4%)
Query: 448 VATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVG 507
           +  GL Y+HS      +H+D+  SN+LL++    KI +F +AR A+            V 
Sbjct: 133 ILRGLKYIHSANV---LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 189
Query: 508 TKGYMAPEYLENGLVSTK-LDVYAFGVLILEMLTGK 542
           T+ Y APE + N    TK +D+++ G ++ EML+ +
Sbjct: 190 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 36/118 (30%), Positives = 58/118 (49%), Gaps = 10/118 (8%)
Query: 448 VATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVG 507
           +  GL Y+HS      +H+D+  SN+LL++    KI +F +AR A+            V 
Sbjct: 138 ILRGLKYIHSANV---LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 194
Query: 508 TKGYMAPEYLENGLVSTK-LDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVL 564
           T+ Y APE + N    TK +D+++ G ++ EML+ +            H  D LN +L
Sbjct: 195 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFP------GKHYLDQLNHIL 246

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 36/118 (30%), Positives = 58/118 (49%), Gaps = 10/118 (8%)
Query: 448 VATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVG 507
           +  GL Y+HS      +H+D+  SN+LL++    KI +F +AR A+            V 
Sbjct: 139 ILRGLKYIHSANV---LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 195
Query: 508 TKGYMAPEYLENGLVSTK-LDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVL 564
           T+ Y APE + N    TK +D+++ G ++ EML+ +            H  D LN +L
Sbjct: 196 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFP------GKHYLDQLNHIL 247

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 36/118 (30%), Positives = 58/118 (49%), Gaps = 10/118 (8%)
Query: 448 VATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVG 507
           +  GL Y+HS      +H+D+  SN+LL++    KI +F +AR A+            V 
Sbjct: 130 ILRGLKYIHSANV---LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 186
Query: 508 TKGYMAPEYLENGLVSTK-LDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVL 564
           T+ Y APE + N    TK +D+++ G ++ EML+ +            H  D LN +L
Sbjct: 187 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFP------GKHYLDQLNHIL 238

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 36/118 (30%), Positives = 58/118 (49%), Gaps = 10/118 (8%)
Query: 448 VATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVG 507
           +  GL Y+HS      +H+D+  SN+LL++    KI +F +AR A+            V 
Sbjct: 137 ILRGLKYIHSANV---LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 193
Query: 508 TKGYMAPEYLENGLVSTK-LDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVL 564
           T+ Y APE + N    TK +D+++ G ++ EML+ +            H  D LN +L
Sbjct: 194 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFP------GKHYLDQLNHIL 245

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 36/118 (30%), Positives = 58/118 (49%), Gaps = 10/118 (8%)
Query: 448 VATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVG 507
           +  GL Y+HS      +H+D+  SN+LL++    KI +F +AR A+            V 
Sbjct: 137 ILRGLKYIHSANV---LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 193
Query: 508 TKGYMAPEYLENGLVSTK-LDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVL 564
           T+ Y APE + N    TK +D+++ G ++ EML+ +            H  D LN +L
Sbjct: 194 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFP------GKHYLDQLNHIL 245

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 31/96 (32%), Positives = 52/96 (54%), Gaps = 4/96 (4%)
Query: 448 VATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVG 507
           +  GL Y+HS      +H+D+  SN+LL++    KI +F +AR A+            V 
Sbjct: 133 ILRGLKYIHSANV---LHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVA 189
Query: 508 TKGYMAPEYLENGLVSTK-LDVYAFGVLILEMLTGK 542
           T+ Y APE + N    TK +D+++ G ++ EML+ +
Sbjct: 190 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 45/181 (24%), Positives = 89/181 (49%), Gaps = 20/181 (11%)
Query: 370 GGFAA--IKKVNGDVSKEIALLNKIN-HSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWV 426
           G F+A  ++++     KE+ +L K++ H N+I L          +LV++    G L D++
Sbjct: 56  GSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL 115
Query: 427 FSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANF 486
            + K      + ++ ++  L+V   L+ L+       VH+D+   N+LLD D+  K+ +F
Sbjct: 116 -TEKVTLSEKETRKIMRALLEVICALHKLNI------VHRDLKPENILLDDDMNIKLTDF 168
Query: 487 AMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGL------VSTKLDVYAFGVLILEMLT 540
             +   +  E      R + GT  Y+APE +E  +         ++D+++ GV++  +L 
Sbjct: 169 GFSCQLDPGEK----LRSVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLA 224
Query: 541 G 541
           G
Sbjct: 225 G 225

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 36/118 (30%), Positives = 58/118 (49%), Gaps = 10/118 (8%)
Query: 448 VATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVG 507
           +  GL Y+HS      +H+D+  SN+LL++    KI +F +AR A+            V 
Sbjct: 131 ILRGLKYIHSANV---LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 187
Query: 508 TKGYMAPEYLENGLVSTK-LDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVL 564
           T+ Y APE + N    TK +D+++ G ++ EML+ +            H  D LN +L
Sbjct: 188 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFP------GKHYLDQLNHIL 239

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 36/118 (30%), Positives = 58/118 (49%), Gaps = 10/118 (8%)
Query: 448 VATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVG 507
           +  GL Y+HS      +H+D+  SN+LL++    KI +F +AR A+            V 
Sbjct: 141 ILRGLKYIHSANV---LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 197
Query: 508 TKGYMAPEYLENGLVSTK-LDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVL 564
           T+ Y APE + N    TK +D+++ G ++ EML+ +            H  D LN +L
Sbjct: 198 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFP------GKHYLDQLNHIL 249

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 36/118 (30%), Positives = 58/118 (49%), Gaps = 10/118 (8%)
Query: 448 VATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVG 507
           +  GL Y+HS      +H+D+  SN+LL++    KI +F +AR A+            V 
Sbjct: 133 ILRGLKYIHSANV---LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 189
Query: 508 TKGYMAPEYLENGLVSTK-LDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVL 564
           T+ Y APE + N    TK +D+++ G ++ EML+ +            H  D LN +L
Sbjct: 190 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFP------GKHYLDQLNHIL 241

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 46/172 (26%), Positives = 82/172 (47%), Gaps = 34/172 (19%)
Query: 384 KEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWV-------FSNKNEGKYL 436
           +E+ LL  + H N+I L  V            +  + TL D+        F   + GK +
Sbjct: 73  RELRLLKHMRHENVIGLLDV------------FTPDETLDDFTDFYLVMPFMGTDLGKLM 120
Query: 437 DWKQ----RIQ-IALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARP 491
             ++    RIQ +   +  GL Y+H+      +H+D+   N+ ++ D   KI +F +AR 
Sbjct: 121 KHEKLGEDRIQFLVYQMLKGLRYIHAAGI---IHRDLKPGNLAVNEDCELKILDFGLARQ 177
Query: 492 AEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTK-LDVYAFGVLILEMLTGK 542
           A+ +     +TR       Y APE + N +  T+ +D+++ G ++ EM+TGK
Sbjct: 178 ADSEMXGXVVTR------WYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 36/118 (30%), Positives = 58/118 (49%), Gaps = 10/118 (8%)
Query: 448 VATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVG 507
           +  GL Y+HS      +H+D+  SN+LL++    KI +F +AR A+            V 
Sbjct: 153 ILRGLKYIHSANV---LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 209
Query: 508 TKGYMAPEYLENGLVSTK-LDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVL 564
           T+ Y APE + N    TK +D+++ G ++ EML+ +            H  D LN +L
Sbjct: 210 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFP------GKHYLDQLNHIL 261

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 36/118 (30%), Positives = 58/118 (49%), Gaps = 10/118 (8%)
Query: 448 VATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVG 507
           +  GL Y+HS      +H+D+  SN+LL++    KI +F +AR A+            V 
Sbjct: 137 ILRGLKYIHSANV---LHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVA 193
Query: 508 TKGYMAPEYLENGLVSTK-LDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVL 564
           T+ Y APE + N    TK +D+++ G ++ EML+ +            H  D LN +L
Sbjct: 194 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFP------GKHYLDQLNHIL 245

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 35/132 (26%), Positives = 65/132 (49%), Gaps = 11/132 (8%)
Query: 411 YLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINS 470
           ++V EY   G+L+D V         +D  Q   +  +    L +LHS      +H++I S
Sbjct: 94  WVVMEYLAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHSNQ---VIHRNIKS 145
Query: 471 SNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYA 530
            N+LL  D   K+ +F        ++ + +    +VGT  +MAPE +       K+D+++
Sbjct: 146 DNILLGMDGSVKLTDFGFCAQITPEQSKRST---MVGTPYWMAPEVVTRKAYGPKVDIWS 202
Query: 531 FGVLILEMLTGK 542
            G++ +EM+ G+
Sbjct: 203 LGIMAIEMIEGE 214

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 31/96 (32%), Positives = 52/96 (54%), Gaps = 4/96 (4%)
Query: 448 VATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVG 507
           +  GL Y+HS      +H+D+  SN+LL++    KI +F +AR A+            V 
Sbjct: 153 ILRGLKYIHSANV---LHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVA 209
Query: 508 TKGYMAPEYLENGLVSTK-LDVYAFGVLILEMLTGK 542
           T+ Y APE + N    TK +D+++ G ++ EML+ +
Sbjct: 210 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 31/96 (32%), Positives = 52/96 (54%), Gaps = 4/96 (4%)
Query: 448 VATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVG 507
           +  GL Y+HS      +H+D+  SN+LL++    KI +F +AR A+            V 
Sbjct: 133 ILRGLKYIHSANV---LHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVA 189
Query: 508 TKGYMAPEYLENGLVSTK-LDVYAFGVLILEMLTGK 542
           T+ Y APE + N    TK +D+++ G ++ EML+ +
Sbjct: 190 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 97/215 (45%), Gaps = 31/215 (14%)
Query: 346 LQSATDNFSFTCRIQGSVY------RGKINGGFAAIKKV----------NGDVSKEIALL 389
            Q  +D +    ++    Y      + K+ G   AIK +          +G +  E+A+L
Sbjct: 16  FQGLSDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVL 75
Query: 390 NKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVA 449
            +++H N++ L     ++ N YLV E    G L D +   +   K+ +    + I   V 
Sbjct: 76  KQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQ---KFSEVDAAV-IMKQVL 131
Query: 450 TGLNYLHSFTNPPHVHKDINSSNVLLDSDLR---AKIANFAMARPAEGQEGEFALTRHIV 506
           +G  YLH       VH+D+   N+LL+S  R    KI +F ++  A  + G     +  +
Sbjct: 132 SGTTYLHKHNI---VHRDLKPENLLLESKSRDALIKIVDFGLS--AHFEVG--GKMKERL 184
Query: 507 GTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTG 541
           GT  Y+APE L       K DV++ GV++  +L G
Sbjct: 185 GTAYYIAPEVLRKK-YDEKCDVWSCGVILYILLCG 218

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 48/207 (23%), Positives = 91/207 (43%), Gaps = 31/207 (14%)
Query: 361 GSVYRGKING-------GFAAIK----KVNGDVSKEI----ALLNKINHSNLIILSGVCF 405
           G VY+G + G          AIK    K  G + +E      L  ++ H N++ L GV  
Sbjct: 40  GKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVT 99
Query: 406 NEGNCYLVYEYAVNGTLSDWVF------------SNKNEGKYLDWKQRIQIALDVATGLN 453
            +    +++ Y  +G L +++              ++     L+    + +   +A G+ 
Sbjct: 100 KDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGME 159
Query: 454 YLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMA 513
           YL S      VHKD+ + NVL+   L  KI++  + R     +    L   ++  + +MA
Sbjct: 160 YLSSHHV---VHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIR-WMA 215
Query: 514 PEYLENGLVSTKLDVYAFGVLILEMLT 540
           PE +  G  S   D++++GV++ E+ +
Sbjct: 216 PEAIMYGKFSIDSDIWSYGVVLWEVFS 242

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 35/118 (29%), Positives = 59/118 (50%), Gaps = 10/118 (8%)
Query: 448 VATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVG 507
           +  GL Y+HS      +H+D+  SN+L+++    KI +F +AR A+ +          V 
Sbjct: 153 ILRGLKYIHSANV---LHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVA 209
Query: 508 TKGYMAPEYLENGLVSTK-LDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVL 564
           T+ Y APE + N    TK +D+++ G ++ EML+ +            H  D LN +L
Sbjct: 210 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFP------GKHYLDQLNHIL 261

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 46/187 (24%), Positives = 83/187 (44%), Gaps = 22/187 (11%)
Query: 365 RGKINGGFAAIKKV-------NGDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYA 417
           + ++ G   A+K +       +  +  EIA+L KI H N++ L  +  +  + YLV +  
Sbjct: 29  KQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLV 88
Query: 418 VNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLL-- 475
             G L D +      G Y + K    +   V + + YLH       VH+D+   N+L   
Sbjct: 89  SGGELFDRILER---GVYTE-KDASLVIQQVLSAVKYLH---ENGIVHRDLKPENLLYLT 141
Query: 476 -DSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVL 534
            + + +  I +F +++  +       +     GT GY+APE L     S  +D ++ GV+
Sbjct: 142 PEENSKIMITDFGLSKMEQN-----GIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVI 196
Query: 535 ILEMLTG 541
              +L G
Sbjct: 197 TYILLCG 203

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 41/165 (24%), Positives = 79/165 (47%), Gaps = 20/165 (12%)
Query: 384 KEIALLNKINHSNLIILSGV-----CFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDW 438
           +E+ LL  + H N+I L  V        E N   +  + +   L++ V   K    ++ +
Sbjct: 70  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 129
Query: 439 KQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGE 498
                +   +  GL Y+HS      +H+D+  SN+ ++ D   KI +F +AR  + +   
Sbjct: 130 -----LIYQILRGLKYIHSADI---IHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG 181
Query: 499 FALTRHIVGTKGYMAPEYLENGL-VSTKLDVYAFGVLILEMLTGK 542
           +      V T+ Y APE + N +  +  +D+++ G ++ E+LTG+
Sbjct: 182 Y------VATRWYRAPEIMLNAMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 31/96 (32%), Positives = 52/96 (54%), Gaps = 4/96 (4%)
Query: 448 VATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVG 507
           +  GL Y+HS      +H+D+  SN+LL++    KI +F +AR A+            V 
Sbjct: 133 ILRGLKYIHSANV---LHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVA 189
Query: 508 TKGYMAPEYLENGLVSTK-LDVYAFGVLILEMLTGK 542
           T+ Y APE + N    TK +D+++ G ++ EML+ +
Sbjct: 190 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 98/227 (43%), Gaps = 41/227 (18%)
Query: 342 SFKELQSATDNFSFTCRIQ-----GSVYRGKINGGFAAIKKVNGDVSK------------ 384
            F  +Q A   F+   R Q     GS  +G +   F  +  +N  V K            
Sbjct: 7   QFYSVQVADSTFTVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAK 66
Query: 385 ----EIALLNKINHSNLIILSGVCFNEG------NCYLVYEYAVNGTLSDWVFSNKNEGK 434
               E+ LL  +NH N+I L  V   +       + YLV E  ++  L   +        
Sbjct: 67  RAYRELVLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL-MDANLCQVIHME----- 120
Query: 435 YLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEG 494
            LD ++   +   +  G+ +LHS      +H+D+  SN+++ SD   KI +F +AR A  
Sbjct: 121 -LDHERMSYLLYQMLCGIKHLHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLARTAST 176
Query: 495 QEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTG 541
               F +T ++V T+ Y APE +        +D+++ G ++ E++ G
Sbjct: 177 N---FMMTPYVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGELVKG 219

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 55/245 (22%), Positives = 108/245 (44%), Gaps = 39/245 (15%)
Query: 385 EIALLNKI-NHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEG---------- 433
           E+ +++ +  H N++ L G C + G   ++ EY   G L +++   +  G          
Sbjct: 99  ELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHN 158
Query: 434 --KYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARP 491
             + L  +  +  +  VA G+ +L S      +H+D+ + NVLL +   AKI +F +AR 
Sbjct: 159 PEEQLSSRDLLHFSSQVAQGMAFLASKNC---IHRDVAARNVLLTNGHVAKIGDFGLARD 215
Query: 492 AEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEE 551
                         +  K +MAPE + + + + + DV+++G+L+ E+ +      L    
Sbjct: 216 IMNDSNYIVKGNARLPVK-WMAPESIFDCVYTVQSDVWSYGILLWEIFS----LGL---- 266
Query: 552 NNMHLSDVLNAVLTK--EDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRP 609
            N +   ++N+   K  +DG +  +    P             +  ++ AC   +PT RP
Sbjct: 267 -NPYPGILVNSKFYKLVKDGYQMAQPAFAPK-----------NIYSIMQACWALEPTHRP 314
Query: 610 TMYEI 614
           T  +I
Sbjct: 315 TFQQI 319

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 44/158 (27%), Positives = 74/158 (46%), Gaps = 15/158 (9%)
Query: 385 EIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSN-KNEGKYLDWKQRIQ 443
           E  +L  +N   L+ L     +  N Y+V EY   G +    FS+ +  G++ +   R  
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFSEPHARFY 146
Query: 444 IALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTR 503
            A  V T   YLHS      +++D+   N+L+D     ++ +F  A+  +G+      T 
Sbjct: 147 AAQIVLT-FEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR------TW 196
Query: 504 HIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTG 541
            + GT  Y+AP  + +   +  +D +A GVLI EM  G
Sbjct: 197 XLCGTPEYLAPAIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 48/207 (23%), Positives = 91/207 (43%), Gaps = 31/207 (14%)
Query: 361 GSVYRGKING-------GFAAIK----KVNGDVSKEI----ALLNKINHSNLIILSGVCF 405
           G VY+G + G          AIK    K  G + +E      L  ++ H N++ L GV  
Sbjct: 23  GKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVT 82
Query: 406 NEGNCYLVYEYAVNGTLSDWVF------------SNKNEGKYLDWKQRIQIALDVATGLN 453
            +    +++ Y  +G L +++              ++     L+    + +   +A G+ 
Sbjct: 83  KDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGME 142
Query: 454 YLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMA 513
           YL S      VHKD+ + NVL+   L  KI++  + R     +    L   ++  + +MA
Sbjct: 143 YLSSHHV---VHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIR-WMA 198
Query: 514 PEYLENGLVSTKLDVYAFGVLILEMLT 540
           PE +  G  S   D++++GV++ E+ +
Sbjct: 199 PEAIMYGKFSIDSDIWSYGVVLWEVFS 225

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 42/162 (25%), Positives = 75/162 (46%), Gaps = 11/162 (6%)
Query: 382 VSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQR 441
           V  E+ +  ++ H +++ L     +    YLV E   NG ++ ++   KN  K     + 
Sbjct: 58  VQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYL---KNRVKPFSENEA 114
Query: 442 IQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAE-GQEGEFA 500
                 + TG+ YLHS      +H+D+  SN+LL  ++  KIA+F +A   +   E  + 
Sbjct: 115 RHFMHQIITGMLYLHSHGI---LHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT 171
Query: 501 LTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGK 542
           L     GT  Y++PE         + DV++ G +   +L G+
Sbjct: 172 L----CGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGR 209

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 42/164 (25%), Positives = 77/164 (46%), Gaps = 15/164 (9%)
Query: 382 VSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQR 441
           + +E  +   + H N++ L      EG+ YL+++    G L + + + +   +  D    
Sbjct: 57  LEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSE-ADASHC 115
Query: 442 IQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRA---KIANFAMARPAEG-QEG 497
           IQ  L+     + +        VH+++   N+LL S L+    K+A+F +A   EG Q+ 
Sbjct: 116 IQQILEAVLHCHQMGV------VHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQA 169
Query: 498 EFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTG 541
            F       GT GY++PE L        +D++A GV++  +L G
Sbjct: 170 WFGFA----GTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVG 209

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 31/96 (32%), Positives = 52/96 (54%), Gaps = 4/96 (4%)
Query: 448 VATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVG 507
           +  GL Y+HS      +H+D+  SN+LL++    KI +F +AR A+            V 
Sbjct: 135 ILRGLKYIHSANV---LHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVA 191
Query: 508 TKGYMAPEYLENGLVSTK-LDVYAFGVLILEMLTGK 542
           T+ Y APE + N    TK +D+++ G ++ EML+ +
Sbjct: 192 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 41/165 (24%), Positives = 79/165 (47%), Gaps = 20/165 (12%)
Query: 384 KEIALLNKINHSNLIILSGV-----CFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDW 438
           +E+ LL  + H N+I L  V        E N   +  + +   L++ V   K    ++ +
Sbjct: 70  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQF 129
Query: 439 KQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGE 498
                +   +  GL Y+HS      +H+D+  SN+ ++ D   KI +F +AR  + +   
Sbjct: 130 -----LIYQILRGLKYIHSADI---IHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTG 181
Query: 499 FALTRHIVGTKGYMAPEYLENGL-VSTKLDVYAFGVLILEMLTGK 542
           +      V T+ Y APE + N +  +  +D+++ G ++ E+LTG+
Sbjct: 182 Y------VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 62/276 (22%), Positives = 111/276 (40%), Gaps = 60/276 (21%)
Query: 361 GSVYRGKINGGFAAIK---------KVNGDVSKEIALLNKINHSNLIILSGVCFNEGNCY 411
           G +++G+  G    +K         + + D ++E   L   +H N++ + G C +    +
Sbjct: 24  GELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPH 83
Query: 412 --LVYEYAVNGTLSDWVFSNKNEGK--YLDWKQRIQIALDVATGLNYLHSFTN--PPHVH 465
             L+  +   G+L    ++  +EG    +D  Q ++ ALD A G  +LH+     P H  
Sbjct: 84  PTLITHWXPYGSL----YNVLHEGTNFVVDQSQAVKFALDXARGXAFLHTLEPLIPRHA- 138
Query: 466 KDINSSNVLLDSDLRAKIA----NFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGL 521
             +NS +V +D D  A+I+     F+   P                   ++APE L+   
Sbjct: 139 --LNSRSVXIDEDXTARISXADVKFSFQSPGRXY------------APAWVAPEALQKKP 184
Query: 522 VST---KLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFID 578
             T     D ++F VL+ E++T             +  +D+ N  +  +   E LR  I 
Sbjct: 185 EDTNRRSADXWSFAVLLWELVT-----------REVPFADLSNXEIGXKVALEGLRPTIP 233
Query: 579 PTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEI 614
           P +  +        V +L   C  +DP  RP    I
Sbjct: 234 PGISPH--------VSKLXKICXNEDPAKRPKFDXI 261

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 48/190 (25%), Positives = 84/190 (44%), Gaps = 20/190 (10%)
Query: 361 GSVYRGKINGGFAAIK------KVNGDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVY 414
             + R K+     A+K       ++ +V +EI     + H N++    V     +  ++ 
Sbjct: 36  ARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIM 95
Query: 415 EYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVL 474
           EYA  G L + +    N G++ + + R      + +G++Y HS       H+D+   N L
Sbjct: 96  EYASGGELYERIC---NAGRFSEDEARFFFQ-QLLSGVSYCHSMQI---CHRDLKLENTL 148
Query: 475 LDSD--LRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKL-DVYAF 531
           LD     R KI +F  ++ +       +  +  VGT  Y+APE L       K+ DV++ 
Sbjct: 149 LDGSPAPRLKICDFGYSKSSVLH----SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSC 204
Query: 532 GVLILEMLTG 541
           GV +  ML G
Sbjct: 205 GVTLYVMLVG 214

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 41/165 (24%), Positives = 79/165 (47%), Gaps = 20/165 (12%)
Query: 384 KEIALLNKINHSNLIILSGV-----CFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDW 438
           +E+ LL  + H N+I L  V        E N   +  + +   L++ V   K    ++ +
Sbjct: 99  RELRLLKHMKHENVIGLLDVFTPATSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 158
Query: 439 KQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGE 498
                +   +  GL Y+HS      +H+D+  SN+ ++ D   KI +F +AR  + +   
Sbjct: 159 -----LIYQILRGLKYIHSADI---IHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG 210
Query: 499 FALTRHIVGTKGYMAPEYLENGL-VSTKLDVYAFGVLILEMLTGK 542
           +      V T+ Y APE + N +  +  +D+++ G ++ E+LTG+
Sbjct: 211 Y------VATRWYRAPEIMLNWMHYNMTVDIWSVGCIMAELLTGR 249

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 41/165 (24%), Positives = 79/165 (47%), Gaps = 20/165 (12%)
Query: 384 KEIALLNKINHSNLIILSGV-----CFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDW 438
           +E+ LL  + H N+I L  V        E N   +  + +   L++ V   K    ++ +
Sbjct: 70  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 129
Query: 439 KQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGE 498
                +   +  GL Y+HS      +H+D+  SN+ ++ D   KI +F +AR  + +   
Sbjct: 130 -----LIYQILRGLKYIHSADI---IHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG 181
Query: 499 FALTRHIVGTKGYMAPEYLENGL-VSTKLDVYAFGVLILEMLTGK 542
           +      V T+ Y APE + N +  +  +D+++ G ++ E+LTG+
Sbjct: 182 Y------VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 46/190 (24%), Positives = 89/190 (46%), Gaps = 11/190 (5%)
Query: 354 SFTCRIQGSVYRGKINGGFAAIKKVNGDVSKEIALLNKINHSNLIILSGVCFNEGNCYLV 413
           ++  R++  V   K++  F ++        +E+ LL  + H N+I L  V     +    
Sbjct: 47  AYDARLRQKVAVKKLSRPFQSLIHAR-RTYRELRLLKHLKHENVIGLLDVFTPATSIEDF 105
Query: 414 YEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNV 473
            E  +  TL     +N  + + L  +    +   +  GL Y+HS      +H+D+  SNV
Sbjct: 106 SEVYLVTTLMGADLNNIVKSQALSDEHVQFLVYQLLRGLKYIHSAGI---IHRDLKPSNV 162
Query: 474 LLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGL-VSTKLDVYAFG 532
            ++ D   +I +F +AR A+ +   +      V T+ Y APE + N +  +  +D+++ G
Sbjct: 163 AVNEDSELRILDFGLARQADEEMTGY------VATRWYRAPEIMLNWMHYNQTVDIWSVG 216
Query: 533 VLILEMLTGK 542
            ++ E+L GK
Sbjct: 217 CIMAELLQGK 226

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 51/167 (30%), Positives = 78/167 (46%), Gaps = 18/167 (10%)
Query: 381 DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQ 440
           +V  EI +L K+NH  +I +    F+  + Y+V E    G L D V  NK   +      
Sbjct: 67  NVETEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLY 125
Query: 441 RIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDS---DLRAKIANFAMARPAEGQEG 497
             Q+ L V     YLH       +H+D+   NVLL S   D   KI +F  ++      G
Sbjct: 126 FYQMLLAV----QYLHENGI---IHRDLKPENVLLSSQEEDCLIKITDFGHSKIL----G 174
Query: 498 EFALTRHIVGTKGYMAPEYLEN---GLVSTKLDVYAFGVLILEMLTG 541
           E +L R + GT  Y+APE L +      +  +D ++ GV++   L+G
Sbjct: 175 ETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 221

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 41/165 (24%), Positives = 79/165 (47%), Gaps = 20/165 (12%)
Query: 384 KEIALLNKINHSNLIILSGV-----CFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDW 438
           +E+ LL  + H N+I L  V        E N   +  + +   L++ V   K    ++ +
Sbjct: 70  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQF 129
Query: 439 KQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGE 498
                +   +  GL Y+HS      +H+D+  SN+ ++ D   KI +F +AR  + +   
Sbjct: 130 -----LIYQILRGLKYIHSADI---IHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG 181
Query: 499 FALTRHIVGTKGYMAPEYLENGL-VSTKLDVYAFGVLILEMLTGK 542
           +      V T+ Y APE + N +  +  +D+++ G ++ E+LTG+
Sbjct: 182 Y------VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 41/165 (24%), Positives = 79/165 (47%), Gaps = 20/165 (12%)
Query: 384 KEIALLNKINHSNLIILSGV-----CFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDW 438
           +E+ LL  + H N+I L  V        E N   +  + +   L++ V   K    ++ +
Sbjct: 75  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 134
Query: 439 KQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGE 498
                +   +  GL Y+HS      +H+D+  SN+ ++ D   KI +F +AR  + +   
Sbjct: 135 -----LIYQILRGLKYIHSADI---IHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTG 186
Query: 499 FALTRHIVGTKGYMAPEYLENGL-VSTKLDVYAFGVLILEMLTGK 542
           +      V T+ Y APE + N +  +  +D+++ G ++ E+LTG+
Sbjct: 187 Y------VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 41/165 (24%), Positives = 79/165 (47%), Gaps = 20/165 (12%)
Query: 384 KEIALLNKINHSNLIILSGV-----CFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDW 438
           +E+ LL  + H N+I L  V        E N   +  + +   L++ V   K    ++ +
Sbjct: 75  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 134
Query: 439 KQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGE 498
                +   +  GL Y+HS      +H+D+  SN+ ++ D   KI +F +AR  + +   
Sbjct: 135 -----LIYQILRGLKYIHSADI---IHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG 186
Query: 499 FALTRHIVGTKGYMAPEYLENGL-VSTKLDVYAFGVLILEMLTGK 542
           +      V T+ Y APE + N +  +  +D+++ G ++ E+LTG+
Sbjct: 187 Y------VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 46/195 (23%), Positives = 89/195 (45%), Gaps = 21/195 (10%)
Query: 354 SFTCRIQGSVYRGKINGGFAAIKKVNGDVSKEIALLNKINHSNLIILSGV-----CFNEG 408
           +F  +    V   K++  F +I        +E+ LL  + H N+I L  V        E 
Sbjct: 41  AFDTKTGHRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLDVFTPARSLEEF 99
Query: 409 NCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDI 468
           N   +  + +   L++ V   K    ++ +     +   +  GL Y+HS      +H+D+
Sbjct: 100 NDVYLVTHLMGADLNNIVKCQKLTDDHVQF-----LIYQILRGLKYIHSADI---IHRDL 151
Query: 469 NSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGL-VSTKLD 527
             SN+ ++ D   KI +F +AR  + +   +      V T+ Y APE + N +  +  +D
Sbjct: 152 KPSNLAVNEDCELKILDFGLARHTDDEMTGY------VATRWYRAPEIMLNWMHYNQTVD 205
Query: 528 VYAFGVLILEMLTGK 542
           +++ G ++ E+LTG+
Sbjct: 206 IWSVGCIMAELLTGR 220

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 41/165 (24%), Positives = 79/165 (47%), Gaps = 20/165 (12%)
Query: 384 KEIALLNKINHSNLIILSGV-----CFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDW 438
           +E+ LL  + H N+I L  V        E N   +  + +   L++ V   K    ++ +
Sbjct: 69  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 128
Query: 439 KQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGE 498
                +   +  GL Y+HS      +H+D+  SN+ ++ D   KI +F +AR  + +   
Sbjct: 129 -----LIYQILRGLKYIHSADI---IHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG 180
Query: 499 FALTRHIVGTKGYMAPEYLENGL-VSTKLDVYAFGVLILEMLTGK 542
           +      V T+ Y APE + N +  +  +D+++ G ++ E+LTG+
Sbjct: 181 Y------VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 219

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 41/165 (24%), Positives = 79/165 (47%), Gaps = 20/165 (12%)
Query: 384 KEIALLNKINHSNLIILSGV-----CFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDW 438
           +E+ LL  + H N+I L  V        E N   +  + +   L++ V   K    ++ +
Sbjct: 70  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 129
Query: 439 KQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGE 498
                +   +  GL Y+HS      +H+D+  SN+ ++ D   KI +F +AR  + +   
Sbjct: 130 -----LIYQILRGLKYIHSADI---IHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG 181
Query: 499 FALTRHIVGTKGYMAPEYLENGL-VSTKLDVYAFGVLILEMLTGK 542
           +      V T+ Y APE + N +  +  +D+++ G ++ E+LTG+
Sbjct: 182 Y------VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 41/165 (24%), Positives = 79/165 (47%), Gaps = 20/165 (12%)
Query: 384 KEIALLNKINHSNLIILSGV-----CFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDW 438
           +E+ LL  + H N+I L  V        E N   +  + +   L++ V   K    ++ +
Sbjct: 75  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 134
Query: 439 KQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGE 498
                +   +  GL Y+HS      +H+D+  SN+ ++ D   KI +F +AR  + +   
Sbjct: 135 -----LIYQILRGLKYIHSADI---IHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTG 186
Query: 499 FALTRHIVGTKGYMAPEYLENGL-VSTKLDVYAFGVLILEMLTGK 542
           +      V T+ Y APE + N +  +  +D+++ G ++ E+LTG+
Sbjct: 187 Y------VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 46/169 (27%), Positives = 80/169 (47%), Gaps = 14/169 (8%)
Query: 376 KKVNGDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKY 435
           +K++ +V +EI     + H N++    V     +  +V EYA  G L + +    N G++
Sbjct: 56  EKIDENVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERIC---NAGRF 112
Query: 436 LDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSD--LRAKIANFAMARPAE 493
            + + R      + +G++Y H+       H+D+   N LLD     R KIA+F  ++ + 
Sbjct: 113 SEDEARF-FFQQLISGVSYAHAMQV---AHRDLKLENTLLDGSPAPRLKIADFGYSKASV 168
Query: 494 GQEGEFALTRHIVGTKGYMAPEYLENGLVSTKL-DVYAFGVLILEMLTG 541
                 +  +  VGT  Y+APE L       K+ DV++ GV +  ML G
Sbjct: 169 LH----SQPKSAVGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVG 213

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 41/165 (24%), Positives = 79/165 (47%), Gaps = 20/165 (12%)
Query: 384 KEIALLNKINHSNLIILSGV-----CFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDW 438
           +E+ LL  + H N+I L  V        E N   +  + +   L++ V   K    ++ +
Sbjct: 70  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 129
Query: 439 KQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGE 498
                +   +  GL Y+HS      +H+D+  SN+ ++ D   KI +F +AR  + +   
Sbjct: 130 -----LIYQILRGLKYIHSADI---IHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG 181
Query: 499 FALTRHIVGTKGYMAPEYLENGL-VSTKLDVYAFGVLILEMLTGK 542
           +      V T+ Y APE + N +  +  +D+++ G ++ E+LTG+
Sbjct: 182 Y------VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 46/190 (24%), Positives = 89/190 (46%), Gaps = 11/190 (5%)
Query: 354 SFTCRIQGSVYRGKINGGFAAIKKVNGDVSKEIALLNKINHSNLIILSGVCFNEGNCYLV 413
           ++  R++  V   K++  F ++        +E+ LL  + H N+I L  V     +    
Sbjct: 39  AYDARLRQKVAVKKLSRPFQSLIHARR-TYRELRLLKHLKHENVIGLLDVFTPATSIEDF 97
Query: 414 YEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNV 473
            E  +  TL     +N  + + L  +    +   +  GL Y+HS      +H+D+  SNV
Sbjct: 98  SEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQLLRGLKYIHSAGI---IHRDLKPSNV 154
Query: 474 LLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGL-VSTKLDVYAFG 532
            ++ D   +I +F +AR A+ +   +      V T+ Y APE + N +  +  +D+++ G
Sbjct: 155 AVNEDCELRILDFGLARQADEEMTGY------VATRWYRAPEIMLNWMHYNQTVDIWSVG 208
Query: 533 VLILEMLTGK 542
            ++ E+L GK
Sbjct: 209 CIMAELLQGK 218

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 41/165 (24%), Positives = 79/165 (47%), Gaps = 20/165 (12%)
Query: 384 KEIALLNKINHSNLIILSGV-----CFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDW 438
           +E+ LL  + H N+I L  V        E N   +  + +   L++ V   K    ++ +
Sbjct: 72  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 131
Query: 439 KQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGE 498
                +   +  GL Y+HS      +H+D+  SN+ ++ D   KI +F +AR  + +   
Sbjct: 132 -----LIYQILRGLKYIHSADI---IHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG 183
Query: 499 FALTRHIVGTKGYMAPEYLENGL-VSTKLDVYAFGVLILEMLTGK 542
           +      V T+ Y APE + N +  +  +D+++ G ++ E+LTG+
Sbjct: 184 Y------VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 41/165 (24%), Positives = 79/165 (47%), Gaps = 20/165 (12%)
Query: 384 KEIALLNKINHSNLIILSGV-----CFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDW 438
           +E+ LL  + H N+I L  V        E N   +  + +   L++ V   K    ++ +
Sbjct: 70  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 129
Query: 439 KQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGE 498
                +   +  GL Y+HS      +H+D+  SN+ ++ D   KI +F +AR  + +   
Sbjct: 130 -----LIYQILRGLKYIHSADI---IHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG 181
Query: 499 FALTRHIVGTKGYMAPEYLENGL-VSTKLDVYAFGVLILEMLTGK 542
           +      V T+ Y APE + N +  +  +D+++ G ++ E+LTG+
Sbjct: 182 Y------VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 51/190 (26%), Positives = 92/190 (48%), Gaps = 28/190 (14%)
Query: 367 KINGGFAAIKKVNGDVS---------KEIALLNKINHSNLIILSGVCFNEGNCYLVYEYA 417
           K +G   AIKK++             +E+ LL  + H N+I L  V     +    Y++ 
Sbjct: 46  KRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFY 105
Query: 418 VNGTLSDWVFSNKNEGKYLDWK---QRIQ-IALDVATGLNYLHSFTNPPHVHKDINSSNV 473
           +        F   +  K +  K   ++IQ +   +  GL Y+HS      VH+D+   N+
Sbjct: 106 LVMP-----FMQTDLQKIMGLKFSEEKIQYLVYQMLKGLKYIHSAGV---VHRDLKPGNL 157
Query: 474 LLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGL-VSTKLDVYAFG 532
            ++ D   KI +F +AR A+ +     +T ++V T+ Y APE + + +  +  +D+++ G
Sbjct: 158 AVNEDCELKILDFGLARHADAE-----MTGYVV-TRWYRAPEVILSWMHYNQTVDIWSVG 211
Query: 533 VLILEMLTGK 542
            ++ EMLTGK
Sbjct: 212 CIMAEMLTGK 221

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 41/165 (24%), Positives = 79/165 (47%), Gaps = 20/165 (12%)
Query: 384 KEIALLNKINHSNLIILSGV-----CFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDW 438
           +E+ LL  + H N+I L  V        E N   +  + +   L++ V   K    ++ +
Sbjct: 70  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 129
Query: 439 KQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGE 498
                +   +  GL Y+HS      +H+D+  SN+ ++ D   KI +F +AR  + +   
Sbjct: 130 -----LIYQILRGLKYIHSADI---IHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG 181
Query: 499 FALTRHIVGTKGYMAPEYLENGL-VSTKLDVYAFGVLILEMLTGK 542
           +      V T+ Y APE + N +  +  +D+++ G ++ E+LTG+
Sbjct: 182 Y------VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 41/165 (24%), Positives = 79/165 (47%), Gaps = 20/165 (12%)
Query: 384 KEIALLNKINHSNLIILSGV-----CFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDW 438
           +E+ LL  + H N+I L  V        E N   +  + +   L++ V   K    ++ +
Sbjct: 89  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 148
Query: 439 KQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGE 498
                +   +  GL Y+HS      +H+D+  SN+ ++ D   KI +F +AR  + +   
Sbjct: 149 -----LIYQILRGLKYIHSADI---IHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG 200
Query: 499 FALTRHIVGTKGYMAPEYLENGL-VSTKLDVYAFGVLILEMLTGK 542
           +      V T+ Y APE + N +  +  +D+++ G ++ E+LTG+
Sbjct: 201 Y------VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 41/165 (24%), Positives = 79/165 (47%), Gaps = 20/165 (12%)
Query: 384 KEIALLNKINHSNLIILSGV-----CFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDW 438
           +E+ LL  + H N+I L  V        E N   +  + +   L++ V   K    ++ +
Sbjct: 76  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 135
Query: 439 KQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGE 498
                +   +  GL Y+HS      +H+D+  SN+ ++ D   KI +F +AR  + +   
Sbjct: 136 -----LIYQILRGLKYIHSADI---IHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG 187
Query: 499 FALTRHIVGTKGYMAPEYLENGL-VSTKLDVYAFGVLILEMLTGK 542
           +      V T+ Y APE + N +  +  +D+++ G ++ E+LTG+
Sbjct: 188 Y------VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 46/195 (23%), Positives = 89/195 (45%), Gaps = 21/195 (10%)
Query: 354 SFTCRIQGSVYRGKINGGFAAIKKVNGDVSKEIALLNKINHSNLIILSGV-----CFNEG 408
           +F  +    V   K++  F +I        +E+ LL  + H N+I L  V        E 
Sbjct: 51  AFDTKTGHRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLDVFTPARSLEEF 109
Query: 409 NCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDI 468
           N   +  + +   L++ V   K    ++ +     +   +  GL Y+HS      +H+D+
Sbjct: 110 NDVYLVTHLMGADLNNIVKCQKLTDDHVQF-----LIYQILRGLKYIHSADI---IHRDL 161
Query: 469 NSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGL-VSTKLD 527
             SN+ ++ D   KI +F +AR  + +   +      V T+ Y APE + N +  +  +D
Sbjct: 162 KPSNLAVNEDCELKILDFGLARHTDDEMTGY------VATRWYRAPEIMLNWMHYNQTVD 215
Query: 528 VYAFGVLILEMLTGK 542
           +++ G ++ E+LTG+
Sbjct: 216 IWSVGCIMAELLTGR 230

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 41/165 (24%), Positives = 79/165 (47%), Gaps = 20/165 (12%)
Query: 384 KEIALLNKINHSNLIILSGV-----CFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDW 438
           +E+ LL  + H N+I L  V        E N   +  + +   L++ V   K    ++ +
Sbjct: 72  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 131
Query: 439 KQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGE 498
                +   +  GL Y+HS      +H+D+  SN+ ++ D   KI +F +AR  + +   
Sbjct: 132 -----LIYQILRGLKYIHSADI---IHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG 183
Query: 499 FALTRHIVGTKGYMAPEYLENGL-VSTKLDVYAFGVLILEMLTGK 542
           +      V T+ Y APE + N +  +  +D+++ G ++ E+LTG+
Sbjct: 184 Y------VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 41/165 (24%), Positives = 79/165 (47%), Gaps = 20/165 (12%)
Query: 384 KEIALLNKINHSNLIILSGV-----CFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDW 438
           +E+ LL  + H N+I L  V        E N   +  + +   L++ V   K    ++ +
Sbjct: 75  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 134
Query: 439 KQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGE 498
                +   +  GL Y+HS      +H+D+  SN+ ++ D   KI +F +AR  + +   
Sbjct: 135 -----LIYQILRGLKYIHSADI---IHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG 186
Query: 499 FALTRHIVGTKGYMAPEYLENGL-VSTKLDVYAFGVLILEMLTGK 542
           +      V T+ Y APE + N +  +  +D+++ G ++ E+LTG+
Sbjct: 187 Y------VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 41/165 (24%), Positives = 79/165 (47%), Gaps = 20/165 (12%)
Query: 384 KEIALLNKINHSNLIILSGV-----CFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDW 438
           +E+ LL  + H N+I L  V        E N   +  + +   L++ V   K    ++ +
Sbjct: 70  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 129
Query: 439 KQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGE 498
                +   +  GL Y+HS      +H+D+  SN+ ++ D   KI +F +AR  + +   
Sbjct: 130 -----LIYQILRGLKYIHSADI---IHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG 181
Query: 499 FALTRHIVGTKGYMAPEYLENGL-VSTKLDVYAFGVLILEMLTGK 542
           +      V T+ Y APE + N +  +  +D+++ G ++ E+LTG+
Sbjct: 182 Y------VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 41/165 (24%), Positives = 79/165 (47%), Gaps = 20/165 (12%)
Query: 384 KEIALLNKINHSNLIILSGV-----CFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDW 438
           +E+ LL  + H N+I L  V        E N   +  + +   L++ V   K    ++ +
Sbjct: 77  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 136
Query: 439 KQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGE 498
                +   +  GL Y+HS      +H+D+  SN+ ++ D   KI +F +AR  + +   
Sbjct: 137 -----LIYQILRGLKYIHSADI---IHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG 188
Query: 499 FALTRHIVGTKGYMAPEYLENGL-VSTKLDVYAFGVLILEMLTGK 542
           +      V T+ Y APE + N +  +  +D+++ G ++ E+LTG+
Sbjct: 189 Y------VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/167 (30%), Positives = 78/167 (46%), Gaps = 18/167 (10%)
Query: 381 DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQ 440
           +V  EI +L K+NH  +I +    F+  + Y+V E    G L D V  NK   +      
Sbjct: 61  NVETEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLY 119
Query: 441 RIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDS---DLRAKIANFAMARPAEGQEG 497
             Q+ L V     YLH       +H+D+   NVLL S   D   KI +F  ++      G
Sbjct: 120 FYQMLLAV----QYLHENGI---IHRDLKPENVLLSSQEEDCLIKITDFGHSKIL----G 168
Query: 498 EFALTRHIVGTKGYMAPEYLEN---GLVSTKLDVYAFGVLILEMLTG 541
           E +L R + GT  Y+APE L +      +  +D ++ GV++   L+G
Sbjct: 169 ETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 41/165 (24%), Positives = 79/165 (47%), Gaps = 20/165 (12%)
Query: 384 KEIALLNKINHSNLIILSGV-----CFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDW 438
           +E+ LL  + H N+I L  V        E N   +  + +   L++ V   K    ++ +
Sbjct: 68  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 127
Query: 439 KQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGE 498
                +   +  GL Y+HS      +H+D+  SN+ ++ D   KI +F +AR  + +   
Sbjct: 128 -----LIYQILRGLKYIHSADI---IHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG 179
Query: 499 FALTRHIVGTKGYMAPEYLENGL-VSTKLDVYAFGVLILEMLTGK 542
           +      V T+ Y APE + N +  +  +D+++ G ++ E+LTG+
Sbjct: 180 Y------VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 218

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 41/165 (24%), Positives = 79/165 (47%), Gaps = 20/165 (12%)
Query: 384 KEIALLNKINHSNLIILSGV-----CFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDW 438
           +E+ LL  + H N+I L  V        E N   +  + +   L++ V   K    ++ +
Sbjct: 66  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 125
Query: 439 KQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGE 498
                +   +  GL Y+HS      +H+D+  SN+ ++ D   KI +F +AR  + +   
Sbjct: 126 -----LIYQILRGLKYIHSADI---IHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG 177
Query: 499 FALTRHIVGTKGYMAPEYLENGL-VSTKLDVYAFGVLILEMLTGK 542
           +      V T+ Y APE + N +  +  +D+++ G ++ E+LTG+
Sbjct: 178 Y------VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 41/165 (24%), Positives = 79/165 (47%), Gaps = 20/165 (12%)
Query: 384 KEIALLNKINHSNLIILSGV-----CFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDW 438
           +E+ LL  + H N+I L  V        E N   +  + +   L++ V   K    ++ +
Sbjct: 72  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 131
Query: 439 KQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGE 498
                +   +  GL Y+HS      +H+D+  SN+ ++ D   KI +F +AR  + +   
Sbjct: 132 -----LIYQILRGLKYIHSADI---IHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG 183
Query: 499 FALTRHIVGTKGYMAPEYLENGL-VSTKLDVYAFGVLILEMLTGK 542
           +      V T+ Y APE + N +  +  +D+++ G ++ E+LTG+
Sbjct: 184 Y------VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/167 (30%), Positives = 78/167 (46%), Gaps = 18/167 (10%)
Query: 381 DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQ 440
           +V  EI +L K+NH  +I +    F+  + Y+V E    G L D V  NK   +      
Sbjct: 61  NVETEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLY 119
Query: 441 RIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDS---DLRAKIANFAMARPAEGQEG 497
             Q+ L V     YLH       +H+D+   NVLL S   D   KI +F  ++      G
Sbjct: 120 FYQMLLAV----QYLHENGI---IHRDLKPENVLLSSQEEDCLIKITDFGHSKIL----G 168
Query: 498 EFALTRHIVGTKGYMAPEYLEN---GLVSTKLDVYAFGVLILEMLTG 541
           E +L R + GT  Y+APE L +      +  +D ++ GV++   L+G
Sbjct: 169 ETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 41/165 (24%), Positives = 79/165 (47%), Gaps = 20/165 (12%)
Query: 384 KEIALLNKINHSNLIILSGV-----CFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDW 438
           +E+ LL  + H N+I L  V        E N   +  + +   L++ V   K    ++ +
Sbjct: 70  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 129
Query: 439 KQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGE 498
                +   +  GL Y+HS      +H+D+  SN+ ++ D   KI +F +AR  + +   
Sbjct: 130 -----LIYQILRGLKYIHSADI---IHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG 181
Query: 499 FALTRHIVGTKGYMAPEYLENGL-VSTKLDVYAFGVLILEMLTGK 542
           +      V T+ Y APE + N +  +  +D+++ G ++ E+LTG+
Sbjct: 182 Y------VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/167 (30%), Positives = 78/167 (46%), Gaps = 18/167 (10%)
Query: 381 DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQ 440
           +V  EI +L K+NH  +I +    F+  + Y+V E    G L D V  NK   +      
Sbjct: 61  NVETEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLY 119
Query: 441 RIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDS---DLRAKIANFAMARPAEGQEG 497
             Q+ L V     YLH       +H+D+   NVLL S   D   KI +F  ++      G
Sbjct: 120 FYQMLLAV----QYLHENGI---IHRDLKPENVLLSSQEEDCLIKITDFGHSKIL----G 168
Query: 498 EFALTRHIVGTKGYMAPEYLEN---GLVSTKLDVYAFGVLILEMLTG 541
           E +L R + GT  Y+APE L +      +  +D ++ GV++   L+G
Sbjct: 169 ETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 41/165 (24%), Positives = 79/165 (47%), Gaps = 20/165 (12%)
Query: 384 KEIALLNKINHSNLIILSGV-----CFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDW 438
           +E+ LL  + H N+I L  V        E N   +  + +   L++ V   K    ++ +
Sbjct: 93  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 152
Query: 439 KQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGE 498
                +   +  GL Y+HS      +H+D+  SN+ ++ D   KI +F +AR  + +   
Sbjct: 153 -----LIYQILRGLKYIHSADI---IHRDLKPSNLAVNEDCELKILDFGLARHTDDEMXG 204
Query: 499 FALTRHIVGTKGYMAPEYLENGL-VSTKLDVYAFGVLILEMLTGK 542
           +      V T+ Y APE + N +  +  +D+++ G ++ E+LTG+
Sbjct: 205 Y------VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/167 (30%), Positives = 78/167 (46%), Gaps = 18/167 (10%)
Query: 381 DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQ 440
           +V  EI +L K+NH  +I +    F+  + Y+V E    G L D V  NK   +      
Sbjct: 60  NVETEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLY 118
Query: 441 RIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDS---DLRAKIANFAMARPAEGQEG 497
             Q+ L V     YLH       +H+D+   NVLL S   D   KI +F  ++      G
Sbjct: 119 FYQMLLAV----QYLHENGI---IHRDLKPENVLLSSQEEDCLIKITDFGHSKIL----G 167
Query: 498 EFALTRHIVGTKGYMAPEYLEN---GLVSTKLDVYAFGVLILEMLTG 541
           E +L R + GT  Y+APE L +      +  +D ++ GV++   L+G
Sbjct: 168 ETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 214

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 41/165 (24%), Positives = 79/165 (47%), Gaps = 20/165 (12%)
Query: 384 KEIALLNKINHSNLIILSGV-----CFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDW 438
           +E+ LL  + H N+I L  V        E N   +  + +   L++ V   K    ++ +
Sbjct: 90  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 149
Query: 439 KQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGE 498
                +   +  GL Y+HS      +H+D+  SN+ ++ D   KI +F +AR  + +   
Sbjct: 150 -----LIYQILRGLKYIHSADI---IHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG 201
Query: 499 FALTRHIVGTKGYMAPEYLENGL-VSTKLDVYAFGVLILEMLTGK 542
           +      V T+ Y APE + N +  +  +D+++ G ++ E+LTG+
Sbjct: 202 Y------VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 41/165 (24%), Positives = 79/165 (47%), Gaps = 20/165 (12%)
Query: 384 KEIALLNKINHSNLIILSGV-----CFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDW 438
           +E+ LL  + H N+I L  V        E N   +  + +   L++ V   K    ++ +
Sbjct: 93  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 152
Query: 439 KQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGE 498
                +   +  GL Y+HS      +H+D+  SN+ ++ D   KI +F +AR  + +   
Sbjct: 153 -----LIYQILRGLKYIHSADI---IHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG 204
Query: 499 FALTRHIVGTKGYMAPEYLENGL-VSTKLDVYAFGVLILEMLTGK 542
           +      V T+ Y APE + N +  +  +D+++ G ++ E+LTG+
Sbjct: 205 Y------VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 41/165 (24%), Positives = 79/165 (47%), Gaps = 20/165 (12%)
Query: 384 KEIALLNKINHSNLIILSGV-----CFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDW 438
           +E+ LL  + H N+I L  V        E N   +  + +   L++ V   K    ++ +
Sbjct: 82  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 141
Query: 439 KQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGE 498
                +   +  GL Y+HS      +H+D+  SN+ ++ D   KI +F +AR  + +   
Sbjct: 142 -----LIYQILRGLKYIHSADI---IHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG 193
Query: 499 FALTRHIVGTKGYMAPEYLENGL-VSTKLDVYAFGVLILEMLTGK 542
           +      V T+ Y APE + N +  +  +D+++ G ++ E+LTG+
Sbjct: 194 Y------VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 41/165 (24%), Positives = 79/165 (47%), Gaps = 20/165 (12%)
Query: 384 KEIALLNKINHSNLIILSGV-----CFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDW 438
           +E+ LL  + H N+I L  V        E N   +  + +   L++ V   K    ++ +
Sbjct: 67  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 126
Query: 439 KQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGE 498
                +   +  GL Y+HS      +H+D+  SN+ ++ D   KI +F +AR  + +   
Sbjct: 127 -----LIYQILRGLKYIHSADI---IHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG 178
Query: 499 FALTRHIVGTKGYMAPEYLENGL-VSTKLDVYAFGVLILEMLTGK 542
           +      V T+ Y APE + N +  +  +D+++ G ++ E+LTG+
Sbjct: 179 Y------VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 41/165 (24%), Positives = 79/165 (47%), Gaps = 20/165 (12%)
Query: 384 KEIALLNKINHSNLIILSGV-----CFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDW 438
           +E+ LL  + H N+I L  V        E N   +  + +   L++ V   K    ++ +
Sbjct: 82  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 141
Query: 439 KQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGE 498
                +   +  GL Y+HS      +H+D+  SN+ ++ D   KI +F +AR  + +   
Sbjct: 142 -----LIYQILRGLKYIHSADI---IHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG 193
Query: 499 FALTRHIVGTKGYMAPEYLENGL-VSTKLDVYAFGVLILEMLTGK 542
           +      V T+ Y APE + N +  +  +D+++ G ++ E+LTG+
Sbjct: 194 Y------VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 41/165 (24%), Positives = 79/165 (47%), Gaps = 20/165 (12%)
Query: 384 KEIALLNKINHSNLIILSGV-----CFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDW 438
           +E+ LL  + H N+I L  V        E N   +  + +   L++ V   K    ++ +
Sbjct: 82  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 141
Query: 439 KQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGE 498
                +   +  GL Y+HS      +H+D+  SN+ ++ D   KI +F +AR  + +   
Sbjct: 142 -----LIYQILRGLKYIHSADI---IHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG 193
Query: 499 FALTRHIVGTKGYMAPEYLENGL-VSTKLDVYAFGVLILEMLTGK 542
           +      V T+ Y APE + N +  +  +D+++ G ++ E+LTG+
Sbjct: 194 Y------VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 41/165 (24%), Positives = 79/165 (47%), Gaps = 20/165 (12%)
Query: 384 KEIALLNKINHSNLIILSGV-----CFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDW 438
           +E+ LL  + H N+I L  V        E N   +  + +   L++ V   K    ++ +
Sbjct: 90  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 149
Query: 439 KQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGE 498
                +   +  GL Y+HS      +H+D+  SN+ ++ D   KI +F +AR  + +   
Sbjct: 150 -----LIYQILRGLKYIHSADI---IHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG 201
Query: 499 FALTRHIVGTKGYMAPEYLENGL-VSTKLDVYAFGVLILEMLTGK 542
           +      V T+ Y APE + N +  +  +D+++ G ++ E+LTG+
Sbjct: 202 Y------VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 41/165 (24%), Positives = 79/165 (47%), Gaps = 20/165 (12%)
Query: 384 KEIALLNKINHSNLIILSGV-----CFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDW 438
           +E+ LL  + H N+I L  V        E N   +  + +   L++ V   K    ++ +
Sbjct: 76  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 135
Query: 439 KQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGE 498
                +   +  GL Y+HS      +H+D+  SN+ ++ D   KI +F +AR  + +   
Sbjct: 136 -----LIYQILRGLKYIHSADI---IHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG 187
Query: 499 FALTRHIVGTKGYMAPEYLENGL-VSTKLDVYAFGVLILEMLTGK 542
           +      V T+ Y APE + N +  +  +D+++ G ++ E+LTG+
Sbjct: 188 Y------VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 41/165 (24%), Positives = 79/165 (47%), Gaps = 20/165 (12%)
Query: 384 KEIALLNKINHSNLIILSGV-----CFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDW 438
           +E+ LL  + H N+I L  V        E N   +  + +   L++ V   K    ++ +
Sbjct: 81  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 140
Query: 439 KQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGE 498
                +   +  GL Y+HS      +H+D+  SN+ ++ D   KI +F +AR  + +   
Sbjct: 141 -----LIYQILRGLKYIHSADI---IHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTG 192
Query: 499 FALTRHIVGTKGYMAPEYLENGL-VSTKLDVYAFGVLILEMLTGK 542
           +      V T+ Y APE + N +  +  +D+++ G ++ E+LTG+
Sbjct: 193 Y------VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/195 (23%), Positives = 89/195 (45%), Gaps = 21/195 (10%)
Query: 354 SFTCRIQGSVYRGKINGGFAAIKKVNGDVSKEIALLNKINHSNLIILSGV-----CFNEG 408
           +F  +    V   K++  F +I        +E+ LL  + H N+I L  V        E 
Sbjct: 47  AFDTKTGHRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLDVFTPARSLEEF 105
Query: 409 NCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDI 468
           N   +  + +   L++ V   K    ++ +     +   +  GL Y+HS      +H+D+
Sbjct: 106 NDVYLVTHLMGADLNNIVKCQKLTDDHVQF-----LIYQILRGLKYIHSADI---IHRDL 157
Query: 469 NSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGL-VSTKLD 527
             SN+ ++ D   KI +F +AR  + +   +      V T+ Y APE + N +  +  +D
Sbjct: 158 KPSNLAVNEDCELKILDFGLARHTDDEMTGY------VATRWYRAPEIMLNWMHYNQTVD 211
Query: 528 VYAFGVLILEMLTGK 542
           +++ G ++ E+LTG+
Sbjct: 212 IWSVGCIMAELLTGR 226

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 41/165 (24%), Positives = 79/165 (47%), Gaps = 20/165 (12%)
Query: 384 KEIALLNKINHSNLIILSGV-----CFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDW 438
           +E+ LL  + H N+I L  V        E N   +  + +   L++ V   K    ++ +
Sbjct: 66  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 125
Query: 439 KQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGE 498
                +   +  GL Y+HS      +H+D+  SN+ ++ D   KI +F +AR  + +   
Sbjct: 126 -----LIYQILRGLKYIHSADI---IHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG 177
Query: 499 FALTRHIVGTKGYMAPEYLENGL-VSTKLDVYAFGVLILEMLTGK 542
           +      V T+ Y APE + N +  +  +D+++ G ++ E+LTG+
Sbjct: 178 Y------VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 41/165 (24%), Positives = 79/165 (47%), Gaps = 20/165 (12%)
Query: 384 KEIALLNKINHSNLIILSGV-----CFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDW 438
           +E+ LL  + H N+I L  V        E N   +  + +   L++ V   K    ++ +
Sbjct: 89  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 148
Query: 439 KQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGE 498
                +   +  GL Y+HS      +H+D+  SN+ ++ D   KI +F +AR  + +   
Sbjct: 149 -----LIYQILRGLKYIHSADI---IHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG 200
Query: 499 FALTRHIVGTKGYMAPEYLENGL-VSTKLDVYAFGVLILEMLTGK 542
           +      V T+ Y APE + N +  +  +D+++ G ++ E+LTG+
Sbjct: 201 Y------VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 50/165 (30%), Positives = 75/165 (45%), Gaps = 12/165 (7%)
Query: 382 VSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQR 441
           + +EIAL   + H N++   G     G   +  E    G+LS  + S    G   D +Q 
Sbjct: 66  LHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSK--WGPLKDNEQT 123
Query: 442 IQI-ALDVATGLNYLHSFTNPPHVHKDINSSNVLLDS-DLRAKIANFAMARPAEGQEGEF 499
           I      +  GL YLH   +   VH+DI   NVL+++     KI++F  ++   G     
Sbjct: 124 IGFYTKQILEGLKYLH---DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN--- 177
Query: 500 ALTRHIVGTKGYMAPEYLENGL--VSTKLDVYAFGVLILEMLTGK 542
             T    GT  YMAPE ++ G        D+++ G  I+EM TGK
Sbjct: 178 PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGK 222

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 41/165 (24%), Positives = 79/165 (47%), Gaps = 20/165 (12%)
Query: 384 KEIALLNKINHSNLIILSGV-----CFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDW 438
           +E+ LL  + H N+I L  V        E N   +  + +   L++ V   K    ++ +
Sbjct: 67  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 126
Query: 439 KQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGE 498
                +   +  GL Y+HS      +H+D+  SN+ ++ D   KI +F +AR  + +   
Sbjct: 127 -----LIYQILRGLKYIHSADI---IHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG 178
Query: 499 FALTRHIVGTKGYMAPEYLENGL-VSTKLDVYAFGVLILEMLTGK 542
           +      V T+ Y APE + N +  +  +D+++ G ++ E+LTG+
Sbjct: 179 Y------VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/242 (21%), Positives = 109/242 (45%), Gaps = 29/242 (11%)
Query: 387 ALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIAL 446
           ++++K++H +L++  GVC       LV E+   G+L  ++  NKN    L WK  +++A 
Sbjct: 64  SMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINIL-WK--LEVAK 120
Query: 447 DVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIV 506
            +A  +++L   T    +H ++ + N+LL  +   K  N    + ++       L + I+
Sbjct: 121 QLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDIL 177
Query: 507 GTK-GYMAPEYLENGL-VSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVL 564
             +  ++ PE +EN   ++   D ++FG  + E+ +G +                    L
Sbjct: 178 QERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKP------------------L 219
Query: 565 TKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNA 624
           +  D +  L+ + D   +   P   A  +  LI+ C+  +P  RP+   I   L+++   
Sbjct: 220 SALDSQRKLQFYED---RHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTP 276
Query: 625 SL 626
            L
Sbjct: 277 DL 278

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 41/165 (24%), Positives = 79/165 (47%), Gaps = 20/165 (12%)
Query: 384 KEIALLNKINHSNLIILSGV-----CFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDW 438
           +E+ LL  + H N+I L  V        E N   +  + +   L++ V   K    ++ +
Sbjct: 81  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 140
Query: 439 KQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGE 498
                +   +  GL Y+HS      +H+D+  SN+ ++ D   KI +F +AR  + +   
Sbjct: 141 -----LIYQILRGLKYIHSADI---IHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG 192
Query: 499 FALTRHIVGTKGYMAPEYLENGL-VSTKLDVYAFGVLILEMLTGK 542
           +      V T+ Y APE + N +  +  +D+++ G ++ E+LTG+
Sbjct: 193 Y------VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/190 (28%), Positives = 90/190 (47%), Gaps = 25/190 (13%)
Query: 365 RGKINGGFAAIKKV----------NGDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVY 414
           + K+ G   AIK +          +G +  E+A+L +++H N++ L     ++ N YLV 
Sbjct: 24  KDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKLYEFFEDKRNYYLVM 83
Query: 415 EYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVL 474
           E    G L D +   +   K+ +    + I   V +G  YLH       VH+D+   N+L
Sbjct: 84  EVYRGGELFDEIILRQ---KFSEVDAAV-IMKQVLSGTTYLHKHNI---VHRDLKPENLL 136
Query: 475 LDSDLR---AKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAF 531
           L+S  R    KI +F ++  A  + G     +  +GT  Y+APE L       K DV++ 
Sbjct: 137 LESKSRDALIKIVDFGLS--AHFEVG--GKMKERLGTAYYIAPEVLRKK-YDEKCDVWSC 191
Query: 532 GVLILEMLTG 541
           GV++  +L G
Sbjct: 192 GVILYILLCG 201

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 44/158 (27%), Positives = 74/158 (46%), Gaps = 15/158 (9%)
Query: 385 EIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSN-KNEGKYLDWKQRIQ 443
           E  +L  +N   L+ L     +  N Y+V EY   G +    FS+ +  G++ +   R  
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFSEPHARFY 146
Query: 444 IALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTR 503
            A  V T   YLHS      +++D+   N+L+D     ++ +F  A+  +G+      T 
Sbjct: 147 AAQIVLT-FEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR------TW 196
Query: 504 HIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTG 541
            + GT   +APE + +   +  +D +A GVLI EM  G
Sbjct: 197 XLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/195 (23%), Positives = 89/195 (45%), Gaps = 21/195 (10%)
Query: 354 SFTCRIQGSVYRGKINGGFAAIKKVNGDVSKEIALLNKINHSNLIILSGV-----CFNEG 408
           +F  +    V   K++  F +I        +E+ LL  + H N+I L  V        E 
Sbjct: 41  AFDTKTGHRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLDVFTPARSLEEF 99
Query: 409 NCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDI 468
           N   +  + +   L++ V   K    ++ +     +   +  GL Y+HS      +H+D+
Sbjct: 100 NDVYLVTHLMGADLNNIVKCQKLTDDHVQF-----LIYQILRGLKYIHSADI---IHRDL 151
Query: 469 NSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGL-VSTKLD 527
             SN+ ++ D   KI +F +AR  + +   +      V T+ Y APE + N +  +  +D
Sbjct: 152 KPSNLAVNEDCELKILDFYLARHTDDEMTGY------VATRWYRAPEIMLNWMHYNQTVD 205
Query: 528 VYAFGVLILEMLTGK 542
           +++ G ++ E+LTG+
Sbjct: 206 IWSVGCIMAELLTGR 220

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/164 (31%), Positives = 77/164 (46%), Gaps = 11/164 (6%)
Query: 381 DVSKEIALLNKINHSNLIILSGVCFNEGNC-YLVYEYAVNGTLSDWVFSNKNEGKYLDWK 439
           ++ KEI +   +NH N++   G    EGN  YL  EY   G L D +    + G      
Sbjct: 51  NIKKEICINKMLNHENVVKFYG-HRREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDA 107
Query: 440 QRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEF 499
           QR    L    G+ YLH        H+DI   N+LLD     KI++F +A        E 
Sbjct: 108 QRFFHQL--MAGVVYLHGIGI---THRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 162
Query: 500 ALTRHIVGTKGYMAPEYLENG-LVSTKLDVYAFGVLILEMLTGK 542
            L + + GT  Y+APE L+     +  +DV++ G+++  ML G+
Sbjct: 163 LLNK-MCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/210 (23%), Positives = 93/210 (44%), Gaps = 29/210 (13%)
Query: 361 GSVYRGK--INGGFAAIKKVNGD--------VSKEIALLNKINHSNLIILSGVCFNEGNC 410
            +VY+GK  +     A+K++  +          +E++LL  + H+N++ L  +   E + 
Sbjct: 16  ATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSL 75
Query: 411 YLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINS 470
            LV+EY ++  L  ++    + G  ++          +  GL Y H       +H+D+  
Sbjct: 76  TLVFEY-LDKDLKQYL---DDCGNIINMHNVKLFLFQLLRGLAYCH---RQKVLHRDLKP 128
Query: 471 SNVLLDSDLRAKIANFAMAR----PAEGQEGEFALTRHIVGTKGYMAPEYLENGL-VSTK 525
            N+L++     K+A+F +AR    P +  + E       V T  Y  P+ L      ST+
Sbjct: 129 QNLLINERGELKLADFGLARAKSIPTKTYDNE-------VVTLWYRPPDILLGSTDYSTQ 181
Query: 526 LDVYAFGVLILEMLTGKEAAALHAEENNMH 555
           +D++  G +  EM TG+        E  +H
Sbjct: 182 IDMWGVGCIFYEMATGRPLFPGSTVEEQLH 211

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/189 (28%), Positives = 86/189 (45%), Gaps = 25/189 (13%)
Query: 370 GGFAAIKKVNGDVSK--------EIALLNKINHSNLI----ILSGVCFNEGN--CYLVYE 415
           G   AIK+   ++S         EI ++ K+NH N++    +  G+     N    L  E
Sbjct: 39  GEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAME 98
Query: 416 YAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLL 475
           Y   G L  ++   +N     +   R  ++ D+++ L YLH       +H+D+   N++L
Sbjct: 99  YCEGGDLRKYLNQFENCCGLKEGPIRTLLS-DISSALRYLHENRI---IHRDLKPENIVL 154
Query: 476 D---SDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFG 532
                 L  KI +   A+  E  +GE  L    VGT  Y+APE LE    +  +D ++FG
Sbjct: 155 QPGPQRLIHKIIDLGYAK--ELDQGE--LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFG 210
Query: 533 VLILEMLTG 541
            L  E +TG
Sbjct: 211 TLAFECITG 219

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/164 (31%), Positives = 77/164 (46%), Gaps = 11/164 (6%)
Query: 381 DVSKEIALLNKINHSNLIILSGVCFNEGNC-YLVYEYAVNGTLSDWVFSNKNEGKYLDWK 439
           ++ KEI +   +NH N++   G    EGN  YL  EY   G L D +    + G      
Sbjct: 50  NIKKEICINKMLNHENVVKFYG-HRREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDA 106
Query: 440 QRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEF 499
           QR    L    G+ YLH        H+DI   N+LLD     KI++F +A        E 
Sbjct: 107 QRFFHQL--MAGVVYLHGIGI---THRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 161
Query: 500 ALTRHIVGTKGYMAPEYLENG-LVSTKLDVYAFGVLILEMLTGK 542
            L + + GT  Y+APE L+     +  +DV++ G+++  ML G+
Sbjct: 162 LLNK-MCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 41/165 (24%), Positives = 79/165 (47%), Gaps = 20/165 (12%)
Query: 384 KEIALLNKINHSNLIILSGV-----CFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDW 438
           +E+ LL  + H N+I L  V        E N   +  + +   L++ V S K    ++ +
Sbjct: 70  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKSQKLTDDHVQF 129
Query: 439 KQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGE 498
                +   +  GL Y+HS      +H+D+  SN+ ++ D   KI +F + R  + +   
Sbjct: 130 -----LIYQILRGLKYIHSADI---IHRDLKPSNLAVNEDSELKILDFGLCRHTDDEMTG 181
Query: 499 FALTRHIVGTKGYMAPEYLENGL-VSTKLDVYAFGVLILEMLTGK 542
           +      V T+ Y APE + N +  +  +D+++ G ++ E+LTG+
Sbjct: 182 Y------VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 50/165 (30%), Positives = 75/165 (45%), Gaps = 12/165 (7%)
Query: 382 VSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQR 441
           + +EIAL   + H N++   G     G   +  E    G+LS  + S    G   D +Q 
Sbjct: 52  LHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSK--WGPLKDNEQT 109
Query: 442 IQI-ALDVATGLNYLHSFTNPPHVHKDINSSNVLLDS-DLRAKIANFAMARPAEGQEGEF 499
           I      +  GL YLH   +   VH+DI   NVL+++     KI++F  ++   G     
Sbjct: 110 IGFYTKQILEGLKYLH---DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN--- 163
Query: 500 ALTRHIVGTKGYMAPEYLENGL--VSTKLDVYAFGVLILEMLTGK 542
             T    GT  YMAPE ++ G        D+++ G  I+EM TGK
Sbjct: 164 PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGK 208

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/189 (28%), Positives = 86/189 (45%), Gaps = 25/189 (13%)
Query: 370 GGFAAIKKVNGDVSK--------EIALLNKINHSNLI----ILSGVCFNEGN--CYLVYE 415
           G   AIK+   ++S         EI ++ K+NH N++    +  G+     N    L  E
Sbjct: 40  GEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAME 99
Query: 416 YAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLL 475
           Y   G L  ++   +N     +   R  ++ D+++ L YLH       +H+D+   N++L
Sbjct: 100 YCEGGDLRKYLNQFENCCGLKEGPIRTLLS-DISSALRYLHENRI---IHRDLKPENIVL 155
Query: 476 D---SDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFG 532
                 L  KI +   A+  E  +GE  L    VGT  Y+APE LE    +  +D ++FG
Sbjct: 156 QPGPQRLIHKIIDLGYAK--ELDQGE--LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFG 211
Query: 533 VLILEMLTG 541
            L  E +TG
Sbjct: 212 TLAFECITG 220

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/164 (31%), Positives = 77/164 (46%), Gaps = 11/164 (6%)
Query: 381 DVSKEIALLNKINHSNLIILSGVCFNEGNC-YLVYEYAVNGTLSDWVFSNKNEGKYLDWK 439
           ++ KEI +   +NH N++   G    EGN  YL  EY   G L D +    + G      
Sbjct: 51  NIKKEICINKMLNHENVVKFYG-HRREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDA 107
Query: 440 QRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEF 499
           QR    L    G+ YLH        H+DI   N+LLD     KI++F +A        E 
Sbjct: 108 QRFFHQL--MAGVVYLHGIGI---THRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 162
Query: 500 ALTRHIVGTKGYMAPEYLENG-LVSTKLDVYAFGVLILEMLTGK 542
            L + + GT  Y+APE L+     +  +DV++ G+++  ML G+
Sbjct: 163 LLNK-MCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/164 (31%), Positives = 77/164 (46%), Gaps = 11/164 (6%)
Query: 381 DVSKEIALLNKINHSNLIILSGVCFNEGNC-YLVYEYAVNGTLSDWVFSNKNEGKYLDWK 439
           ++ KEI +   +NH N++   G    EGN  YL  EY   G L D +    + G      
Sbjct: 51  NIKKEICINKMLNHENVVKFYG-HRREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDA 107
Query: 440 QRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEF 499
           QR    L    G+ YLH        H+DI   N+LLD     KI++F +A        E 
Sbjct: 108 QRFFHQL--MAGVVYLHGIGI---THRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 162
Query: 500 ALTRHIVGTKGYMAPEYLENG-LVSTKLDVYAFGVLILEMLTGK 542
            L + + GT  Y+APE L+     +  +DV++ G+++  ML G+
Sbjct: 163 LLNK-MCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/164 (31%), Positives = 77/164 (46%), Gaps = 11/164 (6%)
Query: 381 DVSKEIALLNKINHSNLIILSGVCFNEGNC-YLVYEYAVNGTLSDWVFSNKNEGKYLDWK 439
           ++ KEI +   +NH N++   G    EGN  YL  EY   G L D +    + G      
Sbjct: 51  NIKKEICINKMLNHENVVKFYG-HRREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDA 107
Query: 440 QRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEF 499
           QR    L    G+ YLH        H+DI   N+LLD     KI++F +A        E 
Sbjct: 108 QRFFHQL--MAGVVYLHGIGI---THRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 162
Query: 500 ALTRHIVGTKGYMAPEYLENG-LVSTKLDVYAFGVLILEMLTGK 542
            L + + GT  Y+APE L+     +  +DV++ G+++  ML G+
Sbjct: 163 LLNK-MCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 44/164 (26%), Positives = 81/164 (49%), Gaps = 20/164 (12%)
Query: 384 KEIALLNKINHSNLIILSGVCFNEG------NCYLVYEYAVNGTLSDWVFSNKNEGKYLD 437
           +E+ L+  +NH N+I L  V   +       + Y+V E  ++  LS  +         LD
Sbjct: 72  RELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVME-LMDANLSQVIQME------LD 124
Query: 438 WKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEG 497
            ++   +   +  G+ +LHS      +H+D+  SN+++ SD   KI +F +AR A     
Sbjct: 125 HERMSYLLYQMLVGIKHLHSAGI---IHRDLKPSNIVVKSDATLKILDFGLARTAGTS-- 179
Query: 498 EFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTG 541
            F +T ++V T+ Y APE +        +D+++ G ++ EM+ G
Sbjct: 180 -FMMTPYVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 41/165 (24%), Positives = 79/165 (47%), Gaps = 20/165 (12%)
Query: 384 KEIALLNKINHSNLIILSGV-----CFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDW 438
           +E+ LL  + H N+I L  V        E N   +  + +   L++ V   K    ++ +
Sbjct: 72  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 131
Query: 439 KQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGE 498
                +   +  GL Y+HS      +H+D+  SN+ ++ D   KI +F +AR  + +   
Sbjct: 132 -----LIYQILRGLKYIHSADI---IHRDLKPSNLAVNEDSELKILDFGLARHTDDEMTG 183
Query: 499 FALTRHIVGTKGYMAPEYLENGL-VSTKLDVYAFGVLILEMLTGK 542
           +      V T+ Y APE + N +  +  +D+++ G ++ E+LTG+
Sbjct: 184 Y------VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 65/287 (22%), Positives = 125/287 (43%), Gaps = 51/287 (17%)
Query: 361 GSVYRGKI---NGGFA--AIKKVNGDVS---------KEIALLNKINHSNLIILSGVCFN 406
           GSV   ++   +G F   A+K +  D+          +E A + + +H ++  L GV   
Sbjct: 37  GSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLR 96
Query: 407 ---EGNC---YLVYEYAVNGTLSDWVFSNK-NEGKY-LDWKQRIQIALDVATGLNYLHSF 458
              +G      ++  +  +G L  ++ +++  E  + L  +  ++  +D+A G+ YL S 
Sbjct: 97  SRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR 156
Query: 459 TNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTK---GYMAPE 515
                +H+D+ + N +L  D+   +A+F ++R      G++   R    +K    ++A E
Sbjct: 157 N---FIHRDLAARNCMLAEDMTVCVADFGLSRKI--YSGDY--YRQGCASKLPVKWLALE 209
Query: 516 YLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRH 575
            L + L +   DV+AFGV + E++T  +      E      +++ N ++    G   L+ 
Sbjct: 210 SLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIEN-----AEIYNYLI----GGNRLKQ 260
Query: 576 FIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNIL 622
                     P E    V  L+  C   DP  RP+   +   L NIL
Sbjct: 261 ----------PPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENIL 297

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 41/165 (24%), Positives = 79/165 (47%), Gaps = 20/165 (12%)
Query: 384 KEIALLNKINHSNLIILSGV-----CFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDW 438
           +E+ LL  + H N+I L  V        E N   +  + +   L++ V   K    ++ +
Sbjct: 76  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 135
Query: 439 KQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGE 498
                +   +  GL Y+HS      +H+D+  SN+ ++ D   KI +F +AR  + +   
Sbjct: 136 -----LIYQILRGLKYIHSADI---IHRDLKPSNLAVNEDSELKILDFGLARHTDDEMTG 187
Query: 499 FALTRHIVGTKGYMAPEYLENGL-VSTKLDVYAFGVLILEMLTGK 542
           +      V T+ Y APE + N +  +  +D+++ G ++ E+LTG+
Sbjct: 188 Y------VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/166 (25%), Positives = 85/166 (51%), Gaps = 17/166 (10%)
Query: 381 DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQ 440
           ++ +E+++L ++ H N+I L  V  N  +  L+ E    G L D++   ++    L  ++
Sbjct: 61  EIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKES----LSEEE 116
Query: 441 RIQIALDVATGLNYLHSFTNPPHVHKDINSSNV-LLDSDL---RAKIANFAMARPAEGQE 496
                  +  G+NYLH+       H D+   N+ LLD ++     K+ +F +A   E ++
Sbjct: 117 ATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH--EIED 171
Query: 497 G-EFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTG 541
           G EF   ++I GT  ++APE +    +  + D+++ GV+   +L+G
Sbjct: 172 GVEF---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/164 (31%), Positives = 77/164 (46%), Gaps = 11/164 (6%)
Query: 381 DVSKEIALLNKINHSNLIILSGVCFNEGNC-YLVYEYAVNGTLSDWVFSNKNEGKYLDWK 439
           ++ KEI +   +NH N++   G    EGN  YL  EY   G L D +    + G      
Sbjct: 51  NIKKEICINKMLNHENVVKFYG-HRREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDA 107
Query: 440 QRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEF 499
           QR    L    G+ YLH        H+DI   N+LLD     KI++F +A        E 
Sbjct: 108 QRFFHQL--MAGVVYLHGIGI---THRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 162
Query: 500 ALTRHIVGTKGYMAPEYLENG-LVSTKLDVYAFGVLILEMLTGK 542
            L + + GT  Y+APE L+     +  +DV++ G+++  ML G+
Sbjct: 163 LLNK-MCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/164 (31%), Positives = 77/164 (46%), Gaps = 11/164 (6%)
Query: 381 DVSKEIALLNKINHSNLIILSGVCFNEGNC-YLVYEYAVNGTLSDWVFSNKNEGKYLDWK 439
           ++ KEI +   +NH N++   G    EGN  YL  EY   G L D +    + G      
Sbjct: 49  NIKKEICINKMLNHENVVKFYG-HRREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDA 105
Query: 440 QRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEF 499
           QR    L    G+ YLH        H+DI   N+LLD     KI++F +A        E 
Sbjct: 106 QRFFHQL--MAGVVYLHGIGI---THRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 160
Query: 500 ALTRHIVGTKGYMAPEYLENG-LVSTKLDVYAFGVLILEMLTGK 542
            L + + GT  Y+APE L+     +  +DV++ G+++  ML G+
Sbjct: 161 LLNK-MCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 203

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/166 (25%), Positives = 85/166 (51%), Gaps = 17/166 (10%)
Query: 381 DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQ 440
           ++ +E+++L ++ H N+I L  V  N  +  L+ E    G L D++   ++    L  ++
Sbjct: 61  EIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKES----LSEEE 116
Query: 441 RIQIALDVATGLNYLHSFTNPPHVHKDINSSNV-LLDSDL---RAKIANFAMARPAEGQE 496
                  +  G+NYLH+       H D+   N+ LLD ++     K+ +F +A   E ++
Sbjct: 117 ATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH--EIED 171
Query: 497 G-EFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTG 541
           G EF   ++I GT  ++APE +    +  + D+++ GV+   +L+G
Sbjct: 172 GVEF---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/166 (25%), Positives = 85/166 (51%), Gaps = 17/166 (10%)
Query: 381 DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQ 440
           ++ +E+++L ++ H N+I L  V  N  +  L+ E    G L D++   ++    L  ++
Sbjct: 61  EIEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKES----LSEEE 116
Query: 441 RIQIALDVATGLNYLHSFTNPPHVHKDINSSNV-LLDSDL---RAKIANFAMARPAEGQE 496
                  +  G+NYLH+       H D+   N+ LLD ++     K+ +F +A   E ++
Sbjct: 117 ATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH--EIED 171
Query: 497 G-EFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTG 541
           G EF   ++I GT  ++APE +    +  + D+++ GV+   +L+G
Sbjct: 172 GVEF---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 41/165 (24%), Positives = 78/165 (47%), Gaps = 20/165 (12%)
Query: 384 KEIALLNKINHSNLIILSGV-----CFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDW 438
           +E+ LL  + H N+I L  V        E N   +  + +   L++ V   K    ++ +
Sbjct: 70  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 129
Query: 439 KQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGE 498
                +   +  GL Y+HS      +H+D+  SN+ ++ D   KI  F +AR  + +   
Sbjct: 130 -----LIYQILRGLKYIHSADI---IHRDLKPSNLAVNEDCELKILGFGLARHTDDEMTG 181
Query: 499 FALTRHIVGTKGYMAPEYLENGL-VSTKLDVYAFGVLILEMLTGK 542
           +      V T+ Y APE + N +  +  +D+++ G ++ E+LTG+
Sbjct: 182 Y------VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/190 (24%), Positives = 89/190 (46%), Gaps = 11/190 (5%)
Query: 354 SFTCRIQGSVYRGKINGGFAAIKKVNGDVSKEIALLNKINHSNLIILSGVCFNEGNCYLV 413
           ++  R++  V   K++  F ++        +E+ LL  + H N+I L  V     +    
Sbjct: 47  AYDARLRQKVAVKKLSRPFQSLIHAR-RTYRELRLLKHLKHENVIGLLDVFTPATSIEDF 105
Query: 414 YEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNV 473
            E  +  TL     +N  + + L  +    +   +  GL Y+HS      +H+D+  SNV
Sbjct: 106 SEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQLLRGLKYIHSAGI---IHRDLKPSNV 162
Query: 474 LLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGL-VSTKLDVYAFG 532
            ++ D   +I +F +AR A+ +   +      V T+ Y APE + N +  +  +D+++ G
Sbjct: 163 AVNEDSELRILDFGLARQADEEMTGY------VATRWYRAPEIMLNWMHYNQTVDIWSVG 216
Query: 533 VLILEMLTGK 542
            ++ E+L GK
Sbjct: 217 CIMAELLQGK 226

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/164 (31%), Positives = 77/164 (46%), Gaps = 11/164 (6%)
Query: 381 DVSKEIALLNKINHSNLIILSGVCFNEGNC-YLVYEYAVNGTLSDWVFSNKNEGKYLDWK 439
           ++ KEI +   +NH N++   G    EGN  YL  EY   G L D +    + G      
Sbjct: 51  NIKKEICINKMLNHENVVKFYG-HRREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDA 107
Query: 440 QRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEF 499
           QR    L    G+ YLH        H+DI   N+LLD     KI++F +A        E 
Sbjct: 108 QRFFHQL--MAGVVYLHGIGI---THRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 162
Query: 500 ALTRHIVGTKGYMAPEYLENG-LVSTKLDVYAFGVLILEMLTGK 542
            L + + GT  Y+APE L+     +  +DV++ G+++  ML G+
Sbjct: 163 LLNK-MCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/164 (31%), Positives = 77/164 (46%), Gaps = 11/164 (6%)
Query: 381 DVSKEIALLNKINHSNLIILSGVCFNEGNC-YLVYEYAVNGTLSDWVFSNKNEGKYLDWK 439
           ++ KEI +   +NH N++   G    EGN  YL  EY   G L D +    + G      
Sbjct: 50  NIKKEICINKMLNHENVVKFYG-HRREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDA 106
Query: 440 QRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEF 499
           QR    L    G+ YLH        H+DI   N+LLD     KI++F +A        E 
Sbjct: 107 QRFFHQL--MAGVVYLHGIGI---THRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 161
Query: 500 ALTRHIVGTKGYMAPEYLENG-LVSTKLDVYAFGVLILEMLTGK 542
            L + + GT  Y+APE L+     +  +DV++ G+++  ML G+
Sbjct: 162 LLNK-MCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/167 (30%), Positives = 78/167 (46%), Gaps = 18/167 (10%)
Query: 381 DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQ 440
           +V  EI +L K+NH  +I +    F+  + Y+V E    G L D V  NK   +      
Sbjct: 186 NVETEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLY 244
Query: 441 RIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDS---DLRAKIANFAMARPAEGQEG 497
             Q+ L V     YLH       +H+D+   NVLL S   D   KI +F  ++      G
Sbjct: 245 FYQMLLAV----QYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL----G 293
Query: 498 EFALTRHIVGTKGYMAPEYLEN---GLVSTKLDVYAFGVLILEMLTG 541
           E +L R + GT  Y+APE L +      +  +D ++ GV++   L+G
Sbjct: 294 ETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 340

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/164 (31%), Positives = 77/164 (46%), Gaps = 11/164 (6%)
Query: 381 DVSKEIALLNKINHSNLIILSGVCFNEGNC-YLVYEYAVNGTLSDWVFSNKNEGKYLDWK 439
           ++ KEI +   +NH N++   G    EGN  YL  EY   G L D +    + G      
Sbjct: 50  NIKKEICINKMLNHENVVKFYG-HRREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDA 106
Query: 440 QRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEF 499
           QR    L    G+ YLH        H+DI   N+LLD     KI++F +A        E 
Sbjct: 107 QRFFHQL--MAGVVYLHGIGI---THRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 161
Query: 500 ALTRHIVGTKGYMAPEYLENG-LVSTKLDVYAFGVLILEMLTGK 542
            L + + GT  Y+APE L+     +  +DV++ G+++  ML G+
Sbjct: 162 LLNK-MCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 41/165 (24%), Positives = 79/165 (47%), Gaps = 20/165 (12%)
Query: 384 KEIALLNKINHSNLIILSGV-----CFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDW 438
           +E+ LL  + H N+I L  V        E N   +  + +   L++ V   K    ++ +
Sbjct: 66  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCAKLTDDHVQF 125
Query: 439 KQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGE 498
                +   +  GL Y+HS      +H+D+  SN+ ++ D   KI +F +AR  + +   
Sbjct: 126 -----LIYQILRGLKYIHSADI---IHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG 177
Query: 499 FALTRHIVGTKGYMAPEYLENGL-VSTKLDVYAFGVLILEMLTGK 542
           +      V T+ Y APE + N +  +  +D+++ G ++ E+LTG+
Sbjct: 178 Y------VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/166 (25%), Positives = 85/166 (51%), Gaps = 17/166 (10%)
Query: 381 DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQ 440
           ++ +E+++L ++ H N+I L  V  N  +  L+ E    G L D++   ++    L  ++
Sbjct: 61  EIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKES----LSEEE 116
Query: 441 RIQIALDVATGLNYLHSFTNPPHVHKDINSSNV-LLDSDL---RAKIANFAMARPAEGQE 496
                  +  G+NYLH+       H D+   N+ LLD ++     K+ +F +A   E ++
Sbjct: 117 ATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH--EIED 171
Query: 497 G-EFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTG 541
           G EF   ++I GT  ++APE +    +  + D+++ GV+   +L+G
Sbjct: 172 GVEF---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/167 (30%), Positives = 78/167 (46%), Gaps = 18/167 (10%)
Query: 381 DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQ 440
           +V  EI +L K+NH  +I +    F+  + Y+V E    G L D V  NK   +      
Sbjct: 200 NVETEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLY 258
Query: 441 RIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDS---DLRAKIANFAMARPAEGQEG 497
             Q+ L V     YLH       +H+D+   NVLL S   D   KI +F  ++      G
Sbjct: 259 FYQMLLAV----QYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL----G 307
Query: 498 EFALTRHIVGTKGYMAPEYLEN---GLVSTKLDVYAFGVLILEMLTG 541
           E +L R + GT  Y+APE L +      +  +D ++ GV++   L+G
Sbjct: 308 ETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 354

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/164 (31%), Positives = 77/164 (46%), Gaps = 11/164 (6%)
Query: 381 DVSKEIALLNKINHSNLIILSGVCFNEGNC-YLVYEYAVNGTLSDWVFSNKNEGKYLDWK 439
           ++ KEI +   +NH N++   G    EGN  YL  EY   G L D +    + G      
Sbjct: 50  NIKKEICINKMLNHENVVKFYG-HRREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDA 106
Query: 440 QRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEF 499
           QR    L    G+ YLH        H+DI   N+LLD     KI++F +A        E 
Sbjct: 107 QRFFHQL--MAGVVYLHGIGI---THRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 161
Query: 500 ALTRHIVGTKGYMAPEYLENG-LVSTKLDVYAFGVLILEMLTGK 542
            L + + GT  Y+APE L+     +  +DV++ G+++  ML G+
Sbjct: 162 LLNK-MCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/164 (31%), Positives = 77/164 (46%), Gaps = 11/164 (6%)
Query: 381 DVSKEIALLNKINHSNLIILSGVCFNEGNC-YLVYEYAVNGTLSDWVFSNKNEGKYLDWK 439
           ++ KEI +   +NH N++   G    EGN  YL  EY   G L D +    + G      
Sbjct: 50  NIKKEICINKMLNHENVVKFYG-HRREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDA 106
Query: 440 QRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEF 499
           QR    L    G+ YLH        H+DI   N+LLD     KI++F +A        E 
Sbjct: 107 QRFFHQL--MAGVVYLHGIGI---THRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 161
Query: 500 ALTRHIVGTKGYMAPEYLENG-LVSTKLDVYAFGVLILEMLTGK 542
            L + + GT  Y+APE L+     +  +DV++ G+++  ML G+
Sbjct: 162 LLNK-MCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/164 (31%), Positives = 77/164 (46%), Gaps = 11/164 (6%)
Query: 381 DVSKEIALLNKINHSNLIILSGVCFNEGNC-YLVYEYAVNGTLSDWVFSNKNEGKYLDWK 439
           ++ KEI +   +NH N++   G    EGN  YL  EY   G L D +    + G      
Sbjct: 50  NIKKEICINKMLNHENVVKFYG-HRREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDA 106
Query: 440 QRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEF 499
           QR    L    G+ YLH        H+DI   N+LLD     KI++F +A        E 
Sbjct: 107 QRFFHQL--MAGVVYLHGIGI---THRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 161
Query: 500 ALTRHIVGTKGYMAPEYLENG-LVSTKLDVYAFGVLILEMLTGK 542
            L + + GT  Y+APE L+     +  +DV++ G+++  ML G+
Sbjct: 162 LLNK-MCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/164 (31%), Positives = 77/164 (46%), Gaps = 11/164 (6%)
Query: 381 DVSKEIALLNKINHSNLIILSGVCFNEGNC-YLVYEYAVNGTLSDWVFSNKNEGKYLDWK 439
           ++ KEI +   +NH N++   G    EGN  YL  EY   G L D +    + G      
Sbjct: 50  NIKKEICINKMLNHENVVKFYG-HRREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDA 106
Query: 440 QRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEF 499
           QR    L    G+ YLH        H+DI   N+LLD     KI++F +A        E 
Sbjct: 107 QRFFHQL--MAGVVYLHGIGI---THRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 161
Query: 500 ALTRHIVGTKGYMAPEYLENG-LVSTKLDVYAFGVLILEMLTGK 542
            L + + GT  Y+APE L+     +  +DV++ G+++  ML G+
Sbjct: 162 LLNK-MCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/164 (31%), Positives = 77/164 (46%), Gaps = 11/164 (6%)
Query: 381 DVSKEIALLNKINHSNLIILSGVCFNEGNC-YLVYEYAVNGTLSDWVFSNKNEGKYLDWK 439
           ++ KEI +   +NH N++   G    EGN  YL  EY   G L D +    + G      
Sbjct: 50  NIKKEICINKMLNHENVVKFYG-HRREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDA 106
Query: 440 QRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEF 499
           QR    L    G+ YLH        H+DI   N+LLD     KI++F +A        E 
Sbjct: 107 QRFFHQL--MAGVVYLHGIGI---THRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 161
Query: 500 ALTRHIVGTKGYMAPEYLENG-LVSTKLDVYAFGVLILEMLTGK 542
            L + + GT  Y+APE L+     +  +DV++ G+++  ML G+
Sbjct: 162 LLNK-MXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/164 (31%), Positives = 77/164 (46%), Gaps = 11/164 (6%)
Query: 381 DVSKEIALLNKINHSNLIILSGVCFNEGNC-YLVYEYAVNGTLSDWVFSNKNEGKYLDWK 439
           ++ KEI +   +NH N++   G    EGN  YL  EY   G L D +    + G      
Sbjct: 50  NIKKEIXINKMLNHENVVKFYG-HRREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDA 106
Query: 440 QRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEF 499
           QR    L    G+ YLH        H+DI   N+LLD     KI++F +A        E 
Sbjct: 107 QRFFHQL--MAGVVYLHGIGI---THRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 161
Query: 500 ALTRHIVGTKGYMAPEYLENG-LVSTKLDVYAFGVLILEMLTGK 542
            L + + GT  Y+APE L+     +  +DV++ G+++  ML G+
Sbjct: 162 LLNK-MCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 41/165 (24%), Positives = 78/165 (47%), Gaps = 20/165 (12%)
Query: 384 KEIALLNKINHSNLIILSGV-----CFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDW 438
           +E+ LL  + H N+I L  V        E N   +  + +   L++ V   K    ++ +
Sbjct: 77  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 136
Query: 439 KQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGE 498
                +   +  GL Y+HS      +H+D+  SN+ ++ D   KI +F +AR    +   
Sbjct: 137 -----LIYQILRGLKYIHSADI---IHRDLKPSNLAVNEDCELKILDFGLARHTADEMTG 188
Query: 499 FALTRHIVGTKGYMAPEYLENGL-VSTKLDVYAFGVLILEMLTGK 542
           +      V T+ Y APE + N +  +  +D+++ G ++ E+LTG+
Sbjct: 189 Y------VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/166 (25%), Positives = 85/166 (51%), Gaps = 17/166 (10%)
Query: 381 DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQ 440
           ++ +E+++L ++ H N+I L  V  N  +  L+ E    G L D++   ++    L  ++
Sbjct: 61  EIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKES----LSEEE 116
Query: 441 RIQIALDVATGLNYLHSFTNPPHVHKDINSSNV-LLDSDL---RAKIANFAMARPAEGQE 496
                  +  G+NYLH+       H D+   N+ LLD ++     K+ +F +A   E ++
Sbjct: 117 ATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH--EIED 171
Query: 497 G-EFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTG 541
           G EF   ++I GT  ++APE +    +  + D+++ GV+   +L+G
Sbjct: 172 GVEF---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 68/273 (24%), Positives = 114/273 (41%), Gaps = 47/273 (17%)
Query: 338 LKVYSFKELQSATDNFSFTCRIQGSVY------RGKINGGFAAIKKVNG--DVS------ 383
           LK  SF       D +     I    Y      R ++ G   AIKK+    DV       
Sbjct: 42  LKARSFDVTFDVGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRT 101
Query: 384 -KEIALLNKINHSNLIILSG-----VCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLD 437
            +E+ +L    H N+I +       V + E     V    +   L   + S++     L 
Sbjct: 102 LRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQP----LT 157
Query: 438 WKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMAR-----PA 492
            +        +  GL Y+HS      +H+D+  SN+L++ +   KI +F MAR     PA
Sbjct: 158 LEHVRYFLYQLLRGLKYMHSAQV---IHRDLKPSNLLVNENCELKIGDFGMARGLCTSPA 214
Query: 493 EGQEGEFALTRHIVGTKGYMAPEYLENGLVSTK-LDVYAFGVLILEMLTGKEAAALHAEE 551
           E Q   + +T + V T+ Y APE + +    T+ +D+++ G +  EML  ++   L   +
Sbjct: 215 EHQ---YFMTEY-VATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ---LFPGK 267
Query: 552 NNMHLSDVLNAVL-------TKEDGEESLRHFI 577
           N +H   ++  VL        +  G E +R +I
Sbjct: 268 NYVHQLQLIMMVLGTPSPAVIQAVGAERVRAYI 300

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 44/164 (26%), Positives = 81/164 (49%), Gaps = 20/164 (12%)
Query: 384 KEIALLNKINHSNLIILSGVCFNEG------NCYLVYEYAVNGTLSDWVFSNKNEGKYLD 437
           +E+ L+  +NH N+I L  V   +       + Y+V E  ++  LS  +         LD
Sbjct: 72  RELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVME-LMDANLSQVIQME------LD 124
Query: 438 WKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEG 497
            ++   +   +  G+ +LHS      +H+D+  SN+++ SD   KI +F +AR A     
Sbjct: 125 HERMSYLLYQMLCGIKHLHSAGI---IHRDLKPSNIVVKSDATLKILDFGLARTAGTS-- 179
Query: 498 EFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTG 541
            F +T ++V T+ Y APE +        +D+++ G ++ EM+ G
Sbjct: 180 -FMMTPYVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 41/165 (24%), Positives = 78/165 (47%), Gaps = 20/165 (12%)
Query: 384 KEIALLNKINHSNLIILSGV-----CFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDW 438
           +E+ LL  + H N+I L  V        E N   +  + +   L++ V   K    ++ +
Sbjct: 77  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 136
Query: 439 KQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGE 498
                +   +  GL Y+HS      +H+D+  SN+ ++ D   KI +F +AR    +   
Sbjct: 137 -----LIYQILRGLKYIHSADI---IHRDLKPSNLAVNEDCELKILDFGLARHTADEMTG 188
Query: 499 FALTRHIVGTKGYMAPEYLENGL-VSTKLDVYAFGVLILEMLTGK 542
           +      V T+ Y APE + N +  +  +D+++ G ++ E+LTG+
Sbjct: 189 Y------VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/166 (25%), Positives = 85/166 (51%), Gaps = 17/166 (10%)
Query: 381 DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQ 440
           ++ +E+++L ++ H N+I L  V  N  +  L+ E    G L D++   ++    L  ++
Sbjct: 61  EIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKES----LSEEE 116
Query: 441 RIQIALDVATGLNYLHSFTNPPHVHKDINSSNV-LLDSDL---RAKIANFAMARPAEGQE 496
                  +  G+NYLH+       H D+   N+ LLD ++     K+ +F +A   E ++
Sbjct: 117 ATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH--EIED 171
Query: 497 G-EFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTG 541
           G EF   ++I GT  ++APE +    +  + D+++ GV+   +L+G
Sbjct: 172 GVEF---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/164 (31%), Positives = 77/164 (46%), Gaps = 11/164 (6%)
Query: 381 DVSKEIALLNKINHSNLIILSGVCFNEGNC-YLVYEYAVNGTLSDWVFSNKNEGKYLDWK 439
           ++ KEI +   +NH N++   G    EGN  YL  EY   G L D +    + G      
Sbjct: 50  NIKKEIXINKMLNHENVVKFYG-HRREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDA 106
Query: 440 QRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEF 499
           QR    L    G+ YLH        H+DI   N+LLD     KI++F +A        E 
Sbjct: 107 QRFFHQL--MAGVVYLHGIGI---THRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 161
Query: 500 ALTRHIVGTKGYMAPEYLENG-LVSTKLDVYAFGVLILEMLTGK 542
            L + + GT  Y+APE L+     +  +DV++ G+++  ML G+
Sbjct: 162 LLNK-MXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/164 (31%), Positives = 77/164 (46%), Gaps = 11/164 (6%)
Query: 381 DVSKEIALLNKINHSNLIILSGVCFNEGNC-YLVYEYAVNGTLSDWVFSNKNEGKYLDWK 439
           ++ KEI +   +NH N++   G    EGN  YL  EY   G L D +    + G      
Sbjct: 50  NIKKEICINKMLNHENVVKFYG-HRREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDA 106
Query: 440 QRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEF 499
           QR    L    G+ YLH        H+DI   N+LLD     KI++F +A        E 
Sbjct: 107 QRFFHQL--MAGVVYLHGIGI---THRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 161
Query: 500 ALTRHIVGTKGYMAPEYLENG-LVSTKLDVYAFGVLILEMLTGK 542
            L + + GT  Y+APE L+     +  +DV++ G+++  ML G+
Sbjct: 162 LLNK-MXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/164 (31%), Positives = 77/164 (46%), Gaps = 11/164 (6%)
Query: 381 DVSKEIALLNKINHSNLIILSGVCFNEGNC-YLVYEYAVNGTLSDWVFSNKNEGKYLDWK 439
           ++ KEI +   +NH N++   G    EGN  YL  EY   G L D +    + G      
Sbjct: 50  NIKKEICINKMLNHENVVKFYG-HRREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDA 106
Query: 440 QRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEF 499
           QR    L    G+ YLH        H+DI   N+LLD     KI++F +A        E 
Sbjct: 107 QRFFHQL--MAGVVYLHGIGI---THRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 161
Query: 500 ALTRHIVGTKGYMAPEYLENG-LVSTKLDVYAFGVLILEMLTGK 542
            L + + GT  Y+APE L+     +  +DV++ G+++  ML G+
Sbjct: 162 LLNK-MXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 41/165 (24%), Positives = 78/165 (47%), Gaps = 20/165 (12%)
Query: 384 KEIALLNKINHSNLIILSGV-----CFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDW 438
           +E+ LL  + H N+I L  V        E N   +  + +   L++ V   K    ++ +
Sbjct: 77  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 136
Query: 439 KQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGE 498
                +   +  GL Y+HS      +H+D+  SN+ ++ D   KI +F +AR    +   
Sbjct: 137 -----LIYQILRGLKYIHSADI---IHRDLKPSNLAVNEDCELKILDFGLARHTADEMTG 188
Query: 499 FALTRHIVGTKGYMAPEYLENGL-VSTKLDVYAFGVLILEMLTGK 542
           +      V T+ Y APE + N +  +  +D+++ G ++ E+LTG+
Sbjct: 189 Y------VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/164 (31%), Positives = 77/164 (46%), Gaps = 11/164 (6%)
Query: 381 DVSKEIALLNKINHSNLIILSGVCFNEGNC-YLVYEYAVNGTLSDWVFSNKNEGKYLDWK 439
           ++ KEI +   +NH N++   G    EGN  YL  EY   G L D +    + G      
Sbjct: 51  NIKKEIXINKMLNHENVVKFYG-HRREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDA 107
Query: 440 QRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEF 499
           QR    L    G+ YLH        H+DI   N+LLD     KI++F +A        E 
Sbjct: 108 QRFFHQL--MAGVVYLHGIGI---THRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 162
Query: 500 ALTRHIVGTKGYMAPEYLENG-LVSTKLDVYAFGVLILEMLTGK 542
            L + + GT  Y+APE L+     +  +DV++ G+++  ML G+
Sbjct: 163 LLNK-MXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 41/165 (24%), Positives = 78/165 (47%), Gaps = 20/165 (12%)
Query: 384 KEIALLNKINHSNLIILSGV-----CFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDW 438
           +E+ LL  + H N+I L  V        E N   +  + +   L++ V   K    ++ +
Sbjct: 90  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 149
Query: 439 KQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGE 498
                +   +  GL Y+HS      +H+D+  SN+ ++ D   KI +F +AR  + +   
Sbjct: 150 -----LIYQILRGLKYIHSADI---IHRDLKPSNLAVNEDCELKILDFGLARHTDDE--- 198
Query: 499 FALTRHIVGTKGYMAPEYLENGL-VSTKLDVYAFGVLILEMLTGK 542
                  V T+ Y APE + N +  +  +D+++ G ++ E+LTG+
Sbjct: 199 ---MXGXVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/227 (24%), Positives = 99/227 (43%), Gaps = 41/227 (18%)
Query: 342 SFKELQSATDNFSFTCRIQ-----GSVYRGKINGGFAAIKKVNGDVSK------------ 384
            F  ++ A   F+   R Q     GS  +G +   F  +  +N  V K            
Sbjct: 9   QFYSVEVADSTFTVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAK 68
Query: 385 ----EIALLNKINHSNLIILSGVCFNEG------NCYLVYEYAVNGTLSDWVFSNKNEGK 434
               E+ LL  +NH N+I L  V   +       + YLV E  ++  L   +        
Sbjct: 69  RAYRELVLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL-MDANLCQVIHME----- 122
Query: 435 YLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEG 494
            LD ++   +   +  G+ +LHS      +H+D+  SN+++ SD   KI +F +AR A  
Sbjct: 123 -LDHERMSYLLYQMLCGIKHLHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLARTACT 178
Query: 495 QEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTG 541
               F +T ++V T+ Y APE +     +  +D+++ G ++ E++ G
Sbjct: 179 N---FMMTPYVV-TRYYRAPEVILGMGYAANVDIWSVGCIMGELVKG 221

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 40/165 (24%), Positives = 79/165 (47%), Gaps = 20/165 (12%)
Query: 384 KEIALLNKINHSNLIILSGV-----CFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDW 438
           +E+ LL  + H N+I L  V        E N   +  + +   L++ V   K    ++ +
Sbjct: 70  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 129
Query: 439 KQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGE 498
                +   +  GL Y+HS      +H+D+  SN+ ++ D   KI ++ +AR  + +   
Sbjct: 130 -----LIYQILRGLKYIHSADI---IHRDLKPSNLAVNEDCELKILDYGLARHTDDEMTG 181
Query: 499 FALTRHIVGTKGYMAPEYLENGL-VSTKLDVYAFGVLILEMLTGK 542
           +      V T+ Y APE + N +  +  +D+++ G ++ E+LTG+
Sbjct: 182 Y------VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/207 (24%), Positives = 84/207 (40%), Gaps = 39/207 (18%)
Query: 365 RGKINGGFAAIKKVNGDVSK------EIALLNKINHSNLIILSGVCFNEGN--------- 409
           R  ++  + AIKK+     K      E+ LL  +NH  ++          N         
Sbjct: 26  RNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVK 85
Query: 410 ----CYLVYEYAVNGTLSDWVFS-NKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHV 464
                ++  EY  N TL D + S N N+ +   W+   QI       L+Y+HS      +
Sbjct: 86  KKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYWRLFRQIL----EALSYIHS---QGII 138
Query: 465 HKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRH-----------IVGTKGYMA 513
           H+D+   N+ +D     KI +F +A+          L               +GT  Y+A
Sbjct: 139 HRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVA 198
Query: 514 PEYLE-NGLVSTKLDVYAFGVLILEML 539
            E L+  G  + K+D+Y+ G++  EM+
Sbjct: 199 TEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/185 (25%), Positives = 83/185 (44%), Gaps = 15/185 (8%)
Query: 361 GSVYRGKINGGFAAIKKVNGDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNG 420
           G  Y  KI        + +  + +E  +   + H N++ L      EG  YLV++    G
Sbjct: 29  GQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGG 88
Query: 421 TLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLR 480
            L + + + +   +  D    IQ  L+    +N+ H       VH+D+   N+LL S  +
Sbjct: 89  ELFEDIVAREYYSE-ADASHCIQQILE---SVNHCHLNGI---VHRDLKPENLLLASKSK 141
Query: 481 A---KIANFAMARPAEG-QEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLIL 536
               K+A+F +A   +G Q+  F       GT GY++PE L        +D++A GV++ 
Sbjct: 142 GAAVKLADFGLAIEVQGDQQAWFGFA----GTPGYLSPEVLRKDPYGKPVDMWACGVILY 197
Query: 537 EMLTG 541
            +L G
Sbjct: 198 ILLVG 202

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 44/164 (26%), Positives = 81/164 (49%), Gaps = 20/164 (12%)
Query: 384 KEIALLNKINHSNLIILSGVCFNEG------NCYLVYEYAVNGTLSDWVFSNKNEGKYLD 437
           +E+ L+  +NH N+I L  V   +       + Y+V E  ++  LS  +         LD
Sbjct: 72  RELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVME-LMDANLSQVIQME------LD 124
Query: 438 WKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEG 497
            ++   +   +  G+ +LHS      +H+D+  SN+++ SD   KI +F +AR A     
Sbjct: 125 HERMSYLLYQMLCGIKHLHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLARTAGTS-- 179
Query: 498 EFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTG 541
            F +T ++V T+ Y APE +        +D+++ G ++ EM+ G
Sbjct: 180 -FMMTPYVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/243 (22%), Positives = 107/243 (44%), Gaps = 37/243 (15%)
Query: 385 EIALLNKI-NHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQ 443
           E+ +++ +  H N++ L G C + G   ++ EY   G L +++   + + + L+      
Sbjct: 99  ELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFL---RRKSRVLETDPAFA 155
Query: 444 IALDVATGLNYLHSFTNPPH----------VHKDINSSNVLLDSDLRAKIANFAMARPAE 493
           IA   A+  + LH  +              +H+D+ + NVLL +   AKI +F +AR   
Sbjct: 156 IANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIM 215
Query: 494 GQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENN 553
                       +  K +MAPE + + + + + DV+++G+L+ E+ +      L     N
Sbjct: 216 NDSNYIVKGNARLPVK-WMAPESIFDCVYTVQSDVWSYGILLWEIFS----LGL-----N 265
Query: 554 MHLSDVLNAVLTK--EDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTM 611
            +   ++N+   K  +DG +  +    P             +  ++ AC   +PT RPT 
Sbjct: 266 PYPGILVNSKFYKLVKDGYQMAQPAFAPK-----------NIYSIMQACWALEPTHRPTF 314
Query: 612 YEI 614
            +I
Sbjct: 315 QQI 317

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 49/190 (25%), Positives = 85/190 (44%), Gaps = 20/190 (10%)
Query: 361 GSVYRGKINGGFAAIK------KVNGDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVY 414
             + R K +    A+K      K++ +V +EI     + H N++    V     +  +V 
Sbjct: 34  ARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSLRHPNIVRFKEVILTPTHLAIVM 93
Query: 415 EYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVL 474
           EYA  G L + +    N G++ + + R      + +G++Y H+       H+D+   N L
Sbjct: 94  EYASGGELFERIC---NAGRFSEDEARFFFQ-QLISGVSYCHAMQV---CHRDLKLENTL 146
Query: 475 LDSD--LRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKL-DVYAF 531
           LD     R KI +F  ++ +       +  +  VGT  Y+APE L       K+ DV++ 
Sbjct: 147 LDGSPAPRLKICDFGYSKSSVLH----SQPKSTVGTPAYIAPEVLLKKEYDGKVADVWSC 202
Query: 532 GVLILEMLTG 541
           GV +  ML G
Sbjct: 203 GVTLYVMLVG 212

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 41/165 (24%), Positives = 78/165 (47%), Gaps = 20/165 (12%)
Query: 384 KEIALLNKINHSNLIILSGV-----CFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDW 438
           +E+ LL  + H N+I L  V        E N   +  + +   L++ V   K    ++ +
Sbjct: 70  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 129
Query: 439 KQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGE 498
                +   +  GL Y+HS      +H+D+  SN+ ++ D   KI +F +AR  + +   
Sbjct: 130 -----LIYQILRGLKYIHSADI---IHRDLKPSNLAVNEDCELKILDFGLARHTDDE--- 178
Query: 499 FALTRHIVGTKGYMAPEYLENGL-VSTKLDVYAFGVLILEMLTGK 542
                  V T+ Y APE + N +  +  +D+++ G ++ E+LTG+
Sbjct: 179 ---MTGXVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/190 (26%), Positives = 92/190 (48%), Gaps = 28/190 (14%)
Query: 367 KINGGFAAIKKVNGDVS---------KEIALLNKINHSNLIILSGVCFNEGNCYLVYEYA 417
           K +G   AIKK++             +E+ LL  + H N+I L  V     +    Y++ 
Sbjct: 64  KRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFY 123
Query: 418 VNGTLSDWVFSNKNEGKYLDWK---QRIQ-IALDVATGLNYLHSFTNPPHVHKDINSSNV 473
           +        F   +  K +  +   ++IQ +   +  GL Y+HS      VH+D+   N+
Sbjct: 124 LVMP-----FMQTDLQKIMGMEFSEEKIQYLVYQMLKGLKYIHSAGV---VHRDLKPGNL 175
Query: 474 LLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGL-VSTKLDVYAFG 532
            ++ D   KI +F +AR A+ +     +T ++V T+ Y APE + + +  +  +D+++ G
Sbjct: 176 AVNEDCELKILDFGLARHADAE-----MTGYVV-TRWYRAPEVILSWMHYNQTVDIWSVG 229
Query: 533 VLILEMLTGK 542
            ++ EMLTGK
Sbjct: 230 CIMAEMLTGK 239

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 44/164 (26%), Positives = 81/164 (49%), Gaps = 20/164 (12%)
Query: 384 KEIALLNKINHSNLIILSGVCFNEG------NCYLVYEYAVNGTLSDWVFSNKNEGKYLD 437
           +E+ L+  +NH N+I L  V   +       + Y+V E  ++  LS  +         LD
Sbjct: 72  RELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVME-LMDANLSQVIQME------LD 124
Query: 438 WKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEG 497
            ++   +   +  G+ +LHS      +H+D+  SN+++ SD   KI +F +AR A     
Sbjct: 125 HERMSYLLYQMLCGIKHLHSAGI---IHRDLKPSNIVVKSDATLKILDFGLARTAGTS-- 179
Query: 498 EFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTG 541
            F +T ++V T+ Y APE +        +D+++ G ++ EM+ G
Sbjct: 180 -FMMTPYVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 56/236 (23%), Positives = 101/236 (42%), Gaps = 40/236 (16%)
Query: 393 NHSNLIILSGVCFNEGNCYLVYEYAVNGTL------------SDWVFSNKNEGKYLDWKQ 440
            H N++ L G C + G   ++ EY   G L            +D  F+  N    L  + 
Sbjct: 108 QHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANST--LSTRD 165
Query: 441 RIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFA 500
            +  +  VA G+ +L S      +H+D+ + NVLL +   AKI +F +AR          
Sbjct: 166 LLHFSSQVAQGMAFLASKNC---IHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIV 222
Query: 501 LTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVL 560
                +  K +MAPE + + + + + DV+++G+L+ E+ +      L     N +   ++
Sbjct: 223 KGNARLPVK-WMAPESIFDCVYTVQSDVWSYGILLWEIFS----LGL-----NPYPGILV 272
Query: 561 NAVLTK--EDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEI 614
           N+   K  +DG +  +    P             +  ++ AC   +PT RPT  +I
Sbjct: 273 NSKFYKLVKDGYQMAQPAFAPK-----------NIYSIMQACWALEPTHRPTFQQI 317

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 49/190 (25%), Positives = 84/190 (44%), Gaps = 20/190 (10%)
Query: 361 GSVYRGKINGGFAAIK------KVNGDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVY 414
             + R K +    A+K      K+  +V +EI     + H N++    V     +  +V 
Sbjct: 35  ARLMRDKQSNELVAVKYIERGEKIAANVKREIINHRSLRHPNIVRFKEVILTPTHLAIVM 94
Query: 415 EYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVL 474
           EYA  G L + +    N G++ + + R      + +G++Y H+       H+D+   N L
Sbjct: 95  EYASGGELFERIC---NAGRFSEDEARFFFQ-QLISGVSYCHAMQV---CHRDLKLENTL 147
Query: 475 LDSD--LRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKL-DVYAF 531
           LD     R KI +F  ++ +       +  +  VGT  Y+APE L       K+ DV++ 
Sbjct: 148 LDGSPAPRLKICDFGYSKSSVLH----SQPKSTVGTPAYIAPEVLLKKEYDGKVADVWSC 203
Query: 532 GVLILEMLTG 541
           GV +  ML G
Sbjct: 204 GVTLYVMLVG 213

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 49/189 (25%), Positives = 87/189 (46%), Gaps = 27/189 (14%)
Query: 374 AIKKVNG-----DVSKEIALLNKINHSNLIILSGVCFNEGN--CYLVYEYAVNGTLSDWV 426
           A+K++ G        +EIALL ++ H N+I L  V  +  +   +L+++YA +       
Sbjct: 52  ALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIK 111
Query: 427 FSNKNEGKYLDWKQRIQIA--------LDVATGLNYLHSFTNPPHVHKDINSSNVLLDSD 478
           F   ++      K+ +Q+           +  G++YLH+      +H+D+  +N+L+  +
Sbjct: 112 FHRASKAN----KKPVQLPRGMVKSLLYQILDGIHYLHANWV---LHRDLKPANILVMGE 164
Query: 479 ----LRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTK-LDVYAFGV 533
                R KIA+   AR         A    +V T  Y APE L      TK +D++A G 
Sbjct: 165 GPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGC 224
Query: 534 LILEMLTGK 542
           +  E+LT +
Sbjct: 225 IFAELLTSE 233

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 48/185 (25%), Positives = 83/185 (44%), Gaps = 15/185 (8%)
Query: 361 GSVYRGKINGGFAAIKKVNGDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNG 420
           G  Y  KI        + +  + +E  +   + H N++ L      EG  YLV++    G
Sbjct: 29  GQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGG 88
Query: 421 TLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLR 480
            L + + + +   +  D    IQ  L+    +N+ H       VH+D+   N+LL S  +
Sbjct: 89  ELFEDIVAREYYSE-ADASHCIQQILE---SVNHCHLNGI---VHRDLKPENLLLASKSK 141
Query: 481 A---KIANFAMARPAEG-QEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLIL 536
               K+A+F +A   +G Q+  F       GT GY++PE L        +D++A GV++ 
Sbjct: 142 GAAVKLADFGLAIEVQGDQQAWFGFA----GTPGYLSPEVLRKDPYGKPVDMWACGVILY 197
Query: 537 EMLTG 541
            +L G
Sbjct: 198 ILLVG 202

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 51/164 (31%), Positives = 77/164 (46%), Gaps = 11/164 (6%)
Query: 381 DVSKEIALLNKINHSNLIILSGVCFNEGNC-YLVYEYAVNGTLSDWVFSNKNEGKYLDWK 439
           ++ KEI +   +NH N++   G    EGN  YL  EY   G L D +    + G      
Sbjct: 51  NIKKEICINAMLNHENVVKFYG-HRREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDA 107
Query: 440 QRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEF 499
           QR    L    G+ YLH        H+DI   N+LLD     KI++F +A        E 
Sbjct: 108 QRFFHQL--MAGVVYLHGIGI---THRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 162
Query: 500 ALTRHIVGTKGYMAPEYLENG-LVSTKLDVYAFGVLILEMLTGK 542
            L + + GT  Y+APE L+     +  +DV++ G+++  ML G+
Sbjct: 163 LLNK-MCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 46/172 (26%), Positives = 75/172 (43%), Gaps = 15/172 (8%)
Query: 375 IKKVNGDVSKEIALLNKI-NHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEG 433
           I K   D ++EI +L +   H N+I L  V  +    Y+V E    G L D +   K   
Sbjct: 55  IDKSKRDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQK--- 111
Query: 434 KYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDL----RAKIANFAMA 489
            +   ++   +   +   + YLH+      VH+D+  SN+L   +       +I +F  A
Sbjct: 112 -FFSEREASAVLFTITKTVEYLHAQGV---VHRDLKPSNILYVDESGNPESIRICDFGFA 167
Query: 490 RPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTG 541
           +    + G   L      T  ++APE LE        D+++ GVL+  MLTG
Sbjct: 168 KQLRAENG---LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTG 216

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 51/200 (25%), Positives = 87/200 (43%), Gaps = 34/200 (17%)
Query: 361 GSVYRG---------KINGGFAAIK-----KVNGDVSKEIALLNKINHSNLIILSGVCFN 406
           G+VY+G         KI      ++     K N ++  E  ++  +    +  L G+C  
Sbjct: 31  GTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVSRLLGICLT 90
Query: 407 EGNCYLVYEYAVNGTLSDWVFSNKNE---GKYLDWKQRIQIALDVATGLNYLHSFTNPPH 463
                LV +    G L D V  N+        L+W       + +A G++YL        
Sbjct: 91  -STVQLVTQLMPYGCLLDHVRENRGRLGSQDLLNW------CMQIAKGMSYLEDVR---L 140
Query: 464 VHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTK---GYMAPEYLENG 520
           VH+D+ + NVL+ S    KI +F +AR  +  E E+    H  G K    +MA E +   
Sbjct: 141 VHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEY----HADGGKVPIKWMALESILRR 196
Query: 521 LVSTKLDVYAFGVLILEMLT 540
             + + DV+++GV + E++T
Sbjct: 197 RFTHQSDVWSYGVTVWELMT 216

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 44/165 (26%), Positives = 80/165 (48%), Gaps = 20/165 (12%)
Query: 384 KEIALLNKINHSNLIILSGVCFNEG------NCYLVYEYAVNGTLSDWVFSNKNEGKYLD 437
           +E+ L+  +NH N+I L  V   +       + YLV E  ++  L   +         LD
Sbjct: 72  RELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVME-LMDANLXQVIQME------LD 124
Query: 438 WKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEG 497
            ++   +   +  G+ +LHS      +H+D+  SN+++ SD   KI +F +AR A     
Sbjct: 125 HERMSYLLYQMLXGIKHLHSAGI---IHRDLKPSNIVVKSDXTLKILDFGLARTA---GT 178
Query: 498 EFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGK 542
            F +T ++V T+ Y APE +        +D+++ G ++ EM+  K
Sbjct: 179 SFMMTPYVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 44/163 (26%), Positives = 69/163 (42%), Gaps = 27/163 (16%)
Query: 448 VATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVG 507
           + +GL +LH       +++D+   NVLLD D   +I++  +A   E + G+   T+   G
Sbjct: 298 IVSGLEHLHQRNI---IYRDLKPENVLLDDDGNVRISDLGLA--VELKAGQ-TKTKGYAG 351
Query: 508 TKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAE--ENNMHLSDVLNAVLT 565
           T G+MAPE L        +D +A GV + EM+  +       E  EN      VL   +T
Sbjct: 352 TPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVT 411
Query: 566 KEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDR 608
                              YP + +       +A L+KDP  R
Sbjct: 412 -------------------YPDKFSPASKDFCEALLQKDPEKR 435

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 44/163 (26%), Positives = 69/163 (42%), Gaps = 27/163 (16%)
Query: 448 VATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVG 507
           + +GL +LH       +++D+   NVLLD D   +I++  +A   E + G+   T+   G
Sbjct: 298 IVSGLEHLHQRNI---IYRDLKPENVLLDDDGNVRISDLGLA--VELKAGQ-TKTKGYAG 351
Query: 508 TKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAE--ENNMHLSDVLNAVLT 565
           T G+MAPE L        +D +A GV + EM+  +       E  EN      VL   +T
Sbjct: 352 TPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVT 411
Query: 566 KEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDR 608
                              YP + +       +A L+KDP  R
Sbjct: 412 -------------------YPDKFSPASKDFCEALLQKDPEKR 435

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 68/273 (24%), Positives = 114/273 (41%), Gaps = 47/273 (17%)
Query: 338 LKVYSFKELQSATDNFSFTCRIQGSVY------RGKINGGFAAIKKVNG--DVS------ 383
           LK  SF       D +     I    Y      R ++ G   AIKK+    DV       
Sbjct: 41  LKARSFDVTFDVGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRT 100
Query: 384 -KEIALLNKINHSNLIILSG-----VCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLD 437
            +E+ +L    H N+I +       V + E     V    +   L   + S++     L 
Sbjct: 101 LRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQP----LT 156
Query: 438 WKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMAR-----PA 492
            +        +  GL Y+HS      +H+D+  SN+L++ +   KI +F MAR     PA
Sbjct: 157 LEHVRYFLYQLLRGLKYMHSAQV---IHRDLKPSNLLVNENCELKIGDFGMARGLCTSPA 213
Query: 493 EGQEGEFALTRHIVGTKGYMAPEYLENGLVSTK-LDVYAFGVLILEMLTGKEAAALHAEE 551
           E Q   + +T + V T+ Y APE + +    T+ +D+++ G +  EML  ++   L   +
Sbjct: 214 EHQ---YFMTEY-VATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ---LFPGK 266
Query: 552 NNMHLSDVLNAVL-------TKEDGEESLRHFI 577
           N +H   ++  VL        +  G E +R +I
Sbjct: 267 NYVHQLQLIMMVLGTPSPAVIQAVGAERVRAYI 299

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 44/163 (26%), Positives = 69/163 (42%), Gaps = 27/163 (16%)
Query: 448 VATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVG 507
           + +GL +LH       +++D+   NVLLD D   +I++  +A   E + G+   T+   G
Sbjct: 298 IVSGLEHLHQRNI---IYRDLKPENVLLDDDGNVRISDLGLA--VELKAGQ-TKTKGYAG 351
Query: 508 TKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAE--ENNMHLSDVLNAVLT 565
           T G+MAPE L        +D +A GV + EM+  +       E  EN      VL   +T
Sbjct: 352 TPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVT 411
Query: 566 KEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDR 608
                              YP + +       +A L+KDP  R
Sbjct: 412 -------------------YPDKFSPASKDFCEALLQKDPEKR 435

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 44/163 (26%), Positives = 69/163 (42%), Gaps = 27/163 (16%)
Query: 448 VATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVG 507
           + +GL +LH       +++D+   NVLLD D   +I++  +A   E + G+   T+   G
Sbjct: 298 IVSGLEHLHQRNI---IYRDLKPENVLLDDDGNVRISDLGLA--VELKAGQ-TKTKGYAG 351
Query: 508 TKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAE--ENNMHLSDVLNAVLT 565
           T G+MAPE L        +D +A GV + EM+  +       E  EN      VL   +T
Sbjct: 352 TPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVT 411
Query: 566 KEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDR 608
                              YP + +       +A L+KDP  R
Sbjct: 412 -------------------YPDKFSPASKDFCEALLQKDPEKR 435

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 44/163 (26%), Positives = 76/163 (46%), Gaps = 11/163 (6%)
Query: 378 VNGDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLD 437
           +N    +EI LL +++H N+I L     ++ N  LV+++      +D     K+    L 
Sbjct: 55  INRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFME----TDLEVIIKDNSLVLT 110
Query: 438 WKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEG 497
                   L    GL YLH       +H+D+  +N+LLD +   K+A+F +A+       
Sbjct: 111 PSHIKAYMLMTLQGLEYLHQHWI---LHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR 167
Query: 498 EFALTRHIVGTKGYMAPEYLENG-LVSTKLDVYAFGVLILEML 539
            +    H V T+ Y APE L    +    +D++A G ++ E+L
Sbjct: 168 AYX---HQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELL 207

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 49/190 (25%), Positives = 84/190 (44%), Gaps = 20/190 (10%)
Query: 361 GSVYRGKINGGFAAIK------KVNGDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVY 414
             + R K +    A+K      K++ +V +EI     + H N++    V     +  +V 
Sbjct: 35  ARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSLRHPNIVRFKEVILTPTHLAIVM 94
Query: 415 EYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVL 474
           EYA  G L + +    N G++ + + R      + +G++Y H+       H+D+   N L
Sbjct: 95  EYASGGELFERIC---NAGRFSEDEARF-FFQQLISGVSYCHAMQV---CHRDLKLENTL 147
Query: 475 LDSD--LRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKL-DVYAF 531
           LD     R KI  F  ++ +       +  +  VGT  Y+APE L       K+ DV++ 
Sbjct: 148 LDGSPAPRLKICAFGYSKSSVLH----SQPKSTVGTPAYIAPEVLLKKEYDGKVADVWSC 203
Query: 532 GVLILEMLTG 541
           GV +  ML G
Sbjct: 204 GVTLYVMLVG 213

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 44/165 (26%), Positives = 80/165 (48%), Gaps = 20/165 (12%)
Query: 384 KEIALLNKINHSNLIILSGVCFNEG------NCYLVYEYAVNGTLSDWVFSNKNEGKYLD 437
           +E+ L+  +NH N+I L  V   +       + YLV E  ++  L   +         LD
Sbjct: 72  RELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVME-LMDANLXQVIQME------LD 124
Query: 438 WKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEG 497
            ++   +   +  G+ +LHS      +H+D+  SN+++ SD   KI +F +AR A     
Sbjct: 125 HERMSYLLYQMLCGIKHLHSAGI---IHRDLKPSNIVVKSDXTLKILDFGLARTA---GT 178
Query: 498 EFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGK 542
            F +T ++V T+ Y APE +        +D+++ G ++ EM+  K
Sbjct: 179 SFMMTPYVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|4EBY|A Chain A, Crystal Structure Of The Ectodomain Of A Receptor Like Kinase Length = 212

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 34/111 (30%), Positives = 64/111 (57%), Gaps = 4/111 (3%)
Query: 103 VIVPVNCSCS-GQYYQSNTTYTIQNGDTYLFIANNTFQGLSTCQALEDQNGSP-TNLIIG 160
           V+VP  C C  G +   N +Y+++  DTY  +A + +  L+T ++L+ +N  P TN+ + 
Sbjct: 61  VLVPFPCECQPGDFLGHNFSYSVRQEDTYERVAISNYANLTTMESLQARNPFPATNIPLS 120
Query: 161 AGVTVPLRCACPTENQTDEGFPFLLSYLVAEGDTVSGISSRFGVDTGEILQ 211
           A + V + C+C  E+ + + F   ++Y +   D++S I+   GV + +ILQ
Sbjct: 121 ATLNVLVNCSCGDESVSKD-FGLFVTYPLRPEDSLSSIARSSGV-SADILQ 169

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 49/190 (25%), Positives = 84/190 (44%), Gaps = 20/190 (10%)
Query: 361 GSVYRGKINGGFAAIK------KVNGDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVY 414
             + R K +    A+K      K++ +V +EI     + H N++    V     +  +V 
Sbjct: 35  ARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSLRHPNIVRFKEVILTPTHLAIVM 94
Query: 415 EYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVL 474
           EYA  G L + +    N G++ + + R      + +G++Y H+       H+D+   N L
Sbjct: 95  EYASGGELFERIC---NAGRFSEDEARF-FFQQLISGVSYCHAMQV---CHRDLKLENTL 147
Query: 475 LDSD--LRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKL-DVYAF 531
           LD     R KI  F  ++ +       +  +  VGT  Y+APE L       K+ DV++ 
Sbjct: 148 LDGSPAPRLKICAFGYSKSSVLH----SQPKDTVGTPAYIAPEVLLKKEYDGKVADVWSC 203
Query: 532 GVLILEMLTG 541
           GV +  ML G
Sbjct: 204 GVTLYVMLVG 213

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 52/196 (26%), Positives = 96/196 (48%), Gaps = 23/196 (11%)
Query: 361 GSVYRGKI--NGGFAAIKKVNGDV---SKEIALLNKINHSNLIILSGVCFNEGNCY-LVY 414
           G VY+ K+  +G   AIKKV  D    ++E+ ++ K++H N++ L    ++ G    +VY
Sbjct: 34  GVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDVVY 93
Query: 415 EYAVNGTLSDWVFSNKNEGKYLDWKQRIQI------ALDVATGLNYLHSFTNPPHVHKDI 468
              V   + + V+  +    Y   KQ + +         +   L Y+HSF      H+DI
Sbjct: 94  LNLVLDYVPETVY--RVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGI---CHRDI 148
Query: 469 NSSNVLLDSDLRA-KIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGL-VSTKL 526
              N+LLD D    K+ +F  A+  +   GE  ++   + ++ Y APE +      ++ +
Sbjct: 149 KPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVS--XICSRYYRAPELIFGATDYTSSI 204
Query: 527 DVYAFGVLILEMLTGK 542
           DV++ G ++ E+L G+
Sbjct: 205 DVWSAGCVLAELLLGQ 220

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 44/165 (26%), Positives = 80/165 (48%), Gaps = 20/165 (12%)
Query: 384 KEIALLNKINHSNLIILSGVCFNEG------NCYLVYEYAVNGTLSDWVFSNKNEGKYLD 437
           +E+ L+  +NH N+I L  V   +       + YLV E  ++  L   +         LD
Sbjct: 110 RELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL-MDANLCQVIQME------LD 162
Query: 438 WKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEG 497
            ++   +   +  G+ +LHS      +H+D+  SN+++ SD   KI +F +AR A     
Sbjct: 163 HERMSYLLYQMLCGIKHLHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLARTA---GT 216
Query: 498 EFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGK 542
            F +T ++V T+ Y APE +        +D+++ G ++ EM+  K
Sbjct: 217 SFMMTPYVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 53/169 (31%), Positives = 75/169 (44%), Gaps = 19/169 (11%)
Query: 381 DVSKEIALLNKINHSNLIILSGVCFNE--GNCYLVYEYAVNGTLSDWVFSNKNEGKYLDW 438
           +V KEI LL ++ H N+I L  V +NE     Y+V EY V G        +    K    
Sbjct: 52  NVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQE---MLDSVPEKRFPV 108
Query: 439 KQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGE 498
            Q       +  GL YLHS      VHKDI   N+LL +    KI+   +A         
Sbjct: 109 CQAHGYFCQLIDGLEYLHSQGI---VHKDIKPGNLLLTTGGTLKISALGVAEALH----P 161
Query: 499 FAL---TRHIVGTKGYMAPEYLENGLVS---TKLDVYAFGVLILEMLTG 541
           FA     R   G+  +  PE + NGL +    K+D+++ GV +  + TG
Sbjct: 162 FAADDTCRTSQGSPAFQPPE-IANGLDTFSGFKVDIWSAGVTLYNITTG 209

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 51/98 (52%), Gaps = 7/98 (7%)
Query: 445 ALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRH 504
           A ++  GL  LH       V++D+   N+LLD     +I++  +A      EG+    R 
Sbjct: 292 AAEICCGLEDLHRERI---VYRDLKPENILLDDHGHIRISDLGLA--VHVPEGQTIKGR- 345
Query: 505 IVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGK 542
            VGT GYMAPE ++N   +   D +A G L+ EM+ G+
Sbjct: 346 -VGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQ 382

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 44/165 (26%), Positives = 80/165 (48%), Gaps = 20/165 (12%)
Query: 384 KEIALLNKINHSNLIILSGVCFNEG------NCYLVYEYAVNGTLSDWVFSNKNEGKYLD 437
           +E+ L+  +NH N+I L  V   +       + YLV E  ++  L   +         LD
Sbjct: 72  RELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVME-LMDANLCQVIQME------LD 124
Query: 438 WKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEG 497
            ++   +   +  G+ +LHS      +H+D+  SN+++ SD   KI +F +AR A     
Sbjct: 125 HERMSYLLYQMLCGIKHLHSAGI---IHRDLKPSNIVVKSDXTLKILDFGLARTA---GT 178
Query: 498 EFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGK 542
            F +T ++V T+ Y APE +        +D+++ G ++ EM+  K
Sbjct: 179 SFMMTPYVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 46/186 (24%), Positives = 82/186 (44%), Gaps = 32/186 (17%)
Query: 442 IQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMAR-----PAEGQE 496
           I  +  VA G+ +L S      +H+D+ + N+LL  +   KI +F +AR     P   ++
Sbjct: 202 ISYSFQVARGMEFLSSRKC---IHRDLAARNILLSENNVVKICDFGLARDIYKNPDYVRK 258
Query: 497 GEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHL 556
           G+  L         +MAPE + + + STK DV+++GVL+ E+ +   +            
Sbjct: 259 GDTRLPLK------WMAPESIFDKIYSTKSDVWSYGVLLWEIFSLGGSP----------- 301
Query: 557 SDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEH 616
                 V   ED    LR      ++   P      + +++  C  +DP +RP   E+  
Sbjct: 302 ---YPGVQMDEDFCSRLRE----GMRMRAPEYSTPEIYQIMLDCWHRDPKERPRFAELVE 354
Query: 617 SLSNIL 622
            L ++L
Sbjct: 355 KLGDLL 360

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 44/165 (26%), Positives = 80/165 (48%), Gaps = 20/165 (12%)
Query: 384 KEIALLNKINHSNLIILSGVCFNEG------NCYLVYEYAVNGTLSDWVFSNKNEGKYLD 437
           +E+ L+  +NH N+I L  V   +       + YLV E  ++  L   +         LD
Sbjct: 110 RELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVME-LMDANLCQVIQME------LD 162
Query: 438 WKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEG 497
            ++   +   +  G+ +LHS      +H+D+  SN+++ SD   KI +F +AR A     
Sbjct: 163 HERMSYLLYQMLCGIKHLHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLARTA---GT 216
Query: 498 EFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGK 542
            F +T ++V T+ Y APE +        +D+++ G ++ EM+  K
Sbjct: 217 SFMMTPYVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 87/202 (43%), Gaps = 40/202 (19%)
Query: 361 GSVYRG--KINGGFAAIKKVN---------GDVSKEIALLNKINHSNLIILSGVCFNEGN 409
           G VY+    +     AIK++          G   +E++LL ++ H N+I L  V  +   
Sbjct: 48  GEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHR 107
Query: 410 CYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIAL------DVATGLNYLHSFTNPPH 463
            +L++EYA N           +  KY+D    + + +       +  G+N+ HS      
Sbjct: 108 LHLIFEYAEN-----------DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRC--- 153
Query: 464 VHKDINSSNVLLD-SDLRA----KIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLE 518
           +H+D+   N+LL  SD       KI +F +AR       +F    H + T  Y  PE L 
Sbjct: 154 LHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFT---HEIITLWYRPPEILL 210
Query: 519 NGL-VSTKLDVYAFGVLILEML 539
                ST +D+++   +  EML
Sbjct: 211 GSRHYSTSVDIWSIACIWAEML 232

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 44/165 (26%), Positives = 80/165 (48%), Gaps = 20/165 (12%)
Query: 384 KEIALLNKINHSNLIILSGVCFNEG------NCYLVYEYAVNGTLSDWVFSNKNEGKYLD 437
           +E+ L+  +NH N+I L  V   +       + YLV E  ++  L   +         LD
Sbjct: 65  RELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVME-LMDANLXQVIQME------LD 117
Query: 438 WKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEG 497
            ++   +   +  G+ +LHS      +H+D+  SN+++ SD   KI +F +AR A     
Sbjct: 118 HERMSYLLYQMLXGIKHLHSAGI---IHRDLKPSNIVVKSDXTLKILDFGLARTA---GT 171
Query: 498 EFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGK 542
            F +T ++V T+ Y APE +        +D+++ G ++ EM+  K
Sbjct: 172 SFMMTPYVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 51/98 (52%), Gaps = 7/98 (7%)
Query: 445 ALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRH 504
           A ++  GL  LH       V++D+   N+LLD     +I++  +A      EG+    R 
Sbjct: 292 AAEICCGLEDLHRERI---VYRDLKPENILLDDHGHIRISDLGLA--VHVPEGQTIKGR- 345
Query: 505 IVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGK 542
            VGT GYMAPE ++N   +   D +A G L+ EM+ G+
Sbjct: 346 -VGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQ 382

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 44/165 (26%), Positives = 80/165 (48%), Gaps = 20/165 (12%)
Query: 384 KEIALLNKINHSNLIILSGVCFNEG------NCYLVYEYAVNGTLSDWVFSNKNEGKYLD 437
           +E+ L+  +NH N+I L  V   +       + YLV E  ++  L   +         LD
Sbjct: 72  RELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVME-LMDANLXQVIQME------LD 124
Query: 438 WKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEG 497
            ++   +   +  G+ +LHS      +H+D+  SN+++ SD   KI +F +AR A     
Sbjct: 125 HERMSYLLYQMLXGIKHLHSAGI---IHRDLKPSNIVVKSDXTLKILDFGLARTA---GT 178
Query: 498 EFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGK 542
            F +T ++V T+ Y APE +        +D+++ G ++ EM+  K
Sbjct: 179 SFMMTPYVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 43/163 (26%), Positives = 75/163 (46%), Gaps = 14/163 (8%)
Query: 382 VSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQR 441
           + +E  +  K+ H N++ L      E   YLV++    G L + + + +   +  D    
Sbjct: 52  LEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSE-ADASHC 110
Query: 442 IQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRA---KIANFAMARPAEGQEGE 498
           IQ  L+    + Y HS      VH+++   N+LL S  +    K+A+F +A      E  
Sbjct: 111 IQQILE---SIAYCHSNGI---VHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW 164
Query: 499 FALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTG 541
                   GT GY++PE L+    S  +D++A GV++  +L G
Sbjct: 165 HGFA----GTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 203

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 43/164 (26%), Positives = 80/164 (48%), Gaps = 20/164 (12%)
Query: 384 KEIALLNKINHSNLIILSGVCFNEG------NCYLVYEYAVNGTLSDWVFSNKNEGKYLD 437
           +E+ L+  +NH N+I L  V   +       + Y+V E  ++  L   +         LD
Sbjct: 73  RELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVME-LMDANLCQVIQME------LD 125
Query: 438 WKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEG 497
            ++   +   +  G+ +LHS      +H+D+  SN+++ SD   KI +F +AR A     
Sbjct: 126 HERMSYLLYQMLCGIKHLHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLARTAGTS-- 180
Query: 498 EFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTG 541
            F +T ++V T+ Y APE +        +D+++ G ++ EM+ G
Sbjct: 181 -FMMTPYVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 222

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 44/165 (26%), Positives = 80/165 (48%), Gaps = 20/165 (12%)
Query: 384 KEIALLNKINHSNLIILSGVCFNEG------NCYLVYEYAVNGTLSDWVFSNKNEGKYLD 437
           +E+ L+  +NH N+I L  V   +       + YLV E  ++  L   +         LD
Sbjct: 65  RELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVME-LMDANLCQVIQME------LD 117
Query: 438 WKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEG 497
            ++   +   +  G+ +LHS      +H+D+  SN+++ SD   KI +F +AR A     
Sbjct: 118 HERMSYLLYQMLCGIKHLHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLARTA---GT 171
Query: 498 EFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGK 542
            F +T ++V T+ Y APE +        +D+++ G ++ EM+  K
Sbjct: 172 SFMMTPYVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 44/165 (26%), Positives = 80/165 (48%), Gaps = 20/165 (12%)
Query: 384 KEIALLNKINHSNLIILSGVCFNEG------NCYLVYEYAVNGTLSDWVFSNKNEGKYLD 437
           +E+ L+  +NH N+I L  V   +       + YLV E  ++  L   +         LD
Sbjct: 71  RELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVME-LMDANLCQVIQME------LD 123
Query: 438 WKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEG 497
            ++   +   +  G+ +LHS      +H+D+  SN+++ SD   KI +F +AR A     
Sbjct: 124 HERMSYLLYQMLCGIKHLHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLARTA---GT 177
Query: 498 EFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGK 542
            F +T ++V T+ Y APE +        +D+++ G ++ EM+  K
Sbjct: 178 SFMMTPYVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 221

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 44/165 (26%), Positives = 80/165 (48%), Gaps = 20/165 (12%)
Query: 384 KEIALLNKINHSNLIILSGVCFNEG------NCYLVYEYAVNGTLSDWVFSNKNEGKYLD 437
           +E+ L+  +NH N+I L  V   +       + YLV E  ++  L   +         LD
Sbjct: 72  RELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVME-LMDANLCQVIQME------LD 124
Query: 438 WKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEG 497
            ++   +   +  G+ +LHS      +H+D+  SN+++ SD   KI +F +AR A     
Sbjct: 125 HERMSYLLYQMLCGIKHLHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLARTA---GT 178
Query: 498 EFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGK 542
            F +T ++V T+ Y APE +        +D+++ G ++ EM+  K
Sbjct: 179 SFMMTPYVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 43/164 (26%), Positives = 80/164 (48%), Gaps = 20/164 (12%)
Query: 384 KEIALLNKINHSNLIILSGVCFNEG------NCYLVYEYAVNGTLSDWVFSNKNEGKYLD 437
           +E+ L+  +NH N+I L  V   +       + Y+V E  ++  L   +         LD
Sbjct: 72  RELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVME-LMDANLCQVIQME------LD 124
Query: 438 WKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEG 497
            ++   +   +  G+ +LHS      +H+D+  SN+++ SD   KI +F +AR A     
Sbjct: 125 HERMSYLLYQMLCGIKHLHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLARTAGTS-- 179
Query: 498 EFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTG 541
            F +T ++V T+ Y APE +        +D+++ G ++ EM+ G
Sbjct: 180 -FMMTPYVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 43/163 (26%), Positives = 75/163 (46%), Gaps = 14/163 (8%)
Query: 382 VSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQR 441
           + +E  +  K+ H N++ L      E   YLV++    G L + + + +   +  D    
Sbjct: 52  LEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSE-ADASHC 110
Query: 442 IQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRA---KIANFAMARPAEGQEGE 498
           IQ  L+    + Y HS      VH+++   N+LL S  +    K+A+F +A      E  
Sbjct: 111 IQQILE---SIAYCHSNGI---VHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW 164
Query: 499 FALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTG 541
                   GT GY++PE L+    S  +D++A GV++  +L G
Sbjct: 165 HGFA----GTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 203

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 44/165 (26%), Positives = 80/165 (48%), Gaps = 20/165 (12%)
Query: 384 KEIALLNKINHSNLIILSGVCFNEG------NCYLVYEYAVNGTLSDWVFSNKNEGKYLD 437
           +E+ L+  +NH N+I L  V   +       + YLV E  ++  L   +         LD
Sbjct: 66  RELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVME-LMDANLCQVIQME------LD 118
Query: 438 WKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEG 497
            ++   +   +  G+ +LHS      +H+D+  SN+++ SD   KI +F +AR A     
Sbjct: 119 HERMSYLLYQMLCGIKHLHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLARTA---GT 172
Query: 498 EFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGK 542
            F +T ++V T+ Y APE +        +D+++ G ++ EM+  K
Sbjct: 173 SFMMTPYVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 216

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 43/163 (26%), Positives = 75/163 (46%), Gaps = 14/163 (8%)
Query: 382 VSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQR 441
           + +E  +  K+ H N++ L      E   YLV++    G L + + + +   +  D    
Sbjct: 51  LEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSE-ADASHC 109
Query: 442 IQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRA---KIANFAMARPAEGQEGE 498
           IQ  L+    + Y HS      VH+++   N+LL S  +    K+A+F +A      E  
Sbjct: 110 IQQILE---SIAYCHSNGI---VHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW 163
Query: 499 FALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTG 541
                   GT GY++PE L+    S  +D++A GV++  +L G
Sbjct: 164 HGFA----GTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 202

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 44/165 (26%), Positives = 80/165 (48%), Gaps = 20/165 (12%)
Query: 384 KEIALLNKINHSNLIILSGVCFNEG------NCYLVYEYAVNGTLSDWVFSNKNEGKYLD 437
           +E+ L+  +NH N+I L  V   +       + YLV E  ++  L   +         LD
Sbjct: 73  RELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVME-LMDANLCQVIQME------LD 125
Query: 438 WKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEG 497
            ++   +   +  G+ +LHS      +H+D+  SN+++ SD   KI +F +AR A     
Sbjct: 126 HERMSYLLYQMLCGIKHLHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLARTA---GT 179
Query: 498 EFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGK 542
            F +T ++V T+ Y APE +        +D+++ G ++ EM+  K
Sbjct: 180 SFMMTPYVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 223

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 44/165 (26%), Positives = 80/165 (48%), Gaps = 20/165 (12%)
Query: 384 KEIALLNKINHSNLIILSGVCFNEG------NCYLVYEYAVNGTLSDWVFSNKNEGKYLD 437
           +E+ L+  +NH N+I L  V   +       + YLV E  ++  L   +         LD
Sbjct: 73  RELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVME-LMDANLCQVIQME------LD 125
Query: 438 WKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEG 497
            ++   +   +  G+ +LHS      +H+D+  SN+++ SD   KI +F +AR A     
Sbjct: 126 HERMSYLLYQMLCGIKHLHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLARTA---GT 179
Query: 498 EFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGK 542
            F +T ++V T+ Y APE +        +D+++ G ++ EM+  K
Sbjct: 180 SFMMTPYVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 223

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 44/165 (26%), Positives = 80/165 (48%), Gaps = 20/165 (12%)
Query: 384 KEIALLNKINHSNLIILSGVCFNEG------NCYLVYEYAVNGTLSDWVFSNKNEGKYLD 437
           +E+ L+  +NH N+I L  V   +       + YLV E  ++  L   +         LD
Sbjct: 72  RELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVME-LMDANLCQVIQME------LD 124
Query: 438 WKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEG 497
            ++   +   +  G+ +LHS      +H+D+  SN+++ SD   KI +F +AR A     
Sbjct: 125 HERMSYLLYQMLCGIKHLHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLARTA---GT 178
Query: 498 EFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGK 542
            F +T ++V T+ Y APE +        +D+++ G ++ EM+  K
Sbjct: 179 SFMMTPYVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 44/165 (26%), Positives = 80/165 (48%), Gaps = 20/165 (12%)
Query: 384 KEIALLNKINHSNLIILSGVCFNEG------NCYLVYEYAVNGTLSDWVFSNKNEGKYLD 437
           +E+ L+  +NH N+I L  V   +       + YLV E  ++  L   +         LD
Sbjct: 66  RELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVME-LMDANLCQVIQME------LD 118
Query: 438 WKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEG 497
            ++   +   +  G+ +LHS      +H+D+  SN+++ SD   KI +F +AR A     
Sbjct: 119 HERMSYLLYQMLCGIKHLHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLARTA---GT 172
Query: 498 EFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGK 542
            F +T ++V T+ Y APE +        +D+++ G ++ EM+  K
Sbjct: 173 SFMMTPYVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 216

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 43/164 (26%), Positives = 80/164 (48%), Gaps = 20/164 (12%)
Query: 384 KEIALLNKINHSNLIILSGVCFNEG------NCYLVYEYAVNGTLSDWVFSNKNEGKYLD 437
           +E+ L+  +NH N+I L  V   +       + Y+V E  ++  L   +         LD
Sbjct: 72  RELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVME-LMDANLCQVIQME------LD 124
Query: 438 WKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEG 497
            ++   +   +  G+ +LHS      +H+D+  SN+++ SD   KI +F +AR A     
Sbjct: 125 HERMSYLLYQMLCGIKHLHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLARTAGTS-- 179
Query: 498 EFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTG 541
            F +T ++V T+ Y APE +        +D+++ G ++ EM+ G
Sbjct: 180 -FMMTPYVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 43/163 (26%), Positives = 75/163 (46%), Gaps = 14/163 (8%)
Query: 382 VSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQR 441
           + +E  +  K+ H N++ L      E   YLV++    G L + + + +   +  D    
Sbjct: 75  LEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSE-ADASHC 133
Query: 442 IQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRA---KIANFAMARPAEGQEGE 498
           IQ  L+    + Y HS      VH+++   N+LL S  +    K+A+F +A      E  
Sbjct: 134 IQQILE---SIAYCHSNGI---VHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW 187
Query: 499 FALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTG 541
                   GT GY++PE L+    S  +D++A GV++  +L G
Sbjct: 188 HGF----AGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 226

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/172 (27%), Positives = 76/172 (44%), Gaps = 15/172 (8%)
Query: 375 IKKVNGDVSKEIALLNKI-NHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEG 433
           I K   D S+EI +L +   H N+I L  V  +  + YLV E    G L D +   K   
Sbjct: 60  IDKSKRDPSEEIEILLRYGQHPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQK--- 116
Query: 434 KYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVL-LDSDLRA---KIANFAMA 489
            +   ++   +   +   + YLHS      VH+D+  SN+L +D        +I +F  A
Sbjct: 117 -FFSEREASFVLHTIGKTVEYLHSQGV---VHRDLKPSNILYVDESGNPECLRICDFGFA 172
Query: 490 RPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTG 541
           +    + G   L      T  ++APE L+        D+++ G+L+  ML G
Sbjct: 173 KQLRAENG---LLMTPCYTANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAG 221

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/172 (27%), Positives = 76/172 (44%), Gaps = 15/172 (8%)
Query: 375 IKKVNGDVSKEIALLNKI-NHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEG 433
           I K   D S+EI +L +   H N+I L  V  +  + YLV E    G L D +   K   
Sbjct: 60  IDKSKRDPSEEIEILLRYGQHPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQK--- 116
Query: 434 KYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVL-LDSDLRA---KIANFAMA 489
            +   ++   +   +   + YLHS      VH+D+  SN+L +D        +I +F  A
Sbjct: 117 -FFSEREASFVLHTIGKTVEYLHSQGV---VHRDLKPSNILYVDESGNPECLRICDFGFA 172
Query: 490 RPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTG 541
           +    + G   L      T  ++APE L+        D+++ G+L+  ML G
Sbjct: 173 KQLRAENG---LLMTPCYTANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAG 221

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 43/164 (26%), Positives = 79/164 (48%), Gaps = 20/164 (12%)
Query: 384 KEIALLNKINHSNLIILSGVCFNEG------NCYLVYEYAVNGTLSDWVFSNKNEGKYLD 437
           +E+ L+  +NH N+I L  V   +       + Y+V E  ++  L   +         LD
Sbjct: 72  RELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMEL-MDANLCQVIQME------LD 124
Query: 438 WKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEG 497
            ++   +   +  G+ +LHS      +H+D+  SN+++ SD   KI +F +AR A     
Sbjct: 125 HERMSYLLYQMLCGIKHLHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLARTAGTS-- 179
Query: 498 EFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTG 541
            F +T  +V T+ Y APE +        +D+++ G ++ EM+ G
Sbjct: 180 -FMMTPEVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 40/165 (24%), Positives = 78/165 (47%), Gaps = 20/165 (12%)
Query: 384 KEIALLNKINHSNLIILSGV-----CFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDW 438
           +E+ LL  + H N+I L  V        E N   +  + +   L++ V   K    ++ +
Sbjct: 70  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 129
Query: 439 KQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGE 498
                +   +  GL Y+HS      +H+D+  SN+ ++ D   KI +  +AR  + +   
Sbjct: 130 -----LIYQILRGLKYIHSADI---IHRDLKPSNLAVNEDCELKILDAGLARHTDDEMTG 181
Query: 499 FALTRHIVGTKGYMAPEYLENGL-VSTKLDVYAFGVLILEMLTGK 542
           +      V T+ Y APE + N +  +  +D+++ G ++ E+LTG+
Sbjct: 182 Y------VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 40/165 (24%), Positives = 78/165 (47%), Gaps = 20/165 (12%)
Query: 384 KEIALLNKINHSNLIILSGV-----CFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDW 438
           +E+ LL  + H N+I L  V        E N   +  + +   L++ V   K    ++ +
Sbjct: 70  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 129
Query: 439 KQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGE 498
                +   +  GL Y+HS      +H+D+  SN+ ++ D   KI +  +AR  + +   
Sbjct: 130 -----LIYQILRGLKYIHSADI---IHRDLKPSNLAVNEDCELKILDRGLARHTDDEMTG 181
Query: 499 FALTRHIVGTKGYMAPEYLENGL-VSTKLDVYAFGVLILEMLTGK 542
           +      V T+ Y APE + N +  +  +D+++ G ++ E+LTG+
Sbjct: 182 Y------VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 45/162 (27%), Positives = 74/162 (45%), Gaps = 15/162 (9%)
Query: 383 SKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRI 442
            +EI ++  ++H N+I L     +  + YLV E    G L    F      +        
Sbjct: 54  KQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGEL----FERVVHKRVFRESDAA 109
Query: 443 QIALDVATGLNYLHSFTNPPHVHKDINSSNVLL--DS-DLRAKIANFAMARPAEGQEGEF 499
           +I  DV + + Y H        H+D+   N L   DS D   K+ +F +A  A  + G+ 
Sbjct: 110 RIMKDVLSAVAYCHKLNV---AHRDLKPENFLFLTDSPDSPLKLIDFGLA--ARFKPGKM 164
Query: 500 ALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTG 541
             T+  VGT  Y++P+ LE GL   + D ++ GV++  +L G
Sbjct: 165 MRTK--VGTPYYVSPQVLE-GLYGPECDEWSAGVMMYVLLCG 203

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 45/162 (27%), Positives = 74/162 (45%), Gaps = 15/162 (9%)
Query: 383 SKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRI 442
            +EI ++  ++H N+I L     +  + YLV E    G L    F      +        
Sbjct: 71  KQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGEL----FERVVHKRVFRESDAA 126
Query: 443 QIALDVATGLNYLHSFTNPPHVHKDINSSNVLL--DS-DLRAKIANFAMARPAEGQEGEF 499
           +I  DV + + Y H        H+D+   N L   DS D   K+ +F +A  A  + G+ 
Sbjct: 127 RIMKDVLSAVAYCHKLNV---AHRDLKPENFLFLTDSPDSPLKLIDFGLA--ARFKPGKM 181
Query: 500 ALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTG 541
             T+  VGT  Y++P+ LE GL   + D ++ GV++  +L G
Sbjct: 182 MRTK--VGTPYYVSPQVLE-GLYGPECDEWSAGVMMYVLLCG 220

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 100/209 (47%), Gaps = 31/209 (14%)
Query: 384 KEIALLNKINHSNLIILSGVCFNEGN--------------CYLVYEYAVNGTLSDWVFSN 429
           +EI ++ +++H N++ +  +    G+               Y+V EY +   L++ +   
Sbjct: 57  REIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEY-METDLANVL--- 112
Query: 430 KNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDS-DLRAKIANFAM 488
             +G  L+   R+     +  GL Y+HS      +H+D+  +N+ +++ DL  KI +F +
Sbjct: 113 -EQGPLLEEHARL-FMYQLLRGLKYIHSANV---LHRDLKPANLFINTEDLVLKIGDFGL 167
Query: 489 AR---PAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTK-LDVYAFGVLILEMLTGKEA 544
           AR   P    +G   L+  +V TK Y +P  L +    TK +D++A G +  EMLTGK  
Sbjct: 168 ARIMDPHYSHKGH--LSEGLV-TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTL 224
Query: 545 AALHAEENNMHLSDVLNAVLTKEDGEESL 573
            A   E   M L      V+ +ED +E L
Sbjct: 225 FAGAHELEQMQLILESIPVVHEEDRQELL 253

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 45/172 (26%), Positives = 74/172 (43%), Gaps = 15/172 (8%)
Query: 375 IKKVNGDVSKEIALLNKI-NHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEG 433
           I K   D ++EI +L +   H N+I L  V  +    Y+V E    G L D +   K   
Sbjct: 55  IDKSKRDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELXKGGELLDKILRQK--- 111
Query: 434 KYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDL----RAKIANFAMA 489
            +   ++   +   +   + YLH+      VH+D+  SN+L   +       +I +F  A
Sbjct: 112 -FFSEREASAVLFTITKTVEYLHAQGV---VHRDLKPSNILYVDESGNPESIRICDFGFA 167
Query: 490 RPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTG 541
           +    + G   L      T  ++APE LE        D+++ GVL+   LTG
Sbjct: 168 KQLRAENG---LLXTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTXLTG 216

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/196 (26%), Positives = 95/196 (48%), Gaps = 23/196 (11%)
Query: 361 GSVYRGKI--NGGFAAIKKVNGDV---SKEIALLNKINHSNLIILSGVCFNEGNCY-LVY 414
           G VY+ K+  +G   AIKKV  D    ++E+ ++ K++H N++ L    ++ G     VY
Sbjct: 35  GVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 94
Query: 415 EYAVNGTLSDWVFSNKNEGKYLDWKQRIQI------ALDVATGLNYLHSFTNPPHVHKDI 468
              V   + + V+  +    Y   KQ + +         +   L Y+HSF      H+DI
Sbjct: 95  LNLVLDYVPETVY--RVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGI---CHRDI 149
Query: 469 NSSNVLLDSDLRA-KIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGL-VSTKL 526
              N+LLD D    K+ +F  A+  +   GE  ++   + ++ Y APE +      ++ +
Sbjct: 150 KPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVS--XICSRYYRAPELIFGATDYTSSI 205
Query: 527 DVYAFGVLILEMLTGK 542
           DV++ G ++ E+L G+
Sbjct: 206 DVWSAGCVLAELLLGQ 221

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 40/165 (24%), Positives = 78/165 (47%), Gaps = 20/165 (12%)
Query: 384 KEIALLNKINHSNLIILSGV-----CFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDW 438
           +E+ LL  + H N+I L  V        E N   +  + +   L++ V   K    ++ +
Sbjct: 70  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 129
Query: 439 KQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGE 498
                +   +  GL Y+HS      +H+D+  SN+ ++ D   KI +  +AR  + +   
Sbjct: 130 -----LIYQILRGLKYIHSADI---IHRDLKPSNLAVNEDCELKILDGGLARHTDDEMTG 181
Query: 499 FALTRHIVGTKGYMAPEYLENGL-VSTKLDVYAFGVLILEMLTGK 542
           +      V T+ Y APE + N +  +  +D+++ G ++ E+LTG+
Sbjct: 182 Y------VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/196 (26%), Positives = 95/196 (48%), Gaps = 23/196 (11%)
Query: 361 GSVYRGKI--NGGFAAIKKVNGDV---SKEIALLNKINHSNLIILSGVCFNEGNCY-LVY 414
           G VY+ K+  +G   AIKKV  D    ++E+ ++ K++H N++ L    ++ G     VY
Sbjct: 34  GVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 93
Query: 415 EYAVNGTLSDWVFSNKNEGKYLDWKQRIQI------ALDVATGLNYLHSFTNPPHVHKDI 468
              V   + + V+  +    Y   KQ + +         +   L Y+HSF      H+DI
Sbjct: 94  LNLVLDYVPETVY--RVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGI---CHRDI 148
Query: 469 NSSNVLLDSDLRA-KIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGL-VSTKL 526
              N+LLD D    K+ +F  A+  +   GE  ++   + ++ Y APE +      ++ +
Sbjct: 149 KPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVS--XICSRYYRAPELIFGATDYTSSI 204
Query: 527 DVYAFGVLILEMLTGK 542
           DV++ G ++ E+L G+
Sbjct: 205 DVWSAGCVLAELLLGQ 220

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 35/143 (24%), Positives = 63/143 (44%), Gaps = 23/143 (16%)
Query: 411 YLVYEYAVNGTLSDWV-----FSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVH 465
           Y+  +      L DW+       ++  G  L       I + +A  + +LHS      +H
Sbjct: 137 YIQMQLCRKENLKDWMNRRCSLEDREHGVCL------HIFIQIAEAVEFLHSKG---LMH 187
Query: 466 KDINSSNVLLDSDLRAKIANFAMARPAEGQEGE---------FALTRHIVGTKGYMAPEY 516
           +D+  SN+    D   K+ +F +    +  E E         +A     VGTK YM+PE 
Sbjct: 188 RDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHXGQVGTKLYMSPEQ 247
Query: 517 LENGLVSTKLDVYAFGVLILEML 539
           +     S K+D+++ G+++ E+L
Sbjct: 248 IHGNNYSHKVDIFSLGLILFELL 270

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/196 (26%), Positives = 95/196 (48%), Gaps = 23/196 (11%)
Query: 361 GSVYRGKI--NGGFAAIKKVNGDV---SKEIALLNKINHSNLIILSGVCFNEGNCY-LVY 414
           G VY+ K+  +G   AIKKV  D    ++E+ ++ K++H N++ L    ++ G     VY
Sbjct: 34  GVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 93
Query: 415 EYAVNGTLSDWVFSNKNEGKYLDWKQRIQI------ALDVATGLNYLHSFTNPPHVHKDI 468
              V   + + V+  +    Y   KQ + +         +   L Y+HSF      H+DI
Sbjct: 94  LNLVLDYVPETVY--RVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGI---CHRDI 148
Query: 469 NSSNVLLDSDLRA-KIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGL-VSTKL 526
              N+LLD D    K+ +F  A+  +   GE  ++   + ++ Y APE +      ++ +
Sbjct: 149 KPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVS--XICSRYYRAPELIFGATDYTSSI 204
Query: 527 DVYAFGVLILEMLTGK 542
           DV++ G ++ E+L G+
Sbjct: 205 DVWSAGCVLAELLLGQ 220

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/196 (26%), Positives = 95/196 (48%), Gaps = 23/196 (11%)
Query: 361 GSVYRGKI--NGGFAAIKKVNGDV---SKEIALLNKINHSNLIILSGVCFNEGNCY-LVY 414
           G VY+ K+  +G   AIKKV  D    ++E+ ++ K++H N++ L    ++ G     VY
Sbjct: 34  GVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 93
Query: 415 EYAVNGTLSDWVFSNKNEGKYLDWKQRIQI------ALDVATGLNYLHSFTNPPHVHKDI 468
              V   + + V+  +    Y   KQ + +         +   L Y+HSF      H+DI
Sbjct: 94  LNLVLDYVPETVY--RVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGI---CHRDI 148
Query: 469 NSSNVLLDSDLRA-KIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGL-VSTKL 526
              N+LLD D    K+ +F  A+  +   GE  ++   + ++ Y APE +      ++ +
Sbjct: 149 KPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVS--YICSRYYRAPELIFGATDYTSSI 204
Query: 527 DVYAFGVLILEMLTGK 542
           DV++ G ++ E+L G+
Sbjct: 205 DVWSAGCVLAELLLGQ 220

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/196 (26%), Positives = 95/196 (48%), Gaps = 23/196 (11%)
Query: 361 GSVYRGKI--NGGFAAIKKVNGDV---SKEIALLNKINHSNLIILSGVCFNEGNCY-LVY 414
           G VY+ K+  +G   AIKKV  D    ++E+ ++ K++H N++ L    ++ G     VY
Sbjct: 46  GVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 105
Query: 415 EYAVNGTLSDWVFSNKNEGKYLDWKQRIQI------ALDVATGLNYLHSFTNPPHVHKDI 468
              V   + + V+  +    Y   KQ + +         +   L Y+HSF      H+DI
Sbjct: 106 LNLVLDYVPETVY--RVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGI---CHRDI 160
Query: 469 NSSNVLLDSDLRA-KIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGL-VSTKL 526
              N+LLD D    K+ +F  A+  +   GE  ++   + ++ Y APE +      ++ +
Sbjct: 161 KPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVS--XICSRYYRAPELIFGATDYTSSI 216
Query: 527 DVYAFGVLILEMLTGK 542
           DV++ G ++ E+L G+
Sbjct: 217 DVWSAGCVLAELLLGQ 232

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/196 (26%), Positives = 95/196 (48%), Gaps = 23/196 (11%)
Query: 361 GSVYRGKI--NGGFAAIKKVNGDV---SKEIALLNKINHSNLIILSGVCFNEGNCY-LVY 414
           G VY+ K+  +G   AIKKV  D    ++E+ ++ K++H N++ L    ++ G     VY
Sbjct: 62  GVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 121
Query: 415 EYAVNGTLSDWVFSNKNEGKYLDWKQRIQI------ALDVATGLNYLHSFTNPPHVHKDI 468
              V   + + V+  +    Y   KQ + +         +   L Y+HSF      H+DI
Sbjct: 122 LNLVLDYVPETVY--RVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGI---CHRDI 176
Query: 469 NSSNVLLDSDLRA-KIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGL-VSTKL 526
              N+LLD D    K+ +F  A+  +   GE  ++   + ++ Y APE +      ++ +
Sbjct: 177 KPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVS--YICSRYYRAPELIFGATDYTSSI 232
Query: 527 DVYAFGVLILEMLTGK 542
           DV++ G ++ E+L G+
Sbjct: 233 DVWSAGCVLAELLLGQ 248

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/196 (26%), Positives = 95/196 (48%), Gaps = 23/196 (11%)
Query: 361 GSVYRGKI--NGGFAAIKKVNGDV---SKEIALLNKINHSNLIILSGVCFNEGNCY-LVY 414
           G VY+ K+  +G   AIKKV  D    ++E+ ++ K++H N++ L    ++ G     VY
Sbjct: 47  GVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 106
Query: 415 EYAVNGTLSDWVFSNKNEGKYLDWKQRIQI------ALDVATGLNYLHSFTNPPHVHKDI 468
              V   + + V+  +    Y   KQ + +         +   L Y+HSF      H+DI
Sbjct: 107 LNLVLDYVPETVY--RVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGI---CHRDI 161
Query: 469 NSSNVLLDSDLRA-KIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGL-VSTKL 526
              N+LLD D    K+ +F  A+  +   GE  ++   + ++ Y APE +      ++ +
Sbjct: 162 KPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVS--YICSRYYRAPELIFGATDYTSSI 217
Query: 527 DVYAFGVLILEMLTGK 542
           DV++ G ++ E+L G+
Sbjct: 218 DVWSAGCVLAELLLGQ 233

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/196 (26%), Positives = 95/196 (48%), Gaps = 23/196 (11%)
Query: 361 GSVYRGKI--NGGFAAIKKVNGDV---SKEIALLNKINHSNLIILSGVCFNEGNCY-LVY 414
           G VY+ K+  +G   AIKKV  D    ++E+ ++ K++H N++ L    ++ G     VY
Sbjct: 68  GVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 127
Query: 415 EYAVNGTLSDWVFSNKNEGKYLDWKQRIQI------ALDVATGLNYLHSFTNPPHVHKDI 468
              V   + + V+  +    Y   KQ + +         +   L Y+HSF      H+DI
Sbjct: 128 LNLVLDYVPETVY--RVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGI---CHRDI 182
Query: 469 NSSNVLLDSDLRA-KIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGL-VSTKL 526
              N+LLD D    K+ +F  A+  +   GE  ++   + ++ Y APE +      ++ +
Sbjct: 183 KPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVS--XICSRYYRAPELIFGATDYTSSI 238
Query: 527 DVYAFGVLILEMLTGK 542
           DV++ G ++ E+L G+
Sbjct: 239 DVWSAGCVLAELLLGQ 254

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/196 (26%), Positives = 95/196 (48%), Gaps = 23/196 (11%)
Query: 361 GSVYRGKI--NGGFAAIKKVNGDV---SKEIALLNKINHSNLIILSGVCFNEGNCY-LVY 414
           G VY+ K+  +G   AIKKV  D    ++E+ ++ K++H N++ L    ++ G     VY
Sbjct: 42  GVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 101
Query: 415 EYAVNGTLSDWVFSNKNEGKYLDWKQRIQI------ALDVATGLNYLHSFTNPPHVHKDI 468
              V   + + V+  +    Y   KQ + +         +   L Y+HSF      H+DI
Sbjct: 102 LNLVLDYVPETVY--RVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGI---CHRDI 156
Query: 469 NSSNVLLDSDLRA-KIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGL-VSTKL 526
              N+LLD D    K+ +F  A+  +   GE  ++   + ++ Y APE +      ++ +
Sbjct: 157 KPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVS--XICSRYYRAPELIFGATDYTSSI 212
Query: 527 DVYAFGVLILEMLTGK 542
           DV++ G ++ E+L G+
Sbjct: 213 DVWSAGCVLAELLLGQ 228

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 45/192 (23%), Positives = 86/192 (44%), Gaps = 23/192 (11%)
Query: 361 GSVYRGK--INGGFAAIKKVNG-------DVSKEIALLNKINHSNLIILSGVCFNEGNCY 411
           G VY+ K    G  AA K +         D   EI +L   +H  ++ L G  +++G  +
Sbjct: 25  GKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLW 84
Query: 412 LVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSS 471
           ++ E+   G + D +    + G  L   Q   +   +   LN+LHS      +H+D+ + 
Sbjct: 85  IMIEFCPGGAV-DAIMLELDRG--LTEPQIQVVCRQMLEALNFLHSKRI---IHRDLKAG 138
Query: 472 NVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEY-----LENGLVSTKL 526
           NVL+  +   ++A+F +   +             +GT  +MAPE      +++     K 
Sbjct: 139 NVLMTLEGDIRLADFGV---SAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKA 195
Query: 527 DVYAFGVLILEM 538
           D+++ G+ ++EM
Sbjct: 196 DIWSLGITLIEM 207

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/196 (26%), Positives = 95/196 (48%), Gaps = 23/196 (11%)
Query: 361 GSVYRGKI--NGGFAAIKKVNGDV---SKEIALLNKINHSNLIILSGVCFNEGNCY-LVY 414
           G VY+ K+  +G   AIKKV  D    ++E+ ++ K++H N++ L    ++ G     VY
Sbjct: 53  GVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 112
Query: 415 EYAVNGTLSDWVFSNKNEGKYLDWKQRIQI------ALDVATGLNYLHSFTNPPHVHKDI 468
              V   + + V+  +    Y   KQ + +         +   L Y+HSF      H+DI
Sbjct: 113 LNLVLDYVPETVY--RVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGI---CHRDI 167
Query: 469 NSSNVLLDSDLRA-KIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGL-VSTKL 526
              N+LLD D    K+ +F  A+  +   GE  ++   + ++ Y APE +      ++ +
Sbjct: 168 KPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVS--XICSRYYRAPELIFGATDYTSSI 223
Query: 527 DVYAFGVLILEMLTGK 542
           DV++ G ++ E+L G+
Sbjct: 224 DVWSAGCVLAELLLGQ 239

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/196 (26%), Positives = 95/196 (48%), Gaps = 23/196 (11%)
Query: 361 GSVYRGKI--NGGFAAIKKVNGDV---SKEIALLNKINHSNLIILSGVCFNEGNCY-LVY 414
           G VY+ K+  +G   AIKKV  D    ++E+ ++ K++H N++ L    ++ G     VY
Sbjct: 46  GVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 105
Query: 415 EYAVNGTLSDWVFSNKNEGKYLDWKQRIQI------ALDVATGLNYLHSFTNPPHVHKDI 468
              V   + + V+  +    Y   KQ + +         +   L Y+HSF      H+DI
Sbjct: 106 LNLVLDYVPETVY--RVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGI---CHRDI 160
Query: 469 NSSNVLLDSDLRA-KIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGL-VSTKL 526
              N+LLD D    K+ +F  A+  +   GE  ++   + ++ Y APE +      ++ +
Sbjct: 161 KPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVS--XICSRYYRAPELIFGATDYTSSI 216
Query: 527 DVYAFGVLILEMLTGK 542
           DV++ G ++ E+L G+
Sbjct: 217 DVWSAGCVLAELLLGQ 232

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/196 (26%), Positives = 95/196 (48%), Gaps = 23/196 (11%)
Query: 361 GSVYRGKI--NGGFAAIKKVNGDV---SKEIALLNKINHSNLIILSGVCFNEGNCY-LVY 414
           G VY+ K+  +G   AIKKV  D    ++E+ ++ K++H N++ L    ++ G     VY
Sbjct: 38  GVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 97
Query: 415 EYAVNGTLSDWVFSNKNEGKYLDWKQRIQI------ALDVATGLNYLHSFTNPPHVHKDI 468
              V   + + V+  +    Y   KQ + +         +   L Y+HSF      H+DI
Sbjct: 98  LNLVLDYVPETVY--RVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGI---CHRDI 152
Query: 469 NSSNVLLDSDLRA-KIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGL-VSTKL 526
              N+LLD D    K+ +F  A+  +   GE  ++   + ++ Y APE +      ++ +
Sbjct: 153 KPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVS--XICSRYYRAPELIFGATDYTSSI 208
Query: 527 DVYAFGVLILEMLTGK 542
           DV++ G ++ E+L G+
Sbjct: 209 DVWSAGCVLAELLLGQ 224

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/196 (26%), Positives = 95/196 (48%), Gaps = 23/196 (11%)
Query: 361 GSVYRGKI--NGGFAAIKKVNGDV---SKEIALLNKINHSNLIILSGVCFNEGNCY-LVY 414
           G VY+ K+  +G   AIKKV  D    ++E+ ++ K++H N++ L    ++ G     VY
Sbjct: 68  GVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 127
Query: 415 EYAVNGTLSDWVFSNKNEGKYLDWKQRIQI------ALDVATGLNYLHSFTNPPHVHKDI 468
              V   + + V+  +    Y   KQ + +         +   L Y+HSF      H+DI
Sbjct: 128 LNLVLDYVPETVY--RVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGI---CHRDI 182
Query: 469 NSSNVLLDSDLRA-KIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGL-VSTKL 526
              N+LLD D    K+ +F  A+  +   GE  ++   + ++ Y APE +      ++ +
Sbjct: 183 KPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVS--YICSRYYRAPELIFGATDYTSSI 238
Query: 527 DVYAFGVLILEMLTGK 542
           DV++ G ++ E+L G+
Sbjct: 239 DVWSAGCVLAELLLGQ 254

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/196 (26%), Positives = 95/196 (48%), Gaps = 23/196 (11%)
Query: 361 GSVYRGKI--NGGFAAIKKVNGDV---SKEIALLNKINHSNLIILSGVCFNEGNCY-LVY 414
           G VY+ K+  +G   AIKKV  D    ++E+ ++ K++H N++ L    ++ G     VY
Sbjct: 70  GVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 129
Query: 415 EYAVNGTLSDWVFSNKNEGKYLDWKQRIQI------ALDVATGLNYLHSFTNPPHVHKDI 468
              V   + + V+  +    Y   KQ + +         +   L Y+HSF      H+DI
Sbjct: 130 LNLVLDYVPETVY--RVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGI---CHRDI 184
Query: 469 NSSNVLLDSDLRA-KIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGL-VSTKL 526
              N+LLD D    K+ +F  A+  +   GE  ++   + ++ Y APE +      ++ +
Sbjct: 185 KPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVS--YICSRYYRAPELIFGATDYTSSI 240
Query: 527 DVYAFGVLILEMLTGK 542
           DV++ G ++ E+L G+
Sbjct: 241 DVWSAGCVLAELLLGQ 256

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 40/164 (24%), Positives = 74/164 (45%), Gaps = 9/164 (5%)
Query: 381 DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQ 440
           D+ +E ++ + + H +++ L     ++G  Y+V+E+     L   +    + G       
Sbjct: 72  DLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAV 131
Query: 441 RIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRA---KIANFAMARPAEGQEG 497
                  +   L Y H       +H+D+   NVLL S   +   K+ +F +A    G+ G
Sbjct: 132 ASHYMRQILEALRYCHDNNI---IHRDVKPENVLLASKENSAPVKLGDFGVAIQL-GESG 187
Query: 498 EFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTG 541
             A  R  VGT  +MAPE ++       +DV+  GV++  +L+G
Sbjct: 188 LVAGGR--VGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSG 229

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/196 (26%), Positives = 95/196 (48%), Gaps = 23/196 (11%)
Query: 361 GSVYRGKI--NGGFAAIKKVNGDV---SKEIALLNKINHSNLIILSGVCFNEGNCY-LVY 414
           G VY+ K+  +G   AIKKV  D    ++E+ ++ K++H N++ L    ++ G     VY
Sbjct: 39  GVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 98
Query: 415 EYAVNGTLSDWVFSNKNEGKYLDWKQRIQI------ALDVATGLNYLHSFTNPPHVHKDI 468
              V   + + V+  +    Y   KQ + +         +   L Y+HSF      H+DI
Sbjct: 99  LNLVLDYVPETVY--RVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGI---CHRDI 153
Query: 469 NSSNVLLDSDLRA-KIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGL-VSTKL 526
              N+LLD D    K+ +F  A+  +   GE  ++   + ++ Y APE +      ++ +
Sbjct: 154 KPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVS--YICSRYYRAPELIFGATDYTSSI 209
Query: 527 DVYAFGVLILEMLTGK 542
           DV++ G ++ E+L G+
Sbjct: 210 DVWSAGCVLAELLLGQ 225

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 45/192 (23%), Positives = 86/192 (44%), Gaps = 23/192 (11%)
Query: 361 GSVYRGK--INGGFAAIKKVNG-------DVSKEIALLNKINHSNLIILSGVCFNEGNCY 411
           G VY+ K    G  AA K +         D   EI +L   +H  ++ L G  +++G  +
Sbjct: 33  GKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLW 92
Query: 412 LVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSS 471
           ++ E+   G + D +    + G  L   Q   +   +   LN+LHS      +H+D+ + 
Sbjct: 93  IMIEFCPGGAV-DAIMLELDRG--LTEPQIQVVCRQMLEALNFLHSKRI---IHRDLKAG 146
Query: 472 NVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEY-----LENGLVSTKL 526
           NVL+  +   ++A+F +   +             +GT  +MAPE      +++     K 
Sbjct: 147 NVLMTLEGDIRLADFGV---SAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKA 203
Query: 527 DVYAFGVLILEM 538
           D+++ G+ ++EM
Sbjct: 204 DIWSLGITLIEM 215

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/196 (26%), Positives = 95/196 (48%), Gaps = 23/196 (11%)
Query: 361 GSVYRGKI--NGGFAAIKKVNGDV---SKEIALLNKINHSNLIILSGVCFNEGNCY-LVY 414
           G VY+ K+  +G   AIKKV  D    ++E+ ++ K++H N++ L    ++ G     VY
Sbjct: 72  GVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 131
Query: 415 EYAVNGTLSDWVFSNKNEGKYLDWKQRIQI------ALDVATGLNYLHSFTNPPHVHKDI 468
              V   + + V+  +    Y   KQ + +         +   L Y+HSF      H+DI
Sbjct: 132 LNLVLDYVPETVY--RVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGI---CHRDI 186
Query: 469 NSSNVLLDSDLRA-KIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGL-VSTKL 526
              N+LLD D    K+ +F  A+  +   GE  ++   + ++ Y APE +      ++ +
Sbjct: 187 KPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVS--YICSRYYRAPELIFGATDYTSSI 242
Query: 527 DVYAFGVLILEMLTGK 542
           DV++ G ++ E+L G+
Sbjct: 243 DVWSAGCVLAELLLGQ 258

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/196 (26%), Positives = 95/196 (48%), Gaps = 23/196 (11%)
Query: 361 GSVYRGKI--NGGFAAIKKVNGDV---SKEIALLNKINHSNLIILSGVCFNEGNCY-LVY 414
           G VY+ K+  +G   AIKKV  D    ++E+ ++ K++H N++ L    ++ G     VY
Sbjct: 113 GVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 172
Query: 415 EYAVNGTLSDWVFSNKNEGKYLDWKQRIQI------ALDVATGLNYLHSFTNPPHVHKDI 468
              V   + + V+  +    Y   KQ + +         +   L Y+HSF      H+DI
Sbjct: 173 LNLVLDYVPETVY--RVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGI---CHRDI 227
Query: 469 NSSNVLLDSDLRA-KIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGL-VSTKL 526
              N+LLD D    K+ +F  A+  +   GE  ++   + ++ Y APE +      ++ +
Sbjct: 228 KPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVS--YICSRYYRAPELIFGATDYTSSI 283
Query: 527 DVYAFGVLILEMLTGK 542
           DV++ G ++ E+L G+
Sbjct: 284 DVWSAGCVLAELLLGQ 299

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 43/197 (21%), Positives = 84/197 (42%), Gaps = 23/197 (11%)
Query: 366 GKINGGFAAIKKV-------NGDVSKEIALLNKINHSNLIILSGVCFNE----GNCYLVY 414
           G  +G F A+K++         +  +E  +    NH N++ L   C  E       +L+ 
Sbjct: 50  GLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLL 109
Query: 415 EYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVL 474
            +   GTL + +   K++G +L   Q + + L +  GL  +H+     + H+D+  +N+L
Sbjct: 110 PFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA---KGYAHRDLKPTNIL 166
Query: 475 LDSDLRAKIANFAMARPA----EGQEGEFALTRHIVG--TKGYMAPEYL---ENGLVSTK 525
           L  + +  + +      A    EG      L        T  Y APE      + ++  +
Sbjct: 167 LGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDER 226
Query: 526 LDVYAFGVLILEMLTGK 542
            DV++ G ++  M+ G+
Sbjct: 227 TDVWSLGCVLYAMMFGE 243

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 38/160 (23%), Positives = 78/160 (48%), Gaps = 7/160 (4%)
Query: 381 DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQ 440
           ++ +E  +++++++  ++ L GVC  E    LV E A  G L  ++   + E   +    
Sbjct: 56  EMMREAQIMHQLDNPYIVRLIGVCQAEA-LMLVMEMAGGGPLHKFLVGKREE---IPVSN 111
Query: 441 RIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFA 500
             ++   V+ G+ YL        VH+D+ + NVLL +   AKI++F +++     +  + 
Sbjct: 112 VAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYT 168
Query: 501 LTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT 540
                     + APE +     S++ DV+++GV + E L+
Sbjct: 169 ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALS 208

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 42/164 (25%), Positives = 77/164 (46%), Gaps = 20/164 (12%)
Query: 384 KEIALLNKINHSNLIILSGVCFNEG------NCYLVYEYAVNGTLSDWVFSNKNEGKYLD 437
           +E+ L+  +NH N+I L  V   +       + Y+V E  ++  L   +         LD
Sbjct: 74  RELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMEL-MDANLCQVIQME------LD 126
Query: 438 WKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEG 497
            ++   +   +  G+ +LHS      +H+D+  SN+++ SD   KI +F +AR A    G
Sbjct: 127 HERMSYLLYQMLCGIKHLHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLARTA----G 179
Query: 498 EFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTG 541
              +    V T+ Y APE +        +D+++ G ++ EM+ G
Sbjct: 180 TSFMMVPFVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 223

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 43/190 (22%), Positives = 88/190 (46%), Gaps = 15/190 (7%)
Query: 359 IQGSVYRGKINGGFAAIKKVNG--------DVSKEIALLNKINHSNLIILSGVCFNEGNC 410
           ++  VYR +      AIK +          ++ +E  +++++++  ++ L GVC  E   
Sbjct: 352 VRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEA-L 410
Query: 411 YLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINS 470
            LV E A  G L  ++   + E   +      ++   V+ G+ YL        VH+++ +
Sbjct: 411 MLVMEMAGGGPLHKFLVGKREE---IPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAA 464
Query: 471 SNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYA 530
            NVLL +   AKI++F +++     +  +           + APE +     S++ DV++
Sbjct: 465 RNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWS 524
Query: 531 FGVLILEMLT 540
           +GV + E L+
Sbjct: 525 YGVTMWEALS 534

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 39/162 (24%), Positives = 80/162 (49%), Gaps = 14/162 (8%)
Query: 382 VSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKN---EGKYLDW 438
           V+  +  +  ++H++++ L G+C    +  LV +Y   G+L D V  ++        L+W
Sbjct: 80  VTDHMLAIGSLDHAHIVRLLGLCPG-SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNW 138
Query: 439 KQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGE 498
                  + +A G+ YL        VH+++ + NVLL S  + ++A+F +A      + +
Sbjct: 139 ------GVQIAKGMYYLEEHGM---VHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQ 189
Query: 499 FALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT 540
              +      K +MA E +  G  + + DV+++GV + E++T
Sbjct: 190 LLYSEAKTPIK-WMALESIHFGKYTHQSDVWSYGVTVWELMT 230

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 63/238 (26%), Positives = 100/238 (42%), Gaps = 20/238 (8%)
Query: 312 NEKPSNKKFDEESQDFLESISGVAQSLKVYSFKE-LQSATDNFSFTCRIQGSVYR--GKI 368
           + +PS K  D E     E +  V      Y ++E +  AT          G V+R   K 
Sbjct: 43  SREPSPKTEDNEGVLLTEKLKPVD-----YEYREEVHWATHQLRLGRGSFGEVHRMEDKQ 97
Query: 369 NGGFAAIKKVNGDV--SKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWV 426
            G   A+KKV  +V  ++E+     +    ++ L G         +  E    G+L   V
Sbjct: 98  TGFQCAVKKVRLEVFRAEELMACAGLTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLV 157
Query: 427 FSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSD-LRAKIAN 485
              K +G  L   + +        GL YLHS      +H D+ + NVLL SD   A + +
Sbjct: 158 ---KEQG-CLPEDRALYYLGQALEGLEYLHSRRI---LHGDVKADNVLLSSDGSHAALCD 210
Query: 486 F--AMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTG 541
           F  A+    +G   +     +I GT+ +MAPE +       K+DV++   ++L ML G
Sbjct: 211 FGHAVCLQPDGLGKDLLTGDYIPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNG 268

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 43/165 (26%), Positives = 80/165 (48%), Gaps = 20/165 (12%)
Query: 384 KEIALLNKINHSNLIILSGVCFNEG------NCYLVYEYAVNGTLSDWVFSNKNEGKYLD 437
           +E+ L+  +NH N+I L  V   +       + Y+V E  ++  L   +         LD
Sbjct: 77  RELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVME-LMDANLCQVIQME------LD 129
Query: 438 WKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEG 497
            ++   +   +  G+ +LHS      +H+D+  SN+++ SD   KI +F +AR A     
Sbjct: 130 HERMSYLLYQMLCGIKHLHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLARTAGTS-- 184
Query: 498 EFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGK 542
            F +T ++V T+ Y APE +        +D+++ G ++ EM+  K
Sbjct: 185 -FMMTPYVV-TRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHK 227

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 39/162 (24%), Positives = 80/162 (49%), Gaps = 14/162 (8%)
Query: 382 VSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKN---EGKYLDW 438
           V+  +  +  ++H++++ L G+C    +  LV +Y   G+L D V  ++        L+W
Sbjct: 62  VTDHMLAIGSLDHAHIVRLLGLCPGS-SLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNW 120
Query: 439 KQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGE 498
                  + +A G+ YL        VH+++ + NVLL S  + ++A+F +A      + +
Sbjct: 121 ------GVQIAKGMYYLEEHGM---VHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQ 171
Query: 499 FALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT 540
              +      K +MA E +  G  + + DV+++GV + E++T
Sbjct: 172 LLYSEAKTPIK-WMALESIHFGKYTHQSDVWSYGVTVWELMT 212

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 51/192 (26%), Positives = 92/192 (47%), Gaps = 21/192 (10%)
Query: 361 GSVYRGKINGGFA-AIKKVNGDVS---------KEIALLNKINHSNLIILSGVCFNEGNC 410
           G VY+ + N G   A+KK+  +           +EI++L ++ HSN++ L  V   +   
Sbjct: 16  GVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRL 75
Query: 411 YLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINS 470
            LV+E+ ++  L   +  +  EG  L+        L +  G+ Y H       +H+D+  
Sbjct: 76  VLVFEH-LDQDLKKLL--DVCEGG-LESVTAKSFLLQLLNGIAYCHDRRV---LHRDLKP 128
Query: 471 SNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLE-NGLVSTKLDVY 529
            N+L++ +   KIA+F +AR       ++    H V T  Y AP+ L  +   ST +D++
Sbjct: 129 QNLLINREGELKIADFGLARAFGIPVRKYT---HEVVTLWYRAPDVLMGSKKYSTTIDIW 185
Query: 530 AFGVLILEMLTG 541
           + G +  EM+ G
Sbjct: 186 SVGCIFAEMVNG 197

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 43/165 (26%), Positives = 80/165 (48%), Gaps = 20/165 (12%)
Query: 384 KEIALLNKINHSNLIILSGVCFNEG------NCYLVYEYAVNGTLSDWVFSNKNEGKYLD 437
           +E+ L+  +NH N+I L  V   +       + Y+V E  ++  L   +         LD
Sbjct: 66  RELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVME-LMDANLCQVIQME------LD 118
Query: 438 WKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEG 497
            ++   +   +  G+ +LHS      +H+D+  SN+++ SD   KI +F +AR A     
Sbjct: 119 HERMSYLLYQMLCGIKHLHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLARTAGTS-- 173
Query: 498 EFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGK 542
            F +T ++V T+ Y APE +        +D+++ G ++ EM+  K
Sbjct: 174 -FMMTPYVV-TRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHK 216

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 51/192 (26%), Positives = 92/192 (47%), Gaps = 21/192 (10%)
Query: 361 GSVYRGKINGGFA-AIKKVNGDVS---------KEIALLNKINHSNLIILSGVCFNEGNC 410
           G VY+ + N G   A+KK+  +           +EI++L ++ HSN++ L  V   +   
Sbjct: 16  GVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRL 75
Query: 411 YLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINS 470
            LV+E+ ++  L   +  +  EG  L+        L +  G+ Y H       +H+D+  
Sbjct: 76  VLVFEH-LDQDLKKLL--DVCEGG-LESVTAKSFLLQLLNGIAYCHDRRV---LHRDLKP 128
Query: 471 SNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLE-NGLVSTKLDVY 529
            N+L++ +   KIA+F +AR       ++    H V T  Y AP+ L  +   ST +D++
Sbjct: 129 QNLLINREGELKIADFGLARAFGIPVRKYT---HEVVTLWYRAPDVLMGSKKYSTTIDIW 185
Query: 530 AFGVLILEMLTG 541
           + G +  EM+ G
Sbjct: 186 SVGCIFAEMVNG 197

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 50/186 (26%), Positives = 76/186 (40%), Gaps = 17/186 (9%)
Query: 361 GSVYRGKINGGFAAIKKVNGDVSKEIALLNKINHSNLII-LSGVCFNEGNCYLVYEYAVN 419
           G  Y  K        +    ++  EIA+L        +I L  V  N     L+ EYA  
Sbjct: 54  GQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAG 113
Query: 420 GTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDS-- 477
           G +         E   +     I++   +  G+ YLH       VH D+   N+LL S  
Sbjct: 114 GEIFSLCLPELAE--MVSENDVIRLIKQILEGVYYLHQNNI---VHLDLKPQNILLSSIY 168
Query: 478 ---DLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVL 534
              D+  KI +F M+R      G     R I+GT  Y+APE L    ++T  D++  G++
Sbjct: 169 PLGDI--KIVDFGMSRKI----GHACELREIMGTPEYLAPEILNYDPITTATDMWNIGII 222
Query: 535 ILEMLT 540
              +LT
Sbjct: 223 AYMLLT 228

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 39/157 (24%), Positives = 74/157 (47%), Gaps = 10/157 (6%)
Query: 385 EIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQI 444
           E  +L ++ H  ++ L       G  YL+ EY   G L       + EG +++      +
Sbjct: 71  ERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGEL---FMQLEREGIFMEDTACFYL 127
Query: 445 ALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRH 504
           A +++  L +LH       +++D+   N++L+     K+ +F + + +   +G   +T  
Sbjct: 128 A-EISMALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESI-HDG--TVTHX 180
Query: 505 IVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTG 541
             GT  YMAPE L     +  +D ++ G L+ +MLTG
Sbjct: 181 FCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTG 217

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 51/212 (24%), Positives = 91/212 (42%), Gaps = 30/212 (14%)
Query: 361 GSVYRG--KINGGFAAIKKVNG-------DVSKEIALLNKINHSNLIILSGVCFNEGNCY 411
           G VY+   K     AA K ++        D   EI +L   +H N++ L    + E N +
Sbjct: 51  GKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLW 110
Query: 412 LVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSS 471
           ++ E+   G +   +   +   + L   Q   +       LNYLH   +   +H+D+ + 
Sbjct: 111 ILIEFCAGGAVDAVMLELE---RPLTESQIQVVCKQTLDALNYLH---DNKIIHRDLKAG 164
Query: 472 NVLLDSDLRAKIANFAMARPAEGQEGEFALTRH--IVGTKGYMAPEYL-----ENGLVST 524
           N+L   D   K+A+F ++      +    + R    +GT  +MAPE +     ++     
Sbjct: 165 NILFTLDGDIKLADFGVS-----AKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDY 219
Query: 525 KLDVYAFGVLILEMLTGKEAAALHAEENNMHL 556
           K DV++ G+ ++EM    E    H E N M +
Sbjct: 220 KADVWSLGITLIEM---AEIEPPHHELNPMRV 248

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 39/157 (24%), Positives = 74/157 (47%), Gaps = 10/157 (6%)
Query: 385 EIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQI 444
           E  +L ++ H  ++ L       G  YL+ EY   G L       + EG +++      +
Sbjct: 71  ERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGEL---FMQLEREGIFMEDTACFYL 127
Query: 445 ALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRH 504
           A +++  L +LH       +++D+   N++L+     K+ +F + + +   +G   +T  
Sbjct: 128 A-EISMALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESI-HDG--TVTHT 180
Query: 505 IVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTG 541
             GT  YMAPE L     +  +D ++ G L+ +MLTG
Sbjct: 181 FCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTG 217

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 63/238 (26%), Positives = 99/238 (41%), Gaps = 20/238 (8%)
Query: 312 NEKPSNKKFDEESQDFLESISGVAQSLKVYSFKE-LQSATDNFSFTCRIQGSVYR--GKI 368
           + +PS K  D E     E +  V      Y ++E +  AT          G V+R   K 
Sbjct: 62  SREPSPKTEDNEGVLLTEKLKPVD-----YEYREEVHWATHQLRLGRGSFGEVHRMEDKQ 116
Query: 369 NGGFAAIKKVNGDV--SKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWV 426
            G   A+KKV  +V  ++E+     +    ++ L G         +  E    G+L   V
Sbjct: 117 TGFQCAVKKVRLEVFRAEELMACAGLTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLV 176
Query: 427 FSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSD-LRAKIAN 485
              K +G  L   + +        GL YLHS      +H D+ + NVLL SD   A + +
Sbjct: 177 ---KEQG-CLPEDRALYYLGQALEGLEYLHSRRI---LHGDVKADNVLLSSDGSHAALCD 229
Query: 486 F--AMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTG 541
           F  A+    +G         +I GT+ +MAPE +       K+DV++   ++L ML G
Sbjct: 230 FGHAVCLQPDGLGKSLLTGDYIPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNG 287

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 51/212 (24%), Positives = 91/212 (42%), Gaps = 30/212 (14%)
Query: 361 GSVYRG--KINGGFAAIKKVNG-------DVSKEIALLNKINHSNLIILSGVCFNEGNCY 411
           G VY+   K     AA K ++        D   EI +L   +H N++ L    + E N +
Sbjct: 51  GKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLW 110
Query: 412 LVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSS 471
           ++ E+   G +   +   +   + L   Q   +       LNYLH   +   +H+D+ + 
Sbjct: 111 ILIEFCAGGAVDAVMLELE---RPLTESQIQVVCKQTLDALNYLH---DNKIIHRDLKAG 164
Query: 472 NVLLDSDLRAKIANFAMARPAEGQEGEFALTRH--IVGTKGYMAPEYL-----ENGLVST 524
           N+L   D   K+A+F ++      +    + R    +GT  +MAPE +     ++     
Sbjct: 165 NILFTLDGDIKLADFGVS-----AKNTRXIQRRDSFIGTPYWMAPEVVMCETSKDRPYDY 219
Query: 525 KLDVYAFGVLILEMLTGKEAAALHAEENNMHL 556
           K DV++ G+ ++EM    E    H E N M +
Sbjct: 220 KADVWSLGITLIEM---AEIEPPHHELNPMRV 248

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 51/212 (24%), Positives = 91/212 (42%), Gaps = 30/212 (14%)
Query: 361 GSVYRG--KINGGFAAIKKVNG-------DVSKEIALLNKINHSNLIILSGVCFNEGNCY 411
           G VY+   K     AA K ++        D   EI +L   +H N++ L    + E N +
Sbjct: 51  GKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLW 110
Query: 412 LVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSS 471
           ++ E+   G +   +   +   + L   Q   +       LNYLH   +   +H+D+ + 
Sbjct: 111 ILIEFCAGGAVDAVMLELE---RPLTESQIQVVCKQTLDALNYLH---DNKIIHRDLKAG 164
Query: 472 NVLLDSDLRAKIANFAMARPAEGQEGEFALTRH--IVGTKGYMAPEYL-----ENGLVST 524
           N+L   D   K+A+F ++      +    + R    +GT  +MAPE +     ++     
Sbjct: 165 NILFTLDGDIKLADFGVS-----AKNTRXIQRRDXFIGTPYWMAPEVVMCETSKDRPYDY 219
Query: 525 KLDVYAFGVLILEMLTGKEAAALHAEENNMHL 556
           K DV++ G+ ++EM    E    H E N M +
Sbjct: 220 KADVWSLGITLIEM---AEIEPPHHELNPMRV 248

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 50/192 (26%), Positives = 92/192 (47%), Gaps = 21/192 (10%)
Query: 361 GSVYRGKINGGFA-AIKKVNGDVS---------KEIALLNKINHSNLIILSGVCFNEGNC 410
           G VY+ + N G   A+KK+  +           +EI++L ++ HSN++ L  V   +   
Sbjct: 16  GVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRL 75
Query: 411 YLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINS 470
            LV+E+ ++  L   +  +  EG  L+        L +  G+ Y H       +H+D+  
Sbjct: 76  VLVFEH-LDQDLKKLL--DVCEGG-LESVTAKSFLLQLLNGIAYCHDRRV---LHRDLKP 128
Query: 471 SNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLE-NGLVSTKLDVY 529
            N+L++ +   KIA+F +AR       ++    H + T  Y AP+ L  +   ST +D++
Sbjct: 129 QNLLINREGELKIADFGLARAFGIPVRKYT---HEIVTLWYRAPDVLMGSKKYSTTIDIW 185
Query: 530 AFGVLILEMLTG 541
           + G +  EM+ G
Sbjct: 186 SVGCIFAEMVNG 197

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 51/196 (26%), Positives = 94/196 (47%), Gaps = 23/196 (11%)
Query: 361 GSVYRGKI--NGGFAAIKKV---NGDVSKEIALLNKINHSNLIILSGVCFNEGNCY-LVY 414
           G VY+ K+  +G   AIKKV       ++E+ ++ K++H N++ L    ++ G     VY
Sbjct: 34  GVVYQAKLCDSGELVAIKKVLQGKAFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 93
Query: 415 EYAVNGTLSDWVFSNKNEGKYLDWKQRIQI------ALDVATGLNYLHSFTNPPHVHKDI 468
              V   + + V+  +    Y   KQ + +         +   L Y+HSF      H+DI
Sbjct: 94  LNLVLDYVPETVY--RVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGI---CHRDI 148
Query: 469 NSSNVLLDSDLRA-KIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGL-VSTKL 526
              N+LLD D    K+ +F  A+  +   GE  ++   + ++ Y APE +      ++ +
Sbjct: 149 KPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVS--YICSRYYRAPELIFGATDYTSSI 204
Query: 527 DVYAFGVLILEMLTGK 542
           DV++ G ++ E+L G+
Sbjct: 205 DVWSAGCVLAELLLGQ 220

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 51/196 (26%), Positives = 94/196 (47%), Gaps = 23/196 (11%)
Query: 361 GSVYRGKI--NGGFAAIKKV---NGDVSKEIALLNKINHSNLIILSGVCFNEGNCY-LVY 414
           G VY+ K+  +G   AIKKV       ++E+ ++ K++H N++ L    ++ G     VY
Sbjct: 34  GVVYQAKLCDSGELVAIKKVLQGKAFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 93
Query: 415 EYAVNGTLSDWVFSNKNEGKYLDWKQRIQI------ALDVATGLNYLHSFTNPPHVHKDI 468
              V   + + V+  +    Y   KQ + +         +   L Y+HSF      H+DI
Sbjct: 94  LNLVLDYVPETVY--RVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGI---CHRDI 148
Query: 469 NSSNVLLDSDLRA-KIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGL-VSTKL 526
              N+LLD D    K+ +F  A+  +   GE  ++   + ++ Y APE +      ++ +
Sbjct: 149 KPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVS--YICSRYYRAPELIFGATDYTSSI 204
Query: 527 DVYAFGVLILEMLTGK 542
           DV++ G ++ E+L G+
Sbjct: 205 DVWSAGCVLAELLLGQ 220

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 52/197 (26%), Positives = 95/197 (48%), Gaps = 25/197 (12%)
Query: 361 GSVYRGKI--NGGFAAIKKV---NGDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYE 415
           G VY+ K+  +G   AIKKV       ++E+ ++ K++H N++ L    ++ G      E
Sbjct: 34  GVVYQAKLCDSGELVAIKKVLQGKAFKNRELQIMRKLDHCNIVRLRYFFYSSGE--KKDE 91
Query: 416 YAVNGTLSDWVFSN--KNEGKYLDWKQRIQI------ALDVATGLNYLHSFTNPPHVHKD 467
             +N  L D+V +   +    Y   KQ + +         +   L Y+HSF      H+D
Sbjct: 92  VYLNLVL-DYVPATVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGI---CHRD 147
Query: 468 INSSNVLLDSDLRA-KIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGL-VSTK 525
           I   N+LLD D    K+ +F  A+  +   GE  ++   + ++ Y APE +      ++ 
Sbjct: 148 IKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVS--XICSRYYRAPELIFGATDYTSS 203
Query: 526 LDVYAFGVLILEMLTGK 542
           +DV++ G ++ E+L G+
Sbjct: 204 IDVWSAGCVLAELLLGQ 220

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 32/124 (25%), Positives = 61/124 (49%), Gaps = 10/124 (8%)
Query: 445 ALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRH 504
           A ++  GL ++H   N   V++D+  +N+LLD     +I++  +A     ++   +    
Sbjct: 298 AAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---- 350
Query: 505 IVGTKGYMAPEYLENGLV-STKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAV 563
            VGT GYMAPE L+ G+   +  D ++ G ++ ++L G      H  ++  H  D +   
Sbjct: 351 -VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-HEIDRMTLT 408
Query: 564 LTKE 567
           +  E
Sbjct: 409 MAVE 412

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 32/124 (25%), Positives = 61/124 (49%), Gaps = 10/124 (8%)
Query: 445 ALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRH 504
           A ++  GL ++H   N   V++D+  +N+LLD     +I++  +A     ++   +    
Sbjct: 298 AAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---- 350
Query: 505 IVGTKGYMAPEYLENGLV-STKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAV 563
            VGT GYMAPE L+ G+   +  D ++ G ++ ++L G      H  ++  H  D +   
Sbjct: 351 -VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-HEIDRMTLT 408
Query: 564 LTKE 567
           +  E
Sbjct: 409 MAVE 412

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 32/124 (25%), Positives = 61/124 (49%), Gaps = 10/124 (8%)
Query: 445 ALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRH 504
           A ++  GL ++H   N   V++D+  +N+LLD     +I++  +A     ++   +    
Sbjct: 297 AAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---- 349
Query: 505 IVGTKGYMAPEYLENGLV-STKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAV 563
            VGT GYMAPE L+ G+   +  D ++ G ++ ++L G      H  ++  H  D +   
Sbjct: 350 -VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-HEIDRMTLT 407
Query: 564 LTKE 567
           +  E
Sbjct: 408 MAVE 411

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 32/124 (25%), Positives = 61/124 (49%), Gaps = 10/124 (8%)
Query: 445 ALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRH 504
           A ++  GL ++H   N   V++D+  +N+LLD     +I++  +A     ++   +    
Sbjct: 298 AAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---- 350
Query: 505 IVGTKGYMAPEYLENGLV-STKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAV 563
            VGT GYMAPE L+ G+   +  D ++ G ++ ++L G      H  ++  H  D +   
Sbjct: 351 -VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-HEIDRMTLT 408
Query: 564 LTKE 567
           +  E
Sbjct: 409 MAVE 412

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 41/169 (24%), Positives = 71/169 (42%), Gaps = 26/169 (15%)
Query: 382 VSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQR 441
           V KEI  ++ + H  L+ L     ++    ++YE+   G L + V    N+   +   + 
Sbjct: 201 VRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK---MSEDEA 257
Query: 442 IQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFAL 501
           ++    V  GL ++H      +VH D+   N++           F   R  E +  +F L
Sbjct: 258 VEYMRQVCKGLCHMHENN---YVHLDLKPENIM-----------FTTKRSNELKLIDFGL 303
Query: 502 TRHI---------VGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTG 541
           T H+          GT  + APE  E   V    D+++ GVL   +L+G
Sbjct: 304 TAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSG 352

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 49/194 (25%), Positives = 85/194 (43%), Gaps = 30/194 (15%)
Query: 361 GSVYRGKIN--GGFAAIKKVNGD---------VSKEIALLNKINHSNLIILSGVCFNEGN 409
           G+V++ K        A+K+V  D           +EI LL ++ H N++ L  V  ++  
Sbjct: 16  GTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKK 75
Query: 410 CYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDIN 469
             LV+E+  +  L  +  S   +   LD +        +  GL + HS      +H+D+ 
Sbjct: 76  LTLVFEFC-DQDLKKYFDSCNGD---LDPEIVKSFLFQLLKGLGFCHSRNV---LHRDLK 128
Query: 470 SSNVLLDSDLRAKIANFAMAR----PAEGQEGEFALTRHIVGTKGYMAPEYLENG-LVST 524
             N+L++ +   K+ANF +AR    P      E       V T  Y  P+ L    L ST
Sbjct: 129 PQNLLINRNGELKLANFGLARAFGIPVRCYSAE-------VVTLWYRPPDVLFGAKLYST 181
Query: 525 KLDVYAFGVLILEM 538
            +D+++ G +  E+
Sbjct: 182 SIDMWSAGCIFAEL 195

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 38/142 (26%), Positives = 68/142 (47%), Gaps = 13/142 (9%)
Query: 406 NEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVH 465
           ++ N YLV +Y V G L      +K E +  +   R  +A ++   ++ +H      +VH
Sbjct: 145 DDNNLYLVMDYYVGGDL--LTLLSKFEDRLPEEMARFYLA-EMVIAIDSVHQLH---YVH 198
Query: 466 KDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLE-----NG 520
           +DI   N+L+D +   ++A+F      +  E     +   VGT  Y++PE L+      G
Sbjct: 199 RDIKPDNILMDMNGHIRLADFGSC--LKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKG 256
Query: 521 LVSTKLDVYAFGVLILEMLTGK 542
               + D ++ GV + EML G+
Sbjct: 257 RYGPECDWWSLGVCMYEMLYGE 278

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 47/185 (25%), Positives = 80/185 (43%), Gaps = 21/185 (11%)
Query: 367 KINGGFAAI---KKVNGDVSKEIALLNKIN-HSNLIILSGVCFNEGNCYLVYEYAVNGTL 422
           K N  FA     K++  +  KEI  L     H N++ L  V  ++ + +LV E    G L
Sbjct: 34  KSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGEL 93
Query: 423 SDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLL---DSDL 479
               F    + K+    +   I   + + ++++H       VH+D+   N+L    + +L
Sbjct: 94  ----FERIKKKKHFSETEASYIMRKLVSAVSHMHDVGV---VHRDLKPENLLFTDENDNL 146
Query: 480 RAKIANFAMAR--PAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILE 537
             KI +F  AR  P + Q       +    T  Y APE L         D+++ GV++  
Sbjct: 147 EIKIIDFGFARLKPPDNQP-----LKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYT 201
Query: 538 MLTGK 542
           ML+G+
Sbjct: 202 MLSGQ 206

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 42/165 (25%), Positives = 77/165 (46%), Gaps = 20/165 (12%)
Query: 384 KEIALLNKINHSNLIILSGVCFNEG------NCYLVYEYAVNGTLSDWVFSNKNEGKYLD 437
           +E+ L+  +NH N+I L  V   +       + Y+V E  ++  L   +         LD
Sbjct: 72  RELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVME-LMDANLCQVIQME------LD 124
Query: 438 WKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEG 497
            ++   +   +  G+ +LHS      +H+D+  SN+++ SD   KI +F +AR A    G
Sbjct: 125 HERMSYLLYQMLCGIKHLHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLARTA----G 177
Query: 498 EFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGK 542
              +    V T+ Y APE +        +D+++ G ++ EM+  K
Sbjct: 178 TSFMMEPEVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVCHK 222

>pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 60/313 (19%), Positives = 120/313 (38%), Gaps = 74/313 (23%)
Query: 365 RGKINGGFAAIKKVNGD---------VSKEIALLNKINHSNLIILSGVCFNEGNCYLVYE 415
           R K  G +  ++++N +         +  E+ +    NH N++        +   ++V  
Sbjct: 47  RYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTS 106
Query: 416 YAVNGTLSDWVFSNKNEGKYLDWKQRIQIAL---DVATGLNYLHSFTNPPHVHKDINSSN 472
           +   G+  D + ++     ++D    + IA     V   L+Y+H      +VH+ + +S+
Sbjct: 107 FMAYGSAKDLICTH-----FMDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASH 158
Query: 473 VLLDSDLRAKI----ANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGL--VSTKL 526
           +L+  D +  +    +N +M    + Q       ++ V    +++PE L+  L     K 
Sbjct: 159 ILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKS 218
Query: 527 DVYAFGV-------------------LILEMLTGK-----EAAALHAEENNMH------- 555
           D+Y+ G+                   ++LE L G      + + + AEE  M        
Sbjct: 219 DIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVAN 278
Query: 556 --LSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYE 613
             LSD L     +    +S  H    T   ++           ++ CL+++P  RP    
Sbjct: 279 SGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFH--------HFVEQCLQRNPDARP---- 326
Query: 614 IEHSLSNILNASL 626
              S S +LN S 
Sbjct: 327 ---SASTLLNHSF 336

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 41/169 (24%), Positives = 71/169 (42%), Gaps = 26/169 (15%)
Query: 382 VSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQR 441
           V KEI  ++ + H  L+ L     ++    ++YE+   G L + V    N+   +   + 
Sbjct: 95  VRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK---MSEDEA 151
Query: 442 IQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFAL 501
           ++    V  GL ++H      +VH D+   N++           F   R  E +  +F L
Sbjct: 152 VEYMRQVCKGLCHMHENN---YVHLDLKPENIM-----------FTTKRSNELKLIDFGL 197
Query: 502 TRHI---------VGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTG 541
           T H+          GT  + APE  E   V    D+++ GVL   +L+G
Sbjct: 198 TAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSG 246

>pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 60/313 (19%), Positives = 120/313 (38%), Gaps = 74/313 (23%)
Query: 365 RGKINGGFAAIKKVNGD---------VSKEIALLNKINHSNLIILSGVCFNEGNCYLVYE 415
           R K  G +  ++++N +         +  E+ +    NH N++        +   ++V  
Sbjct: 31  RYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTS 90
Query: 416 YAVNGTLSDWVFSNKNEGKYLDWKQRIQIAL---DVATGLNYLHSFTNPPHVHKDINSSN 472
           +   G+  D + ++     ++D    + IA     V   L+Y+H      +VH+ + +S+
Sbjct: 91  FMAYGSAKDLICTH-----FMDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASH 142
Query: 473 VLLDSDLRAKI----ANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGL--VSTKL 526
           +L+  D +  +    +N +M    + Q       ++ V    +++PE L+  L     K 
Sbjct: 143 ILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKS 202
Query: 527 DVYAFGV-------------------LILEMLTGK-----EAAALHAEENNMH------- 555
           D+Y+ G+                   ++LE L G      + + + AEE  M        
Sbjct: 203 DIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVAN 262
Query: 556 --LSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYE 613
             LSD L     +    +S  H    T   ++           ++ CL+++P  RP    
Sbjct: 263 SGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFH--------HFVEQCLQRNPDARP---- 310
Query: 614 IEHSLSNILNASL 626
              S S +LN S 
Sbjct: 311 ---SASTLLNHSF 320

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 57/264 (21%), Positives = 112/264 (42%), Gaps = 48/264 (18%)
Query: 369 NGGFAAIKK----VNGDVSKEIAL-----LNKINHSNLIILSGVCFNEGNCYLVYEYAVN 419
           +G   A+K+    VN    K + +     +  ++    +   G  F EG+ ++  E  ++
Sbjct: 75  SGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMEL-MD 133
Query: 420 GTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDL 479
            +L  +     ++G+ +      +IA+ +   L +LHS  +   +H+D+  SNVL+++  
Sbjct: 134 TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS--VIHRDVKPSNVLINALG 191
Query: 480 RAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGL----VSTKLDVYAFGVLI 535
           + K+ +F ++    G   +        G K YMAPE +   L     S K D+++ G+ +
Sbjct: 192 QVKMCDFGIS----GYLVDSVAKTIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITM 247
Query: 536 LEMLTGKEAAALHAEENN-----MHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELA 590
           +E+      A L    ++       L  V+     +   ++    F+D T Q        
Sbjct: 248 IEL------AILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFSAEFVDFTSQ-------- 293
Query: 591 LLVIRLIDACLKKDPTDRPTMYEI 614
                    CLKK+  +RPT  E+
Sbjct: 294 ---------CLKKNSKERPTYPEL 308

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 45/181 (24%), Positives = 86/181 (47%), Gaps = 31/181 (17%)
Query: 384 KEIALLNKIN-HSNLIILSGVCF--NEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQ 440
           +EI +L +++ H N++ L  V    N+ + YLV++Y +   L   + +N      L+   
Sbjct: 57  REIMILTELSGHENIVNLLNVLRADNDRDVYLVFDY-METDLHAVIRAN-----ILEPVH 110
Query: 441 RIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARP--------- 491
           +  +   +   + YLHS      +H+D+  SN+LL+++   K+A+F ++R          
Sbjct: 111 KQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTN 167
Query: 492 ---------AEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTK-LDVYAFGVLILEMLTG 541
                     E  + +  +    V T+ Y APE L      TK +D+++ G ++ E+L G
Sbjct: 168 NIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCG 227
Query: 542 K 542
           K
Sbjct: 228 K 228

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 42/165 (25%), Positives = 77/165 (46%), Gaps = 20/165 (12%)
Query: 384 KEIALLNKINHSNLIILSGVCFNEG------NCYLVYEYAVNGTLSDWVFSNKNEGKYLD 437
           +E+ L+  +NH N+I L  V   +       + Y+V E  ++  L   +         LD
Sbjct: 72  RELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVME-LMDANLCQVIQME------LD 124
Query: 438 WKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEG 497
            ++   +   +  G+ +LHS      +H+D+  SN+++ SD   KI +F +AR A    G
Sbjct: 125 HERMSYLLYQMLCGIKHLHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLARTA----G 177
Query: 498 EFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGK 542
              +    V T+ Y APE +        +D+++ G ++ EM+  K
Sbjct: 178 TSFMMEPEVVTRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHK 222

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 60/249 (24%), Positives = 107/249 (42%), Gaps = 35/249 (14%)
Query: 372 FAAIKKVNGD----VSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVF 427
            A   KV G     V KEI++LN   H N++ L     +     +++E+ ++G     +F
Sbjct: 34  MAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF-ISGLD---IF 89
Query: 428 SNKNEGKY-LDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRA--KIA 484
              N   + L+ ++ +     V   L +LHS       H DI   N++  +   +  KI 
Sbjct: 90  ERINTSAFELNEREIVSYVHQVCEALQFLHSHNIG---HFDIRPENIIYQTRRSSTIKII 146
Query: 485 NFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEA 544
            F  AR  +  +      R +     Y APE  ++ +VST  D+++ G L+  +L+G   
Sbjct: 147 EFGQARQLKPGDN----FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSG--I 200
Query: 545 AALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKD 604
               AE N   + +++NA  T +  EE+ +             E+++  +  +D  L K+
Sbjct: 201 NPFLAETNQQIIENIMNAEYTFD--EEAFK-------------EISIEAMDFVDRLLVKE 245
Query: 605 PTDRPTMYE 613
              R T  E
Sbjct: 246 RKSRMTASE 254

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 49/94 (52%), Gaps = 6/94 (6%)
Query: 451 GLNYLHSFTNPPHVHKDINSSNVLLDSD-LRAKIANF--AMARPAEGQEGEFALTRHIVG 507
           GL YLH+      +H D+ + NVLL SD  RA + +F  A+    +G         +I G
Sbjct: 162 GLEYLHTRRI---LHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPG 218
Query: 508 TKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTG 541
           T+ +MAPE +       K+D+++   ++L ML G
Sbjct: 219 TETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNG 252

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 39/164 (23%), Positives = 72/164 (43%), Gaps = 9/164 (5%)
Query: 381 DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQ 440
           D+ +E ++ + + H +++ L     ++G  Y+V+E+     L   +    + G       
Sbjct: 74  DLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAV 133
Query: 441 RIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRA---KIANFAMARPAEGQEG 497
                  +   L Y H       +H+D+    VLL S   +   K+  F +A    G+ G
Sbjct: 134 ASHYMRQILEALRYCHDNNI---IHRDVKPHCVLLASKENSAPVKLGGFGVAIQL-GESG 189
Query: 498 EFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTG 541
             A  R  VGT  +MAPE ++       +DV+  GV++  +L+G
Sbjct: 190 LVAGGR--VGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSG 231

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 40/162 (24%), Positives = 73/162 (45%), Gaps = 12/162 (7%)
Query: 382 VSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQR 441
           V  EI+++N+++H  LI L     ++    L+ E+   G L D + +   E   +   + 
Sbjct: 95  VKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAA---EDYKMSEAEV 151
Query: 442 IQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRA--KIANFAMARPAEGQEGEF 499
           I        GL ++H  +    VH DI   N++ ++   +  KI +F +A      E   
Sbjct: 152 INYMRQACEGLKHMHEHSI---VHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE--- 205
Query: 500 ALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTG 541
            + +    T  + APE ++   V    D++A GVL   +L+G
Sbjct: 206 -IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSG 246

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 49/94 (52%), Gaps = 6/94 (6%)
Query: 451 GLNYLHSFTNPPHVHKDINSSNVLLDSD-LRAKIANF--AMARPAEGQEGEFALTRHIVG 507
           GL YLH+      +H D+ + NVLL SD  RA + +F  A+    +G         +I G
Sbjct: 178 GLEYLHTRRI---LHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPG 234
Query: 508 TKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTG 541
           T+ +MAPE +       K+D+++   ++L ML G
Sbjct: 235 TETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNG 268

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 49/94 (52%), Gaps = 6/94 (6%)
Query: 451 GLNYLHSFTNPPHVHKDINSSNVLLDSD-LRAKIANF--AMARPAEGQEGEFALTRHIVG 507
           GL YLH+      +H D+ + NVLL SD  RA + +F  A+    +G         +I G
Sbjct: 176 GLEYLHTRRI---LHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPG 232
Query: 508 TKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTG 541
           T+ +MAPE +       K+D+++   ++L ML G
Sbjct: 233 TETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNG 266

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 48/194 (24%), Positives = 85/194 (43%), Gaps = 30/194 (15%)
Query: 361 GSVYRGK--INGGFAAIKKVNGD---------VSKEIALLNKINHSNLIILSGVCFNEGN 409
           G+V++ K        A+K+V  D           +EI LL ++ H N++ L  V  ++  
Sbjct: 16  GTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKK 75
Query: 410 CYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDIN 469
             LV+E+  +  L  +  S   +   LD +        +  GL + HS      +H+D+ 
Sbjct: 76  LTLVFEFC-DQDLKKYFDSCNGD---LDPEIVKSFLFQLLKGLGFCHSRNV---LHRDLK 128
Query: 470 SSNVLLDSDLRAKIANFAMAR----PAEGQEGEFALTRHIVGTKGYMAPEYLENG-LVST 524
             N+L++ +   K+A+F +AR    P      E       V T  Y  P+ L    L ST
Sbjct: 129 PQNLLINRNGELKLADFGLARAFGIPVRCYSAE-------VVTLWYRPPDVLFGAKLYST 181
Query: 525 KLDVYAFGVLILEM 538
            +D+++ G +  E+
Sbjct: 182 SIDMWSAGCIFAEL 195

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/155 (28%), Positives = 76/155 (49%), Gaps = 11/155 (7%)
Query: 380 GDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWK 439
           G V+ EIA+L+++ H+N+I +  +  N+G   LV E   +G L  + F +++    LD  
Sbjct: 74  GKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSG-LDLFAFIDRH--PRLDEP 130
Query: 440 QRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEF 499
               I   + + + YL        +H+DI   N+++  D   K+ +F  A  A  + G+ 
Sbjct: 131 LASYIFRQLVSAVGYLRL---KDIIHRDIKDENIVIAEDFTIKLIDFGSA--AYLERGKL 185
Query: 500 ALTRHIVGTKGYMAPEYLE-NGLVSTKLDVYAFGV 533
             T    GT  Y APE L  N     +L++++ GV
Sbjct: 186 FYT--FCGTIEYCAPEVLMGNPYRGPELEMWSLGV 218

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 39/164 (23%), Positives = 72/164 (43%), Gaps = 9/164 (5%)
Query: 381 DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQ 440
           D+ +E ++ + + H +++ L     ++G  Y+V+E+     L   +    + G       
Sbjct: 72  DLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAV 131
Query: 441 RIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRA---KIANFAMARPAEGQEG 497
                  +   L Y H       +H+D+    VLL S   +   K+  F +A    G+ G
Sbjct: 132 ASHYMRQILEALRYCHDNNI---IHRDVKPHCVLLASKENSAPVKLGGFGVAIQL-GESG 187
Query: 498 EFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTG 541
             A  R  VGT  +MAPE ++       +DV+  GV++  +L+G
Sbjct: 188 LVAGGR--VGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSG 229

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 49/187 (26%), Positives = 79/187 (42%), Gaps = 19/187 (10%)
Query: 362 SVYRGKINGGFAAIKKVNGDVSKEIALLNKINHSNLIILSGVCFNEGN-CYLVYEYAVNG 420
            VY  K+   F  IK+ +     E   +    +S  ++     F +    Y+V EY   G
Sbjct: 100 KVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGG 159
Query: 421 TLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLR 480
            L + + +     K+     R   A +V   L+ +HS      +H+D+   N+LLD    
Sbjct: 160 DLVNLMSNYDVPEKW----ARFYTA-EVVLALDAIHSMG---FIHRDVKPDNMLLDKSGH 211
Query: 481 AKIANFA--MARPAEGQEGEFALTRHIVGTKGYMAPEYLE----NGLVSTKLDVYAFGVL 534
            K+A+F   M    EG           VGT  Y++PE L+    +G    + D ++ GV 
Sbjct: 212 LKLADFGTCMKMNKEG----MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVF 267
Query: 535 ILEMLTG 541
           + EML G
Sbjct: 268 LYEMLVG 274

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 49/187 (26%), Positives = 79/187 (42%), Gaps = 19/187 (10%)
Query: 362 SVYRGKINGGFAAIKKVNGDVSKEIALLNKINHSNLIILSGVCFNEGN-CYLVYEYAVNG 420
            VY  K+   F  IK+ +     E   +    +S  ++     F +    Y+V EY   G
Sbjct: 95  KVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGG 154
Query: 421 TLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLR 480
            L + + +     K+     R   A +V   L+ +HS      +H+D+   N+LLD    
Sbjct: 155 DLVNLMSNYDVPEKW----ARFYTA-EVVLALDAIHSMG---FIHRDVKPDNMLLDKSGH 206
Query: 481 AKIANFA--MARPAEGQEGEFALTRHIVGTKGYMAPEYLE----NGLVSTKLDVYAFGVL 534
            K+A+F   M    EG           VGT  Y++PE L+    +G    + D ++ GV 
Sbjct: 207 LKLADFGTCMKMNKEG----MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVF 262
Query: 535 ILEMLTG 541
           + EML G
Sbjct: 263 LYEMLVG 269

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 46/177 (25%), Positives = 76/177 (42%), Gaps = 24/177 (13%)
Query: 381 DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSN---KNEGKYLD 437
           +V KE+ ++  + H  L+ L     +E + ++V +  + G L   +  N   K E   L 
Sbjct: 61  NVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKL- 119
Query: 438 WKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMAR--PAEGQ 495
                    ++   L+YL    N   +H+D+   N+LLD      I +F +A   P E Q
Sbjct: 120 ------FICELVMALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ 170
Query: 496 EGEFALTRHIVGTKGYMAPEYL---ENGLVSTKLDVYAFGVLILEMLTGKEAAALHA 549
               A      GTK YMAPE     +    S  +D ++ GV   E+L G+    + +
Sbjct: 171 ITTMA------GTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRS 221

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 38/164 (23%), Positives = 73/164 (44%), Gaps = 22/164 (13%)
Query: 393 NHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQI-------- 444
           NH N++ L G C   G   ++ EY   G L +  F  +    ++  K    I        
Sbjct: 101 NHMNIVNLLGACTIGGPTLVITEYCCYGDLLN--FLRRKRDSFICSKTSPAIMEDDELAL 158
Query: 445 --------ALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQE 496
                   +  VA G+ +L S      +H+D+ + N+LL      KI +F +AR  +  +
Sbjct: 159 DLEDLLSFSYQVAKGMAFLASKNC---IHRDLAARNILLTHGRITKICDFGLARDIK-ND 214
Query: 497 GEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT 540
             + +  +      +MAPE + N + + + DV+++G+ + E+ +
Sbjct: 215 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 258

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 57/225 (25%), Positives = 97/225 (43%), Gaps = 39/225 (17%)
Query: 344 KELQSATDNFSFTCRIQGSVYRGKINGGFAAIKKVNGDVSKEIALLNK-----------I 392
           KE+Q   ++F     I   + RG   G  A +K  N +    + +LNK            
Sbjct: 67  KEMQLHREDFE----IIKVIGRGAF-GEVAVVKMKNTERIYAMKILNKWEMLKRAETACF 121
Query: 393 NHSNLIILSGVCF----------NEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRI 442
                ++++G C           +E + YLV +Y V G L      +K E K  +   R 
Sbjct: 122 REERDVLVNGDCQWITALHYAFQDENHLYLVMDYYVGGDLL--TLLSKFEDKLPEDMARF 179
Query: 443 QIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALT 502
            I  ++   ++ +H      +VH+DI   NVLLD +   ++A+F      +  +     +
Sbjct: 180 YIG-EMVLAIDSIHQLH---YVHRDIKPDNVLLDVNGHIRLADFGSC--LKMNDDGTVQS 233
Query: 503 RHIVGTKGYMAPEYL---ENGL--VSTKLDVYAFGVLILEMLTGK 542
              VGT  Y++PE L   E+G+     + D ++ GV + EML G+
Sbjct: 234 SVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGE 278

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 49/187 (26%), Positives = 79/187 (42%), Gaps = 19/187 (10%)
Query: 362 SVYRGKINGGFAAIKKVNGDVSKEIALLNKINHSNLIILSGVCFNEGN-CYLVYEYAVNG 420
            VY  K+   F  IK+ +     E   +    +S  ++     F +    Y+V EY   G
Sbjct: 100 KVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGG 159
Query: 421 TLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLR 480
            L + + +     K+     R   A +V   L+ +HS      +H+D+   N+LLD    
Sbjct: 160 DLVNLMSNYDVPEKW----ARFYTA-EVVLALDAIHSMG---FIHRDVKPDNMLLDKSGH 211
Query: 481 AKIANFA--MARPAEGQEGEFALTRHIVGTKGYMAPEYLE----NGLVSTKLDVYAFGVL 534
            K+A+F   M    EG           VGT  Y++PE L+    +G    + D ++ GV 
Sbjct: 212 LKLADFGTCMKMNKEG----MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVF 267
Query: 535 ILEMLTG 541
           + EML G
Sbjct: 268 LYEMLVG 274

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 38/164 (23%), Positives = 73/164 (44%), Gaps = 22/164 (13%)
Query: 393 NHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQI-------- 444
           NH N++ L G C   G   ++ EY   G L +  F  +    ++  K    I        
Sbjct: 85  NHMNIVNLLGACTIGGPTLVITEYCCYGDLLN--FLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 445 --------ALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQE 496
                   +  VA G+ +L S      +H+D+ + N+LL      KI +F +AR  +  +
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASKNC---IHRDLAARNILLTHGRITKICDFGLARDIK-ND 198
Query: 497 GEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT 540
             + +  +      +MAPE + N + + + DV+++G+ + E+ +
Sbjct: 199 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 57/225 (25%), Positives = 97/225 (43%), Gaps = 39/225 (17%)
Query: 344 KELQSATDNFSFTCRIQGSVYRGKINGGFAAIKKVNGDVSKEIALLNK-----------I 392
           KE+Q   ++F     I   + RG   G  A +K  N +    + +LNK            
Sbjct: 83  KEMQLHREDFE----IIKVIGRGAF-GEVAVVKMKNTERIYAMKILNKWEMLKRAETACF 137
Query: 393 NHSNLIILSGVCF----------NEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRI 442
                ++++G C           +E + YLV +Y V G L      +K E K  +   R 
Sbjct: 138 REERDVLVNGDCQWITALHYAFQDENHLYLVMDYYVGGDLL--TLLSKFEDKLPEDMARF 195
Query: 443 QIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALT 502
            I  ++   ++ +H      +VH+DI   NVLLD +   ++A+F      +  +     +
Sbjct: 196 YIG-EMVLAIDSIHQLH---YVHRDIKPDNVLLDVNGHIRLADFGSC--LKMNDDGTVQS 249
Query: 503 RHIVGTKGYMAPEYL---ENGL--VSTKLDVYAFGVLILEMLTGK 542
              VGT  Y++PE L   E+G+     + D ++ GV + EML G+
Sbjct: 250 SVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGE 294

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 38/164 (23%), Positives = 73/164 (44%), Gaps = 22/164 (13%)
Query: 393 NHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQI-------- 444
           NH N++ L G C   G   ++ EY   G L +  F  +    ++  K    I        
Sbjct: 108 NHMNIVNLLGACTIGGPTLVITEYCCYGDLLN--FLRRKRDSFICSKTSPAIMEDDELAL 165
Query: 445 --------ALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQE 496
                   +  VA G+ +L S      +H+D+ + N+LL      KI +F +AR  +  +
Sbjct: 166 DLEDLLSFSYQVAKGMAFLASKNC---IHRDLAARNILLTHGRITKICDFGLARDIK-ND 221
Query: 497 GEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT 540
             + +  +      +MAPE + N + + + DV+++G+ + E+ +
Sbjct: 222 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 265

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 38/164 (23%), Positives = 73/164 (44%), Gaps = 22/164 (13%)
Query: 393 NHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQI-------- 444
           NH N++ L G C   G   ++ EY   G L +  F  +    ++  K    I        
Sbjct: 103 NHMNIVNLLGACTIGGPTLVITEYCCYGDLLN--FLRRKRDSFICSKTSPAIMEDDELAL 160
Query: 445 --------ALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQE 496
                   +  VA G+ +L S      +H+D+ + N+LL      KI +F +AR  +  +
Sbjct: 161 DLEDLLSFSYQVAKGMAFLASKNC---IHRDLAARNILLTHGRITKICDFGLARDIK-ND 216
Query: 497 GEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT 540
             + +  +      +MAPE + N + + + DV+++G+ + E+ +
Sbjct: 217 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 260

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 38/164 (23%), Positives = 73/164 (44%), Gaps = 22/164 (13%)
Query: 393 NHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQI-------- 444
           NH N++ L G C   G   ++ EY   G L +  F  +    ++  K    I        
Sbjct: 108 NHMNIVNLLGACTIGGPTLVITEYCCYGDLLN--FLRRKRDSFICSKTSPAIMEDDELAL 165
Query: 445 --------ALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQE 496
                   +  VA G+ +L S      +H+D+ + N+LL      KI +F +AR  +  +
Sbjct: 166 DLEDLLSFSYQVAKGMAFLASKNC---IHRDLAARNILLTHGRITKICDFGLARHIK-ND 221
Query: 497 GEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT 540
             + +  +      +MAPE + N + + + DV+++G+ + E+ +
Sbjct: 222 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 265

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 28/94 (29%), Positives = 45/94 (47%), Gaps = 8/94 (8%)
Query: 448 VATGLNYLHSFTNPPHVHKDINSSNVLLDSDL-RAKIANFAMARPAEGQEGEFALTRHIV 506
           +  GL +LH+ T PP +H+D+   N+ +       KI +  +A          +  + ++
Sbjct: 138 ILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA-----SFAKAVI 191
Query: 507 GTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT 540
           GT  + APE  E     + +DVYAFG   LE  T
Sbjct: 192 GTPEFXAPEXYEEKYDES-VDVYAFGXCXLEXAT 224

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 46/196 (23%), Positives = 84/196 (42%), Gaps = 32/196 (16%)
Query: 435 YLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMAR---- 490
           +L  +  I  +  VA G+ +L S      +H+D+ + N+LL      KI +F +AR    
Sbjct: 189 FLTLEHLICYSFQVAKGMEFLASRKC---IHRDLAARNILLSEKNVVKICDFGLARDIYK 245
Query: 491 -PAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHA 549
            P   ++G+  L         +MAPE + + + + + DV++FGVL+ E+ +   +     
Sbjct: 246 DPDYVRKGDARLPLK------WMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 299
Query: 550 EENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRP 609
           + +                 EE  R   + T           +   ++D C   +P+ RP
Sbjct: 300 KID-----------------EEFCRRLKEGTRMRAPDYTTPEMYQTMLD-CWHGEPSQRP 341
Query: 610 TMYEIEHSLSNILNAS 625
           T  E+   L N+L A+
Sbjct: 342 TFSELVEHLGNLLQAN 357

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 51/222 (22%), Positives = 97/222 (43%), Gaps = 39/222 (17%)
Query: 402 GVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNP 461
           G  F EG+ ++  E  ++ +L  +     ++G+ +      +IA+ +   L +LHS  + 
Sbjct: 73  GALFREGDVWICMEL-MDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSV 131
Query: 462 PHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGL 521
             +H+D+  SNVL+++  + K+ +F ++    G   +        G K YMAPE +   L
Sbjct: 132 --IHRDVKPSNVLINALGQVKMCDFGIS----GYLVDDVAKDIDAGCKPYMAPERINPEL 185
Query: 522 ----VSTKLDVYAFGVLILEMLTGKEAAALHAEENN-----MHLSDVLNAVLTKEDGEES 572
                S K D+++ G+ ++E+      A L    ++       L  V+     +   ++ 
Sbjct: 186 NQKGYSVKSDIWSLGITMIEL------AILRFPYDSWGTPFQQLKQVVEEPSPQLPADKF 239
Query: 573 LRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEI 614
              F+D T Q                 CLKK+  +RPT  E+
Sbjct: 240 SAEFVDFTSQ-----------------CLKKNSKERPTYPEL 264

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 46/196 (23%), Positives = 84/196 (42%), Gaps = 32/196 (16%)
Query: 435 YLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMAR---- 490
           +L  +  I  +  VA G+ +L S      +H+D+ + N+LL      KI +F +AR    
Sbjct: 187 FLTLEHLICYSFQVAKGMEFLASRKC---IHRDLAARNILLSEKNVVKICDFGLARDIYK 243
Query: 491 -PAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHA 549
            P   ++G+  L         +MAPE + + + + + DV++FGVL+ E+ +   +     
Sbjct: 244 DPDYVRKGDARLPLK------WMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 297
Query: 550 EENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRP 609
           + +                 EE  R   + T           +   ++D C   +P+ RP
Sbjct: 298 KID-----------------EEFCRRLKEGTRMRAPDYTTPEMYQTMLD-CWHGEPSQRP 339
Query: 610 TMYEIEHSLSNILNAS 625
           T  E+   L N+L A+
Sbjct: 340 TFSELVEHLGNLLQAN 355

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 46/196 (23%), Positives = 84/196 (42%), Gaps = 32/196 (16%)
Query: 435 YLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMAR---- 490
           +L  +  I  +  VA G+ +L S      +H+D+ + N+LL      KI +F +AR    
Sbjct: 196 FLTLEHLICYSFQVAKGMEFLASRKC---IHRDLAARNILLSEKNVVKICDFGLARDIYK 252
Query: 491 -PAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHA 549
            P   ++G+  L         +MAPE + + + + + DV++FGVL+ E+ +   +     
Sbjct: 253 DPDYVRKGDARLPLK------WMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 306
Query: 550 EENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRP 609
           + +                 EE  R   + T           +   ++D C   +P+ RP
Sbjct: 307 KID-----------------EEFCRRLKEGTRMRAPDYTTPEMYQTMLD-CWHGEPSQRP 348
Query: 610 TMYEIEHSLSNILNAS 625
           T  E+   L N+L A+
Sbjct: 349 TFSELVEHLGNLLQAN 364

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 45/185 (24%), Positives = 77/185 (41%), Gaps = 15/185 (8%)
Query: 362 SVYRGKINGGFAAIKKVNGDVSKEIALLNKINHSNLIILSGVCFNEGN-CYLVYEYAVNG 420
            VY  K+   F  IK+ +     E   +    +S  ++     F +    Y+V EY   G
Sbjct: 101 KVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGG 160
Query: 421 TLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLR 480
            L + + +     K+  +        +V   L+ +HS      +H+D+   N+LLD    
Sbjct: 161 DLVNLMSNYDVPEKWAKF-----YTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGH 212
Query: 481 AKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLE----NGLVSTKLDVYAFGVLIL 536
            K+A+F      +  E         VGT  Y++PE L+    +G    + D ++ GV + 
Sbjct: 213 LKLADFGTCMKMD--ETGMVHCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLF 270
Query: 537 EMLTG 541
           EML G
Sbjct: 271 EMLVG 275

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 55/229 (24%), Positives = 97/229 (42%), Gaps = 56/229 (24%)
Query: 367 KINGGFAAIKKV---------NGDVSKEIALLNKINHSNLIILSGVCFNEG-----NCYL 412
           K+     AIKK+            + +EIA+LN++NH +++ +  +   +        Y+
Sbjct: 75  KLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYV 134
Query: 413 VYEYAVNGTLSDWVFSNK-NEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSS 471
           V E      ++D  F        YL       +  ++  G+ Y+HS      +H+D+  +
Sbjct: 135 VLE------IADSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGI---LHRDLKPA 185
Query: 472 NVLLDSDLRAKIANFAMAR------------PAEGQEGEF-------------ALTRHIV 506
           N L++ D   K+ +F +AR            P   +E +               LT H+V
Sbjct: 186 NCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVV 245
Query: 507 GTKGYMAPEYL---ENGLVSTKLDVYAFGVLILEMLTG-KEAAALHAEE 551
            T+ Y APE +   EN   +  +DV++ G +  E+L   KE  A HA+ 
Sbjct: 246 -TRWYRAPELILLQEN--YTEAIDVWSIGCIFAELLNMIKENVAYHADR 291

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 46/196 (23%), Positives = 84/196 (42%), Gaps = 32/196 (16%)
Query: 435 YLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMAR---- 490
           +L  +  I  +  VA G+ +L S      +H+D+ + N+LL      KI +F +AR    
Sbjct: 194 FLTLEHLICYSFQVAKGMEFLASRKC---IHRDLAARNILLSEKNVVKICDFGLARDIYK 250
Query: 491 -PAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHA 549
            P   ++G+  L         +MAPE + + + + + DV++FGVL+ E+ +   +     
Sbjct: 251 DPDYVRKGDARLPLK------WMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 304
Query: 550 EENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRP 609
           + +                 EE  R   + T           +   ++D C   +P+ RP
Sbjct: 305 KID-----------------EEFCRRLKEGTRMRAPDYTTPEMYQTMLD-CWHGEPSQRP 346
Query: 610 TMYEIEHSLSNILNAS 625
           T  E+   L N+L A+
Sbjct: 347 TFSELVEHLGNLLQAN 362

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 61/233 (26%), Positives = 106/233 (45%), Gaps = 38/233 (16%)
Query: 361 GSVY--RGKINGGFAAIKKVNGDVSKE---------IALLNKINHSNLIILSGVC----- 404
           G V+  R +  G   A+KKV  +  KE         I +L  + H N++ L  +C     
Sbjct: 32  GEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKAS 91
Query: 405 -FN--EGNCYLVY---EYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSF 458
            +N  +G+ YLV+   E+ + G LS+ +     +    + K+ +Q+ L+   GL Y+H  
Sbjct: 92  PYNRCKGSIYLVFDFCEHDLAGLLSNVLV----KFTLSEIKRVMQMLLN---GLYYIHRN 144
Query: 459 TNPPHVHKDINSSNVLLDSDLRAKIANFAMARP---AEGQEGEFALTRHIVGTKGYMAPE 515
                +H+D+ ++NVL+  D   K+A+F +AR    A+  +      R  V T  Y  PE
Sbjct: 145 KI---LHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNR--VVTLWYRPPE 199
Query: 516 YLENGL-VSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKE 567
            L         +D++  G ++ EM T       + E++ + L   L   +T E
Sbjct: 200 LLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE 252

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 35/136 (25%), Positives = 62/136 (45%), Gaps = 15/136 (11%)
Query: 361 GSVYRGKINGGFAA----IKKVNGD----VSKEIALLNKINHSNLIILSGVCFNEGNCYL 412
           G VY G+ +G  A     I++ N D      +E+    +  H N+++  G C +  +  +
Sbjct: 47  GQVYHGRWHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAI 106
Query: 413 VYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSN 472
           +       TL   V   ++    LD  +  QIA ++  G+ YLH+      +HKD+ S N
Sbjct: 107 ITSLCKGRTLYSVV---RDAKIVLDVNKTRQIAQEIVKGMGYLHA---KGILHKDLKSKN 160
Query: 473 VLLDSDLRAKIANFAM 488
           V  D+  +  I +F +
Sbjct: 161 VFYDNG-KVVITDFGL 175

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 49/202 (24%), Positives = 88/202 (43%), Gaps = 40/202 (19%)
Query: 367 KINGGFAAIKKVNG--------DVSKEIALLNKINHSNLIILSGVC-------FNEGNCY 411
           K  G   AIKK+             +EI +L    H N+I +  +        FNE   Y
Sbjct: 33  KPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE--VY 90
Query: 412 LVYEYA---VNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDI 468
           ++ E     ++  +S  + S+ +   ++    R   A+ V  G N          +H+D+
Sbjct: 91  IIQELMQTDLHRVISTQMLSDDHIQYFIYQTLR---AVKVLHGSNV---------IHRDL 138
Query: 469 NSSNVLLDSDLRAKIANFAMAR-----PAEGQE--GEFALTRHIVGTKGYMAPE-YLENG 520
             SN+L++S+   K+ +F +AR      A+  E  G+ +     V T+ Y APE  L + 
Sbjct: 139 KPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEXVATRWYRAPEVMLTSA 198
Query: 521 LVSTKLDVYAFGVLILEMLTGK 542
             S  +DV++ G ++ E+   +
Sbjct: 199 KYSRAMDVWSCGCILAELFLRR 220

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 49/202 (24%), Positives = 88/202 (43%), Gaps = 40/202 (19%)
Query: 367 KINGGFAAIKKVNG--------DVSKEIALLNKINHSNLIILSGVC-------FNEGNCY 411
           K  G   AIKK+             +EI +L    H N+I +  +        FNE   Y
Sbjct: 33  KPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE--VY 90
Query: 412 LVYEYA---VNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDI 468
           ++ E     ++  +S  + S+ +   ++    R   A+ V  G N          +H+D+
Sbjct: 91  IIQELMQTDLHRVISTQMLSDDHIQYFIYQTLR---AVKVLHGSNV---------IHRDL 138
Query: 469 NSSNVLLDSDLRAKIANFAMAR-----PAEGQE--GEFALTRHIVGTKGYMAPE-YLENG 520
             SN+L++S+   K+ +F +AR      A+  E  G+ +     V T+ Y APE  L + 
Sbjct: 139 KPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSA 198
Query: 521 LVSTKLDVYAFGVLILEMLTGK 542
             S  +DV++ G ++ E+   +
Sbjct: 199 KYSRAMDVWSCGCILAELFLRR 220

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 61/233 (26%), Positives = 106/233 (45%), Gaps = 38/233 (16%)
Query: 361 GSVY--RGKINGGFAAIKKVNGDVSKE---------IALLNKINHSNLIILSGVC----- 404
           G V+  R +  G   A+KKV  +  KE         I +L  + H N++ L  +C     
Sbjct: 31  GEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKAS 90
Query: 405 -FN--EGNCYLVY---EYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSF 458
            +N  +G+ YLV+   E+ + G LS+ +     +    + K+ +Q+ L+   GL Y+H  
Sbjct: 91  PYNRCKGSIYLVFDFCEHDLAGLLSNVLV----KFTLSEIKRVMQMLLN---GLYYIHRN 143
Query: 459 TNPPHVHKDINSSNVLLDSDLRAKIANFAMARP---AEGQEGEFALTRHIVGTKGYMAPE 515
                +H+D+ ++NVL+  D   K+A+F +AR    A+  +      R  V T  Y  PE
Sbjct: 144 KI---LHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNR--VVTLWYRPPE 198
Query: 516 YLENGL-VSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKE 567
            L         +D++  G ++ EM T       + E++ + L   L   +T E
Sbjct: 199 LLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE 251

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 61/233 (26%), Positives = 106/233 (45%), Gaps = 38/233 (16%)
Query: 361 GSVY--RGKINGGFAAIKKVNGDVSKE---------IALLNKINHSNLIILSGVC----- 404
           G V+  R +  G   A+KKV  +  KE         I +L  + H N++ L  +C     
Sbjct: 32  GEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKAS 91
Query: 405 -FN--EGNCYLVY---EYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSF 458
            +N  +G+ YLV+   E+ + G LS+ +     +    + K+ +Q+ L+   GL Y+H  
Sbjct: 92  PYNRCKGSIYLVFDFCEHDLAGLLSNVLV----KFTLSEIKRVMQMLLN---GLYYIHRN 144
Query: 459 TNPPHVHKDINSSNVLLDSDLRAKIANFAMARP---AEGQEGEFALTRHIVGTKGYMAPE 515
                +H+D+ ++NVL+  D   K+A+F +AR    A+  +      R  V T  Y  PE
Sbjct: 145 KI---LHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNR--VVTLWYRPPE 199
Query: 516 YLENGL-VSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKE 567
            L         +D++  G ++ EM T       + E++ + L   L   +T E
Sbjct: 200 LLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE 252

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 49/202 (24%), Positives = 88/202 (43%), Gaps = 40/202 (19%)
Query: 367 KINGGFAAIKKVNG--------DVSKEIALLNKINHSNLIILSGVC-------FNEGNCY 411
           K  G   AIKK+             +EI +L    H N+I +  +        FNE   Y
Sbjct: 33  KPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE--VY 90
Query: 412 LVYEYA---VNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDI 468
           ++ E     ++  +S  + S+ +   ++    R   A+ V  G N          +H+D+
Sbjct: 91  IIQELMQTDLHRVISTQMLSDDHIQYFIYQTLR---AVKVLHGSNV---------IHRDL 138
Query: 469 NSSNVLLDSDLRAKIANFAMAR-----PAEGQE--GEFALTRHIVGTKGYMAPE-YLENG 520
             SN+L++S+   K+ +F +AR      A+  E  G+ +     V T+ Y APE  L + 
Sbjct: 139 KPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEYVATRWYRAPEVMLTSA 198
Query: 521 LVSTKLDVYAFGVLILEMLTGK 542
             S  +DV++ G ++ E+   +
Sbjct: 199 KYSRAMDVWSCGCILAELFLRR 220

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 62/231 (26%), Positives = 95/231 (41%), Gaps = 24/231 (10%)
Query: 361 GSVYRGKINGGFAAIKKVNGDVS---KEIALLNKINHSNLIILSGVCFNEGNCYLVYEYA 417
           G VY  KI   +  +K+  G+VS   +E  +L   +   +  L     +E   YLV EY 
Sbjct: 86  GQVYAMKIMNKWDMLKR--GEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYY 143
Query: 418 VNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDS 477
           V G L      +K   +      R  +A ++   ++ +H      +VH+DI   N+LLD 
Sbjct: 144 VGGDLL--TLLSKFGERIPAEMARFYLA-EIVMAIDSVHRLG---YVHRDIKPDNILLDR 197
Query: 478 DLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLE-------NGLVSTKLDVYA 530
               ++A+F             +L    VGT  Y++PE L+        G    + D +A
Sbjct: 198 CGHIRLADFGSCLKLRADGTVRSLV--AVGTPDYLSPEILQAVGGGPGTGSYGPECDWWA 255
Query: 531 FGVLILEMLTGKEA--AALHAEENN--MHLSDVLNAVLTKEDGEESLRHFI 577
            GV   EM  G+    A   AE     +H  + L+  L  E   E  R FI
Sbjct: 256 LGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDEGVPEEARDFI 306

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 43/163 (26%), Positives = 75/163 (46%), Gaps = 9/163 (5%)
Query: 382 VSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQR 441
           V +EI LLN  +H N++ L  +  +     +   Y V   +   +    ++ + +   Q 
Sbjct: 76  VLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQH 135
Query: 442 IQIAL-DVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFA 500
           IQ  +  +  GL+ LH       VH+D++  N+LL  +    I +F +AR    ++   A
Sbjct: 136 IQYFMYHILLGLHVLHEAGV---VHRDLHPGNILLADNNDITICDFNLAR----EDTADA 188
Query: 501 LTRHIVGTKGYMAPEYLENGLVSTKL-DVYAFGVLILEMLTGK 542
              H V  + Y APE +      TKL D+++ G ++ EM   K
Sbjct: 189 NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 43/163 (26%), Positives = 75/163 (46%), Gaps = 9/163 (5%)
Query: 382 VSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQR 441
           V +EI LLN  +H N++ L  +  +     +   Y V   +   +    ++ + +   Q 
Sbjct: 76  VLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQH 135
Query: 442 IQIAL-DVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFA 500
           IQ  +  +  GL+ LH       VH+D++  N+LL  +    I +F +AR    ++   A
Sbjct: 136 IQYFMYHILLGLHVLHEAGV---VHRDLHPGNILLADNNDITICDFNLAR----EDTADA 188
Query: 501 LTRHIVGTKGYMAPEYLENGLVSTKL-DVYAFGVLILEMLTGK 542
              H V  + Y APE +      TKL D+++ G ++ EM   K
Sbjct: 189 NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 40/165 (24%), Positives = 76/165 (46%), Gaps = 17/165 (10%)
Query: 363 VYRGKINGGFAAIKKVNGD----VSKEIALLNKIN-HSNLIILSGVCFNEGNCYLVYEYA 417
           VYRG  +    A+K++  +      +E+ LL + + H N+I       +    Y+  E  
Sbjct: 41  VYRGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC 100
Query: 418 VNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLD- 476
              TL ++V   + +  +L  +  I +     +GL +LHS      VH+D+   N+L+  
Sbjct: 101 A-ATLQEYV--EQKDFAHLGLEP-ITLLQQTTSGLAHLHSLNI---VHRDLKPHNILISM 153
Query: 477 ----SDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYL 517
                 ++A I++F + +        F+    + GT+G++APE L
Sbjct: 154 PNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEML 198

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 57/264 (21%), Positives = 110/264 (41%), Gaps = 48/264 (18%)
Query: 369 NGGFAAIKKVNGDVS--KEIALLNKINHSN-------LIILSGVCFNEGNCYLVYEYAVN 419
           +G   A+K++   V+  ++  LL  ++ S         +   G  F EG+ ++  E   +
Sbjct: 58  SGQIXAVKRIRATVNSQEQKRLLXDLDISXRTVDCPFTVTFYGALFREGDVWICXELX-D 116
Query: 420 GTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDL 479
            +L  +     ++G+ +      +IA+ +   L +LHS  +   +H+D+  SNVL+++  
Sbjct: 117 TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS--VIHRDVKPSNVLINALG 174
Query: 480 RAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGL----VSTKLDVYAFGVLI 535
           + K  +F ++    G   +        G K Y APE +   L     S K D+++ G+  
Sbjct: 175 QVKXCDFGIS----GYLVDDVAKDIDAGCKPYXAPERINPELNQKGYSVKSDIWSLGITX 230
Query: 536 LEMLTGKEAAALHAEENN-----MHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELA 590
           +E+      A L    ++       L  V+     +   ++    F+D T Q        
Sbjct: 231 IEL------AILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFSAEFVDFTSQ-------- 276
Query: 591 LLVIRLIDACLKKDPTDRPTMYEI 614
                    CLKK+  +RPT  E+
Sbjct: 277 ---------CLKKNSKERPTYPEL 291

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 60/233 (25%), Positives = 105/233 (45%), Gaps = 38/233 (16%)
Query: 361 GSVY--RGKINGGFAAIKKVNGDVSKE---------IALLNKINHSNLIILSGVC----- 404
           G V+  R +  G   A+KKV  +  KE         I +L  + H N++ L  +C     
Sbjct: 32  GEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKAS 91
Query: 405 -FN--EGNCYLVY---EYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSF 458
            +N  + + YLV+   E+ + G LS+ +     +    + K+ +Q+ L+   GL Y+H  
Sbjct: 92  PYNRCKASIYLVFDFCEHDLAGLLSNVLV----KFTLSEIKRVMQMLLN---GLYYIHRN 144
Query: 459 TNPPHVHKDINSSNVLLDSDLRAKIANFAMARP---AEGQEGEFALTRHIVGTKGYMAPE 515
                +H+D+ ++NVL+  D   K+A+F +AR    A+  +      R  V T  Y  PE
Sbjct: 145 KI---LHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNR--VVTLWYRPPE 199
Query: 516 YLENGL-VSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKE 567
            L         +D++  G ++ EM T       + E++ + L   L   +T E
Sbjct: 200 LLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE 252

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 60/243 (24%), Positives = 102/243 (41%), Gaps = 41/243 (16%)
Query: 385 EIALLNKIN-HSNLII-LSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRI 442
           EIA LNK+  HS+ II L      +   Y+V E   N  L+ W+   K+    +D  +R 
Sbjct: 76  EIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKS----IDPWERK 130
Query: 443 QIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALT 502
               ++   ++ +H       VH D+  +N L+  D   K+ +F +A   +  +    + 
Sbjct: 131 SYWKNMLEAVHTIHQHGI---VHSDLKPANFLI-VDGMLKLIDFGIANQMQP-DXXXVVK 185
Query: 503 RHIVGTKGYMAPEYL-------ENGLVSTKL----DVYAFGVLILEMLTGKEAAALHAEE 551
              VGT  YM PE +       ENG   +K+    DV++ G ++  M  GK         
Sbjct: 186 DSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP------- 238
Query: 552 NNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTM 611
                  ++N +         L   IDP  +  +P      +  ++  CLK+DP  R ++
Sbjct: 239 ----FQQIINQI-------SKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISI 287
Query: 612 YEI 614
            E+
Sbjct: 288 PEL 290

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 40/161 (24%), Positives = 70/161 (43%), Gaps = 27/161 (16%)
Query: 464 VHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLE----- 518
           +H+D+  SN+LLD   + K+ +F ++    G+  +        G   YMAPE ++     
Sbjct: 147 IHRDVKPSNILLDERGQIKLCDFGIS----GRLVDDKAKDRSAGCAAYMAPERIDPPDPT 202
Query: 519 NGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFID 578
                 + DV++ G+ ++E+ TG+        +N     +VL  VL +E           
Sbjct: 203 KPDYDIRADVWSLGISLVELATGQ-----FPYKNCKTDFEVLTKVLQEE----------P 247
Query: 579 PTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYE-IEHSL 618
           P L G+  +  +      +  CL KD   RP   + +EHS 
Sbjct: 248 PLLPGH--MGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSF 286

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 42.7 bits (99), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 34/143 (23%), Positives = 68/143 (47%), Gaps = 19/143 (13%)
Query: 411 YLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINS 470
           YLV+E    G+    + ++  + K+ + ++  ++  DVA  L++LH+       H+D+  
Sbjct: 87  YLVFEKLQGGS----ILAHIQKQKHFNEREASRVVRDVAAALDFLHT---KGIAHRDLKP 139
Query: 471 SNVLLDSDLR---AKIANFAMARPAEGQEGEFALTRHIV----GTKGYMAPEYLE----- 518
            N+L +S  +    KI +F +    +       +T   +    G+  YMAPE +E     
Sbjct: 140 ENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQ 199
Query: 519 NGLVSTKLDVYAFGVLILEMLTG 541
                 + D+++ GV++  ML+G
Sbjct: 200 ATFYDKRCDLWSLGVVLYIMLSG 222

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 60/243 (24%), Positives = 100/243 (41%), Gaps = 41/243 (16%)
Query: 385 EIALLNKIN-HSNLII-LSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRI 442
           EIA LNK+  HS+ II L      +   Y+V E   N  L+ W+   K+    +D  +R 
Sbjct: 57  EIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKS----IDPWERK 111
Query: 443 QIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALT 502
               ++   ++ +H       VH D+  +N L+  D   K+ +F +A   +         
Sbjct: 112 SYWKNMLEAVHTIHQHGI---VHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKD 167
Query: 503 RHIVGTKGYMAPEYL-------ENGLVSTKL----DVYAFGVLILEMLTGKEAAALHAEE 551
              VGT  YM PE +       ENG   +K+    DV++ G ++  M  GK         
Sbjct: 168 SQ-VGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP------- 219
Query: 552 NNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTM 611
                  ++N +         L   IDP  +  +P      +  ++  CLK+DP  R ++
Sbjct: 220 ----FQQIINQI-------SKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISI 268
Query: 612 YEI 614
            E+
Sbjct: 269 PEL 271

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 60/243 (24%), Positives = 100/243 (41%), Gaps = 41/243 (16%)
Query: 385 EIALLNKIN-HSNLII-LSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRI 442
           EIA LNK+  HS+ II L      +   Y+V E   N  L+ W+   K+    +D  +R 
Sbjct: 60  EIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKS----IDPWERK 114
Query: 443 QIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALT 502
               ++   ++ +H       VH D+  +N L+  D   K+ +F +A   +         
Sbjct: 115 SYWKNMLEAVHTIHQHGI---VHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKD 170
Query: 503 RHIVGTKGYMAPEYL-------ENGLVSTKL----DVYAFGVLILEMLTGKEAAALHAEE 551
              VGT  YM PE +       ENG   +K+    DV++ G ++  M  GK         
Sbjct: 171 SQ-VGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP------- 222
Query: 552 NNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTM 611
                  ++N +         L   IDP  +  +P      +  ++  CLK+DP  R ++
Sbjct: 223 ----FQQIINQI-------SKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISI 271
Query: 612 YEI 614
            E+
Sbjct: 272 PEL 274

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 42.4 bits (98), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 60/243 (24%), Positives = 100/243 (41%), Gaps = 41/243 (16%)
Query: 385 EIALLNKIN-HSNLII-LSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRI 442
           EIA LNK+  HS+ II L      +   Y+V E   N  L+ W+   K+    +D  +R 
Sbjct: 104 EIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKS----IDPWERK 158
Query: 443 QIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALT 502
               ++   ++ +H       VH D+  +N L+  D   K+ +F +A   +         
Sbjct: 159 SYWKNMLEAVHTIHQHGI---VHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKD 214
Query: 503 RHIVGTKGYMAPEYL-------ENGLVSTKL----DVYAFGVLILEMLTGKEAAALHAEE 551
              VGT  YM PE +       ENG   +K+    DV++ G ++  M  GK         
Sbjct: 215 SQ-VGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP------- 266
Query: 552 NNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTM 611
                  ++N +         L   IDP  +  +P      +  ++  CLK+DP  R ++
Sbjct: 267 ----FQQIINQI-------SKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISI 315
Query: 612 YEI 614
            E+
Sbjct: 316 PEL 318

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 42.4 bits (98), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 60/243 (24%), Positives = 100/243 (41%), Gaps = 41/243 (16%)
Query: 385 EIALLNKIN-HSNLII-LSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRI 442
           EIA LNK+  HS+ II L      +   Y+V E   N  L+ W+   K+    +D  +R 
Sbjct: 76  EIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKS----IDPWERK 130
Query: 443 QIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALT 502
               ++   ++ +H       VH D+  +N L+  D   K+ +F +A   +         
Sbjct: 131 SYWKNMLEAVHTIHQHGI---VHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKD 186
Query: 503 RHIVGTKGYMAPEYL-------ENGLVSTKL----DVYAFGVLILEMLTGKEAAALHAEE 551
              VGT  YM PE +       ENG   +K+    DV++ G ++  M  GK         
Sbjct: 187 SQ-VGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP------- 238
Query: 552 NNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTM 611
                  ++N +         L   IDP  +  +P      +  ++  CLK+DP  R ++
Sbjct: 239 ----FQQIINQI-------SKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISI 287
Query: 612 YEI 614
            E+
Sbjct: 288 PEL 290

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 42.4 bits (98), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 60/243 (24%), Positives = 100/243 (41%), Gaps = 41/243 (16%)
Query: 385 EIALLNKIN-HSNLII-LSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRI 442
           EIA LNK+  HS+ II L      +   Y+V E   N  L+ W+   K+    +D  +R 
Sbjct: 56  EIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKS----IDPWERK 110
Query: 443 QIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALT 502
               ++   ++ +H       VH D+  +N L+  D   K+ +F +A   +         
Sbjct: 111 SYWKNMLEAVHTIHQHGI---VHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKD 166
Query: 503 RHIVGTKGYMAPEYL-------ENGLVSTKL----DVYAFGVLILEMLTGKEAAALHAEE 551
              VGT  YM PE +       ENG   +K+    DV++ G ++  M  GK         
Sbjct: 167 SQ-VGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP------- 218
Query: 552 NNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTM 611
                  ++N +         L   IDP  +  +P      +  ++  CLK+DP  R ++
Sbjct: 219 ----FQQIINQI-------SKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISI 267
Query: 612 YEI 614
            E+
Sbjct: 268 PEL 270

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 42.4 bits (98), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 61/243 (25%), Positives = 100/243 (41%), Gaps = 41/243 (16%)
Query: 385 EIALLNKIN-HSNLII-LSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRI 442
           EIA LNK+  HS+ II L      +   Y+V E   N  L+ W+   K+    +D  +R 
Sbjct: 104 EIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKS----IDPWERK 158
Query: 443 QIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALT 502
               ++   L  +H+      VH D+  +N L+  D   K+ +F +A   +         
Sbjct: 159 SYWKNM---LEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKD 214
Query: 503 RHIVGTKGYMAPEYL-------ENGLVSTKL----DVYAFGVLILEMLTGKEAAALHAEE 551
              VGT  YM PE +       ENG   +K+    DV++ G ++  M  GK         
Sbjct: 215 SQ-VGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP------- 266
Query: 552 NNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTM 611
                  ++N +         L   IDP  +  +P      +  ++  CLK+DP  R ++
Sbjct: 267 ----FQQIINQI-------SKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISI 315
Query: 612 YEI 614
            E+
Sbjct: 316 PEL 318

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	628
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	7e-78
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	9e-78
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	2e-76
3soc_A	322	Activin receptor type-2A; structural genomics cons	3e-70
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	4e-62
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	1e-57
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	6e-57
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	3e-56
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	5e-56
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	8e-53
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	8e-52
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	2e-51
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	3e-51
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	4e-51
3q4u_A	301	Activin receptor type-1; structural genomics conso	4e-50
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	6e-50
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	2e-48
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	4e-48
4eby_A	212	Chitin elicitor receptor kinase 1; pathogen-associ	2e-39
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	7e-37
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	1e-36
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	3e-35
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	4e-35
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	2e-34
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	2e-34
2a19_B	284	Interferon-induced, double-stranded RNA-activated	3e-33
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	3e-33
3pls_A	298	Macrophage-stimulating protein receptor; protein k	4e-33
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	7e-33
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	1e-32
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	2e-32
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	2e-32
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	3e-32
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	5e-32
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	6e-32
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	1e-31
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	1e-31
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	1e-31
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	2e-31
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	2e-31
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	3e-31
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	3e-31
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	4e-31
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	4e-31
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	4e-31
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	5e-31
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	6e-31
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	6e-31
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	7e-31
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	7e-31
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	8e-31
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	1e-30
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	2e-30
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	3e-30
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	3e-30
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	7e-30
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	8e-30
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	8e-30
4aoj_A	329	High affinity nerve growth factor receptor; transf	1e-29
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	1e-29
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	2e-29
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	3e-29
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	4e-29
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	4e-29
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	4e-29
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	4e-29
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	5e-29
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	9e-29
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	9e-29
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	1e-28
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	1e-28
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	1e-28
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	2e-28
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	2e-28
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	2e-28
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	2e-28
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	3e-28
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	1e-27
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	1e-27
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	2e-27
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	2e-27
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	2e-27
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	3e-27
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	3e-27
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	3e-27
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	6e-27
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	7e-27
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	1e-26
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	2e-26
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	4e-26
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	5e-26
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	9e-26
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	3e-25
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	3e-25
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	6e-25
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	7e-25
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	7e-25
3an0_A	340	Dual specificity mitogen-activated protein kinase;	1e-24
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	1e-24
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	2e-24
3ork_A	311	Serine/threonine protein kinase; structural genomi	3e-24
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	4e-24
3fme_A	290	Dual specificity mitogen-activated protein kinase;	4e-24
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	1e-23
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	2e-23
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	2e-23
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	2e-23
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	2e-23
3aln_A	327	Dual specificity mitogen-activated protein kinase;	4e-23
2dyl_A	318	Dual specificity mitogen-activated protein kinase	4e-23
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	4e-23
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	8e-23
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	1e-22
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	2e-22
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	3e-22
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	3e-21
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	3e-21
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	4e-21
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	4e-21
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	5e-21
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	2e-20
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	9e-20
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	5e-19
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	5e-19
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	9e-19
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	3e-18
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	6e-18
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	7e-18
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	9e-18
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	9e-18
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	2e-17
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	3e-17
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	4e-17
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	5e-17
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	7e-17
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	7e-17
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	1e-16
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	1e-16
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	1e-16
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	2e-16
3bhy_A	283	Death-associated protein kinase 3; death associate	2e-16
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	3e-16
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	4e-16
3niz_A	311	Rhodanese family protein; structural genomics, str	4e-16
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	4e-16
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	4e-16
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	4e-16
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	5e-16
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	5e-16
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	5e-16
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	6e-16
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	9e-16
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	1e-15
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	1e-15
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	1e-15
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	1e-15
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	1e-15
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	1e-15
3o0g_A	292	Cell division protein kinase 5; kinase activator c	2e-15
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	2e-15
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	3e-15
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	3e-15
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	3e-15
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	3e-15
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	3e-15
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	3e-15
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	3e-15
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	6e-15
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	8e-15
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	9e-15
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	9e-15
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	1e-14
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	1e-14
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	1e-14
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	1e-14
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	2e-14
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	2e-14
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	3e-14
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	3e-14
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	3e-14
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	4e-14
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	7e-14
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	7e-14
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	1e-13
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	1e-13
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	1e-13
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	2e-13
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	2e-13
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	2e-13
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	3e-13
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	3e-13
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	4e-13
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	5e-13
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	1e-12
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	1e-12
3uqc_A	286	Probable conserved transmembrane protein; structur	1e-12
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	1e-12
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	1e-12
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	2e-12
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	2e-12
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	4e-12
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	5e-12
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	5e-12
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	7e-12
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	7e-12
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	8e-12
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	9e-12
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	1e-11
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	2e-11
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	4e-11
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	4e-11
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	5e-11
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	1e-10
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	2e-04
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	2e-10
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	3e-10
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	3e-10
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	4e-10
2djp_A	77	Hypothetical protein SB145; LYSM, structural genom	4e-10
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	1e-09
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	5e-09
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	3e-08
3rp9_A	458	Mitogen-activated protein kinase; structural genom	5e-08
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	1e-07
1e0g_A	48	Membrane-bound lytic murein transglycosylase D; ce	7e-07
2l9y_A	167	CVNH-LYSM lectin; carbohydrate, sugar binding prot	2e-06
2l9y_A	167	CVNH-LYSM lectin; carbohydrate, sugar binding prot	3e-05
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	5e-06
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	1e-04
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	2e-04
1y7m_A	164	Hypothetical protein BSU14040; surface mutagenesis	4e-04

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  249 bits (637), Expect = 7e-78
 Identities = 91/323 (28%), Positives = 148/323 (45%), Gaps = 45/323 (13%)

Query: 329 ESISGVAQSLKVYSFKELQSATDNFSFTCRIQ----------GSVYRGKINGGFAAIKKV 378
           +S+         +SF EL++ T+NF                 G VY+G +N    A+KK+
Sbjct: 3   KSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKL 62

Query: 379 NGDVSK-----------EIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVF 427
              V             EI ++ K  H NL+ L G   +  +  LVY Y  NG+L D + 
Sbjct: 63  AAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLS 122

Query: 428 SNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFA 487
              +    L W  R +IA   A G+N+LH      H+H+DI S+N+LLD    AKI++F 
Sbjct: 123 -CLDGTPPLSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFG 178

Query: 488 MARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAAL 547
           +AR +  +  +  +T  IVGT  YMAPE L  G ++ K D+Y+FGV++LE++TG  A   
Sbjct: 179 LARAS-EKFAQTVMTSRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDE 236

Query: 548 HAEENNM------HLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACL 601
           H E   +         +           E+++  +ID  +  +        +  +   CL
Sbjct: 237 HREPQLLLDIKEEIEDE-----------EKTIEDYIDKKM-NDADSTSVEAMYSVASQCL 284

Query: 602 KKDPTDRPTMYEIEHSLSNILNA 624
            +    RP + +++  L  +  +
Sbjct: 285 HEKKNKRPDIKKVQQLLQEMTAS 307

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  249 bits (638), Expect = 9e-78
 Identities = 100/314 (31%), Positives = 168/314 (53%), Gaps = 24/314 (7%)

Query: 320 FDEESQDFLESISGVAQSLKVYSFKELQSATDNFSFTCRIQ----GSVYRGKI-NGGFAA 374
           FD  +++  E   G    LK +S +ELQ A+DNFS    +     G VY+G++ +G   A
Sbjct: 2   FDVPAEEDPEVHLG---QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVA 58

Query: 375 IKKVNGDVSK--------EIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWV 426
           +K++  + ++        E+ +++   H NL+ L G C       LVY Y  NG+++  +
Sbjct: 59  VKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCL 118

Query: 427 FSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANF 486
                    LDW +R +IAL  A GL YLH   +P  +H+D+ ++N+LLD +  A + +F
Sbjct: 119 RERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDF 178

Query: 487 AMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEA-- 544
            +A+  +    +  +T  + GT G++APEYL  G  S K DV+ +GV++LE++TG+ A  
Sbjct: 179 GLAKLMD--YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 236

Query: 545 AALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKD 604
            A  A ++++ L D +  +L ++  E      +D  LQGNY  E    +I++   C +  
Sbjct: 237 LARLANDDDVMLLDWVKGLLKEKKLEA----LVDVDLQGNYKDEEVEQLIQVALLCTQSS 292

Query: 605 PTDRPTMYEIEHSL 618
           P +RP M E+   L
Sbjct: 293 PMERPKMSEVVRML 306

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  245 bits (627), Expect = 2e-76
 Identities = 86/323 (26%), Positives = 137/323 (42%), Gaps = 27/323 (8%)

Query: 314 KPSNKKFDEESQDFLESISGVAQSLKVYSFKELQSATDNFSFTCRIQ----GSVYRGKIN 369
           K +N   D  S  +L                +L+ AT+NF     I     G VY+G + 
Sbjct: 7   KATNSINDALSSSYLVPFES-----YRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLR 61

Query: 370 GGFA-AIKKVNGDVSK--------EIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNG 420
            G   A+K+   + S         EI  L+   H +L+ L G C       L+Y+Y  NG
Sbjct: 62  DGAKVALKRRTPE-SSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENG 120

Query: 421 TLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLR 480
            L   ++ +      + W+QR++I +  A GL+YLH       +H+D+ S N+LLD +  
Sbjct: 121 NLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLDENFV 177

Query: 481 AKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT 540
            KI +F +++     +     T  + GT GY+ PEY   G ++ K DVY+FGV++ E+L 
Sbjct: 178 PKITDFGISKKGTELDQTHLSTV-VKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLC 236

Query: 541 GKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDAC 600
            + A         ++L++              L   +DP L      E           C
Sbjct: 237 ARSAIVQSLPREMVNLAEWAVESHNNGQ----LEQIVDPNLADKIRPESLRKFGDTAVKC 292

Query: 601 LKKDPTDRPTMYEIEHSLSNILN 623
           L     DRP+M ++   L   L 
Sbjct: 293 LALSSEDRPSMGDVLWKLEYALR 315

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  229 bits (586), Expect = 3e-70
 Identities = 69/308 (22%), Positives = 126/308 (40%), Gaps = 34/308 (11%)

Query: 342 SFKELQSATDNFSFTCRIQ----GSVYRGKINGGFAAIKKVNG------DVSKEIALLNK 391
             + L   +              G V++ ++   + A+K              E+  L  
Sbjct: 15  GTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQDKQSWQNEYEVYSLPG 74

Query: 392 INHSNLIILSGVCFNEGN----CYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALD 447
           + H N++   G      +     +L+  +   G+LSD++ +N      + W +   IA  
Sbjct: 75  MKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV-----VSWNELCHIAET 129

Query: 448 VATGLNYLHS-------FTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFA 500
           +A GL YLH           P   H+DI S NVLL ++L A IA+F +A   E  +    
Sbjct: 130 MARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSA-G 188

Query: 501 LTRHIVGTKGYMAPEYLENGL-----VSTKLDVYAFGVLILEMLTGKEAAALHAEENNMH 555
            T   VGT+ YMAPE LE  +        ++D+YA G+++ E+ +   AA    +E  + 
Sbjct: 189 DTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLP 248

Query: 556 LSDVLNAVLTKEDGEES-LRHFIDPTLQGNYPLELAL-LVIRLIDACLKKDPTDRPTMYE 613
             + +    + ED +E  +     P L+  +     + ++   I+ C   D   R +   
Sbjct: 249 FEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGC 308

Query: 614 IEHSLSNI 621
           +   ++ +
Sbjct: 309 VGERITQM 316

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  207 bits (529), Expect = 4e-62
 Identities = 73/276 (26%), Positives = 137/276 (49%), Gaps = 33/276 (11%)

Query: 360 QGSVYRGKINGGFAAIKKVNG---------DVSKEIALLNKINHSNLIILSGVCFNEGNC 410
            G+V+R + +G   A+K +           +  +E+A++ ++ H N+++  G      N 
Sbjct: 50  FGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNL 109

Query: 411 YLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINS 470
            +V EY   G+L   +       + LD ++R+ +A DVA G+NYLH+  NPP VH+++ S
Sbjct: 110 SIVTEYLSRGSLYR-LLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR-NPPIVHRNLKS 167

Query: 471 SNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYA 530
            N+L+D     K+ +F ++R    +   F  ++   GT  +MAPE L +   + K DVY+
Sbjct: 168 PNLLVDKKYTVKVCDFGLSRL---KASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYS 224

Query: 531 FGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELA 590
           FGV++ E+ T ++         N++ + V+ AV     G +  R      +  N   ++A
Sbjct: 225 FGVILWELATLQQPWG------NLNPAQVVAAV-----GFKCKR----LEIPRNLNPQVA 269

Query: 591 LLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNASL 626
                +I+ C   +P  RP+   I   L  ++ +++
Sbjct: 270 ----AIIEGCWTNEPWKRPSFATIMDLLRPLIKSAV 301

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  195 bits (498), Expect = 1e-57
 Identities = 71/269 (26%), Positives = 118/269 (43%), Gaps = 33/269 (12%)

Query: 360 QGSVYRGKINGGFAAIKKVN-----GDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVY 414
            G V + K      AIK++           E+  L+++NH N++ L G C N     LV 
Sbjct: 21  FGVVCKAKWRAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVM 78

Query: 415 EYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVL 474
           EYA  G+L + V        Y      +   L  + G+ YLHS      +H+D+   N+L
Sbjct: 79  EYAEGGSLYN-VLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLL 137

Query: 475 LDSDLR-AKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGV 533
           L +     KI +F  A   +       +T +  G+  +MAPE  E    S K DV+++G+
Sbjct: 138 LVAGGTVLKICDFGTACDIQTH-----MTNN-KGSAAWMAPEVFEGSNYSEKCDVFSWGI 191

Query: 534 LILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLV 593
           ++ E++T ++      +E       ++ AV          R    P L  N P  +    
Sbjct: 192 ILWEVITRRKP----FDEIGGPAFRIMWAV------HNGTR----PPLIKNLPKPIE--- 234

Query: 594 IRLIDACLKKDPTDRPTMYEIEHSLSNIL 622
             L+  C  KDP+ RP+M EI   +++++
Sbjct: 235 -SLMTRCWSKDPSQRPSMEEIVKIMTHLM 262

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  194 bits (495), Expect = 6e-57
 Identities = 71/324 (21%), Positives = 114/324 (35%), Gaps = 51/324 (15%)

Query: 342 SFKELQSATDNFSFTCRI-QGS---VYRGKINGGFAAIKKVN-GDVS-----KEIALLNK 391
           +  E     DN      I +G    VY+G ++    A+K  +  +       K I  +  
Sbjct: 4   AASEPSLDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFANRQNFINEKNIYRVPL 63

Query: 392 INHSNLIILSGVC-----FNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIAL 446
           + H N+                   LV EY  NG+L  ++  +       DW    ++A 
Sbjct: 64  MEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT-----SDWVSSCRLAH 118

Query: 447 DVATGLNYLHS------FTNPPHVHKDINSSNVLLDSDLRAKIANFAMAR-----PAEGQ 495
            V  GL YLH+         P   H+D+NS NVL+ +D    I++F ++           
Sbjct: 119 SVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRP 178

Query: 496 EGEFALTRHIVGTKGYMAPEYLENGL-------VSTKLDVYAFGVLILEMLTGKEAAA-- 546
             E       VGT  YMAPE LE  +          ++D+YA G++  E+          
Sbjct: 179 GEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPG 238

Query: 547 LHAEENNMHLSDVLNAVLTKED-----GEESLRHFIDPTLQGNYPLELALL--VIRLIDA 599
               E  M     +    T ED       E  R    P     +      +  +   I+ 
Sbjct: 239 ESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQR----PKFPEAWKENSLAVRSLKETIED 294

Query: 600 CLKKDPTDRPTMYEIEHSLSNILN 623
           C  +D   R T    E  ++ ++ 
Sbjct: 295 CWDQDAEARLTAQXAEERMAELMM 318

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  190 bits (485), Expect = 3e-56
 Identities = 75/281 (26%), Positives = 112/281 (39%), Gaps = 48/281 (17%)

Query: 360 QGSVYRGKINGGFAAIKKVNG-----------DVSKEIALLNKINHSNLIILSGVCFNEG 408
            G VYR    G   A+K               +V +E  L   + H N+I L GVC  E 
Sbjct: 20  FGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEP 79

Query: 409 NCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDI 468
           N  LV E+A  G L+  +      GK +     +  A+ +A G+NYLH     P +H+D+
Sbjct: 80  NLCLVMEFARGGPLNRVL-----SGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDL 134

Query: 469 NSSNVLLDSDLR--------AKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENG 520
            SSN+L+   +          KI +F +AR                G   +MAPE +   
Sbjct: 135 KSSNILILQKVENGDLSNKILKITDFGLAREWHRTT-----KMSAAGAYAWMAPEVIRAS 189

Query: 521 LVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPT 580
           + S   DV+++GVL+ E+LTG+           +    V   V         L       
Sbjct: 190 MFSKGSDVWSYGVLLWELLTGEVPFR------GIDGLAVAYGV-----AMNKLA----LP 234

Query: 581 LQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNI 621
           +    P   A    +L++ C   DP  RP+   I   L+ I
Sbjct: 235 IPSTCPEPFA----KLMEDCWNPDPHSRPSFTNILDQLTTI 271

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  189 bits (483), Expect = 5e-56
 Identities = 56/277 (20%), Positives = 117/277 (42%), Gaps = 44/277 (15%)

Query: 361 GSVYRGKINGGFAAIKKVNG---------DVSKEIALLNKINHSNLIILSGVCFN--EGN 409
           G +++G+  G    +K +           D ++E   L   +H N++ + G C +    +
Sbjct: 24  GELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPH 83

Query: 410 CYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDIN 469
             L+  +   G+L + +  ++     +D  Q ++ ALD+A G+ +LH+   P      +N
Sbjct: 84  PTLITHWMPYGSLYNVL--HEGTNFVVDQSQAVKFALDMARGMAFLHTL-EPLIPRHALN 140

Query: 470 SSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLEN---GLVSTKL 526
           S +V++D D+ A+I+   +             +   +    ++APE L+           
Sbjct: 141 SRSVMIDEDMTARISMADVKF--------SFQSPGRMYAPAWVAPEALQKKPEDTNRRSA 192

Query: 527 DVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYP 586
           D+++F VL+ E++T +   A      ++   ++   V       E LR    PT+     
Sbjct: 193 DMWSFAVLLWELVTREVPFA------DLSNMEIGMKV-----ALEGLR----PTIPPGIS 237

Query: 587 LELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILN 623
             ++    +L+  C+ +DP  RP    I   L  + +
Sbjct: 238 PHVS----KLMKICMNEDPAKRPKFDMIVPILEKMQD 270

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  181 bits (462), Expect = 8e-53
 Identities = 70/284 (24%), Positives = 127/284 (44%), Gaps = 52/284 (18%)

Query: 361 GSVYRG--KINGGFAAIKKVNGDVS--------------KEIALLNKINHSNLIILSGVC 404
           G V++G    +    AIK +    S              +E+ +++ +NH N++ L G+ 
Sbjct: 33  GLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLM 92

Query: 405 FNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHV 464
            N     +V E+   G L   +    ++   + W  ++++ LD+A G+ Y+ +  NPP V
Sbjct: 93  HN--PPRMVMEFVPCGDLYHRL---LDKAHPIKWSVKLRLMLDIALGIEYMQNQ-NPPIV 146

Query: 465 HKDINSSNVLLDS-----DLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYL-- 517
           H+D+ S N+ L S      + AK+A+F +++ +            ++G   +MAPE +  
Sbjct: 147 HRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHS------VSGLLGNFQWMAPETIGA 200

Query: 518 ENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFI 577
           E    + K D Y+F +++  +LTG+       E +   +   +N +      EE LR   
Sbjct: 201 EEESYTEKADTYSFAMILYTILTGEGP---FDEYSYGKIK-FINMI-----REEGLR--- 248

Query: 578 DPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNI 621
            PT+  + P  L      +I+ C   DP  RP    I   LS +
Sbjct: 249 -PTIPEDCPPRLR----NVIELCWSGDPKKRPHFSYIVKELSEL 287

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  180 bits (458), Expect = 2e-51
 Identities = 66/289 (22%), Positives = 119/289 (41%), Gaps = 36/289 (12%)

Query: 361 GSVYRGKINGGFAAIKKVNGDVS------KEIALLNKINHSNLIILSGVCFNEGN----C 410
           G V+RGK  G   A+K  +           EI     + H N++        +       
Sbjct: 56  GEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL 115

Query: 411 YLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFT-----NPPHVH 465
           +LV +Y  +G+L D++         +  +  I++AL  A+GL +LH         P   H
Sbjct: 116 WLVSDYHEHGSLFDYLNRYT-----VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAH 170

Query: 466 KDINSSNVLLDSDLRAKIANFAMARP-AEGQEGEFALTRHIVGTKGYMAPEYLENGL--- 521
           +D+ S N+L+  +    IA+  +A       +       H VGTK YMAPE L++ +   
Sbjct: 171 RDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMK 230

Query: 522 ---VSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKED-----GEESL 573
                 + D+YA G++  E+        +H +    +  D++ +  + E+      E+ L
Sbjct: 231 HFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY-YDLVPSDPSVEEMRKVVCEQKL 289

Query: 574 RHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNIL 622
           R  I    Q    L    ++ +++  C   +   R T   I+ +LS + 
Sbjct: 290 RPNIPNRWQSCEALR---VMAKIMRECWYANGAARLTALRIKKTLSQLS 335

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  179 bits (455), Expect = 3e-51
 Identities = 76/344 (22%), Positives = 133/344 (38%), Gaps = 51/344 (14%)

Query: 315 PSNKKFDEESQDFLESISGVAQSLKVY--SFKELQSATDNFSFTCRI-QGS---VYRGKI 368
           P  +   +  +    S SG    L V     K++Q          +I +G    V+ GK 
Sbjct: 6   PPGESLRDLIEQSQSSGSGSGLPLLVQRTIAKQIQ-------MVKQIGKGRYGEVWMGKW 58

Query: 369 NGGFAAIKKVNGDVS------KEIALLNKINHSNLIILSGVC----FNEGNCYLVYEYAV 418
            G   A+K              EI     + H N++           +    YL+ +Y  
Sbjct: 59  RGEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHE 118

Query: 419 NGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFT-----NPPHVHKDINSSNV 473
           NG+L D++ S       LD K  +++A    +GL +LH+        P   H+D+ S N+
Sbjct: 119 NGSLYDYLKSTT-----LDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNI 173

Query: 474 LLDSDLRAKIANFAMARPAEGQEGE-FALTRHIVGTKGYMAPEYLENGL------VSTKL 526
           L+  +    IA+  +A        E        VGTK YM PE L+  L           
Sbjct: 174 LVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMA 233

Query: 527 DVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKED-----GEESLRHFIDPTL 581
           D+Y+FG+++ E+     +     EE  +   D++ +  + ED       + LR    P+ 
Sbjct: 234 DMYSFGLILWEVARRCVSGG-IVEEYQLPYHDLVPSDPSYEDMREIVCIKKLR----PSF 288

Query: 582 QGNYPLELALLVIR-LIDACLKKDPTDRPTMYEIEHSLSNILNA 624
              +  +  L  +  L+  C   +P  R T   ++ +L+ +  +
Sbjct: 289 PNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSES 332

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  177 bits (452), Expect = 4e-51
 Identities = 64/283 (22%), Positives = 113/283 (39%), Gaps = 44/283 (15%)

Query: 361 GSVYRG--KINGGFAAIKKVNG-------DVSKEIALLNKINHSNLIILSGVCFNEGNCY 411
           G   +   +  G    +K++            KE+ ++  + H N++   GV + +    
Sbjct: 24  GQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLN 83

Query: 412 LVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSS 471
            + EY   GTL   +   K+      W QR+  A D+A+G+ YLHS      +H+D+NS 
Sbjct: 84  FITEYIKGGTLRGII---KSMDSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSH 137

Query: 472 NVLLDSDLRAKIANFAMAR-----------PAEGQEGEFALTRHIVGTKGYMAPEYLENG 520
           N L+  +    +A+F +AR               ++ +      +VG   +MAPE +   
Sbjct: 138 NCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGR 197

Query: 521 LVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPT 580
               K+DV++FG+++ E++    A      +      D    V          R F+D  
Sbjct: 198 SYDEKVDVFSFGIVLCEIIGRVNA----DPDYLPRTMDFGLNV----------RGFLDRY 243

Query: 581 LQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILN 623
              N P         +   C   DP  RP+  ++EH L  +  
Sbjct: 244 CPPNCPPSFF----PITVRCCDLDPEKRPSFVKLEHWLETLRM 282

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  175 bits (445), Expect = 4e-50
 Identities = 64/289 (22%), Positives = 117/289 (40%), Gaps = 38/289 (13%)

Query: 361 GSVYRGKINGGFAAIKKVNGDVS------KEIALLNKINHSNLIILSGVC----FNEGNC 410
           G V+RG   G   A+K  +           E+     + H N++           +    
Sbjct: 22  GEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL 81

Query: 411 YLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHS-----FTNPPHVH 465
           +L+  Y   G+L D++         LD    ++I L +A+GL +LH         P   H
Sbjct: 82  WLITHYHEMGSLYDYLQLTT-----LDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAH 136

Query: 466 KDINSSNVLLDSDLRAKIANFAMAR--PAEGQEGEFALTRHIVGTKGYMAPEYLENGLV- 522
           +D+ S N+L+  + +  IA+  +A        + +       VGTK YMAPE L+  +  
Sbjct: 137 RDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNN-PRVGTKRYMAPEVLDETIQV 195

Query: 523 -----STKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKED-----GEES 572
                  ++D++AFG+++ E+     +     E+      DV+    + ED       + 
Sbjct: 196 DCFDSYKRVDIWAFGLVLWEVARRMVSNG-IVEDYKPPFYDVVPNDPSFEDMRKVVCVDQ 254

Query: 573 LRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNI 621
            R  I      +  L     + +L+  C  ++P+ R T   I+ +L+ I
Sbjct: 255 QRPNIPNRWFSDPTLT---SLAKLMKECWYQNPSARLTALRIKKTLTKI 300

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  174 bits (443), Expect = 6e-50
 Identities = 69/275 (25%), Positives = 121/275 (44%), Gaps = 36/275 (13%)

Query: 360 QGSVYRGKINGGFAAIKKVNG---------DVSKEIALLNKINHSNLIILSGVCFNEGNC 410
            G+VY+GK +G   A+K +N              E+ +L K  H N+++  G        
Sbjct: 37  FGTVYKGKWHGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQL 94

Query: 411 YLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINS 470
            +V ++    +L   +          + K+ I IA   A G++YLH+      +H+D+ S
Sbjct: 95  AIVTQWCEGSSLYHHL---HASETKFEMKKLIDIARQTARGMDYLHA---KSIIHRDLKS 148

Query: 471 SNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPE---YLENGLVSTKLD 527
           +N+ L  D   KI +F +A       G     +   G+  +MAPE     ++   S + D
Sbjct: 149 NNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLS-GSILWMAPEVIRMQDSNPYSFQSD 207

Query: 528 VYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPL 587
           VYAFG+++ E++TG+     ++  NN     ++  V     G  SL   +   ++ N P 
Sbjct: 208 VYAFGIVLYELMTGQL---PYSNINNR--DQIIEMV-----GRGSLSPDL-SKVRSNCPK 256

Query: 588 ELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNIL 622
            +     RL+  CLKK   +RP+   I   +  + 
Sbjct: 257 RMK----RLMAECLKKKRDERPSFPRILAEIEELA 287

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  170 bits (434), Expect = 2e-48
 Identities = 49/282 (17%), Positives = 102/282 (36%), Gaps = 47/282 (16%)

Query: 361 GSVYRGKINGGFAAIKKVNG---------DVSKEIALLNKINHSNLIILSGVCFNEGNCY 411
           G VY G+ +G   AI+ ++             +E+    +  H N+++  G C +  +  
Sbjct: 47  GQVYHGRWHGE-VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLA 105

Query: 412 LVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSS 471
           ++       TL   V   ++    LD  +  QIA ++  G+ YLH+      +HKD+ S 
Sbjct: 106 IITSLCKGRTLYSVV---RDAKIVLDVNKTRQIAQEIVKGMGYLHA---KGILHKDLKSK 159

Query: 472 NVLLDSDLRAKIANFAMARPAEGQEGEFALTRHI--VGTKGYMAPEYLENGLV------- 522
           NV  D + +  I +F +   +   +      +     G   ++APE +            
Sbjct: 160 NVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKL 218

Query: 523 --STKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPT 580
             S   DV+A G +  E+   +                ++  +         ++  +   
Sbjct: 219 PFSKHSDVFALGTIWYELHAREWPFK------TQPAEAIIWQM------GTGMKPNLSQI 266

Query: 581 LQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNIL 622
                  E++     ++  C   +  +RPT  ++   L  + 
Sbjct: 267 ---GMGKEIS----DILLFCWAFEQEERPTFTKLMDMLEKLP 301

>4eby_A Chitin elicitor receptor kinase 1; pathogen-associated molecular patterns, pattern recognition receptors, LYSM, lysine chitin oligomer; HET: NAG BMA; 1.65A {Arabidopsis thaliana} PDB: 4ebz_A* Length = 212

 Score =  142 bits (360), Expect = 2e-39
 Identities = 46/207 (22%), Positives = 86/207 (41%), Gaps = 21/207 (10%)

Query: 57  NKSCRAYLTFRSQPPFNTVASISTLLGSEPSLLSQINSV-------------SLETNRLV 103
             SC   L         T++ I+  L S  +   QIN                ++    V
Sbjct: 2   RTSCPLALASYYLENGTTLSVINQNLNSSIAPYDQINFDPILRYNSNIKDKDRIQMGSRV 61

Query: 104 IVPVNCSCS-GQYYQSNTTYTIQNGDTYLFIANNTFQGLSTCQALEDQNG-SPTNLIIGA 161
           +VP  C C  G +   N +Y+++  DTY  +A + +  L+T ++L+ +N    TN+ + A
Sbjct: 62  LVPFPCECQPGDFLGHNFSYSVRQEDTYERVAISNYANLTTMESLQARNPFPATNIPLSA 121

Query: 162 GVTVPLRCACPTENQTDEGFPFLLSYLVAEGDTVSGISSRFGVDTGEILQANSLSGSNIF 221
            + V + C+C  E+ +   F   ++Y +   D++S I+   GV    + + N     N  
Sbjct: 122 TLNVLVNCSCGDESVSK-DFGLFVTYPLRPEDSLSSIARSSGVSADILQRYNPGVNFNS- 179

Query: 222 PFTTLLIPLENPPTSSQTVEPPSSTPV 248
               + +P  +P  +     PP  +  
Sbjct: 180 GNGIVYVPGRDPNGA----FPPFKSSK 202

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  140 bits (355), Expect = 7e-37
 Identities = 65/282 (23%), Positives = 106/282 (37%), Gaps = 56/282 (19%)

Query: 361 GSVYRGKINGGFA--AIKKVNGDVS--------KEIALLNKINHSNLIILSGVCFNEGNC 410
           G V+ G++       A+K     +         +E  +L + +H N++ L GVC  +   
Sbjct: 128 GEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPI 187

Query: 411 YLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINS 470
           Y+V E    G    ++   + EG  L  K  +Q+  D A G+ YL S      +H+D+ +
Sbjct: 188 YIVMELVQGGDFLTFL---RTEGARLRVKTLLQMVGDAAAGMEYLES---KCCIHRDLAA 241

Query: 471 SNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGY----MAPEYLENGLVSTKL 526
            N L+      KI++F M+R                G +       APE L  G  S++ 
Sbjct: 242 RNCLVTEKNVLKISDFGMSREEADGV----YAAS-GGLRQVPVKWTAPEALNYGRYSSES 296

Query: 527 DVYAFGVLILEMLTGKEAAALHAEE--NNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGN 584
           DV++FG+L+ E  +              N+        V   E G               
Sbjct: 297 DVWSFGILLWETFS-------LGASPYPNLSNQQTREFV---EKG--------------- 331

Query: 585 Y----PLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNIL 622
                P      V RL++ C   +P  RP+   I   L +I 
Sbjct: 332 GRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIR 373

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  137 bits (348), Expect = 1e-36
 Identities = 53/266 (19%), Positives = 99/266 (37%), Gaps = 45/266 (16%)

Query: 361 GSVYRG--KINGGFAAIKKVN---------GDVSKEIALLNKINHSNLIILSGVCF---- 405
            +VY+G         A  ++              +E  +L  + H N++           
Sbjct: 40  KTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVK 99

Query: 406 NEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVH 465
            +    LV E   +GTL  ++       K +  K        +  GL +LH+   PP +H
Sbjct: 100 GKKCIVLVTELMTSGTLKTYL----KRFKVMKIKVLRSWCRQILKGLQFLHT-RTPPIIH 154

Query: 466 KDINSSNVLLDSDL-RAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVST 524
           +D+   N+ +       KI +  +A             + ++GT  +MAPE  E      
Sbjct: 155 RDLKCDNIFITGPTGSVKIGDLGLATLKRASF-----AKAVIGTPEFMAPEMYEEK-YDE 208

Query: 525 KLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGN 584
            +DVYAFG+ +LEM T +     ++E  N      +   +T      S      P ++  
Sbjct: 209 SVDVYAFGMCMLEMATSEYP---YSECQNAA---QIYRRVTSGVKPASFDKVAIPEVK-- 260

Query: 585 YPLELALLVIRLIDACLKKDPTDRPT 610
                      +I+ C++++  +R +
Sbjct: 261 ----------EIIEGCIRQNKDERYS 276

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  134 bits (339), Expect = 3e-35
 Identities = 52/292 (17%), Positives = 107/292 (36%), Gaps = 49/292 (16%)

Query: 361 GSVY--RGKINGGFAAIKKVN-------GDVSKEIALLNKINHSNLIILSGVCFNEGNC- 410
             V    G  +G F A+K++         +  +E  +    NH N++ L   C  E    
Sbjct: 43  SYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAK 102

Query: 411 ---YLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKD 467
              +L+  +   GTL + +   K++G +L   Q + + L +  GL  +H+     + H+D
Sbjct: 103 HEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA---KGYAHRD 159

Query: 468 INSSNVLLDSDLRAKIANFAMARPA--------EGQEGEFALTRHIVGTKGYMAPEYLE- 518
           +  +N+LL  + +  + +      A        +    +    +    T  Y APE    
Sbjct: 160 LKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQR--CTISYRAPELFSV 217

Query: 519 --NGLVSTKLDVYAFGVLILEMLTGKEAAALHA-EENNMHLSDVLNAVLTKEDGEESLRH 575
             + ++  + DV++ G ++  M+ G+        +        V  AV            
Sbjct: 218 QSHCVIDERTDVWSLGCVLYAMMFGE-----GPYDMVFQKGDSVALAV---------QNQ 263

Query: 576 FIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNASLN 627
              P     +   L     +L+++ +  DP  RP +  +   L  +   +  
Sbjct: 264 LSIP-QSPRHSSAL----WQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAPG 310

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  133 bits (338), Expect = 4e-35
 Identities = 67/274 (24%), Positives = 113/274 (41%), Gaps = 51/274 (18%)

Query: 361 GSVYRG--KINGGFAAIKKVN----------GDVSKEIALLNKINHSNLIILSGVCFNEG 408
             VYR    ++G   A+KKV            D  KEI LL ++NH N+I      F E 
Sbjct: 46  SEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYA-SFIED 104

Query: 409 NC-YLVYEYAVNGTLSDWVFSNKNEGKYLD----WKQRIQIALDVATGLNYLHSFTNPPH 463
           N   +V E A  G LS  +   K + + +     WK  +Q+       L ++HS      
Sbjct: 105 NELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCS----ALEHMHS-----R 155

Query: 464 --VHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGL 521
             +H+DI  +NV + +    K+ +  + R    +    A +  +VGT  YM+PE +    
Sbjct: 156 RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT-TAAHS--LVGTPYYMSPERIHENG 212

Query: 522 VSTKLDVYAFGVLILEMLTGKEAAALHA-EENNMHLSDVLNAVLTKEDGEESLRHFIDPT 580
            + K D+++ G L+ EM   +          + M+L  +   +   +           P 
Sbjct: 213 YNFKSDIWSLGCLLYEMAALQ-----SPFYGDKMNLYSLCKKIEQCD---------YPPL 258

Query: 581 LQGNYPLELALLVIRLIDACLKKDPTDRPTMYEI 614
              +Y  EL     +L++ C+  DP  RP +  +
Sbjct: 259 PSDHYSEEL----RQLVNMCINPDPEKRPDVTYV 288

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  135 bits (342), Expect = 2e-34
 Identities = 67/276 (24%), Positives = 113/276 (40%), Gaps = 40/276 (14%)

Query: 361 GSVYRGKINGGFA--AIKKVNGDVS------KEIALLNKINHSNLIILSGVCFNEGNCYL 412
           G VY G         A+K +  D        KE A++ +I H NL+ L GVC  E   Y+
Sbjct: 234 GEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 293

Query: 413 VYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHS--FTNPPHVHKDINS 470
           + E+   G L D  +  +   + +     + +A  +++ + YL    F     +H+++ +
Sbjct: 294 ITEFMTYGNLLD--YLRECNRQEVSAVVLLYMATQISSAMEYLEKKNF-----IHRNLAA 346

Query: 471 SNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYA 530
            N L+  +   K+A+F ++R        +           + APE L     S K DV+A
Sbjct: 347 RNCLVGENHLVKVADFGLSRLMT--GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWA 404

Query: 531 FGVLILEMLT-GKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLEL 589
           FGVL+ E+ T G            + LS V   +   E      R    P      P ++
Sbjct: 405 FGVLLWEIATYGMSPYP------GIDLSQVYELL---EKDYRMER----PE---GCPEKV 448

Query: 590 ALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNAS 625
             L+      C + +P+DRP+  EI  +   +   S
Sbjct: 449 YELMRA----CWQWNPSDRPSFAEIHQAFETMFQES 480

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  130 bits (330), Expect = 2e-34
 Identities = 58/270 (21%), Positives = 105/270 (38%), Gaps = 40/270 (14%)

Query: 361 GSVY--RGKINGGFAAIKKVN---------GDVSKEIALLNKINHSNLIILSGVCFNEGN 409
           G     R K +G     K+++           +  E+ LL ++ H N++       +  N
Sbjct: 20  GRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTN 79

Query: 410 C--YLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPH--VH 465
              Y+V EY   G L+  +     E +YLD +  +++   +   L   H  ++  H  +H
Sbjct: 80  TTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLH 139

Query: 466 KDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTK 525
           +D+  +NV LD     K+ +F +AR     +  FA T   VGT  YM+PE +     + K
Sbjct: 140 RDLKPANVFLDGKQNVKLGDFGLARILN-HDTSFAKT--FVGTPYYMSPEQMNRMSYNEK 196

Query: 526 LDVYAFGVLILEMLTGKEAAALHA-EENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGN 584
            D+++ G L+ E+               +    ++   +   +             +   
Sbjct: 197 SDIWSLGCLLYELCALM-----PPFTAFSQK--ELAGKIREGK---------FRR-IPYR 239

Query: 585 YPLELALLVIRLIDACLKKDPTDRPTMYEI 614
           Y  EL      +I   L      RP++ EI
Sbjct: 240 YSDEL----NEIITRMLNLKDYHRPSVEEI 265

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  128 bits (323), Expect = 3e-33
 Identities = 56/275 (20%), Positives = 109/275 (39%), Gaps = 55/275 (20%)

Query: 361 GSVYRG--KINGGFAAIKKVNGD---VSKEIALLNKINHSNLI----------------I 399
           G V++   +I+G    IK+V  +     +E+  L K++H N++                 
Sbjct: 25  GQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84

Query: 400 LSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFT 459
            +         ++  E+   GTL  W+   K  G+ LD    +++   +  G++Y+HS  
Sbjct: 85  KNSSRSKTKCLFIQMEFCDKGTLEQWI--EKRRGEKLDKVLALELFEQITKGVDYIHSKK 142

Query: 460 NPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLEN 519
               +++D+  SN+ L    + KI +F +    +             GT  YM+PE + +
Sbjct: 143 ---LINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDG----KRTRSKGTLRYMSPEQISS 195

Query: 520 GLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDP 579
                ++D+YA G+++ E+L   +     A E +   +D+ +                  
Sbjct: 196 QDYGKEVDLYALGLILAELLHVCD----TAFETSKFFTDLRD-----------------G 234

Query: 580 TLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEI 614
            +   +  +       L+   L K P DRP   EI
Sbjct: 235 IISDIFDKKEK----TLLQKLLSKKPEDRPNTSEI 265

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  131 bits (332), Expect = 3e-33
 Identities = 77/275 (28%), Positives = 123/275 (44%), Gaps = 40/275 (14%)

Query: 361 GSVYRGKING-GFAAIKKVNGDVS------KEIALLNKINHSNLIILSGVCFNEGNCYLV 413
           G V+ G  NG    AIK +           +E  ++ K+ H  L+ L  V   E   Y+V
Sbjct: 198 GEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPI-YIV 256

Query: 414 YEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHS--FTNPPHVHKDINSS 471
            EY   G+L D  F     GKYL   Q + +A  +A+G+ Y+    +     VH+D+ ++
Sbjct: 257 TEYMSKGSLLD--FLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY-----VHRDLRAA 309

Query: 472 NVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAF 531
           N+L+  +L  K+A+F +AR  E  E   A        K + APE    G  + K DV++F
Sbjct: 310 NILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIK-WTAPEAALYGRFTIKSDVWSF 367

Query: 532 GVLILEMLT-GKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELA 590
           G+L+ E+ T G+           M   +VL+ V   E G         P      P  L 
Sbjct: 368 GILLTELTTKGRVPYP------GMVNREVLDQV---ERGYRMPC----PP---ECPESLH 411

Query: 591 LLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNAS 625
            L+ +    C +K+P +RPT   ++  L +   ++
Sbjct: 412 DLMCQ----CWRKEPEERPTFEYLQAFLEDYFTST 442

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  127 bits (322), Expect = 4e-33
 Identities = 68/293 (23%), Positives = 118/293 (40%), Gaps = 62/293 (21%)

Query: 361 GSVYRGKINGGFA-----AIKKVNGDVS--------KEIALLNKINHSNLIILSGVCF-N 406
           G VY G+           AIK ++            +E  L+  +NH N++ L G+    
Sbjct: 35  GVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPP 94

Query: 407 EGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYL--HSFTNPPHV 464
           EG  +++  Y  +G L  ++   ++  +    K  I   L VA G+ YL    F     V
Sbjct: 95  EGLPHVLLPYMCHGDLLQFI---RSPQRNPTVKDLISFGLQVARGMEYLAEQKF-----V 146

Query: 465 HKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTK---GYMAPEYLENGL 521
           H+D+ + N +LD     K+A+F +AR     + E+   +     +    + A E L+   
Sbjct: 147 HRDLAARNCMLDESFTVKVADFGLARDIL--DREYYSVQQHRHARLPVKWTALESLQTYR 204

Query: 522 VSTKLDVYAFGVLILEMLT-------GKEAAALHAEENNMHLSDVLNAVLTKEDGEESLR 574
            +TK DV++FGVL+ E+LT                    +   D+ + +     G    +
Sbjct: 205 FTTKSDVWSFGVLLWELLTRGAPPYRH------------IDPFDLTHFL---AQGRRLPQ 249

Query: 575 HFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNASLN 627
               P      P  L  ++ +    C + DP  RPT   +   +  I++A L 
Sbjct: 250 ----PE---YCPDSLYQVMQQ----CWEADPAVRPTFRVLVGEVEQIVSALLG 291

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  126 bits (320), Expect = 7e-33
 Identities = 70/281 (24%), Positives = 116/281 (41%), Gaps = 50/281 (17%)

Query: 361 GSVYRGKINGGFA--AIKKVNGDVS------KEIALLNKINHSNLIILSGVCFNEGNCYL 412
           G VY G         A+K +  D        KE A++ +I H NL+ L GVC  E   Y+
Sbjct: 27  GEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 86

Query: 413 VYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYL--HSFTNPPHVHKDINS 470
           + E+   G L D  +  +   + +     + +A  +++ + YL   +F     +H+D+ +
Sbjct: 87  ITEFMTYGNLLD--YLRECNRQEVSAVVLLYMATQISSAMEYLEKKNF-----IHRDLAA 139

Query: 471 SNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKG-----YMAPEYLENGLVSTK 525
            N L+  +   K+A+F ++R   G         +           + APE L     S K
Sbjct: 140 RNCLVGENHLVKVADFGLSRLMTGDT-------YTAHAGAKFPIKWTAPESLAYNKFSIK 192

Query: 526 LDVYAFGVLILEMLT-GKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGN 584
            DV+AFGVL+ E+ T G            + LS V   +   E      R    P     
Sbjct: 193 SDVWAFGVLLWEIATYGMSPYP------GIDLSQVYELL---EKDYRMER----PE---G 236

Query: 585 YPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNAS 625
            P ++      L+ AC + +P+DRP+  EI  +   +   S
Sbjct: 237 CPEKVY----ELMRACWQWNPSDRPSFAEIHQAFETMFQES 273

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  127 bits (322), Expect = 1e-32
 Identities = 62/268 (23%), Positives = 112/268 (41%), Gaps = 45/268 (16%)

Query: 361 GSVYRG--KINGGFAAIKKVN---------GDVSKEIALLNKINHSNLIILSGVCFNEGN 409
           G         +G    IK++N          +  +E+A+L  + H N++      F E  
Sbjct: 38  GKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRE-SFEENG 96

Query: 410 C-YLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHV-HKD 467
             Y+V +Y   G L   +  N  +G      Q +   + +   L ++H       + H+D
Sbjct: 97  SLYIVMDYCEGGDLFKRI--NAQKGVLFQEDQILDWFVQICLALKHVHD----RKILHRD 150

Query: 468 INSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLD 527
           I S N+ L  D   ++ +F +AR       E A     +GT  Y++PE  EN   + K D
Sbjct: 151 IKSQNIFLTKDGTVQLGDFGIARVLN-STVELARA--CIGTPYYLSPEICENKPYNNKSD 207

Query: 528 VYAFGVLILEMLTGKEAAALHA-EENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYP 586
           ++A G ++ E+ T K     HA E  +M   +++  +++             P +  +Y 
Sbjct: 208 IWALGCVLYELCTLK-----HAFEAGSMK--NLVLKIISGS---------FPP-VSLHYS 250

Query: 587 LELALLVIRLIDACLKKDPTDRPTMYEI 614
            +L      L+    K++P DRP++  I
Sbjct: 251 YDLR----SLVSQLFKRNPRDRPSVNSI 274

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  129 bits (327), Expect = 2e-32
 Identities = 72/282 (25%), Positives = 114/282 (40%), Gaps = 64/282 (22%)

Query: 361 GSVYRGKINGGFAAIKKVNGDVS-----KEIALLNKINHSNLIILSGVCFNE-GNCYLVY 414
           G V  G   G   A+K +  D +      E +++ ++ HSNL+ L GV   E G  Y+V 
Sbjct: 207 GDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 266

Query: 415 EYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHS--FTNPPHVHKDINSSN 472
           EY   G+L D  +        L     ++ +LDV   + YL    F     VH+D+ + N
Sbjct: 267 EYMAKGSLVD--YLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNF-----VHRDLAARN 319

Query: 473 VLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTK---GYMAPEYLENGLVSTKLDVY 529
           VL+  D  AK+++F + + A   +            K    + APE L     STK DV+
Sbjct: 320 VLVSEDNVAKVSDFGLTKEASSTQ---------DTGKLPVKWTAPEALREKKFSTKSDVW 370

Query: 530 AFGVLILEMLT-GKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNY--- 585
           +FG+L+ E+ + G+           + L DV+  V   E G               Y   
Sbjct: 371 SFGILLWEIYSFGRVPYP------RIPLKDVVPRV---EKG---------------YKMD 406

Query: 586 -----PLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNIL 622
                P  +  ++      C   D   RPT  ++   L +I 
Sbjct: 407 APDGCPPAVYDVMKN----CWHLDAATRPTFLQLREQLEHIR 444

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  130 bits (329), Expect = 2e-32
 Identities = 77/275 (28%), Positives = 123/275 (44%), Gaps = 40/275 (14%)

Query: 361 GSVYRGKING-GFAAIKKVNGDVS------KEIALLNKINHSNLIILSGVCFNEGNCYLV 413
           G V+ G  NG    AIK +           +E  ++ K+ H  L+ L  V   E   Y+V
Sbjct: 281 GEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPI-YIV 339

Query: 414 YEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHS--FTNPPHVHKDINSS 471
            EY   G+L D  F     GKYL   Q + +A  +A+G+ Y+    +     VH+D+ ++
Sbjct: 340 TEYMSKGSLLD--FLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY-----VHRDLRAA 392

Query: 472 NVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAF 531
           N+L+  +L  K+A+F +AR  E  E   A        K + APE    G  + K DV++F
Sbjct: 393 NILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIK-WTAPEAALYGRFTIKSDVWSF 450

Query: 532 GVLILEMLT-GKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELA 590
           G+L+ E+ T G+           M   +VL+ V   E G         P      P  L 
Sbjct: 451 GILLTELTTKGRVPYP------GMVNREVLDQV---ERGYRMPC----PP---ECPESLH 494

Query: 591 LLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNAS 625
            L+ +    C +K+P +RPT   ++  L +   ++
Sbjct: 495 DLMCQ----CWRKEPEERPTFEYLQAFLEDYFTST 525

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  125 bits (315), Expect = 3e-32
 Identities = 70/275 (25%), Positives = 117/275 (42%), Gaps = 48/275 (17%)

Query: 361 GSVYRGKINGGFAAIKKVNGDVS-----KEIALLNKINHSNLIILSGVCF-NEGNCYLVY 414
           G V  G   G   A+K +  D +      E +++ ++ HSNL+ L GV    +G  Y+V 
Sbjct: 35  GDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 94

Query: 415 EYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYL--HSFTNPPHVHKDINSSN 472
           EY   G+L D  +        L     ++ +LDV   + YL  ++F     VH+D+ + N
Sbjct: 95  EYMAKGSLVD--YLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNF-----VHRDLAARN 147

Query: 473 VLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTK---GYMAPEYLENGLVSTKLDVY 529
           VL+  D  AK+++F + + A   +            K    + APE L     STK DV+
Sbjct: 148 VLVSEDNVAKVSDFGLTKEASSTQD---------TGKLPVKWTAPEALREKKFSTKSDVW 198

Query: 530 AFGVLILEMLT-GKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLE 588
           +FG+L+ E+ + G+           + L DV+  V   E G +       P      P  
Sbjct: 199 SFGILLWEIYSFGRVPYP------RIPLKDVVPRV---EKGYKMDA----PD---GCPPA 242

Query: 589 LALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILN 623
           +      ++  C   D   RP+  ++   L +I  
Sbjct: 243 VY----EVMKNCWHLDAAMRPSFLQLREQLEHIKT 273

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  124 bits (313), Expect = 5e-32
 Identities = 73/280 (26%), Positives = 120/280 (42%), Gaps = 46/280 (16%)

Query: 361 GSVYRGKINGGFA-AIKKVNGDVS------KEIALLNKINHSNLIILSGVCFNEGNCYLV 413
           G V  GK  G +  A+K +           +E   + K++H  L+   GVC  E   Y+V
Sbjct: 22  GVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIV 81

Query: 414 YEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYL--HSFTNPPHVHKDINSS 471
            EY  NG L +++   ++ GK L+  Q +++  DV  G+ +L  H F     +H+D+ + 
Sbjct: 82  TEYISNGCLLNYL---RSHGKGLEPSQLLEMCYDVCEGMAFLESHQF-----IHRDLAAR 133

Query: 472 NVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTK---GYMAPEYLENGLVSTKLDV 528
           N L+D DL  K+++F M R     +         VGTK    + APE       S+K DV
Sbjct: 134 NCLVDRDLCVKVSDFGMTRYVLDDQ----YVSS-VGTKFPVKWSAPEVFHYFKYSSKSDV 188

Query: 529 YAFGVLILEMLT-GKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPL 587
           +AFG+L+ E+ + GK              S+V+  V     G    R    P        
Sbjct: 189 WAFGILMWEVFSLGKMPYD------LYTNSEVVLKV---SQGHRLYR----PH---LASD 232

Query: 588 ELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNASLN 627
            +  ++      C  + P  RPT  ++  S+  +     +
Sbjct: 233 TIYQIMYS----CWHELPEKRPTFQQLLSSIEPLREKDKH 268

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  125 bits (316), Expect = 6e-32
 Identities = 68/296 (22%), Positives = 125/296 (42%), Gaps = 58/296 (19%)

Query: 361 GSVYRGKINGGFA------AIK--KVNG-----DVSKEIALLNKINHSNLIILSGVCFNE 407
           GSV   + +          A+K  + +G     D  +EI +L  ++   ++   GV +  
Sbjct: 37  GSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGP 96

Query: 408 GNC--YLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHS--FTNPPH 463
           G     LV EY  +G L D++  ++     LD  + +  +  +  G+ YL S        
Sbjct: 97  GRQSLRLVMEYLPSGCLRDFLQRHRAR---LDASRLLLYSSQICKGMEYLGSRRC----- 148

Query: 464 VHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKG-----YMAPEYLE 518
           VH+D+ + N+L++S+   KIA+F +A+     +  +     +V   G     + APE L 
Sbjct: 149 VHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYY-----VVREPGQSPIFWYAPESLS 203

Query: 519 NGLVSTKLDVYAFGVLILEMLT---------GKEAAALHAEENNMHLSDVLNAVLTKEDG 569
           + + S + DV++FGV++ E+ T          +    +  E +   LS +L  +   E+G
Sbjct: 204 DNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELL---EEG 260

Query: 570 EESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNAS 625
           +        P      P E+  L+      C    P DRP+   +   L  + + S
Sbjct: 261 QRLPA----PP---ACPAEVHELMKL----CWAPSPQDRPSFSALGPQLDMLWSGS 305

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  123 bits (311), Expect = 1e-31
 Identities = 56/286 (19%), Positives = 104/286 (36%), Gaps = 59/286 (20%)

Query: 361 GSVY--RGKINGGFAAIKKVN--------GDVSKEIALLNKINHSNLIILSGVCFNEGNC 410
           G V+  + K++    AIK++           V +E+  L K+ H  ++      + E N 
Sbjct: 19  GVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFN-AWLEKNT 77

Query: 411 -------------YLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHS 457
                        Y+  +      L DW+ + +   +  +    + I L +A  + +LHS
Sbjct: 78  TEKLQPSSPKVYLYIQMQLCRKENLKDWM-NGRCTIEERERSVCLHIFLQIAEAVEFLHS 136

Query: 458 FTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQE---------GEFALTRHIVGT 508
                 +H+D+  SN+    D   K+ +F +    +  E           +A     VGT
Sbjct: 137 KG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGT 193

Query: 509 KGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKED 568
           K YM+PE +     S K+D+++ G+++ E+        L+     M     L        
Sbjct: 194 KLYMSPEQIHGNSYSHKVDIFSLGLILFEL--------LYPFSTQMERVRTLT------- 238

Query: 569 GEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEI 614
               +R+   P L              ++   L   P +RP    I
Sbjct: 239 ---DVRNLKFPPLFTQKYPCEY----VMVQDMLSPSPMERPEAINI 277

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  123 bits (310), Expect = 1e-31
 Identities = 76/277 (27%), Positives = 122/277 (44%), Gaps = 44/277 (15%)

Query: 361 GSVYRGKINGGFA-AIKKVNGDVS------KEIALLNKINHSNLIILSGVCFNEGNCYLV 413
           G V+ G  NG    A+K +            E  L+ ++ H  L+ L  V   E   Y++
Sbjct: 27  GEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPI-YII 85

Query: 414 YEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNV 473
            EY  NG+L D  F     G  L   + + +A  +A G+ ++       ++H+D+ ++N+
Sbjct: 86  TEYMENGSLVD--FLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANI 140

Query: 474 LLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTK---GYMAPEYLENGLVSTKLDVYA 530
           L+   L  KIA+F +AR  E  E     T    G K    + APE +  G  + K DV++
Sbjct: 141 LVSDTLSCKIADFGLARLIEDNE----YTAR-EGAKFPIKWTAPEAINYGTFTIKSDVWS 195

Query: 531 FGVLILEMLTGKEAAALHAEE--NNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLE 588
           FG+L+ E++T       H       M   +V+  +   E G   +R    P    N P E
Sbjct: 196 FGILLTEIVT-------HGRIPYPGMTNPEVIQNL---ERGYRMVR----PD---NCPEE 238

Query: 589 LALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNAS 625
           L     +L+  C K+ P DRPT   +   L +   A+
Sbjct: 239 LY----QLMRLCWKERPEDRPTFDYLRSVLEDFFTAT 271

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  127 bits (320), Expect = 1e-31
 Identities = 70/277 (25%), Positives = 120/277 (43%), Gaps = 44/277 (15%)

Query: 361 GSVYRGKING-GFAAIKKVNGDVS------KEIALLNKINHSNLIILSGVCFNEGNCYLV 413
           G V+    N     A+K +            E  ++  + H  L+ L  V   E   Y++
Sbjct: 202 GEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTKEPI-YII 260

Query: 414 YEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNV 473
            E+   G+L D  F   +EG      + I  +  +A G+ ++       ++H+D+ ++N+
Sbjct: 261 TEFMAKGSLLD--FLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANI 315

Query: 474 LLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKG---YMAPEYLENGLVSTKLDVYA 530
           L+ + L  KIA+F +AR  E  E          G K    + APE +  G  + K DV++
Sbjct: 316 LVSASLVCKIADFGLARVIEDNEYT-----AREGAKFPIKWTAPEAINFGSFTIKSDVWS 370

Query: 531 FGVLILEMLTGKEAAALHAEE--NNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLE 588
           FG+L++E++T       +       M   +V+ A+   E G    R    P    N P E
Sbjct: 371 FGILLMEIVT-------YGRIPYPGMSNPEVIRAL---ERGYRMPR----PE---NCPEE 413

Query: 589 LALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNAS 625
           L  +++R    C K  P +RPT   I+  L +   A+
Sbjct: 414 LYNIMMR----CWKNRPEERPTFEYIQSVLDDFYTAT 446

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  123 bits (312), Expect = 2e-31
 Identities = 66/297 (22%), Positives = 113/297 (38%), Gaps = 61/297 (20%)

Query: 361 GSVYRGKINGGFA------AIKKVNGDVS--------KEIALLNKINHSNLIILSGVCFN 406
           G V     +          A+K +  D          +EI +L  + H ++I   G C +
Sbjct: 45  GKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCED 104

Query: 407 EGN--CYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHS--FTNPP 462
            G     LV EY   G+L D++  +      +   Q +  A  +  G+ YLH+  +    
Sbjct: 105 AGAASLQLVMEYVPLGSLRDYLPRHS-----IGLAQLLLFAQQICEGMAYLHAQHY---- 155

Query: 463 HVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKG-----YMAPEYL 517
            +H+D+ + NVLLD+D   KI +F +A+        +      V   G     + APE L
Sbjct: 156 -IHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYY-----RVREDGDSPVFWYAPECL 209

Query: 518 ENGLVSTKLDVYAFGVLILEMLT-GKEAAALHAEEN--------NMHLSDVLNAVLTKED 568
           +        DV++FGV + E+LT    + +   +           M +  +   +   E 
Sbjct: 210 KEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELL---ER 266

Query: 569 GEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNAS 625
           GE   R    P      P E+  L+      C + + + RPT   +   L  +    
Sbjct: 267 GERLPR----PD---KCPAEVYHLMKN----CWETEASFRPTFENLIPILKTVHEKY 312

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  122 bits (308), Expect = 2e-31
 Identities = 66/279 (23%), Positives = 114/279 (40%), Gaps = 46/279 (16%)

Query: 361 GSVYRGKINGGFA-AIKKVNGDVS------KEIALLNKINHSNLIILSGVCFNEGNCYLV 413
           G V+ G        AIK +           +E  ++ K++H  L+ L GVC  +    LV
Sbjct: 22  GLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLV 81

Query: 414 YEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYL--HSFTNPPHVHKDINSS 471
            E+  +G LSD  +     G     +  + + LDV  G+ YL          +H+D+ + 
Sbjct: 82  TEFMEHGCLSD--YLRTQRGL-FAAETLLGMCLDVCEGMAYLEEACV-----IHRDLAAR 133

Query: 472 NVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTK---GYMAPEYLENGLVSTKLDV 528
           N L+  +   K+++F M R     +     T    GTK    + +PE       S+K DV
Sbjct: 134 NCLVGENQVIKVSDFGMTRFVLDDQ----YTSS-TGTKFPVKWASPEVFSFSRYSSKSDV 188

Query: 529 YAFGVLILEMLT-GKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPL 587
           ++FGVL+ E+ + GK          N   S+V+  +     G    +    P        
Sbjct: 189 WSFGVLMWEVFSEGKIPYE------NRSNSEVVEDI---STGFRLYK----PR---LAST 232

Query: 588 ELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNASL 626
            +     ++++ C ++ P DRP    +   L+ I  + L
Sbjct: 233 HVY----QIMNHCWRERPEDRPAFSRLLRQLAEIAESGL 267

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  123 bits (310), Expect = 3e-31
 Identities = 65/336 (19%), Positives = 102/336 (30%), Gaps = 58/336 (17%)

Query: 299 EPDSIVVSGSFQANEKPSNKKFDEESQDFLESISGVAQSLKVYSFKELQSATDNFSFTCR 358
             D    +  FQ+  +   ++     +      S      +  SF +      +F    R
Sbjct: 10  GVDLGTENLYFQSMHQLQPRRVSFRGEASETLQSPGYDPSRPESFFQ-----QSFQRLSR 64

Query: 359 I-QGS---VYRG--KINGGFAAIKKVNGDVSKE----------IALLNKINHSNLIILSG 402
           +  GS   V++   K +G   A+K+                   +      H   + L  
Sbjct: 65  LGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQ 124

Query: 403 VCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPP 462
                G  YL  E     +L       +  G  L   Q      D    L +LHS     
Sbjct: 125 AWEEGGILYLQTELC-GPSLQQHC---EAWGASLPEAQVWGYLRDTLLALAHLHSQGL-- 178

Query: 463 HVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLV 522
            VH D+  +N+ L    R K+ +F +    E             G   YMAPE L+    
Sbjct: 179 -VHLDVKPANIFLGPRGRCKLGDFGLLV--ELGTAGAGEV--QEGDPRYMAPELLQGSY- 232

Query: 523 STKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRH-FIDPTL 581
            T  DV++ G+ ILE+    E   L                         LR  ++ P  
Sbjct: 233 GTAADVFSLGLTILEVACNME---LPHGGEGWQ----------------QLRQGYLPPEF 273

Query: 582 QGNYPLELALLVIRLIDACLKKDPTDRPTMYEI-EH 616
                 EL      ++   L+ DP  R T   +   
Sbjct: 274 TAGLSSEL----RSVLVMMLEPDPKLRATAEALLAL 305

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  122 bits (309), Expect = 3e-31
 Identities = 56/289 (19%), Positives = 102/289 (35%), Gaps = 62/289 (21%)

Query: 361 GSVY--RGKINGGFAAIKKVN------GDVSKEIALLNKINHSNLIILSGVCFNEGNC-- 410
           G V   R  ++  + AIKK+         +  E+ LL  +NH  ++          N   
Sbjct: 20  GQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVK 79

Query: 411 -----------YLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFT 459
                      ++  EY  NGTL D +    +E       +  ++   +   L+Y+HS  
Sbjct: 80  PMTAVKKKSTLFIQMEYCENGTLYDLI---HSENLNQQRDEYWRLFRQILEALSYIHS-- 134

Query: 460 NPPH--VHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHI-----------V 506
                 +H+D+   N+ +D     KI +F +A+          L               +
Sbjct: 135 ---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAI 191

Query: 507 GTKGYMAPEYLEN-GLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLT 565
           GT  Y+A E L+  G  + K+D+Y+ G++  EM+        +     M   ++L  + +
Sbjct: 192 GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI--------YPFSTGMERVNILKKLRS 243

Query: 566 KEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEI 614
                        P    N          ++I   +  DP  RP    +
Sbjct: 244 VS-------IEFPPDFDDNKMKVE----KKIIRLLIDHDPNKRPGARTL 281

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  123 bits (310), Expect = 4e-31
 Identities = 64/286 (22%), Positives = 123/286 (43%), Gaps = 53/286 (18%)

Query: 361 GSVYRGKINGGFA------AIKKVNGDVS--------KEIALLNKINHSNLIILSGVCFN 406
           G VY+G +           AIK +    +         E  ++ + +H N+I L GV   
Sbjct: 58  GEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK 117

Query: 407 EGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYL--HSFTNPPHV 464
                ++ EY  NG L    F  + +G+     Q + +   +A G+ YL   ++     V
Sbjct: 118 YKPMMIITEYMENGALDK--FLREKDGE-FSVLQLVGMLRGIAAGMKYLANMNY-----V 169

Query: 465 HKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTK---GYMAPEYLENGL 521
           H+D+ + N+L++S+L  K+++F ++R  E    E   T    G K    + APE +    
Sbjct: 170 HRDLAARNILVNSNLVCKVSDFGLSRVLEDDP-EATYTTS--GGKIPIRWTAPEAISYRK 226

Query: 522 VSTKLDVYAFGVLILEMLTGKEAAALHAEE--NNMHLSDVLNAVLTKEDGEESLRHFIDP 579
            ++  DV++FG+++ E++T       + E     +   +V+ A+    DG         P
Sbjct: 227 FTSASDVWSFGIVMWEVMT-------YGERPYWELSNHEVMKAI---NDGFRLPT----P 272

Query: 580 TLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNAS 625
               + P  +  L+++    C +++   RP   +I   L  ++ A 
Sbjct: 273 M---DCPSAIYQLMMQ----CWQQERARRPKFADIVSILDKLIRAP 311

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  122 bits (308), Expect = 4e-31
 Identities = 68/295 (23%), Positives = 118/295 (40%), Gaps = 66/295 (22%)

Query: 361 GSVYRGKINGGFA-----AIKKVNGDVS--------KEIALLNKINHSNLIILSGVCF-N 406
           G VY G +          A+K +N             E  ++   +H N++ L G+C  +
Sbjct: 39  GCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS 98

Query: 407 EGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHS--FTNPPHV 464
           EG+  +V  Y  +G L +++ +  +       K  I   L VA G+ YL S  F     V
Sbjct: 99  EGSPLVVLPYMKHGDLRNFIRNETHN---PTVKDLIGFGLQVAKGMKYLASKKF-----V 150

Query: 465 HKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKG-----YMAPEYLEN 519
           H+D+ + N +LD     K+A+F +AR    +E      +    T       +MA E L+ 
Sbjct: 151 HRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNK----TGAKLPVKWMALESLQT 206

Query: 520 GLVSTKLDVYAFGVLILEMLT-------GKEAAALHAEENNMHLSDVLNAVLTKEDGEES 572
              +TK DV++FGVL+ E++T                    ++  D+   +     G   
Sbjct: 207 QKFTTKSDVWSFGVLLWELMTRGAPPYPD------------VNTFDITVYL---LQGRRL 251

Query: 573 LRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNASLN 627
           L+    P      P  L  ++++    C       RP+  E+   +S I +  + 
Sbjct: 252 LQ----PE---YCPDPLYEVMLK----CWHPKAEMRPSFSELVSRISAIFSTFIG 295

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  122 bits (309), Expect = 4e-31
 Identities = 58/300 (19%), Positives = 115/300 (38%), Gaps = 73/300 (24%)

Query: 361 GSVYRGKINGGFA-----AIKKVNGDVS---------KEIALLNKINHSNLIILSGVCFN 406
           GSV   ++          A+K +  D+          +E A + + +H ++  L GV   
Sbjct: 37  GSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLR 96

Query: 407 EGNC------YLVYEYAVNGTLSDWVFSNK--NEGKYLDWKQRIQIALDVATGLNYLHS- 457
                      ++  +  +G L  ++ +++       L  +  ++  +D+A G+ YL S 
Sbjct: 97  SRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR 156

Query: 458 -FTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKG-----Y 511
            F     +H+D+ + N +L  D+   +A+F ++R     +       +  G        +
Sbjct: 157 NF-----IHRDLAARNCMLAEDMTVCVADFGLSRKIYSGD------YYRQGCASKLPVKW 205

Query: 512 MAPEYLENGLVSTKLDVYAFGVLILEMLT-------GKEAAALHAEENNMHLSDVLNAVL 564
           +A E L + L +   DV+AFGV + E++T       G            +  +++ N + 
Sbjct: 206 LALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAG------------IENAEIYNYL- 252

Query: 565 TKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNA 624
               G    +    P        E+  L+ +    C   DP  RP+   +   L NIL  
Sbjct: 253 --IGGNRLKQ----PP---ECMEEVYDLMYQ----CWSADPKQRPSFTCLRMELENILGH 299

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  122 bits (308), Expect = 5e-31
 Identities = 64/294 (21%), Positives = 129/294 (43%), Gaps = 59/294 (20%)

Query: 361 GSVYRGKINGGFA------AIKKVNGDVS--------KEIALLNKINHSNLIILSGVCFN 406
           G V   + +          A+K +  +          KEI +L  + H N++   G+C  
Sbjct: 35  GKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTE 94

Query: 407 EGNC--YLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHS--FTNPP 462
           +G     L+ E+  +G+L +++  NKN+   ++ KQ+++ A+ +  G++YL S  +    
Sbjct: 95  DGGNGIKLIMEFLPSGSLKEYLPKNKNK---INLKQQLKYAVQICKGMDYLGSRQY---- 147

Query: 463 HVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKG-----YMAPEYL 517
            VH+D+ + NVL++S+ + KI +F + +  E  +  +      V         + APE L
Sbjct: 148 -VHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYY-----TVKDDRDSPVFWYAPECL 201

Query: 518 ENGLVSTKLDVYAFGVLILEMLT-GKEAAALHAEEN--------NMHLSDVLNAVLTKED 568
                    DV++FGV + E+LT     ++  A            M ++ ++N +   ++
Sbjct: 202 MQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTL---KE 258

Query: 569 GEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNIL 622
           G+        P    N P E+  L+ +    C +  P++R +   +      +L
Sbjct: 259 GKRLPC----PP---NCPDEVYQLMRK----CWEFQPSNRTSFQNLIEGFEALL 301

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  122 bits (309), Expect = 6e-31
 Identities = 61/284 (21%), Positives = 121/284 (42%), Gaps = 57/284 (20%)

Query: 361 GSVYRG--KINGGFA----AIK--------KVNGDVSKEIALLNKINHSNLIILSGVCFN 406
           G+VY+G     G       AIK        K N ++  E  ++  +++ ++  L G+C  
Sbjct: 29  GTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT 88

Query: 407 EGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYL--HSFTNPPHV 464
                L+ +    G L D+V  +K+    +  +  +   + +A G+NYL          V
Sbjct: 89  S-TVQLITQLMPFGCLLDYVREHKDN---IGSQYLLNWCVQIAKGMNYLEDRRL-----V 139

Query: 465 HKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTK---GYMAPEYLENGL 521
           H+D+ + NVL+ +    KI +F +A+    +E E+       G K    +MA E + + +
Sbjct: 140 HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE----GGKVPIKWMALESILHRI 195

Query: 522 VSTKLDVYAFGVLILEMLT-GKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPT 580
            + + DV+++GV + E++T G +          +  S++ + +   E GE   R      
Sbjct: 196 YTHQSDVWSYGVTVWELMTFGSKPYD------GIPASEISSIL---EKGE---R------ 237

Query: 581 LQ--GNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNIL 622
           L       +++ +++ +    C   D   RP   E+    S + 
Sbjct: 238 LPQPPICTIDVYMIMRK----CWMIDADSRPKFRELIIEFSKMA 277

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  124 bits (314), Expect = 6e-31
 Identities = 53/273 (19%), Positives = 112/273 (41%), Gaps = 48/273 (17%)

Query: 363 VYRGKINGGFAAIKKVNGD----VSKEIALLNKIN-HSNLIILSGVCFNEGNCYLVYEYA 417
           VYRG  +    A+K++  +      +E+ LL + + H N+I       +    Y+  E  
Sbjct: 41  VYRGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIEL- 99

Query: 418 VNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPH--VHKDINSSNVLL 475
              TL ++V   + +  +L   + I +     +GL +LHS        VH+D+   N+L+
Sbjct: 100 CAATLQEYV--EQKDFAHLG-LEPITLLQQTTSGLAHLHS-----LNIVHRDLKPHNILI 151

Query: 476 -----DSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLE---NGLVSTKLD 527
                   ++A I++F + +        F+    + GT+G++APE L        +  +D
Sbjct: 152 SMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVD 211

Query: 528 VYAFGVLILEMLTGKE---AAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGN 584
           +++ G +   +++        +L  + N +  +  L+ +  ++  +   R          
Sbjct: 212 IFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKHEDVIARE--------- 262

Query: 585 YPLELALLVIRLIDACLKKDPTDRPTMYEI-EH 616
                      LI+  +  DP  RP+   + +H
Sbjct: 263 -----------LIEKMIAMDPQKRPSAKHVLKH 284

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  122 bits (308), Expect = 7e-31
 Identities = 72/302 (23%), Positives = 118/302 (39%), Gaps = 72/302 (23%)

Query: 361 GSVYRGKINGGFA-------AIKKVNGDVS--------KEIALLNKINHSNLIILSGVCF 405
           G VY G   G          AIK VN   S         E +++ + N  +++ L GV  
Sbjct: 39  GMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS 98

Query: 406 NEGNCYLVYEYAVNGTLSDW------VFSNKNEGKYLDWKQRIQIALDVATGLNYLHS-- 457
                 ++ E    G L  +        +N          + IQ+A ++A G+ YL++  
Sbjct: 99  QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK 158

Query: 458 FTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGY-----M 512
           F     VH+D+ + N ++  D   KI +F M R     E ++    +  G KG      M
Sbjct: 159 F-----VHRDLAARNCMVAEDFTVKIGDFGMTRDIY--ETDY----YRKGGKGLLPVRWM 207

Query: 513 APEYLENGLVSTKLDVYAFGVLILEMLT-------GKEAAALHAEENNMHLSDVLNAVLT 565
           +PE L++G+ +T  DV++FGV++ E+ T       G            +    VL  V  
Sbjct: 208 SPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQG------------LSNEQVLRFV-- 253

Query: 566 KEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNAS 625
             +G    +    P    N P  L  L+      C + +P  RP+  EI  S+   +   
Sbjct: 254 -MEGGLLDK----PD---NCPDMLFELMRM----CWQYNPKMRPSFLEIISSIKEEMEPG 301

Query: 626 LN 627
             
Sbjct: 302 FR 303

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  123 bits (310), Expect = 7e-31
 Identities = 67/290 (23%), Positives = 120/290 (41%), Gaps = 56/290 (19%)

Query: 361 GSVYRGKINGGFA-----AIKKVNGDVS--------KEIALLNKINHSNLIILSGVCF-N 406
           G VY G +          A+K +N             E  ++   +H N++ L G+C  +
Sbjct: 103 GCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS 162

Query: 407 EGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHS--FTNPPHV 464
           EG+  +V  Y  +G L +++ +  +       K  I   L VA G+ +L S  F     V
Sbjct: 163 EGSPLVVLPYMKHGDLRNFIRNETHN---PTVKDLIGFGLQVAKGMKFLASKKF-----V 214

Query: 465 HKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKG-----YMAPEYLEN 519
           H+D+ + N +LD     K+A+F +AR    +E +    +    T       +MA E L+ 
Sbjct: 215 HRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNK----TGAKLPVKWMALESLQT 270

Query: 520 GLVSTKLDVYAFGVLILEMLTGKEAAALHAEE--NNMHLSDVLNAVLTKEDGEESLRHFI 577
              +TK DV++FGVL+ E++T              +++  D+   +     G   L+   
Sbjct: 271 QKFTTKSDVWSFGVLLWELMT-------RGAPPYPDVNTFDITVYL---LQGRRLLQ--- 317

Query: 578 DPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNASLN 627
            P      P  L  ++++    C       RP+  E+   +S I +  + 
Sbjct: 318 -PE---YCPDPLYEVMLK----CWHPKAEMRPSFSELVSRISAIFSTFIG 359

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  122 bits (307), Expect = 8e-31
 Identities = 60/299 (20%), Positives = 117/299 (39%), Gaps = 72/299 (24%)

Query: 361 GSVYRGKINGGFA-----AIKKVNGDVS---------KEIALLNKINHSNLIILSGVCFN 406
           GSV  G +          A+K +  D S          E A +   +H N+I L GVC  
Sbjct: 48  GSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIE 107

Query: 407 EG-----NCYLVYEYAVNGTLSDWVFSNK--NEGKYLDWKQRIQIALDVATGLNYL--HS 457
                     ++  +   G L  ++  ++     K++  +  ++  +D+A G+ YL   +
Sbjct: 108 MSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN 167

Query: 458 FTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKG-----YM 512
           F     +H+D+ + N +L  D+   +A+F +++     +       +  G        ++
Sbjct: 168 F-----LHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDY------YRQGRIAKMPVKWI 216

Query: 513 APEYLENGLVSTKLDVYAFGVLILEMLT-------GKEAAALHAEENNMHLSDVLNAVLT 565
           A E L + + ++K DV+AFGV + E+ T       G            +   ++ + +  
Sbjct: 217 AIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPG------------VQNHEMYDYL-- 262

Query: 566 KEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNA 624
              G    +    P    +   EL  ++      C + DP DRPT   +   L  +L +
Sbjct: 263 -LHGHRLKQ----PE---DCLDELYEIMYS----CWRTDPLDRPTFSVLRLQLEKLLES 309

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  120 bits (304), Expect = 1e-30
 Identities = 60/276 (21%), Positives = 116/276 (42%), Gaps = 46/276 (16%)

Query: 361 GSVYRGKINGGFA-AIKKVNGDVS------KEIALLNKINHSNLIILSGVCFNEGNCYLV 413
           G V  GK  G +  AIK +           +E  ++  ++H  L+ L GVC  +   +++
Sbjct: 38  GVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFII 97

Query: 414 YEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYL--HSFTNPPHVHKDINSS 471
            EY  NG L +  +  +   +    +Q +++  DV   + YL    F     +H+D+ + 
Sbjct: 98  TEYMANGCLLN--YLREMRHR-FQTQQLLEMCKDVCEAMEYLESKQF-----LHRDLAAR 149

Query: 472 NVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTK---GYMAPEYLENGLVSTKLDV 528
           N L++     K+++F ++R     E     T   VG+K    +  PE L     S+K D+
Sbjct: 150 NCLVNDQGVVKVSDFGLSRYVLDDE----YTSS-VGSKFPVRWSPPEVLMYSKFSSKSDI 204

Query: 529 YAFGVLILEMLT-GKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPL 587
           +AFGVL+ E+ + GK              S+    +     G    R    P        
Sbjct: 205 WAFGVLMWEIYSLGKMPYE------RFTNSETAEHI---AQGLRLYR----PH---LASE 248

Query: 588 ELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILN 623
           ++      ++ +C  +   +RPT   +  ++ ++++
Sbjct: 249 KVY----TIMYSCWHEKADERPTFKILLSNILDVMD 280

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  120 bits (302), Expect = 2e-30
 Identities = 61/297 (20%), Positives = 120/297 (40%), Gaps = 59/297 (19%)

Query: 361 GSVYRGKINGGFA------AIKKVNGDVS-------KEIALLNKINHSNLIILSGVCFNE 407
           GSV   + +          A+KK+            +EI +L  + H N++   GVC++ 
Sbjct: 24  GSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA 83

Query: 408 GNC--YLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHS--FTNPPH 463
           G     L+ EY   G+L D++  +K     +D  + +Q    +  G+ YL +  +     
Sbjct: 84  GRRNLKLIMEYLPYGSLRDYLQKHKER---IDHIKLLQYTSQICKGMEYLGTKRY----- 135

Query: 464 VHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKG-----YMAPEYLE 518
           +H+D+ + N+L++++ R KI +F + +     +  F      V   G     + APE L 
Sbjct: 136 IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFF-----KVKEPGESPIFWYAPESLT 190

Query: 519 NGLVSTKLDVYAFGVLILEMLTGKEAAALHAEEN----------NMHLSDVLNAVLTKED 568
               S   DV++FGV++ E+ T  E +     E            M +  ++  +   ++
Sbjct: 191 ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL---KN 247

Query: 569 GEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNAS 625
                R    P      P E+ +++      C   +   RP+  ++   +  I +  
Sbjct: 248 NGRLPR----PD---GCPDEIYMIMTE----CWNNNVNQRPSFRDLALRVDQIRDNM 293

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  119 bits (300), Expect = 3e-30
 Identities = 61/282 (21%), Positives = 113/282 (40%), Gaps = 50/282 (17%)

Query: 361 GSVYRGKINGGFA----AIKKVNGDVS--------KEIALLNKINHSNLIILSGVCFNEG 408
           GSV +G           AIK +             +E  +++++++  ++ L GVC  E 
Sbjct: 24  GSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEA 83

Query: 409 NCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYL--HSFTNPPHVHK 466
              LV E A  G L  ++     + + +      ++   V+ G+ YL   +F     VH+
Sbjct: 84  L-MLVMEMAGGGPLHKFL---VGKREEIPVSNVAELLHQVSMGMKYLEEKNF-----VHR 134

Query: 467 DINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTK---GYMAPEYLENGLVS 523
           D+ + NVLL +   AKI++F +++     +  +         K    + APE +     S
Sbjct: 135 DLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR---SAGKWPLKWYAPECINFRKFS 191

Query: 524 TKLDVYAFGVLILEMLT-GKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQ 582
           ++ DV+++GV + E L+ G++          M   +V+  +   E G+        P   
Sbjct: 192 SRSDVWSYGVTMWEALSYGQKPYK------KMKGPEVMAFI---EQGKRMEC----PP-- 236

Query: 583 GNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNA 624
              P EL  L+      C      DRP    +E  +     +
Sbjct: 237 -ECPPELYALMSD----CWIYKWEDRPDFLTVEQRMRACYYS 273

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  120 bits (302), Expect = 3e-30
 Identities = 60/297 (20%), Positives = 120/297 (40%), Gaps = 59/297 (19%)

Query: 361 GSVYRGKINGGFA------AIKKVNGDVS-------KEIALLNKINHSNLIILSGVCFNE 407
           GSV   + +          A+KK+            +EI +L  + H N++   GVC++ 
Sbjct: 55  GSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA 114

Query: 408 GNC--YLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHS--FTNPPH 463
           G     L+ EY   G+L D++  +K     +D  + +Q    +  G+ YL +  +     
Sbjct: 115 GRRNLKLIMEYLPYGSLRDYLQKHKER---IDHIKLLQYTSQICKGMEYLGTKRY----- 166

Query: 464 VHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKG-----YMAPEYLE 518
           +H+D+ + N+L++++ R KI +F + +     +  +      V   G     + APE L 
Sbjct: 167 IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYY-----KVKEPGESPIFWYAPESLT 221

Query: 519 NGLVSTKLDVYAFGVLILEMLTGKEAAALHAEEN----------NMHLSDVLNAVLTKED 568
               S   DV++FGV++ E+ T  E +     E            M +  ++  +   ++
Sbjct: 222 ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL---KN 278

Query: 569 GEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNAS 625
                R    P      P E+ +++      C   +   RP+  ++   +  I +  
Sbjct: 279 NGRLPR----PD---GCPDEIYMIMTE----CWNNNVNQRPSFRDLALRVDQIRDQM 324

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  119 bits (300), Expect = 7e-30
 Identities = 68/294 (23%), Positives = 109/294 (37%), Gaps = 60/294 (20%)

Query: 361 GSVYRGKINGGFA-------AIKKVNGDVS--------KEIALLNKINHSNLIILSGVCF 405
           G VY G+++G          A+K +    S         E  +++K NH N++   GV  
Sbjct: 44  GEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSL 103

Query: 406 NEGNCYLVYEYAVNGTLSDWVFSNK---NEGKYLDWKQRIQIALDVATGLNYL--HSFTN 460
                +++ E    G L  ++   +   ++   L     + +A D+A G  YL  + F  
Sbjct: 104 QSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHF-- 161

Query: 461 PPHVHKDINSSNVLLD---SDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGY-----M 512
              +H+DI + N LL        AKI +F MAR            R   G         M
Sbjct: 162 ---IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAS----YYR--KGGCAMLPVKWM 212

Query: 513 APEYLENGLVSTKLDVYAFGVLILEMLT-GKEAAALHAEENNMHLSDVLNAVLTKEDGEE 571
            PE    G+ ++K D ++FGVL+ E+ + G           +    +VL  V     G  
Sbjct: 213 PPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYP------SKSNQEVLEFV---TSG-- 261

Query: 572 SLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNAS 625
                +DP      P      V R++  C +  P DRP    I   +       
Sbjct: 262 ---GRMDP------PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP 306

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  119 bits (300), Expect = 8e-30
 Identities = 71/285 (24%), Positives = 122/285 (42%), Gaps = 52/285 (18%)

Query: 361 GSVYRGKINGGFA-----AIKKVNGDVS--------KEIALLNKINHSNLIILSGVCFNE 407
           G V  G++          AIK +    +         E +++ + +H N+I L GV    
Sbjct: 63  GEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRG 122

Query: 408 GNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYL--HSFTNPPHVH 465
               +V EY  NG+L  ++ ++  +       Q + +   V  G+ YL    +     VH
Sbjct: 123 RLAMIVTEYMENGSLDTFLRTHDGQ---FTIMQLVGMLRGVGAGMRYLSDLGY-----VH 174

Query: 466 KDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTK---GYMAPEYLENGLV 522
           +D+ + NVL+DS+L  K+++F ++R  E    + A T    G K    + APE +     
Sbjct: 175 RDLAARNVLVDSNLVCKVSDFGLSRVLEDDP-DAAYTTT--GGKIPIRWTAPEAIAFRTF 231

Query: 523 STKLDVYAFGVLILEMLTGKEAAALHAEE--NNMHLSDVLNAVLTKEDGEESLRHFIDPT 580
           S+  DV++FGV++ E+L        + E    NM   DV+++V   E+G         P 
Sbjct: 232 SSASDVWSFGVVMWEVLA-------YGERPYWNMTNRDVISSV---EEGYRLPA----PM 277

Query: 581 LQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNAS 625
                P  L  L++     C  KD   RP   +I   L  ++ + 
Sbjct: 278 ---GCPHALHQLMLD----CWHKDRAQRPRFSQIVSVLDALIRSP 315

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  118 bits (298), Expect = 8e-30
 Identities = 63/307 (20%), Positives = 118/307 (38%), Gaps = 81/307 (26%)

Query: 361 GSVYRGKINGGFA-------AIKKVNG-------DVSKEIALLNKINHSNLIILSGVCFN 406
           G V+  +             A+K +         D  +E  LL  + H +++   GVC +
Sbjct: 29  GKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGD 88

Query: 407 EGNCYLVYEYAVNGTLSD------------WVFSNKNEGKYLDWKQRIQIALDVATGLNY 454
                +V+EY  +G L+                  +     L   Q + IA  +A+G+ Y
Sbjct: 89  GDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVY 148

Query: 455 L--HSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKG-- 510
           L    F     VH+D+ + N L+ ++L  KI +F M+R     +      R  VG     
Sbjct: 149 LASQHF-----VHRDLATRNCLVGANLLVKIGDFGMSRDVYSTD----YYR--VGGHTML 197

Query: 511 ---YMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEE--NNMHLSDVLNAVLT 565
              +M PE +     +T+ DV++FGV++ E+ T       + ++    +  ++V+  +  
Sbjct: 198 PIRWMPPESIMYRKFTTESDVWSFGVILWEIFT-------YGKQPWFQLSNTEVIECI-- 248

Query: 566 KEDGEESLRHFIDPTLQGNY-------PLELALLVIRLIDACLKKDPTDRPTMYEIEHSL 618
                           QG         P E+  +++     C +++P  R  + EI   L
Sbjct: 249 ---------------TQGRVLERPRVCPKEVYDVMLG----CWQREPQQRLNIKEIYKIL 289

Query: 619 SNILNAS 625
             +  A+
Sbjct: 290 HALGKAT 296

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  118 bits (299), Expect = 1e-29
 Identities = 59/299 (19%), Positives = 113/299 (37%), Gaps = 66/299 (22%)

Query: 361 GSVYRGKINGGFA-------AIKKVNG-------DVSKEIALLNKINHSNLIILSGVCFN 406
           G V+  + +           A+K +         D  +E  LL  + H +++   GVC  
Sbjct: 55  GKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTE 114

Query: 407 EGNCYLVYEYAVNGTL-----------SDWVFSNKNEGKYLDWKQRIQIALDVATGLNYL 455
                +V+EY  +G L                        L   Q + +A  VA G+ YL
Sbjct: 115 GRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYL 174

Query: 456 --HSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKG--- 510
               F     VH+D+ + N L+   L  KI +F M+R     +      R  VG +    
Sbjct: 175 AGLHF-----VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTD----YYR--VGGRTMLP 223

Query: 511 --YMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEE--NNMHLSDVLNAVLTK 566
             +M PE +     +T+ DV++FGV++ E+ T       + ++    +  ++ ++ +   
Sbjct: 224 IRWMPPESILYRKFTTESDVWSFGVVLWEIFT-------YGKQPWYQLSNTEAIDCI--- 273

Query: 567 EDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNAS 625
             G       ++       P      V  ++  C +++P  R ++ ++   L  +  A 
Sbjct: 274 TQG-----RELER------PRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAP 321

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  119 bits (300), Expect = 1e-29
 Identities = 71/312 (22%), Positives = 124/312 (39%), Gaps = 83/312 (26%)

Query: 361 GSVYRGKINGGFA---------AIKKVNGDVS--------KEIALLNKI-NHSNLIILSG 402
           G V   +  G            A+K +  D +         E+ ++  I  H N+I L G
Sbjct: 95  GQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLG 154

Query: 403 VCFNEGNCYLVYEYAVNGTLSD------------WVFSNKNEGKYLDWKQRIQIALDVAT 450
            C  +G  Y++ EYA  G L +                N+   + + +K  +     +A 
Sbjct: 155 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLAR 214

Query: 451 GLNYLHS--FTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGT 508
           G+ YL S        +H+D+ + NVL+  +   KIA+F +AR     +       +   T
Sbjct: 215 GMEYLASQKC-----IHRDLAARNVLVTENNVMKIADFGLARDINNID------YYKKTT 263

Query: 509 KG-----YMAPEYLENGLVSTKLDVYAFGVLILEMLT-------GKEAAALHAEENNMHL 556
            G     +MAPE L + + + + DV++FGVL+ E+ T       G            + +
Sbjct: 264 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG------------IPV 311

Query: 557 SDVLNAVLTKEDGEESLRHFID-PTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIE 615
            ++   +   ++G     H +D P    N   EL +++      C    P+ RPT  ++ 
Sbjct: 312 EELFKLL---KEG-----HRMDKPA---NCTNELYMMMRD----CWHAVPSQRPTFKQLV 356

Query: 616 HSLSNILNASLN 627
             L  IL  + N
Sbjct: 357 EDLDRILTLTTN 368

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  119 bits (299), Expect = 2e-29
 Identities = 66/282 (23%), Positives = 124/282 (43%), Gaps = 52/282 (18%)

Query: 361 GSVYRGKINGGFA-----AIKKVNGDVS--------KEIALLNKINHSNLIILSGVCFNE 407
           G V  G++          AIK +    +         E +++ + +H N+I L GV    
Sbjct: 59  GEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKS 118

Query: 408 GNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYL--HSFTNPPHVH 465
               +V EY  NG+L    F  K++ +     Q + +   +A+G+ YL    +     VH
Sbjct: 119 KPVMIVTEYMENGSLDS--FLRKHDAQ-FTVIQLVGMLRGIASGMKYLSDMGY-----VH 170

Query: 466 KDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTK---GYMAPEYLENGLV 522
           +D+ + N+L++S+L  K+++F + R  E    E A T    G K    + +PE +     
Sbjct: 171 RDLAARNILINSNLVCKVSDFGLGRVLEDDP-EAAYTTR--GGKIPIRWTSPEAIAYRKF 227

Query: 523 STKLDVYAFGVLILEMLTGKEAAALHAEE--NNMHLSDVLNAVLTKEDGEESLRHFIDPT 580
           ++  DV+++G+++ E+++       + E     M   DV+ AV   ++G         P 
Sbjct: 228 TSASDVWSYGIVLWEVMS-------YGERPYWEMSNQDVIKAV---DEGYRLPP----PM 273

Query: 581 LQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNIL 622
              + P  L  L++     C +KD  +RP   +I   L  ++
Sbjct: 274 ---DCPAALYQLMLD----CWQKDRNNRPKFEQIVSILDKLI 308

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  117 bits (295), Expect = 3e-29
 Identities = 62/282 (21%), Positives = 103/282 (36%), Gaps = 56/282 (19%)

Query: 361 GSVYRGK-INGGFAAIKKVN---------GDVSKEIALLNKINHSNLII--LSGVCFNEG 408
             V++         AIK VN              EIA LNK+   +  I  L      + 
Sbjct: 42  SKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ 101

Query: 409 NCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPH--VHK 466
             Y+V E   N  L+ W+   K +   +D  +R     ++   ++ +H      H  VH 
Sbjct: 102 YIYMVMECG-NIDLNSWL---KKKKS-IDPWERKSYWKNMLEAVHTIHQ-----HGIVHS 151

Query: 467 DINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLEN------- 519
           D+  +N L+      K+ +F +A   +            VGT  YM PE +++       
Sbjct: 152 DLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKD-SQVGTVNYMPPEAIKDMSSSREN 209

Query: 520 ----GLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRH 575
                 +S K DV++ G ++  M  GK         N +                  L  
Sbjct: 210 GKSKSKISPKSDVWSLGCILYYMTYGK--TPFQQIINQI----------------SKLHA 251

Query: 576 FIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEI-EH 616
            IDP  +  +P      +  ++  CLK+DP  R ++ E+  H
Sbjct: 252 IIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 293

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  116 bits (292), Expect = 4e-29
 Identities = 62/287 (21%), Positives = 113/287 (39%), Gaps = 59/287 (20%)

Query: 361 GSVYRGKINGGFA-----AIKKVNGDVS--------KEIALLNKINHSNLIILSGVCFNE 407
           G VY G            A+K    D +         E  ++  ++H +++ L G+   E
Sbjct: 26  GEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE 85

Query: 408 GNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYL--HSFTNPPHVH 465
              +++ E    G L  ++  NKN    L     +  +L +   + YL   +      VH
Sbjct: 86  -PTWIIMELYPYGELGHYLERNKNS---LKVLTLVLYSLQICKAMAYLESINC-----VH 136

Query: 466 KDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKG-----YMAPEYLENG 520
           +DI   N+L+ S    K+ +F ++R  E ++       +   +       +M+PE +   
Sbjct: 137 RDIAVRNILVASPECVKLGDFGLSRYIEDED-------YYKASVTRLPIKWMSPESINFR 189

Query: 521 LVSTKLDVYAFGVLILEMLTGKEAAALHAEE--NNMHLSDVLNAVLTKEDGEESLRHFID 578
             +T  DV+ F V + E+L+         ++    +   DV+  +   E G+   +    
Sbjct: 190 RFTTASDVWMFAVCMWEILS-------FGKQPFFWLENKDVIGVL---EKGDRLPK---- 235

Query: 579 PTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNAS 625
           P      P  L  L+ R    C   DP+DRP   E+  SLS++    
Sbjct: 236 PD---LCPPVLYTLMTR----CWDYDPSDRPRFTELVCSLSDVYQME 275

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  117 bits (295), Expect = 4e-29
 Identities = 71/312 (22%), Positives = 123/312 (39%), Gaps = 83/312 (26%)

Query: 361 GSVYRGKINGGFA---------AIKKVNGDVS--------KEIALLNKI-NHSNLIILSG 402
           G V   +  G            A+K +  D +         E+ ++  I  H N+I L G
Sbjct: 49  GQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLG 108

Query: 403 VCFNEGNCYLVYEYAVNGTLSD------------WVFSNKNEGKYLDWKQRIQIALDVAT 450
            C  +G  Y++ EYA  G L +                N+   + + +K  +     +A 
Sbjct: 109 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLAR 168

Query: 451 GLNYLHS--FTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGT 508
           G+ YL S        +H+D+ + NVL+  +   KIA+F +AR     +       +   T
Sbjct: 169 GMEYLASQKC-----IHRDLAARNVLVTENNVMKIADFGLARDINNID------YYKKTT 217

Query: 509 KG-----YMAPEYLENGLVSTKLDVYAFGVLILEMLT-------GKEAAALHAEENNMHL 556
            G     +MAPE L + + + + DV++FGVL+ E+ T       G            + +
Sbjct: 218 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG------------IPV 265

Query: 557 SDVLNAVLTKEDGEESLRHFID-PTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIE 615
            ++   +   ++G     H +D P    N   EL      ++  C    P+ RPT  ++ 
Sbjct: 266 EELFKLL---KEG-----HRMDKPA---NCTNELY----MMMRDCWHAVPSQRPTFKQLV 310

Query: 616 HSLSNILNASLN 627
             L  IL  + N
Sbjct: 311 EDLDRILTLTTN 322

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  117 bits (295), Expect = 4e-29
 Identities = 62/282 (21%), Positives = 103/282 (36%), Gaps = 56/282 (19%)

Query: 361 GSVYRGK-INGGFAAIKKVN---------GDVSKEIALLNKINHSNLII--LSGVCFNEG 408
             V++         AIK VN              EIA LNK+   +  I  L      + 
Sbjct: 23  SKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ 82

Query: 409 NCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPH--VHK 466
             Y+V E   N  L+ W+   K +   +D  +R     ++   ++ +H      H  VH 
Sbjct: 83  YIYMVMECG-NIDLNSWL---KKKKS-IDPWERKSYWKNMLEAVHTIHQ-----HGIVHS 132

Query: 467 DINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLEN------- 519
           D+  +N L+      K+ +F +A   +            VGT  YM PE +++       
Sbjct: 133 DLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKD-SQVGTVNYMPPEAIKDMSSSREN 190

Query: 520 ----GLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRH 575
                 +S K DV++ G ++  M  GK         N +                  L  
Sbjct: 191 GKSKSKISPKSDVWSLGCILYYMTYGK--TPFQQIINQI----------------SKLHA 232

Query: 576 FIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEI-EH 616
            IDP  +  +P      +  ++  CLK+DP  R ++ E+  H
Sbjct: 233 IIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 274

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  116 bits (292), Expect = 4e-29
 Identities = 66/287 (22%), Positives = 120/287 (41%), Gaps = 52/287 (18%)

Query: 361 GSVYRGKINGGFA----AIKKVNGDVS---------KEIALLNKINHSNLIILSGVCFNE 407
           G+V +G           A+K +  + +          E  ++ ++++  ++ + G+C  E
Sbjct: 31  GTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE 90

Query: 408 GNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYL--HSFTNPPHVH 465
               LV E A  G L+ ++     + +++  K  I++   V+ G+ YL   +F     VH
Sbjct: 91  SW-MLVMEMAELGPLNKYL----QQNRHVKDKNIIELVHQVSMGMKYLEESNF-----VH 140

Query: 466 KDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTK---GYMAPEYLENGLV 522
           +D+ + NVLL +   AKI++F +++     E  +         K    + APE +     
Sbjct: 141 RDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT---HGKWPVKWYAPECINYYKF 197

Query: 523 STKLDVYAFGVLILEMLT-GKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTL 581
           S+K DV++FGVL+ E  + G++          M  S+V   +   E GE        P  
Sbjct: 198 SSKSDVWSFGVLMWEAFSYGQKPYR------GMKGSEVTAML---EKGERMGC----PA- 243

Query: 582 QGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNASLNW 628
               P E+  L+      C   D  +RP    +E  L N     +N 
Sbjct: 244 --GCPREMYDLMNL----CWTYDVENRPGFAAVELRLRNYYYDVVNE 284

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  115 bits (291), Expect = 5e-29
 Identities = 52/281 (18%), Positives = 94/281 (33%), Gaps = 55/281 (19%)

Query: 361 GSVYRG--KINGGFAAIKKVNGDVS---------KEIALLNKI-NHSNLIILSGVCFNEG 408
           GSV++   +++G   AIK+    ++         +E+     +  HS+++        + 
Sbjct: 25  GSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDD 84

Query: 409 NCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPH--VHK 466
           +  +  EY   G+L+D +  N     Y    +   + L V  GL Y+HS        VH 
Sbjct: 85  HMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHS-----MSLVHM 139

Query: 467 DINSSNVLLDSDLRAKIANFAMARPAEGQE------GEFALTRHI------VGTKGYMAP 514
           DI  SN+ +        A+                 G+      I       G   ++A 
Sbjct: 140 DIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEEGDSRFLAN 199

Query: 515 EYL-ENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESL 573
           E L EN     K D++A  + ++     +    L    +  H                 +
Sbjct: 200 EVLQENYTHLPKADIFALALTVVCAAGAEP---LPRNGDQWH----------------EI 240

Query: 574 RHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEI 614
           R    P +      E       L+   +  DP  RP+   +
Sbjct: 241 RQGRLPRIPQVLSQEF----TELLKVMIHPDPERRPSAMAL 277

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  116 bits (292), Expect = 9e-29
 Identities = 75/304 (24%), Positives = 129/304 (42%), Gaps = 79/304 (25%)

Query: 361 GSVYRGKINGG----FAAIKKVNGDVS--------KEIALLNKI-NHSNLIILSGVCFNE 407
           G V + +I        AAIK++    S         E+ +L K+ +H N+I L G C + 
Sbjct: 39  GQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR 98

Query: 408 GNCYLVYEYAVNGTLSDW------------VFSNKNEGKYLDWKQRIQIALDVATGLNYL 455
           G  YL  EYA +G L D+                 +    L  +Q +  A DVA G++YL
Sbjct: 99  GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL 158

Query: 456 --HSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKG--- 510
               F     +H+D+ + N+L+  +  AKIA+F ++R  E              T G   
Sbjct: 159 SQKQF-----IHRDLAARNILVGENYVAKIADFGLSRGQEVYV---------KKTMGRLP 204

Query: 511 --YMAPEYLENGLVSTKLDVYAFGVLILEMLT-------GKEAAALHAEENNMHLSDVLN 561
             +MA E L   + +T  DV+++GVL+ E+++       G            M  +++  
Sbjct: 205 VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG------------MTCAELYE 252

Query: 562 AVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNI 621
            +     G     + ++  L  N   E+  L+ +    C ++ P +RP+  +I  SL+ +
Sbjct: 253 KL---PQG-----YRLEKPL--NCDDEVYDLMRQ----CWREKPYERPSFAQILVSLNRM 298

Query: 622 LNAS 625
           L   
Sbjct: 299 LEER 302

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  115 bits (289), Expect = 9e-29
 Identities = 71/286 (24%), Positives = 115/286 (40%), Gaps = 59/286 (20%)

Query: 361 GSVYRGKINGGFA-----AIKKVNGDVS--------KEIALLNKINHSNLIILSGVCFNE 407
           G V++G            AIK      S        +E   + + +H +++ L GV    
Sbjct: 29  GDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITEN 88

Query: 408 GNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYL--HSFTNPPHVH 465
              +++ E    G L  ++   K     LD    I  A  ++T L YL    F     VH
Sbjct: 89  -PVWIIMELCTLGELRSFLQVRKYS---LDLASLILYAYQLSTALAYLESKRF-----VH 139

Query: 466 KDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKG-----YMAPEYLENG 520
           +DI + NVL+ S+   K+ +F ++R  E          +   +KG     +MAPE +   
Sbjct: 140 RDIAARNVLVSSNDCVKLGDFGLSRYMEDST-------YYKASKGKLPIKWMAPESINFR 192

Query: 521 LVSTKLDVYAFGVLILEMLTGKEAAALHAEE--NNMHLSDVLNAVLTKEDGEESLRHFID 578
             ++  DV+ FGV + E+L        H  +    +  +DV+  +   E+GE        
Sbjct: 193 RFTSASDVWMFGVCMWEILM-------HGVKPFQGVKNNDVIGRI---ENGERLPM---- 238

Query: 579 PTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNA 624
           P    N P  L  L+ +    C   DP+ RP   E++  LS IL  
Sbjct: 239 PP---NCPPTLYSLMTK----CWAYDPSRRPRFTELKAQLSTILEE 277

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  115 bits (289), Expect = 1e-28
 Identities = 66/288 (22%), Positives = 116/288 (40%), Gaps = 52/288 (18%)

Query: 361 GSVYRGKINGGFA-----AIK----------KVNGDVSKEIALLNKINHSNLIILSGVCF 405
           G V RG+ +         A+K          +   D  +E+  ++ ++H NLI L GV  
Sbjct: 32  GVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVL 91

Query: 406 NEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYL--HSFTNPPH 463
                 +V E A  G+L D +  ++            + A+ VA G+ YL    F     
Sbjct: 92  TPPM-KMVTELAPLGSLLDRLRKHQGH---FLLGTLSRYAVQVAEGMGYLESKRF----- 142

Query: 464 VHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTK---GYMAPEYLENG 520
           +H+D+ + N+LL +    KI +F + R     +  + +       K    + APE L+  
Sbjct: 143 IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE---HRKVPFAWCAPESLKTR 199

Query: 521 LVSTKLDVYAFGVLILEMLT-GKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDP 579
             S   D + FGV + EM T G+E          ++ S +L+ +   ++GE   R    P
Sbjct: 200 TFSHASDTWMFGVTLWEMFTYGQEPWI------GLNGSQILHKI--DKEGERLPR----P 247

Query: 580 TLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNASLN 627
               + P ++  ++++    C    P DRPT   +   L       + 
Sbjct: 248 E---DCPQDIYNVMVQ----CWAHKPEDRPTFVALRDFLLEAQPTDMR 288

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  114 bits (288), Expect = 1e-28
 Identities = 58/299 (19%), Positives = 109/299 (36%), Gaps = 68/299 (22%)

Query: 361 GSVYRGKINGGFA-------AIKKVNGDVS--------KEIALLNKINHSNLIILSGVCF 405
           G VY+G + G          AIK +              E  L  ++ H N++ L GV  
Sbjct: 23  GKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVT 82

Query: 406 NEGNCYLVYEYAVNGTLSD------------WVFSNKNEGKYLDWKQRIQIALDVATGLN 453
            +    +++ Y  +G L +                ++     L+    + +   +A G+ 
Sbjct: 83  KDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGME 142

Query: 454 YL--HSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKG- 510
           YL  H       VHKD+ + NVL+   L  KI++  + R     +       + +     
Sbjct: 143 YLSSHHV-----VHKDLATRNVLVYDKLNVKISDLGLFREVYAAD------YYKLLGNSL 191

Query: 511 ----YMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEE--NNMHLSDVLNAVL 564
               +MAPE +  G  S   D++++GV++ E+ +       +  +        DV+  + 
Sbjct: 192 LPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS-------YGLQPYCGYSNQDVVEMI- 243

Query: 565 TKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILN 623
              + +        P    + P  +  L+I     C  + P+ RP   +I   L    N
Sbjct: 244 --RNRQVLPC----PD---DCPAWVYALMIE----CWNEFPSRRPRFKDIHSRLRAWGN 289

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  117 bits (294), Expect = 1e-28
 Identities = 61/282 (21%), Positives = 102/282 (36%), Gaps = 56/282 (19%)

Query: 361 GSVYRGK-INGGFAAIKKVN---------GDVSKEIALLNKINHSNLII--LSGVCFNEG 408
             V++         AIK VN              EIA LNK+   +  I  L      + 
Sbjct: 70  SKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ 129

Query: 409 NCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPH--VHK 466
             Y+V E   N  L+ W+   K+    +D  +R     ++   ++ +H      H  VH 
Sbjct: 130 YIYMVMECG-NIDLNSWLKKKKS----IDPWERKSYWKNMLEAVHTIHQ-----HGIVHS 179

Query: 467 DINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLEN------- 519
           D+  +N L+      K+ +F +A   +            VG   YM PE +++       
Sbjct: 180 DLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKD-SQVGAVNYMPPEAIKDMSSSREN 237

Query: 520 ----GLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRH 575
                 +S K DV++ G ++  M  GK         N +                  L  
Sbjct: 238 GKSKSKISPKSDVWSLGCILYYMTYGK--TPFQQIINQI----------------SKLHA 279

Query: 576 FIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEI-EH 616
            IDP  +  +P      +  ++  CLK+DP  R ++ E+  H
Sbjct: 280 IIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 321

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  115 bits (290), Expect = 2e-28
 Identities = 60/282 (21%), Positives = 121/282 (42%), Gaps = 53/282 (18%)

Query: 361 GSVYRGKINGGFA------AIK--------KVNGDVSKEIALLNKINHSNLIILSGVCFN 406
           G+VY+G             AIK        K N ++  E  ++  +++ ++  L G+C  
Sbjct: 29  GTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT 88

Query: 407 EGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYL--HSFTNPPHV 464
                L+ +    G L D+V  +K+    +  +  +   + +A G+NYL          V
Sbjct: 89  S-TVQLITQLMPFGCLLDYVREHKDN---IGSQYLLNWCVQIAKGMNYLEDRRL-----V 139

Query: 465 HKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTK---GYMAPEYLENGL 521
           H+D+ + NVL+ +    KI +F +A+    +E E     H  G K    +MA E + + +
Sbjct: 140 HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE----YHAEGGKVPIKWMALESILHRI 195

Query: 522 VSTKLDVYAFGVLILEMLT-GKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPT 580
            + + DV+++GV + E++T G +          +  S++ + +   E GE   +    P 
Sbjct: 196 YTHQSDVWSYGVTVWELMTFGSKPYD------GIPASEISSIL---EKGERLPQ----PP 242

Query: 581 LQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNIL 622
                 +++ +++++    C   D   RP   E+    S + 
Sbjct: 243 ---ICTIDVYMIMVK----CWMIDADSRPKFRELIIEFSKMA 277

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  117 bits (295), Expect = 2e-28
 Identities = 58/287 (20%), Positives = 109/287 (37%), Gaps = 55/287 (19%)

Query: 363 VYRGKINGGFAAIKKVN----GDVSKEIALLNKI-NHSNLIILSGVCFNEGNCYLVYEYA 417
           V++G   G   A+K++          EI LL +  +H N+I        +   Y+  E  
Sbjct: 32  VFQGSFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALEL- 90

Query: 418 VNGTLSDWVFSNKN---EGKYLDWKQRIQIALDVATGLNYLHSFTNPPH--VHKDINSSN 472
            N  L D V S        K       I +   +A+G+ +LHS        +H+D+   N
Sbjct: 91  CNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS-----LKIIHRDLKPQN 145

Query: 473 VLLDS-------------DLRAKIANFAMARP-AEGQEGEFALTRHIVGTKGYMAPEYLE 518
           +L+ +             +LR  I++F + +    GQ        +  GT G+ APE LE
Sbjct: 146 ILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLE 205

Query: 519 NGLV-------STKLDVYAFGVLILEMLTGKEAAALHA-EENNMHLSDVLNAVLTKEDGE 570
                      +  +D+++ G +   +L+  +    H   +     S+++  + + ++  
Sbjct: 206 ESNNLQTKRRLTRSIDIFSMGCVFYYILSKGK----HPFGDKYSRESNIIRGIFSLDE-- 259

Query: 571 ESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEI-EH 616
                     ++  +   L      LI   +  DP  RPT  ++  H
Sbjct: 260 ----------MKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRH 296

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  116 bits (292), Expect = 2e-28
 Identities = 68/292 (23%), Positives = 109/292 (37%), Gaps = 60/292 (20%)

Query: 361 GSVYRGKINGGFA-------AIKKVNGDVS--------KEIALLNKINHSNLIILSGVCF 405
           G VY G+++G          A+K +    S         E  +++K NH N++   GV  
Sbjct: 85  GEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSL 144

Query: 406 NEGNCYLVYEYAVNGTLSDWVFSNK---NEGKYLDWKQRIQIALDVATGLNYL--HSFTN 460
                +++ E    G L  ++   +   ++   L     + +A D+A G  YL  + F  
Sbjct: 145 QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHF-- 202

Query: 461 PPHVHKDINSSNVLLD---SDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGY-----M 512
              +H+DI + N LL        AKI +F MAR            R   G         M
Sbjct: 203 ---IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAG----YYR--KGGCAMLPVKWM 253

Query: 513 APEYLENGLVSTKLDVYAFGVLILEMLT-GKEAAALHAEENNMHLSDVLNAVLTKEDGEE 571
            PE    G+ ++K D ++FGVL+ E+ + G           +    +VL  V     G  
Sbjct: 254 PPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYP------SKSNQEVLEFV---TSG-- 302

Query: 572 SLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILN 623
                +DP      P      V R++  C +  P DRP    I   +     
Sbjct: 303 ---GRMDP------PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 345

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  116 bits (292), Expect = 2e-28
 Identities = 74/312 (23%), Positives = 124/312 (39%), Gaps = 83/312 (26%)

Query: 361 GSVYRGKINGGFA---------AIKKVNGDVS--------KEIALLNKI-NHSNLIILSG 402
           G V   +  G            A+K +  D +         E+ ++  I  H N+I L G
Sbjct: 83  GQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLG 142

Query: 403 VCFNEGNCYLVYEYAVNGTLSD------------WVFSNKNEGKYLDWKQRIQIALDVAT 450
            C  +G  Y++ EYA  G L +                + N  + L  K  +  A  VA 
Sbjct: 143 ACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVAR 202

Query: 451 GLNYLHS--FTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGT 508
           G+ YL S        +H+D+ + NVL+  D   KIA+F +AR     +       +   T
Sbjct: 203 GMEYLASKKC-----IHRDLAARNVLVTEDNVMKIADFGLARDIHHID------YYKKTT 251

Query: 509 KG-----YMAPEYLENGLVSTKLDVYAFGVLILEMLT-------GKEAAALHAEENNMHL 556
            G     +MAPE L + + + + DV++FGVL+ E+ T       G            + +
Sbjct: 252 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG------------VPV 299

Query: 557 SDVLNAVLTKEDGEESLRHFID-PTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIE 615
            ++   +   ++G     H +D P+   N   EL      ++  C    P+ RPT  ++ 
Sbjct: 300 EELFKLL---KEG-----HRMDKPS---NCTNELY----MMMRDCWHAVPSQRPTFKQLV 344

Query: 616 HSLSNILNASLN 627
             L  I+  + N
Sbjct: 345 EDLDRIVALTSN 356

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  113 bits (286), Expect = 3e-28
 Identities = 49/301 (16%), Positives = 113/301 (37%), Gaps = 77/301 (25%)

Query: 361 GSVYRGKINGGFA---------AIKKVNGDVS-------KEIALLNKINHSNLIILSGVC 404
             +++G                 +K ++           +  ++++K++H +L++  GVC
Sbjct: 22  TKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVC 81

Query: 405 FNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYL--HSFTNPP 462
                  LV E+   G+L  ++  NKN    ++   ++++A  +A  +++L  ++     
Sbjct: 82  VCGDENILVQEFVKFGSLDTYLKKNKNC---INILWKLEVAKQLAAAMHFLEENTL---- 134

Query: 463 HVHKDINSSNVLLDSDLR--------AKIANFAMARPAEGQEGEFALTRHIVGTKGY--- 511
            +H ++ + N+LL  +           K+++  ++               ++        
Sbjct: 135 -IHGNVCAKNILLIREEDRKTGNPPFIKLSDPGIS-------------ITVLPKDILQER 180

Query: 512 ---MAPEYLENGLV-STKLDVYAFGVLILEMLT-GKEAAALHAEENNMHLSDVLNAVLTK 566
              + PE +EN    +   D ++FG  + E+ + G +  +       +     L      
Sbjct: 181 IPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLS------ALDSQRKLQFY--- 231

Query: 567 EDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNASL 626
           ED  +         L      ELA     LI+ C+  +P  RP+   I   L+++    L
Sbjct: 232 EDRHQ---------LPAPKAAELA----NLINNCMDYEPDHRPSFRAIIRDLNSLFTPDL 278

Query: 627 N 627
            
Sbjct: 279 V 279

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  113 bits (284), Expect = 1e-27
 Identities = 59/282 (20%), Positives = 122/282 (43%), Gaps = 53/282 (18%)

Query: 361 GSVYRGKINGGFA------AIK--------KVNGDVSKEIALLNKINHSNLIILSGVCFN 406
           G+V++G              IK        +    V+  +  +  ++H++++ L G+C  
Sbjct: 27  GTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPG 86

Query: 407 EGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYL--HSFTNPPHV 464
                LV +Y   G+L D V  ++     L  +  +   + +A G+ YL  H       V
Sbjct: 87  SSL-QLVTQYLPLGSLLDHVRQHRGA---LGPQLLLNWGVQIAKGMYYLEEHGM-----V 137

Query: 465 HKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTK---GYMAPEYLENGL 521
           H+++ + NVLL S  + ++A+F +A      + +   +      K    +MA E +  G 
Sbjct: 138 HRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYS----EAKTPIKWMALESIHFGK 193

Query: 522 VSTKLDVYAFGVLILEMLT-GKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPT 580
            + + DV+++GV + E++T G E  A       + L++V + +   E GE   +    P 
Sbjct: 194 YTHQSDVWSYGVTVWELMTFGAEPYA------GLRLAEVPDLL---EKGERLAQ----PQ 240

Query: 581 LQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNIL 622
                 +++ +++++    C   D   RPT  E+ +  + + 
Sbjct: 241 ---ICTIDVYMVMVK----CWMIDENIRPTFKELANEFTRMA 275

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  113 bits (284), Expect = 1e-27
 Identities = 59/257 (22%), Positives = 97/257 (37%), Gaps = 32/257 (12%)

Query: 361 GSVYRG--KINGGFAAIKKVN--GDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEY 416
           G V+R   K  G   A+KKV       +E+     ++   ++ L G         +  E 
Sbjct: 72  GEVHRMKDKQTGFQCAVKKVRLEVFRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL 131

Query: 417 AVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLD 476
              G+L   +   K  G  L   + +        GL YLH+      +H D+ + NVLL 
Sbjct: 132 LEGGSLGQLI---KQMGC-LPEDRALYYLGQALEGLEYLHTRRI---LHGDVKADNVLLS 184

Query: 477 SD-LRAKIANFAMARPAEGQEGEFALTRH--IVGTKGYMAPEYLENGLVSTKLDVYAFGV 533
           SD  RA + +F  A   +      +L     I GT+ +MAPE +       K+D+++   
Sbjct: 185 SDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCC 244

Query: 534 LILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLV 593
           ++L ML G        +            +         L+   +P      P   A L 
Sbjct: 245 MMLHMLNGCHP---WTQYFRG-------PLC--------LKIASEPPPIREIPPSCAPLT 286

Query: 594 IRLIDACLKKDPTDRPT 610
            + I   L+K+P  R +
Sbjct: 287 AQAIQEGLRKEPVHRAS 303

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  112 bits (282), Expect = 2e-27
 Identities = 65/315 (20%), Positives = 122/315 (38%), Gaps = 88/315 (27%)

Query: 361 GSVYRGKINGGFA-------AIKKVNGDVS--------KEIALLNKINHSNLIILSGVCF 405
           G V +               A+K +  + S         E  +L ++NH ++I L G C 
Sbjct: 37  GKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACS 96

Query: 406 NEGNCYLVYEYAVNGTLSD--------------------WVFSNKNEGKYLDWKQRIQIA 445
            +G   L+ EYA  G+L                          +  + + L     I  A
Sbjct: 97  QDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFA 156

Query: 446 LDVATGLNYLHS--FTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTR 503
             ++ G+ YL          VH+D+ + N+L+    + KI++F ++R    ++       
Sbjct: 157 WQISQGMQYLAEMKL-----VHRDLAARNILVAEGRKMKISDFGLSRDVYEED------S 205

Query: 504 HIVGTKG-----YMAPEYLENGLVSTKLDVYAFGVLILEMLT-------GKEAAALHAEE 551
           ++  ++G     +MA E L + + +T+ DV++FGVL+ E++T       G          
Sbjct: 206 YVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG---------- 255

Query: 552 NNMHLSDVLNAVLTKEDGEESLRHFID-PTLQGNYPLELALLVIRLIDACLKKDPTDRPT 610
             +    + N +   + G     H ++ P    N   E+     RL+  C K++P  RP 
Sbjct: 256 --IPPERLFNLL---KTG-----HRMERPD---NCSEEMY----RLMLQCWKQEPDKRPV 298

Query: 611 MYEIEHSLSNILNAS 625
             +I   L  ++   
Sbjct: 299 FADISKDLEKMMVKR 313

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  112 bits (281), Expect = 2e-27
 Identities = 71/265 (26%), Positives = 121/265 (45%), Gaps = 51/265 (19%)

Query: 361 GSVYRG--KINGGFAAIKKVN--------GDVSKEIALLNKINHSNLIILSGVCFNEGNC 410
           G V++G         AIK ++         D+ +EI +L++ +   +    G    +   
Sbjct: 36  GEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKL 95

Query: 411 YLVYEYAVNGTLSDWVFSNK-NEGKYLDWKQRIQIAL---DVATGLNYLHSFTNPPHVHK 466
           +++ EY   G+  D +     +E          QIA    ++  GL+YLHS      +H+
Sbjct: 96  WIIMEYLGGGSALDLLEPGPLDET---------QIATILREILKGLDYLHSEK---KIHR 143

Query: 467 DINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRH-IVGTKGYMAPEYLENGLVSTK 525
           DI ++NVLL      K+A+F +A    GQ  +  + R+  VGT  +MAPE ++     +K
Sbjct: 144 DIKAANVLLSEHGEVKLADFGVA----GQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSK 199

Query: 526 LDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNY 585
            D+++ G+  +E+  G+     H+E + M    VL  +               PTL+GNY
Sbjct: 200 ADIWSLGITAIELARGE---PPHSELHPM---KVLFLIPKNN----------PPTLEGNY 243

Query: 586 PLELALLVIRLIDACLKKDPTDRPT 610
              L       ++ACL K+P+ RPT
Sbjct: 244 SKPL----KEFVEACLNKEPSFRPT 264

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  112 bits (283), Expect = 2e-27
 Identities = 67/321 (20%), Positives = 117/321 (36%), Gaps = 100/321 (31%)

Query: 361 GSVYRGKINGGFA-------AIKKVNGDVS--------KEIALLNKINHSNLIILSGVCF 405
           G V++ +  G          A+K +  + S        +E AL+ + ++ N++ L GVC 
Sbjct: 61  GRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA 120

Query: 406 NEGNCYLVYEYAVNGTLSDW--------------------VFSNKNEGKYLDWKQRIQIA 445
                 L++EY   G L+++                       +      L   +++ IA
Sbjct: 121 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIA 180

Query: 446 LDVATGLNYLHS--FTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTR 503
             VA G+ YL    F     VH+D+ + N L+  ++  KIA+F ++R       ++    
Sbjct: 181 RQVAAGMAYLSERKF-----VHRDLATRNCLVGENMVVKIADFGLSR--NIYSADY---- 229

Query: 504 HIVGTKGY-----MAPEYLENGLVSTKLDVYAFGVLILEMLT-------GKEAAALHAEE 551
           +            M PE +     +T+ DV+A+GV++ E+ +       G          
Sbjct: 230 YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG---------- 279

Query: 552 NNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNY-------PLELALLVIRLIDACLKKD 604
             M   +V+  V                   GN        PLEL      L+  C  K 
Sbjct: 280 --MAHEEVIYYV-----------------RDGNILACPENCPLELY----NLMRLCWSKL 316

Query: 605 PTDRPTMYEIEHSLSNILNAS 625
           P DRP+   I   L  +   +
Sbjct: 317 PADRPSFCSIHRILQRMCERA 337

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  115 bits (290), Expect = 3e-27
 Identities = 60/282 (21%), Positives = 116/282 (41%), Gaps = 50/282 (17%)

Query: 361 GSVYRGKINGGFA----AIK--------KVNGDVSKEIALLNKINHSNLIILSGVCFNEG 408
           GSV +G           AIK            ++ +E  +++++++  ++ L GVC  E 
Sbjct: 350 GSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEA 409

Query: 409 NCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYL--HSFTNPPHVHK 466
              LV E A  G L  ++   + E   +      ++   V+ G+ YL   +F     VH+
Sbjct: 410 L-MLVMEMAGGGPLHKFLVGKREE---IPVSNVAELLHQVSMGMKYLEEKNF-----VHR 460

Query: 467 DINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTK---GYMAPEYLENGLVS 523
           ++ + NVLL +   AKI++F +++     +  +         K    + APE +     S
Sbjct: 461 NLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR---SAGKWPLKWYAPECINFRKFS 517

Query: 524 TKLDVYAFGVLILEMLT-GKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQ 582
           ++ DV+++GV + E L+ G++          M   +V+  +   E G+   R      ++
Sbjct: 518 SRSDVWSYGVTMWEALSYGQKPYK------KMKGPEVMAFI---EQGK---R------ME 559

Query: 583 GNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNA 624
              P E    +  L+  C      DRP    +E  +     +
Sbjct: 560 C--PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 599

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  112 bits (282), Expect = 3e-27
 Identities = 49/290 (16%), Positives = 107/290 (36%), Gaps = 45/290 (15%)

Query: 361 GSVYRGKINGGFAAIKKVN------------------------GDVSKEIALLNKINHSN 396
             +   + +  F A+KK                           D   E+ ++  I +  
Sbjct: 45  NKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEY 104

Query: 397 LIILSGVCFNEGNCYLVYEYAVNGTLSDWV----FSNKNEGKYLDWKQRIQIALDVATGL 452
            +   G+  N    Y++YEY  N ++  +       +KN   ++  +    I   V    
Sbjct: 105 CLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSF 164

Query: 453 NYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYM 512
           +Y+H+  N    H+D+  SN+L+D + R K+++F  +     +       +   GT  +M
Sbjct: 165 SYIHNEKNI--CHRDVKPSNILMDKNGRVKLSDFGESEYMVDK-----KIKGSRGTYEFM 217

Query: 513 APEYLENGLV--STKLDVYAFGVLILEMLTGKEAAAL--HAEENNMHL-SDVLNAVLTKE 567
            PE+  N       K+D+++ G+ +  M        +    + + + L +++    +   
Sbjct: 218 PPEFFSNESSYNGAKVDIWSLGICLYVMFYNV----VPFSLKISLVELFNNIRTKNIEYP 273

Query: 568 DGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEI-EH 616
                  + +           L+   I  +   L+K+P +R T  +  +H
Sbjct: 274 LDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH 323

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  115 bits (290), Expect = 3e-27
 Identities = 73/287 (25%), Positives = 117/287 (40%), Gaps = 59/287 (20%)

Query: 361 GSVYRG--KINGGFA---AIKKVNGDVS--------KEIALLNKINHSNLIILSGVCFNE 407
           G V++G        A   AIK      S        +E   + + +H +++ L GV    
Sbjct: 404 GDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITEN 463

Query: 408 GNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHS--FTNPPHVH 465
              +++ E    G L  ++   K     LD    I  A  ++T L YL S  F     VH
Sbjct: 464 -PVWIIMELCTLGELRSFLQVRKFS---LDLASLILYAYQLSTALAYLESKRF-----VH 514

Query: 466 KDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKG-----YMAPEYLENG 520
           +DI + NVL+ S+   K+ +F ++R  E          +   +KG     +MAPE +   
Sbjct: 515 RDIAARNVLVSSNDCVKLGDFGLSRYMEDST-------YYKASKGKLPIKWMAPESINFR 567

Query: 521 LVSTKLDVYAFGVLILEMLTGKEAAALHAEE--NNMHLSDVLNAVLTKEDGEESLRHFID 578
             ++  DV+ FGV + E+L        H  +    +  +DV+  +   E+GE        
Sbjct: 568 RFTSASDVWMFGVCMWEILM-------HGVKPFQGVKNNDVIGRI---ENGERLPM---- 613

Query: 579 PTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNAS 625
           P    N P  L  L+ +    C   DP+ RP   E++  LS IL   
Sbjct: 614 PP---NCPPTLYSLMTK----CWAYDPSRRPRFTELKAQLSTILEEE 653

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  111 bits (278), Expect = 6e-27
 Identities = 53/292 (18%), Positives = 101/292 (34%), Gaps = 58/292 (19%)

Query: 361 GSVY--RGKINGGFAAIKKVNG-------DVSKEIALLNKI-NHSNLI-------ILSGV 403
             VY  +   +G   A+K++          + +E+  + K+  H N++       I    
Sbjct: 42  AFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEE 101

Query: 404 CFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPH 463
                  +L+      G L +           L     ++I       + ++H    PP 
Sbjct: 102 SDTGQAEFLLLTELCKGQLVE-FLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQ-KPPI 159

Query: 464 VHKDINSSNVLLDSDLRAKIANFAMARPA-----------EGQEGEFALTRHIVGTKGYM 512
           +H+D+   N+LL +    K+ +F  A                   E  +TR+   T  Y 
Sbjct: 160 IHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRN--TTPMYR 217

Query: 513 APEYLE---NGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDG 569
            PE ++   N  +  K D++A G ++  +   +     H  E+   L  ++N        
Sbjct: 218 TPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQ-----HPFEDGAKLR-IVNG------- 264

Query: 570 EESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNI 621
                 +  P                LI A L+ +P +R ++ E+ H L  I
Sbjct: 265 -----KYSIPPHD-TQYTVF----HSLIRAMLQVNPEERLSIAEVVHQLQEI 306

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  112 bits (281), Expect = 7e-27
 Identities = 46/292 (15%), Positives = 104/292 (35%), Gaps = 47/292 (16%)

Query: 361 GSVYRG--KINGGFAAIKKVN---------GDVSKEIALLNKINHSNLIILSGVCFNEGN 409
            +V     K  G +  ++++N           +  E+ +    NH N++        +  
Sbjct: 41  MTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNE 100

Query: 410 CYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDIN 469
            ++V  +   G+  D + ++  +G  ++      I   V   L+Y+H      +VH+ + 
Sbjct: 101 LWVVTSFMAYGSAKDLICTHFMDG--MNELAIAYILQGVLKALDYIHHMG---YVHRSVK 155

Query: 470 SSNVLLDSDLRAKIANF----AMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLV--S 523
           +S++L+  D +  ++      +M    + Q       ++ V    +++PE L+  L    
Sbjct: 156 ASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYD 215

Query: 524 TKLDVYAFGVLILEMLTGK-------------------------EAAALHAEENNMHLSD 558
            K D+Y+ G+   E+  G                           +     E        
Sbjct: 216 AKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRS 275

Query: 559 VLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPT 610
           V N+ L+      + R     +    Y    +      ++ CL+++P  RP+
Sbjct: 276 VANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPS 327

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  110 bits (276), Expect = 1e-26
 Identities = 60/307 (19%), Positives = 110/307 (35%), Gaps = 76/307 (24%)

Query: 361 GSVYRGKINGGFA-------AIKKVNGDVS--------KEIALLNKI-NHSNLIILSGVC 404
           G V      G          A+K +              E+ +++ +  H N++ L G C
Sbjct: 60  GKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGAC 119

Query: 405 FNEGNCYLVYEYAVNGTLSDW----------VFSNKNEGKYLDWKQRIQIALDVATGLNY 454
            + G   ++ EY   G L ++            +          +  +  +  VA G+ +
Sbjct: 120 THGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAF 179

Query: 455 LHS--FTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKG-- 510
           L S        +H+D+ + NVLL +   AKI +F +AR             +IV      
Sbjct: 180 LASKNC-----IHRDVAARNVLLTNGHVAKIGDFGLARDIMNDS------NYIVKGNARL 228

Query: 511 ---YMAPEYLENGLVSTKLDVYAFGVLILEMLT-------GKEAAALHAEENNMHLSDVL 560
              +MAPE + + + + + DV+++G+L+ E+ +       G            +  S   
Sbjct: 229 PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGI-----------LVNSKFY 277

Query: 561 NAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSN 620
             V   +DG +  +    P      P  +      ++ AC   +PT RPT  +I   L  
Sbjct: 278 KLV---KDGYQMAQ----PA---FAPKNIY----SIMQACWALEPTHRPTFQQICSFLQE 323

Query: 621 ILNASLN 627
                  
Sbjct: 324 QAQEDRR 330

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  109 bits (274), Expect = 2e-26
 Identities = 61/311 (19%), Positives = 111/311 (35%), Gaps = 81/311 (26%)

Query: 361 GSVYRGKINGGFA-------AIKKVNGDVS--------KEIALLNKI-NHSNLIILSGVC 404
           G V      G          A+K +    +         E+ +L  I +H N++ L G C
Sbjct: 41  GQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGAC 100

Query: 405 FNEGN-CYLVYEYAVNGTLSD------------WVFSNKNEGKYLDWKQRIQIALDVATG 451
              G    ++ E+   G LS              V        +L  +  I  +  VA G
Sbjct: 101 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKG 160

Query: 452 LNYLHS--FTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTK 509
           + +L S        +H+D+ + N+LL      KI +F +AR             ++    
Sbjct: 161 MEFLASRKC-----IHRDLAARNILLSEKNVVKICDFGLARDIYKDP------DYVRKGD 209

Query: 510 G-----YMAPEYLENGLVSTKLDVYAFGVLILEMLT-------GKEAAALHAEENNMHLS 557
                 +MAPE + + + + + DV++FGVL+ E+ +       G +              
Sbjct: 210 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE----------- 258

Query: 558 DVLNAVLTKEDGEESLRHFID-PTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEH 616
           +    +   ++G       +  P        E+     + +  C   +P+ RPT  E+  
Sbjct: 259 EFCRRL---KEG-----TRMRAPD---YTTPEMY----QTMLDCWHGEPSQRPTFSELVE 303

Query: 617 SLSNILNASLN 627
            L N+L A+  
Sbjct: 304 HLGNLLQANAQ 314

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  108 bits (272), Expect = 4e-26
 Identities = 45/240 (18%), Positives = 89/240 (37%), Gaps = 37/240 (15%)

Query: 385 EIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQI 444
           +I  ++  +  N +        +   Y+  +      L DW+ + +   +  +    + I
Sbjct: 111 KIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWM-NRRCSLEDREHGVCLHI 169

Query: 445 ALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRH 504
            + +A  + +LHS      +H+D+  SN+    D   K+ +F +    + Q+ E      
Sbjct: 170 FIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMD-QDEEEQTVLT 225

Query: 505 I----------VGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNM 554
                      VGTK YM+PE +     S K+D+++ G+++ E+L              M
Sbjct: 226 PMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQ--------M 277

Query: 555 HLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEI 614
               ++  V   +                 YP E       ++   L   PT+RP   +I
Sbjct: 278 ERVRIITDVRNLK---------FPLLFTQKYPQE-----HMMVQDMLSPSPTERPEATDI 323

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  107 bits (270), Expect = 5e-26
 Identities = 68/272 (25%), Positives = 112/272 (41%), Gaps = 41/272 (15%)

Query: 361 GSVYRG--KINGGFAAIKKVN--------GDVSKEIALLNKINHSNLIILSGVCFNEGNC 410
             V            AIK++N         ++ KEI  +++ +H N++        +   
Sbjct: 29  AVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDEL 88

Query: 411 YLVYEYAVNGTLSDWVFSNKNEGKYLDWKQR-IQIAL---DVATGLNYLHSFTNPPHVHK 466
           +LV +    G++ D +     +G++         IA    +V  GL YLH       +H+
Sbjct: 89  WLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHR 145

Query: 467 DINSSNVLLDSDLRAKIANFAM-ARPAEGQEGEFALTRH-IVGTKGYMAPEYLENGLV-S 523
           D+ + N+LL  D   +IA+F + A  A G +      R   VGT  +MAPE +E      
Sbjct: 146 DVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYD 205

Query: 524 TKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQG 583
            K D+++FG+  +E+ TG       A  +      VL   L  +           P+L+ 
Sbjct: 206 FKADIWSFGITAIELATG------AAPYHKYPPMKVLMLTLQND----------PPSLET 249

Query: 584 NYPLELALL----VIR-LIDACLKKDPTDRPT 610
               +  L       R +I  CL+KDP  RPT
Sbjct: 250 GVQDKEMLKKYGKSFRKMISLCLQKDPEKRPT 281

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  106 bits (267), Expect = 9e-26
 Identities = 67/270 (24%), Positives = 108/270 (40%), Gaps = 48/270 (17%)

Query: 361 GSVY--RGKINGGFAAIK----------KVNGDVSKEIALLNKINHSNLIILSGVCFNEG 408
           G+VY  R K +    A+K           V   + +E+ + + + H N++ L G   +  
Sbjct: 23  GNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDAT 82

Query: 409 NCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHV-HKD 467
             YL+ EYA  GT+   +   +   K+ + +       ++A  L+Y HS      V H+D
Sbjct: 83  RVYLILEYAPLGTVYREL---QKLSKFDEQRTA-TYITELANALSYCHSK----RVIHRD 134

Query: 468 INSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLD 527
           I   N+LL S    KIA+F  +  A            + GT  Y+ PE +E  +   K+D
Sbjct: 135 IKPENLLLGSAGELKIADFGWSVHAPSS-----RRTDLCGTLDYLPPEMIEGRMHDEKVD 189

Query: 528 VYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPL 587
           +++ GVL  E L GK      A         +     T                   +P 
Sbjct: 190 LWSLGVLCYEFLVGK--PPFEANTYQETYKRISRVEFT-------------------FPD 228

Query: 588 ELALLVIRLIDACLKKDPTDRPTMYEI-EH 616
            +      LI   LK +P+ RP + E+ EH
Sbjct: 229 FVTEGARDLISRLLKHNPSQRPMLREVLEH 258

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  105 bits (265), Expect = 3e-25
 Identities = 58/297 (19%), Positives = 112/297 (37%), Gaps = 44/297 (14%)

Query: 361 GSVYRG--KINGGFAAIKKVN--------GDVSKEIALLNKINHSNLIILSGV--CFNEG 408
            +V+RG  K  G   AIK  N            +E  +L K+NH N++ L  +       
Sbjct: 23  ANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTR 82

Query: 409 NCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPH--VHK 466
           +  L+ E+   G+L   +    N    L   + + +  DV  G+N+L       +  VH+
Sbjct: 83  HKVLIMEFCPCGSLYTVLEEPSNAYG-LPESEFLIVLRDVVGGMNHLRE-----NGIVHR 136

Query: 467 DINSSNVLL----DSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLV 522
           +I   N++     D     K+ +F  AR  E ++ E  ++  + GT+ Y+ P+  E  ++
Sbjct: 137 NIKPGNIMRVIGEDGQSVYKLTDFGAAR--ELEDDEQFVS--LYGTEEYLHPDMYERAVL 192

Query: 523 ST--------KLDVYAFGVLILEMLTGK------EAAALHAE--ENNMHLSDVLNAVLTK 566
                      +D+++ GV      TG       E    + E     +           +
Sbjct: 193 RKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQ 252

Query: 567 EDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILN 623
           +     +    D  +  +    L +L+  ++   L+ D        +     S+IL+
Sbjct: 253 KAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH 309

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  105 bits (263), Expect = 3e-25
 Identities = 59/247 (23%), Positives = 109/247 (44%), Gaps = 48/247 (19%)

Query: 391 KINHSNLIILSGVCFNEGNCYLVYEYAVNG-TLSDWVFSNKNEGKYLDWKQRIQIALDVA 449
           +++H N++ +  V   +   YLV EY + G TLS+++         L     I     + 
Sbjct: 67  QLSHQNIVSMIDVDEEDDCYYLVMEY-IEGPTLSEYI----ESHGPLSVDTAINFTNQIL 121

Query: 450 TGLNYLHSFTNPPH--VHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVG 507
            G+ + H         VH+DI   N+L+DS+   KI +F +A+     E     T H++G
Sbjct: 122 DGIKHAHD-----MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALS--ETSLTQTNHVLG 174

Query: 508 TKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKE--------AAALHAEENNMHLSDV 559
           T  Y +PE  +        D+Y+ G+++ EML G+         + A+       H+ D 
Sbjct: 175 TVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAI------KHIQDS 228

Query: 560 LNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRP-TMYEIEHSL 618
           +  V T           +   +    P  L+ +++R      +KD  +R  T+ E++  L
Sbjct: 229 VPNVTTD----------VRKDI----PQSLSNVILR----ATEKDKANRYKTIQEMKDDL 270

Query: 619 SNILNAS 625
           S++L+ +
Sbjct: 271 SSVLHEN 277

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  104 bits (262), Expect = 6e-25
 Identities = 45/217 (20%), Positives = 87/217 (40%), Gaps = 48/217 (22%)

Query: 361 GSVYRGKINGGFA-------AIKKVNGDVS--------KEIALLNKI-NHSNLIILSGVC 404
           G V      G          A+K +              E+ +L+ + NH N++ L G C
Sbjct: 37  GKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGAC 96

Query: 405 FNEGNCYLVYEYAVNGTLSDW--------------VFSNKNEGKYLDWKQRIQIALDVAT 450
              G   ++ EY   G L ++                  +++   LD +  +  +  VA 
Sbjct: 97  TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAK 156

Query: 451 GLNYLHS--FTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGT 508
           G+ +L S        +H+D+ + N+LL      KI +F +AR  +          ++V  
Sbjct: 157 GMAFLASKNC-----IHRDLAARNILLTHGRITKICDFGLARDIKNDS------NYVVKG 205

Query: 509 KG-----YMAPEYLENGLVSTKLDVYAFGVLILEMLT 540
                  +MAPE + N + + + DV+++G+ + E+ +
Sbjct: 206 NARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  106 bits (265), Expect = 7e-25
 Identities = 57/297 (19%), Positives = 108/297 (36%), Gaps = 44/297 (14%)

Query: 361 GSVYRG--KINGGFAAIKKVNGD--------VSKEIALLNKINHSNLIILSGV--CFNEG 408
            +V+RG  K  G   AIK  N            +E  +L K+NH N++ L  +       
Sbjct: 23  ANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTR 82

Query: 409 NCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPH--VHK 466
           +  L+ E+   G+L   +    N    L   + + +  DV  G+N+L       +  VH+
Sbjct: 83  HKVLIMEFCPCGSLYTVLEEPSNAYG-LPESEFLIVLRDVVGGMNHLRE-----NGIVHR 136

Query: 467 DINSSNVLL----DSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLV 522
           +I   N++     D     K+ +F  AR  E ++ E  ++  + GT+ Y+ P+  E  ++
Sbjct: 137 NIKPGNIMRVIGEDGQSVYKLTDFGAAR--ELEDDEQFVS--LYGTEEYLHPDMYERAVL 192

Query: 523 ST--------KLDVYAFGVLILEMLTGK-------EAAALHAEENNMHLSDVLNAVLTKE 567
                      +D+++ GV      TG                   +       A+   +
Sbjct: 193 RKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQ 252

Query: 568 DGEESLRHFIDPTLQGN-YPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILN 623
             E     +             L +L+  ++   L+ D        +     S+IL+
Sbjct: 253 KAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH 309

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  104 bits (261), Expect = 7e-25
 Identities = 64/264 (24%), Positives = 109/264 (41%), Gaps = 48/264 (18%)

Query: 361 GSVYRG--KINGGFAAIKKVN-------GDVSKEIALLNKINHSNLIILSGVCFNEGNCY 411
           G+VY       G   AI+++N         +  EI ++ +  + N++            +
Sbjct: 34  GTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELW 93

Query: 412 LVYEYAVNGTLSDWVFSNK-NEGKYLDWKQRIQIAL---DVATGLNYLHSFTNPPHVHKD 467
           +V EY   G+L+D V     +EG         QIA    +    L +LHS      +H+D
Sbjct: 94  VVMEYLAGGSLTDVVTETCMDEG---------QIAAVCRECLQALEFLHSNQV---IHRD 141

Query: 468 INSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRH-IVGTKGYMAPEYLENGLVSTKL 526
           I S N+LL  D   K+ +F        Q       R  +VGT  +MAPE +       K+
Sbjct: 142 IKSDNILLGMDGSVKLTDFGFC----AQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKV 197

Query: 527 DVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYP 586
           D+++ G++ +EM+ G+     +  EN +     L  + T             P LQ   P
Sbjct: 198 DIWSLGIMAIEMIEGEPP---YLNENPLR---ALYLIATNG----------TPELQN--P 239

Query: 587 LELALLVIRLIDACLKKDPTDRPT 610
            +L+ +    ++ CL+ D   R +
Sbjct: 240 EKLSAIFRDFLNRCLEMDVEKRGS 263

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  104 bits (261), Expect = 1e-24
 Identities = 49/222 (22%), Positives = 89/222 (40%), Gaps = 53/222 (23%)

Query: 361 GSVYRGKINGGFA-------AIKKVNGDVS--------KEIALLNKI-NHSNLIILSGVC 404
           G V      G          A+K +              E+ ++ ++ +H N++ L G C
Sbjct: 59  GKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGAC 118

Query: 405 FNEGNCYLVYEYAVNGTLSDW-------------------VFSNKNEGKYLDWKQRIQIA 445
              G  YL++EY   G L ++                       + +   L ++  +  A
Sbjct: 119 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFA 178

Query: 446 LDVATGLNYL--HSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTR 503
             VA G+ +L   S      VH+D+ + NVL+      KI +F +AR     +  +    
Sbjct: 179 YQVAKGMEFLEFKSC-----VHRDLAARNVLVTHGKVVKICDFGLARDIM-SDSNY---- 228

Query: 504 HIVGTKG-----YMAPEYLENGLVSTKLDVYAFGVLILEMLT 540
            +V         +MAPE L  G+ + K DV+++G+L+ E+ +
Sbjct: 229 -VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  102 bits (257), Expect = 2e-24
 Identities = 67/258 (25%), Positives = 118/258 (45%), Gaps = 36/258 (13%)

Query: 361 GSVYRG--KINGGFAAIKKVN-----GDVSKEIALLNKINHSNLIILSGVCFNEGNCYLV 413
           GSVY+   K  G   AIK+V       ++ KEI+++ + +  +++   G  F   + ++V
Sbjct: 43  GSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIV 102

Query: 414 YEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNV 473
            EY   G++SD +   +   K L   +   I      GL YLH       +H+DI + N+
Sbjct: 103 MEYCGAGSVSDII---RLRNKTLTEDEIATILQSTLKGLEYLHFMRK---IHRDIKAGNI 156

Query: 474 LLDSDLRAKIANFAMARPAEGQEGEFALTRH-IVGTKGYMAPEYLENGLVSTKLDVYAFG 532
           LL+++  AK+A+F +A    GQ  +    R+ ++GT  +MAPE ++    +   D+++ G
Sbjct: 157 LLNTEGHAKLADFGVA----GQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLG 212

Query: 533 VLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALL 592
           +  +EM  GK     +A+ + M     +  + T             PT +   P   +  
Sbjct: 213 ITAIEMAEGKPP---YADIHPMR---AIFMIPTNP----------PPTFRK--PELWSDN 254

Query: 593 VIRLIDACLKKDPTDRPT 610
               +  CL K P  R T
Sbjct: 255 FTDFVKQCLVKSPEQRAT 272

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  102 bits (257), Expect = 3e-24
 Identities = 53/227 (23%), Positives = 93/227 (40%), Gaps = 47/227 (20%)

Query: 411 YLVYEYAVNG-TLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPH--VHKD 467
           Y+V EY V+G TL D V     EG  +  K+ I++  D    LN+ H      +  +H+D
Sbjct: 92  YIVMEY-VDGVTLRDIV---HTEGP-MTPKRAIEVIADACQALNFSHQ-----NGIIHRD 141

Query: 468 INSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLD 527
           +  +N+++ +    K+ +F +AR           T  ++GT  Y++PE      V  + D
Sbjct: 142 VKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSD 201

Query: 528 VYAFGVLILEMLTGKE--------AAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDP 579
           VY+ G ++ E+LTG+         + A        H+ +                     
Sbjct: 202 VYSLGCVLYEVLTGEPPFTGDSPVSVAY------QHVREDP----------IPPSAR-HE 244

Query: 580 TLQGNYPLELALLVIRLIDACLKKDPTDRP-TMYEIEHSLSNILNAS 625
            L      +L  +V++     L K+P +R  T  E+   L  + N  
Sbjct: 245 GL----SADLDAVVLK----ALAKNPENRYQTAAEMRADLVRVHNGE 283

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  103 bits (258), Expect = 4e-24
 Identities = 57/294 (19%), Positives = 118/294 (40%), Gaps = 53/294 (18%)

Query: 361 GSVYRG--KINGGFAAIKKVNGDVS--------KEIALLNKINHSNLIILSGVCFNEGNC 410
           G V++   K +G   A K ++ ++         +E+ +L++ N   ++   G  +++G  
Sbjct: 47  GVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEI 106

Query: 411 YLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINS 470
            +  E+   G+L   +     +   +  +   ++++ V  GL YL        +H+D+  
Sbjct: 107 SICMEHMDGGSLDQVL----KKAGRIPEQILGKVSIAVIKGLTYLREKHKI--MHRDVKP 160

Query: 471 SNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHI----VGTKGYMAPEYLENGLVSTKL 526
           SN+L++S    K+ +F ++    GQ     L   +    VGT+ YM+PE L+    S + 
Sbjct: 161 SNILVNSRGEIKLCDFGVS----GQ-----LIDSMANSFVGTRSYMSPERLQGTHYSVQS 211

Query: 527 DVYAFGVLILEMLTGK------EAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPT 580
           D+++ G+ ++EM  G+      +A  L          D              L  F   +
Sbjct: 212 DIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDS 271

Query: 581 LQGNYPLELALLVIR-----------------LIDACLKKDPTDRPTMYE-IEH 616
                  EL   ++                   ++ CL K+P +R  + + + H
Sbjct: 272 RPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 325

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  101 bits (255), Expect = 4e-24
 Identities = 54/271 (19%), Positives = 110/271 (40%), Gaps = 52/271 (19%)

Query: 361 GSVYRG--KINGGFAAIKKVNGDVSKEI---------ALLNKINHSNLIILSGVCFNEGN 409
           G V +     +G   A+K++   V+ +            +  ++    +   G  F EG+
Sbjct: 21  GVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGD 80

Query: 410 CYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDIN 469
            ++  E  ++ +L  +     ++G+ +      +IA+ +   L +LHS  +   +H+D+ 
Sbjct: 81  VWICMEL-MDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSV--IHRDVK 137

Query: 470 SSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHI-----VGTKGYMAPEYLENGLV-- 522
            SNVL+++  + K+ +F ++    G      L   +      G K YMAPE +   L   
Sbjct: 138 PSNVLINALGQVKMCDFGIS----GY-----LVDDVAKDIDAGCKPYMAPERINPELNQK 188

Query: 523 --STKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPT 580
             S K D+++ G+ ++E+   +        ++       L  V+ +            P 
Sbjct: 189 GYSVKSDIWSLGITMIELAILR-----FPYDSWGTPFQQLKQVVEEPS----------PQ 233

Query: 581 L-QGNYPLELALLVIRLIDACLKKDPTDRPT 610
           L    +  E     +     CLKK+  +RPT
Sbjct: 234 LPADKFSAEF----VDFTSQCLKKNSKERPT 260

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  100 bits (251), Expect = 1e-23
 Identities = 67/271 (24%), Positives = 98/271 (36%), Gaps = 55/271 (20%)

Query: 361 GSVYRG--KINGGFAAIKKVN-------GDVSKEIALLNKINHSNLIILSGVCFNEGNCY 411
           G VY G    N    AIK++          + +EIAL   + H N++   G     G   
Sbjct: 36  GIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIK 95

Query: 412 LVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQ-IALDVATGLNYLHSFTNPPHVHKDINS 470
           +  E    G+LS         G   D +Q I      +  GL YLH       VH+DI  
Sbjct: 96  IFMEQVPGGSLSA--LLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQI---VHRDIKG 150

Query: 471 SNVLLDSDL-RAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLV--STKLD 527
            NVL+++     KI++F  ++   G       T    GT  YMAPE ++ G        D
Sbjct: 151 DNVLINTYSGVLKISDFGTSKRLAGIN---PCTETFTGTLQYMAPEIIDKGPRGYGKAAD 207

Query: 528 VYAFGVLILEMLTGK--------EAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDP 579
           +++ G  I+EM TGK          AA+               V   +           P
Sbjct: 208 IWSLGCTIIEMATGKPPFYELGEPQAAMF-------------KVGMFKV---------HP 245

Query: 580 TLQGNYPLELALLVIRLIDACLKKDPTDRPT 610
            +    P  ++      I  C + DP  R  
Sbjct: 246 EI----PESMSAEAKAFILKCFEPDPDKRAC 272

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  101 bits (253), Expect = 2e-23
 Identities = 49/312 (15%), Positives = 89/312 (28%), Gaps = 51/312 (16%)

Query: 344 KELQSATDNFSFTCRI-QGS---VYRGK-------INGGFAAIKKVNGDVSKE------- 385
            E Q  +        + +G+   VY           N     +K        E       
Sbjct: 58  TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQL 117

Query: 386 IALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKN-EGKYLDWKQRIQI 444
           +  L        +        +    LV E    GTL + +   KN   K +     I  
Sbjct: 118 MERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISF 177

Query: 445 ALDVATGLNYLHSFTNPPHVHKDINSSNVLL-----------DSDLRAKIANFAMARPAE 493
           A+ +   +  +H       +H DI   N +L           D      + +   +   +
Sbjct: 178 AMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMK 234

Query: 494 GQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTG------------ 541
                   T     T G+   E L N   + ++D +     +  ML G            
Sbjct: 235 LFPKGTIFTAKC-ETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC 293

Query: 542 KEAAALHAEENNMHLSDVLNAVLTKEDGE-----ESLRHFIDPTLQGNYPLELALLVIRL 596
           K         +    ++  + +L   D       + LR  +    Q +Y  ++  L  RL
Sbjct: 294 KPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRL 353

Query: 597 IDACLKKDPTDR 608
           I   L+   + +
Sbjct: 354 IVLLLECKRSRK 365

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score = 99.6 bits (249), Expect = 2e-23
 Identities = 61/274 (22%), Positives = 106/274 (38%), Gaps = 56/274 (20%)

Query: 361 GSVY--RGKINGGFAAIK----------KVNGDVSKEIALLNKINHSNLIILSGVCFNEG 408
           G+VY  R K N    A+K           V   + +EI + + + H N++ +     +  
Sbjct: 28  GNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRK 87

Query: 409 NCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHV-HKD 467
             YL+ E+A  G L   +   +  G++ + +    +  ++A  L+Y H       V H+D
Sbjct: 88  RIYLMLEFAPRGELYKEL---QKHGRFDEQRSATFME-ELADALHYCHER----KVIHRD 139

Query: 468 INSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLD 527
           I   N+L+      KIA+F  +  A          R + GT  Y+ PE +E      K+D
Sbjct: 140 IKPENLLMGYKGELKIADFGWSVHAPSL-----RRRTMCGTLDYLPPEMIEGKTHDEKVD 194

Query: 528 VYAFGVLILEMLTGK---EAAALHAEENNMHLSD-VLNAVLTKEDGEESLRHFIDPTLQG 583
           ++  GVL  E L G    ++       ++      ++N  L                   
Sbjct: 195 LWCAGVLCYEFLVGMPPFDS------PSHTETHRRIVNVDLK------------------ 230

Query: 584 NYPLELALLVIRLIDACLKKDPTDRPTMYEI-EH 616
            +P  L+     LI   L+  P  R  +  + EH
Sbjct: 231 -FPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEH 263

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score = 99.5 bits (249), Expect = 2e-23
 Identities = 60/272 (22%), Positives = 109/272 (40%), Gaps = 49/272 (18%)

Query: 361 GSVY--RGKINGGFAAIK----------KVNGDVSKEIALLNKINHSNLIILSGVCFNEG 408
             VY       G   AIK           +   V  E+ +  ++ H +++ L     +  
Sbjct: 25  AGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSN 84

Query: 409 NCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHV-HKD 467
             YLV E   NG ++ ++   KN  K     +       + TG+ YLHS      + H+D
Sbjct: 85  YVYLVLEMCHNGEMNRYL---KNRVKPFSENEARHFMHQIITGMLYLHSH----GILHRD 137

Query: 468 INSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLD 527
           +  SN+LL  ++  KIA+F +A   +    E   T  + GT  Y++PE         + D
Sbjct: 138 LTLSNLLLTRNMNIKIADFGLATQLK-MPHEKHYT--LCGTPNYISPEIATRSAHGLESD 194

Query: 528 VYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNY-- 585
           V++ G +   +L G+       + +       +   L K          +   +  +Y  
Sbjct: 195 VWSLGCMFYTLLIGR----PPFDTDT------VKNTLNK----------V---VLADYEM 231

Query: 586 PLELALLVIRLIDACLKKDPTDRPTMYEI-EH 616
           P  L++    LI   L+++P DR ++  + +H
Sbjct: 232 PSFLSIEAKDLIHQLLRRNPADRLSLSSVLDH 263

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  100 bits (250), Expect = 2e-23
 Identities = 57/264 (21%), Positives = 114/264 (43%), Gaps = 48/264 (18%)

Query: 361 GSVYRG--KINGGFAAIKKVN-------GDVSKEIALLNKINHSNLIILSGVCFNEGNCY 411
           G V     K +G   A+K ++         +  E+ ++    H N++ +          +
Sbjct: 59  GIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELW 118

Query: 412 LVYEYAVNGTLSDWVFSNK-NEGKYLDWKQRIQIAL---DVATGLNYLHSFTNPPHVHKD 467
           ++ E+   G L+D V   + NE          QIA     V   L YLH+      +H+D
Sbjct: 119 VLMEFLQGGALTDIVSQVRLNEE---------QIATVCEAVLQALAYLHA---QGVIHRD 166

Query: 468 INSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRH-IVGTKGYMAPEYLENGLVSTKL 526
           I S ++LL  D R K+++F        Q  +    R  +VGT  +MAPE +   L +T++
Sbjct: 167 IKSDSILLTLDGRVKLSDFGFC----AQISKDVPKRKSLVGTPYWMAPEVISRSLYATEV 222

Query: 527 DVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYP 586
           D+++ G++++EM+ G+     +  ++ +     +  +               P L+    
Sbjct: 223 DIWSLGIMVIEMVDGEPP---YFSDSPVQ---AMKRLRDSP----------PPKLKN--S 264

Query: 587 LELALLVIRLIDACLKKDPTDRPT 610
            +++ ++   ++  L +DP +R T
Sbjct: 265 HKVSPVLRDFLERMLVRDPQERAT 288

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score = 99.7 bits (249), Expect = 4e-23
 Identities = 57/268 (21%), Positives = 107/268 (39%), Gaps = 42/268 (15%)

Query: 361 GSVYRG--KINGGFAAIKKVNGDVS--------KEIALLNK-INHSNLIILSGVCFNEGN 409
           GSV +   K +G   A+K++   V          ++ ++ +  +   ++   G  F EG+
Sbjct: 36  GSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGD 95

Query: 410 CYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDIN 469
           C++  E         + +        +  +   +I L     LN+L        +H+DI 
Sbjct: 96  CWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKI--IHRDIK 153

Query: 470 SSNVLLDSDLRAKIANFAMARPAEGQEGEFALT---RHIVGTKGYMAPEYLENGLV---- 522
            SN+LLD     K+ +F       G  G+   +       G + YMAPE ++        
Sbjct: 154 PSNILLDRSGNIKLCDF-------GISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGY 206

Query: 523 STKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQ 582
             + DV++ G+ + E+ TG+     + + N++   D L  V+  +           P L 
Sbjct: 207 DVRSDVWSLGITLYELATGR---FPYPKWNSVF--DQLTQVVKGDP----------PQLS 251

Query: 583 GNYPLELALLVIRLIDACLKKDPTDRPT 610
            +   E +   I  ++ CL KD + RP 
Sbjct: 252 NSEEREFSPSFINFVNLCLTKDESKRPK 279

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 99.4 bits (248), Expect = 4e-23
 Identities = 51/271 (18%), Positives = 102/271 (37%), Gaps = 53/271 (19%)

Query: 361 GSVYRG--KINGGFAAIKKVNGDVS--------KEIALLNK-INHSNLIILSGVCFNEGN 409
           G V++   +  G   A+K++    +         ++ ++ K  +   ++   G      +
Sbjct: 39  GQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTD 98

Query: 410 CYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDIN 469
            ++  E    GT ++ +   K     +  +   ++ + +   L YL        +H+D+ 
Sbjct: 99  VFIAMELM--GTCAEKLK--KRMQGPIPERILGKMTVAIVKALYYLKEKHG--VIHRDVK 152

Query: 470 SSNVLLDSDLRAKIANFAMARPAEGQEGEFALT---RHIVGTKGYMAPEYLENGLV---- 522
            SN+LLD   + K+ +F       G  G            G   YMAPE ++        
Sbjct: 153 PSNILLDERGQIKLCDF-------GISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPD 205

Query: 523 -STKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTL 581
              + DV++ G+ ++E+ TG+        + +    +VL  VL +E           P L
Sbjct: 206 YDIRADVWSLGISLVELATGQ--FPYKNCKTDF---EVLTKVLQEEP----------PLL 250

Query: 582 QGN--YPLELALLVIRLIDACLKKDPTDRPT 610
            G+  +  +        +  CL KD   RP 
Sbjct: 251 PGHMGFSGDF----QSFVKDCLTKDHRKRPK 277

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score = 98.8 bits (247), Expect = 4e-23
 Identities = 59/276 (21%), Positives = 101/276 (36%), Gaps = 58/276 (21%)

Query: 361 GSVYRGK--INGGFAAIK----------KVNGDVSKEIALLNKINHSNLIILSGVCFNEG 408
              +           A K               +S EI++   + H +++   G   +  
Sbjct: 29  AKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDND 88

Query: 409 NCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQR---IQIALDVATGLNYLHSFTNPPH-- 463
             ++V E     +L +     K      + + R    QI      G  YLH      +  
Sbjct: 89  FVFVVLELCRRRSLLELH---KRRKALTEPEARYYLRQI----VLGCQYLHR-----NRV 136

Query: 464 VHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVS 523
           +H+D+   N+ L+ DL  KI +F +A   E  +GE      + GT  Y+APE L     S
Sbjct: 137 IHRDLKLGNLFLNEDLEVKIGDFGLATKVE-YDGERKKV--LCGTPNYIAPEVLSKKGHS 193

Query: 524 TKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQG 583
            ++DV++ G ++  +L GK       E + +                +     I    + 
Sbjct: 194 FEVDVWSIGCIMYTLLVGK----PPFETSCL----------------KETYLRI---KKN 230

Query: 584 NY--PLELALLVIRLIDACLKKDPTDRPTMYEI-EH 616
            Y  P  +  +   LI   L+ DPT RPT+ E+   
Sbjct: 231 EYSIPKHINPVAASLIQKMLQTDPTARPTINELLND 266

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score = 98.9 bits (247), Expect = 8e-23
 Identities = 59/276 (21%), Positives = 101/276 (36%), Gaps = 58/276 (21%)

Query: 361 GSVYRGK--INGGFAAIK----------KVNGDVSKEIALLNKINHSNLIILSGVCFNEG 408
              +           A K               +S EI++   + H +++   G   +  
Sbjct: 55  AKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDND 114

Query: 409 NCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQR---IQIALDVATGLNYLHSFTNPPH-- 463
             ++V E     +L +     K      + + R    QI      G  YLH      +  
Sbjct: 115 FVFVVLELCRRRSLLELH---KRRKALTEPEARYYLRQI----VLGCQYLHR-----NRV 162

Query: 464 VHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVS 523
           +H+D+   N+ L+ DL  KI +F +A   E  +GE      + GT  Y+APE L     S
Sbjct: 163 IHRDLKLGNLFLNEDLEVKIGDFGLATKVE-YDGERKKV--LCGTPNYIAPEVLSKKGHS 219

Query: 524 TKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQG 583
            ++DV++ G ++  +L GK       E + +                +     I    + 
Sbjct: 220 FEVDVWSIGCIMYTLLVGK----PPFETSCL----------------KETYLRI---KKN 256

Query: 584 NY--PLELALLVIRLIDACLKKDPTDRPTMYEI-EH 616
            Y  P  +  +   LI   L+ DPT RPT+ E+   
Sbjct: 257 EYSIPKHINPVAASLIQKMLQTDPTARPTINELLND 292

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  101 bits (252), Expect = 1e-22
 Identities = 59/280 (21%), Positives = 102/280 (36%), Gaps = 34/280 (12%)

Query: 361 GSVYRG--KINGGFAAIKKVNGD--------VSKEIALLNKINHSNLIIL------SGVC 404
           G V R   +  G   AIK+   +           EI ++ K+NH N++            
Sbjct: 28  GYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKL 87

Query: 405 FNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPH- 463
                  L  EY   G L  ++   +N    L       +  D+++ L YLH      + 
Sbjct: 88  APNDLPLLAMEYCEGGDLRKYLNQFENCCG-LKEGPIRTLLSDISSALRYLHE-----NR 141

Query: 464 -VHKDINSSNVLLDS---DLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLEN 519
            +H+D+   N++L      L  KI +   A+  E  +GE       VGT  Y+APE LE 
Sbjct: 142 IIHRDLKPENIVLQPGPQRLIHKIIDLGYAK--ELDQGELCTEF--VGTLQYLAPELLEQ 197

Query: 520 GLVSTKLDVYAFGVLILEMLTGK---EAAALHAEENNMHLSDVLNAVLTKEDGEESLRHF 576
              +  +D ++FG L  E +TG           + +          ++  +D   +++  
Sbjct: 198 KKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFS 257

Query: 577 IDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEH 616
                  +    LA  + R +   L      R T  +  +
Sbjct: 258 SVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPN 297

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score = 97.4 bits (243), Expect = 2e-22
 Identities = 59/265 (22%), Positives = 110/265 (41%), Gaps = 43/265 (16%)

Query: 361 GSVYRG--KINGGFAAIKKVN-------GDVSKEIALLNKINHSNLIILSGVCFNEGNCY 411
           G VY+   K  G  AA K +         D   EI +L   +H  ++ L G  +++G  +
Sbjct: 33  GKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLW 92

Query: 412 LVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSS 471
           ++ E+   G +   +       + L   Q   +   +   LN+LHS      +H+D+ + 
Sbjct: 93  IMIEFCPGGAVDAIM---LELDRGLTEPQIQVVCRQMLEALNFLHSKRI---IHRDLKAG 146

Query: 472 NVLLDSDLRAKIANFAMARPAEGQEGEFALTRH-IVGTKGYMAPEYLENGLVS-----TK 525
           NVL+  +   ++A+F ++     +  +    R   +GT  +MAPE +    +       K
Sbjct: 147 NVLMTLEGDIRLADFGVS----AKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYK 202

Query: 526 LDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNY 585
            D+++ G+ ++EM   +     H E N M    VL  +   +           PTL    
Sbjct: 203 ADIWSLGITLIEMAQIEPP---HHELNPMR---VLLKIAKSD----------PPTLLT-- 244

Query: 586 PLELALLVIRLIDACLKKDPTDRPT 610
           P + ++     +   L K+P  RP+
Sbjct: 245 PSKWSVEFRDFLKIALDKNPETRPS 269

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score = 98.2 bits (244), Expect = 3e-22
 Identities = 29/302 (9%), Positives = 56/302 (18%), Gaps = 68/302 (22%)

Query: 361 GSVYRG--KINGGFAAIKKVNG----------DVSKEIALLNKINHSNLIILSGVC---- 404
             V+           A+K               + +      ++   +            
Sbjct: 76  SVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLL 135

Query: 405 ----------------------FNEGNCYLVYEYAV--NGTLSDWVFSNKNEGKYLDWKQ 440
                                 +   N  L+   A      L   +              
Sbjct: 136 PSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILA 195

Query: 441 RIQIALDVATGLNYLHSFTNPPH--VHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGE 498
              +   +      L S        VH      N+ +  D R  + + +           
Sbjct: 196 LHILTAQLIRLAANLQS-----KGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVG----- 245

Query: 499 FALTRHIVGTKGYMAPEYL--ENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHL 556
                       Y   E+L       +  L+ +  G+ I  +        L         
Sbjct: 246 -TRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSW 304

Query: 557 SDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEI-E 615
                 V   +         +   ++             LI   L  D   R    E  E
Sbjct: 305 KRPSLRVPGTDSLAFGSCTPLPDFVK------------TLIGRFLNFDRRRRLLPLEAME 352

Query: 616 HS 617
             
Sbjct: 353 TP 354

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score = 95.1 bits (236), Expect = 3e-21
 Identities = 43/296 (14%), Positives = 86/296 (29%), Gaps = 55/296 (18%)

Query: 338 LKVYSFKELQSATDNFSFTCRIQGSVYRGKINGGFAAIKKVNGDVSKEIALLNKINHSNL 397
           + V  F E   +         +        I     A   +      ++    +      
Sbjct: 103 VHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIR 162

Query: 398 IILSGVCFNEGNCYLVYEYAV--NGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYL 455
           + L        + + +Y        T  + + S+ +  K L    R+Q+ L V   L  L
Sbjct: 163 VRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASL 222

Query: 456 HSFTNPPH--VHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMA 513
           H      +  VH  +   +++LD      +  F         +G   ++     ++G+  
Sbjct: 223 HH-----YGLVHTYLRPVDIVLDQRGGVFLTGFEHLVR----DGARVVS---SVSRGFEP 270

Query: 514 PEYL-----------ENGLVSTKLDVYAFGVLILEMLTGKEAAAL-HAEENNMHLSDVLN 561
           PE                L++   D +A G++I  +        L   ++  +  S+   
Sbjct: 271 PELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD----LPITKDAALGGSE--- 323

Query: 562 AVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEI-EH 616
                         F       N P      V  L++  L+    DR    +  E 
Sbjct: 324 ------------WIFRSCK---NIPQP----VRALLEGFLRYPKEDRLLPLQAMET 360

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score = 93.9 bits (234), Expect = 3e-21
 Identities = 44/213 (20%), Positives = 86/213 (40%), Gaps = 47/213 (22%)

Query: 407 EGNCYLVYEYAVNG-TLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPH-- 463
           +G  Y+     +NG  L+  +   + +G  L   + + I   + + L+  H+        
Sbjct: 106 DGQLYVDMRL-INGVDLAAML---RRQGP-LAPPRAVAIVRQIGSALDAAHA-----AGA 155

Query: 464 VHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTR--HIVGTKGYMAPEYLENGL 521
            H+D+   N+L+ +D  A + +F +A        +  LT+  + VGT  YMAPE      
Sbjct: 156 THRDVKPENILVSADDFAYLVDFGIASAT----TDEKLTQLGNTVGTLYYMAPERFSESH 211

Query: 522 VSTKLDVYAFGVLILEMLTGK-----EAAALHAEENNMHLSDVLNAVLTKEDGEESLRHF 576
            + + D+YA   ++ E LTG      +  ++       H++  +    T           
Sbjct: 212 ATYRADIYALTCVLYECLTGSPPYQGDQLSVMG----AHINQAIPRPST----------- 256

Query: 577 IDPTLQGNYPLELALLVIRLIDACLKKDPTDRP 609
           + P +    P+    ++ R     + K+P DR 
Sbjct: 257 VRPGI----PVAFDAVIAR----GMAKNPEDRY 281

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 94.0 bits (234), Expect = 4e-21
 Identities = 68/314 (21%), Positives = 123/314 (39%), Gaps = 56/314 (17%)

Query: 330 SISGVAQSLKVYSFKELQSATDNFSFTCRI-QGS---VYRG--KINGGFAAIKKVN---- 379
           +    A+SL       L+     F     +  G+   VY+G     G  AAIK ++    
Sbjct: 3   ASDSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD 62

Query: 380 --GDVSKEIALLNKI-NHSNLI------ILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNK 430
              ++ +EI +L K  +H N+       I       +   +LV E+   G+++D +    
Sbjct: 63  EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLI--KN 120

Query: 431 NEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMAR 490
            +G  L  +    I  ++  GL++LH       +H+DI   NVLL  +   K+ +F ++ 
Sbjct: 121 TKGNTLKEEWIAYICREILRGLSHLHQHKV---IHRDIKGQNVLLTENAEVKLVDFGVS- 176

Query: 491 PAEGQEGEFALTRH-IVGTKGYMAPEYLENGLVS-----TKLDVYAFGVLILEMLTGKEA 544
               Q       R+  +GT  +MAPE +            K D+++ G+  +EM  G   
Sbjct: 177 ---AQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP 233

Query: 545 AALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQG-NYPLELALLVIRLIDACLKK 603
                   +MH    L  +               P L+   +  +        I++CL K
Sbjct: 234 LC------DMHPMRALFLIPRNP----------APRLKSKKWSKKF----QSFIESCLVK 273

Query: 604 DPTDRPTMYE-IEH 616
           + + RP   + ++H
Sbjct: 274 NHSQRPATEQLMKH 287

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score = 96.8 bits (241), Expect = 4e-21
 Identities = 37/204 (18%), Positives = 67/204 (32%), Gaps = 55/204 (26%)

Query: 411 YLVYEYAVNG-TLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPH--VHKD 467
           Y+V EY V G +L         +G+ L   + I   L++   L+YLHS        V+ D
Sbjct: 160 YIVMEY-VGGQSLKRS------KGQKLPVAEAIAYLLEILPALSYLHS-----IGLVYND 207

Query: 468 INSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTR--HIVGTKGYMAPEYLENGLVSTK 525
           +   N++L  + + K+ +               +    ++ GT G+ APE +  G  +  
Sbjct: 208 LKPENIMLTEE-QLKLIDLGAVS---------RINSFGYLYGTPGFQAPEIVRTG-PTVA 256

Query: 526 LDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNY 585
            D+Y  G  +  +                             +G   +    +       
Sbjct: 257 TDIYTVGRTLAALTLDL----------------------PTRNG-RYVDGLPEDDPVLKT 293

Query: 586 PLELALLVIRLIDACLKKDPTDRP 609
                 L+ R     +  DP  R 
Sbjct: 294 YDSYGRLLRR----AIDPDPRQRF 313

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score = 94.7 bits (235), Expect = 5e-21
 Identities = 33/223 (14%), Positives = 64/223 (28%), Gaps = 57/223 (25%)

Query: 409 NCYLVYEYAV--NGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPH--V 464
           + + +Y        T  + + S+ +  K L    R+Q+ L V   L  LH      +  V
Sbjct: 179 SRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH-----YGLV 233

Query: 465 HKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYL------- 517
           H  +   +++LD      +  F         +G  A++      +G+  PE         
Sbjct: 234 HTYLRPVDIVLDQRGGVFLTGFEHLVR----DGASAVSP---IGRGFAPPETTAERMLPF 286

Query: 518 ---ENGLVSTKLDVYAFGVLILEMLTGK---EAAALHAEENNMHLSDVLNAVLTKEDGEE 571
                 L++   D +  G+ I  +          A                +        
Sbjct: 287 GQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALG---------GSEWIFRSCK--- 334

Query: 572 SLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEI 614
                       N P  +      L++  L+    DR    + 
Sbjct: 335 ------------NIPQPVR----ALLEGFLRYPKEDRLLPLQA 361

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score = 92.1 bits (229), Expect = 2e-20
 Identities = 82/300 (27%), Positives = 115/300 (38%), Gaps = 59/300 (19%)

Query: 335 AQSLKVYSFKELQSATD---NFSFTCRI-QGS---VYRG--KINGGFAAIKKVN------ 379
           A SLK     EL    D    FS    I  GS   VY      N    AIKK++      
Sbjct: 35  AGSLKDPDVAELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQS 94

Query: 380 ----GDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKY 435
                D+ KE+  L K+ H N I   G    E   +LV EY   G+ SD +   +   K 
Sbjct: 95  NEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEY-CLGSASDLL---EVHKKP 150

Query: 436 LDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQ 495
           L   +   +      GL YLHS      +H+D+ + N+LL      K+ +F  A      
Sbjct: 151 LQEVEIAAVTHGALQGLAYLHSHNM---IHRDVKAGNILLSEPGLVKLGDFGSA----SI 203

Query: 496 EGEFALTRH--IVGTKGYMAPE---YLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAE 550
                +      VGT  +MAPE    ++ G    K+DV++ G+  +E+   K        
Sbjct: 204 -----MAPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP---LFN 255

Query: 551 ENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPT 610
            N M     L  +   E           P LQ       +      +D+CL+K P DRPT
Sbjct: 256 MNAMS---ALYHIAQNE----------SPALQSG---HWSEYFRNFVDSCLQKIPQDRPT 299

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 91.3 bits (227), Expect = 9e-20
 Identities = 63/267 (23%), Positives = 102/267 (38%), Gaps = 55/267 (20%)

Query: 367 KINGGFAAIKKVNGDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWV 426
           K   G A       +V  EI +L K+NH  +I +    F+  + Y+V E    G L D V
Sbjct: 172 KFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKV 230

Query: 427 FSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPH--VHKDINSSNVLLDS---DLRA 481
             N    +  +   +      +   + YLH      +  +H+D+   NVLL S   D   
Sbjct: 231 VGN---KRLKEATCK-LYFYQMLLAVQYLHE-----NGIIHRDLKPENVLLSSQEEDCLI 281

Query: 482 KIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLV---STKLDVYAFGVLILEM 538
           KI +F  ++      GE +L R + GT  Y+APE L +      +  +D ++ GV++   
Sbjct: 282 KITDFGHSK----ILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFIC 337

Query: 539 LTGKEAAALHAEENNMHLSDVLNAVL--TKEDGEESLRHFIDPTLQGNYPLE------LA 590
           L+G                         ++   + SL+  I     G Y         ++
Sbjct: 338 LSG---------------------YPPFSEHRTQVSLKDQI---TSGKYNFIPEVWAEVS 373

Query: 591 LLVIRLIDACLKKDPTDRPTMYEI-EH 616
              + L+   L  DP  R T  E   H
Sbjct: 374 EKALDLVKKLLVVDPKARFTTEEALRH 400

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 86.9 bits (216), Expect = 5e-19
 Identities = 61/272 (22%), Positives = 99/272 (36%), Gaps = 44/272 (16%)

Query: 361 GSVYRG--KINGGFAAIK-----KVNGDVSK---EIALLNKINHSNLIILSGVCFNEGNC 410
           G V+    + +G    IK     +    + +   EI +L  ++H N+I +  V  +  N 
Sbjct: 36  GDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNM 95

Query: 411 YLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPH--VHKDI 468
           Y+V E    G L + + S +  GK L      ++   +   L Y HS        VHKD+
Sbjct: 96  YIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHS-----QHVVHKDL 150

Query: 469 NSSNVLLDS---DLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTK 525
              N+L          KI +F +A   +    E +      GT  YMAPE      V+ K
Sbjct: 151 KPENILFQDTSPHSPIKIIDFGLAELFK--SDEHSTN--AAGTALYMAPEVF-KRDVTFK 205

Query: 526 LDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNY 585
            D+++ GV++  +LTG                                  +         
Sbjct: 206 CDIWSAGVVMYFLLTGCL--PFTGTSLEEVQQKATYKEPN----------YAVE------ 247

Query: 586 PLELALLVIRLIDACLKKDPTDRPTMYEI-EH 616
              L    + L+   L KDP  RP+  ++  H
Sbjct: 248 CRPLTPQAVDLLKQMLTKDPERRPSAAQVLHH 279

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 88.6 bits (220), Expect = 5e-19
 Identities = 53/245 (21%), Positives = 95/245 (38%), Gaps = 31/245 (12%)

Query: 312 NEKPSNKKFDEESQDFLESISGVAQSLKVYSFKELQSATDNFSFTCRI----QGSVYRG- 366
            + P    +D+  +D  +        +K  S        D +     +     G V+R  
Sbjct: 18  YDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVY------DYYDILEELGSGAFGVVHRCV 71

Query: 367 -KINGGFAAIKKVNG-------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAV 418
            K  G     K +N         V  EI+++N+++H  LI L     ++    L+ E+  
Sbjct: 72  EKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLS 131

Query: 419 NGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDS- 477
            G L D + +   E   +   + I        GL ++H  +    VH DI   N++ ++ 
Sbjct: 132 GGELFDRIAA---EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETK 185

Query: 478 -DLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLIL 536
                KI +F +A      E    + +    T  + APE ++   V    D++A GVL  
Sbjct: 186 KASSVKIIDFGLATKLNPDE----IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGY 241

Query: 537 EMLTG 541
            +L+G
Sbjct: 242 VLLSG 246

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 86.2 bits (214), Expect = 9e-19
 Identities = 63/241 (26%), Positives = 104/241 (43%), Gaps = 36/241 (14%)

Query: 382 VSKEIALLNKINHSNLIILSGV--CFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWK 439
           V +EIA+L K++H N++ L  V    NE + Y+V+E    G + +           L   
Sbjct: 83  VYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKP-----LSED 137

Query: 440 QRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEF 499
           Q      D+  G+ YLH       +H+DI  SN+L+  D   KIA+F ++   +G +   
Sbjct: 138 QARFYFQDLIKGIEYLHYQK---IIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDA-- 192

Query: 500 ALTRHIVGTKGYMAPEYLENGLVS---TKLDVYAFGVLILEMLTGKEAAALHAEENNMHL 556
            L  + VGT  +MAPE L           LDV+A GV +   + G+        +  +  
Sbjct: 193 -LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ----CPFMDERI-- 245

Query: 557 SDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEI-E 615
             + + + ++            P    + P ++A  +  LI   L K+P  R  + EI  
Sbjct: 246 MCLHSKIKSQA--------LEFP----DQP-DIAEDLKDLITRMLDKNPESRIVVPEIKL 292

Query: 616 H 616
           H
Sbjct: 293 H 293

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score = 87.1 bits (216), Expect = 3e-18
 Identities = 65/273 (23%), Positives = 108/273 (39%), Gaps = 48/273 (17%)

Query: 361 GSVYRG--KINGGFAAIKKVN---------GDVSKEIALLNKINHSNLIILSGVCFNEGN 409
           G V     K+     AIK +            + +E+A+L  ++H N++ L     ++ N
Sbjct: 51  GEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRN 110

Query: 410 CYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPH--VHKD 467
            YLV E    G L D +    +  K+ +      I   V +G+ YLH      H  VH+D
Sbjct: 111 YYLVMECYKGGELFDEI---IHRMKFNE-VDAAVIIKQVLSGVTYLHK-----HNIVHRD 161

Query: 468 INSSNVLLDS---DLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVST 524
           +   N+LL+S   D   KI +F ++   E Q+      +  +GT  Y+APE L       
Sbjct: 162 LKPENLLLESKEKDALIKIVDFGLSAVFENQK----KMKERLGTAYYIAPEVL-RKKYDE 216

Query: 525 KLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGN 584
           K DV++ GV++  +L G        +       ++L  V   +            T    
Sbjct: 217 KCDVWSIGVILFILLAGY--PPFGGQ----TDQEILRKVEKGK-----------YTFDSP 259

Query: 585 YPLELALLVIRLIDACLKKDPTDRPTMYEI-EH 616
               ++     LI   L+ D   R +  +  EH
Sbjct: 260 EWKNVSEGAKDLIKQMLQFDSQRRISAQQALEH 292

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 84.2 bits (209), Expect = 6e-18
 Identities = 44/193 (22%), Positives = 79/193 (40%), Gaps = 24/193 (12%)

Query: 361 GSVYRG--KINGGFAAIKKVNG------DVSKEIALLNKINHSNLIILSGVCFNEGNCYL 412
           G V+R     +      K V         V KEI++LN   H N++ L     +     +
Sbjct: 19  GIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVM 78

Query: 413 VYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPH--VHKDINS 470
           ++E+     + + + +       L+ ++ +     V   L +LHS     H   H DI  
Sbjct: 79  IFEFISGLDIFERINT---SAFELNEREIVSYVHQVCEALQFLHS-----HNIGHFDIRP 130

Query: 471 SNVLLDS--DLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDV 528
            N++  +      KI  F  AR  +  +      R +     Y APE  ++ +VST  D+
Sbjct: 131 ENIIYQTRRSSTIKIIEFGQARQLKPGD----NFRLLFTAPEYYAPEVHQHDVVSTATDM 186

Query: 529 YAFGVLILEMLTG 541
           ++ G L+  +L+G
Sbjct: 187 WSLGTLVYVLLSG 199

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 84.2 bits (209), Expect = 7e-18
 Identities = 74/276 (26%), Positives = 112/276 (40%), Gaps = 40/276 (14%)

Query: 361 GSVYRG--KINGGFAAIKKVNGDVSK---------EIALLNKINHSNLIILSGVCFNEGN 409
           G V +   K  G   AIKK                EI LL ++ H NL+ L  VC  +  
Sbjct: 39  GMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKR 98

Query: 410 CYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPH--VHKD 467
            YLV+E+ V+ T+ D +   +     LD++   +    +  G+ + HS     H  +H+D
Sbjct: 99  WYLVFEF-VDHTILDDL---ELFPNGLDYQVVQKYLFQIINGIGFCHS-----HNIIHRD 149

Query: 468 INSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYL-ENGLVSTKL 526
           I   N+L+      K+ +F  AR      GE       V T+ Y APE L  +      +
Sbjct: 150 IKPENILVSQSGVVKLCDFGFAR-TLAAPGE-VYD-DEVATRWYRAPELLVGDVKYGKAV 206

Query: 527 DVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAV--LTKED--GEESLRHFID---P 579
           DV+A G L+ EM  G+       + +   L  ++  +  L             F     P
Sbjct: 207 DVWAIGCLVTEMFMGE--PLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLP 264

Query: 580 TLQGNYPLE-----LALLVIRLIDACLKKDPTDRPT 610
            ++   PLE     L+ +VI L   CL  DP  RP 
Sbjct: 265 EIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPF 300

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 86.0 bits (213), Expect = 9e-18
 Identities = 48/261 (18%), Positives = 96/261 (36%), Gaps = 31/261 (11%)

Query: 296 RKKEPDSIVVSGSFQANEKPSNKKFDEESQDFLESISGVAQSLKVYSFKELQSATDNFSF 355
           +++    +   G     +   +  +D    D  +        +K           D++  
Sbjct: 108 KRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVL------DHYDI 161

Query: 356 TCRI----QGSVYRG--KINGGFAAIKKVN-------GDVSKEIALLNKINHSNLIILSG 402
              +     G V+R   +  G   A K V          V KEI  ++ + H  L+ L  
Sbjct: 162 HEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHD 221

Query: 403 VCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPP 462
              ++    ++YE+   G L + V     E   +   + ++    V  GL ++H      
Sbjct: 222 AFEDDNEMVMIYEFMSGGELFEKVAD---EHNKMSEDEAVEYMRQVCKGLCHMHENN--- 275

Query: 463 HVHKDINSSNVLLDS--DLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENG 520
           +VH D+   N++  +      K+ +F +    + ++      +   GT  + APE  E  
Sbjct: 276 YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ----SVKVTTGTAEFAAPEVAEGK 331

Query: 521 LVSTKLDVYAFGVLILEMLTG 541
            V    D+++ GVL   +L+G
Sbjct: 332 PVGYYTDMWSVGVLSYILLSG 352

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score = 85.5 bits (212), Expect = 9e-18
 Identities = 62/274 (22%), Positives = 115/274 (41%), Gaps = 49/274 (17%)

Query: 361 GSVYRG--KINGGFAAIKKVN----------GDVSKEIALLNKINHSNLIILSGVCFNEG 408
           G V     KI G   A+K ++            + +E+ LL +++H N++ L     ++G
Sbjct: 40  GEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKG 99

Query: 409 NCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPH--VHK 466
             YLV E    G L D +    +  ++ +     +I   V +G+ Y+H      +  VH+
Sbjct: 100 YFYLVGEVYTGGELFDEI---ISRKRFSE-VDAARIIRQVLSGITYMHK-----NKIVHR 150

Query: 467 DINSSNVLLDS---DLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVS 523
           D+   N+LL+S   D   +I +F ++   E  +      +  +GT  Y+APE L +G   
Sbjct: 151 DLKPENLLLESKSKDANIRIIDFGLSTHFEASK----KMKDKIGTAYYIAPEVL-HGTYD 205

Query: 524 TKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQG 583
            K DV++ GV++  +L+G      +         D+L  V   +            T + 
Sbjct: 206 EKCDVWSTGVILYILLSGC--PPFNGANE----YDILKKVEKGK-----------YTFEL 248

Query: 584 NYPLELALLVIRLIDACLKKDPTDRPTMYEI-EH 616
               +++     LI   L   P+ R +  +  +H
Sbjct: 249 PQWKKVSESAKDLIRKMLTYVPSMRISARDALDH 282

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 82.7 bits (205), Expect = 2e-17
 Identities = 61/260 (23%), Positives = 98/260 (37%), Gaps = 41/260 (15%)

Query: 367 KINGGFAAIKKVNGDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWV 426
           K   G A       +V  EI +L K+NH  +I +    F+  + Y+V E    G L D V
Sbjct: 47  KFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKV 105

Query: 427 FSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPH--VHKDINSSNVLLDS---DLRA 481
             N    +  +   +      +   + YLH      +  +H+D+   NVLL S   D   
Sbjct: 106 VGN---KRLKEATCK-LYFYQMLLAVQYLHE-----NGIIHRDLKPENVLLSSQEEDCLI 156

Query: 482 KIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLV---STKLDVYAFGVLILEM 538
           KI +F  ++     E     T  + GT  Y+APE L +      +  +D ++ GV++   
Sbjct: 157 KITDFGHSKILG--ETSLMRT--LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFIC 212

Query: 539 LTGKEAAALHAEENNMHLSD-VLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLI 597
           L+G            + L D + +              FI          E++   + L+
Sbjct: 213 LSGYP--PFSEHRTQVSLKDQITSGKYN----------FIPE-----VWAEVSEKALDLV 255

Query: 598 DACLKKDPTDRPTMYEI-EH 616
              L  DP  R T  E   H
Sbjct: 256 KKLLVVDPKARFTTEEALRH 275

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 82.2 bits (204), Expect = 3e-17
 Identities = 61/277 (22%), Positives = 106/277 (38%), Gaps = 42/277 (15%)

Query: 361 GSVYRG--KINGGFAAIKKVNGDVSK---------EIALLNKINHSNLIILSGVCFNEGN 409
           G V++   +  G   AIKK                EI +L ++ H NL+ L  V   +  
Sbjct: 17  GVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRR 76

Query: 410 CYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPH--VHKD 467
            +LV+EY  + T+   +       + +       I       +N+ H      H  +H+D
Sbjct: 77  LHLVFEY-CDHTVLHEL---DRYQRGVPEHLVKSITWQTLQAVNFCHK-----HNCIHRD 127

Query: 468 INSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLV-STKL 526
           +   N+L+      K+ +F  AR       +       V T+ Y +PE L         +
Sbjct: 128 VKPENILITKHSVIKLCDFGFAR-LLTGPSD-YYD-DEVATRWYRSPELLVGDTQYGPPV 184

Query: 527 DVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVL---TKED--GEESLRHFID--- 578
           DV+A G +  E+L+G     L   ++++    ++   L            + ++F     
Sbjct: 185 DVWAIGCVFAELLSGV---PLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKI 241

Query: 579 PTLQGNYPLELAL-----LVIRLIDACLKKDPTDRPT 610
           P  +   PLEL         + L+  CL  DPT+R T
Sbjct: 242 PDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLT 278

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 82.1 bits (203), Expect = 4e-17
 Identities = 53/269 (19%), Positives = 102/269 (37%), Gaps = 69/269 (25%)

Query: 365 RGKINGGFAAIKKVNGDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGT-LS 423
           + K+           G V+ EIA+L+++ H+N+I +  +  N+G   LV E   +G  L 
Sbjct: 59  KEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLF 118

Query: 424 DWVFSNKNEGKYLDWKQRI----------QIALDVATGLNYLHSFTNPPH--VHKDINSS 471
                      ++D   R+          Q+     + + YL          +H+DI   
Sbjct: 119 A----------FIDRHPRLDEPLASYIFRQL----VSAVGYLRL-----KDIIHRDIKDE 159

Query: 472 NVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLE-NGLVSTKLDVYA 530
           N+++  D   K+ +F  A  A  + G+   T    GT  Y APE L  N     +L++++
Sbjct: 160 NIVIAEDFTIKLIDFGSA--AYLERGKLFYT--FCGTIEYCAPEVLMGNPYRGPELEMWS 215

Query: 531 FGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNY--PLE 588
            GV +  ++  +                         + EE        T++     P  
Sbjct: 216 LGVTLYTLVFEE---------------------NPFCELEE--------TVEAAIHPPYL 246

Query: 589 LALLVIRLIDACLKKDPTDRPTMYEI-EH 616
           ++  ++ L+   L+  P  R T+ ++   
Sbjct: 247 VSKELMSLVSGLLQPVPERRTTLEKLVTD 275

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 81.6 bits (202), Expect = 5e-17
 Identities = 55/236 (23%), Positives = 104/236 (44%), Gaps = 37/236 (15%)

Query: 382 VSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQR 441
           + +E+ ++  +NH N++ L  V   E   YL+ EYA  G + D++ ++      +  K+ 
Sbjct: 61  LFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAH----GRMKEKEA 116

Query: 442 IQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFAL 501
                 + + + Y H       VH+D+ + N+LLD+D+  KIA+F  +   E   G    
Sbjct: 117 RSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFS--NEFTVGGKLD 171

Query: 502 TRHIVGTKGYMAPEYLENGL-VSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVL 560
                G   Y APE  +       ++DV++ GV++  +++G    +L  +  N+      
Sbjct: 172 AF--CGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSG----SLPFDGQNL------ 219

Query: 561 NAVLTKEDGEESLRHFIDPTLQGNY--PLELALLVIRLIDACLKKDPTDRPTMYEI 614
                     + LR  +   L+G Y  P  ++     L+   L  +P  R T+ +I
Sbjct: 220 ----------KELRERV---LRGKYRIPFYMSTDCENLLKRFLVLNPIKRGTLEQI 262

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 80.8 bits (200), Expect = 7e-17
 Identities = 65/281 (23%), Positives = 106/281 (37%), Gaps = 58/281 (20%)

Query: 361 GSVYRGK--INGGFAAIKKVN-----------GDVSKEIALLNKINHSNLIILSGVCFNE 407
           G V            A+K +             +V KEI LL ++ H N+I L  V +NE
Sbjct: 19  GKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNE 78

Query: 408 --GNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQR---IQIALDVATGLNYLHSFTNPP 462
                Y+V EY V G     +  +  E ++   +      Q+      GL YLHS     
Sbjct: 79  EKQKMYMVMEYCVCGMQE--MLDSVPEKRFPVCQAHGYFCQLI----DGLEYLHSQG--- 129

Query: 463 HVHKDINSSNVLLDSDLRAKIANFAM-ARPAEGQEGEFALTRHIVGTKGYMAPEYLEN-- 519
            VHKDI   N+LL +    KI+   +          +   T    G+  +  PE      
Sbjct: 130 IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQ--GSPAFQPPEIANGLD 187

Query: 520 GLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDP 579
                K+D+++ GV +  + TG        E +N++                 L   I  
Sbjct: 188 TFSGFKVDIWSAGVTLYNITTGL----YPFEGDNIY----------------KLFENI-- 225

Query: 580 TLQGNY--PLELALLVIRLIDACLKKDPTDRPTMYEI-EHS 617
             +G+Y  P +    +  L+   L+ +P  R ++ +I +HS
Sbjct: 226 -GKGSYAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHS 265

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 80.3 bits (199), Expect = 7e-17
 Identities = 71/280 (25%), Positives = 114/280 (40%), Gaps = 66/280 (23%)

Query: 361 GSVYRGK--INGGFAAIKKVN-------GDVSK---EIALLNKINHSNLIILSGVCFNEG 408
           G V  G+  + G   A+K +N         V K   EI  L    H ++I L  V     
Sbjct: 25  GKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPT 84

Query: 409 NCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVA--------TGLNYLHSFTN 460
           + ++V EY   G L D          Y+    R++     A        + ++Y H    
Sbjct: 85  DFFMVMEYVSGGELFD----------YICKHGRVEE--MEARRLFQQILSAVDYCHRHM- 131

Query: 461 PPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENG 520
              VH+D+   NVLLD+ + AKIA+F ++      +GEF  T    G+  Y APE +   
Sbjct: 132 --VVHRDLKPENVLLDAHMNAKIADFGLS--NMMSDGEFLRTS--CGSPNYAAPEVISGR 185

Query: 521 L-VSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDP 579
           L    ++D+++ GV++  +L G     L  ++ ++                 +L   I  
Sbjct: 186 LYAGPEVDIWSCGVILYALLCG----TLPFDDEHVP----------------TLFKKI-- 223

Query: 580 TLQGNY--PLELALLVIRLIDACLKKDPTDRPTMYEI-EH 616
              G +  P  L   V  L+   L+ DP  R T+ +I EH
Sbjct: 224 -RGGVFYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREH 262

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 82.5 bits (204), Expect = 1e-16
 Identities = 76/339 (22%), Positives = 127/339 (37%), Gaps = 59/339 (17%)

Query: 300 PDSIVVSGSFQANEKPSNKKFDEESQDFLESISGVA-----QSLKVYSF-----KELQSA 349
           P  +V + + +  + P    F E ++   E +S         S+    F      E Q  
Sbjct: 122 PRQLVTNCTQRLEQGPCKDLFQELTRLTHEYLSVAPFADYLDSIYFNRFLQWKWLERQPV 181

Query: 350 T-DNFSFTCRI--QGS---VY--RGKINGGFAAIKKVNGDVSK----------EIALLNK 391
           T + F    R+  +G    V   + +  G   A KK+     K          E  +L K
Sbjct: 182 TKNTFRQ-YRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEK 240

Query: 392 INHSNLIILSGVCF-NEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQI-ALDVA 449
           +N   ++ L+   +  +    LV    +NG   D  F   + G+    + R    A ++ 
Sbjct: 241 VNSRFVVSLAY-AYETKDALCLVLTL-MNG--GDLKFHIYHMGQAGFPEARAVFYAAEIC 296

Query: 450 TGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTK 509
            GL  LH       V++D+   N+LLD     +I++  +A      EG+    R  VGT 
Sbjct: 297 CGLEDLHRERI---VYRDLKPENILLDDHGHIRISDLGLAV--HVPEGQTIKGR--VGTV 349

Query: 510 GYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDG 569
           GYMAPE ++N   +   D +A G L+ EM+ G+  +     +  +   +V   V    + 
Sbjct: 350 GYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQ--SPFQQRKKKIKREEVERLVKEVPE- 406

Query: 570 EESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDR 608
                          Y    +     L    L KDP +R
Sbjct: 407 --------------EYSERFSPQARSLCSQLLCKDPAER 431

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 80.0 bits (198), Expect = 1e-16
 Identities = 42/202 (20%), Positives = 83/202 (41%), Gaps = 34/202 (16%)

Query: 361 GSVYRG--KINGGFAAIKKVNG-------------DVSKEIALLNKINHSNLIILSGVCF 405
             V +   K  G   A K +               ++ +E+++L ++ H N+I L  V  
Sbjct: 26  AIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYE 85

Query: 406 NEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPH-- 463
           N  +  L+ E    G L D++     +    + ++       +  G+NYLH+        
Sbjct: 86  NRTDVVLILELVSGGELFDFLAQ---KESLSE-EEATSFIKQILDGVNYLHT-----KKI 136

Query: 464 VHKDINSSNVLLDS----DLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLEN 519
            H D+   N++L          K+ +F +A   E         ++I GT  ++APE +  
Sbjct: 137 AHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV----EFKNIFGTPEFVAPEIVNY 192

Query: 520 GLVSTKLDVYAFGVLILEMLTG 541
             +  + D+++ GV+   +L+G
Sbjct: 193 EPLGLEADMWSIGVITYILLSG 214

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 80.5 bits (199), Expect = 1e-16
 Identities = 42/202 (20%), Positives = 83/202 (41%), Gaps = 34/202 (16%)

Query: 361 GSVYRG--KINGGFAAIKKVNG-------------DVSKEIALLNKINHSNLIILSGVCF 405
             V +   K  G   A K +               ++ +E+++L ++ H N+I L  V  
Sbjct: 26  AIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYE 85

Query: 406 NEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPH-- 463
           N  +  L+ E    G L D++     +    + ++       +  G+NYLH+        
Sbjct: 86  NRTDVVLILELVSGGELFDFLAQ---KESLSE-EEATSFIKQILDGVNYLHT-----KKI 136

Query: 464 VHKDINSSNVLLDS----DLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLEN 519
            H D+   N++L          K+ +F +A   E         ++I GT  ++APE +  
Sbjct: 137 AHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV----EFKNIFGTPEFVAPEIVNY 192

Query: 520 GLVSTKLDVYAFGVLILEMLTG 541
             +  + D+++ GV+   +L+G
Sbjct: 193 EPLGLEADMWSIGVITYILLSG 214

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 79.6 bits (197), Expect = 2e-16
 Identities = 41/176 (23%), Positives = 80/176 (45%), Gaps = 22/176 (12%)

Query: 375 IKKVNGDVSKEIALLNKIN-HSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEG 433
           ++++     KE+ +L K++ H N+I L          +LV++    G L D++       
Sbjct: 63  VQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK---V 119

Query: 434 KYLDWKQRIQIALDVATGLNYLHSFTNPPH--VHKDINSSNVLLDSDLRAKIANFAMARP 491
              + + R +I   +   +  LH         VH+D+   N+LLD D+  K+ +F  +  
Sbjct: 120 TLSEKETR-KIMRALLEVICALHK-----LNIVHRDLKPENILLDDDMNIKLTDFGFSCQ 173

Query: 492 AEGQEGEFALTRHIVGTKGYMAPEYLENGLVST------KLDVYAFGVLILEMLTG 541
            +   GE      + GT  Y+APE +E  +         ++D+++ GV++  +L G
Sbjct: 174 LD--PGEKLRE--VCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 78.8 bits (195), Expect = 2e-16
 Identities = 39/167 (23%), Positives = 78/167 (46%), Gaps = 19/167 (11%)

Query: 381 DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQ 440
           ++ +E+ +L +I H N+I L  +  N+ +  L+ E    G L D++     +    +  +
Sbjct: 54  EIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAE---KESLTE-DE 109

Query: 441 RIQIALDVATGLNYLHSFTNPPH--VHKDINSSNVLLDS----DLRAKIANFAMARPAEG 494
             Q    +  G++YLHS         H D+   N++L      + R K+ +F +A   E 
Sbjct: 110 ATQFLKQILDGVHYLHS-----KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEA 164

Query: 495 QEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTG 541
                   ++I GT  ++APE +    +  + D+++ GV+   +L+G
Sbjct: 165 GN----EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 207

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 79.5 bits (196), Expect = 3e-16
 Identities = 60/317 (18%), Positives = 105/317 (33%), Gaps = 86/317 (27%)

Query: 361 GSVYRG--KINGGFAAIKKVN------------GDVSKEIALLNKINHSNLIILSGVCFN 406
           G V            AIK +N              +  E+ L+ K++H N+  L  V  +
Sbjct: 40  GVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED 99

Query: 407 EGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQ----------------------- 443
           E    LV E    G L D +    ++         ++                       
Sbjct: 100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRE 159

Query: 444 -------------IALDVATGLNYLHSFTNPPH--VHKDINSSNVLLDSDLRA--KIANF 486
                        I   + + L+YLH+         H+DI   N L  ++     K+ +F
Sbjct: 160 SLDFVQREKLISNIMRQIFSALHYLHN-----QGICHRDIKPENFLFSTNKSFEIKLVDF 214

Query: 487 AMARP-AEGQEGEFALTRHIVGTKGYMAPEYLENGL--VSTKLDVYAFGVLILEMLTGK- 542
            +++   +   GE+       GT  ++APE L         K D ++ GVL+  +L G  
Sbjct: 215 GLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAV 274

Query: 543 --EAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDAC 600
                      N+   +D ++ VL K+        F +P         L+ L   L+   
Sbjct: 275 PFPG------VND---ADTISQVLNKKL------CFENPNYN-----VLSPLARDLLSNL 314

Query: 601 LKKDPTDRPTMYEI-EH 616
           L ++  +R       +H
Sbjct: 315 LNRNVDERFDAMRALQH 331

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 80.5 bits (199), Expect = 4e-16
 Identities = 59/242 (24%), Positives = 97/242 (40%), Gaps = 37/242 (15%)

Query: 381 DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQ 440
           ++  EI+LL  ++H N+I L  V  ++   YLV E+   G L + +    N  K+ +   
Sbjct: 92  EIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQI---INRHKFDE-CD 147

Query: 441 RIQIALDVATGLNYLHSFTNPPH--VHKDINSSNVLLDS---DLRAKIANFAMARPAEGQ 495
              I   + +G+ YLH      H  VH+DI   N+LL++    L  KI +F ++      
Sbjct: 148 AANIMKQILSGICYLHK-----HNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKD 202

Query: 496 EGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMH 555
                  R  +GT  Y+APE L     + K DV++ GV++  +L G        +    +
Sbjct: 203 Y----KLRDRLGTAYYIAPEVL-KKKYNEKCDVWSCGVIMYILLCGY--PPFGGQ----N 251

Query: 556 LSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEI- 614
             D++  V   +                N    ++     LI   L  D   R T  E  
Sbjct: 252 DQDIIKKVEKGK-----------YYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEAL 300

Query: 615 EH 616
             
Sbjct: 301 NS 302

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 78.8 bits (195), Expect = 4e-16
 Identities = 69/284 (24%), Positives = 116/284 (40%), Gaps = 58/284 (20%)

Query: 361 GSVYRGK-INGGFAAIKKVNGDVSK---------EIALLNKINHSNLIILSGVCFNEGNC 410
           G VY+ K   G   A+K++  D            EI+LL +++H N++ L  V  +E   
Sbjct: 35  GVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCL 94

Query: 411 YLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVAT----------GLNYLHSFTN 460
            LV+E+ +   L           K LD     +  L  +           G+ + H    
Sbjct: 95  TLVFEF-MEKDLK----------KVLD---ENKTGLQDSQIKIYLYQLLRGVAHCHQ--- 137

Query: 461 PPH--VHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLE 518
             H  +H+D+   N+L++SD   K+A+F +AR A G     + T H V T  Y AP+ L 
Sbjct: 138 --HRILHRDLKPQNLLINSDGALKLADFGLAR-AFGIPVR-SYT-HEVVTLWYRAPDVLM 192

Query: 519 NGLV-STKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLT-KED---GEESL 573
                ST +D+++ G +  EM+TGK         ++  L  + + + T         + L
Sbjct: 193 GSKKYSTSVDIWSIGCIFAEMITGK--PLFPGVTDDDQLPKIFSILGTPNPREWPQVQEL 250

Query: 574 RHFIDPTLQGNYPLELALLV-------IRLIDACLKKDPTDRPT 610
             +   T Q       + ++       I L+   L  DP  R +
Sbjct: 251 PLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRIS 294

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 79.3 bits (196), Expect = 4e-16
 Identities = 41/200 (20%), Positives = 76/200 (38%), Gaps = 27/200 (13%)

Query: 361 GSVYRG--KINGGFAAIKKVN------------GDVSKEIALLNKINHSNLIILSGVCFN 406
             V R   +  G   A+K V+             D+ +E ++ + + H +++ L     +
Sbjct: 38  SVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSS 97

Query: 407 EGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPH--V 464
           +G  Y+V+E+     L   +    + G              +   L Y H      +  +
Sbjct: 98  DGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD-----NNII 152

Query: 465 HKDINSSNVLLDS---DLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGL 521
           H+D+    VLL S       K+  F +A                VGT  +MAPE ++   
Sbjct: 153 HRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVA---GGRVGTPHFMAPEVVKREP 209

Query: 522 VSTKLDVYAFGVLILEMLTG 541
               +DV+  GV++  +L+G
Sbjct: 210 YGKPVDVWGCGVILFILLSG 229

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 78.4 bits (194), Expect = 4e-16
 Identities = 46/196 (23%), Positives = 83/196 (42%), Gaps = 24/196 (12%)

Query: 361 GSVY--RGKINGGFAAIKKVNGD----------VSKEIALLNKINHSNLIILSGVCF-NE 407
            +V   R        AIK +             V++E  ++++++H   + L    F ++
Sbjct: 44  STVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF-TFQDD 102

Query: 408 GNCYLVYEYAVNGTLSDWVFSN-KNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHK 466
              Y    YA NG L        +  G + +   R   A ++ + L YLH       +H+
Sbjct: 103 EKLYFGLSYAKNGEL----LKYIRKIGSFDETCTRFYTA-EIVSALEYLHGKG---IIHR 154

Query: 467 DINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKL 526
           D+   N+LL+ D+  +I +F  A+     E + A     VGT  Y++PE L         
Sbjct: 155 DLKPENILLNEDMHIQITDFGTAKVLS-PESKQARANSFVGTAQYVSPELLTEKSACKSS 213

Query: 527 DVYAFGVLILEMLTGK 542
           D++A G +I +++ G 
Sbjct: 214 DLWALGCIIYQLVAGL 229

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 80.2 bits (198), Expect = 5e-16
 Identities = 73/280 (26%), Positives = 116/280 (41%), Gaps = 66/280 (23%)

Query: 361 GSVYRGK--INGGFAAIKKVN-------GDVSK---EIALLNKINHSNLIILSGVCFNEG 408
           G V  GK  + G   A+K +N         V K   EI  L    H ++I L  V     
Sbjct: 30  GKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPS 89

Query: 409 NCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVA--------TGLNYLHSFTN 460
           + ++V EY   G L D          Y+    R+      +        +G++Y H    
Sbjct: 90  DIFMVMEYVSGGELFD----------YICKNGRLDE--KESRRLFQQILSGVDYCHRHM- 136

Query: 461 PPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENG 520
              VH+D+   NVLLD+ + AKIA+F ++      +GEF  T    G+  Y APE +   
Sbjct: 137 --VVHRDLKPENVLLDAHMNAKIADFGLS--NMMSDGEFLRTS--CGSPNYAAPEVISGR 190

Query: 521 L-VSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDP 579
           L    ++D+++ GV++  +L G     L  +++++                 +L   I  
Sbjct: 191 LYAGPEVDIWSSGVILYALLCG----TLPFDDDHVP----------------TLFKKI-- 228

Query: 580 TLQGNY--PLELALLVIRLIDACLKKDPTDRPTMYEI-EH 616
              G +  P  L   VI L+   L+ DP  R T+ +I EH
Sbjct: 229 -CDGIFYTPQYLNPSVISLLKHMLQVDPMKRATIKDIREH 267

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 79.4 bits (196), Expect = 5e-16
 Identities = 48/194 (24%), Positives = 86/194 (44%), Gaps = 25/194 (12%)

Query: 361 GSVYRG--KINGGFAAIKKVNG-------DVSKEIALLNKINHSNLIILSGVCFNEGNCY 411
           G V++      G   A K +         +V  EI+++N+++H+NLI L     ++ +  
Sbjct: 103 GQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIV 162

Query: 412 LVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPH--VHKDIN 469
           LV EY   G L D +     E   L     I     +  G+ ++H         +H D+ 
Sbjct: 163 LVMEYVDGGELFDRIID---ESYNLTELDTILFMKQICEGIRHMHQ-----MYILHLDLK 214

Query: 470 SSNVLLDS--DLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLD 527
             N+L  +    + KI +F +AR  + +E      +   GT  ++APE +    VS   D
Sbjct: 215 PENILCVNRDAKQIKIIDFGLARRYKPRE----KLKVNFGTPEFLAPEVVNYDFVSFPTD 270

Query: 528 VYAFGVLILEMLTG 541
           +++ GV+   +L+G
Sbjct: 271 MWSVGVIAYMLLSG 284

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 80.2 bits (198), Expect = 5e-16
 Identities = 72/358 (20%), Positives = 133/358 (37%), Gaps = 63/358 (17%)

Query: 285 GATIFCKFFYTRKKEPDSIVVSGS-FQANEKPSNKKFDEESQDFLESISGVA-----QSL 338
              +   +   + +   S + + +  +A     +  F    +  L  +          SL
Sbjct: 107 AQALRAAYLEPQAQLFCSFLDAETVARARAGAGDGLFQPLLRAVLAHLGQAPFQEFLDSL 166

Query: 339 KVYSF-----KELQSAT-DNFSFTCRI--QGS---VY--RGKINGGFAAIKKVNGDV--- 382
               F      E Q    D F    R+  +G    V+  + K  G   A KK+N      
Sbjct: 167 YFLRFLQWKWLEAQPMGEDWFLD-FRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKK 225

Query: 383 SKEIA-------LLNKINHSNLIILSGVCF-NEGNCYLVYEYAVNGTLSDWVF----SNK 430
            K          +L K++   ++ L+   F  + +  LV    +NG   D  +     ++
Sbjct: 226 RKGYQGAMVEKKILAKVHSRFIVSLAY-AFETKTDLCLVMTI-MNG--GDIRYHIYNVDE 281

Query: 431 NEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMAR 490
           +   + + +     A  + +GL +LH       +++D+   NVLLD D   +I++  +A 
Sbjct: 282 DNPGFQEPRAIFYTA-QIVSGLEHLHQRNI---IYRDLKPENVLLDDDGNVRISDLGLAV 337

Query: 491 PAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAE 550
             E + G+   T+   GT G+MAPE L        +D +A GV + EM+  +      A 
Sbjct: 338 --ELKAGQ-TKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR--GPFRAR 392

Query: 551 ENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDR 608
              +   ++   VL +      +           YP + +       +A L+KDP  R
Sbjct: 393 GEKVENKELKQRVLEQA-----VT----------YPDKFSPASKDFCEALLQKDPEKR 435

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 79.7 bits (197), Expect = 6e-16
 Identities = 63/273 (23%), Positives = 111/273 (40%), Gaps = 48/273 (17%)

Query: 361 GSVYRG--KINGGFAAIKKVN---------GDVSKEIALLNKINHSNLIILSGVCFNEGN 409
           G V +   +I     A+K +N           + +E+ LL K++H N++ L  +  +  +
Sbjct: 36  GEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSS 95

Query: 410 CYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPH--VHKD 467
            Y+V E    G L D +       ++ +     +I   V +G+ Y+H      H  VH+D
Sbjct: 96  FYIVGELYTGGELFDEI---IKRKRFSE-HDAARIIKQVFSGITYMHK-----HNIVHRD 146

Query: 468 INSSNVLLDS---DLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVST 524
           +   N+LL+S   D   KI +F ++   +  +         +GT  Y+APE L  G    
Sbjct: 147 LKPENILLESKEKDCDIKIIDFGLSTCFQ--QNTKMKD--RIGTAYYIAPEVLR-GTYDE 201

Query: 525 KLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGN 584
           K DV++ GV++  +L+G      + +       D+L  V T +                 
Sbjct: 202 KCDVWSAGVILYILLSGT--PPFYGKNE----YDILKRVETGK-----------YAFDLP 244

Query: 585 YPLELALLVIRLIDACLKKDPTDRPTMYEI-EH 616
               ++     LI   L   P+ R T  +  EH
Sbjct: 245 QWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 77.7 bits (192), Expect = 9e-16
 Identities = 48/198 (24%), Positives = 76/198 (38%), Gaps = 28/198 (14%)

Query: 361 GSVYRG--KINGGFAAIKKVN---------GDVSKEIALLNKINHS-NLIILSGVCFNEG 408
             V +   K  G   A K +           ++  EIA+L        +I L  V  N  
Sbjct: 43  AVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTS 102

Query: 409 NCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPH--VHK 466
              L+ EYA  G +       +      +    I++   +  G+ YLH      +  VH 
Sbjct: 103 EIILILEYAAGGEIFSLCLP-ELAEMVSE-NDVIRLIKQILEGVYYLHQ-----NNIVHL 155

Query: 467 DINSSNVLL---DSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVS 523
           D+   N+LL         KI +F M+R            R I+GT  Y+APE L    ++
Sbjct: 156 DLKPQNILLSSIYPLGDIKIVDFGMSRKIG--HACE--LREIMGTPEYLAPEILNYDPIT 211

Query: 524 TKLDVYAFGVLILEMLTG 541
           T  D++  G++   +LT 
Sbjct: 212 TATDMWNIGIIAYMLLTH 229

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 77.4 bits (191), Expect = 1e-15
 Identities = 59/281 (20%), Positives = 96/281 (34%), Gaps = 68/281 (24%)

Query: 361 GSVYRGK--INGGFAAIKKVN-------------GDVSKEIALLNKINHS--NLIILSGV 403
           GSVY G    +    AIK V                V  E+ LL K++     +I L   
Sbjct: 57  GSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW 116

Query: 404 CFNEGNCYLVYEYAVN-GTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPP 462
                +  L+ E       L D++         L  +        V   + + H+     
Sbjct: 117 FERPDSFVLILERPEPVQDLFDFITERGA----LQEELARSFFWQVLEAVRHCHN----- 167

Query: 463 H--VHKDINSSNVLLDSD-LRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLEN 519
              +H+DI   N+L+D +    K+ +F     A  ++  +       GT+ Y  PE++  
Sbjct: 168 CGVLHRDIKDENILIDLNRGELKLIDFGSG--ALLKDTVY---TDFDGTRVYSPPEWIRY 222

Query: 520 GL-VSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFID 578
                    V++ G+L+ +M+ G                      +  E  EE +R    
Sbjct: 223 HRYHGRSAAVWSLGILLYDMVCGD---------------------IPFEHDEEIIR---- 257

Query: 579 PTLQGNY--PLELALLVIRLIDACLKKDPTDRPTMYEI-EH 616
               G       ++     LI  CL   P+DRPT  EI  H
Sbjct: 258 ----GQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 294

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 76.9 bits (190), Expect = 1e-15
 Identities = 57/280 (20%), Positives = 98/280 (35%), Gaps = 62/280 (22%)

Query: 361 GSVYRGK--INGGFAAIKKVNGD--------VSKEIALLNKINHSNLIILSGVCFNEGNC 410
           G V      +     A+K V+          + KEI +   +NH N++   G        
Sbjct: 21  GEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQ 80

Query: 411 YLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVA--------TGLNYLHSFTNPP 462
           YL  EY   G L D           ++    +      A         G+ YLH      
Sbjct: 81  YLFLEYCSGGELFD----------RIEPDIGMPE--PDAQRFFHQLMAGVVYLHGIG--- 125

Query: 463 HVHKDINSSNVLLDSDLRAKIANFAM-ARPAEGQEGEFALTRHIVGTKGYMAPEYLEN-G 520
             H+DI   N+LLD     KI++F +                   GT  Y+APE L+   
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM--CGTLPYVAPELLKRRE 183

Query: 521 LVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPT 580
             +  +DV++ G+++  ML G+                     L  +   +S + + D  
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGE---------------------LPWDQPSDSCQEYSDWK 222

Query: 581 LQGNYPLELALL---VIRLIDACLKKDPTDRPTMYEI-EH 616
            +  Y      +    + L+   L ++P+ R T+ +I + 
Sbjct: 223 EKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 262

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 77.7 bits (192), Expect = 1e-15
 Identities = 64/280 (22%), Positives = 103/280 (36%), Gaps = 67/280 (23%)

Query: 361 GSVYRGK--INGGFAAIKKVN----------GDVSKEIALLNKINHSNLIILSGVCFNEG 408
           G V            A+K ++            V +EI+ L  + H ++I L  V     
Sbjct: 23  GKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPT 82

Query: 409 NCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVA--------TGLNYLHSFTN 460
           +  +V EY   G L D          Y+  K+R+    D            + Y H    
Sbjct: 83  DIVMVIEY-AGGELFD----------YIVEKKRMTE--DEGRRFFQQIICAIEYCHRHK- 128

Query: 461 PPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENG 520
              VH+D+   N+LLD +L  KIA+F ++      +G F  T    G+  Y APE +   
Sbjct: 129 --IVHRDLKPENLLLDDNLNVKIADFGLS--NIMTDGNFLKTS--CGSPNYAAPEVINGK 182

Query: 521 L-VSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDP 579
           L    ++DV++ G+++  ML G     L  ++  +                 +L   +  
Sbjct: 183 LYAGPEVDVWSCGIVLYVMLVG----RLPFDDEFIP----------------NLFKKV-- 220

Query: 580 TLQGNY--PLELALLVIRLIDACLKKDPTDRPTMYEI-EH 616
                Y  P  L+     LI   +  DP  R T+ EI   
Sbjct: 221 -NSCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRD 259

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 76.5 bits (189), Expect = 1e-15
 Identities = 62/271 (22%), Positives = 101/271 (37%), Gaps = 46/271 (16%)

Query: 361 GSVYRG--KINGGFAAIK-----KVNG--DVSKEIALLNKINHSNLIILSGVCFNEGNCY 411
           G V     K      A K      V       +EI ++  ++H N+I L     +  + Y
Sbjct: 23  GEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIY 82

Query: 412 LVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPH--VHKDIN 469
           LV E    G L + V     +  + +     +I  DV + + Y H          H+D+ 
Sbjct: 83  LVMELCTGGELFERVVH---KRVFRE-SDAARIMKDVLSAVAYCHK-----LNVAHRDLK 133

Query: 470 SSNVLLDS---DLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKL 526
             N L  +   D   K+ +F +A   +   G+   T   VGT  Y++P+ LE GL   + 
Sbjct: 134 PENFLFLTDSPDSPLKLIDFGLAARFK--PGKMMRT--KVGTPYYVSPQVLE-GLYGPEC 188

Query: 527 DVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYP 586
           D ++ GV++  +L G       A  +    S+V+  +                T      
Sbjct: 189 DEWSAGVMMYVLLCGYP--PFSAPTD----SEVMLKIREG-----------TFTFPEKDW 231

Query: 587 LELALLVIRLIDACLKKDPTDRPTMYEI-EH 616
           L ++     LI   L K P  R T  +  EH
Sbjct: 232 LNVSPQAESLIRRLLTKSPKQRITSLQALEH 262

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 77.3 bits (191), Expect = 1e-15
 Identities = 45/202 (22%), Positives = 85/202 (42%), Gaps = 34/202 (16%)

Query: 361 GSVYRG--KINGGFAAIKKVNG-------------DVSKEIALLNKINHSNLIILSGVCF 405
             V +   K  G   A K +               D+ +E+++L +I H N+I L  V  
Sbjct: 25  AVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYE 84

Query: 406 NEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPH-- 463
           N+ +  L+ E    G L D++     +    + ++  +    +  G+ YLHS        
Sbjct: 85  NKTDVILILELVAGGELFDFLAE---KESLTE-EEATEFLKQILNGVYYLHS-----LQI 135

Query: 464 VHKDINSSNVLLDS----DLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLEN 519
            H D+   N++L        R KI +F +A   +         ++I GT  ++APE +  
Sbjct: 136 AHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN----EFKNIFGTPEFVAPEIVNY 191

Query: 520 GLVSTKLDVYAFGVLILEMLTG 541
             +  + D+++ GV+   +L+G
Sbjct: 192 EPLGLEADMWSIGVITYILLSG 213

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 77.4 bits (191), Expect = 1e-15
 Identities = 40/184 (21%), Positives = 85/184 (46%), Gaps = 22/184 (11%)

Query: 367 KINGGFAAIKKVNGDVSKEIALLNKI-NHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDW 425
                   +++V     +E  +L ++  H ++I L     +    +LV++    G L D+
Sbjct: 131 AERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDY 190

Query: 426 VFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPH--VHKDINSSNVLLDSDLRAKI 483
           +          + + R  I   +   +++LH+     +  VH+D+   N+LLD +++ ++
Sbjct: 191 LTEK---VALSEKETR-SIMRSLLEAVSFLHA-----NNIVHRDLKPENILLDDNMQIRL 241

Query: 484 ANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLV------STKLDVYAFGVLILE 537
           ++F  +   E   GE      + GT GY+APE L+  +         ++D++A GV++  
Sbjct: 242 SDFGFSCHLE--PGEKLRE--LCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFT 297

Query: 538 MLTG 541
           +L G
Sbjct: 298 LLAG 301

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 76.4 bits (189), Expect = 2e-15
 Identities = 48/205 (23%), Positives = 83/205 (40%), Gaps = 40/205 (19%)

Query: 361 GSVYRG--KINGGFAAIKKVNGDVSK---------EIALLNKINHSNLIILSGVCFNEGN 409
           G+V++   +      A+K+V  D            EI LL ++ H N++ L  V  ++  
Sbjct: 16  GTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKK 75

Query: 410 CYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVAT-------GLNYLHSFTNPP 462
             LV+E+  +  L           KY D          V +       GL + HS     
Sbjct: 76  LTLVFEF-CDQDLK----------KYFDSCNGDLDPEIVKSFLFQLLKGLGFCHS----- 119

Query: 463 H--VHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENG 520
              +H+D+   N+L++ +   K+ANF +AR A G       +   V T  Y  P+ L   
Sbjct: 120 RNVLHRDLKPQNLLINRNGELKLANFGLAR-AFGIPVR-CYS-AEVVTLWYRPPDVLFGA 176

Query: 521 LV-STKLDVYAFGVLILEMLTGKEA 544
            + ST +D+++ G +  E+      
Sbjct: 177 KLYSTSIDMWSAGCIFAELANAGRP 201

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 76.5 bits (189), Expect = 2e-15
 Identities = 50/207 (24%), Positives = 85/207 (41%), Gaps = 44/207 (21%)

Query: 361 GSVYRG--KINGGFAAIKKVNGDVSK---------EIALLNKINHSNLIILSGVCFNEGN 409
           G VY+    +     AIK++  +  +         E++LL ++ H N+I L  V  +   
Sbjct: 48  GEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHR 107

Query: 410 CYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIAL------DVATGLNYLHSFTNPPH 463
            +L++EY     L           KY+D    + + +       +  G+N+ HS      
Sbjct: 108 LHLIFEY-AENDLK----------KYMDKNPDVSMRVIKSFLYQLINGVNFCHS-----R 151

Query: 464 --VHKDINSSNVLLDSDLRA-----KIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEY 516
             +H+D+   N+LL     +     KI +F +AR A G       T H + T  Y  PE 
Sbjct: 152 RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR-AFGIPIR-QFT-HEIITLWYRPPEI 208

Query: 517 LENGLV-STKLDVYAFGVLILEMLTGK 542
           L      ST +D+++   +  EML   
Sbjct: 209 LLGSRHYSTSVDIWSIACIWAEMLMKT 235

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 76.2 bits (188), Expect = 3e-15
 Identities = 56/280 (20%), Positives = 97/280 (34%), Gaps = 62/280 (22%)

Query: 361 GSVYRGK--INGGFAAIK--------KVNGDVSKEIALLNKINHSNLIILSGVCFNEGNC 410
           G V      +     A+K            ++ KEI +   +NH N++   G        
Sbjct: 21  GEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQ 80

Query: 411 YLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVA--------TGLNYLHSFTNPP 462
           YL  EY   G L D           ++    +      A         G+ YLH      
Sbjct: 81  YLFLEYCSGGELFD----------RIEPDIGMPE--PDAQRFFHQLMAGVVYLHGIG--- 125

Query: 463 HVHKDINSSNVLLDSDLRAKIANFAM-ARPAEGQEGEFALTRHIVGTKGYMAPEYLEN-G 520
             H+DI   N+LLD     KI++F +                   GT  Y+APE L+   
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM--CGTLPYVAPELLKRRE 183

Query: 521 LVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPT 580
             +  +DV++ G+++  ML G+                     L  +   +S + + D  
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGE---------------------LPWDQPSDSCQEYSDWK 222

Query: 581 LQGNYPLELALL---VIRLIDACLKKDPTDRPTMYEI-EH 616
            +  Y      +    + L+   L ++P+ R T+ +I + 
Sbjct: 223 EKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 262

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 76.5 bits (189), Expect = 3e-15
 Identities = 60/297 (20%), Positives = 109/297 (36%), Gaps = 69/297 (23%)

Query: 361 GSVYRG--KINGGFAAIKKVNGDVSK---------EIALLNKINHSNLIILSGVCFNEGN 409
           G V++   +  G   A+KKV  +  K         EI +L  + H N++ L  +C  + +
Sbjct: 31  GEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKAS 90

Query: 410 C--------YLVYEYA---VNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSF 458
                    YLV+++    + G LS       N        +  ++   +  GL Y+H  
Sbjct: 91  PYNRCKGSIYLVFDFCEHDLAGLLS-------NVLVKFTLSEIKRVMQMLLNGLYYIHR- 142

Query: 459 TNPPH--VHKDINSSNVLLDSDLRAKIANFAMARP--AEGQEGEFALTRHIVGTKGYMAP 514
               +  +H+D+ ++NVL+  D   K+A+F +AR             T + V T  Y  P
Sbjct: 143 ----NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYT-NRVVTLWYRPP 197

Query: 515 E-------YLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVL--- 564
           E       Y         +D++  G ++ EM T      +       H   +++ +    
Sbjct: 198 ELLLGERDY------GPPIDLWGAGCIMAEMWTRS---PIMQGNTEQHQLALISQLCGSI 248

Query: 565 TKED--GEESLRHFIDPTLQGNYPLELALLV---------IRLIDACLKKDPTDRPT 610
           T E     ++   +    L      ++   +         + LID  L  DP  R  
Sbjct: 249 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRID 305

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 75.7 bits (187), Expect = 3e-15
 Identities = 48/197 (24%), Positives = 81/197 (41%), Gaps = 29/197 (14%)

Query: 361 GSVYRG--KINGGFAAIKKVN---------GDVSKEIALLNKINHSNLIILSGVCFNEGN 409
             V R   K  G   A K +N           + +E  +  K+ H N++ L      E  
Sbjct: 20  SVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESF 79

Query: 410 CYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPH--VHKD 467
            YLV++    G L + + +      Y +          +   + Y HS     +  VH++
Sbjct: 80  HYLVFDLVTGGELFEDIVA---REFYSEADAS-HCIQQILESIAYCHS-----NGIVHRN 130

Query: 468 INSSNVLLDS---DLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVST 524
           +   N+LL S       K+A+F +A   E  + E        GT GY++PE L+    S 
Sbjct: 131 LKPENLLLASKAKGAAVKLADFGLAI--EVNDSEAWHG--FAGTPGYLSPEVLKKDPYSK 186

Query: 525 KLDVYAFGVLILEMLTG 541
            +D++A GV++  +L G
Sbjct: 187 PVDIWACGVILYILLVG 203

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 75.7 bits (187), Expect = 3e-15
 Identities = 50/197 (25%), Positives = 89/197 (45%), Gaps = 30/197 (15%)

Query: 361 GSVYRG--KINGGFAAIK-----KVNG----DVSKEIALLNKINHSNLIILSGVCFNEGN 409
           G V +   +I     A+K              + +E+ LL K++H N++ L  +  +  +
Sbjct: 36  GEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSS 95

Query: 410 CYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPH--VHKD 467
            Y+V E    G L D +       ++ +     +I   V +G+ Y+H      H  VH+D
Sbjct: 96  FYIVGELYTGGELFDEIIK---RKRFSE-HDAARIIKQVFSGITYMHK-----HNIVHRD 146

Query: 468 INSSNVLLDS---DLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVST 524
           +   N+LL+S   D   KI +F ++   +  +         +GT  Y+APE L  G    
Sbjct: 147 LKPENILLESKEKDCDIKIIDFGLSTCFQ--QNTKMKD--RIGTAYYIAPEVL-RGTYDE 201

Query: 525 KLDVYAFGVLILEMLTG 541
           K DV++ GV++  +L+G
Sbjct: 202 KCDVWSAGVILYILLSG 218

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 77.5 bits (191), Expect = 3e-15
 Identities = 80/363 (22%), Positives = 144/363 (39%), Gaps = 75/363 (20%)

Query: 290 CKFFYTRKKEPDSIVVSGSFQAN--EKPSNKKFDEESQDFLESISGVAQSLKVYSFKELQ 347
           C+   T +  P++ ++         E+  + +  EE +++  +I  VA  LK  +  E+ 
Sbjct: 60  CQLMKTERPRPNTFIIRCLQWTTVIERTFHVETPEEREEWTTAIQTVADGLKKQAAAEMD 119

Query: 348 SAT-------------------------DNFSFTCRI-QGS---VY--RGKINGGFAAIK 376
             +                         + F +   + +G+   V   + K  G + A+K
Sbjct: 120 FRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMK 179

Query: 377 KVNGDV---SKEIA-------LLNKINHSNLIILSGVCF-NEGNCYLVYEYAVNGTLSDW 425
            +  +V     E+A       +L    H  L  L    F        V EY  NG   + 
Sbjct: 180 ILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY-SFQTHDRLCFVMEY-ANG--GEL 235

Query: 426 VFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIAN 485
            F    E  + + + R   A ++ + L+YLHS  N   V++D+   N++LD D   KI +
Sbjct: 236 FFHLSRERVFSEDRARFYGA-EIVSALDYLHSEKNV--VYRDLKLENLMLDKDGHIKITD 292

Query: 486 FAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAA 545
           F + +  EG +   A  +   GT  Y+APE LE+      +D +  GV++ EM+ G+   
Sbjct: 293 FGLCK--EGIKDG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR--L 347

Query: 546 ALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDP 605
             + +++      +   +L +E     +R          +P  L      L+   LKKDP
Sbjct: 348 PFYNQDHE----KLFELILMEE-----IR----------FPRTLGPEAKSLLSGLLKKDP 388

Query: 606 TDR 608
             R
Sbjct: 389 KQR 391

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 75.8 bits (187), Expect = 3e-15
 Identities = 57/283 (20%), Positives = 94/283 (33%), Gaps = 70/283 (24%)

Query: 361 GSVYRGK--INGGFAAIKKVN-------------GDVSKEIALLNKIN----HSNLIILS 401
           G+V+ G    +    AIK +                   E+ALL K+     H  +I L 
Sbjct: 45  GTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL 104

Query: 402 GVCFNEGNCYLVYEYAVNGT-LSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTN 460
                +    LV E  +    L D++         L           V   + + HS   
Sbjct: 105 DWFETQEGFMLVLERPLPAQDLFDYITEKGP----LGEGPSRCFFGQVVAAIQHCHS--- 157

Query: 461 PPH--VHKDINSSNVLLDSD-LRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYL 517
                VH+DI   N+L+D     AK+ +F     A   +  +       GT+ Y  PE++
Sbjct: 158 --RGVVHRDIKDENILIDLRRGCAKLIDFGSG--ALLHDEPYTDF---DGTRVYSPPEWI 210

Query: 518 ENGL-VSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHF 576
                 +    V++ G+L+ +M+ G                      +  E  +E L   
Sbjct: 211 SRHQYHALPATVWSLGILLYDMVCGD---------------------IPFERDQEILE-- 247

Query: 577 IDPTLQGNY--PLELALLVIRLIDACLKKDPTDRPTMYEI-EH 616
                      P  ++     LI  CL   P+ RP++ EI   
Sbjct: 248 ------AELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLD 284

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 75.8 bits (187), Expect = 6e-15
 Identities = 50/265 (18%), Positives = 102/265 (38%), Gaps = 48/265 (18%)

Query: 361 GSVY--RGKINGGFAAIKKVNGDV---SKEIA-------LLNKINHSNLIILSGVCF-NE 407
           G V   +        A+K +N        E+        ++  + H  L+ L    F +E
Sbjct: 29  GKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWY-SFQDE 87

Query: 408 GNCYLVYEYAVNGTLSDWVFSN-KNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHK 466
            + ++V +  + G L      + +    + +   ++ I  ++   L+YL +      +H+
Sbjct: 88  EDMFMVVDLLLGGDL----RYHLQQNVHFKEETVKLFIC-ELVMALDYLQNQRI---IHR 139

Query: 467 DINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLV---S 523
           D+   N+LLD      I +F +A            T  + GTK YMAPE   +      S
Sbjct: 140 DMKPDNILLDEHGHVHITDFNIAA--MLPRETQITT--MAGTKPYMAPEMFSSRKGAGYS 195

Query: 524 TKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQG 583
             +D ++ GV   E+L G+    + +  ++    ++++   T       +          
Sbjct: 196 FAVDWWSLGVTAYELLRGRRPYHIRSSTSSK---EIVHTFETTV-----VT--------- 238

Query: 584 NYPLELALLVIRLIDACLKKDPTDR 608
            YP   +  ++ L+   L+ +P  R
Sbjct: 239 -YPSAWSQEMVSLLKKLLEPNPDQR 262

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 75.0 bits (185), Expect = 8e-15
 Identities = 60/278 (21%), Positives = 100/278 (35%), Gaps = 57/278 (20%)

Query: 361 GSVYRG--KINGGFAAIK---KVNGDVSKEIALLNK-INHSNLIILSGVCFNEGNCYLVY 414
               R   K      A+K   K   D ++EI +L +   H N+I L  V  +    Y+V 
Sbjct: 36  SVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT 95

Query: 415 EYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPH--VHKDINSSN 472
           E    G L D +     +  + + +    +   +   + YLH+        VH+D+  SN
Sbjct: 96  ELMKGGELLDKILR---QKFFSEREAS-AVLFTITKTVEYLHA-----QGVVHRDLKPSN 146

Query: 473 VLLDSD----LRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDV 528
           +L   +       +I +F  A+     E    +T     T  ++APE LE        D+
Sbjct: 147 ILYVDESGNPESIRICDFGFAKQLRA-ENGLLMT--PCYTANFVAPEVLERQGYDAACDI 203

Query: 529 YAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPL- 587
           ++ GVL+  MLTG    A   ++      ++L  +                   G + L 
Sbjct: 204 WSLGVLLYTMLTGYTPFANGPDDTP---EEILARI-----------------GSGKFSLS 243

Query: 588 --------ELALLVIRLIDACLKKDPTDRPTMYEI-EH 616
                   + A     L+   L  DP  R T   +  H
Sbjct: 244 GGYWNSVSDTAK---DLVSKMLHVDPHQRLTAALVLRH 278

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 74.5 bits (184), Expect = 9e-15
 Identities = 50/198 (25%), Positives = 91/198 (45%), Gaps = 26/198 (13%)

Query: 361 GSVYRG--KINGGFAAIKKVNGDVSK--------EIALLNKINHSNLIILSGVCFNEGNC 410
            +VY+G  K  G + A+K+V  D  +        EI+L+ ++ H N++ L  V   E   
Sbjct: 19  ATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKL 78

Query: 411 YLVYEYA---VNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPH--VH 465
            LV+E+    +   +     +  N  + L+          +  GL + H      +  +H
Sbjct: 79  TLVFEFMDNDLKKYMDS--RTVGNTPRGLELNLVKYFQWQLLQGLAFCHE-----NKILH 131

Query: 466 KDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLV-ST 524
           +D+   N+L++   + K+ +F +AR A G       +   V T  Y AP+ L      ST
Sbjct: 132 RDLKPQNLLINKRGQLKLGDFGLAR-AFGIPVN-TFS-SEVVTLWYRAPDVLMGSRTYST 188

Query: 525 KLDVYAFGVLILEMLTGK 542
            +D+++ G ++ EM+TGK
Sbjct: 189 SIDIWSCGCILAEMITGK 206

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 74.6 bits (184), Expect = 9e-15
 Identities = 60/281 (21%), Positives = 108/281 (38%), Gaps = 52/281 (18%)

Query: 361 GSVYRG--KINGGFAAIKKVNGDVSK--------EIALLNKINHSNLIILSGVCFNEGNC 410
            +VY+G  K+     A+K++  +  +        E++LL  + H+N++ L  +   E + 
Sbjct: 16  ATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSL 75

Query: 411 YLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVAT-------GLNYLHSFTNPPH 463
            LV+EY ++  L           +YLD    I    +V         GL Y H       
Sbjct: 76  TLVFEY-LDKDLK----------QYLDDCGNIINMHNVKLFLFQLLRGLAYCHR-----Q 119

Query: 464 --VHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGL 521
             +H+D+   N+L++     K+A+F +AR A+    +     + V T  Y  P+ L    
Sbjct: 120 KVLHRDLKPQNLLINERGELKLADFGLAR-AKSIPTK-TYD-NEVVTLWYRPPDILLGST 176

Query: 522 V-STKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLT-KED---GEESLRHF 576
             ST++D++  G +  EM TG+             L  +   + T  E+   G  S   F
Sbjct: 177 DYSTQIDMWGVGCIFYEMATGR--PLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEF 234

Query: 577 IDPTLQGNYPLELALLV-------IRLIDACLKKDPTDRPT 610
                       L             L+   L+ +  +R +
Sbjct: 235 KTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRIS 275

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 74.1 bits (183), Expect = 1e-14
 Identities = 49/195 (25%), Positives = 84/195 (43%), Gaps = 28/195 (14%)

Query: 361 GSVYRG--KINGGFAAIKKVN-------GDVSKEIALLNKINHSNLIILSGVCFNEGNCY 411
             V+    ++ G   A+K +          +  EIA+L KI H N++ L  +  +  + Y
Sbjct: 23  SEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYY 82

Query: 412 LVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPH--VHKDIN 469
           LV +    G L D +      G Y + K    +   V + + YLH      +  VH+D+ 
Sbjct: 83  LVMQLVSGGELFDRILE---RGVYTE-KDASLVIQQVLSAVKYLHE-----NGIVHRDLK 133

Query: 470 SSNVLLDS---DLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKL 526
             N+L  +   + +  I +F +++    Q G         GT GY+APE L     S  +
Sbjct: 134 PENLLYLTPEENSKIMITDFGLSK--MEQNGIM---STACGTPGYVAPEVLAQKPYSKAV 188

Query: 527 DVYAFGVLILEMLTG 541
           D ++ GV+   +L G
Sbjct: 189 DCWSIGVITYILLCG 203

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 73.7 bits (182), Expect = 1e-14
 Identities = 54/205 (26%), Positives = 90/205 (43%), Gaps = 45/205 (21%)

Query: 361 GSVYRGKINGG-FAAIKKVNGDVSK---------EIALLNKINHSNLIILSGVCFNEGNC 410
           G VY+ + N G   A+KK+  +            EI++L ++ HSN++ L  V   +   
Sbjct: 16  GVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRL 75

Query: 411 YLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVAT----------GLNYLHSFTN 460
            LV+E+ ++  L           K LD     +  L+  T          G+ Y H    
Sbjct: 76  VLVFEH-LDQDLK----------KLLD---VCEGGLESVTAKSFLLQLLNGIAYCHD--- 118

Query: 461 PPH--VHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLE 518
                +H+D+   N+L++ +   KIA+F +AR A G       T H + T  Y AP+ L 
Sbjct: 119 --RRVLHRDLKPQNLLINREGELKIADFGLAR-AFGIPVR-KYT-HEIVTLWYRAPDVLM 173

Query: 519 NGLV-STKLDVYAFGVLILEMLTGK 542
                ST +D+++ G +  EM+ G 
Sbjct: 174 GSKKYSTTIDIWSVGCIFAEMVNGT 198

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 76.1 bits (187), Expect = 1e-14
 Identities = 52/277 (18%), Positives = 107/277 (38%), Gaps = 48/277 (17%)

Query: 300 PDSIVVSGSFQANEKPSNKKFDEESQDFLESISGVAQSLKVYSFKELQSAT--------- 350
             +I         ++     F    ++  +++ G      + S K  +            
Sbjct: 126 KSAIEHVQGHLVKKQVPPDLFQPYIEEICQNLRGDVFQKFIESDKFTRFCQWKNVELNIH 185

Query: 351 ---DNFSFTCRI--QGS---VY--RGKINGGFAAIKKVNGDVSKE-------------IA 387
              ++FS   RI  +G    VY  R    G   A+K ++    K              ++
Sbjct: 186 LTMNDFSV-HRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLS 244

Query: 388 LLNKINHSNLIILSGVCF-NEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIAL 446
           L++  +   ++ +S   F        + +  +NG   D  +     G + +   R   A 
Sbjct: 245 LVSTGDCPFIVCMSY-AFHTPDKLSFILDL-MNG--GDLHYHLSQHGVFSEADMRFYAA- 299

Query: 447 DVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIV 506
           ++  GL ++H+      V++D+  +N+LLD     +I++  +A   +  + +       V
Sbjct: 300 EIILGLEHMHNRFV---VYRDLKPANILLDEHGHVRISDLGLAC--DFSKKK---PHASV 351

Query: 507 GTKGYMAPEYLENGLVSTK-LDVYAFGVLILEMLTGK 542
           GT GYMAPE L+ G+      D ++ G ++ ++L G 
Sbjct: 352 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGH 388

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 74.7 bits (184), Expect = 1e-14
 Identities = 65/270 (24%), Positives = 109/270 (40%), Gaps = 44/270 (16%)

Query: 361 GSVYRG--KINGGFAAIKKVN-----GDVSKEIALLNKINHSNLIILSGVCFNEGNCYLV 413
             VYR   K      A+K +        V  EI +L +++H N+I L  +        LV
Sbjct: 67  SIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLV 126

Query: 414 YEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPH--VHKDINSS 471
            E    G L D +     +G Y + +        +   + YLH      +  VH+D+   
Sbjct: 127 LELVTGGELFDRIVE---KGYYSE-RDAADAVKQILEAVAYLHE-----NGIVHRDLKPE 177

Query: 472 NVLL---DSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDV 528
           N+L      D   KIA+F +++  E Q     L + + GT GY APE L       ++D+
Sbjct: 178 NLLYATPAPDAPLKIADFGLSKIVEHQV----LMKTVCGTPGYCAPEILRGCAYGPEVDM 233

Query: 529 YAFGVLILEMLTGKEAAALHAEENNMHLSD-VLNAVLTKEDGEESLRHFIDPTLQGNYPL 587
           ++ G++   +L G E    + E  +  +   +LN              FI P     +  
Sbjct: 234 WSVGIITYILLCGFE--PFYDERGDQFMFRRILNCEYY----------FISP-----WWD 276

Query: 588 ELALLVIRLIDACLKKDPTDRPTMYEI-EH 616
           E++L    L+   +  DP  R T ++  +H
Sbjct: 277 EVSLNAKDLVRKLIVLDPKKRLTTFQALQH 306

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 74.8 bits (184), Expect = 2e-14
 Identities = 59/285 (20%), Positives = 114/285 (40%), Gaps = 49/285 (17%)

Query: 295 TRKKEPDSIVVSGSFQANEKPSNKK---------FDEESQDFLESISGVAQSLKVYS--- 342
            R ++ +  ++ G  Q N +  + +         +DE +   L     + + L+      
Sbjct: 4   VRLRQLEQFILDGPAQTNGQCFSVETLLDILICLYDECNNSPLRREKNILEYLEWAKPFT 63

Query: 343 --FKELQSATDNFSFTCRI-QGS---VY--RGKINGGFAAIKKVNGDV---SKEIA---- 387
              K+++   ++F     I +G+   V   + K      A+K +N        E A    
Sbjct: 64  SKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFRE 123

Query: 388 ---LLNKINHSNLIILSGVCF-NEGNCYLVYEYAVNGTLSDWVFS--NKNEGKYLDWKQR 441
              +L   +   +  L    F ++ N YLV +Y V G L     +  +K E +  +   R
Sbjct: 124 ERDVLVNGDSKWITTLHY-AFQDDNNLYLVMDYYVGGDL----LTLLSKFEDRLPEEMAR 178

Query: 442 IQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFAL 501
             +A ++   ++ +H      +VH+DI   N+L+D +   ++A+F      +  E     
Sbjct: 179 FYLA-EMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSC--LKLMEDGTVQ 232

Query: 502 TRHIVGTKGYMAPEYLENGLVSTKL-----DVYAFGVLILEMLTG 541
           +   VGT  Y++PE L+             D ++ GV + EML G
Sbjct: 233 SSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYG 277

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 74.3 bits (183), Expect = 2e-14
 Identities = 61/289 (21%), Positives = 117/289 (40%), Gaps = 60/289 (20%)

Query: 361 GSVYRGKIN-GGFAAIKKVNGDV---SKEIALLNKINHSNLIIL------SGVCFNEGNC 410
           G V++ K+      AIKKV  D    ++E+ ++  + H N++ L      +G   +E   
Sbjct: 54  GVVFQAKLVESDEVAIKKVLQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFL 113

Query: 411 YLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVAT----------GLNYLHSFTN 460
            LV EY V  T+           +      +++  + +             L Y+HS   
Sbjct: 114 NLVLEY-VPETVY----------RASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHS--- 159

Query: 461 PPH--VHKDINSSNVLLDSDLRA-KIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYL 517
                 H+DI   N+LLD      K+ +F  A+     E       +I  ++ Y APE +
Sbjct: 160 --IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGE---PNVSYIC-SRYYRAPELI 213

Query: 518 ENGLV-STKLDVYAFGVLILEMLTGKEAAALHAEENNMH-LSDVLNAVL---TKEDGEES 572
                 +T +D+++ G ++ E++ G+    L   E+ +  L +++  VL   ++E  +  
Sbjct: 214 FGATNYTTNIDIWSTGCVMAELMQGQ---PLFPGESGIDQLVEIIK-VLGTPSREQIKTM 269

Query: 573 LRHFIDPTLQGNYPLELALLV--------IRLIDACLKKDPTDRPTMYE 613
             ++++       P   + +         I LI   L+  P+ R T  E
Sbjct: 270 NPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIE 318

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 74.0 bits (182), Expect = 3e-14
 Identities = 61/294 (20%), Positives = 110/294 (37%), Gaps = 79/294 (26%)

Query: 374 AIKKV-----NGDVSK----EIALLNKINHSNLIILSGV--------CFNEGNCYLVYEY 416
           AIKK+     N   +K    E+ L+  +NH N+I L  V         F +   Y+V E 
Sbjct: 54  AIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQD--VYIVMEL 111

Query: 417 -------AVNGTLSDWVFSNKNEGKYLDWKQRIQIAL-DVATGLNYLHSFTNPPHV-HKD 467
                   +   L                 +R+   L  +  G+ +LHS      + H+D
Sbjct: 112 MDANLCQVIQMELDH---------------ERMSYLLYQMLCGIKHLHS----AGIIHRD 152

Query: 468 INSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLD 527
           +  SN+++ SD   KI +F +AR A      F +T + V T+ Y APE +        +D
Sbjct: 153 LKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPY-VVTRYYRAPEVILGMGYKENVD 208

Query: 528 VYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGE------ESLRHFI---- 577
           +++ G ++ EM+ G     L    +++   + +   L     E       ++R ++    
Sbjct: 209 IWSVGCIMGEMIKGG---VLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRP 265

Query: 578 --------------DPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYE-IEH 616
                                +    A     L+   L  D + R ++ E ++H
Sbjct: 266 KYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 319

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 73.5 bits (181), Expect = 3e-14
 Identities = 48/192 (25%), Positives = 78/192 (40%), Gaps = 30/192 (15%)

Query: 361 GSVYRG--KINGGFAAIKKVN---------GDVSKEIALLNKINHSNLIILSGVCFNEGN 409
             V R   K  G   A K +N           + +E  +  K+ H N++ L      E  
Sbjct: 43  SVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESF 102

Query: 410 CYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPH--VHKD 467
            YLV++    G L + + +      Y +          +   + Y HS     +  VH++
Sbjct: 103 HYLVFDLVTGGELFEDIVA---REFYSE-ADASHCIQQILESIAYCHS-----NGIVHRN 153

Query: 468 INSSNVLLDS---DLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVST 524
           +   N+LL S       K+A+F +A   E  + E        GT GY++PE L+    S 
Sbjct: 154 LKPENLLLASKAKGAAVKLADFGLAI--EVNDSEAWHG--FAGTPGYLSPEVLKKDPYSK 209

Query: 525 KLDVYAFGVLIL 536
            +D++A GV IL
Sbjct: 210 PVDIWACGV-IL 220

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 73.4 bits (180), Expect = 3e-14
 Identities = 42/207 (20%), Positives = 80/207 (38%), Gaps = 46/207 (22%)

Query: 431 NEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMAR 490
               +L  +  I  +  VA G+ +L S      +H+D+ + N+LL      KI +F +AR
Sbjct: 185 LYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLAR 241

Query: 491 PAEGQEGEFALTRHIVGTKG-----YMAPEYLENGLVSTKLDVYAFGVLILEMLT----- 540
                        ++          +MAPE + + + + + DV++FGVL+ E+ +     
Sbjct: 242 DIYKDP------DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 295

Query: 541 --GKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLID 598
             G +              +    +   ++G         P        E+     + + 
Sbjct: 296 YPGVKID-----------EEFCRRL---KEGTRMRA----PD---YTTPEMY----QTML 330

Query: 599 ACLKKDPTDRPTMYEIEHSLSNILNAS 625
            C   +P+ RPT  E+   L N+L A+
Sbjct: 331 DCWHGEPSQRPTFSELVEHLGNLLQAN 357

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 72.7 bits (179), Expect = 4e-14
 Identities = 41/193 (21%), Positives = 78/193 (40%), Gaps = 24/193 (12%)

Query: 361 GSVYRG--KINGGFAAIKKVN----GDVSKEIALLNKI-NHSNLIILSGVCFNEGNCYLV 413
               +   K +    A+K ++     +  KEI  L     H N++ L  V  ++ + +LV
Sbjct: 25  SICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLV 84

Query: 414 YEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPH--VHKDINSS 471
            E    G L + +     +  + +  +   I   + + ++++H         VH+D+   
Sbjct: 85  MELLNGGELFERIKK---KKHFSE-TEASYIMRKLVSAVSHMHD-----VGVVHRDLKPE 135

Query: 472 NVLL---DSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDV 528
           N+L    + +L  KI +F  AR            +    T  Y APE L         D+
Sbjct: 136 NLLFTDENDNLEIKIIDFGFARLKPPDNQPL---KTPCFTLHYAAPELLNQNGYDESCDL 192

Query: 529 YAFGVLILEMLTG 541
           ++ GV++  ML+G
Sbjct: 193 WSLGVILYTMLSG 205

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 72.4 bits (178), Expect = 7e-14
 Identities = 61/276 (22%), Positives = 98/276 (35%), Gaps = 54/276 (19%)

Query: 361 GSVY--RGKINGGFAAIK------KVNGDVSKEIALLNKINHSNLIILSGVCFNEGNCYL 412
           G     R K+     A+K       ++ +V +EI     + H N++    V     +  +
Sbjct: 34  GVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 93

Query: 413 VYEYAVNGTLSDWVFSNK----NEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDI 468
           + EYA  G L + + +      +E ++       Q+     +G++Y HS       H+D+
Sbjct: 94  IMEYASGGELYERICNAGRFSEDEARFFFQ----QL----LSGVSYCHSMQ---ICHRDL 142

Query: 469 NSSNVLLDSD--LRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLEN-GLVSTK 525
              N LLD     R KI +F  +            +   VGT  Y+APE L         
Sbjct: 143 KLENTLLDGSPAPRLKICDFGYS--KSSVLHSQPKST--VGTPAYIAPEVLLRQEYDGKI 198

Query: 526 LDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNY 585
            DV++ GV +  ML G    A   E+                      R  I   L   Y
Sbjct: 199 ADVWSCGVTLYVMLVG----AYPFEDPEE---------------PRDYRKTIQRILSVKY 239

Query: 586 PL----ELALLVIRLIDACLKKDPTDRPTMYEI-EH 616
            +     ++     LI      DP  R ++ EI  H
Sbjct: 240 SIPDDIRISPECCHLISRIFVADPATRISIPEIKTH 275

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 72.2 bits (178), Expect = 7e-14
 Identities = 53/215 (24%), Positives = 89/215 (41%), Gaps = 61/215 (28%)

Query: 361 GSVYRG--KINGGFAAIKKV---NGDVSK---------EIALLNKINHSNLIILSGVCFN 406
            +VY+   K      AIKK+   +   +K         EI LL +++H N+I L     +
Sbjct: 24  ATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGH 83

Query: 407 EGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVAT----------GLNYLH 456
           + N  LV+++ +   L             +       + L  +           GL YLH
Sbjct: 84  KSNISLVFDF-METDLE----------VIIK---DNSLVLTPSHIKAYMLMTLQGLEYLH 129

Query: 457 SFTNPPH--VHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAP 514
                 H  +H+D+  +N+LLD +   K+A+F +A+ + G     A T H V T+ Y AP
Sbjct: 130 Q-----HWILHRDLKPNNLLLDENGVLKLADFGLAK-SFGSPNR-AYT-HQVVTRWYRAP 181

Query: 515 E-------YLENGLVSTKLDVYAFGVLILEMLTGK 542
           E       Y         +D++A G ++ E+L   
Sbjct: 182 ELLFGARMY------GVGVDMWAVGCILAELLLRV 210

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 73.1 bits (179), Expect = 1e-13
 Identities = 53/206 (25%), Positives = 90/206 (43%), Gaps = 32/206 (15%)

Query: 404 CF-NEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPP 462
           CF      Y V EY VNG   D ++  +  G++ +       A ++A GL +L S     
Sbjct: 410 CFQTMDRLYFVMEY-VNG--GDLMYHIQQVGRFKEPHAVFYAA-EIAIGLFFLQSKGI-- 463

Query: 463 HVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLV 522
            +++D+   NV+LDS+   KIA+F M +  E        T+   GT  Y+APE +     
Sbjct: 464 -IYRDLKLDNVMLDSEGHIKIADFGMCK--ENIWDG-VTTKTFCGTPDYIAPEIIAYQPY 519

Query: 523 STKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQ 582
              +D +AFGVL+ EML G+  A    E+ +    ++  +++        +         
Sbjct: 520 GKSVDWWAFGVLLYEMLAGQ--APFEGEDED----ELFQSIMEHN-----VA-------- 560

Query: 583 GNYPLELALLVIRLIDACLKKDPTDR 608
             YP  ++   + +    + K P  R
Sbjct: 561 --YPKSMSKEAVAICKGLMTKHPGKR 584

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 72.0 bits (177), Expect = 1e-13
 Identities = 71/293 (24%), Positives = 121/293 (41%), Gaps = 60/293 (20%)

Query: 361 GSVYRGKI--NGGFAAIKKVNGDV---SKEIALLNKINHSNLIIL------SGVCFNEGN 409
           G VY+ K+  +G   AIKKV  D    ++E+ ++ K++H N++ L      SG   +E  
Sbjct: 68  GVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 127

Query: 410 CYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVAT----------GLNYLHSFT 459
             LV +Y V  T+           +      R +  L V             L Y+HSF 
Sbjct: 128 LNLVLDY-VPETVY----------RVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF- 175

Query: 460 NPPHV-HKDINSSNVLLDSDLRA-KIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYL 517
               + H+DI   N+LLD D    K+ +F  A+      GE     +I  ++ Y APE +
Sbjct: 176 ---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEP-NVSYIC-SRYYRAPELI 228

Query: 518 ENGLV-STKLDVYAFGVLILEMLTGKEAAALHAEENNMH-LSDVLNAVL---TKEDGEES 572
                 ++ +DV++ G ++ E+L G+    +   ++ +  L +++  VL   T+E   E 
Sbjct: 229 FGATDYTSSIDVWSAGCVLAELLLGQ---PIFPGDSGVDQLVEIIK-VLGTPTREQIREM 284

Query: 573 LRHFIDPTLQGNYPLELALLV--------IRLIDACLKKDPTDRPTMYEI-EH 616
             ++ +             +         I L    L+  PT R T  E   H
Sbjct: 285 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 337

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 71.5 bits (176), Expect = 1e-13
 Identities = 57/211 (27%), Positives = 95/211 (45%), Gaps = 33/211 (15%)

Query: 404 CF-NEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPP 462
           CF  E   + V EY VNG   D +F  + + K  +   R   A +++  LNYLH      
Sbjct: 78  CFQTESRLFFVIEY-VNG--GDLMFHMQRQRKLPEEHARFYSA-EISLALNYLHERGI-- 131

Query: 463 HVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLV 522
            +++D+   NVLLDS+   K+ ++ M +  EG       T    GT  Y+APE L     
Sbjct: 132 -IYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPG-DTTSTFCGTPNYIAPEILRGEDY 187

Query: 523 STKLDVYAFGVLILEMLTGK-----EAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFI 577
              +D +A GVL+ EM+ G+       ++ + ++N      +   +L K+     +R   
Sbjct: 188 GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTE--DYLFQVILEKQ-----IR--- 237

Query: 578 DPTLQGNYPLELALLVIRLIDACLKKDPTDR 608
                   P  L++    ++ + L KDP +R
Sbjct: 238 -------IPRSLSVKAASVLKSFLNKDPKER 261

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 71.1 bits (175), Expect = 2e-13
 Identities = 55/215 (25%), Positives = 89/215 (41%), Gaps = 56/215 (26%)

Query: 361 GSVYRG---KINGGFAAIKKVNGDVSK---------EIALL---NKINHSNLIILSGVC- 404
           G V++    K  G F A+K+V     +         E+A+L       H N++ L  VC 
Sbjct: 25  GKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCT 84

Query: 405 ----FNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVA--------TGL 452
                 E    LV+E+ V+  L+           YLD      +  +           GL
Sbjct: 85  VSRTDRETKLTLVFEH-VDQDLT----------TYLDKVPEPGVPTETIKDMMFQLLRGL 133

Query: 453 NYLHSFTNPPH--VHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTR---HIVG 507
           ++LHS     H  VH+D+   N+L+ S  + K+A+F +AR        ++       +V 
Sbjct: 134 DFLHS-----HRVVHRDLKPQNILVTSSGQIKLADFGLARI-------YSFQMALTSVVV 181

Query: 508 TKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGK 542
           T  Y APE L     +T +D+++ G +  EM   K
Sbjct: 182 TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 71.9 bits (177), Expect = 2e-13
 Identities = 42/192 (21%), Positives = 76/192 (39%), Gaps = 29/192 (15%)

Query: 361 GSVYRG--KINGGFAAIKKVN---------GDVSKEIALLNKINHSNLIILSGVCFNEGN 409
             V R    + G   A   +N           + +E  +   + H N++ L      EG+
Sbjct: 25  SVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGH 84

Query: 410 CYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPH--VHKD 467
            YL+++    G L + + +      Y +          +   + + H         VH++
Sbjct: 85  HYLIFDLVTGGELFEDIVA---REYYSE-ADASHCIQQILEAVLHCHQ-----MGVVHRN 135

Query: 468 INSSNVLLDS---DLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVST 524
           +   N+LL S       K+A+F +A   EG++  +       GT GY++PE L       
Sbjct: 136 LKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAW---FGFAGTPGYLSPEVLRKDPYGK 192

Query: 525 KLDVYAFGVLIL 536
            +D++A GV IL
Sbjct: 193 PVDLWACGV-IL 203

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 71.7 bits (176), Expect = 2e-13
 Identities = 50/248 (20%), Positives = 92/248 (37%), Gaps = 37/248 (14%)

Query: 320 FDEESQDFLESISGVAQSLKVYS-----FKELQSATDNFSFTCRI-QGS---VY--RGKI 368
             +     L     +   L  Y       ++L+   +++     I +G+   V   R K 
Sbjct: 33  VYDLDFPALRKNKNIDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKS 92

Query: 369 NGGFAAIKKVNGDV---SKEIA-------LLNKINHSNLIILSGVCF-NEGNCYLVYEYA 417
                A+K ++        + A       ++   N   ++ L    F ++   Y+V EY 
Sbjct: 93  TRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFY-AFQDDRYLYMVMEYM 151

Query: 418 VNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDS 477
             G L     +  +     +   R   A +V   L+ +HS      +H+D+   N+LLD 
Sbjct: 152 PGGDL----VNLMSNYDVPEKWARFYTA-EVVLALDAIHSMG---FIHRDVKPDNMLLDK 203

Query: 478 DLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTK----LDVYAFGV 533
               K+A+F      +  +         VGT  Y++PE L++           D ++ GV
Sbjct: 204 SGHLKLADFGTC--MKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGV 261

Query: 534 LILEMLTG 541
            + EML G
Sbjct: 262 FLYEMLVG 269

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 69.9 bits (172), Expect = 3e-13
 Identities = 54/217 (24%), Positives = 86/217 (39%), Gaps = 58/217 (26%)

Query: 361 GSVYRG--KINGGFAAIKKVNGDVSK------------EIALL---NKINHSNLIILSGV 403
           G+VY+     +G F A+K V                  E+ALL       H N++ L  V
Sbjct: 23  GTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDV 82

Query: 404 C-----FNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVA--------T 450
           C       E    LV+E+ V+  L            YLD      +  +           
Sbjct: 83  CATSRTDREIKVTLVFEH-VDQDLR----------TYLDKAPPPGLPAETIKDLMRQFLR 131

Query: 451 GLNYLHSFTNPPH--VHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTR---HI 505
           GL++LH+     +  VH+D+   N+L+ S    K+A+F +AR        ++       +
Sbjct: 132 GLDFLHA-----NCIVHRDLKPENILVTSGGTVKLADFGLAR-------IYSYQMALTPV 179

Query: 506 VGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGK 542
           V T  Y APE L     +T +D+++ G +  EM   K
Sbjct: 180 VVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 70.8 bits (174), Expect = 3e-13
 Identities = 57/211 (27%), Positives = 95/211 (45%), Gaps = 33/211 (15%)

Query: 404 CF-NEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPP 462
           CF  E   + V EY VNG   D +F  + + K  +   R   A +++  LNYLH      
Sbjct: 121 CFQTESRLFFVIEY-VNG--GDLMFHMQRQRKLPEEHARFYSA-EISLALNYLHERGI-- 174

Query: 463 HVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLV 522
            +++D+   NVLLDS+   K+ ++ M +  EG       T    GT  Y+APE L     
Sbjct: 175 -IYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPG-DTTSTFCGTPNYIAPEILRGEDY 230

Query: 523 STKLDVYAFGVLILEMLTGK-----EAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFI 577
              +D +A GVL+ EM+ G+       ++ + ++N      +   +L K+     +R   
Sbjct: 231 GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTE--DYLFQVILEKQ-----IR--- 280

Query: 578 DPTLQGNYPLELALLVIRLIDACLKKDPTDR 608
                   P  L++    ++ + L KDP +R
Sbjct: 281 -------IPRSLSVKAASVLKSFLNKDPKER 304

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 70.5 bits (173), Expect = 4e-13
 Identities = 58/251 (23%), Positives = 97/251 (38%), Gaps = 40/251 (15%)

Query: 316 SNKKFDEESQDFLESISGVAQSLKVYSFKELQSATDNFSFTCRI-QGS---VY--RGKIN 369
           S    D+   DFL+    +   LK     E++   D+F     I +G+   V   + K  
Sbjct: 31  SELAQDKYVADFLQWAEPIVVRLK-----EVRLQRDDFEILKVIGRGAFSEVAVVKMKQT 85

Query: 370 GGFAAIKKVNGDV---SKEIA-------LLNKINHSNLIILSGVCF-NEGNCYLVYEYAV 418
           G   A+K +N        E++       +L   +   +  L    F +E   YLV EY  
Sbjct: 86  GQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHF-AFQDENYLYLVMEY-Y 143

Query: 419 NGTLSDWVFSNKNEGKYLDWKQ-RIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDS 477
            G   D +      G+ +  +  R  +A ++   ++ +H      +VH+DI   N+LLD 
Sbjct: 144 VG--GDLLTLLSKFGERIPAEMARFYLA-EIVMAIDSVHRLG---YVHRDIKPDNILLDR 197

Query: 478 DLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVY-------A 530
               ++A+F      + +      +   VGT  Y++PE L+          Y       A
Sbjct: 198 CGHIRLADFGSC--LKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWA 255

Query: 531 FGVLILEMLTG 541
            GV   EM  G
Sbjct: 256 LGVFAYEMFYG 266

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 70.6 bits (173), Expect = 5e-13
 Identities = 61/293 (20%), Positives = 107/293 (36%), Gaps = 77/293 (26%)

Query: 374 AIKKVNGDVSK---------EIALLNKINHSNLIILSGV--------CFNEGNCYLVYEY 416
           AIKK++              E+ L+  +NH N+I L  V         F +   YLV E 
Sbjct: 91  AIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD--VYLVMEL 148

Query: 417 A-------VNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHV-HKDI 468
                   +   L            YL      Q+      G+ +LHS      + H+D+
Sbjct: 149 MDANLCQVIQMELDH------ERMSYL----LYQMLC----GIKHLHS----AGIIHRDL 190

Query: 469 NSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDV 528
             SN+++ SD   KI +F +AR A      F +T + V T+ Y APE +        +D+
Sbjct: 191 KPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPY-VVTRYYRAPEVILGMGYKENVDI 246

Query: 529 YAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGE------ESLRHFI----- 577
           ++ G ++ EM+  K    L    + +   + +   L     E       ++R+++     
Sbjct: 247 WSVGCIMGEMVRHK---ILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPK 303

Query: 578 -------------DPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYE-IEH 616
                               +    A     L+   L  DP  R ++ + ++H
Sbjct: 304 YAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 68.9 bits (169), Expect = 1e-12
 Identities = 49/194 (25%), Positives = 86/194 (44%), Gaps = 27/194 (13%)

Query: 361 GSVY--RGKINGGFAAIKKVNGDV---SKEIA-------LLNKINHSNLIILSGVCFNEG 408
           G V   + K +G   A+K ++       K+I        +L  +N   L+ L     +  
Sbjct: 55  GRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNS 114

Query: 409 NCYLVYEYAVNGTLSDWVFSN-KNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKD 467
           N Y+V EY   G +    FS+ +  G++ +   R   A  +     YLHS      +++D
Sbjct: 115 NLYMVMEYVAGGEM----FSHLRRIGRFSEPHARFYAA-QIVLTFEYLHSLD---LIYRD 166

Query: 468 INSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLD 527
           +   N+L+D     ++ +F  A+  +G+      T  + GT   +APE + +   +  +D
Sbjct: 167 LKPENLLIDQQGYIQVTDFGFAKRVKGR------TWTLCGTPEALAPEIILSKGYNKAVD 220

Query: 528 VYAFGVLILEMLTG 541
            +A GVLI EM  G
Sbjct: 221 WWALGVLIYEMAAG 234

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 68.9 bits (169), Expect = 1e-12
 Identities = 64/283 (22%), Positives = 112/283 (39%), Gaps = 69/283 (24%)

Query: 374 AIKKV-----NGDVSK----EIALLNKINHSNLIILSGV--------CFNEGNCYLVYEY 416
           AIKK+     +   +K    E+ LL  + H N+I L  V         F +   YLV  +
Sbjct: 53  AIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD--FYLVMPF 110

Query: 417 -------AVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDIN 469
                   +    S+         +YL +    Q+      GL Y+HS      VH+D+ 
Sbjct: 111 MQTDLQKIMGLKFSEEKI------QYLVY----QMLK----GLKYIHS-AGV--VHRDLK 153

Query: 470 SSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPE-YLENGLVSTKLDV 528
             N+ ++ D   KI +F +AR A+ +   + +TR       Y APE  L     +  +D+
Sbjct: 154 PGNLAVNEDCELKILDFGLARHADAEMTGYVVTRW------YRAPEVILSWMHYNQTVDI 207

Query: 529 YAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVL---TKED----GEESLRHFIDPTL 581
           ++ G ++ EMLTGK    L   ++ +     +  V      E      +++ + +I  +L
Sbjct: 208 WSVGCIMAEMLTGK---TLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQ-SL 263

Query: 582 QGNYPLELALLV-------IRLIDACLKKDPTDRPTMYE-IEH 616
                 +   L          L++  L+ D   R T  + + H
Sbjct: 264 PQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 67.8 bits (166), Expect = 1e-12
 Identities = 26/220 (11%), Positives = 59/220 (26%), Gaps = 55/220 (25%)

Query: 391 KINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVAT 450
           +I+   +  +  V        +V E+   G+L +       +         I+    +A 
Sbjct: 87  RIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVA-----DTS-PSPVGAIRAMQSLAA 140

Query: 451 GLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKG 510
             +  H            + S V +  D    +A  A    A  Q+              
Sbjct: 141 AADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPATMPDANPQD-------------- 183

Query: 511 YMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGE 570
                           D+   G  +  +L  +         + +       A   ++   
Sbjct: 184 ----------------DIRGIGASLYALLVNRWPLPEAGVRSGL-------APAERDTAG 220

Query: 571 ESLR-HFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRP 609
           + +    ID  +    P +++ +  R     ++ D   R 
Sbjct: 221 QPIEPADIDRDI----PFQISAVAAR----SVQGDGGIRS 252

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 68.4 bits (168), Expect = 1e-12
 Identities = 58/206 (28%), Positives = 92/206 (44%), Gaps = 32/206 (15%)

Query: 404 CF-NEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPP 462
           CF      + V E+ VNG   D +F  +   ++ + + R   A ++ + L +LH      
Sbjct: 92  CFQTPDRLFFVMEF-VNG--GDLMFHIQKSRRFDEARARFYAA-EIISALMFLHDKGI-- 145

Query: 463 HVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLV 522
            +++D+   NVLLD +   K+A+F M +  EG       T    GT  Y+APE L+  L 
Sbjct: 146 -IYRDLKLDNVLLDHEGHCKLADFGMCK--EGICNG-VTTATFCGTPDYIAPEILQEMLY 201

Query: 523 STKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQ 582
              +D +A GVL+ EML G   A   AE  +    D+  A+L  E     +         
Sbjct: 202 GPAVDWWAMGVLLYEMLCGH--APFEAENED----DLFEAILNDE-----VV-------- 242

Query: 583 GNYPLELALLVIRLIDACLKKDPTDR 608
             YP  L      ++ + + K+PT R
Sbjct: 243 --YPTWLHEDATGILKSFMTKNPTMR 266

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 68.0 bits (167), Expect = 1e-12
 Identities = 58/221 (26%), Positives = 92/221 (41%), Gaps = 33/221 (14%)

Query: 389 LNKINHSNLIILSGVCF-NEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALD 447
           L    H  L  L    F        V EY  NG   +  F    E  + + + R   A +
Sbjct: 59  LQNTRHPFLTALKY-AFQTHDRLCFVMEY-ANG--GELFFHLSRERVFTEERARFYGA-E 113

Query: 448 VATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVG 507
           + + L YLHS      V++DI   N++LD D   KI +F + +  EG     A  +   G
Sbjct: 114 IVSALEYLHSRDV---VYRDIKLENLMLDKDGHIKITDFGLCK--EGISDG-ATMKTFCG 167

Query: 508 TKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKE 567
           T  Y+APE LE+      +D +  GV++ EM+ G+     + +++      +   +L +E
Sbjct: 168 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFYNQDHE----RLFELILMEE 221

Query: 568 DGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDR 608
                +R          +P  L+     L+   LKKDP  R
Sbjct: 222 -----IR----------FPRTLSPEAKSLLAGLLKKDPKQR 247

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 68.3 bits (167), Expect = 2e-12
 Identities = 54/218 (24%), Positives = 92/218 (42%), Gaps = 55/218 (25%)

Query: 361 GSVYRGK----INGGFAAIKKVNGDVS-----KEIALLNKINHSNLIILSGVCFNEGNC- 410
           G VY+ K     +    A+K++ G        +EIALL ++ H N+I L  V  +  +  
Sbjct: 35  GHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHADRK 94

Query: 411 -YLVYEYA------------VNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHS 457
            +L+++YA             +      V   +   K L +    QI LD   G++YLH+
Sbjct: 95  VWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLY----QI-LD---GIHYLHA 146

Query: 458 FTNPPH--VHKDINSSNVLLDSDLRA----KIANFAMARPAEGQEGEFALTRHIVGTKGY 511
                +  +H+D+  +N+L+  +       KIA+   AR         A    +V T  Y
Sbjct: 147 -----NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWY 201

Query: 512 MAPE-------YLENGLVSTKLDVYAFGVLILEMLTGK 542
            APE       Y      +  +D++A G +  E+LT +
Sbjct: 202 RAPELLLGARHY------TKAIDIWAIGCIFAELLTSE 233

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 67.7 bits (166), Expect = 2e-12
 Identities = 64/297 (21%), Positives = 104/297 (35%), Gaps = 83/297 (27%)

Query: 374 AIKKVNGDVSK------------------EIALLNKINHSNLIILSGV-------CFNEG 408
           AIK+V   VS                   EI LLN  +H N++ L  +         ++ 
Sbjct: 50  AIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHK- 108

Query: 409 NCYLVYEY----------AVNGTLSDWVFSNKNEGKYLDWKQRI--QIALDVATGLNYLH 456
             YLV E                +S                Q     I L    GL+ LH
Sbjct: 109 -LYLVTELMRTDLAQVIHDQRIVISP------------QHIQYFMYHILL----GLHVLH 151

Query: 457 SFTNPPHV-HKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPE 515
                  V H+D++  N+LL  +    I +F +AR       +   T + V  + Y APE
Sbjct: 152 E----AGVVHRDLHPGNILLADNNDITICDFNLAR---EDTADANKTHY-VTHRWYRAPE 203

Query: 516 YLENGLVSTK-LDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVL---TKED--- 568
            +      TK +D+++ G ++ EM   K   AL       +  + +  V+     ED   
Sbjct: 204 LVMQFKGFTKLVDMWSAGCVMAEMFNRK---ALFRGSTFYNQLNKIVEVVGTPKIEDVVM 260

Query: 569 -GEESLRHFIDPTLQGNYPLELALLV-------IRLIDACLKKDPTDRPTMYE-IEH 616
               S R ++  +L          +V       + LI   L+ +P  R +  + + H
Sbjct: 261 FSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 66.5 bits (163), Expect = 4e-12
 Identities = 60/292 (20%), Positives = 103/292 (35%), Gaps = 70/292 (23%)

Query: 361 GSVYRG--KINGGFAAIKKVNGDVSK----EIALL-NKINHSNLIILSGVC--FNEGNCY 411
             V+      N     +K +     K    EI +L N     N+I L+ +          
Sbjct: 50  SEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPA 109

Query: 412 LVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALD---------VATGLNYLHSFTNPP 462
           LV+E+ VN T               D+KQ  Q   D         +   L+Y HS     
Sbjct: 110 LVFEH-VNNT---------------DFKQLYQTLTDYDIRFYMYEILKALDYCHS----- 148

Query: 463 H--VHKDINSSNVLLDSDLRA-KIANFAMARPA-EGQEGEFALTRHIVGTKGYMAPEYLE 518
              +H+D+   NV++D + R  ++ ++ +A     GQE         V ++ +  PE L 
Sbjct: 149 MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE----YN-VRVASRYFKGPELLV 203

Query: 519 NGLV-STKLDVYAFGVLILEMLTGKEAAALHAEENNMH-LSDVLNAVLTKED-------G 569
           +  +    LD+++ G ++  M+  KE        +N   L  +   + T++         
Sbjct: 204 DYQMYDYSLDMWSLGCMLASMIFRKE--PFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN 261

Query: 570 EESLRHFID-------PTLQGNYPLELALLV----IRLIDACLKKDPTDRPT 610
            E    F D          +     E   LV    +  +D  L+ D   R T
Sbjct: 262 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLT 313

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 67.0 bits (164), Expect = 5e-12
 Identities = 65/296 (21%), Positives = 117/296 (39%), Gaps = 59/296 (19%)

Query: 356 TCRIQGSVYRGKINGGFAAIKKVNGDVSK---------EIALLNKINHSNLIILSGV--- 403
                 + +     G   A+KK++              E+ LL  + H N+I L  V   
Sbjct: 41  AYGSVCAAF-DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP 99

Query: 404 -----CFNEGNCYLVYEYAVNGT-LSDWVFSNKNEGKYLDWKQRIQ-IALDVATGLNYLH 456
                 FN+   YLV      G  L++ V   K     L     +Q +   +  GL Y+H
Sbjct: 100 ARSLEEFND--VYLVTHLM--GADLNNIVKCQK-----LT-DDHVQFLIYQILRGLKYIH 149

Query: 457 SFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPE- 515
           S  +   +H+D+  SN+ ++ D   KI +F +AR    +   +  TR       Y APE 
Sbjct: 150 S-ADI--IHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATRW------YRAPEI 200

Query: 516 YLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVL---TKED---- 568
            L     +  +D+++ G ++ E+LTG+    L    +++    ++  ++     E     
Sbjct: 201 MLNWMHYNQTVDIWSVGCIMAELLTGR---TLFPGTDHIDQLKLILRLVGTPGAELLKKI 257

Query: 569 GEESLRHFIDPTLQGNYPLELALLV-------IRLIDACLKKDPTDRPTMYE-IEH 616
             ES R++I  +L     +  A +        + L++  L  D   R T  + + H
Sbjct: 258 SSESARNYIQ-SLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 66.6 bits (163), Expect = 5e-12
 Identities = 51/280 (18%), Positives = 99/280 (35%), Gaps = 58/280 (20%)

Query: 361 GSVYRG--KINGGFAAIKKVN--GDVSKEIALLNKI-NHSNLIILSGVCFNEGNC----Y 411
           G V     +  G   A+K +       +E+    +     +++ +  V  N  +      
Sbjct: 43  GKVLECFHRRTGQKCALKLLYDSPKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLL 102

Query: 412 LVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPH--VHKDIN 469
           ++ E    G L   +   + +  + + ++  +I  D+ T + +LHS     H   H+D+ 
Sbjct: 103 IIMECMEGGELFSRIQE-RGDQAFTE-REAAEIMRDIGTAIQFLHS-----HNIAHRDVK 155

Query: 470 SSNVLL---DSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKL 526
             N+L    + D   K+ +F  A+     +      +    T  Y+APE L         
Sbjct: 156 PENLLYTSKEKDAVLKLTDFGFAKETT--QNAL---QTPCYTPYYVAPEVLGPEKYDKSC 210

Query: 527 DVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYP 586
           D+++ GV++  +L G      ++         +   +                   G Y 
Sbjct: 211 DMWSLGVIMYILLCGF--PPFYSNTGQAISPGMKRRI-----------------RLGQYG 251

Query: 587 L---------ELALLVIRLIDACLKKDPTDRPTMYEI-EH 616
                     E A    +LI   LK DPT+R T+ +   H
Sbjct: 252 FPNPEWSEVSEDAK---QLIRLLLKTDPTERLTITQFMNH 288

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 66.0 bits (162), Expect = 7e-12
 Identities = 50/195 (25%), Positives = 91/195 (46%), Gaps = 29/195 (14%)

Query: 361 GSVY--RGKINGGFAAIKKVNGDV---SKEIA-------LLNKINHSNLIILSGVCF-NE 407
           G V+  R + NG + A+K +  ++    K++        +L+ + H  +I + G  F + 
Sbjct: 20  GRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWG-TFQDA 78

Query: 408 GNCYLVYEYAVNGTLSDWVFSN-KNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHK 466
              +++ +Y   G L    FS  +   ++ +   +   A +V   L YLHS      +++
Sbjct: 79  QQIFMIMDYIEGGEL----FSLLRKSQRFPNPVAKFYAA-EVCLALEYLHSKD---IIYR 130

Query: 467 DINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKL 526
           D+   N+LLD +   KI +F  A+           T  + GT  Y+APE +     +  +
Sbjct: 131 DLKPENILLDKNGHIKITDFGFAKYVPDV------TYTLCGTPDYIAPEVVSTKPYNKSI 184

Query: 527 DVYAFGVLILEMLTG 541
           D ++FG+LI EML G
Sbjct: 185 DWWSFGILIYEMLAG 199

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 66.2 bits (162), Expect = 7e-12
 Identities = 61/287 (21%), Positives = 112/287 (39%), Gaps = 76/287 (26%)

Query: 374 AIKKV-----NGDVSK----EIALLNKINHSNLIILSGV--------CFNEGNCYLVYEY 416
           AIKK+     +   +K    E+ LL  + H N+I L  V         F +   YLV  +
Sbjct: 54  AIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTD--FYLVMPF 111

Query: 417 ------AV--NGTLSDWVFSNKNEGKYLDWKQRI--QIALDVATGLNYLHSFTNPPHV-H 465
                  +  +  L +            D  Q +  Q+      GL Y+H+      + H
Sbjct: 112 MGTDLGKLMKHEKLGE------------DRIQFLVYQMLK----GLRYIHA----AGIIH 151

Query: 466 KDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEY-LENGLVST 524
           +D+   N+ ++ D   KI +F +AR A+ +   + +TR       Y APE  L     + 
Sbjct: 152 RDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRW------YRAPEVILNWMRYTQ 205

Query: 525 KLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVL---TKED----GEESLRHFI 577
            +D+++ G ++ EM+TGK    L    +++     +  V      E       +  ++++
Sbjct: 206 TVDIWSVGCIMAEMITGK---TLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYM 262

Query: 578 DPTLQGNYPLELALLV-------IRLIDACLKKDPTDRPTMYE-IEH 616
              L      + A ++       + L++  L  D   R T  E + H
Sbjct: 263 K-GLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 308

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 66.1 bits (162), Expect = 8e-12
 Identities = 53/206 (25%), Positives = 90/206 (43%), Gaps = 32/206 (15%)

Query: 404 CF-NEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPP 462
           CF      Y V EY VNG   D ++  +  G++ +       A ++A GL +L S     
Sbjct: 89  CFQTMDRLYFVMEY-VNG--GDLMYHIQQVGRFKEPHAVFYAA-EIAIGLFFLQSKGI-- 142

Query: 463 HVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLV 522
            +++D+   NV+LDS+   KIA+F M +  E        T+   GT  Y+APE +     
Sbjct: 143 -IYRDLKLDNVMLDSEGHIKIADFGMCK--ENIWDG-VTTKTFCGTPDYIAPEIIAYQPY 198

Query: 523 STKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQ 582
              +D +AFGVL+ EML G+  A    E+ +    ++  +++        +         
Sbjct: 199 GKSVDWWAFGVLLYEMLAGQ--APFEGEDED----ELFQSIMEHN-----VA-------- 239

Query: 583 GNYPLELALLVIRLIDACLKKDPTDR 608
             YP  ++   + +    + K P  R
Sbjct: 240 --YPKSMSKEAVAICKGLMTKHPGKR 263

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 65.7 bits (161), Expect = 9e-12
 Identities = 57/222 (25%), Positives = 95/222 (42%), Gaps = 33/222 (14%)

Query: 388 LLNKINHSNLIILSGVCF-NEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIAL 446
           L     H  L  +    F  + N + V EY +NG   D ++  ++  K+   +     A 
Sbjct: 71  LSLAWEHPFLTHMFC-TFQTKENLFFVMEY-LNG--GDLMYHIQSCHKFDLSRATFYAA- 125

Query: 447 DVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIV 506
           ++  GL +LHS      V++D+   N+LLD D   KIA+F M +  E   G+ A T    
Sbjct: 126 EIILGLQFLHSKGI---VYRDLKLDNILLDKDGHIKIADFGMCK--ENMLGD-AKTNTFC 179

Query: 507 GTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTK 566
           GT  Y+APE L     +  +D ++FGVL+ EML G+  +  H ++      ++ +++   
Sbjct: 180 GTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ--SPFHGQDEE----ELFHSIRMD 233

Query: 567 EDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDR 608
                             YP  L      L+     ++P  R
Sbjct: 234 N-----PF----------YPRWLEKEAKDLLVKLFVREPEKR 260

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 65.8 bits (161), Expect = 1e-11
 Identities = 49/196 (25%), Positives = 83/196 (42%), Gaps = 49/196 (25%)

Query: 374 AIKKVN--GDVS------KEIALLNKINHSNLIILSGV-------CFNEGNCYLVYEYA- 417
           AIKK++     +      +EI +L +  H N+I ++ +          +   Y+V +   
Sbjct: 56  AIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD--VYIVQDLME 113

Query: 418 -------VNGTLSDWVFSNKNEGKYLDWKQRI--QIALDVATGLNYLHSFTNPPHV-HKD 467
                      LS+            D       QI      GL Y+HS     +V H+D
Sbjct: 114 TDLYKLLKTQHLSN------------DHICYFLYQILR----GLKYIHS----ANVLHRD 153

Query: 468 INSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTK-L 526
           +  SN+LL++    KI +F +AR A+            V T+ Y APE + N    TK +
Sbjct: 154 LKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSI 213

Query: 527 DVYAFGVLILEMLTGK 542
           D+++ G ++ EML+ +
Sbjct: 214 DIWSVGCILAEMLSNR 229

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 65.4 bits (160), Expect = 2e-11
 Identities = 50/209 (23%), Positives = 89/209 (42%), Gaps = 31/209 (14%)

Query: 404 CF-NEGNCYLVYEYAVNGTLSDWVFSN-KNEGKYLDWKQRIQIALDVATGLNYLHSFTNP 461
            F  E   +L+ +Y   G L    F++     ++ + + +I +  ++   L +LH     
Sbjct: 127 AFQTETKLHLILDYINGGEL----FTHLSQRERFTEHEVQIYVG-EIVLALEHLHKLGI- 180

Query: 462 PHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGL 521
             +++DI   N+LLDS+    + +F +++  E    E        GT  YMAP+ +  G 
Sbjct: 181 --IYRDIKLENILLDSNGHVVLTDFGLSK--EFVADETERAYDFCGTIEYMAPDIVRGGD 236

Query: 522 V--STKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDP 579
                 +D ++ GVL+ E+LTG  A+    +      +++   +L  E            
Sbjct: 237 SGHDKAVDWWSLGVLMYELLTG--ASPFTVDGEKNSQAEISRRILKSE-----PP----- 284

Query: 580 TLQGNYPLELALLVIRLIDACLKKDPTDR 608
                YP E++ L   LI   L KDP  R
Sbjct: 285 -----YPQEMSALAKDLIQRLLMKDPKKR 308

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 64.2 bits (157), Expect = 4e-11
 Identities = 45/156 (28%), Positives = 72/156 (46%), Gaps = 12/156 (7%)

Query: 388 LLNKINHSNLIILSGVCF-NEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIAL 446
           LL  + H  L+ L    F      Y V +Y +NG   +  +  + E  +L+ + R   A 
Sbjct: 92  LLKNVKHPFLVGLHF-SFQTADKLYFVLDY-ING--GELFYHLQRERCFLEPRARFYAA- 146

Query: 447 DVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIV 506
           ++A+ L YLHS      V++D+   N+LLDS     + +F + +  E  E   + T    
Sbjct: 147 EIASALGYLHSLNI---VYRDLKPENILLDSQGHIVLTDFGLCK--ENIEHN-STTSTFC 200

Query: 507 GTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGK 542
           GT  Y+APE L        +D +  G ++ EML G 
Sbjct: 201 GTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGL 236

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 63.8 bits (156), Expect = 4e-11
 Identities = 47/204 (23%), Positives = 81/204 (39%), Gaps = 33/204 (16%)

Query: 361 GSVYRGKI--NGGFAAIKKVNGDVS------KEIALLNKINHSNLIIL-------SGVCF 405
           G+V  GK    G   AIKKV  D        + +  L  ++H N++ L            
Sbjct: 37  GTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDR 96

Query: 406 NEGNCYLVYEYAVNGTLSDWVFSNKNEGKYL--DWKQRI--QIALDVATGLNYLHSFTNP 461
            +    +V EY V  TL     +             +    Q+       +  LH  +  
Sbjct: 97  RDIYLNVVMEY-VPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIR----SIGCLHLPS-- 149

Query: 462 PHV-HKDINSSNVLLD-SDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLEN 519
            +V H+DI   NVL++ +D   K+ +F  A+     E       +I  ++ Y APE +  
Sbjct: 150 VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSE---PNVAYIC-SRYYRAPELIFG 205

Query: 520 GLV-STKLDVYAFGVLILEMLTGK 542
               +T +D+++ G +  EM+ G+
Sbjct: 206 NQHYTTAVDIWSVGCIFAEMMLGE 229

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 63.5 bits (155), Expect = 5e-11
 Identities = 55/290 (18%), Positives = 106/290 (36%), Gaps = 54/290 (18%)

Query: 361 GSVYRG--KINGGFAAIKKVN-------GDVSKEIALLNKI-NHSNLIILSGVCFNEGNC 410
             V      I     A+K +          V +E+ +L +   H N++ L      E   
Sbjct: 27  ARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRF 86

Query: 411 YLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPH--VHKDI 468
           YLV+E    G++     S+ ++ ++ +  +   +  DVA+ L++LH+         H+D+
Sbjct: 87  YLVFEKMRGGSI----LSHIHKRRHFNELEASVVVQDVASALDFLHN-----KGIAHRDL 137

Query: 469 NSSNVLL---DSDLRAKIANFAMARPAEGQEGEFALTRH----IVGTKGYMAPEYLENGL 521
              N+L    +     KI +F +    +       ++        G+  YMAPE +E   
Sbjct: 138 KPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFS 197

Query: 522 VSTKL-----DVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHF 576
               +     D+++ GV++  +L+G           +    D   A    ++    L   
Sbjct: 198 EEASIYDKRCDLWSLGVILYILLSGY--PPFVGRCGSDCGWDRGEACPACQNM---LFES 252

Query: 577 IDPTLQGNYPL---------ELALLVIRLIDACLKKDPTDRPTMYEI-EH 616
           I    +G Y             A     LI   L +D   R +  ++ +H
Sbjct: 253 I---QEGKYEFPDKDWAHISCAA---KDLISKLLVRDAKQRLSAAQVLQH 296

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 63.7 bits (154), Expect = 1e-10
 Identities = 62/369 (16%), Positives = 125/369 (33%), Gaps = 90/369 (24%)

Query: 297 KKEPDSIVVSGSFQAN---------EKPSN--KKFDEESQ----DFL-ESISGVAQS--- 337
           K+E D I++S    +           K     +KF EE       FL   I    +    
Sbjct: 48  KEEIDHIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSM 107

Query: 338 -LKVYSFKELQSATDNFSFTCRIQGSVYRGKINGGFAAIKKVNGDVSKEIALLNKINHSN 396
             ++Y  +  +   DN  F    + +V R +    +  +++           L ++  + 
Sbjct: 108 MTRMYIEQRDRLYNDNQVFA---KYNVSRLQP---YLKLRQA----------LLELRPAK 151

Query: 397 LIILSGV--CFNEGNCYLVYEYAVNGTLSDWVFSNKNEGK--YLDWKQRIQIALDVATGL 452
            +++ GV      G  ++  +         +    K + K  +L+ K        +    
Sbjct: 152 NVLIDGVLGS---GKTWVALD-----VCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQ 203

Query: 453 NYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYM 512
             L+          D +S+  L    ++A++     ++P      E  L   +V      
Sbjct: 204 KLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKP-----YENCL---LV------ 249

Query: 513 APEYLENGLVSTK--LDVYAFGVLILEMLTG-KEAAALHAEENNMHLS-DVLNAVLTKED 568
               L N  V      + +     IL + T  K+     +     H+S D  +  LT ++
Sbjct: 250 ----LLN--VQNAKAWNAFNLSCKIL-LTTRFKQVTDFLSAATTTHISLDHHSMTLTPDE 302

Query: 569 GEESLRHFID------P--TLQGNYPLELALLVIRLIDACLKKDPTDRPTMYE-IEHS-L 618
            +  L  ++D      P   L  N P  L+++      A   +D       ++ +    L
Sbjct: 303 VKSLLLKYLDCRPQDLPREVLTTN-PRRLSII------AESIRDGLATWDNWKHVNCDKL 355

Query: 619 SNILNASLN 627
           + I+ +SLN
Sbjct: 356 TTIIESSLN 364

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 44.1 bits (103), Expect = 2e-04
 Identities = 17/96 (17%), Positives = 36/96 (37%), Gaps = 8/96 (8%)

Query: 526 LDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNY 585
            D      +   +L+ +E   +   ++ +  +  L   L     EE ++ F++  L+ NY
Sbjct: 33  FDCKDVQDMPKSILSKEEIDHIIMSKDAVSGTLRLFWTL-LSKQEEMVQKFVEEVLRINY 91

Query: 586 PLELALLVIRLIDACLKKDPTDRPTMYEIEHS-LSN 620
                 L+  +      + P+    MY  +   L N
Sbjct: 92  K----FLMSPIKTEQ--RQPSMMTRMYIEQRDRLYN 121

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 61.4 bits (150), Expect = 2e-10
 Identities = 44/155 (28%), Positives = 77/155 (49%), Gaps = 12/155 (7%)

Query: 389 LNKINHSNLIILSGVCF-NEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALD 447
           L ++NH  ++ L    F  EG  YL+ ++ + G   D       E  + +   +  +A +
Sbjct: 80  LVEVNHPFIVKLH-YAFQTEGKLYLILDF-LRG--GDLFTRLSKEVMFTEEDVKFYLA-E 134

Query: 448 VATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVG 507
           +A  L++LHS      +++D+   N+LLD +   K+ +F +++  E  + E        G
Sbjct: 135 LALALDHLHSLGI---IYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHE-KKAYSFCG 188

Query: 508 TKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGK 542
           T  YMAPE +     +   D ++FGVL+ EMLTG 
Sbjct: 189 TVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGT 223

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 61.1 bits (149), Expect = 3e-10
 Identities = 50/205 (24%), Positives = 84/205 (40%), Gaps = 58/205 (28%)

Query: 374 AIKKV---NGDVSK----EIALLNKINHSNLIIL----------------SGVCFNEGNC 410
           AIKK+   +    K    EI ++ +++H N++ +                S    N    
Sbjct: 40  AIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNS--V 97

Query: 411 YLVYEYA--------VNGTLSDWVFSNKNEGKYLDWKQRI--QIALDVATGLNYLHSFTN 460
           Y+V EY           G L +            +  +    Q+      GL Y+HS   
Sbjct: 98  YIVQEYMETDLANVLEQGPLLE------------EHARLFMYQLL----RGLKYIHS--- 138

Query: 461 PPHV-HKDINSSNVLLDS-DLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLE 518
             +V H+D+  +N+ +++ DL  KI +F +AR  +            + TK Y +P  L 
Sbjct: 139 -ANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLL 197

Query: 519 NGLVSTK-LDVYAFGVLILEMLTGK 542
           +    TK +D++A G +  EMLTGK
Sbjct: 198 SPNNYTKAIDMWAAGCIFAEMLTGK 222

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 61.0 bits (149), Expect = 3e-10
 Identities = 40/156 (25%), Positives = 72/156 (46%), Gaps = 14/156 (8%)

Query: 389 LNKINHSNLIILSGVCF-NEGNCYLVYEYAVNGTLSDWVFSN-KNEGKYLDWKQRIQIAL 446
           L ++ H  ++ L    F   G  YL+ EY   G L    F   + EG +++      +A 
Sbjct: 75  LEEVKHPFIVDLI-YAFQTGGKLYLILEYLSGGEL----FMQLEREGIFMEDTACFYLA- 128

Query: 447 DVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIV 506
           +++  L +LH       +++D+   N++L+     K+ +F + +  E       +T    
Sbjct: 129 EISMALGHLHQKGI---IYRDLKPENIMLNHQGHVKLTDFGLCK--ESIHDG-TVTHTFC 182

Query: 507 GTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGK 542
           GT  YMAPE L     +  +D ++ G L+ +MLTG 
Sbjct: 183 GTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGA 218

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 60.7 bits (148), Expect = 4e-10
 Identities = 62/293 (21%), Positives = 107/293 (36%), Gaps = 76/293 (25%)

Query: 374 AIKKVN--GDVS------KEIALLNKINHSNLIILSGV-------CFNEGNCYLVYEY-- 416
           AIKK+             +EI +L    H N+I +  +        FNE   Y++ E   
Sbjct: 40  AIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE--VYIIQELMQ 97

Query: 417 ----AV--NGTLSDWVFSNKNEGKYLDWKQRI--QIALDVATGLNYLHSFTNPPHV-HKD 467
                V     LSD            D  Q    Q  L     +  LH      +V H+D
Sbjct: 98  TDLHRVISTQMLSD------------DHIQYFIYQT-L---RAVKVLHG----SNVIHRD 137

Query: 468 INSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHI-------VGTKGYMAPEYLENG 520
           +  SN+L++S+   K+ +F +AR  +    + +            V T+ Y APE +   
Sbjct: 138 LKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTS 197

Query: 521 LVSTK-LDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESL------ 573
              ++ +DV++ G ++ E+   +    +    +  H   ++  ++     +  L      
Sbjct: 198 AKYSRAMDVWSCGCILAELFLRR---PIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESP 254

Query: 574 --RHFIDPTLQGNYPLELALLV-------IRLIDACLKKDPTDRPTMYE-IEH 616
             R +I  +L       L  +        I L+   L  DP  R T  E +EH
Sbjct: 255 RAREYIK-SLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH 306

>2djp_A Hypothetical protein SB145; LYSM, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} Length = 77

 Score = 55.2 bits (133), Expect = 4e-10
 Identities = 20/61 (32%), Positives = 33/61 (54%), Gaps = 1/61 (1%)

Query: 185 LSYLVAEGDTVSGISSRFGVDTGEILQANSLSGSN-IFPFTTLLIPLENPPTSSQTVEPP 243
           L + +  GDT++G++ ++GV   +I +AN L  ++ IF   TL IP+   P       P 
Sbjct: 16  LEHQLEPGDTLAGLALKYGVTMEQIKRANRLYTNDSIFLKKTLYIPILTEPRDLFNSGPS 75

Query: 244 S 244
           S
Sbjct: 76  S 76

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 59.7 bits (145), Expect = 1e-09
 Identities = 38/197 (19%), Positives = 72/197 (36%), Gaps = 29/197 (14%)

Query: 361 GSVYRG--KINGGFAAIKKVN--GDVSKEIALLNKI-NHSNLIILSGVC----FNEGNCY 411
           G V +   K      A+K +       +E+ L  +     +++ +  V            
Sbjct: 76  GKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 135

Query: 412 LVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPH--VHKDIN 469
           +V E    G L   +    +  +    ++  +I   +   + YLHS         H+D+ 
Sbjct: 136 IVMECLDGGELFSRIQDRGD--QAFTEREASEIMKSIGEAIQYLHS-----INIAHRDVK 188

Query: 470 SSNVLL-----DSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVST 524
             N+L      ++ L  K+ +F  A+  E        T     T  Y+APE L       
Sbjct: 189 PENLLYTSKRPNAIL--KLTDFGFAK--ETTSHNSLTT--PCYTPYYVAPEVLGPEKYDK 242

Query: 525 KLDVYAFGVLILEMLTG 541
             D+++ GV++  +L G
Sbjct: 243 SCDMWSLGVIMYILLCG 259

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 57.8 bits (140), Expect = 5e-09
 Identities = 60/319 (18%), Positives = 115/319 (36%), Gaps = 80/319 (25%)

Query: 361 GSVYRGKIN--GGFAAIKKVNGDVSK---EIALLNKINHSNLIILSGVCFNEGNC----- 410
           G V        G   A+KKV  D      E+ ++  ++H N+I L    +  G+      
Sbjct: 21  GIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPP 80

Query: 411 ---------------------------------YLVYEYAVNGTLSDWVFSNKNEGKYL- 436
                                             ++ EY V  TL   + S    G+ + 
Sbjct: 81  QPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEY-VPDTLHKVLKSFIRSGRSIP 139

Query: 437 -DWKQRI--QIALDVATGLNYLHSFTNPPHV-HKDINSSNVLLDS-DLRAKIANFAMARP 491
            +       Q+       + ++HS      + H+DI   N+L++S D   K+ +F  A+ 
Sbjct: 140 MNLISIYIYQLFR----AVGFIHSL----GICHRDIKPQNLLVNSKDNTLKLCDFGSAKK 191

Query: 492 AEGQEGEFALTRHIVGTKGYMAPEYLENGLV-STKLDVYAFGVLILEMLTGKEAAALHAE 550
               E       +I  ++ Y APE +      +  +D+++ G +  E++ GK    L + 
Sbjct: 192 LIPSE---PSVAYIC-SRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGK---PLFSG 244

Query: 551 ENNMH-LSDVLNAVL---TKEDGEESLRHFIDPTLQGNYPLELALLV--------IRLID 598
           E ++  L  ++  ++   TKE       H+ +         +   ++        I L++
Sbjct: 245 ETSIDQLVRIIQ-IMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLE 303

Query: 599 ACLKKDPTDRPTMYEI-EH 616
             L+ +P  R   YE   H
Sbjct: 304 QILRYEPDLRINPYEAMAH 322

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 55.1 bits (133), Expect = 3e-08
 Identities = 49/221 (22%), Positives = 85/221 (38%), Gaps = 70/221 (31%)

Query: 374 AIKKVNGDVSK---------EIALLNKINHSNLIIL-------SGVCFNEGNCYLVYEYA 417
           AIKKVN              EI +LN++    +I L         + F+E   Y+V E A
Sbjct: 55  AIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE--LYIVLEIA 112

Query: 418 ---------VNGTLSDWVFSNKNEGKYLDWKQRIQ-IALDVATGLNYLHSFTNPPHV-HK 466
                        L++               + I+ I  ++  G N++H       + H+
Sbjct: 113 DSDLKKLFKTPIFLTE---------------EHIKTILYNLLLGENFIHES----GIIHR 153

Query: 467 DINSSNVLLDSDLRAKIANFAMARPAEGQEGEFA--------------------LTRHIV 506
           D+  +N LL+ D   K+ +F +AR    ++                        LT H+V
Sbjct: 154 DLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVV 213

Query: 507 GTKGYMAPEYLENGLVSTK-LDVYAFGVLILEMLTGKEAAA 546
            T+ Y APE +      TK +D+++ G +  E+L   ++  
Sbjct: 214 -TRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 54.4 bits (131), Expect = 5e-08
 Identities = 50/248 (20%), Positives = 92/248 (37%), Gaps = 81/248 (32%)

Query: 361 GSVYRG--KINGGFAAIKKVNGDVSK---------EIALLNKINHSNLIILSGVC----- 404
           G V     K+     AIKK+               EIA+LN++NH +++ +  +      
Sbjct: 67  GHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDV 126

Query: 405 --FNEGNCYLVYEYA---------VNGTLSDWVFSNKNEGKYLDWKQRI--QIALDVATG 451
             F+E   Y+V E A             L++               + +   + L    G
Sbjct: 127 EKFDE--LYVVLEIADSDFKKLFRTPVYLTE------------LHIKTLLYNL-L---VG 168

Query: 452 LNYLHSFTNPPH--VHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFA--------- 500
           + Y+HS        +H+D+  +N L++ D   K+ +F +AR  +  E   +         
Sbjct: 169 VKYVHS-----AGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPRED 223

Query: 501 ----------------LTRHIVGTKGYMAPEYLENGLV-STKLDVYAFGVLILEMLTGKE 543
                           LT H+V T+ Y APE +      +  +DV++ G +  E+L   +
Sbjct: 224 DMNLVTFPHTKNLKRQLTGHVV-TRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIK 282

Query: 544 AAALHAEE 551
               +  +
Sbjct: 283 ENVAYHAD 290

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 53.2 bits (128), Expect = 1e-07
 Identities = 49/214 (22%), Positives = 86/214 (40%), Gaps = 68/214 (31%)

Query: 374 AIKKVNGDVSK---------EIALLNKIN-HSNLIILSGVC----FNEGNCYLVYEYA-- 417
           A+KK+               EI +L +++ H N++ L  V       +   YLV++Y   
Sbjct: 38  AVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD--VYLVFDYMET 95

Query: 418 ------VNGTLSDWVFSNKNEGKYLDWKQRI--QIALDVATGLNYLHSFTNPPHV-HKDI 468
                     L                KQ +  Q+ +     + YLHS      + H+D+
Sbjct: 96  DLHAVIRANILEP------------VHKQYVVYQL-I---KVIKYLHS----GGLLHRDM 135

Query: 469 NSSNVLLDSDLRAKIANFAMAR-------------------PAEGQEGEFALTRHIVGTK 509
             SN+LL+++   K+A+F ++R                        + +  LT + V T+
Sbjct: 136 KPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDY-VATR 194

Query: 510 GYMAPEYLENGLVSTK-LDVYAFGVLILEMLTGK 542
            Y APE L      TK +D+++ G ++ E+L GK
Sbjct: 195 WYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228

>1e0g_A Membrane-bound lytic murein transglycosylase D; cell WALL, hydrolase, glycosidase, lipoprotein, outer membrane, multigene family; NMR {Escherichia coli} SCOP: d.7.1.1 Length = 48

 Score = 45.2 bits (108), Expect = 7e-07
 Identities = 14/47 (29%), Positives = 31/47 (65%), Gaps = 1/47 (2%)

Query: 185 LSYLVAEGDTVSGISSRFGVDTGEILQANSLSGSNIFPFTTLLIPLE 231
           ++Y V +GD++S I+ R GV+  ++++ NS + +N+ P   L + ++
Sbjct: 3   ITYRVRKGDSLSSIAKRHGVNIKDVMRWNSDT-ANLQPGDKLTLFVK 48

>2l9y_A CVNH-LYSM lectin; carbohydrate, sugar binding protein; NMR {Magnaporthe oryzae 70-15} Length = 167

 Score = 47.7 bits (113), Expect = 2e-06
 Identities = 16/62 (25%), Positives = 27/62 (43%), Gaps = 1/62 (1%)

Query: 186 SYLVAEGDTVSGISSRFGVDTGEILQANSLSGSN-IFPFTTLLIPLENPPTSSQTVEPPS 244
           +  V +GDT+  I  RF  D  EI + N++   + I+P   L +P +            S
Sbjct: 64  TVTVQQGDTLRDIGRRFDCDFHEIARRNNIQNEDLIYPGQVLQVPTKGGSGGGAGNFWDS 123

Query: 245 ST 246
           + 
Sbjct: 124 AR 125

>2l9y_A CVNH-LYSM lectin; carbohydrate, sugar binding protein; NMR {Magnaporthe oryzae 70-15} Length = 167

 Score = 44.2 bits (104), Expect = 3e-05
 Identities = 19/119 (15%), Positives = 31/119 (26%), Gaps = 13/119 (10%)

Query: 107 VNCSCSGQYYQSNTTYTIQNGDTYLFIAN--NTFQGLSTCQALEDQNG-SPTNLI-IGAG 162
                 G       T T+Q GDT   I    +          +  +N     +LI  G  
Sbjct: 50  FRWVSGGGGGGGTATVTVQQGDTLRDIGRRFDC-----DFHEIARRNNIQNEDLIYPGQV 104

Query: 163 VTVPLRCACPTENQTDEGFPFLLSYLVAEGDTVSGISSRFG--VDTGEILQANSLSGSN 219
           + VP +                    + +G  V     R+    +   I     +   N
Sbjct: 105 LQVPTKGGSGGGAGNFWDSAR--DVRLVDGGKVLEAELRYSGGWNRSRIYLDEHIGNRN 161

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 48.0 bits (113), Expect = 5e-06
 Identities = 27/214 (12%), Positives = 55/214 (25%), Gaps = 66/214 (30%)

Query: 336 QSLKVYSFKELQSATDNFSFTCRI-QGS---VYRGKINGGFAAIKKV------------- 378
                  F      T+      +I +G    V++   +    AIK +             
Sbjct: 6   SQKGPVPFSHC-LPTEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQ 64

Query: 379 --NGDVSKEIALLNKI---------NHSNLIILSGVCFNEGNC----------------- 410
               ++  EI +  ++              I L+ V   +G+                  
Sbjct: 65  KTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGS 124

Query: 411 -------------YLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHS 457
                        ++V E+   G   + + +     K         I   +   L     
Sbjct: 125 ANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-----KLSSLATAKSILHQLTASLAVAE- 178

Query: 458 FTNPPHVHKDINSSNVLLDSDLRAKIANFAMARP 491
             +    H+D++  NVLL      K+      + 
Sbjct: 179 -ASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKS 211

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 43.9 bits (104), Expect = 1e-04
 Identities = 39/204 (19%), Positives = 70/204 (34%), Gaps = 41/204 (20%)

Query: 443 QIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRA------KIANFAMARPAEGQE 496
           QI+  +  GL+Y+H       +H DI   NVL++           KIA+   A   +   
Sbjct: 135 QISKQLLLGLDYMHRRCGI--IHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHY 192

Query: 497 GEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKE----AAALHAEEN 552
                TR       Y +PE L         D+++   LI E++TG             ++
Sbjct: 193 TNSIQTRE------YRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD 246

Query: 553 NMHLS---DVLNAVLTK--EDGEESLRHFID----------------PTLQGNYPL--EL 589
           + H++   ++L  + +    +G+ +   F                    L   Y    + 
Sbjct: 247 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDE 306

Query: 590 ALLVIRLIDACLKKDPTDRPTMYE 613
           A  +   +   L+ DP  R     
Sbjct: 307 AKEISDFLSPMLQLDPRKRADAGG 330

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 43.4 bits (102), Expect = 2e-04
 Identities = 62/341 (18%), Positives = 99/341 (29%), Gaps = 107/341 (31%)

Query: 367 KINGGFAAIKKVNGDVSKEIALLNKINHSN-------LIILSGVCFN----EGN--CYLV 413
           K+     + +        EI LL  + +S+       +++     F      G   C +V
Sbjct: 68  KV---VKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHIC-MV 123

Query: 414 YEYAVNG-TLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSN 472
           +E    G  L  W+  +  +G  L   +  +I   V  GL+YLH+      +H DI   N
Sbjct: 124 FEVL--GHHLLKWIIKSNYQGLPLPCVK--KIIQQVLQGLDYLHTKCR--IIHTDIKPEN 177

Query: 473 VLL-------------------------------------------------DSDLRAKI 483
           +LL                                                    L+ KI
Sbjct: 178 ILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKI 237

Query: 484 ANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKE 543
           A+   A        E   TR       Y + E L     +T  D+++   +  E+ TG  
Sbjct: 238 ADLGNACWVHKHFTEDIQTRQ------YRSLEVLIGSGYNTPADIWSTACMAFELATGDY 291

Query: 544 AAALHAEENNMHLSDVL---NAVLTK------EDGEESLRHF------IDPTLQGNYPLE 588
               H+ E      D +     +L K        G+ S   F         T    + L 
Sbjct: 292 LFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLF 351

Query: 589 LAL------------LVIRLIDACLKKDPTDRPTMYE-IEH 616
             L                 +   L+  P  R T  E + H
Sbjct: 352 EVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392

>1y7m_A Hypothetical protein BSU14040; surface mutagenesis, cysteine proteases, cell WALL catabolism, structural genomics, PSI; 2.05A {Bacillus subtilis subsp} SCOP: b.160.1.1 d.7.1.1 Length = 164

 Score = 40.4 bits (95), Expect = 4e-04
 Identities = 17/59 (28%), Positives = 33/59 (55%), Gaps = 1/59 (1%)

Query: 184 LLSYLVAEGDTVSGISSRFGVDTGEILQANSLSGSNIFPFTTLLIPLE-NPPTSSQTVE 241
           +L+Y V +GDT++ I++ F + T  +LQAN    + +    +++IP   +P T    + 
Sbjct: 1   MLTYQVKQGDTLNSIAADFRISTAALLQANPSLQAGLTAGQSIVIPGLPDPYTIPYHIA 59

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	628
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
4eby_A	212	Chitin elicitor receptor kinase 1; pathogen-associ	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	99.98
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	99.97
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	99.97
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	99.97
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.94
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.88
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.77
4eby_A	212	Chitin elicitor receptor kinase 1; pathogen-associ	99.75
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.59
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.3
2l9y_A	167	CVNH-LYSM lectin; carbohydrate, sugar binding prot	99.29
2djp_A	77	Hypothetical protein SB145; LYSM, structural genom	99.18
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.11
1e0g_A	48	Membrane-bound lytic murein transglycosylase D; ce	99.01
2gu1_A	361	Zinc peptidase; alpha/beta, beta barrel, structura	98.98
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	98.88
2l9y_A	167	CVNH-LYSM lectin; carbohydrate, sugar binding prot	98.86
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	98.82
2djp_A	77	Hypothetical protein SB145; LYSM, structural genom	98.76
1e0g_A	48	Membrane-bound lytic murein transglycosylase D; ce	98.7
2gu1_A	361	Zinc peptidase; alpha/beta, beta barrel, structura	98.59
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.45
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.1
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.08
4a1k_A	165	Putative L, D-transpeptidase YKUD; transferase, pe	98.0
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.0
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	97.94
3ats_A	357	Putative uncharacterized protein; hypothetical pro	97.78
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.66
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	97.58
4a1k_A	165	Putative L, D-transpeptidase YKUD; transferase, pe	97.56
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.04
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	96.73
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	96.62
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	96.56
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	96.49
3slu_A	371	M23 peptidase domain protein; outer membrane, hydr	96.28
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	95.92
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	95.87
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	95.66
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	95.66
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	95.58
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	95.35
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	95.24
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	95.24
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	95.22
2ks1_B	44	Epidermal growth factor receptor; ERBB1, ERBB2, tr	94.66
2l2t_A	44	Receptor tyrosine-protein kinase ERBB-4; transmemb	94.66
3mes_A	424	Choline kinase; malaria, structural genomics, stru	93.49
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	92.88
3slu_A	371	M23 peptidase domain protein; outer membrane, hydr	92.63
2jwa_A	44	Receptor tyrosine-protein kinase ERBB-2; transmemb	90.5
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	83.81
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	81.39
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	80.27

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=9.6e-51  Score=416.97  Aligned_cols=241  Identities=26%  Similarity=0.449  Sum_probs=199.0

Q ss_pred             eEEEEEEEC-------CceEEEEEecc-------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHh
Q 039626          361 GSVYRGKIN-------GGFAAIKKVNG-------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWV  426 (628)
Q Consensus       361 G~Vy~g~~~-------g~~vavK~~~~-------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l  426 (628)
                      |.||+|++.       +..||||+++.       +|.+|+++|++++|||||+++|+|.+++..+||||||++|+|.++|
T Consensus        27 G~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~l  106 (299)
T 4asz_A           27 GKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFL  106 (299)
T ss_dssp             CCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHH
T ss_pred             cEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEcCCCCcHHHHH
Confidence            899999873       56899999864       4788999999999999999999999999999999999999999999


Q ss_pred             hhcC---------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCC
Q 039626          427 FSNK---------NEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEG  497 (628)
Q Consensus       427 ~~~~---------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~  497 (628)
                      +...         .....++|.++++|+.|||+||+|||+   ++|+||||||+|||+++++.+||+|||+|+.......
T Consensus       107 ~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~  183 (299)
T 4asz_A          107 RAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDY  183 (299)
T ss_dssp             HHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGC
T ss_pred             HhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCccCHhhEEECCCCcEEECCcccceecCCCCc
Confidence            7542         234569999999999999999999999   4599999999999999999999999999987643321


Q ss_pred             cceeeecccCCccccCccccccCCCCcccccHHHHHHHHHHHh-CCCccccccccccccHHHHHHHHhccccchhhhccc
Q 039626          498 EFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT-GKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHF  576 (628)
Q Consensus       498 ~~~~~~~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELlt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  576 (628)
                       ........||+.|||||++.+..++.|+|||||||++|||+| |+.||.....      .+.+..+....         
T Consensus       184 -~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~------~~~~~~i~~~~---------  247 (299)
T 4asz_A          184 -YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN------NEVIECITQGR---------  247 (299)
T ss_dssp             -EEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH------HHHHHHHHHTC---------
T ss_pred             -eeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH------HHHHHHHHcCC---------
Confidence             122334579999999999999999999999999999999999 8999864321      22222222111         


Q ss_pred             cCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhc
Q 039626          577 IDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNAS  625 (628)
Q Consensus       577 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~~~~  625 (628)
                           ....|..++..+.+|+.+||+.||++||||+||++.|+++..++
T Consensus       248 -----~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~~  291 (299)
T 4asz_A          248 -----VLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKAS  291 (299)
T ss_dssp             -----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHS
T ss_pred             -----CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcC
Confidence                 01223344566889999999999999999999999999988754

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=3.1e-50  Score=418.76  Aligned_cols=241  Identities=24%  Similarity=0.431  Sum_probs=191.6

Q ss_pred             eEEEEEEEC-------CceEEEEEecc-------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHh
Q 039626          361 GSVYRGKIN-------GGFAAIKKVNG-------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWV  426 (628)
Q Consensus       361 G~Vy~g~~~-------g~~vavK~~~~-------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l  426 (628)
                      |.||+|++.       +..||||+++.       +|.+|+++|++++|||||+++|+|.+++..+||||||++|+|.++|
T Consensus        55 G~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~l  134 (329)
T 4aoj_A           55 GKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFL  134 (329)
T ss_dssp             EEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHH
T ss_pred             cEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCcHHHHH
Confidence            999999873       57899999964       4789999999999999999999999999999999999999999999


Q ss_pred             hhcCC-----------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCC
Q 039626          427 FSNKN-----------EGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQ  495 (628)
Q Consensus       427 ~~~~~-----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~  495 (628)
                      +....           ....++|.++++|+.|||+||+|||+   .+|+||||||+||||++++.+||+|||+++.....
T Consensus       135 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDLKp~NILl~~~~~~Ki~DFGla~~~~~~  211 (329)
T 4aoj_A          135 RSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAG---LHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYST  211 (329)
T ss_dssp             HTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTTEEEECCCC--------
T ss_pred             HhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecccccHhhEEECCCCcEEEcccccceeccCC
Confidence            76432           23469999999999999999999998   45999999999999999999999999999976433


Q ss_pred             CCcceeeecccCCccccCccccccCCCCcccccHHHHHHHHHHHh-CCCccccccccccccHHHHHHHHhccccchhhhc
Q 039626          496 EGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT-GKEAAALHAEENNMHLSDVLNAVLTKEDGEESLR  574 (628)
Q Consensus       496 ~~~~~~~~~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELlt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  574 (628)
                      .. ........||+.|||||++.+..++.++|||||||+||||+| |+.||.....      .+.+..+...        
T Consensus       212 ~~-~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~------~~~~~~i~~g--------  276 (329)
T 4aoj_A          212 DY-YRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN------TEAIDCITQG--------  276 (329)
T ss_dssp             ---------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCH------HHHHHHHHHT--------
T ss_pred             Cc-ceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCH------HHHHHHHHcC--------
Confidence            21 123345679999999999999999999999999999999999 8999864321      2222222211        


Q ss_pred             cccCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhc
Q 039626          575 HFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNAS  625 (628)
Q Consensus       575 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~~~~  625 (628)
                        ..+    ..|..++..+.+|+.+||+.||++||||+||++.|+.|.+++
T Consensus       277 --~~~----~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~p  321 (329)
T 4aoj_A          277 --REL----ERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAP  321 (329)
T ss_dssp             --CCC----CCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHSC
T ss_pred             --CCC----CCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhCC
Confidence              011    223344566889999999999999999999999999998764

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=6.3e-51  Score=420.08  Aligned_cols=238  Identities=24%  Similarity=0.422  Sum_probs=195.8

Q ss_pred             eEEEEEEE-------CCceEEEEEecc--------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHH
Q 039626          361 GSVYRGKI-------NGGFAAIKKVNG--------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDW  425 (628)
Q Consensus       361 G~Vy~g~~-------~g~~vavK~~~~--------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~  425 (628)
                      |.||+|++       ++..||||+++.        +|.+|+.+|++++|||||+++|+|.+++..+||||||++|+|.++
T Consensus        40 G~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~  119 (308)
T 4gt4_A           40 GKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEF  119 (308)
T ss_dssp             CEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCSSCBHHHH
T ss_pred             cEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEEEEEcCCCCcHHHH
Confidence            99999997       346899999853        478999999999999999999999999999999999999999999


Q ss_pred             hhhcCC------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCC
Q 039626          426 VFSNKN------------EGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAE  493 (628)
Q Consensus       426 l~~~~~------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~  493 (628)
                      |+....            ....++|.++++|+.|||+||+|||+.   +||||||||+||||++++++||+|||+++...
T Consensus       120 L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl~~~~~~Ki~DFGlar~~~  196 (308)
T 4gt4_A          120 LVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLFREVY  196 (308)
T ss_dssp             HHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCSCCBCGGG
T ss_pred             HHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEECCCCCEEECCcccceecc
Confidence            965421            124599999999999999999999994   49999999999999999999999999998764


Q ss_pred             CCCCcceeeecccCCccccCccccccCCCCcccccHHHHHHHHHHHh-CCCccccccccccccHHHHHHHHhccccchhh
Q 039626          494 GQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT-GKEAAALHAEENNMHLSDVLNAVLTKEDGEES  572 (628)
Q Consensus       494 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELlt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  572 (628)
                      .... ........||+.|||||++.++.++.++|||||||+||||+| |+.||.....      .+.+..+...      
T Consensus       197 ~~~~-~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~------~~~~~~i~~~------  263 (308)
T 4gt4_A          197 AADY-YKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN------QDVVEMIRNR------  263 (308)
T ss_dssp             GGGC-BCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH------HHHHHHHHTT------
T ss_pred             CCCc-eeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCH------HHHHHHHHcC------
Confidence            3321 123345689999999999999999999999999999999998 8888864322      2222222211      


Q ss_pred             hccccCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhH
Q 039626          573 LRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNIL  622 (628)
Q Consensus       573 l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~  622 (628)
                              .....|.+++..+.+|+.+||+.||++||||+||++.|+.+.
T Consensus       264 --------~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~  305 (308)
T 4gt4_A          264 --------QVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWG  305 (308)
T ss_dssp             --------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred             --------CCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhcc
Confidence                    011223445567889999999999999999999999998654

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=9.9e-50  Score=409.78  Aligned_cols=239  Identities=26%  Similarity=0.447  Sum_probs=187.0

Q ss_pred             eEEEEEEECCceEEEEEecc---------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhcCC
Q 039626          361 GSVYRGKINGGFAAIKKVNG---------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKN  431 (628)
Q Consensus       361 G~Vy~g~~~g~~vavK~~~~---------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~  431 (628)
                      |.||+|++.+ .||||.++.         +|.+|+++|++++|||||+++|+|.+ ++.+||||||++|+|.++|+..  
T Consensus        50 G~Vy~~~~~~-~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy~~gGsL~~~l~~~--  125 (307)
T 3omv_A           50 GTVYKGKWHG-DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQWCEGSSLYKHLHVQ--  125 (307)
T ss_dssp             SEEEEEESSS-EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCSSCBHHHHHHTS--
T ss_pred             cEEEEEEECC-cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEcCCCCCHHHHHhhc--
Confidence            8999999866 589998862         47889999999999999999999865 5689999999999999999643  


Q ss_pred             CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCCccc
Q 039626          432 EGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGY  511 (628)
Q Consensus       432 ~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~Y  511 (628)
                       ...++|.++++|+.|||.||+|||+   .+|+||||||+||||++++.+||+|||+|+........ .......||+.|
T Consensus       126 -~~~l~~~~~~~i~~qia~gL~yLH~---~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~-~~~~~~~GT~~y  200 (307)
T 3omv_A          126 -ETKFQMFQLIDIARQTAQGMDYLHA---KNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGS-QQVEQPTGSVLW  200 (307)
T ss_dssp             -CCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCCSSSEEEETTEEEEECCCSSCBC-------------CCCCTTS
T ss_pred             -CCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCccCHHHEEECCCCcEEEeeccCceecccCCcc-eeecccccCCCc
Confidence             3459999999999999999999999   45999999999999999999999999999876432211 223456899999


Q ss_pred             cCcccccc---CCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCHH
Q 039626          512 MAPEYLEN---GLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLE  588 (628)
Q Consensus       512 ~APE~l~~---~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~  588 (628)
                      ||||++.+   +.++.|+|||||||+||||+||+.||......      ..+......        ....|.+. ..+.+
T Consensus       201 mAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~------~~~~~~~~~--------~~~~p~~~-~~~~~  265 (307)
T 3omv_A          201 MAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNR------DQIIFMVGR--------GYASPDLS-KLYKN  265 (307)
T ss_dssp             CCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH------HHHHHHHHT--------TCCCCCST-TSCTT
T ss_pred             cCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChH------HHHHHHHhc--------CCCCCCcc-ccccc
Confidence            99999864   46899999999999999999999998632211      111111111        11112111 22334


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHh
Q 039626          589 LALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILN  623 (628)
Q Consensus       589 ~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~~  623 (628)
                      ++..+.+|+.+||+.||++||||.||++.|+.|..
T Consensus       266 ~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~  300 (307)
T 3omv_A          266 CPKAMKRLVADCVKKVKEERPLFPQILSSIELLQH  300 (307)
T ss_dssp             SCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHT
T ss_pred             chHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence            45678899999999999999999999999987764

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=2.3e-49  Score=408.68  Aligned_cols=251  Identities=24%  Similarity=0.391  Sum_probs=192.1

Q ss_pred             eEEEEEEECCceEEEEEeccc------hHHHHHHHhhcCCCceeeeeeeeecCC----eEEEEEEecCCCChHHHhhhcC
Q 039626          361 GSVYRGKINGGFAAIKKVNGD------VSKEIALLNKINHSNLIILSGVCFNEG----NCYLVYEYAVNGTLSDWVFSNK  430 (628)
Q Consensus       361 G~Vy~g~~~g~~vavK~~~~~------~~~E~~~l~~l~H~nIv~l~g~~~~~~----~~~lV~E~~~~gsL~~~l~~~~  430 (628)
                      |.||+|+++|+.||||+++.+      +..|+..+.+++|||||+++|+|.+++    ..+||||||++|+|.++|+.  
T Consensus        17 G~Vy~~~~~g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~~~gsL~~~l~~--   94 (303)
T 3hmm_A           17 GEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR--   94 (303)
T ss_dssp             SEEEEEEETTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHH--
T ss_pred             eEEEEEEECCEEEEEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecCCCCCcHHHHHHh--
Confidence            899999999999999999753      234666778899999999999998654    57999999999999999964  


Q ss_pred             CCCCCCCHHHHHHHHHHHHHHHHHHhcC-----CCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcc-eeeec
Q 039626          431 NEGKYLDWKQRIQIALDVATGLNYLHSF-----TNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEF-ALTRH  504 (628)
Q Consensus       431 ~~~~~l~~~~~~~i~~~ia~gL~yLH~~-----~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~-~~~~~  504 (628)
                         ..++|..+++++.|++.||+|||+.     ..++|+||||||+|||||+++++||+|||+++......... .....
T Consensus        95 ---~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~  171 (303)
T 3hmm_A           95 ---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNH  171 (303)
T ss_dssp             ---CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEESCC---
T ss_pred             ---CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccccCCCCceeeeccc
Confidence               2489999999999999999999985     23579999999999999999999999999998765433221 12334


Q ss_pred             ccCCccccCccccccC------CCCcccccHHHHHHHHHHHhCCCcccccccccc--------ccHHHHHHHHhccccch
Q 039626          505 IVGTKGYMAPEYLENG------LVSTKLDVYAFGVLILEMLTGKEAAALHAEENN--------MHLSDVLNAVLTKEDGE  570 (628)
Q Consensus       505 ~~gt~~Y~APE~l~~~------~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~--------~~~~~~~~~~~~~~~~~  570 (628)
                      ..||+.|||||++.+.      .++.|+|||||||+||||+||+.|+........        ....+.+....      
T Consensus       172 ~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~------  245 (303)
T 3hmm_A          172 RVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVV------  245 (303)
T ss_dssp             --CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHH------
T ss_pred             ccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchHHHHHHHH------
Confidence            6899999999999764      468899999999999999999887654322110        00011111111      


Q ss_pred             hhhccccCCcCCCCC-CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhh
Q 039626          571 ESLRHFIDPTLQGNY-PLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNA  624 (628)
Q Consensus       571 ~~l~~~~d~~l~~~~-~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~~~  624 (628)
                        ..+.++|.++..+ +.+....+.+|+.+||+.||++||||.||++.|++|.+.
T Consensus       246 --~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~  298 (303)
T 3hmm_A          246 --CEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ  298 (303)
T ss_dssp             --TTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             --hcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence              1112233332221 235667889999999999999999999999999999765

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=2.3e-48  Score=407.94  Aligned_cols=261  Identities=24%  Similarity=0.377  Sum_probs=204.9

Q ss_pred             HHHHHHHhcCCCcCCccc----eEEEEEEECC-------ceEEEEEecc--------chHHHHHHHhhcCC-Cceeeeee
Q 039626          343 FKELQSATDNFSFTCRIQ----GSVYRGKING-------GFAAIKKVNG--------DVSKEIALLNKINH-SNLIILSG  402 (628)
Q Consensus       343 ~~el~~at~~f~~~~~i~----G~Vy~g~~~g-------~~vavK~~~~--------~~~~E~~~l~~l~H-~nIv~l~g  402 (628)
                      .++++--.++|.....+|    |.||+|++.+       +.||||+++.        ++.+|+++|.+++| ||||+++|
T Consensus        56 ~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g  135 (353)
T 4ase_A           56 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG  135 (353)
T ss_dssp             HHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             CcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEE
Confidence            333333345565555564    8999999733       4799999864        36789999999965 89999999


Q ss_pred             eeecC-CeEEEEEEecCCCChHHHhhhcCC------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCC
Q 039626          403 VCFNE-GNCYLVYEYAVNGTLSDWVFSNKN------------EGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDIN  469 (628)
Q Consensus       403 ~~~~~-~~~~lV~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik  469 (628)
                      +|.++ +..+||||||++|+|.++|+....            ....++|..++.++.|||+||+|||+.   +|||||||
T Consensus       136 ~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRDLK  212 (353)
T 4ase_A          136 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLA  212 (353)
T ss_dssp             EECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCS
T ss_pred             EEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCccC
Confidence            99765 568999999999999999975432            134599999999999999999999994   59999999


Q ss_pred             CCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCCccccCccccccCCCCcccccHHHHHHHHHHHh-CCCccccc
Q 039626          470 SSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT-GKEAAALH  548 (628)
Q Consensus       470 ~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELlt-G~~p~~~~  548 (628)
                      |+|||+++++.+||+|||+|+....... ........||+.|||||++.+..++.++|||||||+||||+| |+.||...
T Consensus       213 ~~NILl~~~~~vKi~DFGlar~~~~~~~-~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~  291 (353)
T 4ase_A          213 ARNILLSEKNVVKICDFGLARDIYKDPD-YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV  291 (353)
T ss_dssp             GGGEEECGGGCEEECCCGGGSCTTTCTT-SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred             ccceeeCCCCCEEECcchhhhhcccCCC-ceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCC
Confidence            9999999999999999999997654322 233445689999999999999999999999999999999998 89998643


Q ss_pred             cccccccHHHHHHHHhccccchhhhccccCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhcc
Q 039626          549 AEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNASL  626 (628)
Q Consensus       549 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~~~~~  626 (628)
                      ...      +.+...+..         ...+    ..|...+..+.+++.+||+.||++|||+.||++.|+++++++.
T Consensus       292 ~~~------~~~~~~i~~---------g~~~----~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~~~  350 (353)
T 4ase_A          292 KID------EEFCRRLKE---------GTRM----RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA  350 (353)
T ss_dssp             CCS------HHHHHHHHH---------TCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTC
T ss_pred             CHH------HHHHHHHHc---------CCCC----CCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHHhh
Confidence            211      111111111         1111    2233345568899999999999999999999999999998753

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=3.2e-47  Score=395.01  Aligned_cols=239  Identities=23%  Similarity=0.285  Sum_probs=193.2

Q ss_pred             eEEEEEEE--CCceEEEEEeccc--hHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhcCCCCCCC
Q 039626          361 GSVYRGKI--NGGFAAIKKVNGD--VSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYL  436 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~~--~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l  436 (628)
                      |.||+|+.  +|+.||||+++.+  ..+|+.+|++++|||||++++++.+++..||||||++||+|.++|...    ..+
T Consensus        72 G~Vy~a~~~~~g~~vAiK~i~~~~~~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~~----~~l  147 (336)
T 4g3f_A           72 GEVHRMKDKQTGFQCAVKKVRLEVFRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQM----GCL  147 (336)
T ss_dssp             EEEEEEEETTTCCEEEEEEEETTTCCTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHHH----SSC
T ss_pred             eEEEEEEECCCCCEEEEEEECHHHhHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcHHHHHHHc----CCC
Confidence            89999998  6889999999754  458999999999999999999999999999999999999999999643    359


Q ss_pred             CHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCC-cEEEccccccccCCCCCCc--ceeeecccCCccccC
Q 039626          437 DWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDL-RAKIANFAMARPAEGQEGE--FALTRHIVGTKGYMA  513 (628)
Q Consensus       437 ~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~-~~kl~Dfgla~~~~~~~~~--~~~~~~~~gt~~Y~A  513 (628)
                      ++.....++.||+.||+|||+.   +|+||||||+||||+.++ ++||+|||+|+........  .......+||+.|||
T Consensus       148 ~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~~~~~~~GT~~YmA  224 (336)
T 4g3f_A          148 PEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMA  224 (336)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTCEEC------------CCCCCCGGGCC
T ss_pred             CHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccceecCCccccCccccC
Confidence            9999999999999999999984   499999999999999987 6999999999977543211  112234579999999


Q ss_pred             ccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCHHHHHHH
Q 039626          514 PEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLV  593 (628)
Q Consensus       514 PE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l  593 (628)
                      ||.+.+..++.++|||||||++|||++|+.||.......  .+...    .....   ..         ...+...+..+
T Consensus       225 PE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~--~~~~i----~~~~~---~~---------~~~~~~~s~~~  286 (336)
T 4g3f_A          225 PEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGP--LCLKI----ASEPP---PI---------REIPPSCAPLT  286 (336)
T ss_dssp             HHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSC--CHHHH----HHSCC---GG---------GGSCTTSCHHH
T ss_pred             HHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH--HHHHH----HcCCC---Cc---------hhcCccCCHHH
Confidence            999999999999999999999999999999997433221  11111    11110   00         01223345667


Q ss_pred             HHHHHHhcccCCCCCCCHHHHHHHHHHhHhh
Q 039626          594 IRLIDACLKKDPTDRPTMYEIEHSLSNILNA  624 (628)
Q Consensus       594 ~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~~~  624 (628)
                      .+++.+||+.||++|||+.|+++.|.+.++.
T Consensus       287 ~~li~~~L~~dP~~R~sa~el~~~l~~~l~~  317 (336)
T 4g3f_A          287 AQAIQEGLRKEPVHRASAMELRRKVGKALQE  317 (336)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHHccCCHhHCcCHHHHHHHHHHHHhh
Confidence            8999999999999999999999999888764

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=7.4e-47  Score=385.57  Aligned_cols=227  Identities=22%  Similarity=0.382  Sum_probs=182.1

Q ss_pred             eEEEEEEE--CCceEEEEEecc---------chHHHHHHHhhcCCCceeeeeeeeec----CCeEEEEEEecCCCChHHH
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG---------DVSKEIALLNKINHSNLIILSGVCFN----EGNCYLVYEYAVNGTLSDW  425 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~---------~~~~E~~~l~~l~H~nIv~l~g~~~~----~~~~~lV~E~~~~gsL~~~  425 (628)
                      |.||+|..  .+..||+|++..         .+.+|+++|++++|||||++++++.+    ++..|||||||++|+|.++
T Consensus        40 g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvmEy~~gg~L~~~  119 (290)
T 3fpq_A           40 KTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTY  119 (290)
T ss_dssp             EEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEEECCCSCBHHHH
T ss_pred             cEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEEeCCCCCCHHHH
Confidence            99999998  578999999853         36789999999999999999999875    3458999999999999999


Q ss_pred             hhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCC-CCcEEEccccccccCCCCCCcceeeec
Q 039626          426 VFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDS-DLRAKIANFAMARPAEGQEGEFALTRH  504 (628)
Q Consensus       426 l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~-~~~~kl~Dfgla~~~~~~~~~~~~~~~  504 (628)
                      |...    ..+++..+..|+.||+.||+|||+.+ ++|+||||||+||||+. ++.+||+|||+|+.....     ....
T Consensus       120 l~~~----~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~~-----~~~~  189 (290)
T 3fpq_A          120 LKRF----KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS-----FAKA  189 (290)
T ss_dssp             HHHH----SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCTT-----SBEE
T ss_pred             HHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCCCC-----ccCC
Confidence            9643    45999999999999999999999965 56999999999999984 799999999999865322     2345


Q ss_pred             ccCCccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCC
Q 039626          505 IVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGN  584 (628)
Q Consensus       505 ~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~  584 (628)
                      ..||+.|||||.+.+ .++.++|||||||++|||++|+.||.....     .......+.....         .+..   
T Consensus       190 ~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~-----~~~~~~~i~~~~~---------~~~~---  251 (290)
T 3fpq_A          190 VIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN-----AAQIYRRVTSGVK---------PASF---  251 (290)
T ss_dssp             SCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS-----HHHHHHHHTTTCC---------CGGG---
T ss_pred             cccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCc-----HHHHHHHHHcCCC---------CCCC---
Confidence            689999999998875 699999999999999999999999863221     1222222211110         0011   


Q ss_pred             CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          585 YPLELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       585 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                       +...+..+.+|+.+||+.||++|||++|+++
T Consensus       252 -~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~  282 (290)
T 3fpq_A          252 -DKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             -GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             -CccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence             1112345789999999999999999999874

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=1.3e-46  Score=392.12  Aligned_cols=228  Identities=25%  Similarity=0.432  Sum_probs=189.5

Q ss_pred             eEEEEEEE--CCceEEEEEecc---------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhc
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG---------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSN  429 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~---------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~  429 (628)
                      |.||+++.  +|+.||||+++.         .+.+|+++|++++|||||++++++.+++..||||||++||+|.++|...
T Consensus        38 g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmEy~~gg~L~~~i~~~  117 (350)
T 4b9d_A           38 GKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQ  117 (350)
T ss_dssp             -CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHT
T ss_pred             eEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHHc
Confidence            89999998  689999999853         3678999999999999999999999999999999999999999999643


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCCc
Q 039626          430 KNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTK  509 (628)
Q Consensus       430 ~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~  509 (628)
                        .+..+++.+.+.|+.||+.||+|||+.   +|+||||||+||||++++.+||+|||+|+.....   .......+||+
T Consensus       118 --~~~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~---~~~~~~~~GT~  189 (350)
T 4b9d_A          118 --KGVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST---VELARACIGTP  189 (350)
T ss_dssp             --TTCCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTEESCCCHH---HHHHHHHHSCC
T ss_pred             --CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccccceeecCC---cccccccCCCc
Confidence              344689999999999999999999994   4999999999999999999999999999876432   11234568999


Q ss_pred             cccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCHHH
Q 039626          510 GYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLEL  589 (628)
Q Consensus       510 ~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~  589 (628)
                      .|||||.+.+..++.++|||||||++|||++|+.||....      ..+.+..+.....          +..    +...
T Consensus       190 ~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~------~~~~~~~i~~~~~----------~~~----~~~~  249 (350)
T 4b9d_A          190 YYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGS------MKNLVLKIISGSF----------PPV----SLHY  249 (350)
T ss_dssp             TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS------HHHHHHHHHHTCC----------CCC----CTTS
T ss_pred             cccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC------HHHHHHHHHcCCC----------CCC----CccC
Confidence            9999999999999999999999999999999999996432      2233333322110          111    2233


Q ss_pred             HHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          590 ALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       590 ~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      +..+.+|+.+||+.||++|||++|+++
T Consensus       250 s~~~~~li~~~L~~dP~~R~s~~e~l~  276 (350)
T 4b9d_A          250 SYDLRSLVSQLFKRNPRDRPSVNSILE  276 (350)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            456789999999999999999999975

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=5.1e-46  Score=387.06  Aligned_cols=227  Identities=23%  Similarity=0.405  Sum_probs=189.1

Q ss_pred             eEEEEEEE--CCceEEEEEecc-------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhcCC
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG-------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKN  431 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~-------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~  431 (628)
                      |.||+|+.  +|+.||||+++.       .+.+|+++|++++|||||++++++.+++..||||||+++|+|.+++..   
T Consensus        88 G~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~---  164 (346)
T 4fih_A           88 GIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTH---  164 (346)
T ss_dssp             CEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCCTTEEHHHHHHH---
T ss_pred             eEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHc---
Confidence            89999998  689999999853       478999999999999999999999999999999999999999999853   


Q ss_pred             CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCCccc
Q 039626          432 EGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGY  511 (628)
Q Consensus       432 ~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~Y  511 (628)
                        ..+++.....++.||+.||+|||+.   +|+||||||+||||+.++.+||+|||+|+.......   .....+||+.|
T Consensus       165 --~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~---~~~~~~GTp~Y  236 (346)
T 4fih_A          165 --TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP---RRKSLVGTPYW  236 (346)
T ss_dssp             --SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC---CBCCCCSCGGG
T ss_pred             --CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCceecCCCCC---cccccccCcCc
Confidence              2489999999999999999999995   499999999999999999999999999987654321   23457899999


Q ss_pred             cCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCHHHHH
Q 039626          512 MAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELAL  591 (628)
Q Consensus       512 ~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~  591 (628)
                      ||||.+.+..++.++|||||||++|||++|+.||.....      .+.+..+...          ..+.+  ..+...+.
T Consensus       237 mAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~------~~~~~~i~~~----------~~~~~--~~~~~~s~  298 (346)
T 4fih_A          237 MAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP------LKAMKMIRDN----------LPPRL--KNLHKVSP  298 (346)
T ss_dssp             CCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHHHHHS----------SCCCC--SCGGGSCH
T ss_pred             CCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH------HHHHHHHHcC----------CCCCC--CccccCCH
Confidence            999999999999999999999999999999999864221      1222222111          11111  11223456


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          592 LVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       592 ~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      .+.+|+.+||+.||++|||+.|+++
T Consensus       299 ~~~dli~~~L~~dP~~R~ta~e~l~  323 (346)
T 4fih_A          299 SLKGFLDRLLVRDPAQRATAAELLK  323 (346)
T ss_dssp             HHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             HHHHHHHHHcCCChhHCcCHHHHhc
Confidence            6889999999999999999999864

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=5.4e-46  Score=381.30  Aligned_cols=235  Identities=23%  Similarity=0.355  Sum_probs=193.6

Q ss_pred             CCCcCCccc----eEEEEEEE--CCceEEEEEecc----------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEE
Q 039626          352 NFSFTCRIQ----GSVYRGKI--NGGFAAIKKVNG----------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYE  415 (628)
Q Consensus       352 ~f~~~~~i~----G~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  415 (628)
                      +|.....+|    |.||+++.  +|+.||||.+..          .+.+|+++|++++|||||++++++.+++..|||||
T Consensus        33 dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivmE  112 (311)
T 4aw0_A           33 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLS  112 (311)
T ss_dssp             GEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence            355444554    89999998  688999999853          36689999999999999999999999999999999


Q ss_pred             ecCCCChHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCC
Q 039626          416 YAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQ  495 (628)
Q Consensus       416 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~  495 (628)
                      |++||+|.+++...    ..+++.....++.||+.||+|||+.   +|+||||||+|||+++++.+||+|||+|+.....
T Consensus       113 y~~gG~L~~~i~~~----~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~  185 (311)
T 4aw0_A          113 YAKNGELLKYIRKI----GSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE  185 (311)
T ss_dssp             CCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             cCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence            99999999999643    3599999999999999999999995   4999999999999999999999999999977533


Q ss_pred             CCcceeeecccCCccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhcc
Q 039626          496 EGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRH  575 (628)
Q Consensus       496 ~~~~~~~~~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  575 (628)
                      .. .......+||+.|||||.+.+..++.++||||+||++|||++|+.||.....      .+....+....        
T Consensus       186 ~~-~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~------~~~~~~i~~~~--------  250 (311)
T 4aw0_A          186 SK-QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE------GLIFAKIIKLE--------  250 (311)
T ss_dssp             TT-CCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHTC--------
T ss_pred             CC-cccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHcCC--------
Confidence            21 1234557899999999999999999999999999999999999999964321      22232322211        


Q ss_pred             ccCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 039626          576 FIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIE  615 (628)
Q Consensus       576 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~  615 (628)
                         .    .+|...+..+.+|+.+||+.||++|||++|+.
T Consensus       251 ---~----~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~  283 (311)
T 4aw0_A          251 ---Y----DFPEKFFPKARDLVEKLLVLDATKRLGCEEME  283 (311)
T ss_dssp             ---C----CCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred             ---C----CCCcccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence               1    12223345678999999999999999999874

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=5.7e-45  Score=388.42  Aligned_cols=235  Identities=23%  Similarity=0.394  Sum_probs=192.1

Q ss_pred             CCcCCccc----eEEEEEEE--CCceEEEEEecc-------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCC
Q 039626          353 FSFTCRIQ----GSVYRGKI--NGGFAAIKKVNG-------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVN  419 (628)
Q Consensus       353 f~~~~~i~----G~Vy~g~~--~g~~vavK~~~~-------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~  419 (628)
                      |....+||    |.||+|+.  +|+.||||++..       .+.+|+++|++++|||||++++++.+++.+|||||||+|
T Consensus       153 y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~~g  232 (423)
T 4fie_A          153 LDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG  232 (423)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred             cEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCCCC
Confidence            44444454    89999998  689999999852       478999999999999999999999999999999999999


Q ss_pred             CChHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcc
Q 039626          420 GTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEF  499 (628)
Q Consensus       420 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~  499 (628)
                      |+|.+++..     ..+++.+...|+.||+.||+|||+.   +|+||||||+||||+.++.+||+|||+|+.+.....  
T Consensus       233 G~L~~~i~~-----~~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~--  302 (423)
T 4fie_A          233 GALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--  302 (423)
T ss_dssp             EEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC--
T ss_pred             CcHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccceECCCCCc--
Confidence            999999853     2489999999999999999999995   499999999999999999999999999987654321  


Q ss_pred             eeeecccCCccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCC
Q 039626          500 ALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDP  579 (628)
Q Consensus       500 ~~~~~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~  579 (628)
                       .....+||+.|||||.+.+..++.++|||||||++|||++|+.||.....      .+.+..+...          ..+
T Consensus       303 -~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~------~~~~~~i~~~----------~~~  365 (423)
T 4fie_A          303 -RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP------LKAMKMIRDN----------LPP  365 (423)
T ss_dssp             -CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHHHHHS----------CCC
T ss_pred             -cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH------HHHHHHHHcC----------CCC
Confidence             23456899999999999999999999999999999999999999863221      1222222111          111


Q ss_pred             cCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          580 TLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       580 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      .+  ..+...+..+.+|+.+||+.||++|||+.|+++
T Consensus       366 ~~--~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~  400 (423)
T 4fie_A          366 RL--KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK  400 (423)
T ss_dssp             CC--SCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CC--cccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            11  111233456789999999999999999999875

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=5.1e-45  Score=368.82  Aligned_cols=233  Identities=24%  Similarity=0.378  Sum_probs=181.0

Q ss_pred             cCCCcCCccc----eEEEEEEE--CCceEEEEEecc----------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEE
Q 039626          351 DNFSFTCRIQ----GSVYRGKI--NGGFAAIKKVNG----------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVY  414 (628)
Q Consensus       351 ~~f~~~~~i~----G~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~  414 (628)
                      ++|.....+|    |.||+++.  +|+.||||+++.          .+.+|+++|++++|||||++++++.+++..|+||
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm   92 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI   92 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence            3555555554    89999987  689999998853          3678999999999999999999999999999999


Q ss_pred             EecCCCChHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCC
Q 039626          415 EYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEG  494 (628)
Q Consensus       415 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~  494 (628)
                      ||+ +|+|.+++..    ...+++.....++.||+.||+|||+.   +|+||||||+|||+++++++||+|||+|+....
T Consensus        93 Ey~-~g~L~~~l~~----~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~  164 (275)
T 3hyh_A           93 EYA-GNELFDYIVQ----RDKMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD  164 (275)
T ss_dssp             ECC-CEEHHHHHHH----SCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSSCC-----
T ss_pred             eCC-CCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecCCCeecCC
Confidence            999 7899999854    24599999999999999999999995   499999999999999999999999999987643


Q ss_pred             CCCcceeeecccCCccccCccccccCCC-CcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhh
Q 039626          495 QEGEFALTRHIVGTKGYMAPEYLENGLV-STKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESL  573 (628)
Q Consensus       495 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~-s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  573 (628)
                      ..    ......||+.|||||.+.+..+ +.++||||+||++|||++|+.||....      .......+....      
T Consensus       165 ~~----~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~------~~~~~~~i~~~~------  228 (275)
T 3hyh_A          165 GN----FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDES------IPVLFKNISNGV------  228 (275)
T ss_dssp             --------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHHTC------
T ss_pred             CC----ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCC------HHHHHHHHHcCC------
Confidence            22    2344689999999999998775 579999999999999999999986422      122222222111      


Q ss_pred             ccccCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          574 RHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       574 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                           +    .+|...+..+.+|+.+||+.||++|||++|+++
T Consensus       229 -----~----~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~  262 (275)
T 3hyh_A          229 -----Y----TLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ  262 (275)
T ss_dssp             -----C----CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             -----C----CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence                 1    112233456789999999999999999999876

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=2e-45  Score=376.90  Aligned_cols=220  Identities=24%  Similarity=0.359  Sum_probs=176.9

Q ss_pred             eEEEEEEE-----CCceEEEEEecc---------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHh
Q 039626          361 GSVYRGKI-----NGGFAAIKKVNG---------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWV  426 (628)
Q Consensus       361 G~Vy~g~~-----~g~~vavK~~~~---------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l  426 (628)
                      |.||+++.     .++.||||.++.         .+.+|+++|++++|||||++++++.+++..||||||++||+|.++|
T Consensus        38 g~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy~~gg~L~~~l  117 (304)
T 3ubd_A           38 GKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRL  117 (304)
T ss_dssp             CEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEEEECCCTTCEEHHHH
T ss_pred             eEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEEcCCCCCHHHHH
Confidence            89999986     357899998853         3678999999999999999999999999999999999999999999


Q ss_pred             hhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeeccc
Q 039626          427 FSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIV  506 (628)
Q Consensus       427 ~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~  506 (628)
                      ...    ..+++.....++.||+.||+|||+.   +|+||||||+|||+++++.+||+|||+|+.......   ......
T Consensus       118 ~~~----~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~---~~~~~~  187 (304)
T 3ubd_A          118 SKE----VMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK---KAYSFC  187 (304)
T ss_dssp             HHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEEEEC-----C---CCCSCC
T ss_pred             Hhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEecccccceeccCCCc---cccccc
Confidence            643    3599999999999999999999995   499999999999999999999999999986543221   234568


Q ss_pred             CCccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCC
Q 039626          507 GTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYP  586 (628)
Q Consensus       507 gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~  586 (628)
                      ||+.|||||.+.+..++.++|||||||++|||++|+.||.....      .+....+....               ..+|
T Consensus       188 GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~------~~~~~~i~~~~---------------~~~p  246 (304)
T 3ubd_A          188 GTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDR------KETMTMILKAK---------------LGMP  246 (304)
T ss_dssp             CCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHCC---------------CCCC
T ss_pred             cCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCH------HHHHHHHHcCC---------------CCCC
Confidence            99999999999999999999999999999999999999974322      22222222111               1123


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCCH
Q 039626          587 LELALLVIRLIDACLKKDPTDRPTM  611 (628)
Q Consensus       587 ~~~~~~l~~l~~~Cl~~dP~~RPs~  611 (628)
                      ...+..+.+|+.+||+.||++|||+
T Consensus       247 ~~~s~~~~~li~~~L~~dP~~R~ta  271 (304)
T 3ubd_A          247 QFLSPEAQSLLRMLFKRNPANRLGA  271 (304)
T ss_dssp             TTSCHHHHHHHHHHTCSSGGGSTTC
T ss_pred             CcCCHHHHHHHHHHcccCHHHCCCC
Confidence            3345568899999999999999995

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=1.9e-43  Score=363.19  Aligned_cols=230  Identities=23%  Similarity=0.367  Sum_probs=170.4

Q ss_pred             eEEEEEEE--CCceEEEEEecc--------chHHHHHHHhhcCCCceeeeeeeeecCC------------eEEEEEEecC
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG--------DVSKEIALLNKINHSNLIILSGVCFNEG------------NCYLVYEYAV  418 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~--------~~~~E~~~l~~l~H~nIv~l~g~~~~~~------------~~~lV~E~~~  418 (628)
                      |.||+|+.  +|+.||||+++.        .+.+|+++|++++|||||++++++.+.+            ..|+||||++
T Consensus        19 g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~~~~~l~ivmE~~~   98 (299)
T 4g31_A           19 GVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCR   98 (299)
T ss_dssp             -EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC----------CEEEEEEEECCC
T ss_pred             eEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccCCCcEEEEEEecCC
Confidence            89999998  688999998852        3678999999999999999999987543            3699999999


Q ss_pred             CCChHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCc
Q 039626          419 NGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGE  498 (628)
Q Consensus       419 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~  498 (628)
                      +|+|.+++.... ......+...+.|+.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+|+........
T Consensus        99 gg~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vKl~DFGla~~~~~~~~~  174 (299)
T 4g31_A           99 KENLKDWMNGRC-TIEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEE  174 (299)
T ss_dssp             SCCHHHHHHTCC-SGGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCCCC---------
T ss_pred             CCcHHHHHHhcC-CCChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEEEccCccceecCCCccc
Confidence            999999996432 223467788899999999999999995   4999999999999999999999999999877543211


Q ss_pred             c---------eeeecccCCccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccc
Q 039626          499 F---------ALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDG  569 (628)
Q Consensus       499 ~---------~~~~~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~  569 (628)
                      .         ......+||+.|||||.+.+..++.++|||||||++|||++   |+....+     ....+..+...   
T Consensus       175 ~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~-----~~~~~~~~~~~---  243 (299)
T 4g31_A          175 QTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQME-----RVRTLTDVRNL---  243 (299)
T ss_dssp             -----------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHH-----HHHHHHHHHTT---
T ss_pred             cccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccH-----HHHHHHHHhcC---
Confidence            1         11233579999999999999999999999999999999996   4432110     11111111110   


Q ss_pred             hhhhccccCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          570 EESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       570 ~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                                ..+ ....+....+.+|+.+||+.||++|||+.|+++
T Consensus       244 ----------~~p-~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  279 (299)
T 4g31_A          244 ----------KFP-PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE  279 (299)
T ss_dssp             ----------CCC-HHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ----------CCC-CCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence                      000 001123345678999999999999999999875

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=2e-42  Score=360.59  Aligned_cols=280  Identities=34%  Similarity=0.622  Sum_probs=237.0

Q ss_pred             CcceeecHHHHHHHhcCCCcCCccc----eEEEEEEE-CCceEEEEEecc--------chHHHHHHHhhcCCCceeeeee
Q 039626          336 QSLKVYSFKELQSATDNFSFTCRIQ----GSVYRGKI-NGGFAAIKKVNG--------DVSKEIALLNKINHSNLIILSG  402 (628)
Q Consensus       336 ~~~~~~~~~el~~at~~f~~~~~i~----G~Vy~g~~-~g~~vavK~~~~--------~~~~E~~~l~~l~H~nIv~l~g  402 (628)
                      ...+.|+++++..++++|.....+|    |.||+|.. +|+.||||+++.        .+.+|++++++++|+||+++++
T Consensus        15 ~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~   94 (326)
T 3uim_A           15 GQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRG   94 (326)
T ss_dssp             CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCE
T ss_pred             CccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEE
Confidence            4467899999999999999888886    89999988 688999999864        4678999999999999999999


Q ss_pred             eeecCCeEEEEEEecCCCChHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEE
Q 039626          403 VCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAK  482 (628)
Q Consensus       403 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~k  482 (628)
                      ++.+++..++||||+++|+|.+++.........++|..+..++.|++.||+|||+...++++||||||+|||+++++.+|
T Consensus        95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~k  174 (326)
T 3uim_A           95 FCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV  174 (326)
T ss_dssp             EECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEE
T ss_pred             EEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEE
Confidence            99999999999999999999999977655666799999999999999999999996434799999999999999999999


Q ss_pred             EccccccccCCCCCCcceeeecccCCccccCccccccCCCCcccccHHHHHHHHHHHhCCCcccccccc--ccccHHHHH
Q 039626          483 IANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEE--NNMHLSDVL  560 (628)
Q Consensus       483 l~Dfgla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~--~~~~~~~~~  560 (628)
                      |+|||+++.......  .......||+.|+|||.+.+..++.++||||||++++||++|+.|+......  ......+++
T Consensus       175 l~Dfg~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~  252 (326)
T 3uim_A          175 VGDFGLAKLMDYKDT--HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWV  252 (326)
T ss_dssp             ECCCSSCEECCSSSS--CEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHH
T ss_pred             eccCccccccCcccc--cccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHH
Confidence            999999987653322  2234456999999999999989999999999999999999999998643221  223334443


Q ss_pred             HHHhccccchhhhccccCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 039626          561 NAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNI  621 (628)
Q Consensus       561 ~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l  621 (628)
                      .....    ...+....+..+...++.+.+..+.+++.+||+.||.+|||+.||++.|++.
T Consensus       253 ~~~~~----~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~  309 (326)
T 3uim_A          253 KGLLK----EKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD  309 (326)
T ss_dssp             TTTTS----SCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred             HHHhh----chhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence            33222    3445666777777888899999999999999999999999999999999753

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=3.1e-42  Score=358.57  Aligned_cols=281  Identities=28%  Similarity=0.509  Sum_probs=230.5

Q ss_pred             eeecHHHHHHHhcCCCcCCccc----eEEEEEEE-CCceEEEEEecc-------chHHHHHHHhhcCCCceeeeeeeeec
Q 039626          339 KVYSFKELQSATDNFSFTCRIQ----GSVYRGKI-NGGFAAIKKVNG-------DVSKEIALLNKINHSNLIILSGVCFN  406 (628)
Q Consensus       339 ~~~~~~el~~at~~f~~~~~i~----G~Vy~g~~-~g~~vavK~~~~-------~~~~E~~~l~~l~H~nIv~l~g~~~~  406 (628)
                      ..+.+.++..++++|.....+|    |.||+|++ +|+.||+|+...       .+.+|++++++++||||+++++++.+
T Consensus        27 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  106 (321)
T 2qkw_B           27 YRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDE  106 (321)
T ss_dssp             ---CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCC
T ss_pred             eeecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcC
Confidence            3455566777888998877775    89999998 588999998753       46789999999999999999999999


Q ss_pred             CCeEEEEEEecCCCChHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccc
Q 039626          407 EGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANF  486 (628)
Q Consensus       407 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Df  486 (628)
                      ++..++||||+++|+|.+++.........++|..++.++.|++.||+|||+.   +++||||||+||+++.++.+||+||
T Consensus       107 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Df  183 (321)
T 2qkw_B          107 RNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDF  183 (321)
T ss_dssp             TTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEECCC
T ss_pred             CCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEeec
Confidence            9999999999999999999965544445699999999999999999999994   5999999999999999999999999


Q ss_pred             cccccCCCCCCcceeeecccCCccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhcc
Q 039626          487 AMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTK  566 (628)
Q Consensus       487 gla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~  566 (628)
                      |+++........ .......||+.|+|||.+.+..++.++||||||+++|||++|+.|+.............+...... 
T Consensus       184 g~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~-  261 (321)
T 2qkw_B          184 GISKKGTELDQT-HLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHN-  261 (321)
T ss_dssp             TTCEECSSSSCC-CCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHT-
T ss_pred             cccccccccccc-ccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccc-
Confidence            999865432211 122345689999999999999999999999999999999999999875544433333333322221 


Q ss_pred             ccchhhhccccCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhccC
Q 039626          567 EDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNASLN  627 (628)
Q Consensus       567 ~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~~~~~~  627 (628)
                         ...+...+++.+....+.+....+.+++.+||+.||++|||+.|+++.|+.++...-+
T Consensus       262 ---~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~~~~  319 (321)
T 2qkw_B          262 ---NGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQES  319 (321)
T ss_dssp             ---TTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSCC
T ss_pred             ---cccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhcccC
Confidence               2345566777777778889999999999999999999999999999999999875544

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.7e-41  Score=361.91  Aligned_cols=245  Identities=22%  Similarity=0.330  Sum_probs=181.9

Q ss_pred             eEEEEEEE--CCceEEEEEecc---------chHHHHHHHhhcCCCceeeeeeeeec------CCeEEEEEEecCCCChH
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG---------DVSKEIALLNKINHSNLIILSGVCFN------EGNCYLVYEYAVNGTLS  423 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~---------~~~~E~~~l~~l~H~nIv~l~g~~~~------~~~~~lV~E~~~~gsL~  423 (628)
                      |.||+|+.  +|+.||||+++.         .+.+|+++|++++|||||++++++..      .+..|||||||+ |+|.
T Consensus        68 G~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~~ivmE~~~-g~L~  146 (398)
T 4b99_A           68 GVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLME-SDLH  146 (398)
T ss_dssp             CEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCEEEEEECCS-EEHH
T ss_pred             eEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEEEEEEeCCC-CCHH
Confidence            89999998  689999999964         25679999999999999999999763      357899999995 7899


Q ss_pred             HHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCC-cceee
Q 039626          424 DWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEG-EFALT  502 (628)
Q Consensus       424 ~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~-~~~~~  502 (628)
                      +++..    .+.+++.....++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+|+....... .....
T Consensus       147 ~~i~~----~~~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~~~~~~~~~  219 (398)
T 4b99_A          147 QIIHS----SQPLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFM  219 (398)
T ss_dssp             HHHTS----SSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCBCC-------CCCC
T ss_pred             HHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeecceeeecccCcccccccc
Confidence            99843    45699999999999999999999995   499999999999999999999999999987643221 11233


Q ss_pred             ecccCCccccCccccccC-CCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccch-------hhhc
Q 039626          503 RHIVGTKGYMAPEYLENG-LVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGE-------ESLR  574 (628)
Q Consensus       503 ~~~~gt~~Y~APE~l~~~-~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~l~  574 (628)
                      ...+||+.|||||++.+. .++.++||||+||+++||++|+.||......+   ....+..........       ....
T Consensus       220 ~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~---~l~~I~~~~g~p~~~~~~~~~~~~~~  296 (398)
T 4b99_A          220 TEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVH---QLQLIMMVLGTPSPAVIQAVGAERVR  296 (398)
T ss_dssp             CSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHH---HHHHHHHHHCCCCGGGTC-----CHH
T ss_pred             ccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHH---HHHHHHHhcCCCChHHhhhhhhhhhh
Confidence            456899999999998775 56999999999999999999999997543221   111121111111000       0000


Q ss_pred             cccCCc-CCCCCCH-----HHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          575 HFIDPT-LQGNYPL-----ELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       575 ~~~d~~-l~~~~~~-----~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      ..+... .....+.     ..+..+.+|+.+||+.||++|||+.|+++
T Consensus       297 ~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  344 (398)
T 4b99_A          297 AYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR  344 (398)
T ss_dssp             HHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             hhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            000000 0000111     12346789999999999999999999875

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=8.1e-40  Score=337.76  Aligned_cols=276  Identities=33%  Similarity=0.575  Sum_probs=223.4

Q ss_pred             cceeecHHHHHHHhcCCCcC------Cccc----eEEEEEEECCceEEEEEecc-----------chHHHHHHHhhcCCC
Q 039626          337 SLKVYSFKELQSATDNFSFT------CRIQ----GSVYRGKINGGFAAIKKVNG-----------DVSKEIALLNKINHS  395 (628)
Q Consensus       337 ~~~~~~~~el~~at~~f~~~------~~i~----G~Vy~g~~~g~~vavK~~~~-----------~~~~E~~~l~~l~H~  395 (628)
                      ....|+++++..++++|...      ..+|    |.||+|+.+++.+|+|++..           .+.+|++++++++||
T Consensus        11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~   90 (307)
T 2nru_A           11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHE   90 (307)
T ss_dssp             CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEESSSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCT
T ss_pred             CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEECCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCC
Confidence            35789999999999999977      5554    89999999999999999853           366899999999999


Q ss_pred             ceeeeeeeeecCCeEEEEEEecCCCChHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEe
Q 039626          396 NLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLL  475 (628)
Q Consensus       396 nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl  475 (628)
                      ||+++++++.+++..++||||+++|+|.+++.... ....++|..++.++.+++.||+|||+.   +++||||||+||++
T Consensus        91 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nili  166 (307)
T 2nru_A           91 NLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLD-GTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILL  166 (307)
T ss_dssp             TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGG-GCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEE
T ss_pred             CeEEEEEEEecCCceEEEEEecCCCcHHHHHHhcc-CCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEE
Confidence            99999999999999999999999999999996432 245699999999999999999999995   49999999999999


Q ss_pred             CCCCcEEEccccccccCCCCCCcceeeecccCCccccCccccccCCCCcccccHHHHHHHHHHHhCCCcccccccccccc
Q 039626          476 DSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMH  555 (628)
Q Consensus       476 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~  555 (628)
                      ++++.+||+|||+++........ .......||+.|+|||.+.+ .++.++||||||+++|||++|+.|+.......  .
T Consensus       167 ~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--~  242 (307)
T 2nru_A          167 DEAFTAKISDFGLARASEKFAQT-VMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQ--L  242 (307)
T ss_dssp             CTTCCEEECCCTTCEECCSCSSC-EECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSS--B
T ss_pred             cCCCcEEEeeccccccccccccc-ccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchH--H
Confidence            99999999999999876533221 22344579999999998865 58999999999999999999999987544322  1


Q ss_pred             HHHHHHHHhccccchhhhccccCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhh
Q 039626          556 LSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNA  624 (628)
Q Consensus       556 ~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~~~  624 (628)
                      +..+.......   ...+..++++.+. ..+......+.+++.+||+.||.+|||++||++.|+++..+
T Consensus       243 ~~~~~~~~~~~---~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~s  307 (307)
T 2nru_A          243 LLDIKEEIEDE---EKTIEDYIDKKMN-DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS  307 (307)
T ss_dssp             TTHHHHHHHTT---SCCHHHHSCSSCS-CCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC--
T ss_pred             HHHHHHHhhhh---hhhhhhhcccccc-ccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhcC
Confidence            22222222111   2233444554443 45677888899999999999999999999999999998653

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=7e-41  Score=353.19  Aligned_cols=190  Identities=21%  Similarity=0.324  Sum_probs=159.1

Q ss_pred             HHhcCCCcCCccc----eEEEEEEE-----CCceEEEEEecc-----chHHHHHHHhhc-CCCceeeeeeeeecCCeEEE
Q 039626          348 SATDNFSFTCRIQ----GSVYRGKI-----NGGFAAIKKVNG-----DVSKEIALLNKI-NHSNLIILSGVCFNEGNCYL  412 (628)
Q Consensus       348 ~at~~f~~~~~i~----G~Vy~g~~-----~g~~vavK~~~~-----~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~l  412 (628)
                      ...+.|.....+|    |.||+|+.     .++.||+|++..     ++.+|+++|+++ +|||||++++++.++++.|+
T Consensus        18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~l   97 (361)
T 4f9c_A           18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVI   97 (361)
T ss_dssp             GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEE
T ss_pred             CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEE
Confidence            3456677666665    89999975     357899999864     367899999998 69999999999999999999


Q ss_pred             EEEecCCCChHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCC-CcEEEcccccccc
Q 039626          413 VYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSD-LRAKIANFAMARP  491 (628)
Q Consensus       413 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~-~~~kl~Dfgla~~  491 (628)
                      ||||+++|+|.+++.       .+++.+...++.|++.||+|||+.+   |+||||||+|||++.+ +.+||+|||+|+.
T Consensus        98 vmE~~~g~~L~~~~~-------~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFGla~~  167 (361)
T 4f9c_A           98 AMPYLEHESFLDILN-------SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGLAQG  167 (361)
T ss_dssp             EEECCCCCCHHHHHT-------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred             EEeCCCcccHHHHHc-------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCCCCcc
Confidence            999999999999982       3899999999999999999999954   9999999999999877 7999999999986


Q ss_pred             CCCCCCc-------------------------ceeeecccCCccccCccccccC-CCCcccccHHHHHHHHHHHhCCCcc
Q 039626          492 AEGQEGE-------------------------FALTRHIVGTKGYMAPEYLENG-LVSTKLDVYAFGVLILEMLTGKEAA  545 (628)
Q Consensus       492 ~~~~~~~-------------------------~~~~~~~~gt~~Y~APE~l~~~-~~s~k~DV~SfGvvl~ELltG~~p~  545 (628)
                      .......                         .......+||+.|+|||.+.+. .++.++||||+||+++||++|+.||
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf  247 (361)
T 4f9c_A          168 THDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPF  247 (361)
T ss_dssp             CTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSS
T ss_pred             cCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCC
Confidence            5432110                         0112335799999999999775 5899999999999999999999998


Q ss_pred             cc
Q 039626          546 AL  547 (628)
Q Consensus       546 ~~  547 (628)
                      ..
T Consensus       248 ~~  249 (361)
T 4f9c_A          248 YK  249 (361)
T ss_dssp             SC
T ss_pred             CC
Confidence            63

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=2.6e-40  Score=368.01  Aligned_cols=231  Identities=20%  Similarity=0.312  Sum_probs=186.2

Q ss_pred             cCCCcCCccc----eEEEEEEE--CCceEEEEEeccc----------hH---HHHHHHhhcCCCceeeeeeeeecCCeEE
Q 039626          351 DNFSFTCRIQ----GSVYRGKI--NGGFAAIKKVNGD----------VS---KEIALLNKINHSNLIILSGVCFNEGNCY  411 (628)
Q Consensus       351 ~~f~~~~~i~----G~Vy~g~~--~g~~vavK~~~~~----------~~---~E~~~l~~l~H~nIv~l~g~~~~~~~~~  411 (628)
                      ++|.....||    |.||+++.  +|+.+|||++++.          +.   .++.+++.++|||||++++++.+++.+|
T Consensus       189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly  268 (689)
T 3v5w_A          189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS  268 (689)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence            4566655665    89999998  6899999998642          22   3467778889999999999999999999


Q ss_pred             EEEEecCCCChHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEcccccccc
Q 039626          412 LVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARP  491 (628)
Q Consensus       412 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~  491 (628)
                      |||||++||+|.++|...    ..+++.....++.||+.||+|||+.   +|+||||||+||||+.+|.+||+|||+|+.
T Consensus       269 lVmEy~~GGdL~~~l~~~----~~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~DFGlA~~  341 (689)
T 3v5w_A          269 FILDLMNGGDLHYHLSQH----GVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACD  341 (689)
T ss_dssp             EEECCCCSCBHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             EEEecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEecccceeee
Confidence            999999999999999643    3589999999999999999999995   499999999999999999999999999987


Q ss_pred             CCCCCCcceeeecccCCccccCcccccc-CCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccch
Q 039626          492 AEGQEGEFALTRHIVGTKGYMAPEYLEN-GLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGE  570 (628)
Q Consensus       492 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  570 (628)
                      .....     ....+||+.|||||++.. ..++.++|+||+||++|||++|+.||.......   ............   
T Consensus       342 ~~~~~-----~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~---~~~i~~~i~~~~---  410 (689)
T 3v5w_A          342 FSKKK-----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD---KHEIDRMTLTMA---  410 (689)
T ss_dssp             CSSCC-----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCC---HHHHHHHHHHCC---
T ss_pred             cCCCC-----CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHhhcCCC---
Confidence            65332     334689999999999964 579999999999999999999999997543221   122222221110   


Q ss_pred             hhhccccCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCH
Q 039626          571 ESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTM  611 (628)
Q Consensus       571 ~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~  611 (628)
                                  ..+|...+..+.+|+.+||+.||.+|++.
T Consensus       411 ------------~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~  439 (689)
T 3v5w_A          411 ------------VELPDSFSPELRSLLEGLLQRDVNRRLGC  439 (689)
T ss_dssp             ------------CCCCTTSCHHHHHHHHHHTCSCGGGCTTC
T ss_pred             ------------CCCCccCCHHHHHHHHHHccCCHhHCCCC
Confidence                        12233445668899999999999999983

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=5.5e-40  Score=340.04  Aligned_cols=251  Identities=28%  Similarity=0.486  Sum_probs=191.9

Q ss_pred             cCCCcCCccc----eEEEEEEECCceEEEEEecc---------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEec
Q 039626          351 DNFSFTCRIQ----GSVYRGKINGGFAAIKKVNG---------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYA  417 (628)
Q Consensus       351 ~~f~~~~~i~----G~Vy~g~~~g~~vavK~~~~---------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~  417 (628)
                      ++|.....+|    |.||+++.+|..||+|++..         ++.+|++++++++|+||+++++++.+.+..++||||+
T Consensus        37 ~~y~i~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~  116 (309)
T 3p86_A           37 CDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYL  116 (309)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEECC
T ss_pred             hHceeeeEeecCCCeEEEEEEECCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEecC
Confidence            3454444454    89999999999999999853         3668999999999999999999999999999999999


Q ss_pred             CCCChHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCC
Q 039626          418 VNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEG  497 (628)
Q Consensus       418 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~  497 (628)
                      ++|+|.+++.... ....+++..++.++.|++.||+|||+.+ ++++||||||+|||++.++.+||+|||+++...... 
T Consensus       117 ~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~-  193 (309)
T 3p86_A          117 SRGSLYRLLHKSG-AREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTF-  193 (309)
T ss_dssp             TTCBHHHHHHSTT-HHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC----------
T ss_pred             CCCcHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCCccccccc-
Confidence            9999999995421 1234999999999999999999999954 459999999999999999999999999998654321 


Q ss_pred             cceeeecccCCccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhcccc
Q 039626          498 EFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFI  577 (628)
Q Consensus       498 ~~~~~~~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  577 (628)
                        .......||+.|+|||.+.+..++.++||||||+++|||++|+.||.....      .+....+...         . 
T Consensus       194 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~------~~~~~~~~~~---------~-  255 (309)
T 3p86_A          194 --LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNP------AQVVAAVGFK---------C-  255 (309)
T ss_dssp             ----------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCH------HHHHHHHHHS---------C-
T ss_pred             --cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHhc---------C-
Confidence              123345799999999999999999999999999999999999999864322      1111111100         0 


Q ss_pred             CCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhc
Q 039626          578 DPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNAS  625 (628)
Q Consensus       578 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~~~~  625 (628)
                         .....+...+..+.+++.+||+.||.+|||+.|+++.|+.++.+.
T Consensus       256 ---~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~  300 (309)
T 3p86_A          256 ---KRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA  300 (309)
T ss_dssp             ---CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC--
T ss_pred             ---CCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhC
Confidence               011222334456889999999999999999999999999998653

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=9.3e-40  Score=364.88  Aligned_cols=239  Identities=22%  Similarity=0.296  Sum_probs=192.3

Q ss_pred             cCCCcCCccc----eEEEEEEE--CCceEEEEEecc-------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEec
Q 039626          351 DNFSFTCRIQ----GSVYRGKI--NGGFAAIKKVNG-------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYA  417 (628)
Q Consensus       351 ~~f~~~~~i~----G~Vy~g~~--~g~~vavK~~~~-------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~  417 (628)
                      ++|.....||    |.||+++.  +|+.+|+|+++.       .+.+|+++|++++|||||++++++.+++..|||||||
T Consensus       157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~  236 (573)
T 3uto_A          157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM  236 (573)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeec
Confidence            3455444554    89999998  689999998853       3678999999999999999999999999999999999


Q ss_pred             CCCChHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCC--CcEEEccccccccCCCC
Q 039626          418 VNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSD--LRAKIANFAMARPAEGQ  495 (628)
Q Consensus       418 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~--~~~kl~Dfgla~~~~~~  495 (628)
                      +||+|.++|..   ....+++.+...++.||+.||+|||+.   +|+||||||+|||++.+  +.+||+|||+++.+...
T Consensus       237 ~gg~L~~~i~~---~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~  310 (573)
T 3uto_A          237 SGGELFEKVAD---EHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK  310 (573)
T ss_dssp             CCCBHHHHHTC---TTSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT
T ss_pred             CCCcHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccceeEccCC
Confidence            99999999843   334699999999999999999999995   49999999999999854  89999999999987543


Q ss_pred             CCcceeeecccCCccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhcc
Q 039626          496 EGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRH  575 (628)
Q Consensus       496 ~~~~~~~~~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  575 (628)
                      .    ......||+.|||||.+.+..++.++||||+||++|||++|+.||.....      .+.+..+.....       
T Consensus       311 ~----~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~------~~~~~~i~~~~~-------  373 (573)
T 3uto_A          311 Q----SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND------DETLRNVKSCDW-------  373 (573)
T ss_dssp             S----EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH------HHHHHHHHTTCC-------
T ss_pred             C----ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH------HHHHHHHHhCCC-------
Confidence            2    23456899999999999999999999999999999999999999864322      222222222110       


Q ss_pred             ccCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          576 FIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       576 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                          ..........+..+.+|+.+||+.||.+|||+.|+++
T Consensus       374 ----~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~  410 (573)
T 3uto_A          374 ----NMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE  410 (573)
T ss_dssp             ----CCCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             ----CCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                0000111123456789999999999999999999875

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=9.9e-40  Score=340.59  Aligned_cols=239  Identities=26%  Similarity=0.409  Sum_probs=192.3

Q ss_pred             eEEEEEEE-----CCceEEEEEecc--------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhh
Q 039626          361 GSVYRGKI-----NGGFAAIKKVNG--------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVF  427 (628)
Q Consensus       361 G~Vy~g~~-----~g~~vavK~~~~--------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~  427 (628)
                      |.||+|.+     .+..||||+++.        ++.+|++++++++|+||+++++++.+++..++||||+++|+|.+++.
T Consensus        63 g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~  142 (325)
T 3kul_A           63 GEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLR  142 (325)
T ss_dssp             EEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEEEECCTTCBHHHHHH
T ss_pred             cEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEEeeCCCCCcHHHHHH
Confidence            89999998     234599999874        36789999999999999999999999999999999999999999995


Q ss_pred             hcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccC
Q 039626          428 SNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVG  507 (628)
Q Consensus       428 ~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~g  507 (628)
                      .   ....+++..++.++.+++.||+|||+.   +|+||||||+|||++.++.+||+|||+++................+
T Consensus       143 ~---~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~  216 (325)
T 3kul_A          143 T---HDGQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKI  216 (325)
T ss_dssp             T---TTTCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSSCEECC----CCEECC---C
T ss_pred             h---cccCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCcccccccCccceeeccCCCC
Confidence            4   234599999999999999999999995   4999999999999999999999999999877544332223334467


Q ss_pred             CccccCccccccCCCCcccccHHHHHHHHHHHh-CCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCC
Q 039626          508 TKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT-GKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYP  586 (628)
Q Consensus       508 t~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELlt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~  586 (628)
                      |+.|+|||.+.+..++.++||||||+++|||++ |+.|+.....      .+....+...              .....+
T Consensus       217 t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~------~~~~~~~~~~--------------~~~~~~  276 (325)
T 3kul_A          217 PIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTN------RDVISSVEEG--------------YRLPAP  276 (325)
T ss_dssp             CGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCH------HHHHHHHHTT--------------CCCCCC
T ss_pred             cccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCH------HHHHHHHHcC--------------CCCCCC
Confidence            889999999999999999999999999999999 9988853322      1222221110              111122


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhc
Q 039626          587 LELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNAS  625 (628)
Q Consensus       587 ~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~~~~  625 (628)
                      ...+..+.+++.+||+.||.+|||+.||++.|++++...
T Consensus       277 ~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~  315 (325)
T 3kul_A          277 MGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSP  315 (325)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSC
T ss_pred             CCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCc
Confidence            334456889999999999999999999999999998764

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=5.4e-40  Score=342.02  Aligned_cols=255  Identities=25%  Similarity=0.401  Sum_probs=194.3

Q ss_pred             eEEEEEEECCceEEEEEeccc------hHHHHHHHhhcCCCceeeeeeeeecCC----eEEEEEEecCCCChHHHhhhcC
Q 039626          361 GSVYRGKINGGFAAIKKVNGD------VSKEIALLNKINHSNLIILSGVCFNEG----NCYLVYEYAVNGTLSDWVFSNK  430 (628)
Q Consensus       361 G~Vy~g~~~g~~vavK~~~~~------~~~E~~~l~~l~H~nIv~l~g~~~~~~----~~~lV~E~~~~gsL~~~l~~~~  430 (628)
                      |.||+|++.++.||||++..+      ...|+.++++++||||+++++++....    ..++||||+++|+|.+++..  
T Consensus        38 g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~--  115 (322)
T 3soc_A           38 GCVWKAQLLNEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA--  115 (322)
T ss_dssp             CEEEEEEETTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHH--
T ss_pred             eEEEEEEECCCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEEecCCCCCHHHHHHh--
Confidence            899999999999999998642      456888999999999999999998743    47999999999999999954  


Q ss_pred             CCCCCCCHHHHHHHHHHHHHHHHHHhcC-------CCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeee
Q 039626          431 NEGKYLDWKQRIQIALDVATGLNYLHSF-------TNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTR  503 (628)
Q Consensus       431 ~~~~~l~~~~~~~i~~~ia~gL~yLH~~-------~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~  503 (628)
                         ..++|..+..++.|++.||+|||+.       ..++|+||||||+|||++.++.+||+|||+++........ ....
T Consensus       116 ---~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a~~~~~~~~~-~~~~  191 (322)
T 3soc_A          116 ---NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSA-GDTH  191 (322)
T ss_dssp             ---CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTTCEEECTTSCC-CCCT
T ss_pred             ---cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCcccccccccCc-cccc
Confidence               2489999999999999999999985       0126999999999999999999999999999876543221 1223


Q ss_pred             cccCCccccCcccccc-----CCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchh----hhc
Q 039626          504 HIVGTKGYMAPEYLEN-----GLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEE----SLR  574 (628)
Q Consensus       504 ~~~gt~~Y~APE~l~~-----~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~----~l~  574 (628)
                      ...||+.|+|||.+.+     ..++.++||||||+++|||++|+.|+................   .......    ...
T Consensus       192 ~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~  268 (322)
T 3soc_A          192 GQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIG---QHPSLEDMQEVVVH  268 (322)
T ss_dssp             TCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHC---SSCCHHHHHHHHTT
T ss_pred             cCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhc---cCCchhhhhhhhhc
Confidence            3579999999999986     356678999999999999999999987544332222111100   0000000    001


Q ss_pred             cccCCcCCCC-CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhh
Q 039626          575 HFIDPTLQGN-YPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNA  624 (628)
Q Consensus       575 ~~~d~~l~~~-~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~~~  624 (628)
                      ....+.+... ........+.+++.+||+.||++|||+.||++.|++|...
T Consensus       269 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~  319 (322)
T 3soc_A          269 KKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL  319 (322)
T ss_dssp             SCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence            1111111111 1224566799999999999999999999999999998764

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=1.6e-39  Score=336.25  Aligned_cols=240  Identities=25%  Similarity=0.434  Sum_probs=191.7

Q ss_pred             eEEEEEEE--CCceEEEEEecc-------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhcCC
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG-------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKN  431 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~-------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~  431 (628)
                      |.||++..  +++.+|+|++..       .+.+|++++++++||||+++++++.+++..++||||+++|+|.+++...  
T Consensus        24 g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--  101 (310)
T 3s95_A           24 GQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSM--  101 (310)
T ss_dssp             EEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHC--
T ss_pred             EEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEecCCCcHHHHHHhc--
Confidence            89999998  588999998853       4678999999999999999999999999999999999999999999652  


Q ss_pred             CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcc-----------e
Q 039626          432 EGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEF-----------A  500 (628)
Q Consensus       432 ~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~-----------~  500 (628)
                       ...++|..++.++.|++.||+|||+.   +++||||||+|||++.++.+||+|||+++.........           .
T Consensus       102 -~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~  177 (310)
T 3s95_A          102 -DSQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRK  177 (310)
T ss_dssp             -CTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEECC------------------
T ss_pred             -cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccceecccccccccccccccccccc
Confidence             34599999999999999999999995   49999999999999999999999999998764332111           0


Q ss_pred             eeecccCCccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCc
Q 039626          501 LTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPT  580 (628)
Q Consensus       501 ~~~~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~  580 (628)
                      ......||+.|+|||.+.+..++.++||||||+++|||++|..|+..........              ........+..
T Consensus       178 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~--------------~~~~~~~~~~~  243 (310)
T 3s95_A          178 KRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDF--------------GLNVRGFLDRY  243 (310)
T ss_dssp             --CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTS--------------SBCHHHHHHHT
T ss_pred             cccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHH--------------hhhhhcccccc
Confidence            1114579999999999999999999999999999999999998876432221100              00001111111


Q ss_pred             CCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhh
Q 039626          581 LQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNA  624 (628)
Q Consensus       581 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~~~  624 (628)
                      ....    .+..+.+++.+||+.||++|||+.|+++.|+.+...
T Consensus       244 ~~~~----~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~  283 (310)
T 3s95_A          244 CPPN----CPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMH  283 (310)
T ss_dssp             CCTT----CCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCCC----CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence            1122    234578999999999999999999999999988753

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=1e-39  Score=347.03  Aligned_cols=247  Identities=24%  Similarity=0.409  Sum_probs=184.9

Q ss_pred             CCCcCCccc----eEEEEEEEC-----CceEEEEEecc--------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEE
Q 039626          352 NFSFTCRIQ----GSVYRGKIN-----GGFAAIKKVNG--------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVY  414 (628)
Q Consensus       352 ~f~~~~~i~----G~Vy~g~~~-----g~~vavK~~~~--------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~  414 (628)
                      +|.....+|    |.||+|++.     +..||||+++.        ++.+|++++++++||||+++++++.+++..++||
T Consensus        46 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  125 (373)
T 2qol_A           46 NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVT  125 (373)
T ss_dssp             GCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             hceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEEE
Confidence            445445554    899999873     56799999863        4678999999999999999999999999999999


Q ss_pred             EecCCCChHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCC
Q 039626          415 EYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEG  494 (628)
Q Consensus       415 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~  494 (628)
                      ||+++|+|.+++..   ....+++.+++.++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++....
T Consensus       126 e~~~~~sL~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  199 (373)
T 2qol_A          126 EYMENGSLDSFLRK---HDAQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRVLED  199 (373)
T ss_dssp             ECCTTCBHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred             eCCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCcccccccc
Confidence            99999999999954   234699999999999999999999995   499999999999999999999999999987654


Q ss_pred             CCCcceeeecccCCccccCccccccCCCCcccccHHHHHHHHHHHh-CCCccccccccccccHHHHHHHHhccccchhhh
Q 039626          495 QEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT-GKEAAALHAEENNMHLSDVLNAVLTKEDGEESL  573 (628)
Q Consensus       495 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELlt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  573 (628)
                      ............++..|+|||.+.+..++.++||||||+++|||++ |+.|+.....      .+....+..        
T Consensus       200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~------~~~~~~i~~--------  265 (373)
T 2qol_A          200 DPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN------QDVIKAVDE--------  265 (373)
T ss_dssp             --------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCH------HHHHHHHHT--------
T ss_pred             CCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCH------HHHHHHHHc--------
Confidence            3222112223356788999999999999999999999999999998 9988853221      122211111        


Q ss_pred             ccccCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhh
Q 039626          574 RHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNA  624 (628)
Q Consensus       574 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~~~  624 (628)
                            ......+...+..+.+++.+||+.||.+||++.||++.|++++..
T Consensus       266 ------~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~  310 (373)
T 2qol_A          266 ------GYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN  310 (373)
T ss_dssp             ------TEECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             ------CCCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence                  011112223456688999999999999999999999999999764

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=3.6e-39  Score=342.49  Aligned_cols=241  Identities=26%  Similarity=0.422  Sum_probs=194.1

Q ss_pred             eEEEEEEEC---------CceEEEEEecc--------chHHHHHHHhhc-CCCceeeeeeeeecCCeEEEEEEecCCCCh
Q 039626          361 GSVYRGKIN---------GGFAAIKKVNG--------DVSKEIALLNKI-NHSNLIILSGVCFNEGNCYLVYEYAVNGTL  422 (628)
Q Consensus       361 G~Vy~g~~~---------g~~vavK~~~~--------~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL  422 (628)
                      |.||+++..         +..||||+++.        ++.+|+++|+++ +||||++++++|.+++..++||||+++|+|
T Consensus        95 g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L  174 (370)
T 2psq_A           95 GQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL  174 (370)
T ss_dssp             SEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSSSCEEEEECCTTCBH
T ss_pred             eeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCCCEEEEEEcCCCCCH
Confidence            899999862         34699999864        367899999999 899999999999999999999999999999


Q ss_pred             HHHhhhcCC------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccc
Q 039626          423 SDWVFSNKN------------EGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMAR  490 (628)
Q Consensus       423 ~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~  490 (628)
                      .+++.....            ....+++..++.++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++
T Consensus       175 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~  251 (370)
T 2psq_A          175 REYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLAR  251 (370)
T ss_dssp             HHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCSSCE
T ss_pred             HHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchhhEEECCCCCEEEccccCCc
Confidence            999976432            124589999999999999999999995   49999999999999999999999999998


Q ss_pred             cCCCCCCcceeeecccCCccccCccccccCCCCcccccHHHHHHHHHHHh-CCCccccccccccccHHHHHHHHhccccc
Q 039626          491 PAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT-GKEAAALHAEENNMHLSDVLNAVLTKEDG  569 (628)
Q Consensus       491 ~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELlt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~  569 (628)
                      ........ .......+|+.|+|||.+.+..++.++|||||||++|||++ |+.|+.......   +..   .+..    
T Consensus       252 ~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~---~~~---~~~~----  320 (370)
T 2psq_A          252 DINNIDYY-KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE---LFK---LLKE----  320 (370)
T ss_dssp             ETTCCCTT-CTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---HHH---HHHT----
T ss_pred             ccCcccce-ecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHH---HHhc----
Confidence            76533211 12233467889999999999999999999999999999999 888876432211   111   1111    


Q ss_pred             hhhhccccCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhc
Q 039626          570 EESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNAS  625 (628)
Q Consensus       570 ~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~~~~  625 (628)
                            ..    ....+..++..+.+++.+||+.||.+||++.|+++.|+++++..
T Consensus       321 ------~~----~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~  366 (370)
T 2psq_A          321 ------GH----RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT  366 (370)
T ss_dssp             ------TC----CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             ------CC----CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence                  00    11222334456889999999999999999999999999998754

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=1.1e-39  Score=334.96  Aligned_cols=251  Identities=23%  Similarity=0.414  Sum_probs=189.4

Q ss_pred             eEEEEEEE------CCceEEEEEecc-------chHHHHHHHhhcCCCceeeeeeeeecC--CeEEEEEEecCCCChHHH
Q 039626          361 GSVYRGKI------NGGFAAIKKVNG-------DVSKEIALLNKINHSNLIILSGVCFNE--GNCYLVYEYAVNGTLSDW  425 (628)
Q Consensus       361 G~Vy~g~~------~g~~vavK~~~~-------~~~~E~~~l~~l~H~nIv~l~g~~~~~--~~~~lV~E~~~~gsL~~~  425 (628)
                      |.||++++      +++.||||++..       .+.+|++++++++|+||+++++++...  ...++||||+++|+|.++
T Consensus        24 g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~  103 (295)
T 3ugc_A           24 GSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDY  103 (295)
T ss_dssp             EEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCEEEEECCTTCBHHHH
T ss_pred             EEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceEEEEEeCCCCCHHHH
Confidence            89999985      578999999864       467899999999999999999999754  568999999999999999


Q ss_pred             hhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecc
Q 039626          426 VFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHI  505 (628)
Q Consensus       426 l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~  505 (628)
                      +...   ...+++..++.++.|++.||+|||+.   +++||||||+|||++.++.+||+|||+++...............
T Consensus       104 l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~  177 (295)
T 3ugc_A          104 LQKH---KERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPG  177 (295)
T ss_dssp             HHHC---GGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCSCC-------------CT
T ss_pred             HHhc---ccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCcccccccCCcceeeeccCC
Confidence            9653   23589999999999999999999994   59999999999999999999999999998775433222233345


Q ss_pred             cCCccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccc---hhhhccccCCcCC
Q 039626          506 VGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDG---EESLRHFIDPTLQ  582 (628)
Q Consensus       506 ~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~~l~~~~d~~l~  582 (628)
                      .++..|+|||.+.+..++.++||||||+++|||++|..|+......       ...........   ...+...+.....
T Consensus       178 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (295)
T 3ugc_A          178 ESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE-------FMRMIGNDKQGQMIVFHLIELLKNNGR  250 (295)
T ss_dssp             TCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHH-------HHHHHCTTCCTHHHHHHHHHHHHTTCC
T ss_pred             CCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHH-------HHhhhcCccccchhHHHHHHHHhccCc
Confidence            6788899999999999999999999999999999999887543211       00000000000   0001111111112


Q ss_pred             CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhh
Q 039626          583 GNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNA  624 (628)
Q Consensus       583 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~~~  624 (628)
                      ...+...+..+.+++.+||+.||++|||+.|+++.|+++.+.
T Consensus       251 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~  292 (295)
T 3ugc_A          251 LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN  292 (295)
T ss_dssp             CCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             CCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence            223334456788999999999999999999999999999764

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=1.2e-38  Score=327.58  Aligned_cols=246  Identities=25%  Similarity=0.399  Sum_probs=187.2

Q ss_pred             eEEEEEEECCceEEEEEeccc----hHHHHHHHhh--cCCCceeeeeeeeecC----CeEEEEEEecCCCChHHHhhhcC
Q 039626          361 GSVYRGKINGGFAAIKKVNGD----VSKEIALLNK--INHSNLIILSGVCFNE----GNCYLVYEYAVNGTLSDWVFSNK  430 (628)
Q Consensus       361 G~Vy~g~~~g~~vavK~~~~~----~~~E~~~l~~--l~H~nIv~l~g~~~~~----~~~~lV~E~~~~gsL~~~l~~~~  430 (628)
                      |.||+|+++|+.||||++..+    +..|.+++..  ++||||+++++++...    ...++||||+++|+|.+++.   
T Consensus        22 g~V~~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~---   98 (301)
T 3q4u_A           22 GEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQ---   98 (301)
T ss_dssp             EEEEEEEETTEEEEEEEECGGGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEEECCCTTCBHHHHHT---
T ss_pred             cEEEEEEECCEEEEEEEeccccchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEehhhccCCCHHHHHh---
Confidence            899999999999999998753    4456676666  7999999999997643    45899999999999999993   


Q ss_pred             CCCCCCCHHHHHHHHHHHHHHHHHHhcCC-----CCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcce-eeec
Q 039626          431 NEGKYLDWKQRIQIALDVATGLNYLHSFT-----NPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFA-LTRH  504 (628)
Q Consensus       431 ~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-----~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~-~~~~  504 (628)
                        ...+++..+++++.|++.||+|||+..     ..+++||||||+|||++.++.+||+|||+++.......... ....
T Consensus        99 --~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~  176 (301)
T 3q4u_A           99 --LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNP  176 (301)
T ss_dssp             --TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEEECCCCC
T ss_pred             --hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCCCeeecccccccccccccc
Confidence              235999999999999999999999210     25699999999999999999999999999986644332211 1233


Q ss_pred             ccCCccccCccccccC------CCCcccccHHHHHHHHHHHhC----------CCccccccccccccHHHHHHHHhcccc
Q 039626          505 IVGTKGYMAPEYLENG------LVSTKLDVYAFGVLILEMLTG----------KEAAALHAEENNMHLSDVLNAVLTKED  568 (628)
Q Consensus       505 ~~gt~~Y~APE~l~~~------~~s~k~DV~SfGvvl~ELltG----------~~p~~~~~~~~~~~~~~~~~~~~~~~~  568 (628)
                      ..||+.|+|||.+.+.      .+++++||||||+++|||++|          +.|+........ .. ...........
T Consensus       177 ~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~~-~~-~~~~~~~~~~~  254 (301)
T 3q4u_A          177 RVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDP-SF-EDMRKVVCVDQ  254 (301)
T ss_dssp             CCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSC-CH-HHHHHHHTTSC
T ss_pred             cccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCCc-ch-hhhhHHHhccC
Confidence            4799999999999876      456799999999999999999          666643222111 11 11111111110


Q ss_pred             chhhhccccCCcCC-CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 039626          569 GEESLRHFIDPTLQ-GNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNI  621 (628)
Q Consensus       569 ~~~~l~~~~d~~l~-~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l  621 (628)
                              ..+... ...+...+..+.+++.+||+.||++|||+.||++.|++|
T Consensus       255 --------~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i  300 (301)
T 3q4u_A          255 --------QRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI  300 (301)
T ss_dssp             --------CCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred             --------CCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence                    011111 112345677899999999999999999999999999986

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=2e-38  Score=330.16  Aligned_cols=249  Identities=22%  Similarity=0.377  Sum_probs=199.2

Q ss_pred             eeecHHHHHHHhcCC----------CcCCccc----eEEEEEEE--CCceEEEEEecc-------chHHHHHHHhhcCCC
Q 039626          339 KVYSFKELQSATDNF----------SFTCRIQ----GSVYRGKI--NGGFAAIKKVNG-------DVSKEIALLNKINHS  395 (628)
Q Consensus       339 ~~~~~~el~~at~~f----------~~~~~i~----G~Vy~g~~--~g~~vavK~~~~-------~~~~E~~~l~~l~H~  395 (628)
                      ..+++++++.+++..          .....+|    |.||+|+.  +|+.||||++..       .+.+|+.++++++|+
T Consensus        23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~  102 (321)
T 2c30_A           23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF  102 (321)
T ss_dssp             --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred             CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence            568889999888753          2223343    89999998  688999999853       367899999999999


Q ss_pred             ceeeeeeeeecCCeEEEEEEecCCCChHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEe
Q 039626          396 NLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLL  475 (628)
Q Consensus       396 nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl  475 (628)
                      ||+++++++..++..++||||+++|+|.+++..     ..++|..+..++.|++.||+|||+.   +++||||||+|||+
T Consensus       103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-----~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll  174 (321)
T 2c30_A          103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ-----VRLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILL  174 (321)
T ss_dssp             TBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEE
T ss_pred             CcceEEEEEEECCEEEEEEecCCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEE
Confidence            999999999999999999999999999999842     3599999999999999999999995   59999999999999


Q ss_pred             CCCCcEEEccccccccCCCCCCcceeeecccCCccccCccccccCCCCcccccHHHHHHHHHHHhCCCcccccccccccc
Q 039626          476 DSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMH  555 (628)
Q Consensus       476 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~  555 (628)
                      +.++.+||+|||+++.......   ......||+.|+|||.+.+..++.++||||||++++||++|+.|+.....     
T Consensus       175 ~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~-----  246 (321)
T 2c30_A          175 TLDGRVKLSDFGFCAQISKDVP---KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSP-----  246 (321)
T ss_dssp             CTTCCEEECCCTTCEECCSSSC---CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-----
T ss_pred             CCCCcEEEeeeeeeeecccCcc---ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----
Confidence            9999999999999987653321   12345799999999999999999999999999999999999999864321     


Q ss_pred             HHHHHHHHhccccchhhhccccCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          556 LSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       556 ~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                       .+....+...          ..+.+.  .+...+..+.+++.+||+.||++|||+.|+++
T Consensus       247 -~~~~~~~~~~----------~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  294 (321)
T 2c30_A          247 -VQAMKRLRDS----------PPPKLK--NSHKVSPVLRDFLERMLVRDPQERATAQELLD  294 (321)
T ss_dssp             -HHHHHHHHHS----------SCCCCT--TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             -HHHHHHHhcC----------CCCCcC--ccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence             1111111111          111111  11223456789999999999999999999976

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=1.1e-38  Score=347.47  Aligned_cols=235  Identities=29%  Similarity=0.439  Sum_probs=193.5

Q ss_pred             eEEEEEEECCceEEEEEecc-----chHHHHHHHhhcCCCceeeeeeeeecCC-eEEEEEEecCCCChHHHhhhcCCCCC
Q 039626          361 GSVYRGKINGGFAAIKKVNG-----DVSKEIALLNKINHSNLIILSGVCFNEG-NCYLVYEYAVNGTLSDWVFSNKNEGK  434 (628)
Q Consensus       361 G~Vy~g~~~g~~vavK~~~~-----~~~~E~~~l~~l~H~nIv~l~g~~~~~~-~~~lV~E~~~~gsL~~~l~~~~~~~~  434 (628)
                      |.||+|.+.|..||||+++.     ++.+|+++|++++|+||+++++++.+.. ..++||||+++|+|.+++...  ...
T Consensus       207 g~V~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~--~~~  284 (450)
T 1k9a_A          207 GDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR--GRS  284 (450)
T ss_dssp             EEEEEEEETTEEEEEEEESSCTTSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECCTTCBHHHHHHHH--CTT
T ss_pred             eeEEEEEecCCeEEEEEeCCchHHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEecCCCcHHHHHHhc--CCC
Confidence            89999999999999999975     4789999999999999999999987665 799999999999999999653  233


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCCccccCc
Q 039626          435 YLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAP  514 (628)
Q Consensus       435 ~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~Y~AP  514 (628)
                      .+++..++.++.|++.||+|||+.   +++||||||+|||+++++.+||+|||+++.....      .....++..|+||
T Consensus       285 ~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~------~~~~~~~~~y~aP  355 (450)
T 1k9a_A          285 VLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST------QDTGKLPVKWTAP  355 (450)
T ss_dssp             TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTCEECC------------CCCTTTSCH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCccccccc------ccCCCCCcceeCH
Confidence            479999999999999999999995   4999999999999999999999999999854321      1223578899999


Q ss_pred             cccccCCCCcccccHHHHHHHHHHHh-CCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCHHHHHHH
Q 039626          515 EYLENGLVSTKLDVYAFGVLILEMLT-GKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLV  593 (628)
Q Consensus       515 E~l~~~~~s~k~DV~SfGvvl~ELlt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l  593 (628)
                      |.+.+..++.++||||||+++|||++ |+.|+......      +....+..          .    .+...+..++..+
T Consensus       356 E~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~------~~~~~i~~----------~----~~~~~p~~~~~~l  415 (450)
T 1k9a_A          356 EALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK------DVVPRVEK----------G----YKMDAPDGCPPAV  415 (450)
T ss_dssp             HHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTT------THHHHHHT----------T----CCCCCCTTCCHHH
T ss_pred             HHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH------HHHHHHHc----------C----CCCCCCCcCCHHH
Confidence            99999999999999999999999998 99888643221      11111111          0    1112233445668


Q ss_pred             HHHHHHhcccCCCCCCCHHHHHHHHHHhHhhcc
Q 039626          594 IRLIDACLKKDPTDRPTMYEIEHSLSNILNASL  626 (628)
Q Consensus       594 ~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~~~~~  626 (628)
                      .+++.+||+.||.+|||+.++++.|+.+...++
T Consensus       416 ~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~~l  448 (450)
T 1k9a_A          416 YDVMKNCWHLDAATRPTFLQLREQLEHIRTHEL  448 (450)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTTT
T ss_pred             HHHHHHHcCCChhHCcCHHHHHHHHHHHHHhhc
Confidence            899999999999999999999999999988765

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=5.6e-39  Score=325.12  Aligned_cols=238  Identities=26%  Similarity=0.456  Sum_probs=193.9

Q ss_pred             eEEEEEEE-CCceEEEEEecc------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhcCCCC
Q 039626          361 GSVYRGKI-NGGFAAIKKVNG------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEG  433 (628)
Q Consensus       361 G~Vy~g~~-~g~~vavK~~~~------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~  433 (628)
                      |.||++.. +++.||+|++..      ++.+|++++++++||||+++++++.+++..++||||+++|+|.+++..   ..
T Consensus        24 g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~  100 (269)
T 4hcu_A           24 GLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRT---QR  100 (269)
T ss_dssp             CEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHT---TT
T ss_pred             cEEEEEEecCCCeEEEEEecccccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCCCCcHHHHHHh---cC
Confidence            89999999 778899999864      477899999999999999999999999999999999999999999954   23


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCCccccC
Q 039626          434 KYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMA  513 (628)
Q Consensus       434 ~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~Y~A  513 (628)
                      ..+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||+++......  ........+|+.|+|
T Consensus       101 ~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~~y~a  175 (269)
T 4hcu_A          101 GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ--YTSSTGTKFPVKWAS  175 (269)
T ss_dssp             TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHH--HHSTTSTTCCGGGCC
T ss_pred             cccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEeccccccccccccc--cccccCcccccccCC
Confidence            4589999999999999999999995   49999999999999999999999999998654321  111223457788999


Q ss_pred             ccccccCCCCcccccHHHHHHHHHHHh-CCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCHHHHHH
Q 039626          514 PEYLENGLVSTKLDVYAFGVLILEMLT-GKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALL  592 (628)
Q Consensus       514 PE~l~~~~~s~k~DV~SfGvvl~ELlt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~  592 (628)
                      ||.+.+..++.++||||||++++||++ |+.|+.....      .+....+...          ..+    ..+...+..
T Consensus       176 PE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~------~~~~~~~~~~----------~~~----~~~~~~~~~  235 (269)
T 4hcu_A          176 PEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN------SEVVEDISTG----------FRL----YKPRLASTH  235 (269)
T ss_dssp             HHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH------HHHHHHHHTT----------CCC----CCCTTSCHH
T ss_pred             HHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCH------HHHHHHHhcC----------ccC----CCCCcCCHH
Confidence            999999999999999999999999999 8888764322      1222221111          111    112223456


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhcc
Q 039626          593 VIRLIDACLKKDPTDRPTMYEIEHSLSNILNASL  626 (628)
Q Consensus       593 l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~~~~~  626 (628)
                      +.+++.+||+.||++||++.|+++.|+++.++.+
T Consensus       236 ~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~gl  269 (269)
T 4hcu_A          236 VYQIMNHCWRERPEDRPAFSRLLRQLAEIAESGL  269 (269)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC--
T ss_pred             HHHHHHHHccCCcccCcCHHHHHHHHHHHHHccC
Confidence            7899999999999999999999999999988653

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=3.2e-39  Score=343.82  Aligned_cols=236  Identities=27%  Similarity=0.423  Sum_probs=190.6

Q ss_pred             eEEEEEEE--CCceEEEEEecc--------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhcC
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG--------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNK  430 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~--------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~  430 (628)
                      |.||+|++  ++..||||.++.        ++.+|+++|++++||||++++|+|.+++..++||||+++|+|.+++... 
T Consensus       128 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-  206 (377)
T 3cbl_A          128 GEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTE-  206 (377)
T ss_dssp             EEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHH-
T ss_pred             CeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEcCCCCCHHHHHHhc-
Confidence            89999999  588999999864        4678999999999999999999999999999999999999999999643 


Q ss_pred             CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCCcc
Q 039626          431 NEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKG  510 (628)
Q Consensus       431 ~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~  510 (628)
                        +..+++..++.++.|++.||+|||+.   +++||||||+|||+++++.+||+|||+++........ .......++..
T Consensus       207 --~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~-~~~~~~~~~~~  280 (377)
T 3cbl_A          207 --GARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYA-ASGGLRQVPVK  280 (377)
T ss_dssp             --GGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEE-CCSSCCEEEGG
T ss_pred             --CCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCCceecCCCcee-ecCCCCCCCcC
Confidence              34589999999999999999999995   4999999999999999999999999999865432100 01112235778


Q ss_pred             ccCccccccCCCCcccccHHHHHHHHHHHh-CCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCHHH
Q 039626          511 YMAPEYLENGLVSTKLDVYAFGVLILEMLT-GKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLEL  589 (628)
Q Consensus       511 Y~APE~l~~~~~s~k~DV~SfGvvl~ELlt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~  589 (628)
                      |+|||.+.+..++.++||||||+++|||++ |+.|+......      +....+ ..             ..+...+..+
T Consensus       281 y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~------~~~~~~-~~-------------~~~~~~~~~~  340 (377)
T 3cbl_A          281 WTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQ------QTREFV-EK-------------GGRLPCPELC  340 (377)
T ss_dssp             GSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHH------HHHHHH-HT-------------TCCCCCCTTC
T ss_pred             cCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH------HHHHHH-Hc-------------CCCCCCCCCC
Confidence            999999999999999999999999999998 88887643211      111111 10             0011122334


Q ss_pred             HHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHh
Q 039626          590 ALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILN  623 (628)
Q Consensus       590 ~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~~  623 (628)
                      +..+.+++.+||+.||++|||+.++++.|+++..
T Consensus       341 ~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~  374 (377)
T 3cbl_A          341 PDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRK  374 (377)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHh
Confidence            4568899999999999999999999999999875

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=7e-39  Score=324.50  Aligned_cols=232  Identities=32%  Similarity=0.492  Sum_probs=181.4

Q ss_pred             eEEEEEEECCceEEEEEecc-----------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhc
Q 039626          361 GSVYRGKINGGFAAIKKVNG-----------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSN  429 (628)
Q Consensus       361 G~Vy~g~~~g~~vavK~~~~-----------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~  429 (628)
                      |.||++++.|+.+|+|+.+.           .+.+|++++++++||||+++++++.+++..++||||+++|+|.+++.  
T Consensus        21 g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~--   98 (271)
T 3dtc_A           21 GKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLS--   98 (271)
T ss_dssp             EEEEEEEETTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEEECCTTEEHHHHHT--
T ss_pred             eEEEEEEEcCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEEcCCCCCHHHHhh--
Confidence            89999999999999998753           36689999999999999999999999999999999999999999983  


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCC--------CCcEEEccccccccCCCCCCccee
Q 039626          430 KNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDS--------DLRAKIANFAMARPAEGQEGEFAL  501 (628)
Q Consensus       430 ~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~--------~~~~kl~Dfgla~~~~~~~~~~~~  501 (628)
                         ...+++..+..++.|++.||+|||+.+..+++||||||+|||++.        ++.+||+|||+++......     
T Consensus        99 ---~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~-----  170 (271)
T 3dtc_A           99 ---GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTT-----  170 (271)
T ss_dssp             ---SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC-------------
T ss_pred             ---cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCccccccccc-----
Confidence               346899999999999999999999965445999999999999986        7789999999998664322     


Q ss_pred             eecccCCccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcC
Q 039626          502 TRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTL  581 (628)
Q Consensus       502 ~~~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l  581 (628)
                      .....||+.|+|||.+.+..++.++||||||++++||++|+.|+......      .........             ..
T Consensus       171 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~~~~~~~~~-------------~~  231 (271)
T 3dtc_A          171 KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGL------AVAYGVAMN-------------KL  231 (271)
T ss_dssp             -----CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHH------HHHHHHHTS-------------CC
T ss_pred             ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHhhhcC-------------CC
Confidence            22357999999999999999999999999999999999999998643221      111111110             11


Q ss_pred             CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 039626          582 QGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNI  621 (628)
Q Consensus       582 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l  621 (628)
                      ....+...+..+.+++.+||+.||.+|||+.|+++.|++|
T Consensus       232 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l  271 (271)
T 3dtc_A          232 ALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI  271 (271)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred             CCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence            1122233445688999999999999999999999999864

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=4e-39  Score=340.06  Aligned_cols=261  Identities=24%  Similarity=0.385  Sum_probs=203.2

Q ss_pred             cHHHHHHHhcCCCcCCccc----eEEEEEEE-------CCceEEEEEecc--------chHHHHHHHhhc-CCCceeeee
Q 039626          342 SFKELQSATDNFSFTCRIQ----GSVYRGKI-------NGGFAAIKKVNG--------DVSKEIALLNKI-NHSNLIILS  401 (628)
Q Consensus       342 ~~~el~~at~~f~~~~~i~----G~Vy~g~~-------~g~~vavK~~~~--------~~~~E~~~l~~l-~H~nIv~l~  401 (628)
                      ...++....++|.....+|    |.||+|++       +++.||||+++.        .+.+|++++.++ +||||++++
T Consensus        13 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~   92 (359)
T 3vhe_A           13 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL   92 (359)
T ss_dssp             CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             CcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeee
Confidence            3444444556676666664    89999985       347899999864        367899999999 899999999


Q ss_pred             eeeecCC-eEEEEEEecCCCChHHHhhhcCCC------------------------------------------------
Q 039626          402 GVCFNEG-NCYLVYEYAVNGTLSDWVFSNKNE------------------------------------------------  432 (628)
Q Consensus       402 g~~~~~~-~~~lV~E~~~~gsL~~~l~~~~~~------------------------------------------------  432 (628)
                      +++.+.+ ..++||||+++|+|.+++......                                                
T Consensus        93 ~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  172 (359)
T 3vhe_A           93 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKS  172 (359)
T ss_dssp             EEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------------------
T ss_pred             eeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccc
Confidence            9998765 489999999999999999754321                                                


Q ss_pred             --------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCc
Q 039626          433 --------------GKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGE  498 (628)
Q Consensus       433 --------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~  498 (628)
                                    ...+++..++.++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++....... 
T Consensus       173 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~-  248 (359)
T 3vhe_A          173 LSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD-  248 (359)
T ss_dssp             -----------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT-
T ss_pred             cchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeeccccc-
Confidence                          12289999999999999999999995   499999999999999999999999999987643322 


Q ss_pred             ceeeecccCCccccCccccccCCCCcccccHHHHHHHHHHHh-CCCccccccccccccHHHHHHHHhccccchhhhcccc
Q 039626          499 FALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT-GKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFI  577 (628)
Q Consensus       499 ~~~~~~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELlt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  577 (628)
                      ........||+.|+|||.+.+..++.++||||||++++||++ |+.|+.......  .....+..             ..
T Consensus       249 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~~~~~~~~-------------~~  313 (359)
T 3vhe_A          249 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--EFCRRLKE-------------GT  313 (359)
T ss_dssp             CEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH--HHHHHHHH-------------TC
T ss_pred             chhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhH--HHHHHHHc-------------CC
Confidence            223344578999999999999999999999999999999998 999886432211  11111110             00


Q ss_pred             CCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhc
Q 039626          578 DPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNAS  625 (628)
Q Consensus       578 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~~~~  625 (628)
                      ..    ..+...+..+.+++.+||+.||.+|||+.|+++.|++++++.
T Consensus       314 ~~----~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~  357 (359)
T 3vhe_A          314 RM----RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN  357 (359)
T ss_dssp             CC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             CC----CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHHh
Confidence            11    112223456789999999999999999999999999999875

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=1.7e-38  Score=326.87  Aligned_cols=237  Identities=24%  Similarity=0.399  Sum_probs=191.4

Q ss_pred             cCCCcCCccc----eEEEEEEE--CCceEEEEEecc-------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEec
Q 039626          351 DNFSFTCRIQ----GSVYRGKI--NGGFAAIKKVNG-------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYA  417 (628)
Q Consensus       351 ~~f~~~~~i~----G~Vy~g~~--~g~~vavK~~~~-------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~  417 (628)
                      +.|.....+|    |.||++..  +|+.||+|++..       .+.+|+.++++++||||+++++++..++..++||||+
T Consensus        20 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~   99 (297)
T 3fxz_A           20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (297)
T ss_dssp             GTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             hceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECC
Confidence            3455444554    89999986  788999999853       3678999999999999999999999999999999999


Q ss_pred             CCCChHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCC
Q 039626          418 VNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEG  497 (628)
Q Consensus       418 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~  497 (628)
                      ++|+|.+++..     ..+++..+..++.|++.||+|||+.   +++||||||+|||++.++.+||+|||+++.......
T Consensus       100 ~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  171 (297)
T 3fxz_A          100 AGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS  171 (297)
T ss_dssp             TTCBHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred             CCCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc
Confidence            99999999954     2489999999999999999999995   499999999999999999999999999987654322


Q ss_pred             cceeeecccCCccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhcccc
Q 039626          498 EFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFI  577 (628)
Q Consensus       498 ~~~~~~~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  577 (628)
                         ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......      +..........         
T Consensus       172 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~------~~~~~~~~~~~---------  233 (297)
T 3fxz_A          172 ---KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL------RALYLIATNGT---------  233 (297)
T ss_dssp             ---CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHHHCS---------
T ss_pred             ---ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhCCC---------
Confidence               233457999999999999999999999999999999999999998643221      11111111000         


Q ss_pred             CCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          578 DPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       578 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                       +  ....+...+..+.+++.+||+.||++|||++|+++
T Consensus       234 -~--~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  269 (297)
T 3fxz_A          234 -P--ELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ  269 (297)
T ss_dssp             -C--CCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             -C--CCCCccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence             0  01122334556889999999999999999999875

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=1.8e-38  Score=320.88  Aligned_cols=233  Identities=24%  Similarity=0.401  Sum_probs=189.5

Q ss_pred             eEEEEEEECCceEEEEEecc---------chHHHHHHHhhcCCCceeeeeeeeecC--CeEEEEEEecCCCChHHHhhhc
Q 039626          361 GSVYRGKINGGFAAIKKVNG---------DVSKEIALLNKINHSNLIILSGVCFNE--GNCYLVYEYAVNGTLSDWVFSN  429 (628)
Q Consensus       361 G~Vy~g~~~g~~vavK~~~~---------~~~~E~~~l~~l~H~nIv~l~g~~~~~--~~~~lV~E~~~~gsL~~~l~~~  429 (628)
                      |.||+|+++++.+|+|+++.         .+.+|+.++++++||||+++++++.+.  +..++||||+++|+|.+++...
T Consensus        24 g~V~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~  103 (271)
T 3kmu_A           24 GELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEG  103 (271)
T ss_dssp             EEEEEEEETTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEEECCTTCBHHHHHHSC
T ss_pred             ceEEEEEECCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeeecccCCCcHHHHHhhc
Confidence            89999999999999999863         367899999999999999999999877  7789999999999999999642


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCCc
Q 039626          430 KNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTK  509 (628)
Q Consensus       430 ~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~  509 (628)
                        ....+++..++.++.|++.||+|||+.+ ++++||||||+||+++.++.++|.|||++.....        ....||+
T Consensus       104 --~~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~--------~~~~~t~  172 (271)
T 3kmu_A          104 --TNFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQS--------PGRMYAP  172 (271)
T ss_dssp             --SSCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC--------TTCBSCG
T ss_pred             --ccCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeeecc--------cCccCCc
Confidence              2336999999999999999999999854 5599999999999999999999999988765432        2246899


Q ss_pred             cccCccccccCCCCc---ccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCC
Q 039626          510 GYMAPEYLENGLVST---KLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYP  586 (628)
Q Consensus       510 ~Y~APE~l~~~~~s~---k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~  586 (628)
                      .|+|||.+.+...+.   ++||||||+++|||++|+.|+.....      .+.......         ....+    ..+
T Consensus       173 ~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~------~~~~~~~~~---------~~~~~----~~~  233 (271)
T 3kmu_A          173 AWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSN------MEIGMKVAL---------EGLRP----TIP  233 (271)
T ss_dssp             GGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCH------HHHHHHHHH---------SCCCC----CCC
T ss_pred             cccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccCh------HHHHHHHHh---------cCCCC----CCC
Confidence            999999998765444   89999999999999999999863321      111111111         11111    222


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHh
Q 039626          587 LELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILN  623 (628)
Q Consensus       587 ~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~~  623 (628)
                      ...+..+.+++.+||+.||++|||++|+++.|+++.+
T Consensus       234 ~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~  270 (271)
T 3kmu_A          234 PGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD  270 (271)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred             CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence            3344568899999999999999999999999998864

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=1.6e-38  Score=327.17  Aligned_cols=249  Identities=23%  Similarity=0.413  Sum_probs=194.9

Q ss_pred             eEEEEEEE------CCceEEEEEecc--------chHHHHHHHhhcCCCceeeeeeeeecC--CeEEEEEEecCCCChHH
Q 039626          361 GSVYRGKI------NGGFAAIKKVNG--------DVSKEIALLNKINHSNLIILSGVCFNE--GNCYLVYEYAVNGTLSD  424 (628)
Q Consensus       361 G~Vy~g~~------~g~~vavK~~~~--------~~~~E~~~l~~l~H~nIv~l~g~~~~~--~~~~lV~E~~~~gsL~~  424 (628)
                      |.||++++      +++.||+|+++.        .+.+|++++++++|+||+++++++.+.  ...++||||+++|+|.+
T Consensus        35 g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~  114 (302)
T 4e5w_A           35 GKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKE  114 (302)
T ss_dssp             EEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCEEEEEECCTTCBHHH
T ss_pred             eEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceEEEEEEeCCCCcHHH
Confidence            89999984      678999999863        367899999999999999999999876  56899999999999999


Q ss_pred             HhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeec
Q 039626          425 WVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRH  504 (628)
Q Consensus       425 ~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~  504 (628)
                      ++...   ...+++..++.++.|++.||+|||+.   +++||||||+|||++.++.+||+|||+++..............
T Consensus       115 ~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~  188 (302)
T 4e5w_A          115 YLPKN---KNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDD  188 (302)
T ss_dssp             HHHHH---TTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCCEEECCCC
T ss_pred             HHHhc---cccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECcccccccccCCCcceeccCC
Confidence            99543   23589999999999999999999995   4999999999999999999999999999887654433333445


Q ss_pred             ccCCccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhcccc---chhhhccccCCcC
Q 039626          505 IVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKED---GEESLRHFIDPTL  581 (628)
Q Consensus       505 ~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~l~~~~d~~l  581 (628)
                      ..||..|+|||.+.+..++.++||||||++++||++|+.|+.....        ..........   ....+...+....
T Consensus       189 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (302)
T 4e5w_A          189 RDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMA--------LFLKMIGPTHGQMTVTRLVNTLKEGK  260 (302)
T ss_dssp             TTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHH--------HHHHHHCSCCGGGHHHHHHHHHHTTC
T ss_pred             CCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhh--------HHhhccCCcccccCHHHHHHHHhccC
Confidence            6788999999999999999999999999999999999987643211        0001100000   0011111111111


Q ss_pred             CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHh
Q 039626          582 QGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILN  623 (628)
Q Consensus       582 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~~  623 (628)
                      ....+...+..+.+++.+||+.||.+|||+.|+++.|+++++
T Consensus       261 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll~  302 (302)
T 4e5w_A          261 RLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALLK  302 (302)
T ss_dssp             CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred             CCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhC
Confidence            222333445678899999999999999999999999999863

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=9.5e-38  Score=326.08  Aligned_cols=243  Identities=16%  Similarity=0.183  Sum_probs=194.9

Q ss_pred             eEEEEEEE--CCceEEEEEecc-----chHHHHHHHhhc-CCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhcCCC
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG-----DVSKEIALLNKI-NHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNE  432 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~-----~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~  432 (628)
                      |.||+|+.  +|+.||||.+..     ++.+|+++++++ +|+||+++++++..++..++||||+ +|+|.+++...   
T Consensus        23 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~---   98 (330)
T 2izr_A           23 GELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL-GPSLEDLFDLC---   98 (330)
T ss_dssp             TSEEEEEETTTTEEEEEEEEETTCSSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC-CCBHHHHHHHT---
T ss_pred             ceEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC-CCCHHHHHHHc---
Confidence            89999996  788999998853     588999999999 9999999999999999999999999 99999999643   


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCc-----EEEccccccccCCCCCCcce----eee
Q 039626          433 GKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLR-----AKIANFAMARPAEGQEGEFA----LTR  503 (628)
Q Consensus       433 ~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~-----~kl~Dfgla~~~~~~~~~~~----~~~  503 (628)
                      ...+++..++.++.|++.||+|||+.   +|+||||||+|||++.++.     +||+|||+++..........    ...
T Consensus        99 ~~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~  175 (330)
T 2izr_A           99 DRTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHK  175 (330)
T ss_dssp             TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTTTCCBCCCCCCC
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecCCCCccccccccC
Confidence            34699999999999999999999995   4999999999999999887     99999999987644322111    123


Q ss_pred             cccCCccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCC
Q 039626          504 HIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQG  583 (628)
Q Consensus       504 ~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~  583 (628)
                      ...||+.|+|||.+.+..++.++||||||++++||++|+.||.......   ..+....+.....      ......+..
T Consensus       176 ~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~---~~~~~~~i~~~~~------~~~~~~~~~  246 (330)
T 2izr_A          176 SLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADT---LKERYQKIGDTKR------ATPIEVLCE  246 (330)
T ss_dssp             CCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSS---HHHHHHHHHHHHH------HSCHHHHTT
T ss_pred             CcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCcccccccc---HHHHHHHHHhhhc------cCCHHHHhc
Confidence            5689999999999999999999999999999999999999987543222   2222222111000      000000111


Q ss_pred             CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhh
Q 039626          584 NYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNA  624 (628)
Q Consensus       584 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~~~  624 (628)
                      .    .+ .+.+++.+||+.||.+||++++|.+.|+++...
T Consensus       247 ~----~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~  282 (330)
T 2izr_A          247 N----FP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDR  282 (330)
T ss_dssp             T----CH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred             c----Ch-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHH
Confidence            1    22 688999999999999999999999999998864

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=6.5e-38  Score=321.73  Aligned_cols=244  Identities=16%  Similarity=0.148  Sum_probs=194.2

Q ss_pred             eEEEEEEE--CCceEEEEEecc-----chHHHHHHHhhc-CCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhcCCC
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG-----DVSKEIALLNKI-NHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNE  432 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~-----~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~  432 (628)
                      |.||+|..  +|+.||+|++..     .+.+|++++.++ +|+|++++++++.++...++||||+ +++|.+++...   
T Consensus        24 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~---   99 (298)
T 1csn_A           24 GVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLC---   99 (298)
T ss_dssp             CEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHT---
T ss_pred             EEEEEEEECCCCcEEEEEEeccCCccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec-CCCHHHHHHHh---
Confidence            89999996  788999998853     578999999999 8999999999999999999999999 99999999642   


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCc-----EEEccccccccCCCCCCcc----eeee
Q 039626          433 GKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLR-----AKIANFAMARPAEGQEGEF----ALTR  503 (628)
Q Consensus       433 ~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~-----~kl~Dfgla~~~~~~~~~~----~~~~  503 (628)
                      +..+++..+..++.|++.||+|||+.   +++||||||+|||++.++.     +||+|||+++.........    ....
T Consensus       100 ~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~  176 (298)
T 1csn_A          100 GRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKK  176 (298)
T ss_dssp             TTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCC
T ss_pred             ccCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEEECccccccccccccccccccCcc
Confidence            34599999999999999999999984   5999999999999987776     9999999998765432211    1234


Q ss_pred             cccCCccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCC
Q 039626          504 HIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQG  583 (628)
Q Consensus       504 ~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~  583 (628)
                      ...||+.|+|||.+.+..++.++||||||++++||++|+.||........   ......+..... ....     +.+..
T Consensus       177 ~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~---~~~~~~~~~~~~-~~~~-----~~~~~  247 (298)
T 1csn_A          177 NLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATN---KQKYERIGEKKQ-STPL-----RELCA  247 (298)
T ss_dssp             CCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCH---HHHHHHHHHHHH-HSCH-----HHHTT
T ss_pred             CCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhcccc---HHHHHHHHhhcc-CccH-----HHHHh
Confidence            45799999999999999999999999999999999999999875432221   111111111000 0000     00111


Q ss_pred             CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhh
Q 039626          584 NYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNA  624 (628)
Q Consensus       584 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~~~  624 (628)
                      .    .+..+.+++.+||+.||++||++++|++.|++++..
T Consensus       248 ~----~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~  284 (298)
T 1csn_A          248 G----FPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLER  284 (298)
T ss_dssp             T----SCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred             h----CcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHh
Confidence            2    235678999999999999999999999999999854

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=1.1e-38  Score=351.77  Aligned_cols=237  Identities=26%  Similarity=0.439  Sum_probs=194.5

Q ss_pred             eEEEEEEEC--CceEEEEEecc------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhcCCC
Q 039626          361 GSVYRGKIN--GGFAAIKKVNG------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNE  432 (628)
Q Consensus       361 G~Vy~g~~~--g~~vavK~~~~------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~  432 (628)
                      |.||+|++.  +..||||.++.      ++.+|+++|++++||||++++++|.+++..++||||+++|+|.+++...  .
T Consensus       234 g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~--~  311 (495)
T 1opk_A          234 GEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLREC--N  311 (495)
T ss_dssp             SSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHS--C
T ss_pred             eEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEccCCCCHHHHHHhc--C
Confidence            899999994  78999999864      4778999999999999999999999999999999999999999999653  2


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCCcccc
Q 039626          433 GKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYM  512 (628)
Q Consensus       433 ~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~Y~  512 (628)
                      ...+++..++.++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++......  ........++..|+
T Consensus       312 ~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~--~~~~~~~~~~~~y~  386 (495)
T 1opk_A          312 RQEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWT  386 (495)
T ss_dssp             TTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEECCTTCC--EECCTTCCCCGGGC
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecccceeccCCc--eeecCCCcCCccee
Confidence            34589999999999999999999995   49999999999999999999999999998764322  11223345678999


Q ss_pred             CccccccCCCCcccccHHHHHHHHHHHh-CCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCHHHHH
Q 039626          513 APEYLENGLVSTKLDVYAFGVLILEMLT-GKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELAL  591 (628)
Q Consensus       513 APE~l~~~~~s~k~DV~SfGvvl~ELlt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~  591 (628)
                      |||.+.+..++.++||||||+++|||++ |+.|+......   ...+.+    .             ...+...+..++.
T Consensus       387 aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~---~~~~~~----~-------------~~~~~~~~~~~~~  446 (495)
T 1opk_A          387 APESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS---QVYELL----E-------------KDYRMERPEGCPE  446 (495)
T ss_dssp             CHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG---GHHHHH----H-------------TTCCCCCCTTCCH
T ss_pred             CHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHH---HHHHHH----H-------------cCCCCCCCCCCCH
Confidence            9999999999999999999999999999 88887643221   111111    0             0111122334456


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhh
Q 039626          592 LVIRLIDACLKKDPTDRPTMYEIEHSLSNILNA  624 (628)
Q Consensus       592 ~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~~~  624 (628)
                      .+.+|+.+||+.||.+|||+.||++.|+.+++.
T Consensus       447 ~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~~  479 (495)
T 1opk_A          447 KVYELMRACWQWNPSDRPSFAEIHQAFETMFQE  479 (495)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCSS
T ss_pred             HHHHHHHHHcCcChhHCcCHHHHHHHHHHHHhc
Confidence            688999999999999999999999999988654

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=4.3e-38  Score=335.70  Aligned_cols=241  Identities=27%  Similarity=0.428  Sum_probs=195.0

Q ss_pred             eEEEEEEEC---------CceEEEEEecc--------chHHHHHHHhhc-CCCceeeeeeeeecCCeEEEEEEecCCCCh
Q 039626          361 GSVYRGKIN---------GGFAAIKKVNG--------DVSKEIALLNKI-NHSNLIILSGVCFNEGNCYLVYEYAVNGTL  422 (628)
Q Consensus       361 G~Vy~g~~~---------g~~vavK~~~~--------~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL  422 (628)
                      |.||+++..         +..||+|+++.        ++.+|+++++++ +|+||+++++++..++..++||||+++|+|
T Consensus        83 g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L  162 (382)
T 3tt0_A           83 GQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL  162 (382)
T ss_dssp             EEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBH
T ss_pred             eEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccCCceEEEEEecCCCcH
Confidence            899999862         24799999864        366899999999 999999999999999999999999999999


Q ss_pred             HHHhhhcCC------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccc
Q 039626          423 SDWVFSNKN------------EGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMAR  490 (628)
Q Consensus       423 ~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~  490 (628)
                      .+++.....            ....+++..++.++.|++.||+|||+.   +|+||||||+|||+++++.+||+|||+++
T Consensus       163 ~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DFG~a~  239 (382)
T 3tt0_A          163 REYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLAR  239 (382)
T ss_dssp             HHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSCSCCC
T ss_pred             HHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcceEEEcCCCcEEEcccCccc
Confidence            999976432            124599999999999999999999995   59999999999999999999999999998


Q ss_pred             cCCCCCCcceeeecccCCccccCccccccCCCCcccccHHHHHHHHHHHh-CCCccccccccccccHHHHHHHHhccccc
Q 039626          491 PAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT-GKEAAALHAEENNMHLSDVLNAVLTKEDG  569 (628)
Q Consensus       491 ~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELlt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~  569 (628)
                      ....... ........+|+.|+|||.+.+..++.++||||||++++||++ |+.|+.....      .+....+...   
T Consensus       240 ~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~------~~~~~~~~~~---  309 (382)
T 3tt0_A          240 DIHHIDY-YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV------EELFKLLKEG---  309 (382)
T ss_dssp             CSSCCCT-TCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH------HHHHHHHHTT---
T ss_pred             ccccccc-cccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH------HHHHHHHHcC---
Confidence            7653321 112334567889999999999999999999999999999999 9888763321      1222221111   


Q ss_pred             hhhhccccCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhc
Q 039626          570 EESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNAS  625 (628)
Q Consensus       570 ~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~~~~  625 (628)
                             ..+    ..+...+..+.+++.+||+.||++|||++||++.|++++...
T Consensus       310 -------~~~----~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~  354 (382)
T 3tt0_A          310 -------HRM----DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALT  354 (382)
T ss_dssp             -------CCC----CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHS
T ss_pred             -------CCC----CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHH
Confidence                   011    112233456889999999999999999999999999998754

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=1e-38  Score=334.73  Aligned_cols=252  Identities=26%  Similarity=0.433  Sum_probs=198.6

Q ss_pred             HhcCCCcCCccc----eEEEEEEECC-------ceEEEEEecc--------chHHHHHHHhhcCCCceeeeeeeeecCCe
Q 039626          349 ATDNFSFTCRIQ----GSVYRGKING-------GFAAIKKVNG--------DVSKEIALLNKINHSNLIILSGVCFNEGN  409 (628)
Q Consensus       349 at~~f~~~~~i~----G~Vy~g~~~g-------~~vavK~~~~--------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~  409 (628)
                      ..++|.....+|    |.||+++..+       ..||+|.++.        .+.+|++++++++||||+++++++.+++.
T Consensus        45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~  124 (343)
T 1luf_A           45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP  124 (343)
T ss_dssp             CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred             cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCc
Confidence            345565555554    8999999853       7899999864        36789999999999999999999999999


Q ss_pred             EEEEEEecCCCChHHHhhhcCCC--------------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCC
Q 039626          410 CYLVYEYAVNGTLSDWVFSNKNE--------------------GKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDIN  469 (628)
Q Consensus       410 ~~lV~E~~~~gsL~~~l~~~~~~--------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik  469 (628)
                      .++||||+++|+|.+++......                    ...+++..++.++.|++.||+|||+.   +++|||||
T Consensus       125 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlk  201 (343)
T 1luf_A          125 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLA  201 (343)
T ss_dssp             CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCS
T ss_pred             eEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCC
Confidence            99999999999999999753211                    25699999999999999999999995   49999999


Q ss_pred             CCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCCccccCccccccCCCCcccccHHHHHHHHHHHh-CCCccccc
Q 039626          470 SSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT-GKEAAALH  548 (628)
Q Consensus       470 ~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELlt-G~~p~~~~  548 (628)
                      |+|||++.++.+||+|||+++....... ........+|+.|+|||.+.+..++.++||||||+++|||++ |+.|+...
T Consensus       202 p~NIl~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~  280 (343)
T 1luf_A          202 TRNCLVGENMVVKIADFGLSRNIYSADY-YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM  280 (343)
T ss_dssp             GGGEEECGGGCEEECCCSCHHHHTGGGC-BC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred             cceEEECCCCeEEEeecCCCcccccCcc-ccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCC
Confidence            9999999999999999999986543221 112234568899999999999999999999999999999999 98888632


Q ss_pred             cccccccHHHHHHHHhccccchhhhccccCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhh
Q 039626          549 AEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNA  624 (628)
Q Consensus       549 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~~~  624 (628)
                      ..      .+....+....          .+    ..+...+..+.+++.+||+.||.+||++.|+++.|+++.+.
T Consensus       281 ~~------~~~~~~~~~~~----------~~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~  336 (343)
T 1luf_A          281 AH------EEVIYYVRDGN----------IL----ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCER  336 (343)
T ss_dssp             CH------HHHHHHHHTTC----------CC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC-
T ss_pred             Ch------HHHHHHHhCCC----------cC----CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhh
Confidence            21      12222211110          01    12223345688999999999999999999999999998754

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=6.6e-38  Score=327.15  Aligned_cols=234  Identities=24%  Similarity=0.389  Sum_probs=189.9

Q ss_pred             cCCCcCCccc----eEEEEEEE--CCceEEEEEecc---------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEE
Q 039626          351 DNFSFTCRIQ----GSVYRGKI--NGGFAAIKKVNG---------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYE  415 (628)
Q Consensus       351 ~~f~~~~~i~----G~Vy~g~~--~g~~vavK~~~~---------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  415 (628)
                      ++|.....+|    |.||++..  +|+.||||++..         .+.+|+++|++++||||+++++++..++..++|||
T Consensus        15 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e   94 (328)
T 3fe3_A           15 GNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIME   94 (328)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             CCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEE
Confidence            3444444443    89999997  789999999854         25689999999999999999999999999999999


Q ss_pred             ecCCCChHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCC
Q 039626          416 YAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQ  495 (628)
Q Consensus       416 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~  495 (628)
                      |+++|+|.+++...    ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++.....
T Consensus        95 ~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~  167 (328)
T 3fe3_A           95 YASGGEVFDYLVAH----GRMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG  167 (328)
T ss_dssp             CCTTCBHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS
T ss_pred             CCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccCceecCCC
Confidence            99999999999653    3489999999999999999999995   4999999999999999999999999999866433


Q ss_pred             CCcceeeecccCCccccCccccccCCCC-cccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhc
Q 039626          496 EGEFALTRHIVGTKGYMAPEYLENGLVS-TKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLR  574 (628)
Q Consensus       496 ~~~~~~~~~~~gt~~Y~APE~l~~~~~s-~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  574 (628)
                      .    ......||+.|+|||.+.+..+. .++|||||||+++||++|+.||....      ..+....+....       
T Consensus       168 ~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~------~~~~~~~i~~~~-------  230 (328)
T 3fe3_A          168 G----KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN------LKELRERVLRGK-------  230 (328)
T ss_dssp             C----GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHHCC-------
T ss_pred             C----ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCC------HHHHHHHHHhCC-------
Confidence            2    23345799999999999887765 89999999999999999999986432      122222222111       


Q ss_pred             cccCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          575 HFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       575 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                              ...|...+..+.+++.+||+.||.+|||++|+++
T Consensus       231 --------~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~  264 (328)
T 3fe3_A          231 --------YRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMK  264 (328)
T ss_dssp             --------CCCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred             --------CCCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence                    0112223456789999999999999999999875

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=2.2e-38  Score=330.59  Aligned_cols=236  Identities=23%  Similarity=0.375  Sum_probs=185.0

Q ss_pred             eEEEEEEE--CCce----EEEEEecc--------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHh
Q 039626          361 GSVYRGKI--NGGF----AAIKKVNG--------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWV  426 (628)
Q Consensus       361 G~Vy~g~~--~g~~----vavK~~~~--------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l  426 (628)
                      |.||+|++  +++.    ||+|+++.        ++.+|+.++++++|+||++++++|.++. .++|+||+++|+|.+++
T Consensus        29 g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~v~e~~~~g~L~~~l  107 (327)
T 3poz_A           29 GTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYV  107 (327)
T ss_dssp             EEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEEEEECCTTCBHHHHH
T ss_pred             eEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEEEEEecCCCcHHHHH
Confidence            89999997  4443    58887642        4678999999999999999999998754 78999999999999999


Q ss_pred             hhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeeccc
Q 039626          427 FSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIV  506 (628)
Q Consensus       427 ~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~  506 (628)
                      ...   ...+++..++.++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++........ .......
T Consensus       108 ~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~~  180 (327)
T 3poz_A          108 REH---KDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE-YHAEGGK  180 (327)
T ss_dssp             HHS---TTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTTCC--------C
T ss_pred             Hhc---CCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCcceeEccCCccc-ccccCCC
Confidence            653   34599999999999999999999995   4999999999999999999999999999876543322 1223346


Q ss_pred             CCccccCccccccCCCCcccccHHHHHHHHHHHh-CCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCC
Q 039626          507 GTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT-GKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNY  585 (628)
Q Consensus       507 gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELlt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~  585 (628)
                      +|+.|+|||.+.+..++.++||||||+++|||++ |+.|+.......   +...+.                 .......
T Consensus       181 ~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~~~~~~-----------------~~~~~~~  240 (327)
T 3poz_A          181 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISSILE-----------------KGERLPQ  240 (327)
T ss_dssp             CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHHHHH-----------------TTCCCCC
T ss_pred             ccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH---HHHHHH-----------------cCCCCCC
Confidence            7889999999999999999999999999999999 999886433211   111111                 0011112


Q ss_pred             CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhh
Q 039626          586 PLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNA  624 (628)
Q Consensus       586 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~~~  624 (628)
                      +...+..+.+++.+||+.||.+||++.|+++.|+++...
T Consensus       241 ~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~  279 (327)
T 3poz_A          241 PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD  279 (327)
T ss_dssp             CTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred             CccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence            233445688999999999999999999999999998753

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=6.2e-38  Score=320.41  Aligned_cols=232  Identities=26%  Similarity=0.512  Sum_probs=185.9

Q ss_pred             eEEEEEEE--CCceEEEEEec--------------cchHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHH
Q 039626          361 GSVYRGKI--NGGFAAIKKVN--------------GDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSD  424 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~--------------~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~  424 (628)
                      |.||+++.  +++.||+|++.              ..+.+|++++++++|+||+++++++.+..  ++||||+++|+|.+
T Consensus        33 g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~lv~e~~~~~~L~~  110 (287)
T 4f0f_A           33 GLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP--RMVMEFVPCGDLYH  110 (287)
T ss_dssp             SCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--EEEEECCTTCBHHH
T ss_pred             eeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--eEEEEecCCCCHHH
Confidence            89999998  68899999874              24678999999999999999999997655  69999999999999


Q ss_pred             HhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCc-----EEEccccccccCCCCCCcc
Q 039626          425 WVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLR-----AKIANFAMARPAEGQEGEF  499 (628)
Q Consensus       425 ~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~-----~kl~Dfgla~~~~~~~~~~  499 (628)
                      ++..   ....+++..++.++.|++.||+|||+.+ ++++||||||+|||++.++.     +||+|||+++....     
T Consensus       111 ~l~~---~~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~~~~~~~-----  181 (287)
T 4f0f_A          111 RLLD---KAHPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVH-----  181 (287)
T ss_dssp             HHHC---TTSCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEECCCTTCBCCSS-----
T ss_pred             HHhc---ccCCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeCCCCccccccc-----
Confidence            8854   3456999999999999999999999954 45999999999999988776     99999999985432     


Q ss_pred             eeeecccCCccccCcccc--ccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhcccc
Q 039626          500 ALTRHIVGTKGYMAPEYL--ENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFI  577 (628)
Q Consensus       500 ~~~~~~~gt~~Y~APE~l--~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  577 (628)
                       ......||+.|+|||.+  ....++.++||||||+++|||++|+.||.......    .........         ...
T Consensus       182 -~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~----~~~~~~~~~---------~~~  247 (287)
T 4f0f_A          182 -SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK----IKFINMIRE---------EGL  247 (287)
T ss_dssp             -CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCH----HHHHHHHHH---------SCC
T ss_pred             -cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccH----HHHHHHHhc---------cCC
Confidence             13345799999999998  45567899999999999999999999986433211    111111111         111


Q ss_pred             CCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 039626          578 DPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNI  621 (628)
Q Consensus       578 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l  621 (628)
                      .+    ..+...+..+.+++.+||+.||.+|||++|+++.|++|
T Consensus       248 ~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l  287 (287)
T 4f0f_A          248 RP----TIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL  287 (287)
T ss_dssp             CC----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred             CC----CCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence            11    22333446688999999999999999999999999864

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=3.8e-38  Score=325.82  Aligned_cols=244  Identities=22%  Similarity=0.406  Sum_probs=196.1

Q ss_pred             eEEEEEEE-------CCceEEEEEecc--------chHHHHHHHhhc-CCCceeeeeeeeecCCeEEEEEEecCCCChHH
Q 039626          361 GSVYRGKI-------NGGFAAIKKVNG--------DVSKEIALLNKI-NHSNLIILSGVCFNEGNCYLVYEYAVNGTLSD  424 (628)
Q Consensus       361 G~Vy~g~~-------~g~~vavK~~~~--------~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~  424 (628)
                      |.||++++       .+..||+|+++.        .+.+|+++++++ +||||+++++++.+++..++||||+++|+|.+
T Consensus        37 g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~  116 (313)
T 1t46_A           37 GKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLN  116 (313)
T ss_dssp             EEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHH
T ss_pred             cceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCCcEEEEecCCCCCHHH
Confidence            89999985       356899999863        366899999999 99999999999999999999999999999999


Q ss_pred             HhhhcCC--------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccc
Q 039626          425 WVFSNKN--------------EGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMAR  490 (628)
Q Consensus       425 ~l~~~~~--------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~  490 (628)
                      ++.....              ....+++..++.++.|++.||+|||+.   +++||||||+||+++.++.+||+|||+++
T Consensus       117 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  193 (313)
T 1t46_A          117 FLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLAR  193 (313)
T ss_dssp             HHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEETTTEEEECCCGGGS
T ss_pred             HHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEcCCCCEEEccccccc
Confidence            9975432              123589999999999999999999995   59999999999999999999999999998


Q ss_pred             cCCCCCCcceeeecccCCccccCccccccCCCCcccccHHHHHHHHHHHh-CCCccccccccccccHHHHHHHHhccccc
Q 039626          491 PAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT-GKEAAALHAEENNMHLSDVLNAVLTKEDG  569 (628)
Q Consensus       491 ~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELlt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~  569 (628)
                      ....... ........+|+.|+|||.+.+..++.++||||||++++||++ |+.|+.......  .....+..       
T Consensus       194 ~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~~~~~~~~-------  263 (313)
T 1t46_A          194 DIKNDSN-YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS--KFYKMIKE-------  263 (313)
T ss_dssp             CTTSCTT-SEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH--HHHHHHHH-------
T ss_pred             ccccccc-ceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchh--HHHHHhcc-------
Confidence            7754332 122334567889999999999999999999999999999999 888876432211  11111111       


Q ss_pred             hhhhccccCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhccC
Q 039626          570 EESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNASLN  627 (628)
Q Consensus       570 ~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~~~~~~  627 (628)
                            ...+    ..+...+..+.+++.+||+.||.+|||+.|+++.|++++....+
T Consensus       264 ------~~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~  311 (313)
T 1t46_A          264 ------GFRM----LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISESTN  311 (313)
T ss_dssp             ------TCCC----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTCC
T ss_pred             ------CCCC----CCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHhhc
Confidence                  0111    11222345678999999999999999999999999999987654

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=4e-38  Score=325.81  Aligned_cols=240  Identities=26%  Similarity=0.447  Sum_probs=193.2

Q ss_pred             eEEEEEEE-------CCceEEEEEecc--------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHH
Q 039626          361 GSVYRGKI-------NGGFAAIKKVNG--------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDW  425 (628)
Q Consensus       361 G~Vy~g~~-------~g~~vavK~~~~--------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~  425 (628)
                      |.||++..       .+..||+|+++.        ++.+|++++++++||||+++++++.+++..++||||+++|+|.++
T Consensus        37 g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~  116 (314)
T 2ivs_A           37 GKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGF  116 (314)
T ss_dssp             SEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHH
T ss_pred             eeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCceEEEEeecCCCCHHHH
Confidence            89999986       237899999864        356899999999999999999999999999999999999999999


Q ss_pred             hhhcCC--------------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEcc
Q 039626          426 VFSNKN--------------------EGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIAN  485 (628)
Q Consensus       426 l~~~~~--------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~D  485 (628)
                      +.....                    ....+++..++.++.|++.||+|||+.   +++||||||+|||+++++.+||+|
T Consensus       117 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dikp~NIli~~~~~~kl~D  193 (314)
T 2ivs_A          117 LRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRDLAARNILVAEGRKMKISD  193 (314)
T ss_dssp             HHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTEEEECC
T ss_pred             HHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCcccccchheEEEcCCCCEEEcc
Confidence            975432                    123489999999999999999999995   499999999999999999999999


Q ss_pred             ccccccCCCCCCcceeeecccCCccccCccccccCCCCcccccHHHHHHHHHHHh-CCCccccccccccccHHHHHHHHh
Q 039626          486 FAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT-GKEAAALHAEENNMHLSDVLNAVL  564 (628)
Q Consensus       486 fgla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELlt-G~~p~~~~~~~~~~~~~~~~~~~~  564 (628)
                      ||+++....... ........+|+.|+|||.+.+..++.++||||||++++||++ |+.|+.......   +.+.+.   
T Consensus       194 fg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~---~~~~~~---  266 (314)
T 2ivs_A          194 FGLSRDVYEEDS-YVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPER---LFNLLK---  266 (314)
T ss_dssp             CTTCEECTTTSC-EECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---HHHHHH---
T ss_pred             cccccccccccc-ceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHhh---
Confidence            999987654322 112233467889999999999999999999999999999999 998886433211   111111   


Q ss_pred             ccccchhhhccccCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhh
Q 039626          565 TKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNA  624 (628)
Q Consensus       565 ~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~~~  624 (628)
                      .          ...+    ..+...+..+.+++.+||+.||.+||++.|+++.|++++..
T Consensus       267 ~----------~~~~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~  312 (314)
T 2ivs_A          267 T----------GHRM----ERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK  312 (314)
T ss_dssp             T----------TCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             c----------CCcC----CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence            0          0011    12223345688999999999999999999999999998764

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=3e-38  Score=322.11  Aligned_cols=236  Identities=22%  Similarity=0.381  Sum_probs=192.4

Q ss_pred             eEEEEEEEC-CceEEEEEecc------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhcCCCC
Q 039626          361 GSVYRGKIN-GGFAAIKKVNG------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEG  433 (628)
Q Consensus       361 G~Vy~g~~~-g~~vavK~~~~------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~  433 (628)
                      |.||++.+. +..||+|+++.      ++.+|++++.+++|+||+++++++.+++..++||||+++|+|.+++...   .
T Consensus        38 g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~  114 (283)
T 3gen_A           38 GVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREM---R  114 (283)
T ss_dssp             EEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCCTTCBHHHHHHCG---G
T ss_pred             ceEEEEEEcCCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEeccCCCcHHHHHHHh---c
Confidence            899999994 55899999864      4778999999999999999999999999999999999999999999542   3


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCCccccC
Q 039626          434 KYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMA  513 (628)
Q Consensus       434 ~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~Y~A  513 (628)
                      ..+++..++.++.|++.||+|||+.   +++||||||+||+++.++.+||+|||+++......  ........+|+.|+|
T Consensus       115 ~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~~y~a  189 (283)
T 3gen_A          115 HRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE--YTSSVGSKFPVRWSP  189 (283)
T ss_dssp             GCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHH--HHSTTSTTSCGGGCC
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEccccccccccccc--cccccCCccCcccCC
Confidence            4599999999999999999999995   49999999999999999999999999998664321  111223457788999


Q ss_pred             ccccccCCCCcccccHHHHHHHHHHHh-CCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCHHHHHH
Q 039626          514 PEYLENGLVSTKLDVYAFGVLILEMLT-GKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALL  592 (628)
Q Consensus       514 PE~l~~~~~s~k~DV~SfGvvl~ELlt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~  592 (628)
                      ||.+.+..++.++||||||++++||++ |+.|+......      +....+..          ....    ..+...+..
T Consensus       190 PE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~------~~~~~~~~----------~~~~----~~~~~~~~~  249 (283)
T 3gen_A          190 PEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS------ETAEHIAQ----------GLRL----YRPHLASEK  249 (283)
T ss_dssp             HHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHH------HHHHHHHT----------TCCC----CCCTTCCHH
T ss_pred             HHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChh------HHHHHHhc----------ccCC----CCCCcCCHH
Confidence            999999999999999999999999998 99888643221      11111111          0111    112222356


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHHHHHHHhHhh
Q 039626          593 VIRLIDACLKKDPTDRPTMYEIEHSLSNILNA  624 (628)
Q Consensus       593 l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~~~  624 (628)
                      +.+++.+||+.||.+|||++|+++.|+++++.
T Consensus       250 l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~  281 (283)
T 3gen_A          250 VYTIMYSCWHEKADERPTFKILLSNILDVMDE  281 (283)
T ss_dssp             HHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence            78999999999999999999999999999875

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=5e-38  Score=317.79  Aligned_cols=236  Identities=28%  Similarity=0.433  Sum_probs=191.5

Q ss_pred             eEEEEEEEC-CceEEEEEecc------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhcCCCC
Q 039626          361 GSVYRGKIN-GGFAAIKKVNG------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEG  433 (628)
Q Consensus       361 G~Vy~g~~~-g~~vavK~~~~------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~  433 (628)
                      |.||++... +..+|+|+++.      ++.+|++++.+++||||+++++++.+++..++||||+++|+|.+++...   +
T Consensus        22 g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~   98 (268)
T 3sxs_A           22 GVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSH---G   98 (268)
T ss_dssp             EEEEEEEETTTEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHHH---G
T ss_pred             ceEEEEEecCceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccCCCcHHHHHHHc---C
Confidence            899999984 55799999864      4678999999999999999999999999999999999999999999653   3


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCCccccC
Q 039626          434 KYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMA  513 (628)
Q Consensus       434 ~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~Y~A  513 (628)
                      ..+++..++.++.|++.||+|||+.   +++||||||+||+++.++.+||+|||+++......  ........+|+.|+|
T Consensus        99 ~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~--~~~~~~~~~~~~y~a  173 (268)
T 3sxs_A           99 KGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ--YVSSVGTKFPVKWSA  173 (268)
T ss_dssp             GGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEEECCTTC--EEECCSCCCCGGGCC
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccceecchhh--hhcccCCCcCcccCC
Confidence            4599999999999999999999995   49999999999999999999999999998765432  112233456778999


Q ss_pred             ccccccCCCCcccccHHHHHHHHHHHh-CCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCHHHHHH
Q 039626          514 PEYLENGLVSTKLDVYAFGVLILEMLT-GKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALL  592 (628)
Q Consensus       514 PE~l~~~~~s~k~DV~SfGvvl~ELlt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~  592 (628)
                      ||.+.+..++.++||||||++++||++ |+.|+......      +.........          ..    ..+...+..
T Consensus       174 PE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~------~~~~~~~~~~----------~~----~~~~~~~~~  233 (268)
T 3sxs_A          174 PEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNS------EVVLKVSQGH----------RL----YRPHLASDT  233 (268)
T ss_dssp             HHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHH------HHHHHHHTTC----------CC----CCCTTSCHH
T ss_pred             HHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChH------HHHHHHHcCC----------CC----CCCCcChHH
Confidence            999999899999999999999999999 99888643221      1111111100          01    111122346


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHHHHHHHhHhh
Q 039626          593 VIRLIDACLKKDPTDRPTMYEIEHSLSNILNA  624 (628)
Q Consensus       593 l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~~~  624 (628)
                      +.+++.+||+.||.+|||+.|+++.|+.+.+.
T Consensus       234 l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~  265 (268)
T 3sxs_A          234 IYQIMYSCWHELPEKRPTFQQLLSSIEPLREK  265 (268)
T ss_dssp             HHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred             HHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence            78999999999999999999999999988653

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=3.3e-38  Score=329.04  Aligned_cols=254  Identities=24%  Similarity=0.391  Sum_probs=195.0

Q ss_pred             eEEEEEEE------CCceEEEEEecc-------chHHHHHHHhhcCCCceeeeeeeee--cCCeEEEEEEecCCCChHHH
Q 039626          361 GSVYRGKI------NGGFAAIKKVNG-------DVSKEIALLNKINHSNLIILSGVCF--NEGNCYLVYEYAVNGTLSDW  425 (628)
Q Consensus       361 G~Vy~g~~------~g~~vavK~~~~-------~~~~E~~~l~~l~H~nIv~l~g~~~--~~~~~~lV~E~~~~gsL~~~  425 (628)
                      |.||++++      .+..||+|++..       .+.+|++++++++|+||+++++++.  ++...++||||+++|+|.++
T Consensus        37 g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~  116 (327)
T 3lxl_A           37 GSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDF  116 (327)
T ss_dssp             EEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEEEEEECCTTCBHHHH
T ss_pred             eEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEEEEEeecCCCCHHHH
Confidence            89999985      577899999864       3678999999999999999999987  45668999999999999999


Q ss_pred             hhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecc
Q 039626          426 VFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHI  505 (628)
Q Consensus       426 l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~  505 (628)
                      +....   ..+++..++.++.|++.||+|||+.   +++||||||+|||++.++.+||+|||+++...............
T Consensus       117 l~~~~---~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~  190 (327)
T 3lxl_A          117 LQRHR---ARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPG  190 (327)
T ss_dssp             HHHHG---GGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGGGCEECCTTCSEEECSSCC
T ss_pred             HHhcc---cCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEcccccceecccCCccceeeccC
Confidence            96532   3589999999999999999999994   59999999999999999999999999998775443332333445


Q ss_pred             cCCccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhcc--ccchhhhccccCCcCCC
Q 039626          506 VGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTK--EDGEESLRHFIDPTLQG  583 (628)
Q Consensus       506 ~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~~~d~~l~~  583 (628)
                      .||..|+|||.+.+..++.++||||||++++||++|+.|+.......       .......  ......+...+......
T Consensus       191 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (327)
T 3lxl_A          191 QSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEF-------LRMMGCERDVPALSRLLELLEEGQRL  263 (327)
T ss_dssp             CSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHH-------HHHCC----CCHHHHHHHHHHTTCCC
T ss_pred             CccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchh-------hhhcccccccccHHHHHHHhhcccCC
Confidence            78889999999999999999999999999999999999886433211       0000000  00001111111222222


Q ss_pred             CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhccC
Q 039626          584 NYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNASLN  627 (628)
Q Consensus       584 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~~~~~~  627 (628)
                      ..+...+..+.+++.+||+.||.+|||++|+++.|+.+....-+
T Consensus       264 ~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~  307 (327)
T 3lxl_A          264 PAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRG  307 (327)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC------
T ss_pred             CCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhcC
Confidence            33444556788999999999999999999999999999876543

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.7e-38  Score=337.00  Aligned_cols=240  Identities=25%  Similarity=0.409  Sum_probs=191.4

Q ss_pred             eEEEEEEE-------CCceEEEEEecc--------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHH
Q 039626          361 GSVYRGKI-------NGGFAAIKKVNG--------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDW  425 (628)
Q Consensus       361 G~Vy~g~~-------~g~~vavK~~~~--------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~  425 (628)
                      |.||+|++       .+..||||+++.        ++.+|+.++++++|+||+++++++.+++..++||||+++|+|.++
T Consensus        85 g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~  164 (367)
T 3l9p_A           85 GEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSF  164 (367)
T ss_dssp             SCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHH
T ss_pred             EEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCEEEEEeCCCCCHHHH
Confidence            89999995       345899999853        367899999999999999999999999999999999999999999


Q ss_pred             hhhcCC---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCC---cEEEccccccccCCCCCCcc
Q 039626          426 VFSNKN---EGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDL---RAKIANFAMARPAEGQEGEF  499 (628)
Q Consensus       426 l~~~~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~---~~kl~Dfgla~~~~~~~~~~  499 (628)
                      +.....   ....+++..++.++.|++.||+|||+.   +|+||||||+|||++.++   .+||+|||+++....... .
T Consensus       165 l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~-~  240 (367)
T 3l9p_A          165 LRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGY-Y  240 (367)
T ss_dssp             HHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHHHSS-C
T ss_pred             HHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCceEEECCCccccccccccc-c
Confidence            976542   234599999999999999999999995   499999999999999554   599999999975432111 1


Q ss_pred             eeeecccCCccccCccccccCCCCcccccHHHHHHHHHHHh-CCCccccccccccccHHHHHHHHhccccchhhhccccC
Q 039626          500 ALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT-GKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFID  578 (628)
Q Consensus       500 ~~~~~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELlt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d  578 (628)
                      .......||+.|+|||.+.+..++.++|||||||+++||++ |+.|+.....      .+....+....           
T Consensus       241 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~------~~~~~~i~~~~-----------  303 (367)
T 3l9p_A          241 RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN------QEVLEFVTSGG-----------  303 (367)
T ss_dssp             TTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH------HHHHHHHHTTC-----------
T ss_pred             ccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH------HHHHHHHHcCC-----------
Confidence            12234568999999999999999999999999999999998 8888864321      12222221110           


Q ss_pred             CcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhh
Q 039626          579 PTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNA  624 (628)
Q Consensus       579 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~~~  624 (628)
                         ....+...+..+.+++.+||+.||.+||++.||++.|+.+.+.
T Consensus       304 ---~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~  346 (367)
T 3l9p_A          304 ---RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD  346 (367)
T ss_dssp             ---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             ---CCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhC
Confidence               1111223345688999999999999999999999999988764

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.6e-38  Score=330.12  Aligned_cols=251  Identities=23%  Similarity=0.414  Sum_probs=196.6

Q ss_pred             cCCCcCCccc----eEEEEEEE-------CCceEEEEEecc--------chHHHHHHHhhc-CCCceeeeeeeeecCCeE
Q 039626          351 DNFSFTCRIQ----GSVYRGKI-------NGGFAAIKKVNG--------DVSKEIALLNKI-NHSNLIILSGVCFNEGNC  410 (628)
Q Consensus       351 ~~f~~~~~i~----G~Vy~g~~-------~g~~vavK~~~~--------~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~  410 (628)
                      ++|.....+|    |.||+|+.       .+..||+|.++.        .+.+|+.++.++ +||||+++++++..++..
T Consensus        45 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~  124 (344)
T 1rjb_A           45 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI  124 (344)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCcc
Confidence            4455444554    89999996       345799999863        367899999999 999999999999999999


Q ss_pred             EEEEEecCCCChHHHhhhcCCC-------------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCC
Q 039626          411 YLVYEYAVNGTLSDWVFSNKNE-------------------GKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSS  471 (628)
Q Consensus       411 ~lV~E~~~~gsL~~~l~~~~~~-------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~  471 (628)
                      ++||||+++|+|.+++......                   ...++|..++.++.|++.||+|||+.   +|+||||||+
T Consensus       125 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~  201 (344)
T 1rjb_A          125 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAAR  201 (344)
T ss_dssp             EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCSGG
T ss_pred             EEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChh
Confidence            9999999999999999654221                   13489999999999999999999995   5999999999


Q ss_pred             CEEeCCCCcEEEccccccccCCCCCCcceeeecccCCccccCccccccCCCCcccccHHHHHHHHHHHh-CCCccccccc
Q 039626          472 NVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT-GKEAAALHAE  550 (628)
Q Consensus       472 NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELlt-G~~p~~~~~~  550 (628)
                      |||++.++.+||+|||+++....... ........||+.|+|||.+.+..++.++||||||+++|||++ |+.|+.....
T Consensus       202 NIll~~~~~~kL~Dfg~~~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~  280 (344)
T 1rjb_A          202 NVLVTHGKVVKICDFGLARDIMSDSN-YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV  280 (344)
T ss_dssp             GEEEETTTEEEECCCGGGSCGGGCTT-SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred             hEEEcCCCcEEeCCCccCcccccCcc-ceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCc
Confidence            99999999999999999987653322 223344567889999999999999999999999999999998 9988864322


Q ss_pred             cccccHHHHHHHHhccccchhhhccccCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhh
Q 039626          551 ENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNA  624 (628)
Q Consensus       551 ~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~~~  624 (628)
                      ..      .+......         ..    ....+...+..+.+++.+||+.||.+|||+.|+++.|+.++..
T Consensus       281 ~~------~~~~~~~~---------~~----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~  335 (344)
T 1rjb_A          281 DA------NFYKLIQN---------GF----KMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLAD  335 (344)
T ss_dssp             SH------HHHHHHHT---------TC----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred             HH------HHHHHHhc---------CC----CCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence            11      11111110         01    1112223345688999999999999999999999999998765

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=4.7e-38  Score=325.14  Aligned_cols=237  Identities=28%  Similarity=0.463  Sum_probs=184.9

Q ss_pred             eEEEEEEECCceEEEEEecc-----chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhcCCCCCC
Q 039626          361 GSVYRGKINGGFAAIKKVNG-----DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKY  435 (628)
Q Consensus       361 G~Vy~g~~~g~~vavK~~~~-----~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~  435 (628)
                      |.||++++.++.||+|++..     .+.+|++++++++||||+++++++.+  ..++||||+++|+|.+++.... ....
T Consensus        22 g~V~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~-~~~~   98 (307)
T 2eva_A           22 GVVCKAKWRAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAEGGSLYNVLHGAE-PLPY   98 (307)
T ss_dssp             SEEEEEEETTEEEEEEECSSTTHHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCTTCBHHHHHHCSS-SEEC
T ss_pred             ceEEEEEECCeeEEEEEecChhHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCCCCCHHHHHhccC-CCCc
Confidence            89999999999999999864     36789999999999999999999874  4789999999999999996432 2235


Q ss_pred             CCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCc-EEEccccccccCCCCCCcceeeecccCCccccCc
Q 039626          436 LDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLR-AKIANFAMARPAEGQEGEFALTRHIVGTKGYMAP  514 (628)
Q Consensus       436 l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~-~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~Y~AP  514 (628)
                      +++..++.++.|+++||+|||+....+++||||||+|||++.++. +||+|||+++.....      .....||+.|+||
T Consensus        99 ~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~------~~~~~gt~~y~aP  172 (307)
T 2eva_A           99 YTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH------MTNNKGSAAWMAP  172 (307)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC------------------CCTTSSCH
T ss_pred             cCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc------cccCCCCCceECh
Confidence            789999999999999999999954456999999999999998886 799999999765422      1234699999999


Q ss_pred             cccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCHHHHHHHH
Q 039626          515 EYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVI  594 (628)
Q Consensus       515 E~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~  594 (628)
                      |.+.+..++.++||||||++++||++|+.|+......    ..........          ...+.....    .+..+.
T Consensus       173 E~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~----~~~~~~~~~~----------~~~~~~~~~----~~~~l~  234 (307)
T 2eva_A          173 EVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGP----AFRIMWAVHN----------GTRPPLIKN----LPKPIE  234 (307)
T ss_dssp             HHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSS----HHHHHHHHHT----------TCCCCCBTT----CCHHHH
T ss_pred             hhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCcc----HHHHHHHHhc----------CCCCCcccc----cCHHHH
Confidence            9999999999999999999999999999998643221    1111111111          011112222    334578


Q ss_pred             HHHHHhcccCCCCCCCHHHHHHHHHHhHhh
Q 039626          595 RLIDACLKKDPTDRPTMYEIEHSLSNILNA  624 (628)
Q Consensus       595 ~l~~~Cl~~dP~~RPs~~ev~~~L~~l~~~  624 (628)
                      +++.+||+.||.+|||++|+++.|+.+...
T Consensus       235 ~li~~~l~~dp~~Rps~~ell~~L~~~~~~  264 (307)
T 2eva_A          235 SLMTRCWSKDPSQRPSMEEIVKIMTHLMRY  264 (307)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHHHHHHGGG
T ss_pred             HHHHHHhcCChhhCcCHHHHHHHHHHHHHh
Confidence            999999999999999999999999998753

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=5.1e-38  Score=326.48  Aligned_cols=251  Identities=23%  Similarity=0.357  Sum_probs=194.6

Q ss_pred             eEEEEEEE------CCceEEEEEecc--------chHHHHHHHhhcCCCceeeeeeeeecC--CeEEEEEEecCCCChHH
Q 039626          361 GSVYRGKI------NGGFAAIKKVNG--------DVSKEIALLNKINHSNLIILSGVCFNE--GNCYLVYEYAVNGTLSD  424 (628)
Q Consensus       361 G~Vy~g~~------~g~~vavK~~~~--------~~~~E~~~l~~l~H~nIv~l~g~~~~~--~~~~lV~E~~~~gsL~~  424 (628)
                      |.||++.+      +++.||||+++.        .+.+|++++++++|+||+++++++.+.  ...++||||+++|+|.+
T Consensus        45 g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~  124 (318)
T 3lxp_A           45 GKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRD  124 (318)
T ss_dssp             EEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEEEECCCTTCBHHH
T ss_pred             eEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEEEEecccCCcHHH
Confidence            89998876      578899999875        267899999999999999999999874  57899999999999999


Q ss_pred             HhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeec
Q 039626          425 WVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRH  504 (628)
Q Consensus       425 ~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~  504 (628)
                      ++..     ..+++..++.++.+++.||+|||+.   +++||||||+|||++.++.+||+|||+++..............
T Consensus       125 ~l~~-----~~~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~  196 (318)
T 3lxp_A          125 YLPR-----HSIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVRED  196 (318)
T ss_dssp             HGGG-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECCTTCSEEEC---
T ss_pred             HHhh-----CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCccccccccccccccccccC
Confidence            9943     2389999999999999999999995   4999999999999999999999999999887654333233445


Q ss_pred             ccCCccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCC
Q 039626          505 IVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGN  584 (628)
Q Consensus       505 ~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~  584 (628)
                      ..+|..|+|||.+.+..++.++||||||++++||++|+.|+........    ... ...........+...++......
T Consensus       197 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~----~~~-~~~~~~~~~~~~~~~~~~~~~~~  271 (318)
T 3lxp_A          197 GDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFL----ELI-GIAQGQMTVLRLTELLERGERLP  271 (318)
T ss_dssp             CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHH----HHH-CSCCHHHHHHHHHHHHHTTCCCC
T ss_pred             CCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhh----hhh-cccccchhHHHHHHHHhcccCCC
Confidence            5788899999999999999999999999999999999998864322100    000 00000000011111122222223


Q ss_pred             CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhh
Q 039626          585 YPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNA  624 (628)
Q Consensus       585 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~~~  624 (628)
                      .+...+..+.+++.+||+.||.+|||+.|+++.|+++.+.
T Consensus       272 ~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~  311 (318)
T 3lxp_A          272 RPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEK  311 (318)
T ss_dssp             CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHh
Confidence            3344556789999999999999999999999999998764

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=2.3e-38  Score=325.36  Aligned_cols=240  Identities=24%  Similarity=0.370  Sum_probs=188.3

Q ss_pred             eEEEEEEE--CCceEEEEEecc----------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhh
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG----------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFS  428 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  428 (628)
                      |.||++..  .+..+|+|++..          .+.+|+.++++++||||+++++++.+++..++||||+++|+|.+++..
T Consensus        25 g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~  104 (294)
T 4eqm_A           25 STVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIES  104 (294)
T ss_dssp             EEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHH
T ss_pred             EEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEEeCCCCCCHHHHHHh
Confidence            89999987  688999998732          367899999999999999999999999999999999999999999964


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCC
Q 039626          429 NKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGT  508 (628)
Q Consensus       429 ~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt  508 (628)
                      .    ..+++..+..++.|++.||+|||+.   +++||||||+|||++.++.+||+|||+++.......  .......||
T Consensus       105 ~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~gt  175 (294)
T 4eqm_A          105 H----GPLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSL--TQTNHVLGT  175 (294)
T ss_dssp             H----CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCSSSTTC---------------C
T ss_pred             c----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCCCccccccccc--cccCccccC
Confidence            3    3589999999999999999999995   499999999999999999999999999987643221  123345799


Q ss_pred             ccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCHH
Q 039626          509 KGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLE  588 (628)
Q Consensus       509 ~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~  588 (628)
                      +.|+|||.+.+..++.++||||||+++|||++|+.||......      +..........          +......+.+
T Consensus       176 ~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~------~~~~~~~~~~~----------~~~~~~~~~~  239 (294)
T 4eqm_A          176 VQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAV------SIAIKHIQDSV----------PNVTTDVRKD  239 (294)
T ss_dssp             CSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHH------HHHHHHHSSCC----------CCHHHHSCTT
T ss_pred             ccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH------HHHHHHhhccC----------CCcchhcccC
Confidence            9999999999999999999999999999999999998643221      11111111110          0000011122


Q ss_pred             HHHHHHHHHHHhcccCCCCCC-CHHHHHHHHHHhHhhc
Q 039626          589 LALLVIRLIDACLKKDPTDRP-TMYEIEHSLSNILNAS  625 (628)
Q Consensus       589 ~~~~l~~l~~~Cl~~dP~~RP-s~~ev~~~L~~l~~~~  625 (628)
                      .+..+.+++.+||+.||.+|| +++++.+.|+.++...
T Consensus       240 ~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~  277 (294)
T 4eqm_A          240 IPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHEN  277 (294)
T ss_dssp             SCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSS
T ss_pred             CCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhc
Confidence            345678999999999999998 9999999999887543

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=4.1e-38  Score=333.51  Aligned_cols=255  Identities=17%  Similarity=0.206  Sum_probs=192.5

Q ss_pred             CCCcCCccc----eEEEEEEEC-------CceEEEEEeccc---hH---------------HHHHHHhhcCCCceeeeee
Q 039626          352 NFSFTCRIQ----GSVYRGKIN-------GGFAAIKKVNGD---VS---------------KEIALLNKINHSNLIILSG  402 (628)
Q Consensus       352 ~f~~~~~i~----G~Vy~g~~~-------g~~vavK~~~~~---~~---------------~E~~~l~~l~H~nIv~l~g  402 (628)
                      +|.....+|    |.||+|.+.       +..||||.+..+   +.               .|+..+.+++|+||+++++
T Consensus        36 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~  115 (364)
T 3op5_A           36 AWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWG  115 (364)
T ss_dssp             EEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEEE
T ss_pred             eEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEEe
Confidence            444444443    899999883       468999997542   22               3455666778999999999


Q ss_pred             eeecC----CeEEEEEEecCCCChHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeC--
Q 039626          403 VCFNE----GNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLD--  476 (628)
Q Consensus       403 ~~~~~----~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~--  476 (628)
                      ++...    ...+|||||+ +|+|.+++..   ....+++..++.|+.|++.||+|||+.   +|+||||||+|||++  
T Consensus       116 ~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~---~~~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nill~~~  188 (364)
T 3op5_A          116 SGLHDKNGKSYRFMIMDRF-GSDLQKIYEA---NAKRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLLNYK  188 (364)
T ss_dssp             EEEEEETTEEEEEEEEECE-EEEHHHHHHH---TTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEESS
T ss_pred             eeeeccCCcceEEEEEeCC-CCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEEEecC
Confidence            99864    4589999999 9999999964   235699999999999999999999995   599999999999999  


Q ss_pred             CCCcEEEccccccccCCCCCCcc----eeeecccCCccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccc
Q 039626          477 SDLRAKIANFAMARPAEGQEGEF----ALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEEN  552 (628)
Q Consensus       477 ~~~~~kl~Dfgla~~~~~~~~~~----~~~~~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~  552 (628)
                      .++.+||+|||+++.........    .......||+.|+|||.+.+..++.++|||||||++|||++|+.||.......
T Consensus       189 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~  268 (364)
T 3op5_A          189 NPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDP  268 (364)
T ss_dssp             CTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCH
T ss_pred             CCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCH
Confidence            88999999999998764322111    11133469999999999999999999999999999999999999997432221


Q ss_pred             cccHHHHHHHHhccccchhhhccccCCcCC-CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhh
Q 039626          553 NMHLSDVLNAVLTKEDGEESLRHFIDPTLQ-GNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNA  624 (628)
Q Consensus       553 ~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~-~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~~~  624 (628)
                        ..........     ...+..++++.+. ..+    +..+.+++.+||+.||.+||++.+|++.|++++..
T Consensus       269 --~~~~~~~~~~-----~~~~~~~~~~~~~~~~~----~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~  330 (364)
T 3op5_A          269 --KYVRDSKIRY-----RENIASLMDKCFPAANA----PGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKA  330 (364)
T ss_dssp             --HHHHHHHHHH-----HHCHHHHHHHHSCTTCC----CHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred             --HHHHHHHHHh-----hhhHHHHHHHhcccccC----HHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Confidence              1111111111     1122233333322 122    34578999999999999999999999999999864

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=1.6e-38  Score=346.70  Aligned_cols=236  Identities=25%  Similarity=0.436  Sum_probs=191.2

Q ss_pred             eEEEEEEE-CCceEEEEEecc------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhcCCCC
Q 039626          361 GSVYRGKI-NGGFAAIKKVNG------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEG  433 (628)
Q Consensus       361 G~Vy~g~~-~g~~vavK~~~~------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~  433 (628)
                      |.||+|.+ ++..||||+++.      ++.+|+++|++++||||+++++++. ++..++||||+++|+|.+++...  ..
T Consensus       202 g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~~~g~L~~~l~~~--~~  278 (454)
T 1qcf_A          202 GEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMAKGSLLDFLKSD--EG  278 (454)
T ss_dssp             EEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCCTTCBHHHHHHSH--HH
T ss_pred             eEEEEEEECCccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeecCCCcHHHHHHhc--cC
Confidence            89999999 477899999874      4789999999999999999999987 56789999999999999999642  12


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCCccccC
Q 039626          434 KYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMA  513 (628)
Q Consensus       434 ~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~Y~A  513 (628)
                      ..+++..++.++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++......  ........++..|+|
T Consensus       279 ~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~--~~~~~~~~~~~~y~a  353 (454)
T 1qcf_A          279 SKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNE--YTAREGAKFPIKWTA  353 (454)
T ss_dssp             HTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHH--HHTTCSSSSCGGGSC
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCc--eeccCCCcccccccC
Confidence            3588999999999999999999995   49999999999999999999999999998764321  111223456788999


Q ss_pred             ccccccCCCCcccccHHHHHHHHHHHh-CCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCHHHHHH
Q 039626          514 PEYLENGLVSTKLDVYAFGVLILEMLT-GKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALL  592 (628)
Q Consensus       514 PE~l~~~~~s~k~DV~SfGvvl~ELlt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~  592 (628)
                      ||.+....++.++||||||+++|||++ |+.|+.....      .+....+...          .    +...+..++..
T Consensus       354 PE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~------~~~~~~i~~~----------~----~~~~~~~~~~~  413 (454)
T 1qcf_A          354 PEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN------PEVIRALERG----------Y----RMPRPENCPEE  413 (454)
T ss_dssp             HHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH------HHHHHHHHHT----------C----CCCCCTTSCHH
T ss_pred             HHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCH------HHHHHHHHcC----------C----CCCCCCCCCHH
Confidence            999999999999999999999999999 9988864321      1222221110          0    11112334456


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHHHHHHHhHhh
Q 039626          593 VIRLIDACLKKDPTDRPTMYEIEHSLSNILNA  624 (628)
Q Consensus       593 l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~~~  624 (628)
                      +.+++.+||+.||++|||+++|++.|+.+..+
T Consensus       414 l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~  445 (454)
T 1qcf_A          414 LYNIMMRCWKNRPEERPTFEYIQSVLDDFYTA  445 (454)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSS
T ss_pred             HHHHHHHHccCChhHCcCHHHHHHHHHHHHhc
Confidence            88999999999999999999999999998764

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=6.6e-38  Score=320.23  Aligned_cols=237  Identities=27%  Similarity=0.423  Sum_probs=195.1

Q ss_pred             eEEEEEEE--CCceEEEEEecc------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhcCCC
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNE  432 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~  432 (628)
                      |.||+|..  .+..+|+|++..      ++.+|++++++++|+||+++++++.+++..++||||+++|+|.+++...  .
T Consensus        27 g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~--~  104 (288)
T 3kfa_A           27 GEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLREC--N  104 (288)
T ss_dssp             CSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHC--C
T ss_pred             eeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEcCCCCcHHHHHHhc--c
Confidence            89999999  478999999864      3678999999999999999999999999999999999999999999653  3


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCCcccc
Q 039626          433 GKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYM  512 (628)
Q Consensus       433 ~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~Y~  512 (628)
                      ...+++..++.++.+++.||+|||+.+   ++||||||+||+++.++.+||+|||+++.......  .......+|+.|+
T Consensus       105 ~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~--~~~~~~~~~~~y~  179 (288)
T 3kfa_A          105 RQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY--TAHAGAKFPIKWT  179 (288)
T ss_dssp             TTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSS--EEETTEEECGGGC
T ss_pred             cCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceeccCCcc--ccccCCccccCcC
Confidence            456999999999999999999999954   99999999999999999999999999987654321  2233446788999


Q ss_pred             CccccccCCCCcccccHHHHHHHHHHHh-CCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCHHHHH
Q 039626          513 APEYLENGLVSTKLDVYAFGVLILEMLT-GKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELAL  591 (628)
Q Consensus       513 APE~l~~~~~s~k~DV~SfGvvl~ELlt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~  591 (628)
                      |||.+.+..++.++||||||++++||++ |+.|+.......   ..+.+             ....    ....+...+.
T Consensus       180 aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~---~~~~~-------------~~~~----~~~~~~~~~~  239 (288)
T 3kfa_A          180 APESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---VYELL-------------EKDY----RMERPEGCPE  239 (288)
T ss_dssp             CHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---HHHHH-------------HTTC----CCCCCTTCCH
T ss_pred             ChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHH-------------hccC----CCCCCCCCCH
Confidence            9999999999999999999999999999 888876432211   11111             1111    1122233345


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhh
Q 039626          592 LVIRLIDACLKKDPTDRPTMYEIEHSLSNILNA  624 (628)
Q Consensus       592 ~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~~~  624 (628)
                      .+.+++.+||+.||.+|||+.|+++.|+.+++.
T Consensus       240 ~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~  272 (288)
T 3kfa_A          240 KVYELMRACWQWNPSDRPSFAEIHQAFETMFQE  272 (288)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHh
Confidence            688999999999999999999999999998865

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=7e-37  Score=317.87  Aligned_cols=251  Identities=22%  Similarity=0.315  Sum_probs=195.8

Q ss_pred             eEEEEEEE--CCceEEEEEecc--------chHHHHHHHhhcCCCceeeeeeeeecCC--eEEEEEEecCCCChHHHhhh
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG--------DVSKEIALLNKINHSNLIILSGVCFNEG--NCYLVYEYAVNGTLSDWVFS  428 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~--------~~~~E~~~l~~l~H~nIv~l~g~~~~~~--~~~lV~E~~~~gsL~~~l~~  428 (628)
                      |.||+|+.  +|+.||||+++.        .+.+|++++++++|+||+++++++....  ..++||||+++|+|.+++..
T Consensus        23 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~  102 (319)
T 4euu_A           23 ANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEE  102 (319)
T ss_dssp             EEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEECCTTCBHHHHHHS
T ss_pred             eEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEEeCCCCCCHHHHHHH
Confidence            89999999  488999999864        3568999999999999999999998654  78999999999999999965


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEe----CCCCcEEEccccccccCCCCCCcceeeec
Q 039626          429 NKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLL----DSDLRAKIANFAMARPAEGQEGEFALTRH  504 (628)
Q Consensus       429 ~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl----~~~~~~kl~Dfgla~~~~~~~~~~~~~~~  504 (628)
                      .. ....+++..++.++.|++.||+|||+.   +|+||||||+|||+    +.++.+||+|||+++.......    ...
T Consensus       103 ~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~~~~~----~~~  174 (319)
T 4euu_A          103 PS-NAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ----FVS  174 (319)
T ss_dssp             GG-GTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCCTTCEECCTTCC----BCC
T ss_pred             hc-cccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccCCCceecCCCCc----eee
Confidence            32 223499999999999999999999995   49999999999999    8888999999999987654321    234


Q ss_pred             ccCCccccCccccc--------cCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccc--hhhhc
Q 039626          505 IVGTKGYMAPEYLE--------NGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDG--EESLR  574 (628)
Q Consensus       505 ~~gt~~Y~APE~l~--------~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~l~  574 (628)
                      ..||+.|+|||.+.        +..++.++||||||+++|||++|+.||........  ..+....+......  ...+.
T Consensus       175 ~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~~~p~~~~~~~~  252 (319)
T 4euu_A          175 LYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRR--NKEVMYKIITGKPSGAISGVQ  252 (319)
T ss_dssp             CCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGG--CHHHHHHHHHHCCTTCCEEEE
T ss_pred             cccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccch--hHHHHHHHhcCCCcccchhhh
Confidence            57999999999886        57889999999999999999999999874333221  12223333221110  00000


Q ss_pred             c-------cc-CCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 039626          575 H-------FI-DPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNI  621 (628)
Q Consensus       575 ~-------~~-d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l  621 (628)
                      .       +. +.......+......+.+++.+||+.||++|||++|+++..++-
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~  307 (319)
T 4euu_A          253 KAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI  307 (319)
T ss_dssp             CSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred             cccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence            0       00 11112345678888999999999999999999999999887653

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9.7e-38  Score=326.63  Aligned_cols=239  Identities=24%  Similarity=0.415  Sum_probs=185.4

Q ss_pred             eEEEEEEECC------ceEEEEEecc--------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHh
Q 039626          361 GSVYRGKING------GFAAIKKVNG--------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWV  426 (628)
Q Consensus       361 G~Vy~g~~~g------~~vavK~~~~--------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l  426 (628)
                      |.||+|....      ..||+|.++.        ++.+|++++++++|+||+++++++.+.+..++||||+++|+|.+++
T Consensus        58 g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l  137 (333)
T 1mqb_A           58 GEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFL  137 (333)
T ss_dssp             SEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHH
T ss_pred             eEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEEEEeCCCCCcHHHHH
Confidence            8999998732      2599999864        3668999999999999999999999999999999999999999999


Q ss_pred             hhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeeccc
Q 039626          427 FSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIV  506 (628)
Q Consensus       427 ~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~  506 (628)
                      ...   ...+++..++.++.|++.||+|||+.   +++||||||+|||++.++.+||+|||+++................
T Consensus       138 ~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~  211 (333)
T 1mqb_A          138 REK---DGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGK  211 (333)
T ss_dssp             HHT---TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-----------------C
T ss_pred             HhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCCcchhhccccccccccCCCC
Confidence            642   34599999999999999999999995   499999999999999999999999999987654322222223345


Q ss_pred             CCccccCccccccCCCCcccccHHHHHHHHHHHh-CCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCC
Q 039626          507 GTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT-GKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNY  585 (628)
Q Consensus       507 gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELlt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~  585 (628)
                      +|+.|+|||.+.+..++.++||||||+++|||++ |+.|+.....      .+....+...          .    ....
T Consensus       212 ~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~------~~~~~~~~~~----------~----~~~~  271 (333)
T 1mqb_A          212 IPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN------HEVMKAINDG----------F----RLPT  271 (333)
T ss_dssp             CCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH------HHHHHHHHTT----------C----CCCC
T ss_pred             ccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCH------HHHHHHHHCC----------C----cCCC
Confidence            6889999999999999999999999999999999 9988853221      1222211110          0    0111


Q ss_pred             CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhc
Q 039626          586 PLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNAS  625 (628)
Q Consensus       586 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~~~~  625 (628)
                      +...+..+.+++.+||+.||.+||++.|+++.|++++...
T Consensus       272 ~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~  311 (333)
T 1mqb_A          272 PMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP  311 (333)
T ss_dssp             CTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred             cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence            2234456889999999999999999999999999988653

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.8e-37  Score=321.72  Aligned_cols=263  Identities=23%  Similarity=0.369  Sum_probs=195.3

Q ss_pred             HHhcCCCcCCccc----eEEEEEEECCceEEEEEeccc----hHHHHHHHhhc--CCCceeeeeeeeecC----CeEEEE
Q 039626          348 SATDNFSFTCRIQ----GSVYRGKINGGFAAIKKVNGD----VSKEIALLNKI--NHSNLIILSGVCFNE----GNCYLV  413 (628)
Q Consensus       348 ~at~~f~~~~~i~----G~Vy~g~~~g~~vavK~~~~~----~~~E~~~l~~l--~H~nIv~l~g~~~~~----~~~~lV  413 (628)
                      ...++|.....+|    |.||+|+..|+.||||++...    +..|.+++..+  +|+||+++++++...    ...++|
T Consensus        34 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv  113 (337)
T 3mdy_A           34 TIAKQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLI  113 (337)
T ss_dssp             THHHHCEEEEEEEEETTEEEEEEEETTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEEEE
T ss_pred             ccccceEEEeEeecCCCeEEEEEEECCceEEEEEEeccccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceEEE
Confidence            3445666666665    899999999999999998643    34555655554  999999999999877    689999


Q ss_pred             EEecCCCChHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC-----CCCeEecCCCCCCEEeCCCCcEEEccccc
Q 039626          414 YEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFT-----NPPHVHKDINSSNVLLDSDLRAKIANFAM  488 (628)
Q Consensus       414 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-----~~~iiH~dik~~NILl~~~~~~kl~Dfgl  488 (628)
                      |||+++|+|.+++..     ..+++..++.++.|++.||+|||+..     .++++||||||+|||++.++.+||+|||+
T Consensus       114 ~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~  188 (337)
T 3mdy_A          114 TDYHENGSLYDYLKS-----TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL  188 (337)
T ss_dssp             ECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred             EeccCCCcHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCCC
Confidence            999999999999954     24899999999999999999999851     13699999999999999999999999999


Q ss_pred             cccCCCCCCcce-eeecccCCccccCccccccCCCCcc------cccHHHHHHHHHHHhCC----------Ccccccccc
Q 039626          489 ARPAEGQEGEFA-LTRHIVGTKGYMAPEYLENGLVSTK------LDVYAFGVLILEMLTGK----------EAAALHAEE  551 (628)
Q Consensus       489 a~~~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~s~k------~DV~SfGvvl~ELltG~----------~p~~~~~~~  551 (628)
                      ++.......... ......||+.|+|||.+.+...+.+      +|||||||++|||++|+          .|+......
T Consensus       189 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~  268 (337)
T 3mdy_A          189 AVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPS  268 (337)
T ss_dssp             CEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCS
T ss_pred             ceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCC
Confidence            987643322111 1234579999999999987766665      99999999999999994          444322111


Q ss_pred             ccccHHHHHHHHhccccchhhhccccCCcCCCC-CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhc
Q 039626          552 NNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGN-YPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNAS  625 (628)
Q Consensus       552 ~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~-~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~~~~  625 (628)
                      . .. ..........        ....+..... .+.++...+.+++.+||+.||.+|||+.||++.|+++.++.
T Consensus       269 ~-~~-~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~  333 (337)
T 3mdy_A          269 D-PS-YEDMREIVCI--------KKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQ  333 (337)
T ss_dssp             S-CC-HHHHHHHHTT--------SCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred             C-Cc-hhhhHHHHhh--------hccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhc
Confidence            1 11 1111111111        0111111111 12367788999999999999999999999999999998753

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.7e-37  Score=317.49  Aligned_cols=238  Identities=22%  Similarity=0.355  Sum_probs=193.0

Q ss_pred             eEEEEEEE----CCceEEEEEecc--------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhh
Q 039626          361 GSVYRGKI----NGGFAAIKKVNG--------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFS  428 (628)
Q Consensus       361 G~Vy~g~~----~g~~vavK~~~~--------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  428 (628)
                      |.||+|++    .+..||+|.++.        ++.+|++++++++||||+++++++ ..+..++||||+++|+|.+++..
T Consensus        24 g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~  102 (287)
T 1u59_A           24 GSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVG  102 (287)
T ss_dssp             EEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEEECCTTEEHHHHHTT
T ss_pred             eeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEEEEeCCCCCHHHHHHh
Confidence            89999986    467899999864        366899999999999999999999 45678999999999999999953


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCC
Q 039626          429 NKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGT  508 (628)
Q Consensus       429 ~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt  508 (628)
                         ....+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||+++................+|
T Consensus       103 ---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~  176 (287)
T 1u59_A          103 ---KREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWP  176 (287)
T ss_dssp             ---CTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCC
T ss_pred             ---CCccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcccceeeeccCcceeecccccccc
Confidence               345699999999999999999999995   49999999999999999999999999998775433222222334678


Q ss_pred             ccccCccccccCCCCcccccHHHHHHHHHHHh-CCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCH
Q 039626          509 KGYMAPEYLENGLVSTKLDVYAFGVLILEMLT-GKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPL  587 (628)
Q Consensus       509 ~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELlt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~  587 (628)
                      +.|+|||.+.+..++.++||||||++++||++ |+.|+......      +....+...          ..    ...+.
T Consensus       177 ~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~------~~~~~i~~~----------~~----~~~~~  236 (287)
T 1u59_A          177 LKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP------EVMAFIEQG----------KR----MECPP  236 (287)
T ss_dssp             GGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH------HHHHHHHTT----------CC----CCCCT
T ss_pred             ccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH------HHHHHHhcC----------Cc----CCCCC
Confidence            99999999998899999999999999999998 99988643221      111111110          01    11223


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhc
Q 039626          588 ELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNAS  625 (628)
Q Consensus       588 ~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~~~~  625 (628)
                      ..+..+.+++.+||+.||.+||++.|+++.|++++.+.
T Consensus       237 ~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~  274 (287)
T 1u59_A          237 ECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL  274 (287)
T ss_dssp             TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             CcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence            34456889999999999999999999999999998764

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=5.2e-38  Score=321.93  Aligned_cols=237  Identities=24%  Similarity=0.376  Sum_probs=189.9

Q ss_pred             eEEEEEEE----CCceEEEEEecc---------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhh
Q 039626          361 GSVYRGKI----NGGFAAIKKVNG---------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVF  427 (628)
Q Consensus       361 G~Vy~g~~----~g~~vavK~~~~---------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~  427 (628)
                      |.||+|.+    .+..+|||.++.         ++.+|++++++++|+||+++++++ ..+..++||||+++|+|.+++.
T Consensus        31 g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~  109 (291)
T 1xbb_A           31 GTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQ  109 (291)
T ss_dssp             EEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEEEEECCTTEEHHHHHH
T ss_pred             eeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEEEEEeCCCCCHHHHHH
Confidence            89999965    357899999864         366899999999999999999999 5677899999999999999996


Q ss_pred             hcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccC
Q 039626          428 SNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVG  507 (628)
Q Consensus       428 ~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~g  507 (628)
                      .    ...+++..++.++.|++.||+|||+.   +++||||||+||+++.++.+||+|||+++................+
T Consensus       110 ~----~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~  182 (291)
T 1xbb_A          110 Q----NRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKW  182 (291)
T ss_dssp             H----CTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----CC
T ss_pred             h----CcCCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEccCCcceeeccCCCcccccccCCC
Confidence            4    23589999999999999999999995   4999999999999999999999999999877544332222233457


Q ss_pred             CccccCccccccCCCCcccccHHHHHHHHHHHh-CCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCC
Q 039626          508 TKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT-GKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYP  586 (628)
Q Consensus       508 t~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELlt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~  586 (628)
                      ++.|+|||.+.+..++.++||||||++++||++ |+.|+......      +....+...          ..+    ..+
T Consensus       183 ~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~------~~~~~~~~~----------~~~----~~~  242 (291)
T 1xbb_A          183 PVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS------EVTAMLEKG----------ERM----GCP  242 (291)
T ss_dssp             CGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH------HHHHHHHTT----------CCC----CCC
T ss_pred             CceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHH------HHHHHHHcC----------CCC----CCC
Confidence            789999999998889999999999999999999 99988643221      111111110          011    122


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhc
Q 039626          587 LELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNAS  625 (628)
Q Consensus       587 ~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~~~~  625 (628)
                      ...+..+.+++.+||+.||.+||++.|+++.|++++...
T Consensus       243 ~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~  281 (291)
T 1xbb_A          243 AGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV  281 (291)
T ss_dssp             TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred             CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHH
Confidence            334456889999999999999999999999999998653

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=1.1e-37  Score=324.95  Aligned_cols=230  Identities=25%  Similarity=0.327  Sum_probs=184.1

Q ss_pred             eEEEEEEE--CCceEEEEEec--------cchHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhcC
Q 039626          361 GSVYRGKI--NGGFAAIKKVN--------GDVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNK  430 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~--------~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~  430 (628)
                      |.||++..  +++.||+|++.        ..+.+|+.++++++|+||+++++++.+++..++||||+++|+|.+++.   
T Consensus        21 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~---   97 (323)
T 3tki_A           21 GEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE---   97 (323)
T ss_dssp             EEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCTTEEGGGGSB---
T ss_pred             EEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEcCCCCcHHHHHh---
Confidence            89999988  68899999874        246789999999999999999999999999999999999999999984   


Q ss_pred             CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCCcc
Q 039626          431 NEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKG  510 (628)
Q Consensus       431 ~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~  510 (628)
                       ....+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++....... ........||+.
T Consensus        98 -~~~~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~~gt~~  172 (323)
T 3tki_A           98 -PDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR-ERLLNKMCGTLP  172 (323)
T ss_dssp             -TTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTE-ECCBCSCCSCGG
T ss_pred             -hcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeeccceeccCCc-ccccCCCccCcC
Confidence             334599999999999999999999995   499999999999999999999999999986543221 112334679999


Q ss_pred             ccCccccccCCC-CcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCHHH
Q 039626          511 YMAPEYLENGLV-STKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLEL  589 (628)
Q Consensus       511 Y~APE~l~~~~~-s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~  589 (628)
                      |+|||.+.+..+ +.++||||||++++||++|+.||........ ...    ......             .........
T Consensus       173 y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~----~~~~~~-------------~~~~~~~~~  234 (323)
T 3tki_A          173 YVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYS----DWKEKK-------------TYLNPWKKI  234 (323)
T ss_dssp             GSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSH-HHH----HHHTTC-------------TTSTTGGGS
T ss_pred             ccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHH-HHH----HHhccc-------------ccCCccccC
Confidence            999999987765 7899999999999999999999864332211 011    111000             000001223


Q ss_pred             HHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          590 ALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       590 ~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      ...+.+|+.+||+.||.+|||+.|+++
T Consensus       235 ~~~~~~li~~~L~~dP~~R~t~~eil~  261 (323)
T 3tki_A          235 DSAPLALLHKILVENPSARITIPDIKK  261 (323)
T ss_dssp             CHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHhh
Confidence            455789999999999999999999875

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=3.8e-37  Score=328.89  Aligned_cols=253  Identities=24%  Similarity=0.387  Sum_probs=194.2

Q ss_pred             cCCCcCCccc----eEEEEEEE--CCceEEEEEeccc----------hHHHHHHHhhc-CCCceeeeeeeeecCCeEEEE
Q 039626          351 DNFSFTCRIQ----GSVYRGKI--NGGFAAIKKVNGD----------VSKEIALLNKI-NHSNLIILSGVCFNEGNCYLV  413 (628)
Q Consensus       351 ~~f~~~~~i~----G~Vy~g~~--~g~~vavK~~~~~----------~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV  413 (628)
                      ++|.....+|    |.||+++.  +++.+|+|+++..          +..|..+|.++ +||||+++++++.+++..++|
T Consensus        52 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV  131 (396)
T 4dc2_A           52 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV  131 (396)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEE
Confidence            3455444554    89999998  5788999998642          56799999887 899999999999999999999


Q ss_pred             EEecCCCChHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCC
Q 039626          414 YEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAE  493 (628)
Q Consensus       414 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~  493 (628)
                      |||+++|+|.+++...    ..+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++...
T Consensus       132 ~E~~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFGla~~~~  204 (396)
T 4dc2_A          132 IEYVNGGDLMFHMQRQ----RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL  204 (396)
T ss_dssp             EECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred             EEcCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeecceeeecc
Confidence            9999999999999643    3599999999999999999999995   49999999999999999999999999998633


Q ss_pred             CCCCcceeeecccCCccccCccccccCCCCcccccHHHHHHHHHHHhCCCcccccccccc--ccHHH-HHHHHhccccch
Q 039626          494 GQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENN--MHLSD-VLNAVLTKEDGE  570 (628)
Q Consensus       494 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~--~~~~~-~~~~~~~~~~~~  570 (628)
                      ...   .......||+.|+|||++.+..++.++|||||||++|||++|+.||........  ....+ ....+...    
T Consensus       205 ~~~---~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~----  277 (396)
T 4dc2_A          205 RPG---DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK----  277 (396)
T ss_dssp             CTT---CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHC----
T ss_pred             cCC---CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcc----
Confidence            221   123456899999999999999999999999999999999999999964322111  00111 11111110    


Q ss_pred             hhhccccCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHH---HHHHHHHHhHhhccCC
Q 039626          571 ESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMY---EIEHSLSNILNASLNW  628 (628)
Q Consensus       571 ~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~---ev~~~L~~l~~~~~~w  628 (628)
                                 ...+|...+..+.+|+.+||+.||.+||++.   .+.+.++.-.-..+||
T Consensus       278 -----------~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~w  327 (396)
T 4dc2_A          278 -----------QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDW  327 (396)
T ss_dssp             -----------CCCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTCCH
T ss_pred             -----------ccCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCCCH
Confidence                       0122333455678999999999999999973   4444444444444444

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.6e-37  Score=350.70  Aligned_cols=237  Identities=22%  Similarity=0.353  Sum_probs=187.6

Q ss_pred             eEEEEEEE----CCceEEEEEecc--------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhh
Q 039626          361 GSVYRGKI----NGGFAAIKKVNG--------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFS  428 (628)
Q Consensus       361 G~Vy~g~~----~g~~vavK~~~~--------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  428 (628)
                      |.||+|.+    ++..||||+++.        ++.+|+++|++++|+|||+++++|.. +..++||||+++|+|.+++..
T Consensus       350 G~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~L~~~l~~  428 (613)
T 2ozo_A          350 GSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVG  428 (613)
T ss_dssp             SEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCBHHHHHTT
T ss_pred             cEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCcHHHHHhh
Confidence            89999987    345799999864        36789999999999999999999976 568999999999999999953


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCC
Q 039626          429 NKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGT  508 (628)
Q Consensus       429 ~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt  508 (628)
                         ....+++..++.++.||+.||+|||+.   +|+||||||+|||+++++.+||+|||+++................++
T Consensus       429 ---~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~  502 (613)
T 2ozo_A          429 ---KREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWP  502 (613)
T ss_dssp             ---CTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC--------------C
T ss_pred             ---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeeccCCCCc
Confidence               345699999999999999999999995   49999999999999999999999999998765433222222233567


Q ss_pred             ccccCccccccCCCCcccccHHHHHHHHHHHh-CCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCH
Q 039626          509 KGYMAPEYLENGLVSTKLDVYAFGVLILEMLT-GKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPL  587 (628)
Q Consensus       509 ~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELlt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~  587 (628)
                      +.|+|||++.+..++.++|||||||++|||++ |+.||......      +....+...              .+...+.
T Consensus       503 ~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~------~~~~~i~~~--------------~~~~~p~  562 (613)
T 2ozo_A          503 LKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP------EVMAFIEQG--------------KRMECPP  562 (613)
T ss_dssp             CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSH------HHHHHHHTT--------------CCCCCCT
T ss_pred             cceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHH------HHHHHHHcC--------------CCCCCCC
Confidence            89999999999999999999999999999998 99998643221      111111110              1112233


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhh
Q 039626          588 ELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNA  624 (628)
Q Consensus       588 ~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~~~  624 (628)
                      .++..+.+++.+||+.||++||++.+|++.|+.+..+
T Consensus       563 ~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~  599 (613)
T 2ozo_A          563 ECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS  599 (613)
T ss_dssp             TCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred             cCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence            4456788999999999999999999999999998754

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.9e-37  Score=318.80  Aligned_cols=226  Identities=29%  Similarity=0.389  Sum_probs=180.4

Q ss_pred             eEEEEEEE--CCceEEEEEecc---------------------------------chHHHHHHHhhcCCCceeeeeeeee
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG---------------------------------DVSKEIALLNKINHSNLIILSGVCF  405 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~---------------------------------~~~~E~~~l~~l~H~nIv~l~g~~~  405 (628)
                      |.||+++.  +++.||||++..                                 .+.+|+++|++++||||+++++++.
T Consensus        27 g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~  106 (298)
T 2zv2_A           27 GVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLD  106 (298)
T ss_dssp             CEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred             EEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence            89999987  678999998742                                 3678999999999999999999998


Q ss_pred             c--CCeEEEEEEecCCCChHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEE
Q 039626          406 N--EGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKI  483 (628)
Q Consensus       406 ~--~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl  483 (628)
                      +  ++..++||||+++|+|.+++     ....+++..+..++.|++.||+|||+.   +++||||||+|||++.++.+||
T Consensus       107 ~~~~~~~~lv~e~~~~~~l~~~~-----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl  178 (298)
T 2zv2_A          107 DPNEDHLYMVFELVNQGPVMEVP-----TLKPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKI  178 (298)
T ss_dssp             CSSSSEEEEEEECCTTCBSCCSS-----CSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEE
T ss_pred             cCCCCEEEEEEecCCCCcHHHHh-----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCCEEE
Confidence            6  56899999999999998865     234699999999999999999999995   4999999999999999999999


Q ss_pred             ccccccccCCCCCCcceeeecccCCccccCccccccCC---CCcccccHHHHHHHHHHHhCCCccccccccccccHHHHH
Q 039626          484 ANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGL---VSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVL  560 (628)
Q Consensus       484 ~Dfgla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~---~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~  560 (628)
                      +|||+++.......   ......||+.|+|||.+.+..   .+.++||||||+++|||++|+.||.....      ....
T Consensus       179 ~Dfg~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~------~~~~  249 (298)
T 2zv2_A          179 ADFGVSNEFKGSDA---LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERI------MCLH  249 (298)
T ss_dssp             CCCTTCEECSSSSC---EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHH
T ss_pred             ecCCCccccccccc---cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccH------HHHH
Confidence            99999987654321   233457999999999997754   47899999999999999999999863221      1111


Q ss_pred             HHHhccccchhhhccccCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          561 NAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       561 ~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      ..+....         .......    ..+..+.+++.+||+.||++||++.|+++
T Consensus       250 ~~~~~~~---------~~~~~~~----~~~~~l~~li~~~l~~dp~~R~s~~e~l~  292 (298)
T 2zv2_A          250 SKIKSQA---------LEFPDQP----DIAEDLKDLITRMLDKNPESRIVVPEIKL  292 (298)
T ss_dssp             HHHHHCC---------CCCCSSS----CCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             HHHhccc---------CCCCCcc----ccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence            1111100         0000111    23345789999999999999999999864

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=7.6e-38  Score=327.20  Aligned_cols=251  Identities=25%  Similarity=0.356  Sum_probs=185.1

Q ss_pred             eEEEEEEECCceEEEEEeccc----hHHH--HHHHhhcCCCceeeeeeeeec-----CCeEEEEEEecCCCChHHHhhhc
Q 039626          361 GSVYRGKINGGFAAIKKVNGD----VSKE--IALLNKINHSNLIILSGVCFN-----EGNCYLVYEYAVNGTLSDWVFSN  429 (628)
Q Consensus       361 G~Vy~g~~~g~~vavK~~~~~----~~~E--~~~l~~l~H~nIv~l~g~~~~-----~~~~~lV~E~~~~gsL~~~l~~~  429 (628)
                      |.||+|+.+++.||||++...    +..|  +..+..++|+||+++++.+..     ....++||||+++|+|.+++...
T Consensus        27 g~Vy~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~  106 (336)
T 3g2f_A           27 GAVYKGSLDERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH  106 (336)
T ss_dssp             EEEEEEEETTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEEECCCTTCBHHHHHHHC
T ss_pred             eEEEEEEECCeEEEEEEeeccchhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEEEEecCCCCcHHHHHhhc
Confidence            899999999999999998642    3334  444556899999999986542     33678999999999999999542


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHHHHHHhcCC------CCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCC-----c
Q 039626          430 KNEGKYLDWKQRIQIALDVATGLNYLHSFT------NPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEG-----E  498 (628)
Q Consensus       430 ~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~------~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~-----~  498 (628)
                           ..+|..+..++.|++.||+|||+..      .++|+||||||+|||++.++.+||+|||+++.......     .
T Consensus       107 -----~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG~a~~~~~~~~~~~~~~  181 (336)
T 3g2f_A          107 -----TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEE  181 (336)
T ss_dssp             -----CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCTTCEECSSSSCC-----
T ss_pred             -----ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeeccceeecccccccCcccc
Confidence                 3589999999999999999999851      12699999999999999999999999999987643221     1


Q ss_pred             ceeeecccCCccccCcccccc-------CCCCcccccHHHHHHHHHHHhCCCccccccccccc--cH---------HHHH
Q 039626          499 FALTRHIVGTKGYMAPEYLEN-------GLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNM--HL---------SDVL  560 (628)
Q Consensus       499 ~~~~~~~~gt~~Y~APE~l~~-------~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~--~~---------~~~~  560 (628)
                      ........||+.|+|||.+.+       ..++.++||||||+++|||++|+.|+.........  ..         .+..
T Consensus       182 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (336)
T 3g2f_A          182 DNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDM  261 (336)
T ss_dssp             ----CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCTTHHHHCSSCCHHHH
T ss_pred             ccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHHhhhcccCCCchHHHH
Confidence            112234579999999999986       45678999999999999999998776533221110  00         0011


Q ss_pred             HHHhccccchhhhccccCCcCCCCC--CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhh
Q 039626          561 NAVLTKEDGEESLRHFIDPTLQGNY--PLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNA  624 (628)
Q Consensus       561 ~~~~~~~~~~~~l~~~~d~~l~~~~--~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~~~  624 (628)
                      .....        .....+.+...+  ....+..+.+++.+||+.||++|||++|+++.|++++..
T Consensus       262 ~~~~~--------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~  319 (336)
T 3g2f_A          262 QVLVS--------REKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMI  319 (336)
T ss_dssp             HHHHT--------TSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             Hhhhc--------ccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHH
Confidence            11111        011111222111  234667899999999999999999999999999999853

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=4.2e-38  Score=326.09  Aligned_cols=232  Identities=23%  Similarity=0.288  Sum_probs=179.4

Q ss_pred             cCCCcCCccc----eEEEEEEE--CCceEEEEEecc---------chHHHHHHHhhc-CCCceeeeeeeeecCCeEEEEE
Q 039626          351 DNFSFTCRIQ----GSVYRGKI--NGGFAAIKKVNG---------DVSKEIALLNKI-NHSNLIILSGVCFNEGNCYLVY  414 (628)
Q Consensus       351 ~~f~~~~~i~----G~Vy~g~~--~g~~vavK~~~~---------~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV~  414 (628)
                      ++|.....+|    |.||+|+.  +|+.||||++..         +...|+..+.++ +|+||++++++|.+++..++||
T Consensus        57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~  136 (311)
T 3p1a_A           57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT  136 (311)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence            3455555554    89999998  588999999853         133455555555 9999999999999999999999


Q ss_pred             EecCCCChHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCC
Q 039626          415 EYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEG  494 (628)
Q Consensus       415 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~  494 (628)
                      ||+ +|+|.+++...   +..++|..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++....
T Consensus       137 e~~-~~~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~  209 (311)
T 3p1a_A          137 ELC-GPSLQQHCEAW---GASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGT  209 (311)
T ss_dssp             ECC-CCBHHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCTTCEECC-
T ss_pred             ecc-CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccceeeeeccc
Confidence            999 78999998653   34599999999999999999999995   499999999999999999999999999887643


Q ss_pred             CCCcceeeecccCCccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhc
Q 039626          495 QEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLR  574 (628)
Q Consensus       495 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  574 (628)
                      ..    ......||++|+|||++.+ .++.++||||||+++|||++|+.++.....         ...+...        
T Consensus       210 ~~----~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~---------~~~~~~~--------  267 (311)
T 3p1a_A          210 AG----AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG---------WQQLRQG--------  267 (311)
T ss_dssp             ---------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH---------HHHHTTT--------
T ss_pred             CC----CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH---------HHHHhcc--------
Confidence            22    2234569999999998876 789999999999999999999766542111         1111110        


Q ss_pred             cccCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          575 HFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       575 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                       ...+..    +...+..+.+++.+||+.||++|||++|+++
T Consensus       268 -~~~~~~----~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  304 (311)
T 3p1a_A          268 -YLPPEF----TAGLSSELRSVLVMMLEPDPKLRATAEALLA  304 (311)
T ss_dssp             -CCCHHH----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             -CCCccc----ccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence             001111    1123456889999999999999999999875

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=8.1e-38  Score=315.78  Aligned_cols=237  Identities=26%  Similarity=0.441  Sum_probs=193.1

Q ss_pred             eEEEEEEE-CCceEEEEEecc------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhcCCCC
Q 039626          361 GSVYRGKI-NGGFAAIKKVNG------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEG  433 (628)
Q Consensus       361 G~Vy~g~~-~g~~vavK~~~~------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~  433 (628)
                      |.||++.. +++.+|+|+++.      ++.+|++++++++||||+++++++.+++..++||||+++|+|.+++...   .
T Consensus        22 g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~---~   98 (267)
T 3t9t_A           22 GLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQ---R   98 (267)
T ss_dssp             EEEEEEEETTTEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCTTCBHHHHHHHT---T
T ss_pred             eeEEEEEecCCCeEEEEEccccCCCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCCCCcHHHHHhhC---c
Confidence            89999998 677899999864      4678999999999999999999999999999999999999999999643   3


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCCccccC
Q 039626          434 KYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMA  513 (628)
Q Consensus       434 ~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~Y~A  513 (628)
                      ..+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||+++......  ........++..|+|
T Consensus        99 ~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~~y~a  173 (267)
T 3t9t_A           99 GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ--YTSSTGTKFPVKWAS  173 (267)
T ss_dssp             TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH--HHSTTSTTCCGGGCC
T ss_pred             ccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEccccccccccccc--ccccccccccccccC
Confidence            4589999999999999999999995   49999999999999999999999999998664221  111223457788999


Q ss_pred             ccccccCCCCcccccHHHHHHHHHHHh-CCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCHHHHHH
Q 039626          514 PEYLENGLVSTKLDVYAFGVLILEMLT-GKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALL  592 (628)
Q Consensus       514 PE~l~~~~~s~k~DV~SfGvvl~ELlt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~  592 (628)
                      ||.+.+..++.++||||||++++||++ |+.|+.....      .+....+...          ..+    ..+...+..
T Consensus       174 PE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~------~~~~~~i~~~----------~~~----~~~~~~~~~  233 (267)
T 3t9t_A          174 PEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN------SEVVEDISTG----------FRL----YKPRLASTH  233 (267)
T ss_dssp             HHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH------HHHHHHHHTT----------CCC----CCCTTSCHH
T ss_pred             hhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCH------HHHHHHHhcC----------CcC----CCCccCcHH
Confidence            999998899999999999999999999 8888763221      1222221111          001    112223456


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhc
Q 039626          593 VIRLIDACLKKDPTDRPTMYEIEHSLSNILNAS  625 (628)
Q Consensus       593 l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~~~~  625 (628)
                      +.+++.+||+.||++||++.|+++.|+++.++.
T Consensus       234 l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~~  266 (267)
T 3t9t_A          234 VYQIMNHCWRERPEDRPAFSRLLRQLAEIAESG  266 (267)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred             HHHHHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence            789999999999999999999999999998765

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=8e-38  Score=325.99  Aligned_cols=236  Identities=25%  Similarity=0.376  Sum_probs=185.3

Q ss_pred             eEEEEEEE--CCce----EEEEEecc--------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHh
Q 039626          361 GSVYRGKI--NGGF----AAIKKVNG--------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWV  426 (628)
Q Consensus       361 G~Vy~g~~--~g~~----vavK~~~~--------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l  426 (628)
                      |.||+|++  +++.    +|+|.+..        .+.+|+.++++++|+||+++++++. ++..++||||+++|+|.+++
T Consensus        27 g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~~~L~~~l  105 (325)
T 3kex_A           27 GTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQLVTQYLPLGSLLDHV  105 (325)
T ss_dssp             CEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEEEEECCTTCBSHHHH
T ss_pred             ceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEEEEEeCCCCCHHHHH
Confidence            89999998  4444    78887642        4668999999999999999999986 56689999999999999999


Q ss_pred             hhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeeccc
Q 039626          427 FSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIV  506 (628)
Q Consensus       427 ~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~  506 (628)
                      ...   ...+++..++.++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++........ .......
T Consensus       106 ~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~~  178 (325)
T 3kex_A          106 RQH---RGALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQ-LLYSEAK  178 (325)
T ss_dssp             HSS---GGGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCCTTC-CC-----
T ss_pred             HHc---cccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCcccccCccccc-ccccCCC
Confidence            542   34689999999999999999999995   4999999999999999999999999999977543322 1234457


Q ss_pred             CCccccCccccccCCCCcccccHHHHHHHHHHHh-CCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCC
Q 039626          507 GTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT-GKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNY  585 (628)
Q Consensus       507 gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELlt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~  585 (628)
                      +|..|+|||.+.+..++.++||||||+++|||++ |+.|+......   ...+.+   ....              ....
T Consensus       179 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~~~~~---~~~~--------------~~~~  238 (325)
T 3kex_A          179 TPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLA---EVPDLL---EKGE--------------RLAQ  238 (325)
T ss_dssp             CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTT---HHHHHH---HTTC--------------BCCC
T ss_pred             CcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHH---HHHHHH---HcCC--------------CCCC
Confidence            8889999999999999999999999999999999 99998643221   111111   1100              0011


Q ss_pred             CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhh
Q 039626          586 PLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNA  624 (628)
Q Consensus       586 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~~~  624 (628)
                      +...+..+.+++.+||+.||.+||++.|+++.|+++...
T Consensus       239 ~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~  277 (325)
T 3kex_A          239 PQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARD  277 (325)
T ss_dssp             CTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTS
T ss_pred             CCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence            112233467899999999999999999999999998753

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=4.1e-38  Score=343.31  Aligned_cols=236  Identities=29%  Similarity=0.477  Sum_probs=186.6

Q ss_pred             eEEEEEEECC-ceEEEEEecc------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhcCCCC
Q 039626          361 GSVYRGKING-GFAAIKKVNG------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEG  433 (628)
Q Consensus       361 G~Vy~g~~~g-~~vavK~~~~------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~  433 (628)
                      |.||+|.+.+ ..||||+++.      ++.+|+++|++++||||+++++++.+ +..++||||+++|+|.+++...  .+
T Consensus       198 g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~~gsL~~~l~~~--~~  274 (452)
T 1fmk_A          198 GEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGE--TG  274 (452)
T ss_dssp             CEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTCBHHHHHSHH--HH
T ss_pred             eEEEEEEECCCceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhhcCCCHHHHHHhc--CC
Confidence            8999999954 6799999874      47899999999999999999999976 6789999999999999999542  22


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCCccccC
Q 039626          434 KYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMA  513 (628)
Q Consensus       434 ~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~Y~A  513 (628)
                      ..+++..++.++.|++.||+|||+.   +++||||||+|||+++++.+||+|||+++.......  .......++..|+|
T Consensus       275 ~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~--~~~~~~~~~~~y~a  349 (452)
T 1fmk_A          275 KYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY--TARQGAKFPIKWTA  349 (452)
T ss_dssp             TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC----------------CCGGGSC
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCccceecCCCce--ecccCCcccccccC
Confidence            4589999999999999999999995   499999999999999999999999999987653221  12233457889999


Q ss_pred             ccccccCCCCcccccHHHHHHHHHHHh-CCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCHHHHHH
Q 039626          514 PEYLENGLVSTKLDVYAFGVLILEMLT-GKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALL  592 (628)
Q Consensus       514 PE~l~~~~~s~k~DV~SfGvvl~ELlt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~  592 (628)
                      ||.+.+..++.++||||||+++|||++ |+.|+.....      .+....+...              .+...+..++..
T Consensus       350 PE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~------~~~~~~i~~~--------------~~~~~~~~~~~~  409 (452)
T 1fmk_A          350 PEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN------REVLDQVERG--------------YRMPCPPECPES  409 (452)
T ss_dssp             HHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH------HHHHHHHHTT--------------CCCCCCTTSCHH
T ss_pred             HhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCH------HHHHHHHHcC--------------CCCCCCCCCCHH
Confidence            999999999999999999999999999 8888763221      1222221110              111223344566


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHHHHHHHhHhh
Q 039626          593 VIRLIDACLKKDPTDRPTMYEIEHSLSNILNA  624 (628)
Q Consensus       593 l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~~~  624 (628)
                      +.+++.+||+.||++|||++++++.|+.+..+
T Consensus       410 l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~  441 (452)
T 1fmk_A          410 LHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS  441 (452)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred             HHHHHHHHccCChhhCcCHHHHHHHHHHHhcc
Confidence            88999999999999999999999999998754

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=7.1e-37  Score=320.43  Aligned_cols=225  Identities=25%  Similarity=0.370  Sum_probs=185.2

Q ss_pred             eEEEEEEE--CCceEEEEEecc----------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhh
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG----------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFS  428 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  428 (628)
                      |.||+++.  +|+.+|+|.++.          .+.+|+++|++++||||+++++++.+.+..++||||+++|+|.+++..
T Consensus        19 g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~   98 (337)
T 1o6l_A           19 GKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSR   98 (337)
T ss_dssp             EEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH
T ss_pred             eEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHh
Confidence            89999998  588999999864          256799999999999999999999999999999999999999999954


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCC
Q 039626          429 NKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGT  508 (628)
Q Consensus       429 ~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt  508 (628)
                      .    ..+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++.......   ......||
T Consensus        99 ~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~---~~~~~~gt  168 (337)
T 1o6l_A           99 E----RVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA---TMKTFCGT  168 (337)
T ss_dssp             H----SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC---CBCCCEEC
T ss_pred             c----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeeccchhhcccCCC---cccccccC
Confidence            3    3589999999999999999999995   499999999999999999999999999986432211   23446799


Q ss_pred             ccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCHH
Q 039626          509 KGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLE  588 (628)
Q Consensus       509 ~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~  588 (628)
                      +.|+|||.+.+..++.++||||||+++|||++|+.|+.....      .+....+....           .    .+|..
T Consensus       169 ~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~------~~~~~~i~~~~-----------~----~~p~~  227 (337)
T 1o6l_A          169 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH------ERLFELILMEE-----------I----RFPRT  227 (337)
T ss_dssp             GGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHCC-----------C----CCCTT
T ss_pred             hhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCH------HHHHHHHHcCC-----------C----CCCCC
Confidence            999999999999999999999999999999999999864221      12222221110           0    12223


Q ss_pred             HHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 039626          589 LALLVIRLIDACLKKDPTDRP-----TMYEIEH  616 (628)
Q Consensus       589 ~~~~l~~l~~~Cl~~dP~~RP-----s~~ev~~  616 (628)
                      .+..+.+++.+||+.||++||     +++|+++
T Consensus       228 ~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~  260 (337)
T 1o6l_A          228 LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             SCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             CCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence            445678999999999999999     7888764

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=1.1e-37  Score=317.91  Aligned_cols=236  Identities=26%  Similarity=0.362  Sum_probs=179.0

Q ss_pred             eEEEEEEEC-----CceEEEEEecc--------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhh
Q 039626          361 GSVYRGKIN-----GGFAAIKKVNG--------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVF  427 (628)
Q Consensus       361 G~Vy~g~~~-----g~~vavK~~~~--------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~  427 (628)
                      |.||+|...     +..+|+|+.+.        .+.+|+.++++++||||+++++++. ++..++||||+++|+|.+++.
T Consensus        29 g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~lv~e~~~~~~L~~~l~  107 (281)
T 1mp8_A           29 GDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQ  107 (281)
T ss_dssp             SEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEEECCTTEEHHHHHH
T ss_pred             eeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEEEEecCCCCCHHHHHH
Confidence            899999882     34689998764        3678999999999999999999985 567899999999999999996


Q ss_pred             hcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccC
Q 039626          428 SNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVG  507 (628)
Q Consensus       428 ~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~g  507 (628)
                      ..   ...+++..++.++.|++.||+|||+.   +++||||||+|||++.++.+||+|||+++.......  .......+
T Consensus       108 ~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~  179 (281)
T 1mp8_A          108 VR---KYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY--YKASKGKL  179 (281)
T ss_dssp             HT---TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC---------------------C
T ss_pred             hc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECccccccccCcccc--cccccCCC
Confidence            42   34589999999999999999999995   499999999999999999999999999987643321  12233457


Q ss_pred             CccccCccccccCCCCcccccHHHHHHHHHHHh-CCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCC
Q 039626          508 TKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT-GKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYP  586 (628)
Q Consensus       508 t~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELlt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~  586 (628)
                      ++.|+|||.+.+..++.++||||||++++||++ |+.|+.......      ....+...          ...    ..+
T Consensus       180 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~------~~~~i~~~----------~~~----~~~  239 (281)
T 1mp8_A          180 PIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND------VIGRIENG----------ERL----PMP  239 (281)
T ss_dssp             CGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG------HHHHHHTT----------CCC----CCC
T ss_pred             cccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHH------HHHHHHcC----------CCC----CCC
Confidence            889999999999999999999999999999996 888886433211      11111110          001    122


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhc
Q 039626          587 LELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNAS  625 (628)
Q Consensus       587 ~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~~~~  625 (628)
                      ...+..+.+++.+||+.||++|||+.|+++.|++++...
T Consensus       240 ~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~  278 (281)
T 1mp8_A          240 PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE  278 (281)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence            233456789999999999999999999999999998753

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=2.9e-37  Score=319.13  Aligned_cols=241  Identities=24%  Similarity=0.353  Sum_probs=185.6

Q ss_pred             eEEEEEEE--CCceEEEEEecc----------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhh
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG----------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFS  428 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  428 (628)
                      |.||++..  +|..+|+|+++.          ++.+|++++++++|+||+++++++.+++..++||||+++|+|.+++..
T Consensus        46 g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~  125 (310)
T 2wqm_A           46 SEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKH  125 (310)
T ss_dssp             CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCCSCBHHHHHHH
T ss_pred             ceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEEecCCCCCHHHHHHH
Confidence            89999997  688999998863          366899999999999999999999999999999999999999999965


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCC
Q 039626          429 NKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGT  508 (628)
Q Consensus       429 ~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt  508 (628)
                      .......+++..++.++.+++.||.|||+.   +++||||||+||+++.++.+||+|||+++.......   ......|+
T Consensus       126 ~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~  199 (310)
T 2wqm_A          126 FKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT---AAHSLVGT  199 (310)
T ss_dssp             HHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC---------------------C
T ss_pred             hcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEeccceeeecCCCc---cccccCCC
Confidence            444556799999999999999999999995   499999999999999999999999999986643221   12345789


Q ss_pred             ccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCHH
Q 039626          509 KGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLE  588 (628)
Q Consensus       509 ~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~  588 (628)
                      +.|+|||.+.+..++.++||||||++++||++|+.|+.....    ........+....          .+...   +..
T Consensus       200 ~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~----~~~~~~~~~~~~~----------~~~~~---~~~  262 (310)
T 2wqm_A          200 PYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLYSLCKKIEQCD----------YPPLP---SDH  262 (310)
T ss_dssp             CSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---C----CHHHHHHHHHTTC----------SCCCC---TTT
T ss_pred             eeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccch----hHHHHHHHhhccc----------CCCCc---ccc
Confidence            999999999999999999999999999999999998863221    1122222211100          01111   112


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhh
Q 039626          589 LALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNA  624 (628)
Q Consensus       589 ~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~~~  624 (628)
                      .+..+.+++.+||+.||.+|||+.||++.|++|...
T Consensus       263 ~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~  298 (310)
T 2wqm_A          263 YSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHAC  298 (310)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             cCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence            345678999999999999999999999999998764

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.1e-37  Score=322.46  Aligned_cols=229  Identities=23%  Similarity=0.306  Sum_probs=186.4

Q ss_pred             eEEEEEEE--CCceEEEEEecc------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhcCCC
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNE  432 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~  432 (628)
                      |.||+++.  ++..+|+|.++.      .+.+|+.++++++||||+++++++.+.+..++||||+++|+|.+++..   .
T Consensus        19 g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~---~   95 (321)
T 1tki_A           19 GIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINT---S   95 (321)
T ss_dssp             EEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBHHHHHTS---S
T ss_pred             eEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeCCCCCHHHHHHh---c
Confidence            89999998  578999998863      367899999999999999999999999999999999999999999943   2


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCC--CCcEEEccccccccCCCCCCcceeeecccCCcc
Q 039626          433 GKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDS--DLRAKIANFAMARPAEGQEGEFALTRHIVGTKG  510 (628)
Q Consensus       433 ~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~--~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~  510 (628)
                      ...+++..+..++.|++.||+|||+.   +++||||||+|||++.  ++.+||+|||+++......    ......||+.
T Consensus        96 ~~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~~~gt~~  168 (321)
T 1tki_A           96 AFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD----NFRLLFTAPE  168 (321)
T ss_dssp             SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC----EEEEEESCGG
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC----ccccccCChh
Confidence            34699999999999999999999995   4999999999999987  7899999999998765432    2334579999


Q ss_pred             ccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCHHHH
Q 039626          511 YMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELA  590 (628)
Q Consensus       511 Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~  590 (628)
                      |+|||.+.+..++.++||||||+++|||++|+.||.....      .+....+......       .++...    ...+
T Consensus       169 y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~------~~~~~~i~~~~~~-------~~~~~~----~~~s  231 (321)
T 1tki_A          169 YYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN------QQIIENIMNAEYT-------FDEEAF----KEIS  231 (321)
T ss_dssp             GSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHHHTCCC-------CCHHHH----TTSC
T ss_pred             hcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCH------HHHHHHHHcCCCC-------CChhhh----ccCC
Confidence            9999999998899999999999999999999999864322      1222222211100       000000    1224


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          591 LLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       591 ~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      ..+.+++.+||+.||.+|||+.|+++
T Consensus       232 ~~~~~li~~~L~~dp~~Rpt~~e~l~  257 (321)
T 1tki_A          232 IEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             HHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            56789999999999999999999986

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=1.7e-37  Score=322.90  Aligned_cols=251  Identities=23%  Similarity=0.389  Sum_probs=184.4

Q ss_pred             cCCCcCCccc----eEEEEEEEC--Cc---eEEEEEecc---------chHHHHHHHhhcCCCceeeeeeeeecCCeE--
Q 039626          351 DNFSFTCRIQ----GSVYRGKIN--GG---FAAIKKVNG---------DVSKEIALLNKINHSNLIILSGVCFNEGNC--  410 (628)
Q Consensus       351 ~~f~~~~~i~----G~Vy~g~~~--g~---~vavK~~~~---------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~--  410 (628)
                      ++|.....+|    |.||+|+..  ++   .||||.++.         ++.+|++++++++|+||+++++++......  
T Consensus        23 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  102 (323)
T 3qup_A           23 QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGR  102 (323)
T ss_dssp             --CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-----
T ss_pred             hHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccccC
Confidence            4455545554    899999873  22   799998864         367899999999999999999999877654  


Q ss_pred             ----EEEEEecCCCChHHHhhhcCC--CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEc
Q 039626          411 ----YLVYEYAVNGTLSDWVFSNKN--EGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIA  484 (628)
Q Consensus       411 ----~lV~E~~~~gsL~~~l~~~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~  484 (628)
                          ++||||+++|+|.+++.....  ....+++..++.++.|++.||+|||+.   +++||||||+|||+++++.+||+
T Consensus       103 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~~~~kl~  179 (323)
T 3qup_A          103 LPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMTVCVA  179 (323)
T ss_dssp             --CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEEC
T ss_pred             CCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCCCCEEEe
Confidence                999999999999999965432  223599999999999999999999995   49999999999999999999999


Q ss_pred             cccccccCCCCCCcceeeecccCCccccCccccccCCCCcccccHHHHHHHHHHHh-CCCccccccccccccHHHHHHHH
Q 039626          485 NFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT-GKEAAALHAEENNMHLSDVLNAV  563 (628)
Q Consensus       485 Dfgla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELlt-G~~p~~~~~~~~~~~~~~~~~~~  563 (628)
                      |||+++........ .......+++.|+|||.+.+..++.++||||||++++||++ |+.|+.......   .   ....
T Consensus       180 Dfg~a~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~---~---~~~~  252 (323)
T 3qup_A          180 DFGLSRKIYSGDYY-RQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE---I---YNYL  252 (323)
T ss_dssp             CCCC------------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---H---HHHH
T ss_pred             eccccccccccccc-cccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHH---H---HHHH
Confidence            99999876433211 11223457889999999999999999999999999999999 888876433211   1   1111


Q ss_pred             hccccchhhhccccCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhc
Q 039626          564 LTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNAS  625 (628)
Q Consensus       564 ~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~~~~  625 (628)
                      ....              ....+...+..+.+++.+||+.||++|||+.|+++.|++++...
T Consensus       253 ~~~~--------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~  300 (323)
T 3qup_A          253 IGGN--------------RLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHL  300 (323)
T ss_dssp             HTTC--------------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred             hcCC--------------CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence            1100              01112233456889999999999999999999999999998754

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=1.2e-37  Score=352.80  Aligned_cols=238  Identities=24%  Similarity=0.371  Sum_probs=188.6

Q ss_pred             eEEEEEEE----CCceEEEEEecc---------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhh
Q 039626          361 GSVYRGKI----NGGFAAIKKVNG---------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVF  427 (628)
Q Consensus       361 G~Vy~g~~----~g~~vavK~~~~---------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~  427 (628)
                      |.||+|.+    .+..||||+++.         ++.+|+++|++++|+|||+++++|.. +..++||||+++|+|.+++.
T Consensus       383 G~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~g~L~~~l~  461 (635)
T 4fl3_A          383 GTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQ  461 (635)
T ss_dssp             EEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTTEEHHHHHH
T ss_pred             EEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCCCCHHHHHh
Confidence            89999976    356899999864         46789999999999999999999964 56899999999999999995


Q ss_pred             hcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccC
Q 039626          428 SNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVG  507 (628)
Q Consensus       428 ~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~g  507 (628)
                      .    ...+++..++.|+.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++................+
T Consensus       462 ~----~~~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~  534 (635)
T 4fl3_A          462 Q----NRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKW  534 (635)
T ss_dssp             H----CTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-------------
T ss_pred             h----CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccccCCCC
Confidence            4    34589999999999999999999995   4999999999999999999999999999877543322222334467


Q ss_pred             CccccCccccccCCCCcccccHHHHHHHHHHHh-CCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCC
Q 039626          508 TKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT-GKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYP  586 (628)
Q Consensus       508 t~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELlt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~  586 (628)
                      |+.|+|||++.+..++.++|||||||++|||++ |+.|+......      +....+...              .....+
T Consensus       535 t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~------~~~~~i~~~--------------~~~~~p  594 (635)
T 4fl3_A          535 PVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS------EVTAMLEKG--------------ERMGCP  594 (635)
T ss_dssp             CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH------HHHHHHHTT--------------CCCCCC
T ss_pred             ceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH------HHHHHHHcC--------------CCCCCC
Confidence            889999999999999999999999999999998 99998643221      111111110              111223


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhcc
Q 039626          587 LELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNASL  626 (628)
Q Consensus       587 ~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~~~~~  626 (628)
                      ..++..+.+++.+||+.||++||++.+|++.|+++...-.
T Consensus       595 ~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~l~  634 (635)
T 4fl3_A          595 AGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV  634 (635)
T ss_dssp             TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHC
T ss_pred             CCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhc
Confidence            3445668899999999999999999999999999887543

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=1.9e-37  Score=326.92  Aligned_cols=232  Identities=22%  Similarity=0.325  Sum_probs=187.0

Q ss_pred             eEEEEEEE--CCceEEEEEecc------------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHh
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG------------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWV  426 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~------------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l  426 (628)
                      |.||++..  +|+.||||.+..            .+.+|++++++++||||+++++++.+++..++||||+++|+|.+++
T Consensus        38 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~~~l  117 (351)
T 3c0i_A           38 SVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEI  117 (351)
T ss_dssp             EEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSSCBHHHHH
T ss_pred             EEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEeCCCCCCHHHHH
Confidence            89999988  688999998742            3678999999999999999999999999999999999999999988


Q ss_pred             hhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCc---EEEccccccccCCCCCCcceeee
Q 039626          427 FSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLR---AKIANFAMARPAEGQEGEFALTR  503 (628)
Q Consensus       427 ~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~---~kl~Dfgla~~~~~~~~~~~~~~  503 (628)
                      ......+..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.   +||+|||+++......   ....
T Consensus       118 ~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~---~~~~  191 (351)
T 3c0i_A          118 VKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESG---LVAG  191 (351)
T ss_dssp             HHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEECCCTTCEECCTTS---CBCC
T ss_pred             HHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEecCcceeEecCCC---eeec
Confidence            66544555689999999999999999999995   4999999999999987655   9999999998765432   1233


Q ss_pred             cccCCccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCC
Q 039626          504 HIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQG  583 (628)
Q Consensus       504 ~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~  583 (628)
                      ...||+.|+|||.+.+..++.++|||||||++|||++|+.|+.....       +....+......       .++....
T Consensus       192 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-------~~~~~i~~~~~~-------~~~~~~~  257 (351)
T 3c0i_A          192 GRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE-------RLFEGIIKGKYK-------MNPRQWS  257 (351)
T ss_dssp             CCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH-------HHHHHHHHTCCC-------CCHHHHT
T ss_pred             CCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH-------HHHHHHHcCCCC-------CCccccc
Confidence            45799999999999999999999999999999999999999864321       112121111100       0000001


Q ss_pred             CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          584 NYPLELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       584 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                          ..+..+.+++.+||+.||++|||+.|+++
T Consensus       258 ----~~s~~~~~li~~~L~~dP~~R~s~~e~l~  286 (351)
T 3c0i_A          258 ----HISESAKDLVRRMLMLDPAERITVYEALN  286 (351)
T ss_dssp             ----TSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ----cCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence                12356789999999999999999999975

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=8.3e-38  Score=338.27  Aligned_cols=252  Identities=21%  Similarity=0.280  Sum_probs=199.2

Q ss_pred             ecHHHHHHHhcCCCcCCccc----eEEEEEEE--CCceEEEEEecc----------chHHHHHHHhhcCCCceeeeeeee
Q 039626          341 YSFKELQSATDNFSFTCRIQ----GSVYRGKI--NGGFAAIKKVNG----------DVSKEIALLNKINHSNLIILSGVC  404 (628)
Q Consensus       341 ~~~~el~~at~~f~~~~~i~----G~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~nIv~l~g~~  404 (628)
                      +.++++...+++|.....+|    |.||+++.  .++.+|+|+++.          .+.+|..++.+++|+||++++++|
T Consensus        64 ~~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~  143 (437)
T 4aw2_A           64 SKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAF  143 (437)
T ss_dssp             HHHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred             chhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence            34566677788888777775    89999998  468899999864          267899999999999999999999


Q ss_pred             ecCCeEEEEEEecCCCChHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEc
Q 039626          405 FNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIA  484 (628)
Q Consensus       405 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~  484 (628)
                      .+++..+|||||+++|+|.+++..   ....+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+
T Consensus       144 ~~~~~~~lV~Ey~~gg~L~~~l~~---~~~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL~  217 (437)
T 4aw2_A          144 QDDNNLYLVMDYYVGGDLLTLLSK---FEDRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLA  217 (437)
T ss_dssp             ECSSEEEEEECCCTTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEEC
T ss_pred             eeCCEEEEEEecCCCCcHHHHHHH---ccCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEEc
Confidence            999999999999999999999954   234599999999999999999999995   49999999999999999999999


Q ss_pred             cccccccCCCCCCcceeeecccCCccccCccccc-----cCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHH
Q 039626          485 NFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLE-----NGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDV  559 (628)
Q Consensus       485 Dfgla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~-----~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~  559 (628)
                      |||+++.......  .......||+.|+|||++.     ...++.++|||||||++|||++|+.||.....      .+.
T Consensus       218 DFGla~~~~~~~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~------~~~  289 (437)
T 4aw2_A          218 DFGSCLKLMEDGT--VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL------VET  289 (437)
T ss_dssp             CCTTCEECCTTSC--EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSH------HHH
T ss_pred             chhhhhhcccCCC--cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCCh------hHH
Confidence            9999986643321  1233468999999999987     56789999999999999999999999874322      122


Q ss_pred             HHHHhccccchhhhccccCCcCCCCCCHHHHHHHHHHHHHhcccCCCC--CCCHHHHHH
Q 039626          560 LNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTD--RPTMYEIEH  616 (628)
Q Consensus       560 ~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPs~~ev~~  616 (628)
                      ...+....   .   .+.-|...    ...+..+.+|+++||..+|++  ||+++|+++
T Consensus       290 ~~~i~~~~---~---~~~~p~~~----~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~  338 (437)
T 4aw2_A          290 YGKIMNHK---E---RFQFPTQV----TDVSENAKDLIRRLICSREHRLGQNGIEDFKK  338 (437)
T ss_dssp             HHHHHTHH---H---HCCCCSSC----CCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred             HHhhhhcc---c---cccCCccc----ccCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence            22222100   0   00011111    123455789999999888888  999988764

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=9.6e-37  Score=312.52  Aligned_cols=255  Identities=16%  Similarity=0.202  Sum_probs=196.5

Q ss_pred             hcCCCcCCccc----eEEEEEEE--CCceEEEEEec-----cchHHHHHHHhhcCCCceeeeeeee-ecCCeEEEEEEec
Q 039626          350 TDNFSFTCRIQ----GSVYRGKI--NGGFAAIKKVN-----GDVSKEIALLNKINHSNLIILSGVC-FNEGNCYLVYEYA  417 (628)
Q Consensus       350 t~~f~~~~~i~----G~Vy~g~~--~g~~vavK~~~-----~~~~~E~~~l~~l~H~nIv~l~g~~-~~~~~~~lV~E~~  417 (628)
                      .++|.....+|    |.||+|+.  +++.||+|...     .++.+|++++++++|++++..++.+ ..++..++||||+
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~   87 (296)
T 4hgt_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL   87 (296)
T ss_dssp             ---CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred             CCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEcc
Confidence            34565555554    89999996  78899999754     3578999999999998877777666 4567789999999


Q ss_pred             CCCChHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEe---CCCCcEEEccccccccCCC
Q 039626          418 VNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLL---DSDLRAKIANFAMARPAEG  494 (628)
Q Consensus       418 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl---~~~~~~kl~Dfgla~~~~~  494 (628)
                       +|+|.+++...   ...+++..+..++.|++.||+|||+.   +++||||||+|||+   ++++.+||+|||+++....
T Consensus        88 -~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~  160 (296)
T 4hgt_A           88 -GPSLEDLFNFC---SRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD  160 (296)
T ss_dssp             -CCBHHHHHHHT---TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred             -CCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCccceeccC
Confidence             99999998542   34599999999999999999999995   49999999999999   7899999999999987654


Q ss_pred             CCCcc----eeeecccCCccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHH-HHHHhccccc
Q 039626          495 QEGEF----ALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDV-LNAVLTKEDG  569 (628)
Q Consensus       495 ~~~~~----~~~~~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~-~~~~~~~~~~  569 (628)
                      .....    .......||+.|+|||.+.+..++.++||||||++++||++|+.||.............. ........  
T Consensus       161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--  238 (296)
T 4hgt_A          161 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP--  238 (296)
T ss_dssp             TTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC--
T ss_pred             cccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccch--
Confidence            32211    122345799999999999999999999999999999999999999975443332222221 11111100  


Q ss_pred             hhhhccccCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhc
Q 039626          570 EESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNAS  625 (628)
Q Consensus       570 ~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~~~~  625 (628)
                      ..        .....+    +..+.+++.+||+.||++||++.++++.|++++...
T Consensus       239 ~~--------~~~~~~----~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~  282 (296)
T 4hgt_A          239 IE--------VLCKGY----PSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ  282 (296)
T ss_dssp             HH--------HHTTTS----CHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred             hh--------hhhccC----CHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHh
Confidence            00        011122    346789999999999999999999999999998743

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=4.1e-37  Score=325.20  Aligned_cols=228  Identities=22%  Similarity=0.334  Sum_probs=185.5

Q ss_pred             eEEEEEEE--CCceEEEEEecc-------------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHH
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG-------------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDW  425 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~-------------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~  425 (628)
                      |.||++..  +|..+|+|.++.             .+.+|+.+|++++||||+++++++.+++..++||||+++|+|.++
T Consensus        26 g~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~~~gg~L~~~  105 (361)
T 2yab_A           26 AIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDF  105 (361)
T ss_dssp             EEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHH
T ss_pred             EEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEEEEEEcCCCCcHHHH
Confidence            89999998  588999998853             357899999999999999999999999999999999999999999


Q ss_pred             hhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCC----cEEEccccccccCCCCCCccee
Q 039626          426 VFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDL----RAKIANFAMARPAEGQEGEFAL  501 (628)
Q Consensus       426 l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~----~~kl~Dfgla~~~~~~~~~~~~  501 (628)
                      +..    ...+++..+..++.||+.||+|||+.   +|+||||||+|||++.++    .+||+|||+++......    .
T Consensus       106 l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~~~~----~  174 (361)
T 2yab_A          106 LAQ----KESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV----E  174 (361)
T ss_dssp             HTT----CSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCSSCEECCTTC----C
T ss_pred             HHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEEEecCCceEcCCCC----c
Confidence            943    34699999999999999999999995   499999999999998877    79999999998765432    1


Q ss_pred             eecccCCccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcC
Q 039626          502 TRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTL  581 (628)
Q Consensus       502 ~~~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l  581 (628)
                      .....||+.|+|||.+.+..++.++|||||||++|||++|+.||.....      .+....+......       +++..
T Consensus       175 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~------~~~~~~i~~~~~~-------~~~~~  241 (361)
T 2yab_A          175 FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK------QETLANITAVSYD-------FDEEF  241 (361)
T ss_dssp             CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH------HHHHHHHHTTCCC-------CCHHH
T ss_pred             cccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHhcCCC-------CCchh
Confidence            2345799999999999999999999999999999999999999864322      1222222211100       00000


Q ss_pred             CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          582 QGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       582 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                          ....+..+.+|+.+||..||.+|||+.|+++
T Consensus       242 ----~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  272 (361)
T 2yab_A          242 ----FSQTSELAKDFIRKLLVKETRKRLTIQEALR  272 (361)
T ss_dssp             ----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             ----ccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence                0122345789999999999999999999874

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=6.4e-37  Score=320.86  Aligned_cols=264  Identities=23%  Similarity=0.370  Sum_probs=200.0

Q ss_pred             HHHhcCCCcCCccc----eEEEEEEECCceEEEEEecc----chHHHHHHHhh--cCCCceeeeeeeeecCC----eEEE
Q 039626          347 QSATDNFSFTCRIQ----GSVYRGKINGGFAAIKKVNG----DVSKEIALLNK--INHSNLIILSGVCFNEG----NCYL  412 (628)
Q Consensus       347 ~~at~~f~~~~~i~----G~Vy~g~~~g~~vavK~~~~----~~~~E~~~l~~--l~H~nIv~l~g~~~~~~----~~~l  412 (628)
                      ....++|.....+|    |.||+|+.+|+.||||++..    .+.+|.+++..  ++|+||+++++++....    ..++
T Consensus        38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~l  117 (342)
T 1b6c_B           38 RTIARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL  117 (342)
T ss_dssp             HHHHHHCEEEEEEEEETTEEEEEEEETTEEEEEEEECGGGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEEE
T ss_pred             ccccccEEEEeeecCCCCcEEEEEEEcCccEEEEEeCchhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeEE
Confidence            33445666666664    89999999999999999875    35678888887  79999999999998775    7899


Q ss_pred             EEEecCCCChHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC-----CCCeEecCCCCCCEEeCCCCcEEEcccc
Q 039626          413 VYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFT-----NPPHVHKDINSSNVLLDSDLRAKIANFA  487 (628)
Q Consensus       413 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-----~~~iiH~dik~~NILl~~~~~~kl~Dfg  487 (628)
                      ||||+++|+|.+++..     ..+++..++.++.+++.||+|||...     ..+++||||||+|||++.++.+||+|||
T Consensus       118 v~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg  192 (342)
T 1b6c_B          118 VSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG  192 (342)
T ss_dssp             EECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCCT
T ss_pred             EEeecCCCcHHHHHhc-----cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEECC
Confidence            9999999999999954     24899999999999999999999310     1569999999999999999999999999


Q ss_pred             ccccCCCCCCcce-eeecccCCccccCccccccC------CCCcccccHHHHHHHHHHHhC----------CCccccccc
Q 039626          488 MARPAEGQEGEFA-LTRHIVGTKGYMAPEYLENG------LVSTKLDVYAFGVLILEMLTG----------KEAAALHAE  550 (628)
Q Consensus       488 la~~~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~------~~s~k~DV~SfGvvl~ELltG----------~~p~~~~~~  550 (628)
                      +++.......... ......||+.|+|||.+.+.      .++.++||||||+++|||++|          +.|+.....
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~  272 (342)
T 1b6c_B          193 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP  272 (342)
T ss_dssp             TCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSC
T ss_pred             CceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCc
Confidence            9987654332211 22345799999999999775      334789999999999999999          455543221


Q ss_pred             cccccHHHHHHHHhccccchhhhccccCCcCCCC-CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhc
Q 039626          551 ENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGN-YPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNAS  625 (628)
Q Consensus       551 ~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~-~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~~~~  625 (628)
                      .. .........+..         ....+.+... .+.+....+.+++.+||+.||++|||+.||++.|+++.+..
T Consensus       273 ~~-~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~~  338 (342)
T 1b6c_B          273 SD-PSVEEMRKVVCE---------QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE  338 (342)
T ss_dssp             SS-CCHHHHHHHHTT---------SCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred             Cc-ccHHHHHHHHHH---------HHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHHh
Confidence            11 111122111111         1111212111 12366778999999999999999999999999999998653

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=5.5e-38  Score=319.41  Aligned_cols=235  Identities=29%  Similarity=0.447  Sum_probs=186.2

Q ss_pred             eEEEEEEECCceEEEEEecc-----chHHHHHHHhhcCCCceeeeeeeeecC-CeEEEEEEecCCCChHHHhhhcCCCCC
Q 039626          361 GSVYRGKINGGFAAIKKVNG-----DVSKEIALLNKINHSNLIILSGVCFNE-GNCYLVYEYAVNGTLSDWVFSNKNEGK  434 (628)
Q Consensus       361 G~Vy~g~~~g~~vavK~~~~-----~~~~E~~~l~~l~H~nIv~l~g~~~~~-~~~~lV~E~~~~gsL~~~l~~~~~~~~  434 (628)
                      |.||+++.+|+.+|+|.++.     .+.+|++++++++|+||+++++++.+. +..++||||+++|+|.+++....  ..
T Consensus        35 g~V~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~  112 (278)
T 1byg_A           35 GDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRG--RS  112 (278)
T ss_dssp             CEEEEEEETTEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHHHHHHHHH--HH
T ss_pred             ceEEEEEEcCCEEEEEEecchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecCCCCCHHHHHHhcc--cc
Confidence            89999999999999999865     367899999999999999999997654 47899999999999999996431  23


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCCccccCc
Q 039626          435 YLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAP  514 (628)
Q Consensus       435 ~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~Y~AP  514 (628)
                      .+++..+..++.+++.||+|||+.   +++||||||+||+++.++.+||+|||+++......      ....+++.|+||
T Consensus       113 ~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~------~~~~~~~~y~aP  183 (278)
T 1byg_A          113 VLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ------DTGKLPVKWTAP  183 (278)
T ss_dssp             HCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC------------------CCTTTSCH
T ss_pred             cCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeeccccccccccc------cCCCccccccCH
Confidence            488999999999999999999995   49999999999999999999999999988654321      223578899999


Q ss_pred             cccccCCCCcccccHHHHHHHHHHHh-CCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCHHHHHHH
Q 039626          515 EYLENGLVSTKLDVYAFGVLILEMLT-GKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLV  593 (628)
Q Consensus       515 E~l~~~~~s~k~DV~SfGvvl~ELlt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l  593 (628)
                      |.+.+..++.++||||||++++||++ |+.|+......      +....+.          ....+    ..+...+..+
T Consensus       184 E~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~------~~~~~~~----------~~~~~----~~~~~~~~~l  243 (278)
T 1byg_A          184 EALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK------DVVPRVE----------KGYKM----DAPDGCPPAV  243 (278)
T ss_dssp             HHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG------GHHHHHT----------TTCCC----CCCTTCCHHH
T ss_pred             HHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHH------HHHHHHh----------cCCCC----CCcccCCHHH
Confidence            99999999999999999999999998 99887643221      1111111          11111    1222334568


Q ss_pred             HHHHHHhcccCCCCCCCHHHHHHHHHHhHhhcc
Q 039626          594 IRLIDACLKKDPTDRPTMYEIEHSLSNILNASL  626 (628)
Q Consensus       594 ~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~~~~~  626 (628)
                      .+++.+||+.||.+||++.|+++.|+++....+
T Consensus       244 ~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~~~  276 (278)
T 1byg_A          244 YEVMKNCWHLDAAMRPSFLQLREQLEHIKTHEL  276 (278)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCC
T ss_pred             HHHHHHHhcCChhhCCCHHHHHHHHHHHHhhhc
Confidence            899999999999999999999999999987665

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=1.9e-37  Score=317.44  Aligned_cols=239  Identities=27%  Similarity=0.474  Sum_probs=177.3

Q ss_pred             eEEEEEEECCceEEEEEecc---------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhcCC
Q 039626          361 GSVYRGKINGGFAAIKKVNG---------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKN  431 (628)
Q Consensus       361 G~Vy~g~~~g~~vavK~~~~---------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~  431 (628)
                      |.||+|++.+ .+|+|+++.         .+.+|++++++++|+||+++++++. ....++||||+++++|.+++..   
T Consensus        38 g~Vy~~~~~~-~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~---  112 (289)
T 3og7_A           38 GTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIVTQWCEGSSLYHHLHA---  112 (289)
T ss_dssp             EEEEEEESSS-EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEECCCEEEHHHHHTT---
T ss_pred             eEEEEEEEcC-ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeecc-CCccEEEEEecCCCcHHHHHhh---
Confidence            8999998765 599998863         3678999999999999999999764 5568999999999999999953   


Q ss_pred             CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCCccc
Q 039626          432 EGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGY  511 (628)
Q Consensus       432 ~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~Y  511 (628)
                      ....+++..++.++.|++.||+|||+.   +++||||||+|||++.++.+||+|||+++........ .......||+.|
T Consensus       113 ~~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~gt~~y  188 (289)
T 3og7_A          113 SETKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGS-HQFEQLSGSILW  188 (289)
T ss_dssp             C---CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC-------------------CCCTT
T ss_pred             ccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccceecccccccccc-ccccccCCCccc
Confidence            345699999999999999999999995   4999999999999999999999999999865432211 122345799999


Q ss_pred             cCccccc---cCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCHH
Q 039626          512 MAPEYLE---NGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLE  588 (628)
Q Consensus       512 ~APE~l~---~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~  588 (628)
                      +|||.+.   +..++.++||||||++++||++|+.||......      +.+........        ..+.+ ......
T Consensus       189 ~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------~~~~~~~~~~~--------~~~~~-~~~~~~  253 (289)
T 3og7_A          189 MAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR------DQIIEMVGRGS--------LSPDL-SKVRSN  253 (289)
T ss_dssp             CCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCH------HHHHHHHHHTS--------CCCCT-TSSCTT
T ss_pred             cCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchH------HHHHHHhcccc--------cCcch-hhcccc
Confidence            9999986   567899999999999999999999998643221      11111111110        01111 111223


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHh
Q 039626          589 LALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILN  623 (628)
Q Consensus       589 ~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~~  623 (628)
                      ++..+.+++.+||+.||.+|||+.|+++.|+++..
T Consensus       254 ~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~  288 (289)
T 3og7_A          254 CPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR  288 (289)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             CCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence            34568899999999999999999999999998864

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.8e-37  Score=322.22  Aligned_cols=228  Identities=25%  Similarity=0.374  Sum_probs=184.9

Q ss_pred             eEEEEEEE--CCceEEEEEecc-------------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHH
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG-------------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDW  425 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~-------------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~  425 (628)
                      |.||++..  +|..+|+|.++.             ++.+|+.+|++++||||+++++++.+++..++||||+++|+|.++
T Consensus        25 g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~  104 (326)
T 2y0a_A           25 AVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDF  104 (326)
T ss_dssp             EEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHH
T ss_pred             eEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEEcCCCCCHHHH
Confidence            89999998  588999998753             367899999999999999999999999999999999999999999


Q ss_pred             hhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCC----cEEEccccccccCCCCCCccee
Q 039626          426 VFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDL----RAKIANFAMARPAEGQEGEFAL  501 (628)
Q Consensus       426 l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~----~~kl~Dfgla~~~~~~~~~~~~  501 (628)
                      +..    ...+++..+..++.|++.||.|||+.   +++||||||+|||++.++    .+||+|||+++......    .
T Consensus       105 l~~----~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~----~  173 (326)
T 2y0a_A          105 LAE----KESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN----E  173 (326)
T ss_dssp             HTT----SSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEEECCCTTCEECCTTS----C
T ss_pred             HHh----cCCcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeECCCCC----c
Confidence            943    34699999999999999999999995   499999999999999887    89999999998764322    1


Q ss_pred             eecccCCccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcC
Q 039626          502 TRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTL  581 (628)
Q Consensus       502 ~~~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l  581 (628)
                      .....||+.|+|||.+.+..++.++||||||++++||++|+.|+.....      .+....+.....           ..
T Consensus       174 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~------~~~~~~~~~~~~-----------~~  236 (326)
T 2y0a_A          174 FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK------QETLANVSAVNY-----------EF  236 (326)
T ss_dssp             CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH------HHHHHHHHHTCC-----------CC
T ss_pred             cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCH------HHHHHHHHhcCC-----------Cc
Confidence            2345799999999999999999999999999999999999999864322      111111111000           00


Q ss_pred             CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          582 QGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       582 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      ........+..+.+++.+||+.||++|||+.|+++
T Consensus       237 ~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  271 (326)
T 2y0a_A          237 EDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  271 (326)
T ss_dssp             CHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             CccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            00000112345789999999999999999999986

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=1.2e-37  Score=322.55  Aligned_cols=260  Identities=23%  Similarity=0.386  Sum_probs=201.7

Q ss_pred             HHHHHHHhcCCCcCCccc----eEEEEEEE-------CCceEEEEEecc--------chHHHHHHHhhc-CCCceeeeee
Q 039626          343 FKELQSATDNFSFTCRIQ----GSVYRGKI-------NGGFAAIKKVNG--------DVSKEIALLNKI-NHSNLIILSG  402 (628)
Q Consensus       343 ~~el~~at~~f~~~~~i~----G~Vy~g~~-------~g~~vavK~~~~--------~~~~E~~~l~~l-~H~nIv~l~g  402 (628)
                      ..+.....++|.....+|    |.||++++       +++.||||.++.        .+.+|++++.++ +||||+++++
T Consensus        19 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~   98 (316)
T 2xir_A           19 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG   98 (316)
T ss_dssp             HHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             ccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEE
Confidence            334444456666655664    89999985       347899999864        356899999999 7999999999


Q ss_pred             eeecCC-eEEEEEEecCCCChHHHhhhcCCC------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCC
Q 039626          403 VCFNEG-NCYLVYEYAVNGTLSDWVFSNKNE------------GKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDIN  469 (628)
Q Consensus       403 ~~~~~~-~~~lV~E~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik  469 (628)
                      ++...+ ..++||||+++|+|.+++......            ...+++..++.++.|++.||+|||+.   +++|||||
T Consensus        99 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dik  175 (316)
T 2xir_A           99 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLA  175 (316)
T ss_dssp             EECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCSCCS
T ss_pred             EEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---CcccccCc
Confidence            998654 589999999999999999654321            22389999999999999999999995   59999999


Q ss_pred             CCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCCccccCccccccCCCCcccccHHHHHHHHHHHh-CCCccccc
Q 039626          470 SSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT-GKEAAALH  548 (628)
Q Consensus       470 ~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELlt-G~~p~~~~  548 (628)
                      |+||+++.++.+||+|||+++....... ........||+.|+|||.+.+..++.++||||||++++||++ |+.|+...
T Consensus       176 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~  254 (316)
T 2xir_A          176 ARNILLSEKNVVKICDFGLARDIYKDPD-YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV  254 (316)
T ss_dssp             GGGEEECGGGCEEECCCGGGSCTTTCTT-SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             cceEEECCCCCEEECCCccccccccCcc-ceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCccc
Confidence            9999999999999999999987654322 122334568899999999999999999999999999999998 99888643


Q ss_pred             cccccccHHHHHHHHhccccchhhhccccCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhc
Q 039626          549 AEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNAS  625 (628)
Q Consensus       549 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~~~~  625 (628)
                      ....     .........          .....    +...+..+.+++.+||+.||.+|||+.|+++.|+.++++.
T Consensus       255 ~~~~-----~~~~~~~~~----------~~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~  312 (316)
T 2xir_A          255 KIDE-----EFCRRLKEG----------TRMRA----PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN  312 (316)
T ss_dssp             CCSH-----HHHHHHHHT----------CCCCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             chhH-----HHHHHhccC----------ccCCC----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence            2211     111111100          01111    2223456789999999999999999999999999999865

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=3.8e-37  Score=322.10  Aligned_cols=241  Identities=25%  Similarity=0.440  Sum_probs=192.5

Q ss_pred             eEEEEEEEC---------CceEEEEEecc--------chHHHHHHHhhc-CCCceeeeeeeeecCCeEEEEEEecCCCCh
Q 039626          361 GSVYRGKIN---------GGFAAIKKVNG--------DVSKEIALLNKI-NHSNLIILSGVCFNEGNCYLVYEYAVNGTL  422 (628)
Q Consensus       361 G~Vy~g~~~---------g~~vavK~~~~--------~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL  422 (628)
                      |.||+++..         +..||+|+++.        ++.+|+++++++ +||||+++++++.+++..++||||+++|+|
T Consensus        49 g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L  128 (334)
T 2pvf_A           49 GQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL  128 (334)
T ss_dssp             CEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCCEEEEECCTTCBH
T ss_pred             eeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccCCceEEEEECCCCCcH
Confidence            899999863         45799999864        356899999999 999999999999999999999999999999


Q ss_pred             HHHhhhcCCC------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccc
Q 039626          423 SDWVFSNKNE------------GKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMAR  490 (628)
Q Consensus       423 ~~~l~~~~~~------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~  490 (628)
                      .+++......            ...+++..++.++.|++.||+|||+.   +++||||||+|||++.++.+||+|||+++
T Consensus       129 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~  205 (334)
T 2pvf_A          129 REYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLAR  205 (334)
T ss_dssp             HHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             HHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccceEEEcCCCCEEEccccccc
Confidence            9999754321            23489999999999999999999995   49999999999999999999999999998


Q ss_pred             cCCCCCCcceeeecccCCccccCccccccCCCCcccccHHHHHHHHHHHh-CCCccccccccccccHHHHHHHHhccccc
Q 039626          491 PAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT-GKEAAALHAEENNMHLSDVLNAVLTKEDG  569 (628)
Q Consensus       491 ~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELlt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~  569 (628)
                      ....... ........+|+.|+|||.+.+..++.++||||||+++|||++ |+.|+.....      .+....+...   
T Consensus       206 ~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~------~~~~~~~~~~---  275 (334)
T 2pvf_A          206 DINNIDY-YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV------EELFKLLKEG---  275 (334)
T ss_dssp             ECTTTSS-EECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCH------HHHHHHHHHT---
T ss_pred             ccccccc-ccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCH------HHHHHHHhcC---
Confidence            7654321 112233467889999999999899999999999999999999 9888764321      1111111110   


Q ss_pred             hhhhccccCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhc
Q 039626          570 EESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNAS  625 (628)
Q Consensus       570 ~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~~~~  625 (628)
                             ..+    ..+...+..+.+++.+||+.||.+||++.|+++.|++++...
T Consensus       276 -------~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~  320 (334)
T 2pvf_A          276 -------HRM----DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT  320 (334)
T ss_dssp             -------CCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             -------CCC----CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence                   011    112233456789999999999999999999999999998643

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=4.6e-37  Score=320.35  Aligned_cols=238  Identities=30%  Similarity=0.474  Sum_probs=190.5

Q ss_pred             eEEEEEEE--CCce--EEEEEecc--------chHHHHHHHhhc-CCCceeeeeeeeecCCeEEEEEEecCCCChHHHhh
Q 039626          361 GSVYRGKI--NGGF--AAIKKVNG--------DVSKEIALLNKI-NHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVF  427 (628)
Q Consensus       361 G~Vy~g~~--~g~~--vavK~~~~--------~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~  427 (628)
                      |.||+++.  ++..  +|+|+++.        .+.+|+++++++ +||||+++++++.+++..++||||+++|+|.+++.
T Consensus        39 g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~  118 (327)
T 1fvr_A           39 GQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLR  118 (327)
T ss_dssp             CEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHH
T ss_pred             ceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEEEecCCCCCHHHHHH
Confidence            89999987  5554  48998753        367899999999 99999999999999999999999999999999996


Q ss_pred             hcC------------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCC
Q 039626          428 SNK------------NEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQ  495 (628)
Q Consensus       428 ~~~------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~  495 (628)
                      ...            .....+++..++.++.|++.||+|||+.   +++||||||+|||++.++.+||+|||+++.....
T Consensus       119 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kL~Dfg~~~~~~~~  195 (327)
T 1fvr_A          119 KSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVY  195 (327)
T ss_dssp             TTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEESSCEE
T ss_pred             hcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEcCCCeEEEcccCcCcccccc
Confidence            543            2235699999999999999999999995   5999999999999999999999999999754321


Q ss_pred             CCcceeeecccCCccccCccccccCCCCcccccHHHHHHHHHHHh-CCCccccccccccccHHHHHHHHhccccchhhhc
Q 039626          496 EGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT-GKEAAALHAEENNMHLSDVLNAVLTKEDGEESLR  574 (628)
Q Consensus       496 ~~~~~~~~~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELlt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  574 (628)
                      .    ......+++.|+|||.+.+..++.++||||||++++||++ |+.|+.....      .+....+..         
T Consensus       196 ~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~------~~~~~~~~~---------  256 (327)
T 1fvr_A          196 V----KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC------AELYEKLPQ---------  256 (327)
T ss_dssp             C----CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH------HHHHHHGGG---------
T ss_pred             c----cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcH------HHHHHHhhc---------
Confidence            1    1223457889999999998889999999999999999998 9998864321      112211111         


Q ss_pred             cccCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhc
Q 039626          575 HFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNAS  625 (628)
Q Consensus       575 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~~~~  625 (628)
                       ....    ..+...+..+.+++.+||+.||.+|||+.|+++.|++++...
T Consensus       257 -~~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~  302 (327)
T 1fvr_A          257 -GYRL----EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER  302 (327)
T ss_dssp             -TCCC----CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred             -CCCC----CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhh
Confidence             1111    122233456889999999999999999999999999998754

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=2.7e-37  Score=325.65  Aligned_cols=230  Identities=28%  Similarity=0.412  Sum_probs=183.7

Q ss_pred             cCCCcCCccc----eEEEEEEE--CCceEEEEEeccc----------hHHHHHHHhhc-CCCceeeeeeeeecCCeEEEE
Q 039626          351 DNFSFTCRIQ----GSVYRGKI--NGGFAAIKKVNGD----------VSKEIALLNKI-NHSNLIILSGVCFNEGNCYLV  413 (628)
Q Consensus       351 ~~f~~~~~i~----G~Vy~g~~--~g~~vavK~~~~~----------~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV  413 (628)
                      ++|.....+|    |.||+++.  +|+.+|+|+++.+          +.+|.+++.++ +||||+++++++.+++..++|
T Consensus        23 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv  102 (353)
T 3txo_A           23 DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFV  102 (353)
T ss_dssp             CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEE
Confidence            4555555554    89999998  5789999998742          45789999988 799999999999999999999


Q ss_pred             EEecCCCChHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCC
Q 039626          414 YEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAE  493 (628)
Q Consensus       414 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~  493 (628)
                      |||+++|+|.+++...    ..+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++...
T Consensus       103 ~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG~a~~~~  175 (353)
T 3txo_A          103 MEFVNGGDLMFHIQKS----RRFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGI  175 (353)
T ss_dssp             EECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred             EeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEccccceeecc
Confidence            9999999999999643    3589999999999999999999995   49999999999999999999999999998643


Q ss_pred             CCCCcceeeecccCCccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhh
Q 039626          494 GQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESL  573 (628)
Q Consensus       494 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  573 (628)
                      ...   .......||+.|+|||.+.+..++.++|||||||++|||++|+.||.....      .+....+....      
T Consensus       176 ~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~------~~~~~~i~~~~------  240 (353)
T 3txo_A          176 CNG---VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENE------DDLFEAILNDE------  240 (353)
T ss_dssp             C------------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHCC------
T ss_pred             cCC---ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCH------HHHHHHHHcCC------
Confidence            221   123456799999999999998899999999999999999999999864322      22222222111      


Q ss_pred             ccccCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCH
Q 039626          574 RHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTM  611 (628)
Q Consensus       574 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~  611 (628)
                               ..++......+.+++++||+.||.+||++
T Consensus       241 ---------~~~p~~~~~~~~~li~~lL~~dP~~R~~~  269 (353)
T 3txo_A          241 ---------VVYPTWLHEDATGILKSFMTKNPTMRLGS  269 (353)
T ss_dssp             ---------CCCCTTSCHHHHHHHHHHTCSSGGGSTTS
T ss_pred             ---------CCCCCCCCHHHHHHHHHHhhhCHHHccCC
Confidence                     11222344567899999999999999998

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.8e-37  Score=323.35  Aligned_cols=251  Identities=23%  Similarity=0.424  Sum_probs=192.5

Q ss_pred             eEEEEEEE------CCceEEEEEecc-------chHHHHHHHhhcCCCceeeeeeeeecCC--eEEEEEEecCCCChHHH
Q 039626          361 GSVYRGKI------NGGFAAIKKVNG-------DVSKEIALLNKINHSNLIILSGVCFNEG--NCYLVYEYAVNGTLSDW  425 (628)
Q Consensus       361 G~Vy~g~~------~g~~vavK~~~~-------~~~~E~~~l~~l~H~nIv~l~g~~~~~~--~~~lV~E~~~~gsL~~~  425 (628)
                      |.||++++      +|+.||+|++..       .+.+|++++++++|+||+++++++...+  ..++||||+++|+|.++
T Consensus        55 g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~  134 (326)
T 2w1i_A           55 GSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDY  134 (326)
T ss_dssp             EEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCEEEECCCTTCBHHHH
T ss_pred             eEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceEEEEECCCCCCHHHH
Confidence            89999985      578999999864       4678999999999999999999987654  68999999999999999


Q ss_pred             hhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecc
Q 039626          426 VFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHI  505 (628)
Q Consensus       426 l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~  505 (628)
                      +...   ...+++..++.++.|++.||+|||+.   +++||||||+||+++.++.+||+|||+++...............
T Consensus       135 l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~  208 (326)
T 2w1i_A          135 LQKH---KERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPG  208 (326)
T ss_dssp             HHHS---TTSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECCSSCSEEECSSCC
T ss_pred             HHhc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCcchhhccccccccccccCC
Confidence            9653   34589999999999999999999994   59999999999999999999999999998775443222222334


Q ss_pred             cCCccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccc---hhhhccccCCcCC
Q 039626          506 VGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDG---EESLRHFIDPTLQ  582 (628)
Q Consensus       506 ~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~~l~~~~d~~l~  582 (628)
                      .++..|+|||.+.+..++.++||||||++++||++|+.|+......       ...........   ...+...+.....
T Consensus       209 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (326)
T 2w1i_A          209 ESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE-------FMRMIGNDKQGQMIVFHLIELLKNNGR  281 (326)
T ss_dssp             SCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHH-------HHHHHCTTCCTHHHHHHHHHHHHTTCC
T ss_pred             CCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHH-------HHHhhccccchhhhHHHHHHHhhcCCC
Confidence            6788899999999988999999999999999999999887532110       00000000000   0001111111111


Q ss_pred             CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhh
Q 039626          583 GNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNA  624 (628)
Q Consensus       583 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~~~  624 (628)
                      ...+...+..+.+++.+||+.||++|||+.|+++.|+.+.+.
T Consensus       282 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~  323 (326)
T 2w1i_A          282 LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQ  323 (326)
T ss_dssp             CCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence            122334456688999999999999999999999999998764

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=3.9e-37  Score=324.19  Aligned_cols=239  Identities=26%  Similarity=0.374  Sum_probs=177.8

Q ss_pred             cCCCcCCccc----eEEEEEEE--CCceEEEEEecc-----chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCC
Q 039626          351 DNFSFTCRIQ----GSVYRGKI--NGGFAAIKKVNG-----DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVN  419 (628)
Q Consensus       351 ~~f~~~~~i~----G~Vy~g~~--~g~~vavK~~~~-----~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~  419 (628)
                      +.|.....+|    |.||+++.  .++.||||+++.     .+.+|++++++++|+||+++++++.+++..++||||+++
T Consensus        53 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  132 (349)
T 2w4o_A           53 DFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTG  132 (349)
T ss_dssp             GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC----------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred             CcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccchhHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeCCC
Confidence            3444444443    89999999  467899999864     366899999999999999999999999999999999999


Q ss_pred             CChHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCC---CCcEEEccccccccCCCCC
Q 039626          420 GTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDS---DLRAKIANFAMARPAEGQE  496 (628)
Q Consensus       420 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~---~~~~kl~Dfgla~~~~~~~  496 (628)
                      |+|.+++..    ...+++..+..++.|++.||+|||+.   +++||||||+|||++.   ++.+||+|||+++......
T Consensus       133 ~~L~~~l~~----~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~  205 (349)
T 2w4o_A          133 GELFDRIVE----KGYYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV  205 (349)
T ss_dssp             CBHHHHHTT----CSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC---------
T ss_pred             CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCccccccCccc
Confidence            999999943    34589999999999999999999995   4999999999999975   8999999999998764321


Q ss_pred             CcceeeecccCCccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccc
Q 039626          497 GEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHF  576 (628)
Q Consensus       497 ~~~~~~~~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  576 (628)
                          ......||+.|+|||.+.+..++.++|||||||++|||++|+.|+......     ......+.....      ..
T Consensus       206 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-----~~~~~~i~~~~~------~~  270 (349)
T 2w4o_A          206 ----LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGD-----QFMFRRILNCEY------YF  270 (349)
T ss_dssp             -----------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCH-----HHHHHHHHTTCC------CC
T ss_pred             ----ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCccc-----HHHHHHHHhCCC------cc
Confidence                223457999999999999999999999999999999999999998632221     111222211110      00


Q ss_pred             cCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          577 IDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       577 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                           ......+.+..+.+++.+||+.||++|||+.|+++
T Consensus       271 -----~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  305 (349)
T 2w4o_A          271 -----ISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ  305 (349)
T ss_dssp             -----CTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             -----CCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                 01111233456789999999999999999999875

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=1.3e-36  Score=311.71  Aligned_cols=253  Identities=16%  Similarity=0.204  Sum_probs=195.5

Q ss_pred             cCCCcCCccc----eEEEEEEE--CCceEEEEEecc-----chHHHHHHHhhcCCCceeeeeeee-ecCCeEEEEEEecC
Q 039626          351 DNFSFTCRIQ----GSVYRGKI--NGGFAAIKKVNG-----DVSKEIALLNKINHSNLIILSGVC-FNEGNCYLVYEYAV  418 (628)
Q Consensus       351 ~~f~~~~~i~----G~Vy~g~~--~g~~vavK~~~~-----~~~~E~~~l~~l~H~nIv~l~g~~-~~~~~~~lV~E~~~  418 (628)
                      ++|.....+|    |.||+|+.  +|+.||+|++..     ++.+|+.++++++|++++..++++ ..++..++||||+ 
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-   87 (296)
T 3uzp_A            9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-   87 (296)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-
T ss_pred             cEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcchhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec-
Confidence            3444444443    89999996  788999998753     578999999999998877666666 4567789999999 


Q ss_pred             CCChHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEe---CCCCcEEEccccccccCCCC
Q 039626          419 NGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLL---DSDLRAKIANFAMARPAEGQ  495 (628)
Q Consensus       419 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl---~~~~~~kl~Dfgla~~~~~~  495 (628)
                      +++|.+++...   ...+++..++.++.|++.||+|||+.   +++||||||+|||+   ++++.+||+|||+++.....
T Consensus        88 ~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~  161 (296)
T 3uzp_A           88 GPSLEDLFNFC---SRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA  161 (296)
T ss_dssp             CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred             CCCHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccc
Confidence            99999999532   34599999999999999999999995   49999999999999   58899999999999876543


Q ss_pred             CCcc----eeeecccCCccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHH-HHHHHhccccch
Q 039626          496 EGEF----ALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSD-VLNAVLTKEDGE  570 (628)
Q Consensus       496 ~~~~----~~~~~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~  570 (628)
                      ....    .......||+.|+|||.+.+..++.++||||||++++||++|+.|+............. .........  .
T Consensus       162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~  239 (296)
T 3uzp_A          162 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP--I  239 (296)
T ss_dssp             TTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC--H
T ss_pred             ccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCc--h
Confidence            3211    11234579999999999999999999999999999999999999987543332222222 111111100  0


Q ss_pred             hhhccccCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhh
Q 039626          571 ESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNA  624 (628)
Q Consensus       571 ~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~~~  624 (628)
                              +.+...+    +..+.+++.+||+.||.+||++.++++.|++++..
T Consensus       240 --------~~~~~~~----~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~  281 (296)
T 3uzp_A          240 --------EVLCKGY----PSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR  281 (296)
T ss_dssp             --------HHHTTTS----CHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHH
T ss_pred             --------HHHHhhC----CHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHh
Confidence                    0011122    34578999999999999999999999999999855

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=1.5e-37  Score=316.28  Aligned_cols=237  Identities=26%  Similarity=0.452  Sum_probs=190.3

Q ss_pred             eEEEEEEEC-CceEEEEEecc------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhcCCCC
Q 039626          361 GSVYRGKIN-GGFAAIKKVNG------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEG  433 (628)
Q Consensus       361 G~Vy~g~~~-g~~vavK~~~~------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~  433 (628)
                      |.||+|... +..+|+|+++.      .+.+|++++++++|+||+++++++. ++..++||||+++|+|.+++...  .+
T Consensus        27 g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~~--~~  103 (279)
T 1qpc_A           27 GEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTP--SG  103 (279)
T ss_dssp             EEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCTTCBHHHHTTSH--HH
T ss_pred             eEEEEEEEcCCcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEecCCCCCHHHHHhcC--CC
Confidence            899999985 55899999864      3678999999999999999999987 45689999999999999999532  12


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCCccccC
Q 039626          434 KYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMA  513 (628)
Q Consensus       434 ~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~Y~A  513 (628)
                      ..+++..++.++.|++.||+|||+.   +++||||||+||++++++.+||+|||+++......  ........++..|+|
T Consensus       104 ~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~~y~a  178 (279)
T 1qpc_A          104 IKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE--YTAREGAKFPIKWTA  178 (279)
T ss_dssp             HTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC--EECCTTCCCCTTTSC
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCcccccccCcc--cccccCCCCccCccC
Confidence            3589999999999999999999995   49999999999999999999999999998765432  112233457889999


Q ss_pred             ccccccCCCCcccccHHHHHHHHHHHh-CCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCHHHHHH
Q 039626          514 PEYLENGLVSTKLDVYAFGVLILEMLT-GKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALL  592 (628)
Q Consensus       514 PE~l~~~~~s~k~DV~SfGvvl~ELlt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~  592 (628)
                      ||.+.+..++.++||||||++++||++ |+.|+.....      .+....+...          ...    ..+...+..
T Consensus       179 PE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~------~~~~~~~~~~----------~~~----~~~~~~~~~  238 (279)
T 1qpc_A          179 PEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN------PEVIQNLERG----------YRM----VRPDNCPEE  238 (279)
T ss_dssp             HHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH------HHHHHHHHTT----------CCC----CCCTTCCHH
T ss_pred             hhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCH------HHHHHHHhcc----------cCC----CCcccccHH
Confidence            999998899999999999999999999 8888763221      1122211110          111    112233456


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhc
Q 039626          593 VIRLIDACLKKDPTDRPTMYEIEHSLSNILNAS  625 (628)
Q Consensus       593 l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~~~~  625 (628)
                      +.+++.+||+.||++|||++++++.|+.+....
T Consensus       239 l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~  271 (279)
T 1qpc_A          239 LYQLMRLCWKERPEDRPTFDYLRSVLEDFFTAT  271 (279)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             HHHHHHHHhccChhhCCCHHHHHHHHHHHHHhc
Confidence            889999999999999999999999999998653

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=1.3e-36  Score=319.54  Aligned_cols=226  Identities=25%  Similarity=0.381  Sum_probs=181.2

Q ss_pred             eEEEEEEE--CCceEEEEEeccc----------hHHHHHHHhhc-CCCceeeeeeeeecCCeEEEEEEecCCCChHHHhh
Q 039626          361 GSVYRGKI--NGGFAAIKKVNGD----------VSKEIALLNKI-NHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVF  427 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~~----------~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~  427 (628)
                      |.||+++.  +++.+|+|+++..          +.+|..++.++ +||||+++++++.+++..++||||+++|+|.+++.
T Consensus        23 g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~  102 (345)
T 3a8x_A           23 AKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQ  102 (345)
T ss_dssp             EEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHH
T ss_pred             eEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEEEeCCCCCcHHHHHH
Confidence            89999998  5789999998642          56799999988 89999999999999999999999999999999996


Q ss_pred             hcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccC
Q 039626          428 SNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVG  507 (628)
Q Consensus       428 ~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~g  507 (628)
                      ..    ..+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++......   .......|
T Consensus       103 ~~----~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~---~~~~~~~g  172 (345)
T 3a8x_A          103 RQ----RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG---DTTSTFCG  172 (345)
T ss_dssp             HH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTT---CCBCCCCS
T ss_pred             Hc----CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEeccccccccCCC---CcccccCC
Confidence            43    3589999999999999999999995   49999999999999999999999999998643221   12345689


Q ss_pred             CccccCccccccCCCCcccccHHHHHHHHHHHhCCCcccccccccc---ccHHHHHHHHhccccchhhhccccCCcCCCC
Q 039626          508 TKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENN---MHLSDVLNAVLTKEDGEESLRHFIDPTLQGN  584 (628)
Q Consensus       508 t~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~  584 (628)
                      |+.|+|||.+.+..++.++|||||||++|||++|+.||........   .........+...             .  ..
T Consensus       173 t~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~-------------~--~~  237 (345)
T 3a8x_A          173 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK-------------Q--IR  237 (345)
T ss_dssp             CGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHC-------------C--CC
T ss_pred             CccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcC-------------C--CC
Confidence            9999999999999999999999999999999999999864221110   0011111111110             0  11


Q ss_pred             CCHHHHHHHHHHHHHhcccCCCCCCCH
Q 039626          585 YPLELALLVIRLIDACLKKDPTDRPTM  611 (628)
Q Consensus       585 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~  611 (628)
                      +|...+..+.+++.+||+.||.+||++
T Consensus       238 ~p~~~s~~~~~li~~lL~~dP~~R~~~  264 (345)
T 3a8x_A          238 IPRSLSVKAASVLKSFLNKDPKERLGC  264 (345)
T ss_dssp             CCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred             CCCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence            233344567899999999999999996

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=4.7e-37  Score=318.25  Aligned_cols=243  Identities=26%  Similarity=0.338  Sum_probs=184.0

Q ss_pred             eEEEEEEE-CCceEEEEEecc---------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhcC
Q 039626          361 GSVYRGKI-NGGFAAIKKVNG---------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNK  430 (628)
Q Consensus       361 G~Vy~g~~-~g~~vavK~~~~---------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~  430 (628)
                      |.||+++. +|+.+|+|+++.         .+.+|++++++++||||+++++++.+++..++||||++ |+|.+++..  
T Consensus        35 g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~--  111 (311)
T 3niz_A           35 GVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFME-KDLKKVLDE--  111 (311)
T ss_dssp             CEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEECCS-EEHHHHHHT--
T ss_pred             eEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcCCC-CCHHHHHHh--
Confidence            89999998 788999999863         35689999999999999999999999999999999997 588888854  


Q ss_pred             CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCCcc
Q 039626          431 NEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKG  510 (628)
Q Consensus       431 ~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~  510 (628)
                       ....+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++.......   ......||+.
T Consensus       112 -~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~~t~~  184 (311)
T 3niz_A          112 -NKTGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVR---SYTHEVVTLW  184 (311)
T ss_dssp             -CTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC------CCCCCCT
T ss_pred             -ccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcCceecCCCcc---cccCCcccCC
Confidence             234589999999999999999999995   599999999999999999999999999987643221   1234578999


Q ss_pred             ccCcccccc-CCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchh-----hhccccCCcCC--
Q 039626          511 YMAPEYLEN-GLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEE-----SLRHFIDPTLQ--  582 (628)
Q Consensus       511 Y~APE~l~~-~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~l~~~~d~~l~--  582 (628)
                      |+|||.+.+ ..++.++||||||++++||++|+.||.......  .+.. +...........     .+..+.+....  
T Consensus       185 y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--~~~~-i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (311)
T 3niz_A          185 YRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDD--QLPK-IFSILGTPNPREWPQVQELPLWKQRTFQVF  261 (311)
T ss_dssp             TCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTT--HHHH-HHHHHCCCCTTTSGGGTTSHHHHSCCCCCC
T ss_pred             cCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHH--HHHH-HHHHHCCCChHHhhhhhccchhhhcccccc
Confidence            999999876 568999999999999999999999987543322  1222 222221111100     00000000000  


Q ss_pred             CCC-----CHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          583 GNY-----PLELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       583 ~~~-----~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      ...     .......+.+|+.+||+.||++|||++|+++
T Consensus       262 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  300 (311)
T 3niz_A          262 EKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN  300 (311)
T ss_dssp             CCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             cCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            000     1122346789999999999999999999875

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=1.5e-37  Score=324.76  Aligned_cols=251  Identities=22%  Similarity=0.386  Sum_probs=196.1

Q ss_pred             cCCCcCCccc----eEEEEEEEC--C-----ceEEEEEecc--------chHHHHHHHhhc-CCCceeeeeeeeecCCeE
Q 039626          351 DNFSFTCRIQ----GSVYRGKIN--G-----GFAAIKKVNG--------DVSKEIALLNKI-NHSNLIILSGVCFNEGNC  410 (628)
Q Consensus       351 ~~f~~~~~i~----G~Vy~g~~~--g-----~~vavK~~~~--------~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~  410 (628)
                      ++|.....+|    |.||+|...  +     ..||+|.++.        .+.+|+++++++ +||||+++++++.+++..
T Consensus        46 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~  125 (333)
T 2i1m_A           46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPV  125 (333)
T ss_dssp             TSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCce
Confidence            4444444443    899999983  2     3799999864        367899999999 899999999999999999


Q ss_pred             EEEEEecCCCChHHHhhhcCC----------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCc
Q 039626          411 YLVYEYAVNGTLSDWVFSNKN----------EGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLR  480 (628)
Q Consensus       411 ~lV~E~~~~gsL~~~l~~~~~----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~  480 (628)
                      ++||||+++|+|.+++.....          ....+++..++.++.|++.||+|||+.   +++||||||+|||++.++.
T Consensus       126 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~  202 (333)
T 2i1m_A          126 LVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNGHV  202 (333)
T ss_dssp             EEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGCEEEGGGE
T ss_pred             EEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceEEECCCCe
Confidence            999999999999999965321          134589999999999999999999995   5999999999999999999


Q ss_pred             EEEccccccccCCCCCCcceeeecccCCccccCccccccCCCCcccccHHHHHHHHHHHh-CCCccccccccccccHHHH
Q 039626          481 AKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT-GKEAAALHAEENNMHLSDV  559 (628)
Q Consensus       481 ~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELlt-G~~p~~~~~~~~~~~~~~~  559 (628)
                      +||+|||+++....... ........+|+.|+|||.+.+..++.++||||||+++|||++ |+.|+.......  .....
T Consensus       203 ~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~--~~~~~  279 (333)
T 2i1m_A          203 AKIGDFGLARDIMNDSN-YIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS--KFYKL  279 (333)
T ss_dssp             EEBCCCGGGCCGGGCTT-SEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSH--HHHHH
T ss_pred             EEECccccccccccccc-eeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhH--HHHHH
Confidence            99999999987643322 122334567889999999999999999999999999999998 888876432111  11111


Q ss_pred             HHHHhccccchhhhccccCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhh
Q 039626          560 LNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNA  624 (628)
Q Consensus       560 ~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~~~  624 (628)
                      ...             ....    ..+...+..+.+++.+||+.||.+|||+.|+++.|+++...
T Consensus       280 ~~~-------------~~~~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~  327 (333)
T 2i1m_A          280 VKD-------------GYQM----AQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQE  327 (333)
T ss_dssp             HHH-------------TCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             Hhc-------------CCCC----CCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHh
Confidence            111             0111    11122245678999999999999999999999999988764

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=1.4e-37  Score=333.82  Aligned_cols=248  Identities=21%  Similarity=0.278  Sum_probs=196.6

Q ss_pred             cHHHHHHHhcCCCcCCccc----eEEEEEEE--CCceEEEEEecc----------chHHHHHHHhhcCCCceeeeeeeee
Q 039626          342 SFKELQSATDNFSFTCRIQ----GSVYRGKI--NGGFAAIKKVNG----------DVSKEIALLNKINHSNLIILSGVCF  405 (628)
Q Consensus       342 ~~~el~~at~~f~~~~~i~----G~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~nIv~l~g~~~  405 (628)
                      .+.+++...++|.....+|    |.||+++.  +++.+|+|+++.          .+.+|+.+++.++|||||++++++.
T Consensus        60 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~  139 (410)
T 3v8s_A           60 KIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQ  139 (410)
T ss_dssp             HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             HHHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence            3455566677888777775    89999998  578999999854          2678999999999999999999999


Q ss_pred             cCCeEEEEEEecCCCChHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEcc
Q 039626          406 NEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIAN  485 (628)
Q Consensus       406 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~D  485 (628)
                      +++..++||||+++|+|.+++..     ..+++..+..++.+|+.||+|||+.   +|+||||||+|||++.++.+||+|
T Consensus       140 ~~~~~~lV~E~~~gg~L~~~l~~-----~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~D  211 (410)
T 3v8s_A          140 DDRYLYMVMEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLAD  211 (410)
T ss_dssp             CSSEEEEEECCCTTEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECC
T ss_pred             ECCEEEEEEeCCCCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEec
Confidence            99999999999999999999853     2489999999999999999999995   499999999999999999999999


Q ss_pred             ccccccCCCCCCcceeeecccCCccccCccccccCC----CCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHH
Q 039626          486 FAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGL----VSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLN  561 (628)
Q Consensus       486 fgla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~----~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~  561 (628)
                      ||+++......  ........||+.|+|||++.+..    ++.++|||||||++|||++|+.||.....      .+...
T Consensus       212 FG~a~~~~~~~--~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~------~~~~~  283 (410)
T 3v8s_A          212 FGTCMKMNKEG--MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL------VGTYS  283 (410)
T ss_dssp             CTTCEECCTTS--EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHH
T ss_pred             cceeEeeccCC--cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCCh------hhHHH
Confidence            99998764322  12234568999999999998655    78999999999999999999999874322      12222


Q ss_pred             HHhccccchhhhccccCCcCCCCCCHHHHHHHHHHHHHhcccCCCC--CCCHHHHHH
Q 039626          562 AVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTD--RPTMYEIEH  616 (628)
Q Consensus       562 ~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPs~~ev~~  616 (628)
                      .+....   ..   +.-|     .....+..+.+|+.+||..+|.+  ||+++||++
T Consensus       284 ~i~~~~---~~---~~~p-----~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~  329 (410)
T 3v8s_A          284 KIMNHK---NS---LTFP-----DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKR  329 (410)
T ss_dssp             HHHTHH---HH---CCCC-----TTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHT
T ss_pred             HHHhcc---cc---ccCC-----CcccccHHHHHHHHHHccChhhhCCCCCHHHHhc
Confidence            222110   00   0000     00123456789999999999988  999998864

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.3e-37  Score=314.35  Aligned_cols=241  Identities=28%  Similarity=0.408  Sum_probs=190.0

Q ss_pred             eEEEEEEE--CCc---eEEEEEecc--------chHHHHHHHhhcCCCceeeeeeeeecCCeE-EEEEEecCCCChHHHh
Q 039626          361 GSVYRGKI--NGG---FAAIKKVNG--------DVSKEIALLNKINHSNLIILSGVCFNEGNC-YLVYEYAVNGTLSDWV  426 (628)
Q Consensus       361 G~Vy~g~~--~g~---~vavK~~~~--------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~-~lV~E~~~~gsL~~~l  426 (628)
                      |.||+|.+  ++.   .+|+|++..        .+.+|+.++++++|+||+++++++.+.+.. ++|+||+.+|+|.+++
T Consensus        35 g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~~  114 (298)
T 3pls_A           35 GVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFI  114 (298)
T ss_dssp             EEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEECCCTTCBHHHHH
T ss_pred             ceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEEecccCCCHHHHH
Confidence            89999987  222   689999864        366899999999999999999999876654 9999999999999999


Q ss_pred             hhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCC-cceeeecc
Q 039626          427 FSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEG-EFALTRHI  505 (628)
Q Consensus       427 ~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~~  505 (628)
                      ..   ....+++..+..++.|++.||+|||+.   +++||||||+|||+++++.+||+|||+++....... ........
T Consensus       115 ~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~  188 (298)
T 3pls_A          115 RS---PQRNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHA  188 (298)
T ss_dssp             HC---TTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGGGCSCCSSCT
T ss_pred             hc---cccCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCcccccCCcccccccCcCC
Confidence            54   345689999999999999999999995   499999999999999999999999999986643221 11123345


Q ss_pred             cCCccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCC
Q 039626          506 VGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNY  585 (628)
Q Consensus       506 ~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~  585 (628)
                      .+++.|+|||.+.+..++.++||||||++++||++|+.|+......  ......+..             ...    ...
T Consensus       189 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~--~~~~~~~~~-------------~~~----~~~  249 (298)
T 3pls_A          189 RLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDP--FDLTHFLAQ-------------GRR----LPQ  249 (298)
T ss_dssp             TCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCG--GGHHHHHHT-------------TCC----CCC
T ss_pred             CCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCH--HHHHHHhhc-------------CCC----CCC
Confidence            7889999999999999999999999999999999976664422211  111111110             001    111


Q ss_pred             CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhcc
Q 039626          586 PLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNASL  626 (628)
Q Consensus       586 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~~~~~  626 (628)
                      +...+..+.+++.+||+.||.+|||++|+++.|++++..-.
T Consensus       250 ~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~  290 (298)
T 3pls_A          250 PEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALL  290 (298)
T ss_dssp             CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCC
T ss_pred             CccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHh
Confidence            22334568899999999999999999999999999987643

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=8.2e-37  Score=313.15  Aligned_cols=244  Identities=23%  Similarity=0.279  Sum_probs=182.9

Q ss_pred             eEEEEEEE--CCceEEEEEecc---------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhc
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG---------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSN  429 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~---------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~  429 (628)
                      |.||+++.  +|+.+|+|+++.         .+.+|++++++++|+||+++++++.+++..++||||+++ +|.+++.. 
T Consensus        16 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~-   93 (292)
T 3o0g_A           16 GTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDS-   93 (292)
T ss_dssp             SEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSE-EHHHHHHH-
T ss_pred             eEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEecCCC-CHHHHHHh-
Confidence            89999998  678999999852         356899999999999999999999999999999999975 66666543 


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCCc
Q 039626          430 KNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTK  509 (628)
Q Consensus       430 ~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~  509 (628)
                        ....+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++.......   ......||+
T Consensus        94 --~~~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~t~  165 (292)
T 3o0g_A           94 --CNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR---CYSAEVVTL  165 (292)
T ss_dssp             --TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCS---CCCSCCSCG
T ss_pred             --CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecCCccc---cccCCcccc
Confidence              234599999999999999999999995   499999999999999999999999999987643221   223457899


Q ss_pred             cccCccccccCC-CCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccc--hhhhccccCC-------
Q 039626          510 GYMAPEYLENGL-VSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDG--EESLRHFIDP-------  579 (628)
Q Consensus       510 ~Y~APE~l~~~~-~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~l~~~~d~-------  579 (628)
                      .|+|||.+.+.. ++.++||||||++++||++|+.|+.......  .....+.........  ...+....+.       
T Consensus       166 ~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~--~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (292)
T 3o0g_A          166 WYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD--DQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYP  243 (292)
T ss_dssp             GGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHH--HHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCC
T ss_pred             CCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHH--HHHHHHHHHhCCCChhhhhhhccccccccccccc
Confidence            999999998765 7999999999999999999988864322111  111111121111110  0111111000       


Q ss_pred             --cCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          580 --TLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       580 --~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                        .............+.+++.+||+.||++|||++|+++
T Consensus       244 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  282 (292)
T 3o0g_A          244 ATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             TTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence              0001112234566789999999999999999999875

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=6.9e-37  Score=325.70  Aligned_cols=226  Identities=22%  Similarity=0.359  Sum_probs=183.8

Q ss_pred             eEEEEEEE--CCceEEEEEecc----------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhh
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG----------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFS  428 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  428 (628)
                      |.||++..  +++.+|+|.+..          .+.+|+++|++++|||||++++++.+.+..++||||+++|+|.+++..
T Consensus        29 G~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~  108 (384)
T 4fr4_A           29 GKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQ  108 (384)
T ss_dssp             CCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHT
T ss_pred             eEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecCCCCcHHHHHHh
Confidence            89999998  578899999853          356799999999999999999999999999999999999999999953


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCC
Q 039626          429 NKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGT  508 (628)
Q Consensus       429 ~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt  508 (628)
                          ...+++..+..++.+++.||.|||+.   +|+||||||+|||++.++.+||+|||+++......    ......||
T Consensus       109 ----~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~----~~~~~~gt  177 (384)
T 4fr4_A          109 ----NVHFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET----QITTMAGT  177 (384)
T ss_dssp             ----TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTC----CBCCCCSC
T ss_pred             ----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccceeeeccCCC----ceeccCCC
Confidence                34599999999999999999999995   49999999999999999999999999998764332    23446799


Q ss_pred             ccccCcccccc---CCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCC
Q 039626          509 KGYMAPEYLEN---GLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNY  585 (628)
Q Consensus       509 ~~Y~APE~l~~---~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~  585 (628)
                      +.|+|||.+..   ..++.++|||||||++|||++|+.||.......   ...........               ...+
T Consensus       178 ~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~---~~~~~~~~~~~---------------~~~~  239 (384)
T 4fr4_A          178 KPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTS---SKEIVHTFETT---------------VVTY  239 (384)
T ss_dssp             GGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSC---HHHHHHHHHHC---------------CCCC
T ss_pred             ccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCcc---HHHHHHHHhhc---------------ccCC
Confidence            99999999864   458999999999999999999999987433222   11222111110               0122


Q ss_pred             CHHHHHHHHHHHHHhcccCCCCCCC-HHHHH
Q 039626          586 PLELALLVIRLIDACLKKDPTDRPT-MYEIE  615 (628)
Q Consensus       586 ~~~~~~~l~~l~~~Cl~~dP~~RPs-~~ev~  615 (628)
                      +...+..+.+++.+||+.||.+||+ ++++.
T Consensus       240 p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~  270 (384)
T 4fr4_A          240 PSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQ  270 (384)
T ss_dssp             CTTSCHHHHHHHHHHSCSSGGGSCCSHHHHH
T ss_pred             CCcCCHHHHHHHHHHhcCCHhHhcccHHHHH
Confidence            3334466889999999999999998 55554

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=6e-37  Score=320.75  Aligned_cols=223  Identities=26%  Similarity=0.379  Sum_probs=183.5

Q ss_pred             eEEEEEEE--CCceEEEEEecc----------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhh
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG----------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFS  428 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  428 (628)
                      |.||++..  +++.||+|++..          .+.+|+.++++++||||+++++++.+++..++||||+ +|+|.+++..
T Consensus        23 g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~-~g~l~~~l~~  101 (336)
T 3h4j_B           23 GKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVE  101 (336)
T ss_dssp             EEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCC-CEEHHHHHHH
T ss_pred             eEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEECC-CCcHHHHHHH
Confidence            89999998  788999999853          3678999999999999999999999999999999999 7899999864


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCC
Q 039626          429 NKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGT  508 (628)
Q Consensus       429 ~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt  508 (628)
                      .    ..+++..+..++.|++.||+|||+.+   ++||||||+|||+++++.+||+|||+++......    ......||
T Consensus       102 ~----~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~----~~~~~~gt  170 (336)
T 3h4j_B          102 K----KRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN----FLKTSCGS  170 (336)
T ss_dssp             H----CSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB----TTCCCTTS
T ss_pred             c----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceeccCCc----ccccccCC
Confidence            3    35999999999999999999999954   9999999999999999999999999998764332    12345799


Q ss_pred             ccccCccccccCCC-CcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCH
Q 039626          509 KGYMAPEYLENGLV-STKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPL  587 (628)
Q Consensus       509 ~~Y~APE~l~~~~~-s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~  587 (628)
                      +.|+|||.+.+..+ ++++||||||+++|||++|+.||.......                   ........  ....+.
T Consensus       171 ~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~-------------------~~~~i~~~--~~~~p~  229 (336)
T 3h4j_B          171 PNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPN-------------------LFKKVNSC--VYVMPD  229 (336)
T ss_dssp             TTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTT-------------------CBCCCCSS--CCCCCT
T ss_pred             cCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHH-------------------HHHHHHcC--CCCCcc
Confidence            99999999988776 789999999999999999999986422111                   00000000  011233


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          588 ELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       588 ~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      ..+..+.+++.+||+.||.+|||++|+++
T Consensus       230 ~~s~~~~~li~~~L~~dP~~Rpt~~eil~  258 (336)
T 3h4j_B          230 FLSPGAQSLIRRMIVADPMQRITIQEIRR  258 (336)
T ss_dssp             TSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred             cCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence            34556789999999999999999999875

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=7.4e-37  Score=323.65  Aligned_cols=238  Identities=23%  Similarity=0.322  Sum_probs=189.2

Q ss_pred             cCCCcCCccc----eEEEEEEE--CCceEEEEEecc---------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEE
Q 039626          351 DNFSFTCRIQ----GSVYRGKI--NGGFAAIKKVNG---------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYE  415 (628)
Q Consensus       351 ~~f~~~~~i~----G~Vy~g~~--~g~~vavK~~~~---------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  415 (628)
                      ++|.....+|    |.||++..  +|..+|+|++..         .+.+|++++++++||||+++++++.+++..++|||
T Consensus        29 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e  108 (362)
T 2bdw_A           29 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD  108 (362)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             cCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence            4455555554    89999998  588999999853         35689999999999999999999999999999999


Q ss_pred             ecCCCChHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCC---CcEEEccccccccC
Q 039626          416 YAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSD---LRAKIANFAMARPA  492 (628)
Q Consensus       416 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~---~~~kl~Dfgla~~~  492 (628)
                      |+++|+|.+++..    ...+++..+..++.||+.||+|||+.   +|+||||||+|||++.+   +.+||+|||+++..
T Consensus       109 ~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~  181 (362)
T 2bdw_A          109 LVTGGELFEDIVA----REFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV  181 (362)
T ss_dssp             CCCSCBHHHHHTT----CSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCC
T ss_pred             cCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeecCcceEe
Confidence            9999999999843    34689999999999999999999995   49999999999999865   45999999999876


Q ss_pred             CCCCCcceeeecccCCccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhh
Q 039626          493 EGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEES  572 (628)
Q Consensus       493 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  572 (628)
                      ....    ......||+.|+|||.+.+..++.++|||||||++|||++|+.||.....      .+....+.....    
T Consensus       182 ~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~------~~~~~~i~~~~~----  247 (362)
T 2bdw_A          182 NDSE----AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ------HRLYAQIKAGAY----  247 (362)
T ss_dssp             TTCC----SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHTCC----
T ss_pred             cCCc----ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH------HHHHHHHHhCCC----
Confidence            5332    12345799999999999998999999999999999999999999864321      122222211100    


Q ss_pred             hccccCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          573 LRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       573 l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                        .+     ........+..+.+++.+||+.||++||++.|+++
T Consensus       248 --~~-----~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  284 (362)
T 2bdw_A          248 --DY-----PSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK  284 (362)
T ss_dssp             --CC-----CTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             --CC-----CcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence              00     00001123456789999999999999999999875

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=4.3e-37  Score=320.92  Aligned_cols=236  Identities=23%  Similarity=0.379  Sum_probs=181.9

Q ss_pred             eEEEEEEE--CCce----EEEEEecc--------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHh
Q 039626          361 GSVYRGKI--NGGF----AAIKKVNG--------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWV  426 (628)
Q Consensus       361 G~Vy~g~~--~g~~----vavK~~~~--------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l  426 (628)
                      |.||+|..  +++.    +|+|.+..        .+.+|+.++++++||||+++++++..+. .++|+||+++|+|.+++
T Consensus        29 g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~v~~~~~~g~L~~~l  107 (327)
T 3lzb_A           29 GTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYV  107 (327)
T ss_dssp             EEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEEEECCCSSCBHHHHH
T ss_pred             eEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceEEEEecCCCcHHHHH
Confidence            89999998  4544    47777642        4678999999999999999999998654 78999999999999999


Q ss_pred             hhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeeccc
Q 039626          427 FSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIV  506 (628)
Q Consensus       427 ~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~  506 (628)
                      ...   ...+++..++.++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++........ .......
T Consensus       108 ~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~~~~-~~~~~~~  180 (327)
T 3lzb_A          108 REH---KDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE-YHAEGGK  180 (327)
T ss_dssp             HHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC-----------------C
T ss_pred             Hhc---CCCCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCcceeEccCcccc-ccccCCC
Confidence            653   34589999999999999999999995   4999999999999999999999999999876433221 1223345


Q ss_pred             CCccccCccccccCCCCcccccHHHHHHHHHHHh-CCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCC
Q 039626          507 GTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT-GKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNY  585 (628)
Q Consensus       507 gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELlt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~  585 (628)
                      +|+.|+|||.+.+..++.++||||||+++|||++ |+.||.......   +...+.   .              ......
T Consensus       181 ~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~---~~~~~~---~--------------~~~~~~  240 (327)
T 3lzb_A          181 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISSILE---K--------------GERLPQ  240 (327)
T ss_dssp             CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHHHHH---T--------------TCCCCC
T ss_pred             ccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH---HHHHHH---c--------------CCCCCC
Confidence            7889999999999999999999999999999999 999886433221   111111   0              001112


Q ss_pred             CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhh
Q 039626          586 PLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNA  624 (628)
Q Consensus       586 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~~~  624 (628)
                      +...+..+.+++.+||+.||.+||++.|+++.|+++...
T Consensus       241 ~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  279 (327)
T 3lzb_A          241 PPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD  279 (327)
T ss_dssp             CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred             CccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence            223345688999999999999999999999999998854

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=8.8e-37  Score=321.76  Aligned_cols=257  Identities=12%  Similarity=0.160  Sum_probs=195.3

Q ss_pred             CCCcCCccc----eEEEEEEEC----------CceEEEEEecc--chHHHHHHHhhcCCCceee---------------e
Q 039626          352 NFSFTCRIQ----GSVYRGKIN----------GGFAAIKKVNG--DVSKEIALLNKINHSNLII---------------L  400 (628)
Q Consensus       352 ~f~~~~~i~----G~Vy~g~~~----------g~~vavK~~~~--~~~~E~~~l~~l~H~nIv~---------------l  400 (628)
                      +|.....+|    |.||+|+..          ++.+|+|.+..  .+.+|++++++++|+||++               +
T Consensus        43 ~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i~~~  122 (352)
T 2jii_A           43 QWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPTC  122 (352)
T ss_dssp             EEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETTSTHHHHHHHHHHHCCHHHHHHHHHHTTCTTCSCCCC
T ss_pred             eEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEecccchHHHHHHHHHHhcccchhhhhhhhccCCccCccch
Confidence            444444443    899999983          67999999875  4899999999999999987               6


Q ss_pred             eeeeec-CCeEEEEEEecCCCChHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCC
Q 039626          401 SGVCFN-EGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDL  479 (628)
Q Consensus       401 ~g~~~~-~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~  479 (628)
                      ++++.. ++..++||||+ +|+|.+++...  ....+++..++.++.|++.||+|||+.   +++||||||+|||++.++
T Consensus       123 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIl~~~~~  196 (352)
T 2jii_A          123 MGFGVHQDKYRFLVLPSL-GRSLQSALDVS--PKHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTAENIFVDPED  196 (352)
T ss_dssp             CEEEEETTTEEEEEEECC-CEEHHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCGGGEEEETTE
T ss_pred             hhccccCCcEEEEEecCC-CcCHHHHHHhC--CcCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEEcCCC
Confidence            777775 67889999999 99999999653  235699999999999999999999995   599999999999999998


Q ss_pred             --cEEEccccccccCCCCCCcc----eeeecccCCccccCccccccCCCCcccccHHHHHHHHHHHhCCCcccccccccc
Q 039626          480 --RAKIANFAMARPAEGQEGEF----ALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENN  553 (628)
Q Consensus       480 --~~kl~Dfgla~~~~~~~~~~----~~~~~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~  553 (628)
                        .+||+|||+++.........    .......||+.|+|||.+.+..++.++||||||+++|||++|+.||....... 
T Consensus       197 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~-  275 (352)
T 2jii_A          197 QSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNT-  275 (352)
T ss_dssp             EEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCH-
T ss_pred             CceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCCcCH-
Confidence              99999999998765332111    11233579999999999999999999999999999999999999987543211 


Q ss_pred             ccHHHHHHHHhccccchhhhccccCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhh
Q 039626          554 MHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNA  624 (628)
Q Consensus       554 ~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~~~  624 (628)
                      ............      ....+.+....   ....+..+.+++.+||+.||.+||+++|+++.|++++..
T Consensus       276 ~~~~~~~~~~~~------~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~  337 (352)
T 2jii_A          276 EDIMKQKQKFVD------KPGPFVGPCGH---WIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQD  337 (352)
T ss_dssp             HHHHHHHHHHHH------SCCCEECTTSC---EECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHhccC------Chhhhhhhccc---cCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHh
Confidence            111111111111      11111111110   011235678999999999999999999999999999844

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=4.8e-37  Score=312.94  Aligned_cols=236  Identities=24%  Similarity=0.370  Sum_probs=186.2

Q ss_pred             eEEEEEEECC-----ceEEEEEecc--------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhh
Q 039626          361 GSVYRGKING-----GFAAIKKVNG--------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVF  427 (628)
Q Consensus       361 G~Vy~g~~~g-----~~vavK~~~~--------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~  427 (628)
                      |.||+|++.+     ..||+|.++.        .+.+|++++++++||||+++++++.+ +..++||||+++|+|.+++.
T Consensus        26 g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~l~  104 (281)
T 3cc6_A           26 GEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWIIMELYPYGELGHYLE  104 (281)
T ss_dssp             SEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHHH
T ss_pred             eeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEEEEecCCCCCHHHHHH
Confidence            8999998732     2599999864        36679999999999999999999865 45689999999999999996


Q ss_pred             hcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccC
Q 039626          428 SNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVG  507 (628)
Q Consensus       428 ~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~g  507 (628)
                      ..   ...+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||+++.......  .......+
T Consensus       105 ~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~  176 (281)
T 3cc6_A          105 RN---KNSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDY--YKASVTRL  176 (281)
T ss_dssp             HH---TTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCCGGGCC-----------CCCC
T ss_pred             hc---cccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccCCCcccccccc--cccccCCC
Confidence            53   34589999999999999999999995   499999999999999999999999999987653321  11233467


Q ss_pred             CccccCccccccCCCCcccccHHHHHHHHHHHh-CCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCC
Q 039626          508 TKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT-GKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYP  586 (628)
Q Consensus       508 t~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELlt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~  586 (628)
                      ++.|+|||.+.+..++.++||||||++++||++ |+.|+.......   ....+..   .          ...    ..+
T Consensus       177 ~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~---~~~~~~~---~----------~~~----~~~  236 (281)
T 3cc6_A          177 PIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD---VIGVLEK---G----------DRL----PKP  236 (281)
T ss_dssp             CGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGG---HHHHHHH---T----------CCC----CCC
T ss_pred             CcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHH---HHHHHhc---C----------CCC----CCC
Confidence            889999999999999999999999999999998 999886433221   1111111   0          001    111


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhc
Q 039626          587 LELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNAS  625 (628)
Q Consensus       587 ~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~~~~  625 (628)
                      ...+..+.+++.+||+.||.+||++.|+++.|+.+.+.+
T Consensus       237 ~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~  275 (281)
T 3cc6_A          237 DLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQME  275 (281)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             CCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHhh
Confidence            223456889999999999999999999999999998764

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=1.5e-37  Score=322.99  Aligned_cols=255  Identities=24%  Similarity=0.387  Sum_probs=198.4

Q ss_pred             HHHHhcCCCcCCccc----eEEEEEEEC-------CceEEEEEecc--------chHHHHHHHhhcCCCceeeeeeeeec
Q 039626          346 LQSATDNFSFTCRIQ----GSVYRGKIN-------GGFAAIKKVNG--------DVSKEIALLNKINHSNLIILSGVCFN  406 (628)
Q Consensus       346 l~~at~~f~~~~~i~----G~Vy~g~~~-------g~~vavK~~~~--------~~~~E~~~l~~l~H~nIv~l~g~~~~  406 (628)
                      ++...++|.....+|    |.||+|+..       +..||+|++..        ++.+|++++++++|+||+++++++.+
T Consensus        20 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   99 (322)
T 1p4o_A           20 WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ   99 (322)
T ss_dssp             TBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS
T ss_pred             hcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEcc
Confidence            333445555555554    899999864       56899999864        36689999999999999999999999


Q ss_pred             CCeEEEEEEecCCCChHHHhhhcC------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCc
Q 039626          407 EGNCYLVYEYAVNGTLSDWVFSNK------NEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLR  480 (628)
Q Consensus       407 ~~~~~lV~E~~~~gsL~~~l~~~~------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~  480 (628)
                      ++..++||||+++|+|.+++....      .....+++..+++++.|++.||+|||+.   +++||||||+||+++.++.
T Consensus       100 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli~~~~~  176 (322)
T 1p4o_A          100 GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFT  176 (322)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCC
T ss_pred             CCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEEcCCCe
Confidence            999999999999999999996432      1124579999999999999999999995   4999999999999999999


Q ss_pred             EEEccccccccCCCCCCcceeeecccCCccccCccccccCCCCcccccHHHHHHHHHHHh-CCCccccccccccccHHHH
Q 039626          481 AKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT-GKEAAALHAEENNMHLSDV  559 (628)
Q Consensus       481 ~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELlt-G~~p~~~~~~~~~~~~~~~  559 (628)
                      +||+|||+++....... ........+|+.|+|||.+.+..++.++||||||+++|||++ |+.|+.....      .+.
T Consensus       177 ~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~------~~~  249 (322)
T 1p4o_A          177 VKIGDFGMTRDIYETDY-YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN------EQV  249 (322)
T ss_dssp             EEECCTTCCCGGGGGGC-EEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH------HHH
T ss_pred             EEECcCccccccccccc-cccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCH------HHH
Confidence            99999999986543221 111223457889999999999999999999999999999999 7877753221      122


Q ss_pred             HHHHhccccchhhhccccCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhh
Q 039626          560 LNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNA  624 (628)
Q Consensus       560 ~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~~~  624 (628)
                      ...+....              ....+...+..+.+++.+||+.||.+|||+.|+++.|++++..
T Consensus       250 ~~~~~~~~--------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~  300 (322)
T 1p4o_A          250 LRFVMEGG--------------LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP  300 (322)
T ss_dssp             HHHHHTTC--------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCT
T ss_pred             HHHHHcCC--------------cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhcc
Confidence            22211110              0011223345678999999999999999999999999887653

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=1.8e-36  Score=314.94  Aligned_cols=222  Identities=24%  Similarity=0.366  Sum_probs=184.3

Q ss_pred             eEEEEEEE--CCceEEEEEecc----------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhh
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG----------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFS  428 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  428 (628)
                      |.||+++.  +|+.+|+|.++.          .+.+|..++++++||||+++++++.+.+..++||||+++|+|.+++..
T Consensus        20 g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~   99 (318)
T 1fot_A           20 GRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRK   99 (318)
T ss_dssp             CEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHH
T ss_pred             EEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEEeCCCCCCHHHHHHH
Confidence            89999998  688999999864          245799999999999999999999999999999999999999999954


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCC
Q 039626          429 NKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGT  508 (628)
Q Consensus       429 ~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt  508 (628)
                          ...+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++.....      .....||
T Consensus       100 ----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~------~~~~~gt  166 (318)
T 1fot_A          100 ----SQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV------TYTLCGT  166 (318)
T ss_dssp             ----TSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSSC------BCCCCSC
T ss_pred             ----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeecCcceecCCc------cccccCC
Confidence                23589999999999999999999985   4999999999999999999999999999876432      2345799


Q ss_pred             ccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCHH
Q 039626          509 KGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLE  588 (628)
Q Consensus       509 ~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~  588 (628)
                      +.|+|||.+.+..++.++||||||+++|||++|+.||.....      .+....+....           .    .++..
T Consensus       167 ~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~------~~~~~~i~~~~-----------~----~~p~~  225 (318)
T 1fot_A          167 PDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT------MKTYEKILNAE-----------L----RFPPF  225 (318)
T ss_dssp             TTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHHHCC-----------C----CCCTT
T ss_pred             ccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH------HHHHHHHHhCC-----------C----CCCCC
Confidence            999999999999999999999999999999999999864221      12222222110           0    12223


Q ss_pred             HHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 039626          589 LALLVIRLIDACLKKDPTDRP-----TMYEIEH  616 (628)
Q Consensus       589 ~~~~l~~l~~~Cl~~dP~~RP-----s~~ev~~  616 (628)
                      ....+.+++.+||+.||.+||     +++|+++
T Consensus       226 ~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~  258 (318)
T 1fot_A          226 FNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  258 (318)
T ss_dssp             SCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             CCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence            345678999999999999999     7777763

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=7.1e-37  Score=323.73  Aligned_cols=230  Identities=23%  Similarity=0.326  Sum_probs=176.3

Q ss_pred             eEEEEEEE--CCceEEEEEecc------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhcCCC
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNE  432 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~  432 (628)
                      |.||+++.  +++.||+|++..      .+.+|+.++++++||||+++++++.+.+..++||||+++|+|.+++...   
T Consensus        34 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---  110 (361)
T 3uc3_A           34 GVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNA---  110 (361)
T ss_dssp             SSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHH---
T ss_pred             EEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeCCCCCHHHHHHhc---
Confidence            89999998  688999999864      4678999999999999999999999999999999999999999999543   


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCc--EEEccccccccCCCCCCcceeeecccCCcc
Q 039626          433 GKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLR--AKIANFAMARPAEGQEGEFALTRHIVGTKG  510 (628)
Q Consensus       433 ~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~--~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~  510 (628)
                       ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.  +||+|||+++......    ......||+.
T Consensus       111 -~~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~----~~~~~~gt~~  182 (361)
T 3uc3_A          111 -GRFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS----QPKSTVGTPA  182 (361)
T ss_dssp             -SSCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCCC-------------------CT
T ss_pred             -CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCccccccccC----CCCCCcCCCC
Confidence             3489999999999999999999995   4999999999999987765  9999999997543221    1234579999


Q ss_pred             ccCccccccCCCCcc-cccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCHHH
Q 039626          511 YMAPEYLENGLVSTK-LDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLEL  589 (628)
Q Consensus       511 Y~APE~l~~~~~s~k-~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~  589 (628)
                      |+|||.+.+..++.+ +||||||+++|||++|+.||......  ......+........             ........
T Consensus       183 y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~--~~~~~~~~~~~~~~~-------------~~~~~~~~  247 (361)
T 3uc3_A          183 YIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP--RDYRKTIQRILSVKY-------------SIPDDIRI  247 (361)
T ss_dssp             TSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----C--CCHHHHHHHHHTTCC-------------CCCTTSCC
T ss_pred             cCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccH--HHHHHHHHHHhcCCC-------------CCCCcCCC
Confidence            999999988877666 89999999999999999998753322  223333333322110             00001122


Q ss_pred             HHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          590 ALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       590 ~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      +..+.+|+.+||+.||++|||+.|+++
T Consensus       248 s~~~~~li~~~L~~dP~~Rps~~ell~  274 (361)
T 3uc3_A          248 SPECCHLISRIFVADPATRISIPEIKT  274 (361)
T ss_dssp             CHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             CHHHHHHHHHHccCChhHCcCHHHHHh
Confidence            356789999999999999999999976

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=1.1e-36  Score=330.47  Aligned_cols=239  Identities=21%  Similarity=0.315  Sum_probs=190.3

Q ss_pred             cCCCcCCccc----eEEEEEEE--CCceEEEEEecc---------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEE
Q 039626          351 DNFSFTCRIQ----GSVYRGKI--NGGFAAIKKVNG---------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYE  415 (628)
Q Consensus       351 ~~f~~~~~i~----G~Vy~g~~--~g~~vavK~~~~---------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  415 (628)
                      ++|.....+|    |.||++..  +|+.+|+|++..         .+.+|++++++++||||+++++++.+++..++|||
T Consensus        11 ~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E   90 (444)
T 3soa_A           11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFD   90 (444)
T ss_dssp             HHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEEC
T ss_pred             CCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEE
Confidence            3444444443    89999987  788999998853         36789999999999999999999999999999999


Q ss_pred             ecCCCChHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeC---CCCcEEEccccccccC
Q 039626          416 YAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLD---SDLRAKIANFAMARPA  492 (628)
Q Consensus       416 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~---~~~~~kl~Dfgla~~~  492 (628)
                      |+++|+|.+++..    ...+++..+..++.|++.||+|||+.   +|+||||||+|||++   +++.+||+|||+++..
T Consensus        91 ~~~gg~L~~~i~~----~~~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~  163 (444)
T 3soa_A           91 LVTGGELFEDIVA----REYYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEV  163 (444)
T ss_dssp             CCBCCBHHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCC
T ss_pred             eCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCceeEEe
Confidence            9999999999864    24599999999999999999999995   499999999999998   5688999999999876


Q ss_pred             CCCCCcceeeecccCCccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhh
Q 039626          493 EGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEES  572 (628)
Q Consensus       493 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  572 (628)
                      .....   ......||+.|+|||.+.+..++.++|||||||++|||++|+.||.....      .+....+.....    
T Consensus       164 ~~~~~---~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~------~~~~~~i~~~~~----  230 (444)
T 3soa_A          164 EGEQQ---AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQ------HRLYQQIKAGAY----  230 (444)
T ss_dssp             CTTCC---BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHHHTCC----
T ss_pred             cCCCc---eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccH------HHHHHHHHhCCC----
Confidence            54321   22346799999999999999999999999999999999999999864321      122222211110    


Q ss_pred             hccccCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          573 LRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       573 l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                        .+..+     .....+..+.+++.+||+.||.+|||+.|+++
T Consensus       231 --~~~~~-----~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~  267 (444)
T 3soa_A          231 --DFPSP-----EWDTVTPEAKDLINKMLTINPSKRITAAEALK  267 (444)
T ss_dssp             --CCCTT-----TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             --CCCcc-----ccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence              00001     11123456789999999999999999999976

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=7.1e-37  Score=318.59  Aligned_cols=230  Identities=23%  Similarity=0.359  Sum_probs=179.7

Q ss_pred             eEEEEEEE--CCceEEEEEecc--------chHHHHHHHhhcCCCceeeeeeeeecCC----------------------
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG--------DVSKEIALLNKINHSNLIILSGVCFNEG----------------------  408 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~--------~~~~E~~~l~~l~H~nIv~l~g~~~~~~----------------------  408 (628)
                      |.||+++.  +|+.||||+++.        .+.+|+++|++++||||+++++++.+..                      
T Consensus        20 g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   99 (332)
T 3qd2_B           20 GVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPL   99 (332)
T ss_dssp             SEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHHHC------------
T ss_pred             eEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhhhhhhhccccccccc
Confidence            89999998  688999999852        4678999999999999999999986543                      


Q ss_pred             -----------------------------------eEEEEEEecCCCChHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHH
Q 039626          409 -----------------------------------NCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLN  453 (628)
Q Consensus       409 -----------------------------------~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~  453 (628)
                                                         ..++||||+++|+|.+++.... ......+..++.++.|++.||+
T Consensus       100 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~  178 (332)
T 3qd2_B          100 SSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRC-SLEDREHGVCLHIFIQIAEAVE  178 (332)
T ss_dssp             --------------------------------CCCEEEEEEECCCSSCHHHHHHTCC-SGGGSCHHHHHHHHHHHHHHHH
T ss_pred             cCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhccc-CccchhhHHHHHHHHHHHHHHH
Confidence                                               2799999999999999996532 2345688889999999999999


Q ss_pred             HHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcc---------eeeecccCCccccCccccccCCCCc
Q 039626          454 YLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEF---------ALTRHIVGTKGYMAPEYLENGLVST  524 (628)
Q Consensus       454 yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~---------~~~~~~~gt~~Y~APE~l~~~~~s~  524 (628)
                      |||+.   +++||||||+|||++.++.+||+|||+++.........         .......||+.|+|||.+.+..++.
T Consensus       179 ~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~  255 (332)
T 3qd2_B          179 FLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSH  255 (332)
T ss_dssp             HHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGSCHHHHHCCCCCT
T ss_pred             HHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCccChHHhcCCCCcc
Confidence            99995   49999999999999999999999999998775432111         1223357999999999999999999


Q ss_pred             ccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCHHHHHHHHHHHHHhcccC
Q 039626          525 KLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKD  604 (628)
Q Consensus       525 k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~d  604 (628)
                      ++||||||++++||++|..+....        ...........          .+    .........+.+++.+||+.|
T Consensus       256 ~~Di~slG~il~el~~~~~~~~~~--------~~~~~~~~~~~----------~~----~~~~~~~~~~~~li~~~l~~~  313 (332)
T 3qd2_B          256 KVDIFSLGLILFELLYSFSTQMER--------VRIITDVRNLK----------FP----LLFTQKYPQEHMMVQDMLSPS  313 (332)
T ss_dssp             HHHHHHHHHHHHHHHSCCCCHHHH--------HHHHHHHHTTC----------CC----HHHHHHCHHHHHHHHHHHCSS
T ss_pred             hhhHHHHHHHHHHHHHcCCChhHH--------HHHHHHhhccC----------CC----cccccCChhHHHHHHHHccCC
Confidence            999999999999999987654211        11111111000          00    001233456789999999999


Q ss_pred             CCCCCCHHHHHH
Q 039626          605 PTDRPTMYEIEH  616 (628)
Q Consensus       605 P~~RPs~~ev~~  616 (628)
                      |++|||+.|+++
T Consensus       314 p~~Rps~~~~l~  325 (332)
T 3qd2_B          314 PTERPEATDIIE  325 (332)
T ss_dssp             GGGSCCHHHHHH
T ss_pred             CCcCCCHHHHhh
Confidence            999999999875

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=8.3e-37  Score=313.78  Aligned_cols=239  Identities=26%  Similarity=0.390  Sum_probs=185.2

Q ss_pred             eEEEEEEECC-----ceEEEEEecc--------chHHHHHHHhhcCCCceeeeeeeeec-CCeEEEEEEecCCCChHHHh
Q 039626          361 GSVYRGKING-----GFAAIKKVNG--------DVSKEIALLNKINHSNLIILSGVCFN-EGNCYLVYEYAVNGTLSDWV  426 (628)
Q Consensus       361 G~Vy~g~~~g-----~~vavK~~~~--------~~~~E~~~l~~l~H~nIv~l~g~~~~-~~~~~lV~E~~~~gsL~~~l  426 (628)
                      |.||+|++.+     ..+|+|+++.        .+.+|+.++++++|+||++++++|.. ++..++||||+++|+|.+++
T Consensus        39 g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~l  118 (298)
T 3f66_A           39 GCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI  118 (298)
T ss_dssp             EEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEEECCTTCBHHHHH
T ss_pred             ceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEEEeCCCCCCHHHHH
Confidence            8999998722     2589998863        36789999999999999999999754 56789999999999999999


Q ss_pred             hhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCc-ceeeecc
Q 039626          427 FSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGE-FALTRHI  505 (628)
Q Consensus       427 ~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~~  505 (628)
                      ..   ....+++..++.++.|++.||+|||+.   +++||||||+||++++++.+||+|||+++........ .......
T Consensus       119 ~~---~~~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~  192 (298)
T 3f66_A          119 RN---ETHNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGA  192 (298)
T ss_dssp             HC---TTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGGGCBC-----C
T ss_pred             Hh---cccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECcccccccccccchhccccccCC
Confidence            53   345689999999999999999999995   4999999999999999999999999999876433211 1122345


Q ss_pred             cCCccccCccccccCCCCcccccHHHHHHHHHHHhCCCc-cccccccccccHHHHHHHHhccccchhhhccccCCcCCCC
Q 039626          506 VGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEA-AALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGN  584 (628)
Q Consensus       506 ~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~  584 (628)
                      .+|+.|+|||.+.+..++.++||||||++++||++|+.| +.....   .....   .....          ...    .
T Consensus       193 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~---~~~~~---~~~~~----------~~~----~  252 (298)
T 3f66_A          193 KLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT---FDITV---YLLQG----------RRL----L  252 (298)
T ss_dssp             CBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCT---TTHHH---HHHTT----------CCC----C
T ss_pred             CCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCH---HHHHH---HHhcC----------CCC----C
Confidence            678899999999999999999999999999999995544 432211   11111   11110          001    1


Q ss_pred             CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhc
Q 039626          585 YPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNAS  625 (628)
Q Consensus       585 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~~~~  625 (628)
                      .+...+..+.+++.+||+.||.+|||+.|+++.|++++..-
T Consensus       253 ~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~  293 (298)
T 3f66_A          253 QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF  293 (298)
T ss_dssp             CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTS
T ss_pred             CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence            11223346889999999999999999999999999998753

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=2.3e-36  Score=313.87  Aligned_cols=242  Identities=24%  Similarity=0.369  Sum_probs=185.7

Q ss_pred             eEEEEEEE--CCceEEEEEecc--------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhcC
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG--------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNK  430 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~--------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~  430 (628)
                      |.||+|..  +|+.||+|+++.        .+.+|++++++++||||+++++++.+++..++||||++ |+|.+++....
T Consensus        19 g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~   97 (317)
T 2pmi_A           19 ATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEFMD-NDLKKYMDSRT   97 (317)
T ss_dssp             CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEECCC-CBHHHHHHHHH
T ss_pred             EEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEecC-CCHHHHHHhcc
Confidence            89999987  588999998852        36789999999999999999999999999999999997 69999986542


Q ss_pred             --CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCC
Q 039626          431 --NEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGT  508 (628)
Q Consensus       431 --~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt  508 (628)
                        .....+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++.......   ......||
T Consensus        98 ~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~t  171 (317)
T 2pmi_A           98 VGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVN---TFSSEVVT  171 (317)
T ss_dssp             SSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSSCEETTSCCC---CCCCCCSC
T ss_pred             ccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCccceecCCCcc---cCCCCccc
Confidence              2234589999999999999999999995   599999999999999999999999999987643221   12345789


Q ss_pred             ccccCcccccc-CCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccc--hhh-------------
Q 039626          509 KGYMAPEYLEN-GLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDG--EES-------------  572 (628)
Q Consensus       509 ~~Y~APE~l~~-~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~-------------  572 (628)
                      +.|+|||.+.+ ..++.++|||||||+++||++|+.||.......   ....+.........  ...             
T Consensus       172 ~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (317)
T 2pmi_A          172 LWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEE---QLKLIFDIMGTPNESLWPSVTKLPKYNPNIQQ  248 (317)
T ss_dssp             CTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCSCCTTTCGGGGGCTTCCTTCCC
T ss_pred             ccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHHhCCCChhHhhhhhhhhhccccccc
Confidence            99999999876 468999999999999999999999987543221   11111111111000  000             


Q ss_pred             -----hccccCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          573 -----LRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       573 -----l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                           +...+.+....    ..+..+.+++.+||+.||++|||++|+++
T Consensus       249 ~~~~~~~~~~~~~~~~----~~~~~l~~li~~~L~~dP~~Rpt~~e~l~  293 (317)
T 2pmi_A          249 RPPRDLRQVLQPHTKE----PLDGNLMDFLHGLLQLNPDMRLSAKQALH  293 (317)
T ss_dssp             CCCCCSHHHHGGGCSS----CCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             ccchhHHHhhcccccc----cCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence                 00111111111    22346889999999999999999999874

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=1.1e-37  Score=346.78  Aligned_cols=236  Identities=29%  Similarity=0.479  Sum_probs=191.0

Q ss_pred             eEEEEEEEC-CceEEEEEecc------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhcCCCC
Q 039626          361 GSVYRGKIN-GGFAAIKKVNG------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEG  433 (628)
Q Consensus       361 G~Vy~g~~~-g~~vavK~~~~------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~  433 (628)
                      |.||+|++. +..||||+++.      ++.+|+++|++++|+||+++++++.+ +..+|||||+++|+|.++|...  .+
T Consensus       281 g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~--~~  357 (535)
T 2h8h_A          281 GEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGE--TG  357 (535)
T ss_dssp             EEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTEEHHHHHSHH--HH
T ss_pred             eEEEEEEECCCceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehhcCCcHHHHHhhc--CC
Confidence            899999995 46799999874      47899999999999999999999976 6789999999999999999542  22


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCCccccC
Q 039626          434 KYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMA  513 (628)
Q Consensus       434 ~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~Y~A  513 (628)
                      ..+++..++.|+.||+.||+|||+.   +|+||||||+|||+++++.+||+|||+++......  ........++..|+|
T Consensus       358 ~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~--~~~~~~~~~~~~y~a  432 (535)
T 2h8h_A          358 KYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNE--YTARQGAKFPIKWTA  432 (535)
T ss_dssp             TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHH--HHTTCSTTSCGGGSC
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEcccccceecCCCc--eecccCCcCcccccC
Confidence            4589999999999999999999995   49999999999999999999999999998764321  111223457789999


Q ss_pred             ccccccCCCCcccccHHHHHHHHHHHh-CCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCHHHHHH
Q 039626          514 PEYLENGLVSTKLDVYAFGVLILEMLT-GKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALL  592 (628)
Q Consensus       514 PE~l~~~~~s~k~DV~SfGvvl~ELlt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~  592 (628)
                      ||.+.+..++.++||||||+++|||++ |+.|+.....      .+....+...              .+...+..++..
T Consensus       433 PE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~------~~~~~~i~~~--------------~~~~~~~~~~~~  492 (535)
T 2h8h_A          433 PEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN------REVLDQVERG--------------YRMPCPPECPES  492 (535)
T ss_dssp             HHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCH------HHHHHHHHTT--------------CCCCCCTTCCHH
T ss_pred             HHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH------HHHHHHHHcC--------------CCCCCCCCCCHH
Confidence            999999999999999999999999999 8888763221      1222222110              011122334456


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHHHHHHHhHhh
Q 039626          593 VIRLIDACLKKDPTDRPTMYEIEHSLSNILNA  624 (628)
Q Consensus       593 l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~~~  624 (628)
                      +.+|+.+||+.||++|||+++|++.|+.+..+
T Consensus       493 l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~  524 (535)
T 2h8h_A          493 LHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS  524 (535)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCC
T ss_pred             HHHHHHHHcCCChhHCcCHHHHHHHHHHHhhc
Confidence            88999999999999999999999999988754

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=9.8e-37  Score=315.66  Aligned_cols=240  Identities=23%  Similarity=0.407  Sum_probs=182.3

Q ss_pred             eEEEEEEEC-----CceEEEEEecc---------chHHHHHHHhhcCCCceeeeeeeeecCC-----eEEEEEEecCCCC
Q 039626          361 GSVYRGKIN-----GGFAAIKKVNG---------DVSKEIALLNKINHSNLIILSGVCFNEG-----NCYLVYEYAVNGT  421 (628)
Q Consensus       361 G~Vy~g~~~-----g~~vavK~~~~---------~~~~E~~~l~~l~H~nIv~l~g~~~~~~-----~~~lV~E~~~~gs  421 (628)
                      |.||+|.+.     +..||+|+++.         .+.+|++++++++||||+++++++.+.+     ..++||||+++|+
T Consensus        48 g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~v~e~~~~~~  127 (313)
T 3brb_A           48 GSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGD  127 (313)
T ss_dssp             CCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-------CEEEEEECCTTCB
T ss_pred             eEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCCcccEEEEecccCCC
Confidence            899999872     33799998863         3678999999999999999999998654     3599999999999


Q ss_pred             hHHHhhhcC--CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcc
Q 039626          422 LSDWVFSNK--NEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEF  499 (628)
Q Consensus       422 L~~~l~~~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~  499 (628)
                      |.+++....  .....+++..++.++.|++.||.|||+.   +++||||||+||+++.++.+||+|||+++....... .
T Consensus       128 L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~-~  203 (313)
T 3brb_A          128 LHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDY-Y  203 (313)
T ss_dssp             HHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTTSCEEECSCSCC----------
T ss_pred             HHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEEeecCcceecccccc-c
Confidence            999985433  2345699999999999999999999985   599999999999999999999999999987643221 1


Q ss_pred             eeeecccCCccccCccccccCCCCcccccHHHHHHHHHHHh-CCCccccccccccccHHHHHHHHhccccchhhhccccC
Q 039626          500 ALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT-GKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFID  578 (628)
Q Consensus       500 ~~~~~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELlt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d  578 (628)
                      .......+++.|+|||.+.+..++.++||||||++++||++ |+.|+.......   ..+   .....          ..
T Consensus       204 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~~~---~~~~~----------~~  267 (313)
T 3brb_A          204 RQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE---MYD---YLLHG----------HR  267 (313)
T ss_dssp             -------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---HHH---HHHTT----------CC
T ss_pred             CcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHH---HHH---HHHcC----------CC
Confidence            12233467889999999999999999999999999999999 887776432211   111   11110          01


Q ss_pred             CcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhh
Q 039626          579 PTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNA  624 (628)
Q Consensus       579 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~~~  624 (628)
                      +    ..+...+..+.+++.+||+.||.+||++.++++.|+++++.
T Consensus       268 ~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~  309 (313)
T 3brb_A          268 L----KQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLES  309 (313)
T ss_dssp             C----CCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             C----CCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence            1    11223345688999999999999999999999999999865

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=1.1e-37  Score=318.80  Aligned_cols=231  Identities=19%  Similarity=0.359  Sum_probs=183.1

Q ss_pred             eEEEEEEEC--C-------ceEEEEEecc-------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHH
Q 039626          361 GSVYRGKIN--G-------GFAAIKKVNG-------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSD  424 (628)
Q Consensus       361 G~Vy~g~~~--g-------~~vavK~~~~-------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~  424 (628)
                      |.||+|...  +       ..+|+|.+..       .+.+|++++++++|+||+++++++.+++..++||||+++|+|.+
T Consensus        22 g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~  101 (289)
T 4fvq_A           22 TKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDT  101 (289)
T ss_dssp             EEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCCEEEEECCTTCBHHH
T ss_pred             ceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCCEEEEECCCCCCHHH
Confidence            899999873  3       4699999853       36789999999999999999999999999999999999999999


Q ss_pred             HhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCc--------EEEccccccccCCCCC
Q 039626          425 WVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLR--------AKIANFAMARPAEGQE  496 (628)
Q Consensus       425 ~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~--------~kl~Dfgla~~~~~~~  496 (628)
                      ++...   ...+++..++.++.|++.||+|||+.   +++||||||+|||++.++.        +||+|||+++..... 
T Consensus       102 ~l~~~---~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-  174 (289)
T 4fvq_A          102 YLKKN---KNCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPK-  174 (289)
T ss_dssp             HHHHT---GGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBCCEEEECCCCSCTTTSCH-
T ss_pred             HHHhC---CCCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCcccccccceeeeccCcccccccCc-
Confidence            99642   33489999999999999999999995   4999999999999998887        999999998765321 


Q ss_pred             CcceeeecccCCccccCcccccc-CCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhcc
Q 039626          497 GEFALTRHIVGTKGYMAPEYLEN-GLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRH  575 (628)
Q Consensus       497 ~~~~~~~~~~gt~~Y~APE~l~~-~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  575 (628)
                            ....||+.|+|||.+.+ ..++.++||||||+++|||++|+.++.....     ..........          
T Consensus       175 ------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~-----~~~~~~~~~~----------  233 (289)
T 4fvq_A          175 ------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALD-----SQRKLQFYED----------  233 (289)
T ss_dssp             ------HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSC-----HHHHHHHHHT----------
T ss_pred             ------cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccc-----hHHHHHHhhc----------
Confidence                  23458899999999987 7799999999999999999997655432211     1111111100          


Q ss_pred             ccCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhc
Q 039626          576 FIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNAS  625 (628)
Q Consensus       576 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~~~~  625 (628)
                        .......    .+..+.+++.+||+.||.+|||+.|+++.|++++.+.
T Consensus       234 --~~~~~~~----~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~  277 (289)
T 4fvq_A          234 --RHQLPAP----KAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPD  277 (289)
T ss_dssp             --TCCCCCC----SSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC---
T ss_pred             --cCCCCCC----CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCC
Confidence              0011111    1234789999999999999999999999999998754

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.7e-36  Score=324.84  Aligned_cols=254  Identities=22%  Similarity=0.322  Sum_probs=198.7

Q ss_pred             eEEEEEEE--CCceEEEEEecc--------chHHHHHHHhhcCCCceeeeeeeeecCC--eEEEEEEecCCCChHHHhhh
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG--------DVSKEIALLNKINHSNLIILSGVCFNEG--NCYLVYEYAVNGTLSDWVFS  428 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~--------~~~~E~~~l~~l~H~nIv~l~g~~~~~~--~~~lV~E~~~~gsL~~~l~~  428 (628)
                      |.||+|..  +|+.||||+++.        .+.+|++++++++|+||+++++++...+  ..++||||+++|+|.+++..
T Consensus        23 g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~  102 (396)
T 4eut_A           23 ANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEE  102 (396)
T ss_dssp             EEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEECCCTTEEHHHHTTS
T ss_pred             eEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEEecCCCCCHHHHHHh
Confidence            89999998  488999999864        3568999999999999999999998654  78999999999999999964


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEe----CCCCcEEEccccccccCCCCCCcceeeec
Q 039626          429 NKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLL----DSDLRAKIANFAMARPAEGQEGEFALTRH  504 (628)
Q Consensus       429 ~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl----~~~~~~kl~Dfgla~~~~~~~~~~~~~~~  504 (628)
                      ... ...+++..++.++.|++.||+|||+.   +|+||||||+|||+    +.++.+||+|||+++......    ....
T Consensus       103 ~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~~~~----~~~~  174 (396)
T 4eut_A          103 PSN-AYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE----QFVS  174 (396)
T ss_dssp             GGG-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCGGGCEECCCGG----GSSC
T ss_pred             hhc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecCCCceEccCCC----cccc
Confidence            322 23499999999999999999999995   49999999999999    888889999999998764322    1234


Q ss_pred             ccCCccccCcccccc--------CCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccch--hhhc
Q 039626          505 IVGTKGYMAPEYLEN--------GLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGE--ESLR  574 (628)
Q Consensus       505 ~~gt~~Y~APE~l~~--------~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--~~l~  574 (628)
                      ..||+.|+|||.+.+        ..++.++|||||||++|||++|+.||........  ..+....+.......  ..+.
T Consensus       175 ~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~--~~~~~~~~~~~~p~~~~~~~~  252 (396)
T 4eut_A          175 LYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRR--NKEVMYKIITGKPSGAISGVQ  252 (396)
T ss_dssp             SSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTT--CHHHHHHHHHSCCTTCCEEEE
T ss_pred             ccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccc--hHHHHHHHhcCCCcccchhhe
Confidence            579999999999865        5678899999999999999999999975433221  223333333221100  0000


Q ss_pred             c-------cc-CCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhh
Q 039626          575 H-------FI-DPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNA  624 (628)
Q Consensus       575 ~-------~~-d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~~~  624 (628)
                      .       +. +.......+......+.+++.+||+.||++||+++|+++.++++++.
T Consensus       253 ~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~  310 (396)
T 4eut_A          253 KAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR  310 (396)
T ss_dssp             CSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred             eccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence            0       00 11112345578888999999999999999999999999999999864

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.3e-37  Score=327.60  Aligned_cols=239  Identities=27%  Similarity=0.409  Sum_probs=178.1

Q ss_pred             eEEEEEEE--CC---ceEEEEEecc--------chHHHHHHHhhcCCCceeeeeeeeec-CCeEEEEEEecCCCChHHHh
Q 039626          361 GSVYRGKI--NG---GFAAIKKVNG--------DVSKEIALLNKINHSNLIILSGVCFN-EGNCYLVYEYAVNGTLSDWV  426 (628)
Q Consensus       361 G~Vy~g~~--~g---~~vavK~~~~--------~~~~E~~~l~~l~H~nIv~l~g~~~~-~~~~~lV~E~~~~gsL~~~l  426 (628)
                      |.||+|++  ++   ..+|+|.++.        ++.+|+.++++++||||++++++|.. ++..++||||+++|+|.+++
T Consensus       103 g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~e~~~~g~L~~~l  182 (373)
T 3c1x_A          103 GCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI  182 (373)
T ss_dssp             SEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEEECCTTCBHHHHH
T ss_pred             eEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEEECCCCCCHHHHH
Confidence            89999987  22   3579998753        36789999999999999999999764 45789999999999999999


Q ss_pred             hhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCc-ceeeecc
Q 039626          427 FSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGE-FALTRHI  505 (628)
Q Consensus       427 ~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~~  505 (628)
                      ..   ....+++..++.++.|++.||+|||+.   +|+||||||+|||+++++.+||+|||+++........ .......
T Consensus       183 ~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~  256 (373)
T 3c1x_A          183 RN---ETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGA  256 (373)
T ss_dssp             HC---TTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC--------------------
T ss_pred             hh---cccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeeccccccccccccccccccCCC
Confidence            53   334589999999999999999999995   4999999999999999999999999999876433211 1112334


Q ss_pred             cCCccccCccccccCCCCcccccHHHHHHHHHHHh-CCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCC
Q 039626          506 VGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT-GKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGN  584 (628)
Q Consensus       506 ~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELlt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~  584 (628)
                      .+|+.|+|||.+.+..++.++||||||+++|||++ |..|+......   .....+   ...          ...    .
T Consensus       257 ~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~---~~~~~~---~~~----------~~~----~  316 (373)
T 3c1x_A          257 KLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF---DITVYL---LQG----------RRL----L  316 (373)
T ss_dssp             -CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSS---CHHHHH---HTT----------CCC----C
T ss_pred             CCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHH---HHHHHH---HcC----------CCC----C
Confidence            67889999999999999999999999999999999 55555432211   111111   110          001    1


Q ss_pred             CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhc
Q 039626          585 YPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNAS  625 (628)
Q Consensus       585 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~~~~  625 (628)
                      .+...+..+.+++.+||+.||++||++.|+++.|++++.+-
T Consensus       317 ~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~  357 (373)
T 3c1x_A          317 QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF  357 (373)
T ss_dssp             CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred             CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence            12223456889999999999999999999999999998653

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=1.6e-36  Score=323.63  Aligned_cols=239  Identities=24%  Similarity=0.317  Sum_probs=190.4

Q ss_pred             cCCCcCCccc----eEEEEEEE--CCceEEEEEecc-------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEec
Q 039626          351 DNFSFTCRIQ----GSVYRGKI--NGGFAAIKKVNG-------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYA  417 (628)
Q Consensus       351 ~~f~~~~~i~----G~Vy~g~~--~g~~vavK~~~~-------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~  417 (628)
                      +.|.....+|    |.||++..  +|+.+|+|.+..       .+.+|+++|++++|+||+++++++.+++..++||||+
T Consensus        51 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~  130 (387)
T 1kob_A           51 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL  130 (387)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred             cceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcC
Confidence            3455444454    89999998  578899998864       3678999999999999999999999999999999999


Q ss_pred             CCCChHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCC--CCcEEEccccccccCCCC
Q 039626          418 VNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDS--DLRAKIANFAMARPAEGQ  495 (628)
Q Consensus       418 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~--~~~~kl~Dfgla~~~~~~  495 (628)
                      ++|+|.+++..   ....+++..+..++.|++.||+|||+.   +|+||||||+|||++.  ++.+||+|||+++.....
T Consensus       131 ~gg~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~  204 (387)
T 1kob_A          131 SGGELFDRIAA---EDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD  204 (387)
T ss_dssp             CCCBHHHHTTC---TTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred             CCCcHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecccceecCCC
Confidence            99999999843   234699999999999999999999995   4999999999999974  578999999999876533


Q ss_pred             CCcceeeecccCCccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhcc
Q 039626          496 EGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRH  575 (628)
Q Consensus       496 ~~~~~~~~~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  575 (628)
                      .    ......||+.|+|||.+.+..++.++|||||||++|||++|+.|+.....      .+....+.....       
T Consensus       205 ~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~------~~~~~~i~~~~~-------  267 (387)
T 1kob_A          205 E----IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD------LETLQNVKRCDW-------  267 (387)
T ss_dssp             S----CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH------HHHHHHHHHCCC-------
T ss_pred             c----ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCH------HHHHHHHHhCCC-------
Confidence            2    12345799999999999999999999999999999999999999864321      122222211110       


Q ss_pred             ccCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          576 FIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       576 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      ..++.    .....+..+.+++.+||+.||.+|||+.|+++
T Consensus       268 ~~~~~----~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  304 (387)
T 1kob_A          268 EFDED----AFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE  304 (387)
T ss_dssp             CCCSS----TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             CCCcc----ccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence            01111    11223456789999999999999999999975

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=2.4e-36  Score=318.43  Aligned_cols=230  Identities=25%  Similarity=0.364  Sum_probs=185.8

Q ss_pred             cCCCcCCccc----eEEEEEEE--CCceEEEEEeccc----------hHHHHHHHhhc-CCCceeeeeeeeecCCeEEEE
Q 039626          351 DNFSFTCRIQ----GSVYRGKI--NGGFAAIKKVNGD----------VSKEIALLNKI-NHSNLIILSGVCFNEGNCYLV  413 (628)
Q Consensus       351 ~~f~~~~~i~----G~Vy~g~~--~g~~vavK~~~~~----------~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV  413 (628)
                      ++|.....+|    |.||+++.  +|+.+|+|.++..          +..|.++|..+ +|+||+++++++.+.+..|+|
T Consensus        20 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv   99 (353)
T 2i0e_A           20 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFV   99 (353)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEE
T ss_pred             HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEE
Confidence            4455444554    89999998  4678999998642          45789999988 899999999999999999999


Q ss_pred             EEecCCCChHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCC
Q 039626          414 YEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAE  493 (628)
Q Consensus       414 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~  493 (628)
                      |||+++|+|.+++...    ..+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++...
T Consensus       100 ~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~  172 (353)
T 2i0e_A          100 MEYVNGGDLMYHIQQV----GRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENI  172 (353)
T ss_dssp             EECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred             EeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCCcccccc
Confidence            9999999999999643    3489999999999999999999995   49999999999999999999999999998643


Q ss_pred             CCCCcceeeecccCCccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhh
Q 039626          494 GQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESL  573 (628)
Q Consensus       494 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  573 (628)
                      ...   .......||+.|+|||.+.+..++.++|||||||++|||++|+.||.....      .+....+....      
T Consensus       173 ~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~------~~~~~~i~~~~------  237 (353)
T 2i0e_A          173 WDG---VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE------DELFQSIMEHN------  237 (353)
T ss_dssp             CTT---CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHCC------
T ss_pred             cCC---cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCH------HHHHHHHHhCC------
Confidence            221   123456799999999999999999999999999999999999999864321      12222222110      


Q ss_pred             ccccCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCH
Q 039626          574 RHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTM  611 (628)
Q Consensus       574 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~  611 (628)
                               ..+|...+..+.+++.+||+.||.+||+.
T Consensus       238 ---------~~~p~~~s~~~~~li~~lL~~dP~~R~~~  266 (353)
T 2i0e_A          238 ---------VAYPKSMSKEAVAICKGLMTKHPGKRLGC  266 (353)
T ss_dssp             ---------CCCCTTSCHHHHHHHHHHTCSCTTSCTTC
T ss_pred             ---------CCCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence                     11223345568899999999999999975

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=2.9e-36  Score=317.48  Aligned_cols=231  Identities=23%  Similarity=0.331  Sum_probs=188.3

Q ss_pred             CCCcCCccc----eEEEEEEE--CCceEEEEEecc----------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEE
Q 039626          352 NFSFTCRIQ----GSVYRGKI--NGGFAAIKKVNG----------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYE  415 (628)
Q Consensus       352 ~f~~~~~i~----G~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  415 (628)
                      +|.....+|    |.||+++.  +|+.+|+|.++.          .+.+|+++|++++||||+++++++.+++..++|||
T Consensus        42 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e  121 (350)
T 1rdq_E           42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVME  121 (350)
T ss_dssp             GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             HCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEc
Confidence            444444443    89999998  588999999853          25679999999999999999999999999999999


Q ss_pred             ecCCCChHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCC
Q 039626          416 YAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQ  495 (628)
Q Consensus       416 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~  495 (628)
                      |+++|+|.+++...    ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++.....
T Consensus       122 ~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~  194 (350)
T 1rdq_E          122 YVAGGEMFSHLRRI----GRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR  194 (350)
T ss_dssp             CCTTCBHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred             CCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcccccceeccCC
Confidence            99999999999643    3489999999999999999999995   4999999999999999999999999999876432


Q ss_pred             CCcceeeecccCCccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhcc
Q 039626          496 EGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRH  575 (628)
Q Consensus       496 ~~~~~~~~~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  575 (628)
                            .....||+.|+|||.+.+..++.++|||||||+++||++|+.||.....      .+....+....        
T Consensus       195 ------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~------~~~~~~i~~~~--------  254 (350)
T 1rdq_E          195 ------TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP------IQIYEKIVSGK--------  254 (350)
T ss_dssp             ------BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHCC--------
T ss_pred             ------cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCH------HHHHHHHHcCC--------
Confidence                  2335799999999999999999999999999999999999999864321      12222222110        


Q ss_pred             ccCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 039626          576 FIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPT-----MYEIEH  616 (628)
Q Consensus       576 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~ev~~  616 (628)
                         .    .++...+..+.+++.+||+.||.+||+     ++||++
T Consensus       255 ---~----~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~  293 (350)
T 1rdq_E          255 ---V----RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             ---C----CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             ---C----CCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence               0    122233456789999999999999998     777653

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=7.2e-37  Score=318.93  Aligned_cols=235  Identities=21%  Similarity=0.291  Sum_probs=167.7

Q ss_pred             eEEEEEEE--CCceEEEEEecc----chHHHHHHHhhcC-CCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhcCCCC
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG----DVSKEIALLNKIN-HSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEG  433 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~----~~~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~  433 (628)
                      |.||++..  +|+.+|||++..    ++.+|+.++++++ ||||+++++++.+++..++||||+++|+|.+++..    .
T Consensus        25 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~  100 (325)
T 3kn6_A           25 SICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKK----K  100 (325)
T ss_dssp             EEEEEEEETTTCCEEEEEEEEGGGHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHH----C
T ss_pred             eEEEEEEECCCCCEEEEEEEChhhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcHHHHHHh----c
Confidence            89999998  588999999875    3567999999997 99999999999999999999999999999999964    3


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCC---cEEEccccccccCCCCCCcceeeecccCCcc
Q 039626          434 KYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDL---RAKIANFAMARPAEGQEGEFALTRHIVGTKG  510 (628)
Q Consensus       434 ~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~---~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~  510 (628)
                      ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++   .+||+|||+++.......   ......||+.
T Consensus       101 ~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~~t~~  174 (325)
T 3kn6_A          101 KHFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ---PLKTPCFTLH  174 (325)
T ss_dssp             SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC----------------
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC---cccccCCCcC
Confidence            4599999999999999999999995   599999999999997765   899999999986543221   2234578999


Q ss_pred             ccCccccccCCCCcccccHHHHHHHHHHHhCCCcccccccccc-ccHHHHHHHHhccccchhhhccccCCcCCCCCCHHH
Q 039626          511 YMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENN-MHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLEL  589 (628)
Q Consensus       511 Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~  589 (628)
                      |+|||.+.+..++.++||||||++++||++|+.||........ ....+....+.....           ..........
T Consensus       175 y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~-----------~~~~~~~~~~  243 (325)
T 3kn6_A          175 YAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDF-----------SFEGEAWKNV  243 (325)
T ss_dssp             ---------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCC-----------CCCSHHHHTS
T ss_pred             ccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCC-----------CCCcccccCC
Confidence            9999999999999999999999999999999999875433211 112222222211110           0000001123


Q ss_pred             HHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          590 ALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       590 ~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      +..+.+|+.+||+.||.+|||+.|+++
T Consensus       244 s~~~~~li~~~L~~dP~~Rpt~~ell~  270 (325)
T 3kn6_A          244 SQEAKDLIQGLLTVDPNKRLKMSGLRY  270 (325)
T ss_dssp             CHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred             CHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence            456889999999999999999998863

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=4.4e-37  Score=330.23  Aligned_cols=261  Identities=23%  Similarity=0.309  Sum_probs=200.9

Q ss_pred             eecHHHHHHHhcCCCcCCccc----eEEEEEEE--CCceEEEEEecc----------chHHHHHHHhhcCCCceeeeeee
Q 039626          340 VYSFKELQSATDNFSFTCRIQ----GSVYRGKI--NGGFAAIKKVNG----------DVSKEIALLNKINHSNLIILSGV  403 (628)
Q Consensus       340 ~~~~~el~~at~~f~~~~~i~----G~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~nIv~l~g~  403 (628)
                      .+.++++....++|.....+|    |.||+++.  +|+.+|+|++++          .+.+|.+++.+++|+||++++++
T Consensus        50 ~~~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~  129 (412)
T 2vd5_A           50 VVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFA  129 (412)
T ss_dssp             HHHHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEE
T ss_pred             hhhhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEE
Confidence            355667777788888777775    89999998  688999999863          36789999999999999999999


Q ss_pred             eecCCeEEEEEEecCCCChHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEE
Q 039626          404 CFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKI  483 (628)
Q Consensus       404 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl  483 (628)
                      +.+++..||||||+++|+|.+++...   +..+++..+..++.+|+.||+|||+.   +|+||||||+|||++.++.+||
T Consensus       130 ~~~~~~~~lVmE~~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL  203 (412)
T 2vd5_A          130 FQDENYLYLVMEYYVGGDLLTLLSKF---GERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRL  203 (412)
T ss_dssp             EECSSEEEEEECCCCSCBHHHHHHHH---SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEE
T ss_pred             EeeCCEEEEEEcCCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEE
Confidence            99999999999999999999999643   23589999999999999999999995   4999999999999999999999


Q ss_pred             ccccccccCCCCCCcceeeecccCCccccCccccc-------cCCCCcccccHHHHHHHHHHHhCCCccccccccccccH
Q 039626          484 ANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLE-------NGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHL  556 (628)
Q Consensus       484 ~Dfgla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~-------~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~  556 (628)
                      +|||+++.......  .......||+.|+|||++.       ...++.++|||||||++|||++|+.||.....      
T Consensus       204 ~DFGla~~~~~~~~--~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~------  275 (412)
T 2vd5_A          204 ADFGSCLKLRADGT--VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADST------  275 (412)
T ss_dssp             CCCTTCEECCTTSC--EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSH------
T ss_pred             eechhheeccCCCc--cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCH------
Confidence            99999987643321  1223458999999999987       45789999999999999999999999864322      


Q ss_pred             HHHHHHHhccccchhhhccccCCcCCCCCCHHHHHHHHHHHHHhcccCCCCC---CCHHHHHHHHHHhHhhccCC
Q 039626          557 SDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDR---PTMYEIEHSLSNILNASLNW  628 (628)
Q Consensus       557 ~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~R---Ps~~ev~~~L~~l~~~~~~w  628 (628)
                      .+....+....   .   ...-|...    ...+..+.+|+.+||. +|.+|   |+++|+++   .-.-..+||
T Consensus       276 ~~~~~~i~~~~---~---~~~~p~~~----~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~---Hpff~~i~w  336 (412)
T 2vd5_A          276 AETYGKIVHYK---E---HLSLPLVD----EGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT---HPFFFGLDW  336 (412)
T ss_dssp             HHHHHHHHTHH---H---HCCCC--------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT---SGGGTTCCS
T ss_pred             HHHHHHHHhcc---c---CcCCCccc----cCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc---CCCcCCCCH
Confidence            11222221100   0   00011111    1234567899999999 99998   57777643   333344555

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=1.4e-36  Score=322.90  Aligned_cols=229  Identities=24%  Similarity=0.336  Sum_probs=185.4

Q ss_pred             eEEEEEEE--CCceEEEEEecc-------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhcCC
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG-------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKN  431 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~-------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~  431 (628)
                      |.||++..  +|..||+|+++.       ++.+|+++|++++|+||+++++++.+++..+|||||+++|+|.+++...  
T Consensus       103 g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~--  180 (373)
T 2x4f_A          103 GQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDE--  180 (373)
T ss_dssp             -CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEEHHHHHHT--
T ss_pred             EEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcHHHHHHhc--
Confidence            89999998  688999998864       4678999999999999999999999999999999999999999998642  


Q ss_pred             CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEe--CCCCcEEEccccccccCCCCCCcceeeecccCCc
Q 039626          432 EGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLL--DSDLRAKIANFAMARPAEGQEGEFALTRHIVGTK  509 (628)
Q Consensus       432 ~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl--~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~  509 (628)
                       ...+++..+..++.|++.||+|||+.   +|+||||||+|||+  +.++.+||+|||+++......    ......||+
T Consensus       181 -~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~----~~~~~~gt~  252 (373)
T 2x4f_A          181 -SYNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE----KLKVNFGTP  252 (373)
T ss_dssp             -GGGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC----BCCCCCSSC
T ss_pred             -CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc----ccccccCCC
Confidence             34589999999999999999999995   49999999999999  677899999999998765332    123346999


Q ss_pred             cccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCHHH
Q 039626          510 GYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLEL  589 (628)
Q Consensus       510 ~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~  589 (628)
                      .|+|||.+.+..++.++|||||||+++||++|+.||.....      .+.+..+......       +.+...    ...
T Consensus       253 ~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~------~~~~~~i~~~~~~-------~~~~~~----~~~  315 (373)
T 2x4f_A          253 EFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDND------AETLNNILACRWD-------LEDEEF----QDI  315 (373)
T ss_dssp             TTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHHHTCCC-------SCSGGG----TTS
T ss_pred             cEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHhccCC-------CChhhh----ccC
Confidence            99999999999999999999999999999999999864322      1222222211100       000001    123


Q ss_pred             HHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          590 ALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       590 ~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      +..+.+|+.+||+.||.+||++.|+++
T Consensus       316 ~~~~~~li~~~L~~dp~~Rps~~e~l~  342 (373)
T 2x4f_A          316 SEEAKEFISKLLIKEKSWRISASEALK  342 (373)
T ss_dssp             CHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             CHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            356789999999999999999999986

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=9.1e-37  Score=319.57  Aligned_cols=219  Identities=23%  Similarity=0.332  Sum_probs=182.3

Q ss_pred             eEEEEEEE--CCceEEEEEecc---------------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCC-Ch
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG---------------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNG-TL  422 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~---------------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~g-sL  422 (628)
                      |.||++..  +++.||||+++.               .+.+|++++++++|+||+++++++.+++..++||||+.+| +|
T Consensus        38 g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~~g~~l  117 (335)
T 3dls_A           38 GFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDL  117 (335)
T ss_dssp             CSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTSCBH
T ss_pred             EEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCEEEEEEEeCCCCccH
Confidence            89999987  788999998753               3567999999999999999999999999999999999777 99


Q ss_pred             HHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceee
Q 039626          423 SDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALT  502 (628)
Q Consensus       423 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~  502 (628)
                      .+++..    ...+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++......    ..
T Consensus       118 ~~~~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~----~~  186 (335)
T 3dls_A          118 FAFIDR----HPRLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGK----LF  186 (335)
T ss_dssp             HHHHHT----CCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECCTTC----CB
T ss_pred             HHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEEeecccceECCCCC----ce
Confidence            999853    34599999999999999999999995   49999999999999999999999999998765432    12


Q ss_pred             ecccCCccccCccccccCCC-CcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcC
Q 039626          503 RHIVGTKGYMAPEYLENGLV-STKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTL  581 (628)
Q Consensus       503 ~~~~gt~~Y~APE~l~~~~~-s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l  581 (628)
                      ....||+.|+|||.+.+..+ +.++||||||+++|||++|+.|+......                     ......   
T Consensus       187 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---------------------~~~~~~---  242 (335)
T 3dls_A          187 YTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET---------------------VEAAIH---  242 (335)
T ss_dssp             CEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG---------------------TTTCCC---
T ss_pred             eccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH---------------------HhhccC---
Confidence            34579999999999988776 88999999999999999999998632110                     000000   


Q ss_pred             CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 039626          582 QGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHS  617 (628)
Q Consensus       582 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~  617 (628)
                         .+...+..+.+++.+||+.||++|||+.|+++.
T Consensus       243 ---~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h  275 (335)
T 3dls_A          243 ---PPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD  275 (335)
T ss_dssp             ---CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred             ---CCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence               111233557899999999999999999999863

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=3.8e-36  Score=318.50  Aligned_cols=246  Identities=14%  Similarity=0.154  Sum_probs=196.2

Q ss_pred             cCCCcCCccc----eEEEEEE-------ECCceEEEEEecc----chHHHHHHHhhcC---CCceeeeeeeeecCCeEEE
Q 039626          351 DNFSFTCRIQ----GSVYRGK-------INGGFAAIKKVNG----DVSKEIALLNKIN---HSNLIILSGVCFNEGNCYL  412 (628)
Q Consensus       351 ~~f~~~~~i~----G~Vy~g~-------~~g~~vavK~~~~----~~~~E~~~l~~l~---H~nIv~l~g~~~~~~~~~l  412 (628)
                      +.|.....+|    |.||+|.       ..++.||+|+++.    ++..|++++.+++   |+||+++++++..++..++
T Consensus        65 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~~l  144 (365)
T 3e7e_A           65 KLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVL  144 (365)
T ss_dssp             SEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSCEEE
T ss_pred             EEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCCcEE
Confidence            4444444443    8999993       2688999999975    4667888888887   9999999999999999999


Q ss_pred             EEEecCCCChHHHhhhcCC-CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCC-----------CCc
Q 039626          413 VYEYAVNGTLSDWVFSNKN-EGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDS-----------DLR  480 (628)
Q Consensus       413 V~E~~~~gsL~~~l~~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~-----------~~~  480 (628)
                      ||||+++|+|.+++..... ....++|..++.|+.|++.||+|||+.   +|+||||||+|||++.           ++.
T Consensus       145 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~~~~~~~~~~~~  221 (365)
T 3e7e_A          145 VGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSAG  221 (365)
T ss_dssp             EECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGTCC------CTT
T ss_pred             EEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccccCccccccccCC
Confidence            9999999999999965432 345699999999999999999999995   4999999999999998           899


Q ss_pred             EEEccccccccCCCCCCcceeeecccCCccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHH
Q 039626          481 AKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVL  560 (628)
Q Consensus       481 ~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~  560 (628)
                      +||+|||+++........ .......||++|+|||++.+..++.++|||||||++|||++|+.|+.......        
T Consensus       222 ~kl~DFG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~--------  292 (365)
T 3e7e_A          222 LALIDLGQSIDMKLFPKG-TIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE--------  292 (365)
T ss_dssp             EEECCCTTCEEGGGSCTT-EEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE--------
T ss_pred             EEEeeCchhhhhhccCCC-ceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc--------
Confidence            999999999765422211 23345679999999999999999999999999999999999999886432211        


Q ss_pred             HHHhccccchhhhccccCCcCCCCCCHHHHHHHHHHHHHhcccCCCCC-CCHHHHHHHHHHhHhhc
Q 039626          561 NAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDR-PTMYEIEHSLSNILNAS  625 (628)
Q Consensus       561 ~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~R-Ps~~ev~~~L~~l~~~~  625 (628)
                                ..+.    ..+.. ++  ....+.+++..|++.+|.+| |+++++.+.|++++...
T Consensus       293 ----------~~~~----~~~~~-~~--~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~  341 (365)
T 3e7e_A          293 ----------CKPE----GLFRR-LP--HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQH  341 (365)
T ss_dssp             ----------EEEC----SCCTT-CS--SHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHH
T ss_pred             ----------eeec----hhccc-cC--cHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHh
Confidence                      0011    11111 11  13456789999999999998 78999999999888654

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=1.5e-36  Score=318.86  Aligned_cols=235  Identities=28%  Similarity=0.403  Sum_probs=189.3

Q ss_pred             hcCCCcCCccc----eEEEEEEE--CCceEEEEEeccc----------hHHHHHHHhhc-CCCceeeeeeeeecCCeEEE
Q 039626          350 TDNFSFTCRIQ----GSVYRGKI--NGGFAAIKKVNGD----------VSKEIALLNKI-NHSNLIILSGVCFNEGNCYL  412 (628)
Q Consensus       350 t~~f~~~~~i~----G~Vy~g~~--~g~~vavK~~~~~----------~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~l  412 (628)
                      .++|.....+|    |.||+++.  +|+.+|+|+++.+          +..|.+++.++ +||||+++++++.+.+..++
T Consensus        16 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~l   95 (345)
T 1xjd_A           16 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF   95 (345)
T ss_dssp             CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEE
Confidence            45565555554    89999998  5889999998642          45688899887 99999999999999999999


Q ss_pred             EEEecCCCChHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccC
Q 039626          413 VYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPA  492 (628)
Q Consensus       413 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~  492 (628)
                      ||||+++|+|.+++...    ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++..
T Consensus        96 v~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~  168 (345)
T 1xjd_A           96 VMEYLNGGDLMYHIQSC----HKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKEN  168 (345)
T ss_dssp             EEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred             EEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeEChhhhhc
Confidence            99999999999999642    3589999999999999999999995   4999999999999999999999999999864


Q ss_pred             CCCCCcceeeecccCCccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhh
Q 039626          493 EGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEES  572 (628)
Q Consensus       493 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  572 (628)
                      ....   .......||+.|+|||.+.+..++.++|||||||++|||++|+.||.....      .+....+...      
T Consensus       169 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~------~~~~~~i~~~------  233 (345)
T 1xjd_A          169 MLGD---AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE------EELFHSIRMD------  233 (345)
T ss_dssp             CCTT---CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHC------
T ss_pred             ccCC---CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCH------HHHHHHHHhC------
Confidence            3222   123456899999999999999999999999999999999999999864322      1222222111      


Q ss_pred             hccccCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHH-HHH
Q 039626          573 LRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMY-EIE  615 (628)
Q Consensus       573 l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~-ev~  615 (628)
                           .+    .++...+..+.+++.+||+.||.+||++. |+.
T Consensus       234 -----~~----~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~  268 (345)
T 1xjd_A          234 -----NP----FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR  268 (345)
T ss_dssp             -----CC----CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred             -----CC----CCCcccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence                 01    12223345678999999999999999997 553

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=8.9e-37  Score=310.83  Aligned_cols=230  Identities=24%  Similarity=0.439  Sum_probs=188.5

Q ss_pred             eEEEEEEE--CCceEEEEEecc---chHHHHHHHhhcCCCceeeeeeeeec----------------CCeEEEEEEecCC
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG---DVSKEIALLNKINHSNLIILSGVCFN----------------EGNCYLVYEYAVN  419 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~---~~~~E~~~l~~l~H~nIv~l~g~~~~----------------~~~~~lV~E~~~~  419 (628)
                      |.||+++.  +|+.+|+|+++.   .+.+|++++++++||||+++++++..                ....++||||+++
T Consensus        25 g~V~~~~~~~~~~~vavK~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~  104 (284)
T 2a19_B           25 GQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDK  104 (284)
T ss_dssp             CCEEEEEETTTCCEEEEEEEECCSGGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---------CCEEEEEEEEECCCCS
T ss_pred             eEEEEEEEcCCCeEEEEEEeccccHHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccccccccCcceEEEEEeccCC
Confidence            89999998  588999999863   58899999999999999999999864                3458999999999


Q ss_pred             CChHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcc
Q 039626          420 GTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEF  499 (628)
Q Consensus       420 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~  499 (628)
                      |+|.+++....  ...+++..++.++.|++.||.|||+.   +++||||||+||++++++.+||+|||+++.......  
T Consensus       105 ~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--  177 (284)
T 2a19_B          105 GTLEQWIEKRR--GEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGK--  177 (284)
T ss_dssp             CBHHHHHHHGG--GSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEESSCCSC--
T ss_pred             CCHHHHHhhcc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEcCCCCEEECcchhheecccccc--
Confidence            99999996532  34689999999999999999999995   499999999999999999999999999987654321  


Q ss_pred             eeeecccCCccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCC
Q 039626          500 ALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDP  579 (628)
Q Consensus       500 ~~~~~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~  579 (628)
                        .....||+.|+|||.+.+..++.++||||||++++||++|+.|+....        ......             .+.
T Consensus       178 --~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~--------~~~~~~-------------~~~  234 (284)
T 2a19_B          178 --RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETS--------KFFTDL-------------RDG  234 (284)
T ss_dssp             --CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHH--------HHHHHH-------------HTT
T ss_pred             --ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHH--------HHHHHh-------------hcc
Confidence              233469999999999999999999999999999999999998764211        111111             011


Q ss_pred             cCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhh
Q 039626          580 TLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNA  624 (628)
Q Consensus       580 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~~~  624 (628)
                      .....+    +..+.+++.+||+.||.+||++.|+++.|+.+..+
T Consensus       235 ~~~~~~----~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~  275 (284)
T 2a19_B          235 IISDIF----DKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKS  275 (284)
T ss_dssp             CCCTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-
T ss_pred             cccccC----CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhC
Confidence            111222    34578999999999999999999999999987654

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=2.3e-36  Score=309.25  Aligned_cols=243  Identities=25%  Similarity=0.339  Sum_probs=181.0

Q ss_pred             eEEEEEEE-CCceEEEEEecc---------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhcC
Q 039626          361 GSVYRGKI-NGGFAAIKKVNG---------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNK  430 (628)
Q Consensus       361 G~Vy~g~~-~g~~vavK~~~~---------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~  430 (628)
                      |.||+++. .|+.+|+|+++.         .+.+|++++++++||||+++++++.+++..++||||+++ +|.+++... 
T Consensus        16 g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~-   93 (288)
T 1ob3_A           16 GVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVC-   93 (288)
T ss_dssp             EEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSE-EHHHHHHTS-
T ss_pred             EEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEecCC-CHHHHHHhc-
Confidence            89999998 588999999853         356899999999999999999999999999999999975 999988542 


Q ss_pred             CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCCcc
Q 039626          431 NEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKG  510 (628)
Q Consensus       431 ~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~  510 (628)
                        ...+++..+..++.|++.||+|||+.   +++||||||+|||++.++.+||+|||+++.......   ......||+.
T Consensus        94 --~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~t~~  165 (288)
T 1ob3_A           94 --EGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR---KYTHEIVTLW  165 (288)
T ss_dssp             --TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------------CCCT
T ss_pred             --ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECccccccCcccc---cccccccccc
Confidence              34589999999999999999999995   599999999999999999999999999986543211   1233578999


Q ss_pred             ccCcccccc-CCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccc--hhhhc--cccCCcCC---
Q 039626          511 YMAPEYLEN-GLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDG--EESLR--HFIDPTLQ---  582 (628)
Q Consensus       511 Y~APE~l~~-~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~l~--~~~d~~l~---  582 (628)
                      |+|||.+.+ ..++.++||||||++++||++|+.||.......  .+.... ........  .....  ...++...   
T Consensus       166 y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (288)
T 1ob3_A          166 YRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD--QLMRIF-RILGTPNSKNWPNVTELPKYDPNFTVYE  242 (288)
T ss_dssp             TCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHH-HHHCCCCTTTSTTGGGSTTCCTTCCCCC
T ss_pred             ccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHH-HHHCCCChhhchhhhccccccccccccc
Confidence            999999876 458999999999999999999999986433211  111111 11111100  00000  00111110   


Q ss_pred             ----CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          583 ----GNYPLELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       583 ----~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                          .......+..+.+++.+||+.||++|||+.|+++
T Consensus       243 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  280 (288)
T 1ob3_A          243 PLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (288)
T ss_dssp             CCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence                0111234456789999999999999999999875

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=6.7e-37  Score=317.34  Aligned_cols=252  Identities=18%  Similarity=0.299  Sum_probs=193.9

Q ss_pred             CCCcCCccc----eEEEEEEE--CCceEEEEEecc-------chHHHHHHHhhcCCCceeeeeeeeec----CCeEEEEE
Q 039626          352 NFSFTCRIQ----GSVYRGKI--NGGFAAIKKVNG-------DVSKEIALLNKINHSNLIILSGVCFN----EGNCYLVY  414 (628)
Q Consensus       352 ~f~~~~~i~----G~Vy~g~~--~g~~vavK~~~~-------~~~~E~~~l~~l~H~nIv~l~g~~~~----~~~~~lV~  414 (628)
                      +|.....+|    |.||+++.  +|+.||+|++..       .+.+|++++++++|+||+++++++..    ....++||
T Consensus        30 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~  109 (317)
T 2buj_A           30 HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLL  109 (317)
T ss_dssp             EEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEEE
T ss_pred             EEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEEE
Confidence            344444443    89999997  788999998742       46789999999999999999999973    34789999


Q ss_pred             EecCCCChHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCC
Q 039626          415 EYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEG  494 (628)
Q Consensus       415 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~  494 (628)
                      ||+++|+|.+++......+..+++..++.++.|++.||+|||+.   +++||||||+|||++.++.+||+|||+++....
T Consensus       110 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~  186 (317)
T 2buj_A          110 PFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACI  186 (317)
T ss_dssp             ECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSSCEESCE
T ss_pred             EeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCcchhccc
Confidence            99999999999976555567799999999999999999999995   499999999999999999999999999876532


Q ss_pred             CCCcc------eeeecccCCccccCccccccCC---CCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhc
Q 039626          495 QEGEF------ALTRHIVGTKGYMAPEYLENGL---VSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLT  565 (628)
Q Consensus       495 ~~~~~------~~~~~~~gt~~Y~APE~l~~~~---~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~  565 (628)
                      .....      .......||+.|+|||.+.+..   ++.++||||||+++|||++|+.|+......... ......    
T Consensus       187 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~-~~~~~~----  261 (317)
T 2buj_A          187 HVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDS-VALAVQ----  261 (317)
T ss_dssp             EEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSC-HHHHHH----
T ss_pred             ccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccch-hhHHhh----
Confidence            11000      0012245799999999987553   689999999999999999999998642221111 111110    


Q ss_pred             cccchhhhccccCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhh
Q 039626          566 KEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNA  624 (628)
Q Consensus       566 ~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~~~  624 (628)
                               ...    ....+...+..+.+++.+||+.||.+||++.|+++.|+.+...
T Consensus       262 ---------~~~----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~  307 (317)
T 2buj_A          262 ---------NQL----SIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPP  307 (317)
T ss_dssp             ---------CC------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCC
T ss_pred             ---------ccC----CCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCC
Confidence                     000    0011122345688999999999999999999999999988643

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=1.8e-36  Score=335.09  Aligned_cols=239  Identities=23%  Similarity=0.338  Sum_probs=192.2

Q ss_pred             cCCCcCCccc----eEEEEEEE--CCceEEEEEecc----------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEE
Q 039626          351 DNFSFTCRIQ----GSVYRGKI--NGGFAAIKKVNG----------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVY  414 (628)
Q Consensus       351 ~~f~~~~~i~----G~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~  414 (628)
                      ++|.....+|    |.||+++.  +|+.+|+|++..          .+.+|+++|++++||||+++++++.+.+..|+||
T Consensus       185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm  264 (543)
T 3c4z_A          185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM  264 (543)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence            3444444444    89999998  588999999854          2567999999999999999999999999999999


Q ss_pred             EecCCCChHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCC
Q 039626          415 EYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEG  494 (628)
Q Consensus       415 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~  494 (628)
                      ||+++|+|.+++.........+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++....
T Consensus       265 E~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~  341 (543)
T 3c4z_A          265 TIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKA  341 (543)
T ss_dssp             CCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             EeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence            99999999999976544455799999999999999999999995   499999999999999999999999999987653


Q ss_pred             CCCcceeeecccCCccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhc
Q 039626          495 QEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLR  574 (628)
Q Consensus       495 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  574 (628)
                      ...   ......||+.|+|||.+.+..++.++|||||||++|||++|+.||.......  ...+....+....       
T Consensus       342 ~~~---~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~--~~~~~~~~i~~~~-------  409 (543)
T 3c4z_A          342 GQT---KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV--ENKELKQRVLEQA-------  409 (543)
T ss_dssp             TCC---CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCC--CHHHHHHHHHHCC-------
T ss_pred             CCc---ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccch--hHHHHHHHHhhcc-------
Confidence            321   2334589999999999999999999999999999999999999987543211  1222222222110       


Q ss_pred             cccCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHH
Q 039626          575 HFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMY  612 (628)
Q Consensus       575 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~  612 (628)
                              ..++...+..+.+++.+||+.||.+||++.
T Consensus       410 --------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~  439 (543)
T 3c4z_A          410 --------VTYPDKFSPASKDFCEALLQKDPEKRLGFR  439 (543)
T ss_dssp             --------CCCCTTSCHHHHHHHHHHSCSSGGGSCCCB
T ss_pred             --------cCCCcccCHHHHHHHHHhccCCHhHCCCCc
Confidence                    122333456678999999999999999864

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1e-36  Score=319.83  Aligned_cols=249  Identities=24%  Similarity=0.294  Sum_probs=186.7

Q ss_pred             HHhcCCCcCCccc----eEEEEEEE--CCceEEEEEecc------------chHHHHHHHhhcCCCceeeeeeeeecCCe
Q 039626          348 SATDNFSFTCRIQ----GSVYRGKI--NGGFAAIKKVNG------------DVSKEIALLNKINHSNLIILSGVCFNEGN  409 (628)
Q Consensus       348 ~at~~f~~~~~i~----G~Vy~g~~--~g~~vavK~~~~------------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~  409 (628)
                      ...++|.....+|    |.||++..  ++..+|+|.+..            .+.+|++++++++||||+++++++.+++.
T Consensus        23 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~  102 (345)
T 3hko_A           23 ELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQY  102 (345)
T ss_dssp             HHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             hhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCe
Confidence            3445555555554    89999998  577899998753            36679999999999999999999999999


Q ss_pred             EEEEEEecCCCChHHHhhhcCCC------------------------------------CCCCCHHHHHHHHHHHHHHHH
Q 039626          410 CYLVYEYAVNGTLSDWVFSNKNE------------------------------------GKYLDWKQRIQIALDVATGLN  453 (628)
Q Consensus       410 ~~lV~E~~~~gsL~~~l~~~~~~------------------------------------~~~l~~~~~~~i~~~ia~gL~  453 (628)
                      .++||||+++|+|.+++......                                    ...+++..+..++.|++.||+
T Consensus       103 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~  182 (345)
T 3hko_A          103 ICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALH  182 (345)
T ss_dssp             EEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHH
Confidence            99999999999999998421110                                    223467788899999999999


Q ss_pred             HHhcCCCCCeEecCCCCCCEEeCCCC--cEEEccccccccCCCCCC-cceeeecccCCccccCcccccc--CCCCccccc
Q 039626          454 YLHSFTNPPHVHKDINSSNVLLDSDL--RAKIANFAMARPAEGQEG-EFALTRHIVGTKGYMAPEYLEN--GLVSTKLDV  528 (628)
Q Consensus       454 yLH~~~~~~iiH~dik~~NILl~~~~--~~kl~Dfgla~~~~~~~~-~~~~~~~~~gt~~Y~APE~l~~--~~~s~k~DV  528 (628)
                      |||+.   +++||||||+|||++.++  .+||+|||+++....... .........||+.|+|||.+.+  ..++.++||
T Consensus       183 ~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di  259 (345)
T 3hko_A          183 YLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDA  259 (345)
T ss_dssp             HHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHH
T ss_pred             HHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHH
Confidence            99995   499999999999998776  899999999986543221 1112344579999999999875  678999999


Q ss_pred             HHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCHHHHHHHHHHHHHhcccCCCCC
Q 039626          529 YAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDR  608 (628)
Q Consensus       529 ~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~R  608 (628)
                      ||||+++|||++|+.||.....      .+....+......      +..+     .....+..+.+++.+||+.||.+|
T Consensus       260 wslG~il~el~~g~~pf~~~~~------~~~~~~~~~~~~~------~~~~-----~~~~~~~~~~~li~~~l~~~p~~R  322 (345)
T 3hko_A          260 WSAGVLLHLLLMGAVPFPGVND------ADTISQVLNKKLC------FENP-----NYNVLSPLARDLLSNLLNRNVDER  322 (345)
T ss_dssp             HHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHCCCC------TTSG-----GGGGSCHHHHHHHHHHSCSCTTTS
T ss_pred             HHHHHHHHHHHHCCCCCCCCCh------HHHHHHHHhcccc------cCCc-----ccccCCHHHHHHHHHHcCCChhHC
Confidence            9999999999999999864332      1222222211100      0000     011234567899999999999999


Q ss_pred             CCHHHHHH
Q 039626          609 PTMYEIEH  616 (628)
Q Consensus       609 Ps~~ev~~  616 (628)
                      |++.|+++
T Consensus       323 ps~~~~l~  330 (345)
T 3hko_A          323 FDAMRALQ  330 (345)
T ss_dssp             CCHHHHHH
T ss_pred             CCHHHHhc
Confidence            99999976

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=1.2e-36  Score=320.37  Aligned_cols=224  Identities=31%  Similarity=0.464  Sum_probs=181.5

Q ss_pred             eEEEEEEE--CCceEEEEEecc----------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhh
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG----------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFS  428 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  428 (628)
                      |.||+|+.  +|+.||||++..          ++.+|++++++++||||+++++++.+++..++||||++ |+|.+++..
T Consensus        68 g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~-g~l~~~l~~  146 (348)
T 1u5q_A           68 GAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEV  146 (348)
T ss_dssp             EEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHHH
T ss_pred             EEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEEecCC-CCHHHHHHH
Confidence            89999997  688999999852          36789999999999999999999999999999999996 688888854


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCC
Q 039626          429 NKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGT  508 (628)
Q Consensus       429 ~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt  508 (628)
                      .   ...+++..+..++.|++.||+|||+.   +++||||||+|||++.++.+||+|||+++.....       ....||
T Consensus       147 ~---~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~-------~~~~gt  213 (348)
T 1u5q_A          147 H---KKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-------NSFVGT  213 (348)
T ss_dssp             H---TSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB-------CCCCSC
T ss_pred             h---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCceecCCC-------CcccCC
Confidence            3   34589999999999999999999995   4999999999999999999999999999866432       234799


Q ss_pred             ccccCccccc---cCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCC
Q 039626          509 KGYMAPEYLE---NGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNY  585 (628)
Q Consensus       509 ~~Y~APE~l~---~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~  585 (628)
                      +.|+|||.+.   ...++.++||||||++++||++|+.|+.....      .+.+..+....          .+...   
T Consensus       214 ~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~------~~~~~~~~~~~----------~~~~~---  274 (348)
T 1u5q_A          214 PYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA------MSALYHIAQNE----------SPALQ---  274 (348)
T ss_dssp             GGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHHHHHSC----------CCCCC---
T ss_pred             cceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHHHhcC----------CCCCC---
Confidence            9999999984   56789999999999999999999999863321      11122221111          11111   


Q ss_pred             CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 039626          586 PLELALLVIRLIDACLKKDPTDRPTMYEIEHS  617 (628)
Q Consensus       586 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~  617 (628)
                      +...+..+.+++.+||+.||++|||++|+++.
T Consensus       275 ~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h  306 (348)
T 1u5q_A          275 SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH  306 (348)
T ss_dssp             CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred             CCCCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence            11223457899999999999999999998753

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=2.5e-36  Score=315.17  Aligned_cols=225  Identities=22%  Similarity=0.331  Sum_probs=177.1

Q ss_pred             eEEEEEEE-----CCceEEEEEecc-----------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHH
Q 039626          361 GSVYRGKI-----NGGFAAIKKVNG-----------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSD  424 (628)
Q Consensus       361 G~Vy~g~~-----~g~~vavK~~~~-----------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~  424 (628)
                      |.||+++.     +|+.+|+|+++.           .+.+|+++|++++|+||+++++++..++..++||||+++|+|.+
T Consensus        31 g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~  110 (327)
T 3a62_A           31 GKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFM  110 (327)
T ss_dssp             EEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCEEEEEECCTTEEHHH
T ss_pred             EEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEEEEEEeCCCCCcHHH
Confidence            89999987     578999998864           24579999999999999999999999999999999999999999


Q ss_pred             HhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeec
Q 039626          425 WVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRH  504 (628)
Q Consensus       425 ~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~  504 (628)
                      ++...    ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++......   .....
T Consensus       111 ~l~~~----~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~---~~~~~  180 (327)
T 3a62_A          111 QLERE----GIFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDG---TVTHT  180 (327)
T ss_dssp             HHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCCSCC-------------CT
T ss_pred             HHHhC----CCCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeCCcccccccCC---ccccc
Confidence            99643    3588999999999999999999995   49999999999999999999999999997643221   12334


Q ss_pred             ccCCccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCC
Q 039626          505 IVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGN  584 (628)
Q Consensus       505 ~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~  584 (628)
                      ..||+.|+|||.+.+..++.++||||||+++|||++|+.||.....      .+....+....           .    .
T Consensus       181 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~~~~~~i~~~~-----------~----~  239 (327)
T 3a62_A          181 FCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENR------KKTIDKILKCK-----------L----N  239 (327)
T ss_dssp             TSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHHHTC-----------C----C
T ss_pred             cCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCH------HHHHHHHHhCC-----------C----C
Confidence            5799999999999998999999999999999999999999864322      12222222110           0    1


Q ss_pred             CCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 039626          585 YPLELALLVIRLIDACLKKDPTDRP-----TMYEIEH  616 (628)
Q Consensus       585 ~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~ev~~  616 (628)
                      .+...+..+.+++.+||+.||.+||     ++.|+++
T Consensus       240 ~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~  276 (327)
T 3a62_A          240 LPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA  276 (327)
T ss_dssp             CCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred             CCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence            1223345678999999999999999     5556543

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=3.9e-36  Score=305.91  Aligned_cols=234  Identities=26%  Similarity=0.411  Sum_probs=186.3

Q ss_pred             cCCCcCCccc----eEEEEEEE--CCceEEEEEecc----------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEE
Q 039626          351 DNFSFTCRIQ----GSVYRGKI--NGGFAAIKKVNG----------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVY  414 (628)
Q Consensus       351 ~~f~~~~~i~----G~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~  414 (628)
                      ++|.....+|    |.||++..  ++..+|+|.+..          .+.+|+.++++++||||+++++++.+++..++||
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   88 (279)
T 3fdn_A            9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL   88 (279)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEE
Confidence            3444444443    89999998  566899998853          3667999999999999999999999999999999


Q ss_pred             EecCCCChHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCC
Q 039626          415 EYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEG  494 (628)
Q Consensus       415 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~  494 (628)
                      ||+++|+|.+++...    ..+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||++.....
T Consensus        89 e~~~~~~l~~~l~~~----~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~  161 (279)
T 3fdn_A           89 EYAPLGTVYRELQKL----SKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPS  161 (279)
T ss_dssp             CCCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCCEESCC--
T ss_pred             ecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEeccccccCCc
Confidence            999999999999643    3489999999999999999999984   599999999999999999999999999865533


Q ss_pred             CCCcceeeecccCCccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhc
Q 039626          495 QEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLR  574 (628)
Q Consensus       495 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  574 (628)
                      ..     .....||+.|+|||.+.+..++.++||||||++++||++|+.|+.....      .+....+...        
T Consensus       162 ~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~--------  222 (279)
T 3fdn_A          162 SR-----RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY------QETYKRISRV--------  222 (279)
T ss_dssp             -----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHHHT--------
T ss_pred             cc-----ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcH------HHHHHHHHhC--------
Confidence            21     2345789999999999999999999999999999999999999864321      1111111110        


Q ss_pred             cccCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 039626          575 HFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHS  617 (628)
Q Consensus       575 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~  617 (628)
                         .    ...+...+..+.+++.+||+.||.+||+++|+++-
T Consensus       223 ---~----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h  258 (279)
T 3fdn_A          223 ---E----FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH  258 (279)
T ss_dssp             ---C----CCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred             ---C----CCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence               0    11222234567899999999999999999999863

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=7.1e-37  Score=321.35  Aligned_cols=229  Identities=26%  Similarity=0.367  Sum_probs=177.4

Q ss_pred             eEEEEEEE-CCceEEEEEecc---------chHHHHHHHhhcCC--CceeeeeeeeecCCeEEEEEEecCCCChHHHhhh
Q 039626          361 GSVYRGKI-NGGFAAIKKVNG---------DVSKEIALLNKINH--SNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFS  428 (628)
Q Consensus       361 G~Vy~g~~-~g~~vavK~~~~---------~~~~E~~~l~~l~H--~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  428 (628)
                      |.||++.. +++.||||++..         .+.+|+.+|.+++|  +||+++++++.+++..++|||+ .+|+|.+++..
T Consensus        23 g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e~-~~~~L~~~l~~  101 (343)
T 3dbq_A           23 SKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKK  101 (343)
T ss_dssp             EEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECC-CSEEHHHHHHH
T ss_pred             eEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEEeC-CCCCHHHHHHh
Confidence            89999988 677899998852         36789999999976  9999999999999999999995 58899999964


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCC
Q 039626          429 NKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGT  508 (628)
Q Consensus       429 ~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt  508 (628)
                          ...+++..+..++.|++.||+|||+.   +|+||||||+|||++ ++.+||+|||+++........ .......||
T Consensus       102 ----~~~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~~-~~~~~~~gt  172 (343)
T 3dbq_A          102 ----KKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTS-VVKDSQVGT  172 (343)
T ss_dssp             ----SCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC-------------CCC
T ss_pred             ----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeecccccccCccccc-ccCCCCcCC
Confidence                34589999999999999999999995   499999999999997 578999999999876533211 123345799


Q ss_pred             ccccCcccccc-----------CCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhcccc
Q 039626          509 KGYMAPEYLEN-----------GLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFI  577 (628)
Q Consensus       509 ~~Y~APE~l~~-----------~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  577 (628)
                      +.|+|||++.+           ..++.++|||||||++|||++|+.||.....     ......             ..+
T Consensus       173 ~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-----~~~~~~-------------~~~  234 (343)
T 3dbq_A          173 VNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-----QISKLH-------------AII  234 (343)
T ss_dssp             CSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCS-----HHHHHH-------------HHH
T ss_pred             cCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhh-----HHHHHH-------------HHh
Confidence            99999999865           6789999999999999999999999863211     111111             122


Q ss_pred             CCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 039626          578 DPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHS  617 (628)
Q Consensus       578 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~  617 (628)
                      ++.....++......+.+++.+||+.||.+|||+.|+++.
T Consensus       235 ~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h  274 (343)
T 3dbq_A          235 DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  274 (343)
T ss_dssp             CTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             cCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence            2222223333334567899999999999999999999753

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=8.3e-37  Score=312.36  Aligned_cols=239  Identities=26%  Similarity=0.382  Sum_probs=185.3

Q ss_pred             eEEEEEEE---CCc--eEEEEEecc----------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHH
Q 039626          361 GSVYRGKI---NGG--FAAIKKVNG----------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDW  425 (628)
Q Consensus       361 G~Vy~g~~---~g~--~vavK~~~~----------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~  425 (628)
                      |.||+|++   ++.  .||+|+++.          ++.+|++++++++|+||+++++++.++. .++|+||+++|+|.++
T Consensus        32 g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~e~~~~~~L~~~  110 (291)
T 1u46_A           32 GVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDR  110 (291)
T ss_dssp             CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CEEEEECCTTCBHHHH
T ss_pred             eeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ceeeEecccCCCHHHH
Confidence            89999986   222  589998753          3568999999999999999999998665 8899999999999999


Q ss_pred             hhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecc
Q 039626          426 VFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHI  505 (628)
Q Consensus       426 l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~  505 (628)
                      +...   ...+++..+..++.|++.||+|||+.   +++|+||||+||+++.++.+||+|||+++...............
T Consensus       111 l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~  184 (291)
T 1u46_A          111 LRKH---QGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHR  184 (291)
T ss_dssp             HHHH---GGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECCC-CCEEEC----
T ss_pred             HHhc---cCCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEccccccccccccccchhhhccC
Confidence            9653   24589999999999999999999995   49999999999999999999999999998775443333333445


Q ss_pred             cCCccccCccccccCCCCcccccHHHHHHHHHHHh-CCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCC
Q 039626          506 VGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT-GKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGN  584 (628)
Q Consensus       506 ~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELlt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~  584 (628)
                      .+|..|+|||.+.+..++.++||||||++++||++ |+.|+.....      .+....+....             ....
T Consensus       185 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~------~~~~~~~~~~~-------------~~~~  245 (291)
T 1u46_A          185 KVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG------SQILHKIDKEG-------------ERLP  245 (291)
T ss_dssp             -CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH------HHHHHHHHTSC-------------CCCC
T ss_pred             CCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCH------HHHHHHHHccC-------------CCCC
Confidence            78889999999998889999999999999999999 9988864322      12222221110             0011


Q ss_pred             CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhc
Q 039626          585 YPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNAS  625 (628)
Q Consensus       585 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~~~~  625 (628)
                      .+...+..+.+++.+||+.||.+||++.++++.|+++....
T Consensus       246 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~  286 (291)
T 1u46_A          246 RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTD  286 (291)
T ss_dssp             CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred             CCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCccc
Confidence            12233456889999999999999999999999999887654

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=2.1e-36  Score=307.59  Aligned_cols=226  Identities=26%  Similarity=0.419  Sum_probs=164.6

Q ss_pred             eEEEEEEE--CCceEEEEEecc----------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhh
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG----------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFS  428 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  428 (628)
                      |.||+++.  +|+.||+|.+..          .+.+|++++++++||||+++++++.+++..++||||+++++|.+++..
T Consensus        25 g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~  104 (278)
T 3cok_A           25 AGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKN  104 (278)
T ss_dssp             EEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEEECCTTEEHHHHHHT
T ss_pred             eEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEEecCCCCcHHHHHhh
Confidence            89999997  788999999853          356899999999999999999999999999999999999999999954


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCC
Q 039626          429 NKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGT  508 (628)
Q Consensus       429 ~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt  508 (628)
                         ....+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||++........   ......||
T Consensus       105 ---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~  175 (278)
T 3cok_A          105 ---RVKPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHE---KHYTLCGT  175 (278)
T ss_dssp             ---CSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTTCEECC---------------
T ss_pred             ---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCC---cceeccCC
Confidence               235689999999999999999999995   499999999999999999999999999987643221   12235789


Q ss_pred             ccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCHH
Q 039626          509 KGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLE  588 (628)
Q Consensus       509 ~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~  588 (628)
                      +.|+|||.+.+..++.++||||||++++||++|+.|+.......      .......           .+.    ..+..
T Consensus       176 ~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~-----------~~~----~~~~~  234 (278)
T 3cok_A          176 PNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKN------TLNKVVL-----------ADY----EMPSF  234 (278)
T ss_dssp             ----------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----------CCS-----------SCC----CCCTT
T ss_pred             CCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHH------HHHHHhh-----------ccc----CCccc
Confidence            99999999999899999999999999999999999986432211      0000000           011    11223


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          589 LALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       589 ~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      .+..+.+++.+||+.||++|||++|+++
T Consensus       235 ~~~~~~~li~~~l~~dp~~Rps~~~~l~  262 (278)
T 3cok_A          235 LSIEAKDLIHQLLRRNPADRLSLSSVLD  262 (278)
T ss_dssp             SCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             cCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence            3456789999999999999999999875

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=1.4e-36  Score=310.59  Aligned_cols=230  Identities=28%  Similarity=0.374  Sum_probs=179.8

Q ss_pred             eEEEEEEE--CCceEEEEEecc--------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhcC
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG--------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNK  430 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~--------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~  430 (628)
                      |.||++..  ++..+|+|++..        .+.+|++++++++||||+++++++.+.+..++||||+++|+|.+++....
T Consensus        36 g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~  115 (285)
T 3is5_A           36 GDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQ  115 (285)
T ss_dssp             CEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCSCCBHHHHHHHHH
T ss_pred             eEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEeCCCCcHHHHHHhhh
Confidence            89999998  578999999854        36789999999999999999999999999999999999999999996654


Q ss_pred             CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEe---CCCCcEEEccccccccCCCCCCcceeeecccC
Q 039626          431 NEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLL---DSDLRAKIANFAMARPAEGQEGEFALTRHIVG  507 (628)
Q Consensus       431 ~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl---~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~g  507 (628)
                      ..+..+++..+..++.|++.||+|||+.   +++||||||+|||+   +.++.+||+|||+++......    ......|
T Consensus       116 ~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~~~~  188 (285)
T 3is5_A          116 ARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDE----HSTNAAG  188 (285)
T ss_dssp             HHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--------------CT
T ss_pred             hcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeeecceecCCcc----cCcCccc
Confidence            4456799999999999999999999995   49999999999999   556889999999998664322    1234579


Q ss_pred             CccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCH
Q 039626          508 TKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPL  587 (628)
Q Consensus       508 t~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~  587 (628)
                      |+.|+|||.+. +.++.++||||||++++||++|+.|+.....      .+..........        ........   
T Consensus       189 t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~------~~~~~~~~~~~~--------~~~~~~~~---  250 (285)
T 3is5_A          189 TALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSL------EEVQQKATYKEP--------NYAVECRP---  250 (285)
T ss_dssp             TGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHCCC--------CCCC--CC---
T ss_pred             ccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCH------HHHHhhhccCCc--------ccccccCc---
Confidence            99999999886 5689999999999999999999999864321      111111111000        00000011   


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          588 ELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       588 ~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                       .+..+.+++.+||+.||++|||+.|+++
T Consensus       251 -~~~~~~~li~~~L~~dP~~Rps~~e~l~  278 (285)
T 3is5_A          251 -LTPQAVDLLKQMLTKDPERRPSAAQVLH  278 (285)
T ss_dssp             -CCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred             -CCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence             2345789999999999999999999875

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=1.9e-36  Score=329.70  Aligned_cols=236  Identities=25%  Similarity=0.365  Sum_probs=184.0

Q ss_pred             cCCCcCCccc----eEEEEEEE--CCceEEEEEecc----------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEE
Q 039626          351 DNFSFTCRIQ----GSVYRGKI--NGGFAAIKKVNG----------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVY  414 (628)
Q Consensus       351 ~~f~~~~~i~----G~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~  414 (628)
                      ++|.....+|    |.||+++.  +|+.||||+++.          .+.+|++++++++||||+++++++.+.+..++||
T Consensus       148 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~  227 (446)
T 4ejn_A          148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVM  227 (446)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEE
T ss_pred             HHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEE
Confidence            3444444454    89999998  688999999864          2457999999999999999999999999999999


Q ss_pred             EecCCCChHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCC
Q 039626          415 EYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEG  494 (628)
Q Consensus       415 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~  494 (628)
                      ||+++|+|.+++...    ..+++..+..++.|++.||+|||+.  .+|+||||||+|||++.++.+||+|||+++....
T Consensus       228 e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~--~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~  301 (446)
T 4ejn_A          228 EYANGGELFFHLSRE----RVFSEDRARFYGAEIVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK  301 (446)
T ss_dssp             CCCSSCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHH--TCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC
T ss_pred             eeCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHhhc--CCEEECCCCHHHEEECCCCCEEEccCCCceeccC
Confidence            999999999999543    3589999999999999999999971  3499999999999999999999999999986432


Q ss_pred             CCCcceeeecccCCccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhc
Q 039626          495 QEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLR  574 (628)
Q Consensus       495 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  574 (628)
                      ..   .......||+.|+|||++.+..++.++|||||||+++||++|+.||.....      .+....+....       
T Consensus       302 ~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~------~~~~~~i~~~~-------  365 (446)
T 4ejn_A          302 DG---ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH------EKLFELILMEE-------  365 (446)
T ss_dssp             --------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHCC-------
T ss_pred             CC---cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH------HHHHHHHHhCC-------
Confidence            21   123446899999999999999999999999999999999999999864322      12222221110       


Q ss_pred             cccCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 039626          575 HFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRP-----TMYEIEH  616 (628)
Q Consensus       575 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~ev~~  616 (628)
                          .    .++...+..+.+|+.+||+.||.+||     +++|+++
T Consensus       366 ----~----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~  404 (446)
T 4ejn_A          366 ----I----RFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ  404 (446)
T ss_dssp             ----C----CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             ----C----CCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence                0    12223345678999999999999999     9888864

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=9.8e-37  Score=315.69  Aligned_cols=238  Identities=21%  Similarity=0.314  Sum_probs=176.8

Q ss_pred             eEEEEEEE--CCceEEEEEecc----------chHHHHHHHhhcCCCceeeeeeeeecCC----eEEEEEEecCCCChHH
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG----------DVSKEIALLNKINHSNLIILSGVCFNEG----NCYLVYEYAVNGTLSD  424 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~nIv~l~g~~~~~~----~~~lV~E~~~~gsL~~  424 (628)
                      |.||+++.  +++.||||+++.          .+.+|++++++++||||+++++++....    ..++||||+++|+|.+
T Consensus        26 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~lv~e~~~g~~L~~  105 (311)
T 3ork_A           26 SEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRD  105 (311)
T ss_dssp             EEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEEEEEEECCCEEEHHH
T ss_pred             EEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcccEEEEecCCCCCHHH
Confidence            89999997  788999999864          3568999999999999999999987654    3499999999999999


Q ss_pred             HhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeec
Q 039626          425 WVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRH  504 (628)
Q Consensus       425 ~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~  504 (628)
                      ++...    ..+++..++.++.|++.||+|||+.   +++||||||+|||++.++.+||+|||+++..............
T Consensus       106 ~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~  178 (311)
T 3ork_A          106 IVHTE----GPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAA  178 (311)
T ss_dssp             HHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCCSCC---------------
T ss_pred             HHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeeccCcccccccccccccccc
Confidence            99643    3589999999999999999999995   4999999999999999999999999999876543332223344


Q ss_pred             ccCCccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCC
Q 039626          505 IVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGN  584 (628)
Q Consensus       505 ~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~  584 (628)
                      ..||+.|+|||.+.+..++.++||||||+++|||++|+.||.....      .+.............       ....  
T Consensus       179 ~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~------~~~~~~~~~~~~~~~-------~~~~--  243 (311)
T 3ork_A          179 VIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP------VSVAYQHVREDPIPP-------SARH--  243 (311)
T ss_dssp             ---CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHHHCCCCCH-------HHHS--
T ss_pred             cCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHHhcCCCCCc-------cccc--
Confidence            5799999999999999999999999999999999999999864322      111111111110000       0001  


Q ss_pred             CCHHHHHHHHHHHHHhcccCCCCCCCHHH-HHHHHHHhH
Q 039626          585 YPLELALLVIRLIDACLKKDPTDRPTMYE-IEHSLSNIL  622 (628)
Q Consensus       585 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~e-v~~~L~~l~  622 (628)
                        ...+..+.+++.+||+.||++||+..+ +...|.++.
T Consensus       244 --~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~  280 (311)
T 3ork_A          244 --EGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH  280 (311)
T ss_dssp             --TTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             --CCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHh
Confidence              123355789999999999999996655 445555544

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=1.5e-36  Score=318.82  Aligned_cols=232  Identities=25%  Similarity=0.364  Sum_probs=185.4

Q ss_pred             eEEEEEEE--CCceEEEEEecc---chHHHHHHHhhc-CCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhcCCCCC
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG---DVSKEIALLNKI-NHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGK  434 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~---~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~  434 (628)
                      |.||++..  +|+.+|+|.++.   +..+|++++.++ +||||+++++++.+++..++||||+++|+|.+++..    ..
T Consensus        36 g~V~~~~~~~~~~~~avK~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~i~~----~~  111 (342)
T 2qr7_A           36 SVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILR----QK  111 (342)
T ss_dssp             EEEEEEEETTTTEEEEEEEEETTTCCCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHT----CT
T ss_pred             EEEEEEEECCCCCEEEEEEEEcccCChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeCCCCCcHHHHHHH----cC
Confidence            89999998  588999999865   467899999998 799999999999999999999999999999999953    34


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCC----CcEEEccccccccCCCCCCcceeeecccCCcc
Q 039626          435 YLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSD----LRAKIANFAMARPAEGQEGEFALTRHIVGTKG  510 (628)
Q Consensus       435 ~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~----~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~  510 (628)
                      .+++..+..++.+|+.||+|||+.   +|+||||||+|||+.++    +.+||+|||+++.......   ......||+.
T Consensus       112 ~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~gt~~  185 (342)
T 2qr7_A          112 FFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENG---LLMTPCYTAN  185 (342)
T ss_dssp             TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTTC---CBCCSSCCSS
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCCC---ceeccCCCcc
Confidence            589999999999999999999995   49999999999998443    3599999999987643321   2334578999


Q ss_pred             ccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCHHHH
Q 039626          511 YMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELA  590 (628)
Q Consensus       511 Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~  590 (628)
                      |+|||.+.+..++.++|||||||++|||++|+.||......   ...+....+....           ......+....+
T Consensus       186 y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~---~~~~~~~~i~~~~-----------~~~~~~~~~~~s  251 (342)
T 2qr7_A          186 FVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDD---TPEEILARIGSGK-----------FSLSGGYWNSVS  251 (342)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTS---CHHHHHHHHHHCC-----------CCCCSTTTTTSC
T ss_pred             ccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcC---CHHHHHHHHccCC-----------cccCccccccCC
Confidence            99999998888999999999999999999999998743221   1222222222111           001111222344


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          591 LLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       591 ~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      ..+.+++.+||+.||++||++.|+++
T Consensus       252 ~~~~~li~~~L~~dP~~R~t~~~il~  277 (342)
T 2qr7_A          252 DTAKDLVSKMLHVDPHQRLTAALVLR  277 (342)
T ss_dssp             HHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             HHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            56789999999999999999999875

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=4.2e-36  Score=320.94  Aligned_cols=249  Identities=16%  Similarity=0.297  Sum_probs=183.6

Q ss_pred             eEEEEEEE--CCceEEEEEecc---------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhc
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG---------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSN  429 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~---------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~  429 (628)
                      |.||+++.  +|+.||||+++.         .+.+|++++++++|||||++++++.+++..++||||+++|+|.+++...
T Consensus        41 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~  120 (389)
T 3gni_B           41 MTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTH  120 (389)
T ss_dssp             EEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHT
T ss_pred             eEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEEEEccCCCCHHHHHhhh
Confidence            78999998  588999999863         3567999999999999999999999999999999999999999999653


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCc----ceeeecc
Q 039626          430 KNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGE----FALTRHI  505 (628)
Q Consensus       430 ~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~----~~~~~~~  505 (628)
                        ....+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||.+.........    .......
T Consensus       121 --~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~  195 (389)
T 3gni_B          121 --FMDGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYS  195 (389)
T ss_dssp             --CTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCGGGCEECEETTEECSCBCCCCTTC
T ss_pred             --cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccccceeeccccccccccccccccc
Confidence              234599999999999999999999995   4999999999999999999999999998754322110    1112234


Q ss_pred             cCCccccCcccccc--CCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhc----ccc-chhh------
Q 039626          506 VGTKGYMAPEYLEN--GLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLT----KED-GEES------  572 (628)
Q Consensus       506 ~gt~~Y~APE~l~~--~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~----~~~-~~~~------  572 (628)
                      .||+.|+|||.+.+  ..++.++|||||||+++||++|+.||.......  .+.........    ... ..+.      
T Consensus       196 ~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (389)
T 3gni_B          196 VKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQ--MLLEKLNGTVPCLLDTSTIPAEELTMSPS  273 (389)
T ss_dssp             TTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTT--HHHHC------------------------
T ss_pred             cccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHH--HHHHHhcCCCCcccccccccccccccccc
Confidence            78999999999987  679999999999999999999999986432211  11111100000    000 0000      


Q ss_pred             -------hccccC---------CcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          573 -------LRHFID---------PTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       573 -------l~~~~d---------~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                             +...+.         ......++...+..+.+|+.+||+.||++|||+.|+++
T Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~  333 (389)
T 3gni_B          274 RSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLN  333 (389)
T ss_dssp             --------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             ccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence                   000000         00001123344567889999999999999999999974

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=1.3e-36  Score=321.15  Aligned_cols=198  Identities=23%  Similarity=0.345  Sum_probs=168.2

Q ss_pred             eecHHHHHHHhcCCCcCCccc----eEEEEEEE--CCceEEEEEecc------chHHHHHHHhhcC-----CCceeeeee
Q 039626          340 VYSFKELQSATDNFSFTCRIQ----GSVYRGKI--NGGFAAIKKVNG------DVSKEIALLNKIN-----HSNLIILSG  402 (628)
Q Consensus       340 ~~~~~el~~at~~f~~~~~i~----G~Vy~g~~--~g~~vavK~~~~------~~~~E~~~l~~l~-----H~nIv~l~g  402 (628)
                      .|++++.....++|.....+|    |.||+++.  +++.||||+++.      .+..|++++++++     |+||+++++
T Consensus        24 ~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~  103 (360)
T 3llt_A           24 HFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHG  103 (360)
T ss_dssp             SCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEE
T ss_pred             eeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccc
Confidence            344444445566777666665    89999998  788999999864      3567999999996     999999999


Q ss_pred             eeecCCeEEEEEEecCCCChHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCC-----
Q 039626          403 VCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDS-----  477 (628)
Q Consensus       403 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~-----  477 (628)
                      ++...+..++||||+ +++|.+++...  ....+++..+..++.|++.||+|||+.   +|+||||||+|||++.     
T Consensus       104 ~~~~~~~~~lv~e~~-~~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~  177 (360)
T 3llt_A          104 KFMYYDHMCLIFEPL-GPSLYEIITRN--NYNGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDPYFEK  177 (360)
T ss_dssp             EEEETTEEEEEECCC-CCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCTTCCE
T ss_pred             eeeECCeeEEEEcCC-CCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEccccccc
Confidence            999999999999999 99999999653  234589999999999999999999995   4999999999999976     


Q ss_pred             --------------------CCcEEEccccccccCCCCCCcceeeecccCCccccCccccccCCCCcccccHHHHHHHHH
Q 039626          478 --------------------DLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILE  537 (628)
Q Consensus       478 --------------------~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~E  537 (628)
                                          ++.+||+|||+++.....      .....||+.|+|||.+.+..++.++|||||||++||
T Consensus       178 ~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~e  251 (360)
T 3llt_A          178 SLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY------HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAE  251 (360)
T ss_dssp             EEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC------CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHH
T ss_pred             cccchhcccccccccccccCCCCEEEEeccCceecCCC------CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHH
Confidence                                789999999999865432      234578999999999999999999999999999999


Q ss_pred             HHhCCCcccccc
Q 039626          538 MLTGKEAAALHA  549 (628)
Q Consensus       538 LltG~~p~~~~~  549 (628)
                      |++|+.||....
T Consensus       252 ll~g~~pf~~~~  263 (360)
T 3llt_A          252 LYTGSLLFRTHE  263 (360)
T ss_dssp             HHHSSCSCCCSS
T ss_pred             HHHCCCCCCCCc
Confidence            999999987533

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=1.2e-36  Score=319.76  Aligned_cols=244  Identities=15%  Similarity=0.169  Sum_probs=185.3

Q ss_pred             eEEEEEEE-----CCceEEEEEeccc------------------hHHHHHHHhhcCCCceeeeeeeeec----CCeEEEE
Q 039626          361 GSVYRGKI-----NGGFAAIKKVNGD------------------VSKEIALLNKINHSNLIILSGVCFN----EGNCYLV  413 (628)
Q Consensus       361 G~Vy~g~~-----~g~~vavK~~~~~------------------~~~E~~~l~~l~H~nIv~l~g~~~~----~~~~~lV  413 (628)
                      |.||+|..     .+..+|+|+...+                  +.+|+..+..++|+||+++++++..    +...++|
T Consensus        51 g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv  130 (345)
T 2v62_A           51 GLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMV  130 (345)
T ss_dssp             -CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEEEEEESSSCEEEEEE
T ss_pred             eEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecccccccCCCcEEEEE
Confidence            89999998     4568999987531                  3457778888899999999999987    6789999


Q ss_pred             EEecCCCChHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCC--cEEEcccccccc
Q 039626          414 YEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDL--RAKIANFAMARP  491 (628)
Q Consensus       414 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~--~~kl~Dfgla~~  491 (628)
                      |||+ +++|.+++...    ..+++..++.++.|++.||+|||+.   +|+||||||+|||++.++  .+||+|||+++.
T Consensus       131 ~e~~-~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kL~Dfg~a~~  202 (345)
T 2v62_A          131 MERL-GIDLQKISGQN----GTFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYKNPDQVYLADYGLSYR  202 (345)
T ss_dssp             EECE-EEEHHHHCBGG----GBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEESSSTTSEEECCCTTCEE
T ss_pred             Eecc-CCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEccCCCCcEEEEeCCCcee
Confidence            9999 99999998542    2699999999999999999999995   599999999999999887  999999999987


Q ss_pred             CCCCCCc----ceeeecccCCccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccc
Q 039626          492 AEGQEGE----FALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKE  567 (628)
Q Consensus       492 ~~~~~~~----~~~~~~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~  567 (628)
                      .......    ........||+.|+|||.+.+..++.++||||||+++|||++|+.||........ ........... .
T Consensus       203 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~-~~~~~~~~~~~-~  280 (345)
T 2v62_A          203 YCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPV-AVQTAKTNLLD-E  280 (345)
T ss_dssp             SSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHH-HHHHHHHHHHH-T
T ss_pred             cccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccH-HHHHHHHhhcc-c
Confidence            6432211    0111345799999999999999999999999999999999999999864222111 11111111110 0


Q ss_pred             cchhhhccccCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhH
Q 039626          568 DGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNIL  622 (628)
Q Consensus       568 ~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~  622 (628)
                      . ...+.....   ..    ..+..+.+++.+||+.||++||++.+|++.|+.+.
T Consensus       281 ~-~~~~~~~~~---~~----~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~  327 (345)
T 2v62_A          281 L-PQSVLKWAP---SG----SSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHG  327 (345)
T ss_dssp             T-THHHHHHSC---TT----SCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTC
T ss_pred             c-cHHHHhhcc---cc----ccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccC
Confidence            0 011111100   01    23346889999999999999999999999998754

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=5e-36  Score=327.62  Aligned_cols=224  Identities=29%  Similarity=0.463  Sum_probs=185.2

Q ss_pred             eEEEEEEE--CCceEEEEEecc----------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhh
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG----------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFS  428 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  428 (628)
                      |.||+|+.  +|+.||||+++.          .+.+|+++|++++||||+++++++...+..++||||+++|+|.+++..
T Consensus        30 g~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~  109 (476)
T 2y94_A           30 GKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICK  109 (476)
T ss_dssp             SCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSSEEHHHHTTS
T ss_pred             eEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHh
Confidence            89999998  689999999853          356899999999999999999999999999999999999999999943


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCC
Q 039626          429 NKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGT  508 (628)
Q Consensus       429 ~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt  508 (628)
                          ...+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++......    ......||
T Consensus       110 ----~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~----~~~~~~gt  178 (476)
T 2y94_A          110 ----NGRLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE----FLRTSCGS  178 (476)
T ss_dssp             ----SSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCSSCEECCTTC----CBCCCCSC
T ss_pred             ----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEeccchhhccccc----cccccCCC
Confidence                34699999999999999999999985   49999999999999999999999999998765332    23345799


Q ss_pred             ccccCccccccCCC-CcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCH
Q 039626          509 KGYMAPEYLENGLV-STKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPL  587 (628)
Q Consensus       509 ~~Y~APE~l~~~~~-s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~  587 (628)
                      +.|+|||.+.+..+ +.++|||||||+++||++|+.||.....      ......+....             .  ..+.
T Consensus       179 ~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~------~~~~~~i~~~~-------------~--~~p~  237 (476)
T 2y94_A          179 PNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHV------PTLFKKICDGI-------------F--YTPQ  237 (476)
T ss_dssp             STTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSS------HHHHHHHHTTC-------------C--CCCT
T ss_pred             cCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCH------HHHHHHHhcCC-------------c--CCCc
Confidence            99999999988765 7899999999999999999999863221      12222221110             0  1122


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          588 ELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       588 ~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      .....+.+++.+||+.||.+|||++|+++
T Consensus       238 ~~s~~~~~Li~~~L~~dP~~Rpt~~eil~  266 (476)
T 2y94_A          238 YLNPSVISLLKHMLQVDPMKRATIKDIRE  266 (476)
T ss_dssp             TCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             cCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence            23356789999999999999999999986

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=2.3e-36  Score=320.77  Aligned_cols=237  Identities=23%  Similarity=0.345  Sum_probs=182.3

Q ss_pred             eEEEEEEE--CCceEEEEEeccc----------hHHHHHH-HhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhh
Q 039626          361 GSVYRGKI--NGGFAAIKKVNGD----------VSKEIAL-LNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVF  427 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~~----------~~~E~~~-l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~  427 (628)
                      |.||+++.  ++..+|+|+++..          +..|..+ ++.++||||+++++++.+.+..|+||||+++|+|.+++.
T Consensus        52 g~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~  131 (373)
T 2r5t_A           52 GKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQ  131 (373)
T ss_dssp             CEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHH
T ss_pred             eEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEEEeCCCCCcHHHHHH
Confidence            89999998  5778999998542          3445555 577899999999999999999999999999999999996


Q ss_pred             hcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccC
Q 039626          428 SNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVG  507 (628)
Q Consensus       428 ~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~g  507 (628)
                      ..    ..+++.....++.+|+.||+|||+.   +|+||||||+|||++.++.+||+|||+++......   .......|
T Consensus       132 ~~----~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~---~~~~~~~g  201 (373)
T 2r5t_A          132 RE----RCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN---STTSTFCG  201 (373)
T ss_dssp             HH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCC---CCCCSBSC
T ss_pred             hc----CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCccccccccCC---CccccccC
Confidence            43    3588999999999999999999995   49999999999999999999999999998643221   12345689


Q ss_pred             CccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCH
Q 039626          508 TKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPL  587 (628)
Q Consensus       508 t~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~  587 (628)
                      |+.|+|||.+.+..++.++|+|||||++|||++|+.||.....      .+....+....           .    .++.
T Consensus       202 t~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~------~~~~~~i~~~~-----------~----~~~~  260 (373)
T 2r5t_A          202 TPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT------AEMYDNILNKP-----------L----QLKP  260 (373)
T ss_dssp             CCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBH------HHHHHHHHHSC-----------C----CCCS
T ss_pred             CccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH------HHHHHHHHhcc-----------c----CCCC
Confidence            9999999999999999999999999999999999999864322      22222222110           0    1122


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCCHHHHH-HHHHHhHhhccCC
Q 039626          588 ELALLVIRLIDACLKKDPTDRPTMYEIE-HSLSNILNASLNW  628 (628)
Q Consensus       588 ~~~~~l~~l~~~Cl~~dP~~RPs~~ev~-~~L~~l~~~~~~w  628 (628)
                      ..+..+.+++.+||+.||.+||++.+.+ +.++.-.-..+||
T Consensus       261 ~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~~w  302 (373)
T 2r5t_A          261 NITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLINW  302 (373)
T ss_dssp             SSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTCCH
T ss_pred             CCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccCCCH
Confidence            2345678999999999999999986433 3333333344454

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=2e-36  Score=312.97  Aligned_cols=243  Identities=23%  Similarity=0.343  Sum_probs=179.8

Q ss_pred             eEEEEEEE--CCceEEEEEecc---------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhc
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG---------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSN  429 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~---------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~  429 (628)
                      |.||++..  +|+.+|+|++..         .+.+|++++++++|+||+++++++.+++..++||||+++++|.+++.. 
T Consensus        17 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-   95 (311)
T 4agu_A           17 GVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRY-   95 (311)
T ss_dssp             EEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHT-
T ss_pred             eEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEEeCCCchHHHHHhh-
Confidence            89999998  488999998843         356799999999999999999999999999999999999999988743 


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCCc
Q 039626          430 KNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTK  509 (628)
Q Consensus       430 ~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~  509 (628)
                         ...+++..+..++.+++.||+|||+.   +++||||||+||+++.++.+||+|||+++.......   ......||+
T Consensus        96 ---~~~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~  166 (311)
T 4agu_A           96 ---QRGVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSD---YYDDEVATR  166 (311)
T ss_dssp             ---SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC---------------G
T ss_pred             ---hcCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCchhccCccc---ccCCCcCCc
Confidence               34589999999999999999999995   499999999999999999999999999987653221   223457899


Q ss_pred             cccCcccccc-CCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccch--------hhhc--cccC
Q 039626          510 GYMAPEYLEN-GLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGE--------ESLR--HFID  578 (628)
Q Consensus       510 ~Y~APE~l~~-~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~l~--~~~d  578 (628)
                      .|+|||.+.+ ..++.++||||||++++||++|+.|+........   ...+..........        ....  ...+
T Consensus       167 ~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (311)
T 4agu_A          167 WYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQ---LYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPD  243 (311)
T ss_dssp             GGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCSCCHHHHHHHHTCGGGTTCCCCC
T ss_pred             cccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHhcccccccccccccccccccCcCCC
Confidence            9999999876 6789999999999999999999999875433221   11111111110000        0000  0001


Q ss_pred             CcCCCCC---CHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          579 PTLQGNY---PLELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       579 ~~l~~~~---~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      +......   ....+..+.+++.+||+.||.+|||++|+++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  284 (311)
T 4agu_A          244 PEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH  284 (311)
T ss_dssp             CSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred             ccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence            1000000   0123445789999999999999999999974

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=6.4e-36  Score=306.07  Aligned_cols=227  Identities=22%  Similarity=0.373  Sum_probs=179.9

Q ss_pred             eEEEEEEE--CCceEEEEEecc---------chHHHHHHHhhcCCCceeeeeeeeec----CCeEEEEEEecCCCChHHH
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG---------DVSKEIALLNKINHSNLIILSGVCFN----EGNCYLVYEYAVNGTLSDW  425 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~---------~~~~E~~~l~~l~H~nIv~l~g~~~~----~~~~~lV~E~~~~gsL~~~  425 (628)
                      |.||+|..  ++..||+|++..         .+.+|+.++++++||||+++++++..    +...++||||+++|+|.++
T Consensus        40 g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~  119 (290)
T 1t4h_A           40 KTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTY  119 (290)
T ss_dssp             EEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHH
T ss_pred             eEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEEEEecCCCCHHHH
Confidence            89999998  567899998853         26789999999999999999999875    3568999999999999999


Q ss_pred             hhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeC-CCCcEEEccccccccCCCCCCcceeeec
Q 039626          426 VFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLD-SDLRAKIANFAMARPAEGQEGEFALTRH  504 (628)
Q Consensus       426 l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~-~~~~~kl~Dfgla~~~~~~~~~~~~~~~  504 (628)
                      +...    ..+++..+..++.+++.||.|||+.+ ++++||||||+|||++ +++.+||+|||++.......     ...
T Consensus       120 l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~~~-----~~~  189 (290)
T 1t4h_A          120 LKRF----KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF-----AKA  189 (290)
T ss_dssp             HHHH----SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTTS-----BEE
T ss_pred             HHHc----cCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCcccccccc-----ccc
Confidence            9543    45899999999999999999999954 4599999999999998 78999999999997654321     234


Q ss_pred             ccCCccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCC
Q 039626          505 IVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGN  584 (628)
Q Consensus       505 ~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~  584 (628)
                      ..||+.|+|||.+.+ .++.++||||||++++||++|+.|+.....     .............         ....   
T Consensus       190 ~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~-----~~~~~~~~~~~~~---------~~~~---  251 (290)
T 1t4h_A          190 VIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN-----AAQIYRRVTSGVK---------PASF---  251 (290)
T ss_dssp             SCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS-----HHHHHHHHTTTCC---------CGGG---
T ss_pred             ccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCc-----HHHHHHHHhccCC---------cccc---
Confidence            579999999998874 589999999999999999999999863221     1122222211100         0011   


Q ss_pred             CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          585 YPLELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       585 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                       +......+.+++.+||+.||.+|||+.|+++
T Consensus       252 -~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  282 (290)
T 1t4h_A          252 -DKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             -GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             -CCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence             1112245789999999999999999999875

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=1.6e-36  Score=309.11  Aligned_cols=233  Identities=21%  Similarity=0.308  Sum_probs=184.2

Q ss_pred             cCCCcCCccc----eEEEEEEE--CCceEEEEEecc---------chHHHHHHHhhc-CCCceeeeeeeeecCCeEEEEE
Q 039626          351 DNFSFTCRIQ----GSVYRGKI--NGGFAAIKKVNG---------DVSKEIALLNKI-NHSNLIILSGVCFNEGNCYLVY  414 (628)
Q Consensus       351 ~~f~~~~~i~----G~Vy~g~~--~g~~vavK~~~~---------~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV~  414 (628)
                      ++|.....+|    |.||++..  +++.||+|+++.         ++.+|+..+.++ +||||+++++++.+++..++||
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~   90 (289)
T 1x8b_A           11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQN   90 (289)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEE
T ss_pred             chhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            3444444443    89999998  688999999863         356789999999 9999999999999999999999


Q ss_pred             EecCCCChHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCC-----------------
Q 039626          415 EYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDS-----------------  477 (628)
Q Consensus       415 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~-----------------  477 (628)
                      ||+++|+|.+++.........+++..+..++.|++.||+|||+.   +|+||||||+|||++.                 
T Consensus        91 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~  167 (289)
T 1x8b_A           91 EYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWA  167 (289)
T ss_dssp             ECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC------------------
T ss_pred             EecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCccccccccccccc
Confidence            99999999999976543345699999999999999999999995   4999999999999984                 


Q ss_pred             --CCcEEEccccccccCCCCCCcceeeecccCCccccCccccccC-CCCcccccHHHHHHHHHHHhCCCccccccccccc
Q 039626          478 --DLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENG-LVSTKLDVYAFGVLILEMLTGKEAAALHAEENNM  554 (628)
Q Consensus       478 --~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~-~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~  554 (628)
                        ...+||+|||++.......       ...||+.|+|||.+.+. .+++++||||||++++||++|+.++....     
T Consensus       168 ~~~~~~kl~Dfg~~~~~~~~~-------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~-----  235 (289)
T 1x8b_A          168 SNKVMFKIGDLGHVTRISSPQ-------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD-----  235 (289)
T ss_dssp             --CCCEEECCCTTCEETTCSC-------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH-----
T ss_pred             CCceEEEEcccccccccCCcc-------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh-----
Confidence              4489999999998765322       23589999999999765 66789999999999999999987653211     


Q ss_pred             cHHHHHHHHhccccchhhhccccCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          555 HLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       555 ~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                       ..   ..+..          ...+.+..    ..+..+.+++.+||+.||++|||+.|+++
T Consensus       236 -~~---~~~~~----------~~~~~~~~----~~~~~~~~li~~~l~~dp~~Rps~~~ll~  279 (289)
T 1x8b_A          236 -QW---HEIRQ----------GRLPRIPQ----VLSQEFTELLKVMIHPDPERRPSAMALVK  279 (289)
T ss_dssp             -HH---HHHHT----------TCCCCCSS----CCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -HH---HHHHc----------CCCCCCCc----ccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence             11   11110          01112222    23456789999999999999999999875

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=5.6e-37  Score=311.82  Aligned_cols=235  Identities=21%  Similarity=0.353  Sum_probs=185.2

Q ss_pred             eEEEEEEE--CCceEEEEEecc---------chHHHHHHHhhcCCCceeeeeeeeec--CCeEEEEEEecCCCChHHHhh
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG---------DVSKEIALLNKINHSNLIILSGVCFN--EGNCYLVYEYAVNGTLSDWVF  427 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~---------~~~~E~~~l~~l~H~nIv~l~g~~~~--~~~~~lV~E~~~~gsL~~~l~  427 (628)
                      |.||++..  +|+.+|+|++..         .+.+|++++++++|+||+++++++.+  ++..++||||+++|+|.+++.
T Consensus        20 g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~   99 (279)
T 2w5a_A           20 GRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVIT   99 (279)
T ss_dssp             SEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEEEECCTTEEHHHHHH
T ss_pred             cEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEEEeCCCCCCHHHHHH
Confidence            89999998  688999999853         36789999999999999999998853  568999999999999999997


Q ss_pred             hcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC--CCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecc
Q 039626          428 SNKNEGKYLDWKQRIQIALDVATGLNYLHSFT--NPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHI  505 (628)
Q Consensus       428 ~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~  505 (628)
                      ........+++..++.++.|++.||+|||+.+  ..+++||||||+||+++.++.+||+|||+++.......   .....
T Consensus       100 ~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~~~~~~~~---~~~~~  176 (279)
T 2w5a_A          100 KGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTS---FAKTF  176 (279)
T ss_dssp             HHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHHHC---CH---HHHHH
T ss_pred             hhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchheeeccccc---ccccc
Confidence            65555566999999999999999999999843  12399999999999999999999999999987643221   12335


Q ss_pred             cCCccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCC
Q 039626          506 VGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNY  585 (628)
Q Consensus       506 ~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~  585 (628)
                      .||+.|+|||.+.+..++.++||||||++++||++|+.|+.....      .+....+...          ..+.+    
T Consensus       177 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~i~~~----------~~~~~----  236 (279)
T 2w5a_A          177 VGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ------KELAGKIREG----------KFRRI----  236 (279)
T ss_dssp             HSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHT----------CCCCC----
T ss_pred             CCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCH------HHHHHHHhhc----------ccccC----
Confidence            789999999999999999999999999999999999998864321      1111111110          00111    


Q ss_pred             CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 039626          586 PLELALLVIRLIDACLKKDPTDRPTMYEIEHSL  618 (628)
Q Consensus       586 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L  618 (628)
                      +...+..+.+++.+||+.||.+||++.|+++.+
T Consensus       237 ~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~  269 (279)
T 2w5a_A          237 PYRYSDELNEIITRMLNLKDYHRPSVEEILENP  269 (279)
T ss_dssp             CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTST
T ss_pred             CcccCHHHHHHHHHHcCCCcccCCCHHHHHhCh
Confidence            223345678999999999999999999998754

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=1.6e-36  Score=316.22  Aligned_cols=240  Identities=25%  Similarity=0.411  Sum_probs=188.7

Q ss_pred             eEEEEEEE-------CCceEEEEEecc--------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHH
Q 039626          361 GSVYRGKI-------NGGFAAIKKVNG--------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDW  425 (628)
Q Consensus       361 G~Vy~g~~-------~g~~vavK~~~~--------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~  425 (628)
                      |.||+|++       .+..||||++..        ++.+|+.++++++|+||+++++++.+++..++||||+++|+|.++
T Consensus        44 g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~  123 (327)
T 2yfx_A           44 GEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSF  123 (327)
T ss_dssp             SCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHH
T ss_pred             eeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCcEEEEecCCCCcHHHH
Confidence            89999984       456899999853        367899999999999999999999999999999999999999999


Q ss_pred             hhhcCCC---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCC---CCcEEEccccccccCCCCCCcc
Q 039626          426 VFSNKNE---GKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDS---DLRAKIANFAMARPAEGQEGEF  499 (628)
Q Consensus       426 l~~~~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~---~~~~kl~Dfgla~~~~~~~~~~  499 (628)
                      +......   ...+++..++.++.|++.||.|||+.   +++||||||+|||++.   +..+||+|||+++....... .
T Consensus       124 l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~~~kl~Dfg~~~~~~~~~~-~  199 (327)
T 2yfx_A          124 LRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASY-Y  199 (327)
T ss_dssp             HHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHC-----
T ss_pred             HHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcceEEECccccccccccccc-c
Confidence            9764322   24589999999999999999999995   4999999999999984   45699999999976532221 1


Q ss_pred             eeeecccCCccccCccccccCCCCcccccHHHHHHHHHHHh-CCCccccccccccccHHHHHHHHhccccchhhhccccC
Q 039626          500 ALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT-GKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFID  578 (628)
Q Consensus       500 ~~~~~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELlt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d  578 (628)
                      .......||+.|+|||.+.+..++.++||||||+++|||++ |+.|+.....      .+....+....          .
T Consensus       200 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~------~~~~~~~~~~~----------~  263 (327)
T 2yfx_A          200 RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN------QEVLEFVTSGG----------R  263 (327)
T ss_dssp             --CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH------HHHHHHHHTTC----------C
T ss_pred             ccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCH------HHHHHHHhcCC----------C
Confidence            12234568899999999999999999999999999999998 8888763321      11221111110          0


Q ss_pred             CcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhh
Q 039626          579 PTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNA  624 (628)
Q Consensus       579 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~~~  624 (628)
                      +    ..+...+..+.+++.+||+.||.+||++.|+++.|+.+.+.
T Consensus       264 ~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~  305 (327)
T 2yfx_A          264 M----DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD  305 (327)
T ss_dssp             C----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             C----CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcC
Confidence            1    11223345678999999999999999999999999988753

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=4.2e-36  Score=322.16  Aligned_cols=234  Identities=20%  Similarity=0.251  Sum_probs=177.8

Q ss_pred             eEEEEEEE--CCceEEEEEecc--chHHHHHHHhh-cCCCceeeeeeeeec----CCeEEEEEEecCCCChHHHhhhcCC
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG--DVSKEIALLNK-INHSNLIILSGVCFN----EGNCYLVYEYAVNGTLSDWVFSNKN  431 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~--~~~~E~~~l~~-l~H~nIv~l~g~~~~----~~~~~lV~E~~~~gsL~~~l~~~~~  431 (628)
                      |.||++..  +|+.||||+++.  .+.+|++++.+ .+|+||+++++++..    ++..++||||+++|+|.+++...  
T Consensus        76 g~V~~~~~~~~~~~vAiK~~~~~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~--  153 (400)
T 1nxk_A           76 GKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDR--  153 (400)
T ss_dssp             EEEEEEEETTTCCEEEEEEEECSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHCC--
T ss_pred             eEEEEEEECCCCCEEEEEEeCcchhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEeCCCCcHHHHHHHh--
Confidence            89999998  588999999864  46789988754 589999999999875    56789999999999999999642  


Q ss_pred             CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCC---CCcEEEccccccccCCCCCCcceeeecccCC
Q 039626          432 EGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDS---DLRAKIANFAMARPAEGQEGEFALTRHIVGT  508 (628)
Q Consensus       432 ~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~---~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt  508 (628)
                      ....+++..+..|+.||+.||+|||+.   +|+||||||+|||++.   ++.+||+|||+++......    ......||
T Consensus       154 ~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~~----~~~~~~gt  226 (400)
T 1nxk_A          154 GDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN----SLTTPCYT  226 (400)
T ss_dssp             ---CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC---------------
T ss_pred             CCCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEecccccccCCCC----ccccCCCC
Confidence            234699999999999999999999995   4999999999999998   7899999999998654321    12345789


Q ss_pred             ccccCccccccCCCCcccccHHHHHHHHHHHhCCCcccccccccc-ccHHHHHHHHhccccchhhhccccCCcCCCCCCH
Q 039626          509 KGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENN-MHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPL  587 (628)
Q Consensus       509 ~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~  587 (628)
                      +.|+|||++.+..++.++|||||||++|||++|+.||........ ......+..   ..        +   ........
T Consensus       227 ~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~---~~--------~---~~~~~~~~  292 (400)
T 1nxk_A          227 PYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRM---GQ--------Y---EFPNPEWS  292 (400)
T ss_dssp             CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHH---TC--------C---CCCTTTTT
T ss_pred             CCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHc---Cc--------c---cCCCcccc
Confidence            999999999999999999999999999999999999875433221 111111110   00        0   00000011


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 039626          588 ELALLVIRLIDACLKKDPTDRPTMYEIEHS  617 (628)
Q Consensus       588 ~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~  617 (628)
                      ..+..+.+|+.+||+.||++|||+.|+++-
T Consensus       293 ~~s~~~~~li~~~L~~dP~~Rpt~~eil~h  322 (400)
T 1nxk_A          293 EVSEEVKMLIRNLLKTEPTQRMTITEFMNH  322 (400)
T ss_dssp             TSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             cCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            234567899999999999999999999863

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=1.6e-36  Score=313.40  Aligned_cols=253  Identities=25%  Similarity=0.354  Sum_probs=187.2

Q ss_pred             hcCCCcCCccc----eEEEEEEE--CCceEEEEEecc------------chHHHHHHHhhcC---CCceeeeeeeeecCC
Q 039626          350 TDNFSFTCRIQ----GSVYRGKI--NGGFAAIKKVNG------------DVSKEIALLNKIN---HSNLIILSGVCFNEG  408 (628)
Q Consensus       350 t~~f~~~~~i~----G~Vy~g~~--~g~~vavK~~~~------------~~~~E~~~l~~l~---H~nIv~l~g~~~~~~  408 (628)
                      +++|.....+|    |.||+++.  +|+.||+|+++.            .+.+|++++++++   ||||+++++++....
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~   87 (308)
T 3g33_A            8 TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSR   87 (308)
T ss_dssp             --CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccC
Confidence            44565555554    89999996  788999998852            4567888877775   999999999998654


Q ss_pred             -----eEEEEEEecCCCChHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEE
Q 039626          409 -----NCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKI  483 (628)
Q Consensus       409 -----~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl  483 (628)
                           ..++||||+. |+|.+++...  ....+++..+..++.|++.||+|||+.+   ++||||||+|||++.++.+||
T Consensus        88 ~~~~~~~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl  161 (308)
T 3g33_A           88 TDREIKVTLVFEHVD-QDLRTYLDKA--PPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKL  161 (308)
T ss_dssp             SSSEEEEEEEEECCC-CBHHHHHHTC--CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEEE
T ss_pred             CCCceeEEEEehhhh-cCHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEE
Confidence                 5799999996 6999999643  2334999999999999999999999954   999999999999999999999


Q ss_pred             ccccccccCCCCCCcceeeecccCCccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHH
Q 039626          484 ANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAV  563 (628)
Q Consensus       484 ~Dfgla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~  563 (628)
                      +|||+++......    ......||+.|+|||.+.+..++.++|||||||+++||++|+.|+.......  .+..... .
T Consensus       162 ~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--~~~~i~~-~  234 (308)
T 3g33_A          162 ADFGLARIYSYQM----ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD--QLGKIFD-L  234 (308)
T ss_dssp             CSCSCTTTSTTCC----CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHH--HHHHHHH-H
T ss_pred             eeCccccccCCCc----ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHH-H
Confidence            9999998764322    2234679999999999999999999999999999999999999986433221  1111111 1


Q ss_pred             hccccchhhhc-------cccCCcCCC---CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          564 LTKEDGEESLR-------HFIDPTLQG---NYPLELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       564 ~~~~~~~~~l~-------~~~d~~l~~---~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      ..... .....       ..+.+....   ....+....+.+++.+||+.||++|||+.|+++
T Consensus       235 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  296 (308)
T 3g33_A          235 IGLPP-EDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ  296 (308)
T ss_dssp             HCCCC-TTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hCCCC-hhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence            11110 00000       000000000   001123456789999999999999999999875

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=7.7e-36  Score=304.25  Aligned_cols=238  Identities=23%  Similarity=0.326  Sum_probs=188.4

Q ss_pred             cCCCcCCccc----eEEEEEEE--CCceEEEEEecc---------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEE
Q 039626          351 DNFSFTCRIQ----GSVYRGKI--NGGFAAIKKVNG---------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYE  415 (628)
Q Consensus       351 ~~f~~~~~i~----G~Vy~g~~--~g~~vavK~~~~---------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  415 (628)
                      ++|.....+|    |.||++..  +|..+|+|++..         .+.+|++++++++|+||+++++++.+++..++|||
T Consensus         6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   85 (284)
T 3kk8_A            6 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD   85 (284)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             hhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEe
Confidence            3444444454    89999988  588999999853         35679999999999999999999999999999999


Q ss_pred             ecCCCChHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCc---EEEccccccccC
Q 039626          416 YAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLR---AKIANFAMARPA  492 (628)
Q Consensus       416 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~---~kl~Dfgla~~~  492 (628)
                      |+++|+|.+++...    ..+++..+..++.|++.||+|||+.   +++||||||+||+++.++.   +||+|||++...
T Consensus        86 ~~~~~~l~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~  158 (284)
T 3kk8_A           86 LVTGGELFEDIVAR----EFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV  158 (284)
T ss_dssp             CCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred             cCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEc
Confidence            99999999988643    4589999999999999999999995   4999999999999987655   999999999876


Q ss_pred             CCCCCcceeeecccCCccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhh
Q 039626          493 EGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEES  572 (628)
Q Consensus       493 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  572 (628)
                      ....    ......||+.|+|||.+.+..++.++||||||++++||++|+.|+.....      ......+.....    
T Consensus       159 ~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~------~~~~~~~~~~~~----  224 (284)
T 3kk8_A          159 NDSE----AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ------HRLYAQIKAGAY----  224 (284)
T ss_dssp             CSSC----BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHTCC----
T ss_pred             ccCc----cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCch------hHHHHHHHhccc----
Confidence            5332    12345799999999999999999999999999999999999999864322      111111111100    


Q ss_pred             hccccCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          573 LRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       573 l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                        ....     ......+..+.+++.+||+.||++|||+.|+++
T Consensus       225 --~~~~-----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  261 (284)
T 3kk8_A          225 --DYPS-----PEWDTVTPEAKSLIDSMLTVNPKKRITADQALK  261 (284)
T ss_dssp             --CCCT-----TTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             --cCCc-----hhhcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence              0000     011123456789999999999999999999976

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=1.9e-36  Score=315.98  Aligned_cols=238  Identities=20%  Similarity=0.301  Sum_probs=171.1

Q ss_pred             eEEEEEEE--CCceEEEEEecc-------chHHHHHHHhhcC-CCceeeeeeeee--------cCCeEEEEEEecCCCCh
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG-------DVSKEIALLNKIN-HSNLIILSGVCF--------NEGNCYLVYEYAVNGTL  422 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~-------~~~~E~~~l~~l~-H~nIv~l~g~~~--------~~~~~~lV~E~~~~gsL  422 (628)
                      |.||+++.  +++.||+|++..       .+.+|+.++.++. |+||+++++++.        .....++||||+. |+|
T Consensus        42 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~-g~L  120 (337)
T 3ll6_A           42 AFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCK-GQL  120 (337)
T ss_dssp             EEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSEEEEEEEECCS-EEH
T ss_pred             eEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCceEEEEEEecC-CCH
Confidence            89999998  788999998843       3678999999996 999999999994        3345899999995 799


Q ss_pred             HHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcc---
Q 039626          423 SDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEF---  499 (628)
Q Consensus       423 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~---  499 (628)
                      .+++.... ....+++..++.++.|++.||+|||+.+ ++++||||||+|||++.++.+||+|||+++.........   
T Consensus       121 ~~~l~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~  198 (337)
T 3ll6_A          121 VEFLKKME-SRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSA  198 (337)
T ss_dssp             HHHHHHHH-TTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBCCCTTCBCCSSCC------
T ss_pred             HHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEecCccceeccccCcccccc
Confidence            99986432 2346999999999999999999999854 459999999999999999999999999998765432110   


Q ss_pred             ------eeeecccCCccccCcccc---ccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccch
Q 039626          500 ------ALTRHIVGTKGYMAPEYL---ENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGE  570 (628)
Q Consensus       500 ------~~~~~~~gt~~Y~APE~l---~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  570 (628)
                            .......||+.|+|||.+   .+..++.++||||||+++|||++|+.|+......      .....        
T Consensus       199 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~------~~~~~--------  264 (337)
T 3ll6_A          199 QRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL------RIVNG--------  264 (337)
T ss_dssp             -------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-------------------------
T ss_pred             cccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHH------HhhcC--------
Confidence                  011134689999999998   5667899999999999999999999998632211      00000        


Q ss_pred             hhhccccCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhh
Q 039626          571 ESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNA  624 (628)
Q Consensus       571 ~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~~~  624 (628)
                           .........    ....+.+++.+||+.||.+||++.|+++.|+.+...
T Consensus       265 -----~~~~~~~~~----~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~  309 (337)
T 3ll6_A          265 -----KYSIPPHDT----QYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAA  309 (337)
T ss_dssp             ------CCCCTTCC----SSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             -----cccCCcccc----cchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence                 000001111    123467899999999999999999999999998754

>4eby_A Chitin elicitor receptor kinase 1; pathogen-associated molecular patterns, pattern recognition receptors, LYSM, lysine chitin oligomer; HET: NAG BMA; 1.65A {Arabidopsis thaliana} PDB: 4ebz_A*

Probab=100.00  E-value=1.3e-35  Score=285.64  Aligned_cols=173  Identities=24%  Similarity=0.433  Sum_probs=154.6

Q ss_pred             cccc-eeEeeecCCCCCCHHHHHHHhCCCh--------Hhhhhhc-Ccc----ccCCcEEEEcccCccCC-CCcccceeE
Q 039626           58 KSCR-AYLTFRSQPPFNTVASISTLLGSEP--------SLLSQIN-SVS----LETNRLVIVPVNCSCSG-QYYQSNTTY  122 (628)
Q Consensus        58 ~~c~-~~~~~~~~~~~~tl~~Ia~~~~~~~--------~~i~~~N-~~~----~~~gq~l~vp~~c~c~~-~~~~~~~~y  122 (628)
                      .+|+ +|..|++++ ||||+.||++||+++        ++|+++| +++    |.+||.|.||.+|.|.+ ...++..+|
T Consensus         3 ~~C~~a~~~Y~V~~-GDTL~~IA~~~~vsv~~~~~~~~~~I~~~Np~l~~~~~l~~Gq~L~IP~~~~~~~~~~~~~~~~Y   81 (212)
T 4eby_A            3 TSCPLALASYYLEN-GTTLSVINQNLNSSIAPYDQINFDPILRYNSNIKDKDRIQMGSRVLVPFPCECQPGDFLGHNFSY   81 (212)
T ss_dssp             CCCSCEEEEEECCT-TCCHHHHHHHTCCSSSCCCSSCCHHHHTTCTTCSCTTSCCTTCEEEEEECCEEETTTEEEEEEEE
T ss_pred             CCCccceEEEEeCC-CCCHHHHHHHHCCCchhccccCHHHHHHhccCCCCcCccCCCCEEEEeccccccCCccccCceEE
Confidence            5899 999999975 999999999999998        9999999 994    99999999999999974 345566789


Q ss_pred             EEecCChHHHHHhhhcCCCccHHHHHhccCCC-CccCCCcEEEEeecCCCCCCCCCCCCCCeEEEEEccCCCcHHHHHHH
Q 039626          123 TIQNGDTYLFIANNTFQGLSTCQALEDQNGSP-TNLIIGAGVTVPLRCACPTENQTDEGFPFLLSYLVAEGDTVSGISSR  201 (628)
Q Consensus       123 ~V~~gdt~~~IA~~~~~~l~t~~~l~~~N~~~-~~l~~Gq~l~vp~~~~c~~~~~~~~~~~~~~~y~v~~gdtl~~ia~~  201 (628)
                      +|++|||||.||++.|.+++++++|+++|+.. +.|++||+|.||..|+|++. +.+++.....+|+|++|||||+||++
T Consensus        82 ~V~~GDTL~~IA~~~y~~lvt~~~L~~~N~~~~~~l~~Gq~L~IP~~~~~~~~-~~~~~~~~~~~Y~V~~GDTL~~IA~~  160 (212)
T 4eby_A           82 SVRQEDTYERVAISNYANLTTMESLQARNPFPATNIPLSATLNVLVNCSCGDE-SVSKDFGLFVTYPLRPEDSLSSIARS  160 (212)
T ss_dssp             ECCTTCCHHHHHHTTTTTSSCHHHHHHHCCSCTTCCCTTCEEEEEEECCCCCT-TTCSSCCCEEEEECCTTCCHHHHHHH
T ss_pred             EecCCCcHHHHHHHhcCCCCCHHHHHHhcCCCcccCCCCCEEEEcCCCcCCCc-ccccCCCCeEEEEECCCCcHHHHHHH
Confidence            99999999999966677899999999999977 89999999999999999874 45566677899999999999999999


Q ss_pred             hCCChHHHhhhcCCCCCCccccceeeccCCCC
Q 039626          202 FGVDTGEILQANSLSGSNIFPFTTLLIPLENP  233 (628)
Q Consensus       202 f~~~~~~l~~~N~~~~~~~~~~~~l~iP~~~~  233 (628)
                      ||+++++|++||++.+..+.+|+ |+||.+.+
T Consensus       161 fgvsv~~L~~~N~~~~~~~~~g~-l~IP~~~~  191 (212)
T 4eby_A          161 SGVSADILQRYNPGVNFNSGNGI-VYVPGRDP  191 (212)
T ss_dssp             HTSCHHHHHHHSTTCCTTSCSSE-EEEECCCT
T ss_pred             HCcCHHHHHHhcCCCccCCCCCE-EEecCCCC
Confidence            99999999999998766666666 99999874

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=3.4e-36  Score=311.42  Aligned_cols=247  Identities=19%  Similarity=0.280  Sum_probs=185.2

Q ss_pred             cCCCcCCccc----eEEEEEEE--CCceEEEEEecc----------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEE
Q 039626          351 DNFSFTCRIQ----GSVYRGKI--NGGFAAIKKVNG----------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVY  414 (628)
Q Consensus       351 ~~f~~~~~i~----G~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~  414 (628)
                      ++|.....+|    |.||++..  +++.||+|.+..          .+.+|+.++++++||||+++++++..++..++||
T Consensus        34 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  113 (309)
T 2h34_A           34 GPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDM  113 (309)
T ss_dssp             CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             ccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEE
Confidence            3444444443    89999997  578999999853          3567999999999999999999999999999999


Q ss_pred             EecCCCChHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCC
Q 039626          415 EYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEG  494 (628)
Q Consensus       415 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~  494 (628)
                      ||+++++|.+++...    ..+++..++.++.+++.||+|||+.   +++||||||+|||++.++.+||+|||++.....
T Consensus       114 e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  186 (309)
T 2h34_A          114 RLINGVDLAAMLRRQ----GPLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATTD  186 (309)
T ss_dssp             ECCCCEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCCC------
T ss_pred             EecCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCccCccccc
Confidence            999999999999643    3589999999999999999999995   499999999999999999999999999986643


Q ss_pred             CCCcceeeecccCCccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhc
Q 039626          495 QEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLR  574 (628)
Q Consensus       495 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  574 (628)
                      ...  .......|++.|+|||.+.+..++.++||||||++++||++|+.||......       ...........     
T Consensus       187 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------~~~~~~~~~~~-----  252 (309)
T 2h34_A          187 EKL--TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS-------VMGAHINQAIP-----  252 (309)
T ss_dssp             ------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH-------HHHHHHHSCCC-----
T ss_pred             ccc--ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH-------HHHHHhccCCC-----
Confidence            221  1223457999999999999999999999999999999999999998643211       11111111100     


Q ss_pred             cccCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHHHhHhh
Q 039626          575 HFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRP-TMYEIEHSLSNILNA  624 (628)
Q Consensus       575 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-s~~ev~~~L~~l~~~  624 (628)
                         .+   ...+...+..+.+++.+||+.||++|| +++++++.|++.+..
T Consensus       253 ---~~---~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~  297 (309)
T 2h34_A          253 ---RP---STVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALAT  297 (309)
T ss_dssp             ---CG---GGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC-
T ss_pred             ---Cc---cccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHh
Confidence               00   011122334578999999999999999 999999999987654

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=2.5e-36  Score=322.91  Aligned_cols=228  Identities=26%  Similarity=0.376  Sum_probs=177.2

Q ss_pred             eEEEEEEE-CCceEEEEEecc---------chHHHHHHHhhcC--CCceeeeeeeeecCCeEEEEEEecCCCChHHHhhh
Q 039626          361 GSVYRGKI-NGGFAAIKKVNG---------DVSKEIALLNKIN--HSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFS  428 (628)
Q Consensus       361 G~Vy~g~~-~g~~vavK~~~~---------~~~~E~~~l~~l~--H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  428 (628)
                      |.||++.. .++.||||++..         .+.+|+++|.+++  |+||+++++++..++..++||| +.+++|.+++..
T Consensus        70 g~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~E-~~~~~L~~~l~~  148 (390)
T 2zmd_A           70 SKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKK  148 (390)
T ss_dssp             EEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEE-CCSEEHHHHHHH
T ss_pred             eEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEEe-cCCCCHHHHHHh
Confidence            89999988 578899998842         3678999999996  5999999999999999999999 568899999964


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCC
Q 039626          429 NKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGT  508 (628)
Q Consensus       429 ~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt  508 (628)
                      .    ..+++..+..++.||+.||+|||+.   +|+||||||+|||++ ++.+||+|||+++........ .......||
T Consensus       149 ~----~~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~-~~~~~~~gt  219 (390)
T 2zmd_A          149 K----KSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTS-VVKDSQVGA  219 (390)
T ss_dssp             C----SSCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCSSSCCC----------CCSCCC
T ss_pred             c----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecCccccccCCCcc-ccCCCCCcC
Confidence            2    3589999999999999999999985   499999999999996 588999999999876433211 123345799


Q ss_pred             ccccCcccccc-----------CCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhcccc
Q 039626          509 KGYMAPEYLEN-----------GLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFI  577 (628)
Q Consensus       509 ~~Y~APE~l~~-----------~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  577 (628)
                      +.|+|||++.+           ..++.++|||||||++|||++|+.||.....     ....+..+             +
T Consensus       220 ~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~-----~~~~~~~~-------------~  281 (390)
T 2zmd_A          220 VNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-----QISKLHAI-------------I  281 (390)
T ss_dssp             GGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCC-----HHHHHHHH-------------H
T ss_pred             CCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhH-----HHHHHHHH-------------h
Confidence            99999999865           4689999999999999999999999863211     11112222             1


Q ss_pred             CCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          578 DPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       578 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      ++.....++......+.+|+.+||+.||.+||++.|+++
T Consensus       282 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~  320 (390)
T 2zmd_A          282 DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA  320 (390)
T ss_dssp             CTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhh
Confidence            222222222222456789999999999999999999975

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=3.1e-36  Score=313.39  Aligned_cols=228  Identities=22%  Similarity=0.330  Sum_probs=185.2

Q ss_pred             eEEEEEEE--CCceEEEEEecc-------------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHH
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG-------------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDW  425 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~-------------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~  425 (628)
                      |.||++..  +|..+|+|.++.             ++.+|++++++++||||+++++++.+++..++||||+++++|.++
T Consensus        26 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~  105 (321)
T 2a2a_A           26 AIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDF  105 (321)
T ss_dssp             EEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHH
T ss_pred             EEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEEcCCCCcHHHH
Confidence            89999998  588999998853             267899999999999999999999999999999999999999999


Q ss_pred             hhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCC----cEEEccccccccCCCCCCccee
Q 039626          426 VFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDL----RAKIANFAMARPAEGQEGEFAL  501 (628)
Q Consensus       426 l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~----~~kl~Dfgla~~~~~~~~~~~~  501 (628)
                      +..    ...+++..+..++.|++.||+|||+.   +++||||||+||+++.++    .+||+|||+++......    .
T Consensus       106 l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~~~~----~  174 (321)
T 2a2a_A          106 LAQ----KESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV----E  174 (321)
T ss_dssp             HHT----CSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCTTCEECCTTC----C
T ss_pred             HHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEEccCccceecCccc----c
Confidence            953    34589999999999999999999995   499999999999999988    79999999998765432    1


Q ss_pred             eecccCCccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcC
Q 039626          502 TRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTL  581 (628)
Q Consensus       502 ~~~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l  581 (628)
                      .....||+.|+|||.+.+..++.++||||||++++||++|+.|+.....      .+....+.....       ..++..
T Consensus       175 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~~~~~i~~~~~-------~~~~~~  241 (321)
T 2a2a_A          175 FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK------QETLANITSVSY-------DFDEEF  241 (321)
T ss_dssp             CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH------HHHHHHHHTTCC-------CCCHHH
T ss_pred             ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCH------HHHHHHHHhccc-------ccChhh
Confidence            2345799999999999999999999999999999999999999864322      122222111100       000000


Q ss_pred             CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          582 QGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       582 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      ..    ..+..+.+++.+||+.||++|||+.|+++
T Consensus       242 ~~----~~~~~~~~li~~~l~~dp~~Rps~~e~l~  272 (321)
T 2a2a_A          242 FS----HTSELAKDFIRKLLVKETRKRLTIQEALR  272 (321)
T ss_dssp             HT----TCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred             hc----ccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            11    12345789999999999999999999975

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=5.3e-36  Score=303.99  Aligned_cols=230  Identities=25%  Similarity=0.345  Sum_probs=183.5

Q ss_pred             eEEEEEEE--CCceEEEEEecc--------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhcC
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG--------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNK  430 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~--------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~  430 (628)
                      |.||++..  +++.||+|.+..        .+.+|+.++++++|+||+++++++.+++..++||||+++|+|.+++.   
T Consensus        21 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~---   97 (276)
T 2yex_A           21 GEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE---   97 (276)
T ss_dssp             SEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEGGGGSB---
T ss_pred             cEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEecCCCcHHHHHh---
Confidence            89999998  588999999853        36789999999999999999999999999999999999999999884   


Q ss_pred             CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCCcc
Q 039626          431 NEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKG  510 (628)
Q Consensus       431 ~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~  510 (628)
                       ....+++..+..++.|++.||+|||+.   +++|+||||+||+++.++.+||+|||++........ ........||+.
T Consensus        98 -~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~~  172 (276)
T 2yex_A           98 -PDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR-ERLLNKMCGTLP  172 (276)
T ss_dssp             -TTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTE-ECCBCCCCSCGG
T ss_pred             -hccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCCccccCCCcc-hhcccCCccccC
Confidence             234689999999999999999999995   499999999999999999999999999986542211 112334579999


Q ss_pred             ccCccccccCCC-CcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCHHH
Q 039626          511 YMAPEYLENGLV-STKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLEL  589 (628)
Q Consensus       511 Y~APE~l~~~~~-s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~  589 (628)
                      |+|||.+.+..+ +.++||||||++++||++|+.|+........ ...    .......       ..      ......
T Consensus       173 y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~----~~~~~~~-------~~------~~~~~~  234 (276)
T 2yex_A          173 YVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYS----DWKEKKT-------YL------NPWKKI  234 (276)
T ss_dssp             GCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH-HHH----HHHTTCT-------TS------TTGGGS
T ss_pred             ccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH-HHH----Hhhhccc-------cc------Cchhhc
Confidence            999999987665 7899999999999999999999864332111 011    1111000       00      001123


Q ss_pred             HHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          590 ALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       590 ~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      +..+.+++.+||+.||.+|||++|+++
T Consensus       235 ~~~~~~li~~~l~~~p~~Rps~~~il~  261 (276)
T 2yex_A          235 DSAPLALLHKILVENPSARITIPDIKK  261 (276)
T ss_dssp             CHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence            456789999999999999999999875

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=6.6e-36  Score=303.75  Aligned_cols=223  Identities=24%  Similarity=0.351  Sum_probs=182.6

Q ss_pred             eEEEEEEE--CCceEEEEEecc-------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhcCC
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG-------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKN  431 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~-------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~  431 (628)
                      |.||+|..  ++..+|+|++..       .+.+|++++++++|+||+++++++.+++..++||||+++++|.+++...  
T Consensus        23 g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--  100 (277)
T 3f3z_A           23 GEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHK--  100 (277)
T ss_dssp             EEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHH--
T ss_pred             EEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEeccCCCcHHHHHHHc--
Confidence            89999998  466899999864       4678999999999999999999999999999999999999999998643  


Q ss_pred             CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEe---CCCCcEEEccccccccCCCCCCcceeeecccCC
Q 039626          432 EGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLL---DSDLRAKIANFAMARPAEGQEGEFALTRHIVGT  508 (628)
Q Consensus       432 ~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl---~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt  508 (628)
                        ..+++..+..++.|++.||+|||+.   +++||||||+||++   +.++.+||+|||++.......    ......||
T Consensus       101 --~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~----~~~~~~~t  171 (277)
T 3f3z_A          101 --RVFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK----MMRTKVGT  171 (277)
T ss_dssp             --CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTS----CBCCCCSC
T ss_pred             --CCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEecccceeccCcc----chhccCCC
Confidence              3489999999999999999999995   49999999999999   888999999999998765332    22345799


Q ss_pred             ccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCH-
Q 039626          509 KGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPL-  587 (628)
Q Consensus       509 ~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~-  587 (628)
                      +.|+|||.+.+. ++.++||||||++++||++|+.|+......      +....+.....               ..+. 
T Consensus       172 ~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~~~~~~~~~~~---------------~~~~~  229 (277)
T 3f3z_A          172 PYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDS------EVMLKIREGTF---------------TFPEK  229 (277)
T ss_dssp             TTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHCCC---------------CCCHH
T ss_pred             CCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHH------HHHHHHHhCCC---------------CCCch
Confidence            999999988764 899999999999999999999998643221      11111111100               0111 


Q ss_pred             ---HHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          588 ---ELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       588 ---~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                         ..+..+.+++.+||+.||.+||++.|+++
T Consensus       230 ~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~  261 (277)
T 3f3z_A          230 DWLNVSPQAESLIRRLLTKSPKQRITSLQALE  261 (277)
T ss_dssp             HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             hhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence               12456789999999999999999999975

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=6.6e-36  Score=331.57  Aligned_cols=239  Identities=23%  Similarity=0.309  Sum_probs=191.4

Q ss_pred             cCCCcCCccc----eEEEEEEE--CCceEEEEEecc----------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEE
Q 039626          351 DNFSFTCRIQ----GSVYRGKI--NGGFAAIKKVNG----------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVY  414 (628)
Q Consensus       351 ~~f~~~~~i~----G~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~  414 (628)
                      ++|.....+|    |.||+++.  +|+.+|+|++..          .+.+|+++|++++||||+++++++.+++..++||
T Consensus       184 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm  263 (576)
T 2acx_A          184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVL  263 (576)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEE
Confidence            4455555554    89999998  688999999853          2567999999999999999999999999999999


Q ss_pred             EecCCCChHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCC
Q 039626          415 EYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEG  494 (628)
Q Consensus       415 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~  494 (628)
                      ||+++|+|.+++...  ....+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++....
T Consensus       264 Ey~~gg~L~~~l~~~--~~~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~  338 (576)
T 2acx_A          264 TLMNGGDLKFHIYHM--GQAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPE  338 (576)
T ss_dssp             CCCCSCBHHHHHHSS--SSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             EcCCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEecccceeccc
Confidence            999999999999643  234589999999999999999999995   499999999999999999999999999987653


Q ss_pred             CCCcceeeecccCCccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhc
Q 039626          495 QEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLR  574 (628)
Q Consensus       495 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  574 (628)
                      ..    ......||+.|+|||.+.+..++.++|||||||++|||++|+.||.......  ........+...        
T Consensus       339 ~~----~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~--~~~~i~~~i~~~--------  404 (576)
T 2acx_A          339 GQ----TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI--KREEVERLVKEV--------  404 (576)
T ss_dssp             TC----CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCC--CHHHHHHHHHHC--------
T ss_pred             Cc----cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccch--hHHHHHHHhhcc--------
Confidence            32    1234589999999999999999999999999999999999999987533211  111111111110        


Q ss_pred             cccCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHH
Q 039626          575 HFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRP-----TMYEIE  615 (628)
Q Consensus       575 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~ev~  615 (628)
                             ...++...+..+.+|+.+||+.||.+||     +++||+
T Consensus       405 -------~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil  443 (576)
T 2acx_A          405 -------PEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVK  443 (576)
T ss_dssp             -------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHH
T ss_pred             -------cccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHH
Confidence                   1122333445688999999999999999     566665

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=3.7e-36  Score=320.80  Aligned_cols=257  Identities=21%  Similarity=0.325  Sum_probs=190.3

Q ss_pred             HHhcCCCcCCccc----eEEEEEEE--CCceEEEEEeccc---hHHHHHHHhhcCCCceeeeeeeeecC-----------
Q 039626          348 SATDNFSFTCRIQ----GSVYRGKI--NGGFAAIKKVNGD---VSKEIALLNKINHSNLIILSGVCFNE-----------  407 (628)
Q Consensus       348 ~at~~f~~~~~i~----G~Vy~g~~--~g~~vavK~~~~~---~~~E~~~l~~l~H~nIv~l~g~~~~~-----------  407 (628)
                      ...+.|.....+|    |.||++..  +|+.||||++..+   ..+|+++|++++|+||+++++++...           
T Consensus         4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~   83 (383)
T 3eb0_A            4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPP   83 (383)
T ss_dssp             --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTSCCHHHHHHTTCCCTTBCCEEEEEEEC-----------
T ss_pred             cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcchHHHHHHHHHHcCCCCccchhheeeecCcccccccccc
Confidence            3445566555554    89999988  7889999998653   56899999999999999999998543           


Q ss_pred             ---------------------------CeEEEEEEecCCCChHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCC
Q 039626          408 ---------------------------GNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTN  460 (628)
Q Consensus       408 ---------------------------~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~  460 (628)
                                                 ...++||||++ |+|.+.+......+..+++..+..++.|++.||+|||+.  
T Consensus        84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~--  160 (383)
T 3eb0_A           84 DDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL--  160 (383)
T ss_dssp             --------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT--
T ss_pred             cccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC--
Confidence                                       34889999997 588888865444566799999999999999999999985  


Q ss_pred             CCeEecCCCCCCEEeC-CCCcEEEccccccccCCCCCCcceeeecccCCccccCccccccC-CCCcccccHHHHHHHHHH
Q 039626          461 PPHVHKDINSSNVLLD-SDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENG-LVSTKLDVYAFGVLILEM  538 (628)
Q Consensus       461 ~~iiH~dik~~NILl~-~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~-~~s~k~DV~SfGvvl~EL  538 (628)
                       +|+||||||+|||++ .++.+||+|||+++.......    .....||+.|+|||.+.+. .++.++|||||||+++||
T Consensus       161 -gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el  235 (383)
T 3eb0_A          161 -GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP----SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGEL  235 (383)
T ss_dssp             -TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC----CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHH
T ss_pred             -cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC----CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHH
Confidence             499999999999998 689999999999987643321    2335789999999998765 589999999999999999


Q ss_pred             HhCCCccccccccccccHHHHHHHHhccccchhhhc-------cccCCcC-----CCCCCHHHHHHHHHHHHHhcccCCC
Q 039626          539 LTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLR-------HFIDPTL-----QGNYPLELALLVIRLIDACLKKDPT  606 (628)
Q Consensus       539 ltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~-------~~~d~~l-----~~~~~~~~~~~l~~l~~~Cl~~dP~  606 (628)
                      ++|+.||......+  .+...+. ...... .+.+.       ...-+..     ....+...+..+.+|+.+||+.||.
T Consensus       236 l~g~~pf~~~~~~~--~~~~i~~-~~g~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~  311 (383)
T 3eb0_A          236 ILGKPLFSGETSID--QLVRIIQ-IMGTPT-KEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPD  311 (383)
T ss_dssp             HHSSCSSCCSSHHH--HHHHHHH-HHCCCC-HHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGG
T ss_pred             HhCCCCCCCCChHH--HHHHHHH-HhCCCC-HHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChh
Confidence            99999987533221  1112211 111111 00000       0000000     0012223445688999999999999


Q ss_pred             CCCCHHHHHH
Q 039626          607 DRPTMYEIEH  616 (628)
Q Consensus       607 ~RPs~~ev~~  616 (628)
                      +|||+.|+++
T Consensus       312 ~R~t~~e~l~  321 (383)
T 3eb0_A          312 LRINPYEAMA  321 (383)
T ss_dssp             GSCCHHHHHT
T ss_pred             hCCCHHHHhc
Confidence            9999999974

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=2.7e-36  Score=308.46  Aligned_cols=231  Identities=21%  Similarity=0.311  Sum_probs=172.0

Q ss_pred             eEEEEEEE--CCceEEEEEeccc---------hHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhc
Q 039626          361 GSVYRGKI--NGGFAAIKKVNGD---------VSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSN  429 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~~---------~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~  429 (628)
                      |.||++..  +|+.+|+|+++..         +.++...++.++||||+++++++.+++..++||||++ |+|.+++...
T Consensus        21 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~   99 (290)
T 3fme_A           21 GVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELMD-TSLDKFYKQV   99 (290)
T ss_dssp             EEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEEECCS-EEHHHHHHHH
T ss_pred             eEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEEehhc-cchHHHHHHH
Confidence            89999998  7889999998642         2345556888899999999999999999999999996 5898888654


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCCc
Q 039626          430 KNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTK  509 (628)
Q Consensus       430 ~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~  509 (628)
                      ...+..+++..+..++.|++.||+|||+.  .+++||||||+||+++.++.+||+|||+++......    ......||+
T Consensus       100 ~~~~~~~~~~~~~~i~~qi~~~l~~lH~~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~----~~~~~~~t~  173 (290)
T 3fme_A          100 IDKGQTIPEDILGKIAVSIVKALEHLHSK--LSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDV----AKDIDAGCK  173 (290)
T ss_dssp             HHTTCCCCHHHHHHHHHHHHHHHHHHHHH--SCCCCCCCSGGGCEECTTCCEEBCCC-------------------CCCC
T ss_pred             HhcCCCCCHHHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHEEECCCCCEEEeecCCcccccccc----cccccCCCc
Confidence            44566799999999999999999999984  159999999999999999999999999998764322    122347999


Q ss_pred             cccCcccc----ccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCC
Q 039626          510 GYMAPEYL----ENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNY  585 (628)
Q Consensus       510 ~Y~APE~l----~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~  585 (628)
                      .|+|||.+    .+..++.++||||||++++||++|+.|+......     ...........             .....
T Consensus       174 ~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----~~~~~~~~~~~-------------~~~~~  235 (290)
T 3fme_A          174 PYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTP-----FQQLKQVVEEP-------------SPQLP  235 (290)
T ss_dssp             CCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCH-----HHHHHHHHHSC-------------CCCCC
T ss_pred             cccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCch-----HHHHHHHhccC-------------CCCcc
Confidence            99999996    5667899999999999999999999998632211     11111111111             00011


Q ss_pred             CHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          586 PLELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       586 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      +...+..+.+++.+||+.||++|||+.|+++
T Consensus       236 ~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~  266 (290)
T 3fme_A          236 ADKFSAEFVDFTSQCLKKNSKERPTYPELMQ  266 (290)
T ss_dssp             TTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             cccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence            1123456789999999999999999999986

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=1.8e-35  Score=301.86  Aligned_cols=223  Identities=24%  Similarity=0.376  Sum_probs=184.7

Q ss_pred             eEEEEEEE--CCceEEEEEecc----------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhh
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG----------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFS  428 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  428 (628)
                      |.||+++.  ++..+|+|.+..          .+.+|++++++++|+||+++++++.+++..++||||+++|+|.+++..
T Consensus        28 g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~  107 (284)
T 2vgo_A           28 GNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQK  107 (284)
T ss_dssp             EEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHH
T ss_pred             eEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEEEeCCCCcHHHHHHh
Confidence            89999998  567899999843          367899999999999999999999999999999999999999999965


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCC
Q 039626          429 NKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGT  508 (628)
Q Consensus       429 ~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt  508 (628)
                      .    ..+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||++.......     .....|+
T Consensus       108 ~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~-----~~~~~~~  175 (284)
T 2vgo_A          108 H----GRFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR-----RRTMCGT  175 (284)
T ss_dssp             H----SSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCTTCEECSSSC-----BCCCCSC
T ss_pred             c----CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecccccccCcccc-----cccccCC
Confidence            3    3489999999999999999999984   59999999999999999999999999987654321     2345789


Q ss_pred             ccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCHH
Q 039626          509 KGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLE  588 (628)
Q Consensus       509 ~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~  588 (628)
                      +.|+|||.+.+..++.++||||||++++||++|+.|+.....      .+....+...           +.    .++..
T Consensus       176 ~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~~~~~~~~~-----------~~----~~~~~  234 (284)
T 2vgo_A          176 LDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSH------TETHRRIVNV-----------DL----KFPPF  234 (284)
T ss_dssp             GGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHHTT-----------CC----CCCTT
T ss_pred             CCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCH------hHHHHHHhcc-----------cc----CCCCc
Confidence            999999999999999999999999999999999999864322      1111111110           11    12223


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          589 LALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       589 ~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      .+..+.+++.+||+.||.+||+++|+++
T Consensus       235 ~~~~~~~li~~~l~~~p~~Rps~~~ll~  262 (284)
T 2vgo_A          235 LSDGSKDLISKLLRYHPPQRLPLKGVME  262 (284)
T ss_dssp             SCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence            3456789999999999999999999975

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=3.9e-35  Score=321.11  Aligned_cols=254  Identities=17%  Similarity=0.212  Sum_probs=195.8

Q ss_pred             cCCCcCCccc----eEEEEEEE--CCceEEEEEecc-----chHHHHHHHhhcCC-CceeeeeeeeecCCeEEEEEEecC
Q 039626          351 DNFSFTCRIQ----GSVYRGKI--NGGFAAIKKVNG-----DVSKEIALLNKINH-SNLIILSGVCFNEGNCYLVYEYAV  418 (628)
Q Consensus       351 ~~f~~~~~i~----G~Vy~g~~--~g~~vavK~~~~-----~~~~E~~~l~~l~H-~nIv~l~g~~~~~~~~~lV~E~~~  418 (628)
                      ++|.....||    |.||+|+.  +++.||||.+..     ++..|+++++.++| +++..+..++...+..+|||||+ 
T Consensus         7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~-   85 (483)
T 3sv0_A            7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-   85 (483)
T ss_dssp             TTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC-
T ss_pred             CcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC-
Confidence            4555555554    89999997  588999998753     58899999999987 45556666667788899999999 


Q ss_pred             CCChHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEe---CCCCcEEEccccccccCCCC
Q 039626          419 NGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLL---DSDLRAKIANFAMARPAEGQ  495 (628)
Q Consensus       419 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl---~~~~~~kl~Dfgla~~~~~~  495 (628)
                      +++|.+++...   ...+++..++.|+.||+.||+|||+.   +|+||||||+|||+   +.++.+||+|||+++.....
T Consensus        86 g~sL~~ll~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~  159 (483)
T 3sv0_A           86 GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT  159 (483)
T ss_dssp             CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred             CCCHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCCcceeccCC
Confidence            99999999542   34599999999999999999999995   49999999999999   68899999999999876543


Q ss_pred             CCcc----eeeecccCCccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchh
Q 039626          496 EGEF----ALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEE  571 (628)
Q Consensus       496 ~~~~----~~~~~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  571 (628)
                      ....    .......||+.|+|||.+.+..++.++|||||||++|||++|+.||........   .+.+..+..... ..
T Consensus       160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~---~~~~~~i~~~~~-~~  235 (483)
T 3sv0_A          160 STHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK---KQKYEKISEKKV-AT  235 (483)
T ss_dssp             TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSH---HHHHHHHHHHHH-HS
T ss_pred             ccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhH---HHHHHHHhhccc-cc
Confidence            3211    112356799999999999999999999999999999999999999875433221   111111111000 00


Q ss_pred             hhccccCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhh
Q 039626          572 SLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNA  624 (628)
Q Consensus       572 ~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~~~  624 (628)
                      .+..     +...+    +..+.+++.+||+.||++||++.+|++.|+.++..
T Consensus       236 ~~~~-----l~~~~----p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~  279 (483)
T 3sv0_A          236 SIEA-----LCRGY----PTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIR  279 (483)
T ss_dssp             CHHH-----HHTTS----CHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred             cHHH-----HhcCC----cHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHH
Confidence            0000     11122    34678999999999999999999999999999764

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=2.9e-36  Score=318.68  Aligned_cols=254  Identities=20%  Similarity=0.321  Sum_probs=188.2

Q ss_pred             CCCcCCccc----eEEEEEEE--CCceEEEEEecc--------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEec
Q 039626          352 NFSFTCRIQ----GSVYRGKI--NGGFAAIKKVNG--------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYA  417 (628)
Q Consensus       352 ~f~~~~~i~----G~Vy~g~~--~g~~vavK~~~~--------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~  417 (628)
                      +|.....+|    |.||++..  ++..+|+|.+..        .+.+|++++++++|+||+++++++.+++..++||||+
T Consensus        34 ~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  113 (360)
T 3eqc_A           34 DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHM  113 (360)
T ss_dssp             GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             cceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEECC
Confidence            444444443    89999999  488999998853        3678999999999999999999999999999999999


Q ss_pred             CCCChHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCC
Q 039626          418 VNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEG  497 (628)
Q Consensus       418 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~  497 (628)
                      ++|+|.+++...    ..+++..+..++.+++.||+|||+.  .+++||||||+|||++.++.+||+|||+++.....  
T Consensus       114 ~~~~L~~~l~~~----~~~~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--  185 (360)
T 3eqc_A          114 DGGSLDQVLKKA----GRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--  185 (360)
T ss_dssp             TTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHH--HCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH--
T ss_pred             CCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHh--CCEEcCCccHHHEEECCCCCEEEEECCCCcccccc--
Confidence            999999999653    3489999999999999999999983  24999999999999999999999999998755321  


Q ss_pred             cceeeecccCCccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHH------------------
Q 039626          498 EFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDV------------------  559 (628)
Q Consensus       498 ~~~~~~~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~------------------  559 (628)
                         ......||+.|+|||.+.+..++.++||||||++++||++|+.||..............                  
T Consensus       186 ---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  262 (360)
T 3eqc_A          186 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR  262 (360)
T ss_dssp             ---C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-------------------
T ss_pred             ---cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCC
Confidence               12345799999999999999999999999999999999999999864332110000000                  


Q ss_pred             -HHHHh----ccccchhhhccccCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          560 -LNAVL----TKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       560 -~~~~~----~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                       .....    ......+.+............+...+..+.+|+.+||+.||++|||++|+++
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  324 (360)
T 3eqc_A          263 PLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV  324 (360)
T ss_dssp             -----------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             cccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence             00000    0000000011111111111111223456889999999999999999999986

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=7.4e-36  Score=307.58  Aligned_cols=226  Identities=29%  Similarity=0.461  Sum_probs=185.8

Q ss_pred             eEEEEEEE--CCceEEEEEecc--------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhcC
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG--------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNK  430 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~--------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~  430 (628)
                      |.||+|..  +++.||+|.+..        .+.+|+.++++++|+||+++++++.+++..++||||+++++|.+++.   
T Consensus        36 g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~---  112 (303)
T 3a7i_A           36 GEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLE---  112 (303)
T ss_dssp             SEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHT---
T ss_pred             eEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEeCCCCcHHHHHh---
Confidence            89999987  588999999852        46789999999999999999999999999999999999999999984   


Q ss_pred             CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCCcc
Q 039626          431 NEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKG  510 (628)
Q Consensus       431 ~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~  510 (628)
                        ...+++..+..++.+++.||.|||+.   +++||||||+||+++.++.+||+|||++........   ......||+.
T Consensus       113 --~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~~  184 (303)
T 3a7i_A          113 --PGPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI---KRNTFVGTPF  184 (303)
T ss_dssp             --TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBC---CBCCCCSCGG
T ss_pred             --cCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccceecCcccc---ccCccCCCcC
Confidence              24589999999999999999999995   499999999999999999999999999987643221   1234578999


Q ss_pred             ccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCHHHH
Q 039626          511 YMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELA  590 (628)
Q Consensus       511 Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~  590 (628)
                      |+|||.+.+..++.++||||||++++||++|+.|+.....      .+....+..          ...+.+...+    +
T Consensus       185 y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~----------~~~~~~~~~~----~  244 (303)
T 3a7i_A          185 WMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHP------MKVLFLIPK----------NNPPTLEGNY----S  244 (303)
T ss_dssp             GCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHHHHH----------SCCCCCCSSC----C
T ss_pred             ccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCH------HHHHHHhhc----------CCCCCCcccc----C
Confidence            9999999999999999999999999999999998863221      111111111          0111222233    3


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHHH
Q 039626          591 LLVIRLIDACLKKDPTDRPTMYEIEHS  617 (628)
Q Consensus       591 ~~l~~l~~~Cl~~dP~~RPs~~ev~~~  617 (628)
                      ..+.+++.+||+.||.+|||+.|+++.
T Consensus       245 ~~l~~li~~~l~~dp~~Rps~~~ll~~  271 (303)
T 3a7i_A          245 KPLKEFVEACLNKEPSFRPTAKELLKH  271 (303)
T ss_dssp             HHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence            457899999999999999999999874

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=1.1e-35  Score=320.82  Aligned_cols=239  Identities=26%  Similarity=0.359  Sum_probs=179.4

Q ss_pred             hcCCCcCCccc----eEEEEEEE--CCceEEEEEecc---------------chHHHHHHHhhcCCCceeeeeeeeecCC
Q 039626          350 TDNFSFTCRIQ----GSVYRGKI--NGGFAAIKKVNG---------------DVSKEIALLNKINHSNLIILSGVCFNEG  408 (628)
Q Consensus       350 t~~f~~~~~i~----G~Vy~g~~--~g~~vavK~~~~---------------~~~~E~~~l~~l~H~nIv~l~g~~~~~~  408 (628)
                      .++|.....+|    |.||+|..  +++.||+|.+..               .+.+|+++|++++||||+++++++. .+
T Consensus       134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~  212 (419)
T 3i6u_A          134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-AE  212 (419)
T ss_dssp             HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-SS
T ss_pred             hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-cC
Confidence            45666555554    89999998  578999998753               3678999999999999999999975 55


Q ss_pred             eEEEEEEecCCCChHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCC---CcEEEcc
Q 039626          409 NCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSD---LRAKIAN  485 (628)
Q Consensus       409 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~---~~~kl~D  485 (628)
                      ..++||||+++|+|.+++..    ...+++..+..++.|++.||+|||+.   +|+||||||+|||++.+   +.+||+|
T Consensus       213 ~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kl~D  285 (419)
T 3i6u_A          213 DYYIVLELMEGGELFDKVVG----NKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITD  285 (419)
T ss_dssp             EEEEEEECCTTCBGGGGTSS----SCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCEEECC
T ss_pred             ceEEEEEcCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceEEEee
Confidence            68999999999999998843    34699999999999999999999995   49999999999999654   4599999


Q ss_pred             ccccccCCCCCCcceeeecccCCccccCcccccc---CCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHH
Q 039626          486 FAMARPAEGQEGEFALTRHIVGTKGYMAPEYLEN---GLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNA  562 (628)
Q Consensus       486 fgla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~---~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~  562 (628)
                      ||+++......    ......||+.|+|||++.+   ..++.++||||||++++||++|+.||......  ..+.+.+..
T Consensus       286 FG~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~--~~~~~~i~~  359 (419)
T 3i6u_A          286 FGHSKILGETS----LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ--VSLKDQITS  359 (419)
T ss_dssp             SSTTTSCC---------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSS--CCHHHHHHT
T ss_pred             cccceecCCCc----cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcch--HHHHHHHhc
Confidence            99998764322    2344679999999999853   67889999999999999999999998643221  112221111


Q ss_pred             HhccccchhhhccccCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          563 VLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       563 ~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                         ...      . ..+...    ...+..+.+++.+||+.||++||++.|+++
T Consensus       360 ---~~~------~-~~~~~~----~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  399 (419)
T 3i6u_A          360 ---GKY------N-FIPEVW----AEVSEKALDLVKKLLVVDPKARFTTEEALR  399 (419)
T ss_dssp             ---TCC------C-CCHHHH----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             ---CCC------C-CCchhh----cccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence               000      0 000000    112456789999999999999999999875

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=1.3e-35  Score=304.10  Aligned_cols=231  Identities=27%  Similarity=0.386  Sum_probs=182.9

Q ss_pred             eEEEEEEE--CCceEEEEEecc-------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhcCC
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG-------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKN  431 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~-------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~  431 (628)
                      |.||+|..  ++..||+|++..       .+.+|+.++++++|+||+++++++.+.+..++||||+++++|.+++.... 
T Consensus        36 g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-  114 (295)
T 2clq_A           36 GIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKW-  114 (295)
T ss_dssp             SEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEEEHHHHHHHTT-
T ss_pred             EEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCHHHHHHhhc-
Confidence            89999998  678999998753       36789999999999999999999999999999999999999999996532 


Q ss_pred             CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCC-CCcEEEccccccccCCCCCCcceeeecccCCcc
Q 039626          432 EGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDS-DLRAKIANFAMARPAEGQEGEFALTRHIVGTKG  510 (628)
Q Consensus       432 ~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~-~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~  510 (628)
                      ....+++..+..++.|++.||+|||+.   +++|+||||+||+++. ++.+||+|||+++.......   ......||+.
T Consensus       115 ~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~~  188 (295)
T 2clq_A          115 GPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP---CTETFTGTLQ  188 (295)
T ss_dssp             CCCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC--------CCCCCCGG
T ss_pred             cCCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecccccccCCCCC---cccccCCCcc
Confidence            234578999999999999999999995   4999999999999987 89999999999987643221   1234578999


Q ss_pred             ccCccccccCC--CCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCHH
Q 039626          511 YMAPEYLENGL--VSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLE  588 (628)
Q Consensus       511 Y~APE~l~~~~--~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~  588 (628)
                      |+|||.+.+..  ++.++||||||+++|||++|+.|+.......    ........          ....+.    .+..
T Consensus       189 y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~----~~~~~~~~----------~~~~~~----~~~~  250 (295)
T 2clq_A          189 YMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQ----AAMFKVGM----------FKVHPE----IPES  250 (295)
T ss_dssp             GCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHH----HHHHHHHH----------HCCCCC----CCTT
T ss_pred             ccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchh----HHHHhhcc----------cccccc----cccc
Confidence            99999987643  8899999999999999999999986322111    01110000          001112    2233


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          589 LALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       589 ~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      .+..+.+++.+||+.||++||++.|+++
T Consensus       251 ~~~~~~~li~~~l~~dp~~Rps~~~ll~  278 (295)
T 2clq_A          251 MSAEAKAFILKCFEPDPDKRACANDLLV  278 (295)
T ss_dssp             SCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred             CCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            3456789999999999999999999874

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=7.6e-36  Score=304.10  Aligned_cols=234  Identities=24%  Similarity=0.351  Sum_probs=184.7

Q ss_pred             eEEEEEEE--CCceEEEEEecc-------------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHH
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG-------------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDW  425 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~-------------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~  425 (628)
                      |.||++..  +|+.+|+|.++.             .+.+|++++++++||||+++++++.+++..++||||+++++|.++
T Consensus        19 g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~   98 (283)
T 3bhy_A           19 AIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDF   98 (283)
T ss_dssp             EEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHH
T ss_pred             eEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEEEEEeecCCCcHHHH
Confidence            89999998  588999998753             367899999999999999999999999999999999999999999


Q ss_pred             hhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCC----cEEEccccccccCCCCCCccee
Q 039626          426 VFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDL----RAKIANFAMARPAEGQEGEFAL  501 (628)
Q Consensus       426 l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~----~~kl~Dfgla~~~~~~~~~~~~  501 (628)
                      +...    ..+++..+..++.|++.||.|||+.   +++||||||+||+++.++    .+||+|||+++......    .
T Consensus        99 l~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~~~----~  167 (283)
T 3bhy_A           99 LAEK----ESLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN----E  167 (283)
T ss_dssp             HHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC--------
T ss_pred             HHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceEEEecccceeccCCC----c
Confidence            9542    3589999999999999999999995   599999999999999887    89999999998764322    1


Q ss_pred             eecccCCccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcC
Q 039626          502 TRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTL  581 (628)
Q Consensus       502 ~~~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l  581 (628)
                      .....|++.|+|||.+.+..++.++||||||++++||++|+.|+.....      .+....+.....       ..++..
T Consensus       168 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~~~-------~~~~~~  234 (283)
T 3bhy_A          168 FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETK------QETLTNISAVNY-------DFDEEY  234 (283)
T ss_dssp             ----CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHHTTCC-------CCCHHH
T ss_pred             ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcch------HHHHHHhHhccc-------CCcchh
Confidence            2345699999999999999999999999999999999999999864322      111111111100       000000


Q ss_pred             CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHHHhH
Q 039626          582 QGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEH--SLSNIL  622 (628)
Q Consensus       582 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~--~L~~l~  622 (628)
                      ..    ..+..+.+++.+||+.||.+||++.|+++  .++.+.
T Consensus       235 ~~----~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~  273 (283)
T 3bhy_A          235 FS----NTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIR  273 (283)
T ss_dssp             HT----TCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHH
T ss_pred             cc----cCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHH
Confidence            01    12345789999999999999999999987  344444

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2e-36  Score=323.32  Aligned_cols=253  Identities=21%  Similarity=0.364  Sum_probs=181.8

Q ss_pred             cCCCcCCccc----eEEEEEEE--CCceEEEEEecc---------chHHHHHHHhhcC-CCceeeeeeeeecCC--eEEE
Q 039626          351 DNFSFTCRIQ----GSVYRGKI--NGGFAAIKKVNG---------DVSKEIALLNKIN-HSNLIILSGVCFNEG--NCYL  412 (628)
Q Consensus       351 ~~f~~~~~i~----G~Vy~g~~--~g~~vavK~~~~---------~~~~E~~~l~~l~-H~nIv~l~g~~~~~~--~~~l  412 (628)
                      ++|.....+|    |.||++..  +|+.||||++..         .+.+|+.+|.+++ |+||+++++++..++  ..|+
T Consensus         9 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l   88 (388)
T 3oz6_A            9 RKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYL   88 (388)
T ss_dssp             TTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEE
T ss_pred             CceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEE
Confidence            3454444443    89999987  688999999853         2457999999997 999999999997543  7899


Q ss_pred             EEEecCCCChHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccC
Q 039626          413 VYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPA  492 (628)
Q Consensus       413 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~  492 (628)
                      ||||++ |+|.+++..     ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++..
T Consensus        89 v~e~~~-~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~  159 (388)
T 3oz6_A           89 VFDYME-TDLHAVIRA-----NILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSF  159 (388)
T ss_dssp             EEECCS-EEHHHHHHH-----TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEES
T ss_pred             EecccC-cCHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCcccccc
Confidence            999996 689998854     3589999999999999999999995   4999999999999999999999999999865


Q ss_pred             CCCCC------------------cceeeecccCCccccCcccccc-CCCCcccccHHHHHHHHHHHhCCCcccccccccc
Q 039626          493 EGQEG------------------EFALTRHIVGTKGYMAPEYLEN-GLVSTKLDVYAFGVLILEMLTGKEAAALHAEENN  553 (628)
Q Consensus       493 ~~~~~------------------~~~~~~~~~gt~~Y~APE~l~~-~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~  553 (628)
                      .....                  .........||+.|+|||.+.+ ..++.++|||||||+++||++|+.||....... 
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~-  238 (388)
T 3oz6_A          160 VNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMN-  238 (388)
T ss_dssp             SSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-
T ss_pred             cccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHH-
Confidence            33110                  0112234589999999999976 678999999999999999999999987543221 


Q ss_pred             ccHHHHHHHHhccccchhhhcccc------------------CCcCCCCC------------CHHHHHHHHHHHHHhccc
Q 039626          554 MHLSDVLNAVLTKEDGEESLRHFI------------------DPTLQGNY------------PLELALLVIRLIDACLKK  603 (628)
Q Consensus       554 ~~~~~~~~~~~~~~~~~~~l~~~~------------------d~~l~~~~------------~~~~~~~l~~l~~~Cl~~  603 (628)
                        ....+...+..... +.+....                  .......+            +......+.+|+.+||+.
T Consensus       239 --~~~~i~~~~~~p~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~  315 (388)
T 3oz6_A          239 --QLERIIGVIDFPSN-EDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQF  315 (388)
T ss_dssp             --HHHHHHHHHCCCCH-HHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCS
T ss_pred             --HHHHHHHhcCCCCH-HHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhcc
Confidence              11111111111110 0000000                  00000000            002234678999999999


Q ss_pred             CCCCCCCHHHHHH
Q 039626          604 DPTDRPTMYEIEH  616 (628)
Q Consensus       604 dP~~RPs~~ev~~  616 (628)
                      ||++|||++|+++
T Consensus       316 dP~~R~t~~e~l~  328 (388)
T 3oz6_A          316 NPNKRISANDALK  328 (388)
T ss_dssp             SGGGSCCHHHHTT
T ss_pred             CcccCCCHHHHhC
Confidence            9999999999875

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9.3e-36  Score=314.43  Aligned_cols=231  Identities=25%  Similarity=0.376  Sum_probs=183.7

Q ss_pred             eEEEEEEE-----CCceEEEEEecc-----------chHHHHHHHhhc-CCCceeeeeeeeecCCeEEEEEEecCCCChH
Q 039626          361 GSVYRGKI-----NGGFAAIKKVNG-----------DVSKEIALLNKI-NHSNLIILSGVCFNEGNCYLVYEYAVNGTLS  423 (628)
Q Consensus       361 G~Vy~g~~-----~g~~vavK~~~~-----------~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~  423 (628)
                      |.||+++.     +|+.||||+++.           .+.+|+++|+++ +|+||+++++++..++..++||||+++|+|.
T Consensus        68 g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~  147 (355)
T 1vzo_A           68 GKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELF  147 (355)
T ss_dssp             EEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEEEECCCCSCBHH
T ss_pred             EEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCceEEEEeecCCCCCHH
Confidence            89999987     678999998753           256799999999 6999999999999999999999999999999


Q ss_pred             HHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeee
Q 039626          424 DWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTR  503 (628)
Q Consensus       424 ~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~  503 (628)
                      +++...    ..+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++.......  ....
T Consensus       148 ~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~--~~~~  218 (355)
T 1vzo_A          148 THLSQR----ERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADET--ERAY  218 (355)
T ss_dssp             HHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEEECCGGGG--GGGC
T ss_pred             HHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEeeCCCCeecccCCC--Cccc
Confidence            999643    3589999999999999999999995   499999999999999999999999999986543221  1233


Q ss_pred             cccCCccccCcccccc--CCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcC
Q 039626          504 HIVGTKGYMAPEYLEN--GLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTL  581 (628)
Q Consensus       504 ~~~gt~~Y~APE~l~~--~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l  581 (628)
                      ...||+.|+|||.+.+  ..++.++|||||||++|||++|+.||.......  ............           .   
T Consensus       219 ~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~--~~~~~~~~~~~~-----------~---  282 (355)
T 1vzo_A          219 DFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN--SQAEISRRILKS-----------E---  282 (355)
T ss_dssp             GGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCC--CHHHHHHHHHHC-----------C---
T ss_pred             CcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccc--hHHHHHHHHhcc-----------C---
Confidence            4579999999999985  357899999999999999999999987433221  122222222111           1   


Q ss_pred             CCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 039626          582 QGNYPLELALLVIRLIDACLKKDPTDRP-----TMYEIEHS  617 (628)
Q Consensus       582 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~ev~~~  617 (628)
                       ..++.+.+..+.+++.+||+.||.+||     +++|+++.
T Consensus       283 -~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h  322 (355)
T 1vzo_A          283 -PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH  322 (355)
T ss_dssp             -CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred             -CCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcC
Confidence             122333445678999999999999999     88887653

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=1.7e-35  Score=303.49  Aligned_cols=226  Identities=24%  Similarity=0.351  Sum_probs=185.2

Q ss_pred             eEEEEEEE--CCceEEEEEecc----------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhh
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG----------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFS  428 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  428 (628)
                      |.||++..  .++.+|+|.+..          .+.+|+.++++++|+||+++++++.+++..++||||+++++|.+++..
T Consensus        29 g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~  108 (294)
T 2rku_A           29 AKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKR  108 (294)
T ss_dssp             EEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH
T ss_pred             EEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEEecCCCCCHHHHHHh
Confidence            89999998  477899998753          356799999999999999999999999999999999999999998854


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCC
Q 039626          429 NKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGT  508 (628)
Q Consensus       429 ~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt  508 (628)
                      .    ..+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||+++.......   ......||
T Consensus       109 ~----~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~  178 (294)
T 2rku_A          109 R----KALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE---RKKVLCGT  178 (294)
T ss_dssp             H----CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTC---CBCCCCSC
T ss_pred             c----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEeccCceecccCcc---ccccccCC
Confidence            2    3589999999999999999999995   499999999999999999999999999987643221   12345799


Q ss_pred             ccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCHH
Q 039626          509 KGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLE  588 (628)
Q Consensus       509 ~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~  588 (628)
                      +.|+|||.+.+..++.++||||||++++||++|+.|+.....      .+.........           .    ..+..
T Consensus       179 ~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~------~~~~~~~~~~~-----------~----~~~~~  237 (294)
T 2rku_A          179 PNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL------KETYLRIKKNE-----------Y----SIPKH  237 (294)
T ss_dssp             CSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHHTTC-----------C----CCCTT
T ss_pred             CCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHhhcc-----------C----CCccc
Confidence            999999999998899999999999999999999999864321      11111111100           0    11222


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 039626          589 LALLVIRLIDACLKKDPTDRPTMYEIEHS  617 (628)
Q Consensus       589 ~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~  617 (628)
                      ....+.+++.+||+.||++|||++|+++.
T Consensus       238 ~~~~~~~li~~~l~~~p~~Rps~~~ll~~  266 (294)
T 2rku_A          238 INPVAASLIQKMLQTDPTARPTINELLND  266 (294)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             cCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence            33567899999999999999999999863

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=1.7e-35  Score=313.69  Aligned_cols=245  Identities=23%  Similarity=0.358  Sum_probs=190.9

Q ss_pred             HHHHHHhcCCCcCCccc----eEEEEEEE--CCceEEEEEecc---------------chHHHHHHHhhc-CCCceeeee
Q 039626          344 KELQSATDNFSFTCRIQ----GSVYRGKI--NGGFAAIKKVNG---------------DVSKEIALLNKI-NHSNLIILS  401 (628)
Q Consensus       344 ~el~~at~~f~~~~~i~----G~Vy~g~~--~g~~vavK~~~~---------------~~~~E~~~l~~l-~H~nIv~l~  401 (628)
                      +......++|.....+|    |.||+++.  +|+.||||.+..               .+.+|+.++.++ +||||++++
T Consensus        87 ~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~  166 (365)
T 2y7j_A           87 AAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLI  166 (365)
T ss_dssp             HHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred             hhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEE
Confidence            33344455666555554    89999998  588999998742               246799999999 899999999


Q ss_pred             eeeecCCeEEEEEEecCCCChHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcE
Q 039626          402 GVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRA  481 (628)
Q Consensus       402 g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~  481 (628)
                      +++...+..++||||+++|+|.+++...    ..+++..+..++.|++.||.|||+.   +++|+||||+|||++.++.+
T Consensus       167 ~~~~~~~~~~lv~e~~~g~~L~~~l~~~----~~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~i  239 (365)
T 2y7j_A          167 DSYESSSFMFLVFDLMRKGELFDYLTEK----VALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQI  239 (365)
T ss_dssp             EEEEBSSEEEEEECCCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCE
T ss_pred             EEEeeCCEEEEEEEeCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCE
Confidence            9999999999999999999999999642    3589999999999999999999995   49999999999999999999


Q ss_pred             EEccccccccCCCCCCcceeeecccCCccccCcccccc------CCCCcccccHHHHHHHHHHHhCCCcccccccccccc
Q 039626          482 KIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLEN------GLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMH  555 (628)
Q Consensus       482 kl~Dfgla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~------~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~  555 (628)
                      ||+|||++.......    ......||+.|+|||++.+      ..++.++||||||+++|||++|+.||.....     
T Consensus       240 kl~DfG~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~-----  310 (365)
T 2y7j_A          240 RLSDFGFSCHLEPGE----KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQ-----  310 (365)
T ss_dssp             EECCCTTCEECCTTC----CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH-----
T ss_pred             EEEecCcccccCCCc----ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCH-----
Confidence            999999998765332    1234679999999999863      3588999999999999999999999864221     


Q ss_pred             HHHHHHHHhccccchhhhccccCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          556 LSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       556 ~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                       ......+..... .     ...+.. .    ..+..+.+++.+||+.||++||++.|+++
T Consensus       311 -~~~~~~i~~~~~-~-----~~~~~~-~----~~~~~~~~li~~~L~~dP~~Rps~~ell~  359 (365)
T 2y7j_A          311 -ILMLRMIMEGQY-Q-----FSSPEW-D----DRSSTVKDLISRLLQVDPEARLTAEQALQ  359 (365)
T ss_dssp             -HHHHHHHHHTCC-C-----CCHHHH-S----SSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             -HHHHHHHHhCCC-C-----CCCccc-c----cCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence             111111111100 0     000000 0    12345789999999999999999999975

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=8.1e-36  Score=311.18  Aligned_cols=230  Identities=24%  Similarity=0.316  Sum_probs=181.8

Q ss_pred             eEEEEEEE--CCceEEEEEecc---------chHHHHHHHhhc-CCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhh
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG---------DVSKEIALLNKI-NHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFS  428 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~---------~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  428 (628)
                      |.||++..  +|+.||+|+++.         .+.+|+.++.++ +|+||+++++++.+.+..++||||+++|+|.+++..
T Consensus        43 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~  122 (327)
T 3lm5_A           43 AVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLP  122 (327)
T ss_dssp             EEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCTTEEGGGGGSS
T ss_pred             eEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEEEEecCCCcHHHHHHH
Confidence            89999998  588999998853         467899999999 569999999999999999999999999999999843


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCC---CCcEEEccccccccCCCCCCcceeeecc
Q 039626          429 NKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDS---DLRAKIANFAMARPAEGQEGEFALTRHI  505 (628)
Q Consensus       429 ~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~---~~~~kl~Dfgla~~~~~~~~~~~~~~~~  505 (628)
                        .....+++..++.++.|++.||+|||+.   +++||||||+|||++.   ++.+||+|||+++......    .....
T Consensus       123 --~~~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~----~~~~~  193 (327)
T 3lm5_A          123 --ELAEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHAC----ELREI  193 (327)
T ss_dssp             --CC-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC-------------
T ss_pred             --hcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCCCcEEEeeCccccccCCcc----ccccc
Confidence              2345699999999999999999999995   4999999999999998   7899999999998764322    12345


Q ss_pred             cCCccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCC
Q 039626          506 VGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNY  585 (628)
Q Consensus       506 ~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~  585 (628)
                      .||+.|+|||.+.+..++.++||||||++++||++|+.|+......      +....+....           .......
T Consensus       194 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~------~~~~~i~~~~-----------~~~~~~~  256 (327)
T 3lm5_A          194 MGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQ------ETYLNISQVN-----------VDYSEET  256 (327)
T ss_dssp             CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHTC-----------CCCCTTT
T ss_pred             cCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch------HHHHHHHhcc-----------cccCchh
Confidence            7999999999999999999999999999999999999998643221      1111111100           0011111


Q ss_pred             CHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          586 PLELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       586 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      ....+..+.+++.+||+.||.+|||++|+++
T Consensus       257 ~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~  287 (327)
T 3lm5_A          257 FSSVSQLATDFIQSLLVKNPEKRPTAEICLS  287 (327)
T ss_dssp             TTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             hcccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence            1233456789999999999999999999874

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=2.3e-36  Score=315.59  Aligned_cols=253  Identities=24%  Similarity=0.334  Sum_probs=181.0

Q ss_pred             cCCCcCCccc----eEEEEEEE--CCceEEEEEecc---------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEE
Q 039626          351 DNFSFTCRIQ----GSVYRGKI--NGGFAAIKKVNG---------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYE  415 (628)
Q Consensus       351 ~~f~~~~~i~----G~Vy~g~~--~g~~vavK~~~~---------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  415 (628)
                      ++|.....+|    |.||++..  +++.||||+++.         .+.+|++++++++|+||+++++++.+++..++|||
T Consensus        34 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  113 (329)
T 3gbz_A           34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFE  113 (329)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEEe
Confidence            4455555554    89999987  688999998853         35689999999999999999999999999999999


Q ss_pred             ecCCCChHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEe-----CCCCcEEEccccccc
Q 039626          416 YAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLL-----DSDLRAKIANFAMAR  490 (628)
Q Consensus       416 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl-----~~~~~~kl~Dfgla~  490 (628)
                      |++ |+|.+++...    ..+++..+..++.|++.||+|||+.   +|+||||||+|||+     ++++.+||+|||+++
T Consensus       114 ~~~-~~L~~~~~~~----~~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~  185 (329)
T 3gbz_A          114 YAE-NDLKKYMDKN----PDVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR  185 (329)
T ss_dssp             CCS-EEHHHHHHHC----TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEECCTTHHH
T ss_pred             cCC-CCHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEECcCCCcc
Confidence            997 5999998542    3489999999999999999999995   49999999999999     556679999999998


Q ss_pred             cCCCCCCcceeeecccCCccccCccccccC-CCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccc
Q 039626          491 PAEGQEGEFALTRHIVGTKGYMAPEYLENG-LVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDG  569 (628)
Q Consensus       491 ~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~-~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~  569 (628)
                      .......   ......||+.|+|||.+.+. .++.++|||||||+++||++|+.|+.......  .+.............
T Consensus       186 ~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--~~~~~~~~~~~~~~~  260 (329)
T 3gbz_A          186 AFGIPIR---QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEID--QLFKIFEVLGLPDDT  260 (329)
T ss_dssp             HHC--------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHHHCCCCTT
T ss_pred             ccCCccc---ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHH--HHHHHHHHhCCCchh
Confidence            7643221   12345789999999999874 58999999999999999999999986433211  111221111100000


Q ss_pred             -hh---hhccccC--CcCCCC-----CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          570 -EE---SLRHFID--PTLQGN-----YPLELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       570 -~~---~l~~~~d--~~l~~~-----~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                       ..   .+..+..  +.....     .+......+.+|+.+||+.||++|||++|+++
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  318 (329)
T 3gbz_A          261 TWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE  318 (329)
T ss_dssp             TSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             hhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence             00   0000000  000000     01113456789999999999999999999875

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=2.6e-36  Score=314.52  Aligned_cols=242  Identities=22%  Similarity=0.334  Sum_probs=179.9

Q ss_pred             eEEEEEEE--CCceEEEEEecc--------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhcC
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG--------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNK  430 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~--------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~  430 (628)
                      |.||+|+.  +++.||+|+++.        .+.+|++++++++|+||+++++++.+++..++||||++ |+|.+++... 
T Consensus        16 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~-   93 (324)
T 3mtl_A           16 ATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD-KDLKQYLDDC-   93 (324)
T ss_dssp             EEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEECCS-EEHHHHHHHT-
T ss_pred             EEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecccc-cCHHHHHHhc-
Confidence            89999998  588999998864        24469999999999999999999999999999999996 6999988642 


Q ss_pred             CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCCcc
Q 039626          431 NEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKG  510 (628)
Q Consensus       431 ~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~  510 (628)
                        +..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++.......   ......||+.
T Consensus        94 --~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~~t~~  165 (324)
T 3mtl_A           94 --GNIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK---TYDNEVVTLW  165 (324)
T ss_dssp             --TTCCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEECC---------------CGG
T ss_pred             --CCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCcccccccCCcc---ccccccCccc
Confidence              34689999999999999999999995   499999999999999999999999999986543221   1234578999


Q ss_pred             ccCcccccc-CCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccc---------cCCc
Q 039626          511 YMAPEYLEN-GLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHF---------IDPT  580 (628)
Q Consensus       511 Y~APE~l~~-~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~---------~d~~  580 (628)
                      |+|||.+.+ ..++.++||||||++++||++|+.||......+   ....+........ .+.....         ..+.
T Consensus       166 y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~i~~~~~~~~-~~~~~~~~~~~~~~~~~~~~  241 (324)
T 3mtl_A          166 YRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEE---QLHFIFRILGTPT-EETWPGILSNEEFKTYNYPK  241 (324)
T ss_dssp             GCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCCCC-TTTSTTGGGCHHHHHTCCCC
T ss_pred             ccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCCC-hHhchhhhcchhhccccccc
Confidence            999999876 568999999999999999999999987543221   1222222221111 0000000         0000


Q ss_pred             CCCC----CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          581 LQGN----YPLELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       581 l~~~----~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      ....    ........+.+|+.+||+.||.+|||++|+++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  281 (324)
T 3mtl_A          242 YRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK  281 (324)
T ss_dssp             CCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             ccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence            0000    01123456789999999999999999999875

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=3e-36  Score=313.70  Aligned_cols=249  Identities=24%  Similarity=0.438  Sum_probs=186.2

Q ss_pred             ecHHHHHHHhcCCCcCCccc----eEEEEEEE--CCceEEEEEecc------chHHHHHHHhhc-CCCceeeeeeeeec-
Q 039626          341 YSFKELQSATDNFSFTCRIQ----GSVYRGKI--NGGFAAIKKVNG------DVSKEIALLNKI-NHSNLIILSGVCFN-  406 (628)
Q Consensus       341 ~~~~el~~at~~f~~~~~i~----G~Vy~g~~--~g~~vavK~~~~------~~~~E~~~l~~l-~H~nIv~l~g~~~~-  406 (628)
                      +++.++....+.|.....+|    |.||+|+.  +|+.||+|.+..      ++.+|+.+++++ +|+||+++++++.. 
T Consensus        14 ~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   93 (326)
T 2x7f_A           14 IDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKK   93 (326)
T ss_dssp             --CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEEC
T ss_pred             ccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeec
Confidence            33444445566666665564    89999998  788999998753      477899999999 89999999999986 


Q ss_pred             -----CCeEEEEEEecCCCChHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcE
Q 039626          407 -----EGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRA  481 (628)
Q Consensus       407 -----~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~  481 (628)
                           .+..++||||+++|+|.+++...  ....+++..+..++.|++.||+|||+.   +++|+||||+||+++.++.+
T Consensus        94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~  168 (326)
T 2x7f_A           94 NPPGMDDQLWLVMEFCGAGSVTDLIKNT--KGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEV  168 (326)
T ss_dssp             C--CCCCEEEEEEECCTTEEHHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCE
T ss_pred             cCccccceEEEEEEcCCCCcHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCCE
Confidence                 46789999999999999999653  234689999999999999999999995   49999999999999999999


Q ss_pred             EEccccccccCCCCCCcceeeecccCCccccCccccc-----cCCCCcccccHHHHHHHHHHHhCCCccccccccccccH
Q 039626          482 KIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLE-----NGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHL  556 (628)
Q Consensus       482 kl~Dfgla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~-----~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~  556 (628)
                      ||+|||++........   ......||+.|+|||.+.     +..++.++||||||+++|||++|+.|+.....      
T Consensus       169 kl~Dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------  239 (326)
T 2x7f_A          169 KLVDFGVSAQLDRTVG---RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP------  239 (326)
T ss_dssp             EECCCTTTC----------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCH------
T ss_pred             EEeeCcCceecCcCcc---ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcH------
Confidence            9999999986643211   123357899999999987     56789999999999999999999998853221      


Q ss_pred             HHHHHHHhccccchhhhccccCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          557 SDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       557 ~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      ...........          .+..   .+...+..+.+++.+||+.||.+||++.|+++
T Consensus       240 ~~~~~~~~~~~----------~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  286 (326)
T 2x7f_A          240 MRALFLIPRNP----------APRL---KSKKWSKKFQSFIESCLVKNHSQRPATEQLMK  286 (326)
T ss_dssp             HHHHHHHHHSC----------CCCC---SCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             HHHHHHhhcCc----------cccC---CccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence            11111111110          0111   01122346789999999999999999999986

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.4e-35  Score=311.95  Aligned_cols=254  Identities=23%  Similarity=0.302  Sum_probs=186.6

Q ss_pred             cCCCcCCccc----eEEEEEEE--CCceEEEEEecc------------chHHHHHHHhhcCCCceeeeeeeeecCCeEEE
Q 039626          351 DNFSFTCRIQ----GSVYRGKI--NGGFAAIKKVNG------------DVSKEIALLNKINHSNLIILSGVCFNEGNCYL  412 (628)
Q Consensus       351 ~~f~~~~~i~----G~Vy~g~~--~g~~vavK~~~~------------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l  412 (628)
                      ++|.....+|    |.||+++.  +|+.||+|+++.            .+.+|++++++++|+||+++++++.+.+..++
T Consensus        10 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   89 (346)
T 1ua2_A           10 KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISL   89 (346)
T ss_dssp             ---CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEE
T ss_pred             cccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceEE
Confidence            4455444454    89999998  588999998752            35689999999999999999999999999999


Q ss_pred             EEEecCCCChHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccC
Q 039626          413 VYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPA  492 (628)
Q Consensus       413 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~  492 (628)
                      ||||+++ +|.+++..   ....+++..+..++.|++.||+|||+.+   ++||||||+|||++.++.+||+|||+++..
T Consensus        90 v~e~~~~-~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~  162 (346)
T 1ua2_A           90 VFDFMET-DLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSF  162 (346)
T ss_dssp             EEECCSE-EHHHHHTT---CCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTT
T ss_pred             EEEcCCC-CHHHHHHh---cCcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEecccceec
Confidence            9999975 89888843   3346889999999999999999999954   999999999999999999999999999876


Q ss_pred             CCCCCcceeeecccCCccccCccccccC-CCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhcccc-ch
Q 039626          493 EGQEGEFALTRHIVGTKGYMAPEYLENG-LVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKED-GE  570 (628)
Q Consensus       493 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~-~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~  570 (628)
                      .....   ......||+.|+|||.+.+. .++.++||||||++++||++|..|+.......  .+............ ..
T Consensus       163 ~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~--~~~~i~~~~~~~~~~~~  237 (346)
T 1ua2_A          163 GSPNR---AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD--QLTRIFETLGTPTEEQW  237 (346)
T ss_dssp             TSCCC---CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHHHCCCCTTTS
T ss_pred             cCCcc---cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH--HHHHHHHHcCCCChhhh
Confidence            43321   22345789999999998764 58999999999999999999998876433211  11122211111000 00


Q ss_pred             h---hhccccCCcCCCCCC-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          571 E---SLRHFIDPTLQGNYP-----LELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       571 ~---~l~~~~d~~l~~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      .   .+...+........+     ...+..+.+++.+||+.||.+|||+.|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  291 (346)
T 1ua2_A          238 PDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK  291 (346)
T ss_dssp             SSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             hhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhc
Confidence            0   000110000000111     123456889999999999999999999875

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=1.8e-36  Score=322.53  Aligned_cols=220  Identities=17%  Similarity=0.194  Sum_probs=171.3

Q ss_pred             eEEEEEEE--CCceEEEEEecc----------chHHHH---HHHhhcCCCceeeee-------eeeecCC----------
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG----------DVSKEI---ALLNKINHSNLIILS-------GVCFNEG----------  408 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~----------~~~~E~---~~l~~l~H~nIv~l~-------g~~~~~~----------  408 (628)
                      |.||+|+.  +|+.||||++..          .+.+|+   ++|++++|||||+++       +++.+++          
T Consensus        87 g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (377)
T 3byv_A           87 YAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLD  166 (377)
T ss_dssp             EEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEECTTSCSEEEC---
T ss_pred             EEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhhccCCccccccccC
Confidence            89999996  588999999852          366899   556666899999998       5555443          


Q ss_pred             -------eEEEEEEecCCCChHHHhhhcCC---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCC
Q 039626          409 -------NCYLVYEYAVNGTLSDWVFSNKN---EGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSD  478 (628)
Q Consensus       409 -------~~~lV~E~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~  478 (628)
                             ..++||||+ +|+|.+++.....   ....++|..++.|+.||+.||+|||+.   +|+||||||+|||++.+
T Consensus       167 ~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~  242 (377)
T 3byv_A          167 ERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQR  242 (377)
T ss_dssp             ---CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTT
T ss_pred             CCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCC
Confidence                   278999999 7899999965321   123466789999999999999999995   49999999999999999


Q ss_pred             CcEEEccccccccCCCCCCcceeeecccCCccccCccccccC-----------CCCcccccHHHHHHHHHHHhCCCcccc
Q 039626          479 LRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENG-----------LVSTKLDVYAFGVLILEMLTGKEAAAL  547 (628)
Q Consensus       479 ~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~-----------~~s~k~DV~SfGvvl~ELltG~~p~~~  547 (628)
                      +.+||+|||+++....      ......| +.|+|||.+.+.           .++.++|||||||++|||++|+.||..
T Consensus       243 ~~~kL~DFG~a~~~~~------~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg~~Pf~~  315 (377)
T 3byv_A          243 GGVFLTGFEHLVRDGA------RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITK  315 (377)
T ss_dssp             CCEEECCGGGCEETTC------EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHSSCCC--
T ss_pred             CCEEEEechhheecCC------cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHHHCCCCCcc
Confidence            9999999999986432      2334567 999999999887           899999999999999999999999864


Q ss_pred             ccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          548 HAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       548 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      ......                   .......  ...+    +..+.+++.+||+.||++||++.|+++
T Consensus       316 ~~~~~~-------------------~~~~~~~--~~~~----~~~~~~li~~~L~~dp~~Rpt~~e~l~  359 (377)
T 3byv_A          316 DAALGG-------------------SEWIFRS--CKNI----PQPVRALLEGFLRYPKEDRLLPLQAME  359 (377)
T ss_dssp             ----CC-------------------SGGGGSS--CCCC----CHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred             cccccc-------------------hhhhhhh--ccCC----CHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence            322111                   0111110  0122    345789999999999999999999985

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=2.6e-35  Score=308.33  Aligned_cols=225  Identities=24%  Similarity=0.353  Sum_probs=184.9

Q ss_pred             eEEEEEEE--CCceEEEEEecc----------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhh
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG----------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFS  428 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  428 (628)
                      |.||++..  +++.+|+|.+..          .+.+|+.++++++|+||+++++++.+++..++||||+++++|.+++..
T Consensus        55 g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~  134 (335)
T 2owb_A           55 AKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKR  134 (335)
T ss_dssp             EEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHH
T ss_pred             eEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEecCCCCCHHHHHhc
Confidence            89999998  577899998753          356799999999999999999999999999999999999999998854


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCC
Q 039626          429 NKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGT  508 (628)
Q Consensus       429 ~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt  508 (628)
                      .    ..+++..++.++.|++.||+|||+.   +++||||||+|||++.++.+||+|||+++.......   ......||
T Consensus       135 ~----~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~gt  204 (335)
T 2owb_A          135 R----KALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE---RKKVLCGT  204 (335)
T ss_dssp             H----CSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTC---CBCCCCSC
T ss_pred             c----CCCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccCceecccCcc---cccccCCC
Confidence            2    3589999999999999999999995   499999999999999999999999999987643221   12345799


Q ss_pred             ccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCHH
Q 039626          509 KGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLE  588 (628)
Q Consensus       509 ~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~  588 (628)
                      +.|+|||.+.+..++.++||||||+++|||++|+.|+.....      .+....+....           ..    .+..
T Consensus       205 ~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~~~~~~~~~~-----------~~----~~~~  263 (335)
T 2owb_A          205 PNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL------KETYLRIKKNE-----------YS----IPKH  263 (335)
T ss_dssp             CSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHHHTC-----------CC----CCTT
T ss_pred             ccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCH------HHHHHHHhcCC-----------CC----CCcc
Confidence            999999999999999999999999999999999999864321      11111111100           01    1122


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          589 LALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       589 ~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      ....+.+++.+||+.||++||++.|+++
T Consensus       264 ~~~~~~~li~~~l~~dp~~Rps~~ell~  291 (335)
T 2owb_A          264 INPVAASLIQKMLQTDPTARPTINELLN  291 (335)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             CCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            3345789999999999999999999986

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=6.4e-36  Score=312.34  Aligned_cols=243  Identities=28%  Similarity=0.442  Sum_probs=180.8

Q ss_pred             eEEEEEEE--CCceEEEEEecc---------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhc
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG---------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSN  429 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~---------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~  429 (628)
                      |.||+++.  +|+.||+|++..         .+.+|++++++++|+||+++++++.+++..++||||+++++|.+++.. 
T Consensus        39 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-  117 (331)
T 4aaa_A           39 GMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELF-  117 (331)
T ss_dssp             SSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHS-
T ss_pred             EEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEecCCcchHHHHHhh-
Confidence            89999998  488999998743         256899999999999999999999999999999999999999887642 


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCCc
Q 039626          430 KNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTK  509 (628)
Q Consensus       430 ~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~  509 (628)
                         ...+++..+..++.+++.||+|||+.   +++||||||+|||++.++.+||+|||+++.......   ......||+
T Consensus       118 ---~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~t~  188 (331)
T 4aaa_A          118 ---PNGLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE---VYDDEVATR  188 (331)
T ss_dssp             ---TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTTC---------------CCCCC
T ss_pred             ---ccCCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCCceeecCCcc---ccCCCcCCc
Confidence               33599999999999999999999995   499999999999999999999999999986643221   223457899


Q ss_pred             cccCccccccC-CCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccc--------hhhhccccCCc
Q 039626          510 GYMAPEYLENG-LVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDG--------EESLRHFIDPT  580 (628)
Q Consensus       510 ~Y~APE~l~~~-~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~l~~~~d~~  580 (628)
                      .|+|||.+.+. .++.++||||||++++||++|+.|+........  +...... ......        .........+.
T Consensus       189 ~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  265 (331)
T 4aaa_A          189 WYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQ--LYHIMMC-LGNLIPRHQELFNKNPVFAGVRLPE  265 (331)
T ss_dssp             TTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHHHH-HCSCCHHHHHHHHHCGGGTTCCCCC
T ss_pred             cccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHH--HHHHHHH-hCCCChhhhhHhhhccccccccCcc
Confidence            99999999875 789999999999999999999999875432211  1111110 000000        00011111111


Q ss_pred             CCCCCCH-----HHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          581 LQGNYPL-----ELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       581 l~~~~~~-----~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      .....+.     ..+..+.+|+.+||+.||++|||+.|+++
T Consensus       266 ~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  306 (331)
T 4aaa_A          266 IKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH  306 (331)
T ss_dssp             CSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             ccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            1111111     23566889999999999999999999875

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=3.2e-35  Score=334.99  Aligned_cols=230  Identities=25%  Similarity=0.364  Sum_probs=188.1

Q ss_pred             cCCCcCCccc----eEEEEEEE--CCceEEEEEeccc----------hHHHHHHHhhc-CCCceeeeeeeeecCCeEEEE
Q 039626          351 DNFSFTCRIQ----GSVYRGKI--NGGFAAIKKVNGD----------VSKEIALLNKI-NHSNLIILSGVCFNEGNCYLV  413 (628)
Q Consensus       351 ~~f~~~~~i~----G~Vy~g~~--~g~~vavK~~~~~----------~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV  413 (628)
                      ++|.....||    |.||+++.  +++.||||+++.+          +..|..+|..+ +|+||+++++++.+.+..|||
T Consensus       341 ~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV  420 (674)
T 3pfq_A          341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFV  420 (674)
T ss_dssp             TTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEE
T ss_pred             cceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEE
Confidence            4555544554    89999998  5778999998742          45688999887 799999999999999999999


Q ss_pred             EEecCCCChHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCC
Q 039626          414 YEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAE  493 (628)
Q Consensus       414 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~  493 (628)
                      |||+++|+|.+++...    ..+++..+..++.||+.||+|||+.   +|+||||||+||||+.++.+||+|||+++...
T Consensus       421 ~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~  493 (674)
T 3pfq_A          421 MEYVNGGDLMYHIQQV----GRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENI  493 (674)
T ss_dssp             EECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCTTCEECC
T ss_pred             EeCcCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeecceeeccc
Confidence            9999999999999653    3589999999999999999999995   49999999999999999999999999998643


Q ss_pred             CCCCcceeeecccCCccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhh
Q 039626          494 GQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESL  573 (628)
Q Consensus       494 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  573 (628)
                      ...   .......||+.|+|||++.+..++.++|||||||++|||++|+.||.....      .+....+....      
T Consensus       494 ~~~---~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~------~~~~~~i~~~~------  558 (674)
T 3pfq_A          494 WDG---VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE------DELFQSIMEHN------  558 (674)
T ss_dssp             CTT---CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHSSC------
T ss_pred             cCC---cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCH------HHHHHHHHhCC------
Confidence            222   123456899999999999999999999999999999999999999874322      22222222211      


Q ss_pred             ccccCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCH
Q 039626          574 RHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTM  611 (628)
Q Consensus       574 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~  611 (628)
                               ..+|...+..+.+|+.+||+.||.+||++
T Consensus       559 ---------~~~p~~~s~~~~~li~~lL~~dP~~R~~~  587 (674)
T 3pfq_A          559 ---------VAYPKSMSKEAVAICKGLMTKHPGKRLGC  587 (674)
T ss_dssp             ---------CCCCTTSCHHHHHHHHHHSCSSSTTCTTC
T ss_pred             ---------CCCCccCCHHHHHHHHHHccCCHHHCCCC
Confidence                     12333455678899999999999999998

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=3.1e-35  Score=304.38  Aligned_cols=229  Identities=27%  Similarity=0.434  Sum_probs=186.1

Q ss_pred             eEEEEEEE--CCceEEEEEecc-----chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhcCCCC
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG-----DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEG  433 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~-----~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~  433 (628)
                      |.||+|..  +|+.||+|++..     ++.+|+.++++++|+||+++++++..++..++||||+++|+|.+++...   .
T Consensus        43 g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~---~  119 (314)
T 3com_A           43 GSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLR---N  119 (314)
T ss_dssp             CEEEEEEETTTCCEEEEEEEETTSCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHHH---T
T ss_pred             eEEEEEEECCCCCEEEEEecCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeecCCCCCHHHHHHhc---C
Confidence            89999998  488999999863     4788999999999999999999999999999999999999999998532   3


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCCccccC
Q 039626          434 KYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMA  513 (628)
Q Consensus       434 ~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~Y~A  513 (628)
                      ..+++..+..++.+++.||.|||+.   +++|+||||+||+++.++.+||+|||++........   ......||+.|+|
T Consensus       120 ~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~~y~a  193 (314)
T 3com_A          120 KTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA---KRNTVIGTPFWMA  193 (314)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBS---CBCCCCSCGGGCC
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccchhhhhhcc---ccCccCCCCCccC
Confidence            4589999999999999999999995   499999999999999999999999999987643221   1234578999999


Q ss_pred             ccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCHHHHHHH
Q 039626          514 PEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLV  593 (628)
Q Consensus       514 PE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l  593 (628)
                      ||.+.+..++.++||||||++++||++|+.|+.....      ...........          .+..  ..+...+..+
T Consensus       194 PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~~----------~~~~--~~~~~~~~~l  255 (314)
T 3com_A          194 PEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHP------MRAIFMIPTNP----------PPTF--RKPELWSDNF  255 (314)
T ss_dssp             HHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHHHHHSC----------CCCC--SSGGGSCHHH
T ss_pred             hhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHHhcCC----------Cccc--CCcccCCHHH
Confidence            9999999999999999999999999999998863221      11111111100          0000  1122234567


Q ss_pred             HHHHHHhcccCCCCCCCHHHHHH
Q 039626          594 IRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       594 ~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      .+++.+||+.||.+||++.++++
T Consensus       256 ~~li~~~l~~dp~~Rpt~~~ll~  278 (314)
T 3com_A          256 TDFVKQCLVKSPEQRATATQLLQ  278 (314)
T ss_dssp             HHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             HHHHHHHccCChhhCcCHHHHHh
Confidence            89999999999999999999975

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=4.2e-35  Score=297.51  Aligned_cols=225  Identities=26%  Similarity=0.417  Sum_probs=176.3

Q ss_pred             eEEEEEEE--CCceEEEEEecc----------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhh
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG----------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFS  428 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  428 (628)
                      |.||+|+.  +|+.+|+|.+..          .+.+|++++++++|+||+++++++.+.+..++||||+++++|.+++..
T Consensus        25 g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~  104 (276)
T 2h6d_A           25 GKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICK  104 (276)
T ss_dssp             EEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHH
T ss_pred             eEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEEeccCCCcHHHHHhc
Confidence            89999998  588999999853          356899999999999999999999999999999999999999999964


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCC
Q 039626          429 NKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGT  508 (628)
Q Consensus       429 ~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt  508 (628)
                      .    ..+++..+..++.|++.||+|||+.+   ++|+||||+||+++.++.+||+|||++.......    ......|+
T Consensus       105 ~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~  173 (276)
T 2h6d_A          105 H----GRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE----FLRTSCGS  173 (276)
T ss_dssp             H----CSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCCC--------------
T ss_pred             c----CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccCCCc----ceecccCC
Confidence            3    34899999999999999999999954   9999999999999999999999999998764322    12345789


Q ss_pred             ccccCccccccCCC-CcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCH
Q 039626          509 KGYMAPEYLENGLV-STKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPL  587 (628)
Q Consensus       509 ~~Y~APE~l~~~~~-s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~  587 (628)
                      +.|+|||.+.+..+ +.++||||||++++||++|+.|+.....      ......+....           .    ..+.
T Consensus       174 ~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~------~~~~~~~~~~~-----------~----~~~~  232 (276)
T 2h6d_A          174 PNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHV------PTLFKKIRGGV-----------F----YIPE  232 (276)
T ss_dssp             ---CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHCC-----------C----CCCT
T ss_pred             ccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcH------HHHHHHhhcCc-----------c----cCch
Confidence            99999999987765 6899999999999999999999863221      11111111100           0    1122


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 039626          588 ELALLVIRLIDACLKKDPTDRPTMYEIEHS  617 (628)
Q Consensus       588 ~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~  617 (628)
                      .....+.+++.+||+.||.+|||+.|+++.
T Consensus       233 ~~~~~l~~li~~~l~~~p~~Rps~~~~l~h  262 (276)
T 2h6d_A          233 YLNRSVATLLMHMLQVDPLKRATIKDIREH  262 (276)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             hcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence            234567899999999999999999999873

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=1.7e-35  Score=323.24  Aligned_cols=183  Identities=25%  Similarity=0.408  Sum_probs=145.5

Q ss_pred             cCCCcCCccc----eEEEEEEE--CCceEEEEEecc---------chHHHHHHHhhcCCCceeeeeeeeecC-----CeE
Q 039626          351 DNFSFTCRIQ----GSVYRGKI--NGGFAAIKKVNG---------DVSKEIALLNKINHSNLIILSGVCFNE-----GNC  410 (628)
Q Consensus       351 ~~f~~~~~i~----G~Vy~g~~--~g~~vavK~~~~---------~~~~E~~~l~~l~H~nIv~l~g~~~~~-----~~~  410 (628)
                      ++|.....+|    |.||++..  +|+.||||++..         .+.+|+++|++++|+||+++++++...     ...
T Consensus        53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  132 (458)
T 3rp9_A           53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDEL  132 (458)
T ss_dssp             TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred             CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceE
Confidence            3455444554    89999987  688999999864         356899999999999999999999543     568


Q ss_pred             EEEEEecCCCChHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccc
Q 039626          411 YLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMAR  490 (628)
Q Consensus       411 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~  490 (628)
                      |+||||+ +|+|.+++..    ...+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++
T Consensus       133 ~lv~e~~-~~~L~~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGla~  204 (458)
T 3rp9_A          133 YVVLEIA-DSDFKKLFRT----PVYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLAR  204 (458)
T ss_dssp             EEEECCC-SEEHHHHHHS----SCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred             EEEEecc-ccchhhhccc----CCCCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeecccccch
Confidence            9999998 6799998843    34699999999999999999999995   49999999999999999999999999998


Q ss_pred             cCCCCCCcc------------------------eeeecccCCccccCcccc-ccCCCCcccccHHHHHHHHHHHhC
Q 039626          491 PAEGQEGEF------------------------ALTRHIVGTKGYMAPEYL-ENGLVSTKLDVYAFGVLILEMLTG  541 (628)
Q Consensus       491 ~~~~~~~~~------------------------~~~~~~~gt~~Y~APE~l-~~~~~s~k~DV~SfGvvl~ELltG  541 (628)
                      .........                        ......+||+.|+|||++ ....++.++|||||||++|||++|
T Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg  280 (458)
T 3rp9_A          205 TVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM  280 (458)
T ss_dssp             CTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred             hccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence            764321110                        112345789999999976 566799999999999999999994

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=6.4e-36  Score=322.87  Aligned_cols=244  Identities=25%  Similarity=0.375  Sum_probs=181.3

Q ss_pred             eEEEEEEE--CCceEEEEEeccc---hHHHHHHHhhcCCCceeeeeeeeecC------CeEEEEEEecCCCChHHHhhhc
Q 039626          361 GSVYRGKI--NGGFAAIKKVNGD---VSKEIALLNKINHSNLIILSGVCFNE------GNCYLVYEYAVNGTLSDWVFSN  429 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~~---~~~E~~~l~~l~H~nIv~l~g~~~~~------~~~~lV~E~~~~gsL~~~l~~~  429 (628)
                      |.||+|+.  +|+.||||++..+   ..+|+++|++++|+|||++++++...      ...++||||+++ +|.+.+...
T Consensus        68 g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~  146 (420)
T 1j1b_A           68 GVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHY  146 (420)
T ss_dssp             EEEEEEEETTTCCEEEEEEEECCTTSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEEEECCCE-EHHHHHHHH
T ss_pred             EEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEeehhcccc-cHHHHHHHH
Confidence            89999999  5889999998653   45799999999999999999998642      236799999975 677766543


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCC-CcEEEccccccccCCCCCCcceeeecccCC
Q 039626          430 KNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSD-LRAKIANFAMARPAEGQEGEFALTRHIVGT  508 (628)
Q Consensus       430 ~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~-~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt  508 (628)
                      ......+++..+..++.||++||+|||+.   +|+||||||+|||++.+ +.+||+|||+++.......    .....||
T Consensus       147 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~~~~----~~~~~~t  219 (420)
T 1j1b_A          147 SRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP----NVSYICS  219 (420)
T ss_dssp             HHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCTTCEECCTTCC----CCSCCSC
T ss_pred             hhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccchhhhhcccCCC----ceeeeeC
Confidence            33456799999999999999999999985   49999999999999965 6789999999987643321    2335789


Q ss_pred             ccccCccccccC-CCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhc-------cccCCc
Q 039626          509 KGYMAPEYLENG-LVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLR-------HFIDPT  580 (628)
Q Consensus       509 ~~Y~APE~l~~~-~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~-------~~~d~~  580 (628)
                      +.|+|||++.+. .++.++|||||||++|||++|+.||.......  .+.+.+.. +.... .+.+.       .+..+.
T Consensus       220 ~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~--~l~~i~~~-lg~p~-~~~~~~~~~~~~~~~~p~  295 (420)
T 1j1b_A          220 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD--QLVEIIKV-LGTPT-REQIREMNPNYTEFKFPQ  295 (420)
T ss_dssp             TTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHH-HCSCC-HHHHHHHCSCCCCCCCCC
T ss_pred             CCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHH-hCCCC-HHHHHhhChhhhhhccCc
Confidence            999999998764 78999999999999999999999987533211  12222221 11110 11111       111111


Q ss_pred             CCCC-----CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          581 LQGN-----YPLELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       581 l~~~-----~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      +...     ++...+..+.+|+.+||+.||.+||++.|+++
T Consensus       296 ~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~  336 (420)
T 1j1b_A          296 IKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA  336 (420)
T ss_dssp             CCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence            1100     11223456889999999999999999999874

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=3.2e-35  Score=321.21  Aligned_cols=249  Identities=23%  Similarity=0.267  Sum_probs=180.5

Q ss_pred             cCCCcCCccc----eEEEEEEE--CCceEEEEEecc---------chHHHHHHHhhcCCCceeeeeeeeecC------Ce
Q 039626          351 DNFSFTCRIQ----GSVYRGKI--NGGFAAIKKVNG---------DVSKEIALLNKINHSNLIILSGVCFNE------GN  409 (628)
Q Consensus       351 ~~f~~~~~i~----G~Vy~g~~--~g~~vavK~~~~---------~~~~E~~~l~~l~H~nIv~l~g~~~~~------~~  409 (628)
                      ++|.....+|    |.||++..  +|+.||||++..         .+.+|+.+|++++|+||+++++++...      .+
T Consensus        62 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~  141 (464)
T 3ttj_A           62 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD  141 (464)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCe
Confidence            4455444554    89999987  688999999853         356899999999999999999999654      45


Q ss_pred             EEEEEEecCCCChHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEcccccc
Q 039626          410 CYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMA  489 (628)
Q Consensus       410 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla  489 (628)
                      .++||||+++ +|.+.+.      ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||++
T Consensus       142 ~~lv~E~~~~-~l~~~~~------~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DFG~a  211 (464)
T 3ttj_A          142 VYLVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA  211 (464)
T ss_dssp             EEEEEECCSE-EHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCCC
T ss_pred             EEEEEeCCCC-CHHHHHh------hcCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEEEee
Confidence            7999999965 5666662      2389999999999999999999995   4999999999999999999999999999


Q ss_pred             ccCCCCCCcceeeecccCCccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccc
Q 039626          490 RPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDG  569 (628)
Q Consensus       490 ~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~  569 (628)
                      +......    ......||+.|+|||.+.+..++.++|||||||+++||++|+.||.......   ....+...+.....
T Consensus       212 ~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~---~~~~i~~~lg~p~~  284 (464)
T 3ttj_A          212 RTAGTSF----MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID---QWNKVIEQLGTPCP  284 (464)
T ss_dssp             -----CC----CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHHHCSCCH
T ss_pred             eecCCCc----ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHhcCCCCH
Confidence            8764321    2344689999999999999999999999999999999999999987533211   11111111111100


Q ss_pred             ------hhhhccccCC---------------cCCCC---CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          570 ------EESLRHFIDP---------------TLQGN---YPLELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       570 ------~~~l~~~~d~---------------~l~~~---~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                            ....+.+++.               .+...   ........+.+|+.+||+.||++|||++|+++
T Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  355 (464)
T 3ttj_A          285 EFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ  355 (464)
T ss_dssp             HHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence                  0001111110               00000   01122567899999999999999999999875

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=4.2e-36  Score=311.46  Aligned_cols=237  Identities=22%  Similarity=0.343  Sum_probs=181.0

Q ss_pred             eEEEEEEECCceEEEEEecc---------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhcCC
Q 039626          361 GSVYRGKINGGFAAIKKVNG---------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKN  431 (628)
Q Consensus       361 G~Vy~g~~~g~~vavK~~~~---------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~  431 (628)
                      |.||+|+..+ .+|+|+++.         .+.+|+.++++++|+||+++++++.+++..++||||+++++|.+++..   
T Consensus        47 g~V~~~~~~~-~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~---  122 (319)
T 2y4i_B           47 GQVYHGRWHG-EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRD---  122 (319)
T ss_dssp             SEEEEEEESS-SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECBCCCSEEHHHHTTS---
T ss_pred             eEEEEEEEcC-eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEeecccCCcHHHHHHh---
Confidence            8999999866 489998753         367899999999999999999999999999999999999999999943   


Q ss_pred             CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCC--cceeeecccCCc
Q 039626          432 EGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEG--EFALTRHIVGTK  509 (628)
Q Consensus       432 ~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~--~~~~~~~~~gt~  509 (628)
                      ....+++..+..++.|++.||+|||+.   +++||||||+|||++ ++.+||+|||+++.......  .........||+
T Consensus       123 ~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~  198 (319)
T 2y4i_B          123 AKIVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWL  198 (319)
T ss_dssp             SCCCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCCSCCC----------CCSCBCCSGGG
T ss_pred             cCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeecCCccccccccccccccccccCCCcc
Confidence            234689999999999999999999995   499999999999998 67999999999876532211  111223346899


Q ss_pred             cccCcccccc---------CCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCc
Q 039626          510 GYMAPEYLEN---------GLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPT  580 (628)
Q Consensus       510 ~Y~APE~l~~---------~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~  580 (628)
                      .|+|||.+.+         ..++.++||||||++++||++|+.|+.....      ......+...          ..+.
T Consensus       199 ~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~------~~~~~~~~~~----------~~~~  262 (319)
T 2y4i_B          199 CHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPA------EAIIWQMGTG----------MKPN  262 (319)
T ss_dssp             GTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCH------HHHHHHHHTT----------CCCC
T ss_pred             cccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHhccC----------CCCC
Confidence            9999999864         4578999999999999999999999864322      1112121111          1111


Q ss_pred             CCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhh
Q 039626          581 LQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNA  624 (628)
Q Consensus       581 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~~~  624 (628)
                      ..   +...+..+.+++.+||+.||.+|||+.|+++.|+++...
T Consensus       263 ~~---~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~  303 (319)
T 2y4i_B          263 LS---QIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKR  303 (319)
T ss_dssp             CC---CSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC---
T ss_pred             CC---cCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHh
Confidence            11   011223478999999999999999999999999988754

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=1.9e-35  Score=310.53  Aligned_cols=253  Identities=21%  Similarity=0.347  Sum_probs=191.0

Q ss_pred             cCCCcCCccc----eEEEEEEECCceEEEEEec------------------------cchHHHHHHHhhcCCCceeeeee
Q 039626          351 DNFSFTCRIQ----GSVYRGKINGGFAAIKKVN------------------------GDVSKEIALLNKINHSNLIILSG  402 (628)
Q Consensus       351 ~~f~~~~~i~----G~Vy~g~~~g~~vavK~~~------------------------~~~~~E~~~l~~l~H~nIv~l~g  402 (628)
                      ++|.....+|    |.||++..+|+.||+|++.                        ..+.+|++++++++|+||+++++
T Consensus        31 ~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~  110 (348)
T 2pml_X           31 NDYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEG  110 (348)
T ss_dssp             TTEEEEEEEECCSSCCEEEEEETTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCSE
T ss_pred             CceEEEEEEcCCCCeEEEEEEcCCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEEE
Confidence            3444444443    8999999999999999874                        34678999999999999999999


Q ss_pred             eeecCCeEEEEEEecCCCChHHHhhh----cCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCeEecCCCCCCEEeCC
Q 039626          403 VCFNEGNCYLVYEYAVNGTLSDWVFS----NKNEGKYLDWKQRIQIALDVATGLNYLHS-FTNPPHVHKDINSSNVLLDS  477 (628)
Q Consensus       403 ~~~~~~~~~lV~E~~~~gsL~~~l~~----~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~iiH~dik~~NILl~~  477 (628)
                      ++.+.+..++||||+++|+|.+++..    .......+++..+..++.|++.||+|||+ .+   ++||||||+||+++.
T Consensus       111 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Nil~~~  187 (348)
T 2pml_X          111 IITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNILMDK  187 (348)
T ss_dssp             EEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGEEECT
T ss_pred             EEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhEEEcC
Confidence            99999999999999999999998321    11224679999999999999999999998 54   999999999999999


Q ss_pred             CCcEEEccccccccCCCCCCcceeeecccCCccccCccccccC-CCCc-ccccHHHHHHHHHHHhCCCcccccccccccc
Q 039626          478 DLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENG-LVST-KLDVYAFGVLILEMLTGKEAAALHAEENNMH  555 (628)
Q Consensus       478 ~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~-~~s~-k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~  555 (628)
                      ++.+||+|||+++.....     ......||..|+|||.+.+. .++. ++||||||++++||++|+.|+......    
T Consensus       188 ~~~~kl~dfg~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~----  258 (348)
T 2pml_X          188 NGRVKLSDFGESEYMVDK-----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL----  258 (348)
T ss_dssp             TSCEEECCCTTCEECBTT-----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS----
T ss_pred             CCcEEEeccccccccccc-----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH----
Confidence            999999999999876432     23446799999999999877 6666 999999999999999999998743321    


Q ss_pred             HHHHHHHHhccccc-hhhhccccCCcC---CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          556 LSDVLNAVLTKEDG-EESLRHFIDPTL---QGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       556 ~~~~~~~~~~~~~~-~~~l~~~~d~~l---~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                       .+....+...... ......+..+..   ........+..+.+++.+||+.||.+||++.|+++
T Consensus       259 -~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~  322 (348)
T 2pml_X          259 -VELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK  322 (348)
T ss_dssp             -HHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             -HHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence             1222222211100 000000000000   00011234456889999999999999999999976

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=2.6e-35  Score=303.77  Aligned_cols=227  Identities=24%  Similarity=0.372  Sum_probs=185.0

Q ss_pred             eEEEEEEE--CCceEEEEEecc-------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhcCC
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG-------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKN  431 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~-------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~  431 (628)
                      |.||+++.  +|+.+|+|.++.       .+.+|++++++++||||+++++++.+++..++||||+++|+|.+++...  
T Consensus        23 g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--  100 (304)
T 2jam_A           23 SEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILER--  100 (304)
T ss_dssp             EEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHH--
T ss_pred             ceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcCCCccHHHHHHHc--
Confidence            89999998  688999998853       3678999999999999999999999999999999999999999998543  


Q ss_pred             CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEe---CCCCcEEEccccccccCCCCCCcceeeecccCC
Q 039626          432 EGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLL---DSDLRAKIANFAMARPAEGQEGEFALTRHIVGT  508 (628)
Q Consensus       432 ~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl---~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt  508 (628)
                        ..+++..+..++.|++.||+|||+.   +++||||||+||++   ++++.+||+|||+++......     .....||
T Consensus       101 --~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~~~~  170 (304)
T 2jam_A          101 --GVYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI-----MSTACGT  170 (304)
T ss_dssp             --SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCBT-----THHHHSC
T ss_pred             --CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCCcceecCCCc-----cccccCC
Confidence              3589999999999999999999995   49999999999999   788999999999997654321     2234689


Q ss_pred             ccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCHH
Q 039626          509 KGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLE  588 (628)
Q Consensus       509 ~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~  588 (628)
                      +.|+|||.+.+..++.++||||||++++||++|+.|+.....      .+....+.....      .     ........
T Consensus       171 ~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~~~~~i~~~~~------~-----~~~~~~~~  233 (304)
T 2jam_A          171 PGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETE------SKLFEKIKEGYY------E-----FESPFWDD  233 (304)
T ss_dssp             CCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHHHHHCCC------C-----CCTTTTTT
T ss_pred             CCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH------HHHHHHHHcCCC------C-----CCcccccc
Confidence            999999999999999999999999999999999999864321      112222111100      0     01111223


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          589 LALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       589 ~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      .+..+.+++.+||+.||++||++.|+++
T Consensus       234 ~~~~~~~li~~~l~~dp~~Rps~~~~l~  261 (304)
T 2jam_A          234 ISESAKDFICHLLEKDPNERYTCEKALS  261 (304)
T ss_dssp             SCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             CCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            3456889999999999999999999975

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=1.9e-35  Score=306.32  Aligned_cols=234  Identities=20%  Similarity=0.297  Sum_probs=178.5

Q ss_pred             eEEEEEEE--CCceEEEEEecc-------chHHHHHHHhhc-CCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhcC
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG-------DVSKEIALLNKI-NHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNK  430 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~-------~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~  430 (628)
                      |.||+++.  +++.||||++..       .+.+|++++.++ +|+||+++++++.+++..++||||+++|+|.+++... 
T Consensus        27 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-  105 (316)
T 2ac3_A           27 ARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKR-  105 (316)
T ss_dssp             EEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHH-
T ss_pred             EEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEcCCCCcHHHHHhcc-
Confidence            89999987  688999999853       367899999985 7999999999999999999999999999999999653 


Q ss_pred             CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCc---EEEccccccccCCCCCCc----ceeee
Q 039626          431 NEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLR---AKIANFAMARPAEGQEGE----FALTR  503 (628)
Q Consensus       431 ~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~---~kl~Dfgla~~~~~~~~~----~~~~~  503 (628)
                         ..+++..+..++.|++.||+|||+.   +++||||||+|||++.++.   +||+|||+++........    .....
T Consensus       106 ---~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~  179 (316)
T 2ac3_A          106 ---RHFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELL  179 (316)
T ss_dssp             ---SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-----------------
T ss_pred             ---CCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCccccccccccc
Confidence               3589999999999999999999995   4999999999999998776   999999999865422111    01122


Q ss_pred             cccCCccccCcccccc-----CCCCcccccHHHHHHHHHHHhCCCccccccccccccH---------HHHHHHHhccccc
Q 039626          504 HIVGTKGYMAPEYLEN-----GLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHL---------SDVLNAVLTKEDG  569 (628)
Q Consensus       504 ~~~gt~~Y~APE~l~~-----~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~---------~~~~~~~~~~~~~  569 (628)
                      ...||+.|+|||.+.+     ..++.++||||||++++||++|+.||.........+.         ......+...   
T Consensus       180 ~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~---  256 (316)
T 2ac3_A          180 TPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEG---  256 (316)
T ss_dssp             --CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHHHHHHHHC---
T ss_pred             cccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHHHHHHHhcc---
Confidence            3469999999999875     5688999999999999999999999875432221100         0111111110   


Q ss_pred             hhhhccccCCcCCCCCCH----HHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          570 EESLRHFIDPTLQGNYPL----ELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       570 ~~~l~~~~d~~l~~~~~~----~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                                .  ...+.    ..+..+.+++.+||+.||.+|||+.|+++
T Consensus       257 ----------~--~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  295 (316)
T 2ac3_A          257 ----------K--YEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ  295 (316)
T ss_dssp             ----------C--CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             ----------C--cccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence                      0  01111    12456889999999999999999999976

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=3.1e-35  Score=310.39  Aligned_cols=262  Identities=23%  Similarity=0.275  Sum_probs=186.9

Q ss_pred             HHHHHhcCCCcCCccc----eEEEEEEE--CCceEEEEEecc------chHHHHHHHhhcCCCceeeeeeeeecCCe---
Q 039626          345 ELQSATDNFSFTCRIQ----GSVYRGKI--NGGFAAIKKVNG------DVSKEIALLNKINHSNLIILSGVCFNEGN---  409 (628)
Q Consensus       345 el~~at~~f~~~~~i~----G~Vy~g~~--~g~~vavK~~~~------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~---  409 (628)
                      +.....++|.....+|    |.||+|+.  +|..||||++..      ...+|++.+.+++|+||+++++++...+.   
T Consensus        17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~   96 (360)
T 3e3p_A           17 RSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDR   96 (360)
T ss_dssp             HHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCT
T ss_pred             hchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhccccccc
Confidence            3445566777666665    89999998  588999998853      35678888899999999999999975433   


Q ss_pred             ----EEEEEEecCCCChHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCC-CCcEEEc
Q 039626          410 ----CYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDS-DLRAKIA  484 (628)
Q Consensus       410 ----~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~-~~~~kl~  484 (628)
                          .++||||+++ +|.+.+.........+++..+..++.+++.||.|||.+. .+|+||||||+|||++. ++.+||+
T Consensus        97 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~-~~ivH~Dlkp~NIll~~~~~~~kl~  174 (360)
T 3e3p_A           97 RDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLC  174 (360)
T ss_dssp             TCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTT-TCCBCSCCCGGGEEEETTTTEEEEC
T ss_pred             cceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCC-CCeecCcCCHHHEEEeCCCCcEEEe
Confidence                7899999975 666655443345567899999999999999999999322 56999999999999997 8999999


Q ss_pred             cccccccCCCCCCcceeeecccCCccccCccccccC-CCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHH
Q 039626          485 NFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENG-LVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAV  563 (628)
Q Consensus       485 Dfgla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~-~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~  563 (628)
                      |||+++.......    .....||+.|+|||.+.+. .++.++||||||+++|||++|+.||.......  .+..... .
T Consensus       175 Dfg~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~--~~~~~~~-~  247 (360)
T 3e3p_A          175 DFGSAKKLSPSEP----NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAG--QLHEIVR-V  247 (360)
T ss_dssp             CCTTCBCCCTTSC----CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHH-H
T ss_pred             eCCCceecCCCCC----cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHH--HHHHHHH-H
Confidence            9999987654321    2345789999999998664 48999999999999999999999987533221  1111111 1


Q ss_pred             hccccchhhhcccc---------CC------cCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          564 LTKEDGEESLRHFI---------DP------TLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       564 ~~~~~~~~~l~~~~---------d~------~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      ..... .+.+..+.         +.      ......+...+..+.+|+.+||+.||.+|||+.|+++
T Consensus       248 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  314 (360)
T 3e3p_A          248 LGCPS-REVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC  314 (360)
T ss_dssp             HCCCC-HHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             cCCCC-HHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence            11100 00000000         00      0001112234667899999999999999999999875

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=4e-35  Score=308.82  Aligned_cols=245  Identities=22%  Similarity=0.318  Sum_probs=181.3

Q ss_pred             eEEEEEEE--CCceEEEEEecc---------chHHHHHHHhhcCCCceeeeeeeeec--------CCeEEEEEEecCCCC
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG---------DVSKEIALLNKINHSNLIILSGVCFN--------EGNCYLVYEYAVNGT  421 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~---------~~~~E~~~l~~l~H~nIv~l~g~~~~--------~~~~~lV~E~~~~gs  421 (628)
                      |.||+++.  +|+.||+|++..         .+.+|++++++++|+||+++++++..        ++..++||||+++ +
T Consensus        31 g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~  109 (351)
T 3mi9_A           31 GEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-D  109 (351)
T ss_dssp             TSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------CEEEEEEECCSE-E
T ss_pred             cEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCCceEEEEEeccCC-C
Confidence            89999998  688999998743         35689999999999999999999986        3468999999964 7


Q ss_pred             hHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCC-cce
Q 039626          422 LSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEG-EFA  500 (628)
Q Consensus       422 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~-~~~  500 (628)
                      |.+.+..   ....+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++....... ...
T Consensus       110 l~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~  183 (351)
T 3mi9_A          110 LAGLLSN---VLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPN  183 (351)
T ss_dssp             HHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCCCSSSSCC
T ss_pred             HHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEccchhccccccccccccc
Confidence            8777743   234599999999999999999999995   499999999999999999999999999987643221 112


Q ss_pred             eeecccCCccccCcccccc-CCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccc---
Q 039626          501 LTRHIVGTKGYMAPEYLEN-GLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHF---  576 (628)
Q Consensus       501 ~~~~~~gt~~Y~APE~l~~-~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~---  576 (628)
                      ......||+.|+|||.+.+ ..++.++||||||++++||++|+.|+.......   ....+........ .+.....   
T Consensus       184 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~---~~~~i~~~~~~~~-~~~~~~~~~~  259 (351)
T 3mi9_A          184 RYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQH---QLALISQLCGSIT-PEVWPNVDNY  259 (351)
T ss_dssp             CCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCCCC-TTTSTTGGGC
T ss_pred             ccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHHhCCCC-hhhccccccc
Confidence            2344578999999998876 458999999999999999999999987543221   1122222211110 0000000   


Q ss_pred             -----cCCcCCCCCCH-H------HHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          577 -----IDPTLQGNYPL-E------LALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       577 -----~d~~l~~~~~~-~------~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                           +.......... +      ....+.+|+.+||+.||++|||++|+++
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  311 (351)
T 3mi9_A          260 ELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  311 (351)
T ss_dssp             GGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence                 00000000011 1      1245789999999999999999999875

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=1.6e-35  Score=336.37  Aligned_cols=245  Identities=26%  Similarity=0.365  Sum_probs=190.6

Q ss_pred             cCCCcCCccc----eEEEEEEEC-----CceEEEEEecc--------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEE
Q 039626          351 DNFSFTCRIQ----GSVYRGKIN-----GGFAAIKKVNG--------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLV  413 (628)
Q Consensus       351 ~~f~~~~~i~----G~Vy~g~~~-----g~~vavK~~~~--------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV  413 (628)
                      ++|.....+|    |.||+|.+.     +..+|+|+.+.        .+.+|+.++++++||||++++|++. ++..++|
T Consensus       390 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~lv  468 (656)
T 2j0j_A          390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWII  468 (656)
T ss_dssp             GGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEE
T ss_pred             ccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceEEE
Confidence            3444444444    899999982     34689998763        4678999999999999999999985 4568999


Q ss_pred             EEecCCCChHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCC
Q 039626          414 YEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAE  493 (628)
Q Consensus       414 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~  493 (628)
                      |||+++|+|.+++...   ...+++..++.++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++...
T Consensus       469 ~E~~~~g~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~DFG~a~~~~  542 (656)
T 2j0j_A          469 MELCTLGELRSFLQVR---KFSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYME  542 (656)
T ss_dssp             EECCTTCBHHHHHHHT---TTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCCCCSCC
T ss_pred             EEcCCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEecCCCeecC
Confidence            9999999999999642   34589999999999999999999995   49999999999999999999999999998765


Q ss_pred             CCCCcceeeecccCCccccCccccccCCCCcccccHHHHHHHHHHHh-CCCccccccccccccHHHHHHHHhccccchhh
Q 039626          494 GQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT-GKEAAALHAEENNMHLSDVLNAVLTKEDGEES  572 (628)
Q Consensus       494 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELlt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  572 (628)
                      ....  .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.|+.....      .+....+....     
T Consensus       543 ~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~------~~~~~~i~~~~-----  609 (656)
T 2j0j_A          543 DSTY--YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN------NDVIGRIENGE-----  609 (656)
T ss_dssp             C------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH------HHHHHHHHHTC-----
T ss_pred             CCcc--eeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCH------HHHHHHHHcCC-----
Confidence            3321  12233467889999999999999999999999999999997 8888764322      12222211110     


Q ss_pred             hccccCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhh
Q 039626          573 LRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNA  624 (628)
Q Consensus       573 l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~~~  624 (628)
                           .+    ..+...+..+.+++.+||+.||.+||++.|+++.|+++++.
T Consensus       610 -----~~----~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~  652 (656)
T 2j0j_A          610 -----RL----PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE  652 (656)
T ss_dssp             -----CC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             -----CC----CCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence                 11    12223345678999999999999999999999999999865

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=2.8e-35  Score=311.19  Aligned_cols=262  Identities=24%  Similarity=0.315  Sum_probs=189.5

Q ss_pred             ecHHHHHHHhcCCCcCCccc----eEEEEEEE-CCceEEEEEecc------------------chHHHHHHHhhcCCCce
Q 039626          341 YSFKELQSATDNFSFTCRIQ----GSVYRGKI-NGGFAAIKKVNG------------------DVSKEIALLNKINHSNL  397 (628)
Q Consensus       341 ~~~~el~~at~~f~~~~~i~----G~Vy~g~~-~g~~vavK~~~~------------------~~~~E~~~l~~l~H~nI  397 (628)
                      ..++++....++|.....+|    |.||+|.. +|..||||++..                  .+.+|++++++++||||
T Consensus        12 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i   91 (362)
T 3pg1_A           12 DLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNI   91 (362)
T ss_dssp             HHHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTB
T ss_pred             HHHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCc
Confidence            34678888889998877776    89999987 688999998842                  36789999999999999


Q ss_pred             eeeeeeeec-----CCeEEEEEEecCCCChHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCC
Q 039626          398 IILSGVCFN-----EGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSN  472 (628)
Q Consensus       398 v~l~g~~~~-----~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~N  472 (628)
                      +++++++..     ....++||||++ |+|.+++..   ....+++..+..++.|++.||+|||+.   +++||||||+|
T Consensus        92 v~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~N  164 (362)
T 3pg1_A           92 LGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHD---QRIVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGN  164 (362)
T ss_dssp             CCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGG
T ss_pred             cceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHH
Confidence            999999853     336899999997 688888853   344699999999999999999999995   49999999999


Q ss_pred             EEeCCCCcEEEccccccccCCCCCCcceeeecccCCccccCcccccc-CCCCcccccHHHHHHHHHHHhCCCcccccccc
Q 039626          473 VLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLEN-GLVSTKLDVYAFGVLILEMLTGKEAAALHAEE  551 (628)
Q Consensus       473 ILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~  551 (628)
                      ||++.++.+||+|||+++......    ......||+.|+|||.+.+ ..++.++||||||++++||++|+.|+......
T Consensus       165 Il~~~~~~~kl~Dfg~~~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~  240 (362)
T 3pg1_A          165 ILLADNNDITICDFNLAREDTADA----NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFY  240 (362)
T ss_dssp             EEECTTCCEEECCTTC-------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred             EEEcCCCCEEEEecCccccccccc----ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHH
Confidence            999999999999999998543322    2234578999999999877 67899999999999999999999998743321


Q ss_pred             ccccHHHHHHHHhccccch-------hhhccccCCcCC---CC----CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          552 NNMHLSDVLNAVLTKEDGE-------ESLRHFIDPTLQ---GN----YPLELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       552 ~~~~~~~~~~~~~~~~~~~-------~~l~~~~d~~l~---~~----~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      .  .+.... .........       ......+.....   ..    ........+.+++.+||+.||.+|||+.|+++
T Consensus       241 ~--~~~~i~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  316 (362)
T 3pg1_A          241 N--QLNKIV-EVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR  316 (362)
T ss_dssp             H--HHHHHH-HHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             H--HHHHHH-HHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence            1  111111 111111000       000111111000   00    01122456789999999999999999999875

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=8e-35  Score=303.48  Aligned_cols=240  Identities=19%  Similarity=0.282  Sum_probs=182.2

Q ss_pred             eEEEEEEE--CCceEEEEEecc----chHHHHHHHhhcC-CCceeeeeeeeec--CCeEEEEEEecCCCChHHHhhhcCC
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG----DVSKEIALLNKIN-HSNLIILSGVCFN--EGNCYLVYEYAVNGTLSDWVFSNKN  431 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~----~~~~E~~~l~~l~-H~nIv~l~g~~~~--~~~~~lV~E~~~~gsL~~~l~~~~~  431 (628)
                      |.||++..  +++.||+|.++.    .+.+|++++++++ |+||+++++++.+  ....++||||+++++|.+++.    
T Consensus        50 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~----  125 (330)
T 3nsz_A           50 SEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ----  125 (330)
T ss_dssp             EEEEEEEETTTCCEEEEEEECSCCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEECCCCCCHHHHGG----
T ss_pred             eEEEEEEECCCCcEEEEEEecccchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEeccCchhHHHHHH----
Confidence            89999987  788999999874    4778999999997 9999999999987  567899999999999999883    


Q ss_pred             CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCC-cEEEccccccccCCCCCCcceeeecccCCcc
Q 039626          432 EGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDL-RAKIANFAMARPAEGQEGEFALTRHIVGTKG  510 (628)
Q Consensus       432 ~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~-~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~  510 (628)
                         .+++..+..++.|++.||+|||+.   +++||||||+|||++.++ .+||+|||+++.......    .....||..
T Consensus       126 ---~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~----~~~~~~~~~  195 (330)
T 3nsz_A          126 ---TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE----YNVRVASRY  195 (330)
T ss_dssp             ---GCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTCC----CCSCCSCGG
T ss_pred             ---hCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCCc----ccccccccc
Confidence               288999999999999999999995   499999999999999776 899999999987643321    233578999


Q ss_pred             ccCcccccc-CCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccch-----------hhhcccc-
Q 039626          511 YMAPEYLEN-GLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGE-----------ESLRHFI-  577 (628)
Q Consensus       511 Y~APE~l~~-~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-----------~~l~~~~-  577 (628)
                      |+|||.+.+ ..++.++||||||++++||++|+.|+....... ..+.... .........           ....... 
T Consensus       196 y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~-~~l~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (330)
T 3nsz_A          196 FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNY-DQLVRIA-KVLGTEDLYDYIDKYNIELDPRFNDILG  273 (330)
T ss_dssp             GCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHH-HHHHHHH-HHHCHHHHHHHHHHTTCCCCTHHHHHHC
T ss_pred             ccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchH-HHHHHHH-HhcCCchhhhHHHHhccccccchhhhhh
Confidence            999999877 678999999999999999999999985322111 0011110 100000000           0000000 


Q ss_pred             -------CCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          578 -------DPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       578 -------d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                             ........+...+..+.+|+.+||+.||++|||++|+++
T Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~  319 (330)
T 3nsz_A          274 RHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  319 (330)
T ss_dssp             CCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             hccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence                   000111112224567889999999999999999999975

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=1.6e-35  Score=304.51  Aligned_cols=242  Identities=26%  Similarity=0.371  Sum_probs=174.7

Q ss_pred             eEEEEEEE--CCceEEEEEecc--------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhcC
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG--------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNK  430 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~--------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~  430 (628)
                      |.||++..  +++.||||++..        ++.+|++++++++||||+++++++..++..++||||+++|+|.+++....
T Consensus        29 g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~  108 (303)
T 2vwi_A           29 AVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIV  108 (303)
T ss_dssp             CCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEECCTTCBHHHHHHHHH
T ss_pred             eEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEehhccCCchHHHHHHHh
Confidence            89999987  688999998753        46689999999999999999999999999999999999999999986421


Q ss_pred             ----CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCC--cceeeec
Q 039626          431 ----NEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEG--EFALTRH  504 (628)
Q Consensus       431 ----~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~--~~~~~~~  504 (628)
                          .....+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||+++.......  .......
T Consensus       109 ~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~  185 (303)
T 2vwi_A          109 AKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKT  185 (303)
T ss_dssp             HTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCHHHHHCC-------------
T ss_pred             hccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEEeccchheeccCCCccchhhhcc
Confidence                1245699999999999999999999995   499999999999999999999999999876643221  1112234


Q ss_pred             ccCCccccCcccccc-CCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCC
Q 039626          505 IVGTKGYMAPEYLEN-GLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQG  583 (628)
Q Consensus       505 ~~gt~~Y~APE~l~~-~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~  583 (628)
                      ..||+.|+|||.+.+ ..++.++||||||++++||++|+.|+.......      .......... ........++....
T Consensus       186 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~------~~~~~~~~~~-~~~~~~~~~~~~~~  258 (303)
T 2vwi_A          186 FVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMK------VLMLTLQNDP-PSLETGVQDKEMLK  258 (303)
T ss_dssp             --CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGG------HHHHHHTSSC-CCTTC-----CCCC
T ss_pred             cCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhh------HHHHHhccCC-Cccccccccchhhh
Confidence            579999999999876 568999999999999999999999986433221      1111111100 00001111122222


Q ss_pred             CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          584 NYPLELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       584 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      .+    +..+.+++.+||+.||.+||++.|+++
T Consensus       259 ~~----~~~~~~li~~~l~~dp~~Rps~~~ll~  287 (303)
T 2vwi_A          259 KY----GKSFRKMISLCLQKDPEKRPTAAELLR  287 (303)
T ss_dssp             CC----CHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             hh----hHHHHHHHHHHccCChhhCcCHHHHhh
Confidence            33    345789999999999999999999975

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=6.5e-35  Score=316.16  Aligned_cols=186  Identities=25%  Similarity=0.385  Sum_probs=151.4

Q ss_pred             CCCcCCccc----eEEEEEEE--CCceEEEEEecc---------chHHHHHHHhhcCCCceeeeeeeeecC-----CeEE
Q 039626          352 NFSFTCRIQ----GSVYRGKI--NGGFAAIKKVNG---------DVSKEIALLNKINHSNLIILSGVCFNE-----GNCY  411 (628)
Q Consensus       352 ~f~~~~~i~----G~Vy~g~~--~g~~vavK~~~~---------~~~~E~~~l~~l~H~nIv~l~g~~~~~-----~~~~  411 (628)
                      +|.....+|    |.||+++.  +++.||||+++.         .+.+|+++|++++|+||+++++++...     ...|
T Consensus        27 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~  106 (432)
T 3n9x_A           27 NYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELY  106 (432)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEE
T ss_pred             CEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeEE
Confidence            444444443    89999988  678999999864         356899999999999999999999866     5789


Q ss_pred             EEEEecCCCChHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEcccccccc
Q 039626          412 LVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARP  491 (628)
Q Consensus       412 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~  491 (628)
                      +||||++ |+|.+++..    ...+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++.
T Consensus       107 lv~e~~~-~~L~~~~~~----~~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla~~  178 (432)
T 3n9x_A          107 IVLEIAD-SDLKKLFKT----PIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLART  178 (432)
T ss_dssp             EEEECCS-EEHHHHHHS----SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEecCC-cCHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCccc
Confidence            9999985 699999843    345999999999999999999999954   99999999999999999999999999987


Q ss_pred             CCCCCCcc-------------------eeeecccCCccccCcccc-ccCCCCcccccHHHHHHHHHHHhCCCcc
Q 039626          492 AEGQEGEF-------------------ALTRHIVGTKGYMAPEYL-ENGLVSTKLDVYAFGVLILEMLTGKEAA  545 (628)
Q Consensus       492 ~~~~~~~~-------------------~~~~~~~gt~~Y~APE~l-~~~~~s~k~DV~SfGvvl~ELltG~~p~  545 (628)
                      ........                   .......||+.|+|||.+ ....++.++|||||||+++||++|..|+
T Consensus       179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~  252 (432)
T 3n9x_A          179 INSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH  252 (432)
T ss_dssp             C-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred             ccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence            64332110                   112456899999999986 5667999999999999999999865544

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=6.9e-35  Score=299.32  Aligned_cols=228  Identities=24%  Similarity=0.330  Sum_probs=183.0

Q ss_pred             eEEEEEEE--CCceEEEEEecc----------------chHHHHHHHhhcC-CCceeeeeeeeecCCeEEEEEEecCCCC
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG----------------DVSKEIALLNKIN-HSNLIILSGVCFNEGNCYLVYEYAVNGT  421 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~----------------~~~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~lV~E~~~~gs  421 (628)
                      |.||++..  +|+.||+|.++.                .+.+|++++++++ ||||+++++++..++..++||||+++|+
T Consensus        31 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~  110 (298)
T 1phk_A           31 SVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGE  110 (298)
T ss_dssp             EEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCB
T ss_pred             eEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccCCeEEEEEeccCCCc
Confidence            89999998  678999999842                3567999999995 9999999999999999999999999999


Q ss_pred             hHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCccee
Q 039626          422 LSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFAL  501 (628)
Q Consensus       422 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~  501 (628)
                      |.+++...    ..+++..+..++.|++.||+|||+.   +++|+||||+||+++.++.+||+|||++.......    .
T Consensus       111 L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~----~  179 (298)
T 1phk_A          111 LFDYLTEK----VTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE----K  179 (298)
T ss_dssp             HHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECCTTC----C
T ss_pred             HHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCcEEEecccchhhcCCCc----c
Confidence            99999642    3589999999999999999999995   49999999999999999999999999998765332    1


Q ss_pred             eecccCCccccCccccc------cCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhcc
Q 039626          502 TRHIVGTKGYMAPEYLE------NGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRH  575 (628)
Q Consensus       502 ~~~~~gt~~Y~APE~l~------~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  575 (628)
                      .....|++.|+|||.+.      ...++.++||||||++++||++|+.|+.....      ......+.....      .
T Consensus       180 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~------~~~~~~~~~~~~------~  247 (298)
T 1phk_A          180 LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ------MLMLRMIMSGNY------Q  247 (298)
T ss_dssp             BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHTCC------C
T ss_pred             cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccH------HHHHHHHhcCCc------c
Confidence            23457899999999885      45688999999999999999999999864321      111111111100      0


Q ss_pred             ccCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          576 FIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       576 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                           .........+..+.+++.+||+.||.+|||+.|+++
T Consensus       248 -----~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (298)
T 1phk_A          248 -----FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  283 (298)
T ss_dssp             -----CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             -----cCcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence                 000111233456889999999999999999999875

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=7.1e-35  Score=320.77  Aligned_cols=227  Identities=27%  Similarity=0.350  Sum_probs=182.3

Q ss_pred             eEEEEEEE--CCceEEEEEecc---------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhc
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG---------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSN  429 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~---------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~  429 (628)
                      |.||+++.  +++.||||++..         .+.+|+++|++++||||+++++++.+.+..++||||+++|+|.+++...
T Consensus        36 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~  115 (486)
T 3mwu_A           36 GEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKR  115 (486)
T ss_dssp             SEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHH
T ss_pred             EEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEEcCCCCcHHHHHHhc
Confidence            89999998  588999999853         3678999999999999999999999999999999999999999998653


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeC---CCCcEEEccccccccCCCCCCcceeeeccc
Q 039626          430 KNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLD---SDLRAKIANFAMARPAEGQEGEFALTRHIV  506 (628)
Q Consensus       430 ~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~---~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~  506 (628)
                          ..+++..+..++.|++.||.|||+.   +|+||||||+|||++   .++.+||+|||+++......    ......
T Consensus       116 ----~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~~~  184 (486)
T 3mwu_A          116 ----KRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT----KMKDRI  184 (486)
T ss_dssp             ----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC--------CCT
T ss_pred             ----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCC----ccCCCc
Confidence                3589999999999999999999995   499999999999995   56689999999998764322    223457


Q ss_pred             CCccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCC
Q 039626          507 GTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYP  586 (628)
Q Consensus       507 gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~  586 (628)
                      ||+.|+|||.+.+ .++.++|||||||++|||++|+.||.....      .+....+..... ..      +    ....
T Consensus       185 gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~------~~~~~~i~~~~~-~~------~----~~~~  246 (486)
T 3mwu_A          185 GTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE------YDILKRVETGKY-AF------D----LPQW  246 (486)
T ss_dssp             TGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHTCC-CS------C----SGGG
T ss_pred             CCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHhCCC-CC------C----Cccc
Confidence            9999999999876 589999999999999999999999864322      222222221110 00      0    0001


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          587 LELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       587 ~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      ...+..+.+++.+||+.||.+|||+.|+++
T Consensus       247 ~~~s~~~~~li~~~L~~dp~~R~t~~~~l~  276 (486)
T 3mwu_A          247 RTISDDAKDLIRKMLTFHPSLRITATQCLE  276 (486)
T ss_dssp             GGSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             CCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            123456789999999999999999999986

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=3.2e-35  Score=314.69  Aligned_cols=244  Identities=22%  Similarity=0.329  Sum_probs=179.8

Q ss_pred             eEEEEEEE-CCceEEEEEeccc---hHHHHHHHhhcCCCceeeeeeeeecCC------eEEEEEEecCCCChHHHhhhcC
Q 039626          361 GSVYRGKI-NGGFAAIKKVNGD---VSKEIALLNKINHSNLIILSGVCFNEG------NCYLVYEYAVNGTLSDWVFSNK  430 (628)
Q Consensus       361 G~Vy~g~~-~g~~vavK~~~~~---~~~E~~~l~~l~H~nIv~l~g~~~~~~------~~~lV~E~~~~gsL~~~l~~~~  430 (628)
                      |.||+++. .++.+|+|++..+   ..+|+++|++++|+||+++++++...+      ..++||||++++ +.+.+....
T Consensus        54 g~V~~a~~~~~~~~aikk~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~  132 (394)
T 4e7w_A           54 GVVFQAKLVESDEVAIKKVLQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPET-VYRASRHYA  132 (394)
T ss_dssp             EEEEEEEETTTEEEEEEEEECCTTSCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEEECCSEE-HHHHHHHHH
T ss_pred             eEEEEEEECCCCeEEEEEEecCcchHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEeeccCcc-HHHHHHHHH
Confidence            89999998 5667999988543   457999999999999999999996543      378999999765 444443222


Q ss_pred             CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeC-CCCcEEEccccccccCCCCCCcceeeecccCCc
Q 039626          431 NEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLD-SDLRAKIANFAMARPAEGQEGEFALTRHIVGTK  509 (628)
Q Consensus       431 ~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~-~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~  509 (628)
                      .....+++..+..++.|++.||+|||+.   +|+||||||+|||++ .++.+||+|||+++.......    .....||+
T Consensus       133 ~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~~~----~~~~~~t~  205 (394)
T 4e7w_A          133 KLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEP----NVSYICSR  205 (394)
T ss_dssp             HTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEECCTTCC----CCSSCSCG
T ss_pred             hhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCCCcccccCCCC----CcccccCc
Confidence            3355699999999999999999999995   499999999999999 799999999999987643321    23457899


Q ss_pred             cccCccccccC-CCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhh----ccccCCcCCC-
Q 039626          510 GYMAPEYLENG-LVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESL----RHFIDPTLQG-  583 (628)
Q Consensus       510 ~Y~APE~l~~~-~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l----~~~~d~~l~~-  583 (628)
                      .|+|||.+.+. .++.++|||||||+++||++|+.||.......  .+...+. ...... .+.+    ..+.+..... 
T Consensus       206 ~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~--~l~~i~~-~~g~p~-~~~~~~~~~~~~~~~~~~~  281 (394)
T 4e7w_A          206 YYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGID--QLVEIIK-VLGTPS-REQIKTMNPNYMEHKFPQI  281 (394)
T ss_dssp             GGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHH-HHCCCC-HHHHHHHCGGGSSSCCCCC
T ss_pred             CccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHH-HhCCCC-HHHHHhhChhhhhhccccc
Confidence            99999998764 58999999999999999999999987543221  1122221 111110 0000    0111111100 


Q ss_pred             -------CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          584 -------NYPLELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       584 -------~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                             .++...+..+.+|+.+||+.||.+|||+.|+++
T Consensus       282 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  321 (394)
T 4e7w_A          282 RPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC  321 (394)
T ss_dssp             CCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             cCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc
Confidence                   011223456889999999999999999999875

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=3.1e-35  Score=305.80  Aligned_cols=228  Identities=27%  Similarity=0.361  Sum_probs=179.2

Q ss_pred             eEEEEEEE--CCceEEEEEecc---------------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChH
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG---------------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLS  423 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~---------------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~  423 (628)
                      |.||++..  +++.||||.+..               .+.+|+++|++++|+||+++++++..+. .++||||+++|+|.
T Consensus        24 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~~lv~e~~~~~~L~  102 (322)
T 2ycf_A           24 GEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELF  102 (322)
T ss_dssp             EEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-EEEEEECCTTEETH
T ss_pred             EEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-eEEEEecCCCCcHH
Confidence            89999998  578999998753               3678999999999999999999987654 89999999999999


Q ss_pred             HHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCc---EEEccccccccCCCCCCcce
Q 039626          424 DWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLR---AKIANFAMARPAEGQEGEFA  500 (628)
Q Consensus       424 ~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~---~kl~Dfgla~~~~~~~~~~~  500 (628)
                      +++..    ...+++..+..++.|++.||+|||+.   +++||||||+|||++.++.   +||+|||+++......    
T Consensus       103 ~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~----  171 (322)
T 2ycf_A          103 DKVVG----NKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS----  171 (322)
T ss_dssp             HHHST----TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCEEECCCTTCEECCCCH----
T ss_pred             HHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeEEEccCccceeccccc----
Confidence            99843    34689999999999999999999995   4999999999999987654   9999999998764321    


Q ss_pred             eeecccCCccccCccccc---cCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhcccc
Q 039626          501 LTRHIVGTKGYMAPEYLE---NGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFI  577 (628)
Q Consensus       501 ~~~~~~gt~~Y~APE~l~---~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  577 (628)
                      ......||+.|+|||.+.   ...++.++||||||++++||++|+.|+......  ..+.+.+.....     .     .
T Consensus       172 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~~~-----~-----~  239 (322)
T 2ycf_A          172 LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ--VSLKDQITSGKY-----N-----F  239 (322)
T ss_dssp             HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCS--SCHHHHHHHTCC-----C-----C
T ss_pred             ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchH--HHHHHHHHhCcc-----c-----c
Confidence            123457999999999874   567899999999999999999999998643322  112222211000     0     0


Q ss_pred             CCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          578 DPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       578 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      .+....    ..+..+.+++.+||+.||++||++.|+++
T Consensus       240 ~~~~~~----~~~~~~~~li~~~l~~dP~~Rps~~~~l~  274 (322)
T 2ycf_A          240 IPEVWA----EVSEKALDLVKKLLVVDPKARFTTEEALR  274 (322)
T ss_dssp             CHHHHT----TSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             Cchhhh----hcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence            000001    12356789999999999999999999874

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=1.1e-34  Score=310.06  Aligned_cols=255  Identities=22%  Similarity=0.260  Sum_probs=191.0

Q ss_pred             cCCCcCCccc----eEEEEEEE--CCceEEEEEecc------chHHHHHHHhhcC--------CCceeeeeeeee----c
Q 039626          351 DNFSFTCRIQ----GSVYRGKI--NGGFAAIKKVNG------DVSKEIALLNKIN--------HSNLIILSGVCF----N  406 (628)
Q Consensus       351 ~~f~~~~~i~----G~Vy~g~~--~g~~vavK~~~~------~~~~E~~~l~~l~--------H~nIv~l~g~~~----~  406 (628)
                      ++|.....+|    |.||+++.  +++.||||+++.      .+.+|++++++++        |+||+++++++.    +
T Consensus        37 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~~  116 (397)
T 1wak_A           37 GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVN  116 (397)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEETT
T ss_pred             CeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCCC
Confidence            4455444554    89999987  678999999874      3568999999995        788999999998    5


Q ss_pred             CCeEEEEEEecCCCChHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCC-------
Q 039626          407 EGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDL-------  479 (628)
Q Consensus       407 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~-------  479 (628)
                      ....++||||+ +|+|.+++...  ....+++..+..++.||+.||+|||+.  .+|+||||||+|||++.++       
T Consensus       117 ~~~~~lv~e~~-~~~l~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~~--~givHrDikp~NIll~~~~~~~~~~~  191 (397)
T 1wak_A          117 GTHICMVFEVL-GHHLLKWIIKS--NYQGLPLPCVKKIIQQVLQGLDYLHTK--CRIIHTDIKPENILLSVNEQYIRRLA  191 (397)
T ss_dssp             EEEEEEEECCC-CCBHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHHHT--TCEECCCCSGGGEEECCCHHHHHHHH
T ss_pred             CceEEEEEecc-CccHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHHh--CCEecCCCCHHHeeEeccchhhhhhh
Confidence            56789999999 67777777542  234699999999999999999999994  1599999999999999775       


Q ss_pred             ------------------------------------------cEEEccccccccCCCCCCcceeeecccCCccccCcccc
Q 039626          480 ------------------------------------------RAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYL  517 (628)
Q Consensus       480 ------------------------------------------~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~Y~APE~l  517 (628)
                                                                .+||+|||+++.....      .....||+.|+|||.+
T Consensus       192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~------~~~~~gt~~y~aPE~~  265 (397)
T 1wak_A          192 AEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH------FTEDIQTRQYRSLEVL  265 (397)
T ss_dssp             HHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC------SCSCCSCGGGCCHHHH
T ss_pred             hhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc------CccCCCCCcccCChhh
Confidence                                                      8999999999876432      2234789999999999


Q ss_pred             ccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHH---HHhccccch---------------hhhccccCC
Q 039626          518 ENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLN---AVLTKEDGE---------------ESLRHFIDP  579 (628)
Q Consensus       518 ~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~---------------~~l~~~~d~  579 (628)
                      .+..++.++|||||||++|||++|+.||............+.+.   .........               ..+..+.+.
T Consensus       266 ~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  345 (397)
T 1wak_A          266 IGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKL  345 (397)
T ss_dssp             HTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCC
T ss_pred             cCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccccccc
Confidence            99999999999999999999999999997544332211111111   111110000               000000000


Q ss_pred             c---------CCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          580 T---------LQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       580 ~---------l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      .         -....+.+.+..+.+|+.+||+.||++|||+.|+++
T Consensus       346 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  391 (397)
T 1wak_A          346 KPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR  391 (397)
T ss_dssp             CCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred             CCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence            0         011345677888999999999999999999999875

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=3.5e-35  Score=315.65  Aligned_cols=251  Identities=26%  Similarity=0.363  Sum_probs=173.3

Q ss_pred             eEEEEEEE----CCceEEEEEecc-----chHHHHHHHhhcCCCceeeeeeeeec--CCeEEEEEEecCCCChHHHhhhc
Q 039626          361 GSVYRGKI----NGGFAAIKKVNG-----DVSKEIALLNKINHSNLIILSGVCFN--EGNCYLVYEYAVNGTLSDWVFSN  429 (628)
Q Consensus       361 G~Vy~g~~----~g~~vavK~~~~-----~~~~E~~~l~~l~H~nIv~l~g~~~~--~~~~~lV~E~~~~gsL~~~l~~~  429 (628)
                      |.||+++.    .+..||+|++..     .+.+|+.+|++++||||+++++++..  +...++||||++ |+|.+++...
T Consensus        35 g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~  113 (405)
T 3rgf_A           35 GHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE-HDLWHIIKFH  113 (405)
T ss_dssp             -EEEEEEESSSSCCCCEEEEECSSSSCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEECCS-EEHHHHHHHH
T ss_pred             eEEEEEEEccCCCCeEEEEEEECCCCCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeCCC-CCHHHHHHHh
Confidence            89999996    367899999864     47789999999999999999999954  678999999995 5888887533


Q ss_pred             C-----CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEe----CCCCcEEEccccccccCCCCCCcce
Q 039626          430 K-----NEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLL----DSDLRAKIANFAMARPAEGQEGEFA  500 (628)
Q Consensus       430 ~-----~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl----~~~~~~kl~Dfgla~~~~~~~~~~~  500 (628)
                      .     .....+++..+..++.|++.||+|||+.+   |+||||||+|||+    +.++.+||+|||+++..........
T Consensus       114 ~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~  190 (405)
T 3rgf_A          114 RASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLA  190 (405)
T ss_dssp             HHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEEECCTTCCC----------
T ss_pred             ccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEEEEECCCceecCCCCcccc
Confidence            2     12235999999999999999999999954   9999999999999    7789999999999987654322222


Q ss_pred             eeecccCCccccCcccccc-CCCCcccccHHHHHHHHHHHhCCCccccccccc---c---ccHHHHHHHHhccccc--hh
Q 039626          501 LTRHIVGTKGYMAPEYLEN-GLVSTKLDVYAFGVLILEMLTGKEAAALHAEEN---N---MHLSDVLNAVLTKEDG--EE  571 (628)
Q Consensus       501 ~~~~~~gt~~Y~APE~l~~-~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~---~---~~~~~~~~~~~~~~~~--~~  571 (628)
                      ......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||.......   .   ......+...+.....  ..
T Consensus       191 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~  270 (405)
T 3rgf_A          191 DLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWE  270 (405)
T ss_dssp             ------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHHHHHHCCCCTTTCG
T ss_pred             cCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHHHHHhhCCCChhhcc
Confidence            2344689999999999987 458999999999999999999999996543221   0   0111111111111100  00


Q ss_pred             hhc----------cccCCcCCCCCCH---------HHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          572 SLR----------HFIDPTLQGNYPL---------ELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       572 ~l~----------~~~d~~l~~~~~~---------~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      .+.          .+...... ....         .....+.+|+.+||+.||.+|||++|+++
T Consensus       271 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~  333 (405)
T 3rgf_A          271 DIKKMPEHSTLMKDFRRNTYT-NCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ  333 (405)
T ss_dssp             GGGGSTTHHHHHHHCCGGGGT-TCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hhhcCcchhhhhhhccccCCC-cchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            000          00000000 0000         01345789999999999999999999875

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=2.2e-35  Score=324.62  Aligned_cols=227  Identities=26%  Similarity=0.348  Sum_probs=184.1

Q ss_pred             eEEEEEEE--CCceEEEEEecc----------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhh
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG----------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFS  428 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  428 (628)
                      |.||+++.  +|+.+|||++..          .+.+|+.++++++||||+++++++.+.+..++||||+.+|+|.+++..
T Consensus        40 g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~  119 (484)
T 3nyv_A           40 GEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIIS  119 (484)
T ss_dssp             EEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHT
T ss_pred             EEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecCCCCCHHHHHHh
Confidence            89999998  688999999742          367899999999999999999999999999999999999999999853


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEe---CCCCcEEEccccccccCCCCCCcceeeecc
Q 039626          429 NKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLL---DSDLRAKIANFAMARPAEGQEGEFALTRHI  505 (628)
Q Consensus       429 ~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl---~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~  505 (628)
                          ...+++..+..++.|++.||+|||+.   +|+||||||+|||+   +.++.+||+|||+++......    .....
T Consensus       120 ----~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~~  188 (484)
T 3nyv_A          120 ----RKRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK----KMKDK  188 (484)
T ss_dssp             ----CSCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCCC----SHHHH
T ss_pred             ----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccccc----ccccC
Confidence                34589999999999999999999995   49999999999999   567899999999998765332    12345


Q ss_pred             cCCccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCC
Q 039626          506 VGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNY  585 (628)
Q Consensus       506 ~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~  585 (628)
                      .||+.|+|||.+.+ .++.++|||||||++|||++|+.||.....      .+....+..... ..          ....
T Consensus       189 ~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~------~~~~~~i~~~~~-~~----------~~~~  250 (484)
T 3nyv_A          189 IGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANE------YDILKKVEKGKY-TF----------ELPQ  250 (484)
T ss_dssp             TTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHCCC-CC----------CSGG
T ss_pred             CCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCH------HHHHHHHHcCCC-CC----------CCcc
Confidence            79999999999876 689999999999999999999999864322      122222221110 00          0000


Q ss_pred             CHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          586 PLELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       586 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      ....+..+.+++.+||+.||.+|||+.|+++
T Consensus       251 ~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  281 (484)
T 3nyv_A          251 WKKVSESAKDLIRKMLTYVPSMRISARDALD  281 (484)
T ss_dssp             GGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             cccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence            1123456789999999999999999999875

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=7.2e-35  Score=321.35  Aligned_cols=227  Identities=26%  Similarity=0.360  Sum_probs=181.5

Q ss_pred             eEEEEEEE--CCceEEEEEecc---------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhc
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG---------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSN  429 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~---------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~  429 (628)
                      |.||+++.  .+..+|+|+++.         .+.+|+.++++++||||+++++++.+.+..++||||+++|+|.+++...
T Consensus        51 g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~  130 (494)
T 3lij_A           51 GEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHR  130 (494)
T ss_dssp             -EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHH
T ss_pred             EEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCcHHHHHHHc
Confidence            89999998  678999998753         3678999999999999999999999999999999999999999988543


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCC---CcEEEccccccccCCCCCCcceeeeccc
Q 039626          430 KNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSD---LRAKIANFAMARPAEGQEGEFALTRHIV  506 (628)
Q Consensus       430 ~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~---~~~kl~Dfgla~~~~~~~~~~~~~~~~~  506 (628)
                          ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.+   +.+||+|||+++......    ......
T Consensus       131 ----~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~----~~~~~~  199 (494)
T 3lij_A          131 ----MKFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK----KMKERL  199 (494)
T ss_dssp             ----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTB----CBCCCC
T ss_pred             ----CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCc----cccccC
Confidence                3489999999999999999999995   49999999999999764   559999999998765332    223457


Q ss_pred             CCccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCC
Q 039626          507 GTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYP  586 (628)
Q Consensus       507 gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~  586 (628)
                      ||+.|+|||.+. ..++.++|||||||++|||++|+.||.....      .+....+.....      .+..+..     
T Consensus       200 gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~------~~~~~~i~~~~~------~~~~~~~-----  261 (494)
T 3lij_A          200 GTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTD------QEILRKVEKGKY------TFDSPEW-----  261 (494)
T ss_dssp             SCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHTCC------CCCSGGG-----
T ss_pred             CCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHhCCC------CCCchhc-----
Confidence            999999999886 4689999999999999999999999864332      122222211110      0000100     


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          587 LELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       587 ~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      ...+..+.+++.+||+.||.+|||+.|+++
T Consensus       262 ~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  291 (494)
T 3lij_A          262 KNVSEGAKDLIKQMLQFDSQRRISAQQALE  291 (494)
T ss_dssp             TTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence            123356789999999999999999999875

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=2.4e-35  Score=313.06  Aligned_cols=230  Identities=15%  Similarity=0.027  Sum_probs=162.6

Q ss_pred             eEEEEEEE--CCceEEEEEeccc----------hHHHH---HHHhhcCCCceeeee-------eeeecC-----------
Q 039626          361 GSVYRGKI--NGGFAAIKKVNGD----------VSKEI---ALLNKINHSNLIILS-------GVCFNE-----------  407 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~~----------~~~E~---~~l~~l~H~nIv~l~-------g~~~~~-----------  407 (628)
                      |.||+|+.  +|+.||||+++..          +.+|+   ++|++ +||||++++       +++...           
T Consensus        76 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~~~~~~~~~~~~~~~~  154 (371)
T 3q60_A           76 SVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPG  154 (371)
T ss_dssp             EEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEEEEETTSCSSSBCSCC
T ss_pred             EEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehheecCCCCCeeeccCC
Confidence            89999997  6889999998752          34674   45555 799988755       444322           


Q ss_pred             ------CeEEEEEEecCCCChHHHhhhcCCCCCCCCHHHH------HHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEe
Q 039626          408 ------GNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQR------IQIALDVATGLNYLHSFTNPPHVHKDINSSNVLL  475 (628)
Q Consensus       408 ------~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~------~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl  475 (628)
                            ...++||||++ |+|.+++...   +..+.+..+      +.++.|++.||+|||+.   +|+||||||+|||+
T Consensus       155 ~~~~~~~~~~lv~e~~~-~~L~~~l~~~---~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~---~ivHrDikp~NIll  227 (371)
T 3q60_A          155 QDDYAVANYLLLMPAAS-VDLELLFSTL---DFVYVFRGDEGILALHILTAQLIRLAANLQSK---GLVHGHFTPDNLFI  227 (371)
T ss_dssp             ---CCEEEEEEEECCCS-EEHHHHHHHH---HHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHT---TEEETTCSGGGEEE
T ss_pred             cccceeeeEEEEecCCC-CCHHHHHHHh---ccccchhhhhhhhhHHHHHHHHHHHHHHHHHC---CCccCcCCHHHEEE
Confidence                  34799999998 8999999653   223455666      78889999999999995   49999999999999


Q ss_pred             CCCCcEEEccccccccCCCCCCcceeeecccCCccccCcccccc--CCCCcccccHHHHHHHHHHHhCCCcccccccccc
Q 039626          476 DSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLEN--GLVSTKLDVYAFGVLILEMLTGKEAAALHAEENN  553 (628)
Q Consensus       476 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~--~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~  553 (628)
                      +.++.+||+|||+++.....      .....+|+.|+|||.+.+  ..++.++|||||||++|||++|+.||........
T Consensus       228 ~~~~~~kL~DFG~a~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~  301 (371)
T 3q60_A          228 MPDGRLMLGDVSALWKVGTR------GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIK  301 (371)
T ss_dssp             CTTSCEEECCGGGEEETTCE------EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCCTTCT
T ss_pred             CCCCCEEEEecceeeecCCC------ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcCcccc
Confidence            99999999999999866421      224567799999999987  6799999999999999999999999875432211


Q ss_pred             ccHHHHHHHHhccccchhhhccccCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          554 MHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       554 ~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      ..            ......................+..+.+|+.+||+.||++|||+.|+++
T Consensus       302 ~~------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  352 (371)
T 3q60_A          302 GS------------WKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME  352 (371)
T ss_dssp             TC------------CCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred             cc------------hhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            00            0000000000111111111234566889999999999999999999863

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=4.1e-34  Score=294.57  Aligned_cols=239  Identities=24%  Similarity=0.317  Sum_probs=184.7

Q ss_pred             cCCCcCCccc----eEEEEEEE--CCceEEEEEecc-----------chHHHHHHHhhcCCCceeeeeeeee--cCCeEE
Q 039626          351 DNFSFTCRIQ----GSVYRGKI--NGGFAAIKKVNG-----------DVSKEIALLNKINHSNLIILSGVCF--NEGNCY  411 (628)
Q Consensus       351 ~~f~~~~~i~----G~Vy~g~~--~g~~vavK~~~~-----------~~~~E~~~l~~l~H~nIv~l~g~~~--~~~~~~  411 (628)
                      ++|.....+|    |.||++..  ++..+|+|.++.           .+.+|++++++++|+||+++++++.  +....+
T Consensus         5 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~   84 (305)
T 2wtk_C            5 GKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMY   84 (305)
T ss_dssp             CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEE
T ss_pred             cceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEE
Confidence            4555555554    89999998  678999999863           3568999999999999999999985  445789


Q ss_pred             EEEEecCCCChHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEcccccccc
Q 039626          412 LVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARP  491 (628)
Q Consensus       412 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~  491 (628)
                      +||||+++| |.+++...  ....+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||++..
T Consensus        85 lv~e~~~~~-l~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~  158 (305)
T 2wtk_C           85 MVMEYCVCG-MQEMLDSV--PEKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEA  158 (305)
T ss_dssp             EEEECCSEE-HHHHHHHS--TTCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEehhccCC-HHHHHHhC--cccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeeccccccc
Confidence            999999876 77777543  245699999999999999999999995   499999999999999999999999999987


Q ss_pred             CCCCCCcceeeecccCCccccCccccccCC--CCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccc
Q 039626          492 AEGQEGEFALTRHIVGTKGYMAPEYLENGL--VSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDG  569 (628)
Q Consensus       492 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~--~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~  569 (628)
                      ....... .......||+.|+|||.+.+..  .+.++||||||++++||++|+.|+....      ..+....+....  
T Consensus       159 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~------~~~~~~~i~~~~--  229 (305)
T 2wtk_C          159 LHPFAAD-DTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN------IYKLFENIGKGS--  229 (305)
T ss_dssp             CCTTCSS-CEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSS------HHHHHHHHHHCC--
T ss_pred             cCccccc-cccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCch------HHHHHHHHhcCC--
Confidence            6432211 1233457999999999987643  4789999999999999999999986422      112222211110  


Q ss_pred             hhhhccccCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 039626          570 EESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHS  617 (628)
Q Consensus       570 ~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~  617 (628)
                               ...    +......+.+++.+||+.||.+|||+.|+++.
T Consensus       230 ---------~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  264 (305)
T 2wtk_C          230 ---------YAI----PGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH  264 (305)
T ss_dssp             ---------CCC----CSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred             ---------CCC----CCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence                     111    12234567899999999999999999999863

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9.1e-35  Score=308.22  Aligned_cols=236  Identities=24%  Similarity=0.332  Sum_probs=180.5

Q ss_pred             eEEEEEEE--CCceEEEEEecc---------chHHHHHHHhhcCCCceeeeeeeeecCC------eEEEEEEecCCCChH
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG---------DVSKEIALLNKINHSNLIILSGVCFNEG------NCYLVYEYAVNGTLS  423 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~---------~~~~E~~~l~~l~H~nIv~l~g~~~~~~------~~~lV~E~~~~gsL~  423 (628)
                      |.||+|..  +|+.||||++..         .+.+|+++|++++|+||+++++++...+      ..++||||+ +++|.
T Consensus        39 g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~e~~-~~~L~  117 (367)
T 1cm8_A           39 GAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLG  117 (367)
T ss_dssp             -CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEECC-SEEHH
T ss_pred             eEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCceEEEEEecC-CCCHH
Confidence            89999998  688999999843         3568999999999999999999998653      469999999 88999


Q ss_pred             HHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeee
Q 039626          424 DWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTR  503 (628)
Q Consensus       424 ~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~  503 (628)
                      +++..     ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++.....      ..
T Consensus       118 ~~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~------~~  183 (367)
T 1cm8_A          118 KLMKH-----EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQADSE------MT  183 (367)
T ss_dssp             HHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCSS------CC
T ss_pred             HHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEeeecccccccc------cC
Confidence            99854     3489999999999999999999995   4999999999999999999999999999876432      23


Q ss_pred             cccCCccccCcccccc-CCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhh---------
Q 039626          504 HIVGTKGYMAPEYLEN-GLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESL---------  573 (628)
Q Consensus       504 ~~~gt~~Y~APE~l~~-~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l---------  573 (628)
                      ...+|+.|+|||.+.+ ..++.++|||||||+++||++|+.||.......   ....+........ .+.+         
T Consensus       184 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~---~l~~i~~~~g~~~-~~~~~~~~~~~~~  259 (367)
T 1cm8_A          184 GYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLD---QLKEIMKVTGTPP-AEFVQRLQSDEAK  259 (367)
T ss_dssp             SSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHHHCCCC-HHHHHTCSCHHHH
T ss_pred             cCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHhcCCCC-HHHHHHhhhHHHH
Confidence            3578999999999887 679999999999999999999999987433211   1111111111100 0000         


Q ss_pred             ---cc---ccCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          574 ---RH---FIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       574 ---~~---~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                         ..   .....+. .........+.+|+.+||+.||.+|||+.|+++
T Consensus       260 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~  307 (367)
T 1cm8_A          260 NYMKGLPELEKKDFA-SILTNASPLAVNLLEKMLVLDAEQRVTAGEALA  307 (367)
T ss_dssp             HHHHHSCCCCCCCGG-GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHHHhCCCCCCCCHH-HHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence               00   0000000 111223456789999999999999999999876

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=3.9e-35  Score=301.76  Aligned_cols=229  Identities=23%  Similarity=0.400  Sum_probs=179.0

Q ss_pred             eEEEEEEE--CCceEEEEEecc-------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhcCC
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG-------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKN  431 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~-------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~  431 (628)
                      |.||+|+.  ++..+|+|.+..       ++.+|++++++++||||+++++++..++..++||||+++++|.+++...  
T Consensus        33 g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~--  110 (302)
T 2j7t_A           33 GKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLEL--  110 (302)
T ss_dssp             CCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEECCTTEEHHHHHHHH--
T ss_pred             eEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeCCCCcHHHHHHhh--
Confidence            89999999  478999998753       4678999999999999999999999999999999999999999998643  


Q ss_pred             CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCCccc
Q 039626          432 EGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGY  511 (628)
Q Consensus       432 ~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~Y  511 (628)
                       ...+++..+..++.+++.||.|||+.   +++||||||+||+++.++.+||+|||++......   ........||+.|
T Consensus       111 -~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~~~~~y  183 (302)
T 2j7t_A          111 -DRGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT---LQKRDSFIGTPYW  183 (302)
T ss_dssp             -TSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH---HHC-----CCGGG
T ss_pred             -ccCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCCcccccc---ccccccccCChhh
Confidence             34589999999999999999999995   4999999999999999999999999987643211   0112234689999


Q ss_pred             cCcccc-----ccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCC
Q 039626          512 MAPEYL-----ENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYP  586 (628)
Q Consensus       512 ~APE~l-----~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~  586 (628)
                      +|||.+     .+..++.++||||||++++||++|+.|+.....      .+..........          +.  ...+
T Consensus       184 ~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~~~----------~~--~~~~  245 (302)
T 2j7t_A          184 MAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP------MRVLLKIAKSDP----------PT--LLTP  245 (302)
T ss_dssp             CCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHHHHHSCC----------CC--CSSG
T ss_pred             cCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCH------HHHHHHHhccCC----------cc--cCCc
Confidence            999998     366789999999999999999999998864322      111211111110          00  0112


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          587 LELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       587 ~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      ...+..+.+++.+||+.||.+|||+.|+++
T Consensus       246 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  275 (302)
T 2j7t_A          246 SKWSVEFRDFLKIALDKNPETRPSAAQLLE  275 (302)
T ss_dssp             GGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred             cccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence            233456789999999999999999999875

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=1.1e-34  Score=320.52  Aligned_cols=237  Identities=26%  Similarity=0.342  Sum_probs=187.2

Q ss_pred             cCCCcCCccc----eEEEEEEE--CCceEEEEEecc--------------------chHHHHHHHhhcCCCceeeeeeee
Q 039626          351 DNFSFTCRIQ----GSVYRGKI--NGGFAAIKKVNG--------------------DVSKEIALLNKINHSNLIILSGVC  404 (628)
Q Consensus       351 ~~f~~~~~i~----G~Vy~g~~--~g~~vavK~~~~--------------------~~~~E~~~l~~l~H~nIv~l~g~~  404 (628)
                      +.|.....+|    |.||+++.  .+..+|+|.++.                    .+.+|+.+|++++||||+++++++
T Consensus        36 ~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~  115 (504)
T 3q5i_A           36 ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVF  115 (504)
T ss_dssp             GTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             cceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence            4454444454    89999998  578899998752                    256799999999999999999999


Q ss_pred             ecCCeEEEEEEecCCCChHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCC---cE
Q 039626          405 FNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDL---RA  481 (628)
Q Consensus       405 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~---~~  481 (628)
                      .+++..++||||+++|+|.+++...    ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++   .+
T Consensus       116 ~~~~~~~lv~e~~~gg~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~  188 (504)
T 3q5i_A          116 EDKKYFYLVTEFYEGGELFEQIINR----HKFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLNI  188 (504)
T ss_dssp             ECSSEEEEEEECCTTCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTTCCSSE
T ss_pred             EcCCEEEEEEecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCCCCccE
Confidence            9999999999999999999998643    3499999999999999999999995   499999999999998776   69


Q ss_pred             EEccccccccCCCCCCcceeeecccCCccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHH
Q 039626          482 KIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLN  561 (628)
Q Consensus       482 kl~Dfgla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~  561 (628)
                      ||+|||+++......    ......||+.|+|||.+. +.++.++|||||||++|||++|+.||.....      .+.+.
T Consensus       189 kl~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~------~~~~~  257 (504)
T 3q5i_A          189 KIVDFGLSSFFSKDY----KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQND------QDIIK  257 (504)
T ss_dssp             EECCCTTCEECCTTS----CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHH
T ss_pred             EEEECCCCEEcCCCC----ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCH------HHHHH
Confidence            999999998765332    233457999999999987 4689999999999999999999999874322      12222


Q ss_pred             HHhccccchhhhccccCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          562 AVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       562 ~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      .+..... ......      .    ...+..+.+++.+||+.||.+|||+.|+++
T Consensus       258 ~i~~~~~-~~~~~~------~----~~~s~~~~~li~~~L~~dp~~R~t~~e~l~  301 (504)
T 3q5i_A          258 KVEKGKY-YFDFND------W----KNISDEAKELIKLMLTYDYNKRCTAEEALN  301 (504)
T ss_dssp             HHHHCCC-CCCHHH------H----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHcCCC-CCCccc------c----CCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            2221110 000000      0    112356789999999999999999999875

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=2.2e-34  Score=305.72  Aligned_cols=245  Identities=24%  Similarity=0.267  Sum_probs=176.9

Q ss_pred             CCCcCCccc----eEEEEEEE--CCceEEEEEecc---------chHHHHHHHhhcCCCceeeeeeeeecCC------eE
Q 039626          352 NFSFTCRIQ----GSVYRGKI--NGGFAAIKKVNG---------DVSKEIALLNKINHSNLIILSGVCFNEG------NC  410 (628)
Q Consensus       352 ~f~~~~~i~----G~Vy~g~~--~g~~vavK~~~~---------~~~~E~~~l~~l~H~nIv~l~g~~~~~~------~~  410 (628)
                      +|.....+|    |.||++..  +++.||||++..         .+.+|+.++++++||||+++++++...+      ..
T Consensus        26 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~  105 (371)
T 2xrw_A           26 RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDV  105 (371)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCEE
T ss_pred             heeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccce
Confidence            444444443    89999987  688999999853         3568999999999999999999998654      78


Q ss_pred             EEEEEecCCCChHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccc
Q 039626          411 YLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMAR  490 (628)
Q Consensus       411 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~  490 (628)
                      ++||||++ |+|.+++.      ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++
T Consensus       106 ~lv~e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~  175 (371)
T 2xrw_A          106 YIVMELMD-ANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR  175 (371)
T ss_dssp             EEEEECCS-EEHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCC--
T ss_pred             EEEEEcCC-CCHHHHHh------hccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEeeccc
Confidence            99999996 57888873      2389999999999999999999995   49999999999999999999999999998


Q ss_pred             cCCCCCCcceeeecccCCccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhcccc-c
Q 039626          491 PAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKED-G  569 (628)
Q Consensus       491 ~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~-~  569 (628)
                      ......    ......||+.|+|||.+.+..++.++|||||||+++||++|+.||......      +....+..... .
T Consensus       176 ~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------~~~~~i~~~~~~~  245 (371)
T 2xrw_A          176 TAGTSF----MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHI------DQWNKVIEQLGTP  245 (371)
T ss_dssp             ------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHC-CCCC
T ss_pred             cccccc----ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHHHhCCC
Confidence            664321    223457999999999999999999999999999999999999998643321      11111111000 0


Q ss_pred             -----------------------hhhhccccCCcCCC---CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          570 -----------------------EESLRHFIDPTLQG---NYPLELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       570 -----------------------~~~l~~~~d~~l~~---~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                                             ...+...+......   ..+......+.+|+.+||+.||.+|||++|+++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  318 (371)
T 2xrw_A          246 CPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ  318 (371)
T ss_dssp             CHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             CHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence                                   00000000000000   011234667899999999999999999999976

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=1.6e-34  Score=296.67  Aligned_cols=231  Identities=22%  Similarity=0.400  Sum_probs=174.6

Q ss_pred             eEEEEEEE--CCceEEEEEecc------chHHHHHHHhhcCCCceeeeeeeeec-------------CCeEEEEEEecCC
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG------DVSKEIALLNKINHSNLIILSGVCFN-------------EGNCYLVYEYAVN  419 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~------~~~~E~~~l~~l~H~nIv~l~g~~~~-------------~~~~~lV~E~~~~  419 (628)
                      |.||+|+.  +|+.||||++..      .+.+|+.++++++||||+++++++.+             .+..++||||+++
T Consensus        20 g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~   99 (303)
T 1zy4_A           20 GQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCEN   99 (303)
T ss_dssp             EEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------CEEEEEEEEECCCS
T ss_pred             EEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcccccCCceEEEEecCCC
Confidence            89999997  688999999864      36789999999999999999999865             3568999999999


Q ss_pred             CChHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCC--
Q 039626          420 GTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEG--  497 (628)
Q Consensus       420 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~--  497 (628)
                      |+|.+++..   ....+++..++.++.|++.||+|||+.   +++||||||+|||++.++.+||+|||+++.......  
T Consensus       100 ~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~  173 (303)
T 1zy4_A          100 GTLYDLIHS---ENLNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDIL  173 (303)
T ss_dssp             CBHHHHHHH---SCGGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCCCSCTTC-----
T ss_pred             CCHHHhhhc---cccccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCCEEEeeCcchhhcccccchh
Confidence            999999964   234588899999999999999999995   499999999999999999999999999987643210  


Q ss_pred             ---------cceeeecccCCccccCccccccC-CCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccc
Q 039626          498 ---------EFALTRHIVGTKGYMAPEYLENG-LVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKE  567 (628)
Q Consensus       498 ---------~~~~~~~~~gt~~Y~APE~l~~~-~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~  567 (628)
                               .........||+.|+|||.+.+. .++.++||||||+++|||+++   +.....     ..+....+..  
T Consensus       174 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~p---~~~~~~-----~~~~~~~~~~--  243 (303)
T 1zy4_A          174 KLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP---FSTGME-----RVNILKKLRS--  243 (303)
T ss_dssp             --------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHSC---CSSHHH-----HHHHHHHHHS--
T ss_pred             ccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHhc---cCCchh-----HHHHHHhccc--
Confidence                     01112345789999999999764 789999999999999999983   221110     1111111111  


Q ss_pred             cchhhhccccCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          568 DGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       568 ~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                               ........++...+..+.+++.+||+.||.+|||+.|+++
T Consensus       244 ---------~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  283 (303)
T 1zy4_A          244 ---------VSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN  283 (303)
T ss_dssp             ---------TTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ---------cccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence                     0111222333444566789999999999999999999985

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=1.4e-34  Score=306.35  Aligned_cols=252  Identities=23%  Similarity=0.323  Sum_probs=186.5

Q ss_pred             CCCcCCccc----eEEEEEEE--CCceEEEEEecc--------chHHHHHHHhhcCCCceeeeeeeeecC-----CeEEE
Q 039626          352 NFSFTCRIQ----GSVYRGKI--NGGFAAIKKVNG--------DVSKEIALLNKINHSNLIILSGVCFNE-----GNCYL  412 (628)
Q Consensus       352 ~f~~~~~i~----G~Vy~g~~--~g~~vavK~~~~--------~~~~E~~~l~~l~H~nIv~l~g~~~~~-----~~~~l  412 (628)
                      +|.....+|    |.||++..  ++..||||++..        .+.+|+++|.+++|+||+++++++...     ...++
T Consensus        28 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~i  107 (364)
T 3qyz_A           28 RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYI  107 (364)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEE
T ss_pred             cEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEEE
Confidence            444444443    89999987  678999999863        366899999999999999999999754     36899


Q ss_pred             EEEecCCCChHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccC
Q 039626          413 VYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPA  492 (628)
Q Consensus       413 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~  492 (628)
                      ||||++ |+|.+++..     ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++..
T Consensus       108 v~e~~~-~~L~~~l~~-----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~  178 (364)
T 3qyz_A          108 VQDLME-TDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVA  178 (364)
T ss_dssp             EEECCS-EEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEcccC-cCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCcceEec
Confidence            999996 699998853     2489999999999999999999995   4999999999999999999999999999876


Q ss_pred             CCCCCcceeeecccCCccccCcccccc-CCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchh
Q 039626          493 EGQEGEFALTRHIVGTKGYMAPEYLEN-GLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEE  571 (628)
Q Consensus       493 ~~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  571 (628)
                      ..............||+.|+|||.+.+ ..++.++||||||++++||++|+.||.......   ....+........ .+
T Consensus       179 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~---~~~~i~~~~~~~~-~~  254 (364)
T 3qyz_A          179 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD---QLNHILGILGSPS-QE  254 (364)
T ss_dssp             CGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGG---HHHHHHHHHCSCC-HH
T ss_pred             CCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHH---HHHHHHHHhCCCC-HH
Confidence            533222222344589999999998754 458999999999999999999999986543221   1122212111111 00


Q ss_pred             hhcccc---------CCcCCCCCC-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          572 SLRHFI---------DPTLQGNYP-----LELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       572 ~l~~~~---------d~~l~~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      .+....         ........+     ......+.+|+.+||+.||.+|||+.|+++
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  313 (364)
T 3qyz_A          255 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA  313 (364)
T ss_dssp             HHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            000000         000000111     122456789999999999999999999975

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=1.3e-34  Score=313.46  Aligned_cols=177  Identities=20%  Similarity=0.271  Sum_probs=154.1

Q ss_pred             eEEEEEEE--CCceEEEEEecc------chHHHHHHHhhc------CCCceeeeeeeeecCCeEEEEEEecCCCChHHHh
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG------DVSKEIALLNKI------NHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWV  426 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~------~~~~E~~~l~~l------~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l  426 (628)
                      |.||+|..  .++.||||+++.      ++.+|+++++.+      +|+||+++++++...+..++||||+. |+|.+++
T Consensus       111 g~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l  189 (429)
T 3kvw_A          111 GQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLS-MNLYELI  189 (429)
T ss_dssp             EEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEEEEECCCC-CBHHHHH
T ss_pred             EEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEEEEEeccC-CCHHHHH
Confidence            89999988  578999999965      356788888887      57799999999999999999999995 7999998


Q ss_pred             hhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCc--EEEccccccccCCCCCCcceeeec
Q 039626          427 FSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLR--AKIANFAMARPAEGQEGEFALTRH  504 (628)
Q Consensus       427 ~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~--~kl~Dfgla~~~~~~~~~~~~~~~  504 (628)
                      ...  ....+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.  +||+|||+++.....      ...
T Consensus       190 ~~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~~~~------~~~  258 (429)
T 3kvw_A          190 KKN--KFQGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQR------VYT  258 (429)
T ss_dssp             HHT--TTCCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECCCTTCEETTCC------CCS
T ss_pred             Hhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEeecccceecCCc------ccc
Confidence            653  234589999999999999999999995   4999999999999999987  999999999765432      223


Q ss_pred             ccCCccccCccccccCCCCcccccHHHHHHHHHHHhCCCcccccc
Q 039626          505 IVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHA  549 (628)
Q Consensus       505 ~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~  549 (628)
                      ..||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus       259 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~  303 (429)
T 3kvw_A          259 YIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED  303 (429)
T ss_dssp             SCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             cCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence            578999999999999999999999999999999999999987543

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=1.7e-34  Score=301.35  Aligned_cols=240  Identities=21%  Similarity=0.266  Sum_probs=185.1

Q ss_pred             eEEEEEEE---CCceEEEEEecc------chHHHHHHHhhcCCCc------eeeeeeeeecCCeEEEEEEecCCCChHHH
Q 039626          361 GSVYRGKI---NGGFAAIKKVNG------DVSKEIALLNKINHSN------LIILSGVCFNEGNCYLVYEYAVNGTLSDW  425 (628)
Q Consensus       361 G~Vy~g~~---~g~~vavK~~~~------~~~~E~~~l~~l~H~n------Iv~l~g~~~~~~~~~lV~E~~~~gsL~~~  425 (628)
                      |.||++..   +++.||+|+++.      .+.+|++++++++|+|      ++++++++.+++..++||||+ +++|.++
T Consensus        28 g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~l~~~  106 (339)
T 1z57_A           28 GKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELL-GLSTYDF  106 (339)
T ss_dssp             EEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEEEEEEECC-CCBHHHH
T ss_pred             eEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcEEEEEcCC-CCCHHHH
Confidence            89999986   578999999874      4667999999987654      999999999999999999999 8999999


Q ss_pred             hhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCC-------------------CCcEEEccc
Q 039626          426 VFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDS-------------------DLRAKIANF  486 (628)
Q Consensus       426 l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~-------------------~~~~kl~Df  486 (628)
                      +...  ....+++..+..++.|++.||+|||+.   +++||||||+|||++.                   ++.+||+||
T Consensus       107 l~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Df  181 (339)
T 1z57_A          107 IKEN--GFLPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDF  181 (339)
T ss_dssp             HHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEEC----CEEEEESCCCEEECCC
T ss_pred             HHhc--CCCCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccccCCccccccccccCCCceEeeC
Confidence            9653  234689999999999999999999995   4999999999999988                   678999999


Q ss_pred             cccccCCCCCCcceeeecccCCccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhcc
Q 039626          487 AMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTK  566 (628)
Q Consensus       487 gla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~  566 (628)
                      |+++.....      .....||+.|+|||.+.+..++.++||||||++++||++|+.|+.......   ....+......
T Consensus       182 g~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~---~~~~~~~~~~~  252 (339)
T 1z57_A          182 GSATYDDEH------HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKE---HLAMMERILGP  252 (339)
T ss_dssp             SSCEETTSC------CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHH---HHHHHHHHHCS
T ss_pred             cccccCccc------cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHHhCC
Confidence            999865432      233578999999999999999999999999999999999999987543322   11111111111


Q ss_pred             ccchhhhc--------------------------cccCCc-CCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          567 EDGEESLR--------------------------HFIDPT-LQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       567 ~~~~~~l~--------------------------~~~d~~-l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      .. ...+.                          ....+. .....+......+.+++.+||+.||.+|||+.|+++
T Consensus       253 ~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  328 (339)
T 1z57_A          253 LP-KHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALK  328 (339)
T ss_dssp             CC-HHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             CC-HHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHHHHhc
Confidence            00 00000                          000000 001123456678999999999999999999999874

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=1.7e-35  Score=306.50  Aligned_cols=229  Identities=26%  Similarity=0.368  Sum_probs=175.1

Q ss_pred             eEEEEEEE-CCceEEEEEecc---------chHHHHHHHhhcC--CCceeeeeeeeecCCeEEEEEEecCCCChHHHhhh
Q 039626          361 GSVYRGKI-NGGFAAIKKVNG---------DVSKEIALLNKIN--HSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFS  428 (628)
Q Consensus       361 G~Vy~g~~-~g~~vavK~~~~---------~~~~E~~~l~~l~--H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  428 (628)
                      |.||++.. +++.+|+|++..         .+.+|++++.+++  |+||+++++++.+++..++||| +.+++|.+++..
T Consensus        42 g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e-~~~~~L~~~l~~  120 (313)
T 3cek_A           42 SKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKK  120 (313)
T ss_dssp             EEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEEEC-CCSEEHHHHHHH
T ss_pred             EEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEEEe-cCCCcHHHHHHh
Confidence            89999988 678899998842         3678999999997  5999999999999999999999 568899999964


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCC
Q 039626          429 NKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGT  508 (628)
Q Consensus       429 ~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt  508 (628)
                          ...+++..+..++.|++.||.|||+.   +++||||||+|||+++ +.+||+|||+++........ .......||
T Consensus       121 ----~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~~~~-~~~~~~~gt  191 (313)
T 3cek_A          121 ----KKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTS-VVKDSQVGT  191 (313)
T ss_dssp             ----CSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET-TEEEECCCSSSCC---------------CC
T ss_pred             ----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC-CeEEEeeccccccccCcccc-ccccCCCCC
Confidence                24589999999999999999999995   4999999999999965 89999999999876433211 122345799


Q ss_pred             ccccCcccccc-----------CCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhcccc
Q 039626          509 KGYMAPEYLEN-----------GLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFI  577 (628)
Q Consensus       509 ~~Y~APE~l~~-----------~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  577 (628)
                      +.|+|||.+.+           ..++.++||||||++++||++|+.|+.....     ........             +
T Consensus       192 ~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~-----~~~~~~~~-------------~  253 (313)
T 3cek_A          192 VNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-----QISKLHAI-------------I  253 (313)
T ss_dssp             GGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCS-----HHHHHHHH-------------H
T ss_pred             CCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHH-----HHHHHHHH-------------H
Confidence            99999999875           4788999999999999999999999863221     11111111             1


Q ss_pred             CCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 039626          578 DPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHS  617 (628)
Q Consensus       578 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~  617 (628)
                      ++.....++...+..+.+++.+||+.||.+||++.|+++.
T Consensus       254 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  293 (313)
T 3cek_A          254 DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  293 (313)
T ss_dssp             CTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             hcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence            1111222222234567899999999999999999999863

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=5e-34  Score=296.76  Aligned_cols=253  Identities=25%  Similarity=0.384  Sum_probs=187.7

Q ss_pred             hcCCCcCCccc----eEEEEEEE---CCceEEEEEecc---------chHHHHHHHhhc---CCCceeeeeeeee-----
Q 039626          350 TDNFSFTCRIQ----GSVYRGKI---NGGFAAIKKVNG---------DVSKEIALLNKI---NHSNLIILSGVCF-----  405 (628)
Q Consensus       350 t~~f~~~~~i~----G~Vy~g~~---~g~~vavK~~~~---------~~~~E~~~l~~l---~H~nIv~l~g~~~-----  405 (628)
                      .++|.....+|    |.||++..   +|+.||+|+++.         .+.+|+.+++++   +||||+++++++.     
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~   89 (326)
T 1blx_A           10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   89 (326)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             hhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccC
Confidence            34555555554    89999987   467899998752         466788887777   8999999999997     


Q ss_pred             cCCeEEEEEEecCCCChHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEcc
Q 039626          406 NEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIAN  485 (628)
Q Consensus       406 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~D  485 (628)
                      .....++||||++ |+|.+++...  ....+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|
T Consensus        90 ~~~~~~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~kl~D  163 (326)
T 1blx_A           90 RETKLTLVFEHVD-QDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLAD  163 (326)
T ss_dssp             SEEEEEEEEECCS-CBHHHHHHHS--CTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECS
T ss_pred             CCceEEEEEecCC-CCHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEEEec
Confidence            4567899999997 6999999653  234589999999999999999999995   499999999999999999999999


Q ss_pred             ccccccCCCCCCcceeeecccCCccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhc
Q 039626          486 FAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLT  565 (628)
Q Consensus       486 fgla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~  565 (628)
                      ||+++......    ......||+.|+|||.+.+..++.++||||||++++||++|+.|+.......  .+..... ...
T Consensus       164 fg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~i~~-~~~  236 (326)
T 1blx_A          164 FGLARIYSFQM----ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD--QLGKILD-VIG  236 (326)
T ss_dssp             CCSCCCCCGGG----GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHH-HHC
T ss_pred             CcccccccCCC----CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHH--HHHHHHH-HcC
Confidence            99998664221    1234578999999999999999999999999999999999999987433211  1111111 111


Q ss_pred             cccchhhhc-------cccC---CcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          566 KEDGEESLR-------HFID---PTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       566 ~~~~~~~l~-------~~~d---~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      ... .....       ..+.   ...........+..+.+++.+||+.||.+||++.|+++
T Consensus       237 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  296 (326)
T 1blx_A          237 LPG-EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  296 (326)
T ss_dssp             CCC-GGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             CCC-cccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            100 00000       0000   00001112234456789999999999999999999874

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=1e-34  Score=302.50  Aligned_cols=234  Identities=22%  Similarity=0.354  Sum_probs=161.4

Q ss_pred             eEEEEEEE--CCceEEEEEecc--------chHHHHH-HHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhc
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG--------DVSKEIA-LLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSN  429 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~--------~~~~E~~-~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~  429 (628)
                      |.||++..  +|+.||||+++.        ++..|+. +++.++|+||+++++++.+++..++||||+++ +|.+++...
T Consensus        36 g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~  114 (327)
T 3aln_A           36 GSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMST-SFDKFYKYV  114 (327)
T ss_dssp             EEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEECCCSE-EHHHHHHHH
T ss_pred             EEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEeecCC-ChHHHHHHH
Confidence            89999998  488999999864        2334554 77888999999999999999999999999975 888877432


Q ss_pred             -CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCC
Q 039626          430 -KNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGT  508 (628)
Q Consensus       430 -~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt  508 (628)
                       ......+++..+..++.+++.||.|||+.  .+++||||||+|||++.++.+||+|||+++......    ......||
T Consensus       115 ~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~--~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~----~~~~~~gt  188 (327)
T 3aln_A          115 YSVLDDVIPEEILGKITLATVKALNHLKEN--LKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSI----AKTRDAGC  188 (327)
T ss_dssp             HHTTCCCCCHHHHHHHHHHHHHHHHHHHHH--HSCCCSCCCGGGEEEETTTEEEECCCSSSCC-----------------
T ss_pred             HhhhcccCcHHHHHHHHHHHHHHHHHHhcc--CCEeECCCCHHHEEEcCCCCEEEccCCCceeccccc----ccccCCCC
Confidence             12245689999999999999999999994  159999999999999999999999999998764322    12234699


Q ss_pred             ccccCcccc----ccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCC
Q 039626          509 KGYMAPEYL----ENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGN  584 (628)
Q Consensus       509 ~~Y~APE~l----~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~  584 (628)
                      +.|+|||.+    .+..++.++||||||++++||++|+.|+.......     +...          .+.....+.+...
T Consensus       189 ~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-----~~~~----------~~~~~~~~~~~~~  253 (327)
T 3aln_A          189 RPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVF-----DQLT----------QVVKGDPPQLSNS  253 (327)
T ss_dssp             -----------------CCSHHHHHHHHHHHHHHHHSCCCSSCC------------C----------CCCCSCCCCCCCC
T ss_pred             ccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHH-----HHHH----------HHhcCCCCCCCCc
Confidence            999999998    45678999999999999999999999986422110     0000          0000011111111


Q ss_pred             CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          585 YPLELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       585 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      ........+.+++.+||+.||.+||++.|+++
T Consensus       254 ~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  285 (327)
T 3aln_A          254 EEREFSPSFINFVNLCLTKDESKRPKYKELLK  285 (327)
T ss_dssp             SSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             ccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence            11223456889999999999999999999975

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.5e-34  Score=312.88  Aligned_cols=231  Identities=23%  Similarity=0.358  Sum_probs=171.2

Q ss_pred             eE-EEEEEECCceEEEEEecc----chHHHHHHHhhc-CCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhcCCCCC
Q 039626          361 GS-VYRGKINGGFAAIKKVNG----DVSKEIALLNKI-NHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGK  434 (628)
Q Consensus       361 G~-Vy~g~~~g~~vavK~~~~----~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~  434 (628)
                      |. ||++..+|+.||||++..    .+.+|+++|+++ +|||||++++++.++...++||||+. |+|.+++....   .
T Consensus        38 G~V~~~~~~~~~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~-g~L~~~l~~~~---~  113 (432)
T 3p23_A           38 GTIVYRGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKD---F  113 (432)
T ss_dssp             GCEEEEEESSSSEEEEEEECTTTEEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHHSSS---C
T ss_pred             EEEEEEEEeCCeEEEEEEECHHHHHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC-CCHHHHHHhcC---C
Confidence            66 677777999999999865    367899999999 89999999999999999999999995 69999996432   2


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCC-----CCcEEEccccccccCCCCCCcceeeecccCCc
Q 039626          435 YLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDS-----DLRAKIANFAMARPAEGQEGEFALTRHIVGTK  509 (628)
Q Consensus       435 ~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~-----~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~  509 (628)
                      .+.+..+..++.||+.||+|||+.+   |+||||||+|||++.     ...+||+|||+++................||+
T Consensus       114 ~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~  190 (432)
T 3p23_A          114 AHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTE  190 (432)
T ss_dssp             CCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC------------CCSCT
T ss_pred             CccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCcceeeccccCCCc
Confidence            3444556789999999999999954   999999999999943     34688999999987754332222334567999


Q ss_pred             cccCccccc---cCCCCcccccHHHHHHHHHHHh-CCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCC
Q 039626          510 GYMAPEYLE---NGLVSTKLDVYAFGVLILEMLT-GKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNY  585 (628)
Q Consensus       510 ~Y~APE~l~---~~~~s~k~DV~SfGvvl~ELlt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~  585 (628)
                      .|+|||.+.   ...++.++|||||||+++||++ |+.|+.....       ...........         ....  ..
T Consensus       191 ~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~-------~~~~~~~~~~~---------~~~~--~~  252 (432)
T 3p23_A          191 GWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQ-------RQANILLGACS---------LDCL--HP  252 (432)
T ss_dssp             TSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTT-------HHHHHHTTCCC---------CTTS--CT
T ss_pred             CccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhH-------HHHHHHhccCC---------cccc--Cc
Confidence            999999997   4567889999999999999999 8887742211       11111111000         0000  11


Q ss_pred             CHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          586 PLELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       586 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      .......+.+|+.+||+.||.+|||+.||++
T Consensus       253 ~~~~~~~~~~li~~~L~~dP~~Rps~~evl~  283 (432)
T 3p23_A          253 EKHEDVIARELIEKMIAMDPQKRPSAKHVLK  283 (432)
T ss_dssp             TCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence            2244556789999999999999999999983

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.2e-34  Score=300.25  Aligned_cols=244  Identities=23%  Similarity=0.311  Sum_probs=176.5

Q ss_pred             eEEEEEEE--CCceEEEEEecc-------chHHHHHHHhhcCCCceeeeeeeee--------------cCCeEEEEEEec
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG-------DVSKEIALLNKINHSNLIILSGVCF--------------NEGNCYLVYEYA  417 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~-------~~~~E~~~l~~l~H~nIv~l~g~~~--------------~~~~~~lV~E~~  417 (628)
                      |.||+|..  .|+.||+|++..       ++.+|++++++++||||+++++++.              +....++||||+
T Consensus        25 g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~  104 (320)
T 2i6l_A           25 GLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM  104 (320)
T ss_dssp             -CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----CCSCSEEEEEEECC
T ss_pred             eEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccccccccCceeEEeecc
Confidence            89999998  488999998753       4678999999999999999999874              346789999999


Q ss_pred             CCCChHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeC-CCCcEEEccccccccCCCCC
Q 039626          418 VNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLD-SDLRAKIANFAMARPAEGQE  496 (628)
Q Consensus       418 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~-~~~~~kl~Dfgla~~~~~~~  496 (628)
                      + |+|.+++.     ...+++..+..++.|++.||+|||+.   +++||||||+|||++ +++.+||+|||+++......
T Consensus       105 ~-~~L~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~kl~Dfg~~~~~~~~~  175 (320)
T 2i6l_A          105 E-TDLANVLE-----QGPLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHY  175 (320)
T ss_dssp             S-EEHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTTEEEECCCTTCBCC----
T ss_pred             C-CCHHHHhh-----cCCccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCeEEEccCccccccCCCc
Confidence            7 69999983     24589999999999999999999995   499999999999997 57799999999998764322


Q ss_pred             CcceeeecccCCccccCcccccc-CCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccc--hhhh
Q 039626          497 GEFALTRHIVGTKGYMAPEYLEN-GLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDG--EESL  573 (628)
Q Consensus       497 ~~~~~~~~~~gt~~Y~APE~l~~-~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~l  573 (628)
                      ..........+|..|+|||.+.+ ..++.++||||||++++||++|+.|+.......  ........ ......  ...+
T Consensus       176 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~--~~~~~~~~-~~~~~~~~~~~~  252 (320)
T 2i6l_A          176 SHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELE--QMQLILES-IPVVHEEDRQEL  252 (320)
T ss_dssp             ----CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHH-SCCCCHHHHHHH
T ss_pred             ccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHh-cCCCchhhhhhh
Confidence            21122334568999999998865 678999999999999999999999987433211  01111111 000000  0000


Q ss_pred             cc----ccCCcCC-CC-----CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          574 RH----FIDPTLQ-GN-----YPLELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       574 ~~----~~d~~l~-~~-----~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      ..    .+..... ..     .....+..+.+++.+||+.||++|||+.|+++
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (320)
T 2i6l_A          253 LSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS  305 (320)
T ss_dssp             HTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             hhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence            00    0000000 00     01123456889999999999999999999975

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=4.3e-34  Score=304.70  Aligned_cols=189  Identities=21%  Similarity=0.291  Sum_probs=158.7

Q ss_pred             hcCCCcCCccc----eEEEEEEE--CCceEEEEEecc------chHHHHHHHhhcC-CC-----ceeeeeeeeecCCeEE
Q 039626          350 TDNFSFTCRIQ----GSVYRGKI--NGGFAAIKKVNG------DVSKEIALLNKIN-HS-----NLIILSGVCFNEGNCY  411 (628)
Q Consensus       350 t~~f~~~~~i~----G~Vy~g~~--~g~~vavK~~~~------~~~~E~~~l~~l~-H~-----nIv~l~g~~~~~~~~~  411 (628)
                      .++|.....+|    |.||+|..  +++.||||+++.      ++..|+++++.++ |+     +|+++++++..++..+
T Consensus        53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~  132 (382)
T 2vx3_A           53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLC  132 (382)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEE
T ss_pred             eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceE
Confidence            45565555554    89999988  578999999964      3456888888885 44     4999999999999999


Q ss_pred             EEEEecCCCChHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeC--CCCcEEEcccccc
Q 039626          412 LVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLD--SDLRAKIANFAMA  489 (628)
Q Consensus       412 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~--~~~~~kl~Dfgla  489 (628)
                      +||||++ |+|.+++...  ....+++..+..++.|++.||.|||++. .+|+||||||+|||++  .++.+||+|||++
T Consensus       133 lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~-~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a  208 (382)
T 2vx3_A          133 LVFEMLS-YNLYDLLRNT--NFRGVSLNLTRKFAQQMCTALLFLATPE-LSIIHCDLKPENILLCNPKRSAIKIVDFGSS  208 (382)
T ss_dssp             EEEECCC-CBHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHTSTT-TCEECCCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred             EEEecCC-CCHHHHHhhc--CcCCCCHHHHHHHHHHHHHHHHHhccCC-CCEEcCCCCcccEEEecCCCCcEEEEeccCc
Confidence            9999995 6999999653  2245899999999999999999999643 6799999999999994  5788999999999


Q ss_pred             ccCCCCCCcceeeecccCCccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccc
Q 039626          490 RPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALH  548 (628)
Q Consensus       490 ~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~  548 (628)
                      +.....      .....||+.|+|||.+.+..++.++|||||||+++||++|+.||...
T Consensus       209 ~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~  261 (382)
T 2vx3_A          209 CQLGQR------IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGA  261 (382)
T ss_dssp             EETTCC------CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             eecccc------cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            876432      23457899999999999999999999999999999999999998754

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=7.8e-35  Score=315.71  Aligned_cols=236  Identities=24%  Similarity=0.379  Sum_probs=171.9

Q ss_pred             eEEE-EEEECCceEEEEEeccc----hHHHHHHHhhc-CCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhcCCCCC
Q 039626          361 GSVY-RGKINGGFAAIKKVNGD----VSKEIALLNKI-NHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGK  434 (628)
Q Consensus       361 G~Vy-~g~~~g~~vavK~~~~~----~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~  434 (628)
                      |+|| ++..+|+.||||++..+    +.+|+++|.++ +||||+++++++.+++..++||||+. |+|.+++........
T Consensus        29 g~V~~~~~~~g~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-gsL~~~l~~~~~~~~  107 (434)
T 2rio_A           29 GTVVFQGSFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDE  107 (434)
T ss_dssp             TCEEEEEESSSSEEEEEEEEGGGHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-EEHHHHHHTC-----
T ss_pred             eEEEEEEEECCeEEEEEEEcHHHHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-CCHHHHHhccCCCch
Confidence            7785 55568999999998654    56799999987 89999999999999999999999995 699999965432222


Q ss_pred             C---CCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCC-------------CcEEEccccccccCCCCCCc
Q 039626          435 Y---LDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSD-------------LRAKIANFAMARPAEGQEGE  498 (628)
Q Consensus       435 ~---l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~-------------~~~kl~Dfgla~~~~~~~~~  498 (628)
                      .   .++..++.++.||+.||+|||+.   +|+||||||+|||++.+             +.+||+|||+++........
T Consensus       108 ~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG~a~~~~~~~~~  184 (434)
T 2rio_A          108 NLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSS  184 (434)
T ss_dssp             -------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCCTTCEECCC----
T ss_pred             hhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCCceEEEEcccccceecCCCCcc
Confidence            1   23445678999999999999995   49999999999999654             58999999999877543221


Q ss_pred             ce-eeecccCCccccCcccccc-------CCCCcccccHHHHHHHHHHHh-CCCccccccccccccHHHHHHHHhccccc
Q 039626          499 FA-LTRHIVGTKGYMAPEYLEN-------GLVSTKLDVYAFGVLILEMLT-GKEAAALHAEENNMHLSDVLNAVLTKEDG  569 (628)
Q Consensus       499 ~~-~~~~~~gt~~Y~APE~l~~-------~~~s~k~DV~SfGvvl~ELlt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~  569 (628)
                      .. ......||+.|+|||.+.+       ..++.++|||||||+++||++ |+.|+......    .........     
T Consensus       185 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~----~~~i~~~~~-----  255 (434)
T 2rio_A          185 FRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR----ESNIIRGIF-----  255 (434)
T ss_dssp             ----------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTH----HHHHHHTCC-----
T ss_pred             ceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhh----HHHHhcCCC-----
Confidence            11 1234579999999999975       678999999999999999999 88887532211    111111000     


Q ss_pred             hhhhccccCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          570 EESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       570 ~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                             ..+......+...+..+.+++.+||+.||.+|||+.|+++
T Consensus       256 -------~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  295 (434)
T 2rio_A          256 -------SLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR  295 (434)
T ss_dssp             -------CCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -------CcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence                   0011112224566778999999999999999999999975

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=7.5e-35  Score=306.62  Aligned_cols=254  Identities=20%  Similarity=0.306  Sum_probs=183.9

Q ss_pred             cCCCcCCccc----eEEEEEEE--CCceEEEEEecc--------chHHHHHHHhhcCCCceeeeeeeeecC-----CeEE
Q 039626          351 DNFSFTCRIQ----GSVYRGKI--NGGFAAIKKVNG--------DVSKEIALLNKINHSNLIILSGVCFNE-----GNCY  411 (628)
Q Consensus       351 ~~f~~~~~i~----G~Vy~g~~--~g~~vavK~~~~--------~~~~E~~~l~~l~H~nIv~l~g~~~~~-----~~~~  411 (628)
                      ++|.....+|    |.||+|..  +|+.||||+++.        .+.+|++++++++|+||+++++++..+     ...+
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   90 (353)
T 2b9h_A           11 SDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVY   90 (353)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEE
T ss_pred             cceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEE
Confidence            3444444443    89999998  488999999853        356899999999999999999998754     6789


Q ss_pred             EEEEecCCCChHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEcccccccc
Q 039626          412 LVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARP  491 (628)
Q Consensus       412 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~  491 (628)
                      +||||+. |+|.+++..     ..+++..+..++.|++.||+|||+.   +++||||||+|||++.++.+||+|||+++.
T Consensus        91 lv~e~~~-~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~  161 (353)
T 2b9h_A           91 IIQELMQ-TDLHRVIST-----QMLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARI  161 (353)
T ss_dssp             EEECCCS-EEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEeccC-ccHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEecccccc
Confidence            9999996 699998854     3589999999999999999999995   499999999999999999999999999987


Q ss_pred             CCCCCCcc-------eeeecccCCccccCcccccc-CCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHH
Q 039626          492 AEGQEGEF-------ALTRHIVGTKGYMAPEYLEN-GLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAV  563 (628)
Q Consensus       492 ~~~~~~~~-------~~~~~~~gt~~Y~APE~l~~-~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~  563 (628)
                      ........       .......||+.|+|||.+.+ ..++.++||||||++++||++|+.|+.......   ....+...
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~~~~~~  238 (353)
T 2b9h_A          162 IDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRH---QLLLIFGI  238 (353)
T ss_dssp             CC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHH
T ss_pred             cccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHH---HHHHHHHH
Confidence            65322110       01223478999999998764 778999999999999999999999987543211   11111111


Q ss_pred             hccccchhh--------hccccCC--cCCCC----CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          564 LTKEDGEES--------LRHFIDP--TLQGN----YPLELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       564 ~~~~~~~~~--------l~~~~d~--~l~~~----~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      .........        ..+.+..  .....    .....+..+.+++.+||+.||++|||+.|+++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (353)
T 2b9h_A          239 IGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE  305 (353)
T ss_dssp             HCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence            111100000        0000000  00000    00123456789999999999999999999875

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=2.7e-34  Score=300.85  Aligned_cols=233  Identities=20%  Similarity=0.261  Sum_probs=158.9

Q ss_pred             eEEEEEEE--CCceEEEEEeccc--hHHHH-HHHhhcCCCceeeeeeeeec----CCeEEEEEEecCCCChHHHhhhcCC
Q 039626          361 GSVYRGKI--NGGFAAIKKVNGD--VSKEI-ALLNKINHSNLIILSGVCFN----EGNCYLVYEYAVNGTLSDWVFSNKN  431 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~~--~~~E~-~~l~~l~H~nIv~l~g~~~~----~~~~~lV~E~~~~gsL~~~l~~~~~  431 (628)
                      |.||++..  +|+.||||++..+  ..+|+ ..+..++|+||+++++++..    +...++||||+++|+|.+++...  
T Consensus        43 g~V~~~~~~~~~~~vavK~~~~~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~--  120 (336)
T 3fhr_A           43 GKVLECFHRRTGQKCALKLLYDSPKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQER--  120 (336)
T ss_dssp             EEEEEEEETTTCCEEEEEEEESSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCTTEEHHHHHHTC--
T ss_pred             eEEEEEEECCCCCEEEEEEecCcHHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEEEeccCCCCHHHHHHhc--
Confidence            89999998  5889999998653  33333 44667799999999999976    44589999999999999999643  


Q ss_pred             CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCC---CCcEEEccccccccCCCCCCcceeeecccCC
Q 039626          432 EGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDS---DLRAKIANFAMARPAEGQEGEFALTRHIVGT  508 (628)
Q Consensus       432 ~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~---~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt  508 (628)
                      ....+++..+..++.|++.||+|||+.   +++||||||+|||++.   ++.+||+|||+++......     .....||
T Consensus       121 ~~~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~~~t  192 (336)
T 3fhr_A          121 GDQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA-----LQTPCYT  192 (336)
T ss_dssp             -CCCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC----------------
T ss_pred             CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEeccccceeccccc-----cccCCCC
Confidence            234699999999999999999999995   4999999999999976   4559999999998654321     2345789


Q ss_pred             ccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCHH
Q 039626          509 KGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLE  588 (628)
Q Consensus       509 ~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~  588 (628)
                      +.|+|||.+.+..++.++||||||++++||++|+.|+.........  .........        .   ...........
T Consensus       193 ~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--~~~~~~~~~--------~---~~~~~~~~~~~  259 (336)
T 3fhr_A          193 PYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAIS--PGMKRRIRL--------G---QYGFPNPEWSE  259 (336)
T ss_dssp             -----------CHHHHHHHHHHHHHHHHHHHHSSCCC----------------------------------CCCTTTSTT
T ss_pred             cCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhh--hhHHHhhhc--------c---ccccCchhhcc
Confidence            9999999999999999999999999999999999998643322110  000000000        0   00001111123


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          589 LALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       589 ~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      .+..+.+++.+||+.||.+|||+.|+++
T Consensus       260 ~~~~~~~li~~~L~~dP~~Rpt~~ell~  287 (336)
T 3fhr_A          260 VSEDAKQLIRLLLKTDPTERLTITQFMN  287 (336)
T ss_dssp             CCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             CCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            3456789999999999999999999987

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=4.4e-34  Score=302.90  Aligned_cols=245  Identities=22%  Similarity=0.295  Sum_probs=183.0

Q ss_pred             eEEEEEEE--CCceEEEEEecc------chHHHHHHHhhcC-----------CCceeeeeeeeecCC----eEEEEEEec
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG------DVSKEIALLNKIN-----------HSNLIILSGVCFNEG----NCYLVYEYA  417 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~------~~~~E~~~l~~l~-----------H~nIv~l~g~~~~~~----~~~lV~E~~  417 (628)
                      |.||+++.  +++.||||.+..      .+.+|++++++++           |+||+++++++...+    ..++||||+
T Consensus        33 g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~lv~e~~  112 (373)
T 1q8y_A           33 STVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL  112 (373)
T ss_dssp             EEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTEEEEEEEECCC
T ss_pred             eEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhccCCCCceEEEEEecC
Confidence            89999997  788999999874      3567999999886           899999999998654    789999999


Q ss_pred             CCCChHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeC------CCCcEEEcccccccc
Q 039626          418 VNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLD------SDLRAKIANFAMARP  491 (628)
Q Consensus       418 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~------~~~~~kl~Dfgla~~  491 (628)
                       +++|.+++...  ....+++..+..++.||+.||+|||+.  .+|+||||||+|||++      .++.+||+|||+++.
T Consensus       113 -~~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~~--~~ivH~Dikp~NIll~~~~~~~~~~~~kl~Dfg~a~~  187 (373)
T 1q8y_A          113 -GENLLALIKKY--EHRGIPLIYVKQISKQLLLGLDYMHRR--CGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACW  187 (373)
T ss_dssp             -CEEHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHHHT--TCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEE
T ss_pred             -CCCHHHHHHHh--hccCCcHHHHHHHHHHHHHHHHHHHhc--CCEEecCCChHHeEEeccCCCcCcceEEEcccccccc
Confidence             99999999653  234589999999999999999999994  1599999999999994      455899999999987


Q ss_pred             CCCCCCcceeeecccCCccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHh---cccc
Q 039626          492 AEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVL---TKED  568 (628)
Q Consensus       492 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~---~~~~  568 (628)
                      ....      .....||+.|+|||.+.+..++.++||||||+++|||++|+.||............+.+..+.   ....
T Consensus       188 ~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p  261 (373)
T 1q8y_A          188 YDEH------YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELP  261 (373)
T ss_dssp             TTBC------CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCC
T ss_pred             cCCC------CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHHHHHhcCCCC
Confidence            6432      223478999999999999999999999999999999999999987543222111111111111   1000


Q ss_pred             c---------------hhhhccccCC---------cCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          569 G---------------EESLRHFIDP---------TLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       569 ~---------------~~~l~~~~d~---------~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      .               ...+......         .....++...+..+.+|+.+||+.||++|||+.|+++
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  333 (373)
T 1q8y_A          262 SYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVN  333 (373)
T ss_dssp             HHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHT
T ss_pred             HHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHHHhh
Confidence            0               0000000000         0012356678889999999999999999999999975

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=4.1e-34  Score=292.27  Aligned_cols=236  Identities=26%  Similarity=0.378  Sum_probs=184.9

Q ss_pred             CCCcCCccc----eEEEEEEE--CCceEEEEEecc---------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEe
Q 039626          352 NFSFTCRIQ----GSVYRGKI--NGGFAAIKKVNG---------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEY  416 (628)
Q Consensus       352 ~f~~~~~i~----G~Vy~g~~--~g~~vavK~~~~---------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~  416 (628)
                      +|.....+|    |.||+++.  +++.||+|++..         .+.+|++++++++|+||+++++++.+.+..++|+||
T Consensus        23 ~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  102 (287)
T 2wei_A           23 RYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGEL  102 (287)
T ss_dssp             HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             cceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEEEc
Confidence            444444443    89999998  688999999753         366899999999999999999999999999999999


Q ss_pred             cCCCChHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCC---CcEEEccccccccCC
Q 039626          417 AVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSD---LRAKIANFAMARPAE  493 (628)
Q Consensus       417 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~---~~~kl~Dfgla~~~~  493 (628)
                      +++++|.+++...    ..+++..+..++.|++.||.|||+.   +++||||||+||+++.+   +.+||+|||+++...
T Consensus       103 ~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~  175 (287)
T 2wei_A          103 YTGGELFDEIIKR----KRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ  175 (287)
T ss_dssp             CCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBC
T ss_pred             cCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEeccCcceeec
Confidence            9999999998643    3589999999999999999999995   49999999999999764   479999999998764


Q ss_pred             CCCCcceeeecccCCccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhh
Q 039626          494 GQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESL  573 (628)
Q Consensus       494 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  573 (628)
                      ....    .....||+.|+|||.+.+ .++.++||||||++++||++|+.|+.....      .+....+..... .   
T Consensus       176 ~~~~----~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~------~~~~~~~~~~~~-~---  240 (287)
T 2wei_A          176 QNTK----MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE------YDILKRVETGKY-A---  240 (287)
T ss_dssp             CCSS----CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHCCC-C---
T ss_pred             CCCc----cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCH------HHHHHHHHcCCC-C---
Confidence            3221    223468899999998876 489999999999999999999999864322      122222211110 0   


Q ss_pred             ccccCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          574 RHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       574 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                         .+.....    ..+..+.+++.+||+.||.+|||+.|+++
T Consensus       241 ---~~~~~~~----~~~~~~~~li~~~l~~dp~~Rps~~ell~  276 (287)
T 2wei_A          241 ---FDLPQWR----TISDDAKDLIRKMLTFHPSLRITATQCLE  276 (287)
T ss_dssp             ---CCSGGGT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ---CCchhhh----hcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence               0000001    22356789999999999999999999987

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=4e-34  Score=303.19  Aligned_cols=237  Identities=25%  Similarity=0.350  Sum_probs=168.2

Q ss_pred             eEEEEEEE--CCceEEEEEecc---------chHHHHHHHhhcCCCceeeeeeeeecC------CeEEEEEEecCCCChH
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG---------DVSKEIALLNKINHSNLIILSGVCFNE------GNCYLVYEYAVNGTLS  423 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~---------~~~~E~~~l~~l~H~nIv~l~g~~~~~------~~~~lV~E~~~~gsL~  423 (628)
                      |.||+|..  +|+.||||++..         .+.+|+++|++++|+||+++++++...      ...++|+||+ +++|.
T Consensus        43 g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~  121 (367)
T 2fst_X           43 GSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLN  121 (367)
T ss_dssp             CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEEECC-CEECC
T ss_pred             eEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCeEEEEeccc-CCCHH
Confidence            89999987  688999999853         355899999999999999999998754      5679999999 78999


Q ss_pred             HHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeee
Q 039626          424 DWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTR  503 (628)
Q Consensus       424 ~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~  503 (628)
                      +++..     ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++.....      ..
T Consensus       122 ~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~------~~  187 (367)
T 2fst_X          122 NIVKC-----QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTADE------MT  187 (367)
T ss_dssp             ----------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC------------------
T ss_pred             HHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeecccccccccc------CC
Confidence            98842     4599999999999999999999995   4999999999999999999999999999865422      23


Q ss_pred             cccCCccccCcccccc-CCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhh--------c
Q 039626          504 HIVGTKGYMAPEYLEN-GLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESL--------R  574 (628)
Q Consensus       504 ~~~gt~~Y~APE~l~~-~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l--------~  574 (628)
                      ...||+.|+|||.+.+ ..++.++|||||||+++||++|+.||.......   ....+........ .+.+        +
T Consensus       188 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~---~l~~i~~~~g~p~-~~~~~~~~~~~~~  263 (367)
T 2fst_X          188 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID---QLKLILRLVGTPG-AELLKKISSESAR  263 (367)
T ss_dssp             ---CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCSCC-HHHHTTCCCHHHH
T ss_pred             CcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCCC-HHHHHHhhhHHHH
Confidence            4579999999999877 678999999999999999999999987533211   1111112111110 0100        0


Q ss_pred             cccCCcC-CCCCCH-----HHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          575 HFIDPTL-QGNYPL-----ELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       575 ~~~d~~l-~~~~~~-----~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      .++.... ....+.     .....+.+|+.+||+.||.+|||+.|+++
T Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~  311 (367)
T 2fst_X          264 NYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  311 (367)
T ss_dssp             HHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence            1100000 000010     12356789999999999999999999875

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=1e-34  Score=301.91  Aligned_cols=228  Identities=24%  Similarity=0.336  Sum_probs=183.8

Q ss_pred             hcCCCcCCccc----eEEEEEEE--CCceEEEEEecc-------------chHHHHHHHhhcC--CCceeeeeeeeecCC
Q 039626          350 TDNFSFTCRIQ----GSVYRGKI--NGGFAAIKKVNG-------------DVSKEIALLNKIN--HSNLIILSGVCFNEG  408 (628)
Q Consensus       350 t~~f~~~~~i~----G~Vy~g~~--~g~~vavK~~~~-------------~~~~E~~~l~~l~--H~nIv~l~g~~~~~~  408 (628)
                      .++|.....+|    |.||+|+.  +++.||||+++.             .+.+|+.++++++  |+||+++++++.+++
T Consensus        42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~  121 (320)
T 3a99_A           42 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD  121 (320)
T ss_dssp             TTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred             cCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCC
Confidence            34455444443    89999987  688999998853             3557999999996  599999999999999


Q ss_pred             eEEEEEEecCC-CChHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeC-CCCcEEEccc
Q 039626          409 NCYLVYEYAVN-GTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLD-SDLRAKIANF  486 (628)
Q Consensus       409 ~~~lV~E~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~-~~~~~kl~Df  486 (628)
                      ..++|+||+.+ ++|.+++...    ..+++..+..++.|++.||+|||+.   +|+||||||+|||++ +++.+||+||
T Consensus       122 ~~~lv~e~~~~~~~L~~~l~~~----~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~kL~Df  194 (320)
T 3a99_A          122 SFVLILERPEPVQDLFDFITER----GALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDF  194 (320)
T ss_dssp             EEEEEEECCSSEEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCC
T ss_pred             cEEEEEEcCCCCccHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCCCCCEEEeeC
Confidence            99999999976 8999999642    3589999999999999999999995   499999999999999 7899999999


Q ss_pred             cccccCCCCCCcceeeecccCCccccCccccccCCC-CcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhc
Q 039626          487 AMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLV-STKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLT  565 (628)
Q Consensus       487 gla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~-s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~  565 (628)
                      |+++......     .....||+.|+|||.+.+..+ +.++||||||+++|||++|+.|+.....        ..    .
T Consensus       195 g~~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~--------~~----~  257 (320)
T 3a99_A          195 GSGALLKDTV-----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE--------II----R  257 (320)
T ss_dssp             TTCEECCSSC-----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH--------HH----H
T ss_pred             cccccccccc-----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh--------hh----c
Confidence            9998765322     233569999999999987665 7889999999999999999999853211        00    0


Q ss_pred             cccchhhhccccCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          566 KEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       566 ~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      ..           ......+    +..+.+++.+||+.||++||+++|+++
T Consensus       258 ~~-----------~~~~~~~----~~~~~~li~~~l~~dp~~Rps~~~ll~  293 (320)
T 3a99_A          258 GQ-----------VFFRQRV----SSECQHLIRWCLALRPSDRPTFEEIQN  293 (320)
T ss_dssp             CC-----------CCCSSCC----CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             cc-----------ccccccC----CHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            00           0011222    345789999999999999999999976

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=8.1e-34  Score=301.38  Aligned_cols=236  Identities=25%  Similarity=0.334  Sum_probs=176.0

Q ss_pred             eEEEEEEE--CCceEEEEEecc---------chHHHHHHHhhcCCCceeeeeeeeecCCeE------EEEEEecCCCChH
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG---------DVSKEIALLNKINHSNLIILSGVCFNEGNC------YLVYEYAVNGTLS  423 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~---------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~------~lV~E~~~~gsL~  423 (628)
                      |.||+|..  +|+.||||++..         .+.+|+.++++++|+||+++++++...+..      ++||||+. |+|.
T Consensus        56 g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~  134 (371)
T 4exu_A           56 GSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQ  134 (371)
T ss_dssp             EEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCCCEEEEECCC-EEHH
T ss_pred             eEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccceeEEEEEcccc-ccHH
Confidence            89999987  688999999864         356899999999999999999999876654      99999996 6888


Q ss_pred             HHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeee
Q 039626          424 DWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTR  503 (628)
Q Consensus       424 ~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~  503 (628)
                      +++.      ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++.....      ..
T Consensus       135 ~~~~------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~------~~  199 (371)
T 4exu_A          135 KIMG------MEFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHADAE------MT  199 (371)
T ss_dssp             HHTT------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSTTCC--------------
T ss_pred             HHhh------cCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEecCcccccccC------cC
Confidence            8772      2389999999999999999999995   4999999999999999999999999999865432      23


Q ss_pred             cccCCccccCcccccc-CCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhc--------
Q 039626          504 HIVGTKGYMAPEYLEN-GLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLR--------  574 (628)
Q Consensus       504 ~~~gt~~Y~APE~l~~-~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~--------  574 (628)
                      ...||+.|+|||.+.+ ..++.++||||||++++||++|+.||.......  .+.... ....... .+...        
T Consensus       200 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~i~-~~~~~~~-~~~~~~~~~~~~~  275 (371)
T 4exu_A          200 GYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD--QLTQIL-KVTGVPG-TEFVQKLNDKAAK  275 (371)
T ss_dssp             CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHH-HHHCCCC-HHHHTTCSCHHHH
T ss_pred             CcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHH-HHhCCCc-HHHHHHhhhhhhh
Confidence            4578999999999887 688999999999999999999999987433211  111111 1111000 00000        


Q ss_pred             cc---cCCcCCCC---CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          575 HF---IDPTLQGN---YPLELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       575 ~~---~d~~l~~~---~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      .+   +.......   .....+..+.+|+.+||+.||++|||+.|+++
T Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  323 (371)
T 4exu_A          276 SYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT  323 (371)
T ss_dssp             HHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             hhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence            00   00000000   01123456889999999999999999999875

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.6e-34  Score=296.23  Aligned_cols=228  Identities=24%  Similarity=0.341  Sum_probs=179.0

Q ss_pred             hcCCCcCCccc----eEEEEEEE--CCceEEEEEecc-------------chHHHHHHHhhc----CCCceeeeeeeeec
Q 039626          350 TDNFSFTCRIQ----GSVYRGKI--NGGFAAIKKVNG-------------DVSKEIALLNKI----NHSNLIILSGVCFN  406 (628)
Q Consensus       350 t~~f~~~~~i~----G~Vy~g~~--~g~~vavK~~~~-------------~~~~E~~~l~~l----~H~nIv~l~g~~~~  406 (628)
                      .++|.....+|    |.||+|..  +++.||+|++..             .+.+|+.++.++    +|+||+++++++..
T Consensus        30 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~  109 (312)
T 2iwi_A           30 EAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFET  109 (312)
T ss_dssp             ---CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC--
T ss_pred             hhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEec
Confidence            34565555554    89999988  678999999853             244699999999    89999999999999


Q ss_pred             CCeEEEEEEe-cCCCChHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeC-CCCcEEEc
Q 039626          407 EGNCYLVYEY-AVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLD-SDLRAKIA  484 (628)
Q Consensus       407 ~~~~~lV~E~-~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~-~~~~~kl~  484 (628)
                      .+..++|+|| +.+++|.+++...    ..+++..++.++.|++.||+|||+.   +++||||||+||+++ +++.+||+
T Consensus       110 ~~~~~~v~e~~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~kl~  182 (312)
T 2iwi_A          110 QEGFMLVLERPLPAQDLFDYITEK----GPLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRGCAKLI  182 (312)
T ss_dssp             ---CEEEEECCSSEEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETTTTEEEEC
T ss_pred             CCeEEEEEEecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCCCCeEEEE
Confidence            9999999999 7899999999653    3589999999999999999999995   499999999999999 88999999


Q ss_pred             cccccccCCCCCCcceeeecccCCccccCccccccCCC-CcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHH
Q 039626          485 NFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLV-STKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAV  563 (628)
Q Consensus       485 Dfgla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~-s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~  563 (628)
                      |||+++......     .....||..|+|||.+.+..+ +.++||||||++++||++|+.|+....        +..   
T Consensus       183 dfg~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~--------~~~---  246 (312)
T 2iwi_A          183 DFGSGALLHDEP-----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ--------EIL---  246 (312)
T ss_dssp             CCSSCEECCSSC-----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--------HHH---
T ss_pred             EcchhhhcccCc-----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH--------HHh---
Confidence            999998765432     234569999999999887665 459999999999999999999885321        100   


Q ss_pred             hccccchhhhccccCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          564 LTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       564 ~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                       ..           ..    ..+......+.+++.+||+.||++||+++|+++
T Consensus       247 -~~-----------~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~  283 (312)
T 2iwi_A          247 -EA-----------EL----HFPAHVSPDCCALIRRCLAPKPSSRPSLEEILL  283 (312)
T ss_dssp             -HT-----------CC----CCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             -hh-----------cc----CCcccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence             00           00    112223456789999999999999999999986

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=1.8e-33  Score=296.53  Aligned_cols=235  Identities=25%  Similarity=0.320  Sum_probs=176.5

Q ss_pred             eEEEEEEE--CCceEEEEEecc---------chHHHHHHHhhcCCCceeeeeeeeecCCe------EEEEEEecCCCChH
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG---------DVSKEIALLNKINHSNLIILSGVCFNEGN------CYLVYEYAVNGTLS  423 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~---------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~------~~lV~E~~~~gsL~  423 (628)
                      |.||+|..  +|+.||||++..         .+.+|+.++++++|+||+++++++...+.      .++||||+. |+|.
T Consensus        38 g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~  116 (353)
T 3coi_A           38 GSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQ  116 (353)
T ss_dssp             EEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEEECCS-EEGG
T ss_pred             eEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccceeEEEEecccc-CCHH
Confidence            89999988  688999999853         35679999999999999999999987653      499999996 6888


Q ss_pred             HHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeee
Q 039626          424 DWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTR  503 (628)
Q Consensus       424 ~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~  503 (628)
                      +++.      ..+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||+++.....      ..
T Consensus       117 ~~~~------~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~------~~  181 (353)
T 3coi_A          117 KIMG------LKFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHADAE------MT  181 (353)
T ss_dssp             GTTT------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTTCTTC------------
T ss_pred             HHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeecccccCCCCC------cc
Confidence            8772      2389999999999999999999995   4999999999999999999999999999865422      23


Q ss_pred             cccCCccccCcccccc-CCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhh---------
Q 039626          504 HIVGTKGYMAPEYLEN-GLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESL---------  573 (628)
Q Consensus       504 ~~~gt~~Y~APE~l~~-~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l---------  573 (628)
                      ...||+.|+|||.+.+ ..++.++||||||++++||++|+.||.......  .+.... ....... .+..         
T Consensus       182 ~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~--~~~~i~-~~~~~~~-~~~~~~~~~~~~~  257 (353)
T 3coi_A          182 GYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD--QLTQIL-KVTGVPG-TEFVQKLNDKAAK  257 (353)
T ss_dssp             --CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHH--HHHHHH-HHHCBCC-HHHHTTCSCHHHH
T ss_pred             ccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHH-HHhCCCC-HHHHHHHhhHHHH
Confidence            3578999999999877 678999999999999999999999987433211  111111 1111000 0000         


Q ss_pred             ---c---cccCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          574 ---R---HFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       574 ---~---~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                         .   ....+.+. ......+..+.+++.+||+.||.+|||+.|+++
T Consensus       258 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  305 (353)
T 3coi_A          258 SYIQSLPQTPRKDFT-QLFPRASPQAADLLEKMLELDVDKRLTAAQALT  305 (353)
T ss_dssp             HHHHTSCBCSSCCTT-TTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             HHHHhCcCCCCccHH-HhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence               0   00000110 112234567889999999999999999999875

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=8.7e-34  Score=298.05  Aligned_cols=240  Identities=20%  Similarity=0.264  Sum_probs=182.1

Q ss_pred             eEEEEEEE--CC-ceEEEEEecc------chHHHHHHHhhcCCCc------eeeeeeeeecCCeEEEEEEecCCCChHHH
Q 039626          361 GSVYRGKI--NG-GFAAIKKVNG------DVSKEIALLNKINHSN------LIILSGVCFNEGNCYLVYEYAVNGTLSDW  425 (628)
Q Consensus       361 G~Vy~g~~--~g-~~vavK~~~~------~~~~E~~~l~~l~H~n------Iv~l~g~~~~~~~~~lV~E~~~~gsL~~~  425 (628)
                      |.||++..  .+ ..||+|.++.      .+.+|++++++++|++      ++.+.+++...+..++||||+ +++|.++
T Consensus        33 g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~  111 (355)
T 2eu9_A           33 GKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELL-GKNTFEF  111 (355)
T ss_dssp             EEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEEEEEEECC-CCBHHHH
T ss_pred             eEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeEEEEEecc-CCChHHH
Confidence            89999997  34 6899999864      3567999999997766      899999999999999999999 7778887


Q ss_pred             hhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEe-------------------CCCCcEEEccc
Q 039626          426 VFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLL-------------------DSDLRAKIANF  486 (628)
Q Consensus       426 l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl-------------------~~~~~~kl~Df  486 (628)
                      +...  ....+++..+..++.|++.||+|||+.   +|+||||||+|||+                   +.++.+||+||
T Consensus       112 l~~~--~~~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~kl~Df  186 (355)
T 2eu9_A          112 LKEN--NFQPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADF  186 (355)
T ss_dssp             HHHT--TTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEEECCC-CCCEEEESCCCEEECCC
T ss_pred             HHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecccccccccccccccccccCCCcEEEeec
Confidence            7542  234699999999999999999999985   59999999999999                   67889999999


Q ss_pred             cccccCCCCCCcceeeecccCCccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhcc
Q 039626          487 AMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTK  566 (628)
Q Consensus       487 gla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~  566 (628)
                      |+++.....      .....||+.|+|||.+.+..++.++||||||++++||++|+.|+.......   ....+......
T Consensus       187 g~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~---~~~~~~~~~~~  257 (355)
T 2eu9_A          187 GSATFDHEH------HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENRE---HLVMMEKILGP  257 (355)
T ss_dssp             TTCEETTSC------CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCC
T ss_pred             Ccccccccc------ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHcCC
Confidence            999865432      223579999999999999999999999999999999999999987543321   11111111110


Q ss_pred             ccchhhhcc------c--------------------cCC-cCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          567 EDGEESLRH------F--------------------IDP-TLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       567 ~~~~~~l~~------~--------------------~d~-~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      . ....+..      +                    ..+ .............+.+|+.+||+.||++|||+.|+++
T Consensus       258 ~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~  333 (355)
T 2eu9_A          258 I-PSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALL  333 (355)
T ss_dssp             C-CHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             C-cHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence            0 0000000      0                    000 0000112345667899999999999999999999874

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=1.2e-33  Score=316.69  Aligned_cols=266  Identities=23%  Similarity=0.276  Sum_probs=192.9

Q ss_pred             cCCCcCCccc----eEEEEEEE--CCceEEEEEecc--------chHHHHHHHhhcCCCceeeeeeeeec------CCeE
Q 039626          351 DNFSFTCRIQ----GSVYRGKI--NGGFAAIKKVNG--------DVSKEIALLNKINHSNLIILSGVCFN------EGNC  410 (628)
Q Consensus       351 ~~f~~~~~i~----G~Vy~g~~--~g~~vavK~~~~--------~~~~E~~~l~~l~H~nIv~l~g~~~~------~~~~  410 (628)
                      ++|.....+|    |.||++..  +|+.||||+++.        .+.+|++++++++||||+++++++..      ++..
T Consensus        14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~   93 (676)
T 3qa8_A           14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP   93 (676)
T ss_dssp             ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred             CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence            4455555554    89999987  688999998764        36679999999999999999999865      6678


Q ss_pred             EEEEEecCCCChHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCc---EEEcccc
Q 039626          411 YLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLR---AKIANFA  487 (628)
Q Consensus       411 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~---~kl~Dfg  487 (628)
                      ++||||+++|+|.+++.... ....+++..+..++.+++.||+|||+.   +++||||||+||+++.++.   +||+|||
T Consensus        94 ~LVmEy~~ggsL~~~L~~~~-~~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~DFG  169 (676)
T 3qa8_A           94 LLAMEYCEGGDLRKYLNQFE-NCCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLG  169 (676)
T ss_dssp             CCEEECCSSCBHHHHHHSSS-CTTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred             EEEEEeCCCCCHHHHHHhcc-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEcccc
Confidence            99999999999999996532 234589999999999999999999995   4999999999999997665   9999999


Q ss_pred             ccccCCCCCCcceeeecccCCccccCccccccCCCCcccccHHHHHHHHHHHhCCCcccccccccc---ccHHHHHHHHh
Q 039626          488 MARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENN---MHLSDVLNAVL  564 (628)
Q Consensus       488 la~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~---~~~~~~~~~~~  564 (628)
                      +++......    ......||+.|+|||.+.+..++.++||||||+++|||++|+.||........   ...........
T Consensus       170 ~a~~~~~~~----~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~  245 (676)
T 3qa8_A          170 YAKELDQGE----LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIV  245 (676)
T ss_dssp             CCCBTTSCC----CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CC
T ss_pred             ccccccccc----ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhh
Confidence            998765432    12345799999999999999999999999999999999999999864321100   00000000000


Q ss_pred             ccccchhhhccccCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHH-----HHHHHHHhHhh
Q 039626          565 TKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYE-----IEHSLSNILNA  624 (628)
Q Consensus       565 ~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~e-----v~~~L~~l~~~  624 (628)
                      ..........-.-........+...+..+.+++.+||+.||++|||+.|     ..+.++.+++.
T Consensus       246 ~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~~  310 (676)
T 3qa8_A          246 VYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILSL  310 (676)
T ss_dssp             SCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHCC
T ss_pred             hhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHhc
Confidence            0000000000000111123345567788999999999999999999988     56777776643

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=2.9e-33  Score=289.85  Aligned_cols=229  Identities=20%  Similarity=0.334  Sum_probs=166.4

Q ss_pred             eEEEEEEE--CCceEEEEEeccc---------hHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhc
Q 039626          361 GSVYRGKI--NGGFAAIKKVNGD---------VSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSN  429 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~~---------~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~  429 (628)
                      |.||++..  +|+.||||++...         +.++..+++.++|+||+++++++.+++..++||||+ ++.+..+... 
T Consensus        39 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~~~~l~~~-  116 (318)
T 2dyl_A           39 GQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-GTCAEKLKKR-  116 (318)
T ss_dssp             -CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCC-SEEHHHHHHH-
T ss_pred             eeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEecc-CCcHHHHHHH-
Confidence            89999998  5889999998642         234455788889999999999999999999999999 5555555432 


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCCc
Q 039626          430 KNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTK  509 (628)
Q Consensus       430 ~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~  509 (628)
                        ....+++..+..++.+++.||.|||+.  .+++||||||+||+++.++.+||+|||+++......    ......||+
T Consensus       117 --~~~~~~~~~~~~~~~~i~~~l~~lH~~--~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~  188 (318)
T 2dyl_A          117 --MQGPIPERILGKMTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK----AKDRSAGCA  188 (318)
T ss_dssp             --HTSCCCHHHHHHHHHHHHHHHHHHHHH--HCCCCCCCCGGGEEECTTSCEEECCCTTC------------------CC
T ss_pred             --hccCCCHHHHHHHHHHHHHHHHHHHhh--CCEEeCCCCHHHEEECCCCCEEEEECCCchhccCCc----cccccCCCc
Confidence              134589999999999999999999983  149999999999999999999999999997664322    123357999


Q ss_pred             cccCccccc-----cCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCC
Q 039626          510 GYMAPEYLE-----NGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGN  584 (628)
Q Consensus       510 ~Y~APE~l~-----~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~  584 (628)
                      .|+|||.+.     ...++.++||||||++++||++|+.|+.....     ..+.........          .+.+.. 
T Consensus       189 ~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-----~~~~~~~~~~~~----------~~~~~~-  252 (318)
T 2dyl_A          189 AYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKT-----DFEVLTKVLQEE----------PPLLPG-  252 (318)
T ss_dssp             TTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCS-----HHHHHHHHHHSC----------CCCCCS-
T ss_pred             cccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCc-----cHHHHHHHhccC----------CCCCCc-
Confidence            999999984     56788999999999999999999999863221     112222222111          011110 


Q ss_pred             CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          585 YPLELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       585 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                       ....+..+.+++.+||+.||.+||+++|+++
T Consensus       253 -~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (318)
T 2dyl_A          253 -HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE  283 (318)
T ss_dssp             -SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             -cCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence             0122345789999999999999999999976

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=6.5e-33  Score=317.37  Aligned_cols=228  Identities=21%  Similarity=0.290  Sum_probs=179.5

Q ss_pred             cCCCcCCccc----eEEEEEEE---CCceEEEEEecc--------chHHHHHHHhhcCCCceeeeeeeeecCCe-----E
Q 039626          351 DNFSFTCRIQ----GSVYRGKI---NGGFAAIKKVNG--------DVSKEIALLNKINHSNLIILSGVCFNEGN-----C  410 (628)
Q Consensus       351 ~~f~~~~~i~----G~Vy~g~~---~g~~vavK~~~~--------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~-----~  410 (628)
                      ++|.....+|    |.||++..   +|+.||||++..        .+.+|++++++++||||+++++++...+.     .
T Consensus        80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~  159 (681)
T 2pzi_A           80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVG  159 (681)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred             CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCcee
Confidence            3455444443    89999997   478999998853        35689999999999999999999987655     7


Q ss_pred             EEEEEecCCCChHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccc
Q 039626          411 YLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMAR  490 (628)
Q Consensus       411 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~  490 (628)
                      ||||||+++++|.+++..      .++|.+++.++.||+.||.|||+.   +|+||||||+|||++.+ .+||+|||+++
T Consensus       160 ~lv~E~~~g~~L~~~~~~------~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG~a~  229 (681)
T 2pzi_A          160 YIVMEYVGGQSLKRSKGQ------KLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAVS  229 (681)
T ss_dssp             EEEEECCCCEECC----C------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCTTCE
T ss_pred             EEEEEeCCCCcHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEecccch
Confidence            999999999999987732      599999999999999999999995   49999999999999986 89999999998


Q ss_pred             cCCCCCCcceeeecccCCccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccch
Q 039626          491 PAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGE  570 (628)
Q Consensus       491 ~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  570 (628)
                      .....       ....||++|+|||++.+.. +.++|||||||+++||++|..|+........                 
T Consensus       230 ~~~~~-------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~-----------------  284 (681)
T 2pzi_A          230 RINSF-------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDGL-----------------  284 (681)
T ss_dssp             ETTCC-------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSSC-----------------
T ss_pred             hcccC-------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccccc-----------------
Confidence            76432       2357999999999987654 8999999999999999999877653211100                 


Q ss_pred             hhhccccCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHHHhHh
Q 039626          571 ESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRP-TMYEIEHSLSNILN  623 (628)
Q Consensus       571 ~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-s~~ev~~~L~~l~~  623 (628)
                                ............+.+++.+||+.||.+|| +++++.+.|.+++.
T Consensus       285 ----------~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~  328 (681)
T 2pzi_A          285 ----------PEDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLR  328 (681)
T ss_dssp             ----------CTTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHH
T ss_pred             ----------cccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHHH
Confidence                      00000112335678999999999999999 57777777776653

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=99.98  E-value=3.5e-32  Score=278.26  Aligned_cols=211  Identities=11%  Similarity=0.068  Sum_probs=163.8

Q ss_pred             eEEEEEEE--CCceEEEEEecc----------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhh
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG----------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFS  428 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  428 (628)
                      |.||+|..  .|+.||||.+..          .+.+|+.++.+++|+||+++++++.+++..|+||||+++++|.+++..
T Consensus        45 g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~  124 (286)
T 3uqc_A           45 LQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVADT  124 (286)
T ss_dssp             CEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCCEEEHHHHHTT
T ss_pred             eEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEEEecCCCCHHHHHhc
Confidence            89999998  488999999863          367899999999999999999999999999999999999999999832


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCC
Q 039626          429 NKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGT  508 (628)
Q Consensus       429 ~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt  508 (628)
                           . ....+..+|+.|++.||+|||+.   +|+||||||+|||++.++.+||+++|                     
T Consensus       125 -----~-~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~~---------------------  174 (286)
T 3uqc_A          125 -----S-PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPA---------------------  174 (286)
T ss_dssp             -----C-CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSCC---------------------
T ss_pred             -----C-CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEecc---------------------
Confidence                 1 34557888999999999999995   49999999999999999999998543                     


Q ss_pred             ccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCHH
Q 039626          509 KGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLE  588 (628)
Q Consensus       509 ~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~  588 (628)
                        |++|       ++.++||||||+++|||++|+.||............            ...+.....+  ......+
T Consensus       175 --~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~------------~~~~~~~~~~--~~~~~~~  231 (286)
T 3uqc_A          175 --TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPA------------ERDTAGQPIE--PADIDRD  231 (286)
T ss_dssp             --CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEEC------------CBCTTSCBCC--HHHHCTT
T ss_pred             --ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHH------------HHHhccCCCC--hhhcccC
Confidence              3333       588999999999999999999998754332110000            0000000000  0001112


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhc
Q 039626          589 LALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNAS  625 (628)
Q Consensus       589 ~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~~~~  625 (628)
                      .+..+.+++.+||+.||++| |+.|+++.|+++....
T Consensus       232 ~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~  267 (286)
T 3uqc_A          232 IPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVA  267 (286)
T ss_dssp             SCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC--
T ss_pred             CCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccC
Confidence            34568899999999999999 9999999999987543

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=99.97  E-value=2.1e-31  Score=274.01  Aligned_cols=209  Identities=20%  Similarity=0.259  Sum_probs=164.0

Q ss_pred             eEEEEEEE--CCceEEEEEecc--chHHHHHHH-hhcCCCceeeeeeeeec----CCeEEEEEEecCCCChHHHhhhcCC
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG--DVSKEIALL-NKINHSNLIILSGVCFN----EGNCYLVYEYAVNGTLSDWVFSNKN  431 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~--~~~~E~~~l-~~l~H~nIv~l~g~~~~----~~~~~lV~E~~~~gsL~~~l~~~~~  431 (628)
                      |.||++..  +++.||+|+++.  .+.+|+.++ +.++|+||+++++++..    +...++||||+++|+|.+++...  
T Consensus        32 g~V~~~~~~~~~~~vaiK~~~~~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--  109 (299)
T 3m2w_A           32 GKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDR--  109 (299)
T ss_dssp             EEEEEEEETTTCCEEEEEEEECSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEECCCCSCBHHHHHHHC--
T ss_pred             eEEEEEEEcCCCcEEEEEEecccHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEeecCCCcHHHHHHhc--
Confidence            89999988  688999999865  577899988 56699999999999986    66789999999999999999653  


Q ss_pred             CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCC---CCcEEEccccccccCCCCCCcceeeecccCC
Q 039626          432 EGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDS---DLRAKIANFAMARPAEGQEGEFALTRHIVGT  508 (628)
Q Consensus       432 ~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~---~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt  508 (628)
                      ....+++..+..++.|++.||+|||+.   +++||||||+|||++.   ++.+||+|||++....               
T Consensus       110 ~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~---------------  171 (299)
T 3m2w_A          110 GDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT---------------  171 (299)
T ss_dssp             TTCCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECT---------------
T ss_pred             cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEeccccccccc---------------
Confidence            234699999999999999999999995   4999999999999998   7899999999986542               


Q ss_pred             ccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCC--
Q 039626          509 KGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYP--  586 (628)
Q Consensus       509 ~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~--  586 (628)
                                +..++.++||||||+++|||++|+.||........          ..     ..........  ...+  
T Consensus       172 ----------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~----------~~-----~~~~~~~~~~--~~~~~~  224 (299)
T 3m2w_A          172 ----------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI----------SP-----GMKTRIRMGQ--YEFPNP  224 (299)
T ss_dssp             ----------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-----------------C-----CSCCSSCTTC--CSSCHH
T ss_pred             ----------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhh----------hH-----HHHHHHhhcc--ccCCch
Confidence                      13467899999999999999999999864322110          00     0000000000  0111  


Q ss_pred             --HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          587 --LELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       587 --~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                        ...+..+.+++.+||+.||.+|||+.|+++
T Consensus       225 ~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~  256 (299)
T 3m2w_A          225 EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  256 (299)
T ss_dssp             HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence              123456889999999999999999999986

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=99.97  E-value=4.5e-32  Score=292.09  Aligned_cols=228  Identities=16%  Similarity=0.170  Sum_probs=167.3

Q ss_pred             CCCcCCccc----eEEEEEEE--CCceEEEEEecc----------chHHHHHHHhhcCC-Ccee---------------e
Q 039626          352 NFSFTCRIQ----GSVYRGKI--NGGFAAIKKVNG----------DVSKEIALLNKINH-SNLI---------------I  399 (628)
Q Consensus       352 ~f~~~~~i~----G~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H-~nIv---------------~  399 (628)
                      .|.....+|    |.||+|+.  +|+.||||+++.          .+.+|+.+++.++| +|..               .
T Consensus        79 ~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  158 (413)
T 3dzo_A           79 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVK  158 (413)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEE
T ss_pred             eEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcc
Confidence            344444454    89999998  589999999872          36789999999987 2211               1


Q ss_pred             e------eeeeec-----CCeEEEEEEecCCCChHHHhhhc---CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEe
Q 039626          400 L------SGVCFN-----EGNCYLVYEYAVNGTLSDWVFSN---KNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVH  465 (628)
Q Consensus       400 l------~g~~~~-----~~~~~lV~E~~~~gsL~~~l~~~---~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH  465 (628)
                      +      ..++..     ....+++|+++ +++|.+++...   ......++|..++.++.|++.||+|||+.   +|+|
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~iiH  234 (413)
T 3dzo_A          159 DPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLVH  234 (413)
T ss_dssp             CCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEC
T ss_pred             cCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---Cccc
Confidence            1      111111     12356777765 78999888421   23455689999999999999999999995   4999


Q ss_pred             cCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCCccccCcccc----------ccCCCCcccccHHHHHHH
Q 039626          466 KDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYL----------ENGLVSTKLDVYAFGVLI  535 (628)
Q Consensus       466 ~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~Y~APE~l----------~~~~~s~k~DV~SfGvvl  535 (628)
                      |||||+|||++.++.+||+|||+++.....      .....| +.|+|||.+          ....++.++|||||||++
T Consensus       235 rDiKp~NILl~~~~~~kL~DFG~a~~~~~~------~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil  307 (413)
T 3dzo_A          235 TYLRPVDIVLDQRGGVFLTGFEHLVRDGAS------AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAI  307 (413)
T ss_dssp             SCCCGGGEEECTTCCEEECCGGGCEETTEE------ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHH
T ss_pred             CCcccceEEEecCCeEEEEeccceeecCCc------cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHH
Confidence            999999999999999999999998865422      334567 999999999          555688999999999999


Q ss_pred             HHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 039626          536 LEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIE  615 (628)
Q Consensus       536 ~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~  615 (628)
                      |||++|+.||........                   ....+..  ....+    ..+.+|+.+||+.||++||++.|++
T Consensus       308 ~elltg~~Pf~~~~~~~~-------------------~~~~~~~--~~~~~----~~~~~li~~~l~~dP~~Rpt~~~~l  362 (413)
T 3dzo_A          308 YWIWCADLPNTDDAALGG-------------------SEWIFRS--CKNIP----QPVRALLEGFLRYPKEDRLLPLQAM  362 (413)
T ss_dssp             HHHHHSSCCCCTTGGGSC-------------------SGGGGSS--CCCCC----HHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred             HHHHHCCCCCCCcchhhh-------------------HHHHHhh--cccCC----HHHHHHHHHHccCChhhCcCHHHHH
Confidence            999999999864332111                   0111110  01223    5588999999999999999987774

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=99.97  E-value=3.9e-32  Score=284.24  Aligned_cols=220  Identities=15%  Similarity=0.170  Sum_probs=166.0

Q ss_pred             eEEEEEEECCceEEEEEecc---------------chHHHHHHHhhcC---------CCceeeeeeee------------
Q 039626          361 GSVYRGKINGGFAAIKKVNG---------------DVSKEIALLNKIN---------HSNLIILSGVC------------  404 (628)
Q Consensus       361 G~Vy~g~~~g~~vavK~~~~---------------~~~~E~~~l~~l~---------H~nIv~l~g~~------------  404 (628)
                      |.||+|+.+|+.||||+++.               .+.+|+++|++++         |+|||++.+++            
T Consensus        34 g~V~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~~~~~~~~~~hp~iv~  113 (336)
T 2vuw_A           34 GEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLK  113 (336)
T ss_dssp             EEEEEEEETTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEEEEEEEESSCCHHHHH
T ss_pred             eEEEEEEeCCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhcceeEecCCCcHHHHH
Confidence            89999999999999999863               3678999999886         66666666553            


Q ss_pred             -----ec-------------CCeEEEEEEecCCCChHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHh-cCCCCCeEe
Q 039626          405 -----FN-------------EGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLH-SFTNPPHVH  465 (628)
Q Consensus       405 -----~~-------------~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH-~~~~~~iiH  465 (628)
                           .+             ++..++||||+++|++.+.+..     ..+++..+..++.||+.||+||| +.   +|+|
T Consensus       114 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-----~~~~~~~~~~i~~qi~~aL~~lH~~~---~ivH  185 (336)
T 2vuw_A          114 AWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-----KLSSLATAKSILHQLTASLAVAEASL---RFEH  185 (336)
T ss_dssp             HHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-----TCCCHHHHHHHHHHHHHHHHHHHHHH---CCBC
T ss_pred             HHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHhC---CEeE
Confidence                 32             6789999999999977666622     45899999999999999999999 74   4999


Q ss_pred             cCCCCCCEEeCCCC--------------------cEEEccccccccCCCCCCcceeeecccCCccccCccccccCCCCcc
Q 039626          466 KDINSSNVLLDSDL--------------------RAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTK  525 (628)
Q Consensus       466 ~dik~~NILl~~~~--------------------~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~k  525 (628)
                      |||||+|||++.++                    .+||+|||+++.....        ...||+.|+|||.+.+.. +.+
T Consensus       186 rDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~--------~~~gt~~y~aPE~~~g~~-~~~  256 (336)
T 2vuw_A          186 RDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG--------IVVFCDVSMDEDLFTGDG-DYQ  256 (336)
T ss_dssp             SCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT--------EEECCCCTTCSGGGCCCS-SHH
T ss_pred             CCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC--------cEEEeecccChhhhcCCC-ccc
Confidence            99999999999887                    9999999999866421        247999999999998766 999


Q ss_pred             cccHHHHHH-HHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCHHHHHHHHHHHHHhcccC
Q 039626          526 LDVYAFGVL-ILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKD  604 (628)
Q Consensus       526 ~DV~SfGvv-l~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~d  604 (628)
                      +||||+|++ ..++++|..|+...     .+............        ..........+...+..+.+|+.+||+.|
T Consensus       257 ~Diwsl~~~~~~~~~~g~~p~~~~-----~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~s~~~~dli~~~L~~d  323 (336)
T 2vuw_A          257 FDIYRLMKKENNNRWGEYHPYSNV-----LWLHYLTDKMLKQM--------TFKTKCNTPAMKQIKRKIQEFHRTMLNFS  323 (336)
T ss_dssp             HHHHHHHHHHHTTCTTSCCTHHHH-----HHHHHHHHHHHHTC--------CCSSCCCSHHHHHHHHHHHHHHHHGGGSS
T ss_pred             eehhhhhCCCCcccccccCCCcch-----hhhhHHHHhhhhhh--------ccCcccchhhhhhcCHHHHHHHHHHhccC
Confidence            999998777 77788898887421     00011111111100        00011111123457788999999999977


Q ss_pred             CCCCCCHHHHH
Q 039626          605 PTDRPTMYEIE  615 (628)
Q Consensus       605 P~~RPs~~ev~  615 (628)
                           |++|++
T Consensus       324 -----sa~e~l  329 (336)
T 2vuw_A          324 -----SATDLL  329 (336)
T ss_dssp             -----SHHHHH
T ss_pred             -----CHHHHH
Confidence                 888876

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.94  E-value=9.1e-28  Score=267.99  Aligned_cols=162  Identities=17%  Similarity=0.095  Sum_probs=122.3

Q ss_pred             CCceEEEEEecc-----------------chHHHHHHHhhc-CCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhcC
Q 039626          369 NGGFAAIKKVNG-----------------DVSKEIALLNKI-NHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNK  430 (628)
Q Consensus       369 ~g~~vavK~~~~-----------------~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~  430 (628)
                      .|+.+|+|.+..                 ++.+|+++|+++ +|+||+++++++.+++..||||||++||+|.++|..  
T Consensus       258 fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVMEyv~G~~L~d~i~~--  335 (569)
T 4azs_A          258 FGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVMEKLPGRLLSDMLAA--  335 (569)
T ss_dssp             ECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEEECCCSEEHHHHHHT--
T ss_pred             ccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEEecCCCCcHHHHHHh--
Confidence            688999998853                 377899999999 799999999999999999999999999999999953  


Q ss_pred             CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCCcc
Q 039626          431 NEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKG  510 (628)
Q Consensus       431 ~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~  510 (628)
                        +..++..   +|+.||+.||+|+|+.+   ||||||||+|||+++++++||+|||+|+......   .......||++
T Consensus       336 --~~~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~---~~~~t~vGTp~  404 (569)
T 4azs_A          336 --GEEIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDC---SWPTNLVQSFF  404 (569)
T ss_dssp             --TCCCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC------CCSHHHHHHHH
T ss_pred             --CCCCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCCCCC---ccccCceechh
Confidence              3346653   58899999999999954   9999999999999999999999999998765332   12345689999


Q ss_pred             ccCccccccCCCCcccccHHHHHHHHHHHhCCCc
Q 039626          511 YMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEA  544 (628)
Q Consensus       511 Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p  544 (628)
                      |||||.+.+ .+..++|+|++|++++++.++..+
T Consensus       405 YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~  437 (569)
T 4azs_A          405 VFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN  437 (569)
T ss_dssp             HHHHHHC------------------CCCCTTHHH
T ss_pred             hccHHHhCC-CCCCcccccccccchhhhccccch
Confidence            999999876 467789999999998887766543

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.88  E-value=8.5e-24  Score=234.60  Aligned_cols=168  Identities=14%  Similarity=0.147  Sum_probs=141.4

Q ss_pred             eEEEEEEECCceEEEEEecc---------------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHH
Q 039626          361 GSVYRGKINGGFAAIKKVNG---------------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDW  425 (628)
Q Consensus       361 G~Vy~g~~~g~~vavK~~~~---------------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~  425 (628)
                      |.||++.+.+..+++|+...               .+.+|+++|++++|+||+++..++...++.+|||||+++|+|.++
T Consensus       350 g~Vy~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE~~~ggsL~~~  429 (540)
T 3en9_A          350 ADIKRDSYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMSYINGKLAKDV  429 (540)
T ss_dssp             EEEEEEECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEECCCSEEHHHH
T ss_pred             EEEEEEEECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEECCCCCCHHHH
Confidence            89999998999999998632               257899999999999999777777777788999999999999999


Q ss_pred             hhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcc----ee
Q 039626          426 VFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEF----AL  501 (628)
Q Consensus       426 l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~----~~  501 (628)
                      +..            +..++.|+++||+|||+.   +|+||||||+|||+++  ++||+|||+++.........    ..
T Consensus       430 l~~------------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~~~~~~~  492 (540)
T 3en9_A          430 IED------------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKAVDLIVF  492 (540)
T ss_dssp             STT------------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHHHHHHHH
T ss_pred             HHH------------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECccCEECCCccccccchhhh
Confidence            843            557999999999999995   4999999999999999  99999999999875422110    01


Q ss_pred             eecccCCccccCcccccc--CCCCcccccHHHHHHHHHHHhCCCcc
Q 039626          502 TRHIVGTKGYMAPEYLEN--GLVSTKLDVYAFGVLILEMLTGKEAA  545 (628)
Q Consensus       502 ~~~~~gt~~Y~APE~l~~--~~~s~k~DV~SfGvvl~ELltG~~p~  545 (628)
                      .+...||+.|||||++..  ..|+.+.|+|+..+-.++-+.++.++
T Consensus       493 ~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          493 KKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             HHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             hhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence            235689999999999987  56888999999999999988877544

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.77  E-value=1.5e-19  Score=183.91  Aligned_cols=139  Identities=16%  Similarity=0.069  Sum_probs=108.1

Q ss_pred             HHHHHhcCCCcCCccc----eEEEEEEE-CCceEEEEEecc-------------------------chHHHHHHHhhcCC
Q 039626          345 ELQSATDNFSFTCRIQ----GSVYRGKI-NGGFAAIKKVNG-------------------------DVSKEIALLNKINH  394 (628)
Q Consensus       345 el~~at~~f~~~~~i~----G~Vy~g~~-~g~~vavK~~~~-------------------------~~~~E~~~l~~l~H  394 (628)
                      .+......|.....+|    |.||+|.. +|+.+|+|.++.                         .+.+|+.+|++++ 
T Consensus        84 ~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~-  162 (282)
T 1zar_A           84 RLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ-  162 (282)
T ss_dssp             HHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT-
T ss_pred             HHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc-
Confidence            3333344444444554    89999999 688999999852                         2568999999999 


Q ss_pred             CceeeeeeeeecCCeEEEEEEecCCCChHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEE
Q 039626          395 SNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVL  474 (628)
Q Consensus       395 ~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NIL  474 (628)
                       | +++.+++. .+..++||||+++|+|.+ +..          .....++.|++.||.|||+.   +|+||||||+|||
T Consensus       163 -~-~~v~~~~~-~~~~~lvmE~~~g~~L~~-l~~----------~~~~~i~~qi~~~l~~lH~~---giiHrDlkp~NIL  225 (282)
T 1zar_A          163 -G-LAVPKVYA-WEGNAVLMELIDAKELYR-VRV----------ENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVL  225 (282)
T ss_dssp             -T-SSSCCEEE-EETTEEEEECCCCEEGGG-CCC----------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEE
T ss_pred             -C-CCcCeEEe-ccceEEEEEecCCCcHHH-cch----------hhHHHHHHHHHHHHHHHHHC---CCEeCCCCHHHEE
Confidence             5 66777554 355699999999999988 411          12346999999999999985   4999999999999


Q ss_pred             eCCCCcEEEccccccccCCCCCCcceeeecccCCccccCccccc
Q 039626          475 LDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLE  518 (628)
Q Consensus       475 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~  518 (628)
                      ++ ++.+||+|||+++..                ..|+|||++.
T Consensus       226 l~-~~~vkl~DFG~a~~~----------------~~~~a~e~l~  252 (282)
T 1zar_A          226 VS-EEGIWIIDFPQSVEV----------------GEEGWREILE  252 (282)
T ss_dssp             EE-TTEEEECCCTTCEET----------------TSTTHHHHHH
T ss_pred             EE-CCcEEEEECCCCeEC----------------CCCCHHHHHH
Confidence            99 999999999998743                3468899875

>4eby_A Chitin elicitor receptor kinase 1; pathogen-associated molecular patterns, pattern recognition receptors, LYSM, lysine chitin oligomer; HET: NAG BMA; 1.65A {Arabidopsis thaliana} PDB: 4ebz_A*

Probab=99.75  E-value=2e-18  Score=165.85  Aligned_cols=109  Identities=22%  Similarity=0.359  Sum_probs=91.4

Q ss_pred             eeEEEecCChHHHHHhhhcCCCc-----cHHHHHhcc-CCC--CccCCCcEEEEeecCCCCCCCCCCCCCCeEEEEEccC
Q 039626          120 TTYTIQNGDTYLFIANNTFQGLS-----TCQALEDQN-GSP--TNLIIGAGVTVPLRCACPTENQTDEGFPFLLSYLVAE  191 (628)
Q Consensus       120 ~~y~V~~gdt~~~IA~~~~~~l~-----t~~~l~~~N-~~~--~~l~~Gq~l~vp~~~~c~~~~~~~~~~~~~~~y~v~~  191 (628)
                      .+|+|++|||||.||++|+...+     +.++|+++| .+.  +.|.+||.|.||..|.|....    ......+|+|++
T Consensus        10 ~~Y~V~~GDTL~~IA~~~~vsv~~~~~~~~~~I~~~Np~l~~~~~l~~Gq~L~IP~~~~~~~~~----~~~~~~~Y~V~~   85 (212)
T 4eby_A           10 ASYYLENGTTLSVINQNLNSSIAPYDQINFDPILRYNSNIKDKDRIQMGSRVLVPFPCECQPGD----FLGHNFSYSVRQ   85 (212)
T ss_dssp             EEEECCTTCCHHHHHHHTCCSSSCCCSSCCHHHHTTCTTCSCTTSCCTTCEEEEEECCEEETTT----EEEEEEEEECCT
T ss_pred             EEEEeCCCCCHHHHHHHHCCCchhccccCHHHHHHhccCCCCcCccCCCCEEEEeccccccCCc----cccCceEEEecC
Confidence            47999999999999998876331     128999999 663  789999999999999986421    122357899999


Q ss_pred             CCcHHHHH-HHhC--CChHHHhhhcCCCCCCccccceeeccCCC
Q 039626          192 GDTVSGIS-SRFG--VDTGEILQANSLSGSNIFPFTTLLIPLEN  232 (628)
Q Consensus       192 gdtl~~ia-~~f~--~~~~~l~~~N~~~~~~~~~~~~l~iP~~~  232 (628)
                      |||||.|| ++|+  +++++|+++|++..+.|++||+|.||...
T Consensus        86 GDTL~~IA~~~y~~lvt~~~L~~~N~~~~~~l~~Gq~L~IP~~~  129 (212)
T 4eby_A           86 EDTYERVAISNYANLTTMESLQARNPFPATNIPLSATLNVLVNC  129 (212)
T ss_dssp             TCCHHHHHHTTTTTSSCHHHHHHHCCSCTTCCCTTCEEEEEEEC
T ss_pred             CCcHHHHHHHhcCCCCCHHHHHHhcCCCcccCCCCCEEEEcCCC
Confidence            99999999 7999  99999999999766699999999999853

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.59  E-value=1.9e-15  Score=151.54  Aligned_cols=116  Identities=18%  Similarity=0.114  Sum_probs=91.6

Q ss_pred             eEEEEEEE--CCce--EEEEEecc-------------------------------chHHHHHHHhhcCCCce--eeeeee
Q 039626          361 GSVYRGKI--NGGF--AAIKKVNG-------------------------------DVSKEIALLNKINHSNL--IILSGV  403 (628)
Q Consensus       361 G~Vy~g~~--~g~~--vavK~~~~-------------------------------~~~~E~~~l~~l~H~nI--v~l~g~  403 (628)
                      |.||+|..  +|+.  ||||..+.                               .+.+|+.+|.+++|+++  ..++++
T Consensus        61 g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~  140 (258)
T 1zth_A           61 ANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAKEAGVSVPQPYTY  140 (258)
T ss_dssp             EEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHHHTTCCCCCEEEE
T ss_pred             EEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHHhCCCCCCeEEEc
Confidence            89999998  7888  99997532                               35679999999988764  334432


Q ss_pred             eecCCeEEEEEEecCC-C----ChHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHh-cCCCCCeEecCCCCCCEEeCC
Q 039626          404 CFNEGNCYLVYEYAVN-G----TLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLH-SFTNPPHVHKDINSSNVLLDS  477 (628)
Q Consensus       404 ~~~~~~~~lV~E~~~~-g----sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH-~~~~~~iiH~dik~~NILl~~  477 (628)
                          +..+|||||+.+ |    +|.++...       .++.....++.|++.||.||| +.   +|+||||||+|||+++
T Consensus       141 ----~~~~lVmE~~g~~g~~~~~L~~~~~~-------~~~~~~~~i~~qi~~~l~~lH~~~---givHrDlkp~NILl~~  206 (258)
T 1zth_A          141 ----MKNVLLMEFIGEDELPAPTLVELGRE-------LKELDVEGIFNDVVENVKRLYQEA---ELVHADLSEYNIMYID  206 (258)
T ss_dssp             ----ETTEEEEECCEETTEECCBHHHHGGG-------GGGSCHHHHHHHHHHHHHHHHHTS---CEECSSCSTTSEEESS
T ss_pred             ----CCCEEEEEecCCCCCccccHHHHhhc-------cChHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEEcC
Confidence                356899999942 4    67666522       224456789999999999999 74   5999999999999998


Q ss_pred             CCcEEEccccccccC
Q 039626          478 DLRAKIANFAMARPA  492 (628)
Q Consensus       478 ~~~~kl~Dfgla~~~  492 (628)
                        .++|+|||++...
T Consensus       207 --~~~liDFG~a~~~  219 (258)
T 1zth_A          207 --KVYFIDMGQAVTL  219 (258)
T ss_dssp             --SEEECCCTTCEET
T ss_pred             --cEEEEECcccccC
Confidence              9999999999755

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.30  E-value=8.3e-13  Score=138.38  Aligned_cols=124  Identities=15%  Similarity=0.127  Sum_probs=88.8

Q ss_pred             CCcCCccc----eEEEEEEE-CCceEEEEEeccc-----------------------------hHHHHHHHhhcCCCcee
Q 039626          353 FSFTCRIQ----GSVYRGKI-NGGFAAIKKVNGD-----------------------------VSKEIALLNKINHSNLI  398 (628)
Q Consensus       353 f~~~~~i~----G~Vy~g~~-~g~~vavK~~~~~-----------------------------~~~E~~~l~~l~H~nIv  398 (628)
                      +.....||    |.||+|.. +|+.||||..+..                             ..+|...|.++++.++.
T Consensus        97 Y~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~  176 (397)
T 4gyi_A           97 YSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFP  176 (397)
T ss_dssp             SEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred             EEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCC
Confidence            45555554    78999997 7889999976420                             12466666666554432


Q ss_pred             --eeeeeeecCCeEEEEEEecCCCChHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeC
Q 039626          399 --ILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLD  476 (628)
Q Consensus       399 --~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~  476 (628)
                        ..+++    ...+|||||++|++|.++..        .  .....++.|++.+|.|||+.+   +|||||||.|||++
T Consensus       177 vp~p~~~----~~~~LVME~i~G~~L~~l~~--------~--~~~~~l~~qll~~l~~lH~~g---IVHrDLKp~NILl~  239 (397)
T 4gyi_A          177 VPEPIAQ----SRHTIVMSLVDALPMRQVSS--------V--PDPASLYADLIALILRLAKHG---LIHGDFNEFNILIR  239 (397)
T ss_dssp             CCCEEEE----ETTEEEEECCSCEEGGGCCC--------C--SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEE
T ss_pred             CCeeeec----cCceEEEEecCCccHhhhcc--------c--HHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEe
Confidence              22222    12379999999988876541        1  123467899999999999954   99999999999998


Q ss_pred             CCC----------cEEEccccccccCC
Q 039626          477 SDL----------RAKIANFAMARPAE  493 (628)
Q Consensus       477 ~~~----------~~kl~Dfgla~~~~  493 (628)
                      +++          .+.|+||+-+....
T Consensus       240 ~dgd~~d~~~~~~~~~iID~~Q~V~~~  266 (397)
T 4gyi_A          240 EEKDAEDPSSITLTPIIIXFPQMVSMD  266 (397)
T ss_dssp             EEECSSCTTSEEEEEEECCCTTCEETT
T ss_pred             CCCCcccccccccceEEEEeCCcccCC
Confidence            877          38999999876543

>2l9y_A CVNH-LYSM lectin; carbohydrate, sugar binding protein; NMR {Magnaporthe oryzae 70-15}

Probab=99.29  E-value=3.3e-13  Score=124.49  Aligned_cols=94  Identities=16%  Similarity=0.047  Sum_probs=74.5

Q ss_pred             cceeEEEecCChHHHHHhhhcCCCccHHHHHhccCCC--CccCCCcEEEEeecCCCCCCCCCCCCCCeEEEEEccCCCcH
Q 039626          118 SNTTYTIQNGDTYLFIANNTFQGLSTCQALEDQNGSP--TNLIIGAGVTVPLRCACPTENQTDEGFPFLLSYLVAEGDTV  195 (628)
Q Consensus       118 ~~~~y~V~~gdt~~~IA~~~~~~l~t~~~l~~~N~~~--~~l~~Gq~l~vp~~~~c~~~~~~~~~~~~~~~y~v~~gdtl  195 (628)
                      +..+|+||+|||||.||++|.   +++.+|.++|++.  +.|++||+|.||....-+... ..........|+|+.||+|
T Consensus        61 ~~~~y~V~~GDTL~~IA~~~~---~~~~~l~~~N~~~~~~~i~~Gq~L~ip~~~~~~~~~-~~~~~~~~~~~~v~~GdtL  136 (167)
T 2l9y_A           61 GTATVTVQQGDTLRDIGRRFD---CDFHEIARRNNIQNEDLIYPGQVLQVPTKGGSGGGA-GNFWDSARDVRLVDGGKVL  136 (167)
T ss_dssp             SCEEEEECTTCCHHHHHHHTT---CCHHHHHHHHTCCGGGCCCTTEEEEESCCCCCSSSS-CCGGGGEEEEEEETTTTEE
T ss_pred             CCceEEECCCCcHHHHHHHcC---CCHHHHHHHcCCCCcccccCCCEEEEcCCCCccccc-cccccccceEEEeCCcCCh
Confidence            346799999999999999874   5899999999887  799999999999754321100 1111123467999999999


Q ss_pred             HHHHHHhCCChHHHhhhcCC
Q 039626          196 SGISSRFGVDTGEILQANSL  215 (628)
Q Consensus       196 ~~ia~~f~~~~~~l~~~N~~  215 (628)
                      ++||++||.+++..+++|+.
T Consensus       137 ~aIA~r~G~~v~s~i~Ln~~  156 (167)
T 2l9y_A          137 EAELRYSGGWNRSRIYLDEH  156 (167)
T ss_dssp             EEEEEETTEEEEEEECGGGT
T ss_pred             HHHHHHcCCceEEEEEcccc
Confidence            99999999999988888875

>2djp_A Hypothetical protein SB145; LYSM, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens}

Probab=99.18  E-value=2e-11  Score=97.86  Aligned_cols=61  Identities=33%  Similarity=0.498  Sum_probs=53.3

Q ss_pred             CCcEEEEeecCCCCCCCCCCCCCCeEEEEEccCCCcHHHHHHHhCCChHHHhhhcCCCCC-CccccceeeccCCC
Q 039626          159 IGAGVTVPLRCACPTENQTDEGFPFLLSYLVAEGDTVSGISSRFGVDTGEILQANSLSGS-NIFPFTTLLIPLEN  232 (628)
Q Consensus       159 ~Gq~l~vp~~~~c~~~~~~~~~~~~~~~y~v~~gdtl~~ia~~f~~~~~~l~~~N~~~~~-~~~~~~~l~iP~~~  232 (628)
                      .||.|.+|..             ....+|+|++|||||.||++||+++++|+++|++... .|++||+|.||...
T Consensus         3 ~Gq~l~ip~~-------------~~~~~y~V~~GDTL~~IA~~~~~~~~~l~~~N~l~~~~~l~~Gq~l~iP~~~   64 (77)
T 2djp_A            3 SGSSGCSPVR-------------ERRLEHQLEPGDTLAGLALKYGVTMEQIKRANRLYTNDSIFLKKTLYIPILT   64 (77)
T ss_dssp             CCCCCCCCCC-------------EEEEEECCCTTCCHHHHHHHHTCCHHHHHHHHTCCCSSCGGGSSCEEEEEEC
T ss_pred             CCcEeeccCC-------------CCcEEEEECCCCcHHHHHHHHCcCHHHHHHHcCCCCccccCCCCEEEECCCC
Confidence            5888888742             2467899999999999999999999999999999754 99999999999864

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.11  E-value=3.5e-10  Score=113.01  Aligned_cols=121  Identities=16%  Similarity=0.105  Sum_probs=98.5

Q ss_pred             eEEEEEEECCceEEEEEecc-------chHHHHHHHhhcC-CCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhcCCC
Q 039626          361 GSVYRGKINGGFAAIKKVNG-------DVSKEIALLNKIN-HSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNE  432 (628)
Q Consensus       361 G~Vy~g~~~g~~vavK~~~~-------~~~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~  432 (628)
                      +.||+....++.+++|....       ++.+|+++++.+. |..+.++++++.+.+..|+||||++|.+|.+.+.     
T Consensus        28 ~~v~~~~~~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~~~-----  102 (263)
T 3tm0_A           28 AKVYKLVGENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYE-----  102 (263)
T ss_dssp             SEEEEEECSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHCC-----
T ss_pred             CeEEEEECCCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecCCeehhhccC-----
Confidence            57999988889999999864       5789999999995 6677899999988889999999999999987641     


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhcCC-----------------------------------------------------
Q 039626          433 GKYLDWKQRIQIALDVATGLNYLHSFT-----------------------------------------------------  459 (628)
Q Consensus       433 ~~~l~~~~~~~i~~~ia~gL~yLH~~~-----------------------------------------------------  459 (628)
                          +......++.+++++|..||+..                                                     
T Consensus       103 ----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~  178 (263)
T 3tm0_A          103 ----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEK  178 (263)
T ss_dssp             ----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHHHHHHHHHHCC
T ss_pred             ----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCHHHHHHHHHhcC
Confidence                11223468899999999999821                                                     


Q ss_pred             ---CCCeEecCCCCCCEEeCCCCcEEEccccccc
Q 039626          460 ---NPPHVHKDINSSNVLLDSDLRAKIANFAMAR  490 (628)
Q Consensus       460 ---~~~iiH~dik~~NILl~~~~~~kl~Dfgla~  490 (628)
                         ...++|+|+++.|||++++....|+||+.+.
T Consensus       179 ~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          179 PEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             CCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             CCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence               1348999999999999876667799998764

>1e0g_A Membrane-bound lytic murein transglycosylase D; cell WALL, hydrolase, glycosidase, lipoprotein, outer membrane, multigene family; NMR {Escherichia coli} SCOP: d.7.1.1

Probab=99.01  E-value=2.9e-10  Score=82.03  Aligned_cols=46  Identities=30%  Similarity=0.549  Sum_probs=42.0

Q ss_pred             EEEEccCCCcHHHHHHHhCCChHHHhhhcCCCCCCccccceeeccCC
Q 039626          185 LSYLVAEGDTVSGISSRFGVDTGEILQANSLSGSNIFPFTTLLIPLE  231 (628)
Q Consensus       185 ~~y~v~~gdtl~~ia~~f~~~~~~l~~~N~~~~~~~~~~~~l~iP~~  231 (628)
                      .+|+|++|||||+||++||++.++|.++|+ ....++|||.|.||+.
T Consensus         3 ~~y~V~~GDtl~~Ia~~~~~~~~~l~~~N~-~~~~l~~G~~l~ip~~   48 (48)
T 1e0g_A            3 ITYRVRKGDSLSSIAKRHGVNIKDVMRWNS-DTANLQPGDKLTLFVK   48 (48)
T ss_dssp             CEEEECTTCCHHHHHHHHTCCHHHHHHHCS-CGGGCCTTEEEECCCC
T ss_pred             EEEEEcCCCcHHHHHHHHCcCHHHHHHhCC-CCCcCCcCCEEEEecC
Confidence            379999999999999999999999999999 4449999999999963

>2gu1_A Zinc peptidase; alpha/beta, beta barrel, structural genomics, PSI, protein structure initiative; 1.90A {Vibrio cholerae}

Probab=98.98  E-value=3.8e-10  Score=117.87  Aligned_cols=109  Identities=11%  Similarity=0.045  Sum_probs=80.6

Q ss_pred             eeEEEecCChHHHHHhhhcCCCccHHHHHhccCCC------CccCCCcEEEEeecCCCCC--------CC------CCCC
Q 039626          120 TTYTIQNGDTYLFIANNTFQGLSTCQALEDQNGSP------TNLIIGAGVTVPLRCACPT--------EN------QTDE  179 (628)
Q Consensus       120 ~~y~V~~gdt~~~IA~~~~~~l~t~~~l~~~N~~~------~~l~~Gq~l~vp~~~~c~~--------~~------~~~~  179 (628)
                      .+|+|++||||+.||++++.   +.++|.++|+..      +.|++||+|.||....-.-        ..      ....
T Consensus         8 ~~~~Vk~GDTL~~Ia~r~gv---s~~~l~~~n~~~~~~~~~~~L~~Gq~L~i~~~~~~~l~~l~~~~~~~~~~~~~~~~~   84 (361)
T 2gu1_A            8 IHYMVKVGDTLSGIFAQLGV---PYSILQKILSVDLDHLQLDMIQPGEELELMMDDMGQLSRLIYHMSIVEKAIYTREND   84 (361)
T ss_dssp             EEEECCTTCCHHHHHHHTTC---CHHHHHHHHHHGGGTCCGGGCCTTCEEEEEECTTSCEEEEEEEEETTEEEEEEECTT
T ss_pred             eEEEECCCCcHHHHHHHcCC---CHHHHHHHHhhcccccchhcCCCCCEEEEEECCCCcceEEEEEcCccceEEEEecCC
Confidence            46999999999999998876   666666666542      5899999999997421100        00      0001


Q ss_pred             C-----------CCeEEEEEccCCCcHHHHHHHhCCChHHHhhhcCCCC------CCccccceeeccCC
Q 039626          180 G-----------FPFLLSYLVAEGDTVSGISSRFGVDTGEILQANSLSG------SNIFPFTTLLIPLE  231 (628)
Q Consensus       180 ~-----------~~~~~~y~v~~gdtl~~ia~~f~~~~~~l~~~N~~~~------~~~~~~~~l~iP~~  231 (628)
                      +           .....+|.|+.|||||.||++||++.+.|+++|++..      ..|++|+++.|+..
T Consensus        85 g~f~~~~~~~~~~~~~~~~~v~igdSL~~iA~~~Gvs~~~i~~ln~i~~~~idf~~~Lr~GD~l~V~~~  153 (361)
T 2gu1_A           85 GSFSYDFQEISGEWREILFSGEINGSFSVSARRVGLTSSQVANITQVMKDKIDFSRSLRAGDRFDILVK  153 (361)
T ss_dssp             SCEEEEEEECCCEEEEEEEEEESSSCHHHHHHHTTCCHHHHHHHHHHHTTTCCTTTCCCC-CEEEEEEE
T ss_pred             CcceeeecccCceEEEEEEEEEECCcHHHHHHHcCCCHHHHHHHHHhhcccccccccCCCCCEEEEEEE
Confidence            1           1123578999999999999999999999999999744      25999999998864

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=98.88  E-value=3.3e-09  Score=105.23  Aligned_cols=118  Identities=14%  Similarity=0.150  Sum_probs=91.4

Q ss_pred             eEEEEEEE-CCceEEEEEecc----chHHHHHHHhhcCCCce--eeeeeeeecCCeEEEEEEecCCCChHHHhhhcCCCC
Q 039626          361 GSVYRGKI-NGGFAAIKKVNG----DVSKEIALLNKINHSNL--IILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEG  433 (628)
Q Consensus       361 G~Vy~g~~-~g~~vavK~~~~----~~~~E~~~l~~l~H~nI--v~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~  433 (628)
                      +.||+... +|..+++|....    ++..|+.+++.+++.++  .+++++...++..++||||++|.+|.  ..   .  
T Consensus        34 ~~v~~~~~~~g~~~vlK~~~~~~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~--~~---~--  106 (264)
T 1nd4_A           34 AAVFRLSAQGRPVLFVKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL--SS---H--  106 (264)
T ss_dssp             CEEEEEECTTSCCEEEEEECSCTTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT--TS---C--
T ss_pred             ceEEEEecCCCCeEEEEeCCcccchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC--cC---c--
Confidence            78999977 466799998764    46789999999965554  46888888878899999999998884  21   0  


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhcCC------------------------------------------------------
Q 039626          434 KYLDWKQRIQIALDVATGLNYLHSFT------------------------------------------------------  459 (628)
Q Consensus       434 ~~l~~~~~~~i~~~ia~gL~yLH~~~------------------------------------------------------  459 (628)
                        ..   ...++.++++.|..||+..                                                      
T Consensus       107 --~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  181 (264)
T 1nd4_A          107 --LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDG  181 (264)
T ss_dssp             --CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSS
T ss_pred             --CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHHHHhcCCC
Confidence              11   2357778888888888743                                                      


Q ss_pred             -CCCeEecCCCCCCEEeCCCCcEEEccccccc
Q 039626          460 -NPPHVHKDINSSNVLLDSDLRAKIANFAMAR  490 (628)
Q Consensus       460 -~~~iiH~dik~~NILl~~~~~~kl~Dfgla~  490 (628)
                       ...++|+|++|.|||++++...+|.||+.+.
T Consensus       182 ~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~  213 (264)
T 1nd4_A          182 EDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  213 (264)
T ss_dssp             CCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             CCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence             1129999999999999887767899999875

>2l9y_A CVNH-LYSM lectin; carbohydrate, sugar binding protein; NMR {Magnaporthe oryzae 70-15}

Probab=98.86  E-value=3.6e-10  Score=104.11  Aligned_cols=75  Identities=12%  Similarity=0.181  Sum_probs=59.9

Q ss_pred             eEeeecCCCCCCHHHHHHHhCCChHhhhhhcCcc----ccCCcEEEEcccCccC---CCCc-ccceeEEEecCChHHHHH
Q 039626           63 YLTFRSQPPFNTVASISTLLGSEPSLLSQINSVS----LETNRLVIVPVNCSCS---GQYY-QSNTTYTIQNGDTYLFIA  134 (628)
Q Consensus        63 ~~~~~~~~~~~tl~~Ia~~~~~~~~~i~~~N~~~----~~~gq~l~vp~~c~c~---~~~~-~~~~~y~V~~gdt~~~IA  134 (628)
                      .-+|+++ +||||+.||.+||++..+|+++|++.    |.+||.|.||..-.-.   .... .....|+|++||||+.||
T Consensus        62 ~~~y~V~-~GDTL~~IA~~~~~~~~~l~~~N~~~~~~~i~~Gq~L~ip~~~~~~~~~~~~~~~~~~~~~v~~GdtL~aIA  140 (167)
T 2l9y_A           62 TATVTVQ-QGDTLRDIGRRFDCDFHEIARRNNIQNEDLIYPGQVLQVPTKGGSGGGAGNFWDSARDVRLVDGGKVLEAEL  140 (167)
T ss_dssp             CEEEEEC-TTCCHHHHHHHTTCCHHHHHHHHTCCGGGCCCTTEEEEESCCCCCSSSSCCGGGGEEEEEEETTTTEEEEEE
T ss_pred             CceEEEC-CCCcHHHHHHHcCCCHHHHHHHcCCCCcccccCCCEEEEcCCCCccccccccccccceEEEeCCcCChHHHH
Confidence            4478776 49999999999999999999999988    9999999999764421   1111 122469999999999999


Q ss_pred             hhhc
Q 039626          135 NNTF  138 (628)
Q Consensus       135 ~~~~  138 (628)
                      ++++
T Consensus       141 ~r~G  144 (167)
T 2l9y_A          141 RYSG  144 (167)
T ss_dssp             EETT
T ss_pred             HHcC
Confidence            8844

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=98.82  E-value=1.5e-08  Score=106.00  Aligned_cols=125  Identities=12%  Similarity=0.219  Sum_probs=100.4

Q ss_pred             eEEEEEEECCceEEEEEec----------cchHHHHHHHhhcCC--CceeeeeeeeecC---CeEEEEEEecCCCChHHH
Q 039626          361 GSVYRGKINGGFAAIKKVN----------GDVSKEIALLNKINH--SNLIILSGVCFNE---GNCYLVYEYAVNGTLSDW  425 (628)
Q Consensus       361 G~Vy~g~~~g~~vavK~~~----------~~~~~E~~~l~~l~H--~nIv~l~g~~~~~---~~~~lV~E~~~~gsL~~~  425 (628)
                      +.||+....++.+++|+..          .++.+|..+++.+++  ..+.++++++.+.   +..++||||++|..+.+.
T Consensus        52 n~~y~v~~~~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme~v~G~~l~~~  131 (359)
T 3dxp_A           52 NPTFKLVTPGQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIMEFVSGRVLWDQ  131 (359)
T ss_dssp             SCEEEEECSSCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEECCCCBCCCCT
T ss_pred             ceEEEEEECCceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEEecCCeecCCC
Confidence            6799998888888998875          257789999999974  4577889988766   458999999999887542


Q ss_pred             hhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC----------------------------------------------
Q 039626          426 VFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFT----------------------------------------------  459 (628)
Q Consensus       426 l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~----------------------------------------------  459 (628)
                      .      -..++..++..++.++++.|..||+..                                              
T Consensus       132 ~------~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  205 (359)
T 3dxp_A          132 S------LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMDSLMDWLP  205 (359)
T ss_dssp             T------CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHHHHHHHGG
T ss_pred             c------cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHHHHHHHHH
Confidence            1      123678888999999999999999731                                              


Q ss_pred             ---------CCCeEecCCCCCCEEeCCCCc--EEEcccccccc
Q 039626          460 ---------NPPHVHKDINSSNVLLDSDLR--AKIANFAMARP  491 (628)
Q Consensus       460 ---------~~~iiH~dik~~NILl~~~~~--~kl~Dfgla~~  491 (628)
                               ...++|+|+++.|||++.++.  +.|.||+.+..
T Consensus       206 ~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          206 QHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             GCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             hcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                     246999999999999997753  68999998864

>2djp_A Hypothetical protein SB145; LYSM, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens}

Probab=98.76  E-value=5.5e-09  Score=83.51  Aligned_cols=61  Identities=15%  Similarity=0.134  Sum_probs=51.2

Q ss_pred             CCcEEEEcccCccCCCCcccceeEEEecCChHHHHHhhhcCCCccHHHHHhccCCC--CccCCCcEEEEeecCC
Q 039626           99 TNRLVIVPVNCSCSGQYYQSNTTYTIQNGDTYLFIANNTFQGLSTCQALEDQNGSP--TNLIIGAGVTVPLRCA  170 (628)
Q Consensus        99 ~gq~l~vp~~c~c~~~~~~~~~~y~V~~gdt~~~IA~~~~~~l~t~~~l~~~N~~~--~~l~~Gq~l~vp~~~~  170 (628)
                      .||.+.||..-        ...+|+|++|||||.||++|+.   ++++|+++|++.  +.|++||+|.||..-.
T Consensus         3 ~Gq~l~ip~~~--------~~~~y~V~~GDTL~~IA~~~~~---~~~~l~~~N~l~~~~~l~~Gq~l~iP~~~~   65 (77)
T 2djp_A            3 SGSSGCSPVRE--------RRLEHQLEPGDTLAGLALKYGV---TMEQIKRANRLYTNDSIFLKKTLYIPILTE   65 (77)
T ss_dssp             CCCCCCCCCCE--------EEEEECCCTTCCHHHHHHHHTC---CHHHHHHHHTCCCSSCGGGSSCEEEEEECC
T ss_pred             CCcEeeccCCC--------CcEEEEECCCCcHHHHHHHHCc---CHHHHHHHcCCCCccccCCCCEEEECCCCC
Confidence            58899998642        2356999999999999998875   888999999986  6899999999998643

>1e0g_A Membrane-bound lytic murein transglycosylase D; cell WALL, hydrolase, glycosidase, lipoprotein, outer membrane, multigene family; NMR {Escherichia coli} SCOP: d.7.1.1

Probab=98.70  E-value=1.3e-08  Score=73.27  Aligned_cols=44  Identities=25%  Similarity=0.285  Sum_probs=40.0

Q ss_pred             eeEEEecCChHHHHHhhhcCCCccHHHHHhccCCC-CccCCCcEEEEee
Q 039626          120 TTYTIQNGDTYLFIANNTFQGLSTCQALEDQNGSP-TNLIIGAGVTVPL  167 (628)
Q Consensus       120 ~~y~V~~gdt~~~IA~~~~~~l~t~~~l~~~N~~~-~~l~~Gq~l~vp~  167 (628)
                      .+|+|++|||+|.||++|+.   ++++|.++|+ . +.|.+||+|.||+
T Consensus         3 ~~y~V~~GDtl~~Ia~~~~~---~~~~l~~~N~-~~~~l~~G~~l~ip~   47 (48)
T 1e0g_A            3 ITYRVRKGDSLSSIAKRHGV---NIKDVMRWNS-DTANLQPGDKLTLFV   47 (48)
T ss_dssp             CEEEECTTCCHHHHHHHHTC---CHHHHHHHCS-CGGGCCTTEEEECCC
T ss_pred             EEEEEcCCCcHHHHHHHHCc---CHHHHHHhCC-CCCcCCcCCEEEEec
Confidence            46999999999999998865   7888999999 8 8999999999996

>2gu1_A Zinc peptidase; alpha/beta, beta barrel, structural genomics, PSI, protein structure initiative; 1.90A {Vibrio cholerae}

Probab=98.59  E-value=6.1e-08  Score=101.16  Aligned_cols=101  Identities=13%  Similarity=0.149  Sum_probs=75.8

Q ss_pred             EeeecCCCCCCHHHHHHHhCCChHhhhhhcCc-------c-ccCCcEEEEcccCccC--------------------CCC
Q 039626           64 LTFRSQPPFNTVASISTLLGSEPSLLSQINSV-------S-LETNRLVIVPVNCSCS--------------------GQY  115 (628)
Q Consensus        64 ~~~~~~~~~~tl~~Ia~~~~~~~~~i~~~N~~-------~-~~~gq~l~vp~~c~c~--------------------~~~  115 (628)
                      ..|+.+ +||||+.|+++||+++.+|.++|++       . |.+||.|.||..-.-.                    ++.
T Consensus         8 ~~~~Vk-~GDTL~~Ia~r~gvs~~~l~~~n~~~~~~~~~~~L~~Gq~L~i~~~~~~~l~~l~~~~~~~~~~~~~~~~~g~   86 (361)
T 2gu1_A            8 IHYMVK-VGDTLSGIFAQLGVPYSILQKILSVDLDHLQLDMIQPGEELELMMDDMGQLSRLIYHMSIVEKAIYTRENDGS   86 (361)
T ss_dssp             EEEECC-TTCCHHHHHHHTTCCHHHHHHHHHHGGGTCCGGGCCTTCEEEEEECTTSCEEEEEEEEETTEEEEEEECTTSC
T ss_pred             eEEEEC-CCCcHHHHHHHcCCCHHHHHHHHhhcccccchhcCCCCCEEEEEECCCCcceEEEEEcCccceEEEEecCCCc
Confidence            467775 5999999999999999999999954       2 9999999999753210                    000


Q ss_pred             cc----------cceeEEEecCChHHHHHhhhcCCCccHHHHHhccCCC-------CccCCCcEEEEeec
Q 039626          116 YQ----------SNTTYTIQNGDTYLFIANNTFQGLSTCQALEDQNGSP-------TNLIIGAGVTVPLR  168 (628)
Q Consensus       116 ~~----------~~~~y~V~~gdt~~~IA~~~~~~l~t~~~l~~~N~~~-------~~l~~Gq~l~vp~~  168 (628)
                      +.          ....|+|+.|||||.||++++.   +...|+++|++.       ..|++||+|.|+..
T Consensus        87 f~~~~~~~~~~~~~~~~~v~igdSL~~iA~~~Gv---s~~~i~~ln~i~~~~idf~~~Lr~GD~l~V~~~  153 (361)
T 2gu1_A           87 FSYDFQEISGEWREILFSGEINGSFSVSARRVGL---TSSQVANITQVMKDKIDFSRSLRAGDRFDILVK  153 (361)
T ss_dssp             EEEEEEECCCEEEEEEEEEESSSCHHHHHHHTTC---CHHHHHHHHHHHTTTCCTTTCCCC-CEEEEEEE
T ss_pred             ceeeecccCceEEEEEEEEEECCcHHHHHHHcCC---CHHHHHHHHHhhcccccccccCCCCCEEEEEEE
Confidence            10          1125889999999999998876   667777777642       36999999999863

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.45  E-value=1.3e-07  Score=96.49  Aligned_cols=173  Identities=19%  Similarity=0.199  Sum_probs=108.9

Q ss_pred             eEEEEEEECCceEEEEEecc-----chHHHHHHHhhcC-CCc--eeeeeeeeecCC---eEEEEEEecCCCChHHHhhhc
Q 039626          361 GSVYRGKINGGFAAIKKVNG-----DVSKEIALLNKIN-HSN--LIILSGVCFNEG---NCYLVYEYAVNGTLSDWVFSN  429 (628)
Q Consensus       361 G~Vy~g~~~g~~vavK~~~~-----~~~~E~~~l~~l~-H~n--Iv~l~g~~~~~~---~~~lV~E~~~~gsL~~~l~~~  429 (628)
                      ..||+.   ++.+++|....     .+.+|.++|+.+. +..  +.++++....++   ..|+||||++|.+|.+...  
T Consensus        34 n~v~~v---~~~~vlR~~~~~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G~~l~~~~~--  108 (304)
T 3sg8_A           34 CIAYEI---NRDFIFKFPKHSRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKGVPLTPLLL--  108 (304)
T ss_dssp             EEEEES---TTSEEEEEESSHHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCCEECCHHHH--
T ss_pred             ceEEEE---CCEEEEEecCCcchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCCeECCcccc--
Confidence            345654   36788888764     3678999999884 333  335555544333   3489999999988875432  


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHHHHHHhcCC--------------------------------------------------
Q 039626          430 KNEGKYLDWKQRIQIALDVATGLNYLHSFT--------------------------------------------------  459 (628)
Q Consensus       430 ~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~--------------------------------------------------  459 (628)
                          ..++..++..++.++++.|..||+..                                                  
T Consensus       109 ----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~  184 (304)
T 3sg8_A          109 ----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDFYRDILENE  184 (304)
T ss_dssp             ----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHHHHHHHTCG
T ss_pred             ----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHHHHHHHhcc
Confidence                12666777788888888888888521                                                  


Q ss_pred             -----CCCeEecCCCCCCEEeCC--CCcEEEccccccccCCCCCCcceee-e-----------cccCCccccC-cccccc
Q 039626          460 -----NPPHVHKDINSSNVLLDS--DLRAKIANFAMARPAEGQEGEFALT-R-----------HIVGTKGYMA-PEYLEN  519 (628)
Q Consensus       460 -----~~~iiH~dik~~NILl~~--~~~~kl~Dfgla~~~~~~~~~~~~~-~-----------~~~gt~~Y~A-PE~l~~  519 (628)
                           .+.++|+|+++.||++++  +..+.|.||+.+....... ..... .           ......+... |+....
T Consensus       185 ~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~-Dl~~~~~~~~~~~~~~~~~~l~~Y~~~~~~~~~~r  263 (304)
T 3sg8_A          185 IYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDN-DFISLMEDDEEYGMEFVSKILNHYKHKDIPTVLEK  263 (304)
T ss_dssp             GGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTH-HHHTTCCTTTSCCHHHHHHHHHHHTCSCHHHHHHH
T ss_pred             ccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHH-HHHHHHhhccccCHHHHHHHHHHcCCCCcHHHHHH
Confidence                 134799999999999998  5668899999876532110 00000 0           0000001111 222111


Q ss_pred             CCCCcccccHHHHHHHHHHHhCCCcc
Q 039626          520 GLVSTKLDVYAFGVLILEMLTGKEAA  545 (628)
Q Consensus       520 ~~~s~k~DV~SfGvvl~ELltG~~p~  545 (628)
                        ..-..+.|++|.+++++.+|+.++
T Consensus       264 --~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          264 --YRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             --HHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             --HHHHHHHHHHHHHHHHHHcCCHHH
Confidence              112368999999999999998654

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.08  E-value=1.6e-05  Score=79.21  Aligned_cols=122  Identities=19%  Similarity=0.143  Sum_probs=87.2

Q ss_pred             eEEEEEEE--CCceEEEEEecc----chHHHHHHHhhcCC-CceeeeeeeeecCCeEEEEEEecCCCChHHHhhhcCCCC
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG----DVSKEIALLNKINH-SNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEG  433 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~----~~~~E~~~l~~l~H-~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~  433 (628)
                      ..||+-..  .+..+.+|+...    ++..|...|+.+.. --+-++++++.+++..++|||+++|.++.+.....    
T Consensus        39 ~~v~rl~~~~~~~~~~lk~~~~~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~~~~~~~----  114 (272)
T 4gkh_A           39 ATIYRLYGKPNAPELFLKHGKGSVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQVLEEY----  114 (272)
T ss_dssp             CEEEEEECCTTCCCEEEEEEETHHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHHHHHHHC----
T ss_pred             CeEEEEEecCCCeEEEEEECCCCCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccccccccCC----
Confidence            47898766  355788888754    57789999988852 23568889998889999999999998887654221    


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhcCC------------------------------------------------------
Q 039626          434 KYLDWKQRIQIALDVATGLNYLHSFT------------------------------------------------------  459 (628)
Q Consensus       434 ~~l~~~~~~~i~~~ia~gL~yLH~~~------------------------------------------------------  459 (628)
                          ...+..+..+++..|.-||...                                                      
T Consensus       115 ----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  190 (272)
T 4gkh_A          115 ----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMHKLLPFS  190 (272)
T ss_dssp             ----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHHTTCCCC
T ss_pred             ----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHHHhccccc
Confidence                1122334555555555555310                                                      


Q ss_pred             -CCCeEecCCCCCCEEeCCCCcEEEccccccc
Q 039626          460 -NPPHVHKDINSSNVLLDSDLRAKIANFAMAR  490 (628)
Q Consensus       460 -~~~iiH~dik~~NILl~~~~~~kl~Dfgla~  490 (628)
                       .+.++|+|+.+.|||+++++..-|.||+.+.
T Consensus       191 ~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~  222 (272)
T 4gkh_A          191 PDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG  222 (272)
T ss_dssp             CCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             CCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence             1227899999999999988777899998875

>4a1k_A Putative L, D-transpeptidase YKUD; transferase, peptidoglycan synthesis; HET: CME; 1.75A {Bacillus subtilis} PDB: 4a1j_A 4a1i_A* 1y7m_A 3zqd_A 4a52_A*

Probab=98.00  E-value=3.5e-06  Score=77.43  Aligned_cols=47  Identities=32%  Similarity=0.540  Sum_probs=42.3

Q ss_pred             EEEEEccCCCcHHHHHHHhCCChHHHhhhcCCCCCCccccceeeccC
Q 039626          184 LLSYLVAEGDTVSGISSRFGVDTGEILQANSLSGSNIFPFTTLLIPL  230 (628)
Q Consensus       184 ~~~y~v~~gdtl~~ia~~f~~~~~~l~~~N~~~~~~~~~~~~l~iP~  230 (628)
                      +++|+|++||||+.||++|+++..+|+++|+..+..+.+|+++.||.
T Consensus         2 ~~~y~V~~GdtL~~IA~~f~~g~~~l~~aNp~vd~~l~~g~~i~ip~   48 (165)
T 4a1k_A            2 MLTYQVKQGDTLNSIAADFRISTAALLQANPSLQAGLTAGQSIVIPG   48 (165)
T ss_dssp             CEEEECCTTCCHHHHHHHTTCCHHHHHHHCGGGGGCCCTTCEEEETT
T ss_pred             CEEEEECCCCCHHHHHHHhCCCHHHHHHhCccCCCccCCCccccCcc
Confidence            47999999999999999999999999999986555678999999984

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.00  E-value=4.4e-05  Score=77.76  Aligned_cols=122  Identities=20%  Similarity=0.221  Sum_probs=82.6

Q ss_pred             eEEEEEEECCceEEEEEecc-----chHHHHHHHhhcCCC---ceeeeeeeee-cCCeEEEEEEecCCCChHHHhhhcCC
Q 039626          361 GSVYRGKINGGFAAIKKVNG-----DVSKEIALLNKINHS---NLIILSGVCF-NEGNCYLVYEYAVNGTLSDWVFSNKN  431 (628)
Q Consensus       361 G~Vy~g~~~g~~vavK~~~~-----~~~~E~~~l~~l~H~---nIv~l~g~~~-~~~~~~lV~E~~~~gsL~~~l~~~~~  431 (628)
                      ..||+.   |+.+++|.-..     .+..|.++|+.+.+.   .+.+++.++. ..+..++||||++|..|.+....   
T Consensus        33 n~v~~v---g~~~VlR~~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~~l~~~~~~---  106 (306)
T 3tdw_A           33 NYAILV---NGDWVFRFPKSQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQILGEDGMA---  106 (306)
T ss_dssp             EEEEEE---TTTEEEEEESSHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSEECHHHHHT---
T ss_pred             eeEEEE---CCEEEEEecCCchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCeECchhhhh---
Confidence            467776   67888888653     367899999999753   3456677764 45667899999999888763211   


Q ss_pred             CCCCCCHHHHHHHHHHHHHHHHHHhcC-----------------------------------------------------
Q 039626          432 EGKYLDWKQRIQIALDVATGLNYLHSF-----------------------------------------------------  458 (628)
Q Consensus       432 ~~~~l~~~~~~~i~~~ia~gL~yLH~~-----------------------------------------------------  458 (628)
                         .++..++..++.++++.|..||+.                                                     
T Consensus       107 ---~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~l~~~  183 (306)
T 3tdw_A          107 ---VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLRFQSYMTHP  183 (306)
T ss_dssp             ---TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHHHHHHHHCH
T ss_pred             ---hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHHHHHHHhCc
Confidence               123344444444444444444432                                                     


Q ss_pred             ----CCCCeEecCCCCCCEEeCC---CCc-EEEcccccccc
Q 039626          459 ----TNPPHVHKDINSSNVLLDS---DLR-AKIANFAMARP  491 (628)
Q Consensus       459 ----~~~~iiH~dik~~NILl~~---~~~-~kl~Dfgla~~  491 (628)
                          ..+.++|+|+++.||+++.   ++. ..|.||+.+..
T Consensus       184 ~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          184 VYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             HHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             ccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence                1235799999999999988   455 58999998764

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=97.78  E-value=6.5e-05  Score=78.05  Aligned_cols=64  Identities=5%  Similarity=0.052  Sum_probs=46.7

Q ss_pred             eEEEEEEEC--------CceEEEEEecc----------chHHHHHHHhhcCC---CceeeeeeeeecC---CeEEEEEEe
Q 039626          361 GSVYRGKIN--------GGFAAIKKVNG----------DVSKEIALLNKINH---SNLIILSGVCFNE---GNCYLVYEY  416 (628)
Q Consensus       361 G~Vy~g~~~--------g~~vavK~~~~----------~~~~E~~~l~~l~H---~nIv~l~g~~~~~---~~~~lV~E~  416 (628)
                      +.+|+....        ++.+++|....          ++..|..+|+.+..   -.+.++++++.+.   +..++||||
T Consensus        35 n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~g~~~~v~e~  114 (357)
T 3ats_A           35 SETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVLGTPFFLMDY  114 (357)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTTSSCEEEEEC
T ss_pred             ceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCccCCceEEEEe
Confidence            678887765        67788887532          46789999998853   3466788887655   456899999


Q ss_pred             cCCCChHH
Q 039626          417 AVNGTLSD  424 (628)
Q Consensus       417 ~~~gsL~~  424 (628)
                      ++|..+.+
T Consensus       115 l~G~~l~~  122 (357)
T 3ats_A          115 VEGVVPPD  122 (357)
T ss_dssp             CCCBCCCB
T ss_pred             cCCCChhh
Confidence            99877653

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=97.58  E-value=0.00045  Score=70.84  Aligned_cols=130  Identities=14%  Similarity=0.181  Sum_probs=79.8

Q ss_pred             eEEEEEEECCceEEEEEeccc---hHHHHHHHhhcCCC--ceeeeee------eeecCCeEEEEEEecCCCChH------
Q 039626          361 GSVYRGKINGGFAAIKKVNGD---VSKEIALLNKINHS--NLIILSG------VCFNEGNCYLVYEYAVNGTLS------  423 (628)
Q Consensus       361 G~Vy~g~~~g~~vavK~~~~~---~~~E~~~l~~l~H~--nIv~l~g------~~~~~~~~~lV~E~~~~gsL~------  423 (628)
                      +.||+...+++.+++|+....   +..|..++..+...  .+.+++.      +....+..+++|||++|..+.      
T Consensus        46 n~~~~v~~~~~~~vlk~~~~~~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~i~G~~~~~~~~~~  125 (346)
T 2q83_A           46 ALVWKVHTDSGAVCLKRIHRPEKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDWIEGRPFELTVKQD  125 (346)
T ss_dssp             CEEEEEEETTEEEEEEEECSCHHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEECCCCBCCCTTSHHH
T ss_pred             CcEEEEEeCCCCEEEEecCCCHHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEeecCccCCCCCHHH
Confidence            689998887778999998753   44566666666321  2334443      112456789999999986542      


Q ss_pred             --------HHhhhcCCC-----C-----CCCCHHHHH-------------------------------HHHHHHHHHHHH
Q 039626          424 --------DWVFSNKNE-----G-----KYLDWKQRI-------------------------------QIALDVATGLNY  454 (628)
Q Consensus       424 --------~~l~~~~~~-----~-----~~l~~~~~~-------------------------------~i~~~ia~gL~y  454 (628)
                              ..+|.....     .     ..-.|....                               .+...+..++++
T Consensus       126 ~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  205 (346)
T 2q83_A          126 LEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEIDGFIEDGLRIKDR  205 (346)
T ss_dssp             HHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHHHHHHHHHHHHHHH
Confidence                    112221110     0     112343211                               011123445666


Q ss_pred             Hhc----------CCCCCeEecCCCCCCEEeCCCCcEEEccccccc
Q 039626          455 LHS----------FTNPPHVHKDINSSNVLLDSDLRAKIANFAMAR  490 (628)
Q Consensus       455 LH~----------~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~  490 (628)
                      |+.          .....++|+|+++.|||++.++.+.|+||+.+.
T Consensus       206 l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          206 LLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             HHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             HHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence            763          023679999999999999888899999998764

>4a1k_A Putative L, D-transpeptidase YKUD; transferase, peptidoglycan synthesis; HET: CME; 1.75A {Bacillus subtilis} PDB: 4a1j_A 4a1i_A* 1y7m_A 3zqd_A 4a52_A*

Probab=97.56  E-value=4.1e-05  Score=70.26  Aligned_cols=45  Identities=31%  Similarity=0.374  Sum_probs=39.9

Q ss_pred             eeEEEecCChHHHHHhhhcCCCccHHHHHhccCCC-CccCCCcEEEEee
Q 039626          120 TTYTIQNGDTYLFIANNTFQGLSTCQALEDQNGSP-TNLIIGAGVTVPL  167 (628)
Q Consensus       120 ~~y~V~~gdt~~~IA~~~~~~l~t~~~l~~~N~~~-~~l~~Gq~l~vp~  167 (628)
                      .+|+||+||||..||++|..   ..++|+++|+.. ..|.+||+|.||.
T Consensus         3 ~~y~V~~GdtL~~IA~~f~~---g~~~l~~aNp~vd~~l~~g~~i~ip~   48 (165)
T 4a1k_A            3 LTYQVKQGDTLNSIAADFRI---STAALLQANPSLQAGLTAGQSIVIPG   48 (165)
T ss_dssp             EEEECCTTCCHHHHHHHTTC---CHHHHHHHCGGGGGCCCTTCEEEETT
T ss_pred             EEEEECCCCCHHHHHHHhCC---CHHHHHHhCccCCCccCCCccccCcc
Confidence            57999999999999998876   677899999977 6789999999984

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.04  E-value=0.003  Score=64.23  Aligned_cols=126  Identities=13%  Similarity=0.112  Sum_probs=83.3

Q ss_pred             eEEEEEEECCceEEEEEecc----chHHHHHHHhhcC---CCceeeeeeeeecCCeEEEEEEecCCCChHH---------
Q 039626          361 GSVYRGKINGGFAAIKKVNG----DVSKEIALLNKIN---HSNLIILSGVCFNEGNCYLVYEYAVNGTLSD---------  424 (628)
Q Consensus       361 G~Vy~g~~~g~~vavK~~~~----~~~~E~~~l~~l~---H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~---------  424 (628)
                      ..+|+...+++.+++|....    .+..|...|+.|.   ...+.++++++...+..++||||+++..+..         
T Consensus        50 n~~y~v~~~~~~~vlK~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~~~~~~~~~lG~~  129 (312)
T 3jr1_A           50 NEIWLINDEVQTVFVKINERSYRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSKNKQSSFTIFAEK  129 (312)
T ss_dssp             SEEEEEESSSCEEEEEEEEGGGHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCCCCTTHHHHHHHH
T ss_pred             eeeeEEEECCCeEEEEeCCcccHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCCCCchhHHHHHHH
Confidence            57999888888899998754    3678998888884   3567788998888888999999999886521         


Q ss_pred             --HhhhcCC-CC-----------------CCCCHHHH-----HHHH--------------HHHHHHH-HHHhc-CCCCCe
Q 039626          425 --WVFSNKN-EG-----------------KYLDWKQR-----IQIA--------------LDVATGL-NYLHS-FTNPPH  463 (628)
Q Consensus       425 --~l~~~~~-~~-----------------~~l~~~~~-----~~i~--------------~~ia~gL-~yLH~-~~~~~i  463 (628)
                        .||.... ..                 -.-+|...     +.-.              ..+...+ ..|.. ...+.+
T Consensus       130 LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l~~~L~~~~~~~~l  209 (312)
T 3jr1_A          130 IAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIVADTLSKHNPKPSI  209 (312)
T ss_dssp             HHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHHHHHHTTCCCCCEE
T ss_pred             HHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHHHHHhccCCCCcee
Confidence              1233211 00                 01246432     1111              1122122 23432 224779


Q ss_pred             EecCCCCCCEEeCCCCcEEEcccc
Q 039626          464 VHKDINSSNVLLDSDLRAKIANFA  487 (628)
Q Consensus       464 iH~dik~~NILl~~~~~~kl~Dfg  487 (628)
                      +|+|+.+.|++++.++ +.|.|+.
T Consensus       210 ~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          210 LHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             ECSSCSGGGEEEETTE-EEECSCC
T ss_pred             EeCCCCcCcEeecCCC-eEEEcCc
Confidence            9999999999999887 8899973

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=96.73  E-value=0.0058  Score=62.45  Aligned_cols=128  Identities=15%  Similarity=0.133  Sum_probs=74.1

Q ss_pred             EEEEEEC-CceEEEEEec----cchHHHHHHHhhcCCCc--eeeeeeeeecCCeEEEEEEecCCCChHHHhhhcC-----
Q 039626          363 VYRGKIN-GGFAAIKKVN----GDVSKEIALLNKINHSN--LIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNK-----  430 (628)
Q Consensus       363 Vy~g~~~-g~~vavK~~~----~~~~~E~~~l~~l~H~n--Iv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~-----  430 (628)
                      +|+.... |+.+++|...    .++..|+.++..+....  +.+++.+..+.+  +++||++.+..+.+++....     
T Consensus        35 ~~r~~~~~~~~~vlk~~~~~~~~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~~l~~~l~~~~~~~~~  112 (333)
T 3csv_A           35 YQRLRSPTGAKAVLMDWSPEEGGDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDALFTEVINNDPAQEMP  112 (333)
T ss_dssp             CEEEECTTCCEEEEEECCTTTTCCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSCBHHHHHHHCGGGHHH
T ss_pred             EEEEEcCCCCeEEEEECCCCCCccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCcchHHHhcCCCccHHH
Confidence            5566653 6777777653    45678999888885323  446676654444  78999997767765542210     


Q ss_pred             ----------------CCC-CCCCHHHHH-------H-------------HHHHHHHHHHHHh---cCCCCCeEecCCCC
Q 039626          431 ----------------NEG-KYLDWKQRI-------Q-------------IALDVATGLNYLH---SFTNPPHVHKDINS  470 (628)
Q Consensus       431 ----------------~~~-~~l~~~~~~-------~-------------i~~~ia~gL~yLH---~~~~~~iiH~dik~  470 (628)
                                      ... ..++.....       .             ....+...++.+.   ....+.++|+|+.+
T Consensus       113 ~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~~~~~~~lvHgD~~~  192 (333)
T 3csv_A          113 LYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQLEGDMVFVHRDFHA  192 (333)
T ss_dssp             HHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHHCCSCCEEECSCCSG
T ss_pred             HHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhcccCCCeeEeCCcCc
Confidence                            000 011111000       0             0011112222221   11235699999999


Q ss_pred             CCEEeCCC----CcEEEccccccccC
Q 039626          471 SNVLLDSD----LRAKIANFAMARPA  492 (628)
Q Consensus       471 ~NILl~~~----~~~kl~Dfgla~~~  492 (628)
                      .|||++.+    ..+.|.||+.+...
T Consensus       193 ~Nil~~~~~~~~~~~~lIDf~~a~~G  218 (333)
T 3csv_A          193 QNLLWLPEREGLARVGVIDFQDAKLG  218 (333)
T ss_dssp             GGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred             ccEEeccCcCCCCCeEEEeCCCcCcC
Confidence            99999875    68999999987643

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=96.62  E-value=0.0054  Score=64.42  Aligned_cols=58  Identities=14%  Similarity=-0.019  Sum_probs=38.3

Q ss_pred             eEEEEEEE--CCceEEEEEecc--------------chHHHHHHHhhcCC--Ccee-eeeeeeecCCeEEEEEEecCCC
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG--------------DVSKEIALLNKINH--SNLI-ILSGVCFNEGNCYLVYEYAVNG  420 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~--------------~~~~E~~~l~~l~H--~nIv-~l~g~~~~~~~~~lV~E~~~~g  420 (628)
                      +.||++..  .++.+++|....              .+..|.++|+.+.+  +..+ +++.+  +.+..++||||+++.
T Consensus        44 n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~lvmE~l~g~  120 (397)
T 2olc_A           44 NYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTVMEDLSHL  120 (397)
T ss_dssp             EEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEEECCCTTS
T ss_pred             EEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEEEEEeCCCc
Confidence            78999965  567899996421              24679999988743  3333 55544  344568999999764

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=96.56  E-value=0.0086  Score=60.73  Aligned_cols=130  Identities=13%  Similarity=0.115  Sum_probs=77.9

Q ss_pred             eEEEEEEECCceEEEEEecc-----chHHHHHHHhhcCCCce--eeeeee------eecCCeEEEEEEecCCCChHH---
Q 039626          361 GSVYRGKINGGFAAIKKVNG-----DVSKEIALLNKINHSNL--IILSGV------CFNEGNCYLVYEYAVNGTLSD---  424 (628)
Q Consensus       361 G~Vy~g~~~g~~vavK~~~~-----~~~~E~~~l~~l~H~nI--v~l~g~------~~~~~~~~lV~E~~~~gsL~~---  424 (628)
                      ..+|+...+++.+++|....     ++..|+.++..+...++  .+++..      ....+..+++++|++|..+..   
T Consensus        36 n~~~~v~~~~g~~vlk~~~~~~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~  115 (322)
T 2ppq_A           36 NSNFLLHTTKDPLILTLYEKRVEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISFLEGMWLRKPEA  115 (322)
T ss_dssp             EEEEEEEESSCCEEEEEECC---CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCH
T ss_pred             cceEEEEeCCccEEEEEeCCCCCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCH
Confidence            57898888777888998754     46678888887753232  333321      112356789999998865421   


Q ss_pred             -----------HhhhcCCC---C-----CCCCHHHHHH------------HHHHHHHHHHHHhcC----CCCCeEecCCC
Q 039626          425 -----------WVFSNKNE---G-----KYLDWKQRIQ------------IALDVATGLNYLHSF----TNPPHVHKDIN  469 (628)
Q Consensus       425 -----------~l~~~~~~---~-----~~l~~~~~~~------------i~~~ia~gL~yLH~~----~~~~iiH~dik  469 (628)
                                 .+|.....   .     ....|.....            +...+...++++++.    ....++|+|+.
T Consensus       116 ~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~  195 (322)
T 2ppq_A          116 KHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLF  195 (322)
T ss_dssp             HHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCC
T ss_pred             HHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCcccCCcccCCCCCC
Confidence                       12221110   0     0112433111            011244455566532    12458999999


Q ss_pred             CCCEEeCCCCcEEEccccccc
Q 039626          470 SSNVLLDSDLRAKIANFAMAR  490 (628)
Q Consensus       470 ~~NILl~~~~~~kl~Dfgla~  490 (628)
                      +.|||++++....|.||+.+.
T Consensus       196 ~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          196 QDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             GGGEEEETTEEEEECCCTTCE
T ss_pred             ccCEEEeCCceEEEecchhcc
Confidence            999999987666899998764

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=96.49  E-value=0.0083  Score=63.58  Aligned_cols=78  Identities=8%  Similarity=0.031  Sum_probs=48.2

Q ss_pred             CCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecc-cCCccccCccccccC---CCCcccccHHHHHHHH
Q 039626          461 PPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHI-VGTKGYMAPEYLENG---LVSTKLDVYAFGVLIL  536 (628)
Q Consensus       461 ~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~-~gt~~Y~APE~l~~~---~~s~k~DV~SfGvvl~  536 (628)
                      +.++|+|+++.|||++.++ +++.||+.+.......   ...... .-...|.+|+.....   ......++......+|
T Consensus       232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~---Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (420)
T 2pyw_A          232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGF---DIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTW  307 (420)
T ss_dssp             CEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHH---HHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHH
T ss_pred             CeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHH---HHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHH
Confidence            6699999999999998876 9999999886532110   000000 011346666655321   1122355667888888


Q ss_pred             HHHhCC
Q 039626          537 EMLTGK  542 (628)
Q Consensus       537 ELltG~  542 (628)
                      +.++++
T Consensus       308 ~~y~~~  313 (420)
T 2pyw_A          308 NLFNKR  313 (420)
T ss_dssp             HHHHHH
T ss_pred             HHHHHH
Confidence            877754

>3slu_A M23 peptidase domain protein; outer membrane, hydrolase; 2.41A {Neisseria meningitidis}

Probab=96.28  E-value=0.0087  Score=61.89  Aligned_cols=111  Identities=13%  Similarity=0.079  Sum_probs=75.1

Q ss_pred             eeEEEecCChHHHHHhhhcCCCccHHHHHhccCCC---CccCCCcEEEEeecCCCCCCCC----C-CCCCCeEE------
Q 039626          120 TTYTIQNGDTYLFIANNTFQGLSTCQALEDQNGSP---TNLIIGAGVTVPLRCACPTENQ----T-DEGFPFLL------  185 (628)
Q Consensus       120 ~~y~V~~gdt~~~IA~~~~~~l~t~~~l~~~N~~~---~~l~~Gq~l~vp~~~~c~~~~~----~-~~~~~~~~------  185 (628)
                      ..|+|++||||..|-++++..-.+..++.++....   ..|++||+|.+.+...-. ...    . ..+....+      
T Consensus        15 ~~~~V~~GDTL~~IL~r~Gls~~di~~i~~~~~~~~~l~~LrpGq~l~i~~~~~~~-l~~l~~~~~~~~~~~~v~i~~~d   93 (371)
T 3slu_A           15 VQEAVQPGDSLADVLARSGMARDEIARITEKYGGEADLRHLRADQSVHVLVGGDGG-AREVQFFTDEDGERNLVALEKKG   93 (371)
T ss_dssp             EEEECCTTCCHHHHHHHTTCCHHHHHHHHTTC------CCBCSSSEEEEEECTTSC-EEEEEEEECCTTEEEEEEEEEET
T ss_pred             EEEEECCCCcHHHHHHHcCCCHHHHHHHHHhccccCchhhCCCCCEEEEEECCCCC-eEEEEEEecCCCceeEEEEEecC
Confidence            35999999999999999888666667776665432   799999999998742110 000    0 00000000      


Q ss_pred             -E----------------EEccCCCcHHHHHHHhCCChHHHhhhcCCCCC-----CccccceeeccCC
Q 039626          186 -S----------------YLVAEGDTVSGISSRFGVDTGEILQANSLSGS-----NIFPFTTLLIPLE  231 (628)
Q Consensus       186 -~----------------y~v~~gdtl~~ia~~f~~~~~~l~~~N~~~~~-----~~~~~~~l~iP~~  231 (628)
                       .                +.+.-.++|+..|.+.|++.+.+++++.+-.+     .|.+|+.+.|...
T Consensus        94 g~f~~~~~~~~~~~~~~~~~g~I~~Sl~~a~~~agl~~~~~~~l~~i~~~~idf~~l~~GD~f~v~~~  161 (371)
T 3slu_A           94 GIWRRSASEADMKVLPTLRSVVVKTSARGSLARAEVPVEIRESLSGIFAGRFSLDGLKEGDAVRLIYD  161 (371)
T ss_dssp             TEEEECCCGGGEEEEEEEEEEECSSCHHHHHHHTTCCHHHHHHHHHHHTTTCCTTCCCTTCEEEEEEE
T ss_pred             CeeEEEeeecccceeeeEEEEEEeccHHHHHHHcCCCHHHHHHHHHHHccCcCHHHcCCCCEEEEEEE
Confidence             1                22334899999999999999999998876332     3789998888764

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=95.92  E-value=0.018  Score=57.89  Aligned_cols=56  Identities=14%  Similarity=0.151  Sum_probs=36.5

Q ss_pred             eEEEEEEECCceEEEEEecc------chHHHHHHHhhcCCCcee-eeeeeeecCCeEEEEEEec-CCCCh
Q 039626          361 GSVYRGKINGGFAAIKKVNG------DVSKEIALLNKINHSNLI-ILSGVCFNEGNCYLVYEYA-VNGTL  422 (628)
Q Consensus       361 G~Vy~g~~~g~~vavK~~~~------~~~~E~~~l~~l~H~nIv-~l~g~~~~~~~~~lV~E~~-~~gsL  422 (628)
                      ..+|+.    +.+++|....      +...|..+++.+...++. ++++++  .+.-++++||+ ++.+|
T Consensus        32 N~~~~~----~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g~~l   95 (301)
T 3dxq_A           32 NLVFRA----GDLCLRIPGKGTEEYINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGAQTM   95 (301)
T ss_dssp             EEEEEE----TTEEEEEECC----CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTCEEC
T ss_pred             ccccee----eeEEEECCCCCccceeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCCccC
Confidence            578887    6677887643      346798888887543443 555543  33347899999 55444

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=95.87  E-value=0.01  Score=63.24  Aligned_cols=58  Identities=12%  Similarity=0.158  Sum_probs=40.6

Q ss_pred             eEEEEEEEC---------CceEEEEEecc-----chHHHHHHHhhcCCCce-eeeeeeeecCCeEEEEEEecCCCCh
Q 039626          361 GSVYRGKIN---------GGFAAIKKVNG-----DVSKEIALLNKINHSNL-IILSGVCFNEGNCYLVYEYAVNGTL  422 (628)
Q Consensus       361 G~Vy~g~~~---------g~~vavK~~~~-----~~~~E~~~l~~l~H~nI-v~l~g~~~~~~~~~lV~E~~~~gsL  422 (628)
                      ..+|+....         ++.+++|....     .+..|..++..+...++ .++++.+.+    .+|+||++|.+|
T Consensus        87 N~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e~l~G~~l  159 (429)
T 1nw1_A           87 NMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEYIPSRPL  159 (429)
T ss_dssp             EEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECCCCEEEC
T ss_pred             cceEEEEeCCCccccCCCCceEEEEEeCCCCcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEEEeCCccc
Confidence            689998874         46788888733     45679999888854444 466766542    289999986444

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=95.66  E-value=0.039  Score=54.95  Aligned_cols=58  Identities=17%  Similarity=0.141  Sum_probs=41.3

Q ss_pred             eEEEEEEE-CCceEEEEEecc-------chHHHHHHHhhcCCC---ceeeeeeeeecCCeEEEEEEecCCCCh
Q 039626          361 GSVYRGKI-NGGFAAIKKVNG-------DVSKEIALLNKINHS---NLIILSGVCFNEGNCYLVYEYAVNGTL  422 (628)
Q Consensus       361 G~Vy~g~~-~g~~vavK~~~~-------~~~~E~~~l~~l~H~---nIv~l~g~~~~~~~~~lV~E~~~~gsL  422 (628)
                      +.||+.++ +|+.+.+|+...       .+..|...|+.|.-.   -+.+++++.    ..++||||++++..
T Consensus        29 ~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~l~~~~~   97 (288)
T 3f7w_A           29 WHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEWVDERPP   97 (288)
T ss_dssp             EEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEECCCCCCC
T ss_pred             eEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEeecccCC
Confidence            68999998 678899998543       267899999988432   234555542    24789999987654

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=95.66  E-value=0.042  Score=58.81  Aligned_cols=58  Identities=10%  Similarity=-0.023  Sum_probs=42.0

Q ss_pred             eEEEEEEECC--ceEEEEEecc------chHHHHHHHhhcCCCcee-eeeeeeecCCeEEEEEEecCCCCh
Q 039626          361 GSVYRGKING--GFAAIKKVNG------DVSKEIALLNKINHSNLI-ILSGVCFNEGNCYLVYEYAVNGTL  422 (628)
Q Consensus       361 G~Vy~g~~~g--~~vavK~~~~------~~~~E~~~l~~l~H~nIv-~l~g~~~~~~~~~lV~E~~~~gsL  422 (628)
                      ..+|+....+  +.+++|....      +...|..++..|...++. ++++++.  +  .+||||++|..|
T Consensus       122 N~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~l  188 (458)
T 2qg7_A          122 NILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYAL  188 (458)
T ss_dssp             EEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEEC
T ss_pred             eEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCccC
Confidence            5799998865  7888887642      236899999999766654 6777663  2  259999987544

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=95.58  E-value=0.035  Score=52.58  Aligned_cols=101  Identities=13%  Similarity=0.074  Sum_probs=66.1

Q ss_pred             CChHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcc
Q 039626          420 GTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEF  499 (628)
Q Consensus       420 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~  499 (628)
                      -+|.+.|..   .+.++++.+.+.++.|.+.+|.-+-... .+ ..+=+.|..|++..+|.+.+.+ ..+.         
T Consensus        33 vSL~eIL~~---~~~PlsEEqaWALc~Qc~~~L~~~~~~~-~~-~~~i~~~~~i~l~~dG~V~f~~-~~s~---------   97 (229)
T 2yle_A           33 LSLEEILRL---YNQPINEEQAWAVCYQCCGSLRAAARRR-QP-RHRVRSAAQIRVWRDGAVTLAP-AADD---------   97 (229)
T ss_dssp             EEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHTT-CC-CCCCCSGGGEEEETTSCEEECC-C------------
T ss_pred             ccHHHHHHH---cCCCcCHHHHHHHHHHHHHHHHhhhhcc-cC-CceecCCcceEEecCCceeccc-cccc---------
Confidence            379999854   3567999999999999999987762111 11 1334457899999999887774 1110         


Q ss_pred             eeeecccCCccccCccccccCCCCcccccHHHHHHHHHHHhCC
Q 039626          500 ALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGK  542 (628)
Q Consensus       500 ~~~~~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~  542 (628)
                            .....+.|||... ...+.+.=|||+|+++|.-+--.
T Consensus        98 ------~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDyg  133 (229)
T 2yle_A           98 ------AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYG  133 (229)
T ss_dssp             ---------------CCSS-SSSCHHHHHHHHHHHHHHHHTTT
T ss_pred             ------ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcC
Confidence                  0122356788663 34578889999999999988644

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=95.35  E-value=0.051  Score=55.66  Aligned_cols=62  Identities=10%  Similarity=0.048  Sum_probs=42.1

Q ss_pred             eEEEEEEECCceEEEEEeccc-hHHHHHHHhhcCC---Cceeeeeee------eecCCeEEEEEEecCCCCh
Q 039626          361 GSVYRGKINGGFAAIKKVNGD-VSKEIALLNKINH---SNLIILSGV------CFNEGNCYLVYEYAVNGTL  422 (628)
Q Consensus       361 G~Vy~g~~~g~~vavK~~~~~-~~~E~~~l~~l~H---~nIv~l~g~------~~~~~~~~lV~E~~~~gsL  422 (628)
                      ..||+....++.+++|+.... ...|+.++..|..   +++.+++..      ...++..+++|||++|..+
T Consensus        37 N~vy~v~~~~g~~vLK~~~~~~~~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~G~~~  108 (339)
T 3i1a_A           37 AFAYQADSESKSYFIKLKYGYHDEINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIHAPNG  108 (339)
T ss_dssp             CEEEEEECSSCEEEEEEEECSSCCHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCCCCBT
T ss_pred             cceEEEEeCCCCEEEEEecCccchHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccCCCcC
Confidence            478999876668999987543 3568887777732   224455432      2235678999999998765

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=95.24  E-value=0.032  Score=57.86  Aligned_cols=58  Identities=9%  Similarity=0.144  Sum_probs=39.1

Q ss_pred             eEEEEEEECC----------ceEEEEEecc------chHHHHHHHhhcCCCcee-eeeeeeecCCeEEEEEEecCCCCh
Q 039626          361 GSVYRGKING----------GFAAIKKVNG------DVSKEIALLNKINHSNLI-ILSGVCFNEGNCYLVYEYAVNGTL  422 (628)
Q Consensus       361 G~Vy~g~~~g----------~~vavK~~~~------~~~~E~~~l~~l~H~nIv-~l~g~~~~~~~~~lV~E~~~~gsL  422 (628)
                      ..+|+....+          +.+++|....      +...|..+++.+...+++ ++++..  .+  ++||||++|..+
T Consensus        47 N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~~--~~v~e~i~G~~l  121 (369)
T 3c5i_A           47 NQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELYNTISEFEVYKTMSKYKIAPQLLNTF--NG--GRIEEWLYGDPL  121 (369)
T ss_dssp             CEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTSCHHHHHHHHHHHHHTTSSCCEEEEE--TT--EEEEECCCSEEC
T ss_pred             ceEEEEEeCCCCcccccCCCceEEEEecCCCccceecHHHHHHHHHHHHhcCCCCceEEec--CC--cEEEEEecCCcC
Confidence            5788888754          5778887643      246799998888544443 666544  22  689999987543

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=95.24  E-value=0.14  Score=51.77  Aligned_cols=129  Identities=10%  Similarity=0.098  Sum_probs=73.2

Q ss_pred             eEEEEEEE-CCceEEEEEecc------chHHHHHHHhhcCCCc--eeeeeee-----eecCCeEEEEEEecCCCChH---
Q 039626          361 GSVYRGKI-NGGFAAIKKVNG------DVSKEIALLNKINHSN--LIILSGV-----CFNEGNCYLVYEYAVNGTLS---  423 (628)
Q Consensus       361 G~Vy~g~~-~g~~vavK~~~~------~~~~E~~~l~~l~H~n--Iv~l~g~-----~~~~~~~~lV~E~~~~gsL~---  423 (628)
                      ..||+... +|+.+++|....      ++..|..++..+....  +.+++..     ...++..+++|||++|..+.   
T Consensus        39 n~~y~v~~~~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i~G~~~~~~~  118 (328)
T 1zyl_A           39 NRVYQFQDEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEADN  118 (328)
T ss_dssp             SEEEEECCTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSSC
T ss_pred             cceEEEEcCCCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEecCCCCCCCCC
Confidence            57998876 455799999852      3567888888874322  3444443     12245668899999875432   


Q ss_pred             --HH---------hhhcCCC-----CCCCCHHHH----HHH---------------HHHHHHHHHHHhc----CCCCCeE
Q 039626          424 --DW---------VFSNKNE-----GKYLDWKQR----IQI---------------ALDVATGLNYLHS----FTNPPHV  464 (628)
Q Consensus       424 --~~---------l~~~~~~-----~~~l~~~~~----~~i---------------~~~ia~gL~yLH~----~~~~~ii  464 (628)
                        .+         +|.....     ...+++...    ..+               ...+...++.+..    .....++
T Consensus       119 ~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~  198 (328)
T 1zyl_A          119 IDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLRL  198 (328)
T ss_dssp             HHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEEC
T ss_pred             HHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHhhhcCCeeee
Confidence              11         1211110     112232211    000               1111122233321    1224589


Q ss_pred             ecCCCCCCEEeCCCCcEEEcccccccc
Q 039626          465 HKDINSSNVLLDSDLRAKIANFAMARP  491 (628)
Q Consensus       465 H~dik~~NILl~~~~~~kl~Dfgla~~  491 (628)
                      |+|+++.|||++ + .+.|.||+.+..
T Consensus       199 HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          199 HGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             CSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             eCCCCcccEeEc-C-CCEEEECCCCCc
Confidence            999999999999 4 899999987754

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=95.22  E-value=0.032  Score=58.21  Aligned_cols=126  Identities=15%  Similarity=0.142  Sum_probs=76.4

Q ss_pred             eEEEEEEEC---------CceEEEEEecc------chHHHHHHHhhcCCCce-eeeeeeeecCCeEEEEEEecCCCChHH
Q 039626          361 GSVYRGKIN---------GGFAAIKKVNG------DVSKEIALLNKINHSNL-IILSGVCFNEGNCYLVYEYAVNGTLSD  424 (628)
Q Consensus       361 G~Vy~g~~~---------g~~vavK~~~~------~~~~E~~~l~~l~H~nI-v~l~g~~~~~~~~~lV~E~~~~gsL~~  424 (628)
                      ..+|+....         ++.+++|+...      ++.+|.++++.+.-.++ .++++++.+    -+||||++|..|..
T Consensus        64 N~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e~i~G~~l~~  139 (379)
T 3feg_A           64 NLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQYIPSRPLKT  139 (379)
T ss_dssp             CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEECCSEEECCG
T ss_pred             ccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEEEecCccCCh
Confidence            568888763         36788887532      35679999988853333 466666643    28999999865531


Q ss_pred             H-----------------hhhcCC-CCCCCC--HHHHHHHHHHHH-------------------HHHHHH----hcC-CC
Q 039626          425 W-----------------VFSNKN-EGKYLD--WKQRIQIALDVA-------------------TGLNYL----HSF-TN  460 (628)
Q Consensus       425 ~-----------------l~~~~~-~~~~l~--~~~~~~i~~~ia-------------------~gL~yL----H~~-~~  460 (628)
                      -                 ||.... -++...  |.+..++..++.                   ..+..|    ... ..
T Consensus       140 ~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~~L~~~~~~  219 (379)
T 3feg_A          140 QELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRKLLESTPSP  219 (379)
T ss_dssp             GGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHHHHHTSCCC
T ss_pred             hHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHHHHhhcCCC
Confidence            1                 121111 112222  445555544332                   123333    221 12


Q ss_pred             CCeEecCCCCCCEEeCCC----CcEEEccccccc
Q 039626          461 PPHVHKDINSSNVLLDSD----LRAKIANFAMAR  490 (628)
Q Consensus       461 ~~iiH~dik~~NILl~~~----~~~kl~Dfgla~  490 (628)
                      ..++|+|+.+.|||++.+    +.+.++||..+.
T Consensus       220 ~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~  253 (379)
T 3feg_A          220 VVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS  253 (379)
T ss_dssp             EEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred             cEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence            458999999999999876    789999998764

>2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens}

Probab=94.66  E-value=0.0045  Score=42.41  Aligned_cols=28  Identities=21%  Similarity=0.243  Sum_probs=18.4

Q ss_pred             EEehhhHHHHHHHHHHHHhheeeEEecc
Q 039626          270 IVAGVLGGITLTLIFGATIFCKFFYTRK  297 (628)
Q Consensus       270 i~~~v~~~~~~~~~~~~~~~~~~~~~r~  297 (628)
                      |+++|++|++++++++++++++++|||+
T Consensus        13 IA~gVVgGv~~~~ii~~~~~~~~RRr~~   40 (44)
T 2ks1_B           13 IATGMVGALLLLLVVALGIGLFMRRRHI   40 (44)
T ss_dssp             STHHHHHHHHHHHHHHHHHHHHHHTTTC
T ss_pred             EEeehhHHHHHHHHHHHHHHHHhhhhHh
Confidence            6778888887776666665555544443

>2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens}

Probab=94.66  E-value=0.0046  Score=42.27  Aligned_cols=30  Identities=33%  Similarity=0.458  Sum_probs=19.3

Q ss_pred             EEEehhhHHHHHHHHHHHHhheeeEEeccC
Q 039626          269 YIVAGVLGGITLTLIFGATIFCKFFYTRKK  298 (628)
Q Consensus       269 ~i~~~v~~~~~~~~~~~~~~~~~~~~~r~~  298 (628)
                      .|+++|++|+++++++++++++++||||++
T Consensus        11 aIA~gVVgGv~~v~ii~~~~~~~~RRRr~~   40 (44)
T 2l2t_A           11 LIAAGVIGGLFILVIVGLTFAVYVRRKSIK   40 (44)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHHHHHTTCSS
T ss_pred             eEEEeehHHHHHHHHHHHHHHHHhhhhhhh
Confidence            377888888877766666655555544443

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=93.49  E-value=0.2  Score=52.91  Aligned_cols=125  Identities=10%  Similarity=0.113  Sum_probs=75.7

Q ss_pred             eEEEEEEEC---------CceEEEEEecc------chHHHHHHHhhcCCCce-eeeeeeeecCCeEEEEEEecCCCChHH
Q 039626          361 GSVYRGKIN---------GGFAAIKKVNG------DVSKEIALLNKINHSNL-IILSGVCFNEGNCYLVYEYAVNGTLSD  424 (628)
Q Consensus       361 G~Vy~g~~~---------g~~vavK~~~~------~~~~E~~~l~~l~H~nI-v~l~g~~~~~~~~~lV~E~~~~gsL~~  424 (628)
                      ..+|+....         ++.+++|+...      +..+|..+++.+...++ .++++.+  .+  ++|+||++|..|..
T Consensus        84 N~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~idR~~E~~~l~~L~~~gi~P~l~~~~--~~--~~I~efI~G~~l~~  159 (424)
T 3mes_A           84 NQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYDSKVELDVFRYLSNINIAPNIIADF--PE--GRIEEFIDGEPLTT  159 (424)
T ss_dssp             SEEEEEEECCC-----CCCSEEEEEECCCCC-CCCCHHHHHHHHHHHHHTTSSCCEEEEE--TT--EEEEECCCSEECCT
T ss_pred             cceEEEEeCCCcccccCCCCeEEEEECCCCcchhcCHHHHHHHHHHHHhcCCCCCEEEEc--CC--CEEEEEeCCccCCh
Confidence            578988875         57788887543      35689999988854344 3555543  22  68999999865421


Q ss_pred             H-----------------hhhcCC---------CCCCCCHHHHHHHHHHH-------------------HHHHHHHhc--
Q 039626          425 W-----------------VFSNKN---------EGKYLDWKQRIQIALDV-------------------ATGLNYLHS--  457 (628)
Q Consensus       425 ~-----------------l~~~~~---------~~~~l~~~~~~~i~~~i-------------------a~gL~yLH~--  457 (628)
                      -                 ||....         ...+.-|.+..++..++                   ...+.+|.+  
T Consensus       160 ~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~e~~~L~~~l  239 (424)
T 3mes_A          160 KQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKILEEIDQLEELI  239 (424)
T ss_dssp             GGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHHHHHHHHHHHH
T ss_pred             hhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHHHHHHHHHHHH
Confidence            0                 111101         11222344444433222                   223333321  


Q ss_pred             -------------------CCCCCeEecCCCCCCEEeCCCCcEEEccccccc
Q 039626          458 -------------------FTNPPHVHKDINSSNVLLDSDLRAKIANFAMAR  490 (628)
Q Consensus       458 -------------------~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~  490 (628)
                                         .....++|+|+.+.||+ +.++.+.++||..+.
T Consensus       240 ~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~  290 (424)
T 3mes_A          240 MGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSA  290 (424)
T ss_dssp             HTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCE
T ss_pred             hhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCC
Confidence                               11234899999999999 888899999998765

>3slu_A M23 peptidase domain protein; outer membrane, hydrolase; 2.41A {Neisseria meningitidis}

Probab=92.63  E-value=0.14  Score=52.86  Aligned_cols=52  Identities=13%  Similarity=0.216  Sum_probs=43.6

Q ss_pred             CCCeEEEEEccCCCcHHHHHHHhCCChHHHhhhcCCC----C-CCccccceeeccCC
Q 039626          180 GFPFLLSYLVAEGDTVSGISSRFGVDTGEILQANSLS----G-SNIFPFTTLLIPLE  231 (628)
Q Consensus       180 ~~~~~~~y~v~~gdtl~~ia~~f~~~~~~l~~~N~~~----~-~~~~~~~~l~iP~~  231 (628)
                      ...+..+|+|+.||||.+|-+++|++.+++.+++...    . ..|.|||++.+.+.
T Consensus        10 ~~~~W~~~~V~~GDTL~~IL~r~Gls~~di~~i~~~~~~~~~l~~LrpGq~l~i~~~   66 (371)
T 3slu_A           10 QTAYWVQEAVQPGDSLADVLARSGMARDEIARITEKYGGEADLRHLRADQSVHVLVG   66 (371)
T ss_dssp             CCCEEEEEECCTTCCHHHHHHHTTCCHHHHHHHHTTC------CCBCSSSEEEEEEC
T ss_pred             CCCceEEEEECCCCcHHHHHHHcCCCHHHHHHHHHhccccCchhhCCCCCEEEEEEC
Confidence            3457789999999999999999999999999886643    2 38999999998764

>2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A

Probab=90.50  E-value=0.034  Score=37.88  Aligned_cols=28  Identities=25%  Similarity=0.421  Sum_probs=13.3

Q ss_pred             EEehhhHHHHHHHHHHHHhheeeEEeccC
Q 039626          270 IVAGVLGGITLTLIFGATIFCKFFYTRKK  298 (628)
Q Consensus       270 i~~~v~~~~~~~~~~~~~~~~~~~~~r~~  298 (628)
                      |+++|++ +++++++++++++++||||.+
T Consensus        14 Ia~~vVG-vll~vi~~l~~~~~~RRR~~~   41 (44)
T 2jwa_A           14 IISAVVG-ILLVVVLGVVFGILIKRRQQK   41 (44)
T ss_dssp             HHHHHHH-HHHHHHHHHHHHHHHHHHCSC
T ss_pred             hHHHHHH-HHHHHHHHHHHHhheehhhhh
Confidence            4445554 444444444445444444433

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=83.81  E-value=3  Score=39.43  Aligned_cols=115  Identities=9%  Similarity=0.087  Sum_probs=76.2

Q ss_pred             CCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHH-HHhcCCCCCeEecCCCCC
Q 039626          393 NHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLN-YLHSFTNPPHVHKDINSS  471 (628)
Q Consensus       393 ~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~-yLH~~~~~~iiH~dik~~  471 (628)
                      .||++  -..+-.+++...+.|+--+++-=...+       +.++...+++++..|+.-.. +++.     -+|--+.|+
T Consensus        48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i-------~~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~  113 (219)
T 4ano_A           48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAI-------RKTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPE  113 (219)
T ss_dssp             SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHH-------HTSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGG
T ss_pred             cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHH-------HhcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCc
Confidence            67777  334445667777777665443222222       23778899999999988777 6665     688899999


Q ss_pred             CEEeCCCCcEEEccccccccCCCCCCcceeeecccCCccccCccccccCCCCcccccHHHHHHHHHHHhCCCccc
Q 039626          472 NVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAA  546 (628)
Q Consensus       472 NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~  546 (628)
                      ||++|.++.+++.-.|+-..+                    +|.-+     ++.-=.-.+=+++..++.++..|.
T Consensus       114 NL~f~~~~~p~i~hRGi~~~l--------------------pP~e~-----~ee~fl~qyKali~all~~K~~Fe  163 (219)
T 4ano_A          114 NLMFNRALEPFFLHVGVKESL--------------------PPDEW-----DDERLLREVKATVLALTEGEYRFD  163 (219)
T ss_dssp             GEEECTTCCEEESCCEETTTB--------------------SSCSC-----CHHHHHHHHHHHHHHHTTCSSCHH
T ss_pred             eEEEeCCCcEEEEEcCCcccC--------------------CCCCC-----CHHHHHHHHHHHHHHHHcCCCCHH
Confidence            999999999999988874433                    22211     111112366778888888876554

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=81.39  E-value=0.74  Score=48.08  Aligned_cols=28  Identities=21%  Similarity=0.455  Sum_probs=23.9

Q ss_pred             eEecCCCCCCEEe------CCCCcEEEccccccc
Q 039626          463 HVHKDINSSNVLL------DSDLRAKIANFAMAR  490 (628)
Q Consensus       463 iiH~dik~~NILl------~~~~~~kl~Dfgla~  490 (628)
                      ++|+|+.+.|||+      +++..++++||-.|.
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~  279 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS  279 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence            5799999999999      456789999998765

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=80.27  E-value=3.5  Score=38.77  Aligned_cols=123  Identities=10%  Similarity=0.078  Sum_probs=81.8

Q ss_pred             HHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeE
Q 039626          385 EIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHV  464 (628)
Q Consensus       385 E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ii  464 (628)
                      |+.+|. ..||+.+.. .+-.+++...+.|+.-  .+...|-     .-+.++...+++++..|+.-..+++.     =+
T Consensus        36 el~LL~-~~~~~Fl~~-~I~e~eD~v~~~y~~~--~~~~~f~-----~ik~~~~~eKlr~l~ni~~l~~~~~~-----r~  101 (215)
T 4ann_A           36 LMYLLE-QHSPYFIDA-ELTELRDSFQIHYDIN--DNHTPFD-----NIKSFTKNEKLRYLLNIKNLEEVNRT-----RY  101 (215)
T ss_dssp             GGGGGG-SCCTTBCCE-EEEECSSEEEEEECCC--TTSEEGG-----GGGGSCHHHHHHHHHHGGGGGGGGGS-----SE
T ss_pred             HHHHHh-ccCCcccce-EEEEcccEEEEEEEcC--cccCCHH-----HHHhcCHHHHHHHHHHHHHHHHHhcC-----ce
Confidence            444443 368888866 4555566655555543  3333322     12337788999999999998877765     57


Q ss_pred             ecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCCccccCccccccCCCCcccccHHHHHHHHHHHhCCCc
Q 039626          465 HKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEA  544 (628)
Q Consensus       465 H~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p  544 (628)
                      |--+.|+||++|.++.+++.-.|+-..+.                    |.     ..++..=.-.+=+++..+++++..
T Consensus       102 tf~L~P~NL~f~~~~~p~i~~RGik~~l~--------------------P~-----~~~ee~fL~qyKAliiall~~K~~  156 (215)
T 4ann_A          102 TFVLAPDELFFTRDGLPIAKTRGLQNVVD--------------------PL-----PVSEAEFLTRYKALVICAFNEKQS  156 (215)
T ss_dssp             ECCCSGGGEEECTTSCEEESCCEETTTBS--------------------CC-----CCCHHHHHHHHHHHHHHHHCTTCC
T ss_pred             EEEEecceEEEcCCCCEEEEEccCccCCC--------------------CC-----CCCHHHHHHHHHHHHHHHHcCCCC
Confidence            88999999999999999999888744332                    11     112222233677888899999876


Q ss_pred             cc
Q 039626          545 AA  546 (628)
Q Consensus       545 ~~  546 (628)
                      |.
T Consensus       157 Fe  158 (215)
T 4ann_A          157 FD  158 (215)
T ss_dssp             HH
T ss_pred             HH
Confidence            65

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	628
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	1e-57
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	9e-57
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	5e-54
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	5e-54
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	3e-53
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	1e-52
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	4e-52
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	1e-51
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	8e-51
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	2e-50
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	3e-50
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	1e-49
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	5e-49
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	6e-49
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	8e-49
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	8e-49
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	1e-48
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	1e-47
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	2e-47
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	2e-47
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	2e-47
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	9e-47
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	1e-46
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	2e-46
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	4e-45
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	9e-45
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	2e-44
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	2e-44
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	3e-44
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	4e-44
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	1e-43
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	6e-43
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	6e-43
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	7e-43
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	3e-42
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	6e-42
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	1e-41
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	3e-40
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	5e-39
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	2e-38
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	8e-38
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	4e-37
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	5e-37
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	7e-37
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	1e-36
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	5e-36
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	1e-35
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	1e-35
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	3e-35
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	2e-34
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	2e-33
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	4e-33
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	6e-33
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	8e-32
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	2e-31
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	4e-31
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	2e-28
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	4e-27
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	6e-27
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	1e-26
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	3e-26
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	4e-24
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	7e-12
d1y7ma2	48	d.7.1.1 (A:1-48) Hypothetical protein YkuD, N-term	5e-08
d1e0ga_	48	d.7.1.1 (A:) Membrane-bound lytic murein transclyc	3e-07

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  193 bits (492), Expect = 1e-57
 Identities = 66/274 (24%), Positives = 122/274 (44%), Gaps = 36/274 (13%)

Query: 361 GSVYRGKINGGFAAIKKVNGDVS---------KEIALLNKINHSNLIILSGVCFNEGNCY 411
           G+VY+GK +G  A +K +N              E+ +L K  H N+++  G         
Sbjct: 22  GTVYKGKWHGDVA-VKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLA 79

Query: 412 LVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSS 471
           +V ++    +L   +   + +    +  + I IA   A G++YLH       +H+D+ S+
Sbjct: 80  IVTQWCEGSSLYHHLHIIETK---FEMIKLIDIARQTAQGMDYLH---AKSIIHRDLKSN 133

Query: 472 NVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYL---ENGLVSTKLDV 528
           N+ L  DL  KI +F +A       G     + + G+  +MAPE +   +    S + DV
Sbjct: 134 NIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQ-LSGSILWMAPEVIRMQDKNPYSFQSDV 192

Query: 529 YAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLE 588
           YAFG+++ E++TG+         +N++  D +  ++ +              ++ N P  
Sbjct: 193 YAFGIVLYELMTGQLP------YSNINNRDQIIFMVGRG-----YLSPDLSKVRSNCPKA 241

Query: 589 LALLVIRLIDACLKKDPTDRPTMYEIEHSLSNIL 622
           +     RL+  CLKK   +RP   +I  S+  + 
Sbjct: 242 MK----RLMAECLKKKRDERPLFPQILASIELLA 271

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  191 bits (487), Expect = 9e-57
 Identities = 62/286 (21%), Positives = 115/286 (40%), Gaps = 28/286 (9%)

Query: 361 GSVYRGKINGGFAAIKKVNGDVSK------EIALLNKINHSNLIILSGVCFNEGNC---- 410
           G V+RGK  G   A+K  +    +      EI     + H N++        +       
Sbjct: 17  GEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL 76

Query: 411 YLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSF-----TNPPHVH 465
           +LV +Y  +G+L D++         +  +  I++AL  A+GL +LH         P   H
Sbjct: 77  WLVSDYHEHGSLFDYLNRYT-----VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAH 131

Query: 466 KDINSSNVLLDSDLRAKIANFA-MARPAEGQEGEFALTRHIVGTKGYMAPEYLENGL--- 521
           +D+ S N+L+  +    IA+     R     +       H VGTK YMAPE L++ +   
Sbjct: 132 RDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMK 191

Query: 522 ---VSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFID 578
                 + D+YA G++  E+        +H +    +   V +    +E  +      + 
Sbjct: 192 HFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLR 251

Query: 579 PTLQGNY-PLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILN 623
           P +   +   E   ++ +++  C   +   R T   I+ +LS +  
Sbjct: 252 PNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  183 bits (465), Expect = 5e-54
 Identities = 66/269 (24%), Positives = 108/269 (40%), Gaps = 36/269 (13%)

Query: 361 GSVYRGKINGGFAAIKKVNGDVS-----KEIALLNKINHSNLIILSGVCFNE-GNCYLVY 414
           G V  G   G   A+K +  D +      E +++ ++ HSNL+ L GV   E G  Y+V 
Sbjct: 21  GDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 80

Query: 415 EYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVL 474
           EY   G+L D++ S       L     ++ +LDV   + YL        VH+D+ + NVL
Sbjct: 81  EYMAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVL 135

Query: 475 LDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVL 534
           +  D  AK+++F + + A                  + APE L     STK DV++FG+L
Sbjct: 136 VSEDNVAKVSDFGLTKEASST------QDTGKLPVKWTAPEALREKKFSTKSDVWSFGIL 189

Query: 535 ILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVI 594
           + E+ +             + L DV+  V                      P  +     
Sbjct: 190 LWEIYSFG-----RVPYPRIPLKDVVPRVEKGY----------KMDAPDGCPPAV----Y 230

Query: 595 RLIDACLKKDPTDRPTMYEIEHSLSNILN 623
            ++  C   D   RP+  ++   L +I  
Sbjct: 231 EVMKNCWHLDAAMRPSFLQLREQLEHIKT 259

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  185 bits (470), Expect = 5e-54
 Identities = 54/309 (17%), Positives = 122/309 (39%), Gaps = 49/309 (15%)

Query: 346 LQSATDNFSFTCRI----QGSVYRG--KINGGFAAIKKVNGDVSK--------EIALLNK 391
           ++   D+F     +     G V++   K +G   A K ++ ++          E+ +L++
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60

Query: 392 INHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATG 451
            N   ++   G  +++G   +  E+   G+L   +     +   +  +   ++++ V  G
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL----KKAGRIPEQILGKVSIAVIKG 116

Query: 452 LNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGY 511
           L YL        +H+D+  SN+L++S    K+ +F ++           +    VGT+ Y
Sbjct: 117 LTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-----MANSFVGTRSY 169

Query: 512 MAPEYLENGLVSTKLDVYAFGVLILEMLTGK-------------------EAAALHAEEN 552
           M+PE L+    S + D+++ G+ ++EM  G+                   E  A      
Sbjct: 170 MSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPR 229

Query: 553 NMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLV----IRLIDACLKKDPTDR 608
                  L++         ++   +D  +    P   + +        ++ CL K+P +R
Sbjct: 230 PRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAER 289

Query: 609 PTMYEI-EH 616
             + ++  H
Sbjct: 290 ADLKQLMVH 298

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  181 bits (460), Expect = 3e-53
 Identities = 67/286 (23%), Positives = 119/286 (41%), Gaps = 38/286 (13%)

Query: 351 DNFSFTCRI----QGSVYRGKINGG-FAAIKKVNGD------VSKEIALLNKINHSNLII 399
           +      R+     G V+ G  NG    A+K +            E  L+ ++ H  L+ 
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVR 72

Query: 400 LSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFT 459
           L  V   +   Y++ EY  NG+L D++      G  L   + + +A  +A G+ ++    
Sbjct: 73  LYAVV-TQEPIYIITEYMENGSLVDFLK--TPSGIKLTINKLLDMAAQIAEGMAFIEE-- 127

Query: 460 NPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLEN 519
              ++H+D+ ++N+L+   L  KIA+F +AR  E  + E+           + APE +  
Sbjct: 128 -RNYIHRDLRAANILVSDTLSCKIADFGLARLIE--DNEYTAREGAKFPIKWTAPEAINY 184

Query: 520 GLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDP 579
           G  + K DV++FG+L+ E++T             M   +V+  +                
Sbjct: 185 GTFTIKSDVWSFGILLTEIVTHG-----RIPYPGMTNPEVIQNL----------ERGYRM 229

Query: 580 TLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNAS 625
               N P EL     +L+  C K+ P DRPT   +   L +   A+
Sbjct: 230 VRPDNCPEEL----YQLMRLCWKERPEDRPTFDYLRSVLEDFFTAT 271

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  180 bits (458), Expect = 1e-52
 Identities = 62/310 (20%), Positives = 132/310 (42%), Gaps = 53/310 (17%)

Query: 341 YSFKELQSATDNFSFTCRIQ-------------GSVYRGKI-----NGGFAAIKKVNGDV 382
           ++F++   A   F+    I              G V  G +        F AIK +    
Sbjct: 7   FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66

Query: 383 SK--------EIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGK 434
           ++        E +++ + +H N+I L GV        ++ E+  NG+L  +    +    
Sbjct: 67  TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSF---LRQNDG 123

Query: 435 YLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEG 494
                Q + +   +A G+ YL    +  +VH+D+ + N+L++S+L  K+++F ++R  E 
Sbjct: 124 QFTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180

Query: 495 QEGEFALTRHI--VGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEEN 552
              +   T  +       + APE ++    ++  DV+++G+++ E+++  E         
Sbjct: 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPY-----W 235

Query: 553 NMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMY 612
           +M   DV+NA              I+   +   P++    + +L+  C +KD   RP   
Sbjct: 236 DMTNQDVINA--------------IEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFG 281

Query: 613 EIEHSLSNIL 622
           +I ++L  ++
Sbjct: 282 QIVNTLDKMI 291

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (453), Expect = 4e-52
 Identities = 57/289 (19%), Positives = 109/289 (37%), Gaps = 43/289 (14%)

Query: 348 SATDNFSFTCRI----QGSVYRG--KINGGFAAIKKVNGD---------VSKEIALLNKI 392
           S  +++     I     G   +   K +G     K+++           +  E+ LL ++
Sbjct: 1   SRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL 60

Query: 393 NHSNLIILSGVCFNEGNC--YLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVAT 450
            H N++       +  N   Y+V EY   G L+  +     E +YLD +  +++   +  
Sbjct: 61  KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL 120

Query: 451 GLNYLHSFTNPPH--VHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGT 508
            L   H  ++  H  +H+D+  +NV LD     K+ +F +AR         +  +  VGT
Sbjct: 121 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDT---SFAKAFVGT 177

Query: 509 KGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKED 568
             YM+PE +     + K D+++ G L+ E+                   ++   +   + 
Sbjct: 178 PYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPP------FTAFSQKELAGKIREGK- 230

Query: 569 GEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEI-EH 616
                       +   Y  EL      +I   L      RP++ EI E+
Sbjct: 231 ---------FRRIPYRYSDEL----NEIITRMLNLKDYHRPSVEEILEN 266

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (448), Expect = 1e-51
 Identities = 64/285 (22%), Positives = 119/285 (41%), Gaps = 38/285 (13%)

Query: 351 DNFSFTCRI----QGSVYRGK-INGGFAAIKKVNGDVS------KEIALLNKINHSNLII 399
              +F   I     G V+ G  +N    AIK +           +E  ++ K++H  L+ 
Sbjct: 5   SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQ 64

Query: 400 LSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFT 459
           L GVC  +    LV+E+  +G LSD+    + +      +  + + LDV  G+ YL    
Sbjct: 65  LYGVCLEQAPICLVFEFMEHGCLSDY---LRTQRGLFAAETLLGMCLDVCEGMAYLEE-- 119

Query: 460 NPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLEN 519
               +H+D+ + N L+  +   K+++F M R     + ++  +        + +PE    
Sbjct: 120 -ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVL--DDQYTSSTGTKFPVKWASPEVFSF 176

Query: 520 GLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDP 579
              S+K DV++FGVL+ E+ +  +         N   S+V+  + T             P
Sbjct: 177 SRYSSKSDVWSFGVLMWEVFSEGKIP-----YENRSNSEVVEDISTGFR-------LYKP 224

Query: 580 TLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNA 624
            L   +       V ++++ C K+ P DRP    +   L+ I  +
Sbjct: 225 RLASTH-------VYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  175 bits (444), Expect = 8e-51
 Identities = 66/286 (23%), Positives = 122/286 (42%), Gaps = 38/286 (13%)

Query: 351 DNFSFTCRI----QGSVYRGKINGG-FAAIKKVNGDVS------KEIALLNKINHSNLII 399
           ++     ++     G V+ G  NG    AIK +           +E  ++ K+ H  L+ 
Sbjct: 17  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQ 76

Query: 400 LSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFT 459
           L  V   E   Y+V EY   G+L D++      GKYL   Q + +A  +A+G+ Y+    
Sbjct: 77  LYAVVSEE-PIYIVTEYMSKGSLLDFLKGET--GKYLRLPQLVDMAAQIASGMAYVE--- 130

Query: 460 NPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLEN 519
              +VH+D+ ++N+L+  +L  K+A+F +AR  E  + E+   +       + APE    
Sbjct: 131 RMNYVHRDLRAANILVGENLVCKVADFGLARLIE--DNEYTARQGAKFPIKWTAPEAALY 188

Query: 520 GLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDP 579
           G  + K DV++FG+L+ E+ T                                +   ++ 
Sbjct: 189 GRFTIKSDVWSFGILLTELTTKGRV-------------------PYPGMVNREVLDQVER 229

Query: 580 TLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNAS 625
             +   P E    +  L+  C +K+P +RPT   ++  L +   ++
Sbjct: 230 GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 275

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  174 bits (441), Expect = 2e-50
 Identities = 63/281 (22%), Positives = 116/281 (41%), Gaps = 40/281 (14%)

Query: 361 GSVYRG----KINGGFAAIKKVNGDVSK---------EIALLNKINHSNLIILSGVCFNE 407
           G+V +G    K      A+K +  + +          E  ++ ++++  ++ + G+C  E
Sbjct: 21  GTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE 80

Query: 408 GNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKD 467
            +  LV E A  G L+ ++  N+    ++  K  I++   V+ G+ YL        VH+D
Sbjct: 81  -SWMLVMEMAELGPLNKYLQQNR----HVKDKNIIELVHQVSMGMKYLE---ESNFVHRD 132

Query: 468 INSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLD 527
           + + NVLL +   AKI++F +++     E  +    H      + APE +     S+K D
Sbjct: 133 LAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSD 192

Query: 528 VYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPL 587
           V++FGVL+ E  +  +          M  S+V   +   E                  P 
Sbjct: 193 VWSFGVLMWEAFSYGQKPY-----RGMKGSEVTAMLEKGE----------RMGCPAGCPR 237

Query: 588 ELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNASLNW 628
           E+      L++ C   D  +RP    +E  L N     +N 
Sbjct: 238 EMY----DLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNE 274

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  174 bits (441), Expect = 3e-50
 Identities = 64/296 (21%), Positives = 119/296 (40%), Gaps = 38/296 (12%)

Query: 342 SFKELQSATDNFSFTCRI----QGSVYRG--KINGGFAAIKKVNGDVS------KEIALL 389
           ++ + +    + +   ++     G VY G  K      A+K +  D        KE A++
Sbjct: 8   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVM 67

Query: 390 NKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVA 449
            +I H NL+ L GVC  E   Y++ E+   G L D++   +   + +     + +A  ++
Sbjct: 68  KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR--ECNRQEVSAVVLLYMATQIS 125

Query: 450 TGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTK 509
           + + YL        +H+D+ + N L+  +   K+A+F ++R   G    +          
Sbjct: 126 SAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG--DTYTAHAGAKFPI 180

Query: 510 GYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDG 569
            + APE L     S K DV+AFGVL+ E+ T   +                         
Sbjct: 181 KWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMS-------------------PYPGID 221

Query: 570 EESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNAS 625
              +   ++   +   P      V  L+ AC + +P+DRP+  EI  +   +   S
Sbjct: 222 LSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 277

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  172 bits (436), Expect = 1e-49
 Identities = 69/320 (21%), Positives = 119/320 (37%), Gaps = 62/320 (19%)

Query: 342 SFKELQSATDNFSFTCRI----QGSVYRGKINGGFA-------AIKKVNGDVSK------ 384
               L+   +N  +   I     G V++ +  G          A+K +  + S       
Sbjct: 4   KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADF 63

Query: 385 --EIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKY------- 435
             E AL+ + ++ N++ L GVC       L++EY   G L++++ S              
Sbjct: 64  QREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 123

Query: 436 -------------LDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAK 482
                        L   +++ IA  VA G+ YL        VH+D+ + N L+  ++  K
Sbjct: 124 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVK 180

Query: 483 IANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGK 542
           IA+F ++R     +   A          +M PE +     +T+ DV+A+GV++ E+ +  
Sbjct: 181 IADFGLSRNIYSADYYKADGN-DAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYG 239

Query: 543 EAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLK 602
                      M   +V+  V                    N PLEL      L+  C  
Sbjct: 240 LQP-----YYGMAHEEVIYYVRDGN----------ILACPENCPLEL----YNLMRLCWS 280

Query: 603 KDPTDRPTMYEIEHSLSNIL 622
           K P DRP+   I   L  + 
Sbjct: 281 KLPADRPSFCSIHRILQRMC 300

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  170 bits (432), Expect = 5e-49
 Identities = 64/297 (21%), Positives = 113/297 (38%), Gaps = 45/297 (15%)

Query: 344 KELQSATDNFSFTCRIQ------GSVYRGKI----NGGFAAIKKVNGDVSK--------E 385
           K+L    DN      I+      GSV +G           AIK +     K        E
Sbjct: 1   KKLFLKRDNLLIA-DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMRE 59

Query: 386 IALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIA 445
             +++++++  ++ L GVC       LV E A  G L  ++   + E   +      ++ 
Sbjct: 60  AQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREE---IPVSNVAELL 115

Query: 446 LDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHI 505
             V+ G+ YL        VH+D+ + NVLL +   AKI++F +++     +  +      
Sbjct: 116 HQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAG 172

Query: 506 VGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLT 565
                + APE +     S++ DV+++GV + E L+  +          M   +V+  +  
Sbjct: 173 KWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKP-----YKKMKGPEVMAFI-- 225

Query: 566 KEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNIL 622
               E+  R    P      P EL      L+  C      DRP    +E  +    
Sbjct: 226 ----EQGKRMECPP----ECPPELY----ALMSDCWIYKWEDRPDFLTVEQRMRACY 270

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (429), Expect = 6e-49
 Identities = 55/282 (19%), Positives = 117/282 (41%), Gaps = 38/282 (13%)

Query: 351 DNFSFTCRI----QGSVYRGKINGGFA-AIKKVNGDVS------KEIALLNKINHSNLII 399
            + +F   +     G V  GK  G +  AIK +           +E  ++  ++H  L+ 
Sbjct: 4   KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQ 63

Query: 400 LSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFT 459
           L GVC  +   +++ EY  NG L +++   +        +Q +++  DV   + YL    
Sbjct: 64  LYGVCTKQRPIFIITEYMANGCLLNYLREMR---HRFQTQQLLEMCKDVCEAMEYLE--- 117

Query: 460 NPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLEN 519
           +   +H+D+ + N L++     K+++F ++R     + E+  +        +  PE L  
Sbjct: 118 SKQFLHRDLAARNCLVNDQGVVKVSDFGLSR--YVLDDEYTSSVGSKFPVRWSPPEVLMY 175

Query: 520 GLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDP 579
              S+K D++AFGVL+ E+ +  +    +    N   ++                  I  
Sbjct: 176 SKFSSKSDIWAFGVLMWEIYSLGKMP--YERFTNSETAE-----------------HIAQ 216

Query: 580 TLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNI 621
            L+   P   +  V  ++ +C  +   +RPT   +  ++ ++
Sbjct: 217 GLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  170 bits (432), Expect = 8e-49
 Identities = 68/272 (25%), Positives = 103/272 (37%), Gaps = 49/272 (18%)

Query: 361 GSVYRG--KINGGFAAIKKVN----------GDVSKEIALLNKINHSNLIILSGVCFNEG 408
           G+VY      N    AIKK++           D+ KE+  L K+ H N I   G    E 
Sbjct: 29  GAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREH 88

Query: 409 NCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDI 468
             +LV EY +           +   K L   +   +      GL YLHS      +H+D+
Sbjct: 89  TAWLVMEYCLGSASDLL----EVHKKPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDV 141

Query: 469 NSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLE---NGLVSTK 525
            + N+LL      K+ +F  A          A     VGT  +MAPE +     G    K
Sbjct: 142 KAGNILLSEPGLVKLGDFGSASI-------MAPANSFVGTPYWMAPEVILAMDEGQYDGK 194

Query: 526 LDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNY 585
           +DV++ G+  +E+   K          NM+    L  +   E               G++
Sbjct: 195 VDVWSLGITCIELAERKPPL------FNMNAMSALYHIAQNES---------PALQSGHW 239

Query: 586 PLELALLVIRLIDACLKKDPTDRPTMYEI-EH 616
                      +D+CL+K P DRPT   + +H
Sbjct: 240 SEYF----RNFVDSCLQKIPQDRPTSEVLLKH 267

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  170 bits (430), Expect = 8e-49
 Identities = 57/278 (20%), Positives = 113/278 (40%), Gaps = 39/278 (14%)

Query: 361 GSVYRGKINGG------FAAIKKVNGDVS--------KEIALLNKINHSNLIILSGVCFN 406
           G VY+G +           AIK +    +         E  ++ + +H N+I L GV   
Sbjct: 21  GEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK 80

Query: 407 EGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHK 466
                ++ EY  NG L  +    + +       Q + +   +A G+ YL    N  +VH+
Sbjct: 81  YKPMMIITEYMENGALDKF---LREKDGEFSVLQLVGMLRGIAAGMKYLA---NMNYVHR 134

Query: 467 DINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKL 526
           D+ + N+L++S+L  K+++F ++R  E        T        + APE +     ++  
Sbjct: 135 DLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSAS 194

Query: 527 DVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYP 586
           DV++FG+++ E++T  E                       E     +   I+   +   P
Sbjct: 195 DVWSFGIVMWEVMTYGERPY-------------------WELSNHEVMKAINDGFRLPTP 235

Query: 587 LELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNA 624
           ++    + +L+  C +++   RP   +I   L  ++ A
Sbjct: 236 MDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (428), Expect = 1e-48
 Identities = 57/282 (20%), Positives = 108/282 (38%), Gaps = 42/282 (14%)

Query: 351 DNFSFTCRI----QGSVYRG--KINGGFAAIKKVNGD--------VSKEIALLNKINHSN 396
           +++     +     G V     ++     A+K V+          + KEI +   +NH N
Sbjct: 5   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64

Query: 397 LIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLH 456
           ++   G        YL  EY   G L D +  +      +      +    +  G+ YLH
Sbjct: 65  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG----MPEPDAQRFFHQLMAGVVYLH 120

Query: 457 SFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEY 516
                   H+DI   N+LLD     KI++F +A           L   + GT  Y+APE 
Sbjct: 121 G---IGITHRDIKPENLLLDERDNLKISDFGLAT-VFRYNNRERLLNKMCGTLPYVAPEL 176

Query: 517 LENG-LVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRH 575
           L+     +  +DV++ G+++  ML G+    L  ++ +              D  +    
Sbjct: 177 LKRREFHAEPVDVWSCGIVLTAMLAGE----LPWDQPS--------------DSCQEYSD 218

Query: 576 FIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEI-EH 616
           + +     N   ++    + L+   L ++P+ R T+ +I + 
Sbjct: 219 WKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 260

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  165 bits (420), Expect = 1e-47
 Identities = 64/283 (22%), Positives = 110/283 (38%), Gaps = 50/283 (17%)

Query: 351 DNFSFTCRI----QGSVYRG--KINGGFAAIKKVNGD----------VSKEIALLNKINH 394
           ++F     +     G+VY    K +    A+K +             + +E+ + + + H
Sbjct: 6   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65

Query: 395 SNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNY 454
            N++ L G   +    YL+ EYA  GT+   +          D ++      ++A  L+Y
Sbjct: 66  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELANALSY 121

Query: 455 LHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAP 514
            HS      +H+DI   N+LL S    KIA+F  +  A            + GT  Y+ P
Sbjct: 122 CHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR-----RTTLCGTLDYLPP 173

Query: 515 EYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLR 574
           E +E  +   K+D+++ GVL  E L GK               +    +      E +  
Sbjct: 174 EMIEGRMHDEKVDLWSLGVLCYEFLVGK---PPFEANTYQ---ETYKRISR---VEFTFP 224

Query: 575 HFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEI-EH 616
            F+    +             LI   LK +P+ RP + E+ EH
Sbjct: 225 DFVTEGAR------------DLISRLLKHNPSQRPMLREVLEH 255

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  166 bits (421), Expect = 2e-47
 Identities = 58/271 (21%), Positives = 104/271 (38%), Gaps = 42/271 (15%)

Query: 361 GSVYRG--KINGGFAAIKKVNG-------DVSKEIALLNKINHSNLIILSGVCFNEGNCY 411
           G VY+   K     AA K ++        D   EI +L   +H N++ L    + E N +
Sbjct: 26  GKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLW 85

Query: 412 LVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSS 471
           ++ E+   G +   +   +   + L   Q   +       LNYLH       +H+D+ + 
Sbjct: 86  ILIEFCAGGAVDAVMLELE---RPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAG 139

Query: 472 NVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYL-----ENGLVSTKL 526
           N+L   D   K+A+F ++                +GT  +MAPE +     ++     K 
Sbjct: 140 NILFTLDGDIKLADFGVSAKN---TRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKA 196

Query: 527 DVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYP 586
           DV++ G+ ++EM   +     H E N M    VL  +   E    +         +    
Sbjct: 197 DVWSLGITLIEMAEIE---PPHHELNPM---RVLLKIAKSEPPTLAQPSRWSSNFK---- 246

Query: 587 LELALLVIRLIDACLKKDPTDRPTMYEI-EH 616
                     +  CL+K+   R T  ++ +H
Sbjct: 247 --------DFLKKCLEKNVDARWTTSQLLQH 269

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  166 bits (422), Expect = 2e-47
 Identities = 54/297 (18%), Positives = 110/297 (37%), Gaps = 52/297 (17%)

Query: 361 GSVYRGKI-------NGGFAAIKKVNGDVS--------KEIALLNKI-NHSNLIILSGVC 404
           G V                 A+K +              E+ +L+ + NH N++ L G C
Sbjct: 37  GKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGAC 96

Query: 405 FNEGNCYLVYEYAVNGTLSDWVFSNK--------------NEGKYLDWKQRIQIALDVAT 450
              G   ++ EY   G L +++   +              ++   LD +  +  +  VA 
Sbjct: 97  TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAK 156

Query: 451 GLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKG 510
           G+ +L S      +H+D+ + N+LL      KI +F +AR  +  +  + +  +      
Sbjct: 157 GMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIK-NDSNYVVKGNARLPVK 212

Query: 511 YMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGE 570
           +MAPE + N + + + DV+++G+ + E+ +   +       ++                 
Sbjct: 213 WMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK---------------- 256

Query: 571 ESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNASLN 627
                 I    +   P      +  ++  C   DP  RPT  +I   +   ++ S N
Sbjct: 257 --FYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISESTN 311

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  166 bits (421), Expect = 2e-47
 Identities = 57/266 (21%), Positives = 105/266 (39%), Gaps = 39/266 (14%)

Query: 361 GSVYRG--KINGGFAAIKKVNGD-------VSKEIALLNKINHSNLIILSGVCFNEGNCY 411
           G+VY       G   AI+++N         +  EI ++ +  + N++            +
Sbjct: 34  GTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELW 93

Query: 412 LVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSS 471
           +V EY   G+L+D V          D  Q   +  +    L +LHS      +H+DI S 
Sbjct: 94  VVMEYLAGGSLTDVVTETCM-----DEGQIAAVCRECLQALEFLHSN---QVIHRDIKSD 145

Query: 472 NVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAF 531
           N+LL  D   K+ +F        ++ +      +VGT  +MAPE +       K+D+++ 
Sbjct: 146 NILLGMDGSVKLTDFGFCAQITPEQSK---RSTMVGTPYWMAPEVVTRKAYGPKVDIWSL 202

Query: 532 GVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELAL 591
           G++ +EM+ G+     +  EN +     L  + T    E      +    +         
Sbjct: 203 GIMAIEMIEGE---PPYLNENPL---RALYLIATNGTPELQNPEKLSAIFR--------- 247

Query: 592 LVIRLIDACLKKDPTDRPTMYEI-EH 616
                ++ CL  D   R +  E+ +H
Sbjct: 248 ---DFLNRCLDMDVEKRGSAKELLQH 270

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  165 bits (418), Expect = 9e-47
 Identities = 73/301 (24%), Positives = 128/301 (42%), Gaps = 55/301 (18%)

Query: 351 DNFSFTCRI----QGSVYRGKINGG----FAAIKKVNGDVSK--------EIALLNKI-N 393
           ++  F   I     G V + +I        AAIK++    SK        E+ +L K+ +
Sbjct: 10  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69

Query: 394 HSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSN------------KNEGKYLDWKQR 441
           H N+I L G C + G  YL  EYA +G L D++  +             +    L  +Q 
Sbjct: 70  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129

Query: 442 IQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFAL 501
           +  A DVA G++YL        +H+D+ + N+L+  +  AKIA+F ++R     +  +  
Sbjct: 130 LHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR----GQEVYVK 182

Query: 502 TRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLN 561
                    +MA E L   + +T  DV+++GVL+ E+++             M  +++  
Sbjct: 183 KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLG-----GTPYCGMTCAELYE 237

Query: 562 AVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNI 621
            +      E               PL     V  L+  C ++ P +RP+  +I  SL+ +
Sbjct: 238 KLPQGYRLE--------------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 283

Query: 622 L 622
           L
Sbjct: 284 L 284

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  163 bits (414), Expect = 1e-46
 Identities = 53/273 (19%), Positives = 101/273 (36%), Gaps = 46/273 (16%)

Query: 361 GSVYRG--KINGGFAAIKKVNGD---------VSKEIALLNKINHSNLIILSGVCF---- 405
            +VY+G         A  ++              +E  +L  + H N++           
Sbjct: 23  KTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVK 82

Query: 406 NEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVH 465
            +    LV E   +GTL  ++       K +  K        +  GL +LH+   PP +H
Sbjct: 83  GKKCIVLVTELMTSGTLKTYLK----RFKVMKIKVLRSWCRQILKGLQFLHTR-TPPIIH 137

Query: 466 KDINSSNVLLDS-DLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVST 524
           +D+   N+ +       KI +  +A             + ++GT  +MAPE  E      
Sbjct: 138 RDLKCDNIFITGPTGSVKIGDLGLATLKRAS-----FAKAVIGTPEFMAPEMYEEK-YDE 191

Query: 525 KLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGN 584
            +DVYAFG+ +LEM T +     ++E  N                 +  R         +
Sbjct: 192 SVDVYAFGMCMLEMATSE---YPYSECQNA---------------AQIYRRVTSGVKPAS 233

Query: 585 YPLELALLVIRLIDACLKKDPTDRPTMYEI-EH 616
           +       V  +I+ C++++  +R ++ ++  H
Sbjct: 234 FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 266

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  164 bits (415), Expect = 2e-46
 Identities = 66/282 (23%), Positives = 116/282 (41%), Gaps = 40/282 (14%)

Query: 361 GSVYRGKINGG-----FAAIKKVNGDVS--------KEIALLNKINHSNLIILSGVCF-N 406
           G VY G +          A+K +N             E  ++   +H N++ L G+C  +
Sbjct: 41  GCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS 100

Query: 407 EGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHK 466
           EG+  +V  Y  +G L +++    NE      K  I   L VA G+ +L    +   VH+
Sbjct: 101 EGSPLVVLPYMKHGDLRNFIR---NETHNPTVKDLIGFGLQVAKGMKFLA---SKKFVHR 154

Query: 467 DINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTR-HIVGTKGYMAPEYLENGLVSTK 525
           D+ + N +LD     K+A+F +AR    +E +    +        +MA E L+    +TK
Sbjct: 155 DLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTK 214

Query: 526 LDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNY 585
            DV++FGVL+ E++T            +++  D+   +L         R  + P      
Sbjct: 215 SDVWSFGVLLWELMTRGAPP-----YPDVNTFDITVYLLQG-------RRLLQPE---YC 259

Query: 586 PLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNASLN 627
           P  L      ++  C       RP+  E+   +S I +  + 
Sbjct: 260 PDPL----YEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 297

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  159 bits (403), Expect = 4e-45
 Identities = 68/275 (24%), Positives = 110/275 (40%), Gaps = 41/275 (14%)

Query: 361 GSVYRGKI----NGGFA-AIKKVNGDVS--------KEIALLNKINHSNLIILSGVCFNE 407
           G V++G      N   A AIK      S        +E   + + +H +++ L GV   E
Sbjct: 21  GDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TE 79

Query: 408 GNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKD 467
              +++ E    G L  ++   K     LD    I  A  ++T L YL S      VH+D
Sbjct: 80  NPVWIIMELCTLGELRSFLQVRKYS---LDLASLILYAYQLSTALAYLES---KRFVHRD 133

Query: 468 INSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLD 527
           I + NVL+ S+   K+ +F ++R  E  +  +           +MAPE +     ++  D
Sbjct: 134 IAARNVLVSSNDCVKLGDFGLSRYME--DSTYYKASKGKLPIKWMAPESINFRRFTSASD 191

Query: 528 VYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPL 587
           V+ FGV + E+L              +  +DV+  +   E             +  N P 
Sbjct: 192 VWMFGVCMWEILMHGVKP-----FQGVKNNDVIGRIENGE----------RLPMPPNCPP 236

Query: 588 ELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNIL 622
            L      L+  C   DP+ RP   E++  LS IL
Sbjct: 237 TLY----SLMTKCWAYDPSRRPRFTELKAQLSTIL 267

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  160 bits (405), Expect = 9e-45
 Identities = 55/293 (18%), Positives = 107/293 (36%), Gaps = 57/293 (19%)

Query: 361 GSVYRGKINGG-------FAAIKKVNGDVS--------KEIALLNKI-NHSNLIILSGVC 404
           G V      G          A+K +              E+ ++ ++ +H N++ L G C
Sbjct: 51  GKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGAC 110

Query: 405 FNEGNCYLVYEYAVNGTLSDWVFSNKN-------------------EGKYLDWKQRIQIA 445
              G  YL++EY   G L +++ S +                    +   L ++  +  A
Sbjct: 111 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFA 170

Query: 446 LDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHI 505
             VA G+ +L        VH+D+ + NVL+      KI +F +AR     +  + +  + 
Sbjct: 171 YQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARDIM-SDSNYVVRGNA 226

Query: 506 VGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLT 565
                +MAPE L  G+ + K DV+++G+L+ E+ +                         
Sbjct: 227 RLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP------------------YP 268

Query: 566 KEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSL 618
               + +    I    + + P      +  ++ +C   D   RP+   +   L
Sbjct: 269 GIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL 321

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  159 bits (404), Expect = 2e-44
 Identities = 60/268 (22%), Positives = 105/268 (39%), Gaps = 39/268 (14%)

Query: 361 GSVYRG--KINGGFAAIKKVNGD-------VSKEIALLNKINHSNLIILSGVCFNEGNCY 411
           G V+R   K  G     K +N         V  EI+++N+++H  LI L     ++    
Sbjct: 43  GVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMV 102

Query: 412 LVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSS 471
           L+ E+   G L D +     E   +   + I        GL ++H       VH DI   
Sbjct: 103 LILEFLSGGELFDRI---AAEDYKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPE 156

Query: 472 NVLLDS--DLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVY 529
           N++ ++      KI +F +A      E    + +    T  + APE ++   V    D++
Sbjct: 157 NIMCETKKASSVKIIDFGLATKLNPDE----IVKVTTATAEFAAPEIVDREPVGFYTDMW 212

Query: 530 AFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLEL 589
           A GVL   +L+G    +  A E+++   + L  V              D     +    +
Sbjct: 213 AIGVLGYVLLSGL---SPFAGEDDL---ETLQNVKRC-----------DWEFDEDAFSSV 255

Query: 590 ALLVIRLIDACLKKDPTDRPTMYEI-EH 616
           +      I   L+K+P  R T+++  EH
Sbjct: 256 SPEAKDFIKNLLQKEPRKRLTVHDALEH 283

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (398), Expect = 2e-44
 Identities = 61/287 (21%), Positives = 112/287 (39%), Gaps = 44/287 (15%)

Query: 351 DNFSFTCRI----QGSVYRGKIN-----GGFAAIKKVNGDVS----------KEIALLNK 391
            +     ++     G V RG+ +         A+K +  DV           +E+  ++ 
Sbjct: 8   KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67

Query: 392 INHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATG 451
           ++H NLI L GV        +V E A  G+L D +  ++    +       + A+ VA G
Sbjct: 68  LDHRNLIRLYGVVL-TPPMKMVTELAPLGSLLDRLRKHQ---GHFLLGTLSRYAVQVAEG 123

Query: 452 LNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGY 511
           + YL S      +H+D+ + N+LL +    KI +F + R     +  + +  H      +
Sbjct: 124 MGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAW 180

Query: 512 MAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEE 571
            APE L+    S   D + FGV + EM T  +          ++ S +L+ +  + +   
Sbjct: 181 CAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP-----WIGLNGSQILHKIDKEGE--- 232

Query: 572 SLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSL 618
                       + P ++      ++  C    P DRPT   +   L
Sbjct: 233 ------RLPRPEDCPQDI----YNVMVQCWAHKPEDRPTFVALRDFL 269

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  158 bits (400), Expect = 3e-44
 Identities = 62/289 (21%), Positives = 108/289 (37%), Gaps = 40/289 (13%)

Query: 343 FKELQSATDNFSFTCRI----QGSVYRG--KINGGFAAIKKVN--------GDVSKEIAL 388
           +K+ +   D + F   +       V     K      AIK +         G +  EIA+
Sbjct: 1   WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAV 60

Query: 389 LNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDV 448
           L+KI H N++ L  +  + G+ YL+ +    G L D +        +   +   ++   V
Sbjct: 61  LHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG----FYTERDASRLIFQV 116

Query: 449 ATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGT 508
              + YLH         K  N     LD D +  I++F +++     E   ++     GT
Sbjct: 117 LDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK----MEDPGSVLSTACGT 172

Query: 509 KGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKED 568
            GY+APE L     S  +D ++ GV+   +L G        +EN+     +   +L  E 
Sbjct: 173 PGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGY---PPFYDENDA---KLFEQILKAE- 225

Query: 569 GEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEI-EH 616
                 +  D     +            I   ++KDP  R T  +  +H
Sbjct: 226 ------YEFDSPYWDDISDSA----KDFIRHLMEKDPEKRFTCEQALQH 264

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (397), Expect = 4e-44
 Identities = 56/298 (18%), Positives = 107/298 (35%), Gaps = 50/298 (16%)

Query: 351 DNFSFTCRI----QGSVYRG--KINGGFAAIKKVNGD----------VSKEIALLNKINH 394
           ++F F   +      +V            AIK +             V++E  ++++++H
Sbjct: 8   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67

Query: 395 SNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNY 454
              + L     ++   Y    YA NG L  ++    +     D         ++ + L Y
Sbjct: 68  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS----FDETCTRFYTAEIVSALEY 123

Query: 455 LHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAP 514
           LH       +H+D+   N+LL+ D+  +I +F  A+     E + A     VGT  Y++P
Sbjct: 124 LHG---KGIIHRDLKPENILLNEDMHIQITDFGTAK-VLSPESKQARANSFVGTAQYVSP 179

Query: 515 EYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLR 574
           E L         D++A G +I +++ G          N      +   ++  E       
Sbjct: 180 ELLTEKSACKSSDLWALGCIIYQLVAGL---PPFRAGNEY---LIFQKIIKLE------- 226

Query: 575 HFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILN----ASLNW 628
                    ++P +       L++  L  D T R    E+E     +       S+ W
Sbjct: 227 --------YDFPEKFFPKARDLVEKLLVLDATKRLGCEEME-GYGPLKAHPFFESVTW 275

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  157 bits (398), Expect = 1e-43
 Identities = 55/268 (20%), Positives = 103/268 (38%), Gaps = 39/268 (14%)

Query: 361 GSVYRG--KINGGFAAIKKVNGD-------VSKEIALLNKINHSNLIILSGVCFNEGNCY 411
           G V+R   +  G   A K V          V KEI  ++ + H  L+ L     ++    
Sbjct: 40  GVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMV 99

Query: 412 LVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSS 471
           ++YE+   G L + V    +E   +   + ++    V  GL ++H      +VH D+   
Sbjct: 100 MIYEFMSGGELFEKVA---DEHNKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPE 153

Query: 472 NVLLDSDL--RAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVY 529
           N++  +      K+ +F +    + ++      +   GT  + APE  E   V    D++
Sbjct: 154 NIMFTTKRSNELKLIDFGLTAHLDPKQ----SVKVTTGTAEFAAPEVAEGKPVGYYTDMW 209

Query: 530 AFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLEL 589
           + GVL   +L+G   +    E ++  L +V +               +D +       + 
Sbjct: 210 SVGVLSYILLSGL--SPFGGENDDETLRNVKSCDWN-----------MDDSAFSGISEDG 256

Query: 590 ALLVIRLIDACLKKDPTDRPTMYEI-EH 616
                  I   L  DP  R T+++  EH
Sbjct: 257 ----KDFIRKLLLADPNTRMTIHQALEH 280

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (391), Expect = 6e-43
 Identities = 52/277 (18%), Positives = 107/277 (38%), Gaps = 41/277 (14%)

Query: 361 GSVYR------GKINGGFAAIKKVNGDVS--------KEIALLNKINHSNLIILSGVCFN 406
           G+VY+      G+      AIK++    S         E  ++  +++ ++  L G+C  
Sbjct: 23  GTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICL- 81

Query: 407 EGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHK 466
                L+ +    G L D+V  +K     +  +  +   + +A G+NYL    +   VH+
Sbjct: 82  TSTVQLITQLMPFGCLLDYVREHK---DNIGSQYLLNWCVQIAKGMNYLE---DRRLVHR 135

Query: 467 DINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKL 526
           D+ + NVL+ +    KI +F +A+    +E E+           +MA E + + + + + 
Sbjct: 136 DLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG-GKVPIKWMALESILHRIYTHQS 194

Query: 527 DVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYP 586
           DV+++GV + E++T                                +   ++   +   P
Sbjct: 195 DVWSYGVTVWELMTFGSKP-------------------YDGIPASEISSILEKGERLPQP 235

Query: 587 LELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILN 623
               + V  ++  C   D   RP   E+    S +  
Sbjct: 236 PICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (390), Expect = 6e-43
 Identities = 62/283 (21%), Positives = 112/283 (39%), Gaps = 44/283 (15%)

Query: 361 GSVYRGKI-------NGGFAAIKKVNGDVS--------KEIALLNKINHSNLIILSGVCF 405
           G VY G              AIK VN   S         E +++ + N  +++ L GV  
Sbjct: 34  GMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS 93

Query: 406 NEGNCYLVYEYAVNGTLSDWVFSNKNEGKY------LDWKQRIQIALDVATGLNYLHSFT 459
                 ++ E    G L  ++ S +               + IQ+A ++A G+ YL++  
Sbjct: 94  QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA-- 151

Query: 460 NPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLEN 519
               VH+D+ + N ++  D   KI +F M R    +   +      +    +M+PE L++
Sbjct: 152 -NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDI-YETDYYRKGGKGLLPVRWMSPESLKD 209

Query: 520 GLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDP 579
           G+ +T  DV++FGV++ E+ T  E          +    VL  V+     +         
Sbjct: 210 GVFTTYSDVWSFGVVLWEIATLAEQP-----YQGLSNEQVLRFVMEGGLLD--------- 255

Query: 580 TLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNIL 622
                 P     ++  L+  C + +P  RP+  EI  S+   +
Sbjct: 256 -----KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM 293

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (389), Expect = 7e-43
 Identities = 66/295 (22%), Positives = 116/295 (39%), Gaps = 53/295 (17%)

Query: 361 GSVYRGK---------INGGFAAIKKVNGDVSK--------EIALLNKI-NHSNLIILSG 402
           G V   +               A+K +  D ++        E+ ++  I  H N+I L G
Sbjct: 27  GQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLG 86

Query: 403 VCFNEGNCYLVYEYAVNGTLSDWVFSNK------------NEGKYLDWKQRIQIALDVAT 450
            C  +G  Y++ EYA  G L +++ + +            N  + L  K  +  A  VA 
Sbjct: 87  ACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVAR 146

Query: 451 GLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKG 510
           G+ YL S      +H+D+ + NVL+  D   KIA+F +AR        +  T +      
Sbjct: 147 GMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIH-HIDYYKKTTNGRLPVK 202

Query: 511 YMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGE 570
           +MAPE L + + + + DV++FGVL+ E+ T   +                          
Sbjct: 203 WMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS-------------------PYPGVPV 243

Query: 571 ESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNAS 625
           E L   +    + + P      +  ++  C    P+ RPT  ++   L  I+  +
Sbjct: 244 EELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALT 298

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (384), Expect = 3e-42
 Identities = 61/294 (20%), Positives = 114/294 (38%), Gaps = 51/294 (17%)

Query: 361 GSVYRG-------KINGGFAAIKKVNGDVS--------KEIALLNKINHSNLII-LSGVC 404
           G V                 A+K +    +         E+ +L  I H   ++ L G C
Sbjct: 27  GQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGAC 86

Query: 405 FNEGNC-YLVYEYAVNGTLSDWVFSNKNE------------GKYLDWKQRIQIALDVATG 451
              G    ++ E+   G LS ++ S +NE              +L  +  I  +  VA G
Sbjct: 87  TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKG 146

Query: 452 LNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGY 511
           + +L S      +H+D+ + N+LL      KI +F +AR    ++ ++           +
Sbjct: 147 MEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDI-YKDPDYVRKGDARLPLKW 202

Query: 512 MAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEE 571
           MAPE + + + + + DV++FGVL+ E+ +        +    + + +     L KE    
Sbjct: 203 MAPETIFDRVYTIQSDVWSFGVLLWEIFSLG-----ASPYPGVKIDEEFCRRL-KEGTRM 256

Query: 572 SLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNAS 625
               +  P +             + +  C   +P+ RPT  E+   L N+L A+
Sbjct: 257 RAPDYTTPEM------------YQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 298

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (384), Expect = 6e-42
 Identities = 55/267 (20%), Positives = 100/267 (37%), Gaps = 38/267 (14%)

Query: 361 GSVYRG--KINGGFAAIKKVNGD------VSKEIALLNKINHSNLIILSGVCFNEGNCYL 412
           G V+R     +      K V         V KEI++LN   H N++ L     +     +
Sbjct: 19  GIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVM 78

Query: 413 VYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSN 472
           ++E+     + + +         L+ ++ +     V   L +LHS       H DI   N
Sbjct: 79  IFEFISGLDIFERI---NTSAFELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPEN 132

Query: 473 VLLDSD--LRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYA 530
           ++  +      KI  F  AR  +  +      R +     Y APE  ++ +VST  D+++
Sbjct: 133 IIYQTRRSSTIKIIEFGQARQLKPGD----NFRLLFTAPEYYAPEVHQHDVVSTATDMWS 188

Query: 531 FGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELA 590
            G L+  +L+G         E N     ++  ++  E            T       E++
Sbjct: 189 LGTLVYVLLSGI---NPFLAETNQ---QIIENIMNAE-----------YTFDEEAFKEIS 231

Query: 591 LLVIRLIDACLKKDPTDRPTMYEI-EH 616
           +  +  +D  L K+   R T  E  +H
Sbjct: 232 IEAMDFVDRLLVKERKSRMTASEALQH 258

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  149 bits (378), Expect = 1e-41
 Identities = 56/280 (20%), Positives = 107/280 (38%), Gaps = 41/280 (14%)

Query: 361 GSVYRG--KINGGFAAIKKVNGDVSK----------EIALLNKINHSNLIILSGVCFNEG 408
             V+           A+K +  D+++          E      +NH  ++ +      E 
Sbjct: 21  SEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET 80

Query: 409 N----CYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHV 464
                 Y+V EY    TL D V +       +  K+ I++  D    LN+ H       +
Sbjct: 81  PAGPLPYIVMEYVDGVTLRDIVHTEGP----MTPKRAIEVIADACQALNFSHQ---NGII 133

Query: 465 HKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVST 524
           H+D+  +N+++ +    K+ +F +AR           T  ++GT  Y++PE      V  
Sbjct: 134 HRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDA 193

Query: 525 KLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGN 584
           + DVY+ G ++ E+LTG+        ++ +    V    + +           DP     
Sbjct: 194 RSDVYSLGCVLYEVLTGE---PPFTGDSPV---SVAYQHVRE-----------DPIPPSA 236

Query: 585 YPLELALLVIRLIDACLKKDPTDRP-TMYEIEHSLSNILN 623
               L+  +  ++   L K+P +R  T  E+   L  + N
Sbjct: 237 RHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 276

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  146 bits (369), Expect = 3e-40
 Identities = 61/296 (20%), Positives = 108/296 (36%), Gaps = 58/296 (19%)

Query: 351 DNFSFTCRI----QGSVYRG--KINGGFAAIKKVNGD----------------VSKEIAL 388
           +N+     +       V R   K      A+K ++                    KE+ +
Sbjct: 3   ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62

Query: 389 LNKIN-HSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALD 447
           L K++ H N+I L          +LV++    G L D++     E   L  K+  +I   
Sbjct: 63  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL----TEKVTLSEKETRKIMRA 118

Query: 448 VATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVG 507
           +   +  LH       VH+D+   N+LLD D+  K+ +F  +   +  E      R + G
Sbjct: 119 LLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE----KLREVCG 171

Query: 508 TKGYMAPEYLENGLV------STKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLN 561
           T  Y+APE +E  +         ++D+++ GV++  +L G            M    +L 
Sbjct: 172 TPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGS---PPFWHRKQM---LMLR 225

Query: 562 AVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEI-EH 616
            +++          F  P    +Y   +      L+   L   P  R T  E   H
Sbjct: 226 MIMSGN------YQFGSPEWD-DYSDTV----KDLVSRFLVVQPQKRYTAEEALAH 270

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  143 bits (361), Expect = 5e-39
 Identities = 45/276 (16%), Positives = 83/276 (30%), Gaps = 33/276 (11%)

Query: 361 GSVYRG--KINGGFAAIKKVN-----GDVSKEIALLNKINHSNLIILSGVCFNEGNCYLV 413
           G +Y G     G   AIK          +  E  +   +     I     C  EG+  ++
Sbjct: 21  GDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM 80

Query: 414 YEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNV 473
               +  +L D         +    K  + +A  + + + Y+HS      +H+D+   N 
Sbjct: 81  VMELLGPSLEDL---FNFCSRKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNF 134

Query: 474 L---LDSDLRAKIANFAMAR----PAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKL 526
           L           I +F +A+        Q   +   +++ GT  Y +         S + 
Sbjct: 135 LMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRD 194

Query: 527 DVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYP 586
           D+ + G +++    G                         E   E         L   YP
Sbjct: 195 DLESLGYVLMYFNLGSLPWQGLKAATKRQK---------YERISEKKMSTPIEVLCKGYP 245

Query: 587 LELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNIL 622
            E A      ++ C      D+P    +     N+ 
Sbjct: 246 SEFA----TYLNFCRSLRFDDKPDYSYLRQLFRNLF 277

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (357), Expect = 2e-38
 Identities = 58/276 (21%), Positives = 108/276 (39%), Gaps = 48/276 (17%)

Query: 361 GSVYRG--KINGGFAAIKKVNG-------------DVSKEIALLNKINHSNLIILSGVCF 405
             V +   K  G   A K +               D+ +E+++L +I H N+I L  V  
Sbjct: 24  AVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYE 83

Query: 406 NEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVH 465
           N+ +  L+ E    G L D++   ++    L  ++  +    +  G+ YLHS       H
Sbjct: 84  NKTDVILILELVAGGELFDFLAEKES----LTEEEATEFLKQILNGVYYLHS---LQIAH 136

Query: 466 KDINSSNVLLDSD----LRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGL 521
            D+   N++L        R KI +F +A   +         ++I GT  ++APE +    
Sbjct: 137 FDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN----EFKNIFGTPEFVAPEIVNYEP 192

Query: 522 VSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTL 581
           +  + D+++ GV+   +L+G        +     L++V                 ++   
Sbjct: 193 LGLEADMWSIGVITYILLSGAS--PFLGDTKQETLANVSA---------------VNYEF 235

Query: 582 QGNYPLELALLVIRLIDACLKKDPTDRPTMYEI-EH 616
           +  Y    + L    I   L KDP  R T+ +  +H
Sbjct: 236 EDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 271

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (353), Expect = 8e-38
 Identities = 61/285 (21%), Positives = 109/285 (38%), Gaps = 41/285 (14%)

Query: 361 GSVYRG---KINGGFAAIKKVNGDVS---------KEIALLNKI---NHSNLIILSGVCF 405
           G V++    K  G F A+K+V              +E+A+L  +    H N++ L  VC 
Sbjct: 21  GKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCT 80

Query: 406 -----NEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTN 460
                 E    LV+E+      +   + +K     +  +    +   +  GL++LHS   
Sbjct: 81  VSRTDRETKLTLVFEHVDQDLTT---YLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH-- 135

Query: 461 PPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENG 520
              VH+D+   N+L+ S  + K+A+F +AR              +V T  Y APE L   
Sbjct: 136 -RVVHRDLKPQNILVTSSGQIKLADFGLAR----IYSFQMALTSVVVTLWYRAPEVLLQS 190

Query: 521 LVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGE--------ES 572
             +T +D+++ G +  EM   K         +   L  +L+ +    + +          
Sbjct: 191 SYATPVDLWSVGCIFAEMFRRK--PLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQ 248

Query: 573 LRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEI-EH 616
             H         +  ++  L   L+  CL  +P  R + Y    H
Sbjct: 249 AFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (347), Expect = 4e-37
 Identities = 61/281 (21%), Positives = 107/281 (38%), Gaps = 37/281 (13%)

Query: 361 GSVYRG--KINGGFAAIKKVNGD------------VSKEIALLNKINHSNLIILSGVCFN 406
            +VY+   K      AIKK+                 +EI LL +++H N+I L     +
Sbjct: 12  ATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGH 71

Query: 407 EGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHK 466
           + N  LV+++             K+    L         L    GL YLH       +H+
Sbjct: 72  KSNISLVFDFMETDLEVII----KDNSLVLTPSHIKAYMLMTLQGLEYLHQ---HWILHR 124

Query: 467 DINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLEN-GLVSTK 525
           D+  +N+LLD +   K+A+F +A+             H V T+ Y APE L    +    
Sbjct: 125 DLKPNNLLLDENGVLKLADFGLAKS---FGSPNRAYTHQVVTRWYRAPELLFGARMYGVG 181

Query: 526 LDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGE----ESLRHFIDPTL 581
           +D++A G ++ E+L       L  + +   L+ +   + T  + +     SL  ++    
Sbjct: 182 VDMWAVGCILAELLLRV--PFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKS 239

Query: 582 QGNYPLELAL-----LVIRLIDACLKKDPTDRPTMYEI-EH 616
               PL          ++ LI      +P  R T  +  + 
Sbjct: 240 FPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (350), Expect = 5e-37
 Identities = 55/281 (19%), Positives = 103/281 (36%), Gaps = 32/281 (11%)

Query: 361 GSVYRG--KINGGFAAIKKVNGDVSK--------EIALLNKINHSNLIILSGVCFNEGNC 410
           G V      +N    AIKK++    +        EI +L +  H N+I ++ +       
Sbjct: 22  GMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIE 81

Query: 411 YLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINS 470
            +   Y V   +   ++        L           +  GL Y+HS      +H+D+  
Sbjct: 82  QMKDVYLVTHLMGADLYKLLKTQH-LSNDHICYFLYQILRGLKYIHS---ANVLHRDLKP 137

Query: 471 SNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVST-KLDVY 529
           SN+LL++    KI +F +AR A+            V T+ Y APE + N    T  +D++
Sbjct: 138 SNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIW 197

Query: 530 AFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPL-- 587
           + G ++ EML+ +    +   ++ +   + +  +L     E+               L  
Sbjct: 198 SVGCILAEMLSNR---PIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPH 254

Query: 588 -----------ELALLVIRLIDACLKKDPTDRPTMYEI-EH 616
                            + L+D  L  +P  R  + +   H
Sbjct: 255 KNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (346), Expect = 7e-37
 Identities = 68/294 (23%), Positives = 115/294 (39%), Gaps = 40/294 (13%)

Query: 351 DNFSFTCRI----QGSVYRG--KINGGFAAIKKVNGDVS---------KEIALLNKINHS 395
           +NF    +I     G VY+   K+ G   A+KK+  D           +EI+LL ++NH 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61

Query: 396 NLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYL 455
           N++ L  V   E   YLV+E+          F + +    +           +  GL + 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQDLKK---FMDASALTGIPLPLIKSYLFQLLQGLAFC 118

Query: 456 HSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPE 515
           HS      +H+D+   N+L++++   K+A+F +AR        +    H V T  Y APE
Sbjct: 119 HS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY---THEVVTLWYRAPE 172

Query: 516 -YLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLR 574
             L     ST +D+++ G +  EM+T +   AL   ++ +     +   L   D      
Sbjct: 173 ILLGCKYYSTAVDIWSLGCIFAEMVTRR---ALFPGDSEIDQLFRIFRTLGTPDEVVWPG 229

Query: 575 HFIDPTLQGNYP-----------LELALLVIRLIDACLKKDPTDRPTMYEI-EH 616
               P  + ++P             L      L+   L  DP  R +      H
Sbjct: 230 VTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (346), Expect = 1e-36
 Identities = 50/269 (18%), Positives = 90/269 (33%), Gaps = 35/269 (13%)

Query: 361 GSVYRG--KINGGFAAIKKVNG--DVSKEIALLNKI-NHSNLIILSGVCFN----EGNCY 411
           G V +   K      A+K +       +E+ L  +     +++ +  V  N         
Sbjct: 26  GKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 85

Query: 412 LVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSS 471
           +V E    G L   +       +    ++  +I   +   + YLHS       H+D+   
Sbjct: 86  IVMECLDGGELFSRI--QDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPE 140

Query: 472 NVLLDS---DLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDV 528
           N+L  S   +   K+ +F  A+                 T  Y+APE L         D+
Sbjct: 141 NLLYTSKRPNAILKLTDFGFAKETTSHN----SLTTPCYTPYYVAPEVLGPEKYDKSCDM 196

Query: 529 YAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLE 588
           ++ GV++  +L G          + + +S  +   +     E                 E
Sbjct: 197 WSLGVIMYILLCGY---PPFYSNHGLAISPGMKTRIRMGQYE------FPNPEWSEVSEE 247

Query: 589 LALLVIRLIDACLKKDPTDRPTMYEI-EH 616
           +      LI   LK +PT R T+ E   H
Sbjct: 248 V----KMLIRNLLKTEPTQRMTITEFMNH 272

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  136 bits (344), Expect = 5e-36
 Identities = 52/302 (17%), Positives = 108/302 (35%), Gaps = 56/302 (18%)

Query: 351 DNFSFTCRI----QGSVYRG--KINGGFAAIKKVNGDVSK-------------EIALLNK 391
           ++FS    I     G VY       G   A+K ++    K              ++L++ 
Sbjct: 4   NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63

Query: 392 INHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATG 451
            +   ++ +S           + +    G L   +  +               A ++  G
Sbjct: 64  GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVF----SEADMRFYAAEIILG 119

Query: 452 LNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGY 511
           L ++H+      V++D+  +N+LLD     +I++  +A     ++         VGT GY
Sbjct: 120 LEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-----PHASVGTHGY 171

Query: 512 MAPEYLENGL-VSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGE 570
           MAPE L+ G+   +  D ++ G ++ ++L G      H  ++   +              
Sbjct: 172 MAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI-------------- 217

Query: 571 ESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILN----ASL 626
           + +   +   L  ++  EL      L++  L++D   R            +       SL
Sbjct: 218 DRMTLTMAVELPDSFSPEL----RSLLEGLLQRDVNRRLGCL--GRGAQEVKESPFFRSL 271

Query: 627 NW 628
           +W
Sbjct: 272 DW 273

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (338), Expect = 1e-35
 Identities = 60/280 (21%), Positives = 101/280 (36%), Gaps = 48/280 (17%)

Query: 351 DNFSFTCRI----QGSVYRG--KINGGFAAIKKVNGDVSK-----------EIALLNKIN 393
           ++F     +     G V+    K    F AIK +  DV             +  L     
Sbjct: 2   EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61

Query: 394 HSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLN 453
           H  L  +      + N + V EY   G L   + S        D  +    A ++  GL 
Sbjct: 62  HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK----FDLSRATFYAAEIILGLQ 117

Query: 454 YLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMA 513
           +LHS      V++D+   N+LLD D   KIA+F M +     + +        GT  Y+A
Sbjct: 118 FLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT---NTFCGTPDYIA 171

Query: 514 PEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESL 573
           PE L     +  +D ++FGVL+ EML G+        ++     ++ +++          
Sbjct: 172 PEILLGQKYNHSVDWWSFGVLLYEMLIGQS---PFHGQDEE---ELFHSIRMD------- 218

Query: 574 RHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYE 613
               +P        E       L+     ++P  R  +  
Sbjct: 219 ----NPFYPRWLEKEA----KDLLVKLFVREPEKRLGVRG 250

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  134 bits (338), Expect = 1e-35
 Identities = 57/298 (19%), Positives = 111/298 (37%), Gaps = 56/298 (18%)

Query: 351 DNFSFTCRI----QGSVYRG--KINGGFAAIKKVNGDVS----------KEIALLNKINH 394
            +F     +     G V+    + NG + A+K +  ++            E  +L+ + H
Sbjct: 4   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63

Query: 395 SNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNY 454
             +I + G   +    +++ +Y   G L   +  ++              A +V   L Y
Sbjct: 64  PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRF----PNPVAKFYAAEVCLALEY 119

Query: 455 LHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAP 514
           LHS      +++D+   N+LLD +   KI +F  A+           T  + GT  Y+AP
Sbjct: 120 LHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV------TYTLCGTPDYIAP 170

Query: 515 EYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLR 574
           E +     +  +D ++FG+LI EML G        + N M        +L     E    
Sbjct: 171 EVVSTKPYNKSIDWWSFGILIYEMLAGY---TPFYDSNTM---KTYEKILN---AELRFP 221

Query: 575 HFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILN----ASLNW 628
            F +  ++             L+   + +D + R     +++   ++ N      + W
Sbjct: 222 PFFNEDVK------------DLLSRLITRDLSQRLGN--LQNGTEDVKNHPWFKEVVW 265

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  132 bits (333), Expect = 3e-35
 Identities = 43/279 (15%), Positives = 81/279 (29%), Gaps = 35/279 (12%)

Query: 361 GSVYRG--KINGGFAAIKKVN-----GDVSKEIALLNKINHSNLIILSGVCFNEGNCYLV 413
           G ++ G   +N    AIK          +  E      +     I        EG   ++
Sbjct: 19  GVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVL 78

Query: 414 YEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNV 473
               +  +L D +      G+    K     A  +   +  +H       V++DI   N 
Sbjct: 79  VIDLLGPSLEDLL---DLCGRKFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNF 132

Query: 474 LLDSDLR-----AKIANFAMAR----PAEGQEGEFALTRHIVGTKGYMAPEYLENGLVST 524
           L+            + +F M +    P   Q   +   +++ GT  YM+         S 
Sbjct: 133 LIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSR 192

Query: 525 KLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGN 584
           + D+ A G + +  L G           N    + +          E  +      L   
Sbjct: 193 RDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERI---------GEKKQSTPLRELCAG 243

Query: 585 YPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILN 623
           +P E      + +           P    ++   S +L 
Sbjct: 244 FPEEFY----KYMHYARNLAFDATPDYDYLQGLFSKVLE 278

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  130 bits (327), Expect = 2e-34
 Identities = 62/279 (22%), Positives = 107/279 (38%), Gaps = 36/279 (12%)

Query: 361 GSVYRGKINGG-FAAIKKVNGDVS---------KEIALLNKINHSNLIILSGVCFNEGNC 410
           G VY+ + N G   A+KK+  +           +EI++L ++ HSN++ L  V   +   
Sbjct: 16  GVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRL 75

Query: 411 YLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINS 470
            LV+E+                   L+        L +  G+ Y H       +H+D+  
Sbjct: 76  VLVFEHLDQDLKKLLDVCEGG----LESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKP 128

Query: 471 SNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLEN-GLVSTKLDVY 529
            N+L++ +   KIA+F +AR       +     H + T  Y AP+ L      ST +D++
Sbjct: 129 QNLLINREGELKIADFGLARAFGIPVRK---YTHEIVTLWYRAPDVLMGSKKYSTTIDIW 185

Query: 530 AFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPL-- 587
           + G +  EM+ G     L    +       +  +L   + +        P    N+ +  
Sbjct: 186 SVGCIFAEMVNGT---PLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYE 242

Query: 588 ---------ELALLVIRLIDACLKKDPTDRPTMYEI-EH 616
                     L    I L+   LK DP  R T  +  EH
Sbjct: 243 PLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  127 bits (319), Expect = 2e-33
 Identities = 58/283 (20%), Positives = 98/283 (34%), Gaps = 59/283 (20%)

Query: 361 GSVYRG--KINGGFAAIKKVNGD-------------VSKEIALLNKIN--HSNLIILSGV 403
           GSVY G    +    AIK V  D             V  E+ LL K++   S +I L   
Sbjct: 18  GSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW 77

Query: 404 CFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPH 463
                +  L+ E            + +     L  +        V   + + H+      
Sbjct: 78  FERPDSFVLILERPEPVQDLFDFITER---GALQEELARSFFWQVLEAVRHCHN---CGV 131

Query: 464 VHKDINSSNVLLDSD-LRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENG-L 521
           +H+DI   N+L+D +    K+ +F      +             GT+ Y  PE++     
Sbjct: 132 LHRDIKDENILIDLNRGELKLIDFGSGALLKDTV-----YTDFDGTRVYSPPEWIRYHRY 186

Query: 522 VSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTL 581
                 V++ G+L+ +M+ G                      +  E  EE +R  +    
Sbjct: 187 HGRSAAVWSLGILLYDMVCGD---------------------IPFEHDEEIIRGQVF--- 222

Query: 582 QGNYPLELALLVIRLIDACLKKDPTDRPTMYEI-EHS-LSNIL 622
              +   ++     LI  CL   P+DRPT  EI  H  + ++L
Sbjct: 223 ---FRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 262

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  127 bits (319), Expect = 4e-33
 Identities = 60/289 (20%), Positives = 108/289 (37%), Gaps = 40/289 (13%)

Query: 361 GSVYRG--KINGGFAAIKKVNGDVSK---------EIALLNKINHSNLIILSGVCF---- 405
           G V++   +  G   A+KKV  +  K         EI +L  + H N++ L  +C     
Sbjct: 24  GEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKAS 83

Query: 406 ----NEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNP 461
                +G+ YLV+++  +           N        +  ++   +  GL Y+H     
Sbjct: 84  PYNRCKGSIYLVFDFCEHDLAGLL----SNVLVKFTLSEIKRVMQMLLNGLYYIHRN--- 136

Query: 462 PHVHKDINSSNVLLDSDLRAKIANFAMARP-AEGQEGEFALTRHIVGTKGYMAPEYLENG 520
             +H+D+ ++NVL+  D   K+A+F +AR  +  +  +     + V T  Y  PE L   
Sbjct: 137 KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGE 196

Query: 521 -LVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGE--------- 570
                 +D++  G ++ EM T       + E++ + L   L   +T E            
Sbjct: 197 RDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYE 256

Query: 571 --ESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEI-EH 616
             E ++                   + LID  L  DP  R    +   H
Sbjct: 257 KLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  127 bits (320), Expect = 6e-33
 Identities = 57/278 (20%), Positives = 103/278 (37%), Gaps = 30/278 (10%)

Query: 361 GSVYRG--KINGGFAAIKKVNGD---VSKEIALLNKINHSNLIILSGVCFNEGNC----- 410
           G VY+     +G   AIKKV  D    ++E+ ++ K++H N++ L    ++ G       
Sbjct: 34  GVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 93

Query: 411 -YLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDIN 469
             LV +Y            ++ +   L           +   L Y+HS       H+DI 
Sbjct: 94  LNLVLDYVPETVYRVARHYSRAKQT-LPVIYVKLYMYQLFRSLAYIHS---FGICHRDIK 149

Query: 470 SSNVLLDSD-LRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAP-EYLENGLVSTKLD 527
             N+LLD D    K+ +F  A+     E         + ++ Y AP         ++ +D
Sbjct: 150 PQNLLLDPDTAVLKLCDFGSAKQLVRGE----PNVSYICSRYYRAPELIFGATDYTSSID 205

Query: 528 VYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPL 587
           V++ G ++ E+L G+      +  + +     +    T+E   E   ++ +         
Sbjct: 206 VWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAH 265

Query: 588 ELALLV--------IRLIDACLKKDPTDRPTMYEI-EH 616
               +         I L    L+  PT R T  E   H
Sbjct: 266 PWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 303

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  122 bits (307), Expect = 8e-32
 Identities = 59/279 (21%), Positives = 107/279 (38%), Gaps = 34/279 (12%)

Query: 361 GSVYRG--KINGGFAAIKKVNGDVSK---------EIALLNKINHSNLIILSGVCFNEGN 409
           G+V++   +      A+K+V  D            EI LL ++ H N++ L  V  ++  
Sbjct: 16  GTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKK 75

Query: 410 CYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDIN 469
             LV+E+        +   N      LD +        +  GL + H   +   +H+D+ 
Sbjct: 76  LTLVFEFCDQDLKKYFDSCN----GDLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLK 128

Query: 470 SSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLEN-GLVSTKLDV 528
             N+L++ +   K+ANF +AR               V T  Y  P+ L    L ST +D+
Sbjct: 129 PQNLLINRNGELKLANFGLARAFGIPV---RCYSAEVVTLWYRPPDVLFGAKLYSTSIDM 185

Query: 529 YAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLT-KEDGEESLRHFIDPTLQGNYPL 587
           ++ G +  E+            + +  L  +   + T  E+   S+    D      YP 
Sbjct: 186 WSAGCIFAELANAGR-PLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPA 244

Query: 588 ELALLVIR---------LIDACLKKDPTDRPTMYEI-EH 616
             +L+ +          L+   LK +P  R +  E  +H
Sbjct: 245 TTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (308), Expect = 2e-31
 Identities = 58/282 (20%), Positives = 103/282 (36%), Gaps = 38/282 (13%)

Query: 361 GSVYRG--KINGGFAAIKKVNGDVSK---------EIALLNKINHSNLIILSGVCFNEGN 409
           G+V        G   AIKK+               E+ LL  + H N+I L  V   +  
Sbjct: 32  GAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDET 91

Query: 410 CYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDIN 469
                ++ +             + + L   +   +   +  GL Y+H+      +H+D+ 
Sbjct: 92  LDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLK 148

Query: 470 SSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGL-VSTKLDV 528
             N+ ++ D   KI +F +AR A+ +          V T+ Y APE + N +  +  +D+
Sbjct: 149 PGNLAVNEDCELKILDFGLARQADSE------MTGYVVTRWYRAPEVILNWMRYTQTVDI 202

Query: 529 YAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPL- 587
           ++ G ++ EM+TGK    L    +++     +  V      E   R   D        L 
Sbjct: 203 WSVGCIMAEMITGK---TLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLP 259

Query: 588 ------------ELALLVIRLIDACLKKDPTDRPTMYEI-EH 616
                         + L + L++  L  D   R T  E   H
Sbjct: 260 ELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 301

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  122 bits (306), Expect = 4e-31
 Identities = 62/298 (20%), Positives = 105/298 (35%), Gaps = 53/298 (17%)

Query: 351 DNFSFTCRI----QGSVYRG--KINGGFAAIKKVNGDVS----------KEIALLNKINH 394
           ++F +   +     G V     K  G + A+K +  +V            E  +L    H
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64

Query: 395 SNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNY 454
             L  L            V EYA  G L   +    +  +    ++      ++ + L Y
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHL----SRERVFTEERARFYGAEIVSALEY 120

Query: 455 LHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAP 514
           LHS      V++DI   N++LD D   KI +F + +         A  +   GT  Y+AP
Sbjct: 121 LHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG---ATMKTFCGTPEYLAP 174

Query: 515 EYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLR 574
           E LE+      +D +  GV++ EM+ G+        +++     +   +L +E       
Sbjct: 175 EVLEDNDYGRAVDWWGLGVVMYEMMCGR---LPFYNQDHE---RLFELILMEE------- 221

Query: 575 HFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILN----ASLNW 628
                        E       L+   LKKDP  R            ++      S+NW
Sbjct: 222 ----IRFPRTLSPEA----KSLLAGLLKKDPKQRLGGG--PSDAKEVMEHRFFLSINW 269

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  114 bits (287), Expect = 2e-28
 Identities = 64/344 (18%), Positives = 127/344 (36%), Gaps = 66/344 (19%)

Query: 306 SGSFQANEKPSNKKFDEESQ-DFLESISGVAQSLKVYSFKELQSATDNFSFTCRI----Q 360
           + + + +E+ S K+F  +++ DFL+     +Q+          +  D F     +     
Sbjct: 4   AAAKKGSEQESVKEFLAKAKEDFLKKWETPSQN---------TAQLDQFDRIKTLGTGSF 54

Query: 361 GSVYRG--KINGGFAAIKKVNGD----------VSKEIALLNKINHSNLIILSGVCFNEG 408
           G V     K +G   A+K ++               E  +L  +N   L+ L     +  
Sbjct: 55  GRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNS 114

Query: 409 NCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDI 468
           N Y+V EY   G +   +                  A  +     YLHS      +++D+
Sbjct: 115 NLYMVMEYVAGGEMFSHLRRIGR----FSEPHARFYAAQIVLTFEYLHSL---DLIYRDL 167

Query: 469 NSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDV 528
              N+L+D     ++ +F  A+  +G+      T  + GT   +APE + +   +  +D 
Sbjct: 168 KPENLLIDQQGYIQVTDFGFAKRVKGR------TWTLCGTPEALAPEIILSKGYNKAVDW 221

Query: 529 YAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLE 588
           +A GVLI EM  G         +  + + + +                       ++  +
Sbjct: 222 WALGVLIYEMAAGY---PPFFADQPIQIYEKI--------------VSGKVRFPSHFSSD 264

Query: 589 LALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILN----ASLNW 628
           L      L+   L+ D T R     +++ +++I N    A+ +W
Sbjct: 265 L----KDLLRNLLQVDLTKRFG--NLKNGVNDIKNHKWFATTDW 302

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  110 bits (276), Expect = 4e-27
 Identities = 57/297 (19%), Positives = 109/297 (36%), Gaps = 57/297 (19%)

Query: 361 GSVYRG--KINGGFAAIKKVNGDVS---------KEIALLNKINHSNLIILSGVCFNEG- 408
           G V      +     AIKK++             +E+ L+  +NH N+I L  V   +  
Sbjct: 31  GIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKT 90

Query: 409 -----NCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPH 463
                + YLV E                    LD ++   +   +  G+ +LHS      
Sbjct: 91  LEEFQDVYLVMELMDANLCQVI-------QMELDHERMSYLLYQMLCGIKHLHSA---GI 140

Query: 464 VHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVS 523
           +H+D+  SN+++ SD   KI +F +AR A        +    V T+ Y APE +      
Sbjct: 141 IHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF----MMTPYVVTRYYRAPEVILGMGYK 196

Query: 524 TKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTK-----EDGEESLRHFID 578
             +D+++ G ++ EM+  K        +     + V+  + T      +  + ++R++++
Sbjct: 197 ENVDIWSVGCIMGEMVRHK--ILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 254

Query: 579 ------------------PTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEI-EH 616
                                   +    A     L+   L  DP  R ++ +  +H
Sbjct: 255 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  109 bits (273), Expect = 6e-27
 Identities = 48/301 (15%), Positives = 103/301 (34%), Gaps = 51/301 (16%)

Query: 351 DNFSFTCRI----QGSVYRG--KINGGFAAIKKVNGD----VSKEIALLNKIN-HSNLII 399
           D++    ++       V+      N     +K +       + +EI +L  +    N+I 
Sbjct: 35  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIIT 94

Query: 400 LSGVC--FNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHS 457
           L+ +          LV+E+  N              + L          ++   L+Y HS
Sbjct: 95  LADIVKDPVSRTPALVFEHVNNTDFKQLY-------QTLTDYDIRFYMYEILKALDYCHS 147

Query: 458 FTNPPHVHKDINSSNVLLDSD-LRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPE- 515
                 +H+D+   NV++D +  + ++ ++ +A      +         V ++ +  PE 
Sbjct: 148 MG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ----EYNVRVASRYFKGPEL 200

Query: 516 YLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEE---- 571
            ++  +    LD+++ G ++  M+  KE        +N      +  VL  ED  +    
Sbjct: 201 LVDYQMYDYSLDMWSLGCMLASMIFRKEP--FFHGHDNYDQLVRIAKVLGTEDLYDYIDK 258

Query: 572 ---------------SLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEI-E 615
                            R   +  +       ++   +  +D  L+ D   R T  E  E
Sbjct: 259 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318

Query: 616 H 616
           H
Sbjct: 319 H 319

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  108 bits (270), Expect = 1e-26
 Identities = 58/284 (20%), Positives = 100/284 (35%), Gaps = 49/284 (17%)

Query: 351 DNFSFTCRI----QGSVYRG-----KINGGFAAIKKVNGD-----------VSKEIALLN 390
           +NF     +     G V+          G   A+K +                 E  +L 
Sbjct: 24  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83

Query: 391 KINHSNLII-LSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVA 449
            I  S  ++ L      E   +L+ +Y   G L   +   +         +      ++ 
Sbjct: 84  HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER----FTEHEVQIYVGEIV 139

Query: 450 TGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTK 509
             L +LH       +++DI   N+LLDS+    + +F +++     E E        GT 
Sbjct: 140 LALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETER--AYDFCGTI 194

Query: 510 GYMAPEYLENGL--VSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKE 567
            YMAP+ +  G       +D ++ GVL+ E+LTG   +    +      +++   +L  E
Sbjct: 195 EYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA--SPFTVDGEKNSQAEISRRILKSE 252

Query: 568 DGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTM 611
                            YP E++ L   LI   L KDP  R   
Sbjct: 253 P---------------PYPQEMSALAKDLIQRLLMKDPKKRLGC 281

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  108 bits (269), Expect = 3e-26
 Identities = 59/278 (21%), Positives = 106/278 (38%), Gaps = 30/278 (10%)

Query: 361 GSVYRG--KINGGFAAIKKVNGDVS---------KEIALLNKINHSNLIILSGVCFNEGN 409
           GSV        G   A+KK++             +E+ LL  + H N+I L  V     +
Sbjct: 32  GSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS 91

Query: 410 CYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDIN 469
                +  +   L     +N  + + L       +   +  GL Y+HS      +H+D+ 
Sbjct: 92  LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLK 148

Query: 470 SSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVY 529
            SN+ ++ D   KI +F +AR  + +   +  TR             L     +  +D++
Sbjct: 149 PSNLAVNEDCELKILDFGLARHTDDEMTGYVATRW-----YRAPEIMLNWMHYNQTVDIW 203

Query: 530 AFGVLILEMLTGK----EAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQ--- 582
           + G ++ E+LTG+        +   +  + L     A L K+   ES R++I    Q   
Sbjct: 204 SVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPK 263

Query: 583 ---GNYPLELALLVIRLIDACLKKDPTDRPTMYEI-EH 616
               N  +    L + L++  L  D   R T  +   H
Sbjct: 264 MNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 301

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  102 bits (253), Expect = 4e-24
 Identities = 52/304 (17%), Positives = 95/304 (31%), Gaps = 50/304 (16%)

Query: 361 GSVYRG--KINGGFAAIKKVNGD------VSKEIALLNKINHSNLIILSGVC-------- 404
            +V+     +N    A+K V GD         EI LL ++N ++      +         
Sbjct: 27  STVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLL 86

Query: 405 ----FNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTN 460
                   N   V         +      K E + +      QI+  +  GL+Y+H    
Sbjct: 87  DHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMH--RR 144

Query: 461 PPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENG 520
              +H DI   NVL++     +                     + + T+ Y +PE L   
Sbjct: 145 CGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGA 204

Query: 521 LVSTKLDVYAFGVLILEMLTGK---EAAALHAEENNMHLSDVLNAVLTK------EDGEE 571
                 D+++   LI E++TG    E    H+   +      +  +L +       +G+ 
Sbjct: 205 PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKY 264

Query: 572 SLRHFIDPTLQGN------------------YPLELALLVIRLIDACLKKDPTDRPTMYE 613
           +   F    L  N                  +  + A  +   +   L+ DP  R     
Sbjct: 265 TRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGG 324

Query: 614 I-EH 616
           +  H
Sbjct: 325 LVNH 328

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 62.5 bits (151), Expect = 7e-12
 Identities = 27/195 (13%), Positives = 54/195 (27%), Gaps = 35/195 (17%)

Query: 361 GSVYRGK-INGGFAAIKKVNGD-----------------VSKEIALLNKINHSNLIILSG 402
            +V+       G   +K                       S       +     L  L G
Sbjct: 14  SAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG 73

Query: 403 VCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPP 462
           +        +   YA  G        +  E   +  +   ++   +   +   +      
Sbjct: 74  LA-------VPKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFYH---RG 123

Query: 463 HVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLV 522
            VH D++  NVL+  +    I +F  +     +     L R +     Y +  Y      
Sbjct: 124 IVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGEEGWREILERDVRNIITYFSRTY------ 176

Query: 523 STKLDVYAFGVLILE 537
            T+ D+ +    IL+
Sbjct: 177 RTEKDINSAIDRILQ 191

>d1y7ma2 d.7.1.1 (A:1-48) Hypothetical protein YkuD, N-terminal domain {Bacillus subtilis [TaxId: 1423]} Length = 48

class: Alpha and beta proteins (a+b)
fold: LysM domain
superfamily: LysM domain
family: LysM domain
domain: Hypothetical protein YkuD, N-terminal domain
species: Bacillus subtilis [TaxId: 1423]

 Score = 47.1 bits (112), Expect = 5e-08
 Identities = 15/46 (32%), Positives = 29/46 (63%)

Query: 184 LLSYLVAEGDTVSGISSRFGVDTGEILQANSLSGSNIFPFTTLLIP 229
           +L+Y V +GDT++ I++ F + T  +LQAN    + +    +++IP
Sbjct: 1   MLTYQVKQGDTLNSIAADFRISTAALLQANPSLQAGLTAGQSIVIP 46

>d1e0ga_ d.7.1.1 (A:) Membrane-bound lytic murein transclycosylase D, MltD {Escherichia coli [TaxId: 562]} Length = 48

class: Alpha and beta proteins (a+b)
fold: LysM domain
superfamily: LysM domain
family: LysM domain
domain: Membrane-bound lytic murein transclycosylase D, MltD
species: Escherichia coli [TaxId: 562]

 Score = 45.0 bits (107), Expect = 3e-07
 Identities = 14/47 (29%), Positives = 31/47 (65%), Gaps = 1/47 (2%)

Query: 185 LSYLVAEGDTVSGISSRFGVDTGEILQANSLSGSNIFPFTTLLIPLE 231
           ++Y V +GD++S I+ R GV+  ++++ NS + +N+ P   L + ++
Sbjct: 3   ITYRVRKGDSLSSIAKRHGVNIKDVMRWNSDT-ANLQPGDKLTLFVK 48

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	628
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	99.97
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.75
d1y7ma2	48	Hypothetical protein YkuD, N-terminal domain {Baci	99.36
d1e0ga_	48	Membrane-bound lytic murein transclycosylase D, Ml	99.35
d1e0ga_	48	Membrane-bound lytic murein transclycosylase D, Ml	99.1
d1y7ma2	48	Hypothetical protein YkuD, N-terminal domain {Baci	99.01
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.26
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.55
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	96.02
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	95.58
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	95.05
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	93.77

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.5e-48  Score=399.41  Aligned_cols=259  Identities=24%  Similarity=0.436  Sum_probs=194.2

Q ss_pred             ecHHHHHHHhcCCCcC---------Cccc----eEEEEEEEC--Cc---eEEEEEecc--------chHHHHHHHhhcCC
Q 039626          341 YSFKELQSATDNFSFT---------CRIQ----GSVYRGKIN--GG---FAAIKKVNG--------DVSKEIALLNKINH  394 (628)
Q Consensus       341 ~~~~el~~at~~f~~~---------~~i~----G~Vy~g~~~--g~---~vavK~~~~--------~~~~E~~~l~~l~H  394 (628)
                      ++++++..++.+|+.+         ..||    |.||+|.+.  |+   .||||++..        ++.+|+++|++++|
T Consensus         7 ~t~~d~~~a~~~f~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H   86 (299)
T d1jpaa_           7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDH   86 (299)
T ss_dssp             GGSSSHHHHHHHHSCBCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCC
T ss_pred             CCHHHHHHHHhhhchhhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCC
Confidence            4556666666666532         2343    899999982  32   588998753        47789999999999


Q ss_pred             CceeeeeeeeecCCeEEEEEEecCCCChHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEE
Q 039626          395 SNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVL  474 (628)
Q Consensus       395 ~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NIL  474 (628)
                      ||||+++|+|.+++..++||||+++|+|.+++..   ....++|.+++.++.||++||+|||+.   +|+||||||+|||
T Consensus        87 pnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~---~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NIL  160 (299)
T d1jpaa_          87 PNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQ---NDGQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNIL  160 (299)
T ss_dssp             TTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEE
T ss_pred             CCCccEEEEEeeCCEEEEEEEecCCCcceeeecc---ccCCCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEE
Confidence            9999999999999999999999999999998854   334699999999999999999999994   5999999999999


Q ss_pred             eCCCCcEEEccccccccCCCCCCcce--eeecccCCccccCccccccCCCCcccccHHHHHHHHHHHh-CCCcccccccc
Q 039626          475 LDSDLRAKIANFAMARPAEGQEGEFA--LTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT-GKEAAALHAEE  551 (628)
Q Consensus       475 l~~~~~~kl~Dfgla~~~~~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELlt-G~~p~~~~~~~  551 (628)
                      ++.++.+||+|||+++..........  ......||+.|||||.+.++.++.++|||||||++|||+| |+.|+..... 
T Consensus       161 l~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~-  239 (299)
T d1jpaa_         161 VNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN-  239 (299)
T ss_dssp             ECTTCCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-
T ss_pred             ECCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCH-
Confidence            99999999999999997754332211  1223468999999999999999999999999999999998 8888763221 


Q ss_pred             ccccHHHHHHHHhccccchhhhccccCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhc
Q 039626          552 NNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNAS  625 (628)
Q Consensus       552 ~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~~~~  625 (628)
                           .+....+...              .+...+.+.+..+.+|+.+||+.||++||||+||++.|+++++++
T Consensus       240 -----~~~~~~i~~~--------------~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~p  294 (299)
T d1jpaa_         240 -----QDVINAIEQD--------------YRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNP  294 (299)
T ss_dssp             -----HHHHHHHHTT--------------CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred             -----HHHHHHHHcC--------------CCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcCh
Confidence                 2222222111              111223344566889999999999999999999999999998754

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-48  Score=388.92  Aligned_cols=237  Identities=26%  Similarity=0.420  Sum_probs=184.9

Q ss_pred             eEEEEEEE-CCceEEEEEecc------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhcCCCC
Q 039626          361 GSVYRGKI-NGGFAAIKKVNG------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEG  433 (628)
Q Consensus       361 G~Vy~g~~-~g~~vavK~~~~------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~  433 (628)
                      |.||+|++ +++.||||+++.      ++.+|++++++++|||||+++|+|.+++..++||||+++|+|.+++..   ..
T Consensus        19 g~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g~L~~~l~~---~~   95 (263)
T d1sm2a_          19 GLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRT---QR   95 (263)
T ss_dssp             CCEEEEEETTTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHT---TT
T ss_pred             eEEEEEEECCCCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCCCcHHHHhhc---cc
Confidence            89999999 677899999864      478999999999999999999999999999999999999999999854   34


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCCccccC
Q 039626          434 KYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMA  513 (628)
Q Consensus       434 ~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~Y~A  513 (628)
                      ..++|..++.++.|+|.||+|||+.   +|+||||||+|||+|+++.+||+|||+++.......  .......||+.|+|
T Consensus        96 ~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~--~~~~~~~gt~~y~a  170 (263)
T d1sm2a_          96 GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY--TSSTGTKFPVKWAS  170 (263)
T ss_dssp             TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC--------------------CTTSCC
T ss_pred             cCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchheeccCCCc--eeecceecCcccCC
Confidence            5689999999999999999999994   599999999999999999999999999987654321  12234578999999


Q ss_pred             ccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCHHHHHHH
Q 039626          514 PEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLV  593 (628)
Q Consensus       514 PE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l  593 (628)
                      ||.+.+..++.|+|||||||++|||++++.|+....     ...+....+...          .    +...|...+..+
T Consensus       171 PE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~-----~~~~~~~~i~~~----------~----~~~~p~~~~~~l  231 (263)
T d1sm2a_         171 PEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR-----SNSEVVEDISTG----------F----RLYKPRLASTHV  231 (263)
T ss_dssp             HHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSC-----CHHHHHHHHHHT----------C----CCCCCTTSCHHH
T ss_pred             hHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCC-----CHHHHHHHHHhc----------C----CCCCccccCHHH
Confidence            999999999999999999999999999655543211     112222222111          0    111222334568


Q ss_pred             HHHHHHhcccCCCCCCCHHHHHHHHHHhHhh
Q 039626          594 IRLIDACLKKDPTDRPTMYEIEHSLSNILNA  624 (628)
Q Consensus       594 ~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~~~  624 (628)
                      .+++.+||+.||++||||+||++.|++|.++
T Consensus       232 ~~li~~cl~~~p~~Rps~~~il~~L~~i~es  262 (263)
T d1sm2a_         232 YQIMNHCWKERPEDRPAFSRLLRQLAEIAES  262 (263)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHHccCCHhHCcCHHHHHHHHHHHHhC
Confidence            8999999999999999999999999999875

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-47  Score=386.74  Aligned_cols=249  Identities=27%  Similarity=0.458  Sum_probs=189.7

Q ss_pred             CCCcCCccc----eEEEEEEECCceEEEEEecc---------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecC
Q 039626          352 NFSFTCRIQ----GSVYRGKINGGFAAIKKVNG---------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAV  418 (628)
Q Consensus       352 ~f~~~~~i~----G~Vy~g~~~g~~vavK~~~~---------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~  418 (628)
                      +|.....+|    |.||+|++++ .||||+++.         .+.+|+++|++++|||||+++|++.+ ++.++||||++
T Consensus         9 ~~~~~~~lG~G~fg~Vy~~~~~~-~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~Ey~~   86 (276)
T d1uwha_           9 QITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQWCE   86 (276)
T ss_dssp             CCCCCSEEEECSSCEEEEEESSS-EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCC
T ss_pred             cEEEEEEEeeCCCcEEEEEEECC-EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEecCC
Confidence            344444454    8999999865 599999852         46789999999999999999999864 56899999999


Q ss_pred             CCChHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCc
Q 039626          419 NGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGE  498 (628)
Q Consensus       419 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~  498 (628)
                      +|+|.+++...   ...++|..++.|+.||++||+|||+   .+|+||||||+|||++.++.+||+|||+++........
T Consensus        87 ~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~gl~yLH~---~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~  160 (276)
T d1uwha_          87 GSSLYHHLHII---ETKFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGS  160 (276)
T ss_dssp             EEEHHHHHHTS---CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTSSEEECCCCCSCC-------
T ss_pred             CCCHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHhc---CCEeccccCHHHEEEcCCCCEEEccccceeeccccCCc
Confidence            99999999642   3459999999999999999999999   45999999999999999999999999999876533221


Q ss_pred             ceeeecccCCccccCcccccc---CCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhcc
Q 039626          499 FALTRHIVGTKGYMAPEYLEN---GLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRH  575 (628)
Q Consensus       499 ~~~~~~~~gt~~Y~APE~l~~---~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  575 (628)
                       .......||+.|||||.+.+   ..++.++|||||||++|||++|+.||......      ..+.......        
T Consensus       161 -~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~------~~~~~~~~~~--------  225 (276)
T d1uwha_         161 -HQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR------DQIIFMVGRG--------  225 (276)
T ss_dssp             ------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH------HHHHHHHHHT--------
T ss_pred             -ccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChH------HHHHHHHhcC--------
Confidence             22345689999999999864   35799999999999999999999998643211      1111111111        


Q ss_pred             ccCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhh
Q 039626          576 FIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNA  624 (628)
Q Consensus       576 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~~~  624 (628)
                      ...|.+ ...+.+++..+.+|+.+||+.||++|||++||++.|+.|..+
T Consensus       226 ~~~p~~-~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~  273 (276)
T d1uwha_         226 YLSPDL-SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARS  273 (276)
T ss_dssp             SCCCCG-GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             CCCCcc-hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHc
Confidence            111111 011223345688999999999999999999999999988764

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.7e-47  Score=387.71  Aligned_cols=238  Identities=27%  Similarity=0.430  Sum_probs=196.0

Q ss_pred             eEEEEEEE--CCceEEEEEecc------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhcCCC
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNE  432 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~  432 (628)
                      |.||+|++  +|..||||+++.      ++.+|+++|++++|||||+++|+|.+++..++||||+++|+|.+++...  .
T Consensus        31 g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~~~l~~~--~  108 (287)
T d1opja_          31 GEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLREC--N  108 (287)
T ss_dssp             SSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHS--C
T ss_pred             eEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeecccCcchHHHhhhc--c
Confidence            89999998  578899999864      4789999999999999999999999999999999999999999999653  3


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCCcccc
Q 039626          433 GKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYM  512 (628)
Q Consensus       433 ~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~Y~  512 (628)
                      ...++|..++.|+.||+.||+|||+.   +|+||||||+|||+++++.+||+|||+++.......  .......|++.|+
T Consensus       109 ~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~--~~~~~~~g~~~y~  183 (287)
T d1opja_         109 RQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY--TAHAGAKFPIKWT  183 (287)
T ss_dssp             TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSS--EEETTEEECGGGC
T ss_pred             ccchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEccccceeecCCCCc--eeecccccccccc
Confidence            45799999999999999999999994   599999999999999999999999999997754322  2233456899999


Q ss_pred             CccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCHHHHHH
Q 039626          513 APEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALL  592 (628)
Q Consensus       513 APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~  592 (628)
                      |||++.+..++.|+|||||||++|||++|+.|+.....     ...... .+.             ...+...+...+..
T Consensus       184 aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~-----~~~~~~-~i~-------------~~~~~~~~~~~~~~  244 (287)
T d1opja_         184 APESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-----LSQVYE-LLE-------------KDYRMERPEGCPEK  244 (287)
T ss_dssp             CHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCC-----HHHHHH-HHH-------------TTCCCCCCTTCCHH
T ss_pred             ChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcch-----HHHHHH-HHh-------------cCCCCCCCccchHH
Confidence            99999999999999999999999999998776542211     111111 111             11112233344566


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHHHHHHHhHhh
Q 039626          593 VIRLIDACLKKDPTDRPTMYEIEHSLSNILNA  624 (628)
Q Consensus       593 l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~~~  624 (628)
                      +.+|+.+||+.||++|||++||++.|+.+.+.
T Consensus       245 l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~  276 (287)
T d1opja_         245 VYELMRACWQWNPSDRPSFAEIHQAFETMFQE  276 (287)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSS
T ss_pred             HHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence            88999999999999999999999999998654

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.5e-47  Score=385.03  Aligned_cols=240  Identities=24%  Similarity=0.403  Sum_probs=187.4

Q ss_pred             eEEEEEEECC------ceEEEEEecc--------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHh
Q 039626          361 GSVYRGKING------GFAAIKKVNG--------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWV  426 (628)
Q Consensus       361 G~Vy~g~~~g------~~vavK~~~~--------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l  426 (628)
                      |.||+|++.+      ..||||+++.        ++.+|+++|++++|||||+++|+|.+.+..++||||+.+|+|.+++
T Consensus        21 G~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v~e~~~~~~l~~~~  100 (283)
T d1mqba_          21 GEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFL  100 (283)
T ss_dssp             SEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHH
T ss_pred             eEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEEEEEecccCcchhhh
Confidence            8999999832      2689999853        4678999999999999999999999999999999999999999988


Q ss_pred             hhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeeccc
Q 039626          427 FSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIV  506 (628)
Q Consensus       427 ~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~  506 (628)
                      ..   ....++|.+++.++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++................
T Consensus       101 ~~---~~~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~  174 (283)
T d1mqba_         101 RE---KDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGK  174 (283)
T ss_dssp             HH---TTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-----------------C
T ss_pred             hc---ccccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccchhhcccCCCccceEeccCC
Confidence            54   334699999999999999999999994   599999999999999999999999999997754332222334457


Q ss_pred             CCccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCC
Q 039626          507 GTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYP  586 (628)
Q Consensus       507 gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~  586 (628)
                      ||+.|+|||++.++.++.++|||||||++|||++|+.|+.....     ..+....+..              ..+...+
T Consensus       175 gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~-----~~~~~~~i~~--------------~~~~~~~  235 (283)
T d1mqba_         175 IPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS-----NHEVMKAIND--------------GFRLPTP  235 (283)
T ss_dssp             CCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC-----HHHHHHHHHT--------------TCCCCCC
T ss_pred             CCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCC-----HHHHHHHHhc--------------cCCCCCc
Confidence            89999999999999999999999999999999997766542211     1122222111              1122233


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhc
Q 039626          587 LELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNAS  625 (628)
Q Consensus       587 ~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~~~~  625 (628)
                      .+.+..+.+|+.+||+.||++||||.||++.|+++++++
T Consensus       236 ~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~p  274 (283)
T d1mqba_         236 MDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP  274 (283)
T ss_dssp             TTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred             hhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhCc
Confidence            445567899999999999999999999999999998754

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-47  Score=383.79  Aligned_cols=238  Identities=26%  Similarity=0.431  Sum_probs=192.5

Q ss_pred             eEEEEEEEC-CceEEEEEecc------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhcCCCC
Q 039626          361 GSVYRGKIN-GGFAAIKKVNG------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEG  433 (628)
Q Consensus       361 G~Vy~g~~~-g~~vavK~~~~------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~  433 (628)
                      |.||+|.++ +..||||+++.      ++.+|+++|++++|||||+++|++.+ +..++||||+++|+|.+++...  ..
T Consensus        27 g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~~g~L~~~~~~~--~~  103 (272)
T d1qpca_          27 GEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTP--SG  103 (272)
T ss_dssp             EEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHTTSH--HH
T ss_pred             cEEEEEEECCCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeCCCCcHHHHHhhc--CC
Confidence            899999995 56899999864      47899999999999999999998864 5679999999999999988542  23


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCCccccC
Q 039626          434 KYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMA  513 (628)
Q Consensus       434 ~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~Y~A  513 (628)
                      ..++|..+++|+.||++||+|||+   .+|+||||||+|||+++++.+||+|||+++......  ........||+.|+|
T Consensus       104 ~~l~~~~~~~i~~qi~~gl~~lH~---~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~--~~~~~~~~gt~~y~A  178 (272)
T d1qpca_         104 IKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE--YTAREGAKFPIKWTA  178 (272)
T ss_dssp             HTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC--EECCTTCCCCTTTSC
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCccchhheeeecccceeeccccceEEccCCc--cccccccCCcccccC
Confidence            359999999999999999999999   459999999999999999999999999999775432  222344578999999


Q ss_pred             ccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCHHHHHHH
Q 039626          514 PEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLV  593 (628)
Q Consensus       514 PE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l  593 (628)
                      ||.+.++.++.++|||||||++|||+||+.|+.....     ..+....+..          ...+.    .|...+..+
T Consensus       179 PE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~-----~~~~~~~i~~----------~~~~~----~p~~~~~~l  239 (272)
T d1qpca_         179 PEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT-----NPEVIQNLER----------GYRMV----RPDNCPEEL  239 (272)
T ss_dssp             HHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC-----HHHHHHHHHT----------TCCCC----CCTTCCHHH
T ss_pred             hHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCC-----HHHHHHHHHh----------cCCCC----CcccChHHH
Confidence            9999999999999999999999999997665442211     1222222211          11111    222344568


Q ss_pred             HHHHHHhcccCCCCCCCHHHHHHHHHHhHhhc
Q 039626          594 IRLIDACLKKDPTDRPTMYEIEHSLSNILNAS  625 (628)
Q Consensus       594 ~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~~~~  625 (628)
                      .+|+.+||+.||++||||+||++.|+.+..++
T Consensus       240 ~~li~~cl~~~P~~Rpt~~ei~~~L~~~ftst  271 (272)
T d1qpca_         240 YQLMRLCWKERPEDRPTFDYLRSVLEDFFTAT  271 (272)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             HHHHHHHcCCCHhHCcCHHHHHHHhhhhhhcC
Confidence            89999999999999999999999999998765

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-46  Score=380.76  Aligned_cols=237  Identities=22%  Similarity=0.355  Sum_probs=193.0

Q ss_pred             eEEEEEEE----CCceEEEEEecc--------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhh
Q 039626          361 GSVYRGKI----NGGFAAIKKVNG--------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFS  428 (628)
Q Consensus       361 G~Vy~g~~----~g~~vavK~~~~--------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  428 (628)
                      |.||+|.+    ++..||||+++.        ++.+|+++|++++|||||+++|+|.+ +..+|||||+++|+|.+++..
T Consensus        23 g~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvmE~~~~g~L~~~l~~  101 (285)
T d1u59a_          23 GSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVG  101 (285)
T ss_dssp             EEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTTEEHHHHHTT
T ss_pred             eEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEEEEeCCCCcHHHHhhc
Confidence            99999987    234799999863        47789999999999999999999975 468999999999999999843


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCC
Q 039626          429 NKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGT  508 (628)
Q Consensus       429 ~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt  508 (628)
                         ....++|..++.++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++................||
T Consensus       102 ---~~~~l~~~~~~~i~~qi~~gL~ylH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt  175 (285)
T d1u59a_         102 ---KREEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWP  175 (285)
T ss_dssp             ---CTTTSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCC
T ss_pred             ---cccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCcCchhheeeccCCceeeccchhhhcccccccccccccccccC
Confidence               34569999999999999999999999   459999999999999999999999999999876544333333445789


Q ss_pred             ccccCccccccCCCCcccccHHHHHHHHHHHh-CCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCH
Q 039626          509 KGYMAPEYLENGLVSTKLDVYAFGVLILEMLT-GKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPL  587 (628)
Q Consensus       509 ~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELlt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~  587 (628)
                      +.|+|||.+.++.++.++|||||||++|||+| |+.||.....      .+....+..          ...+    ..|.
T Consensus       176 ~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~------~~~~~~i~~----------~~~~----~~p~  235 (285)
T d1u59a_         176 LKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG------PEVMAFIEQ----------GKRM----ECPP  235 (285)
T ss_dssp             GGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT------HHHHHHHHT----------TCCC----CCCT
T ss_pred             ccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCH------HHHHHHHHc----------CCCC----CCCC
Confidence            99999999999999999999999999999998 8998864321      122222111          1111    2233


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhh
Q 039626          588 ELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNA  624 (628)
Q Consensus       588 ~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~~~  624 (628)
                      ..+..+.+|+.+||+.||++||||.+|++.|+.+..+
T Consensus       236 ~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~  272 (285)
T d1u59a_         236 ECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS  272 (285)
T ss_dssp             TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             cCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence            4456688999999999999999999999999987653

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-46  Score=381.48  Aligned_cols=236  Identities=24%  Similarity=0.380  Sum_probs=189.9

Q ss_pred             eEEEEEEEC----CceEEEEEecc---------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhh
Q 039626          361 GSVYRGKIN----GGFAAIKKVNG---------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVF  427 (628)
Q Consensus       361 G~Vy~g~~~----g~~vavK~~~~---------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~  427 (628)
                      |.||+|.+.    ++.||||+++.         ++.+|+++|++++|||||+++|+|.+ +..+|||||+++|+|.+++.
T Consensus        21 G~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~g~L~~~l~   99 (277)
T d1xbba_          21 GTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQ   99 (277)
T ss_dssp             EEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTTEEHHHHHH
T ss_pred             eEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCCCcHHHHHh
Confidence            999999872    35799999853         36789999999999999999999965 46789999999999999985


Q ss_pred             hcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccC
Q 039626          428 SNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVG  507 (628)
Q Consensus       428 ~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~g  507 (628)
                      .    ...++|..++.++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++................|
T Consensus       100 ~----~~~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~g  172 (277)
T d1xbba_         100 Q----NRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKW  172 (277)
T ss_dssp             H----CTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----CC
T ss_pred             h----ccCCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhccccccccccccccCC
Confidence            4    34599999999999999999999994   5999999999999999999999999999977554433333445679


Q ss_pred             CccccCccccccCCCCcccccHHHHHHHHHHHh-CCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCC
Q 039626          508 TKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT-GKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYP  586 (628)
Q Consensus       508 t~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELlt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~  586 (628)
                      |+.|+|||.+.+..++.++|||||||++|||++ |+.||.....      .+....+...              .+...|
T Consensus       173 t~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~------~~~~~~i~~~--------------~~~~~p  232 (277)
T d1xbba_         173 PVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG------SEVTAMLEKG--------------ERMGCP  232 (277)
T ss_dssp             CGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH------HHHHHHHHTT--------------CCCCCC
T ss_pred             CceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCH------HHHHHHHHcC--------------CCCCCC
Confidence            999999999999999999999999999999998 8988863221      1222221110              111223


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhh
Q 039626          587 LELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNA  624 (628)
Q Consensus       587 ~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~~~  624 (628)
                      ..++..+.+|+.+||+.||++|||+++|++.|+.....
T Consensus       233 ~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~  270 (277)
T d1xbba_         233 AGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD  270 (277)
T ss_dssp             TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred             cccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhh
Confidence            33445688999999999999999999999999887644

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.2e-46  Score=373.12  Aligned_cols=230  Identities=24%  Similarity=0.317  Sum_probs=185.5

Q ss_pred             eEEEEEEE--CCceEEEEEecc--------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhcC
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG--------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNK  430 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~--------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~  430 (628)
                      |.||+|+.  +|+.||||++..        ++.+|+++|++++|||||++++++.+++..||||||+++|+|.+++.   
T Consensus        19 g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~~~l~---   95 (271)
T d1nvra_          19 GEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE---   95 (271)
T ss_dssp             EEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEGGGGSB---
T ss_pred             eEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEeccCCCcHHHHHh---
Confidence            89999998  588999998742        47789999999999999999999999999999999999999999984   


Q ss_pred             CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCCcc
Q 039626          431 NEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKG  510 (628)
Q Consensus       431 ~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~  510 (628)
                       ....+++..+..++.|++.||+|||+.   +|+||||||+|||+++++++||+|||+|+...... .........||+.
T Consensus        96 -~~~~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~-~~~~~~~~~GT~~  170 (271)
T d1nvra_          96 -PDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNN-RERLLNKMCGTLP  170 (271)
T ss_dssp             -TTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECEETT-EECCBCCCCSCGG
T ss_pred             -cCCCCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhheeeccCC-ccccccceeeCcC
Confidence             344699999999999999999999995   49999999999999999999999999998764332 1122345689999


Q ss_pred             ccCccccccCCC-CcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCHHH
Q 039626          511 YMAPEYLENGLV-STKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLEL  589 (628)
Q Consensus       511 Y~APE~l~~~~~-s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~  589 (628)
                      |||||.+.+..+ +.++|||||||++|||++|+.||.......  ...   .......             .........
T Consensus       171 Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~--~~~---~~~~~~~-------------~~~~~~~~~  232 (271)
T d1nvra_         171 YVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC--QEY---SDWKEKK-------------TYLNPWKKI  232 (271)
T ss_dssp             GSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTS--HHH---HHHHTTC-------------TTSTTGGGS
T ss_pred             ccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHH--HHH---HHHhcCC-------------CCCCccccC
Confidence            999999988775 678999999999999999999986433211  111   1111100             000111223


Q ss_pred             HHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          590 ALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       590 ~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      +..+.+|+.+||+.||++|||++|+++
T Consensus       233 s~~~~~li~~~L~~dP~~R~t~~eil~  259 (271)
T d1nvra_         233 DSAPLALLHKILVENPSARITIPDIKK  259 (271)
T ss_dssp             CHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            456789999999999999999999864

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-45  Score=368.53  Aligned_cols=243  Identities=23%  Similarity=0.378  Sum_probs=197.0

Q ss_pred             cCCCcCCccc----eEEEEEEE-CCceEEEEEecc------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCC
Q 039626          351 DNFSFTCRIQ----GSVYRGKI-NGGFAAIKKVNG------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVN  419 (628)
Q Consensus       351 ~~f~~~~~i~----G~Vy~g~~-~g~~vavK~~~~------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~  419 (628)
                      ++|.....+|    |.||+|++ ++..||||+++.      ++.+|++++++++|||||+++|+|.+++..++||||+++
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~   83 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMAN   83 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTT
T ss_pred             HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCC
Confidence            3455555554    89999999 456899999864      578999999999999999999999999999999999999


Q ss_pred             CChHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcc
Q 039626          420 GTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEF  499 (628)
Q Consensus       420 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~  499 (628)
                      |+|.+++...   ...++|..+.+++.|+++||+|||+   .+|+||||||+|||+++++.+||+|||+++........ 
T Consensus        84 g~l~~~~~~~---~~~~~~~~~~~i~~qi~~gl~~LH~---~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~-  156 (258)
T d1k2pa_          84 GCLLNYLREM---RHRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT-  156 (258)
T ss_dssp             EEHHHHHHSG---GGCCCHHHHHHHHHHHHHHHHHHHH---TTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC-
T ss_pred             CcHHHhhhcc---ccCCcHHHHHHHHHHHHHHHHHHhh---cCcccccccceeEEEcCCCcEEECcchhheeccCCCce-
Confidence            9999998543   3458999999999999999999999   45999999999999999999999999999876543221 


Q ss_pred             eeeecccCCccccCccccccCCCCcccccHHHHHHHHHHHh-CCCccccccccccccHHHHHHHHhccccchhhhccccC
Q 039626          500 ALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT-GKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFID  578 (628)
Q Consensus       500 ~~~~~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELlt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d  578 (628)
                       ......||+.|+|||.+.+..++.|+|||||||++|||+| |+.||.....      .+....+...            
T Consensus       157 -~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~------~~~~~~i~~~------------  217 (258)
T d1k2pa_         157 -SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN------SETAEHIAQG------------  217 (258)
T ss_dssp             -CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCH------HHHHHHHHTT------------
T ss_pred             -eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCH------HHHHHHHHhC------------
Confidence             2334579999999999999999999999999999999998 7888764322      1222222111            


Q ss_pred             CcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 039626          579 PTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNI  621 (628)
Q Consensus       579 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l  621 (628)
                        .+...|...+..+.+|+.+||+.||++|||++||++.|.+|
T Consensus       218 --~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di  258 (258)
T d1k2pa_         218 --LRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV  258 (258)
T ss_dssp             --CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred             --CCCCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence              11122233445688999999999999999999999988643

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-46  Score=376.83  Aligned_cols=233  Identities=21%  Similarity=0.363  Sum_probs=178.1

Q ss_pred             eEEEEEEE--CCceEEEEEecc---------chHHHHHHHhhcCCCceeeeeeeeec--CCeEEEEEEecCCCChHHHhh
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG---------DVSKEIALLNKINHSNLIILSGVCFN--EGNCYLVYEYAVNGTLSDWVF  427 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~---------~~~~E~~~l~~l~H~nIv~l~g~~~~--~~~~~lV~E~~~~gsL~~~l~  427 (628)
                      |.||+|+.  +|+.||+|+++.         .+.+|+++|++++|||||++++++.+  ++..|+||||+++|+|.+++.
T Consensus        18 g~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivmEy~~~g~L~~~i~   97 (269)
T d2java1          18 GRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVIT   97 (269)
T ss_dssp             EEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEEECCTTEEHHHHHH
T ss_pred             eEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEEecCCCCcHHHHHH
Confidence            89999998  688999999853         26789999999999999999999975  456899999999999999997


Q ss_pred             hcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC--CCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecc
Q 039626          428 SNKNEGKYLDWKQRIQIALDVATGLNYLHSFT--NPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHI  505 (628)
Q Consensus       428 ~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~  505 (628)
                      .....+..+++..++.++.|++.||+|||+.+  ..+|+||||||+|||++.++.+||+|||+++......   ......
T Consensus        98 ~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~---~~~~~~  174 (269)
T d2java1          98 KGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDT---SFAKAF  174 (269)
T ss_dssp             HHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHHC-------------
T ss_pred             hccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceeecccCC---CccccC
Confidence            65445667999999999999999999999853  2459999999999999999999999999998775322   123456


Q ss_pred             cCCccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCC
Q 039626          506 VGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNY  585 (628)
Q Consensus       506 ~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~  585 (628)
                      .||+.|||||.+.+..++.++|||||||++|||++|+.||.....      .+....+....          .+.+    
T Consensus       175 ~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~------~~~~~~i~~~~----------~~~~----  234 (269)
T d2java1         175 VGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ------KELAGKIREGK----------FRRI----  234 (269)
T ss_dssp             -CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHHHTC----------CCCC----
T ss_pred             CCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCH------HHHHHHHHcCC----------CCCC----
Confidence            899999999999999999999999999999999999999864321      12222221111          0111    


Q ss_pred             CHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          586 PLELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       586 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      +...+..+.+|+.+||+.||++|||+.|+++
T Consensus       235 ~~~~s~~l~~li~~~L~~dp~~Rps~~ell~  265 (269)
T d2java1         235 PYRYSDELNEIITRMLNLKDYHRPSVEEILE  265 (269)
T ss_dssp             CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence            2233456889999999999999999999864

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-45  Score=366.48  Aligned_cols=232  Identities=26%  Similarity=0.414  Sum_probs=191.3

Q ss_pred             CCCcCCccc----eEEEEEEE--CCceEEEEEecc----------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEE
Q 039626          352 NFSFTCRIQ----GSVYRGKI--NGGFAAIKKVNG----------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYE  415 (628)
Q Consensus       352 ~f~~~~~i~----G~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  415 (628)
                      +|.....+|    |.||+++.  +|+.||+|++..          .+.+|+++|++++|||||++++++.+++..++|||
T Consensus         7 dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmE   86 (263)
T d2j4za1           7 DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILE   86 (263)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             HeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEe
Confidence            344444443    89999998  578999999853          35689999999999999999999999999999999


Q ss_pred             ecCCCChHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCC
Q 039626          416 YAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQ  495 (628)
Q Consensus       416 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~  495 (628)
                      |+++|+|.+++...    ..+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++.....
T Consensus        87 y~~~g~L~~~l~~~----~~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~  159 (263)
T d2j4za1          87 YAPLGTVYRELQKL----SKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS  159 (263)
T ss_dssp             CCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC
T ss_pred             ecCCCcHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccceeeecCCC
Confidence            99999999999643    3599999999999999999999995   4999999999999999999999999999876432


Q ss_pred             CCcceeeecccCCccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhcc
Q 039626          496 EGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRH  575 (628)
Q Consensus       496 ~~~~~~~~~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  575 (628)
                      .     .....||+.|+|||.+.+..++.++|||||||++|||++|+.||.....      .+....+....        
T Consensus       160 ~-----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~------~~~~~~i~~~~--------  220 (263)
T d2j4za1         160 R-----RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY------QETYKRISRVE--------  220 (263)
T ss_dssp             C-----CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHHTTC--------
T ss_pred             c-----ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCH------HHHHHHHHcCC--------
Confidence            2     3346799999999999999999999999999999999999999864321      22222222111        


Q ss_pred             ccCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          576 FIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       576 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                         +    ..|...+..+.+|+.+||+.||++|||++|+++
T Consensus       221 ---~----~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~  254 (263)
T d2j4za1         221 ---F----TFPDFVTEGARDLISRLLKHNPSQRPMLREVLE  254 (263)
T ss_dssp             ---C----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ---C----CCCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence               1    122334456789999999999999999999975

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-45  Score=379.49  Aligned_cols=246  Identities=23%  Similarity=0.435  Sum_probs=193.6

Q ss_pred             CCCcCCccc----eEEEEEEECC-------ceEEEEEecc--------chHHHHHHHhhc-CCCceeeeeeeeecCCeEE
Q 039626          352 NFSFTCRIQ----GSVYRGKING-------GFAAIKKVNG--------DVSKEIALLNKI-NHSNLIILSGVCFNEGNCY  411 (628)
Q Consensus       352 ~f~~~~~i~----G~Vy~g~~~g-------~~vavK~~~~--------~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~  411 (628)
                      +|.....+|    |.||+|++.+       ..||+|++..        .+.+|+.+|.++ +|||||+++|+|.+.+..+
T Consensus        38 ~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~  117 (325)
T d1rjba_          38 NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIY  117 (325)
T ss_dssp             GEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             HeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeEE
Confidence            344444443    8999999832       2589998753        367899999998 8999999999999999999


Q ss_pred             EEEEecCCCChHHHhhhcCC-------------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCC
Q 039626          412 LVYEYAVNGTLSDWVFSNKN-------------------EGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSN  472 (628)
Q Consensus       412 lV~E~~~~gsL~~~l~~~~~-------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~N  472 (628)
                      +||||+++|+|.++|+..+.                   ....++|..++.++.||+.||+|||+.   +|+||||||+|
T Consensus       118 lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRDlKp~N  194 (325)
T d1rjba_         118 LIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARN  194 (325)
T ss_dssp             EEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCSGGG
T ss_pred             EEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCchhc
Confidence            99999999999999965432                   123589999999999999999999994   59999999999


Q ss_pred             EEeCCCCcEEEccccccccCCCCCCcceeeecccCCccccCccccccCCCCcccccHHHHHHHHHHHh-CCCcccccccc
Q 039626          473 VLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT-GKEAAALHAEE  551 (628)
Q Consensus       473 ILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELlt-G~~p~~~~~~~  551 (628)
                      ||++.++.+||+|||+|+....... ........||+.|||||.+.++.++.++|||||||++|||++ |+.||......
T Consensus       195 ill~~~~~~Kl~DFGla~~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~  273 (325)
T d1rjba_         195 VLVTHGKVVKICDFGLARDIMSDSN-YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD  273 (325)
T ss_dssp             EEEETTTEEEECCCGGGSCGGGCTT-SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred             cccccCCeEEEeeccccccccCCCc-eeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHH
Confidence            9999999999999999987654332 222344578999999999999999999999999999999998 89888643221


Q ss_pred             ccccHHHHHHHHhccccchhhhccccCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 039626          552 NNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSN  620 (628)
Q Consensus       552 ~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~  620 (628)
                            +.+..+...             ..+...|...+..+.+|+.+||+.||++|||++||++.|..
T Consensus       274 ------~~~~~~~~~-------------~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~  323 (325)
T d1rjba_         274 ------ANFYKLIQN-------------GFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC  323 (325)
T ss_dssp             ------HHHHHHHHT-------------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             ------HHHHHHHhc-------------CCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHhC
Confidence                  111111111             11112233445678899999999999999999999999864

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-45  Score=373.18  Aligned_cols=238  Identities=28%  Similarity=0.440  Sum_probs=186.7

Q ss_pred             eEEEEEEE-CCceEEEEEecc------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhcCCCC
Q 039626          361 GSVYRGKI-NGGFAAIKKVNG------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNEG  433 (628)
Q Consensus       361 G~Vy~g~~-~g~~vavK~~~~------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~  433 (628)
                      |.||+|++ ++..||||+++.      ++.+|+.+|++++|+|||+++|+|.+ ++.++||||+++|+|.+++....  .
T Consensus        31 g~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~~g~l~~~~~~~~--~  107 (285)
T d1fmka3          31 GEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGET--G  107 (285)
T ss_dssp             CEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTCBHHHHHSHHH--H
T ss_pred             eEEEEEEECCCCEEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecCCCchhhhhhhcc--c
Confidence            89999999 556899999863      48899999999999999999999864 56789999999999999986532  2


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCCccccC
Q 039626          434 KYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMA  513 (628)
Q Consensus       434 ~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~Y~A  513 (628)
                      ..++|.+++.++.||+.||+|||+.   +|+||||||+|||+|+++.+||+|||+++.......  .......||+.|+|
T Consensus       108 ~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~--~~~~~~~gt~~y~a  182 (285)
T d1fmka3         108 KYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY--TARQGAKFPIKWTA  182 (285)
T ss_dssp             TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC----------------CCGGGSC
T ss_pred             ccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhhccCCCc--eeeccccccccccC
Confidence            3599999999999999999999994   599999999999999999999999999987643321  12334579999999


Q ss_pred             ccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCHHHHHHH
Q 039626          514 PEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLV  593 (628)
Q Consensus       514 PE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l  593 (628)
                      ||++..+.++.++||||||+++|||++|+.|+.....     ..+.+..+...              .+...+...+..+
T Consensus       183 PE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~-----~~~~~~~i~~~--------------~~~~~~~~~~~~l  243 (285)
T d1fmka3         183 PEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV-----NREVLDQVERG--------------YRMPCPPECPESL  243 (285)
T ss_dssp             HHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC-----HHHHHHHHHTT--------------CCCCCCTTSCHHH
T ss_pred             hHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCC-----HHHHHHHHHhc--------------CCCCCCcccCHHH
Confidence            9999999999999999999999999997766543221     12222222111              1112233445568


Q ss_pred             HHHHHHhcccCCCCCCCHHHHHHHHHHhHhhc
Q 039626          594 IRLIDACLKKDPTDRPTMYEIEHSLSNILNAS  625 (628)
Q Consensus       594 ~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~~~~  625 (628)
                      .+++.+||+.||++||||++|++.|+..+.+.
T Consensus       244 ~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~  275 (285)
T d1fmka3         244 HDLMCQCWRKEPEERPTFEYLQAFLEDYFTST  275 (285)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred             HHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence            89999999999999999999999999877543

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-44  Score=368.86  Aligned_cols=227  Identities=25%  Similarity=0.409  Sum_probs=187.6

Q ss_pred             eEEEEEEE--CCceEEEEEecc-------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhcCC
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG-------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKN  431 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~-------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~  431 (628)
                      |.||+|..  +|+.||||+++.       .+.+|+++|++++|||||++++++.+++..|+||||+++|+|.+++..   
T Consensus        34 g~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~~~~~~---  110 (293)
T d1yhwa1          34 GTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE---  110 (293)
T ss_dssp             CEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHH---
T ss_pred             cEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEecCCCcHHHHhhc---
Confidence            89999997  689999999853       367899999999999999999999999999999999999999998743   


Q ss_pred             CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCCccc
Q 039626          432 EGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGY  511 (628)
Q Consensus       432 ~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~Y  511 (628)
                        ..+++.++..++.||+.||+|||+.   +|+||||||+|||++.++++||+|||+++.......   ......||+.|
T Consensus       111 --~~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~---~~~~~~gt~~Y  182 (293)
T d1yhwa1         111 --TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS---KRSTMVGTPYW  182 (293)
T ss_dssp             --SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC---CBCCCCSCGGG
T ss_pred             --cCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhheeeccccc---cccccccCCCc
Confidence              2489999999999999999999994   599999999999999999999999999987653321   23456799999


Q ss_pred             cCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCHHHHH
Q 039626          512 MAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELAL  591 (628)
Q Consensus       512 ~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~  591 (628)
                      +|||.+.+..++.++|||||||++|||++|+.||.....      .+.+........          +  ....+...+.
T Consensus       183 ~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~------~~~~~~~~~~~~----------~--~~~~~~~~s~  244 (293)
T d1yhwa1         183 MAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP------LRALYLIATNGT----------P--ELQNPEKLSA  244 (293)
T ss_dssp             CCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHHHHHHCS----------C--CCSSGGGSCH
T ss_pred             cChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCH------HHHHHHHHhCCC----------C--CCCCcccCCH
Confidence            999999999999999999999999999999999863321      112222211110          0  0112233456


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          592 LVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       592 ~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      .+.+|+.+||+.||++|||++|+++
T Consensus       245 ~~~~li~~~L~~dP~~R~s~~eil~  269 (293)
T d1yhwa1         245 IFRDFLNRCLDMDVEKRGSAKELLQ  269 (293)
T ss_dssp             HHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             HHHHHHHHHccCChhHCcCHHHHhc
Confidence            6889999999999999999999864

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-45  Score=367.62  Aligned_cols=234  Identities=28%  Similarity=0.445  Sum_probs=186.3

Q ss_pred             eEEEEEEECCceEEEEEecc-----chHHHHHHHhhcCCCceeeeeeeeecC-CeEEEEEEecCCCChHHHhhhcCCCCC
Q 039626          361 GSVYRGKINGGFAAIKKVNG-----DVSKEIALLNKINHSNLIILSGVCFNE-GNCYLVYEYAVNGTLSDWVFSNKNEGK  434 (628)
Q Consensus       361 G~Vy~g~~~g~~vavK~~~~-----~~~~E~~~l~~l~H~nIv~l~g~~~~~-~~~~lV~E~~~~gsL~~~l~~~~~~~~  434 (628)
                      |.||+|.+.|..||||+++.     ++.+|++++++++|||||+++|+|.++ +..++||||+++|+|.++|+..  ...
T Consensus        21 g~Vy~~~~~~~~vAvK~i~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~g~L~~~l~~~--~~~   98 (262)
T d1byga_          21 GDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR--GRS   98 (262)
T ss_dssp             CEEEEEEETTEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHHHHHHHH--HHH
T ss_pred             eEEEEEEECCeEEEEEEECcHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccCCCCHHHHHHhc--CCC
Confidence            89999999999999999965     478899999999999999999999754 5689999999999999999653  223


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCCccccCc
Q 039626          435 YLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAP  514 (628)
Q Consensus       435 ~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~Y~AP  514 (628)
                      .++|..+++|+.||+.||+|||+   .+++||||||+|||++.++.+|++|||+++.....      .....+|..|+||
T Consensus        99 ~l~~~~~~~i~~~i~~al~ylH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~------~~~~~~~~~y~aP  169 (262)
T d1byga_          99 VLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST------QDTGKLPVKWTAP  169 (262)
T ss_dssp             HCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC------------------CCTTTSCH
T ss_pred             CCCHHHHHHHHHHHHhhcccccc---CceeccccchHhheecCCCCEeecccccceecCCC------CccccccccCCCh
Confidence            58999999999999999999998   45999999999999999999999999999865432      2234688999999


Q ss_pred             cccccCCCCcccccHHHHHHHHHHHh-CCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCHHHHHHH
Q 039626          515 EYLENGLVSTKLDVYAFGVLILEMLT-GKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLV  593 (628)
Q Consensus       515 E~l~~~~~s~k~DV~SfGvvl~ELlt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l  593 (628)
                      |++.++.+++++||||||+++|||+| |+.|+......      +....+.          ....+    ..+...+..+
T Consensus       170 E~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~------~~~~~i~----------~~~~~----~~~~~~~~~~  229 (262)
T d1byga_         170 EALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK------DVVPRVE----------KGYKM----DAPDGCPPAV  229 (262)
T ss_dssp             HHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG------GHHHHHT----------TTCCC----CCCTTCCHHH
T ss_pred             HHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHH------HHHHHHH----------cCCCC----CCCccCCHHH
Confidence            99999999999999999999999998 56665432211      1111111          11112    2233344668


Q ss_pred             HHHHHHhcccCCCCCCCHHHHHHHHHHhHhhc
Q 039626          594 IRLIDACLKKDPTDRPTMYEIEHSLSNILNAS  625 (628)
Q Consensus       594 ~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~~~~  625 (628)
                      .+|+.+||+.||++||||.|+++.|++|.+.+
T Consensus       230 ~~li~~cl~~dP~~Rps~~~l~~~L~~i~~~~  261 (262)
T d1byga_         230 YEVMKNCWHLDAAMRPSFLQLREQLEHIKTHE  261 (262)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             HHHHHHHcccCHhHCcCHHHHHHHHHHHHhCC
Confidence            89999999999999999999999999997754

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-44  Score=364.52  Aligned_cols=227  Identities=22%  Similarity=0.382  Sum_probs=181.1

Q ss_pred             eEEEEEEE--CCceEEEEEecc---------chHHHHHHHhhcCCCceeeeeeeeec----CCeEEEEEEecCCCChHHH
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG---------DVSKEIALLNKINHSNLIILSGVCFN----EGNCYLVYEYAVNGTLSDW  425 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~---------~~~~E~~~l~~l~H~nIv~l~g~~~~----~~~~~lV~E~~~~gsL~~~  425 (628)
                      |.||+|..  ++..||+|++..         .+.+|+++|++++|||||++++++.+    +...++||||+++|+|.++
T Consensus        23 g~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivmE~~~~g~L~~~  102 (270)
T d1t4ha_          23 KTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTY  102 (270)
T ss_dssp             EEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHH
T ss_pred             cEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEEeCCCCCcHHHH
Confidence            89999998  577899998753         36789999999999999999999874    3468999999999999999


Q ss_pred             hhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeC-CCCcEEEccccccccCCCCCCcceeeec
Q 039626          426 VFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLD-SDLRAKIANFAMARPAEGQEGEFALTRH  504 (628)
Q Consensus       426 l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~-~~~~~kl~Dfgla~~~~~~~~~~~~~~~  504 (628)
                      +...    ..+++..+..++.||+.||+|||+.+ ++|+||||||+|||++ +++.+||+|||+++.....     ....
T Consensus       103 l~~~----~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~-----~~~~  172 (270)
T d1t4ha_         103 LKRF----KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS-----FAKA  172 (270)
T ss_dssp             HHHH----SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT-----SBEE
T ss_pred             Hhcc----ccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceeccCC-----ccCC
Confidence            9643    45899999999999999999999854 5699999999999996 5799999999999865432     2345


Q ss_pred             ccCCccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCC
Q 039626          505 IVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGN  584 (628)
Q Consensus       505 ~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~  584 (628)
                      ..||+.|||||.+.+ .++.++|||||||++|||++|+.||.....     .......+..... .        +..   
T Consensus       173 ~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~-----~~~~~~~i~~~~~-~--------~~~---  234 (270)
T d1t4ha_         173 VIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN-----AAQIYRRVTSGVK-P--------ASF---  234 (270)
T ss_dssp             SCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS-----HHHHHHHHTTTCC-C--------GGG---
T ss_pred             cccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCccc-----HHHHHHHHHcCCC-C--------ccc---
Confidence            689999999998875 599999999999999999999999863221     1122222211110 0        011   


Q ss_pred             CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          585 YPLELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       585 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                       +.....++.+|+.+||+.||++|||++|+++
T Consensus       235 -~~~~~~~~~~li~~~l~~dp~~R~s~~ell~  265 (270)
T d1t4ha_         235 -DKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  265 (270)
T ss_dssp             -GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             -CccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence             1122345789999999999999999999874

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-45  Score=375.59  Aligned_cols=252  Identities=24%  Similarity=0.399  Sum_probs=191.9

Q ss_pred             eEEEEEEECCceEEEEEeccc----h--HHHHHHHhhcCCCceeeeeeeeecCC----eEEEEEEecCCCChHHHhhhcC
Q 039626          361 GSVYRGKINGGFAAIKKVNGD----V--SKEIALLNKINHSNLIILSGVCFNEG----NCYLVYEYAVNGTLSDWVFSNK  430 (628)
Q Consensus       361 G~Vy~g~~~g~~vavK~~~~~----~--~~E~~~l~~l~H~nIv~l~g~~~~~~----~~~lV~E~~~~gsL~~~l~~~~  430 (628)
                      |.||+|+++|+.||||+++.+    +  ..|+..+.+++|||||+++|+|.+++    ..++||||+++|+|.++|+.  
T Consensus        17 g~Vy~~~~~g~~vAvK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~--   94 (303)
T d1vjya_          17 GEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR--   94 (303)
T ss_dssp             SEEEEEEETTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHH--
T ss_pred             eEEEEEEECCEEEEEEEECccchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEecccCCCHHHHHhc--
Confidence            899999999999999998653    2  23555667889999999999998654    57999999999999999964  


Q ss_pred             CCCCCCCHHHHHHHHHHHHHHHHHHhcC-----CCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcce-eeec
Q 039626          431 NEGKYLDWKQRIQIALDVATGLNYLHSF-----TNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFA-LTRH  504 (628)
Q Consensus       431 ~~~~~l~~~~~~~i~~~ia~gL~yLH~~-----~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~-~~~~  504 (628)
                         ..++|.++++++.|+|.||+|||+.     ..++|+||||||+|||+++++.+||+|||+++.......... ....
T Consensus        95 ---~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~~~~~~~~~~~~~  171 (303)
T d1vjya_          95 ---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNH  171 (303)
T ss_dssp             ---CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEECC----
T ss_pred             ---CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccccCCCcceeccccc
Confidence               2489999999999999999999974     236799999999999999999999999999987754332211 2345


Q ss_pred             ccCCccccCccccccCC------CCcccccHHHHHHHHHHHhCCCccccccccccc--------cHHHHHHHHhccccch
Q 039626          505 IVGTKGYMAPEYLENGL------VSTKLDVYAFGVLILEMLTGKEAAALHAEENNM--------HLSDVLNAVLTKEDGE  570 (628)
Q Consensus       505 ~~gt~~Y~APE~l~~~~------~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~--------~~~~~~~~~~~~~~~~  570 (628)
                      ..||+.|+|||++.+..      ++.|+|||||||+||||++|+.|+.........        ...+.......     
T Consensus       172 ~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----  246 (303)
T d1vjya_         172 RVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVC-----  246 (303)
T ss_dssp             CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHT-----
T ss_pred             eecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchHHHHHHHHh-----
Confidence            68999999999987643      678999999999999999998876543222110        01111111111     


Q ss_pred             hhhccccCCcCCCCC-CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhc
Q 039626          571 ESLRHFIDPTLQGNY-PLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNAS  625 (628)
Q Consensus       571 ~~l~~~~d~~l~~~~-~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~~~~  625 (628)
                         ...++|.+...+ +.+....+.+++.+||+.||++|||+.||++.|++|.+.+
T Consensus       247 ---~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~  299 (303)
T d1vjya_         247 ---EQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE  299 (303)
T ss_dssp             ---TSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             ---ccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHhc
Confidence               111222222222 2345667899999999999999999999999999998653

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.8e-45  Score=375.87  Aligned_cols=262  Identities=19%  Similarity=0.304  Sum_probs=192.7

Q ss_pred             cCCCcCCccc----eEEEEEEE--CCceEEEEEecc--------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEe
Q 039626          351 DNFSFTCRIQ----GSVYRGKI--NGGFAAIKKVNG--------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEY  416 (628)
Q Consensus       351 ~~f~~~~~i~----G~Vy~g~~--~g~~vavK~~~~--------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~  416 (628)
                      ++|.....||    |.||+|+.  +|+.||+|+++.        ++.+|+++|++++|||||+++++|.++++.++||||
T Consensus         6 d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmEy   85 (322)
T d1s9ja_           6 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH   85 (322)
T ss_dssp             GGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             cCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            4455444444    89999998  688999999853        367899999999999999999999999999999999


Q ss_pred             cCCCChHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCC
Q 039626          417 AVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQE  496 (628)
Q Consensus       417 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~  496 (628)
                      +++|+|.+++...    ..+++..+..++.|++.||+|||+.  .+|+||||||+|||+++++++||+|||+|+..... 
T Consensus        86 ~~gg~L~~~l~~~----~~l~~~~~~~~~~qil~aL~yLH~~--~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~-  158 (322)
T d1s9ja_          86 MDGGSLDQVLKKA----GRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-  158 (322)
T ss_dssp             CTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHH--HCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH-
T ss_pred             CCCCcHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHHh--CCEEccccCHHHeeECCCCCEEEeeCCCccccCCC-
Confidence            9999999999643    3589999999999999999999972  24999999999999999999999999999866432 


Q ss_pred             CcceeeecccCCccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccH-HHHHHHHh-----------
Q 039626          497 GEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHL-SDVLNAVL-----------  564 (628)
Q Consensus       497 ~~~~~~~~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~-~~~~~~~~-----------  564 (628)
                          .....+||+.|+|||++.+..++.++||||+||+++||++|+.||........... ........           
T Consensus       159 ----~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (322)
T d1s9ja_         159 ----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG  234 (322)
T ss_dssp             ----TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-------------------
T ss_pred             ----ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccc
Confidence                12346899999999999999999999999999999999999999875332110000 00000000           


Q ss_pred             -------cc----ccchhhhccccCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHHHhHh
Q 039626          565 -------TK----EDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEH--SLSNILN  623 (628)
Q Consensus       565 -------~~----~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~--~L~~l~~  623 (628)
                             ..    ....+.+................+.++.+|+.+||+.||++|||++|+++  .+++.-.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~~~  306 (322)
T d1s9ja_         235 RPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDA  306 (322)
T ss_dssp             -----------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHHHH
T ss_pred             ccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcCCc
Confidence                   00    00000000000000000001112456789999999999999999999987  3544433

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-44  Score=365.93  Aligned_cols=229  Identities=24%  Similarity=0.357  Sum_probs=185.8

Q ss_pred             eEEEEEEE--CCceEEEEEecc-------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhcCC
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG-------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKN  431 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~-------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~  431 (628)
                      |.||+|+.  +|..||||+++.       .+.+|+++|++++|||||++++++.+++..++||||+++|+|.+++...  
T Consensus        26 g~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~~g~L~~~~~~~--  103 (288)
T d2jfla1          26 GKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLEL--  103 (288)
T ss_dssp             EEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHHH--
T ss_pred             cEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCCCCcHHHHHHhc--
Confidence            89999998  678999999853       4778999999999999999999999999999999999999999998542  


Q ss_pred             CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCCccc
Q 039626          432 EGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGY  511 (628)
Q Consensus       432 ~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~Y  511 (628)
                       .+.+++.++..++.||+.||+|||+.   +|+||||||+|||++.++++||+|||+++......   .......||+.|
T Consensus       104 -~~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~---~~~~~~~Gt~~y  176 (288)
T d2jfla1         104 -ERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI---QRRDSFIGTPYW  176 (288)
T ss_dssp             -TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH---HHHTCCCSCCTT
T ss_pred             -CCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhccCCCc---cccccccccccc
Confidence             34599999999999999999999995   49999999999999999999999999997653211   122346799999


Q ss_pred             cCccccc-----cCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCC
Q 039626          512 MAPEYLE-----NGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYP  586 (628)
Q Consensus       512 ~APE~l~-----~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~  586 (628)
                      +|||++.     +..++.++|||||||++|||++|+.||.......      .+..+.....          +  ....+
T Consensus       177 ~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~------~~~~i~~~~~----------~--~~~~~  238 (288)
T d2jfla1         177 MAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR------VLLKIAKSEP----------P--TLAQP  238 (288)
T ss_dssp             CCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG------HHHHHHHSCC----------C--CCSSG
T ss_pred             CCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHH------HHHHHHcCCC----------C--CCCcc
Confidence            9999984     4568999999999999999999999986432211      1112211110          0  01122


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          587 LELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       587 ~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      ...+..+.+|+.+||+.||++|||++|+++
T Consensus       239 ~~~s~~~~~li~~~L~~dp~~R~t~~ell~  268 (288)
T d2jfla1         239 SRWSSNFKDFLKKCLEKNVDARWTTSQLLQ  268 (288)
T ss_dssp             GGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            334566889999999999999999999875

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=7.8e-45  Score=372.45  Aligned_cols=250  Identities=26%  Similarity=0.412  Sum_probs=197.7

Q ss_pred             HhcCCCcCCccc----eEEEEEEECC-------ceEEEEEecc--------chHHHHHHHhhcCCCceeeeeeeeecCCe
Q 039626          349 ATDNFSFTCRIQ----GSVYRGKING-------GFAAIKKVNG--------DVSKEIALLNKINHSNLIILSGVCFNEGN  409 (628)
Q Consensus       349 at~~f~~~~~i~----G~Vy~g~~~g-------~~vavK~~~~--------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~  409 (628)
                      ..++|.....||    |.||+|++.|       ..||||+++.        ++.+|+++|++++|+||++++++|.+.+.
T Consensus        11 p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~   90 (301)
T d1lufa_          11 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP   90 (301)
T ss_dssp             CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred             CHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCc
Confidence            345566555554    8999999743       6899999853        47889999999999999999999999999


Q ss_pred             EEEEEEecCCCChHHHhhhcCC--------------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCC
Q 039626          410 CYLVYEYAVNGTLSDWVFSNKN--------------------EGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDIN  469 (628)
Q Consensus       410 ~~lV~E~~~~gsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik  469 (628)
                      .++||||+++|+|.++++....                    ....++|..++.|+.|++.||+|||+.   +++|||||
T Consensus        91 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~ivHrDlK  167 (301)
T d1lufa_          91 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLA  167 (301)
T ss_dssp             CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCS
T ss_pred             eEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---CeEeeEEc
Confidence            9999999999999999964321                    123589999999999999999999994   59999999


Q ss_pred             CCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCCccccCccccccCCCCcccccHHHHHHHHHHHhCCC-ccccc
Q 039626          470 SSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKE-AAALH  548 (628)
Q Consensus       470 ~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~-p~~~~  548 (628)
                      |+|||+|.++.+||+|||+++....... ........||+.|+|||.+.+..++.|+|||||||++|||++|.. |+...
T Consensus       168 p~NILld~~~~~Kl~DFGls~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~  246 (301)
T d1lufa_         168 TRNCLVGENMVVKIADFGLSRNIYSADY-YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM  246 (301)
T ss_dssp             GGGEEECGGGCEEECCCSCHHHHTGGGC-BC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred             ccceEECCCCcEEEccchhheeccCCcc-ccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCC
Confidence            9999999999999999999986643321 223345678999999999999999999999999999999999975 44422


Q ss_pred             cccccccHHHHHHHHhccccchhhhccccCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhH
Q 039626          549 AEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNIL  622 (628)
Q Consensus       549 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~  622 (628)
                      .      ..+....+....              ....+...+..+.+|+.+||+.||++||||.||++.|++|.
T Consensus       247 ~------~~e~~~~v~~~~--------------~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~  300 (301)
T d1lufa_         247 A------HEEVIYYVRDGN--------------ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC  300 (301)
T ss_dssp             C------HHHHHHHHHTTC--------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             C------HHHHHHHHHcCC--------------CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence            1      122222222111              11223334456889999999999999999999999999985

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-44  Score=365.31  Aligned_cols=228  Identities=22%  Similarity=0.348  Sum_probs=185.7

Q ss_pred             eEEEEEEE--CCceEEEEEecc----------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhh
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG----------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFS  428 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  428 (628)
                      |.||+|+.  +|+.||||+++.          .+.+|+++|++++|||||++++++.+++..|+||||+++|+|.+++..
T Consensus        22 g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy~~gg~L~~~~~~  101 (288)
T d1uu3a_          22 STVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK  101 (288)
T ss_dssp             CEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHH
T ss_pred             eEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEEEccCCCCHHHhhhc
Confidence            89999998  588999999853          367899999999999999999999999999999999999999999854


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCC
Q 039626          429 NKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGT  508 (628)
Q Consensus       429 ~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt  508 (628)
                      .    +.+++..+..++.|++.||+|||+.   +|+||||||+|||+++++.+||+|||+++........ .......||
T Consensus       102 ~----~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~-~~~~~~~GT  173 (288)
T d1uu3a_         102 I----GSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ-ARANSFVGT  173 (288)
T ss_dssp             H----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC-----------CCCC
T ss_pred             c----CCCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccccceecccCCcc-cccccccCC
Confidence            3    3599999999999999999999994   5999999999999999999999999999876533211 123446799


Q ss_pred             ccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCHH
Q 039626          509 KGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLE  588 (628)
Q Consensus       509 ~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~  588 (628)
                      +.|+|||.+.+..++.++|||||||++|||++|+.||.....      .+....+....           .    .+|..
T Consensus       174 ~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~------~~~~~~i~~~~-----------~----~~p~~  232 (288)
T d1uu3a_         174 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE------YLIFQKIIKLE-----------Y----DFPEK  232 (288)
T ss_dssp             GGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHTTC-----------C----CCCTT
T ss_pred             ccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCH------HHHHHHHHcCC-----------C----CCCcc
Confidence            999999999999999999999999999999999999864321      22222222111           1    12233


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 039626          589 LALLVIRLIDACLKKDPTDRPTMYEIEHS  617 (628)
Q Consensus       589 ~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~  617 (628)
                      .+..+.+|+.+||+.||++|||++|++..
T Consensus       233 ~s~~~~~li~~~L~~dP~~R~t~~e~~~~  261 (288)
T d1uu3a_         233 FFPKARDLVEKLLVLDATKRLGCEEMEGY  261 (288)
T ss_dssp             CCHHHHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred             CCHHHHHHHHHHccCCHhHCcCHHHHcCC
Confidence            44567899999999999999999997543

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5e-44  Score=367.77  Aligned_cols=238  Identities=29%  Similarity=0.462  Sum_probs=191.5

Q ss_pred             eEEEEEEE--CCc--eEEEEEecc--------chHHHHHHHhhc-CCCceeeeeeeeecCCeEEEEEEecCCCChHHHhh
Q 039626          361 GSVYRGKI--NGG--FAAIKKVNG--------DVSKEIALLNKI-NHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVF  427 (628)
Q Consensus       361 G~Vy~g~~--~g~--~vavK~~~~--------~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~  427 (628)
                      |.||+|++  +|.  .||||+++.        ++.+|+++|+++ +|||||+++|+|.+++..++||||+++|+|.++|+
T Consensus        24 g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV~ey~~~g~L~~~l~  103 (309)
T d1fvra_          24 GQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLR  103 (309)
T ss_dssp             CEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHH
T ss_pred             cEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEEEEecCCCcHHHHHh
Confidence            99999998  343  578888742        478999999999 79999999999999999999999999999999996


Q ss_pred             hcC------------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCC
Q 039626          428 SNK------------NEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQ  495 (628)
Q Consensus       428 ~~~------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~  495 (628)
                      ...            .....++|.++++++.||+.||.|||+.   +++||||||+|||++.++.+||+|||+++.....
T Consensus       104 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~~~kl~DfG~a~~~~~~  180 (309)
T d1fvra_         104 KSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVY  180 (309)
T ss_dssp             TTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEESSCEE
T ss_pred             hccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcCCCceEEcccccccccccc
Confidence            531            2346799999999999999999999994   5999999999999999999999999999865432


Q ss_pred             CCcceeeecccCCccccCccccccCCCCcccccHHHHHHHHHHHhCCCc-cccccccccccHHHHHHHHhccccchhhhc
Q 039626          496 EGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEA-AALHAEENNMHLSDVLNAVLTKEDGEESLR  574 (628)
Q Consensus       496 ~~~~~~~~~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  574 (628)
                      .    ......||..|+|||.+.+..++.++|||||||++|||++|..| +...      ...+....+...        
T Consensus       181 ~----~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~------~~~~~~~~i~~~--------  242 (309)
T d1fvra_         181 V----KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM------TCAELYEKLPQG--------  242 (309)
T ss_dssp             C----CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC------CHHHHHHHGGGT--------
T ss_pred             c----cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCC------CHHHHHHHHHhc--------
Confidence            2    12334689999999999999999999999999999999998754 4321      122222222111        


Q ss_pred             cccCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhc
Q 039626          575 HFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNAS  625 (628)
Q Consensus       575 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~~~~  625 (628)
                        .    +...+...+..+.+|+.+||+.||++||||+||++.|+++++..
T Consensus       243 --~----~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~  287 (309)
T d1fvra_         243 --Y----RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER  287 (309)
T ss_dssp             --C----CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred             --C----CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcC
Confidence              1    11223344567889999999999999999999999999998643

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3.9e-44  Score=367.70  Aligned_cols=223  Identities=30%  Similarity=0.438  Sum_probs=182.4

Q ss_pred             eEEEEEEE--CCceEEEEEecc----------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhh
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG----------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFS  428 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  428 (628)
                      |.||+|+.  +|+.||||+++.          ++.+|+++|++++|||||++++++.+++..++||||+++|+|..++..
T Consensus        29 g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~~~~~~  108 (309)
T d1u5ra_          29 GAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVH  108 (309)
T ss_dssp             SEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHH
T ss_pred             eEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEEecCCCchHHHHHh
Confidence            89999997  688999999853          367899999999999999999999999999999999999999876643


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCC
Q 039626          429 NKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGT  508 (628)
Q Consensus       429 ~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt  508 (628)
                          ...+++..+..++.||+.||+|||+.   +|+||||||+|||+++++++||+|||+++.....       ....||
T Consensus       109 ----~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~-------~~~~GT  174 (309)
T d1u5ra_         109 ----KKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-------NSFVGT  174 (309)
T ss_dssp             ----TSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB-------CCCCSC
T ss_pred             ----CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecccccccCCC-------CccccC
Confidence                34699999999999999999999995   4999999999999999999999999999865432       235799


Q ss_pred             ccccCcccccc---CCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCC
Q 039626          509 KGYMAPEYLEN---GLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNY  585 (628)
Q Consensus       509 ~~Y~APE~l~~---~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~  585 (628)
                      +.|||||++.+   ..++.++|||||||++|||++|+.|+.....      .+.+..+....          .+...   
T Consensus       175 ~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~------~~~~~~i~~~~----------~~~~~---  235 (309)
T d1u5ra_         175 PYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA------MSALYHIAQNE----------SPALQ---  235 (309)
T ss_dssp             GGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHHHHHSC----------CCCCS---
T ss_pred             ccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCH------HHHHHHHHhCC----------CCCCC---
Confidence            99999999864   4689999999999999999999999863221      12222222111          01111   


Q ss_pred             CHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          586 PLELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       586 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      +...+..+.+|+.+||+.||.+|||++|+++
T Consensus       236 ~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  266 (309)
T d1u5ra_         236 SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK  266 (309)
T ss_dssp             CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             CCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence            1123456789999999999999999999875

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-44  Score=362.70  Aligned_cols=235  Identities=27%  Similarity=0.383  Sum_probs=186.0

Q ss_pred             eEEEEEEEC---C--ceEEEEEecc----------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHH
Q 039626          361 GSVYRGKIN---G--GFAAIKKVNG----------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDW  425 (628)
Q Consensus       361 G~Vy~g~~~---g--~~vavK~~~~----------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~  425 (628)
                      |.||+|+++   +  ..||||+++.          ++.+|+++|++++|||||+++|+|.+ +..++||||+++|+|.++
T Consensus        22 g~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~lv~e~~~~~~l~~~  100 (273)
T d1u46a_          22 GVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDR  100 (273)
T ss_dssp             CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHH
T ss_pred             eEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchheeeeeecCcchhhh
Confidence            899999873   2  2689998753          46789999999999999999999975 467899999999999998


Q ss_pred             hhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecc
Q 039626          426 VFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHI  505 (628)
Q Consensus       426 l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~  505 (628)
                      +...   ...++|..++.++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++...............
T Consensus       101 ~~~~---~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~~~~~~~~~~~  174 (273)
T d1u46a_         101 LRKH---QGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHR  174 (273)
T ss_dssp             HHHH---GGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECCC-CCEEEC----
T ss_pred             hhcc---cCCCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccchhhhhcccCCCcceecCcc
Confidence            8653   34599999999999999999999994   59999999999999999999999999999876554444444556


Q ss_pred             cCCccccCccccccCCCCcccccHHHHHHHHHHHh-CCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCC
Q 039626          506 VGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT-GKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGN  584 (628)
Q Consensus       506 ~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELlt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~  584 (628)
                      .|+..|+|||.+.+..++.++|||||||++|||++ |+.||....      ..+....+....             .+.+
T Consensus       175 ~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~------~~~~~~~i~~~~-------------~~~~  235 (273)
T d1u46a_         175 KVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN------GSQILHKIDKEG-------------ERLP  235 (273)
T ss_dssp             -CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCC------HHHHHHHHHTSC-------------CCCC
T ss_pred             ccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcC------HHHHHHHHHhCC-------------CCCC
Confidence            78899999999999999999999999999999998 888876322      222333322211             1112


Q ss_pred             CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHh
Q 039626          585 YPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNI  621 (628)
Q Consensus       585 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l  621 (628)
                      .+...+..+.+|+.+||+.||++||||.||++.|++.
T Consensus       236 ~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~  272 (273)
T d1u46a_         236 RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA  272 (273)
T ss_dssp             CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence            2233445688999999999999999999999988864

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-44  Score=367.19  Aligned_cols=251  Identities=24%  Similarity=0.364  Sum_probs=186.1

Q ss_pred             CCCcCCccc----eEEEEEEEC-------CceEEEEEecc--------chHHHHHHHhhc-CCCceeeeeeeeecC-CeE
Q 039626          352 NFSFTCRIQ----GSVYRGKIN-------GGFAAIKKVNG--------DVSKEIALLNKI-NHSNLIILSGVCFNE-GNC  410 (628)
Q Consensus       352 ~f~~~~~i~----G~Vy~g~~~-------g~~vavK~~~~--------~~~~E~~~l~~l-~H~nIv~l~g~~~~~-~~~  410 (628)
                      +|.....||    |.||+|.+.       ++.||||+++.        .+.+|..++.++ +|+|||.+++++.++ ...
T Consensus        14 ~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~   93 (299)
T d1ywna1          14 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPL   93 (299)
T ss_dssp             GEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCC
T ss_pred             HEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCeE
Confidence            344444443    899999872       35799999864        355677777777 689999999998765 468


Q ss_pred             EEEEEecCCCChHHHhhhcCC------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCC
Q 039626          411 YLVYEYAVNGTLSDWVFSNKN------------EGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSD  478 (628)
Q Consensus       411 ~lV~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~  478 (628)
                      ++||||+++|+|.++|+....            ....++|.+++.++.||++||+|||+.   +|+||||||+|||++++
T Consensus        94 ~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlKp~NILl~~~  170 (299)
T d1ywna1          94 MVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEK  170 (299)
T ss_dssp             EEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGG
T ss_pred             EEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcCCccceeECCC
Confidence            999999999999999975432            134589999999999999999999994   59999999999999999


Q ss_pred             CcEEEccccccccCCCCCCcceeeecccCCccccCccccccCCCCcccccHHHHHHHHHHHhCCC-ccccccccccccHH
Q 039626          479 LRAKIANFAMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKE-AAALHAEENNMHLS  557 (628)
Q Consensus       479 ~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~-p~~~~~~~~~~~~~  557 (628)
                      +.+||+|||+|+....... ........||+.|+|||.+.+..++.++|||||||++|||++|.. |+......  ..+.
T Consensus       171 ~~~Kl~DFGla~~~~~~~~-~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~--~~~~  247 (299)
T d1ywna1         171 NVVKICDFGLARDIYKDPD-YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID--EEFC  247 (299)
T ss_dssp             GCEEECC------CCSCTT-SCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS--HHHH
T ss_pred             CcEEEccCcchhhcccccc-ccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHH--HHHH
Confidence            9999999999987643322 122344679999999999999999999999999999999999764 55422111  1111


Q ss_pred             HHHHHHhccccchhhhccccCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhc
Q 039626          558 DVLNAVLTKEDGEESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNAS  625 (628)
Q Consensus       558 ~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~~~~  625 (628)
                      ..+    .         ....+    ..+...+..+.+++.+||+.||++|||++||++.|++|++++
T Consensus       248 ~~~----~---------~~~~~----~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~n  298 (299)
T d1ywna1         248 RRL----K---------EGTRM----RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN  298 (299)
T ss_dssp             HHH----H---------HTCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             HHH----h---------cCCCC----CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhCC
Confidence            111    1         11111    222334456889999999999999999999999999999864

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-43  Score=363.97  Aligned_cols=239  Identities=26%  Similarity=0.409  Sum_probs=190.7

Q ss_pred             eEEEEEEECC-----ceEEEEEecc--------chHHHHHHHhhcCCCceeeeeeeeec-CCeEEEEEEecCCCChHHHh
Q 039626          361 GSVYRGKING-----GFAAIKKVNG--------DVSKEIALLNKINHSNLIILSGVCFN-EGNCYLVYEYAVNGTLSDWV  426 (628)
Q Consensus       361 G~Vy~g~~~g-----~~vavK~~~~--------~~~~E~~~l~~l~H~nIv~l~g~~~~-~~~~~lV~E~~~~gsL~~~l  426 (628)
                      |+||+|++.+     ..||||+++.        ++.+|+++|++++|||||+++|+|.+ ++..++||||+++|+|.+++
T Consensus        41 g~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~~~g~l~~~~  120 (311)
T d1r0pa_          41 GCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI  120 (311)
T ss_dssp             EEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECCTTCBHHHHH
T ss_pred             eEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEeecCchhhhh
Confidence            8999999822     2589999863        47899999999999999999999875 56899999999999999998


Q ss_pred             hhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCc-ceeeecc
Q 039626          427 FSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGE-FALTRHI  505 (628)
Q Consensus       427 ~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~~  505 (628)
                      ..   ....++|..+++++.|++.||.|||+   ++|+||||||+|||+++++.+||+|||+++........ .......
T Consensus       121 ~~---~~~~~~~~~~~~i~~qia~gL~~lH~---~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~~~~~~~  194 (311)
T d1r0pa_         121 RN---ETHNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGA  194 (311)
T ss_dssp             HC---TTCCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCTTCTTCS
T ss_pred             cc---ccccchHHHHHHHHHHHHHhhhhhcc---cCcccCCccHHhEeECCCCCEEEecccchhhccccccccceecccc
Confidence            54   34458899999999999999999998   45999999999999999999999999999976543221 1122345


Q ss_pred             cCCccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCC
Q 039626          506 VGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNY  585 (628)
Q Consensus       506 ~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~  585 (628)
                      .||+.|+|||.+..+.++.++||||||+++|||++|+.|+......     .+....+....          .+    ..
T Consensus       195 ~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~-----~~~~~~i~~g~----------~~----~~  255 (311)
T d1r0pa_         195 KLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT-----FDITVYLLQGR----------RL----LQ  255 (311)
T ss_dssp             SCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-----------CHHHHHTTC----------CC----CC
T ss_pred             cccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCH-----HHHHHHHHcCC----------CC----CC
Confidence            7899999999999999999999999999999999988876532211     11111111110          11    11


Q ss_pred             CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhh
Q 039626          586 PLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNA  624 (628)
Q Consensus       586 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~~~  624 (628)
                      |...+..+.+|+.+||+.||++||+|.||++.|++++++
T Consensus       256 p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~  294 (311)
T d1r0pa_         256 PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST  294 (311)
T ss_dssp             CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             cccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence            223345688999999999999999999999999999875

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.5e-44  Score=359.97  Aligned_cols=235  Identities=26%  Similarity=0.367  Sum_probs=179.6

Q ss_pred             eEEEEEEEC-----CceEEEEEecc--------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhh
Q 039626          361 GSVYRGKIN-----GGFAAIKKVNG--------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVF  427 (628)
Q Consensus       361 G~Vy~g~~~-----g~~vavK~~~~--------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~  427 (628)
                      |.||+|++.     +..||||+++.        .+.+|+++|++++|||||+++|++. ++..++||||+++|+|.+++.
T Consensus        21 g~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv~E~~~~g~l~~~~~   99 (273)
T d1mp8a_          21 GDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQ   99 (273)
T ss_dssp             SEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEEECCTTEEHHHHHH
T ss_pred             cEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEEEEeccCCcHHhhhh
Confidence            899999873     23688998853        3678999999999999999999996 567899999999999999875


Q ss_pred             hcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccC
Q 039626          428 SNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVG  507 (628)
Q Consensus       428 ~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~g  507 (628)
                      .   ....+++..++.++.||++||+|||+.   +++||||||+||++++++.+||+|||+++.......  .......|
T Consensus       100 ~---~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~~--~~~~~~~g  171 (273)
T d1mp8a_         100 V---RKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY--YKASKGKL  171 (273)
T ss_dssp             H---TTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC---------------------C
T ss_pred             c---cCCCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccchhheeccCCcc--eeccceec
Confidence            4   234699999999999999999999994   599999999999999999999999999987653321  22344578


Q ss_pred             CccccCccccccCCCCcccccHHHHHHHHHHHh-CCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCC
Q 039626          508 TKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT-GKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYP  586 (628)
Q Consensus       508 t~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELlt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~  586 (628)
                      |+.|+|||.+.+..++.++|||||||++|||++ |+.|+......      +....+...          ..+    ..+
T Consensus       172 t~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~------~~~~~i~~~----------~~~----~~~  231 (273)
T d1mp8a_         172 PIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN------DVIGRIENG----------ERL----PMP  231 (273)
T ss_dssp             CGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG------GHHHHHHTT----------CCC----CCC
T ss_pred             CcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHH------HHHHHHHcC----------CCC----CCC
Confidence            999999999999999999999999999999998 78777643221      111111111          011    122


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhh
Q 039626          587 LELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNA  624 (628)
Q Consensus       587 ~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~~~  624 (628)
                      ...+..+.+|+.+||+.||++|||+.||++.|+.+++.
T Consensus       232 ~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~  269 (273)
T d1mp8a_         232 PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE  269 (273)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence            33446688999999999999999999999999999865

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-43  Score=366.13  Aligned_cols=236  Identities=23%  Similarity=0.375  Sum_probs=186.3

Q ss_pred             eEEEEEEE--CCc----eEEEEEecc--------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHh
Q 039626          361 GSVYRGKI--NGG----FAAIKKVNG--------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWV  426 (628)
Q Consensus       361 G~Vy~g~~--~g~----~vavK~~~~--------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l  426 (628)
                      |.||+|++  +|+    .||+|+++.        ++.+|+++|++++|||||+++|+|.++ ..++++||+.+|+|.+++
T Consensus        23 G~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~v~e~~~~~~l~~~~  101 (317)
T d1xkka_          23 GTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYV  101 (317)
T ss_dssp             EEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEEEECCTTCBHHHHH
T ss_pred             eEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeEEEEeccCCcccccc
Confidence            89999998  343    589998753        477899999999999999999999865 567889999999999988


Q ss_pred             hhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeeccc
Q 039626          427 FSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIV  506 (628)
Q Consensus       427 ~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~  506 (628)
                      ..   ....++|..+++++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++........ .......
T Consensus       102 ~~---~~~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~~~-~~~~~~~  174 (317)
T d1xkka_         102 RE---HKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE-YHAEGGK  174 (317)
T ss_dssp             HH---TSSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTCC---------
T ss_pred             cc---cccCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeeccccceeccccccc-ccccccc
Confidence            64   345699999999999999999999994   5999999999999999999999999999987543322 2233457


Q ss_pred             CCccccCccccccCCCCcccccHHHHHHHHHHHh-CCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCC
Q 039626          507 GTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT-GKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNY  585 (628)
Q Consensus       507 gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELlt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~  585 (628)
                      ||+.|+|||.+.++.++.++|||||||++|||+| |+.|+......   .+...+..                 ..+...
T Consensus       175 gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~---~~~~~i~~-----------------~~~~~~  234 (317)
T d1xkka_         175 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS---EISSILEK-----------------GERLPQ  234 (317)
T ss_dssp             CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGG---GHHHHHHH-----------------TCCCCC
T ss_pred             cCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHH---HHHHHHHc-----------------CCCCCC
Confidence            8999999999999999999999999999999998 67777543221   11121111                 011122


Q ss_pred             CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhh
Q 039626          586 PLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNA  624 (628)
Q Consensus       586 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~~~  624 (628)
                      |..++..+.+|+.+||+.||.+|||+.||++.|+++...
T Consensus       235 p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~~  273 (317)
T d1xkka_         235 PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD  273 (317)
T ss_dssp             CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             CcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHhC
Confidence            334456688999999999999999999999999988653

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.3e-43  Score=361.83  Aligned_cols=228  Identities=24%  Similarity=0.396  Sum_probs=174.9

Q ss_pred             eEEEEEEE--CCceEEEEEecc--------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhcC
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG--------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNK  430 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~--------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~  430 (628)
                      |.||+++.  +|+.||||++..        .+.+|+++|++++|||||++++++.+++..||||||+++|+|.+++..  
T Consensus        23 g~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~~~gg~L~~~l~~--  100 (307)
T d1a06a_          23 SEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVE--  100 (307)
T ss_dssp             GGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHT--
T ss_pred             eEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcHHHhhhc--
Confidence            89999998  588999998853        255799999999999999999999999999999999999999999953  


Q ss_pred             CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeC---CCCcEEEccccccccCCCCCCcceeeecccC
Q 039626          431 NEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLD---SDLRAKIANFAMARPAEGQEGEFALTRHIVG  507 (628)
Q Consensus       431 ~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~---~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~g  507 (628)
                        ...+++.....++.||+.||+|||+.   +|+||||||+|||++   +++.+||+|||+++......    ......|
T Consensus       101 --~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~----~~~~~~G  171 (307)
T d1a06a_         101 --KGFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS----VLSTACG  171 (307)
T ss_dssp             --CSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC---------------------
T ss_pred             --ccCCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEeccceeEEccCCC----eeeeeee
Confidence              34699999999999999999999994   599999999999994   57899999999998764322    2334679


Q ss_pred             CccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCH
Q 039626          508 TKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPL  587 (628)
Q Consensus       508 t~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~  587 (628)
                      |+.|||||.+.+..++.++|||||||++|||++|+.||.....      .+....+....           .......+.
T Consensus       172 T~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~------~~~~~~i~~~~-----------~~~~~~~~~  234 (307)
T d1a06a_         172 TPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEND------AKLFEQILKAE-----------YEFDSPYWD  234 (307)
T ss_dssp             -CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHHTTC-----------CCCCTTTTT
T ss_pred             CccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCH------HHHHHHHhccC-----------CCCCCcccc
Confidence            9999999999999999999999999999999999999863221      12222222211           011111222


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          588 ELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       588 ~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      +.+..+.+|+.+||+.||++|||++|+++
T Consensus       235 ~~s~~~~~li~~~L~~dP~~R~s~~eil~  263 (307)
T d1a06a_         235 DISDSAKDFIRHLMEKDPEKRFTCEQALQ  263 (307)
T ss_dssp             TSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             CCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence            34456889999999999999999999976

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-43  Score=362.54  Aligned_cols=244  Identities=21%  Similarity=0.390  Sum_probs=195.3

Q ss_pred             eEEEEEEE-------CCceEEEEEecc--------chHHHHHHHhhc-CCCceeeeeeeeecCCeEEEEEEecCCCChHH
Q 039626          361 GSVYRGKI-------NGGFAAIKKVNG--------DVSKEIALLNKI-NHSNLIILSGVCFNEGNCYLVYEYAVNGTLSD  424 (628)
Q Consensus       361 G~Vy~g~~-------~g~~vavK~~~~--------~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~  424 (628)
                      |.||+|++       .+..||||+++.        ++.+|+.+++++ +|||||+++|+|.+++..++||||+++|+|.+
T Consensus        37 g~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~~lvmE~~~~g~l~~  116 (311)
T d1t46a_          37 GKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLN  116 (311)
T ss_dssp             EEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHH
T ss_pred             eEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEEEEEEEcCCCCCHHH
Confidence            89999986       235899999864        367899999999 69999999999999999999999999999999


Q ss_pred             HhhhcCC--------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccc
Q 039626          425 WVFSNKN--------------EGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMAR  490 (628)
Q Consensus       425 ~l~~~~~--------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~  490 (628)
                      +++....              ....+++..+++++.||+.||+|||+.   +++||||||+|||++.++.+|++|||+++
T Consensus       117 ~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~NIl~~~~~~~ki~DfG~~~  193 (311)
T d1t46a_         117 FLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLAR  193 (311)
T ss_dssp             HHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEETTTEEEECCCGGGS
T ss_pred             HHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccccccccccccCcccccccchhe
Confidence            9975432              223589999999999999999999995   49999999999999999999999999999


Q ss_pred             cCCCCCCcceeeecccCCccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccch
Q 039626          491 PAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGE  570 (628)
Q Consensus       491 ~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  570 (628)
                      ....... ........||+.|+|||.+.++.++.++|||||||++|||++++.|+...... ...+.+.+..        
T Consensus       194 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~-~~~~~~~i~~--------  263 (311)
T d1t46a_         194 DIKNDSN-YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV-DSKFYKMIKE--------  263 (311)
T ss_dssp             CTTSCTT-SEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS-SHHHHHHHHH--------
T ss_pred             eccCCCc-ceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCH-HHHHHHHHhc--------
Confidence            8754332 23345568999999999999999999999999999999999955444321111 1111111111        


Q ss_pred             hhhccccCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhcc
Q 039626          571 ESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNASL  626 (628)
Q Consensus       571 ~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~~~~~  626 (628)
                               ..+...+...+..+.+|+.+||+.||++||||.||++.|++++.++-
T Consensus       264 ---------~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~~~  310 (311)
T d1t46a_         264 ---------GFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISEST  310 (311)
T ss_dssp             ---------TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTC
T ss_pred             ---------CCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhccCC
Confidence                     11112223344568899999999999999999999999999887764

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=1.3e-42  Score=362.38  Aligned_cols=229  Identities=22%  Similarity=0.290  Sum_probs=187.1

Q ss_pred             eEEEEEEE--CCceEEEEEecc-------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhcCC
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG-------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKN  431 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~-------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~  431 (628)
                      |.||+++.  +|+.||||++..       .+.+|+++|++++|||||++++++.+++..++||||+++|+|.+++..   
T Consensus        40 g~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~~~l~~---  116 (350)
T d1koaa2          40 GVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVAD---  116 (350)
T ss_dssp             EEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTC---
T ss_pred             eEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCCHHHHHHh---
Confidence            89999998  688999999864       356899999999999999999999999999999999999999999843   


Q ss_pred             CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeC--CCCcEEEccccccccCCCCCCcceeeecccCCc
Q 039626          432 EGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLD--SDLRAKIANFAMARPAEGQEGEFALTRHIVGTK  509 (628)
Q Consensus       432 ~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~--~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~  509 (628)
                      ....+++..+..++.||+.||+|||+.   +|+||||||+|||++  .++.+||+|||+++......    ......||+
T Consensus       117 ~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~----~~~~~~gT~  189 (350)
T d1koaa2         117 EHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ----SVKVTTGTA  189 (350)
T ss_dssp             TTSCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS----CEEEECSCT
T ss_pred             hcCCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecchheeccccc----ccceecCcc
Confidence            334699999999999999999999995   499999999999995  46889999999998775432    234468999


Q ss_pred             cccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCHHH
Q 039626          510 GYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLEL  589 (628)
Q Consensus       510 ~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~  589 (628)
                      .|||||++.+..++.++|||||||++|||++|+.||.....      .+.+..+.....           ..........
T Consensus       190 ~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~------~~~~~~i~~~~~-----------~~~~~~~~~~  252 (350)
T d1koaa2         190 EFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND------DETLRNVKSCDW-----------NMDDSAFSGI  252 (350)
T ss_dssp             TTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHTCC-----------CSCCGGGGGC
T ss_pred             cccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCH------HHHHHHHHhCCC-----------CCCcccccCC
Confidence            99999999999999999999999999999999999864322      222222221110           0001111123


Q ss_pred             HHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          590 ALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       590 ~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      +..+.+|+.+||+.||++|||++|+++
T Consensus       253 s~~~~~li~~~L~~dP~~R~t~~eil~  279 (350)
T d1koaa2         253 SEDGKDFIRKLLLADPNTRMTIHQALE  279 (350)
T ss_dssp             CHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            456789999999999999999999875

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-43  Score=359.21  Aligned_cols=241  Identities=27%  Similarity=0.425  Sum_probs=192.5

Q ss_pred             eEEEEEEECC---------ceEEEEEecc--------chHHHHHHHhhc-CCCceeeeeeeeecCCeEEEEEEecCCCCh
Q 039626          361 GSVYRGKING---------GFAAIKKVNG--------DVSKEIALLNKI-NHSNLIILSGVCFNEGNCYLVYEYAVNGTL  422 (628)
Q Consensus       361 G~Vy~g~~~g---------~~vavK~~~~--------~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL  422 (628)
                      |.||+|+..+         ..||||+++.        ++.+|...+.++ +|||||+++|+|.+++..++||||+++|+|
T Consensus        27 g~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~~~~~v~e~~~~g~l  106 (299)
T d1fgka_          27 GQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL  106 (299)
T ss_dssp             -CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEECCCTTCBH
T ss_pred             cEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCCeEEEEEEccCCCcH
Confidence            8999998622         3689999864        356688888888 899999999999999999999999999999


Q ss_pred             HHHhhhcCC------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccc
Q 039626          423 SDWVFSNKN------------EGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMAR  490 (628)
Q Consensus       423 ~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~  490 (628)
                      .++|.....            ....++|.++++++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++
T Consensus       107 ~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~NiLl~~~~~~kl~dfg~~~  183 (299)
T d1fgka_         107 REYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLAR  183 (299)
T ss_dssp             HHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSTTCCC
T ss_pred             HHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeecccceeecCCCCeEeccchhhc
Confidence            999965432            234699999999999999999999995   49999999999999999999999999999


Q ss_pred             cCCCCCCcceeeecccCCccccCccccccCCCCcccccHHHHHHHHHHHh-CCCccccccccccccHHHHHHHHhccccc
Q 039626          491 PAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLT-GKEAAALHAEENNMHLSDVLNAVLTKEDG  569 (628)
Q Consensus       491 ~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELlt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~  569 (628)
                      ........ .......||+.|+|||.+.++.+++|+||||||+++|||++ |+.|+.....      .+....+..    
T Consensus       184 ~~~~~~~~-~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~------~~~~~~i~~----  252 (299)
T d1fgka_         184 DIHHIDYY-KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV------EELFKLLKE----  252 (299)
T ss_dssp             CGGGCCTT-CCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH------HHHHHHHHT----
T ss_pred             cccccccc-cccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCH------HHHHHHHHc----
Confidence            77543322 22345679999999999999999999999999999999998 5766653221      112111111    


Q ss_pred             hhhhccccCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhhc
Q 039626          570 EESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNAS  625 (628)
Q Consensus       570 ~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~~~~  625 (628)
                            ...+    ..+...+..+.+|+.+||+.||.+|||+.||++.|++|+..+
T Consensus       253 ------~~~~----~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a~~  298 (299)
T d1fgka_         253 ------GHRM----DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALT  298 (299)
T ss_dssp             ------TCCC----CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             ------CCCC----CCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhhcC
Confidence                  1111    222233456889999999999999999999999999998643

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=1.5e-42  Score=351.20  Aligned_cols=239  Identities=22%  Similarity=0.318  Sum_probs=184.3

Q ss_pred             eEEEEEEE--CCceEEEEEecc----------chHHHHHHHhhcCCCceeeeeeeeecCC----eEEEEEEecCCCChHH
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG----------DVSKEIALLNKINHSNLIILSGVCFNEG----NCYLVYEYAVNGTLSD  424 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~nIv~l~g~~~~~~----~~~lV~E~~~~gsL~~  424 (628)
                      |.||+|+.  +|+.||||+++.          .+.+|+++|++++|||||++++++..++    ..||||||+++|+|.+
T Consensus        21 g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~lvmE~~~g~~L~~  100 (277)
T d1o6ya_          21 SEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRD  100 (277)
T ss_dssp             EEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEEEEEECCCEEEHHH
T ss_pred             eEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceEEEEEECCCCCEehh
Confidence            89999997  688999999853          3678999999999999999999998653    3799999999999999


Q ss_pred             HhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeec
Q 039626          425 WVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRH  504 (628)
Q Consensus       425 ~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~  504 (628)
                      ++...    ..+++.+++.++.||+.||+|||+.   +|+||||||+|||++.++..+++|||.++..............
T Consensus       101 ~~~~~----~~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~~~~~~~~~  173 (277)
T d1o6ya_         101 IVHTE----GPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAA  173 (277)
T ss_dssp             HHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTCEECC-----------
T ss_pred             hhccc----CCCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhhhhhhhcccccccccccc
Confidence            88543    3599999999999999999999994   5999999999999999999999999998766443333333455


Q ss_pred             ccCCccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCC
Q 039626          505 IVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGN  584 (628)
Q Consensus       505 ~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~  584 (628)
                      ..||+.|+|||.+.+..+++++|||||||++|||++|+.||.....      .+..........           .....
T Consensus       174 ~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~------~~~~~~~~~~~~-----------~~~~~  236 (277)
T d1o6ya_         174 VIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP------VSVAYQHVREDP-----------IPPSA  236 (277)
T ss_dssp             -----TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHHHCCC-----------CCGGG
T ss_pred             ccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCH------HHHHHHHHhcCC-----------CCCch
Confidence            6899999999999999999999999999999999999999864322      122222222110           00001


Q ss_pred             CCHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHHHhHh
Q 039626          585 YPLELALLVIRLIDACLKKDPTDRP-TMYEIEHSLSNILN  623 (628)
Q Consensus       585 ~~~~~~~~l~~l~~~Cl~~dP~~RP-s~~ev~~~L~~l~~  623 (628)
                      ...+.+..+.+++.+||+.||.+|| |++++.+.|.++.+
T Consensus       237 ~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~n  276 (277)
T d1o6ya_         237 RHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN  276 (277)
T ss_dssp             TSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHC
T ss_pred             hccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHhC
Confidence            1112345678999999999999999 89999999998864

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=2.9e-42  Score=359.99  Aligned_cols=229  Identities=24%  Similarity=0.322  Sum_probs=188.0

Q ss_pred             eEEEEEEE--CCceEEEEEecc-------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhcCC
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG-------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKN  431 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~-------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~  431 (628)
                      |.||+|..  +|+.||||+++.       .+.+|+++|++++|||||++++++.+++..||||||+++|+|.+++..   
T Consensus        43 g~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~~~~~~---  119 (352)
T d1koba_          43 GVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAA---  119 (352)
T ss_dssp             EEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCCCBHHHHTTC---
T ss_pred             eEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCChHHHHHHh---
Confidence            89999997  688999999854       356799999999999999999999999999999999999999988743   


Q ss_pred             CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeC--CCCcEEEccccccccCCCCCCcceeeecccCCc
Q 039626          432 EGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLD--SDLRAKIANFAMARPAEGQEGEFALTRHIVGTK  509 (628)
Q Consensus       432 ~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~--~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~  509 (628)
                      .+..+++.....|+.||+.||+|||+.   +|+||||||+|||++  .++.+||+|||+|+......    ......||+
T Consensus       120 ~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~----~~~~~~gt~  192 (352)
T d1koba_         120 EDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE----IVKVTTATA  192 (352)
T ss_dssp             TTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS----CEEEECSSG
T ss_pred             cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecccceecCCCC----ceeeccCcc
Confidence            344699999999999999999999995   599999999999998  67899999999998875432    234467999


Q ss_pred             cccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCHHH
Q 039626          510 GYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLEL  589 (628)
Q Consensus       510 ~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~  589 (628)
                      .|+|||++.+..++.++|||||||++|||++|+.||.....      .+.+..+....           ...........
T Consensus       193 ~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~------~~~~~~i~~~~-----------~~~~~~~~~~~  255 (352)
T d1koba_         193 EFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD------LETLQNVKRCD-----------WEFDEDAFSSV  255 (352)
T ss_dssp             GGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH------HHHHHHHHHCC-----------CCCCSSTTTTS
T ss_pred             cccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHhCC-----------CCCCcccccCC
Confidence            99999999999999999999999999999999999864322      22222222111           01111122234


Q ss_pred             HHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          590 ALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       590 ~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      +..+.+|+.+||+.||.+|||+.|+++
T Consensus       256 s~~~~~li~~~L~~dp~~R~s~~eil~  282 (352)
T d1koba_         256 SPEAKDFIKNLLQKEPRKRLTVHDALE  282 (352)
T ss_dssp             CHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            456789999999999999999999975

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-42  Score=353.23  Aligned_cols=228  Identities=25%  Similarity=0.376  Sum_probs=185.7

Q ss_pred             eEEEEEEE--CCceEEEEEecc-------------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHH
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG-------------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDW  425 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~-------------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~  425 (628)
                      |.||+|+.  +|+.||||+++.             .+.+|+++|++++|||||++++++.+++..+|||||+++|+|.++
T Consensus        24 g~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~gg~L~~~  103 (293)
T d1jksa_          24 AVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDF  103 (293)
T ss_dssp             EEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHH
T ss_pred             eEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCccccch
Confidence            89999998  588999998742             367899999999999999999999999999999999999999999


Q ss_pred             hhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCC----cEEEccccccccCCCCCCccee
Q 039626          426 VFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDL----RAKIANFAMARPAEGQEGEFAL  501 (628)
Q Consensus       426 l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~----~~kl~Dfgla~~~~~~~~~~~~  501 (628)
                      +...    ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++    .+|++|||+++......    .
T Consensus       104 i~~~----~~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~~~~----~  172 (293)
T d1jksa_         104 LAEK----ESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN----E  172 (293)
T ss_dssp             HHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECTTSC----B
T ss_pred             hccc----cccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEecchhhhhhcCCCc----c
Confidence            9643    3599999999999999999999995   499999999999998876    59999999998775332    2


Q ss_pred             eecccCCccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcC
Q 039626          502 TRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTL  581 (628)
Q Consensus       502 ~~~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l  581 (628)
                      .....||+.|+|||.+.+..++.++|||||||++|||++|+.||.....      .+....+.....           ..
T Consensus       173 ~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~------~~~~~~i~~~~~-----------~~  235 (293)
T d1jksa_         173 FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK------QETLANVSAVNY-----------EF  235 (293)
T ss_dssp             CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHTTCC-----------CC
T ss_pred             ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCH------HHHHHHHHhcCC-----------CC
Confidence            2345799999999999999999999999999999999999999864322      122222221110           00


Q ss_pred             CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          582 QGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       582 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      ....+...+..+.+|+++||+.||++|||++|+++
T Consensus       236 ~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  270 (293)
T d1jksa_         236 EDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  270 (293)
T ss_dssp             CHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             CchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            00001123346789999999999999999999875

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.4e-43  Score=358.30  Aligned_cols=240  Identities=25%  Similarity=0.382  Sum_probs=193.9

Q ss_pred             eEEEEEEEC-------CceEEEEEecc--------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHH
Q 039626          361 GSVYRGKIN-------GGFAAIKKVNG--------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDW  425 (628)
Q Consensus       361 G~Vy~g~~~-------g~~vavK~~~~--------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~  425 (628)
                      |.||+|.+.       +..||||+++.        .+.+|++++++++|||||+++|+|..++..++||||+++|+|.++
T Consensus        34 G~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g~l~~~  113 (308)
T d1p4oa_          34 GMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSY  113 (308)
T ss_dssp             SEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHH
T ss_pred             eEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCceeEEEeecCCCCHHHH
Confidence            899999874       46899999964        367899999999999999999999999999999999999999999


Q ss_pred             hhhcC------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcc
Q 039626          426 VFSNK------NEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEF  499 (628)
Q Consensus       426 l~~~~------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~  499 (628)
                      ++...      .....++|..+.+++.++++||.|||+.   +|+||||||+|||+|+++++||+|||+++....... .
T Consensus       114 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~~~Kl~DFGla~~~~~~~~-~  189 (308)
T d1p4oa_         114 LRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY-Y  189 (308)
T ss_dssp             HHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGC-E
T ss_pred             HHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCceEEEeecccceeccCCcc-e
Confidence            86432      2234589999999999999999999994   599999999999999999999999999987654322 1


Q ss_pred             eeeecccCCccccCccccccCCCCcccccHHHHHHHHHHHhCCC-ccccccccccccHHHHHHHHhccccchhhhccccC
Q 039626          500 ALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKE-AAALHAEENNMHLSDVLNAVLTKEDGEESLRHFID  578 (628)
Q Consensus       500 ~~~~~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d  578 (628)
                      .......||+.|+|||.+.+..++.++||||||+++|||++|+. |+...      ...+....+....           
T Consensus       190 ~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~------~~~~~~~~i~~~~-----------  252 (308)
T d1p4oa_         190 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL------SNEQVLRFVMEGG-----------  252 (308)
T ss_dssp             EGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS------CHHHHHHHHHTTC-----------
T ss_pred             eeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCC------CHHHHHHHHHhCC-----------
Confidence            22334578999999999999999999999999999999999864 44321      2222332222111           


Q ss_pred             CcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhh
Q 039626          579 PTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNA  624 (628)
Q Consensus       579 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~~~  624 (628)
                         ....+...+..+.+++.+||+.||.+||||.||++.|++.++.
T Consensus       253 ---~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~  295 (308)
T d1p4oa_         253 ---LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP  295 (308)
T ss_dssp             ---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCT
T ss_pred             ---CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCC
Confidence               0112223445689999999999999999999999999887664

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-41  Score=353.09  Aligned_cols=225  Identities=25%  Similarity=0.368  Sum_probs=186.1

Q ss_pred             eEEEEEEE--CCceEEEEEecc----------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhh
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG----------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFS  428 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  428 (628)
                      |.||+++.  +|+.+|||++++          .+.+|+.+|++++|||||++++++.+++..|+||||+++|+|.+++..
T Consensus        19 g~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ey~~gg~L~~~~~~   98 (337)
T d1o6la_          19 GKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSR   98 (337)
T ss_dssp             EEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH
T ss_pred             eEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccceeccCCCchhhhhhc
Confidence            89999997  689999999864          256799999999999999999999999999999999999999999864


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCC
Q 039626          429 NKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGT  508 (628)
Q Consensus       429 ~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt  508 (628)
                      .    ..+++.....++.|++.||+|||+.   +|+||||||+|||+++++.+||+|||+|+.......   ......||
T Consensus        99 ~----~~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~---~~~~~~GT  168 (337)
T d1o6la_          99 E----RVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA---TMKTFCGT  168 (337)
T ss_dssp             H----SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC---CBCCCEEC
T ss_pred             c----cCCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeecccccccccCCc---ccccceeC
Confidence            3    3588999999999999999999995   599999999999999999999999999987643221   23456899


Q ss_pred             ccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCHH
Q 039626          509 KGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLE  588 (628)
Q Consensus       509 ~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~  588 (628)
                      +.|+|||++.+..++.++||||+||++|||++|+.|+.....      .+.........           .    .+|..
T Consensus       169 ~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~------~~~~~~i~~~~-----------~----~~p~~  227 (337)
T d1o6la_         169 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH------ERLFELILMEE-----------I----RFPRT  227 (337)
T ss_dssp             GGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHCC-----------C----CCCTT
T ss_pred             HHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCH------HHHHHHHhcCC-----------C----CCCcc
Confidence            999999999999999999999999999999999999874332      12222221110           1    12333


Q ss_pred             HHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 039626          589 LALLVIRLIDACLKKDPTDRPT-----MYEIEH  616 (628)
Q Consensus       589 ~~~~l~~l~~~Cl~~dP~~RPs-----~~ev~~  616 (628)
                      .+..+.+|+.+||+.||.+||+     +.|+++
T Consensus       228 ~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~  260 (337)
T d1o6la_         228 LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             SCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             CCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence            4456789999999999999996     666654

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=6.8e-42  Score=352.24  Aligned_cols=222  Identities=24%  Similarity=0.364  Sum_probs=185.3

Q ss_pred             eEEEEEEE--CCceEEEEEecc----------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhh
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG----------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFS  428 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  428 (628)
                      |.||+++.  +|+.||||+++.          .+.+|+.+|++++|||||++++++.+++..|+||||++||+|..++..
T Consensus        18 g~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~l~~~~~~   97 (316)
T d1fota_          18 GRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRK   97 (316)
T ss_dssp             CEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHH
T ss_pred             cEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEeeecCCccccccccc
Confidence            89999997  588999999863          356799999999999999999999999999999999999999998854


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCC
Q 039626          429 NKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGT  508 (628)
Q Consensus       429 ~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt  508 (628)
                          ...+++.....++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++.....      .....||
T Consensus        98 ----~~~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~------~~~~~Gt  164 (316)
T d1fota_          98 ----SQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV------TYTLCGT  164 (316)
T ss_dssp             ----TSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSSC------BCCCCSC
T ss_pred             ----cccccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCccceEeccc------cccccCc
Confidence                34578889999999999999999984   5999999999999999999999999999877532      2346899


Q ss_pred             ccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCHH
Q 039626          509 KGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLE  588 (628)
Q Consensus       509 ~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~  588 (628)
                      +.|||||.+.+..++.++|||||||++|||++|+.||....      ..+....+....           .    .+|..
T Consensus       165 ~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~------~~~~~~~i~~~~-----------~----~~p~~  223 (316)
T d1fota_         165 PDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN------TMKTYEKILNAE-----------L----RFPPF  223 (316)
T ss_dssp             TTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS------HHHHHHHHHHCC-----------C----CCCTT
T ss_pred             ccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcC------HHHHHHHHHcCC-----------C----CCCCC
Confidence            99999999999999999999999999999999999986432      122222222211           1    12223


Q ss_pred             HHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 039626          589 LALLVIRLIDACLKKDPTDRP-----TMYEIEH  616 (628)
Q Consensus       589 ~~~~l~~l~~~Cl~~dP~~RP-----s~~ev~~  616 (628)
                      .+..+.+++.+||+.||.+|+     |++|+++
T Consensus       224 ~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~  256 (316)
T d1fota_         224 FNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  256 (316)
T ss_dssp             SCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             CCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence            345678999999999999996     8888864

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=3.4e-41  Score=340.41  Aligned_cols=228  Identities=24%  Similarity=0.323  Sum_probs=185.8

Q ss_pred             eEEEEEEE--CCceEEEEEecc----------------chHHHHHHHhhcC-CCceeeeeeeeecCCeEEEEEEecCCCC
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG----------------DVSKEIALLNKIN-HSNLIILSGVCFNEGNCYLVYEYAVNGT  421 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~----------------~~~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~lV~E~~~~gs  421 (628)
                      |+||+++.  +|+.+|||+++.                .+.+|+.+|++++ |||||++++++.+++..||||||+++|+
T Consensus        17 g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~ivmE~~~~g~   96 (277)
T d1phka_          17 SVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGE   96 (277)
T ss_dssp             EEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCB
T ss_pred             eEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccCcceEEEEEcCCCch
Confidence            89999998  788999999743                2668999999997 9999999999999999999999999999


Q ss_pred             hHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCccee
Q 039626          422 LSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFAL  501 (628)
Q Consensus       422 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~  501 (628)
                      |.++|...    ..+++.++..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++......    .
T Consensus        97 L~~~l~~~----~~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~----~  165 (277)
T d1phka_          97 LFDYLTEK----VTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE----K  165 (277)
T ss_dssp             HHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECCTTC----C
T ss_pred             HHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEccchheeEccCCC----c
Confidence            99999642    3599999999999999999999994   49999999999999999999999999998775432    2


Q ss_pred             eecccCCccccCcccccc------CCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhcc
Q 039626          502 TRHIVGTKGYMAPEYLEN------GLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRH  575 (628)
Q Consensus       502 ~~~~~gt~~Y~APE~l~~------~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  575 (628)
                      .....||+.|+|||.+.+      ..++.++||||+||+++||++|+.||.....      .+....+.....       
T Consensus       166 ~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~------~~~~~~i~~~~~-------  232 (277)
T d1phka_         166 LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ------MLMLRMIMSGNY-------  232 (277)
T ss_dssp             BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHTCC-------
T ss_pred             eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCH------HHHHHHHHhCCC-------
Confidence            344679999999999863      3568899999999999999999999874322      122222222110       


Q ss_pred             ccCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          576 FIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       576 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                          ..........+..+.+|+.+||+.||.+|||++||++
T Consensus       233 ----~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~  269 (277)
T d1phka_         233 ----QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  269 (277)
T ss_dssp             ----CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             ----CCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence                0111112234567889999999999999999999864

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-41  Score=350.90  Aligned_cols=232  Identities=21%  Similarity=0.243  Sum_probs=183.8

Q ss_pred             eEEEEEEE--CCceEEEEEecc--chHHHHHHHhhc-CCCceeeeeeeeec----CCeEEEEEEecCCCChHHHhhhcCC
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG--DVSKEIALLNKI-NHSNLIILSGVCFN----EGNCYLVYEYAVNGTLSDWVFSNKN  431 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~--~~~~E~~~l~~l-~H~nIv~l~g~~~~----~~~~~lV~E~~~~gsL~~~l~~~~~  431 (628)
                      |.||+|+.  +|+.||||+++.  .+.+|+.++.++ +|||||++++++.+    +...|+||||++||+|.++|...  
T Consensus        26 g~Vy~a~~~~~~~~vAiK~i~~~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~~gg~L~~~i~~~--  103 (335)
T d2ozaa1          26 GKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDR--  103 (335)
T ss_dssp             CEEEEEEETTTCCEEEEEEEECSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHSC--
T ss_pred             eEEEEEEECCCCCEEEEEEECCcHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEECCCCCcHHHHHHhc--
Confidence            89999997  688999999865  577899987665 89999999999875    45689999999999999999642  


Q ss_pred             CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCC---CCcEEEccccccccCCCCCCcceeeecccCC
Q 039626          432 EGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDS---DLRAKIANFAMARPAEGQEGEFALTRHIVGT  508 (628)
Q Consensus       432 ~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~---~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt  508 (628)
                      ....+++.+...|+.|++.||+|||+.   +|+||||||+|||+++   ++.+||+|||+++......    ......||
T Consensus       104 ~~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~~----~~~~~~gt  176 (335)
T d2ozaa1         104 GDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN----SLTTPCYT  176 (335)
T ss_dssp             SCCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCCC----CCCCCSCC
T ss_pred             CCCCcCHHHHHHHHHHHHHHHHHHHHc---CCccccccccccccccccccccccccccceeeeccCCC----ccccccCC
Confidence            235699999999999999999999995   4999999999999986   5679999999998765432    23346799


Q ss_pred             ccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCc--CCCCCC
Q 039626          509 KGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPT--LQGNYP  586 (628)
Q Consensus       509 ~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~--l~~~~~  586 (628)
                      +.|+|||++.+..++.++|||||||++|||++|+.||........   ...+..            ......  .+....
T Consensus       177 ~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~---~~~~~~------------~i~~~~~~~~~~~~  241 (335)
T d2ozaa1         177 PYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI---SPGMKT------------RIRMGQYEFPNPEW  241 (335)
T ss_dssp             CSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----------------------CCCSCSSSCCTTHH
T ss_pred             cccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHH---HHHHHH------------HHhcCCCCCCCccc
Confidence            999999999999999999999999999999999999974332211   000000            000001  111111


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          587 LELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       587 ~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      ...+..+.+|+.+||+.||++|||+.|+++
T Consensus       242 ~~~s~~~~~li~~~L~~dP~~R~s~~eil~  271 (335)
T d2ozaa1         242 SEVSEEVKMLIRNLLKTEPTQRMTITEFMN  271 (335)
T ss_dssp             HHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             ccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence            244567899999999999999999999976

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=2.5e-41  Score=354.73  Aligned_cols=234  Identities=21%  Similarity=0.319  Sum_probs=184.8

Q ss_pred             CCCcCCccc----eEEEEEEE--CCceEEEEEeccc----------hH---HHHHHHhhcCCCceeeeeeeeecCCeEEE
Q 039626          352 NFSFTCRIQ----GSVYRGKI--NGGFAAIKKVNGD----------VS---KEIALLNKINHSNLIILSGVCFNEGNCYL  412 (628)
Q Consensus       352 ~f~~~~~i~----G~Vy~g~~--~g~~vavK~~~~~----------~~---~E~~~l~~l~H~nIv~l~g~~~~~~~~~l  412 (628)
                      +|.....||    |.||+|+.  +|+.||||++...          +.   +|+++++.++|||||++++++.+++..|+
T Consensus         5 dy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~i   84 (364)
T d1omwa3           5 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSF   84 (364)
T ss_dssp             TEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEE
T ss_pred             hCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEEE
Confidence            444444454    89999998  6889999998531          22   34777888899999999999999999999


Q ss_pred             EEEecCCCChHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccC
Q 039626          413 VYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPA  492 (628)
Q Consensus       413 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~  492 (628)
                      ||||+++|+|.++|...    ..+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+|+..
T Consensus        85 vmE~~~gg~L~~~l~~~----~~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~~~  157 (364)
T d1omwa3          85 ILDLMNGGDLHYHLSQH----GVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDF  157 (364)
T ss_dssp             EECCCCSCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCEEC
T ss_pred             EEEecCCCcHHHHHHhc----ccccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeeceeeec
Confidence            99999999999999643    3588999999999999999999994   5999999999999999999999999999876


Q ss_pred             CCCCCcceeeecccCCccccCcccccc-CCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchh
Q 039626          493 EGQEGEFALTRHIVGTKGYMAPEYLEN-GLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEE  571 (628)
Q Consensus       493 ~~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  571 (628)
                      ....     .....||+.|+|||++.. ..++.++|||||||++|||++|+.||.......   ..........      
T Consensus       158 ~~~~-----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~---~~~~~~~~~~------  223 (364)
T d1omwa3         158 SKKK-----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD---KHEIDRMTLT------  223 (364)
T ss_dssp             SSSC-----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSC---HHHHHHHSSS------
T ss_pred             CCCc-----ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHhccc------
Confidence            5432     234579999999999875 568999999999999999999999987533221   1111111111      


Q ss_pred             hhccccCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHH
Q 039626          572 SLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPT-----MYEIE  615 (628)
Q Consensus       572 ~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~ev~  615 (628)
                           ..    ...+...+..+.+|+.+||+.||++|||     ++|++
T Consensus       224 -----~~----~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil  263 (364)
T d1omwa3         224 -----MA----VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVK  263 (364)
T ss_dssp             -----CC----CCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHH
T ss_pred             -----CC----CCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHH
Confidence                 01    1122234456789999999999999999     46665

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=7.7e-41  Score=349.09  Aligned_cols=231  Identities=23%  Similarity=0.328  Sum_probs=189.8

Q ss_pred             CCCcCCccc----eEEEEEEE--CCceEEEEEecc----------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEE
Q 039626          352 NFSFTCRIQ----GSVYRGKI--NGGFAAIKKVNG----------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYE  415 (628)
Q Consensus       352 ~f~~~~~i~----G~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  415 (628)
                      +|.....||    |.||+++.  +|+.||||++..          .+.+|+++|++++|||||++++++.+....++|||
T Consensus        42 ~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e  121 (350)
T d1rdqe_          42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVME  121 (350)
T ss_dssp             GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccccc
Confidence            455444554    89999998  689999999853          25689999999999999999999999999999999


Q ss_pred             ecCCCChHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCC
Q 039626          416 YAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQ  495 (628)
Q Consensus       416 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~  495 (628)
                      |+.+|+|.+++...    ..+++.....++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++.....
T Consensus       122 ~~~~g~l~~~l~~~----~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~  194 (350)
T d1rdqe_         122 YVAGGEMFSHLRRI----GRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR  194 (350)
T ss_dssp             CCTTCBHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred             cccccchhhhHhhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeeceeeeecccc
Confidence            99999999999643    3589999999999999999999995   4999999999999999999999999999977532


Q ss_pred             CCcceeeecccCCccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhcc
Q 039626          496 EGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRH  575 (628)
Q Consensus       496 ~~~~~~~~~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  575 (628)
                            .....||+.|||||.+.+..++.++|||||||++|||++|+.||....      .......+....        
T Consensus       195 ------~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~------~~~~~~~i~~~~--------  254 (350)
T d1rdqe_         195 ------TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ------PIQIYEKIVSGK--------  254 (350)
T ss_dssp             ------BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHHCC--------
T ss_pred             ------cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcC------HHHHHHHHhcCC--------
Confidence                  234579999999999999999999999999999999999999986432      122222222111        


Q ss_pred             ccCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 039626          576 FIDPTLQGNYPLELALLVIRLIDACLKKDPTDRP-----TMYEIEH  616 (628)
Q Consensus       576 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~ev~~  616 (628)
                         +    ..+...+..+.+++.+||+.||.+|+     +++|+++
T Consensus       255 ---~----~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~  293 (350)
T d1rdqe_         255 ---V----RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             ---C----CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             ---C----CCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence               1    11223345678999999999999994     8888864

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-41  Score=344.87  Aligned_cols=243  Identities=23%  Similarity=0.287  Sum_probs=182.9

Q ss_pred             eEEEEEEE--CCceEEEEEecc------------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHh
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG------------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWV  426 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~------------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l  426 (628)
                      |.||+|+.  +|+.||||+++.            .+.+|+++|++++|||||++++++.+++..++||||+.++++..++
T Consensus        12 g~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~~~~~~~~~~   91 (299)
T d1ua2a_          12 ATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIK   91 (299)
T ss_dssp             EEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCSEEHHHHHT
T ss_pred             eEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhhcchHHhhhh
Confidence            89999997  688999998742            3668999999999999999999999999999999999888776655


Q ss_pred             hhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeeccc
Q 039626          427 FSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIV  506 (628)
Q Consensus       427 ~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~  506 (628)
                          ..+..+++..+..++.||+.||+|||+.   +|+||||||+|||+++++.+||+|||+++.......   ......
T Consensus        92 ----~~~~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~---~~~~~~  161 (299)
T d1ua2a_          92 ----DNSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR---AYTHQV  161 (299)
T ss_dssp             ----TCCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC---CCCCSC
T ss_pred             ----hcccCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccccccCCCcc---ccccee
Confidence                2345688899999999999999999995   499999999999999999999999999987654321   223457


Q ss_pred             CCccccCccccccC-CCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccch-----hhhccccCCc
Q 039626          507 GTKGYMAPEYLENG-LVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGE-----ESLRHFIDPT  580 (628)
Q Consensus       507 gt~~Y~APE~l~~~-~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~l~~~~d~~  580 (628)
                      ||+.|+|||.+... .++.++|||||||++|||++|+.||......+   ....+..........     ........-.
T Consensus       162 gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~---~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~  238 (299)
T d1ua2a_         162 VTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD---QLTRIFETLGTPTEEQWPDMCSLPDYVTFK  238 (299)
T ss_dssp             CCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHHHCCCCTTTSSSTTSSTTCCCCC
T ss_pred             cChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHH---HHHHHHHhcCCCChhhccchhccchhhhhc
Confidence            99999999988654 57999999999999999999999886433221   111111221111000     0000000000


Q ss_pred             CCCCCC-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          581 LQGNYP-----LELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       581 l~~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      .....+     ......+.+|+.+||+.||++|||++|+++
T Consensus       239 ~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~  279 (299)
T d1ua2a_         239 SFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK  279 (299)
T ss_dssp             CCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             cCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence            000111     122456889999999999999999999875

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.1e-41  Score=345.17  Aligned_cols=224  Identities=28%  Similarity=0.400  Sum_probs=183.0

Q ss_pred             eEEEEEEE--CCceEEEEEecc----------chHHHHHHHh-hcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhh
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG----------DVSKEIALLN-KINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVF  427 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~----------~~~~E~~~l~-~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~  427 (628)
                      |+||+|+.  +|+.||||+++.          .+..|..++. .++|||||++++++.+++..|+||||+++|+|.+++.
T Consensus        16 g~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivmEy~~~g~L~~~i~   95 (320)
T d1xjda_          16 GKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQ   95 (320)
T ss_dssp             SEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHH
T ss_pred             cEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEEeecCCCcHHHHhh
Confidence            89999998  688999999863          2345666665 6899999999999999999999999999999999996


Q ss_pred             hcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccC
Q 039626          428 SNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVG  507 (628)
Q Consensus       428 ~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~g  507 (628)
                      ..    ..+++.+...++.||+.||+|||+.   +++||||||+|||+++++++||+|||+++......   .......|
T Consensus        96 ~~----~~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~---~~~~~~~g  165 (320)
T d1xjda_          96 SC----HKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD---AKTNTFCG  165 (320)
T ss_dssp             HH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT---CCBCCCCS
T ss_pred             cc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccchhhhccccc---ccccccCC
Confidence            43    3488999999999999999999995   49999999999999999999999999998664322   12344689


Q ss_pred             CccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCH
Q 039626          508 TKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPL  587 (628)
Q Consensus       508 t~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~  587 (628)
                      |+.|+|||++.+..++.++|||||||++|||++|+.||.....      .+....+...           .+    .+|.
T Consensus       166 t~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~------~~~~~~i~~~-----------~~----~~p~  224 (320)
T d1xjda_         166 TPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE------EELFHSIRMD-----------NP----FYPR  224 (320)
T ss_dssp             CGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHC-----------CC----CCCT
T ss_pred             CCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCH------HHHHHHHHcC-----------CC----CCCc
Confidence            9999999999999999999999999999999999999974322      1222222111           11    1222


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCCHH-HHH
Q 039626          588 ELALLVIRLIDACLKKDPTDRPTMY-EIE  615 (628)
Q Consensus       588 ~~~~~l~~l~~~Cl~~dP~~RPs~~-ev~  615 (628)
                      ..+..+.+|+.+||+.||.+||++. |++
T Consensus       225 ~~s~~~~dli~~~L~~dP~~R~s~~~~l~  253 (320)
T d1xjda_         225 WLEKEAKDLLVKLFVREPEKRLGVRGDIR  253 (320)
T ss_dssp             TSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred             cCCHHHHHHHHHhcccCCCCCcCHHHHHH
Confidence            3345678999999999999999995 664

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.9e-41  Score=346.08  Aligned_cols=229  Identities=23%  Similarity=0.305  Sum_probs=185.9

Q ss_pred             eEEEEEEE--CCceEEEEEecc------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhcCCC
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNE  432 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~  432 (628)
                      |.||+|..  +|+.+|||.++.      .+.+|+++|++++|||||++++++.+++..|+||||+++|+|.+++..   .
T Consensus        19 g~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~gg~L~~~i~~---~   95 (321)
T d1tkia_          19 GIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINT---S   95 (321)
T ss_dssp             EEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBHHHHHTS---S
T ss_pred             eEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecCCCCcHHHHHHh---c
Confidence            89999998  588999999864      366899999999999999999999999999999999999999999943   2


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCC--CcEEEccccccccCCCCCCcceeeecccCCcc
Q 039626          433 GKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSD--LRAKIANFAMARPAEGQEGEFALTRHIVGTKG  510 (628)
Q Consensus       433 ~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~--~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~  510 (628)
                      +..+++.+...++.||+.||+|||+.   +|+||||||+|||++.+  ..+||+|||+++......    ......+|+.
T Consensus        96 ~~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~----~~~~~~~t~~  168 (321)
T d1tkia_          96 AFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD----NFRLLFTAPE  168 (321)
T ss_dssp             SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC----EEEEEESCGG
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccchhhccccCC----cccccccccc
Confidence            34599999999999999999999995   49999999999999854  589999999998764332    2344578999


Q ss_pred             ccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCcCCCCCCHHHH
Q 039626          511 YMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPTLQGNYPLELA  590 (628)
Q Consensus       511 Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~  590 (628)
                      |+|||.+.+..++.++||||+||++|||++|+.||.....      .+....+......       ++....    ...+
T Consensus       169 y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~------~~~~~~i~~~~~~-------~~~~~~----~~~s  231 (321)
T d1tkia_         169 YYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN------QQIIENIMNAEYT-------FDEEAF----KEIS  231 (321)
T ss_dssp             GSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHHHTCCC-------CCHHHH----TTSC
T ss_pred             cccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCH------HHHHHHHHhCCCC-------CChhhc----cCCC
Confidence            9999999999999999999999999999999999864322      2222222221100       000000    0123


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          591 LLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       591 ~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      ..+.+|+.+||+.||.+|||++|+++
T Consensus       232 ~~~~~li~~~L~~dp~~R~s~~eil~  257 (321)
T d1tkia_         232 IEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             HHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHHccCChhHCcCHHHHhc
Confidence            45789999999999999999999986

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.1e-40  Score=336.00  Aligned_cols=245  Identities=25%  Similarity=0.348  Sum_probs=181.9

Q ss_pred             eEEEEEEE--CCceEEEEEecc---------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhc
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG---------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSN  429 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~---------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~  429 (628)
                      |.||+|+.  +|+.||||+++.         .+.+|+++|++++|||||++++++.++++.|+||||+.+ ++.+++.. 
T Consensus        16 g~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~~~~-~~~~~~~~-   93 (298)
T d1gz8a_          16 GVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDA-   93 (298)
T ss_dssp             SEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSE-EHHHHHHH-
T ss_pred             eEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEeecCC-chhhhhhh-
Confidence            89999998  588999999843         467899999999999999999999999999999999965 45555433 


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCCc
Q 039626          430 KNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTK  509 (628)
Q Consensus       430 ~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~  509 (628)
                       .....+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++......   .......||+
T Consensus        94 -~~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~---~~~~~~~gt~  166 (298)
T d1gz8a_          94 -SALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV---RTYTHEVVTL  166 (298)
T ss_dssp             -TTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS---BCTTCCBCCC
T ss_pred             -hcccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCCc---ccceeecccc
Confidence             23456999999999999999999999954   9999999999999999999999999998764322   1233457999


Q ss_pred             cccCccccccCC-CCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhcccc-chhhhccccC--CcCCC--
Q 039626          510 GYMAPEYLENGL-VSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKED-GEESLRHFID--PTLQG--  583 (628)
Q Consensus       510 ~Y~APE~l~~~~-~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~~~d--~~l~~--  583 (628)
                      .|+|||.+.... ++.++|||||||++|||++|+.||.......  .+............ .........+  .....  
T Consensus       167 ~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~--~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (298)
T d1gz8a_         167 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID--QLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWA  244 (298)
T ss_dssp             TTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHHHCCCCTTTSTTGGGSTTCCTTSCCCC
T ss_pred             eeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHH--HHHHHHHhcCCCchhhcccccccccccccccccc
Confidence            999999876654 5899999999999999999999987433211  11222211111110 0001110000  00000  


Q ss_pred             CC-----CHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          584 NY-----PLELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       584 ~~-----~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      ..     ....+..+.+|+.+||+.||++|||++|+++
T Consensus       245 ~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~  282 (298)
T d1gz8a_         245 RQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA  282 (298)
T ss_dssp             CCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence            00     0122356789999999999999999999975

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.6e-41  Score=336.93  Aligned_cols=217  Identities=25%  Similarity=0.345  Sum_probs=177.6

Q ss_pred             eEEEEEEE--CCceEEEEEecc-------------chHHHHHHHhhcC--CCceeeeeeeeecCCeEEEEEEecCC-CCh
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG-------------DVSKEIALLNKIN--HSNLIILSGVCFNEGNCYLVYEYAVN-GTL  422 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~-------------~~~~E~~~l~~l~--H~nIv~l~g~~~~~~~~~lV~E~~~~-gsL  422 (628)
                      |.||+|+.  +|+.||||+++.             .+.+|+.+|++++  |||||++++++.+++..++||||+.+ +++
T Consensus        18 g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~~~lv~e~~~~~~~l   97 (273)
T d1xwsa_          18 GSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDL   97 (273)
T ss_dssp             EEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEEEECCSSEEEH
T ss_pred             eEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCeEEEEEEeccCcchH
Confidence            89999998  688999998853             2568999999997  89999999999999999999999976 678


Q ss_pred             HHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCC-CCcEEEccccccccCCCCCCccee
Q 039626          423 SDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDS-DLRAKIANFAMARPAEGQEGEFAL  501 (628)
Q Consensus       423 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~-~~~~kl~Dfgla~~~~~~~~~~~~  501 (628)
                      .+++..    ...+++..+..++.|++.||+|||+   .+|+||||||+|||++. ++.+||+|||+++......     
T Consensus        98 ~~~~~~----~~~l~e~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~~~~-----  165 (273)
T d1xwsa_          98 FDFITE----RGALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV-----  165 (273)
T ss_dssp             HHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTCEECCSSC-----
T ss_pred             HHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHH---CCCccccCcccceEEecCCCeEEECccccceeccccc-----
Confidence            887754    2459999999999999999999999   45999999999999985 4799999999998654322     


Q ss_pred             eecccCCccccCccccccCCC-CcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhccccCCc
Q 039626          502 TRHIVGTKGYMAPEYLENGLV-STKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRHFIDPT  580 (628)
Q Consensus       502 ~~~~~gt~~Y~APE~l~~~~~-s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~  580 (628)
                      .....||+.|+|||++.+..+ +.++|||||||++|||++|+.||.....            +....           ..
T Consensus       166 ~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~------------i~~~~-----------~~  222 (273)
T d1xwsa_         166 YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------------IIRGQ-----------VF  222 (273)
T ss_dssp             BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------------HHHCC-----------CC
T ss_pred             ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH------------Hhhcc-----------cC
Confidence            234679999999999987665 6779999999999999999999863210            11100           01


Q ss_pred             CCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          581 LQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       581 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      .+..    .+..+.+|+.+||+.||++|||++|+++
T Consensus       223 ~~~~----~s~~~~~li~~~L~~dp~~R~s~~eil~  254 (273)
T d1xwsa_         223 FRQR----VSSECQHLIRWCLALRPSDRPTFEEIQN  254 (273)
T ss_dssp             CSSC----CCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CCCC----CCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence            1122    2355789999999999999999999875

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=1.8e-39  Score=329.95  Aligned_cols=243  Identities=24%  Similarity=0.319  Sum_probs=180.7

Q ss_pred             eEEEEEEE-CCceEEEEEecc---------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhcC
Q 039626          361 GSVYRGKI-NGGFAAIKKVNG---------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNK  430 (628)
Q Consensus       361 G~Vy~g~~-~g~~vavK~~~~---------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~  430 (628)
                      |+||+|+. +|+.||||+++.         .+.+|+.+|++++|||||++++++.+++..++++||+.++.+..+..   
T Consensus        16 g~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~~~~~~~~~~~~---   92 (286)
T d1ob3a_          16 GVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDV---   92 (286)
T ss_dssp             EEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSEEHHHHHHT---
T ss_pred             cEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEeehhhhHHHHHh---
Confidence            89999998 678999999853         46789999999999999999999999999999999998777666652   


Q ss_pred             CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCCcc
Q 039626          431 NEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTKG  510 (628)
Q Consensus       431 ~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~~  510 (628)
                       ....+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+|++|||++........   ......+++.
T Consensus        93 -~~~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~---~~~~~~~~~~  165 (286)
T d1ob3a_          93 -CEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR---KYTHEIVTLW  165 (286)
T ss_dssp             -STTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------------CCCT
T ss_pred             -hcCCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccceecccCcc---ccceecccch
Confidence             345699999999999999999999995   499999999999999999999999999987643221   2233468999


Q ss_pred             ccCccccccC-CCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccc--hhhhccc---------cC
Q 039626          511 YMAPEYLENG-LVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDG--EESLRHF---------ID  578 (628)
Q Consensus       511 Y~APE~l~~~-~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~l~~~---------~d  578 (628)
                      |+|||.+.+. .++.++|||||||+++||++|+.||.......  .+.... ........  .......         ..
T Consensus       166 y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~--~~~~i~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (286)
T d1ob3a_         166 YRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD--QLMRIF-RILGTPNSKNWPNVTELPKYDPNFTVYE  242 (286)
T ss_dssp             TCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHH-HHHCCCCTTTSTTGGGSTTCCTTCCCCC
T ss_pred             hhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHH--HHHHHH-HhhCCCChhhccchhhhhhccccccccc
Confidence            9999998754 56999999999999999999999986432211  111111 11111100  0000000         00


Q ss_pred             CcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          579 PTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       579 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      +..........+..+.+|+++||+.||++|||++|+++
T Consensus       243 ~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~  280 (286)
T d1ob3a_         243 PLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (286)
T ss_dssp             CCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            00001112233456789999999999999999999874

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-39  Score=334.04  Aligned_cols=253  Identities=25%  Similarity=0.373  Sum_probs=184.6

Q ss_pred             cCCCcCCccc----eEEEEEEE--C-CceEEEEEecc---------chHHHHHHHhhc---CCCceeeeeeeeec-----
Q 039626          351 DNFSFTCRIQ----GSVYRGKI--N-GGFAAIKKVNG---------DVSKEIALLNKI---NHSNLIILSGVCFN-----  406 (628)
Q Consensus       351 ~~f~~~~~i~----G~Vy~g~~--~-g~~vavK~~~~---------~~~~E~~~l~~l---~H~nIv~l~g~~~~-----  406 (628)
                      ++|.....+|    |.||+++.  + ++.||||+++.         .+.+|+.+|+.+   +||||++++++|..     
T Consensus         7 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~   86 (305)
T d1blxa_           7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   86 (305)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSS
T ss_pred             CCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccccc
Confidence            3454444454    89999987  3 55789998753         356788887766   89999999999863     


Q ss_pred             CCeEEEEEEecCCCChHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccc
Q 039626          407 EGNCYLVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANF  486 (628)
Q Consensus       407 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Df  486 (628)
                      ....+++|||+++|++.....   .....+++.....++.|++.||+|||+.   +|+||||||+|||+++++.+||+||
T Consensus        87 ~~~~~~~~e~~~~~~~~~~~~---~~~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~df  160 (305)
T d1blxa_          87 ETKLTLVFEHVDQDLTTYLDK---VPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADF  160 (305)
T ss_dssp             EEEEEEEEECCSCBHHHHHHH---SCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECSC
T ss_pred             CceEEEEEEeccCCchhhhhh---ccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeeecch
Confidence            346899999998877665442   2345689999999999999999999995   4999999999999999999999999


Q ss_pred             cccccCCCCCCcceeeecccCCccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhcc
Q 039626          487 AMARPAEGQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTK  566 (628)
Q Consensus       487 gla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~  566 (628)
                      |+++......    ......||+.|+|||.+.+..++.++||||+||++|||++|+.||.......  .+.... .....
T Consensus       161 g~~~~~~~~~----~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~--~~~~i~-~~~~~  233 (305)
T d1blxa_         161 GLARIYSFQM----ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD--QLGKIL-DVIGL  233 (305)
T ss_dssp             CSCCCCCGGG----GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHH-HHHCC
T ss_pred             hhhhhhcccc----cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHH--HHHHHH-HhhCC
Confidence            9988654321    2345689999999999999999999999999999999999999987433221  111111 11111


Q ss_pred             ccchh-----hh-cccc---CCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          567 EDGEE-----SL-RHFI---DPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       567 ~~~~~-----~l-~~~~---d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      .....     .. ....   .......+....+..+.+|+.+||+.||++|||++|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~  292 (305)
T d1blxa_         234 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  292 (305)
T ss_dssp             CCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             CchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            10000     00 0000   000001122234456789999999999999999999864

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=2.7e-38  Score=322.18  Aligned_cols=253  Identities=16%  Similarity=0.167  Sum_probs=195.4

Q ss_pred             CCCcCCccc----eEEEEEEE--CCceEEEEEecc-----chHHHHHHHhhcCC-CceeeeeeeeecCCeEEEEEEecCC
Q 039626          352 NFSFTCRIQ----GSVYRGKI--NGGFAAIKKVNG-----DVSKEIALLNKINH-SNLIILSGVCFNEGNCYLVYEYAVN  419 (628)
Q Consensus       352 ~f~~~~~i~----G~Vy~g~~--~g~~vavK~~~~-----~~~~E~~~l~~l~H-~nIv~l~g~~~~~~~~~lV~E~~~~  419 (628)
                      +|.....||    |.||+|+.  +|+.||||.+..     ++.+|++.++.++| +|++.+++++..+...++||||+ +
T Consensus         6 ~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~-~   84 (293)
T d1csna_           6 HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-G   84 (293)
T ss_dssp             TEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-C
T ss_pred             ceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec-C
Confidence            344444443    89999997  688999998743     47889999999976 89999999999999999999998 7


Q ss_pred             CChHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCC-----CCcEEEccccccccCCC
Q 039626          420 GTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDS-----DLRAKIANFAMARPAEG  494 (628)
Q Consensus       420 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~-----~~~~kl~Dfgla~~~~~  494 (628)
                      |+|.+++..   .+..+++..+..++.|++.||+|||+.   +|+||||||+|||++.     ++.+||+|||+++....
T Consensus        85 ~~l~~~~~~---~~~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~  158 (293)
T d1csna_          85 PSLEDLLDL---CGRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRD  158 (293)
T ss_dssp             CBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBC
T ss_pred             CCHHHHHHh---hccchhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEcccceeEEccc
Confidence            899998854   234689999999999999999999994   4999999999999974     57899999999987654


Q ss_pred             CCCc----ceeeecccCCccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccch
Q 039626          495 QEGE----FALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGE  570 (628)
Q Consensus       495 ~~~~----~~~~~~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  570 (628)
                      ....    ........||+.|||||.+.+..++.++||||||+++|||++|+.||..............+.......   
T Consensus       159 ~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~---  235 (293)
T d1csna_         159 PVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST---  235 (293)
T ss_dssp             TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS---
T ss_pred             CccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCC---
Confidence            3221    112334679999999999999999999999999999999999999997543322111111111100000   


Q ss_pred             hhhccccCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhh
Q 039626          571 ESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNA  624 (628)
Q Consensus       571 ~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~~~  624 (628)
                       ..     +.+....|    .++.+++..|+..+|++||+++.+.+.|+++++.
T Consensus       236 -~~-----~~l~~~~p----~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~  279 (293)
T d1csna_         236 -PL-----RELCAGFP----EEFYKYMHYARNLAFDATPDYDYLQGLFSKVLER  279 (293)
T ss_dssp             -CH-----HHHTTTSC----HHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred             -Ch-----HHhcCCCC----HHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHH
Confidence             00     01112233    4578899999999999999999999999998753

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.6e-38  Score=325.00  Aligned_cols=243  Identities=16%  Similarity=0.177  Sum_probs=183.2

Q ss_pred             eEEEEEEE--CCceEEEEEecc-----chHHHHHHHhhcCCCceeeee-eeeecCCeEEEEEEecCCCChHHHhhhcCCC
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG-----DVSKEIALLNKINHSNLIILS-GVCFNEGNCYLVYEYAVNGTLSDWVFSNKNE  432 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~-----~~~~E~~~l~~l~H~nIv~l~-g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~  432 (628)
                      |.||+|+.  +|+.||||.+..     ++..|++++++++|+|++..+ ++..+++..++||||+ +|+|.+.+..   .
T Consensus        21 G~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~-~~~l~~~~~~---~   96 (299)
T d1ckia_          21 GDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNF---C   96 (299)
T ss_dssp             SEEEEEEETTTTEEEEEEEEESCTTSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHH---T
T ss_pred             cEEEEEEECCCCCEEEEEEEchhccCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEc-CCchhhhhhh---c
Confidence            89999998  588999998653     578899999999887766554 4456677889999999 6677776643   3


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeC---CCCcEEEccccccccCCCCCCc----ceeeecc
Q 039626          433 GKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLD---SDLRAKIANFAMARPAEGQEGE----FALTRHI  505 (628)
Q Consensus       433 ~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~---~~~~~kl~Dfgla~~~~~~~~~----~~~~~~~  505 (628)
                      ...+++..++.++.|++.||+|||+.   +|+||||||+|||++   .+..+||+|||+|+........    .......
T Consensus        97 ~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~  173 (299)
T d1ckia_          97 SRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNL  173 (299)
T ss_dssp             TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCCBCCCCBCCSC
T ss_pred             cCCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCcceeccccccccceeccccCCc
Confidence            44699999999999999999999995   499999999999975   4567999999999987543321    1123446


Q ss_pred             cCCccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHH-HHHHHHhccccchhhhccccCCcCCCC
Q 039626          506 VGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLS-DVLNAVLTKEDGEESLRHFIDPTLQGN  584 (628)
Q Consensus       506 ~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~~~d~~l~~~  584 (628)
                      .||+.|+|||.+.+..++.++|||||||+++||++|+.||............ .........          ..+.+...
T Consensus       174 ~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~  243 (299)
T d1ckia_         174 TGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST----------PIEVLCKG  243 (299)
T ss_dssp             CCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHS----------CHHHHTTT
T ss_pred             CCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCC----------ChhHhccC
Confidence            8999999999999999999999999999999999999998754433221111 111110000          00111122


Q ss_pred             CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhHhh
Q 039626          585 YPLELALLVIRLIDACLKKDPTDRPTMYEIEHSLSNILNA  624 (628)
Q Consensus       585 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~~L~~l~~~  624 (628)
                      +    +.++.+++.+||+.||.+||++.++.+.|+.+...
T Consensus       244 ~----p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~  279 (299)
T d1ckia_         244 Y----PSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR  279 (299)
T ss_dssp             S----CHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHH
T ss_pred             C----CHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHH
Confidence            2    34578999999999999999999999999988653

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.5e-39  Score=334.37  Aligned_cols=244  Identities=24%  Similarity=0.343  Sum_probs=180.0

Q ss_pred             eEEEEEEE--CCceEEEEEecc---chHHHHHHHhhcCCCceeeeeeeeecC------CeEEEEEEecCCCChHHHhhhc
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG---DVSKEIALLNKINHSNLIILSGVCFNE------GNCYLVYEYAVNGTLSDWVFSN  429 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~---~~~~E~~~l~~l~H~nIv~l~g~~~~~------~~~~lV~E~~~~gsL~~~l~~~  429 (628)
                      |+||+|+.  +|+.||||+++.   ...+|+++|++++|+||+++++++...      ...+|||||+++|.+ +.+...
T Consensus        34 g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~Ey~~~~~~-~~l~~~  112 (350)
T d1q5ka_          34 GVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVY-RVARHY  112 (350)
T ss_dssp             EEEEEEEETTTCCEEEEEEEECCSSSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEECCSEEHH-HHHHHH
T ss_pred             eEEEEEEECCCCCEEEEEEECccchHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEEeccCCccH-HHHHhh
Confidence            89999998  688999999865   356899999999999999999998643      347999999976644 444332


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCC-cEEEccccccccCCCCCCcceeeecccCC
Q 039626          430 KNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDL-RAKIANFAMARPAEGQEGEFALTRHIVGT  508 (628)
Q Consensus       430 ~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~-~~kl~Dfgla~~~~~~~~~~~~~~~~~gt  508 (628)
                      ......+++.++..++.||+.||+|||+.   +|+||||||+|||++.++ .+||+|||+++......    ......||
T Consensus       113 ~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~~----~~~~~~gt  185 (350)
T d1q5ka_         113 SRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE----PNVSYICS  185 (350)
T ss_dssp             HHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTCEECCTTS----CCCSCCSC
T ss_pred             hhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccchhhccCCc----cccccccc
Confidence            23455799999999999999999999984   599999999999999775 89999999998765432    12345799


Q ss_pred             ccccCcccccc-CCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhhhcc----ccCCcC--
Q 039626          509 KGYMAPEYLEN-GLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEESLRH----FIDPTL--  581 (628)
Q Consensus       509 ~~Y~APE~l~~-~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~----~~d~~l--  581 (628)
                      +.|+|||.+.+ ..++.++||||+||+++||++|+.||.......  .+...+. ...... .+.+..    ..+...  
T Consensus       186 ~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~--~l~~i~~-~~g~~~-~~~~~~~~~~~~~~~~~~  261 (350)
T d1q5ka_         186 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD--QLVEIIK-VLGTPT-REQIREMNPNYTEFKFPQ  261 (350)
T ss_dssp             TTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHH--HHHHHHH-HHCCCC-HHHHHHHCC---CCCCCC
T ss_pred             ccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHH--HHHHHHH-HhCCCh-HHhhhhhccchhhccccc
Confidence            99999998765 578999999999999999999999987543221  1111111 111100 000000    000000  


Q ss_pred             ------CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          582 ------QGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       582 ------~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                            ........+..+.+|+.+||+.||++|||+.|+++
T Consensus       262 ~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  302 (350)
T d1q5ka_         262 IKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA  302 (350)
T ss_dssp             CCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                  00111223456789999999999999999999985

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-38  Score=324.68  Aligned_cols=246  Identities=22%  Similarity=0.298  Sum_probs=177.5

Q ss_pred             eEEEEEEE--CCceEEEEEecc---------chHHHHHHHhhcCCCceeeeeeeeec--------CCeEEEEEEecCCCC
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG---------DVSKEIALLNKINHSNLIILSGVCFN--------EGNCYLVYEYAVNGT  421 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~---------~~~~E~~~l~~l~H~nIv~l~g~~~~--------~~~~~lV~E~~~~gs  421 (628)
                      |+||+|+.  +|+.||||++..         ++.+|+++|++++|+||+++++++..        ++..++||||+.++.
T Consensus        24 g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~  103 (318)
T d3blha1          24 GEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDL  103 (318)
T ss_dssp             SEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC----------CEEEEEECCCEEH
T ss_pred             eEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccCceEEEEEeccCCCc
Confidence            89999998  688999998742         36789999999999999999999865        346899999998877


Q ss_pred             hHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCc-ce
Q 039626          422 LSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGE-FA  500 (628)
Q Consensus       422 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~-~~  500 (628)
                      +..+.    .....++...+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++........ ..
T Consensus       104 ~~~~~----~~~~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~~~~~~~~~~  176 (318)
T d3blha1         104 AGLLS----NVLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPN  176 (318)
T ss_dssp             HHHHT----CTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCC-----CC
T ss_pred             cchhh----hcccccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEeeecceeeecccccccccc
Confidence            66544    2345688899999999999999999994   5999999999999999999999999999876533211 11


Q ss_pred             eeecccCCccccCccccccC-CCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccch--hh-----
Q 039626          501 LTRHIVGTKGYMAPEYLENG-LVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGE--ES-----  572 (628)
Q Consensus       501 ~~~~~~gt~~Y~APE~l~~~-~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--~~-----  572 (628)
                      ......||+.|+|||.+.+. .+++++|||||||+++||++|+.||.......   ....+..........  ..     
T Consensus       177 ~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~---~~~~i~~~~~~~~~~~~~~~~~~~  253 (318)
T d3blha1         177 RYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQH---QLALISQLCGSITPEVWPNVDNYE  253 (318)
T ss_dssp             CCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCCCCTTTSTTCCCC-
T ss_pred             cccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHH---HHHHHHHhcCCCChhhccccchhh
Confidence            22335799999999998765 68999999999999999999999986433211   112222222111100  00     


Q ss_pred             hccccCCcCCCCCCH-------HHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          573 LRHFIDPTLQGNYPL-------ELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       573 l~~~~d~~l~~~~~~-------~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      ....+........+.       .....+.+|+.+||+.||++|||++|+++
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~  304 (318)
T d3blha1         254 LYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  304 (318)
T ss_dssp             ------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             hhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence            000000000001111       11335678999999999999999999874

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.5e-38  Score=327.50  Aligned_cols=245  Identities=21%  Similarity=0.300  Sum_probs=180.9

Q ss_pred             eEEEEEEE--CCceEEEEEecc--------chHHHHHHHhhcCCCceeeeeeeeecCC----eEEEEEEecCCCChHHHh
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG--------DVSKEIALLNKINHSNLIILSGVCFNEG----NCYLVYEYAVNGTLSDWV  426 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~--------~~~~E~~~l~~l~H~nIv~l~g~~~~~~----~~~lV~E~~~~gsL~~~l  426 (628)
                      |+||+|+.  +|+.||||+++.        .+.+|+++|++++||||+++++++....    ..++++||+.+|+|.+++
T Consensus        22 g~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l~~~~~~g~L~~~l  101 (345)
T d1pmea_          22 GMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLL  101 (345)
T ss_dssp             CCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEECCCEEHHHHH
T ss_pred             eEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEEEEeecCCchhhhh
Confidence            89999987  689999999863        3568999999999999999999997543    234555667799999999


Q ss_pred             hhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeeccc
Q 039626          427 FSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIV  506 (628)
Q Consensus       427 ~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~  506 (628)
                      ..     ..+++..+..++.|++.||+|||+.   +|+||||||+|||+++++.+||+|||+++................
T Consensus       102 ~~-----~~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~  173 (345)
T d1pmea_         102 KT-----QHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV  173 (345)
T ss_dssp             HH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCC
T ss_pred             hc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCceeeccCCCccceeecccc
Confidence            53     2489999999999999999999995   599999999999999999999999999987654333222344567


Q ss_pred             CCccccCccccc-cCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccchhh-------hcc-cc
Q 039626          507 GTKGYMAPEYLE-NGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDGEES-------LRH-FI  577 (628)
Q Consensus       507 gt~~Y~APE~l~-~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------l~~-~~  577 (628)
                      ||+.|+|||.+. +..++.++||||+||+++||++|+.||.......   .................       ... ..
T Consensus       174 gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (345)
T d1pmea_         174 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD---QLNHILGILGSPSQEDLNCIINLKARNYLL  250 (345)
T ss_dssp             SCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCSCCHHHHHTCCCHHHHHHHH
T ss_pred             ccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHH---HHHHHhhhccCCChhhhhhhhhhhhhcccc
Confidence            999999999985 4567899999999999999999999986433211   11111111111110000       000 00


Q ss_pred             CCcCCCCCCH-----HHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          578 DPTLQGNYPL-----ELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       578 d~~l~~~~~~-----~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      ........+.     .....+.+|+.+||+.||.+|||+.|+++
T Consensus       251 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~  294 (345)
T d1pmea_         251 SLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA  294 (345)
T ss_dssp             TSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             cCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            0000011111     12345789999999999999999999985

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-37  Score=314.65  Aligned_cols=244  Identities=23%  Similarity=0.256  Sum_probs=184.8

Q ss_pred             eEEEEEEE--CCceEEEEEecc---------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhc
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG---------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSN  429 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~---------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~  429 (628)
                      |+||+|+.  +|+.||||+++.         .+.+|+.+|++++|+||+++++++.+....++|+|++.+++|..++.. 
T Consensus        16 g~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~~~~~~l~~~~~~-   94 (292)
T d1unla_          16 GTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSC-   94 (292)
T ss_dssp             SEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSEEHHHHHHHT-
T ss_pred             eEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEeeecccccccccccc-
Confidence            89999998  678999999853         357899999999999999999999999999999999999998887743 


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeecccCCc
Q 039626          430 KNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRHIVGTK  509 (628)
Q Consensus       430 ~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~gt~  509 (628)
                         .+.+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||.++.......   ......++.
T Consensus        95 ---~~~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~---~~~~~~~~~  165 (292)
T d1unla_          95 ---NGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR---CYSAEVVTL  165 (292)
T ss_dssp             ---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS---CCCSCCSCG
T ss_pred             ---ccccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchhhcccCCCc---cceeecccc
Confidence               45688999999999999999999995   499999999999999999999999999987654321   223346788


Q ss_pred             cccCccccccCC-CCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccc--hhhhccccCC-------
Q 039626          510 GYMAPEYLENGL-VSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDG--EESLRHFIDP-------  579 (628)
Q Consensus       510 ~Y~APE~l~~~~-~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~l~~~~d~-------  579 (628)
                      .|+|||.+.+.. ++.++|||||||+++||++|+.|+......  ......+.........  ........+.       
T Consensus       166 ~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (292)
T d1unla_         166 WYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV--DDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYP  243 (292)
T ss_dssp             GGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSH--HHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCC
T ss_pred             chhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCH--HHHHHHHHhhcCCCChhhhhhhhhccccccccccc
Confidence            999999887654 699999999999999999999987532211  1111222222111110  0000000000       


Q ss_pred             --cCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          580 --TLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       580 --~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                        .............+.+|+.+||+.||++|||++|+++
T Consensus       244 ~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~  282 (292)
T d1unla_         244 ATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             TTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             ccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence              0011122234456789999999999999999999864

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-37  Score=325.82  Aligned_cols=237  Identities=24%  Similarity=0.354  Sum_probs=178.5

Q ss_pred             eEEEEEEE--CCceEEEEEecc---------chHHHHHHHhhcCCCceeeeeeeeecCC------eEEEEEEecCCCChH
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG---------DVSKEIALLNKINHSNLIILSGVCFNEG------NCYLVYEYAVNGTLS  423 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~---------~~~~E~~~l~~l~H~nIv~l~g~~~~~~------~~~lV~E~~~~gsL~  423 (628)
                      |.||+|..  +|+.||||+++.         .+.+|+++|++++|||||+++++|...+      +.++||||+ +++|.
T Consensus        32 g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~-~~~l~  110 (346)
T d1cm8a_          32 GAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLG  110 (346)
T ss_dssp             -CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEECC-SEEHH
T ss_pred             eEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccceEEEEEecc-cccHH
Confidence            89999998  589999999863         3567999999999999999999998654      579999999 66788


Q ss_pred             HHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeee
Q 039626          424 DWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTR  503 (628)
Q Consensus       424 ~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~  503 (628)
                      +++..     ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+|++|||+++.....      ..
T Consensus       111 ~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~~------~~  176 (346)
T d1cm8a_         111 KLMKH-----EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQADSE------MT  176 (346)
T ss_dssp             HHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCSS------CC
T ss_pred             HHHHh-----ccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhcccccccccccccceeccCCc------cc
Confidence            77642     3499999999999999999999995   4999999999999999999999999999876533      23


Q ss_pred             cccCCccccCcccccc-CCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhcccc----------c---
Q 039626          504 HIVGTKGYMAPEYLEN-GLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKED----------G---  569 (628)
Q Consensus       504 ~~~gt~~Y~APE~l~~-~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~----------~---  569 (628)
                      ...||+.|+|||.+.+ ..++.++||||+||+++||++|+.|+........  +.... .......          .   
T Consensus       177 ~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~--~~~~~-~~~~~~~~~~~~~~~~~~~~~  253 (346)
T d1cm8a_         177 GYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQ--LKEIM-KVTGTPPAEFVQRLQSDEAKN  253 (346)
T ss_dssp             SSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHH-HHHCCCCHHHHHTCSCHHHHH
T ss_pred             cccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHH--HHHHH-hccCCCcHHHHhhhcchhhhh
Confidence            4579999999999876 4579999999999999999999999865432211  11111 1110000          0   


Q ss_pred             -hhhhccccCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          570 -EESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       570 -~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                       ...+.......+. .........+.+|+.+||+.||.+|||++|+++
T Consensus       254 ~~~~~~~~~~~~~~-~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~  300 (346)
T d1cm8a_         254 YMKGLPELEKKDFA-SILTNASPLAVNLLEKMLVLDAEQRVTAGEALA  300 (346)
T ss_dssp             HHHHSCCCCCCCGG-GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             hhccCCcccccchH-HhccCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence             0000000000000 011123345789999999999999999999986

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=5.6e-37  Score=317.72  Aligned_cols=249  Identities=17%  Similarity=0.280  Sum_probs=183.7

Q ss_pred             CCCcCCccc----eEEEEEEE--CCceEEEEEecc----chHHHHHHHhhcC-CCceeeeeeeeec--CCeEEEEEEecC
Q 039626          352 NFSFTCRIQ----GSVYRGKI--NGGFAAIKKVNG----DVSKEIALLNKIN-HSNLIILSGVCFN--EGNCYLVYEYAV  418 (628)
Q Consensus       352 ~f~~~~~i~----G~Vy~g~~--~g~~vavK~~~~----~~~~E~~~l~~l~-H~nIv~l~g~~~~--~~~~~lV~E~~~  418 (628)
                      +|.....+|    |.||+|+.  +|+.||||+++.    ++.+|+++|++++ ||||+++++++..  ....++||||+.
T Consensus        36 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~~  115 (328)
T d3bqca1          36 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVN  115 (328)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEECCC
T ss_pred             CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHHHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEeecC
Confidence            455545554    89999998  688999999874    4678999999995 9999999999974  356899999999


Q ss_pred             CCChHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCC-cEEEccccccccCCCCCC
Q 039626          419 NGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDL-RAKIANFAMARPAEGQEG  497 (628)
Q Consensus       419 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~-~~kl~Dfgla~~~~~~~~  497 (628)
                      +|+|.++.       +.+++..+..++.||+.||+|||+.+   |+||||||+|||++.++ .+||+|||+++...... 
T Consensus       116 ~~~L~~~~-------~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~-  184 (328)
T d3bqca1         116 NTDFKQLY-------QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ-  184 (328)
T ss_dssp             SCBGGGTT-------TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECCTTC-
T ss_pred             CCcHHHHh-------cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceeccCCC-
Confidence            99997654       24899999999999999999999954   99999999999998654 69999999998765432 


Q ss_pred             cceeeecccCCccccCccccccC-CCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccc---------
Q 039626          498 EFALTRHIVGTKGYMAPEYLENG-LVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKE---------  567 (628)
Q Consensus       498 ~~~~~~~~~gt~~Y~APE~l~~~-~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~---------  567 (628)
                         ......+|+.|+|||.+.+. .++.++||||+||+++||++|+.|+........  ....+...+...         
T Consensus       185 ---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~--~~~~i~~~~g~~~~~~~~~~~  259 (328)
T d3bqca1         185 ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD--QLVRIAKVLGTEDLYDYIDKY  259 (328)
T ss_dssp             ---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHH--HHHHHHHHHCHHHHHHHHHHT
T ss_pred             ---cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHH--HHHHHHHHHCCchhhhhhhhc
Confidence               12345789999999998765 579999999999999999999999864332111  111111111000         


Q ss_pred             --cchhhhccccC--------CcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          568 --DGEESLRHFID--------PTLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       568 --~~~~~l~~~~d--------~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                        ...........        ...........+.++.+|+++||+.||++|||++|+++
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~  318 (328)
T d3bqca1         260 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  318 (328)
T ss_dssp             TCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence              00000000000        00111112234456789999999999999999999874

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-37  Score=317.01  Aligned_cols=238  Identities=25%  Similarity=0.381  Sum_probs=185.2

Q ss_pred             CCcCCccc----eEEEEEEE-----CCceEEEEEecc-----------chHHHHHHHhhcCC-CceeeeeeeeecCCeEE
Q 039626          353 FSFTCRIQ----GSVYRGKI-----NGGFAAIKKVNG-----------DVSKEIALLNKINH-SNLIILSGVCFNEGNCY  411 (628)
Q Consensus       353 f~~~~~i~----G~Vy~g~~-----~g~~vavK~~~~-----------~~~~E~~~l~~l~H-~nIv~l~g~~~~~~~~~  411 (628)
                      |.....||    |.||+++.     +|+.||||.++.           .+.+|+++|++++| |||+++++++.+....+
T Consensus        26 y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~~  105 (322)
T d1vzoa_          26 FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLH  105 (322)
T ss_dssp             EEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEE
T ss_pred             eEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCcee
Confidence            44444443    89999976     467899998753           35689999999976 79999999999999999


Q ss_pred             EEEEecCCCChHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEcccccccc
Q 039626          412 LVYEYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARP  491 (628)
Q Consensus       412 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~  491 (628)
                      ++|||+.+|+|.+++...    ..++......++.|++.||+|||+.   +++||||||+|||++.++.+||+|||+++.
T Consensus       106 ~v~e~~~~~~L~~~i~~~----~~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~a~~  178 (322)
T d1vzoa_         106 LILDYINGGELFTHLSQR----ERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKE  178 (322)
T ss_dssp             EEECCCCSCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred             eeeecccccHHHHHHHhc----ccccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeeccchhh
Confidence            999999999999999653    3467888899999999999999994   499999999999999999999999999987


Q ss_pred             CCCCCCcceeeecccCCccccCccccccC--CCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccc
Q 039626          492 AEGQEGEFALTRHIVGTKGYMAPEYLENG--LVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDG  569 (628)
Q Consensus       492 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~--~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~  569 (628)
                      ......  .......|++.|+|||.+.+.  .++.++|||||||+||||++|+.||.......  ............   
T Consensus       179 ~~~~~~--~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~--~~~~i~~~~~~~---  251 (322)
T d1vzoa_         179 FVADET--ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN--SQAEISRRILKS---  251 (322)
T ss_dssp             CCGGGG--GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCC--CHHHHHHHHHHC---
T ss_pred             hccccc--ccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHhcccC---
Confidence            643322  123446799999999998754  47889999999999999999999987543322  122222221111   


Q ss_pred             hhhhccccCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 039626          570 EESLRHFIDPTLQGNYPLELALLVIRLIDACLKKDPTDRPT-----MYEIEH  616 (628)
Q Consensus       570 ~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~ev~~  616 (628)
                              .    ..++...+..+.+|+.+||+.||++|||     ++|+++
T Consensus       252 --------~----~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~  291 (322)
T d1vzoa_         252 --------E----PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE  291 (322)
T ss_dssp             --------C----CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred             --------C----CCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence                    0    1223344567889999999999999995     677764

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-36  Score=315.07  Aligned_cols=240  Identities=23%  Similarity=0.259  Sum_probs=172.4

Q ss_pred             eEEEEEEE--CCceEEEEEecc---------chHHHHHHHhhcCCCceeeeeeeeec------CCeEEEEEEecCCCChH
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG---------DVSKEIALLNKINHSNLIILSGVCFN------EGNCYLVYEYAVNGTLS  423 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~---------~~~~E~~~l~~l~H~nIv~l~g~~~~------~~~~~lV~E~~~~gsL~  423 (628)
                      |+||+|..  +|+.||||+++.         .+.+|+.+|++++|||||++++++..      ....|+||||+.++.+ 
T Consensus        31 g~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~~iv~Ey~~~~l~-  109 (355)
T d2b1pa1          31 GIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLC-  109 (355)
T ss_dssp             CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEECCSEEHH-
T ss_pred             eEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCceeEEEEeccchHHH-
Confidence            89999998  589999999863         35689999999999999999999964      3678999999966544 


Q ss_pred             HHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeee
Q 039626          424 DWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTR  503 (628)
Q Consensus       424 ~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~  503 (628)
                      +.+.      ..+++..+..++.||+.||+|||+.   +|+||||||+|||++.++..|++|||+++......    ...
T Consensus       110 ~~~~------~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~~----~~~  176 (355)
T d2b1pa1         110 QVIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF----MMT  176 (355)
T ss_dssp             HHHT------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC---------------
T ss_pred             Hhhh------cCCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechhhhhcccccc----ccc
Confidence            4442      2489999999999999999999995   49999999999999999999999999988664322    234


Q ss_pred             cccCCccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHh------------------c
Q 039626          504 HIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVL------------------T  565 (628)
Q Consensus       504 ~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~------------------~  565 (628)
                      ...+|+.|+|||.+.+..+++++||||+||+++||++|+.||.......  ..........                  .
T Consensus       177 ~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~--~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  254 (355)
T d2b1pa1         177 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID--QWNKVIEQLGTPCPEFMKKLQPTVRNYVE  254 (355)
T ss_dssp             ----CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHHHCCCCHHHHTTSCHHHHHHHH
T ss_pred             cccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHH--HHHHHHHhccCCCHHHHHHhhhhHHHHhh
Confidence            4579999999999999999999999999999999999999986432211  1111111110                  0


Q ss_pred             ccc--chhhhccccCCc-CC--CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          566 KED--GEESLRHFIDPT-LQ--GNYPLELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       566 ~~~--~~~~l~~~~d~~-l~--~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      ...  ............ ..  .......+..+.+|+++||+.||++|||++|+++
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~  310 (355)
T d2b1pa1         255 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ  310 (355)
T ss_dssp             TSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             cCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            000  000000000000 01  1112345667899999999999999999999974

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-36  Score=315.40  Aligned_cols=239  Identities=24%  Similarity=0.319  Sum_probs=174.7

Q ss_pred             eEEEEEEE--CCceEEEEEecc---------chHHHHHHHhhcCCCceeeeeeeeecC-----CeEEEEEEecCCCChHH
Q 039626          361 GSVYRGKI--NGGFAAIKKVNG---------DVSKEIALLNKINHSNLIILSGVCFNE-----GNCYLVYEYAVNGTLSD  424 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~---------~~~~E~~~l~~l~H~nIv~l~g~~~~~-----~~~~lV~E~~~~gsL~~  424 (628)
                      |+||+|+.  +|+.||||+++.         .+.+|+++|++++|+|||++++++...     ...++++||+.+|+|.+
T Consensus        32 g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~~i~~~~~gg~L~~  111 (348)
T d2gfsa1          32 GSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNN  111 (348)
T ss_dssp             SSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCCEEEEECCSEEHHH
T ss_pred             eEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceEEEEEeecCCchhh
Confidence            89999987  689999999863         356899999999999999999998633     34567778888999999


Q ss_pred             HhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCCCCCcceeeec
Q 039626          425 WVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEGQEGEFALTRH  504 (628)
Q Consensus       425 ~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~  504 (628)
                      ++..     +.+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+|++|||++......      ...
T Consensus       112 ~~~~-----~~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~~------~~~  177 (348)
T d2gfsa1         112 IVKC-----QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE------MTG  177 (348)
T ss_dssp             HHTT-----CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC----CCTGG------GSS
T ss_pred             hccc-----ccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccchhcccCcc------ccc
Confidence            9842     3599999999999999999999995   4999999999999999999999999999765432      234


Q ss_pred             ccCCccccCccccccC-CCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHHHHhccccc-------hhhhccc
Q 039626          505 IVGTKGYMAPEYLENG-LVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLNAVLTKEDG-------EESLRHF  576 (628)
Q Consensus       505 ~~gt~~Y~APE~l~~~-~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~l~~~  576 (628)
                      ..||+.|+|||.+.+. .++.++|||||||+++||++|+.||.......   ....+.........       .......
T Consensus       178 ~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~---~~~~i~~~~~~~~~~~~~~~~~~~~~~~  254 (348)
T d2gfsa1         178 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID---QLKLILRLVGTPGAELLKKISSESARNY  254 (348)
T ss_dssp             SCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCCCCHHHHTTCCCHHHHHH
T ss_pred             ccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHH---HHHHHHHhcCCCChHHhhhccchhhhhh
Confidence            5789999999987665 56899999999999999999999986433211   11111111111000       0000000


Q ss_pred             cCCcC-CCCCC-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          577 IDPTL-QGNYP-----LELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       577 ~d~~l-~~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                      ..... ....+     ......+.+|+.+||+.||.+|||++|+++
T Consensus       255 ~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~  300 (348)
T d2gfsa1         255 IQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  300 (348)
T ss_dssp             HTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence            00000 00000     122345789999999999999999999975

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.97  E-value=7.7e-32  Score=282.51  Aligned_cols=247  Identities=23%  Similarity=0.277  Sum_probs=175.5

Q ss_pred             eEEEEEEE--CCceEEEEEeccc------hHHHHHHHhhcC-----------CCceeeeeeeeecC--CeEEEEEEecCC
Q 039626          361 GSVYRGKI--NGGFAAIKKVNGD------VSKEIALLNKIN-----------HSNLIILSGVCFNE--GNCYLVYEYAVN  419 (628)
Q Consensus       361 G~Vy~g~~--~g~~vavK~~~~~------~~~E~~~l~~l~-----------H~nIv~l~g~~~~~--~~~~lV~E~~~~  419 (628)
                      |.||+|+.  +|+.||||+++.+      +.+|++++++++           |+||+++++++...  ...++++++...
T Consensus        27 g~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~~~~~~~  106 (362)
T d1q8ya_          27 STVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL  106 (362)
T ss_dssp             EEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTEEEEEEEECCC
T ss_pred             eEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeeccccceeeeeeeccc
Confidence            89999997  6899999998753      467999998885           57899999998643  456777777766


Q ss_pred             CChHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCC------cEEEccccccccCC
Q 039626          420 GTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDL------RAKIANFAMARPAE  493 (628)
Q Consensus       420 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~------~~kl~Dfgla~~~~  493 (628)
                      +........ ......+++..+..++.||+.||+|||+.  .+|+||||||+|||++.++      .+|++|||.+....
T Consensus       107 ~~~~~~~~~-~~~~~~~~~~~i~~i~~qil~al~~lh~~--~~IvHrDlKp~NIll~~~~~~~~~~~~kl~dfg~s~~~~  183 (362)
T d1q8ya_         107 GENLLALIK-KYEHRGIPLIYVKQISKQLLLGLDYMHRR--CGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYD  183 (362)
T ss_dssp             CEEHHHHHH-HTTTSCCCHHHHHHHHHHHHHHHHHHHHT--TCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETT
T ss_pred             ccccccccc-cccccCCcHHHHHHHHHHHHHHHHHHhhh--cCcccccCChhHeeeeccCcccccceeeEeecccccccc
Confidence            544333322 23455688999999999999999999972  4599999999999998665      39999999998654


Q ss_pred             CCCCcceeeecccCCccccCccccccCCCCcccccHHHHHHHHHHHhCCCccccccccccccHHHHHH---HHhccccch
Q 039626          494 GQEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLILEMLTGKEAAALHAEENNMHLSDVLN---AVLTKEDGE  570 (628)
Q Consensus       494 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~ELltG~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~  570 (628)
                      ..      .....||+.|+|||.+.+..++.++||||+||+++||++|+.||............+...   ..+......
T Consensus       184 ~~------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~~lg~~~~~  257 (362)
T d1q8ya_         184 EH------YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSY  257 (362)
T ss_dssp             BC------CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHH
T ss_pred             cc------cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHHHHhCCCCHH
Confidence            32      234579999999999999999999999999999999999999987543322111111111   111110000


Q ss_pred             -----hhhccccC---------C----------cCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 039626          571 -----ESLRHFID---------P----------TLQGNYPLELALLVIRLIDACLKKDPTDRPTMYEIEH  616 (628)
Q Consensus       571 -----~~l~~~~d---------~----------~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev~~  616 (628)
                           .......+         .          ......+...+..+.+|+.+||+.||.+|||++|+++
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~  327 (362)
T d1q8ya_         258 LLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVN  327 (362)
T ss_dssp             HHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHT
T ss_pred             HhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence                 00000000         0          0112345677888999999999999999999999875

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.75  E-value=3.1e-19  Score=168.49  Aligned_cols=151  Identities=15%  Similarity=0.075  Sum_probs=106.4

Q ss_pred             eEEEEEEE-CCceEEEEEecc-------------------------chHHHHHHHhhcCCCceeeeeeeeecCCeEEEEE
Q 039626          361 GSVYRGKI-NGGFAAIKKVNG-------------------------DVSKEIALLNKINHSNLIILSGVCFNEGNCYLVY  414 (628)
Q Consensus       361 G~Vy~g~~-~g~~vavK~~~~-------------------------~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~  414 (628)
                      |.||+|.. +|+.||||..+.                         ...+|...+.+++|.+++..+++..    .+++|
T Consensus        14 g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~~----~~lvm   89 (191)
T d1zara2          14 SAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWEG----NAVLM   89 (191)
T ss_dssp             EEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEET----TEEEE
T ss_pred             eEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEecC----CEEEE
Confidence            89999997 788999997642                         1235888999999999998876632    37999


Q ss_pred             EecCCCChHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEccccccccCCC
Q 039626          415 EYAVNGTLSDWVFSNKNEGKYLDWKQRIQIALDVATGLNYLHSFTNPPHVHKDINSSNVLLDSDLRAKIANFAMARPAEG  494 (628)
Q Consensus       415 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~~~~~  494 (628)
                      ||++++.+.+           +++....+++.|++.+|+|||+.+   |+||||||+|||++++ .++|+|||+|+....
T Consensus        90 e~~~~~~~~~-----------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~-~~~liDFG~a~~~~~  154 (191)
T d1zara2          90 ELIDAKELYR-----------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE-GIWIIDFPQSVEVGE  154 (191)
T ss_dssp             ECCCCEEGGG-----------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT-EEEECCCTTCEETTS
T ss_pred             Eeeccccccc-----------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCC-CEEEEECCCcccCCC
Confidence            9998765533           233345678999999999999954   9999999999999975 489999999976543


Q ss_pred             CCCcceeeecccCCccccCccccccCCCCcccccHHHHHHHH
Q 039626          495 QEGEFALTRHIVGTKGYMAPEYLENGLVSTKLDVYAFGVLIL  536 (628)
Q Consensus       495 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~k~DV~SfGvvl~  536 (628)
                      ........+.....     .|.+ ...++.++|+||..--++
T Consensus       155 ~~~~~~l~rd~~~~-----~~~f-~r~y~~~~d~~s~~~~~~  190 (191)
T d1zara2         155 EGWREILERDVRNI-----ITYF-SRTYRTEKDINSAIDRIL  190 (191)
T ss_dssp             TTHHHHHHHHHHHH-----HHHH-HHHHCCCCCHHHHHHHHH
T ss_pred             CCcHHHHHHHHHHH-----HHHH-cCCCCCcccHHHHHHHHh
Confidence            22110000000000     0111 245678899999765444

>d1y7ma2 d.7.1.1 (A:1-48) Hypothetical protein YkuD, N-terminal domain {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: LysM domain
superfamily: LysM domain
family: LysM domain
domain: Hypothetical protein YkuD, N-terminal domain
species: Bacillus subtilis [TaxId: 1423]

Probab=99.36  E-value=1.3e-13  Score=97.10  Aligned_cols=47  Identities=32%  Similarity=0.540  Sum_probs=44.3

Q ss_pred             EEEEEccCCCcHHHHHHHhCCChHHHhhhcCCCCCCccccceeeccC
Q 039626          184 LLSYLVAEGDTVSGISSRFGVDTGEILQANSLSGSNIFPFTTLLIPL  230 (628)
Q Consensus       184 ~~~y~v~~gdtl~~ia~~f~~~~~~l~~~N~~~~~~~~~~~~l~iP~  230 (628)
                      .++|+|++|||||+||++||+++++|+++|++.++.|++||.|.||.
T Consensus         1 ~i~y~V~~GDTL~~IA~~y~v~~~~i~~~N~~~~~~l~~Gq~L~IPg   47 (48)
T d1y7ma2           1 MLTYQVKQGDTLNSIAADFRISTAALLQANPSLQAGLTAGQSIVIPG   47 (48)
T ss_dssp             CEEEECCTTCCHHHHHHHTTSCCCCCCCTSCTTCSSCCTTCEEEETT
T ss_pred             CEEEEECCCCCHHHHHHHhCCCHHHHHHHcCCCCCCCCCCCEEEeCC
Confidence            36899999999999999999999999999999877999999999984

>d1e0ga_ d.7.1.1 (A:) Membrane-bound lytic murein transclycosylase D, MltD {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: LysM domain
superfamily: LysM domain
family: LysM domain
domain: Membrane-bound lytic murein transclycosylase D, MltD
species: Escherichia coli [TaxId: 562]

Probab=99.35  E-value=2.6e-13  Score=95.12  Aligned_cols=46  Identities=30%  Similarity=0.530  Sum_probs=43.0

Q ss_pred             EEEEccCCCcHHHHHHHhCCChHHHhhhcCCCCCCccccceeeccCC
Q 039626          185 LSYLVAEGDTVSGISSRFGVDTGEILQANSLSGSNIFPFTTLLIPLE  231 (628)
Q Consensus       185 ~~y~v~~gdtl~~ia~~f~~~~~~l~~~N~~~~~~~~~~~~l~iP~~  231 (628)
                      ++|+|++|||||+||++||+++++|+++|++.+ .|+|||+|.||++
T Consensus         3 v~y~V~~GDTl~~IA~~y~vs~~~i~~~N~l~~-~l~~Gq~L~i~vk   48 (48)
T d1e0ga_           3 ITYRVRKGDSLSSIAKRHGVNIKDVMRWNSDTA-NLQPGDKLTLFVK   48 (48)
T ss_dssp             CEEEECTTCCHHHHHHHHTCCHHHHHHHCSCGG-GCCTTEEEECCCC
T ss_pred             EEEEECCCCCHHHHHHHHCCCHHHHHHHcCCcc-cCcCCCEEEEEeC
Confidence            589999999999999999999999999999864 7999999999975

>d1e0ga_ d.7.1.1 (A:) Membrane-bound lytic murein transclycosylase D, MltD {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: LysM domain
superfamily: LysM domain
family: LysM domain
domain: Membrane-bound lytic murein transclycosylase D, MltD
species: Escherichia coli [TaxId: 562]

Probab=99.10  E-value=2.6e-11  Score=84.74  Aligned_cols=46  Identities=24%  Similarity=0.302  Sum_probs=41.4

Q ss_pred             eeEEEecCChHHHHHhhhcCCCccHHHHHhccCCCCccCCCcEEEEeec
Q 039626          120 TTYTIQNGDTYLFIANNTFQGLSTCQALEDQNGSPTNLIIGAGVTVPLR  168 (628)
Q Consensus       120 ~~y~V~~gdt~~~IA~~~~~~l~t~~~l~~~N~~~~~l~~Gq~l~vp~~  168 (628)
                      .+|+|++|||+|.||++|+.   ++++|+++|++.+.|++||+|.||++
T Consensus         3 v~y~V~~GDTl~~IA~~y~v---s~~~i~~~N~l~~~l~~Gq~L~i~vk   48 (48)
T d1e0ga_           3 ITYRVRKGDSLSSIAKRHGV---NIKDVMRWNSDTANLQPGDKLTLFVK   48 (48)
T ss_dssp             CEEEECTTCCHHHHHHHHTC---CHHHHHHHCSCGGGCCTTEEEECCCC
T ss_pred             EEEEECCCCCHHHHHHHHCC---CHHHHHHHcCCcccCcCCCEEEEEeC
Confidence            47999999999999998875   88999999987767999999999963

>d1y7ma2 d.7.1.1 (A:1-48) Hypothetical protein YkuD, N-terminal domain {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: LysM domain
superfamily: LysM domain
family: LysM domain
domain: Hypothetical protein YkuD, N-terminal domain
species: Bacillus subtilis [TaxId: 1423]

Probab=99.01  E-value=3.5e-11  Score=84.44  Aligned_cols=45  Identities=31%  Similarity=0.374  Sum_probs=40.4

Q ss_pred             eeEEEecCChHHHHHhhhcCCCccHHHHHhccCCC-CccCCCcEEEEee
Q 039626          120 TTYTIQNGDTYLFIANNTFQGLSTCQALEDQNGSP-TNLIIGAGVTVPL  167 (628)
Q Consensus       120 ~~y~V~~gdt~~~IA~~~~~~l~t~~~l~~~N~~~-~~l~~Gq~l~vp~  167 (628)
                      .+|+||+|||+|.||++|+.   ++++|+++|++. +.|++||+|.||.
T Consensus         2 i~y~V~~GDTL~~IA~~y~v---~~~~i~~~N~~~~~~l~~Gq~L~IPg   47 (48)
T d1y7ma2           2 LTYQVKQGDTLNSIAADFRI---STAALLQANPSLQAGLTAGQSIVIPG   47 (48)
T ss_dssp             EEEECCTTCCHHHHHHHTTS---CCCCCCCTSCTTCSSCCTTCEEEETT
T ss_pred             EEEEECCCCCHHHHHHHhCC---CHHHHHHHcCCCCCCCCCCCEEEeCC
Confidence            47999999999999999876   667799999988 8899999999983

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.26  E-value=3.3e-06  Score=81.39  Aligned_cols=121  Identities=15%  Similarity=0.107  Sum_probs=85.9

Q ss_pred             eEEEEEEECCceEEEEEecc-------chHHHHHHHhhcC-CCceeeeeeeeecCCeEEEEEEecCCCChHHHhhhcCCC
Q 039626          361 GSVYRGKINGGFAAIKKVNG-------DVSKEIALLNKIN-HSNLIILSGVCFNEGNCYLVYEYAVNGTLSDWVFSNKNE  432 (628)
Q Consensus       361 G~Vy~g~~~g~~vavK~~~~-------~~~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~  432 (628)
                      ..||+...+++.+.+|+...       ++..|...+..+. +--+.+++.++.+++..++||++++|..+.+.....   
T Consensus        28 ~~v~rv~~~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~~~~---  104 (263)
T d1j7la_          28 AKVYKLVGENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYEDE---  104 (263)
T ss_dssp             SEEEEEECSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHTTTC---
T ss_pred             CcEEEEEeCCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEeccccccccccccc---
Confidence            47999988888899998864       3678998888774 333567788888888999999999998876543110   


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhcCC-----------------------------------------------------
Q 039626          433 GKYLDWKQRIQIALDVATGLNYLHSFT-----------------------------------------------------  459 (628)
Q Consensus       433 ~~~l~~~~~~~i~~~ia~gL~yLH~~~-----------------------------------------------------  459 (628)
                            .....++.++++.+..||+..                                                     
T Consensus       105 ------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  178 (263)
T d1j7la_         105 ------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEK  178 (263)
T ss_dssp             ------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHHHHSC
T ss_pred             ------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHHHHHhcC
Confidence                  112223444555555555311                                                     


Q ss_pred             ---CCCeEecCCCCCCEEeCCCCcEEEccccccc
Q 039626          460 ---NPPHVHKDINSSNVLLDSDLRAKIANFAMAR  490 (628)
Q Consensus       460 ---~~~iiH~dik~~NILl~~~~~~kl~Dfgla~  490 (628)
                         ...++|+|+.+.|||++++...-|.||+.+.
T Consensus       179 ~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T d1j7la_         179 PEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             CCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             CcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence               1227899999999999987777799998765

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.55  E-value=0.00011  Score=69.96  Aligned_cols=130  Identities=16%  Similarity=0.122  Sum_probs=78.8

Q ss_pred             eEEEEEEECC-ceEEEEEecc----chHHHHHHHhhcCCCc--eeeeeeeeecCCeEEEEEEecCCCChHHH--------
Q 039626          361 GSVYRGKING-GFAAIKKVNG----DVSKEIALLNKINHSN--LIILSGVCFNEGNCYLVYEYAVNGTLSDW--------  425 (628)
Q Consensus       361 G~Vy~g~~~g-~~vavK~~~~----~~~~E~~~l~~l~H~n--Iv~l~g~~~~~~~~~lV~E~~~~gsL~~~--------  425 (628)
                      ..||+...++ ..+.+|....    ++..|...|+.+....  +.++++++.+++..++||||++|.++.+.        
T Consensus        25 ~~v~r~~~~~~~~~vlK~~~~~~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~~~~~~~~~~~  104 (255)
T d1nd4a_          25 AAVFRLSAQGRPVLFVKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLLSSHLAPAEKV  104 (255)
T ss_dssp             CEEEEEECTTSCCEEEEEECSCTTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETTTSCCCHHHHH
T ss_pred             CeEEEEEeCCCCEEEEEeCCccCHhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccccccccccHHHHH
Confidence            5789988854 4577787653    5778999998885433  45678888888889999999988665331        


Q ss_pred             ------h---hhcCCCCCC--CCHHHHHHHH--------------------HHHHHHHHHHhcC----CCCCeEecCCCC
Q 039626          426 ------V---FSNKNEGKY--LDWKQRIQIA--------------------LDVATGLNYLHSF----TNPPHVHKDINS  470 (628)
Q Consensus       426 ------l---~~~~~~~~~--l~~~~~~~i~--------------------~~ia~gL~yLH~~----~~~~iiH~dik~  470 (628)
                            +   |........  -.+.....-.                    ......+..+...    ..+.++|+|+.|
T Consensus       105 ~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~liHgD~~~  184 (255)
T d1nd4a_         105 SIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACL  184 (255)
T ss_dssp             HHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCG
T ss_pred             HHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHHhCCccCCceEEeCCCCC
Confidence                  0   100000000  0111111000                    0011222333221    112379999999


Q ss_pred             CCEEeCCCCcEEEccccccc
Q 039626          471 SNVLLDSDLRAKIANFAMAR  490 (628)
Q Consensus       471 ~NILl~~~~~~kl~Dfgla~  490 (628)
                      .|||++++..+-|.||+.+.
T Consensus       185 ~Nvl~~~~~~~~iID~~~~~  204 (255)
T d1nd4a_         185 PNIMVENGRFSGFIDCGRLG  204 (255)
T ss_dssp             GGEEEETTEEEEECCCTTCE
T ss_pred             cceEEeCCceEEEEEchhcc
Confidence            99999988777899998764

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=96.02  E-value=0.016  Score=58.29  Aligned_cols=30  Identities=13%  Similarity=0.242  Sum_probs=25.6

Q ss_pred             CCeEecCCCCCCEEeCCCCcEEEcccccccc
Q 039626          461 PPHVHKDINSSNVLLDSDLRAKIANFAMARP  491 (628)
Q Consensus       461 ~~iiH~dik~~NILl~~~~~~kl~Dfgla~~  491 (628)
                      ..++|+|+.+.|||++++. ++|.||-.+..
T Consensus       223 ~~LiHGDl~~gNIlv~~~~-~~vID~E~a~~  252 (392)
T d2pula1         223 ETLIHGDLHTGSIFASEHE-TKVIDPEFAFY  252 (392)
T ss_dssp             CEEECSCCCGGGEEECSSC-EEECCCTTCEE
T ss_pred             cceeccCCcCCceeEcCCc-eEEechhhccc
Confidence            3589999999999998765 89999987754

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=95.58  E-value=0.02  Score=55.85  Aligned_cols=60  Identities=10%  Similarity=0.082  Sum_probs=40.3

Q ss_pred             eEEEEEEE-CCceEEEEEecc------chHHHHHHHhhcCCCce--eeeee-----eeecCCeEEEEEEecCCC
Q 039626          361 GSVYRGKI-NGGFAAIKKVNG------DVSKEIALLNKINHSNL--IILSG-----VCFNEGNCYLVYEYAVNG  420 (628)
Q Consensus       361 G~Vy~g~~-~g~~vavK~~~~------~~~~E~~~l~~l~H~nI--v~l~g-----~~~~~~~~~lV~E~~~~g  420 (628)
                      ..||+... +|..+++|..+.      ++..|...+..|...++  +..+.     ....++..+.+++|++|.
T Consensus        36 N~vy~v~~~dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~  109 (325)
T d1zyla1          36 NRVYQFQDEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR  109 (325)
T ss_dssp             SEEEEECCTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred             ceeEEEEcCCCCEEEEEEeCCCCCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence            47999998 677899998753      36778888888753332  11111     112345678999999764

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=95.05  E-value=0.044  Score=52.88  Aligned_cols=150  Identities=11%  Similarity=-0.015  Sum_probs=81.8

Q ss_pred             ecHHHHHHHhcCCCcCCcc------c---eEEEEEEECCceEEEEEecc-----chHHHHHHHhhcCCCcee--eeee--
Q 039626          341 YSFKELQSATDNFSFTCRI------Q---GSVYRGKINGGFAAIKKVNG-----DVSKEIALLNKINHSNLI--ILSG--  402 (628)
Q Consensus       341 ~~~~el~~at~~f~~~~~i------~---G~Vy~g~~~g~~vavK~~~~-----~~~~E~~~l~~l~H~nIv--~l~g--  402 (628)
                      .+.+|++.....|..+...      +   .+.|+.+.+++..++|....     ++..|++++..|++.++.  ..+-  
T Consensus         3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~yVLri~~~~~~~~~l~~~~~~l~~L~~~g~pvp~pi~~~   82 (316)
T d2ppqa1           3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDPLILTLYEKRVEKNDLPFFLGLMQHLAAKGLSCPLPLPRK   82 (316)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCCEEEEEECC---CCHHHHHHHHHHHHHHTTCCCCCBCCBT
T ss_pred             CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCcEEEEEcCCCCCHHHHHHHHHHHHhhhhccccccccceec
Confidence            4556777777777643222      1   35799888888899998753     345688888887543332  1111  


Q ss_pred             ----eeecCCeEEEEEEecCCCChHHH--------------hhhcCC------CCCCCCH-H----------------HH
Q 039626          403 ----VCFNEGNCYLVYEYAVNGTLSDW--------------VFSNKN------EGKYLDW-K----------------QR  441 (628)
Q Consensus       403 ----~~~~~~~~~lV~E~~~~gsL~~~--------------l~~~~~------~~~~l~~-~----------------~~  441 (628)
                          +....+....++.++.+......              ++....      ......+ .                ..
T Consensus        83 ~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (316)
T d2ppqa1          83 DGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGL  162 (316)
T ss_dssp             TCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTH
T ss_pred             CCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhH
Confidence                11123456677777766433210              110000      0000111 0                11


Q ss_pred             HHHHHHHHHHHHHHhc-CCCCCeEecCCCCCCEEeCCCCcEEEccccccc
Q 039626          442 IQIALDVATGLNYLHS-FTNPPHVHKDINSSNVLLDSDLRAKIANFAMAR  490 (628)
Q Consensus       442 ~~i~~~ia~gL~yLH~-~~~~~iiH~dik~~NILl~~~~~~kl~Dfgla~  490 (628)
                      ...+......+.-.+. .-..++||+|+.+.||+++.+...-|.||+.+.
T Consensus       163 ~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         163 REEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             HHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence            1122222222332222 112458999999999999998878899999874

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=93.77  E-value=0.059  Score=53.92  Aligned_cols=58  Identities=12%  Similarity=0.151  Sum_probs=38.2

Q ss_pred             eEEEEEEECC---------ceEEEEEecc-----chHHHHHHHhhcCCCcee-eeeeeeecCCeEEEEEEecCCCCh
Q 039626          361 GSVYRGKING---------GFAAIKKVNG-----DVSKEIALLNKINHSNLI-ILSGVCFNEGNCYLVYEYAVNGTL  422 (628)
Q Consensus       361 G~Vy~g~~~g---------~~vavK~~~~-----~~~~E~~~l~~l~H~nIv-~l~g~~~~~~~~~lV~E~~~~gsL  422 (628)
                      -.+|+.....         +.+.++..-.     +..+|..+++.+.-.+++ ++++++.+    .+|+||++|..|
T Consensus        56 N~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~efi~g~~l  128 (395)
T d1nw1a_          56 NMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEYIPSRPL  128 (395)
T ss_dssp             EEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECCCCEEEC
T ss_pred             cceEEEEeCCCCccccCCCCcEEEEecCCcchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEEEeccccC
Confidence            4799988632         3455554321     356799998888544554 77777643    589999987544